PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Innes-Brown, H; Barutchu, A; Crewther, DP				Innes-Brown, Hamish; Barutchu, Ayla; Crewther, David P.			Neural Responses in Parietal and Occipital Areas in Response to Visual Events Are Modulated by Prior Multisensory Stimuli	PLOS ONE			English	Article							ELECTROMAGNETIC TOMOGRAPHY; MULTIMODAL INTEGRATION; HUMAN V1; SOUND; CORTEX; BRAIN; REPRESENTATION; PROJECTION; PRIMATE; HUMANS	The effect of multi-modal vs uni-modal prior stimuli on the subsequent processing of a simple flash stimulus was studied in the context of the audio-visual 'flash-beep' illusion, in which the number of flashes a person sees is influenced by accompanying beep stimuli. EEG recordings were made while combinations of simple visual and audio-visual stimuli were presented. The experiments found that the electric field strength related to a flash stimulus was stronger when it was preceded by a multi-modal flash/beep stimulus, compared to when it was preceded by another uni-modal flash stimulus. This difference was found to be significant in two distinct timeframes - an early timeframe, from 130-160 ms, and a late timeframe, from 300-320 ms. Source localisation analysis found that the increased activity in the early interval was localised to an area centred on the inferior and superior parietal lobes, whereas the later increase was associated with stronger activity in an area centred on primary and secondary visual cortex, in the occipital lobe. The results suggest that processing of a visual stimulus can be affected by the presence of an immediately prior multisensory event. Relatively long-lasting interactions generated by the initial auditory and visual stimuli altered the processing of a subsequent visual stimulus.	[Innes-Brown, Hamish] Bion Inst, Melbourne, Vic, Australia; [Innes-Brown, Hamish] Swinburne Univ Technol, Melbourne, Vic, Australia; [Barutchu, Ayla] Deakin Univ, Melbourne, Vic, Australia; [Barutchu, Ayla] Florey Inst Neurosci & Mental Hlth Melbourne, Melbourne, Vic, Australia; [Crewther, David P.] Swinburne Univ Technol, Ctr Human Psychopharmacol, Melbourne, Vic, Australia	Bionics Institute; Swinburne University of Technology; Deakin University; Florey Institute of Neuroscience & Mental Health; Swinburne University of Technology	Innes-Brown, H (corresponding author), Bion Inst, Melbourne, Vic, Australia.	hinnes-brown@bionicsinstitute.org	Innes-Brown, Hamish/H-3298-2019; Crewther, Sheila G/A-2165-2008	Innes-Brown, Hamish/0000-0002-1512-2823; 	Victorian Government; Swinburne University Postgraduate Award	Victorian Government; Swinburne University Postgraduate Award	The Bionics Institute acknowledges the support it receives from the Victorian Government through its Operational Infrastructure Support Program. HIB was supported by a Swinburne University Postgraduate Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarado JC, 2007, J NEUROSCI, V27, P12775, DOI 10.1523/JNEUROSCI.3524-07.2007; Andersen RA, 1997, PHILOS T ROY SOC B, V352, P1421, DOI 10.1098/rstb.1997.0128; BELL AJ, 1995, NEURAL COMPUT, V7, P1129, DOI 10.1162/neco.1995.7.6.1129; Benjamini Y, 2001, ANN STAT, V29, P1165; Bhattacharya J, 2002, NEUROREPORT, V13, P1727, DOI 10.1097/00001756-200210070-00007; Bolognini N, 2011, NEUROPSYCHOLOGIA, V49, P231, DOI 10.1016/j.neuropsychologia.2010.11.015; Butler JS, 2012, J NEUROSCI, V32, P15338, DOI 10.1523/JNEUROSCI.1796-12.2012; Calvert GA, 2001, NEUROIMAGE, V14, P427, DOI 10.1006/nimg.2001.0812; Calvert GA, 2001, CEREB CORTEX, V11, P1110, DOI 10.1093/cercor/11.12.1110; Cappe C, 2009, HEARING RES, V258, P28, DOI 10.1016/j.heares.2009.04.017; Cappe C, 2010, J NEUROSCI, V30, P12572, DOI 10.1523/JNEUROSCI.1099-10.2010; Cappe C, 2009, CEREB CORTEX, V19, P2025, DOI 10.1093/cercor/bhn228; Chen YC, 2009, EXP BRAIN RES, V198, P209, DOI 10.1007/s00221-009-1831-4; Clavagnier S, 2004, COGN AFFECT BEHAV NE, V4, P117, DOI 10.3758/CABN.4.2.117; de Haas B, 2012, P ROY SOC B-BIOL SCI, V279, P4955, DOI 10.1098/rspb.2012.2132; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Delorme A, 2006, ENCYCL MED DEVICES I, DOI [10.1002/0471732877.emd318, DOI 10.1002/0471732877.EMD318]; Falchier A, 2002, J NEUROSCI, V22, P5749; Falchier A, 2010, CEREB CORTEX, V20, P1529, DOI 10.1093/cercor/bhp213; GUTHRIE D, 1991, PSYCHOPHYSIOLOGY, V28, P240, DOI 10.1111/j.1469-8986.1991.tb00417.x; Holmes AP, 1996, J CEREBR BLOOD F MET, V16, P7, DOI 10.1097/00004647-199601000-00002; Holmes CJ, 1998, J COMPUT ASSIST TOMO, V22, P324, DOI 10.1097/00004728-199803000-00032; Howell D., 2009, STAT METHODS PSYCHOL, V7th; Innes-Brown H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006450; Jones EG, 1980, BRAIN, V93, P793; Kamke MR, 2012, NEUROIMAGE, V62, P1334, DOI 10.1016/j.neuroimage.2012.05.063; Lakatos P, 2005, NEUROREPORT, V16, P933, DOI 10.1097/00001756-200506210-00011; Lancaster JL, 2000, HUM BRAIN MAPP, V10, P120, DOI 10.1002/1097-0193(200007)10:3<120::AID-HBM30>3.0.CO;2-8; Meylan RV, 2007, NEUROIMAGE, V35, P244, DOI 10.1016/j.neuroimage.2006.11.033; Mishra J, 2007, J NEUROSCI, V27, P4120, DOI 10.1523/JNEUROSCI.4912-06.2007; Mognon A, 2010, PSYCHOPHYSIOLOGY; Molholm S, 2006, J NEUROPHYSIOL, V96, P721, DOI 10.1152/jn.00285.2006; Murray MM, 2008, BRAIN TOPOGR, V20, P249, DOI 10.1007/s10548-008-0054-5; Musacchia G, 2009, HEARING RES, V258, P72, DOI 10.1016/j.heares.2009.06.018; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Pascual-Marqui RD, 2002, METHOD FIND EXP CLIN, V24, P5; PASCUALMARQUI RD, 1994, INT J PSYCHOPHYSIOL, V18, P49, DOI 10.1016/0167-8760(84)90014-X; Rockland KS, 2003, INT J PSYCHOPHYSIOL, V50, P19, DOI 10.1016/S0167-8760(03)00121-1; Rosenthal O, 2009, BRAIN TOPOGR, V21, P185, DOI 10.1007/s10548-009-0090-9; Schroeder C. E., 2004, COGN PROCESS, V5, P140; Senkowski D, 2011, NEUROIMAGE, V56, P2200, DOI 10.1016/j.neuroimage.2011.03.075; Shams L, 2000, NATURE, V408, P788, DOI 10.1038/35048669; Shams L, 2005, NEUROSCI LETT, V378, P76, DOI 10.1016/j.neulet.2004.12.035; Shams L, 2002, COGNITIVE BRAIN RES, V14, P147, DOI 10.1016/S0926-6410(02)00069-1; Shams L, 2001, NEUROREPORT, V12, P3849, DOI 10.1097/00001756-200112040-00049; Teder-Salejarvi WA, 2002, COGNITIVE BRAIN RES, V14, P106, DOI 10.1016/S0926-6410(02)00065-4; Valdes-Hernandez PA, 2009, J NEUROSCI METH, V185, P125, DOI 10.1016/j.jneumeth.2009.09.005; WALTER WG, 1964, NATURE, V203, P380, DOI 10.1038/203380a0; Watkins S, 2007, NEUROIMAGE, V37, P572, DOI 10.1016/j.neuroimage.2007.05.027; Watkins S, 2006, NEUROIMAGE, V31, P1247, DOI 10.1016/j.neuroimage.2006.01.016	50	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84331	10.1371/journal.pone.0084331	http://dx.doi.org/10.1371/journal.pone.0084331			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391939	gold, Green Published			2022-12-25	WOS:000329323900082
J	Kim, J; Frey, WD; He, HZ; Kim, H; Ekram, MB; Bakshi, A; Faisal, M; Perera, BPU; Ye, A; Teruyama, R				Kim, Joomyeong; Frey, Wesley D.; He, Hongzhi; Kim, Hana; Ekram, Muhammad B.; Bakshi, Arundhati; Faisal, Mohammad; Perera, Bambarendage P. U.; Ye, An; Teruyama, Ryoichi			Peg3 Mutational Effects on Reproduction and Placenta-Specific Gene Families	PLOS ONE			English	Article							EXPRESSED IMPRINTED GENE; TUMOR-SUPPRESSOR GENES; METHYLATION; YY1; PROGENITOR; EVOLUTION; PW1/PEG3; BINDING; GROWTH; STEM	Peg3 (paternally expressed gene 3) is an imprinted gene encoding a DNA-binding protein. This gene plays important roles in controlling fetal growth rates and nurturing behaviors. In the current study, a new mutant mouse model has been generated to further characterize the functions of this DNA-binding protein. Besides known phenotypes, this new mutant model also revealed potential roles of Peg3 in mammalian reproduction. Female heterozygotes produce a much smaller number of mature oocytes than the wild-type littermates, resulting in reduced litter sizes. According to genome-wide expression analyses, several placenta-specific gene families are de-repressed in the brain of Peg3 heterozygous embryos, including prolactin, cathepsin and carcinoembryonic antigen cell adhesion molecule (Ceacam) families. The observed derepression is more pronounced in females than in males. The de-repression of several members of these gene families is observed even in the adult brain, suggesting potential defects in epigenetic setting of the placenta-specific gene families in the Peg3 mutants. Overall, these results indicate that Peg3 likely controls the transcription of several placenta-specific gene families, and further suggest that this predicted transcriptional control by Peg3 might be mediated through unknown epigenetic mechanisms.	[Kim, Joomyeong; Frey, Wesley D.; He, Hongzhi; Kim, Hana; Ekram, Muhammad B.; Bakshi, Arundhati; Faisal, Mohammad; Perera, Bambarendage P. U.; Ye, An; Teruyama, Ryoichi] Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA	Louisiana State University System; Louisiana State University	Kim, J (corresponding author), Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA.	jkim@lsu.edu		Frey, Wesley/0000-0003-0392-5714; Bakshi, Arundhati/0000-0001-8483-1597; Teruyama, Ryoichi/0000-0002-9356-8310	National Institutes of Health [R01-GM066225, R01-GM097974, R15-ES019118]; COBRE [NIH P20 GM103528]; NORC [NIH 2P30DK072476]; National Institutes of Health; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK072476] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R15ES019118] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103528, R01GM066225] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); COBRE; NORC; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by National Institutes of Health (J.K. R01-GM066225, R01-GM097974, and R15-ES019118). The Pennington Biomedical Genomics Core Facility is supported in part by COBRE (NIH P20 GM103528) and NORC (NIH 2P30DK072476) center grants from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Besson V, 2011, P NATL ACAD SCI USA, V108, P11470, DOI 10.1073/pnas.1103873108; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Chen MY, 2011, CANCER-AM CANCER SOC, V117, P4424, DOI 10.1002/cncr.26073; Curley JP, 2005, FASEB J, V19, P1302, DOI 10.1096/fj.04-3216fje; Curley JP, 2004, P ROY SOC B-BIOL SCI, V271, P1303, DOI 10.1098/rspb.2004.2725; Do Kim J, 2009, NUCLEIC ACIDS RES, V37, P5656, DOI 10.1093/nar/gkp613; Dowdy SC, 2005, GYNECOL ONCOL, V99, P126, DOI 10.1016/j.ygyno.2005.05.036; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Feng WW, 2008, CANCER-AM CANCER SOC, V112, P1489, DOI 10.1002/cncr.23323; Friedel Roland H., 2007, Briefings in Functional Genomics & Proteomics, V6, P180, DOI 10.1093/bfgp/elm022; Huang JM, 2009, GENE, V442, P18, DOI 10.1016/j.gene.2009.04.016; Ivanova E, 2011, J MOL ENDOCRINOL, V47, pR67, DOI 10.1530/JME-11-0065; Jiang XL, 2010, J BIOL CHEM, V285, P8472, DOI 10.1074/jbc.M109.069450; Kim J, 2003, HUM MOL GENET, V12, P233, DOI 10.1093/hmg/ddg028; Kim J, 1997, GENOME RES, V7, P532, DOI 10.1101/gr.7.5.532; Kim JD, 2007, GENOMICS, V89, P262, DOI 10.1016/j.ygeno.2006.09.009; Kim J, 2008, HUM MOL GENET, V17, P391, DOI 10.1093/hmg/ddm316; Kim J, 2007, GENOMICS, V90, P85, DOI 10.1016/j.ygeno.2007.03.012; Kim J, 2012, HUM MOL GENET, V21, P2677, DOI 10.1093/hmg/dds092; Knox K, 2008, GENOME RES, V18, P695, DOI 10.1101/gr.071407.107; Kohda T, 2001, GENES CELLS, V6, P237, DOI 10.1046/j.1365-2443.2001.00412.x; Kuroiwa Y, 1996, NAT GENET, V12, P186, DOI 10.1038/ng0296-186; Li LL, 1999, SCIENCE, V284, P330, DOI 10.1126/science.284.5412.330; Maegawa S, 2001, MOL CARCINOGEN, V31, P1, DOI 10.1002/mc.1034; Mitchell KJ, 2010, NAT CELL BIOL, V12, P257, DOI 10.1038/ncb2025; Paquette J, 2010, BIOINFORMATICS, V26, P285, DOI 10.1093/bioinformatics/btp656; Radford EJ, 2012, PLOS GENET, V8, P41, DOI 10.1371/journal.pgen.1002605; Rawn SM, 2008, ANNU REV CELL DEV BI, V24, P159, DOI 10.1146/annurev.cellbio.24.110707.175418; Relaix F, 1996, DEV BIOL, V177, P383, DOI 10.1006/dbio.1996.0172; Relaix F, 1998, NAT GENET, V18, P287, DOI 10.1038/ng0398-287; Relaix F, 2000, P NATL ACAD SCI USA, V97, P2105, DOI 10.1073/pnas.040378897; Reynolds BA, 1996, DEV BIOL, V175, P1, DOI 10.1006/dbio.1996.0090; Smyth GK, 2005, BIOINFORMATICS, V21, P2067, DOI 10.1093/bioinformatics/bti270; Swaney WT, 2008, BEHAV NEUROSCI, V122, P963, DOI 10.1037/a0012706; Thiaville MM, 2013, GENE, V512, P314, DOI 10.1016/j.gene.2012.10.005; Yamaguchi A, 2002, J BIOL CHEM, V277, P623, DOI 10.1074/jbc.M107435200	37	46	50	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83359	10.1371/journal.pone.0083359	http://dx.doi.org/10.1371/journal.pone.0083359			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391757	gold, Green Published, Green Submitted			2022-12-25	WOS:000329325200054
J	Koetsier, A; van Asten, L; Dijkstra, F; van der Hoek, W; Snijders, BE; van den Wijngaard, CC; Boshuizen, HC; Donker, GA; de Lange, DW; de Keizer, NF; Peek, N				Koetsier, Antonie; van Asten, Liselotte; Dijkstra, Frederika; van der Hoek, Wim; Snijders, Bianca E.; van den Wijngaard, Cees C.; Boshuizen, Hendriek C.; Donker, Ge A.; de Lange, Dylan W.; de Keizer, Nicolette F.; Peek, Niels			Do Intensive Care Data on Respiratory Infections Reflect Influenza Epidemics?	PLOS ONE			English	Article							REGRESSION; SEVERITY; MODELS	Objectives: Severe influenza can lead to Intensive Care Unit (ICU) admission. We explored whether ICU data reflect influenza like illness (ILI) activity in the general population, and whether ICU respiratory infections can predict influenza epidemics. Methods: We calculated the time lag and correlation between ILI incidence (from ILI sentinel surveillance, based on general practitioners (GP) consultations) and percentages of ICU admissions with a respiratory infection (from the Dutch National Intensive Care Registry) over the years 2003-2011. In addition, ICU data of the first three years was used to build three regression models to predict the start and end of influenza epidemics in the years thereafter, one to three weeks ahead. The predicted start and end of influenza epidemics were compared with observed start and end of such epidemics according to the incidence of ILI. Results: Peaks in respiratory ICU admissions lasted longer than peaks in ILI incidence rates. Increases in ICU admissions occurred on average two days earlier compared to ILI. Predicting influenza epidemics one, two, or three weeks ahead yielded positive predictive values ranging from 0.52 to 0.78, and sensitivities from 0.34 to 0.51. Conclusions: ICU data was associated with ILI activity, with increases in ICU data often occurring earlier and for a longer time period. However, in the Netherlands, predicting influenza epidemics in the general population using ICU data was imprecise, with low positive predictive values and sensitivities.	[Koetsier, Antonie; de Keizer, Nicolette F.; Peek, Niels] Univ Amsterdam, Acad Med Ctr, Dept Med Informat, NL-1105 AZ Amsterdam, Netherlands; [van Asten, Liselotte; Dijkstra, Frederika; van der Hoek, Wim; Snijders, Bianca E.; van den Wijngaard, Cees C.] Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control, NL-3720 BA Bilthoven, Netherlands; [Boshuizen, Hendriek C.] Natl Inst Publ Hlth & Environm, Dept Stat Math Modeling & Data Logist, NL-3720 BA Bilthoven, Netherlands; [Donker, Ge A.] Dutch Sentinel Gen Practice Network, Netherlands Inst Hlth Serv Res, NIVEL, Utrecht, Netherlands; [de Lange, Dylan W.] Univ Med Ctr, Dept Intens Care, Utrecht, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; Netherlands National Institute for Public Health & the Environment; Netherlands National Institute for Public Health & the Environment; Netherlands Institute for Health Services Research; Utrecht University; Utrecht University Medical Center	Koetsier, A (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Med Informat, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	a.koetsier@amc.uva.nl	Donker, Gé/AAX-8564-2021; Peek, Niels/AAD-9334-2019; Boshuizen, Hendriek/M-3415-2014; Dijkstra, Frederika/ABF-3865-2021; Boshuizen, Hendriek C/B-3718-2014; De Lange, Dylan W/ABB-8172-2020	Peek, Niels/0000-0002-6393-9969; Boshuizen, Hendriek/0000-0002-3916-9095; Dijkstra, Frederika/0000-0003-0012-740X; De Lange, Dylan W/0000-0002-0191-7270; Donker, Ge/0000-0001-6314-9249				Alonso TV, 2004, INT CONGR SER, V1263, P281, DOI 10.1016/j.ics.2004.02.121; Amato-Gauci A, 2011, EURO SURVEILL, V16, P19903; Arts DGT, 2002, J AM MED INFORM ASSN, V9, P600, DOI 10.1197/jamia.M1087; Boshuizen Hendriek C, 2010, Epidemiol Perspect Innov, V7, P4, DOI 10.1186/1742-5573-7-4; Cameron AC, 1996, J BUS ECON STAT, V14, P209, DOI 10.2307/1392433; Closas P, 2012, BMC MED INFORM DECIS, V12, DOI 10.1186/1472-6947-12-112; Donker GA, 2013, CONTINUOUS MORBIDITY; EFRON B, 1986, J AM STAT ASSOC, V81, P461, DOI 10.2307/2289236; HOCKING RR, 1976, BIOMETRICS, V32, P1, DOI 10.2307/2529336; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; Nationale Intensive Care Evaluatie, STICHT NICE; Pan W, 2001, BIOMETRICS, V57, P120, DOI 10.1111/j.0006-341X.2001.00120.x; Pel JZS, 1965, HUIS WETEN, V8, P321; Steiner SH, 2010, BMC MED INFORM DECIS, V10, DOI 10.1186/1472-6947-10-37; Stolwijk AM, 1999, J EPIDEMIOL COMMUN H, V53, P235, DOI 10.1136/jech.53.4.235; Thomson G, 2010, EURO SURVEILL, V15; van den Wijngaard CC, 2010, AM J PUBLIC HEALTH, V100, P2248, DOI 10.2105/AJPH.2009.168245; Wijngaard CC, 2012, PLOS ONE, V7	19	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83854	10.1371/journal.pone.0083854	http://dx.doi.org/10.1371/journal.pone.0083854			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	284NF	24391837	gold, Green Submitted, Green Published			2022-12-25	WOS:000329325200135
J	McLure, KG; Gesner, EM; Tsujikawa, L; Kharenko, OA; Attwell, S; Campeau, E; Wasiak, S; Stein, A; White, A; Fontano, E; Suto, RK; Wong, NCW; Wagner, GS; Hansen, HC; Young, PR				McLure, Kevin G.; Gesner, Emily M.; Tsujikawa, Laura; Kharenko, Olesya A.; Attwell, Sarah; Campeau, Eric; Wasiak, Sylwia; Stein, Adam; White, Andre; Fontano, Eric; Suto, Robert K.; Wong, Norman C. W.; Wagner, Gregory S.; Hansen, Henrik C.; Young, Peter R.			RVX-208, an Inducer of ApoA-I in Humans, Is a BET Bromodomain Antagonist	PLOS ONE			English	Article							DENSITY-LIPOPROTEIN CHOLESTEROL; APOLIPOPROTEIN-A-I; SMALL-MOLECULE INHIBITORS; CORONARY ATHEROSCLEROSIS; CARDIOVASCULAR RISK; LDL CHOLESTEROL; CYCLOSPORINE-A; SAFETY; EFFICACY; PARTICIPANTS	Increased synthesis of Apolipoprotein A-I (ApoA-I) and HDL is believed to provide a new approach to treating atherosclerosis through the stimulation of reverse cholesterol transport. RVX-208 increases the production of ApoA-I in hepatocytes in vitro, and in vivo in monkeys and humans, which results in increased HDL-C, but the molecular target was not previously reported. Using binding assays and X-ray crystallography, we now show that RVX-208 selectively binds to bromodomains of the BET (Bromodomain and Extra Terminal) family, competing for a site bound by the endogenous ligand, acetylated lysine, and that this accounts for its pharmacological activity. siRNA experiments further suggest that induction of ApoA-I mRNA is mediated by BET family member BRD4. These data indicate that RVX-208 increases ApoA-I production through an epigenetic mechanism and suggests that BET inhibition may be a promising new approach to the treatment of atherosclerosis.	[McLure, Kevin G.; Gesner, Emily M.; Tsujikawa, Laura; Kharenko, Olesya A.; Attwell, Sarah; Campeau, Eric; Wasiak, Sylwia; Wong, Norman C. W.; Wagner, Gregory S.; Hansen, Henrik C.; Young, Peter R.] Resverlogix Corp, Calgary, AB, Canada; [Stein, Adam; White, Andre; Fontano, Eric; Suto, Robert K.] Xtal BioStruct Inc, Natick, MD USA		McLure, KG (corresponding author), Resverlogix Corp, Calgary, AB, Canada.	kevin@resverlogix.com	Kharenko, Olesya A./AAC-5873-2019	Kharenko, Olesya A./0000-0003-4710-3886	Resverlogix Corp; Alberta Innovates	Resverlogix Corp; Alberta Innovates	This work was funded by Resverlogix Corp, www.resverlogix.com. EMG received salary support from Alberta Innovates www.albertatechfutures.ca. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arkin MR, 2004, NAT REV DRUG DISCOV, V3, P301, DOI 10.1038/nrd1343; Arrowsmith CH, 2012, NAT REV DRUG DISCOV, V11, P384, DOI 10.1038/nrd3674; Baigent C, 2010, LANCET, V376, P1670, DOI 10.1016/S0140-6736(10)61350-5; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Bailey D, 2010, J AM COLL CARDIOL, V55, P2580, DOI 10.1016/j.jacc.2010.02.035; Barter PJ, 2007, NEW ENGL J MED, V357, P2109, DOI 10.1056/NEJMoa0706628; Cheng C, 2009, CIRCULATION, V119, P3017, DOI 10.1161/CIRCULATIONAHA.108.808618; Chung CW, 2011, J MED CHEM, V54, P3827, DOI 10.1021/jm200108t; Collaboration IRGCERF, 2012, LANCET; Consortium I-RMRAIRM, 2012, LANCET; Creider JC, 2012, NATURE REV ENDOCRINO; Danesh J, 2008, PLOS MED, V5, P600, DOI 10.1371/journal.pmed.0050078; Dawson MA, 2012, NEW ENGL J MED, V367, P647, DOI 10.1056/NEJMra1112635; de la Llera-Moya M, 2010, ARTERIOSCL THROM VAS, V30, P796, DOI 10.1161/ATVBAHA.109.199158; Degoma EM, 2011, NAT REV CARDIOL, V8, P266, DOI 10.1038/nrcardio.2010.200; Di Angelantonio E, 2009, JAMA-J AM MED ASSOC, V302, P1993, DOI 10.1001/jama.2009.1619; ENGH RA, 1991, ACTA CRYSTALLOGR A, V47, P392, DOI 10.1107/S0108767391001071; Filippakopoulos P, 2012, FEBS LETT, V586, P2692, DOI 10.1016/j.febslet.2012.04.045; Filippakopoulos P, 2010, NATURE, V468, P1067, DOI 10.1038/nature09504; Frikke-Schmidt R, 2008, JAMA-J AM MED ASSOC, V299, P2524, DOI 10.1001/jama.299.21.2524; Gutstein DE, 2012, CLIN PHARMACOL THER, V91, P109, DOI 10.1038/clpt.2011.271; Hansen H. C., 2012, US Patent, Patent No. [8,114,995, 8114995]; Hansen H. C., 2011, US Patent, Patent No. [8,053,440, 8053440]; HEITMAN J, 1991, SCIENCE, V253, P905, DOI 10.1126/science.1715094; Kamanna VS, 2008, AM J CARDIOL, V101, p20B, DOI 10.1016/j.amjcard.2008.02.029; Khera AV, 2011, NEW ENGL J MED, V364, P127, DOI 10.1056/NEJMoa1001689; Luscher TF, 2012, EUROPEAN HEART J; Mirguet O, 2012, BIOORGANIC MED CHEM; Mrowietz U, 2005, TRENDS MOL MED, V11, P43, DOI 10.1016/j.molmed.2004.11.003; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nicholls SJ, 2012, APOA 1 INDUCTION POT; Nicholls SJ, 2011, JAMA-J AM MED ASSOC, V306, P2099, DOI 10.1001/jama.2011.1649; Nicholls SJ, 2011, J AM COLL CARDIOL, V57, P1111, DOI 10.1016/j.jacc.2010.11.015; Nicodeme E, 2010, NATURE, V468, P1119, DOI 10.1038/nature09589; Nissen SE, 2003, JAMA-J AM MED ASSOC, V290, P2292, DOI 10.1001/jama.290.17.2292; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646; Stahelin HF, 1996, EXPERIENTIA, V52, P5, DOI 10.1007/BF01922409; Swinney DC, 2011, NAT REV DRUG DISCOV, V10, P507, DOI 10.1038/nrd3480; Taddei A, 2001, NAT CELL BIOL, V3, P114, DOI 10.1038/35055010; Tardif JC, 2007, JAMA-J AM MED ASSOC, V297, P1675, DOI 10.1001/jama.297.15.jpc70004; Taverna SD, 2007, NAT STRUCT MOL BIOL, V14, P1025, DOI 10.1038/nsmb1338; Vaisar T, 2012, CURRENT VASCULAR PHA; van der Steeg WA, 2008, J AM COLL CARDIOL, V51, P634, DOI 10.1016/j.jacc.2007.09.060; VEZINA C, 1975, J ANTIBIOT, V28, P721, DOI 10.7164/antibiotics.28.721; Vidler LR, 2012, J MED CHEM, V55, P7346, DOI 10.1021/jm300346w; Waksman R, 2010, J AM COLL CARDIOL, V55, P2727, DOI 10.1016/j.jacc.2009.12.067; WALSH CT, 1992, J BIOL CHEM, V267, P13115; Yoo CB, 2006, NAT REV DRUG DISCOV, V5, P37, DOI 10.1038/nrd1930; Zhu Y., 2012, LEUKEMIA LYMPHOMA	50	141	176	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83190	10.1371/journal.pone.0083190	http://dx.doi.org/10.1371/journal.pone.0083190			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391744	Green Submitted, Green Published, gold			2022-12-25	WOS:000329325200041
J	Rossi, S; Bozzali, M; Bari, M; Mori, F; Studer, V; Motta, C; Buttari, F; Cercignani, M; Gravina, P; Mastrangelo, N; Castelli, M; Mancino, R; Nucci, C; Sottile, F; Bernardini, S; Maccarrone, M; Centonze, D				Rossi, Silvia; Bozzali, Marco; Bari, Monica; Mori, Francesco; Studer, Valeria; Motta, Caterina; Buttari, Fabio; Cercignani, Mara; Gravina, Paolo; Mastrangelo, Nicolina; Castelli, Maura; Mancino, Raffaele; Nucci, Carlo; Sottile, Fabrizio; Bernardini, Sergio; Maccarrone, Mauro; Centonze, Diego			Association between a Genetic Variant of Type-1 Cannabinoid Receptor and Inflammatory Neurodegeneration in Multiple Sclerosis	PLOS ONE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; OPTICAL COHERENCE TOMOGRAPHY; TRAUMATIC BRAIN-INJURY; NERVE-FIBER LAYER; COGNITIVE IMPAIRMENT; ENDOCANNABINOID SYSTEM; CB2 RECEPTORS; DISEASE; ATROPHY; ABNORMALITIES	Genetic ablation of type-1 cannabinoid receptors (CB(1)Rs) exacerbates the neurodegenerative damage of experimental autoimmune encephalomyelitis, the rodent model of multiple sclerosis (MS). To address the role on CB(1)Rs in the pathophysiology of human MS, we first investigated the impact of AAT trinucleotide short tandem repeat polymorphism of CNR1 gene on CB1R cell expression, and secondly on the inflammatory neurodegeneration process responsible for irreversible disability in MS patients. We found that MS patients with long AAT repeats within the CNR1 gene (>= 12 in both alleles) had more pronounced neuronal degeneration in response to inflammatory white matter damage both in the optic nerve and in the cortex. Optical Coherence Tomography (OCT), in fact, showed more severe alterations of the retinal nerve fiber layer (RNFL) thickness and of the macular volume (MV) after an episode of optic neuritis in MS patients carrying the long AAT genotype of CNR1. MS patients with long AAT repeats also had magnetic resonance imaging (MRI) evidence of increased gray matter damage in response to inflammatory lesions of the white matter, especially in areas with a major role in cognition. In parallel, visual abilities evaluated at the low contrast acuity test, and cognitive performances were negatively influenced by the long AAT CNR1 genotype in our sample of MS patients. Our results demonstrate the biological relevance of the (AAT)(n) CNR1 repeats in the inflammatory neurodegenerative damage of MS.	[Rossi, Silvia; Mori, Francesco; Studer, Valeria; Motta, Caterina; Buttari, Fabio; Castelli, Maura; Centonze, Diego] Univ Roma Tor Vergata, Dipartimento Med Sistemi, Clin Neurol, Rome, Italy; [Rossi, Silvia; Bozzali, Marco; Mori, Francesco; Studer, Valeria; Motta, Caterina; Buttari, Fabio; Cercignani, Mara; Castelli, Maura; Maccarrone, Mauro; Centonze, Diego] Fdn Santa Lucia, CERC, Rome, Italy; [Bari, Monica; Mastrangelo, Nicolina] Univ Roma Tor Vergata, Dipartimento Med Sperimentale & Chirurg, Rome, Italy; [Cercignani, Mara] Univ Sussex, Clin Imaging Sci Ctr, Brighton & Sussex Med Sch, Brighton, E Sussex, England; [Gravina, Paolo; Bernardini, Sergio] Policlin Tor Vergata, Dipartimento Med Lab, Rome, Italy; [Mancino, Raffaele; Nucci, Carlo] Univ Roma Tor Vergata, Dipartimento Biopatol, Clin Oculist, Rome, Italy; [Sottile, Fabrizio] IRCCS Ctr Neurolesi Bonino Pulejo, Messina, Italy; [Bernardini, Sergio] Univ Roma Tor Vergata, Dipartimento Med Interna, Rome, Italy; [Maccarrone, Mauro] Campus Biomed Univ Rome, Sch Med, Ctr Integrated Res, Rome, Italy	University of Rome Tor Vergata; IRCCS Santa Lucia; University of Rome Tor Vergata; University of Brighton; University of Sussex; University of Rome Tor Vergata; Policlin Tor Vergata; University of Rome Tor Vergata; IRCCS Bonino Pulejo; University of Rome Tor Vergata; University Campus Bio-Medico - Rome Italy	Centonze, D (corresponding author), Univ Roma Tor Vergata, Dipartimento Med Sistemi, Clin Neurol, Rome, Italy.	centonze@uniroma2.it	Maccarrone, Mauro/K-5398-2012; Motta, Caterina/L-1513-2018; Centonze, Diego/J-7767-2016; Mori, Francesco/AGX-1659-2022; Bozzali, Marco/AAC-1031-2022	Maccarrone, Mauro/0000-0002-3990-2963; Centonze, Diego/0000-0002-8390-8545; Mori, Francesco/0000-0002-4761-6174; studer, valeria/0000-0003-2529-7640; Bozzali, Marco/0000-0002-0568-2026; Rossi, Silvia/0000-0003-3257-8248; MANCINO, Raffaele/0000-0001-9968-9714; Cercignani, Mara/0000-0002-4550-2456	Fondazione Italiana Sclerosi Multipla (FISM Special Project); Italian National Ministero dell'Universita	Fondazione Italiana Sclerosi Multipla (FISM Special Project); Italian National Ministero dell'Universita	This investigation was supported by Fondazione Italiana Sclerosi Multipla (FISM Special Project to DC), and by the Italian National Ministero dell'Universita to DC and MM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbar N, 2010, CAN J NEUROL SCI, V37, P608, DOI 10.1017/S0317167100010775; Amato MP, 2006, MULT SCLER, V12, P787, DOI 10.1177/1352458506070933; Amato MP, 2007, ARCH NEUROL-CHICAGO, V64, P1157, DOI 10.1001/archneur.64.8.1157; Amato MP, 2006, J NEUROL, V253, P1054, DOI 10.1007/s00415-006-0161-8; Amato MP, 2004, NEUROLOGY, V63, P89, DOI 10.1212/01.WNL.0000129544.79539.D5; Arevalo-Martin A, 2012, NEUROPHARMACOLOGY, V63, P385, DOI 10.1016/j.neuropharm.2012.04.012; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Ashburner J, 2001, NEUROIMAGE, V14, P1238, DOI 10.1006/nimg.2001.0961; Baier ML, 2005, NEUROLOGY, V64, P992, DOI 10.1212/01.WNL.0000154521.40686.63; Bamdad MJ, 2003, BRAIN INJURY, V17, P1011, DOI 10.1080/0269905031000110553; Barbarotto R, 1998, ITAL J NEUROL SCI, V19, P161, DOI 10.1007/BF00831566; Barkhof F, 2009, NAT REV NEUROL, V5, P256, DOI 10.1038/nrneurol.2009.41; Bisogno T, 2010, CNS NEUROL DISORD-DR, V9, P564, DOI 10.2174/187152710793361568; Burkholder BM, 2009, ARCH NEUROL-CHICAGO, V66, P1366, DOI 10.1001/archneurol.2009.230; Camp SJ, 1999, BRAIN, V122, P1341, DOI 10.1093/brain/122.7.1341; Catani MV, 2010, CURR NEUROVASC RES, V7, P311; Cencioni MT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008688; Centonze D, 2007, BRAIN, V130, P2543, DOI 10.1093/brain/awm160; Costello F, 2011, MULT SCLER INT, V2011, DOI 10.1155/2011/148394; Delis DC, 2004, J INT NEUROPSYCH SOC, V10, P301, DOI 10.1017/S1355617704102191; Fine EM, 2009, J CLIN EXP NEUROPSYC, V31, P624, DOI 10.1080/13803390802419017; Forder JP, 2009, NEUROSCIENCE, V158, P293, DOI 10.1016/j.neuroscience.2008.10.021; Forn C, 2007, HUM BRAIN MAPP, V28, P424, DOI 10.1002/hbm.20284; Frohman EM, 2008, NAT CLIN PRACT NEURO, V4, P664, DOI 10.1038/ncpneuro0950; Gordon-Lipkin E, 2007, NEUROLOGY, V69, P1603, DOI 10.1212/01.wnl.0000295995.46586.ae; Horakova D, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-10; Howlett AC, 2010, CURR MED CHEM, V17, P1382, DOI 10.2174/092986710790980023; Huey ED, 2009, NEUROLOGY, V72, P453, DOI 10.1212/01.wnl.0000341781.39164.26; Katona I, 2008, NAT MED, V14, P923, DOI 10.1038/nm.f.1869; Katona I, 2009, CURR TOP BEHAV NEURO, V1, P65, DOI 10.1007/978-3-540-88955-7_3; Krueger F, 2011, J NEUROSCI, V31, P598, DOI 10.1523/JNEUROSCI.1399-10.2011; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Lanz M, 2007, J NEUROL, V254, P43, DOI 10.1007/s00415-007-2011-8; Li YC, 2004, MOL BIOL EVOL, V21, P991, DOI 10.1093/molbev/msh073; Lidster K, 2012, CNS NEUROL DISORD-DR, V11, P518, DOI 10.2174/187152712801661185; Lou ZY, 2012, J NEUROSCI RES, V90, P84, DOI 10.1002/jnr.22721; Mandolesi G, 2010, NEUROL SCI, V31, P255, DOI 10.1007/s10072-010-0369-3; Moll NM, 2011, ANN NEUROL, V70, P764, DOI 10.1002/ana.22521; MONTGOMERY SA, 1979, BRIT J PSYCHIAT, V134, P382, DOI 10.1192/bjp.134.4.382; Patti F, 2009, MULT SCLER J, V15, P779, DOI 10.1177/1352458509105544; Patti F, 2009, MULT SCLER J, V15, P2, DOI 10.1177/1352458508096684; Pertwee RG, 2010, PHARMACOL REV, V62, P588, DOI 10.1124/pr.110.003004; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; Pryce G, 2003, BRAIN, V126, P2191, DOI 10.1093/brain/awg224; Ramil E, 2010, MULT SCLER J, V16, P139, DOI 10.1177/1352458509355071; Rao S, 1990, MANUAL BRIEF REPEATA; Reguero L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026167; Rossi S, 2012, J NEUROSCI, V32, P13896, DOI 10.1523/JNEUROSCI.1515-12.2012; Rossi S, 2012, ANN NEUROL, V71, P76, DOI 10.1002/ana.22512; Rossi S, 2011, BRAIN BEHAV IMMUN, V25, P1242, DOI 10.1016/j.bbi.2011.03.017; Rossi S, 2011, MULT SCLER J, V17, P281, DOI 10.1177/1352458510388680; Rypma B, 2005, CORTEX, V41, P582, DOI 10.1016/S0010-9452(08)70198-9; Saito VM, 2012, CURR NEUROPHARMACOL, V10, P159, DOI 10.2174/157015912800604515; Scotter EL, 2010, BRIT J PHARMACOL, V160, P480, DOI 10.1111/j.1476-5381.2010.00735.x; Sepulcre J, 2007, NEUROLOGY, V68, P1488, DOI 10.1212/01.wnl.0000260612.51849.ed; Sweet LH, 2006, HUM BRAIN MAPP, V27, P28, DOI 10.1002/hbm.20163; Trip SA, 2006, NEUROIMAGE, V31, P286, DOI 10.1016/j.neuroimage.2005.11.051; Zhang PW, 2004, MOL PSYCHIATR, V9, P916, DOI 10.1038/sj.mp.4001560	58	18	19	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e82848	10.1371/journal.pone.0082848	http://dx.doi.org/10.1371/journal.pone.0082848			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391723	Green Accepted, gold, Green Published			2022-12-25	WOS:000329325200020
J	Underkoffler, LA; Carr, E; Nelson, A; Ryan, MJ; Schultz, R; Loomes, KM				Underkoffler, Lara A.; Carr, Erikka; Nelson, Anthony; Ryan, Matthew J.; Schultz, Reiner; Loomes, Kathleen M.			Microarray Data Reveal Relationship between Jag1 and Ddr1 in Mouse Liver	PLOS ONE			English	Article							BILE-DUCT PROLIFERATION; EXTRACELLULAR-MATRIX; ALAGILLE SYNDROME; MICE LACKING; RECEPTOR; JAGGED1; MUTATIONS; DEFECTS	Alagille syndrome is an autosomal dominant disorder involving bile duct paucity and cholestasis in addition to cardiac, skeletal, ophthalmologic, renal and vascular manifestations. Mutations in JAG1, encoding a ligand in the Notch signaling pathway, are found in 95% of patients meeting clinical criteria for Alagille syndrome. In order to define the role of Jag1 in the bile duct developmental abnormalities seen in ALGS, we previously created a Jag1 conditional knockout mouse model. Mice heterozygous for the Jag1 conditional and null alleles demonstrate abnormalities in postnatal bile duct growth and remodeling, with portal expansion and increased numbers of malformed bile ducts. In this study we report the results of microarray analysis and identify genes and pathways differentially expressed in the Jag1 conditional/ null livers as compared with littermate controls. In the initial microarray analysis, we found that many of the genes up-regulated in the Jag1 conditional/ null mutant livers were related to extracellular matrix (ECM) interactions, cell adhesion and cell migration. One of the most highly up-regulated genes was Ddr1, encoding a receptor tyrosine kinase (RTK) belonging to a large RTK family. We have found extensive co-localization of Jag1 and Ddr1 in bile ducts and blood vessels in postnatal liver. In addition, coimmunoprecipitation data provide evidence for a novel protein interaction between Jag1 and Ddr1. Further studies will be required to define the nature of this interaction and its functional consequences, which may have significant implications for bile duct remodeling and repair of liver injury.	[Underkoffler, Lara A.; Carr, Erikka; Nelson, Anthony; Ryan, Matthew J.; Loomes, Kathleen M.] Childrens Hosp Philadelphia, Div Gastroenterol Hepatol & Nutr, Philadelphia, PA 19104 USA; [Ryan, Matthew J.; Loomes, Kathleen M.] Univ Penn, Dept Pediat, Raymond & Ruth Perelman Sch Med, Philadelphia, PA 19104 USA; [Schultz, Reiner] Kings Coll London, Dept Med Genet, London WC2R 2LS, England	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; University of London; King's College London	Loomes, KM (corresponding author), Childrens Hosp Philadelphia, Div Gastroenterol Hepatol & Nutr, Philadelphia, PA 19104 USA.	loomes@email.chop.edu	Schulz, Reiner/A-5940-2011	Schulz, Reiner/0000-0001-5047-7921	NIH [R01 DK071841]; Engineering and Physical Sciences Research Council [836374] Funding Source: researchfish; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071841] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was funded by NIH R01 DK071841 to KML. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aho S, 2004, J CELL BIOCHEM, V92, P1271, DOI 10.1002/jcb.20125; Albig AR, 2008, MICROVASC RES, V76, P7, DOI 10.1016/j.mvr.2008.01.001; Chen J, 2010, BRIT J CANCER, V102, P351, DOI 10.1038/sj.bjc.6605486; Eswaramoorthy R, 2010, J CELL PHYSIOL, V224, P387, DOI 10.1002/jcp.22134; Fujimoto N, 2006, EXP DERMATOL, V15, P300, DOI 10.1111/j.0906-6705.2006.00409.x; Hou GP, 2002, CIRC RES, V90, P1147, DOI 10.1161/01.RES.0000022166.74073.F8; Jian ZX, 2012, MED ONCOL, V29, P3077, DOI 10.1007/s12032-012-0277-x; Kamath BM, 2012, J MED GENET, V49, P138, DOI 10.1136/jmedgenet-2011-100544; Kiernan AE, 2001, P NATL ACAD SCI USA, V98, P3873, DOI 10.1073/pnas.071496998; Kim HG, 2011, J BIOL CHEM, V286, P17672, DOI 10.1074/jbc.M111.236612; Kwon SM, 2008, CIRCULATION, V118, P157, DOI 10.1161/CIRCULATIONAHA.107.754978; Leong KG, 2007, J EXP MED, V204, P2935, DOI 10.1084/jem.20071082; Lindner V, 2001, AM J PATHOL, V159, P875, DOI 10.1016/S0002-9440(10)61763-4; Loomes KM, 2007, HEPATOLOGY, V45, P323, DOI 10.1002/hep.21460; Lu FM, 2003, AM J HUM GENET, V72, P1065, DOI 10.1086/374386; McDaniell R, 2006, AM J HUM GENET, V79, P169, DOI 10.1086/505332; Nehring LC, 2005, J BIOL CHEM, V280, P20349, DOI 10.1074/jbc.M500273200; Nielsen JS, 2008, J CELL SCI, V121, P4145, DOI 10.1242/jcs.03504; Roberts ME, 2011, EUR RESPIR J, V37, P1482, DOI 10.1183/09031936.00039710; Ryan MJ, 2008, HEPATOLOGY, V48, P1989, DOI 10.1002/hep.22538; Song SM, 2011, AM J PATHOL, V178, P1134, DOI 10.1016/j.ajpath.2010.11.068; Vogel W, 1997, MOL CELL, V1, P13, DOI 10.1016/S1097-2765(00)80003-9; Vogel WF, 2006, CELL SIGNAL, V18, P1108, DOI 10.1016/j.cellsig.2006.02.012; Wang CZ, 2005, J CELL PHYSIOL, V203, P295, DOI 10.1002/jcp.20227; Warthen DM, 2006, HUM MUTAT, V27, P436, DOI 10.1002/humu.20310; Xue YZ, 1999, HUM MOL GENET, V8, P723, DOI 10.1093/hmg/8.5.723; Yovchev MI, 2007, HEPATOLOGY, V45, P139, DOI 10.1002/hep.21448; Zhang LP, 2005, CELL METAB, V2, P141, DOI 10.1016/j.cmet.2005.07.002; Zhang XJ, 2013, INT J BIOCHEM CELL B, V45, P1274, DOI 10.1016/j.biocel.2013.03.020; zum Gottesberge AMM, 2008, LAB INVEST, V88, P27, DOI 10.1038/labinvest.3700692	30	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84383	10.1371/journal.pone.0084383	http://dx.doi.org/10.1371/journal.pone.0084383			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391948	Green Published, gold, Green Submitted			2022-12-25	WOS:000329323900091
J	Vaswani, K; Hum, MWC; Chan, HW; Ryan, J; Wood-Bradley, RJ; Nitert, MD; Mitchell, MD; Armitage, JA; Rice, GE				Vaswani, Kanchan; Hum, Melissa Wen-Ching; Chan, Hsiu-Wen; Ryan, Jennifer; Wood-Bradley, Ryan J.; Nitert, Marloes Dekker; Mitchell, Murray D.; Armitage, James A.; Rice, Gregory E.			The Effect of Gestational Age on Angiogenic Gene Expression in the Rat Placenta	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; IN-OVINE COTYLEDONS; SIGNALING PATHWAY; HUMAN LABOR; PROMOTES; CELLS; TROPHOBLAST; ACTIVATION; INDUCTION; CD36	The placenta plays a central role in determining the outcome of pregnancy. It undergoes changes during gestation as the fetus develops and as demands for energy substrate transfer and gas exchange increase. The molecular mechanisms that coordinate these changes have yet to be fully elucidated. The study performed a large scale screen of the transcriptome of the rat placenta throughout mid-late gestation (E14.25-E20) with emphasis on characterizing gestational age associated changes in the expression of genes invoved in angiogenic pathways. Sprague Dawley dams were sacrificed at E14.25, E15.25, E17.25 and E20 (n = 6 per group) and RNA was isolated from one placenta per dam. Changes in placental gene expression were identifed using Illumina Rat Ref-12 Expression BeadChip Microarrays. Differentially expressed genes (>2 fold change, <1% false discovery rate, FDR) were functionally categorised by gene ontology pathway analysis. A subset of differentially expressed genes identified by microarrays were confirmed using Real-Time qPCR. The expression of thirty one genes involved in the angiogenic pathway was shown to change over time, using microarray analysis (22 genes displayed increased and 9 gene decreased expression). Five genes (4 up regulated: Cd36, Mmp14, Rhob and Angpt4 and 1 down regulated: Foxm1) involved in angiogenesis and blood vessel morphogenesis were subjected to further validation. qPCR confirmed late gestational increased expression of Cd36, Mmp14, Rhob and Angpt4 and a decrease in expression of Foxm1 before labour onset (P<0.0001). The observed acute, pre-labour changes in the expression of the 31 genes during gestation warrant further investigation to elucidate their role in pregnancy.	[Vaswani, Kanchan; Hum, Melissa Wen-Ching; Chan, Hsiu-Wen; Ryan, Jennifer; Nitert, Marloes Dekker; Mitchell, Murray D.; Rice, Gregory E.] Univ Queensland, Clin Res Ctr, Herston, Qld, Australia; [Wood-Bradley, Ryan J.; Armitage, James A.] Deakin Univ, Sch Med Optometry, Waurn Ponds, Vic, Australia; [Armitage, James A.] Monash Univ, Dept Anat & Dev Biol, Clayton, Vic, Australia	University of Queensland; Deakin University; Monash University	Vaswani, K (corresponding author), Univ Queensland, Clin Res Ctr, Royal Brisbane & Womens Hosp Campus, Herston, Qld, Australia.	k.vaswani@uq.edu.au	Armitage, James/AAX-1294-2021; RICE, GREGORY E/F-2412-2010; Mitchell, Murray/A-8639-2010; Nitert, Marloes D/A-8822-2011	RICE, GREGORY E/0000-0001-7177-0246; Mitchell, Murray/0000-0002-6167-7176; Nitert, Marloes D/0000-0002-1909-8920; Armitage, James/0000-0002-3762-0911	NHMRC; Royal Brisbane and Women's Hospital Foundation	NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Royal Brisbane and Women's Hospital Foundation	GER was in receipt of an NHMRC Principal Research Fellowship. MDN received support from the Royal Brisbane and Women's Hospital Foundation. JAA was a Monash Fellow and Heart Foundation Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar A, 2011, ADV ENZYME REGULATIO; Aplin J, 2000, SEMIN CELL DEV BIOL, V11, P115, DOI 10.1006/scdb.2000.0157; APLIN JD, 1993, PLACENTA, V14, P203, DOI 10.1016/S0143-4004(05)80261-9; Belkacemi L, 2010, BIOL REPROD, V83, P325, DOI 10.1095/biolreprod.110.084517; BENNETT PR, 1992, AM J OBSTET GYNECOL, V167, P212, DOI 10.1016/S0002-9378(11)91660-3; Borowicz PP, 2007, BIOL REPROD, V76, P259, DOI 10.1095/biolreprod.106.054684; Brunckhorst MK, 2010, CANCER RES, V70, P7283, DOI 10.1158/0008-5472.CAN-09-4125; Buffat C, 2007, J PATHOL, V213, P337, DOI 10.1002/path.2233; Charnock-Jones DS, 2004, PLACENTA, V25, P103, DOI 10.1016/j.placenta.2003.10.004; Cobellis L, 2007, CELL TISSUE RES, V330, P527, DOI 10.1007/s00441-007-0511-6; Constancia M, 2005, P NATL ACAD SCI USA, V102, P19219, DOI 10.1073/pnas.0504468103; De Falco M, 2007, PLACENTA, V28, P118, DOI 10.1016/j.placenta.2006.03.010; Dube E, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.111.098095; Farina MG, 2007, REPRODUCTION, V134, P355, DOI 10.1530/REP-07-0078; Febbraio M, 2001, J CLIN INVEST, V108, P785, DOI 10.1172/JCI200114006; Feng L, 2012, J CELL PHYSIOL, V227, P2480, DOI 10.1002/jcp.22984; Funahashi Y, 2011, VASC CELL, V3, DOI 10.1186/2045-824X-3-2; GAFFNEY RC, 1990, REPROD FERT DEVELOP, V2, P603, DOI 10.1071/RD9900603; Godfrey K M, 2001, Public Health Nutr, V4, P611; Godfrey KM, 2002, PLACENTA, V23, pS20, DOI 10.1053/plac.2002.0773; Goyal R, 2010, PLACENTA, V31, P568, DOI 10.1016/j.placenta.2010.05.004; Howe GA, 2012, VASC CELL, V4, DOI 10.1186/2045-824X-4-1; Huang C, 2012, CANCER RES, V72, P655, DOI 10.1158/0008-5472.CAN-11-3102; Kuda O, 2011, J BIOL CHEM, V286, P17785, DOI 10.1074/jbc.M111.232975; KURUVILLA AG, 1994, J CLIN INVEST, V94, P689, DOI 10.1172/JCI117386; Lee HJ, 2004, FASEB J, V18, P1200, DOI 10.1096/fj.03-1466com; Lim R, 2012, PLACENTA, V33, P52, DOI 10.1016/j.placenta.2011.10.004; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mizutani T, 2004, ENDOCR J, V51, P569, DOI 10.1507/endocrj.51.569; Pfarrer C, 2003, PLACENTA, V24, P588, DOI 10.1016/S0143-4004(03)00059-6; Reynolds LP, 2005, PLACENTA, V26, P689, DOI 10.1016/j.placenta.2004.11.010; Reynolds LP, 2001, BIOL REPROD, V64, P1033, DOI 10.1095/biolreprod64.4.1033; RICE GE, 1990, EICOSANOIDS, V3, P231; RICE GE, 1992, PLACENTA, V13, P429, DOI 10.1016/0143-4004(92)90050-4; Santulli P, 2012, FERTIL STERIL, V97, P904, DOI 10.1016/j.fertnstert.2011.12.051; Serrano-Sanchez M, 2008, ENDOCRINOLOGY, V149, P4669, DOI 10.1210/en.2008-1756; Shankar K, 2012, ENDOCRINOLOGY, V153, P1999, DOI 10.1210/en.2011-1833; Silverstein RL, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.272re3; Sonveaux P, 2004, CIRC RES, V95, P154, DOI 10.1161/01.RES.0000136344.27825.72; Suzuki T, 2009, J VET MED SCI, V71, P495, DOI 10.1292/jvms.71.495; Szabova L, 2010, BLOOD, V116, P5752, DOI 10.1182/blood-2009-10-249847; Tontonoz P, 1998, CELL, V93, P241, DOI 10.1016/S0092-8674(00)81575-5; Torry DS, 1997, AM J REPROD IMMUNOL, V37, P21; Venkatesha S, 2006, NAT MED, V12, P642, DOI 10.1038/nm1429; Weinlander K, 2008, FASEB J, V22, P4168, DOI 10.1096/fj.08-107524; Withington SL, 2006, DEV BIOL, V294, P67, DOI 10.1016/j.ydbio.2006.02.025; Xie H, 2011, PLACENTA, V32, P546, DOI 10.1016/j.placenta.2011.04.003; Yamakawa M, 2003, CIRC RES, V93, P664, DOI 10.1161/01.RES.0000093984.48643.D7; Zhang YJ, 2008, CANCER RES, V68, P8733, DOI 10.1158/0008-5472.CAN-08-1968; Zhao WX, 2012, INT J MED SCI, V9, P447, DOI 10.7150/ijms.4593	50	11	11	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83762	10.1371/journal.pone.0083762	http://dx.doi.org/10.1371/journal.pone.0083762			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391823	Green Submitted, Green Published, gold			2022-12-25	WOS:000329325200121
J	Wang, CC; Held, RG; Hall, BJ				Wang, Chih-Chieh; Held, Richard G.; Hall, Benjamin J.			SynGAP Regulates Protein Synthesis and Homeostatic Synaptic Plasticity in Developing Cortical Networks	PLOS ONE			English	Article							GTPASE-ACTIVATING PROTEIN; LONG-TERM POTENTIATION; GLUN2B-CONTAINING NMDA RECEPTORS; KINASE-II; IN-VIVO; DEVELOPMENTAL SWITCH; TUBEROUS SCLEROSIS; MAMMALIAN TARGET; ERK ACTIVATION; UP-REGULATION	Disrupting the balance between excitatory and inhibitory neurotransmission in the developing brain has been causally linked with intellectual disability (ID) and autism spectrum disorders (ASD). Excitatory synapse strength is regulated in the central nervous system by controlling the number of postsynaptic alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors (AMPARs). De novo genetic mutations of the synaptic GTPase-activating protein (SynGAP) are associated with ID and ASD. SynGAP is enriched at excitatory synapses and genetic suppression of SynGAP increases excitatory synaptic strength. However, exactly how SynGAP acts to maintain synaptic AMPAR content is unclear. We show here that SynGAP limits excitatory synaptic strength, in part, by suppressing protein synthesis in cortical neurons. The data presented here from in vitro, rat and mouse cortical networks, demonstrate that regulation of translation by SynGAP involves ERK, mTOR, and the small GTP-binding protein Rheb. Furthermore, these data show that GluN2B-containing NMDARs and the cognitive kinase CaMKII act upstream of SynGAP and that this signaling cascade is required for proper translation-dependent homeostatic synaptic plasticity of excitatory synapses in developing cortical networks.	[Wang, Chih-Chieh; Hall, Benjamin J.] Tulane Univ, Sch Sci & Engn, Neurosci Program, New Orleans, LA 70118 USA; [Held, Richard G.; Hall, Benjamin J.] Tulane Univ, Sch Sci & Engn, Dept Cell & Mol Biol, New Orleans, LA 70118 USA	Tulane University; Tulane University	Hall, BJ (corresponding author), Tulane Univ, Sch Sci & Engn, Neurosci Program, New Orleans, LA 70118 USA.	benhall@tulane.edu		Held, Richard/0000-0001-8231-0341	National Institute for Mental Health [MH099378-01]; National Science Foundation CAREER award [NS065374]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH099378] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS065374] Funding Source: NIH RePORTER; Division Of Integrative Organismal Systems [0952455] Funding Source: National Science Foundation	National Institute for Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Science Foundation CAREER award(National Science Foundation (NSF)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by a grant from the National Institute for Mental Health (MH099378-01 to BJH) and a National Science Foundation CAREER award (NS065374 to BJH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adesnik H, 2008, P NATL ACAD SCI USA, V105, P5597, DOI 10.1073/pnas.0800946105; Aoto J, 2008, NEURON, V60, P308, DOI 10.1016/j.neuron.2008.08.012; Auerbach BD, 2011, NATURE, V480, P63, DOI 10.1038/nature10658; Bai XC, 2007, SCIENCE, V318, P977, DOI 10.1126/science.1147379; Barria A, 2005, NEURON, V48, P289, DOI 10.1016/j.neuron.2005.08.034; Bateup HS, 2011, J NEUROSCI, V31, P8862, DOI 10.1523/JNEUROSCI.1617-11.2011; Berglund K, 2002, J NEUROSCI, V22, P4776, DOI 10.1523/JNEUROSCI.22-12-04776.2002; Bhattacharya A, 2012, NEURON, V76, P325, DOI 10.1016/j.neuron.2012.07.022; Blackman MP, 2012, J NEUROSCI, V32, P13529, DOI 10.1523/JNEUROSCI.3077-12.2012; Brigman JL, 2010, J NEUROSCI, V30, P4590, DOI 10.1523/JNEUROSCI.0640-10.2010; Carroll RC, 1998, J NEUROPHYSIOL, V80, P2797, DOI 10.1152/jn.1998.80.5.2797; Chen HJ, 1998, NEURON, V20, P895, DOI 10.1016/S0896-6273(00)80471-7; Chen HX, 2003, J NEUROPHYSIOL, V89, P2482, DOI 10.1152/jn.01031.2002; Clement JP, 2012, CELL, V151, P709, DOI 10.1016/j.cell.2012.08.045; Desai NS, 2002, NAT NEUROSCI, V5, P783, DOI 10.1038/nn878; Di Cristo G, 2001, SCIENCE, V292, P2337, DOI 10.1126/science.1059075; Dieterich DC, 2010, NAT NEUROSCI, V13, P897, DOI 10.1038/nn.2580; El Gaamouch F, 2012, J NEUROSCI, V32, P10767, DOI 10.1523/JNEUROSCI.5622-11.2012; Fonseca BD, 2011, J BIOL CHEM, V286, P27111, DOI 10.1074/jbc.M111.260794; Foster KA, 2010, J NEUROSCI, V30, P2676, DOI 10.1523/JNEUROSCI.4022-09.2010; Gelinas JN, 2007, J BIOL CHEM, V282, P27527, DOI 10.1074/jbc.M701077200; Gkogkas CG, 2013, NATURE, V493, P371, DOI 10.1038/nature11628; Gobert D, 2008, J NEUROCHEM, V106, P1160, DOI 10.1111/j.1471-4159.2008.05470.x; Gray JA, 2011, NEURON, V71, P1085, DOI 10.1016/j.neuron.2011.08.007; Guo XC, 2009, NEUROPSYCHOPHARMACOL, V34, P1659, DOI 10.1038/npp.2008.223; Hagerman RJ, 2009, PEDIATRICS, V123, P378, DOI 10.1542/peds.2008-0317; Hall BJ, 2008, TRENDS NEUROSCI, V31, P82, DOI 10.1016/j.tins.2007.11.010; Hall BJ, 2007, J NEUROSCI, V27, P13446, DOI 10.1523/JNEUROSCI.3793-07.2007; Halt AR, 2012, EMBO J, V31, P1203, DOI 10.1038/emboj.2011.482; Hamdan FF, 2011, BIOL PSYCHIAT, V69, P898, DOI 10.1016/j.biopsych.2010.11.015; Hamdan FF, 2009, NEW ENGL J MED, V360, P599, DOI 10.1056/NEJMoa0805392; Henry FE, 2012, J NEUROSCI, V32, P17128, DOI 10.1523/JNEUROSCI.2149-12.2012; Hoeffer CA, 2012, GENES BRAIN BEHAV, V11, P332, DOI 10.1111/j.1601-183X.2012.00768.x; Hoeffer CA, 2010, TRENDS NEUROSCI, V33, P67, DOI 10.1016/j.tins.2009.11.003; Inoki K, 2003, GENE DEV, V17, P1829, DOI 10.1101/gad.1110003; Iossifov I, 2012, NEURON, V74, P285, DOI 10.1016/j.neuron.2012.04.009; Ju W, 2004, NAT NEUROSCI, V7, P244, DOI 10.1038/nn1189; Kelleher RJ, 2008, CELL, V135, P401, DOI 10.1016/j.cell.2008.10.017; Kelleher RJ, 2004, CELL, V116, P467, DOI 10.1016/S0092-8674(04)00115-1; Kim JH, 2003, J NEUROSCI, V23, P1119; Kim JH, 1998, NEURON, V20, P683, DOI 10.1016/S0896-6273(00)81008-9; Kim MJ, 2005, NEURON, V46, P745, DOI 10.1016/j.neuron.2005.04.031; Kogan MD, 2009, PEDIATRICS, V124, P1395, DOI 10.1542/peds.2009-1522; Komiyama NH, 2002, J NEUROSCI, V22, P9721; Krapivinsky G, 2004, NEURON, V43, P563, DOI 10.1016/j.neuron.2004.08.003; Krepischi ACV, 2010, AM J MED GENET A, V152A, P2376, DOI 10.1002/ajmg.a.33554; Kumar SS, 2002, J NEUROSCI, V22, P3005, DOI 10.1523/JNEUROSCI.22-08-03005.2002; Kutsuwada T, 1996, NEURON, V16, P333, DOI 10.1016/S0896-6273(00)80051-3; Leonard AS, 1999, P NATL ACAD SCI USA, V96, P3239, DOI 10.1073/pnas.96.6.3239; Luikart BW, 2011, J NEUROSCI, V31, P4345, DOI 10.1523/JNEUROSCI.0061-11.2011; Ma L, 2005, CELL, V121, P179, DOI 10.1016/j.cell.2005.02.031; Ma T, 2011, J NEUROSCI, V31, P17537, DOI 10.1523/JNEUROSCI.4761-11.2011; McMahon AC, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1900; O'Donnell WT, 2002, ANNU REV NEUROSCI, V25, P315, DOI 10.1146/annurev.neuro.25.112701.142909; O'Roak BJ, 2012, NATURE, V485, P246, DOI 10.1038/nature10989; Oh JS, 2004, J BIOL CHEM, V279, P17980, DOI 10.1074/jbc.M314109200; Osterweil EK, 2010, J NEUROSCI, V30, P15616, DOI 10.1523/JNEUROSCI.3888-10.2010; Penagarikano O, 2007, ANNU REV GENOM HUM G, V8, P109, DOI 10.1146/annurev.genom.8.080706.092249; Pi HJ, 2010, J NEUROSCI, V30, P8704, DOI 10.1523/JNEUROSCI.0133-10.2010; Pozo K, 2010, NEURON, V66, P337, DOI 10.1016/j.neuron.2010.04.028; Qin M, 2005, J NEUROSCI, V25, P5087, DOI 10.1523/JNEUROSCI.0093-05.2005; Rubenstein JLR, 2003, GENES BRAIN BEHAV, V2, P255, DOI 10.1034/j.1601-183X.2003.00037.x; Rumbaugh G, 2006, P NATL ACAD SCI USA, V103, P4344, DOI 10.1073/pnas.0600084103; Santini E, 2013, NATURE, V493, P411, DOI 10.1038/nature11782; Schmitt JM, 2005, J NEUROSCI, V25, P1281, DOI 10.1523/JNEUROSCI.4086-04.2005; Sharma A, 2010, J NEUROSCI, V30, P694, DOI 10.1523/JNEUROSCI.3696-09.2010; Shepherd JD, 2006, NEURON, V52, P475, DOI 10.1016/j.neuron.2006.08.034; Slipczuk L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006007; Stoica L, 2011, P NATL ACAD SCI USA, V108, P3791, DOI 10.1073/pnas.1014715108; Strack S, 2000, J BIOL CHEM, V275, P23798, DOI 10.1074/jbc.M001471200; Strack S, 1998, J BIOL CHEM, V273, P20689, DOI 10.1074/jbc.273.33.20689; Sutton MA, 2006, CELL, V125, P785, DOI 10.1016/j.cell.2006.03.040; Tang SJ, 2002, P NATL ACAD SCI USA, V99, P467, DOI 10.1073/pnas.012605299; Tsokas P, 2007, J NEUROSCI, V27, P5885, DOI 10.1523/JNEUROSCI.4548-06.2007; Turrigiano GG, 2004, NAT REV NEUROSCI, V5, P97, DOI 10.1038/nrn1327; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103; Turrigiano GG, 2008, CELL, V135, P422, DOI 10.1016/j.cell.2008.10.008; Vazquez LE, 2004, J NEUROSCI, V24, P8862, DOI 10.1523/JNEUROSCI.3213-04.2004; Wang CC, 2011, NEURON, V72, P789, DOI 10.1016/j.neuron.2011.09.023; Wierenga CJ, 2005, J NEUROSCI, V25, P2895, DOI 10.1523/JNEUROSCI.5217-04.2005; Wu XS, 2001, J NEUROSCI, V21, P7928, DOI 10.1523/JNEUROSCI.21-20-07928.2001; YAMAGATA K, 1994, J BIOL CHEM, V269, P16333; Yang Y, 2011, NEUROSCIENCE, V192, P132, DOI 10.1016/j.neuroscience.2011.06.061; Yasuda H, 2003, NAT NEUROSCI, V6, P15, DOI 10.1038/nn985; Ying SW, 2002, J NEUROSCI, V22, P1532, DOI 10.1523/JNEUROSCI.22-05-01532.2002; Zhang Y, 2003, NAT CELL BIOL, V5, P578, DOI 10.1038/ncb999	86	12	14	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83941	10.1371/journal.pone.0083941	http://dx.doi.org/10.1371/journal.pone.0083941			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391850	gold, Green Published, Green Submitted			2022-12-25	WOS:000329325200148
J	Jia, XM; Zheng, SH; Xie, XX; Zhang, YJ; Wang, WZ; Wang, ZS; Zhang, Y; Wang, JR; Gao, M; Hou, YL				Jia, Xiaomeng; Zheng, Shaohua; Xie, Xinxing; Zhang, Yujiao; Wang, Weizong; Wang, Zhongsu; Zhang, Yong; Wang, Jiangrong; Gao, Mei; Hou, Yinglong			MicroRNA-1 Accelerates the Shortening of Atrial Effective Refractory Period by Regulating KCNE1 and KCNB2 Expression: An Atrial Tachypacing Rabbit Model	PLOS ONE			English	Article							CARDIAC POTASSIUM CURRENT; MUSCLE-SPECIFIC MICRORNA; K+ CHANNEL; DOWN-REGULATION; FIBRILLATION; MYOCYTES; GENES; PROFILES; K(V)LQT1; PROTEINS	Background: The potential mechanisms of microRNA-1 (miR-1) in the electrical remodeling of atrial fibrillation remain unclear. The purpose of this study was to evaluate the effects of miR-1 on the atrial effective refractory period (AERP) in a right atrial tachypacing model and to elucidate the potential mechanisms. Methods and Results: QRT-PCR and western blot were used to detect the expression of the miR-1, KCNE1, and KCNB2 genes after 1-week of right atrial tachypacing in New Zealand white rabbits. The AERP was measured using a programmable multichannel stimulator, and atrial fibrillation was induced by burst stimulation in vivo. The slowly activating delayed rectifier potassium current (IKs) and AERP in atrial cells were measured by whole cell patch clamp in vitro. Right atrial tachypacing upregulated miR-1 expression and downregulated KCNE1 and KCNB2 in this study, while the AERP was decreased and the atrial IKs increased. The downregulation of KCNE1 and KCNB2 levels was greater when miR-1 was further upregulated through in vivo lentiviral infection. Electrophysiological tests indicated a shorter AERP, a great increase in the IKs and a higher atrial fibrillation inducibility. In addition, similar results were found when the levels of KCNE1 and KCNB2 were downregulated by small interfering RNA while keeping miR-1 level unaltered. Conversely, knockdown of miR-1 by anti-miR-1 inhibitor oligonucleotides alleviated the downregulation of KCNE1 and KCNB2, the shortening of AERP, and the increase in the IKs. KCNE1 and KCNB2 as the target genes for miR-1 were confirmed by luciferase activity assay. Conclusions: These results indicate that miR-1 accelerates right atrial tachypacing-induced AERP shortening by targeting potassium channel genes, which further suggests that miR-1 plays an important role in the electrical remodeling of atrial fibrillation and exhibits significant clinical relevance as a potential therapeutic target for atrial fibrillation.	[Jia, Xiaomeng; Zheng, Shaohua; Xie, Xinxing; Zhang, Yujiao; Wang, Weizong; Wang, Zhongsu; Zhang, Yong; Wang, Jiangrong; Gao, Mei; Hou, Yinglong] Shandong Univ, Shandong Prov Qianfoshan Hosp, Dept Cardiol, Jinan 250100, Shandong, Peoples R China	Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University	Hou, YL (corresponding author), Shandong Univ, Shandong Prov Qianfoshan Hosp, Dept Cardiol, Jinan 250100, Shandong, Peoples R China.	black.berry.1984@163.com	WANG, WEIZONG/A-2039-2012	WANG, WEIZONG/0000-0002-6022-1441	Ph.D. Programs Foundation of Ministry of Education of China [20110131110063]; National Natural Science Foundation of China [81270237]; Science and Technology Development Planning of Shandong Province [2011GSF11837]	Ph.D. Programs Foundation of Ministry of Education of China(Ministry of Education, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Development Planning of Shandong Province	This work was supported by the Ph.D. Programs Foundation of Ministry of Education of China (No. 20110131110063), the National Natural Science Foundation of China (No. 81270237) and the Science and Technology Development Planning of Shandong Province (No. 2011GSF11837). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barhanin J, 1996, NATURE, V384, P78, DOI 10.1038/384078a0; Brahmajothi MV, 1996, CIRC RES, V78, P1083, DOI 10.1161/01.RES.78.6.1083; Burstein B, 2008, J AM COLL CARDIOL, V51, P802, DOI 10.1016/j.jacc.2007.09.064; Cooley N, 2012, PHYSIOL GENOMICS, V44, P211, DOI 10.1152/physiolgenomics.00111.2011; Frey BW, 2000, NEUROGASTROENT MOTIL, V12, P509, DOI 10.1046/j.1365-2982.2000.00225.x; Gelband CH, 1999, CIRC RES, V84, P352, DOI 10.1161/01.RES.84.3.352; Girmatsion Z, 2009, HEART RHYTHM, V6, P1802, DOI 10.1016/j.hrthm.2009.08.035; GROSS GJ, 1995, CARDIOVASC RES, V29, P112, DOI 10.1016/0008-6363(96)88555-5; Heck A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029337; Heerdt PM, 2012, J MOL CELL CARDIOL, V53, P350, DOI 10.1016/j.yjmcc.2012.05.010; Kamiyama N, 1998, JPN CIRC J, V62, P837, DOI 10.1253/jcj.62.837; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Liang Y, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-166; Lim ST, 2000, NEURON, V25, P385, DOI 10.1016/S0896-6273(00)80902-2; Lu YJ, 2010, CIRCULATION, V122, P2378, DOI 10.1161/CIRCULATIONAHA.110.958967; Luo XB, 2010, CELL PHYSIOL BIOCHEM, V25, P571, DOI 10.1159/000315076; Murphy NF, 2007, HEART, V93, P606, DOI 10.1136/hrt.2006.107573; Ninio DM, 2005, J CARDIOVASC ELECTR, V16, P1189, DOI 10.1111/j.1540-8167.2005.50007.x; Sanguinetti MC, 1996, NATURE, V384, P80, DOI 10.1038/384080a0; Temple J, 2005, CIRC RES, V97, P62, DOI 10.1161/01.RES.0000173047.42236.88; Terentyev D, 2009, CIRC RES, V104, P514, DOI 10.1161/CIRCRESAHA.108.181651; Thibault K, 2012, PAIN, V153, P1636, DOI 10.1016/j.pain.2012.04.016; Wang ZG, 2011, CARDIOVASC RES, V89, P710, DOI 10.1093/cvr/cvq350; Workman AJ, 1999, CARDIOVASC RES, V43, P974, DOI 10.1016/S0008-6363(99)00166-2; Xiao L, 2008, CIRCULATION, V118, P983, DOI 10.1161/CIRCULATIONAHA.107.758672; Xu CL, 1999, AM J PHYSIOL-GASTR L, V277, pG1055, DOI 10.1152/ajpgi.1999.277.5.G1055; Yan LZ, 2004, DIABETES, V53, P597, DOI 10.2337/diabetes.53.3.597; Yang BF, 2008, CARDIOVASC RES, V79, P571, DOI 10.1093/cvr/cvn181; Yang BF, 2007, NAT MED, V13, P486, DOI 10.1038/nm1569; Yu JH, 2011, CELL PHYSIOL BIOCHEM, V28, P87, DOI 10.1159/000331717; Yu LL, 2012, HEART RHYTHM, V9, P804, DOI 10.1016/j.hrthm.2011.12.023; Zhao Y, 2005, NATURE, V436, P214, DOI 10.1038/nature03817	33	20	22	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e85639	10.1371/journal.pone.0085639	http://dx.doi.org/10.1371/journal.pone.0085639			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386485	gold, Green Published, Green Submitted			2022-12-25	WOS:000329194700144
J	Kohler, EE; Wary, KK; Li, F; Chatterjee, I; Urao, N; Toth, PT; Ushio-Fukai, M; Rehman, J; Park, C; Malik, AB				Kohler, Erin E.; Wary, Kishore K.; Li, Fei; Chatterjee, Ishita; Urao, Norifumi; Toth, Peter T.; Ushio-Fukai, Masuko; Rehman, Jalees; Park, Changwon; Malik, Asrar B.			Flk1+and VE-Cadherin plus Endothelial Cells Derived from iPSCs Recapitulates Vascular Development during Differentiation and Display Similar Angiogenic Potential as ESC-Derived Cells	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; PROGENITOR CELLS; BONE-MARROW; EXPRESSION; MESODERM; INDUCTION; BLOOD; VASCULOGENESIS; LETHALITY; PRECURSOR	Rationale: Induced pluripotent stem (iPS) cells have emerged as a source of potentially unlimited supply of autologous endothelial cells (ECs) for vascularization. However, the regenerative function of these cells relative to adult ECs and ECs derived from embryonic stem (ES) cells is unknown. The objective was to define the differentiation characteristics and vascularization potential of Fetal liver kinase (Flk)1(+) and Vascular Endothelial (VE)-cadherin(+) ECs derived identically from mouse (m) ES and miPS cells. Methods and Results: Naive mES and miPS cells cultured in type IV collagen (IV Col) in defined media for 5 days induced the formation of adherent cell populations, which demonstrated similar expression of Flk1 and VE-cadherin and the emergence of EC progenies. FACS purification resulted in 100% Flk1(+) VE-cadherin(+) cells from both mES and miPS cells. Emergence of Flk1(+) VE-cadherin(+) cells entailed expression of the vascular developmental transcription factor Er71, which bound identically to Flk1, VE-cadherin, and CD31 promoters in both populations. Immunostaining with anti-VE-cadherin and anti-CD31 antibodies and microscopy demonstrated the endothelial nature of these cells. Each cell population (unlike mature ECs) organized into well-developed vascular structures in vitro and incorporated into CD31(+) neovessels in matrigel plugs implanted in nude mice in vivo. Conclusion: Thus, iPS cell-derived Flk1(+) VE-cadherin(+) cells expressing the Er71 are as angiogenic as mES cell-derived cells and incorporate into CD31(+) neovessels. Their vessel forming capacity highlights the potential of autologous iPS cells-derived EC progeny for therapeutic angiogenesis.	[Kohler, Erin E.; Wary, Kishore K.; Li, Fei; Chatterjee, Ishita; Urao, Norifumi; Ushio-Fukai, Masuko; Rehman, Jalees; Park, Changwon; Malik, Asrar B.] Univ Illinois, Dept Pharmacol, Chicago, IL 60607 USA; [Kohler, Erin E.; Wary, Kishore K.; Li, Fei; Chatterjee, Ishita; Urao, Norifumi; Ushio-Fukai, Masuko; Rehman, Jalees; Park, Changwon; Malik, Asrar B.] Univ Illinois, Ctr Lung & Vasc Biol, Chicago, IL USA; [Toth, Peter T.] Univ Illinois, Res Resources Ctr, Chicago, IL USA; [Rehman, Jalees] Univ Illinois, Dept Med, Cardiol Sect, Chicago, IL USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Wary, KK (corresponding author), Univ Illinois, Dept Pharmacol, Chicago, IL 60607 USA.	kkwary@uic.edu	Rehman, Jalees/GVU-1981-2022; Rehman, Jalees/J-8258-2012; Urao, Norifumi/O-7313-2015	Rehman, Jalees/0000-0002-2787-9292; Rehman, Jalees/0000-0002-2787-9292; Urao, Norifumi/0000-0001-9750-8406; Wary, Kishore/0000-0001-8851-8565; Malik, Asrar/0000-0002-8205-7128; Toth, Peter/0000-0003-2168-0124	National Institutes of Health [HL079356, HL112293, GM094220, HL090152]; American Heart Association [12PRE1208000, 12GRNT12070159]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL090152, R21HL112293, R01HL079356] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM094220] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the National Institutes of Health to KKW (HL079356), MUF (HL112293), JR (GM094220), and ABM (HL090152), and awards from the American Heart Association to EEK (12PRE1208000) and KKW (12GRNT12070159). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams WJ, 2013, STEM CELL REP, V1, P105, DOI 10.1016/j.stemcr.2013.06.007; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Boland MJ, 2009, NATURE, V461, P91, DOI 10.1038/nature08310; Breier G, 1996, BLOOD, V87, P630, DOI 10.1182/blood.V87.2.630.bloodjournal872630; Carmeliet P, 1996, NATURE, V380, P435, DOI 10.1038/380435a0; Chappell JC, 2013, ARTERIOSCL THROM VAS, V33, P1952, DOI 10.1161/ATVBAHA.113.301805; Choi K, 1998, DEVELOPMENT, V125, P725; Chun CZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014732; Cowan CE, 2010, CIRC RES, V107, P959, DOI 10.1161/CIRCRESAHA.110.219592; De Val S, 2008, CELL, V135, P1053, DOI 10.1016/j.cell.2008.10.049; Faber JE, 2012, CIRC RES, V110, P192, DOI 10.1161/CIRCRESAHA.111.261495; Feng Q, 2010, STEM CELLS, V28, P704, DOI 10.1002/stem.321; Ferrara N, 1996, NATURE, V380, P439, DOI 10.1038/380439a0; Hanna JH, 2010, CELL, V143, P508, DOI 10.1016/j.cell.2010.10.008; Hirschi KK, 2008, ARTERIOSCL THROM VAS, V28, P1584, DOI 10.1161/ATVBAHA.107.155960; Huber TL, 2004, NATURE, V432, P625, DOI 10.1038/nature03122; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Kataoka H, 2011, BLOOD, V118, P6975, DOI 10.1182/blood-2011-05-352658; Kohler EE, 2011, BLOOD, V117, P1761, DOI 10.1182/blood-2010-07-295261; Lee D, 2008, CELL STEM CELL, V2, P497, DOI 10.1016/j.stem.2008.03.008; Levenberg S, 2007, BLOOD, V110, P806, DOI 10.1182/blood-2006-08-019190; Liu F, 2012, BLOOD, V119, P3295, DOI 10.1182/blood-2012-01-403766; Losordo DW, 2004, CIRCULATION, V109, P2692, DOI 10.1161/01.CIR.0000128596.49339.05; Narazaki G, 2008, CIRCULATION, V118, P498, DOI 10.1161/CIRCULATIONAHA.108.769562; Palencia-Desai S, 2011, DEVELOPMENT, V138, P4721, DOI 10.1242/dev.064998; Park C, 2013, CIRC RES, V112, P1380, DOI 10.1161/CIRCRESAHA.113.301078; Quinlan AR, 2011, CELL STEM CELL, V9, P366, DOI 10.1016/j.stem.2011.07.018; Ramirez-Bergeron DL, 2004, DEVELOPMENT, V131, P4623, DOI 10.1242/dev.01310; Rasmussen TL, 2011, DEVELOPMENT, V138, P4801, DOI 10.1242/dev.070912; Rufaihah AJ, 2011, ARTERIOSCL THROM VAS, V31, pE72, DOI 10.1161/ATVBAHA.111.230938; SHALABY F, 1995, NATURE, V376, P62, DOI 10.1038/376062a0; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Takahashi T, 1999, NAT MED, V5, P434, DOI 10.1038/7434; Taura D, 2009, ARTERIOSCL THROM VAS, V29, P1100, DOI 10.1161/ATVBAHA.108.182162; Urao N, 2008, CIRC RES, V103, P212, DOI 10.1161/CIRCRESAHA.108.176230; van Bueren KL, 2012, CURR OPIN HEMATOL, V19, P199, DOI 10.1097/MOH.0b013e3283523e07; Vittet D, 1997, P NATL ACAD SCI USA, V94, P6273, DOI 10.1073/pnas.94.12.6273; Vittet D, 1996, BLOOD, V88, P3424, DOI 10.1182/blood.V88.9.3424.bloodjournal8893424; Vodyanik MA, 2010, CELL STEM CELL, V7, P718, DOI 10.1016/j.stem.2010.11.011; Wary KK, 2009, STEM CELLS, V27, P3112, DOI 10.1002/stem.241; Yamashita J, 2000, NATURE, V408, P92, DOI 10.1038/35040568; Yin LY, 2012, CIRC RES, V110, P241, DOI 10.1161/CIRCRESAHA.111.250126; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	44	27	30	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e85549	10.1371/journal.pone.0085549	http://dx.doi.org/10.1371/journal.pone.0085549			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386480	Green Submitted, gold, Green Published			2022-12-25	WOS:000329194700140
J	Wang, Q; Hu, WN; Lei, MM; Wang, Y; Yan, B; Liu, J; Zhang, R; Jin, YZ				Wang, Qi; Hu, Weina; Lei, Mingming; Wang, Yong; Yan, Bing; Liu, Jun; Zhang, Ren; Jin, Yuanzhe			MiR-17-5p Impairs Trafficking of H-ERG K+ Channel Protein by Targeting Multiple ER Stress-Related Chaperones during Chronic Oxidative Stress	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; LONG QT SYNDROME; HEART-FAILURE; PHARMACOLOGICAL RESCUE; CARDIAC-HYPERTROPHY; ATRIAL-FIBRILLATION; RAT CARDIOMYOCYTES; POTASSIUM CHANNEL; HERG TRAFFICKING; MUTANT CHANNELS	Background: To investigate if microRNAs (miRNAs) play a role in regulating h-ERG trafficking in the setting of chronic oxidative stress as a common deleterious factor for many cardiac disorders. Methods: We treated neonatal rat ventricular myocytes and HEK293 cells with stable expression of h-ERG with H2O2 for 12 h and 48 h. Expression of miR-17-5p seed miRNAs was quantified by real-time RT-PCR. Protein levels of chaperones and h-ERG trafficking were measured by Western blot analysis. Luciferase reporter gene assay was used to study miRNA and target interactions. Whole-cell patch-clamp techniques were employed to record h-ERG K+ current. Results: H-ERG trafficking was impaired by H2O2 after 48 h treatment, accompanied by reciprocal changes of expression between miR-17-5p seed miRNAs and several chaperones (Hsp70, Hsc70, CANX, and Golga2), with the former upregulated and the latter downregulated. We established these chaperones as targets for miR-17-5p. Application miR-17-5p inhibitor rescued H2O2-induced impairment of h-ERG trafficking. Upregulation of endogenous by H2O2 or forced miR-17-5p expression either reduced h-ERG current. Sequestration of AP1 by its decoy molecule eliminated the upregulation of miR-17-5p, and ameliorated impairment of h-ERG trafficking. Conclusions: Collectively, deregulation of the miR-17-5p seed family miRNAs can cause severe impairment of h-ERG trafficking through targeting multiple ER stress-related chaperones, and activation of AP1 likely accounts for the deleterious upregulation of these miRNAs, in the setting of prolonged duration of oxidative stress. These findings revealed the role of miRNAs in h-ERG trafficking, which may contribute to the cardiac electrical disturbances associated with oxidative stress.	[Wang, Qi; Hu, Weina; Lei, Mingming; Wang, Yong; Yan, Bing; Liu, Jun; Zhang, Ren; Jin, Yuanzhe] China Med Univ, Affiliated Hosp 4, Shenyang, Liaoning Provin, Peoples R China	China Medical University	Jin, YZ (corresponding author), China Med Univ, Affiliated Hosp 4, Shenyang, Liaoning Provin, Peoples R China.	cmujyz@gmail.com						Alfonso-Jaume MA, 2006, AM J PHYSIOL-HEART C, V291, pH1838, DOI 10.1152/ajpheart.00026.2006; Baaklini I, 2012, J BIOL CHEM, V287, P41939, DOI 10.1074/jbc.M112.413278; Bai YL, 2007, CELL PHYSIOL BIOCHEM, V20, P429, DOI 10.1159/000107527; Belevych AE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028324; Bhandary B, 2013, INT J MOL SCI, V14, P434, DOI 10.3390/ijms14010434; Byrne JA, 2003, ARCH MAL COEUR VAISS, V96, P214; Carrillo ED, 2011, J CARDIOVASC PHARM, V58, P470, DOI 10.1097/FJC.0b013e31822a789b; Delisle BP, 2009, J BIOL CHEM, V284, P2844, DOI 10.1074/jbc.M807289200; Dennis A, 2007, BIOCHEM SOC T, V35, P1060, DOI 10.1042/BST0351060; Dickhout JG, 2011, CIRC RES, V108, P629, DOI 10.1161/CIRCRESAHA.110.226803; Elmen J, 2005, NUCLEIC ACIDS RES, V33, P439, DOI 10.1093/nar/gki193; Ficker E, 2003, CIRC RES, V92, pE87, DOI 10.1161/01.RES.0000079028.31393.15; Gong QM, 2006, J BIOL CHEM, V281, P4069, DOI 10.1074/jbc.M511765200; Gonzalez-Gronow M, 2009, ANTIOXID REDOX SIGN, V11, P2299, DOI [10.1089/ars.2009.2568, 10.1089/ARS.2009.2568]; Grieve David J, 2004, Heart Lung Circ, V13, P132, DOI 10.1016/j.hlc.2004.02.008; Groenendyk J, 2010, CIRC RES, V107, P1185, DOI 10.1161/CIRCRESAHA.110.227033; Guo J, 2007, J PHARMACOL EXP THER, V321, P911, DOI 10.1124/jpet.107.120931; Hosoi T, 2010, CLIN SCI, V118, P19, DOI 10.1042/CS20080680; Lu YJ, 2010, CIRCULATION, V122, P2378, DOI 10.1161/CIRCULATIONAHA.110.958967; Luo XB, 2013, J CLIN INVEST, V123, P1939, DOI 10.1172/JCI62185; Malhotra JD, 2007, ANTIOXID REDOX SIGN, V9, P2277, DOI 10.1089/ars.2007.1782; Marban E, 2002, NATURE, V415, P213, DOI 10.1038/415213a; Maulik SK, 2012, TOXICOL MECH METHOD, V22, P359, DOI 10.3109/15376516.2012.666650; Maurel M, 2013, AM J PHYSIOL-CELL PH, V304, pC1117, DOI 10.1152/ajpcell.00061.2013; Mendell JT, 2008, CELL, V133, P217, DOI 10.1016/j.cell.2008.04.001; Minamino T, 2010, CIRC RES, V107, P1071, DOI 10.1161/CIRCRESAHA.110.227819; Obad S, 2011, NAT GENET, V43, P371, DOI 10.1038/ng.786; PENG M, 1995, CELL MOL BIOL RES, V41, P189; Peterson LB, 2012, MOL PHARMACEUT, V9, P1841, DOI 10.1021/mp300138n; Petrocca F, 2008, CANCER RES, V68, P8191, DOI 10.1158/0008-5472.CAN-08-1768; Priebe L, 1998, CIRC RES, V82, P1206, DOI 10.1161/01.RES.82.11.1206; Quinones QJ, 2008, HISTOL HISTOPATHOL, V23, P1409, DOI 10.14670/HH-23.1409; Robertson GA, 2006, HANDB EXP PHARMACOL, V171, P349; Serva A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052555; Smith JL, 2011, AM J PHYSIOL-CELL PH, V301, pC75, DOI 10.1152/ajpcell.00494.2010; Staudacher I, 2010, CURR OPIN DRUG DISC, V13, P23; Thomas M, 2012, RNA BIOL, V9, P1088, DOI 10.4161/rna.21165; Townsend Claire, 2013, Curr Protoc Pharmacol, VChapter 10, DOI 10.1002/0471141755.ph1016s61; Turczynska KM, 2012, J BIOL CHEM, V287, P19199, DOI 10.1074/jbc.M112.341073; Vandenberg JI, 2012, PHYSIOL REV, V92, P1393, DOI 10.1152/physrev.00036.2011; Walker VE, 2007, J BIOL CHEM, V282, P23509, DOI 10.1074/jbc.M701006200; Walker VE, 2010, J BIOL CHEM, V285, P3319, DOI 10.1074/jbc.M109.024000; Wang JX, 2004, J BIOL CHEM, V279, P13289, DOI 10.1074/jbc.C400025200; Wang Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029885; Wu SL, 2005, FREE RADICAL BIO MED, V39, P1601, DOI 10.1016/j.freeradbiomed.2005.08.006; Yang BF, 2007, NAT MED, V13, P486, DOI 10.1038/nm1569; Zhang YQ, 2006, AM J PHYSIOL-HEART C, V291, pH1446, DOI 10.1152/ajpheart.01356.2005; Zhang YQ, 2011, CELL PHYSIOL BIOCHEM, V28, P97, DOI 10.1159/000331718; Zhang YQ, 2003, J BIOL CHEM, V278, P10417, DOI 10.1074/jbc.M211044200	49	9	10	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e84984	10.1371/journal.pone.0084984	http://dx.doi.org/10.1371/journal.pone.0084984			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386440	Green Submitted, Green Published, gold			2022-12-25	WOS:000329194700125
J	Wong, VK; Pickard, DJ; Barquist, L; Sivaraman, K; Page, AJ; Hart, PJ; Arends, MJ; Holt, KE; Kane, L; Mottram, LF; Ellison, L; Bautista, R; McGee, CJ; Kay, SJ; Wileman, TM; Kenney, LJ; MacLennan, CA; Kingsley, RA; Dougan, G				Wong, Vanessa K.; Pickard, Derek J.; Barquist, Lars; Sivaraman, Karthikeyan; Page, Andrew J.; Hart, Peter J.; Arends, Mark J.; Holt, Kathryn E.; Kane, Leanne; Mottram, Lynda F.; Ellison, Louise; Bautista, Ruben; McGee, Chris J.; Kay, Sally J.; Wileman, Thomas M.; Kenney, Linda J.; MacLennan, Calman A.; Kingsley, Robert A.; Dougan, Gordon			Characterization of the yehUT Two-Component Regulatory System of Salmonella enterica Serovar Typhi and Typhimurium	PLOS ONE			English	Article							SIGNAL-TRANSDUCTION SYSTEMS; CARBON STARVATION GENE; ESCHERICHIA-COLI K-12; RESPONSE REGULATORS; FUNCTIONAL-CHARACTERIZATION; SEROTYPE TYPHIMURIUM; CHROMOSOMAL GENES; CROSS-REGULATION; CYCLIC-AMP; IN-VITRO	Proteins exhibiting hyper-variable sequences within a bacterial pathogen may be associated with host adaptation. Several lineages of the monophyletic pathogen Salmonella enterica serovar Typhi (S. Typhi) have accumulated non-synonymous mutations in the putative two-component regulatory system yehUT. Consequently we evaluated the function of yehUT in S. Typhi BRD948 and S. Typhimurium ST4/74. Transcriptome analysis identified the cstA gene, encoding a carbon starvation protein as the predominantly yehUT regulated gene in both these serovars. Deletion of yehUT had no detectable effect on the ability of these mutant Salmonella to invade cultured epithelial cells (S. Typhi and S. Typhimurium) or induce colitis in a murine model (S. Typhimurium only). Growth, metabolic and antimicrobial susceptibility tests identified no obvious influences of yehUT on these phenotypes.	[Wong, Vanessa K.; Pickard, Derek J.; Barquist, Lars; Page, Andrew J.; Kane, Leanne; Mottram, Lynda F.; Ellison, Louise; Bautista, Ruben; McGee, Chris J.; Kay, Sally J.; Wileman, Thomas M.; Kingsley, Robert A.; Dougan, Gordon] Wellcome Trust Sanger Inst, Cambridge, England; [Wong, Vanessa K.; Arends, Mark J.] Univ Cambridge, Addenbrookes Hosp, Dept Pathol, Cambridge CB2 2QQ, England; [Barquist, Lars; Sivaraman, Karthikeyan] European Bioinformat Inst EMBL EBI, European Mol Biol Lab, Cambridge, England; [Sivaraman, Karthikeyan] Posit Biosci Ltd, Bombay, Maharashtra, India; [Hart, Peter J.; MacLennan, Calman A.] Univ Birmingham, MRC, Ctr Immune Regulat, Birmingham, W Midlands, England; [Hart, Peter J.; MacLennan, Calman A.] Univ Birmingham, Clin Immunol Serv, Inst Biomed Res, Sch Immun & Infect,Coll Med & Dent Sci, Birmingham, W Midlands, England; [Arends, Mark J.] Univ Edinburgh, Western Gen Hosp, Div Pathol, Edinburgh Canc Res Ctr,Inst Genet & Mol Med, Edinburgh, Midlothian, Scotland; [Holt, Kathryn E.] Univ Melbourne, Dept Biochem & Mol Biol, Parkville, Vic 3052, Australia; [Holt, Kathryn E.] Univ Melbourne, Mol Sci & Biotechnol Inst Bio21, Parkville, Vic 3052, Australia; [Mottram, Lynda F.; MacLennan, Calman A.] Novartis Vaccines Inst Global Hlth, Siena, Italy; [Kenney, Linda J.] Natl Univ Singapore, Mechanobiol Inst, T Lab, Singapore 117548, Singapore; [Kenney, Linda J.] Univ Illinois, Dept Microbiol & Immunol MC 790, Chicago, IL USA	Wellcome Trust Sanger Institute; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; European Molecular Biology Laboratory (EMBL); University of Birmingham; University of Birmingham; University of Edinburgh; University of Melbourne; University of Melbourne; Novartis; National University of Singapore; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Kingsley, RA (corresponding author), Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Cambridge, England.	rak@sanger.ac.uk	Jung, Kirsten/K-4196-2014; Barquist, Lars/H-6529-2019; MacLennan, Calman A/L-9343-2014; Holt, Kathryn E/A-8108-2012	Jung, Kirsten/0000-0003-0779-6841; Barquist, Lars/0000-0003-4732-2667; MacLennan, Calman A/0000-0001-9694-0846; Holt, Kathryn E/0000-0003-3949-2471; Page, Andrew/0000-0001-6919-6062; Wileman, Thomas/0000-0002-5211-5016; Kingsley, Robert/0000-0002-0194-6485	Wellcome Trust [09805]; MRC [G9818340] Funding Source: UKRI; Medical Research Council [G9818340] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Wellcome Trust (Grant no: 09805; http://www.wellcome.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett T, 2011, NUCLEIC ACIDS RES, V39, pD1005, DOI 10.1093/nar/gkq1184; Barthel M, 2003, INFECT IMMUN, V71, P2839, DOI 10.1128/IAI.71.5.2839-2858.2003; BLUM PH, 1990, J BACTERIOL, V172, P3813, DOI 10.1128/jb.172.7.3813-3820.1990; Bochner BR, 2001, GENOME RES, V11, P1246, DOI 10.1101/gr.186501; Chan W, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm163; CHEREPANOV PP, 1995, GENE, V158, P9, DOI 10.1016/0378-1119(95)00193-A; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Deng W, 2003, J BACTERIOL, V185, P2330, DOI 10.1128/JB.185.7.2330-2337.2003; DIZDAROGLU M, 1993, BIOCHEMISTRY-US, V32, P12105, DOI 10.1021/bi00096a022; Dubey AK, 2003, J BACTERIOL, V185, P4450, DOI 10.1128/JB.185.15.4450-4460.2003; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; El Ghany MA, 2007, INFECT IMMUN, V75, P1835, DOI 10.1128/IAI.01655-06; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Gao R, 2007, TRENDS BIOCHEM SCI, V32, P225, DOI 10.1016/j.tibs.2007.03.002; Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313; Hirakawa H, 2003, J ANTIMICROB CHEMOTH, V52, P576, DOI 10.1093/jac/dkg406; Hirakawa H, 2003, J BACTERIOL, V185, P1851, DOI 10.1128/JB.185.6.1851-1856.2003; Ho YSJ, 2000, EMBO J, V19, P5288, DOI 10.1093/emboj/19.20.5288; HOISETH SK, 1981, NATURE, V291, P238, DOI 10.1038/291238a0; Holt KE, 2008, NAT GENET, V40, P987, DOI 10.1038/ng.195; Holt KE, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-36; Homann OR, 2005, PLOS GENET, V1, P715, DOI 10.1371/journal.pgen.0010080; House D, 2001, CURR OPIN INFECT DIS, V14, P573, DOI 10.1097/00001432-200110000-00011; Hsing WH, 1997, J BACTERIOL, V179, P3729, DOI 10.1128/jb.179.11.3729-3735.1997; Hunter S, 2009, NUCLEIC ACIDS RES, V37, pD211, DOI 10.1093/nar/gkn785; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; JONES PW, 1988, VET REC, V123, P536, DOI 10.1136/vr.123.21.536; Kao KC, 2004, P NATL ACAD SCI USA, V101, P641, DOI 10.1073/pnas.0305287101; KASHKET ER, 1969, BIOCHIM BIOPHYS ACTA, V193, P294, DOI 10.1016/0005-2736(69)90190-4; Khil PP, 2004, PROTEINS, V54, P371, DOI 10.1002/prot.10430; Kingsley RA, 2003, INFECT IMMUN, V71, P629, DOI 10.1128/IAI.71.2.629-640.2003; Kraxenberger T, 2012, J BACTERIOL, V194, P4272, DOI 10.1128/JB.00409-12; Kroger C, 2012, P NATL ACAD SCI USA, V109, pE1277, DOI 10.1073/pnas.1201061109; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Langridge GC, 2009, GENOME RES, V19, P2308, DOI 10.1101/gr.097097.109; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Linehan SA, 2005, INFECT IMMUN, V73, P4354, DOI 10.1128/IAI.73.7.4354-4362.2005; MacLennan CA, 2008, J CLIN INVEST, V118, P1553, DOI 10.1172/JCI33998; MAEBA P, 1969, J BIOL CHEM, V244, P2549; McFarland J, 1907, J AMER MED ASSOC, V49, P1176; Mirold S, 2001, J BACTERIOL, V183, P2348, DOI 10.1128/JB.183.7.2348-2358.2001; Nikolskaya AN, 2002, NUCLEIC ACIDS RES, V30, P2453, DOI 10.1093/nar/30.11.2453; Noriega CE, 2010, MOL MICROBIOL, V75, P394, DOI 10.1111/j.1365-2958.2009.06987.x; Parkhill J, 2001, NATURE, V413, P848, DOI 10.1038/35101607; Perkins TT, 2013, MOL MICROBIOL, V87, P526, DOI 10.1111/mmi.12111; Perkins TT, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000569; PICKARD D, 1994, INFECT IMMUN, V62, P3984, DOI 10.1128/IAI.62.9.3984-3993.1994; Pickard D, 2003, J BACTERIOL, V185, P5055, DOI 10.1128/JB.185.17.5055-5065.2003; Pickard D, 2010, J BACTERIOL, V192, P5746, DOI 10.1128/JB.00659-10; Rad R, 2006, GASTROENTEROLOGY, V131, P525, DOI 10.1053/j.gastro.2006.05.001; Rathman M, 1996, INFECT IMMUN, V64, P2765, DOI 10.1128/IAI.64.7.2765-2773.1996; Richardson AR, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000451; Richardson EJ, 2011, J BACTERIOL, V193, P3162, DOI 10.1128/JB.00394-11; Roumagnac P, 2006, SCIENCE, V314, P1301, DOI 10.1126/science.1134933; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; SCHULTZ JE, 1988, J BACTERIOL, V170, P3903, DOI 10.1128/jb.170.9.3903-3909.1988; SCHULTZ JE, 1991, J MOL BIOL, V218, P129, DOI 10.1016/0022-2836(91)90879-B; Smyth GK., 2005, LIMMA LINEAR MODELS; Tacket CO, 1997, INFECT IMMUN, V65, P452, DOI 10.1128/IAI.65.2.452-456.1997; Uzzau S, 2001, P NATL ACAD SCI USA, V98, P15264, DOI 10.1073/pnas.261348198; WANG RF, 1991, GENE, V100, P195, DOI 10.1016/0378-1119(91)90366-J; WANNER BL, 1992, J BACTERIOL, V174, P2053, DOI 10.1128/JB.174.7.2053-2058.1992; Winter SE, 2009, INFECT IMMUN, V77, P1904, DOI 10.1128/IAI.01341-08; Wolanin PM, 2002, GENOME BIOL, V3; Yamamoto K, 2005, J BIOL CHEM, V280, P1448, DOI 10.1074/jbc.M410104200; Zhang HF, 2012, CURR MICROBIOL, V64, P283, DOI 10.1007/s00284-011-0066-3; Zhou L, 2003, J BACTERIOL, V185, P4956, DOI 10.1128/JB.185.16.4956-4972.2003	68	8	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e84567	10.1371/journal.pone.0084567	http://dx.doi.org/10.1371/journal.pone.0084567			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386394	Green Published, gold			2022-12-25	WOS:000329194700111
J	Zaim, M; Ali, A; Joseph, J; Khan, F				Zaim, Mohammad; Ali, Ashif; Joseph, Jomon; Khan, Feroz			Serological and Molecular Studies of a Novel Virus Isolate Causing Yellow Mosaic of Patchouli [Pogostemon cablin (Blanco) Benth]	PLOS ONE			English	Article							POTYVIRUSES	Here we have identified and characterized a devastating virus capable of inducing yellow mosaic on the leaves of Patchouli [Pogostemon cablin (Blanco) Benth]. The diagnostic tools used were host range, transmission studies, cytopathology, electron microscopy, serology and partial coat protein (CP) gene sequencing. Evidence from biological, serological and sequence data suggested that the causal virus belonged to genus Potyvirus, family Potyviridae. The isolate, designated as Patchouli Yellow Mosaic Virus (PaYMV), was transmitted through grafting, sap and the insect Myzus persicae (Sulz.). Flexuous rod shaped particles with a mean length of 800 nm were consistently observed in leaf-dip preparations from natural as well as alternate hosts, and in purified preparation. Cytoplasmic cylindrical inclusions, pinwheels and laminar aggregates were observed in ultra-thin sections of infected patchouli leaves. The purified capsid protein has a relative mass of 43 kDa. Polyclonal antibodies were raised in rabbits against the coat protein separated on SDS - PAGE; which were used in ELISA and western blotting. Using specific antibodies in ELISA, PaYMV was frequently detected at patchouli plantations at Lucknow and Bengaluru. Potyvirus-specific degenerate primer pair (U335 and D335) had consistently amplified partial CP gene from crude preparations of infected tissues by reverse transcription polymerase chain reaction (RT-PCR). Comparison of the PCR product sequence (290 bp) with the corresponding regions of established potyviruses showed 78-82% and 91-95% sequence similarity at the nucleotide and amino acid levels, respectively. The results clearly established that the virus under study has close homology with watermelon mosaic virus (WMV) in the coat protein region and therefore could share a common ancestor family. Further studies are required to authenticate the identity of PaYMV as a distinct virus or as an isolate of WMV.	[Zaim, Mohammad; Ali, Ashif] Cent Inst Med & Aromat Plants, CSIR, Crop Protect Div, Lucknow 226016, Uttar Pradesh, India; [Joseph, Jomon] Natl Ctr Cell Sci, Pune, Maharashtra, India; [Khan, Feroz] Cent Inst Med & Aromat Plants, CSIR, Div Plant Biol, Lucknow 226016, Uttar Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Institute of Medicinal & Aromatic Plants (CIMAP); Department of Biotechnology (DBT) India; National Centre for Cell Science, Pune (NCCS); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Institute of Medicinal & Aromatic Plants (CIMAP)	Zaim, M (corresponding author), Cent Inst Med & Aromat Plants, CSIR, Crop Protect Div, Lucknow 226016, Uttar Pradesh, India.	zaimm2001@yahoo.com; f.khan@cimap.res.in	Khan, Feroz/AHC-3474-2022; Joseph, Jomon/C-1397-2009	Khan, Feroz/0000-0002-2704-5925; Joseph, Jomon/0000-0002-3042-6286	Council of Scientific and Industrial Research (CSIR), New Delhi [BSC0203]	Council of Scientific and Industrial Research (CSIR), New Delhi(Council of Scientific & Industrial Research (CSIR) - India)	The authors acknowledge the Council of Scientific and Industrial Research (CSIR), New Delhi for financial support through 'ChemBio' project (BSC0203) at CSIR-Central Institute of Medicinal and Aromatic Plants (CIMAP), Lucknow, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anonymous, 1977, KO HSUEH TUNG PAO, V22, P318; [Anonymous], 1994, POTYVIRIDAE; Baum RH, 1980, THESIS U FLORIDA US, P99, DOI DOI 10.5962/BHL.TITLE.42365); Benson Dennis A, 2005, Nucleic Acids Res, V33, pD34; BIRNBOIM HC, 1979, NUCLEIC ACIDS RES, V7, P1513; CLARK MF, 1977, J GEN VIROL, V34, P475, DOI 10.1099/0022-1317-34-3-475; Fauquet CM, 2005, 8 INT COMM TAX VIR, P1259; Gama MICS, 1979, THESIS BRASILIA, P72; Gama MICS, 1980, FITOPATOL BRAS, V8, P395; GLAUERT AM, 1958, J BIOPHYS BIOCHEM CY, V4, P191, DOI 10.1083/jcb.4.2.191; KITAJIMA E W, 1979, Fitopatologia Brasileira, V4, P55; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANGEVELD SA, 1991, J GEN VIROL, V72, P1531, DOI 10.1099/0022-1317-72-7-1531; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Meissner Filho Paulo E., 1997, Fitopatologia Brasileira, V22, P569; Meissner FO, 1992, FITOPATOL BRAS, V17, P179; Meissner PE, 2002, ANN APPL BIOL, V141, P267, DOI 10.1111/j.1744-7348.2002.tb00218.x; Milne R. G., 1988, PLANT VIRUSES FILAME, V4, P333; NATSUAKI KT, 1994, PLANT DIS, V78, P1094, DOI 10.1094/PD-78-1094; RAO BLS, 1986, PHYTOPATHOLOGY, V76, P1109; Ravi KS, 1997, PLANT DIS, V81, P673, DOI 10.1094/PDIS.1997.81.6.673; REYNOLDS ES, 1963, J CELL BIOL, V17, P208, DOI 10.1083/jcb.17.1.208; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SASTRY KS, 1981, CURR SCI INDIA, V50, P767; Sharma R, 2003, MED PLANTS INDIA ENC, P197; SHUKLA DD, 1989, ADV VIRUS RES, V36, P273, DOI 10.1016/S0065-3527(08)60588-6; Singh MK, 2009, J PLANT DIS PROTECT, V116, P2, DOI 10.1007/BF03356278; Singh RP, 1996, J VIROL METHODS, V59, P189, DOI 10.1016/0166-0934(96)02043-5; VAN REGENMORTEL M. H. V., 1962, Phytopathologische Zeitschrift, V45, P205; WANG YY, 1993, ARCH VIROL, V129, P93, DOI 10.1007/BF01316887; WARD CW, 1991, INTERVIROLOGY, V32, P269, DOI 10.1159/000150211; Zaim M, 1999, NAT S CHANG PROSP PL	33	3	3	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e83790	10.1371/journal.pone.0083790	http://dx.doi.org/10.1371/journal.pone.0083790			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386278	Green Published, gold, Green Submitted			2022-12-25	WOS:000329194700069
J	Zigouris, J; Schaefer, JA; Fortin, C; Kyle, CJ				Zigouris, Joanna; Schaefer, James A.; Fortin, Clement; Kyle, Christopher J.			Phylogeography and Post-Glacial Recolonization in Wolverines (Gulo gulo) from across Their Circumpolar Distribution	PLOS ONE			English	Article							APPROXIMATE BAYESIAN COMPUTATION; CRYPTIC GLACIAL REFUGIA; POPULATION HISTORY; GENETIC-STRUCTURE; WIDE PHYLOGEOGRAPHY; NORTH-AMERICA; HOME-RANGE; MITOCHONDRIAL; DNA; CONSERVATION	Interglacial-glacial cycles of the Quaternary are widely recognized in shaping phylogeographic structure. Patterns from cold adapted species can be especially informative - in particular, uncovering additional glacial refugia, identifying likely recolonization patterns, and increasing our understanding of species' responses to climate change. We investigated phylogenetic structure of the wolverine, a wide-ranging cold adapted carnivore, using a 318 bp of the mitochondrial DNA control region for 983 wolverines (n = 209 this study, n = 774 from GenBank) from across their full Holarctic distribution. Bayesian phylogenetic tree reconstruction and the distribution of observed pairwise haplotype differences (mismatch distribution) provided evidence of a single rapid population expansion across the wolverine's Holarctic range. Even though molecular evidence corroborated a single refugium, significant subdivisions of population genetic structure (0.01 < Phi(ST) < 0.99, P < 0.05) were detected. Pairwise Phi(ST) estimates separated Scandinavia from Russia and Mongolia, and identified five main divisions within North America - the Central Arctic, a western region, an eastern region consisting of Ontario and Quebec/Labrador, Manitoba, and California. These data are in contrast to the nearly panmictic structure observed in northwestern North America using nuclear microsatellites, but largely support the nuclear DNA separation of contemporary Manitoba and Ontario wolverines from northern populations. Historic samples (c. 1900) from the functionally extirpated eastern population of Quebec/Labrador displayed genetic similarities to contemporary Ontario wolverines. To understand these divergence patterns, four hypotheses were tested using Approximate Bayesian Computation (ABC). The most supported hypothesis was a single Beringia incursion during the last glacial maximum that established the northwestern population, followed by a west-to-east colonization during the Holocene. This pattern is suggestive of colonization occurring in accordance with glacial retreat, and supports expansion from a single refugium. These data are significant relative to current discussions on the conservation status of this species across its range.	[Zigouris, Joanna] Trent Univ, Environm & Life Sci Gradate Program, Peterborough, ON K9J 7B8, Canada; [Schaefer, James A.] Trent Univ, Dept Biol, Peterborough, ON K9J 7B8, Canada; [Fortin, Clement] Carcajou Quebec, Stoneham Et Tewkesbury, PQ, Canada; [Kyle, Christopher J.] Trent Univ, Dept Forens Sci, Peterborough, ON K9J 7B8, Canada	Trent University; Trent University; Trent University	Zigouris, J (corresponding author), Trent Univ, Environm & Life Sci Gradate Program, Peterborough, ON K9J 7B8, Canada.	joannazigouris@gmail.com		Schaefer, James/0000-0002-3416-1748	Ontario Living Legacy Trust; Wildlife Conservation Society Canada; Wolverine Foundation, Inc.; Ontario Ministry of Natural Resources; Mountain Equipment Co-op Research Grant; Natural Sciences and Engineering Research Council of Canada	Ontario Living Legacy Trust; Wildlife Conservation Society Canada; Wolverine Foundation, Inc.; Ontario Ministry of Natural Resources; Mountain Equipment Co-op Research Grant; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	Funding for this study was provided by the Ontario Living Legacy Trust, Wildlife Conservation Society Canada, The Wolverine Foundation, Inc., Ontario Ministry of Natural Resources, Mountain Equipment Co-op Research Grant, and Discovery Grants from the Natural Sciences and Engineering Research Council of Canada to JAS and CJK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott RJ, 2000, SCIENCE, V289, P1343, DOI 10.1126/science.289.5483.1343; Abramov A, 2009, IUCN RED LIST THREAT; Allendorf FW, 2010, NAT REV GENET, V11, P697, DOI 10.1038/nrg2844; ANDERSON E, 1977, Bulletin of the Museum of Comparative Zoology, V148, P1; Arnason U, 2007, MOL PHYLOGENET EVOL, V45, P863, DOI 10.1016/j.ympev.2007.06.019; Aubry KB, 2007, J WILDLIFE MANAGE, V71, P2147, DOI 10.2193/2006-548; Aubry KB, 2009, MOL ECOL, V18, P2668, DOI 10.1111/j.1365-294X.2009.04222.x; BANCI V, 1990, HOLARCTIC ECOL, V13, P195; Banci V, 1994, RM2541184 USDA FOR E; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Beatty GE, 2010, MOL ECOL, V19, P5009, DOI 10.1111/j.1365-294X.2010.04859.x; Beaumont MA, 2002, GENETICS, V162, P2025; Bermond G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050129; Bertorelle G, 2010, MOL ECOL, V19, P2609, DOI 10.1111/j.1365-294X.2010.04690.x; Bhagwat SA, 2008, J BIOGEOGR, V35, P464, DOI 10.1111/j.1365-2699.2007.01861.x; Bowman J, 2010, CAN J ZOOL, V88, P454, DOI 10.1139/Z10-019; BRYANT HN, 1987, CAN J EARTH SCI, V24, P654, DOI 10.1139/e87-063; Cassel-Lundhagen A, 2009, ECOGRAPHY, V32, P591, DOI 10.1111/j.1600-0587.2008.05685.x; Cegelski CC, 2006, CONSERV GENET, V7, P197, DOI 10.1007/s10592-006-9126-9; Cegelski CC, 2003, MOL ECOL, V12, P2907, DOI 10.1046/j.1365-294X.2003.01969.x; Chappell DE, 2004, CONSERV GENET, V5, P759, DOI 10.1007/s10592-004-1976-4; Copeland JP, 2010, CAN J ZOOL, V88, P233, DOI 10.1139/Z09-136; Cornuet J-M, BIOINFORMATICS UNPUB; Cornuet JM, 2008, BIOINFORMATICS, V24, P2713, DOI 10.1093/bioinformatics/btn514; COSEWIC, 2003, COSEWIC ASS UPD STAT; COSEWIC (Committee on the Status of Endangered Species in Canada), 2004, GUID REC DES UN; Cossios D, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-68; Crandall KA, 2000, TRENDS ECOL EVOL, V15, P290, DOI 10.1016/S0169-5347(00)01876-0; Dalen L, 2005, BIOL J LINN SOC, V84, P79, DOI 10.1111/j.1095-8312.2005.00415.x; Davidson AD, 2009, P NATL ACAD SCI USA, V106, P10702, DOI 10.1073/pnas.0901956106; Davison A, 2001, MOL ECOL, V10, P2479, DOI 10.1046/j.1365-294X.2001.01381.x; Dawson FN, 2010, CAN FIELD NAT, V124, P139, DOI 10.22621/cfn.v124i2.1052; Diedrich Cajus G., 2009, Annalen des Naturhistorischen Museums in Wien A Mineralogie Petrologie Geologie Palaeontologie Archaeozoologie Anthropologie Praehistorie, V110A, P123; Doeppes D., 2001, Cadernos Laboratorio Xeoloxico de Laxe, V26, P479; Drew RE, 2003, MOL ECOL, V12, P51, DOI 10.1046/j.1365-294X.2003.01715.x; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Dupanloup I, 2002, MOL ECOL, V11, P2571, DOI 10.1046/j.1365-294X.2002.01650.x; Excoffier L, 1999, P NATL ACAD SCI USA, V96, P10597, DOI 10.1073/pnas.96.19.10597; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fedorov VB, 2001, P ROY SOC B-BIOL SCI, V268, P809, DOI 10.1098/rspb.2001.1584; Flagstad O, 2003, EVOLUTION, V57, P658; Fleming MA, 2002, MOL ECOL, V11, P795, DOI 10.1046/j.1365-294X.2002.01472.x; Fortin C., 2005, NATL RECOVERY PLAN W; Frances J., 2008, THESIS U NEW MEXICO; Fu YX, 1997, GENETICS, V147, P915; GARDNER CL, 1986, J MAMMAL, V67, P603, DOI 10.2307/1381300; GASTON KJ, 1990, BIOL REV, V65, P105, DOI 10.1111/j.1469-185X.1990.tb01185.x; Hadly EA, 2004, PLOS BIOL, V2, P1600, DOI 10.1371/journal.pbio.0020290; Hampe A, 2005, ECOL LETT, V8, P461, DOI 10.1111/j.1461-0248.2005.00739.x; Handley LJL, 2007, MOL ECOL, V16, P1559, DOI 10.1111/j.1365-294X.2006.03152.x; HARPENDING HC, 1994, HUM BIOL, V66, P591; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Haskell JP, 2002, NATURE, V418, P527, DOI 10.1038/nature00840; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hewitt GM, 1996, BIOL J LINN SOC, V58, P247, DOI 10.1111/j.1095-8312.1996.tb01434.x; Holder K, 1999, EVOLUTION, V53, P1936, DOI 10.1111/j.1558-5646.1999.tb04574.x; Huck S, 2009, J BIOGEOGR, V36, P1588, DOI 10.1111/j.1365-2699.2009.02096.x; Ibrahim KM, 1996, HEREDITY, V77, P282, DOI 10.1038/hdy.1996.142; IUCN, 2019, IUCN RED LIST THREAT; Jensen JL, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-13; Klutsch CFC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052661; Koen EL, 2008, SURVEYING MONITORING; Koepfli KP, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-10; Kutschera VE, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-114; Kyle CJ, 2002, J MAMMAL, V83, P1141, DOI 10.1644/1545-1542(2002)083<1141:COPACP>2.0.CO;2; Kyle CJ, 2001, MOL ECOL, V10, P337, DOI 10.1046/j.1365-294x.2001.01222.x; Laliberte AS, 2004, BIOSCIENCE, V54, P123, DOI 10.1641/0006-3568(2004)054[0123:RCONAC]2.0.CO;2; Landa A, 2000, COUNC EUR CONV CONS; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Latch EK, 2009, MOL ECOL, V18, P1730, DOI 10.1111/j.1365-294X.2009.04153.x; LESICA P, 1995, CONSERV BIOL, V9, P753, DOI 10.1046/j.1523-1739.1995.09040753.x; Loehr J, 2006, J EVOLUTION BIOL, V19, P419, DOI 10.1111/j.1420-9101.2005.01027.x; Lofroth EC, 2007, J WILDLIFE MANAGE, V71, P2159, DOI 10.2193/2007-094; MANTEL N, 1967, CANCER RES, V27, P209; Mcrae BH, 2005, MOL ECOL, V14, P1965, DOI 10.1111/j.1365-294X.2005.02571.x; National Geographic Society, 2002, WOLV RANG; Norwegian Biodiversity Information Centre, 2010, RED LIST SPEC FACT S; Oomen RA, 2013, MOL ECOL RESOUR, V13, P103, DOI 10.1111/1755-0998.12027; Peterman WE, 2013, BIOL CONSERV, V158, P351, DOI 10.1016/j.biocon.2012.07.028; Pielou E.C., 1991, ICE AGE RETURN LIFE; PORTER L, 1988, ARCTIC, V41, P303; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Provan J, 2008, TRENDS ECOL EVOL, V23, P564, DOI 10.1016/j.tree.2008.06.010; Rambaut A, 2009, FIGTREE V1 3 1; Rambaut A, 2009, TRACER V1 5; Rambaut A., 2009, BAYESIAN EVOLUTIONAR; Robert CP, 2011, P NATL ACAD SCI USA, V108, P15112, DOI 10.1073/pnas.1102900108; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Rousset F, 1997, GENETICS, V145, P1219; Rull V, 2010, J BIOGEOGR, V37, P1623, DOI 10.1111/j.1365-2699.2010.02340.x; Sato JJ, 2009, MOL PHYLOGENET EVOL, V53, P907, DOI 10.1016/j.ympev.2009.08.019; Schmitt T, 2012, FRONT ZOOL, V9, DOI 10.1186/1742-9994-9-22; Schneider S, 1999, GENETICS, V152, P1079; Schreiber A., 1989, WEASELS CIVETS MONGO; Schwartz MK, 2007, J WILDLIFE MANAGE, V71, P2170, DOI 10.2193/2007-026; Schwartz MK, 2009, ECOLOGY, V90, P3222, DOI 10.1890/08-1287.1; Shafer ABA, 2010, MOL ECOL, V19, P4589, DOI 10.1111/j.1365-294X.2010.04828.x; SLATKIN M, 1990, GENETICS, V126, P249; Slough BG, 2007, WILDLIFE BIOL, V13, P76, DOI 10.2981/0909-6396(2007)13[76:SOTWGG]2.0.CO;2; Steele CA, 2006, MOL ECOL, V15, P2477, DOI 10.1111/j.1365-294X.2006.02950.x; Stewart JR, 2010, P ROY SOC B-BIOL SCI, V277, P661, DOI 10.1098/rspb.2009.1272; Stuart AJ, 2004, NATURE, V431, P684, DOI 10.1038/nature02890; Szpiech ZA, 2008, BIOINFORMATICS, V24, P2498, DOI 10.1093/bioinformatics/btn478; TAJIMA F, 1989, GENETICS, V123, P585; Tougard C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003532; Vila C, 1999, MOL ECOL, V8, P2089, DOI 10.1046/j.1365-294x.1999.00825.x; Villesen P, 2007, MOL ECOL NOTES, V7, P965, DOI 10.1111/j.1471-8286.2007.01821.x; Walker CW, 2001, MOL ECOL, V10, P53, DOI 10.1046/j.1365-294X.2001.01184.x; WARD RH, 1991, P NATL ACAD SCI USA, V88, P8720, DOI 10.1073/pnas.88.19.8720; Wilson D.E., 1982, P644; Wilson GM, 2000, J MAMMAL, V81, P186, DOI 10.1644/1545-1542(2000)081<0186:GVOWGG>2.0.CO;2; Zigouris J, 2012, CONSERV GENET, V13, P1543, DOI 10.1007/s10592-012-0399-x	113	21	21	0	99	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e83837	10.1371/journal.pone.0083837	http://dx.doi.org/10.1371/journal.pone.0083837			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386287	gold, Green Published, Green Submitted			2022-12-25	WOS:000329194700071
J	Gravel, A; Sinnett, D; Flamand, L				Gravel, Annie; Sinnett, Daniel; Flamand, Louis			Frequency of Chromosomally-Integrated Human Herpesvirus 6 in Children with Acute Lymphoblastic Leukemia	PLOS ONE			English	Article							TELOMERASE MUTATIONS; APLASTIC-ANEMIA; HUMAN-HERPESVIRUS-6; GENOME; BLOOD; MONONUCLEAR; HHV-6; IDENTIFICATION; QUANTITATION; INFECTIONS	Introduction: Human herpesvirus 6 (HHV-6) is a ubiquitous pathogen infecting nearly 100% of the human population. Of these individuals, between 0.2% and 1% of them carry chromosomally-integrated HHV-6 (ciHHV-6). The biological consequences of chromosomal integration by HHV-6 remain unknown. Objective: To determine and compare the frequency of ciHHV-6 in children with acute lymphoblastic leukemia to healthy blood donors. Methodology: A total of 293 DNA samples from children with pre-B (n = 255), pre-pre-B (n = 4), pre-T (n = 26) and undetermined (n = 8) leukemia were analyzed for ciHHV-6 by quantitative TaqMan PCR (QPCR) using HHV-6 specific primers and probe. As control, DNA samples from 288 healthy individuals were used. Primers and probe specific to the cellular GAPDH gene were used to estimate integrity and DNA content. Results: Out of 293 DNA samples from the leukemic cohort, 287 contained amplifiable DNA. Of these, only 1 (0.35%) contained ciHHV-6. Variant typing indicates that the ci-HHV-6 corresponds to variant A. None of the 288 DNA samples from healthy individuals contained ciHHV-6. Conclusion: The frequency of ciHHV-6 in children with acute lymphoblastic leukemia is similar (p = 0.5) to that of healthy individuals. These results suggest that acute lymphoblastic leukemia does not originate as a consequence to integration of HHV-6 within the chromosomes.	[Gravel, Annie; Flamand, Louis] CHU Quebec Res Ctr, Div Infect Dis & Immun, Quebec City, PQ, Canada; [Sinnett, Daniel] Univ Montreal, Dept Pediat, Ctr Rech, Serv Hematol Oncol,CHU St Justine, Montreal, PQ H3C 3J7, Canada; [Flamand, Louis] Univ Laval, Dept Microbiol Infect Dis & Immunol, Quebec City, PQ, Canada	Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; Laval University	Flamand, L (corresponding author), CHU Quebec Res Ctr, Div Infect Dis & Immun, Quebec City, PQ, Canada.	Louis.flamand@crchul.ulaval.ca	sinnett, daniel/S-4589-2017	sinnett, daniel/0000-0003-3625-6676; Flamand, Louis/0000-0001-5010-4586; Gravel, Annie/0000-0001-5229-5750	CIHR	CIHR(Canadian Institutes of Health Research (CIHR))	This work was supported by a CIHR grant awarded to LF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ablashi D, 2014, ARCH VIROL, V159, P863, DOI 10.1007/s00705-013-1902-5; Adams MJ, 2012, ARCH VIROL, V157, P1411, DOI 10.1007/s00705-012-1299-6; Arbuckle JH, 2010, P NATL ACAD SCI USA, V107, P5563, DOI 10.1073/pnas.0913586107; Armanios MY, 2007, NEW ENGL J MED, V356, P1317, DOI 10.1056/NEJMoa066157; Artandi SE, 2006, NEW ENGL J MED, V355, P1195, DOI 10.1056/NEJMp068187; Bates M, 2009, J MED VIROL, V81, P779, DOI 10.1002/jmv.21455; Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; Boutolleau D, 2006, J CLIN VIROL, V35, P257, DOI 10.1016/j.jcv.2005.08.002; Calado RT, 2009, NEW ENGL J MED, V361, P2353, DOI 10.1056/NEJMra0903373; Calado RT, 2009, P NATL ACAD SCI USA, V106, P1187, DOI 10.1073/pnas.0807057106; Capper R, 2007, GENE DEV, V21, P2495, DOI 10.1101/gad.439107; Daibata M, 1999, BLOOD, V94, P1545, DOI 10.1182/blood.V94.5.1545.417a25_1545_1549; Flamand L, 2008, J CLIN MICROBIOL, V46, P2700, DOI 10.1128/JCM.00370-08; Gautheret-Dejean A, 2002, J VIROL METHODS, V100, P27, DOI 10.1016/S0166-0934(01)00390-1; Geraudie B, 2012, J CLIN VIROL, V53, P151, DOI 10.1016/j.jcv.2011.10.017; Hall CB, 2008, PEDIATRICS, V122, P513, DOI 10.1542/peds.2007-2838; Hall CB, 2004, J PEDIATR-US, V145, P472, DOI 10.1016/j.jpeds.2004.06.017; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; Healy J, 2007, BLOOD, V109, P683, DOI 10.1182/blood-2006-02-003236; Hemann MT, 2001, CELL, V107, P67, DOI 10.1016/S0092-8674(01)00504-9; Hubacek P, 2009, J MED VIROL, V81, P258, DOI 10.1002/jmv.21371; Kaufer BB, 2011, J EXP MED, V208, P605, DOI 10.1084/jem.20101402; Leong HN, 2007, J MED VIROL, V79, P45, DOI 10.1002/jmv.20760; LUPPI M, 1994, LEUKEMIA, V8, pS41; LUPPI M, 1993, J MED VIROL, V40, P44, DOI 10.1002/jmv.1890400110; Luppi M, 1998, LANCET, V352, P1707, DOI 10.1016/S0140-6736(05)61483-3; Mitchell JR, 1999, NATURE, V402, P551, DOI 10.1038/990141; Morissette G, 2010, J VIROL, V84, P12100, DOI 10.1128/JVI.01169-10; Nacheva EP, 2008, J MED VIROL, V80, P1952, DOI 10.1002/jmv.21299; O'Sullivan JN, 2002, NAT GENET, V32, P280, DOI 10.1038/ng989; OHYASHIKI JH, 1994, CANCER RES, V54, P3557; Osterrieder N, 2006, NAT REV MICROBIOL, V4, P283, DOI 10.1038/nrmicro1382; Pellett PE, 2012, REV MED VIROL, V22, P144, DOI 10.1002/rmv.715; Qazilbash MH, 1997, ACTA HAEMATOL-BASEL, V97, P164; Roy-Gagnon MH, 2011, HUM GENET, V129, P521, DOI 10.1007/s00439-010-0945-x; Sahin E, 2011, NATURE, V470, P359, DOI 10.1038/nature09787; Seror E, 2008, J MED VIROL, V80, P689, DOI 10.1002/jmv.21118; Tanaka-Taya K, 2004, J MED VIROL, V73, P465, DOI 10.1002/jmv.20113; TORELLI G, 1995, J MED VIROL, V46, P178, DOI 10.1002/jmv.1890460303; Vulliamy T, 2002, LANCET, V359, P2168, DOI 10.1016/S0140-6736(02)09087-6; Ward KN, 2006, J CLIN MICROBIOL, V44, P1571, DOI 10.1128/JCM.44.4.1571-1574.2006; WILKIE AOM, 1990, NATURE, V346, P868, DOI 10.1038/346868a0; Yamaguchi H, 2005, NEW ENGL J MED, V352, P1413, DOI 10.1056/NEJMoa042980; YAMANISHI K, 1988, LANCET, V1, P1065	44	18	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e84322	10.1371/journal.pone.0084322	http://dx.doi.org/10.1371/journal.pone.0084322			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281QS	24386368	gold, Green Published, Green Submitted			2022-12-25	WOS:000329116700103
J	Kear, BP; Rich, TH; Vickers-Rich, P; Ali, MA; Al-Mufarreh, YA; Matari, AH; Al-Massari, AM; Nasser, AH; Attia, Y; Halawani, MA				Kear, Benjamin P.; Rich, Thomas H.; Vickers-Rich, Patricia; Ali, Mohammed A.; Al-Mufarreh, Yahya A.; Matari, Adel H.; Al-Massari, Abdu M.; Nasser, Abdulaziz H.; Attia, Yousry; Halawani, Mohammed A.			First Dinosaurs from Saudi Arabia	PLOS ONE			English	Article							SAUROPOD DINOSAUR; DENTAL MORPHOLOGY; THEROPODA; PHYLOGENY; TOOTH; OSTEOLOGY; EVOLUTION; REPTILES; TRACKS; TEETH	Dinosaur remains from the Arabian subcontinent are exceedingly rare, and those that have been documented manifest indeterminate affinities. Consequently the discovery of a small, but diagnostic, accumulation of elements from Campanian-Maastrichtian (similar to 75 Ma) deposits in northwestern Saudi Arabia is significant because it constitutes the first taxonomically identifiable dinosaur material described from the Arabian Peninsula. The fossils include a series of possible lithostrotian titanosaur caudal vertebrae, and some isolated theropod marginal teeth that share unique character states and metric parameters (analyzed using multivariate statistical methods) with derived abelisaurids - this is the first justifiable example of a non-avian carnivorous dinosaur clade from Arabia. The recognition of titanosaurians and abelisaurids from Saudi Arabia extends the palaeogeographical range of these groups along the entire northern Gondwanan margin during the latest Cretaceous. Moreover, given the extreme paucity of coeval occurrences elsewhere, the Saudi Arabian fossils provide a tantalizing glimpse into dinosaurian assemblage diversity within the region.	[Kear, Benjamin P.] Uppsala Univ, Dept Earth Sci, Uppsala, Sweden; [Rich, Thomas H.] Museum Victoria, Dept Palaeontol, Melbourne, Vic, Australia; [Vickers-Rich, Patricia] Monash Univ, Sch Geosci, Melbourne, Vic 3004, Australia; [Ali, Mohammed A.; Al-Mufarreh, Yahya A.; Matari, Adel H.; Al-Massari, Abdu M.; Nasser, Abdulaziz H.; Attia, Yousry; Halawani, Mohammed A.] Saudi Geol Survey, Jeddah, Saudi Arabia	Uppsala University; Museum Victoria; Monash University; Saudi Geological Survey	Kear, BP (corresponding author), Uppsala Univ, Dept Earth Sci, Uppsala, Sweden.	benjamin.kear@geo.uu.se			Saudi Geological Survey	Saudi Geological Survey	Funding for this work was provided by the Saudi Geological Survey. As a standard requirement of their duties, staff from the Saudi Geological Survey participated in data collection, preparation of the manuscript, and the decision to publish.	AVNIMELECH M, 1962, NATURE, V196, P264, DOI 10.1038/196264a0; Brusatte SL, 2008, J SYST PALAEONTOL, V6, P155, DOI 10.1017/S1477201907002404; Brusatte SL, 2007, J VERTEBR PALEONTOL, V27, P1052, DOI 10.1671/0272-4634(2007)27[1052:TSUOTE]2.0.CO;2; Buckley LG, 2010, CAN J EARTH SCI, V47, P1227, DOI 10.1139/E10-029; Buffetaut E, 2006, NATURWISSENSCHAFTEN, V93, P440, DOI 10.1007/s00114-006-0124-z; Buffetaut Eric, 2005, Kaupia Darmstaedter Beitraege zur Naturgeschichte, V14, P3; Canale J, 2009, NATURWISSENSCHAFTEN, V96, P409, DOI 10.1007/s00114-008-0487-4; Carrano MT, 2008, J SYST PALAEONTOL, V6, P183, DOI 10.1017/S1477201907002246; Carrano MT, 2002, J VERTEBR PALEONTOL, V22, P510, DOI 10.1671/0272-4634(2002)022[0510:TOOMKA]2.0.CO;2; Currie P.J., 1990, P107, DOI 10.1017/CBO9780511608377.011; D'Emic MD, 2012, ZOOL J LINN SOC-LOND, V166, P624, DOI 10.1111/j.1096-3642.2012.00853.x; Dalla Vecchia FM, 2002, J VERTEBR PALEONTOL, V22, P856; Fanti F, 2007, ACTA PALAEONTOL POL, V52, P155; Filatoff J, 1996, J AFR EARTH SCI, V22, P535, DOI 10.1016/0899-5362(96)00035-8; Grainger DJ, 2007, GEOLOGIC EVOLUTION S; Hammer O, 2006, PALEONTOLOGICAL DATA ANALYSIS, P1; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Holtz Jr T. R., 2000, GAIA, V15, P5; HOOIJER DA, 1968, PROC K NED AKAD B-PH, V71, P150; Hughes GWA, 2005, GEOARABIA, V10, P49; Jacobs LL, 1999, FOSSIL VERTEBRATES OF ARABIA, P454; Kaddumi H.F., 2005, AMBER JORDAN OLDEST; Kear BP, 2008, GEOL MAG, V145, P648, DOI 10.1017/S0016756808005062; Kear BP, 2009, CRETACEOUS RES, V30, P1164, DOI 10.1016/j.cretres.2009.05.002; LARSON D, 2013, PLOS ONE, V8, DOI DOI 10.1371/J0URNAL.P0NE.0054329; Mannion PD, 2011, PALAEOGEOGR PALAEOCL, V299, P529, DOI 10.1016/j.palaeo.2010.12.003; Martill David M., 1996, Neues Jahrbuch fuer Geologie und Palaeontologie Monatshefte, V3, P147; Mateus O, 2011, AN ACAD BRAS CIENC, V83, P221, DOI 10.1590/S0001-37652011000100012; McKinney M.L., 1990, P75; Rogers KC, 2005, SAUROPODS: EVOLUTION AND PALEOBIOLOGY, P50; Rogers KC, 2009, J VERTEBR PALEONTOL, V29, P1046, DOI 10.1671/039.029.0432; Salgado Leonardo, 1997, Ameghiniana, V34, P3; Samman T, 2005, ACTA PALAEONTOL POL, V50, P757; SCHLEE D, 1973, Journal fuer Ornithologie, V114, P207, DOI 10.1007/BF01641171; Schulp A.S., 2008, SULTAN QABOOS U J SC, V13, P27; Schulp AS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002243; Schulp AS, 2000, CRETACEOUS RES, V21, P851, DOI 10.1006/cres.2000.0235; Senter P, 2007, J SYST PALAEONTOL, V5, P429, DOI 10.1017/S1477201907002143; Smith JB, 2005, ANAT REC PART A, V285A, P699, DOI 10.1002/ar.a.20206; Smith JB, 2007, J VERTEBR PALEONTOL, V27, P103, DOI 10.1671/0272-4634(2007)27[103:DMAVIM]2.0.CO;2; Smith JB, 2006, J AFR EARTH SCI, V46, P240, DOI 10.1016/j.jafrearsci.2006.05.007; Smith JB, 2006, NATURWISSENSCHAFTEN, V93, P242, DOI 10.1007/s00114-006-0092-3; Soto M, 2008, J VERTEBR PALEONTOL, V28, P439, DOI 10.1671/0272-4634(2008)28[439:ACDTFT]2.0.CO;2; Suberbiola XP, 2004, J AFR EARTH SCI, V40, P81, DOI 10.1016/j.jafrearsci.2004.07.002; Sues HD, 2002, J VERTEBR PALEONTOL, V22, P535, DOI 10.1671/0272-4634(2002)022[0535:ICASDT]2.0.CO;2; Turner AH, 2012, B AM MUS NAT HIST, P5; Weishampel DB., 2004, DINOSAURIA; Wilson JA, 2002, ZOOL J LINN SOC-LOND, V136, P217; Wilson J, 2006, J VERTEBR PALEONTOL, V26, p140A	49	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e84041	10.1371/journal.pone.0084041	http://dx.doi.org/10.1371/journal.pone.0084041			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281QS	24386326	Green Published, Green Submitted, gold			2022-12-25	WOS:000329116700094
J	Lai, FJ; Chiu, CC; Yang, TH; Huang, YM; Wu, WS				Lai, Fu-Jou; Chiu, Chia-Chun; Yang, Tzu-Hsien; Huang, Yueh-Min; Wu, Wei-Sheng			Identifying Functional Transcription Factor Binding Sites in Yeast by Considering Their Positional Preference in the Promoters	PLOS ONE			English	Article							REGULATORY ELEMENTS; GENE-EXPRESSION; IDENTIFICATION; MICROARRAY; LANDSCAPE; NETWORKS; DATABASE; REVEALS; TARGETS	Transcription factor binding site (TFBS) identification plays an important role in deciphering gene regulatory codes. With comprehensive knowledge of TFBSs, one can understand molecular mechanisms of gene regulation. In the recent decades, various computational approaches have been proposed to predict TFBSs in the genome. The TFBS dataset of a TF generated by each algorithm is a ranked list of predicted TFBSs of that TF, where top ranked TFBSs are statistically significant ones. However, whether these statistically significant TFBSs are functional (i.e. biologically relevant) is still unknown. Here we develop a post-processor, called the functional propensity calculator (FPC), to assign a functional propensity to each TFBS in the existing computationally predicted TFBS datasets. It is known that functional TFBSs reveal strong positional preference towards the transcriptional start site (TSS). This motivates us to take TFBS position relative to the TSS as the key idea in building our FPC. Based on our calculated functional propensities, the TFBSs of a TF in the original TFBS dataset could be reordered, where top ranked TFBSs are now the ones with high functional propensities. To validate the biological significance of our results, we perform three published statistical tests to assess the enrichment of Gene Ontology (GO) terms, the enrichment of physical protein-protein interactions, and the tendency of being co-expressed. The top ranked TFBSs in our reordered TFBS dataset outperform the top ranked TFBSs in the original TFBS dataset, justifying the effectiveness of our post-processor in extracting functional TFBSs from the original TFBS dataset. More importantly, assigning functional propensities to putative TFBSs enables biologists to easily identify which TFBSs in the promoter of interest are likely to be biologically relevant and are good candidates to do further detailed experimental investigation. The FPC is implemented as a web tool at http://santiago.ee.ncku.edu.tw/FPC/.	[Lai, Fu-Jou; Huang, Yueh-Min] Natl Cheng Kung Univ, Dept Engn Sci, Tainan 70101, Taiwan; [Chiu, Chia-Chun; Yang, Tzu-Hsien; Wu, Wei-Sheng] Natl Cheng Kung Univ, Dept Elect Engn, Tainan 70101, Taiwan	National Cheng Kung University; National Cheng Kung University	Wu, WS (corresponding author), Natl Cheng Kung Univ, Dept Elect Engn, 1 Univ Rd, Tainan 70101, Taiwan.	wessonwu@gmail.com	Wu, Wei-Sheng/P-5367-2019	Yang, Tzu-Hsien/0000-0001-9420-196X	College of Electrical Engineering and Computer Science, National Cheng Kung University; Taiwan National Science Council [NSC 99-2628-B-006-015-MY3]	College of Electrical Engineering and Computer Science, National Cheng Kung University; Taiwan National Science Council(Ministry of Science and Technology, Taiwan)	This study was supported by College of Electrical Engineering and Computer Science, National Cheng Kung University and Taiwan National Science Council NSC 99-2628-B-006-015-MY3. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulrehman D, 2011, NUCLEIC ACIDS RES, V39, pD136, DOI 10.1093/nar/gkq964; Allocco DJ, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-18; Boyle EI, 2004, BIOINFORMATICS, V20, P3710, DOI 10.1093/bioinformatics/bth456; Chang DTH, 2013, GENE, V518, P26, DOI 10.1016/j.gene.2012.11.089; Chang DTH, 2011, NUCLEIC ACIDS RES, V39, pD647, DOI 10.1093/nar/gkq1086; Cherry JM, 2012, NUCLEIC ACIDS RES, V40, pD700, DOI 10.1093/nar/gkr1029; Erb I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024279; Ge H, 2001, NAT GENET, V29, P482, DOI 10.1038/ng776; GuhaThakurta D, 2006, NUCLEIC ACIDS RES, V34, P3585, DOI 10.1093/nar/gkl372; Gyenesei A, 2007, BIOINFORMATICS, V23, P1927, DOI 10.1093/bioinformatics/btm276; Hannenhalli S, 2008, BIOINFORMATICS, V24, P1325, DOI 10.1093/bioinformatics/btn198; Hansen L, 2010, NUCLEIC ACIDS RES, V38, P1772, DOI 10.1093/nar/gkp1195; Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800; Hibbs MA, 2007, BIOINFORMATICS, V23, P2692, DOI 10.1093/bioinformatics/btm403; Hohmann S, 2003, YEAST STRESS RESPONS; Holloway Dustin T, 2005, Genome Inform, V16, P83; Kel AE, 2001, J MOL BIOL, V309, P99, DOI 10.1006/jmbi.2001.4650; Klimova NV, 2006, MOL BIOL+, V40, P454, DOI 10.1134/S0026893306030125; Kolchanov NA, 2007, BRIEF BIOINFORM, V8, P266, DOI 10.1093/bib/bbm027; LAWRENCE CE, 1993, SCIENCE, V262, P208, DOI 10.1126/science.8211139; Lee TI, 2002, SCIENCE, V298, P799, DOI 10.1126/science.1075090; Lin ZG, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-581; MacIsaac KD, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-113; Meierhans D, 1997, NUCLEIC ACIDS RES, V25, P4537, DOI 10.1093/nar/25.22.4537; MULLIGAN ME, 1984, NUCLEIC ACIDS RES, V12, P789, DOI 10.1093/nar/12.1Part2.789; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; ONEILL MC, 1991, NUCLEIC ACIDS RES, V19, P313, DOI 10.1093/nar/19.2.313; Pachkov M, 2013, NUCLEIC ACIDS RES, V41, pD214, DOI 10.1093/nar/gks1145; Reimand J, 2010, NUCLEIC ACIDS RES, V38, P4768, DOI 10.1093/nar/gkq232; Simon I, 2001, CELL, V106, P697, DOI 10.1016/S0092-8674(01)00494-9; Stark C, 2011, NUCLEIC ACIDS RES, V39, pD698, DOI 10.1093/nar/gkq1116; STARR DB, 1995, J MOL BIOL, V250, P434; Stormo GD, 2000, BIOINFORMATICS, V16, P16, DOI 10.1093/bioinformatics/16.1.16; Tabach Y, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000807; Tronche F, 1997, J MOL BIOL, V266, P231, DOI 10.1006/jmbi.1996.0760; Wu WS, 2011, BIOINFORM BIOL INSIG, V5, P1, DOI 10.4137/BBI.S6362; Wu WS, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-439; Yang TH, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-102; Zheng W, 2010, NATURE, V464, P1187, DOI 10.1038/nature08934	39	1	1	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e83791	10.1371/journal.pone.0083791	http://dx.doi.org/10.1371/journal.pone.0083791			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281QS	24386279	gold, Green Submitted, Green Published			2022-12-25	WOS:000329116700077
J	Chen, XL; Wee, NLJE; Hiong, KC; Ong, JLY; Chng, YR; Ching, BY; Wong, WP; Chew, SF; Ip, YK				Chen, Xiu L.; Wee, Nicklaus L. J. E.; Hiong, Kum C.; Ong, Jasmine L. Y.; Chng, You R.; Ching, Biyun; Wong, Wai P.; Chew, Shit F.; Ip, Yuen K.			Properties and Expression of Na+/K+-ATPase alpha-Subunit Isoforms in the Brain of the Swamp Eel, Monopterus albus, Which Has Unusually High Brain Ammonia Tolerance	PLOS ONE			English	Article							NA,K-ATPASE ALPHA; OXIDATIVE STRESS; PERIOPHTHALMODON-SCHLOSSERI; ENVIRONMENTAL AMMONIA; SEAWATER ACCLIMATION; NITROGEN-METABOLISM; MOLECULAR-CLONING; GIANT MUDSKIPPER; CLIMBING PERCH; BINDING SITES	The swamp eel, Monopterus albus, can survive in high concentrations of ammonia (>75 mmol l(-1)) and accumulate ammonia to high concentrations in its brain (similar to 4.5 mu mol g(-1)). Na+/K+-ATPase (Nka) is an essential transporter in brain cells, and since NH4+ can substitute for K+ to activate Nka, we hypothesized that the brain of M. albus expressed multiple forms of Nka alpha-subunits, some of which might have high K+ specificity. Thus, this study aimed to clone and sequence the nka alpha-subunits from the brain of M. albus, and to determine the effects of ammonia exposure on their mRNA expression and overall protein abundance. The effectiveness of NH4+ to activate brain Nka from M. albus and Mus musculus was also examined by comparing their Na+/K+-ATPase and Na+/NH4+-ATPase activities over a range of K+/NH4+ concentrations. The full length cDNA coding sequences of three nka alpha (nka alpha 1, nka alpha 3a and nka alpha 3b) were identified in the brain of M. albus, but nka alpha 2 expression was undetectable. Exposure to 50 mmol l(-1) NH4Cl for 1 day or 6 days resulted in significant decreases in the mRNA expression of nka alpha 1, nka alpha 3a and nka alpha 3b. The overall Nka protein abundance also decreased significantly after 6 days of ammonia exposure. For M. albus, brain Na+/NH4+-ATPase activities were significantly lower than the Na+/K+-ATPase activities assayed at various NH4+/K+ concentrations. Furthermore, the effectiveness of NH4+ to activate Nka from the brain of M. albus was significantly lower than that from the brain of M. musculus, which is ammonia-sensitive. Hence, the (1) lack of nka alpha 2 expression, (2) high K+ specificity of K+ binding sites of Nka alpha 1, Nka alpha 3a and Nka alpha 3b, and (3) down-regulation of mRNA expression of all three nka alpha isoforms and the overall Nka protein abundance in response to ammonia exposure might be some of the contributing factors to the high brain ammonia tolerance in M. albus.	[Chen, Xiu L.; Wee, Nicklaus L. J. E.; Hiong, Kum C.; Ong, Jasmine L. Y.; Chng, You R.; Ching, Biyun; Wong, Wai P.; Ip, Yuen K.] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore; [Chew, Shit F.] Nanyang Technol Univ, Natl Inst Educ, Singapore 639798, Singapore	National University of Singapore; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; National Institute of Education (NIE) Singapore	Ip, YK (corresponding author), Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore.	dbsipyk@nus.edu.sg	Ip, Yuen Kwong/H-8041-2012; Chew, Shit Fun/I-2248-2012	Ip, Yuen Kwong/0000-0001-9124-7911; Chew, Shit Fun/0000-0003-4599-5817	Singapore Ministry of Education [R154-000-470-112]; National Research Foundation Singapore (NRF) under NRF Environmental and Water Technologies (EWT)	Singapore Ministry of Education(Ministry of Education, Singapore); National Research Foundation Singapore (NRF) under NRF Environmental and Water Technologies (EWT)	This study was supported by the Singapore Ministry of Education through a grant (R154-000-470-112) to Yuen K. Ip. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Xiu L. Chen is supported by the National Research Foundation Singapore (NRF) under its NRF Environmental and Water Technologies (EWT) PhD Scholarship Programme administered by the Environment and Water Industry Programme Office (EWI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALABASTER JS, 1980, AMMONIA WATER QUALIT; APERIA A, 1994, FASEB J, V8, P436, DOI 10.1096/fasebj.8.6.8168694; Balshaw DM, 2000, BIOPHYS J, V79, P853, DOI 10.1016/S0006-3495(00)76341-7; BEGUIN P, 1994, J BIOL CHEM, V269, P24437; Bergmeyer HU., 1985, METHOD ENZYMAT AN, V8, P454; Blanco G, 1998, AM J PHYSIOL-RENAL, V275, pF633, DOI 10.1152/ajprenal.1998.275.5.F633; BLEI AT, 1994, HEPATOLOGY, V19, P1437, DOI 10.1002/hep.1840190619; Bosoi CR, 2012, METAB BRAIN DIS, P1; Bosoi CR, 2012, FREE RADICAL BIO MED, V52, P1228, DOI 10.1016/j.freeradbiomed.2012.01.006; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brusilow SW, 2002, MEDICINE, V81, P240, DOI 10.1097/00005792-200205000-00007; Chew SF, 2005, PHYSIOL BIOCHEM ZOOL, V78, P620, DOI 10.1086/430233; Chew SF, 2013, J FISH BIOL IN PRESS; Chew SF, 2007, J EXP ZOOL PART A, V307A, P357, DOI 10.1002/jez.385; Chew Shit F., 2006, Fish Physiology, V21, P307; COOPER AJL, 1987, PHYSIOL REV, V67, P440, DOI 10.1152/physrev.1987.67.2.440; Crambert G, 2000, J BIOL CHEM, V275, P1976, DOI 10.1074/jbc.275.3.1976; Davidson A, 1975, FISH FISH DISHES LAO, P1; Dostanic-Larson I, 2005, P NATL ACAD SCI USA, V102, P15845, DOI 10.1073/pnas.0507358102; Felipo V, 2002, PROG NEUROBIOL, V67, P259, DOI 10.1016/S0301-0082(02)00019-9; Felsenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Feschenko MS, 1997, J BIOL CHEM, V272, P17726, DOI 10.1074/jbc.272.28.17726; FRENEY JR, 1981, AUST J AGR RES, V32, P37, DOI 10.1071/AR9810037; Gerwick L, 2007, FISH SHELLFISH IMMUN, V22, P157, DOI 10.1016/j.fsi.2006.04.003; GLYNN IM, 1984, J PHYSIOL-LONDON, V351, P531, DOI 10.1113/jphysiol.1984.sp015261; Graham JB, 1997, AIR BREATHING FISHES, P234; Guynn SR, 2002, J EXP MAR BIOL ECOL, V273, P15, DOI 10.1016/S0022-0981(02)00136-3; Hall T, 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008; Hermenegildo C, 1996, NEUROCHEM RES, V21, P1237, DOI 10.1007/BF02532401; Horisberger JD, 2002, J PHYSIOL-LONDON, V539, P669, DOI 10.1113/jphysiol.2001.013201; Hosoi R, 1997, J NEUROCHEM, V69, P2189; Illarionova NB, 2010, NEUROSCIENCE, V168, P915, DOI 10.1016/j.neuroscience.2009.11.062; Ip Y.K., 2001, Fish Physiology, V20, P109; Ip YK, 2004, J EXP BIOL, V207, P3015, DOI 10.1242/jeb.01137; Ip YK, 2004, PHYSIOL BIOCHEM ZOOL, V77, P390, DOI 10.1086/383510; Ip YK, 2010, FRONT PHYSIOL, V1, DOI 10.3389/fphys.2010.00134; Ip YK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069512; Ip YK, 2012, J COMP PHYSIOL B, V182, P793, DOI 10.1007/s00360-012-0664-9; Ip YK, 2012, AM J PHYSIOL-REG I, V303, pR112, DOI 10.1152/ajpregu.00618.2011; Jayakumar AR, 2006, J NEUROSCI, V26, P4774, DOI 10.1523/JNEUROSCI.0120-06.2006; JEWELL EA, 1991, J BIOL CHEM, V266, P16925; JORGENSEN PL, 1980, BIOCHIM BIOPHYS ACTA, V597, P305, DOI 10.1016/0005-2736(80)90108-X; Kala G, 2000, NEUROCHEM INT, V36, P203, DOI 10.1016/S0197-0186(99)00117-5; Kosenko E, 1999, FREE RADICAL BIO MED, V26, P1369, DOI 10.1016/S0891-5849(98)00339-6; KOSENKO E, 1994, J NEUROCHEM, V63, P2172; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li CM, 2005, P NATL ACAD SCI USA, V102, P12706, DOI 10.1073/pnas.0505980102; LINGREL JB, 1992, J BIOENERG BIOMEMBR, V24, P263; Lingrel JB, 1998, ACTA PHYSIOL SCAND, V163, P69; Loong AM, 2012, J COMP PHYSIOL B, V182, P367, DOI 10.1007/s00360-011-0626-7; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; McLean WJ, 2008, JARO-J ASSOC RES OTO, V10, P37; Minana MD, 1996, J PHARMACOL EXP THER, V279, P194; Morth JP, 2007, NATURE, V450, P1043, DOI 10.1038/nature06419; Nishi A, 1999, EUR J NEUROSCI, V11, P2589, DOI 10.1046/j.1460-9568.1999.00724.x; Norenberg MD, 2009, METAB BRAIN DIS, V24, P103, DOI 10.1007/s11011-008-9113-6; NORENBERG MD, 1987, NEUROCHEM PATHOL, V6, P13, DOI 10.1007/BF02833599; Ogawa H, 2002, P NATL ACAD SCI USA, V99, P15977, DOI 10.1073/pnas.202622299; Ott P, 2004, NEUROCHEM INT, V44, P185, DOI 10.1016/S0197-0186(03)00153-0; Pasantes-Morales H, 2012, NEUROCHEM RES, V37, P2379, DOI 10.1007/s11064-012-0777-2; Peng KW, 1998, FISH PHYSIOL BIOCHEM, V19, P59, DOI 10.1023/A:1007745003948; Peng L, 1997, J NEUROSCI, V17, P3488; Peng L, 2010, NEURON GLIA BIOL, V26, P1; Rainboth WJ, 1996, FISHES CAMBODIAN MEK, P177; Semple JW, 2002, MAR BIOTECHNOL, V4, P512, DOI 10.1007/s10126-002-0031-z; SHULL GE, 1986, BIOCHEMISTRY-US, V25, P8125, DOI 10.1021/bi00373a001; Taguchi K, 2007, NEUROSCI LETT, V413, P42, DOI 10.1016/j.neulet.2006.11.061; Tay ASL, 2003, J EXP BIOL, V206, P2473, DOI 10.1242/jeb.00464; Tay YL, 2006, J EXP BIOL, V209, P4475, DOI 10.1242/jeb.02557; Therien AG, 2000, AM J PHYSIOL-CELL PH, V279, pC541, DOI 10.1152/ajpcell.2000.279.3.C541; Tng YYM, 2009, J EXP ZOOL PART A, V311A, P676, DOI 10.1002/jez.555; Wilkie MP, 2002, J EXP ZOOL, V293, P284, DOI 10.1002/jez.10123; WRIGHT PA, 1995, J EXP BIOL, V198, P273; Xue ZX, 2010, NEUROCHEM INT, V57, P395, DOI 10.1016/j.neuint.2010.04.014; Zahler R, 1997, J GEN PHYSIOL, V110, P201, DOI 10.1085/jgp.110.2.201; ZAUGG WS, 1982, CAN J FISH AQUAT SCI, V39, P215, DOI 10.1139/f82-027	76	3	3	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84298	10.1371/journal.pone.0084298	http://dx.doi.org/10.1371/journal.pone.0084298			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391932	Green Submitted, gold, Green Published			2022-12-25	WOS:000329323900075
J	Fan, J; Xie, JB; Wang, JL; Qu, JS				Fan Jing; Xie Jianbin; Wang Jinlong; Qu Jinshuai			Uncovering and Testing the Fuzzy Clusters Based on Lumped Markov Chain in Complex Network	PLOS ONE			English	Article							COMMUNITY STRUCTURE; GAUSSIAN MIXTURE	Identifying clusters, namely groups of nodes with comparatively strong internal connectivity, is a fundamental task for deeply understanding the structure and function of a network. By means of a lumped Markov chain model of a random walker, we propose two novel ways of inferring the lumped markov transition matrix. Furthermore, some useful results are proposed based on the analysis of the properties of the lumped Markov process. To find the best partition of complex networks, a novel framework including two algorithms for network partition based on the optimal lumped Markovian dynamics is derived to solve this problem. The algorithms are constructed to minimize the objective function under this framework. It is demonstrated by the simulation experiments that our algorithms can efficiently determine the probabilities with which a node belongs to different clusters during the learning process and naturally supports the fuzzy partition. Moreover, they are successfully applied to real-world network, including the social interactions between members of a karate club.	[Fan Jing; Wang Jinlong; Qu Jinshuai] Yunnan Univ Nationalities, Univ Key Lab Wireless Sensor Networks Yunnan Prov, Kunming, Peoples R China; [Xie Jianbin] Yunnan Univ, Sch Urban Construct & Management, Kunming, Peoples R China	Yunnan Minzu University; Yunnan University	Fan, J (corresponding author), Yunnan Univ Nationalities, Univ Key Lab Wireless Sensor Networks Yunnan Prov, Kunming, Peoples R China.	fanjing9476@163.com			National Natural Science Foundation of China [60963026, 61163061]; Application Basic Research Fund of Yunnan Province [2011FZ174]; National Natural Science Foundation of China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Application Basic Research Fund of Yunnan Province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (grant No. 60963026, No. 61163061), and the Application Basic Research Fund of Yunnan Province (grant No. 2011FZ174). Tthe National Natural Science Foundation of China: http://www.nsfc.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Borner K, 2007, ANNU REV INFORM SCI, V41, P537, DOI 10.1002/aris.2007.1440410119; Chorin AJ, 1999, COMMUN PUR APPL MATH, V52, P1231, DOI 10.1002/(SICI)1097-0312(199910)52:10<1231::AID-CPA3>3.0.CO;2-C; Chorin AJ, 2003, MULTISCALE MODEL SIM, V1, P105, DOI 10.1137/S1540345902405556; Chung F., 1997, SPECTRAL GRAPH THEOR, DOI DOI 10.1090/CBMS/092; Danon L, 2005, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2005/09/P09008; Devijver P, 1982, PATTERN RECOGNITION; Friedman J., 2001, ELEMENTS STAT LEARNI, DOI DOI 10.1007/978-0-387-84858-7; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Hofman JM, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.258701; Lafon S, 2006, IEEE T PATTERN ANAL, V28, P1393, DOI 10.1109/TPAMI.2006.184; Lancichinetti A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011976; Li TJ, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.026106; Lovasz L, 1993, BOLYAI MATH STUD, V1, P9; Ma JW, 2006, NEURAL PROCESS LETT, V24, P19, DOI 10.1007/s11063-006-9008-7; Ma JW, 2005, INT J PATTERN RECOGN, V19, P701, DOI 10.1142/S0218001405004228; Ma JW, 2004, NEUROCOMPUTING, V56, P481, DOI 10.1016/j.neucom.2003.10.009; Meila M, 2001, RANDOM WALKS VIEW SP; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Newman MEJ, 2004, EUR PHYS J B, V38, P321, DOI 10.1140/epjb/e2004-00124-y; Newman MEJ, 2004, PHYS REV E, V69, DOI [10.1103/PhysRevE.69.026113, 10.1103/PhysRevE.70.056131]; Newman MEJ., 2006, STRUCTURE DYNAMICS N; Qian N, 1999, NEURAL NETWORKS, V12, P145, DOI 10.1016/S0893-6080(98)00116-6; Schilders WHA, 2008, EUR CONSORT MATH IND, P1, DOI 10.1007/978-3-540-78841-6; Shi JB, 2000, IEEE T PATTERN ANAL, V22, P888, DOI 10.1109/34.868688; Weinan E, 2008, P NATL ACAD SCI USA, V105, P7907, DOI 10.1073/pnas.0707563105; ZACHARY WW, 1977, J ANTHROPOL RES, V33, P452, DOI 10.1086/jar.33.4.3629752	27	0	0	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e82964	10.1371/journal.pone.0082964	http://dx.doi.org/10.1371/journal.pone.0082964			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391729	Green Published, gold, Green Submitted			2022-12-25	WOS:000329325200026
J	Huffman, MD; Baldridge, A; Bloomfield, GS; Colantonio, LD; Prabhakaran, P; Ajay, VS; Suh, S; Lewison, G; Prabhakaran, D				Huffman, Mark D.; Baldridge, Abigail; Bloomfield, Gerald S.; Colantonio, Lisandro D.; Prabhakaran, Poornima; Ajay, Vamadevan S.; Suh, Sarah; Lewison, Grant; Prabhakaran, Dorairaj			Global Cardiovascular Research Output, Citations, and Collaborations: A Time-Trend, Bibliometric Analysis (1999-2008)	PLOS ONE			English	Article							PUBLICATION; DISEASE	Introduction: Health research is one mechanism to improve population-level health and should generally match the health needs of populations. However, there have been limited data to assess the trends in national-level cardiovascular research output, even as cardiovascular disease [CVD] has become the leading cause of morbidity and mortality worldwide. Materials and Methods: We performed a time trends analysis of cardiovascular research publications (1999-2008) downloaded from Web of Knowledge using a iteratively-tested cardiovascular bibliometric filter with >90% precision and recall. We evaluated cardiovascular research publications, five-year running actual citation indices [ACIs], and degree of international collaboration measured through the ratio of the fractional count of addresses from one country against all addresses for each publication. Results and Discussion: Global cardiovascular publication volume increased from 40 661 publications in 1999 to 55 284 publications in 2008, which represents a 36% increase. The proportion of cardiovascular publications from high-income, Organization for Economic Cooperation and Development [OECD] countries declined from 93% to 84% of the total share over the study period. High-income, OECD countries generally had higher fractional counts, which suggest less international collaboration, than lower income countries from 1999-2008. There was an inverse relationship between cardiovascular publications and age-standardized CVD morbidity and mortality rates, but a direct, curvilinear relationship between cardiovascular publications and Human Development Index from 1999-2008. Conclusions: Cardiovascular health research output has increased substantially in the past decade, with a greater share of citations being published from low-and middle-income countries. However, low-and middle-income countries with the higher burdens of cardiovascular disease continue to have lower research output than high-income countries, and thus require targeted research investments to improve cardiovascular health.	[Huffman, Mark D.; Prabhakaran, Dorairaj] Ctr Chron Dis Control, New Delhi, India; [Huffman, Mark D.; Baldridge, Abigail; Suh, Sarah] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA; [Bloomfield, Gerald S.] Duke Univ, Med Ctr, Durham, NC USA; [Colantonio, Lisandro D.] Univ Alabama Birmingham, Sch Publ Hlth, Birmingham, AL 35294 USA; [Prabhakaran, Poornima; Ajay, Vamadevan S.] Publ Hlth Fdn India, New Delhi, India; [Lewison, Grant] Kings Coll London, London WC2R 2LS, England	Northwestern University; Feinberg School of Medicine; Duke University; University of Alabama System; University of Alabama Birmingham; Public Health Foundation of India; University of London; King's College London	Huffman, MD (corresponding author), Ctr Chron Dis Control, New Delhi, India.	m-huffman@northwestern.edu	Prabhakaran, Dorairaj/B-4147-2011	Prabhakaran, Dorairaj/0000-0002-3172-834X; Ajay, Vamadevan S/0000-0002-4102-0505; Colantonio, Lisandro/0000-0001-8742-1788; Huffman, Mark/0000-0001-7412-2519; Bloomfield, Gerald/0000-0002-7176-1611	Global Forum for Health Research; Fogarty International Center; National Heart, Lung, and Blood Institute (NHLBI) [1K99HL107749-01A1]; Fogarty International Center of the National Institutes of Health [K01TW008407]; Wellcome Trust Capacity Strengthening Strategic Award; NHLBI [HHS N268200900026C]; National Institute of Child Health and Human Development [1D43HD065249]; FOGARTY INTERNATIONAL CENTER [K01TW008407] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K99HL107749] Funding Source: NIH RePORTER	Global Forum for Health Research; Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Fogarty International Center of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Wellcome Trust Capacity Strengthening Strategic Award(Wellcome Trust); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by Global Forum for Health Research and the Fogarty International Center. Neither participated in the study design, analysis, writing, or decision to publish. MDH is supported by a National Heart, Lung, and Blood Institute (NHLBI) Pathway to Independence award [1K99HL107749-01A1]. GSB is supported by the Fogarty International Center of the National Institutes of Health [K01TW008407]. PP and VSA are supported by a Wellcome Trust Capacity Strengthening Strategic Award to the Public Health Foundation of India and a consortium of United Kingdom universities. DP receives partial salary support from a contract award [HHS N268200900026C] from NHLBI and a grant award [1D43HD065249] from National Institute of Child Health and Human Development. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	[Anonymous], 2012, PLOS MED, V9; Baussano I, 2008, EMERG THEMES EPIDEMI, V5, DOI 10.1186/1742-7622-5-16; Bonita R, 2013, LANCET, V381, P575, DOI 10.1016/S0140-6736(12)61993-X; Callaham M, 2002, JAMA-J AM MED ASSOC, V287, P2847, DOI 10.1001/jama.287.21.2847; Clarke A, 2007, EUR J PUBLIC HEALTH, V17, P43, DOI 10.1093/eurpub/ckm063; deJong JW, 1996, EUR HEART J, V17, P35; Durieux V, 2010, RADIOLOGY, V255, P342, DOI 10.1148/radiol.09090626; Falagas ME, 2008, FASEB J, V22, P2623, DOI 10.1096/fj.08-107938; Kulkarni AV, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000403; Larsen PO, 2010, SCIENTOMETRICS, V84, P575, DOI 10.1007/s11192-010-0202-z; Lewison G, 1996, RES EVALUAT, V6, P25; Lewison G, 2011, DESIDOC J LIB INF TE, V31, P333, DOI 10.14429/djlit.31.5.1189; Lewison G, 2010, EUR J CANCER, V46, P912, DOI 10.1016/j.ejca.2009.12.020; McKee MD, 2012, PEDIATRIC BONE: BIOLOGY & DISEASES, 2ND EDITION, P9, DOI 10.1016/B978-0-12-382040-2.10002-4; McVeigh ME, 2009, JAMA-J AM MED ASSOC, V302, P1107, DOI 10.1001/jama.2009.1301; Mendis S, 2003, LANCET, V361, P2246, DOI 10.1016/S0140-6736(03)13753-1; Mori H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057371; Pan RK, 2012, SCI REP-UK, V2, DOI 10.1038/srep00902; Prabhakaran P, 2007, J AM COLL CARDIOL, V50, P2322, DOI 10.1016/j.jacc.2007.08.040; The Commission on Health Research for Development, 1990, HLTH RES ESS LINK EQ	20	46	46	3	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83440	10.1371/journal.pone.0083440	http://dx.doi.org/10.1371/journal.pone.0083440			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391769	Green Published, Green Submitted, gold			2022-12-25	WOS:000329325200066
J	Lemoh, C; Ryan, CE; Sekawi, Z; Hearps, AC; Aleksic, E; Chibo, D; Grierson, J; Baho, S; Street, A; Hellard, M; Biggs, BA; Crowe, SM				Lemoh, Chris; Ryan, Claire E.; Sekawi, Zamberi; Hearps, Anna C.; Aleksic, Eman; Chibo, Doris; Grierson, Jeffrey; Baho, Samia; Street, Alan; Hellard, Margaret; Biggs, Beverley-Ann; Crowe, Suzanne M.			Acquisition of HIV by African-Born Residents of Victoria, Australia: Insights from Molecular Epidemiology	PLOS ONE			English	Article							VIRUS TYPE-1 SUBTYPES; INJECTING DRUG-USERS; GLOBAL EPIDEMIOLOGY; GENETIC DIVERSITY; TRANSMISSION; INFECTION; RISK; SEX; MEN; SURVEILLANCE	African-born Australians are a recognised "priority population" in Australia's Sixth National HIV/AIDS Strategy. We compared exposure location and route for African-born people living with HIV (PLHIV) in Victoria, Australia, with HIV-1 pol subtype from drug resistance assays and geographical origin suggested by phylogenetic analysis of env gene. Twenty adult HIV positive African-born Victorian residents were recruited via treating doctors. HIV exposure details were obtained from interviews and case notes. Viral RNA was extracted from participant stored plasma or whole blood. The env V3 region was sequenced and compared to globally representative reference HIV-1 sequences in the Los Alamos National Library HIV Database. Twelve participants reported exposure via heterosexual sex and two via iatrogenic blood exposures; four were men having sex with men (MSM); two were exposed via unknown routes. Eight participants reported exposure in their countries of birth, seven in Australia, three in other countries and two in unknown locations. Genotype results (pol) were available for ten participants. HIV env amplification was successful in eighteen cases. HIV-1 subtype was identified in all participants: eight both pol and env; ten env alone and two pol alone. Twelve were subtype C, four subtype B, three subtype A and one subtype CRF02_AG. Reported exposure location was consistent with the phylogenetic clustering of env sequences. African Australians are members of multiple transnational social and sexual networks influencing their exposure to HIV. Phylogenetic analysis may complement traditional surveillance to discern patterns of HIV exposure, providing focus for HIV prevention programs in mobile populations.	[Lemoh, Chris; Hellard, Margaret] Burnet Inst, Ctr Populat Hlth, Melbourne, Vic, Australia; [Lemoh, Chris; Baho, Samia; Biggs, Beverley-Ann] Univ Melbourne, Dept Med, Melbourne, Vic, Australia; [Lemoh, Chris; Street, Alan; Biggs, Beverley-Ann] Royal Melbourne Hosp, Victorian Infect Dis Serv, Melbourne, Vic, Australia; [Ryan, Claire E.; Sekawi, Zamberi; Hearps, Anna C.; Aleksic, Eman; Crowe, Suzanne M.] Burnet Inst, Ctr Biomed Res, Melbourne, Vic, Australia; [Sekawi, Zamberi] Univ Putra Malaysia, Fac Med & Hlth Sci, Serdang 43400, Selangor, Malaysia; [Chibo, Doris] Victorian Infect Dis Reference Lab, HIV State Reference Lab, Melbourne, Australia; [Grierson, Jeffrey] La Trobe Univ, Australian Res Ctr Sex Hlth & Soc, Melbourne, Vic, Australia; [Hellard, Margaret; Crowe, Suzanne M.] Alfred Hosp, Dept Infect Dis, Melbourne, Vic, Australia	Burnet Institute; University of Melbourne; Royal Melbourne Hospital; Burnet Institute; Universiti Putra Malaysia; Victorian Infectious Diseases Reference Laboratory; La Trobe University; Florey Institute of Neuroscience & Mental Health	Lemoh, C (corresponding author), Burnet Inst, Ctr Populat Hlth, Melbourne, Vic, Australia.	chris.lemoh@gmail.com	Nightingale, Claire Elizabeth/K-1667-2019; Sekawi, Zamberi/I-1755-2013	Nightingale, Claire Elizabeth/0000-0002-4103-6240; Sekawi, Zamberi/0000-0002-5387-9640; Chibo, Doris/0000-0002-6950-6910; Biggs, Beverley-Ann/0000-0002-2961-9793; Grierson, Jeffrey/0000-0003-1619-2054; Lemoh, Christopher/0000-0002-8383-9471	Centre for Clinical Research Excellence in Infectious Diseases; Department of Medicine; Victorian Government Department of Human Services; Victor Hurley Research Fund; Australasian Society for Infectious Diseases; Victorian Department of Innovation and Industry; Australian National Health and Medical Research Council; National Health and Medical Research Council	Centre for Clinical Research Excellence in Infectious Diseases; Department of Medicine; Victorian Government Department of Human Services; Victor Hurley Research Fund; Australasian Society for Infectious Diseases; Victorian Department of Innovation and Industry; Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	The authors are grateful for the financial and material support provided by the Centre for Clinical Research Excellence in Infectious Diseases and the Department of Medicine; the financial support received from the Victorian Government Department of Human Services, the Victor Hurley Research Fund and the Australasian Society for Infectious Diseases; and the material support provided by the Burnet Institute, the Victorian Infectious Diseases Laboratories and the Victorian Infectious Diseases Service. The authors acknowledge the funding for institutional infrastructure provided by the Victorian Department of Innovation and Industry and the Australian National Health and Medical Research Council. Suzanne Crowe holds a Principal Research Fellowship from the National Health and Medical Research Council. Margaret Hellard holds a Senior Research Fellowship from the National Health and Medical Research Council. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors gratefully acknowledge the contribution to this work of the Victorian Operational Infrastructure Support Program.	Aggarwal I, 2006, JAIDS-J ACQ IMM DEF, V41, P201, DOI 10.1097/01.qai.0000179430.34660.11; Akouamba BS, 2005, EMERG INFECT DIS, V11, P1230, DOI 10.3201/eid1108.040877; Antinori A, 2011, HIV MED, V12, P61, DOI 10.1111/j.1468-1293.2010.00857.x; Australian Bureau of Statistics, 2007, 2006 CENS POP HOUS; Beyrer C, 2012, LANCET, V380, P367, DOI 10.1016/S0140-6736(12)60821-6; BULL JJ, 1993, SYST BIOL, V42, P384, DOI 10.2307/2992473; Caridha R, 2012, AIDS RES HUM RETROV, V28, P852, DOI [10.1089/AID.2011.0033, 10.1089/aid.2011.0033]; Carr JK, 1999, AIDS, V13, P1819, DOI 10.1097/00002030-199910010-00003; Chibo D, 2012, AIDS RES HUM RETROV, V28, P578, DOI [10.1089/aid.2011.0200, 10.1089/AID.2011.0200]; Chibo D, 2012, AIDS RES HUM RETROV, V28, P460, DOI [10.1089/AID.2011.0137, 10.1089/aid.2011.0137]; De Cock KM, 2012, AIDS, V26, P1205, DOI 10.1097/QAD.0b013e328354622a; de Coul ELMO, 2001, AIDS, V15, P2277, DOI 10.1097/00002030-200111230-00009; Dept Health and Ageing, 2010, 6 NAT HIV STRAT 2010; Dore GJ, 2001, J ACQ IMMUN DEF SYND, V26, P283, DOI 10.1097/00126334-200103010-00012; Dubois-Arber F, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-528; EuroHIV, 2007, HIV AIDS SURV EUR EN; Gifford RJ, 2007, J VIROL, V81, P13050, DOI 10.1128/JVI.00889-07; Graw F, 2012, EPIDEMICS-NETH, V4, P104, DOI 10.1016/j.epidem.2012.04.002; Hayman A, 2001, AIDS RES HUM RETROV, V17, P689, DOI 10.1089/088922201750236960; Hemelaar J, 2006, AIDS, V20, pW13, DOI 10.1097/01.aids.0000247564.73009.bc; Herring BL, 2003, J CLIN MICROBIOL, V41, P4600, DOI 10.1128/JCM.41.10.4600-4604.2003; HILLIS DM, 1993, SYST BIOL, V42, P182, DOI 10.2307/2992540; Hughes GJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000590; Jennes W, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0037402, DOI 10.1371/J0URNAL.P0NE.0037402]; Kaldor J, 2003, JAIDS-J ACQ IMM DEF, V32, pS18, DOI 10.1097/00126334-200302011-00004; Kandathil AJ, 2005, INDIAN J MED RES, V121, P333; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kouyos RD, 2010, J INFECT DIS, V201, P1488, DOI 10.1086/651951; Lemoh C, 2006, REDUCING RISK TRAND; Lemoh C, 2009, SEX HEALTH, V6, P117, DOI 10.1071/SH08028; Lemoh CN, 2010, SEX HEALTH, V7, P142, DOI 10.1071/SH09120; Liitsola K, 2000, SCAND J INFECT DIS, V32, P475, DOI 10.1080/003655400458721; Lospitao E, 2005, HIV MED, V6, P313, DOI 10.1111/j.1468-1293.2005.00313.x; McCutchan FE, 2006, J MED VIROL, V78, pS7, DOI 10.1002/jmv.20599; McMichael C, 2010, CULT HEALTH SEX, V12, P263, DOI 10.1080/13691050903359265; Medew J, 2007, AGE             0428; Metlikovec J, 2007, HERALD SUN      0414; Monno L, 2005, J MED VIROL, V75, P483, DOI 10.1002/jmv.20300; Op de Coul ELM, 1998, AIDS, V12, P1253, DOI 10.1097/00002030-199810000-00024; Palmer R., 2009, DIVERSITY HLTH CARE, V6, P109; Papathanasopoulos MA, 2003, VIRUS GENES, V26, P151, DOI 10.1023/A:1023435429841; Paraskevis D, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-49; Ramsey PG, 1998, AM J MED, V104, P152, DOI 10.1016/S0002-9343(97)00310-0; Ryan CE, 2004, AIDS RES HUM RETROV, V20, P1364, DOI 10.1089/aid.2004.20.1364; Ryan CE, 2007, AIDS RES HUM RETROV, V23, P941, DOI 10.1089/aid.2007.0043; SACKETT DL, 1992, JAMA-J AM MED ASSOC, V267, P2650, DOI 10.1001/jama.267.19.2650; Scaduto DI, 2010, P NATL ACAD SCI USA, V107, P21242, DOI 10.1073/pnas.1015673107; Smith AD, 2009, LANCET, V374, P416, DOI 10.1016/S0140-6736(09)61118-1; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; The Kirby Institute, 2012, HIV VIR HEP SEX TRAN; von Wyl V, 2011, J INFECT DIS, V204, P1095, DOI 10.1093/infdis/jir491; Yebra G, 2009, AIDS RES HUM RETROV, V25, P37, DOI 10.1089/aid.2008.0134; Yirrell DL, 1999, SEX TRANSM INFECT, V75, P392, DOI 10.1136/sti.75.6.392	53	5	5	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84008	10.1371/journal.pone.0084008	http://dx.doi.org/10.1371/journal.pone.0084008			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391866	Green Published, gold, Green Accepted			2022-12-25	WOS:000329323900009
J	Liang, J; Zhou, MQ; Zhou, X; Jin, YJ; Xu, M; Lin, J				Liang, Jing; Zhou, Mingqi; Zhou, Xin; Jin, Yuanjie; Xu, Ming; Lin, Juan			JcLEA, a Novel LEA-Like Protein from Jatropha curcas, Confers a High Level of Tolerance to Dehydration and Salinity in Arabidopsis thaliana	PLOS ONE			English	Article							EMBRYOGENESIS ABUNDANT PROTEIN; PLANT CRATEROSTIGMA-PLANTAGINEUM; FUNCTIONAL-CHARACTERIZATION; MOLECULAR RESPONSES; DESICCATION STRESS; DROUGHT TOLERANCE; GENE-EXPRESSION; WATER-DEFICIT; STABILIZATION; NEMATODE	Jatropha curcas L. is a highly drought and salt tolerant plant species that is typically used as a traditional folk medicine and biofuel crop in many countries. Understanding the molecular mechanisms that underlie the response to various abiotic environmental stimuli, especially to drought and salt stresses, in J. curcas could be important to crop improvement efforts. In this study, we cloned and characterized the gene for a late embryogenesis abundant (LEA) protein from J. curcas that we designated JcLEA. Sequence analyses showed that the JcLEA protein belongs to group 5, a subgroup of the LEA protein family. In young seedlings, expression of JcLEA is significantly induced by abscisic acid (ABA), dehydration, and salt stress. Subcellular localization analysis shows that that JcLEA protein is distributed in both the nucleus and cytoplasm. Moreover, based on growth status and physiological indices, the overexpression of JcLEA in transgenic Arabidopsis plants conferred increased resistance to both drought and salt stresses compared to the WT. Our data suggests that the group 5 JcLEA protein contributes to drought and salt stress tolerance in plants. Thus, JcLEA is a potential candidate gene for plant genetic modification.	[Liang, Jing; Zhou, Mingqi; Zhou, Xin; Jin, Yuanjie; Xu, Ming; Lin, Juan] Fudan Univ, Sch Life Sci, Inst Plant Biol, State Key Lab Genet Engn, Shanghai 200433, Peoples R China	Fudan University	Lin, J (corresponding author), Fudan Univ, Sch Life Sci, Inst Plant Biol, State Key Lab Genet Engn, Shanghai 200433, Peoples R China.	linjuan@fudan.edu.cn	Zhou, Mingqi/P-1305-2019; Zhou, Xin/B-9779-2012; Zhou, Mingqi/C-4693-2015	Zhou, Mingqi/0000-0002-4605-5467; Zhou, Xin/0000-0001-8089-4507; Zhou, Mingqi/0000-0002-4605-5467; Lin, Juan/0000-0002-8608-9370	Natural Science Foundation of China [31170287]; Major Program for the Fundamental Research of Shanghai, China [09JC1401700]; National High Technology Research and Development Program of China [2008AA10Z105]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major Program for the Fundamental Research of Shanghai, China; National High Technology Research and Development Program of China(National High Technology Research and Development Program of China)	The authors are grateful for the financial support from the Natural Science Foundation of China (31170287)((sic)560000), the Major Program for the Fundamental Research of Shanghai, China (09JC1401700)((sic)300000) and the National High Technology Research and Development Program of China (2008AA10Z105) ((sic)500000). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abba' S, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-39; Arenas-Mena C, 1999, PLANT MOL BIOL, V40, P355, DOI 10.1023/A:1006219315562; BAKER J, 1988, PLANT MOL BIOL, V11, P277, DOI 10.1007/BF00027385; Battaglia M, 2008, PLANT PHYSIOL, V148, P6, DOI 10.1104/pp.108.120725; Bies-Etheve N, 2008, PLANT MOL BIOL, V67, P107, DOI 10.1007/s11103-008-9304-x; Bolen D W, 2001, Methods Mol Biol, V168, P17; Borovskii Genadii B, 2002, BMC Plant Biol, V2, P5, DOI 10.1186/1471-2229-2-5; Boudet J, 2006, PLANT PHYSIOL, V140, P1418, DOI 10.1104/pp.105.074039; BRAY EA, 1993, PLANT PHYSIOL, V103, P1035, DOI 10.1104/pp.103.4.1035; Bray EA, 1994, STRESS INDUCED GENE, P1; Browne JA, 2004, EUKARYOT CELL, V3, P966, DOI 10.1128/EC.3.4.966-975.2004; Chakrabortee S, 2007, P NATL ACAD SCI USA, V104, P18073, DOI 10.1073/pnas.0706964104; Checker VG, 2012, TRANSGENIC RES, V21, P939, DOI 10.1007/s11248-011-9577-8; Cheng ZQ, 2002, MOL BREEDING, V10, P71, DOI 10.1023/A:1020329401191; CLOSE TJ, 1993, PLANT PHYSIOL, V101, P773, DOI 10.1104/pp.101.3.773; CUMING AC, 1979, EUR J BIOCHEM, V99, P217, DOI 10.1111/j.1432-1033.1979.tb13248.x; Diaz-Lopez L, 2012, PLANT PHYSIOL BIOCH, V54, P34, DOI 10.1016/j.plaphy.2012.02.005; DURE L, 1981, BIOCHEMISTRY-US, V20, P4162, DOI 10.1021/bi00517a033; Eichinger L, 2005, NATURE, V435, P43, DOI 10.1038/nature03481; Finkelstein Ruth R., 2002, Plant Cell, V14, pS15; Gal TZ, 2004, FEBS LETT, V577, P21, DOI 10.1016/j.febslet.2004.09.049; Ghars MA, 2008, J PLANT PHYSIOL, V165, P588, DOI 10.1016/j.jplph.2007.05.014; Grelet J, 2005, PLANT PHYSIOL, V137, P157, DOI 10.1104/pp.104.052480; Haegeman A, 2009, MOL BIOCHEM PARASIT, V167, P32, DOI 10.1016/j.molbiopara.2009.04.004; Hand SC, 2011, ANNU REV PHYSIOL, V73, P115, DOI 10.1146/annurev-physiol-012110-142203; Hasegawa PM, 2000, ANNU REV PLANT PHYS, V51, P463, DOI 10.1146/annurev.arplant.51.1.463; He S, 2012, MOL GENET GENOMICS, V287, P39, DOI 10.1007/s00438-011-0660-x; Huang Jing, 2009, Sichuan Daxue Xuebao (Ziran Kexueban), V46, P223; Hundertmark M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-118; ITURRIAGA G, 1992, PLANT MOL BIOL, V20, P555, DOI 10.1007/BF00040614; Jiao JY, 2011, ACTA ECOLOGICA SINIC, V30, P4460; Karakas B, 1997, PLANT CELL ENVIRON, V20, P609, DOI 10.1111/j.1365-3040.1997.00132.x; Kaye C, 1998, PLANT PHYSIOL, V116, P1367, DOI 10.1104/pp.116.4.1367; Kim HS, 2005, GENE, V344, P115, DOI 10.1016/j.gene.2004.09.012; KIYOSUE T, 1992, PLANT MOL BIOL, V19, P239, DOI 10.1007/BF00027345; Lin Sha, 2008, Chinese Journal of Applied and Environmental Biology, V14, P692, DOI 10.3724/SP.J.1145.2008.00692; LIN TY, 1994, BIOCHEMISTRY-US, V33, P12695, DOI 10.1021/bi00208a021; Mastan SG, 2012, GENE, V508, P125, DOI 10.1016/j.gene.2012.07.063; Park SC, 2011, PLANTA, V233, P621, DOI 10.1007/s00425-010-1326-3; PIATKOWSKI D, 1990, PLANT PHYSIOL, V94, P1682, DOI 10.1104/pp.94.4.1682; PLA M, 1991, MOL GEN GENET, V230, P394, DOI 10.1007/BF00280296; Shao HB, 2005, COLLOID SURFACE B, V45, P131, DOI 10.1016/j.colsurfb.2005.07.017; Shih MD, 2008, ADV BOT RES, V48, P211, DOI 10.1016/S0065-2296(08)00404-7; Silva EN, 2010, ENVIRON EXP BOT, V69, P279, DOI 10.1016/j.envexpbot.2010.05.001; Sivamani E, 2000, PLANT SCI, V155, P1, DOI 10.1016/S0168-9452(99)00247-2; Solomon A, 2000, PARASITOLOGY, V121, P409, DOI 10.1017/S0031182099006563; Staden R, 2001, METHOD BIOCHEM ANAL, V43, P302; Tunnacliffe A, 2007, NATURWISSENSCHAFTEN, V94, P791, DOI 10.1007/s00114-007-0254-y; Tyson T, 2007, INT J PARASITOL, V37, P763, DOI 10.1016/j.ijpara.2006.12.015; Wang WX, 2003, PLANTA, V218, P1, DOI 10.1007/s00425-003-1105-5; Warner AH, 2010, J BIOCHEM, V148, P581, DOI 10.1093/jb/mvq091; Wise MJ, 2004, TRENDS PLANT SCI, V9, P13, DOI 10.1016/j.tplants.2003.10.012; Wu LH, 2012, J PLANT PHYSIOL, V169, P1408, DOI 10.1016/j.jplph.2012.05.016; Xie GF, 1997, BIOPHYS CHEM, V64, P25, DOI 10.1016/S0301-4622(96)02222-3; Xu DP, 1996, PLANT PHYSIOL, V110, P249, DOI 10.1104/pp.110.1.249; Yang HP, 1996, PHYSIOL PLANTARUM, V98, P661, DOI 10.1111/j.1399-3054.1996.tb05724.x; Yin ZM, 2006, PLANT SCI, V170, P1164, DOI 10.1016/j.plantsci.2006.02.002; Zegzouti H, 1997, PLANT MOL BIOL, V35, P847, DOI 10.1023/A:1005860302313; Zhou MQ, 2012, MOL BREEDING, V30, P1611, DOI 10.1007/s11032-012-9744-5; Zhou MQ, 2012, MOL BIOL REP, V39, P5169, DOI 10.1007/s11033-011-1313-1; Zhu JK, 2003, CURR OPIN PLANT BIOL, V6, P441, DOI 10.1016/S1369-5266(03)00085-2	61	30	31	0	130	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83056	10.1371/journal.pone.0083056	http://dx.doi.org/10.1371/journal.pone.0083056			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391737	Green Published, gold, Green Submitted			2022-12-25	WOS:000329325200034
J	Qi, LN; Li, LQ; Chen, YY; Chen, ZH; Bai, T; Xiang, BD; Qin, X; Xiao, KY; Peng, MH; Liu, ZM; Liu, TW; Qin, X; Li, S; Han, ZG; Mo, ZN; Santella, RM; Winkler, CA; O'Brien, SJ; Peng, T				Qi, Lu-Nan; Li, Le-Qun; Chen, Yuan-Yuan; Chen, Zhao-Hong; Bai, Tao; Xiang, Bang-De; Qin, Xiao; Xiao, Kai-Yin; Peng, Min-Hao; Liu, Zhi-Ming; Liu, Tang-Wei; Qin, Xue; Li, Shan; Han, Ze-Guang; Mo, Zeng-Nan; Santella, Regina M.; Winkler, Cheryl A.; O'Brien, Stephen J.; Peng, Tao			Genome-Wide and Differential Proteomic Analysis of Hepatitis B Virus and Aflatoxin B1 Related Hepatocellular Carcinoma in Guangxi, China	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; RISK-FACTORS; DNA DOMAIN; AKR1B10; EXPRESSION; OVEREXPRESSION; HYBRIDIZATION; ABERRATIONS; TP53; MUTATIONS	Both hepatitis B virus (HBV) and aflatoxin B1 (AFB1) exposure can cause liver damage as well as increase the probability of hepatocellular carcinoma (HCC). To investigate the underlying genetic changes that may influence development of HCC associated with HBV infection and AFB1 exposure, HCC patients were subdivided into 4 groups depending upon HBV and AFB1 exposure status: (HBV(+)/AFB1(+), HBV(+)/AFB1(-), HBV(-)/AFB1(+), HBV(-)/AFB1(-)). Genetic abnormalities and protein expression profiles were analyzed by array-based comparative genomic hybridization and isobaric tagging for quantitation. A total of 573 chromosomal aberrations (CNAs) including 184 increased and 389 decreased were detected in our study population. Twenty-five recurrently altered regions (RARs; chromosomal alterations observed in >= 10 patients) in chromosomes were identified. Loss of 4q13.3-q35.2, 13q12.1-q21.2 and gain of 7q11.2-q35 were observed with a higher frequency in the HBV(+)/AFB1(+), HBV(+)/AFB1(-) and HBV(-)/AFB1(+) groups compared to the HBV(-)/AFB(-) group. Loss of 8p12-p23.2 was associated with high TNM stage tumors (P = 0.038) and was an unfavorable prognostic factor for tumor-free survival (P =0.045). A total of 133 differentially expressed proteins were identified in iTRAQ proteomics analysis, 69 (51.8%) of which mapped within identified RARs. The most common biological processes affected by HBV and AFB1 status in HCC tumorigenesis were detoxification and drug metabolism pathways, antigen processing and anti-apoptosis pathways. Expression of AKR1B10 was increased significantly in the HBV(+)/AFB1(+) and HBV(-)/AFB1(+) groups. A significant correlation between the expression of AKR1B10 mRNA and protein levels as well as AKR1B10 copy number was observered, which suggest that AKR1B10 may play a role in AFB1-related hepatocarcinogenesis. In summary, a number of genetic and gene expression alterations were found to be associated with HBV and AFB1- related HCC. The possible synergistic effects of HBV and AFB1 in hepatocarcinogenesis warrant further investigations.	[Qi, Lu-Nan; Li, Le-Qun; Chen, Zhao-Hong; Bai, Tao; Xiang, Bang-De] Guangxi Med Univ, Tumor Hosp, Dept Hepatobiliary Surg, Nanning, Guangxi Provinc, Peoples R China; [Chen, Yuan-Yuan] Guangxi Med Univ, Affiliated Hosp 1, Dept Ultrasound, Nanning, Guangxi Provinc, Peoples R China; [Qin, Xiao; Xiao, Kai-Yin; Peng, Min-Hao; Liu, Zhi-Ming; Liu, Tang-Wei; Peng, Tao] Guangxi Med Univ, Affiliated Hosp 1, Dept Hepatobiliary Surg, Nanning, Guangxi Provinc, Peoples R China; [Qin, Xue; Li, Shan] Guangxi Med Univ, Affiliated Hosp 1, Dept Clin Lab, Nanning, Guangxi Provinc, Peoples R China; [Han, Ze-Guang] China Natl Human Genome Ctr Shanghai, Shanghai, Peoples R China; [Mo, Zeng-Nan] Guangxi Med Univ, Affiliated Hosp 1, Dept Urol & Nephrol Surg, Nanning, Guangxi Provinc, Peoples R China; [Santella, Regina M.] Columbia Univ, Dept Environm Hlth Sci, Mailman Sch Publ Hlth, New York, NY USA; [Winkler, Cheryl A.; O'Brien, Stephen J.; Peng, Tao] NCI, Lab Genom Divers, NIH, Frederick, MD 21701 USA	Guangxi Medical University; Guangxi Medical University; Guangxi Medical University; Guangxi Medical University; Guangxi Medical University; Columbia University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Peng, T (corresponding author), Guangxi Med Univ, Affiliated Hosp 1, Dept Hepatobiliary Surg, Nanning, Guangxi Provinc, Peoples R China.	pengtaocn@hotmail.com	LI, LI QING/GRR-8855-2022; li, li/HII-4157-2022; Chen, Yuanyuan/GXG-2130-2022; Li, Li/AEM-3636-2022; OBRIEN, STEPHEN/ABD-1346-2020; LI, LI/GVS-5344-2022	Han, Ze-Guang/0000-0002-1018-1752; O'Brien, Stephen J./0000-0001-7353-8301; mo, zengnan/0000-0002-3047-3138; OBRIEN, STEPHEN/0000-0001-7857-0757	National Nature Science Foundation of China [NSFC 81072321, 30960021, 30460143, 30560133]; Program for New Century Excellent Talents in University (NCET, Chinese Ministry of Educationministry of educationministry of education); Guangxi Nature Sciences [GKJ 0236030, 0632007-1E, 0640101, GKG 0592007-1A]; Guangxi Health Ministry Medicine [Z2010108]; USA National Institutes of Health [ES05116, ES09089]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES005116, P30ES009089] Funding Source: NIH RePORTER	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University (NCET, Chinese Ministry of Educationministry of educationministry of education); Guangxi Nature Sciences; Guangxi Health Ministry Medicine; USA National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported in part by the National Nature Science Foundation of China (NSFC 81072321, 30960021, 30460143, and 30560133), Program for New Century Excellent Talents in University (NCET, 2009 Chinese Ministry of Educationministry of educationministry of education), Guangxi Nature Sciences Grant (GKJ 0236030,0632007-1E, 0640101, GKG 0592007-1A), Guangxi Health Ministry Medicine Grant (Z2010108), and the USA National Institutes of Health Grants (ES05116 and ES09089). The authors thank Ms. Li Guan and Yu-Chun Zhou (Laboratory of Genomic Diversity, National Cancer Institute at Frederick, USA) and Mr. Li Jia Quan (Laboratory Center, GMU, China) for their laboratory assistance. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aravalli RN, 2008, HEPATOLOGY, V48, P2047, DOI 10.1002/hep.22580; Bedard LL, 2006, CANCER LETT, V241, P174, DOI 10.1016/j.canlet.2005.11.018; Besaratinia A, 2009, GASTROENTEROLOGY, V137, P1127, DOI 10.1053/j.gastro.2009.06.002; Blagosklonny MV, 2001, J NATL CANCER I, V93, P239, DOI 10.1093/jnci/93.3.239-a; BLANQUET V, 1988, HUM GENET, V80, P274, DOI 10.1007/BF01790096; BUETOW KH, 1989, P NATL ACAD SCI USA, V86, P8852, DOI 10.1073/pnas.86.22.8852; Cabibbo G, 2010, EUR REV MED PHARMACO, V14, P352; Chung YT, 2012, MODERN PATHOL, V25, P758, DOI 10.1038/modpathol.2011.191; Fukumoto S, 2005, CLIN CANCER RES, V11, P1776, DOI 10.1158/1078-0432.CCR-04-1238; Gao J, 2012, ASIAN PAC J CANCER P, V13, P743, DOI 10.7314/APJCP.2012.13.3.743; Garrido C, 2001, BIOCHEM BIOPH RES CO, V286, P433, DOI 10.1006/bbrc.2001.5427; Gouas D, 2009, CANCER LETT, V286, P29, DOI 10.1016/j.canlet.2009.02.057; Gupta S.D., 2010, CHEM-BIOL INTERACT, V183, P293, DOI DOI 10.1016/J.CBI.2009.11.006.PUBMED:19913524; Hashimoto K, 2004, MODERN PATHOL, V17, P617, DOI 10.1038/modpathol.3800107; Helmbrecht K, 2000, CELL PROLIFERAT, V33, P341, DOI 10.1046/j.1365-2184.2000.00189.x; Hu JM, 1996, P NATL ACAD SCI USA, V93, P1060, DOI 10.1073/pnas.93.3.1060; Iizuka N, 2002, CANCER RES, V62, P3939; Jaattela M, 1999, EXP CELL RES, V248, P30, DOI 10.1006/excr.1999.4455; Jackson PE, 1999, BEST PRACT RES CL GA, V13, P545, DOI 10.1053/bega.1999.0047; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Kang MW, 2011, J INT MED RES, V39, P78, DOI 10.1177/147323001103900110; Katiyar S, 2000, CANCER, V88, P1565, DOI 10.1002/(SICI)1097-0142(20000401)88:7<1565::AID-CNCR10>3.0.CO;2-9; Kim TM, 2008, INT J CANCER, V123, P2808, DOI 10.1002/ijc.23901; Kim W, 2003, CLIN CANCER RES, V9, P5493; Lebret T, 2003, CANCER, V98, P970, DOI 10.1002/cncr.11594; Li CP, 2008, PATHOL RES PRACT, V204, P295, DOI 10.1016/j.prp.2006.12.012; Liu ZM, 2008, CANCER LETT, V263, P212, DOI 10.1016/j.canlet.2008.01.006; MCGLYNN KA, 1995, P NATL ACAD SCI USA, V92, P2384, DOI 10.1073/pnas.92.6.2384; Moinzadeh P, 2005, BRIT J CANCER, V92, P935, DOI 10.1038/sj.bjc.6602448; Nishida N, 2011, CURR GENOMICS, V12, P130, DOI 10.2174/138920211795564359; PASQUINELLI C, 1988, J VIROL, V62, P629, DOI 10.1128/JVI.62.2.629-632.1988; Patil MA, 2005, CARCINOGENESIS, V26, P2050, DOI 10.1093/carcin/bgi178; Paul C, 2010, EXP CELL RES, V316, P1535, DOI 10.1016/j.yexcr.2010.03.006; Pomara G, 2003, J UROLOGY, V170, P927, DOI 10.1097/01.ju.0000080564.23671.32; Qin LX, 2001, J CANCER RES CLIN, V127, P482, DOI 10.1007/s004320100236; Shirabe K, 2011, LIVER INT, V31, P1366, DOI 10.1111/j.1478-3231.2011.02572.x; Staib F, 2003, HUM MUTAT, V21, P201, DOI 10.1002/humu.10176; Su Q, 2000, MUTAT RES-REV MUTAT, V462, P365, DOI 10.1016/S1383-5742(00)00026-0; Sun W, 2007, MOL CELL PROTEOMICS, V6, P1798, DOI 10.1074/mcp.M600449-MCP200; Taniguchi K, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-530; van Noort JM, 2012, INT J BIOCHEM CELL B, V44, P1670, DOI 10.1016/j.biocel.2011.12.010; Varma G, 2005, BRIT J CANCER, V93, P699, DOI 10.1038/sj.bjc.6602784; Wang C, 2009, J BIOL CHEM, V284, P26742, DOI 10.1074/jbc.M109.022897; Wild CP, 2002, MUTAGENESIS, V17, P471, DOI 10.1093/mutage/17.6.471; Wong N, 2000, CLIN CANCER RES, V6, P4000; Xue Kai-Xian, 2005, Ai Zheng, V24, P757; YEH FS, 1989, CANCER RES, V49, P2506; Zhong LL, 2011, TOXICOL APPL PHARM, V255, P40, DOI 10.1016/j.taap.2011.05.014; Zhou TL, 1997, CANCER RES, V57, P2749	49	23	23	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83465	10.1371/journal.pone.0083465	http://dx.doi.org/10.1371/journal.pone.0083465			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391771	gold, Green Submitted, Green Published			2022-12-25	WOS:000329325200068
J	Qualls, DA; Crosby, K; Brown, H; Borchelt, DR				Qualls, David A.; Crosby, Keith; Brown, Hilda; Borchelt, David R.			An Analysis of Interactions between Fluorescently-Tagged Mutant and Wild-Type SOD1 in Intracellular Inclusions	PLOS ONE			English	Article							AGGREGATION; COPPER	Background: By mechanisms yet to be discerned, the co-expression of high levels of wild-type human superoxide dismutase 1 (hSOD1) with variants of hSOD1 encoding mutations linked familial amyotrophic lateral sclerosis (fALS) hastens the onset of motor neuron degeneration in transgenic mice. Although it is known that spinal cords of paralyzed mice accumulate detergent insoluble forms of WT hSOD1 along with mutant hSOD1, it has been difficult to determine whether there is co-deposition of the proteins in inclusion structures. Methodology/Principal Findings: In the present study, we use cell culture models of mutant SOD1 aggregation, focusing on the A4V, G37R, and G85R variants, to examine interactions between WT-hSOD1 and misfolded mutant SOD1. In these studies, we fuse WT and mutant proteins to either yellow or red fluorescent protein so that the two proteins can be distinguished within inclusions structures. Conclusions/Significance: Although the interpretation of the data is not entirely straightforward because we have strong evidence that the nature of the fused fluorophores affects the organization of the inclusions that form, our data are most consistent with the idea that normal dimeric WT-hSOD1 does not readily interact with misfolded forms of mutant hSOD1. We also demonstrate the monomerization of WT-hSOD1 by experimental mutation does induce the protein to aggregate, although such monomerization may enable interactions with misfolded mutant SOD1. Our data suggest that WT-hSOD1 is not prone to become intimately associated with misfolded mutant hSOD1 within intracellular inclusions that can be generated in cultured cells.	[Qualls, David A.; Crosby, Keith; Brown, Hilda; Borchelt, David R.] Univ Florida, Coll Med, Dept Neurosci,SantaFe HealthCare Alzheimers Dis R, Ctr Translat Res Neurodegenerat Dis,McKnight Brai, Gainesville, FL 32610 USA	State University System of Florida; University of Florida	Borchelt, DR (corresponding author), Univ Florida, Coll Med, Dept Neurosci,SantaFe HealthCare Alzheimers Dis R, Ctr Translat Res Neurodegenerat Dis,McKnight Brai, Gainesville, FL 32610 USA.	drb1@ufl.edu	Qualls, David/GWZ-9672-2022		National Institutes of Neurological Disease and Stroke [P01 NS049134-08]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS049134] Funding Source: NIH RePORTER	National Institutes of Neurological Disease and Stroke; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The work was funded by the National Institutes of Neurological Disease and Stroke (P01 NS049134-08). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banci L, 1998, BIOCHEMISTRY-US, V37, P11780, DOI 10.1021/bi9803473; BERTINI I, 1994, EUR BIOPHYS J BIOPHY, V23, P167, DOI 10.1007/BF01007608; BORCHELT DR, 1995, J BIOL CHEM, V270, P3234, DOI 10.1074/jbc.270.7.3234; Callahan J, 2009, BIOMACROMOLECULES, V10, P1704, DOI 10.1021/bm801514x; Francis G, 2002, BRIT J NUTR, V88, P587, DOI 10.1079/BJN2002725; FRIDOVICH I, 1986, ADV ENZYMOL RAMB, V58, P61; Karch CM, 2008, J BIOL CHEM, V283, P13528, DOI 10.1074/jbc.M800564200; Karch CM, 2010, ARCH BIOCHEM BIOPHYS, V503, P175, DOI 10.1016/j.abb.2010.07.027; MIZUSHIMA S, 1990, NUCLEIC ACIDS RES, V18, P5322, DOI 10.1093/nar/18.17.5322; Prudencio M, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-77; Prudencio M, 2010, HUM MOL GENET, V19, P4774, DOI 10.1093/hmg/ddq408; Prudencio M, 2009, HUM MOL GENET, V18, P3217, DOI 10.1093/hmg/ddp260; Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819; Stevens JC, 2010, PLOS ONE, V5, pA8, DOI 10.1371/journal.pone.0009541; SYMONS MH, 1991, J CELL BIOL, V114, P503, DOI 10.1083/jcb.114.3.503	15	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83981	10.1371/journal.pone.0083981	http://dx.doi.org/10.1371/journal.pone.0083981			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391857	gold, Green Published, Green Submitted			2022-12-25	WOS:000329325200155
J	Terra, R; Wang, XH; Hu, Y; Charpentier, T; Lamarre, A; Zhong, M; Sun, H; Mao, JN; Qi, SJ; Luo, HY; Wu, JP				Terra, Rafik; Wang, Xuehai; Hu, Yan; Charpentier, Tania; Lamarre, Alain; Zhong, Ming; Sun, Hui; Mao, Jianning; Qi, Shijie; Luo, Hongyu; Wu, Jiangping			To Investigate the Necessity of STRA6 Upregulation in T Cells during T Cell Immune Responses	PLOS ONE			English	Article							RETINOL-BINDING-PROTEIN; VITAMIN-A-DEFICIENCY; MATTHEW-WOOD-SYNDROME; MICROPHTHALMIA MAPS; MICE LACKING; RECEPTOR; ACID; MUTATIONS; DIFFERENTIATION; ANOPHTHALMIA	Our earlier study revealed that STRA6 (stimulated by retinoic acid gene 6) was up-regulated within 3 h of TCR stimulation. STRA6 is the high-affinity receptor for plasma retinol-binding protein (RBP) and mediates cellular vitamin A uptake. We generated STRA6 knockout (KO) mice to assess whether such up-regulation was critical for T-cell activation, differentiation and function. STRA6 KO mice under vitamin A sufficient conditions were fertile without apparent anomalies upon visual inspection. The size, cellularity and lymphocyte subpopulations of STRA6 KO thymus and spleen were comparable to those of their wild type (WT) controls. KO and WT T cells were similar in terms of TCR-stimulated proliferation in vitro and homeostatic expansion in vivo. Naive KO CD4 cells differentiated in vitro into Th1, Th2, Th17 as well as regulatory T cells in an analogous manner as their WT counterparts. In vivo experiments revealed that anti-viral immune responses to lymphocytic choriomeningitis virus in KO mice were comparable to those of WT controls. We also demonstrated that STRA6 KO and WT mice had similar glucose tolerance. Total vitamin A levels are dramatically lower in the eyes of KO mice as compared to those of WT mice, but the levels in other organs were not significantly affected after STRA6 deletion under vitamin A sufficient conditions, indicating that the eye is the mouse organ most sensitive to the loss of STRA6. Our results demonstrate that 1) in vitamin A sufficiency, the deletion of STRA6 in T cells does no affect the T-cell immune responses so-far tested, including those depend on STAT5 signaling; 2) STRA6-independent vitamin A uptake compensated the lack of STRA6 in lymphoid organs under vitamin A sufficient conditions in mice; 3) STRA6 is critical for vitamin A uptake in the eyes even in vitamin A sufficiency.	[Terra, Rafik; Wang, Xuehai; Hu, Yan; Mao, Jianning; Qi, Shijie; Luo, Hongyu; Wu, Jiangping] Hop Notre Dame de Bon Secours, Ctr Hosp Univ Montreal CRCHUM, Ctr Rech, Lab Immunol, Montreal, PQ H2L 4K8, Canada; [Wu, Jiangping] Hop Notre Dame de Bon Secours, Ctr Hosp Univ Montreal CRCHUM, Ctr Rech, Serv Nephrol, Montreal, PQ H2L 4K8, Canada; [Charpentier, Tania; Lamarre, Alain] Univ Quebec, Inst Armand Frappier, INRS, Laval, PQ, Canada; [Zhong, Ming; Sun, Hui] Univ Calif Los Angeles, David Geffen Sch Med, Jules Stein Eye Inst, Dept Physiol, Los Angeles, CA 90095 USA	Universite de Montreal; Universite de Montreal; University of Quebec; Institut national de la recherche scientifique (INRS); University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Wu, JP (corresponding author), Hop Notre Dame de Bon Secours, Ctr Hosp Univ Montreal CRCHUM, Ctr Rech, Lab Immunol, Montreal, PQ H2L 4K8, Canada.	jianping.wu@umontreal.ca			Canadian Institutes of Health Research [MOP69089, MOP123389, MOP97829, MOP89797]; Heart and Stroke Foundation of Quebec; Natural Sciences and Engineering Research Council of Canada [203906-2012]; Juvenile Diabetes Research Foundation [17-2013-440]; Fonds de Recherche Quebec-Sante/National Sciences Foundation of China [AG-6]; Jean-Louis Levesque Foundation	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Quebec; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Fonds de Recherche Quebec-Sante/National Sciences Foundation of China; Jean-Louis Levesque Foundation	This work was supported by grants from the Canadian Institutes of Health Research to J.W. (MOP69089 and MOP123389), H. L. (MOP97829) and A. L. (MOP89797). It was also made possible by grants from the Heart and Stroke Foundation of Quebec, the Natural Sciences and Engineering Research Council of Canada (203906-2012), Juvenile Diabetes Research Foundation (17-2013-440) and Fonds de Recherche Quebec-Sante/National Sciences Foundation of China to J.W. (AG-6), and the Jean-Louis Levesque Foundation to J.W. and A.L. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alapatt P, 2013, J BIOL CHEM, V288, P1250, DOI 10.1074/jbc.M112.369132; Bavik C, 1996, P NATL ACAD SCI USA, V93, P3110, DOI 10.1073/pnas.93.7.3110; Benson MJ, 2007, J EXP MED, V204, P1765, DOI 10.1084/jem.20070719; Berry DC, 2011, P NATL ACAD SCI USA, V108, P4340, DOI 10.1073/pnas.1011115108; Bessant DAR, 1998, AM J HUM GENET, V62, P1113, DOI 10.1086/301843; BLOMHOFF R, 1990, SCIENCE, V250, P399, DOI 10.1126/science.2218545; Bouillet P, 1997, MECH DEVELOP, V63, P173, DOI 10.1016/S0925-4773(97)00039-7; CANTORNA MT, 1994, J IMMUNOL, V152, P1515; Casey J, 2011, HUM MUTAT, V32, P1417, DOI 10.1002/humu.21590; Chassaing N, 2009, HUM MUTAT, V30, pE673, DOI 10.1002/humu.21023; D'Ambrosio DN, 2011, NUTRIENTS, V3, P63, DOI 10.3390/nu3010063; Dong S, 2002, BLOOD, V99, P2637, DOI 10.1182/blood.V99.8.2637; Golczak M, 2008, J BIOL CHEM, V283, P9543, DOI 10.1074/jbc.M708982200; GRAHAM CA, 1991, OPHTHALMIC PAED GEN, V12, P43, DOI 10.3109/13816819109023084; Hall JA, 2011, IMMUNITY, V35, P13, DOI 10.1016/j.immuni.2011.07.002; Han B, 2007, ARTHRITIS RHEUM-US, V56, P3748, DOI 10.1002/art.22978; Hmani-Aifa M, 2009, HUM GENET, V126, P575, DOI 10.1007/s00439-009-0688-8; Isken A, 2008, CELL METAB, V7, P258, DOI 10.1016/j.cmet.2008.01.009; Kang SG, 2007, J IMMUNOL, V179, P3724, DOI 10.4049/jimmunol.179.6.3724; Kawaguchi R, 2007, SCIENCE, V315, P820, DOI 10.1126/science.1136244; Kawaguchi R, 2011, ACS CHEM BIOL, V6, P1041, DOI 10.1021/cb200178w; Lacasse P, 2008, J VIROL, V82, P785, DOI 10.1128/JVI.01811-07; Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203; Luo HY, 2011, J BIOL CHEM, V286, P44976, DOI 10.1074/jbc.M111.316414; Luo HY, 2011, J BIOL CHEM, V286, P41135, DOI 10.1074/jbc.M111.302596; Maeda A, 2008, J BIOL CHEM, V283, P26684, DOI 10.1074/jbc.M804505200; Maeda A, 2009, INVEST OPHTH VIS SCI, V50, P5435, DOI 10.1167/iovs.09-3944; Mao JN, 2006, J BIOL CHEM, V281, P12587, DOI 10.1074/jbc.M600497200; Morle L, 2000, AM J HUM GENET, V67, P1592, DOI 10.1086/316894; Mucida D, 2007, SCIENCE, V317, P256, DOI 10.1126/science.1145697; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Naylor HM, 1999, BIOCHEMISTRY-US, V38, P2647, DOI 10.1021/bi982291i; Ng WY, 2013, CLIN GENET, V83, P162, DOI 10.1111/j.1399-0004.2012.01851.x; Pasutto F, 2007, AM J HUM GENET, V80, P550, DOI 10.1086/512203; Quadro L, 2005, ENDOCRINOLOGY, V146, P4479, DOI 10.1210/en.2005-0158; Quadro L, 1999, EMBO J, V18, P4633, DOI 10.1093/emboj/18.17.4633; Quadro L, 2004, AM J PHYSIOL-ENDOC M, V286, pE844, DOI 10.1152/ajpendo.00556.2003; Quadro L, 2000, J INFECT DIS, V182, pS97, DOI 10.1086/315920; Quadro L, 2003, MOL ASPECTS MED, V24, P421, DOI 10.1016/S0098-2997(03)00038-4; RACKE MK, 1995, J IMMUNOL, V154, P450; Ruiz A, 2012, INVEST OPHTH VIS SCI, V53, P3027, DOI 10.1167/iovs.11-8476; Sommer A, 2008, J NUTR, V138, P1835, DOI 10.1093/jn/138.10.1835; Stephensen CB, 2002, J IMMUNOL, V168, P4495, DOI 10.4049/jimmunol.168.9.4495; Sun CM, 2007, J EXP MED, V204, P1775, DOI 10.1084/jem.20070602; Weng J, 1999, CELL, V98, P13, DOI 10.1016/S0092-8674(00)80602-9; Yao Z, 2007, BLOOD, V109, P4368, DOI 10.1182/blood-2006-11-055756; Yu G, 2006, J BIOL CHEM, V281, P10222, DOI 10.1074/jbc.M510320200; Yu G, 2003, J BIOL CHEM, V278, P47209, DOI 10.1074/jbc.M306659200; Zhang J, 2009, J IMMUNOL, V183, P5350, DOI 10.4049/jimmunol.0802645	49	21	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e82808	10.1371/journal.pone.0082808	http://dx.doi.org/10.1371/journal.pone.0082808			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391722	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000329325200019
J	Zhao, HF; Li, M; Li, LH; Yang, XM; Lan, GB; Zhang, Y				Zhao, Huafu; Li, Mei; Li, Lihua; Yang, Xiaoming; Lan, Guobo; Zhang, Yu			MiR-133b Is Down-Regulated in Human Osteosarcoma and Inhibits Osteosarcoma Cells Proliferation, Migration and Invasion, and Promotes Apoptosis	PLOS ONE			English	Article							COLORECTAL-CANCER; BCL-W; MICRORNA; EXPRESSION; METASTASIS; GROWTH; IDENTIFICATION; SIGNATURES; RECEPTOR; PATHWAY	MicroRNAs (miRNAs) decrease the expression of specific target oncogenes or tumor suppressor genes and thereby play crucial roles in tumorigenesis and tumor growth. To date, the potential miRNAs regulating osteosarcoma growth and progression are not fully identified yet. In this study, the miRNA microarray assay and hierarchical clustering analysis were performed in human osteosarcoma samples. In comparison with normal human skeletal muscle, 43 miRNAs were significantly differentially expressed in human osteosarcomas (fold change >= 2 and p <= 0.05). Among these miRNAs, miR-133a and miR-133b expression was decreased by 135 folds and 47 folds respectively and the decreased expression was confirmed in both frozen and paraffin-embedded osteosarcoma samples. The miR-133b precursor expression vector was then transfected into osteosarcoma cell lines U2-OS and MG-63, and the stable transfectants were selected by puromycin. We found that stable over-expression of miR-133b in osteosarcoma cell lines U2-OS and MG-63 inhibited cell proliferation, invasion and migration, and induced apoptosis. Further, over-expression of miR-133b decreased the expression of predicted target genes BCL2L2, MCL-1, IGF1R and MET, as well as the expression of phospho-Akt and FAK. This study provides a new insight into miRNAs dysregulation in osteosarcoma, and indicates that miR-133b may play as a tumor suppressor gene in osteosarcoma.	[Zhao, Huafu] Liu Hua Qiao Hosp, Dept Med Res, Guangzhou, Guangdong, Peoples R China; [Li, Mei; Li, Lihua; Yang, Xiaoming; Lan, Guobo; Zhang, Yu] Liu Hua Qiao Hosp, Dept Orthoped Surg, Guangzhou, Guangdong, Peoples R China		Zhang, Y (corresponding author), Liu Hua Qiao Hosp, Dept Orthoped Surg, Guangzhou, Guangdong, Peoples R China.	luck_2001@126.com			Guangdong Key Lab of Orthopaedic Technology and Implant Materials Construction [2011233-32]	Guangdong Key Lab of Orthopaedic Technology and Implant Materials Construction	This study is supported by Guangdong Key Lab of Orthopaedic Technology and Implant Materials Construction Grant (No. 2011233-32). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdellatif M, 2010, CIRC RES, V106, P16, DOI 10.1161/CIRCRESAHA.109.212183; Bandres E, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-29; Boguslawska J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024541; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Cance WG, 2000, CLIN CANCER RES, V6, P2417; Care A, 2007, NAT MED, V13, P613, DOI 10.1038/nm1582; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Cheng YH, 2007, AM J PATHOL, V170, P1831, DOI 10.2353/ajpath.2007.061170; Crawford M, 2009, BIOCHEM BIOPH RES CO, V388, P483, DOI 10.1016/j.bbrc.2009.07.143; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; Duan ZF, 2011, MOL CANCER THER, V10, P1337, DOI 10.1158/1535-7163.MCT-11-0096; Guo JM, 2009, J GASTROEN HEPATOL, V24, P652, DOI 10.1111/j.1440-1746.2008.05666.x; Holmgreen SP, 1999, CELL DEATH DIFFER, V6, P525, DOI 10.1038/sj.cdd.4400519; Hu G, 2010, CANCER BIOL THER, V10, P190, DOI 10.4161/cbt.10.2.12186; Ichikawa T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031422; Ichimi T, 2009, INT J CANCER, V125, P345, DOI 10.1002/ijc.24390; Ji F, 2013, BONE, V56, P220, DOI 10.1016/j.bone.2013.05.020; Jones KB, 2012, CANCER RES, V72, P1865, DOI 10.1158/0008-5472.CAN-11-2663; Kano M, 2010, INT J CANCER, V127, P2804, DOI 10.1002/ijc.25284; Liu BN, 2012, BBA-MOL BASIS DIS, V1822, P1692, DOI 10.1016/j.bbadis.2012.07.019; Lulla Rishi R., 2011, Sarcoma, V2011, P732690, DOI 10.1155/2011/732690; MacEwen EG, 2004, J CELL BIOCHEM, V92, P77, DOI 10.1002/jcb.20046; Maire G, 2011, CANCER GENET-NY, V204, P138, DOI 10.1016/j.cancergen.2010.12.012; Namlos HM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048086; Ning HX, 2009, DIFFERENTIATION, V78, P253, DOI 10.1016/j.diff.2009.07.009; Nohata N, 2012, ONCOTARGET, V3, P9; Novello C, 2013, INT J ONCOL, V42, P667, DOI 10.3892/ijo.2012.1717; Osaki M, 2011, MOL THER, V19, P1123, DOI 10.1038/mt.2011.53; Ottaviani G, 2009, CANCER TREAT RES, V152, P3, DOI 10.1007/978-1-4419-0284-9_1; Reid JF, 2012, MOL CANCER RES, V10, P504, DOI 10.1158/1541-7786.MCR-11-0342; Shi XB, 2008, CELL CYCLE, V7, P1529, DOI 10.4161/cc.7.11.5977; Skaftnesmo KO, 2007, CURR PHARM BIOTECHNO, V8, P320, DOI 10.2174/138920107783018390; Subramanian S, 2008, ONCOGENE, V27, P2015, DOI 10.1038/sj.onc.1210836; Takaya T, 2009, CIRC J, V73, P1492, DOI 10.1253/circj.CJ-08-1032; Tan ML, 2009, CANCER BIOL THER, V8, P106, DOI 10.4161/cbt.8.2.7385; Tao J, 2012, ONCOL REP, V27, P1967, DOI 10.3892/or.2012.1711; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Wang YH, 2012, J SURG ONCOL, V105, P235, DOI 10.1002/jso.22077; Wang YH, 2010, MOL CELL BIOCHEM, V341, P225, DOI 10.1007/s11010-010-0453-2; Wang YH, 2009, MOL CELL BIOCHEM, V327, P257, DOI 10.1007/s11010-009-0064-y; Willis SN, 2005, GENE DEV, V19, P1294, DOI 10.1101/gad.1304105; Wu ZY, 2011, MED ONCOL, V28, P1469, DOI 10.1007/s12032-010-9563-7; Yan K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033778; Yan W, 2000, MOL ENDOCRINOL, V14, P682, DOI 10.1210/me.14.5.682; Yoshino H, 2011, BRIT J CANCER, V104, P808, DOI 10.1038/bjc.2011.23; Zhu H, 2009, AUTOPHAGY, V5, P816, DOI 10.4161/auto.9064	46	88	93	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83571	10.1371/journal.pone.0083571	http://dx.doi.org/10.1371/journal.pone.0083571			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391788	Green Submitted, Green Published, gold			2022-12-25	WOS:000329325200085
J	Kochi, T; Imai, Y; Takeda, A; Watanabe, Y; Mori, S; Tachi, M; Kodama, T				Kochi, Takashi; Imai, Yoshimichi; Takeda, Atsushi; Watanabe, Yukiko; Mori, Shiro; Tachi, Masahiro; Kodama, Tetsuya			Characterization of the Arterial Anatomy of the Murine Hindlimb: Functional Role in the Design and Understanding of Ischemia Models	PLOS ONE			English	Article							FIBROBLAST-GROWTH-FACTOR; THERAPEUTIC ANGIOGENESIS; SUSTAINED DELIVERY; MOUSE MODEL; PERFUSION; ARTERIOGENESIS; LIMB; COLLATERALS; DISEASE; GENE	Rationale: Appropriate ischemia models are required for successful studies of therapeutic angiogenesis. While collateral routes are known to be present within the innate vasculature, there are no reports describing the detailed vascular anatomy of the murine hindlimb. In addition, differences in the descriptions of anatomical names and locations in the literature impede understanding of the circulation and the design of hindlimb ischemia models. To understand better the collateral circulation in the whole hindlimb, clarification of all the feeding arteries of the hindlimb is required. Objective: The aim of this study is to reveal the detailed arterial anatomy and collateral routes in murine hindlimb to enable the appropriate design of therapeutic angiogenesis studies and to facilitate understanding of the circulation in ischemia models. Methods and Results: Arterial anatomy in the murine hindlimb was investigated by contrast-enhanced X-ray imaging and surgical dissection. The observed anatomy is shown in photographic images and in a schema. Previously unnoticed but relatively large arteries were observed in deep, cranial and lateral parts of the thigh. The data indicates that there are three collateral routes through the medial thigh, quadriceps femoris, and the biceps femoris muscles. Furthermore, anatomical variations were found at the origins of the three feeding arteries. Conclusions: The detailed arterial anatomy of murine hindlimb and collateral routes deduced from the anatomy are described. Limitations on designs of ischemia models in view of anatomical variations are proposed. These observations will contribute to the development of animal studies of therapeutic angiogenesis using murine hindlimb ischemia models.	[Kochi, Takashi; Imai, Yoshimichi; Tachi, Masahiro] Tohoku Univ, Grad Sch Med, Dept Plast & Reconstruct Surg, Sendai, Miyagi 980, Japan; [Takeda, Atsushi] Tohoku Univ Hosp, Dept Plast & Reconstruct Surg, Sendai, Miyagi, Japan; [Kochi, Takashi; Watanabe, Yukiko; Mori, Shiro; Kodama, Tetsuya] Tohoku Univ, Grad Sch Biomed Engn, Sendai, Miyagi 980, Japan; [Mori, Shiro] Tohoku Univ Hosp, Dept Oral & Maxillofacial Surg, Sendai, Miyagi, Japan	Tohoku University; Tohoku University; Tohoku University; Tohoku University	Kodama, T (corresponding author), Tohoku Univ, Grad Sch Biomed Engn, Sendai, Miyagi 980, Japan.	kodama@bme.tohoku.ac.jp	Perry, George/A-8611-2009; Kodama, Tetsuya/T-2246-2019; Imai, Yoshimichi/H-6719-2019	Perry, George/0000-0002-6547-0172; Imai, Yoshimichi/0000-0001-5360-958X; Kodama, Tetsuya/0000-0003-4727-9558	Japanese Society for the Promotion of Science;  [23592638];  [24659884];  [20015005];  [23300183];  [18650140];  [24650286]; Grants-in-Aid for Scientific Research [23592638] Funding Source: KAKEN	Japanese Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); ; ; ; ; ; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by a Grant-in-Aid for Scientific Research (C) (23592638) awarded to A. Takeda, a Grant-in-Aid for JSPS Fellows awarded to Y. Watanabe; a Grant-in-Aid for Challenging Exploratory Research (24659884) awarded to S. Mori; and a Grant-in-Aid for Scientific Research on Priority Area (20015005), a Grant-in-Aid for Scientific Research (B) (23300183) and a Grant-in-Aid for Challenging Exploratory Research (18650140, 24650286) awarded to T. Kodama. All funding was provided by the Japanese Society for the Promotion of Science (URL:http://www.jsps.go.jp/english/e-grants/grants01.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annex BH, 2013, NAT REV CARDIOL, V10, P387, DOI 10.1038/nrcardio.2013.70; Arredondo J, 2013, J FELINE MED SURG, V15, P111, DOI 10.1177/1098612X12462704; ASAHARA T, 1995, CIRCULATION, V92, P365, DOI 10.1161/01.CIR.92.9.365; Bobek V, 2006, VASC PHARMACOL, V44, P395, DOI 10.1016/j.vph.2006.03.009; Botnar RM, 2012, PROG MOL BIOL TRANSL, V105, P227, DOI 10.1016/B978-0-12-394596-9.00008-1; Budras K. D., 2007, ANATOMY DOG; Budras K.D., 2012, ANATOMY HORSE, V6th ed.; Couffinhal T, 1998, AM J PATHOL, V152, P1667; COYLE P, 1982, ANAT REC, V203, P397, DOI 10.1002/ar.1092030309; Crouch JE, 1969, TEXT ATLAS CAT ANATO; Evans HE, 2010, GUIDE DISSECTION DOG; Fiebig T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031179; Hardy B, 2008, BIOCHEM PHARMACOL, V75, P891, DOI 10.1016/j.bcp.2007.10.008; Helisch A, 2006, ARTERIOSCL THROM VAS, V26, P520, DOI 10.1161/01.ATV.0000202677.55012.a0; Hellingman AA, 2010, EUR J VASC ENDOVASC, V40, P796, DOI 10.1016/j.ejvs.2010.07.009; Hiraoka K, 2003, CIRCULATION, V108, P2689, DOI 10.1161/01.CIR.0000093275.78676.F4; HOULIND K, 2013, ARTERY BYPASS, pCH24; Hua J, 2005, CIRCULATION, V111, P3255, DOI 10.1161/CIRCULATIONAHA.104.485029; Jang HS, 2004, MOL THER, V9, P464, DOI 10.1016/j.ymthe.2003.12.002; *JAP ASS VET AN, 2000, TERM VET AN HIST EMB; Jeon O, 2006, BIOMATERIALS, V27, P1617, DOI 10.1016/j.biomaterials.2005.09.009; Jeon O, 2006, J ENDOVASC THER, V13, P175, DOI 10.1583/05-1713MR.1; Kawamura I, 2011, J CARDIOVASC PHARM, V57, P416, DOI 10.1097/FJC.0b013e31820c9776; Konig H.E., 2006, VET ANATOMY DOMESTIC, V3rd; Lee JS, 2007, BIOCHEM BIOPH RES CO, V360, P752, DOI 10.1016/j.bbrc.2007.06.120; Limbourg A, 2009, NAT PROTOC, V4, P1737, DOI 10.1038/nprot.2009.185; Lu QL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046998; Negishi Y, 2011, PHARM RES-DORDR, V28, P712, DOI 10.1007/s11095-010-0286-4; Raval Z, 2013, CIRC RES, V112, P1288, DOI 10.1161/CIRCRESAHA.113.300565; REIGHARD J, 1935, ANATOMY CAT; Scholz D, 2002, J MOL CELL CARDIOL, V34, P775, DOI 10.1006/jmcc.2002.2013; Senthilkumar A, 2007, ARTERIOSCL THROM VAS, V27, P1947, DOI 10.1161/ATVBAHA.107.147421; Shireman PK, 2005, J SURG RES, V129, P242, DOI 10.1016/j.jss.2005.06.013; Sisson S, 1953, ANATOMY DOMESTIC ANI, V3; Sun QH, 2005, PHARM RES-DORDR, V22, P1110, DOI 10.1007/s11095-005-5644-2; Tang G, 2004, J VASC SURG, V40, P786, DOI 10.1016/j.jvs.2004.07.012; Velazquez OC, 2007, J VASC SURG, V45, p39A, DOI 10.1016/j.jvs.2007.02.068; von Degenfeld G, 2006, FASEB J, V20, P2657, DOI 10.1096/fj.06-6568fje; Waters RE, 2004, J APPL PHYSIOL, V97, P773, DOI 10.1152/japplphysiol.00107.2004; Westvik TS, 2009, J VASC SURG, V49, P464, DOI 10.1016/j.jvs.2008.08.077; Zbinden S, 2007, AM J PHYSIOL-HEART C, V292, pH1891, DOI 10.1152/ajpheart.00537.2006	41	51	51	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e84047	10.1371/journal.pone.0084047	http://dx.doi.org/10.1371/journal.pone.0084047			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386328	Green Published, Green Submitted, gold			2022-12-25	WOS:000329194700087
J	Li, GL; Lian, LL; Wan, L; Zhang, JR; Zhao, XQ; Jiang, Y; Zhao, LL; Liu, HC; Wan, KL				Li, Guilian; Lian, Lu-lu; Wan, Li; Zhang, Jingrui; Zhao, Xiuqin; Jiang, Yi; Zhao, Li-li; Liu, Haican; Wan, Kanglin			Antimicrobial Susceptibility of Standard Strains of Nontuberculous Mycobacteria by Microplate Alamar Blue Assay	PLOS ONE			English	Article							RAPIDLY GROWING MYCOBACTERIA; IN-VITRO ACTIVITIES; TUBERCULOSIS; ABSCESSUS; IDENTIFICATION; CIPROFLOXACIN; CAPREOMYCIN; RESISTANCE; DIAGNOSIS; COMPLEX	In this study, 24 standard nontuberculous mycobacteria (NTM) species strains including 12 slowly growing mycobacteria strains and 12 rapidly growing mycobacteria strains were subjected to drug susceptibility testing using microplate Alamar Blue assay-based 7H9 broth. The most active antimicrobial agents against the 24 NTM strains were streptomycin, amikacin, the fluoroquinolones, and the tetracyclines. Mycobacterium chelonae, Mycobacterium abscessus, Mycobacterium bolletii, and Mycobacterium simiae are resistant to most antimicrobial agents. The susceptibility results of this study from 24 NTM standard strains can be referenced by clinicians before susceptibility testing for clinical isolates is performed or when conditions do not allow for susceptibility testing. The application of broth-based methods is recommended by the Clinical and Laboratory Standards Institute, and the documentation of the susceptibility patterns of standard strains of mycobacteria can improve the international standardization of susceptibility testing methods.	[Li, Guilian; Lian, Lu-lu; Wan, Li; Zhang, Jingrui; Zhao, Xiuqin; Jiang, Yi; Zhao, Li-li; Liu, Haican; Wan, Kanglin] Chinese Ctr Dis Control & Prevent, Natl Inst Communicable Dis Control & Prevent, Beijing, Peoples R China; [Li, Guilian; Lian, Lu-lu; Wan, Li; Zhang, Jingrui; Zhao, Xiuqin; Jiang, Yi; Zhao, Li-li; Liu, Haican; Wan, Kanglin] State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China; [Li, Guilian; Zhao, Xiuqin; Jiang, Yi; Zhao, Li-li; Liu, Haican; Wan, Kanglin] Collaborat Innovat Ctr Diag & Treatment Infect Di, Hangzhou, Zhejiang, Peoples R China; [Lian, Lu-lu; Wan, Kanglin] Univ South China, Pathogen Biol Inst, Hengyang, Hunan, Peoples R China; [Zhang, Jingrui; Wan, Kanglin] Wenzhou Med Coll, Key Lab Lab Med, Wenzhou, Zhejiang, Peoples R China	Chinese Center for Disease Control & Prevention; National Institute for Communicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Chinese Center for Disease Control & Prevention; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases; University of South China; Wenzhou Medical University	Wan, KL (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Inst Communicable Dis Control & Prevent, Beijing, Peoples R China.	wankanglin@icdc.cn			National Key Programme of Mega Infectious Diseases [2013ZX10003002-001, 2011ZX10004-001]	National Key Programme of Mega Infectious Diseases	This work was financially supported by the projects 2013ZX10003002-001 and 2011ZX10004-001 of the National Key Programme of Mega Infectious Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aubry A, 2000, ANTIMICROB AGENTS CH, V44, P3133, DOI 10.1128/AAC.44.11.3133-3136.2000; Bicmen C, 2011, J CLIN MICROBIOL, V49, P2874, DOI 10.1128/JCM.00612-11; Bicmen C, 2010, NEW MICROBIOL, V33, P399; Brown-Elliott BA, 2002, CLIN MICROBIOL REV, V15, P716, DOI 10.1128/CMR.15.4.716-746.2002; Cavusoglu C, 2012, NEW MICROBIOL, V35, P73; Chauca JA, 2007, INT J TUBERC LUNG D, V11, P820; Colombo RE, 2008, SEMIN RESP CRIT CARE, V29, P577, DOI 10.1055/s-0028-1085709; David S, 2001, J ANTIMICROB CHEMOTH, V47, P203, DOI 10.1093/jac/47.2.203; Fernandez-Roblas R, 2008, ANTIMICROB AGENTS CH, V52, P4184, DOI 10.1128/AAC.00695-08; Garcia-Agudo L, 2009, REV MED CHILE, V137, P912, DOI /S0034-98872009000700008; Gayathri R, 2010, J POSTGRAD MED, V56, P19, DOI 10.4103/0022-3859.65278; Griffith DE, 2007, AM J RESP CRIT CARE, V175, P367, DOI 10.1164/rccm.200604-571ST; Huang YC, 2010, J MICROBIOL IMMUNOL, V43, P401, DOI 10.1016/S1684-1182(10)60063-1; Leonard B, 2008, J CLIN MICROBIOL, V46, P3526, DOI 10.1128/JCM.02083-07; National Committee for Clinical Laboratory Standards, 2003, M24A NCCLS; Park S, 2008, J KOREAN MED SCI, V23, P49, DOI 10.3346/jkms.2008.23.1.49; Petrini B, 2006, APMIS, V114, P319, DOI 10.1111/j.1600-0463.2006.apm_390.x; Richter E, 2006, J CLIN MICROBIOL, V44, P1769, DOI 10.1128/JCM.44.5.1769-1775.2006; Shen GH, 2007, ANTIMICROB AGENTS CH, V51, P1849, DOI 10.1128/AAC.01551-06; van Ingen J, 2010, INT J ANTIMICROB AG, V35, P169, DOI 10.1016/j.ijantimicag.2009.09.023; Vanitha JD, 2004, DIAGN MICR INFEC DIS, V49, P179, DOI 10.1016/j.diagmicrobio.2004.04.003; WALLACE RJ, 1990, ANTIMICROB AGENTS CH, V34, P65, DOI 10.1128/AAC.34.1.65; WALLACE RJ, 1991, ANTIMICROB AGENTS CH, V35, P773, DOI 10.1128/AAC.35.4.773; Wallace RJ, 2002, ANTIMICROB AGENTS CH, V46, P3164, DOI 10.1128/AAC.46.10.3164-3167.2002; WHO, 2011, WHO GLOBAL TUBERCULO; World Health organization, 2008, POL GUID DRUG SUSC T; Yang SC, 2003, ANTIMICROB AGENTS CH, V47, P1958, DOI 10.1128/AAC.47.6.1958-1962.2003	27	43	48	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e84065	10.1371/journal.pone.0084065	http://dx.doi.org/10.1371/journal.pone.0084065			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386332	gold, Green Published, Green Submitted			2022-12-25	WOS:000329194700089
J	Meinhardt, S; Manley, MW; Parente, DJ; Swint-Kruse, L				Meinhardt, Sarah; Manley, Michael W., Jr.; Parente, Daniel J.; Swint-Kruse, Liskin			Rheostats and Toggle Switches for Modulating Protein Function	PLOS ONE			English	Article							AMINO-ACID SUBSTITUTION; LAC REPRESSOR; SPECIFICITY DETERMINANTS; SEQUENCE; RESIDUES; FAMILY; PURR; IDENTIFICATION; CONSERVATION; PREDICTION	The millions of protein sequences generated by genomics are expected to transform protein engineering and personalized medicine. To achieve these goals, tools for predicting outcomes of amino acid changes must be improved. Currently, advances are hampered by insufficient experimental data about nonconserved amino acid positions. Since the property "nonconserved" is identified using a sequence alignment, we designed experiments to recapitulate that context: Mutagenesis and functional characterization was carried out in 15 LacI/GalR homologs (rows) at 12 nonconserved positions (columns). Multiple substitutions were made at each position, to reveal how various amino acids of a nonconserved column were tolerated in each protein row. Results showed that amino acid preferences of nonconserved positions were highly context-dependent, had few correlations with physico-chemical similarities, and were not predictable from their occurrence in natural LacI/GalR sequences. Further, unlike the "toggle switch" behaviors of conserved positions, substitutions at nonconserved positions could be rank-ordered to show a "rheostatic", progressive effect on function that spanned several orders of magnitude. Comparisons to various sequence analyses suggested that conserved and strongly co-evolving positions act as functional toggles, whereas other important, nonconserved positions serve as rheostats for modifying protein function. Both the presence of rheostat positions and the sequence analysis strategy appear to be generalizable to other protein families and should be considered when engineering protein modifications or predicting the impact of protein polymorphisms.	[Meinhardt, Sarah; Manley, Michael W., Jr.; Parente, Daniel J.; Swint-Kruse, Liskin] Univ Kansas, Med Ctr, Dept Biochem & Mol Biol, Kansas City, KS USA	University of Kansas; University of Kansas Medical Center	Swint-Kruse, L (corresponding author), Univ Kansas, Med Ctr, Dept Biochem & Mol Biol, Kansas City, KS USA.	lswint-kruse@kumc.edu	Parente, Daniel/AAM-3887-2021	Parente, Daniel/0000-0002-7990-4576; Swint-Kruse, Liskin/0000-0002-5925-9741	National Institutes of Health [GM079432]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was funded by the National Institutes of Health (GM079432 and the American Recovery and Reinvestment Act) and by donations from private citizens. Aside from the financial contributions from the corresponding author, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addington TA, 2013, J MOL BIOL, V425, P1378, DOI 10.1016/j.jmb.2013.01.034; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Arvidson DN, 1998, NAT STRUCT BIOL, V5, P436, DOI 10.1038/nsb0698-436; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Bell CE, 2000, NAT STRUCT BIOL, V7, P209; Benitez-Paez A, 2012, BRIEF BIOINFORM, V13, P329, DOI 10.1093/bib/bbr052; Brown CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010779; Cargill M, 1999, NAT GENET, V22, P231, DOI 10.1038/10290; CHEN J, 1992, J BIOL CHEM, V267, P13843; Cho BK, 2011, NUCLEIC ACIDS RES, V39, P6456, DOI 10.1093/nar/gkr307; DeBartolo J, 2012, J MOL BIOL, V422, P124, DOI 10.1016/j.jmb.2012.05.022; Fodor AA, 2004, PROTEINS, V56, P211, DOI 10.1002/prot.20098; Fowler DM, 2010, NAT METHODS, V7, P741, DOI 10.1038/nmeth.1492; Francke C, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-145; GILBERT W, 1973, P NATL ACAD SCI USA, V70, P3581, DOI 10.1073/pnas.70.12.3581; GRANTHAM R, 1974, SCIENCE, V185, P862, DOI 10.1126/science.185.4154.862; Gray VE, 2012, BIOINFORMATICS, V28, P2093, DOI 10.1093/bioinformatics/bts336; Halabi N, 2009, CELL, V138, P774, DOI 10.1016/j.cell.2009.07.038; Hall T, 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; Hicks S, 2011, HUM MUTAT, V32, P661, DOI 10.1002/humu.21490; Kc DB, 2011, IEEE ACM T COMPUT BI, V8, P226, DOI 10.1109/TCBB.2009.60; Kumar S, 1998, PROTEINS, V31, P460, DOI 10.1002/(SICI)1097-0134(19980601)31:4<460::AID-PROT12>3.0.CO;2-D; MARKIEWICZ P, 1994, J MOL BIOL, V240, P421, DOI 10.1006/jmbi.1994.1458; Mazin PV, 2010, ALGORITHM MOL BIOL, V5, DOI 10.1186/1748-7188-5-29; McLaughlin RN, 2012, NATURE, V491, P138, DOI 10.1038/nature11500; Meinhardt S, 2012, NUCLEIC ACIDS RES, V40, P11139, DOI 10.1093/nar/gks806; Meinhardt S, 2008, PROTEINS, V73, P941, DOI 10.1002/prot.22121; MILLER S, 1987, J MOL BIOL, V196, P641, DOI 10.1016/0022-2836(87)90038-6; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Pal G, 2006, J BIOL CHEM, V281, P22378, DOI 10.1074/jbc.M603826200; Pruitt KD, 2009, NUCLEIC ACIDS RES, V37, pD32, DOI 10.1093/nar/gkn721; Radivojac P, 2013, NAT METHODS, V10, P221, DOI [10.1038/NMETH.2340, 10.1038/nmeth.2340]; SADLER JR, 1983, P NATL ACAD SCI-BIOL, V80, P6785, DOI 10.1073/pnas.80.22.6785; Schumacher MA, 1997, J BIOL CHEM, V272, P22648, DOI 10.1074/jbc.272.36.22648; Sobolev V, 1999, BIOINFORMATICS, V15, P327, DOI 10.1093/bioinformatics/15.4.327; Starita LM, 2013, P NATL ACAD SCI USA, V110, pE1263, DOI 10.1073/pnas.1303309110; Stoebel DM, 2008, GENETICS, V178, P1653, DOI 10.1534/genetics.107.085399; Suckow J, 1996, J MOL BIOL, V261, P509, DOI 10.1006/jmbi.1996.0479; Suel GM, 2003, NAT STRUCT BIOL, V10, P59, DOI 10.1038/nsb881; Swint-Kruse L, 2002, PROTEIN SCI, V11, P778, DOI 10.1110/ps.4050102; Taraban M, 2008, J MOL BIOL, V376, P466, DOI 10.1016/j.jmb.2007.11.067; Tungtur S, 2007, PROTEINS, V68, P375, DOI 10.1002/prot.21412; Tungtur S, 2011, BIOPHYS CHEM, V159, P142, DOI 10.1016/j.bpc.2011.06.005; Tungtur S, 2011, PROTEINS, V79, P1589, DOI 10.1002/prot.22985; Tungtur S, 2010, J MOL BIOL, V395, P785, DOI 10.1016/j.jmb.2009.10.001; WEICKERT MJ, 1992, J MOL BIOL, V226, P69, DOI 10.1016/0022-2836(92)90125-4; Wilkins AD, 2012, CURR OPIN STRUC BIOL, V22, P316, DOI 10.1016/j.sbi.2012.05.001; Wilson CJ, 2007, CELL MOL LIFE SCI, V64, P3, DOI 10.1007/s00018-006-6296-z; Wimley WC, 1996, BIOCHEMISTRY-US, V35, P5109, DOI 10.1021/bi9600153; Ye K, 2008, BIOINFORMATICS, V24, P908, DOI 10.1093/bioinformatics/btn057; Zhan HL, 2008, BIOCHEMISTRY-US, V47, P8058, DOI 10.1021/bi800443k	53	38	38	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e83502	10.1371/journal.pone.0083502	http://dx.doi.org/10.1371/journal.pone.0083502			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386217	Green Submitted, gold, Green Published			2022-12-25	WOS:000329194700047
J	Van den Bogert, B; Boekhorst, J; Herrmann, R; Smid, EJ; Zoetendal, EG; Kleerebezem, M				Van den Bogert, Bartholomeus; Boekhorst, Jos; Herrmann, Ruth; Smid, Eddy J.; Zoetendal, Erwin G.; Kleerebezem, Michiel			Comparative Genomics Analysis of Streptococcus Isolates from the Human Small Intestine Reveals their Adaptation to a Highly Dynamic Ecosystem	PLOS ONE			English	Article							GROUP-B STREPTOCOCCUS; BACTERIAL SAMPLES; TRANSPORT-SYSTEM; MICROBIOTA; COMPETENCE; SEQUENCE; DNA; IDENTIFICATION; LACTOBACILLUS; TRANSCRIPTION	The human small-intestinal microbiota is characterised by relatively large and dynamic Streptococcus populations. In this study, genome sequences of small-intestinal streptococci from S. mitis, S. bovis, and S. salivarius species-groups were determined and compared with those from 58 Streptococcus strains in public databases. The Streptococcus pangenome consists of 12,403 orthologous groups of which 574 are shared among all sequenced streptococci and are defined as the Streptococcus core genome. Genome mining of the small-intestinal streptococci focused on functions playing an important role in the interaction of these streptococci in the small-intestinal ecosystem, including natural competence and nutrient-transport and metabolism. Analysis of the small-intestinal Streptococcus genomes predicts a high capacity to synthesize amino acids and various vitamins as well as substantial divergence in their carbohydrate transport and metabolic capacities, which is in agreement with observed physiological differences between these Streptococcus strains. Gene-specific PCR-strategies enabled evaluation of conservation of Streptococcus populations in intestinal samples from different human individuals, revealing that the S. salivarius strains were frequently detected in the small-intestine microbiota, supporting the representative value of the genomes provided in this study. Finally, the Streptococcus genomes allow prediction of the effect of dietary substances on Streptococcus population dynamics in the human small-intestine.	[Van den Bogert, Bartholomeus; Herrmann, Ruth; Smid, Eddy J.; Zoetendal, Erwin G.; Kleerebezem, Michiel] TIFN, Wageningen, Netherlands; [Van den Bogert, Bartholomeus; Herrmann, Ruth; Zoetendal, Erwin G.; Kleerebezem, Michiel] Wageningen Univ, Microbiol Lab, NL-6700 AP Wageningen, Netherlands; [Boekhorst, Jos] Radboud Univ Nijmegen, Med Ctr, Ctr Mol & Biomol Informat, NL-6525 ED Nijmegen, Netherlands; [Boekhorst, Jos; Kleerebezem, Michiel] NIZO Food Res BV, Ede, Netherlands; [Smid, Eddy J.] Wageningen Univ, Food Microbiol Lab, NL-6700 AP Wageningen, Netherlands; [Kleerebezem, Michiel] Wageningen Univ, Host Microbe Interact Grp, NL-6700 AP Wageningen, Netherlands	Top Institute Food & Nutrition; Wageningen University & Research; Radboud University Nijmegen; NIZO Food Research; Wageningen University & Research; Wageningen University & Research	Kleerebezem, M (corresponding author), TIFN, Wageningen, Netherlands.	michiel.kleerebezem@wur.nl	Kleerebezem, Michiel/AAT-2078-2021	Kleerebezem, Michiel/0000-0001-8552-2235; Boekhorst, Jos/0000-0002-4807-7838	Top Institute Food and Nutrition, Wageningen, The Netherlands; Netherlands Bioinformatics Centre (NBIC)	Top Institute Food and Nutrition, Wageningen, The Netherlands(Netherlands Government); Netherlands Bioinformatics Centre (NBIC)	This work was supported by a project from the Top Institute Food and Nutrition, Wageningen, The Netherlands and by the Netherlands Bioinformatics Centre (NBIC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aas JA, 2005, J CLIN MICROBIOL, V43, P5721, DOI 10.1128/JCM.43.11.5721-5732.2005; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andersson AF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002836; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Bik EM, 2006, P NATL ACAD SCI USA, V103, P732, DOI 10.1073/pnas.0506655103; Boetzer M, 2011, BIOINFORMATICS, V27, P578, DOI 10.1093/bioinformatics/btq683; Bolotin A, 2004, NAT BIOTECHNOL, V22, P1554, DOI 10.1038/nbt1034; Booijink CCGM, 2007, FUTURE MICROBIOL, V2, P285, DOI 10.2217/17460913.2.3.285; Booijink CCGM, 2010, ENVIRON MICROBIOL, V12, P3213, DOI 10.1111/j.1462-2920.2010.02294.x; Busuioc M, 2009, J BACTERIOL, V191, P7315, DOI 10.1128/JB.00425-09; Carver TJ, 2005, BIOINFORMATICS, V21, P3422, DOI 10.1093/bioinformatics/bti553; Cheng Q, 2002, INFECT IMMUN, V70, P2408, DOI 10.1128/IAI.70.5.2408-2413.2002; Claverys JP, 1998, MOL MICROBIOL, V29, P1126, DOI 10.1046/j.1365-2958.1998.01005.x; Cotter PD, 2005, NAT REV MICROBIOL, V3, P777, DOI 10.1038/nrmicro1273; Croucher NJ, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-120; de Jong A, 2010, NUCLEIC ACIDS RES, V38, pW647, DOI 10.1093/nar/gkq365; Delorme C, 2007, J BACTERIOL, V189, P1330, DOI 10.1128/JB.01058-06; Detmers FJM, 1998, BIOCHEMISTRY-US, V37, P16671, DOI 10.1021/bi981712t; Durbin R., 1998, BIOL SEQUENCE ANAL P; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fontaine L, 2010, J BACTERIOL, V192, P1444, DOI 10.1128/JB.01251-09; Giammarinaro P, 1999, MICROBIOL-UK, V145, P1859, DOI 10.1099/13500872-145-8-1859; Glaser P, 2001, SCIENCE, V294, P849; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Havarstein LS, 2010, MOL MICROBIOL, V78, P541, DOI 10.1111/j.1365-2958.2010.07380.x; HUTKINS RW, 1991, APPL ENVIRON MICROB, V57, P941, DOI 10.1128/AEM.57.4.941-944.1991; Kadioglu A, 2008, NAT REV MICROBIOL, V6, P288, DOI 10.1038/nrmicro1871; KANDLER O, 1983, A VAN LEEUW J MICROB, V49, P209, DOI 10.1007/BF00399499; Kanehisa M, 2002, NOVART FDN SYMP, V247, P91; Kant R, 2011, MICROB BIOTECHNOL, V4, P323, DOI 10.1111/j.1751-7915.2010.00215.x; Keijser BJF, 2008, J DENT RES, V87, P1016, DOI 10.1177/154405910808701104; Kleerebezem M, 2004, PEPTIDES, V25, P1405, DOI 10.1016/j.peptides.2003.10.021; Kleerebezem M, 2003, P NATL ACAD SCI USA, V100, P1990, DOI 10.1073/pnas.0337704100; Kreft J, 2001, INT J MED MICROBIOL, V291, P145, DOI 10.1078/1438-4221-00111; Kunji ERS, 1998, MOL MICROBIOL, V27, P1107, DOI 10.1046/j.1365-2958.1998.00769.x; Lahtinen S, 2012, LACTIC ACID BACTERIA: MICROBIOLOGICAL AND FUNCTIONAL ASPECTS, 4TH EDITION, P1; Lamy MC, 2004, MOL MICROBIOL, V54, P1250, DOI 10.1111/j.1365-2958.2004.04365.x; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lefebure T, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r71; Leser TD, 2009, ENVIRON MICROBIOL, V11, P2194, DOI 10.1111/j.1462-2920.2009.01941.x; Lessard C, 2003, J BACTERIOL, V185, P6764, DOI 10.1128/JB.185.23.6764-6772.2003; Luca-Harari B, 2009, J CLIN MICROBIOL, V47, P1155, DOI 10.1128/JCM.02155-08; Lukjancenko O, 2012, MICROB ECOL, V63, P651, DOI 10.1007/s00248-011-9948-y; MARTIN B, 1992, NUCLEIC ACIDS RES, V20, P3479, DOI 10.1093/nar/20.13.3479; Mascher T, 2003, J BACTERIOL, V185, P60, DOI 10.1128/JB.185.1.60-70.2003; Mashburn-Warren L, 2010, MOL MICROBIOL, V78, P589, DOI 10.1111/j.1365-2958.2010.07361.x; Nelson KE, 2010, SCIENCE, V328, P994, DOI 10.1126/science.1183605; Oggioni MR, 1999, MICROBIOL-SGM, V145, P2647, DOI 10.1099/00221287-145-10-2647; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Pei ZH, 2004, P NATL ACAD SCI USA, V101, P4250, DOI 10.1073/pnas.0306398101; Poyart C, 2002, INT J SYST EVOL MICR, V52, P1247, DOI 10.1099/00207713-52-4-1247; Quach D, 2009, J BACTERIOL, V191, P2023, DOI 10.1128/JB.01216-08; ROGERS AH, 1973, ARCH ORAL BIOL, V18, P227, DOI 10.1016/0003-9969(73)90142-8; Rozen S, 2000, Methods Mol Biol, V132, P365; Rusniok C, 2010, J BACTERIOL, V192, P2266, DOI 10.1128/JB.01659-09; RUSSELL RRB, 1992, J BIOL CHEM, V267, P4631; Salonen A, 2010, J MICROBIOL METH, V81, P127, DOI 10.1016/j.mimet.2010.02.007; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Schleifer K.H., 2009, BERGEYS MANUAL SYSTE, VVolume 3; Siezen RJ, 2011, MICROB BIOTECHNOL, V4, P383, DOI 10.1111/j.1751-7915.2011.00247.x; Siguier P, 2006, NUCLEIC ACIDS RES, V34, pD32, DOI 10.1093/nar/gkj014; Siguier P, 2006, CURR OPIN MICROBIOL, V9, P526, DOI 10.1016/j.mib.2006.08.005; Simpson CL, 1998, J BACTERIOL, V180, P4711, DOI 10.1128/JB.180.17.4711-4717.1998; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; Tatusov RL, 2001, NUCLEIC ACIDS RES, V29, P22, DOI 10.1093/nar/29.1.22; Tims S, 2013, ISME J, V7, P707, DOI 10.1038/ismej.2012.146; Tran-Winkler HJ, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002361; Utaida S, 2003, MICROBIOL-SGM, V149, P2719, DOI 10.1099/mic.0.26426-0; Van den Bogert B, 2011, HDB MOL MICROBIAL EC, VII, P170; van den Bogert B, 2013, FEMS MICROBIOL ECOL, V85, P376, DOI 10.1111/1574-6941.12127; van den Bogert B, 2011, APPL ENVIRON MICROB, V77, P2071, DOI 10.1128/AEM.02477-10; van Kraaij C, 1999, NAT PROD REP, V16, P575, DOI 10.1039/a804531c; WEXLER DE, 1985, P NATL ACAD SCI USA, V82, P8144, DOI 10.1073/pnas.82.23.8144; WHITEHEAD TR, 1995, CURR MICROBIOL, V30, P143, DOI 10.1007/BF00296199; Zoetendal EG, 2006, NAT PROTOC, V1, P954, DOI 10.1038/nprot.2006.143; Zoetendal EG, 2006, NAT PROTOC, V1, P870, DOI 10.1038/nprot.2006.142; Zoetendal EG, 2012, ISME J, V6, P1415, DOI 10.1038/ismej.2011.212	77	34	37	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e83418	10.1371/journal.pone.0083418	http://dx.doi.org/10.1371/journal.pone.0083418			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386196	Green Published, Green Submitted, gold			2022-12-25	WOS:000329194700040
J	Wang, YH; Wei, W; Kang, DM; Ma, KP				Wang, Ying-hao; Wei, Wei; Kang, Ding-ming; Ma, Ke-ping			Seed Coat Microsculpturing Is Related to Genomic Components in Wild Brassica juncea and Sinapis arvensis	PLOS ONE			English	Article							NAPUS; COLOR; MICROSATELLITE; IDENTIFICATION; INHERITANCE; CRUCIFERAE; TAXONOMY; MARKER; RAPA	It has been reported that wild Brassica and related species are widely distributed across Xinjiang, China, and there has been an argument for species identification. Seed coat microsculpturing (SCM) is known to be an excellent character for taxonomic and evolutionary studies. By identifying collections from Xinjiang, China, and combining SCM pattern, flow cytometry, and genome-specific DNA markers as well as sexual compatibility with known species, this study aimed to detect potential relationships between SCM and genomic types in wild Brassica and related species. Three wild collections were found to be tetraploid with a SCM reticulate pattern similar to B. juncea, and containing A and B genome-specific loci, indicating relatively high sexual compatibility with B. juncea. The others were diploid, carrying S-genome-specific DNA markers, and having relatively high sexual compatibility with Sinapis arvensis. Moreover, their SCM was in a rugose pattern similar to that of S. arvensis. It was suggested that SCM, as a morphological characteristic, can reflect genomic type, and be used to distinguish B-genome species such as B. juncea from the related S. arvensis. The relationship between SCM and genomic type can support taxonomic studies of the wild Brassica species and related species.	[Wang, Ying-hao; Kang, Ding-ming] China Agr Univ, Coll Agr & Biotechnol, Beijing 100094, Peoples R China; [Wang, Ying-hao; Wei, Wei; Ma, Ke-ping] Chinese Acad Sci, Inst Bot, State Key Lab Vegetat & Environm Change, Beijing, Peoples R China	China Agricultural University; Chinese Academy of Sciences; Institute of Botany, CAS	Wei, W (corresponding author), Chinese Acad Sci, Inst Bot, State Key Lab Vegetat & Environm Change, Beijing, Peoples R China.	weiwei@ibcas.ac.cn; kdm@pku.edu.cn	, Weiwei/B-2681-2008	, Weiwei/0000-0002-1815-9314	Natural Science Foundation of China [31370357, 31270578]; China-European Union cooperation special project of the Ministry of Science and Technology of China [0807]; China-UK Sustainable Agriculture Innovation Network (SAIN project: CWR China)	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China-European Union cooperation special project of the Ministry of Science and Technology of China; China-UK Sustainable Agriculture Innovation Network (SAIN project: CWR China)	This work was supported by two projects of the Natural Science Foundation of China (grant no. 31370357 and no. 31270578) and partially by the China-European Union cooperation special project of the Ministry of Science and Technology of China (contract 0807) and the China-UK Sustainable Agriculture Innovation Network (SAIN project: CWR China). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Shehbaz IA, 2006, PLANT SYST EVOL, V259, P89, DOI 10.1007/s00606-006-0415-z; Beeckman T, 2000, J PLANT RES, V113, P139, DOI 10.1007/PL00013924; BUTH G M, 1987, Phytomorphology, V37, P341; BUTH G M, 1981, Phytomorphology, V31, P69; CHEN BY, 1992, EUPHYTICA, V59, P157, DOI 10.1007/BF00041268; Corner E. J. H., 1976, SEEDS DICOTYLEDONS; Dean G, 2011, MOL PLANT, V4, P1074, DOI 10.1093/mp/ssr040; Dolezel J, 2007, NAT PROTOC, V2, P2233, DOI 10.1038/nprot.2007.310; Ford-Lloyd BV, 2011, BIOSCIENCE, V61, P559, DOI 10.1525/bio.2011.61.7.10; Guan ChunYun, 1996, Acta Agronomica Sinica, V22, P214; Hu Q, 2002, PLANT CELL REP, V21, P147, DOI 10.1007/s00299-002-0491-7; Koul KK, 2000, ANN BOT-LONDON, V86, P385, DOI 10.1006/anbo.2000.1197; Lei L, 2010, THESIS CHINESE ACAD; Lersten N. R., 1979, Proceedings of the Iowa Academy of Science, V86, P102; Liu XL, 2001, THESIS HUNAN AGR U C; Lowe AJ, 2004, THEOR APPL GENET, V108, P1103, DOI 10.1007/s00122-003-1522-7; Lowe AJ, 2002, MOL ECOL NOTES, V2, P7, DOI 10.1046/j.1471-8286.2002.00126.x; Mao SF, 2012, HEREDITAS, V149, P86, DOI 10.1111/j.1601-5223.2012.02248.x; MULLIGAN GA, 1975, CAN J PLANT SCI, V55, P171, DOI 10.4141/cjps75-026; MULLIGAN GA, 1976, ECON BOT, V30, P143, DOI 10.1007/BF02862959; MURLEY MR, 1951, AM MIDL NAT, V46, P1, DOI 10.2307/2421948; Pankin AA, 2011, AM J BOT, V98, pE54, DOI 10.3732/ajb.1000422; Qian XiuZhen, 1998, Acta Agronomica Sinica, V24, P338; Raybould AF, 1999, GENET RESOUR CROP EV, V46, P351, DOI 10.1023/A:1008658630440; REJDALI M, 1990, BOT J LINN SOC, V103, P317, DOI 10.1111/j.1095-8339.1990.tb00193.x; Ren CW, 1998, SEED SCI RES, V8, P385, DOI 10.1017/S0960258500004311; Schelfhout CJ, 2004, THEOR APPL GENET, V109, P917, DOI 10.1007/s00122-004-1713-x; SCHWETKA A, 1982, THEOR APPL GENET, V62, P161, DOI 10.1007/BF00293352; Snowdon RJ, 2000, THEOR APPL GENET, V101, P1008, DOI 10.1007/s001220051574; SzewcMcFadden AK, 1996, THEOR APPL GENET, V93, P534, DOI 10.1007/BF00417944; U. N., 1935, Japanese Journal of Botany, V7, P389; VANDEYNZE AE, 1995, GENOME, V38, P534, DOI 10.1139/g95-069; VAUGHAN JG, 1971, BOT J LINN SOC, V64, P383, DOI 10.1111/j.1095-8339.1971.tb02153.x; Wan LL, 2002, PLANT J, V30, P1, DOI 10.1046/j.1365-313X.2002.01262.x; WANG L, 1982, Acta Botanica Yunnanica, V4, P367; WARWICK SI, 1993, CAN J BOT, V71, P906, DOI 10.1139/b93-102; Wei WH, 2010, THEOR APPL GENET, V120, P1089, DOI 10.1007/s00122-009-1236-6; Wu XiaoMing, 2001, Chinese Journal of Oil Crop Sciences, V23, P1; Zeng CL, 2004, ANN BOT-LONDON, V93, P555, DOI 10.1093/aob/mch080; Zhou TY, 2001, FLORA CHINA, V8	40	4	4	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e83634	10.1371/journal.pone.0083634	http://dx.doi.org/10.1371/journal.pone.0083634			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386242	gold, Green Submitted, Green Published			2022-12-25	WOS:000329194700054
J	Biffi, E; Regalia, G; Menegon, A; Ferrigno, G; Pedrocchi, A				Biffi, Emilia; Regalia, Giulia; Menegon, Andrea; Ferrigno, Giancarlo; Pedrocchi, Alessandra			The Influence of Neuronal Density and Maturation on Network Activity of Hippocampal Cell Cultures: A Methodological Study	PLOS ONE			English	Article							PATTERNS	It is known that cell density influences the maturation process of in vitro neuronal networks. Neuronal cultures plated with different cell densities differ in number of synapses per neuron and thus in single neuron synaptic transmission, which results in a density-dependent neuronal network activity. Although many authors provided detailed information about the effects of cell density on neuronal culture activity, a dedicated report of density and age influence on neuronal hippocampal culture activity has not yet been reported. Therefore, this work aims at providing reference data to researchers that set up an experimental study on hippocampal neuronal cultures, helping in planning and decoding the experiments. In this work, we analysed the effects of both neuronal density and culture age on functional attributes of maturing hippocampal cultures. We characterized the electrophysiological activity of neuronal cultures seeded at three different cell densities, recording their spontaneous electrical activity over maturation by means of MicroElectrode Arrays (MEAs). We had gather data from 86 independent hippocampal cultures to achieve solid statistic results, considering the high culture-to-culture variability. Network activity was evaluated in terms of simple spiking, burst and network burst features. We observed that electrical descriptors were characterized by a functional peak during maturation, followed by a stable phase (for sparse and medium density cultures) or by a decrease phase (for high dense neuronal cultures). Moreover, 900 cells/mm(2) cultures showed characteristics suitable for long lasting experiments (e.g. chronic effect of drug treatments) while 1800 cells/mm(2) cultures should be preferred for experiments that require intense electrical activity (e.g. to evaluate the effect of inhibitory molecules). Finally, cell cultures at 3600 cells/mm(2) are more appropriate for experiments in which time saving is relevant (e.g. drug screenings). These results are intended to be a reference for the planning of in vitro neurophysiological and neuropharmacological experiments with MEAs.	[Biffi, Emilia; Regalia, Giulia; Ferrigno, Giancarlo; Pedrocchi, Alessandra] Politecn Milan, Neuroengn & Med Robot Lab, Dept Elect Informat & Bioengn, I-20133 Milan, Italy; [Biffi, Emilia; Menegon, Andrea] Ist Sci San Raffaele, Adv Light & Electron Microscopy Bioimaging Ctr, Expt Imaging Ctr, I-20132 Milan, Italy	Polytechnic University of Milan; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Biffi, E (corresponding author), IRCCS Eugenio Medea, Bioengn Lab, Inst Sci, Bosisio Parini, Lecco, Italy.	emilia.biffi@polimi.it	Ferrigno, Giancarlo/O-5833-2015; Pedrocchi, Alessandra/A-6634-2012; menegon, andrea/AAN-3736-2020; Biffi, Emilia/B-7982-2012; Pedrocchi, Alessandra/AAF-2655-2019; Biffi, Emilia/AAO-9249-2020	Ferrigno, Giancarlo/0000-0001-5913-9451; Pedrocchi, Alessandra/0000-0001-9957-2786; menegon, andrea/0000-0002-2396-756X; Pedrocchi, Alessandra/0000-0001-9957-2786; Biffi, Emilia/0000-0002-2568-9735				Akum BF, 2004, NAT NEUROSCI, V7, P145, DOI 10.1038/nn1179; Ben-Ari Y, 2001, TRENDS NEUROSCI, V24, P353, DOI 10.1016/S0166-2236(00)01813-0; Biffi E, 2012, BIOTECHNOL BIOENG, V109, P2553, DOI 10.1002/bit.24526; Biffi E, 2011, J NEUROSCI METH, V199, P321, DOI 10.1016/j.jneumeth.2011.05.010; Biffi E, 2012, BIOMICROFLUIDICS, V6, DOI 10.1063/1.3699975; Biffi E, 2012, BIOTECHNOL BIOENG, V109, P166, DOI 10.1002/bit.23310; Chiappalone M, 2006, BRAIN RES, V1093, P41, DOI 10.1016/j.brainres.2006.03.049; Cohen E, 2008, BRAIN RES, V1235, P21, DOI 10.1016/j.brainres.2008.06.022; Cullen DK, 2010, BRAIN RES, V1359, P44, DOI 10.1016/j.brainres.2010.08.058; ICHIKAWA M, 1993, NEUROSCI RES, V16, P95, DOI 10.1016/0168-0102(93)90076-3; Ivenshitz M, 2010, J NEUROPHYSIOL, V104, P1052, DOI 10.1152/jn.00914.2009; Morin FO, 2005, J BIOSCI BIOENG, V100, P131, DOI 10.1263/jbb.100.131; Previtera ML, 2010, J BIOSCI BIOENG, V110, P459, DOI 10.1016/j.jbiosc.2010.04.004; Rossi S, 2011, BRAIN BEHAV IMMUN, V25, P947, DOI 10.1016/j.bbi.2010.10.004; Wagenaar DA, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-11	15	77	77	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e83899	10.1371/journal.pone.0083899	http://dx.doi.org/10.1371/journal.pone.0083899			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281RE	24386305	gold, Green Published, Green Submitted			2022-12-25	WOS:000329117900068
J	Leung, L; Radulovich, N; Zhu, CQ; Wang, D; To, C; Ibrahimov, E; Tsao, MS				Leung, Lisa; Radulovich, Nikolina; Zhu, Chang-Qi; Wang, Dennis; To, Christine; Ibrahimov, Emin; Tsao, Ming-Sound			Loss of Canonical Smad4 Signaling Promotes KRAS Driven Malignant Transformation of Human Pancreatic Duct Epithelial Cells and Metastasis	PLOS ONE			English	Article							ONCOGENIC K-RAS; TUMOR BIOLOGY; DPC4 GENE; CANCER; EXPRESSION; ADENOCARCINOMA; PROGRESSION; INVASION; SUPPRESSION; RESTORATION	Pancreatic ductal adenocarcinoma (PDAC) is the fourth most common cause of cancer death in North America. Activating KRAS mutations and Smad4 loss occur in approximately 90% and 55% of PDAC, respectively. While their roles in the early stages of PDAC development have been confirmed in genetically modified mouse models, their roles in the multistep malignant transformation of human pancreatic duct cells have not been directly demonstrated. Here, we report that Smad4 represents a barrier in KRAS-mediated malignant transformation of the near normal immortalized human pancreatic duct epithelial (HPDE) cell line model. Marked Smad4 downregulation by shRNA in KRAS(G12V) expressing HPDE cells failed to cause tumorigenic transformation. However, KRAS-mediated malignant transformation occurred in a new HPDE-TGF-beta resistant (T beta R) cell line that completely lacks Smad4 protein expression and is resistant to the mito-inhibitory activity of TGF-beta. This transformation resulted in tumor formation and development of metastatic phenotype when the cells were implanted orthotopically into the mouse pancreas. Smad4 restoration re-established TGF-beta sensitivity, markedly increased tumor latency by promoting apoptosis, and decreased metastatic potential. These results directly establish the critical combination of the KRAS oncogene and complete Smad4 inactivation in the multi-stage malignant transformation and metastatic progression of normal human HPDE cells.	[Leung, Lisa; Tsao, Ming-Sound] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Radulovich, Nikolina; Tsao, Ming-Sound] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Leung, Lisa; Radulovich, Nikolina; Zhu, Chang-Qi; Wang, Dennis; To, Christine; Ibrahimov, Emin; Tsao, Ming-Sound] Univ Toronto, Ontario Canc Inst, Princess Margaret Hosp, Toronto, ON M5S 1A1, Canada; [Leung, Lisa; Radulovich, Nikolina; Zhu, Chang-Qi; Wang, Dennis; To, Christine; Ibrahimov, Emin; Tsao, Ming-Sound] Univ Toronto, Univ Hlth Network, Toronto, ON, Canada	University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Tsao, MS (corresponding author), Univ Toronto, Dept Med Biophys, Toronto, ON, Canada.	Ming.Tsao@uhn.on.ca	Tsao, Ming Sound/AFQ-7332-2022; Tsao, Ming-Sound/M-3503-2017	Tsao, Ming Sound/0000-0002-9160-5405; Zhu, ChangQi/0000-0002-9992-0258; Wang, Dennis/0000-0003-0068-1005	Canadian Institutes of Health Research [MOP-49585]; Canadian Cancer Society Research Institute [700809]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Cancer Society Research Institute(Canadian Cancer Society (CCS))	Supported by the Canadian Institutes of Health Research grant MOP-49585, and Canadian Cancer Society Research Institute grant 700809. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agbunag C, 2004, CANCER RES, V64, P5659, DOI 10.1158/0008-5472.CAN-04-0807; Ahmed MM, 2002, J BIOL CHEM, V277, P2234, DOI 10.1074/jbc.M110168200; Bardeesy N, 2006, P NATL ACAD SCI USA, V103, P5947, DOI 10.1073/pnas.0601273103; Bardeesy N, 2006, GENE DEV, V20, P3130, DOI 10.1101/gad.1478706; Biankin AV, 2012, NATURE, V491, P399, DOI 10.1038/nature11547; Brummelkamp TR, 2002, CANCER CELL, V2, P243, DOI 10.1016/S1535-6108(02)00122-8; Campbell PM, 2007, CANCER RES, V67, P2098, DOI 10.1158/0008-5472.CAN-06-3752; Dai JL, 1999, P NATL ACAD SCI USA, V96, P1427, DOI 10.1073/pnas.96.4.1427; Duda DG, 2003, ONCOGENE, V22, P6857, DOI 10.1038/sj.onc.1206751; Furukawa T, 1996, AM J PATHOL, V148, P1763; Hahn SA, 1996, SCIENCE, V271, P350, DOI 10.1126/science.271.5247.350; HAHN SA, 1995, CANCER RES, V55, P4670; Hidalgo M, 2010, NEW ENGL J MED, V362, P1605, DOI 10.1056/NEJMra0901557; Hingorani SR, 2003, CANCER CELL, V4, P437, DOI 10.1016/S1535-6108(03)00309-X; Hingorani SR, 2005, CANCER CELL, V7, P469, DOI 10.1016/j.ccr.2005.04.023; Hong OY, 2000, AM J PATHOL, V157, P1623, DOI 10.1016/S0002-9440(10)64800-6; Hruban RH, 2000, AM J PATHOL, V156, P1821, DOI 10.1016/S0002-9440(10)65054-7; Iacobuzio-Donahue CA, 2009, J CLIN ONCOL, V27, P1806, DOI 10.1200/JCO.2008.17.7188; Izeradjene K, 2007, CANCER CELL, V11, P229, DOI 10.1016/j.ccr.2007.01.017; John T, 2009, ONCOGENE, V28, pS14, DOI 10.1038/onc.2009.197; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Kojima K, 2007, CANCER RES, V67, P8121, DOI 10.1158/0008-5472.CAN-06-4167; Lefter LP, 2002, GENE CHROMOSOME CANC, V34, P234, DOI 10.1002/gcc.10060; Leung L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046677; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; Lohr M, 2001, VIRCHOWS ARCH, V438, P581, DOI 10.1007/s004280100397; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Mazur PK, 2012, GUT, V61, P1488, DOI 10.1136/gutjnl-2011-300756; Oshima M, 2013, ANN SURG, V258, P336, DOI 10.1097/SLA.0b013e3182827a65; Peng BL, 2002, CLIN CANCER RES, V8, P3628; Qian JY, 2005, CANCER RES, V65, P5045, DOI 10.1158/0008-5472.CAN-04-3208; Radulovich N, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-24; Radutovich N, 2008, METHOD ENZYMOL, V439, P1, DOI 10.1016/S0076-6879(07)00401-6; Schubbert S, 2007, NAT REV CANCER, V7, P295, DOI 10.1038/nrc2109; Schutte M, 1996, CANCER RES, V56, P2527; Shin SH, 2013, PANCREAS, V42, P216, DOI 10.1097/MPA.0b013e31825b6ab0; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Singh A, 2009, CANCER CELL, V15, P489, DOI 10.1016/j.ccr.2009.03.022; Wilentz RE, 2000, CANCER RES, V60, P2002; Yasutome M, 2005, CLIN EXP METASTAS, V22, P461, DOI 10.1007/s10585-005-2891-x; Zhao SJ, 2008, CANCER RES, V68, P4221, DOI 10.1158/0008-5472.CAN-07-5123; Zhao S, 2008, J BIOL CHEM, V283, P11293, DOI 10.1074/jbc.M800154200; Zhao SJ, 2010, INT J CANCER, V127, P2076, DOI 10.1002/ijc.25412	43	25	27	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e84366	10.1371/journal.pone.0084366	http://dx.doi.org/10.1371/journal.pone.0084366			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281RE	24386371	Green Published, Green Submitted, gold			2022-12-25	WOS:000329117900090
J	Nishimura, S; Ishii, K; Iwamoto, K; Arita, Y; Matsunaga, S; Ohno-Iwashita, Y; Sato, SB; Kakeya, H; Kobayashi, T; Yoshida, M				Nishimura, Shinichi; Ishii, Kumiko; Iwamoto, Kunihiko; Arita, Yuko; Matsunaga, Shigeki; Ohno-Iwashita, Yoshiko; Sato, Satoshi B.; Kakeya, Hideaki; Kobayashi, Toshihide; Yoshida, Minoru			Visualization of Sterol-Rich Membrane Domains with Fluorescently-Labeled Theonellamides	PLOS ONE			English	Article							CHOLESTEROL; TRANSPORT; GLYCOPEPTIDE; SWINHOEI; PEPTIDE; BINDING; PROTEIN; CELLS; RAFTS	Cholesterol plays important roles in biological membranes. The cellular location where cholesterol molecules work is prerequisite information for understanding their dynamic action. Bioimaging probes for cholesterol molecules would be the most powerful means for unraveling the complex nature of lipid membranes. However, only a limited number of chemical or protein probes have been developed so far for cytological analysis. Here we show that fluorescently-labeled derivatives of theonellamides act as new sterol probes in mammalian cultured cells. The fluorescent probes recognized cholesterol molecules and bound to liposomes in a cholesterol-concentration dependent manner. The probes showed patchy distribution in the plasma membrane, while they stained specific organelle in the cytoplasm. These data suggest that fTNMs will be valuable sterol probes for studies on the role of sterols in the biological membrane under a variety of experimental conditions.	[Nishimura, Shinichi; Arita, Yuko; Yoshida, Minoru] RIKEN Ctr Sustainable Resource Sci, Chem Genom Res Grp, Saitama, Japan; [Nishimura, Shinichi; Kakeya, Hideaki] Kyoto Univ, Div Bioinformat & Chem Genom, Grad Sch Pharmaceut Sci, Kyoto, Japan; [Ishii, Kumiko; Iwamoto, Kunihiko; Kobayashi, Toshihide] RIKEN, Lipid Biol Lab, Saitama, Japan; [Matsunaga, Shigeki] Univ Tokyo, Lab Aquat Nat Prod Chem, Grad Sch Agr & Life Sci, Tokyo, Japan; [Ohno-Iwashita, Yoshiko] Iwaki Meisei Univ, Fac Pharm, Iwaki, Fukushima 970, Japan; [Sato, Satoshi B.] Kyoto Univ, Res Ctr Low Temp & Mat Sci, Kyoto, Japan	RIKEN; Kyoto University; RIKEN; University of Tokyo; Iwaki Meisei University; Kyoto University	Nishimura, S (corresponding author), RIKEN Ctr Sustainable Resource Sci, Chem Genom Res Grp, Saitama, Japan.	nshin@pharm.kyoto-u.ac.jp; yoshidam@riken.jp	Yoshida, Minoru/C-8049-2014; KOBAYASHI, TOSHIHIDE/S-8313-2019; Kobayashi, Toshihide/B-6298-2015; Nishimura, Shinichi/AGE-1316-2022; Kakeya, Hideaki/B-3527-2012	Yoshida, Minoru/0000-0002-4376-5674; KOBAYASHI, TOSHIHIDE/0000-0002-4811-7270; Kobayashi, Toshihide/0000-0002-4811-7270; Nishimura, Shinichi/0000-0002-5998-3780; Kakeya, Hideaki/0000-0002-4293-7331	Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Society for the Promotion of Science; Chemical Genomics Research Project, RIKEN Advanced Science Institute; Grants-in-Aid for Scientific Research [24657143, 25702048] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Chemical Genomics Research Project, RIKEN Advanced Science Institute; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by a Grant-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan and the Japan Society for the Promotion of Science, and the Chemical Genomics Research Project, RIKEN Advanced Science Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez FJ, 2007, EUKARYOT CELL, V6, P755, DOI 10.1128/EC.00008-07; BEWLEY CA, 1994, J ORG CHEM, V59, P4849, DOI 10.1021/jo00096a028; Boutte Y, 2011, NAT PROTOC, V6, P446, DOI 10.1038/nprot.2011.323; BRETSCHER MS, 1993, SCIENCE, V261, P1280, DOI 10.1126/science.8362242; DEKRUIJFF B, 1974, BIOCHIM BIOPHYS ACTA, V339, P57, DOI 10.1016/0005-2736(74)90332-0; DRABIKOWSKI W, 1973, BIOCHIM BIOPHYS ACTA, V291, P61, DOI 10.1016/0005-2736(73)90060-6; Espiritu RA, 2013, BIOCHEMISTRY; Espiritu RA, 2013, BIOCHEMISTRY-US, V52, P2410, DOI 10.1021/bi4000854; Gimpl G, 2010, SUBCELL BIOCHEM, V51, P1, DOI 10.1007/978-90-481-8622-8_1; Ho CH, 2009, NAT BIOTECHNOL, V27, P369, DOI 10.1038/nbt.1534; Ishitsuka R, 2011, J LIPID RES, V52, P2084, DOI 10.1194/jlr.D018184; Ishiwata H, 1997, BBA-MOL CELL RES, V1359, P123, DOI 10.1016/S0167-4889(97)00061-X; Iwamoto K, 2007, BIOPHYS J, V93, P1608, DOI 10.1529/biophysj.106.101584; Iwamoto M, 1997, BBA-BIOMEMBRANES, V1327, P222, DOI 10.1016/S0005-2736(97)00061-8; Kasai Y, 2008, CHEM-EUR J, V14, P1178, DOI 10.1002/chem.200701256; KILSDONK EPC, 1995, J BIOL CHEM, V270, P17250, DOI 10.1074/jbc.270.29.17250; Kobayashi T, 1999, NAT CELL BIOL, V1, P113, DOI 10.1038/10084; LISCUM L, 1989, J BIOL CHEM, V264, P11796; MATSUNAGA S, 1995, J ORG CHEM, V60, P1177, DOI 10.1021/jo00110a020; MATSUNAGA S, 1989, J AM CHEM SOC, V111, P2582, DOI 10.1021/ja00189a035; MILLER RG, 1984, CELL BIOL INT REP, V8, P519, DOI 10.1016/0309-1651(84)90050-X; Nakamura N, 1995, J CELL BIOL, V131, P1715, DOI 10.1083/jcb.131.6.1715; Nishimura S, 2010, NAT CHEM BIOL, V6, P519, DOI [10.1038/nchembio.387, 10.1038/NCHEMBIO.387]; Ohno-Iwashita Y, 2010, SUBCELL BIOCHEM, V51, P597, DOI 10.1007/978-90-481-8622-8_22; Sato SB, 2004, J BIOL CHEM, V279, P23790, DOI 10.1074/jbc.M313568200; Schmidt EW, 1998, J ORG CHEM, V63, P1254, DOI 10.1021/jo9718455; Simons K, 2004, ANNU REV BIOPH BIOM, V33, P269, DOI 10.1146/annurev.biophys.32.110601.141803; Waheed AA, 2001, P NATL ACAD SCI USA, V98, P4926, DOI 10.1073/pnas.091090798	28	23	23	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e83716	10.1371/journal.pone.0083716	http://dx.doi.org/10.1371/journal.pone.0083716			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281RE	24386262	Green Published, gold, Green Submitted			2022-12-25	WOS:000329117900056
J	Rementer, CW; Wu, MT; Buranaphatthana, W; Yang, HYL; Scatena, M; Giachelli, CM				Rementer, Cameron W.; Wu, Meiting; Buranaphatthana, Worakanya; Yang, Hsueh-Ying L.; Scatena, Marta; Giachelli, Cecilia M.			An Inducible, Ligand-Independent Receptor Activator of NF-kappa B Gene to Control Osteoclast Differentiation from Monocytic Precursors	PLOS ONE			English	Article							SIGNAL-TRANSDUCTION; CELL THERAPY; CALCIFICATION; PROLIFERATION; INHIBITION; GROWTH	Osteoclasts are bone-resorbing cells that are critical for the normal formation and maintenance of teeth and skeleton. Osteoclast deficiency can contribute to heterotopic ossification (HO), a pathology that is particularly detrimental to the mechanical functions of joints, valves and blood vessels. On the other hand, osteoclast over-activity is a major cause of osteoporosis. A reliable method for controlled generation of osteoclasts would be useful as a potential autologous cell therapy for HO, as well as high-throughput drug screening for anti-osteoporotic drugs. In this report, we describe the development of a cell engineering approach to control monocytic precursor cell differentiation to osteoclasts. Oligomerization of receptor activator of nuclear factor kappa B (RANK) is known to be essential for osteoclast differentiation from monocyte/macrophage precursors. We engineered a murine monocytic cell line, RAW264.7 to express a fusion protein comprising the intracellular RANK signaling domain and FK506-derived dimerization domains that bind to a small molecule chemical inducer of dimerization (CID). Virally infected cells expressing this fusion protein were treated with CID and dose-dependent induction of tartrate-resistant acid phosphatase activity, as well as multinucleated osteoclast formation were observed. Furthermore, NF-kappa B signaling was upregulated in a CID-dependent fashion, demonstrating effective RANK intracellular signaling. Functionally CID-induced osteoclasts had robust mineral resorptive activity in both two-dimensional and three-dimensional in vitro resorption assays. In addition, the CID-induced osteoclasts have the same life span as native RANKL-induced osteoclasts. Most importantly and crucially, the engineered cells differentiated into osteoclasts that were resistant to the potent osteoclast inhibitor, osteoprotegerin. Taken together, these studies are the first to describe a method for inducible control of monocytic precursor differentiation to osteoclasts that may be useful for future development of an engineered autologous cell therapy as well as high-throughput drug testing systems to treat diseases of osteoclast over-activity that are independent of osteoprotegerin.	[Rementer, Cameron W.; Wu, Meiting; Yang, Hsueh-Ying L.; Scatena, Marta; Giachelli, Cecilia M.] Univ Washington, Dept Bioengn, Seattle, WA 98195 USA; [Buranaphatthana, Worakanya] Univ Washington, Dept Oral Hlth Sci, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Giachelli, CM (corresponding author), Univ Washington, Dept Bioengn, Seattle, WA 98195 USA.	ceci@uw.edu			Life Sciences Discovery Fund [2361524]; NIH [R01HL114611-01, T32EB001650]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL114611] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [T32EB001650] Funding Source: NIH RePORTER	Life Sciences Discovery Fund; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work is supported by Life Sciences Discovery Fund 2361524, NIH grant R01HL114611-01 and NIH training grant T32EB001650. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DM, 1997, NATURE, V390, P175, DOI 10.1038/36593; Blair HC, 2005, BIOCHEM BIOPH RES CO, V328, P728, DOI 10.1016/j.bbrc.2004.11.077; Blau CA, 1997, P NATL ACAD SCI USA, V94, P3076, DOI 10.1073/pnas.94.7.3076; BOYDE A, 1984, BRIT DENT J, V156, P216, DOI 10.1038/sj.bdj.4805313; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Collin-Osdoby P, 2012, METHODS MOL BIOL, V816, P187, DOI 10.1007/978-1-61779-415-5_13; Courter DL, 2005, J BIOL CHEM, V280, P12145, DOI 10.1074/jbc.M412555200; Dismuke AD, 2009, BIOL PROCED ONLINE, V11, P130, DOI 10.1007/s12575-009-9014-z; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; Forsberg Jonathan Agner, 2010, J Surg Orthop Adv, V19, P54; Giachelli CM, 1999, AM J PATHOL, V154, P671, DOI 10.1016/S0002-9440(10)65313-8; Hashem R, 2011, CANCER RADIOTHER, V15, P261, DOI 10.1016/j.canrad.2010.10.003; Hsu HL, 1999, P NATL ACAD SCI USA, V96, P3540, DOI 10.1073/pnas.96.7.3540; Iwamoto K, 2004, BIOCHEM BIOPH RES CO, V325, P229, DOI 10.1016/j.bbrc.2004.10.024; Janckila AJ, 2001, J BONE MINER RES, V16, P788, DOI 10.1359/jbmr.2001.16.4.788; Jin LQ, 1998, BLOOD, V91, P890, DOI 10.1182/blood.V91.3.890.890_890_897; Simpson CL, 2007, CARDIOVASC PATHOL, V16, P29, DOI 10.1016/j.carpath.2006.07.001; Lee ZH, 2003, BIOCHEM BIOPH RES CO, V305, P211, DOI 10.1016/S0006-291X(03)00695-8; Lippuner K, 2012, SWISS MED WKLY, V142, DOI 10.4414/smw.2012.13624; Liu CZ, 2010, J IMMUNOL, V184, P6910, DOI 10.4049/jimmunol.0904033; Mohler ER, 2001, CIRCULATION, V103, P1522, DOI 10.1161/01.cir.103.11.1522; Neff T, 2001, BLOOD, V97, P2535, DOI 10.1182/blood.V97.9.2535; Ollivere B, 2012, J BONE JOINT SURG BR, V94B, P10, DOI 10.1302/0301-620X.94B1.28047; Osathanon T, 2008, BIOMATERIALS, V29, P4091, DOI 10.1016/j.biomaterials.2008.06.030; Paparodis R, 2013, ENDOCR PRACT, V21, P1; Pichardo SE, 2012, J CRANIOMAXILLOFAC S, V41, pe65; Pohjolainen V, 2008, HUM PATHOL, V39, P1695, DOI 10.1016/j.humpath.2008.04.015; ROBERTS JB, 1979, J BONE JOINT SURG AM, V61, P760, DOI 10.2106/00004623-197961050-00018; Scatena M, 1998, J CELL BIOL, V141, P1083, DOI 10.1083/jcb.141.4.1083; Shehab D, 2002, J NUCL MED, V43, P346; SPENCER DM, 1993, SCIENCE, V262, P1019, DOI 10.1126/science.7694365; Susa Mira, 2004, J Transl Med, V2, P6, DOI 10.1186/1479-5876-2-6; Tey SK, 2007, BIOL BLOOD MARROW TR, V13, P913, DOI 10.1016/j.bbmt.2007.04.005; Tiscornia G, 2006, NAT PROTOC, V1, P241, DOI 10.1038/nprot.2006.37; Van den Wyngaert T, 2011, SUPPORT CARE CANCER, V19, P2035, DOI 10.1007/s00520-010-1061-0; Wada T, 1999, CIRC RES, V84, P166, DOI 10.1161/01.RES.84.2.166; Weinreich MA, 2006, BLOOD, V108, P3713, DOI 10.1182/blood-2006-01-012278; Whitney ML, 2001, J BIOL CHEM, V276, P41191, DOI 10.1074/jbc.M103191200; Zeng H, 2001, BLOOD, V98, P328, DOI 10.1182/blood.V98.2.328	39	10	11	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e84465	10.1371/journal.pone.0084465	http://dx.doi.org/10.1371/journal.pone.0084465			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281RE	24386387	Green Published, Green Submitted, gold			2022-12-25	WOS:000329117900097
J	Suzaki, Y; Katsuki, M; Miyatake, T; Okada, Y				Suzaki, Yu; Katsuki, Masako; Miyatake, Takahisa; Okada, Yasukazu			Male Courtship Behavior and Weapon Trait as Indicators of Indirect Benefit in the Bean Bug, Riptortus pedestris	PLOS ONE			English	Article							CLAVATUS THUNBERG HETEROPTERA; SEXUAL SELECTION; MALE COMPETITION; MATE CHOICE; GENETIC CORRELATIONS; FEMALE PREFERENCE; MATING SUCCESS; BODY-SIZE; MULTIPLE; COSTS	Females prefer male traits that are associated with direct and/or indirect benefits to themselves. Male-male competition also drives evolution of male traits that represent competitive ability. Because female choice and male-male competition rarely act independently, exploring how these two mechanisms interact is necessary for integrative understanding of the evolution of sexually selected traits. Here, we focused on direct and indirect benefits to females from male attractiveness, courtship, and weapon characters in the armed bug Riptortus pedestris. The males use their hind legs to fight other males over territory and perform courtship displays for successful copulation. Females of R. pedestris receive no direct benefit from mating with attractive males. On the other hand, we found that male attractiveness, courtship rate, and weapon size were significantly heritable and that male attractiveness had positive genetic covariances with both courtship rate and weapon traits. Thus, females obtain indirect benefits from mating with attractive males by producing sons with high courtship success rates and high competitive ability. Moreover, it is evident that courtship rate and hind leg length act as evaluative cues of female choice. Therefore, female mate choice and male-male competition may facilitate each other in R. pedestris. This is consistent with current basic concepts of sexual selection.	[Suzaki, Yu; Miyatake, Takahisa] Okayama Univ, Grad Sch Environm Sci, Okayama, Japan; [Katsuki, Masako] Univ Tsukuba, Fac Life & Environm Sci, Ibaraki, Japan; [Miyatake, Takahisa] Okayama Univ, Grad Sch Environm & Life Sci, Okayama, Japan; [Okada, Yasukazu] Univ Tokyo, Dept Gen Syst Studies, Tokyo, Japan	Okayama University; University of Tsukuba; Okayama University; University of Tokyo	Suzaki, Y (corresponding author), Okayama Univ, Grad Sch Environm Sci, Okayama, Japan.	gev421204@s.okayama-u.ac.jp	Miyatake, Takahisa/B-6580-2017; Okada, Yasukazu/B-1590-2014	Miyatake, Takahisa/0000-0002-5476-0676; Okada, Yasukazu/0000-0003-4528-2980	Japan Society for the Promotion of Science [245168, 23570027]; Grants-in-Aid for Scientific Research [13J01662] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was partly supported by Grant-in-Aid for JSPS Fellows (245168) to YS and Grant-in-Aid for Scientific Research (KAKENHI 23570027) to TM, both from the Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akesson M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001739; Andersson M, 1996, TRENDS ECOL EVOL, V11, P53, DOI 10.1016/0169-5347(96)81042-1; Andersson M, 2006, ESSAYS ANIMAL BEHAV, P255; Andersson M, 2006, TRENDS ECOL EVOL, V21, P296, DOI 10.1016/j.tree.2006.03.015; Andersson Malte, 1994; Andersson S, 2002, AM NAT, V160, P683, DOI 10.1086/342817; Arnqvist Goran, 2005, pUnpaginated; BAKKER TCM, 1993, NATURE, V363, P255, DOI 10.1038/363255a0; Barth M, 1997, ANIM BEHAV, V53, P25, DOI 10.1006/anbe.1996.0275; Berglund A, 1996, BIOL J LINN SOC, V58, P385, DOI 10.1111/j.1095-8312.1996.tb01442.x; Boake CRB, 1998, EVOLUTION, V52, P1487, DOI 10.1111/j.1558-5646.1998.tb02030.x; Bonduriansky R, 2003, EVOLUTION, V57, P2046, DOI 10.1111/j.0014-3820.2003.tb00384.x; Bretman A, 2011, CURR BIOL, V21, P617, DOI 10.1016/j.cub.2011.03.008; Cameron E, 2003, J EVOLUTION BIOL, V16, P1055, DOI 10.1046/j.1420-9101.2003.00584.x; Candolin U, 2003, BIOL REV, V78, P575, DOI 10.1017/S1464793103006158; Candolin U, 2005, P ROY SOC B-BIOL SCI, V272, P47, DOI 10.1098/rspb.2004.2932; Candolin U, 2004, EVOLUTION, V58, P1861; Charlesworth B., 1987, Life Sciences Research Report, V39, P21; Darwin G., 1871, P423; Darwin C., 1859, ORIGIN SPECIES MEANS; Eberhard W.G., 1979, P231; Eberhard W. G., 1996, FEMALE CONTROL SEXUA; Emlen DJ, 2000, ANNU REV ENTOMOL, V45, P661, DOI 10.1146/annurev.ento.45.1.661; Emlen DJ, 2001, SCIENCE, V291, P1534, DOI 10.1126/science.1056607; Emlen DJ, 2008, ANNU REV ECOL EVOL S, V39, P387, DOI 10.1146/annurev.ecolsys.39.110707.173502; Etges WJ, 2002, GENETICA, V116, P151, DOI 10.1023/A:1021284426383; Falconer D. S, 1996, INTRO QUANTITATIVE G; Fedina TY, 2008, BIOL REV, V83, P151, DOI 10.1111/j.1469-185X.2008.00037.x; Fisher R.A., 1930, GENETICAL THEORY NAT; Grafen A., 2002, MODERN STAT LIFE SCI; HAINES SE, 1994, NATURE, V370, P512, DOI 10.1038/370512a0; Head ML, 2005, PLOS BIOL, V3, P289, DOI 10.1371/journal.pbio.0030033; HOELZER GA, 1989, ANIM BEHAV, V38, P1067, DOI 10.1016/S0003-3472(89)80146-0; Hosken DJ, 2004, TRENDS ECOL EVOL, V19, P87, DOI 10.1016/j.tree.2003.11.012; Houde E, 1997, SEX COLOR MATE CHOIC; Hunt J, 2004, TRENDS ECOL EVOL, V19, P329, DOI 10.1016/j.tree.2004.03.035; Hunt J, 2009, J EVOLUTION BIOL, V22, P13, DOI 10.1111/j.1420-9101.2008.01633.x; Jennions MD, 2000, BIOL REV, V75, P21, DOI 10.1017/S0006323199005423; JOHNSTONE RA, 1995, BIOL REV, V70, P1, DOI 10.1111/j.1469-185X.1995.tb01439.x; Kamano S, 1991, REARING METHODS INSE, P46; Kimura S, 2008, JPN J APPL ENTOMOL Z, V52, P13, DOI 10.1303/jjaez.2008.13; Kirkpatrick M, 1997, P NATL ACAD SCI USA, V94, P1282, DOI 10.1073/pnas.94.4.1282; Kirkpatrick M, 1996, EVOLUTION, V50, P2125, DOI [10.2307/2410684, 10.1111/j.1558-5646.1996.tb03603.x]; Kokko H, 2003, P ROY SOC B-BIOL SCI, V270, P653, DOI 10.1098/rspb.2002.2235; Kokko H, 2006, ANNU REV ECOL EVOL S, V37, P43, DOI 10.1146/annurev.ecolsys.37.091305.110259; Kotiaho JS, 2001, NATURE, V410, P684, DOI 10.1038/35070557; Kotiaho JS, 2002, BEHAV ECOL, V13, P791, DOI 10.1093/beheco/13.6.791; Kotiaho JS, 2001, BIOL REV, V76, P365, DOI 10.1017/S1464793101005711; Lailvaux SP, 2010, ECOLOGY, V91, P1530, DOI 10.1890/09-0963.1; LANDE R, 1981, P NATL ACAD SCI-BIOL, V78, P3721, DOI 10.1073/pnas.78.6.3721; Lynch M., 1998, GENETICS ANAL QUANTI; Mead LS, 2004, TRENDS ECOL EVOL, V19, P264, DOI 10.1016/j.tree.2004.03.003; Moller AP, 1999, P ROY SOC B-BIOL SCI, V266, P85, DOI 10.1098/rspb.1999.0607; MOLLER AP, 1993, BEHAV ECOL SOCIOBIOL, V32, P167; Moller AP, 2001, NATURWISSENSCHAFTEN, V88, P401, DOI 10.1007/s001140100255; Natuhara Y, 1985, SEIKATSU EISEI, V29, P102; Nijhout HF, 1998, P NATL ACAD SCI USA, V95, P3685, DOI 10.1073/pnas.95.7.3685; NUMATA H, 1986, APPL ENTOMOL ZOOL, V21, P119, DOI 10.1303/aez.21.119; NUMATA H, 1990, APPL ENTOMOL ZOOL, V25, P144, DOI 10.1303/aez.25.144; Okada K, 2011, J EVOLUTION BIOL, V24, P1737, DOI 10.1111/j.1420-9101.2011.02303.x; Okada K, 2013, BEHAV ECOL SOCIOBIOL, V67, P53, DOI 10.1007/s00265-012-1424-2; Okada K, 2011, ZOOL SCI, V28, P659, DOI 10.2108/zsj.28.659; Okada Y, 2012, ANIM BEHAV, V83, P1001, DOI 10.1016/j.anbehav.2012.01.021; Omae Y, 2012, APPL ENTOMOL ZOOL, V47, P157, DOI 10.1007/s13355-012-0103-0; PARTRIDGE L, 1990, J INSECT PHYSIOL, V36, P419, DOI 10.1016/0022-1910(90)90059-O; PRICE T, 1993, BIOL J LINN SOC, V48, P187, DOI 10.1111/j.1095-8312.1993.tb00887.x; Qvarnstrom A, 1998, TRENDS ECOL EVOL, V13, P498, DOI 10.1016/S0169-5347(98)01513-4; Ritchie MG, 1999, ANIM BEHAV, V58, P649, DOI 10.1006/anbe.1999.1167; Roff Derek, 2002, pi; Ronning B, 2007, J EVOLUTION BIOL, V20, P1815, DOI 10.1111/j.1420-9101.2007.01384.x; Rowe L, 1996, P ROY SOC B-BIOL SCI, V263, P1415, DOI 10.1098/rspb.1996.0207; Sakurai G, 2008, ANIM BEHAV, V75, P1367, DOI 10.1016/j.anbehav.2007.09.010; Scheuber H, 2004, P ROY SOC B-BIOL SCI, V271, P2453, DOI 10.1098/rspb.2004.2907; Shackleton MA, 2005, BEHAV ECOL SOCIOBIOL, V58, P1, DOI 10.1007/s00265-004-0907-1; Shuster SM, 2003, MATING SYSTEM STRATE, P553; Simmons L. W., 2001, MG BEH ECOL; Simmons LW, 2011, BIOL LETTERS, V7, P419, DOI 10.1098/rsbl.2010.0976; Taylor ML, 2008, BEHAV ECOL SOCIOBIOL, V62, P721, DOI 10.1007/s00265-007-0497-9; Taylor ML, 2007, CURR BIOL, V17, pR959, DOI 10.1016/j.cub.2007.09.054; Thornhill R., 1983, pi; Tomkins JL, 2004, TRENDS ECOL EVOL, V19, P323, DOI 10.1016/j.tree.2004.03.029; Wedell N, 1999, EVOLUTION, V53, P620, DOI 10.1111/j.1558-5646.1999.tb03797.x; WILLIAMS GC, 1966, AM NAT, V100, P687, DOI 10.1086/282461; Wong BBM, 2005, BIOL REV, V80, P559, DOI 10.1017/S1464793105006809; Yamane T, 2010, P ROY SOC B-BIOL SCI, V277, P1705, DOI 10.1098/rspb.2009.2017	85	15	16	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e83278	10.1371/journal.pone.0083278	http://dx.doi.org/10.1371/journal.pone.0083278			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281RE	24386170	Green Published, gold, Green Submitted			2022-12-25	WOS:000329117900030
J	McLenachan, S; Zhang, D; Palomo, ABA; Edel, MJ; Chen, FK				McLenachan, Samuel; Zhang, Dan; Alvarez Palomo, Ana Belen; Edel, Michael J.; Chen, Fred K.			mRNA Transfection of Mouse and Human Neural Stem Cell Cultures	PLOS ONE			English	Article							SUBVENTRICULAR ZONE; NEUROSPHERE CELLS; GENERATION; PLURIPOTENCY; DIFFERENTIATION; EFFICIENT; BRAIN	The use of synthetic mRNA as an alternative gene delivery vector to traditional DNA-based constructs provides an effective method for inducing transient gene expression in cell cultures without genetic modification. Delivery of mRNA has been proposed as a safer alternative to viral vectors in the induction of pluripotent cells for regenerative therapies. Although mRNA transfection of fibroblasts, dendritic and embryonic stem cells has been described, mRNA delivery to neurosphere cultures has not been previously reported. Here we sought to establish an efficient method for delivering mRNA to primary neurosphere cultures. Neurospheres derived from the subventricular zone of adult mice or from human embryonic stem cells were transfected with EGFP mRNA by lipofection and electroporation. Transfection efficiency and expression levels were monitored by flow cytometry. Cell survival following transfection was examined using live cell counting and the MTT assay. Both lipofection and electroporation provided high efficiency transfection of neurospheres. In comparison with lipofection, electroporation resulted in increased transfection efficiencies, but lower expression per cell and shorter durations of expression. Additional rounds of lipofection renewed EGFP expression in neurospheres, suggesting this method may be suitable for reprogramming applications. In summary, we have developed a protocol for achieving high efficiency transfection rates in mouse and human neurosphere cell culture that can be applied for future studies of gene function studies in neural stem cells, such as defining efficient differentiation protocols for glial and neuronal linages.	[McLenachan, Samuel; Zhang, Dan; Chen, Fred K.] Univ Western Australia, Ctr Ophthalmol & Visual Sci, Crawley, WA, Australia; [McLenachan, Samuel; Zhang, Dan; Chen, Fred K.] Lions Eye Inst, Ocular Tissue Engn Lab, Nedlands, WA, Australia; [Alvarez Palomo, Ana Belen; Edel, Michael J.] Univ Barcelona, Mol Genet Res Grp, Control Pluripotency Lab, Dept Physiol Sci 1, Barcelona, Spain; [Edel, Michael J.] Univ Sydney, Fac Med, Westmead Childrens Hosp, Div Pediat & Child Hlth,Sch Med, Sydney, NSW 2006, Australia; [Chen, Fred K.] Royal Perth Hosp, Dept Ophthalmol, Perth, WA 6001, Australia	University of Western Australia; Lions Eye Institute; University of Western Australia; University of Barcelona; University of Sydney; Royal Perth Hospital; University of Western Australia	McLenachan, S (corresponding author), Univ Western Australia, Ctr Ophthalmol & Visual Sci, Crawley, WA, Australia.	smclenachan@lei.org.au	, Fred/B-8158-2013; Edel, Michael J/L-1954-2014	, Fred/0000-0003-2809-9930; Edel, Michael J/0000-0002-5619-8680; McLenachan, Samuel/0000-0001-5732-7387	University of Western Australia; Lions Eye Institute National Health & Medical Research Council of Australia; MINECO Ramon y Cajal Grant [RYC-2010-06512]; MINECO [BFU-2011-26596]	University of Western Australia; Lions Eye Institute National Health & Medical Research Council of Australia; MINECO Ramon y Cajal Grant; MINECO(Spanish Government)	Funding sources included The University of Western Australia (www.uwa.edu.au), Lions Eye Institute (www.lei.org.au) National Health & Medical Research Council of Australia (http://www.nhmrc.gov.au) Early Career Fellowship, MINECO Ramon y Cajal Grant RYC-2010-06512 and MINECO Grant BFU-2011-26596 (http://www.idi.mineco.gob.es). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aasen T, 2008, NAT BIOTECHNOL, V26, P1276, DOI 10.1038/nbt.1503; Abrous DN, 2005, PHYSIOL REV, V85, P523, DOI 10.1152/physrev.00055.2003; Ahmadi N, 2012, TISSUE CELL, V44, P87, DOI 10.1016/j.tice.2011.11.006; Angel M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011756; Balasubramanian S, 2009, STEM CELLS, V27, P3053, DOI 10.1002/stem.242; Boczkowski D, 2009, CANCER GENE THER, V16, P900, DOI 10.1038/cgt.2009.39; Chen XL, 2012, BRIT J OPHTHALMOL, V96, P1431, DOI 10.1136/bjophthalmol-2012-301546; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Joo KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0025936; Kim JB, 2008, NATURE, V454, P646, DOI 10.1038/nature07061; Liu XW, 2011, J LARYNGOL OTOL, V125, P686, DOI 10.1017/S0022215110002914; Lum M, 2009, J NEUROIMMUNOL, V206, P32, DOI 10.1016/j.jneuroim.2008.10.009; Ma K, 2011, NEUROL RES, V33, P1083, DOI 10.1179/1743132811Y.0000000053; Mandal PK, 2013, NAT PROTOC, V8, P568, DOI 10.1038/nprot.2013.019; McLenachan S, 2009, GROWTH HORM IGF RES, V19, P212, DOI 10.1016/j.ghir.2008.09.003; McLenachan S, 2007, GENOMICS, V89, P708, DOI 10.1016/j.ygeno.2007.02.006; McLenachan S, 2012, STEM CELLS DEV, V21, P2891, DOI 10.1089/scd.2012.0190; Murrell W, 2005, DEV DYNAM, V233, P496, DOI 10.1002/dvdy.20360; Narsinh KH, 2011, NAT PROTOC, V6, P78, DOI 10.1038/nprot.2010.173; Navarro-Quiroga I, 2006, J COMP NEUROL, V497, P833, DOI 10.1002/cne.21037; Rietze RL, 2006, METHOD ENZYMOL, V419, P3, DOI 10.1016/S0076-6879(06)19001-1; Ruau D, 2008, STEM CELLS, V26, P920, DOI 10.1634/stemcells.2007-0649; Schultz SS, 2006, J NEUROSCI METH, V152, P144, DOI 10.1016/j.jneumeth.2005.08.022; Shih CC, 2002, LEUKEMIA LYMPHOMA, V43, P2263, DOI 10.1080/1042819021000040215; Song Y, 2009, BJU INT, V104, P257, DOI 10.1111/j.1464-410X.2009.08352.x; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Warren L, 2012, SCI REP-UK, V2, DOI 10.1038/srep00657; Warren L, 2010, CELL STEM CELL, V7, P618, DOI 10.1016/j.stem.2010.08.012	28	19	20	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e83596	10.1371/journal.pone.0083596	http://dx.doi.org/10.1371/journal.pone.0083596			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281QS	24386231	Green Published, Green Submitted, gold			2022-12-25	WOS:000329116700060
J	Shimizu, F; Shiiba, M; Ogawara, K; Kimura, R; Minakawa, Y; Baba, T; Yokota, S; Nakashima, D; Higo, M; Kasamatsu, A; Sakamoto, Y; Tanzawa, H; Uzawa, K				Shimizu, Fumie; Shiiba, Masashi; Ogawara, Katsunori; Kimura, Ryota; Minakawa, Yasuyuki; Baba, Takao; Yokota, Satoshi; Nakashima, Dai; Higo, Morihiro; Kasamatsu, Atsushi; Sakamoto, Yosuke; Tanzawa, Hideki; Uzawa, Katsuhiro			Overexpression of LIM and SH3 Protein 1 Leading to Accelerated G2/M Phase Transition Contributes to Enhanced Tumourigenesis in Oral Cancer	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; INFLUENCES ZYXIN LOCALIZATION; COLORECTAL-CANCER; TUMOR-SUPPRESSOR; OVARIAN-CANCER; BREAST-CANCER; CYCLE CONTROL; LASP-1; MIGRATION; PROLIFERATION	Background: LIM and SH3 protein 1 (LASP-1) is a specific focal adhesion protein involved in several malignant tumors. However, its role in oral squamous cell carcinoma (OSCC) is unknown. The aim of this study was to characterize the role and molecular status/mechanism of LASP-1 in OSCC. Methods: We evaluated LASP-1 mRNA and protein expressions in OSCC-derived cell lines and primary OSCCs. Using an shRNA system, we analyzed the effect of LASP-1 on the biology and function of the OSCC cell lines, HSC-3 and Ca9-22. The cells also were subcutaneously injected to evaluate tumor growth in vivo. Data were analyzed by the Fisher's exact test or the Mann-Whitney U test. Bonferroni correction was used for multiple testing. Results: Significant up-regulation of LASP-1 was detected in OSCC-derived cell lines (n = 7, P<0.007) and primary OSCCs (n = 50, P<0.001) compared to normal controls. LASP-1 knockdown cells significantly inhibited cellular proliferation compared with shMock-transfected cells (P<0.025) by arresting cell-cycle progression at the G2 phase. We observed dramatic reduction in the growth of shLASP-1 OSCC xenografts compared with shMock xenografts in vivo. Conclusion: Our results suggested that overexpression of LASP-1 is linked closely to oral tumourigenicity and further provide novel evidence that LASP-1 plays an essential role in tumor cellular growth by mediating G2/M transition.	[Shimizu, Fumie; Kimura, Ryota; Minakawa, Yasuyuki; Baba, Takao; Yokota, Satoshi; Nakashima, Dai; Tanzawa, Hideki; Uzawa, Katsuhiro] Chiba Univ, Grad Sch Med, Dept Clin Mol Biol, Chiba, Japan; [Shiiba, Masashi] Chiba Univ, Grad Sch Med, Dept Clin Oncol, Chiba, Japan; [Ogawara, Katsunori; Higo, Morihiro; Kasamatsu, Atsushi; Sakamoto, Yosuke; Tanzawa, Hideki; Uzawa, Katsuhiro] Chiba Univ Hosp, Div Dent & Oral Maxillofacial Surg, Chiba, Japan	Chiba University; Chiba University; Chiba University	Ogawara, K (corresponding author), Chiba Univ Hosp, Div Dent & Oral Maxillofacial Surg, Chiba, Japan.	katsunori.ogawara@faculty.chiba-u.jp; uzawak@faculty.chiba-u.jp		Uzawa, Katsuhiro/0000-0002-7036-0859				Chew CS, 1998, AM J PHYSIOL-CELL PH, V275, pC56, DOI 10.1152/ajpcell.1998.275.1.C56; Chiyomaru T, 2012, UROL ONCOL-SEMIN ORI, V30, P434, DOI 10.1016/j.urolonc.2010.05.008; COLEMAN TR, 1994, CURR OPIN CELL BIOL, V6, P877, DOI 10.1016/0955-0674(94)90060-4; Collins I, 2005, CURR OPIN PHARMACOL, V5, P366, DOI 10.1016/j.coph.2005.04.009; Diaz-Rodriguez E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027583; Endo Y, 2004, INT J CANCER, V110, P225, DOI 10.1002/ijc.20118; Frietsch JJ, 2010, BRIT J CANCER, V102, P1645, DOI 10.1038/sj.bjc.6605685; GAUTIER J, 1991, CELL, V67, P197, DOI 10.1016/0092-8674(91)90583-K; Grunewald TGP, 2007, BRIT J CANCER, V96, P296, DOI 10.1038/sj.bjc.6603545; Grunewald TGP, 2006, EXP CELL RES, V312, P974, DOI 10.1016/j.yexcr.2005.12.016; Hirota T, 2000, J CELL BIOL, V149, P1073, DOI 10.1083/jcb.149.5.1073; Hsu LC, 2006, ONCOGENE, V25, P5517, DOI 10.1038/sj.onc.1209563; Ignatov T, 2013, J OVARIAN RES, V6, DOI 10.1186/1757-2215-6-51; Ruiz EJ, 2010, CURR BIOL, V20, P717, DOI 10.1016/j.cub.2010.02.050; Kasamatsu A, 2005, INT J MOL MED, V16, P269; Kouzu Y, 2006, BRIT J CANCER, V94, P717, DOI 10.1038/sj.bjc.6602991; Kudo V, 1998, CANCER, V83, P2447, DOI 10.1002/(SICI)1097-0142(19981215)83:12<2447::AID-CNCR7>3.0.CO;2-A; Lin YH, 2004, J CELL BIOL, V165, P421, DOI 10.1083/jcb.200311045; Lombardi DP, 1999, CANCER RES, V59, P5724; Nix DA, 2001, J BIOL CHEM, V276, P34759, DOI 10.1074/jbc.M102820200; NURSE P, 1990, NATURE, V344, P503, DOI 10.1038/344503a0; PAGANO M, 1992, EMBO J, V11, P961, DOI 10.1002/j.1460-2075.1992.tb05135.x; PARKER LL, 1992, SCIENCE, V257, P1955, DOI 10.1126/science.1384126; PINES J, 1989, CELL, V58, P833, DOI 10.1016/0092-8674(89)90936-7; Schultz J, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-53; Shames DS, 2006, PLOS MED, V3, P2244, DOI 10.1371/journal.pmed.0030486; Shao Y, 2013, CANCER CELL INT, V13, DOI 10.1186/1475-2867-13-51; Shi Y, 2009, GUT, V58, P1443, DOI 10.1136/gut.2009.181735; Shimada K, 2005, BRIT J CANCER, V92, P1915, DOI 10.1038/sj.bjc.6602594; Shubbar E, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-1; Sun Meiqian, 2010, Front Biosci (Schol Ed), V2, P1127; Taylor WR, 2001, ONCOGENE, V20, P1803, DOI 10.1038/sj.onc.1204252; TOMASETTO C, 1995, FEBS LETT, V373, P245, DOI 10.1016/0014-5793(95)01040-L; Traenka C, 2010, CANCER RES, V70, P8003, DOI 10.1158/0008-5472.CAN-10-0592; Verburg FA, 2010, HORM METAB RES, V42, P736, DOI 10.1055/s-0030-1254132; Wang H, 2013, EUR J CANCER, V49, P974, DOI 10.1016/j.ejca.2012.09.032; Yam CH, 2002, CELL MOL LIFE SCI, V59, P1317, DOI 10.1007/s00018-002-8510-y; Zhao LA, 2010, GUT, V59, P1226, DOI 10.1136/gut.2009.202739	38	33	34	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e83187	10.1371/journal.pone.0083187	http://dx.doi.org/10.1371/journal.pone.0083187			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281QS	24386158	Green Published, gold, Green Submitted			2022-12-25	WOS:000329116700034
J	Zhang, SY; Edwards, H; Yates, P; Guo, QH; Li, CB				Zhang, Shuying; Edwards, Helen; Yates, Patsy; Guo, Qihao; Li, Chunbo			Partial Mediation Role of Self-Efficacy between Positive Social Interaction and Mental Health in Family Caregivers for Dementia Patients in Shanghai	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; PHYSICAL HEALTH; STRESS PROCESS; SYMPTOMS; QUESTIONNAIRE; VALIDATION; SUPPORT; PEOPLE	We explored the mediation effect of caregiver self-efficacy on the influences of behavioral and psychological symptoms (BPSD) of dementia care recipients (CRs) or family caregivers' (CGs) social supports (informational, tangible and affectionate support and positive social interaction) on CGs' mental health. We interviewed 196 CGs, using a battery of measures including demographic data of the dyads, CRs' dementia-related impairments, and CGs' social support, self-efficacy and the Medical Outcome Study (MOS) Short-Form (SF-36) Health Survey. Multiple regression analyses showed that gathering information on self-efficacy and managing CG distress self-efficacy were the partial mediators of the relationship between positive social interaction and CG mental health. Managing caregiving distress self-efficacy also partial mediated the impact of BPSD on CG mental health. We discuss implications of the results for improving mental health of the target population in mainland China.	[Zhang, Shuying] Tongji Univ, Sch Med, Shanghai 200092, Peoples R China; [Guo, Qihao] Fudan Univ, Dept Neurol, Shanghai 200433, Peoples R China; [Guo, Qihao] Fudan Univ, Shanghai Med Coll, State Key Lab Med Neurobiol, Inst Neurol,Huashan Hosp, Shanghai 200433, Peoples R China; [Edwards, Helen; Yates, Patsy] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld 4001, Australia; [Li, Chunbo] Shanghai Jiao Tong Univ, Sch Med, Shanghai Inst Mental Hlth, Dept Biol Psychiat,Shanghai Mental Hlth Ctr, Shanghai 200030, Peoples R China	Tongji University; Fudan University; Fudan University; Queensland University of Technology (QUT); Shanghai Jiao Tong University	Guo, QH (corresponding author), Fudan Univ, Dept Neurol, Shanghai 200433, Peoples R China.	dr.guoqihao@126.com	Edwards, Helen/GPX-3511-2022	Yates, Patsy/0000-0001-8946-8504; Edwards, Helen/0000-0002-4451-0577	National Natural Science Foundation of China [81171019]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The data analysis and preparation of this manuscript were funded by the National Natural Science Foundation of China (ID: 81171019). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alzheimer's Association, 2013, ALZH DIS FACTS FIG; Au A, 2010, CLIN GERONTOLOGIST, V33, P298, DOI 10.1080/07317115.2010.502817; Au A, 2009, AGING MENT HEALTH, V13, P761, DOI 10.1080/13607860902918223; Ballard C, 2008, INT REV PSYCHIATR, V20, P396, DOI 10.1080/09540260802099968; Bandura A, 1997, SELF EFFICACY EXERCI; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Crellin N, 2011, AGING MENT HEALTH, V15, P28; Depp C, 2005, AM J GERIAT PSYCHIAT, V13, P787, DOI 10.1176/appi.ajgp.13.9.787; Finkel S, 1997, INT J GERIATR PSYCH, V12, P1060; Fortinsky RH, 2002, AGING MENT HEALTH, V6, P153, DOI 10.1080/13607860220126763; Fuh J L, 1999, Int Psychogeriatr, V11, P181, DOI 10.1017/S1041610299005736; Fuh JL, 1999, DEMENT GERIATR COGN, V10, P186, DOI 10.1159/000017118; Gallo JL, 2008, DEMENTIA, V7, P397; Gilliam CM, 2006, AGING MENT HEALTH, V10, P79, DOI 10.1080/13607860500310658; Gottlieb BH, 2003, CAN J AGING, V22, P95, DOI 10.1017/S0714980800003767; Kalaria RN, 2008, LANCET NEUROL, V7, P812, DOI 10.1016/S1474-4422(08)70169-8; Lasprilla JCA, 2009, AM J ALZHEIMERS DIS, V24, P384, DOI 10.1177/1533317509341465; Li Lu, 2002, Zhonghua Yufang Yixue Zazhi, V36, P109; Luppa M, 2008, DEMENT GERIATR COGN, V26, P65, DOI 10.1159/000144027; Mok CCM, 2005, DEMENT GERIATR COGN, V20, P112, DOI 10.1159/000086612; Pinquart M, 2003, J GERONTOL B-PSYCHOL, V58, pP112, DOI 10.1093/geronb/58.2.P112; Pinquart M, 2003, PSYCHOL AGING, V18, P250, DOI 10.1037/0882-7974.18.2.250; Prince M, 2004, INT J GERIATR PSYCH, V19, P170, DOI 10.1002/gps.1046; Rabinowitz YG, 2007, J AGING HEALTH, V19, P946, DOI 10.1177/0898264307308559; Rabinowitz YG, 2006, AM J GERIAT PSYCHIAT, V14, P642, DOI 10.1097/01.JGP.0000192496.73673.e5; Roth DL, 2003, PSYCHOL AGING, V18, P906, DOI 10.1037/0882-7974.18.4.906; Shaji K S, 2009, Indian J Psychiatry, V51, P45, DOI 10.4103/0019-5545.44905; Shyu YIL, 2006, NURS RES, V55, P411, DOI 10.1097/00006199-200611000-00005; Sobel M.E, 1986, SOCIOL METHODOL, V16, P159, DOI DOI 10.2307/270922; Son J, 2007, J AGING HEALTH, V19, P871, DOI 10.1177/0898264307308568; Spitznagel MB, 2006, J GERIATR PSYCH NEUR, V19, P16, DOI 10.1177/0891988705284713; Steffen A. M., 2002, J GERONTOL B-PSYCHOL, V57, P74, DOI [DOI 10.1093/GERONB/57.1.P74, DOI 10.1093/GER0NB/57.1.P74]; Zeiss A., 1999, J CLIN GEROPSYCHOL, V5, P221, DOI [DOI 10.1023/A:1022955817074, 10.1023/A:1022955817074]; Zhang SY, 2013, AGING MENT HEALTH, V17, P630, DOI 10.1080/13607863.2013.771615; Zhang SY, 2012, INT J MENT HEALTH NU, V21, P358, DOI 10.1111/j.1447-0349.2011.00791.x	35	8	8	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e83326	10.1371/journal.pone.0083326	http://dx.doi.org/10.1371/journal.pone.0083326			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	281QS	24386178	Green Published, Green Submitted, gold			2022-12-25	WOS:000329116700041
J	Dafna, E; Tarasiuk, A; Zigel, Y				Dafna, Eliran; Tarasiuk, Ariel; Zigel, Yaniv			Automatic Detection of Whole Night Snoring Events Using Non-Contact Microphone	PLOS ONE			English	Article							SLEEP-APNEA SYNDROME; LOW SOCIOECONOMIC-STATUS; CARDIOVASCULAR-DISEASE; DAYTIME SLEEPINESS; ACOUSTIC ANALYSIS; RISK-FACTOR; HEART-RATE; SOUND; CLASSIFICATION; PREVALENCE	Objective: Although awareness of sleep disorders is increasing, limited information is available on whole night detection of snoring. Our study aimed to develop and validate a robust, high performance, and sensitive whole-night snore detector based on non-contact technology. Design: Sounds during polysomnography (PSG) were recorded using a directional condenser microphone placed 1 m above the bed. An AdaBoost classifier was trained and validated on manually labeled snoring and non-snoring acoustic events. Patients: Sixty-seven subjects (age 52.5 +/- 13.5 years, BMI 30.8 +/- 4.7 kg/m(2), m/f 40/27) referred for PSG for obstructive sleep apnea diagnoses were prospectively and consecutively recruited. Twenty-five subjects were used for the design study; the validation study was blindly performed on the remaining forty-two subjects. Measurements and Results: To train the proposed sound detector, >76,600 acoustic episodes collected in the design study were manually classified by three scorers into snore and non-snore episodes (e. g., bedding noise, coughing, environmental). A feature selection process was applied to select the most discriminative features extracted from time and spectral domains. The average snore/non-snore detection rate (accuracy) for the design group was 98.4% based on a ten-fold cross-validation technique. When tested on the validation group, the average detection rate was 98.2% with sensitivity of 98.0% (snore as a snore) and specificity of 98.3% (noise as noise). Conclusions: Audio-based features extracted from time and spectral domains can accurately discriminate between snore and non-snore acoustic events. This audio analysis approach enables detection and analysis of snoring sounds from a full night in order to produce quantified measures for objective follow-up of patients.	[Dafna, Eliran; Zigel, Yaniv] Ben Gurion Univ Negev, Dept Biomed Engn, IL-84105 Beer Sheva, Israel; [Tarasiuk, Ariel] Ben Gurion Univ Negev, Sleep Wake Disorders Unit, Soroka Univ Med Ctr, IL-84105 Beer Sheva, Israel; [Tarasiuk, Ariel] Ben Gurion Univ Negev, Fac Hlth Sci, Dept Physiol, Beer Sheva, Israel	Ben Gurion University; Ben Gurion University; Soroka Medical Center; Ben Gurion University	Zigel, Y (corresponding author), Ben Gurion Univ Negev, Dept Biomed Engn, IL-84105 Beer Sheva, Israel.	yaniv@bgu.ac.il		Zigel, Yaniv/0000-0002-1994-4242	Israel Ministry of Industry, Trade and Labor - the Kamin Program [46168]	Israel Ministry of Industry, Trade and Labor - the Kamin Program	This work was supported by the Israel Ministry of Industry, Trade and Labor - the Kamin Program, award no. 46168 to YZ and AT. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alshaer H, 2013, J CLIN MONIT COMPUT; Fiz JA, 2010, LARYNGOSCOPE, V120, P854, DOI 10.1002/lary.20815; Azarbarzin A., 2012, MED ENG PHYS; Azarbarzin A, 2011, IEEE T BIO-MED ENG, V58, P1156, DOI 10.1109/TBME.2010.2061846; Ben-Israel N, 2012, SLEEP, V35, P1299, DOI 10.5665/sleep.2092; BLIWISE DL, 1991, CHEST, V99, P600, DOI 10.1378/chest.99.3.600; Cavusoglu M, 2007, PHYSIOL MEAS, V28, P841, DOI 10.1088/0967-3334/28/8/007; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Counter P, 2004, SLEEP MED REV, V8, P433, DOI 10.1016/j.smrv.2004.03.007; Dafna E., 2011, P 7 INT WORKSH MOD A, P17; Deller J. R., 2000, DISCRETE TIME PROCES; Duckitt WD, 2006, PHYSIOL MEAS, V27, P1047, DOI 10.1088/0967-3334/27/10/010; Fiz JA, 1996, EUR RESPIR J, V9, P2365, DOI 10.1183/09031936.96.09112365; Freund Y, 1997, J COMPUT SYST SCI, V55, P119, DOI 10.1006/jcss.1997.1504; Greenberg-Dotan S, 2007, SLEEP, V30, P1173, DOI 10.1093/sleep/30.9.1173; GUILLEMINAULT C, 1991, CHEST, V99, P40, DOI 10.1378/chest.99.1.40; Hasan MK, 2004, IEEE SIGNAL PROC LET, V11, P450, DOI 10.1109/LSP.2004.824017; Hoffstein V, 1996, CHEST, V109, P201, DOI 10.1378/chest.109.1.201; HOFFSTEIN V, 1994, SLEEP, V17, P522, DOI 10.1093/sleep/17.6.522; HOFFSTEIN V, 1993, SLEEP, V16, P118; Iber C., 2007, AASM MANUAL SCORING, P1, DOI DOI 10.1016/J.SLEEP.2004.06.007; ISSA FG, 1993, AM REV RESPIR DIS, V148, P1023, DOI 10.1164/ajrccm/148.4_Pt_1.1023; Jain AK, 2000, IEEE T PATTERN ANAL, V22, P4, DOI 10.1109/34.824819; Jane R, 2011, IEEE ENG MED BIO, P8331, DOI 10.1109/IEMBS.2011.6092054; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Jones TM, 2005, EUR RESPIR J, V25, P1044, DOI 10.1183/09031936.05.00101703; Karunajeewa AS, 2008, PHYSIOL MEAS, V29, P227, DOI 10.1088/0967-3334/29/2/006; KUMP K, 1994, AM J RESP CRIT CARE, V150, P735, DOI 10.1164/ajrccm.150.3.8087345; Lee HK, 2013, PHYSIOL MEAS, V34, pN41, DOI 10.1088/0967-3334/34/5/N41; Lee LA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053481; LEIBERMAN A, 1986, INT J PEDIATR OTORHI, V12, P173, DOI 10.1016/S0165-5876(86)80074-X; Marin JM, 1997, INT J EPIDEMIOL, V26, P381, DOI 10.1093/ije/26.2.381; PEREZPADILLA JR, 1987, SLEEP, V10, P249, DOI 10.1093/sleep/10.3.249; PEREZPADILLA JR, 1993, AM REV RESPIR DIS, V147, P635, DOI 10.1164/ajrccm/147.3.635; Pevernagie D, 2010, SLEEP MED REV, V14, P131, DOI 10.1016/j.smrv.2009.06.002; Rabiner L. R., 1978, DIGITAL PROCESSING S; RAUSCHER H, 1991, EUR RESPIR J, V4, P655; Reuveni H, 2004, SLEEP, V27, P1518, DOI 10.1093/sleep/27.8.1518; Rotem AY, 2003, SLEEP, V26, P747, DOI 10.1093/sleep/26.6.747; Sands M, 2013, AM J CARDIOL, V111, P540, DOI 10.1016/j.amjcard.2012.10.039; Scalart P, 1996, INT CONF ACOUST SPEE, P629, DOI 10.1109/ICASSP.1996.543199; SERIES F, 1993, CHEST, V103, P1769, DOI 10.1378/chest.103.6.1769; Simon-Tuval T, 2009, SLEEP, V32, P545, DOI 10.1093/sleep/32.4.545; SKATVEDT O, 1993, ACTA OTO-LARYNGOL, V113, P206, DOI 10.3109/00016489309135794; STOOHS R, 1991, RESP PHYSIOL, V85, P151, DOI 10.1016/0034-5687(91)90058-Q; Stoohs RA, 1998, EUR RESPIR J, V11, P451, DOI 10.1183/09031936.98.11020451; Tarasiuk A, 2006, CHEST, V130, P766, DOI 10.1378/chest.130.3.766; Tarasiuk A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033178; WIGGINS CL, 1990, SLEEP, V13, P245, DOI 10.1093/sleep/13.3.245; Wilson K, 1999, CHEST, V115, P762, DOI 10.1378/chest.115.3.762; WILSON K, 1985, LARYNGOSCOPE, V95, P1174; Yadollahi A, 2010, MED ENG PHYS, V32, P985, DOI 10.1016/j.medengphy.2010.06.013	52	73	78	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84139	10.1371/journal.pone.0084139	http://dx.doi.org/10.1371/journal.pone.0084139			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391903	Green Submitted, Green Published, gold			2022-12-25	WOS:000329323900046
J	Irwin, CR; Favis, NA; Agopsowicz, KC; Hitt, MM; Evans, DH				Irwin, Chad R.; Favis, Nicole A.; Agopsowicz, Kate C.; Hitt, Mary M.; Evans, David H.			Myxoma Virus Oncolytic Efficiency Can Be Enhanced Through Chemical or Genetic Disruption of the Actin Cytoskeleton	PLOS ONE			English	Article							ENVELOPED VACCINIA VIRUS; F11L-MEDIATED INHIBITION; FIBROMA VIRUSES; RABBIT MYXOMA; CELL MOTILITY; LIM KINASES; RHOA; INFECTION; SPREAD; PROTEIN	Myxoma virus (MYXV) is one of many animal viruses that exhibit oncolytic properties in transformed human cells. Compared to orthopoxviruses like vaccinia (VACV), MYXV spreads inefficiently, which could compromise its use in treating tumors and their associated metastases. The VACV F11 protein promotes virus exit and rapid spread by inhibiting Rho signalling, which results in a disruption of cortical actin. We have previously shown that although MYXV lacks an F11 homolog, the F11L gene can be introduced into MYXV promoting the spread of this Leporipoxvirus in natural host cells. Here we show that the F11-encoding (F11L(+)) MYXV strain replicates to higher levels in a number of human cancer cells. We also show that F11L(+) MYXV induces better tumor control and prolonged survival of mice bearing MDA-MB-231 cancer cells. Furthermore, we show that this virus also spreads more efficiently from the site of growth in one injected tumor, to a second untreated tumor. While we focused mostly on the use of a modified MYXV we were able to show that the effects of F11 on MYXV growth in cancer cells could be mimicked through the use of pharmacological inhibition or siRNA-mediated silencing of key regulators of cortical actin (RhoA, RhoC, mDia1, or LIMK2). These data suggest that it may be possible to increase the oncolytic efficacy of wild-type MYXV using chemical inhibitors of RhoA/C or their downstream targets. Furthermore, since all viruses must overcome barriers to exit posed by structures like cortical actin, these findings suggest that the oncolytic activity of other viruses may be enhanced through similar strategies.	[Irwin, Chad R.; Favis, Nicole A.; Evans, David H.] Univ Alberta, Dept Med Microbiol & Immunol, Edmonton, AB, Canada; [Agopsowicz, Kate C.; Hitt, Mary M.] Univ Alberta, Dept Oncol, Edmonton, AB, Canada; [Hitt, Mary M.; Evans, David H.] Univ Alberta, Li Ka Shing Inst Virol, Edmonton, AB, Canada	University of Alberta; University of Alberta; University of Alberta	Evans, DH (corresponding author), Univ Alberta, Dept Med Microbiol & Immunol, Edmonton, AB, Canada.	devans@ualberta.ca	Evans, David H/M-1912-2016	Evans, David H/0000-0001-5871-299X	Alberta Cancer Board Legacy program; Alberta Cancer Foundation; Canadian Institutes of Health Research; Li Ka Shing Institute for Virology; Canada Foundation for Innovation; Alberta Cancer Research Institute; Queen Elisabeth II Doctoral Award	Alberta Cancer Board Legacy program; Alberta Cancer Foundation; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Li Ka Shing Institute for Virology; Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Alberta Cancer Research Institute; Queen Elisabeth II Doctoral Award	This work was funded by operating grants from the Alberta Cancer Board Legacy program, Alberta Cancer Foundation, Canadian Institutes of Health Research, and the Li Ka Shing Institute for Virology. The authors also thank the Canada Foundation for Innovation and its partners for infrastructure support. CRI has been supported by a graduate studentship from the Alberta Cancer Research Institute, a Walter Johns 75th Anniversary Award, and a Queen Elisabeth II Doctoral Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREWES CH, 1957, VIROLOGY, V4, P346, DOI 10.1016/0042-6822(57)90068-5; Arakawa Y, 2007, CELL HOST MICROBE, V1, P227, DOI 10.1016/j.chom.2007.04.006; Arakawa Y, 2007, CELL HOST MICROBE, V1, P213, DOI 10.1016/j.chom.2007.04.007; Barry M, 1997, VIROLOGY, V239, P360, DOI 10.1006/viro.1997.8894; Bennett CJ, 2003, VIROLOGY, V315, P10, DOI 10.1016/S0042-6822(03)00512-9; BLASCO R, 1993, J VIROL, V67, P3319, DOI 10.1128/JVI.67.6.3319-3325.1993; CHAPRONIERE DM, 1957, VIROLOGY, V4, P351, DOI 10.1016/0042-6822(57)90069-7; Cordeiro JV, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008506; Doceul V, 2010, SCIENCE, V327, P873, DOI 10.1126/science.1183173; Duteyrat JL, 2006, ARCH VIROL, V151, P2161, DOI 10.1007/s00705-006-0791-2; Gauvin TJ, 2009, BIOCHEMISTRY-US, V48, P9327, DOI 10.1021/bi901354z; Gouin E, 2005, CURR OPIN MICROBIOL, V8, P35, DOI 10.1016/j.mib.2004.12.013; Handa Y, 2013, CELL HOST MICROBE, V14, P51, DOI 10.1016/j.chom.2013.06.006; Harrison BA, 2009, J MED CHEM, V52, P6515, DOI 10.1021/jm901226j; Horsington J, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003239; Ichihashi Y, 1996, VIROLOGY, V217, P478, DOI 10.1006/viro.1996.0142; Irwin CR, 2012, J VIROL, V86, P7167, DOI 10.1128/JVI.06936-11; Johnston JB, 2005, VIROLOGY, V332, P235, DOI 10.1016/j.virol.2004.11.030; Karlsson R, 2009, BBA-REV CANCER, V1796, P91, DOI 10.1016/j.bbcan.2009.03.003; Kato SEM, 2004, J VIROL METHODS, V115, P31, DOI 10.1016/j.jviromet.2003.09.011; Kirn DH, 2008, CANCER RES, V68, P2071, DOI 10.1158/0008-5472.CAN-07-6515; Lun XQ, 2005, CANCER RES, V65, P9982, DOI 10.1158/0008-5472.CAN-05-1201; Mardilovich K, 2012, FUTURE ONCOL, V8, P165, DOI [10.2217/fon.11.143, 10.2217/FON.11.143]; McFadden G, 2005, NAT REV MICROBIOL, V3, P201, DOI 10.1038/nrmicro1099; McHenry PR, 2010, CURR DRUG TARGETS, V11, P1043, DOI 10.2174/138945010792006852; Morales I, 2008, TRAFFIC, V9, P1283, DOI 10.1111/j.1600-0854.2008.00762.x; OPGENORTH A, 1992, J VIROL, V66, P4720, DOI 10.1128/JVI.66.8.4720-4731.1992; PAYNE LG, 1982, ARCH VIROL, V74, P11, DOI 10.1007/BF01320778; Ridley AJ, 2013, J MICROSC; Riento K, 2003, NAT REV MOL CELL BIO, V4, P446, DOI 10.1038/nrm1128; Roberts KL, 2008, TRENDS MICROBIOL; Scott RW, 2007, J MOL MED, V85, P555, DOI 10.1007/s00109-007-0165-6; Scott RW, 2010, J CELL BIOL, V191, P169, DOI 10.1083/jcb.201002041; Shang X, 2012, CHEM BIOL, V19, P699, DOI 10.1016/j.chembiol.2012.05.009; Shmulevitz M, 2012, J VIROL, V86, P7403, DOI 10.1128/JVI.00304-12; Smallwood Sherin E, 2010, Curr Protoc Microbiol, VChapter 14, DOI 10.1002/9780471729259.mc14a01s17; Smith GL, 1998, ADV EXP MED BIOL, V440, P395; Smith GL, 2003, ANNU REV MICROBIOL, V57, P323, DOI 10.1146/annurev.micro.57.030502.091037; Smith GL, 2002, J GEN VIROL, V83, P2915, DOI 10.1099/0022-1317-83-12-2915; Sypula J., 2004, GENE THER MOL BIOL, V8, P103; Taylor MP, 2011, NAT REV MICROBIOL, V9, P427, DOI 10.1038/nrmicro2574; Teferi WM, 2013, J VIROL; Thirunavukarasu P, 2013, MOL THER, V21, P1024, DOI 10.1038/mt.2013.27; Valderrama F, 2006, SCIENCE, V311, P377, DOI 10.1126/science.1122411; Vanderplasschen A, 1998, P NATL ACAD SCI USA, V95, P7544, DOI 10.1073/pnas.95.13.7544; Vega FM, 2011, J CELL BIOL, V193, P655, DOI 10.1083/jcb.201011038; Wang F, 2004, NAT IMMUNOL, V5, P1266, DOI 10.1038/ni1132; Wang FA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000099; Wang F, 2009, VIROLOGY, V387, P136, DOI 10.1016/j.virol.2009.02.013; Wang G, 2006, P NATL ACAD SCI USA, V103, P4640, DOI 10.1073/pnas.0509341103; Wheeler AP, 2004, EXP CELL RES, V301, P43, DOI 10.1016/j.yexcr.2004.08.012; Zwilling J, 2010, VIROLOGY, V404, P231, DOI 10.1016/j.virol.2010.05.008	52	13	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84134	10.1371/journal.pone.0084134	http://dx.doi.org/10.1371/journal.pone.0084134			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391902	Green Published, Green Submitted, gold			2022-12-25	WOS:000329323900045
J	Methner, C; Buonincontri, G; Hu, CH; Vujic, A; Kretschmer, A; Sawiak, S; Carpenter, A; Stasch, JP; Krieg, T				Methner, Carmen; Buonincontri, Guido; Hu, Chou-Hui; Vujic, Ana; Kretschmer, Axel; Sawiak, Stephen; Carpenter, Adrian; Stasch, Johannes-Peter; Krieg, Thomas			Riociguat Reduces Infarct Size and Post-Infarct Heart Failure in Mouse Hearts: Insights from MRI/PET Imaging	PLOS ONE			English	Article							SOLUBLE GUANYLATE-CYCLASE; TARGETED S-NITROSOTHIOL; NITRIC-OXIDE; PULMONARY-HYPERTENSION; MYOCARDIAL-INFARCTION; RAT HEARTS; REPERFUSION; MICE; VARDENAFIL; ISCHEMIA	Aim: Stimulation of the nitric oxide (NO) - soluble guanylate (sGC) - protein kinase G (PKG) pathway confers protection against acute ischaemia/reperfusion injury, but more chronic effects in reducing post-myocardial infarction (MI) heart failure are less defined. The aim of this study was to not only determine whether the sGC stimulator riociguat reduces infarct size but also whether it protects against the development of post-MI heart failure. Methods and Results: Mice were subjected to 30 min ischaemia via ligation of the left main coronary artery to induce MI and either placebo or riociguat (1.2 mu mol/l) were given as a bolus 5 min before and 5 min after onset of reperfusion. After 24 hours, both, late gadolinium-enhanced magnetic resonance imaging (LGE-MRI) and F-18-FDG-positron emission tomography (PET) were performed to determine infarct size. In the riociguat-treated mice, the resulting infarct size was smaller (8.5 +/- 2.5% of total LV mass vs. 21.8%+/- 1.7%. in controls, p = 0.005) and LV systolic function analysed by MRI was better preserved (60.1%+/- 3.4% of preischaemic vs. 44.2% +/- 3.1% in controls, p = 0.005). After 28 days, LV systolic function by echocardiography treated group was still better preserved (63.5% +/- 3.2% vs. 48.2% +/- 2.2% in control, p = 0.004). Conclusion: Taken together, mice treated acutely at the onset of reperfusion with the sGC stimulator riociguat have smaller infarct size and better long-term preservation of LV systolic function. These findings suggest that sGC stimulation during reperfusion therapy may be a powerful therapeutic treatment strategy for preventing post-MI heart failure.	[Methner, Carmen; Hu, Chou-Hui; Vujic, Ana; Krieg, Thomas] Univ Cambridge, Dept Med, Cambridge CB2 2QQ, England; [Buonincontri, Guido; Kretschmer, Axel; Sawiak, Stephen; Carpenter, Adrian] Univ Cambridge, Wolfson Brain Imaging Ctr, Cambridge, England; [Stasch, Johannes-Peter] Bayer HealthCare, Wuppertal, Germany	University of Cambridge; University of Cambridge; Bayer AG; Bayer Healthcare Pharmaceuticals	Krieg, T (corresponding author), Univ Cambridge, Dept Med, Cambridge CB2 2QQ, England.	tk382@medschl.cam.ac.uk	Vujic, Ana/AAQ-8417-2020; Sawiak, Stephen J/I-8944-2012; Vujic, Ana/GYJ-6199-2022; Buonincontri, Guido/L-5207-2017	Vujic, Ana/0000-0002-0559-5299; Sawiak, Stephen J/0000-0003-4210-9816; Buonincontri, Guido/0000-0002-8386-639X; Krieg, Thomas/0000-0002-5192-580X	Bayer HealthCare	Bayer HealthCare(Bayer AGBayer Healthcare Pharmaceuticals)	This study supported by funding from Bayer HealthCare. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buonincontri G, 2013, J MAGN RESON IMAGING, V38, P468, DOI 10.1002/jmri.24001; Burley DS, 2007, BASIC RES CARDIOL, V102, P529, DOI 10.1007/s00395-007-0672-1; Epstein FH, 2004, MAGN RESON MED, V52, P774, DOI 10.1002/mrm.20232; Ertl G, 2005, CARDIOVASC RES, V66, P22, DOI 10.1016/j.cardiores.2005.01.011; Flynn TJ, 1997, J OPT SOC AM A, V14, P2692, DOI 10.1364/JOSAA.14.002692; Geschka S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021853; Ghofrani HA, 2013, NEW ENGL J MED, V369, P330, DOI 10.1056/NEJMoa1209655; Ghofrani HA, 2013, NEW ENGL J MED, V369, P319, DOI 10.1056/NEJMoa1209657; Gilson WD, 2005, AM J PHYSIOL-HEART C, V288, pH1491, DOI 10.1152/ajpheart.00632.2004; Hawkes RC, 2010, TECHNOL CANCER RES T, V9, P53, DOI 10.1177/153303461000900106; Heiberg Einar, 2010, BMC Med Imaging, V10, P1, DOI 10.1186/1471-2342-10-1; Hung CL, 2010, J AM COLL CARDIOL, V56, P1812, DOI 10.1016/j.jacc.2010.06.044; Krieg T, 2009, EUR HEART J, V30, P1607, DOI 10.1093/eurheartj/ehp143; Maas O, 2008, BRIT J PHARMACOL, V154, P25, DOI 10.1038/bjp.2008.71; MAROKO PR, 1971, CIRCULATION, V43, P67, DOI 10.1161/01.CIR.43.1.67; MAROKO PR, 1976, CIRCULATION, V53, P162; Methner C, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-013-0337-1; Ott IM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042623; Prime TA, 2009, P NATL ACAD SCI USA, V106, P10764, DOI 10.1073/pnas.0903250106; Salloum FN, 2007, J MOL CELL CARDIOL, V42, P453, DOI 10.1016/j.yjmcc.2006.10.015; Sawiak SJ, 2009, NEUROBIOL DIS, V33, P20, DOI 10.1016/j.nbd.2008.09.016; Schmidt K, 2010, EUR HEART J, V31, P1655, DOI 10.1093/eurheartj/ehp555; Sharkovska Y, 2010, J HYPERTENS, V28, P1666, DOI 10.1097/HJH.0b013e32833b558c; Stasch JP, 2011, CIRCULATION, V123, P2263, DOI 10.1161/CIRCULATIONAHA.110.981738; Stegger L, 2006, J NUCL MED, V47, P1837; Sun JH, 2013, FREE RADICAL BIO MED, V54, P105, DOI 10.1016/j.freeradbiomed.2012.09.005; Sun JH, 2010, CIRC RES, V106, P285, DOI 10.1161/CIRCRESAHA.109.209452; Tse MT, 2012, NAT REV DRUG DISCOV, V11, P896, DOI 10.1038/nrd3906	28	30	33	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83910	10.1371/journal.pone.0083910	http://dx.doi.org/10.1371/journal.pone.0083910			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391843	Green Published, Green Submitted, gold			2022-12-25	WOS:000329325200141
J	Yang, M; Zhang, W; Dong, HX; Zhang, YY; Lv, K; Wang, DJ; Lian, XM				Yang, Meng; Zhang, Wan; Dong, Huaxia; Zhang, Yuanyuan; Lv, Kai; Wang, Dujun; Lian, Xingming			OsNRAMP3 Is a Vascular Bundles-Specific Manganese Transporter That Is Responsible for Manganese Distribution in Rice	PLOS ONE			English	Article							METAL-NICOTIANAMINE TRANSPORTER; CATION TRANSPORTERS; CA2+/MN2+ PUMP; ZIP FAMILY; T-DNA; ARABIDOPSIS; IRON; TOLERANCE; CADMIUM; PHLOEM	Manganese (Mn) is an essential trace element for plants. Recently, the genes responsible for uptake of Mn in plants were identified in Arabidopsis and rice. However, the mechanism of Mn distribution in plants has not been clarified. In the present study we identified a natural resistance-associated macrophage protein (NRAMP) family gene in rice, OsNRAMP3, involved in Mn distribution. OsNRAMP3 encodes a plasma membrane-localized protein and was specifically expressed in vascular bundles, especially in phloem cells. Yeast complementation assay showed that OsNRAMP3 is a functional Mn-influx transporter. When OsNRAMP3 was absent, rice plants showed high sensitivity to Mn deficiency. Serious necrosis appeared on young leaves and root tips of the OsNRAMP3 knockout line cultivated under low Mn conditions, and high Mn supplies could rescue this phenotype. However, the necrotic young leaves of the knockout line possessed similar levels of Mn to the wild type, suggesting that the necrotic appearance was caused by disturbed distribution of Mn but not a general Mn shortage. Additionally, compared with wild type, leaf Mn content in osnramp3 plants was mostly in older leaves. We conclude that OsNRAMP3 is a vascular bundle-localized Mn-influx transporter involved in Mn distribution and contributes to remobilization of Mn from old to young leaves.	[Yang, Meng; Zhang, Wan; Dong, Huaxia; Zhang, Yuanyuan; Lv, Kai; Wang, Dujun; Lian, Xingming] Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan, Peoples R China; [Yang, Meng; Zhang, Wan; Dong, Huaxia; Zhang, Yuanyuan; Lv, Kai; Wang, Dujun; Lian, Xingming] Huazhong Agr Univ, Natl Ctr Plant Gene Res Wuhan, Wuhan, Peoples R China	Huazhong Agricultural University; Huazhong Agricultural University	Lian, XM (corresponding author), Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan, Peoples R China.	xmlian@mail.hzau.edu.cn	zhang, yuanyuan/GYA-4428-2022	Lian, Xingming/0000-0002-5307-2839; Yang, Meng/0000-0001-8882-1417	National High Technology Research and Development Program of China [2012AA10A303, 2012AA10A304]; National Basic Research Program of China [2011CB100304]; National Natural Science Foundation of China [31172017]; transgenic project [2013ZX08001005]	National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); transgenic project	This work was supported by grants from the National High Technology Research and Development Program of China (2012AA10A303 and 2012AA10A304), the National Basic Research Program of China (2011CB100304), the National Natural Science Foundation of China (31172017) and transgenic project 2013ZX08001005. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bereczky Z, 2003, J BIOL CHEM, V278, P24697, DOI 10.1074/jbc.M301365200; Cailliatte R, 2010, PLANT CELL, V22, P904, DOI 10.1105/tpc.109.073023; Delhaize E, 2003, PLANT CELL, V15, P1131, DOI 10.1105/tpc.009134; Delhaize E, 2007, PLANT J, V51, P198, DOI 10.1111/j.1365-313X.2007.03138.x; Eckhardt U, 2001, PLANT MOL BIOL, V45, P437, DOI 10.1023/A:1010620012803; Edmond C, 2009, BIOCHEM J, V418, P145, DOI 10.1042/BJ20081814; Hebbern CA, 2005, PLANT SOIL, V272, P233, DOI 10.1007/s11104-004-5048-9; HIEI Y, 1994, PLANT J, V6, P271, DOI 10.1046/j.1365-313X.1994.6020271.x; Hirschi KD, 2000, PLANT PHYSIOL, V124, P125, DOI 10.1104/pp.124.1.125; Hirschi KD, 1996, P NATL ACAD SCI USA, V93, P8782, DOI 10.1073/pnas.93.16.8782; Ishimaru Y, 2012, SCI REP-UK, V2, DOI 10.1038/srep00286; Ishimaru Y, 2010, PLANT J, V62, P379, DOI 10.1111/j.1365-313X.2010.04158.x; JEFFERSON RA, 1987, EMBO J, V6, P3901; Jeon JS, 2000, PLANT J, V22, P561, DOI 10.1046/j.1365-313x.2000.00767.x; Kamiya T, 2005, PLANT CELL PHYSIOL, V46, P1735, DOI 10.1093/pcp/pci173; Koike S, 2004, PLANT J, V39, P415, DOI 10.1111/j.1365-313X.2004.02146.x; Korshunova YO, 1999, PLANT MOL BIOL, V40, P37, DOI 10.1023/A:1026438615520; Lanquar V, 2010, PLANT PHYSIOL, V152, P1986, DOI 10.1104/pp.109.150946; Li XY, 2008, PLANT PHYSIOL, V147, P1675, DOI 10.1104/pp.108.119909; Lopez-Millan AF, 2004, PLANT MOL BIOL, V54, P583, DOI 10.1023/B:PLAN.0000038271.96019.aa; Lu LL, 2013, NEW PHYTOL, V198, P721, DOI 10.1111/nph.12168; Marschner P, 2012, MARSCHNER'S MINERAL NUTRITION OF HIGHER PLANTS, 3RD EDITION, P1; Mills RF, 2008, PLANT PHYSIOL, V146, P116, DOI 10.1104/pp.107.110817; Milner MJ, 2013, J EXP BOT, V64, P369, DOI 10.1093/jxb/ers315; Nishiyama R, 2012, PLANT CELL PHYSIOL, V53, P381, DOI 10.1093/pcp/pcr188; Oomen RJFJ, 2009, NEW PHYTOL, V181, P637, DOI 10.1111/j.1469-8137.2008.02694.x; Pedas P, 2008, PLANT PHYSIOL, V148, P455, DOI 10.1104/pp.108.118851; Peiter E, 2007, P NATL ACAD SCI USA, V104, P8532, DOI 10.1073/pnas.0609507104; Pittman JK, 2005, NEW PHYTOL, V167, P733, DOI 10.1111/j.1469-8137.2005.01453.x; Sasaki A, 2012, PLANT CELL, V24, P2155, DOI 10.1105/tpc.112.096925; Sasaki A, 2011, PLANT PHYSIOL, V157, P1832, DOI 10.1104/pp.111.186031; Schaaf G, 2002, PLANT BIOLOGY, V4, P612, DOI 10.1055/s-2002-35432; Supek F, 1996, P NATL ACAD SCI USA, V93, P5105, DOI 10.1073/pnas.93.10.5105; Thomine S, 2003, PLANT J, V34, P685, DOI 10.1046/j.1365-313X.2003.01760.x; Thomine S, 2000, P NATL ACAD SCI USA, V97, P4991, DOI 10.1073/pnas.97.9.4991; Tsukamoto T, 2006, SOIL SCI PLANT NUTR, V52, P717, DOI 10.1111/j.1747-0765.2006.00096.x; Wu ZY, 2002, PLANT PHYSIOL, V130, P128, DOI 10.1104/pp.004440; Yamaguchi N, 2012, J EXP BOT, V63, P2729, DOI 10.1093/jxb/err455; Yamaji N, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3442; Ye RJ, 2012, PLANT CELL REP, V31, P1159, DOI 10.1007/s00299-012-1238-8; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199; Yoshida S., 1976, LAB MANUAL PHYSL STU; Zheng LQ, 2012, PLANT CELL, V24, P3767, DOI 10.1105/tpc.112.103820	43	33	36	2	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83990	10.1371/journal.pone.0083990	http://dx.doi.org/10.1371/journal.pone.0083990			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391861	Green Submitted, gold, Green Published			2022-12-25	WOS:000329323900004
J	Banerjee, A; Rathee, V; Krishnaswamy, R; Bhattacharjee, P; Ray, P; Sood, AK; Sengupta, K				Banerjee, Avinanda; Rathee, Vikram; Krishnaswamy, Rema; Bhattacharjee, Pritha; Ray, Pulak; Sood, Ajay K.; Sengupta, Kaushik			Viscoelastic Behavior of Human Lamin A Proteins in the Context of Dilated Cardiomyopathy	PLOS ONE			English	Article							ATOMIC-FORCE MICROSCOPY; EMBRYONIC STEM-CELLS; F-ACTIN SOLUTIONS; B-TYPE LAMINS; NUCLEAR-ENVELOPE; MECHANICAL-PROPERTIES; FILAMENT NETWORKS; CARDIAC MYOCYTES; IN-VITRO; A-TYPE	Lamins are intermediate filament proteins of type V constituting a nuclear lamina or filamentous meshwork which lines the nucleoplasmic side of the inner nuclear membrane. This protein mesh provides a supporting scaffold for the nuclear envelope and tethers interphase chromosome to the nuclear periphery. Mutations of mainly A-type lamins are found to be causative for at least 11 human diseases collectively termed as laminopathies majority of which are characterised by aberrant nuclei with altered structural rigidity, deformability and poor mechanotransduction behaviour. But the investigation of viscoelastic behavior of lamin A continues to elude the field. In order to address this problem, we hereby present the very first report on viscoelastic properties of wild type human lamin A and some of its mutants linked with Dilated cardiomyopathy (DCM) using quantitative rheological measurements. We observed a dramatic strain-softening effect on lamin A network as an outcome of the strain amplitude sweep measurements which could arise from the large compliance of the quasi-cross-links in the network or that of the lamin A rods. In addition, the drastic stiffening of the differential elastic moduli on superposition of rotational and oscillatory shear stress reflect the increase in the stiffness of the laterally associated lamin A rods. These findings present a preliminary insight into distinct biomechanical properties of wild type lamin A protein and its mutants which in turn revealed interesting differences.	[Banerjee, Avinanda; Bhattacharjee, Pritha; Ray, Pulak; Sengupta, Kaushik] Saha Inst Nucl Phys, Biophys & Struct Genom Div, Kolkata, W Bengal, India; [Rathee, Vikram; Sood, Ajay K.] Indian Inst Sci, Dept Phys, Bangalore 560012, Karnataka, India; [Krishnaswamy, Rema] Jawaharlal Nehru Ctr Adv Sci Res, Bangalore, Karnataka, India	Saha Institute of Nuclear Physics; Indian Institute of Science (IISC) - Bangalore; Department of Science & Technology (India); Jawaharlal Nehru Center for Advanced Scientific Research (JNCASR)	Sengupta, K (corresponding author), Saha Inst Nucl Phys, Biophys & Struct Genom Div, 1 AF Bidhannagar, Kolkata, W Bengal, India.	kaushik.sengupta@saha.ac.in	Sood, Anoop Kumar/A-7344-2013; Rathee, V./AAQ-3746-2020; bhattacharjee, pritha/I-5171-2019	Sood, Anoop Kumar/0000-0001-5702-4108; Bhattacharjee, Pritha/0000-0002-2146-4408; Krishnaswamy, Rema/0000-0002-8835-5564	University Grants Council, Government of India; Council of Scientific and Industrial Research (Government of India); Department of Science and Technology, Government of India	University Grants Council, Government of India; Council of Scientific and Industrial Research (Government of India)(Council of Scientific & Industrial Research (CSIR) - India); Department of Science and Technology, Government of India(Department of Science & Technology (India))	AB thanks University Grants Council, Government of India for the fellowship. AKS thanks Council of Scientific and Industrial Research, (Government of India) Bhatnagar Fellowship for support. RK thanks support under Ramanujan Fellowship, Department of Science and Technology, Government of India. KSG thanks MMDDA and BARD projects of Department of Atomic Energy, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1980, VISCOELASTIC PROPERT; Arbustini E, 2002, J AM COLL CARDIOL, V39, P981, DOI 10.1016/S0735-1097(02)01724-2; Arimura T, 2005, HUM MOL GENET, V14, P155, DOI 10.1093/hmg/ddi017; Bhattacharjee P, 2013, BIOCHEMISTRY-US, V52, P4229, DOI 10.1021/bi400337t; BRIDGER JM, 1993, J CELL SCI, V104, P297; Broers JLV, 2005, EXP CELL RES, V304, P582, DOI 10.1016/j.yexcr.2004.11.020; Butler JT, 2009, J CELL BIOCHEM, V107, P609, DOI 10.1002/jcb.22183; Chaudhuri O, 2007, NATURE, V445, P295, DOI 10.1038/nature05459; Dahl KN, 2005, BIOPHYS J, V89, P2855, DOI 10.1529/biophysj.105.062554; Dahl KN, 2004, J CELL SCI, V117, P4779, DOI 10.1242/jcs.01357; Dechat T, 2008, GENE DEV, V22, P832, DOI 10.1101/gad.1652708; Delbarre E, 2006, HUM MOL GENET, V15, P1113, DOI 10.1093/hmg/ddl026; Esue O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008855; Fatkin D, 1999, NEW ENGL J MED, V341, P1715, DOI 10.1056/NEJM199912023412302; FAWCETT DW, 1966, AM J ANAT, V119, P129, DOI 10.1002/aja.1001190108; Gardel ML, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.188102; Gardel ML, 2004, SCIENCE, V304, P1301, DOI 10.1126/science.1095087; GERACE L, 1988, ANNU REV CELL BIOL, V4, P335, DOI 10.1146/annurev.cb.04.110188.002003; Gisler T, 1999, PHYS REV LETT, V82, P1606, DOI 10.1103/PhysRevLett.82.1606; Goldberg MW, 2008, J CELL SCI, V121, P215, DOI 10.1242/jcs.022020; Goldberg MW, 2008, BIOCHEM SOC T, V36, P1339, DOI 10.1042/BST0361339; GOLDMAN AE, 1992, J CELL BIOL, V119, P725, DOI 10.1083/jcb.119.4.725; Herrmann H, 2004, ANNU REV BIOCHEM, V73, P749, DOI 10.1146/annurev.biochem.73.011303.073823; Hofmann I, 1997, EUR J CELL BIOL, V72, P122; HOZAK P, 1995, J CELL SCI, V108, P635; JANMEY PA, 1991, J CELL BIOL, V113, P155, DOI 10.1083/jcb.113.1.155; Kim Y, 2011, SCIENCE, V334, P1706, DOI 10.1126/science.1211222; Kolb T, 2011, NUCLEUS-PHILA, V2, P425, DOI 10.4161/nucl.2.5.17765; Kroy K, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/11/416; Lammerding J, 2004, ANN NY ACAD SCI, V1015, P53, DOI 10.1196/annals.1302.005; Lammerding J, 2003, IEEE ENG MED BIOL, V22, P124, DOI 10.1109/MEMB.2003.1256282; Lammerding J, 2007, METHOD CELL BIOL, V83, P269, DOI 10.1016/S0091-679X(07)83011-1; Lammerding Jan, 2005, V264, P264, DOI 10.1002/0470093765.ch18; Larson R. G., 1999, STRUCTURE RHEOLOGY C, P443; Lin YC, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.058101; LUDERUS MEE, 1992, EUR J BIOCHEM, V208, P235, DOI 10.1111/j.1432-1033.1992.tb17178.x; Melcer S, 2007, EXP CELL RES, V313, P2157, DOI 10.1016/j.yexcr.2007.03.004; MOIR RD, 1991, J CELL SCI, V99, P363; MOIR RD, 1994, J CELL BIOL, V125, P1201, DOI 10.1083/jcb.125.6.1201; Moir RD, 2000, J CELL BIOL, V151, P1155, DOI 10.1083/jcb.151.6.1155; MORI Y, 1982, J POLYM SCI POL PHYS, V20, P2111, DOI 10.1002/pol.1982.180201112; NEMOTO N, 1975, BIOPOLYMERS, V14, P409, DOI 10.1002/bip.1975.360140213; NEWPORT JW, 1987, ANNU REV BIOCHEM, V56, P535; Pajerowski JD, 2007, P NATL ACAD SCI USA, V104, P15619, DOI 10.1073/pnas.0702576104; Panorchan P, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.041906; Panorchan P, 2004, J BIOL CHEM, V279, P43462, DOI 10.1074/jbc.M402474200; Pasotti M, 2008, J AM COLL CARDIOL, V52, P1250, DOI 10.1016/j.jacc.2008.06.044; Pawelzyk P, 2013, SOFT MATTER, V9, P8871, DOI 10.1039/c3sm51999f; Perrot A, 2009, BASIC RES CARDIOL, V104, P90, DOI 10.1007/s00395-008-0748-6; Puckelwartz MJ, 2011, NUCLEUS-PHILA, V2, P162, DOI [10.4161/nucl.2.3.16003, 10.1083/jcb.201101046]; Radmacher M, 2007, METHOD CELL BIOL, V83, P347, DOI 10.1016/S0091-679X(07)83015-9; Rowat AC, 2008, BIOESSAYS, V30, P226, DOI 10.1002/bies.20720; Schape J, 2009, BIOPHYS J, V96, P4319, DOI 10.1016/j.bpj.2009.02.048; Schirmer EC, 2004, J BIOL CHEM, V279, P42811, DOI 10.1074/jbc.M407705200; Schopferer M, 2009, J MOL BIOL, V388, P133, DOI 10.1016/j.jmb.2009.03.005; Sebillon P, 2003, J MED GENET, V40, P560, DOI 10.1136/jmg.40.8.560; Semmrich C, 2007, P NATL ACAD SCI USA, V104, P20199, DOI 10.1073/pnas.0705513104; Shimi T, 2008, GENE DEV, V22, P3409, DOI 10.1101/gad.1735208; Stewart CL, 2007, EXP CELL RES, V313, P2144, DOI 10.1016/j.yexcr.2007.03.026; Storm C, 2005, NATURE, V435, P191, DOI 10.1038/nature03521; Swift J, 2013, SCIENCE, V341, DOI 10.1126/science.1240104; Watanabe TM, 2012, BIOCHEM BIOPH RES CO, V418, P742, DOI 10.1016/j.bbrc.2012.01.091; Xu JY, 2000, J BIOL CHEM, V275, P35886, DOI 10.1074/jbc.M002377200; Yamada S, 2003, J STRUCT BIOL, V143, P45, DOI 10.1016/S1047-8477(03)00101-1; Yao NY, 2008, J RHEOL, V52, P1013, DOI 10.1122/1.2933171; Zhang CM, 1996, J CELL SCI, V109, P2275	66	25	25	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e83410	10.1371/journal.pone.0083410	http://dx.doi.org/10.1371/journal.pone.0083410			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386194	gold, Green Published, Green Submitted, Green Accepted			2022-12-25	WOS:000329194700039
J	Jeffries, AR; Collier, DA; Vassos, E; Curran, S; Ogilvie, CM; Price, J				Jeffries, Aaron R.; Collier, David A.; Vassos, Evangelos; Curran, Sarah; Ogilvie, Caroline M.; Price, Jack			Random or Stochastic Monoallelic Expressed Genes Are Enriched for Neurodevelopmental Disorder Candidate Genes	PLOS ONE			English	Article							AUTISM-SPECTRUM DISORDERS; COPY-NUMBER VARIATION; GENOME-WIDE SCREEN; ALLELIC EXPRESSION; STEM-CELLS; ARRAY CGH; ASSOCIATION; DISEASES; REVEALS; VARIANT	Random or stochastic monoallelic expressed genes (StMA genes) represent a unique form of monoallelic expression where allelic choice is made at random early in development. The consequential clonal diversity provides opportunity for functional heterozygosity in tissues such as the brain, and can impact on both development and disease. We investigate the relationship of StMA expressed genes previously identified in clonal neural stem cells with the neurodevelopmental disorders autism and schizophrenia. We found that StMA genes show an overrepresentation of schizophrenia risk candidates identified by genome wide association studies from the genetic association database. Similar suggestive enrichment was also found for genes from the NHGRI genome-wide association study catalog and a psychiatric genetics consortium schizophrenia dataset although these latter more robust gene lists did not achieve statistical significance. We also examined multiple sources of copy number variation (CNV) datasets from autism and schizophrenia cohorts. After taking into account total gene numbers and CNV size, both autism and schizophrenia associated CNVs appeared to show an enrichment of StMA genes relative to the control CNV datasets. Since the StMA genes were originally identified in neural stem cells, bias due to the neural transcriptome is possible. To address this, we randomly sampled neural stem cell expressed genes and repeated the tests. After a significant number of iterations, neural stem cell expressed genes did not show an overrepresentation in autism or schizophrenia CNV datasets. Therefore, irrespective of the neural derived transcriptome, StMA genes originally identified in neural stem cells show an overrepresentation in CNVs associated with autism and schizophrenia. If this association is functional, then the regulation (or dysregulation) of this form of allelic expression status within tissues such as the brain may be a contributory risk factor for neurodevelopmental disorders and may also influence disease discordance sometimes observed in monozygotic twins.	[Jeffries, Aaron R.; Price, Jack] Kings Coll London, Inst Psychiat, Ctr Cellular Basis Behav, Dept Neurosci, London WC2R 2LS, England; [Collier, David A.] Eli Lilly & Co Ltd, Discovery Neurosci Res, Windlesham, Surrey, England; [Collier, David A.; Vassos, Evangelos; Curran, Sarah] Kings Coll London, Inst Psychiat, Social Genet & Dev Psychiat Ctr, London WC2R 2LS, England; [Ogilvie, Caroline M.] Guys & St Thomas NHS Fdn Trust, Dept Cytogenet, London, England	University of London; King's College London; Eli Lilly; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust	Jeffries, AR (corresponding author), Kings Coll London, Inst Psychiat, Ctr Cellular Basis Behav, Dept Neurosci, London WC2R 2LS, England.	Aaron.R.Jeffries@kcl.ac.uk	Price, Jack/G-9510-2011; Vassos, Evangelos/F-9825-2013; Jeffries, Aaron/D-1256-2014; curran, sarah/D-1027-2009; Ogilve, Caroline/AAW-3793-2021; Collier, David A/D-1649-2011	Vassos, Evangelos/0000-0001-6363-0438; Jeffries, Aaron/0000-0002-1235-8291; Collier, David A/0000-0003-4087-1559; Price, Jack/0000-0003-2235-9180	National Institute for Health Research (NIHR) Biomedical Research Centre for Mental Health at South London; Maudsley NHS Foundation Trust; Institute of Psychiatry, King's College London; National Institute for Health Research (NIHR); Innovative Medicines Initiative; European Union	National Institute for Health Research (NIHR) Biomedical Research Centre for Mental Health at South London(National Institute for Health Research (NIHR)); Maudsley NHS Foundation Trust; Institute of Psychiatry, King's College London; National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); Innovative Medicines Initiative; European Union(European Commission)	The authors acknowledge the financial support of the National Institute for Health Research (NIHR) Biomedical Research Centre for Mental Health at South London and Maudsley NHS Foundation Trust and Institute of Psychiatry, King's College London. This article presents independent research funded by the National Institute for Health Research (NIHR). The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health. The research leading to these results has received support from the Innovative Medicines Initiative Joint Undertaking under grant agreements n degrees 115439, resources of which are composed of financial contribution from the European Union's Seventh Framework Programme (FP7/2007 - 2013) and EFPIA companies' in kind contribution. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker KG, 2004, NAT GENET, V36, P431, DOI 10.1038/ng0504-431; Ben-David E, 2011, HUM MOL GENET, V20, P3632, DOI 10.1093/hmg/ddr283; Chess A, 2012, NAT REV GENET, V13, P421, DOI 10.1038/nrg3239; Conrad DF, 2010, NATURE, V464, P704, DOI 10.1038/nature08516; Cook DL, 1998, P NATL ACAD SCI USA, V95, P15641, DOI 10.1073/pnas.95.26.15641; Cooper GM, 2011, NAT GENET, V43, P838, DOI 10.1038/ng.909; Craddock N, 2010, NATURE, V464, P713, DOI 10.1038/nature08979; de Smith AJ, 2007, HUM MOL GENET, V16, P2783, DOI 10.1093/hmg/ddm208; Ge B, 2009, NAT GENET, V41, P1216, DOI 10.1038/ng.473; Gimelbrant A, 2007, SCIENCE, V318, P1136, DOI 10.1126/science.1148910; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Hogart A, 2007, HUM MOL GENET, V16, P691, DOI 10.1093/hmg/ddm014; Jeffries AR, 2012, STEM CELLS, V30, P1938, DOI 10.1002/stem.1155; Kopsida E, 2011, HORM BEHAV, V59, P375, DOI 10.1016/j.yhbeh.2010.04.005; Li SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031751; Lin MY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044017; Luo R, 2012, AM J HUM GENET, V91, P38, DOI 10.1016/j.ajhg.2012.05.011; Mowry BJ, 2013, MOL PSYCHIATR, V18, P38, DOI 10.1038/mp.2012.34; Murdoch JD, 2013, CURR OPIN GENET DEV, V23, P310, DOI 10.1016/j.gde.2013.02.003; Park H, 2010, NAT GENET, V42, P400, DOI 10.1038/ng.555; Perry GH, 2008, AM J HUM GENET, V82, P685, DOI 10.1016/j.ajhg.2007.12.010; Prendergast JGD, 2012, EPIGENET CHROMATIN, V5, DOI 10.1186/1756-8935-5-6; PRICE J, 1988, DEVELOPMENT, V104, P473; Richards AL, 2012, MOL PSYCHIATR, V17, P193, DOI 10.1038/mp.2011.11; Ripke S, 2011, NAT GENET, V43, P969, DOI 10.1038/ng.940; Stefansson H, 2008, NATURE, V455, P232, DOI 10.1038/nature07229; Zwemer LM, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-2-r10	27	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e85093	10.1371/journal.pone.0085093	http://dx.doi.org/10.1371/journal.pone.0085093			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281RE	24386451	gold, Green Published, Green Submitted			2022-12-25	WOS:000329117900124
J	Marthaler, AG; Tiemann, U; Arauzo-Bravo, MJ; Wu, GM; Zaehres, H; Hyun, JK; Han, DW; Scholer, HR; Tapia, N				Marthaler, Adele G.; Tiemann, Ulf; Arauzo-Bravo, Marcos J.; Wu, Guangming; Zaehres, Holm; Hyun, Jung Keun; Han, Dong Wook; Schoeler, Hans R.; Tapia, Natalia			Reprogramming to Pluripotency through a Somatic Stem Cell Intermediate	PLOS ONE			English	Article							SPINAL-CORD-INJURY; DEFINED FACTORS; EPIGENETIC MEMORY; HUMAN FIBROBLASTS; GENE-EXPRESSION; NEURONS; MOUSE; DIFFERENTIATION; CONVERSION; RECOVERY	Transcription factor-based reprogramming can lead to the successful switching of cell fates. We have recently reported that mouse embryonic fibroblasts (MEFs) can be directly reprogrammed into induced neural stem cells (iNSCs) after the forced expression of Brn4, Sox2, Klf4, and Myc. Here, we tested whether iNSCs could be further reprogrammed into induced pluripotent stem cells (iPSCs). The two factors Oct4 and Klf4 were sufficient to induce pluripotency in iNSCs. Immunocytochemistry and gene expression analysis showed that iNSC-derived iPSCs (iNdiPSCs) are similar to embryonic stem cells at the molecular level. In addition, iNdiPSCs could differentiate into cells of all three germ layers, both in vitro and in vivo, proving that iNdiPSCs are bona fide pluripotent cells. Furthermore, analysis of the global gene expression profile showed that iNdiPSCs, in contrast to iNSCs, do not retain any MEF transcriptional memory even at early passages after reprogramming. Overall, our results demonstrate that iNSCs can be reprogrammed to pluripotency and suggest that cell fate can be redirected numerous times. Importantly, our findings indicate that the induced pluripotent cell state may erase the donor-cell type epigenetic memory more efficiently than other induced somatic cell fates.	[Marthaler, Adele G.; Tiemann, Ulf; Arauzo-Bravo, Marcos J.; Wu, Guangming; Zaehres, Holm; Schoeler, Hans R.; Tapia, Natalia] Max Planck Inst Mol Biomed, Dept Cell & Dev Biol, D-48149 Munster, Germany; [Hyun, Jung Keun] Dankook Univ, Grad Sch, Dept Nanobiomed Sci, Cheonan, South Korea; [Hyun, Jung Keun] Dandook Univ, Dept Rehabil Med, Cheonan, South Korea; [Han, Dong Wook] Konkuk Univ, Sch Med, Dept Stem Cell Biol, Seoul, South Korea; [Schoeler, Hans R.] Univ Munster, Fac Med, D-48149 Munster, Germany	Max Planck Society; Dankook University; Konkuk University; Konkuk University Medical Center; University of Munster	Tapia, N (corresponding author), Max Planck Inst Mol Biomed, Dept Cell & Dev Biol, D-48149 Munster, Germany.	ntapia@mpi-muenster.mpg.de	Hyun, Jung Keun/ABB-2173-2020; , HS/AAB-4434-2019; Tiemann, Ulf/N-8037-2015; Marcos, Arauzo-Bravo/A-1706-2011; Tapia, Natalia/H-5500-2012	Hyun, Jung Keun/0000-0001-9254-4424; , HS/0000-0003-2643-5136; Tiemann, Ulf/0000-0002-3919-1663; Marcos, Arauzo-Bravo/0000-0002-3264-464X; Tapia, Natalia/0000-0003-0226-1952; Wu, Guangming/0000-0003-1923-7609	International Max Planck Research School, Molecular Biomedicine	International Max Planck Research School, Molecular Biomedicine	A.G.M. and U.T. are supported by a fellowship of the International Max Planck Research School, Molecular Biomedicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acampora D, 2013, DEVELOPMENT, V140, P43, DOI 10.1242/dev.085290; Bar-Nur O, 2011, CELL STEM CELL, V9, P17, DOI 10.1016/j.stem.2011.06.007; Bowles J, 2003, CYTOGENET GENOME RES, V101, P261, DOI 10.1159/000074346; Caiazzo M, 2011, NATURE, V476, P224, DOI 10.1038/nature10284; Ghosh Z, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008975; Han DW, 2012, CELL STEM CELL, V10, P465, DOI 10.1016/j.stem.2012.02.021; Han DW, 2011, NAT CELL BIOL, V13, P66, DOI 10.1038/ncb2136; Han DW, 2009, STEM CELLS, V27, P1088, DOI 10.1002/stem.43; Hanna J, 2009, NATURE, V462, P595, DOI 10.1038/nature08592; Ieda M, 2010, CELL, V142, P375, DOI 10.1016/j.cell.2010.07.002; Kim JB, 2008, NATURE, V454, P646, DOI 10.1038/nature07061; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; Kim K, 2011, NAT BIOTECHNOL, V29, P1117, DOI 10.1038/nbt.2052; Kumagai G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007706; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Nichols J, 2009, CELL STEM CELL, V4, P487, DOI 10.1016/j.stem.2009.05.015; Ohi Y, 2011, NAT CELL BIOL, V13, P541, DOI 10.1038/ncb2239; Park WB, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-119; Polo JM, 2010, NAT BIOTECHNOL, V28, P848, DOI 10.1038/nbt.1667; Son EY, 2011, CELL STEM CELL, V9, P205, DOI 10.1016/j.stem.2011.07.014; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tapia N, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2229; Tsuji O, 2010, P NATL ACAD SCI USA, V107, P12704, DOI 10.1073/pnas.0910106107; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797	24	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e85138	10.1371/journal.pone.0085138	http://dx.doi.org/10.1371/journal.pone.0085138			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281RE	24386457	Green Published, gold, Green Submitted			2022-12-25	WOS:000329117900125
J	Krimmer, D; Ichimaru, Y; Burgess, J; Black, J; Oliver, B				Krimmer, David; Ichimaru, Yukikazu; Burgess, Janette; Black, Judith; Oliver, Brian			Exposure to Biomass Smoke Extract Enhances Fibronectin Release from Fibroblasts	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; AIRWAY SMOOTH-MUSCLE; HUMAN LUNG FIBROBLASTS; EXTRACELLULAR-MATRIX PROTEINS; EPITHELIAL-CELL MIGRATION; CIGARETTE-SMOKE; GENE-EXPRESSION; INCREASED RISK; COPD; ERK	COPD induced following biomass smoke exposure has been reported to be associated with a more fibrotic phenotype than cigarette smoke induced COPD. This study aimed to investigate if biomass smoke induced extracellular matrix (ECM) protein production from primary human lung fibroblasts in vitro. Primary human lung fibroblasts (n = 5-10) were stimulated in vitro for up to 72 hours with increasing concentrations of biomass smoke extract (BME) or cigarette smoke extract (CSE) prior to being assessed for deposition of ECM proteins, cytokine release, and activation of intracellular signalling molecules. Deposition of the ECM proteins perlecan and fibronectin was upregulated by both CSE (p<0.05) and BME (p<0.05). The release of the neutrophilic chemokine IL-8 was also enhanced by BME. ERK1/2 phosphorylation was significantly upregulated by BME (p<0.05). Chemical inhibition of ERK signalling molecules partially attenuated these effects (p<0.05). Stimulation with endotoxin had no effect. This study demonstrated that BME had similar effects to CSE in vitro and had the capacity to directly induce fibrosis by upregulating production of ECM proteins. The mechanisms by which both biomass and cigarette smoke exposure cause lung damage may be similar.	[Krimmer, David; Ichimaru, Yukikazu; Burgess, Janette; Black, Judith; Oliver, Brian] Woolcock Inst Med Res, Sydney, NSW, Australia; [Krimmer, David; Ichimaru, Yukikazu; Burgess, Janette; Black, Judith; Oliver, Brian] Univ Sydney, Discipline Pharmacol, Sydney, NSW 2006, Australia	University of Sydney; Woolcock Institute of Medical Research; University of Sydney	Oliver, B (corresponding author), Woolcock Inst Med Res, Sydney, NSW, Australia.	brian.oliver@sydney.edu.au	Burgess, Janette/M-7117-2019; Oliver, Brian/E-7939-2010; Burgess, Janette K/A-3597-2010	Oliver, Brian/0000-0002-7122-9262; Burgess, Janette/0000-0001-9868-9966	National Health and Medical Research Council Australia; Australian Respiratory Council; NHMRC Career Development Fellowship [1032695, 1026880]; NHMRC Senior Principal Research Fellowship [571098]	National Health and Medical Research Council Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Respiratory Council; NHMRC Career Development Fellowship(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Senior Principal Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the National Health and Medical Research Council Australia, and the Australian Respiratory Council. JKB was supported by a NHMRC Career Development Fellowship #1032695. JLB was supported by a NHMRC Senior Principal Research Fellowship #571098. BGO was supported by a NHMRC Career Development Fellowship #1026880. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agency USEP, 1993, SUMM EM CHAR NONC RE; Brunzell DH, 2003, J NEUROCHEM, V84, P1431, DOI 10.1046/j.1471-4159.2003.01640.x; Calabrese C, 2006, RESP MED, V100, P1415, DOI 10.1016/j.rmed.2005.11.009; Chin BY, 1998, AM J PHYSIOL-LUNG C, V275, pL942, DOI 10.1152/ajplung.1998.275.5.L942; de Boer WI, 2000, J PATHOL, V190, P619, DOI 10.1002/(SICI)1096-9896(200004)190:5<619::AID-PATH555>3.0.CO;2-6; Dekkers BGJ, 2007, AM J PHYSIOL-LUNG C, V292, pL1405, DOI 10.1152/ajplung.00331.2006; Desalu OO, 2010, J BRAS PNEUMOL, V36, P441, DOI 10.1590/S1806-37132010000400008; Deveci F, 2004, RESPIRATION, V71, P602, DOI 10.1159/000081761; Dunsmore SE, 1996, AM J PHYSIOL-LUNG C, V270, pL3, DOI 10.1152/ajplung.1996.270.1.L3; Freyer AM, 2001, AM J RESP CELL MOL, V25, P569, DOI 10.1165/ajrcmb.25.5.4605; Geraghty P, 2011, J BIOL CHEM, V286, P30211, DOI 10.1074/jbc.M111.238824; Gupta J, 2011, CANCER BIOL THER, V11, P311, DOI 10.4161/cbt.11.3.14096; Han SW, 2005, CANCER LETT, V219, P71, DOI 10.1016/j.canlet.2004.07.040; Hasegawa M, 2006, AM J RESP CRIT CARE, V173, P1309, DOI 10.1164/rccm.200601-037OC; Hewson CA, 2004, J MOL BIOL, V344, P683, DOI 10.1016/j.jmb.2004.09.059; Hirst SJ, 2000, AM J RESP CELL MOL, V23, P335, DOI 10.1165/ajrcmb.23.3.3990; Hocking DC, 2003, AM J PHYSIOL-LUNG C, V285, pL169, DOI 10.1152/ajplung.00371.2002; Hoffmann E, 2002, J LEUKOCYTE BIOL, V72, P847; Hogg JC, 2004, NEW ENGL J MED, V350, P2645, DOI 10.1056/NEJMoa032158; Kargin R, 2011, ECHOCARDIOGR-J CARD, V28, P52, DOI 10.1111/j.1540-8175.2010.01278.x; Keatings VM, 1996, AM J RESP CRIT CARE, V153, P530, DOI 10.1164/ajrccm.153.2.8564092; Kicic A, 2010, AM J RESP CRIT CARE, V181, P889, DOI 10.1164/rccm.200907-1071OC; Kim HJ, 1997, AM J PHYSIOL-LUNG C, V273, pL134, DOI 10.1152/ajplung.1997.273.1.L134; Kim YJ, 2009, RESP MED, V103, P757, DOI 10.1016/j.rmed.2008.11.011; Kranenburg AR, 2006, AM J CLIN PATHOL, V126, P725, DOI 10.1309/JC477FAEL1YKV54W; Krimmer DI, 2012, AM J RESP CELL MOL, V46, P34, DOI 10.1165/rcmb.2010-0426OC; Kroening PR, 2008, J IMMUNOL, V181, P1536, DOI 10.4049/jimmunol.181.2.1536; KUNKEL SL, 1991, EXP LUNG RES, V17, P17, DOI 10.3109/01902149109063278; Lamprecht B, 2011, CHEST, V139, P752, DOI 10.1378/chest.10-1253; Laumbach RJ, 2012, J ALLERGY CLIN IMMUN, V129, P3, DOI 10.1016/j.jaci.2011.11.021; Martey CA, 2005, AM J PHYSIOL-LUNG C, V289, pL391, DOI 10.1152/ajplung.00062.2005; MENENDEZ R, 1995, RESPIRATION, V62, P312; Mercer Becky, 2006, Proc Am Thorac Soc, V3, P477, DOI 10.1513/pats.200603-041MS; Moir LM, 2008, J ALLERGY CLIN IMMUN, V121, P1034, DOI 10.1016/j.jaci.2007.12.1159; Moon HJ, 2007, INT J BIOCHEM CELL B, V39, P1224, DOI 10.1016/j.biocel.2007.03.017; Morissette MC, 2008, AM J RESP CRIT CARE, V178, P240, DOI 10.1164/rccm.200710-1486OC; Mourgeon E, 1999, AM J PHYSIOL-LUNG C, V277, pL142, DOI 10.1152/ajplung.1999.277.1.L142; Mukaida N, 2003, AM J PHYSIOL-LUNG C, V284, pL566, DOI 10.1152/ajplung.00233.2002; Muro AF, 2008, AM J RESP CRIT CARE, V177, P638, DOI 10.1164/rccm.200708-1291OC; Park JW, 2010, J TOXICOL SCI, V35, P33, DOI 10.2131/jts.35.33; Pera T, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-48; Pignatti P, 2005, J ALLERGY CLIN IMMUN, V115, P88, DOI 10.1016/j.jaci.2004.08.048; Po JYT, 2011, THORAX, V66, P232, DOI 10.1136/thx.2010.147884; Profita M, 2005, ALLERGY, V60, P1361, DOI 10.1111/j.1398-9995.2005.00892.x; Rivera RM, 2008, INT J TUBERC LUNG D, V12, P972; Roman J, 2005, AM J PHYSIOL-LUNG C, V288, pL975, DOI 10.1152/ajplung.00003.2004; Roman J, 2004, FASEB J, V18, P1436, DOI 10.1096/fj.03-0826fje; Salvi S, 2010, CHEST, V138, P3, DOI 10.1378/chest.10-0645; Salvi SS, 2009, LANCET, V374, P733, DOI 10.1016/S0140-6736(09)61303-9; Semple S, 2010, ENVIRON HEALTH PERSP, V118, P988, DOI 10.1289/ehp.0901605; Shi L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032128; Sood A, 2010, AM J RESP CRIT CARE, V182, P1098, DOI 10.1164/rccm.201002-0222OC; Stockley RA, 2002, CHEST, V121, p151S, DOI 10.1378/chest.121.5_suppl.151S; Tsukagoshi H, 2002, TOXICOL APPL PHARM, V184, P127, DOI 10.1006/taap.2002.9514; Wang T, 2010, AM J RESP CELL MOL, V42, P442, DOI 10.1165/rcmb.2008-0402OC; Zhang J, 2011, CYTOKINE, V54, P289, DOI 10.1016/j.cyto.2011.02.018; Zheng Y, 2007, AM J RESP CELL MOL, V37, P681, DOI 10.1165/rcmb.2007-0051OC	57	30	30	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e83938	10.1371/journal.pone.0083938	http://dx.doi.org/10.1371/journal.pone.0083938			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281QS	24386310	Green Published, gold, Green Submitted			2022-12-25	WOS:000329116700089
J	Talha, SM; Hytonen, J; Westhorpe, A; Kumar, S; Khanna, N; Pettersson, K				Talha, Sheikh M.; Hytonen, Jukka; Westhorpe, Adam; Kumar, Sushil; Khanna, Navin; Pettersson, Kim			Europium Nanoparticle-Based High Performing Immunoassay for the Screening of Treponemal Antibodies	PLOS ONE			English	Article							LABORATORY DIAGNOSIS; SYPHILIS; PALLIDUM; TESTS; LIPOPROTEIN; TRANSFUSION; ANTIGEN; DISEASE; TIME	Treponema pallidum subspecies pallidum (Tp) is the causative agent of syphilis which mainly spreads through sexual contact, blood transfusion and perinatal route. In order to curtail the spread of the infection and to clinically manage the disease, timely, accurate and reliable diagnosis is very important. We have developed an immunoassay for the detection of treponemal antibodies in human serum or plasma samples. In vivo biotinylated and non-biotinylated versions of the recombinant antigen were designed by the fusion of three Tp-specific antigens namely Tp15, Tp17 and Tp47. These fusion antigens were expressed in E. coli and purified using single-step metal affinity chromatography. Biotinylated fusion antigen immobilized on streptavidin coated plate was used to capture the treponemal antibodies and the non-biotinylated antigen coated on europium nanoparticles was used as tracer. Assays with two different incubation times of 10 min and 1 h were developed, and following the incubation the europium fluorescence was measured using time-resolved fluorometry. The developed time-resolved fluorometric (TRF) immunoassays were evaluated with in-house and commercial serum/plasma sample panels. For well-established treponemal antibodies positive or negative samples, the sensitivity of TRF immunoassay with 10 min incubation time was 97.4%, and of TRF immunoassay with 1 h incubation time was 98.7%, and the specificities of both the TRF immunoassays were 99.2%. For the samples with discordant results with the reference assays, both the TRF immunoassays showed better specificity than the Enzygnost syphilis enzyme immunoassay as a screening test. The two different incubation times did not have any significant effect on the signal to cutoff (S/Co) ratios obtained with the two immunoassays (p = 0.06). Our results indicate that the developed immunoassay with a short incubation time of 10 min has the potential to be used in clinical laboratories and in blood-bank settings as a screening test for treponemal antibodies.	[Talha, Sheikh M.; Pettersson, Kim] Univ Turku, Dept Biotechnol, Turku, Finland; [Hytonen, Jukka] Univ Turku, Dept Med Microbiol & Immunol, Turku, Finland; [Westhorpe, Adam] Univ Surrey, Guildford GU2 5XH, Surrey, England; [Kumar, Sushil; Khanna, Navin] Int Ctr Genet Engn & Biotechnol, Recombinant Gene Prod Grp, New Delhi, India	University of Turku; University of Turku; University of Surrey; Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi	Talha, SM (corresponding author), Univ Turku, Dept Biotechnol, Turku, Finland.	talshe@utu.fi	; KUMAR, SUSHIL/T-8493-2017	Hytonen, Jukka/0000-0002-0585-9338; Khanna, Navin/0000-0003-1208-614X; KUMAR, SUSHIL/0000-0001-8481-9221; Talha, Sheikh Mohammad/0000-0003-1997-9530	Finnish Funding Agency for Technology and Innovation (TEKES), Finland; Department of Biotechnology (DBT), Government of India	Finnish Funding Agency for Technology and Innovation (TEKES), Finland(Finnish Funding Agency for Technology & Innovation (TEKES)); Department of Biotechnology (DBT), Government of India(Department of Biotechnology (DBT) India)	This work has been carried out under a bilateral Indo-Finnish collaborative research programme, and was supported by funding from the Finnish Funding Agency for Technology and Innovation (TEKES), Finland, and Department of Biotechnology (DBT), Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batra G, 2010, PROTEIN EXPRES PURIF, V74, P99, DOI 10.1016/j.pep.2010.04.017; Baughn RE, 1996, J IMMUNOL, V157, P720; Baughn RE, 1996, INFECT IMMUN, V64, P2457, DOI 10.1128/IAI.64.7.2457-2466.1996; Binnicker MJ, 2012, J CLIN MICROBIOL, V50, P148, DOI 10.1128/JCM.05636-11; Clyne B, 2000, J EMERG MED, V18, P361, DOI 10.1016/S0736-4679(99)00230-9; Harma H, 2001, CLIN CHEM, V47, P561; Herremans T, 2010, EUR J CLIN MICROBIOL, V29, P495, DOI 10.1007/s10096-010-0900-8; Ho EL, 2011, J CLIN INVEST, V121, P4584, DOI 10.1172/JCI57173; Kiss Szilard, 2005, Semin Ophthalmol, V20, P161, DOI 10.1080/08820530500232092; Kubio C, 2012, TRANSFUSION, V52, P2161, DOI 10.1111/j.1537-2995.2012.03709.x; LARSEN SA, 1995, CLIN MICROBIOL REV, V8, P1; Loeffelholz MJ, 2012, J CLIN MICROBIOL, V50, P2, DOI 10.1128/JCM.06347-11; Marangoni A, 2009, J CLIN LAB ANAL, V23, P1, DOI 10.1002/jcla.20268; Newman L, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001396; NORRIS SJ, 1993, MICROBIOL REV, V57, P750, DOI 10.1128/MMBR.57.3.750-779.1993; Pallavi P, 2011, INDIAN J HEMATOL BLO, V27, P1, DOI 10.1007/s12288-010-0047-x; Rostopira N, 2003, FOLIA MICROBIOL, V48, P549, DOI 10.1007/BF02931339; Schmidt PJ, 2001, TRANSFUSION, V41, P1069, DOI 10.1046/j.1537-2995.2001.41081069.x; Sena AC, 2010, CLIN INFECT DIS, V51, P700, DOI 10.1086/655832; Soukka T, 2001, ANAL CHEM, V73, P2254, DOI 10.1021/ac001287l; Stoner BP, 2007, CLIN INFECT DIS, V44, pS130, DOI 10.1086/511426; Sun AH, 2009, CLIN CHEM LAB MED, V47, P321, DOI 10.1515/CCLM.2009.071; Talha SM, 2011, J VIROL METHODS, V173, P24, DOI 10.1016/j.jviromet.2011.01.001; Tucker JD, 2010, LANCET INFECT DIS, V10, P381, DOI 10.1016/S1473-3099(10)70092-X; World Health Organization website, SCREEN DON BLOOD TRA; World Health Organization website, 2008, GLOB INC PREV SEL CU	26	4	4	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e84050	10.1371/journal.pone.0084050	http://dx.doi.org/10.1371/journal.pone.0084050			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281QS	24386329	Green Submitted, Green Published, gold			2022-12-25	WOS:000329116700095
J	Tao, ZX; Zhang, Y; Liu, Y; Xu, AQ; Lin, XJ; Yoshida, H; Xiong, P; Zhu, SL; Wang, ST; Yan, DM; Song, LZ; Wang, HY; Cui, N; Xu, WB				Tao, Zexin; Zhang, Yong; Liu, Yao; Xu, Aiqiang; Lin, Xiaojuan; Yoshida, Hiromu; Xiong, Ping; Zhu, Shuangli; Wang, Suting; Yan, Dongmei; Song, Lizhi; Wang, Haiyan; Cui, Ning; Xu, Wenbo			Isolation and Characterization of a Type 2 Vaccine-Derived Poliovirus from Environmental Surveillance in China, 2012	PLOS ONE			English	Article							SHANDONG PROVINCE; SEWAGE	Environmental surveillance of poliovirus on sewage has been conducted in Shandong Province, China since 2008. A type 2 vaccine-derived poliovirus (VDPV) with 7 mutations in VP1 coding region was isolated from the sewage collected in the city of Jinan in December 2012. The complete genome sequencing analysis of this isolate revealed 25 nucleotide substitutions, 7 of which resulted in amino acid alteration. No evidence of recombination with other poliovirus serotypes was observed. The virus did not lose temperature sensitive phenotype at 40 degrees C. An estimation based on the evolution rate of the P1 coding region suggested that evolution time of this strain might be 160-176 days. VP1 sequence analysis revealed that this VDPV strain is of no close relationship with other local type 2 polioviruses (n = 66) from sewage collected between May 2012 and June 2013, suggesting the lack of its circulation in the local population. The person who excreted the virus was not known and no closely related virus was isolated in local population via acute flaccid paralysis surveillance. By far this is the first report of VDPV isolated from sewage in China, and these results underscore the value of environmental surveillance in the polio surveillance system even in countries with high rates of OPV coverage.	[Tao, Zexin; Liu, Yao; Xu, Aiqiang; Lin, Xiaojuan; Xiong, Ping; Wang, Suting; Song, Lizhi; Wang, Haiyan] Shandong Univ, Acad Prevent Med, Jinan 250100, Peoples R China; [Tao, Zexin; Liu, Yao; Xu, Aiqiang; Lin, Xiaojuan; Xiong, Ping; Wang, Suting] Shandong Ctr Dis Control & Prevent, Shandong Prov Key Lab Infect Dis Control & Preven, Jinan, Peoples R China; [Zhang, Yong; Zhu, Shuangli; Yan, Dongmei; Xu, Wenbo] Chinese Ctr Dis Control & Prevent, WHO WPRO Reg Polio Reference Lab, Inst Viral Dis Control & Prevent, Beijing, Peoples R China; [Zhang, Yong; Zhu, Shuangli; Yan, Dongmei; Xu, Wenbo] Chinese Ctr Dis Control & Prevent, State Key Lab Mol Virol & Genet Engn, Inst Viral Dis Control & Prevent, Beijing, Peoples R China; [Xu, Aiqiang] Shandong Univ, Sch Publ Hlth, Jinan 250100, Peoples R China; [Yoshida, Hiromu] Natl Inst Infect Dis, Dept Virol 2, Tokyo, Japan; [Cui, Ning] Shandong Univ Tradit Chinese Med, Coll Basic Med Sci, Dept Prevent Med, Jinan, Peoples R China	Shandong University; Chinese Center for Disease Control & Prevention; Chinese Center for Disease Control & Prevention; Shandong University; National Institute of Infectious Diseases (NIID); Shandong University of Traditional Chinese Medicine	Xu, AQ (corresponding author), Shandong Univ, Acad Prevent Med, Jinan 250100, Peoples R China.	aqxuepi@163.com; wenbo_xu1@aliyun.com		Tao, Zexin/0000-0002-1747-2034; Yoshida, Hiromu/0000-0002-1488-8309; Zhang, Yong/0000-0002-2692-5437	National Natural Science Foundation of China [81302481]; Ministry of Health, Labor and Welfare of Japan	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This study was supported by the National Natural Science Foundation of China (project no. 81302481)(http://www.nsfc.gov.cn) and a grant for Research on Emerging and Re-emerging Infectious Diseases from the Ministry of Health, Labor and Welfare of Japan (http://www.mhlw.go.jp/english/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, WKLY EPIDEMIOL REC, V84, P110; BALANANT J, 1991, VIROLOGY, V184, P645, DOI 10.1016/0042-6822(91)90434-D; Blomqvist S, 2004, J VIROL, V78, P4876, DOI 10.1128/JVI.78.9.4876-4883.2004; Blomqvist S, 2003, J GEN VIROL, V84, P573, DOI 10.1099/vir.0.18708-0; Chen P, 2013, J MED VIROL, V85, P483, DOI 10.1002/jmv.23478; El Bassioni L, 2003, AM J EPIDEMIOL, V158, P807, DOI 10.1093/aje/kwg202; Grassly NC, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0140; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Hovi T, 2012, EPIDEMIOL INFECT, V140, P1, DOI 10.1017/S095026881000316X; Iwai M, 2006, APPL ENVIRON MICROB, V72, P6381, DOI 10.1128/AEM.02621-05; Jorba J, 2008, J VIROL, V82, P4429, DOI 10.1128/JVI.02354-07; Kew Olen M., 2012, Morbidity and Mortality Weekly Report, V61, P741; Kew OM, 2005, ANNU REV MICROBIOL, V59, P587, DOI 10.1146/annurev.micro.58.030603.123625; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; RICOHESSE R, 1987, VIROLOGY, V160, P311, DOI 10.1016/0042-6822(87)90001-8; Roberts L, 2009, SCIENCE, V323, P702, DOI [10.1126/science.323.5915.702, 10.1126/science.323.5915.705]; Shulman LM, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000069; Shulman LM, 2000, J CLIN MICROBIOL, V38, P3729, DOI 10.1128/JCM.38.10.3729-3734.2000; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tao ZX, 2012, EMERG INFECT DIS, V18, P1865, DOI 10.3201/eid1811.120090; Tao ZX, 2011, APPL ENVIRON MICROB, V77, P3786, DOI 10.1128/AEM.03044-10; Tao ZX, 2010, VIRUS RES, V150, P56, DOI 10.1016/j.virusres.2010.02.014; WHO, 2004, POL LAB MAN; World Health Organization, 2003, GUID ENV SURV POL CI; Yang CF, 2003, J VIROL, V77, P8366, DOI 10.1128/JVI.77.15.8366-8377.2003; Yoshida H, 2002, J GEN VIROL, V83, P1107, DOI 10.1099/0022-1317-83-5-1107; Zhang Y, 2010, J GEN VIROL, V91, P421, DOI 10.1099/vir.0.014258-0; Zhang Y, 2009, J CLIN VIROL, V44, P262, DOI 10.1016/j.jcv.2009.02.002	28	14	16	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e83975	10.1371/journal.pone.0083975	http://dx.doi.org/10.1371/journal.pone.0083975			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281QS	24386319	Green Submitted, Green Published, gold			2022-12-25	WOS:000329116700092
J	Barth, VC; Rodrigues, BA; Bonatto, GD; Gallo, SW; Pagnussatti, VE; Ferreira, CAS; de Oliveira, SD				Barth, Valdir Cristovao, Jr.; Rodrigues, Belisa Avila; Bonatto, Grasiela Daiane; Gallo, Stephanie Wagner; Pagnussatti, Vany Elisa; Sanchez Ferreira, Carlos Alexandre; de Oliveira, Silvia Dias			Heterogeneous Persister Cells Formation in Acinetobacter baumannii	PLOS ONE			English	Article							TOXIN-ANTITOXIN SYSTEMS; ESCHERICHIA-COLI; BACTERICIDAL ANTIBIOTICS; MULTIDRUG TOLERANCE; DORMANCY; DEATH; INFECTIONS; MECHANISMS	Bacterial persistence is a feature that allows susceptible bacteria to survive extreme concentrations of antibiotics and it has been verified in a number of species, such as Escherichia coli, Pseudomonas aeruginosa, Staphylococcus spp., Mycobacterium spp. However, even though Acinetobacter baumannii is an important nosocomial pathogen, data regarding its persistence phenotype are still lacking. Therefore, the aim of this study was to evaluate the persistence phenotype in A. baumannii strains, as well as its variation among strains after treatment with polymyxin B and tobramycin. Stationary cultures of 37 polymyxin B-susceptible clinical strains of A. baumannii were analyzed for surviving cells after exposure to 15 mu g/mL of polymyxin B for 6 h, by serial dilutions and colony counting. Among these, the 30 tobramycin-susceptible isolates also underwent tobramycin treatment at a concentration of 160 mu g/mL and persister cells occurrence was evaluated equally. A high heterogeneity of persister cells formation patterns among isolates was observed. Polymyxin B-treated cultures presented persister cells corresponding from 0.0007% to 10.1% of the initial population and two isolates failed to produce detectable persister cells under this condition. A high variability could also be observed when cells were treated with tobramycin: the persister fraction corresponded to 0.0003%-11.84% of the pre-treatment population. Moreover, no correlation was found between persister subpopulations comparing both antibiotics among isolates, indicating that different mechanisms underlie the internal control of this phenotype. This is the first report of persister cells occurrence in A. baumannii. Our data suggest that distinct factors regulate the tolerance for unrelated antibiotics in this species, contrasting the multi-drug tolerance observed in other species (eg. dormancy-mediated tolerance). Supporting this observation, polymyxin B -an antibiotic that is believed to act on non-dividing cells as well-failed to eradicate persister cells in the majority of the isolates, possibly reflecting a disconnection between persistence and dormancy.	[Barth, Valdir Cristovao, Jr.; Rodrigues, Belisa Avila; Bonatto, Grasiela Daiane; Gallo, Stephanie Wagner; Sanchez Ferreira, Carlos Alexandre; de Oliveira, Silvia Dias] Pontificia Univ Rio Grande Sul, Fac Biociencias, Lab Imunol & Microbiol, Porto Alegre, RS, Brazil; [Pagnussatti, Vany Elisa] Pontificia Univ Rio Grande Sul, Hosp Sao Lucas, Lab Patol Clin, Dept Microbiol, Porto Alegre, RS, Brazil	Pontificia Universidade Catolica Do Rio Grande Do Sul; Pontificia Universidade Catolica Do Rio Grande Do Sul	de Oliveira, SD (corresponding author), Pontificia Univ Rio Grande Sul, Fac Biociencias, Lab Imunol & Microbiol, Porto Alegre, RS, Brazil.	silviadias@pucrs.br	Oliveira, Sílvia D/G-3436-2012; Ferreira, Carlos A S/J-3672-2015; Junior, Valdir Cristovao Barth/G-9353-2011	Oliveira, Sílvia D/0000-0002-7296-5085; Ferreira, Carlos A S/0000-0002-3727-5097; Junior, Valdir Cristovao Barth/0000-0002-7410-1598	CAPES, Brazil	CAPES, Brazil(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	Valdir C. Barth Jr. received a scholarship from CAPES, Brazil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernier SP, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003144; Bigger JW, 1944, LANCET, V2, P497; Clinical and Laboratory Standards Institute, 2012, APPROV STAND 9 EDITI, V32, P3; CLSI, 2012, PERFORMANCE STANDARD, V7th; Correia FF, 2006, J BACTERIOL, V188, P8360, DOI 10.1128/JB.01237-06; Dorr T, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000317; Fasani RA, 2013, P NATL ACAD SCI USA, V110, pE2528, DOI 10.1073/pnas.1301023110; Fauvart M, 2011, J MED MICROBIOL, V60, P699, DOI 10.1099/jmm.0.030932-0; Grant SS, 2012, P NATL ACAD SCI USA, V109, P12147, DOI 10.1073/pnas.1203735109; Hofsteenge N, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-25; Jurenaite M, 2013, J BACTERIOL, V195, P3165, DOI 10.1128/JB.00237-13; Keren I, 2004, J BACTERIOL, V186, P8172, DOI 10.1128/JB.186.24.8172-8180.2004; Keren I, 2013, SCIENCE, V339, P1213, DOI 10.1126/science.1232688; Knudsen GM, 2013, APPL ENVIRON MICROB, V79, P7390, DOI 10.1128/AEM.02184-13; Kohanski MA, 2007, CELL, V130, P797, DOI 10.1016/j.cell.2007.06.049; Lewis K, 2007, NAT REV MICROBIOL, V5, P48, DOI 10.1038/nrmicro1557; Liu YY, 2013, SCIENCE, V339, P1210, DOI 10.1126/science.1232751; Maisonneuve E, 2011, P NATL ACAD SCI USA, V108, P13206, DOI 10.1073/pnas.1100186108; Moker N, 2010, J BACTERIOL, V192, P1946, DOI 10.1128/JB.01231-09; Moffatt JH, 2010, ANTIMICROB AGENTS CH, V54, P4971, DOI 10.1128/AAC.00834-10; Orman MA, 2013, ANTIMICROB AGENTS CH, V57, P3230, DOI 10.1128/AAC.00243-13; Renggli S, 2013, J BACTERIOL, V195, P4067, DOI 10.1128/JB.00393-13; Sampson TR, 2012, ANTIMICROB AGENTS CH, V56, P5642, DOI 10.1128/AAC.00756-12; Stewart B, 2012, EVOLUTION, V66, P933, DOI 10.1111/j.1558-5646.2011.01467.x; Tashiro Y, 2012, J BACTERIOL, V194, P1169, DOI 10.1128/JB.06628-11; Wakamoto Y, 2013, SCIENCE, V339, P91, DOI 10.1126/science.1229858; Wu YX, 2012, ANTIMICROB AGENTS CH, V56, P4922, DOI 10.1128/AAC.00921-12	27	37	40	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84361	10.1371/journal.pone.0084361	http://dx.doi.org/10.1371/journal.pone.0084361			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391945	gold, Green Submitted, Green Published			2022-12-25	WOS:000329323900088
J	Chen, Y; Molnar, M; Li, L; Friberg, P; Gan, LM; Brismar, H; Fu, Y				Chen, Yun; Molnar, Matyas; Li, Li; Friberg, Peter; Gan, Li-Ming; Brismar, Hjalmar; Fu, Ying			Characterization of VCAM-1-Binding Peptide-Functionalized Quantum Dots for Molecular Imaging of Inflamed Endothelium	PLOS ONE			English	Article							IN-VIVO; GOLD NANOPARTICLES; E-SELECTIN; VCAM-1; CELLS; ATHEROSCLEROSIS; EXPRESSION; ICAM-1; ACTIVATION; PECAM	Inflammation-induced activation of endothelium constitutes one of the earliest changes during atherogenesis. New imaging techniques that allow detecting activated endothelial cells can improve the identification of persons at high cardiovascular risk in early stages. Quantum dots (QDs) have attractive optical properties such as bright fluorescence and high photostability, and have been increasingly studied and developed for bio-imaging and bio-targeting applications. We report here the development of vascular cell adhesion molecule-1 binding peptide (VCAM-1 binding peptide) functionalized QDs (VQDs) from amino QDs. It was found that the QD fluorescence signal in tumor necrosis factor alpha (TNF-alpha) treated endothelial cells in vitro was significantly higher when these cells were labeled with VQDs than amino QDs. The VQD labeling of TNF-alpha-treated endothelial cells was VCAM-1 specific since pre-incubation with recombinant VCAM-1 blocked cells' uptake of VQDs. Our ex vivo and in vivo experiments showed that in the inflamed endothelium, QD fluorescence signal from VQDs was also much stronger than that of amino QDs. Moreover, we observed that the QD fluorescence peak was significantly blue-shifted after VQDs interacted with aortic endothelial cells in vivo and in vitro. A similar blue-shift was observed after VQDs were incubated with recombinant VCAM-1 in tube. We anticipate that the specific interaction between VQDs and VCAM-1 and the blue-shift of the QD fluorescence peak can be very useful for VCAM-1 detection in vivo.	[Chen, Yun; Friberg, Peter; Gan, Li-Ming] Univ Gothenburg, Dept Mol & Clin Med Clin Physiol, Sahlgrenska Acad, Gothenburg, Sweden; [Chen, Yun; Friberg, Peter; Gan, Li-Ming] Univ Gothenburg, Univ Hosp, Gothenburg, Sweden; [Molnar, Matyas; Li, Li; Brismar, Hjalmar; Fu, Ying] Royal Inst Technol, Dept Appl Phys, Sci Life Lab, Stockholm, Sweden; [Gan, Li-Ming] AstraZeneca R&D, Molndal, Sweden	University of Gothenburg; University of Gothenburg; Royal Institute of Technology; AstraZeneca	Fu, Y (corresponding author), Royal Inst Technol, Dept Appl Phys, Sci Life Lab, Stockholm, Sweden.	fu@kth.se	Brismar, Hjalmar/E-8524-2011	Brismar, Hjalmar/0000-0003-0578-4003; Chen, Yun/0000-0002-3746-594X	Swedish Vinnova [P35914-1]; Swedish Foundation for Strategic Research; Swedish Research Council [621-2011-4381]	Swedish Vinnova(Vinnova); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Swedish Research Council(Swedish Research CouncilEuropean Commission)	The work was supported by Swedish Vinnova (project number P35914-1), the Swedish Foundation for Strategic Research (Strategic Mobility 2010), and the Swedish Research Council (grant number 621-2011-4381). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhtar AM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012800; Arosio D, 2011, BIOCONJUGATE CHEM, V22, P664, DOI 10.1021/bc100448r; Bernardin A, 2010, BIOCONJUGATE CHEM, V21, P583, DOI 10.1021/bc900564w; Chen YH, 2001, J CELL BIOCHEM, V82, P512, DOI 10.1002/jcb.1176; Cybulsky MI, 2001, J CLIN INVEST, V107, P1255, DOI 10.1172/JCI11871; Daou TJ, 2009, LANGMUIR, V25, P3040, DOI 10.1021/la8035083; DAVIES MJ, 1993, J PATHOL, V171, P223, DOI 10.1002/path.1711710311; Derfus AM, 2007, BIOCONJUGATE CHEM, V18, P1391, DOI 10.1021/bc060367e; Drbohlavova J, 2009, INT J MOL SCI, V10, P656, DOI 10.3390/ijms10020656; Fitzpatrick JAJ, 2009, NANO LETT, V9, P2736, DOI 10.1021/nl901534q; FRIES JWU, 1993, AM J PATHOL, V143, P725; FU Y, 1994, J APPL PHYS, V76, P4225, DOI 10.1063/1.357330; Gao XH, 2003, TRENDS BIOTECHNOL, V21, P371, DOI 10.1016/S0167-7799(03)00209-9; Gao XH, 2004, NAT BIOTECHNOL, V22, P969, DOI 10.1038/nbt994; Gao XH, 2005, CURR OPIN BIOTECH, V16, P63, DOI 10.1016/j.copbio.2004.11.003; Gregg AJ, 2008, VET IMMUNOL IMMUNOP, V122, P295, DOI 10.1016/j.vetimm.2007.11.008; HASHIDA S, 1984, Journal of Applied Biochemistry, V6, P56; Idowu M, 2008, J PHOTOCH PHOTOBIO A, V198, P7, DOI 10.1016/j.jphotochem.2008.02.008; Jaiswal JK, 2004, NAT METHODS, V1, P73, DOI 10.1038/nmeth1004-73; Jiang W, 2004, TRENDS BIOTECHNOL, V22, P607, DOI 10.1016/j.tibtech.2004.10.012; Kim JH, 2004, SENSOR ACTUAT B-CHEM, V102, P315, DOI 10.1016/j.snb.2004.04.107; Li L, 2013, J PHYS CHEM C, V117, P4844, DOI 10.1021/jp311975h; Libby P, 2002, CIRCULATION, V105, P1135, DOI 10.1161/hc0902.104353; Medintz IL, 2005, NAT MATER, V4, P435, DOI 10.1038/nmat1390; Michalet X, 2005, SCIENCE, V307, P538, DOI 10.1126/science.1104274; Molnar M, 2011, SENSOR ACTUAT B-CHEM, V155, P823, DOI 10.1016/j.snb.2011.01.055; Molnar M, 2010, CELL MED, V1, P105, DOI 10.3727/215517910X451603; Molnar Matyas, 2010, Journal of Nanobiotechnology, V8, P2, DOI 10.1186/1477-3155-8-2; Nahrendorf M, 2006, CIRCULATION, V114, P1504, DOI 10.1161/CIRCULATIONAHA.106.646380; Ning ZJ, 2011, PHYS CHEM CHEM PHYS, V13, P5848, DOI 10.1039/c0cp02688c; Patel KG, 2011, BIOCONJUGATE CHEM, V22, P376, DOI 10.1021/bc100367u; Ricard I, 1998, EUR J IMMUNOL, V28, P1708, DOI 10.1002/(SICI)1521-4141(199805)28:05<1708::AID-IMMU1708>3.0.CO;2-Y; Riegler Juergen, 2008, Journal of Nanobiotechnology, V6, P7, DOI 10.1186/1477-3155-6-7; Smith AM, 2006, ANN BIOMED ENG, V34, P3, DOI 10.1007/s10439-005-9000-9; Stringer RC, 2008, SENSOR ACTUAT B-CHEM, V134, P427, DOI 10.1016/j.snb.2008.05.018; Tsourkas A, 2005, BIOCONJUGATE CHEM, V16, P576, DOI 10.1021/bc050002e; Wang QB, 2007, J AM CHEM SOC, V129, P6380, DOI 10.1021/ja071434y; Xing Y, 2007, NAT PROTOC, V2, P1152, DOI 10.1038/nprot.2007.107	38	14	14	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83805	10.1371/journal.pone.0083805	http://dx.doi.org/10.1371/journal.pone.0083805			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391829	gold, Green Published, Green Submitted			2022-12-25	WOS:000329325200127
J	Christensen, AS; Linnet, TE; Borg, M; Boomsma, W; Lindorff-Larsen, K; Hamelryck, T; Jensen, JH				Christensen, Anders S.; Linnet, Troels E.; Borg, Mikael; Boomsma, Wouter; Lindorff-Larsen, Kresten; Hamelryck, Thomas; Jensen, Jan H.			Protein Structure Validation and Refinement Using Amide Proton Chemical Shifts Derived from Quantum Mechanics	PLOS ONE			English	Article							DENSITY-FUNCTIONAL METHODS; HYDROGEN-BONDS; UBIQUITIN; PREDICTION; C-13(ALPHA); (3H)J(NC'); DATABASE; PDB2PQR; N-15; H-1	We present the ProCS method for the rapid and accurate prediction of protein backbone amide proton chemical shifts sensitive probes of the geometry of key hydrogen bonds that determine protein structure. ProCS is parameterized against quantum mechanical (QM) calculations and reproduces high level QM results obtained for a small protein with an RMSD of 0.25 ppm (r = 0.94). ProCS is interfaced with the PHAISTOS protein simulation program and is used to infer statistical protein ensembles that reflect experimentally measured amide proton chemical shift values. Such chemical shift-based structural refinements, starting from high-resolution X-ray structures of Protein G, ubiquitin, and SMN Tudor Domain, result in average chemical shifts, hydrogen bond geometries, and trans-hydrogen bond ((h3)J(NC')) spin-spin coupling constants that are in excellent agreement with experiment. We show that the structural sensitivity of the QM-based amide proton chemical shift predictions is needed to obtain this agreement. The ProCS method thus offers a powerful new tool for refining the structures of hydrogen bonding networks to high accuracy with many potential applications such as protein flexibility in ligand binding.	[Christensen, Anders S.; Jensen, Jan H.] Univ Copenhagen, Dept Chem, DK-2100 Copenhagen, Denmark; [Linnet, Troels E.; Boomsma, Wouter; Lindorff-Larsen, Kresten] Univ Copenhagen, Dept Biol, Struct Biol & NMR Lab, Copenhagen, Denmark; [Borg, Mikael; Hamelryck, Thomas] Univ Copenhagen, Dept Biol, Sect Computat & RNA Biol, Struct Bioinformat Grp, Copenhagen, Denmark	University of Copenhagen; University of Copenhagen; University of Copenhagen	Christensen, AS (corresponding author), Univ Copenhagen, Dept Chem, DK-2100 Copenhagen, Denmark.	andersx@nano.ku.dk	Jensen, Jan Halborg/G-4338-2010; Lindorff-Larsen, Kresten/K-6469-2014; Linnet, Troels Emtekær/B-4929-2015; Boomsma, Wouter/K-2903-2014; Hamelryck, Thomas/A-3923-2012	Jensen, Jan Halborg/0000-0002-1465-1010; Lindorff-Larsen, Kresten/0000-0002-4750-6039; Linnet, Troels Emtekær/0000-0003-4684-2361; Boomsma, Wouter/0000-0002-8257-3827; Borg, Mikael/0000-0002-0646-4231; Hamelryck, Thomas/0000-0003-2917-3602	Novo Nordisk STAR PhD program; Danish Council for Independent Research (FTP) [09-066546]; Novo Nordisk Foundation; Novo Nordisk Fonden [NNF11OC1014446] Funding Source: researchfish	Novo Nordisk STAR PhD program(Novo Nordisk); Danish Council for Independent Research (FTP)(Det Frie Forskningsrad (DFF)); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Novo Nordisk Fonden(Novo Nordisk Foundation)	ASC is funded by the Novo Nordisk STAR PhD program. MB is funded by the Danish Council for Independent Research (FTP, 09-066546). WB and KL-L are supported by a Hallas-Moller stipend (to KL-L) from the Novo Nordisk Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexeev D, 2003, CHEMBIOCHEM, V4, P894, DOI 10.1002/cbic.200300699; Barfield M, 2002, J AM CHEM SOC, V124, P4158, DOI 10.1021/ja012674v; Bax A, 2003, PROTEIN SCI, V12, P1, DOI 10.1110/ps.0233303; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Boomsma W, 2013, J COMPUT CHEM, V34, P1697, DOI 10.1002/jcc.23292; Bottaro S, 2012, J CHEM THEORY COMPUT, V8, P695, DOI 10.1021/ct200641m; Fenwick RB, 2011, J AM CHEM SOC, V133, P10336, DOI 10.1021/ja200461n; Case DA, 2013, CURR OPIN STRUC BIOL, V23, P172, DOI 10.1016/j.sbi.2013.01.007; Christensen AS, 2011, J CHEM THEORY COMPUT, V7, P2078, DOI 10.1021/ct2002607; Cordier F, 1999, J AM CHEM SOC, V121, P1601, DOI 10.1021/ja983945d; Cornilescu G, 1999, J AM CHEM SOC, V121, P6275, DOI 10.1021/ja9909024; Cornilescu G, 1998, J AM CHEM SOC, V120, P6836, DOI 10.1021/ja9812610; Czinki E, 2004, J MOL STRUC-THEOCHEM, V675, P107, DOI 10.1016/j.theochem.2003.12.034; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Dolinsky TJ, 2007, NUCLEIC ACIDS RES, V35, pW522, DOI 10.1093/nar/gkm276; Frisch M., 2016, GAUSSIAN 16 REVISION; Hamelryck T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013714; Jain R, 2009, J ORG CHEM, V74, P4017, DOI 10.1021/jo900482q; Jin L, 2000, J BIOL CHEM, V275, P27238; Kaminski GA, 2001, J PHYS CHEM B, V105, P6474, DOI 10.1021/jp003919d; Kohlhoff KJ, 2009, J AM CHEM SOC, V131, P13894, DOI 10.1021/ja903772t; Lange OF, 2008, SCIENCE, V320, P1471, DOI 10.1126/science.1157092; Li H, 2005, PROTEINS, V61, P704, DOI 10.1002/prot.20660; Lindorff-Larsen K, 2005, NATURE, V433, P128, DOI 10.1038/nature03199; Losonczi JA, 1999, J MAGN RESON, V138, P334, DOI 10.1006/jmre.1999.1754; Markwick PRL, 2003, J AM CHEM SOC, V125, P644, DOI 10.1021/ja028875w; Meiler J, 2003, J BIOMOL NMR, V26, P25, DOI 10.1023/A:1023060720156; Moon S, 2007, J BIOMOL NMR, V38, P139, DOI 10.1007/s10858-007-9156-8; Mulder FAA, 2010, CHEM SOC REV, V39, P578, DOI 10.1039/b811366c; Neal S, 2003, J BIOMOL NMR, V26, P215, DOI 10.1023/A:1023812930288; Parker LL, 2006, J AM CHEM SOC, V128, P9863, DOI 10.1021/ja0617901; POPLE JA, 1956, J CHEM PHYS, V24, P1111, DOI 10.1063/1.1742701; POPLE JA, 1958, MOL PHYS, V1, P175, DOI 10.1080/00268975800100211; Qiu D, 1997, J PHYS CHEM A, V101, P3005, DOI 10.1021/jp961992r; Rablen PR, 1999, J PHYS CHEM A, V103, P7357, DOI 10.1021/jp9916889; RAMAGE R, 1994, BIOCHEM J, V299, P151, DOI 10.1042/bj2990151; Richter B, 2007, J BIOMOL NMR, V37, P117, DOI 10.1007/s10858-006-9117-7; Rieping W, 2005, SCIENCE, V309, P303, DOI 10.1126/science.1110428; Shen Y, 2007, J BIOMOL NMR, V38, P289, DOI 10.1007/s10858-007-9166-6; Shen Y, 2010, J BIOMOL NMR, V48, P13, DOI 10.1007/s10858-010-9433-9; Ulrich EL, 2008, NUCLEIC ACIDS RES, V36, pD402, DOI 10.1093/nar/gkm957; VIJAYKUMAR S, 1987, J MOL BIOL, V194, P531, DOI 10.1016/0022-2836(87)90679-6; Vila JA, 2009, P NATL ACAD SCI USA, V106, P16972, DOI 10.1073/pnas.0908833106; Vila JA, 2009, ACCOUNTS CHEM RES, V42, P1545, DOI 10.1021/ar900068s; Wishart DS, 2001, METHOD ENZYMOL, V338, P3; Xu XP, 2001, J BIOMOL NMR, V21, P321, DOI 10.1023/A:1013324104681; Zhang HY, 2003, J BIOMOL NMR, V25, P173, DOI 10.1023/A:1022836027055	47	17	17	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84123	10.1371/journal.pone.0084123	http://dx.doi.org/10.1371/journal.pone.0084123			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391900	Green Published, Green Submitted, gold			2022-12-25	WOS:000329323900043
J	de Luis, M; Cufar, K; Di Filippo, A; Novak, K; Papadopoulos, A; Piovesan, G; Rathgeber, CBK; Raventos, J; Saz, MA; Smith, KT				de Luis, Martin; Cufar, Katarina; Di Filippo, Alfredo; Novak, Klemen; Papadopoulos, Andreas; Piovesan, Gianluca; Rathgeber, Cyrille B. K.; Raventos, Jose; Angel Saz, Miguel; Smith, Kevin T.			Plasticity in Dendroclimatic Response across the Distribution Range of Aleppo Pine (Pinus halepensis)	PLOS ONE			English	Article							INTRAANNUAL DENSITY-FLUCTUATIONS; CLIMATE-GROWTH RELATIONSHIPS; TREE-RING WIDTHS; PHENOTYPIC PLASTICITY; GLOBAL CHANGE; GENETIC DIVERSITY; WOOD STRUCTURE; CO2 INCREASE; LARGE-SCALE; ABIES-ALBA	We investigated the variability of the climate-growth relationship of Aleppo pine across its distribution range in the Mediterranean Basin. We constructed a network of tree-ring index chronologies from 63 sites across the region. Correlation function analysis identified the relationships of tree-ring index to climate factors for each site. We also estimated the dominant climatic gradients of the region using principal component analysis of monthly, seasonal, and annual mean temperature and total precipitation from 1,068 climatic gridpoints. Variation in ring width index was primarily related to precipitation and secondarily to temperature. However, we found that the dendroclimatic relationship depended on the position of the site along the climatic gradient. In the southern part of the distribution range, where temperature was generally higher and precipitation lower than the regional average, reduced growth was also associated with warm and dry conditions. In the northern part, where the average temperature was lower and the precipitation more abundant than the regional average, reduced growth was associated with cool conditions. Thus, our study highlights the substantial plasticity of Aleppo pine in response to different climatic conditions. These results do not resolve the source of response variability as being due to either genetic variation in provenance, to phenotypic plasticity, or a combination of factors. However, as current growth responses to inter-annual climate variability vary spatially across existing climate gradients, future climate-growth relationships will also likely be determined by differential adaptation and/or acclimation responses to spatial climatic variation. The contribution of local adaptation and/or phenotypic plasticity across populations to the persistence of species under global warming could be decisive for prediction of climate change impacts across populations. In this sense, a more complex forest dynamics modeling approach that includes the contribution of genetic variation and phenotypic plasticity can improve the reliability of the ecological inferences derived from the climate-growth relationships.	[de Luis, Martin; Novak, Klemen; Angel Saz, Miguel] Univ Zaragoza, Dept Geog & Ordenac Terr, Zaragoza, Spain; [de Luis, Martin; Novak, Klemen; Angel Saz, Miguel] Univ Zaragoza, Inst Invest Ciencias Ambientales IUCA, Zaragoza, Spain; [Cufar, Katarina] Univ Ljubljana, Dept Wood Sci & Technol, Ljubljana, Slovenia; [Di Filippo, Alfredo; Piovesan, Gianluca] Univ Tuscia, DendrologyLab DAFNE, Viterbo, Italy; [Papadopoulos, Andreas] Technol Educ Inst Lamia, Dept Forestry & Nat Environm Management, Karpenissi, Greece; [Rathgeber, Cyrille B. K.] Ctr INRA Nancy, Lab Etud Ressources Foret Bois LERFoB, Champenoux, France; [Raventos, Jose] Univ Alicante, Dept Ecol, San Vicente Del Raspeig, Spain; [Smith, Kevin T.] US Forest Serv, No Res Stn, USDA, Durham, NC USA	University of Zaragoza; University of Zaragoza; University of Ljubljana; Tuscia University; INRAE; Universitat d'Alacant; United States Department of Agriculture (USDA); United States Forest Service	de Luis, M (corresponding author), Univ Zaragoza, Dept Geog & Ordenac Terr, Zaragoza, Spain.	mdla@unizar.es	Di Filippo, Alfredo/G-1794-2010; CABAL, ANDREA AHC HEVIA/M-1361-2014; Piovesan, Gianluca/C-2720-2008; Novak, Klemen/K-1008-2017; Cufar, Katarina/AAE-6288-2020; de Luis, Martin/F-2559-2010; RATHGEBER, Cyrille/A-6510-2009	Di Filippo, Alfredo/0000-0001-5863-8339; CABAL, ANDREA AHC HEVIA/0000-0001-6352-1442; Piovesan, Gianluca/0000-0002-3214-0839; Novak, Klemen/0000-0003-0993-5286; Cufar, Katarina/0000-0002-7403-3994; de Luis, Martin/0000-0002-7585-3636; RATHGEBER, Cyrille/0000-0001-7359-8320; Bistinas, Ioannis/0000-0002-4221-6817; Papadopoulos, Andreas/0000-0003-0050-9053; Raventos, Jose/0000-0002-5693-510X; /0000-0001-8979-0253	Spanish Ministry of Education and Science; FEDER program [CGL2012-31668]; European Union; National Ministry of Education and Religion of Greece (EPEAEK- Environment - Archimedes); Slovenian Research Agency [P4-0015]; USDA Forest Service; COST Action [FP1106]	Spanish Ministry of Education and Science(Spanish Government); FEDER program(European Commission); European Union(European Commission); National Ministry of Education and Religion of Greece (EPEAEK- Environment - Archimedes); Slovenian Research Agency(Slovenian Research Agency - Slovenia); USDA Forest Service(United States Department of Agriculture (USDA)United States Forest Service); COST Action(European Cooperation in Science and Technology (COST))	This work was partially supported by Spanish Ministry of Education and Science co-funded by FEDER program (CGL2012-31668), the European Union and the National Ministry of Education and Religion of Greece (EPEAEK- Environment - Archimedes), the Slovenian Research Agency (program P4-0015), and the USDA Forest Service. The cooperation among international partners was supported by the COST Action FP1106, STREeSS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcamo J, 2007, AR4 CLIMATE CHANGE 2007: IMPACTS, ADAPTATION, AND VULNERABILITY, P541; Andreu L, 2007, GLOBAL CHANGE BIOL, V13, P804, DOI 10.1111/j.1365-2486.2007.01322.x; ATTOLINI MR, 1990, THEOR APPL CLIMATOL, V41, P121, DOI 10.1007/BF00866435; Babst F, 2013, GLOBAL ECOL BIOGEOGR, V22, P706, DOI 10.1111/geb.12023; Baquedano FJ, 2008, EUR J FOREST RES, V127, P495, DOI 10.1007/s10342-008-0232-8; Barbero Marcel, 1998, P153; Garzon MB, 2011, GLOBAL ECOL BIOGEOGR, V20, P766, DOI 10.1111/j.1466-8238.2010.00646.x; Biondi F, 2004, COMPUT GEOSCI-UK, V30, P303, DOI 10.1016/j.cageo.2003.11.004; Briffa KR, 1998, NATURE, V391, P678, DOI 10.1038/35596; Buntgen U, 2008, GLOBAL CHANGE BIOL, V14, P2443, DOI 10.1111/j.1365-2486.2008.01640.x; Buntgen U, 2010, TREES-STRUCT FUNCT, V24, P261, DOI 10.1007/s00468-009-0396-y; Gonzalez-Hidalgo JC, 2011, INT J CLIMATOL, V31, P715, DOI 10.1002/joc.2115; Carrer M, 2004, ECOLOGY, V85, P730, DOI 10.1890/02-0478; Carrer M, 2007, J ECOL, V95, P1072, DOI 10.1111/j.1365-2745.2007.01281.x; Carrer M, 2010, OIKOS, V119, P1515, DOI 10.1111/j.1600-0706.2010.18293.x; Chambel MR, 2007, ANN FOREST SCI, V64, P87, DOI 10.1051/forest:2006092; Chen PY, 2010, GLOBAL CHANGE BIOL, V16, P3374, DOI 10.1111/j.1365-2486.2010.02166.x; Cherubini P, 2003, BIOL REV, V78, P119, DOI 10.1017/S1464793102006000; Christensen JH, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P847; Climent JM, 2006, FOREST ECOL MANAG, V231, P164, DOI 10.1016/j.foreco.2006.05.042; Climent J, 2008, AM J BOT, V95, P833, DOI 10.3732/ajb.2007354; Cook E.R., 2013, METHODS DENDROCHRONO; Cook E.R., 1985, TIME SERIES ANAL APP, P175; Critchfield WB, 1966, USDA FOR SERV MISC P, V991; Cuesta B, 2010, FOREST ECOL MANAG, V260, P71, DOI 10.1016/j.foreco.2010.04.002; D'Arrigo R, 2008, GLOBAL PLANET CHANGE, V60, P289, DOI 10.1016/j.gloplacha.2007.03.004; De Luis M, 2007, IAWA J, V28, P389, DOI 10.1163/22941932-90001651; de Luis M, 2011, FOREST ECOL MANAG, V262, P1630, DOI 10.1016/j.foreco.2011.07.013; de Luis M, 2011, DENDROCHRONOLOGIA, V29, P163, DOI 10.1016/j.dendro.2011.01.005; De Luis M, 2009, TREES-STRUCT FUNCT, V23, P1065, DOI 10.1007/s00468-009-0349-5; Di Filippo A, 2007, J BIOGEOGR, V34, P1873, DOI 10.1111/j.1365-2699.2007.01747.x; Esper J, 2010, GLOBAL CHANGE BIOL, V16, P386, DOI 10.1111/j.1365-2486.2009.01913.x; Fritts H. C., 1976, TREE RINGS CLIMATE; Froux F, 2004, ANN FOREST SCI, V61, P235, DOI 10.1051/forest:2004016; Esteban LG, 2010, TREES-STRUCT FUNCT, V24, P19, DOI 10.1007/s00468-009-0375-3; Gindel I., 1967, Proceedings 14th Congress International Union Forestry Research Organ., Munich Pt. IV, Section 23, 1967, P188; Giorgi F, 2008, GLOBAL PLANET CHANGE, V63, P90, DOI 10.1016/j.gloplacha.2007.09.005; Gomez A, 2001, ANN FOR SCI, V58, P869, DOI 10.1051/forest:2001170; Hamann A, 2005, AGR FOREST METEOROL, V128, P211, DOI 10.1016/j.agrformet.2004.10.004; Iverson LR, 2008, FOREST ECOL MANAG, V254, P390, DOI 10.1016/j.foreco.2007.07.023; Jolliffe I.T., 1986, PRINCIPAL COMPONENT, P487, DOI [DOI 10.1007/B98835, 10.1007/978-1-4757-1904-8_8]; Camarero JJ, 2010, NEW PHYTOL, V185, P471, DOI 10.1111/j.1469-8137.2009.03073.x; KAISER HF, 1992, PERCEPT MOTOR SKILL, V74, P595, DOI 10.2466/PMS.74.2.595-598; Keenan T, 2011, GLOBAL CHANGE BIOL, V17, P565, DOI 10.1111/j.1365-2486.2010.02254.x; Lebourgeois F, 2010, J VEG SCI, V21, P364, DOI 10.1111/j.1654-1103.2009.01148.x; Lev-Yadun S, 2000, ECOLOGY, BIOGEOGRAPHY AND MANAGEMENT OF PINUS HALEPENSIS AND P BRUTIA FOREST ECOSYSTEMS IN THE MEDITERRANEAN BASIN, P67; Lindner M, 2010, FOREST ECOL MANAG, V259, P698, DOI 10.1016/j.foreco.2009.09.023; LIPHSCHITZ N, 1984, IAWA BULL, V5, P263, DOI 10.1163/22941932-90000413; Maiorano L, 2013, GLOBAL ECOL BIOGEOGR, V22, P302, DOI 10.1111/j.1466-8238.2012.00767.x; Matesanz S, 2014, ENVIRON EXP BOT, V103, P53, DOI 10.1016/j.envexpbot.2013.09.004; Matesanz S, 2010, ANN NY ACAD SCI, V1206, P35, DOI 10.1111/j.1749-6632.2010.05704.x; Merian P, 2011, FOREST ECOL MANAG, V261, P1382, DOI 10.1016/j.foreco.2011.01.019; Michelozzi M, 2011, PHOTOSYNTHETICA, V49, P564, DOI 10.1007/s11099-011-0068-1; Mitchell T., 2004, WORKING PAPER; Mitchell TD, 2005, INT J CLIMATOL, V25, P693, DOI 10.1002/joc.1181; Monnier Y, 2013, EUR J FOREST RES, V132, P325, DOI 10.1007/s10342-012-0677-7; Monnier Y, 2011, TREES-STRUCT FUNCT, V25, P497, DOI 10.1007/s00468-010-0525-7; Montoya D, 2009, GLOBAL ECOL BIOGEOGR, V18, P662, DOI 10.1111/j.1466-8238.2009.00478.x; Ne'eman G, 2004, PLANT ECOL, V171, P69, DOI 10.1023/B:VEGE.0000029380.04821.99; Ne'eman G., 2000, BIOGEOGRAPHY MANAGEM; Nicotra AB, 2010, TRENDS PLANT SCI, V15, P684, DOI 10.1016/j.tplants.2010.09.008; Novak K, 2013, IAWA J, V34, P459, DOI 10.1163/22941932-00000037; Novak K, 2013, TREES-STRUCT FUNCT, V27, P927, DOI 10.1007/s00468-013-0845-5; Olivar J, 2012, DENDROCHRONOLOGIA, V30, P35, DOI 10.1016/j.dendro.2011.06.001; Papadopoulos A., 2001, Ecologia Mediterranea, V27, P89; Pardos M, 2003, TREES-STRUCT FUNCT, V17, P442, DOI 10.1007/s00468-003-0259-x; Pasho E, 2011, AGR FOREST METEOROL, V151, P1106, DOI 10.1016/j.agrformet.2011.03.016; Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12, P361, DOI 10.1046/j.1466-822X.2003.00042.x; Penuelas J, 2003, GLOBAL CHANGE BIOL, V9, P131, DOI 10.1046/j.1365-2486.2003.00566.x; Penuelas J, 2011, GLOBAL ECOL BIOGEOGR, V20, P597, DOI 10.1111/j.1466-8238.2010.00608.x; Quezel P, 2000, ECOLOGY, BIOGEOGRAPHY AND MANAGEMENT OF PINUS HALEPENSIS AND P BRUTIA FOREST ECOSYSTEMS IN THE MEDITERRANEAN BASIN, P1; Randall DA, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P589; Rathgeber C, 2003, ECOL MODEL, V166, P239, DOI 10.1016/S0304-3800(03)00161-3; Rathgeber C, 2000, GLOBAL PLANET CHANGE, V26, P405, DOI 10.1016/S0921-8181(00)00053-9; Richardson David M., 1998, P3; RICHMAN MB, 1986, J CLIMATOL, V6, P293, DOI 10.1002/joc.3370060305; Roberts DR, 2012, GLOBAL ECOL BIOGEOGR, V21, P121, DOI 10.1111/j.1466-8238.2011.00657.x; Rodder D, 2009, GLOBAL ECOL BIOGEOGR, V18, P674, DOI 10.1111/j.1466-8238.2009.00477.x; Santos-del-Blanco L, 2013, J EVOLUTION BIOL, V26, P1912, DOI 10.1111/jeb.12187; Santos-del-Blanco L, 2010, FOREST SYST, V19, P381; Sardans J, 2004, PLANT ECOL, V174, P305, DOI 10.1023/B:VEGE.0000049110.88127.a0; Sarris D, 2007, GLOBAL CHANGE BIOL, V13, P1187, DOI 10.1111/j.1365-2486.2007.01348.x; SCHILLER G, 1986, SILVAE GENET, V35, P11; Schroter D, 2005, SCIENCE, V310, P1333, DOI 10.1126/science.1115233; Serra-Diaz JM, 2013, J BIOGEOGR, V40, P1928, DOI 10.1111/jbi.12142; Singh J., 2008, CLIMATE DISCUSSIONS, V4, P741, DOI DOI 10.5194/CPD-4-741-2008; Soto A, 2010, MOL ECOL, V19, P1396, DOI 10.1111/j.1365-294X.2010.04571.x; Speer JH, 2010, FUNDAMENTALS TREE RI; Thuiller W, 2006, DIVERS DISTRIB, V12, P49, DOI 10.1111/j.1366-9516.2006.00216.x; Thuiller W, 2005, P NATL ACAD SCI USA, V102, P8245, DOI 10.1073/pnas.0409902102; Thuiller W, 2004, J BIOGEOGR, V31, P353, DOI 10.1046/j.0305-0270.2003.00991.x; Touchan R, 2005, CLIM DYNAM, V25, P75, DOI 10.1007/s00382-005-0016-5; Touchan R, 1999, J ARID ENVIRON, V42, P291, DOI 10.1006/jare.1999.0507; Voltas J, 2008, TREES-STRUCT FUNCT, V22, P759, DOI 10.1007/s00468-008-0236-5; Wagner F, 1996, P NATL ACAD SCI USA, V93, P11705, DOI 10.1073/pnas.93.21.11705; WIGLEY TML, 1984, J CLIM APPL METEOROL, V23, P201, DOI 10.1175/1520-0450(1984)023<0201:OTAVOC>2.0.CO;2; Willson M.F., 1983, PLANT REPROD ECOLOGY; Zavala MA, 2011, CAN J FOREST RES, V41, P1432, DOI [10.1139/X11-050, 10.1139/x11-050]	98	92	92	1	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83550	10.1371/journal.pone.0083550	http://dx.doi.org/10.1371/journal.pone.0083550			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391786	Green Published, gold, Green Submitted			2022-12-25	WOS:000329325200083
J	Donaszi-Ivanov, A; Mohorianu, I; Dalmay, T; Powell, PP				Donaszi-Ivanov, Andras; Mohorianu, Irina; Dalmay, Tamas; Powell, Penny P.			Small RNA Analysis in Sindbis Virus Infected Human HEK293 Cells	PLOS ONE			English	Article							DOUBLE-STRANDED-RNA; ANTIVIRAL IMMUNITY; PROTEIN EXPRESSION; MICRORNA; INTERFERENCE; INNATE; IDENTIFICATION; PATHOGENESIS; REPLICATION; TRANSLATION	Introduction: In contrast to the defence mechanism of RNA interference (RNAi) in plants and invertebrates, its role in the innate response to virus infection of mammals is a matter of debate. Since RNAi has a well-established role in controlling infection of the alphavirus Sindbis virus (SINV) in insects, we have used this virus to investigate the role of RNAi in SINV infection of human cells. Results: SINV AR339 and TR339-GFP were adapted to grow in HEK293 cells. Deep sequencing of small RNAs (sRNAs) early in SINV infection (4 and 6 hpi) showed low abundance (0.8%) of viral sRNAs (vsRNAs), with no size, sequence or location specific patterns characteristic of Dicer products nor did they possess any discernible pattern to ascribe to a specific RNAi biogenesis pathway. This was supported by multiple variants for each sequence, and lack of hot spots along the viral genome sequence. The abundance of the best defined vsRNAs was below the limit of Northern blot detection. The adaptation of the virus to HEK293 cells showed little sequence changes compared to the reference; however, a SNP in E1 gene with a preference from G to C was found. Deep sequencing results showed little variation of expression of cellular microRNAs (miRNAs) at 4 and 6 hpi compared to uninfected cells. Twelve miRNAs exhibiting some minor differential expression by sequencing, showed no difference in expression by Northern blot analysis. Conclusions: We show that, unlike SINV infection of invertebrates, generation of Dicer-dependent svRNAs and change in expression of cellular miRNAs were not detected as part of the Human response to SINV.	[Donaszi-Ivanov, Andras; Powell, Penny P.] Univ E Anglia, Norwich Med Sch, Norwich NR4 7TJ, Norfolk, England; [Mohorianu, Irina; Dalmay, Tamas] Univ E Anglia, Sch Biol Sci, Norwich NR4 7TJ, Norfolk, England	University of East Anglia; University of East Anglia	Powell, PP (corresponding author), Univ E Anglia, Norwich Med Sch, Norwich NR4 7TJ, Norfolk, England.	p.powell@uea.ac.uk	Mohorianu, Irina/J-2549-2019; Dalmay, Tamas/E-1377-2011	Powell, Penny/0000-0002-5347-0490; Mohorianu, Irina/0000-0003-4863-761X; Dalmay, Tamas/0000-0003-1492-5429	Biotechnology and Biological Sciences Research Council [BBS/B/00689, BB/J021601/1]; BBSRC [BB/J021601/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Biotechnology and Biological Sciences Research Council grant BBS/B/00689 to PPP and BB/J021601/1 to TD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abend JR, 2010, J VIROL, V84, P12139, DOI 10.1128/JVI.00884-10; Adelman ZN, 2012, INSECT MOL BIOL, V21, P357, DOI 10.1111/j.1365-2583.2012.01141.x; Ahluwalia JK, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-117; Burke CW, 2009, VIROLOGY, V395, P121, DOI 10.1016/j.virol.2009.08.039; Campbell CL, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-47; Chakrabarti A, 2011, J INTERF CYTOK RES, V31, P49, DOI 10.1089/jir.2010.0120; Choy EYW, 2008, J EXP MED, V205, P2551, DOI 10.1084/jem.20072581; Cirimotich CM, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-49; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; Cullen BR, 2006, NAT IMMUNOL, V7, P563, DOI 10.1038/ni1352; Ding SW, 2007, CELL, V130, P413, DOI 10.1016/j.cell.2007.07.039; Du LQ, 2009, MOL CANCER RES, V7, P1234, DOI 10.1158/1541-7786.MCR-08-0507; Fang JL, 2012, J VIROL, V86, P1010, DOI 10.1128/JVI.06169-11; Gantier MP, 2012, NUCLEIC ACIDS RES, V40, P8048, DOI 10.1093/nar/gks521; Gatto G, 2008, NUCLEIC ACIDS RES, V36, P6608, DOI 10.1093/nar/gkn666; Gottwein E, 2008, CELL HOST MICROBE, V3, P375, DOI 10.1016/j.chom.2008.05.002; Greene IP, 2005, J VIROL, V79, P14253, DOI 10.1128/JVI.79.22.14253-14260.2005; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Hariharan M, 2005, BIOCHEM BIOPH RES CO, V337, P1214, DOI 10.1016/j.bbrc.2005.09.183; Henke JI, 2008, EMBO J, V27, P3300, DOI 10.1038/emboj.2008.244; Ho BC, 2011, CELL HOST MICROBE, V9, P58, DOI 10.1016/j.chom.2010.12.001; Hou WH, 2010, HEPATOLOGY, V51, P1494, DOI 10.1002/hep.23401; Ishii KJ, 2008, CELL HOST MICROBE, V3, P352, DOI 10.1016/j.chom.2008.05.003; Kawai T, 2006, NAT IMMUNOL, V7, P131, DOI 10.1038/ni1303; Kim Y, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002577; Kincaid RP, 2012, P NATL ACAD SCI USA, V109, P3077, DOI 10.1073/pnas.1116107109; Klimstra WB, 1998, J VIROL, V72, P7357, DOI 10.1128/JVI.72.9.7357-7366.1998; Koyama S, 2008, CYTOKINE, V43, P336, DOI 10.1016/j.cyto.2008.07.009; Lei XF, 2010, NAT CELL BIOL, V12, P193, DOI 10.1038/ncb2019; Leung JYS, 2011, ADV VIROL, V2011, DOI 10.1155/2011/249640; Li Y, 2013, SCIENCE, V342, P231, DOI 10.1126/science.1241911; Ma F, 2011, NAT IMMUNOL, V12, P861, DOI 10.1038/ni.2073; Maillard PV, 2013, SCIENCE, V342, P235, DOI 10.1126/science.1241930; Mardis ER, 2008, ANNU REV GENOM HUM G, V9, P387, DOI 10.1146/annurev.genom.9.081307.164359; McKnight KL, 1996, J VIROL, V70, P1981, DOI 10.1128/JVI.70.3.1981-1989.1996; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Mohorianu I, 2013, RNA BIOL, V10, P1221, DOI 10.4161/rna.25538; Mohorianu I, 2011, PLANT J, V67, P232, DOI 10.1111/j.1365-313X.2011.04586.x; Morazzani EM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002470; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Moxon S, 2008, BIOINFORMATICS, V24, P2252, DOI 10.1093/bioinformatics/btn428; Myles KM, 2008, P NATL ACAD SCI USA, V105, P19938, DOI 10.1073/pnas.0803408105; Parameswaran P, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000764; Pilcher RLR, 2007, PLANTA, V226, P709, DOI 10.1007/s00425-007-0518-y; Prufer K, 2008, BIOINFORMATICS, V24, P1530, DOI 10.1093/bioinformatics/btn223; Saleh MC, 2009, NATURE, V458, P346, DOI 10.1038/nature07712; Saumet A, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-3; Skalsky RL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002484; Stocks MB, 2012, BIOINFORMATICS, V28, P2059, DOI 10.1093/bioinformatics/bts311; STOLLAR V, 1972, VIROLOGY, V47, P122, DOI 10.1016/0042-6822(72)90245-0; STRAUSS EG, 1984, VIROLOGY, V133, P92, DOI 10.1016/0042-6822(84)90428-8; Szittya G, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-593; tenOever BR, 2013, NAT REV MICROBIOL, V11, P169, DOI 10.1038/nrmicro2971; Vodovar N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030861; Weber F, 2006, J VIROL, V80, P5059, DOI 10.1128/JVI.80.10.5059-5064.2006; Williams RW, 2002, P NATL ACAD SCI USA, V99, P6889, DOI 10.1073/pnas.072190799; Witwer KW, 2010, J IMMUNOL, V184, P2369, DOI 10.4049/jimmunol.0902712; Wu YQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030988	58	10	11	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84070	10.1371/journal.pone.0084070	http://dx.doi.org/10.1371/journal.pone.0084070			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391886	Green Accepted, gold, Green Published, Green Submitted			2022-12-25	WOS:000329323900029
J	Kim, H; Kwon, B; Sin, JI				Kim, Ha; Kwon, Byungsuk; Sin, Jeong-Im			Combined Stimulation of IL-2 and 4-1BB Receptors Augments the Antitumor Activity of E7 DNA Vaccines by Increasing Ag-Specific CTL Responses	PLOS ONE			English	Article							ANIMAL TUMOR-MODEL; HUMAN-PAPILLOMAVIRUS VACCINES; T-CELL PROLIFERATION; IN-VIVO; IMMUNE-RESPONSES; CERVICAL-CANCER; RECOMBINANT INTERLEUKIN-2; INCREASED SENSITIVITY; PROTECTIVE IMMUNITY; DOSE INTERLEUKIN-2	Human papillomavirus (HPV) infection is a major cause of cervical cancer. Here, we investigate whether concurrent therapy using HPV E7 DNA vaccines (pE7) plus IL-2 vs. IL-15 cDNA and anti-4-1BB Abs might augment antitumor activity against established tumors. IL-2 cDNA was slightly better than IL-15 cDNA as a pE7 adjuvant. Co-delivery of pE7+IL-2 cDNA increased tumor cure rates from 7% to 27%, whereas co-delivery of pE7+IL-2 cDNA with anti-4-1BB Abs increased tumor cure rates from 27% to 67% and elicited long-term memory responses. This increased activity was concomitant with increased induction of Ag-specific CTL activity and IFN-gamma responses, but not with Ag-specific IgG production. Moreover, the combined stimulation of IL-2 and 4-1BB receptors with rIL-2 and anti-4-1BB Abs resulted in enhanced production of IFN-gamma from Ag-specific CD8+ T cells. However, this effect was abolished by treatment with anti-IL-2 Abs and 4-1BB-Fc, suggesting that the observed effect was IL-2- and anti-4-1BB Ab-specific. A similar result was also obtained for Ag-specific CTL activity. Thus, these studies demonstrate that combined stimulation through the IL-2 and 4-1BB receptors augments the Ag-specific CD8+ CTL responses induced by pE7, increasing tumor cure rates and long-term antitumor immune memory. These findings may have implications for the design of DNA-based therapeutic vaccines against cancer.	[Sin, Jeong-Im] Kangwon Natl Univ, Dept Microbiol, Sch Med, Chunchon, Gangwon Do, South Korea; [Kwon, Byungsuk] Univ Ulsan, Sch Biol Sci, Ulsan 680749, South Korea	Kangwon National University; University of Ulsan	Sin, JI (corresponding author), Kangwon Natl Univ, Dept Microbiol, Sch Med, Chunchon, Gangwon Do, South Korea.	jsin1964@hanmail.net			National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology [2012R1A1A2038430]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2012R1A1A2038430). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlen G, 2007, J IMMUNOL, V179, P4741, DOI 10.4049/jimmunol.179.7.4741; Bae SH, 2007, CLIN CANCER RES, V13, P341, DOI 10.1158/1078-0432.CCR-06-1838; Bagarazzi ML, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004414; BAMFORD RN, 1994, P NATL ACAD SCI USA, V91, P4940, DOI 10.1073/pnas.91.11.4940; Cannons JL, 2000, J IMMUNOL, V165, P6193, DOI 10.4049/jimmunol.165.11.6193; Capitini Christian M, 2009, Am J Immunol, V5, P65; Cheng WF, 2002, HUM GENE THER, V13, P553, DOI 10.1089/10430340252809847; Cheng WF, 2001, J CLIN INVEST, V108, P669, DOI 10.1172/JCI200112346; Chianese-Bullock KA, 2005, J IMMUNOTHER, V28, P412, DOI 10.1097/01.cji.0000171314.00924.2b; Colpitts SL, 2012, J IMMUNOL, V188, P2483, DOI 10.4049/jimmunol.1103609; Fehniger TA, 2002, CYTOKINE GROWTH F R, V13, P169, DOI 10.1016/S1359-6101(01)00021-1; Fisher RI, 2000, CANCER J SCI AM, V6, pS55; HURTADO JC, 1995, J IMMUNOL, V155, P3360; Jang IK, 1998, BIOCHEM BIOPH RES CO, V242, P613, DOI 10.1006/bbrc.1997.8016; JOHNSTON JA, 1995, P NATL ACAD SCI USA, V92, P8705, DOI 10.1073/pnas.92.19.8705; Kim HJ, 2012, P NATL ACAD SCI USA, V109, pE13, DOI 10.1073/pnas.1112256109; Kim JJ, 1998, EUR J IMMUNOL, V28, P1089, DOI 10.1002/(SICI)1521-4141(199803)28:03<1089::AID-IMMU1089>3.0.CO;2-L; Kim MS, 2005, IMMUNOLOGY, V116, P255, DOI 10.1111/j.1365-2567.2005.02219.x; Kim TG, 2004, IMMUNOLOGY, V112, P117, DOI 10.1111/j.1365-2567.2004.01851.x; Kim TW, 2005, HUM GENE THER, V16, P26, DOI 10.1089/hum.2005.16.26; Kim TW, 2004, CANCER RES, V64, P400, DOI 10.1158/0008-5472.CAN-03-1475; Kim TY, 2002, CANCER RES, V62, P7234; Klebanoff CA, 2004, P NATL ACAD SCI USA, V101, P1969, DOI 10.1073/pnas.0307298101; Kobayashi H, 2000, CANCER RES, V60, P3577; Kocak E, 2006, CANCER RES, V66, P7276, DOI 10.1158/0008-5472.CAN-05-2128; Lee IH, 2011, DNA CELL BIOL, V30, P975, DOI 10.1089/dna.2011.1266; Li B, 2007, CLIN IMMUNOL, V125, P76, DOI 10.1016/j.clim.2007.07.005; LIN JX, 1995, IMMUNITY, V2, P331, DOI 10.1016/1074-7613(95)90141-8; Moriggl R, 1999, IMMUNITY, V11, P225, DOI 10.1016/S1074-7613(00)80097-7; Nam KO, 2005, J IMMUNOL, V174, P1898, DOI 10.4049/jimmunol.174.4.1898; Noh KH, 2012, J CLIN INVEST, V122, P4077, DOI 10.1172/JCI64057; POLLOK KE, 1993, J IMMUNOL, V150, P771; Powell DJ, 2006, J IMMUNOL, V177, P6527, DOI 10.4049/jimmunol.177.9.6527; Rosenberg SA, 1998, ANN SURG, V228, P307, DOI 10.1097/00000658-199809000-00004; Shimizu K, 2000, CANCER J SCI AM, V6, pS67; Shuford WW, 1997, J EXP MED, V186, P47, DOI 10.1084/jem.186.1.47; Simon AJ, 2008, VACCINE, V26, P5202, DOI 10.1016/j.vaccine.2008.03.058; Sin JI, 2006, EXPERT REV VACCINES, V5, P783, DOI 10.1586/14760584.5.6.783; Sin JI, 2013, CANCER LETT, V330, P190, DOI 10.1016/j.canlet.2012.11.045; Sin JI, 2009, EXPERT REV ANTICANC, V9, P1, DOI 10.1586/14737140.9.1.1; Sin JI, 1999, J VIROL, V73, P501, DOI 10.1128/JVI.73.1.501-509.1999; Smith SE, 2011, CANCER IMMUNOL IMMUN, V60, P1775, DOI 10.1007/s00262-011-1075-6; Stoklasek TA, 2006, J IMMUNOL, V177, P6072, DOI 10.4049/jimmunol.177.9.6072; Taraban VY, 2002, EUR J IMMUNOL, V32, P3617, DOI 10.1002/1521-4141(200212)32:12<3617::AID-IMMU3617>3.0.CO;2-M; Teglund S, 1998, CELL, V93, P841, DOI 10.1016/S0092-8674(00)81444-0; Waldmann TA, 2002, J CLIN IMMUNOL, V22, P51, DOI 10.1023/A:1014416616687; Waldmann TA, 2001, IMMUNITY, V14, P105, DOI 10.1016/S1074-7613(01)00093-0; Waldmann TA, 2006, NAT REV IMMUNOL, V6, P595, DOI 10.1038/nri1901; Ye GW, 2007, MOL THER, V15, P1564, DOI 10.1038/sj.mt.6300149; Zhang LX, 2003, P NATL ACAD SCI USA, V100, P15101, DOI 10.1073/pnas.2135379100	50	18	22	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83765	10.1371/journal.pone.0083765	http://dx.doi.org/10.1371/journal.pone.0083765			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391824	Green Submitted, gold, Green Published			2022-12-25	WOS:000329325200122
J	Panigrahi, R; Adina-Zada, A; Whelan, J; Vrielink, A				Panigrahi, Rashmi; Adina-Zada, Abdussalam; Whelan, James; Vrielink, Alice			Ligand Recognition by the TPR Domain of the Import Factor Toc64 from Arabidopsis thaliana	PLOS ONE			English	Article							PROTEIN SECONDARY STRUCTURE; CIRCULAR-DICHROISM SPECTRA; MOLECULAR-DYNAMICS; STRUCTURAL INSIGHTS; REPEAT PROTEINS; OUTER-MEMBRANE; CHLOROPLASTS; PREDICTION; COMPLEXES; RECEPTOR	The specific targeting of protein to organelles is achieved by targeting signals being recognised by their cognate receptors. Cytosolic chaperones, bound to precursor proteins, are recognized by specific receptors of the import machinery enabling transport into the specific organelle. The aim of this study was to gain greater insight into the mode of recognition of the C-termini of Hsp70 and Hsp90 chaperones by the Tetratricopeptide Repeat (TPR) domain of the chloroplast import receptor Toc64 from Arabidopsis thaliana (At). The monomeric TPR domain binds with 1:1 stoichiometry in similar micromolar affinity to both Hsp70 and Hsp90 as determined by isothermal titration calorimetry (ITC). Mutations of the terminal EEVD motif caused a profound decrease in affinity. Additionally, this study considered the contributions of residues upstream as alanine scanning experiments of these residues showed reduced binding affinity. Molecular dynamics simulations of the TPR domain helices upon peptide binding predicted that two helices within the TPR domain move backwards, exposing the cradle surface for interaction with the peptide. Our findings from ITC and molecular dynamics studies suggest that AtToc64_TPR does not discriminate between C-termini peptides of Hsp70 and Hsp90.	[Panigrahi, Rashmi; Adina-Zada, Abdussalam; Vrielink, Alice] Univ Western Australia, Sch Chem & Biochem, Crawley, WA, Australia; [Whelan, James] Univ Western Australia, ARC Ctr Excellence Plant Energy Biol, Crawley, WA, Australia; [Whelan, James] La Trobe Univ, Sch Life Sci, Dept Bot, Bundoora, Vic, Australia	University of Western Australia; University of Western Australia; La Trobe University	Vrielink, A (corresponding author), Univ Western Australia, Sch Chem & Biochem, Crawley, WA, Australia.	alice.vrielink@uwa.edu.au	Whelan, James/F-6402-2011; Panigrahi, Rashmi/AAK-2432-2020; Vrielink, Alice/D-3652-2013	Whelan, James/0000-0001-5754-025X; Panigrahi, Rashmi/0000-0002-1727-9269; Vrielink, Alice/0000-0001-8197-3725				Allan RK, 2011, CELL STRESS CHAPERON, V16, P353, DOI 10.1007/s12192-010-0248-0; AMADEI A, 1993, PROTEINS, V17, P412, DOI 10.1002/prot.340170408; Baker MJ, 2007, TRENDS CELL BIOL, V17, P456, DOI 10.1016/j.tcb.2007.07.010; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Boersma YL, 2011, CURR OPIN BIOTECH, V22, P849, DOI 10.1016/j.copbio.2011.06.004; Brinker A, 2002, J BIOL CHEM, V277, P19265, DOI 10.1074/jbc.M109002200; Brocard C, 2006, BBA-MOL CELL RES, V1763, P1565, DOI 10.1016/j.bbamcr.2006.08.022; Buchan DWA, 2010, NUCLEIC ACIDS RES, V38, pW563, DOI 10.1093/nar/gkq427; Case D. A., 2012, AMBER 12; Cheng CY, 2006, BIOCHEMISTRY-US, V45, P12175, DOI 10.1021/bi060819a; COMPTON LA, 1986, ANAL BIOCHEM, V155, P155, DOI 10.1016/0003-2697(86)90241-1; D'Andrea LD, 2003, TRENDS BIOCHEM SCI, V28, P655, DOI 10.1016/j.tibs.2003.10.007; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Deng YQ, 2009, J PHYS CHEM B, V113, P2234, DOI 10.1021/jp807701h; Freyer MW, 2008, METHOD CELL BIOL, V84, P79, DOI 10.1016/S0091-679X(07)84004-0; Gotz AW, 2012, J CHEM THEORY COMPUT, V8, P1542, DOI 10.1021/ct200909j; Grant BJ, 2006, BIOINFORMATICS, V22, P2695, DOI 10.1093/bioinformatics/btl461; GREENFIE.N, 1969, BIOCHEMISTRY-US, V8, P4108, DOI 10.1021/bi00838a031; Grove TZ, 2008, CURR OPIN STRUC BIOL, V18, P507, DOI 10.1016/j.sbi.2008.05.008; Hainzl O, 2004, J BIOL CHEM, V279, P23267, DOI 10.1074/jbc.M402189200; HARTE WE, 1990, P NATL ACAD SCI USA, V87, P8864, DOI 10.1073/pnas.87.22.8864; Hinnah SC, 2002, BIOPHYS J, V83, P899, DOI 10.1016/S0006-3495(02)75216-8; HIRANO T, 1990, CELL, V60, P319, DOI 10.1016/0092-8674(90)90746-2; Hubbard S. J., 1993, NACCESS; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; ICHIYE T, 1991, PROTEINS, V11, P205, DOI 10.1002/prot.340110305; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kajander T, 2005, J AM CHEM SOC, V127, P10188, DOI 10.1021/ja0524494; Koenig P, 2008, STRUCTURE, V16, P585, DOI 10.1016/j.str.2008.01.008; Kollman PA, 2000, ACCOUNTS CHEM RES, V33, P889, DOI 10.1021/ar000033j; Krieger F, 2005, J AM CHEM SOC, V127, P3346, DOI 10.1021/ja042798i; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Lebowitz J, 2002, PROTEIN SCI, V11, P2067, DOI 10.1110/ps.0207702; Li HM, 2010, ANNU REV PLANT BIOL, V61, P157, DOI 10.1146/annurev-arplant-042809-112222; London N, 2011, NUCLEIC ACIDS RES, V39, pW249, DOI 10.1093/nar/gkr431; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Lunelli M, 2009, P NATL ACAD SCI USA, V106, P9661, DOI 10.1073/pnas.0812900106; MANAVALAN P, 1987, ANAL BIOCHEM, V167, P76, DOI 10.1016/0003-2697(87)90135-7; MCDONALD IK, 1994, J MOL BIOL, V238, P777, DOI 10.1006/jmbi.1994.1334; Mirus O, 2009, J MOL MODEL, V15, P971, DOI 10.1007/s00894-008-0449-y; Morlot C, 2007, P NATL ACAD SCI USA, V104, P14923, DOI 10.1073/pnas.0705310104; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; Qbadou S, 2007, J MOL BIOL, V367, P1330, DOI 10.1016/j.jmb.2007.01.047; Qbadou S, 2006, EMBO J, V25, P1836, DOI 10.1038/sj.emboj.7601091; Ralston G, INTRO ANAL ULTRACENT, P1; Raveh B, 2010, PROTEINS, V78, P2029, DOI 10.1002/prot.22716; Roy A, 2011, JOVE-J VIS EXP, DOI 10.3791/3259; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Salomon-Ferrer R, 2012, J CHEM THEORY UNPUB; Sampathkumar P, 2008, J MOL BIOL, V381, P867, DOI 10.1016/j.jmb.2008.05.089; Scheufler C, 2000, CELL, V101, P199, DOI 10.1016/S0092-8674(00)80830-2; SCHULTZ J, 1990, MOL CELL BIOL, V10, P4744, DOI 10.1128/MCB.10.9.4744; SIKORSKI RS, 1990, CELL, V60, P307, DOI 10.1016/0092-8674(90)90745-Z; Smith MD, 2004, J CELL BIOL, V165, P323, DOI 10.1083/jcb.200311074; Sohrt K, 2000, J CELL BIOL, V148, P1213, DOI 10.1083/jcb.148.6.1213; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Srinivasan J, 1998, J BIOMOL STRUCT DYN, V16, P671, DOI 10.1080/07391102.1998.10508279; Trevino SR, 2007, J MOL BIOL, V373, P211, DOI 10.1016/j.jmb.2007.07.061; Velazquez-Campoy A, 2006, NAT PROTOC, V1, P186, DOI 10.1038/nprot.2006.28; Venclovas C, 2005, PROTEINS, V61, P99, DOI 10.1002/prot.20725; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; Zeytuni N, 2012, STRUCTURE, V20, P397, DOI 10.1016/j.str.2012.01.006; Zeytuni N, 2011, P NATL ACAD SCI USA, V108, pE480, DOI 10.1073/pnas.1103367108; Zhang ZG, 2010, EMBO J, V29, P3733, DOI 10.1038/emboj.2010.247	68	10	10	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83461	10.1371/journal.pone.0083461	http://dx.doi.org/10.1371/journal.pone.0083461			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391770	gold, Green Submitted, Green Published			2022-12-25	WOS:000329325200067
J	Polston, JE; Pritchett, CE; Tomasko, JM; Rogers, AM; Leggio, L; Thanos, PK; Volkow, ND; Hajnal, A				Polston, James E.; Pritchett, Carolyn E.; Tomasko, Jonathan M.; Rogers, Ann M.; Leggio, Lorenzo; Thanos, Panayotis K.; Volkow, Nora D.; Hajnal, Andras			Roux-en-Y Gastric Bypass Increases Intravenous Ethanol Self-Administration in Dietary Obese Rats	PLOS ONE			English	Article							STIMULATES LOCOMOTOR-ACTIVITY; BARIATRIC SURGERY; NUCLEUS-ACCUMBENS; ALCOHOL METABOLISM; ENERGY-EXPENDITURE; GHRELIN LEVELS; FOOD REWARD; SWEET TASTE; DOPAMINE; CONSUMPTION	Roux-en-Y gastric bypass surgery (RYGB) is an effective treatment for severe obesity. Clinical studies however have reported susceptibility to increased alcohol use after RYGB, and preclinical studies have shown increased alcohol intake in obese rats after RYGB. This could reflect a direct enhancement of alcohol's rewarding effects in the brain or an indirect effect due to increased alcohol absorption after RGYB. To rule out the contribution that changes in alcohol absorption have on its rewarding effects, here we assessed the effects of RYGB on intravenously (IV) administered ethanol (1%). For this purpose, high fat (60% kcal from fat) diet-induced obese male Sprague Dawley rats were tested similar to 2 months after RYGB or sham surgery (SHAM) using both fixed and progressive ratio schedules of reinforcement to evaluate if RGYB modified the reinforcing effects of IV ethanol. Compared to SHAM, RYGB rats made significantly more active spout responses to earn IV ethanol during the fixed ratio schedule, and achieved higher breakpoints during the progressive ratio schedule. Although additional studies are needed, our results provide preliminary evidence that RYGB increases the rewarding effects of alcohol independent of its effects on alcohol absorption.	[Polston, James E.; Pritchett, Carolyn E.; Hajnal, Andras] Penn State Univ, Dept Neural & Behav Sci, Coll Med, Hershey, PA 17033 USA; [Tomasko, Jonathan M.; Rogers, Ann M.; Hajnal, Andras] Penn State Univ, Dept Surg, Coll Med, Hershey, PA USA; [Leggio, Lorenzo] NIAAA, Sect Clin Psychoneuroendocrinol & Neuropsychophar, Lab Clin & Translat Studies, NIH, Bethesda, MD USA; [Leggio, Lorenzo] NIDA, Intramural Res Program, NIH, Baltimore, MD USA; [Leggio, Lorenzo] Brown Univ, Dept Behav & Social Sci, Providence, RI 02912 USA; [Thanos, Panayotis K.] SUNY Stony Brook, Dept Psychol, Stony Brook, NY 11794 USA; [Volkow, Nora D.] NIAAA Intramural Program, Lab Neuroimaging, NIH, Bethesda, MD USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); NIH National Institute on Drug Abuse (NIDA); Brown University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)	Hajnal, A (corresponding author), Penn State Univ, Dept Neural & Behav Sci, Coll Med, Hershey, PA 17033 USA.	ahajnal@psu.edu	Leggio, Lorenzo/M-2972-2016	Pritchett, Carolyn/0000-0002-3880-6603; Hajnal, Andras/0000-0001-7297-7134	National Institute of Diabetes and Digestive and Kidney Diseases [DK080899]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080899] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000550] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This research was supported by National Institute of Diabetes and Digestive and Kidney Diseases Grant DK080899 (to AH). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abizaid A, 2011, NEUROSCIENCE, V192, P500, DOI 10.1016/j.neuroscience.2011.06.001; Abizaid A, 2009, J NEUROENDOCRINOL, V21, P787, DOI 10.1111/j.1365-2826.2009.01896.x; Beckman LM, 2011, JPEN-PARENTER ENTER, V35, P169, DOI 10.1177/0148607110381403; Boileau I, 2003, SYNAPSE, V49, P226, DOI 10.1002/syn.10226; Briggs DI, 2010, ENDOCRINOLOGY, V151, P4745, DOI 10.1210/en.2010-0556; BROWN EK, 1982, J AM DIET ASSOC, V80, P437; CARROLL ME, 1979, SCIENCE, V205, P319, DOI 10.1126/science.36665; Cummings DE, 2004, AM J PHYSIOL-ENDOC M, V287, pE297, DOI 10.1152/ajpendo.00582.2003; Davis JF, 2013, OBES SURG, V23, P920, DOI 10.1007/s11695-013-0884-4; Davis JF, 2012, BIOL PSYCHIAT, V72, P354, DOI 10.1016/j.biopsych.2012.01.035; Davis JF, 2008, BEHAV NEUROSCI, V122, P1257, DOI 10.1037/a0013111; de Vaca SC, 1998, J NEUROSCI, V18, P7502; Dunn JP, 2012, DIABETES CARE, V35, P1105, DOI 10.2337/dc11-2250; Dunn JP, 2010, BRAIN RES, V1350, P123, DOI 10.1016/j.brainres.2010.03.064; Ertelt TW, 2008, SURG OBES RELAT DIS, V4, P647, DOI 10.1016/j.soard.2008.01.004; Figlewicz DP, 2009, AM J PHYSIOL-REG I, V296, pR9, DOI 10.1152/ajpregu.90725.2008; Geraedts MCP, 2012, AM J PHYSIOL-ENDOC M, V303, pE464, DOI 10.1152/ajpendo.00163.2012; Grigson PS, 2002, BEHAV NEUROSCI, V116, P321, DOI 10.1037/0735-7044.116.2.321; Hagedorn JC, 2007, SURG OBES RELAT DIS, V3, P543, DOI 10.1016/j.soard.2007.07.003; Hajnal A, 2010, AM J PHYSIOL-GASTR L, V299, pG967, DOI 10.1152/ajpgi.00070.2010; HALMI KA, 1981, INT J OBESITY, V5, P457; Holt PR, 2011, LANCET, V378, P767, DOI 10.1016/S0140-6736(11)61372-X; Howard EC, 2008, NEUROSCIENCE, V154, P1042, DOI 10.1016/j.neuroscience.2008.04.014; Hsu LKG, 1998, PSYCHOSOM MED, V60, P338, DOI 10.1097/00006842-199805000-00021; Hyytia P, 1996, PSYCHOPHARMACOLOGY, V125, P248, DOI 10.1007/BF02247335; Jerlhag E, 2007, ADDICT BIOL, V12, P6, DOI 10.1111/j.1369-1600.2006.00041.x; Jerlhag E, 2006, ADDICT BIOL, V11, P45, DOI 10.1111/j.1369-1600.2006.00002.x; Jerlhag E, 2009, P NATL ACAD SCI USA, V106, P11318, DOI 10.1073/pnas.0812809106; JULKUNEN RJK, 1985, ALCOHOL, V2, P437, DOI 10.1016/0741-8329(85)90111-9; Kenna GA, 2012, NEUROPSYCHOL REV, V22, P211, DOI 10.1007/s11065-012-9209-y; King WC, 2012, JAMA-J AM MED ASSOC, V307, P2516, DOI 10.1001/jama.2012.6147; Klockhoff H, 2002, BRIT J CLIN PHARMACO, V54, P587, DOI 10.1046/j.1365-2125.2002.01698.x; Korner J, 2009, INT J OBESITY, V33, P786, DOI 10.1038/ijo.2009.79; Kumar R, 2011, SURGERY, V149, P654, DOI 10.1016/j.surg.2010.11.015; Kuzmin A, 1999, EUR NEUROPSYCHOPHARM, V9, P197, DOI 10.1016/S0924-977X(98)00025-X; le Roux CW, 2011, AM J PHYSIOL-REG I, V301, pR1057, DOI 10.1152/ajpregu.00139.2011; Maluenda F, 2010, OBES SURG, V20, P744, DOI 10.1007/s11695-010-0136-9; Miras AD, 2013, NAT REV GASTROENTERO; Olbers T, 2006, ANN SURG, V244, P715, DOI 10.1097/01.sla.0000218085.25902.f8; Saules KK, 2010, SURG OBES RELAT DIS, V6, P615, DOI 10.1016/j.soard.2009.12.008; Shin AC, 2011, INT J OBESITY, V35, P642, DOI 10.1038/ijo.2010.174; Shin AC, 2010, ENDOCRINOLOGY, V151, P1588, DOI 10.1210/en.2009-1332; Steele KE, 2010, OBES SURG, V20, P369, DOI 10.1007/s11695-009-0015-4; Stylopoulos N, 2009, OBESITY, V17, P1839, DOI 10.1038/oby.2009.207; Suzuki J, 2012, OBES SURG, V22, P201, DOI 10.1007/s11695-010-0346-1; Tam CS, 2011, OBES REV, V12, P984, DOI 10.1111/j.1467-789X.2011.00902.x; Thanos PK, 2012, OBES SURG, V22, P1884, DOI 10.1007/s11695-012-0749-2; Tschop M, 2001, DIABETES, V50, P707, DOI 10.2337/diabetes.50.4.707; Volkow ND, 2011, TRENDS COGN SCI, V15, P37, DOI 10.1016/j.tics.2010.11.001; Wang GJ, 2001, LANCET, V357, P354, DOI 10.1016/S0140-6736(00)03643-6; Werling M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060280; Woodard GA, 2011, J AM COLL SURGEONS, V212, P209, DOI 10.1016/j.jamcollsurg.2010.09.020	52	36	37	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83741	10.1371/journal.pone.0083741	http://dx.doi.org/10.1371/journal.pone.0083741			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391816	Green Published, gold, Green Submitted			2022-12-25	WOS:000329325200114
J	Jiao, WW; Liu, ZG; Han, R; Zhao, XQ; Dong, F; Dong, HY; Huang, HR; Tian, JL; Li, QJ; Lian, LL; Yin, QQ; Song, WQ; Wan, KL; Shen, AD				Jiao, Weiwei; Liu, Zhiguang; Han, Rui; Zhao, Xiuqin; Dong, Fang; Dong, Haiyan; Huang, Hairong; Tian, Jianling; Li, Qinjing; Lian, Lulu; Yin, Qingqin; Song, Wenqi; Wan, Kanglin; Shen, A-dong			A Country-Wide Study of Spoligotype and Drug Resistance Characteristics of Mycobacterium tuberculosis Isolates from Children in China	PLOS ONE			English	Article							BEIJING GENOTYPE; STRAINS; EPIDEMIOLOGY; PROVINCES	Background: Tuberculosis (TB) is still a big threat to human health, especially in children. However, an isolation of Mycobacterium tuberculosis culture from pediatric cases remains a challenge. In order to provide some scientific basis for children TB control, we investigated the genotyping and drug resistance characteristics of M. tuberculosis isolates from pediatric cases in China. Methodology/Principal Findings: In this study, a total of 440 strains including 90 from children (<15 years), 159 from adolescents (15-18 years) and 191 from adults (>18 years) isolated in 25 provinces across China were subjected to spoligotyping and drug susceptibility testing. As a result, Beijing family strains were shown to remain predominant in China (85.6%, 81.1% and 75.4% in three above groups, respectively), especially among new children cases (91.0% vs. 69.6% in previously treated cases, P = 0.03). The prevalence of the Beijing genotype isolates was higher in northern and central China in the total collection (85.1% in northern and 83.9% in central vs. 61.6% in southern China, P<0.001) and a similar trend was seen in all three age groups (P = 0.708, <0.001 and 0.025, respectively). In adolescents, the frequencies of isoniazid (INH)-resistant and ethambutol (EMB)-resistant isolates were significantly higher among Beijing strains compared to non-Beijing genotype strains (P = 0.028 for INH and P = 0.027 for EMB). Furthermore, strong association was observed between resistance to rifampicine (RIF), streptomycin (STR) and multidrug resistance (MDR) among Beijing compared to non-Beijing strains in previously treated cases of children (P = 0.01, 0.01 and 0.025, respectively). Conclusion/Significance: Beijing family was more prevalent in northern and central China compared to southern China and these strains were predominant in all age groups. The genetic diversity of M. tuberculosis isolates from children was similar to that found in adolescents and adults. Beijing genotype was associated with RIF, STR and MDR resistance in previously treated children.	[Jiao, Weiwei; Han, Rui; Dong, Fang; Tian, Jianling; Li, Qinjing; Yin, Qingqin; Song, Wenqi; Shen, A-dong] Capital Med Univ, Beijing Childrens Hosp, Key Lab Major Dis Children, Minist Educ,Beijing Pediat Res Inst, Beijing, Peoples R China; [Jiao, Weiwei; Han, Rui; Dong, Fang; Tian, Jianling; Li, Qinjing; Yin, Qingqin; Song, Wenqi; Shen, A-dong] Capital Med Univ, Beijing Childrens Hosp, Natl Key Discipline Pediat, Minist Educ,Beijing Pediat Res Inst, Beijing, Peoples R China; [Liu, Zhiguang; Zhao, Xiuqin; Dong, Haiyan; Lian, Lulu; Wan, Kanglin] Chinese Ctr Dis Control & Prevent, Natl Inst Communicable Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China; [Liu, Zhiguang; Zhao, Xiuqin; Dong, Haiyan; Lian, Lulu; Wan, Kanglin] Collaborat Innovat Ctr Diag & Treatment Infect Di, Hangzhou, Zhejiang, Peoples R China; [Huang, Hairong] Capital Med Univ, Beijing Chest Hosp, Natl TB Clin Lab, Beijing, Peoples R China	Capital Medical University; Capital Medical University; Chinese Center for Disease Control & Prevention; National Institute for Communicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases; Capital Medical University	Wan, KL (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Inst Communicable Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China.	wankanglin@icdc.cn; shenad16@hotmail.com		Song, Wenqi/0000-0002-2660-8992	Capital Health Research and Development of Special Grant [2011-1007-01, 2011-2009-05]; National Science and Technology Major Project of China [2013ZX10003003]; Open Project of Beijing Key Laboratory of Capital Medical University [2013NYJH02]; National Natural Science Foundation of China [81271889]	Capital Health Research and Development of Special Grant; National Science and Technology Major Project of China; Open Project of Beijing Key Laboratory of Capital Medical University; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the Capital Health Research and Development of Special Grant (No. 2011-1007-01, No. 2011-2009-05), National Science and Technology Major Project of China (2013ZX10003003), Open Project of Beijing Key Laboratory of Capital Medical University (2013NYJH02) and National Natural Science Foundation of China (No. 81271889). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, EMERG INFECT DIS, V12, P736, DOI [10.3201/eid1205.050400, DOI 10.3201/EID1205.050400]; Bifani PJ, 2002, TRENDS MICROBIOL, V10, P45, DOI 10.1016/S0966-842X(01)02277-6; Demay C, 2012, INFECT GENET EVOL, V12, P755, DOI 10.1016/j.meegid.2012.02.004; Dong HY, 2010, J CLIN MICROBIOL, V48, P4102, DOI 10.1128/JCM.00549-10; Guo YL, 2011, INT J TUBERC LUNG D, V15, P789, DOI 10.5588/ijtld.10.0403; Hanekom M, 2011, TUBERCULOSIS, V91, P510, DOI 10.1016/j.tube.2011.07.005; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Kremer K, 2004, J CLIN MICROBIOL, V42, P4040, DOI 10.1128/JCM.42.9.4040-4049.2004; Li Liang, 2004, Zhonghua Yi Xue Za Zhi, V84, P1678; Liu Bin-Bin, 2012, Zhonghua Yu Fang Yi Xue Za Zhi, V46, P158; Lopez B, 2003, CLIN EXP IMMUNOL, V133, P30, DOI 10.1046/j.1365-2249.2003.02171.x; Pang Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032976; Parwati I, 2010, LANCET INFECT DIS, V10, P103, DOI 10.1016/S1473-3099(09)70330-5; Tsenova L, 2007, VACCINE, V25, P5126, DOI 10.1016/j.vaccine.2006.11.024; VANEMBDEN JDA, 1993, J CLIN MICROBIOL, V31, P406, DOI 10.1128/JCM.31.2.406-409.1993; VANSOOLINGEN D, 1995, J CLIN MICROBIOL, V33, P3234, DOI 10.1128/JCM.33.12.3234-3238.1995; Wan KL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029190; Word Health Organization, GLOB TUB REP 2012; World Health Organization, GUID SURV DRUG RES T; Xing L, 2012, EUR J CLIN MICROBIOL, V31, P1735, DOI 10.1007/s10096-011-1494-5; Yang CG, 2012, CLIN INFECT DIS, V55, P1179, DOI 10.1093/cid/cis670	21	9	9	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e84315	10.1371/journal.pone.0084315	http://dx.doi.org/10.1371/journal.pone.0084315			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386365	Green Published, gold, Green Submitted			2022-12-25	WOS:000329194700102
J	Sattayasai, J; Chaonapan, P; Arkaravichie, T; Soi-ampornkul, R; Junnu, S; Charoensilp, P; Samer, J; Jantaravinid, J; Masaratana, P; Suktitipat, B; Manissorn, J; Thongboonkerd, V; Neungton, N; Moongkarndi, P				Sattayasai, Jintana; Chaonapan, Pongsatorn; Arkaravichie, Tarinee; Soi-ampornkul, Rungtip; Junnu, Sarawut; Charoensilp, Patcharakajee; Samer, Jutima; Jantaravinid, Jiraporn; Masaratana, Patarabutr; Suktitipat, Bhoom; Manissorn, Juthatip; Thongboonkerd, Visith; Neungton, Neelobol; Moongkarndi, Primchanien			Protective Effects of Mangosteen Extract on H2O2-Induced Cytotoxicity in SK-N-SH Cells and Scopolamine-Induced Memory Impairment in Mice	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; ACETYLCHOLINESTERASE INHIBITORS; ANTIOXIDANT; TOXICITY; CLEAVAGE; PERICARP; BIOLOGY; AGE	Mangosteen extracts (ME) contain high levels of polyphenolic compounds and antioxidant activity. Protective effects of ME against beta-amyloid peptide (A beta), induced cytotoxicity have been reported. Here, we further studied the protective effects of ME against oxidative stress induced by hydrogen peroxide (H2O2) and polychlorinated biphenyls (PCBs), and demonstrated the protection against memory impairment in mice. The cytoprotective effects of ME were measured as cell viability and the reduction in ROS activity. In SK-N-SH cell cultures, 200 mu g/ml ME could partially antagonize the effects of 150 or 300 mu M H2O2 on cell viability, ROS level and caspase-3 activity. At 200, 400 or 800 mu g/ml, ME reduced AChE activity of SK-N-SH cells to about 60% of the control. In vivo study, Morris water maze and passive avoidance tests were used to assess the memory of the animals. ME, especially at 100 mg/kg body weight, could improve the animal's memory and also antagonize the effect of scopolamine on memory. The increase in ROS level and caspase-3 activity in the brain of scopolamine-treated mice were antagonized by the ME treatment. The study demonstrated cytoprotective effects of ME against H2O2 and PCB-52 toxicity and having AChE inhibitory effect in cell culture. ME treatment in mice could attenuate scopolamine-induced memory deficit and oxidative stress in brain.	[Sattayasai, Jintana; Chaonapan, Pongsatorn; Arkaravichie, Tarinee] Khon Kaen Univ, Fac Med, Dept Pharmacol, Khon Kaen, Thailand; [Soi-ampornkul, Rungtip; Junnu, Sarawut; Charoensilp, Patcharakajee; Jantaravinid, Jiraporn; Masaratana, Patarabutr; Suktitipat, Bhoom; Neungton, Neelobol] Mahidol Univ, Siriraj Hosp, Fac Med, Dept Biochem, Bangkok 10700, Thailand; [Samer, Jutima; Moongkarndi, Primchanien] Mahidol Univ, Fac Pharm, Dept Microbiol, Bangkok 10700, Thailand; [Manissorn, Juthatip; Thongboonkerd, Visith] Mahidol Univ, Siriraj Hosp, Fac Med, Med Prote Unit,Off Res & Dev, Bangkok 10700, Thailand	Khon Kaen University; Mahidol University; Mahidol University; Mahidol University	Moongkarndi, P (corresponding author), Mahidol Univ, Fac Pharm, Dept Microbiol, Bangkok 10700, Thailand.	primchanien.moo@mahidol.ac.th	Thongboonkerd, Visith/C-6920-2009; Suktitipat, Bhoom/H-4239-2019	Thongboonkerd, Visith/0000-0001-7865-0765; Suktitipat, Bhoom/0000-0001-8034-7757; , Patarabutr/0000-0001-7228-7176	Graduate Research, Faculty of Medicine Siriraj Hospital; Mahidol University; Thai Traditional Medical Knowledge Fund; Ministry of Public Health, Thailand; Thailand Research Fund; Thai government	Graduate Research, Faculty of Medicine Siriraj Hospital; Mahidol University; Thai Traditional Medical Knowledge Fund; Ministry of Public Health, Thailand; Thailand Research Fund(Thailand Research Fund (TRF)); Thai government	This work was supported by Siriraj Grant for Graduate Research, Faculty of Medicine Siriraj Hospital, Mahidol University, Thai Traditional Medical Knowledge Fund, Ministry of Public Health, Thailand, and the Thailand Research Fund. The grants belong to the Thai government support for scientific merit-study and had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Salam OME, 2013, EXCLI J, V12, P193; Ancelin ML, 2007, DEMENT GERIATR COGN, V24, P1, DOI 10.1159/000102567; [Anonymous], 2008, CMU J NATL SCI; BARTUS RT, 1985, PHARMACOL BIOCHEM BE, V23, P125, DOI 10.1016/0091-3057(85)90139-X; BECKER JT, 1988, ARCH NEUROL-CHICAGO, V45, P263, DOI 10.1001/archneur.1988.00520270037018; Blennow K, 2006, LANCET, V368, P387, DOI 10.1016/S0140-6736(06)69113-7; Chantarasriwong O, 2010, CHEM-EUR J, V16, P9944, DOI 10.1002/chem.201000741; Chivapat S, 2011, THAI J VET MED, V41, P45; Cook A, 2007, ANNU REV BIOCHEM, V76, P647, DOI 10.1146/annurev.biochem.76.052705.161529; Deiana S, 2009, PSYCHOPHARMACOLOGY, V202, P53, DOI 10.1007/s00213-008-1394-2; Driver AS, 2000, NEUROTOXICOL TERATOL, V22, P175, DOI 10.1016/S0892-0362(99)00069-0; Fischbein A, 1979, Ann N Y Acad Sci, V320, P703, DOI 10.1111/j.1749-6632.1979.tb13188.x; Gamblin TC, 2003, P NATL ACAD SCI USA, V100, P10032, DOI 10.1073/pnas.1630428100; Giridharan VV, 2011, FOOD FUNCT, V2, P320, DOI 10.1039/c1fo10037h; Goverdhan Puchchakayala, 2012, Int J Alzheimers Dis, V2012, P974013, DOI 10.1155/2012/974013; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hasselmo ME, 2006, CURR OPIN NEUROBIOL, V16, P710, DOI 10.1016/j.conb.2006.09.002; Hatip-Al-Khatib I, 2005, BRIT J PHARMACOL, V145, P1035, DOI 10.1038/sj.bjp.0706288; Hutadilok-Towatana N, 2010, J MED PLANTS RES, V4, P969; JORM AF, 1987, ACTA PSYCHIAT SCAND, V76, P465, DOI 10.1111/j.1600-0447.1987.tb02906.x; Jung HA, 2006, J AGR FOOD CHEM, V54, P2077, DOI 10.1021/jf052649z; Kim DH, 2010, ARCH PHARM RES, V33, P1685, DOI 10.1007/s12272-010-1019-2; Kosem N, 2013, J NAT MED-TOKYO, V67, P255, DOI 10.1007/s11418-012-0673-8; Kosem Nuttavut, 2007, ScienceAsia, V33, P283, DOI 10.2306/scienceasia1513-1874.2007.33.283; Marquez-Valadez B, 2009, NUTR NEUROSCI, V12, P35, DOI 10.1179/147683009X388850; MOLCHAN SE, 1992, BRAIN RES REV, V17, P215, DOI 10.1016/0165-0173(92)90017-G; Moongkarndi P, 2010, J PROTEOME RES, V9, P2076, DOI 10.1021/pr100049v; Mukherjee PK, 2007, PHYTOMEDICINE, V14, P289, DOI 10.1016/j.phymed.2007.02.002; Ngawhirunpat T, 2010, PHARM BIOL, V48, P55, DOI 10.3109/13880200903046138; Onoue S, 2002, PEPTIDES, V23, P1471, DOI 10.1016/S0196-9781(02)00085-2; Pachauri SD, 2012, J ETHNOPHARMACOL, V139, P34, DOI 10.1016/j.jep.2011.09.057; Pedraza-Chaverri J, 2008, FOOD CHEM TOXICOL, V46, P3227, DOI 10.1016/j.fct.2008.07.024; Rogers SL, 1996, DEMENTIA, V7, P293, DOI 10.1159/000106895; RUSTED JM, 1988, PSYCHOPHARMACOLOGY, V96, P145; Sanchez-Perez Y, 2010, CHEM-BIOL INTERACT, V188, P144, DOI 10.1016/j.cbi.2010.06.014; Sekler Alejandra, 2008, Neuropsychiatr Dis Treat, V4, P715; Tabet N, 2006, AGE AGEING, V35, P336, DOI 10.1093/ageing/afl027; Vassar R, 2007, NEURON, V54, P671, DOI 10.1016/j.neuron.2007.05.018; WESNES K, 1988, HUMAN PSYCHOPHARMACO, V3, P27, DOI DOI 10.1002/HUP.470030106; World Health Organization, 2000, US; Yang Dongren, 2010, Curr Neurobiol, V1, P70	41	36	37	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e85053	10.1371/journal.pone.0085053	http://dx.doi.org/10.1371/journal.pone.0085053			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281RE	24386444	Green Published, gold, Green Submitted			2022-12-25	WOS:000329117900120
J	Yoshioka, S; Abe, H; Sakumoto, R; Okuda, K				Yoshioka, Shin; Abe, Hironori; Sakumoto, Ryosuke; Okuda, Kiyoshi			Proliferation of Luteal Steroidogenic Cells in Cattle	PLOS ONE			English	Article							BOVINE CORPUS-LUTEUM; CORPORA-LUTEA; GRANULOSA-CELLS; ANGIOGENESIS; EXPRESSION; GROWTH; PROGESTERONE; REGULATORS; DIFFERENTIATION; IDENTIFICATION	The rapid growth of the corpus luteum (CL) after ovulation is believed to be mainly due to an increase in the size of luteal cells (hypertrophy) rather than an increase in their number. However, the relationship between luteal growth and the proliferation of luteal steroidogenic cells (LSCs) is not fully understood. One goal of the present study was to determine whether LSCs proliferate during CL growth. A second goal was to determine whether luteinizing hormone (LH), which is known have roles in the proliferation and differentiation of follicular cells, also affects the proliferation of LSCs. Ki-67 (a cell proliferation marker) was expressed during the early, developing and mid luteal stages and some Ki-67-positive cells co-expressed HSD3B (a steroidogenic marker). DNA content in LSCs isolated from the developing CL increased much more rapidly (indicating rapid growth) than did DNA content in LSCs isolated from the mid CL. The cell cycle-progressive genes CCND2 (cyclin D2) and CCNE1 (cyclin E1) mRNA were expressed more strongly in the small luteal cells than in the large luteal cells. LH decreased the rate of increase of DNA in LSCs isolated from the mid luteal stage but not in LSCs from the developing stage. LH suppressed CCND2 expression in LSCs from the mid luteal stage but not from the developing luteal stage. Furthermore, LH receptor (LHCGR) mRNA expression was higher at the mid luteal stage than at the developing luteal stage. The overall results suggest that the growth of the bovine CL is due to not only hypertrophy of LSCs but also an increase in their number, and that the proliferative ability of luteal steroidogenic cells decreases between the developing and mid luteal stages.	[Yoshioka, Shin; Okuda, Kiyoshi] Okayama Univ, Grad Sch Nat Sci & Technol, Okayama 7008530, Japan; [Abe, Hironori; Okuda, Kiyoshi] Okayama Univ, Grad Sch Environm & Life Sci, Okayama 7008530, Japan; [Sakumoto, Ryosuke] Natl Inst Agrobiol Sci, Reprod Biol Res Unit, Tsukuba, Ibaraki, Japan	Okayama University; Okayama University; National Institute of Agrobiological Sciences - Japan	Okuda, K (corresponding author), Okayama Univ, Grad Sch Nat Sci & Technol, Okayama 7008530, Japan.	kokuda@cc.okayama-u.ac.jp	OKUDA, Kiyoshi/AAC-8606-2020		Japan Society for the Promotion Science (JSPS) [25-612, 24380155]	Japan Society for the Promotion Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This research was supported by the Grants-in-Aid for Japan Society for Promotion of Science fellows (No. 25-612) and for Scientific Research (No. 24380155) from the Japan Society for the Promotion Science (JSPS; http://www.jsps.go.jp/english/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-zi'abil MO, 2003, REPRODUCTION, V125, P259, DOI 10.1530/rep.0.1250259; ALILA HW, 1984, BIOL REPROD, V31, P1015, DOI 10.1095/biolreprod31.5.1015; ALILA HW, 1988, J REPROD FERTIL, V82, P645, DOI 10.1530/jrf.0.0820645; Baird D, 1984, OVARY; Cannon JD, 2005, ENDOCRINOLOGY, V146, P414, DOI 10.1210/en.2004-0581; Chaffin CL, 2003, ENDOCRINOLOGY, V144, P1249, DOI 10.1210/en.2002-220664; Ciuffreda L, 2012, J MOL MED, V90, P667, DOI 10.1007/s00109-011-0844-1; FITZ TA, 1982, BIOL REPROD, V27, P703, DOI 10.1095/biolreprod27.3.703; Hampl A, 2000, BIOL REPROD, V62, P1393, DOI 10.1095/biolreprod62.5.1393; Hansel W, 1996, THERIOGENOLOGY, V45, P1267, DOI 10.1016/0093-691X(96)00098-2; Hazzard TM, 2000, BEST PRACT RES CL OB, V14, P883, DOI 10.1053/beog.2000.0133; JABLONKASHARIFF A, 1993, ENDOCRINOLOGY, V133, P1871, DOI 10.1210/en.133.4.1871; Jirawatnotai S, 2003, J BIOL CHEM, V278, P17021, DOI 10.1074/jbc.M301206200; Kayani AR, 2009, REPRODUCTION, V137, P67, DOI 10.1530/REP-08-0198; Koos R, 1981, LARGE SMALL CELLS BO; LABARCA C, 1980, ANAL BIOCHEM, V102, P344, DOI 10.1016/0003-2697(80)90165-7; LEI ZM, 1991, BIOL REPROD, V44, P1148, DOI 10.1095/biolreprod44.6.1148; LEMON M, 1982, J REPROD FERTIL, V64, P315, DOI 10.1530/jrf.0.0640315; McBride D, 2012, REPRODUCTION, V144, P221, DOI 10.1530/REP-12-0025; MCCLELLAN MC, 1975, CELL TISSUE RES, V164, P291, DOI 10.1007/BF00223011; Meidan R, 1999, J REPROD FERTIL, P217; MEYER GT, 1979, ANAT REC, V193, P823, DOI 10.1002/ar.1091930406; Miyamoto Y, 2000, BIOL REPROD, V62, P1109, DOI 10.1095/biolreprod62.5.1109; MORGAN DO, 1995, NATURE, V374, P131, DOI 10.1038/374131a0; MOSS S, 1954, ANAT REC, V120, P409, DOI 10.1002/ar.1091200205; Nakajima K, 2011, DEVELOPMENT, V138, P1771, DOI 10.1242/dev.059295; OKUDA K, 1992, BIOL REPROD, V46, P1001, DOI 10.1095/biolreprod46.6.1001; OSHEA JD, 1989, J REPROD FERTIL, V85, P483, DOI 10.1530/jrf.0.0850483; OSHEA JD, 1979, J ANAT, V128, P239; Pate JL, 1996, THERIOGENOLOGY, V45, P1381, DOI 10.1016/0093-691X(96)00102-1; Phin S, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00240; Poliseno L, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000594; Reynolds Lawrence P., 1994, Progress in Growth Factor Research, V5, P159, DOI 10.1016/0955-2235(94)90003-5; Richards JS, 1998, MOL CELL ENDOCRINOL, V145, P47, DOI 10.1016/S0303-7207(98)00168-3; Richards JS, 2002, ANNU REV PHYSIOL, V64, P69, DOI 10.1146/annurev.physiol.64.081501.131029; Robker RL, 1998, MOL ENDOCRINOL, V12, P924, DOI 10.1210/me.12.7.924; Sakumoto R, 2006, DOMEST ANIM ENDOCRIN, V31, P246, DOI 10.1016/j.domaniend.2005.11.001; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Stevaux O, 2002, CURR OPIN CELL BIOL, V14, P684, DOI 10.1016/S0955-0674(02)00388-5; Stocco C, 2007, ENDOCR REV, V28, P117, DOI 10.1210/er.2006-0022; Sugino N, 2005, J CLIN ENDOCR METAB, V90, P6141, DOI 10.1210/jc.2005-0643; Suzuki T, 1998, HUM REPROD, V13, P953, DOI 10.1093/humrep/13.4.953; TAMURA H, 1987, BIOL REPROD, V36, P1149, DOI 10.1095/biolreprod36.5.1149; Vara JAF, 2004, CANCER TREAT REV, V30, P193, DOI 10.1016/j.ctrv.2003.07.007; Young FM, 2000, HUM REPROD, V15, P557, DOI 10.1093/humrep/15.3.557; ZHENG J, 1994, BIOL REPROD, V51, P623, DOI 10.1095/biolreprod51.4.623	46	24	25	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e84186	10.1371/journal.pone.0084186	http://dx.doi.org/10.1371/journal.pone.0084186			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281RE	24386349	Green Published, gold, Green Submitted			2022-12-25	WOS:000329117900082
J	Debuisson, D; Mari, N; Denanglaire, S; Leo, O; Andris, F				Debuisson, Delphine; Mari, Nathalie; Denanglaire, Sebastien; Leo, Oberdan; Andris, Fabienne			Myor/ABF-1 Mrna Expression Marks Follicular Helper T Cells but Is Dispensable for Tfh Cell Differentiation and Function In Vivo	PLOS ONE			English	Article							HELIX TRANSCRIPTION FACTOR; LYMPHOCYTE DEVELOPMENT; LINEAGE COMMITMENT; IMMUNE-RESPONSES; B-CELLS; IL-21; PROTEINS; MYOR; INTERLEUKIN-21; GENERATION	Follicular T helper cells (Tfh) are crucial for effective antibody responses and long term T cell-dependent humoral immunity. Although many studies are devoted to this novel T helper cell population, the molecular mechanisms governing Tfh cell differentiation have yet to be characterized. MyoR/ABF-1 is a basic helix-loop-helix transcription factor that plays a role in the differentiation of the skeletal muscle and Hodgkin lymphoma. Here we show that MyoR mRNA is progressively induced during the course of Tfh-like cell differentiation in vitro and is expressed in Tfh responding to Alum-precipitated antigens in vivo. This expression pattern suggests that MyoR could play a role in the differentiation and/or function of Tfh cells. We tested this hypothesis using MyoR-deficient mice and found this deficiency had no impact on Tfh differentiation. Hence, MyoR-deficient mice developed optimal T-dependent humoral responses to Alum-precipitated antigens. In conclusion, MyoR is a transcription factor selectively up-regulated in CD4 T cells during Tfh cell differentiation in vitro and upon response to alum-protein vaccines in vivo, but the functional significance of this up-regulation remains uncertain.	[Debuisson, Delphine; Mari, Nathalie; Denanglaire, Sebastien; Leo, Oberdan; Andris, Fabienne] Univ Libre Brussels, Immunobiol Lab, Gosselies, Belgium		Andris, F (corresponding author), Univ Libre Brussels, Immunobiol Lab, Gosselies, Belgium.	fandris@ulb.ac.be			Belgian Program in Interuniversity Poles of Attraction; Research Concerted Action of the Communaute francaise de Belgique; European Regional Development Fund; Walloon Region; FNRS, Belgium; GlaxoSmithKline Biologicals s.a.; Belgian State, Prime Minister's office, Science Policy Programming	Belgian Program in Interuniversity Poles of Attraction; Research Concerted Action of the Communaute francaise de Belgique; European Regional Development Fund(European Commission); Walloon Region; FNRS, Belgium(Fonds de la Recherche Scientifique - FNRS); GlaxoSmithKline Biologicals s.a.(GlaxoSmithKline); Belgian State, Prime Minister's office, Science Policy Programming	This work was supported by The Belgian Program in Interuniversity Poles of Attraction Initiated by the Belgian State, Prime Minister's office, Science Policy Programming, by a Research Concerted Action of the Communaute francaise de Belgique and by a grant from the European Regional Development Fund and the Walloon Region. FA is a Research Associate at the National Fund for Scientific Research, FNRS, Belgium and DD was supported by a Televie grant from the FNRS, Belgium. FA and OL received research grants from GlaxoSmithKline Biologicals s.a. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bain G, 1999, J EXP MED, V190, P1605, DOI 10.1084/jem.190.11.1605; Bain G, 1997, MOL CELL BIOL, V17, P4782, DOI 10.1128/MCB.17.8.4782; Barndt RJ, 2000, MOL CELL BIOL, V20, P6677, DOI 10.1128/MCB.20.18.6677-6685.2000; Bauquet AT, 2009, NAT IMMUNOL, V10, P167, DOI 10.1038/ni.1690; Cannons JL, 2013, TRENDS IMMUNOL, V34, P200, DOI 10.1016/j.it.2013.01.001; Choi YS, 2011, IMMUNITY, V34, P932, DOI 10.1016/j.immuni.2011.03.023; Chtanova T, 2004, J IMMUNOL, V173, P68, DOI 10.4049/jimmunol.173.1.68; Crotty S, 2012, IMMUNOL REV, V247, P133, DOI 10.1111/j.1600-065X.2012.01117.x; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; de Pooter RF, 2010, IMMUNOL REV, V238, P93, DOI 10.1111/j.1600-065X.2010.00957.x; Pham D, 2012, J IMMUNOL, V189, P832, DOI 10.4049/jimmunol.1200854; Eddahri F, 2006, EUR J IMMUNOL, V36, P855, DOI 10.1002/eji.200535500; Eddahri F, 2009, BLOOD, V113, P2426, DOI 10.1182/blood-2008-04-154682; Eto D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017739; Glimcher LH, 2000, GENE DEV, V14, P1693; Hale JS, 2013, IMMUNITY, V38, P805, DOI 10.1016/j.immuni.2013.02.020; Haynes NM, 2007, J IMMUNOL, V179, P5099, DOI 10.4049/jimmunol.179.8.5099; Hishikawa K, 2005, J CELL BIOL, V169, P921, DOI 10.1083/jcb.200412167; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Johnston RJ, 2009, SCIENCE, V325, P1006, DOI 10.1126/science.1175870; Kamiura N, 2013, AM J PHYSIOL-RENAL, V304, pF1159, DOI 10.1152/ajprenal.00510.2012; Kaplan MH, 1996, IMMUNITY, V4, P313, DOI 10.1016/S1074-7613(00)80439-2; King C, 2009, NAT REV IMMUNOL, V9, P757, DOI 10.1038/nri2644; Kroenke MA, 2012, J IMMUNOL, V188, P3734, DOI 10.4049/jimmunol.1103246; Kuppers R, 2003, J CLIN INVEST, V111, P529, DOI 10.1172/JC1200316624; Li QL, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002320; Liu ZD, 2009, J IMMUNOL, V183, P6320, DOI 10.4049/jimmunol.0900975; Lu BF, 2004, P NATL ACAD SCI USA, V101, P3023, DOI 10.1073/pnas.0307743100; Lu JR, 1999, P NATL ACAD SCI USA, V96, P552, DOI 10.1073/pnas.96.2.552; Lu JR, 2002, SCIENCE, V298, P2378, DOI 10.1126/science.1078273; Lu KT, 2011, IMMUNITY, V35, P622, DOI 10.1016/j.immuni.2011.07.015; Ma CS, 2012, J EXP MED, V209, P1241, DOI 10.1084/jem.20120994; Mari N, 2013, EUR J IMMUNOL, V43, P1489, DOI 10.1002/eji.201242938; Massari ME, 1998, MOL CELL BIOL, V18, P3130, DOI 10.1128/MCB.18.6.3130; Massari ME, 2000, MOL CELL BIOL, V20, P429, DOI 10.1128/MCB.20.2.429-440.2000; Mathas S, 2006, NAT IMMUNOL, V7, P207, DOI 10.1038/ni1285; Murre C, 2005, NAT IMMUNOL, V6, P1079, DOI 10.1038/ni1260; Niesner U, 2008, J EXP MED, V205, P1889, DOI 10.1084/jem.20072468; Nurieva RI, 2008, IMMUNITY, V29, P138, DOI 10.1016/j.immuni.2008.05.009; Nurieva RI, 2009, SCIENCE, V325, P1001, DOI 10.1126/science.1176676; O'Shea JJ, 2011, NAT REV IMMUNOL, V11, P239, DOI 10.1038/nri2958; Ozaki K, 2002, SCIENCE, V298, P1630, DOI 10.1126/science.1077002; Pham D., 2013, J BIOL CHEM; Rasheed AU, 2006, EUR J IMMUNOL, V36, P1892, DOI 10.1002/eji.200636136; Rasheed MAU, 2013, J VIROL, V87, P7737, DOI 10.1128/JVI.00063-13; Robb L, 1998, MECH DEVELOP, V76, P197, DOI 10.1016/S0925-4773(98)00122-1; ROBERTS VJ, 1993, P NATL ACAD SCI USA, V90, P7583, DOI 10.1073/pnas.90.16.7583; SAWADA S, 1993, MOL CELL BIOL, V13, P5620, DOI 10.1128/MCB.13.9.5620; Schaerli P, 2000, J EXP MED, V192, P1553, DOI 10.1084/jem.192.11.1553; Spolski R, 2010, INT IMMUNOL, V22, P7, DOI 10.1093/intimm/dxp112; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Szabo SJ, 2003, ANNU REV IMMUNOL, V21, P713, DOI 10.1146/annurev.immunol.21.120601.140942; Tangye SG, 2013, NAT REV IMMUNOL, V13, P412, DOI 10.1038/nri3447; Vogelzang A, 2008, IMMUNITY, V29, P127, DOI 10.1016/j.immuni.2008.06.001; Wei L, 2007, J BIOL CHEM, V282, P34605, DOI 10.1074/jbc.M705100200; Youngblood B, 2013, IMMUNOLOGY, V139, P277, DOI 10.1111/imm.12074; Yu D, 2009, IMMUNITY, V31, P457, DOI 10.1016/j.immuni.2009.07.002; Yu LM, 2003, EXP CELL RES, V289, P162, DOI 10.1016/S0014-4827(03)00252-0; Zhu JF, 2010, IMMUNOL CELL BIOL, V88, P244, DOI 10.1038/icb.2009.114; Zotos D, 2010, J EXP MED, V207, P365, DOI 10.1084/jem.20091777	60	5	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e84415	10.1371/journal.pone.0084415	http://dx.doi.org/10.1371/journal.pone.0084415			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281QS	24386375	Green Submitted, gold, Green Published			2022-12-25	WOS:000329116700106
J	van der Walt, A; Kolbe, SC; Wang, YJE; Klistorner, A; Shuey, N; Ahmadi, G; Paine, M; Marriott, M; Mitchell, P; Egan, GF; Butzkueven, H; Kilpatrick, TJ				van der Walt, Anneke; Kolbe, Scott C.; Wang, Yejun E.; Klistorner, Alexander; Shuey, Neil; Ahmadi, Gelareh; Paine, Mark; Marriott, Mark; Mitchell, Peter; Egan, Gary F.; Butzkueven, Helmut; Kilpatrick, Trevor J.			Optic Nerve Diffusion Tensor Imaging after Acute Optic Neuritis Predicts Axonal and Visual Outcomes	PLOS ONE			English	Article							CONTRAST LETTER ACUITY; MULTIPLE-SCLEROSIS; FIBER LAYER; DEGENERATION; DISABILITY; DYSFUNCTION; IMPAIRMENT; ATROPHY; MYELIN	Background: Early markers of axonal and clinical outcomes are required for early phase testing of putative neuroprotective therapies for multiple sclerosis (MS). Objectives: To assess whether early measurement of diffusion tensor imaging (DTI) parameters (axial and radial diffusivity) within the optic nerve during and after acute demyelinating optic neuritis (ON) could predict axonal (retinal nerve fibre layer thinning and multi-focal visual evoked potential amplitude reduction) or clinical (visual acuity and visual field loss) outcomes at 6 or 12 months. Methods: Thirty-seven patients presenting with acute, unilateral ON were studied at baseline, one, three, six and 12 months using optic nerve DTI, clinical and paraclinical markers of axonal injury and clinical visual dysfunction. Results: Affected nerve axial diffusivity (AD) was reduced at baseline, 1 and 3 months. Reduced 1-month AD correlated with retinal nerve fibre layer (RNFL) thinning at 6 (R=0.38, p=0.04) and 12 months (R=0.437, p=0.008) and VEP amplitude loss at 6 (R=0.414, p=0.019) and 12 months (R=0.484, p=0.003). AD reduction at three months correlated with high contrast visual acuity at 6 (rho = -0.519, p = 0.001) and 12 months (rho = -0.414, p=0.011). The time-course for AD reduction for each patient was modelled using a quadratic regression. AD normalised after a median of 18 weeks and longer normalisation times were associated with more pronounced RNFL thinning and mfVEP amplitude loss at 12 months. Affected nerve radial diffusivity (RD) was unchanged until three months, after which time it remained elevated. Conclusions: These results demonstrate that AD reduces during acute ON. One month AD reduction correlates with the extent of axonal loss and persistent AD reduction at 3 months predicts poorer visual outcomes. This suggests that acute ON therapies that normalise optic nerve AD by 3 months could also promote axon survival and improve visual outcomes.	[van der Walt, Anneke; Kolbe, Scott C.; Wang, Yejun E.; Ahmadi, Gelareh; Kilpatrick, Trevor J.] Univ Melbourne, Dept Anat & Neurosci, Melbourne, Vic, Australia; [van der Walt, Anneke; Marriott, Mark; Butzkueven, Helmut; Kilpatrick, Trevor J.] Royal Melbourne Hosp, Dept Neurol, Melbourne, Vic, Australia; [van der Walt, Anneke; Shuey, Neil; Paine, Mark] Royal Victorian Eye & Ear Hosp, Dept Neuroophthalmol, Melbourne, Vic 3002, Australia; [Klistorner, Alexander] Univ Sydney, Save Sight Inst, Sydney, NSW 2006, Australia; [Mitchell, Peter] Royal Melbourne Hosp, Dept Radiol, Melbourne, Vic, Australia; [Egan, Gary F.] Monash Univ, Melbourne, Vic 3004, Australia; [van der Walt, Anneke; Butzkueven, Helmut] Univ Melbourne, Royal Melbourne Hosp, Melbourne Brain Ctr, Melbourne, Vic 3050, Australia	University of Melbourne; Royal Melbourne Hospital; Royal Victorian Eye & Ear Hospital; University of Sydney; Royal Melbourne Hospital; Monash University; Royal Melbourne Hospital; University of Melbourne	van der Walt, A (corresponding author), Univ Melbourne, Dept Anat & Neurosci, Melbourne, Vic, Australia.	anneke.vanderwalt@mh.org.au	Egan, Gary F./A-1381-2013	Kolbe, Scott/0000-0003-4685-1380; Egan, Gary/0000-0002-3186-4026; Klistorner, Alexander/0000-0003-0361-6399; Kilpatrick, Trevor/0000-0003-3999-085X; Butzkueven, Helmut/0000-0003-3940-8727	National MS Society [RG4211A4/2]; National Health and Medical Research Council of Australia [628415]; Bayer Australia; Biogen Idec; Merck Serono; GlaxoSmithKline	National MS Society(National Multiple Sclerosis Society); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Bayer Australia; Biogen Idec(Biogen); Merck Serono(Merck & Company); GlaxoSmithKline(GlaxoSmithKline)	This research was supported by the National MS Society (Grant RG4211A4/2#) and the National Health and Medical Research Council of Australia (Grant 628415). The authors received small unrestricted grants from Bayer Australia, Biogen Idec, Merck Serono and GlaxoSmithKline. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baier ML, 2005, NEUROLOGY, V64, P992, DOI 10.1212/01.WNL.0000154521.40686.63; Balcer LJ, 2007, NEUROLOGY, V68, P1299, DOI 10.1212/01.wnl.0000259521.14704.a8; Balcer LJ, 2003, NEUROLOGY, V61, P1367, DOI 10.1212/01.WNL.0000094315.19931.90; Barkhof F, 1999, MULT SCLER J, V5, P283, DOI 10.1177/135245859900500415; BECH RW, 1991, ARCH OPHTHALMOL-CHIC, V109, P1673, DOI 10.1001/archopht.1991.01080120057025; Beck RW, 2004, AM J OPHTHALMOL, V137, P77, DOI 10.1016/S0002-9394(02)00862-6; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Brusa A, 2001, BRAIN, V124, P468, DOI 10.1093/brain/124.3.468; Cleary PA, 1997, J NEURO-OPHTHALMOL, V17, P18; Costello F, 2008, MULT SCLER J, V14, P893, DOI 10.1177/1352458508091367; Costello F, 2009, J NEUROL SCI, V281, P74, DOI 10.1016/j.jns.2009.02.354; de la Cruz J, 2006, BRIT J OPHTHALMOL, V90, P551, DOI 10.1136/bjo.2005.085399; Fraser CL, 2006, OPHTHALMOLOGY, V113, P315, DOI 10.1016/j.ophtha.2005.10.017; Frohman EM, 2008, ARCH NEUROL-CHICAGO, V65, P26, DOI 10.1001/archneurol.2007.10; Fu QL, 2008, INVEST OPHTH VIS SCI, V49, P975, DOI 10.1167/iovs.07-1199; HALLIDAY AM, 1972, LANCET, V1, P982; Hayreh SS, 2008, OPHTHALMOLOGY, V115, P298, DOI 10.1016/j.ophtha.2007.05.027; Henderson APD, 2008, BRAIN, V131, P277, DOI 10.1093/brain/awm285; Hickman SJ, 2005, AM J NEURORADIOL, V26, P951; Ishihara S, 1982, ISHIHARAS TESTS COLO; Jenkins TM, 2010, ANN NEUROL, V67, P99, DOI 10.1002/ana.21823; Klistorner A, 2008, ANN NEUROL, V64, P325, DOI 10.1002/ana.21474; Klistorner A, 2007, INVEST OPHTH VIS SCI, V48, P4549, DOI 10.1167/iovs.07-0381; Kolbe S, 2009, NEUROIMAGE, V45, P679, DOI 10.1016/j.neuroimage.2008.12.047; Kolbe SC, 2012, INVEST OPHTH VIS SCI, V53, P825, DOI 10.1167/iovs.11-8864; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Mac Donald CL, 2007, EXP NEUROL, V205, P116, DOI 10.1016/j.expneurol.2007.01.035; Mi S, 2005, NAT NEUROSCI, V8, P745, DOI 10.1038/nn1460; Naismith RT, 2009, NEUROLOGY, V72, P589, DOI 10.1212/01.wnl.0000335766.22758.cd; Naismith RT, 2012, ARCH NEUROL-CHICAGO, V69, P65, DOI 10.1001/archneurol.2011.243; O'riordan J, 1998, BRAIN; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; Rocca MA, 2005, MULT SCLER J, V11, P537, DOI 10.1191/1352458505ms1213oa; Song SK, 2003, NEUROIMAGE, V20, P1714, DOI 10.1016/j.neuroimage.2003.07.005; Suhs KW, 2012, ANN NEUROL, V72, P199, DOI 10.1002/ana.23573; Talman LS, 2010, ANN NEUROL, V67, P749, DOI 10.1002/ana.22005; Van der Walt A, 2010, PHARMACOL THERAPEUT, V126, P82, DOI 10.1016/j.pharmthera.2010.01.006; Wang YJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052291; Wu QZ, 2007, NEUROIMAGE, V37, P1138, DOI 10.1016/j.neuroimage.2007.06.029	39	38	38	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e83825	10.1371/journal.pone.0083825	http://dx.doi.org/10.1371/journal.pone.0083825			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281QS	24386285	Green Published, gold, Green Submitted			2022-12-25	WOS:000329116700081
J	Ganapathy, S; Xiao, SW; Yang, M; Qi, M; Choi, DE; Ha, CS; Little, JB; Yuan, ZM				Ganapathy, Suthakar; Xiao, Shaowen; Yang, Mei; Qi, Min; Choi, Doo Eun; Ha, Chul S.; Little, John B.; Yuan, Zhi-Min			A Low-dose Arsenic-induced p53 Protein-mediated Metabolic Mechanism of Radiotherapy Protection*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA Damage; Glycolysis; Metabolism; p53; Signal Transduction	HYPOXIA-INDUCIBLE FACTORS; IN-VIVO	Background: Radiotherapy protection depends on a selective protection of normal tissues but not tumors. Results: We demonstrate that low doses of arsenic induce a p53/HIF-1-dependent metabolic reprogramming specific to normal cells, resulting in increased resistance to radiation toxicity. Conclusion: p53-mediated metabolic reprogramming can be explored for normal tissue protection. Significance: The use of low-dose arsenic for selective protection of normal tissues may have important therapeutic implications. Radiotherapy is the current frontline cancer treatment, but the resulting severe side effects often pose a significant threat to cancer patients, raising a pressing need for the development of effective strategies for radiotherapy protection. We exploited the distinct metabolic characteristics between normal and malignant cells for a metabolic mechanism of normal tissue protection. We showed that low doses of arsenic induce HIF-1, which activates a metabolic shift from oxidative phosphorylation to glycolysis, resulting in increased cellular resistance to radiation. Of importance is that low-dose arsenic-induced HIF-1 requires functional p53, limiting the glycolytic shift to normal cells. Using tumor-bearing mice, we provide proof of principle for selective normal tissue protection against radiation injury.	[Ganapathy, Suthakar; Yang, Mei; Choi, Doo Eun; Little, John B.; Yuan, Zhi-Min] Harvard Univ, Sch Publ Hlth, Dept Genet & Complex Dis, Boston, MA 02115 USA; [Xiao, Shaowen; Qi, Min; Ha, Chul S.] Univ Texas Hlth Sci Ctr San Antonio, Dept Radiat Oncol, San Antonio, TX 78229 USA	Harvard University; Harvard T.H. Chan School of Public Health; University of Texas System; University of Texas Health San Antonio	Yuan, ZM (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Genet & Complex Dis, SPH 1,Rm 509,655 Huntington Ave, Boston, MA 02115 USA.	zyuan@hsph.harvard.edu	Ha, C/GZL-9046-2022	yang, mei/0000-0001-9574-2282	NCI, National Institutes of Health [2 R01CA085679, RO1CA167814, RO1CA125144]; Morningside Foundation; Department of Energy [DOE 110976, 65089]; NATIONAL CANCER INSTITUTE [R01CA125144, R01CA183074, R01CA085679, R01CA167814] Funding Source: NIH RePORTER	NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Morningside Foundation; Department of Energy(United States Department of Energy (DOE)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by NCI, National Institutes of Health Grants 2 R01CA085679, RO1CA167814, and RO1CA125144. This work was also supported by the Morningside Foundation and by Department of Energy Grants DOE 110976 and 65089.	Chan SY, 2009, CELL METAB, V10, P273, DOI 10.1016/j.cmet.2009.08.015; Corn PG, 2008, CANCER BIOL THER, V7, P265, DOI 10.4161/cbt.7.2.5745; Finkel T, 2012, J BIOL CHEM, V287, P4434, DOI 10.1074/jbc.R111.271999; Ganapathy S., 2013, ONCOGENE; Giaccia AJ., 2006, RADIOBIOLOGY RADIOLO, P5; Gordan JD, 2007, CURR OPIN GENET DEV, V17, P71, DOI 10.1016/j.gde.2006.12.006; KASTAN MB, 1991, CANCER RES, V51, P6304; Koppenol WH, 2011, NAT REV CANCER, V11, P325, DOI 10.1038/nrc3038; Lunt SY, 2011, ANNU REV CELL DEV BI, V27, P441, DOI 10.1146/annurev-cellbio-092910-154237; Pan Y, 2007, MOL CELL BIOL, V27, P912, DOI 10.1128/MCB.01223-06; Powell BL, 2011, EXPERT REV ANTICANC, V11, P1317, DOI [10.1586/era.11.128, 10.1586/ERA.11.128]; Rius J, 2008, NATURE, V453, P807, DOI 10.1038/nature06905; Semenza GL, 2012, CELL, V148, P399, DOI 10.1016/j.cell.2012.01.021; Sermeus A, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.48; van Uden P, 2008, BIOCHEM J, V412, P477, DOI 10.1042/BJ20080476; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Vousden KH, 2009, NAT REV CANCER, V9, P691, DOI 10.1038/nrc2715; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Yuan M, 2012, NAT PROTOC, V7, P872, DOI 10.1038/nprot.2012.024	19	15	15	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 21	2014	289	8					5340	5347		10.1074/jbc.M113.531020	http://dx.doi.org/10.1074/jbc.M113.531020			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB2FF	24391088	hybrid, Green Published			2022-12-25	WOS:000331607900074
J	Falcone, R; Bevacqua, S; Cerasti, E; Brunamonti, E; Cervelloni, M; Genovesio, A				Falcone, Rossella; Bevacqua, Sara; Cerasti, Erika; Brunamonti, Emiliano; Cervelloni, Milena; Genovesio, Aldo			Transfer of the Nonmatch-to-Goal rule in Monkeys across Cognitive Domains	PLOS ONE			English	Article							PRIMATE PREFRONTAL CORTEX; REVERSE-REWARD CONTINGENCY; CROSS-MODAL TRANSFER; CHIMPANZEES PAN-TROGLODYTES; BABOONS PAPIO-PAPIO; NEURONAL-ACTIVITY; MACACA-MULATTA; RHESUS-MONKEYS; CEBUS-APELLA; EULEMUR-FULVUS	To solve novel problems, it is advantageous to abstract relevant information from past experience to transfer on related problems. To study whether macaque monkeys were able to transfer an abstract rule across cognitive domains, we trained two monkeys on a nonmatch-to-goal (NMTG) task. In the object version of the task (O-NMTG), the monkeys were required to choose between two object-like stimuli, which differed either only in shape or in shape and color. For each choice, they were required to switch from their previously chosen object-goal to a different one. After they reached a performance level of over 90% correct on the O-NMTG task, the monkeys were tested for rule transfer on a spatial version of the task (S-NMTG). To receive a reward, the monkeys had to switch from their previously chosen location to a different one. In both the O-NMTG and S-NMTG tasks, there were four potential choices, presented in pairs from trial-to-trial. We found that both monkeys transferred successfully the NMTG rule within the first testing session, showing effective transfer of the learned rule between two cognitive domains.	[Falcone, Rossella; Bevacqua, Sara; Cerasti, Erika; Brunamonti, Emiliano; Cervelloni, Milena; Genovesio, Aldo] Univ Roma La Sapienza, Dept Physiol & Pharmacol, I-00185 Rome, Italy	Sapienza University Rome	Genovesio, A (corresponding author), Univ Roma La Sapienza, Dept Physiol & Pharmacol, Piazzale Aldo Moro 5, I-00185 Rome, Italy.	aldo.genovesio@uniroma1.it		Brunamonti, Emiliano/0000-0002-5119-6950; Genovesio, Aldo/0000-0003-2521-143X; FALCONE, ROSSELLA/0000-0001-5068-2984	Italian Ministry of Research, "Fondo per gli investimenti della ricerca di base" FIRB [RBFR10G5W9_001]	Italian Ministry of Research, "Fondo per gli investimenti della ricerca di base" FIRB(Ministry of Education, Universities and Research (MIUR))	The work was supported by the Italian Ministry of Research, "Fondo per gli investimenti della ricerca di base" FIRB 2010 (Protocol number: RBFR10G5W9_001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JR, 2008, J COMP PSYCHOL, V122, P445, DOI 10.1037/a0012624; Blakemore CB, 1966, NATURE, V210, P117; BLAKESLEE P, 1966, BEHAVIOUR, V26, P76, DOI 10.1163/156853966X00029; Bodily KD, 2008, J EXP PSYCHOL ANIM B, V34, P178, DOI 10.1037/0097-7403.34.1.178; Bongard S, 2010, P NATL ACAD SCI USA, V107, P2277, DOI 10.1073/pnas.0909180107; Cole MW, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00142; Cook RG, 2007, PSYCHON B REV, V14, P1107, DOI 10.3758/BF03193099; Cromer JA, 2010, NEURON, V66, P796, DOI 10.1016/j.neuron.2010.05.005; D'Amato MR, 1984, COGNITIVE PROCESSES; ETTLINGER G, 1976, NATURE, V259, P44, DOI 10.1038/259044b0; Fagot J, 2011, PSYCHOL SCI, V22, P1304, DOI 10.1177/0956797611422916; Fagot J, 2010, J EXP PSYCHOL-ANIM B, V36, P184, DOI 10.1037/a0017169; Falcone R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040283; Falcone R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032209; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; Flemming TM, 2008, J COMP PSYCHOL, V122, P176, DOI 10.1037/0735-7036.122.2.176; Flemming TM, 2013, ANIM COGN, V16, P519, DOI 10.1007/s10071-013-0596-0; Genovesio A, 2005, NEURON, V47, P307, DOI 10.1016/j.neuron.2005.06.006; Genovesio A., 2008, NEUROSCIENCE RULE GU, P81; Genovesio A, 2007, J NEUROSCI METH, V165, P38, DOI 10.1016/j.jneumeth.2007.05.026; Genovesio A, 2012, NEURON, V74, P656, DOI 10.1016/j.neuron.2012.02.023; Genovesio A, 2011, J NEUROSCI, V31, P3968, DOI 10.1523/JNEUROSCI.5373-10.2011; Genty E, 2004, ANIM BEHAV, V67, P925, DOI 10.1016/j.anbehav.2003.09.007; Genty E, 2007, J COMP PSYCHOL, V121, P354, DOI 10.1037/0735-7036.121.4.354; Glady Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048378; HARLOW HF, 1949, PSYCHOL REV, V56, P51, DOI 10.1037/h0062474; Hauser MD, 1999, ANIM BEHAV, V57, P565, DOI 10.1006/anbe.1998.1032; Hoshi E, 2000, J NEUROPHYSIOL, V83, P2355, DOI 10.1152/jn.2000.83.4.2355; JACKSON WJ, 1970, PSYCHOL REP, V27, P839, DOI 10.2466/pr0.1970.27.3.839; Jordan KE, 2008, COGNITION, V108, P617, DOI 10.1016/j.cognition.2008.05.006; KOJIMA T, 1982, JPN PSYCHOL RES, V24, P155, DOI 10.4992/psycholres1954.24.155; Kornell N, 2007, PSYCHOL SCI, V18, P64, DOI 10.1111/j.1467-9280.2007.01850.x; Kralik JD, 2012, J COMP PSYCHOL, V126, P255, DOI 10.1037/a0026019; Levy R, 2000, EXP BRAIN RES, V133, P23, DOI 10.1007/s002210000397; Mansouri FA, 2006, J NEUROSCI, V26, P2745, DOI 10.1523/JNEUROSCI.5238-05.2006; Martin-Ordas G, 2008, ANIM COGN, V11, P423, DOI 10.1007/s10071-007-0132-1; Murphy RA, 2008, SCIENCE, V319, P1849, DOI 10.1126/science.1151564; Mushiake H, 2009, INT REV NEUROBIOL, V85, P1, DOI 10.1016/S0074-7742(09)85001-0; NISSEN HW, 1948, J COMP PHYSIOL PSYCH, V41, P62, DOI 10.1037/h0061040; ODEN DL, 1988, J EXP PSYCHOL ANIM B, V14, P140, DOI 10.1037/0097-7403.14.2.140; PAN XC, 2012, J NEUROSCI, V35, P1083; PETRIDES M, 1982, NEUROPSYCHOLOGIA, V20, P249, DOI 10.1016/0028-3932(82)90100-2; Procyk E, 2000, COGNITIVE BRAIN RES, V9, P239, DOI 10.1016/S0926-6410(00)00002-1; Rao SC, 1997, SCIENCE, V276, P821, DOI 10.1126/science.276.5313.821; Romo R, 1999, NATURE, V399, P470, DOI 10.1038/20939; Rougier NP, 2005, P NATL ACAD SCI USA, V102, P7338, DOI 10.1073/pnas.0502455102; Rumbaugh D.M., 1984, P569; Rumbaugh D.M., 1984, P221; Saga Y, 2011, J NEUROSCI, V31, P10648, DOI 10.1523/JNEUROSCI.0988-11.2011; Spinozzi G, 2004, J COMP PSYCHOL, V118, P403, DOI 10.1037/0735-7036.118.4.403; Tanji J, 2007, TRENDS COGN SCI, V11, P528, DOI 10.1016/j.tics.2007.09.007; Truppa V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023809; Tsujimoto S, 2012, J NEUROSCI, V32, P11017, DOI 10.1523/JNEUROSCI.1230-12.2012; Tsujimoto S, 2011, J NEUROSCI, V31, P4583, DOI 10.1523/JNEUROSCI.5816-10.2011; VISALBERGHI E, 1994, J COMP PSYCHOL, V108, P15, DOI 10.1037/0735-7036.108.1.15; Vonk J, 2003, ANIM COGN, V6, P77, DOI 10.1007/s10071-003-0159-x; Wallis JD, 2001, NATURE, V411, P953, DOI 10.1038/35082081; Washburn DA, 2006, J EXP PSYCHOL ANIM B, V32, P185, DOI 10.1037/0097-7403.32.2.185; White IM, 1999, EXP BRAIN RES, V126, P315, DOI 10.1007/s002210050740; WILSON FAW, 1993, SCIENCE, V260, P1955, DOI 10.1126/science.8316836; Wright A.A., 1984, QUANTITATIVE ANAL BE, V4, P295; WRIGHT AA, 1984, J EXP PSYCHOL ANIM B, V10, P513; Wright AA, 2006, BEHAV PROCESS, V72, P234, DOI 10.1016/j.beproc.2006.03.009; Yamazaki Y, 2012, ANIM COGN, V15, P369, DOI 10.1007/s10071-011-0462-x	64	3	3	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84100	10.1371/journal.pone.0084100	http://dx.doi.org/10.1371/journal.pone.0084100			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391894	Green Published, Green Submitted, gold			2022-12-25	WOS:000329323900037
J	Gupta, P; Jairajpuri, MA; Durani, S				Gupta, Pooja; Jairajpuri, Mohamad Aman; Durani, Susheel			Redox Specificity of 2-Hydroxyacid-Coupled NAD(+)/NADH Dehydrogenases: A Study Exploiting "Reactive" Arginine as a Reporter of Protein Electrostatics	PLOS ONE			English	Article							L-LACTATE DEHYDROGENASE; ANION-BINDING-SITES; AMINO-ACID-SEQUENCE; MALATE-DEHYDROGENASE; BACILLUS-STEAROTHERMOPHILUS; IONIC-STRENGTH; ACTIVE-SITE; RESIDUES; CHARGE; HEART	With "reactive" arginine as a kinetic reporter, 2-hydroxyacid dehydrogenases are assessed in basis of their specialization as NAD(+)-reducing or NADH-oxidizing enzymes. Specifically, M4 and H4 lactate dehydrogenases (LDHs) and cytoplasmic and mitochondrial malate dehydrogenases (MDHs) are compared to assess if their coenzyme specificity may involve electrostatics of cationic or neutral nicotinamide structure as the basis. The enzymes from diverse eukaryote and prokaryote sources thus are assessed in "reactivity" of functionally-critical arginine as a function of salt concentration and pH. Electrostatic calculations were performed on "reactive" arginines and found good correspondence with experiment. The reductive and oxidative LDHs and MDHs are assessed in their count over ionizable residues and in placement details of the residues in their structures as proteins. The variants found to be high or low in Delta pKa of "reactive" arginine are found to be also strong or weak cations that preferentially oxidize NADH (neutral nicotinamide structure) or reduce NAD(+) (cationic nicotinamide structure). The ionized groups of protein structure may thus be important to redox specificity of the enzyme on basis of electrostatic preference for the oxidized (cationic nicotinamide) or reduced (neutral nicotinamide) coenzyme. Detailed comparisons of isozymes establish that the residues contributing in their redox specificity are scrambled in structure of the reductive enzyme.	[Gupta, Pooja; Durani, Susheel] Indian Inst Biotechnol Bombay, Dept Chem, Bombay, Maharashtra, India; [Jairajpuri, Mohamad Aman] Indian Inst Biotechnol Bombay, Dept Biosci & Bioengn, Bombay, Maharashtra, India; [Jairajpuri, Mohamad Aman] Jamia Millia Islamia, Dept Biosci, New Delhi 110025, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Bombay; Jamia Millia Islamia	Durani, S (corresponding author), Indian Inst Biotechnol Bombay, Dept Chem, Bombay, Maharashtra, India.	sdurani@iitb.ac.in	Jairajpuri, Mohamad/AAS-2556-2020		Department of Science and Technology, Government of India	Department of Science and Technology, Government of India(Department of Science & Technology (India))	This work was funded by the Department of Science and Technology, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BABURAJ K, 1991, BIOORG CHEM, V19, P229, DOI 10.1016/0045-2068(91)90049-U; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; BIRKTOFT JJ, 1982, P NATL ACAD SCI-BIOL, V79, P6166, DOI 10.1073/pnas.79.20.6166; BIRKTOFT JJ, 1983, J BIOL CHEM, V258, P472; Buck H, 2005, INT J QUANTUM CHEM, V101, P389, DOI 10.1002/qua.20282; Buck HM, 2003, NUCLEOS NUCLEOT NUCL, V22, P1545, DOI 10.1081/NCN-120023030; CHAKRABARTI P, 1993, J MOL BIOL, V234, P463, DOI 10.1006/jmbi.1993.1599; EVENTOFF W, 1977, P NATL ACAD SCI USA, V74, P2677, DOI 10.1073/pnas.74.7.2677; GIETL C, 1992, BIOCHIM BIOPHYS ACTA, V1100, P217, DOI 10.1016/0167-4838(92)90476-T; GLEASON WB, 1994, BIOCHEMISTRY-US, V33, P2078, DOI 10.1021/bi00174a014; Glomb MA, 2001, J AGR FOOD CHEM, V49, P1493, DOI 10.1021/jf001082d; GOWARD CR, 1994, PROTEIN SCI, V3, P1883, DOI 10.1002/pro.5560031027; Gulotta M, 2002, BIOCHEMISTRY-US, V41, P3353, DOI 10.1021/bi016009a; Gupta P, 2011, INT J BIOL MACROMOL, V49, P999, DOI 10.1016/j.ijbiomac.2011.08.025; HART KW, 1987, BIOCHEM BIOPH RES CO, V146, P346, DOI 10.1016/0006-291X(87)90731-5; Holmes RS, 2009, COMPUT BIOL CHEM, V33, P379, DOI 10.1016/j.compbiolchem.2009.07.006; HONES J, 1985, BIOL CHEM H-S, V366, P561, DOI 10.1515/bchm3.1985.366.1.561; Jairajpuri MA, 1998, BIOCHEMISTRY-US, V37, P10780, DOI 10.1021/bi980058e; KALLWASS HKW, 1992, J AM CHEM SOC, V114, P10704, DOI 10.1021/ja00053a004; LI SSL, 1983, J BIOL CHEM, V258, P7029; Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045; Lsek M.A., 1995, CURR OPIN CHEM BIOL, V5, P775; Madern D, 2002, J MOL EVOL, V54, P825, DOI 10.1007/s00239-001-0088-8; MEDINA M, 1992, ARCH BIOCHEM BIOPHYS, V299, P281, DOI 10.1016/0003-9861(92)90276-3; MITCHELL JBO, 1992, J MOL BIOL, V226, P251, DOI 10.1016/0022-2836(92)90137-9; Mosbach K, 1974, Methods Enzymol, V34, P595; Musrati RA, 1998, GEN PHYSIOL BIOPHYS, V17, P193; NAIK VR, 1968, ARCH BIOCHEM BIOPHYS, V123, P431, DOI 10.1016/0003-9861(68)90163-X; NANDI CL, 1993, PROTEIN ENG, V6, P247, DOI 10.1093/protein/6.3.247; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; QUATTRO JM, 1993, P NATL ACAD SCI USA, V90, P242, DOI 10.1073/pnas.90.1.242; Read JA, 2001, PROTEINS, V43, P175, DOI 10.1002/1097-0134(20010501)43:2<175::AID-PROT1029>3.0.CO;2-#; RIORDAN JF, 1979, MOL CELL BIOCHEM, V26, P71; Rocchia W, 2002, J COMPUT CHEM, V23, P128, DOI 10.1002/jcc.1161; Rocchia W, 2001, J PHYS CHEM B, V105, P6507, DOI 10.1021/jp010454y; Rossman M.G., 1975, ENZYMES, V11, P61, DOI 10.1016/S1874-6047(08)60210-3; SHARP KA, 1990, ANNU REV BIOPHYS BIO, V19, P301, DOI 10.1146/annurev.bb.19.060190.001505; Swiderek K, 2011, J PHYS CHEM B, V115, P6366, DOI 10.1021/jp201626k; Swiderek K, 2011, ARCH BIOCHEM BIOPHYS, V505, P33, DOI 10.1016/j.abb.2010.10.010; Swiderek K, 2010, J PHYS CHEM B, V114, P3393, DOI 10.1021/jp100026z; TURGEON SL, 1992, J FOOD SCI, V57, P601, DOI 10.1111/j.1365-2621.1992.tb08052.x; TYLERCROSS R, 1991, J BIOL CHEM, V266, P22549; van Gunsteren W, 1996, BIOMOLECULAR SIMULAT; Voet D., 2010, BIOCHEMISTRY; WARWICKER J, 1992, J MOL BIOL, V223, P247, DOI 10.1016/0022-2836(92)90729-4; WILCHEK M, 1984, METHOD ENZYMOL, V104, P3; WILKS HM, 1988, SCIENCE, V242, P1541, DOI 10.1126/science.3201242	47	1	1	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83505	10.1371/journal.pone.0083505	http://dx.doi.org/10.1371/journal.pone.0083505			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391777	Green Published, Green Submitted, gold			2022-12-25	WOS:000329325200074
J	Inspector, M; Manor, D; Amir, N; Kushnir, T; Karni, A				Inspector, Michael; Manor, David; Amir, Noam; Kushnir, Tamar; Karni, Avi			A Word by Any Other Intonation: FMRI Evidence for Implicit Memory Traces for Pitch Contours of Spoken Words in Adult Brains	PLOS ONE			English	Article							FUNCTIONAL MRI; PERCEPTUAL SPECIFICITY; REPETITION; CORTEX; RECOGNITION; PROSODY; LATERALIZATION; IDENTIFICATION; SUPPRESSION; ACTIVATION	Objectives: Intonation may serve as a cue for facilitated recognition and processing of spoken words and it has been suggested that the pitch contour of spoken words is implicitly remembered. Thus, using the repetition suppression (RS) effect of BOLD-fMRI signals, we tested whether the same spoken words are differentially processed in language and auditory brain areas depending on whether or not they retain an arbitrary intonation pattern. Experimental design: Words were presented repeatedly in three blocks for passive and active listening tasks. There were three prosodic conditions in each of which a different set of words was used and specific task-irrelevant intonation changes were applied: (i) All words presented in a set flat monotonous pitch contour (ii) Each word had an arbitrary pitch contour that was set throughout the three repetitions. (iii) Each word had a different arbitrary pitch contour in each of its repetition. Principal findings: The repeated presentations of words with a set pitch contour, resulted in robust behavioral priming effects as well as in significant RS of the BOLD signals in primary auditory cortex (BA 41), temporal areas (BA 21 22) bilaterally and in Broca's area. However, changing the intonation of the same words on each successive repetition resulted in reduced behavioral priming and the abolition of RS effects. Conclusions: Intonation patterns are retained in memory even when the intonation is task-irrelevant. Implicit memory traces for the pitch contour of spoken words were reflected in facilitated neuronal processing in auditory and language associated areas. Thus, the results lend support for the notion that prosody and specifically pitch contour is strongly associated with the memory representation of spoken words.	[Inspector, Michael; Manor, David; Karni, Avi] Univ Haifa, Lab Brain Imaging & Learning Res, IL-31999 Haifa, Israel; [Manor, David; Kushnir, Tamar; Karni, Avi] Chaim Sheba Med Ctr, MRI Unit, Dept Diagnost Imaging, IL-52621 Tel Hashomer, Israel; [Amir, Noam] Tel Aviv Univ, Sackler Fac Med, Dept Commun Disorders, IL-69978 Tel Aviv, Israel; [Inspector, Michael; Manor, David] Rambam Med Ctr, MRI Unit, Haifa, Israel	University of Haifa; Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Rambam Health Care Campus; Technion Israel Institute of Technology	Inspector, M (corresponding author), Univ Haifa, Lab Brain Imaging & Learning Res, IL-31999 Haifa, Israel.	hadass2@013.net		Amir, Noam/0000-0002-1704-8444				Badgaiyan RD, 2001, NEUROIMAGE, V13, P272, DOI 10.1006/nimg.2000.0693; BASSILI JN, 1989, Q J EXP PSYCHOL-A, V41, P439, DOI 10.1080/14640748908402375; Belin P, 1996, NEUROLOGY, V47, P1504, DOI 10.1212/WNL.47.6.1504; Bergerbest D, 2004, J COGNITIVE NEUROSCI, V16, P966, DOI 10.1162/0898929041502760; Boersma P, 1992, PRAAT 4 3 04; Boucard CC, 2005, NEUROREPORT, V16, P1335, DOI 10.1097/01.wnr.0000175242.05343.50; Brett M, 2002, NEUROIMAGE, V16; Buckner RL, 2000, BRAIN, V123, P620, DOI 10.1093/brain/123.3.620; Chee MWL, 1999, HUM BRAIN MAPP, V7, P15, DOI 10.1002/(SICI)1097-0193(1999)7:1<15::AID-HBM2>3.3.CO;2-Y; Chen HC, 1997, COGNITIVE PROCESSING OF CHINESE AND RELATED ASIAN LANGUAGES, P77; CHURCH BA, 1994, J EXP PSYCHOL LEARN, V20, P521, DOI 10.1037/0278-7393.20.3.521; CUTLER A, 1979, COGNITION, V7, P49, DOI 10.1016/0010-0277(79)90010-6; DALESSANDRO C, 1994, J ACOUST SOC AM, V95, P1617, DOI 10.1121/1.408548; Dehaene S, 2001, NAT NEUROSCI, V4, P752, DOI 10.1038/89551; DEMB JB, 1995, J NEUROSCI, V15, P5870; Desmond JE, 1995, BRAIN, V118, P1411, DOI 10.1093/brain/118.6.1411; Dogil G, 2002, J NEUROLINGUIST, V15, P59, DOI 10.1016/S0911-6044(00)00021-X; Elman JL, 2004, TRENDS COGN SCI, V8, P301, DOI 10.1016/j.tics.2004.05.003; Friedrich CK, 2004, COGNITIVE BRAIN RES, V20, P300, DOI 10.1016/j.cogbrainres.2004.03.007; Gabrieli JDE, 1996, PSYCHOL SCI, V7, P278, DOI 10.1111/j.1467-9280.1996.tb00374.x; Gagnepain P, 2008, J NEUROSCI, V28, P5281, DOI 10.1523/JNEUROSCI.0565-08.2008; Gandour J, 2003, BRAIN LANG, V84, P318, DOI 10.1016/S0093-934X(02)00505-9; Goldinger SD, 1996, J EXP PSYCHOL LEARN, V22, P1166, DOI 10.1037/0278-7393.22.5.1166; Goodglass H., 1993, UNDERSTANDING APHASI; Grill-Spector K, 2006, TRENDS COGN SCI, V10, P14, DOI 10.1016/j.tics.2005.11.006; Hamburger M, 1994, J ACOUST SOC AM, V95, P2973; Hasson U, 2006, J COGNITIVE NEUROSCI, V18, P2013, DOI 10.1162/jocn.2006.18.12.2013; Hauptmann B, 2002, COGNITIVE BRAIN RES, V13, P313, DOI 10.1016/S0926-6410(01)00124-0; Henson RNA, 2003, PROG NEUROBIOL, V70, P53, DOI 10.1016/S0301-0082(03)00086-8; Hon N, 2006, J NEUROSCI, V26, P9805, DOI 10.1523/JNEUROSCI.3165-06.2006; Johnson Keith, 1997, TALKER VARIABILITY S, P145; Kato K., 1988, Journal of the Acoustical Society of Japan, V44, P180; Kotz SA, 2003, BRAIN LANG, V86, P366, DOI 10.1016/S0093-934X(02)00532-1; Lindfield KC, 1999, BRAIN LANG, V68, P312, DOI 10.1006/brln.1999.2094; Luce PA, 1998, EAR HEARING, V19, P1, DOI 10.1097/00003446-199802000-00001; Maguire EA, 1999, BRAIN, V122, P1839, DOI 10.1093/brain/122.10.1839; Marsolek CJ, 1996, MEM COGNITION, V24, P539, DOI 10.3758/BF03201082; Matsumoto A, 2005, NEUROIMAGE, V24, P624, DOI 10.1016/j.neuroimage.2004.09.008; McLennan CT, 2005, J EXP PSYCHOL LEARN, V31, P306, DOI 10.1037/0278-7393.31.2.306; Meyer M, 2004, BRAIN LANG, V89, P277, DOI 10.1016/S0093-934X(03)00350-X; Muller RA, 2004, BRAIN LANG, V89, P329, DOI 10.1016/S0093-934X(03)00346-8; NORRIS D, 1994, COGNITION, V52, P189, DOI 10.1016/0010-0277(94)90043-4; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Orfanidou E, 2006, J COGNITIVE NEUROSCI, V18, P1237, DOI 10.1162/jocn.2006.18.8.1237; Patterson RD, 1996, J ACOUST SOC AM, V100, P3286, DOI 10.1121/1.417212; Plante E, 2006, BRAIN LANG, V97, P332, DOI 10.1016/j.bandl.2005.12.004; Poppel D, 2003, SPEECH COMMUN, V41, P425; POSNER MI, 1964, PSYCHOL REV, V71, P491, DOI 10.1037/h0041120; Rissman J, 2003, J COGNITIVE NEUROSCI, V15, P1160, DOI 10.1162/089892903322598120; Sayres R, 2006, J NEUROPHYSIOL, V95, P995, DOI 10.1152/jn.00500.2005; SCHACTER DL, 1994, MEMORY, V2, P295, DOI 10.1080/09658219408258950; SCHACTER DL, 1992, J EXP PSYCHOL LEARN, V18, P915, DOI 10.1037/0278-7393.18.5.915; Sommers MS, 1999, J EXP PSYCHOL LEARN, V25, P1236; Taylor KI, 2006, P NATL ACAD SCI USA, V103, P8239, DOI 10.1073/pnas.0509704103; TULVING E, 1990, SCIENCE, V247, P301, DOI 10.1126/science.2296719; Versace R, 1998, CAH PSYCHOL COGN, V17, P533; Wagner AD, 2000, CEREB CORTEX, V10, P1176, DOI 10.1093/cercor/10.12.1176; Wennerstorm AK, 2001, MUSIC EVERYDAY SPEEC; Wingfield A, 1997, APPL PSYCHOLINGUIST, V18, P85, DOI 10.1017/S0142716400009887; Yost WA, 1996, J ACOUST SOC AM, V99, P1066, DOI 10.1121/1.414593	60	5	5	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e82042	10.1371/journal.pone.0082042	http://dx.doi.org/10.1371/journal.pone.0082042			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391713	gold, Green Submitted, Green Published			2022-12-25	WOS:000329325200010
J	Lei, BN; Amar, A; Koeslag, A; Gous, TA; Tate, GJ				Lei, Bonnie; Amar, Arjun; Koeslag, Ann; Gous, Tertius A.; Tate, Gareth J.			Differential Haemoparasite Intensity between Black Sparrowhawk (Accipiter melanoleucus) Morphs Suggests an Adaptive Function for Polymorphism	PLOS ONE			English	Article							MELANOCYTE-STIMULATING HORMONE; AVIAN BLOOD PARASITES; COLOR POLYMORPHISM; IMMUNE-RESPONSE; SEXUAL-DIMORPHISM; PLUMAGE COLOR; EVOLUTION; BIRDS; TESTOSTERONE; GENETICS	Recent research suggests that genes coding for melanin based colouration may have pleiotropic properties, in particular conveying raised immune function. Thus adaptive function of polymorphism may be associated with parasite resistance. The black sparrowhawk Accipiter melanoleucus is a polymorphic raptor with two morphs. Over most of its range the light morph is commonest, however within the recently colonised Western Cape of South Africa the dark morph predominates. The species breeds in winter throughout South Africa, however unlike in the rest of the species' South African range, the Western Cape experiences a winter rainfall regime, where arthropod vectors which transmit haematozoan parasites may be more abundant. We hypothesise that the higher frequency of dark morph birds in this region may be due to their improved parasite resistance, which enables them to cope with higher parasite pressure. If so, we predict that dark morph black sparrowhawks would have lower parasite burdens than light morph birds. Within our population the prevalence of the two most common haematozoan parasites was high, with 72% of adults infected with Haemoproteus nisi and 59% of adults infected with Leucocytozoon toddi. We found no difference in prevalence for either parasite between adult morphs, or between chicks of different parental morphs. However, within adults infected with H. nisi, infection intensity was significantly higher in light morphs than dark morphs. This suggests that dark morphs have lower parasite loads than light morphs due to resistance rather than morph-specific habitat exploitation. Greater resistance to Haemoproteus parasites may therefore be one of the mechanisms through which dark morph black sparrowhawks have a selective advantage in this region and may explain why they are most common in our study area. In other regions, the cost to benefit ratio may be in favour of the light morph, where parasites are less abundant or virulent.	[Lei, Bonnie; Amar, Arjun; Koeslag, Ann; Tate, Gareth J.] Univ Cape Town, Percy FitzPatrick Inst African Ornithol, DST NRF Ctr Excellence, ZA-7925 Cape Town, South Africa; [Lei, Bonnie] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA	National Research Foundation - South Africa; University of Cape Town; Harvard University	Amar, A (corresponding author), Univ Cape Town, Percy FitzPatrick Inst African Ornithol, DST NRF Ctr Excellence, ZA-7925 Cape Town, South Africa.	arjun.amar@uct.ac.za	Amar, Arjun/L-4493-2019; Arjun, Amar/F-3815-2011	Arjun, Amar/0000-0002-7405-1180	Weismann International Internship Program; UCT's University Research Council	Weismann International Internship Program; UCT's University Research Council	Funding for the project was partially provided through a Weismann International Internship Program to BL and through UCT's University Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amar A, 2013, J ZOOL, V289, P60, DOI 10.1111/j.1469-7998.2012.00963.x; Amar A, 2011, J APPL ECOL, V48, P220, DOI 10.1111/j.1365-2664.2010.01896.x; Andersen GN, 2001, CLIN EXP IMMUNOL, V126, P441, DOI 10.1046/j.1365-2249.2001.01604.x; Atkinson CT, 1991, BIRD PARASITE INTERA, P19; Berger D. D., 1959, Bird-Banding, V30, P18, DOI 10.2307/4510726; Boerner M, 2009, BEHAV ECOL, V20, P180, DOI 10.1093/beheco/arn132; CATANIA A, 1993, ENDOCR REV, V14, P564, DOI 10.1210/er.14.5.564; Chakarov N, 2008, FUNCT ECOL, V22, P1062, DOI 10.1111/j.1365-2435.2008.01460.x; Cowling RM, 1996, BIODIVERS CONSERV, V5, P527, DOI 10.1007/BF00137608; Dawson RD, 2000, CONDOR, V102, P814, DOI 10.1650/0010-5422(2000)102[0814:RSOAKT]2.0.CO;2; Dreiss AN, 2012, J EVOLUTION BIOL, V25, P103, DOI 10.1111/j.1420-9101.2011.02407.x; Ducrest AL, 2008, TRENDS ECOL EVOL, V23, P502, DOI 10.1016/j.tree.2008.06.001; EARLE RA, 1991, S AFR J WILDL RES, V21, P47; Ferguson-Lees J, 2001, RAPTORS WORLD; Galeotti P, 2004, BIOL J LINN SOC, V82, P237, DOI 10.1111/j.1095-8312.2004.00355.x; Galeotti P, 2003, J ZOOL, V261, P91, DOI 10.1017/S0952836903003960; Galvan I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013369; Gangoso L, 2011, J EVOLUTION BIOL, V24, P2055, DOI 10.1111/j.1420-9101.2011.02336.x; Garvin MC, 2003, J WILDLIFE DIS, V39, P170, DOI 10.7589/0090-3558-39.1.170; Gasparini J, 2009, J ANIM ECOL, V78, P608, DOI 10.1111/j.1365-2656.2008.01521.x; Gershwin, 1985, NUTR IMMUNITY; Hockey PAR, 2009, OSTRICH, V80, P29, DOI 10.2989/OSTRICH.2009.80.1.4.762; Hoekstra HE, 2006, HEREDITY, V97, P222, DOI 10.1038/sj.hdy.6800861; Horvathova T, 2012, P ROY SOC B-BIOL SCI, V279, P163, DOI 10.1098/rspb.2011.0663; Jacquin L, 2011, J AVIAN BIOL, V42, P11, DOI 10.1111/j.1600-048X.2010.05120.x; Johnson JA, 2012, J HERED, V103, P315, DOI 10.1093/jhered/ess023; Karell P, 2011, J EVOLUTION BIOL, V24, P1783, DOI 10.1111/j.1420-9101.2011.02308.x; Kittilsen S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034281; Krone O, 2001, ACTA PROTOZOOL, V40, P281; LESSELLS CM, 1987, AUK, V104, P116, DOI 10.2307/4087240; Lopez-Rull I, 2011, FUNCT ECOL, V25, P500, DOI 10.1111/j.1365-2435.2010.01783.x; Loser K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008958; Maccoll ADC, 2013, BIOL J LINN SOC, V108, P882, DOI 10.1111/bij.12009; McGraw KJ, 2000, P ROY SOC B-BIOL SCI, V267, P1525, DOI 10.1098/rspb.2000.1174; McGraw KJ, 2002, J EXP BIOL, V205, P3747; Merino S, 2000, P ROY SOC B-BIOL SCI, V267, P2507, DOI 10.1098/rspb.2000.1312; Mettke-Hofmann C, 2012, ETHOLOGY, V118, P906, DOI 10.1111/j.1439-0310.2012.02079.x; Meunier J, 2011, BEHAV ECOL SOCIOBIOL, V65, P559, DOI 10.1007/s00265-010-1092-z; Mills SC, 2009, AM NAT, V173, P475, DOI 10.1086/597222; Mundy NI, 2005, P ROY SOC B-BIOL SCI, V272, P1633, DOI 10.1098/rspb.2005.3107; Nordling D, 1998, P ROY SOC B-BIOL SCI, V265, P1291, DOI 10.1098/rspb.1998.0432; Nunn CL, 2009, PHILOS T R SOC B, V364, P61, DOI 10.1098/rstb.2008.0148; Oettle E.E., 1994, Promerops, V212, P7; PEIRCE MA, 1983, J NAT HIST, V17, P813, DOI 10.1080/00222938300770621; Poulin R, 2012, EVOL ECOL, V26, P1169, DOI 10.1007/s10682-011-9544-0; Redpath SM, 2002, ECOGRAPHY, V25, P533, DOI 10.1034/j.1600-0587.2002.250503.x; Robertson A.S., 1986, Raptor Research, V20, P51; Roulin A, 2001, BEHAV ECOL, V12, P103, DOI 10.1093/oxfordjournals.beheco.a000371; Roulin A, 2000, P ROY SOC B-BIOL SCI, V267, P937, DOI 10.1098/rspb.2000.1093; Roulin A, 2004, BIOL REV, V79, P815, DOI 10.1017/S1464793104006487; Roulin A, 2004, IBIS, V146, P509, DOI 10.1111/j.1474-919x.2004.00292.x; Samuel MD, 2011, ECOL APPL, V21, P2960, DOI 10.1890/10-1311.1; SAS Institute, 2008, SAS STAT US GUID; Sebele L, 2012, THESIS U CAPE TOWN; Sol D, 2000, ECOGRAPHY, V23, P307, DOI 10.1034/j.1600-0587.2000.d01-1639.x; Stjernman M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002463; Stoehr AM, 2006, BEHAV ECOL, V17, P751, DOI 10.1093/beheco/ark018; Taherzadeh S, 1999, AM J PHYSIOL-REG I, V276, pR1289, DOI 10.1152/ajpregu.1999.276.5.R1289; Valkiunas G, 2005, AVIAN MALARIA PARASI; Valkiunas G, 1997, ACTA ZOOLOGICA LITUA, V3-5; Veiga JP, 1998, OIKOS, V82, P313, DOI 10.2307/3546971; Webster LMI, 2011, MOL ECOL, V20, P920, DOI 10.1111/j.1365-294X.2010.04906.x; Zysling DA, 2006, HORM BEHAV, V50, P200, DOI 10.1016/j.yhbeh.2006.03.004	63	22	23	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e81607	10.1371/journal.pone.0081607	http://dx.doi.org/10.1371/journal.pone.0081607			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391707	Green Published, gold, Green Submitted			2022-12-25	WOS:000329325200004
J	Marangon, J; Correia, HD; Brondino, CD; Moura, JJG; Romao, MJ; Gonzalez, PJ; Santos-Silva, T				Marangon, Jacopo; Correia, Hugo D.; Brondino, Carlos D.; Moura, Jose J. G.; Romao, Maria J.; Gonzalez, Pablo J.; Santos-Silva, Teresa			Kinetic and Structural Studies of Aldehyde Oxidoreductase from Desulfovibrio gigas Reveal a Dithiolene-Based Chemistry for Enzyme Activation and Inhibition by H2O2	PLOS ONE			English	Article							XANTHINE-OXIDASE; RADIATION-DAMAGE; MOLYBDENUM ENZYMES; RADICAL FORMATION; CRYSTAL-STRUCTURE; PROTEIN; PYRANOPTERIN; TUNGSTEN; DEHYDROGENASE; VALIDATION	Mononuclear Mo-containing enzymes of the xanthine oxidase (XO) family catalyze the oxidative hydroxylation of aldehydes and heterocyclic compounds. The molybdenum active site shows a distorted square-pyramidal geometry in which two ligands, a hydroxyl/water molecule (the catalytic labile site) and a sulfido ligand, have been shown to be essential for catalysis. The XO family member aldehyde oxidoreductase from Desulfovibrio gigas (DgAOR) is an exception as presents in its catalytically competent form an equatorial oxo ligand instead of the sulfido ligand. Despite this structural difference, inactive samples of DgAOR can be activated upon incubation with dithionite plus sulfide, a procedure similar to that used for activation of desulfo-XO. The fact that DgAOR does not need a sulfido ligand for catalysis indicates that the process leading to the activation of inactive DgAOR samples is different to that of desulfo-XO. We now report a combined kinetic and X-ray crystallographic study to unveil the enzyme modification responsible for the inactivation and the chemistry that occurs at the Mo site when DgAOR is activated. In contrast to XO, which is activated by resulfuration of the Mo site, DgAOR activation/inactivation is governed by the oxidation state of the dithiolene moiety of the pyranopterin cofactor, which demonstrates the non-innocent behavior of the pyranopterin in enzyme activity. We also showed that DgAOR incubation with dithionite plus sulfide in the presence of dioxygen produces hydrogen peroxide not associated with the enzyme activation. The peroxide molecule coordinates to molybdenum in a eta(2) fashion inhibiting the enzyme activity.	[Marangon, Jacopo; Correia, Hugo D.; Moura, Jose J. G.; Romao, Maria J.; Gonzalez, Pablo J.; Santos-Silva, Teresa] Univ Nova Lisboa, Fac Ciencias & Tecnol, Dept Quim, REQUIMTE CQFB, Caparica, Setubal, Portugal; [Brondino, Carlos D.; Gonzalez, Pablo J.] Univ Nacl Litoral, Fac Bioquim & Ciencias Biol, Dept Fis, Santa Fe, Argentina	Universidade Nova de Lisboa; National University of the Littoral	Gonzalez, PJ (corresponding author), Univ Nova Lisboa, Fac Ciencias & Tecnol, Dept Quim, REQUIMTE CQFB, Caparica, Setubal, Portugal.	p.gonzalez@fct.unl.pt; tsss@fct.unl.pt	FCT/UNL, REQUIMTE Biological Chemistry at/V-8183-2017; Moura, José J G/D-6426-2013; Santos-Silva, Teresa/AAE-1795-2019; Santos-Silva, Teresa/D-2050-2013; Romao, Maria J/A-4115-2013; UCIBIO, U Cienc Biom Apl/F-7948-2017	Moura, José J G/0000-0002-4726-2388; Santos-Silva, Teresa/0000-0003-3060-8378; Santos-Silva, Teresa/0000-0003-3060-8378; Romao, Maria J/0000-0002-3004-0543; UCIBIO, U Cienc Biom Apl/0000-0002-3004-0543; Brondino, Carlos D./0000-0002-9468-062X; Gonzalez, Pablo Javier/0000-0001-5430-8981	Fundacao para a Ciencia e a Tecnologia [PTDC/BIA-PRO/118377/2010, PEst-C/EQB/LA0006/2011]	Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission)	This work has been supported by Fundacao para a Ciencia e a Tecnologia through the project PTDC/BIA-PRO/118377/2010 and grant number PEst-C/EQB/LA0006/2011. Funder website: www.fct.mctes.pt. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade SLA, 2003, BIOCHEM BIOPH RES CO, V308, P73, DOI 10.1016/S0006-291X(03)01337-8; ARCHER SL, 1995, CIRC RES, V77, P174, DOI 10.1161/01.RES.77.1.174; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barata B, 1992, ESTUDO BIOQUIMICO ES; BARATA BAS, 1993, BIOCHEMISTRY-US, V32, P11559, DOI 10.1021/bi00094a012; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; BETCHERLANGE SL, 1979, J BIOL CHEM, V254, P8825; Biradar AV, 2009, TETRAHEDRON LETT, V50, P2885, DOI 10.1016/j.tetlet.2009.03.178; Brondino CD, 2006, ACCOUNTS CHEM RES, V39, P788, DOI 10.1021/ar050104k; Brondino CD, 2006, CURR OPIN CHEM BIOL, V10, P109, DOI 10.1016/j.cbpa.2006.01.034; CAMPESTRINI S, 1993, J MOL CATAL, V83, P95, DOI 10.1016/0304-5102(93)87010-6; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Coelho C, 2011, J MOL BIOL, V408, P932, DOI 10.1016/j.jmb.2011.03.016; Cowtan K., 1994, JOINT CCP4 ESF EACBM, V31, P34; CRUTZEN PJ, 1981, ATMOSPHERIC CHEM PRO; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Enroth C, 2000, P NATL ACAD SCI USA, V97, P10723, DOI 10.1073/pnas.97.20.10723; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; FRIDOVICH I, 1970, J BIOL CHEM, V245, P4053; Hille R, 1996, CHEM REV, V96, P2757, DOI 10.1021/cr950061t; Hille R, 2002, TRENDS BIOCHEM SCI, V27, P360, DOI 10.1016/S0968-0004(02)02107-2; Hille R, 2002, MET IONS BIOL SYST, V39, P187; Hille R, 2006, EUR J INORG CHEM, P1913, DOI 10.1002/ejic.200600087; Homer C, 2011, J SYNCHROTRON RADIAT, V18, P338, DOI 10.1107/S0909049511005504; Huber R, 1996, P NATL ACAD SCI USA, V93, P8846, DOI 10.1073/pnas.93.17.8846; Johnson MK, 1996, CHEM REV, V96, P2817, DOI 10.1021/cr950063d; Joosten RP, 2012, ACTA CRYSTALLOGR D, V68, P484, DOI 10.1107/S0907444911054515; Krippahl L, 2006, EUR J INORG CHEM, P3835, DOI 10.1002/ejic.200600418; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Matz KG, 2011, INORG CHEM, V50, P9804, DOI 10.1021/ic200783a; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; MOTTLEY C, 1988, ARCH BIOCHEM BIOPHYS, V267, P681, DOI 10.1016/0003-9861(88)90077-X; MOURA JJG, 1976, BIOCHEM BIOPH RES CO, V72, P782, DOI 10.1016/S0006-291X(76)80201-X; MOURA JJG, 1978, BIOCHEM J, V173, P419, DOI 10.1042/bj1730419; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nayal M, 1996, J MOL BIOL, V256, P228, DOI 10.1006/jmbi.1996.0081; Ravelli RBG, 2003, STRUCTURE, V11, P217, DOI 10.1016/S0969-2126(03)00006-6; Rebelo JM, 2001, J BIOL INORG CHEM, V6, P791, DOI 10.1007/s007750100255; Romao MJ, 2009, DALTON T, P4053, DOI 10.1039/b821108f; ROMAO MJ, 1995, SCIENCE, V270, P1170, DOI 10.1126/science.270.5239.1170; Rothery RA, 2012, P NATL ACAD SCI USA, V109, P14773, DOI 10.1073/pnas.1200671109; Santos-Silva T, 2009, J AM CHEM SOC, V131, P7990, DOI 10.1021/ja809448r; Schiltz M, 2007, J SYNCHROTRON RADIAT, V14, P34, DOI 10.1107/S0909049506038970; Tarini M, 2006, IEEE T VIS COMPUT GR, V12, P1237, DOI 10.1109/TVCG.2006.115; WAHL RC, 1982, J BIOL CHEM, V257, P1354; Weik M, 2000, P NATL ACAD SCI USA, V97, P623, DOI 10.1073/pnas.97.2.623; Zhao HT, 2001, FREE RADICAL BIO MED, V31, P599, DOI 10.1016/S0891-5849(01)00619-0	47	6	6	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83234	10.1371/journal.pone.0083234	http://dx.doi.org/10.1371/journal.pone.0083234			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391748	Green Published, Green Submitted, gold			2022-12-25	WOS:000329325200045
J	Paczkowska, E; Kaczynska, K; Pius-Sadowska, E; Roginska, D; Kawa, M; Ustianowski, P; Safranow, K; Celewicz, Z; Machalinski, B				Paczkowska, Edyta; Kaczynska, Katarzyna; Pius-Sadowska, Ewa; Roginska, Dorota; Kawa, Milosz; Ustianowski, Przemyslaw; Safranow, Krzysztof; Celewicz, Zbigniew; Machalinski, Boguslaw			Humoral Activity of Cord Blood-Derived Stem/Progenitor Cells: Implications for Stem Cell-Based Adjuvant Therapy of Neurodegenerative Disorders	PLOS ONE			English	Article							PERIPHERAL-NERVE REGENERATION; HYPOXIA IN-VITRO; RAT SPINAL-CORD; UMBILICAL-CORD; NEUROTROPHIC FACTORS; BONE-MARROW; CEREBRAL-ISCHEMIA; GROWTH-FACTOR; CD133(+) CELLS; CD34(+) CELLS	Background: Stem/progenitor cells (SPCs) demonstrate neuro-regenerative potential that is dependent upon their humoral activity by producing various trophic factors regulating cell migration, growth, and differentiation. Herein, we compared the expression of neurotrophins (NTs) and their receptors in specific umbilical cord blood (UCB) SPC populations, including lineage-negative, CD34(+), and CD133(+) cells, with that in unsorted, nucleated cells (NCs). Methods and Results: The expression of NTs and their receptors was detected by QRT-PCR, western blotting, and immunofluorescent staining in UCB-derived SPC populations (i.e., NCs vs. lineage-negative, CD34(+), and CD133(+) cells). To better characterize, global gene expression profiles of SPCs were determined using genome-wide RNA microarray technology. Furthermore, the intracellular production of crucial neuro-regenerative NTs (i.e., BDNF and NT-3) was assessed in NCs and lineage-negative cells after incubation for 24, 48, and 72 h in both serum and serum-free conditions. We discovered significantly higher expression of NTs and NT receptors at both the mRNA and protein level in lineage-negative, CD34(+), and CD133(+) cells than in NCs. Global gene expression analysis revealed considerably higher expression of genes associated with the production and secretion of proteins, migration, proliferation, and differentiation in lineage-negative cells than in CD34(+) or CD133(+) cell populations. Notably, after short-term incubation under serum-free conditions, lineage-negative cells and NCs produced significantly higher amounts of BDNF and NT-3 than under steady-state conditions. Finally, conditioned medium (CM) from lineage-negative SPCs exerted a beneficial impact on neural cell survival and proliferation. Conclusions: Collectively, our findings demonstrate that UCB-derived SPCs highly express NTs and their relevant receptors under steady-state conditions, NT expression is greater under stress-related conditions and that CM from SPCs favorable influence neural cell proliferation and survival. Understanding the mechanisms governing the characterization and humoral activity of subsets of SPCs may yield new therapeutic strategies that might be more effective in treating neurodegenerative disorders.	[Paczkowska, Edyta; Kaczynska, Katarzyna; Pius-Sadowska, Ewa; Roginska, Dorota; Kawa, Milosz; Safranow, Krzysztof; Machalinski, Boguslaw] Pomeranian Med Univ, Dept Gen Pathol, Szczecin, Poland; [Ustianowski, Przemyslaw; Celewicz, Zbigniew] Pomeranian Med Univ, Dept Obstet & Gynecol, Szczecin, Poland	Pomeranian Medical University; Pomeranian Medical University	Machalinski, B (corresponding author), Pomeranian Med Univ, Dept Gen Pathol, Szczecin, Poland.	machalin@pum.edu.pl	Ustianowski, Przemysław/I-2405-2014; Rogińska, Dorota/B-4424-2016; Pius-Sadowska, Ewa/O-8254-2014; Kawa, Milosz/O-7715-2014; Kosińska-Kaczyńska, Katarzyna/ABH-5914-2020; Machaliński, Bogusław/P-3025-2014; Safranow, Krzysztof/B-5127-2015; Paczkowska, Edyta/N-1209-2014; Paczkowska, Edyta/AAX-2347-2021	Ustianowski, Przemysław/0000-0002-0563-143X; Rogińska, Dorota/0000-0001-8884-837X; Pius-Sadowska, Ewa/0000-0003-3106-8705; Safranow, Krzysztof/0000-0001-9415-2758; Paczkowska, Edyta/0000-0001-7052-9741; Celewicz, Zbigniew/0000-0002-6571-0404; Machalinski, Boguslaw/0000-0002-6013-0419	National Science Center [N 401 613 740]	National Science Center(National Science Centre, Poland)	This work was supported by the National Science Center grant No. N 401 613 740 (to EP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen SJ, 2013, PHARMACOL THERAPEUT, V138, P155, DOI 10.1016/j.pharmthera.2013.01.004; Arien-Zakay H, 2009, EXP NEUROL, V216, P83, DOI 10.1016/j.expneurol.2008.11.006; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Bakondi B, 2009, MOL THER, V17, P1938, DOI 10.1038/mt.2009.185; Boltze J, 2012, CELL TRANSPLANT, V21, P723, DOI 10.3727/096368911X586783; Bracci-Laudiero L, 2003, J NEUROIMMUNOL, V136, P130, DOI 10.1016/S0165-5728(03)00007-9; Brock JH, 2010, J NEUROSCI, V30, P9728, DOI 10.1523/JNEUROSCI.1924-10.2010; Campagnoli C, 2001, BLOOD, V98, P2396, DOI 10.1182/blood.V98.8.2396; Cantinieaux D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069515; Chen SH, 2006, EXP NEUROL, V199, P67, DOI 10.1016/j.expneurol.2005.11.015; Dao MA, 2003, BLOOD, V101, P112, DOI 10.1182/blood-2002-01-0025; Douglas-Escobar M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051706; Estaquier J, 2012, ADV EXP MED BIOL, V942, P157, DOI 10.1007/978-94-007-2869-1_7; Fan CG, 2005, NEUROSCI LETT, V380, P322, DOI 10.1016/j.neulet.2005.01.070; Flores-Guzman P, 2013, TRANSFUSION, V53, P668, DOI 10.1111/j.1537-2995.2012.03799.x; Forraz N, 2004, STEM CELLS, V22, P100, DOI 10.1634/stemcells.22-1-100; Fu SY, 1997, MOL NEUROBIOL, V14, P67, DOI 10.1007/BF02740621; Fumagalli F, 2006, PHARMACOGENOMICS J, V6, P8, DOI 10.1038/sj.tpj.6500337; Goldenberg-Cohen N, 2012, STEM CELLS DEV, V21, P1488, DOI 10.1089/scd.2011.0366; Greenberg ME, 2009, J NEUROSCI, V29, P12764, DOI 10.1523/JNEUROSCI.3566-09.2009; Guillin O, 2003, EUR J PHARMACOL, V480, P89, DOI 10.1016/j.ejphar.2003.08.096; Guo JS, 2007, SPINAL CORD, V45, P15, DOI 10.1038/sj.sc.3101943; Habich A, 2006, EXP HEMATOL, V34, P914, DOI 10.1016/j.exphem.2006.03.010; Harris DT, 2008, STEM CELL REV, V4, P269, DOI 10.1007/s12015-008-9039-8; Hau S, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-30; Hemmoranta H, 2006, STEM CELLS DEV, V15, P839, DOI 10.1089/scd.2006.15.839; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Iso Y, 2013, STEM CELLS, DOI [10.1002/stem.1546, DOI 10.1002/STEM.1546.[]; Jaatinen T, 2006, STEM CELLS, V24, P631, DOI 10.1634/stemcells.2005-0185; Jiang LX, 2010, STEM CELLS DEV, V19, P221, DOI 10.1089/scd.2009.0170; Kerschensteiner M, 1999, J EXP MED, V189, P865, DOI 10.1084/jem.189.5.865; Kim SU, 2009, J NEUROSCI RES, V87, P2183, DOI 10.1002/jnr.22054; Kwon BK, 2002, P NATL ACAD SCI USA, V99, P3246, DOI 10.1073/pnas.052308899; Leonardo CC, 2010, J NEUROSCI RES, V88, P1213, DOI 10.1002/jnr.22306; Lindholm P, 2010, DEV NEUROBIOL, V70, P360, DOI 10.1002/dneu.20760; Lonne M, 2013, CELL TISSUE RES, V353, P117, DOI 10.1007/s00441-013-1597-7; MAJDIC O, 1994, BLOOD, V83, P1226; McTigue DM, 1998, J NEUROSCI, V18, P5354, DOI 10.1523/JNEUROSCI.18-14-05354.1998; Newman MB, 2006, EXP NEUROL, V199, P201, DOI 10.1016/j.expneurol.2006.04.001; Newman MB, 2005, STEM CELLS DEV, V14, P576, DOI 10.1089/scd.2005.14.576; Ng YY, 2004, J LEUKOCYTE BIOL, V75, P314, DOI 10.1189/jlb.0603287; Paczkowska E, 2009, STROKE, V40, P1237, DOI 10.1161/STROKEAHA.108.535062; Pelagiadis I, 2012, CYTOTHERAPY, V14, P701, DOI 10.3109/14653249.2012.663487; Rao M, 2012, STEM CELLS, V30, P55, DOI 10.1002/stem.770; Reich DM, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-91; Romero MI, 2001, J NEUROSCI, V21, P8408, DOI 10.1523/JNEUROSCI.21-21-08408.2001; Saarma M, 1999, MICROSC RES TECHNIQ, V45, P292, DOI 10.1002/(SICI)1097-0029(19990515/01)45:4/5<292::AID-JEMT13>3.0.CO;2-8; Salgado AJ, 2010, STEM CELLS DEV, V19, P1067, DOI 10.1089/scd.2009.0279; Schwarting S, 2008, STROKE, V39, P2867, DOI 10.1161/STROKEAHA.108.513978; Servida F, 1996, STEM CELLS, V14, P430, DOI 10.1002/stem.140430; Simone MD, 1999, HEMATOL ONCOL, V17, P1; Sohn J, 2012, J NEUROSCI, V32, P12152, DOI 10.1523/JNEUROSCI.0628-12.2012; Stroh A, 2009, MOL IMAGING, V8, P166, DOI 10.2310/7290.2009.00017; Sun YJ, 2003, J CLIN INVEST, V111, P1843, DOI 10.1172/JCI200317977; Taguchi A, 2004, J CLIN INVEST, V114, P330, DOI 10.1172/jci200420622; Terenghi G, 1999, J ANAT, V194, P1, DOI 10.1046/j.1469-7580.1999.19410001.x; Vendrame M, 2005, STEM CELLS DEV, V14, P595, DOI 10.1089/scd.2005.14.595; Wei L, 2012, NEUROBIOL DIS, V46, P635, DOI 10.1016/j.nbd.2012.03.002; Yang CC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003336; Yang ZJ, 2010, ATHEROSCLEROSIS, V211, P103, DOI 10.1016/j.atherosclerosis.2010.02.022; Zanier ER, 2011, CRIT CARE MED, V39, P2501, DOI 10.1097/CCM.0b013e31822629ba	61	32	33	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83833	10.1371/journal.pone.0083833	http://dx.doi.org/10.1371/journal.pone.0083833			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391835	Green Published, gold, Green Submitted			2022-12-25	WOS:000329325200133
J	Seu, L; Ortiz, GM; Epling, L; Sinclair, E; Swainson, LA; Bajpai, UD; Huang, Y; Deeks, SG; Hunt, PW; Martin, JN; McCune, JM				Seu, Lillian; Ortiz, Gabriel M.; Epling, Lorrie; Sinclair, Elizabeth; Swainson, Louise A.; Bajpai, Urmila D.; Huang, Yong; Deeks, Steven G.; Hunt, Peter W.; Martin, Jeffrey N.; McCune, Joseph M.			Higher CD27(+)CD8(+) T Cells Percentages during Suppressive Antiretroviral Therapy Predict Greater Subsequent CD4(+) T Cell Recovery in Treated HIV Infection	PLOS ONE			English	Article							VIRUS TYPE-1 INFECTION; REPLICATIVE SENESCENCE; LYMPHOCYTE-ACTIVATION; EXPRESSION; CD27; SURVIVAL; MEMORY	HIV-mediated immune dysfunction may influence CD4(+) T cell recovery during suppressive antiretroviral therapy (ART). We analyzed cellular biomarkers of immunological inflammation, maturation, and senescence in HIV-infected subjects on early suppressive ART. We performed longitudinal analyses of peripheral immunological biomarkers of subjects on suppressive ART (n = 24) from early treatment (median 6.4 months, interquartile range [IQR] 4.8-13.9 months) to 1-2 years of follow-up (median 19.8 months, IQR 18.3-24.6 months). We performed multivariate regression to determine which biomarkers were associated with and/or predictive of CD4(+) T cell recovery. After adjusting for the pre-ART CD4(+) T cell count, age, proximal CD4(+) T cell count, and length of ART medication, the percentage of CD27(+)CD8(+) T cells remained significantly associated with the CD4(+) T cell recovery rate (beta = 0.092 cells/ul/month, P = 0.028). In HIV-infected subjects starting suppressive ART, patients with the highest percentage of CD8(+) T cells expressing CD27 had the greatest rate of CD4(+) T cell recovery.	[Seu, Lillian; Huang, Yong] Univ Calif San Francisco, Dept Pharm, Dept Bioengn & Therapeut Sci, San Francisco, CA USA; [Seu, Lillian; Ortiz, Gabriel M.; Epling, Lorrie; Sinclair, Elizabeth; Swainson, Louise A.; Bajpai, Urmila D.; McCune, Joseph M.] Univ Calif San Francisco, Dept Med, San Francisco Gen Hosp, Div Expt Med, San Francisco, CA 94143 USA; [Ortiz, Gabriel M.] Univ Calif San Francisco, Dept Med, Div Infect Dis, San Francisco, CA 94143 USA; [Epling, Lorrie; Sinclair, Elizabeth] Univ Calif San Francisco, San Francisco Gen Hosp, Dept Med, Core Immunol Lab, San Francisco, CA USA; [Bajpai, Urmila D.] Univ Calif San Francisco, San Francisco Gen Hosp, Div Rheumatol, Dept Med, San Francisco, CA USA; [Deeks, Steven G.; Hunt, Peter W.; Martin, Jeffrey N.] Univ Calif San Francisco, San Francisco Gen Hosp, Posit Hlth Program, Dept Med, San Francisco, CA USA; [Martin, Jeffrey N.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; University of California System; University of California San Francisco; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; University of California System; University of California San Francisco	McCune, JM (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco Gen Hosp, Div Expt Med, San Francisco, CA 94143 USA.	mike.mccune@ucsf.edu	Hunt, Peter W./P-2976-2017; S., Lillian/D-1165-2011	Hunt, Peter W./0000-0002-4571-4870; S., Lillian/0000-0002-8456-019X	California HIV Research Program grant [D09-SF-313]; National Institutes of Health (NIH) [T32 AI060530, 2T32AI007641]; Gates Foundation [OPP1024421]; NIH [U01 AI43641, R37 AI40312]; Human Frontier Science Program; National Institute of Arthritis and Musculoskeletal and Skin Diseases Academic Rheumatology Training Grant; Rosalind Russell Arthritis Center; National Institutes of Health Director's Pioneer Award as part of the National Institutes of Health Roadmap for Medical Research [DPI OD00329]; Centers for AIDS Research at UCSF [PO AI27763]; CFAR Network of Integrated Systems [R24 AI067039]; UCSF CTSI [UL1 RR024131]; National Institute of Allergy and Infectious Diseases [R01 AI087145, K24AI069994, AI-76174]; AIDS Research Institute at UCSF; Harvey V. Berneking Living Trust; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024131] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI040312, K24AI069994, P01AI076174, T32AI007641, T32AI060530, R24AI067039, R01AI087145, P30AI027763] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000329] Funding Source: NIH RePORTER	California HIV Research Program grant; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Gates Foundation(Bill & Melinda Gates Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Human Frontier Science Program(Human Frontier Science Program); National Institute of Arthritis and Musculoskeletal and Skin Diseases Academic Rheumatology Training Grant; Rosalind Russell Arthritis Center; National Institutes of Health Director's Pioneer Award as part of the National Institutes of Health Roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Centers for AIDS Research at UCSF; CFAR Network of Integrated Systems; UCSF CTSI; National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); AIDS Research Institute at UCSF; Harvey V. Berneking Living Trust; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	LS was supported by a pre-doctoral dissertation California HIV Research Program grant (# D09-SF-313). GMO was supported by National Institutes of Health (NIH) Training Grants T32 AI060530 and 2T32AI007641 as well as the Gates Foundation Award # OPP1024421 and the NIH Loan Repayment Program. LAS is supported by the Human Frontier Science Program. UDB is a University of California at San Francisco (UCSF) Rheumatology Fellow and is funded by a National Institute of Arthritis and Musculoskeletal and Skin Diseases Academic Rheumatology Training Grant and the Rosalind Russell Arthritis Center. JMM was supported by NIH Awards U01 AI43641 and R37 AI40312, and is a recipient of the National Institutes of Health Director's Pioneer Award as part of the National Institutes of Health Roadmap for Medical Research (DPI OD00329). The SCOPE cohort was supported by the Centers for AIDS Research at UCSF (PO AI27763), CFAR Network of Integrated Systems (R24 AI067039), the UCSF CTSI (UL1 RR024131), and National Institute of Allergy and Infectious Diseases (R01 AI087145, K24AI069994, AI-76174). This work was also supported by the AIDS Research Institute at UCSF and the Harvey V. Berneking Living Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker JV, 2008, AIDS, V22, P841, DOI 10.1097/QAD.0b013e3282f7cb76; Brenchley JM, 2003, BLOOD, V101, P2711, DOI 10.1182/blood-2002-07-2103; Cameron PU, 2007, J VIROL, V81, P2297, DOI 10.1128/JVI.01795-06; Deeks SG, 2012, CURR OPIN IMMUNOL, V24, P501, DOI 10.1016/j.coi.2012.05.004; Effros RB, 1996, AIDS, V10, pF17, DOI 10.1097/00002030-199607000-00001; Favre D, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000632; GIORGI JV, 1994, J INFECT DIS, V170, P775, DOI 10.1093/infdis/170.4.775; Giorgi JV, 1999, J INFECT DIS, V179, P859, DOI 10.1086/314660; Hamann D, 1997, J EXP MED, V186, P1407, DOI 10.1084/jem.186.9.1407; HARDING FA, 1992, NATURE, V356, P607, DOI 10.1038/356607a0; Heimbeck I, 2010, CYTOM PART A, V77A, P823, DOI 10.1002/cyto.a.20942; Hunt PW, 2003, J INFECT DIS, V187, P1534, DOI 10.1086/374786; Kelley CF, 2009, CLIN INFECT DIS, V48, P787, DOI 10.1086/597093; KOBATA T, 1994, J IMMUNOL, V153, P5422; Massanella M, 2013, ANTIVIR RES, V100, P420, DOI 10.1016/j.antiviral.2013.07.017; McFarland RD, 2000, P NATL ACAD SCI USA, V97, P4215, DOI 10.1073/pnas.070061597; Mojumdar K, 2012, CYTOM PART B-CLIN CY, V82B, P43, DOI 10.1002/cyto.b.20610; Ochsenbein AF, 2004, J EXP MED, V200, P1407, DOI 10.1084/jem.20040717; Rajasuriar R, 2013, AIDS; Rothman K J, 1990, Epidemiology, V1, P43, DOI 10.1097/00001648-199001000-00010; Swainson LA, 2010, J IMMUNOL, V184, P3639, DOI 10.4049/jimmunol.0903943; Vollbrecht T, 2010, J MED VIROL, V82, P358, DOI 10.1002/jmv.21723; Young J, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001194	23	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84091	10.1371/journal.pone.0084091	http://dx.doi.org/10.1371/journal.pone.0084091			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391889	Green Published, gold, Green Submitted			2022-12-25	WOS:000329323900032
J	Simeon, RL; Chen, ZL				Simeon, Rudo L.; Chen, Zhilei			A Screen for Genetic Suppressor Elements of Hepatitis C Virus Identifies a Supercharged Protein Inhibitor of Viral Replication	PLOS ONE			English	Article							ALPHA-2B PLUS RIBAVIRIN; RNA REPLICATION; EXPRESSION SELECTION; INITIAL TREATMENT; RESISTANCE; COMBINATION; COMPLEX; INTERFERON-ALPHA-2B; ALPHA-DEFENSIN-1; BOCEPREVIR	Genetic suppressor elements (GSEs) are biomolecules derived from a gene or genome of interest that act as transdominant inhibitors of biological functions presumably by disruption of critical biological interfaces. We exploited a cell death reporter cell line for hepatitis C virus (HCV) infection, n4mBid, to develop an iterative selection/enrichment strategy for the identification of anti-HCV GSEs. Using this approach, a library of fragments of an HCV genome was screened for sequences that suppress HCV infection. A 244 amino acid gene fragment, B1, was strongly enriched after 5 rounds of selection. B1 derives from a single-base frameshift of the enhanced green fluorescent protein (eGFP) which was used as a filler during fragment cloning. B1 has a very high net positive charge of 43 at neutral pH and a high charge-to-mass (kDa) ratio of 1.5. We show that B1 expression specifically inhibits HCV replication. In addition, five highly positively charged B1 fragments produced from progressive truncation at the C-terminus all retain the ability to inhibit HCV, suggesting that a high positive charge, rather than a particular motif in B1, likely accounts for B1's anti-HCV activity. Another supercharged protein, +36GFP, was also found to strongly inhibit HCV replication when added to cells at the time of infection. This study reports a new methodology for HCV inhibitor screening and points to the anti-HCV potential of positively charged proteins/peptides.	[Simeon, Rudo L.; Chen, Zhilei] Texas A&M Univ, Artie McFerrin Dept Chem Engn, College Stn, TX 77843 USA; [Chen, Zhilei] Texas A&M Hlth Sci Ctr, Dept Microbial & Mol Pathogenesis, College Stn, TX USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	Chen, ZL (corresponding author), Texas A&M Univ, Artie McFerrin Dept Chem Engn, College Stn, TX 77843 USA.	zchen4@tamu.edu			National Institutes of Health [R21A1083965-01]; Artie McFerrin Department of Chemical Engineering, Texas AM University	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Artie McFerrin Department of Chemical Engineering, Texas AM University	Funding for this study is provided by the National Institutes of Health (R21A1083965-01) and the Artie McFerrin Department of Chemical Engineering, Texas A&M University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bacon BR, 2011, NEW ENGL J MED, V364, P1207, DOI 10.1056/NEJMoa1009482; Blight KJ, 2002, J VIROL, V76, P13001, DOI 10.1128/JVI.76.24.13001-13014.2002; Brown RS, 2005, NATURE, V436, P973, DOI 10.1038/nature04083; Buck CB, 2006, P NATL ACAD SCI USA, V103, P1516, DOI 10.1073/pnas.0508033103; BURNS JC, 1993, P NATL ACAD SCI USA, V90, P8033, DOI 10.1073/pnas.90.17.8033; Carroll SS, 2003, J BIOL CHEM, V278, P11979, DOI 10.1074/jbc.M210914200; Chamoun AM, 2012, ANTIMICROB AGENTS CH, V56, P672, DOI 10.1128/AAC.05722-11; Chang TL, 2005, J CLIN INVEST, V115, P765, DOI 10.1172/JCI200521948; Chen ZL, 2010, ANTIVIR RES, V86, P220, DOI 10.1016/j.antiviral.2010.02.321; Chockalingam K, 2010, P NATL ACAD SCI USA, V107, P3764, DOI 10.1073/pnas.0915117107; Cowan S, 2002, P NATL ACAD SCI USA, V99, P11914, DOI 10.1073/pnas.162299499; Cronican JJ, 2011, CHEM BIOL, V18, P833, DOI 10.1016/j.chembiol.2011.07.003; DAHER KA, 1986, J VIROL, V60, P1068, DOI 10.1128/JVI.60.3.1068-1074.1986; Dunn SJ, 2004, VIROLOGY, V321, P260, DOI 10.1016/j.virol.2004.01.010; Dunn SJ, 1999, GENE THER, V6, P130, DOI 10.1038/sj.gt.3300791; Dusheiko G, 1997, HEPATOLOGY, V26, pS112, DOI 10.1002/hep.510260720; Evans MJ, 2007, NATURE, V446, P801, DOI 10.1038/nature05654; GANZ T, 1995, PHARMACOL THERAPEUT, V66, P191, DOI 10.1016/0163-7258(94)00076-F; Gao L, 2004, J VIROL, V78, P3480, DOI 10.1128/JVI.78.7.3480-3488.2004; Garkavtsev I, 1996, NAT GENET, V14, P415, DOI 10.1038/ng1296-415; Garnier J, 1996, METHOD ENZYMOL, V266, P540; Gastaminza P, 2011, J VIROL, V85, P5513, DOI 10.1128/JVI.02116-10; GUDKOV AV, 1994, P NATL ACAD SCI USA, V91, P3744, DOI 10.1073/pnas.91.9.3744; Hadziyannis SJ, 2004, ANN INTERN MED, V140, P346, DOI 10.7326/0003-4819-140-5-200403020-00010; Hahn B, 1998, J VIROL, V72, P8782, DOI 10.1128/JVI.72.11.8782-8788.1998; Halfon P, 2011, J HEPATOL, V55, P192, DOI 10.1016/j.jhep.2011.01.011; Hanafiah KM, 2013, HEPATOLOGY, V57, P1333, DOI 10.1002/hep.26141; HOLZMAYER TA, 1992, NUCLEIC ACIDS RES, V20, P711, DOI 10.1093/nar/20.4.711; Honda M, 2000, GASTROENTEROLOGY, V118, P152, DOI 10.1016/S0016-5085(00)70424-0; Hsu M, 2003, P NATL ACAD SCI USA, V100, P7271, DOI 10.1073/pnas.0832180100; Levenson VV, 1999, SOMAT CELL MOLEC GEN, V25, P9; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; Lohmann V, 2003, J VIROL, V77, P3007, DOI 10.1128/JVI.77.5.3007-3019.2003; Manns MP, 2001, LANCET, V358, P958, DOI 10.1016/S0140-6736(01)06102-5; Maqbool MA, 2013, J VIROL, V87, P5523, DOI 10.1128/JVI.00585-12; MARTELL M, 1992, J VIROL, V66, P3225, DOI 10.1128/JVI.66.5.3225-3229.1992; Marukian S, 2008, HEPATOLOGY, V48, P1843, DOI 10.1002/hep.22550; McHutchison JG, 1998, NEW ENGL J MED, V339, P1485, DOI 10.1056/NEJM199811193392101; McNaughton BR, 2009, P NATL ACAD SCI USA, V106, P6111, DOI 10.1073/pnas.0807883106; Miyanari Y, 2007, NAT CELL BIOL, V9, P1089, DOI 10.1038/ncb1631; Newcomer BW, 2013, CAN J VET RES, V77, P170; Novoa I, 2001, J CELL BIOL, V153, P1011, DOI 10.1083/jcb.153.5.1011; Pharma T, US Patent Number, Patent No. [6,797,462, 6797462]; Poordad F, 2011, NEW ENGL J MED, V364, P1195, DOI 10.1056/NEJMoa1010494; Primiano T, 2003, CANCER CELL, V4, P41, DOI 10.1016/S1535-6108(03)00169-7; REED L. J., 1938, AMER JOUR HYG, V27, P493; RICE CM, 1987, J VIROL, V61, P3809, DOI 10.1128/JVI.61.12.3809-3819.1987; RONINSON IB, 1995, CANCER RES, V55, P4023; Samuel CE, 2001, CLIN MICROBIOL REV, V14, P778, DOI 10.1128/CMR.14.4.778-809.2001; SELSTED ME, 1985, INFECT IMMUN, V49, P202, DOI 10.1128/IAI.49.1.202-206.1985; SELSTED ME, 1984, INFECT IMMUN, V45, P150, DOI 10.1128/IAI.45.1.150-154.1984; Simeon RL, 2013, ACS CHEM BIOL; Simmonds P, 2005, HEPATOLOGY, V42, P962, DOI 10.1002/hep.20819; Thompson AJ, 2011, CURR OPIN VIROL, V1, P599, DOI 10.1016/j.coviro.2011.10.001; Tscherne DM, 2008, J VIROL, V82, P2427, DOI 10.1128/JVI.02158-07; Tu H, 1999, VIROLOGY, V263, P30, DOI 10.1006/viro.1999.9893; Wasley A, 2000, SEMIN LIVER DIS, V20, P1, DOI 10.1055/s-2000-9506; Wolk B, 2000, J VIROL, V74, P2293, DOI 10.1128/JVI.74.5.2293-2304.2000; World Health Organization, 2012, GUID PREV VIR HEP B; Yang TT, 1996, NUCLEIC ACIDS RES, V24, P4592, DOI 10.1093/nar/24.22.4592; Zennou V, 2000, CELL, V101, P173, DOI 10.1016/S0092-8674(00)80828-4; Zeuzem S, 2006, J HEPATOL, V44, P97, DOI 10.1016/j.jhep.2005.10.003; Zhang LR, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00293; Zhang LQ, 2002, SCIENCE, V298, P995, DOI 10.1126/science.1076185	64	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84022	10.1371/journal.pone.0084022	http://dx.doi.org/10.1371/journal.pone.0084022			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391867	Green Submitted, gold, Green Published			2022-12-25	WOS:000329323900010
J	Upadhyay, SK; Dixit, S; Sharma, S; Singh, H; Kumar, J; Verma, PC; Chandrashekar, K				Upadhyay, Santosh Kumar; Dixit, Sameer; Sharma, Shailesh; Singh, Harpal; Kumar, Jitesh; Verma, Praveen C.; Chandrashekar, K.			siRNA Machinery in Whitefly (Bemisia tabaci)	PLOS ONE			English	Article							RNA INTERFERENCE; SYSTEMIC RNAI; MICRORNA MATURATION; HEMIPTERAN INSECT; DISTINCT ROLES; GENE; INITIATION; ARGONAUTE; TRANSCRIPTOME; REQUIRES	Background: RNA interference has been emerged as an utmost tool for the control of sap sucking insect pests. Systemic response is necessary to control them in field condition. Whitefly is observed to be more prone to siRNA in recent studies, however the siRNA machinery and mechanism is not well established. Methodology/Principal Findings: To identify the core siRNA machinery, we curated transcriptome data of whitefly from NCBI database. Partial mRNA sequences encoding Dicer2, R2D2, Argonaute2 and Sid1 were identified by tblastn search of homologous sequences from Aphis glycines and Tribolium castaneum. Complete encoding sequences were obtained by RACE, protein sequences derived by Expasy translate tool and confirmed by blastp analysis. Conserved domain search and Prosite-Scan showed similar domain architecture as reported in homologs from related insects. We found helicase, PAZ, RNaseIIIa, RNaseIIIb and double-stranded RNA-binding fold (DSRBF) in Dicer2; DsRBD in R2D2; and PAZ and PIWI domains in Argonaute2. Eleven transmembrane domains were detected in Sid1. Sequence homology and phylogenetic analysis revealed that RNAi machinery of whitefly is close to Aphids. Real-time PCR analysis showed similar expression of these genes in different developmental stages as reported in A. glycines and T. castaneum. Further, the expression level of above genes was quite similar to the housekeeping gene actin. Conclusions/Significance: Availability of core siRNA machinery including the Sid1 and their universal expression in reasonable quantity indicated significant response of whitefly towards siRNA. Present report opens the way for controlling whitefly, one of the most destructive crop insect pest.	[Upadhyay, Santosh Kumar; Sharma, Shailesh; Kumar, Jitesh] Govt India, Natl Agri Food Biotechnol Inst, Dept Biotechnol, Mohali, Punjab, India; [Dixit, Sameer; Singh, Harpal; Verma, Praveen C.; Chandrashekar, K.] CSIR, CSIR Natl Bot Res Inst, Lucknow, Uttar Pradesh, India; [Chandrashekar, K.] Indian Agr Res Inst Reg Stn, Pune, Maharashtra, India	Department of Biotechnology (DBT) India; National Agri Food Biotechnology Institute (NABI); Council of Scientific & Industrial Research (CSIR) - India; CSIR - National Botanical Research Institute (NBRI); Indian Council of Agricultural Research (ICAR); ICAR - Indian Agricultural Research Institute	Upadhyay, SK (corresponding author), Govt India, Natl Agri Food Biotechnol Inst, Dept Biotechnol, Mohali, Punjab, India.	santoshnbri@hotmail.com; praveencverma@yahoo.com; kc_shekar2001@yahoo.com	Upadhyay, Santosh/ABD-2302-2020; Verma, Praveen C/F-9709-2010; Kumar, Jitesh/ABB-5150-2021; Chadrashekar, K/AAX-4996-2021	Upadhyay, Santosh/0000-0001-6991-0502; Verma, Praveen C/0000-0002-3732-0564; Kumar, Jitesh/0000-0003-1606-3420; Sharma, Shailesh/0000-0001-8832-8956	CSIR; DST-INSPIRE	CSIR(Council of Scientific & Industrial Research (CSIR) - India); DST-INSPIRE(Department of Science & Technology (India))	This work is supported by CSIR-Empower project grant and DST-INSPIRE Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aronstein K, 2006, J APICULT RES, V45, P20, DOI 10.1080/00218839.2006.11101307; Bansal R, 2013, INT J MOL SCI, V14, P3786, DOI 10.3390/ijms14023786; Baum JA, 2007, NAT BIOTECHNOL, V25, P1322, DOI 10.1038/nbt1359; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Bucher G, 2002, CURR BIOL, V12, pR85, DOI 10.1016/S0960-9822(02)00666-8; Carmell MA, 2004, NAT STRUCT MOL BIOL, V11, P214, DOI 10.1038/nsmb729; Chen J, 2010, INSECT MOL BIOL, V19, P777, DOI 10.1111/j.1365-2583.2010.01038.x; de Castro E, 2006, NUCLEIC ACIDS RES, V34, pW362, DOI 10.1093/nar/gkl124; Dong Y, 2005, BMC BIOTECHNOL, V5, DOI 10.1186/1472-6750-5-25; Dutt U, 2007, ENV NEWS SERVIC 0821; Duxbury MS, 2005, BIOCHEM BIOPH RES CO, V331, P459, DOI 10.1016/j.bbrc.2005.03.199; Elkayam E, 2012, CELL, V150, P100, DOI 10.1016/j.cell.2012.05.017; Faria CA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000600; Feinberg EH, 2003, SCIENCE, V301, P1545, DOI 10.1126/science.1087117; Forstemann K, 2005, PLOS BIOL, V3, P1187, DOI 10.1371/journal.pbio.0030236; Ghanim M, 2007, INSECT BIOCHEM MOLEC, V37, P732, DOI 10.1016/j.ibmb.2007.04.006; Gordon KHJ, 2007, NAT BIOTECHNOL, V25, P1231, DOI 10.1038/nbt1107-1231; Gu LQ, 2013, CROP PROT, V45, P36, DOI 10.1016/j.cropro.2012.10.004; Huvenne H, 2010, J INSECT PHYSIOL, V56, P227, DOI 10.1016/j.jinsphys.2009.10.004; Jaubert-Possamai S, 2010, MOL BIOL EVOL, V27, P979, DOI 10.1093/molbev/msp256; Jiang F, 2005, GENE DEV, V19, P1674, DOI 10.1101/gad.1334005; Ketting RF, 2001, GENE DEV, V15, P2654, DOI 10.1101/gad.927801; Knight SW, 2001, SCIENCE, V293, P2269, DOI 10.1126/science.1062039; Lee YS, 2004, CELL, V117, P69, DOI 10.1016/S0092-8674(04)00261-2; Liu QH, 2003, SCIENCE, V301, P1921, DOI 10.1126/science.1088710; Luo Y, 2012, RNA BIOL, V9, P663, DOI 10.4161/rna.19986; Ma JB, 2004, NATURE, V429, P318, DOI 10.1038/nature02519; Mao YB, 2007, NAT BIOTECHNOL, V25, P1307, DOI 10.1038/nbt1352; Marcus JM, 2005, EVOL DEV, V7, P108, DOI 10.1111/j.1525-142X.2005.05012.x; Meister G, 2004, NATURE, V431, P343, DOI 10.1038/nature02873; Mutti NS, 2006, J INSECT SCI, V6, DOI 10.1673/031.006.3801; Okamura K, 2004, GENE DEV, V18, P1655, DOI 10.1101/gad.1210204; Parker JS, 2006, TRENDS BIOCHEM SCI, V31, P622, DOI 10.1016/j.tibs.2006.09.010; Pham JW, 2004, CELL, V117, P83, DOI 10.1016/S0092-8674(04)00258-2; Pitino M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025709; Price DRG, 2008, TRENDS BIOTECHNOL, V26, P393, DOI 10.1016/j.tibtech.2008.04.004; Richards S, 2008, NATURE, V452, P949, DOI 10.1038/nature06784; Roignant JY, 2003, RNA, V9, P299, DOI 10.1261/rna.2154103; Saito K, 2005, PLOS BIOL, V3, P1202, DOI 10.1371/journal.pbio.0030235; Sanahuja G, 2011, PLANT BIOTECHNOL J, V9, P283, DOI 10.1111/j.1467-7652.2011.00595.x; Shakesby AJ, 2009, INSECT BIOCHEM MOLEC, V39, P1, DOI 10.1016/j.ibmb.2008.08.008; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tomari Y, 2004, SCIENCE, V306, P1377, DOI 10.1126/science.1102755; Tomoyasu Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r10; Upadhyay SK, 2011, J BIOSCIENCES, V36, P153, DOI 10.1007/s12038-011-9009-1; Wang XW, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-529; Wang XW, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-400; Weinstock GM, 2006, NATURE, V443, P931, DOI 10.1038/nature05260; Winston WM, 2002, SCIENCE, V295, P2456, DOI 10.1126/science.1068836; Xie W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035181; Xu WN, 2008, J INSECT SCI, V8, DOI 10.1673/031.008.3001; Yigit E, 2006, CELL, V127, P747, DOI 10.1016/j.cell.2006.09.033; Zhang H, 2013, INSECT SCI, V20, P15, DOI 10.1111/j.1744-7917.2012.01513.x	53	27	28	1	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83692	10.1371/journal.pone.0083692	http://dx.doi.org/10.1371/journal.pone.0083692			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391810	Green Published, gold, Green Submitted			2022-12-25	WOS:000329325200108
J	Wu, WH; Kuo, TC; Lin, YT; Huang, SW; Liu, HF; Wang, J; Chen, YMA				Wu, Wen-Hao; Kuo, Ta-Cheng; Lin, Yu-Ting; Huang, Szu-Wei; Liu, Hsin-Fu; Wang, John; Chen, Yi-Ming Arthur			Molecular Epidemiology of Enterovirus 71 Infection in the Central Region of Taiwan from 2002 to 2012	PLOS ONE			English	Article							EVOLUTION; RECOMBINATION; EMERGENCE; OUTBREAKS; GENOTYPE	Enterovirus 71 (EV71), a causative agent of hand, foot, and mouth disease can be classified into three genotypes and many subtypes. The objectives of this study were to conduct a molecular epidemiological study of EV71 in the central region of Taiwan from 2002-2012 and to test the hypothesis that whether the alternative appearance of different EV71 subtypes in Taiwan is due to transmission from neighboring countries or from re-emergence of pre-existing local strains. We selected 174 EV71 isolates and used reverse transcription-polymerase chain reaction to amplify their VP1 region for DNA sequencing. Phylogenetic analyses were conducted using Neighbor-Joining, Maximum Likelihood and Bayesian methods. We found that the major subtypes of EV71 in Taiwan were B4 for 2002 epidemic, C4 for 2004-2005 epidemic, B5 for 2008-2009 epidemic, C4 for 2010 epidemic and B5 for 2011-2012 epidemic. Phylogenetic analysis demonstrated that the 2002 and 2008 epidemics were associated with EV71 from Malaysia and Singapore; while both 2010 and 2011-2012 epidemics originated from different regions of mainland China including Shanghai, Henan, Xiamen and Gong-Dong. Furthermore, minor strains have been identified in each epidemic and some of them were correlated with the subsequent outbreaks. Therefore, the EV71 infection in Taiwan may originate from pre-existing minor strains or from other regions in Asia including mainland China. In addition, 101 EV71 isolates were selected for the detection of new recombinant strains using the nucleotide sequences spanning the VP1-2A-2B region. No new recombinant strain was found. Analysis of clinical manifestations showed that patients infected with C4 had significantly higher rates of pharyngeal vesicles or ulcers than patients infected with B5. This is the first study demonstrating that different EV 71 genotypes may have different clinical manifestations and the association of EV71 infections between Taiwan and mainland China.	[Wu, Wen-Hao; Liu, Hsin-Fu] Natl Yang Ming Univ, Inst Publ Hlth, Taipei 112, Taiwan; [Wu, Wen-Hao] Wan Fang Hosp, Dept Pediat, Taipei, Taiwan; [Wu, Wen-Hao; Kuo, Ta-Cheng; Lin, Yu-Ting; Huang, Szu-Wei; Chen, Yi-Ming Arthur] Kaohsiung Med Univ, Ctr Infect Dis & Canc Res, Kaohsiung, Taiwan; [Kuo, Ta-Cheng; Huang, Szu-Wei; Chen, Yi-Ming Arthur] Natl Yang Ming Univ, Inst Microbiol & Immunol, Sch Life Sci, Taipei 112, Taiwan; [Liu, Hsin-Fu] Mackay Mem Hosp, Dept Med Res, Taipei, Taiwan; [Wang, John] Taichung Vet Gen Hosp, Dept Pathol, Taichung, Taiwan; [Chen, Yi-Ming Arthur] Kaohsiung Med Univ, Dept Microbiol, Coll Med, Kaohsiung, Taiwan; [Chen, Yi-Ming Arthur] Kaohsiung Med Univ, Inst Med Res, Coll Med, Kaohsiung, Taiwan	National Yang Ming Chiao Tung University; Taipei Municipal WanFang Hospital; Kaohsiung Medical University; National Yang Ming Chiao Tung University; Mackay Memorial Hospital; Taichung Veterans General Hospital; Kaohsiung Medical University; Kaohsiung Medical University	Chen, YMA (corresponding author), Kaohsiung Med Univ, Ctr Infect Dis & Canc Res, Kaohsiung, Taiwan.	arthur@kmu.edu.tw	Huang, Szu-Wei/AAT-1998-2020; Liu, Hsin-Fu/AAR-5960-2020; HUANG, SZU-WEI/AAT-5153-2021	Huang, Szu-Wei/0000-0002-3813-7737; Liu, Hsin-Fu/0000-0003-0082-2269; 	National Science Council of Taiwan [NSC102-2325-B-037-009]; Centers for Disease Control of Taiwan [HZ101060]; Center for Infectious Disease and Cancer Research, Kaohsiung Medical University, Kaohsiung, Taiwan	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Centers for Disease Control of Taiwan; Center for Infectious Disease and Cancer Research, Kaohsiung Medical University, Kaohsiung, Taiwan	This study were partially supported by National Science Council of Taiwan (grant No. NSC102-2325-B-037-009), Centers for Disease Control of Taiwan (grant No. HZ101060) and Center for Infectious Disease and Cancer Research, Kaohsiung Medical University, Kaohsiung, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brown BA, 1999, J VIROL, V73, P9969, DOI 10.1128/JVI.73.12.9969-9975.1999; Chan YF, 2010, INFECT GENET EVOL, V10, P404, DOI 10.1016/j.meegid.2009.05.010; Chang HL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046845; Ho MT, 1999, NEW ENGL J MED, V341, P929, DOI 10.1056/NEJM199909233411301; Huang SW, 2011, EXP BIOL MED, V236, P899, DOI 10.1258/ebm.2010.010233; Huang SW, 2009, J CLIN MICROBIOL, V47, P3653, DOI 10.1128/JCM.00630-09; Huang SC, 2008, VIRUS RES, V131, P250, DOI 10.1016/j.virusres.2007.10.002; Knipe DM, 2007, FIELDS VIROLOGY; Lan YC, 2011, SCAND J INFECT DIS, V43, P354, DOI 10.3109/00365548.2010.545995; Lee MH, 2011, J MICROBIOL IMMUNOL, V44, P178, DOI 10.1016/j.jmii.2011.01.018; Leitch ECM, 2012, J VIROL, V86, P2676, DOI 10.1128/JVI.06065-11; Lin KH, 2006, J MED VIROL, V78, P254, DOI 10.1002/jmv.20534; Lin TY, 2003, EMERG INFECT DIS, V9, P291, DOI 10.3201/eid0903.020285; Robertson DL, 2000, SCIENCE, V288, P55, DOI 10.1126/science.288.5463.55d; Solomon T, 2010, LANCET INFECT DIS, V10, P778, DOI 10.1016/S1473-3099(10)70194-8; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Wang JR, 2002, J CLIN MICROBIOL, V40, P10, DOI 10.1128/JCM.40.1.10-15.2002; Yan JJ, 2000, J CLIN VIROL, V17, P13, DOI 10.1016/S1386-6532(00)00067-6; Yip CCY, 2010, ARCH VIROL, V155, P1413, DOI 10.1007/s00705-010-0722-0; Yoke-Fun C, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-74	20	23	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83711	10.1371/journal.pone.0083711	http://dx.doi.org/10.1371/journal.pone.0083711			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391812	Green Published, gold, Green Submitted			2022-12-25	WOS:000329325200110
J	Galli, G; Shukla, A; Simmons, AN; Davenport, PW; Paulus, MP				Galli, Giulia; Shukla, Akanksha; Simmons, Alan N.; Davenport, Paul W.; Paulus, Martin P.			Sex Differences in the Neural Processing of Aversive Interoceptive Events: The Benefit of Relief	PLOS ONE			English	Article							GENDER-DIFFERENCES; INSULAR CORTEX; BRAIN ACTIVATION; OPPONENT-PROCESS; AIR HUNGER; PERCEPTION; PAIN; DYSPNEA; FMRI; AWARENESS	Do men and women process and experience unpleasant bodily states differently? We used fMRI to determine brain processing before, during and after an aversive respiratory stimulation. No sex difference emerged during anticipation or stimulation. However, after the offset of the stimulation, men but not women showed enhanced activation of brain regions that are important for interoception and reward processing. Moreover, this activation was highest in those males who rated the preceding stimulation as most unpleasant. These results indicate that men are particularly sensitive to reward associated with the termination of an aversive event, which may signal relief.	[Shukla, Akanksha; Simmons, Alan N.; Paulus, Martin P.] Univ Calif San Diego, Dept Psychiat, San Diego, CA 92103 USA; [Simmons, Alan N.; Paulus, Martin P.] Vet Affairs Hlth Care Syst, San Diego, CA USA; [Davenport, Paul W.] Univ Florida, Dept Physiol Sci, Gainesville, FL 32610 USA; [Galli, Giulia] Azienda Osped Univ Senese, Dipartimento Sci Neurol & Neurosensoriali, Siena, Italy	University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); State University System of Florida; University of Florida; University of Siena; University Hospital of Siena	Paulus, MP (corresponding author), Univ Calif San Diego, Dept Psychiat, San Diego, CA 92103 USA.	mpaulus@ucsd.edu	Simmons, Alan N/A-9815-2008	Simmons, Alan N/0000-0003-3963-2112; Galli, Giulia/0000-0001-9894-3514	National Institute on Drug Abuse [R01-DA016663, P20-DA027834, R01-DA027797, R01-DA018307]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA027797, R01DA016663, R01DA018307] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by grants from the National Institute on Drug Abuse (Grant Nos. R01-DA016663, P20-DA027834, R01-DA027797, and R01-DA018307 to Martin Paulus). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander-Miller S, 2010, BIOL PSYCHOL, V84, P147, DOI 10.1016/j.biopsycho.2010.03.004; Anderson K, 2009, CEREB CORTEX, V19, P2131, DOI 10.1093/cercor/bhn234; AXEN K, 1984, J APPL PHYSIOL, V56, P175, DOI 10.1152/jappl.1984.56.1.175; Baker TB, 2004, PSYCHOL REV, V111, P33, DOI 10.1037/0033-295X.111.1.33; Banzett RB, 2000, NEUROREPORT, V11, P2117, DOI 10.1097/00001756-200007140-00012; Becklake MR, 1999, THORAX, V54, P1119, DOI 10.1136/thx.54.12.1119; Biele G, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001089; Boynton GM, 1996, J NEUROSCI, V16, P4207, DOI 10.1523/jneurosci.16-13-04207.1996; Brannan S, 2001, P NATL ACAD SCI USA, V98, P2029, DOI 10.1073/pnas.98.4.2029; Cohen MS, 1997, NEUROIMAGE, V6, P93, DOI 10.1006/nimg.1997.0278; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Craig AD, 2009, NAT REV NEUROSCI, V10, P59, DOI 10.1038/nrn2555; Craig AD, 2000, NAT NEUROSCI, V3, P184, DOI 10.1038/72131; Critchley HD, 2004, NAT NEUROSCI, V7, P189, DOI 10.1038/nn1176; Cross CP, 2011, PSYCHOL BULL, V137, P97, DOI 10.1037/a0021591; Davenport PW, 2009, RESP PHYSIOL NEUROBI, V167, P72, DOI 10.1016/j.resp.2008.10.001; DAVENPORT PW, 1986, J APPL PHYSIOL, V60, P1843, DOI 10.1152/jappl.1986.60.6.1843; Denton D, 1999, P NATL ACAD SCI USA, V96, P5304, DOI 10.1073/pnas.96.9.5304; Eddy WF, 1996, MAGNET RESON MED, V36, P923, DOI 10.1002/mrm.1910360615; Evans KC, 2002, J NEUROPHYSIOL, V88, P1500, DOI 10.1152/jn.2002.88.3.1500; FRISTON KJ, 1995, NEUROIMAGE, V2, P157, DOI 10.1006/nimg.1995.1018; Galli G, 2011, J NEUROSCI, V31, P12364, DOI 10.1523/JNEUROSCI.1619-11.2011; GOTTFRIED SB, 1978, CHEST, V73, P286, DOI 10.1378/chest.73.2.286; Hamann S, 2004, CURR OPIN NEUROBIOL, V14, P233, DOI 10.1016/j.conb.2004.03.010; HARVER A, 1993, PSYCHOPHYSIOLOGY, V30, P223, DOI 10.1111/j.1469-8986.1993.tb03347.x; KATKIN ES, 1981, J PERS SOC PSYCHOL, V40, P1095, DOI 10.1037/0022-3514.40.6.1095; Koch K, 2007, NEUROPSYCHOLOGIA, V45, P2744, DOI 10.1016/j.neuropsychologia.2007.04.012; Leknes S, 2008, EUR J NEUROSCI, V28, P794, DOI 10.1111/j.1460-9568.2008.06380.x; Leknes S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017870; Lighthall NR, 2012, SOC COGN AFFECT NEUR, V7, P476, DOI 10.1093/scan/nsr026; Liotti M, 2001, P NATL ACAD SCI USA, V98, P2035, DOI 10.1073/pnas.98.4.2035; LOPATA M, 1977, AM REV RESPIR DIS, V115, P73; Medford N, 2010, BRAIN STRUCT FUNCT, V214, P535, DOI 10.1007/s00429-010-0265-x; Moore DJ, 2012, Q J EXP PSYCHOL, V65, P565, DOI 10.1080/17470218.2011.626865; Nishino T, 2005, JPN J PHYSIOL, V55, P117, DOI 10.2170/jjphysiol.R2088; Pappens M, 2010, BIOL PSYCHOL, V84, P98, DOI 10.1016/j.biopsycho.2010.02.006; Paulus MP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029394; Peiffer C, 2001, AM J RESP CRIT CARE, V163, P951, DOI 10.1164/ajrccm.163.4.2005057; Peiffer C, 2008, AM J RESP CRIT CARE, V177, P440, DOI 10.1164/rccm.200612-1774OC; Peiffer C, 2009, RESP PHYSIOL NEUROBI, V167, P61, DOI 10.1016/j.resp.2009.04.001; Racine M, 2012, PAIN, V153, P602, DOI 10.1016/j.pain.2011.11.025; Schon D, 2008, PSYCHOPHYSIOLOGY, V45, P1064, DOI 10.1111/j.1469-8986.2008.00704.x; Seo D, 2011, HUM BRAIN MAPP, V32, P1998, DOI 10.1002/hbm.21165; Simmons AN, 2011, HUM BRAIN MAPP, V32, P1836, DOI 10.1002/hbm.21154; SOLOMON RL, 1980, AM PSYCHOL, V35, P691, DOI 10.1037/0003-066X.35.8.691; Spreckelmeyer KN, 2009, SOC COGN AFFECT NEUR, V4, P158, DOI 10.1093/scan/nsn051; Stevens JS, 2012, NEUROPSYCHOLOGIA, V50, P1578, DOI 10.1016/j.neuropsychologia.2012.03.011; Strigo IA, 2013, INT J EAT DISORDER, V46, P23, DOI 10.1002/eat.22045; Suschinsky KD, 2012, ARCH SEX BEHAV, V41, P199, DOI 10.1007/s10508-012-9931-9; Talairach J., 1988, COPLANAR STEREOTAXIC; Thayer JF, 2003, COGNITIVE THER RES, V27, P349, DOI 10.1023/A:1023922618287; Torrubia R, 2001, PERS INDIV DIFFER, V31, P837, DOI 10.1016/S0191-8869(00)00183-5; von Leupoldt A, 2005, CHEST, V128, P3345, DOI 10.1378/chest.128.5.3345; Von Leupoldt A, 2006, PSYCHOPHYSIOLOGY, V43, P641, DOI 10.1111/j.1469-8986.2006.00453.x; Younger J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013309; Zuckerman M, 2000, J PERS, V68, P999, DOI 10.1111/1467-6494.00124	56	4	4	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e84044	10.1371/journal.pone.0084044	http://dx.doi.org/10.1371/journal.pone.0084044			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	282SX	24386327	Green Published, Green Submitted, gold			2022-12-25	WOS:000329194700086
J	Garcia, M; Charlton, BD; Wyman, MT; Fitch, WT; Reby, D				Garcia, Maxime; Charlton, Benjamin D.; Wyman, Megan T.; Fitch, W. Tecumseh; Reby, David			Do Red Deer Stags (Cervus elaphus) Use Roar Fundamental Frequency (F0) to Assess Rivals?	PLOS ONE			English	Article							SOURCE-FILTER THEORY; BABOON LOUD CALLS; BODY-SIZE; ACOUSTIC FEATURES; MALE QUALITY; VOICE PITCH; VOCAL COMMUNICATION; INDICATE LARGER; MENS VOICES; CUES	It is well established that in humans, male voices are disproportionately lower pitched than female voices, and recent studies suggest that this dimorphism in fundamental frequency (F0) results from both intrasexual (male competition) and intersexual (female mate choice) selection for lower pitched voices in men. However, comparative investigations indicate that sexual dimorphism in F0 is not universal in terrestrial mammals. In the highly polygynous and sexually dimorphic Scottish red deer Cervus elaphus scoticus, more successful males give sexually-selected calls (roars) with higher minimum F0s, suggesting that high, rather than low F0s advertise quality in this subspecies. While playback experiments demonstrated that oestrous females prefer higher pitched roars, the potential role of roar F0 in male competition remains untested. Here we examined the response of rutting red deer stags to playbacks of re-synthesized male roars with different median F0s. Our results show that stags' responses (latencies and durations of attention, vocal and approach responses) were not affected by the F0 of the roar. This suggests that intrasexual selection is unlikely to strongly influence the evolution of roar F0 in Scottish red deer stags, and illustrates how the F0 of terrestrial mammal vocal sexual signals may be subject to different selection pressures across species. Further investigations on species characterized by different F0 profiles are needed to provide a comparative background for evolutionary interpretations of sex differences in mammalian vocalizations.	[Garcia, Maxime; Fitch, W. Tecumseh] Univ Vienna, Dept Cognit Biol, Vienna, Austria; [Charlton, Benjamin D.; Wyman, Megan T.; Reby, David] Univ Sussex, Sch Psychol, Brighton, E Sussex, England	University of Vienna; University of Sussex	Reby, D (corresponding author), Univ Sussex, Sch Psychol, Brighton, E Sussex, England.	reby@sussex.ac.uk		Charlton, Benjamin/0000-0002-0218-7177; Reby, David/0000-0001-9261-1711; Garcia, Maxime/0000-0003-2014-7387	University of Vienna	University of Vienna	Funding organization: University of Vienna. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson BM, 1994, SEXUAL SELECTION; [Anonymous], 1998, PRINCIPLES ANIMAL CO; Apicella CL, 2007, BIOL LETTERS, V3, P682, DOI 10.1098/rsbl.2007.0410; BECKFORD NS, 1985, ANN OTO RHINOL LARYN, V94, P634, DOI 10.1177/000348948509400622; Bee MA, 1999, BEHAV ECOL SOCIOBIOL, V45, P177, DOI 10.1007/s002650050551; Bee MA, 2002, BEHAV ECOL, V13, P109, DOI 10.1093/beheco/13.1.109; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Boersma P., 2013, PRAAT DOING PHONETIC; Burgdorf J, 2008, J COMP PSYCHOL, V122, P357, DOI 10.1037/a0012889; Candolin U, 2003, BIOL REV, V78, P575, DOI 10.1017/S1464793103006158; Charlton BD, 2008, J ACOUST SOC AM, V123, P2936, DOI 10.1121/1.2896758; Charlton BD, 2007, ANIM BEHAV, V74, P707, DOI 10.1016/j.anbehav.2006.09.021; Charlton BD, 2007, BIOL LETTERS, V3, P382, DOI 10.1098/rsbl.2007.0244; Charlton BD, 2012, ANIM BEHAV, V84, P1565, DOI 10.1016/j.anbehav.2012.09.034; Charlton BD, 2012, BEHAV ECOL SOCIOBIOL, V66, P969, DOI 10.1007/s00265-012-1345-0; Charlton BD, 2011, J EXP BIOL, V214, P3414, DOI 10.1242/jeb.061358; Charlton BD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020329; Charlton BD, 2011, BIOL LETTERS, V7, P71, DOI 10.1098/rsbl.2010.0582; Charlton BD, 2009, J ACOUST SOC AM, V126, P2721, DOI 10.1121/1.3224720; Charlton BD, 2009, ANIM BEHAV, V78, P893, DOI 10.1016/j.anbehav.2009.06.029; Clutton-Brock TH., 1982, RED DEER BEHAV ECOLO; CLUTTONBROCK TH, 1979, BEHAVIOUR, V69, P145, DOI 10.1163/156853979X00449; Collins SA, 2000, ANIM BEHAV, V60, P773, DOI 10.1006/anbe.2000.1523; Cynx J, 2005, HORM BEHAV, V47, P446, DOI 10.1016/j.yhbeh.2004.11.018; Dabbs JM, 1999, PERS INDIV DIFFER, V27, P801, DOI 10.1016/S0191-8869(98)00272-4; Evans S, 2006, BIOL PSYCHOL, V72, P160, DOI 10.1016/j.biopsycho.2005.09.003; Evans S, 2008, PHYSIOL BEHAV, V93, P783, DOI 10.1016/j.physbeh.2007.11.033; Fant G, 1971, 2 ACOUSTIC THEORY SP; Feinberg DR, 2005, ANIM BEHAV, V69, P561, DOI 10.1016/j.anbehav.2004.06.012; Fischer J, 2004, BEHAV ECOL SOCIOBIOL, V56, P140, DOI 10.1007/s00265-003-0739-4; Fischer J, 2002, J ACOUST SOC AM, V111, P1465, DOI 10.1121/1.1433807; Fitch W. Tecumseh, 2002, TRANSITION LANGUAGE, P21; Fitch WT, 1997, J ACOUST SOC AM, V102, P1213, DOI 10.1121/1.421048; Fitch WT, 2000, TRENDS COGN SCI, V4, P258, DOI 10.1016/S1364-6613(00)01494-7; Fitch WT, 2001, P ROY SOC B-BIOL SCI, V268, P1669, DOI 10.1098/rspb.2001.1704; Hardouin LA, 2007, AM NAT, V169, P552, DOI 10.1086/512136; Hardouin LA, 2009, ANIM BEHAV, V78, P907, DOI 10.1016/j.anbehav.2009.07.016; Harris TR, 2006, ETHOLOGY, V112, P911, DOI 10.1111/j.1439-0310.2006.01247.x; HAUSER MD, 1993, AM NAT, V142, P528, DOI 10.1086/285553; Herbst CT, 2012, SCIENCE, V337, P595, DOI 10.1126/science.1219712; ISHIZAKA K, 1972, AT&T TECH J, V51, P1233, DOI 10.1002/j.1538-7305.1972.tb02651.x; Kidjo N, 2008, BIOACOUSTICS, V18, P159, DOI 10.1080/09524622.2008.9753598; Koren L, 2009, BEHAV ECOL SOCIOBIOL, V63, P581, DOI 10.1007/s00265-008-0693-2; Kreutzer M, 1999, BEHAVIOUR, V136, P1325, DOI 10.1163/156853999500749; LASS NJ, 1978, J ACOUST SOC AM, V63, P1218, DOI 10.1121/1.381808; Lindenfors Patrik, 2007, P16; Malo AF, 2009, P R SOC B, V276, P971, DOI 10.1098/rspb.2008.1367; Martin-Vivaldi M, 1998, J ORNITHOL, V139, P287, DOI 10.1007/BF01653339; MASATAKA N, 1994, FOLIA PRIMATOL, V63, P115, DOI 10.1159/000156803; McComb K, 2003, ANIM BEHAV, V65, P317, DOI 10.1006/anbe.2003.2047; MCCOMB KE, 1991, ANIM BEHAV, V41, P79, DOI 10.1016/S0003-3472(05)80504-4; Minami Masato, 1992, Journal of the Mammalogical Society of Japan, V17, P71; MITANI JC, 1985, ANIM BEHAV, V33, P272, DOI 10.1016/S0003-3472(85)80141-X; MOULINES E, 1990, SPEECH COMMUN, V9, P453, DOI 10.1016/0167-6393(90)90021-Z; Mundry R, 1998, ANIM BEHAV, V56, P256, DOI 10.1006/anbe.1998.0756; Neumann C, 2010, ANIM BEHAV, V79, P187, DOI 10.1016/j.anbehav.2009.10.026; OWREN MJ, 1990, J COMP PSYCHOL, V104, P20; Pfefferle D, 2007, J ACOUST SOC AM, V121, P3947, DOI 10.1121/1.2722507; Pfefferle D, 2006, ANIM BEHAV, V72, P43, DOI 10.1016/j.anbehav.2005.08.021; Puts DA, 2005, EVOL HUM BEHAV, V26, P388, DOI 10.1016/j.evolhumbehav.2005.03.001; Puts DA, 2007, EVOL HUM BEHAV, V28, P340, DOI 10.1016/j.evolhumbehav.2007.05.002; Puts DA, 2006, EVOL HUM BEHAV, V27, P283, DOI 10.1016/j.evolhumbehav.2005.11.003; Reby D, 1998, J ZOOL, V245, P79, DOI 10.1017/S0952836998005093; Reby D, 2005, P ROY SOC B-BIOL SCI, V272, P941, DOI 10.1098/rspb.2004.2954; Reby D, 2003, ADV STUD BEHAV, V33, P231, DOI 10.1016/S0065-3454(03)33005-0; Reby D, 2003, ANIM BEHAV, V65, P519, DOI 10.1006/anbe.2003.2078; Reby D, 2006, J ACOUST SOC AM, V120, P4080, DOI 10.1121/1.2358006; Reby D, 2010, P ROY SOC B-BIOL SCI, V277, P2747, DOI 10.1098/rspb.2010.0467; Rendall D, 2004, J ACOUST SOC AM, V115, P411, DOI 10.1121/1.1635838; Rendall D, 2005, J ACOUST SOC AM, V117, P944, DOI 10.1121/1.1848011; Richardson C, 2010, P ROY SOC B-BIOL SCI, V277, P1247, DOI 10.1098/rspb.2009.1836; RYALLS JH, 1982, J ACOUST SOC AM, V72, P1631, DOI 10.1121/1.388499; Sanvito S, 2007, ANIM BEHAV, V73, P287, DOI 10.1016/j.anbehav.2006.08.005; Stopher KV, 2011, BEHAV ECOL, V22, P808, DOI 10.1093/beheco/arr052; Taylor AM, 2010, J ZOOL, V280, P221, DOI 10.1111/j.1469-7998.2009.00661.x; ten Cate C, 2002, ADV STUD BEHAV, V31, P31; Tigue CC, 2012, EVOL HUM BEHAV, V33, P210, DOI 10.1016/j.evolhumbehav.2011.09.004; Titze IR, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000897; TITZE IR, 1989, J ACOUST SOC AM, V85, P901, DOI 10.1121/1.397562; TITZE IR, 1988, J ACOUST SOC AM, V83, P1536, DOI 10.1121/1.395910; Titze IR, 1994, PRINCIPLES VOICE PRO; Torriani MVG, 2006, AM NAT, V168, P412, DOI 10.1086/506971; Vannoni E, 2007, ETHOLOGY, V113, P223, DOI 10.1111/j.1439-0310.2006.01323.x; Vannoni E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003113; Vignal C, 2007, P ROY SOC B-BIOL SCI, V274, P479, DOI 10.1098/rspb.2006.3744; WAGNER WE, 1989, BEHAV ECOL SOCIOBIOL, V25, P429, DOI 10.1007/BF00300189; Wolff SE, 2010, BEHAV ECOL SOCIOBIOL, V64, P1673, DOI 10.1007/s00265-010-0981-5; Wyman MT, 2012, ANIM BEHAV, V84, P1381, DOI 10.1016/j.anbehav.2012.08.037; Wyman MT, 2008, ANIM BEHAV, V76, P1625, DOI 10.1016/j.anbehav.2008.05.032	89	10	12	0	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e83946	10.1371/journal.pone.0083946	http://dx.doi.org/10.1371/journal.pone.0083946			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386312	gold, Green Published, Green Submitted			2022-12-25	WOS:000329194700079
J	Ghobakhlou, A; Laberge, S; Antoun, H; Wishart, DS; Xia, JG; Krishnamurthy, R; Mandal, R				Ghobakhlou, Abdollah; Laberge, Serge; Antoun, Hani; Wishart, David S.; Xia, Jianguo; Krishnamurthy, Ramanarayan; Mandal, Rupasri			Metabolomic Analysis of Cold Acclimation of Arctic Mesorhizobium sp Strain N-33	PLOS ONE			English	Article							FATTY-ACID-COMPOSITION; LEGUMINOSARUM BV VICIAE; MUTATIONAL ANALYSIS; LOW-TEMPERATURES; STRESS-RESPONSE; RHIZOBIUM SP.; GENES; SEQUENCE; GENOME; ADAPTATION	Arctic Mesorhizobium sp. N-33 isolated from nodules of Oxytropis arctobia in Canada's eastern Arctic has a growth temperature range from 0 degrees C to 30 degrees C and is a well-known cold-adapted rhizobia. The key molecular mechanisms underlying cold adaptation in Arctic rhizobia remains totally unknown. Since the concentration and contents of metabolites are closely related to stress adaptation, we applied GC-MS and NMR to identify and quantify fatty acids and water soluble compounds possibly related to low temperature acclimation in strain N-33. Bacterial cells were grown at three different growing temperatures (4 degrees C, 10 degrees C and 21 degrees C). Cells from 21 degrees C were also cold-exposed to 4uC for different times (2, 4, 8, 60 and 240 minutes). We identified that poly-unsaturated linoleic acids 18:2 (9, 12) & 18: 2 (6, 9) were more abundant in cells growing at 4 or 10 degrees C, than in cells cultivated at 21 degrees C. The mono-unsaturated phospho/neutral fatty acids myristoleic acid 14:1(11) were the most significantly overexpressed (45-fold) after 1hour of exposure to 4 degrees C. As reported in the literature, these fatty acids play important roles in cold adaptability by supplying cell membrane fluidity, and by providing energy to cells. Analysis of water-soluble compounds revealed that isobutyrate, sarcosine, threonine and valine were more accumulated during exposure to 4 degrees C. These metabolites might play a role in conferring cold acclimation to strain N-33 at 4 degrees C, probably by acting as cryoprotectants. Isobutyrate was highly upregulated (19.4-fold) during growth at 4 degrees C, thus suggesting that this compound is a precursor for the cold-regulated fatty acids modification to low temperature adaptation.	[Ghobakhlou, Abdollah; Laberge, Serge] Agr & Agri Food Canada, Soils & Crops Res & Dev Ctr, Quebec City, PQ, Canada; [Ghobakhlou, Abdollah; Antoun, Hani] Univ Laval, Dept Soils & Agri Food Engn, Quebec City, PQ, Canada; [Wishart, David S.; Xia, Jianguo; Krishnamurthy, Ramanarayan; Mandal, Rupasri] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada; [Wishart, David S.] Univ Alberta, Dept Comp Sci, Edmonton, AB, Canada; [Wishart, David S.] Natl Inst Nanotechnol NINT, Natl Res Council, Edmonton, AB, Canada	Agriculture & Agri Food Canada; Laval University; University of Alberta; University of Alberta; National Research Council Canada	Laberge, S (corresponding author), Agr & Agri Food Canada, Soils & Crops Res & Dev Ctr, Quebec City, PQ, Canada.	serge.laberge@agr.gc.ca; hani.antoun.1@ulaval.ca	Wishart, David Scott/ABI-3181-2020; Xia, Jianguo/Z-1935-2019	Xia, Jianguo/0000-0003-2040-2624; Antoun, Hani/0000-0001-9309-420X; Wishart, David S/0000-0002-3207-2434	National Sciences and Engineering Research Council of Canada	National Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	The work was supported by the following: National Sciences and Engineering Research Council of Canada, http://www.nserc-crsng.gc.ca/index_eng. asp; and The Cellulosic Biofuel Network, http://www.cellulosic-biofuel.ca. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakermans C, 2012, POLAR MICROBIOLOGY L, P126, DOI DOI 10.1128/9781555817183.CH6; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bolten CJ, 2007, ANAL CHEM, V79, P3843, DOI 10.1021/ac0623888; Boumahdi M, 2001, ANTON LEEUW INT J G, V79, P73, DOI 10.1023/A:1010291818304; Buescher JM, 2012, SCIENCE, V335, P1099, DOI 10.1126/science.1206871; Campanaro S, 2011, ENVIRON MICROBIOL, V13, P2018, DOI 10.1111/j.1462-2920.2010.02367.x; Casanueva A, 2010, TRENDS MICROBIOL, V18, P374, DOI 10.1016/j.tim.2010.05.002; Chattopadhyay MK, 2006, J BIOSCIENCES, V31, P157, DOI 10.1007/BF02705244; Chattopadhyay MK, 2002, TRENDS MICROBIOL, V10, P311, DOI 10.1016/S0966-842X(02)02395-8; CHLUMSKY LJ, 1995, J BIOL CHEM, V270, P18252, DOI 10.1074/jbc.270.31.18252; Christie W. W., 2003, LIPID ANAL ISOLATION, V15; Cloutier J, 1996, MOL PLANT MICROBE IN, V9, P720, DOI 10.1094/MPMI-9-0720; Cloutier J, 1997, MOL PLANT MICROBE IN, V10, P401, DOI 10.1094/MPMI.1997.10.3.401; Cloutier J, 1996, MOL PLANT MICROBE IN, V9, P523, DOI 10.1094/MPMI-9-0523; Drouin P, 2000, FEMS MICROBIOL ECOL, V32, P111; Dunn WB, 2005, TRAC-TREND ANAL CHEM, V24, P285, DOI 10.1016/j.trac.2004.11.021; Durfee T, 2008, J BACTERIOL, V190, P1084, DOI 10.1128/JB.01092-07; EDWARDS U, 1989, NUCLEIC ACIDS RES, V17, P7843, DOI 10.1093/nar/17.19.7843; Fiehn O, 2002, PLANT MOL BIOL, V48, P155, DOI 10.1023/A:1013713905833; Galinski E A, 1995, Adv Microb Physiol, V37, P272, DOI 10.1016/S0065-2911(08)60148-4; GRAY JX, 1990, J BACTERIOL, V172, P193, DOI 10.1128/JB.172.1.193-203.1990; Hengge-Aronis R, 2002, J MOL MICROB BIOTECH, V4, P341; Jozefczuk S, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.18; Kaan T, 2002, MICROBIOL-SGM, V148, P3441, DOI 10.1099/00221287-148-11-3441; Kawahara Hidehisa, 2008, P229, DOI 10.1007/978-3-540-74335-4_14; Klinkert B, 2009, CELL MOL LIFE SCI, V66, P2661, DOI 10.1007/s00018-009-0041-3; KNEEN BE, 1983, APPL ENVIRON MICROB, V45, P340, DOI 10.1128/AEM.45.1.340-342.1983; Kultz D, 2005, ANNU REV PHYSIOL, V67, P225, DOI 10.1146/annurev.physiol.67.040403.103635; LYNCH DV, 1987, PLANT PHYSIOL, V83, P761, DOI 10.1104/pp.83.4.761; MANDELSTAM J, 1963, ANN NY ACAD SCI, V102, P621, DOI 10.1111/j.1749-6632.1963.tb13664.x; Medigue C, 2005, GENOME RES, V15, P1325, DOI 10.1101/gr.4126905; Merlo ME, 2011, BIOANALYSIS, V3, P2443, DOI [10.4155/BIO.11.248, 10.4155/bio.11.248]; Methe BA, 2005, P NATL ACAD SCI USA, V102, P10913, DOI 10.1073/pnas.0504766102; Mrozik A, 2004, POL J ENVIRON STUD, V13, P487; Mykytczuk NC, 2013, ISME J; ORGAMBIDE GG, 1993, LIPIDS, V28, P975, DOI 10.1007/BF02537117; Phadtare S, 2004, J BACTERIOL, V186, P7007, DOI 10.1128/JB.186.20.7007-7014.2004; Piette F, 2011, ENVIRON MICROBIOL, V13, P1924, DOI 10.1111/j.1462-2920.2011.02436.x; PREVOST D, 1987, FEMS MICROBIOL ECOL, V45, P205, DOI 10.1016/0378-1097(87)90053-X; PREVOST D, 1987, PLANT SOIL, V98, P313, DOI 10.1007/BF02378352; Price PB, 2012, POLAR MICROBIOLOGY L, P243; Psychogios N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016957; RAY MK, 1994, J BACTERIOL, V176, P4243, DOI 10.1128/jb.176.14.4243-4249.1994; Reaves ML, 2011, CURR OPIN BIOTECH, V22, P17, DOI 10.1016/j.copbio.2010.10.001; Roessner U, 2009, PLANT METABOLIC NETWORKS, P39, DOI 10.1007/978-0-387-78745-9_3; Roessner U, 2009, BIOTECHNIQUES, V46, P363, DOI 10.2144/000113133; Russell Nicholas J., 2008, P177, DOI 10.1007/978-3-540-74335-4_11; Simon C, 2009, APPL ENVIRON MICROB, V75, P7519, DOI 10.1128/AEM.00946-09; Theberge MC, 1996, NEW PHYTOL, V134, P657, DOI 10.1111/j.1469-8137.1996.tb04931.x; Ting L, 2010, ENVIRON MICROBIOL, V12, P2658, DOI 10.1111/j.1462-2920.2010.02235.x; van der Werf MJ, 2007, ANAL BIOCHEM, V370, P17, DOI 10.1016/j.ab.2007.07.022; Vincent JM, 1970, IBP HDB; Weljie AM, 2006, ANAL CHEM, V78, P4430, DOI 10.1021/ac060209g; WILLETTS NS, 1967, BIOCHEM J, V103, P453, DOI 10.1042/bj1030453; Wishart DS, 2008, TRAC-TREND ANAL CHEM, V27, P228, DOI 10.1016/j.trac.2007.12.001; Xia JG, 2012, NUCLEIC ACIDS RES, V40, pW127, DOI 10.1093/nar/gks374; Xia JG, 2011, NAT PROTOC, V6, P743, DOI 10.1038/nprot.2011.319; Zhu K, 2005, MICROBIOL-SGM, V151, P615, DOI 10.1099/mic.0.27634-0	58	11	11	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e84801	10.1371/journal.pone.0084801	http://dx.doi.org/10.1371/journal.pone.0084801			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386418	Green Published, gold			2022-12-25	WOS:000329194700118
J	Goncalves, AI; Rodrigues, MT; Lee, SJ; Atala, A; Yoo, JJ; Reis, RL; Gomes, ME				Goncalves, Ana I.; Rodrigues, Marcia T.; Lee, Sang-Jin; Atala, Anthony; Yoo, James J.; Reis, Rui L.; Gomes, Manuela E.			Understanding the Role of Growth Factors in Modulating Stem Cell Tenogenesis	PLOS ONE			English	Article							ANTERIOR CRUCIATE LIGAMENT; FACTOR-BB; IN-VITRO; TGF-BETA; TENDON; PROLIFERATION; REPAIR; DIFFERENTIATION; BIOMECHANICS	Current treatments for tendon injuries often fail to fully restore joint biomechanics leading to the recurrence of symptoms, and thus resulting in a significant health problem with a relevant social impact worldwide. Cell-based approaches involving the use of stem cells might enable tailoring a successful tendon regeneration outcome. As growth factors (GFs) powerfully regulate the cell biological response, their exogenous addition can further stimulate stem cells into the tenogenic lineage, which might eventually depend on stem cells source. In the present study we investigate the tenogenic differentiation potential of human-amniotic fluid stem cells (hAFSCs) and adipose-derived stem cells (hASCs) with several GFs associated to tendon development and healing; namely, EGF, bFGF, PDGF-BB and TGF-beta 1. Stem cells response to biochemical stimuli was studied by screening of tendon-related genes (collagen type I, III, decorin, tenascin C and scleraxis) and proteins found in tendon extracellular matrix (ECM) (Collagen I, III, and Tenascin C). Despite the fact that GFs did not seem to influence the synthesis of tendon ECM proteins, EGF and bFGF influenced the expression of tendon-related genes in hAFSCs, while EGF and PDGF-BB stimulated the genetic expression in hASCs. Overall results on cellular alignment morphology, immunolocalization and PCR analysis indicated that both stem cell source can be biochemically induced towards tenogenic commitment, validating the potential of hASCs and hAFSCs for tendon regeneration strategies.	[Goncalves, Ana I.; Rodrigues, Marcia T.; Reis, Rui L.; Gomes, Manuela E.] Univ Minho, Dept Polymer Engn, Res Grp 3B, Headquarters European Inst Excellence Tissue Engn, Guimaraes, Portugal; [Goncalves, Ana I.; Rodrigues, Marcia T.; Reis, Rui L.; Gomes, Manuela E.] ICVS 3Bs PT Govt Associate Lab, Braga, Portugal; [Lee, Sang-Jin; Atala, Anthony; Yoo, James J.] Wake Forest Sch Med, Wake Forest Inst Regenerat Med, Winston Salem, NC USA	Universidade do Minho; Wake Forest University	Gomes, ME (corresponding author), Univ Minho, Dept Polymer Engn, Res Grp 3B, Headquarters European Inst Excellence Tissue Engn, Guimaraes, Portugal.	megomes@dep.uminho.pt	Yoo, James J./L-4850-2017; Lee, Sang Jin/S-4056-2019; I., Gonçalves A./P-6809-2017; Rodrigues, Marcia/AAB-5242-2020; Reis, Rui L./A-8938-2008; Rodrigues, Márcia T./O-8152-2015	Lee, Sang Jin/0000-0002-3899-1909; I., Gonçalves A./0000-0002-0466-9292; Rodrigues, Marcia/0000-0002-4483-5689; Reis, Rui L./0000-0002-4295-6129; Rodrigues, Márcia T./0000-0002-4483-5689; UMinho, 3B's Research Group/0000-0002-5195-3456; Atala, Anthony/0000-0001-8186-2160	Portuguese Foundation for Science and Technology (FCT) [PTDC/CVT/102972/2008, SFRH/BPD/86775/2012]	Portuguese Foundation for Science and Technology (FCT)(Portuguese Foundation for Science and Technology)	Authors thank the Portuguese Foundation for Science and Technology (FCT) for the research project BIBS (PTDC/CVT/102972/2008) and for the post-doc fellowship grant: SFRH/BPD/86775/2012. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bosman FT, 2003, J PATHOL, V200, P423, DOI 10.1002/path.1437; Canty EG, 2006, J BIOL CHEM, V281, P38592, DOI 10.1074/jbc.M607581200; Cheng MT, 2010, TISSUE ENG PT A, V16, P2237, DOI 10.1089/ten.TEA.2009.0664; Cheng MT, 2009, TISSUE ENG PT A, V15, P3979, DOI [10.1089/ten.tea.2009.0172, 10.1089/ten.TEA.2009.0172]; De Coppi P, 2007, NAT BIOTECHNOL, V25, P100, DOI 10.1038/nbt1274; Eagan MJ, 2012, J TISSUE ENG REGEN M; Guilak F, 2009, CELL STEM CELL, V5, P17, DOI 10.1016/j.stem.2009.06.016; Hebert TL, 2009, J TISSUE ENG REGEN M, V3, P553, DOI 10.1002/term.198; Hee CK, 2012, TISSUE ENG PART B-RE, V18, P225, DOI [10.1089/ten.teb.2011.0603, 10.1089/ten.TEB.2011.0603]; James R, 2008, J HAND SURG-AM, V33A, P102, DOI 10.1016/j.jhsa.2007.09.007; Kjaer M, 2004, PHYSIOL REV, V84, P649, DOI 10.1152/physrev.00031.2003; Klein MB, 2002, J HAND SURG-AM, V27A, P615, DOI 10.1053/jhsu.2002.34004; Liu GP, 2008, CRYOBIOLOGY, V57, P18, DOI 10.1016/j.cryobiol.2008.04.002; Lorda-Diez CI, 2009, J BIOL CHEM, V284, P29988, DOI 10.1074/jbc.M109.014811; Molloy T, 2003, SPORTS MED, V33, P381, DOI 10.2165/00007256-200333050-00004; Pryce BA, 2009, DEVELOPMENT, V136, P1351, DOI 10.1242/dev.027342; Rada T, 2009, J TISSUE ENG REGEN M, V3, P158, DOI 10.1002/term.141; Rada T, 2011, STEM CELL REV REP, V7, P64, DOI 10.1007/s12015-010-9147-0; Reed SA, 2013, CYTOTECHNOLOGY; Rodrigues MT, 2012, TISSUE ENG PT A, V18, P2518, DOI 10.1089/ten.tea.2011.0672; Rodrigues MT, 2012, ACTA BIOMATER, V8, P2795, DOI 10.1016/j.actbio.2012.04.013; Rodrigues MT, 2011, J TISSUE ENG REGEN M; Sakiyama-Elbert SE, 2008, J HAND SURG-AM, V33A, P1548, DOI 10.1016/j.jhsa.2008.05.030; Thomopoulos S, 2007, J ORTHOP RES, V25, P1358, DOI 10.1002/jor.20444; Thomopoulos S, 2010, ANN BIOMED ENG, V38, P225, DOI 10.1007/s10439-009-9844-5; Tucker RP, 2009, BBA-MOL CELL RES, V1793, P888, DOI 10.1016/j.bbamcr.2008.12.012; Uysal AC, 2010, CURR STEM CELL RES T, V5, P161; Uysal CA, 2012, J PLAST RECONSTR AES, V65, P1712, DOI 10.1016/j.bjps.2012.06.011; Villegas SN, 2010, J CELL BIOCHEM, V110, P10, DOI 10.1002/jcb.22536; Wang JHC, 2012, J HAND THER, V25, P133, DOI 10.1016/j.jht.2011.07.004; Woo YK, 2007, J ORTHOP RES, V25, P73, DOI 10.1002/jor.20266; Yun YR, 2010, J TISSUE ENG, V1, DOI 10.4061/2010/218142; Zhang GY, 2006, J CELL BIOCHEM, V98, P1436, DOI 10.1002/jcb.20776	33	72	73	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e83734	10.1371/journal.pone.0083734	http://dx.doi.org/10.1371/journal.pone.0083734			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386267	Green Published, gold, Green Submitted			2022-12-25	WOS:000329194700061
J	Hara, ES; Ono, M; Eguchi, T; Kubota, S; Pham, HT; Sonoyama, W; Tajima, S; Takigawa, M; Calderwood, SK; Kuboki, T				Hara, Emilio Satoshi; Ono, Mitsuaki; Eguchi, Takanori; Kubota, Satoshi; Hai Thanh Pham; Sonoyama, Wataru; Tajima, Shoji; Takigawa, Masaharu; Calderwood, Stuart K.; Kuboki, Takuo			miRNA-720 Controls Stem Cell Phenotype, Proliferation and Differentiation of Human Dental Pulp Cells	PLOS ONE			English	Article							SIDE POPULATION CELLS; MESENCHYMAL STROMAL CELLS; CANCER-CELLS; IN-VIVO; MICRORNA; EXPRESSION; DNA; MOUSE; PLURIPOTENCY; METHYLATION	Dental pulp cells (DPCs) are known to be enriched in stem/progenitor cells but not well characterized yet. Small non-coding microRNAs (miRNAs) have been identified to control protein translation, mRNA stability and transcription, and have been reported to play important roles in stem cell biology, related to cell reprogramming, maintenance of stemness and regulation of cell differentiation. In order to characterize dental pulp stem/progenitor cells and its mechanism of differentiation, we herein sorted stem-cell-enriched side population (SP) cells from human DPCs and periodontal ligament cells (PDLCs), and performed a locked nucleic acid (LNA)-based miRNA array. As a result, miR-720 was highly expressed in the differentiated main population (MP) cells compared to that in SP cells. In silico analysis and a reporter assay showed that miR-720 targets the stem cell marker NANOG, indicating that miR-720 could promote differentiation of dental pulp stem/progenitor cells by repressing NANOG. Indeed, gain-and loss-of-function analyses showed that miR-720 controls NANOG transcript and protein levels. Moreover, transfection of miR-720 significantly decreased the number of cells positive for the early stem cell marker SSEA-4. Concomitantly, mRNA levels of DNA methyltransferases (DNMTs), which are known to play crucial factors during stem cell differentiation, were also increased by miR-720 through unknown mechanism. Finally, miR-720 decreased DPC proliferation as determined by immunocytochemical analysis against ki-67, and promoted odontogenic differentiation as demonstrated by alizarin red staining, as well as alkaline phosphatase and osteopontin mRNA levels. Our findings identify miR-720 as a novel miRNA regulating the differentiation of DPCs.	[Hara, Emilio Satoshi; Ono, Mitsuaki; Hai Thanh Pham; Sonoyama, Wataru; Kuboki, Takuo] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Oral Rehabil & Regenerat Med, Okayama 7008530, Japan; [Eguchi, Takanori; Calderwood, Stuart K.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Radiat Oncol,Div Mol & Cellular Biol, Boston, MA 02215 USA; [Kubota, Satoshi; Takigawa, Masaharu] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Biochem & Mol Dent, Okayama 7008530, Japan; [Tajima, Shoji] Osaka Univ, Inst Prot Res, Lab Epigenet, Suita, Osaka 565, Japan	Okayama University; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Okayama University; Osaka University	Kuboki, T (corresponding author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Oral Rehabil & Regenerat Med, Okayama 7008530, Japan.	kuboki@md.okayama-u.ac.jp	Hara, Emilio S/B-3922-2017; Hara, Emilio Satoshi/ABA-9954-2021; Sonoyama, Wataru/B-2160-2011	Hara, Emilio S/0000-0001-7374-3487; Hara, Emilio Satoshi/0000-0001-7374-3487; Kuboki, Takuo/0000-0003-3756-2835; Pham, Hai Thanh/0000-0002-7226-9346; Eguchi, Takanori/0000-0002-3297-6126	Japan Society for the Promotion of Science [22249064, 23659899, 25670818]; Grants-in-Aid for Scientific Research [22249064] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by the Grants-in-Aid for Scientific Research from Japan Society for the Promotion of Science (#22249064, #23659899 and #25670818). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anokye-Danso F, 2011, CELL STEM CELL, V8, P376, DOI 10.1016/j.stem.2011.03.001; Chang CJ, 2011, NAT CELL BIOL, V13, P317, DOI 10.1038/ncb2173; Eguchi T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058796; Eskildsen T, 2011, P NATL ACAD SCI USA, V108, P6139, DOI 10.1073/pnas.1016758108; Esteve PO, 2011, NAT STRUCT MOL BIOL, V18, P42, DOI 10.1038/nsmb.1939; Gangaraju VK, 2009, NAT REV MOL CELL BIO, V10, P116, DOI 10.1038/nrm2621; Golebiewska A, 2011, CELL STEM CELL, V8, P136, DOI 10.1016/j.stem.2011.01.007; Goodell MA, 1996, J EXP MED, V183, P1797, DOI 10.1084/jem.183.4.1797; Gronthos S, 2002, J DENT RES, V81, P531, DOI 10.1177/154405910208100806; Gronthos S, 2011, METHODS MOL BIOL, V698, P107, DOI 10.1007/978-1-60761-999-4_9; Guo SQ, 2010, P NATL ACAD SCI USA, V107, P14229, DOI 10.1073/pnas.0913574107; Hara ES, 2013, BIOCHIMIE, V95, P374, DOI 10.1016/j.biochi.2012.10.016; Hatfield SD, 2005, NATURE, V435, P974, DOI 10.1038/nature03816; Hatfield S, 2008, CELL TISSUE RES, V331, P57, DOI 10.1007/s00441-007-0530-3; Iida T, 2002, GENES CELLS, V7, P997, DOI 10.1046/j.1365-2443.2002.00584.x; Iohara K, 2006, STEM CELLS, V24, P2493, DOI 10.1634/stemcells.2006-0161; Kawanabe N, 2012, EXP CELL RES, V318, P453, DOI 10.1016/j.yexcr.2012.01.008; Kubota S, 1999, FEBS LETT, V450, P84, DOI 10.1016/S0014-5793(99)00480-9; Li JY, 2007, MOL CELL BIOL, V27, P8748, DOI 10.1128/MCB.01380-07; Miyoshi N, 2011, CELL STEM CELL, V8, P633, DOI 10.1016/j.stem.2011.05.001; Motohashi N, 2012, STEM CELLS DEV, V21, P3031, DOI 10.1089/scd.2011.0721; Ode A, 2011, EUR CELLS MATER, V22, P26, DOI 10.22203/eCM.v022a03; Oskowitz AZ, 2008, P NATL ACAD SCI USA, V105, P18372, DOI 10.1073/pnas.0809807105; Patrawala L, 2005, CANCER RES, V65, P6207, DOI 10.1158/0008-5472.CAN-05-0592; Place RF, 2008, P NATL ACAD SCI USA, V105, P1608, DOI 10.1073/pnas.0707594105; Robertson KD, 2000, NUCLEIC ACIDS RES, V28, P2108, DOI 10.1093/nar/28.10.2108; Rosa A, 2011, EMBO J, V30, P237, DOI 10.1038/emboj.2010.319; Seo BM, 2004, LANCET, V364, P149, DOI 10.1016/S0140-6736(04)16627-0; Shinozuka E, 2013, BIOCHEM BIOPH RES CO, V430, P101, DOI 10.1016/j.bbrc.2012.11.005; Sonoyama W, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000079; Sorrentino A, 2008, EXP HEMATOL, V36, P1035, DOI 10.1016/j.exphem.2008.03.004; TAKAGI H, 1995, EUR J BIOCHEM, V231, P282, DOI 10.1111/j.1432-1033.1995.tb20698.x; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tay YMS, 2008, STEM CELLS, V26, P17, DOI 10.1634/stemcells.2007-0295; Weksberg DC, 2008, BLOOD, V111, P2444, DOI 10.1182/blood-2007-09-115006; Xu XT, 2012, BRIT J CANCER, V106, P1320, DOI 10.1038/bjc.2012.88; Zhao C, 2010, P NATL ACAD SCI USA, V107, P1876, DOI 10.1073/pnas.0908750107; Zhou S, 2001, NAT MED, V7, P1028, DOI 10.1038/nm0901-1028	38	54	58	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e83545	10.1371/journal.pone.0083545	http://dx.doi.org/10.1371/journal.pone.0083545			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386225	gold, Green Published, Green Submitted			2022-12-25	WOS:000329194700049
J	Mironova, N; Patutina, O; Brenner, E; Kurilshikov, A; Vlassov, V; Zenkova, M				Mironova, Nadezhda; Patutina, Olga; Brenner, Evgenyi; Kurilshikov, Alexander; Vlassov, Valentin; Zenkova, Marina			MicroRNA Drop in the Bloodstream and MicroRNA Boost in the Tumour Caused by Treatment with Ribonuclease A Leads to an Attenuation of Tumour Malignancy	PLOS ONE			English	Article							AMINO-ACID-SEQUENCE; CELL-PROLIFERATION; REDUCED EXPRESSION; HUMAN ANGIOGENIN; TRANSFER-RNA; RT-PCR; ONCONASE; INHIBITION; IDENTIFICATION; CANCER	Novel data showing an important role of microRNAs in mediating tumour progression opened a new field of possible molecular targets for cytotoxic ribonucleases. Recently, antitumour and antimetastatic activities of pancreatic ribonuclease A were demonstrated and here genome-wide profiles of microRNAs in the tumour and blood of mice bearing Lewis lung carcinoma after treatment with RNase A were analysed by high-throughput Sequencing by Oligonucleotide Ligation and Detection (SOLiD (TM)) sequencing technology. Sequencing data showed that RNase A therapy resulted in the boost of 116 microRNAs in tumour tissue and a significant drop of 137 microRNAs in the bloodstream that were confirmed by qPCR. The microRNA boost in the tumour was accompanied by the overexpression of microRNA processing genes: RNASEN (Drosha), xpo5, dicer1, and eif2c2 (Ago2). Ribonuclease activity of RNase A was shown to be crucial for the activation of both microRNA synthesis and expression of the microRNA processing genes. In the tumour tissue, RNase A caused the upregulation of both oncomirs and tumour-suppressor microRNAs, including microRNAs of the let-7 family, known to negatively regulate tumour progression. Our results suggest that the alteration of microRNA signature caused by RNase A treatment leads to the attenuation of tumour malignancy.	[Mironova, Nadezhda; Patutina, Olga; Brenner, Evgenyi; Kurilshikov, Alexander; Vlassov, Valentin; Zenkova, Marina] Russian Acad Sci, Lab Nucle Acids Biochem, Inst Chem Biol & Fundamental Med, Siberian Branch, Novosibirsk, Russia	Institute of Chemical Biology & Fundamental Medicine, Siberian Branch of the RAS; Russian Academy of Sciences	Zenkova, M (corresponding author), Russian Acad Sci, Lab Nucle Acids Biochem, Inst Chem Biol & Fundamental Med, Siberian Branch, Novosibirsk, Russia.	marzen@niboch.nsc.ru	Patutina, Olga/F-9159-2013; Zenkova, Marina A./H-4666-2014; Kurilshikov, Alexander/GWC-1519-2022; Zenkova, Marina A/G-5088-2013; Vlassov, Valentin/F-4720-2013	Kurilshikov, Alexander/0000-0003-2541-5627; Zenkova, Marina/0000-0003-4044-1049; Vlassov, Valentin/0000-0003-2845-2992; Mironova, Nadezhda/0000-0003-4375-0269	RAS; Russian Foundation for Basic Research [11-04-01012, 11-04-01429]; Russian Federation [2307.2012.4];  [2972.2012.4]	RAS(Russian Academy of SciencesRegione Sardegna); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Russian Federation(Russian Federation); 	This work was supported by RAS Programs "Molecular and Cellular Biology" and "Fundamental sciences to medicine 2012-24", by grant "Scientific Schools" #2972.2012.4, by Russian Foundation for Basic Research grants 11-04-01012 and 11-04-01429, and by Fellowship of the President of Russian Federation 2307.2012.4. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arroyo JD, 2011, P NATL ACAD SCI USA, V108, P5003, DOI 10.1073/pnas.1019055108; Barbarotto E, 2008, INT J CANCER, V122, P969, DOI 10.1002/ijc.23343; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; BEINTEMA JJ, 1988, BIOCHEMISTRY-US, V27, P4530, DOI 10.1021/bi00412a046; BOND MD, 1990, BIOCHEM BIOPH RES CO, V171, P988, DOI 10.1016/0006-291X(90)90781-H; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen X, 2012, PROTEIN CELL, V3, P28, DOI 10.1007/s13238-012-2003-z; Choi SE, 2013, AGING CELL, V12, P1062, DOI 10.1111/acel.12135; Costanzi J, 2005, CANCER INVEST, V23, P643, DOI 10.1080/07357900500283143; CURRAN TP, 1993, BIOCHEMISTRY-US, V32, P2307, DOI 10.1021/bi00060a023; Dalmay T, 2006, ONCOGENE, V25, P6170, DOI 10.1038/sj.onc.1209911; Davis S, 2009, NUCLEIC ACIDS RES, V37, P70, DOI 10.1093/nar/gkn904; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Goparaju CM, 2011, ONCOGENE, V30, P2767, DOI 10.1038/onc.2010.643; Haigis MC, 2003, NUCLEIC ACIDS RES, V31, P1024, DOI 10.1093/nar/gkg163; Harfe BD, 2005, CURR OPIN GENET DEV, V15, P410, DOI 10.1016/j.gde.2005.06.012; Hwang HW, 2006, BRIT J CANCER, V94, P776, DOI 10.1038/sj.bjc.6603023; Ilinskaya O, 2001, TOXICOLOGY, V156, P101, DOI 10.1016/S0300-483X(00)00335-8; Iordanov MS, 2000, CANCER RES, V60, P1983; Johnson RJ, 2007, J MOL BIOL, V368, P434, DOI 10.1016/j.jmb.2007.02.005; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Karube Y, 2005, CANCER SCI, V96, P111, DOI 10.1111/j.1349-7006.2005.00015.x; Kumar MS, 2007, NAT GENET, V39, P673, DOI 10.1038/ng2003; KURACHI K, 1985, BIOCHEMISTRY-US, V24, P5494, DOI 10.1021/bi00341a032; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lee I, 2000, J SURG ONCOL, V73, P164, DOI 10.1002/(SICI)1096-9098(200003)73:3<164::AID-JSO10>3.3.CO;2-U; Lee JE, 2008, BIODRUGS, V22, P53, DOI 10.2165/00063030-200822010-00006; Lee JE, 2005, BIOCHEMISTRY-US, V44, P15760, DOI 10.1021/bi051668z; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Li ZH, 2012, NUCLEIC ACIDS RES, V40, P6787, DOI 10.1093/nar/gks307; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Lu JI, 2005, BIOCHEM BIOPH RES CO, V334, P319, DOI 10.1016/j.bbrc.2005.05.206; MASTRONICOLA MR, 1995, EUR J BIOCHEM, V230, P242, DOI 10.1111/j.1432-1033.1995.tb20557.x; Mironova NL, 2013, CELL CYCLE, V12, P2120, DOI 10.4161/cc.25164; Mitkevich VA, 2011, CELL CYCLE, V10, P4090, DOI 10.4161/cc.10.23.18210; Mitkevich VA, 2010, FEBS J, V277, P186, DOI 10.1111/j.1742-4658.2009.07471.x; NITTA K, 1994, CANCER RES, V54, P920; OLSON KA, 1995, P NATL ACAD SCI USA, V92, P442, DOI 10.1073/pnas.92.2.442; Patutina OA, 2010, ACTA NATURAE, V2, P88, DOI 10.32607/20758251-2010-2-1-88-93; Patutina O, 2011, BIOCHIMIE, V93, P689, DOI 10.1016/j.biochi.2010.12.011; Qiao M, 2012, CELL RES, V22, P1199, DOI 10.1038/cr.2012.67; Raines RT, 1998, CHEM REV, V98, P1045, DOI 10.1021/cr960427h; Ran S, 2002, CANCER RES, V62, P6132; Saikia M, 2012, J BIOL CHEM, V287, P42708, DOI 10.1074/jbc.M112.371799; Schmittgen TD, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh040; Sevcik J, 2002, J BIOL CHEM, V277, P47325, DOI 10.1074/jbc.M208425200; SHAPIRO R, 1989, BIOCHEMISTRY-US, V28, P7401, DOI 10.1021/bi00444a038; Shklyaeva OA, 2008, DOKL BIOCHEM BIOPHYS, V420, P108, DOI 10.1134/S1607672908030034; STRYDOM DJ, 1985, BIOCHEMISTRY-US, V24, P5486, DOI 10.1021/bi00341a031; Takamizawa J, 2004, CANCER RES, V64, P3753, DOI 10.1158/0008-5472.CAN-04-0637; Tello-Montoliu A, 2006, J THROMB HAEMOST, V4, P1864, DOI 10.1111/j.1538-7836.2006.01995.x; Torres AG, 2012, NUCLEIC ACIDS RES, V40, P2152, DOI 10.1093/nar/gkr885; Trang P, 2010, ONCOGENE, V29, P1580, DOI 10.1038/onc.2009.445; Tsuji T, 2005, CANCER RES, V65, P1352, DOI 10.1158/0008-5472.CAN-04-2058; Turchinovich A, 2011, NUCLEIC ACIDS RES, V39, P7223, DOI 10.1093/nar/gkr254; Vallee BL, 1997, CELL MOL LIFE SCI, V53, P803, DOI 10.1007/s000180050101; Varkonyi-Gasic E, 2007, PLANT METHODS, V3, DOI 10.1186/1746-4811-3-12; Vickers KC, 2011, NAT CELL BIOL, V13, P423, DOI 10.1038/ncb2210; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wei SS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028797; Xu ZP, 2002, BIOCHEM BIOPH RES CO, V294, P287, DOI 10.1016/S0006-291X(02)00479-5; Yamasaki S, 2009, J CELL BIOL, V185, P35, DOI 10.1083/jcb.200811106; Zhao H, 2008, CELL CYCLE, V7, P3258, DOI 10.4161/cc.7.20.6855	64	15	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e83482	10.1371/journal.pone.0083482	http://dx.doi.org/10.1371/journal.pone.0083482			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386211	Green Published, gold, Green Submitted			2022-12-25	WOS:000329194700044
J	Ramkissoon, KR; Miller, JK; Ojha, S; Watson, DS; Bomar, MG; Galande, AK; Shearer, AG				Ramkissoon, Kevin R.; Miller, Jennifer K.; Ojha, Sunil; Watson, Douglas S.; Bomar, Martha G.; Galande, Amit K.; Shearer, Alexander G.			Rapid Identification of Sequences for Orphan Enzymes to Power Accurate Protein Annotation	PLOS ONE			English	Article							DOLICHOL-PHOSPHATE-MANNOSE; GLUCOSE-DEHYDROGENASE; LINKED OLIGOSACCHARIDE; SYNTHASE; PURIFICATION; CELLS	The power of genome sequencing depends on the ability to understand what those genes and their proteins products actually do. The automated methods used to assign functions to putative proteins in newly sequenced organisms are limited by the size of our library of proteins with both known function and sequence. Unfortunately this library grows slowly, lagging well behind the rapid increase in novel protein sequences produced by modern genome sequencing methods. One potential source for rapidly expanding this functional library is the "back catalog" of enzymology-"orphan enzymes," those enzymes that have been characterized and yet lack any associated sequence. There are hundreds of orphan enzymes in the Enzyme Commission (EC) database alone. In this study, we demonstrate how this orphan enzyme "back catalog" is a fertile source for rapidly advancing the state of protein annotation. Starting from three orphan enzyme samples, we applied mass-spectrometry based analysis and computational methods (including sequence similarity networks, sequence and structural alignments, and operon context analysis) to rapidly identify the specific sequence for each orphan while avoiding the most time-and labor-intensive aspects of typical sequence identifications. We then used these three new sequences to more accurately predict the catalytic function of 385 previously uncharacterized or misannotated proteins. We expect that this kind of rapid sequence identification could be efficiently applied on a larger scale to make enzymology's "back catalog" another powerful tool to drive accurate genome annotation.	[Ramkissoon, Kevin R.; Miller, Jennifer K.; Ojha, Sunil; Watson, Douglas S.; Bomar, Martha G.; Galande, Amit K.] SRI Int, Biosci Div, Harrisonburg, VA USA; [Shearer, Alexander G.] Clover Collect, Mountain View, CA USA	SRI International	Shearer, AG (corresponding author), Clover Collect, Mountain View, CA USA.	agshearer@clovercollective.com			National Institute of General Medical Sciences [GM086755]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086755] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by grant GM086755 from the National Institute of General Medical Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMEYAMA M, 1981, J BACTERIOL, V145, P814, DOI 10.1128/JB.145.2.814-823.1981; Atkinson HJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004345; Banerjee DK, 2004, GLYCOCONJUGATE J, V21, P479, DOI 10.1007/s10719-004-5538-2; Banerjee DK, 2005, J BIOL CHEM, V280, P4174, DOI 10.1074/jbc.M406962200; Barrett Alan J., 1997, European Journal of Biochemistry, V250, P1; Bork P, 1996, TRENDS GENET, V12, P425, DOI 10.1016/0168-9525(96)60040-7; Colussi PA, 1997, P NATL ACAD SCI USA, V94, P7873, DOI 10.1073/pnas.94.15.7873; Cozier GE, 1999, BIOCHEM J, V340, P639, DOI 10.1042/0264-6021:3400639; Forsee WT, 1997, EUR J BIOCHEM, V244, P953, DOI 10.1111/j.1432-1033.1997.00953.x; Frishman D, 2007, CHEM REV, V107, P3448, DOI 10.1021/cr068303k; Gerlt JA, 2011, BIOCHEMISTRY-US, V50, P9950, DOI 10.1021/bi201312u; Gurcha SS, 2002, BIOCHEM J, V365, P441, DOI 10.1042/BJ20020107; Hamamatsu N, 2006, APPL MICROBIOL BIOT, V73, P607, DOI 10.1007/s00253-006-0521-4; Lamani E, 2006, GLYCOBIOLOGY, V16, P666, DOI 10.1093/glycob/cwj104; Lespinet O, 2005, SCIENCE, V307, P42; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; MATSUSHITA K, 1989, J BIOCHEM, V105, P633, DOI 10.1093/oxfordjournals.jbchem.a122716; MIDGLEY M, 1973, BIOCHEM J, V132, P141, DOI 10.1042/bj1320141; Pouliot Y, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-244; Rush Jeffrey S., 2006, V347, P13; Schnoes AM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000605; SHIROKANE Y, 1995, FEBS LETT, V367, P177, DOI 10.1016/0014-5793(95)00524-D; Tomita S, 1998, J BIOL CHEM, V273, P9249, DOI 10.1074/jbc.273.15.9249; Urushibata Y, 2008, EXTREMOPHILES, V12, P665, DOI 10.1007/s00792-008-0173-7	24	7	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e84508	10.1371/journal.pone.0084508	http://dx.doi.org/10.1371/journal.pone.0084508			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386392	gold, Green Published, Green Submitted			2022-12-25	WOS:000329194700109
J	Son, M; Baek, A; Sakkiah, S; Park, C; John, S; Lee, KW				Son, Minky; Baek, Ayoung; Sakkiah, Sugunadevi; Park, Chanin; John, Shalini; Lee, Keun Woo			Exploration of Virtual Candidates for Human HMG-CoA Reductase Inhibitors Using Pharmacophore Modeling and Molecular Dynamics Simulations	PLOS ONE			English	Article							PARTICLE MESH EWALD; BIOLOGICAL-ACTIVITY; CATALYTIC PORTION; STRUCTURAL MECHANISM; CRYSTAL-STRUCTURE; DRUG DISCOVERY; DESIGN; LIGAND; LACTONES; INSIGHTS	3-hydroxy-3-methylglutaryl coenzyme A reductase (HMGR) is a rate-controlling enzyme in the mevalonate pathway which involved in biosynthesis of cholesterol and other isoprenoids. This enzyme catalyzes the conversion of HMG-CoA to mevalonate and is regarded as a drug target to treat hypercholesterolemia. In this study, ten qualitative pharmacophore models were generated based on chemical features in active inhibitors of HMGR. The generated models were validated using a test set. In a validation process, the best hypothesis was selected based on the statistical parameters and used for virtual screening of chemical databases to find novel lead candidates. The screened compounds were sorted by applying drug-like properties. The compounds that satisfied all drug-like properties were used for molecular docking study to identify their binding conformations at active site of HMGR. The final hit compounds were selected based on docking score and binding orientation. The HMGR structures in complex with the hit compounds were subjected to 10 ns molecular dynamics simulations to refine the binding orientation as well as to check the stability of the hits. After simulation, binding modes including hydrogen bonding patterns and molecular interactions with the active site residues were analyzed. In conclusion, four hit compounds with new structural scaffold were suggested as novel and potent HMGR inhibitors.	[Son, Minky; Baek, Ayoung; Park, Chanin; John, Shalini; Lee, Keun Woo] GNU, Div Appl Life Sci, Plus Program BK21, SSAC,PMBBRC,RINS, Gazwa Dong, Jinju, South Korea; [Sakkiah, Sugunadevi] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles	Lee, KW (corresponding author), GNU, Div Appl Life Sci, Plus Program BK21, SSAC,PMBBRC,RINS, Gazwa Dong, Jinju, South Korea.	kwlee@gnu.ac.kr		Sakkiah, Suguna Devi/0000-0002-8337-9348	Basic Science Research Program through the National Research Foundation of Korea (NRF) [2012R1A1A4A01013657]; Pioneer Research Center Program through the National Research Foundation of Korea (NRF) [2009-0081539]; Management of Climate Change Program through the National Research Foundation of Korea (NRF) [2010-0029084]; Ministry of Education of Republic of Korea; Next-Generation BioGreen 21 Program from Rural Development Administration (RDA) of Republic of Korea [PJ009486]	Basic Science Research Program through the National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Pioneer Research Center Program through the National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Management of Climate Change Program through the National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education of Republic of Korea(Ministry of Education (MOE), Republic of Korea); Next-Generation BioGreen 21 Program from Rural Development Administration (RDA) of Republic of Korea	This research was supported by Basic Science Research Program (2012R1A1A4A01013657), Pioneer Research Center Program (2009-0081539), and Management of Climate Change Program (2010-0029084) through the National Research Foundation of Korea (NRF) funded by the Ministry of Education of Republic of Korea. And this work was also supported by the Next-Generation BioGreen 21 Program (PJ009486) from Rural Development Administration (RDA) of Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BECK G, 1990, J MED CHEM, V33, P52, DOI 10.1021/jm00163a010; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; Berendsen HJC, 1981, INTERMOLECULAR FORCE, P331, DOI [DOI 10.1007/978-94-015-7658-1_21, 10.1007/978-94-015-7658-1_21]; BONE EA, 1992, J MED CHEM, V35, P3388, DOI 10.1021/jm00096a015; BOUMENDIL E, 1995, EPIDEMIOLOGY, V6, P322, DOI 10.1097/00001648-199505000-00023; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Cai ZY, 2007, BIOORGAN MED CHEM, V15, P7809, DOI 10.1016/j.bmc.2007.08.044; Chen X, 2002, BIOINFORMATICS, V18, P130, DOI 10.1093/bioinformatics/18.1.130; Cosconati S, 2010, EXPERT OPIN DRUG DIS, V5, P597, DOI 10.1517/17460441.2010.484460; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; ENDO A, 1992, J LIPID RES, V33, P1569; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Forli S, 2012, J MED CHEM, V55, P623, DOI 10.1021/jm2005145; FRYE LL, 1993, J MED CHEM, V36, P410, DOI 10.1021/jm00055a012; HARTMAN GD, 1992, J MED CHEM, V35, P3813, DOI 10.1021/jm00099a009; Hebert PR, 1997, JAMA-J AM MED ASSOC, V278, P313, DOI 10.1001/jama.278.4.313; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Istvan ES, 2000, EMBO J, V19, P819, DOI 10.1093/emboj/19.5.819; Istvan ES, 2002, AM HEART J, V144, pS27, DOI 10.1067/mhj.2002.130300; Istvan ES, 2001, CURR OPIN STRUC BIOL, V11, P746, DOI 10.1016/S0959-440X(01)00276-7; Istvan ES, 2000, BBA-MOL CELL BIOL L, V1529, P9, DOI 10.1016/S1388-1981(00)00134-7; Istvan ES, 2001, SCIENCE, V292, P1160, DOI 10.1126/science.1059344; J Alvarez, 2005, VIRTUAL SCREENING DR; JENDRALLA H, 1990, J MED CHEM, V33, P61, DOI 10.1021/jm00163a011; JENDRALLA H, 1991, J MED CHEM, V34, P2962, DOI 10.1021/jm00114a004; John S, 2012, J BIOMOL STRUCT DYN, V29, P921, DOI 10.1080/07391102.2012.10507419; Jones G, 1997, J MOL BIOL, V267, P727, DOI 10.1006/jmbi.1996.0897; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kim HJ, 2008, J CHEM INF MODEL, V48, P197, DOI 10.1021/ci700160t; LARSEN SD, 1994, J MED CHEM, V37, P2343, DOI 10.1021/jm00041a013; Lipinski CA, 1997, ADV DRUG DELIVER REV, V23, P3, DOI 10.1016/S0169-409X(96)00423-1; Liu TQ, 2007, NUCLEIC ACIDS RES, V35, pD198, DOI 10.1093/nar/gkl999; Lyne PD, 2002, DRUG DISCOV TODAY, V7, P1047, DOI 10.1016/S1359-6446(02)02483-2; Medina-Franco JL, 2005, BIOORG MED CHEM LETT, V15, P989, DOI 10.1016/j.bmcl.2004.12.046; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Pak VV, 2010, BIOORGAN MED CHEM, V18, P4300, DOI 10.1016/j.bmc.2010.04.090; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Pfefferkorn JA, 2007, BIOORG MED CHEM LETT, V17, P4538, DOI 10.1016/j.bmcl.2007.05.096; Pfefferkorn JA, 2007, BIOORG MED CHEM LETT, V17, P4531, DOI 10.1016/j.bmcl.2007.05.097; PHAN T, 1995, J NEUROL NEUROSUR PS, V58, P625, DOI 10.1136/jnnp.58.5.625; PROKSCH E, 1995, HAUTARZT, V46, P76, DOI 10.1007/s001050050213; Reddy AS, 2007, CURR PROTEIN PEPT SC, V8, P329; Rosamond W, 2008, CIRCULATION, V117, pE25, DOI 10.1161/CIRCULATIONAHA.107.187998; Sarver RW, 2008, J MED CHEM, V51, P3804, DOI 10.1021/jm7015057; SIT SY, 1992, BIOORG MED CHEM LETT, V2, P1085, DOI 10.1016/S0960-894X(00)80623-X; SLISKOVIC DR, 1992, J MED CHEM, V35, P2095, DOI 10.1021/jm00089a022; Sousa da Silva Alan W, 2012, BMC Res Notes, V5, P367, DOI 10.1186/1756-0500-5-367; Suzuki M, 2001, BIOORG MED CHEM LETT, V11, P1285, DOI 10.1016/S0960-894X(01)00203-7; Tabernero L, 1999, P NATL ACAD SCI USA, V96, P7167, DOI 10.1073/pnas.96.13.7167; Tabernero L, 2003, J BIOL CHEM, V278, P19933, DOI 10.1074/jbc.M213006200; Thangapandian S, 2011, EUR J MED CHEM, V46, P2469, DOI 10.1016/j.ejmech.2011.03.035; Thilagavathi R, 2005, BIOORG MED CHEM LETT, V15, P1027, DOI 10.1016/j.bmcl.2004.12.042; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Verdonk ML, 2003, PROTEINS, V52, P609, DOI 10.1002/prot.10465; Walters WP, 1998, DRUG DISCOV TODAY, V3, P160, DOI 10.1016/S1359-6446(97)01163-X; Wang YL, 2010, NUCLEIC ACIDS RES, V38, pD255, DOI 10.1093/nar/gkp965; Zhao SK, 2009, BIOORGAN MED CHEM, V17, P7915, DOI 10.1016/j.bmc.2009.10.021	57	11	12	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e83496	10.1371/journal.pone.0083496	http://dx.doi.org/10.1371/journal.pone.0083496			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386216	Green Published, Green Submitted, gold			2022-12-25	WOS:000329194700046
J	Aston, E; Channon, A; Day, C; Knight, CG				Aston, Elizabeth; Channon, Alastair; Day, Charles; Knight, Christopher G.			Critical Mutation Rate Has an Exponential Dependence on Population Size in Haploid and Diploid Populations	PLOS ONE			English	Article							ERROR THRESHOLDS; FINITE POPULATIONS; DIGITAL ORGANISMS; ROBUSTNESS; EVOLUTION; EVOLVABILITY; SELECTION; SURVIVAL; FLATTEST; FITNESS	Understanding the effect of population size on the key parameters of evolution is particularly important for populations nearing extinction. There are evolutionary pressures to evolve sequences that are both fit and robust. At high mutation rates, individuals with greater mutational robustness can outcompete those with higher fitness. This is survival-of-the-flattest, and has been observed in digital organisms, theoretically, in simulated RNA evolution, and in RNA viruses. We introduce an algorithmic method capable of determining the relationship between population size, the critical mutation rate at which individuals with greater robustness to mutation are favoured over individuals with greater fitness, and the error threshold. Verification for this method is provided against analytical models for the error threshold. We show that the critical mutation rate for increasing haploid population sizes can be approximated by an exponential function, with much lower mutation rates tolerated by small populations. This is in contrast to previous studies which identified that critical mutation rate was independent of population size. The algorithm is extended to diploid populations in a system modelled on the biological process of meiosis. The results confirm that the relationship remains exponential, but show that both the critical mutation rate and error threshold are lower for diploids, rather than higher as might have been expected. Analyzing the transition from critical mutation rate to error threshold provides an improved definition of critical mutation rate. Natural populations with their numbers in decline can be expected to lose genetic material in line with the exponential model, accelerating and potentially irreversibly advancing their decline, and this could potentially affect extinction, recovery and population management strategy. The effect of population size is particularly strong in small populations with 100 individuals or less; the exponential model has significant potential in aiding population management to prevent local ( and global) extinction events.	[Aston, Elizabeth; Channon, Alastair; Day, Charles] Keele Univ, Res Inst Environm Phys Sci & Appl Math, Keele ST5 5BG, Staffs, England; [Knight, Christopher G.] Univ Manchester, Manchester, Greater Manches, England	Keele University; University of Manchester	Aston, E (corresponding author), Keele Univ, Res Inst Environm Phys Sci & Appl Math, Keele ST5 5BG, Staffs, England.	e.j.aston@keele.ac.uk	Knight, Chris/AAM-3228-2020	Knight, Chris/0000-0001-9815-4267	EPSRC [EP/H031936/1]; Wellcome Trust [082453/Z/07/Z]; Engineering and Physical Sciences Research Council [EP/H031936/1] Funding Source: researchfish	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by EPSRC grant EP/H031936/1; CGK was supported by a fellowship from the Wellcome Trust (082453/Z/07/Z). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves D, 1997, J PHYS A-MATH GEN, V30, P2601, DOI 10.1088/0305-4470/30/8/009; Beslon G, 2010, BIOSYSTEMS, V102, P32, DOI 10.1016/j.biosystems.2010.07.009; Bloom JD, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-29; Boerlijst MC, 1996, P ROY SOC B-BIOL SCI, V263, P1577, DOI 10.1098/rspb.1996.0231; Bornberg-Bauer E, 2010, HFSP J, V4, P105, DOI 10.2976/1.3404403; Bull JJ, 2007, J VIROL, V81, P2930, DOI 10.1128/JVI.01624-06; Bull JJ, 2005, PLOS COMPUT BIOL, V1, P450, DOI 10.1371/journal.pcbi.0010061; Campbell NA, 2005, FDN GENETIC ALGORITH; Campos PRA, 1999, J PHYS A-MATH GEN, V32, pL1, DOI 10.1088/0305-4470/32/1/001; Channon A, 2011, ADV ARTIFICIAL LIFE, P117; Comas I, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-5; Domingo E, 2009, EMBO REP, V10, P444, DOI 10.1038/embor.2009.61; EIGEN M, 1988, J PHYS CHEM-US, V92, P6881, DOI 10.1021/j100335a010; Eigen M, 1979, HYPERCYCLE; Fisher R.A., 1930, GENETICAL THEORY NAT; Forst CV, 1995, LECT NOTES ARTIF INT, V929, P128; Gonzalez A, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0404; Hartl D., 2007, PRINCIPLES POPULATIO; Hutter B, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-116; Huynen MA, 1996, P NATL ACAD SCI USA, V93, P397, DOI 10.1073/pnas.93.1.397; Jones J, 2006, GECCO 2006: GENETIC AND EVOLUTIONARY COMPUTATION CONFERENCE, VOL 1 AND 2, P143; KIMURA M, 1966, GENETICS, V54, P1337; Kimura MA, 1985, NEUTRAL THEORY MOL E; Krakauer DC, 2002, P NATL ACAD SCI USA, V99, P1405, DOI 10.1073/pnas.032668599; Lenski RE, 2006, PLOS BIOL, V4, P2190, DOI 10.1371/journal.pbio.0040428; Lorenz DM, 2013, PHYS REV E, V87, DOI 10.1103/PhysRevE.87.022704; LYNCH M, 1995, AM NAT, V146, P489, DOI 10.1086/285812; Masel J, 2010, TRENDS GENET, V26, P406, DOI 10.1016/j.tig.2010.06.002; Moran P., 1962, STAT PROCESSES EVOLU; NOWAK M, 1989, J THEOR BIOL, V137, P375, DOI 10.1016/S0022-5193(89)80036-0; NOWAK MA, 1992, TRENDS ECOL EVOL, V7, P118, DOI 10.1016/0169-5347(92)90145-2; Nowak MA, 2006, EVOLUTIONARY DYNAMIC; Ochoa G, 1999, LECT NOTES ARTIF INT, V1674, P54; Ochoa G, 2006, LECT NOTES COMPUT SC, V4193, P890; Ochoa G, 2006, EVOL COMPUT, V14, P157, DOI 10.1162/evco.2006.14.2.157; Orr HA, 2010, PHILOS T R SOC B, V365, P1195, DOI 10.1098/rstb.2009.0282; Park JM, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.011902; Sanjuan R, 2007, PLOS GENET, V3, P939, DOI 10.1371/journal.pgen.0030093; Sardanyes J, 2008, J THEOR BIOL, V250, P560, DOI 10.1016/j.jtbi.2007.10.027; Schuster P, 2009, EUR REV, V17, P281, DOI 10.1017/S1062798709000787; Strelioff CC, 2010, J THEOR BIOL, V266, P584, DOI 10.1016/j.jtbi.2010.07.025; Takeuchi N, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-15; Tallmon DA, 2004, TRENDS ECOL EVOL, V19, P489, DOI 10.1016/j.tree.2004.07.003; Tannenbaum E, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.021903; Tejero H, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-2; van Nimwegen E, 1999, P NATL ACAD SCI USA, V96, P9716, DOI 10.1073/pnas.96.17.9716; WIEHE T, 1995, J THEOR BIOL, V177, P1, DOI 10.1006/jtbi.1995.0220; Wilke CO, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-44; Wilke CO, 2001, EVOLUTION, V55, P2412; Wilke CO, 2001, B MATH BIOL, V63, P715, DOI 10.1006/bulm.2001.0244; Wilke CO, 2001, NATURE, V412, P331, DOI 10.1038/35085569; Wright S, 1932, P 6 INT C GEN, P355	52	5	5	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e83438	10.1371/journal.pone.0083438	http://dx.doi.org/10.1371/journal.pone.0083438			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281RE	24386200	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000329117900035
J	Lazic, MM; Kaliontzopoulou, A; Carretero, MA; Crnobrnja-Isailovic, J				Lazic, Marko M.; Kaliontzopoulou, Antigoni; Carretero, Miguel A.; Crnobrnja-Isailovic, Jelka			Lizards from Urban Areas Are More Asymmetric: Using Fluctuating Asymmetry to Evaluate Environmental Disturbance	PLOS ONE			English	Article							DEVELOPMENTAL STABILITY; INCUBATION-TEMPERATURE; INBREEDING DEPRESSION; GENETIC-VARIATION; PODARCIS-MURALIS; LACERTID LIZARD; STRESS; FITNESS; PERFORMANCE; INDICATOR	The increase in human activities that leads to wildlife decline and species extinction poses an urgent need for simple indicators of environmental stress in animal populations. Several studies have suggested that fluctuating asymmetry (FA) can be an easy, direct measure of developmental instability because it is associated to environmental stress and, as such, it can be a useful indicator of population disturbance. We examined three different morphological traits in urban and rural populations of the common wall lizard (Podarcis muralis) to test whether anthropogenic disturbance causes an increase in FA. Compared to rural populations, urban ones showed higher levels of FA in all analyzed traits, thus providing evidence that FA can respond to anthropogenic disturbance. However, we also found significant differences in FA among traits, where femoral pores and subdigital lamellae, traits with a functional relevance, were more stable developmentally compared to supracilliar granules which have no evident function. Unsigned FA [abs(right-left)] exhibited significant, but weak, positive correlations among traits, indicating that developmental noise does not have a uniform effect across characters and thus questioning the view of developmental stability as an organism-wide property. The degree of signed FA (right-left) was more similar between structurally associated traits, possibly as an outcome of morphological integration. In conclusion, our results demonstrate that FA can be a reliable indicator of disturbance provided that it is analyzed on multiple traits simultaneously and examined at the population level.	[Lazic, Marko M.; Crnobrnja-Isailovic, Jelka] Univ Nis, Fac Sci & Math, Dept Biol & Ecol, Nish, Serbia; [Kaliontzopoulou, Antigoni; Carretero, Miguel A.] Univ Porto, Ctr Invest Biodiversidade & Recursos Genet, CIBIO, Vairao, Portugal; [Kaliontzopoulou, Antigoni] Iowa State Univ, Dept Ecol Evolut & Organismal Biol, Ames, IA USA	University of Nis; Universidade do Porto; Iowa State University	Lazic, MM (corresponding author), Univ Nis, Fac Sci & Math, Dept Biol & Ecol, Nish, Serbia.	markol@pmf.ni.ac.rs	Kaliontzopoulou, Antigoni/AAF-6921-2022; Kaliontzopoulou, Antigoni/L-8345-2013; Carretero, Miguel A/A-1472-2013; Kaliontzopoulou, Antigoni/AFJ-9860-2022	Kaliontzopoulou, Antigoni/0000-0002-7897-7204; Kaliontzopoulou, Antigoni/0000-0002-7897-7204; Carretero, Miguel A/0000-0002-2335-7198; Kaliontzopoulou, Antigoni/0000-0002-7897-7204; Crnobrnja-Isailovic, Jelka/0000-0003-4292-5995	Ministry of Education, Science and Technological Development of Republic of Serbia [173025]; MESTD (Serbia); FCT (Portugal);  [PTDC/BIA-BEC/101256/2008];  [SFRH/BPD/68493/2010)]	Ministry of Education, Science and Technological Development of Republic of Serbia; MESTD (Serbia); FCT (Portugal)(Portuguese Foundation for Science and Technology); ; 	The work of MML and JCI was supported by the Grant no. 173025 funded by Ministry of Education, Science and Technological Development of Republic of Serbia (http://www.mpn.gov.rs/). MAC and AK were supported by project PTDC/BIA-BEC/101256/2008 and AK by a postdoctoral grant (SFRH/BPD/68493/2010), all funded by FCT (Portugal)(http://www.fct.pt/). The collaboration between the Portuguese and Serbian teams was also supported by an integrated action co-funded by FCT (Portugal) and MESTD (Serbia). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBERTS AC, 1992, PHYSIOL BEHAV, V51, P729, DOI 10.1016/0031-9384(92)90109-F; Aleksic I., 2001, ARCH BIOL SCI, V53, P73; Amaral MJ, 2012, CHEMOSPHERE, V87, P757, DOI 10.1016/j.chemosphere.2011.12.075; Armbruster P, 2005, HEREDITY, V95, P235, DOI 10.1038/sj.hdy.6800721; Arnold E.N., 2004, P11; Beasley DE, 2013, ECOL INDIC, V30, P218, DOI 10.1016/j.ecolind.2013.02.024; Blas J, 2007, P NATL ACAD SCI USA, V104, P8880, DOI 10.1073/pnas.0700232104; Bohm M, 2013, BIOL CONSERV, V157, P372, DOI 10.1016/j.biocon.2012.07.015; Bonn A, 1996, OECOLOGIA, V108, P596, DOI 10.1007/BF00329031; Brana F, 2000, J EXP ZOOL, V286, P422, DOI 10.1002/(SICI)1097-010X(20000301)286:4<422::AID-JEZ10>3.0.CO;2-D; Carretero M. A., 1993, Historia Animalium, V2, P77; Carter AJR, 2009, HEREDITY, V102, P563, DOI 10.1038/hdy.2009.13; Clarke G.M., 1995, PAC CONSERV BIOL, V2, P146, DOI DOI 10.1071/PC960146); Clarke GM, 1998, HEREDITY, V80, P553, DOI 10.1046/j.1365-2540.1998.00326.x; CLARKE GM, 1986, AUST J BIOL SCI, V39, P145, DOI 10.1071/BI9860145; CLARKE GM, 1995, CONSERV BIOL, V9, P18, DOI 10.1046/j.1523-1739.1995.09010018.x; Clarke GM, 1998, AM NAT, V152, P762, DOI 10.1086/286207; Cooper W.E. Jr, 2004, P83; Crnobrnja-Isailovic J, 2005, AMPHIBIA-REPTILIA, V26, P149, DOI 10.1163/1568538054253500; DiBattista JD, 2008, CONSERV GENET, V9, P141, DOI 10.1007/s10592-007-9317-z; Djordjevic A. V., 2008, QUALITATIVE QUANTITA; Dongen SV, 2006, J EVOLUTION BIOL, V19, P1727, DOI 10.1111/j.1420-9101.2006.01175.x; DOYLE WJ, 1977, GROWTH, V41, P183; Ducic V., 2005, CLIMATE SERBIA; Eeva T, 2000, FUNCT ECOL, V14, P235, DOI 10.1046/j.1365-2435.2000.00406.x; Fox CW, 2011, EVOLUTION, V65, P246, DOI 10.1111/j.1558-5646.2010.01108.x; Garcia-Munoz E, 2010, ACTA HERPETOL, V5, P259; Gasc J. P., 1997, ATLAS AMPHIBIANS REP, P496; Gherghel I, 2009, ACTA HERPETOL, V4, P183; Gilligan DM, 2000, ANIM CONSERV, V3, P97, DOI 10.1017/S1367943000000792; Glossip D, 1997, HERPETOLOGICA, V53, P192; Gomendio M, 2000, P ROY SOC B-BIOL SCI, V267, P875, DOI 10.1098/rspb.2000.1084; Gomez A., 1993, P213; Hardersen S, 2000, ECOL ENTOMOL, V25, P45, DOI 10.1046/j.1365-2311.2000.00204.x; Hughes J.B., 1997, SCIENCE, V278, P689, DOI DOI 10.1126/science.278.5338.689; Ivanovic R., 2011, GLASNIK SRPSKOG GEOG, V91, P83; Jarvis A., 2008, HOLE FILLED SEAMLESS; Ji X, 2002, J EXP ZOOL, V292, P649, DOI 10.1002/jez.10101; Jovanovi B., 2011, BIOL NYSSANA, V2, P1; Kaliontzopoulou A, 2012, ZOOL J LINN SOC-LOND, V164, P173, DOI 10.1111/j.1096-3642.2011.00760.x; Kleinow K, 1999, SETAC SP P, P9; Klingenberg CP, 2000, EVOLUTION, V54, P1273, DOI 10.1111/j.0014-3820.2000.tb00560.x; Knierim U, 2007, PHYSIOL BEHAV, V92, P398, DOI 10.1016/j.physbeh.2007.02.014; Kozlov MV, 1996, J APPL ECOL, V33, P1489, DOI 10.2307/2404787; Kurbalija Z, 2010, EVOL ECOL, V24, P839, DOI 10.1007/s10682-009-9342-0; Lailvaux SP, 2006, ETHOLOGY, V112, P707, DOI 10.1111/j.1439-0310.2006.01210.x; Leamy LJ, 2005, ANNU REV ECOL EVOL S, V36, P1, DOI 10.1146/annurev.ecolsys.36.102003.152640; Lens L, 2002, BIOL REV, V77, P27, DOI 10.1017/S1464793101005796; Lens L, 2002, CONSERV BIOL, V16, P479, DOI 10.1046/j.1523-1739.2002.00516.x; LEUNG B, 2001, DEV INSTABILITY CAUS, P415; Lopez P, 2002, BIOL J LINN SOC, V77, P201, DOI 10.1046/j.1095-8312.2002.00103.x; Marco A, 2004, B ENVIRON CONTAM TOX, V72, P983, DOI 10.1007/s00128-004-0340-1; Marco A, 2004, B ENVIRON CONTAM TOX, V73, P125, DOI 10.1007/s00128-004-0403-3; Marco A, 2004, CAN J ZOOL, V82, P60, DOI [10.1139/z03-209, 10.1139/Z03-209]; MARKOW TA, 1995, ANNU REV ENTOMOL, V40, P105, DOI 10.1146/annurev.en.40.010195.000541; Martin J, 2006, FUNCT ECOL, V20, P1087, DOI 10.1111/j.1365-2435.2006.01183.x; Martin J, 2001, PHYSIOL BIOCHEM ZOOL, V74, P619, DOI 10.1086/322925; McCarthy J.F., 1990, BIOMARKERS ENV CONTA, DOI DOI 10.1201/9781351070263; Moller A.P., 1997, ASYMMETRY DEV STABIL; MOLLER AP, 1992, J EVOLUTION BIOL, V5, P691, DOI 10.1046/j.1420-9101.1992.5040691.x; Moller AP, 1996, OIKOS, V77, P189, DOI 10.2307/3546057; Moller AP, 1997, AM NAT, V149, P916, DOI 10.1086/286030; MOLLER AP, 1995, POULTRY SCI, V74, P1761, DOI 10.3382/ps.0741761; Mpho M, 2002, HEREDITY, V88, P307, DOI 10.1038/sj.hdy.6800045; Nikic D, 2009, TURKISH J PEDIATR, V51, P257; Nosil P, 2001, EVOLUTION, V55, P712, DOI 10.1554/0014-3820(2001)055[0712:TANCAS]2.0.CO;2; OKE TR, 1973, ATMOS ENVIRON, V7, P769, DOI 10.1016/0004-6981(73)90140-6; Oyekunle J. A. O., 2012, African Journal of Environmental Science and Technology, V6, P458; Palmer, 1994, DEV INSTABILITY ITS, P335, DOI DOI 10.1007/978-94-011-0830-0_; Palmer A. Richard, 2003, P279; PALMER AR, 1986, ANNU REV ECOL SYST, V17, P391, DOI 10.1146/annurev.es.17.110186.002135; PARSONS PA, 1992, HEREDITY, V68, P361, DOI 10.1038/hdy.1992.51; PARSONS PA, 1990, BIOL REV, V65, P131, DOI 10.1111/j.1469-185X.1990.tb01186.x; Pertoldi C, 2006, HEREDITY, V96, P122, DOI 10.1038/sj.hdy.6800777; PIMM SL, 1995, SCIENCE, V269, P347, DOI 10.1126/science.269.5222.347; POLAK M, 1993, GENETICA, V89, P255, DOI 10.1007/BF02424519; Polak M, 2002, ENVIRON POLLUT, V118, P19, DOI 10.1016/S0269-7491(01)00281-0; Polak M., 2003, CAUSES CONSEQUENCES; Polak Michal, 2003, P81; Qualls CP, 1999, BIOL J LINN SOC, V67, P353, DOI 10.1006/bijl.1998.0307; Sarre S, 1996, RES POPUL ECOL, V38, P57, DOI 10.1007/BF02514971; Savage A, 1999, HYDROBIOLOGIA, V411, P139, DOI 10.1023/A:1003857919472; Schulte U., 2008, MAUEREIDECHSE ERFOLG; SCIULLI PW, 1979, AM J PHYS ANTHROPOL, V50, P279, DOI 10.1002/ajpa.1330500218; Skrbic B, 2002, J ENVIRON SCI HEAL A, V37, P7, DOI 10.1081/ESE-100108478; Skrbic B, 2002, J ENVIRON SCI HEAL A, V37, P1029, DOI 10.1081/ESE-120004520; SOULE M, 1973, EVOLUTION, V27, P593, DOI 10.1111/j.1558-5646.1973.tb00708.x; SOULE ME, 1973, NATURE, V242, P191, DOI 10.1038/242191a0; Stamenkovic S., 2003, ARCH BIOL SCI, V55, P133; SWADDLE JP, 1994, P ROY SOC B-BIOL SCI, V255, P147, DOI 10.1098/rspb.1994.0021; Tull JC, 2007, J WILDLIFE MANAGE, V71, P1944, DOI 10.2193/2006-397; Unkagevic M, 2009, GEOGR PANNONICA, V13, P4, DOI 10.5937/GeoPan0901004U; Unkasevic M, 2001, THEOR APPL CLIMATOL, V68, P67, DOI 10.1007/s007040170054; VANDAMME R, 1992, HERPETOLOGICA, V48, P220; Warner DA, 2006, OIKOS, V114, P126; Wilsey BJ, 1998, ECOLOGY, V79, P2092, DOI 10.1890/0012-9658(1998)079[2092:LFAIWH]2.0.CO;2; Wordjevic AV, 2011, THERM SCI, V15, P293, DOI 10.2298/TSCI110114033D; Zhdanova Nadezhda P., 2006, P209	98	54	57	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e84190	10.1371/journal.pone.0084190	http://dx.doi.org/10.1371/journal.pone.0084190			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	281RE	24386350	Green Published, Green Submitted, gold			2022-12-25	WOS:000329117900083
J	Firmino, AAP; Fonseca, FCD; de Macedo, LLP; Coelho, RR; de Souza, JDA; Togawa, RC; Silva, OB; Pappas, GJ; da Silva, MCM; Engler, G; Grossi-de-Sa, MF				Pereira Firmino, Alexandre Augusto; de Assis Fonseca, Fernando Campos; Pepino de Macedo, Leonardo Lima; Coelho, Roberta Ramos; Antonino de Souza, Jose Dijair, Jr.; Togawa, Roberto Coiti; Silva-Junior, Orzenil Bonfim; Pappas-, Georgios Joannis, Jr.; Mattar da Silva, Maria Cristina; Engler, Gilbert; Grossi-de-Sa, Maria Fatima			Transcriptome Analysis in Cotton Boll Weevil (Anthonomus grandis) and RNA Interference in Insect Pests	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; CHITIN-SYNTHESIS; CLUSTAL-W; GENE; COLEOPTERA; BEETLE; EXPRESSION; PRINCIPLES; SYNTHASES; SURVIVAL	Cotton plants are subjected to the attack of several insect pests. In Brazil, the cotton boll weevil, Anthonomus grandis, is the most important cotton pest. The use of insecticidal proteins and gene silencing by interference RNA (RNAi) as techniques for insect control are promising strategies, which has been applied in the last few years. For this insect, there are not much available molecular information on databases. Using 454-pyrosequencing methodology, the transcriptome of all developmental stages of the insect pest, A. grandis, was analyzed. The A. grandis transcriptome analysis resulted in more than 500.000 reads and a data set of high quality 20,841 contigs. After sequence assembly and annotation, around 10,600 contigs had at least one BLAST hit against NCBI non-redundant protein database and 65.7% was similar to Tribolium castaneum sequences. A comparison of A. grandis, Drosophila melanogaster and Bombyx mori protein families' data showed higher similarity to dipteran than to lepidopteran sequences. Several contigs of genes encoding proteins involved in RNAi mechanism were found. PAZ Domains sequences extracted from the transcriptome showed high similarity and conservation for the most important functional and structural motifs when compared to PAZ Domains from 5 species. Two SID-like contigs were phylogenetically analyzed and grouped with T. castaneum SID-like proteins. No RdRP gene was found. A contig matching chitin synthase 1 was mined from the transcriptome. dsRNA microinjection of a chitin synthase gene to A. grandis female adults resulted in normal oviposition of unviable eggs and malformed alive larvae that were unable to develop in artificial diet. This is the first study that characterizes the transcriptome of the coleopteran, A. grandis. A new and representative transcriptome database for this insect pest is now available. All data support the state of the art of RNAi mechanism in insects.	[Pereira Firmino, Alexandre Augusto; de Assis Fonseca, Fernando Campos; Pepino de Macedo, Leonardo Lima; Coelho, Roberta Ramos; Antonino de Souza, Jose Dijair, Jr.; Togawa, Roberto Coiti; Silva-Junior, Orzenil Bonfim; Mattar da Silva, Maria Cristina; Grossi-de-Sa, Maria Fatima] Embrapa Recursos Genet & Biotecnol, Brasilia, DF, Brazil; [Pereira Firmino, Alexandre Augusto] Univ Fed Rio Grande do Sul, Ctr Biotechnol, Grad Program Cellular & Mol Biol, Porto Alegre, RS, Brazil; [de Assis Fonseca, Fernando Campos; Coelho, Roberta Ramos; Antonino de Souza, Jose Dijair, Jr.; Pappas-, Georgios Joannis, Jr.] Univ Brasilia, Grad Program Biol Mol, Brasilia, DF, Brazil; [Pepino de Macedo, Leonardo Lima; Grossi-de-Sa, Maria Fatima] Univ Catolica Brasilia, Grad Program Genom Sci & Biotechnol, Brasilia, DF, Brazil; [Engler, Gilbert] INRA, Sophia Antipolis, France	Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Universidade Federal do Rio Grande do Sul; Universidade de Brasilia; Universidade Catolica de Brasilia; INRAE	Firmino, AAP (corresponding author), Embrapa Recursos Genet & Biotecnol, Brasilia, DF, Brazil.	alexfirm@gmail.com; fatima.grossi@embrapa.br	Fonseca, Fernando/AAX-6839-2021; de Souza, Jose Dijair Antonino/I-1028-2014; Silva-Junior, Orzenil/B-3488-2013; Grossi-de-Sa, Maria Fatima/N-7856-2017; Pappas, Georgios J./N-8071-2019	Fonseca, Fernando/0000-0001-6434-5954; de Souza, Jose Dijair Antonino/0000-0002-4992-0698; Silva-Junior, Orzenil/0000-0002-2104-2010; Pappas, Georgios J./0000-0002-1100-976X; Togawa, Roberto/0000-0001-7179-3210; GROSSI-DE-SA, MARIA FATIMA/0000-0001-8184-9599	CAPES; EMBRAPA; CNPq	CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); EMBRAPA(Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by CAPES (http://www.capes.gov.br/), EMBRAPA (http://www.embrapa.br/), and CNPq (http://www.cnpq.br/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnew P, 2003, CONT T ENT, P145; Ahmadian A, 2006, CLIN CHIM ACTA, V363, P83, DOI 10.1016/j.cccn.2005.04.038; [America NCCo US and Northern Mexico], 2009, PEST MAN BOLL WEEV E; Arakane Y, 2008, INSECT BIOCHEM MOLEC, V38, P959, DOI 10.1016/j.ibmb.2008.07.006; Arakane Y, 2011, INSECT BIOCHEM MOLEC, V41, P42, DOI 10.1016/j.ibmb.2010.09.011; Baum JA, 2007, NAT BIOTECHNOL, V25, P1322, DOI 10.1038/nbt1359; Bucher G, 2002, CURR BIOL, V12, pR85, DOI 10.1016/S0960-9822(02)00666-8; Cahais V, 2012, MOL ECOL RESOUR, V12, P834, DOI 10.1111/j.1755-0998.2012.03148.x; Calvo D, 2008, ANN ENTOMOL SOC AM, V101, P881, DOI 10.1603/0013-8746(2008)101[881:HCWAID]2.0.CO;2; Chevreux B, 2004, GENOME RES, V14, P1147, DOI 10.1101/gr.1917404; Conesa Ana, 2008, Int J Plant Genomics, V2008, P619832, DOI 10.1155/2008/619832; Consortium ikI, 2012, ARTHROPOD GENOMES; Fire A, 1999, TRENDS GENET, V15, P358, DOI 10.1016/S0168-9525(99)01818-1; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Freire EC, 2011, ALGODAO CERRADO; Gangishetti U, 2009, EUR J CELL BIOL, V88, P167, DOI 10.1016/j.ejcb.2008.09.002; Gatehouse JA, 2008, PLANT PHYSIOL, V146, P881, DOI 10.1104/pp.107.111096; Gregory R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017418; Grossi-de-Sa MF, 2012, METODO COMPOSICOES C; Hahn DA, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-234; Jorgensen RA, 1996, PLANT MOL BIOL, V31, P957, DOI 10.1007/BF00040715; Karatolos N, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-56; Keeling CI, 2012, INSECT BIOCHEM MOLEC, V42, P525, DOI 10.1016/j.ibmb.2012.03.010; Kennerdell JR, 2000, NAT BIOTECHNOL, V18, P896, DOI 10.1038/78531; Lange CE, 2009, J PARASITOL, V95, P976, DOI 10.1645/GE-1923.1; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Legrand S, 2010, GENE, V450, P55, DOI 10.1016/j.gene.2009.10.004; Li S, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-581; Liu QH, 2010, ANNU REV BIOCHEM, V79, P295, DOI 10.1146/annurev.biochem.052208.151733; Mao YB, 2007, NAT BIOTECHNOL, V25, P1307, DOI 10.1038/nbt1352; Mardis ER, 2008, ANNU REV GENOM HUM G, V9, P387, DOI 10.1146/annurev.genom.9.081307.164359; MCLAUGHLIN RE, 1966, J ECON ENTOMOL, V59, P401, DOI 10.1093/jee/59.2.401; McQuilton P, 2012, NUCLEIC ACIDS RES, V40, pD706, DOI 10.1093/nar/gkr1030; Merzendorfer H, 2003, J EXP BIOL, V206, P4393, DOI 10.1242/jeb.00709; Merzendorfer H, 2011, EUR J CELL BIOL, V90, P759, DOI 10.1016/j.ejcb.2011.04.014; Mita K, 2003, P NATL ACAD SCI USA, V100, P14121, DOI 10.1073/pnas.2234984100; Monnerat R. G., 2000, COMUN TECNICO EMBRAP, V46; MURZIN AG, 1993, EMBO J, V12, P861, DOI 10.1002/j.1460-2075.1993.tb05726.x; Myhre S, 2006, BIOINFORMATICS, V22, P2020, DOI 10.1093/bioinformatics/btl334; Ostrowski S, 2002, GENETICS, V161, P171; Papanicolaou A, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-447; Pauchet Y, 2010, INSECT MOL BIOL, V19, P61, DOI 10.1111/j.1365-2583.2009.00936.x; Pauchet Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015635; Pauchet Y, 2009, INSECT BIOCHEM MOLEC, V39, P403, DOI 10.1016/j.ibmb.2009.04.001; Posnien N, 2009, COLD SPRING HARB PRO, V2009; Price DRG, 2008, TRENDS BIOTECHNOL, V26, P393, DOI 10.1016/j.tibtech.2008.04.004; Rangasamy M, 2012, PEST MANAG SCI, V68, P587, DOI 10.1002/ps.2301; Richards S, 2008, NATURE, V452, P949, DOI 10.1038/nature06784; Sappington TW, 2000, ANN ENTOMOL SOC AM, V93, P610, DOI 10.1603/0013-8746(2000)093[0610:PTFASD]2.0.CO;2; Shin H, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-30; Song JJ, 2003, NAT STRUCT BIOL, V10, P1026, DOI 10.1038/nsb1016; Sontheimer EJ, 2005, NAT REV MOL CELL BIO, V6, P127, DOI 10.1038/nrm1568; Suck D, 1997, NAT STRUCT BIOL, V4, P161, DOI 10.1038/nsb0397-161; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tomoyasu Y, 2004, DEV GENES EVOL, V214, P575, DOI 10.1007/s00427-004-0434-0; Tomoyasu Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r10; Vera JC, 2008, MOL ECOL, V17, P1636, DOI 10.1111/j.1365-294X.2008.03666.x; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Waterhouse PM, 1998, P NATL ACAD SCI USA, V95, P13959, DOI 10.1073/pnas.95.23.13959; Wilson TG, 1997, J EXP ZOOL, V278, P37, DOI 10.1002/(SICI)1097-010X(19970501)278:1&lt;37::AID-JEZ4&gt;3.0.CO;2-7; Wong CNA, 2011, ENVIRON MICROBIOL, V13, P1889, DOI 10.1111/j.1462-2920.2011.02511.x; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Zagrobelny M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-574; Zhang FJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-303; Zhulidov PA, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh031; Zou Z, 2008, INSECT BIOCHEM MOLEC, V38, P677, DOI 10.1016/j.ibmb.2008.03.009	67	46	48	6	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e85079	10.1371/journal.pone.0085079	http://dx.doi.org/10.1371/journal.pone.0085079			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281RE	24386449	Green Published, Green Submitted, gold			2022-12-25	WOS:000329117900123
J	Issman, L; Brenner, B; Talmon, Y; Aharon, A				Issman, Liron; Brenner, Benjamin; Talmon, Yeshayahu; Aharon, Anat			Cryogenic Transmission Electron Microscopy Nanostructural Study of Shed Microparticles	PLOS ONE			English	Article							INDUCED PLATELET MICROPARTICLES; CIRCULATING MICROPARTICLES; ENDOTHELIAL MICROPARTICLES; BLOOD; EXOSOMES; CELLS; SURFACTANT; CRYOPRESERVATION; TEMPERATURE; GENERATION	Microparticles (MPs) are sub-micron membrane vesicles (100-1000 nm) shed from normal and pathologic cells due to stimulation or apoptosis. MPs can be found in the peripheral blood circulation of healthy individuals, whereas elevated concentrations are found in pregnancy and in a variety of diseases. Also, MPs participate in physiological processes, e. g., coagulation, inflammation, and angiogenesis. Since their clinical properties are important, we have developed a new methodology based on nano-imaging that provides significant new data on MPs nanostructure, their composition and function. We are among the first to characterize by direct-imaging cryogenic transmitting electron microscopy (cryo-TEM) the near-to-native nanostructure of MP systems isolated from different cell types and stimulation procedures. We found that there are no major differences between the MP systems we have studied, as most particles were spherical, with diameters from 200 to 400 nm. However, each MP population is very heterogeneous, showing diverse morphologies. We investigated by cryo-TEM the effects of standard techniques used to isolate and store MPs, and found that either high-g centrifugation of MPs for isolation purposes, or slow freezing to -80 degrees C for storage introduce morphological artifacts, which can influence MP nanostructure, and thus affect the efficiency of these particles as future diagnostic tools.	[Issman, Liron; Talmon, Yeshayahu] Technion Israel Inst Technol, Dept Chem Engn, IL-32000 Haifa, Israel; [Issman, Liron; Talmon, Yeshayahu] Technion Israel Inst Technol, Russell Berrie Nanotechnol Inst, Haifa, Israel; [Brenner, Benjamin; Aharon, Anat] Technion Israel Inst Technol, Bruce Rappaport Fac Med, IL-31096 Haifa, Israel; [Brenner, Benjamin; Aharon, Anat] Rambam Hlth Care Campus, Dept Hematol, Thrombosis & Hemostasis Unit, Haifa, Israel	Technion Israel Institute of Technology; Technion Israel Institute of Technology; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Rambam Health Care Campus	Issman, L (corresponding author), Technion Israel Inst Technol, Dept Chem Engn, IL-32000 Haifa, Israel.	Icey77@gmail.com; ishi@tx.technion.ac.il	Talmon, Yeshayahu/N-1076-2019	Talmon, Yeshayahu/0000-0002-9854-3972	Technion Russell Berrie Nanotechnology Institute (RBNI) through a Nevet grant	Technion Russell Berrie Nanotechnology Institute (RBNI) through a Nevet grant	The authors thank the Technion Russell Berrie Nanotechnology Institute (RBNI) for financial support through a Nevet grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aass HCD, 2011, CYTOM PART A, V79A, P990, DOI 10.1002/cyto.a.21147; ADRIAN M, 1984, NATURE, V308, P32, DOI 10.1038/308032a0; Aharon A, 2008, THROMB HAEMOSTASIS, V100, P878, DOI 10.1160/TH07-11-0691; Amabile N, 2005, J AM SOC NEPHROL, V16, P3381, DOI 10.1681/ASN.2005050535; BELLARE JR, 1988, J ELECTRON MICR TECH, V10, P87, DOI 10.1002/jemt.1060100111; Brodsky SV, 2008, J GASTROINTEST LIVER, V17, P261; Combes V, 1999, J CLIN INVEST, V104, P93, DOI 10.1172/JCI4985; Connor DE, 2010, THROMB HAEMOSTASIS, V103, P1044, DOI 10.1160/TH09-09-0644; Freyssinet JM, 2003, J THROMB HAEMOST, V1, P1655, DOI 10.1046/j.1538-7836.2003.00309.x; Germain SJ, 2007, J IMMUNOL, V178, P5949, DOI 10.4049/jimmunol.178.9.5949; Golan S, 2011, LANGMUIR, V27, P6615, DOI 10.1021/la200450x; Heijnen HFG, 1999, BLOOD, V94, P3791, DOI 10.1182/blood.V94.11.3791.423a22_3791_3799; Hoyer FF, 2012, J CELL MOL MED, V16, P2777, DOI 10.1111/j.1582-4934.2012.01595.x; Issman L, 2012, J MICROSC-OXFORD, V246, P60, DOI 10.1111/j.1365-2818.2011.03587.x; Jaiswal R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061515; Katayama Y, 1997, BONE MARROW TRANSPL, V19, P283, DOI 10.1038/sj.bmt.1700644; Katzenell S, 2012, THROMB RES; Keuren JF, 2006, BRIT J HAEMATOL, V134, P307, DOI 10.1111/j.1365-2141.2006.06167.x; Koh CG, 2010, J CONTROL RELEASE, V141, P62, DOI 10.1016/j.jconrel.2009.08.019; Lucic V, 2005, ANNU REV BIOCHEM, V74, P833, DOI 10.1146/annurev.biochem.73.011303.074112; Meziani F, 2008, PHARMACOL REP, V60, P75; MILLER DD, 1987, J PHYS CHEM-US, V91, P674, DOI 10.1021/j100287a036; Perez-Pujol S, 2007, CYTOM PART A, V71A, P38, DOI 10.1002/cyto.a.20354; Piccin A, 2007, BLOOD REV, V21, P157, DOI 10.1016/j.blre.2006.09.001; Pisitkun T, 2004, P NATL ACAD SCI USA, V101, P13368, DOI 10.1073/pnas.0403453101; Pizzey CL, 2008, J PHYS CHEM B, V112, P5849, DOI 10.1021/jp7103903; Redman CWG, 2007, J REPROD IMMUNOL, V76, P61, DOI 10.1016/j.jri.2007.03.008; Robert S, 2009, J THROMB HAEMOST, V7, P190, DOI 10.1111/j.1538-7836.2008.03200.x; RUBINSTEIN P, 1995, P NATL ACAD SCI USA, V92, P10119, DOI 10.1073/pnas.92.22.10119; Shah MD, 2008, PLATELETS, V19, P365, DOI 10.1080/09537100802054107; Shet AS, 2003, BLOOD, V102, P2678, DOI 10.1182/blood-2003-03-0693; Shomer E, 2013, HYPERTENSIO IN PRESS; Simak J, 2004, BRIT J HAEMATOL, V125, P804, DOI 10.1111/j.1365-2141.2004.04974.x; Talmon Y, 1999, SURF SCI SERIES, V83, P147; TALMON Y, 1979, REV SCI INSTRUM, V50, P698, DOI 10.1063/1.1135920; Talmon Y, 1996, BER BUNSEN PHYS CHEM, V100, P364, DOI 10.1002/bbpc.19961000322; TALMON Y, 1983, J COLLOID INTERF SCI, V93, P366, DOI 10.1016/0021-9797(83)90420-4; Talmon Y, 2007, SURFACTANT SCI SER, V140, P163; Toth B, 2007, AM J REPROD IMMUNOL, V58, P389, DOI 10.1111/j.1600-0897.2007.00532.x; Trummer A, 2009, BLOOD COAGUL FIBRIN, V20, P52, DOI 10.1097/MBC.0b013e32831be9c5; Tsimerman G, 2011, THROMB HAEMOSTASIS, V106, P310, DOI 10.1160/TH10-11-0712; van der Meijden PEJ, 2012, J THROMB HAEMOST, V10, P1355, DOI 10.1111/j.1538-7836.2012.04758.x; van der Pol E, 2010, J THROMB HAEMOST, V8, P2596, DOI 10.1111/j.1538-7836.2010.04074.x; von der Malsburg A, 2011, J BIOL CHEM, V286, P37858, DOI 10.1074/jbc.M111.249037; Waisman D, 2007, CLIN PHYSIOL FUNCT I, V27, P375, DOI 10.1111/j.1475-097X.2007.00763.x; Xiao HY, 2002, CRYOBIOLOGY, V44, P179, DOI 10.1016/S0011-2240(02)00024-X; Yuana Y, 2010, J THROMB HAEMOST, V8, P315, DOI 10.1111/j.1538-7836.2009.03654.x; Yuana Y, 2011, THROMB HAEMOSTASIS, V105, P396, DOI 10.1160/TH10-09-0595; Zheng Y, 2000, J PHYS CHEM B, V104, P5263, DOI 10.1021/jp0002998; Zheng Y, 1999, J PHYS CHEM B, V103, P10331, DOI 10.1021/jp9923264	50	57	59	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e83680	10.1371/journal.pone.0083680	http://dx.doi.org/10.1371/journal.pone.0083680			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281QS	24386253	gold, Green Published, Green Submitted			2022-12-25	WOS:000329116700069
J	Smit, PW; Haanpera, M; Rantala, P; Couvin, D; Lyytikainen, O; Rastogi, N; Ruutu, P; Soini, H				Smit, Pieter Willem; Haanpera, Marjo; Rantala, Pirre; Couvin, David; Lyytikainen, Outi; Rastogi, Nalin; Ruutu, Petri; Soini, Hanna			Molecular Epidemiology of Tuberculosis in Finland, 2008-2011	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; IMMIGRATION; IMPACT	In industrialized countries the majority of tuberculosis (TB) cases are linked to immigration. In Finland, most cases are still Finnish born but the number of foreign born cases is steadily increasing. In this 4-year population based study, the TB situation in Finland was characterized by a genotypic analysis of Mycobacterium tuberculosis isolates. A total of 1048 M. tuberculosis isolates (representing 99.4% of all culture positive cases) were analyzed by spoligotyping and MIRU. Spoligotype lineages belonging to the Euro-American family were predominant among the Finnish isolates, particularly T (n=346, 33.0%) and Haarlem (n=237, 22.6%) strains. The lineage signature was unknown for 130 (12.4%) isolates. Out of the 17 multi-drug resistant TB strains, 10 (58.8%) belonged to the Beijing lineage. In total, 23 new SIT designations were given and 51 orphan strains were found, of which 58 patterns were unique to Finland. Phylogeographical TB mapping as compared to neighboring countries showed that the population structure in Finland most closely resembled that observed in Sweden. By combining spoligotyping and MIRU results, 98 clusters comprising 355 isolates (33.9%) were found. Only 10 clusters contained both Finnish and foreign born cases. In conclusion, a large proportion of the M. tuberculosis isolates were from Finnish born elderly patients. Moreover, many previously unidentified spoligotype profiles and isolates belonging to unknown lineages were encountered.	[Smit, Pieter Willem] European Ctr Dis Prevent & Control ECDC, European Publ Hlth Microbiol Training Programme E, Stockholm, Sweden; [Smit, Pieter Willem; Haanpera, Marjo; Rantala, Pirre; Lyytikainen, Outi; Ruutu, Petri; Soini, Hanna] Natl Inst Hlth & Welf, Dept Infect Dis Surveillance & Control, Helsinki, Finland; [Couvin, David; Rastogi, Nalin] Inst Pasteur Guadeloupe, WHO Supranat TB Reference Lab, TB & Mycobacteria Unit, Abymes, France	European Centre for Disease Prevention & Control; Finland National Institute for Health & Welfare	Smit, PW (corresponding author), European Ctr Dis Prevent & Control ECDC, European Publ Hlth Microbiol Training Programme E, Stockholm, Sweden.	Pieter.smit@thl.fi	RASTOGI, NALIN/AAP-1958-2020	RASTOGI, NALIN/0000-0002-7199-7747; Couvin, David/0000-0002-7897-9023				[Anonymous], 1955, Bull World Health Organ, V12, P211; Braden CR, 1997, J INFECT DIS, V175, P1446, DOI 10.1086/516478; Brudey K, 2004, J CLIN MICROBIOL, V42, P3046, DOI 10.1128/JCM.42.7.3046-3051.2004; Chernyaeva E, 2012, EUR J CLIN MICROBIOL, V31, P1753, DOI 10.1007/s10096-011-1497-2; Dahle UR, 2007, AM J RESP CRIT CARE, V176, P930, DOI 10.1164/rccm.200702-187OC; Demay C, 2012, INFECT GENET EVOL, V12, P755, DOI 10.1016/j.meegid.2012.02.004; Easterbrook PJ, 2004, J CLIN MICROBIOL, V42, P4536, DOI 10.1128/JCM.42.10.4536-4544.2004; Groenheit R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046848; Kamper-Jorgensen Z, 2012, J CLIN MICROBIOL, V50, P2660, DOI 10.1128/JCM.06358-11; Kinander W, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008373; Makinen J, 2011, EUR J CLIN MICROBIOL, V30, P1119, DOI 10.1007/s10096-011-1200-7; Mokrousov I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041318; Mokrousov I, 2012, INFECT GENET EVOL, V12, P619, DOI 10.1016/j.meegid.2011.09.026; Puustinen K, 2003, J CLIN MICROBIOL, V41, P1525, DOI 10.1128/JCM.41.4.1525-1528.2003; Svensson E, 2011, CLIN MICROBIOL INFEC, V17, P881, DOI 10.1111/j.1469-0691.2010.03358.x; Vasankari T, 2012, CLIN RESPIR J, V6, P35, DOI 10.1111/j.1752-699X.2011.00242.x; Weniger T, 2010, NUCLEIC ACIDS RES, V38, pW326, DOI 10.1093/nar/gkq351	17	21	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e85027	10.1371/journal.pone.0085027	http://dx.doi.org/10.1371/journal.pone.0085027			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281QS	24386443	Green Submitted, Green Published, gold			2022-12-25	WOS:000329116700127
J	Turkalo, AK; Wrege, PH; Wittemyer, G				Turkalo, Andrea K.; Wrege, Peter H.; Wittemyer, George			Long-Term Monitoring of Dzanga Bai Forest Elephants: Forest Clearing Use Patterns	PLOS ONE			English	Article							LOXODONTA-AFRICANA-CYCLOTIS; NATIONAL-PARK; SEASONAL MOVEMENTS; RAIN-FOREST; POPULATION; MATSCHIE; DENSITY; RESERVE	Individual identification of the relatively cryptic forest elephant (Loxodonta cyclotis) at forest clearings currently provides the highest quality monitoring data on this ecologically important but increasingly threatened species. Here we present baseline data from the first 20 years of an individually based study of this species, conducted at the Dzanga Clearing, Central African Republic. A total of 3,128 elephants were identified over the 20-year study (1,244 adults; 675 females, 569 males). It took approximately four years for the majority of elephants visiting the clearing to be identified, but new elephants entered the clearing every year of the study. The study population was relatively stable, varying from 1,668 to 1,864 individuals (including juveniles and infants), with increasingly fewer males than females over time. The age-class distribution for females remained qualitatively unchanged between 1995 and 2010, while the proportion of adult males decreased from 20% to 10%, likely reflecting increased mortality. Visitation patterns by individuals were highly variable, with some elephants visiting monthly while others were ephemeral users with visits separated by multiple years. The number of individuals in the clearing at any time varied between 40 and 100 individuals, and there was little evidence of a seasonal pattern in this variation. The number of elephants entering the clearing together (defined here as a social group) averaged 1.49 (range 1-12) for males and 2.67 (range 1-14) for females. This collation of 20 years of intensive forest elephant monitoring provides the first detailed, long term look at the ecology of bai visitation for this species, offering insight to the ecological significance and motivation for bai use, social behavior, and threats to forest elephants. We discuss likely drivers (rainfall, compression, illegal killing, etc.) influencing bai visitation rates. This study provides the baseline for future demographic and behavioral studies of this population.	[Turkalo, Andrea K.] Wildlife Conservat Soc, Africa Program, Bronx, NY 10460 USA; [Turkalo, Andrea K.; Wrege, Peter H.] Cornell Lab Ornithol, Elephant Listening Project, Bioacoust Res Program, Ithaca, NY USA; [Wittemyer, George] Colorado State Univ, Dept Fish Wildlife & Conservat Biol, Ft Collins, CO 80523 USA; [Wittemyer, George] Save Elephants, Nairobi, Kenya	Wildlife Conservation Society; Cornell University; Colorado State University	Turkalo, AK (corresponding author), Wildlife Conservat Soc, Africa Program, Bronx, NY 10460 USA.	dzanga@uuplus.net	Wittemyer, George/AFQ-1840-2022		African Elephant Conservation Coordinating Group; Arbogast Foundation; Bonderman Family Foundation; Born Free; Busch Gardens; Congo Basin Forest Program; Disney Wildlife Conservation Fund; Patagonia Inc.; Sacharuna Foundation; World Wildlife Fund; Swedish Defend the Elephants Society; United States Fish and Wildlife Service [98210-5-G165, 98210-6-G157, 98219-7-G206, 98210-8-G750, 96200-9-G178, F11AP00222]	African Elephant Conservation Coordinating Group; Arbogast Foundation; Bonderman Family Foundation; Born Free; Busch Gardens; Congo Basin Forest Program; Disney Wildlife Conservation Fund; Patagonia Inc.; Sacharuna Foundation; World Wildlife Fund; Swedish Defend the Elephants Society; United States Fish and Wildlife Service(US Fish & Wildlife Service)	Financial support to AKT for this long-term study was provided by the African Elephant Conservation Coordinating Group, Arbogast Foundation, Bonderman Family Foundation, Born Free, Busch Gardens, Congo Basin Forest Program, Disney Wildlife Conservation Fund, Patagonia Inc., Sacharuna Foundation (also to PHW), World Wildlife Fund, Swedish Defend the Elephants Society, and United States Fish and Wildlife Service (grant nos. 98210-5-G165, 98210-6-G157, 98219-7-G206, 98210-8-G750, 96200-9-G178, F11AP00222). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blake S, 2001, AFR J ECOL, V39, P178, DOI 10.1046/j.1365-2028.2001.00296.x; Blake S., 2002, ECOLOGY FOREST ELEPH; Blake S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003546; Blake S, 2009, BIOTROPICA, V41, P459, DOI 10.1111/j.1744-7429.2009.00512.x; Blake S, 2007, PLOS BIOL, V5, P945, DOI 10.1371/journal.pbio.0050111; Burn RW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024165; Chiyo PI, 2011, ANIM BEHAV, V81, P1093, DOI 10.1016/j.anbehav.2011.02.013; CITES (Convention on International Trade in Endangered Species of Wild Fauna and Flora) Secretariat, 2012, EL CONS ILL KILL IV; DUDLEY JP, 1992, AFR J ECOL, V30, P116, DOI 10.1111/j.1365-2028.1992.tb00485.x; Fishlock V, 2013, ANIM BEHAV, V85, P357, DOI 10.1016/j.anbehav.2012.11.004; Fishlock V, 2008, PACHYDERM, P17; Foguekem D, 2009, SCI RES ESSAYS, V4, P1423; Gessner J, 2013, AFRICAN J ECOLOGY; Graham MD, 2009, ANIM CONSERV, V12, P445, DOI 10.1111/j.1469-1795.2009.00272.x; Hochschild A., 1998, LEOPOLDS GHOST STORY; Inkamba-Nkulu C, 2007, STRUCTURE MOVEMENTS; Ishida Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020642; Klaus G, 1998, J TROP ECOL, V14, P829, DOI 10.1017/S0266467498000595; Kolowski JM, 2010, AFRICAN J ECOLOGY, P9999; LEE PC, 1986, BEHAV ECOL SOCIOBIOL, V18, P353, DOI 10.1007/BF00299666; LEWIS DM, 1986, AFR J ECOL, V24, P227, DOI 10.1111/j.1365-2028.1986.tb00367.x; Maisels F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059469; MERZ G, 1986, AFR J ECOL, V24, P61, DOI 10.1111/j.1365-2028.1986.tb00344.x; MERZ G, 1981, MAMMALIA, V45, P299, DOI 10.1515/mamm.1981.45.3.299; Momont L, 2007, SELECTION HABITAT OR; Morgan BJ, 2007, AFR J ECOL, V45, P519, DOI 10.1111/j.1365-2028.2007.00762.x; Moss CJ, 2001, J ZOOL, V255, P145, DOI 10.1017/S0952836901001212; Moss CJ, 1983, PRIMATE SOCIAL RELAT, P315; Moss Cynthia, 1996, P58; POOLE J H, 1989, Oryx, V23, P188; Querouil S, 1999, AFR J ECOL, V37, P161, DOI 10.1046/j.1365-2028.1999.00157.x; Ruggiero R., 1990, PACHYDERM, V13, P42; RUGGIERO RG, 1994, AFR J ECOL, V32, P222, DOI 10.1111/j.1365-2028.1994.tb00573.x; SHORT JC, 1983, AFR J ECOL, V21, P175, DOI 10.1111/j.1365-2028.1983.tb01179.x; Turkalo AK, 2013, AFRICAN J ECOLOGY; Turkalo Andrea, 1995, Pachyderm, V20, P45; Turkalo Andrea K., 2001, P207; UN, 2012, AFR HUM DEV REP 2012; Vangroenweghe, 2006, J BELGIAN HIST REV, V36, P323; Vanleeuwe Hilde, 1997, Pachyderm, V24, P46; WHITE LJT, 1994, J TROP ECOL, V10, P121, DOI 10.1017/S0266467400007768; Wittemyer G, 2001, AFR J ECOL, V39, P357, DOI 10.1046/j.1365-2028.2001.00324.x; Wittemyer G, 2013, PLOS ONE, V8; Wittemyer G, 2007, ECOGRAPHY, V30, P42, DOI 10.1111/j.2006.0906-7590.04900.x; Wittemyer G, 2011, CONSERV BIOL, V25, P1002, DOI 10.1111/j.1523-1739.2011.01713.x; Wrege PH, 2012, AFR J ECOL, V50, P176, DOI 10.1111/j.1365-2028.2011.01310.x	47	36	38	4	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e85154	10.1371/journal.pone.0085154	http://dx.doi.org/10.1371/journal.pone.0085154			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281QS	24386460	Green Submitted, Green Published, gold			2022-12-25	WOS:000329116700134
J	Chen, SH; Chan, SC; Chao, YK; Yen, TC				Chen, Shih-Hsin; Chan, Sheng-Chieh; Chao, Yin-Kai; Yen, Tzu-Chen			Detection of Synchronous Cancers by Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography during Primary Staging Workup for Esophageal Squamous Cell Carcinoma in Taiwan	PLOS ONE			English	Article							MULTIPLE PRIMARY CANCERS; ALDEHYDE DEHYDROGENASE-2; PRIMARY NEOPLASMS; ALCOHOL-DRINKING; F-18-FDG PET; RISK; IMPACT; MANAGEMENT; POLYMORPHISMS; EPIDEMIOLOGY	Aim: The aim of this retrospective study was to investigate the ability of fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) in the detection of synchronous cancers during staging workup for esophageal squamous cell carcinoma. Materials and Methods: We performed a retrospective chart review of 426 Taiwanese patients with esophageal cancer who received FDG-PET/CT during their primary staging workup between December 2006 and December 2011. We defined synchronous cancers as those occurring within 6 months of the FDG-PET/CT scan. All of the synchronous lesions were confirmed by histology or imaging follow-up. The study patients were followed for at least 18 months or were censored on the date of last follow-up. Results: Fifty patients were excluded from analysis because of the presence of distant metastases. Of the remaining 376 patients, 359 were diagnosed with squamous cell carcinoma (SCC). We identified 17 patients with synchronous cancers, and all of them had a diagnosis of SCC. Synchronous head and neck cancers were the most frequent (n=13, 76.4%), followed by gastrointestinal cancers (colon cancer, n=2; hepatocellular carcinoma, n=1), and renal cell carcinoma (n=1). FDG-PET/CT successfully detected 15 synchronous cancers (12 head and neck cancers, 2 colon cancers, and 1 renal cell carcinoma). In contrast, conventional workup detected only 9 synchronous cancers (7 head and neck cancers, 1 hepatocellular carcinoma and 1 renal cell carcinoma). The sensitivity of FDG-PET/CT and conventional workup in detecting synchronous cancers were 88.2% and 52.9% respectively. Conclusion: The most frequent synchronous lesions in patients with esophageal SCC were head and neck cancers in Taiwan. Our data indicate that FDG-PET/CT is superior to conventional workup in the detection of synchronous tumors during primary staging for esophageal squamous cell carcinoma.	[Chen, Shih-Hsin; Chan, Sheng-Chieh; Yen, Tzu-Chen] Chang Gung Mem Hosp, Dept Nucl Med, Tao Yuan, Taiwan; [Chao, Yin-Kai] Chang Gung Mem Hosp, Dept Thorac Surg, Tao Yuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung Memorial Hospital	Yen, TC (corresponding author), Chang Gung Mem Hosp, Dept Nucl Med, Tao Yuan, Taiwan.	yentc1110@gmail.com	Chao, YinKai/ABE-7827-2020; Chan, Sheng Chieh/AAF-9127-2019; Stefanadis, Christodoulos/ABH-2232-2020	Chan, Sheng Chieh/0000-0003-3236-395X; Stefanadis, Christodoulos/0000-0001-5974-6454; Huang, Yan-Ping/0000-0002-3301-2847				[Anonymous], 2012, TAIW CANC REG ANN RE; Barber TW, 2012, J NUCL MED, V53, P864, DOI 10.2967/jnumed.111.101568; Bhargava P, 2011, CLIN NUCL MED, V36, pE20, DOI 10.1097/RLU.0b013e318212c872; Cheng NM, 2009, EUR J NUCL MED MOL I, V36, P607, DOI 10.1007/s00259-008-0995-7; Choi JY, 2005, J CLIN ONCOL, V23, P7654, DOI 10.1200/JCO.2005.01.4340; Ding JH, 2010, J HUM GENET, V55, P97, DOI 10.1038/jhg.2009.129; Ferlay J, 2010, IARC CANCERBASE, V10; Gao CM, 2008, WORLD J GASTROENTERO, V14, P5078, DOI 10.3748/wjg.14.5078; Heusner TA, 2009, EUR RADIOL, V19, P2171, DOI 10.1007/s00330-009-1405-7; Hongo M, 2009, J GASTROEN HEPATOL, V24, P729, DOI 10.1111/j.1440-1746.2009.05824.x; Howlader N., 2016, SEER CANC STAT REV; Kagei K, 2002, JPN J CLIN ONCOL, V32, P120, DOI 10.1093/jjco/hyf028; Kumagai Y, 2001, SURG TODAY, V31, P872, DOI 10.1007/s005950170025; Lin YS, 2013, J EPIDEMIOL, V23, P233, DOI 10.2188/jea.JE20120162; Little SG, 2007, EUR J CARDIO-THORAC, V31, P791, DOI 10.1016/j.ejcts.2007.01.037; Malik V, 2012, CLIN NUCL MED, V37, P1152, DOI 10.1097/RLU.0b013e31827083ba; Matsuo K, 2013, CARCINOGENESIS, V34, P1510, DOI 10.1093/carcin/bgt080; Miyata H, 2008, DIS ESOPHAGUS, V21, P144, DOI 10.1111/j.1442-2050.2007.00743.x; National Comprehensive Cancer Network, 2013, NCCN CLIN PRACT GUID; Natsugoe S, 2005, WORLD J SURG, V29, P46, DOI 10.1007/s00268-004-7525-y; Oze I, 2009, CANCER EPIDEM BIOMAR, V18, P3097, DOI 10.1158/1055-9965.EPI-09-0499; Poon RTP, 1998, ANN THORAC SURG, V65, P1529, DOI 10.1016/S0003-4975(98)00177-5; Seitz HK, 2010, GENES NUTR, V5, P121, DOI 10.1007/s12263-009-0154-1; van Westreenen HL, 2005, J NUCL MED, V46, P1321; Vyas S, 2011, J GASTROINTEST SURG, V15, P2127, DOI 10.1007/s11605-011-1686-4; Wu IC, 2006, EUR J CLIN INVEST, V36, P236, DOI 10.1111/j.1365-2362.2006.01621.x	26	25	27	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2013	8	11							e82812	10.1371/journal.pone.0082812	http://dx.doi.org/10.1371/journal.pone.0082812			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261MX	24391852	Green Submitted, gold, Green Published			2022-12-25	WOS:000327670300086
J	Gupta, P; Giri, J; Srivastav, S; Chande, AG; Mukhopadhyaya, R; Das, PK; Ukil, A				Gupta, Purnima; Giri, Jayeeta; Srivastav, Supriya; Chande, Ajit G.; Mukhopadhyaya, Robin; Das, Pijush K.; Ukil, Anindita			Leishmania donovani targets tumor necrosis factor receptor-associated factor (TRAF) 3 for impairing TLR4-mediated host response	FASEB JOURNAL			English	Article						signalosome; ubiquitination; macrophage	EXPERIMENTAL VISCERAL LEISHMANIASIS; NF-KAPPA-B; TOLL-LIKE RECEPTORS; IMMUNE-RESPONSE; PROTEIN; UBIQUITINATION; ACTIVATION; INFECTION; TOLL-LIKE-RECEPTOR-4; PROMASTIGOTES	Intramacrophage pathogen Leishmania donovani escapes host immune response by subverting Toll-like receptor (TLR) signaling, which is critically regulated by protein ubiquitination. In the present study, we identified tumor necrosis factor receptor-associated factor (TRAF) 3, degradative ubiquitination of which is essential for TLR4 activation, as a target for Leishmania to deactivate LPS-mediated TLR4 signaling. We used LPS-treated RAW 264.7 cells and compared the TLR4-mediated immune response in these cells with L. donovani and L. donovani + LPS costimulated macrophages. TRAF3, which was ubiquitinated (2.1-fold over control) at lys 48 position and subsequently degraded following LPS treatment, persisted in L. donovani and L. donovani + LPS costimulated cells due to defective lys 48 ubiquitination. Lys 63-linked ubiquitination of upstream proteins in the cascade (cIAP1/2 and TRAF6), mandatory for TRAF3 degradation, was also reduced postinfection. This may be attributed to reduced association between ubiquitin-conjugating enzyme Ubc13 and TRAF6 during infection. Inhibition of TRAF3 before infection by shRNA in Balb/c mice showed enhanced IL-12 and TNF-alpha (10.8- and 8.1-fold over infected control) and decreased spleen parasite burden (61.3% suppression, P < 0.001), thereby marking reduction in disease progression. Our findings identified TRAF3 as a novel molecular regulator exploited by Leishmania for successful infection.-Gupta, P., Giri, J., Srivastav, S., Chande, A. G., Mukhopadhyaya, R., Das, P. K., Ukil, A. Leishmania donovani targets tumor necrosis factor receptor-associated factor (TRAF) 3 for impairing TLR4-mediated host response.	[Gupta, Purnima; Giri, Jayeeta; Ukil, Anindita] Univ Calcutta, Dept Biochem, Kolkata 700019, India; [Srivastav, Supriya; Das, Pijush K.] Indian Inst Chem Biol, CSIR, Infect Dis & Immunol Div, Kolkata, India; [Chande, Ajit G.; Mukhopadhyaya, Robin] Tata Mem Hosp, ACTREC, Virol Lab, Kharghar, Navi Mumbai, India	University of Calcutta; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB); Tata Memorial Centre (TMC); Advance Centre for Treatment, Research & Education in Cancer (ACTREC); Tata Memorial Hospital	Ukil, A (corresponding author), Univ Calcutta, Dept Biochem, 35 Ballygunge Circular Rd, Kolkata 700019, India.	aninditau@yahoo.com	Chande, Ajit/K-5031-2014; Gupta, Purnima/AAP-8717-2020	Chande, Ajit/0000-0003-2210-5180; GIRI, JAYEETA/0000-0002-2688-7274; Gupta, Purnima/0000-0003-4389-3024	Department of Science and Technology (DST); University Grants Commission (UGC); Department of Biotechnology (DBT); Council of Scientific and Industrial Research (CSIR), Government of India	Department of Science and Technology (DST)(Department of Science & Technology (India)); University Grants Commission (UGC)(University Grants Commission, India); Department of Biotechnology (DBT)(Department of Biotechnology (DBT) India); Council of Scientific and Industrial Research (CSIR), Government of India(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by the Department of Science and Technology (DST), University Grants Commission (UGC), Department of Biotechnology (DBT), and Council of Scientific and Industrial Research (CSIR), Government of India.	ABEHSIRAAMAR O, 1992, J IMMUNOL, V148, P3820; Ball WB, 2011, J IMMUNOL, V187, P1322, DOI 10.4049/jimmunol.1004237; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; Depledge DP, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000829; Dong W, 2006, J BIOL CHEM, V281, P26029, DOI 10.1074/jbc.M513057200; Faria Marilia S., 2012, Journal of Parasitology Research, P930257, DOI 10.1155/2012/930257; Flandin JF, 2006, EUR J IMMUNOL, V36, P411, DOI 10.1002/eji.200535079; Gallego C, 2011, INFECT IMMUN, V79, P2871, DOI 10.1128/IAI.01388-10; Hacker H, 2006, NATURE, V439, P204, DOI 10.1038/nature04369; Kar S, 2010, J LEUKOCYTE BIOL, V88, P9, DOI 10.1189/jlb.0909644; Karin M, 2009, IMMUNOL REV, V228, P225, DOI 10.1111/j.1600-065X.2008.00755.x; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Komander D, 2009, BIOCHEM SOC T, V37, P937, DOI 10.1042/BST0370937; Kropf P, 2004, INFECT IMMUN, V72, P1920, DOI 10.1128/IAI.72.4.1920-1928.2004; Kropf P, 2004, J LEUKOCYTE BIOL, V76, P48, DOI 10.1189/jlb.1003484; Lee J, 2000, J LEUKOCYTE BIOL, V68, P909; Lorick KL, 1999, P NATL ACAD SCI USA, V96, P11364, DOI 10.1073/pnas.96.20.11364; Matsuzawa A, 2008, SCIENCE, V321, P663, DOI 10.1126/science.1157340; Medzhitov R, 1998, MOL CELL, V2, P253, DOI 10.1016/S1097-2765(00)80136-7; Muraille E, 2003, J IMMUNOL, V170, P4237, DOI 10.4049/jimmunol.170.8.4237; MURRAY HW, 1993, J IMMUNOL, V151, P929; Oganesyan G, 2006, NATURE, V439, P208, DOI 10.1038/nature04374; Olivier M, 2005, CLIN MICROBIOL REV, V18, P293, DOI 10.1128/CMR.18.2.293-305.2005; Pei Y, 2006, NAT METHODS, V3, P670, DOI 10.1038/NMETH911; Ruhland A, 2007, CELL MICROBIOL, V9, P84, DOI 10.1111/j.1462-5822.2006.00769.x; Ruse M, 2006, IMMUNOL RES, V34, P33, DOI 10.1385/IR:34:1:33; Santhosh CV, 2008, BIOCHEM BIOPH RES CO, V371, P546, DOI 10.1016/j.bbrc.2008.04.106; Shembade N, 2010, SCIENCE, V327, P1135, DOI 10.1126/science.1182364; Shibolet O, 2007, AM J PHYSIOL-GASTR L, V292, pG1469, DOI 10.1152/ajpgi.00531.2006; Silverman JM, 2012, FRONT CELL INFECT MI, V1, DOI 10.3389/fcimb.2011.00026; Srivastav S, 2012, J IMMUNOL, V189, P924, DOI 10.4049/jimmunol.1102845; Sun SC, 2008, NAT REV IMMUNOL, V8, P501, DOI 10.1038/nri2337; Takaesu G, 2001, MOL CELL BIOL, V21, P2475, DOI 10.1128/MCB.21.7.2475-2484.2001; Tseng PH, 2010, NAT IMMUNOL, V11, P70, DOI 10.1038/ni.1819; Vallabhapurapu S, 2008, NAT IMMUNOL, V9, P1364, DOI 10.1038/ni.1678; Xu Y, 1996, IMMUNITY, V5, P407, DOI 10.1016/S1074-7613(00)80497-5	36	25	26	0	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2014	28	4					1756	1768		10.1096/fj.13-238428	http://dx.doi.org/10.1096/fj.13-238428			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AG3UC	24391131				2022-12-25	WOS:000335344300022
J	Alshalalfa, M; Bader, GD; Bismar, TA; Alhajj, R				Alshalalfa, Mohammed; Bader, Gary D.; Bismar, Tarek A.; Alhajj, Reda			Coordinate MicroRNA-Mediated Regulation of Protein Complexes in Prostate Cancer	PLOS ONE			English	Article							SINGULAR-VALUE DECOMPOSITION; EXPRESSION; NETWORK; RESOURCE; MIRNAS	MicroRNAs are a class of small non-coding regulatory RNA molecules that regulate mRNAs post-transcriptionally. Recent evidence has shown that miRNAs target entire functionally related proteins such as protein complexes and biological pathways. However, characterizing the influence of miRNAs on genes whose encoded proteins are part of protein complexes has not been studied in the context of disease. We propose an entropy-based framework to identify miRNA-mediated dysregulation of functionally related proteins during prostate cancer progression. The proposed framework uses experimentally verified miRNA-target interactions, functionally related proteins and expression data to identify miRNA-influenced protein complexes in prostate cancer, and identify genes that are dysregulated as a result. The framework constructs correlation matrixes between functionally related proteins and miRNAs that have targets in the complex, and assesses the changes in the Shannon entropy of the modules across different stages of prostate cancer. Results reveal that SMAD4 and HDAC containing protein complexes are highly affected and disrupted by miRNAs, particularly miRNA-1 and miRNA-16. Using biological pathways to define functionally related proteins reveals that NF-kB-, RAS-, and Syndecan-mediated pathways are dysregulated due to miRNA-1- and miRNA-16-mediated regulation. These results suggest that miRNA-1 and miRNA-16 are important master regulators of miRNA-mediated regulation in prostate cancer. Moreover, results reveal that miRNAs with high-influence on the disrupted protein complexes are diagnostic and prognostic biomarker candidates for prostate cancer progression. The observation of miRNA-mediated protein complex regulation and miRNA-mediated pathway regulation, with partial experimental verification from previous studies, demonstrates that our framework is a promising approach for the identification of novel miRNAs and protein complexes related to disease progression.	[Alshalalfa, Mohammed; Alhajj, Reda] Univ Calgary, Dept Comp Sci, Calgary, AB T2N 1N4, Canada; [Bader, Gary D.] Univ Toronto, Donnelly Ctr, Toronto, ON, Canada; [Bader, Gary D.] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [Bismar, Tarek A.] Univ Calgary, Dept Pathol, Fac Med, Calgary, AB, Canada; [Bismar, Tarek A.] Univ Calgary, Dept Oncol, Fac Med, Calgary, AB, Canada; [Bismar, Tarek A.] Univ Calgary, Dept Mol Biol & Biochem, Fac Med, Calgary, AB, Canada; [Alshalalfa, Mohammed] Palestine Polytech Univ, Biotechnol Res Ctr, Hebron, Israel	University of Calgary; University of Toronto; University of Toronto; University of Calgary; University of Calgary; University of Calgary	Alshalalfa, M (corresponding author), Univ Calgary, Dept Comp Sci, Calgary, AB T2N 1N4, Canada.	mohamed.alshalalfa@gmail.com	Bismar, Tarek/ABH-6129-2020; Bader, Gary/C-1176-2009	Bader, Gary/0000-0003-0185-8861	NRNB (U.S. National Institutes of Health, National Center for Research Resources) [P41 GM103504]; NSERC; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103504] Funding Source: NIH RePORTER	NRNB (U.S. National Institutes of Health, National Center for Research Resources); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NRNB (U.S. National Institutes of Health, National Center for Research Resources grant number P41 GM103504). This work was funded by NSERC scholarship for Phd students. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas A, 2008, EPIGENETICS-US, V3, P300, DOI 10.4161/epi.3.6.7273; Alter O, 2000, P NATL ACAD SCI USA, V97, P10101, DOI 10.1073/pnas.97.18.10101; Bin Goh WW, 2012, BIOINFORMATICS, V28, P453, DOI 10.1093/bioinformatics/btr693; Blower PE, 2007, MOL CANCER THER, V6, P1483, DOI 10.1158/1535-7163.MCT-07-0009; Brase JC, 2011, INT J CANCER, V128, P608, DOI 10.1002/ijc.25376; Chen JL, 2012, CLIN CANCER RES, V18, P4291, DOI 10.1158/1078-0432.CCR-12-0373; Ding ZH, 2011, NATURE, V470, P269, DOI 10.1038/nature09677; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Hsu CW, 2008, PROTEOMICS, V8, P1975, DOI 10.1002/pmic.200701004; Hsu SD, 2011, NUCLEIC ACIDS RES, V39, pD163, DOI 10.1093/nar/gkq1107; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang J. C., 2009, NATURE METHODS, V4, P1045; Hudson R, 2011, NUCLEIC ACIDS RES, P1; Kiviniemi J, 2004, APMIS, V112, P89, DOI 10.1111/j.1600-0463.2004.apm1120202.x; Liang H, 2007, RNA, V13, P1402, DOI 10.1261/rna.634607; Lin KT, 2012, CLIN CANCER RES, V18, P4691, DOI 10.1158/1078-0432.CCR-12-0633; Martens-Uzunova ES, 2012, ONCOGENE, V31, P978, DOI 10.1038/onc.2011.304; Merico D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013984; MOON YI, 1995, PHYS REV E, V52, P2318, DOI 10.1103/PhysRevE.52.2318; Ozen M, 2008, ONCOGENE, V27, P1788, DOI 10.1038/sj.onc.1210809; Pang YX, 2010, ACTA BIOCH BIOPH SIN, V42, P363, DOI 10.1093/abbs/gmq038; Pawitan Y, 2005, BREAST CANCER RES, V7, pR953, DOI 10.1186/bcr1325; Porkka KP, 2007, CANCER RES, V67, P6130, DOI 10.1158/0008-5472.CAN-07-0533; Priness I, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-111; Ringner M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017911; Ruepp A, 2008, NUCLEIC ACIDS RES, V36, pD646, DOI 10.1093/nar/gkm936; Sass S, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-136; Sboner A, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-8; Schaefer A, 2010, INT J CANCER, V126, P1166, DOI 10.1002/ijc.24827; Schmeier S, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-183; Srivastava Anvesha, 2011, Mol Cell Pharmacol, V3, P115; Sualp M, 2011, BIOSYSTEMS, V105, P201, DOI 10.1016/j.biosystems.2011.04.002; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sumazin P, 2011, CELL, V147, P370, DOI 10.1016/j.cell.2011.09.041; Trang P, 2008, Oncogene, V27 Suppl 2, pS52, DOI 10.1038/onc.2009.353; Varambally S, 2005, CANCER CELL, V8, P393, DOI 10.1016/j.ccr.2005.10.001; Varshavsky R, 2006, BIOINFORMATICS, V22, pE507, DOI 10.1093/bioinformatics/btl214; Wach S, 2012, INT J CANCER, V130, P611, DOI 10.1002/ijc.26064; Xiao FF, 2009, NUCLEIC ACIDS RES, V37, pD105, DOI 10.1093/nar/gkn851; Xu J, 2011, MOL CANCER THER, V10, P1857, DOI 10.1158/1535-7163.MCT-11-0055; Yang G, 2010, INT J BIOL SCI, V6, P1; Yu YP, 2004, J CLIN ONCOL, V22, P2790, DOI 10.1200/JCO.2004.05.158; Zhang BH, 2007, DEV BIOL, V302, P1, DOI 10.1016/j.ydbio.2006.08.028; Zhang LY, 2009, AM J PATHOL, V175, P489, DOI 10.2353/ajpath.2009.080727; Zhang WS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040130; Zhang WS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-338	47	7	7	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84261	10.1371/journal.pone.0084261	http://dx.doi.org/10.1371/journal.pone.0084261			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391925	Green Published, gold			2022-12-25	WOS:000329323900068
J	Bertille, N; Fournier-Charriere, E; Pons, G; Chalumeau, M				Bertille, Nathalie; Fournier-Charriere, Elisabeth; Pons, Gerard; Chalumeau, Martin			Managing Fever in Children: A National Survey of Parents' Knowledge and Practices in France	PLOS ONE			English	Article							CROSS-SECTIONAL SURVEY; CHILDHOOD FEVER; FEBRILE CHILDREN; MANAGEMENT; MOTHERS; CARE; PERCEPTIONS; ATTITUDES; BELIEFS	Introduction: Identifying targets to improve parental practices for managing fever in children is the first step to reducing the overloaded healthcare system related to this common symptom. We aimed to study parents' knowledge and practices and their determinants in managing fever symptoms in children in France as compared with current recommendations. Methods: We conducted an observational national study between 2007 and 2008 of French general practitioners, primary care pediatricians and pharmacists. These healthcare professionals (HPs) were asked to include 5 consecutive patients from 1 month to 12 years old with fever for up to 48 hr who were accompanied by a family member. Parents completed a questionnaire about their knowledge of fever in children and their attitudes about the current fever episode. We used a multilevel logistic regression model to assess the joint effects of patient- and HP-level variables. Results: In all, 1,534 HPs (participation rate 13%) included 6,596 children. Parental concordance with current recommendations for temperature measurement methods, the threshold for defining fever, and physical (oral hydration, undressing, room temperature) and drug treatment was 89%, 61%, 15%, and 23%, respectively. Multivariate multi-level analyses revealed a significant HP effect. In general, high concordance with recommendations was associated with high educational level of parents and the HP consulted being a pediatrician. Conclusions: In France, parents' knowledge and practices related to managing fever symptoms in children frequently differ from recommendations. Targeted health education interventions are needed to effectively manage fever symptoms in children.	[Bertille, Nathalie; Chalumeau, Martin] INSERM, U953, Epidemiol Res Unit Perinatal Hlth & Womens & Chil, Paris, France; [Bertille, Nathalie; Pons, Gerard; Chalumeau, Martin] Paris Descartes Univ, Paris, France; [Bertille, Nathalie; Chalumeau, Martin] Hop Necker Enfants Malad, AP HP, Dept Paediat, Paris, France; [Fournier-Charriere, Elisabeth] Hop Bicetre, AP HP, Pain Unit, Le Kremlin Bicetre, France; [Pons, Gerard] Grp Hosp Cochin Broca Hotel Dieu, AP HP, Paris, France; [Pons, Gerard] INSERM, Pediat Epilepsies & Brain Plast U663, Paris, Bicetre, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm)	Chalumeau, M (corresponding author), INSERM, U953, Epidemiol Res Unit Perinatal Hlth & Womens & Chil, Paris, France.	martin.chalumeau@nck.aphp.fr	Chalumeau, Martin/F-4293-2017	Chalumeau, Martin/0000-0001-8175-3706; Bertille, Nathalie/0000-0001-7159-2646	Laboratoires Guigoz - Societe Francaise de Pediatrie - Groupe de Pediatrie Generale - Groupe de Recherches Epidemiologiques en Pediatrie; Sanofi Aventis	Laboratoires Guigoz - Societe Francaise de Pediatrie - Groupe de Pediatrie Generale - Groupe de Recherches Epidemiologiques en Pediatrie; Sanofi Aventis(Sanofi-Aventis)	NB is supported by an educational grant from Laboratoires Guigoz - Societe Francaise de Pediatrie - Groupe de Pediatrie Generale - Groupe de Recherches Epidemiologiques en Pediatrie. The work was also funded by Sanofi Aventis. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agence nationale de securite du medicament et des produits de sante, 2005, INF TRAIT FIEVR CHEZ; Al-Eissa YA, 2000, ANN SAUDI MED, V20, P202, DOI 10.5144/0256-4947.2000.202; American Academy of Pediatrics, 2002, FEV MAK YOUR CHILD C; BELIN J, 1992, ANN PEDIATR-PARIS, V39, P588; Bilenko N, 2006, CLIN THER, V28, P783, DOI 10.1016/j.clinthera.2006.05.010; Blondel B, 2006, J Gynecol Obstet Biol Reprod (Paris), V35, P373; Blumenthal I, 1998, FAM PRACT, V15, P513, DOI 10.1093/fampra/15.6.513; Bocquet A, 2005, ARCH PEDIATRIE, V12, P1688, DOI 10.1016/j.arcped.2005.06.014; Boivin JM, 2007, ARCH PEDIATRIE, V14, P322, DOI 10.1016/j.arcped.2006.12.018; Cegedim Group, 2012, HEALTHC PROF DAT; Charkaluk ML, 2005, ARCH PEDIATRIE, V12, P1209, DOI 10.1016/j.arcped.2005.02.024; Chiappini E, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-97; Chiappini E, 2012, CLIN THER, V34, P1648, DOI 10.1016/j.clinthera.2012.06.011; Chiappini E, 2009, CLIN THER, V31, P1826, DOI 10.1016/j.clinthera.2009.08.006; Cohee LMS, 2010, CLIN PEDIATR, V49, P221, DOI 10.1177/0009922809336209; Community Paediatrics Committee, 2008, FEV TEMP TAK; Crocetti M, 2001, PEDIATRICS, V107, P1241, DOI 10.1542/peds.107.6.1241; Enarson MC, 2012, PEDIATRICS, V130, pE905, DOI 10.1542/peds.2011-2140; Grass L, 2005, REV PRAT MED GEN, V686-87, P381; Impicciatore P, 1998, PREV MED, V27, P268, DOI 10.1006/pmed.1998.0262; Karwowska Anna, 2002, CJEM, V4, P394; Langer T, 2011, BMC PEDIATR, V11, DOI 10.1186/1471-2431-11-41; Launay E, 2010, PEDIATR CRIT CARE ME, V11, P469, DOI 10.1097/PCC.0b013e3181ce752e; Matziou V, 2008, INT J NURS STUD, V45, P829, DOI 10.1016/j.ijnurstu.2006.04.021; *NAT I HLTH CLIN E, 2007, FEV ILLN CHILDR ASS; Nijman RG, 2010, PEDIATR EMERG CARE, V26, P339, DOI 10.1097/PEC.0b013e3181db1dce; Paula JS, 2012, HEALTH QUAL LIFE OUT, V10, DOI 10.1186/1477-7525-10-6; Pruvost I, 2012, ARCH PEDIATRIE, V19, P248, DOI 10.1016/j.arcped.2011.12.013; Stagnara J, 2005, PRESSE MED, V34, P1129, DOI 10.1016/S0755-4982(05)84136-3; Stagnara J, 2004, ARCH PEDIATRIE, V11, P108, DOI 10.1016/j.arcped.2003.11.006; Taveras EM, 2004, PEDIATR EMERG CARE, V20, P579, DOI 10.1097/01.pec.0000139739.46591.dd; Walsh A, 2008, J ADV NURS, V63, P376, DOI 10.1111/j.1365-2648.2008.04721.x	32	36	38	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83469	10.1371/journal.pone.0083469	http://dx.doi.org/10.1371/journal.pone.0083469			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391772	gold, Green Submitted, Green Published			2022-12-25	WOS:000329325200069
J	Jager, M; Dayraud, C; Mialot, A; Queinnec, E; le Guyader, H; Manuel, M				Jager, Muriel; Dayraud, Cyrielle; Mialot, Antoine; Queinnec, Eric; le Guyader, Herve; Manuel, Michael			Evidence for Involvement of Wnt Signalling in Body Polarities, Cell Proliferation, and the Neuro-Sensory System in an Adult Ctenophore	PLOS ONE			English	Article							SYNTHASE KINASE 3; STEM-CELLS; MNEMIOPSIS-LEIDYI; SELF-RENEWAL; AMPHIMEDON-QUEENSLANDICA; HOMEOBOX GENES; EVOLUTION; EXPRESSION; PATHWAY; CATENIN	Signalling through the Wnt family of secreted proteins originated in a common metazoan ancestor and greatly influenced the evolution of animal body plans. In bilaterians, Wnt signalling plays multiple fundamental roles during embryonic development and in adult tissues, notably in axial patterning, neural development and stem cell regulation. Studies in various cnidarian species have particularly highlighted the evolutionarily conserved role of the Wnt/b-catenin pathway in specification and patterning of the primary embryonic axis. However in another key non-bilaterian phylum, Ctenophora, Wnts are not involved in early establishment of the body axis during embryogenesis. We analysed the expression in the adult of the ctenophore Pleurobrachia pileus of 11 orthologues of Wnt signalling genes including all ctenophore Wnt ligands and Fz receptors and several members of the intracellular b-catenin pathway machinery. All genes are strongly expressed around the mouth margin at the oral pole, evoking the Wnt oral centre of cnidarians. This observation is consistent with primary axis polarisation by the Wnts being a universal metazoan feature, secondarily lost in ctenophores during early development but retained in the adult. In addition, local expression of Wnt signalling genes was seen in various anatomical structures of the body including in the locomotory comb rows, where their complex deployment suggests control by the Wnts of local comb polarity. Other important contexts of Wnt involvement which probably evolved before the ctenophore/ cnidarian/bilaterian split include proliferating stem cells and progenitors irrespective of cell types, and developing as well as differentiated neuro-sensory structures.	[Jager, Muriel; Dayraud, Cyrielle; Mialot, Antoine; Queinnec, Eric; le Guyader, Herve; Manuel, Michael] Univ Paris 06, CNRS, UMR 7138, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite	Manuel, M (corresponding author), Univ Paris 06, CNRS, UMR 7138, Paris, France.	michael.manuel@snv.jussieu.fr			"Agence Nationale de la Recherche'' ANR [ANR-09-BLAN-0236 DiploDevo]; Institut Universitaire de France (IUF)	"Agence Nationale de la Recherche'' ANR(French National Research Agency (ANR)); Institut Universitaire de France (IUF)	This work was supported by grants from the "Agence Nationale de la Recherche'' ANR "programme blanc'' ANR-09-BLAN-0236 DiploDevo and from the Institut Universitaire de France (IUF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamska M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001031; Adamska M, 2011, ZOOLOGY, V114, P1, DOI 10.1016/j.zool.2010.10.003; Adamska M, 2010, EVOL DEV, V12, P494, DOI 10.1111/j.1525-142X.2010.00435.x; Alie A, 2011, DEV BIOL, V350, P183, DOI 10.1016/j.ydbio.2010.10.019; Augustin R, 2006, DEV BIOL, V296, P62, DOI 10.1016/j.ydbio.2006.04.003; Bode HR, 2012, INT J DEV BIOL, V56, P473, DOI 10.1387/ijdb.113448hb; Chang CH, 2004, MECH DEVELOP, V121, P157, DOI 10.1016/j.mod.2003.12.004; Chenn A, 2002, SCIENCE, V297, P365, DOI 10.1126/science.1074192; Cho SJ, 2010, MOL BIOL EVOL, V27, P1645, DOI 10.1093/molbev/msq052; Dayraud C, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-107; Demilly A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2915; Denker E, 2008, DEV BIOL, V315, P99, DOI 10.1016/j.ydbio.2007.12.023; Deves M, 2012, SEMIN CELL DEV BIOL, V23, P290, DOI 10.1016/j.semcdb.2012.03.003; Dunn CW, 2008, NATURE, V452, P745, DOI 10.1038/nature06614; Galliot B, 2010, TRENDS CELL BIOL, V20, P514, DOI 10.1016/j.tcb.2010.05.006; Gee L, 2010, DEV BIOL, V340, P116, DOI 10.1016/j.ydbio.2009.12.036; Gilbert S.F., 2010, DEV BIOL; Guder C, 2006, ONCOGENE, V25, P7450, DOI 10.1038/sj.onc.1210052; Hejnol A, 2009, P ROY SOC B-BIOL SCI, V276, P4261, DOI 10.1098/rspb.2009.0896; Hemmrich G, 2012, MOL BIOL EVOL, V29, P3267, DOI 10.1093/molbev/mss134; Hernandez-Nicaise M.-L., 1991, P359; Hernandez-Nicaise ML, 1994, TRAITE ZOOL, P943; Holstein Thomas W., 2008, V469, P47, DOI 10.1007/978-1-60327-469-5; Jager M, 2011, J EXP ZOOL PART B, V316B, P171, DOI 10.1002/jez.b.21386; Jager M, 2008, J EXP ZOOL PART B, V310B, P650, DOI 10.1002/jez.b.21244; Khalturin K, 2007, DEV BIOL, V309, P32, DOI 10.1016/j.ydbio.2007.06.013; Kuhl SJ, 2013, BBA-GEN SUBJECTS, V1830, P2297, DOI 10.1016/j.bbagen.2012.08.010; Kusserow A, 2005, NATURE, V433, P156, DOI 10.1038/nature03158; Lapebie P, 2011, BIOESSAYS, V33, P759, DOI 10.1002/bies.201100023; Le Dreau G, 2012, DEV NEUROBIOL, V72, P1471, DOI 10.1002/dneu.22015; Lee PN, 2006, SEMIN CELL DEV BIOL, V17, P157, DOI 10.1016/j.semcdb.2006.05.002; Liu F, 2008, DEV BIOL, V313, P210, DOI 10.1016/j.ydbio.2007.10.016; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Manuel M, 2009, CR BIOL, V332, P184, DOI 10.1016/j.crvi.2008.07.009; Marlow H, 2013, DEV BIOL, V380, P324, DOI 10.1016/j.ydbio.2013.05.022; Martin BL, 2009, CURR BIOL, V19, pR215, DOI 10.1016/j.cub.2009.01.052; Martindale Mark Q., 1997, P87; Momose T, 2008, DEVELOPMENT, V135, P2105, DOI 10.1242/dev.021543; Momose T, 2007, PLOS BIOL, V5, P889, DOI 10.1371/journal.pbio.0050070; Mulligan KA, 2012, J NEUROIMMUNE PHARM, V7, P774, DOI 10.1007/s11481-012-9404-x; Niehrs C, 2010, DEVELOPMENT, V137, P845, DOI 10.1242/dev.039651; Oliva CA, 2013, AGEING RES REV; Otto A, 2008, J CELL SCI, V121, P2939, DOI 10.1242/jcs.026534; Pang K, 2008, DEV GENES EVOL, V218, P307, DOI 10.1007/s00427-008-0222-3; Pang K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024152; Pang K, 2010, EVODEVO, V1, DOI 10.1186/2041-9139-1-10; Pang K, 2008, CURR BIOL, V18, pR1119, DOI 10.1016/j.cub.2008.10.004; Petersen CP, 2009, CELL, V139, P1056, DOI 10.1016/j.cell.2009.11.035; Philippe H, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000602; Philippe H, 2009, CURR BIOL, V19, P706, DOI 10.1016/j.cub.2009.02.052; Pick KS, 2010, MOL BIOL EVOL, V27, P1983, DOI 10.1093/molbev/msq089; Plickert G, 2006, DEV BIOL, V298, P368, DOI 10.1016/j.ydbio.2006.06.043; Rayasam GV, 2009, BRIT J PHARMACOL, V156, P885, DOI 10.1111/j.1476-5381.2008.00085.x; Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Rottinger E, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003164; Ryan JF, 2010, EVODEVO, V1, DOI 10.1186/2041-9139-1-9; Schierwater B, 2009, PLOS BIOL, V7, P36, DOI 10.1371/journal.pbio.1000020; Schnitzler CE, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-107; Simmons DK, 2012, EVODEVO, V3, DOI 10.1186/2041-9139-3-2; Slavik MA, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-9; Sokol SY, 2011, DEVELOPMENT, V138, P4341, DOI 10.1242/dev.066209; Srivastava M, 2010, NATURE, V466, P720, DOI 10.1038/nature09201; Sun T, 2009, DEV GROWTH DIFFER, V51, P735, DOI 10.1111/j.1440-169X.2009.01141.x; Tamm S.L., 1982, P266; Tamm SL, 2012, J MORPHOL, V273, P109, DOI 10.1002/jmor.11016; TAMM SL, 1973, J EXP BIOL, V59, P231; Valenta T, 2012, EMBO J, V31, P2714, DOI 10.1038/emboj.2012.150; Wikramanayake AH, 2003, NATURE, V426, P446, DOI 10.1038/nature02113; Zeng YA, 2010, CELL STEM CELL, V6, P568, DOI 10.1016/j.stem.2010.03.020	70	38	39	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84363	10.1371/journal.pone.0084363	http://dx.doi.org/10.1371/journal.pone.0084363			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391946	Green Published, gold, Green Submitted			2022-12-25	WOS:000329323900089
J	Napuri, J; Pilakka-Kanthikeel, S; Raymond, A; Agudelo, M; Yndart-Arias, A; Saxena, SK; Nair, M				Napuri, Jessica; Pilakka-Kanthikeel, Sudheesh; Raymond, Andrea; Agudelo, Marisela; Yndart-Arias, Adriana; Saxena, Shailendra K.; Nair, Madhavan			Cocaine Enhances HIV-1 Infectivity in Monocyte Derived Dendritic Cells by Suppressing microRNA-155	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; BLOOD-BRAIN-BARRIER; TRANSCRIPTION FACTOR PU.1; DC-SIGN; T-CELLS; GENE-EXPRESSION; GM-CSF; REPLICATION; LYMPHOCYTES; IDENTIFICATION	Cocaine and other drugs of abuse increase HIV-induced immunopathogenesis; and neurobiological mechanisms of cocaine addiction implicate a key role for microRNAs (miRNAs), single-stranded non-coding RNAs that regulate gene expression and defend against viruses. In fact, HIV defends against miRNAs by actively suppressing the expression of polycistronic miRNA cluster miRNA-17/92, which encodes miRNAs including miR-20a. IFN-g production by natural killer cells is regulated by miR-155 and this miRNA is also critical to dendritic cell (DC) maturation. However, the impact of cocaine on miR-155 expression and subsequent HIV replication is unknown. We examined the impact of cocaine on two miRNAs, miR-20a and miR-155, which are integral to HIV replication, and immune activation. Using miRNA isolation and analysis, RNA interference, quantitative real time PCR, and reporter assays we explored the effects of cocaine on miR-155 and miR-20 in the context of HIV infection. Here we demonstrate using monocyte-derived dendritic cells (MDCCs) that cocaine significantly inhibited miR-155 and miR-20a expression in a dose dependent manner. Cocaine and HIV synergized to lower miR-155 and miR-20a in MDDCs by 90%. Cocaine treatment elevated LTR-mediated transcription and PU.1 levels in MDCCs. But in context of HIV infection, PU.1 was reduced in MDDCs regardless of cocaine presence. Cocaine increased DC-SIGN and and decreased CD83 expression in MDDC, respectively. Overall, we show that cocaine inhibited miR-155 and prevented maturation of MDDCs; potentially, resulting in increased susceptibility to HIV-1. Our findings could lead to the development of novel miRNA-based therapeutic strategies targeting HIV infected cocaine abusers.	[Napuri, Jessica; Pilakka-Kanthikeel, Sudheesh; Raymond, Andrea; Agudelo, Marisela; Yndart-Arias, Adriana; Nair, Madhavan] Florida Int Univ, Dept Immunol, Herbert Wertheim Coll Med, Miami, FL 33199 USA; [Pilakka-Kanthikeel, Sudheesh; Raymond, Andrea; Agudelo, Marisela; Yndart-Arias, Adriana; Nair, Madhavan] Florida Int Univ, Inst NeuroImmune Pharmacol, Herbert Wertheim Coll Med, Miami, FL 33199 USA; [Pilakka-Kanthikeel, Sudheesh; Yndart-Arias, Adriana; Nair, Madhavan] Florida Int Univ, Ctr Personalized Nanomed, Herbert Wertheim Coll Med, Miami, FL 33199 USA; [Saxena, Shailendra K.] CSIR Ctr Cellular & Mol Biol, Hyderabad, Andhra Pradesh, India	State University System of Florida; Florida International University; State University System of Florida; Florida International University; State University System of Florida; Florida International University; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB)	Nair, M (corresponding author), Florida Int Univ, Dept Immunol, Herbert Wertheim Coll Med, Miami, FL 33199 USA.	nairm@fiu.edu	Saxena, Shailendra K/ABK-6489-2022; Saxena, Shailendra K/X-4252-2019	Saxena, Shailendra K/0000-0003-2856-4185; Saxena, Shailendra K/0000-0003-2856-4185	National Institute of Drug Abuse [R37-DA025576]; NATIONAL INSTITUTE ON DRUG ABUSE [R37DA025576] Funding Source: NIH RePORTER	National Institute of Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by grant from National Institute of Drug Abuse (R37-DA025576). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson KL, 2000, J IMMUNOL, V164, P1855, DOI 10.4049/jimmunol.164.4.1855; CURTIS BM, 1992, P NATL ACAD SCI USA, V89, P8356, DOI 10.1073/pnas.89.17.8356; Dakic A, 2007, TRENDS IMMUNOL, V28, P108, DOI 10.1016/j.it.2007.01.006; Dominguez-Soto A, 2005, J BIOL CHEM, V280, P33123, DOI 10.1074/jbc.M503401200; Dunand-Sauthier I, 2011, BLOOD, V117, P4490, DOI 10.1182/blood-2010-09-308064; Engering A, 2002, J IMMUNOL, V168, P2118, DOI 10.4049/jimmunol.168.5.2118; Fiala AM, 1996, ADV EXP MED BIOL, V402, P145; Fiala M, 2005, J NEUROVIROL, V11, P281, DOI 10.1080/13550280590952835; Fiala M, 1998, ADV EXP MED BIOL, V437, P199; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Fisher RC, 1998, STEM CELLS, V16, P25, DOI 10.1002/stem.160025; Ganesh L, 2004, J VIROL, V78, P11980, DOI 10.1128/JVI.78.21.11980-11987.2004; Geijtenbeek TBH, 2003, CURR TOP MICROBIOL, V276, P31; Geijtenbeek TBH, 2000, CELL, V100, P587, DOI 10.1016/S0092-8674(00)80694-7; Geijtenbeek TBH, 2000, CELL, V100, P575, DOI 10.1016/S0092-8674(00)80693-5; Geiss GK, 2000, VIROLOGY, V266, P8, DOI 10.1006/viro.1999.0044; Guerriero A, 2000, BLOOD, V95, P879, DOI 10.1182/blood.V95.3.879.003k13_879_885; Hart DNJ, 1997, BLOOD, V90, P3245, DOI 10.1182/blood.V90.9.3245; Hollander JA, 2010, NATURE, V466, P197, DOI 10.1038/nature09202; Huang JL, 2007, NAT MED, V13, P1241, DOI 10.1038/nm1639; Kiertscher SM, 1996, J LEUKOCYTE BIOL, V59, P208, DOI 10.1002/jlb.59.2.208; Kim YT, 2003, AM J REPROD IMMUNOL, V49, P230, DOI 10.1034/j.1600-0897.2003.01200.x; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; LANGHOFF E, 1991, P NATL ACAD SCI USA, V88, P7998, DOI 10.1073/pnas.88.18.7998; LARRAT EP, 1993, J PSYCHOACTIVE DRUGS, V25, P207, DOI 10.1080/02791072.1993.10472272; Lee CL, 2009, J BIOL CHEM, V284, P15084, DOI 10.1074/jbc.M807960200; Leng RX, 2011, CYTOKINE GROWTH F R, V22, P141, DOI 10.1016/j.cytogfr.2011.05.002; Lodie TA, 1998, J IMMUNOL, V161, P268; MARTINEZ F, 1990, LIFE SCI, V47, pPL59, DOI 10.1016/0024-3205(90)90205-6; Martinez-Nunez RT, 2011, J BIOL CHEM, V286, P1786, DOI 10.1074/jbc.M110.169367; Martinez-Nunez RT, 2009, J BIOL CHEM, V284, P16334, DOI 10.1074/jbc.M109.011601; Nair MPN, 2005, J IMMUNOL, V174, P6617, DOI 10.4049/jimmunol.174.11.6617; Nair MPN, 2004, J NEUROIMMUNOL, V157, P56, DOI 10.1016/j.jneuroim.2004.08.040; Nath A, 2002, JAIDS-J ACQ IMM DEF, V31, pS62, DOI 10.1097/00126334-200210012-00006; Nishiyama C, 2004, FEBS LETT, V561, P63, DOI 10.1016/S0014-5793(04)00116-4; POPE M, 1994, CELL, V78, P389, DOI 10.1016/0092-8674(94)90418-9; Roth MD, 2002, J INFECT DIS, V185, P701, DOI 10.1086/339012; Ryo A, 2000, AIDS RES HUM RETROV, V16, P995, DOI 10.1089/08892220050058416; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Schmidtmayerova H, 1998, J VIROL, V72, P4633, DOI 10.1128/JVI.72.6.4633-4642.1998; Schratt GM, 2006, NATURE, V439, P283, DOI 10.1038/nature04367; Swaminathan G, PLOS PATHOG, V8; Tenen DG, 1997, BLOOD, V90, P489, DOI 10.1182/blood.V90.2.489.489_489_519; Triboulet R, 2007, SCIENCE, V315, P1579, DOI 10.1126/science.1136319; Turkistany SA, 2011, ARCH IMMUNOL THER EX, V59, P431, DOI 10.1007/s00005-011-0147-9; Turner ML, 2011, J IMMUNOL, V187, P3911, DOI 10.4049/jimmunol.1101137; Vahey MT, 2002, AIDS RES HUM RETROV, V18, P179, DOI 10.1089/08892220252781239; Wu L, 2006, NAT REV IMMUNOL, V6, P859, DOI 10.1038/nri1960; Yao HH, 2011, BLOOD, V117, P2538, DOI 10.1182/blood-2010-10-313593; Yeung ML, 2005, CELL RES, V15, P935, DOI 10.1038/sj.cr.7290371; Zhang L, 1998, J NEUROVIROL, V4, P619, DOI 10.3109/13550289809114228	51	36	38	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83682	10.1371/journal.pone.0083682	http://dx.doi.org/10.1371/journal.pone.0083682			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391808	Green Published, gold, Green Submitted			2022-12-25	WOS:000329325200106
J	Nedrud, JG; Bagheri, N; Schon, K; Xin, W; Bergroth, H; Eliasson, DG; Lycke, NY				Nedrud, John G.; Bagheri, Nayer; Schon, Karin; Xin, Wei; Bergroth, Hilda; Eliasson, Dubravka Grdic; Lycke, Nils Y.			Subcomponent Vaccine Based on CTA1-DD Adjuvant with Incorporated UreB Class II Peptides Stimulates Protective Helicobacter pylori Immunity	PLOS ONE			English	Article							HEAT-LABILE ENTEROTOXIN; UREASE-B-SUBUNIT; CHOLERA-TOXIN; MUCOSAL IMMUNIZATION; ORAL IMMUNIZATION; INDUCED REDUCTION; BALB/C MICE; MOUSE MODEL; INFECTION; IDENTIFICATION	A mucosal vaccine against Helicobacter pylori infection could help prevent gastric cancers and peptic ulcers. While previous attempts to develop such a vaccine have largely failed because of the requirement for safe and effective adjuvants or large amounts of well defined antigens, we have taken a unique approach to combining our strong mucosal CTA1-DD adjuvant with selected peptides from urease B (UreB). The protective efficacy of the selected peptides together with cholera toxin (CT) was first confirmed. However, CT is a strong adjuvant that unfortunately is precluded from clinical use because of its toxicity. To circumvent this problem we have developed a derivative of CT, the CTA1-DD adjuvant, that has been found safe in non-human primates and equally effective compared to CT when used intranasally. We genetically fused the selected peptides into the CTA1-DD plasmid and found after intranasal immunizations of Balb/c mice using purified CTA1-DD with 3 copies of an H. pylori urease T cell epitope (CTA1-UreB3T-DD) that significant protection was stimulated against a live challenge infection. Protection was, however, weaker than with the gold standard, bacterial lysate+CT, but considering that we only used a single epitope in nanomolar amounts the results convey optimism. Protection was associated with enhanced Th1 and Th17 immunity, but immunizations in IL-17A-deficient mice revealed that IL-17 may not be essential for protection. Taken together, we have provided evidence for the rational design of an effective mucosal subcomponent vaccine against H. pylori infection based on well selected protective epitopes from relevant antigens incorporated into the CTA1-DD adjuvant platform.	[Nedrud, John G.; Bagheri, Nayer; Xin, Wei] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA; [Schon, Karin; Bergroth, Hilda; Eliasson, Dubravka Grdic; Lycke, Nils Y.] Univ Gothenburg, Mucosal Immunobiol & Vaccine Res Ctr MIVAC, Gothenburg, Sweden; [Schon, Karin; Bergroth, Hilda; Eliasson, Dubravka Grdic; Lycke, Nils Y.] Univ Gothenburg, Inst Biomed, Dept Microbiolgy & Immunol, Gothenburg, Sweden	Case Western Reserve University; University of Gothenburg; University of Gothenburg	Lycke, NY (corresponding author), Univ Gothenburg, Mucosal Immunobiol & Vaccine Res Ctr MIVAC, Gothenburg, Sweden.	nils.lycke@microbio.gu.se			US National Institutes of Health [AI 083694]; Swedish Research Council; Swedish Cancer Foundation [4992-B10 06-03XCC]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI083694] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by US National Institutes of Health grant AI 083694 to JGN and NYL and Swedish Research Council, the Swedish Cancer Foundation grant 4992-B10 06-03XCC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agren LC, 1999, J IMMUNOL, V162, P2432; Agren LC, 1997, J IMMUNOL, V158, P3936; Akhiani AA, 2006, SCAND J IMMUNOL, V63, P97, DOI 10.1111/j.1365-3083.2005.01713.x; Akhiani AA, 2004, J IMMUNOL, V172, P5024, DOI 10.4049/jimmunol.172.8.5024; Blanchard TG, 2010, ADV M C M, P167, DOI 10.1079/9781845935948.0167; Blanchard TG, 1999, CELL IMMUNOL, V191, P74, DOI 10.1006/cimm.1998.1421; Blanchard TG, 2012, CURRENT PROTOCOLS MI, V24; CORTHESYTHEULAZ I, 1995, GASTROENTEROLOGY, V109, P115, DOI 10.1016/0016-5085(95)90275-9; Czinn SJ, 2011, NAT REV GASTRO HEPAT, V8, P133, DOI 10.1038/nrgastro.2011.1; DeLyria ES, 2011, HELICOBACTER, V16, P169, DOI 10.1111/j.1523-5378.2011.00839.x; Delyria ES, 2009, GASTROENTEROLOGY, V136, P247, DOI 10.1053/j.gastro.2008.09.017; Ding H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069384; Eliasson DG, 2008, VACCINE, V26, P1243, DOI 10.1016/j.vaccine.2007.12.027; Eliasson DG, 2011, VACCINE, V29, P3951, DOI 10.1016/j.vaccine.2011.03.090; Eriksson AM, 2004, J IMMUNOL, V173, P3310, DOI 10.4049/jimmunol.173.5.3310; Ermak TH, 1998, 3 INT WORKSH PATH HO; Every AL, 2013, TRENDS MICROBIOL; Flach CF, 2011, VACCINE, V29, P1235, DOI 10.1016/j.vaccine.2010.11.088; Flach CF, 2011, INFECT IMMUN, V79, P879, DOI 10.1128/IAI.00756-10; Garhart CA, 2003, INFECT IMMUN, V71, P910, DOI 10.1128/IAI.71.2.910-921.2003; Garhart CA, 2002, INFECT IMMUN, V70, P3529, DOI 10.1128/IAI.70.7.3529-3538.2002; Gomez-Duarte OG, 1998, VACCINE, V16, P460, DOI 10.1016/S0264-410X(97)00247-8; Hirota K, 2001, INFECT IMMUN, V69, P6597, DOI 10.1128/IAI.69.11.6597-6603.2001; Lee A, 1997, GASTROENTEROLOGY, V112, P1386, DOI 10.1016/S0016-5085(97)70155-0; Lycke N, 2010, MUCOSAL IMMUNOL; Malfertheiner P, 2008, GASTROENTEROLOGY, V135, P787, DOI 10.1053/j.gastro.2008.05.054; Malfertheiner P, 2012, GUT, V61, P646, DOI 10.1136/gutjnl-2012-302084; Marchetti M, 1998, VACCINE, V16, P33, DOI 10.1016/S0264-410X(97)00153-9; Michetti P, 1999, GASTROENTEROLOGY, V116, P804, DOI 10.1016/S0016-5085(99)70063-6; Nakae S, 2002, IMMUNITY, V17, P375, DOI 10.1016/S1074-7613(02)00391-6; Pappo J, 1999, INFECT IMMUN, V67, P337, DOI 10.1128/IAI.67.1.337-341.1999; Raghavan S, 2010, INFECT IMMUN, V78, P4251, DOI 10.1128/IAI.00536-10; Ruggiero P, 2003, MICROBES INFECT, V5, P749, DOI 10.1016/S1286-4579(03)00125-4; Shi Y, 2007, VACCINE, V25, P2583, DOI 10.1016/j.vaccine.2006.12.024; Smythies LE, 2005, VACCINE, V23, P901, DOI 10.1016/j.vaccine.2004.07.037; SPANGLER BD, 1992, MICROBIOL REV, V56, P622, DOI 10.1128/MMBR.56.4.622-647.1992; Summerton NA, 2010, VACCINE, V28, P1404, DOI 10.1016/j.vaccine.2009.10.147; Sundling C, 2008, J GEN VIROL, V89, P2954, DOI 10.1099/vir.0.2008/005470-0; Sutton P, 2000, IMMUNOL CELL BIOL, V78, P28, DOI 10.1046/j.1440-1711.2000.00881.x; Sutton P, 2013, EXPERT REV VACCINES, V12, P433, DOI [10.1586/erv.13.20, 10.1586/ERV.13.20]; Tepes B, 2012, HELICOBACTER, V17, P36, DOI 10.1111/j.1523-5378.2012.00981.x; Velin D, 2009, GASTROENTEROLOGY, V136, P2237, DOI 10.1053/j.gastro.2009.02.077; *WHO INT AG RES CA, 1994, IARC MON EV CARC RIS, P177; YAMADA T, 1994, JAMA-J AM MED ASSOC, V272, P65, DOI 10.1001/jama.272.1.65; Yang WC, 2013, VACCINE, V31, P1204, DOI 10.1016/j.vaccine.2012.12.058; Zhao WF, 2007, VACCINE, V25, P7664, DOI 10.1016/j.vaccine.2007.08.034; Zhou WY, 2009, VACCINE, V27, P5013, DOI 10.1016/j.vaccine.2009.05.009	47	16	19	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83321	10.1371/journal.pone.0083321	http://dx.doi.org/10.1371/journal.pone.0083321			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391754	Green Submitted, Green Published, gold			2022-12-25	WOS:000329325200051
J	Potiron, VA; Abderrahmani, R; Clement-Colmou, K; Marionneau-Lambot, S; Oullier, T; Paris, F; Supiot, S				Potiron, Vincent A.; Abderrahmani, Rym; Clement-Colmou, Karen; Marionneau-Lambot, Severine; Oullier, Thibauld; Paris, Francois; Supiot, Stephane			Improved Functionality of the Vasculature during Conventionally Fractionated Radiation Therapy of Prostate Cancer	PLOS ONE			English	Article							ENDOTHELIAL-CELLS; TUMOR RESPONSE; HYPOFRACTIONATED RADIOTHERAPY; INDUCED APOPTOSIS; OXYGEN-TENSION; HYPOXIA; IRRADIATION; DENSITY; DAMAGE; MICE	Although endothelial cell apoptosis participates in the tumor shrinkage after single high-dose radiotherapy, little is known regarding the vascular response after conventionally fractionated radiation therapy. Therefore, we evaluated hypoxia, perfusion and vascular microenvironment changes in an orthotopic prostate cancer model of conventionally fractionated radiation therapy at clinically relevant doses (2 Gy fractions, 5 fractions/week). First, conventionally fractionated radiation therapy decreased tumor cell proliferation and increased cell death with kinetics comparable to human prostate cancer radiotherapy. Secondly, the injection of Hoechst 33342 or fluorescent-dextrans showed an increased tumor perfusion within 14 days in irradiated tumors, which was correlated with a clear reduction of hypoxia. Improved perfusion and decreased hypoxia were not explained by increased blood vessel density, size or network morphology. However, a tumor vascular maturation defined by perivascular desmin+/SMA+ cells coverage was clearly observed along with an increase in endothelial, zonula occludens (ZO)-1 positive, intercellular junctions. Our results show that, in addition to tumor cell killing, vascular maturation plays an uncovered role in tumor reoxygenation during fractionated radiation therapy.	[Potiron, Vincent A.; Abderrahmani, Rym; Clement-Colmou, Karen; Paris, Francois; Supiot, Stephane] INSERM, UMR892, Nantes, France; [Potiron, Vincent A.; Abderrahmani, Rym; Clement-Colmou, Karen; Paris, Francois; Supiot, Stephane] Univ Nantes, Nantes, France; [Potiron, Vincent A.; Abderrahmani, Rym; Clement-Colmou, Karen; Paris, Francois; Supiot, Stephane] CNRS, UMR6299, Nantes, France; [Clement-Colmou, Karen; Paris, Francois; Supiot, Stephane] Inst Cancerol Ouest, Dept Radiat Oncol, St Herblain, France; [Marionneau-Lambot, Severine; Oullier, Thibauld] Canceropole Grand Ouest, Plate Forme Vivo, Nantes, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; Centre National de la Recherche Scientifique (CNRS); UNICANCER; Institut de Cancerologie de l'Ouest (ICO)	Supiot, S (corresponding author), INSERM, UMR892, Nantes, France.	stephane.supiot@ico.unicancer.fr	Marionneau-Lambot, Séverine/AAY-1452-2020; Supiot, Stéphane/M-1586-2015; Potiron, Vincent/L-6873-2015; Paris, francois E/L-4915-2015	Marionneau-Lambot, Séverine/0000-0002-5041-8531; Supiot, Stéphane/0000-0003-2094-1708; Potiron, Vincent/0000-0002-3693-6578; Paris, francois E/0000-0002-0176-7348; Clement-Colmou, Karen/0000-0003-0986-2718	Institut National du Cancer (INCA PAIR-prostate); Association pour la Recherche sur le Cancer; Ligue Nationale Contre le Cancer; Region Pays de Loire	Institut National du Cancer (INCA PAIR-prostate)(Institut National du Cancer (INCA) France); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer); Region Pays de Loire(Region Pays de la Loire)	This work was supported by the Institut National du Cancer (INCA PAIR-prostate 2010), the Association pour la Recherche sur le Cancer, the Ligue Nationale Contre le Cancer and the Region Pays de Loire. The funding source was not involved in the collection, analysis and interpretation of data, preparation of the manuscript and decision to publish.	Armulik A, 2011, DEV CELL, V21, P193, DOI 10.1016/j.devcel.2011.07.001; Baumann M, 2001, ACTA ONCOL, V40, P519, DOI 10.1080/028418601750288262; Baumann M, 2008, NAT REV CANCER, V8, P545, DOI 10.1038/nrc2419; Bergers G, 2005, NEURO-ONCOLOGY, V7, P452, DOI 10.1215/S1152851705000232; Bonnaud S, 2007, CANCER RES, V67, P1803, DOI 10.1158/0008-5472.CAN-06-2802; Bristow RG, 2008, NAT REV CANCER, V8, P180, DOI 10.1038/nrc2344; Brizel DM, 1999, RADIOTHER ONCOL, V53, P113, DOI 10.1016/S0167-8140(99)00102-4; Bromfield GP, 2003, PROSTATE CANCER P D, V6, P73, DOI 10.1038/sj.pcan.4500628; Brurberg KG, 2005, RADIOTHER ONCOL, V77, P220, DOI 10.1016/j.radonc.2005.09.009; Burrell K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038366; Carlson DJ, 2011, INT J RADIAT ONCOL, V79, P1188, DOI 10.1016/j.ijrobp.2010.10.007; Chen FH, 2009, CLIN CANCER RES, V15, P1721, DOI 10.1158/1078-0432.CCR-08-1471; Chen FH, 2013, INT J RAD ONCOL BIOL; Corre I, 2010, MUTAT RES-REV MUTAT, V704, P61, DOI 10.1016/j.mrrev.2010.01.014; De Bock K, 2011, CURR OPIN GENET DEV, V21, P73, DOI 10.1016/j.gde.2010.10.008; Dreher MR, 2006, JNCI-J NATL CANCER I, V98, P335, DOI 10.1093/jnci/djj070; Fuks Z, 2005, CANCER CELL, V8, P89, DOI 10.1016/j.ccr.2005.07.014; Gabrys D, 2007, INT J RADIAT ONCOL, V69, P1553, DOI 10.1016/j.ijrobp.2007.08.039; Garcia-Barros M, 2003, SCIENCE, V300, P1155, DOI 10.1126/science.1082504; Graves EE, 2010, CLIN CANCER RES, V16, P4843, DOI 10.1158/1078-0432.CCR-10-1206; Imaizumi N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011084; Killingsworth MC, 2011, PATHOBIOLOGY, V78, P24, DOI 10.1159/000322739; Kwak HJ, 2000, CIRCULATION, V101, P2317, DOI 10.1161/01.CIR.101.19.2317; Lan J, 2013, RADIAT RES, V179, P458, DOI 10.1667/RR3116.1; Laughlin KM, 1996, J PHARMACOL EXP THER, V277, P1049; LORD EM, 1993, CANCER RES, V53, P5721; Lyng H, 2000, INT J RADIAT ONCOL, V46, P935, DOI 10.1016/S0360-3016(99)00497-6; Maeda A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042133; Martin JM, 2011, DRUGS, V71, P1019, DOI 10.2165/11591500-000000000-00000; Milosevic M, 2012, CLIN CANCER RES, V18, P2108, DOI 10.1158/1078-0432.CCR-11-2711; Moeller BJ, 2005, CANCER CELL, V8, P99, DOI 10.1016/j.ccr.2005.06.016; Paris F, 2001, SCIENCE, V293, P293, DOI 10.1126/science.1060191; Park HJ, 2012, RADIAT RES, V177, P311, DOI 10.1667/RR2773.1; Penet MF, 2009, CANCER RES, V69, P8822, DOI 10.1158/0008-5472.CAN-09-1782; Potiron VA, 2013, RADIOTHER ONCOL, V106, P138, DOI 10.1016/j.radonc.2012.11.014; Roe K, 2012, RADIAT ONCOL, V7, DOI 10.1186/1748-717X-7-75; Stewart GD, 2010, BJU INT, V105, P8, DOI 10.1111/j.1464-410X.2009.08921.x; Supiot S, 2013, CANCER RADIOTHER, V17, P349, DOI 10.1016/j.canrad.2013.05.005; Supiot S, 2012, CANCER RADIOTHER, V16, P11, DOI 10.1016/j.canrad.2011.10.006; Supiot S, 2008, RADIOTHER ONCOL, V88, P53, DOI 10.1016/j.radonc.2008.03.019; VANPUTTE.LM, 1968, J NATL CANCER I, V40, P441; Winkler F, 2004, CANCER CELL, V6, P553, DOI 10.1016/S1535-6108(04)00305-8; Yaromina A, 2011, INT J RADIAT ONCOL, V80, P1205, DOI 10.1016/j.ijrobp.2011.02.015; Zovein AC, 2010, DEV CELL, V18, P39, DOI 10.1016/j.devcel.2009.12.006; ZYWIETZ F, 1995, INT J RADIAT ONCOL, V32, P1391, DOI 10.1016/0360-3016(94)00653-3	45	41	41	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84076	10.1371/journal.pone.0084076	http://dx.doi.org/10.1371/journal.pone.0084076			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391887	Green Published, gold, Green Submitted			2022-12-25	WOS:000329323900030
J	Renner, LD; Eswaramoorthy, P; Ramamurthi, KS; Weibel, DB				Renner, Lars D.; Eswaramoorthy, Prahathees; Ramamurthi, Kumaran S.; Weibel, Douglas B.			Studying Biomolecule Localization by Engineering Bacterial Cell Wall Curvature	PLOS ONE			English	Article							ESCHERICHIA-COLI; PROTEIN LOCALIZATION; MEMBRANE CURVATURE; SHAPE; CARDIOLIPIN; DIVISION; DIVIVA; MICRODOMAINS; ORGANIZATION; CYTOSKELETON	In this article we describe two techniques for exploring the relationship between bacterial cell shape and the intracellular organization of proteins. First, we created microchannels in a layer of agarose to reshape live bacterial cells and predictably control their mean cell wall curvature, and quantified the influence of curvature on the localization and distribution of proteins in vivo. Second, we used agarose microchambers to reshape bacteria whose cell wall had been chemically and enzymatically removed. By combining microstructures with different geometries and fluorescence microscopy, we determined the relationship between bacterial shape and the localization for two different membrane-associated proteins: i) the cell-shape related protein MreB of Escherichia coli, which is positioned along the long axis of the rod-shaped cell; and ii) the negative curvature-sensing cell division protein DivIVA of Bacillus subtilis, which is positioned primarily at cell division sites. Our studies of intracellular organization in live cells of E. coli and B. subtilis demonstrate that MreB is largely excluded from areas of high negative curvature, whereas DivIVA localizes preferentially to regions of high negative curvature. These studies highlight a unique approach for studying the relationship between cell shape and intracellular organization in intact, live bacteria.	[Renner, Lars D.; Weibel, Douglas B.] Univ Wisconsin, Dept Biochem, Madison, WI 53705 USA; [Renner, Lars D.] Tech Univ Dresden, D-01062 Dresden, Germany; [Renner, Lars D.] Max Bergmann Ctr Biomat, Dresden, Germany; [Eswaramoorthy, Prahathees; Ramamurthi, Kumaran S.] NCI, NIH, Bethesda, MD 20892 USA; [Weibel, Douglas B.] Univ Wisconsin, Dept Biomed Engn, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; Technische Universitat Dresden; Technische Universitat Dresden; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Wisconsin System; University of Wisconsin Madison	Weibel, DB (corresponding author), Univ Wisconsin, Dept Biochem, 420 Henry Mall, Madison, WI 53705 USA.	weibel@biochem.wisc.edu	Renner, Lars D/D-6291-2012; Eswara, Prahathees/J-2353-2019; Renner, Lars David/AAQ-2732-2021; Ramamurthi, Kumaran/P-3516-2015	Renner, Lars D/0000-0003-0178-1788; Eswara, Prahathees/0000-0003-4430-261X; 	National Science Foundation [DMR-1121288]; National Institutes of Health [1DP2OD008735-01]; Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research; University of Wisconsin Materials Research Science and Engineering Center [DMR-1121288]; DFG; Alfred P. Sloan Foundation; NATIONAL CANCER INSTITUTE [ZIABC011211] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD008735] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); University of Wisconsin Materials Research Science and Engineering Center(National Science Foundation (NSF)); DFG(German Research Foundation (DFG)); Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was funded by the National Science Foundation (DMR-1121288; L. D. R., D. B. W., http://www.nsf.gov/mps/dmr/highlights.jsp), the National Institutes of Health (1DP2OD008735-01; L. D. R., D. B. W., http://www.nih.gov/), and the Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research (K. S. R. and P. E., http://www.nih.gov/). The authors gratefully acknowledge use of facilities and instrumentation supported by the University of Wisconsin Materials Research Science and Engineering Center (DMR-1121288, http://mrsec.wisc.edu/), and acknowledge support from a DFG Postdoctoral Fellowship (to L. D. R., http://www.dfg.de/) and an Alfred P. Sloan Foundation Fellowship (to D. B. W., http://www.sloan.org/sloan-research-fellowships/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arias-Cartin R, 2011, P NATL ACAD SCI USA, V108, P7781, DOI 10.1073/pnas.1010427108; Bendezu FO, 2009, EMBO J, V28, P193, DOI 10.1038/emboj.2008.264; BI E, 1991, NATURE, V354, P161, DOI 10.1038/354161a0; Brake JM, 2003, SCIENCE, V302, P2094, DOI 10.1126/science.1091749; Cha JH, 1997, J BACTERIOL, V179, P1671, DOI 10.1128/jb.179.5.1671-1683.1997; DOI M, 1988, J BACTERIOL, V170, P4619, DOI 10.1128/jb.170.10.4619-4624.1988; Dominguez-Escobar J, 2011, SCIENCE, V333, P225, DOI 10.1126/science.1203466; Edwards DH, 1997, MOL MICROBIOL, V24, P905, DOI 10.1046/j.1365-2958.1997.3811764.x; Eswaramoorthy P, 2011, MBIO, V2, DOI 10.1128/mBio.00257-11; Foss MH, 2011, BIOCHEMISTRY-US, V50, P7719, DOI 10.1021/bi200940d; Gan L, 2008, P NATL ACAD SCI USA, V105, P18953, DOI 10.1073/pnas.0808035105; Garner EC, 2011, SCIENCE, V333, P222, DOI 10.1126/science.1203285; Gold VAM, 2010, P NATL ACAD SCI USA, V107, P10044, DOI 10.1073/pnas.0914680107; Handler AA, 2008, MOL MICROBIOL, V68, P588, DOI 10.1111/j.1365-2958.2008.06173.x; Heinrich M, 2010, P NATL ACAD SCI USA, V107, P7208, DOI 10.1073/pnas.0913997107; Huang KC, 2006, PLOS COMPUT BIOL, V2, P1357, DOI 10.1371/journal.pcbi.0020151; Huang KC, 2010, MOL MICROBIOL, V76, P822, DOI 10.1111/j.1365-2958.2010.07168.x; Huang KC, 2008, P NATL ACAD SCI USA, V105, P19282, DOI 10.1073/pnas.0805309105; Ingerson-Mahar M, 2012, FEMS MICROBIOL REV, V36, P256, DOI 10.1111/j.1574-6976.2011.00316.x; Jones LJF, 2001, CELL, V104, P913, DOI 10.1016/S0092-8674(01)00287-2; Landgraf D, 2012, NAT METHODS, V9, P480, DOI [10.1038/NMETH.1955, 10.1038/nmeth.1955]; Lenarcic R, 2009, EMBO J, V28, P2272, DOI 10.1038/emboj.2009.129; Lin IH, 2011, SCIENCE, V332, P1297, DOI 10.1126/science.1195639; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Lopez D, 2010, GENE DEV, V24, P1893, DOI 10.1101/gad.1945010; MADDOCK JR, 1993, SCIENCE, V259, P1717; Matias VRF, 2008, J BACTERIOL, V190, P7414, DOI 10.1128/JB.00581-08; Matias VRF, 2005, MOL MICROBIOL, V56, P240, DOI 10.1111/j.1365-2958.2005.04535.x; Matsumoto K, 2006, MOL MICROBIOL, V61, P1110, DOI 10.1111/j.1365-2958.2006.05317.x; McMahon HT, 2005, NATURE, V438, P590, DOI 10.1038/nature04396; Mileykovskaya E, 2003, J BIOL CHEM, V278, P22193, DOI 10.1074/jbc.M302603200; Mileykovskaya E, 2000, J BACTERIOL, V182, P1172, DOI 10.1128/JB.182.4.1172-1175.2000; Miller DS, 2013, SOFT MATTER, V9, P374, DOI 10.1039/c2sm26811f; Mukhopadhyay R, 2008, BIOPHYS J, V95, P1034, DOI 10.1529/biophysj.107.126920; Muralimohan A, 2009, TRENDS MICROBIOL, V17, P100, DOI 10.1016/j.tim.2008.11.007; Phillips R, 2009, NATURE, V459, P379, DOI 10.1038/nature08147; Ramamurthi KS, 2009, P NATL ACAD SCI USA, V106, P13541, DOI 10.1073/pnas.0906851106; Ramamurthi KS, 2009, SCIENCE, V323, P1354, DOI 10.1126/science.1169218; Renner LD, 2011, P NATL ACAD SCI USA, V108, P6264, DOI 10.1073/pnas.1015757108; Salje J, 2011, MOL CELL, V43, P478, DOI 10.1016/j.molcel.2011.07.008; SCHAEFFER P, 1976, P NATL ACAD SCI USA, V73, P2151, DOI 10.1073/pnas.73.6.2151; Shapiro L, 2009, SCIENCE, V326, P1225, DOI 10.1126/science.1175685; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Sliusarenko O, 2010, P NATL ACAD SCI USA, V107, P10086, DOI 10.1073/pnas.1000737107; Strahl H, 2012, CURR OPIN MICROBIOL, V15, P731, DOI 10.1016/j.mib.2012.10.006; Swulius MT, 2012, J BACTERIOL, V194, P6382, DOI 10.1128/JB.00505-12; Takeuchi S, 2005, NANO LETT, V5, P1819, DOI 10.1021/nl0507360; Tuson HH, 2012, MOL MICROBIOL, V84, P874, DOI 10.1111/j.1365-2958.2012.08063.x; van Teeffelen S, 2011, P NATL ACAD SCI USA, V108, P15822, DOI 10.1073/pnas.1108999108; Wang S, 2012, P NATL ACAD SCI USA, V109, pE595, DOI 10.1073/pnas.1117132109; Weibel DB, 2007, NAT REV MICROBIOL, V5, P209, DOI 10.1038/nrmicro1616; Werner JN, 2009, P NATL ACAD SCI USA, V106, P7858, DOI 10.1073/pnas.0901781106; White CL, 2012, TRENDS MICROBIOL, V20, P74, DOI 10.1016/j.tim.2011.11.004; Xia YN, 1998, ANGEW CHEM INT EDIT, V37, P550, DOI 10.1002/(SICI)1521-3773(19980316)37:5<550::AID-ANIE550>3.0.CO;2-G; Young KD, 2006, MICROBIOL MOL BIOL R, V70, P660, DOI 10.1128/MMBR.00001-06	55	26	26	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84143	10.1371/journal.pone.0084143	http://dx.doi.org/10.1371/journal.pone.0084143			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391905	Green Published, Green Submitted, gold			2022-12-25	WOS:000329323900048
J	Chung, SS; Aroh, C; Vadgama, JV				Chung, Seyung S.; Aroh, Clement; Vadgama, Jaydutt V.			Constitutive Activation of STAT3 Signaling Regulates hTERT and Promotes Stem Cell-Like Traits in Human Breast Cancer Cells	PLOS ONE			English	Article							REVERSE-TRANSCRIPTASE HTERT; NF-KAPPA-B; HUMAN TELOMERASE; INDUCED APOPTOSIS; GROWTH; PHOSPHORYLATION; ASSOCIATION; SUPPRESSION; EXPRESSION; PATHWAY	Mounting clinical data suggest that high telomerase activity is tightly associated with cancer progression and poor outcomes. Constitutively activated STAT3 is found in similar to 60% of human malignancies and shows a dismal prognosis. We previously reported that activated STAT3 promoted epithelial-mesenchymal transition (EMT) and cancer stem cell phenotype in human breast cancer. However, little is known how STAT3 is regulated in the cancer stem cell and by which mechanisms STAT3 contributes to poor prognosis in aggressive breast cancer. Here we demonstrate that STAT3 physically interacts with CD44 and NF-kB and activates the catalytic subunit of telomerase (hTERT) in human breast cancer stem cells. STAT3 plays a role as a signal transducing molecule between CD44 and NF-kB. In addition to functioning as a catalytic subunit of telomerase, hTERT has been reported to function as a transcription co-factor which drives EMT and cancer stem cell phenotype in human cancer. We observed that activated hTERT increases CD44 (+) subpopulation, whereas targeted knock-down of hTERT abolished cancer stem cell phenotype. Targeted STAT3 knock-down cells also down-regulated hTERT and decreased CD44 subpopulation. Finally, CD44 knock-down resulted in the abrogation of cancer stem cell phenotype and concurrent down-regulation of pSTAT3 and hTERT. Our study delineates the signaling pathway where STAT3 functions as a modulator for CD44 and hTERT, promoting a cancer stem cell phenotype. The constitutive activation of STAT3 signaling that leads to regulation of hTERT pathway may provide novel therapeutic targets for human breast cancer stem cells.	[Chung, Seyung S.; Aroh, Clement; Vadgama, Jaydutt V.] Charles R Drew Univ Med & Sci, Dept Internal Med, Div Canc Res & Training, Los Angeles, CA 90059 USA; [Vadgama, Jaydutt V.] David Geffen UCLA Sch Med, Jonsson Comprehens Canc Ctr, Los Angeles, CA USA	Charles R. Drew University of Medicine & Science; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Vadgama, JV (corresponding author), Charles R Drew Univ Med & Sci, Dept Internal Med, Div Canc Res & Training, 1621 E 120th St, Los Angeles, CA 90059 USA.	jayvadgama@cdrewu.edu			NIH [NCI U56CA101599-01, CA15083-25S3, U54CA14393, NIMHD U54MD007598, NCATS CTSI UL1TR000124]; NATIONAL CANCER INSTITUTE [P30CA015083, U54CA143931, U56CA101599] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000124] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [U54MD007598] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	Funding: Support from NIH (Grant numbers: NCI U56CA101599-01; CA15083-25S3; U54CA14393; NIMHD U54MD007598; and NCATS CTSI UL1TR000124 to J.V.V). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2004, CANCER CELL, V6, P203, DOI 10.1016/j.ccr.2004.09.003; Assimakopoulos D, 2002, HISTOL HISTOPATHOL, V17, P1269, DOI 10.14670/HH-17.1269; Azare J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027851; Beg AA, 1996, SCIENCE, V274, P782, DOI 10.1126/science.274.5288.782; BENZ CC, 1992, BREAST CANCER RES TR, V24, P85, DOI 10.1007/BF01961241; Berishaj M, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1680; Blasco MA, 2003, TRENDS CELL BIOL, V13, P289, DOI 10.1016/S0962-8924(03)00085-0; Bourguignon LYW, 2003, J BIOL CHEM, V278, P29420, DOI 10.1074/jbc.M301885200; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; Dauer DJ, 2005, ONCOGENE, V24, P3397, DOI 10.1038/sj.onc.1208469; Fukada T, 1998, EMBO J, V17, P6670, DOI 10.1093/emboj/17.22.6670; Glukhov AI, 2011, APPL BIOCHEM MICRO+, V47, P655, DOI 10.1134/S0003683811070039; Hartman ZC, 2011, CANCER RES, V71, P4380, DOI 10.1158/0008-5472.CAN-11-0308; Huang HH, 2012, BIOCHEM BIOPH RES CO, V418, P186, DOI 10.1016/j.bbrc.2012.01.004; Kirkpatrick KL, 2001, EUR J SURG ONCOL, V27, P754, DOI 10.1053/ejso.2001.1151; Kogan I, 2006, CANCER RES, V66, P3531, DOI 10.1158/0008-5472.CAN-05-2183; Konnikova L, 2005, CANCER RES, V65, P6516, DOI 10.1158/0008-5472.CAN-05-0924; Kyo S, 2008, CANCER SCI, V99, P1528, DOI 10.1111/j.1349-7006.2008.00878.x; Liu Z, 2013, ONCOGENE, V32, P4203, DOI 10.1038/onc.2012.441; Marotta LLC, 2011, J CLIN INVEST, V121, P2723, DOI 10.1172/JCI44745; Mittra I, 2011, PREV MED, V53, P121, DOI 10.1016/j.ypmed.2011.06.010; Nakayama JI, 1998, NAT GENET, V18, P65, DOI 10.1038/ng0198-65; Park JI, 2009, NATURE, V460, P66, DOI 10.1038/nature08137; Rathore K, 2013, CANCER LETT, V333, P113, DOI 10.1016/j.canlet.2013.01.030; SCHWARTZ HS, 1995, CANCER, V75, P1094, DOI 10.1002/1097-0142(19950301)75:5<1094::AID-CNCR2820750507>3.0.CO;2-B; Sherry MM, 2009, STEM CELLS, V27, P2383, DOI 10.1002/stem.185; Shostak K, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2886; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Stewart SA, 2002, P NATL ACAD SCI USA, V99, P12606, DOI 10.1073/pnas.182407599; Turkson J, 2000, ONCOGENE, V19, P6613, DOI 10.1038/sj.onc.1204086; Urquidi V, 2000, ANNU REV MED, V51, P65, DOI 10.1146/annurev.med.51.1.65; VanAntwerp DJ, 1996, SCIENCE, V274, P787, DOI 10.1126/science.274.5288.787; Wang CY, 1996, SCIENCE, V274, P784, DOI 10.1126/science.274.5288.784; Weinrich SL, 1997, NAT GENET, V17, P498, DOI 10.1038/ng1297-498; Yang CH, 1996, J BIOL CHEM, V271, P8057, DOI 10.1074/jbc.271.14.8057; ZHONG Z, 1994, SCIENCE, V264, P95, DOI 10.1126/science.8140422	38	80	81	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e83971	10.1371/journal.pone.0083971	http://dx.doi.org/10.1371/journal.pone.0083971			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386318	Green Published, gold, Green Submitted			2022-12-25	WOS:000329194700083
J	Jiang, M; Wu, HJ; Qin, CY				Jiang, Man; Wu, Haijian; Qin, Chengyong			Genetic Variant rs401681 at 5p15.33 Modifies Susceptibility to Lung Cancer but Not Esophageal Squamous Cell Carcinoma	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; LEUKOCYTE TELOMERE LENGTH; RISK; LOCUS; TERT-CLPTM1L; METAANALYSIS; POLYMORPHISMS; REPLICATION; CHROMOSOMES; DYSFUNCTION	Background: The human 5p15.33 locus contains two well-known genes, the telomerase reverse transcriptase (TERT) and cleft lip and palate transmembrane 1-like (CLPTM1L) genes, which have been implicated in carcinogenesis. A common sequence variant, rs401681, located in an intronic region of CLPTM1L, has been reported to be associated with lung cancer risk based on genome-wide association study. However, subsequent replication studies in diverse populations have yielded inconsistent results. In addition, genetic variants at 5p15.33, including rs401681, have been shown to be involved in the susceptibility to multiple malignancies. Nevertheless, the role of these TERT-CLPTM1L variants in the etiology of esophageal squamous cell carcinoma (ESCC) remains unknown. Methods: We genotyped the rs401681 polymorphism using TaqMan methodology and analyzed its association with the risk of lung cancer and ESCC in a case-control study of 1,479 cancer patients (726 with lung cancer and 753 with ESCC) and 860 healthy individuals. Results: Logistic regression analyses revealed that rs401681 T genotypes were associated with a significantly decreased risk of lung cancer (CT vs. CC: adjusted OR = 0.782, 95% CI = 0.625-0.978, P = 0.031; CT/TT vs. CC: adjusted OR = 0.786; 95% CI = 0.635-0.972, P = 0.026). Stratification analysis by histology type indicated that rs401681 T genotypes were associated with a significantly reduced risk of both adenocarcinoma and squamous cell carcinoma. Furthermore, no significant association was observed between rs401681 and the risk of ESCC (CT vs. CC: adjusted OR = 0.910, 95% CI = 0.734-1.129, P = 0.392; TT vs. CC: adjusted OR = 0.897, 95% CI = 0.624-1.290, P = 0.558; CT/TT vs. CC: adjusted OR = 0.908, 95% CI = 0.740-1.114, P = 0.355). Conclusions: Our findings provide further evidence supporting rs401681 as a genetic variant associated with the risk of lung cancer. In addition, we investigated the correlation between the rs401681 variant and the risk of ESCC in a Han Chinese population, and our results suggest that this genetic variant may not be involved in ESCC risk.	[Jiang, Man; Qin, Chengyong] Shandong Univ, Prov Hosp, Dept Gastroenterol, Jinan 250100, Shandong, Peoples R China; [Wu, Haijian] Shandong Univ, Qilu Hosp, Dept Radiat Oncol, Jinan 250100, Shandong, Peoples R China	Shandong University; Shandong University	Qin, CY (corresponding author), Shandong Univ, Prov Hosp, Dept Gastroenterol, Jinan 250100, Shandong, Peoples R China.	cyqinsdu@126.com			Shandong Science and Technology Committee of China [2005GG3202192]	Shandong Science and Technology Committee of China	This work was supported by grant number 2005GG3202192 from the Shandong Science and Technology Committee of China (http://www.sdstc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aida J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063860; Asakura T, 2005, ONCOL REP, V14, P601; Bae EY, 2012, RESPIROLOGY, V17, P699, DOI 10.1111/j.1440-1843.2012.02165.x; Chen WQ, 2011, CHINESE J CANCER RES, V23, P3, DOI 10.1007/s11670-011-0003-9; Colombo J, 2009, ONCOL REP, V21, P649, DOI 10.3892/or_00000268; Feldser DM, 2003, NAT REV CANCER, V3, P623, DOI 10.1038/nrc1142; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Gansner JM, 2013, TRANSL RES; Gomez DE, 2012, INT J ONCOL, V41, P1561, DOI 10.3892/ijo.2012.1611; Gu JA, 2011, CANCER PREV RES, V4, P514, DOI 10.1158/1940-6207.CAPR-11-0063; He J, 2005, NEW ENGL J MED, V353, P1124, DOI 10.1056/NEJMsa050467; James MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036116; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Ke JT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062485; Landi MT, 2009, AM J HUM GENET, V85, P679, DOI 10.1016/j.ajhg.2009.09.012; Li C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064988; Ma HX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020466; Maser RS, 2002, SCIENCE, V297, P565, DOI 10.1126/science.297.5581.565; McKay JD, 2008, NAT GENET, V40, P1404, DOI 10.1038/ng.254; Mocellin S, 2012, JNCI-J NATL CANCER I, V104, P840, DOI 10.1093/jnci/djs222; Myneni AA, 2013, LUNG CANCER, V80, P131, DOI 10.1016/j.lungcan.2013.01.021; Ni ZH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052598; Perera SA, 2008, CARCINOGENESIS, V29, P747, DOI 10.1093/carcin/bgn050; Petersen GM, 2010, NAT GENET, V42, P224, DOI 10.1038/ng.522; Rafnar T, 2009, NAT GENET, V41, P221, DOI 10.1038/ng.296; Risques RA, 2007, CANCER EPIDEM BIOMAR, V16, P2649, DOI 10.1158/1055-9965.EPI-07-0624; Shay JW, 2011, SEMIN CANCER BIOL, V21, P349, DOI 10.1016/j.semcancer.2011.10.001; Shete S, 2009, NAT GENET, V41, P899, DOI 10.1038/ng.407; Shi J, 2013, INT J CANCER, V132, P2799, DOI 10.1002/ijc.27959; Sirera R, 2011, J THORAC ONCOL, V6, P286, DOI 10.1097/JTO.0b013e31820189a5; Stacey SN, 2009, NAT GENET, V41, P909, DOI 10.1038/ng.412; Timofeeva MN, 2012, HUM MOL GENET, V21, P4980, DOI 10.1093/hmg/dds334; Wang YF, 2008, NAT GENET, V40, P1407, DOI 10.1038/ng.273; Xing JL, 2009, CANCER PREV RES, V2, P459, DOI 10.1158/1940-6207.CAPR-08-0227; Xu LF, 2013, ANNU REV PATHOL-MECH, V8, P49, DOI 10.1146/annurev-pathol-020712-164030; Yamamoto K, 2001, BIOCHEM BIOPH RES CO, V280, P1148, DOI 10.1006/bbrc.2001.4250; Yang XL, 2013, ARCH DERMATOL RES, V305, P49, DOI 10.1007/s00403-012-1275-8; Yin JY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050650; Zheng YL, 2009, CANCER RES, V69, P1604, DOI 10.1158/0008-5472.CAN-08-3028; Zienolddiny S, 2009, CARCINOGENESIS, V30, P1368, DOI 10.1093/carcin/bgp131	40	9	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e84277	10.1371/journal.pone.0084277	http://dx.doi.org/10.1371/journal.pone.0084277			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386361	Green Published, Green Submitted, gold			2022-12-25	WOS:000329194700100
J	Solomon, LA; Russell, BA; Makar, D; Berube, NG; Beier, F				Solomon, Lauren A.; Russell, Bailey A.; Makar, David; Berube, Nathalie G.; Beier, Frank			Loss of ATRX Does Not Confer Susceptibility to Osteoarthritis	PLOS ONE			English	Article							REDUCED CHONDROCYTE PROLIFERATION; X SYNDROME; MENTAL-RETARDATION; SKELETAL TISSUES; CRE RECOMBINASE; PROTEIN ATRX; BONE-GROWTH; SNF2 FAMILY; EXPRESSION; SURVIVAL	The chromatin remodelling protein ATRX is associated with the rare genetic disorder ATR-X syndrome. This syndrome includes developmental delay, cognitive impairment, and a variety of skeletal deformities. ATRX plays a role in several basic chromatin-mediated cellular events including DNA replication, telomere stability, gene transcription, and chromosome congression and cohesion during cell division. We have used a loss-of-function approach to directly investigate the role of Atrx in the adult skeleton in three different models of selective Atrx loss. We specifically targeted deletion of Atrx to the forelimb mesenchyme, to cartilage and to bone-forming osteoblasts. We previously demonstrated that loss of ATRX in forelimb mesenchyme causes brachydactyly while deletion in chondrocytes had minimal effects during development. We now show that targeted deletion of Atrx in osteoblasts causes minor dwarfism but does not recapitulate most of the skeletal phenotypes seen in ATR-X syndrome patients. In adult mice from all three models, we find that joints lacking Atrx are not more susceptible to osteoarthritis, as determined by OARSI scoring and immunohistochemistry. These results indicate that while ATRX plays limited roles during early stages of skeletal development, deficiency of the protein in adult tissues does not confer susceptibility to osteoarthritis.	[Solomon, Lauren A.; Berube, Nathalie G.] Univ Western Ontario, Schulich Sch Med & Dent, Dept Paediat, London, ON, Canada; [Solomon, Lauren A.; Berube, Nathalie G.] Univ Western Ontario, Schulich Sch Med & Dent, Dept Biochem, London, ON, Canada; [Solomon, Lauren A.; Berube, Nathalie G.; Beier, Frank] Childrens Hlth Res Inst, London, ON, Canada; [Russell, Bailey A.; Makar, David; Beier, Frank] Univ Western Ontario, Schulich Sch Med & Dent, Dept Physiol & Pharmacol, London, ON, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario)	Berube, NG (corresponding author), Univ Western Ontario, Schulich Sch Med & Dent, Dept Paediat, London, ON, Canada.	nberube@uwo.ca; fbeier@uwo.ca	Beier, Frank/T-4734-2019; Beier, Frank/G-4595-2013; Berube, Nathalie G/E-3885-2015	Beier, Frank/0000-0002-8505-7537; Beier, Frank/0000-0002-8505-7537; 	Canadian Institutes for Health Research; Ontario Graduate Studentship (OGS) [PRD19842319];  [MOP102539]	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Ontario Graduate Studentship (OGS); 	This work was supported by an operating grant from the Canadian Institutes for Health Research to N.G.B. and F. B. [MOP102539](http://www.cihr-irsc.gc.ca), and an Ontario Graduate Studentship (OGS) (https://osap.gov.on.ca/OSAPPortal/en/A-ZListofAid/PRD19842319.html) to L. A. S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aigner T, 2007, CURR DRUG TARGETS, V8, P325, DOI 10.2174/138945007779940070; Alvarez-Saavedra M, 2010, HUM MOL GENET, V19, P2177, DOI 10.1093/hmg/ddq096; Appleton CTG, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2120; Aspden RM, 2008, RHEUMATOLOGY, V47, P1452, DOI 10.1093/rheumatology/ken199; Aspden RM, 2011, NAT REV RHEUMATOL, V7, P65, DOI 10.1038/nrrheum.2010.123; Bagheri-Fam S, 2011, HUM MOL GENET, V20, P2213, DOI 10.1093/hmg/ddr109; BELLOWS CG, 1989, DEV BIOL, V133, P8, DOI 10.1016/0012-1606(89)90291-1; Berube NG, 2005, J CLIN INVEST, V115, P258, DOI 10.1172/JCI200522329; Betancourt MCC, 2012, P NATL ACAD SCI USA, V109, P8218, DOI 10.1073/pnas.1119899109; Dhayalan A, 2011, HUM MOL GENET, V20, P2195, DOI 10.1093/hmg/ddr107; Dvir-Ginzberg M, 2013, FRONT BIOSCI-LANDMRK, V18, P343, DOI 10.2741/4105; EISEN JA, 1995, NUCLEIC ACIDS RES, V23, P2715, DOI 10.1093/nar/23.14.2715; Fosang AJ, 1996, FEBS LETT, V380, P17, DOI 10.1016/0014-5793(95)01539-6; Gagarina V, 2010, ARTHRITIS RHEUM-US, V62, P1383, DOI 10.1002/art.27369; Garrick D, 2006, PLOS GENET, V2, P438, DOI 10.1371/journal.pgen.0020058; GIBBONS RJ, 1995, AM J MED GENET, V55, P288, DOI 10.1002/ajmg.1320550309; GIBBONS RJ, 1995, CELL, V80, P837, DOI 10.1016/0092-8674(95)90287-2; Gibbons RJ, 2000, AM J MED GENET, V97, P204, DOI 10.1002/1096-8628(200023)97:3<204::AID-AJMG1038>3.0.CO;2-X; Glasson SS, 2010, OSTEOARTHR CARTILAGE, V18, pS17, DOI 10.1016/j.joca.2010.05.025; Goldring MB, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2592; Huber LC, 2007, ARTHRITIS RHEUM, V56, P1087, DOI 10.1002/art.22512; Huh MS, 2012, J CLIN INVEST, V122, P4412, DOI 10.1172/JCI63765; Liu F, 2004, INT J DEV BIOL, V48, P645, DOI 10.1387/ijdb.041816fl; Logan M, 2002, GENESIS, V33, P77, DOI 10.1002/gene.10092; Medina CF, 2009, HUM MOL GENET, V18, P966, DOI 10.1093/hmg/ddn424; Otani J, 2009, EMBO REP, V10, P1235, DOI 10.1038/embor.2009.218; Panupinthu N, 2008, J CELL BIOL, V181, P859, DOI 10.1083/jcb.200708037; Picketts DJ, 1996, HUM MOL GENET, V5, P1899, DOI 10.1093/hmg/5.12.1899; Pollard TCB, 2008, J BONE JOINT SURG BR, V90B, P411, DOI 10.1302/0301-620X.90B4.20284; Ritchie K, 2008, J CELL BIOL, V180, P315, DOI 10.1083/jcb.200706083; Scheller EL, 2011, CELLS TISSUES ORGANS, V194, P268, DOI 10.1159/000324745; Seah C, 2008, J NEUROSCI, V28, P12570, DOI 10.1523/JNEUROSCI.4048-08.2008; Sedivy JM, 2008, EXP CELL RES, V314, P1909, DOI 10.1016/j.yexcr.2008.02.023; Solomon LA, 2013, HUM MOL GENET, V22, P5015, DOI 10.1093/hmg/ddt351; Solomon LA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007106; Terpstra L, 2003, J CELL BIOL, V162, P139, DOI 10.1083/jcb.200302066; Ulici V, 2009, BONE, V45, P1133, DOI 10.1016/j.bone.2009.08.003; Wang GY, 2007, DEV BIOL, V306, P612, DOI 10.1016/j.ydbio.2007.03.520; Wang J, 1999, FASEB J, V13, P1985, DOI 10.1096/fasebj.13.14.1985; Wang MN, 2011, ANN NY ACAD SCI, V1240, P61, DOI 10.1111/j.1749-6632.2011.06258.x; Watson LA, 2013, J CLIN INVEST, V123, P2049, DOI 10.1172/JCI65634; Wong LH, 2010, GENOME RES, V20, P351, DOI 10.1101/gr.101477.109; Yan QA, 2010, ARTHRITIS RHEUM-US, V62, P2013, DOI 10.1002/art.27486; Young DW, 2005, J CELL BIOCHEM, V94, P720, DOI 10.1002/jcb.20332	44	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e85526	10.1371/journal.pone.0085526	http://dx.doi.org/10.1371/journal.pone.0085526			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386478	gold, Green Submitted, Green Published			2022-12-25	WOS:000329194700139
J	Torrazza, RM; Ukhanova, M; Wang, XY; Sharma, R; Hudak, ML; Neu, J; Mai, V				Torrazza, Roberto Murgas; Ukhanova, Maria; Wang, Xiaoyu; Sharma, Renu; Hudak, Mark Lawrence; Neu, Josef; Mai, Volker			Intestinal Microbial Ecology and Environmental Factors Affecting Necrotizing Enterocolitis	PLOS ONE			English	Article							EMPIRICAL ANTIBIOTIC-TREATMENT; FECAL MICROFLORA; PRETERM INFANTS; COMMUNITY; FLORA; OUTCOMES	Necrotizing enterocolitis (NEC) is the most devastating intestinal disease affecting preterm infants. In addition to being associated with short term mortality and morbidity, survivors are left with significant long term sequelae. The cost of caring for these infants is high. Epidemiologic evidence suggests that use of antibiotics and type of feeding may cause an intestinal dysbiosis important in the pathogenesis of NEC, but the contribution of specific infectious agents is poorly understood. Fecal samples from preterm infants <= 32 weeks gestation were analyzed using 16S rRNA based methods at 2, 1, and 0 weeks, prior to diagnosis of NEC in 18 NEC cases and 35 controls. Environmental factors such as antibiotic usage, feeding type (human milk versus formula) and location of neonatal intensive care unit (NICU) were also evaluated. Microbiota composition differed between the three neonatal units where we observed differences in antibiotic usage. In NEC cases we observed a higher proportion of Proteobacteria (61%) two weeks and of Actinobacteria (3%) 1 week before diagnosis of NEC compared to controls (19% and 0.4%, respectively) and lower numbers of Bifidobacteria counts and Bacteroidetes proportions in the weeks before NEC diagnosis. In the first fecal samples obtained during week one of life we detected a novel signature sequence, distinct from but matching closest to Klebsiella pneumoniae, that was strongly associated with NEC development later in life. Infants who develop NEC exhibit a different pattern of microbial colonization compared to controls. Antibiotic usage correlated with these differences and combined with type of feeding likely plays a critical role in the development of NEC.	[Torrazza, Roberto Murgas; Neu, Josef] Univ Florida, Coll Med, Dept Pediat, Gainesville, FL USA; [Ukhanova, Maria; Wang, Xiaoyu; Mai, Volker] Univ Florida, Coll Publ Hlth & Hlth Profess, Dept Epidemiol, Gainesville, FL 32610 USA; [Ukhanova, Maria; Wang, Xiaoyu; Mai, Volker] Univ Florida, Coll Med, Gainesville, FL USA; [Ukhanova, Maria; Wang, Xiaoyu; Mai, Volker] Univ Florida, Emerging Pathogens Inst, Gainesville, FL USA; [Sharma, Renu; Hudak, Mark Lawrence] Univ Florida, Coll Med, Dept Pediat, Jacksonville, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Mai, V (corresponding author), Univ Florida, Coll Publ Hlth & Hlth Profess, Dept Epidemiol, Gainesville, FL 32610 USA.	vmai@ufl.edu	Neu, Josef/AAI-2799-2020; Wang, Xiaoyu/J-4101-2018	Wang, Xiaoyu/0000-0002-4504-7799	NIH [RO1 HD 059143]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD059143] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by NIH RO1 HD 059143. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander VN, 2011, J PEDIATR-US, V159, P392, DOI 10.1016/j.jpeds.2011.02.035; Boccia D, 2001, EUR J PEDIATR, V160, P385, DOI 10.1007/s004310100749; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Claud EC, 2001, FASEB J, V15, P1398, DOI 10.1096/fj.00-0833hyp; Cotten CM, 2009, PEDIATRICS, V123, P58, DOI 10.1542/peds.2007-3423; Dai D, 1999, Adv Pediatr, V46, P353; Gronlund MM, 1999, J PEDIATR GASTR NUTR, V28, P19, DOI 10.1097/00005176-199901000-00007; Harmsen HJM, 2000, J PEDIATR GASTR NUTR, V30, P61, DOI 10.1097/00005176-200001000-00019; Hattori M, 2009, DNA RES, V16, P1, DOI 10.1093/dnares/dsn033; Holman RC, 2006, PAEDIATR PERINAT EP, V20, P498, DOI 10.1111/j.1365-3016.2006.00756.x; Horbar JD, 2010, CLIN PERINATOL, V37, P29, DOI 10.1016/j.clp.2010.01.003; HOY C, 1990, ARCH DIS CHILD-FETAL, V65, P1057, DOI 10.1136/adc.65.10_Spec_No.1057; Jernberg C, 2007, ISME J, V1, P56, DOI 10.1038/ismej.2007.3; Kuppala VS, 2011, J PEDIATR-US, V159, P720, DOI 10.1016/j.jpeds.2011.05.033; Lozupone C, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-371; Mai V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020647; Mai V, 2006, J CLIN MICROBIOL, V44, P4550, DOI 10.1128/JCM.01542-06; Meinzen-Derr J, 2009, J PEDIATR-US, V154, P656, DOI 10.1016/j.jpeds.2008.11.002; MOLLITT DL, 1988, J PEDIATR SURG, V23, P60, DOI 10.1016/S0022-3468(88)80542-6; Morrow AL, 2013, MICROBIOME, V1, DOI 10.1186/2049-2618-1-13; Mshvildadze M, 2010, J PEDIATR-US, V156, P20, DOI 10.1016/j.jpeds.2009.06.063; Neu J, 2011, NEW ENGL J MED, V364, P255, DOI 10.1056/NEJMra1005408; Penders J, 2006, PEDIATRICS, V118, P511, DOI 10.1542/peds.2005-2824; Smith B, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-73; Stoll BJ, 2010, PEDIATRICS, V126, P443, DOI 10.1542/peds.2009-2959; Sun YJ, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp285; Torrazza RM, 2013, CLIN PERINATOL, V40, P93, DOI 10.1016/j.clp.2012.12.009; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; Underwood MA, 2013, PEDIATR CLIN N AM, V60, P189, DOI 10.1016/j.pcl.2012.09.008; Wang YW, 2009, ISME J, V3, P944, DOI 10.1038/ismej.2009.37; Weintraub AS, 2012, J PERINATOL, V32, P705, DOI 10.1038/jp.2011.180; WESTRAMEIJER CMM, 1983, ARCH DIS CHILD, V58, P523, DOI 10.1136/adc.58.7.523	32	120	126	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e83304	10.1371/journal.pone.0083304	http://dx.doi.org/10.1371/journal.pone.0083304			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386174	Green Published, gold, Green Submitted			2022-12-25	WOS:000329194700031
J	Holmes, KJ; Klass, DM; Guiney, EL; Cyert, MS				Holmes, Kristen J.; Klass, Daniel M.; Guiney, Evan L.; Cyert, Martha S.			Whi3, an S. cerevisiae RNA-Binding Protein, Is a Component of Stress Granules That Regulates Levels of Its Target mRNAs	PLOS ONE			English	Article							ANALYZING P-BODIES; CELL-CYCLE; PROCESSING BODIES; BUDDING YEAST; SACCHAROMYCES; GENE; CLN3; ACCUMULATION; AGGREGATION; DECAY	RNA binding proteins (RBPs) are vital to the regulation of mRNA transcripts, and can alter mRNA localization, degradation, translation, and storage. Whi3 was originally identified in a screen for small cell size mutants, and has since been characterized as an RBP. The identification of Whi3-interacting mRNAs involved in mediating cellular responses to stress suggested that Whi3 might be involved in stress-responsive RNA processing. We show that Whi3 localizes to stress granules in response to glucose deprivation or heat shock. The kinetics and pattern of Whi3 localization in response to a range of temperatures were subtly but distinctly different from those of known components of RNA processing granules. Deletion of Whi3 resulted in an increase in the relative abundance of Whi3 target RNAs, either in the presence or absence of heat shock. Increased levels of the CLN3 mRNA in whi3 Delta cells may explain their decreased cell size. Another mRNA target of Whi3 encodes the zinc-responsive transcription factor Zap1, suggesting a role for Whi3 in response to zinc stress. Indeed, we found that whi3 Delta cells have enhanced sensitivity to zinc toxicity. Together our results suggest an expanded model for Whi3 function: in addition to its role as a regulator of the cell cycle, Whi3 may have a role in stress-dependent RNA processing and responses to a variety of stress conditions.	[Holmes, Kristen J.; Guiney, Evan L.; Cyert, Martha S.] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Klass, Daniel M.] Stanford Univ, Dept Biochem, Sch Med, Stanford, CA 94305 USA; [Klass, Daniel M.] Stanford Univ, Howard Hughes Med Inst, Sch Med, Stanford, CA 94305 USA	Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University	Cyert, MS (corresponding author), Stanford Univ, Dept Biol, Stanford, CA 94305 USA.	mcyert@stanford.edu		Cyert, Martha/0000-0003-3825-7437	National Institute of Health [GM-48728, T32-GM007276]; NSF; Howard Hughes Medical Institute; NIH [CA-77097]; Tom and Susan Ford Stanford Graduate Fellowship; Stanford School of Medicine Jill and John Freidenrich Translational Medicine Fund (JEE); Donald Kennedy Endowment; NATIONAL CANCER INSTITUTE [R01CA077097] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007276, R01GM048729] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Tom and Susan Ford Stanford Graduate Fellowship; Stanford School of Medicine Jill and John Freidenrich Translational Medicine Fund (JEE); Donald Kennedy Endowment; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institute of Health grants GM-48728 (MSC) and T32-GM007276 (KJH, DMK, ELG). DMK was also supported by an NSF predoctoral fellowship, by the Howard Hughes Medical Institute, and by NIH grant CA-77097 to Patrick O. Brown. ELG was also supported by the Tom and Susan Ford Stanford Graduate Fellowship (ELG), and by the Stanford School of Medicine Jill and John Freidenrich Translational Medicine Fund (JEE). KJH was also supported by the Donald Kennedy Endowment, and was a Genentech Fellow in the Biosciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldea M, 2007, CELL CYCLE, V6, P2599, DOI 10.4161/cc.6.21.4920; Anderson P, 2008, TRENDS BIOCHEM SCI, V33, P141, DOI 10.1016/j.tibs.2007.12.003; Balagopal V, 2009, CURR OPIN CELL BIOL, V21, P403, DOI 10.1016/j.ceb.2009.03.005; Bird AJ, 2004, EMBO J, V23, P1123, DOI 10.1038/sj.emboj.7600122; Brengues M, 2007, MOL BIOL CELL, V18, P2592, DOI 10.1091/mbc.E06-12-1149; Buchan JR, 2008, J CELL BIOL, V183, P441, DOI 10.1083/jcb.200807043; Buchan JR, 2011, J CELL SCI, V124, P228, DOI 10.1242/jcs.078444; Buchan JR, 2010, METHOD ENZYMOL, V470, P619, DOI 10.1016/S0076-6879(10)70025-2; Buchan JR, 2009, MOL CELL, V36, P932, DOI 10.1016/j.molcel.2009.11.020; Buttery SM, 2007, MOL BIOL CELL, V18, P1826, DOI 10.1091/mbc.E06-09-0820; Cai Y, 2013, PLOS ONE IN PRESS; Cherry JM, 2012, NUCLEIC ACIDS RES, V40, pD700, DOI 10.1093/nar/gkr1029; Colomina N, 2008, J BIOL CHEM, V283, P28670, DOI 10.1074/jbc.M804604200; Di Talia S, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000221; Eisinger-Mathason TSK, 2008, MOL CELL, V31, P722, DOI 10.1016/j.molcel.2008.06.025; Erickson SL, 2011, J CELL SCI, V124, P293, DOI 10.1242/jcs.072140; Falcon S, 2007, BIOINFORMATICS, V23, P257, DOI 10.1093/bioinformatics/btl567; Frey AG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022535; Gallego C, 1997, EMBO J, V16, P7196, DOI 10.1093/emboj/16.23.7196; Gari E, 2001, GENE DEV, V15, P2803; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Gilks N, 2004, MOL BIOL CELL, V15, P5383, DOI 10.1091/mbc.E04-08-0715; Grousl T, 2009, J CELL SCI, V122, P2078, DOI 10.1242/jcs.045104; Hendrickson DG, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000238; Hilgers V, 2006, RNA, V12, P1835, DOI 10.1261/rna.241006; Hoyle NP, 2007, J CELL BIOL, V179, P65, DOI 10.1083/jcb.200707010; Iyer VR, 1999, SCIENCE, V283, P83, DOI 10.1126/science.283.5398.83; Kedersha N, 2005, J CELL BIOL, V169, P871, DOI 10.1083/jcb.200502088; Lee C, 2013, DEV CELL, V25, P572, DOI 10.1016/j.devcel.2013.05.007; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; NASH R, 1988, EMBO J, V7, P4335, DOI 10.1002/j.1460-2075.1988.tb03332.x; Nash RS, 2001, GENETICS, V157, P1469; Nissan T, 2008, METHOD ENZYMOL, V448, P507, DOI 10.1016/S0076-6879(08)02625-6; Ragni E, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-107; Riordan DP, 2011, NUCLEIC ACIDS RES, V39, P1501, DOI 10.1093/nar/gkq920; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sheth U, 2003, SCIENCE, V300, P805, DOI 10.1126/science.1082320; SIKORSKI RS, 1989, GENETICS, V122, P19; Snaith HA, 2005, EMBO J, V24, P3690, DOI 10.1038/sj.emboj.7600838; Sudbery P, 2002, SCIENCE, V297, P351, DOI 10.1126/science.1073042; Swisher KD, 2009, MOL CELL, V34, P401, DOI 10.1016/j.molcel.2009.05.008; Tarassov K, 2008, SCIENCE, V320, P1465, DOI 10.1126/science.1153878; Teixeira D, 2005, RNA, V11, P371, DOI 10.1261/rna.7258505; Tsvetanova NG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012671; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Verges E, 2007, MOL CELL, V26, P649, DOI 10.1016/j.molcel.2007.04.023; Wang HY, 2004, EMBO J, V23, P180, DOI 10.1038/sj.emboj.7600022; Yoon JH, 2010, J CELL BIOL, V189, P813, DOI 10.1083/jcb.200912019; Zhao H, 1997, MOL CELL BIOL, V17, P5044, DOI 10.1128/MCB.17.9.5044	49	13	13	1	110	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e84060	10.1371/journal.pone.0084060	http://dx.doi.org/10.1371/journal.pone.0084060			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281RE	24386330	Green Published, Green Submitted, gold			2022-12-25	WOS:000329117900073
J	Schoenfuss, HL; Maie, T; Moody, KN; Lesteberg, KE; Blob, RW; Schoenfuss, TC				Schoenfuss, Heiko L.; Maie, Takashi; Moody, Kristine N.; Lesteberg, Kelsey E.; Blob, Richard W.; Schoenfuss, Tonya C.			Stairway to Heaven: Evaluating Levels of Biological Organization Correlated with the Successful Ascent of Natural Waterfalls in the Hawaiian Stream Goby Sicyopterus stimpsoni	PLOS ONE			English	Article							FIBER TYPE DISTRIBUTION; EXTREME ENVIRONMENTS; GOBIID FISHES; PERFORMANCE; SELECTION; CHALLENGES; PROTEOMICS; MIGRATION; RESPONSES; ECOLOGY	Selective pressures generated by locomotor challenges act at the level of the individual. However, phenotypic variation among individuals that might convey a selective advantage may occur across any of multiple levels of biological organization. In this study, we test for differences in external morphology, muscle mechanical advantage, muscle fiber type and protein expression among individuals of the waterfall climbing Hawaiian fish Sicyopterus stimpsoni collected from sequential pools increasing in elevation within a single freshwater stream. Despite predictions from previous laboratory studies of morphological selection, few directional morphometric changes in body shape were observed at successively higher elevations. Similarly, lever arm ratios associated with the main pelvic sucker, central to climbing ability in this species, did not differ between elevations. However, among climbing muscles, the adductor pelvicus complex (largely responsible for generating pelvic suction during climbing) contained a significantly greater red muscle fiber content at upstream sites. A proteomic analysis of the adductor pelvicus revealed two-fold increases in expression levels for two respiratory chain proteins (NADH: ubiquinone reductase and cytochrome b) that are essential for aerobic respiration among individuals from successively higher elevations. Assessed collectively, these evaluations reveal phenotypic differences at some, but not all levels of biological organization that are likely the result of selective pressures experienced during climbing.	[Schoenfuss, Heiko L.; Lesteberg, Kelsey E.] St Cloud State Univ, Aquat Toxicol Lab, St Cloud, MN 56301 USA; [Maie, Takashi; Moody, Kristine N.; Blob, Richard W.] Clemson Univ, Dept Biol Sci, Clemson, SC 29634 USA; [Schoenfuss, Tonya C.] Univ Minnesota, Dept Food Sci & Nutr, St Paul, MN USA	Minnesota State Colleges & Universities; Saint Cloud State University; Clemson University; University of Minnesota System; University of Minnesota Twin Cities	Schoenfuss, HL (corresponding author), St Cloud State Univ, Aquat Toxicol Lab, St Cloud, MN 56301 USA.	hschoenfuss@stcloudstate.edu	Moody, Kristine/AAB-3913-2019	Schoenfuss, Tonya/0000-0002-8353-2226; Schoenfuss, Heiko/0000-0001-5464-992X; Lesteberg, Kelsey/0000-0002-3081-457X; Blob, Richard/0000-0001-5026-343X	NSF [IOS-0817911, IOS-0817794]; St. Cloud State University Faculty Improvement grant; Clemson University Research Investment Fund Award	NSF(National Science Foundation (NSF)); St. Cloud State University Faculty Improvement grant; Clemson University Research Investment Fund Award	This project was supported by funding from NSF grants IOS-0817911 (HLS) and IOS-0817794 (RWB), St. Cloud State University Faculty Improvement grant (HLS), and Clemson University Research Investment Fund Award (RWB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Blake RW, 2006, CAN J ZOOL, V84, P1173, DOI 10.1139/Z06-105; Blakely EL, 2005, FEBS J, V272, P3583, DOI 10.1111/j.1742-4658.2005.04779.x; Blob RW, 2007, J ZOOL, V273, P200, DOI 10.1111/j.1469-7998.2007.00315.x; Blob RW, 2010, INTEGR COMP BIOL, V50, P1185, DOI 10.1093/icb/icq070; Blob RW, 2008, INTEGR COMP BIOL, V48, P734, DOI 10.1093/icb/icn086; Blob RW, 2006, J ZOOL, V268, P315, DOI 10.1111/j.1469-7998.2005.00034.x; Cediel RA, 2008, ZOOLOGY, V111, P114, DOI 10.1016/j.zool.2007.06.004; Cullen JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053274; DEGRAAF F, 1990, Z MIKROSK ANAT FORSC, V104, P593; Dowd WW, 2010, J EXP BIOL, V213, P210, DOI 10.1242/jeb.031781; Endler J.A., 1986, Monographs in Population Biology, pviii; Fitzsimons J. Michael, 2003, Ichthyological Exploration of Freshwaters, V14, P185; Fitzsimons J. Michael, 1993, Ichthyological Exploration of Freshwaters, V4, P1; FITZSIMONS JM, 1995, ENVIRON BIOL FISH, V43, P39, DOI 10.1007/BF00001816; Friedrich T, 2004, BBA-BIOENERGETICS, V1608, P1, DOI 10.1016/j.bbabio.2003.10.002; Herrel A., 2006, ECOLOGY BIOMECHANICS; Irschick DJ, 2008, EVOL ECOL RES, V10, P177; Julius ML, 2005, AQUAT ECOL, V39, P473, DOI 10.1007/s10452-005-9007-1; Karr TL, 2008, HEREDITY, V100, P200, DOI 10.1038/sj.hdy.6801008; Kawano SM, 2013, EVOL ECOL, V27, P949, DOI 10.1007/s10682-012-9621-z; Kido MH, 1996, ENVIRON BIOL FISH, V45, P199, DOI 10.1007/BF00005234; LANDE R, 1983, EVOLUTION, V37, P1210, DOI [10.1111/j.1558-5646.1983.tb00236.x, 10.2307/2408842]; Leonard G, 2012, J FISH BIOL, V81, P903, DOI 10.1111/j.1095-8649.2012.03352.x; Maie T, 2007, COPEIA, P755, DOI 10.1643/0045-8511(2007)2007[755:OSOBPI]2.0.CO;2; Maie T, 2013, J MORPHOL, V274, P733, DOI 10.1002/jmor.20130; Maie T, 2012, J EXP BIOL, V215, P3925, DOI 10.1242/jeb.072967; Maie T, 2011, ZOOLOGY, V114, P340, DOI 10.1016/j.zool.2011.05.005; McDowall RM, 2010, REV FISH BIOL FISHER, V20, P87, DOI 10.1007/s11160-009-9125-2; Morzel M, 2006, J AGR FOOD CHEM, V54, P2997, DOI 10.1021/jf0528759; Mykles DL, 2010, INTEGR COMP BIOL, V50, P6, DOI 10.1093/icb/icq015; Nesatyy VJ, 2007, ENVIRON SCI TECHNOL, V41, P6891, DOI 10.1021/es070561r; Pon LB, 2012, RIVER RES APPL, V28, P1266, DOI 10.1002/rra.1508; RADTKE RL, 1988, ENVIRON BIOL FISH, V23, P205, DOI 10.1007/BF00004911; Reznick David, 1996, P243; Schoenfuss Heiko L., 2007, Bishop Museum Bulletin in Cultural and Environmental Studies, V3, P125; Schoenfuss Heiko L., 1997, Micronesica, V30, P93; Schoenfuss HL, 2003, J ZOOL, V261, P191, DOI 10.1017/S0952836903004102; Sokal R. R., 2012, BIOMETRY; Volpato GL, 2009, MAR FRESHW BEHAV PHY, V42, P307, DOI 10.1080/10236240903299177; Waterman TH, 1999, J EXP ZOOL, V285, P326, DOI 10.1002/(SICI)1097-010X(19991215)285:4<326::AID-JEZ3>3.3.CO;2-K; Wilson MP, 2009, ANAT REC, V292, P935, DOI 10.1002/ar.20929	42	18	18	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e84851	10.1371/journal.pone.0084851	http://dx.doi.org/10.1371/journal.pone.0084851			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281RE	24386424	gold, Green Published			2022-12-25	WOS:000329117900114
J	Zhou, HJ; Dan, YY; Naidoo, N; Li, SC; Yeoh, KG				Zhou, Hui Jun; Dan, Yock Young; Naidoo, Nasheen; Li, Shu Chuen; Yeoh, Khay Guan			A Cost-Effectiveness Analysis Evaluating Endoscopic Surveillance for Gastric Cancer for Populations with Low to Intermediate Risk	PLOS ONE			English	Article							HELICOBACTER-PYLORI; INTESTINAL METAPLASIA; SERUM PEPSINOGEN; CLINICOPATHOLOGICAL FEATURES; CHINESE POPULATION; UTILITY ANALYSIS; FOLLOW-UP; LESIONS; SINGAPORE; COHORT	Background: Gastric cancer (GC) surveillance based on oesophagogastroduodenoscopy (OGD) appears to be a promising strategy for GC prevention. By evaluating the cost-effectiveness of endoscopic surveillance in Singaporean Chinese, this study aimed to inform the implementation of such a program in a population with a low to intermediate GC risk. Methods: Using a reference strategy of no OGD intervention, we evaluated four strategies: 2-yearly OGD surveillance, annual OGD surveillance, 2-yearly OGD screening and 2-yearly screening plus annual surveillance in Singaporean Chinese aged 50-69 years. From a perspective of the healthcare system, Markov models were built to simulate the life experience of the target population. The models projected discounted lifetime costs ($), quality adjusted life year (QALY), and incremental cost-effectiveness ratio (ICER) indicating the cost-effectiveness of each strategy against a Singapore willingness-to-pay of $46,200/QALY. Deterministic and probabilistic sensitivity analyses were used to identify the influential variables and their associated thresholds, and to quantify the influence of parameter uncertainties respectively. Results: With an ICER of $44,098/QALY, the annual OGD surveillance was the optimal strategy while the 2-yearly surveillance was the most cost-effective strategy (ICER = $25,949/QALY). The screening-based strategies were either extendedly dominated or cost-ineffective. The cost-effectiveness heterogeneity of the four strategies was observed across age-gender subgroups. Eight influential parameters were identified each with their specific thresholds to define the choice of optimal strategy. Accounting for the model uncertainties, the probability that the annual surveillance is the optimal strategy in Singapore was 44.5%. Conclusion: Endoscopic surveillance is potentially cost-effective in the prevention of GC for populations at low to intermediate risk. Regarding program implementation, a detailed analysis of influential factors and their associated thresholds is necessary. Multiple strategies should be considered in order to recommend the right strategy for the right population.	[Zhou, Hui Jun; Naidoo, Nasheen] Natl Univ Singapore, Yong Loo Lin Sch Med, Sch Publ Hlth, Singapore 117595, Singapore; [Dan, Yock Young; Yeoh, Khay Guan] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Med, Singapore 117595, Singapore; [Li, Shu Chuen] Univ Newcastle, Discipline Pharm & Expt Pharmacol, Sch Biomed Sci & Pharm, Callaghan, NSW 2308, Australia	National University of Singapore; National University of Singapore; University of Newcastle	Yeoh, KG (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Med, Singapore 117595, Singapore.	mdcykg@nus.edu.sg	/AAR-5357-2020	Naidoo, Navindhra/0000-0001-9142-3751; Naidoo, Nasheen/0000-0001-8613-4808				Ang TL, 2005, J GASTROEN HEPATOL, V20, P1603, DOI 10.1111/j.1440-1746.2005.03898.x; [Anonymous], 2001, MACR HLTH INV HLTH E; Areia M, 2013, HELICOBACTER, V18, P325, DOI 10.1111/hel.12050; Barton GR, 2008, VALUE HEALTH, V11, P886, DOI 10.1111/j.1524-4733.2008.00358.x; Centers for Disease Control and Prevention NBCCEDP, 2005, POL PROC MAN; Chang HS, 2012, ASIAN PAC J CANCER P, V13, P2721, DOI 10.7314/APJCP.2012.13.6.2721; Choi KS, 2009, CANCER EPIDEM BIOMAR, V18, P1390, DOI 10.1158/1055-9965.EPI-08-0940; Dan YY, 2006, CLIN GASTROENTEROL H, V4, P709, DOI 10.1016/j.cgh.2006.03.025; Department of Statistics Singapore, 2012, YB STAT SING 2012; Dinis-Ribeiro M, 2012, ENDOSCOPY, V44, P74, DOI 10.1055/s-0031-1291491; Dinis-Ribeiro M, 2007, J GASTROEN HEPATOL, V22, P1594, DOI 10.1111/j.1440-1746.2007.04863.x; El-Omar EM, 2000, NATURE, V404, P398, DOI 10.1038/35006081; Environmental Protection Agency USA, 2000, COST ILLN HDB, P1; Fock KM, 2008, J GASTROEN HEPATOL, V23, P351, DOI 10.1111/j.1440-1746.2008.05314.x; Gupta N, 2011, GASTROINTEST ENDOSC, V74, P610, DOI 10.1016/j.gie.2011.05.001; Hassan C, 2010, HELICOBACTER, V15, P221, DOI 10.1111/j.1523-5378.2010.00752.x; Hosokawa O, 2008, SCAND J GASTROENTERO, V43, P1112, DOI 10.1080/00365520802085395; Kang JM, 2011, WORLD J GASTROENTERO, V17, P3518, DOI 10.3748/wjg.v17.i30.3518; Kim YS, 2000, J KOREAN MED SCI, V15, P510, DOI 10.3346/jkms.2000.15.5.510; Koong HN, 1996, AUST NZ J SURG, V66, P813, DOI 10.1111/j.1445-2197.1996.tb00755.x; Kubota H, 2000, SURGERY, V128, P41, DOI 10.1067/msy.2000.106812; Kwon YM, 2009, WORLD J GASTROENTERO, V15, P3653, DOI 10.3748/wjg.15.3653; Lee KJ, 2006, INT J CANCER, V118, P2315, DOI 10.1002/ijc.21664; Lee YC, 2007, CANCER EPIDEM BIOMAR, V16, P875, DOI 10.1158/1055-9965.EPI-06-0758; Leung WK, 2008, LANCET ONCOL, V9, P279, DOI 10.1016/S1470-2045(08)70072-X; Liu CY, 2006, J MED SCREEN, V13, pS2; Morabito A, 2009, CRIT REV ONCOL HEMAT, V70, P216, DOI 10.1016/j.critrevonc.2008.08.005; Mukoubayashi C, 2007, INTERNAL MED, V46, P261, DOI 10.2169/internalmedicine.46.6181; Nakashima H, 2010, GASTRIC CANCER, V13, P78, DOI 10.1007/s10120-009-0538-3; Ohata H, 2004, INT J CANCER, V109, P138, DOI 10.1002/ijc.11680; Robert G, 2000, J MED SCREEN, V7, P31, DOI 10.1136/jms.7.1.31; Shapiro J, 1982, EDUC EVAL POLICY AN, P341; Shiroiwa T, 2010, HEALTH ECON, V19, P422, DOI 10.1002/hec.1481; Singapore Cancer Registry Committee, 2012, TRENDS CANC INC SING; Subramanian S, 2011, EVAL PROGRAM PLANN, V34, P147, DOI 10.1016/j.evalprogplan.2010.09.005; Thompson SG, 2000, BRIT MED J, V320, P1197, DOI 10.1136/bmj.320.7243.1197; Tsubono Yoshitaka, 2000, Asian Pac J Cancer Prev, V1, P57; Tsuji I, 2001, Nihon Rinsho, V59 Suppl 4, P533; U. S. Environmental Protection Agency, 2010, COST ILLN HDB; Voutilainen ME, 2005, EUR J GASTROEN HEPAT, V17, P1345, DOI 10.1097/00042737-200512000-00013; Wai CT, 2002, GASTROINTEST ENDOSC, V56, P548, DOI 10.1067/mge.2002.128493; Walter LC, 2009, ANN INTERN MED, V150, P465, DOI 10.7326/0003-4819-150-7-200904070-00006; Watabe H, 2005, GUT, V54, P764, DOI 10.1136/gut.2004.055400; Weinstein MC, 1996, JAMA-J AM MED ASSOC, V276, P1253, DOI 10.1001/jama.276.15.1253; Weinstein MC, 2003, VALUE HEALTH, V6, P9, DOI 10.1046/j.1524-4733.2003.00234.x; Whiting JL, 2002, GUT, V50, P378, DOI 10.1136/gut.50.3.378; Wong BCY, 2004, JAMA-J AM MED ASSOC, V291, P187, DOI 10.1001/jama.291.2.187; Xie F, 2008, INT J TECHNOL ASSESS, V24, P87, DOI 10.1017/S0266462307080117; Xie Feng, 2009, J Am Coll Radiol, V6, P317, DOI 10.1016/j.jacr.2009.01.022; Yeh JM, 2010, GASTROINTEST ENDOSC, V72, P33, DOI 10.1016/j.gie.2010.01.047; Yeh JM, 2010, CANCER-AM CANCER SOC, V116, P2941, DOI 10.1002/cncr.25030; Zhou HJ, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-139; Zhou HJ, 2012, HEALTH QUAL LIFE OUT, V10, DOI 10.1186/1477-7525-10-145; Zhu F, 2009, BMC GASTROENTEROL, V9, DOI 10.1186/1471-230X-9-76	54	24	26	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e83959	10.1371/journal.pone.0083959	http://dx.doi.org/10.1371/journal.pone.0083959			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	281RE	24386314	gold, Green Published, Green Submitted			2022-12-25	WOS:000329117900069
J	Holme, P				Holme, Petter			Extinction Times of Epidemic Outbreaks in Networks	PLOS ONE			English	Article								In the Susceptible-Infectious-Recovered (SIR) model of disease spreading, the time to extinction of the epidemics happens at an intermediate value of the per-contact transmission probability. Too contagious infections burn out fast in the population. Infections that are not contagious enough die out before they spread to a large fraction of people. We characterize how the maximal extinction time in SIR simulations on networks depend on the network structure. For example we find that the average distances in isolated components, weighted by the component size, is a good predictor of the maximal time to extinction. Furthermore, the transmission probability giving the longest outbreaks is larger than, but otherwise seemingly independent of, the epidemic threshold.	[Holme, Petter] Sungkyunkwan Univ, Dept Energy Sci, Suwon, South Korea; [Holme, Petter] Umea Univ, Dept Phys, IceLab, Umea, Sweden; [Holme, Petter] Stockholm Univ, Dept Sociol, S-10691 Stockholm, Sweden	Sungkyunkwan University (SKKU); Umea University; Stockholm University	Holme, P (corresponding author), Sungkyunkwan Univ, Dept Energy Sci, Suwon, South Korea.	holme@skku.edu	Holme, Petter/A-7646-2008	Holme, Petter/0000-0003-2156-1096	Basic Science Research Program through the National Research Foundation of Korea (NRF); Ministry of Education [2013R1A1A2011947]	Basic Science Research Program through the National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (2013R1A1A2011947). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson RM, 2004, INFECT DIS HUMANS; Barthelemy M, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.178701; Bollobas B., 1980, EUROPEAN J COMBIN, V1, P311, DOI [10.1016/S0195-6698(80)80030-8, DOI 10.1016/S0195-6698(80)80030-8]; Buckley F., 1989, DISTANCE GRAPHS, DOI [10.1007/978-0-8176-4789-6-3, DOI 10.1007/978-0-8176-4789-6-3]; Chung F, 2002, P NATL ACAD SCI USA, V99, P15879, DOI 10.1073/pnas.252631999; Danon L., 2011, Interdisciplinary Perspectives on Infectious Diseases, V2011, P284909, DOI 10.1155/2011/284909; Erdos P, 1959, PUBL MATH-DEBRECEN, V6, P290, DOI DOI 10.2307/1999405; Funk S, 2010, J R SOC INTERFACE, V7, P1247, DOI 10.1098/rsif.2010.0142; Holme Petter, 2002, Phys Rev E Stat Nonlin Soft Matter Phys, V65, P066109; Jansson S, 2013, ARXIV13085493; Keeling MJ, 2005, J R SOC INTERFACE, V2, P295, DOI 10.1098/rsif.2005.0051; Latora V, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198701; Liljeros F, 2004, PHYSICA A, V338, P238, DOI 10.1016/j.physa.2004.02.046; Masuda N, 2013, F1000PRIME REP; May RM, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.066112; Morris M, 2010, NETWORK EPIDEMIOLOGY; Newman MEJ, 2004, PHYS REV E, V69, DOI [10.1103/PhysRevE.69.026113, 10.1103/PhysRevE.70.056131]; Pastor-Satorras R, 2001, PHYS REV LETT, V86, P3200, DOI 10.1103/PhysRevLett.86.3200; Salathe M, 2005, J ROY SOC INTERFACE, V2, P533, DOI 10.1098/rsif.2005.0072; Szendroi B, 2004, P ROY SOC B-BIOL SCI, V271, pS364, DOI 10.1098/rsbl.2004.0188	20	14	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e84429	10.1371/journal.pone.0084429	http://dx.doi.org/10.1371/journal.pone.0084429			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281QS	24386377	Green Published, Green Submitted, gold			2022-12-25	WOS:000329116700107
J	Lucky, A; Trautwein, MD; Guenard, BS; Weiser, MD; Dunn, RR				Lucky, Andrea; Trautwein, Michelle D.; Guenard, Benoit S.; Weiser, Michael D.; Dunn, Robert R.			Tracing the Rise of Ants - Out of the Ground	PLOS ONE			English	Article							AMBER HYMENOPTERA; EARLY EVOLUTION; FORMICIDAE; DIVERSIFICATION; PHYLOGENY; DIVERSITY; PONERINAE; TAXA	The evolution of ants (Hymenoptera: Formicidae) is increasingly well-understood due to recent phylogenetic analyses, along with estimates of divergence times and diversification rates. Yet, leading hypotheses regarding the ancestral habitat of ants conflict with new findings that early ant lineages are cryptic and subterranean. Where the ants evolved, in respect to habitat, and how habitat shifts took place over time have not been formally tested. Here, we reconstruct the habitat transitions of crown-group ants through time, focusing on where they nest and forage (in the canopy, litter, or soil). Based on ancestral character reconstructions, we show that in contrast to the current consensus based on verbal arguments that ants evolved in tropical leaf litter, the soil is supported as the ancestral stratum of all ants. We also find subsequent movements up into the litter and, in some cases, into the canopy. Given the global importance of ants, because of their diversity, ecological influence and status as the most successful eusocial lineage on Earth, understanding the early evolution of this lineage provides insight into the factors that made this group so successful today.	[Lucky, Andrea; Guenard, Benoit S.; Weiser, Michael D.; Dunn, Robert R.] N Carolina State Univ, Dept Biol, Raleigh, NC 27695 USA; [Lucky, Andrea] Univ Florida, Dept Entomol & Nematol, Gainesville, FL 32611 USA; [Trautwein, Michelle D.] N Carolina State Univ, Dept Entomol, Raleigh, NC 27695 USA; [Trautwein, Michelle D.] North Carolina Museum Nat Sci, Nat Res Ctr, Raleigh, NC 27695 USA; [Guenard, Benoit S.] Okinawa Inst Sci & Technol, Biodivers & Biocomplex Unit, Onna Son, Okinawa, Japan; [Weiser, Michael D.] Univ Oklahoma, Dept Biol, Norman, OK 73019 USA	University of North Carolina; North Carolina State University; State University System of Florida; University of Florida; University of North Carolina; North Carolina State University; Okinawa Institute of Science & Technology Graduate University; University of Oklahoma System; University of Oklahoma - Norman	Lucky, A (corresponding author), N Carolina State Univ, Dept Biol, Raleigh, NC 27695 USA.	alucky@ufl.edu	Weiser, Michael/E-6215-2011	Weiser, Michael/0000-0001-9080-0834; /0000-0001-6782-917X; Trautwein, Michelle/0000-0003-4469-5839; Guenard, Benoit/0000-0002-7144-1175; Dunn, Robert/0000-0002-6030-4837	NSF-CAREER [0953390]; DOE-PER [DE-FG02-08ER64510]; NASA [NNX09AK22G]; Division Of Environmental Biology [0953390] Funding Source: National Science Foundation	NSF-CAREER(National Science Foundation (NSF)NSF - Office of the Director (OD)); DOE-PER(United States Department of Energy (DOE)); NASA(National Aeronautics & Space Administration (NASA)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	AL was supported by NSF-CAREER grant 0953390; RRD was supported by the following grants: DOE-PER DE-FG02-08ER64510, NASA NNX09AK22G, NSF-CAREER 0953390. (websites: www.nsf.gov, www.doe.gov.) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adl S, 2011, SOIL BIOL BIOCHEM, V43, P726, DOI 10.1016/j.soilbio.2010.12.003; Barden P, 2013, ZOOTAXA, V3681, P405, DOI 10.11646/zootaxa.3681.4.5; Barden P, 2012, AM MUS NOVIT, P1; Blomberg SP, 2003, EVOLUTION, V57, P717, DOI 10.1111/j.0014-3820.2003.tb00285.x; BOLTON B., 2007, BOLTONS CATALOGUE AN; Brady SG, 2006, P NATL ACAD SCI USA, V103, P18172, DOI 10.1073/pnas.0605858103; Brown William L. Jr, 2000, P45; Crisp M, 2004, PHILOS T R SOC B, V359, P1551, DOI 10.1098/rstb.2004.1528; Crozier RH, 1997, NATURWISSENSCHAFTEN, V84, P22, DOI 10.1007/s001140050341; Crozier RH, 2006, P NATL ACAD SCI USA, V103, P18029, DOI 10.1073/pnas.0608880103; Darwin C., 1859, ORIGIN SPECIES MEANS, DOI [10.5962/bhl.title.82303, DOI 10.5962/BHL.TITLE.82303]; Diamond SE, 2012, GLOBAL CHANGE BIOL, V18, P448, DOI 10.1111/j.1365-2486.2011.02542.x; Dlussky GM, 2012, J SYST PALAEONTOL, V10, P725, DOI 10.1080/14772019.2011.628341; Dlussky GM, 2009, PALEONTOL J+, V43, P1043, DOI 10.1134/S0031030109090068; Dlussky Gennady M., 2002, Russian Entomological Journal, V11, P411; Engel MS, 2005, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2005)485[0001:PNAICA]2.0.CO;2; Forel A., 1874, FOURMIS SUISSE SYSTE; Grimaldi D, 2000, P NATL ACAD SCI USA, V97, P13678, DOI 10.1073/pnas.240452097; Harmon LJ, 2008, BIOINFORMATICS, V24, P129, DOI 10.1093/bioinformatics/btm538; Hof C, 2010, ECOGRAPHY, V33, P242, DOI 10.1111/j.1600-0587.2010.06309.x; Holldobler B., 1990, pi; Holldobler B, 2008, SUPERORGANISM BEAUTY; Johnson BR, 2013, CURR BIOL, V23, P1; Kembel SW, 2010, BIOINFORMATICS, V26, P1463, DOI 10.1093/bioinformatics/btq166; Kuck P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021031; LaPolla JS, 2013, ANNU REV ENTOMOL, V58, P609, DOI 10.1146/annurev-ento-120710-100600; Lessard J.-P., 2011, P R SOC B, V279, P266; Machac A, 2011, ECOGRAPHY, V34, P364, DOI 10.1111/j.1600-0587.2010.06629.x; McKellar RC, 2013, B GEOSCI, V88, P583, DOI 10.3140/bull.geosci.1425; Moreau CS, 2013, EVOLUTION, V67, P2240, DOI 10.1111/evo.12105; Moreau CS, 2006, SCIENCE, V312, P101, DOI 10.1126/science.1124891; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; Perrichot V., 2004, Geologica Acta, V2, P9; Perrichot V, 2008, NATURWISSENSCHAFTEN, V95, P85, DOI 10.1007/s00114-007-0301-8; Rabeling C, 2008, P NATL ACAD SCI USA, V105, P14913, DOI 10.1073/pnas.0806187105; Retallack GJ, 2002, PHILOS T R SOC A, V360, P659, DOI 10.1098/rsta.2001.0960; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; Schultz TR, 2000, P NATL ACAD SCI USA, V97, P14028, DOI 10.1073/pnas.011513798; Ward PS, 2010, SYST BIOL, V59, P342, DOI 10.1093/sysbio/syq012; Wiens JJ, 2009, EVOLUTION, V63, P1217, DOI 10.1111/j.1558-5646.2009.00610.x; Wilkie KTR, 2007, NATURWISSENSCHAFTEN, V94, P725, DOI 10.1007/s00114-007-0250-2; WILSON EDWARD O., 1967, PSYCHE J ENTOMOL, V74, P1, DOI 10.1155/1967/89604; Wilson EO, 2005, P NATL ACAD SCI USA, V102, P7411, DOI 10.1073/pnas.0502264102; Yu Y., 2013, RASP RECONSTRUCT ANC	44	40	41	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e84012	10.1371/journal.pone.0084012	http://dx.doi.org/10.1371/journal.pone.0084012			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281QS	24386323	Green Published, gold, Green Submitted			2022-12-25	WOS:000329116700093
J	Moehler, TM; Seckinger, A; Hose, D; Andrulis, M; Moreaux, J; Hielscher, T; Willhauck-Fleckenstein, M; Merling, A; Bertsch, U; Jauch, A; Goldschmidt, H; Klein, B; Schwartz-Albiez, R				Moehler, Thomas M.; Seckinger, Anja; Hose, Dirk; Andrulis, Mindaugas; Moreaux, Jerome; Hielscher, Thomas; Willhauck-Fleckenstein, Martina; Merling, Anette; Bertsch, Uta; Jauch, Anna; Goldschmidt, Hartmut; Klein, Bernard; Schwartz-Albiez, Reinhard			The Glycome of Normal and Malignant Plasma Cells	PLOS ONE			English	Article							HEPARAN-SULFATE PROTEOGLYCANS; BONE-MARROW ENVIRONMENT; RISK-ADAPTED TREATMENT; MULTIPLE-MYELOMA; GROWTH-FACTOR; PROGNOSTIC-FACTOR; B-LYMPHOCYTE; TUMOR-CELLS; EXPRESSION; SYNDECAN-1	The glycome, i.e. the cellular repertoire of glycan structures, contributes to important functions such as adhesion and intercellular communication. Enzymes regulating cellular glycosylation processes are related to the pathogenesis of cancer including multiple myeloma. Here we analyze the transcriptional differences in the glycome of normal (n = 10) and two cohorts of 332 and 345 malignant plasma-cell samples, association with known multiple myeloma subentities as defined by presence of chromosomal aberrations, potential therapeutic targets, and its prognostic impact. We found i) malignant vs. normal plasma cells to show a characteristic glycome-signature. They can ii) be delineated by a lasso-based predictor from normal plasma cells based on this signature. iii) Cytogenetic aberrations lead to distinct glycan-gene expression patterns for t(11; 14), t(4; 14), hyperdiploidy, 1q21-gain and deletion of 13q14. iv) A 38-gene glycome-signature significantly delineates patients with adverse survival in two independent cohorts of 545 patients treated with high-dose melphalan and autologous stem cell transplantation. v) As single gene, expression of the phosphatidyl-inositol-glycan protein M as part of the targetable glycosyl-phosphatidyl-inositol-anchor-biosynthesis pathway is associated with adverse survival. The prognostically relevant glycome deviation in malignant cells invites novel strategies of therapy for multiple myeloma.	[Moehler, Thomas M.; Seckinger, Anja; Hose, Dirk; Bertsch, Uta; Goldschmidt, Hartmut] Univ Klinikum Heidelberg, Med Klin 5, Heidelberg, Germany; [Moehler, Thomas M.; Willhauck-Fleckenstein, Martina; Merling, Anette; Schwartz-Albiez, Reinhard] Deutsch Krebsforschungszentrum, Heidelberg, Germany; [Seckinger, Anja; Hose, Dirk; Goldschmidt, Hartmut] Natl Ctr Tumorerkrankungen, Heidelberg, Germany; [Andrulis, Mindaugas] Heidelberg Univ, Inst Pathol, Heidelberg, Germany; [Moreaux, Jerome; Klein, Bernard] INSERM, U1040, Montpellier, France; [Moreaux, Jerome; Klein, Bernard] Ctr Hosp Univ, Inst Res Biotherapy, Montpellier 3, France; [Moreaux, Jerome; Klein, Bernard] Univ Montpellier I, UFR Med, Montpellier, France; [Hielscher, Thomas] Deutsch Krebsforschungszentrum, Biostat Abt, Heidelberg, Germany; [Jauch, Anna] Heidelberg Univ, Inst Humangenet, Heidelberg, Germany	Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg	Schwartz-Albiez, R (corresponding author), Deutsch Krebsforschungszentrum, Heidelberg, Germany.	r.s-albiez@dkfz.de	moreaux, jerome/HGA-5649-2022; Goldschmidt, Hartmut/AAL-8069-2021; Andrulis, Mindaugas/AAN-5668-2021; J, Moreaux/ABA-2974-2021	J, Moreaux/0000-0002-5717-3207; Andrulis, Mindaugas/0000-0001-9866-4849	Deutsche Forschungsgemeinschaft, Bonn, Germany [SFB/TR79]; Deutsche Jose Carreras Leukamie-Stiftung e.V., Munich, Germany [DJCLS R 10/32f]; German Federal Ministry of Education (BMBF) "CAMPSIM"; German Federal Ministry of Education (BMBF) CLIOMMICS"; 7th EU-framework program "OverMyR"	Deutsche Forschungsgemeinschaft, Bonn, Germany(German Research Foundation (DFG)); Deutsche Jose Carreras Leukamie-Stiftung e.V., Munich, Germany; German Federal Ministry of Education (BMBF) "CAMPSIM"(Federal Ministry of Education & Research (BMBF)); German Federal Ministry of Education (BMBF) CLIOMMICS"(Federal Ministry of Education & Research (BMBF)); 7th EU-framework program "OverMyR"	This work was supported in part by grants from the Deutsche Forschungsgemeinschaft (SFB/TR79), Bonn, Germany, to D. H., T. M., A. S., H. G. and R.S-A.; the Deutsche Jose Carreras Leukamie-Stiftung e.V., Munich, Germany (grant DJCLS R 10/32f) to R.S.-A. and H. G.; the German Federal Ministry of Education (BMBF) "CAMPSIM" to D. H. and H. G., CLIOMMICS" to D. H., H. G., and A. S., and the 7th EU-framework program "OverMyR" to D. H. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrulis M, 2012, HAEMATOL-HEMATOL J, V97, P1674, DOI 10.3324/haematol.2011.061051; Avet-Loiseau H, 2007, BLOOD, V109, P3489, DOI 10.1182/blood-2006-08-040410; Barlogie B, 2006, NEW ENGL J MED, V354, P1021, DOI 10.1056/NEJMoa053583; Barlogie B, 2006, BRIT J HAEMATOL, V135, P158, DOI 10.1111/j.1365-2141.2006.06271.x; Bret C, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-72; Bret C, 2009, BRIT J HAEMATOL, V145, P350, DOI 10.1111/j.1365-2141.2009.07633.x; Cremer FW, 2005, GENE CHROMOSOME CANC, V44, P194, DOI 10.1002/gcc.20231; Derksen PWB, 2002, BLOOD, V99, P1405, DOI 10.1182/blood.V99.4.1405; Durie BGM, 2006, LEUKEMIA, V20, P1467, DOI 10.1038/sj.leu.2404284; Engelmann S, 1997, CARBOHYD RES, V302, P85, DOI 10.1016/S0008-6215(97)00115-8; ENGELMANN S, 1995, BBA-MOL CELL RES, V1267, P6, DOI 10.1016/0167-4889(95)00057-Y; Erdmann M, 2006, GLYCOCONJUGATE J, V23, P627, DOI 10.1007/s10719-006-9000-5; Filmus J, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-5-224; Fonseca Rafael, 2004, Cancer Research, V64, P1546, DOI 10.1158/0008-5472.CAN-03-2876; Goeman JJ, 2004, BIOINFORMATICS, V20, P93, DOI 10.1093/bioinformatics/btg382; Greipp PR, 2005, J CLIN ONCOL, V23, P3412, DOI 10.1200/JCO.2005.04.242; Gu ZJ, 2000, LEUKEMIA, V14, P188, DOI 10.1038/sj.leu.2401632; Harousseau JL, 2009, NEW ENGL J MED, V360, P2645, DOI 10.1056/NEJMct0805626; Hose D, 2011, HAEMATOL-HEMATOL J, V96, P87, DOI 10.3324/haematol.2010.030296; Hose D, 2009, BLOOD, V114, P128, DOI 10.1182/blood-2008-10-184226; Hose D, 2009, BLOOD, V113, P4331, DOI 10.1182/blood-2008-09-178350; Irie A, 2007, BONE, V41, P165, DOI 10.1016/j.bone.2007.04.190; Jurianz K, 1999, MOL IMMUNOL, V36, P929, DOI 10.1016/S0161-5890(99)00115-7; Kannagi R, 2004, CANCER SCI, V95, P377, DOI 10.1111/j.1349-7006.2004.tb03219.x; Kirschfink M, 1997, J IMMUNOL, V158, P1324; Kyle RA, 2004, NEW ENGL J MED, V351, P1860, DOI 10.1056/NEJMra041875; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lowe JB, 2003, CURR OPIN CELL BIOL, V15, P531, DOI 10.1016/j.ceb.2003.08.002; Mahtouk K, 2006, ONCOGENE, V25, P7180, DOI 10.1038/sj.onc.1209699; Mahtouk K, 2005, ONCOGENE, V24, P3512, DOI 10.1038/sj.onc.1208536; Mahtouk K, 2007, BLOOD, V109, P4914, DOI 10.1182/blood-2006-08-043232; Mahtouk K, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-198; Meissner T, 2011, CLIN CANCER RES, V17, P7240, DOI 10.1158/1078-0432.CCR-11-1628; Mikesch JH, 2006, BBA-REV CANCER, V1766, P42, DOI 10.1016/j.bbcan.2006.04.001; Moreaux J, 2009, EUR J HAEMATOL, V83, P119, DOI 10.1111/j.1600-0609.2009.01262.x; Nair B, 2010, BLOOD, V115, P4168, DOI 10.1182/blood-2009-11-255620; Neben K, 2012, BLOOD, V119, P940, DOI 10.1182/blood-2011-09-379164; Paulick MG, 2008, BIOCHEMISTRY-US, V47, P6991, DOI 10.1021/bi8006324; Pilobello KT, 2007, CURR OPIN CHEM BIOL, V11, P300, DOI 10.1016/j.cbpa.2007.05.002; Rebouissou C, 1998, BLOOD, V91, P4727, DOI 10.1182/blood.V91.12.4727.412k35_4727_4737; Reijmers RM, 2013, FEBS J, V280, P2180, DOI 10.1111/febs.12180; Reijmers RM, 2010, BLOOD, V115, P601, DOI 10.1182/blood-2009-02-204396; Samson D, 1998, BRIT J HAEMATOL, V102, P1115; Seckinger A, 2009, ONCOGENE, V28, P3866, DOI 10.1038/onc.2009.257; Shaughnessy JD, 2007, BLOOD, V109, P2276, DOI 10.1182/blood-2006-07-038430; Shaughnessy JD, 2009, BRIT J HAEMATOL, V147, P347, DOI 10.1111/j.1365-2141.2009.07864.x; Shi LM, 2010, NAT BIOTECHNOL, V28, P827, DOI 10.1038/nbt.1665; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Sprynski AC, 2009, BLOOD, V113, P4614, DOI 10.1182/blood-2008-07-170464; Taylor J, 2005, BIOSTATISTICS, V6, P111, DOI 10.1093/biostatistics/kxh021; Warren P, 2007, PROCEEDINGS OF THE 7TH IEEE INTERNATIONAL SYMPOSIUM ON BIOINFORMATICS AND BIOENGINEERING, VOLS I AND II, P108; Willhauck-Fleckenstein M, 2010, ANGIOGENESIS, V13, P25, DOI 10.1007/s10456-010-9162-4; Wu ZJ, 2004, J AM STAT ASSOC, V99, P909, DOI 10.1198/016214504000000683; Wuilleme S, 2005, LEUKEMIA, V19, P275, DOI 10.1038/sj.leu.2403586; Yang Y, 2007, J BIOL CHEM, V282, P13326, DOI 10.1074/jbc.M611259200; Zhang XG, 1998, LEUKEMIA, V12, P610, DOI 10.1038/sj.leu.2400971	56	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e83719	10.1371/journal.pone.0083719	http://dx.doi.org/10.1371/journal.pone.0083719			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281QS	24386263	Green Submitted, gold, Green Published			2022-12-25	WOS:000329116700073
J	Johnson, CM; Fisher, DJ				Johnson, Cayla M.; Fisher, Derek J.			Site-Specific, Insertional Inactivation of incA in Chlamydia trachomatis Using a Group II Intron	PLOS ONE			English	Article							PROTEIN; GENOME; TRANSFORMATION; INFECTIONS; INCLUSIONS; MUTANTS	Chlamydia trachomatis is an obligate, intracellular bacterial pathogen that has until more recently remained recalcitrant to genetic manipulation. However, the field still remains hindered by the absence of tools to create selectable, targeted chromosomal mutations. Previous work with mobile group II introns demonstrated that they can be retargeted by altering DNA sequences within the intron's substrate recognition region to create site-specific gene insertions. This platform (marketed as TargeTron (TM), Sigma) has been successfully employed in a variety of bacteria. We subsequently modified TargeTron (TM) for use in C. trachomatis and as proof of principle used our system to insertionally inactivate incA, a chromosomal gene encoding a protein required for homotypic fusion of chlamydial inclusions. C. trachomatis incA::GII(bla) mutants were selected with ampicillin and plaque purified clones were then isolated for genotypic and phenotypic analysis. PCR, Southern blotting, and DNA sequencing verified proper GII(bla) insertion, while continuous passaging in the absence of selection demonstrated that the insertion was stable. As seen with naturally occurring IncA(-) mutants, light and immunofluorescence microscopy confirmed the presence of non-fusogenic inclusions in cells infected with the incA::GII(bla) mutants at a multiplicity of infection greater than one. Lack of IncA production by mutant clones was further confirmed by Western blotting. Ultimately, the ease of retargeting the intron, ability to select for mutants, and intron stability in the absence of selection makes this method a powerful addition to the growing chlamydial molecular toolbox.	[Johnson, Cayla M.; Fisher, Derek J.] So Illinois Univ, Dept Microbiol, Carbondale, IL 62901 USA	Southern Illinois University System; Southern Illinois University	Fisher, DJ (corresponding author), So Illinois Univ, Dept Microbiol, Carbondale, IL 62901 USA.	fisher@micro.siu.edu		Fisher, Derek/0000-0002-1663-8389	SIU	SIU	Research was supported by internal funds to DJF and an SIU Master's Fellowship to CMJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbdelRahman YM, 2005, FEMS MICROBIOL REV, V29, P949, DOI 10.1016/j.femsre.2005.03.002; Agaisse H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057090; Akhtar P, 2012, PLASMID, V67, P111, DOI 10.1016/j.plasmid.2011.12.012; Banks J, 1970, INFECT IMMUN, V1, P259; Binet R, 2009, P NATL ACAD SCI USA, V106, P292, DOI 10.1073/pnas.0806768106; Cheng CM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003171; Cocchiaro JL, 2008, P NATL ACAD SCI USA, V105, P9379, DOI 10.1073/pnas.0712241105; Collingro A, 2011, MOL BIOL EVOL, V28, P3253, DOI 10.1093/molbev/msr161; Cui XX, 2007, FRONT BIOSCI-LANDMRK, V12, P4972, DOI 10.2741/2442; Darville T, 2013, ADV EXP MED BIOL, V764, P109, DOI 10.1007/978-1-4614-4726-9_8; Delevoye C, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000022; Enyeart PJ, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.41; FALKOW S, 1988, REV INFECT DIS, V10, pS274; Fields KA, 2002, INFECT IMMUN, V70, P3816, DOI 10.1128/IAI.70.7.3816-3823.2002; Fisher DJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046052; Gerard HC, 2013, NANOMEDICINE; Gong S, 2013, J BACTERIOL; Gupta Phaguni, 2008, V435, P217, DOI 10.1007/978-1-59745-232-8_16; Hackstadt T, 1999, CELL MICROBIOL, V1, P119, DOI 10.1046/j.1462-5822.1999.00012.x; Hu VH, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002020; Hybiske K, 2007, P NATL ACAD SCI USA, V104, P11430, DOI 10.1073/pnas.0703218104; Kannan RM, 2013, MICROB PATHOGENESIS, V65, P29, DOI 10.1016/j.micpath.2013.08.003; Kari L, 2011, P NATL ACAD SCI USA, V108, P7189, DOI 10.1073/pnas.1102229108; Lambowitz AM, 2004, ANNU REV GENET, V38, P1, DOI 10.1146/annurev.genet.38.072902.091600; Longbottom D, 2006, VET J, V171, P263, DOI 10.1016/j.tvjl.2004.09.006; Mueller KE, 2013, INFECT IMMUN; Nguyen BD, 2012, P NATL ACAD SCI USA, V109, P1263, DOI 10.1073/pnas.1117884109; Pannekoek Y, 2005, J CLIN MICROBIOL, V43, P2441, DOI 10.1128/JCM.43.5.2441-2443.2005; Perutka J, 2004, J MOL BIOL, V336, P421, DOI 10.1016/j.jmb.2003.12.009; Rodriguez SA, 2009, METHODS, V49, P270, DOI 10.1016/j.ymeth.2009.04.011; Ronzone E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069769; Scidmore-Carlson MA, 1999, MOL MICROBIOL, V33, P753, DOI 10.1046/j.1365-2958.1999.01523.x; Song LH, 2013, INFECT IMMUN, V81, P636, DOI 10.1128/IAI.01305-12; Suchland RJ, 2000, INFECT IMMUN, V68, P360, DOI 10.1128/IAI.68.1.360-367.2000; SUN AN, 1990, INFECT IMMUN, V58, P3770, DOI 10.1128/IAI.58.11.3770-3778.1990; Thomson NR, 2008, GENOME RES, V18, P161, DOI 10.1101/gr.7020108; Wang YB, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002258; Wickstrum J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076743; Xu Shuang, 2013, BMC Res Notes, V6, P377, DOI 10.1186/1756-0500-6-377; Yao J, 2007, APPL ENVIRON MICROB, V73, P2735, DOI 10.1128/AEM.02829-06; Yao J, 2006, RNA, V12, P1271, DOI 10.1261/rna.68706	42	80	83	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83989	10.1371/journal.pone.0083989	http://dx.doi.org/10.1371/journal.pone.0083989			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391860	Green Published, gold, Green Submitted			2022-12-25	WOS:000329323900003
J	Muthumani, K; Wise, MC; Broderick, KE; Hutnick, N; Goodman, J; Flingai, S; Yan, J; Bian, CB; Mendoza, J; Tingey, C; Wilson, C; Wojtak, K; Sardesai, NY; Weiner, DB				Muthumani, Kar; Wise, Megan C.; Broderick, Kate E.; Hutnick, Natalie; Goodman, Jonathan; Flingai, Seleeke; Yan, Jian; Bian, Chaoran B.; Mendoza, Janess; Tingey, Colleen; Wilson, Christine; Wojtak, Krzysztof; Sardesai, Niranjan Y.; Weiner, David B.			HIV-1 Env DNA Vaccine plus Protein Boost Delivered by EP Expands B- and T-Cell Responses and Neutralizing Phenotype In Vivo	PLOS ONE			English	Article							IMMUNE-RESPONSES; NONHUMAN-PRIMATES; ANTIBODY-RESPONSE; RHESUS MACAQUES; SUBTYPE-B; ENVELOPE; IMMUNOGENICITY; VIRUS; ELECTROPORATION; PROTECTION	An effective HIV vaccine will most likely require the induction of strong T-cell responses, broadly neutralizing antibodies (bNAbs), and the elicitation of antibody-dependent cellular cytotoxicity (ADCC). Previously, we demonstrated the induction of strong HIV/SIV cellular immune responses in macaques and humans using synthetic consensus DNA immunogens delivered via adaptive electroporation (EP). However, the ability of this improved DNA approach to prime for relevant antibody responses has not been previously studied. Here, we investigate the immunogenicity of consensus DNA constructs encoding gp140 sequences from HIV-1 subtypes A, B, C and D in a DNA prime-protein boost vaccine regimen. Mice and guinea pigs were primed with single-and multi-clade DNA via EP and boosted with recombinant gp120 protein. Sera were analyzed for gp120 binding and induction of neutralizing antibody activity. Immunization with recombinant Env protein alone induced low-titer binding antibodies with limited neutralization breath. In contrast, the synthetic DNA prime-protein boost protocol induced significantly higher antibody binding titers. Furthermore, sera from DNA prime-protein boost groups were able to neutralize a broader range of viruses in a panel of tier 1 clade B viruses as well as multiple tier 1 clade A and clade C viruses. Further investigation of synthetic DNA prime plus adaptive EP plus protein boost appears warranted.	[Muthumani, Kar; Wise, Megan C.; Hutnick, Natalie; Goodman, Jonathan; Flingai, Seleeke; Bian, Chaoran B.; Tingey, Colleen; Wilson, Christine; Wojtak, Krzysztof; Weiner, David B.] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA USA; [Broderick, Kate E.; Yan, Jian; Mendoza, Janess; Sardesai, Niranjan Y.] Inovio Pharmaceut Inc, Blue Bell, PA USA	University of Pennsylvania	Muthumani, K (corresponding author), Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA USA.	muthuman@mail.med.upenn.edu	Muthumani, Kar/C-8252-2017; Weiner, David B/H-8579-2014; Muthumani, Karuppiah/D-1092-2009; Muthumani, Kar/AAQ-4939-2020	Muthumani, Kar/0000-0002-6807-2065; Muthumani, Kar/0000-0002-6807-2065; Sardesai, Niranjan/0000-0001-6920-1167; WOJTAK, KRZYSZTOF/0000-0002-7834-2946	National Institutes of Health including NIH-CFAR, NIAIDS-HVDDT [HHSN272200800063C]; NIH-NIAID-HIVRAD; National Institutes of Health-Center For Aids Research [-5-P30-AI-045008-13]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI045008] Funding Source: NIH RePORTER	National Institutes of Health including NIH-CFAR, NIAIDS-HVDDT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH-NIAID-HIVRAD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health-Center For Aids Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work is supported by grants funded through the National Institutes of Health including NIH-CFAR, NIAIDS-HVDDT (HHSN272200800063C to Inovio Pharmaceuticals, Inc.) and NIH-NIAID-HIVRAD. KM was supported by the National Institutes of Health-Center For Aids Research training supplemental Grant -5-P30-AI-045008-13. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagarazzi ML, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004414; Boyer JD, 2007, P NATL ACAD SCI USA, V104, P18648, DOI 10.1073/pnas.0709198104; Broderick KE, 2011, GENE THER, V18, P258, DOI 10.1038/gt.2010.137; Brown SA, 2003, J IMMUNOL, V171, P4140, DOI 10.4049/jimmunol.171.8.4140; Burton DR, 2010, SCIENCE, V329, P770, DOI 10.1126/science.1194693; Donnelly JJ, 2002, SCIENCE, V297, P1277, DOI 10.1126/science.297.5585.1277; Fagone P, 2011, GENE THER, V18, P1070, DOI 10.1038/gt.2011.59; Hirao LA, 2011, J INFECT DIS, V203, P95, DOI 10.1093/infdis/jiq017; Hirao LA, 2010, MOL THER, V18, P1568, DOI 10.1038/mt.2010.112; HORAL P, 1991, J VIROL, V65, P2718, DOI 10.1128/JVI.65.5.2718-2723.1991; Hutnick NA, 2012, HUM GENE THER; Kalams SA, 2013, J INFECT DIS, V208, P818, DOI 10.1093/infdis/jit236; Kalams SA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029231; Kent SJ, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000331; Korber B, 2011, SCIENCE, V333, P1589, DOI 10.1126/science.1211919; Koup RA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009015; Kuhs KAL, 2012, MOL THER, V20, P669, DOI 10.1038/mt.2011.188; Kumar S, 2006, DNA CELL BIOL, V25, P383, DOI 10.1089/dna.2006.25.383; Kutzler MA, 2010, GENE THER, V17, P72, DOI 10.1038/gt.2009.112; Kutzler MA, 2005, J IMMUNOL, V175, P112, DOI 10.4049/jimmunol.175.1.112; Kutzler MA, 2008, NAT REV GENET, V9, P776, DOI 10.1038/nrg2432; Laddy DJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002517; Laddy DJ, 2009, J VIROL, V83, P4624, DOI 10.1128/JVI.02335-08; Letvin NL, 2007, J VIROL, V81, P12368, DOI 10.1128/JVI.00822-07; Mallilankaraman K, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000928; Mascola JR, 2010, ANNU REV IMMUNOL, V28, P413, DOI 10.1146/annurev-immunol-030409-101256; Mascola JR, 2006, NATURE, V441, P161, DOI 10.1038/441161a; Moir S, 2011, NAT STRUCT MOL BIOL, V18, P1317, DOI 10.1038/nsmb.2194; Montefiori DC, 2012, J INFECT DIS, V206, P431, DOI 10.1093/infdis/jis367; Morrow MP, 2010, MOL THER, V18, P1714, DOI 10.1038/mt.2010.118; Muthumani K, 2005, BLOOD, V106, P2059, DOI 10.1182/blood-2005-03-0932; Muthumani K, 2003, VIROLOGY, V314, P134, DOI 10.1016/S0042-6822(03)00459-8; Muthumani K, 2008, VACCINE, V26, P5128, DOI 10.1016/j.vaccine.2008.03.060; Muthumani K, 2011, J IMMUNOL, V187, P2932, DOI 10.4049/jimmunol.1100594; Nkolola JP, 2010, J VIROL, V84, P3270, DOI 10.1128/JVI.02252-09; Polonis VR, 2008, VIROLOGY, V375, P315, DOI 10.1016/j.virol.2008.02.007; Seaman MS, 2010, J VIROL, V84, P1439, DOI 10.1128/JVI.02108-09; Shedlock DJ, 2011, VACCINE, V29, P6755, DOI 10.1016/j.vaccine.2010.12.064; Shedlock DJ, 2009, NAT REV IMMUNOL, V9, P717, DOI 10.1038/nri2636; Spearman P, 2011, J INFECT DIS, V203, P1165, DOI 10.1093/infdis/jiq175; Wang SX, 2006, VIROLOGY, V350, P34, DOI 10.1016/j.virol.2006.02.032; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Yan J, 2008, VACCINE, V26, P5210, DOI 10.1016/j.vaccine.2008.03.069; Yan J, 2007, MOL THER, V15, P411, DOI 10.1038/sj.mt.6300036; Yan J, 2011, VACCINE, V29, P7173, DOI 10.1016/j.vaccine.2011.05.076; Yan J, 2009, VACCINE, V27, P3260, DOI 10.1016/j.vaccine.2009.01.065; Yin JM, 2011, VACCINE, V29, P6763, DOI 10.1016/j.vaccine.2010.12.055; Yin JM, 2009, VIROLOGY, V393, P49, DOI 10.1016/j.virol.2009.07.017; Zhou TQ, 2010, SCIENCE, V329, P811, DOI 10.1126/science.1192819; Zolla-Pazner S, 2010, NAT REV IMMUNOL, V10, P527, DOI 10.1038/nri2801	50	22	24	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84234	10.1371/journal.pone.0084234	http://dx.doi.org/10.1371/journal.pone.0084234			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391921	gold, Green Published, Green Submitted			2022-12-25	WOS:000329323900064
J	Nelson-Mora, J; Prieto-Sagredo, J; Loredo-Ranjel, R; Fanjul-Moles, ML				Nelson-Mora, Janikua; Prieto-Sagredo, Julio; Loredo-Ranjel, Rosaura; Luisa Fanjul-Moles, Maria			Putative Pacemakers in the Eyestalk and Brain of the Crayfish Procambarus clarkii Show Circadian Oscillations in Levels of mRNA for Crustacean Hyperglycemic Hormone	PLOS ONE			English	Article							SINUS GLAND COMPLEX; ABSOLUTE QUANTIFICATION; ASTACUS-LEPTODACTYLUS; NERVOUS-SYSTEM; CHH; ISOFORMS; LOCALIZATION; CELLS; OSMOREGULATION; MODULATION	Crustacean hyperglycemic hormone (CHH) synthesizing cells in the optic lobe, one of the pacemakers of the circadian system, have been shown to be present in crayfish. However, the presence of CHH in the central brain, another putative pacemaker of the multi-oscillatory circadian system, of this decapod and its circadian transcription in the optic lobe and brain have yet to be explored. Therefore, using qualitative and quantitative PCR, we isolated and cloned a CHH mRNA fragment from two putative pacemakers of the multi-oscillatory circadian system of Procambarus clarkii, the optic lobe and the central brain. This CHH transcript synchronized to daily light-dark cycles and oscillated under dark, constant conditions demonstrating statistically significant daily and circadian rhythms in both structures. Furthermore, to investigate the presence of the peptide in the central brain of this decapod, we used immunohistochemical methods. Confocal microscopy revealed the presence of CHH-IR in fibers and cells of the protocerebral and tritocerebal clusters and neuropiles, particularly in some neurons located in clusters 6, 14, 15 and 17. The presence of CHH positive neurons in structures of P. clarkii where clock proteins have been reported suggests a relationship between the circadian clockwork and CHH. This work provides new insights into the circadian regulation of CHH, a pleiotropic hormone that regulates many physiological processes such as glucose metabolism and osmoregulatory responses to stress.	[Nelson-Mora, Janikua; Prieto-Sagredo, Julio; Loredo-Ranjel, Rosaura; Luisa Fanjul-Moles, Maria] Univ Nacl Autonoma Mexico, Fac Ciencias, Dept Ecol & Recursos Nat, Lab Neurofisiol Comparada, Mexico City 04510, DF, Mexico	Universidad Nacional Autonoma de Mexico	Fanjul-Moles, ML (corresponding author), Univ Nacl Autonoma Mexico, Fac Ciencias, Dept Ecol & Recursos Nat, Lab Neurofisiol Comparada, Mexico City 04510, DF, Mexico.	mfajul@gmail.com		fanjul-Moles, maria Luisa/0000-0003-2927-0154	PAPIIT,UNAM [IN218811]; Conacyt [178526]	PAPIIT,UNAM(Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT)Universidad Nacional Autonoma de Mexico); Conacyt(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	Financial support was provided by PAPIIT,UNAM IN218811 and Conacyt 178526 to ML Fanjul-Moles. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azzouna A, 2003, GEN COMP ENDOCR, V131, P134, DOI 10.1016/S0016-6480(02)00645-7; Bocking D, 2002, CRUSTACEAN NERVOUS SYSTEM, P84; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chang ES, 1999, J COMP NEUROL, V414, P50; Chen SH, 2004, MAR BIOTECHNOL, V6, P83, DOI 10.1007/s10126-003-0014-8; Chen SH, 2005, MAR BIOTECHNOL, V7, P193, DOI 10.1007/s10126-004-0020-5; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; DEKLEIJN DPV, 1995, BBA-GENE STRUCT EXPR, V1260, P62, DOI 10.1016/0167-4781(94)00173-Z; Dircksen H, 2001, BIOCHEM J, V356, P159, DOI 10.1042/0264-6021:3560159; Escamilla-Chimal EG, 2002, GEN COMP ENDOCR, V125, P283, DOI 10.1006/gcen.2001.7752; Escamilla-Chimal EG, 2010, J EXP BIOL, V213, P3723, DOI 10.1242/jeb.047548; Fanjul-Moles ML, 2006, COMP BIOCHEM PHYS C, V142, P390, DOI 10.1016/j.cbpc.2005.11.021; Fanjul-Moles ML, 2003, MICROSC RES TECHNIQ, V60, P291, DOI 10.1002/jemt.10268; Giulianini PG, 2002, CELL TISSUE RES, V307, P243, DOI 10.1007/s00441-001-0484-9; GORGELSKALLEN JL, 1985, CELL TISSUE RES, V241, P361, DOI 10.1007/BF00217181; GORGELSKALLEN JL, 1981, J MORPHOL, V170, P347, DOI 10.1002/jmor.1051700306; KALLEN JL, 1990, BIOL BULL-US, V179, P351, DOI 10.2307/1542327; Kallen JL, 1988, ASPECTS RECENTS BIOL, V8, P105; KELLER R, 1985, AM ZOOL, V25, P207; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Fanjul-Moles ML, 2010, CHRONOBIOL INT, V27, P34, DOI 10.3109/07420520903398526; MARTIN G, 1984, GEN COMP ENDOCR, V55, P217, DOI 10.1016/0016-6480(84)90104-7; Martin G., 1988, Society for Experimental Biology Seminar Series, P79; NUSSBAUM T, 1995, PHILOS T R SOC B, V347, P139, DOI 10.1098/rstb.1995.0018; Ollivaux C, 2000, EUR J BIOCHEM, V267, P5106, DOI 10.1046/j.1432-1327.2000.01574.x; SANDEMAN D, 1992, BIOL BULL, V183, P304, DOI 10.2307/1542217; Sellars MJ, 2007, J BIOTECHNOL, V129, P391, DOI 10.1016/j.jbiotec.2007.01.029; Serrano L, 2004, J HISTOCHEM CYTOCHEM, V52, P1129, DOI 10.1369/jhc.4A6292.2004; Serrano L, 2003, J EXP BIOL, V206, P979, DOI 10.1242/jeb.00178; Soyez D, 1997, ANN NY ACAD SCI, V814, P319, DOI 10.1111/j.1749-6632.1997.tb46174.x; Strauss J, 2010, FRONT BIOSCI-LANDMRK, V15, P1040, DOI 10.2741/3661; TENSEN CP, 1991, NEUROSCI LETT, V124, P178, DOI 10.1016/0304-3940(91)90088-B; Webster SG, 2012, GEN COMP ENDOCR, V175, P217, DOI 10.1016/j.ygcen.2011.11.035; Whelan JA, 2003, J IMMUNOL METHODS, V278, P261, DOI 10.1016/S0022-1759(03)00223-0; YASUDA A, 1994, GEN COMP ENDOCR, V95, P387, DOI 10.1006/gcen.1994.1138	35	12	14	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83937	10.1371/journal.pone.0083937	http://dx.doi.org/10.1371/journal.pone.0083937			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391849	Green Published, Green Submitted, gold			2022-12-25	WOS:000329325200147
J	Sere, MG; Tortosa, P; Chabanet, P; Turquet, J; Quod, JP; Schleyer, MH				Sere, Mathieu G.; Tortosa, Pablo; Chabanet, Pascale; Turquet, Jean; Quod, Jean-Pascal; Schleyer, Michael H.			Bacterial Communities Associated with Porites White Patch Syndrome (PWPS) on Three Western Indian Ocean (WIO) Coral Reefs	PLOS ONE			English	Article							BLACK BAND DISEASE; SP NOV.; BUILDING CORALS; STONY CORALS; PACIFIC; HEALTHY; VIBRIOS	The scleractinian coral Porites lutea, an important reef-building coral on western Indian Ocean reefs (WIO), is affected by a newly-reported white syndrome (WS) the Porites white patch syndrome (PWPS). Histopathology and culture-independent molecular techniques were used to characterise the microbial communities associated with this emerging disease. Microscopy showed extensive tissue fragmentation generally associated with ovoid basophilic bodies resembling bacterial aggregates. Results of 16S rRNA sequence analysis revealed a high variability between bacterial communities associated with PWPS-infected and healthy tissues in P. lutea, a pattern previously reported in other coral diseases such as black band disease (BBD), white band disease (WBD) and white plague diseases (WPD). Furthermore, substantial variations in bacterial communities were observed at the different sampling locations, suggesting that there is no strong bacterial association in Porites lutea on WIO reefs. Several sequences affiliated with potential pathogens belonging to the Vibrionaceae and Rhodobacteraceae were identified, mainly in PWPS-infected coral tissues. Among them, only two ribotypes affiliated to Shimia marina (NR043300.1) and Vibrio hepatarius (NR025575.1) were consistently found in diseased tissues from the three geographically distant sampling localities. The role of these bacterial species in PWPS needs to be tested experimentally.	[Sere, Mathieu G.; Turquet, Jean; Quod, Jean-Pascal] Agence Rech & Valorisat Marines ARVAM, Ste Clotilde, Reunion, France; [Sere, Mathieu G.; Schleyer, Michael H.] Oceanog Res Inst ORI, Durban, Kwazulu Natal, South Africa; [Sere, Mathieu G.; Chabanet, Pascale] Inst Rech Dev IRD, Ste Clotilde, Reunion, France; [Tortosa, Pablo] Ctr Rech & Veille Malad Emergentes Ocean Indien C, Ste Clotilde, Reunion, France; [Tortosa, Pablo] Univ Reunion Isl, Ste Clotilde, Reunion, France	Institut de Recherche pour le Developpement (IRD); University of La Reunion	Sere, MG (corresponding author), Agence Rech & Valorisat Marines ARVAM, Ste Clotilde, Reunion, France.	mathieu.sere@gmail.com	Chabanet, Pascale/L-9470-2017; Séré, Geoffroy/ABA-7697-2021	Séré, Geoffroy/0000-0003-4310-6115; Chabanet, Pascale/0000-0001-7600-943X; Tortosa, Pablo/0000-0002-7928-7264; Schleyer, Michael/0000-0002-7578-8168	European Union (EU, FEDER); Regional Council of Reunion; French Ministry of Higher Education and Research (DRRT); French Department of Ecology, Sustainable Development, Transportation and Housing (DEAL); South African Association for Marine Biological research (SAAMBR); French Ministry of Overseas (MOM); Western Indian Ocean Marine Science Association(WIOMSA)	European Union (EU, FEDER); Regional Council of Reunion; French Ministry of Higher Education and Research (DRRT); French Department of Ecology, Sustainable Development, Transportation and Housing (DEAL); South African Association for Marine Biological research (SAAMBR); French Ministry of Overseas (MOM); Western Indian Ocean Marine Science Association(WIOMSA)	This work was co-funded by the European Union (EU, FEDER), the Regional Council of Reunion, the French Ministry of Higher Education and Research (DRRT), the French Department of Ecology, Sustainable Development, Transportation and Housing (DEAL), the South African Association for Marine Biological research (SAAMBR), the French Ministry of Overseas (MOM) and the Western Indian Ocean Marine Science Association(WIOMSA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arboleda MDM, 2010, DIS AQUAT ORGAN, V90, P93, DOI 10.3354/dao02222; Austin B, 2005, ENVIRON MICROBIOL, V7, P1488, DOI 10.1111/j.1462-2920.2005.00847.x; Austin B, 2010, VET MICROBIOL, V140, P310, DOI 10.1016/j.vetmic.2009.03.015; Barneah O, 2007, ENVIRON MICROBIOL, V9, P1995, DOI 10.1111/j.1462-2920.2007.01315.x; Bayer T, 2013, MAR ECOL PROG SER, V479, P75, DOI 10.3354/meps10197; Benzoni F, 2010, CORAL REEFS, V29, P153, DOI 10.1007/s00338-009-0571-z; Boyett H. V, 2006, THESIS; Bythell J, 2004, CORAL HEALTH AND DISEASE, P351; Cardenas A, 2012, ISME J, V6, P502, DOI 10.1038/ismej.2011.123; Cervino JM, 2008, J APPL MICROBIOL, V105, P1658, DOI 10.1111/j.1365-2672.2008.03871.x; Cho SH, 2008, J MICROBIOL, V46, P325, DOI 10.1007/s12275-008-0015-4; Cole AJ, 2009, CORAL REEFS, V28, P207, DOI 10.1007/s00338-008-0415-2; Cole AJ, 2008, FISH FISH, V9, P286, DOI 10.1111/j.1467-2979.2008.00290.x; Cunning J, 2009, P 11 INT COR REEF S, V7, P206; Daneshvar MI, 2003, J CLIN MICROBIOL, V41, P1289, DOI 10.1128/JCM.41.3.1289-1294.2003; Frias-Lopez J, 2004, APPL ENVIRON MICROB, V70, P5955, DOI 10.1128/AEM.70.10.5955-5962.2004; Frias-Lopez J, 2002, APPL ENVIRON MICROB, V68, P2214, DOI 10.1128/AEM.68.5.2214-2228.2002; Galloway S.B., 2007, COR DIS HLTH WORKSH; Gil-Agudelo DL, 2007, CAN J MICROBIOL, V53, P465, DOI 10.1139/W07-002; Godwin S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044243; Jensen S, 2010, FEMS MICROBIOL ECOL, V74, P523, DOI 10.1111/j.1574-6941.2010.00981.x; Kurahashi M, 2007, SYST APPL MICROBIOL, V30, P202, DOI 10.1016/j.syapm.2006.07.003; Kvennefors ECE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010401; Luna GM, 2010, ENV MICROBIOL REP, V2, P120, DOI 10.1111/j.1758-2229.2009.00114.x; Miyazaki M, 2008, INT J SYST EVOL MICR, V58, P2815, DOI 10.1099/ijs.0.65826-0; Mohamed A.R., 2012, PROC 12 INT CORAL RE; Myers JL, 2007, APPL ENVIRON MICROB, V73, P5173, DOI 10.1128/AEM.00900-07; Nishijima M, 2013, INT J SYST EVOL MICR, V63, P709, DOI 10.1099/ijs.0.042077-0; Pantos O, 2003, ENVIRON MICROBIOL, V5, P370, DOI 10.1046/j.1462-2920.2003.00427.x; Pantos O, 2006, DIS AQUAT ORGAN, V69, P79, DOI 10.3354/dao069079; Raina JB, 2009, APPL ENVIRON MICROB, V75, P3492, DOI 10.1128/AEM.02567-08; Ravindran J, 1999, CURR SCI INDIA, V76, P233; Roder C., 2013, INT SOC MICROBIAL EC, V1751-7362, P1; Sere MG, 2012, CORAL REEFS, P1; Shafir S, 2008, CORAL REEFS, V27, P379, DOI 10.1007/s00338-008-0353-z; Sudek M, 2012, J INVERTEBRATE PATHO; Sunagawa S, 2009, ISME J, V3, P512, DOI 10.1038/ismej.2008.131; Sussman M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002393; Sutherland KP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023468; Sutherland KP, 2004, MAR ECOL PROG SER, V266, P273, DOI 10.3354/meps266273; Sweet MJ, 2011, CORAL REEFS, V30, P39, DOI 10.1007/s00338-010-0695-1; Sweet M, 2012, ENVIRON MICROBIOL, V14, P2184, DOI 10.1111/j.1462-2920.2012.02746.x; Thompson FL, 2003, INT J SYST EVOL MICR, V53, P1495, DOI 10.1099/ijs.0.02658-0; Ushijima B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046717; Veron J.E.N., 2000, CORALS WORLD, V1-3; Voss JD, 2007, MICROB ECOL, V54, P730, DOI 10.1007/s00248-007-9234-1; Weil E, 2006, DIS AQUAT ORGAN, V69, P1, DOI 10.3354/dao069001; Wilkinson CR, 2004, GLOBAL CORAL REEF MO, V1, P7; Wilson B, 2012, FEMS MICROBIOL ECOL, V80, P509, DOI 10.1111/j.1574-6941.2012.01319.x; Work TM, 2011, J INVERTEBR PATHOL, V107, P127, DOI 10.1016/j.jip.2011.03.009	50	52	54	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83746	10.1371/journal.pone.0083746	http://dx.doi.org/10.1371/journal.pone.0083746			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391819	Green Published, Green Submitted, gold			2022-12-25	WOS:000329325200117
J	Sturdivant, SK; Brush, MJ; Diaz, RJ				Sturdivant, Samuel Kersey; Brush, Mark J.; Diaz, Robert J.			Modeling the Effect of Hypoxia on Macrobenthos Production in the Lower Rappahannock River, Chesapeake Bay, USA	PLOS ONE			English	Article							CLAM MACOMA-BALTHICA; BEHAVIORAL-RESPONSES; OXYGEN DEPLETION; DISSOLVED-OXYGEN; EUTROPHICATION; POPULATION; DYNAMICS; WATER; CONSEQUENCES; POLYCHAETE	Hypoxia in Chesapeake Bay has substantially increased in recent decades, with detrimental effects on macrobenthic production; the production of these fauna link energy transfer from primary consumers to epibenthic and demersal predators. As such, the development of accurate predictive models that determine the impact of hypoxia on macrobenthic production is important. A continuous-time, biomass-based model was developed for the lower Rappahannock River, a Bay tributary prone to seasonal hypoxia. Phytoplankton, zooplankton, and macrobenthic state variables were modeled, with a focus on quantitatively constraining the effect of hypoxia on macrobenthic biomass. This was accomplished through regression with Z': a sigmoidal function between macrobenthic biomass and dissolved oxygen concentration, derived using macrobenthic data collected from the Rappahannock River during the summers of 2007 and 2008, and applied to compute hypoxia-induced mortality as a rate process. The model was verified using independent monitoring data collected by the Chesapeake Bay Program. Simulations showed that macrobenthic biomass was strongly linked to dissolved oxygen concentrations, with fluctuations in biomass related to the duration and severity of hypoxia. Our model demonstrated that hypoxia negatively affected macrobenthic biomass, as longer durations of hypoxia and greater hypoxic severity resulted in an increasing loss in biomass. This exercise represents an important contribution to modeling anthropogenically impacted coastal ecosystems, by providing an empirically constrained relationship between hypoxia and macrobenthic biomass, and applying that empirical relationship in a mechanistic model to quantify the effect of the severity, duration, and frequency of hypoxia on benthic biomass dynamics.	[Sturdivant, Samuel Kersey] Duke Univ, Div Marine Sci & Conservat, Nicholas Sch Environm, Beaufort, NC USA; [Brush, Mark J.; Diaz, Robert J.] Virginia Inst Marine Sci, Coll William & Mary, Gloucester Point, VA 23062 USA	Duke University; William & Mary; Virginia Institute of Marine Science	Sturdivant, SK (corresponding author), Duke Univ, Div Marine Sci & Conservat, Nicholas Sch Environm, Beaufort, NC USA.	kersey.sturdivant@duke.edu			Virginia DEQ; National Oceanic and Atmospheric Administration [NA05NOS4781202]; National Science Foundation; Directorate For Geosciences [0914525] Funding Source: National Science Foundation	Virginia DEQ; National Oceanic and Atmospheric Administration(National Oceanic Atmospheric Admin (NOAA) - USA); National Science Foundation(National Science Foundation (NSF)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	Virginia DEQ funded the benthic monitoring program in the lower Bay. Support for this work was provided by National Oceanic and Atmospheric Administration grant NA05NOS4781202, a National Science Foundation funded Hall-Bonner Fellowship, and a National Oceanic and Atmospheric Administration Graduate Sciences Program fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Bonnet MP, 2001, ECOL MODEL, V141, P19, DOI 10.1016/S0304-3800(00)00434-8; Brante A, 2001, MAR ECOL PROG SER, V209, P301, DOI 10.3354/meps209301; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; Brush MJ, 2010, ECOL MODEL, V221, P1065, DOI 10.1016/j.ecolmodel.2009.11.002; Calvo LMR, 2001, J SHELLFISH RES, V20, P231; Cerco C.F., 2004, 90304004 US EPA CHES; Cerco CF, 2007, ESTUAR COAST, V30, P331, DOI 10.1007/BF02700175; CERCO CF, 1993, J ENVIRON ENG-ASCE, V119, P1006, DOI 10.1061/(ASCE)0733-9372(1993)119:6(1006); Chesapeake Bay Program, 2010, CHES BAY PROGR CHES; Cloern JE, 2001, MAR ECOL PROG SER, V210, P223, DOI 10.3354/meps210223; Dauer DM, 2003, ENVIRON MONIT ASSESS, V81, P175, DOI 10.1023/A:1021329108568; DAUER DM, 1992, ESTUARIES, V15, P384, DOI 10.2307/1352785; Day J.W., 1989, ESTUARINE ECOLOGY; De Robertis A, 2001, MAR ECOL PROG SER, V219, P221, DOI 10.3354/meps219221; Diaz, 1990, PERSPECTIVES CHESAPE, V1990, P25; Diaz R.J., 1992, SCI TOTAL ENVIRON, V1992, P1055; Diaz RJ, 1995, OCEANOGR MAR BIOL, V33, P245; Diaz RJ, 2008, SCIENCE, V321, P926, DOI 10.1126/science.1156401; FONG PP, 1991, J EXP MAR BIOL ECOL, V149, P177, DOI 10.1016/0022-0981(91)90044-W; FRITHSEN JB, 1986, OPHELIA, V25, P169, DOI 10.1080/00785326.1986.10429748; Fulford RS, 2007, MAR ECOL PROG SER, V336, P43, DOI 10.3354/meps336043; Garber JH, 1987, PERSPECTIVES CHESAPE; Hagy JD, 2004, ESTUARIES, V27, P634, DOI 10.1007/BF02907650; HARDEGE JD, 1990, MAR BIOL, V104, P291, DOI 10.1007/BF01313270; Haven DS., 1972, GEOL SOC AM MEM, V133, P121, DOI [10.1130/MEM133-p121, DOI 10.1130/MEM133-P121]; HydroQual, 2000, DEV SUSP FEED DEP FE; JORGENSEN BB, 1980, OIKOS, V34, P68, DOI 10.2307/3544551; Kemp WM, 2005, MAR ECOL PROG SER, V303, P1, DOI 10.3354/meps303001; Kremer J.N., 1978, COASTAL MARINE ECOSY; KUO AY, 1987, ESTUARIES, V10, P277, DOI 10.2307/1351884; KUO AY, 1991, ESTUARIES, V14, P113, DOI 10.2307/1351684; Laidler J.K., 1987, CHEM KINETICS, V3; LEVIN LA, 1994, AM ZOOL, V34, P323; LEVIN LA, 1990, ECOLOGY, V71, P2191, DOI 10.2307/1938632; LLANSO RJ, 1992, ESTUAR COAST SHELF S, V35, P491, DOI 10.1016/S0272-7714(05)80027-7; Long WC, 2008, MAR ECOL PROG SER, V362, P59, DOI 10.3354/meps07395; Luo JG, 2001, ESTUARIES, V24, P545, DOI 10.2307/1353256; Marcus NH, 2004, J EXP MAR BIOL ECOL, V301, P111, DOI 10.1016/j.jembe.2003.09.016; Mayfield SM, 1988, THESIS TEXAS A M U C; Meysman FJR, 2006, TRENDS ECOL EVOL, V21, P688, DOI 10.1016/j.tree.2006.08.002; Nestlerode JA, 1998, MAR ECOL PROG SER, V172, P185, DOI 10.3354/meps172185; Neubauer JR, 1993, THESIS COLL WILLIAM; Newcombe CL, 1939, J MAR RES, V2, P87, DOI 10.1357/002224039806673855; Nilsen M, 2006, MAR ECOL PROG SER, V321, P67, DOI 10.3354/meps321067; NIXON SW, 1995, OPHELIA, V41, P199, DOI 10.1080/00785236.1995.10422044; OFFICER CB, 1984, SCIENCE, V223, P22, DOI 10.1126/science.223.4631.22; Park KO, 1996, ESTUAR COAST SHELF S, V42, P563, DOI 10.1006/ecss.1996.0037; PIHL L, 1991, MAR BIOL, V108, P349, DOI 10.1007/BF01313644; Powers SP, 2001, COAST EST S, V58, P185; PRYOR WA, 1975, GEOL SOC AM BULL, V86, P1244, DOI 10.1130/0016-7606(1975)86<1244:BSAAOA>2.0.CO;2; Rabalais NN., 2004, SEA IDEAOBSERVATIO, P819; Rhodes D., 1982, ANIMAL SEDIMENT RELA, P3, DOI DOI 10.1007/978-1-4757-1317-6; Riedel B, 2008, J EXP MAR BIOL ECOL, V367, P17, DOI 10.1016/j.jembe.2008.08.007; Roden EE, 1996, LIMNOL OCEANOGR, V41, P1733, DOI 10.4319/lo.1996.41.8.1733; ROSENBERG R, 1991, MAR ECOL PROG SER, V79, P127, DOI 10.3354/meps079127; Rosenberg R, 2002, MAR ECOL PROG SER, V234, P43, DOI 10.3354/meps234043; Sale JW, 1917, J FRANKL INST, V184, P0837, DOI 10.1016/S0016-0032(17)90519-8; Schaffner LC, 2002, REV BENTHIC PROCESSE, P1; Seitz RD, 2003, MAR ECOL PROG SER, V257, P179, DOI 10.3354/meps257179; Seitz RD, 2009, J EXP MAR BIOL ECOL, V381, pS4, DOI 10.1016/j.jembe.2009.07.004; Steinberg DK, 1998, MAR ECOL PROG SER, V164, P157, DOI 10.3354/meps164157; Sturdivant SK, 2013, MAR ECOL PROG SER, V490, P53, DOI 10.3354/meps10470; Tallqvist M, 2001, MAR ECOL PROG SER, V212, P183, DOI 10.3354/meps212183; Tiffany MA, 2002, HYDROBIOLOGIA, V473, P103, DOI 10.1023/A:1016529617757; Tyson R.V., 1991, Geological Society Special Publication, V58, P1; Van Colen C, 2010, MAR POLLUT BULL, V60, P178, DOI 10.1016/j.marpolbul.2009.09.028; Vaquer-Sunyer R, 2008, P NATL ACAD SCI USA, V105, P15452, DOI 10.1073/pnas.0803833105; Vaquer-Sunyer R, 2010, LIMNOL OCEANOGR, V55, P1075, DOI 10.4319/lo.2010.55.3.1075; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; WARREN LM, 1976, MAR BIOL, V38, P209, DOI 10.1007/BF00388934; WETZEL RL, 1986, AQUAT BOT, V26, P307, DOI 10.1016/0304-3770(86)90029-X	71	11	12	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84140	10.1371/journal.pone.0084140	http://dx.doi.org/10.1371/journal.pone.0084140			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391904	gold, Green Published, Green Submitted			2022-12-25	WOS:000329323900047
J	Williams, LV; Veliceasa, D; Vinokour, E; Volpert, OV				Williams, LaTanya V.; Veliceasa, Dorina; Vinokour, Elena; Volpert, Olga V.			miR-200b Inhibits Prostate Cancer EMT, Growth and Metastasis	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; MICRORNA EXPRESSION; ANDROGEN RECEPTOR; GASTRIC-CARCINOMA; CELL CARCINOMA; LUNG-CANCER; FAMILY; BIOGENESIS; INVASION; PATHWAY	miRNA regulate gene expression at post-transcriptional level and fine-tune the key biological processes, including cancer progression. Here, we demonstrate the involvement of miR-200b in the metastatic spread of prostate cancer. We identified miR-200b as a downstream target of androgen receptor and linked its expression to decreased tumorigenicity and metastatic capacity of the prostate cancer cells. Overexpression of miR-200b in PC-3 cells significantly inhibited their proliferation and the formation of subcutaneous tumors. Moreover, in an orthotopic model, miR-200b blocked spontaneous metastasis and angiogenesis by PC-3 cells. This decreased metastatic potential was likely due to the reversal of the epithelial-to-mesenchymal transition, as was evidenced by increased pan-epithelial marker E-cadherin and specific markers of prostate epithelium, cytokeratins 8 and 18. In contrast, mesenchymal markers, fibronectin and vimentin, were significantly downregulated by miR-200b. Our results suggest an important role for miR-200b in prostate cancer progression and indicate its potential utility for prostate cancer therapy.	[Williams, LaTanya V.; Veliceasa, Dorina; Vinokour, Elena; Volpert, Olga V.] Northwestern Univ, Feinberg Sch Med, Dept Urol, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Volpert, OV (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Urol, Chicago, IL 60611 USA.	olgavolp@northwestern.edu			Herman L. Kretschmer Fund, via Northwestern University Urology Department; SPORE in Prostate Cancer Pilot Award [P50 CA090386]; Diversifying Higher Education Faculty in Illinois Fellowship Grant; NATIONAL CANCER INSTITUTE [P50CA090386] Funding Source: NIH RePORTER	Herman L. Kretschmer Fund, via Northwestern University Urology Department; SPORE in Prostate Cancer Pilot Award; Diversifying Higher Education Faculty in Illinois Fellowship Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Herman L. Kretschmer Fund, via Northwestern University Urology Department (OV), the SPORE in Prostate Cancer Pilot Award P50 CA090386 (OV), Diversifying Higher Education Faculty in Illinois Fellowship Grant (LVW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balk Steven P, 2008, Nucl Recept Signal, V6, pe001, DOI 10.1621/nrs.06001; Barron N, 2012, PROSTATE, V72, P1193, DOI 10.1002/pros.22469; Blahna MT, 2013, CURR OPIN CELL BIOL, V25, P233, DOI 10.1016/j.ceb.2012.12.005; Bracken CP, 2008, CANCER RES, V68, P7846, DOI 10.1158/0008-5472.CAN-08-1942; Braig S, 2010, CELL MOL LIFE SCI, V67, P3535, DOI 10.1007/s00018-010-0394-7; Chen L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054213; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; He MY, 2013, PROSTATE, V73, P1048, DOI 10.1002/pros.22652; Heisler LE, 1997, MOL CELL ENDOCRINOL, V126, P59, DOI 10.1016/S0303-7207(96)03970-6; Hu XX, 2010, CANCER RES, V70, P1441, DOI 10.1158/0008-5472.CAN-09-3289; Kefas B, 2008, CANCER RES, V68, P3566, DOI 10.1158/0008-5472.CAN-07-6639; Kong DJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012445; Kong DJ, 2009, STEM CELLS, V27, P1712, DOI 10.1002/stem.101; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Kumarswamy R, 2012, INT J CANCER, V130, P2044, DOI 10.1002/ijc.26218; Kurashige J, 2012, ANN SURG ONCOL, V19, pS656, DOI 10.1245/s10434-012-2217-6; Kutner RH, 2009, NAT PROTOC, V4, P495, DOI 10.1038/nprot.2009.22; Li YW, 2009, CANCER RES, V69, P6704, DOI 10.1158/0008-5472.CAN-09-1298; Liu YN, 2013, ONCOGENE, V32, P296, DOI 10.1038/onc.2012.58; Liu Y, 2013, LEUKEMIA RES, V37, P349, DOI 10.1016/j.leukres.2012.12.003; Long RM, 2005, CLIN SCI, V108, P1, DOI 10.1042/CS20040241; Luo HC, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-82; Manavalan TT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062334; Matusik RJ, 2008, DIFFERENTIATION, V76, P682, DOI 10.1111/j.1432-0436.2008.00276.x; Mirochnik Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031052; Mitchell S, 2000, BJU INT, V85, P932, DOI 10.1046/j.1464-410x.2000.00606.x; Mueller DW, 2011, INT J CANCER, V129, P1064, DOI 10.1002/ijc.25768; Nelius T, 2007, INT J CANCER, V121, P999, DOI 10.1002/ijc.22802; Niu YJ, 2008, P NATL ACAD SCI USA, V105, P12182, DOI 10.1073/pnas.0804700105; Okuda H, 2013, CANCER RES, V73, P1434, DOI 10.1158/0008-5472.CAN-12-2037; Panda H, 2012, REPROD SCI, V19, P786, DOI 10.1177/1933719112438448; Park Serk In, 2010, Curr Protoc Pharmacol, VChapter 14, DOI 10.1002/0471141755.ph1415s51; Pecot CV, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3427; Shinozaki A, 2010, CANCER RES, V70, P4719, DOI 10.1158/0008-5472.CAN-09-4620; Slabakova E, 2011, PROSTATE, V71, P1332, DOI 10.1002/pros.21350; Su S.F., 2012, ONCOGENE; Susuki D, 2011, CANCER SCI, V102, P2164, DOI 10.1111/j.1349-7006.2011.02096.x; Tavazoie SF, 2008, NATURE, V451, P147, DOI 10.1038/nature06487; Vallejo DM, 2011, EMBO J, V30, P756, DOI 10.1038/emboj.2010.358; Vosa U, 2013, INT J CANCER, V132, P2884, DOI 10.1002/ijc.27981; Vrba L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008697; Wu CL, 2013, CELL SIGNAL, V25, P1212, DOI 10.1016/j.cellsig.2013.01.028; Xu Y, 2012, BRIT J CANCER, V106, P553, DOI 10.1038/bjc.2011.568; Yates LA, 2013, CELL, V153, P516, DOI 10.1016/j.cell.2013.04.003; Yoshino H, 2013, J HUM GENET; Yu Z, 2013, J MOL HISTOL	46	114	121	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83991	10.1371/journal.pone.0083991	http://dx.doi.org/10.1371/journal.pone.0083991			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391862	gold, Green Published, Green Submitted			2022-12-25	WOS:000329323900005
J	de Medeiros, GF; Pereira, E; Granzotto, N; Ramos, A				de Medeiros, Gabriela Ferreira; Pereira, Elayne; Granzotto, Natalli; Ramos, Andre			Low-Anxiety Rat Phenotypes Can Be Further Reduced through Genetic Intervention	PLOS ONE			English	Article							ELEVATED T-MAZE; ANIMAL-MODELS; TRANSGRESSIVE SEGREGATION; OPEN-FIELD; PLUS-MAZE; DISORDERS; BEHAVIORS; TESTS; STRAINS; STRESS	Background: A previous study using an intercross between the inbred rat strains Lewis (LEW) and Spontaneously Hypertensive Rats (SHR) identified a locus on chromosome 4, named Anxrr16, influencing an experimental index of anxiety and showing a transgressive effect, with alleles from the LEW strain (more anxious) decreasing rather than increasing anxiety. Objective: To confirm the location and isolate the effect of a rat genome region named Anxrr16 through a planned genomic recombination strategy, where the target locus in SHR rats was replaced with LEW genetic material. Methods: A new congenic strain, named SHR. LEW-Anxrr16 (SLA16), was developed from a cross between LEW (donor) and SHR (receptor) rats and then evaluated in several anxiety-related tests. The activity and attention levels of the new strain were also evaluated, since hyperactivity was observed during its construction and because SHR is a model of attention deficit hyperactivity disorder. Results: Significant effects of Anxrr16 were found for open field central locomotion, as well as for other indices of anxiety from the light/dark box, triple test and T-maze. In all cases, the low-anxiety levels of SHR rats were further reduced by the insertion of LEW alleles. Differences in locomotor activity were found only in unfamiliar (hence stressful) environments and no genetic effects were observed in indices of attention. Conclusion: The SLA16 strain can help in the identification of the molecular pathways involved in experimental anxiety and it demonstrates how apparently extreme phenotypes sometimes hide major opposite-acting genes.	[de Medeiros, Gabriela Ferreira; Pereira, Elayne; Granzotto, Natalli; Ramos, Andre] Univ Fed Santa Catarina, Ctr Ciencias Biol, Lab Genet Comportamento, Dept Biol Celular Embriol & Genet, Florianopolis, SC, Brazil	Universidade Federal de Santa Catarina (UFSC)	Pereira, E (corresponding author), Univ Fed Santa Catarina, Ctr Ciencias Biol, Lab Genet Comportamento, Dept Biol Celular Embriol & Genet, Florianopolis, SC, Brazil.	elaynepp@yahoo.com.br	RAMOS, Andre/AAL-2090-2021; Pereira, Elayne/B-7364-2014	Pereira, Elayne/0000-0002-1178-669X; de Avila Ramos, Andre/0000-0003-4449-3866	PRONEX from FAPESC/CNPq [427/2003]; CNPq [470549/2009-2]	PRONEX from FAPESC/CNPq; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was funded by a PRONEX grant 427/2003 from FAPESC/CNPq and the CNPq grant 470549/2009-2. http://www.fapesc.sc.gov.br. http://www.cnpq.br. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Caldarone B, 1997, NAT GENET, V17, P335, DOI 10.1038/ng1197-335; DEVICENTE MC, 1993, GENETICS, V134, P585; Dittrich-Reed DR, 2013, EVOL BIOL, V40, P310, DOI 10.1007/s11692-012-9209-0; Fehr C, 2002, J NEUROSCI, V22, P3730; Floresco SB, 2006, NEUROPSYCHOPHARMACOL, V31, P297, DOI 10.1038/sj.npp.1300825; Fraser LM, 2010, PSYCHOPHARMACOLOGY, V211, P99, DOI 10.1007/s00213-010-1873-0; Graeff FG, 1998, NEUROSCI BIOBEHAV R, V23, P237, DOI 10.1016/S0149-7634(98)00024-4; Gross C, 2004, NEUROTOX RES, V6, P493, DOI 10.1007/BF03033286; Hall C, 1934, J COMP PSYCHOL, V22, P385; Hamilton Steven P., 2009, V23, P165; Hinojosa FR, 2006, BEHAV BRAIN RES, V168, P127, DOI 10.1016/j.bbr.2005.10.019; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Kloting N, 2007, DIABETES-METAB RES, V23, P406, DOI 10.1002/dmrr.713; Lazarus RS, 1991, EMOTION ADAPTATION, P42; LISTER RG, 1990, PHARMACOL THERAPEUT, V46, P321, DOI 10.1016/0163-7258(90)90021-S; Llamas B, 2005, MAMM GENOME, V16, P505, DOI 10.1007/s00335-005-0022-2; Mormede P, 2002, GENES BRAIN BEHAV, V1, P111, DOI 10.1034/j.1601-183X.2002.10206.x; Poltronieri SC, 2003, BEHAV BRAIN RES, V147, P185, DOI 10.1016/S0166-4328(03)00151-7; Ramos A, 2002, BEHAV BRAIN RES, V129, P113, DOI 10.1016/S0166-4328(01)00337-0; Ramos A, 1997, BEHAV BRAIN RES, V85, P57, DOI 10.1016/S0166-4328(96)00164-7; Ramos A, 1998, NEUROSCI BIOBEHAV R, V22, P33; Ramos A, 1999, MOL PSYCHIATR, V4, P453, DOI 10.1038/sj.mp.4000546; Ramos A, 2008, TRENDS PHARMACOL SCI, V29, P493, DOI 10.1016/j.tips.2008.07.005; Ramos A, 2008, BEHAV BRAIN RES, V193, P277, DOI 10.1016/j.bbr.2008.06.007; Rieseberg LH, 1999, HEREDITY, V83, P363, DOI 10.1038/sj.hdy.6886170; Roy V, 2009, PSYCHOPHARMACOLOGY, V203, P131, DOI 10.1007/s00213-008-1378-2; Sagvolden T, 2000, NEUROSCI BIOBEHAV R, V24, P31, DOI 10.1016/S0149-7634(99)00058-5; Sagvolden T, 2009, NEUROPHARMACOLOGY, V57, P619, DOI 10.1016/j.neuropharm.2009.08.004; Silva GJJ, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-17; Smoller JW, 2009, DEPRESS ANXIETY, V26, P965, DOI 10.1002/da.20623; Soares VD, 2011, BEHAV BRAIN RES, V225, P590, DOI 10.1016/j.bbr.2011.08.032; Takahashi A, 2006, BEHAV GENET, V36, P763, DOI 10.1007/s10519-005-9038-3; Teixeira RC, 2000, PHARMACOL BIOCHEM BE, V65, P571, DOI 10.1016/S0091-3057(99)00261-0; Tomida S, 2009, NAT GENET, V41, P688, DOI 10.1038/ng.344; Vendruscolo LF, 2006, GENES BRAIN BEHAV, V5, P441, DOI 10.1111/j.1601-183X.2005.00177.x; Wehrmeister TD, 2010, PHARMACOL BIOCHEM BE, V97, P301, DOI 10.1016/j.pbb.2010.08.014; Weiss SM, 1998, NEUROSCI BIOBEHAV R, V23, P265, DOI 10.1016/S0149-7634(98)00027-X	37	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e83666	10.1371/journal.pone.0083666	http://dx.doi.org/10.1371/journal.pone.0083666			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386249	Green Published, Green Submitted, gold			2022-12-25	WOS:000329194700057
J	Ostman, O; Bostrom, MK; Bergstrom, U; Andersson, J; Lunneryd, SG				Ostman, Orjan; Bostrom, Maria K.; Bergstrom, Ulf; Andersson, Jan; Lunneryd, Sven-Gunnar			Estimating Competition between Wildlife and Humans-A Case of Cormorants and Coastal Fisheries in the Baltic Sea	PLOS ONE			English	Article							PHALACROCORAX-CARBO-SINENSIS; PERCA-FLUVIATILIS L; FISH COMMUNITIES; GREAT CORMORANTS; TEMPORAL-CHANGES; PREDATION; DIET; LAKE; IMPACT; STOCKS	Cormorants and other wildlife populations have come in real or perceived conflicts with humans over exploited fish stocks. From gut contents of cormorants, and using an extension of the Catch equation, we estimated the degree of short term competition between great cormorants and coastal fisheries in two areas along the Swedish Baltic Sea. Cormorants consumed 10 and 44%, in respective area, of the fish biomass of six fish species harvested by humans; eel, flounder, herring, perch, pike, and whitefish. On average, cormorants consumed smaller individuals than harvested in fisheries. But for perch, cod and flounder, cormorants consumed harvestable sized fish corresponding >20% of human catches. Our competition model estimated the direct decrease in fisheries catches due to cormorant predation to be <10% for all species except flounder (>30%) and perch (2-20%). When also including the indirect effects of cormorant predation on smaller fish that never reached harvestable size, the estimated decrease in fisheries catches at least doubled for perch (13-34%) and pike (8-19%). Despite large uncertainties, our model indicates that cormorants may locally have a direct impact on human catches of at least flounder, and when incorporating indirect effects also on perch and pike. The study indicates that the degree of competition between cormorants and humans varies substantially between areas. We also included economical values in the model and concluded that for the commercially most important species, eel and cod, the estimated economic impact of cormorants on fisheries was low.	[Ostman, Orjan; Bostrom, Maria K.; Bergstrom, Ulf; Andersson, Jan; Lunneryd, Sven-Gunnar] Swedish Univ Agr Sci, Dept Aquat Resources, Oregrund, Sweden	Swedish University of Agricultural Sciences	Ostman, O (corresponding author), Uppsala Univ, Dept Ecol & Genet, Uppsala, Sweden.	orjan.ostman@ebc.uu.se	Östman, Örjan/ABF-8714-2020	Östman, Örjan/0000-0002-1930-0148; Bergstrom, Ulf/0000-0002-5478-0634	Swedish Environmental Protection Agency; Swedish Board of Fishery; Swedish Agency for Marine and Water Management	Swedish Environmental Protection Agency; Swedish Board of Fishery; Swedish Agency for Marine and Water Management	This study was funded by the Swedish Environmental Protection Agency (http://naturvardsverket.se/), the Swedish Board of Fishery, and Swedish Agency for Marine and Water Management (https://www.havochvatten.se/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adjers K, 2006, BOREAL ENVIRON RES, V11, P13; Andersen SM, 2007, ICES J MAR SCI, V64, P1235, DOI 10.1093/icesjms/fsm092; [Anonymous], 2003, DOCUMENTS; Bostrom MK, 2012, ICES J MAR SCI, V69, P175, DOI 10.1093/icesjms/fss002; Bostrom MK, 2009, FISH RES, V98, P16, DOI 10.1016/j.fishres.2009.03.011; Bregnballe T, 2009, SKARVEN; Dalton CM, 2009, CAN J FISH AQUAT SCI, V66, P177, DOI 10.1139/F08-198; Diana JS, 2006, J GREAT LAKES RES, V32, P306, DOI 10.3394/0380-1330(2006)32[306:DICPTS]2.0.CO;2; Doucette JL, 2011, ECOL APPL, V21, P2987, DOI 10.1890/10-2384.1; Engstrom H, 2001, ECOGRAPHY, V24, P127, DOI 10.1034/j.1600-0587.2001.240203.x; Eschbaum R., 2003, P72; Fielder DG, 2010, J GREAT LAKES RES, V36, P207, DOI 10.1016/j.jglr.2009.12.015; GREMILLET D, 1995, MAR ECOL PROG SER, V121, P1, DOI 10.3354/meps121001; HANSSON S, 1985, HYDROBIOLOGIA, V121, P3, DOI 10.1007/BF00035223; HELCOM, 2010, POP DEV BALT BIRD SP; ICES, 2013, 2013ACOM10 ICES WGBF; Jennings S., 2001, MARINE FISHERIES ECO; Jepsen N, 2010, MAR FRESHWATER RES, V61, P320, DOI 10.1071/MF09038; Johansson T, 2008, LANSSTYRELSENS MEDDE, V2008, P1; Karas P, 1996, ARCH HYDROBIOL, V138, P99; Lehikoinen A, 2011, BOREAL ENVIRON RES, V16, P61; Leopold MF, 1998, J SEA RES, V40, P93, DOI 10.1016/S1385-1101(98)00028-8; Lindell L, 1993, VAR FAGELVARLD S, V20; LINN IJ, 1992, J APPL ECOL, V29, P619, DOI 10.2307/2404470; Ljunggren L, 2010, ICES J MAR SCI, V67, P1587, DOI 10.1093/icesjms/fsq109; Meier HEM, 2004, AMBIO, V33, P249, DOI 10.1639/0044-7447(2004)033[0249:SDOBSI]2.0.CO;2; Mustamaki N, 2013, AMBIO IN PRESS; Olsson J, 2012, ESTUAR COAST SHELF S, V97, P104, DOI 10.1016/j.ecss.2011.11.032; Ostman O, 2012, CAN J FISH AQUAT SCI, V69, P1047, DOI 10.1139/F2012-042; Putys Z, 2012, THESIS VILNIUS U; Ridgway MS, 2010, J GREAT LAKES RES, V36, P93, DOI 10.1016/j.jglr.2009.10.002; Saulamo K., 2002, FINFO, V2002, P9; Soderberg K, 2004, FINFO, V2004, P7; Stempniewicz L., 2003, P51; Swedish Agency for Marine and Water Management website, KUSTF; Swedish Agency for Marine and Water Management website, FANGSTST YRKESF; Swedish Boards of Fisheries, 2010, SMASK KUSTF; Thornqvist S, 2009, FRITIDSFISKETS UTOVA, P1; van Rijn S., 2003, VOGELWELT, V124, P15; VanDeValk AJ, 2002, T AM FISH SOC, V131, P27, DOI 10.1577/1548-8659(2002)131<0027:COAACH>2.0.CO;2; Vetemaa M, 2010, ICES J MAR SCI, V67, P1972, DOI 10.1093/icesjms/fsq113; Zydelis R, 2008, HYDROBIOLOGIA, V611, P45, DOI 10.1007/s10750-008-9460-7	42	35	35	1	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e83763	10.1371/journal.pone.0083763	http://dx.doi.org/10.1371/journal.pone.0083763			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386272	gold, Green Published, Green Submitted			2022-12-25	WOS:000329194700066
J	Tu, YC; Huang, DY; Shiah, SG; Wang, JS; Lin, WW				Tu, Yu-Cheng; Huang, Duen-Yi; Shiah, Shine-Gwo; Wang, Jang-Shiun; Lin, Wan-Wan			Regulation of c-Fos Gene Expression by NF-kappa B: A p65 Homodimer Binding Site in Mouse Embryonic Fibroblasts but Not Human HEK293 Cells	PLOS ONE			English	Article							SERUM RESPONSE FACTOR; IKK-BETA; TRANSCRIPTION FACTORS; SIGNALING PATHWAYS; PROTEIN-KINASES; FACTOR ELK-1; SERINE 536; ACTIVATION; PHOSPHORYLATION; COMPLEX	The immediate early gene c-Fos is reported to be regulated by Elk-1 and cAMP response element-binding protein (CREB), but whether nuclear factor (NF)-kappa B is also required for controlling c-Fos expression is unclear. In this study, we determined how NF-kappa B's coordination with Elk/serum response factor (SRF) regulates c-fos transcription. We report that PMA strongly induced c-Fos expression, but tumor necrosis factor (TNF)-alpha did not. In mouse embryonic fibroblasts, the PMA induction of c-Fos was suppressed by a deficiency in IKK alpha, IKK beta, IKK gamma, or p65. By contrast, in human embryonic kidney 293 cells, PMA induced c-Fos independently of p65. In accordance with these results, we identified an NF-kappa B binding site in the mouse but not human c-fos promoter. Under PMA stimulation, IKK alpha/beta mediated p65 phosphorylation and the binding of the p65 homodimer to the NF-kappa B site in the mouse c-fos promoter. Furthermore, our studies demonstrated independent but coordinated functions of the IKK alpha/beta-p65 and extracellular signal-regulated kinase (ERK)-Elk-1 pathways in the PMA induction of c-Fos. Collectively, these results reveal the distinct requirement of NF-kappa B for mouse and human c-fos regulation. Binding of the p65 homodimer to the kappa B site was indispensable for mouse c-fos expression, whereas the kappa B binding site was not present in the human c-fos promoter. Because of an inability to evoke sufficient ERK activation and Elk-1 phosphorylation, TNF-alpha induces c-Fos more weakly than PMA does in both mouse and human cells.	[Tu, Yu-Cheng; Huang, Duen-Yi; Wang, Jang-Shiun; Lin, Wan-Wan] Natl Taiwan Univ, Coll Med, Dept Pharmacol, Taipei, Taiwan; [Shiah, Shine-Gwo] Natl Hlth Res Inst, Natl Inst Canc Res, Zhunan, Miaoli County, Taiwan; [Lin, Wan-Wan] Taipei Med Univ, Grad Inst Med Sci, Taipei, Taiwan	National Taiwan University; National Health Research Institutes - Taiwan; Taipei Medical University	Lin, WW (corresponding author), Natl Taiwan Univ, Coll Med, Dept Pharmacol, Taipei, Taiwan.	wwllaura1119@ntu.edu.tw	Shiah, Shine-Gwo/D-2087-2010	Lin, Wan Wan/0000-0002-3207-734X	National Science Council of Taiwan [NSC98-2320-B-002-010-MY3, NSC98-2320-B-400-001-MY3, NSC100-2320-B-002-088-MY3]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by the research grants (NSC98-2320-B-002-010-MY3, NSC98-2320-B-400-001-MY3, and NSC100-2320-B-002-088-MY3) from the National Science Council of Taiwan (www.nsc.gov.twhttp://www.nsc.gov.tw). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adli M, 2006, J BIOL CHEM, V281, P26976, DOI 10.1074/jbc.M603133200; Anest V, 2004, J BIOL CHEM, V279, P31183, DOI 10.1074/jbc.M404380200; BEG AA, 1995, NATURE, V376, P167, DOI 10.1038/376167a0; Bohuslav J, 2004, J BIOL CHEM, V279, P26115, DOI 10.1074/jbc.M313509200; Buss H, 2004, J BIOL CHEM, V279, P55633, DOI 10.1074/jbc.M409825200; Cen B, 2003, MOL CELL BIOL, V23, P6597, DOI 10.1128/MCB.23.18.6597-6608.2003; Chen YQ, 1998, NAT STRUCT BIOL, V5, P67, DOI 10.1038/nsb0198-67; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Delghandi MP, 2005, CELL SIGNAL, V17, P1343, DOI 10.1016/j.cellsig.2005.02.003; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Duan RQ, 2002, BIOCHEM BIOPH RES CO, V294, P384, DOI 10.1016/S0006-291X(02)00499-0; Durchdewald M, 2009, HISTOL HISTOPATHOL, V24, P14451, DOI 10.14670/HH-24.1451; Ely HA, 2011, MOL ENDOCRINOL, V25, P669, DOI 10.1210/me.2010-0437; Eto K, 2010, MOL CELL BIOCHEM, V339, P119, DOI 10.1007/s11010-009-0375-z; Fujioka S, 2004, MOL CELL BIOL, V24, P7806, DOI 10.1128/MCB.24.17.7806-7819.2004; GANCHI PA, 1993, MOL CELL BIOL, V13, P7826, DOI 10.1128/MCB.13.12.7826; Geng H, 2009, EMBO REP, V10, P381, DOI 10.1038/embor.2009.10; GILLE H, 1995, EMBO J, V14, P951, DOI 10.1002/j.1460-2075.1995.tb07076.x; Hazzalin CA, 2002, NAT REV MOL CELL BIO, V3, P30, DOI 10.1038/nrm715; Hoberg JE, 2006, MOL CELL BIOL, V26, P457, DOI 10.1128/MCB.26.2.457-471.2006; Ishihara Y, 2011, FEBS J, V278, P1873, DOI 10.1111/j.1742-4658.2011.08105.x; JOHNSON RS, 1992, CELL, V71, P577, DOI 10.1016/0092-8674(92)90592-Z; KUNSCH C, 1993, MOL CELL BIOL, V13, P6137, DOI 10.1128/MCB.13.10.6137; Lancaster GI, 2012, BIOCHEM J, V442, P723, DOI 10.1042/BJ20112037; Lawrence T, 2005, NATURE, V434, P1138, DOI 10.1038/nature03491; Liu Z, 2005, MOL CELL BIOL, V25, P3220, DOI 10.1128/MCB.25.8.3220-3231.2005; Madrid LV, 2001, J BIOL CHEM, V276, P18934, DOI 10.1074/jbc.M101103200; Maisonnasse-Charital Y, 2009, GENE, V430, P116, DOI 10.1016/j.gene.2008.10.014; Makris C, 2002, MOL CELL BIOL, V22, P6573, DOI 10.1128/MCB.22.18.6573-6581.2002; Malek S, 2003, J BIOL CHEM, V278, P23094, DOI 10.1074/jbc.M301022200; Mandrekar P, 2007, J IMMUNOL, V178, P7686, DOI 10.4049/jimmunol.178.12.7686; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; Murray AJ, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.122re4; O'Donnell A, 2008, MOL CELL, V29, P780, DOI 10.1016/j.molcel.2008.01.019; Oeckinghaus A, 2011, NAT IMMUNOL, V12, P695, DOI 10.1038/ni.2065; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Rahman A, 1999, J IMMUNOL, V162, P5466; Remels AHV, 2009, AM J PHYSIOL-ENDOC M, V297, pE174, DOI 10.1152/ajpendo.90632.2008; Sakurai H, 1999, J BIOL CHEM, V274, P30353, DOI 10.1074/jbc.274.43.30353; Sandersen C, 2001, VET IMMUNOL IMMUNOP, V80, P315, DOI 10.1016/S0165-2427(01)00329-4; Shan B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011662; SHORE P, 1994, MOL CELL BIOL, V14, P3283, DOI 10.1128/MCB.14.5.3283; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Wagner EF, 2010, ANN RHEUM DIS, V69, P86, DOI 10.1136/ard.2009.119396; Wang Y, 2000, ONCOGENE, V19, P1379, DOI 10.1038/sj.onc.1203443; WHITMARSH AJ, 1995, SCIENCE, V269, P403, DOI 10.1126/science.7618106; Whitmarsh AJ, 1997, MOL CELL BIOL, V17, P2360, DOI 10.1128/MCB.17.5.2360; Yang SH, 1999, EMBO J, V18, P5666, DOI 10.1093/emboj/18.20.5666; Yoboua F, 2010, J VIROL, V84, P7267, DOI 10.1128/JVI.00142-10; Zhang HM, 2008, NUCLEIC ACIDS RES, V36, P2594, DOI 10.1093/nar/gkn099	50	13	15	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e84062	10.1371/journal.pone.0084062	http://dx.doi.org/10.1371/journal.pone.0084062			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386331	Green Published, gold, Green Submitted			2022-12-25	WOS:000329194700088
J	Bourbonnais, ML; Nelson, TA; Cattet, MRL; Darimont, CT; Stenhouse, GB				Bourbonnais, Mathieu L.; Nelson, Trisalyn A.; Cattet, Marc R. L.; Darimont, Chris T.; Stenhouse, Gordon B.			Spatial Analysis of Factors Influencing Long-Term Stress in the Grizzly Bear (Ursus arctos) Population of Alberta, Canada	PLOS ONE			English	Article							FOOTHILLS MODEL FOREST; WEST-CENTRAL ALBERTA; BANFF NATIONAL-PARK; HOME-RANGE SIZE; EXTINCTION RISK; HABITAT LOSS; FECAL GLUCOCORTICOIDS; YELLOWHEAD ECOSYSTEM; PHYSIOLOGICAL STRESS; SPECIES DISTRIBUTION	Non-invasive measures for assessing long-term stress in free ranging mammals are an increasingly important approach for understanding physiological responses to landscape conditions. Using a spatially and temporally expansive dataset of hair cortisol concentrations (HCC) generated from a threatened grizzly bear (Ursus arctos) population in Alberta, Canada, we quantified how variables representing habitat conditions and anthropogenic disturbance impact long-term stress in grizzly bears. We characterized spatial variability in male and female HCC point data using kernel density estimation and quantified variable influence on spatial patterns of male and female HCC stress surfaces using random forests. Separate models were developed for regions inside and outside of parks and protected areas to account for substantial differences in anthropogenic activity and disturbance within the study area. Variance explained in the random forest models ranged from 55.34% to 74.96% for males and 58.15% to 68.46% for females. Predicted HCC levels were higher for females compared to males. Generally, high spatially continuous female HCC levels were associated with parks and protected areas while low-to-moderate levels were associated with increased anthropogenic disturbance. In contrast, male HCC levels were low in parks and protected areas and low-to-moderate in areas with increased anthropogenic disturbance. Spatial variability in gender-specific HCC levels reveal that the type and intensity of external stressors are not uniform across the landscape and that male and female grizzly bears may be exposed to, or perceive, potential stressors differently. We suggest observed spatial patterns of long-term stress may be the result of the availability and distribution of foods related to disturbance features, potential sexual segregation in available habitat selection, and may not be influenced by sources of mortality which represent acute traumas. In this wildlife system and others, conservation and management efforts can benefit by understanding spatial-and gender-based stress responses to landscape conditions.	[Bourbonnais, Mathieu L.; Nelson, Trisalyn A.] Univ Victoria, Spatial Pattern Anal & Res Lab, Dept Geog, Victoria, BC, Canada; [Cattet, Marc R. L.] Univ Saskatchewan, Western Coll Vet Med, Canadian Cooperat Wildlife Hlth Ctr, Saskatoon, SK S7N 0W0, Canada; [Darimont, Chris T.] Univ Victoria, Appl Conservat Sci Lab, Dept Geog, Victoria, BC, Canada; [Stenhouse, Gordon B.] Foothills Res Inst, Hinton, AB, Canada	University of Victoria; University of Saskatchewan; University of Victoria	Bourbonnais, ML (corresponding author), Univ Victoria, Spatial Pattern Anal & Res Lab, Dept Geog, Victoria, BC, Canada.	mathieub@uvic.ca		Bourbonnais, Mathieu/0000-0002-8781-1978; Nelson, Trisalyn/0000-0003-2537-6971	Natural Sciences and Engineering Research Council of Canada; Yellowstone; Foothills Research Institute Grizzly Bear Program	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Yellowstone; Foothills Research Institute Grizzly Bear Program	The authors would like to thank the Natural Sciences and Engineering Research Council of Canada, the Yellowstone to Yukon Conservation Initiative, and partners from the Foothills Research Institute Grizzly Bear Program for financial support. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberta Sustainable Resource Development Alberta Conservation Association, 2010, 37 ALB SUST RES DEV; Andison DW, 1998, ECOGRAPHY, V21, P543, DOI 10.1111/j.1600-0587.1998.tb00446.x; Andrew ME, 2012, GLOBAL ECOL BIOGEOGR, V21, P352, DOI 10.1111/j.1466-8238.2011.00676.x; [Anonymous], 1987, BEARS BIOL MANAG; Ashley NT, 2011, GEN COMP ENDOCR, V172, P382, DOI 10.1016/j.ygcen.2011.03.029; Bechshoft TO, 2011, SCI TOTAL ENVIRON, V409, P831, DOI 10.1016/j.scitotenv.2010.10.047; Bender DJ, 1998, ECOLOGY, V79, P517, DOI 10.2307/176950; Benn B, 2002, URSUS, V13, P213; Berland A, 2008, FOREST ECOL MANAG, V256, P1875, DOI 10.1016/j.foreco.2008.07.019; Berry Sandra, 2007, Pacific Conservation Biology, V13, P120; BLANCHARD BM, 1991, BIOL CONSERV, V58, P41, DOI 10.1016/0006-3207(91)90044-A; Boulanger J, 2007, GRIZZLY BEAR POPULAT; Boulanger J, 2009, GRIZZLY BEAR POPULAT; Boulanger J, 2005, GRIZZLY BEAR POPULAT; Bowman AW, 1997, APPL SMOOTHING TECHN; Brearley G, 2012, LANDSCAPE ECOL, V27, P1407, DOI 10.1007/s10980-012-9790-8; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Brooks TM, 2002, CONSERV BIOL, V16, P909, DOI 10.1046/j.1523-1739.2002.00530.x; Bryan H, 2013, PLOS ONE IN PRESS; Duro D, 2007, PROG PHYS GEOG, V31, P235, DOI 10.1177/0309133307079054; Cardillo M, 2005, SCIENCE, V309, P1239, DOI 10.1126/science.1116030; Cattet MRL, 2002, CAN J ZOOL, V80, P1156, DOI 10.1139/Z02-103; Clark DA, 2011, POLICY SCI, V44, P1, DOI 10.1007/s11077-010-9118-y; Coops NC, 2008, ECOL INDIC, V8, P754, DOI 10.1016/j.ecolind.2008.01.007; Coops NC, 2009, J BIOGEOGR, V36, P905, DOI 10.1111/j.1365-2699.2008.02053.x; Cranston J., 2005, 2004 POPULATION INVE; Creel S, 2002, CONSERV BIOL, V16, P809, DOI 10.1046/j.1523-1739.2002.00554.x; Cutler DR, 2007, ECOLOGY, V88, P2783, DOI 10.1890/07-0539.1; Dahle B, 2006, J MAMMAL, V87, P859, DOI 10.1644/05-MAMM-A-352R1.1; Didham RK, 2007, TRENDS ECOL EVOL, V22, P489, DOI 10.1016/j.tree.2007.07.001; DIGGLE P, 1985, J R STAT SOC C-APPL, V34, P138; Ecological Stratification Working Group, 1995, NAT EC FRAM CAN AGR; Elfstrom M, 2014, MAMMAL REV, V44, P5, DOI 10.1111/j.1365-2907.2012.00223.x; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Ewers RM, 2006, BIOL REV, V81, P117, DOI 10.1017/S1464793105006949; Fontana FMA, 2012, REMOTE SENS ENVIRON, V121, P171, DOI 10.1016/j.rse.2012.01.007; Franklin SE, 2002, INT J REMOTE SENS, V23, P4633, DOI 10.1080/01431160110113971; Garshelis DL, 2005, J WILDLIFE MANAGE, V69, P277, DOI 10.2193/0022-541X(2005)069<0277:GBDIAA>2.0.CO;2; GESSLER PE, 1995, INT J GEOGR INF SYST, V9, P421, DOI 10.1080/02693799508902047; Gibeau ML, 2001, URSUS-SERIES, V12, P121; Graham K, 2010, URSUS, V21, P43, DOI 10.2192/09GR010.1; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Gurevitch J, 2004, TRENDS ECOL EVOL, V19, P470, DOI 10.1016/j.tree.2004.07.005; HELLGREN EC, 1993, J MAMMAL, V74, P304, DOI 10.2307/1382385; JOHNSON DH, 1980, ECOLOGY, V61, P65, DOI 10.2307/1937156; Kellert SR, 1996, CONSERV BIOL, V10, P977, DOI 10.1046/j.1523-1739.1996.10040977.x; Kitaysky AS, 2007, MAR ECOL PROG SER, V352, P245, DOI 10.3354/meps07074; KNIGHT RR, 1985, ECOLOGY, V66, P323, DOI 10.2307/1940382; Laliberte AS, 2004, BIOSCIENCE, V54, P123, DOI 10.1641/0006-3568(2004)054[0123:RCONAC]2.0.CO;2; Libal NS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024133; Macbeth BJ, 2010, CAN J ZOOL, V88, P935, DOI 10.1139/Z10-057; MACHUTCHON G., 2008, GRIZZLY BEAR POPULAT; Manly B., 2007, RESOURCE SELECTION A; McDermid GJ, 2005, PROG PHYS GEOG, V29, P449, DOI 10.1191/0309133305pp455ra; Mcdermid GJ, 2005, THESIS U WATERLOO CA; McEwen BS, 2003, HORM BEHAV, V43, P2, DOI 10.1016/S0018-506X(02)00024-7; McLellan BN, 1999, J WILDLIFE MANAGE, V63, P911, DOI 10.2307/3802805; McLellan BN, 2001, J WILDLIFE MANAGE, V65, P92, DOI 10.2307/3803280; McLoughlin PD, 2000, EVOL ECOL, V14, P39, DOI 10.1023/A:1011019031766; Meyer JS, 2012, ENDOCRINOLOGY, V153, P4120, DOI 10.1210/en.2012-1226; Millspaugh JJ, 2001, WILDLIFE SOC B, V29, P899; Morrison ML, 2001, J WILDLIFE MANAGE, V65, P613, DOI 10.2307/3803012; Mowat G, 2006, CAN J ZOOL, V84, P473, DOI 10.1139/z06-016; Munro RHM, 2006, J MAMMAL, V87, P1112, DOI 10.1644/05-MAMM-A-410R3.1; Nadaraya EA, 1964, THEOR PROBAB, P142; Nelson T, 2006, FOREST CHRON, V82, P243, DOI 10.5558/tfc82243-2; Nelson Trisalyn A., 2007, British Columbia Journal of Ecosystems and Management, V8, P91; Nielsen S.E., 2009, J CONSERVATION PLANN, V5, P38; Nielsen SE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053721; Nielsen SE, 2010, BIOL CONSERV, V143, P1623, DOI 10.1016/j.biocon.2010.04.007; Nielsen SE, 2006, BIOL CONSERV, V130, P217, DOI 10.1016/j.biocon.2005.12.016; Nielsen SE, 2004, BIOL CONSERV, V120, P101, DOI 10.1016/j.biocon.2004.02.020; Nielsen SE, 2004, FOREST ECOL MANAG, V199, P51, DOI 10.1016/j.foreco.2004.04.014; Nielsen SE, 2004, FOREST ECOL MANAG, V199, P67, DOI 10.1016/j.foreco.2004.04.015; Nielson SE, 2002, URSUS, V13, P45; Nilsen EB, 2005, ECOSCIENCE, V12, P68, DOI 10.2980/i1195-6860-12-1-68.1; Palme R, 2005, ANN NY ACAD SCI, V1040, P162, DOI 10.1196/annals.1327.021; Prasad AM, 2006, ECOSYSTEMS, V9, P181, DOI 10.1007/s10021-005-0054-1; Proctor MF, 2004, CAN J ZOOL, V82, P1108, DOI 10.1139/z04-077; Proctor MF, 2005, P ROY SOC B-BIOL SCI, V272, P2409, DOI 10.1098/rspb.2005.3246; Proctor MF, 2012, WILDLIFE MONOGR, P1, DOI 10.1002/wmon.6; Purvis A, 2000, P ROY SOC B-BIOL SCI, V267, P1947, DOI 10.1098/rspb.2000.1234; Reeder DM, 2005, J MAMMAL, V86, P225, DOI 10.1644/BHE-003.1; Rhemtulla JM, 2002, CAN J FOREST RES, V32, P2010, DOI 10.1139/X02-112; Rode KD, 2006, ECOLOGY, V87, P2636, DOI 10.1890/0012-9658(2006)87[2636:SDRSAH]2.0.CO;2; Roever CL, 2008, FOREST ECOL MANAG, V256, P1253, DOI 10.1016/j.foreco.2008.06.040; Romero LM, 2004, TRENDS ECOL EVOL, V19, P249, DOI 10.1016/j.tree.2004.03.008; Russell GJ, 1998, CONSERV BIOL, V12, P1365, DOI 10.1046/j.1523-1739.1998.96332.x; Sheriff MJ, 2011, OECOLOGIA, V166, P869, DOI 10.1007/s00442-011-1943-y; Sheriff MJ, 2010, ECOLOGY, V91, P2983, DOI 10.1890/09-1108.1; Stenhouse G, 2005, URSUS, V16, P31, DOI 10.2192/1537-6176(2005)016[0031:GBAATE]2.0.CO;2; Stewart BP, 2013, J WILDLIFE MANAGE, V77, P957, DOI 10.1002/jwmg.535; Stewart BP, 2012, APPL GEOGR, V34, P614, DOI 10.1016/j.apgeog.2012.03.001; Steyaert SMJG, 2013, J ANIM ECOL, V82, P836, DOI 10.1111/1365-2656.12055; Stoen OG, 2005, BEHAV ECOL SOCIOBIOL, V59, P191, DOI 10.1007/s00265-005-0024-9; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Travis JMJ, 2003, P ROY SOC B-BIOL SCI, V270, P467, DOI 10.1098/rspb.2002.2246; Trites AW, 2003, MAMMAL REV, V33, P3, DOI 10.1046/j.1365-2907.2003.00009.x; von der Ohe CG, 2004, PHYSIOL BIOCHEM ZOOL, V77, P313, DOI 10.1086/378139; von der Ohe CG, 2002, WILDLIFE SOC B, V30, P1215; Wasser SK, 2011, FRONT ECOL ENVIRON, V9, P546, DOI 10.1890/100071; Wasser SK, 2004, CAN J ZOOL, V82, P475, DOI 10.1139/Z04-020; Weaver JL, 1996, CONSERV BIOL, V10, P964, DOI 10.1046/j.1523-1739.1996.10040964.x; Webb E, 2010, J ARCHAEOL SCI, V37, P807, DOI 10.1016/j.jas.2009.11.010; Wikelski M, 2006, TRENDS ECOL EVOL, V21, P38, DOI 10.1016/j.tree.2005.10.018; WILCOX BA, 1985, AM NAT, V125, P879, DOI 10.1086/284386; Wilson J.P., 2000, TERRAIN ANAL PRINCIP; Wingfield JC, 2003, J NEUROENDOCRINOL, V15, P711, DOI 10.1046/j.1365-2826.2003.01033.x; Woods JG, 1999, WILDLIFE SOC B, V27, P616; WORTON BJ, 1989, ECOLOGY, V70, P164, DOI 10.2307/1938423; WORTON BJ, 1987, ECOL MODEL, V38, P277, DOI 10.1016/0304-3800(87)90101-3	111	41	41	2	107	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e83768	10.1371/journal.pone.0083768	http://dx.doi.org/10.1371/journal.pone.0083768			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	281RE	24386273	Green Published, gold			2022-12-25	WOS:000329117900057
J	Chen, C; Shin, D; Watanabe, H; Nakanishi, Y; Kambara, H; Yoshimura, N; Nambu, A; Isa, T; Nishimura, Y; Koike, Y				Chen, Chao; Shin, Duk; Watanabe, Hidenori; Nakanishi, Yasuhiko; Kambara, Hiroyuki; Yoshimura, Natsue; Nambu, Atsushi; Isa, Tadashi; Nishimura, Yukio; Koike, Yasuharu			Prediction of Hand Trajectory from Electrocorticography Signals in Primary Motor Cortex	PLOS ONE			English	Article							BRAIN-MACHINE INTERFACES; COMPUTER INTERFACE; MOVEMENT TRAJECTORIES; CORTICAL CONTROL; PROSTHETIC ARM; NEURONS; RECORDINGS; REGRESSION; GRASP	Due to their potential as a control modality in brain-machine interfaces, electrocorticography (ECoG) has received much focus in recent years. Studies using ECoG have come out with success in such endeavors as classification of arm movements and natural grasp types, regression of arm trajectories in two and three dimensions, estimation of muscle activity time series and so on. However, there still remains considerable work to be done before a high performance ECoG-based neural prosthetic can be realized. In this study, we proposed an algorithm to decode hand trajectory from 15 and 32 channel ECoG signals recorded from primary motor cortex (M1) in two primates. To determine the most effective areas for prediction, we applied two electrode selection methods, one based on position relative to the central sulcus (CS) and another based on the electrodes' individual prediction performance. The best coefficients of determination for decoding hand trajectory in the two monkeys were 0.4815 +/- 0.0167 and 0.7780 +/- 0.0164. Performance results from individual ECoG electrodes showed that those with higher performance were concentrated at the lateral areas and areas close to the CS. The results of prediction according with different numbers of electrodes based on proposed methods were also shown and discussed. These results also suggest that superior decoding performance can be achieved from a group of effective ECoG signals rather than an entire ECoG array.	[Chen, Chao; Koike, Yasuharu] Tokyo Inst Technol, Dept Informat Proc, Yokohama, Kanagawa 227, Japan; [Shin, Duk; Nakanishi, Yasuhiko; Kambara, Hiroyuki; Yoshimura, Natsue; Koike, Yasuharu] Tokyo Inst Technol, Precis & Intelligence Lab, Yokohama, Kanagawa 227, Japan; [Watanabe, Hidenori; Isa, Tadashi; Nishimura, Yukio] Natl Inst Nat Sci, Natl Inst Physiol Sci, Dept Dev Physiol, Okazaki, Aichi 4448585, Japan; [Nambu, Atsushi; Isa, Tadashi; Nishimura, Yukio] Grad Univ Adv Studies SOKENDAI, Hayama, Japan; [Nishimura, Yukio] Japan Sci & Technol Agcy, Precursory Res Embryon Sci & Technol, Tokyo, Japan; [Koike, Yasuharu] Japan Sci & Technol Agcy, CREST, Kawaguchi, Japan	Tokyo Institute of Technology; Tokyo Institute of Technology; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Graduate University for Advanced Studies - Japan; Japan Science & Technology Agency (JST); Japan Science & Technology Agency (JST)	Shin, D (corresponding author), Tokyo Inst Technol, Precis & Intelligence Lab, Yokohama, Kanagawa 227, Japan.	shinduk@cns.pi.titech.ac.jp	Kambara, Hiroyuki/E-4546-2014; Koike, Yasuharu/E-9150-2014; Shin, Duk/G-9620-2011; NAKANISHI, Yasuhiko/E-4594-2014; Yoshimura, Natsue/E-7087-2014	Koike, Yasuharu/0000-0002-8169-0044; Yoshimura, Natsue/0000-0002-7495-9113; Chen, Chao/0000-0001-7358-4332; Watanabe, Hidenori/0000-0002-4641-9523; Nambu, Atsushi/0000-0003-2153-5445	Strategic Research Program for Brain Sciences from the MEXT of Japan	Strategic Research Program for Brain Sciences from the MEXT of Japan	This study is supported by the Strategic Research Program for Brain Sciences from the MEXT of Japan. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Birbaumer N, 1999, NATURE, V398, P297, DOI 10.1038/18581; Bjorninen T, 2012, IEEE ANTENN WIREL PR, V11, P1663, DOI 10.1109/LAWP.2013.2239252; Carmena JM, 2003, PLOS BIOL, V1, P193, DOI 10.1371/journal.pbio.0000042; Chao Zenas C, 2010, Front Neuroeng, V3, P3, DOI 10.3389/fneng.2010.00003; Chapin JK, 1999, NAT NEUROSCI, V2, P664, DOI 10.1038/10223; Chestek CA, 2013, J NEURAL ENG, V10, DOI 10.1088/1741-2560/10/2/026002; Chin CM, 2007, J NEURAL ENG, V4, P146, DOI 10.1088/1741-2560/4/2/014; Fagg AH, 2007, J NEUROSCI, V27, P11842, DOI 10.1523/JNEUROSCI.3516-07.2007; GELADI P, 1986, ANAL CHIM ACTA, V185, P1, DOI 10.1016/0003-2670(86)80028-9; Griffin DM, 2008, J NEUROPHYSIOL, V99, P1169, DOI 10.1152/jn.00906.2007; Hadjidimitriou SK, 2012, IEEE T BIO-MED ENG, V59, P3498, DOI 10.1109/TBME.2012.2217495; Hauschild M, 2012, P NATL ACAD SCI USA, V109, P17075, DOI 10.1073/pnas.1215092109; Hirata M, 2011, IEICE T COMMUN, VE94B, P2448, DOI 10.1587/transcom.E94.B.2448; Hochberg LR, 2006, NATURE, V442, P164, DOI 10.1038/nature04970; Hochberg LR, 2012, NATURE, V485, P372, DOI 10.1038/nature11076; Kellis S, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/5/056007; Krishnan A, 2011, NEUROIMAGE, V56, P455, DOI 10.1016/j.neuroimage.2010.07.034; Lebedev MA, 2005, J NEUROSCI, V25, P4681, DOI 10.1523/JNEUROSCI.4088-04.2005; Leuthardt EC, 2004, J NEURAL ENG, V1, P63, DOI 10.1088/1741-2560/1/2/001; Ludwig KA, 2009, J NEUROPHYSIOL, V101, P1679, DOI 10.1152/jn.90989.2008; McFarland DJ, 1997, ELECTROEN CLIN NEURO, V103, P386, DOI 10.1016/S0013-4694(97)00022-2; Pistohl T, 2008, J NEUROSCI METH, V167, P105, DOI 10.1016/j.jneumeth.2007.10.001; Pistohl T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054658; Pistohl T, 2012, NEUROIMAGE, V59, P248, DOI 10.1016/j.neuroimage.2011.06.084; Rathelot JA, 2009, P NATL ACAD SCI USA, V106, P918, DOI 10.1073/pnas.0808362106; Rickert J, 2005, J NEUROSCI, V25, P8815, DOI 10.1523/JNEUROSCI.0816-05.2005; Rosipal R, 2006, LECT NOTES COMPUT SC, V3940, P34, DOI 10.1007/11752790_2; Sanchez JC, 2004, IEEE T BIO-MED ENG, V51, P943, DOI 10.1109/TBME.2004.827061; Schalk G, 2008, J NEURAL ENG, V5, P75, DOI 10.1088/1741-2560/5/1/008; Schalk G, 2007, J NEURAL ENG, V4, P264, DOI 10.1088/1741-2560/4/3/012; Shibata K, 2011, SCIENCE, V334, P1413, DOI 10.1126/science.1212003; Shimoda K, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/3/036015; Shin D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047992; Tankus A, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/5/054001; Taylor DM, 2002, SCIENCE, V296, P1829, DOI 10.1126/science.1070291; Thulasidas M, 2006, IEEE T NEUR SYS REH, V14, P24, DOI 10.1109/TNSRE.2005.862695; Velliste M, 2008, NATURE, V453, P1098, DOI 10.1038/nature06996; Wang W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055344; Watanabe H, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/3/036006; Wessberg J, 2000, NATURE, V408, P361, DOI 10.1038/35042582; Wilson JA, 2006, IEEE T NEUR SYS REH, V14, P246, DOI 10.1109/TNSRE.2006.875570; WOLD S, 1984, SIAM J SCI STAT COMP, V5, P735, DOI 10.1137/0905052; Wolpaw JR, 2004, P NATL ACAD SCI USA, V101, P17849, DOI 10.1073/pnas.0403504101; WOLPAW JR, 1991, ELECTROEN CLIN NEURO, V78, P252, DOI 10.1016/0013-4694(91)90040-B; Yanagisawa T, 2012, ANN NEUROL, V71, P353, DOI 10.1002/ana.22613	45	27	28	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e83534	10.1371/journal.pone.0083534	http://dx.doi.org/10.1371/journal.pone.0083534			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281RE	24386223	Green Published, gold, Green Submitted			2022-12-25	WOS:000329117900043
J	Huang, CF; Zhang, L; Ma, SR; Zhao, ZL; Wang, WM; He, KF; Zhao, YF; Zhang, WF; Liu, B; Sun, ZJ				Huang, Cong-Fa; Zhang, Lu; Ma, Si-Rui; Zhao, Zhi-Li; Wang, Wei-Ming; He, Ke-Fei; Zhao, Yi-Fang; Zhang, Wen-Feng; Liu, Bing; Sun, Zhi-Jun			Clinical Significance of Keap1 and Nrf2 in Oral Squamous Cell Carcinoma	PLOS ONE			English	Article							CANCER-CELLS; PROLIFERATION; METASTASIS; EXPRESSION; ASSOCIATION; CYCLOPHILIN; ACTIVATION; PREVENTION; PROGNOSIS; SURVIVAL	Oxidative stress has been reported to play an important role in progression and prognostication in various kinds of cancers. However, the role and clinical significance of oxidative stress markers Keap1 and Nrf2 in oral squamous cell carcinoma (OSCC) has not been elucidated. This study aimed to investigate the correlation of oxidative stress markers Keap1 and Nrf2 expression and pathological features in OSCC by using tissue microarray. Tissue microarrays containing 17 normal oral mucosa, 7 oral epithelial dysplasia and 43 OSCC specimens were studied by immunohistochemistry. The association among these proteins and pathological features were analyzed. Expression of oxidative stress markers Keap1, Nrf2, and antioxidants PPIA, Prdx6, as well as CD147 was found to increase consecutively from normal oral mucosa to OSCC, and the Keap1, Nrf2, PPIA, Prdx6, CD147 expression in OSCC were significantly higher when compared to normal oral mucosa. Expression of Keap1, Nrf2 in tumors was not found to be significantly associated with T category, lymph node metastases, and pathological grade. Furthermore, we checked the relationship among these oxidative stress markers and found that Keap1 was significantly correlated with Nrf2, Prdx6 and CD147. Significant relationship between Nrf2 and Prdx6 was also detected. Finally, we found patients with overexpression of Keap1 and Nrf2 had not significantly worse overall survival by Kaplan-Meier analysis. These findings suggest that ROS markers are associated with carcinogenesis and progression of OSCC, which may have prognostic value and could be regarded as potential therapeutic targets in OSCC.	[Huang, Cong-Fa; Zhang, Lu; Ma, Si-Rui; Zhao, Zhi-Li; Wang, Wei-Ming; He, Ke-Fei; Zhao, Yi-Fang; Zhang, Wen-Feng; Liu, Bing; Sun, Zhi-Jun] Wuhan Univ, State Key Lab Breeding Base Basic Sci Stomatol, Minist Educ, Sch & Hosp Stomatol, Wuhan, Peoples R China; [Huang, Cong-Fa; Zhang, Lu; Ma, Si-Rui; Zhao, Zhi-Li; Wang, Wei-Ming; He, Ke-Fei; Zhao, Yi-Fang; Zhang, Wen-Feng; Liu, Bing; Sun, Zhi-Jun] Wuhan Univ, Key Lab Oral Biomed, Minist Educ, Sch & Hosp Stomatol, Wuhan, Peoples R China; [Zhao, Yi-Fang; Zhang, Wen-Feng; Liu, Bing; Sun, Zhi-Jun] Wuhan Univ, Sch & Hosp Stomatol, Dept Oral Maxillofacial Head Neck Oncol, Wuhan 430072, Peoples R China	Wuhan University; Wuhan University; Wuhan University	Liu, B (corresponding author), Wuhan Univ, State Key Lab Breeding Base Basic Sci Stomatol, Minist Educ, Sch & Hosp Stomatol, Wuhan, Peoples R China.	liubing9909@126.com; zhijundejia@163.com	zhao, zhili/F-4137-2016; Sun, Zhi-Jun/AAD-8791-2022	zhao, zhili/0000-0002-9030-1979; Sun, Zhi-Jun/0000-0003-0932-8013	National Natural Science Foundation of China [81072203, 81272963, 81272964, 81371106, 81371159]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China 81072203, 81272963 (ZJS). 81272964 (WFZ), 81371106 (LZ), 81371159 (YFZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chang LC, 2013, APPL IMMUNOHISTOCHEM; Chen Y, 2009, CELL DEATH DIFFER, V16, P1040, DOI 10.1038/cdd.2009.49; Dai L, 2013, AM J PATHOL, V182, P577, DOI 10.1016/j.ajpath.2012.10.011; De Nicola GM, 2011, NATURE, V475, P106, DOI 10.1038/nature10189; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Hartikainen JM, 2012, CANCER RES, V72, P5537, DOI 10.1158/0008-5472.CAN-12-1474; Huang CF, 2011, ORAL DIS, V17, P328, DOI 10.1111/j.1601-0825.2010.01730.x; Huang CF, 2012, HISTOPATHOLOGY, V60, P793, DOI 10.1111/j.1365-2559.2011.04130.x; Inoue D, 2012, CANCER SCI, V103, P760, DOI 10.1111/j.1349-7006.2012.02216.x; Kim YJ, 2007, CANCER RES, V67, P546, DOI 10.1158/0008-5472.CAN-06-2401; Li M, 2006, CANCER-AM CANCER SOC, V106, P2284, DOI 10.1002/cncr.21862; Lister A, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-37; Noguti J, 2012, CANCER GENOM PROTEOM, V9, P329; Ohta T, 2008, CANCER RES, V68, P1303, DOI 10.1158/0008-5472.CAN-07-5003; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Paschos A, 2013, PROSTATE CANCER P D, V16, P217, DOI 10.1038/pcan.2013.13; Ronkainen H, 2009, ONCOL REP, V21, P1519, DOI 10.3892/or_00000383; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Shanmugam MK, 2012, CANCER LETT, V320, P158, DOI 10.1016/j.canlet.2012.02.037; Shibata T, 2008, GASTROENTEROLOGY, V135, P1358, DOI 10.1053/j.gastro.2008.06.082; Solis LM, 2010, CLIN CANCER RES, V16, P3743, DOI 10.1158/1078-0432.CCR-09-3352; Stacy DR, 2006, HEAD NECK-J SCI SPEC, V28, P813, DOI 10.1002/hed.20430; Sun ZJ, 2012, CLIN CANCER RES, V18, P5304, DOI 10.1158/1078-0432.CCR-12-1371; Suzuki T, 2013, TRENDS PHARMACOL SCI, V34, P340, DOI 10.1016/j.tips.2013.04.005; Wakabayashi N, 2003, NAT GENET, V35, P238, DOI 10.1038/ng1248; Wu WS, 2006, CANCER METAST REV, V25, P695, DOI 10.1007/s10555-006-9037-8	26	28	29	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e83479	10.1371/journal.pone.0083479	http://dx.doi.org/10.1371/journal.pone.0083479			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281RE	24386210	Green Submitted, gold, Green Published			2022-12-25	WOS:000329117900039
J	Stahel, ABJ; Baggenstos, R; Engels, M; Friess, M; Ackermann, M				Stahel, Anina B. J.; Baggenstos, Rhea; Engels, Monika; Friess, Martina; Ackermann, Mathias			Two Different Macaviruses, ovine herpesvirus-2 and caprine herpesvirus-2, Behave Differently in Water Buffaloes than in Cattle or in Their Respective Reservoir Species	PLOS ONE			English	Article							MALIGNANT-CATARRHAL-FEVER; BISON BISON-BISON; OVINE HERPESVIRUS-2; MULTIGENIC CHARACTERIZATION; NASAL SECRETIONS; BUBALUS-BUBALIS; DAIRY-CATTLE; INFECTION; VIRUS; SHEEP	The ongoing global spread of "exotic'' farm animals, such as water buffaloes, which carry their native sets of viruses, may bear unknown risks for the animals, into whose ecological niches the former are introduced and vice versa. Here, we report on the occurrence of malignant catarrhal fever (MCF) on Swiss farms, where "exotic'' water buffaloes were kept together with "native'' animals, i.e. cattle, sheep, and goats. In the first farm with 56 water buffaloes, eight cases of MCF due to ovine herpesvirus-2 (OvHV-2) were noted, whereas additional ten water buffaloes were subclinically infected with either OvHV-2 or caprine herpesvirus-2 (CpHV-2). On the second farm, 13 water buffaloes were infected with CpHV-2 and two of those succumbed to MCF. In neither farm, any of the two viruses were detected in cattle, but the Macaviruses were present at high prevalence among their original host species, sheep and goats, respectively. On the third farm, sheep were kept well separated from water buffaloes and OvHV-2 was not transmitted to the buffaloes, despite of high prevalence of the virus among the sheep. Macavirus DNA was frequently detected in the nasal secretions of virus-positive animals and in one instance OvHV-2 was transmitted vertically to an unborn water buffalo calf. Thus, water buffaloes seem to be more susceptible than cattle to infection with either Macavirus; however, MCF did not develop as frequently. Therefore, water buffaloes seem to represent an interesting intermediate-type host for Macaviruses. Consequently, water buffaloes in their native, tropic environments may be vulnerable and endangered to viruses that originate from seemingly healthy, imported sheep and goats.	[Stahel, Anina B. J.; Engels, Monika; Friess, Martina; Ackermann, Mathias] Univ Zurich, Inst Virol, Vetsuisse Fac, Zurich, Switzerland; [Baggenstos, Rhea] Univ Zurich, Dept Farm Anim, Vetsuisse Fac, Zurich, Switzerland	University of Zurich; University of Zurich	Ackermann, M (corresponding author), Univ Zurich, Inst Virol, Vetsuisse Fac, Zurich, Switzerland.	email@vetvir.uzh.ch			Swiss National Science Foundation (SNF) [310030_130456]; Swiss Federal Veterinary Office (BVet) [1.13.08]; University of Zurich	Swiss National Science Foundation (SNF)(Swiss National Science Foundation (SNSF)); Swiss Federal Veterinary Office (BVet); University of Zurich	This work was supported by grant #310030_130456 from the Swiss National Science Foundation (SNF), grant #1.13.08 from the Swiss Federal Veterinary Office (BVet), and the University of Zurich. The funders did not play any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albini S, 2003, J CLIN MICROBIOL, V41, P900, DOI 10.1128/JCM.41.2.900-904.2003; BARNARD BJH, 1990, ONDERSTEPOORT J VET, V57, P201; Baxter SIF, 1997, ARCH VIROL, V142, P823, DOI 10.1007/s007050050121; Borghese A., 2005, REU Technical Series, P1; CASTRO AE, 1984, AM J VET RES, V45, P409; Chmielewicz B, 2001, VIRUS RES, V75, P87, DOI 10.1016/S0168-1702(00)00252-5; Cissell RL, 2010, MALIGNANT CATARRHAL; Collins JK, 2000, J VET DIAGN INVEST, V12, P406, DOI 10.1177/104063870001200503; Costa EA, 2009, PESQUI VET BRASIL, V29, P395, DOI 10.1590/S0100-736X2009000500006; Crawford TB, 2002, J AM VET MED ASSOC, V221, P843, DOI 10.2460/javma.2002.221.843; Crawford TB, 2002, J AM VET MED ASSOC, V221, P7; Cunha CW, 2009, J CLIN MICROBIOL, V47, P2586, DOI 10.1128/JCM.00997-09; Daniels PW, 1988, MALIGNANT CATARRHAL, P20; David D, 2005, VET REC, V156, P118, DOI 10.1136/vr.156.4.118; Davison AJ, 2009, ARCH VIROL, V154, P171, DOI 10.1007/s00705-008-0278-4; Dettwiler M, 2011, BMC VET RES, V7, DOI 10.1186/1746-6148-7-78; Fagiolo A., 2005, REU Technical Series, P249; Forster C, 2011, GAMMAHERPESVIREN KLE; Foyle KL, 2009, VET REC, V165, P445, DOI 10.1136/vr.165.15.445; Gailbreath KL, 2010, VET MICROBIOL, V143, P389, DOI 10.1016/j.vetmic.2009.11.026; Gasper D, 2012, VET PATHOL, V49, P492, DOI 10.1177/0300985811429306; Gatesy J, 1997, MOL PHYLOGENET EVOL, V7, P303, DOI 10.1006/mpev.1997.0402; Hart J, 2007, J GEN VIROL, V88, P28, DOI 10.1099/vir.0.82284-0; HILL FI, 1993, NEW ZEAL VET J, V41, P35, DOI 10.1080/00480169.1993.35732; HOFFMANN D, 1984, AUST VET J, V61, P108, DOI 10.1111/j.1751-0813.1984.tb07201.x; Hussy D, 2001, CLIN DIAGN LAB IMMUN, V8, P123, DOI 10.1128/CDLI.8.1.123-128.2001; Keel MK, 2003, J VET DIAGN INVEST, V15, P179, DOI 10.1177/104063870301500215; Kleiboeker SB, 2002, J CLIN MICROBIOL, V40, P1311, DOI 10.1128/JCM.40.4.1311-1318.2002; Klieforth R, 2002, J CLIN MICROBIOL, V40, P3381, DOI 10.1128/JCM.40.9.3381-3390.2002; Li H, 2006, J VET DIAGN INVEST, V18, P119, DOI 10.1177/104063870601800120; Li H, 2005, VET MICROBIOL, V107, P23, DOI 10.1016/j.vetmic.2005.01.014; Li H, 2004, J CLIN MICROBIOL, V42, P5558, DOI 10.1128/JCM.42.12.5558-5564.2004; Li H, 2000, J CLIN MICROBIOL, V38, P1313, DOI 10.1128/JCM.38.4.1313-1318.2000; Li H, 2003, J VET DIAGN INVEST, V15, P46, DOI 10.1177/104063870301500110; Li H, 2001, J GEN VIROL, V82, P227, DOI 10.1099/0022-1317-82-1-227; Li H, 2008, CAN VET J, V49, P183; Li H, 2013, J ZOO WILDLIFE MED, V44, P484, DOI 10.1638/2012-0087R.1; Loken T, 2009, J VET DIAGN INVEST, V21, P257, DOI 10.1177/104063870902100216; Martucciello A., 2006, Large Animal Review, V12, P21; Matzat T, 2012, BEITRAG ZUM BOSARTIG; Moioli B., 2005, REU Technical Series, P51; Muller-Doblies UU, 2001, SCHWEIZ ARCH TIERH, V143, P173; Munday JS, 2008, NEW ZEAL VET J, V56, P89, DOI 10.1080/00480169.2008.36815; National Research Council (, 1981, WAT BUFF NEW PROSP U; O'Toole D, 2007, VET PATHOL, V44, P655, DOI 10.1354/vp.44-5-655; O'Toole D, 2002, J VET DIAGN INVEST, V14, P183, DOI 10.1177/104063870201400301; Okeson DM, 2007, J ZOO WILDLIFE MED, V38, P460, DOI 10.1638/06-046.1; Pfitzer S, 2013, TRANSBOUND IN PRESS; PLOWRIGHT W, 1960, NATURE, V188, P1167, DOI 10.1038/1881167a0; Plowright W., 1990, Virus infections of ruminants., P123; Powers JG, 2005, JAVMA-J AM VET MED A, V227, P606, DOI 10.2460/javma.2005.227.606; REID HW, 1987, VET REC, V121, P276, DOI 10.1136/vr.121.12.276; Reid HW, 1989, HERPESVIRUS DIS CATT, V9, P116; Rohlederer BS, 2010, UNTERSUCHUNGEN PRAVA; Schultheiss PC, 1998, J VET DIAGN INVEST, V10, P255, DOI 10.1177/104063879801000305; Sieber V, 2010, VET MED INT, V2010; Strohbucker S, 2005, VORKOMMEN KLIN BEDEU; Taus NS, 2007, J GEN VIROL, V88, P40, DOI 10.1099/vir.0.82285-0; Taus NS, 2006, VET MICROBIOL, V116, P29, DOI 10.1016/j.vetmic.2006.03.005; Teankam K., 2006, Thai Journal of Veterinary Medicine, V36, P19; Vikoren T, 2006, J WILDLIFE DIS, V42, P797, DOI 10.7589/0090-3558-42.4.797; WIYONO A, 1994, VET MICROBIOL, V42, P45, DOI 10.1016/0378-1135(94)90076-0; Wiyono A., 1999, Jurnal Ilmu Ternak dan Veteriner, V4, P121; Yesilbag K, 2007, TROP ANIM HEALTH PRO, V39, P363, DOI 10.1007/s11250-007-9024-2	64	15	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e83695	10.1371/journal.pone.0083695	http://dx.doi.org/10.1371/journal.pone.0083695			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281RE	24386255	gold, Green Published, Green Accepted			2022-12-25	WOS:000329117900053
J	Mustain, WC; Starr, ME; Valentino, JD; Cohen, DA; Okamura, D; Wang, C; Evers, BM; Saito, H				Mustain, W. Conan; Starr, Marlene E.; Valentino, Joseph D.; Cohen, Donald A.; Okamura, Daiki; Wang, Chi; Evers, B. Mark; Saito, Hiroshi			Inflammatory Cytokine Gene Expression in Mesenteric Adipose Tissue during Acute Experimental Colitis	PLOS ONE			English	Article							CROHNS-DISEASE; BACTERIAL TRANSLOCATION; REACTIVATED COLITIS; MURINE COLITIS; BOWEL-DISEASE; CREEPING FAT; MICE; PROTEIN; OBESE; PREADIPOCYTES	Background: Production of inflammatory cytokines by mesenteric adipose tissue (MAT) has been implicated in the pathogenesis of inflammatory bowel disease (IBD). Animal models of colitis have demonstrated inflammatory changes within MAT, but it is unclear if these changes occur in isolation or as part of a systemic adipose tissue response. It is also unknown what cell types are responsible for cytokine production within MAT. The present study was designed to determine whether cytokine production by MAT during experimental colitis is depot-specific, and also to identify the source of cytokine production within MAT. Methods: Experimental colitis was induced in 6-month-old C57BL/6 mice by administration of dextran sulfate sodium (2% in drinking water) for up to 5 days. The induction of cytokine mRNA within various adipose tissues, including mesenteric, epididymal, and subcutaneous, was analyzed by qRT-PCR. These adipose tissues were also examined for histological evidence of inflammation. The level of cytokine mRNA during acute colitis was compared between mature mesenteric adipocytes, mesenteric stromal vascular fraction (SVF), and mesenteric lymph nodes. Results: During acute colitis, MAT exhibited an increased presence of infiltrating mononuclear cells and fibrotic structures, as well as decreased adipocyte size. The mRNA levels of TNF-alpha, IL-1 beta, and IL-6 were significantly increased in MAT but not other adipose tissue depots. Within the MAT, induction of these cytokines was observed mainly in the SVF. Conclusions: Acute experimental colitis causes a strong site-specific inflammatory response within MAT, which is mediated by cells of the SVF, rather than mature adipocytes or mesenteric lymph nodes.	[Mustain, W. Conan; Starr, Marlene E.; Valentino, Joseph D.; Okamura, Daiki; Wang, Chi; Evers, B. Mark; Saito, Hiroshi] Univ Kentucky, Markey Canc Ctr, Lexington, KY 40536 USA; [Mustain, W. Conan; Starr, Marlene E.; Valentino, Joseph D.; Okamura, Daiki; Evers, B. Mark; Saito, Hiroshi] Univ Kentucky, Dept Surg, Lexington, KY USA; [Cohen, Donald A.] Univ Kentucky, Dept Microbiol Immunol & Mol Genet, Lexington, KY USA; [Wang, Chi] Univ Kentucky, Dept Biostat, Lexington, KY USA; [Saito, Hiroshi] Univ Kentucky, Dept Physiol, Lexington, KY USA	University of Kentucky; University of Kentucky; University of Kentucky; University of Kentucky; University of Kentucky	Saito, H (corresponding author), Univ Kentucky, Markey Canc Ctr, Lexington, KY 40536 USA.	hiroshi.saito@uky.edu			National Institute of Health [R01 AG039732, RO1 DK048498]; Crohn's and Colitis Foundation of America; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK048498] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG039732] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Crohn's and Colitis Foundation of America; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Support was provided by National Institute of Health grants (R01 AG039732 to HS, RO1 DK048498 to BME) and a grant from the Crohn's and Colitis Foundation of America (to DAC); however, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acedo SC, 2011, DIGEST DIS SCI, V56, P2545, DOI 10.1007/s10620-011-1644-8; Arner P, 2001, BIOCHEM SOC T, V29, P72, DOI 10.1042/bst0290072; Batra A, 2012, MUCOSAL IMMUNOL, V5, P580, DOI 10.1038/mi.2012.33; Behr MA, 2010, INFLAMM BOWEL DIS, V16, P896, DOI 10.1002/ibd.21171; Berg DJ, 1996, J CLIN INVEST, V98, P1010, DOI 10.1172/JCI118861; COOPER HS, 1993, LAB INVEST, V69, P238; CROHN BB, 1984, JAMA-J AM MED ASSOC, V251, P73, DOI 10.1001/jama.251.1.73; de Oliveira CC, 2009, INT IMMUNOPHARMACOL, V9, P396, DOI 10.1016/j.intimp.2008.12.015; Desreumaux P, 1999, GASTROENTEROLOGY, V117, P73, DOI 10.1016/S0016-5085(99)70552-4; Dieleman LA, 1998, CLIN EXP IMMUNOL, V114, P385; Drouet M, 2012, NUTRITION, V28, P113, DOI 10.1016/j.nut.2011.09.009; Fain JN, 2004, ENDOCRINOLOGY, V145, P2273, DOI 10.1210/en.2003-1336; Fink C, 2012, INFLAMM BOWEL DIS, V18, P1550, DOI 10.1002/ibd.22893; Flurkey KM, 2007, MOUSE BIOMEDICAL RES, V2nd, P637; Gambero A, 2007, INFLAMM BOWEL DIS, V13, P1357, DOI 10.1002/ibd.20222; Guffey CR, 2013, CURR OPIN CLIN NUTR, V16, P595, DOI 10.1097/MCO.0b013e328362d10b; Harkins JM, 2004, J NUTR, V134, P2673, DOI 10.1093/jn/134.10.2673; Herlinger H, 1998, ABDOM IMAGING, V23, P446, DOI 10.1007/s002619900377; John LJ, 2011, ANTIOXID REDOX SIGN, V15, P1255, DOI 10.1089/ars.2011.3892; Karagiannides L, 2006, P NATL ACAD SCI USA, V103, P5207, DOI 10.1073/pnas.0600821103; Koon HW, 2009, P NATL ACAD SCI USA, V106, P8766, DOI 10.1073/pnas.0903499106; Li H, 2008, METABOLISM, V57, P1704, DOI 10.1016/j.metabol.2008.07.029; Martinez J, 2004, PANCREATOLOGY, V4, P42, DOI 10.1159/000077025; Masuoka HC, 2013, ANN NY ACAD SCI, V1281, P106, DOI 10.1111/nyas.12016; Melgar S, 2005, AM J PHYSIOL-GASTR L, V288, pG1328, DOI 10.1152/ajpgi.00467.2004; O'Rourke RW, 2009, INT J OBESITY, V33, P978, DOI 10.1038/ijo.2009.133; Olivier I, 2011, INFLAMM BOWEL DIS, V17, P747, DOI 10.1002/ibd.21413; OLSON AD, 1995, J PEDIATR GASTR NUTR, V21, P410, DOI 10.1097/00005176-199511000-00007; Paul G, 2006, INFLAMM BOWEL DIS, V12, P471, DOI 10.1097/00054725-200606000-00005; Peyrin-Biroulet L, 2007, GUT, V56, P577, DOI 10.1136/gut.2005.082925; Peyrin-Biroulet L, 2012, GUT, V61, P78, DOI 10.1136/gutjnl-2011-300370; Pond CM, 2001, P NUTR SOC, V60, P365, DOI 10.1079/PNS200198; Starr ME, 2013, AGING CELL, V12, P194, DOI 10.1111/acel.12040; Starr ME, 2009, J GERONTOL A-BIOL, V64, P723, DOI 10.1093/gerona/glp046; Teixeira LG, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-204; Thomaz MA, 2009, PHARMACOL RES, V60, P341, DOI 10.1016/j.phrs.2009.05.003; Wirtz S, 2007, ADV DRUG DELIVER REV, V59, P1073, DOI 10.1016/j.addr.2007.07.003; Yamamoto K, 2005, GUT, V54, P789, DOI 10.1136/gut.2004.046516; Yoshida H, 2010, AM J PATHOL, V177, P2774, DOI 10.2353/ajpath.2010.100205	39	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e83693	10.1371/journal.pone.0083693	http://dx.doi.org/10.1371/journal.pone.0083693			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281QS	24386254	Green Published, gold			2022-12-25	WOS:000329116700070
J	Santos, S; Baptista, CS; Abreu, RMV; Bastos, E; Amorim, I; Gut, IG; Gartner, F; Chaves, R				Santos, Sara; Baptista, Claudia S.; Abreu, Rui M. V.; Bastos, Estela; Amorim, Irina; Gut, Ivo G.; Gaertner, Fatima; Chaves, Raquel			ERBB2 in Cat Mammary Neoplasias Disclosed a Positive Correlation between RNA and Protein Low Expression Levels: A Model for erbB-2 Negative Human Breast Cancer	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; HER2 CODON-655 POLYMORPHISM; TIME RT-PCR; SOMATIC MUTATIONS; I655V POLYMORPHISM; HAPLOTYPE ANALYSIS; KINASE DOMAIN; RISK; HER-2/NEU; TUMOR	Human ERBB2 is a proto-oncogene that codes for the erbB-2 epithelial growth factor receptor. In human breast cancer (HBC), erbB-2 protein overexpression has been repeatedly correlated with poor prognosis. In more recent works, underexpression of this gene has been described in HBC. Moreover, it is also recognised that oncogenes that are commonly amplified or deleted encompass point mutations, and some of these are associated with HBC. In cat mammary lesions (CMLs), the overexpression of ERBB2 (27%-59.6%) has also been described, mostly at the protein level and although cat mammary neoplasias are considered to be a natural model of HBC, molecular information is still scarce. In the present work, a cat ERBB2 fragment, comprising exons 10 to 15 (ERBB2_10-15) was achieved for the first time. Allelic variants and genomic haplotype analyses were also performed, and differences between normal and CML populations were observed. Three amino acid changes, corresponding to 3 non-synonymous genomic sequence variants that were only detected in CMLs, were proposed to damage the 3D structure of the protein. We analysed the cat ERBB2 gene at the DNA (copy number determination), mRNA (expression levels assessment) and protein levels (in extra-and intra protein domains) in CML samples and correlated the last two evaluations with clinicopathological features. We found a positive correlation between the expression levels of the ERBB2 RNA and erbB-2 protein, corresponding to the intracellular region. Additionally, we detected a positive correlation between higher mRNA expression and better clinical outcome. Our results suggest that the ERBB2 gene is post-transcriptionally regulated and that proteins with truncations and single point mutations are present in cat mammary neoplastic lesions. We would like to emphasise that the recurrent occurrence of low erbB-2 expression levels in cat mammary tumours, suggests the cat mammary neoplasias as a valuable model for erbB-2 negative HBC.	[Santos, Sara; Baptista, Claudia S.; Abreu, Rui M. V.; Bastos, Estela; Chaves, Raquel] Univ Tras Os Montes & Alto Douro, Ctr Genom & Biotechnol, Inst Biotechnol & Bioengn, Vila Real, Portugal; [Baptista, Claudia S.] Univ Porto, Inst Biomed Sci Abel Salazar, Vet Clin Univ Porto, P-4100 Oporto, Portugal; [Abreu, Rui M. V.] Inst Politecn Braganca, CIMO ESA, Braganca, Portugal; [Bastos, Estela; Chaves, Raquel] Univ Tras Os Montes & Alto Douro, Sch Life Sci & Environm, Dept Genet & Biotechnol, Vila Real, Portugal; [Amorim, Irina; Gaertner, Fatima] Univ Porto, Inst Pathol & Immunol, P-4100 Oporto, Portugal; [Amorim, Irina; Gaertner, Fatima] Univ Porto, Inst Biomed Sci Abel Salazar, Dept Pathol & Mol Immunol, P-4100 Oporto, Portugal; [Gut, Ivo G.] Ctr Natl Genotypage, Evry, France	University of Tras-os-Montes & Alto Douro; Universidade do Porto; Instituto Politecnico de Braganca; University of Tras-os-Montes & Alto Douro; Universidade do Porto; Universidade do Porto; CEA; UDICE-French Research Universities; Universite Paris Saclay	Chaves, R (corresponding author), Univ Tras Os Montes & Alto Douro, Ctr Genom & Biotechnol, Inst Biotechnol & Bioengn, Vila Real, Portugal.	rchaves@utad.pt	Baptista, Cláudia/F-1231-2017; Chaves, Raquel/S-2882-2019; Chaves, Raquel/K-3044-2013; Gut, Ivo/ABF-3188-2020; Amorim, Irina/F-9953-2013; Abreu, Rui/W-1800-2019; Gartner, Maria de Fatima/A-3530-2010; Santos, Sara/L-3001-2018	Baptista, Cláudia/0000-0002-8158-4743; Chaves, Raquel/0000-0002-5970-7428; Chaves, Raquel/0000-0002-5970-7428; Gut, Ivo/0000-0001-7219-632X; Amorim, Irina/0000-0002-2305-1631; Bastos, Estela/0000-0002-4490-6715; Abreu, Rui/0000-0002-7745-8015; Gartner, Maria de Fatima/0000-0002-5302-0086; Santos, Sara/0000-0002-0106-8942	Science and Technology Foundation (FCT) from Portugal [SFRH/BD/23406/2005, SFRH/BD/31754/2006];  [POCI/CVT/62940/2004]; Fundação para a Ciência e a Tecnologia [POCI/CVT/62940/2004, SFRH/BEST/135028/2017] Funding Source: FCT	Science and Technology Foundation (FCT) from Portugal(Portuguese Foundation for Science and Technology); ; Fundação para a Ciência e a Tecnologia	This work has been funded by project POCI/CVT/62940/2004 and by the PhD grants (SFRH/BD/23406/2005 and SFRH/BD/31754/2006, of the Science and Technology Foundation (FCT) from Portugal. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Bagossi P, 2005, BIOPHYS J, V88, P1354, DOI 10.1529/biophysj.104.046003; Baptista CS, 2012, VET J, V191, P203, DOI 10.1016/j.tvjl.2011.01.011; Benusiglio PR, 2006, BRIT J CANCER, V95, P1689, DOI 10.1038/sj.bjc.6603473; Benusiglio PR, 2005, BREAST CANCER RES, V7, pR204, DOI 10.1186/bcr982; Bieche I, 2003, INT J CANCER, V106, P758, DOI 10.1002/ijc.11273; Bieche I, 1999, CLIN CHEM, V45, P1148; BORG A, 1990, CANCER RES, V50, P4332; Bremm A, 2008, CANCER RES, V68, P707, DOI 10.1158/0008-5472.CAN-07-1588; Breyer JP, 2009, CANCER EPIDEM BIOMAR, V18, P1252, DOI 10.1158/1055-9965.EPI-08-1202; Buerger H, 2000, CANCER RES, V60, P854; Burrai GP, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-156; Camp RL, 2003, CANCER RES, V63, P1445; Campbell LL, 2007, CELL CYCLE, V6, P2332, DOI 10.4161/cc.6.19.4914; Carlson CS, 2004, AM J HUM GENET, V74, P106, DOI 10.1086/381000; Carraro DM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021022; Charpin C, 1997, BRIT J CANCER, V75, P1667, DOI 10.1038/bjc.1997.283; Cho HS, 2003, NATURE, V421, P756, DOI 10.1038/nature01392; Clarke Robert, 2009, Breast Cancer Res, V11 Suppl 3, pS22, DOI 10.1186/bcr2441; Cooke T, 2001, EUR J CANCER, V37, pS3, DOI 10.1016/S0959-8049(00)00402-0; Cuadros M, 2010, PATHOBIOLOGY, V77, P38, DOI 10.1159/000272953; Dahabreh IJ, 2011, CANCER EPIDEMIOL, V35, P503, DOI 10.1016/j.canep.2011.01.007; De Maria R, 2005, CANCER RES, V65, P907; Dibb NJ, 2004, NAT REV CANCER, V4, P718, DOI 10.1038/nrc1434; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Dowsett M, 2000, EUR J CANCER, V36, P170, DOI 10.1016/S0959-8049(99)00264-6; Druker BJ, 2001, NEW ENGL J MED, V344, P1031, DOI 10.1056/NEJM200104053441401; Esteva FJ, 2005, CLIN CANCER RES, V11, P3315, DOI 10.1158/1078-0432.CCR-04-1707; Garrett TPJ, 2003, MOL CELL, V11, P495, DOI 10.1016/S1097-2765(03)00048-0; Gilcrease MZ, 2009, AM J SURG PATHOL, V33, P759, DOI 10.1097/PAS.0b013e31819437f9; Gimenez F, 2010, J FELINE MED SURG, V12, P214, DOI 10.1016/j.jfms.2010.01.004; Ginestier C, 2004, J PATHOL, V202, P286, DOI 10.1002/path.1523; Gouvêa Agostinho Pinto, 2004, J. Bras. Patol. Med. Lab., V40, P27, DOI 10.1590/S1676-24442004000100008; Gschwind A, 2004, NAT REV CANCER, V4, P361, DOI 10.1038/nrc1360; Gullick WJ, 1998, BREAST CANCER RES TR, V52, P43, DOI 10.1023/A:1006107016969; Gutierrez C, 2011, ARCH PATHOL LAB MED, V135, P55, DOI 10.1043/2010-0454-RAR.1; GUY CT, 1992, P NATL ACAD SCI USA, V89, P10578, DOI 10.1073/pnas.89.22.10578; Han W, 2005, CLIN CANCER RES, V11, P4775, DOI 10.1158/1078-0432.CCR-04-2208; Hanna WM, 2001, MODERN PATHOL, V14, P677, DOI 10.1038/modpathol.3880372; Hansen K, 2004, EUR J CANCER, V40, P858, DOI 10.1016/j.ejca.2003.11.031; Haverty PM, 2008, GENE CHROMOSOME CANC, V47, P530, DOI 10.1002/gcc.20558; Hishida A, 2002, J NATL CANCER I, V94, P1807; Hu XQ, 2006, BIOCHEM BIOPH RES CO, V346, P778, DOI 10.1016/j.bbrc.2006.05.206; IGNARTROWBRIDGE DM, 1992, P NATL ACAD SCI USA, V89, P4658, DOI 10.1073/pnas.89.10.4658; Jimenez RE, 2000, MODERN PATHOL, V13, P37, DOI 10.1038/modpathol.3880007; Jorissen RN, 2003, EXP CELL RES, V284, P31, DOI 10.1016/S0014-4827(02)00098-8; Keshava C, 2001, CANCER LETT, V173, P37, DOI 10.1016/S0304-3835(01)00671-1; Klapper LN, 2000, ADV CANCER RES, V77, P25; Koletsa T, 2008, NEOPLASIA, V10, P687, DOI 10.1593/neo.08314; KRAUS MH, 1987, EMBO J, V6, P605, DOI 10.1002/j.1460-2075.1987.tb04797.x; Leary RJ, 2008, P NATL ACAD SCI USA, V105, P16224, DOI 10.1073/pnas.0808041105; Lee JW, 2006, CLIN CANCER RES, V12, P57, DOI 10.1158/1078-0432.CCR-05-0976; MACEWEN EG, 1990, CANCER METAST REV, V9, P125, DOI 10.1007/BF00046339; Matos AJF, 2012, VET J, V193, P24, DOI 10.1016/j.tvjl.2011.12.019; Millanta F, 2005, VET PATHOL, V42, P30, DOI 10.1354/vp.42-1-30; Miller SJ, 1996, DNA CELL BIOL, V15, P749, DOI 10.1089/dna.1996.15.749; Millikan R, 2003, BREAST CANCER RES TR, V79, P355, DOI 10.1023/A:1024068525763; Millikan RC, 2005, BREAST CANCER RES TR, V89, P309, DOI 10.1007/s10549-004-2171-5; Misdorp W., 2002, Tumors in domestic animals, P575, DOI 10.1002/9780470376928.ch12; Misdorp W., 1999, HISTOLOGICAL CLASSIF; Molina MA, 2001, CANCER RES, V61, P4744; Montgomery KG, 2003, CANCER EPIDEM BIOMAR, V12, P1109; MULLER WJ, 1988, CELL, V54, P105, DOI 10.1016/0092-8674(88)90184-5; Namba R, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-275; Nelson SE, 2005, BREAST CANCER RES, V7, pR357, DOI 10.1186/bcr1004; Onay VU, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-114; Ordas J, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-179; Perez-Alenza MD, 2004, BREAST CANCER RES, V6, pR300, DOI 10.1186/bcr790; Pharoah PDP, 2008, NEW ENGL J MED, V358, P2796, DOI 10.1056/NEJMsa0708739; Potemski P, 2006, MED SCI MONITOR, V12, pMT57; Rajasekaran R, 2008, CR BIOL, V331, P409, DOI 10.1016/j.crvi.2008.03.004; Rasotto R, 2011, J COMP PATHOL, V144, P170, DOI 10.1016/j.jcpa.2010.08.010; Ross JS, 2009, ONCOLOGIST, V14, P320, DOI 10.1634/theoncologist.2008-0230; Rutteman G, 2001, SMALL ANIMAL CLIN ON; Santos S, 2012, INT J MOL SCI, V13, P2783, DOI 10.3390/ijms13032783; Santos S, 2009, RES VET SCI, V86, P421, DOI 10.1016/j.rvsc.2008.08.007; Scaltriti M, 2007, J NATL CANCER I, V99, P628, DOI 10.1093/jnci/djk134; Schru┬dinger L, 2011, MAESTR; Selvarajan S, 2004, ANN ACAD MED SINGAP, V33, P473; Shigematsu H, 2005, CANCER RES, V65, P1642, DOI 10.1158/0008-5472.CAN-04-4235; Soares M, 2013, MICROSC MICROANAL, V19, P876, DOI 10.1017/S1431927613001529; Tao WY, 2009, BREAST CANCER RES TR, V114, P371, DOI 10.1007/s10549-008-0010-9; Teschendorff AE, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2236; Thomson TA, 2001, MODERN PATHOL, V14, P1079, DOI 10.1038/modpathol.3880440; Tommasi S, 2004, CANCER LETT, V209, P215, DOI 10.1016/j.canlet.2003.12.014; Torres L, 2007, BREAST CANCER RES TR, V102, P143, DOI 10.1007/s10549-006-9317-6; WEIJER K, 1983, J NATL CANCER I, V70, P709; Winston J, 2005, Vet Comp Oncol, V3, P8, DOI 10.1111/j.1476-5810.2005.00063.x; Wolff AC, 2007, J CLIN ONCOL, V25, P118, DOI 10.1200/JCO.2006.09.2775; Zappulli V, 2005, J DAIRY RES, V72, P98, DOI 10.1017/S0022029905001263	90	16	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e83673	10.1371/journal.pone.0083673	http://dx.doi.org/10.1371/journal.pone.0083673			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281QS	24386251	Green Published, Green Submitted, gold			2022-12-25	WOS:000329116700068
J	Jin, X; Zhao, WK; Shi, KY; Ho, WTT; Zhao, ZZJ				Jin, Xi; Zhao, Wanke; Shi, Kaiyao; Ho, Wanting T.; Zhao, Zhizhuang J.			Generation of a New Congenic Mouse Strain with Enhanced Chymase Expression in Mast Cells	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; GENE POLYMORPHISMS; NEUTRAL PROTEASES; CONVERTING-ENZYME; SERINE-PROTEASE; MICE; ATHEROSCLEROSIS; ASSOCIATION; ANGIOTENSIN; GENOTYPE	Mast cells are effector cells best known for their roles in IgE-associated allergy, but they also play a protective role in defense against pathogens. These cells express high levels of proteases including chymase, tryptase and carboxypeptidase. In the present study, we identified a congenic strain of C57BL/6 mice expressing an extraordinarily high level of chymases Mcp-2 and Mcp-4 in mast cells. The overexpression was associated with variant Mcp-2 and Mcp-4 genes originated from DBA/2 mice that also expressed high levels of the two enzymes. Real time PCR analysis revealed that Mcp-2 and Mcp-4 were selectively overexpressed as tryptases, Cpa3 and several other chymases were kept at normal levels. Reporter gene assays demonstrated that single-nucleotide polymorphisms (SNPs) in the promoter region of Mcp-2 gene may be partly responsible for the increased gene transcription. Our study provides a new model system to study the function of mast cell chymases. The data also suggest that expression of chymases differs considerably in different strains of mice and the increased chymase activity may be responsible for some unique phenotypes observed in DBA/2 mice.	[Jin, Xi; Zhao, Wanke; Shi, Kaiyao; Ho, Wanting T.; Zhao, Zhizhuang J.] Univ Oklahoma, Hlth Sci Ctr, Dept Pathol, Oklahoma City, OK 73190 USA; [Shi, Kaiyao] Jilin Univ, China Japan Union Hosp, Dept Cardiol, Changchun 130023, Peoples R China	University of Oklahoma System; University of Oklahoma Health Sciences Center; Jilin University	Zhao, ZZJ (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Pathol, Oklahoma City, OK 73190 USA.	joe-zhao@ouhsc.edu			National Institutes of Health [HL076309, HL079441]; Oklahoma Center for the Advancement of Science Technology; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079441, R01HL076309] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Oklahoma Center for the Advancement of Science Technology; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study is supported in part by grants HL076309 and HL079441 from the National Institutes of Health and a grant from Oklahoma Center for the Advancement of Science & Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amir RE, 2008, GENET MED, V10, P593, DOI [10.1097/GIM.0b013e3181804b9c, 10.1097GIM.0b013e3181804b9c]; Andersson MK, 2008, MOL IMMUNOL, V45, P766, DOI 10.1016/j.molimm.2007.06.360; Andersson MK, 2009, INT IMMUNOL, V21, P95, DOI 10.1093/intimm/dxn128; Bot I, 2007, CIRCULATION, V115, P2516, DOI 10.1161/CIRCULATIONAHA.106.660472; Bot I, 2011, CARDIOVASC RES, V89, P244, DOI 10.1093/cvr/cvq260; Fukuda M, 2002, HYPERTENS RES, V25, P179, DOI 10.1291/hypres.25.179; Galli SJ, 2012, NAT MED, V18, P693, DOI 10.1038/nm.2755; Ge Y, 2001, AM J PATHOL, V158, P281, DOI 10.1016/S0002-9440(10)63967-3; Gumprecht Janusz, 2002, Med Sci Monit, V8, pCR603; He AN, 2013, CURR PHARM DESIGN, V19, P1114; Heikkilae HM, 2008, ARTERIOSCL THROM VAS, V28, P309, DOI 10.1161/ATVBAHA.107.151340; Ihara M, 1999, HYPERTENSION, V33, P1399, DOI 10.1161/01.HYP.33.6.1399; Jippo T, 1999, BLOOD, V93, P1942, DOI 10.1182/blood.V93.6.1942.406k08_1942_1950; Kerley-Hamilton JS, 2012, TOXICOL SCI, V126, P391, DOI 10.1093/toxsci/kfs002; Kunori Y, 2002, EUR J BIOCHEM, V269, P5921, DOI 10.1046/j.1432-1033.2002.03316.x; Leskinen M, 2001, ARTERIOSCL THROM VAS, V21, P516, DOI 10.1161/01.ATV.21.4.516; LIAO L, 1995, J EXP MED, V181, P1123, DOI 10.1084/jem.181.3.1123; Magnusson SE, 2009, FASEB J, V23, P875, DOI 10.1096/fj.08-120394; Mao XQ, 1996, LANCET, V348, P581, DOI 10.1016/S0140-6736(95)10244-2; Mirghomizadeh F, 2009, J BIOL CHEM, V284, P32635, DOI 10.1074/jbc.M109.015446; Morii E, 1996, BLOOD, V88, P2488, DOI 10.1182/blood.V88.7.2488.bloodjournal8872488; Morii E, 1997, BLOOD, V90, P3057, DOI 10.1182/blood.V90.8.3057; NEBERT DW, 1989, CRIT REV TOXICOL, V20, P153, DOI 10.3109/10408448909017908; NEU N, 1987, J IMMUNOL, V139, P3630; Orinska Z, 2007, NAT MED, V13, P927, DOI 10.1038/nm1615; Ortlepp JR, 2001, CORONARY ARTERY DIS, V12, P493, DOI 10.1097/00019501-200109000-00008; PAIGEN B, 1990, ARTERIOSCLEROSIS, V10, P316, DOI 10.1161/01.ATV.10.2.316; Pejler G, 2007, ADV IMMUNOL, V95, P167, DOI 10.1016/S0065-2776(07)95006-3; Pejler G, 2010, BLOOD, V115, P4981, DOI 10.1182/blood-2010-01-257287; Pemberton AD, 2003, CLIN EXP ALLERGY, V33, P1005, DOI 10.1046/j.1365-2222.2003.01720.x; Pfeufer A, 1996, AM J CARDIOL, V78, P362, DOI 10.1016/S0002-9149(96)00296-2; Piliponsky AM, 2012, AM J PATHOL, V181, P875, DOI 10.1016/j.ajpath.2012.05.013; REYNOLDS DS, 1988, J BIOL CHEM, V263, P12783; SERAFIN WE, 1991, J BIOL CHEM, V266, P1934; SERAFIN WE, 1990, J BIOL CHEM, V265, P423; Sun JS, 2007, NAT MED, V13, P719, DOI 10.1038/nm1601; Tanaka K, 1999, CLIN EXP ALLERGY, V29, P800; Tani K, 2000, J LEUKOCYTE BIOL, V67, P585, DOI 10.1002/jlb.67.4.585; Waern I, 2013, MUCOSAL IMMUNOL, V6, P911, DOI 10.1038/mi.2012.129; Waern I, 2009, J IMMUNOL, V183, P6369, DOI 10.4049/jimmunol.0900180; Weidinger S, 2005, ALLERGY, V60, P1256, DOI 10.1111/j.1398-9995.2005.00879.x; Xia ZN, 1996, J BIOL CHEM, V271, P8747, DOI 10.1074/jbc.271.15.8747; Xing S, 2008, BLOOD, V111, P5109, DOI 10.1182/blood-2007-05-091579	43	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84340	10.1371/journal.pone.0084340	http://dx.doi.org/10.1371/journal.pone.0084340			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391943	Green Submitted, Green Published, gold			2022-12-25	WOS:000329323900086
J	Seidlitz, A; Kotzan, N; Nagel, S; Reske, T; Grabow, N; Harder, C; Petersen, S; Sternberg, K; Weitschies, W				Seidlitz, Anne; Kotzan, Nadine; Nagel, Stefan; Reske, Thomas; Grabow, Niels; Harder, Claus; Petersen, Svea; Sternberg, Katrin; Weitschies, Werner			In Vitro Determination of Drug Transfer from Drug-Coated Balloons	PLOS ONE			English	Article							ELUTING BALLOON; PACLITAXEL; RESTENOSIS; MODEL; ANGIOPLASTY; ABSORPTION; TRANSPORT; CATHETER; DELIVERY; CELL	Drug-coated balloons are medical devices designed to locally deliver drug to diseased segments of the vessel wall. For these dosage forms, drug transfer to the vessel wall needs to be examined in detail, since drug released into the blood is cleared from the site. In order to examine drug transfer, a new in vitro setup was developed combining the estimation of drug loss during advancement to the site of application in a model coronary artery pathway with a hydrogel compartment representing, as a very simplified model, the vessel wall. The transfer of fluorescent model substances as well as the drug paclitaxel from coated balloons to the simulated vessel wall was evaluated using this method. The model was suitable to quantify the fractions transferred to the hydrogel and also to qualitatively assess distribution patterns in the hydrogel film. In the case of fluorescein sodium, rhodamin b and paclitaxel, vast amounts of the coated substance were lost during the simulated passage and only very small fractions of about 1% of the total load were transferred to the gel. This must be attributed to good water solubility of the fluorescent substances and the mechanical instability of the paclitaxel coating. Transfer of the hydrophobic model substance triamterene was however nearly unaffected by the preliminary tracking procedure with transferred fractions ranging from 8% to 14%. Analysis of model substance distribution yielded inhomogeneous distributions indicating that the coating was not evenly distributed on the balloon surface and that a great fraction of the coating liquid did not penetrate the folds of the balloon. This finding is contradictory to the generally accepted assumption of a drug depot inside the folds and emphasizes the necessity to thoroughly characterize in vitro performance of drug-coated balloons to support the very promising clinical data.	[Seidlitz, Anne; Kotzan, Nadine; Nagel, Stefan; Weitschies, Werner] Ernst Moritz Arndt Univ Greifswald, Inst Pharm, Ctr Drug Absorpt & Transport, Greifswald, Germany; [Reske, Thomas; Grabow, Niels; Petersen, Svea; Sternberg, Katrin] Univ Rostock, Inst Biomed Engn, D-18055 Rostock, Germany; [Harder, Claus] Biotron SE & Co KG, Erlangen, Germany	Ernst Moritz Arndt Universitat Greifswald; University of Rostock	Seidlitz, A (corresponding author), Ernst Moritz Arndt Univ Greifswald, Inst Pharm, Ctr Drug Absorpt & Transport, Greifswald, Germany.	anne.seidlitz@uni-greifswald.de	Weitschies, Werner/AAT-7148-2021	Seidlitz, Anne/0000-0003-4493-545X	German Federal Ministry of Education and Research [03IS2081]; German state government of Mecklenburg-Vorpommern from the European social fund; regional development fund [V-630-S-087-210/266, V-630-S-087-210/267]	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); German state government of Mecklenburg-Vorpommern from the European social fund; regional development fund	Funding was provided by the German Federal Ministry of Education and Research (grant 03IS2081), German state government of Mecklenburg-Vorpommern from the European social fund and regional development fund (grant V-630-S-087-210/266 and/267). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afari M, 2012, ENDOVASCULAR TODAY, P53; ARIAS MJ, 1994, J DRUG TARGET, V2, P45, DOI 10.3109/10611869409015892; ASTM International, 2007, F239407 ASTM INT COM; Cortese B, 2013, INT J CARDIOL, V164, P1, DOI 10.1016/j.ijcard.2012.05.037; Cortese B, 2012, INT J CARDIOL, V161, P4, DOI 10.1016/j.ijcard.2011.08.855; Council of Europe, 2010, EUR PHARM ED 7 0 SUP; Forrest ML, 2008, PHARM RES, V25, P194, DOI 10.1007/s11095-007-9451-9; Heilmann T, 2010, EUR CARDIOL REV, DOI [10.15420/ecr.2010.8.2.40, DOI 10.15420/ECR.2010.8.2.40]; Hwang CW, 2001, CIRCULATION, V104, P600, DOI 10.1161/hc3101.092214; Kelsch B, 2011, INVEST RADIOL, V46, P255, DOI 10.1097/RLI.0b013e31820577df; Levin AD, 2004, P NATL ACAD SCI USA, V101, P9463, DOI 10.1073/pnas.0400918101; Liggins RT, 1997, J PHARM SCI, V86, P1458, DOI 10.1021/js9605226; Moes J, 2013, EUR J PHARM BIOPHARM, V83, P87, DOI 10.1016/j.ejpb.2012.09.016; Petersen S, 2013, MAT SCI ENG C-MATER, V33, P4244, DOI 10.1016/j.msec.2013.06.021; Radke PW, 2011, EUROINTERVENTION, V7, P730, DOI 10.4244/EIJV7I6A116; Ruebben A., 2011, INTERVENTIONAL CARDI, V6, P56, DOI 10.15420/ICR.2011.6.1.56; Sakai M, 1997, J PHARM SCI, V86, P779, DOI 10.1021/js960529n; Scheller B, 2004, CIRCULATION, V110, P810, DOI 10.1161/01.CIR.0000138929.71660.E0; Scheller B, 2006, NEW ENGL J MED, V355, P2113, DOI 10.1056/NEJMoa061254; Schnorr B, 2010, MINERVA CARDIOANGIOL, V58, P567; Seidlitz A, 2012, BIOMED ENG-BIOMED TE, V57, P403, DOI 10.1515/bmt-2012-4120; Seidlitz A, 2011, EUR J PHARM BIOPHARM, V78, P36, DOI 10.1016/j.ejpb.2010.12.021; Semmling B, 2013, AAPS PHARMSCITECH, V14, P1209, DOI 10.1208/s12249-013-0011-9; SHARMA US, 1995, J PHARM SCI, V84, P1223, DOI 10.1002/jps.2600841015; Surapaneni Madhu S, 2012, ISRN Pharmacol, V2012, P623139, DOI 10.5402/2012/623139; Tepe G, 2008, NEW ENGL J MED, V358, P689, DOI 10.1056/NEJMoa0706356; Toropainen E, 2001, INVEST OPHTH VIS SCI, V42, P2942; Waksman R, 2009, CIRC-CARDIOVASC INTE, V2, P352, DOI 10.1161/CIRCINTERVENTIONS.109.873703; Watanabe E, 2004, EUR J PHARM BIOPHARM, V58, P659, DOI 10.1016/j.ejpb.2004.03.029; Werk M, 2008, CIRCULATION, V118, P1358, DOI 10.1161/CIRCULATIONAHA.107.735985; Wohrle J, 2012, CURR CARDIOL REP, V14, P635, DOI 10.1007/s11886-012-0290-x; Yazdani SK, 2014, CATHETER CARDIO INTE, V83, P132, DOI 10.1002/ccd.24995; Zhao YN, 2002, RAPID COMMUN MASS SP, V16, P1548, DOI 10.1002/rcm.749	33	36	37	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83992	10.1371/journal.pone.0083992	http://dx.doi.org/10.1371/journal.pone.0083992			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391863	Green Submitted, gold, Green Published			2022-12-25	WOS:000329323900006
J	Sowa, Y; Imura, T; Numajiri, T; Takeda, K; Mabuchi, Y; Matsuzaki, Y; Nishino, K				Sowa, Yoshihiro; Imura, Tetsuya; Numajiri, Toshiaki; Takeda, Kosuke; Mabuchi, Yo; Matsuzaki, Yumi; Nishino, Kenichi			Adipose Stromal Cells Contain Phenotypically Distinct Adipogenic Progenitors Derived from Neural Crest	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; SCHWANN-CELLS; SELF-RENEWAL; IN-VITRO; ORIGIN; LINEAGE; PREADIPOCYTES; MULTIPOTENCY; GENERATION; ADIPOCYTES	Recent studies have shown that adipose-derived stromal/stem cells (ASCs) contain phenotypically and functionally heterogeneous subpopulations of cells, but their developmental origin and their relative differentiation potential remain elusive. In the present study, we aimed at investigating how and to what extent the neural crest contributes to ASCs using Cre-loxP-mediated fate mapping. ASCs harvested from subcutaneous fat depots of either adult P0-Cre/or Wnt1-Cre/Floxed-reporter mice contained a few neural crest-derived ASCs (NCDASCs). This subpopulation of cells was successfully expanded in vitro under standard culture conditions and their growth rate was comparable to non-neural crest derivatives. Although NCDASCs were positive for several mesenchymal stem cell markers as non-neural crest derivatives, they exhibited a unique bipolar or multipolar morphology with higher expression of markers for both neural crest progenitors (p75NTR, Nestin, and Sox2) and preadipocytes (CD24, CD34, S100, Pref-1, GATA2, and C/EBP-delta). NCDASCs were able to differentiate into adipocytes with high efficiency but their osteogenic and chondrogenic potential was markedly attenuated, indicating their commitment to adipogenesis. In vivo, a very small proportion of adipocytes were originated from the neural crest. In addition, p75NTR-positive neural crest-derived cells were identified along the vessels within the subcutaneous adipose tissue, but they were negative for mural and endothelial markers. These results demonstrate that ASCs contain neural crest-derived adipocyte-restricted progenitors whose phenotype is distinct from that of non-neural crest derivatives.	[Sowa, Yoshihiro; Numajiri, Toshiaki; Takeda, Kosuke; Nishino, Kenichi] Kyoto Prefectural Univ Med, Dept Plast & Reconstruct Surg, Kyoto, Japan; [Imura, Tetsuya] Kyoto Prefectural Univ Med, Dept Pathol & Appl Neurobiol, Kyoto, Japan; [Imura, Tetsuya] Fukushima Med Univ, Sch Med, Dept Basic Pathol, Fukushima, Japan; [Mabuchi, Yo; Matsuzaki, Yumi] Keio Univ, Sch Med, Dept Physiol, Tokyo 160, Japan; [Mabuchi, Yo] Tokyo Med & Dent Univ, Grad Sch Hlth Care Sci, Dept Biochem & Biophys, Tokyo, Japan; [Matsuzaki, Yumi] Tokyo Med Univ, Inst Med Sci, Tokyo 1608402, Japan	Kyoto Prefectural University of Medicine; Kyoto Prefectural University of Medicine; Fukushima Medical University; Keio University; Tokyo Medical & Dental University (TMDU); Tokyo Medical University	Imura, T (corresponding author), Kyoto Prefectural Univ Med, Dept Pathol & Appl Neurobiol, Kyoto, Japan.	timura@fmu.ac.jp	Mabuchi, Yo/L-1535-2013	Mabuchi, Yo/0000-0001-8008-3966; Matsuzaki, Yumi/0000-0002-3729-2997; Numajiri, Toshiaki/0000-0002-5390-9723	Ministry of Education, Culture, Sports, Science and Technology of Japan [24791913]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This research was supported by grants-in-aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan (#24791913; http://www.jsps.go.jp/j-grantsinaid/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baer PC, 2012, STEM CELLS INT, V2012, DOI 10.1155/2012/812693; Battula VL, 2009, HAEMATOL-HEMATOL J, V94, P173, DOI 10.3324/haematol.13740; Berry R, 2013, NAT CELL BIOL, V15, P302, DOI 10.1038/ncb2696; Billon N, 2007, DEVELOPMENT, V134, P2283, DOI 10.1242/dev.002642; Cawthorn WP, 2012, J LIPID RES, V53, P227, DOI 10.1194/jlr.R021089; Chang MK, 2008, J IMMUNOL, V181, P1232, DOI 10.4049/jimmunol.181.2.1232; CINTI S, 1989, ANAT REC, V224, P466, DOI 10.1002/ar.1092240403; Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003; Danielian PS, 1998, CURR BIOL, V8, P1323, DOI 10.1016/S0960-9822(07)00562-3; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Dupin E, 2013, CYTOM PART A, V83A, P38, DOI 10.1002/cyto.a.22098; Feng JF, 2011, P NATL ACAD SCI USA, V108, P6503, DOI 10.1073/pnas.1015449108; Fernandes KJL, 2008, PHILOS T R SOC B, V363, P185, DOI 10.1098/rstb.2006.2020; Gesta S, 2007, CELL, V131, P242, DOI 10.1016/j.cell.2007.10.004; Giovannini M, 2000, GENE DEV, V14, P1617; Jeong JY, 2012, J MATER SCI-MATER M, V23, P2773, DOI 10.1007/s10856-012-4718-z; Jiang T, 2010, BIOMATERIALS, V31, P3564, DOI 10.1016/j.biomaterials.2010.01.050; Joseph NM, 2008, CANCER CELL, V13, P129, DOI 10.1016/j.ccr.2008.01.003; Kawamoto S, 2000, FEBS LETT, V470, P263, DOI 10.1016/S0014-5793(00)01338-7; Kruger GM, 2002, NEURON, V35, P657, DOI 10.1016/S0896-6273(02)00827-9; Lemos DR, 2012, STEM CELLS, V30, P1152, DOI 10.1002/stem.1082; Li H, 2011, PLAST RECONSTR SURG, V128, P663, DOI 10.1097/PRS.0b013e318221db33; Liu HX, 2012, DEV BIOL, V368, P294, DOI 10.1016/j.ydbio.2012.05.028; Mabuchi Y, 2013, STEM CELL REP, V1, P152, DOI 10.1016/j.stemcr.2013.06.001; Majka SM, 2010, P NATL ACAD SCI USA, V107, P14781, DOI 10.1073/pnas.1003512107; Masaki T, 2013, CELL, V152, P51, DOI 10.1016/j.cell.2012.12.014; Medici D, 2010, NAT MED, V16, P1400, DOI 10.1038/nm.2252; Mizuno H, 2012, STEM CELLS, V30, P804, DOI 10.1002/stem.1076; Morikawa S, 2009, BIOCHEM BIOPH RES CO, V379, P1114, DOI 10.1016/j.bbrc.2009.01.031; Nagoshi N, 2008, CELL STEM CELL, V2, P392, DOI 10.1016/j.stem.2008.03.005; Nakamura T, 2006, CIRC RES, V98, P1547, DOI 10.1161/01.RES.0000227505.19472.69; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Rada T, 2011, STEM CELL REV REP, V7, P64, DOI 10.1007/s12015-010-9147-0; Rodeheffer MS, 2008, CELL, V135, P240, DOI 10.1016/j.cell.2008.09.036; Satija NK, 2009, J CELL MOL MED, V13, P4385, DOI 10.1111/j.1582-4934.2009.00857.x; Sengenes C, 2005, J CELL PHYSIOL, V205, P114, DOI 10.1002/jcp.20381; Slukvin II, 2011, CELL CYCLE, V10, P1370, DOI 10.4161/cc.10.9.15345; Sowa Y, 2012, STEM CELLS DEV, V21, P1852, DOI 10.1089/scd.2011.0403; Sung JH, 2008, TRANSPL P, V40, P2649, DOI 10.1016/j.transproceed.2008.08.009; Takashima Y, 2007, CELL, V129, P1377, DOI 10.1016/j.cell.2007.04.028; Tang W, 2008, SCIENCE, V322, P583, DOI 10.1126/science.1156232; Traktuev DO, 2008, CIRC RES, V102, P77, DOI 10.1161/CIRCRESAHA.107.159475; Vinatier C, 2007, J BIOMED MATER RES A, V80A, P66, DOI 10.1002/jbm.a.30867; Widera D, 2011, STEM CELLS DEV, V20, P2053, DOI 10.1089/scd.2010.0525; Wrage PC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001453; Yamamoto N, 2007, J DERMATOL SCI, V48, P43, DOI 10.1016/j.jdermsci.2007.05.015; Yamauchi Y, 1999, DEV BIOL, V212, P191, DOI 10.1006/dbio.1999.9323; Zheng B, 2006, TISSUE ENG, V12, P1891, DOI 10.1089/ten.2006.12.1891	48	38	41	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84206	10.1371/journal.pone.0084206	http://dx.doi.org/10.1371/journal.pone.0084206			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391913	gold, Green Submitted, Green Published			2022-12-25	WOS:000329323900056
J	Sun, YBY; Qu, XL; Li, XL; Nikolic-Paterson, DJ; Li, JH				Sun, Yu Bo Yang; Qu, Xinli; Li, Xueling; Nikolic-Paterson, David J.; Li, Jinhua			Endothelial Dysfunction Exacerbates Renal Interstitial Fibrosis through Enhancing Fibroblast Smad3 Linker Phosphorylation in the Mouse Obstructed Kidney	PLOS ONE			English	Article							ENOS DEFICIENCY PREDISPOSES; NITRIC-OXIDE; ANGIOTENSIN-II; TUBULOINTERSTITIAL FIBROSIS; DIABETIC-NEPHROPATHY; PROTECTS; INFLAMMATION; MICE; BLOCKADE; MEDIATOR	Endothelial dysfunction and enhanced transforming growth factor-beta (TGF-beta)/Smad3 signalling are common features of progressive renal fibrosis. This study investigated a potential link between these mechanisms. In unilateral ureteric obstruction (UUO) we observed an acute (6 hr) down-regulation of nitric oxide synthase 3 (NOS3/eNOS) levels and increased phosphorylation of the linker region of Smad3 at T179 and S208 in Smad3/JNK complexes. These events preceded Smad3 C-terminal domain phosphorylation and the induction of myofibroblast proliferation at 48 hrs. Mice deficient in NOS3 showed enhanced myofibroblast proliferation and collagen accumulation compared to wild type mice in a 7 day UUO model. This was associated with enhanced phosphorylation of Smad3 T179 and S208 by 92% and 88%, respectively, whereas Smad3-C-terminal phosphorylation was not affected. Resolvin D1 (RvD1) can suppress renal fibrosis in the UUO model, and further analysis herein showed that RvD1 protected against endothelial dysfunction and suppressed Smad3/JNK complex formation with a consequent reduction in phosphorylation of Smad3 T179 and S208 by 78% and 65%, respectively, while Smad3 C-terminal phosphorylation was unaltered. In vitro, conditioned media from mouse microvascular endothelial cells (MMEC) treated with a general inhibitor of nitric oxide synthase (L-NAME) augmented the proliferation and collagen production of renal fibroblasts (NRK49F cells) compared to control MMEC media and this was associated with increased phosphorylation of JNK and Smad3 T179 and S208, whereas Smad3-C-terminal domain phosphorylation was unaffected. The addition of RvD1 to L-NAME treated MMEC abrogated these effects of the conditioned media on renal fibroblasts. Finally, Smad3 T179/V and S208/A mutations significantly inhibit TGF-beta 1 induced up-regulation collagen I promoter. In conclusion, these data suggest that endothelial dysfunction can exacerbate renal interstitial fibrosis through increased fibroblast proliferation and collagen production via enhanced Smad3 linker phosphorylation.	[Sun, Yu Bo Yang; Qu, Xinli; Li, Jinhua] Monash Univ, Dept Anat & Dev Biol, Clayton, Vic, Australia; [Li, Xueling] Inner Mongolia Univ, Minist Mammalian Reprod Biol & Biotechnol, Key Lab Natl Educ, Hohhot, Inner Mongolia, Peoples R China; [Nikolic-Paterson, David J.] Monash Hlth, Dept Nephrol, Clayton, Vic, Australia; [Nikolic-Paterson, David J.] Monash Univ, Dept Med, Clayton, Vic, Australia	Monash University; Inner Mongolia University; Monash University	Li, JH (corresponding author), Monash Univ, Dept Anat & Dev Biol, Clayton, Vic, Australia.	jinhua.li@monash.edu	Li, Jinhua/I-2741-2014; Li, Jian/I-5538-2016	Li, Jian/0000-0001-7953-8230; Sun, Yu Bo Yang/0000-0003-0863-2769; Nikolic-Paterson, David/0000-0001-5734-2931; Li, Jinhua/0000-0003-4039-5759	Monash University; National Health and Medical Research Council (NHMRC) of Australia; NHMRC	Monash University(Monash University); National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	This study was supported by Monash University Accelerating Programme and the National Health and Medical Research Council (NHMRC) of Australia. JL is the recipient of a NHMRC Career Development Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alarcon C, 2009, CELL, V139, P757, DOI 10.1016/j.cell.2009.09.035; Arita M, 2005, P NATL ACAD SCI USA, V102, P7671, DOI 10.1073/pnas.0409271102; Campanholle G, 2013, AM J PHYSIOL-CELL PH, V304, pC591, DOI 10.1152/ajpcell.00414.2012; Feng XH, 2000, EMBO J, V19, P5178, DOI 10.1093/emboj/19.19.5178; Flanders KC, 2004, INT J EXP PATHOL, V85, P47, DOI 10.1111/j.0959-9673.2004.00377.x; Fujimoto M, 2003, BIOCHEM BIOPH RES CO, V305, P1002, DOI 10.1016/S0006-291X(03)00885-4; GARG UC, 1989, J CLIN INVEST, V83, P1774, DOI 10.1172/JCI114081; Hasturk H, 2006, FASEB J, V20, P401, DOI 10.1096/fj.05-4724fje; Heeringa P, 2000, AM J PATHOL, V156, P879, DOI 10.1016/S0002-9440(10)64957-7; Huang XR, 2010, HYPERTENSION, V55, P1165, DOI 10.1161/HYPERTENSIONAHA.109.147611; ISHIDOYA S, 1995, KIDNEY INT, V47, P1285, DOI 10.1038/ki.1995.183; Ito K, 2005, KIDNEY INT, V68, P515, DOI 10.1111/j.1523-1755.2005.00429.x; Kanetsuna Y, 2007, AM J PATHOL, V170, P1473, DOI 10.2353/ajpath.2007.060481; KATZBERG RW, 1988, LIFE SCI, V42, P1963, DOI 10.1016/0024-3205(88)90495-X; Knowles JW, 2000, J CLIN INVEST, V105, P451, DOI 10.1172/JCI8376; Kretzschmar M, 1999, GENE DEV, V13, P804, DOI 10.1101/gad.13.7.804; Kretzschmar M, 1997, NATURE, V389, P618, DOI 10.1038/39348; Kretzschmar M, 1998, CURR OPIN GENET DEV, V8, P103, DOI 10.1016/S0959-437X(98)80069-5; Lan HY, 2011, INT J BIOL SCI, V7, P1056, DOI 10.7150/ijbs.7.1056; Li F, 2012, J AM SOC NEPHROL, V23, P652, DOI 10.1681/ASN.2011040369; Li JH, 2006, J AM SOC NEPHROL, V17, P2799, DOI 10.1681/ASN.2006020130; Li JH, 2010, DIABETES, V59, P2612, DOI 10.2337/db09-1631; Li YJ, 2013, LIFE SCI, V92, P547, DOI 10.1016/j.lfs.2013.01.018; Lim AKH, 2011, AM J NEPHROL, V34, P337, DOI 10.1159/000331058; Liu QH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032009; Liu XD, 1997, P NATL ACAD SCI USA, V94, P10669, DOI 10.1073/pnas.94.20.10669; Liu Z, 2012, AM J PHYSIOL-RENAL, V302, pF986, DOI 10.1152/ajprenal.00595.2011; Ma FY, 2011, AM J PHYSIOL-RENAL, V300, pF1410, DOI 10.1152/ajprenal.00018.2011; Matsuura I, 2004, NATURE, V430, P226, DOI 10.1038/nature02650; Matsuzaki K, 2012, CELL TISSUE RES, V347, P225, DOI 10.1007/s00441-011-1178-6; MATTANA J, 1995, CELL PHYSIOL BIOCHEM, V5, P176, DOI 10.1159/000154752; McGaha TL, 2002, ARTHRITIS RHEUM, V46, P2748, DOI 10.1002/art.10549; Meng XM, 2010, J AM SOC NEPHROL, V21, P1477, DOI 10.1681/ASN.2009121244; Merched AJ, 2008, FASEB J, V22, P3595, DOI 10.1096/fj.08-112201; Morrissey JJ, 1996, J AM SOC NEPHROL, V7, P2202; Nakagawa T, 2007, J AM SOC NEPHROL, V18, P539, DOI 10.1681/ASN.2006050459; Nakagawa T, 2011, NAT REV NEPHROL, V7, P36, DOI 10.1038/nrneph.2010.152; Nakayama T, 2010, AM J PATHOL, V176, P2198, DOI 10.2353/ajpath.2010.090316; Nakayama T, 2009, AM J PHYSIOL-RENAL, V296, pF317, DOI 10.1152/ajprenal.90450.2008; Patzak A, 2008, AM J PHYSIOL-REG I, V294, pR429, DOI 10.1152/ajpregu.00482.2007; Piek E, 2001, J BIOL CHEM, V276, P19945, DOI 10.1074/jbc.M102382200; Qu XL, 2012, J PATHOL, V228, P506, DOI 10.1002/path.4050; Rezaei HB, 2012, CLIN EXP PHARMACOL P, V39, P661, DOI 10.1111/j.1440-1681.2011.05592.x; Satchell SC, 2012, KIDNEY INT, V82, P949, DOI 10.1038/ki.2012.258; Sato M, 2003, J CLIN INVEST, V112, P1486, DOI 10.1172/JCI200319270; Saura M, 2005, CIRC RES, V97, P1115, DOI 10.1161/01.RES.0000191538.76771.66; Savard S, 2012, NEPHROL DIAL TRANSPL, V27, P2182, DOI 10.1093/ndt/gfr641; Schwab JM, 2007, NATURE, V447, P869, DOI 10.1038/nature05877; Serhan CN, 2008, ANNU REV PATHOL-MECH, V3, P279, DOI 10.1146/annurev.pathmechdis.3.121806.151409; Serhan CN, 2008, PROSTAG OTH LIPID M, V73, P155; Smith RS, 2005, LIFE SCI, V76, P2457, DOI 10.1016/j.lfs.2004.11.028; Sun D, 2012, LIFE SCI, V90, P900, DOI 10.1016/j.lfs.2012.04.018; Sun YBY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055027; Velden J L AJ, 2011, AM J RESP CELL MOL B, V44, P571, DOI DOI 10.1165/RCMB.2009-02820C; Wang A, 2007, AM J PHYSIOL-RENAL, V293, pF1657, DOI 10.1152/ajprenal.00274.2007; Wang GN, 2009, J BIOL CHEM, V284, P9663, DOI 10.1074/jbc.M809281200; Weil EJ, 2012, KIDNEY INT, V82, P1010, DOI 10.1038/ki.2012.234; Yagi S, 2008, CIRC RES, V102, P68, DOI 10.1161/CIRCRESAHA.107.163493; Yuen DA, 2012, J AM SOC NEPHROL, V23, P1810, DOI 10.1681/ASN.2011121170; Zhao HJ, 2006, J AM SOC NEPHROL, V17, P2664, DOI 10.1681/ASN.2006070798; Zimmerman CM, 2000, GENE, V249, P17, DOI 10.1016/S0378-1119(00)00162-1	61	26	28	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84063	10.1371/journal.pone.0084063	http://dx.doi.org/10.1371/journal.pone.0084063			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391884	gold, Green Published, Green Submitted			2022-12-25	WOS:000329323900027
J	Wang, YX; Zeng, X; Peal, L; Tang, YH; Wu, YQ; Mahalingam, R				Wang, Yixing; Zeng, Xin; Peal, Lila; Tang, Yuhong; Wu, Yanqi; Mahalingam, Ramamurthy			Transcriptome Analysis of Nodes and Buds from High and Low Tillering Switchgrass Inbred Lines	PLOS ONE			English	Article							PANICUM-VIRGATUM L.; AXILLARY MERISTEM FORMATION; PLANT DEVELOPMENT; GENE; ARABIDOPSIS; PROTEIN; MAIZE; RICE; ENCODES; BIOMASS	In the last two decades switchgrass has received increasing attention as a promising bioenergy feedstock. Biomass is the principal trait for improvement in switchgrass breeding programs and tillering is an important component of biomass yield. Switchgrass inbred lines derived from a single parent showing vast variation in tiller number trait was used in this study. Axillary buds, which can develop into tillers, and node tissues, which give rise to axillary buds, were collected from high and low tillering inbred lines growing in field conditions. RNA from buds and nodes from the contrasting inbred lines were used for transcriptome profiling with switchgrass Affymetrix genechips. Nearly 7% of the probesets on the genechip exhibited significant differential expression in these lines. Real-time PCR analysis of 30 genes confirmed the differential expression patterns observed with genechips. Cluster analysis aided in identifying probesets unique to high or low tillering lines as well as those specific to buds or nodes of high tillering lines. Rice orthologs of the switchgrass genes were used for gene ontology (GO) analysis with AgriGO. Enrichment of genes associated with amino acid biosynthesis, lipid transport and vesicular transport were observed in low tillering lines. Enrichment of GOs for translation, RNA binding and gene expression in high tillering lines were indicative of active metabolism associated with rapid growth and development. Identification of different classes of transcription factor genes suggests that regulation of many genes determines the complex process of axillary bud initiation and development. Genes identified in this study will complement the current ongoing efforts in quantitative trait loci mapping of tillering in switchgrass.	[Wang, Yixing; Zeng, Xin; Mahalingam, Ramamurthy] Oklahoma State Univ, Dept Biochem & Mol Biol, Stillwater, OK 74078 USA; [Peal, Lila] Langston Univ, Dept Biol, Langston, OK USA; [Tang, Yuhong] Samuel Roberts Noble Fdn Inc, Div Plant Biol, Ardmore, OK USA; [Wu, Yanqi] Oklahoma State Univ, Dept Plant & Soil Sci, Stillwater, OK 74078 USA	Oklahoma State University System; Oklahoma State University - Stillwater; Langston University; Noble Research Institute; Oklahoma State University System; Oklahoma State University - Stillwater	Mahalingam, R (corresponding author), Oklahoma State Univ, Dept Biochem & Mol Biol, Stillwater, OK 74078 USA.	ramamurthy.mahalingam@okstate.edu	Mahalingam, Ramamurthy/AAP-5463-2020; Wu, Yanqi/N-8180-2016	Wu, Yanqi/0000-0003-0802-6881; Tang, Yuhong/0000-0003-2967-778X	National Science Foundation [EPS-0814361]	National Science Foundation(National Science Foundation (NSF))	This research was supported by funding from the National Science Foundation under Grant No. EPS-0814361. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandrova KS, 1996, CROP SCI, V36, P1709, DOI 10.2135/cropsci1996.0011183X003600060049x; Angelovici R, 2011, NEW PHYTOL, V189, P148, DOI 10.1111/j.1469-8137.2010.03478.x; Beveridge CA, 2010, CURR OPIN PLANT BIOL, V13, P34, DOI 10.1016/j.pbi.2009.10.003; Bhandari HS, 2010, CROP SCI, V50, P2355, DOI 10.2135/cropsci2010.02.0109; Boe A, 2008, CROP SCI, V48, P1306, DOI 10.2135/cropsci2007.08.0482; Boe A, 2007, CROP SCI, V47, P636, DOI 10.2135/cropsci2006.04.0260; Bouton Joe, 2008, P295, DOI 10.1007/978-0-387-70805-8_11; Burko Y, 2011, PLANT CELL PHYSIOL, V52, P518, DOI 10.1093/pcp/pcr007; Busov VB, 2008, NEW PHYTOL, V177, P589, DOI 10.1111/j.1469-8137.2007.02324.x; Dancs G, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-65; Das MK, 2004, CROP SCI, V44, P443, DOI 10.2135/cropsci2004.4430; De Angeli A, 2006, NATURE, V442, P939, DOI 10.1038/nature05013; Vivancos PD, 2010, BIOCHEM J, V431, P169, DOI 10.1042/BJ20100409; DOEBLEY J, 1995, GENETICS, V141, P333; DORWEILER J, 1993, SCIENCE, V262, P233, DOI 10.1126/science.262.5131.233; Dorweiler JE, 1997, AM J BOT, V84, P1313, DOI 10.2307/2446130; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Escamilla-Trevino LL, 2010, NEW PHYTOL, V185, P143, DOI 10.1111/j.1469-8137.2009.03018.x; Fang ZM, 2013, PLANT BIOTECHNOL J, V11, P446, DOI 10.1111/pbi.12031; Fu CX, 2012, PLANT BIOTECHNOL J, V10, P443, DOI 10.1111/j.1467-7652.2011.00677.x; Gallavotti A, 2011, PLANT CELL, V23, P1756, DOI 10.1105/tpc.111.084590; Geldner N, 2001, NATURE, V413, P425, DOI 10.1038/35096571; Hadfi K, 1998, DEVELOPMENT, V125, P879; Hubbard L, 2002, GENETICS, V162, P1927; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jahn CE, 2011, PLANT PHYSIOL, V155, P157, DOI 10.1104/pp.110.165654; Jarillo JA, 2009, INT J DEV BIOL, V53, P1581, DOI 10.1387/ijdb.072460jj; Johnson CS, 2002, PLANT CELL, V14, P1359, DOI 10.1105/tpc.001404; Kellogg EA, 1997, CURR BIOL, V7, pR411, DOI 10.1016/S0960-9822(06)00204-1; Komatsu K, 2003, P NATL ACAD SCI USA, V100, P11765, DOI 10.1073/pnas.1932414100; Lagace M, 2004, PLANTA, V219, P185, DOI 10.1007/s00425-004-1253-2; Li XY, 2003, NATURE, V422, P618, DOI 10.1038/nature01518; Liu L, 2013, MOL BREEDING; Liu LL, 2012, BIOENERG RES, V5, P662, DOI 10.1007/s12155-011-9173-z; Liu LL, 2012, G3-GENES GENOM GENET, V2, P357, DOI 10.1534/g3.111.001503; Lukowitz W, 1996, CELL, V84, P61, DOI 10.1016/S0092-8674(00)80993-9; Luo M, 2005, P NATL ACAD SCI USA, V102, P17531, DOI 10.1073/pnas.0508418102; Macknight R, 1997, CELL, V89, P737, DOI 10.1016/S0092-8674(00)80256-1; McSteen P, 2009, PLANT PHYSIOL, V149, P46, DOI 10.1104/pp.108.129056; Mizukami Y, 2000, P NATL ACAD SCI USA, V97, P942, DOI 10.1073/pnas.97.2.942; Oikawa T, 2009, PLANT CELL, V21, P1095, DOI 10.1105/tpc.108.065425; Okada M, 2010, GENETICS, V185, P745, DOI 10.1534/genetics.110.113910; Otsuga D, 2001, PLANT J, V25, P223, DOI 10.1046/j.1365-313x.2001.00959.x; Palmer NA, 2011, BIOENERGY RES; Paul P, 2012, FUNCT INTEGR GENOMIC, V12, P291, DOI 10.1007/s10142-012-0264-5; Potocka I, 2012, PLANT CELL REP, V31, P2031, DOI 10.1007/s00299-012-1314-0; Qiu DY, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-74; Schmitz G, 2002, P NATL ACAD SCI USA, V99, P1064, DOI 10.1073/pnas.022516199; Schomburg FM, 2001, PLANT CELL, V13, P1427, DOI 10.1105/tpc.13.6.1427; Schumacher K, 1999, P NATL ACAD SCI USA, V96, P290, DOI 10.1073/pnas.96.1.290; Sharma MK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033892; Shen H, 2012, NEW PHYTOL, V193, P121, DOI 10.1111/j.1469-8137.2011.03922.x; Skirpan A, 2008, PLANT J, V55, P787, DOI 10.1111/j.1365-313X.2008.03546.x; Stasolla C, 2008, PLANTA, V228, P255, DOI 10.1007/s00425-008-0735-z; Steinmann T, 1999, SCIENCE, V286, P316, DOI 10.1126/science.286.5438.316; STERK P, 1991, PLANT CELL, V3, P907, DOI 10.1105/tpc.3.9.907; Sturn A, 2002, BIOINFORMATICS, V18, P207, DOI 10.1093/bioinformatics/18.1.207; Surpin M, 2004, NAT REV MOL CELL BIO, V5, P100, DOI 10.1038/nrm1311; Takeda T, 2003, PLANT J, V33, P513, DOI 10.1046/j.1365-313X.2003.01648.x; Van Loon LC, 1999, PHYSIOL MOL PLANT P, V55, P85, DOI 10.1006/pmpp.1999.0213; Wang YX, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0034225, 10.1371/journal.pone.0039525, 10.1371/journal.pone.0037152]; Wright L, 2010, BIOMASS BIOENERG, V34, P851, DOI 10.1016/j.biombioe.2010.01.030; Yang DH, 2012, PLANT BIOLOGY, V14, P411, DOI 10.1111/j.1438-8677.2011.00514.x; Yang F, 2012, PLANT J, V71, P61, DOI 10.1111/j.1365-313X.2012.04970.x; Yeats TH, 2008, PROTEIN SCI, V17, P191, DOI 10.1110/ps.073300108; Zhang JY, 2013, PLANT J, V74, P160, DOI 10.1111/tpj.12104	66	7	7	3	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e83772	10.1371/journal.pone.0083772	http://dx.doi.org/10.1371/journal.pone.0083772			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386276	Green Published, Green Submitted, gold			2022-12-25	WOS:000329194700068
J	Fei, D; Krimm, RF				Fei, Da; Krimm, Robin F.			Taste Neurons Consist of Both a Large TrkB-Receptor-Dependent and a Small TrkB-Receptor-Independent Subpopulation	PLOS ONE			English	Article							GENICULATE GANGLION NEURONS; NEUROTROPHIC FACTOR; CHORDA TYMPANI; TARGETED DISRUPTION; FUNGIFORM PAPILLAE; LINGUAL DEFICITS; NEURAL INDUCTION; SENSORY GANGLIA; MESSENGER-RNA; MICE	Brain-derived neurotrophic factor (BDNF) and neurotrophin-4 (NT-4) are two neurotrophins that play distinct roles in geniculate (taste) neuron survival, target innervation, and taste bud formation. These two neurotrophins both activate the tropomyosin-related kinase B (TrkB) receptor and the pan-neurotrophin receptor p75. Although the roles of these neurotrophins have been well studied, the degree to which BDNF and NT-4 act via TrkB to regulate taste development in vivo remains unclear. In this study, we compared taste development in TrkB(-/-) and Bdnf(-/-) /Ntf4(-/-) mice to determine if these deficits were similar. If so, this would indicate that the functions of both BDNF and NT-4 can be accounted for by TrkB-signaling. We found that TrkB(-/-) and Bdnf(-/-) /Ntf4(-/-) mice lose a similar number of geniculate neurons by E13.5, which indicates that both BDNF and NT-4 act primarily via TrkB to regulate geniculate neuron survival. Surprisingly, the few geniculate neurons that remain in TrkB(-/-) mice are more successful at innervating the tongue and taste buds compared with those neurons that remain in Bdnf(-/-) /Ntf4(-/-) mice. The remaining neurons in TrkB(-/-) mice support a significant number of taste buds. In addition, these remaining neurons do not express the TrkB receptor, which indicates that either BDNF or NT-4 must act via additional receptors to influence tongue innervation and/or targeting.	[Fei, Da; Krimm, Robin F.] Univ Louisville, Sch Med, Dept Anat Sci & Neurobiol, Louisville, KY 40292 USA	University of Louisville	Krimm, RF (corresponding author), Univ Louisville, Sch Med, Dept Anat Sci & Neurobiol, Louisville, KY 40292 USA.	rfkrim01@louisville.edu	Krimm, Robin/AAK-3014-2020		National Institute on Deafness and Communication Disorders [DC009418]; National Institutes of Health [8P30GM103507]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103507] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC009418] Funding Source: NIH RePORTER	National Institute on Deafness and Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by National Institute on Deafness and Communication Disorders grant DC009418 to RFK. The project made use of a statistical core facility supported by National Institutes of Health grant 8P30GM103507. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABERCROMBIE M, 1946, ANAT REC, V94, P239, DOI 10.1002/ar.1090940210; Al-Hadlaq SM, 2003, NEUROSCIENCE, V118, P145, DOI 10.1016/S0306-4522(02)00814-X; Bamji SX, 1998, J CELL BIOL, V140, P911, DOI 10.1083/jcb.140.4.911; BARKER PA, 1993, J BIOL CHEM, V268, P15150; Chao MV, 2003, NAT REV NEUROSCI, V4, P299, DOI 10.1038/nrn1078; Cho TT, 1999, MOL BRAIN RES, V68, P1; CONOVER JC, 1995, NATURE, V375, P235, DOI 10.1038/375235a0; D'Autreaux F, 2011, P NATL ACAD SCI USA, V108, P20018, DOI 10.1073/pnas.1110416108; Deppmann CD, 2008, SCIENCE, V320, P369, DOI 10.1126/science.1152677; ElShamy WM, 1997, J NEUROSCI, V17, P8667; ESCANDON E, 1994, J NEUROSCI, V14, P2054; Fan LX, 2004, DEV BRAIN RES, V150, P23, DOI 10.1016/j.devbrainres.2004.02.008; Farbman AI, 2004, J NEUROSCI RES, V78, P659, DOI 10.1002/jnr.20297; Farbman AI, 2004, J NEUROCYTOL, V33, P331, DOI 10.1023/B:NEUR.0000044194.71426.ee; Farinas I, 1998, NEURON, V21, P325, DOI 10.1016/S0896-6273(00)80542-5; FARINAS I, 1994, NATURE, V369, P658, DOI 10.1038/369658a0; Finger TE, 2005, SCIENCE, V310, P1495, DOI 10.1126/science.1118435; Fritzsch B, 1997, INT J DEV NEUROSCI, V15, P563, DOI 10.1016/S0736-5748(96)00111-6; Guagliardo NA, 2007, J COMP NEUROL, V504, P206, DOI 10.1002/cne.21436; Harlow DE, 2011, DEV DYNAM, V240, P309, DOI 10.1002/dvdy.22527; Hoshino N, 2010, DEV NEUROSCI-BASEL, V32, P184, DOI 10.1159/000313902; HOSLEY MA, 1987, J NEUROSCI, V7, P2075; HOSLEY MA, 1987, J COMP NEUROL, V260, P224, DOI 10.1002/cne.902600206; HOSLEY MA, 1987, ANAT RECORD, V218, P216, DOI 10.1002/ar.1092180217; Huang EJ, 2003, ANN REV BIOCH; Ishida Y, 2009, J COMP NEUROL, V514, P131, DOI 10.1002/cne.22000; Ito A, 2009, CELL TISSUE RES, V337, P349, DOI 10.1007/s00441-009-0833-7; Klau M, 2001, J NEUROSCI RES, V66, P327, DOI 10.1002/jnr.10007; KLEIN R, 1993, CELL, V75, P113, DOI 10.1016/0092-8674(93)90683-H; Krimm RF, 2001, DEV BIOL, V232, P508, DOI 10.1006/dbio.2001.0190; Lallemend F, 2012, TRENDS NEUROSCI, V35, P373, DOI 10.1016/j.tins.2012.03.006; Leoni C, 2002, BIOCHEM BIOPH RES CO, V291, P972, DOI 10.1006/bbrc.2002.6571; Li LS, 2011, CELL, V147, P1615, DOI 10.1016/j.cell.2011.11.027; LIU X, 1995, NATURE, V375, P238, DOI 10.1038/375238a0; Lopez GF, 2006, J NEUROBIOL, V66, P1033, DOI 10.1002/neu.20289; Luikart BW, 2003, NEUROSCIENCE, V117, P847, DOI 10.1016/S0306-4522(02)00719-4; Ma LQ, 2009, J NEUROSCI, V29, P3354, DOI 10.1523/JNEUROSCI.3970-08.2009; Matsumoto I, 2001, MOL BRAIN RES, V93, P105, DOI 10.1016/S0169-328X(01)00129-2; Mistretta CM, 1999, J COMP NEUROL, V409, P13; Nagato T, 1995, ACTA ANAT, V153, P301; Ninkina N, 1996, EMBO J, V15, P6385, DOI 10.1002/j.1460-2075.1996.tb01029.x; Nosrat CA, 1996, J COMP NEUROL, V376, P587, DOI 10.1002/(SICI)1096-9861(19961223)376:4<587::AID-CNE7>3.0.CO;2-Y; NOSRAT CA, 1995, J COMP NEUROL, V360, P698, DOI 10.1002/cne.903600413; Nosrat CA, 1997, DEVELOPMENT, V124, P1333; Nosrat IV, 2004, J NEUROCYTOL, V33, P607, DOI 10.1007/s11068-005-3330-2; Oakley B, 1998, DEV BRAIN RES, V105, P85, DOI 10.1016/S0165-3806(97)00178-8; Patel AV, 2012, DEV BIOL, V365, P50, DOI 10.1016/j.ydbio.2012.02.008; Patel AV, 2010, J COMP NEUROL, V518, P3290, DOI 10.1002/cne.22400; Patel AV, 2010, DEV BIOL, V340, P419, DOI 10.1016/j.ydbio.2010.01.024; Sollars SI, 2005, J NEUROBIOL, V64, P310, DOI 10.1002/neu.20140; Sollars SI, 2002, J NEUROBIOL, V51, P223, DOI 10.1002/neu.10055; Stucky CL, 1998, J NEUROSCI, V18, P7040; Sun H, 2002, DEV BIOL, V242, P31, DOI 10.1006/dbio.2001.0526; Tan PK, 2007, MOL PHARMACOL, V72, P1440, DOI 10.1124/mol.107.039636; Tessarollo L, 1997, P NATL ACAD SCI USA, V94, P14776, DOI 10.1073/pnas.94.26.14776; Thirumangalathu S, 2009, DEVELOPMENT, V136, P1519, DOI 10.1242/dev.029090; Yamout A, 2005, DEV NEUROSCI-BASEL, V27, P288, DOI 10.1159/000086708; Zaidi FN, 2007, J NEUROSCI, V27, P13875, DOI 10.1523/JNEUROSCI.2517-07.2007	58	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e83460	10.1371/journal.pone.0083460	http://dx.doi.org/10.1371/journal.pone.0083460			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281RE	24386206	Green Published, gold, Green Submitted			2022-12-25	WOS:000329117900038
J	Won, JC; Lee, YJ; Kim, JM; Han, SY; Noh, JH; Ko, KS; Rhee, BD; Kim, DJ				Won, Jong Chul; Lee, Yun Jeong; Kim, Jung Min; Han, Sang Youb; Noh, Jung Hyun; Ko, Kyung Soo; Rhee, Byoung Doo; Kim, Dong-Jun			Prevalence of and Factors Associated with Albuminuria in the Korean Adult Population: The 2011 Korea National Health and Nutrition Examination Survey	PLOS ONE			English	Article							GLOMERULAR-FILTRATION-RATE; CHRONIC KIDNEY-DISEASE; GENERAL-POPULATION; RISK-FACTORS; METABOLIC SYNDROME; US POPULATION; MICROALBUMINURIA; EXCRETION; HYPERTENSION; PROTEINURIA	Background: Microalbuminuria is associated with increased risk of renal disease and cardiovascular diseases even in nondiabetic subjects. High incidence rates of microalbuminuria have been found in a number of population-based studies. However, the prevalence and risk factors associated with microalbuminuria in the general population in Korea are unclear. Objectives: The present study was performed to estimate the prevalence of microalbuminuria and investigate the associated risk factors in the general adult population using the Fifth Korea National Health and Nutrition Examination Survey (KNHANES V-2) data from 2011. Methods: A total of 5,202 participants (mean age, 45.6 years; men, 2,337; women, 2,865) were included in the analysis. Microalbuminuria was evaluated in participants of KNHANES V-2 based on the urine albumin-creatinine ratio. Estimated glomerular filtration rate was calculated using the Modification of Diet in Renal Disease study equation. Results: The weighted prevalence of microalbuminuria was 5.2% (95% CI, 4.4-6.1) in the general population. The prevalence of albuminuria is increased with age. After adjustment for age and sex, the presence of albuminuria was associated with increased waist circumference, systolic and diastolic blood pressure, aspartate aminotransferase, triglyceride, fasting plasma glucose, and the presence of hypertension and diabetes. In logistic regression analyses, older age, female sex, diabetes, hypertension, and serum aspartate aminotransferase were independently associated with the presence of albuminuria. Conclusion: The prevalence of microalbuminuria was found to be 5.2%, and conventional risk factors for cardiovascular diseases are closely related to the presence of microalbuminuria in Korea. Microalbuminuria may be a useful marker to identify individuals with increased risk of cardiovascular disease.	[Won, Jong Chul; Kim, Jung Min; Ko, Kyung Soo; Rhee, Byoung Doo] Inje Univ, Dept Internal Med, Sanggye Paik Hosp, Cardiovasc & Metab Dis Ctr,Coll Med, Seoul, South Korea; [Lee, Yun Jeong; Han, Sang Youb; Noh, Jung Hyun; Kim, Dong-Jun] Inje Univ, Dept Internal Med, Ilsan Paik Hosp, Coll Med, Koyang, Gyeonggi Do, South Korea	Inje University; Inje University	Kim, DJ (corresponding author), Inje Univ, Dept Internal Med, Ilsan Paik Hosp, Coll Med, Koyang, Gyeonggi Do, South Korea.	djkim@paik.ac.kr	Noh, Junghyun/ABD-9067-2021; Noh, Junghyun/AAU-8113-2020	Noh, Junghyun/0000-0002-7964-0515; Won, Jong Chul/0000-0002-2219-4083; Kim, Jung Min/0000-0002-1848-3747	Inje Research and Scholarship Foundation	Inje Research and Scholarship Foundation	This work was supported by the Inje Research and Scholarship Foundation in 2013 (DK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnlov J, 2005, CIRCULATION, V112, P969, DOI 10.1161/CIRCULATIONAHA.105.538132; Asselbergs FW, 2004, INT J CARDIOL, V93, P211, DOI 10.1016/j.ijcard.2003.04.001; Atkins RC, 2004, KIDNEY INT, V66, pS22, DOI 10.1111/j.1523-1755.2004.09206.x; Bastard JP, 2006, EUR CYTOKINE NETW, V17, P4; Belasco AG, 2002, AM J KIDNEY DIS, V39, P805, DOI 10.1053/ajkd.2002.32001; Borch-Johnsen K, 1999, ARTERIOSCL THROM VAS, V19, P1992, DOI 10.1161/01.ATV.19.8.1992; Chen J, 2004, ANN INTERN MED, V140, P167, DOI 10.7326/0003-4819-140-3-200402030-00007; Choi HS, 2006, CLIN NEPHROL, V65, P256; CONNELL SJ, 1994, DIABETIC MED, V11, P32, DOI 10.1111/j.1464-5491.1994.tb00226.x; Coresh J, 2003, AM J KIDNEY DIS, V41, P1, DOI 10.1053/ajkd.2003.50007; de Jong PE, 2003, NEPHROL DIAL TRANSPL, V18, P10, DOI 10.1093/ndt/18.1.10; Farah SE, 2006, J PEDIATR ENDOCR MET, V19, P937; Foster MC, 2007, ARCH INTERN MED, V167, P1386, DOI 10.1001/archinte.167.13.1386; Hemmelgarn BR, 2010, JAMA-J AM MED ASSOC, V303, P423, DOI 10.1001/jama.2010.39; Hillege HL, 2002, CIRCULATION, V106, P1777, DOI 10.1161/01.CIR.0000031732.78052.81; Imai Enyu, 2007, Clin Exp Nephrol, V11, P156, DOI 10.1007/s10157-007-0463-x; Imanishi M, 1999, DIABETOLOGIA, V42, P999, DOI 10.1007/s001250051259; Jin Dong Chan, 2011, Korean Journal of Internal Medicine, V26, P123, DOI 10.3904/kjim.2011.26.2.123; Jones CA, 2002, AM J KIDNEY DIS, V39, P445, DOI 10.1053/ajkd.2002.31388; Keane WF, 1999, AM J KIDNEY DIS, V33, P1004, DOI 10.1016/S0272-6386(99)70442-7; Kesteloot H, 1996, J HUM HYPERTENS, V10, P245; 임수, 2009, Diabetes and Metabolism Journal, V33, P48; Kim J, 2013, J HUM NUTR DIET, V26, P171, DOI 10.1111/jhn.12098; Kim YI, 2001, DIABETES RES CLIN PR, V52, P145, DOI 10.1016/S0168-8227(01)00228-5; Konta T, 2006, KIDNEY INT, V70, P751, DOI 10.1038/sj.ki.5001504; Lamb EJ, 2005, ANN CLIN BIOCHEM, V42, P321, DOI 10.1258/0004563054889936; Levey AS, 2011, KIDNEY INT, V80, P17, DOI 10.1038/ki.2010.483; Levey AS, 2005, KIDNEY INT, V67, P2089, DOI 10.1111/j.1523-1755.2005.00365.x; MacIsaac RJ, 2006, DIABETES CARE, V29, P1560, DOI 10.2337/dc05-1788; Marin R, 2006, J AM SOC NEPHROL, V17, pS178, DOI 10.1681/ASN.2006080912; Nettleton JA, 2008, AM J CLIN NUTR, V87, P1825, DOI 10.1093/ajcn/87.6.1825; Sato M, 2012, CLIN EXP NEPHROL, V16, P147, DOI 10.1007/s10157-011-0539-5; Son JW, 2012, AM J CARDIOL, V110, P1434, DOI 10.1016/j.amjcard.2012.07.006; Tanaka Satoru, 2013, BMC Res Notes, V6, P256, DOI 10.1186/1756-0500-6-256; TUCKER BJ, 1992, KIDNEY INT, V42, P1160, DOI 10.1038/ki.1992.400; WHO/IASO/IOTF, 2000, ASIA PACIFIC PERSPEC; Zhang LX, 2008, AM J KIDNEY DIS, V51, P373, DOI 10.1053/j.ajkd.2007.11.009	37	19	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e83273	10.1371/journal.pone.0083273	http://dx.doi.org/10.1371/journal.pone.0083273			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281RE	24386169	Green Submitted, gold, Green Published			2022-12-25	WOS:000329117900029
J	Zhang, JF; Xue, CY; Zhu, TQ; Vivekanandan, A; Pennathur, S; Ma, ZA; Chen, YE				Zhang, Jifeng; Xue, Changyong; Zhu, Tianqing; Vivekanandan, Anuradha; Pennathur, Subramaniam; Ma, Zhongmin Alex; Chen, Y. Eugene			A Tripeptide Diapin Effectively Lowers Blood Glucose Levels in Male Type 2 Diabetes Mice by Increasing Blood Levels of Insulin and GLP-1	PLOS ONE			English	Article							GLUCAGON-LIKE PEPTIDE-1; PROTEIN HYDROLYSATE; AMINO-ACID; PLASMA-INSULIN; CO-INGESTION; FATTY-ACIDS; SECRETION; CARBOHYDRATE; HORMONE; TRANSCRIPTION	The prevalence of type 2 diabetes (T2D) is rapidly increasing worldwide. Effective therapies, such as insulin and Glucagon-like peptide-1 (GLP-1), require injections, which are costly and result in less patient compliance. Here, we report the identification of a tripeptide with significant potential to treat T2D. The peptide, referred to as Diapin, is comprised of three natural L-amino acids, GlyGlyLeu. Glucose tolerance tests showed that oral administration of Diapin effectively lowered blood glucose after oral glucose loading in both normal C57BL/6J mice and T2D mouse models, including KKay, db/db, ob/ob mice, and high fat diet-induced obesity/T2D mice. In addition, Diapin treatment significantly reduced casual blood glucose in KKay diabetic mice in a time-dependent manner without causing hypoglycemia. Furthermore, we found that plasma GLP-1 and insulin levels in diabetic models were significantly increased with Diapin treatment compared to that in the controls. In summary, our findings establish that a peptide with minimum of three amino acids can improve glucose homeostasis and Diapin shows promise as a novel pharmaceutical agent to treat patients with T2D through its dual effects on GLP-1 and insulin secretion.	[Zhang, Jifeng; Xue, Changyong; Zhu, Tianqing; Chen, Y. Eugene] Univ Michigan, Med Ctr, Dept Internal Med, Ctr Cardiovasc, Ann Arbor, MI 48109 USA; [Vivekanandan, Anuradha; Pennathur, Subramaniam] Univ Michigan, Med Ctr, Dept Internal Med, Ann Arbor, MI 48109 USA; [Ma, Zhongmin Alex] Diapin Therapeut Ltd Liabil Co, Ann Arbor, MI USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Chen, YE (corresponding author), Univ Michigan, Med Ctr, Dept Internal Med, Ctr Cardiovasc, Ann Arbor, MI 48109 USA.	echunum@umich.edu			National Institutes of Health [HL068878]; University of Michigan of Michigan; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL068878] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020572] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Michigan of Michigan; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work is partially supported by grant from National Institutes of Health (HL068878 to Y.E.C.) and startup fund at University of Michigan of Michigan for Y.E.C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Diabet Assoc, 2009, DIABETES CARE, V32, pS13, DOI 10.2337/dc09-S013; Andrikopoulos S, 2008, AM J PHYSIOL-ENDOC M, V295, pE1323, DOI 10.1152/ajpendo.90617.2008; Broer S, 2008, PHYSIOL REV, V88, P249, DOI 10.1152/physrev.00018.2006; Buteau J, 2008, DIABETES METAB, V34, pS73, DOI 10.1016/S1262-3636(08)73398-6; Chatterjee S, 2012, ANN INTERN MED, V157, DOI 10.7326/0003-4819-157-2-201207170-02013; Choi S, 2007, AM J PHYSIOL-GASTR L, V292, pG1366, DOI 10.1152/ajpgi.00516.2006; Cordier-Bussat M, 1998, DIABETES, V47, P1038, DOI 10.2337/diabetes.47.7.1038; Diakogiannaki E, 2012, PHYSIOL BEHAV, V106, P387, DOI 10.1016/j.physbeh.2011.12.001; ELLIOTT RM, 1993, J ENDOCRINOL, V138, P159, DOI 10.1677/joe.0.1380159; Farilla L, 2002, ENDOCRINOLOGY, V143, P4397, DOI 10.1210/en.2002-220405; Ganapathy V, 1996, Curr Opin Nephrol Hypertens, V5, P395, DOI 10.1097/00041552-199609000-00003; GANNON MC, 1992, METABOLISM, V41, P1137, DOI 10.1016/0026-0495(92)90300-Y; Gannon MC, 1998, DIABETES CARE, V21, P16, DOI 10.2337/diacare.21.1.16; Garber Alan J, 2011, Rev Diabet Stud, V8, P307, DOI 10.1900/RDS.2011.8.307; Hara T, 2011, J PHARM SCI-US, V100, P3594, DOI 10.1002/jps.22639; Hira T, 2009, AM J PHYSIOL-GASTR L, V297, pG663, DOI 10.1152/ajpgi.90635.2008; Hirasawa A, 2005, NAT MED, V11, P90, DOI 10.1038/nm1168; Hossain P, 2007, NEW ENGL J MED, V356, P213, DOI 10.1056/NEJMp068177; IKEDA H, 1994, DIABETES RES CLIN PR, V24, pS313, DOI 10.1016/0168-8227(94)90268-2; Islam D, 2009, AM J PHYSIOL-ENDOC M, V296, pE174, DOI 10.1152/ajpendo.90419.2008; Jang HJ, 2007, P NATL ACAD SCI USA, V104, P15069, DOI 10.1073/pnas.0706890104; Jin TR, 1996, MOL CELL BIOL, V16, P19; Le Neve B, 2011, REGUL PEPTIDES, V167, P14, DOI 10.1016/j.regpep.2010.10.010; Leahy JL, 2005, ARCH MED RES, V36, P197, DOI 10.1016/j.arcmed.2005.01.003; Leibach FH, 1996, ANNU REV NUTR, V16, P99, DOI 10.1146/annurev.nu.16.070196.000531; Lovshin JA, 2009, NAT REV ENDOCRINOL, V5, P262, DOI 10.1038/nrendo.2009.48; Ma J, 2009, DIABETES CARE, V32, P1600, DOI 10.2337/dc09-0723; Ma ZM, 2002, AM J PHYSIOL-ENDOC M, V282, pE820, DOI 10.1152/ajpendo.00165.2001; Manders RJF, 2006, DIABETES CARE, V29, P2721, DOI 10.2337/dc06-1424; Manders RJ, 2006, J NUTR, V136, P1294, DOI 10.1093/jn/136.5.1294; Manders RJF, 2005, AM J CLIN NUTR, V82, P76, DOI 10.1093/ajcn/82.1.76; NUTTALL FQ, 1985, J AM COLL NUTR, V4, P437, DOI 10.1080/07315724.1985.10720086; NUTTALL FQ, 1984, DIABETES CARE, V7, P465, DOI 10.2337/diacare.7.5.465; Okazaki M, 2002, EXP ANIM TOKYO, V51, P191, DOI 10.1538/expanim.51.191; PALLOTTA JA, 1968, METABOLISM, V17, P901, DOI 10.1016/0026-0495(68)90156-X; PORTE D, 1991, DIABETES, V40, P166, DOI 10.2337/diabetes.40.2.166; RABINOWITZ D, 1966, LANCET, V2, P454; Reddi A S, 1988, Adv Exp Med Biol, V246, P7; Reimann F, 2008, CELL METAB, V8, P532, DOI 10.1016/j.cmet.2008.11.002; Seleznev K, 2006, J BIOL CHEM, V281, P22275, DOI 10.1074/jbc.M604330200; Silk DBA, 2008, CIB FDN S 50 PEPT TR, P15; Song K, 2005, MOL ENDOCRINOL, V19, P504, DOI 10.1210/me.2004-0169; Tahrani AA, 2011, LANCET, V378, P182, DOI 10.1016/S0140-6736(11)60207-9; Thomsen C, 1999, AM J CLIN NUTR, V69, P1135; Turner RC, 1998, LANCET, V352, P854, DOI 10.1016/s0140-6736(98)07037-8; Vaag AA, 1996, EUR J ENDOCRINOL, V135, P425, DOI 10.1530/eje.0.1350425; van Loon LJC, 2000, J NUTR, V130, P2508, DOI 10.1093/jn/130.10.2508; van Loon LJC, 2000, AM J CLIN NUTR, V72, P96; Verspohl EJ, 2012, PHARMACOL REV, V64, P188, DOI 10.1124/pr.110.003319	49	5	5	3	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e83509	10.1371/journal.pone.0083509	http://dx.doi.org/10.1371/journal.pone.0083509			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281RE	24386218	gold, Green Submitted, Green Published			2022-12-25	WOS:000329117900041
J	Tari, LW; Li, XM; Trzoss, M; Bensen, DC; Chen, ZY; Lam, T; Zhang, JH; Lee, SJ; Hough, G; Phillipson, D; Akers-Rodriguez, S; Cunningham, ML; Kwan, BP; Nelson, KJ; Castellano, A; Locke, JB; Brown-Driver, V; Murphy, TM; Ong, VS; Pillar, CM; Shinabarger, DL; Nix, J; Lightstone, FC; Wong, SE; Nguyen, TB; Shaw, KJ; Finn, J				Tari, Leslie W.; Li, Xiaoming; Trzoss, Michael; Bensen, Daniel C.; Chen, Zhiyong; Thanh Lam; Zhang, Junhu; Lee, Suk Joong; Hough, Grayson; Phillipson, Doug; Akers-Rodriguez, Suzanne; Cunningham, Mark L.; Kwan, Bryan P.; Nelson, Kirk J.; Castellano, Amanda; Locke, Jeff B.; Brown-Driver, Vickie; Murphy, Timothy M.; Ong, Voon S.; Pillar, Chris M.; Shinabarger, Dean L.; Nix, Jay; Lightstone, Felice C.; Wong, Sergio E.; Nguyen, Toan B.; Shaw, Karen J.; Finn, John			Tricyclic GyrB/ParE (TriBE) Inhibitors: A New Class of Broad-Spectrum Dual-Targeting Antibacterial Agents	PLOS ONE			English	Article							TOPOISOMERASE-IV PARE; GYRASE B GYRB; DNA GYRASE; PYRROLOPYRIMIDINE INHIBITORS; OPTIMIZATION; DISCOVERY; ANTIBIOTICS; VALIDATION; POTENT	Increasing resistance to every major class of antibiotics and a dearth of novel classes of antibacterial agents in development pipelines has created a dwindling reservoir of treatment options for serious bacterial infections. The bacterial type IIA topoisomerases, DNA gyrase and topoisomerase IV, are validated antibacterial drug targets with multiple prospective drug binding sites, including the catalytic site targeted by the fluoroquinolone antibiotics. However, growing resistance to fluoroquinolones, frequently mediated by mutations in the drug-binding site, is increasingly limiting the utility of this antibiotic class, prompting the search for other inhibitor classes that target different sites on the topoisomerase complexes. The highly conserved ATP-binding subunits of DNA gyrase (GyrB) and topoisomerase IV (ParE) have long been recognized as excellent candidates for the development of dual-targeting antibacterial agents with broad-spectrum potential. However, to date, no natural product or small molecule inhibitors targeting these sites have succeeded in the clinic, and no inhibitors of these enzymes have yet been reported with broad-spectrum antibacterial activity encompassing the majority of Gram-negative pathogens. Using structure-based drug design (SBDD), we have created a novel dual-targeting pyrimidoindole inhibitor series with exquisite potency against GyrB and ParE enzymes from a broad range of clinically important pathogens. Inhibitors from this series demonstrate potent, broad-spectrum antibacterial activity against Gram-positive and Gram-negative pathogens of clinical importance, including fluoroquinolone resistant and multidrug resistant strains. Lead compounds have been discovered with clinical potential; they are well tolerated in animals, and efficacious in Gram-negative infection models.	[Tari, Leslie W.; Li, Xiaoming; Trzoss, Michael; Bensen, Daniel C.; Chen, Zhiyong; Thanh Lam; Zhang, Junhu; Lee, Suk Joong; Hough, Grayson; Phillipson, Doug; Akers-Rodriguez, Suzanne; Cunningham, Mark L.; Kwan, Bryan P.; Nelson, Kirk J.; Castellano, Amanda; Locke, Jeff B.; Brown-Driver, Vickie; Ong, Voon S.; Shaw, Karen J.; Finn, John] Trius Therapeut, San Diego, CA USA; [Murphy, Timothy M.] ViviSource Labs, Waltham, MA USA; [Pillar, Chris M.; Shinabarger, Dean L.] Micromyx LLC, Kalamazoo, MI USA; [Nix, Jay] Beamline 4 2 2, Adv Light Source, Berkeley, CA USA; [Lightstone, Felice C.; Wong, Sergio E.; Nguyen, Toan B.] Lawrence Livermore Natl Lab, Phys & Life Sci Directorate, Livermore, CA USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; United States Department of Energy (DOE); Lawrence Livermore National Laboratory	Tari, LW (corresponding author), Trius Therapeut, San Diego, CA USA.	ltari@triusrx.com; jfinn@triusrx.com		Shaw, Karen/0000-0003-3060-1328; Nelson, Kirk/0000-0003-1160-5251	U.S. Department of Energy by Lawrence Livermore National Laboratory [DE-AC52-07NA27344, LLNL-JRNL-565619]; National Institute of Allergy and Infectious Diseases National Institutes of Health, Department of Health and Human Services [HHSN272200800042C]	U.S. Department of Energy by Lawrence Livermore National Laboratory(United States Department of Energy (DOE)); National Institute of Allergy and Infectious Diseases National Institutes of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Part of this work was performed under the auspices of the U.S. Department of Energy by Lawrence Livermore National Laboratory under Contract DE-AC52-07NA27344, LLNL-JRNL-565619. This project has been funded with Federal funds from the National Institute of Allergy and Infectious Diseases National Institutes of Health, Department of Health and Human Services, under Contract No. HHSN272200800042C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appelbaum PC, 2000, INT J ANTIMICROB AG, V16, P5, DOI 10.1016/S0924-8579(00)00192-8; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bellon S, 2004, ANTIMICROB AGENTS CH, V48, P1856, DOI 10.1128/AAC.48.5.1856-1864.2004; Bensen D., 2012, WO Patent WO, Patent No. [2012125746 (A1), 2012125746, WO/2012/125746]; Boehm HJ, 2000, J MED CHEM, V43, P2664, DOI 10.1021/jm000017s; Ceccarelli M, 2008, CURR DRUG TARGETS, V9, P779, DOI 10.2174/138945008785747770; Charifson PS, 2008, J MED CHEM, V51, P5243, DOI 10.1021/jm800318d; Collin F, 2011, APPL MICROBIOL BIOT, V92, P479, DOI 10.1007/s00253-011-3557-z; Cunningham ML, 2013, J BIOMOL SCREEN, V18, P1018, DOI 10.1177/1087057113487208; Dutta R, 2000, TRENDS BIOCHEM SCI, V25, P24, DOI 10.1016/S0968-0004(99)01503-0; Eakin AE, 2012, ANTIMICROB AGENTS CH, V56, P1240, DOI 10.1128/AAC.05485-11; East SP, 2009, BIOORG MED CHEM LETT, V19, P894, DOI 10.1016/j.bmcl.2008.11.102; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fischbach MA, 2009, SCIENCE, V325, P1089, DOI 10.1126/science.1176667; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Grossman TH, 2007, ANTIMICROB AGENTS CH, V51, P657, DOI 10.1128/AAC.00596-06; Hooper DC, 2001, EMERG INFECT DIS, V7, P337, DOI 10.3201/eid0702.010239; Hou TJ, 2011, J COMPUT CHEM, V32, P866, DOI 10.1002/jcc.21666; Lafitte D, 2002, BIOCHEMISTRY-US, V41, P7217, DOI 10.1021/bi0159837; Lambert HP, 1992, COUMARINS; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LESLIE AGW, 1992, JOINT CCP4 ESF EAMBC, V26; Liao CZ, 2009, J CHEM INF MODEL, V49, P2801, DOI 10.1021/ci900289x; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Mani N, 2006, ANTIMICROB AGENTS CH, V50, P1228, DOI 10.1128/AAC.50.4.1228-1237.2006; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; MORRISON JF, 1969, BIOCHIM BIOPHYS ACTA, V185, P269, DOI 10.1016/0005-2744(69)90420-3; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; NIKAIDO H, 1993, ANTIMICROB AGENTS CH, V37, P1393, DOI 10.1128/AAC.37.7.1393; Oblak M, 2007, CURR MED CHEM, V14, P2033; Pflugrath JW, 1999, ACTA CRYSTALLOGR D, V55, P1718, DOI 10.1107/S090744499900935X; Silver LL, 2011, CLIN MICROBIOL REV, V24, P71, DOI 10.1128/CMR.00030-10; Sissi C, 2010, CELL MOL LIFE SCI, V67, P2001, DOI 10.1007/s00018-010-0299-5; Trzoss M, 2013, BIOORG MED CHEM LETT, V23, P1537, DOI 10.1016/j.bmcl.2012.11.073; Walsh C, 2003, NAT REV MICROBIOL, V1, P65, DOI 10.1038/nrmicro727	38	66	70	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e84409	10.1371/journal.pone.0084409	http://dx.doi.org/10.1371/journal.pone.0084409			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281QS	24386374	Green Published, Green Submitted, gold			2022-12-25	WOS:000329116700105
J	Kiss, G; Konrad, C; Pour-Ghaz, I; Mansour, JJ; Nemeth, B; Starkov, AA; Adam-Vizi, V; Chinopoulos, C				Kiss, Gergely; Konrad, Csaba; Pour-Ghaz, Issa; Mansour, Josef J.; Nemeth, Beata; Starkov, Anatoly A.; Adam-Vizi, Vera; Chinopoulos, Christos			Mitochondrial diaphorases as NAD(+) donors to segments of the citric acid cycle that support substrate-level phosphorylation yielding ATP during respiratory inhibition	FASEB JOURNAL			English	Review						adenine nucleotide translocase; DT-diaphorase; reducing equivalent; succinyl-CoA ligase	KETOGLUTARATE DEHYDROGENASE COMPLEX; ADENINE-NUCLEOTIDE TRANSLOCASE; REDUCED PYRIDINE NUCLEOTIDE; SUCCINYL-COA SYNTHETASES; GUINEA-PIG HEART; DT-DIAPHORASE; COENZYME-Q; OXIDATIVE-PHOSPHORYLATION; LIPOAMIDE DEHYDROGENASE; CYTOCHROME-C	Substrate-level phosphorylation mediated by succinyl-CoA ligase in the mitochondrial matrix produces high-energy phosphates in the absence of oxidative phosphorylation. Furthermore, when the electron transport chain is dysfunctional, provision of succinyl-CoA by the alpha-ketoglutarate dehydrogenase complex (KGDHC) is crucial for maintaining the function of succinyl-CoA ligase yielding ATP, preventing the adenine nucleotide translocase from reversing. We addressed the source of the NAD(+) supply for KGDHC under anoxic conditions and inhibition of complex I. Using pharmacologic tools and specific substrates and by examining tissues from pigeon liver exhibiting no diaphorase activity, we showed that mitochondrial diaphorases in the mouse liver contribute up to 81% to the NAD(+) pool during respiratory inhibition. Under these conditions, KGDHC's function, essential for the provision of succinyl-CoA to succinyl-CoA ligase, is supported by NAD(+) derived from diaphorases. Through this process, diaphorases contribute to the maintenance of substrate-level phosphorylation during respiratory inhibition, which is manifested in the forward operation of adenine nucleotide translocase. Finally, we show that reoxidation of the reducible substrates for the diaphorases is mediated by complex III of the respiratory chain.-Kiss, G., Konrad, C., Pour-Ghaz, I., Mansour, J. J., Nemeth, B., Starkov, A. A., Adam-Vizi, V., Chinopoulos, C. Mitochondrial diaphorases as NAD(+) donors to segments of the citric acid cycle that support substrate-level phosphorylation yielding ATP during respiratory inhibition.	[Kiss, Gergely; Konrad, Csaba; Pour-Ghaz, Issa; Mansour, Josef J.; Nemeth, Beata; Adam-Vizi, Vera; Chinopoulos, Christos] Semmelweis Univ, Dept Med Biochem, Hungarian Acad Sci, SE Lab Neurobiochem, H-1094 Budapest, Hungary; [Starkov, Anatoly A.] Cornell Univ, Weill Med Coll, Dept Neurol & Neurosci, New York, NY 10021 USA	Hungarian Academy of Sciences; Semmelweis University; Cornell University	Chinopoulos, C (corresponding author), Semmelweis Univ, Dept Med Biochem, 37-47 Tuzolto St, H-1094 Budapest, Hungary.	chinopoulos.christos@eok.sote.hu	Starkov, Anatoly/B-2688-2012	Starkov, Anatoly/0000-0002-1334-4828; Mansour, Josef/0000-0001-5324-8286; Adam-Vizi, Vera/0000-0002-8350-8701; Chinopoulos, Christos/0000-0003-0183-4149; Pour-Ghaz, Issa/0000-0001-6404-1213	Orszagos Tudomanyos Kutatasi Alapprogram (OTKA) [81983]; Hungarian Academy of Sciences [02001]; Astellas Pharma Kft.-Kerpel-Fronius Odon Tehetseggondozo Program; U.S. National Institutes of Health/National Institute on Aging [AG014930]; MTA-SE Lendulet Neurobiochemistry Research Division [95003]; OTKA NNF [78905]; OTKA [NNF2 85658, K 100918]; EC; NATIONAL INSTITUTE ON AGING [P01AG014930] Funding Source: NIH RePORTER	Orszagos Tudomanyos Kutatasi Alapprogram (OTKA)(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Hungarian Academy of Sciences(Hungarian Academy of Sciences); Astellas Pharma Kft.-Kerpel-Fronius Odon Tehetseggondozo Program; U.S. National Institutes of Health/National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); MTA-SE Lendulet Neurobiochemistry Research Division; OTKA NNF(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); OTKA(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); EC(European CommissionEuropean Commission Joint Research Centre); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by Orszagos Tudomanyos Kutatasi Alapprogram (OTKA) grant 81983 and Hungarian Academy of Sciences grant 02001 (to V.A.-V.); a student grant from Astellas Pharma Kft.-Kerpel-Fronius Odon Tehetseggondozo Program (to G.K.); grant AG014930 from the U.S. National Institutes of Health/National Institute on Aging (to A.A.S.); and grants MTA-SE Lendulet Neurobiochemistry Research Division 95003, OTKA NNF 78905, OTKA NNF2 85658, and OTKA K 100918 (to C.C). Cyb5r2 transgenic mice were provided by the European Mouse Mutant Archive (EMMA) service project, funded by the EC FP7 Capacities Specific Program. The authors declare no conflicts of interest.	AKERMAN KEO, 1976, FEBS LETT, V68, P191, DOI 10.1016/0014-5793(76)80434-6; Bando Y., 1992, J NUTR SCI VITAMINOL, P453; Beyer RE, 1996, P NATL ACAD SCI USA, V93, P2528, DOI 10.1073/pnas.93.6.2528; Bianchet MA, 2004, METHOD ENZYMOL, V382, P144; Chan TS, 2002, FREE RADICAL RES, V36, P421, DOI 10.1080/10715760290021270; CHANCE B, 1960, NATURE, V185, P666, DOI 10.1038/185666a0; Chapple SJ, 2012, INT J BIOCHEM CELL B, V44, P1315, DOI 10.1016/j.biocel.2012.04.021; CHICK WL, 1968, AM J PHYSIOL, V215, P1107, DOI 10.1152/ajplegacy.1968.215.5.1107; Chinopoulos C, 2013, J NEUROSCI RES, V91, P1030, DOI 10.1002/jnr.23196; Chinopoulos C, 2011, J NEUROSCI RES, V89, P1897, DOI 10.1002/jnr.22659; Chinopoulos C, 2011, FEBS LETT, V585, P1255, DOI 10.1016/j.febslet.2011.04.004; Chinopoulos C, 2010, FEBS J, V277, P3637, DOI 10.1111/j.1742-4658.2010.07755.x; Chinopoulos C, 2010, FASEB J, V24, P2405, DOI 10.1096/fj.09-149898; Chinopoulos C, 2010, BBA-MOL BASIS DIS, V1802, P221, DOI 10.1016/j.bbadis.2009.08.008; Chinopoulos C, 2009, BIOPHYS J, V96, P2490, DOI 10.1016/j.bpj.2008.12.3915; CLARK JB, 1979, PHARMACOL THERAPEUT, V7, P351, DOI 10.1016/0163-7258(79)90036-6; COLPABOONSTRA JP, 1958, BIOCHIM BIOPHYS ACTA, V27, P122, DOI 10.1016/0006-3002(58)90298-1; CONOVER TE, 1963, BIOCHIM BIOPHYS ACTA, V67, P268; CONOVER TE, 1960, BIOCHEM BIOPH RES CO, V2, P26, DOI 10.1016/0006-291X(60)90258-8; CONOVER TE, 1962, BIOCHIM BIOPHYS ACTA, V58, P189, DOI 10.1016/0006-3002(62)90998-8; CRESTEIL T, 1991, BIOCHEM PHARMACOL, V42, P1021, DOI 10.1016/0006-2952(91)90284-C; DANIELSON L, 1962, NATURE, V194, P155, DOI 10.1038/194155a0; DANIELSON L, 1960, ACTA CHEM SCAND, V14, P1837, DOI 10.3891/acta.chem.scand.14-1837; DEDUKHOVA V I, 1986, Biokhimiya, V51, P567; Dong HB, 2013, BIOCHEM BIOPH RES CO, V435, P727, DOI 10.1016/j.bbrc.2013.05.051; EDLUND C, 1982, BIOSCIENCE REP, V2, P861, DOI 10.1007/BF01114891; Eliasson M, 1999, BIOCHEM PHARMACOL, V58, P1287, DOI 10.1016/S0006-2952(99)00185-9; ERNSTER L, 1960, BIOCHEM BIOPH RES CO, V2, P88, DOI 10.1016/0006-291X(60)90193-5; ERNSTER L, 1958, FED PROC, V17, P216; ERNSTER L, 1987, CHEM SCRIPTA, V27A, P1; ERNSTER L, 1958, ACTA CHEM SCAND, V12, P595, DOI 10.3891/acta.chem.scand.12-0595; ERNSTER L, 1969, EUR J BIOCHEM, V9, P299, DOI 10.1111/j.1432-1033.1969.tb00609.x; ERNSTER L, 1962, BIOCHIM BIOPHYS ACTA, V58, P171, DOI 10.1016/0006-3002(62)90997-6; ERNSTER L, 1967, METHOD ENZYMOL, V10, P309, DOI DOI 10.1016/0076-6879(67)10059-1; ESTABROOK RW, 1958, J BIOL CHEM, V233, P1014; Faig M, 2001, STRUCTURE, V9, P659, DOI 10.1016/S0969-2126(01)00636-0; FLATMARK T, 1967, J BIOL CHEM, V242, P2454; Freeman HC, 2006, DIABETES, V55, P2153, DOI 10.2337/db06-0358; Giorgio M, 2005, CELL, V122, P221, DOI 10.1016/j.cell.2005.05.011; GIUDITTA A, 1961, BIOCHIM BIOPHYS ACTA, V48, P10, DOI 10.1016/0006-3002(61)90509-1; GIUDITTA A, 1959, J NEUROCHEM, V5, P50, DOI 10.1111/j.1471-4159.1959.tb13332.x; GIUDITTA A, 1963, BIOCHIM BIOPHYS ACTA, V67, P316; Gomez-Diaz C, 2003, PROTOPLASMA, V221, P11, DOI 10.1007/s00709-002-0067-y; GOPAL D, 1988, J BIOL CHEM, V263, P11652; Haefeli RH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017963; HARRIS EJ, 1977, BIOCHEM J, V168, P129, DOI 10.1042/bj1680129; HODNICK WF, 1993, CANCER RES, V53, P4907; HUNTER FE, 1949, J BIOL CHEM, V177, P361; IDE S, 1967, J BIOL CHEM, V242, P54; IYANAGI T, 1970, BIOCHIM BIOPHYS ACTA, V216, P282, DOI 10.1016/0005-2728(70)90220-3; JACKSON JB, 1991, J BIOENERG BIOMEMBR, V23, P715, DOI 10.1007/BF00785998; Johnson JD, 1998, J BIOL CHEM, V273, P27580, DOI 10.1074/jbc.273.42.27580; KAMO N, 1979, J MEMBRANE BIOL, V49, P105, DOI 10.1007/BF01868720; Kiss G, 2013, FASEB J, V27, P2392, DOI 10.1096/fj.12-220202; Klingenberg M, 2008, BBA-BIOMEMBRANES, V1778, P1978, DOI 10.1016/j.bbamem.2008.04.011; Klyachko NL, 2005, J BIOL CHEM, V280, P16106, DOI 10.1074/jbc.M414285200; Kolesova G M, 1993, Biokhimiia, V58, P1630; KOLESOVA G M, 1987, Biokhimiya, V52, P715; KOLESOVA G M, 1989, Biokhimiya, V54, P103; KOLESOVA G M, 1991, Biokhimiya, V56, P1779; KOLI AK, 1969, J BIOL CHEM, V244, P621; Lambeth DO, 2004, J BIOL CHEM, V279, P36621, DOI 10.1074/jbc.M406884200; LENAZ G, 1985, DRUG EXP CLIN RES, V11, P547; LIND C, 1990, METHOD ENZYMOL, V186, P287; LIND C, 1981, ARCH BIOCHEM BIOPHYS, V207, P217, DOI 10.1016/0003-9861(81)90027-8; Long DJ, 2000, CHEM-BIOL INTERACT, V129, P99, DOI 10.1016/S0009-2797(00)00200-3; MAERKI F, 1961, BIOCHEM Z, V334, P293; MARTIUS C, 1954, BIOCHEM Z, V326, P24; MARTIUS C, 1953, BIOCHIM BIOPHYS ACTA, V12, P134, DOI 10.1016/0006-3002(53)90132-2; MASSEY V, 1960, BIOCHIM BIOPHYS ACTA, V37, P314, DOI 10.1016/0006-3002(60)90239-0; Metelkin E, 2009, FEBS J, V276, P6942, DOI 10.1111/j.1742-4658.2009.07394.x; Miyadera H, 2003, P NATL ACAD SCI USA, V100, P473, DOI 10.1073/pnas.0237315100; NICHOLLS DG, 1977, EUR J BIOCHEM, V75, P601, DOI 10.1111/j.1432-1033.1977.tb11560.x; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; PENNEY DG, 1970, BIOCHEM J, V118, P221, DOI 10.1042/bj1180221; PEUHKURINEN KJ, 1983, AM J PHYSIOL, V244, pH281, DOI 10.1152/ajpheart.1983.244.2.H281; Phillips D, 2009, BIOCHEMISTRY-US, V48, P7140, DOI 10.1021/bi900725c; PISARENKO O, 1987, BIOMED BIOCHIM ACTA, V46, pS568; PISARENKO O, 1988, BIOCHIM BIOPHYS ACTA, V934, P55, DOI 10.1016/0005-2728(88)90119-3; PISARENKO OI, 1985, BASIC RES CARDIOL, V80, P126, DOI 10.1007/BF01910459; PREUSCH PC, 1991, FREE RADICAL BIO MED, V11, P77, DOI 10.1016/0891-5849(91)90191-5; PREUSCH PC, 1990, FREE RADICAL RES COM, V8, P401, DOI 10.3109/10715769009053374; RANDALL HM, 1966, AM J PHYSIOL, V211, P493, DOI 10.1152/ajplegacy.1966.211.2.493; REED L J, 1968, Brookhaven Symposia in Biology, V21, P397; Rushmore TH, 2002, CURR DRUG METAB, V3, P481, DOI 10.2174/1389200023337171; Sack MN, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a013102; SANADI DR, 1963, BIOCHEMISTRY-US, V2, P523, DOI 10.1021/bi00903a023; SANBORN T, 1979, AM J PHYSIOL, V237, pH535, DOI 10.1152/ajpheart.1979.237.5.H535; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; TAEGTMEYER H, 1978, CIRC RES, V43, P808, DOI 10.1161/01.RES.43.5.808; TAEGTMEYER H, 1977, J BIOL CHEM, V252, P5010; TEDESCHI G, 1995, J BIOL CHEM, V270, P1198, DOI 10.1074/jbc.270.3.1198; Toye AA, 2005, DIABETOLOGIA, V48, P675, DOI 10.1007/s00125-005-1680-z; Traver RD, 1997, BRIT J CANCER, V75, P69, DOI 10.1038/bjc.1997.11; Tretter L, 2007, J NEUROSCI RES, V85, P3471, DOI 10.1002/jnr.21405; Tyler D. D., 1967, METHOD ENZYMOL, V10, P75, DOI DOI 10.1016/0076-6879(67)10014-1; VALLE VGR, 1986, BIOCHEM BIOPH RES CO, V135, P189, DOI 10.1016/0006-291X(86)90961-7; Vasiliou Vasilis, 2006, Human Genomics, V2, P329; Vaubel RA, 2011, J BIOL CHEM, V286, P40232, DOI 10.1074/jbc.M111.274415; Ventura A, 2004, J BIOL CHEM, V279, P2299, DOI 10.1074/jbc.M307655200; Weinberg JM, 2000, AM J PHYSIOL-RENAL, V279, pF927, DOI 10.1152/ajprenal.2000.279.5.F927; Weinberg JM, 2000, P NATL ACAD SCI USA, V97, P2826, DOI 10.1073/pnas.97.6.2826; WILLIAMS CH, 1959, BIOCHIM BIOPHYS ACTA, V32, P568, DOI 10.1016/0006-3002(59)90643-2; WILSON MA, 1970, BIOCHIM BIOPHYS ACTA, V216, P54, DOI 10.1016/0005-2728(70)90158-1; Winski SL, 2002, CANCER RES, V62, P1420; WOSILAIT WD, 1954, J BIOL CHEM, V206, P271; WOSILAIT WD, 1960, J BIOL CHEM, V235, P1196; WOSILAIT WD, 1954, J BIOL CHEM, V206, P255; Wu KB, 1997, ARCH BIOCHEM BIOPHYS, V347, P221, DOI 10.1006/abbi.1997.0344; Yue Y, 2001, AM J PHYSIOL-HEART C, V281, pH590, DOI 10.1152/ajpheart.2001.281.2.H590; Zhao QJ, 1997, P NATL ACAD SCI USA, V94, P1669, DOI 10.1073/pnas.94.5.1669	111	28	30	2	47	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2014	28	4					1682	1697		10.1096/fj.13-243030	http://dx.doi.org/10.1096/fj.13-243030			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AG3UC	24391134	Green Published			2022-12-25	WOS:000335344300016
J	Matsuoka, K; Asano, Y; Higo, S; Tsukamoto, O; Yan, Y; Yamazaki, S; Matsuzaki, T; Kioka, H; Kato, H; Uno, Y; Asakura, M; Asanuma, H; Minamino, T; Aburatani, H; Kitakaze, M; Komuro, I; Takashima, S				Matsuoka, Ken; Asano, Yoshihiro; Higo, Shuichiro; Tsukamoto, Osamu; Yan, Yi; Yamazaki, Satoru; Matsuzaki, Takashi; Kioka, Hidetaka; Kato, Hisakazu; Uno, Yoshihiro; Asakura, Masanori; Asanuma, Hiroshi; Minamino, Tetsuo; Aburatani, Hiroyuki; Kitakaze, Masafumi; Komuro, Issei; Takashima, Seiji			Noninvasive and quantitative live imaging reveals a potential stress-responsive enhancer in the failing heart	FASEB JOURNAL			English	Article						transcriptional regulation; in vivo assessment; natriuretic peptide	ATRIAL-NATRIURETIC-PEPTIDE; PROTEIN-KINASE-C; CARDIAC-HYPERTROPHY; FACTOR EXPRESSION; FACTOR GENE; SEQUENCES; MICE; ANF; IDENTIFICATION; VERTEBRATE	Recent advances in genome analysis have enabled the identification of numerous distal enhancers that regulate gene expression in various conditions. However, the enhancers involved in pathological conditions are largely unknown because of the lack of in vivo quantitative assessment of enhancer activity in live animals. Here, we established a noninvasive and quantitative live imaging system for monitoring transcriptional activity and identified a novel stress-responsive enhancer of Nppa and Nppb, the most common markers of heart failure. The enhancer is a 650-bp fragment within 50 kb of the Nppa and Nppb loci. A chromosome conformation capture (3C) assay revealed that this distal enhancer directly interacts with the 5 '-flanking regions of Nppa and Nppb. To monitor the enhancer activity in a live heart, we established an imaging system using the firefly luciferase reporter. Using this imaging system, we observed that the novel enhancer activated the reporter gene in pressure overload-induced failing hearts (failing hearts: 5.7 +/- 1.3-fold; sham-surgery hearts: 1.0 +/- 0.2-fold; P < 0.001, repeated-measures ANOVA). This method will be particularly useful for identifying enhancers that function only during pathological conditions.-Matsuoka, K., Asano, Y., Higo, S., Tsukamoto, O., Yan, Y., Yamazaki, S., Matsuzaki, T., Kioka, H., Kato, H., Uno, Y., Asakura, M., Asanuma, H., Minamino, T., Aburatani, H., Kitakaze, M., Komuro, I., and Takashima, S. Noninvasive and quantitative live imaging reveals a potential stress-responsive enhancer in the failing heart.	[Matsuoka, Ken; Asano, Yoshihiro; Higo, Shuichiro; Matsuzaki, Takashi; Kioka, Hidetaka; Minamino, Tetsuo; Komuro, Issei; Takashima, Seiji] Osaka Univ, Grad Sch Med, Inst Expt Anim Sci, Dept Cardiovasc Med, Suita, Osaka 5650871, Japan; [Matsuoka, Ken; Asano, Yoshihiro; Higo, Shuichiro; Tsukamoto, Osamu; Yan, Yi; Kioka, Hidetaka; Kato, Hisakazu; Takashima, Seiji] Osaka Univ, Grad Sch Med, Inst Expt Anim Sci, Dept Med Biochem, Suita, Osaka 5650871, Japan; [Uno, Yoshihiro] Osaka Univ, Grad Sch Med, Inst Expt Anim Sci, Lab Reprod Engn, Suita, Osaka 5650871, Japan; [Yamazaki, Satoru] Natl Cerebral & Cardiovasc Ctr, Res Inst, Dept Cell Biol, Suita, Osaka, Japan; [Asakura, Masanori; Kitakaze, Masafumi] Natl Cerebral & Cardiovasc Ctr, Res Inst, Dept Clin Res & Dev, Suita, Osaka, Japan; [Asanuma, Hiroshi] Kyoto Prefectural Univ, Sch Med, Dept Cardiovasc Sci & Technol, Kyoto 606, Japan; [Aburatani, Hiroyuki] Univ Tokyo, Res Ctr Adv Sci & Technol, Genome Sci Div, Tokyo, Japan	Osaka University; Osaka University; Osaka University; National Cerebral & Cardiovascular Center - Japan; National Cerebral & Cardiovascular Center - Japan; Kyoto Prefectural University; University of Tokyo	Asano, Y (corresponding author), Osaka Univ, Grad Sch Med, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	asano@cardiology.med.osaka-u.ac.jp		Kato, Hisakazu/0000-0003-4619-3680; Tsukamoto, Osamu/0000-0002-9504-8001	Japan Society for the Promotion of Science (JSPS) through the Funding Program for Next Generation World-Leading Researchers (NEXT Program); Council for Science and Technology Policy (CSTP); Ministry of Health, Labor, and Welfare of Japan; Ministry of Education, Culture, Sports, Science, and Technology of Japan; Japan Society for the Promotion of Science; Japan Heart Foundation; Japan Cardiovascular Research Foundation; Japan Medical Association; Japan Intractable Diseases Research Foundation; Uehara Memorial Foundation; Takeda Science Foundation; Ichiro Kanehara Foundation; Inoue Foundation for Science; Mochida Memorial Foundation; Heart Foundation/Novartis Grant for Research Award on Molecular and Cellular Cardiology; Japan Foundation of Applied Enzymology; Naito Foundation; Banyu Foundation; Showa Houkoukai	Japan Society for the Promotion of Science (JSPS) through the Funding Program for Next Generation World-Leading Researchers (NEXT Program)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Council for Science and Technology Policy (CSTP)(Council for Science and Technology Policy (CSTP)); Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Heart Foundation; Japan Cardiovascular Research Foundation; Japan Medical Association; Japan Intractable Diseases Research Foundation; Uehara Memorial Foundation(Uehara Memorial Foundation); Takeda Science Foundation(Takeda Science Foundation (TSF)); Ichiro Kanehara Foundation; Inoue Foundation for Science(Inoue Foundation for Science); Mochida Memorial Foundation; Heart Foundation/Novartis Grant for Research Award on Molecular and Cellular Cardiology; Japan Foundation of Applied Enzymology(Japan Foundation of Applied Enzymology); Naito Foundation(Naito Memorial Foundation); Banyu Foundation; Showa Houkoukai	This research was supported by the Japan Society for the Promotion of Science (JSPS) through the Funding Program for Next Generation World-Leading Researchers (NEXT Program), which was initiated by the Council for Science and Technology Policy (CSTP); grants-in-aid from the Ministry of Health, Labor, and Welfare of Japan; grants-in-aid from the Ministry of Education, Culture, Sports, Science, and Technology of Japan; and grants-in-aid from the Japan Society for the Promotion of Science. This research was also supported by grants from the Japan Heart Foundation, the Japan Cardiovascular Research Foundation, the Japan Medical Association, the Japan Intractable Diseases Research Foundation, the Uehara Memorial Foundation, the Takeda Science Foundation, the Ichiro Kanehara Foundation, the Inoue Foundation for Science, the Mochida Memorial Foundation, a Heart Foundation/Novartis Grant for Research Award on Molecular and Cellular Cardiology, the Japan Foundation of Applied Enzymology, the Naito Foundation, the Banyu Foundation, and Showa Houkoukai. The authors thank Hiroshi Kimura for antibodies, Seitaro Nomura for the ChIP-seq analysis, Saori Ikezawa and Eri Takata for technical assistance, and Yuko Okada and Hiromi Fujii for secretarial support.	Bell AC, 1999, CELL, V98, P387, DOI 10.1016/S0092-8674(00)81967-4; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Blanchette M, 2004, GENOME RES, V14, P708, DOI 10.1101/gr.1933104; Blow MJ, 2010, NAT GENET, V42, P806, DOI 10.1038/ng.650; Burley DS, 2007, BASIC RES CARDIOL, V102, P529, DOI 10.1007/s00395-007-0672-1; Chien KR, 2008, SCIENCE, V322, P1494, DOI 10.1126/science.1163267; de Lange FJ, 2003, GENESIS, V37, P1, DOI 10.1002/gene.10220; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Felsenfeld G, 2004, COLD SPRING HARB SYM, V69, P245, DOI 10.1101/sqb.2004.69.245; Habets PEMH, 2002, GENE DEV, V16, P1234, DOI 10.1101/gad.222902; Hagege H, 2007, NAT PROTOC, V2, P1722, DOI 10.1038/nprot.2007.243; Holtwick R, 2003, J CLIN INVEST, V111, P1399, DOI 10.1172/JCI200317061; Horsthuis T, 2008, CIRC RES, V102, P849, DOI 10.1161/CIRCRESAHA.107.170571; Iaccarino G, 1999, HYPERTENSION, V33, P396, DOI 10.1161/01.HYP.33.1.396; Kitakaze M, 2007, LANCET, V370, P1483, DOI 10.1016/S0140-6736(07)61634-1; KNOWLTON KU, 1995, J CLIN INVEST, V96, P1311, DOI 10.1172/JCI118166; Koch F, 2008, TRENDS BIOCHEM SCI, V33, P265, DOI 10.1016/j.tibs.2008.04.006; Li P, 2008, CIRC RES, V102, P185, DOI 10.1161/CIRCRESAHA.107.157677; Liao YL, 2002, AM J PHYSIOL-HEART C, V282, pH1703, DOI 10.1152/ajpheart.00238.2001; Nobrega MA, 2003, SCIENCE, V302, P413, DOI 10.1126/science.1088328; Olson EN, 2006, SCIENCE, V313, P1922, DOI 10.1126/science.1132292; Pollard KS, 2010, GENOME RES, V20, P110, DOI 10.1101/gr.097857.109; Saadane N, 1999, BRIT J PHARMACOL, V127, P1165, DOI 10.1038/sj.bjp.0702676; SEI CA, 1991, J BIOL CHEM, V266, P15910; SEIDMAN CE, 1988, P NATL ACAD SCI USA, V85, P4104, DOI 10.1073/pnas.85.11.4104; Shen Y, 2012, NATURE, V488, P116, DOI 10.1038/nature11243; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; SIMPSON P, 1982, CIRC RES, V51, P787, DOI 10.1161/01.RES.51.6.787; Small EA, 2003, DEV BIOL, V261, P116, DOI 10.1016/S0012-1606(03)00306-3; Spitz F, 2012, NAT REV GENET, V13, P613, DOI 10.1038/nrg3207; Szutorisz H, 2005, TRENDS BIOCHEM SCI, V30, P593, DOI 10.1016/j.tibs.2005.08.006; Tamura N, 2000, P NATL ACAD SCI USA, V97, P4239, DOI 10.1073/pnas.070371497; Thomas JW, 2003, NATURE, V424, P788, DOI 10.1038/nature01858; Thuerauf DJ, 1997, J BIOL CHEM, V272, P7464, DOI 10.1074/jbc.272.11.7464; Vecchione C, 2002, CIRCULATION, V105, P1700, DOI 10.1161/01.CIR.0000012750.08480.55; Warren SA, 2011, MOL CELL BIOL, V31, P4633, DOI 10.1128/MCB.05940-11; Woolfe A, 2005, PLOS BIOL, V3, P116, DOI 10.1371/journal.pbio.0030007; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	38	9	9	1	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2014	28	4					1870	1879		10.1096/fj.13-245522	http://dx.doi.org/10.1096/fj.13-245522			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AG3UC	24391132				2022-12-25	WOS:000335344300031
J	Fisman, DN; Hauck, TS; Tuite, AR; Greer, AL				Fisman, David N.; Hauck, Tanya S.; Tuite, Ashleigh R.; Greer, Amy L.			An IDEA for Short Term Outbreak Projection: Nearcasting Using the Basic Reproduction Number	PLOS ONE			English	Article							TRANSMISSION DYNAMICS; EPIDEMIC; SPREAD; INFLUENZA; H1N1	Background: Communicable disease outbreaks of novel or existing pathogens threaten human health around the globe. It would be desirable to rapidly characterize such outbreaks and develop accurate projections of their duration and cumulative size even when limited preliminary data are available. Here we develop a mathematical model to aid public health authorities in tracking the expansion and contraction of outbreaks with explicit representation of factors (other than population immunity) that may slow epidemic growth. Methodology: The Incidence Decay and Exponential Adjustment (IDEA) model is a parsimonious function that uses the basic reproduction number R-0, along with a discounting factor to project the growth of outbreaks using only basic epidemiological information (e. g., daily incidence counts). Principal Findings: Compared to simulated data, IDEA provides highly accurate estimates of total size and duration for a given outbreak when R-0 is low or moderate, and also identifies turning points or new waves. When tested with an outbreak of pandemic influenza A (H1N1), the model generates estimated incidence at the i+1th serial interval using data from the ith serial interval within an average of 20% of actual incidence. Conclusions and Significance: This model for communicable disease outbreaks provides rapid assessments of outbreak growth and public health interventions. Further evaluation in the context of real-world outbreaks will establish the utility of IDEA as a tool for front-line epidemiologists.	[Fisman, David N.; Tuite, Ashleigh R.; Greer, Amy L.] Univ Toronto, Fac Med, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Fisman, David N.] Univ Toronto, Fac Med, Dept Med, Toronto, ON, Canada; [Hauck, Tanya S.] Univ Toronto, Fac Med, Dept Psychiat, Toronto, ON M5S 1A1, Canada; [Fisman, David N.; Tuite, Ashleigh R.; Greer, Amy L.] Decis Ctr Infect Dis Epidemiol DeCIDE, Toronto, ON, Canada; [Greer, Amy L.] Publ Hlth Agcy Canada, Ctr Communicable Dis & Infect Control, Modeling & Project Sect,Profess Guidelines, Toronto, ON, Canada; [Greer, Amy L.] Publ Hlth Agcy Canada, Ctr Communicable Dis & Infect Control, Publ Hlth Practice Div, Toronto, ON, Canada	University of Toronto; University of Toronto; University of Toronto; Public Health Agency of Canada; Public Health Agency of Canada	Fisman, DN (corresponding author), Univ Toronto, Fac Med, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada.	david.fisman@utoronto.ca						Arguin PM, 2009, EMERG INFECT DIS, V15, P1713, DOI 10.3201/eid1511.091426; Bautista E, 2010, NEW ENGLAND J MED, V362; Breban R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000282; Chang LY, 2009, J FORMOS MED ASSOC, V108, P526, DOI 10.1016/S0929-6646(09)60369-7; Davis J. R., 2001, EMERGING INFECT DIS; Epstein JM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003955; Goldstein E, 2009, MATH BIOSCI, V221, P11, DOI 10.1016/j.mbs.2009.06.002; Government of Ontario, 2004, GUID CONTR RESP INF; Hadler SC, 2011, AM J EPIDEMIOL, V174, pS36, DOI 10.1093/aje/kwr309; Haymann DL, 2004, CONTROL COMMUNICABLE; He DH, 2011, THEOR ECOL-NETH, V4, P283, DOI 10.1007/s12080-011-0123-3; Hilborn Ray, 1997, V28; Hsieh YH, 2010, BMC RES NOTES, V3; Hsieh YH, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-332; Kenah E, 2008, MATH BIOSCI, V213, P71, DOI 10.1016/j.mbs.2008.02.007; Lipsitch M, 2003, SCIENCE, V300, P1966, DOI 10.1126/science.1086616; Loscher T, 2010, STAT BIOL HEALTH, P39, DOI 10.1007/978-0-387-93835-6_3; Peiris JSM, 2004, NATURE MED, V10; Riley S, 2003, SCIENCE, V300, P1961, DOI 10.1126/science.1086478; Schanzer DL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021471; Schanzer DL, 2010, INFLUENZA OTHER RESP, V4, P295, DOI 10.1111/j.1750-2659.2010.00154.x; StatisticsCanada, 2012, POP DWELL COUNTS CAN; Svensson A, 2007, MATH BIOSCI, V208, P300, DOI 10.1016/j.mbs.2006.10.010; Svoboda T, 2004, NEW ENGL J MED, V350, P2352, DOI 10.1056/NEJMoa032111; Tuite AR, 2011, ANN INTERNAL MED, V155; Tuite AR, 2011, ANN INTERN MED, V154, P593, DOI 10.7326/0003-4819-154-9-201105030-00334; Tuite AR, 2010, CAN MED ASSOC J, V182, P128, DOI 10.1503/cmaj.091807; Vynnycky E., 2010, INTRO INFECT DIS MOD, DOI DOI 10.1038/NRMICRO1845; Wallinga J, 2007, P ROY SOC B-BIOL SCI, V274, P599, DOI 10.1098/rspb.2006.3754; Wang Lin-Fa, 2011, N S W Public Health Bull, V22, P113, DOI 10.1071/NB10078; Wu F, 2007, P NATL ACAD SCI USA, V104, P17599, DOI 10.1073/pnas.0704916104	31	35	35	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83622	10.1371/journal.pone.0083622	http://dx.doi.org/10.1371/journal.pone.0083622			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391797	Green Published, Green Submitted, gold			2022-12-25	WOS:000329325200094
J	Galar, A; Kulldorff, M; Rudnick, W; O'Brien, TF; Stelling, J				Galar, Alicia; Kulldorff, Martin; Rudnick, Wallis; O'Brien, Thomas F.; Stelling, John			Biochemical Phenotypes to Discriminate Microbial Subpopulations and Improve Outbreak Detection	PLOS ONE			English	Article							ANTIMICROBIAL RESISTANCE; KLEBSIELLA-PNEUMONIAE; SURVEILLANCE; WHONET; IDENTIFICATION; EPIDEMIOLOGY; SYSTEM	Background: Clinical microbiology laboratories worldwide constitute an invaluable resource for monitoring emerging threats and the spread of antimicrobial resistance. We studied the growing number of biochemical tests routinely performed on clinical isolates to explore their value as epidemiological markers. Methodology/Principal Findings: Microbiology laboratory results from January 2009 through December 2011 from a 793 bed hospital stored in WHONET were examined. Variables included patient location, collection date, organism, and 47 biochemical and 17 antimicrobial susceptibility test results reported by Vitek 2. To identify biochemical tests that were particularly valuable (stable with repeat testing, but good variability across the species) or problematic (inconsistent results with repeat testing), three types of variance analyses were performed on isolates of K. pneumonia: descriptive analysis of discordant biochemical results in same-day isolates, an average within-patient variance index, and generalized linear mixed model variance component analysis. Results: 4,200 isolates of K. pneumoniae were identified from 2,485 patients, 32% of whom had multiple isolates. The first two variance analyses highlighted SUCT, TyrA, GlyA, and GGT as "nuisance'' biochemicals for which discordant within-patient test results impacted a high proportion of patient results, while dTAG had relatively good within-patient stability with good heterogeneity across the species. Variance component analyses confirmed the relative stability of dTAG, and identified additional biochemicals such as PHOS with a large between patient to within patient variance ratio. A reduced subset of biochemicals improved the robustness of strain definition for carbapenemresistant K. pneumoniae. Surveillance analyses suggest that the reduced biochemical profile could improve the timeliness and specificity of outbreak detection algorithms. Conclusions: The statistical approaches explored can improve the robust recognition of microbial subpopulations with routinely available biochemical test results, of value in the timely detection of outbreak clones and evolutionarily important genetic events.	[Galar, Alicia; O'Brien, Thomas F.; Stelling, John] Harvard Univ, Brigham & Womens Hosp, WHO Collaborating Ctr Surveillance Antimicrobial, Sch Med,Dept Med, Boston, MA 02115 USA; [Kulldorff, Martin] Harvard Univ, Sch Med, Dept Populat Med, Boston, MA USA; [Kulldorff, Martin] Harvard Pilgrim Hlth Care Inst, Boston, MA USA; [Rudnick, Wallis] Mt Sinai Hosp, Dept Med, Toronto, ON M5G 1X5, Canada	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Harvard Pilgrim Health Care; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute	Galar, A (corresponding author), Harvard Univ, Brigham & Womens Hosp, WHO Collaborating Ctr Surveillance Antimicrobial, Sch Med,Dept Med, Boston, MA 02115 USA.	agalar@partners.org		Galar, Alicia/0000-0002-9310-8752; Kulldorff, Martin/0000-0002-5284-2993; Rudnick, Wallis/0000-0003-3457-4216	National Institute of General Medical Science of the National Institutes of Health [R01GM103525]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM103525] Funding Source: NIH RePORTER	National Institute of General Medical Science of the National Institutes of Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Research reported in this publication was supported by the National Institute of General Medical Science of the National Institutes of Health under award number R01GM103525. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	bioMerieux, 2010, VIT 2 SYST PROD INF; Braykov NP, 2013, INFECT CONT HOSP EP, V34, P259, DOI 10.1086/669523; Brisse S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004982; Burke JP, 2003, INFECT CONT HOSP EP, V24, P10, DOI 10.1086/502108; Corporation S, 2011, GLIMMIX PROC; Gaynes R, 2005, CLIN INFECT DIS, V41, P848, DOI 10.1086/432803; Hansen DS, 2004, J CLIN MICROBIOL, V42, P3665, DOI 10.1128/jcm.42.8.3665-3669.2004; Huang SS, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000238; Hussein K, 2013, J HOSP INFECT; Johnson AP, 2013, J MED MICROBIOL; Levert M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001125; Magiorakos AP, 2013, ANTIMICROB RESIST IN, V2, DOI 10.1186/2047-2994-2-6; MARCH SB, 1986, J CLIN MICROBIOL, V23, P869, DOI 10.1128/JCM.23.5.869-872.1986; Nordmann P, 2012, TRENDS MOL MED, V18, P263, DOI 10.1016/j.molmed.2012.03.003; O'Brien TF, 2011, CLIN MICROBIOL REV, V24, P281, DOI 10.1128/CMR.00021-10; OBrien TF, 1996, DIAGN MICR INFEC DIS, V25, P163, DOI 10.1016/S0732-8893(96)00139-3; OBRIEN TF, 1995, EMERG INFECT DIS, V1, P66, DOI 10.3201/eid0102.950209; OBRIEN TF, 1980, ANTIMICROB AGENTS CH, V17, P537, DOI 10.1128/AAC.17.4.537; Sharma A, 2004, Indian J Med Microbiol, V22, P115; Alves MS, 2006, J CLIN MICROBIOL, V44, P3640, DOI 10.1128/JCM.00940-06; Stelling J, 2010, EPIDEMIOL INFECT, V138, P873, DOI 10.1017/S0950268809990884; Stelling JM, 1997, CLIN INFECT DIS, V24, pS157, DOI 10.1093/clinids/24.Supplement_1.S157; Tanne JH, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e1646; TOLMASKY ME, 1988, ANTIMICROB AGENTS CH, V32, P1416, DOI 10.1128/AAC.32.9.1416; Vinas MR, 2013, PLOS NEGL T IN PRESS; Werber D, 2011, LANCET, V377, P298, DOI 10.1016/S0140-6736(11)60090-1; Witte JS, 2000, EPIDEMIOLOGY, V11, P684, DOI 10.1097/00001648-200011000-00012; Wright MO, 2004, INFECT CONT HOSP EP, V25, P325, DOI 10.1086/502400	29	0	0	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84313	10.1371/journal.pone.0084313	http://dx.doi.org/10.1371/journal.pone.0084313			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391936	Green Published, Green Submitted, gold			2022-12-25	WOS:000329323900079
J	Heilmann, A; Schinke, T; Bindl, R; Wehner, T; Rapp, A; Haffner-Luntzer, M; Nemitz, C; Liedert, A; Amling, M; Ignatius, A				Heilmann, Aline; Schinke, Thorsten; Bindl, Ronny; Wehner, Tim; Rapp, Anna; Haffner-Luntzer, Melanie; Nemitz, Claudia; Liedert, Astrid; Amling, Michael; Ignatius, Anita			The Wnt Serpentine Receptor Frizzled-9 Regulates New Bone Formation in Fracture Healing	PLOS ONE			English	Article							REGENERATION; OSTEOPOROSIS; DENSITY; MUTATIONS; TARGETS; MICE	Wnt signaling is a key regulator of bone metabolism and fracture healing. The canonical Wnt/beta-catenin pathway is regarded as the dominant mechanism, and targeting this pathway has emerged as a promising strategy for the treatment of osteoporosis and poorly healing fractures. In contrast, little is known about the role of non-canonical Wnt signaling in bone. Recently, it was demonstrated that the serpentine receptor Fzd9, a Wnt receptor of the Frizzled family, is essential for osteoblast function and positively regulates bone remodeling via the non-canonical Wnt pathway without involving beta-catenin-dependent signaling. Here we investigated whether the Fzd9 receptor is essential for fracture healing using a femur osteotomy model in Fzd9(-/-) mice. After 10, 24 and 32 days the fracture calli were analyzed using biomechanical testing, histomorphometry, immunohistochemistry, and micro-computed tomography. Our results demonstrated significantly reduced amounts of newly formed bone at all investigated healing time points in the absence of Fzd9 and, accordingly, a decreased mechanical competence of the callus tissue in the late phase of fracture healing. In contrast, cartilage formation and numbers of osteoclasts degrading mineralized matrix were unaltered. beta-Catenin immunolocalization showed that canonical Wnt-signaling was not affected in the absence of Fzd9 in osteoblasts as well as in proliferating and mature chondrocytes within the fracture callus. The expression of established differentiation markers was not altered in the absence of Fzd9, whereas chemokines Ccl2 and Cxcl5 seemed to be reduced. Collectively, our results suggest that non-canonical signaling via the Fzd9 receptor positively regulates intramembranous and endochondral bone formation during fracture healing, whereas it does not participate in the formation of cartilage or in the osteoclastic degradation of mineralized matrix. The finding that Fzd9, in addition to its role in physiological bone remodeling, regulates bone repair may have implications for the development of treatments for poorly or non-healing fractures.	[Heilmann, Aline; Bindl, Ronny; Wehner, Tim; Rapp, Anna; Haffner-Luntzer, Melanie; Nemitz, Claudia; Liedert, Astrid; Ignatius, Anita] Univ Ulm, Ctr Musculoskeletal Res, Inst Orthopaed Res & Biomech, D-89069 Ulm, Germany; [Schinke, Thorsten; Amling, Michael] Univ Med Ctr Hamburg Eppendorf, Dept Osteol & Biomech, Hamburg, Germany	Ulm University; University of Hamburg; University Medical Center Hamburg-Eppendorf	Ignatius, A (corresponding author), Univ Ulm, Ctr Musculoskeletal Res, Inst Orthopaed Res & Biomech, D-89069 Ulm, Germany.	anita.ignatius@uni-ulm.de	Ignatius, Anita/M-6012-2013; Haffner-Luntzer, Melanie/L-3562-2019; Rapp, Anna/L-8807-2016	Ignatius, Anita/0000-0002-4782-1979; Haffner-Luntzer, Melanie/0000-0002-3333-2613; Rapp, Anna/0000-0001-5122-765X	German Research Foundation (DFG) (Research Unit) [FOR793, IG18/7 2, SCHI 5004/5 2]	German Research Foundation (DFG) (Research Unit)(German Research Foundation (DFG))	This study was funded by the German Research Foundation (DFG) (Research Unit FOR793, IG18/7 2 and SCHI 5004/5 2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agholme F, 2011, ACTA ORTHOP, V82, P125, DOI [10.3109/17453674.2011.625539, 10.3109/17453674.2011.572252]; Agholme F, 2010, J BONE MINER RES, V25, P2412, DOI 10.1002/jbmr.135; Albers J, 2011, J CELL BIOL, V192, P1057, DOI 10.1083/jcb.201008012; Alblowi J, 2013, BONE, V53, P294, DOI 10.1016/j.bone.2012.12.006; Balemans W, 2001, HUM MOL GENET, V10, P537, DOI 10.1093/hmg/10.5.537; Baron R, 2013, NAT MED, V19, P179, DOI 10.1038/nm.3074; Baron R, 2012, J CLIN ENDOCR METAB, V97, P311, DOI 10.1210/jc.2011-2332; Binder NB, 2009, NAT MED, V15, P417, DOI 10.1038/nm.1945; Boyden LM, 2002, NEW ENGL J MED, V346, P1513, DOI 10.1056/NEJMoa013444; Caetano-Lopes J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016947; Chen Y, 2007, PLOS MED, V4, P1216, DOI 10.1371/journal.pmed.0040249; Cherniske EM, 2004, AM J MED GENET A, V131A, P255, DOI 10.1002/ajmg.a.30400; Chun JS, 2008, BMB REP, V41, P485, DOI 10.5483/BMBRep.2008.41.7.485; Claes L, 2012, NAT REV RHEUMATOL, V8, P133, DOI 10.1038/nrrheum.2012.1; Claes L, 2011, J ORTHOP TRAUMA, V25, P169, DOI 10.1097/BOT.0b013e3181e3d994; Dean DB, 2010, J ANAT, V216, P625, DOI 10.1111/j.1469-7580.2010.01214.x; Gerstenfeld LC, 2003, J CELL BIOCHEM, V88, P873, DOI 10.1002/jcb.10435; Glass DA, 2005, DEV CELL, V8, P751, DOI 10.1016/j.devcel.2005.02.017; Gong YQ, 2001, CELL, V107, P513, DOI 10.1016/S0092-8674(01)00571-2; Hadjiargyrou M, 2002, J BIOL CHEM, V277, P30177, DOI 10.1074/jbc.M203171200; Harada S, 2003, NATURE, V423, P349, DOI 10.1038/nature01660; Heilmann A, 2013, J ORTHOP RES, V31, P1845, DOI 10.1002/jor.22426; Holmen SL, 2005, J BIOL CHEM, V280, P21162, DOI 10.1074/jbc.M501900200; Huang Y, 2012, J ORTHOP RES, V30, P304, DOI 10.1002/jor.21505; Imming P, 2006, NAT REV DRUG DISCOV, V5, P821, DOI 10.1038/nrd2132; Jawad MU, 2013, J ORTHOP RES, V31, P155, DOI 10.1002/jor.22186; Kakar S, 2007, J BONE MINER RES, V22, P1903, DOI 10.1359/JBMR.070724; Kim JB, 2007, J BONE MINER RES, V22, P1913, DOI 10.1359/JBMR.070802; Kim JH, 2013, THER ADV MUSCULOSKEL, V5, P13, DOI 10.1177/1759720X12466608; Kramer I, 2010, MOL CELL BIOL, V30, P3071, DOI 10.1128/MCB.01428-09; Little RD, 2002, AM J HUM GENET, V70, P11, DOI 10.1086/338450; Macsai CE, 2008, J CELL PHYSIOL, V215, P578, DOI 10.1002/jcp.21342; Minear S, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000231; Morgan EF, 2009, BONE, V44, P335, DOI 10.1016/j.bone.2008.10.039; Ominsky MS, 2011, J BONE MINER RES, V26, P1012, DOI 10.1002/jbmr.307; Pober BR, 2010, NEW ENGL J MED, V362, P239, DOI 10.1056/NEJMra0903074; Rachner TD, 2011, LANCET, V377, P1276, DOI 10.1016/S0140-6736(10)62349-5; Rauner M, 2012, J BONE MINER RES, V27, P575, DOI 10.1002/jbmr.1488; Richards JB, 2008, LANCET, V371, P1505, DOI 10.1016/S0140-6736(08)60599-1; Rontgen V, 2010, J ORTHOP RES, V28, P1456, DOI 10.1002/jor.21148; Schubert C, 2009, CELL MOL LIFE SCI, V66, P1178, DOI 10.1007/s00018-008-8401-y; Semenov MV, 2006, J BIOL CHEM, V281, P38276, DOI 10.1074/jbc.M609509200; Wintges K, 2013, J BONE MINER RES, V28, P2070, DOI 10.1002/jbmr.1937; Yates KE, 2005, DNA CELL BIOL, V24, P446, DOI 10.1089/dna.2005.24.446; Zhao C, 2005, P NATL ACAD SCI USA, V102, P10200, DOI 10.1073/pnas.0504754102; Zhong N, 2006, BONE, V39, P5, DOI 10.1016/j.bone.2005.12.008	46	36	41	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84232	10.1371/journal.pone.0084232	http://dx.doi.org/10.1371/journal.pone.0084232			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391920	Green Published, gold, Green Submitted			2022-12-25	WOS:000329323900063
J	Riazi, A; Strong, PCR; Coleman, R; Chen, WX; Hirama, T; van Faassen, H; Henry, M; Logan, SM; Szymanski, CM; MacKenzie, R; Ghahroudi, MA				Riazi, Ali; Strong, Philippa C. R.; Coleman, Russell; Chen, Wangxue; Hirama, Tomoko; van Faassen, Henk; Henry, Matthew; Logan, Susan M.; Szymanski, Christine M.; MacKenzie, Roger; Ghahroudi, Mehdi Arbabi			Pentavalent Single-Domain Antibodies Reduce Campylobacter jejuni Motility and Colonization in Chickens	PLOS ONE			English	Article							INTESTINAL COLONIZATION; BROILER-CHICKENS; POULTRY; FRAGMENTS; INFECTION; RESISTANCE; PROTECTION; IMMUNITY; HOST; BACTERIOPHAGE	Campylobacter jejuni is the leading cause of bacterial foodborne illness in the world, with symptoms ranging from acute diarrhea to severe neurological disorders. Contaminated poultry meat is a major source of C. jejuni infection, and therefore, strategies to reduce this organism in poultry, are expected to reduce the incidence of Campylobacter-associated diseases. We have investigated whether oral administration of C. jejuni-specific single-domain antibodies would reduce bacterial colonization levels in chickens. Llama single-domain antibodies specific for C. jejuni were isolated from a phage display library generated from the heavy chain IgG variable domain repertoire of a llama immunized with C. jejuni flagella. Two flagella-specific single-domain antibodies were pentamerized to yield high avidity antibodies capable of multivalent binding to the target antigen. When administered orally to C. jejuni-infected two-day old chicks, the pentabodies significantly reduced C. jejuni colonization in the ceca. In vitro, the motility of the bacteria was also reduced in the presence of the flagella-specific pentabodies, suggesting the mechanism of action is through either direct interference with flagellar motility or antibody-mediated aggregation. Fluorescent microscopy and Western blot analyses revealed specific binding of the anti-flagella pentabodies to the C. jejuni flagellin.	[Riazi, Ali] AbCelex Technol Inc, Toronto, ON, Canada; [Strong, Philippa C. R.; Coleman, Russell; Chen, Wangxue; Hirama, Tomoko; van Faassen, Henk; Logan, Susan M.; MacKenzie, Roger; Ghahroudi, Mehdi Arbabi] Natl Res Council Canada, Ottawa, ON, Canada; [Henry, Matthew] Dow AgroSci, Indianapolis, IN USA; [Szymanski, Christine M.; MacKenzie, Roger] Univ Alberta, Centennial Ctr Interdisciplinary Sci, Dept Biol Sci, Edmonton, AB, Canada; [Szymanski, Christine M.; MacKenzie, Roger] Univ Alberta, Alberta Glyc Ctr, Edmonton, AB, Canada; [Ghahroudi, Mehdi Arbabi] Univ Guelph, Sch Environm Sci, Guelph, ON N1G 2W1, Canada; [Ghahroudi, Mehdi Arbabi] Carleton Univ, Dept Biol, Ottawa, ON K1S 5B6, Canada	National Research Council Canada; Dow Chemical Company; University of Alberta; University of Alberta; University of Guelph; Carleton University	Ghahroudi, MA (corresponding author), Natl Res Council Canada, Ottawa, ON, Canada.	mehdi.arbabi@nrc-cnrc.gc.ca			Dow AgroSciences; AbCelex Technologies	Dow AgroSciences; AbCelex Technologies	The authors are grateful to Dow AgroSciences and AbCelex Technologies for partially funding this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfredson DA, 2007, FEMS MICROBIOL LETT, V277, P123, DOI 10.1111/j.1574-6968.2007.00935.x; Arbabi-Ghahroudi Mehdi, 2009, V502, P341, DOI 10.1007/978-1-60327-565-1_20; BEERY JT, 1988, APPL ENVIRON MICROB, V54, P2365, DOI 10.1128/AEM.54.10.2365-2370.1988; Behring E, 1890, DEUT MED WOCHENSCHR, V16, P1113, DOI [10.1055/s-0029-1207589, DOI 10.1055/S-0029-1207589]; BLACK RE, 1988, J INFECT DIS, V157, P472, DOI 10.1093/infdis/157.3.472; BLASER MJ, 1986, J INFECT DIS, V153, P552, DOI 10.1093/infdis/153.3.552; Blaser MJ, 1997, J INFECT DIS, V176, pS103, DOI 10.1086/513780; Boyd Y, 2005, IMMUNOGENETICS, V57, P248, DOI 10.1007/s00251-005-0790-6; BURR DH, 1988, INFECT IMMUN, V56, P99, DOI 10.1128/IAI.56.1.99-105.1988; Carrillo CL, 2005, APPL ENVIRON MICROB, V71, P6554, DOI 10.1128/AEM.71.11.6554-6563.2005; Casadevall A, 2004, NAT REV MICROBIOL, V2, P695, DOI 10.1038/nrmicro974; Castillo SL, 2011, J FOOD SCI, V76, pM421, DOI 10.1111/j.1750-3841.2011.02229.x; Cawthraw SA, 2000, CLIN EXP IMMUNOL, V122, P55, DOI 10.1046/j.1365-2249.2000.01349.x; Clark JD, 2012, VACCINE, V30, P2683, DOI 10.1016/j.vaccine.2012.02.002; de los Santos FS, 2009, POULTRY SCI, V88, P61, DOI 10.3382/ps.2008-00228; DOLBY JM, 1986, J HYG-CAMBRIDGE, V96, P143, DOI 10.1017/S0022172400065918; Dooley H, 2003, MOL IMMUNOL, V40, P25, DOI 10.1016/S0161-5890(03)00084-1; EFSA, 2011, EFSA J, V9, P2105, DOI DOI 10.2903/J.EFSA.2011.2105; El-Shibiny A, 2009, J FOOD PROTECT, V72, P733, DOI 10.4315/0362-028X-72.4.733; Gellynck X, 2008, J FOOD PROTECT, V71, P479, DOI 10.4315/0362-028X-71.3.479; Ghahroudi MA, 1997, FEBS LETT, V414, P521, DOI 10.1016/S0014-5793(97)01062-4; GREENBERG AS, 1995, NATURE, V374, P168, DOI 10.1038/374168a0; Guerry P, 2006, MOL MICROBIOL, V60, P299, DOI 10.1111/j.1365-2958.2006.05100.x; HAMERSCASTERMAN C, 1993, NATURE, V363, P446, DOI 10.1038/363446a0; Hariharan H, 2004, VET MED-CZECH, V49, P441, DOI 10.17221/5736-VETMED; Harmsen MM, 2006, APPL MICROBIOL BIOT, V72, P544, DOI 10.1007/s00253-005-0300-7; Harmsen MM, 2005, VET MICROBIOL, V111, P89, DOI 10.1016/j.vetmic.2005.09.005; Harmsen MM, 2000, MOL IMMUNOL, V37, P579, DOI 10.1016/S0161-5890(00)00081-X; Hermans D, 2010, POULTRY SCI, V89, P1144, DOI 10.3382/ps.2010-00717; Hermans D, 2012, VECTOR-BORNE ZOONOT, V12, P89, DOI 10.1089/vbz.2011.0676; Holliger P, 2005, NAT BIOTECHNOL, V23, P1126, DOI 10.1038/nbt1142; Humphrey T, 2007, INT J FOOD MICROBIOL, V117, P237, DOI 10.1016/j.ijfoodmicro.2007.01.006; Kurekci C, 2012, PHYTOTHER RES, V26, P186, DOI 10.1002/ptr.3526; Layton SL, 2011, CLIN VACCINE IMMUNOL, V18, P449, DOI 10.1128/CVI.00379-10; Lin J, 2009, FOODBORNE PATHOG DIS, V6, P755, DOI 10.1089/fpd.2008.0247; Man SM, 2011, NAT REV GASTRO HEPAT, V8, P669, DOI 10.1038/nrgastro.2011.191; Mead GC, 2002, WORLD POULTRY SCI J, V58, P169, DOI 10.1079/WPS20020016; Messaoudi S, 2011, INT MICROBIOL, V14, P103, DOI 10.2436/20.1501.01.140; Molatova Z, 2010, FOLIA MICROBIOL, V55, P215, DOI 10.1007/s12223-010-0031-8; Muyldermans S, 2001, J Biotechnol, V74, P277; Newell DG, 2003, APPL ENVIRON MICROB, V69, P4343, DOI 10.1128/AEM.69.8.4343-4351.2003; NURMI E, 1973, NATURE, V241, P210, DOI 10.1038/241210a0; Nyachuba DG, 2010, NUTR REV, V68, P257, DOI 10.1111/j.1753-4887.2010.00286.x; PAVLOVSKIS OR, 1991, INFECT IMMUN, V59, P2259, DOI 10.1128/IAI.59.7.2259-2264.1991; PENNER JL, 1980, J CLIN MICROBIOL, V12, P732, DOI 10.1128/JCM.12.6.732-737.1980; POWER ME, 1994, J BACTERIOL, V176, P3303, DOI 10.1128/jb.176.11.3303-3313.1994; RAUTELIN H, 1990, SCAND J INFECT DIS, V22, P321, DOI 10.3109/00365549009027054; Rice BE, 1997, VACCINE, V15, P1922, DOI 10.1016/S0264-410X(97)00126-6; ROLLWAGEN FM, 1993, VACCINE, V11, P1316, DOI 10.1016/0264-410X(93)90101-3; Sahin O, 2003, APPL ENVIRON MICROB, V69, P5372, DOI 10.1128/AEM.69.9.5372-5379.2003; Sambrook J, 2001, MOL CLONING LAB MANU; Santini C, 2010, INT J FOOD MICROBIOL, V141, pS98, DOI 10.1016/j.ijfoodmicro.2010.03.039; Silva J, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00200; Sklar IB, 2001, J FOOD SAFETY, V21, P15, DOI 10.1111/j.1745-4565.2001.tb00305.x; SMITH HW, 1987, J GEN MICROBIOL, V133, P1111; Smith JL, 2010, J FOOD PROTECT, V73, P1141, DOI 10.4315/0362-028X-73.6.1141; Stern NJ, 2003, J FOOD PROTECT, V66, P1557, DOI 10.4315/0362-028X-66.9.1557; STERN NJ, 1990, AVIAN DIS, V34, P595, DOI 10.2307/1591250; Suzuki H, 2009, J VET MED SCI, V71, P255, DOI 10.1292/jvms.71.255; Svetoch EA, 2010, POULTRY SCI, V89, P1763, DOI 10.3382/ps.2010-00659; SZYMANSKI CM, 1995, INFECT IMMUN, V63, P4295, DOI 10.1128/IAI.63.11.4295-4300.1995; UEKI Y, 1987, MICROBIOL IMMUNOL, V31, P1161, DOI 10.1111/j.1348-0421.1987.tb01350.x; Vanlandschoot P, 2011, ANTIVIR RES, V92, P389, DOI 10.1016/j.antiviral.2011.09.002; Wagenaar JA, 2006, REV SCI TECH OIE, V25, P581, DOI 10.20506/rst.25.2.1680; Wagenaar JA, 2005, VET MICROBIOL, V109, P275, DOI 10.1016/j.vetmic.2005.06.002; Wagenaar JA, 2008, CAMPYLOBACTER, 3RD EDITION, P667; Widders PR, 1996, BRIT POULTRY SCI, V37, P765, DOI 10.1080/00071669608417906; Willis WL, 2008, POULTRY SCI, V87, P606, DOI 10.3382/ps.2006-00458; Zeng Ximin, 2010, J Vaccines Vaccin, V1; Zhang GD, 2007, J FOOD PROTECT, V70, P867, DOI 10.4315/0362-028X-70.4.867; Zhang JB, 2004, J MOL BIOL, V341, P161, DOI 10.1016/j.jmb.2004.05.069	72	33	35	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83928	10.1371/journal.pone.0083928	http://dx.doi.org/10.1371/journal.pone.0083928			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391847	Green Submitted, Green Published, gold			2022-12-25	WOS:000329325200145
J	Tay, CS; Tagliani, E; Collins, MK; Erlebacher, A				Tay, Chin-Siean; Tagliani, Elisa; Collins, Mary K.; Erlebacher, Adrian			Cis-Acting Pathways Selectively Enforce the Non-Immunogenicity of Shed Placental Antigen for Maternal CD8 T Cells	PLOS ONE			English	Article							MINOR HISTOCOMPATIBILITY ANTIGENS; IMMUNE-RESPONSE; DENDRITIC CELLS; ALLOGENEIC FETUS; PREGNANCY; TOLERANCE; INTERFACE; OVALBUMIN; INFECTION; EXPANSION	Maternal immune tolerance towards the fetus and placenta is thought to be established in part by pathways that attenuate T cell priming to antigens released from the placenta into maternal blood. These pathways remain largely undefined and their existence, at face value, seems incompatible with a mother's need to maintain a functional immune system during pregnancy. A particular conundrum is evident if we consider that maternal antigen presenting cells, activated in order to prime T cells to pathogen-derived antigens, would also have the capacity to prime T cells to co-ingested placental antigens. Here, we address this paradox using a transgenic system in which placental membranes are tagged with a strong surrogate antigen (ovalbumin). We find that although a remarkably large quantity of acellular ovalbumin-containing placental material is released into maternal blood, splenic CD8 T cells in pregnant mice bearing unmanipulated T cell repertoires are not primed to ovalbumin even if the mice are intravenously injected with adjuvants. This failure was largely independent of regulatory T cells, and instead was linked to the intrinsic characteristics of the released material that rendered it selectively non-immunogenic, potentially by sequestering it from CD8 alpha(+) dendritic cells. The release of ovalbumin-containing placental material into maternal blood thus had no discernable impact on CD8 T cell priming to soluble ovalbumin injected intravenously during pregnancy, nor did it induce long-term tolerance to ovalbumin. Together, these results outline a major pathway governing the maternal immune response to the placenta, and suggest how tolerance to placental antigens can be maintained systemically without being detrimental to host defense.	[Tay, Chin-Siean; Tagliani, Elisa; Collins, Mary K.; Erlebacher, Adrian] NYU, Sch Med, Dept Pathol, New York, NY USA; [Erlebacher, Adrian] NYU, Sch Med, Inst Canc, New York, NY USA	New York University; New York University	Erlebacher, A (corresponding author), NYU, Sch Med, Dept Pathol, New York, NY USA.	adrian.erlebacher@nyumc.org	Tagliani, Elisa/AAN-1955-2020		Leona M. and Harry B. Helmsley Charitable Trust [09PG-T1D028]; National Institutes of Health (NIH) National Cancer Institute [P30CA016087]; NATIONAL CANCER INSTITUTE [P30CA016087] Funding Source: NIH RePORTER	Leona M. and Harry B. Helmsley Charitable Trust; National Institutes of Health (NIH) National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a grant from the Leona M. and Harry B. Helmsley Charitable Trust to A. E. (09PG-T1D028). The NYU Cancer Institute's Immune Monitoring core facility was supported by a grant from the National Institutes of Health (NIH) National Cancer Institute (P30CA016087). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahonen CL, 2004, J EXP MED, V199, P775, DOI 10.1084/jem.20031591; Aluvihare VR, 2004, NAT IMMUNOL, V5, P266, DOI 10.1038/ni1037; Badovinac VP, 2007, IMMUNITY, V26, P827, DOI 10.1016/j.immuni.2007.04.013; Bar JJ, 2008, IMMUNITY, V28, P859, DOI 10.1016/j.immuni.2008.04.010; Behrens EM, 2007, J IMMUNOL, V178, P6268, DOI 10.4049/jimmunol.178.10.6268; Benirschke K, 2006, PATHOLOGY HUMAN PLAC, V5th; Bevan MJ, 2001, NAT IMMUNOL, V2, P381, DOI 10.1038/87676; Collins MK, 2009, J CLIN INVEST, V119, P2062, DOI 10.1172/JCI38714; Ehst BD, 2003, AM J TRANSPLANT, V3, P1355, DOI 10.1046/j.1600-6135.2003.00246.x; Erlebacher A, 2007, J CLIN INVEST, V117, P1399, DOI 10.1172/JCI28214; Erlebacher A, 2013, NAT REV IMMUNOL, V13, P23, DOI 10.1038/nri3361; Farrand KJ, 2009, J IMMUNOL, V183, P7732, DOI 10.4049/jimmunol.0902707; Forster R, 1999, CELL, V99, P23, DOI 10.1016/S0092-8674(00)80059-8; GUERIN LR, 2011, BIOL REPROD; Heesters BA, 2013, IMMUNITY, V38, P1164, DOI 10.1016/j.immuni.2013.02.023; Holland OJ, 2012, AM J PATHOL, V180, P256, DOI 10.1016/j.ajpath.2011.09.021; Horwitz DA, 2008, TRENDS IMMUNOL, V29, P429, DOI 10.1016/j.it.2008.06.005; Kastenmuller W, 2011, J IMMUNOL, V187, P3186, DOI 10.4049/jimmunol.1101649; Kemp RA, 2004, J IMMUNOL, V173, P2923, DOI 10.4049/jimmunol.173.5.2923; KINDBERG GM, 1990, BIOCHEM J, V270, P197, DOI 10.1042/bj2700197; Krishnan L, 2013, J REPROD IMMUNOL, V97, P62, DOI 10.1016/j.jri.2012.10.015; Li M, 2001, J IMMUNOL, V166, P6099, DOI 10.4049/jimmunol.166.10.6099; Linscheid C, 2013, AM J REPROD IMMUNOL, V69, P304, DOI 10.1111/aji.12075; McCloskey ML, 2011, J EXP MED, V208, P135, DOI 10.1084/jem.20100354; McNally A, 2011, P NATL ACAD SCI USA, V108, P7529, DOI 10.1073/pnas.1103782108; Mincheva-Nilsson L, 2010, AM J REPROD IMMUNOL, V63, P520, DOI 10.1111/j.1600-0897.2010.00822.x; Moldenhauer LM, 2009, J IMMUNOL, V182, P8080, DOI 10.4049/jimmunol.0804018; Moon JJ, 2011, P NATL ACAD SCI USA, V108, P14602, DOI 10.1073/pnas.1109806108; Nancy P, 2012, SCIENCE, V336, P1317, DOI 10.1126/science.1220030; Phan TG, 2009, NAT IMMUNOL, V10, P786, DOI 10.1038/ni.1745; Qiu CH, 2009, J IMMUNOL, V182, P4127, DOI 10.4049/jimmunol.0803364; Redmond WL, 2005, IMMUNITY, V22, P275, DOI 10.1016/j.immuni.2005.01.010; Rowe JH, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002873; Rowe JH, 2012, NATURE, V490, P102, DOI 10.1038/nature11462; Rowe JH, 2011, CELL HOST MICROBE, V10, P54, DOI 10.1016/j.chom.2011.06.005; Rowe JH, 2013, REPRODUCTION; Samstein RM, 2012, CELL, V150, P29, DOI 10.1016/j.cell.2012.05.031; Serra P, 2003, IMMUNITY, V19, P877, DOI 10.1016/S1074-7613(03)00327-3; Shima T, 2010, J REPROD IMMUNOL, V85, P121, DOI 10.1016/j.jri.2010.02.006; Suvas S, 2003, J EXP MED, V198, P889, DOI 10.1084/jem.20030171; Teles A, 2013, AM J REPROD IMMUNOL, V69, P331, DOI 10.1111/aji.12067; Zhou XY, 2009, CURR OPIN IMMUNOL, V21, P281, DOI 10.1016/j.coi.2009.05.007	42	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84064	10.1371/journal.pone.0084064	http://dx.doi.org/10.1371/journal.pone.0084064			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391885	Green Published, gold, Green Submitted			2022-12-25	WOS:000329323900028
J	Zanforlin, T; Bayer-Santos, E; Cortez, C; Almeida, IC; Yoshida, N; da Silveira, JF				Zanforlin, Tamiris; Bayer-Santos, Ethel; Cortez, Cristian; Almeida, Igor C.; Yoshida, Nobuko; da Silveira, Jose Franco			Molecular Characterization of Trypanosoma cruzi SAP Proteins with Host-Cell Lysosome Exocytosis-Inducing Activity Required for Parasite Invasion	PLOS ONE			English	Article							SURFACE-ANTIGENS; METACYCLIC TRYPOMASTIGOTES; CHAGAS-DISEASE; ALANINE-RICH; SERINE-RICH; ACTIVATION; MEMBRANE; CYSTEINE; IDENTIFICATION; INFECTIVITY	Background: To invade target cells, Trypanosoma cruzi metacyclic forms engage distinct sets of surface and secreted molecules that interact with host components. Serine-, alanine-, and proline-rich proteins (SAP) comprise a multigene family constituted of molecules with a high serine, alanine and proline residue content. SAP proteins have a central domain (SAP-CD) responsible for interaction with and invasion of mammalian cells by metacyclic forms. Methods and Findings: Using a 513 bp sequence from SAP-CD in blastn analysis, we identified 39 full-length SAP genes in the genome of T. cruzi. Although most of these genes were mapped in the T. cruzi in silico chromosome TcChr41, several SAP sequences were spread out across the genome. The level of SAP transcripts was twice as high in metacyclic forms as in epimastigotes. Monoclonal (MAb-SAP) and polyclonal (anti-SAP) antibodies produced against the recombinant protein SAP-CD were used to investigate the expression and localization of SAP proteins. MAb-SAP reacted with a 55 kDa SAP protein released by epimastigotes and metacyclic forms and with distinct sets of SAP variants expressed in amastigotes and tissue culture-derived trypomastigotes (TCTs). Anti-SAP antibodies reacted with components located in the anterior region of epimastigotes and between the nucleus and the kinetoplast in metacyclic trypomastigotes. In contrast, anti-SAP recognized surface components of amastigotes and TCTs, suggesting that SAP proteins are directed to different cellular compartments. Ten SAP peptides were identified by mass spectrometry in vesicle and soluble-protein fractions obtained from parasite conditioned medium. Using overlapping sequences from SAP-CD, we identified a 54-aa peptide (SAP-CE) that was able to induce host-cell lysosome exocytosis and inhibit parasite internalization by 52%. Conclusions: This study provides novel information about the genomic organization, expression and cellular localization of SAP proteins and proposes a triggering role for extracellular SAP proteins in host-cell lysosome exocytosis during metacyclic internalization.	[Zanforlin, Tamiris; Bayer-Santos, Ethel; Cortez, Cristian; Yoshida, Nobuko; da Silveira, Jose Franco] Univ Fed Sao Paulo, Escola Paulista Med, Dept Microbiol Imunol & Parasitol, Sao Paulo, Brazil; [Almeida, Igor C.] Univ Texas El Paso, Dept Biol Sci, Border Biomed Res Ctr, El Paso, TX 79968 USA	Universidade Federal de Sao Paulo (UNIFESP); University of Texas System; University of Texas El Paso	da Silveira, JF (corresponding author), Univ Fed Sao Paulo, Escola Paulista Med, Dept Microbiol Imunol & Parasitol, Sao Paulo, Brazil.	jose.franco@unifesp.br	cortez, cristian/GLT-4441-2022; Bayer-Santos, Ethel/Z-1923-2019; Yoshida, Nobuko/AAL-6082-2020; Bayer-Santos, Ethel/O-5505-2014; Almeida, Igor C./AAF-9409-2019; da Silveira, Jose Franco/F-5390-2012	Bayer-Santos, Ethel/0000-0003-3832-3449; Yoshida, Nobuko/0000-0002-3925-8557; Bayer-Santos, Ethel/0000-0003-3832-3449; Almeida, Igor C./0000-0002-2443-8213; 	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior; National Institutes of Health (NIH) [R01AI070655-A5, R01AI070655-A5S1]; Research Centers in Minority Institutions program from the National Institutes on Minority Health and Health Disparities, a component of the NIH [8G12MD007592, 5G12RR008124-16A1, 5G12RR008124-16A1S1]; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR008124] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI070655] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007592] Funding Source: NIH RePORTER	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research Centers in Minority Institutions program from the National Institutes on Minority Health and Health Disparities, a component of the NIH; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported by grants from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) (www.fapesp.br), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) (www.cnpq.br) and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (www.capes.gov.br) to JFS, and the National Institutes of Health (NIH) grants R01AI070655-A5 and R01AI070655-A5S1 to ICA. TZ was awarded a doctoral fellowship from FAPESP, and EBS and CC were awarded a doctoral fellowship from CNPq. The authors thank the Biomolecule Analysis Core Facility at the University of Texas at El Paso, supported by the Research Centers in Minority Institutions program, grants 8G12MD007592, 5G12RR008124-16A1, and 5G12RR008124-16A1S1, to the Border Biomedical Research Center, from the National Institutes on Minority Health and Health Disparities, a component of the NIH. The funders played no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abuin G, 1996, BRAZ J MED BIOL RES, V29, P335; AFFRANCHINO JL, 1989, MOL BIOCHEM PARASIT, V34, P221, DOI 10.1016/0166-6851(89)90050-9; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andrade D, 2012, BRIT J PHARMACOL, V165, P1333, DOI 10.1111/j.1476-5381.2011.01609.x; ANDREWS NW, 1990, CELL, V61, P1277, DOI 10.1016/0092-8674(90)90692-8; ANDREWS NW, 1987, EXP PARASITOL, V64, P474, DOI 10.1016/0014-4894(87)90062-2; [Anonymous], 2010, Wkly Epidemiol Rec, V85, P334; Aparicio IM, 2004, INFECT IMMUN, V72, P5892, DOI 10.1128/IAI.72.10.5892-5902.2004; Baida RCP, 2006, INFECT IMMUN, V74, P1537, DOI 10.1128/IAI.74.3.1537-1546.2006; Bastos IMD, 2005, BIOCHEM J, V388, P29, DOI 10.1042/BJ20041049; Bayer-Santos E, 2013, J PROTEOME RES, V12, P883, DOI 10.1021/pr300947g; CANO MI, 1995, MOL BIOCHEM PARASIT, V71, P273, DOI 10.1016/0166-6851(95)00066-A; Carmo MS, 2001, INT J PARASITOL, V31, P259, DOI 10.1016/S0020-7519(00)00170-3; Cortez C, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001804; Coura JR, 2010, NATURE, V465, pS6, DOI 10.1038/nature09221; Cuevas IC, 2005, EUKARYOT CELL, V4, P1550, DOI 10.1128/EC.4.9.1550-1561.2005; Doyle PS, 2011, PLOS PATHOG, V7, DOI DOI 10.1371/journal.ppat.1002139; El-Sayed NM, 2005, SCIENCE, V309, P409, DOI 10.1126/science.1112631; Giordanengo L, 2002, EUR J IMMUNOL, V32, P1003, DOI 10.1002/1521-4141(200204)32:4<1003::AID-IMMU1003>3.0.CO;2-P; GONCALVES MF, 1991, EXP PARASITOL, V72, P43, DOI 10.1016/0014-4894(91)90119-H; JAZIN EE, 1995, PARASITOLOGY, V110, P61, DOI 10.1017/S0031182000081051; Maeda FY, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00361; Martins RM, 2011, CELL MICROBIOL, V13, P943, DOI 10.1111/j.1462-5822.2011.01590.x; MORO A, 1995, EMBO J, V14, P2483, DOI 10.1002/j.1460-2075.1995.tb07245.x; MURTA ACM, 1990, MOL BIOCHEM PARASIT, V43, P27, DOI 10.1016/0166-6851(90)90127-8; Nickel W, 2008, ANNU REV CELL DEV BI, V24, P287, DOI 10.1146/annurev.cellbio.24.110707.175320; NORRIS KA, 1994, INFECT IMMUN, V62, P236, DOI 10.1128/IAI.62.1.236-243.1994; Ouaissi A, 1995, IMMUNOL LETT, V48, P221, DOI 10.1016/0165-2478(95)02463-8; RAMIREZ MI, 1993, INFECT IMMUN, V61, P3636, DOI 10.1128/IAI.61.9.3636-3641.1993; Reina-San-Martin B, 2000, NAT MED, V6, P890, DOI 10.1038/78651; Rodriguez A, 1996, J CELL BIOL, V134, P349, DOI 10.1083/jcb.134.2.349; Ruiz RC, 1998, BIOCHEM J, V330, P505; Savino W, 2007, CYTOKINE GROWTH F R, V18, P107, DOI 10.1016/j.cytogfr.2007.01.010; Scharfstein J, 2000, J EXP MED, V192, P1289, DOI 10.1084/jem.192.9.1289; Scharfstein J, 2006, IMMUNOBIOLOGY, V211, P117, DOI 10.1016/j.imbio.2005.10.014; Simpson R.J, 2012, J PROTEOM BIOINFORM, V5, P10000, DOI [10.4172/jpb.10000e10, DOI 10.4172/JPB.10000E10]; Souza RT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023042; Stempin C, 2002, J LEUKOCYTE BIOL, V72, P727; TARDIEUX I, 1992, CELL, V71, P1117, DOI 10.1016/S0092-8674(05)80061-3; TEIXEIRA MMG, 1986, MOL BIOCHEM PARASIT, V18, P271, DOI 10.1016/0166-6851(86)90085-X; Torrecilhas ACT, 2009, MICROBES INFECT, V11, P29, DOI 10.1016/j.micinf.2008.10.003; Umezawa ES, 1996, J CLIN LAB ANAL, V10, P407, DOI 10.1002/(SICI)1098-2825(1996)10:6&lt;407::AID-JCLA16&gt;3.0.CO;2-0; VataruNakamura C, 2005, FEMS MICROBIOL LETT, V242, P227, DOI 10.1016/j.femsle.2004.11.008; Vazquez MP, 1999, GENE, V239, P217, DOI 10.1016/S0378-1119(99)00386-8; Weatherly DB, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-255; Yoshida N, 2006, AN ACAD BRAS CIENC, V78, P87, DOI 10.1590/S0001-37652006000100010; YOSHIDA N, 1989, INFECT IMMUN, V57, P1663, DOI 10.1128/IAI.57.6.1663-1667.1989	47	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83864	10.1371/journal.pone.0083864	http://dx.doi.org/10.1371/journal.pone.0083864			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391838	Green Submitted, gold, Green Published			2022-12-25	WOS:000329325200136
J	Gancarz-Kausch, AM; Schroeder, GL; Panganiban, C; Adank, D; Humby, MS; Kausch, MA; Clark, SD; Dietz, DM				Gancarz-Kausch, Amy M.; Schroeder, Gabrielle L.; Panganiban, Clarisse; Adank, Danielle; Humby, Monica S.; Kausch, Michael A.; Clark, Stewart D.; Dietz, David M.			Transforming Growth Factor Beta Receptor 1 Is Increased following Abstinence from Cocaine Self-Administration, but Not Cocaine Sensitization	PLOS ONE			English	Article							INDUCED STRUCTURAL PLASTICITY; RAT NUCLEUS-ACCUMBENS; SUBSTANCE USE DISORDERS; DRUG-SEEKING BEHAVIOR; INDIVIDUAL-DIFFERENCES; MOLECULAR-MECHANISMS; ADULT NEUROGENESIS; SPINE PLASTICITY; AMPA RECEPTORS; ADDICTION	The addicted phenotype is characterized as a long-lasting, chronically relapsing disorder that persists following long periods of abstinence, suggesting that the underlying molecular changes are stable and endure for long periods even in the absence of drug. Here, we investigated Transforming Growth Factor-Beta Type I receptor (TGF-beta R1) expression in the nucleus accumbens (NAc) following periods of withdrawal from cocaine self-administration (SA) and a sensitizing regimen of non-contingent cocaine. Rats were exposed to either (i) repeated systemic injections (cocaine or saline), or (ii) self-administration (cocaine or saline) and underwent a period of forced abstinence (either 1 or 7 days of drug cessation). Withdrawal from cocaine self-administration resulted in an increase in TGF-beta R1 protein expression in the NAc compared to saline controls. This increase was specific for volitional cocaine intake as no change in expression was observed following a sensitizing regimen of experimenter-administered cocaine. These findings implicate TGF-b signaling as a novel potential therapeutic target for treating drug addiction.	[Gancarz-Kausch, Amy M.; Schroeder, Gabrielle L.; Panganiban, Clarisse; Adank, Danielle; Humby, Monica S.; Kausch, Michael A.; Clark, Stewart D.; Dietz, David M.] SUNY Buffalo, Dept Pharmacol & Toxicol, Buffalo, NY 14260 USA; [Gancarz-Kausch, Amy M.; Clark, Stewart D.; Dietz, David M.] SUNY Buffalo, Res Inst Addict, Buffalo, NY 14260 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Dietz, DM (corresponding author), SUNY Buffalo, Dept Pharmacol & Toxicol, Buffalo, NY 14260 USA.	ddietz@buffalo.edu	Dietz, David/AAW-4574-2021; Dietz, David/J-9458-2015	Dietz, David/0000-0002-6927-9236; Dietz, David/0000-0002-6927-9236; Adank, Danielle/0000-0002-8206-6702; Gancarz-Kausch, Amy/0000-0002-3231-9732	State University of New York at Buffalo; NIAAA [T32-AA007583-11]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [T32AA007583] Funding Source: NIH RePORTER	State University of New York at Buffalo; NIAAA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by the State University of New York at Buffalo and a grant from NIAAA T32-AA007583-11 (A.M.G). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ageta H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001869; ATOR NA, 1993, PSYCHOPHARMACOLOGY, V110, P1, DOI 10.1007/BF02246943; Boudreau AC, 2005, J NEUROSCI, V25, P9144, DOI 10.1523/JNEUROSCI.2252-05.2005; Boudreau AC, 2007, J NEUROSCI, V27, P10621, DOI 10.1523/JNEUROSCI.2163-07.2007; Caffino L, 2013, INT J NEUROPSYCHOPH, P1; Chandra R, 2013, FRONT MOL NEUROSCI, V6, DOI 10.3389/fnmol.2013.00013; Conrad KL, 2010, NEUROSCIENCE, V169, P182, DOI 10.1016/j.neuroscience.2010.04.056; Damez-Werno D, 2012, J NEUROSCI, V32, P10267, DOI 10.1523/JNEUROSCI.1290-12.2012; Deschaux O, 2012, ADDICT BIOL, DOI 10.1111/adb.12019.; Dietz DM, 2009, PHARMACOPSYCHIATRY, V42, pS69, DOI 10.1055/s-0029-1202847; Dietz DM, 2012, NAT NEUROSCI, V15, P891, DOI 10.1038/nn.3094; Dietz DM, 2005, PHYSIOL BEHAV, V86, P347, DOI 10.1016/j.physbeh.2005.08.005; Dow AL, 2005, J NEUROSCI, V25, P4908, DOI 10.1523/JNEUROSCI.5155-04.2005; Dworkin S I, 1986, NIDA Res Monogr, V74, P90; DWORKIN SI, 1995, PSYCHOPHARMACOLOGY, V117, P262, DOI 10.1007/BF02246100; Edlund S, 2002, MOL BIOL CELL, V13, P902, DOI 10.1091/mbc.01-08-0398; Ferrario CR, 2005, BIOL PSYCHIAT, V58, P751, DOI 10.1016/j.biopsych.2005.04.046; Gancarz AM, 2012, PSYCHOPHARMACOLOGY, V222, P215, DOI 10.1007/s00213-012-2637-9; Gipson CD, 2013, NEURON, V77, P867, DOI 10.1016/j.neuron.2013.01.005; Golden S.A., 2012, COLD SPRING HARB PER, V2; Grimm JW, 2003, J NEUROSCI, V23, P742; Guan XW, 2010, J NEUROCHEM, V115, P795, DOI 10.1111/j.1471-4159.2010.06981.x; HOOKS MS, 1991, PHARMACOL BIOCHEM BE, V38, P467, DOI 10.1016/0091-3057(91)90308-O; Hyman SE, 2006, ANNU REV NEUROSCI, V29, P565, DOI 10.1146/annurev.neuro.29.051605.113009; Kalivas PW, 2009, NAT REV NEUROSCI, V10, P561, DOI 10.1038/nrn2515; Kim WY, 2009, NEUROSCIENCE, V163, P501, DOI 10.1016/j.neuroscience.2009.06.067; Kourrich S, 2003, J NEUROPHYSIOL, V89, P2112, DOI 10.1152/jn.00714.2002; Kunwar AJ, 2011, P NATL ACAD SCI USA, V108, P2575, DOI 10.1073/pnas.1013891108; Li X, 2013, J NEUROSCI, V33, P1130, DOI 10.1523/JNEUROSCI.3082-12.2013; Li YL, 2004, EUR J NEUROSCI, V20, P1647, DOI 10.1111/j.1460-9568.2004.03612.x; Loweth J.A., 2013, NEUROPHARMACOLOGY; Loweth JA, 2013, CURR OPIN NEUROBIOL, V23, P500, DOI 10.1016/j.conb.2013.01.009; Luscher C, 2011, NEURON, V69, P650, DOI 10.1016/j.neuron.2011.01.017; Mark GP, 1999, PSYCHOPHARMACOLOGY, V143, P47, DOI 10.1007/s002130050918; Maze I, 2010, SCIENCE, V327, P213, DOI 10.1126/science.1179438; McCutcheon JE, 2011, J NEUROSCI, V31, P5737, DOI 10.1523/JNEUROSCI.0350-11.2011; McFarland K, 2003, J NEUROSCI, V23, P3531; Nestler EJ, 2004, NEUROPHARMACOLOGY, V47, P24, DOI 10.1016/j.neuropharm.2004.06.031; Nestler EJ, 2001, NAT REV NEUROSCI, V2, P119, DOI 10.1038/35053570; Noonan MA, 2010, J NEUROSCI, V30, P304, DOI 10.1523/JNEUROSCI.4256-09.2010; Otaka M, 2013, J NEUROSCI, V33, P6753, DOI 10.1523/JNEUROSCI.4577-12.2013; Pierce RC, 1997, BRAIN RES REV, V25, P192, DOI 10.1016/S0165-0173(97)00021-0; Robinson TE, 2002, SYNAPSE, V46, P271, DOI 10.1002/syn.10146; Robinson TE, 2004, NEUROPHARMACOLOGY, V47, P33, DOI 10.1016/j.neuropharm.2004.06.025; Robison AJ, 2011, NAT REV NEUROSCI, V12, P623, DOI 10.1038/nrn3111; Russo SJ, 2010, TRENDS NEUROSCI, V33, P267, DOI 10.1016/j.tins.2010.02.002; Schuckit MA, 2006, ADDICTION, V101, P76, DOI 10.1111/j.1360-0443.2006.01592.x; Shen HW, 2009, J NEUROSCI, V29, P2876, DOI 10.1523/JNEUROSCI.5638-08.2009; Steketee JD, 2011, PHARMACOL REV, V63, P348, DOI 10.1124/pr.109.001933; Vardouli L, 2005, J BIOL CHEM, V280, P11448, DOI 10.1074/jbc.M402651200; Wachs FP, 2006, J NEUROPATH EXP NEUR, V65, P358, DOI 10.1097/01.jnen.0000218444.53405.f0; Wang XT, 2013, J NEUROSCI, V33, P11012, DOI 10.1523/JNEUROSCI.1097-13.2013; Zilberman ML, 2003, CAN J PSYCHIAT, V48, P5, DOI 10.1177/070674370304800103	53	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e83834	10.1371/journal.pone.0083834	http://dx.doi.org/10.1371/journal.pone.0083834			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386286	Green Published, Green Submitted, gold			2022-12-25	WOS:000329194700070
J	Keogh, E; Moore, DJ; Duggan, GB; Payne, SJ; Eccleston, C				Keogh, Edmund; Moore, David J.; Duggan, Geoffrey B.; Payne, Stephen J.; Eccleston, Christopher			The Disruptive Effects of Pain on Complex Cognitive Performance and Executive Control	PLOS ONE			English	Article							ECOLOGICAL VALIDITY; GENDER-DIFFERENCES; DEFICITS; TASKS; SEX	Pain interferes and disrupts attention. What is less clear is how pain affects performance on complex tasks, and the strategies used to ensure optimal outcomes. The aim of the current study was to examine the effect of pain on higher-order executive control processes involved in managing complex tasks. Sixty-two adult volunteers (40 female) completed two computer-based tasks: a breakfast making task and a word generation puzzle. Both were complex, involving executive control functions, including goal-directed planning and switching. Half of those recruited performed the tasks under conditions of thermal heat pain, and half with no accompanying pain. Whilst pain did not affect central performance on either task, it did have indirect effects. For the breakfast task, pain resulted in a decreased ability to multitask, with performance decrements found on the secondary task. However, no effects of pain were found on the processes thought to underpin this task. For the word generation puzzle, pain did not affect task performance, but did alter subjective accounts of the processes used to complete the task; pain affected the perceived allocation of time to the task, as well as switching perceptions. Sex differences were also found. When studying higher-order cognitive processes, pain-related interference effects are varied, and may result in subtle or indirect changes in cognition.	[Keogh, Edmund] Univ Bath, Dept Psychol, Bath BA2 7AY, Avon, England; [Keogh, Edmund; Moore, David J.; Duggan, Geoffrey B.; Eccleston, Christopher] Univ Bath, Ctr Pain Res, Bath BA2 7AY, Avon, England; [Payne, Stephen J.] Univ Bath, Dept Comp Sci, Bath BA2 7AY, Avon, England	University of Bath; University of Bath; University of Bath	Keogh, E (corresponding author), Univ Bath, Dept Psychol, Bath BA2 7AY, Avon, England.	e.m.keogh@bath.ac.uk		Keogh, Edmund/0000-0002-1615-3699; Moore, David/0000-0002-5228-3124; Eccleston, Christopher/0000-0003-0698-1543	Engineering and Physical Sciences Research Council, United Kingdom [EP/J501402/1]; Engineering and Physical Sciences Research Council [EP/J501402/1] Funding Source: researchfish	Engineering and Physical Sciences Research Council, United Kingdom(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This research was supported by an unrestricted grant (EP/J501402/1) for research from the Engineering and Physical Sciences Research Council, United Kingdom. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey BP, 2008, ACM T COMPUT-HUM INT, V14, DOI 10.1145/1314683.1314689; Bingel U, 2007, NEURON, V55, P157, DOI 10.1016/j.neuron.2007.05.032; Buser T, 2012, EXP ECON, V15, P641, DOI 10.1007/s10683-012-9318-8; Chaytor N, 2003, NEUROPSYCHOL REV, V13, P181, DOI 10.1023/B:NERV.0000009483.91468.fb; Chun MM, 2011, ANNU REV PSYCHOL, V62, P73, DOI 10.1146/annurev.psych.093008.100427; Craik FIM, 2006, MEM COGNITION, V34, P1236, DOI 10.3758/BF03193268; Duggan GB, 2013, INT J HUM-COMPUT ST, V71, P533, DOI 10.1016/j.ijhcs.2013.01.001; Eccleston C, 1999, PSYCHOL BULL, V125, P356, DOI 10.1037/0033-2909.125.3.356; Eysenck M.W., 2015, ANXIETY COGNITIVE PE, DOI 10.4324/9780203775677; Fillingim RB, 2009, J PAIN, V10, P447, DOI 10.1016/j.jpain.2008.12.001; Keogh E, 1999, EUR J PERSONALITY, V13, P209, DOI 10.1002/(SICI)1099-0984(199905/06)13:3<209::AID-PER346>3.0.CO;2-N; Keogh E, 2013, PAIN WOMEN, P94; Keogh E, 2013, PAIN MANAG, V3, P27, DOI [10.2217/PMT.12.70, 10.2217/pmt.12.70]; Keogh E, 2010, PAIN, V151, P18, DOI 10.1016/j.pain.2010.07.014; Keogh E, 2009, EUR J PAIN, V13, P629, DOI 10.1016/j.ejpain.2008.07.002; Legrain V, 2013, CORTEX, V49, P1922, DOI 10.1016/j.cortex.2012.08.014; Legrain V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020926; Legrain V, 2009, PAIN, V144, P230, DOI 10.1016/j.pain.2009.03.020; Mailis-Gagnon A, 2012, CLIN J PAIN, V28, P542, DOI 10.1097/AJP.0b013e3182385332; Mantyla T, 2013, PSYCHOL SCI, V24, P514, DOI 10.1177/0956797612459660; Moore DJ, 2013, PAIN, V154, P190, DOI 10.1016/j.pain.2012.07.016; Moore DJ, 2013, PAIN, V154, P82, DOI 10.1016/j.pain.2012.09.009; Moore DJ, 2012, Q J EXP PSYCHOL, V65, P565, DOI 10.1080/17470218.2011.626865; Nes LS, 2009, ANN BEHAV MED, V37, P173, DOI 10.1007/s12160-009-9096-5; Payne SJ, 2007, J EXP PSYCHOL GEN, V136, P370, DOI 10.1037/0096-3445.136.3.370; Raven J. C., 1998, RAVENS PROGR MATRICE; Raven JC, 1982, MANUAL RAVENS PRO 5A; Spooner DM, 2006, ARCH CLIN NEUROPSYCH, V21, P327, DOI 10.1016/j.acn.2006.04.004; Stevens J, 1996, APPL MULTIVARIATE ST, V3rd ed.; Sullivan MJL, 2000, COGNITIVE THER RES, V24, P121, DOI 10.1023/A:1005459110063; Tabachnick B.G., 2007, USING MULTIVARIATE S, VVolume 5, P481; Torralva T, 2013, J ATTEN DISORD, V17, P11, DOI 10.1177/1087054710389988; Torralva T, 2012, BIPOLAR DISORD, V14, P118, DOI 10.1111/j.1399-5618.2012.00987.x; Van Damme S, 2010, NEUROSCI BIOBEHAV R, V34, P204, DOI 10.1016/j.neubiorev.2009.01.005; Verhoeven K, 2011, EUR J PAIN, V15, P866, DOI 10.1016/j.ejpain.2011.01.009; Zhou H, 2009, P 2009 5 INT C NAT C, P13	36	39	39	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e83272	10.1371/journal.pone.0083272	http://dx.doi.org/10.1371/journal.pone.0083272			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	282SX	24386168	Green Published, gold, Green Submitted			2022-12-25	WOS:000329194700030
J	van Gurp, TP; McIntyre, LM; Verhoeven, KJF				van Gurp, Thomas P.; McIntyre, Lauren M.; Verhoeven, Koen J. F.			Consistent Errors in First Strand cDNA Due to Random Hexamer Mispriming	PLOS ONE			English	Article							RNA; DISCOVERY; BIAS	Priming of random hexamers in cDNA synthesis is known to show sequence bias, but in addition it has been suggested recently that mismatches in random hexamer priming could be a cause of mismatches between the original RNA fragment and observed sequence reads. To explore random hexamer mispriming as a potential source of these errors, we analyzed two independently generated RNA-seq datasets of synthetic ERCC spikes for which the reference is known. First strand cDNA synthesized by random hexamer priming on RNA showed consistent position and nucleotide-specific mismatch errors in the first seven nucleotides. The mismatch errors found in both datasets are consistent in distribution and thermodynamically stable mismatches are more common. This strongly indicates that RNA-DNA mispriming of specific random hexamers causes these errors. Due to their consistency and specificity, mispriming errors can have profound implications for downstream applications if not dealt with properly.	[van Gurp, Thomas P.; Verhoeven, Koen J. F.] Netherlands Inst Ecol NIOO KNAW, Dept Terr Ecol, Wageningen, Netherlands; [McIntyre, Lauren M.] Univ Florida, Genet Inst, Gainesville, FL USA	Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW); State University System of Florida; University of Florida	van Gurp, TP (corresponding author), Netherlands Inst Ecol NIOO KNAW, Dept Terr Ecol, Wageningen, Netherlands.	t.vangurp@nioo.knaw.nl	Verhoeven, Koen JF/C-9920-2010; KNAW, NIOO-KNAW/A-4320-2012	Verhoeven, Koen JF/0000-0003-3002-4102; KNAW, NIOO-KNAW/0000-0002-3835-159X; McIntyre, Lauren/0000-0002-0077-3359	NWO Netherlands (Netherlands Organization for scientific research) [NWO-ALW 820.01.025]	NWO Netherlands (Netherlands Organization for scientific research)	This study was funded by NWO Netherlands (Netherlands Organization for scientific research) (www.nwo.nl) grant number NWO-ALW 820.01.025). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashrafi H, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-571; Benjamini Y, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks001; Dohm JC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn425; Hansen KD, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq224; Jiang LC, 2011, GENOME RES, V21, P1543, DOI 10.1101/gr.121095.111; Kleinman CL, 2012, SCIENCE, V335, DOI [10.1126/science.1209658, 10.1126/science.1210624]; Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111; Li MY, 2011, SCIENCE, V333, P53, DOI 10.1126/science.1207018; Lin W, 2012, SCIENCE, V335, DOI 10.1126/science.1210624; Matvienko M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055913; Schwartz S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016685; Sugimoto N, 2000, BIOCHEMISTRY-US, V39, P11270, DOI 10.1021/bi000819p; Zheng W, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-290; Zook JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041356	14	24	24	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e85583	10.1371/journal.pone.0085583	http://dx.doi.org/10.1371/journal.pone.0085583			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386481	gold, Green Published, Green Submitted			2022-12-25	WOS:000329194700141
J	Zhu, JY; Vereshchagina, N; Sreekumar, V; Burbulla, LF; Costa, AC; Daub, KJ; Woitalla, D; Martins, LM; Kruger, R; Rasse, TM				Zhu, Jun-yi; Vereshchagina, Natalia; Sreekumar, Vrinda; Burbulla, Lena F.; Costa, Ana C.; Daub, Katharina J.; Woitalla, Dirk; Martins, L. Miguel; Krueger, Rejko; Rasse, Tobias M.			Knockdown of Hsc70-5/mortalin Induces Loss of Synaptic Mitochondria in a Drosophila Parkinson's Disease Model	PLOS ONE			English	Article							DOPAMINERGIC-NEURONS; GENETIC-ANALYSIS; MORTALIN; DYSFUNCTION; CHAPERONE; DYNAMICS; MUSCLE; IDENTIFICATION; INACTIVATION; DEGENERATION	Mortalin is an essential component of the molecular machinery that imports nuclear-encoded proteins into mitochondria, assists in their folding, and protects against damage upon accumulation of dysfunctional, unfolded proteins in aging mitochondria. Mortalin dysfunction associated with Parkinson's disease (PD) increases the vulnerability of cultured cells to proteolytic stress and leads to changes in mitochondrial function and morphology. To date, Drosophila melanogaster has been successfully used to investigate pathogenesis following the loss of several other PD-associated genes. We generated the first loss-of-Hsc70-5/mortalin-function Drosophila model. The reduction of Mortalin expression recapitulates some of the defects observed in the existing Drosophila PD-models, which include reduced ATP levels, abnormal wing posture, shortened life span, and reduced spontaneous locomotor and climbing ability. Dopaminergic neurons seem to be more sensitive to the loss of mortalin than other neuronal sub-types and non-neuronal tissues. The loss of synaptic mitochondria is an early pathological change that might cause later degenerative events. It precedes both behavioral abnormalities and structural changes at the neuromuscular junction (NMJ) of mortalin-knockdown larvae that exhibit increased mitochondrial fragmentation. Autophagy is concomitantly up-regulated, suggesting that mitochondria are degraded via mitophagy. Ex vivo data from human fibroblasts identifies increased mitophagy as an early pathological change that precedes apoptosis. Given the specificity of the observed defects, we are confident that the loss-of-mortalin model presented in this study will be useful for further dissection of the complex network of pathways that underlie the development of mitochondrial parkinsonism.	[Zhu, Jun-yi; Vereshchagina, Natalia; Sreekumar, Vrinda; Daub, Katharina J.; Rasse, Tobias M.] Univ Tubingen, Hertie Inst Clin Brain Res, Jr Res Grp Synapt Plast, Tubingen, Germany; [Zhu, Jun-yi; Sreekumar, Vrinda] Univ Tubingen, Grad Sch Cellular & Mol Neurosci, Tubingen, Germany; [Sreekumar, Vrinda; Burbulla, Lena F.; Krueger, Rejko] German Ctr Neurodegenerat Dis, Tubingen, Germany; [Burbulla, Lena F.; Krueger, Rejko] Univ Tubingen, Dept Neurodegenerat Dis, Tubingen, Germany; [Burbulla, Lena F.; Krueger, Rejko] Univ Tubingen, Hertie Inst Clin Brain Res, Tubingen, Germany; [Costa, Ana C.; Martins, L. Miguel] MRC, Cell Death Regulat Lab, Toxicol Unit, Leicester, Leics, England; [Woitalla, Dirk] Ruhr Univ Bochum, St Josef Hosp, Dept Neurol, Bochum, Germany; [Krueger, Rejko] Univ Tubingen, Werner Reichardt Ctr Integrat Neurosci, Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Eberhard Karls University of Tubingen; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Leicester; Ruhr University Bochum; Eberhard Karls University of Tubingen	Kruger, R (corresponding author), German Ctr Neurodegenerat Dis, Tubingen, Germany.	rejko.krueger@uni-tuebingen.de; tobias.rasse@gmail.de		Krueger, Rejko/0000-0003-4258-6241; Zhu, Junyi/0000-0002-4517-101X	Fritz Thyssen Foundation [10.11.2.153, 10.12.1.192]; German Research Council [DFG] [KR2119/8-1, RA 1804/2-1]; Federal Ministry for Education and Research [BMBF, NGFNplus] [01GS08134]; China Scholarship Council; charitable Hertie Foundation; Deutsche Forschungsgemeinschaft; Tubingen University; MRC [MC_U132674518] Funding Source: UKRI; Medical Research Council [MC_U132674518] Funding Source: researchfish	Fritz Thyssen Foundation; German Research Council [DFG](German Research Foundation (DFG)); Federal Ministry for Education and Research [BMBF, NGFNplus](Federal Ministry of Education & Research (BMBF)); China Scholarship Council(China Scholarship Council); charitable Hertie Foundation; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Tubingen University; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by grants from the Fritz Thyssen Foundation (10.11.2.153 to RK and 10.12.1.192 to TMR); the German Research Council [DFG, KR2119/8-1 to RK, RA 1804/2-1 to TMR]; the Federal Ministry for Education and Research [BMBF, NGFNplus; 01GS08134 to RK]. JZ was supported by a fellowship of the China Scholarship Council, LFB by a doctoral scholarship from the charitable Hertie Foundation. We acknowledge support by Deutsche Forschungsgemeinschaft and Open Access Publishing Fund of Tubingen University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALABAN RS, 1986, SCIENCE, V232, P1121, DOI 10.1126/science.3704638; Barzilai A, 2003, TRENDS MOL MED, V9, P126, DOI 10.1016/S1471-4914(03)00020-0; Bolam JP, 2012, MOVEMENT DISORD, V27, P1478, DOI 10.1002/mds.25135; Brenman JE, 2013, GENETICS; Burbulla LF, 2010, HUM MOL GENET, V19, P4437, DOI 10.1093/hmg/ddq370; Burbulla LF, 2010, EUR J CLIN INVEST, V40, P1048, DOI 10.1111/j.1365-2362.2010.02354.x; Burman JL, 2012, P NATL ACAD SCI USA, V109, P10438, DOI 10.1073/pnas.1120688109; Chen J, 2008, GENOME RES, V18, P123, DOI 10.1101/gr.6940108; Chiasserini D, 2011, MOVEMENT DISORD, V26, P1639, DOI 10.1002/mds.23647; Clark IE, 2006, NATURE, V441, P1162, DOI 10.1038/nature04779; Coelho M, 2012, NAT REV NEUROL, V8, P435, DOI 10.1038/nrneurol.2012.126; CRAIG EA, 1987, P NATL ACAD SCI USA, V84, P4156, DOI 10.1073/pnas.84.12.4156; Daigle JG, 2013, HUM MOL GENET, V22, P1193, DOI 10.1093/hmg/dds526; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; Davison EJ, 2009, PROTEOMICS, V9, P4284, DOI 10.1002/pmic.200900126; de Castro P, 2012, CELL DEATH DIFFER, V19, P1308, DOI 10.1038/cdd.2012.5; De Mena L, 2009, J NEURAL TRANSM, V116, P1289, DOI 10.1007/s00702-009-0273-2; Deocaris C, 2008, BIOGERONTOLOGY, V9, P391, DOI 10.1007/s10522-008-9174-2; Deocaris CC, 2009, PROTEIN PEPTIDE LETT, V16, P517, DOI 10.2174/092986609788167770; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Farrer MJ, 2006, NAT REV GENET, V7, P306, DOI 10.1038/nrg1831; Fuger P, 2007, NAT PROTOC, V2, P3285, DOI 10.1038/nprot.2007.472; Fuger P, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003066; Godena VK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017808; Greene JC, 2003, P NATL ACAD SCI USA, V100, P4078, DOI 10.1073/pnas.0737556100; Jin JH, 2007, MOL CELL PROTEOMICS, V6, P845, DOI 10.1074/mcp.M600182-MCP200; Kaul SC, 2003, EXP CELL RES, V286, P96, DOI 10.1016/S0014-4827(03)00101-0; Kirkman MA, 2009, BRAIN, V132, P2317, DOI 10.1093/brain/awp158; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Kohler K, 2009, AUTOPHAGY, V5, P980; KOPIN IJ, 1992, ANN NY ACAD SCI, V648, P96, DOI 10.1111/j.1749-6632.1992.tb24527.x; Menzies FM, 2005, CURR BIOL, V15, P1578, DOI 10.1016/j.cub.2005.07.036; Moreno E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039054; Orsucci D, 2011, J MOL NEUROSCI, V44, P17, DOI 10.1007/s12031-010-9488-9; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; Park J, 2005, GENE, V361, P133, DOI 10.1016/j.gene.2005.06.040; Park J, 2006, NATURE, V441, P1157, DOI 10.1038/nature04788; Perry RJ, 1996, CURR OPIN NEUROL, V9, P281, DOI 10.1097/00019052-199608000-00007; Poole AC, 2008, P NATL ACAD SCI USA, V105, P1638, DOI 10.1073/pnas.0709336105; Rakovic A, 2011, PARKINSONS DIS-US, V2011, DOI 10.4061/2011/153979; Rasse TM, 2005, NAT NEUROSCI, V8, P898, DOI 10.1038/nn1484; Rochet JC, 2012, PROG MOL BIOL TRANSL, V107, P125, DOI 10.1016/B978-0-12-385883-2.00011-4; Sadun A, 1998, Trans Am Ophthalmol Soc, V96, P881; Schmid Andreas, 2008, V420, P239, DOI 10.1007/978-1-59745-583-1_14; SCHNEIDER HC, 1994, NATURE, V371, P768, DOI 10.1038/371768a0; Schnorrer F, 2010, NATURE, V464, P287, DOI 10.1038/nature08799; Shi M, 2008, J NEUROPATH EXP NEUR, V67, P117, DOI 10.1097/nen.0b013e318163354a; Skladal D, 2003, BRAIN, V126, P1905, DOI 10.1093/brain/awg170; Vafai SB, 2012, NATURE, V491, P374, DOI 10.1038/nature11707; Vincent A, 2012, HUM MOL GENET, V21, P1760, DOI 10.1093/hmg/ddr609; Wadhwa R, 2004, J GENE MED, V6, P439, DOI 10.1002/jgm.530; Yaguchi T, 2007, ANN NY ACAD SCI, V1100, P306, DOI 10.1196/annals.1395.032; Yang H, 2011, BIOCHEM BIOPH RES CO, V410, P114, DOI 10.1016/j.bbrc.2011.05.116; Yang YF, 2006, P NATL ACAD SCI USA, V103, P10793, DOI 10.1073/pnas.0602493103; Yokoyama K, 2002, FEBS LETT, V516, P53, DOI 10.1016/S0014-5793(02)02470-5	55	35	35	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e83714	10.1371/journal.pone.0083714	http://dx.doi.org/10.1371/journal.pone.0083714			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386261	Green Published, gold, Green Submitted			2022-12-25	WOS:000329194700059
J	He, LL; Xu, JP; Wu, ZB				He, Lili; Xu, Jiuping; Wu, Zhibin			Coping Strategies as a Mediator of Posttraumatic Growth among Adult Survivors of the Wenchuan Earthquake	PLOS ONE			English	Article							SOCIAL SUPPORT; STRESS; CANCER; ASSOCIATION; INVENTORY; SYMPTOMS; TRAUMA	Objective: By testing the mediating effect of coping strategies on the relationship between social support (SS) and posttraumatic growth (PTG), the aim of this research was to develop a new approach for the study of post-disaster psychological intervention. Methods: A mediating effect model analysis was conducted on 2080 adult survivors selected from 19 of the counties hardest-hit by the 2008 Wenchuan earthquake. The Social Support Rating Scale and the Coping Scale were used to predict the PTG. Results: A bivariate correlation analysis showed that there was a correlation between posttraumatic growth, social support and coping strategies. The mediation analysis revealed that coping strategies played a mediating role between social support and posttraumatic growth in survivors after the earthquake. Conclusion: The results demonstrated that mental health programs for survivors need to focus on the establishment of a good social support network, which was found to be conductive to maintaining and increasing mental health levels. At the same time, adequate social support is able to assist survivors in adopting mature coping strategies, such as problem solving and asking for help. Hence, social support was found to play a vital role in balancing and protecting mental health.	[He, Lili; Xu, Jiuping; Wu, Zhibin] Sichuan Univ, Uncertainty Decis Making Lab, Chengdu 610064, Peoples R China	Sichuan University	Xu, JP (corresponding author), Sichuan Univ, Uncertainty Decis Making Lab, Chengdu 610064, Peoples R China.	xujiuping@scu.edu.cn			National Social Science Foundation of China [12 ZD217]; Sichuan Provincial Social Science Foundation of China [SC13ZD06]; Sichuan University [SKG2013001]	National Social Science Foundation of China; Sichuan Provincial Social Science Foundation of China; Sichuan University(Sichuan University)	This research was supported by the Major Bidding Program of the National Social Science Foundation of China (Grant No. 12 & ZD217), Sichuan Provincial Social Science Foundation of China (Grant No. SC13ZD06), and the research funding of Sichuan University (Grant No. SKG2013001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldwin CM, 1998, LEA SER PER CLIN PSY, P43; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Bonanno GA, 2004, AM PSYCHOL, V59, P20, DOI 10.1037/0003-066X.59.1.20; Calhoun L. G., 2006, HDB POSTTRAUMATIC GR, P3; Cohen LH, 1998, LEA SER PER CLIN PSY, P23; Cordova MJ, 2001, HEALTH PSYCHOL, V20, P176, DOI 10.1037//0278-6133.20.3.176; Dirik G, 2008, J CLIN PSYCHOL MED S, V15, P193, DOI 10.1007/s10880-008-9115-x; Feder A, 2008, PSYCHIATRY, V71, P359, DOI 10.1521/psyc.2008.71.4.359; Hayes AF, 2009, COMMUN MONOGR, V76, P408, DOI 10.1080/03637750903310360; Helgeson VS, 2006, J CONSULT CLIN PSYCH, V74, P797, DOI 10.1037/0022-006X.74.5.797; Ke X, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-573; Kesimci A, 2005, CURR PSYCHOL, V24, P68, DOI 10.1007/s12144-005-1005-x; Kilmer R. P., 2006, HDB POSTTRAUMATIC GR, P264; Kilmer RP, 2010, CHILD DEV, V81, P1211, DOI 10.1111/j.1467-8624.2010.01463.x; Lamela D, 2013, J PSYCHO RES; Lechner SC, 2003, PSYCHO-ONCOL, V12, P491, DOI 10.1002/pon.671; Linley PA, 2004, J TRAUMA STRESS, V17, P11, DOI 10.1023/B:JOTS.0000014671.27856.7e; Liu L, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-219; MacKinnon D.P., 1998, ANN M SOC PREV RES P, V7, P33; MacKinnon DP, 2004, MULTIVAR BEHAV RES, V39, P99, DOI 10.1207/s15327906mbr3901_4; MacKinnon DP, 2002, PSYCHOL METHODS, V7, P83, DOI 10.1037/1082-989X.7.1.83; Maercker A, 2004, PSYCHOL INQ, V15, P41; Prati G, 2009, J LOSS TRAUMA, V14, P364, DOI 10.1080/15325020902724271; Preacher KJ, 2004, BEHAV RES METH INS C, V36, P717, DOI 10.3758/BF03206553; Preacher KJ, 2008, BEHAV RES METHODS, V40, P879, DOI 10.3758/BRM.40.3.879; Sachs-Ericsson N, 2006, J AFFECT DISORDERS, V93, P71, DOI 10.1016/j.jad.2006.02.014; Schaefer J.A., 1992, PERSONAL COPING THEO, P149; Schaefer JA, 1998, LEA SER PER CLIN PSY, P99; Senol-Durak E, 2010, J CLIN PSYCHOL MED S, V17, P150, DOI 10.1007/s10880-010-9192-5; Shakespeare-Finch J., 2005, TRAUMATOLOGY, V11, P325, DOI [10.1177/153476560501100410, DOI 10.1177/153476560501100410]; Shrout PE, 2002, PSYCHOL METHODS, V7, P422, DOI 10.1037//1082-989X.7.4.422; Sobel M.E., 1982, SOCIOL METHODOL, V13, P290, DOI [10.2307/270723, DOI 10.2307/270723]; Taku K, 2008, J TRAUMA STRESS, V21, P158, DOI 10.1002/jts.20305; Tang CSK, 2006, J PSYCHOSOM RES, V61, P699, DOI 10.1016/j.jpsychores.2006.07.014; Tedeschi RG, 2004, PSYCHOL INQ, V15, P1, DOI 10.1207/s15327965pli1501_01; Tedeschi RG, 1998, LEA SER PER CLIN PSY, P1; Tedeschi RG, 1996, J TRAUMA STRESS, V9, P455, DOI 10.1002/jts.2490090305; Tedeschi RG, 1995, TRAUMA TRANSFORMATIO; Thornton AA, 2006, PSYCHO-ONCOL, V15, P285, DOI 10.1002/pon.953; Wang W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041665; Xiao JH., 1996, CHINESE J MENTAL HLT, V10, P164; Xu JP, 2012, PSYCHIAT CLIN NEUROS, V66, P210, DOI 10.1111/j.1440-1819.2012.02331.x; Xu JP, 2011, J AFFECT DISORDERS, V133, P274, DOI 10.1016/j.jad.2011.03.034; Yu XN, 2010, J AFFECT DISORDERS, V123, P327, DOI 10.1016/j.jad.2009.09.019; Zhao CY, 2013, QUAL LIFE RES, V22, P733, DOI 10.1007/s11136-012-0197-4; Zheng YH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029404; Zoellner T, 2006, CLIN PSYCHOL REV, V26, P626, DOI 10.1016/j.cpr.2006.01.008	47	18	18	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e84164	10.1371/journal.pone.0084164	http://dx.doi.org/10.1371/journal.pone.0084164			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	281RE	24386345	gold, Green Submitted, Green Published			2022-12-25	WOS:000329117900079
J	Newnham, L; Jordan, PW; Carballo, JA; Newcombe, S; Hoffmann, E				Newnham, Louise; Jordan, Philip W.; Carballo, Jesus A.; Newcombe, Sonya; Hoffmann, Eva			Ipl1/Aurora Kinase Suppresses S-CDK-Driven Spindle Formation during Prophase I to Ensure Chromosome Integrity during Meiosis	PLOS ONE			English	Article							SYNAPTONEMAL COMPLEX-FORMATION; BUDDING YEAST MEIOSIS; POLO-LIKE KINASE; B-TYPE CYCLINS; SACCHAROMYCES-CEREVISIAE; MEIOTIC RECOMBINATION; CELL-CYCLE; INTERHOMOLOG RECOMBINATION; NONEXCHANGE CHROMOSOMES; DEPENDENT KINASE	Cells coordinate spindle formation with DNA repair and morphological modifications to chromosomes prior to their segregation to prevent cell division with damaged chromosomes. Here we uncover a novel and unexpected role for Aurora kinase in preventing the formation of spindles by Clb5-CDK (S-CDK) during meiotic prophase I and when the DDR is active in budding yeast. This is critical since S-CDK is essential for replication during premeiotic S-phase as well as double-strand break induction that facilitates meiotic recombination and, ultimately, chromosome segregation. Furthermore, we find that depletion of Cdc5 polo kinase activity delays spindle formation in DDR-arrested cells and that ectopic expression of Cdc5 in prophase I enhances spindle formation, when Ipl1 is depleted. Our findings establish a new paradigm for Aurora kinase function in both negative and positive regulation of spindle dynamics.	[Newnham, Louise; Jordan, Philip W.; Carballo, Jesus A.; Newcombe, Sonya; Hoffmann, Eva] Univ Sussex, MRC Genome Damage & Stabil Ctr, Brighton, E Sussex, England	University of Sussex	Hoffmann, E (corresponding author), Univ Sussex, MRC Genome Damage & Stabil Ctr, Brighton, E Sussex, England.	eh58@sussex.ac.uk	Carballo, Jesus/K-9899-2014; hoffmann, eva/AAM-6594-2020	Carballo, Jesus/0000-0003-2259-3743; hoffmann, eva/0000-0002-2588-0652; Jordan, Philip/0000-0003-4890-2647; Newnham, Louise/0000-0002-1627-5530	MRC Centernary Award; BBSCR [BB/E000614/1]; BBSRC [BB/E000614/1] Funding Source: UKRI; MRC [G0902043] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E000614/1] Funding Source: researchfish; Medical Research Council [G0902043] Funding Source: researchfish	MRC Centernary Award(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSCR; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	EH is a MRC Senior Research Fellowship and an EMBO Young Investigator. SG was funded by a MRC Centernary Award. PJ was funded by BBSCR (BB/E000614/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta I, 2011, MOL BIOL CELL, V22, P3478, DOI 10.1091/mbc.E11-06-0482; Bishop AC, 2000, NATURE, V407, P395, DOI 10.1038/35030148; BISHOP DK, 1992, CELL, V69, P439, DOI 10.1016/0092-8674(92)90446-J; Carballo JA, 2008, CELL, V132, P758, DOI 10.1016/j.cell.2008.01.035; Carlile TM, 2008, CELL, V133, P280, DOI 10.1016/j.cell.2008.02.032; Cheslock PS, 2005, NAT GENET, V37, P756, DOI 10.1038/ng1588; Chu S, 1998, MOL CELL, V1, P685, DOI 10.1016/S1097-2765(00)80068-4; Chuang CN, 2012, NUCLEIC ACIDS RES, V40, P11416, DOI 10.1093/nar/gks920; Clyne RK, 2003, NAT CELL BIOL, V5, P480, DOI 10.1038/ncb977; Crasta K, 2008, NAT CELL BIOL, V10, P665, DOI 10.1038/ncb1729; DAHMANN C, 1995, GENETICS, V140, P957; FITCH I, 1992, MOL BIOL CELL, V3, P805, DOI 10.1091/mbc.3.7.805; GRANDIN N, 1993, MOL CELL BIOL, V13, P2113, DOI 10.1128/MCB.13.4.2113; Haase SB, 2001, NAT CELL BIOL, V3, P38, DOI 10.1038/35050543; Henderson KA, 2004, P NATL ACAD SCI USA, V101, P4519, DOI 10.1073/pnas.0400843101; Henderson KA, 2006, CELL, V125, P1321, DOI 10.1016/j.cell.2006.04.039; Hochwagen A, 2005, CELL, V122, P861, DOI 10.1016/j.cell.2005.07.010; Jordan P, 2009, GENE DEV, V23, P2237, DOI 10.1101/gad.536109; Jordan PW, 2012, J CELL SCI, V125, P5061, DOI 10.1242/jcs.105015; Kim S, 2013, GENE DEV, V27, P2139, DOI 10.1101/gad.227454.113; Klein F, 1999, CELL, V98, P91, DOI 10.1016/S0092-8674(00)80609-1; Leu JY, 1998, CELL, V94, P375, DOI 10.1016/S0092-8674(00)81480-4; Lydall D, 1996, NATURE, V383, P840, DOI 10.1038/383840a0; MacQueen AJ, 2011, TRENDS CELL BIOL, V21, P393, DOI 10.1016/j.tcb.2011.03.004; Mardin BR, 2011, CURR BIOL, V21, P1145, DOI 10.1016/j.cub.2011.05.047; Meyer RE, 2013, SCIENCE, V339, P1071, DOI 10.1126/science.1232518; Miller MP, 2012, ELIFE, V1, DOI 10.7554/eLife.00117; Monje-Casas F, 2007, CELL, V128, P477, DOI 10.1016/j.cell.2006.12.040; Nasmyth K, 1996, SCIENCE, V274, P1643, DOI 10.1126/science.274.5293.1643; Newnham L, 2010, P NATL ACAD SCI USA, V107, P781, DOI 10.1073/pnas.0913435107; Okaz E, 2012, CELL, V151, P603, DOI 10.1016/j.cell.2012.08.044; PADMORE R, 1991, CELL, V66, P1239, DOI 10.1016/0092-8674(91)90046-2; Pan J, 2011, CELL, V144, P719, DOI 10.1016/j.cell.2011.02.009; Pinsky BA, 2006, NAT CELL BIOL, V8, P78, DOI 10.1038/ncb1341; Scherthan H, 2007, P NATL ACAD SCI USA, V104, P16934, DOI 10.1073/pnas.0704860104; Shirk K, 2011, J CELL SCI, V124, P2891, DOI 10.1242/jcs.086652; SHUSTER EO, 1989, GENETICS, V123, P29; Smith E, 2011, EMBO J, V30, P2233, DOI 10.1038/emboj.2011.120; Smith KN, 2001, CURR BIOL, V11, P88, DOI 10.1016/S0960-9822(01)00026-4; Sourirajan A, 2008, GENE DEV, V22, P2627, DOI 10.1101/gad.1711408; Stuart D, 1998, GENE DEV, V12, P2698, DOI 10.1101/gad.12.17.2698; Bertran MT, 2011, EMBO J, V30, P2634, DOI 10.1038/emboj.2011.179; Titus S, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004925; Woodbury EL, 2007, NAT CELL BIOL, V9, P106, DOI 10.1038/ncb1523	44	9	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e83982	10.1371/journal.pone.0083982	http://dx.doi.org/10.1371/journal.pone.0083982			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281RE	24386320	Green Accepted, Green Published, Green Submitted, gold			2022-12-25	WOS:000329117900070
J	Sackton, TB; Werren, JH; Clark, AG				Sackton, Timothy B.; Werren, John H.; Clark, Andrew G.			Characterizing the Infection-Induced Transcriptome of Nasonia vitripennis Reveals a Preponderance of Taxonomically-Restricted Immune Genes	PLOS ONE			English	Article							ANTIMICROBIAL PEPTIDE; CYTOPLASMIC INCOMPATIBILITY; ADAPTIVE EVOLUTION; HOST-DEFENSE; DRAFT GENOME; PROTEINS; PATHWAYS; BEES; MECHANISMS; RESPONSES	The innate immune system in insects consists of a conserved core signaling network and rapidly diversifying effector and recognition components, often containing a high proportion of taxonomically-restricted genes. In the absence of functional annotation, genes encoding immune system proteins can thus be difficult to identify, as homology-based approaches generally cannot detect lineage-specific genes. Here, we use RNA-seq to compare the uninfected and infection-induced transcriptome in the parasitoid wasp Nasonia vitripennis to identify genes regulated by infection. We identify 183 genes significantly up-regulated by infection and 61 genes significantly down-regulated by infection. We also produce a new homology-based immune catalog in N. vitripennis, and show that most infection-induced genes cannot be assigned an immune function from homology alone, suggesting the potential for substantial novel immune components in less well-studied systems. Finally, we show that a high proportion of these novel induced genes are taxonomically restricted, highlighting the rapid evolution of immune gene content. The combination of functional annotation using RNA-seq and homology-based annotation provides a robust method to characterize the innate immune response across a wide variety of insects, and reveals significant novel features of the Nasonia immune response.	[Sackton, Timothy B.] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Werren, John H.] Univ Rochester, Dept Biol, Rochester, NY 14627 USA; [Clark, Andrew G.] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY USA	Harvard University; University of Rochester; Cornell University	Sackton, TB (corresponding author), Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA.	tsackton@oeb.harvard.edu		Werren, John/0000-0001-9353-2070; Sackton, Timothy/0000-0003-1673-9216; Clark, Andrew/0000-0001-7159-8511	NIH [R01 AI064950, R24 GM084917]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064950] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R24GM084917] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by NIH grant R01 AI064950 to AGC and NIH grant R24 GM084917 to JHW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert S, 2011, INSECT BIOCHEM MOLEC, V41, P968, DOI 10.1016/j.ibmb.2011.09.006; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Apidianakis Y, 2005, P NATL ACAD SCI USA, V102, P2573, DOI 10.1073/pnas.0409588102; Aronstein KA, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-391; Begun DJ, 2006, GENETICS, V172, P1675, DOI 10.1534/genetics.105.050336; Bonasio R, 2010, SCIENCE, V329, P1068, DOI 10.1126/science.1192428; Bordenstein SR, 2001, NATURE, V409, P707, DOI 10.1038/35055543; Bordenstein SR, 2003, GENETICS, V164, P223; Boutros M, 2002, DEV CELL, V3, P711, DOI 10.1016/S1534-5807(02)00325-8; Bradley RK, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000392; BREEUWER JAJ, 1990, NATURE, V346, P558, DOI 10.1038/346558a0; Brucker RM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045125; Bulmer MS, 2006, MOL BIOL EVOL, V23, P317, DOI 10.1093/molbev/msj037; Cai J, 2008, GENETICS, V179, P487, DOI 10.1534/genetics.107.084491; CASTEELS P, 1990, EUR J BIOCHEM, V187, P381, DOI 10.1111/j.1432-1033.1990.tb15315.x; Chafee ME, 2011, GENETICS, V187, P203, DOI 10.1534/genetics.110.120675; Chan QWT, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-387; Clark AG, 2007, NATURE, V450, P203, DOI 10.1038/nature06341; Cornman RS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043562; Cornman RS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065424; Cox-Foster DL, 2007, SCIENCE, V318, P283, DOI 10.1126/science.1146498; De Gregorio E, 2001, P NATL ACAD SCI USA, V98, P12590, DOI 10.1073/pnas.221458698; Ekengren S, 2001, CURR BIOL, V11, P714, DOI 10.1016/S0960-9822(01)00203-2; Evans JD, 2006, INSECT MOL BIOL, V15, P645, DOI 10.1111/j.1365-2583.2006.00682.x; Evans JD, 2011, TRENDS MICROBIOL, V19, P614, DOI 10.1016/j.tim.2011.09.003; Fehlbaum P, 1996, P NATL ACAD SCI USA, V93, P1221, DOI 10.1073/pnas.93.3.1221; Gadau J, 2012, TRENDS GENET, V28, P14, DOI 10.1016/j.tig.2011.08.005; Gerardo NM, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r21; Harpur BA, 2013, MOL BIOL EVOL, V30, P1665, DOI 10.1093/molbev/mst061; HUGHES AL, 1988, NATURE, V335, P167, DOI 10.1038/335167a0; Johansson KC, 2005, EXP CELL RES, V305, P145, DOI 10.1016/j.yexcr.2004.12.018; Keebaugh ES, 2012, MOL BIOL EVOL, V29, P565, DOI 10.1093/molbev/msr191; Khalturin K, 2009, TRENDS GENET, V25, P404, DOI 10.1016/j.tig.2009.07.006; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kosiol C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000144; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Levine MT, 2006, P NATL ACAD SCI USA, V103, P9935, DOI 10.1073/pnas.0509809103; Lunter G, 2011, GENOME RES, V21, P936, DOI 10.1101/gr.111120.110; Nygaard S, 2011, GENOME RES, V21, P1339, DOI 10.1101/gr.121392.111; Obbard DJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000698; Pal S, 2008, DEV COMP IMMUNOL, V32, P50, DOI 10.1016/j.dci.2007.04.001; Povelones M, 2009, SCIENCE, V324, P258, DOI 10.1126/science.1171400; Raychoudhury R, 2012, HEREDITY, V108, P105, DOI 10.1038/hdy.2011.53; Reinhardt JA, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003860; Rottschaefer SM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000600; Sackton TB, 2007, NAT GENET, V39, P1461, DOI 10.1038/ng.2007.60; Sackton TB, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-259; Savard J, 2006, GENOME RES, V16, P1334, DOI 10.1101/gr.5204306; Schlenke TA, 2003, GENETICS, V164, P1471; Simola DF, 2013, GENOME RES, V23, P1235, DOI 10.1101/gr.155408.113; Smith CR, 2011, P NATL ACAD SCI USA, V108, P5667, DOI 10.1073/pnas.1007901108; Smith CD, 2011, P NATL ACAD SCI USA, V108, P5673, DOI 10.1073/pnas.1008617108; Somogyi K, 2008, MOL BIOL EVOL, V25, P2337, DOI 10.1093/molbev/msn180; Suen G, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002007; Tian CH, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-187; Toll-Riera M, 2009, MOL BIOL EVOL, V26, P603, DOI 10.1093/molbev/msn281; Vanha-aho LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037153; Viljakainen L, 2009, MOL BIOL EVOL, V26, P1791, DOI 10.1093/molbev/msp086; Vizioli J, 2001, P NATL ACAD SCI USA, V98, P12630, DOI 10.1073/pnas.221466798; Vodovar N, 2005, P NATL ACAD SCI USA, V102, P11414, DOI 10.1073/pnas.0502240102; Wang LG, 2012, BIOINFORMATICS, V28, P2184, DOI 10.1093/bioinformatics/bts356; Waterhouse RM, 2007, SCIENCE, V316, P1738, DOI 10.1126/science.1139862; Weinstock GM, 2006, NATURE, V443, P931, DOI 10.1038/nature05260; Werren JH, 1997, ANNU REV ENTOMOL, V42, P587, DOI 10.1146/annurev.ento.42.1.587; Werren JH, 2010, SCIENCE, V327, P343, DOI 10.1126/science.1178028; Wissler L, 2013, GENOME BIOL EVOL, V5, P439, DOI 10.1093/gbe/evt009; Wurm Y, 2011, P NATL ACAD SCI USA, V108, P5679, DOI 10.1073/pnas.1009690108; Yek SH, 2013, MOL ECOL, V22, P2173, DOI 10.1111/mec.12255; Zhang ZT, 2012, DEV COMP IMMUNOL, V38, P262, DOI 10.1016/j.dci.2012.05.003; Zhou Q, 2008, GENOME RES, V18, P1446, DOI 10.1101/gr.076588.108; Zou Z, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r177	72	28	28	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e83984	10.1371/journal.pone.0083984	http://dx.doi.org/10.1371/journal.pone.0083984			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281RE	24386321	Green Submitted, gold, Green Published			2022-12-25	WOS:000329117900071
J	Yang, W; Zhu, CH; Ma, XL; Li, GJ; Gan, LJ; Ng, D; Xia, K				Yang, Wei; Zhu, Changhua; Ma, Xiaoling; Li, Guijun; Gan, Lijun; Ng, Denny; Xia, Kai			Hydrogen Peroxide Is a Second Messenger in the Salicylic Acid-Triggered Adventitious Rooting Process in Mung Bean Seedlings	PLOS ONE			English	Article							NITRIC-OXIDE; ARABIDOPSIS-THALIANA; ANTIOXIDANT ENZYMES; H2O2-METABOLIZING ENZYMES; PHENOLIC-COMPOUNDS; INDOLEACETIC-ACID; METHYL JASMONATE; OXIDATIVE STRESS; OSMOTIC-STRESS; CELL-DEATH	In plants, salicylic acid (SA) is a signaling molecule that regulates disease resistance responses, such as systemic acquired resistance (SAR) and hypertensive response (HR). SA has been implicated as participating in various biotic and abiotic stresses. This study was conducted to investigate the role of SA in adventitious root formation (ARF) in mung bean (Phaseolus radiatus L) hypocotyl cuttings. We observed that hypocotyl treatment with SA could significantly promote the adventitious root formation, and its effects were dose and time dependent. Explants treated with SA displayed a 130% increase in adventitious root number compared with control seedlings. The role of SA in mung bean hypocotyl ARF as well as its interaction with hydrogen peroxide (H2O2) were also elucidated. Pretreatment of mung bean explants with N, N'-dimethylthiourea (DMTU), a scavenger for H2O2, resulted in a significant reduction of SA-induced ARF. Diphenyleneiodonium (DPI), a specific inhibitor of membrane-linked NADPH oxidase, also inhibited the effect of adventitious rooting triggered by SA treatment. The determination of the endogenous H2O2 level indicated that the seedlings treated with SA could induce H2O2 accumulation compared with the control treatment. Our results revealed a distinctive role of SA in the promotion of adventitious rooting via the process of H2O2 accumulation. This conclusion was further supported by antioxidant enzyme activity assays. Based on these results, we conclude that the accumulation of free H2O2 might be a downstream event in response to SAtriggered adventitious root formation in mung bean seedlings.	[Yang, Wei; Zhu, Changhua; Ma, Xiaoling; Li, Guijun; Gan, Lijun; Xia, Kai] Nanjing Agr Univ, Coll Life Sci, Plant Hormone Lab, Nanjing, Jiangsu, Peoples R China; [Ng, Denny] CP Bio Inc, Chino, CA USA	Nanjing Agricultural University	Xia, K (corresponding author), Nanjing Agr Univ, Coll Life Sci, Plant Hormone Lab, Nanjing, Jiangsu, Peoples R China.	xia1965@hotmail.com	MA, XIAO/HHN-5611-2022		National Natural Science Foundation of China [30871460]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (No. 30871460). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Able AJ, 1998, PLANT PHYSIOL, V117, P491, DOI 10.1104/pp.117.2.491; Aebi H, 1984, Methods Enzymol, V105, P121; Agarwal S, 2005, PLANT SCI, V169, P559, DOI 10.1016/j.plantsci.2005.05.004; Ali MB, 2007, MOLECULES, V12, P607, DOI 10.3390/12030607; Alvarez ME, 1998, CELL, V92, P773, DOI 10.1016/S0092-8674(00)81405-1; Anand A, 2008, PLANT PHYSIOL, V146, P703, DOI 10.1104/pp.107.111302; Ananieva EA, 2004, J PLANT PHYSIOL, V161, P319, DOI 10.1078/0176-1617-01022; Beers EP, 2001, CURR OPIN PLANT BIOL, V4, P561, DOI 10.1016/S1369-5266(00)00216-8; Bellamine J, 1998, PLANT GROWTH REGUL, V26, P191, DOI 10.1023/A:1006182801823; BI YM, 1995, PLANT J, V8, P235, DOI 10.1046/j.1365-313X.1995.08020235.x; Bolwell GP, 1998, PLANT PHYSIOL, V116, P1379, DOI 10.1104/pp.116.4.1379; Borsani O, 2001, PLANT PHYSIOL, V126, P1024, DOI 10.1104/pp.126.3.1024; Boyce C. Kevin, 2005, P479; BRENNAN T, 1977, PLANT PHYSIOL, V59, P411, DOI 10.1104/pp.59.3.411; Casano LM, 2001, PLANT PHYSIOL, V125, P1450, DOI 10.1104/pp.125.3.1450; Chamnongpol S, 1998, P NATL ACAD SCI USA, V95, P5818, DOI 10.1073/pnas.95.10.5818; Chen J, 2007, J ENVIRON SCI, V19, P44, DOI 10.1016/S1001-0742(07)60007-2; CHEN ZX, 1993, SCIENCE, V262, P1883, DOI 10.1126/science.8266079; CONNELL JP, 1986, PLANT PHYSIOL, V82, P351, DOI 10.1104/pp.82.2.351; CONRATH U, 1995, P NATL ACAD SCI USA, V92, P7143, DOI 10.1073/pnas.92.16.7143; Dat JF, 1998, PLANT PHYSIOL, V118, P1455, DOI 10.1104/pp.118.4.1455; Dat JF, 1998, PLANT PHYSIOL, V116, P1351, DOI 10.1104/pp.116.4.1351; De Klerk GJ, 2008, PLANT GROWTH REGUL, V56, P203, DOI 10.1007/s10725-008-9301-8; De Klerk GJ, 2011, PLANT GROWTH REGUL, V63, P175, DOI 10.1007/s10725-010-9555-9; Desikan R, 1998, J EXP BOT, V49, P1767, DOI 10.1093/jexbot/49.327.1767; Desikan R, 2004, J EXP BOT, V55, P205, DOI 10.1093/jxb/erh033; Durner J, 1996, J BIOL CHEM, V271, P28492, DOI 10.1074/jbc.271.45.28492; Echevarria-Machado I, 2007, PLANT PHYSIOL BIOCH, V45, P501, DOI 10.1016/j.plaphy.2007.04.003; ELIASSON L, 1984, PHYSIOL PLANTARUM, V61, P293, DOI 10.1111/j.1399-3054.1984.tb05911.x; Falasca G, 2004, PLANT CELL REP, V23, P17, DOI 10.1007/s00299-004-0801-3; Foreman J, 2003, NATURE, V422, P442, DOI 10.1038/nature01485; Foyer CH, 1997, PHYSIOL PLANTARUM, V100, P241, DOI 10.1034/j.1399-3054.1997.1000205.x; Geiss G, 2009, ANN PLANT REV, V37; GIANNOPOLITIS CN, 1977, PLANT PHYSIOL, V59, P315, DOI 10.1104/pp.59.2.309; Guan LQM, 2000, PLANT J, V22, P87, DOI 10.1046/j.1365-313x.2000.00723.x; Gutierrez L, 2012, PLANT CELL, V24, P2515, DOI 10.1105/tpc.112.099119; Gutierrez-Coronado MA, 1998, PLANT PHYSIOL BIOCH, V36, P563, DOI 10.1016/S0981-9428(98)80003-X; HammondKosack KE, 1996, PLANT CELL, V8, P1773, DOI 10.1105/tpc.8.10.1773; Janda T, 1999, PLANTA, V208, P175, DOI 10.1007/s004250050547; JARVIS BC, 1981, PHYSIOL PLANTARUM, V53, P213, DOI 10.1111/j.1399-3054.1981.tb04489.x; Jiang MY, 2002, J EXP BOT, V53, P2401, DOI 10.1093/jxb/erf090; Joo JH, 2001, PLANT PHYSIOL, V126, P1055, DOI 10.1104/pp.126.3.1055; Kang SM, 2004, PLANT SCI, V166, P745, DOI 10.1016/j.plantsci.2003.11.022; Karpinski S, 1999, SCIENCE, V284, P654, DOI 10.1126/science.284.5414.654; Khalafalla MM, 2000, PLANT GROWTH REGUL, V32, P59, DOI 10.1023/A:1006305123585; Khan W, 2003, J PLANT PHYSIOL, V160, P485, DOI 10.1078/0176-1617-00865; Khurana JP, 1987, PLANT CELL PHYSL, V24, P907; KLESSIG DF, 1994, PLANT MOL BIOL, V26, P1439, DOI 10.1007/BF00016484; KLING GJ, 1983, HORTSCIENCE, V18, P352; KORDAN HA, 1985, ANN BOT-LONDON, V55, P267, DOI 10.1093/oxfordjournals.aob.a086899; Lanteri ML, 2008, PLANT PHYSIOL, V147, P188, DOI 10.1104/pp.107.111815; Lee S, 1999, PLANT PHYSIOL, V121, P147, DOI 10.1104/pp.121.1.147; LEE TT, 1965, PHYSIOL PLANTARUM, V18, P386, DOI 10.1111/j.1399-3054.1965.tb06902.x; LEON J, 1995, PLANT PHYSIOL, V108, P1673, DOI 10.1104/pp.108.4.1673; LEVINE A, 1994, CELL, V79, P583, DOI 10.1016/0092-8674(94)90544-4; Li Ling, 1995, Journal of Tropical and Subtropical Botany, V3, P67; Li SW, 2010, IN VITRO CELL DEV-PL, V46, P142, DOI 10.1007/s11627-009-9275-x; Li SW, 2009, ENVIRON EXP BOT, V65, P63, DOI 10.1016/j.envexpbot.2008.06.004; Li SW, 2007, PLANT GROWTH REGUL, V52, P173, DOI 10.1007/s10725-007-9188-9; Maldonado AM, 2002, NATURE, V419, P399, DOI 10.1038/nature00962; Mateo A, 2006, J EXP BOT, V57, P1795, DOI 10.1093/jxb/erj196; Mayers CN, 2005, MOL PLANT MICROBE IN, V18, P428, DOI 10.1094/MPMI-18-0428; McDonald MP, 2003, PLANT BIOLOGY, V5, P550, DOI 10.1055/s-2003-44790; MENSUALISODI A, 1995, PLANT GROWTH REGUL, V17, P205, DOI 10.1007/BF00024727; Munne-Bosch S, 2003, PLANTA, V217, P758, DOI 10.1007/s00425-003-1037-0; Munns R, 2005, NEW PHYTOL, V167, P645, DOI 10.1111/j.1469-8137.2005.01487.x; Mutui TM, 2010, PLANT GROWTH REGUL, V61, P185, DOI 10.1007/s10725-010-9464-y; Nag S, 2001, J PLANT GROWTH REGUL, V20, P182, DOI 10.1007/s003440010016; NAKANO Y, 1981, PLANT CELL PHYSIOL, V22, P867; Neill SJ, 2002, J EXP BOT, V53, P1237, DOI 10.1093/jexbot/53.372.1237; Noctor G, 1998, J EXP BOT, V49, P623, DOI 10.1093/jexbot/49.321.623; Orozco-Cardenas M, 1999, P NATL ACAD SCI USA, V96, P6553, DOI 10.1073/pnas.96.11.6553; Orozco-Cardenas ML, 2001, PLANT CELL, V13, P179, DOI 10.1105/tpc.13.1.179; Pagnussat GC, 2004, PLANT PHYSIOL, V135, P279, DOI 10.1104/pp.103.038554; Pagnussat GC, 2003, PLANT PHYSIOL, V132, P1241, DOI 10.1104/pp.103.022228; Pagnussat GC, 2002, PLANT PHYSIOL, V129, P954, DOI 10.1104/pp.004036; Pancheva TV, 1996, J PLANT PHYSIOL, V149, P57, DOI 10.1016/S0176-1617(96)80173-8; Papadakis AK, 1999, PLANT PHYSIOL, V121, P197, DOI 10.1104/pp.121.1.197; Pei ZM, 2000, NATURE, V406, P731, DOI 10.1038/35021067; Potikha TS, 1999, PLANT PHYSIOL, V119, P849, DOI 10.1104/pp.119.3.849; Qiu QS, 2002, P NATL ACAD SCI USA, V99, P8436, DOI 10.1073/pnas.122224699; Ramirez-Carvajal GA, 2009, PLANT PHYSIOL, V150, P759, DOI 10.1104/pp.109.137505; Rao MV, 1997, PLANT PHYSIOL, V115, P137, DOI 10.1104/pp.115.1.137; RASKIN I, 1987, SCIENCE, V237, P1601, DOI 10.1126/science.237.4822.1601; Ren DT, 2002, J BIOL CHEM, V277, P559, DOI 10.1074/jbc.M109495200; RIOV J, 1989, PLANT GROWTH REGUL, V8, P277, DOI 10.1007/BF00025397; RIOV J, 1989, J PLANT GROWTH REGUL, V8, P131, DOI 10.1007/BF02025280; Sebastiani L., 2002, Advances in Horticultural Science, V16, P7; SEGAL AW, 1992, BIOCHEM J, V284, P781, DOI 10.1042/bj2840781; Singh B, 2003, PLANT GROWTH REGUL, V39, P137, DOI 10.1023/A:1022556103536; Singh S. P., 1993, Advances in Horticulture and Forestry, V3, P207; Sorin C, 2005, PLANT CELL, V17, P1343, DOI 10.1105/tpc.105.031625; STILL SM, 1976, J AM SOC HORTIC SCI, V101, P34; Su GX, 2006, J INTEGR PLANT BIOL, V48, P426, DOI 10.1111/j.1744-7909.2006.00236.x; Syros T, 2004, J PLANT PHYSIOL, V161, P69, DOI 10.1078/0176-1617-00938; Tasgin E, 2006, PHYTOCHEMISTRY, V67, P710, DOI 10.1016/j.phytochem.2006.01.022; TAYLOR WR, 1993, PROTEIN SCI, V2, P1675, DOI 10.1002/pro.5560021013; Tewari RK, 2011, J PLANT GROWTH REGUL, V30, P396, DOI 10.1007/s00344-011-9202-3; ThordalChristensen H, 1997, PLANT J, V11, P1187, DOI 10.1046/j.1365-313X.1997.11061187.x; VanGestelen P, 1997, PLANT PHYSIOL, V115, P543, DOI 10.1104/pp.115.2.543; Werner T, 2003, PLANT CELL, V15, P2532, DOI 10.1105/tpc.014928; Werner T, 2001, P NATL ACAD SCI USA, V98, P10487, DOI 10.1073/pnas.171304098; WU GS, 1995, PLANT CELL, V7, P1357, DOI 10.1105/tpc.7.9.1357; Zhang X, 2001, PLANT PHYSIOL, V126, P1438, DOI 10.1104/pp.126.4.1438; Zhang Y, 2003, ACTA BOT SIN, V45, P1447	105	45	45	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e84580	10.1371/journal.pone.0084580	http://dx.doi.org/10.1371/journal.pone.0084580			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281RE	24386397	Green Published, gold, Green Submitted			2022-12-25	WOS:000329117900102
J	Isari, S; Anto, M; Saiz, E				Isari, Stamatina; Anto, Meritxell; Saiz, Enric			Copepod Foraging on the Basis of Food Nutritional Quality: Can Copepods Really Choose?	PLOS ONE			English	Article							MARINE PLANKTONIC COPEPOD; FRESH-WATER; NUTRIENT LIMITATION; FEEDING-BEHAVIOR; PHOSPHORUS STARVATION; CALANUS-FINMARCHICUS; PARACALANUS-PARVUS; SEASONAL-VARIATION; ACARTIA-HUDSONICA; NUCLEIC-ACID	Copepods have been considered capable of selective feeding based on several factors (i.e., prey size, toxicity, and motility). However, their selective feeding behaviour as a function of food quality remains poorly understood, despite the potential impact of such a process on copepod fitness and trophodynamics. In this study, we aimed to evaluate the ability of copepods to feed selectively according to the nutritional value of the prey. We investigated the feeding performance of the calanoid copepod Acartia grani under nutritionally distinct diets of the dinoflagellate Heterocapsa sp. (nutrient-replete, N-depleted and P-depleted) using unialgal suspensions and mixtures of prey (nutrient-replete vs. nutrient-depleted). Despite the distinct cell elemental composition among algal treatments (e. g., C:N:P molar ratios) and the clear dietary impact on egg production rates (generally higher number of eggs under a nutrient-replete diet), no impact on copepod feeding rates was observed. All unialgal suspensions were cleared at similar rates, and this pattern was independent of food concentration. When the prey were offered as mixtures, we did not detect selective behaviour in either the N-limitation (nutrient-replete vs. N-depleted Heterocapsa cells) or P-limitation (nutrient-replete vs. P-depleted Heterocapsa cells) experiments. The lack of selectivity observed in the current study contrasts with previous observations, in which stronger nutritional differences were tested. Under normal natural circumstances, nutritional differences in natural prey assemblages might not be sufficiently strong to trigger a selective response in copepods based on that factor alone. In addition, our results suggest that nutritional quality might depend not only on the growing conditions but also on the inherent taxonomical properties of the prey.	[Isari, Stamatina; Anto, Meritxell; Saiz, Enric] CSIC, Inst Ciencies Mar, Dept Biol Marina & Oceanog, Barcelona, Catalunya, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Mediterraneo de Investigaciones Marinas y Ambientales (CMIMA); CSIC - Instituto de Ciencias del Mar (ICM)	Isari, S (corresponding author), CSIC, Inst Ciencies Mar, Dept Biol Marina & Oceanog, Barcelona, Catalunya, Spain.	misari@icm.csic.es	Isari, Stamatina/J-6987-2014; Saiz, Enric/K-4263-2014	Isari, Stamatina/0000-0003-3457-0274; Saiz, Enric/0000-0003-2611-0067	project CROA [LS8-1893]; European Social Fund (ESF); Greek State; Spanish Ministry of Economy and Competitiveness [CTM2011-23480]	project CROA; European Social Fund (ESF)(European Social Fund (ESF)); Greek State; Spanish Ministry of Economy and Competitiveness(Spanish Government)	This work was supported by the project CROA (LS8-1893), implemented within the framework of the Action "Supporting Postdoctoral Researchers" of the Operational Program "Education and Lifelong Learning" (Action's Beneficiary: General Secretariat for Research and Technology), and is co-financed by the European Social Fund (ESF) and the Greek State. M. A and E. S were funded by the project CTM2011-23480 from the Spanish Ministry of Economy and Competitiveness. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson TR, 2000, LIMNOL OCEANOGR, V45, P1162, DOI 10.4319/lo.2000.45.5.1162; ANDREWS JC, 1983, CAN J FISH AQUAT SCI, V40, P1293, DOI 10.1139/f83-147; Augustin CB, 2006, J PLANKTON RES, V28, P429, DOI 10.1093/plankt/fbi131; Barofsky A, 2010, J PLANKTON RES, V32, P263, DOI 10.1093/plankt/fbp121; Benitez-Nelson CR, 2000, EARTH-SCI REV, V51, P109, DOI 10.1016/S0012-8252(00)00018-0; BERDALET E, 1994, J PLANKTON RES, V16, P303, DOI 10.1093/plankt/16.4.303; BERDALET E, 1992, HYDROBIOLOGIA, V238, P139, DOI 10.1007/BF00048782; Breteler WCMK, 2005, MAR ECOL PROG SER, V291, P125; Broglio E, 2001, MAR ECOL PROG SER, V220, P179, DOI 10.3354/meps220179; BUTLER NM, 1989, OECOLOGIA, V78, P368, DOI 10.1007/BF00379111; CHESSON J, 1983, ECOLOGY, V64, P1297, DOI 10.2307/1937838; Colin SP, 2003, MAR ECOL PROG SER, V248, P55, DOI 10.3354/meps248055; COWLES TJ, 1988, MAR BIOL, V100, P41, DOI 10.1007/BF00392953; DEMOTT WR, 1986, OECOLOGIA, V69, P334, DOI 10.1007/BF00377053; DEMOTT WR, 1989, LIMNOL OCEANOGR, V34, P140, DOI 10.4319/lo.1989.34.1.0140; DEMOTT WR, 1988, LIMNOL OCEANOGR, V33, P397, DOI 10.4319/lo.1988.33.3.0397; DEMOTT WR, 1995, OECOLOGIA, V103, P230, DOI 10.1007/BF00329085; DONAGHAY PL, 1979, MAR BIOL, V52, P137, DOI 10.1007/BF00390421; Dutz J, 2008, LIMNOL OCEANOGR, V53, P225, DOI 10.4319/lo.2008.53.1.0225; Elser JJ, 2007, ECOL LETT, V10, P1135, DOI 10.1111/j.1461-0248.2007.01113.x; Elser JJ, 2001, ECOLOGY, V82, P898, DOI 10.1890/0012-9658(2001)082[0898:NLRFQF]2.0.CO;2; FRIEDMAN MM, 1975, P NATL ACAD SCI USA, V72, P4185, DOI 10.1073/pnas.72.10.4185; Frigstad H, 2011, BIOGEOSCIENCES, V8, P2917, DOI 10.5194/bg-8-2917-2011; FROST BW, 1972, LIMNOL OCEANOGR, V17, P805, DOI 10.4319/lo.1972.17.6.0805; Geider RJ, 2002, EUR J PHYCOL, V37, P1, DOI 10.1017/S0967026201003456; GILL CW, 1988, MAR ECOL PROG SER, V43, P269, DOI 10.3354/meps043269; Grasshoff K, 1999, METHODS SEAWATER ANA; Guillard R.R.L., 1975, CULTURE MARINE INVER, P29, DOI [10.1007/978-1-4615-8714-9_3, DOI 10.1007/978-1-4615-8714-9_3]; Henriksen CI, 2007, MAR ECOL PROG SER, V331, P119, DOI 10.3354/meps331119; Hessen DO, 2002, ECOLOGY, V83, P1886, DOI 10.2307/3071772; HOUDE SEL, 1987, MAR ECOL PROG SER, V40, P69, DOI 10.3354/meps040069; HUNTLEY M, 1986, MAR ECOL PROG SER, V28, P105, DOI 10.3354/meps028105; HUNTLEY ME, 1983, MAR BIOL, V74, P151, DOI 10.1007/BF00413918; JONASDOTTIR SH, 1994, MAR BIOL, V121, P67, DOI 10.1007/BF00349475; Jones RH, 2005, SCIENCE, V307, P1457, DOI 10.1126/science.1107767; Jones RH, 2002, MAR ECOL PROG SER, V235, P147, DOI 10.3354/meps235147; Kiorboe T, 1999, MAR ECOL PROG SER, V179, P81, DOI 10.3354/meps179081; KIORBOE T, 1989, MAR ECOL PROG SER, V55, P229, DOI 10.3354/meps055229; KLEPPEL GS, 1993, MAR ECOL PROG SER, V99, P183, DOI 10.3354/meps099183; Koski M, 1998, MAR ECOL PROG SER, V170, P169, DOI 10.3354/meps170169; Kuijper LDJ, 2004, J PLANKTON RES, V26, P213, DOI 10.1093/plankt/fbh020; LATASA M, 1994, J PLANKTON RES, V16, P83, DOI 10.1093/plankt/16.1.83; Meyer B, 2002, HELGOLAND MAR RES, V56, P169, DOI 10.1007/s10152-002-0105-3; Meyer-Harms B, 1999, LIMNOL OCEANOGR, V44, P154, DOI 10.4319/lo.1999.44.1.0154; Moore PA, 1999, LIMNOL OCEANOGR, V44, P166, DOI 10.4319/lo.1999.44.1.0166; MULLIN MM, 1963, LIMNOL OCEANOGR, V8, P239, DOI 10.4319/lo.1963.8.2.0239; PAFFENHOFER GA, 1990, J PLANKTON RES, V12, P933, DOI 10.1093/plankt/12.5.933; PAFFENHOFER GA, 1988, B MAR SCI, V43, P430; PAFFENHOFER GA, 1985, MAR ECOL PROG SER, V27, P55, DOI 10.3354/meps027055; POULET SA, 1978, SCIENCE, V200, P1403, DOI 10.1126/science.200.4348.1403; Price H.J., 1985, Advances in Limnology, V21, P115; PRICE HJ, 1988, B MAR SCI, V43, P327; ROMAN MR, 1984, LIMNOL OCEANOGR, V29, P949, DOI 10.4319/lo.1984.29.5.0949; Saba GK, 2009, MAR ECOL PROG SER, V386, P147, DOI 10.3354/meps08070; Saiz E, 2011, HYDROBIOLOGIA, V666, P181, DOI 10.1007/s10750-010-0421-6; Schultz M, 2009, J PLANKTON RES, V31, P553, DOI 10.1093/plankt/fbp010; Siuda ANS, 2010, LIMNOL OCEANOGR, V55, P2107, DOI 10.4319/lo.2010.55.5.2107; Sterner R.W, 2002, ECOLOGICAL STOICHIOM, DOI DOI 10.1086/382444; STERNER RW, 1994, ANNU REV ECOL SYST, V25, P1, DOI 10.1146/annurev.es.25.110194.000245; Svensen C, 2000, J PLANKTON RES, V22, P1155, DOI 10.1093/plankt/22.6.1155; Tang KW, 1999, OIKOS, V84, P537, DOI 10.2307/3546434; Teegarden GJ, 1999, MAR ECOL PROG SER, V181, P163, DOI 10.3354/meps181163; Thingstad TF, 2005, SCIENCE, V309, P1068, DOI 10.1126/science.1112632; Tiselius P, 2013, LIMNOL OCEANOGR, V58, P1657, DOI 10.4319/lo.2013.58.5.1657; TURRIFF N, 1995, MAR BIOL, V123, P55, DOI 10.1007/BF00350323; URABE J, 1992, LIMNOL OCEANOGR, V37, P244, DOI 10.4319/lo.1992.37.2.0244; UYE S, 1990, MAR ECOL PROG SER, V59, P97, DOI 10.3354/meps059097; Vanderploeg Henry A., 1994, P205; Walve J, 1999, J PLANKTON RES, V21, P2309, DOI 10.1093/plankt/21.12.2309; Yen J., 1992, Advances in Limnology, V36, P123	70	44	44	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e84742	10.1371/journal.pone.0084742	http://dx.doi.org/10.1371/journal.pone.0084742			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281QS	24386411	Green Published, Green Submitted, gold			2022-12-25	WOS:000329116700117
J	Nicklas, D; Saiz, L				Nicklas, Daniel; Saiz, Leonor			Characterization of Negative Feedback Network Motifs in the TGF-beta Signaling Pathway	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; ROBUSTNESS ANALYSIS; RECEPTOR; SMAD7; PHOSPHORYLATION; DETERMINANTS; MUTATIONS; DYNAMICS; CELLS	{Chung, 2009 #1} The transforming growth factor-beta (TGF-beta) superfamily of cytokines plays a fundamental role in a wide variety of cellular processes, including growth, differentiation, apoptosis, and tissue homeostasis. Its relevance is emphasized by the mutations of its core components that are associated with diverse human diseases, such as cancer and cardiovascular pathologies. A prominent regulator of the pathway is Smad7, which attenuates the signal and controls its duration in a cell-type-dependent manner through a negative feedback loop. Here, we characterize all the potential Smad7-mediated negative feedback network motifs and investigate their effects on the signaling dynamics upon stimulation with TGF-b and bone morphogenetic protein (BMP) ligands. The results show that the specific negative feedback implementation is a key determinant of both the response of the system to single and multiple ligands of the TGF-b superfamily and its robustness and sensitivity to parameter perturbations.	[Nicklas, Daniel; Saiz, Leonor] Univ Calif Davis, Dept Biomed Engn, Modeling Biol Networks Lab, Davis, CA 95616 USA	University of California System; University of California Davis	Saiz, L (corresponding author), Univ Calif Davis, Dept Biomed Engn, Modeling Biol Networks Lab, Davis, CA 95616 USA.	lsaiz@ucdavis.edu	Saiz, Leonor/I-3557-2015	Saiz, Leonor/0000-0002-6866-9400	University of California, Davis	University of California, Davis(University of California System)	This work was supported by the University of California, Davis (to LS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alon U, 1999, NATURE, V397, P168, DOI 10.1038/16483; Barkai N, 1997, NATURE, V387, P913, DOI 10.1038/43199; Bluthgen N, 2003, J THEOR BIOL, V225, P293, DOI 10.1016/S0022-5193(03)00247-9; Bode HW, 1945, NETWORK ANAL FEEDBAC, V2, p[iii, 1]; Celliere G, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-184; Chen C, 2007, FEBS LETT, V581, P5143, DOI 10.1016/j.febslet.2007.09.063; Chen YG, 1998, GENE DEV, V12, P2144, DOI 10.1101/gad.12.14.2144; Chung SW, 2009, BIOPHYS J, V96, P1733, DOI 10.1016/j.bpj.2008.11.050; Clarke DC, 2006, IEE P SYST BIOL, V153, P412, DOI 10.1049/ip-syb:20050055; Daly AC, 2008, MOL CELL BIOL, V28, P6889, DOI 10.1128/MCB.01192-08; Derynck R, 2008, TGF BETA FAMILY, Vxiv; Ebisawa T, 2001, J BIOL CHEM, V276, P12477, DOI 10.1074/jbc.C100008200; Edlund S, 2005, MOL CELL BIOL, V25, P1475, DOI 10.1128/MCB.25.4.1475-1488.2005; Funahashi Akira, 2003, Biosilico, V1, P159, DOI 10.1016/S1478-5382(03)02370-9; Goto K, 2007, J BIOL CHEM, V282, P20603, DOI 10.1074/jbc.M702100200; Hata A, 1998, GENE DEV, V12, P186, DOI 10.1101/gad.12.2.186; Hata A, 1997, NATURE, V388, P82, DOI 10.1038/40424; Heinrich R, 2002, MOL CELL, V9, P957, DOI 10.1016/S1097-2765(02)00528-2; Hindmarsh AC, 2005, ACM T MATH SOFTWARE, V31, P363, DOI 10.1145/1089014.1089020; Ho J, 2011, BIOPHYS J, V100, P164; Hucka M, 2003, BIOINFORMATICS, V19, P524, DOI 10.1093/bioinformatics/btg015; Inman GJ, 2002, MOL CELL, V10, P283, DOI 10.1016/S1097-2765(02)00585-3; Jones E., 2001, SCIPY OPEN SOURCE SC; Kavsak P, 2000, MOL CELL, V6, P1365, DOI 10.1016/S1097-2765(00)00134-9; Kitano H, 2004, NAT REV GENET, V5, P826, DOI 10.1038/nrg1471; Kitano H, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100179; Kucherenko S, 2009, RELIAB ENG SYST SAFE, V94, P1135, DOI 10.1016/j.ress.2008.05.006; Levy L, 2006, CYTOKINE GROWTH F R, V17, P41, DOI 10.1016/j.cytogfr.2005.09.009; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Melke P, 2006, BIOPHYS J, V91, P4368, DOI [10.1529/biophysj.105.080408, 10.1529/biophysj.106.080408]; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Moren A, 2000, ONCOGENE, V19, P4396, DOI 10.1038/sj.onc.1203798; Moustakas A, 2009, DEVELOPMENT, V136, P3699, DOI 10.1242/dev.030338; Nakao A, 1997, NATURE, V389, P631, DOI 10.1038/39369; Nicklas D, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0363; Nicolas FJ, 2003, ONCOGENE, V22, P3698, DOI 10.1038/sj.onc.1206420; Paulsen M, 2011, P NATL ACAD SCI USA, V108, P10202, DOI 10.1073/pnas.1100179108; Press WH, 2007, NUMERICAL RECIPES AR, pxxi; Schmierer B, 2008, P NATL ACAD SCI USA, V105, P6608, DOI 10.1073/pnas.0710134105; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; ten Dijke P, 2007, NAT REV MOL CELL BIO, V8, P857, DOI 10.1038/nrm2262; Valdimarsdottir G, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-16; Varma A, 1999, PARAMETRIC SENSITIVI, Vxvi; Vilar JMG, 2006, PLOS COMPUT BIOL, V2, P36, DOI 10.1371/journal.pcbi.0020003; Vilar JMG, 2011, BIOPHYS J, V101, P2315, DOI 10.1016/j.bpj.2011.09.035; Wegner K, 2012, BIOPHYS CHEM, V162, P22, DOI 10.1016/j.bpc.2011.12.003; Wrighton KH, 2009, J BIOL CHEM, V284, P9755, DOI 10.1074/jbc.M809223200; Zi Z, 2011, IET SYST BIOL, V5, P336, DOI 10.1049/iet-syb.2011.0015; Zi ZK, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000936; Zi ZK, 2012, FEBS LETT, V586, P1921, DOI 10.1016/j.febslet.2012.03.063; Zi ZK, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.22; Zi ZK, 2005, J COMPUT SCI TECH-CH, V20, P491, DOI 10.1007/s11390-005-0491-5; Zou XF, 2008, BIOSYSTEMS, V91, P245, DOI 10.1016/j.biosystems.2007.10.001	54	11	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e83531	10.1371/journal.pone.0083531	http://dx.doi.org/10.1371/journal.pone.0083531			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276IX	24386222	Green Published, Green Submitted, gold			2022-12-25	WOS:000328745100124
J	Delwig, A; Majumdar, S; Ahern, K; LaVail, MM; Edwards, R; Hnasko, TS; Copenhagen, DR				Delwig, Anton; Majumdar, Sriparna; Ahern, Kelly; LaVail, Matthew M.; Edwards, Robert; Hnasko, Thomas S.; Copenhagen, David R.			Glutamatergic Neurotransmission from Melanopsin Retinal Ganglion Cells Is Required for Neonatal Photoaversion but Not Adult Pupillary Light Reflex	PLOS ONE			English	Article							RAT RETINA; PACAP; EXPRESSION; MICE; REFINEMENT; RESPONSES; NEURONS; PATHWAY; VGLUT2	Melanopsin-expressing retinal ganglion cells (mRGCs) in the eye play an important role in many light-activated non-image-forming functions including neonatal photoaversion and the adult pupillary light reflex (PLR). MRGCs rely on glutamate and possibly PACAP (pituitary adenylate cyclase-activating polypeptide) to relay visual signals to the brain. However, the role of these neurotransmitters for individual non-image-forming responses remains poorly understood. To clarify the role of glutamatergic signaling from mRGCs in neonatal aversion to light and in adult PLR, we conditionally deleted vesicular glutamate transporter (VGLUT2) selectively from mRGCs in mice. We found that deletion of VGLUT2 in mRGCs abolished negative phototaxis and light-induced distress vocalizations in neonatal mice, underscoring a necessary role for glutamatergic signaling. In adult mice, loss of VGLUT2 in mRGCs resulted in a slow and an incomplete PLR. We conclude that glutamatergic neurotransmission from mRGCs is required for neonatal photoaversion but is complemented by another non-glutamatergic signaling mechanism for the pupillary light reflex in adult mice. We speculate that this complementary signaling might be due to PACAP neurotransmission from mRGCs.	[Delwig, Anton; Majumdar, Sriparna; LaVail, Matthew M.; Copenhagen, David R.] Univ Calif San Francisco, Dept Ophthalmol, San Francisco, CA 94143 USA; [Ahern, Kelly; LaVail, Matthew M.] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; [Edwards, Robert; Copenhagen, David R.] Univ Calif San Francisco, Dept Physiol, San Francisco, CA USA; [Edwards, Robert; Hnasko, Thomas S.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA USA; [Hnasko, Thomas S.] Univ Calif San Diego, Dept Neurosci, San Diego, CA 92103 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Diego	Copenhagen, DR (corresponding author), Univ Calif San Francisco, Dept Ophthalmol, San Francisco, CA 94143 USA.	cope@phy.ucsf.edu		Hnasko, Thomas/0000-0001-6176-8513	National Institutes of Health (NIH) [EY01869, P30 EY002162]; Knights Templar Eye Foundation; That Man May See, UCSF/Research to Prevent Blindness (Department of Ophthalmology, UCSF); NATIONAL EYE INSTITUTE [R01EY001869, R37EY001869, P30EY002162] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K01DA026504] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Knights Templar Eye Foundation; That Man May See, UCSF/Research to Prevent Blindness (Department of Ophthalmology, UCSF); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Funding from National Institutes of Health (NIH) EY01869 (DRC); NIH P30 EY002162 (Core Grant); Knights Templar Eye Foundation (AD), http://www.knightstemplar.org/ktef/; That Man May See, UCSF (DRC) http://thatmanmaysee.org/Research to Prevent Blindness (DRC, Department of Ophthalmology, UCSF) https://www.rpbusa.org/rpb/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benezeth Y, 2008, REV EVALUATION COMMO, P1; Delwig A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043787; Douglas RM, 2005, VISUAL NEUROSCI, V22, P677, DOI 10.1017/S0952523805225166; Ecker JL, 2010, NEURON, V67, P49, DOI 10.1016/j.neuron.2010.05.023; Engelund A, 2012, BRAIN RES, V1453, P17, DOI 10.1016/j.brainres.2012.03.005; Engelund A, 2010, CELL TISSUE RES, V340, P243, DOI 10.1007/s00441-010-0950-3; Fahrenkrug J, 2004, NEUROREPORT, V15, P781, DOI 10.1097/00001756-200404090-00008; Fremeau RT, 2004, TRENDS NEUROSCI, V27, P98, DOI 10.1016/j.tins.2003.11.005; Fyk-Kolodziej B, 2004, J COMP NEUROL, V475, P518, DOI 10.1002/cne.20199; Hannibal J, 2004, CELL TISSUE RES, V316, P99, DOI 10.1007/s00441-004-0858-x; Hannibal J, 2002, CELL TISSUE RES, V309, P73, DOI 10.1007/s00441-002-0574-3; Hatori M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002451; Hnasko TS, 2010, NEURON, V65, P643, DOI 10.1016/j.neuron.2010.02.012; Johnson J, 2004, J COMP NEUROL, V477, P386, DOI 10.1002/cne.20250; Johnson J, 2007, J NEUROSCI, V27, P7245, DOI 10.1523/JNEUROSCI.0815-07.2007; Johnson J, 2010, P NATL ACAD SCI USA, V107, P17374, DOI 10.1073/pnas.1008533107; Kawaguchi C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009286; Koch SM, 2011, NEURON, V71, P235, DOI 10.1016/j.neuron.2011.05.045; McNeill DS, 2011, NEURAL DEV, V6, DOI 10.1186/1749-8104-6-8; Olianas MC, 1997, J NEUROCHEM, V69, P1213; Renteria RC, 2006, J NEUROSCI, V26, P11857, DOI 10.1523/JNEUROSCI.1718-06.2006; Scherrer G, 2010, P NATL ACAD SCI USA, V107, P22296, DOI 10.1073/pnas.1013413108; Schmidt-Supprian M, 2007, NAT IMMUNOL, V8, P665, DOI 10.1038/ni0707-665; Stella SL, 2008, BRAIN RES, V1215, P20, DOI 10.1016/j.brainres.2008.03.038; Tian N, 2003, NEURON, V39, P85, DOI 10.1016/S0896-6273(03)00389-1; Zagorodnyuk V, 1996, BRIT J PHARMACOL, V119, P779, DOI 10.1111/j.1476-5381.1996.tb15740.x	26	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83974	10.1371/journal.pone.0083974	http://dx.doi.org/10.1371/journal.pone.0083974			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391855	Green Published, Green Submitted, gold			2022-12-25	WOS:000329325200153
J	Gu, S; Cheung, HH; Lee, TL; Lu, G; Poon, WS; Chan, WY				Gu, Shen; Cheung, Hoi Hung; Lee, Tin Lap; Lu, Gang; Poon, Wai Sang; Chan, Wai Yee			Molecular Mechanisms of Regulation and Action of microRNA-199a in Testicular Germ Cell Tumor and Glioblastomas	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; CANCER CELLS; EXPRESSION; GENES; METHYLATION; RNAS; IDENTIFICATION; PROLIFERATION; MIR-199A; REVEALS	MicroRNA-199a (miRNA-199a) has been shown to have comprehensive functions and behave differently in different systems and diseases. It is encoded by two loci in the human genome, miR-199a-1 in chromosome 19 and miR-199a-2 in chromosome 1. Both loci give rise to the same miRNAs (miR-199a-5p and miR-199a-3p). The cause of the diverse action of the miRNA in different systems is not clear. However, it is likely due to different regulation of the two genomic loci and variable targets of the miRNA in different cells and tissues. Here we studied promoter methylation of miR-199a in testicular germ cell tumors (TGCTs) and glioblastomas (gliomas) and discovered that hypermethylation in TGCTs of both miR-199a-1 and -2 resulted in its reduced expression, while hypomethylation of miR-199a-2 but not -1 in gliomas may be related to its elevated expression. We also identified a common regulator, REST, which preferentially bound to the methylated promoters of both miR-199a-1 and miR-199a-2. The action of miR-199a is dependent on its downstream targets. We identified MAFB as a putative target of miRNA-199a-5p in TGCTs and confirmed that the tumor suppression activity of the microRNA is mediated by its target MAFB. By studying the mechanisms that control the expressions of miR-199a and its various downstream targets, we hope to use miR-199a as a model to understand the complexity of miRNA biology.	[Gu, Shen; Lee, Tin Lap; Lu, Gang; Chan, Wai Yee] Chinese Univ Hong Kong, Sch Biomed Sci, Hong Kong, Hong Kong, Peoples R China; [Cheung, Hoi Hung] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Sect Clin & Dev Genom, NIH, Bethesda, MD USA; [Lu, Gang; Poon, Wai Sang] Chinese Univ Hong Kong, Dept Surg, Hong Kong, Hong Kong, Peoples R China	Chinese University of Hong Kong; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Chinese University of Hong Kong	Chan, WY (corresponding author), Chinese Univ Hong Kong, Sch Biomed Sci, Hong Kong, Hong Kong, Peoples R China.	chanwy@cuhk.edu.hk	Poon, Wai Sang/F-1558-2011; Cheung, Hoi-Hung/AAE-2670-2020; Poon, Wai S/HGD-3084-2022; Lee, Tin-Lap/A-7853-2009; Chan, Wai Yee/R-7442-2018; Gu, Shen/AAE-2641-2020; Lee, Tin-Lap/W-6595-2019	Cheung, Hoi-Hung/0000-0001-7178-9289; Lee, Tin-Lap/0000-0002-6654-0988; Chan, Wai Yee/0000-0002-9714-0936; Gu, Shen/0000-0003-3107-1218; Lee, Tin-Lap/0000-0002-6654-0988; LU, Gang/0000-0001-5921-1839	Chinese University of Hong Kong; Vigconic International project fund; RGC GRF [475910]	Chinese University of Hong Kong(Chinese University of Hong Kong); Vigconic International project fund; RGC GRF(Hong Kong Research Grants Council)	This study is partially supported by the start-up fund provided to WYC by the Chinese University of Hong Kong, the Vigconic International project fund, and RGC GRF No: 475910. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballas N, 2005, CURR OPIN NEUROBIOL, V15, P500, DOI 10.1016/j.conb.2005.08.015; Cardenas CLL, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003291; Carr IM, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm330; Chendrimada TP, 2005, NATURE, V436, P740, DOI 10.1038/nature03868; Cheung HH, 2010, BRIT J CANCER, V102, P419, DOI 10.1038/sj.bjc.6605505; Cheung HH, 2011, ONCOGENE, V30, P3404, DOI 10.1038/onc.2011.60; Fang C, 2013, J CELL BIOCHEM, V114, P1457, DOI 10.1002/jcb.24487; Favreau AJ, 2012, AM J HEMATOL, V87, P442, DOI 10.1002/ajh.23129; Fornari F, 2010, CANCER RES, V70, P5184, DOI 10.1158/0008-5472.CAN-10-0145; Gu S, 2012, INT J MOL SCI, V13, P8449, DOI 10.3390/ijms13078449; Hou J, 2011, CANCER CELL, V19, P232, DOI 10.1016/j.ccr.2011.01.001; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Kim S, 2008, J BIOL CHEM, V283, P18158, DOI 10.1074/jbc.M800186200; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Lagos-Quintana M, 2003, RNA, V9, P175, DOI 10.1261/rna.2146903; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lauvrak SU, 2013, BR J CANC; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lee YB, 2009, NUCLEIC ACIDS RES, V37, P123, DOI 10.1093/nar/gkn920; Lim LP, 2003, SCIENCE, V299, P1540, DOI 10.1126/science.1080372; Magrelli A, 2009, TRANSL ONCOL, V2, P157, DOI 10.1593/tlo.09124; Mudduluru G, 2011, ONCOGENE, V30, P2888, DOI 10.1038/onc.2011.13; Nam EJ, 2008, CLIN CANCER RES, V14, P2690, DOI 10.1158/1078-0432.CCR-07-1731; Ogawa T, 2012, GUT, V61, P1600, DOI 10.1136/gutjnl-2011-300717; Pencheva N, 2012, CELL, V151, P1068, DOI 10.1016/j.cell.2012.10.028; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Sakurai K, 2011, CANCER RES, V71, P1680, DOI 10.1158/0008-5472.CAN-10-2345; Sayed D, 2010, CELL CYCLE, V9, P3213, DOI 10.4161/cc.9.16.12634; Sieweke MH, 1996, CELL, V85, P49, DOI 10.1016/S0092-8674(00)81081-8; Sieweke Michael H., 1997, Leukemia (Basingstoke), V11, P486; Singal R, 1997, P NATL ACAD SCI USA, V94, P13724, DOI 10.1073/pnas.94.25.13724; Tsukigi M, 2012, CANCER LETT, V315, P189, DOI 10.1016/j.canlet.2011.10.008; Ueda T, 2010, LANCET ONCOL, V11, P136, DOI 10.1016/S1470-2045(09)70343-2; Vicente-Duenas C, 2012, CELL CYCLE, V11, P3715, DOI 10.4161/cc.22178; Wang CX, 2011, J GASTROEN HEPATOL, V26, P1630, DOI 10.1111/j.1440-1746.2011.06758.x; Wang FJ, 2010, GYNECOL ONCOL, V119, P586, DOI 10.1016/j.ygyno.2010.07.021; Won KY, 2013, HUM PATHOL, V44, P1648, DOI 10.1016/j.humpath.2013.01.016; Yin G, 2010, ONCOGENE, V29, P3545, DOI 10.1038/onc.2010.111	40	89	93	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83980	10.1371/journal.pone.0083980	http://dx.doi.org/10.1371/journal.pone.0083980			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391856	Green Published, gold, Green Submitted			2022-12-25	WOS:000329325200154
J	Fan, YF; Fan, YB; Li, ZY; Newman, T; Lv, CS; Zhou, Y				Fan, Yifang; Fan, Yubo; Li, Zhiyu; Newman, Tony; Lv, Changsheng; Zhou, Yi			Screening Method Based on Walking Plantar Impulse for Detecting Musculoskeletal Senescence and Injury	PLOS ONE			English	Article							ELDERLY-PEOPLE; SPEED; FOOT; PREVENTION; MUSCLE	No consensus has been reached on how musculoskeletal system injuries or aging can be explained by a walking plantar impulse. We standardize the plantar impulse by defining a principal axis of plantar impulse. Based upon this standardized plantar impulse, two indexes are presented: plantar pressure record time series and plantar-impulse distribution along the principal axis of plantar impulse. These indexes are applied to analyze the plantar impulse collected by plantar pressure plates from three sources: Achilles tendon ruptures; elderly people (ages 62-71); and young people (ages 19-23). Our findings reveal that plantar impulse distribution curves for Achilles tendon ruptures change irregularly with subjects' walking speed changes. When comparing distribution curves of the young, we see a significant difference in the elderly subjects' phalanges plantar pressure record time series. This verifies our hypothesis that a plantar impulse can function as a means to assess and evaluate musculoskeletal system injuries and aging.	[Fan, Yifang; Lv, Changsheng; Zhou, Yi] Guangzhou Inst Phys Educ, Ctr Sci Res, Guangzhou, Guangdong, Peoples R China; [Fan, Yubo] Beihang Univ, Sch Biol Sci & Med Engn, Key Lab Biomech & Mechanobiol, Minist Educ, Beijing, Peoples R China; [Li, Zhiyu; Newman, Tony] Jinan Univ, Coll Foreign Studies, Guangzhou, Guangdong, Peoples R China	Guangzhou Sport University; Beihang University; Jinan University	Fan, YF (corresponding author), Guangzhou Inst Phys Educ, Ctr Sci Res, Guangzhou, Guangdong, Peoples R China.	tfyf@gipe.edu.cn; yubofan@buaa.edu.cn	Fan, Yifang/V-6281-2019	Fan, Yifang/0000-0001-5338-9847	National Natural Science Foundation of China [10925208, 10972061, 11172073]; Guangdong Natural Science Foundation [S2011010001829]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Natural Science Foundation(National Natural Science Foundation of Guangdong Province)	This project was funded by National Natural Science Foundation of China under the Grant Numbers 10925208, 10972061, 11172073 and by Guangdong Natural Science Foundation under the grant number S2011010001829. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe S, 2008, EPL-EUROPHYS LETT, V84, DOI 10.1209/0295-5075/84/60006; ALEXANDER RM, 1976, NATURE, V261, P129, DOI 10.1038/261129a0; ANDRIACCHI TP, 1977, J BIOMECH, V10, P261, DOI 10.1016/0021-9290(77)90049-5; BENDALL MJ, 1989, AGE AGEING, V18, P327, DOI 10.1093/ageing/18.5.327; Bennett MR, 2009, SCIENCE, V323, P1197, DOI 10.1126/science.1168132; Bischoff-Ferrari HA, 2004, AM J CLIN NUTR, V80, P752; Bus SA, 2009, GAIT POSTURE, V29, P618, DOI 10.1016/j.gaitpost.2009.01.003; Dangour AD, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001023; Don R, 2007, CLIN BIOMECH, V22, P211, DOI 10.1016/j.clinbiomech.2006.10.001; Everitt B. S., 2006, CAMBRIDGE DICT STAT; Fan YF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032926; Flaherty JH, 2007, J AM GERIATR SOC, V55, P1295, DOI 10.1111/j.1532-5415.2007.01273.x; Giacomozzi C, 1997, IEEE Trans Rehabil Eng, V5, P322, DOI 10.1109/86.650285; Kang HG, 2008, GAIT POSTURE, V27, P572, DOI 10.1016/j.gaitpost.2007.07.009; Kannus P, 2005, LANCET, V366, P1885, DOI 10.1016/S0140-6736(05)67604-0; Keijsers NLW, 2010, GAIT POSTURE, V31, P140, DOI 10.1016/j.gaitpost.2009.08.248; Keijsers NLW, 2009, J BIOMECH, V42, P87, DOI 10.1016/j.jbiomech.2008.09.038; Leeden MVD, 2006, RHEUMATOLOGY, V45, P465; Lim BO, 2009, AM J SPORT MED, V37, P1728, DOI 10.1177/0363546509334220; Najafi B, 2010, GAIT POSTURE, V31, P87, DOI 10.1016/j.gaitpost.2009.09.003; Olshansky SJ, 2009, MILBANK Q, V87, P842, DOI 10.1111/j.1468-0009.2009.00581.x; Orlin MN, 2000, PHYS THER, V80, P399, DOI 10.1093/ptj/80.4.399; Pandy MG, 2010, ANNU REV BIOMED ENG, V12, P401, DOI 10.1146/annurev-bioeng-070909-105259; Pfeiffer M, 2006, PEDIATRICS, V118, P634, DOI 10.1542/peds.2005-2126; Riener R, 2002, GAIT POSTURE, V15, P32, DOI 10.1016/S0966-6362(01)00162-X; Stanaway FF, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d7679; Titianova EB, 2004, J ELECTROMYOGR KINES, V14, P275, DOI 10.1016/S1050-6411(03)00077-4; van Zee E. H., 1997, J LEARN SCI, V6, P229, DOI 10. 1207/s15327809jls0602_3; Vaughan Christopher L., 1999, DYNAMICS HUMAN GAIT; Verhagen EALM, 2010, SPORTS MED, V40, P899, DOI 10.2165/11536890-000000000-00000; Wrobel James S, 2010, J Diabetes Sci Technol, V4, P833; Zeni JA, 2009, CLIN BIOMECH, V24, P372, DOI 10.1016/j.clinbiomech.2009.02.001	32	1	1	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e83839	10.1371/journal.pone.0083839	http://dx.doi.org/10.1371/journal.pone.0083839			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386288	gold, Green Published, Green Submitted			2022-12-25	WOS:000329194700072
J	Yang, MH; Yu, J; Chen, N; Wang, XY; Liu, XY; Wang, S; Ding, YQ				Yang, Min-Hui; Yu, Jiang; Chen, Na; Wang, Xiao-Yan; Liu, Xiang-Yu; Wang, Shuang; Ding, Yan-Qing			Elevated MicroRNA-31 Expression Regulates Colorectal Cancer Progression by Repressing Its Target Gene SATB2	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; ONCOGENIC MICRORNA; POOR-PROGNOSIS; GASTRIC-CANCER; MIR-31; METASTASIS; SIGNATURE; PROTEIN; MIRNAS	Several studies have brought about increasing evidence to support the hypothesis that miRNAs play a pivotal role in multiple processes of carcinogenesis, including cell growth, apoptosis, differentiation, and metastasis. In this study, we investigated the potential role of miR-31 in colorectal cancer (CRC) aggressiveness and its underlying mechanisms. We found that miR-31 increased in CRC cells originated from metastatic foci and human primary CRC tissues with lymph node metastases. Furthermore, the high-level expression of miR-31 was significantly associated with a more aggressive and poor prognostic phenotype of patients with CRC (p < 0.05). The stable over-expression of miR-31 in CRC cells was sufficient to promote cell proliferation, invasion, and migration in vitro. It facilitated tumor growth and metastasis in vivo too. Further studies showed that miR-31 can directly bind to the 3' untranslated region (3'UTR) of SATB2 mRNA and subsequently repress both the mRNA and protein expressions of SATB2. Ectopic expression of SATB2 by transiently transfected with pCAG-SATB2 vector encoding the entire SATB2 coding sequence could reverse the effects of miR-31 on CRC tumorigenesis and progression. In addition, ectopic overexpression of miR-31 in CRC cells induced epithelial-mesenchymal transition (EMT). Our results illustrated that the up-regulation of miR-31 played an important role in CRC cell proliferation, invasion, and metastasis in vitro and in vivo through direct repressing SATB2, suggesting a potential application of miR-31 in prognosis prediction and therapeutic application in CRC.	[Yang, Min-Hui; Wang, Xiao-Yan; Wang, Shuang; Ding, Yan-Qing] Southern Med Univ, Nanfang Hosp, Dept Pathol, Guangzhou, Guangdong, Peoples R China; [Yang, Min-Hui; Chen, Na; Wang, Xiao-Yan; Wang, Shuang; Ding, Yan-Qing] Southern Med Univ, Sch Basic Med Sci, Dept Pathol, Guangzhou, Guangdong, Peoples R China; [Yu, Jiang] Southern Med Univ, Nanfang Hosp, Dept Gen Surg, Guangzhou, Guangdong, Peoples R China; [Wang, Xiao-Yan] Peking Univ, Hlth Sci Ctr, Beijing 100871, Peoples R China	Southern Medical University - China; Southern Medical University - China; Southern Medical University - China; Peking University	Wang, S (corresponding author), Southern Med Univ, Nanfang Hosp, Dept Pathol, Guangzhou, Guangdong, Peoples R China.	shuangw@126.com; dyqgz@126.com			National Natural Science Foundation of China [81000953, 81172242, 81071735]; Major projects of National Natural Science Foundation of China [81090422]; State Key Program of National Natural Science Foundation of China [U1201226]; National Basic Research Program of China (973 Program) [2010CB529402]; Key Program of National Natural Science Foundation of Guangdong, China [2010B031500012]; National Natural Science Foundation of Guangdong, China [10451051501004710]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major projects of National Natural Science Foundation of China; State Key Program of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China); Key Program of National Natural Science Foundation of Guangdong, China; National Natural Science Foundation of Guangdong, China	This work was supported by the National Natural Science Foundation of China (No. 81000953, 81172242, 81071735), Major projects of National Natural Science Foundation of China((No. 81090422), State Key Program of National Natural Science Foundation of China (U1201226), National Basic Research Program of China (973 Program, No. 2010CB529402), Key Program of National Natural Science Foundation of Guangdong, China (2010B031500012) and National Natural Science Foundation of Guangdong, China (10451051501004710). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Aprelikova O, 2010, CELL CYCLE, V9, P4387, DOI 10.4161/cc.9.21.13674; Bandres E, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-29; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bera A, 2013, CELL SIGNAL, V25, P2575, DOI 10.1016/j.cellsig.2013.08.005; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Croce CM, 2005, CELL, V122, P6, DOI 10.1016/j.cell.2005.06.036; Dobreva G, 2003, GENE DEV, V17, P3048, DOI 10.1101/gad.1153003; Dobreva G, 2006, CELL, V125, P971, DOI 10.1016/j.cell.2006.05.012; Donnem T, 2011, CANCER-AM CANCER SOC, V117, P3193, DOI 10.1002/cncr.25907; Donnem T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029671; Franken NAP, 2006, NAT PROTOC, V1, P2315, DOI 10.1038/nprot.2006.339; Guo JM, 2009, J GASTROEN HEPATOL, V24, P652, DOI 10.1111/j.1440-1746.2008.05666.x; Gyorgy AB, 2008, EUR J NEUROSCI, V27, P865, DOI 10.1111/j.1460-9568.2008.06061.x; Hao JM, 2010, J PATHOL, V220, P475, DOI 10.1002/path.2668; Hu YX, 2011, INT J CANCER, V128, P132, DOI 10.1002/ijc.25330; Ivanov SV, 2010, J BIOL CHEM, V285, P22807, DOI 10.1074/jbc.M110.100354; Korner C, 2013, J BIOL CHEM, V288, P8750, DOI 10.1074/jbc.M112.414128; Liu X, 2010, J CLIN INVEST, V120, P1298, DOI 10.1172/JCI39566; Ma XD, 2013, CARCINOGENESIS, V34, P1216, DOI 10.1093/carcin/bgt044; Menendez P, 2013, J SURG ONCOL, V108, P369, DOI 10.1002/jso.23415; Mitamura T, 2013, ONCOGENESIS, V2, DOI 10.1038/oncsis.2013.3; Nouraee N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073009; Papaconstantinou IG, 2013, PANCREAS, V42, P67, DOI 10.1097/MPA.0b013e3182592ba7; Saxena A, 2013, EUR J CANCER, V49, P3311, DOI 10.1016/j.ejca.2013.05.031; Schee K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066165; Singh SV, 2004, J BIOL CHEM, V279, P25813, DOI 10.1074/jbc.M313538200; Slaby O, 2007, ONCOLOGY-BASEL, V72, P397, DOI 10.1159/000113489; Soumaoro LT, 2004, CLIN CANCER RES, V10, P8465, DOI 10.1158/1078-0432.CCR-04-0653; Stahlhut Espinosa Carlos E, 2006, Yale J Biol Med, V79, P131; Sun DF, 2013, J BIOL CHEM, V288, P9508, DOI 10.1074/jbc.M112.367763; Tan XG, 2011, CLIN CANCER RES, V17, P6802, DOI 10.1158/1078-0432.CCR-11-0419; Tchemitsa O, 2010, J PATHOL, V222, P310, DOI 10.1002/path.2759; Valastyan S, 2009, CELL, V137, P1032, DOI 10.1016/j.cell.2009.03.047; Ventura A, 2009, CELL, V136, P586, DOI 10.1016/j.cell.2009.02.005; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wang CJ, 2009, DIS MARKERS, V26, P27, DOI [10.3233/DMA-2009-0601, 10.1155/2009/921907]; Wang S, 2013, CLIN TRANSL ONCOL, V15, P849, DOI 10.1007/s12094-013-1014-4; Wang S, 2009, J PATHOL, V219, P114, DOI 10.1002/path.2575; Weitz J, 2005, LANCET, V365, P153, DOI 10.1016/S0140-6736(05)17706-X; Wong TS, 2008, CLIN CANCER RES, V14, P2588, DOI 10.1158/1078-0432.CCR-07-0666; Xi YG, 2007, RNA, V13, P1668, DOI 10.1261/rna.642907; Zhang Yan-Fei, 2007, Nan Fang Yi Ke Da Xue Xue Bao, V27, P126; Zhu SM, 2007, J BIOL CHEM, V282, P14328, DOI 10.1074/jbc.M611393200	44	82	92	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e85353	10.1371/journal.pone.0085353	http://dx.doi.org/10.1371/journal.pone.0085353			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386467	Green Submitted, Green Published, gold			2022-12-25	WOS:000329194700133
J	Aubertin, K; Bonneau, S; Silva, AKA; Bacri, JC; Gallet, F; Wilhelm, C				Aubertin, Kelly; Bonneau, Stephanie; Silva, Amanda K. A.; Bacri, Jean-Claude; Gallet, Francois; Wilhelm, Claire			Impact of Photosensitizers Activation on Intracellular Trafficking and Viscosity	PLOS ONE			English	Article							PHOTOCHEMICAL INTERNALIZATION; PHOTODYNAMIC THERAPY; SINGLET OXYGEN; SUBCELLULAR-LOCALIZATION; CELLULAR UPTAKE; GIANT VESICLES; MECHANISMS; TRANSPORT; DETERMINANTS; MICROTUBULES	The intracellular microenvironment is essential for the efficiency of photo-induced therapies, as short-lived reactive oxygen species generated must diffuse through their intracellular surrounding medium to reach their cellular target. Here, by combining measurements of local cytoplasmic dissipation and active trafficking, we found that photosensitizers activation induced small changes in surrounding viscosity but a massive decrease in diffusion. These effects are the signature of a return to thermodynamic equilibrium of the system after photo-activation and correlated with depolymerization of the microtubule network, as shown in a reconstituted system. These mechanical measurements were performed with two intracellular photosensitizing chlorins having similar quantum yield of singlet oxygen production but different intracellular localizations ( cytoplasmic for mTHPC, endosomal for TPCS2a). These two agents demonstrated different intracellular impact.	[Aubertin, Kelly; Silva, Amanda K. A.; Bacri, Jean-Claude; Gallet, Francois; Wilhelm, Claire] CNRS, Lab Mat & Syst Complexes MSC, Paris, France; [Aubertin, Kelly; Silva, Amanda K. A.; Bacri, Jean-Claude; Gallet, Francois; Wilhelm, Claire] Univ Paris Diderot, Paris, France; [Bonneau, Stephanie] Univ Paris 06, CNRS, Lab Jean Perrin, Paris, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite	Wilhelm, C (corresponding author), CNRS, Lab Mat & Syst Complexes MSC, Paris, France.	claire.wilhelm@univ-paris-diderot.fr	Aubertin, Kelly/A-5515-2018; Bonneau, Stéphanie/H-6918-2013; Aubertin, Kelly/N-6931-2019	Aubertin, Kelly/0000-0001-9923-0129; Bonneau, Stéphanie/0000-0003-2039-0037; Aubertin, Kelly/0000-0001-9923-0129; Wilhelm, Claire/0000-0001-7024-9627; Silva, Amanda K. A./0000-0002-7713-1813	European commission's FP7 (project Magnifyco) [NMP4-SL-2009-228622]	European commission's FP7 (project Magnifyco)	This work was supported by the by the European commission's FP7 (project Magnifyco NMP4-SL-2009-228622). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou B, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.160603; Arcizet D, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.248103; Berg K, 1999, CANCER RES, V59, P1180; Berg K, 1997, PHOTOCHEM PHOTOBIOL, V65, P403, DOI 10.1111/j.1751-1097.1997.tb08578.x; BERG K, 1990, INT J RADIAT BIOL, V58, P475, DOI 10.1080/09553009014551821; Berg K, 2005, J MICROSC-OXFORD, V218, P133, DOI 10.1111/j.1365-2818.2005.01471.x; BERG K, 1992, BIOCHIM BIOPHYS ACTA, V1135, P147, DOI 10.1016/0167-4889(92)90130-4; Berg K, 2011, PHOTOCH PHOTOBIO SCI, V10, P1637, DOI 10.1039/c1pp05128h; Bonneau S, 2008, EXPERT OPIN THER PAT, V18, P1011, DOI 10.1517/13543776.18.9.1011; Brangwynne CP, 2009, TRENDS CELL BIOL, V19, P423, DOI 10.1016/j.tcb.2009.04.004; Brangwynne CP, 2008, J CELL BIOL, V183, P583, DOI 10.1083/jcb.200806149; Breitenbach T, 2009, PHOTOCH PHOTOBIO SCI, V8, P442, DOI 10.1039/b809049a; Bruno L, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.011912; Bruno L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018332; Bursac P, 2007, BIOCHEM BIOPH RES CO, V355, P324, DOI 10.1016/j.bbrc.2007.01.191; Castano AP, 2005, PHOTODIAGN PHOTODYN, V2, P91, DOI 10.1016/S1572-1000(05)00060-8; Castro A, 2005, PLOS MED, V2, P1217, DOI 10.1371/journal.pmed.0020338; DeRosa MC, 2002, COORDIN CHEM REV, V233, P351, DOI 10.1016/S0010-8545(02)00034-6; DOGTEROM M, 1993, PHYS REV LETT, V70, P1347, DOI 10.1103/PhysRevLett.70.1347; Dougherty TJ, 1998, JNCI-J NATL CANCER I, V90, P889, DOI 10.1093/jnci/90.12.889; Fayol D, 2013, ADV HEALTHC MATER, V2, P313, DOI 10.1002/adhm.201200294; Goldstein D, 2013, SOFT MATTER, V9, P7167, DOI 10.1039/c3sm50172h; Guo HL, 2006, BIOPHYS J, V90, P2093, DOI 10.1529/biophysj.105.071209; Hatz S, 2008, PHOTOCHEM PHOTOBIOL, V84, P1284, DOI 10.1111/j.1751-1097.2008.00359.x; Herold C, 2012, CHEMPHYSCHEM, V13, P1001, DOI 10.1002/cphc.201100669; Heuvingh J, 2009, BIOPHYS J, V97, P2904, DOI 10.1016/j.bpj.2009.08.056; Juarranz A, 2001, PHOTOCHEM PHOTOBIOL, V73, P283, DOI 10.1562/0031-8655(2001)073<0283:PIBZIP>2.0.CO;2; Kuimova MK, 2009, J AM CHEM SOC, V131, P332, DOI 10.1021/ja807484b; Kuimova MK, 2009, NAT CHEM, V1, P69, DOI [10.1038/nchem.120, 10.1038/NCHEM.120]; Liu TC, 2010, CANCER LETT, V296, P106, DOI 10.1016/j.canlet.2010.04.003; Ma LW, 1996, CANCER LETT, V109, P129, DOI 10.1016/S0304-3835(96)04437-0; MacKintosh FC, 2010, CURR OPIN CELL BIOL, V22, P29, DOI 10.1016/j.ceb.2010.01.002; Marion S, 2004, J CELL SCI, V117, P3271, DOI 10.1242/jcs.01178; MITCHISON T, 1984, NATURE, V312, P237, DOI 10.1038/312237a0; Mojzisova H, 2007, EUR BIOPHYS J BIOPHY, V36, P943, DOI 10.1007/s00249-007-0204-9; Ogilby PR, 2010, CHEM SOC REV, V39, P3181, DOI 10.1039/b926014p; Petrovajova D, 2013, LASER PHYS LETT, V10, DOI 10.1088/1612-2011/10/7/075609; Riviere C, 2007, EUR PHYS J E, V22, P1, DOI 10.1140/epje/e2007-00014-1; Robert D, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.011905; Robert D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010046; Salas-Cortes L, 2005, J CELL SCI, V118, P4823, DOI 10.1242/jcs.02607; Selbo PK, 2001, INT J CANCER, V92, P761, DOI 10.1002/1097-0215(20010601)92:5<761::AID-IJC1238>3.0.CO;2-4; Silva AKA, 2012, NANOMEDICINE-UK, V7, P1713, DOI [10.2217/NNM.12.40, 10.2217/nnm.12.40]; Stuhrmann B, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.020901; Tian F, 2007, BIOMACROMOLECULES, V8, P3767, DOI 10.1021/bm700687x; Vale RD, 2003, CELL, V112, P467, DOI 10.1016/S0092-8674(03)00111-9; Verderio C, 2012, BIOL CELL, V104, P213, DOI 10.1111/boc.201100070; VIKDAL M, BIOCH PHARM; Wang JTW, 2013, PHOTOCH PHOTOBIO SCI, V12, P519, DOI 10.1039/c2pp25328c; Wilhelm C, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.011504; Wilhelm C, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.028101; Yow CMN, 2000, CANCER LETT, V157, P123, DOI 10.1016/S0304-3835(00)00453-5	52	5	5	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e84850	10.1371/journal.pone.0084850	http://dx.doi.org/10.1371/journal.pone.0084850			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281RE	24386423	Green Submitted, Green Published, gold			2022-12-25	WOS:000329117900113
J	Yang, K; Lu, L; Liu, Y; Zhang, Q; Pu, LJ; Wang, LJ; Zhu, ZB; Wang, YN; Meng, H; Zhang, XJ; Du, R; Chen, QJ; Shen, WF				Yang, Ke; Lu, Lin; Liu, Yan; Zhang, Qi; Pu, Li Jin; Wang, Lin Jie; Zhu, Zhen Bing; Wang, Ya Nan; Meng, Hua; Zhang, Xiao Jie; Du, Run; Chen, Qiu Jing; Shen, Wei Feng			Increase of ADAM10 Level in Coronary Artery In-Stent Restenosis Segments in Diabetic Minipigs: High ADAM10 Expression Promoting Growth and Migration in Human Vascular Smooth Muscle Cells via Notch 1 and 3	PLOS ONE			English	Article							MEDIATES NEOINTIMAL FORMATION; ELUTING STENT; RECEPTOR; CLEAVAGE; DISINTEGRIN; RAGE; RELEASE; PROTEIN; MATRIX	Background: This study aimed to identify major proteins in the pathogenesis of coronary artery in-stent restenosis (ISR) in diabetic minipigs with sirolimus-eluting stenting, and to investigate the roles of key candidate molecules, particularly ADAM10, in human arterial smooth muscle cells (HASMCs). Methods and Results: The stents were implanted in the coronary arteries of 15 diabetic and 26 non-diabetic minipigs, and angiography was repeated at six months. The intima of one vascular segment with significant ISR and one with non-ISR in diabetic minipigs were isolated and cultured in conditioned medium (CM). The CM was analyzed by LC-MS/MS to uncover proteins whose levels were significantly increased (>= 1.5-fold) in ISR than in non-ISR tissues. After literature searching, we focused on the identified proteins, whose biological functions were most potentially related to ISR pathophysiology. Among them, ADAM10 was significantly increased in diabetic and nondiabetic ISR tissues as compared with non-ISR controls. In cell experiments, retrovirus-mediated overexpression of ADAM10 promoted growth and migration of HASMCs. The effects of ADAM10 were more remarkable in high-glucose culture than in low-glucose culture. Using shRNA and an inhibitor of.-secretase (GSI), we found that the influences of ADAM10 were in part mediated by Notch1 and notch 3 pathway, which up-regulated Notch downstream genes and enhanced nuclear translocation of the small intracellular component of Notch1 and Notch3. Conclusions: This study has identified significantly increased expression of ADAM10 in the ISR versus non-ISR segment in diabetic minipigs and implicates ADAM10 in the enhanced neointimal formation observed in diabetes after vascular injury.	[Yang, Ke; Lu, Lin; Liu, Yan; Zhang, Qi; Pu, Li Jin; Wang, Lin Jie; Zhu, Zhen Bing; Wang, Ya Nan; Meng, Hua; Zhang, Xiao Jie; Chen, Qiu Jing; Shen, Wei Feng] Jiao Tong Univ, Inst Cardiovasc Dis, Sch Med, Shanghai 200030, Peoples R China; [Lu, Lin; Zhang, Qi; Wang, Lin Jie; Zhu, Zhen Bing; Du, Run; Shen, Wei Feng] Jiao Tong Univ, Dept Cardiol, Rui Jin Hosp, Sch Med, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Shen, WF (corresponding author), Jiao Tong Univ, Inst Cardiovasc Dis, Sch Med, Shanghai 200030, Peoples R China.	rjshenweifeng@yahoo.com.cn	wang, lin/HHM-2225-2022	Yang, Ke/0000-0002-1870-1134	Research Fund for the National Nature Science Funding of China [30871084, 3087127]	Research Fund for the National Nature Science Funding of China	This work was supported by grants from the Research Fund for the National Nature Science Funding of China (No. 30871084 and No. 3087127). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Llamas G, 2007, MOL CELL PROTEOMICS, V6, P589, DOI 10.1074/mcp.M600265-MCP200; Barlis P, 2010, EUR HEART J, V31, P165, DOI 10.1093/eurheartj/ehp480; Campos AH, 2002, CIRC RES, V91, P999, DOI 10.1161/01.RES.0000044944.99984.25; Cao HQ, 2006, CIRC RES, V98, P913, DOI 10.1161/01.RES.0000216954.55724.a2; CAVAGI BE, 2009, MOL CELL BIOL, V29, P5679, DOI DOI 10.1128/MCB.00406-09.PUBMED:19704010; De Strooper B, 1999, NATURE, V398, P518, DOI 10.1038/19083; Donato R, 2007, CURR MOL MED, V7, P711, DOI 10.2174/156652407783220688; Fan CL, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.000901; George J, 2001, J AM COLL CARDIOL, V38, P1564, DOI 10.1016/S0735-1097(01)01579-0; Gough PJ, 2004, J IMMUNOL, V172, P3678, DOI 10.4049/jimmunol.172.6.3678; Hofmann JJ, 2007, CIRC RES, V100, P1556, DOI 10.1161/01.RES.0000266408.42939.e4; Hundhausen C, 2003, BLOOD, V102, P1186, DOI 10.1182/blood-2002-12-3775; Hundhausen C, 2007, J IMMUNOL, V178, P8064, DOI 10.4049/jimmunol.178.12.8064; KASTRATI A, 1993, CIRCULATION, V87, P1498, DOI 10.1161/01.CIR.87.5.1498; Kohutek ZA, 2009, J NEUROSCI, V29, P4605, DOI 10.1523/JNEUROSCI.5126-08.2009; Lammich S, 1999, P NATL ACAD SCI USA, V96, P3922, DOI 10.1073/pnas.96.7.3922; Li YX, 2009, CIRCULATION, V119, P2686, DOI 10.1161/CIRCULATIONAHA.108.790485; Lindner V, 2001, AM J PATHOL, V159, P875, DOI 10.1016/S0002-9440(10)61763-4; Lu L, 2008, INT J EXP PATHOL, V89, P125, DOI 10.1111/j.1365-2613.2008.00579.x; Lu L, 2013, ARTERIOSCL THROM VAS, V33, P572, DOI 10.1161/ATVBAHA.112.301016; Morrow D, 2008, CIRC RES, V103, P1370, DOI 10.1161/CIRCRESAHA.108.187534; Ono M, 2006, MOL CELL PROTEOMICS, V5, P1338, DOI 10.1074/mcp.T500039-MCP200; Raucci A, 2008, FASEB J, V22, P3716, DOI 10.1096/fj.08-109033; Ruan W, 2009, J AM SOC ECHOCARDIOG, V22, P530, DOI 10.1016/j.echo.2009.02.023; Sakaguchi T, 2003, J CLIN INVEST, V111, P959, DOI 10.1172/JCI200317115; Schroeter EH, 1998, NATURE, V393, P382, DOI 10.1038/30756; Stenestrand U, 2010, EUR HEART J, V31, P177, DOI 10.1093/eurheartj/ehp424; Tousseyn T, 2009, J BIOL CHEM, V284, P11738, DOI 10.1074/jbc.M805894200; Uttarwar L, 2011, AM J PHYSIOL-RENAL, V300, pF921, DOI 10.1152/ajprenal.00436.2010; van Tetering G, 2009, J BIOL CHEM, V284, P31018, DOI 10.1074/jbc.M109.006775; Wang WL, 2003, BIOCHEM BIOPH RES CO, V308, P596, DOI 10.1016/S0006-291X(03)01453-0; Wang WL, 2002, J BIOL CHEM, V277, P23165, DOI 10.1074/jbc.M201409200; Xiao T, 2005, MOL CELL PROTEOMICS, V4, P1480, DOI 10.1074/mcp.M500055-MCP200; Zhang Q, 2007, CARDIOVASC DIABETOL, V6, DOI 10.1186/1475-2840-6-16; Zhou ZM, 2003, CIRCULATION, V107, P2238, DOI 10.1161/01.CIR.0000063577.32819.23	35	10	12	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e83853	10.1371/journal.pone.0083853	http://dx.doi.org/10.1371/journal.pone.0083853			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281RE	24386293	Green Published, Green Submitted, gold			2022-12-25	WOS:000329117900062
J	Berger-Muller, S; Sugie, A; Takahashi, F; Tavosanis, G; Hakeda-Suzuki, S; Suzuki, T				Berger-Mueller, Sandra; Sugie, Atsushi; Takahashi, Fumio; Tavosanis, Gaia; Hakeda-Suzuki, Satoko; Suzuki, Takashi			Assessing the Role of Cell-Surface Molecules in Central Synaptogenesis in the Drosophila Visual System	PLOS ONE			English	Article							SYNAPTIC-LAYER SPECIFICITY; TRANSMEMBRANE PROTEIN; FUNCTIONAL DISSECTION; TARGET SPECIFICITY; BOUNDARY FORMATION; AXON; REFINEMENT; EXPRESSION; FLAMINGO; CADHERIN	A hallmark of the central nervous system is its spatial and functional organization in synaptic layers. During neuronal development, axons form transient contacts with potential post-synaptic elements and establish synapses with appropriate partners at specific layers. These processes are regulated by synaptic cell-adhesion molecules. In the Drosophila visual system, R7 and R8 photoreceptor subtypes target distinct layers and form en passant pre-synaptic terminals at stereotypic loci of the axonal shaft. A leucine-rich repeat transmembrane protein, Capricious (Caps), is known to be selectively expressed in R8 axons and their recipient layer, which led to the attractive hypothesis that Caps mediates R8 synaptic specificity by homophilic adhesion. Contradicting this assumption, our results indicate that Caps does not have a prominent role in synaptic-layer targeting and synapse formation in Drosophila photoreceptors, and that the specific recognition of the R8 target layer does not involve Caps homophilic axon-target interactions. We generated flies that express a tagged synaptic marker to evaluate the presence and localization of synapses in R7 and R8 photoreceptors. These genetic tools were used to assess how the synaptic profile is affected when axons are forced to target abnormal layers by expressing axon guidance molecules. When R7 axons were mistargeted to the R8-recipient layer, R7s either maintained an R7-like synaptic profile or acquired a similar profile to r8s depending on the overexpressed protein. When R7 axons were redirected to a more superficial medulla layer, the number of presynaptic terminals was reduced. These results indicate that cell-surface molecules are able to dictate synapse loci by changing the axon terminal identity in a partially cell-autonomous manner, but that presynapse formation at specific sites also requires complex interactions between pre- and post-synaptic elements.	[Berger-Mueller, Sandra; Sugie, Atsushi; Hakeda-Suzuki, Satoko; Suzuki, Takashi] Max Planck Inst Neurobiol, Res Grp Axon Guidance & Neuronal Connect, D-82152 Martinsried, Germany; [Berger-Mueller, Sandra] CNRS 5273, Unite Mixte Rech STROMALab, Toulouse, France; [Sugie, Atsushi; Tavosanis, Gaia] German Ctr Neurodegenerat Dis DZNE, Dendrite Differentiat Grp, Bonn, Germany; [Takahashi, Fumio; Hakeda-Suzuki, Satoko; Suzuki, Takashi] Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Yokohama, Kanagawa 227, Japan	Max Planck Society; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Tokyo Institute of Technology	Suzuki, T (corresponding author), Max Planck Inst Neurobiol, Res Grp Axon Guidance & Neuronal Connect, D-82152 Martinsried, Germany.	suzukit@bio.titech.ac.jp	Suzuki, Takashi/D-3651-2019; Hakeda-suzuki, Satoko/AAU-5348-2020	Suzuki, Takashi/0000-0001-9093-2562; Hakeda-suzuki, Satoko/0000-0001-8749-1479; Tavosanis, Gaia/0000-0002-8679-5515	Alexander von Humboldt Foundation; Max Planck Society; Mitsubishi foundation; Tomizawa foundation; JSPS	Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); Max Planck Society(Max Planck SocietyFoundation CELLEX); Mitsubishi foundation; Tomizawa foundation; JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by the Alexander von Humboldt Foundation (A. S.), the Max Planck Society, Grants-in-Aid for Scientific Research (JSPS) and Mitsubishi foundation and the Tomizawa foundation (T. S.). S.H.-S. is a Research Fellow of Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bazigou E, 2007, CELL, V128, P961, DOI 10.1016/j.cell.2007.02.024; Bukalo O, 2012, ADV EXP MED BIOL, V970, P97, DOI 10.1007/978-3-7091-0932-8_5; Clandinin TR, 2001, NEURON, V32, P237, DOI 10.1016/S0896-6273(01)00474-3; Clements J, 2008, P NATL ACAD SCI USA, V105, P16183, DOI 10.1073/pnas.0708330105; Dalva MB, 2007, NAT REV NEUROSCI, V8, P206, DOI 10.1038/nrn2075; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Edwards TN, 2009, J NEUROSCI, V29, P828, DOI 10.1523/JNEUROSCI.1022-08.2009; Fouquet W, 2009, J CELL BIOL, V186, P129, DOI 10.1083/jcb.200812150; Hakeda-Suzuki S, 2011, NAT NEUROSCI, V14, P314, DOI 10.1038/nn.2756; Hiesinger PR, 2006, CURR BIOL, V16, P1835, DOI 10.1016/j.cub.2006.07.047; Hong WZ, 2009, NAT NEUROSCI, V12, P1542, DOI 10.1038/nn.2442; Keleman K, 2001, NEURON, V32, P605, DOI 10.1016/S0896-6273(01)00505-0; Kohsaka H, 2009, DEVELOPMENT, V136, P1127, DOI 10.1242/dev.027920; Kremer MC, 2010, CURR BIOL, V20, P1938, DOI 10.1016/j.cub.2010.09.060; Kurusu M, 2008, NEURON, V59, P972, DOI 10.1016/j.neuron.2008.07.037; Lee CH, 2001, NEURON, V30, P437, DOI 10.1016/S0896-6273(01)00291-4; Lu B, 2009, CURR OPIN NEUROBIOL, V19, P162, DOI 10.1016/j.conb.2009.04.004; Mao Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001827; Markstein M, 2008, NAT GENET, V40, P476, DOI 10.1038/ng.101; Maurel-Zaffran C, 2001, NEURON, V32, P225, DOI 10.1016/S0896-6273(01)00471-8; Milan M, 2005, DEV DYNAM, V233, P804, DOI 10.1002/dvdy.20384; Milan M, 2001, CELL, V106, P785, DOI 10.1016/S0092-8674(01)00489-5; Morey M, 2008, NATURE, V456, P795, DOI 10.1038/nature07419; Newsome TP, 2000, DEVELOPMENT, V127, P851; Parks AL, 2004, NAT GENET, V36, P288, DOI 10.1038/ng1312; Pfeiffer BD, 2010, GENETICS, V186, P735, DOI 10.1534/genetics.110.119917; Sakurai KT, 2007, DEV BIOL, V309, P126, DOI 10.1016/j.ydbio.2007.07.001; Schmid A, 2008, NAT NEUROSCI, V11, P659, DOI 10.1038/nn.2122; Shinza-Kameda M, 2006, NEURON, V49, P205, DOI 10.1016/j.neuron.2005.11.013; Shishido E, 1998, SCIENCE, V280, P2118, DOI 10.1126/science.280.5372.2118; Siddiqui TJ, 2011, CURR OPIN NEUROBIOL, V21, P132, DOI 10.1016/j.conb.2010.08.016; Takemura SY, 2008, J COMP NEUROL, V509, P493, DOI 10.1002/cne.21757; Taniguchi H, 2000, J NEUROBIOL, V42, P104, DOI 10.1002/(SICI)1097-4695(200001)42:1<104::AID-NEU10>3.0.CO;2-V; Timofeev K, 2012, NEURON, V75, P80, DOI 10.1016/j.neuron.2012.04.037; Tomasi T, 2008, NEURON, V57, P691, DOI 10.1016/j.neuron.2008.01.012; Usui T, 1999, CELL, V98, P585, DOI 10.1016/S0092-8674(00)80046-X; Venken KJT, 2006, SCIENCE, V314, P1747, DOI 10.1126/science.1134426; Wu JS, 2006, NAT PROTOC, V1, P2110, DOI 10.1038/nprot.2006.336	38	22	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e83732	10.1371/journal.pone.0083732	http://dx.doi.org/10.1371/journal.pone.0083732			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281QS	24386266	gold, Green Published, Green Submitted			2022-12-25	WOS:000329116700075
J	Shindo, S; Moore, R; Flake, G; Negishi, M				Shindo, Sawako; Moore, Rick; Flake, Gordon; Negishi, Masahiko			Serine 216 Phosphorylation of Estrogen Receptor alpha in Neutrophils: Migration and Infiltration into the Mouse Uterus	PLOS ONE			English	Article							LACTOFERRIN; EXPRESSION; GENE; RAT	Background: Whereas estrogen receptors are present in immune cells, it is not known if they are phosphorylated to regulate immune cell functions. Here we determined the phosphorylation status of estrogen receptor alpha (ER alpha) at residue serine 216 in mouse neutrophils and examined its role in migration and infiltration. Serine 216 is the conserved phosphorylation site within the DNA binding domains found in the majority of nuclear receptors. Methodology/Principal Findings: A phospho-peptide antibody specific to phosphorylated serine 216 and ER alpha KO mice were utilized in immunohistochemistry, double immuno-staining or Western blot to detect phosphorylation of ER alpha in peripheral blood as well as infiltrating neutrophils in the mouse uterus. Transwell assays were performed to examine migration of neutrophils. An anti-Ly6G antibody identified neutrophils. About 20% of neutrophils expressed phosphorylated ER alpha at serine 216 in peripheral white blood cells (WBC) from C3H/HeNCrIBR females. Phosphorylation was additively segregated between C3H/HeNCrIBR and C57BL/6 females. Only neutrophils that expressed phosphorylated ER alpha migrated in Transwell assays as well as infiltrated the mouse uterus during normal estrous cycles. Conclusions/Significance: ER alpha was phosphorylated at serine 216 in about 20% of mouse peripheral blood neutrophils. Only those that express phosphorylated ER alpha migrate and infiltrate the mouse uterus. This phosphorylation was the first to be characterized in endogenous ER alpha found in normal tissues and cells. Phosphorylated ER alpha may have opened a novel research direction for biological roles of phosphorylation in ER alpha actions and can be developed as a drug target for treatment of immune-related diseases.	[Shindo, Sawako; Moore, Rick; Negishi, Masahiko] NIEHS, Pharmacogenet Sect, Reprod & Dev Toxicol Lab, NIH, Res Triangle Pk, NC 27709 USA; [Flake, Gordon] NIEHS, Pathol Lab, NIH, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Negishi, M (corresponding author), NIEHS, Pharmacogenet Sect, Reprod & Dev Toxicol Lab, NIH, POB 12233, Res Triangle Pk, NC 27709 USA.	negishi@niehs.nih.gov	Negishi, Masahiko/F-7805-2019	Negishi, Masahiko/0000-0002-2076-8928	Intramural Research Program of the NIH, National Institute of Environmental Health [Z01ES1005-01]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES080040] Funding Source: NIH RePORTER	Intramural Research Program of the NIH, National Institute of Environmental Health; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This study was supported by the Intramural Research Program of the NIH, National Institute of Environmental Health: Z01ES1005-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atsriku C, 2009, MOL CELL PROTEOMICS, V8, P467, DOI 10.1074/mcp.M800282-MCP200; Baumgarten SC, 2012, MOL ENDOCRINOL, V26, P360, DOI 10.1210/me.2011-1302; Cunningham M, 2011, CLIN REV ALLERG IMMU, V40, P66, DOI 10.1007/s12016-010-8203-5; Daimon E, 2005, BIOL REPROD, V73, P163, DOI 10.1095/biolreprod.104.038539; Daley JM, 2008, J LEUKOCYTE BIOL, V83, P64, DOI 10.1189/jlb.0407247; Hammes SR, 2007, ENDOCR REV, V28, P726, DOI 10.1210/er.2007-0022; Hewitt SC, 2010, FASEB J, V24, P4660, DOI 10.1096/fj.10-163428; Hickey DK, 2013, INNATE IMMUN-LONDON, V19, P121, DOI 10.1177/1753425912454026; KACHKACHE M, 1991, BIOL REPROD, V45, P860, DOI 10.1095/biolreprod45.6.860; Kaitu'u-Lino TJ, 2007, CELL TISSUE RES, V328, P197, DOI 10.1007/s00441-006-0358-2; Lang TJ, 2004, CLIN IMMUNOL, V113, P224, DOI 10.1016/j.clim.2004.05.011; MCMASTER MT, 1992, MOL ENDOCRINOL, V6, P101, DOI 10.1210/me.6.1.101; Molero L, 2002, CARDIOVASC RES, V56, P43, DOI 10.1016/S0008-6363(02)00505-9; Murphy LC, 2011, ENDOCR-RELAT CANCER, V18, pR1, DOI 10.1677/ERC-10-0070; Mutoh S, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003705; Mutoh S, 2009, J BIOL CHEM, V284, P34785, DOI 10.1074/jbc.M109.048108; Shindo S, 2012, STEROIDS, V77, P448, DOI 10.1016/j.steroids.2012.01.001; Steffl M, 2010, ANIM REPROD SCI, V121, P159, DOI 10.1016/j.anireprosci.2010.05.018; Svenson JL, 2008, CLIN IMMUNOL, V128, P259, DOI 10.1016/j.clim.2008.03.508; Teng CT, 2002, BIOL REPROD, V67, P1439, DOI 10.1095/biolreprod.101.002089; Tibbetts TA, 1999, BIOL REPROD, V60, P1158, DOI 10.1095/biolreprod60.5.1158; Wood GA, 2007, REPRODUCTION, V133, P1035, DOI 10.1530/REP-06-0302	22	20	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e84462	10.1371/journal.pone.0084462	http://dx.doi.org/10.1371/journal.pone.0084462			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281QS	24386386	Green Published, gold, Green Submitted			2022-12-25	WOS:000329116700109
J	Canessa, P; Schumacher, J; Hevia, MA; Tudzynski, P; Larrondo, LF				Canessa, Paulo; Schumacher, Julia; Hevia, Montserrat A.; Tudzynski, Paul; Larrondo, Luis F.			Assessing the Effects of Light on Differentiation and Virulence of the Plant Pathogen Botrytis cinerea: Characterization of the White Collar Complex	PLOS ONE			English	Article							BLUE-LIGHT; PHYSICAL INTERACTION; MOLECULAR-GENETICS; SEXUAL DEVELOPMENT; NEUROSPORA-CRASSA; NEAR-ULTRAVIOLET; CIRCADIAN CLOCK; NADPH OXIDASES; GRAY MOLD; RED-LIGHT	Organisms are exposed to a tough environment, where acute daily challenges, like light, can strongly affect several aspects of an individual's physiology, including pathogenesis. While several fungal models have been widely employed to understand the physiological and molecular events associated with light perception, various other agricultural-relevant fungi still remain, in terms of their responsiveness to light, in the dark. The fungus Botrytis cinerea is an aggressive pathogen able to cause disease on a wide range of plant species. Natural B. cinerea isolates exhibit a high degree of diversity in their predominant mode of reproduction. Thus, the majority of naturally occurring strains are known to reproduce asexually via conidia and sclerotia, and sexually via apothecia. Studies from the 1970's reported on specific developmental responses to treatments with near-UV, blue, red and far-red light. To unravel the signaling machinery triggering development - and possibly also connected with virulence - we initiated the functional characterization of the transcription factor/photoreceptor BcWCL1 and its partner BcWCL2, that form the White Collar Complex (WCC) in B. cinerea. Using mutants either abolished in or exhibiting enhanced WCC signaling (overexpression of both bcwcl1 and bcwcl2), we demonstrate that the WCC is an integral part of the mentioned machinery by mediating transcriptional responses to white light and the inhibition of conidiation in response to this stimulus. Furthermore, the WCC is required for coping with excessive light, oxidative stress and also to achieve full virulence. Although several transcriptional responses are abolished in the absence of bcwcl1, the expression of some genes is still light induced and a distinct conidiation pattern in response to daily light oscillations is enhanced, revealing a complex underlying photobiology. Though overlaps with well-studied fungal systems exist, the light-associated machinery of B. cinerea appears more complex than those of Neurospora crassa and Aspergillus nidulans.	[Canessa, Paulo; Hevia, Montserrat A.; Larrondo, Luis F.] Pontificia Univ Catolica Chile, Fac Ciencias Biol, Dept Mol Genet & Microbiol, Santiago, Chile; [Schumacher, Julia; Tudzynski, Paul] Univ Munster, Inst Biol & Biotechnol Pflanzen, D-48149 Munster, Germany	Pontificia Universidad Catolica de Chile; University of Munster	Larrondo, LF (corresponding author), Pontificia Univ Catolica Chile, Fac Ciencias Biol, Dept Mol Genet & Microbiol, Alameda 340, Santiago, Chile.	llarrondo@bio.puc.cl	Hevia, Montserrat/N-2667-2018; Schumacher, Julia/B-9142-2019; Larrondo, Luis/J-1086-2016	Hevia, Montserrat/0000-0002-6478-6490; Schumacher, Julia/0000-0001-9120-9675; Canessa, Paulo/0000-0003-3138-8223; Larrondo, Luis/0000-0002-8832-7109	Fondo Nacional de Desarrollo Cientifico y Tecnologico Fondecyt-Chile [1131030]; Fondecyt [3110127]; P. Universidad Catolica de Chile; CONICYT Chile [AT-24121100]	Fondo Nacional de Desarrollo Cientifico y Tecnologico Fondecyt-Chile(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Fondecyt(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); P. Universidad Catolica de Chile; CONICYT Chile(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT))	Research was funded by Fondo Nacional de Desarrollo Cientifico y Tecnologico Fondecyt-Chile 1131030 to LFL, Fondecyt Postdoc 3110127 and Postdoc-VRI from P. Universidad Catolica de Chile to PC. MH is a predoctoral fellow supported by CONICYT Chile (AT-24121100). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amselem J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002230; Ballario P, 1996, EMBO J, V15, P1650, DOI 10.1002/j.1460-2075.1996.tb00510.x; Bayram O, 2008, MOL BIOL CELL, V19, P3254, DOI 10.1091/mbc.E08-01-0061; Bayram O, 2010, FUNGAL GENET BIOL, V47, P900, DOI 10.1016/j.fgb.2010.05.008; Belden WJ, 2007, GENE DEV, V21, P1494, DOI 10.1101/gad.1551707; Blumenstein A, 2005, CURR BIOL, V15, P1833, DOI 10.1016/j.cub.2005.08.061; Brierley WB, 1918, B MISCELLANEOUS INFO, V1918, P129; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; BUTTNER P, 1994, CURR GENET, V25, P445, DOI 10.1007/BF00351784; Cano-Dominguez N, 2008, EUKARYOT CELL, V7, P1352, DOI 10.1128/EC.00137-08; Carreras-Villasenor N, 2012, MICROBIOL-SGM, V158, P3, DOI 10.1099/mic.0.052688-0; Carvalho LC, 2008, J PLANT PHYSIOL, V165, P1300, DOI 10.1016/j.jplph.2007.04.009; Casas-Flores S, 2004, MICROBIOL-SGM, V150, P3561, DOI 10.1099/mic.0.27346-0; CENIS JL, 1992, NUCLEIC ACIDS RES, V20, P2380, DOI 10.1093/nar/20.9.2380; Cerrudo I, 2012, PLANT PHYSIOL, V158, P2042, DOI 10.1104/pp.112.193359; Chen CH, 2010, FUNGAL GENET BIOL, V47, P922, DOI 10.1016/j.fgb.2010.07.005; Chen CH, 2010, P NATL ACAD SCI USA, V107, P16715, DOI 10.1073/pnas.1011190107; Chen CH, 2009, EMBO J, V28, P1029, DOI 10.1038/emboj.2009.54; CHRISTIANSON TW, 1992, GENE, V110, P119, DOI 10.1016/0378-1119(92)90454-W; Chung DW, 2011, FUNGAL GENET BIOL, V48, P370, DOI 10.1016/j.fgb.2010.12.008; Coley-Smith JR, 1980, BIOL BOTRYTIS CINERE; Colot HV, 2006, P NATL ACAD SCI USA, V103, P10352, DOI 10.1073/pnas.0601456103; Corrochano LM, 2007, PHOTOCH PHOTOBIO SCI, V6, P725, DOI 10.1039/b702155k; Corrochano LM, 2011, IMA FUNGUS, V2, P25, DOI 10.5598/imafungus.2011.02.01.04; de Wit M, 2013, PLANT J, V75, P90, DOI 10.1111/tpj.12203; Dean R, 2012, MOL PLANT PATHOL, V13, P414, DOI 10.1111/j.1364-3703.2011.00783.x; Demkura PV, 2012, MOL PLANT, V5, P642, DOI 10.1093/mp/sss025; Derckel JP, 1999, PHYTOPATHOLOGY, V89, P197, DOI 10.1094/PHYTO.1999.89.3.197; Dyer PS, 2012, FEMS MICROBIOL REV, V36, P165, DOI 10.1111/j.1574-6976.2011.00308.x; FARETRA F, 1988, J GEN MICROBIOL, V134, P2543; Faretra F., 1987, Phytopathologia Mediterranea, V26, P29; Froehlich AC, 2005, EUKARYOT CELL, V4, P2140, DOI 10.1128/EC.4.12.2140-2152.2005; Froehlich AC, 2002, SCIENCE, V297, P815, DOI 10.1126/science.1073681; Fuller KK, 2013, MBIO, V4, DOI 10.1128/mBio.00142-13; Gettkandt G, 1952, KENNTNIS PHOTOTROPIS; Godfrey GH, 1923, J AGRIC RES, V23, P0679; Goyal A, 2013, TRENDS PLANT SCI, V18, P393, DOI 10.1016/j.tplants.2013.03.002; GRINDLE M, 1979, J GEN MICROBIOL, V111, P109, DOI 10.1099/00221287-111-1-109; Han Kap-Hoon, 2009, Mycobiology, V37, P171, DOI 10.4489/MYCO.2009.37.3.171; Hatakeyama R, 2007, BIOSCI BIOTECH BIOCH, V71, P1844, DOI 10.1271/bbb.60713; He QY, 2002, SCIENCE, V297, P840, DOI 10.1126/science.1072795; Heintzen C, 2001, CELL, V104, P453, DOI 10.1016/S0092-8674(01)00232-X; Heintzen C, 2007, ADV GENET, V58, P25, DOI 10.1016/S0065-2660(06)58002-2; Herrera-Estrella A, 2007, MOL MICROBIOL, V64, P5, DOI 10.1111/j.1365-2958.2007.05632.x; HONDA Y, 1978, PLANT PHYSIOL, V61, P711, DOI 10.1104/pp.61.5.711; Hunt SM, 2010, P NATL ACAD SCI USA, V107, P16709, DOI 10.1073/pnas.1009474107; Idnurm A, 2006, P NATL ACAD SCI USA, V103, P4546, DOI 10.1073/pnas.0600633103; Idnurm A, 2005, PLOS BIOL, V3, P615, DOI 10.1371/journal.pbio.0030095; Idnurm A, 2010, FUNGAL GENET BIOL, V47, P881, DOI 10.1016/j.fgb.2010.04.009; Idnurm A, 2010, MICROBIOL-SGM, V156, P2393, DOI 10.1099/mic.0.039222-0; Idnurm A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000470; Islam SZ, 1998, PLANT DIS, V82, P850, DOI 10.1094/PDIS.1998.82.8.850; JAFFE L, 1962, J CELL BIOL, V13, P13, DOI 10.1083/jcb.13.1.13; JARVIS WR, 1972, T BRIT MYCOL SOC, V58, P526, DOI 10.1016/S0007-1536(72)80108-6; Jarvis WR, 1977, BOTRYOTINIA BOTRYTIS; Kim H, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002113; Kim S, 2011, FUNGAL GENET BIOL, V48, P400, DOI 10.1016/j.fgb.2011.01.004; Kliebenstein DJ, 2005, PLANT J, V44, P25, DOI 10.1111/j.1365-313X.2005.02508.x; Lakin-Thomas PL, 2011, ADV GENET, V74, P55, DOI 10.1016/B978-0-12-387690-4.00003-9; Levis C, 1997, FEMS MICROBIOL LETT, V157, P267, DOI 10.1111/j.1574-6968.1997.tb12783.x; Linden H, 1997, FUNGAL GENET BIOL, V22, P141, DOI 10.1006/fgbi.1997.1013; Luna E, 2011, MOL PLANT MICROBE IN, V24, P183, DOI 10.1094/MPMI-07-10-0149; Malzahn E, 2010, CELL, V142, P762, DOI 10.1016/j.cell.2010.08.010; Montenegro-Montero A, 2013, NEUROSPORA: GENOMICS AND MOLECULAR BIOLOGY, P243; Oldenburg KR, 1997, NUCLEIC ACIDS RES, V25, P451, DOI 10.1093/nar/25.2.451; Patel RM, 2008, J GEN APPL MICROBIOL, V54, P367; PAUL W. R. C., 1929, TRANS BRIT MYCOL SOC, V14, P118; Peltier GL, 1912, MISSOURI BOT GARDEN, V1912, P41; PONTECORVO G, 1953, ADV GENET, V5, P141, DOI 10.1016/S0065-2660(08)60408-3; Purschwitz J, 2008, CURR BIOL, V18, P255, DOI 10.1016/j.cub.2008.01.061; Purschwitz J, 2006, CURR OPIN MICROBIOL, V9, P566, DOI 10.1016/j.mib.2006.10.011; Quidde T, 1998, PHYSIOL MOL PLANT P, V52, P151, DOI 10.1006/pmpp.1998.0142; Rebordinos Laureana, 2000, Revista Iberoamericana de Micologia, V17, pS37; Reino JL, 2004, J PHYTOPATHOL, V152, P563, DOI 10.1111/j.1439-0434.2004.00896.x; Robinson W, 1914, ANN BOT-LONDON, V28, P331, DOI 10.1093/oxfordjournals.aob.a089507; Roca MG, 2012, FUNGAL BIOL-UK, V116, P379, DOI 10.1016/j.funbio.2011.12.007; Roden LC, 2009, PLANT CELL, V21, P2546, DOI 10.1105/tpc.109.069922; Rodriguez-Romero J, 2010, ANNU REV MICROBIOL, V64, P585, DOI 10.1146/annurev.micro.112408.134000; Rohrig J, 2013, CURR GENET, V59, P55, DOI 10.1007/s00294-013-0387-9; Ruger-Herreros C, 2011, GENETICS, V188, P809, DOI 10.1534/genetics.111.130096; Ruiz-Roldan MC, 2008, EUKARYOT CELL, V7, P1227, DOI 10.1128/EC.00072-08; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Sanz C, 2009, P NATL ACAD SCI USA, V106, P7095, DOI 10.1073/pnas.0900879106; Schumacher J, 2013, PLOS GENET IN PRESS; Schumacher J, 2012, MORPHOGENESIS PATHOG, V22, P225, DOI DOI 10.1007/978-3-642-22916-9_11; Schumacher J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053729; Schumacher J, 2012, FUNGAL GENET BIOL, V49, P483, DOI 10.1016/j.fgb.2012.03.005; Segmuller N, 2008, MOL PLANT MICROBE IN, V21, P808, DOI 10.1094/MPMI-21-6-0808; Segmuller N, 2007, EUKARYOT CELL, V6, P211, DOI 10.1128/EC.00153-06; Siewers V, 2005, MOL PLANT MICROBE IN, V18, P602, DOI 10.1094/MPMI-18-0602; Siewers V, 2004, APPL ENVIRON MICROB, V70, P3868, DOI 10.1128/AEM.70.7.3868-3876.2004; Smith KM, 2010, EUKARYOT CELL, V9, P1549, DOI 10.1128/EC.00154-10; Staats M, 2012, EUKARYOT CELL, V11, P1413, DOI 10.1128/EC.00164-12; Staben C, 1989, FUNGAL GENET NEWSL, V36, P79, DOI DOI 10.4148/1941-4765.1519; STEWART TM, 1987, NEW ZEAL J EXP AGR, V15, P389, DOI 10.1080/03015521.1987.10425587; SUZUKI Y, 1979, Annals of the Phytopathological Society of Japan, V45, P54, DOI 10.3186/jjphytopath.45.54; SUZUKI Y, 1977, J GEN MICROBIOL, V98, P199, DOI 10.1099/00221287-98-1-199; TAN KK, 1973, T BRIT MYCOL SOC, V61, P147; TAN KK, 1975, T BRIT MYCOL SOC, V64, P215, DOI 10.1016/S0007-1536(75)80105-7; TAN KK, 1974, J GEN MICROBIOL, V82, P191, DOI 10.1099/00221287-82-1-191; TAN KK, 1975, T BRIT MYCOL SOC, V64, P223, DOI 10.1016/S0007-1536(75)80106-9; Tan KK, 1974, T BR MYCOL SOC, V62; Tudzynski P., 2009, MYCOTA, P29; van Kan JAL, 2006, TRENDS PLANT SCI, V11, P247, DOI 10.1016/j.tplants.2006.03.005; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Williamson B, 2007, MOL PLANT PATHOL, V8, P561, DOI 10.1111/J.1364-3703.2007.00417.X; WINSTON F, 1995, YEAST, V11, P53, DOI 10.1002/yea.320110107	107	96	104	0	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84223	10.1371/journal.pone.0084223	http://dx.doi.org/10.1371/journal.pone.0084223			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391918	Green Published, gold, Green Submitted			2022-12-25	WOS:000329323900061
J	Faso, C; Bischof, S; Hehl, AB				Faso, Carmen; Bischof, Sylvain; Hehl, Adrian B.			The Proteome Landscape of Giardia lamblia Encystation	PLOS ONE			English	Article							LIFE-CYCLE; CYST WALL; TRANSCRIPTIONAL RESPONSE; SECRETORY APPARATUS; ANTIGENIC VARIATION; VENTRAL DISC; PROTEINS; DIFFERENTIATION; GENOME; EXPRESSION	Giardia lamblia is an intestinal protozoan parasite required to survive in the environment in order to be transmitted to a new host. To ensure parasite survival, flagellated trophozoites colonizing the small intestine differentiate into non-motile environmentally-resistant cysts which are then shed in the environment. This cell differentiation process called encystation is characterized by significant morphological remodeling which includes secretion of large amounts of cyst wall material. Although much is known about the transcriptional regulation of encystation and the synthesis and trafficking of cyst wall material, the investigation of global changes in protein content and abundance during G. lamblia encystation is still unaddressed. In this study, we report on the quantitative analysis of the G. lamblia proteome during encystation using tandem mass spectrometry. Quantification of more than 1000 proteins revealed major changes in protein abundance in early, mid and late encystation, notably in constitutive secretory protein trafficking. Early stages of encystation were marked by a striking decrease of endoplasmic reticulum-targeted variant-specific surface proteins and significant increases in cytoskeleton regulatory components, NEK protein kinases and proteins involved in protein folding and glycolysis. This was in stark contrast to cells in the later stages of encystation which presented a surprisingly similar proteome composition to non-encysting trophozoites. Altogether these data constitute the first quantitative atlas of the Giardia proteome covering the whole process of encystation and point towards an important role for post-transcriptional control of gene expression in Giardia differentiation. Furthermore, our data provide a valuable resource for the community-based annotation effort of the G. lamblia genome, where almost 70% of all predicted gene models remains "hypothetical''.	[Faso, Carmen; Hehl, Adrian B.] Univ Zurich, Inst Parasitol, CH-8057 Zurich, Switzerland; [Bischof, Sylvain] ETH, Dept Biol, Zurich, Switzerland	University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich	Faso, C (corresponding author), Univ Zurich, Inst Parasitol, Winterthurerstr 266A, CH-8057 Zurich, Switzerland.	carmen.faso@access.uzh.ch; adrian.hehl@access.uzh.ch	Faso, Carmen/B-2141-2018	Faso, Carmen/0000-0002-1831-9365; Hehl, Adrian/0000-0002-2110-4445	Swiss National Science Foundation [31003A_140803]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was funded by Swiss National Science Foundation grant (#31003A_140803) to ABH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam RD, 2001, CLIN MICROBIOL REV, V14, P447, DOI 10.1128/CMR.14.3.447-475.2001; Adrain C, 2012, NAT REV MOL CELL BIO, V13, P489, DOI 10.1038/nrm3392; ALEY SB, 1993, EXP PARASITOL, V77, P295, DOI 10.1006/expr.1993.1087; Ankarklev J, 2010, NAT REV MICROBIOL, V8, P413, DOI 10.1038/nrmicro2317; ARROYOBEGOVICH A, 1980, J PARASITOL, V66, P735, DOI 10.2307/3280662; Aurrecoechea C, 2009, NUCLEIC ACIDS RES, V37, pD526, DOI 10.1093/nar/gkn631; Baerenfaller K, 2008, SCIENCE, V320, P938, DOI 10.1126/science.1157956; Behnke MS, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002992; Bennett V, 2001, PHYSIOL REV, V81, P1353, DOI 10.1152/physrev.2001.81.3.1353; Bernander R, 2001, CELL MICROBIOL, V3, P55, DOI 10.1046/j.1462-5822.2001.00094.x; Birkeland SR, 2010, MOL BIOCHEM PARASIT, V174, P62, DOI 10.1016/j.molbiopara.2010.05.010; Bischof S, 2011, PLANT CELL, V23, P3911, DOI 10.1105/tpc.111.092882; Brameier M, 2007, BIOINFORMATICS, V23, P1159, DOI 10.1093/bioinformatics/btm066; Castillo-Romero A, 2012, MOL BIOCHEM PARASIT, V184, P122, DOI 10.1016/j.molbiopara.2012.04.011; Chiu PW, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000677; Davids BJ, 2011, MOL BIOCHEM PARASIT, V175, P169, DOI 10.1016/j.molbiopara.2010.11.008; Davids BJ, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000044; DuBois KN, 2008, J BIOL CHEM, V283, P18024, DOI 10.1074/jbc.M802133200; Ehrenkaufer GM, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-7-r77; Elmendorf HG, 2005, INT J PARASITOL, V35, P1001, DOI 10.1016/j.ijpara.2005.03.009; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Faghiri Z, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-91; Faso C, 2013, CELL MICROBIOL, V15, P537, DOI 10.1111/cmi.12054; Faso C, 2011, INT J PARASITOL, V41, P471, DOI 10.1016/j.ijpara.2010.12.014; FRANZEN O, 2013, PLOS COMPUT BIOL, V0009; Furness B W, 2000, MMWR CDC Surveill Summ, V49, P1; GILLIN FD, 1989, EXP PARASITOL, V69, P164, DOI 10.1016/0014-4894(89)90185-9; Guenther MG, 2002, GENE DEV, V16, P3130, DOI 10.1101/gad.1037502; Hagen KD, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001442; Hehl AB, 2000, MOL BIOL CELL, V11, P1789, DOI 10.1091/mbc.11.5.1789; Hirokawa N, 1998, SCIENCE, V279, P519, DOI 10.1126/science.279.5350.519; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Irving JA, 2000, GENOME RES, V10, P1845, DOI 10.1101/gr.GR-1478R; Jedelsky PL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017285; KANE AV, 1991, J PARASITOL, V77, P974, DOI 10.2307/3282752; Kim J, 2009, PARASITOL RES, V104, P475, DOI 10.1007/s00436-008-1223-x; Knodler LA, 1999, J BIOL CHEM, V274, P29805, DOI 10.1074/jbc.274.42.29805; Konrad C, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000835; Lauwaet T, 2007, CURR OPIN MICROBIOL, V10, P554, DOI 10.1016/j.mib.2007.09.011; Lauwaet T, 2007, MOL BIOCHEM PARASIT, V152, P80, DOI 10.1016/j.molbiopara.2006.12.001; Lauwaet T, 2011, INT J PARASITOL, V41, P1079, DOI 10.1016/j.ijpara.2011.06.001; LEWIS VA, 1992, NATURE, V358, P249, DOI 10.1038/358249a0; Lorente-Rodriguez A., 2011, COLD SPRING HARBOR P, V3; Lourenco Daniela, 2012, BMC Research Notes, V5, P41, DOI 10.1186/1756-0500-5-41; Lu P, 2007, NAT BIOTECHNOL, V25, P117, DOI 10.1038/nbt1270; Lunt SY, 2011, ANNU REV CELL DEV BI, V27, P441, DOI 10.1146/annurev-cellbio-092910-154237; Manning G, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-7-r66; Marti M, 2003, J BIOL CHEM, V278, P24837, DOI 10.1074/jbc.M302082200; Marti M, 2003, MOL BIOL CELL, V14, P1433, DOI 10.1091/mbc.E02-08-0467; Mastronicola D, 2011, IUBMB LIFE, V63, P21, DOI 10.1002/iub.409; Mattaj IW, 1998, ANNU REV BIOCHEM, V67, P265, DOI 10.1146/annurev.biochem.67.1.265; Morf L, 2010, EUKARYOT CELL, V9, P1566, DOI 10.1128/EC.00100-10; Morrison HG, 2007, SCIENCE, V317, P1921, DOI 10.1126/science.1143837; Munasinghe VS, 2013, INT J PARASITOL, V43, P879, DOI 10.1016/j.ijpara.2013.06.003; Palm D, 2005, MOL BIOCHEM PARASIT, V141, P199, DOI 10.1016/j.molbiopara.2005.03.005; Prucca CG, 2009, CELL MICROBIOL, V11, P1706, DOI 10.1111/j.1462-5822.2009.01367.x; Prucca CG, 2008, NATURE, V456, P750, DOI 10.1038/nature07585; RASCON AJ, 2013, CURRENT MED CHEM; Rhee SG, 2001, IUBMB LIFE, V52, P35, DOI 10.1080/15216540252774748; Ringqvist E, 2008, MOL BIOCHEM PARASIT, V159, P85, DOI 10.1016/j.molbiopara.2008.02.005; Rivero MR, 2010, BIOCHEM J, V428, P33, DOI 10.1042/BJ20100096; Saraiya AA, 2011, RNA, V17, P2152, DOI 10.1261/rna.028118.111; Saraiya AA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000224; Sener K, 2004, MICROBIOL-SGM, V150, P1225, DOI 10.1099/mic.0.26898-0; Shevchenko A, 1996, P NATL ACAD SCI USA, V93, P14440, DOI 10.1073/pnas.93.25.14440; Smith AJ, 2012, INT J PARASITOL, V42, P411, DOI 10.1016/j.ijpara.2012.03.001; Sonda S, 2010, MOL MICROBIOL, V76, P48, DOI 10.1111/j.1365-2958.2010.07062.x; Spycher C, 2013, MOL MICROBIOL, V88, P754, DOI 10.1111/mmi.12218; Stefanic S, 2006, J BIOL CHEM, V281, P7595, DOI 10.1074/jbc.M510940200; Sun CH, 2003, J BIOL CHEM, V278, P21701, DOI 10.1074/jbc.M302023200; Sun CH, 2002, MOL MICROBIOL, V46, P971, DOI 10.1046/j.1365-2958.2002.03233.x; Tenter AM, 2000, INT J PARASITOL, V30, P1217, DOI 10.1016/S0020-7519(00)00124-7; Vale RD, 2003, CELL, V112, P467, DOI 10.1016/S0092-8674(03)00111-9; Vizcaino JA, 2010, CURR PROTOC PROTEIN; WAGENBACH GE, 1969, J PROTOZOOL, V16, P257, DOI 10.1111/j.1550-7408.1969.tb02266.x; Wu G, 2000, MOL BIOL EVOL, V17, P1156, DOI 10.1093/oxfordjournals.molbev.a026398; YAFFE MB, 1992, NATURE, V358, P245, DOI 10.1038/358245a0; Yee J, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-26	78	29	29	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83207	10.1371/journal.pone.0083207	http://dx.doi.org/10.1371/journal.pone.0083207			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391747	Green Submitted, Green Published, gold, Green Accepted			2022-12-25	WOS:000329325200044
J	Hsin, KY; Ghosh, S; Kitano, H				Hsin, Kun-Yi; Ghosh, Samik; Kitano, Hiroaki			Combining Machine Learning Systems and Multiple Docking Simulation Packages to Improve Docking Prediction Reliability for Network Pharmacology	PLOS ONE			English	Article							SCORING FUNCTIONS; MOLECULAR DOCKING; BINDING-AFFINITY; PROTEIN; INHIBITOR; CARDIOTOXICITY; DISCOVERY; SOFTWARE; PROGRAMS; ACCURATE	Increased availability of bioinformatics resources is creating opportunities for the application of network pharmacology to predict drug effects and toxicity resulting from multi-target interactions. Here we present a high-precision computational prediction approach that combines two elaborately built machine learning systems and multiple molecular docking tools to assess binding potentials of a test compound against proteins involved in a complex molecular network. One of the two machine learning systems is a re-scoring function to evaluate binding modes generated by docking tools. The second is a binding mode selection function to identify the most predictive binding mode. Results from a series of benchmark validations and a case study show that this approach surpasses the prediction reliability of other techniques and that it also identifies either primary or off-targets of kinase inhibitors. Integrating this approach with molecular network maps makes it possible to address drug safety issues by comprehensively investigating network-dependent effects of a drug or drug candidate.	[Hsin, Kun-Yi; Kitano, Hiroaki] Okinawa Inst Sci & Technol Grad Univ, Onna Son, Okinawa, Japan; [Ghosh, Samik; Kitano, Hiroaki] Syst Biol Inst, Minato Ku, Tokyo, Japan; [Ghosh, Samik; Kitano, Hiroaki] RIKEN Ctr Integrat Med Sci, Lab Dis Syst Modeling, Yokohama, Kanagawa, Japan	Okinawa Institute of Science & Technology Graduate University; RIKEN	Hsin, KY (corresponding author), Okinawa Inst Sci & Technol Grad Univ, Onna Son, Okinawa, Japan.	kunyi.hsin@oist.jp; kitano@sbi.jp	Ghosh, Samik/AAF-6207-2021; Kitano, Hiroaki/A-6460-2016	Ghosh, Samik/0000-0002-0239-5400; 	Japan Society for the Promotion of Science (JSPS)	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by the HD-Physiology Project of the Japan Society for the Promotion of Science (JSPS) to the Okinawa Institute of Science and Technology Graduate University (OIST). This work, in part, has been carried out as research collaboration between the United States Food and Drug Administration (FDA) and the Systems Biology Institute (SBI) under Memorandum of Understanding Number 225-12-8000. Funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai JPF, 2013, ANNU REV PHARMACOL, V53, P451, DOI 10.1146/annurev-pharmtox-011112-140248; Ballester PJ, 2010, BIOINFORMATICS, V26, P1169, DOI 10.1093/bioinformatics/btq112; BOHNING D, 1992, ANN I STAT MATH, V44, P197, DOI 10.1007/bf00048682; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Caron E, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.108; Cases M, 2009, DRUG DISCOV TODAY, V14, P479, DOI 10.1016/j.drudis.2009.02.010; Chen Y, 2009, NAT CHEM BIOL, V5, P358, DOI 10.1038/nchembio.155; Cheng TJ, 2009, J CHEM INF MODEL, V49, P1079, DOI 10.1021/ci9000053; Csermely P, 2005, TRENDS PHARMACOL SCI, V26, P178, DOI 10.1016/j.tips.2005.02.007; DALBY A, 1992, J CHEM INF COMP SCI, V32, P244, DOI 10.1021/ci00007a012; EMBL-EBI, 2013, BIOINF SERV MOL DAT; Englebienne P, 2009, J CHEM INF MODEL, V49, P1568, DOI 10.1021/ci8004308; Ferguson J, 2013, ONCOGENE, V32, P86, DOI 10.1038/onc.2012.25; Force T, 2007, NAT REV CANCER, V7, P332, DOI 10.1038/nrc2106; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Geldenhuys WJ, 2013, EXPERT OPINION DRUG, P1; Ghosh S, 2011, NAT REV GENET, V12, P821, DOI 10.1038/nrg3096; Jain AN, 2003, J MED CHEM, V46, P499, DOI 10.1021/jm020406h; Karaman MW, 2008, NAT BIOTECHNOL, V26, P127, DOI 10.1038/nbt1358; Kerkela R, 2009, CTS-CLIN TRANSL SCI, V2, P15, DOI 10.1111/j.1752-8062.2008.00090.x; Kitano H, 2005, NAT BIOTECHNOL, V23, P961, DOI 10.1038/nbt1111; Manousaridis I, 2013, J EUR ACAD DERMATOL, V27, P11, DOI 10.1111/j.1468-3083.2012.04546.x; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; OBOYLE NM, 2011, J CHEMINFORMATICS, V3, DOI [DOI 10.1186/1758-2946-3-33, 10.1186/1758-2946-3-33]; Oda A, 2006, J CHEM INF MODEL, V46, P380, DOI 10.1021/ci050283k; Oda K, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100057; Oda K, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100014; Plewczynski D, 2011, J COMPUT CHEM, V32, P742, DOI 10.1002/jcc.21643; Plewczynski D, 2011, J COMPUT CHEM, V32, P568, DOI 10.1002/jcc.21642; Rarey M, 1996, J MOL BIOL, V261, P470, DOI 10.1006/jmbi.1996.0477; Rose PW, 2013, NUCLEIC ACIDS RES, V41, pD475, DOI 10.1093/nar/gks1200; SADOWSKI J, 1994, J CHEM INF COMP SCI, V34, P1000, DOI 10.1021/ci00020a039; Teramoto R, 2008, J CHEM INF MODEL, V48, P288, DOI 10.1021/ci700239t; Trepalin SV, 2006, MOLECULES, V11, P219, DOI 10.3390/11040219; Tripos, 2009, TRIP SYB MOL2 FIL FO; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Venkatachalam CM, 2003, J MOL GRAPH MODEL, V21, P289, DOI 10.1016/S1093-3263(02)00164-X; Verdonk ML, 2003, PROTEINS, V52, P609, DOI 10.1002/prot.10465; Wang RX, 2004, J MED CHEM, V47, P2977, DOI 10.1021/jm030580l; Wang RX, 2002, J COMPUT AID MOL DES, V16, P11, DOI 10.1023/A:1016357811882; WEININGER D, 1988, J CHEM INF COMP SCI, V28, P31, DOI 10.1021/ci00057a005; Wilhelm S, 2006, NAT REV DRUG DISCOV, V5, P835, DOI 10.1038/nrd2130; Xie L, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000387; Zsoldos Z, 2006, CURR PROTEIN PEPT SC, V7, P421, DOI 10.2174/138920306778559412	44	144	201	12	138	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83922	10.1371/journal.pone.0083922	http://dx.doi.org/10.1371/journal.pone.0083922			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391846	Green Submitted, Green Published, gold			2022-12-25	WOS:000329325200144
J	Nielsen, TK; Xu, ZF; Gozdereliler, E; Aamand, J; Hansen, LH; Sorensen, SR				Nielsen, Tue Kjaergaard; Xu, Zhuofei; Gozdereliler, Erkin; Aamand, Jens; Hansen, Lars Hestbjerg; Sorensen, Sebastian R.			Novel Insight into the Genetic Context of the cadAB Genes from a 4-chloro-2-methylphenoxyacetic Acid-Degrading Sphingomonas	PLOS ONE			English	Article							2,4-DICHLOROPHENOXYACETIC ACID; COMPLETE SEQUENCE; DEGRADATION; ALPHA; TRANSPOSITION; ACCURATE; PLASMID; PATHWAY; TFDA; MONOOXYGENASE	The 2-methyl-4-chlorophenoxyacetic (MCPA) acid-degrader Sphingomonas sp. ERG5 has recently been isolated from MCPA-degrading bacterial communities. Using Illumina-sequencing, the 5.7 Mb genome of this isolate was sequenced in this study, revealing the 138 kbp plasmid pCADAB1 harboring the 32.5 kbp composite transposon Tn6228 which contains genes encoding proteins for the removal of 2,4-dichlorophenoxyacetic acid (2,4-D) and MCPA, as well as the regulation of this pathway. Transposon Tn6228 was confirmed by PCR to be situated on the plasmid and also exist in a circular intermediate state - typical of IS3 elements. The canonical tfdA alpha-gene of group III 2,4-D degraders, encoding the first step in degradation of 2,4-D and related compounds, was not present in the chromosomal contigs. However, the alternative cadAB genes, also providing the initial degradation step, were found in Tn6228, along with the 2,4-D-degradation-associated genes tfdBCDEFKR and cadR. Putative reductase and ferredoxin genes cadCD of Rieske non-heme iron oxygenases were also present in close proximity to cadAB, suggesting that these might have an unknown role in the initial degradation reaction. Parts of the composite transposon contain sequence displaying high similarity to previously analyzed 2,4-D degradation genes, suggesting rapid dissemination and high conservation of the chlorinated-phenoxyacetic acid (PAA)-degradation genotype among the sphingomonads.	[Nielsen, Tue Kjaergaard; Gozdereliler, Erkin; Aamand, Jens; Sorensen, Sebastian R.] Geol Survey Denmark & Greenland, Dept Geochem, Copenhagen, Denmark; [Nielsen, Tue Kjaergaard; Xu, Zhuofei; Hansen, Lars Hestbjerg] Univ Copenhagen, Microbiol Sect, Copenhagen, Denmark	Geological Survey Of Denmark & Greenland; University of Copenhagen	Hansen, LH (corresponding author), Aarhus Univ, ENVS Dept Environm Sci, Roskilde, Denmark.	lhha@dmu.dk	Sørensen, Sebastian R./A-4305-2014; Sørensen, Søren J/J-5015-2014; Sørensen, Sebastian Reinhold/AAM-2406-2020	Sørensen, Søren J/0000-0001-6227-9906; Hestbjerg Hansen, Lars/0000-0003-0027-1524; Aamand, Jens/0000-0002-4641-639X; Nielsen, Tue/0000-0001-6610-8450	Center for Environmental and Agricultural Microbiology - CREAM; Lundbeck Foundation project DK [R44-A4384]; VILLUM FOUNDATION; Lundbeck Foundation [R44-2009-4384] Funding Source: researchfish	Center for Environmental and Agricultural Microbiology - CREAM; Lundbeck Foundation project DK; VILLUM FOUNDATION(Villum Fonden); Lundbeck Foundation(Lundbeckfonden)	This study was partly funded by the Center for Environmental and Agricultural Microbiology - CREAM and the Lundbeck Foundation (www.lundbeckfoundation.com) project DK nr R44-A4384 (Lars Hestbjerg Hansen). CREAM is funded by the VILLUM FOUNDATION (www.villumfoundation.dk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Basta T, 2004, J BACTERIOL, V186, P3862, DOI 10.1128/JB.186.12.3862-3872.2004; Bateman A, 2000, NUCLEIC ACIDS RES, V28, P263, DOI 10.1093/nar/28.1.263; Carver T, 2009, BIOINFORMATICS, V25, P119, DOI 10.1093/bioinformatics/btn578; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Curcio MJ, 2003, NAT REV MOL CELL BIO, V4, P865, DOI 10.1038/nrm1241; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Ditterich F, 2013, FEMS MICROBIOL ECOL; DON RH, 1985, J BACTERIOL, V161, P85, DOI 10.1128/JB.161.1.85-90.1985; Ferraro DJ, 2005, BIOCHEM BIOPH RES CO, V338, P175, DOI 10.1016/j.bbrc.2005.08.222; Filer K, 1997, APPL ENVIRON MICROB, V63, P317, DOI 10.1128/AEM.63.1.317-320.1997; FUKUMORI F, 1993, J BIOL CHEM, V268, P24311; FUKUMORI F, 1993, J BACTERIOL, V175, P2083, DOI 10.1128/JB.175.7.2083-2086.1993; Gibson DT, 2000, CURR OPIN BIOTECH, V11, P236, DOI 10.1016/S0958-1669(00)00090-2; Gozdereliler E, 2013, APPL ENVIRON MICROB, V79, P367, DOI 10.1128/AEM.02536-12; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Harwood CS, 1996, ANNU REV MICROBIOL, V50, P553, DOI 10.1146/annurev.micro.50.1.553; Huong NL, 2007, MICROBES ENVIRONMENT, V22, P243, DOI 10.1264/jsme2.22.243; Hurtubise Y, 1998, J BACTERIOL, V180, P5828, DOI 10.1128/JB.180.22.5828-5835.1998; Itoh K, 2004, APPL ENVIRON MICROB, V70, P2110, DOI 10.1128/AEM.70.4.2110-2118.2004; Itoh K, 2002, APPL ENVIRON MICROB, V68, P3449, DOI 10.1128/AEM.68.7.3449-3454.2002; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Kamagata Y, 1997, APPL ENVIRON MICROB, V63, P2266, DOI 10.1128/AEM.63.6.2266-2272.1997; Kitagawa W, 2002, J BACTERIOL, V184, P509, DOI 10.1128/JB.184.2.509-518.2002; Larsen TS, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-21; Ledger T, 2002, MICROBIOL-SGM, V148, P3431, DOI 10.1099/00221287-148-11-3431; Leveau JHJ, 1998, J BACTERIOL, V180, P2237, DOI 10.1128/JB.180.8.2237-2243.1998; Lindgreen Stinus, 2012, BMC Res Notes, V5, P337, DOI 10.1186/1756-0500-5-337; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; McGowan C, 1998, APPL ENVIRON MICROB, V64, P4089; Muller TA, 2004, APPL ENVIRON MICROB, V70, P6066, DOI 10.1128/AEM.70.10.6066-6075.2004; Nagarajan N, 2013, NAT REV GENET, V14, P157, DOI 10.1038/nrg3367; Nielsen P, 2005, BIOINFORMATICS, V21, P4322, DOI 10.1093/bioinformatics/bti701; Nojiri H, 2004, APPL MICROBIOL BIOT, V64, P154, DOI 10.1007/s00253-003-1509-y; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Ohtsubo E, 2004, ADV BIOPHYS, V38, P125, DOI 10.1016/S0065-227X(04)80121-7; Rasko DA, 2007, J BACTERIOL, V189, P52, DOI 10.1128/JB.01313-06; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Romine MF, 1999, J BACTERIOL, V181, P1585, DOI 10.1128/JB.181.5.1585-1602.1999; Sekine Y, 1999, J MOL BIOL, V294, P21, DOI 10.1006/jmbi.1999.3181; Shimojo M, 2009, J BIOSCI BIOENG, V108, P56, DOI 10.1016/j.jbiosc.2009.02.018; Shintani M, 2007, J BACTERIOL, V189, P2007, DOI 10.1128/JB.01486-06; Siguier P, 2006, NUCLEIC ACIDS RES, V34, pD32, DOI 10.1093/nar/gkj014; Stolz A, 2009, APPL MICROBIOL BIOT, V81, P793, DOI 10.1007/s00253-008-1752-3; STREBER WR, 1987, J BACTERIOL, V169, P2950, DOI 10.1128/jb.169.7.2950-2955.1987; Sullivan MJ, 2011, BIOINFORMATICS, V27, P1009, DOI 10.1093/bioinformatics/btr039; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thiel M, 2005, ARCH MICROBIOL, V183, P80, DOI 10.1007/s00203-004-0748-3; Thorling L, 2011, GEUS 2011; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	54	21	25	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83346	10.1371/journal.pone.0083346	http://dx.doi.org/10.1371/journal.pone.0083346			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391756	Green Published, Green Submitted, gold			2022-12-25	WOS:000329325200053
J	Shi, JY; Yiu, SM; Zhang, YN; Chin, FYL				Shi, Jian-Yu; Yiu, Siu-Ming; Zhang, Yan-Ning; Chin, Francis Yuk-Lun			Effective Moment Feature Vectors for Protein Domain Structures	PLOS ONE			English	Article							SCOP-FOLD CLASSIFICATION; STRUCTURE SPACE; MEAN SHIFT; REPRESENTATION; SUPERFAMILIES; CONSERVATION; RETRIEVAL; DATABASE; HISTORY; GENE	Imaging processing techniques have been shown to be useful in studying protein domain structures. The idea is to represent the pairwise distances of any two residues of the structure in a 2D distance matrix (DM). Features and/or submatrices are extracted from this DM to represent a domain. Existing approaches, however, may involve a large number of features (100-400) or complicated mathematical operations. Finding fewer but more effective features is always desirable. In this paper, based on some key observations on DMs, we are able to decompose a DM image into four basic binary images, each representing the structural characteristics of a fundamental secondary structure element (SSE) or a motif in the domain. Using the concept of moments in image processing, we further derive 45 structural features based on the four binary images. Together with 4 features extracted from the basic images, we represent the structure of a domain using 49 features. We show that our feature vectors can represent domain structures effectively in terms of the following. (1) We show a higher accuracy for domain classification. (2) We show a clear and consistent distribution of domains using our proposed structural vector space. (3) We are able to cluster the domains according to our moment features and demonstrate a relationship between structural variation and functional diversity.	[Shi, Jian-Yu] Northwestern Polytech Univ, Sch Life Sci, Xian, Shaanxi Provinc, Peoples R China; [Shi, Jian-Yu; Yiu, Siu-Ming; Chin, Francis Yuk-Lun] Univ Hong Kong, Dept Comp Sci, Hong Kong, Hong Kong, Peoples R China; [Zhang, Yan-Ning] Northwestern Polytech Univ, Sch Comp Sci, Xian, Shaanxi Provinc, Peoples R China	Northwestern Polytechnical University; University of Hong Kong; Northwestern Polytechnical University	Chin, FYL (corresponding author), Univ Hong Kong, Dept Comp Sci, Hong Kong, Hong Kong, Peoples R China.	chin@cs.hku.hk	Shi, Jian-Yu/S-4485-2019; Yiu, Siu Ming/C-1843-2009	Shi, Jian-Yu/0000-0002-2303-273X; Yiu, Siu Ming/0000-0002-3975-8500	Hong Kong Scholars Program [XJ2011028]; University of Hong Kong [201209176053]; Fundamental Research Foundation of Northwestern Polytechnical University in China [JC201164]	Hong Kong Scholars Program; University of Hong Kong(University of Hong Kong); Fundamental Research Foundation of Northwestern Polytechnical University in China	This work was supported by Hong Kong Scholars Program (No. XJ2011028, http://www.hkscholars.org/) and Small Project Funding of the University of Hong Kong(No. 201209176053, http://www2.caes.hku.hk/research/research-funding/), and partially supported by Fundamental Research Foundation of Northwestern Polytechnical University in China (No. JC201164, http://www.nwpu.edu.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreeva A, 2008, NUCLEIC ACIDS RES, V36, pD419, DOI 10.1093/nar/gkm993; Aung Z, 2007, DRUG DISCOV TODAY, V12, P732, DOI 10.1016/j.drudis.2007.07.014; Bartenhagen C, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-567; Bashton M, 2007, STRUCTURE, V15, P85, DOI 10.1016/j.str.2006.11.009; Bornberg-Bauer E, 2010, CURR OPIN STRUC BIOL, V20, P390, DOI 10.1016/j.sbi.2010.02.005; Budowski-Tal I, 2010, P NATL ACAD SCI USA, V107, P3481, DOI 10.1073/pnas.0914097107; CHENG YZ, 1995, IEEE T PATTERN ANAL, V17, P790, DOI 10.1109/34.400568; Chi PH, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-362; Chi PH, 2009, BIOINFORMATICS, V25, P2559, DOI 10.1093/bioinformatics/btp474; Choi IG, 2004, P NATL ACAD SCI USA, V101, P3797, DOI 10.1073/pnas.0308656100; Choi IG, 2006, P NATL ACAD SCI USA, V103, P14056, DOI 10.1073/pnas.0606239103; Chothia C, 2009, BIOCHEM J, V419, P15, DOI 10.1042/BJ20090122; Clarke R, 2008, NAT REV CANCER, V8, P37, DOI 10.1038/nrc2294; CLEVELAND WS, 1979, J AM STAT ASSOC, V74, P829, DOI 10.2307/2286407; Comaniciu D, 2002, IEEE T PATTERN ANAL, V24, P603, DOI 10.1109/34.1000236; Dessailly BH, 2010, STRUCTURE, V18, P1522, DOI 10.1016/j.str.2010.08.017; Dessailly BH, 2009, CURR OPIN STRUC BIOL, V19, P349, DOI 10.1016/j.sbi.2009.03.009; Greene LH, 2007, NUCLEIC ACIDS RES, V35, pD291, DOI 10.1093/nar/gkl959; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Hou JT, 2005, P NATL ACAD SCI USA, V102, P3651, DOI 10.1073/pnas.0409772102; Hou JT, 2003, P NATL ACAD SCI USA, V100, P2386, DOI 10.1073/pnas.2628030100; Kaufman L, 1990, FINDING GROUPS DATA, P68163; Minary P, 2008, J MOL BIOL, V375, P920, DOI 10.1016/j.jmb.2007.10.087; Morais DADL, 2011, NUCLEIC ACIDS RES, V39, pD427, DOI 10.1093/nar/gkq1130; ORENGO CA, 1994, NATURE, V372, P631, DOI 10.1038/372631a0; Osadchy M, 2011, P NATL ACAD SCI USA, V108, P12301, DOI 10.1073/pnas.1102727108; Penner RC, 2010, COMMUN PUR APPL MATH, V63, P1249, DOI 10.1002/cpa.20340; Penner RC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019670; Ponting CP, 2002, ANNU REV BIOPH BIOM, V31, P45, DOI 10.1146/annurev.biophys.31.082901.134314; PORAT M, 1988, IEEE T PATTERN ANAL, V10, P452, DOI 10.1109/34.3910; Reeves GA, 2006, J MOL BIOL, V360, P725, DOI 10.1016/j.jmb.2006.05.035; Rogen P, 2003, MATH BIOSCI, V182, P167, DOI 10.1016/S0025-5564(02)00216-X; Rogen P, 2003, P NATL ACAD SCI USA, V100, P119, DOI 10.1073/pnas.2636460100; Scholkopf B, 1998, NEURAL COMPUT, V10, P1299, DOI 10.1162/089976698300017467; Shi JY, 2009, LECT N BIOINFORMAT, V5780, P344; Shindyalov IN, 1998, PROTEIN ENG, V11, P739, DOI 10.1093/protein/11.9.739; Swalla BM, 2003, NUCLEIC ACIDS RES, V31, P805, DOI 10.1093/nar/gkg142; TEH CH, 1988, IEEE T PATTERN ANAL, V10, P496, DOI 10.1109/34.3913; Valas RE, 2009, CURR OPIN STRUC BIOL, V19, P329, DOI 10.1016/j.sbi.2009.03.011; WALKER JE, 1990, PHILOS T ROY SOC B, V326, P367, DOI 10.1098/rstb.1990.0018; Yang S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008378	42	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83788	10.1371/journal.pone.0083788	http://dx.doi.org/10.1371/journal.pone.0083788			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391828	Green Submitted, Green Published, gold			2022-12-25	WOS:000329325200126
J	Lortie, CJ; Allesina, S; Aarssen, L; Grod, O; Budden, AE				Lortie, Christopher J.; Allesina, Stefano; Aarssen, Lonnie; Grod, Olyana; Budden, Amber E.			With Great Power Comes Great Responsibility: the Importance of Rejection, Power, and Editors in the Practice of Scientific Publishing	PLOS ONE			English	Article							ECOLOGY	Peer review is an important element of scientific communication but deserves quantitative examination. We used data from the handling service manuscript Central for ten mid-tier ecology and evolution journals to test whether number of external reviews completed improved citation rates for all accepted manuscripts. Contrary to a previous study examining this issue using resubmission data as a proxy for reviews, we show that citation rates of manuscripts do not correlate with the number of individuals that provided reviews. Importantly, externally-reviewed papers do not outperform editor-only reviewed published papers in terms of visibility within a 5-year citation window. These findings suggest that in many instances editors can be all that is needed to review papers (or at least conduct the critical first review to assess general suitability) if the purpose of peer review is to primarily filter and that journals can consider reducing the number of referees associated with reviewing ecology and evolution papers.	[Lortie, Christopher J.; Grod, Olyana] York Univ, Dept Biol, Toronto, ON M3J 2R7, Canada; [Allesina, Stefano] Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA; [Aarssen, Lonnie] Queens Univ, Dept Biol, Kingston, ON K7L 3N6, Canada; [Budden, Amber E.] Univ Calif Santa Barbara, Natl Ctr Ecol Anal & Synth, Santa Barbara, CA 93106 USA	York University - Canada; University of Chicago; Queens University - Canada; National Center for Ecological Analysis & Synthesis; University of California System; University of California Santa Barbara	Lortie, CJ (corresponding author), York Univ, Dept Biol, Toronto, ON M3J 2R7, Canada.	lortie@yorku.ca	lortie, christopher j/F-6241-2014; Allesina, Stefano/A-2255-2009; Budden, Amber/A-2829-2010	lortie, christopher j/0000-0002-4291-7023; Budden, Amber/0000-0003-2885-3980; Allesina, Stefano/0000-0003-0313-8374	National Center for Ecological Analysis and Synthesis; NSF [DEB- 0072909]	National Center for Ecological Analysis and Synthesis; NSF(National Science Foundation (NSF))	This work was conducted as part of the "Role of publication-related biases in ecology" Working Group supported by the National Center for Ecological Analysis and Synthesis, a Center funded by NSF (grant #DEB- 0072909). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarssen LW, 2012, IDEAS ECOL EVOL, V5, P78, DOI 10.4033/iee.2012.5b.16.f; Aarssen LW, 2010, IDEAS ECOL EVOL, V3, P28, DOI 10.4033/iee.2010.3.7.c; Arnqvist G, 2013, TRENDS ECOL EVOL, V28, P448, DOI 10.1016/j.tree.2013.05.007; Ball P., 2012, NATURE NEWS; Barto EK, 2012, OIKOS, V121, P228, DOI 10.1111/j.1600-0706.2011.19401.x; Bowers EK, 2012, SCIENCE, V338, P1029, DOI 10.1126/science.338.6110.1029-a; Budden AE, 2008, TRENDS ECOL EVOL, V23, P4, DOI 10.1016/j.tree.2007.07.008; Calcagno V, 2012, SCIENCE, V338, P1065, DOI 10.1126/science.1227833; Couzin-Frankel J, 2013, SCIENCE, V341, P1331, DOI 10.1126/science.341.6152.1331; Davidoff F, 2004, BRIT MED J, V328, P657, DOI 10.1136/bmj.328.7441.657; Fox J., 2010, B ECOL SOC AM, V91, P325, DOI DOI 10.1890/0012-9623-91.3.325; Grod O., 2009, FRONTIERS ECOLOGY EN, V8, P187; Grod ON, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003202; Hampton SE, 2013, FRONT ECOL ENVIRON, V11, P156, DOI 10.1890/120103; Hampton SE, 2011, BIOSCIENCE, V61, P900, DOI 10.1525/bio.2011.61.11.9; Hochberg ME, 2010, IDEAS ECOL EVOL, V3, P8, DOI 10.4033/iee.2010.3.2.c; Lortie CJ, 2007, OIKOS, V116, P1247, DOI 10.1111/j.0030-1299.2007.15686.x; Rohr JR, 2012, TRENDS ECOL EVOL, V27, P192, DOI 10.1016/j.tree.2012.01.012; SAMUELS ML, 1993, J AM STAT ASSOC, V88, P81, DOI 10.2307/2290700; Scott A, 2007, FUTURES, V39, P827, DOI 10.1016/j.futures.2006.12.009; Sheskin D., 2011, HDB PARAMETRIC NONPA, Vfifth, DOI [DOI 10.1201/9781420036268, 10.2307/2685909]; Thurner S, 2011, EUR PHYS J B, V84, P707, DOI 10.1140/epjb/e2011-20545-7; Ware Mark, 2008, PUBLISHING RES CONSO, V4, P1	23	7	7	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e85382	10.1371/journal.pone.0085382	http://dx.doi.org/10.1371/journal.pone.0085382			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386471	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000329194700135
J	Carne, C; Semple, S; Morrogh-Bernard, H; Zuberbuhler, K; Lehmann, J				Carne, Charlotte; Semple, Stuart; Morrogh-Bernard, Helen; Zuberbuehler, Klaus; Lehmann, Julia			Predicting the Vulnerability of Great Apes to Disease: The Role of Superspreaders and Their Potential Vaccination	PLOS ONE			English	Article							SOCIAL-NETWORK ANALYSIS; INDIVIDUAL VARIATION; PAN-TROGLODYTES; NATIONAL-PARK; CONSERVATION; CHIMPANZEES; TRANSMISSION; ECOLOGY; MAHALE; POPULATION	Disease is a major concern for the conservation of great apes, and one that is likely to become increasingly relevant as deforestation and the rise of ecotourism bring humans and apes into ever closer proximity. Consequently, it is imperative that preventative measures are explored to ensure that future epidemics do not wipe out the remaining populations of these animals. In this paper, social network analysis was used to investigate vulnerability to disease in a population of wild orang-utans and a community of wild chimpanzees. Potential 'superspreaders' of disease - individuals with disproportionately central positions in the community or population - were identified, and the efficacy of vaccinating these individuals assessed using simulations. Three resident female orang-utans were identified as potential superspreaders, and females and unflanged males were predicted to be more influential in disease spread than flanged males. By contrast, no superspreaders were identified in the chimpanzee network, although males were significantly more central than females. In both species, simulating the vaccination of the most central individuals in the network caused a greater reduction in potential disease pathways than removing random individuals, but this effect was considerably more pronounced for orang-utans. This suggests that targeted vaccinations would have a greater impact on reducing disease spread among orang-utans than chimpanzees. Overall, these results have important implications for orang-utan and chimpanzee conservation and highlight the role that certain individuals may play in the spread of disease and its prevention by vaccination.	[Carne, Charlotte; Semple, Stuart; Lehmann, Julia] Univ Roehampton, Ctr Res Evolutionary & Environm Anthropol, London, England; [Morrogh-Bernard, Helen] Univ Palangka Raya, Ctr Int Cooperat Sustainable Management Trop Peat, Orang Utan Trop Peatland Project OuTrop, Palangka Raya, Central Kaliman, Indonesia; [Morrogh-Bernard, Helen] Univ Exeter, Washington Singer Labs, Coll Life & Environm Sci, Ctr Res Anim Behav, Exeter, Devon, England; [Zuberbuehler, Klaus] Univ St Andrews, Sch Psychol & Neurosci, St Andrews, Fife, Scotland; [Zuberbuehler, Klaus] Univ Neuchatel, Ctr Cognit Sci, CH-2000 Neuchatel, Switzerland	Roehampton University; Universitas Palangka Raya (UPR); University of Exeter; University of St Andrews; University of Neuchatel	Carne, C (corresponding author), Univ Roehampton, Ctr Res Evolutionary & Environm Anthropol, London, England.	charlotte.carne@roehampton.ac.uk	Zuberbühler, Klaus/A-9053-2011	Zuberbühler, Klaus/0000-0001-8378-088X; Semple, Stuart/0000-0003-0452-8104; Lehmann, Julia/0000-0001-7278-1705	University of Roehampton; Royal Zoological Society of Scotland; Budongo Conservation Field Station; Wildlife Conservation Society (WCS); US Fish and Wildlife Service Great Ape Conservation Fund; Orang-utan Tropical Peatland Project (OuTrop); Primate Conservation Inc; L.S.B. Leakey Foundation	University of Roehampton; Royal Zoological Society of Scotland; Budongo Conservation Field Station; Wildlife Conservation Society (WCS); US Fish and Wildlife Service Great Ape Conservation Fund(US Fish & Wildlife Service); Orang-utan Tropical Peatland Project (OuTrop); Primate Conservation Inc; L.S.B. Leakey Foundation	Charlotte Carne was funded by a scholarship from the University of Roehampton (http://www.roehampton.ac.uk/home/). The Royal Zoological Society of Scotland (http://www.rzss.org.uk/) provided core funding for the Budongo Conservation Field Station. The orang-utan field research was funded by the Wildlife Conservation Society (WCS: http://www.wcs.org/), the US Fish and Wildlife Service Great Ape Conservation Fund (http://www.fws.gov/international/wildlife-without- borders/great-ape-conservation-fund. html), Orang-utan Tropical Peatland Project (OuTrop: http://www. outrop. com/), Primate Conservation Inc. (http:// www.primate.org/), and the L.S.B. Leakey Foundation (http://leakeyfoundation.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; ANDERSON R M, 1991; Bermejo M, 2006, SCIENCE, V314, P1564, DOI 10.1126/science.1133105; Blancou Jean, 2009, P97, DOI 10.1007/978-4-431-77134-0_6; Boesch C, 2008, AM J PRIMATOL, V70, P722, DOI 10.1002/ajp.20571; BONACICH P, 1987, AM J SOCIOL, V92, P1170, DOI 10.1086/228631; Borgatti SP, 2002, UCINET 6 WINDOWS SOF; Brochier B, 1996, REV SCI TECH OIE, V15, P947, DOI 10.20506/rst.15.3.965; Cabezas S, 2006, J WILDLIFE MANAGE, V70, P1125, DOI 10.2193/0022-541X(2006)70[1125:VSABCI]2.0.CO;2; CAIRNS SJ, 1987, ANIM BEHAV, V35, P1454, DOI 10.1016/S0003-3472(87)80018-0; CHAPMAN CA, 1995, BEHAV ECOL SOCIOBIOL, V36, P59, DOI 10.1007/BF00175729; Chapman CA, 2005, EVOL ANTHROPOL, V14, P134, DOI 10.1002/evan.20068; Chapman CA, 2009, CAM S BIO EVOL ANTHR, V57, P487; Chaverri G, 2010, BEHAV ECOL SOCIOBIOL, V64, P1619, DOI 10.1007/s00265-010-0975-3; Clay CA, 2009, P R SOC B, V276, P1305, DOI 10.1098/rspb.2008.1693; Corner LAL, 2003, PREV VET MED, V59, P147, DOI 10.1016/S0167-5877(03)00075-8; Craft ME, 2011, INTERDISCIPLINARY PE, V2011; Croft DP, 2008, EXPLORING ANIMAL SOCIAL NETWORKS, P1; Csardi G, 2006, INTERJOURNAL; Delgado RA, 2000, EVOL ANTHROPOL, V9, P201; Dijkstra E.W, 1959, NUMER MATH, V1, P269, DOI DOI 10.1007/BF01386390; Doran D, 1997, INT J PRIMATOL, V18, P183, DOI 10.1023/A:1026368518431; Drewe JA, 2010, P ROY SOC B-BIOL SCI, V277, P633, DOI 10.1098/rspb.2009.1775; Foitova I, 2009, PARASITES THEIR IMPA; GALDIKAS BMF, 1985, AM J PRIMATOL, V9, P101, DOI 10.1002/ajp.1350090204; Genton C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037106; Haydon DT, 2006, NATURE, V443, P692, DOI 10.1038/nature05177; Hilser H, 2011, ASSESSMENT PRIMATE H; Huijbregts B, 2003, ORYX, V37, P437, DOI 10.1017/S0030605303000802; HUTCHINS M, 1991, J ZOO WILDLIFE MED, V22, P277; Kanngiesser P, 2011, AM J PRIMATOL, V73, P758, DOI 10.1002/ajp.20914; Kasper C, 2009, PRIMATES, V50, P343, DOI 10.1007/s10329-009-0153-2; Kaur T, 2008, AM J PRIMATOL, V70, P755, DOI 10.1002/ajp.20565; Kaur T, 2008, AM J PRIMATOL, V70, P729, DOI 10.1002/ajp.20569; Kondgen S, 2008, CURR BIOL, V18, P260, DOI 10.1016/j.cub.2008.01.012; Lehmann J, 2008, INT J PRIMATOL, V29, P65, DOI 10.1007/s10764-007-9230-9; Lloyd-Smith JO, 2005, NATURE, V438, P355, DOI 10.1038/nature04153; Lukasik-Braum M, 2008, AM J PRIMATOL, V70, P734, DOI 10.1002/ajp.20568; Lusseau D, 2003, P ROY SOC B-BIOL SCI, V270, pS186, DOI 10.1098/rsbl.2003.0057; Lusseau D, 2004, P ROY SOC B-BIOL SCI, V271, pS477, DOI 10.1098/rsbl.2004.0225; Macfie Elizabeth J., 2010, Occasional Papers of the IUCN Species Survival Commission, V38, pi; MACKINNON J, 1974, ANIM BEHAV, V22, P3, DOI 10.1016/S0003-3472(74)80054-0; Manno TG, 2008, ANIM BEHAV, V75, P1221, DOI 10.1016/j.anbehav.2007.09.025; Mitani JC, 2002, EVOL ANTHROPOL, V11, P9, DOI 10.1002/evan.10008; Morrogh-Bernard H, 2009, ORANGUTAN BEHAV ECOL; Naug D, 2008, BEHAV ECOL SOCIOBIOL, V62, P1719, DOI 10.1007/s00265-008-0600-x; Newman ME, 2001, PHYS REV E, V64; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Opsahl T, 2009, STRUCTURE EVOLUTION; Opsahl T, 2010, SOC NETWORKS, V32, P245, DOI 10.1016/j.socnet.2010.03.006; Pepper JW, 1999, INT J PRIMATOL, V20, P613, DOI 10.1023/A:1020760616641; Pinter-Wollman N, 2011, J R SOC INTERFACE, V8, P1562, DOI 10.1098/rsif.2011.0059; Pusey AE, 2008, AM J PRIMATOL, V70, P738, DOI 10.1002/ajp.20567; Reynolds Vernon, 2005, pi; Rodman P.S., 1973, P171; Rushmore J, 2013, J ANIMAL ECOLOGY; Ryan SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029030; Ryder TB, 2008, P ROY SOC B-BIOL SCI, V275, P1367, DOI 10.1098/rspb.2008.0205; Sandbrook C, 2006, ORYX, V40, P428, DOI 10.1017/S0030605306001323; Sauren SEB, 2009, DEV INDEPENDENCE SUM, P189; Setia Tatang Mitra, 2009, P245; Singleton I, 2002, FOLIA PRIMATOL, V73, P1, DOI 10.1159/000060415; Team R. D. C, 2011, R LANG ENV STAT COMP; van Schaik CP, 1999, PRIMATES, V40, P69, DOI 10.1007/BF02557703; Wallis J, 1999, INT J PRIMATOL, V20, P803, DOI 10.1023/A:1020879700286; Walsh PD, 2003, NATURE, V422, P611, DOI 10.1038/nature01566; Whitehead Hal, 2008, pi; Wich SA, 2004, J HUM EVOL, V47, P385, DOI 10.1016/j.jhevol.2004.08.006; Williams R, 2006, BIOL LETTERS, V2, P497, DOI 10.1098/rsbl.2006.0510; Woodford MH, 2002, ORYX, V36, P153, DOI 10.1017/S0030605302000224	70	19	19	0	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e84642	10.1371/journal.pone.0084642	http://dx.doi.org/10.1371/journal.pone.0084642			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	281RE	24386405	gold, Green Published, Green Submitted			2022-12-25	WOS:000329117900105
J	Suarez-Farinas, M; Arbeit, R; Jiang, WW; Ortenzio, FS; Sullivan, T; Krueger, JG				Suarez-Farinas, Mayte; Arbeit, Robert; Jiang, Weiwen; Ortenzio, Francesca S.; Sullivan, Tim; Krueger, James G.			Suppression of Molecular Inflammatory Pathways by Toll-Like Receptor 7, 8, and 9 Antagonists in a Model of IL-23-Induced Skin Inflammation	PLOS ONE			English	Article							PLASMACYTOID DENDRITIC CELL; T-CELLS; PSORIASIS-VULGARIS; ANTIMICROBIAL PEPTIDES; EPIDERMAL HYPERPLASIA; SIGNALING PATHWAYS; INNATE IMMUNITY; IN-VITRO; EXPRESSION; KERATINOCYTES	Psoriasis is a complex inflammatory disease resulting from the activation of T helper (Th) 1 and Th17 cells. Recent evidence suggests that abnormal activation of Toll-like receptors (TLRs) 7, 8 and 9 contributes to the initiation and maintenance of psoriasis. We have evaluated the effects of TLR antagonists on the gene expression profile in an IL-23-induced skin inflammation model in mice. Psoriasis-like skin lesions were induced in C57BL/6 mice by intradermal injection of IL-23 in the dorsum. Two TLR antagonists were compared: IMO-3100, an antagonist of TLRs 7 and 9, and IMO-8400, an antagonist of TLRs 7, 8 and 9, both of which previously have been shown to reduce epidermal hyperplasia in this model. Skin gene expression profiles of IL-23-induced inflammation were compared with or without TLR antagonist treatment. IL-23 injection resulted in alteration of 5100 gene probes (fold change >= 2, FDR < 0.05) including IL-17 pathways that are up-regulated in psoriasis vulgaris. Targeting TLRs 7, 8 and 9 with IMO-8400 resulted in modulation of more than 2300 mRNAs while targeting TLRs 7 and 9 with IMO-3100 resulted in modulation of more than 1900 mRNAs. Both agents strongly decreased IL-17A expression (> 12-fold reduction), normalized IL-17 induced genes such as beta-defensin and CXCL1, and normalized aberrant expression of keratin 16 (indicating epidermal hyperplasia). These results suggest that IL-23-driven inflammation in mouse skin may be dependent on signaling mediated by TLRs 7, 8, and 9 and that these receptors represent novel therapeutic targets in psoriasis vulgaris and other diseases with similar pathophysiology.	[Suarez-Farinas, Mayte; Ortenzio, Francesca S.; Krueger, James G.] Rockefeller Univ, Lab Invest Dermatol, New York, NY 10021 USA; [Suarez-Farinas, Mayte] Rockefeller Univ, Ctr Clin & Translat Sci, New York, NY 10021 USA; [Arbeit, Robert; Jiang, Weiwen; Sullivan, Tim] Idera Pharmaceut Inc, Cambridge, MA USA	Rockefeller University; Rockefeller University	Krueger, JG (corresponding author), Rockefeller Univ, Lab Invest Dermatol, 1230 York Ave, New York, NY 10021 USA.	kruegej@rockefeller.edu	Suarez-Farinas, Mayte/I-3558-2012	Suarez-Farinas, Mayte/0000-0001-8712-3553	IDERA Pharmaceuticals, Inc	IDERA Pharmaceuticals, Inc	Funding for this study was provided by an unrestricted grant given to Dr. James Krueger by IDERA Pharmaceuticals, Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript, however, they played a partial role in conception of the study and conducted the in vivo model on which this study is based.	Bhan U, 2013, J IMMUNOL, V190, P349, DOI 10.4049/jimmunol.1202225; Chamian F, 2005, P NATL ACAD SCI USA, V102, P2075, DOI 10.1073/pnas.0409569102; Chan JR, 2006, J EXP MED, V203, P2577, DOI 10.1084/jem.20060244; Cook PW, 1997, J CLIN INVEST, V100, P2286, DOI 10.1172/JCI119766; Demaria O, 2010, J CLIN INVEST, V120, P3651, DOI 10.1172/JCI42081; Di Cesare A, 2009, J INVEST DERMATOL, V129, P1339, DOI 10.1038/jid.2009.59; Farkas A, 2012, INT IMMUNOPHARMACOL, V13, P215, DOI 10.1016/j.intimp.2012.04.003; Ganguly D, 2009, J EXP MED, V206, P1983, DOI 10.1084/jem.20090480; Gilliet M, 2004, ARCH DERMATOL, V140, P1490, DOI 10.1001/archderm.140.12.1490; Girolomoni G, 2012, BRIT J DERMATOL, V167, P717, DOI 10.1111/j.1365-2133.2012.11099.x; Gudjonsson JE, 2010, J INVEST DERMATOL, V130, P1829, DOI 10.1038/jid.2010.36; Gudjonsson JE, 2009, J INVEST DERMATOL, V129, P2795, DOI 10.1038/jid.2009.173; Guiducci C, 2009, J INTERN MED, V265, P43, DOI 10.1111/j.1365-2796.2008.02050.x; Hari A, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/437246; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Jabbari A, 2012, J INVEST DERMATOL, V132, P246, DOI 10.1038/jid.2011.267; Jiang W, 2013, J INVEST DERMATOL; Kadowaki N, 2001, J EXP MED, V194, P863, DOI 10.1084/jem.194.6.863; Kao CY, 2004, J IMMUNOL, V173, P3482, DOI 10.4049/jimmunol.173.5.3482; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kimball AB, 2013, J INVEST DERMATOL, V133, pS26; Krueger JG, 2012, J ALLERGY CLIN IMMUN, V130, P145, DOI 10.1016/j.jaci.2012.04.024; Lande R, 2007, NATURE, V449, P564, DOI 10.1038/nature06116; Lebre MC, 2007, J INVEST DERMATOL, V127, P331, DOI 10.1038/sj.jid.5700530; Lee E, 2004, J EXP MED, V199, P125, DOI 10.1084/jem.20030451; Li AG, 2004, EMBO J, V23, P1770, DOI 10.1038/sj.emboj.7600183; Liang SC, 2006, J EXP MED, V203, P2271, DOI 10.1084/jem.20061308; Lowes MA, 2005, P NATL ACAD SCI USA, V102, P19057, DOI 10.1073/pnas.0509736102; Lowes MA, 2008, J INVEST DERMATOL, V128, P1207, DOI 10.1038/sj.jid.5701213; Lowes MA, 2013, TRENDS IMMUNOL, V34, P174, DOI 10.1016/j.it.2012.11.005; Lukacs NW, 2010, J IMMUNOL, V185, P2231, DOI 10.4049/jimmunol.1000733; Morizane S, 2012, J DERMATOL, V39, P225, DOI 10.1111/j.1346-8138.2011.01483.x; Nestle FO, 2009, NAT REV IMMUNOL, V9, P679, DOI 10.1038/nri2622; Nickoloff BJ, 2004, J CLIN INVEST, V113, P1664, DOI 10.1172/JCI200422147; Patel U, 2011, BRIT J DERMATOL, V164, P670, DOI 10.1111/j.1365-2133.2010.10124.x; Piskin G, 2006, J IMMUNOL, V176, P1908, DOI 10.4049/jimmunol.176.3.1908; Rizzo HL, 2011, J IMMUNOL, V186, P1495, DOI 10.4049/jimmunol.1001001; Roberson EDO, 2012, J INVEST DERMATOL, V132, P583, DOI 10.1038/jid.2011.348; Sano S, 2005, NAT MED, V11, P43, DOI 10.1038/nm1162; Suarez-Farinas M, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-294; Suarez-Farinas M, 2012, J INVEST DERMATOL, V132, P2552, DOI 10.1038/jid.2012.184; Suarez-Farinas M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010247; Swindell WR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018266; Tian SY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044274; Tortola L, 2012, J CLIN INVEST, V122, P3965, DOI 10.1172/JCI63451; van der Fits L, 2009, J IMMUNOL, V182, P5836, DOI 10.4049/jimmunol.0802999; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Wang DQ, 2009, J MED CHEM, V52, P551, DOI 10.1021/jm8014316; Wolfram JA, 2009, AM J PATHOL, V174, P1443, DOI 10.2353/ajpath.2009.080858; Yao Y, 2013, TYPE 1 INTERFERON AU, P185; Yao YH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002737; Yu D, 2009, J MED CHEM, V52, P5108, DOI 10.1021/jm900730r; Zaba LC, 2007, J EXP MED, V204, P3183, DOI 10.1084/jem.20071094; Zaba LC, 2009, J INVEST DERMATOL, V129, P79, DOI 10.1038/jid.2008.194; Zhou XH, 2003, PHYSIOL GENOMICS, V13, P69, DOI 10.1152/physiolgenomics.00157.2002	55	81	81	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e84634	10.1371/journal.pone.0084634	http://dx.doi.org/10.1371/journal.pone.0084634			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281RE	24386404	Green Published, Green Submitted, gold			2022-12-25	WOS:000329117900104
J	Suh, M; Kang, DR; Lee, DH; Choi, YJ; Tchoe, B; Nam, CM; Kim, HJ; Lee, JK; Jun, BY; Youm, Y; Bae, GN; Lee, TY; Kim, MS; Shin, DC; Kim, C				Suh, Mina; Kang, Dae Ryong; Lee, Dong Han; Choi, Yoon Jung; Tchoe, Byongho; Nam, Chung Mo; Kim, Hyung Jung; Lee, Jong Koo; Jun, Byung Yool; Youm, Yoosik; Bae, Gwi-Nam; Lee, Tae Yong; Kim, Moon Shik; Shin, Dong Chun; Kim, Changsoo			Socioeconomic Burden of Influenza in the Republic of Korea, 2007-2010	PLOS ONE			English	Article							A H1N1 VIRUS; PANDEMIC INFLUENZA; COST-EFFECTIVENESS; INFECTION	Background: Although the socioeconomic burden of 2009 pandemic influenza A (H1N1) was considerable, no reliable estimates have been reported. Our aim was to compared medical costs and socioeconomic burden resulting from pandemic influenza A (H1N1) 2009 with that of previous seasonal influenza. Methods: We estimated the medical costs and socioeconomic burden of influenza from May 2007 to April 2010. We used representative national data sources(data from the Health Insurance Review Agency, the National Health Insurance Corporation, the Korea Centers for Disease Control and Prevention, and the Korean National Statistics Office) including medical utilization, prescription of antivirals, and vaccination. Uncertainty of data was explored through sensitivity analysis using Monte Carlo simulation. Results: Compared with the seasonal influenza, total medical costs (US$291.7 million) associated with pandemic (H1N1) 2009 increased more than 37-fold. Compared with the 2007-2008 season, outpatient diagnostic costs (US$135.3 million) were 773 times higher in the 2009-2010 season, and the mean diagnostic cost per outpatient visit was 58.8 times higher. Total socioeconomic burden of pandemic (H1N1) 2009 was estimated at US$1581.3 million (10%-90%: US$1436.0-1808.3 million) and those of seasonal influenza was estimated at US$44.7 million (10%-90%: US$32.4-57.9 million) in 2007-2008 season and US$42.3 million (10%-90%: US$31.5-53.8 million) in 2008-2009 season. Indirect costs accounted for 56.0% of total costs in pandemic (H1N1) 2009, and 66.48-68.09% in seasonal influenza. The largest contributors to total burden were productivity losses of caregiver in pandemic (H1N1) 2009, and productivity losses due to morbidity of outpatient in seasonal influenza. Conclusions: In the Republic of Korea, socioeconomic burden of pandemic (H1N1) 2009 were considerably higher than burden of the previous two influenza seasons, primarily because of high diagnostic costs and longer sick leave.	[Suh, Mina] Natl Canc Ctr, Natl Canc Control Inst, Goyang, South Korea; [Kang, Dae Ryong; Nam, Chung Mo; Kim, Hyung Jung; Shin, Dong Chun; Kim, Changsoo] Yonsei Univ, Coll Med, Seoul, South Korea; [Lee, Dong Han; Jun, Byung Yool] Korea Ctr Dis Control & Prevent, Osong, South Korea; [Choi, Yoon Jung; Tchoe, Byongho] Helath Insurance Review & Assessment Serv, Seoul, South Korea; [Lee, Jong Koo] Seoul Natl Univ Hosp, Seoul 110744, South Korea; [Youm, Yoosik] Yonsei Univ, Dept Sociol, Seoul 120749, South Korea; [Bae, Gwi-Nam] Korea Inst Sci & Technol, Environm Sensor Syst Res Ctr, Seoul, South Korea; [Lee, Tae Yong] Chungnam Natl Univ, Dept Prevent Med & Publ Hlth, Sch Med, Taejon, South Korea; [Kim, Moon Shik] Ajou Univ, Sch Publ Hlth, Suwon 441749, South Korea	National Cancer Center - Korea (NCC); Yonsei University; Yonsei University Health System; Korea Centers for Disease Control & Prevention (KCDC); Korea CDC Center for Disease Prevention; Seoul National University (SNU); Seoul National University Hospital; Yonsei University; Korea Institute of Science & Technology (KIST); Chungnam National University; Ajou University	Kim, C (corresponding author), Yonsei Univ, Coll Med, Seoul, South Korea.	preman@yuhs.ac		Kim, Changsoo/0000-0002-5940-5649; Shin, Dong Chun/0000-0003-4252-2280; a, gokul/0000-0003-2226-4691; Nam, Chung Mo/0000-0003-0985-0928	Converging Research Center Program; Ministry of Education, Science and Technology [2011K000754]; Korea Centers for Disease Control and Prevention	Converging Research Center Program; Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Korea Centers for Disease Control and Prevention	This research was supported by the Converging Research Center Program funded by the Ministry of Education, Science and Technology (grant number: 2011K000754) and Korea Centers for Disease Control and Prevention. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bautista E, 2010, NEW ENGL J MED, V362, P1708, DOI 10.1056/NEJMra1000449; Creanga AA, 2011, AM J OBSTET GYNECOL, V204, pS38, DOI 10.1016/j.ajog.2011.02.037; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; Falagas ME, 2010, EUR J CLIN MICROBIOL, V29, P1327, DOI 10.1007/s10096-010-1002-3; Galante M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031696; Gonzalez-Canudas J, 2011, REV PANAM SALUD PUBL, V29, P1; Homaira N, 2012, B WORLD HEALTH ORGAN, V90, P272, DOI 10.2471/BLT.11.095653; KCDC, 2009, PUBLIC HLTH WEEKLY R, V2, P293; Kim JH, 2010, J KOREAN MED SCI, V25, P1109, DOI 10.3346/jkms.2010.25.7.1109; Kim KS, 2010, SOC WORK PUBLIC HLTH, V25, P142, DOI 10.1080/19371910903547017; Korea Centers for Disease Control and Prevention, 2020, 5 KOR NAT HLTH NUTR; Korean National Assembly Budget office, 2010, COMPR AN SETTL; Lee Dong Han, 2010, J Prev Med Public Health, V43, P99, DOI 10.3961/jpmph.2010.43.2.99; Lee JS, 2007, EPIDEMIOL INFECT, V135, P1117, DOI 10.1017/S0950268807007820; Lee JK, 2010, J KOREAN MED ASSOC, V53, P52, DOI 10.5124/jkma.2010.53.1.52; Lee YK, 2011, AM J INFECT CONTROL; Mogasale V, 2011, AUST NZ J PUBL HEAL, V35, P180, DOI 10.1111/j.1753-6405.2010.00639.x; Mota NVYVP, 2011, EMERG INFECT DIS, V17, P1421, DOI 10.3201/eid1708.101546; National Health Insurance Corporation, 2010, 2009 NAT HLTH INS ST; Samsung Economic Research Institute, 2009, CONS ATT SURV; Shrestha SS, 2011, CLIN INFECT DIS, V52, pS75, DOI 10.1093/cid/ciq012; Simmerman JM, 2008, INFLUENZA OTHER RESP, V2, P81, DOI 10.1111/j.1750-2659.2008.00045.x; van Hoek AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017030; World Health Organization, 2009, WORLD NOW START 2009	25	18	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e84121	10.1371/journal.pone.0084121	http://dx.doi.org/10.1371/journal.pone.0084121			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281RE	24386339	gold, Green Published			2022-12-25	WOS:000329117900075
J	Dhaliwal, SS; Welborn, TA; Howat, PA				Dhaliwal, Satvinder S.; Welborn, Timothy A.; Howat, Peter A.			Recreational Physical Activity as an Independent Predictor of Multivariable Cardiovascular Disease Risk	PLOS ONE			English	Article							LIFE-STYLE; HIP RATIO; DEATH; OBESITY; ADULTS	The role of physical activity in preventing CVD has been highlighted by Professor Jerry Morris in the 1950's. We report outcome of a 15-year prospective study with the aim to identify whether physical activity showed cardiovascular benefit independent of common risk factors and of central obesity. Baseline data of 8662 subjects, with no previous history of heart disease, diabetes or stroke, were obtained from an age-and gender-stratified sample of adults in Australian capital cities and were linked with the National Death Index to determine the causes of death of 610 subjects who had died to 31 December 2004. The study consisted of 4175 males (age 42.3+/-13.1 years) and 4487 females (age 42.8+/-13.2 years). Fasting serum lipid levels, systolic and diastolic blood pressure and smoking habits at baseline were recorded. The Framingham Risk Scores of 15-year mortality due to CHD and CVD were calculated using established equations. Subjects were also asked if they engaged in vigorous exercise, less vigorous exercise or walk for recreation and exercise in the past 2 weeks. Subjects in the high recreational physical activity category were 0.16 (0.06-0.43; p<0.001) and 0.12 (0.03-0.48; p = 0.003) times as likely as subjects in the low category for CVD and CHD mortality respectively. After adjusting for both the Framingham Risk Score and central obesity (Waist circumference to Hip circumference Ratio), those in the high recreational physical activity group were 0.35 (0.13-0.98) times less likely compared to the low category for CVD mortality. Recreational physical activity independently predicted reduced cardiovascular mortality over fifteen years. A public health focus on increased physical activity and preventing obesity is required to reduce the risk of CVD and CHD.	[Dhaliwal, Satvinder S.] Curtin Univ, Sch Publ Hlth, Perth, WA 6845, Australia; [Welborn, Timothy A.] Sir Charles Gairdner Hosp, Dept Endocrinol, Perth, WA, Australia; [Howat, Peter A.] Curtin Univ, Ctr Behav Res Canc Control, Perth, WA 6845, Australia	Curtin University; University of Western Australia; Curtin University	Dhaliwal, SS (corresponding author), Curtin Univ, Sch Publ Hlth, Perth, WA 6845, Australia.	S.Dhaliwal@curtin.edu.au			Healthway, the Western Australian Health Promotion Foundation	Healthway, the Western Australian Health Promotion Foundation	This study was originally supported by a competitive grant from Healthway, the Western Australian Health Promotion Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON KM, 1991, AM HEART J, V121, P293, DOI 10.1016/0002-8703(91)90861-B; Australian Risk Factor Prevalence Study Management Committee, 1990, SURV 3 1989; BOYLE CA, 1995, AUST NZ J MED, V25, P316, DOI 10.1111/j.1445-5994.1995.tb01896.x; DAWBER T. R., 1957, AMER JOUR PUBL HEALTH, V47, P4, DOI 10.2105/AJPH.47.4_Pt_2.4; Dhaliwal SS, 2009, PREV MED, V49, P148, DOI 10.1016/j.ypmed.2009.06.023; Dhaliwal SS, 2009, AM J CARDIOL, V103, P1403, DOI 10.1016/j.amjcard.2008.12.048; Hu FB, 2001, NEW ENGL J MED, V345, P790, DOI 10.1056/NEJMoa010492; Hu G, 2004, EUR HEART J, V25, P2212, DOI 10.1016/j.ehj.2004.10.020; Liu K, 2012, CIRCULATION, V125, P996, DOI 10.1161/CIRCULATIONAHA.111.060681; Lopez AD, 2006, GLOBAL BURDEN OF DISEASE AND RISK FACTORS, P1, DOI 10.1596/978-0-8213-6262-4; MORRIS JN, 1953, LANCET, V265, P1111; MORRIS JN, 1990, BRIT HEART J, V63, P325; Samitz G, 2011, INT J EPIDEMIOLOGY; Sesso HD, 1998, CANCER CAUSE CONTROL, V9, P433, DOI 10.1023/A:1008827903302; Warburton DER, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-39; Welborn TA, 2007, EUR J CLIN NUTR, V61, P1373, DOI 10.1038/sj.ejcn.1602656; Welborn TA, 2003, MED J AUSTRALIA, V179, P580, DOI 10.5694/j.1326-5377.2003.tb05704.x; World Health Organization, 1998, INT CLASS DIS MAN IN	18	18	19	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e83435	10.1371/journal.pone.0083435	http://dx.doi.org/10.1371/journal.pone.0083435			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281QS	24386198	gold, Green Published			2022-12-25	WOS:000329116700050
J	Huang, WX; Zheng, JB; He, Y; Luo, C				Huang, Wanxu; Zheng, Jianbo; He, Ying; Luo, Chen			Tandem Repeat Modification during Double-Strand Break Repair Induced by an Engineered TAL Effector Nuclease in Zebrafish Genome	PLOS ONE			English	Article							HOMOLOGOUS RECOMBINATION; CGG REPEAT; DNA; GENE; SEQUENCE; INSTABILITY; EXPANSION; TRACTS; METHYLATION; EXPRESSION	Tandem repeats (TRs) are abundant and widely distributed in eukaryotic genomes. TRs are thought to have various functions in gene transcription, DNA methylation, nucleosome position and chromatin organization. Variation of repeat units in the genome is observed in association with a number of diseases, such as Fragile X Syndrome, Huntington's disease and Friedreich's ataxia. However, the underlying mechanisms involved are poorly understood, largely owing to the technical limitations in modification of TRs at definite sites in the genome in vivo. Transcription activator-like effector nucleases (TALENs) are widely used in recent years in gene targeting for their specific binding to target sequences when engineered in vitro. Here, we show that the repair of a double-strand break (DSB) induced by TALENs adjacent to a TR can produce serial types of mutations in the TR region. Sequencing analysis revealed that there are three types of mutations induced by the DSB repair, including indels only within the TR region or within the flanking TALEN target region or simutaneously within both regions. Therefore, desired TR mutant types can be conveniently obtained by using engineered TALENs. These results demonstrate that TALENs can serve as a convenient tool for modifying TRs in the genome in studying the functions of TRs.	[Huang, Wanxu; Zheng, Jianbo; He, Ying; Luo, Chen] Zhejiang Univ, Coll Life Sci, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University	Luo, C (corresponding author), Zhejiang Univ, Coll Life Sci, Hangzhou 310003, Zhejiang, Peoples R China.	luoc@zju.edu.cn		Huang, Wanxu/0000-0002-9159-3678	State Key Basic Research Project of China [2010CB126301]; Scientific Research Funds of Zhejiang Provincial Science and Technology Department [2012C12907-9]	State Key Basic Research Project of China; Scientific Research Funds of Zhejiang Provincial Science and Technology Department	This work was supported by State Key Basic Research Project of China (2010CB126301) and the Scientific Research Funds of Zhejiang Provincial Science and Technology Department (2012C12907-9). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amunugama R, 2012, PROG MOL BIOL TRANSL, V110, P155, DOI 10.1016/B978-0-12-387665-2.00007-9; Bhakta MS, 2010, METHODS MOL BIOL, V649, P3, DOI 10.1007/978-1-60761-753-2_1; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Bogdanove AJ, 2011, SCIENCE, V333, P1843, DOI 10.1126/science.1204094; BRITTEN RJ, 1968, SCIENCE, V161, P529, DOI 10.1126/science.161.3841.529; Campuzano V, 1996, SCIENCE, V271, P1423, DOI 10.1126/science.271.5254.1423; Chapman JR, 2012, MOL CELL, V47, P497, DOI 10.1016/j.molcel.2012.07.029; DOOLITTLE WF, 1980, NATURE, V284, P601, DOI 10.1038/284601a0; Doyle EL, 2012, NUCLEIC ACIDS RES, V40, pW117, DOI 10.1093/nar/gks608; Dutreix M, 1997, J MOL BIOL, V273, P105, DOI 10.1006/jmbi.1997.1293; Fondon JW, 2008, TRENDS NEUROSCI, V31, P328, DOI 10.1016/j.tins.2008.03.006; FU YH, 1991, CELL, V67, P1047, DOI 10.1016/0092-8674(91)90283-5; Gangloff S, 1996, EMBO J, V15, P1715, DOI 10.1002/j.1460-2075.1996.tb00517.x; Gemayel R, 2010, ANNU REV GENET, V44, P445, DOI 10.1146/annurev-genet-072610-155046; HAMADA H, 1984, MOL CELL BIOL, V4, P2622, DOI 10.1128/MCB.4.12.2622; HAMADA H, 1982, P NATL ACAD SCI-BIOL, V79, P6465, DOI 10.1073/pnas.79.21.6465; Hockemeyer D, 2011, NAT BIOTECHNOL, V29, P731, DOI 10.1038/nbt.1927; Huang P, 2011, NAT BIOTECHNOL, V29, P699, DOI 10.1038/nbt.1939; Joung JK, 2013, NAT REV MOL CELL BIO, V14, P49, DOI 10.1038/nrm3486; KNIGHT SJL, 1993, CELL, V74, P127, DOI 10.1016/0092-8674(93)90300-F; Legendre M, 2007, GENOME RES, V17, P1787, DOI 10.1101/gr.6554007; Lieber MR, 2010, ANNU REV BIOCHEM, V79, P181, DOI 10.1146/annurev.biochem.052308.093131; Lombardo A, 2007, NAT BIOTECHNOL, V25, P1298, DOI 10.1038/nbt1353; Ma SS, 2011, EPIGENETICS-US, V6, P1471, DOI 10.4161/epi.6.12.18177; Martienssen R, 2004, COLD SPRING HARB SYM, V69, P371, DOI 10.1101/sqb.2004.69.371; Martin P, 2005, P NATL ACAD SCI USA, V102, P3800, DOI 10.1073/pnas.0406805102; MIESFELD R, 1981, NUCLEIC ACIDS RES, V9, P5931, DOI 10.1093/nar/9.22.5931; Mittelman D, 2009, P NATL ACAD SCI USA, V106, P9607, DOI 10.1073/pnas.0902420106; Moscou MJ, 2009, SCIENCE, V326, P1501, DOI 10.1126/science.1178817; Mussolino C, 2012, CURR OPIN BIOTECHNOL; OHNO S, 1972, BROOKHAVEN SYM BIOL, P366; PIERETTI M, 1991, CELL, V66, P817, DOI 10.1016/0092-8674(91)90125-I; Pollard LM, 2008, NUCLEIC ACIDS RES, V36, P489, DOI 10.1093/nar/gkm1066; Richard GF, 2008, MICROBIOL MOL BIOL R, V72, P686, DOI 10.1128/MMBR.00011-08; RITCHIE RJ, 1994, HUM MOL GENET, V3, P2115, DOI 10.1093/hmg/3.12.2115; Rubinsztein DC, 1996, AM J HUM GENET, V59, P16; Sander JD, 2011, NAT BIOTECHNOL, V29, P697, DOI 10.1038/nbt.1934; Shan QW, 2013, MOL PLANT, V6, P1365, DOI 10.1093/mp/sss162; STRAND M, 1993, NATURE, V365, P274, DOI 10.1038/365274a0; Symington LS, 2011, ANNU REV GENET, V45, P247, DOI 10.1146/annurev-genet-110410-132435; Tesson L, 2011, NAT BIOTECHNOL, V29, P695, DOI 10.1038/nbt.1940; Usdin K, 2008, GENOME RES, V18, P1011, DOI 10.1101/gr.070409.107; Valerie K, 2003, ONCOGENE, V22, P5792, DOI 10.1038/sj.onc.1206679; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; Vinces MD, 2009, SCIENCE, V324, P1213, DOI 10.1126/science.1170097; Warren ST, 1997, SCIENCE, V275, P408, DOI 10.1126/science.275.5298.408; Wojcik EA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051064; Wood AJ, 2011, SCIENCE, V333, P307, DOI 10.1126/science.1207773; Zu Y, 2013, NAT METHODS, V10, P329, DOI 10.1038/NMETH.2374	49	17	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e84176	10.1371/journal.pone.0084176	http://dx.doi.org/10.1371/journal.pone.0084176			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281QS	24386347	Green Submitted, Green Published, gold			2022-12-25	WOS:000329116700099
J	Jensen, MM; Erichsen, KD; Bjorkling, F; Madsen, J; Jensen, PB; Sehested, M; Hojgaard, L; Kjraer, A				Jensen, Mette Munk; Erichsen, Kamille Dumong; Bjorkling, Fredrik; Madsen, Jacob; Jensen, Peter Buhl; Sehested, Maxwell; Hojgaard, Liselotte; Kjraer, Andreas			Imaging of Treatment Response to the Combination of Carboplatin and Paclitaxel in Human Ovarian Cancer Xenograft Tumors in Mice Using FDG and FLT PET	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; IN-VIVO; KI-67 IMMUNOHISTOCHEMISTRY; INHIBITOR THERAPY; SURROGATE MARKER; THYMIDINE KINASE; F-18-FLT PET; PROLIFERATION; MANAGEMENT; CHEMOTHERAPY	Introduction: A combination of carboplatin and paclitaxel is often used as first line chemotherapy for treatment of ovarian cancer. Therefore the use of imaging biomarkers early after initiation of treatment to determine treatment sensitivity would be valuable in order to identify responders from non-responders. In this study we describe the non-invasive PET imaging of glucose uptake and cell proliferation using 2-deoxy-2-[F-18]fluoro-D-glucose (FDG) and 3'-deoxy-3'-[F-18]fluorothymidine (FLT) for early assessment of treatment response in a pre-clinical mouse model of human ovarian cancer treated with carboplatin and paclitaxel. Methods: In vivo uptake of FLT and FDG in human ovarian cancer xenografts in mice (A2780) was determined before treatment with carboplatin and paclitaxel (CaP) and repeatedday 1, 4 and 8 after treatment start. Tracer uptake was quantified using small animal PET/CT. Tracer uptake was compared with gene expression of Ki67, TK1, GLUT1, HK1 and HK2. Results: Tumors in the CaP group was significantly smaller than in the control group (p=0.03) on day 8. On day 4 FDG SUVmax ratio was significantly lower in the CaP group compared to the control group (105 +/- 4% vs 138 +/- 9%; p=0.002) and on day 8 the FDG SUVmax ratio was lower in the CaP compared to the control group (125 +/- 13% vs 167 +/- 13%; p=0.05). On day 1 the uptake of FLT SUVmax ratio was 89 +/- 9% in the CaP group and 109 +/- 6% in the control group; however the difference was not statistically significant (p=0.08). Conclusions: Our data suggest that both FDG and FLT PET may be used for the assessment of anti-tumor effects of a combination of carboplatin and paclitaxel in the treatment of ovarian cancer. FLT provides an early and transient signal and FDG a later and more prolonged response. This underscores the importance of optimal timing between treatment and FLT or FDG imaging since treatment response may otherwise be overlooked.	[Jensen, Mette Munk; Hojgaard, Liselotte; Kjraer, Andreas] Univ Copenhagen, Fac Hlth & Med Sci, Cluster Mol Imaging, Copenhagen, Denmark; [Jensen, Mette Munk; Madsen, Jacob; Hojgaard, Liselotte; Kjraer, Andreas] Rigshosp, Dept Clin Physiol Nucl Med & PET, DK-2100 Copenhagen, Denmark; [Erichsen, Kamille Dumong; Bjorkling, Fredrik; Jensen, Peter Buhl; Sehested, Maxwell] Topotarget AS, Copenhagen, Denmark; [Bjorkling, Fredrik] Univ Copenhagen, Fac Hlth & Med Sci, Dept Drug Design & Pharmacol, Copenhagen, Denmark	University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Copenhagen	Jensen, MM (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Cluster Mol Imaging, Copenhagen, Denmark.	mettemj@sund.ku.dk	Højgaard, Liselotte/AAK-8329-2020; Kjaer, Andreas/E-8932-2015	Bjorkling, Fredrik/0000-0001-7018-8334; Kjaer, Andreas/0000-0002-2706-5547	National Advanced Technology Foundation; The John and Birthe Meyer Foundation; Danish Medical Research Council; Rigshospitalets Research Foundation; Svend Andersen Foundation; AP Moller Foundation; Novo Nordisk Foundation; Lundbeck Foundation; Danish Cancer Society	National Advanced Technology Foundation; The John and Birthe Meyer Foundation; Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Rigshospitalets Research Foundation; Svend Andersen Foundation; AP Moller Foundation; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Lundbeck Foundation(Lundbeckfonden); Danish Cancer Society(Danish Cancer Society)	Funding came from the National Advanced Technology Foundation, The John and Birthe Meyer Foundation, Danish Medical Research Council, Rigshospitalets Research Foundation, Svend Andersen Foundation, AP Moller Foundation, Novo Nordisk Foundation, Lundbeck Foundation and Danish Cancer Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aide N, 2010, J NUCL MED, V51, P1559, DOI 10.2967/jnumed.109.073288; ARNER ESJ, 1995, PHARMACOL THERAPEUT, V67, P155, DOI 10.1016/0163-7258(95)00015-9; Atkinson DM, 2008, HEAD NECK-J SCI SPEC, V30, P790, DOI 10.1002/hed.20770; Avril N, 2005, J CLIN ONCOL, V23, P7445, DOI 10.1200/JCO.2005.06.965; Avril N, 2011, METHODS MOL BIOL, V727, P171, DOI 10.1007/978-1-61779-062-1_10; Barthel H, 2005, EUR J NUCL MED MOL I, V32, P257, DOI 10.1007/s00259-004-1611-0; Barthel H, 2003, CANCER RES, V63, P3791; Been LB, 2004, EUR J NUCL MED MOL I, V31, P1659, DOI 10.1007/s00259-004-1687-6; Bos R, 2002, J CLIN ONCOL, V20, P379, DOI 10.1200/JCO.20.2.379; Brepoels L, 2009, J NUCL MED; Buck AK, 2003, J NUCL MED, V44, P1426; Buck AK, 2002, CANCER RES, V62, P3331; Cejka D, 2009, BRIT J CANCER, V100, P1739, DOI 10.1038/sj.bjc.6605076; Chen W, 2005, J NUCL MED, V46, P945; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Ferlay J, 2010, EUR J CANCER, V46, P765, DOI 10.1016/j.ejca.2009.12.014; Francis DL, 2003, GUT, V52, P1602, DOI 10.1136/gut.52.11.1602; Fueger BJ, 2006, J NUCL MED, V47, P999; Guarneri V, 2011, EXPERT REV ANTICANC, V11, P49, DOI [10.1586/era.10.204, 10.1586/ERA.10.204]; Guarneri V, 2010, GYNECOL ONCOL, V117, P152, DOI 10.1016/j.ygyno.2009.11.033; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Jensen MM, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-168; Jensen MM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050618; Jensen Mette Munk, 2008, BMC Med Imaging, V8, P16, DOI 10.1186/1471-2342-8-16; Jensen MA, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0011024, 10.1371/journal.pone.0012965]; Jordan MA, 2004, NAT REV CANCER, V4, P253, DOI 10.1038/nrc1317; Lee SJ, 2010, BIOCHEM PHARMACOL, V80, P1528, DOI 10.1016/j.bcp.2010.08.004; Leyton J, 2005, CANCER RES, V65, P4202, DOI 10.1158/0008-5472.CAN-04-4008; Leyton J, 2006, CANCER RES, V66, P7621, DOI 10.1158/0008-5472.CAN-05-3962; Manning HC, 2008, CLIN CANCER RES, V14, P7413, DOI 10.1158/1078-0432.CCR-08-0239; Markman M, 2008, TRENDS PHARMACOL SCI, V29, P515, DOI 10.1016/j.tips.2008.07.007; Martoni AA, 2011, Q J NUCL MED MOL IM, V55, P81; Moroz MA, 2011, CLIN CANCER RES, V17, P1099, DOI 10.1158/1078-0432.CCR-10-1430; Mudd SR, 2011, MOL IMAGING BIOL; Munk Jensen M, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0053410, DOI 10.1371/J0URNAL.P0NE.0053410.PUBMED:23308217]; Perumal M, 2012, MOL IMAGING BIOL, V14, P753, DOI 10.1007/s11307-012-0554-2; Rasey JS, 2002, J NUCL MED, V43, P1210; Richard SD, 2011, NUCL MED BIOL, V38, P485, DOI 10.1016/j.nucmedbio.2010.12.003; Schwartz JL, 2003, J NUCL MED, V44, P2027; Shah C, 2009, CLIN CANCER RES, V15, P4712, DOI 10.1158/1078-0432.CCR-08-2635; SHERLEY JL, 1988, J BIOL CHEM, V263, P8350; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; SOM P, 1980, J NUCL MED, V21, P670; Takeuchi S, 2011, ONCOL REP, V26, P725, DOI 10.3892/or.2011.1338; Ullrich RT, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003908; Vergez S, 2010, CLIN CANCER RES, V16, P4434, DOI 10.1158/1078-0432.CCR-09-2795; Vesselle H, 2002, CLIN CANCER RES, V8, P3315; Waldherr C, 2005, J NUCL MED, V46, P114; Wang D, 2005, NAT REV DRUG DISCOV, V4, P307, DOI 10.1038/nrd1691; Yamamoto Y, 2007, EUR J NUCL MED MOL I, V34, P1610, DOI 10.1007/s00259-007-0449-7; Yap CS, 2006, CHEST, V129, P393, DOI 10.1378/chest.129.2.393; Zhang CC, 2012, CLIN CANCER RES, V18, P1303, DOI 10.1158/1078-0432.CCR-11-1433	52	15	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e85126	10.1371/journal.pone.0085126	http://dx.doi.org/10.1371/journal.pone.0085126			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281QS	24386456	Green Published, Green Submitted, gold			2022-12-25	WOS:000329116700133
J	Juszkat, R; Perek, B; Zabicki, B; Trojnarska, O; Jemielity, M; Staniszewski, R; Smoczyk, W; Pukacki, F				Juszkat, Robert; Perek, Bartlomiej; Zabicki, Bartosz; Trojnarska, Olga; Jemielity, Marek; Staniszewski, Ryszard; Smoczyk, Wieslaw; Pukacki, Fryderyk			Endovascular Treatment of Late Thoracic Aortic Aneurysms after Surgical Repair of Congenital Aortic Coarctation in Childhood	PLOS ONE			English	Article							LATE COMPLICATIONS; MANAGEMENT; SURGERY; GRAFTS; ADULT	Background: In some patients, local surgery-related complications are diagnosed many years after surgery for aortic coarctation. The purposes of this study were: (1) to systematically evaluate asymptomatic adults after Dacron patch repair in childhood, (2) to estimate the formation rate of secondary thoracic aortic aneurysms (TAAs) and (3) to assess outcomes after intravascular treatment for TAAs. Methods: This study involved 37 asymptomatic patients (26 female and 11 male) who underwent surgical repair of aortic coarctation in the childhood. After they had reached adolescence, patients with secondary TAAs were referred to endovascular repair. Results: Follow-up studies revealed TAA in seven cases (19%) (including six with the gothic type of the aortic arch) and mild recoarctation in other six (16%). Six of the TAA patients were treated with stentgrafts, but one refused to undergo an endovascular procedure. In three cases, stengrafts covered the left subclavian artery (LSA), in another the graft was implanted distally to the LSA. In two individuals, elective hybrid procedures were performed with surgical bypass to the supraaortic arteries followed by stengraft implantation. All subjects survived the secondary procedures. One patient developed type Ia endoleak after stentgraft implantation that was eventually treated with a debranching procedure. Conclusions: The long-term course of clinically asymptomatic patients after coarctation patch repair is not uncommonly complicated by formation of TAAs (particularly in individuals with the gothic pattern of the aortic arch) that can be treated effectively with stentgrafts. However, in some patients hybrid procedures may be necessary.	[Juszkat, Robert; Zabicki, Bartosz] Poznan Univ Med Sci, Dept Clin & Intervent Radiol, Poznan, Poland; [Perek, Bartlomiej; Jemielity, Marek] Poznan Univ Med Sci, Dept Cardiac Surg & Transplantol, Poznan, Poland; [Trojnarska, Olga] Poznan Univ Med Sci, Dept Cardiol, Poznan, Poland; [Staniszewski, Ryszard; Pukacki, Fryderyk] Poznan Univ Med Sci, Dept Gen & Vasc Surg, Poznan, Poland; [Smoczyk, Wieslaw] Poznan Univ Med Sci, Dept Pediat Radiol, Poznan, Poland	Poznan University of Medical Sciences; Poznan University of Medical Sciences; Poznan University of Medical Sciences; Poznan University of Medical Sciences; Poznan University of Medical Sciences	Perek, B (corresponding author), Poznan Univ Med Sci, Dept Cardiac Surg & Transplantol, Poznan, Poland.	bperek@yahoo.com	Perek, Bartłomiej/AAS-6564-2021	Perek, Bartłomiej/0000-0003-2398-9571				ALAKULJU K, 1989, ANN THORAC SURG, V47, P853, DOI 10.1016/0003-4975(89)90018-0; Auriacombe L, 2002, ARCH MAL COEUR VAISS, V95, P1081; Botta L, 2009, EUR J CARDIO-THORAC, V36, P670, DOI 10.1016/j.ejcts.2009.04.056; Brueck Martin, 2006, J Interv Cardiol, V19, P539, DOI 10.1111/j.1540-8183.2006.00208.x; COHEN M, 1989, CIRCULATION, V80, P840, DOI 10.1161/01.CIR.80.4.840; DESANTO A, 1987, J THORAC CARDIOV SUR, V94, P720; DOTTER CT, 1969, INVEST RADIOL, V4, P329, DOI 10.1097/00004424-196909000-00008; Dykukha S E, 1997, Klin Khir, P78; Etz CD, 2009, ANN THORAC SURG, V88, P758, DOI 10.1016/j.athoracsur.2009.04.140; Garcia-Pavia P, 2010, REV ESP CARDIOL, V63, P473, DOI 10.1016/S0300-8932(10)70068-3; Hiratzka LF, 2010, J AM COLL CARDIOL, V55, P1509, DOI 10.1016/j.jacc.2010.02.010; Knyshov GV, 1996, ANN THORAC SURG, V61, P935, DOI 10.1016/0003-4975(95)01189-7; Kpodonu J, 2010, ANN THORAC SURG, V90, P1716, DOI 10.1016/j.athoracsur.2009.12.083; Ksiazyk J, 2004, FOLIA CARDIOL, V11, P205; Kutty S, 2008, ANN THORAC SURG, V85, P1332, DOI 10.1016/j.athoracsur.2008.01.012; Marcheix B, 2007, EUR J CARDIO-THORAC, V31, P1004, DOI 10.1016/j.ejcts.2007.02.036; Oliver JM, 2009, AM J CARDIOL, V104, P1001, DOI 10.1016/j.amjcard.2009.05.045; Maxey TS, 2003, ANN THORAC SURG, V76, P1090, DOI 10.1016/S0003-4975(03)00822-1; Olivieri Laura J, 2011, Cardiovasc Eng Technol, V2, P288; Ou P, 2004, EUR HEART J, V25, P1853, DOI 10.1016/j.ehj.2004.07.021; Ou P, 2006, J THORAC CARDIOV SUR, V132, P1105, DOI 10.1016/j.jtcvs.2006.05.061; Pace Napoleone Carlo, 2003, Ital Heart J, V4, P404; Parodi J C, 1991, Ann Vasc Surg, V5, P491, DOI 10.1007/BF02015271; Rokkas CK, 2002, J THORAC CARDIOV SUR, V124, P155, DOI 10.1067/mtc.2002.121494; Smaill BH, 2000, J THORAC CARDIOV SUR, V120, P1053, DOI 10.1067/mtc.2000.110187; Szmidt Jacek, 2007, Interact Cardiovasc Thorac Surg, V6, P490, DOI 10.1510/icvts.2007.152447; Vriend JWJ, 2005, INT J CARDIOL, V101, P399, DOI 10.1016/j.ijcard.2004.03.056; Wagner RH, 2006, GER MED SCI, V4; Wang Y, 2010, HEART SURG FORUM, V13, pE350, DOI 10.1532/HSF98.20101061; Webb G, 2005, SEMIN THORAC CARDIOV, V17, P139, DOI 10.1053/j.semtcvs.2005.03.001; Zipfel B, 2011, ANN THORAC SURG, V91, P85, DOI 10.1016/j.athoracsur.2010.08.053	31	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e83601	10.1371/journal.pone.0083601	http://dx.doi.org/10.1371/journal.pone.0083601			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281QS	24386233	gold, Green Published, Green Submitted			2022-12-25	WOS:000329116700062
J	Pombert, JF; Otis, C; Turmel, M; Lemieux, C				Pombert, Jean-Francois; Otis, Christian; Turmel, Monique; Lemieux, Claude			The Mitochondrial Genome of the Prasinophyte Prasinoderma coloniale Reveals Two Trans-Spliced Group I Introns in the Large Subunit rRNA Gene	PLOS ONE			English	Article							ALGA OLTMANNSIELLOPSIS-VIRIDIS; DNA-SEQUENCE; HOMING ENDONUCLEASES; COMPLETE CHLOROPLAST; EVOLUTIONARY TRENDS; ULVOPHYCEAE; PLANT; ARCHITECTURE; COMPLEX; RDNA	Organelle genes are often interrupted by group I and or group II introns. Splicing of these mobile genetic occurs at the RNA level via serial transesterification steps catalyzed by the introns'own tertiary structures and, sometimes, with the help of external factors. These catalytic ribozymes can be found in cis or trans configuration, and although trans-arrayed group II introns have been known for decades, trans-spliced group I introns have been reported only recently. In the course of sequencing the complete mitochondrial genome of the prasinophyte picoplanktonic green alga Prasinoderma coloniale CCMP 1220 (Prasinococcales, clade VI), we uncovered two additional cases of trans-spliced group I introns. Here, we describe these introns and compare the 54,546 bp-long mitochondrial genome of Prasinoderma with those of four other prasinophytes (clades II, III and V). This comparison underscores the highly variable mitochondrial genome architecture in these ancient chlorophyte lineages. Both Prasinoderma trans-spliced introns reside within the large subunit rRNA gene (rnl) at positions where cis-spliced relatives, often containing homing endonuclease genes, have been found in other organelles. In contrast, all previously reported trans-spliced group I introns occur in different mitochondrial genes (rns or coxI). Each Prasinoderma intron is fragmented into two pieces, forming at the RNA level a secondary structure that resembles those of its cis-spliced counterparts. As observed for other trans-spliced group I introns, the breakpoint of the first intron maps to the variable loop L8, whereas that of the second is uniquely located downstream of P9.1. The breakpoint In each Prasinoderma intron corresponds to the same region where the open reading frame (ORF) occurs when present in cis-spliced orthologs. This correlation between the intron breakpoint and the ORF location in cis-spliced orthologs also holds for other trans-spliced introns; we discuss the possible implications of this interesting observation for trans-splicing of group I introns.	[Pombert, Jean-Francois] IIT, Dept Biol & Chem Sci, Chicago, IL 60616 USA; [Otis, Christian; Turmel, Monique; Lemieux, Claude] Univ Laval, Inst Biol Integrat & Syst, Dept Biochimie Microbiol & Bioinformat, Quebec City, PQ, Canada	Illinois Institute of Technology; Laval University	Lemieux, C (corresponding author), Univ Laval, Inst Biol Integrat & Syst, Dept Biochimie Microbiol & Bioinformat, Quebec City, PQ, Canada.	claude.lemieux@bcm.ulaval.ca	Turmel, Monique/AAC-9752-2020; Lemieux, Claude/L-8831-2015	Turmel, Monique/0000-0001-7060-035X; Lemieux, Claude/0000-0001-9580-8042; Pombert, Jean-Francois/0000-0002-3449-8375	NSERC from the Natural Sciences and Engineering Council [2830]	NSERC from the Natural Sciences and Engineering Council	This work was supported by a NSERC-Discovery grant (no. 2830) from the Natural Sciences and Engineering Council (http://www.nserc-crsng.gc.ca/index_eng.asp) to MT and CL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belhocine K, 2008, RNA, V14, P1782, DOI 10.1261/rna.1083508; Bonen L, 2012, ADV BOT RES, V63, P155, DOI 10.1016/B978-0-12-394279-1.00007-7; BROSIUS J, 1980, P NATL ACAD SCI-BIOL, V77, P201, DOI 10.1073/pnas.77.1.201; Burger G, 2009, TRENDS GENET, V25, P381, DOI 10.1016/j.tig.2009.07.003; BURKE JM, 1987, NUCLEIC ACIDS RES, V15, P7217, DOI 10.1093/nar/15.18.7217; CECH TR, 1990, ANNU REV BIOCHEM, V59, P543, DOI 10.1146/annurev.bi.59.070190.002551; CHAPDELAINE Y, 1991, CELL, V65, P465, DOI 10.1016/0092-8674(91)90464-A; Glanz S, 2009, BIOESSAYS, V31, P921, DOI 10.1002/bies.200900036; GOLDSCHMIDTCLERMONT M, 1990, MOL GEN GENET, V223, P417, DOI 10.1007/BF00264448; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Grewe F, 2009, NUCLEIC ACIDS RES, V37, P5093, DOI 10.1093/nar/gkp532; Guillou L, 2004, PROTIST, V155, P193, DOI 10.1078/143446104774199592; Hasegawa T, 1996, PHYCOLOGIA, V35, P170, DOI 10.2216/i0031-8884-35-2-170.1; Haugen P, 2005, TRENDS GENET, V21, P111, DOI 10.1016/j.tig.2004.12.007; Haugen P, 2004, NUCLEIC ACIDS RES, V32, P2049, DOI 10.1093/nar/gkh520; Hecht J, 2011, GENOME BIOL EVOL, V3, P344, DOI 10.1093/gbe/evr027; Jacobs J, 2013, MOL CELL PROTEOMICS, V12, P1912, DOI 10.1074/mcp.M112.026583; Jacobs J, 2011, CELL MOL LIFE SCI, V68, P735, DOI 10.1007/s00018-010-0523-3; KELLER MD, 1987, J PHYCOL, V23, P633; Knoop V, 1997, MOL GEN GENET, V255, P269, DOI 10.1007/s004380050497; KUCK U, 1987, EMBO J, V6, P2185, DOI 10.1002/j.1460-2075.1987.tb02489.x; Kurtz S, 2001, NUCLEIC ACIDS RES, V29, P4633, DOI 10.1093/nar/29.22.4633; Lambowitz AM, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003616; Leliaert F, 2012, CRIT REV PLANT SCI, V31, P1, DOI 10.1080/07352689.2011.615705; Lohse M, 2007, CURR GENET, V52, P267, DOI 10.1007/s00294-007-0161-y; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Lucas P, 2001, NUCLEIC ACIDS RES, V29, P960, DOI 10.1093/nar/29.4.960; MICHEL F, 1990, J MOL BIOL, V216, P585, DOI 10.1016/0022-2836(90)90386-Z; Nadimi M, 2012, MOL BIOL EVOL, V29, P2199, DOI 10.1093/molbev/mss088; Pelin A, 2012, NEW PHYTOL, V194, P836, DOI 10.1111/j.1469-8137.2012.04072.x; Pombert JF, 2006, CURR GENET, V50, P137, DOI 10.1007/s00294-006-0076-z; Pombert JF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008954; Pombert JF, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-3; Pombert JF, 2005, MOL BIOL EVOL, V22, P1903, DOI 10.1093/molbev/msi182; Pombert JF, 2004, MOL BIOL EVOL, V21, P922, DOI 10.1093/molbev/msh099; Qiu YL, 2004, J MOL EVOL, V59, P80, DOI 10.1007/s00239-004-2606-y; Robbens S, 2007, MOL BIOL EVOL, V24, P956, DOI 10.1093/molbev/msm012; SALDANHA R, 1993, FASEB J, V7, P15, DOI 10.1096/fasebj.7.1.8422962; Smith DR, 2008, MOL BIOL EVOL, V25, P487, DOI 10.1093/molbev/msm245; Smith DR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023624; Stoddard BL, 2011, STRUCTURE, V19, P7, DOI 10.1016/j.str.2010.12.003; Turmel M, 1999, PLANT CELL, V11, P1717, DOI 10.1105/tpc.11.9.1717; Turmel M, 2010, J MOL EVOL, V70, P203, DOI 10.1007/s00239-010-9322-6; Worden AZ, 2009, SCIENCE, V324, P268, DOI 10.1126/science.1167222; Zhou Y, 2008, NUCLEIC ACIDS RES, V36, pD31, DOI 10.1093/nar/gkm766	45	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e84325	10.1371/journal.pone.0084325	http://dx.doi.org/10.1371/journal.pone.0084325			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281QS	24386369	Green Submitted, Green Published, gold			2022-12-25	WOS:000329116700104
J	Sippert, EA; Silva, CDE; Visentainer, JEL; Sell, AM				Sippert, Emilia Angela; de Oliveira e Silva, Cleverson; Laguila Visentainer, Jeane Eliete; Sell, Ana Maria			Association of Duffy Blood Group Gene Polymorphisms with IL8 Gene in Chronic Periodontitis	PLOS ONE			English	Article							CHEMOKINE RECEPTOR; CODING SEQUENCE; INTERLEUKIN-1 GENOTYPE; RISK INDICATORS; EXPRESSION; DISEASE; ANTIGEN; CELLS; COMMON; SUSCEPTIBILITY	The antigens of the Duffy blood group system (DARC) act as a receptor for the interleukin IL-8. IL-8 plays an important role in the pathogenesis of chronic periodontitis due to its chemotactic properties on neutrophils. The aim of this study was to investigate a possible association of Duffy blood group gene polymorphisms with the -353T>A, -845T>C and -738T>A SNPs of the IL8 gene in chronic periodontitis. One hundred and twenty-four individuals with chronic periodontitis and 187 controls were enrolled. DNA was extracted using the salting-out method. The Duffy genotypes and IL8 gene promoter polymorphisms were investigated by PCR-RFLP. Statistical analyses were conducted using the Chi square test with Yates correction or Fisher's Exact Test, and the possibility of associations were evaluated by odds ratio with a 95% confidence interval. When analyzed separately, for the Duffy blood group system, differences in the genotype and allele frequencies were not observed between all the groups analyzed; and, in nonsmokers, the -845C allele (3.6% vs. 0.4%), -845TC genotype (7.3% vs. 0.7%) and the CTA haplotype (3.6% vs. 0.4%) were positively associated with chronic periodontitis. For the first time to our knowledge, the polymorphisms of erythroid DARC plus IL8 -353T>A SNPs were associated with chronic periodontitis in Brazilian individuals. In Afro-Brazilians patients, the FY*02N. 01 with IL8 -353A SNP was associated with protection to chronic periodontitis.	[Sippert, Emilia Angela] Univ Estadual Maringa, Dept Anal Clin & Biomed, Post Grad Program Biosci Appl Pharm, Maringa, Parana, Brazil; [de Oliveira e Silva, Cleverson] Univ Estadual Maringa, Dept Dent, Maringa, Parana, Brazil; [Laguila Visentainer, Jeane Eliete; Sell, Ana Maria] Univ Estadual Maringa, Basic Hlth Sci Dept, Maringa, Parana, Brazil	Universidade Estadual de Maringa; Universidade Estadual de Maringa; Universidade Estadual de Maringa	Sell, AM (corresponding author), Univ Estadual Maringa, Basic Hlth Sci Dept, Maringa, Parana, Brazil.	anamsell@gmail.com	Sippert, Emilia Angela/B-3033-2013; Visentainer, Jeane Eliete Laguila/B-3510-2009; Silva, Cléverson O/G-5907-2012; Visentainer, Jeane/AAJ-1618-2021	Sippert, Emilia Angela/0000-0002-6341-3879; Visentainer, Jeane Eliete Laguila/0000-0002-5815-7903; Silva, Cléverson O/0000-0002-7103-9100; 	CAPES; Fundacao Araucaria; Laboratory of Immunogenetics LIG-UEM	CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao Araucaria(Fundacao Araucaria de Apoio ao Desenvolvimento Cientifico e Tecnologico do Estado do Parana FAFundacao de Amparo a Pesquisa e Inovacoo Estado de Santa Catarina (FAPESC)); Laboratory of Immunogenetics LIG-UEM	The authors wish to thank CAPES, Fundacao Araucaria, and Laboratory of Immunogenetics LIG-UEM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DH, 1997, LANCET, V349, P490, DOI 10.1016/S0140-6736(96)07524-1; Ahluwalia TS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005168; Andia DC, 2011, J PERIODONTOL, V82, P893, DOI 10.1902/jop.2010.100513; Bandyopadhyay S, 2006, NAT MED, V12, P933, DOI 10.1038/nm1444; Bergstrom Jan, 2004, Odontology, V92, P1; Cartron JP, 1998, VOX SANG, V74, P29, DOI 10.1111/j.1423-0410.1998.tb05397.x; Castilho L, 2004, VOX SANG, V87, P190, DOI 10.1111/j.1423-0410.2004.00554.x; CHAUDHURI A, 1995, BLOOD, V85, P615, DOI 10.1182/blood.V85.3.615.bloodjournal853615; CHAUDHURI A, 1994, J BIOL CHEM, V269, P7835; Dan HX, 2010, INFLAMMATION, V33, P76, DOI 10.1007/s10753-009-9160-0; DARBONNE WC, 1991, J CLIN INVEST, V88, P1362, DOI 10.1172/JCI115442; Estalote AC, 2005, GENET MOL RES, V4, P166; Gainet J, 1998, LAB INVEST, V78, P755; Garza-Gonzalez E, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-70; Genco RJ, 1996, J PERIODONTOL, V67, P1041, DOI 10.1902/jop.1996.67.10s.1041; Gonzales JR, 2004, J CLIN PERIODONTOL, V31, P384, DOI 10.1111/j.1600-051X.2004.00492.x; GOVERDHAN V, 2008, BR J OPHTHALMOL, V92, P537, DOI DOI 10.1136/BJ0.2007.123190.PUBMED:18310311; GROSSI SG, 1994, J PERIODONTOL, V65, P260, DOI 10.1902/jop.1994.65.3.260; GROSSI SG, 1995, J PERIODONTOL, V66, P23, DOI 10.1902/jop.1995.66.1.23; Guzman S, 2003, J PERIODONTOL, V74, P1183, DOI 10.1902/jop.2003.74.8.1183; Hadley TJ, 1997, BLOOD, V89, P3077, DOI 10.1182/blood.V89.9.3077; Hansell CAH, 2011, IMMUNOL CELL BIOL, V89, P197, DOI 10.1038/icb.2010.147; He WJ, 2008, CELL HOST MICROBE, V4, P52, DOI 10.1016/j.chom.2008.06.002; Heinzmann A, 2004, J ALLERGY CLIN IMMUN, V114, P671, DOI 10.1016/j.jaci.2004.06.038; HORUK R, 1993, BIOCHEMISTRY-US, V32, P5733, DOI 10.1021/bi00073a002; Howes RE, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1265; Hull J, 2000, THORAX, V55, P1023, DOI 10.1136/thorax.55.12.1023; Ioannidis JPA, 2001, NAT GENET, V29, P306, DOI 10.1038/ng749; Kamali-Sarvestani E, 2007, NEOPLASMA, V54, P484; Kawashima Miwako, 2005, Nippon Ganka Gakkai Zasshi, V109, P596; Kim YJ, 2009, DNA CELL BIOL, V28, P185, DOI 10.1089/dna.2008.0816; Kim YJ, 2010, CLIN CHIM ACTA, V411, P1264, DOI 10.1016/j.cca.2010.05.014; Kornman Kenneth S, 2005, J Dent Educ, V69, P498; Kornman KS, 1997, J CLIN PERIODONTOL, V24, P72, DOI 10.1111/j.1600-051X.1997.tb01187.x; Kyiak Iu H, 2012, Fiziol Zh, V58, P65; Lalla E, 2011, NAT REV ENDOCRINOL, V7, P738, DOI 10.1038/nrendo.2011.106; Lee EB, 2007, TISSUE ANTIGENS, V69, P128, DOI 10.1111/j.1399-0039.2006.00736.x; McCarron SL, 2002, CANCER RES, V62, P3369; Mealey BL, 2006, J AM DENT ASSOC, V137, p26S, DOI 10.14219/jada.archive.2006.0404; Moreira PR, 2005, J PERIODONTAL RES, V40, P306, DOI 10.1111/j.1600-0765.2005.00801.x; MURPHY PM, 1994, ANNU REV IMMUNOL, V12, P593, DOI 10.1146/annurev.iy.12.040194.003113; NELSON RG, 1990, DIABETES CARE, V13, P836, DOI 10.2337/diacare.13.8.836; NEOTE K, 1994, BLOOD, V84, P44; NEOTE K, 1993, J BIOL CHEM, V268, P12247; Novaretti MC, 2000, REV BRAS HEMATOL HEM, V22, P23; Okada H, 1998, CRIT REV ORAL BIOL M, V9, P248, DOI 10.1177/10454411980090030101; Papapanou PN, 2001, J CLIN PERIODONTOL, V28, P389, DOI 10.1034/j.1600-051x.2001.028005389.x; Parasol N, 1998, BLOOD, V92, P2237, DOI 10.1182/blood.V92.7.2237.2237_2237_2243; Probst CM, 2000, HUM BIOL, V72, P597; Rompler H, 2006, GENOMICS, V87, P724, DOI 10.1016/j.ygeno.2006.02.009; Rot A, 2005, CYTOKINE GROWTH F R, V16, P687, DOI 10.1016/j.cytogfr.2005.05.011; Rovin BH, 2002, KIDNEY INT, V62, P261, DOI 10.1046/j.1523-1755.2002.00438.x; Salvi GE, 1997, PERIODONTOL 2000, V14, P173, DOI 10.1111/j.1600-0757.1997.tb00197.x; Soga Y, 2003, J CLIN PERIODONTOL, V30, P524, DOI 10.1034/j.1600-051X.2003.00287.x; Taylor G W, 2001, Ann Periodontol, V6, P99, DOI 10.1902/annals.2001.6.1.99; Tournamille C, 1998, BLOOD, V92, P2147, DOI 10.1182/blood.V92.6.2147.418k04_2147_2156; TOURNAMILLE C, 1995, HUM GENET, V95, P407, DOI 10.1007/BF00208965; TOURNAMILLE C, 1995, NAT GENET, V10, P224, DOI 10.1038/ng0695-224; Tsai C, 2002, COMMUNITY DENT ORAL, V30, P182, DOI 10.1034/j.1600-0528.2002.300304.x; Tuller T, 2013, GENES IMMUN, V14, P67, DOI 10.1038/gene.2012.55; Vairaktaris E, 2007, EJSO-EUR J SURG ONC, V33, P504, DOI 10.1016/j.ejso.2006.11.002; Voisine P, 2004, CIRCULATION, V110, pII280, DOI 10.1161/01.CIR.0000138974.18839.02	62	16	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e83286	10.1371/journal.pone.0083286	http://dx.doi.org/10.1371/journal.pone.0083286			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281QS	24386171	Green Submitted, Green Published, gold			2022-12-25	WOS:000329116700037
J	Xiao, Y; Fan, HH; Zhang, YP; Xing, WJ; Ping, YY; Zhao, HY; Xu, CH; Li, YQ; Wang, L; Li, F; Hu, J; Huang, T; Lv, YL; Ren, H; Li, X				Xiao, Yun; Fan, Huihui; Zhang, Yunpeng; Xing, Wenjing; Ping, Yanyan; Zhao, Hongying; Xu, Chaohan; Li, Yiqun; Wang, Li; Li, Feng; Hu, Jing; Huang, Teng; Lv, Yanling; Ren, Huan; Li, Xia			Systematic Identification of Core Transcription Factors Mediating Dysregulated Links Bridging Inflammatory Bowel Diseases and Colorectal Cancer	PLOS ONE			English	Article							GENE-EXPRESSION PATTERNS; REGULATORY NETWORKS; COEXPRESSION ANALYSIS; STAT3 ACTIVATION; MICROARRAY DATA; HALLMARKS; COLITIS; CELLS; IL-6; ALGORITHMS	Accumulating evidence shows a tight link between inflammation and cancer. However, comprehensive identification of pivotal transcription factors (i.e., core TFs) mediating the dysregulated links remains challenging, mainly due to a lack of samples that can effectively reflect the connections between inflammation and tumorigenesis. Here, we constructed a series of TF-mediated regulatory networks from a large compendium of expression profiling of normal colonic tissues, inflammatory bowel diseases (IBDs) and colorectal cancer (CRC), which contains 1201 samples in total, and then proposed a network-based approach to characterize potential links bridging inflammation and cancer. For this purpose, we computed significantly dysregulated relationships between inflammation and their linked cancer networks, and then 24 core TFs with their dysregulated genes were identified. Collectively, our approach provides us with quite important insight into inflammation-associated tumorigenesis in colorectal cancer, which could also be applied to identify functionally dysregulated relationships mediating the links between other different disease phenotypes.	[Xiao, Yun; Fan, Huihui; Zhang, Yunpeng; Ping, Yanyan; Zhao, Hongying; Xu, Chaohan; Li, Yiqun; Wang, Li; Li, Feng; Hu, Jing; Huang, Teng; Lv, Yanling; Li, Xia] Harbin Med Univ, Coll Bioinformat Sci & Technol, Harbin, Heilongjiang, Peoples R China; [Xing, Wenjing; Ren, Huan] Harbin Med Univ, Dept Immunol, Harbin, Heilongjiang, Peoples R China	Harbin Medical University; Harbin Medical University	Ren, H (corresponding author), Harbin Med Univ, Dept Immunol, Harbin, Heilongjiang, Peoples R China.	huanren2009@126.com; lixia@hrbmu.edu.cn	Ren, Huan/O-5727-2017; Hu, Jing/GPC-4486-2022; Fan, Huihui/AGB-0221-2022; Hu, Jing/AAT-8707-2021; li, xia/HHZ-7468-2022; Xiao, Yun/A-8359-2013	Hu, Jing/0000-0002-5996-4889; Fan, Huihui/0000-0003-4233-5389; Hu, Jing/0000-0002-5996-4889; Ping, Yanyan/0000-0002-1810-1200; Ren, Huan/0000-0001-7114-2012	Creative Research Groups of The National Natural Science Foundation of China [81121003, 91129710, 91029717, 91229112, 31200997]; Specialized Research Fund for the Doctoral Program of Higher Education of China [20102307110022]; Science Foundation of Heilongjiang Province [D200834, C201207]; Science Foundation of Heilongjiang Province Education Department [YJSCX2012-230HLJ]	Creative Research Groups of The National Natural Science Foundation of China; Specialized Research Fund for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Science Foundation of Heilongjiang Province; Science Foundation of Heilongjiang Province Education Department	This work was supported in part by the Creative Research Groups of The National Natural Science Foundation of China (grant numbers 81121003, 91129710, 91029717, 91229112 and 31200997), the Specialized Research Fund for the Doctoral Program of Higher Education of China (grant number 20102307110022), the Science Foundation of Heilongjiang Province (grant numbers D200834 and C201207) and the Science Foundation of Heilongjiang Province Education Department (grant number YJSCX2012-230HLJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdollahi A, 2007, P NATL ACAD SCI USA, V104, P12890, DOI 10.1073/pnas.0705505104; Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Altay G, 2010, BIOINFORMATICS, V26, P1738, DOI 10.1093/bioinformatics/btq259; Ancrile B, 2007, GENE DEV, V21, P1714, DOI 10.1101/gad.1549407; Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Bansal M., 2007, MOL SYSTEMS BIOL, V3; Bansal M, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100120; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Ben-Neriah Y, 2011, NAT IMMUNOL, V12, P715, DOI 10.1038/ni.2060; Bollrath J, 2009, CANCER CELL, V15, P91, DOI 10.1016/j.ccr.2009.01.002; Bromberg J, 2009, CANCER CELL, V15, P79, DOI 10.1016/j.ccr.2009.01.009; Cerami E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008918; Chen GY, 2011, GASTROENTEROLOGY, V141, P1986, DOI 10.1053/j.gastro.2011.10.002; Choi JK, 2005, BIOINFORMATICS, V21, P4348, DOI 10.1093/bioinformatics/bti722; Colotta F, 2009, CARCINOGENESIS, V30, P1073, DOI 10.1093/carcin/bgp127; Greten FR, 2004, CELL, V118, P285, DOI 10.1016/j.cell.2004.07.013; Grivennikov S, 2009, CANCER CELL, V15, P103, DOI 10.1016/j.ccr.2009.01.001; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hartigan J. A., 1979, Applied Statistics, V28, P100, DOI 10.2307/2346830; He B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018516; Huttenhower C, 2009, BIOINFORMATICS, V25, P3267, DOI 10.1093/bioinformatics/btp588; Iliopoulos D, 2010, MOL CELL, V39, P493, DOI 10.1016/j.molcel.2010.07.023; Iliopoulos D, 2009, CELL, V139, P693, DOI 10.1016/j.cell.2009.10.014; Itzkowitz SH, 2004, AM J PHYSIOL-GASTR L, V287, pG7, DOI 10.1152/ajpgi.00079.2004; Jess T, 2012, CLIN GASTROENTEROL H, V10, P639, DOI 10.1016/j.cgh.2012.01.010; Karamanou M, 2010, J BUON, V15, P803; Klein CA, 2002, LANCET, V360, P683, DOI 10.1016/S0140-6736(02)09838-0; KODAKI T, 1994, CURR BIOL, V4, P798, DOI 10.1016/S0960-9822(00)00177-9; Lazebnik Y, 2010, NAT REV CANCER, V10, P232, DOI 10.1038/nrc2827; Lee HK, 2004, GENOME RES, V14, P1085, DOI 10.1101/gr.1910904; Li A, 2007, BIOINFORMATICS, V23, P222, DOI 10.1093/bioinformatics/btl581; Li Y, 2012, INFLAMM BOWEL DIS, V18, P1177, DOI 10.1002/ibd.21884; Mani KM, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.2; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Marbach D, 2010, P NATL ACAD SCI USA, V107, P6286, DOI 10.1073/pnas.0913357107; March HN, 2011, NAT GENET, V43, P1202, DOI 10.1038/ng.990; Margolin AA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S1-S7; Nibbe RK, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000639; Nilsson LM, 2007, AM J PHYSIOL-CELL PH, V292, pC1167, DOI 10.1152/ajpcell.00590.2005; Pozza A, 2011, ANN ITAL CHIR, V82, P19; RODRIGUEZVICIANA P, 1994, NATURE, V370, P527, DOI 10.1038/370527a0; SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sharan R, 2006, NAT BIOTECHNOL, V24, P427, DOI 10.1038/nbt1196; Soranzo N, 2007, BIOINFORMATICS, V23, P1640, DOI 10.1093/bioinformatics/btm163; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Sotiriou C, 2003, P NATL ACAD SCI USA, V100, P10393, DOI 10.1073/pnas.1732912100; Stuart JM, 2003, SCIENCE, V302, P249, DOI 10.1126/science.1087447; Wu XB, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.27; Xiao Y, 2011, GENOMICS, V98, P64, DOI 10.1016/j.ygeno.2011.04.001; Yip AM, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-22	52	4	4	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e83495	10.1371/journal.pone.0083495	http://dx.doi.org/10.1371/journal.pone.0083495			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281QS	24386215	Green Submitted, gold, Green Published			2022-12-25	WOS:000329116700056
J	de Pedro-Cuesta, J; Garcia-Sagredo, P; Alcalde-Cabero, E; Alberquilla, A; Damian, J; Bosca, G; Lopez-Rodriguez, F; Carmona, M; de Tena-Davila, MJ; Garcia-Olmos, L; Salvador, CH				de Pedro-Cuesta, Jesus; Garcia-Sagredo, Pilar; Alcalde-Cabero, Enrique; Alberquilla, Angel; Damian, Javier; Bosca, Graciela; Lopez-Rodriguez, Fernando; Carmona, Monserrat; de Tena-Davila, Maria J.; Garcia-Olmos, Luis; Salvador, Carlos H.			Disability transitions after 30 months in three community-dwelling diagnostic groups in Spain	PLOS ONE			English	Article							HEART-FAILURE; OLDER-ADULTS; FOLLOW-UP; PREVALENCE; HEALTH; CARE; HOME; STROKE; REHABILITATION; LIMITATIONS	Background: Little is known about changes in disability over time among community-dwelling patients. Accordingly, this study sought to assess medium-term disability transitions. Patients and Methods: 300 chronic obstructive pulmonary disease (COPD), chronic heart failure and stroke patients living at home in Madrid were selected from general practitioner lists. In 2009, disability was assessed after a mean of 30 months using the World Health Organisation (WHO) Disability Assessment Schedule 2.0 (WHODAS 2.0). Follow-up was completed using death registries. Losses to follow-up were due to: death, 56; institutionalisation, 9; non-location, 18; and non-participation, 17. Changes in WHODAS 2.0 scores and life status were described and analysed using Cox and multinomial regression. Disability at end of follow-up was imputed for 56 deceased and 44 surviving patients. Results: Mean disability scores for 200 surviving patients at end of follow-up were similar to baseline scores for the whole group, higher than their own baseline scores, and rose by 16.3% when imputed values were added. The strongest Cox predictors of death were: age over 84 years, adjusted hazard ratios with 95% CI 8.18 (3.06-21.85); severe/complete vs. no/mild disability, 5.18 (0.68-39.48); and stroke compared to COPD, 1.40 (0.67-2.91). Non-participants and institutionalised patients had higher proportions with severe/complete baseline disability. A one-point change in baseline WHODAS 2.0 score predicted independent increases in risk of 12% (8%-15%) for severe/ complete disability or death. Conclusions: A considerably high proportion of community-dwelling patients diagnosed with COPD, CHF and stroke undergo medium-term changes in disability or vital status. The main features of the emerging pattern for this group appear to be as follows: approximately two-thirds of patients continue living at home with moderately reduced functional status; 1/3 die or worsen to severe/complete disability; and 1/10 improve. Baseline disability scores, age and diagnosis are associated with disability and death in the medium term.	[de Pedro-Cuesta, Jesus; Alcalde-Cabero, Enrique; Damian, Javier] Natl Ctr Epidemiol, Madrid, Spain; [de Pedro-Cuesta, Jesus; Alcalde-Cabero, Enrique; Damian, Javier] Carlos III Inst Hlth, Madrid, Spain; [Garcia-Sagredo, Pilar; Bosca, Graciela; Lopez-Rodriguez, Fernando; de Tena-Davila, Maria J.; Salvador, Carlos H.] Carlos III Inst Hlth, Telemed & Hlth Unit, Madrid, Spain; [Alberquilla, Angel] Family & Community Care Ctr, Multiprofess Educ Unit, Serv Madrileno Salud, Madrid, Spain; [Carmona, Monserrat] Puerta Hierro Univ, Teaching Hosp, Bioengn & Telemed Unit, Madrid, Spain; [Garcia-Olmos, Luis] Multiprofess Educ Unit Family & Community Care So, Serv Madrileno Salud, Madrid, Spain	Instituto de Salud Carlos III; Instituto de Salud Carlos III	de Pedro-Cuesta, J (corresponding author), Natl Ctr Epidemiol, Madrid, Spain.	jpedro@isciii.es	Carmona, Montserrat/F-7593-2010; Carmona, Montserrat/AAD-7263-2019; Rodríguez, Fernando López/A-7557-2016	Carmona, Montserrat/0000-0002-4680-7745; Carmona, Montserrat/0000-0002-4680-7745; Rodríguez, Fernando López/0000-0002-0519-9624; Damian, Javier/0000-0002-6258-8220	CENIT Program (MICINN-CDTI) [CEN-2007-1010]; Ministry of Health AMP; Consumer Affairs [FIS PI08-0435]; Fondo de Investigaciones Sanitarias [PI06/1098, PI07/90206]; Fundacion Cien/CIBERNED	CENIT Program (MICINN-CDTI); Ministry of Health AMP; Consumer Affairs; Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III); Fundacion Cien/CIBERNED	This study was partially supported by the CENIT Program (MICINN-CDTI) [CEN-2007-1010 "Digital personal environment for health and wellbeing -AmiVital" project], a grant from the Ministry of Health & Consumer Affairs [FIS PI08-0435 Definition, design, development and evaluation of services of monitoring, follow-up and control of aging people in independent life] and by projects PI06/1098 and PI07/90206 from Fondo de Investigaciones Sanitarias. Enrique Alcalde was in part supported by Fundacion Cien/CIBERNED. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abete P, 2013, HEART FAIL REV, V18, P529, DOI 10.1007/s10741-012-9363-6; Alonso-Coello P, 2012, THROMB HAEMOSTASIS, V108, P647, DOI 10.1160/TH12-01-0027; Capistrant BD, 2013, J AM GERIATR SOC, V61, P931, DOI 10.1111/jgs.12270; Carmona M, 2011, FAM PRACT, V28, P128, DOI 10.1093/fampra/cmq084; de Pedro-Cuesta J, 2011, GAC SANIT, V25, P21, DOI 10.1016/j.gaceta.2011.08.005; de Salud Carlos Instituto IIIwebsite, 2010, MORT CAP CAUS SEX; Dewey ME, 2000, INT J EPIDEMIOL, V29, P684; Falk H, 2013, J NURS SCHOLARSHIP, V45, P247, DOI 10.1111/jnu.12025; Garin O, 2010, HEALTH QUAL LIFE OUT, V19, P8, DOI DOI 10.1186/1477-7525-8-51.PUBMED:20482853; Gellis ZD, 2012, GERONTOLOGIST, V52, P541, DOI 10.1093/geront/gnr134; Graciani A, 2004, MATURITAS, V48, P381, DOI 10.1016/j.maturitas.2003.10.004; Greenland S, 2008, MODERN EPIDEMIOLOGY, P44; Kattainen A, 2004, J CLIN EPIDEMIOL, V57, P82, DOI 10.1016/S0895-4356(03)00252-X; Kennedy A, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2882; Klijs B, 2010, DISABIL REHABIL, V32, P1733, DOI 10.3109/09638281003746049; Linder SM, 2013, INT J STROKE, V8, P46, DOI 10.1111/j.1747-4949.2012.00971.x; Mastal MF, 2007, PROF CASE MANAG, V12, P27; McDaid David, 2009, Int J Integr Care, V9, pe60; McLean S, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d120; Prados-Torres A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032190; Riegel B, 2011, NAT REV CARDIOL, V8, P644, DOI 10.1038/nrcardio.2011.95; Riley PL, 2013, EUR J CARDIOVASC NUR; Rubin DB, 1996, J AM STAT ASSOC, V91, P473, DOI 10.1080/01621459.1996.10476908; Rubin DB, 2004, MULTIPLE IMPUTATION; Schafer A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014060; Steventon A, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3874; The Johns Hopkins ACG Case-Mix System, 2005, REF MAN J HOPK ACG C, P4; Thorsen AM, 2005, STROKE, V36, P297, DOI 10.1161/01.STR.0000152288.42701.a6; Ustun TB, 2010, B WORLD HEALTH ORGAN, V88, P815, DOI 10.2471/BLT.09.067231; Upatising B, 2013, INT J GEN MED, V6, P145, DOI 10.2147/IJGM.S40576; Vazquez-Barquero JL, 2006, WHO DIS ASS SCHED 2; Virues-Ortega J, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-176; Widdershoven Jos, 2013, Curr Heart Fail Rep, V10, P244, DOI 10.1007/s11897-013-0139-7; World Health Organization, 2001, INT CLASS FUNCT DIS; Zunzunegui MV, 2006, AGING CLIN EXP RES, V18, P352, DOI 10.1007/BF03324830	35	10	10	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2013	8	10							e77482	10.1371/journal.pone.0077482	http://dx.doi.org/10.1371/journal.pone.0077482			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	244FY	24391687	Green Published, gold			2022-12-25	WOS:000326373800002
J	Cesbron, F; Brunner, M; Diernfellner, ACR				Cesbron, Francois; Brunner, Michael; Diernfellner, Axel C. R.			Light-Dependent and Circadian Transcription Dynamics In Vivo Recorded with a Destabilized Luciferase Reporter in Neurospora	PLOS ONE			English	Article							WHITE-COLLAR COMPLEX; FIREFLY LUCIFERASE; GENE-EXPRESSION; CLOCK GENE; PHOSPHORYLATION; FREQUENCY; FEEDBACK; RHYTHMS; PROTEIN; CRASSA	We show that firefly luciferase is a stable protein when expressed at 25 degrees C in Neurospora, which limits its use as transcription reporter. We created a short-lived luciferase by fusing a PEST signal to its C-terminus (LUC-PEST) and applied the LUC-PEST reporter system to record in vivo transcription dynamics associated with the Neurospora circadian clock and its blue-light photosensory system over the course of several days. We show that the tool is suitable to faithfully monitor rapid, but also subtle changes in transcription in a medium to high throughput format.	[Cesbron, Francois; Brunner, Michael; Diernfellner, Axel C. R.] Heidelberg Univ, Biochem Ctr BZH, Heidelberg, Germany	Ruprecht Karls University Heidelberg	Diernfellner, ACR (corresponding author), Heidelberg Univ, Biochem Ctr BZH, Heidelberg, Germany.	axel.diernfellner@bzh.uni-heidelberg.de		Brunner, Michael/0000-0001-9798-3047	Deutsche Forschungsgemeinschaft: DFG [DI 1874/1-1]	Deutsche Forschungsgemeinschaft: DFG(German Research Foundation (DFG))	This work was supported by grants from the Deutsche Forschungsgemeinschaft: DFG DI 1874/1-1 to AD (http://www.dfg.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARONSON BD, 1994, P NATL ACAD SCI USA, V91, P7683, DOI 10.1073/pnas.91.16.7683; Belden WJ, 2007, GENE DEV, V21, P1494, DOI 10.1101/gad.1551707; Brandes C, 1996, NEURON, V16, P687, DOI 10.1016/S0896-6273(00)80088-4; Chen CH, 2010, P NATL ACAD SCI USA, V107, P16715, DOI 10.1073/pnas.1011190107; CROSTHWAITE SK, 1995, CELL, V81, P1003, DOI 10.1016/S0092-8674(05)80005-4; DANIELS MC, 1993, MOL ENDOCRINOL, V7, P1041, DOI 10.1210/me.7.8.1041; DILELLA AG, 1988, NUCLEIC ACIDS RES, V16, P4159, DOI 10.1093/nar/16.9.4159; Dolz-Edo L, 2013, MOL CELL BIOL, V33, P2228, DOI 10.1128/MCB.00240-13; Elvin M, 2005, GENE DEV, V19, P2593, DOI 10.1101/gad.349305; Geusz ME, 1997, CURR BIOL, V7, P758, DOI 10.1016/S0960-9822(06)00334-4; Gin E, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.24; Gooch VD, 2008, EUKARYOT CELL, V7, P28, DOI 10.1128/EC.00257-07; Gupta R, 2011, NAT METHODS, V8, P879, DOI [10.1038/NMETH.1697, 10.1038/nmeth.1697]; He Q, 2006, GENE DEV, V20, P2552, DOI 10.1101/gad.1463506; He QY, 2005, GENE DEV, V19, P2888, DOI 10.1101/gad.1369605; He QY, 2005, J BIOL CHEM, V280, P17526, DOI 10.1074/jbc.M414010200; Heintzen C, 2001, CELL, V104, P453, DOI 10.1016/S0092-8674(01)00232-X; Koksharov MI, 2011, PHOTOCH PHOTOBIO SCI, V10, P931, DOI 10.1039/c0pp00318b; KONDO T, 1993, P NATL ACAD SCI USA, V90, P5672, DOI 10.1073/pnas.90.12.5672; Larrondo LF, 2012, FUNGAL GENET BIOL, V49, P681, DOI 10.1016/j.fgb.2012.06.001; Leclerc GM, 2000, BIOTECHNIQUES, V29, P590, DOI 10.2144/00293rr02; Malzahn E, 2010, CELL, V142, P762, DOI 10.1016/j.cell.2010.08.010; Merrow M, 2007, COLD SPRING HARB SYM, V72, P279, DOI 10.1101/sqb.2007.72.032; Merrow M, 2011, FEBS LETT, V585, P1383, DOI 10.1016/j.febslet.2011.04.055; MILLAR AJ, 1992, PLANT CELL, V4, P1075, DOI 10.1105/tpc.4.9.1075; Morgan LW, 2003, FUNGAL GENET BIOL, V38, P327, DOI 10.1016/S1087-1845(02)00562-5; OW DW, 1986, SCIENCE, V234, P856, DOI 10.1126/science.234.4778.856; Paguio Aileen, 2010, Curr Chem Genomics, V4, P43, DOI 10.2174/1875397301004010043; PALOMARES AJ, 1989, GENE, V81, P55, DOI 10.1016/0378-1119(89)90336-3; Price-Lloyd N, 2005, BIOCHEM SOC T, V33, P949, DOI 10.1042/BST0330949; Robertson JB, 2008, P NATL ACAD SCI USA, V105, P17988, DOI 10.1073/pnas.0809482105; Roenneberg T, 2007, COLD SPRING HARB SYM, V72, P293, DOI 10.1101/sqb.2007.72.043; Sancar G, 2011, MOL CELL, V44, P687, DOI 10.1016/j.molcel.2011.10.019; Schafmeier T, 2006, GENE DEV, V20, P297, DOI 10.1101/gad.360906; Schafmeier T, 2005, CELL, V122, P235, DOI 10.1016/j.cell.2005.05.032; Schafmeier T, 2011, FEBS LETT, V585, P1467, DOI 10.1016/j.febslet.2011.03.050; Schafmeier T, 2008, GENE DEV, V22, P3397, DOI 10.1101/gad.507408; Schwerdtfeger C, 2001, MOL MICROBIOL, V39, P1080, DOI 10.1046/j.1365-2958.2001.02306.x; Suter DM, 2011, SCIENCE, V332, P472, DOI 10.1126/science.1198817; Tan Y, 2004, CURR BIOL, V14, P433, DOI 10.1016/j.cub.2004.02.035; THOMPSON JF, 1991, GENE, V103, P171, DOI 10.1016/0378-1119(91)90270-L; Ueda HR, 2002, NATURE, V418, P534, DOI 10.1038/nature00906	42	18	18	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83660	10.1371/journal.pone.0083660	http://dx.doi.org/10.1371/journal.pone.0083660			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391804	Green Published, Green Submitted, gold			2022-12-25	WOS:000329325200102
J	Dong, ZH; Imai, A; Krishnamurthy, S; Zhang, ZC; Zeitlin, BD; Nor, JE				Dong, Zhihong; Imai, Atsushi; Krishnamurthy, Sudha; Zhang, Zhaocheng; Zeitlin, Benjamin D.; Noer, Jacques E.			Xenograft Tumors Vascularized with Murine Blood Vessels May Overestimate the Effect of Anti-Tumor Drugs: A Pilot Study	PLOS ONE			English	Article							NF-KAPPA-B; ENDOTHELIAL-CELLS; CROSS-TALK; IN-VITRO; BCL-2; ANGIOGENESIS; DIFFERENTIATION; INDUCTION; MODELS	Recent evidence demonstrated that endothelial cells initiate signaling events that enhance tumor cell survival, proliferation, invasion, and tumor recurrence. Under this new paradigm for cellular crosstalk within the tumor microenvironment, the origin of endothelial cells and tumor cells may have a direct impact on the pathobiology of cancer. The purpose of this pilot study was to evaluate the effect of endothelial cell species (i.e. murine or human) on xenograft tumor growth and response to therapy. Tumor xenografts vascularized either with human or with murine microvascular endothelial cells were engineered, side-by-side, subcutaneously in the dorsum of immunodefficient mice. When tumors reached 200 mm(3), mice were treated for 30 days with either 4 mg/kg cisplatin (i.p.) every 5 days or with 40 mg/kg sunitinib (p.o.) daily. Xenograft human tumors vascularized with human endothelial cells grow faster than xenograft tumors vascularized with mouse endothelial cells (P<0.05). Notably, human tumors vascularized with human endothelial cells exhibited nuclear translocation of p65 (indicative of high NF-kB activity), and were more resistant to treatment with cisplatin or sunitinib than the contralateral tumors vascularized with murine endothelial cells (P<0.05). Collectively, these studies suggest that the species of endothelial cells has a direct impact on xenograft tumor growth and response to treatment with the chemotherapeutic drug cisplatin or with the anti-angiogenic drug sunitinib.	[Dong, Zhihong; Imai, Atsushi; Krishnamurthy, Sudha; Zhang, Zhaocheng; Zeitlin, Benjamin D.; Noer, Jacques E.] Univ Michigan, Sch Dent, Dept Restorat Sci, Angiogenesis Res Lab, Ann Arbor, MI 48109 USA; [Noer, Jacques E.] Univ Michigan, Coll Engn, Dept Biomed Engn, Ann Arbor, MI 48109 USA; [Noer, Jacques E.] Univ Michigan, Dept Otolaryngol, Sch Med, Ann Arbor, MI 48109 USA; [Noer, Jacques E.] Univ Michigan, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Nor, JE (corresponding author), Univ Michigan, Sch Dent, Dept Restorat Sci, Angiogenesis Res Lab, Ann Arbor, MI 48109 USA.	jenor@umich.edu	Nor, Jacques/AAJ-6139-2021; Zeitlin, Benjamin/B-9628-2008	Nor, Jacques/0000-0002-4056-0235; Zeitlin, Benjamin/0000-0003-0110-0188	National Institutes of Health [P50-CA97248, R01-DE16586, R01-DE21139, R01-DE23220]; NATIONAL CANCER INSTITUTE [P50CA097248] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE021139, R01DE023220] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE016586] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was funded by grants P50-CA97248 (University of Michigan Head & Neck SPORE), R01-DE16586, R01-DE21139, R01-DE23220 from the National Institutes of Health (JEN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arkan MC, 2011, CURR TOP MICROBIOL, V349, P159, DOI 10.1007/82_2010_97; Damia G, 2009, EUR J CANCER, V45, P2768, DOI 10.1016/j.ejca.2009.08.008; DiDonato JA, 2012, IMMUNOL REV, V246, P379, DOI 10.1111/j.1600-065X.2012.01099.x; Dong ZH, 2007, EXP CELL RES, V313, P3645, DOI 10.1016/j.yexcr.2007.07.023; Dong ZD, 2007, BIOTECHNIQUES, V43, P73, DOI 10.2144/000112457; Enis DR, 2005, P NATL ACAD SCI USA, V102, P425, DOI 10.1073/pnas.0408357102; Fiebig HH, 2004, EUR J CANCER, V40, P802, DOI 10.1016/j.ejca.2004.01.009; Johnson JI, 2001, BRIT J CANCER, V84, P1424, DOI 10.1054/bjoc.2001.1796; Kaneko T, 2007, CANCER RES, V67, P9685, DOI 10.1158/0008-5472.CAN-07-1497; Karl E, 2007, CELL DEATH DIFFER, V14, P1657, DOI 10.1038/sj.cdd.4402174; Karl E, 2005, CANCER RES, V65, P5063, DOI 10.1158/0008-5472.CAN-05-0140; Koike N, 2004, NATURE, V428, P138, DOI 10.1038/428138a; LAW LW, 1954, CANCER RES, V14, P695; Mischek D, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/437284; Morton CL, 2007, NAT PROTOC, V2, P247, DOI 10.1038/nprot.2007.25; Neiva KG, 2009, NEOPLASIA, V11, P583, DOI 10.1593/neo.09266; Nor JE, 2001, LAB INVEST, V81, P453, DOI 10.1038/labinvest.3780253; Nor JE, 1999, AM J PATHOL, V154, P375, DOI 10.1016/S0002-9440(10)65284-4; Nor JE, 2001, CANCER RES, V61, P2183; POVLSEN CO, 1972, ACTA PATH MICRO IM A, VA 80, P713; Richmond A, 2002, NAT REV IMMUNOL, V2, P664, DOI 10.1038/nri887; Sanz L, 2009, LAB INVEST, V89, P91, DOI 10.1038/labinvest.2008.108; Skakkebaek N E, 1974, Acta Obstet Gynecol Scand Suppl, V29, P73; Skovseth DK, 2002, AM J PATHOL, V160, P1629, DOI 10.1016/S0002-9440(10)61110-8; Tentler JJ, 2012, NAT REV CLIN ONCOL, V9, P338, DOI 10.1038/nrclinonc.2012.61; Warner KA, 2008, NEOPLASIA, V10, P131, DOI 10.1593/neo.07815; WATANABE K, 1993, EUR J BIOCHEM, V214, P267, DOI 10.1111/j.1432-1033.1993.tb17920.x; YOSHIMURA T, 1993, J IMMUNOL, V151, P6225; Zeitlin BD, 2006, CANCER RES, V66, P8698, DOI 10.1158/0008-5472.CAN-05-3691; Zeng QH, 2005, CANCER CELL, V8, P13, DOI 10.1016/j.ccr.2005.06.004	30	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84236	10.1371/journal.pone.0084236	http://dx.doi.org/10.1371/journal.pone.0084236			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391922	Green Submitted, gold, Green Published			2022-12-25	WOS:000329323900065
J	Jimenez-Diaz, A; Remacha, M; Ballesta, JPG; Berlanga, JJ				Jimenez-Diaz, Antonio; Remacha, Miguel; Ballesta, Juan P. G.; Jose Berlanga, Juan			Phosphorylation of Initiation Factor eIF2 in Response to Stress Conditions Is Mediated by Acidic Ribosomal P1/P2 Proteins in Saccharomyces cerevisiae	PLOS ONE			English	Article							FACTOR 2-ALPHA KINASE; TRANSLATION INITIATION; P-PROTEINS; EXTRARIBOSOMAL FUNCTIONS; DIMERIZATION DOMAIN; STRUCTURAL BASIS; GENE-EXPRESSION; TRANSFER-RNA; IN-VIVO; STALK	Eukaryotic cells contain an unusually large cytoplasmic pool of P1/P2 phosphoproteins, which form the highly flexible 60S subunit stalk that is required to interact with and activate soluble translation factors. In cells, cytoplasmic P1/P2 proteins are exchanged for ribosome-bound proteins in a process that can modulate ribosome function and translation. Here, we analysed different S. cerevisiae stalk mutants grown under stress conditions that result in eIF2 alpha phosphorylation. These mutants either lack a cytoplasmic pool of stalk proteins or contain free but not ribosome-bound proteins. Only cells that contain free P1/P2 proteins induce eIF2 phosphorylation in vivo in response to glucose starvation or osmotic stress. Moreover, we show that free S. cerevisiae P1/P2 proteins can induce in vitro phosphorylation of the initiation factor eIF2 by stimulating the autophosphorylation and activation of GCN2 kinase. Indeed, these ribosomal proteins do not stimulate other eIF2 alpha kinases, such as PKR and HRI. P1/P2 and the known GCN2 activator deacylated tRNA compete for stimulating the eIF2 alpha kinase activity of GCN2, although the P1/P2 proteins are considerably more active. These findings reveal a capacity of free cytoplasmic ribosomal stalk components to stimulate eIF2 alpha phosphorylation, which in turn would modulate translation in response to specific forms of stress that may be linked with the previously described regulatory function of the ribosomal stalk.	[Ballesta, Juan P. G.] CSIC, Ctr Biol Mol Severo Ochoa, Madrid, Spain; Univ Autonoma Madrid, CSIC, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC)	Ballesta, JPG (corresponding author), CSIC, Ctr Biol Mol Severo Ochoa, Madrid, Spain.	jpgballesta@cbm.uam.es; jberlanga@cbm.uam.es	Remacha, Miguel/G-1250-2016; Berlanga, Juan José/N-1718-2015	Berlanga, Juan José/0000-0002-2408-6561	Spanish Ministry of Science and Innovation [BFU2009-09738, BFU2009-09469]; Fundacion Ramon Areces	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Fundacion Ramon Areces	This work was supported by grants from the Spanish Ministry of Science and Innovation BFU2009-09738 to J.P.G.B. and BFU2009-09469 to J.J.B., and by an Institutional Grant to Centro de Biologia Molecular Severo Ochoa (CBMSO) from Fundacion Ramon Areces. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayub MJ, 2005, GENE, V357, P129, DOI 10.1016/j.gene.2005.06.006; Ballesta JPG, 1999, FEMS MICROBIOL REV, V23, P537, DOI 10.1111/j.1574-6976.1999.tb00412.x; Ballesta JPG, 1996, PROG NUCLEIC ACID RE, V55, P157, DOI 10.1016/S0079-6603(08)60193-2; BELTRAME M, 1990, MOL CELL BIOL, V10, P2341, DOI 10.1128/MCB.10.5.2341; Berlanga JJ, 1998, J BIOL CHEM, V273, P32340, DOI 10.1074/jbc.273.48.32340; Berlanga JJ, 1999, EUR J BIOCHEM, V265, P754, DOI 10.1046/j.1432-1327.1999.00780.x; Berlanga JJ, 2006, EMBO J, V25, P1730, DOI 10.1038/sj.emboj.7601073; BERMEJO B, 1994, J BIOL CHEM, V269, P3968; BONNEAUD N, 1991, YEAST, V7, P609, DOI 10.1002/yea.320070609; Chiou JC, 2011, INT J BIOCHEM CELL B, V43, P1792, DOI 10.1016/j.biocel.2011.08.018; Costa-Mattioli M, 2005, NATURE, V436, P1166, DOI 10.1038/nature03897; Das S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002858; deHaro C, 1996, FASEB J, V10, P1378, DOI 10.1096/fasebj.10.12.8903508; del Pino J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047272; Dever TE, 2002, CELL, V108, P545, DOI 10.1016/S0092-8674(02)00642-6; DEVER TE, 1992, CELL, V68, P585, DOI 10.1016/0092-8674(92)90193-G; Diaconu M, 2005, CELL, V121, P991, DOI 10.1016/j.cell.2005.04.015; Donnelly N, 2013, CELL MOL LIFE SCI, V70, P3493, DOI 10.1007/s00018-012-1252-6; FAKUNDING JL, 1973, J BIOL CHEM, V248, P8555; GALLIS BM, 1975, BIOCHEMISTRY-US, V14, P1038, DOI 10.1021/bi00676a024; Garriz A, 2009, MOL CELL BIOL, V29, P1592, DOI 10.1128/MCB.01446-08; GIETZ RD, 1995, YEAST, V11, P355, DOI 10.1002/yea.320110408; Gonzalo P, 2003, BIOL CELL, V95, P179, DOI 10.1016/S0248-4900(03)00034-0; Gonzalo P, 2001, J BIOL CHEM, V276, P19762, DOI 10.1074/jbc.M101398200; Goossens A, 2001, J BIOL CHEM, V276, P30753, DOI 10.1074/jbc.M102960200; Guarinos E, 2003, MOL MICROBIOL, V50, P703, DOI 10.1046/j.1365-2958.2003.03733.x; Hagiya A, 2005, J BIOL CHEM, V280, P39193, DOI 10.1074/jbc.M506050200; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Huang CH, 2010, J MOL BIOL, V399, P145, DOI 10.1016/j.jmb.2010.04.009; KAY A, 1973, BIOCHEM BIOPH RES CO, V51, P979, DOI 10.1016/0006-291X(73)90023-5; KISCHA K, 1971, NATURE-NEW BIOL, V233, P62, DOI 10.1038/newbio233062a0; Krokowski D, 2006, MOL MICROBIOL, V60, P386, DOI 10.1111/j.1365-2958.2006.05117.x; Lee KM, 2012, NUCLEIC ACIDS RES, V40, P3172, DOI 10.1093/nar/gkr1143; Mager WH, 1997, NUCLEIC ACIDS RES, V25, P4872, DOI 10.1093/nar/25.24.4872; Mandava CS, 2012, NUCLEIC ACIDS RES, V40, P2054, DOI 10.1093/nar/gkr1031; Martinez-Azorin F, 2008, FEBS LETT, V582, P3029, DOI 10.1016/j.febslet.2008.07.039; MITSUI K, 1989, BIOCHEM BIOPH RES CO, V161, P1001, DOI 10.1016/0006-291X(89)91342-9; NEWTON CH, 1990, J BACTERIOL, V172, P579, DOI 10.1128/jb.172.2.579-588.1990; Nusspaumer G, 2000, EMBO J, V19, P6075, DOI 10.1093/emboj/19.22.6075; Padyana AK, 2005, J BIOL CHEM, V280, P29289, DOI 10.1074/jbc.M504096200; Perez-Fernandez J, 2005, BIOCHEMISTRY-US, V44, P5532, DOI 10.1021/bi047332r; Qiu H, 2001, EMBO J, V20, P1425, DOI 10.1093/emboj/20.6.1425; RAMIREZ M, 1991, MOL CELL BIOL, V11, P3027, DOI 10.1128/MCB.11.6.3027; REMACHA M, 1992, J BIOL CHEM, V267, P12061; REMACHA M, 1995, MOL CELL BIOL, V15, P4754; REMACHA M, 1988, J BIOL CHEM, V263, P9094; Romano PR, 1998, MOL CELL BIOL, V18, P2282, DOI 10.1128/MCB.18.4.2282; SAENZROBLES MT, 1990, BIOCHIM BIOPHYS ACTA, V1050, P51, DOI 10.1016/0167-4781(90)90140-W; SANCHEZMADRID F, 1979, EUR J BIOCHEM, V98, P409, DOI 10.1111/j.1432-1033.1979.tb13200.x; SANTOS C, 1993, BIOCHEMISTRY-US, V32, P4231, DOI 10.1021/bi00067a010; Szick K, 1998, P NATL ACAD SCI USA, V95, P2378, DOI 10.1073/pnas.95.5.2378; Ung TL, 2001, EMBO J, V20, P3728, DOI 10.1093/emboj/20.14.3728; VILELLA MD, 1991, EUR J BIOCHEM, V196, P407, DOI 10.1111/j.1432-1033.1991.tb15831.x; von der Haar T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001078; Warner JR, 2009, MOL CELL, V34, P3, DOI 10.1016/j.molcel.2009.03.006; WEK RC, 1990, MOL CELL BIOL, V10, P2820, DOI 10.1128/MCB.10.6.2820; WEK SA, 1995, MOL CELL BIOL, V15, P4497; Wool IG, 1996, TRENDS BIOCHEM SCI, V21, P164, DOI 10.1016/S0968-0004(96)20011-8; Yang RJ, 2000, MOL CELL BIOL, V20, P2706, DOI 10.1128/MCB.20.8.2706-2717.2000; Zambrano R, 1997, BIOCHEMISTRY-US, V36, P14439, DOI 10.1021/bi971494o; Zurdo J, 2000, BIOCHEMISTRY-US, V39, P8929, DOI 10.1021/bi000362j; Zurdo J, 1997, BIOCHEMISTRY-US, V36, P9625, DOI 10.1021/bi9702400	62	21	22	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84219	10.1371/journal.pone.0084219	http://dx.doi.org/10.1371/journal.pone.0084219			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391917	Green Published, gold, Green Submitted			2022-12-25	WOS:000329323900060
J	Masuda, S; Tani, N; Ueno, S; Lee, SL; Muhammad, N; Kondo, T; Numata, S; Tsumura, Y				Masuda, Shinsuke; Tani, Naoki; Ueno, Saneyoshi; Lee, Soon Leong; Muhammad, Norwati; Kondo, Toshiaki; Numata, Shinya; Tsumura, Yoshihiko			Non-Density Dependent Pollen Dispersal of Shorea maxwelliana (Dipterocarpaceae) Revealed by a Bayesian Mating Model Based on Paternity Analysis in Two Synchronized Flowering Seasons	PLOS ONE			English	Article							TORMINALIS L. CRANTZ; FOREST FRAGMENTATION; MALE FECUNDITY; TROPICAL TREE; RAIN-FOREST; REPRODUCTIVE SUCCESS; GENETIC DIVERSITY; WILDSERVICE TREE; SEED DISPERSAL; FRUIT-SET	Pollinator syndrome is one of the most important determinants regulating pollen dispersal in tropical tree species. It has been widely accepted that the reproduction of tropical forest species, especially dipterocarps that rely on insects with weak flight for their pollination, is positively density-dependent. However differences in pollinator syndrome should affect pollen dispersal patterns and, consequently, influence genetic diversity via the mating process. We examined the pollen dispersal pattern and mating system of Shorea maxwelliana, the flowers of which are larger than those of Shorea species belonging to section Mutica which are thought to be pollinated by thrips (weak flyers). A Bayesian mating model based on the paternity of seeds collected from mother trees during sporadic and mass flowering events revealed that the estimated pollen dispersal kernel and average pollen dispersal distance were similar for both flowering events. This evidence suggests that the putative pollinators - small beetles and weevils - effectively contribute to pollen dispersal and help to maintain a high outcrossing rate even during sporadic flowering events. However, the reduction in pollen donors during a sporadic event results in a reduction in effective pollen donors, which should lead to lower genetic diversity in the next generation derived from seeds produced during such an event. Although sporadic flowering has been considered less effective for outcrossing in Shorea species that depend on thrips for their pollination, effective pollen dispersal by the small beetles and weevils ensures outcrossing during periods of low flowering tree density, as occurs in a sporadic flowering event.	[Masuda, Shinsuke; Tsumura, Yoshihiko] Univ Tsukuba, Sch Life & Environm Sci, Tsukuba, Ibaraki, Japan; [Tani, Naoki] Japan Int Res Ctr Agr Sci, Div Forestry, Tsukuba, Ibaraki, Japan; [Ueno, Saneyoshi; Tsumura, Yoshihiko] Forestry & Forest Prod Res Inst, Dept Forest Genet, Tsukuba, Ibaraki 305, Japan; [Tani, Naoki; Lee, Soon Leong; Muhammad, Norwati] Forest Res Inst Malaysia, Forestry Biotechnol Div, Kepong, Selangor Darul, Malaysia; [Kondo, Toshiaki] Hiroshima Univ, Grad Sch Int Dev & Cooperat, Hiroshima, Japan; [Numata, Shinya] Tokyo Metropolitan Univ, Fac & Grad Sch Urban Environm Sci, Hachioji, Tokyo, Japan	University of Tsukuba; Japan International Research Center for Agricultural Sciences; Forestry & Forest Products Research Institute - Japan; Institute Penyelidikan Perhutanan Malaysia; Hiroshima University; Tokyo Metropolitan University	Tani, N (corresponding author), Japan Int Res Ctr Agr Sci, Div Forestry, Tsukuba, Ibaraki, Japan.	ntani@affrc.go.jp; ytsumu@ffpri.affrc.go.jp	LEE, Soon Leong/AGZ-1887-2022; Kondo, Toshiaki/M-4939-2013; Tani, Naoki/AAB-7991-2022	Kondo, Toshiaki/0000-0001-6003-6118; 	Japan Society for the Promotion of Science [18255010]; Environment Research and Technology Development Fund from Ministry of Environment, Japan [E-091]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Environment Research and Technology Development Fund from Ministry of Environment, Japan	The research budget to produce the manuscript was partly provided from agencies listed: Grant No. 18255010 of a Grant-in-Aid for Scientific Research from Japan Society for the Promotion of Science (http://www.jsps.go.jp/english/index.html), Grant No. E-091 of Environment Research and Technology Development Fund from Ministry of Environment, Japan (http://www.env.go.jp/policy/kenkyu/suishin/english/index.html). There are no funders to provide research funding to produce the manuscript except the two funders listed above. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramowitz M., 1964, HDB MATH FUNCTIONS F; ADAMS WT, 1991, BIOCHEMICAL MARKERS IN THE POPULATION GENETICS OF FOREST TREES, P157; Appanah S., 1985, Journal of Tropical Ecology, V1, P225; APPANAH S, 1981, Malaysian Forester, V44, P234; ASHTON PS, 1988, AM NAT, V132, P44, DOI 10.1086/284837; AUGSPURGER CK, 1983, BIOTROPICA, V15, P257, DOI 10.2307/2387650; Austerlitz F, 2004, MOL ECOL, V13, P937, DOI 10.1111/j.1365-294X.2004.02100.x; Austerlitz F, 2002, GENETICS, V161, P355; BAWA KS, 1985, AM J BOT, V72, P346, DOI 10.2307/2443527; BAWA KS, 1974, EVOLUTION, V28, P85, DOI [10.1111/j.1558-5646.1974.tb00729.x, 10.2307/2407241]; Best NG, 1995, CODA CONVERGENCE DIA; Burczyk J, 2002, MOL ECOL, V11, P2379, DOI 10.1046/j.1365-294X.2002.01603.x; BURD M, 1994, BOT REV, V60, P83, DOI 10.1007/BF02856594; Clark JS, 2006, TRENDS ECOL EVOL, V21, P375, DOI 10.1016/j.tree.2006.03.016; Clark JS, 1999, ECOLOGY, V80, P1475, DOI 10.2307/176541; Clark JS, 1998, AM NAT, V152, P204, DOI 10.1086/286162; Cloutier D, 2007, BIOTROPICA, V39, P406, DOI 10.1111/j.1744-7429.2007.00266.x; DEVLIN B, 1992, EVOLUTION, V46, P1030, DOI 10.1111/j.1558-5646.1992.tb00617.x; Dick C. W., 2008, Tropical Plant Biology, V1, P20, DOI 10.1007/s12042-007-9006-6; Dick CW, 2003, MOL ECOL, V12, P753, DOI 10.1046/j.1365-294X.2003.01760.x; Eckert CG, 2010, TRENDS ECOL EVOL, V25, P35, DOI 10.1016/j.tree.2009.06.013; FEINSINGER P, 1991, ECOLOGY, V72, P1953, DOI 10.2307/1941550; Finger A, 2012, MOL ECOL, V21, P2369, DOI 10.1111/j.1365-294X.2012.05543.x; Gelman A., 1992, STAT SCI, V7, P457, DOI [DOI 10.1214/SS/1177011136, 10.1214/ss/1177011136]; Ghazoul J, 1998, J ECOL, V86, P462, DOI 10.1046/j.1365-2745.1998.00270.x; Hall P, 1996, CONSERV BIOL, V10, P757, DOI 10.1046/j.1523-1739.1996.10030757.x; JANZEN DH, 1970, AM NAT, V104, P501, DOI 10.1086/282687; Jones FA, 2008, P ROY SOC B-BIOL SCI, V275, P2759, DOI 10.1098/rspb.2008.0894; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; Kenta T, 2004, MOL ECOL, V13, P3575, DOI 10.1111/j.1365-294X.2004.02345.x; Kenta T, 2002, AM J BOT, V89, P60, DOI 10.3732/ajb.89.1.60; Kettle CJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016111; Kitamura Keiko, 1994, Plant Species Biology, V9, P37, DOI 10.1111/j.1442-1984.1994.tb00080.x; Klein EK, 2008, MOL ECOL, V17, P3323, DOI 10.1111/j.1365-294X.2008.03809.x; Kondo T, 2011, SINGLE-POLLEN GENOTYPING, P63, DOI 10.1007/978-4-431-53901-8_6; Lourmas M, 2007, HEREDITY, V99, P151, DOI 10.1038/sj.hdy.6800976; Marshall TC, 1998, MOL ECOL, V7, P639, DOI 10.1046/j.1365-294x.1998.00374.x; Masuda S, 2010, CONSERV GENET RESOUR, V2, P109, DOI 10.1007/s12686-010-9225-2; Matsuki Y, 2008, AM J BOT, V95, P925, DOI 10.3732/ajb.0800036; Momose K, 1998, AM J BOT, V85, P1477, DOI 10.2307/2446404; MURAWSKI DA, 1994, BIOTROPICA, V26, P23, DOI 10.2307/2389107; MURAWSKI DA, 1994, CONSERV BIOL, V8, P997, DOI 10.1046/j.1523-1739.1994.08040997.x; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Nagamitsu T, 2001, INT J PLANT SCI, V162, P155, DOI 10.1086/317902; Naito Y, 2008, FOREST ECOL MANAG, V256, P375, DOI 10.1016/j.foreco.2008.04.031; Obayashi K, 2002, INT J PLANT SCI, V163, P151, DOI 10.1086/324549; Oddou-Muratorio S, 2005, MOL ECOL, V14, P4441, DOI 10.1111/j.1365-294X.2005.02720.x; Plummer M., 2003, JAGS PROGRAM ANAL BA, P20; Quesada M, 2004, BIOTROPICA, V36, P131, DOI 10.1111/j.1744-7429.2004.tb00305.x; Robledo-Arnuncio JJ, 2005, HEREDITY, V94, P13, DOI 10.1038/sj.hdy.6800542; Rocha OJ, 2001, AM J BOT, V88, P1600, DOI 10.2307/3558404; Sakai S, 1999, AM J BOT, V86, P62, DOI 10.2307/2656955; Sakai S, 2002, BIOL J LINN SOC, V75, P233, DOI 10.1111/j.1095-8312.2002.tb01424.x; Sakai S, 1999, AM J BOT, V86, P1414, DOI 10.2307/2656924; Sun IF, 2007, J ECOL, V95, P818, DOI 10.1111/j.1365-2745.2007.01235.x; Symington CF, 2004, MALAYAN FOREST RECOR; Tani N, 2012, R SCRIPTS MATING MOD; Tani N, 2012, J ECOL, V100, P405, DOI 10.1111/j.1365-2745.2011.01929.x; Tani N, 2009, ANN BOT-LONDON, V104, P1421, DOI 10.1093/aob/mcp252; Ward M, 2005, HEREDITY, V95, P246, DOI 10.1038/sj.hdy.6800712; Wright S, 1943, GENETICS, V28, P114; Wright SJ, 2002, OECOLOGIA, V130, P1, DOI 10.1007/s004420100809	62	7	7	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e82039	10.1371/journal.pone.0082039	http://dx.doi.org/10.1371/journal.pone.0082039			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391712	Green Published, gold, Green Submitted			2022-12-25	WOS:000329325200009
J	Paul, C; Robaire, B				Paul, Catriona; Robaire, Bernard			Impaired Function of the Blood-Testis Barrier during Aging Is Preceded by a Decline in Cell Adhesion Proteins and GTPases	PLOS ONE			English	Article							BROWN-NORWAY RAT; ADHERENS JUNCTIONS; SEMINIFEROUS EPITHELIUM; ECTOPLASMIC SPECIALIZATION; SEMEN QUALITY; GERM-CELLS; MALE AGE; DYNAMICS; SPERMATOGENESIS; SERTOLI	With increasing age comes many changes in the testis, including germ cell loss. Cell junctions in the testis tether both seminiferous epithelial and germ cells together and assist in the formation of the blood-testis barrier (BTB), which limits transport of biomolecules, ions and electrolytes from the basal to the adluminal compartment and protects post-meiotic germ cells. We hypothesize that as male rats age the proteins involved in forming the junctions decrease and that this alters the ability of the BTB to protect the germ cells. Pachytene spermatocytes were isolated from Brown Norway rat testes at 4 (young) and 18 (aged) months of age using STA-PUT velocity sedimentation technique. RNA was extracted and gene expression was assessed using Affymetrix rat 230 2.0 whole rat genome microarrays. Microarray data were confirmed by qRT- PCR and protein expression by Western blotting. Of the genes that were significantly decreased by at least 1.5 fold, 70 were involved in cell adhesion; of these, at least 20 are known to be specifically involved in junction dynamics within the seminiferous epithelium. The mRNA and protein levels of Jam2, Ocln, cdh2 (N-cadherin), ctnna (a-catenin), and cldn11 (involved in adherens junctions), among others, were decreased by approximately 50% in aged spermatocytes. In addition, the GTPases Rac1 and cdc42, involved in the recruitment of cadherins to the adherens junctions, were similarly decreased. It is therefore not surprising that with lower expression of these proteins that the BTB becomes diminished with age. We saw, using a FITC tracer, a gradual collapse of the BTB between 18 and 24 months. This provides the opportunity for harmful substances and immune cells to cross the BTB and cause the disruption of spermatogenesis that is observed with increasing age.	[Paul, Catriona; Robaire, Bernard] McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ, Canada; [Robaire, Bernard] McGill Univ, Dept Obstet & Gynecol, Montreal, PQ H3A 2T5, Canada	McGill University; McGill University	Robaire, B (corresponding author), McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ, Canada.	bernard.robaire@mcgill.ca			CIHR [MOP-89767]	CIHR(Canadian Institutes of Health Research (CIHR))	These studies were funded by grant MOP-89767 from CIHR. CP was funded by a CIHR postdoctoral fellowship. BR is a James McGill professor. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar-Mahecha A, 2001, BIOL REPROD, V65, P119, DOI 10.1095/biolreprod65.1.119; Anway MD, 2003, BIOL REPROD, V68, P996, DOI 10.1095/biolreprod.102.008045; BELLVE AR, 1977, J CELL BIOL, V74, P68, DOI 10.1083/jcb.74.1.68; Maya WC, 2009, AGING MALE, V12, P100, DOI 10.3109/13685530903322841; Citi S, 2011, MOL MEMBR BIOL, V28, P427, DOI 10.3109/09687688.2011.603101; Duncan MC, 2008, J CELL BIOL, V183, P971, DOI 10.1083/jcb.200811057; Fukuyama T, 2005, J BIOL CHEM, V280, P815, DOI 10.1074/jbc.M411099200; Genetos DC, 2012, J ORTHOP RES, V30, P1979, DOI 10.1002/jor.22172; Hall A, 2000, PHILOS T R SOC B, V355, P965, DOI 10.1098/rstb.2000.0632; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Isabel Molina Rosa, 2010, Archivos Espanoles de Urologia, V63, P214; Kidd SA, 2001, FERTIL STERIL, V75, P237, DOI 10.1016/S0015-0282(00)01679-4; Latendresse JR, 2002, TOXICOL PATHOL, V30, P524, DOI 10.1080/01926230290105721; Lee NPY, 2003, BIOL REPROD, V68, P489, DOI 10.1095/biolreprod.102.005793; Levy S, 1999, J ANDROL, V20, P356; Lie PPY, 2010, PHILOS T R SOC B, V365, P1581, DOI 10.1098/rstb.2009.0261; Lui WY, 2003, BIOL REPROD, V68, P2189, DOI 10.1095/biolreprod.102.011379; Mital P, 2011, BIOL REPROD, V84, P851, DOI 10.1095/biolreprod.110.087452; Mok KW, 2012, INT J ANDROL, V35, P86, DOI 10.1111/j.1365-2605.2011.01183.x; Morimoto S, 2005, J BIOL CHEM, V280, P2220, DOI 10.1074/jbc.M406906200; Mruk DD, 2004, ENDOCR REV, V25, P747, DOI 10.1210/er.2003-0022; Mulholland DJ, 2001, BIOL REPROD, V64, P396, DOI 10.1095/biolreprod64.1.396; Otani T, 2006, J CELL BIOL, V175, P135, DOI 10.1083/jcb.200605012; Paul C, 2011, BIOL REPROD, V85, P1269, DOI 10.1095/biolreprod.111.094219; RUSSELL L, 1977, TISSUE CELL, V9, P475, DOI 10.1016/0040-8166(77)90007-6; Sato T, 2006, J BIOL CHEM, V281, P5288, DOI 10.1074/jbc.M510070200; Syntin P, 2001, J ANDROL, V22, P235; WANG C, 1993, ENDOCRINOLOGY, V133, P2773, DOI 10.1210/en.133.6.2773; Wong CH, 2005, ENDOCRINOLOGY, V146, P1192, DOI 10.1210/en.2004-1275; Wong CH, 2004, J CELL SCI, V117, P783, DOI 10.1242/jcs.00900; Wong EWP, 2009, INT REV CEL MOL BIO, V278, P309, DOI 10.1016/S1937-6448(09)78007-4; Yan HHN, 2005, P NATL ACAD SCI USA, V102, P11722, DOI 10.1073/pnas.0503855102; Zahraoui A, 2000, J CELL BIOL, V151, pF31, DOI 10.1083/jcb.151.5.F31	33	20	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84354	10.1371/journal.pone.0084354	http://dx.doi.org/10.1371/journal.pone.0084354			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391944	Green Published, Green Submitted, gold			2022-12-25	WOS:000329323900087
J	Petri, RM; Schwaiger, T; Penner, GB; Beauchemin, KA; Forster, RJ; McKinnon, JJ; McAllister, TA				Petri, Renee M.; Schwaiger, Tyler; Penner, Greg B.; Beauchemin, Karen A.; Forster, Robert J.; McKinnon, John J.; McAllister, Tim A.			Characterization of the Core Rumen Microbiome in Cattle during Transition from Forage to Concentrate as Well as during and after an Acidotic Challenge	PLOS ONE			English	Article							GRADIENT GEL-ELECTROPHORESIS; HIGH-GRAIN DIET; REAL-TIME PCR; BACTERIAL DIVERSITY; GUT MICROBIOME; RUMINAL ACIDOSIS; RELATIVE QUANTIFICATION; RIBOSOMAL-RNA; BEEF-CATTLE; COW RUMEN	This study investigated the effect of diet and host on the rumen bacterial microbiome and the impact of an acidotic challenge on its composition. Using parallel pyrosequencing of the V3 hypervariable region of 16S rRNA gene, solid and liquid associated bacterial communities of 8 heifers were profiled. Heifers were exclusively fed forage, before being transitioned to a concentrate diet, subjected to an acidotic challenge and allowed to recover. Samples of rumen digesta were collected when heifers were fed forage, mixed forage, high grain, during challenge (4 h and 12 h) and recovery. A total of 560,994 high-quality bacterial sequences were obtained from the solid and liquid digesta. Using cluster analysis, prominent bacterial populations differed (P <= 0.10) in solid and liquid fractions between forage and grain diets. Differences among hosts and diets were not revealed by DGGE, but real time qPCR showed that several bacteria taxon were impacted by changes in diet, with the exception of Streptococcus bovis. Analysis of the core rumen microbiome identified 32 OTU's representing 10 distinct bacterial taxa including Bacteroidetes (32.8%), Firmicutes (43.2%) and Proteobacteria (14.3%). Diversity of OTUs was highest with forage with 38 unique OTUs identified as compared to only 11 with the high grain diet. Comparison of the microbial profiles of clincial vs. subclinical acidotic heifers found a increases in the relative abundances of Acetitomaculum, Lactobacillus, Prevotella, and Streptococcus. Increases in Streptococcus and Lactobacillus likely reflect the tolerance of these species to low pH and their ability to proliferate on surplus fermentable carbohydrate. The acetogen, Acetitomaculum may thereforeplay a role in the conversion of lactate to acetate in acidotic animals. Further profiling of the bacterial populations associated with subclinical and clinical acidosis could establish a microbial fingerprint for these disorders and provide insight into whether there are causative microbial populations that could potentially be therapeutically manipulated.	[Petri, Renee M.; Schwaiger, Tyler; Beauchemin, Karen A.; Forster, Robert J.; McAllister, Tim A.] Agr & Agri Food Canada, Lethbridge Res Ctr, Lethbridge, AB, Canada; [Petri, Renee M.; Schwaiger, Tyler; Penner, Greg B.; McKinnon, John J.] Univ Saskatchewan, Dept Anim & Poultry Sci, Saskatoon, SK S7N 0W0, Canada	Agriculture & Agri Food Canada; University of Saskatchewan	McAllister, TA (corresponding author), Agr & Agri Food Canada, Lethbridge Res Ctr, Lethbridge, AB, Canada.	tim.mcallister@agr.gc.ca	Petri, Renee Maxine/J-6102-2019; Schwaiger, Tyler/ABG-7401-2021; McAllister, Tim A./R-9201-2017	Petri, Renee Maxine/0000-0002-8209-8261; McAllister, Tim A./0000-0002-8266-6513	Alberta Crop Industry Development Fund; Genome Alberta; Agriculture Bio-products Innovation Program	Alberta Crop Industry Development Fund; Genome Alberta; Agriculture Bio-products Innovation Program	Funding support from the Alberta Crop Industry Development Fund, Genome Alberta and the Agriculture Bio-products Innovation Program are greatly appreciated. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen YH, 2011, APPL ENVIRON MICROB, V77, P5770, DOI 10.1128/AEM.00375-11; CHENG KJ, 1997, RUMEN MICROBIAL ECOS, P492; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; Cotta MA, 2004, ANAEROBE, V10, P191, DOI 10.1016/j.anaerobe.2004.04.001; de Menezes AB, 2011, FEMS MICROBIOL ECOL, V78, P256, DOI 10.1111/j.1574-6941.2011.01151.x; Dowd SE, 2008, BMC MICROBIOL, V8, DOI [10.1186/1471-2180-8-125, 10.1186/1471-2180-8-43]; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Fernando SC, 2010, APPL ENVIRON MICROB, V76, P7482, DOI 10.1128/AEM.00388-10; Fouts DE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048289; Goad DW, 1998, J ANIM SCI, V76, P234; Hess M, 2011, SCIENCE, V331, P463, DOI 10.1126/science.1200387; Hungate R.E., 1969, METHODS MICROBIOLO B, P117, DOI [DOI 10.1016/S0580-9517(08)70503-8, 10.1016/S0580-9517(08)70503-8]; HUNGATE RE, 1952, CORNELL VET, V42, P423; HUNGATE RE, 1966, RUMEN ITS MICROBES; Huse SM, 2010, ENVIRON MICROBIOL, V12, P1889, DOI 10.1111/j.1462-2920.2010.02193.x; Jami E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033306; Jouany J. P., 1991, RUMEN MICROBIAL META; Kelly D, 2007, MUTAT RES-FUND MOL M, V622, P58, DOI 10.1016/j.mrfmmm.2007.03.011; Khafipour E, 2011, J DAIRY SCI, V94, P351, DOI 10.3168/jds.2010-3435; Khafipour E, 2009, APPL ENVIRON MICROB, V75, P7115, DOI 10.1128/AEM.00739-09; Kinross JM, 2011, GENOME MED, V3, DOI 10.1186/gm228; Kocherginskaya SA, 2001, ANAEROBE, V7, P119, DOI 10.1006/anae.2001.0378; Koike S, 2003, FEMS MICROBIOL LETT, V229, P23, DOI 10.1016/S0378-1097(03)00760-2; Kong YH, 2010, FEMS MICROBIOL ECOL, V74, P612, DOI 10.1111/j.1574-6941.2010.00977.x; Krause DO, 1996, J DAIRY SCI, V79, P1467, DOI 10.3168/jds.S0022-0302(96)76506-2; Ley RE, 2006, CELL, V124, P837, DOI 10.1016/j.cell.2006.02.017; Li RW, 2012, ENVIRON MICROBIOL, V14, P129, DOI 10.1111/j.1462-2920.2011.02543.x; Li RG, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0037127, 10.1371/journal.pone.0029392, 10.1371/journal.pone.0051897]; Mackie RI, 2003, APPL ENVIRON MICROB, V69, P6808, DOI 10.1128/AEM.69.11.6808-6815.2003; Malmuthuge N, 2012, FEMS MICROBIOL ECOL, V79, P337, DOI 10.1111/j.1574-6941.2011.01220.x; MCALLISTER TA, 1994, J ANIM SCI, V72, P3004, DOI 10.2527/1994.72113004x; Mohammed R, 2012, J DAIRY SCI; Muegge BD, 2011, SCIENCE, V332, P970, DOI 10.1126/science.1198719; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Nagaraja TG, 2007, J DAIRY SCI, V90, pE17, DOI 10.3168/jds.2006-478; Nagaraja TG, 2007, VET CLIN N AM-FOOD A, V23, P333, DOI 10.1016/j.cvfa.2007.04.002; Olfert ED, 1993, GUIDE CARE USE EXPT; Penner GB, 2006, J DAIRY SCI, V89, P2132, DOI 10.3168/jds.S0022-0302(06)72284-6; Petri RM, 2013, APPL ENVIRON MICROB, V79, P3744, DOI 10.1128/AEM.03983-12; Petri RM, 2012, J APPL MICROBIOL, V112, P1152, DOI 10.1111/j.1365-2672.2012.05295.x; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pitta DW, 2010, MICROB ECOL, V59, P511, DOI 10.1007/s00248-009-9609-6; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Sadet S, 2007, ANIMAL, V1, P939, DOI 10.1017/S1751731107000304; Sartor RB, 2004, GASTROENTEROLOGY, V126, P1620, DOI 10.1053/j.gastro.2004.03.024; Schloss PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027310; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schwaiger T, 2013, J ANIMAL SC IN PRESS; Stevenson DM, 2007, APPL MICROBIOL BIOT, V75, P165, DOI 10.1007/s00253-006-0802-y; Tajima K, 2001, APPL ENVIRON MICROB, V67, P2766, DOI 10.1128/AEM.67.6.2766-2774.2001; Tap J, 2009, ENVIRON MICROBIOL, V11, P2574, DOI 10.1111/j.1462-2920.2009.01982.x; THURING RWJ, 1975, ANAL BIOCHEM, V66, P213, DOI 10.1016/0003-2697(75)90739-3; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; WALLACE RJ, 1979, NATURE, V279, P424, DOI 10.1038/279424a0; Wang P, 2011, CAN J MICROBIOL, V57, P590, DOI [10.1139/w11-048, 10.1139/W11-048]; Weimer PJ, 2010, J DAIRY SCI, V93, P5902, DOI 10.3168/jds.2010-3500	58	228	243	2	138	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83424	10.1371/journal.pone.0083424	http://dx.doi.org/10.1371/journal.pone.0083424			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391765	Green Submitted, Green Published, gold			2022-12-25	WOS:000329325200062
J	Singh, A; Soltani, M				Singh, Abhyudai; Soltani, Mohammad			Quantifying Intrinsic and Extrinsic Variability in Stochastic Gene Expression Models	PLOS ONE			English	Article							NEGATIVE FEEDBACK; NOISE; FLUCTUATIONS; SYSTEMS; PROTEIN; DISTRIBUTIONS; INFORMATION; SIMULATION; DYNAMICS	Genetically identical cell populations exhibit considerable intercellular variation in the level of a given protein or mRNA. Both intrinsic and extrinsic sources of noise drive this variability in gene expression. More specifically, extrinsic noise is the expression variability that arises from cell-to-cell differences in cell-specific factors such as enzyme levels, cell size and cell cycle stage. In contrast, intrinsic noise is the expression variability that is not accounted for by extrinsic noise, and typically arises from the inherent stochastic nature of biochemical processes. Two-color reporter experiments are employed to decompose expression variability into its intrinsic and extrinsic noise components. Analytical formulas for intrinsic and extrinsic noise are derived for a class of stochastic gene expression models, where variations in cell-specific factors cause fluctuations in model parameters, in particular, transcription and/ or translation rate fluctuations. Assuming mRNA production occurs in random bursts, transcription rate is represented by either the burst frequency (how often the bursts occur) or the burst size (number of mRNAs produced in each burst). Our analysis shows that fluctuations in the transcription burst frequency enhance extrinsic noise but do not affect the intrinsic noise. On the contrary, fluctuations in the transcription burst size or mRNA translation rate dramatically increase both intrinsic and extrinsic noise components. Interestingly, simultaneous fluctuations in transcription and translation rates arising from randomness in ATP abundance can decrease intrinsic noise measured in a two-color reporter assay. Finally, we discuss how these formulas can be combined with single-cell gene expression data from two-color reporter experiments for estimating model parameters.	[Singh, Abhyudai; Soltani, Mohammad] Univ Delaware, Dept Elect & Comp Engn, Newark, DE 19716 USA; [Singh, Abhyudai] Univ Delaware, Dept Biomed Engn, Newark, DE USA; [Singh, Abhyudai] Univ Delaware, Dept Math Sci, Newark, DE 19716 USA	University of Delaware; University of Delaware; University of Delaware	Singh, A (corresponding author), Univ Delaware, Dept Elect & Comp Engn, Newark, DE 19716 USA.	absingh@udel.edu	Singh, Abhyudai/D-3948-2014		National Science Foundation [DMS-1312926]; University of Delaware Research Foundation (UDRF); Oak Ridge Associated Universities (ORAU); Direct For Mathematical & Physical Scien [1312926] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); University of Delaware Research Foundation (UDRF); Oak Ridge Associated Universities (ORAU); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work is funded by the National Science Foundation Grant DMS-1312926, University of Delaware Research Foundation (UDRF) and Oak Ridge Associated Universities (ORAU). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Arkin A, 1998, GENETICS, V149, P1633; Bahar R, 2006, NATURE, V441, P1011, DOI 10.1038/nature04844; Balaban NQ, 2004, SCIENCE, V305, P1622, DOI 10.1126/science.1099390; Bar-Even A, 2006, NAT GENET, V38, P636, DOI 10.1038/ng1807; Becskei A, 2000, NATURE, V405, P590, DOI 10.1038/35014651; Blake WJ, 2003, NATURE, V422, P633, DOI 10.1038/nature01546; Bleris L, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.49; Bokes P, 2012, J MATH BIOL, V64, P829, DOI 10.1007/s00285-011-0433-5; Cook DL, 1998, P NATL ACAD SCI USA, V95, P15641, DOI 10.1073/pnas.95.26.15641; Dar RD, 2012, P NATL ACAD SCI USA, V109, P17454, DOI 10.1073/pnas.1213530109; Dublanche Y, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100081; El-Samad H, 2006, BIOPHYS J, V90, P3749, DOI 10.1529/biophysj.105.060491; Eldar A, 2010, NATURE, V467, P167, DOI 10.1038/nature09326; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Fraser HB, 2004, PLOS BIOL, V2, P834, DOI 10.1371/journal.pbio.0020137; Gillespie DT, 2001, J CHEM PHYS, V115, P1716, DOI 10.1063/1.1378322; Golding I, 2005, CELL, V123, P1025, DOI 10.1016/j.cell.2005.09.031; Hasty J, 2000, P NATL ACAD SCI USA, V97, P2075, DOI 10.1073/pnas.040411297; Hespanha JP, 2005, INT J ROBUST NONLIN, V15, P669, DOI 10.1002/rnc.1017; Hilfinger A, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.248104; Hilfinger A, 2011, P NATL ACAD SCI USA, V108, P12167, DOI 10.1073/pnas.1018832108; Hornung G, 2012, GENOME RES, V22, P2409, DOI 10.1101/gr.139378.112; Jia T, 2011, J MATH BIOL, V106; Johnston IG, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002416; Kaern M, 2005, NAT REV GENET, V6, P451, DOI 10.1038/nrg1615; Kemkemer R, 2002, P NATL ACAD SCI USA, V99, P13783, DOI 10.1073/pnas.212386999; Kussell E, 2005, SCIENCE, V309, P2075, DOI 10.1126/science.1114383; Lehner B, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.11; Libby E, 2007, P NATL ACAD SCI USA, V104, P7151, DOI 10.1073/pnas.0608963104; Losick R, 2008, SCIENCE, V320, P65, DOI 10.1126/science.1147888; Morishita Y, 2004, J THEOR BIOL, V228, P315, DOI 10.1016/j.jtbi.2004.01.007; Munsky B, 2012, SCIENCE, V336, P183, DOI 10.1126/science.1216379; Munsky B, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.75; Nevozhay D, 2009, P NATL ACAD SCI USA, V106, P5123, DOI 10.1073/pnas.0809901106; Newman JRS, 2006, NATURE, V441, P840, DOI 10.1038/nature04785; Orrell D, 2004, J THEOR BIOL, V230, P301, DOI 10.1016/j.jtbi.2004.05.013; Ozbudak EM, 2002, NAT GENET, V31, P69, DOI 10.1038/ng869; Paulsson J, 2004, NATURE, V427, P415, DOI 10.1038/nature02257; Paulsson J, 2005, PHYS LIFE REV, V2, P157, DOI 10.1016/j.plrev.2005.03.003; Pedraza JM, 2008, SCIENCE, V319, P339, DOI 10.1126/science.1144331; Raj A, 2008, CELL, V135, P216, DOI 10.1016/j.cell.2008.09.050; Raj A, 2006, PLOS BIOL, V4, P1707, DOI 10.1371/journal.pbio.0040309; Raser JM, 2005, SCIENCE, V309, P2010, DOI 10.1126/science.1105891; Scott M, 2006, CHAOS, V16, DOI 10.1063/1.2211787; Shahrezaei V, 2008, P NATL ACAD SCI USA, V105, P17256, DOI 10.1073/pnas.0803850105; Shahrezaei V, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.31; Singh Abhyudai, 2007, 2007 American Control Conference, P1299; Singh A, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.38; Singh A, 2011, IEEE T NANOBIOSCI, V10, P194, DOI 10.1109/TNB.2011.2168826; Singh A, 2011, IEEE T AUTOMAT CONTR, V56, P414, DOI 10.1109/TAC.2010.2088631; Singh A, 2010, PHILOS T R SOC A, V368, P4995, DOI 10.1098/rsta.2010.0211; Singh A, 2010, BIOPHYS J, V98, pL32, DOI 10.1016/j.bpj.2010.03.001; Singh A, 2009, BIOPHYS J, V96, P4013, DOI 10.1016/j.bpj.2009.02.064; Swain PS, 2002, P NATL ACAD SCI USA, V99, P12795, DOI 10.1073/pnas.162041399; Swain PS, 2004, J MOL BIOL, V344, P965, DOI 10.1016/j.jmb.2004.09.073; Taniguchi Y, 2010, SCIENCE, V329, P533, DOI 10.1126/science.1188308; Veening J. W., 2008, ANNU REV MICROBIOL, V62; Weinberger LS, 2008, NAT GENET, V40, P466, DOI 10.1038/ng.116; Weinberger LS, 2005, CELL, V122, P169, DOI 10.1016/j.cell.2005.06.006; Wilkinson D.J, 2011, STOCHASTIC MODELLING	61	26	26	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84301	10.1371/journal.pone.0084301	http://dx.doi.org/10.1371/journal.pone.0084301			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391934	gold, Green Published, Green Submitted			2022-12-25	WOS:000329323900077
J	White, O; Davare, M; Andres, M; Olivier, E				White, Olivier; Davare, Marco; Andres, Michael; Olivier, Etienne			The Role of Left Supplementary Motor Area in Grip Force Scaling	PLOS ONE			English	Article							INTERNAL-MODELS; PRECISION GRIP; MAGNETIC STIMULATION; BRAIN ACTIVITY; PREMOTOR; ACTIVATION; OBJECTS; SMA; CONNECTIVITY; MANIPULATION	Skilled tool use and object manipulation critically relies on the ability to scale anticipatorily the grip force (GF) in relation to object dynamics. This predictive behaviour entails that the nervous system is able to store, and then select, the appropriate internal representation of common object dynamics, allowing GF to be applied in parallel with the arm motor commands. Although psychophysical studies have provided strong evidence supporting the existence of internal representations of object dynamics, known as "internal models", their neural correlates are still debated. Because functional neuroimaging studies have repeatedly designated the supplementary motor area (SMA) as a possible candidate involved in internal model implementation, we used repetitive transcranial magnetic stimulation (rTMS) to interfere with the normal functioning of left or right SMA in healthy participants performing a grip-lift task with either hand. TMS applied over the left, but not right, SMA yielded an increase in both GF and GF rate, irrespective of the hand used to perform the task, and only when TMS was delivered 130-180 ms before the fingers contacted the object. We also found that both left and right SMA rTMS led to a decrease in preload phase durations for contralateral hand movements. The present study suggests that left SMA is a crucial node in the network processing the internal representation of object dynamics although further experiments are required to rule out that TMS does not affect the GF gain. The present finding also further substantiates the left hemisphere dominance in scaling GF.	[Davare, Marco; Andres, Michael; Olivier, Etienne] Catholic Univ Louvain, Inst Neurosci, B-1200 Brussels, Belgium; [White, Olivier] Univ Bourgogne, Unite Format & Rech Sci & Tech Act Phys & Sport, Dijon, France; [White, Olivier] INSERM, U1093, Dijon, France; [Davare, Marco] UCL, UCL Inst Neurol, Sobell Dept Motor Neurosci & Movement Disorders, London, England; [Andres, Michael] Catholic Univ Louvain, Inst Rech Sci Psychol, B-1348 Louvain, Belgium	Universite Catholique Louvain; Universite de Bourgogne; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bourgogne; University of London; University College London; Universite Catholique Louvain	Olivier, E (corresponding author), Catholic Univ Louvain, Inst Neurosci, B-1200 Brussels, Belgium.	etienne.olivier@uclouvain.be	White, Olivier/AAJ-6914-2020; Andres, Michael/I-2306-2019	White, Olivier/0000-0002-9119-1329; Andres, Michael/0000-0002-7505-8157; Davare, Marco/0000-0002-4670-0251	ARC [07/12-007]; "Fonds Speciaux de Recherche" (FSR) of the Universite catholique de Louvain; "Fonds de la Recherche Scientifique Medicale" (FRSM); BBSRC [BB/J014184/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/J014184/1] Funding Source: researchfish	ARC(Australian Research Council); "Fonds Speciaux de Recherche" (FSR) of the Universite catholique de Louvain; "Fonds de la Recherche Scientifique Medicale" (FRSM)(Fonds de la Recherche Scientifique - FNRS); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by an ARC grant 07/12-007 (Communaute Francaise de Belgique - Actions de Recherche Concertees), the "Fonds Speciaux de Recherche" (FSR) of the Universite catholique de Louvain and the "Fonds de la Recherche Scientifique Medicale" (FRSM) to E.O. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akkal D, 2007, J NEUROSCI, V27, P10659, DOI 10.1523/JNEUROSCI.3134-07.2007; Andres M., 2012, CORTEX; Andres M, 2011, NEUROIMAGE, V54, P3048, DOI 10.1016/j.neuroimage.2010.11.009; Binkofski F, 1999, EUR J NEUROSCI, V11, P3276, DOI 10.1046/j.1460-9568.1999.00753.x; Borra E, 2008, CEREB CORTEX, V18, P1094, DOI 10.1093/cercor/bhm146; Bursztyn LLCD, 2006, CURR BIOL, V16, P2440, DOI 10.1016/j.cub.2006.10.051; Cadoret G, 1997, J NEUROPHYSIOL, V77, P153, DOI 10.1152/jn.1997.77.1.153; Dancause N, 2006, CEREB CORTEX, V16, P1057; Davare M, 2006, J NEUROSCI, V26, P2260, DOI 10.1523/JNEUROSCI.3386-05.2006; Davare M, 2007, J NEUROSCI, V27, P3974, DOI 10.1523/JNEUROSCI.0426-07.2007; Davare M, 2011, CURR OPIN NEUROBIOL, V21, P565, DOI 10.1016/j.conb.2011.05.021; Davidson PR, 2005, J NEURAL ENG, V2, DOI 10.1088/1741-2560/2/3/S11; Davidson PR, 2004, EXP BRAIN RES, V155, P334, DOI 10.1007/s00221-003-1730-z; Dawson AM, 2010, BRAIN RES, V1317, P124, DOI 10.1016/j.brainres.2009.11.034; DETTMERS C, 1995, J NEUROPHYSIOL, V74, P802, DOI 10.1152/jn.1995.74.2.802; DUM RP, 1991, J NEUROSCI, V11, P667; Dum RP, 2005, J NEUROSCI, V25, P1375, DOI 10.1523/JNEUROSCI.3902-04.2005; Duque J, 2003, BRAIN, V126, P732, DOI 10.1093/brain/awg069; Ehrsson HH, 2000, J NEUROPHYSIOL, V83, P528, DOI 10.1152/jn.2000.83.1.528; Ehrsson HH, 2001, J NEUROPHYSIOL, V85, P2613, DOI 10.1152/jn.2001.85.6.2613; Flanagan JR, 1997, J NEUROSCI, V17, P1519; Forssberg H, 1999, BRAIN, V122, P1157, DOI 10.1093/brain/122.6.1157; Hattori N, 2009, J NEUROPHYSIOL, V101, P1267, DOI 10.1152/jn.90249.2008; Imamizu H, 2000, NATURE, V403, P192, DOI 10.1038/35003194; Imamizu H, 2007, CORTEX, V43, P338, DOI 10.1016/S0010-9452(08)70459-3; Jenmalm P, 2006, J NEUROSCI, V26, P9015, DOI 10.1523/JNEUROSCI.5045-05.2006; JOHANSSON RS, 1984, EXP BRAIN RES, V56, P550; JOHANSSON RS, 1992, CURR OPIN NEUROBIOL, V2, P815, DOI 10.1016/0959-4388(92)90139-C; JOHANSSON RS, 1988, EXP BRAIN RES, V71, P59; Johnson-Frey SH, 2004, TRENDS COGN SCI, V8, P71, DOI 10.1016/j.tics.2003.12.002; Kawato M, 1998, NOVART FDN SYMP, V218, P291; Kawato M, 1999, CURR OPIN NEUROBIOL, V9, P718, DOI 10.1016/S0959-4388(99)00028-8; Keel JC, 2001, CLIN NEUROPHYSIOL, V112, P720, DOI 10.1016/S1388-2457(00)00518-6; Kinoshita H, 2000, BRAIN RES, V857, P119, DOI 10.1016/S0006-8993(99)02416-6; Kuhtz-Buschbeck JP, 2001, EUR J NEUROSCI, V14, P382, DOI 10.1046/j.0953-816x.2001.01639.x; LUPPINO G, 1993, J COMP NEUROL, V338, P114, DOI 10.1002/cne.903380109; Matsunaga K, 2005, J PHYSIOL-LONDON, V562, P295, DOI 10.1113/jphysiol.2004.070755; Milner TE, 2007, NEUROIMAGE, V36, P388, DOI 10.1016/j.neuroimage.2007.01.057; Mitsuo K, 2003, PROG BRAIN RES, V142, P171; Noirhomme Q, 2004, IEEE T BIO-MED ENG, V51, P1994, DOI 10.1109/TBME.2004.834266; Nowak DA, 2007, NEUROPSYCHOLOGIA, V45, P696, DOI 10.1016/j.neuropsychologia.2006.08.011; Nowak DA, 2006, BRAIN RES REV, V51, P108, DOI 10.1016/j.brainresrev.2005.10.003; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Olivier E, 2007, CURR OPIN NEUROBIOL, V17, P644, DOI 10.1016/j.conb.2008.01.008; Pazzaglia M, 2008, J NEUROSCI, V28, P3030, DOI 10.1523/JNEUROSCI.5748-07.2008; Picard N, 1996, CEREB CORTEX, V6, P342, DOI 10.1093/cercor/6.3.342; Picard N, 2003, CEREB CORTEX, V13, P977, DOI 10.1093/cercor/13.9.977; Picard N, 2001, CURR OPIN NEUROBIOL, V11, P663, DOI 10.1016/S0959-4388(01)00266-5; Serrien DJ, 2006, NAT REV NEUROSCI, V7, P160, DOI 10.1038/nrn1849; SMITH AM, 1979, BRAIN RES, V172, P315, DOI 10.1016/0006-8993(79)90541-9; SMITH AM, 1981, BRAIN RES, V222, P395, DOI 10.1016/0006-8993(81)91043-X; Steyvers M, 2003, EXP BRAIN RES, V151, P309, DOI 10.1007/s00221-003-1490-9; Sunderland A, 2007, CORTEX, V43, P359, DOI 10.1016/S0010-9452(08)70461-1; Terao Y, 2000, BRAIN RES, V859, P137, DOI 10.1016/S0006-8993(00)01975-2; Vaillancourt DE, 2003, J NEUROPHYSIOL, V90, P3330, DOI 10.1152/jn.00394.2003; White O, 2008, J NEUROPHYSIOL; Wolpert DM, 2001, CURR BIOL, V11, pR729, DOI 10.1016/S0960-9822(01)00432-8; Wolpert DM, 1998, NEURAL NETWORKS, V11, P1317, DOI 10.1016/S0893-6080(98)00066-5; Zosso D, 2006, P 14 EUR SIGN PROC C	59	25	26	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83812	10.1371/journal.pone.0083812	http://dx.doi.org/10.1371/journal.pone.0083812			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391832	Green Submitted, Green Published, gold			2022-12-25	WOS:000329325200130
J	Okamatsu-Ogura, Y; Fukano, K; Tsubota, A; Uozumi, A; Terao, A; Kimura, K; Saito, M				Okamatsu-Ogura, Yuko; Fukano, Keigo; Tsubota, Ayumi; Uozumi, Akihiro; Terao, Akira; Kimura, Kazuhiro; Saito, Masayuki			Thermogenic Ability of Uncoupling Protein 1 in Beige Adipocytes in Mice	PLOS ONE			English	Article							BROWN ADIPOSE-TISSUE; ADAPTIVE NONSHIVERING THERMOGENESIS; DIET-INDUCED OBESITY; WHITE FAT; TRANSCRIPTIONAL CONTROL; SKELETAL-MUSCLE; UCP1; RECEPTOR; MOUSE; DIFFERENTIATION	Chronic adrenergic activation leads to the emergence of beige adipocytes in some depots of white adipose tissue in mice. Despite their morphological similarities to brown adipocytes and their expression of uncoupling protein 1 (UCP1), a thermogenic protein exclusively expressed in brown adipocytes, the beige adipocytes have a gene expression pattern distinct from that of brown adipocytes. However, it is unclear whether the thermogenic function of beige adipocytes is different from that of classical brown adipocytes existing in brown adipose tissue. To examine the thermogenic ability of UCP1 expressed in beige and brown adipocytes, the adipocytes were isolated from the fat depots of C57BL/6J mice housed at 24 degrees C (control group) or 10 degrees C (cold-acclimated group) for 3 weeks. Morphological and gene expression analyses revealed that the adipocytes isolated from brown adipose tissue of both the control and cold-acclimated groups consisted mainly of brown adipocytes. These brown adipocytes contained large amounts of UCP1 and increased their oxygen consumption when stimulated with norepinephirine. Adipocytes isolated from the perigonadal white adipose tissues of both groups and the inguinal white adipose tissue of the control group were white adipocytes that showed no increase in oxygen consumption after norepinephrine stimulation. Adipocytes isolated from the inguinal white adipose tissue of the cold-acclimated group were a mixture of white and beige adipocytes, which expressed UCP1 and increased their oxygen consumption in response to norepinephrine. The UCP1 content and thermogenic ability of beige adipocytes estimated on the basis of their abundance in the cell mixture were similar to those of brown adipocytes. These results revealed that the inducible beige adipocytes have potent thermogenic ability comparable to classical brown adipocytes.	[Okamatsu-Ogura, Yuko; Fukano, Keigo; Tsubota, Ayumi; Uozumi, Akihiro; Terao, Akira; Kimura, Kazuhiro; Saito, Masayuki] Hokkaido Univ, Grad Sch Vet Med, Dept Biomed Sci, Sapporo, Hokkaido, Japan; [Saito, Masayuki] Tenshi Coll, Grad Sch Nursing & Nutr, Dept Nutr, Sapporo, Hokkaido, Japan	Hokkaido University	Okamatsu-Ogura, Y (corresponding author), Hokkaido Univ, Grad Sch Vet Med, Dept Biomed Sci, Sapporo, Hokkaido, Japan.	keixxx@vetmed.hokudai.ac.jp	Kimura, Kazuhiro/A-5029-2012; Okamatsu-Ogura, Yuko/AAI-5602-2020; Terao, Akira/A-4850-2012	Terao, Akira/0000-0003-2574-1545	Ministry of Education, Culture, Sport, Science and Technology of Japan [21780261]; Akiyama Life Science Foundation	Ministry of Education, Culture, Sport, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Akiyama Life Science Foundation	This work is supported in part by a Grant-in-Aid for Scientific Research (21780261) from the Ministry of Education, Culture, Sport, Science and Technology of Japan and by a grant from the Akiyama Life Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auffret J, 2012, FASEB J, V26, P3728, DOI 10.1096/fj.12-204958; Barbatelli G, 2010, AM J PHYSIOL-ENDOC M, V298, pE1244, DOI 10.1152/ajpendo.00600.2009; Baumruk F, 1999, FEBS LETT, V444, P206, DOI 10.1016/S0014-5793(99)00053-8; Bordicchia M, 2012, J CLIN INVEST, V122, P1022, DOI 10.1172/JCI59701; Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Cinti S, 2012, DIS MODEL MECH, V5, P588, DOI 10.1242/dmm.009662; Cinti S, 2009, AM J PHYSIOL-ENDOC M, V297, pE977, DOI 10.1152/ajpendo.00183.2009; Collins S, 1997, ENDOCRINOLOGY, V138, P405, DOI 10.1210/en.138.1.405; COUSIN B, 1992, J CELL SCI, V103, P931; Dupuis L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005390; Enerback S, 2010, CELL METAB, V11, P248, DOI 10.1016/j.cmet.2010.03.008; Fisher FM, 2012, GENE DEV, V26, P271, DOI 10.1101/gad.177857.111; Flachs P, 2013, BBA-MOL CELL BIOL L, V1831, P986, DOI 10.1016/j.bbalip.2013.02.003; Frontini A, 2010, CELL METAB, V11, P253, DOI 10.1016/j.cmet.2010.03.004; Ghorbani M, 1997, INT J OBESITY, V21, P465, DOI 10.1038/sj.ijo.0800432; Golozoubova V, 2001, FASEB J, V15, P2048, DOI 10.1096/fj.00-0536fje; Guerra C, 1998, J CLIN INVEST, V102, P412, DOI 10.1172/JCI3155; Han DH, 2004, AM J PHYSIOL-ENDOC M, V286, pE347, DOI 10.1152/ajpendo.00434.2003; Hondares E, 2011, J BIOL CHEM, V286, P12983, DOI 10.1074/jbc.M110.215889; Inokuma K, 2006, AM J PHYSIOL-ENDOC M, V290, pE1014, DOI 10.1152/ajpendo.00105.2005; Kajimura S, 2010, CELL METAB, V11, P257, DOI 10.1016/j.cmet.2010.03.005; Tran KV, 2012, CELL METAB, V15, P222, DOI 10.1016/j.cmet.2012.01.008; Klingenspor M, 2003, EXP PHYSIOL, V88, P141, DOI 10.1113/eph8802508; Kopecky J, 1995, J CLIN INVEST, V96, P2914, DOI 10.1172/JCI118363; LEE P, 2013, INT J OBES IN PRESS; Leonardsson G, 2004, P NATL ACAD SCI USA, V101, P8437, DOI 10.1073/pnas.0401013101; Li B, 2000, NAT MED, V6, P1115, DOI 10.1038/80450; Lidell ME, 2013, NAT MED, V19, P631, DOI 10.1038/nm.3017; LIN CS, 1982, BIOCHEMISTRY-US, V21, P2950, DOI 10.1021/bi00541a023; NEDERGAARD J, 1982, AM J PHYSIOL, V242, pC250, DOI 10.1152/ajpcell.1982.242.3.C250; Nedergaard J, 2001, BBA-BIOENERGETICS, V1504, P82, DOI 10.1016/S0005-2728(00)00247-4; Nedergaard J, 2013, BBA-MOL CELL BIOL L, V1831, P943, DOI 10.1016/j.bbalip.2013.01.009; Ohno H, 2012, CELL METAB, V15, P395, DOI 10.1016/j.cmet.2012.01.019; Okamatsu-Ogura Y, 2011, EXP BIOL MED, V236, P1274, DOI 10.1258/ebm.2011.011143; Omachi A, 2008, RES VET SCI, V85, P214, DOI 10.1016/j.rvsc.2007.11.003; Petrovic N, 2010, J BIOL CHEM, V285, P7153, DOI 10.1074/jbc.M109.053942; Saito M, 2009, DIABETES, V58, P1526, DOI 10.2337/db09-0530; Schulz TJ, 2011, P NATL ACAD SCI USA, V108, P143, DOI 10.1073/pnas.1010929108; Scime A, 2005, CELL METAB, V2, P283, DOI 10.1016/j.cmet.2005.10.002; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; Seale P, 2007, CELL METAB, V6, P38, DOI 10.1016/j.cmet.2007.06.001; Seale P, 2011, J CLIN INVEST, V121, P96, DOI 10.1172/JCI44271; Seale P, 2009, GENE DEV, V23, P788, DOI 10.1101/gad.1779209; Sharp LZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049452; Shimada K, 2012, PEPTIDES, V34, P336, DOI 10.1016/j.peptides.2012.02.012; Soloveva V, 1997, MOL ENDOCRINOL, V11, P27, DOI 10.1210/me.11.1.27; Stefl B, 1998, AM J PHYSIOL-ENDOC M, V274, pE527, DOI 10.1152/ajpendo.1998.274.3.E527; SVARTENGREN J, 1982, EUR J BIOCHEM, V128, P481; Tsukiyama-Kohara K, 2001, NAT MED, V7, P1128, DOI 10.1038/nm1001-1128; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016; Xue BZ, 2007, J LIPID RES, V48, P41, DOI 10.1194/jlr.M600287-JLR200; Yoneshiro T, 2013, J CLIN INVEST, V123, P3404, DOI 10.1172/JCI67803	53	55	60	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e84229	10.1371/journal.pone.0084229	http://dx.doi.org/10.1371/journal.pone.0084229			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386355	Green Published, gold			2022-12-25	WOS:000329194700096
J	Park, SY; Jeong, MH; Wang, HY; Kim, JA; Yu, NH; Kim, S; Cheong, YH; Kang, S; Lee, YH; Hur, JS				Park, Sook-Young; Jeong, Min-Hye; Wang, Hai-Ying; Kim, Jung A.; Yu, Nan-Hee; Kim, Sungbeom; Cheong, Yong Hwa; Kang, Seogchan; Lee, Yong-Hwan; Hur, Jae-Seoun			Agrobacterium tumefaciens-Mediated Transformation of the Lichen Fungus, Umbilicaria muehlenbergii	PLOS ONE			English	Article							ANTIMICROBIAL ACTIVITY; T-DNA; GENETIC-TRANSFORMATION; MAGNAPORTHE-GRISEA; FUSARIUM-OXYSPORUM; ANTITUMOR-ACTIVITY; ACID; EXTRACTS; GENOME; IDENTIFICATION	Transformation-mediated mutagenesis in both targeted and random manners has been widely applied to decipher gene function in diverse fungi. However, a transformation system has not yet been established for lichen fungi, severely limiting our ability to study their biology and mechanism underpinning symbiosis via gene manipulation. Here, we report the first successful transformation of the lichen fungus, Umbilicaria muehlenbergii, via the use of Agrobacterium tumefaciens. We generated a total of 918 transformants employing a binary vector that carries the hygromycin B phosphotransferase gene as a selection marker and the enhanced green fluorescent protein gene for labeling transformants. Randomly selected transformants appeared mitotically stable, based on their maintenance of hygromycin B resistance after five generations of growth without selection. Genomic Southern blot showed that 88% of 784 transformants contained a single T-DNA insert in their genome. A number of putative mutants affected in colony color, size, and/or morphology were found among these transformants, supporting the utility of Agrobacterium tumefaciens-mediated transformation (ATMT) for random insertional mutagenesis of U. muehlenbergii. This ATMT approach potentially offers a systematic gene functional study with genome sequences of U. muehlenbergii that is currently underway.	[Park, Sook-Young; Jeong, Min-Hye; Kim, Jung A.; Yu, Nan-Hee; Cheong, Yong Hwa; Hur, Jae-Seoun] Sunchon Natl Univ, Korean Lichen Res Inst, Sunchon, South Korea; [Park, Sook-Young; Kim, Sungbeom; Lee, Yong-Hwan] Seoul Natl Univ, Ctr Fungal Genet Resources, Dept Agr Biotechnol, Fungal Bioinformat Lab, Seoul, South Korea; [Park, Sook-Young; Kim, Sungbeom; Lee, Yong-Hwan] Seoul Natl Univ, Ctr Fungal Pathogenesis, Seoul, South Korea; [Jeong, Min-Hye; Yu, Nan-Hee] Sunchon Natl Univ, Dept Biol, Sunchon, South Korea; [Wang, Hai-Ying] Shandong Normal Univ, Coll Life Sci, Jinan, Peoples R China; [Kang, Seogchan] Penn State Univ, Dept Plant Pathol & Environm Microbiol, University Pk, PA 16802 USA	Sunchon National University; Seoul National University (SNU); Seoul National University (SNU); Sunchon National University; Shandong Normal University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Lee, YH (corresponding author), Seoul Natl Univ, Ctr Fungal Genet Resources, Dept Agr Biotechnol, Fungal Bioinformat Lab, Seoul, South Korea.	yonglee@snu.ac.kr; jshur1@sunchon.ac.kr		Kang, Seogchan/0000-0003-2291-5634	Korea National Research Resource Center Program through the National Research Foundation of Korea (NRF) [2012M3A9B8021726]; National Institute of Biological Resources (The Genetic Evaluation of Important Biological Resources) of Korea; National Research Foundation of Korea; Korea government [2008-0061897, 2013-003196, 2013-009744, 2013R1A1A2013062]; Next-Generation BioGreen 21 Program of Rural Development Administration in Korea [PJ00821201]	Korea National Research Resource Center Program through the National Research Foundation of Korea (NRF); National Institute of Biological Resources (The Genetic Evaluation of Important Biological Resources) of Korea; National Research Foundation of Korea(National Research Foundation of Korea); Korea government(Korean Government); Next-Generation BioGreen 21 Program of Rural Development Administration in Korea	This work was supported by grants from the Korea National Research Resource Center Program through the National Research Foundation of Korea (NRF, 2012M3A9B8021726), the National Institute of Biological Resources (The Genetic Evaluation of Important Biological Resources) of Korea, the National Research Foundation of Korea grant funded by the Korea government (2008-0061897, 2013-003196, 2013-009744, and 2013R1A1A2013062), and the Next-Generation BioGreen 21 Program of Rural Development Administration in Korea (PJ00821201). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bugni TS, 2009, FITOTERAPIA, V80, P270, DOI 10.1016/j.fitote.2009.03.003; Bundock P, 1996, P NATL ACAD SCI USA, V93, P15272, DOI 10.1073/pnas.93.26.15272; BUNDOCK P, 1995, EMBO J, V14, P3206, DOI 10.1002/j.1460-2075.1995.tb07323.x; Candan M, 2007, Z NATURFORSCH C, V62, P619; Candan M, 2006, Z NATURFORSCH C, V61, P319; Cansaran D, 2006, Z NATURFORSCH C, V61, P773; Chen ECF, 2009, MYCOL RES, V113, P290, DOI 10.1016/j.mycres.2008.11.007; Choi J, 2007, MOL MICROBIOL, V66, P371, DOI 10.1111/j.1365-2958.2007.05918.x; CULBERSON CF, 1992, EXP MYCOL, V16, P52, DOI 10.1016/0147-5975(92)90041-O; DABOUSSI MJ, 1989, CURR GENET, V15, P453, DOI 10.1007/BF00376803; de Groot MJA, 1998, NAT BIOTECHNOL, V16, P839, DOI 10.1038/nbt0998-839; Frandsen RJN, 2011, J MICROBIOL METH, V87, P247, DOI 10.1016/j.mimet.2011.09.004; Gagunashvili AN, 2009, MYCOL RES, V113, P354, DOI 10.1016/j.mycres.2008.11.011; Gambichler T, 2009, BRIT J DERMATOL, V161, P1136, DOI 10.1111/j.1365-2133.2009.09273.x; GOLLAPUDI SR, 1994, J NAT PROD, V57, P934, DOI 10.1021/np50109a009; Gouka RJ, 1999, NAT BIOTECHNOL, V17, P598, DOI 10.1038/9915; Gustin MC, 1998, MICROBIOL MOL BIOL R, V62, P1264, DOI 10.1128/MMBR.62.4.1264-1300.1998; HARMALA P, 1992, Fitoterapia, V63, P217; Hawksworth D.L., 1995, DICT FUNGI, V8th; HIRABAYASHI K, 1989, CHEM PHARM BULL, V37, P2410, DOI 10.1248/cpb.37.2410; HOOYKAAS PJJ, 1979, J GEN MICROBIOL, V110, P99, DOI 10.1099/00221287-110-1-99; Huneck S, 1999, NATURWISSENSCHAFTEN, V86, P559, DOI 10.1007/s001140050676; Huneck S, 1996, IDENTIFICATION LICHE; INGOLFSDOTTIR K, 1985, ANTIMICROB AGENTS CH, V28, P289, DOI 10.1128/AAC.28.2.289; Islam MN, 2012, MICROBIOL RES, V167, P332, DOI 10.1016/j.micres.2012.02.001; Ivanova V, 2010, PREP BIOCHEM BIOTECH, V40, P377, DOI 10.1080/10826068.2010.525432; Jeon J, 2007, NAT GENET, V39, P561, DOI 10.1038/ng2002; Khang CH, 2005, FUNGAL GENET BIOL, V42, P483, DOI 10.1016/j.fgb.2005.03.004; Kim HS, 2011, MOL PLANT MICROBE IN, V24, P719, DOI 10.1094/MPMI-11-10-0267; LEUNG H, 1990, CURR GENET, V17, P409, DOI 10.1007/BF00334519; Liu HW, 2009, CURR MICROBIOL, V58, P279, DOI 10.1007/s00284-008-9334-2; Lutzoni F, 2001, NATURE, V411, P937, DOI 10.1038/35082053; Manojlovic NT, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/452431; Marchand G, 2007, J MICROBIOL METH, V70, P519, DOI 10.1016/j.mimet.2007.06.014; MARMEISSE R, 1992, CURR GENET, V22, P41, DOI 10.1007/BF00351740; Maruthachalam K, 2011, MOL BIOTECHNOL, V49, P209, DOI 10.1007/s12033-011-9392-8; McDonald TR, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-225; Meza TJ, 2002, NUCLEIC ACIDS RES, V30, P4556, DOI 10.1093/nar/gkf568; Mitrovic T, 2011, INT J MOL SCI, V12, P5428, DOI 10.3390/ijms12085428; Molina MD, 2000, MYCOL RES, V104, P595, DOI 10.1017/S0953756299002014; Munch S, 2011, MOL PLANT PATHOL, V12, P43, DOI 10.1111/j.1364-3703.2010.00651.x; Mullins ED, 2001, PHYTOPATHOLOGY, V91, P173, DOI 10.1094/PHYTO.2001.91.2.173; Nash ITH, 1996, LICHEN BIOL; NISHIKAWA Y, 1970, CHEM PHARM BULL, V18, P1431; NISHIKAWA Y, 1981, CHEM PHARM BULL, V29, P3407; Paz Z, 2011, FUNGAL GENET BIOL, V48, P677, DOI 10.1016/j.fgb.2011.02.003; Rankovic B, 2010, MICROBIOLOGY+, V79, P809, DOI 10.1134/S0026261710060135; Rezanka T, 2006, NAT PROD RES, V20, P969, DOI 10.1080/14786410500218674; Rho HS, 2001, MOL CELLS, V12, P407; Rowe JG, 1999, Z NATURFORSCH C, V54, P605; Sha Y, 2004, THEOR APPL GENET, V108, P306, DOI 10.1007/s00122-003-1423-9; Sinnemann SJ, 2000, CURR GENET, V37, P333, DOI 10.1007/s002940050536; Stepanenko L. S., 1998, Chemistry of Natural Compounds, V34, P337, DOI 10.1007/BF02282419; Tanas S, 2010, J NAT MED-TOKYO, V64, P42, DOI 10.1007/s11418-009-0367-z; Tay T, 2004, Z NATURFORSCH C, V59, P384; Turk AO, 2003, Z NATURFORSCH C, V58, P850; Turk H, 2006, Z NATURFORSCH C, V61, P499; WATANABE M, 1986, CHEM PHARM BULL, V34, P2532; WINANS SC, 1992, MICROBIOL REV, V56, P12, DOI 10.1128/MMBR.56.1.12-31.1992; Yamamoto Y., 2002, CULTURE THALLUS FRAG, P34; Yilmaz M, 2005, Z NATURFORSCH C, V60, P35; Yilmaz M, 2004, Z NATURFORSCH C, V59, P249	62	26	26	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e83896	10.1371/journal.pone.0083896	http://dx.doi.org/10.1371/journal.pone.0083896			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386304	gold, Green Submitted, Green Published			2022-12-25	WOS:000329194700077
J	Ribeiro-dos-Santos, AM; de Souza, JES; Almeida, R; Alencar, DO; Barbosa, MS; Gusmao, L; Silva, WA; de Souza, SJ; Silva, A; Ribeiro-dos-Santos, A; Darnet, S; Santos, S				Ribeiro-dos-Santos, Andre M.; Santana de Souza, Jorge Estefano; Almeida, Renan; Alencar, Dayse O.; Barbosa, Maria Silvanira; Gusmao, Leonor; Silva, Wilson A., Jr.; de Souza, Sandro J.; Silva, Artur; Ribeiro-dos-Santos, Andrea; Darnet, Sylvain; Santos, Sidney			High-Throughput Sequencing of a South American Amerindian	PLOS ONE			English	Article							MITOCHONDRIAL-DNA; GENOME SEQUENCE; MTDNA; POPULATION; HAPLOTYPES; DIVERSITY; IDENTIFICATION; COLONIZATION; RESOLUTION; ARGENTINA	The emergence of next-generation sequencing technologies allowed access to the vast amounts of information that are contained in the human genome. This information has contributed to the understanding of individual and population-based variability and improved the understanding of the evolutionary history of different human groups. However, the genome of a representative of the Amerindian populations had not been previously sequenced. Thus, the genome of an individual from a South American tribe was completely sequenced to further the understanding of the genetic variability of Amerindians. A total of 36.8 giga base pairs (Gbp) were sequenced and aligned with the human genome. These Gbp corresponded to 95.92% of the human genome with an estimated miscall rate of 0.0035 per sequenced bp. The data obtained from the alignment were used for SNP (single-nucleotide) and INDEL (insertion-deletion) calling, which resulted in the identification of 502,017 polymorphisms, of which 32,275 were potentially new high-confidence SNPs and 33,795 new INDELs, specific of South Native American populations. The authenticity of the sample as a member of the South Native American populations was confirmed through the analysis of the uniparental (maternal and paternal) lineages. The autosomal comparison distinguished the investigated sample from others continental populations and revealed a close relation to the Eastern Asian populations and Aboriginal Australian. Although, the findings did not discard the classical model of America settlement; it brought new insides to the understanding of the human population history. The present study indicates a remarkable genetic variability in human populations that must still be identified and contributes to the understanding of the genetic variability of South Native American populations and of the human populations history.	[Ribeiro-dos-Santos, Andre M.; Alencar, Dayse O.; Barbosa, Maria Silvanira; Gusmao, Leonor; Silva, Artur; Ribeiro-dos-Santos, Andrea; Darnet, Sylvain; Santos, Sidney] Fed Univ Para, Inst Ciencias Biol, BR-66059 Belem, Para, Brazil; [Santana de Souza, Jorge Estefano; Silva, Wilson A., Jr.] Univ Sao Paulo, Fac Med Ribeirao Preto, Ctr Reg Hemoterapia, Sao Paulo, Brazil; [Santana de Souza, Jorge Estefano; Almeida, Renan; de Souza, Sandro J.] Inst Bioinformat & Biotechnol, Sao Paulo, Brazil; [Gusmao, Leonor] Univ Porto, Inst Mol Pathol & Immunol, P-4100 Porto, Portugal; [Silva, Wilson A., Jr.] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Genet, Sao Paulo, Brazil; [de Souza, Sandro J.] Univ Fed Rio Grande do Norte, Inst Brain, BR-59072970 Natal, RN, Brazil	Universidade Federal do Para; Universidade de Sao Paulo; Universidade do Porto; Universidade de Sao Paulo; Universidade Federal do Rio Grande do Norte	Santos, S (corresponding author), Fed Univ Para, Inst Ciencias Biol, BR-66059 Belem, Para, Brazil.	sidneysantos@ufpa.br	Santos, Ândrea Ribeiro dos/B-6061-2013; Gusmao, Leonor/B-3122-2013; DARNET, Sylvain Henri/G-4912-2012; Almeida, Renan/ABE-2626-2020; Ribeiro dos Santos, Ândrea Kely Campos/W-6339-2019; Luiz Silva, Artur da Costa da/AAI-3516-2021; Silva Jr, Wilson Araújo/E-9487-2011; Gusmão, Leonor/L-8931-2019; de Souza, Sandro Jose/AAG-6270-2020; Silva, Artur/E-1474-2014; CTC USP, CEPID 13 18/J-8951-2014	Santos, Ândrea Ribeiro dos/0000-0001-7001-1483; Gusmao, Leonor/0000-0003-0432-6481; DARNET, Sylvain Henri/0000-0001-6351-0903; Ribeiro dos Santos, Ândrea Kely Campos/0000-0001-7001-1483; Luiz Silva, Artur da Costa da/0000-0002-4082-1132; Silva Jr, Wilson Araújo/0000-0001-9364-2886; Gusmão, Leonor/0000-0003-0432-6481; Silva, Artur/0000-0002-4082-1132; CTC USP, CEPID 13 18/0000-0002-7123-9524	Rede Paraense de Genomica e Proteomica (Governo do Para/Secretaria de Estado de Desenvolvimento, Ciencia e Tecnologia/Fundacao de Amparo a Pesquisa do Estado do Para (FAPESPA)); Pro-Reitoria de Pesquisa e Pos-Graduacao/Universidade Federal do Para; Fundacao de Amparo e Desenvolvimento da Pesquisa; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Capes); FAPESPA; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; CAPES/Brasil	Rede Paraense de Genomica e Proteomica (Governo do Para/Secretaria de Estado de Desenvolvimento, Ciencia e Tecnologia/Fundacao de Amparo a Pesquisa do Estado do Para (FAPESPA)); Pro-Reitoria de Pesquisa e Pos-Graduacao/Universidade Federal do Para; Fundacao de Amparo e Desenvolvimento da Pesquisa; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Capes)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FAPESPA(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)Fundacao Amazonia de Amparo a Estudos e Pesquisas (FAPESPA)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES/Brasil(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	The work was supported by the Rede Paraense de Genomica e Proteomica (Governo do Para/Secretaria de Estado de Desenvolvimento, Ciencia e Tecnologia/Fundacao de Amparo a Pesquisa do Estado do Para (FAPESPA)), Pro-Reitoria de Pesquisa e Pos-Graduacao/Universidade Federal do Para, Fundacao de Amparo e Desenvolvimento da Pesquisa, Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Capes), FAPESPA and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico. LG was supported by a grant from CAPES/Brasil. The funders had no role in the study design, the data collection and analysis, the decision to publish, or the preparation of the manuscript.	Ahn SM, 2009, GENOME RES, V19, P1622, DOI 10.1101/gr.092197.109; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Bailliet G, 2009, AM J PHYS ANTHROPOL, V140, P578, DOI 10.1002/ajpa.21133; Balter M, 2008, SCIENCE, V320, P729, DOI 10.1126/science.320.5877.729; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Bisso-Machado R, 2012, GENET MOL BIOL, V35, P365, DOI 10.1590/S1415-47572012005000027; Blanco-Verea A, 2010, FORENSIC SCI INT-GEN, V4, P187, DOI 10.1016/j.fsigen.2009.08.008; Bortolini MC, 2003, AM J HUM GENET, V73, P524, DOI 10.1086/377588; Burbano HA, 2010, SCIENCE, V328, P723, DOI 10.1126/science.1188046; Demarchi DA, 2004, HUM BIOL, V76, P413, DOI 10.1353/hub.2004.0043; Dos Santos SEB, 1999, AM J PHYS ANTHROPOL, V109, P175, DOI 10.1002/(SICI)1096-8644(199906)109:2<175::AID-AJPA3>3.0.CO;2-#; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fagundes NJR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003157; Falush D, 2007, MOL ECOL NOTES, V7, P574, DOI 10.1111/j.1471-8286.2007.01758.x; Forster P, 1996, AM J HUM GENET, V59, P935; Fujimoto A, 2010, NAT GENET, V42, P931, DOI 10.1038/ng.691; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Goncalves VF, 2013, P NATL ACAD SCI USA, V110, P6465, DOI 10.1073/pnas.1217905110; Gonzaga-Jauregui C, 2012, ANNU REV MED, V63, P35, DOI 10.1146/annurev-med-051010-162644; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; Gupta R, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-440; Jombart T, 2011, BIOINFORMATICS, V27, P3070, DOI 10.1093/bioinformatics/btr521; Karafet TM, 2008, GENOME RES, V18, P830, DOI 10.1101/gr.7172008; Kim JI, 2009, NATURE, V460, P1011, DOI 10.1038/nature08211; Kong QP, 2006, HUM MOL GENET, V15, P2076, DOI 10.1093/hmg/ddl130; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; McKernan KJ, 2009, GENOME RES, V19, P1527, DOI 10.1101/gr.091868.109; O'Rourke DH, 2010, CURR BIOL, V20, pR202, DOI 10.1016/j.cub.2009.11.051; Patowary A, 2012, HUM MUTAT, V33, P1133, DOI 10.1002/humu.22091; Pickrell JK, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002967; R Core Team, 2021, R LANG ENV STAT COMP; Rasmussen M, 2011, SCIENCE, V334, P94, DOI 10.1126/science.1211177; Reich D, 2012, NATURE, V488, P370, DOI 10.1038/nature11258; Reich D, 2009, NATURE, V461, P489, DOI 10.1038/nature08365; RibeirodosSantos AKC, 1996, AM J PHYS ANTHROPOL, V101, P29, DOI 10.1002/(SICI)1096-8644(199609)101:1<29::AID-AJPA3>3.0.CO;2-8; Rodriguez-Delfin LA, 2000, HUM HERED, V51, P97, DOI 10.1159/000022964; Roewer L, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003460; Rothhammer F, 2009, ANN HUM GENET, V73, P540, DOI 10.1111/j.1469-1809.2009.00537.x; Sala A, 2010, HUM BIOL, V82, P433, DOI 10.3378/027.082.0406; Santos SEB, 1996, ANN HUM GENET, V60, P305, DOI 10.1111/j.1469-1809.1996.tb01194.x; Schuster SC, 2010, NATURE, V463, P943, DOI 10.1038/nature08795; Shapiro B, 2010, BIOESSAYS, V32, P388, DOI 10.1002/bies.201000026; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Silva WA, 2002, AM J HUM GENET, V71, P187, DOI 10.1086/341358; Smit A., REPEATMASKER OPEN 3; Smith DG, 1999, AM J PHYS ANTHROPOL, V110, P271, DOI 10.1002/(SICI)1096-8644(199911)110:3<271::AID-AJPA2>3.0.CO;2-C; Starikovskaya EB, 2005, ANN HUM GENET, V69, P67, DOI 10.1046/j.1529-8817.2003.00127.x; Tong P, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-9-r91; Toscanini U, 2011, AM J PHYS ANTHROPOL, V146, P188, DOI 10.1002/ajpa.21562; van Oven M, 2009, HUM MUTAT, V30, pE386, DOI 10.1002/humu.20921; Wang J, 2008, NATURE, V456, P60, DOI 10.1038/nature07484; Zegura SL, 2004, MOL BIOL EVOL, V21, P164, DOI 10.1093/molbev/msh009	55	8	8	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e83340	10.1371/journal.pone.0083340	http://dx.doi.org/10.1371/journal.pone.0083340			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386182	Green Published, Green Submitted, gold			2022-12-25	WOS:000329194700035
J	Russell, RA; Garway-Heath, DF; Crabb, DP				Russell, Richard A.; Garway-Heath, David F.; Crabb, David P.			New Insights into Measurement Variability in Glaucomatous Visual Fields from Computer Modelling	PLOS ONE			English	Article							STANDARD AUTOMATED PERIMETRY; TEST-RETEST VARIABILITY; FREQUENCY-DOUBLING TECHNOLOGY; FULL-THRESHOLD; SUSPECTED GLAUCOMA; MEASURING RATES; OPTIC NEURITIS; SHORT-TERM; SIZE III; PROGRESSION	Objective: To develop a model to simulate visual fields (VFs) in glaucoma patients, and to characterize variability of the Mean Deviation (MD) VF summary measurement using real VFs and simulations. Methods: Pointwise VF variability was previously approximated using longitudinal VF data (24-2 SITA Standard, Humphrey Field Analyzer) from 2,736 patients; these data were used to build a non-parametric model to simulate VFs. One million VF simulations were generated from 1,000 VFs (1,000 simulations per 'ground-truth' VF), and the variability of simulated MDs was characterized as a function of ground-truth MD and Pattern Standard Deviation (PSD). Results: The median (interquartile range, IQR) patient age and MD was 66 (56 to 75) years and -3.5 (-8.3 to -1.1) decibels, respectively. The inferred variability as a function of ground-truth MD and PSD indicated that variability, on average, increased rapidly as glaucoma worsened. However, the pattern of VF damage significantly affects the level of MD variability, with more than three-fold differences between patients with approximately the same levels of MD but different patterns of loss. Conclusions: A novel approach for simulating VFs is introduced. A better understanding of VF variability will help clinicians to differentiate real VF progression from measurement variability. This study highlights that, overall, MD variability increases as the level of damage increases, but variability is highly dependent on the pattern of VF damage. Future research, using VF simulations, could be employed to provide benchmarks for measuring the performance of VF progression detection algorithms and developing new strategies for measuring VF progression.	[Russell, Richard A.; Garway-Heath, David F.; Crabb, David P.] City Univ London, Dept Optometry & Visual Sci, London, England; [Russell, Richard A.; Garway-Heath, David F.] Moorfields Eye Hosp NHS Fdn Trust, NIHR Biomed Res Ctr Ophthalmol, London, England; [Russell, Richard A.; Garway-Heath, David F.] UCL Inst Ophthalmol, London, England	City University London; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; University of London; University College London	Crabb, DP (corresponding author), City Univ London, Dept Optometry & Visual Sci, London, England.	david.crabb.1@city.ac.uk		Crabb, David/0000-0001-8754-3902; Garway-Heath, David/0000-0003-2907-6992	UK National Institute for Health Research (NIHR) Health Services Research program [10/2000/68]; National Institutes of Health (NIH) [R01EY007716]; Department of Health27 dB s National Institute for Health Research (NIHR) Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust; UCL Institute of Ophthalmology; Allergan, Inc.; International Glaucoma Association; NATIONAL EYE INSTITUTE [R01EY007716] Funding Source: NIH RePORTER; National Institute for Health Research [10/2000/68] Funding Source: researchfish	UK National Institute for Health Research (NIHR) Health Services Research program; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Health27 dB s National Institute for Health Research (NIHR) Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust; UCL Institute of Ophthalmology; Allergan, Inc.(AbbVieAllergan); International Glaucoma Association; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Institute for Health Research(National Institute for Health Research (NIHR))	This work was funded in part by the UK National Institute for Health Research (NIHR) Health Services Research program (project number 10/2000/68) and the National Institutes of Health (NIH; grant number R01EY007716). RAR and DFG-H received a proportion of their funding from the Department of Health27 (22 to 30) dB s National Institute for Health Research (NIHR) Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology. RAR is supported by an Investigator Initiated Research grant from Allergan, Inc. DFG-H's chair at UCL is supported by funding from the International Glaucoma Association. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artes PH, 2011, INVEST OPHTH VIS SCI, V52, P4030, DOI 10.1167/iovs.10-6905; Artes PH, 2005, PROG RETIN EYE RES, V24, P333, DOI 10.1016/j.preteyeres.2004.10.002; Artes PH, 2002, INVEST OPHTH VIS SCI, V43, P2654; Artes PH, 2005, INVEST OPHTH VIS SCI, V46, P2451, DOI 10.1167/iovs.05-0135; Bengtsson B, 1997, ACTA OPHTHALMOL SCAN, V75, P368; Chauhan BC, 2008, BRIT J OPHTHALMOL, V92, P569, DOI 10.1136/bjo.2007.135012; Chauhan B C, 1994, J Glaucoma, V3 Suppl 1, pS73; CHAUHAN BC, 1993, INVEST OPHTH VIS SCI, V34, P3534; Cleveland WS, 1992, LOCAL REGRESSION MOD; Ernest PJG, 2012, ACTA OPHTHALMOL, V90, P101, DOI 10.1111/j.1755-3768.2011.02206.x; FLAMMER J, 1984, ARCH OPHTHALMOL-CHIC, V102, P704, DOI 10.1001/archopht.1984.01040030560017; Gardiner SK, 2002, BRIT J OPHTHALMOL, V86, P560, DOI 10.1136/bjo.86.5.560; Gardiner SK, 2002, INVEST OPHTH VIS SCI, V43, P1400; GLASS E, 1995, INVEST OPHTH VIS SCI, V36, P1847; HEIJL A, 1987, ARCH OPHTHALMOL-CHIC, V105, P1544; Heijl A, 1996, ARCH OPHTHALMOL-CHIC, V114, P19, DOI 10.1001/archopht.1996.01100130017003; Heijl A, 1995, Curr Opin Ophthalmol, V6, P46; HEIJL A, 1989, AM J OPHTHALMOL, V108, P130, DOI 10.1016/0002-9394(89)90006-8; Henson DB, 2000, INVEST OPHTH VIS SCI, V41, P417; Hodapp E, 1993, CLIN DECISIONS GLAUC; Jansonius NM, 2010, BRIT J OPHTHALMOL, V94, P1404, DOI 10.1136/bjo.2009.164897; JOHNSON CA, 1992, INVEST OPHTH VIS SCI, V33, P2966; Kingman S, 2004, B WORLD HEALTH ORGAN, V82, P887; Leske MC, 1999, OPHTHALMOLOGY, V106, P2144, DOI 10.1016/S0161-6420(99)90497-9; McKean-Cowdin R, 2008, OPHTHALMOLOGY, V115, P941, DOI 10.1016/j.ophtha.2007.08.037; Montolio FGJ, 2012, INVEST OPHTH VIS SCI, V53, P7010, DOI 10.1167/iovs.12-10268; Montolio FGJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041211; Murata H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058695; Nouri-Mahdavi K, 2011, ARCH OPHTHALMOL-CHIC, V129, P1521, DOI 10.1001/archophthalmol.2011.224; PILTZ JR, 1990, AM J OPHTHALMOL, V109, P109; Quigley HA, 1996, NUMBER, V80, P389; Ramulu P, 2009, CURR OPIN OPHTHALMOL, V20, P92, DOI 10.1097/ICU.0b013e32832401a9; Russell RA, 2012, INVEST OPHTH VIS SCI, V53, P5985, DOI 10.1167/iovs.12-10428; SHAPIRO LR, 1990, APPL OPTICS, V29, P1445, DOI 10.1364/AO.29.001445; Shapiro LR, 1989, KRAKEN COMPUTER SIMU, P431; Spenceley SE, 1996, BRIT J OPHTHALMOL, V80, P304, DOI 10.1136/bjo.80.4.304; Spry PGD, 2001, INVEST OPHTH VIS SCI, V42, P1404; Spry PGD, 2000, INVEST OPHTH VIS SCI, V41, P2192; Tattersall CL, 2007, EYE, V21, P362, DOI 10.1038/sj.eye.6702206; Team RDC, 2010, R LANG ENV STAT COMP; TOBIN J, 1958, ECONOMETRICA, V26, P24, DOI 10.2307/1907382; Turpin A, 2003, INVEST OPHTH VIS SCI, V44, P4787, DOI 10.1167/iovs.03-0023; Turpin A, 2007, INVEST OPHTH VIS SCI, V48, P1627, DOI 10.1167/iovs.06-1074; Wall M, 1998, ARCH OPHTHALMOL-CHIC, V116, P53, DOI 10.1001/archopht.116.1.53; Wall M, 2009, INVEST OPHTH VIS SCI, V50, P974, DOI 10.1167/iovs.08-1789; Wall M, 2013, INVEST OPHTH VIS SCI, V54, P1345, DOI 10.1167/iovs.12-10299	46	26	26	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e83595	10.1371/journal.pone.0083595	http://dx.doi.org/10.1371/journal.pone.0083595			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386230	gold, Green Published, Green Submitted, Green Accepted			2022-12-25	WOS:000329194700051
J	Nettle, D; Monaghan, P; Boner, W; Gillespie, R; Bateson, M				Nettle, Daniel; Monaghan, Pat; Boner, Winnie; Gillespie, Robert; Bateson, Melissa			Bottom of the Heap: Having Heavier Competitors Accelerates Early-Life Telomere Loss in the European Starling, Sturnus vulgaris	PLOS ONE			English	Article							ADVERSE CHILDHOOD EXPERIENCES; NEST PARASITISM; LENGTH; STRESS; AGE; MORTALITY; DISEASE; SPAN; RISK; SEX	Early-life adversity is associated with poorer health and survival in adulthood in humans and other animals. One pathway by which early-life environmental stressors could affect the adult phenotype is via effects on telomere dynamics. Several studies have shown that early-life adversity is associated with relatively short telomeres, but these are often cross-sectional and usually correlational in design. Here, we present a novel experimental system for studying the relationship between early-life adversity and telomere dynamics using a wild bird, the European starling (Sturnus vulgaris). We used cross-fostering to experimentally assign sibling chicks to either small or large broods for twelve days of the growth period. We measured telomere length in red blood cells using quantitative PCR near the beginning of the experimental manipulation (4 days old), at the end of the experimental manipulation (15 days old), and once the birds were independent (55 days old). Being in a larger brood slowed growth and retarded wing development and the timing of fledging. We found no evidence that overall brood size affected telomere dynamics. However, the greater the number of competitors above the focal bird in the within-brood size hierarchy, the greater was the telomere loss during the period of the experimental manipulation. The number of competitors below the focal in the hierarchy had no effect. The effect of heavier competitors was still evident when we controlled for the weight of the focal bird at the end of the manipulation, suggesting it was not due to retarded growth per se. Moreover, the impact of early competition on telomeres was still evident at independence, suggesting persistence beyond early life. Our study provides experimental support for the hypothesis that social stress, in this case induced by the presence of a greater number of dominant competitors, accelerates the rate of telomere loss.	[Nettle, Daniel] Newcastle Univ, Ctr Behav & Evolut, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Nettle, Daniel; Bateson, Melissa] Newcastle Univ, Inst Neurosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Monaghan, Pat; Boner, Winnie; Gillespie, Robert] Univ Glasgow, Inst Biodivers Anim Hlth & Comparat Med, Glasgow G12 8QQ, Lanark, Scotland	Newcastle University - UK; Newcastle University - UK; University of Glasgow	Nettle, D (corresponding author), Newcastle Univ, Ctr Behav & Evolut, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	daniel.nettle@ncl.ac.uk	Bateson, Melissa/B-1874-2008; Monaghan, Pat/E-6810-2015; Bateson, Melissa/AAE-7075-2022	Bateson, Melissa/0000-0002-0861-0191; Bateson, Melissa/0000-0002-0861-0191; Nettle, Daniel/0000-0001-9089-2599	BBSRC (Bateson/Nettle) [BB/J016446/1]; ERC (Monaghan) [ERC AdG 268926]; BBSRC (Monaghan) [BB/J015091/1]; Biotechnology and Biological Sciences Research Council [BB/J015091/1, BB/J016446/1] Funding Source: researchfish; BBSRC [BB/J016446/1, BB/J015091/1] Funding Source: UKRI	BBSRC (Bateson/Nettle); ERC (Monaghan); BBSRC (Monaghan); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the BBSRC under grant numbers BB/J016446/1 (Bateson/Nettle) and BB/J015091/1 (Monaghan), and the ERC under grant number ERC AdG 268926 (Monaghan). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asher L, 2008, LAB ANIM-UK, V42, P111, DOI 10.1258/la.2007.007006; Aubert G, 2008, PHYSIOL REV, V88, P557, DOI 10.1152/physrev.00026.2007; Aviv A., 2011, NUCLEIC ACIDS RES, V39, P5; Bakaysa SL, 2007, AGING CELL, V6, P769, DOI 10.1111/j.1474-9726.2007.00340.x; Barrett ELB, 2013, MOL ECOL, V22, P249, DOI 10.1111/mec.12110; Bateson M, 2010, UFAW HDB CARE MANAGE; Bateson M, 2010, ILAR J, V51, P394, DOI 10.1093/ilar.51.4.394; Bize P, 2009, P R SOC B, V276, P1679, DOI 10.1098/rspb.2008.1817; Blackburn EH, 2012, NATURE, V490, P169, DOI 10.1038/490169a; Boonekamp JJ, 2013, AGING CELL, V12, P330, DOI 10.1111/acel.12050; Boyce WT, 2012, P NATL ACAD SCI US; Cattan V, 2008, FREE RADICAL BIO MED, V44, P1592, DOI 10.1016/j.freeradbiomed.2008.01.007; Cawthon R.M., 2002, NUCLEIC ACIDS RES, V30; Cawthon RM, 2003, LANCET, V361, P393, DOI 10.1016/S0140-6736(03)12384-7; Choi J, 2008, BRAIN BEHAV IMMUN, V22, P600, DOI 10.1016/j.bbi.2007.12.004; Cotton PA, 1999, AM NAT, V153, P412, DOI 10.1086/303178; Criscuolo F, 2009, J AVIAN BIOL, V40, P342, DOI 10.1111/j.1600-048X.2008.04623.x; delaMora AN, 1996, ETHOLOGY, V102, P748; Drummond H, 2013, J EVOLUTION BIOL, V26, P625, DOI 10.1111/jeb.12087; Dube SR, 2003, PREV MED, V37, P268, DOI 10.1016/S0091-7435(03)00123-3; Epel ES, 2009, CURR DIR PSYCHOL SCI, V18, P6, DOI 10.1111/j.1467-8721.2009.01596.x; Epel ES, 2004, P NATL ACAD SCI USA, V101, P17312, DOI 10.1073/pnas.0407162101; Falkstedt D, 2011, EUR J PUBLIC HEALTH, V21, P713, DOI 10.1093/eurpub/ckq158; Feare C.J., 1984, STARLING; Feenders G., 2011, PLOS ONE, V6; Felitti VJ, 1998, AM J PREV MED, V14, P245, DOI 10.1016/S0749-3797(98)00017-8; Foote CG, 2013, MOL ECOL RESOUR, V13, P417, DOI 10.1111/1755-0998.12079; Frenck RW, 1998, P NATL ACAD SCI USA, V95, P5607, DOI 10.1073/pnas.95.10.5607; Fridolfsson AK, 1999, J AVIAN BIOL, V30, P116, DOI 10.2307/3677252; Geronimus AT, 2010, HUM NATURE-INT BIOS, V21, P19, DOI 10.1007/s12110-010-9078-0; Gomes NMV, 2010, COMPARATIVE BIOLOGY OF AGING, P227, DOI 10.1007/978-90-481-3465-6_11; Hart CL, 2003, J EPIDEMIOL COMMUN H, V57, P385, DOI 10.1136/jech.57.5.385; Heidinger BJ, 2012, P NATL ACAD SCI USA, V109, P1743, DOI 10.1073/pnas.1113306109; Joergensen A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020795; Kananen L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010826; Kelly-Irving M, 2013, INT J PUBLIC HEALTH, V58, P3, DOI 10.1007/s00038-012-0370-0; KILNER R, 1995, P ROY SOC B-BIOL SCI, V260, P343, DOI 10.1098/rspb.1995.0102; Kimura M, 2008, AM J EPIDEMIOL, V167, P799, DOI 10.1093/aje/kwm380; Larson K, 2013, INT J PUBLIC HEALTH, V58, P89, DOI 10.1007/s00038-012-0373-x; MARMOT MG, 1991, LANCET, V337, P1387, DOI 10.1016/0140-6736(91)93068-K; MARMOT MG, 1987, ANNU REV PUBL HEALTH, V8, P111, DOI 10.1146/annurev.pu.08.050187.000551; Mock DW, 2009, ANIM BEHAV, V78, P677, DOI 10.1016/j.anbehav.2009.05.032; Monaghan P, 2006, TRENDS ECOL EVOL, V21, P47, DOI 10.1016/j.tree.2005.11.007; Monaghan P, 2013, J EVOLUTION IN PRESS; Nakagawa S, 2004, MOL ECOL, V13, P2523, DOI 10.1111/j.1365-294X.2004.02291.x; PINXTEN R, 1991, ARDEA, V79, P15; Raberg L, 2005, OECOLOGIA, V145, P496, DOI 10.1007/s00442-005-0133-1; Ramsay SE, 2007, INT J EPIDEMIOL, V36, P560, DOI 10.1093/ije/dym060; Rosivall B, 2010, BEHAV ECOL SOCIOBIOL, V64, P1555, DOI 10.1007/s00265-010-0969-1; Salomons HM, 2009, P ROY SOC B-BIOL SCI, V276, P3157, DOI 10.1098/rspb.2009.0517; Salomons HM, 2009, FIGHTING FITNESS TEL; Shalev I, 2013, MOL PSYCHIATR, V18, P576, DOI 10.1038/mp.2012.32; SLAGBOOM PE, 1994, AM J HUM GENET, V55, P876; Tyrka AR, 2010, BIOL PSYCHIAT, V67, P531, DOI 10.1016/j.biopsych.2009.08.014; VAZIRI H, 1993, AM J HUM GENET, V52, P661; von Zglinicki T, 2002, TRENDS BIOCHEM SCI, V27, P339, DOI 10.1016/S0968-0004(02)02110-2; WRIGHT J, 1990, ANIM BEHAV, V40, P462, DOI 10.1016/S0003-3472(05)80526-3; YOMTOV Y, 1974, IBIS, V116, P87, DOI 10.1111/j.1474-919X.1974.tb00226.x; Zafir A, 2009, STRESS, V12, P167, DOI 10.1080/10253890802234168	59	54	54	4	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e83617	10.1371/journal.pone.0083617	http://dx.doi.org/10.1371/journal.pone.0083617			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	281RE	24386235	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000329117900046
J	Duursma, DE; Gallagher, RV; Roger, E; Hughes, L; Downey, PO; Leishman, MR				Duursma, Daisy Englert; Gallagher, Rachael V.; Roger, Erin; Hughes, Lesley; Downey, Paul O.; Leishman, Michelle R.			Next-Generation Invaders? Hotspots for Naturalised Sleeper Weeds in Australia under Future Climates	PLOS ONE			English	Article							SPECIES DISTRIBUTIONS; ALIEN PLANTS; INVASION; NICHE; PREDICTION; DIVERSITY; ECOLOGY; TRAITS; UPDATE; ZONE	Naturalised, but not yet invasive plants, pose a nascent threat to biodiversity. As climate regimes continue to change, it is likely that a new suite of invaders will emerge from the established pool of naturalised plants. Pre-emptive management of locations that may be most suitable for a large number of potentially invasive plants will help to target monitoring, and is vital for effective control. We used species distribution models (SDM) and invasion-hotspot analysis to determine where in Australia suitable habitat may occur for 292 naturalised plants. SDMs were built in MaxEnt using both climate and soil variables for current baseline conditions. Modelled relationships were projected onto two Representative Concentration Pathways for future climates (RCP 4.5 and 8.5), based on seven global climate models, for two time periods (2035, 2065). Model outputs for each of the 292 species were then aggregated into single 'hotspot' maps at two scales: continental, and for each of Australia's 37 ecoregions. Across Australia, areas in the south-east and south-west corners of the continent were identified as potential hotspots for naturalised plants under current and future climates. These regions provided suitable habitat for 288 and 239 species respectively under baseline climates. The areal extent of the continental hotspot was projected to decrease by 8.8% under climates for 2035, and by a further 5.2% by 2065. A similar pattern of hotspot contraction under future climates was seen for the majority of ecoregions examined. However, two ecoregions - Tasmanian temperate forests and Australian Alps montane grasslands - showed increases in the areal extent of hotspots of >45% under climate scenarios for 2065. The alpine ecoregion also had an increase in the number of naturalised plant species with abiotically suitable habitat under future climate scenarios, indicating that this area may be particularly vulnerable to future incursions by naturalised plants.	[Duursma, Daisy Englert; Gallagher, Rachael V.; Roger, Erin; Hughes, Lesley; Leishman, Michelle R.] Macquarie Univ, Dept Biol Sci, Macquarie PK, Australia; [Downey, Paul O.] Univ Canberra, Inst Appl Ecol, Canberra, ACT 2601, Australia	Macquarie University; University of Canberra	Gallagher, RV (corresponding author), Macquarie Univ, Dept Biol Sci, Macquarie PK, Australia.	rachael.gallagher@mq.edu.au	Leishman, Michelle/AAU-4102-2020; Leishman, Michelle M/G-9726-2012	Leishman, Michelle/0000-0003-4830-5797; Leishman, Michelle M/0000-0003-4830-5797; Downey, Paul/0000-0002-8867-248X; Gallagher, Rachael/0000-0002-4680-8115; Roger, Erin/0000-0002-9671-132X; Hughes, Lesley/0000-0003-0313-9780	National Climate Change Adaptation Research Facility; Department of Biological Sciences at Macquarie University	National Climate Change Adaptation Research Facility; Department of Biological Sciences at Macquarie University	This work was funded by the National Climate Change Adaptation Research Facility. We thank the Department of Biological Sciences at Macquarie University for financing this open access publication. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DR., 2002, PRACTICAL INFORM THE, DOI DOI 10.1007/B97636; Araujo MB, 2006, J BIOGEOGR, V33, P1677, DOI 10.1111/j.1365-2699.2006.01584.x; Beaumont LJ, 2008, ECOL LETT, V11, P1135, DOI 10.1111/j.1461-0248.2008.01231.x; Beaumont LJ, 2009, DIVERS DISTRIB, V15, P409, DOI 10.1111/j.1472-4642.2008.00547.x; Bradley BA, 2010, TRENDS ECOL EVOL, V25, P310, DOI 10.1016/j.tree.2009.12.003; Chen JQ, 1999, BIOSCIENCE, V49, P288, DOI 10.2307/1313612; Cousens Roger D., 2013, Cunninghamia, V13, P275, DOI 10.7751/cunninghamia.2013.005; Diez JM, 2009, ECOL LETT, V12, P1174, DOI 10.1111/j.1461-0248.2009.01376.x; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Elith J, 2010, METHODS ECOL EVOL, V1, P330, DOI 10.1111/j.2041-210X.2010.00036.x; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Fordham DA, 2011, ECOL APPL, V21, P3317, DOI 10.1890/11-0314.1; Friedlingstein P, 2010, NAT GEOSCI, V3, P811, DOI 10.1038/ngeo1022; Gallagher RV, 2013, BIOL INVASIONS, V15, P961, DOI 10.1007/s10530-012-0342-6; Gallagher RV, 2010, J ECOL, V98, P790, DOI 10.1111/j.1365-2745.2010.01677.x; Groves RH, 2006, EUPHYTICA, V148, P111, DOI 10.1007/s10681-006-5945-5; Groves R. H., 2005, JUMPING GARDEN FENCE; Gurevitch J., 2002, ECOLOGY PLANTS; Hellmann JJ, 2008, CONSERV BIOL, V22, P534, DOI 10.1111/j.1523-1739.2008.00951.x; Hennessy KJ, 2008, CLIM RES, V35, P255, DOI 10.3354/cr00706; Hijmans R.J., 2012, R PACKAGE; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hijmans RJ, 2013, SPECIES DISTRIBUTION; Hijmans RJ, 2006, GLOBAL CHANGE BIOL, V12, P2272, DOI 10.1111/j.1365-2486.2006.01256.x; Hughes L, 2011, REG ENVIRON CHANGE, V11, pS189, DOI 10.1007/s10113-010-0158-9; Johnston FM, 2001, MT RES DEV, V21, P284, DOI 10.1659/0276-4741(2001)021[0284:APITAA]2.0.CO;2; Krivanek M, 2006, DIVERS DISTRIB, V12, P319, DOI 10.1111/j.1366-9516.2006.00249.x; Kueffer C, 2013, NEW PHYTOL, V200, P615, DOI 10.1111/nph.12415; Lemke D, 2011, FOREST ECOL MANAG, V262, P139, DOI 10.1016/j.foreco.2011.03.014; Lobo JM, 2008, GLOBAL ECOL BIOGEOGR, V17, P145, DOI 10.1111/j.1466-8238.2007.00358.x; Lockwood JL, 2005, TRENDS ECOL EVOL, V20, P223, DOI 10.1016/j.tree.2005.02.004; Merow C, 2013, ECOGRAPHY, V36, P1058, DOI 10.1111/j.1600-0587.2013.07872.x; Milbau A, 2008, CONSERV BIOL, V22, P308, DOI 10.1111/j.1523-1739.2007.00877.x; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; O'Donnell J, 2012, GLOBAL CHANGE BIOL, V18, P617, DOI 10.1111/j.1365-2486.2011.02537.x; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Pattison RR, 2008, GLOBAL CHANGE BIOL, V14, P813, DOI 10.1111/j.1365-2486.2007.01528.x; Pearson RG, 2004, ECOGRAPHY, V27, P285, DOI 10.1111/j.0906-7590.2004.03740.x; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Pickering C, 2008, BIODIVERS CONSERV, V17, P1627, DOI 10.1007/s10531-008-9371-y; Pielke RA, 1998, GLOBAL CHANGE BIOL, V4, P461, DOI 10.1046/j.1365-2486.1998.t01-1-00176.x; Pimentel D, 2005, ECOL ECON, V52, P273, DOI 10.1016/j.ecolecon.2004.10.002; Pyke CR, 2008, CONSERV BIOL, V22, P585, DOI 10.1111/j.1523-1739.2008.00956.x; Pysek Petr, 2007, V193, P97; R Core Team, 2022, R LANG ENV STAT COMP; Randall R. P., 2007, INTRO FLORA AUSTR IT; Reid WV, 1998, TRENDS ECOL EVOL, V13, P275, DOI 10.1016/S0169-5347(98)01363-9; Richardson DM, 2012, NEW PHYTOL, V196, P383, DOI 10.1111/j.1469-8137.2012.04292.x; Richardson David M., 2000, Diversity and Distributions, V6, P93, DOI 10.1046/j.1472-4642.2000.00083.x; Scott J.M., 2002, PREDICTING SPECIES O; Seabloom EW, 2006, ECOL APPL, V16, P1338, DOI 10.1890/1051-0761(2006)016[1338:HIPIAI]2.0.CO;2; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Stohlgren Thomas J., 2001, Biological Invasions, V3, P37, DOI 10.1023/A:1011451417418; Stokes KE, 2006, DIVERS DISTRIB, V12, P593, DOI 10.1111/j.1366-9516.2006.00239.x; Thuiller W, 2005, P NATL ACAD SCI USA, V102, P8245, DOI 10.1073/pnas.0409902102; Vanderwal J, 2011, PACKAGE CLIMATES MET; VanDerWal J, 2009, ECOL MODEL, V220, P589, DOI 10.1016/j.ecolmodel.2008.11.010; Venn SE, 2011, PLANT ECOL, V212, P1491, DOI 10.1007/s11258-011-9923-1; Walther GR, 2009, TRENDS ECOL EVOL, V24, P686, DOI 10.1016/j.tree.2009.06.008; Warren DL, 2010, ECOGRAPHY, V33, P607, DOI 10.1111/j.1600-0587.2009.06142.x; Wiens JJ, 2005, ANNU REV ECOL EVOL S, V36, P519, DOI 10.1146/annurev.ecolsys.36.102803.095431	63	29	30	0	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e84222	10.1371/journal.pone.0084222	http://dx.doi.org/10.1371/journal.pone.0084222			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281QS	24386353	Green Submitted, Green Published, gold			2022-12-25	WOS:000329116700100
J	Tibely, G; Pollner, P; Vicsek, T; Palla, G				Tibely, Gergely; Pollner, Peter; Vicsek, Tamas; Palla, Gergely			Extracting Tag Hierarchies	PLOS ONE			English	Article							COLLECTIVE DYNAMICS; COMMUNITY STRUCTURE; NETWORKS; IDENTIFICATION; EMERGENCE	Tagging items with descriptive annotations or keywords is a very natural way to compress and highlight information about the properties of the given entity. Over the years several methods have been proposed for extracting a hierarchy between the tags for systems with a "flat", egalitarian organization of the tags, which is very common when the tags correspond to free words given by numerous independent people. Here we present a complete framework for automated tag hierarchy extraction based on tag occurrence statistics. Along with proposing new algorithms, we are also introducing different quality measures enabling the detailed comparison of competing approaches from different aspects. Furthermore, we set up a synthetic, computer generated benchmark providing a versatile tool for testing, with a couple of tunable parameters capable of generating a wide range of test beds. Beside the computer generated input we also use real data in our studies, including a biological example with a pre-defined hierarchy between the tags. The encouraging similarity between the pre-defined and reconstructed hierarchy, as well as the seemingly meaningful hierarchies obtained for other real systems indicate that tag hierarchy extraction is a very promising direction for further research with a great potential for practical applications. Tags have become very prevalent nowadays in various online platforms ranging from blogs through scientific publications to protein databases. Furthermore, tagging systems dedicated for voluntary tagging of photos, films, books, etc. with free words are also becoming popular. The emerging large collections of tags associated with different objects are often referred to as folksonomies, highlighting their collaborative origin and the "flat" organization of the tags opposed to traditional hierarchical categorization. Adding a tag hierarchy corresponding to a given folksonomy can very effectively help narrowing or broadening the scope of search. Moreover, recommendation systems could also benefit from a tag hierarchy.	[Tibely, Gergely; Vicsek, Tamas] Eotvos Lorand Univ, Dept Biol Phys, Budapest, Hungary; [Pollner, Peter; Palla, Gergely] HAS, Stat & Biol Phys Res Grp, Budapest, Hungary; [Tibely, Gergely; Pollner, Peter; Vicsek, Tamas; Palla, Gergely] Eotvos Lorand Univ, Reg Knowledge Ctr, Szekesfehervar, Hungary	Eotvos Lorand University; Hungarian Academy of Sciences; Eotvos Lorand University	Palla, G (corresponding author), HAS, Stat & Biol Phys Res Grp, Budapest, Hungary.	pallag@hal.elte.hu	Tibely, Gergely/AAE-6348-2019; Palla, Gergely/H-1767-2016; Pollner, Peter/N-3975-2016	Palla, Gergely/0000-0002-3406-4200; Pollner, Peter/0000-0003-0464-4893	European Union; European Social Fund through project FuturICT.hu [TAMOP-4.2.2.C-11/1/KONV-2012-0013]; Hungarian National Science Fund [OTKA K105447]	European Union(European Commission); European Social Fund through project FuturICT.hu; Hungarian National Science Fund	The research was partially supported by the European Union and the European Social Fund through project FuturICT.hu (grant no.:TAMOP-4.2.2.C-11/1/KONV-2012-0013) and by the Hungarian National Science Fund (OTKA K105447). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aittokallio T, 2006, BRIEF BIOINFORM, V7, P243, DOI 10.1093/bib/bbl022; Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; [Anonymous], [No title captured]; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Castellano C, 2009, REV MOD PHYS, V81, P591, DOI 10.1103/RevModPhys.81.591; Cattuto C, 2007, P NATL ACAD SCI USA, V104, P1461, DOI 10.1073/pnas.0610487104; Cattuto C, 2009, P NATL ACAD SCI USA, V106, P10511, DOI 10.1073/pnas.0901136106; Clauset A, 2008, NATURE, V453, P98, DOI 10.1038/nature06830; Corominas-Murtra B, 2013, ARXIV13032503; Corominas-Murtra B, 2011, CHAOS, V21, DOI 10.1063/1.3562548; Damme C.V., 2007, SOC NETWORKS, V2, P57; Danon L, 2005, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2005/09/P09008; Eguiluz VM, 2005, AM J SOCIOL, V110, P977, DOI 10.1086/428716; Faloutsos M, 1999, COMP COMM R, V29, P251, DOI 10.1145/316194.316229; Finocchiaro G, 2007, NUCLEIC ACIDS RES, V35, P2343, DOI 10.1093/nar/gkm119; Floeck F, 2010, ADV INTEL SOFT COMPU, V76, P75; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; Fred ALN, 2003, PROC CVPR IEEE, P128; Fushing H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017817; Garcia-Molina H., 2006, TECHNICAL REPORT; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Goessmann C, 2000, BEHAV ECOL SOCIOBIOL, V48, P418, DOI 10.1007/s002650000222; Guimera R, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.065103; Holme P, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.056108; IMDb, MOV TV CEL; Jonsson PF, 2006, BIOINFORMATICS, V22, P2291, DOI 10.1093/bioinformatics/btl390; Jonsson PF, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-2; Juszczyszyn K, 2010, STUD COMPUT INTELL, V289, P275; Kossinets G, 2006, SCIENCE, V311, P88, DOI 10.1126/science.1116869; Kozma B, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.016102; Kuncheva LI, 2004, IEEE SYS MAN CYBERN, P1214; Lambiotte R, 2006, LECT NOTES COMPUT SC, V3993, P1114; Lancichinetti A, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.046110; Lancichinetti A, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/3/033015; Lu LY, 2012, PHYS REP, V519, P1, DOI 10.1016/j.physrep.2012.02.006; Ma HW, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-199; Mason O, 2007, IET SYST BIOL, V1, P89, DOI 10.1049/iet-syb:20060038; Mendes J. F. F., 2003, EVOLUTION NETWORKS B; Mika P, 2005, LECT NOTES COMPUT SC, V3729, P522, DOI 10.1007/11574620_38; Mones E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033799; Musial Katarzyna, 2008, Systems Science, V34, P97; Nagy M, 2010, NATURE, V464, P890, DOI 10.1038/nature08891; Palla G, 2005, NATURE, V435, P814, DOI 10.1038/nature03607; Plangprasopchok A., 2011, P 4 ACM WEB SEARCH D; Plangprasopchok A., 2009, P 18 INT C WORLD WID, P781; Pollner P, 2006, EUROPHYS LETT, V73, P478, DOI 10.1209/epl/i2005-10414-6; Pumain D, 2006, METHODS SER, V3, P1, DOI 10.1007/1-4020-4127-6; Ravasz E, 2002, SCIENCE, V297, P1551, DOI 10.1126/science.1073374; Schmitz P., 2006, P COLL WEB TAGG WORK; Spyns P, 2006, P OTM C, P1738; Tibely G, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/5/053009; Trusina A, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.178702; Valverde S, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.046118; Vazquez F, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.108702; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Zhu XW, 2007, GENE DEV, V21, P1010, DOI 10.1101/gad.1528707; Zlatic V, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.036118	59	18	19	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84133	10.1371/journal.pone.0084133	http://dx.doi.org/10.1371/journal.pone.0084133			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391901	Green Published, Green Submitted, gold			2022-12-25	WOS:000329323900044
J	Wahidullah, S; Naik, DN; Devi, P				Wahidullah, Solimabi; Naik, Deepak N.; Devi, Prabha			Fermentation Products of Solvent Tolerant Marine Bacterium Moraxella spp. MB1 and Its Biotechnological Applications in Salicylic Acid Bioconversion	PLOS ONE			English	Article							PHENYLALANINE AMMONIA-LYASE; ESCHERICHIA-COLI; DEGRADATION; PLANT; BIOSYNTHESIS; PATHWAY; HYDROXYBENZOATE; CONSTITUENTS; GENTISATE; ENZYMES	As part of a proactive approach to environmental protection, emerging issues with potential impact on the environment is the subject of ongoing investigation. One emerging area of environmental research concerns pharmaceuticals like salicylic acid, which is the main metabolite of various analgesics including aspirin. It is a common component of sewage effluent and also an intermediate in the degradation pathway of various aromatic compounds which are introduced in the marine environment as pollutants. In this study, biotransformation products of salicylic acid by seaweed, Bryopsis plumosa, associated marine bacterium, Moraxella spp. MB1, have been investigated. Phenol, conjugates of phenol and hydroxy cinnamic acid derivatives (coumaroyl, caffeoyl, feruloyl and trihydroxy cinnamyl) with salicylic acid (3-8) were identified as the bioconversion products by electrospray ionization mass spectrometry. These results show that the microorganism do not degrade phenolic acid but catalyses oxygen dependent transformations without ring cleavage. The degradation of salicylic acid is known to proceed either via gentisic acid pathway or catechol pathway but this is the first report of biotransformation of salicylic acid into cinnamates, without ring cleavage. Besides cinnamic acid derivatives (9-12), metabolites produced by the bacterium include antimicrobial indole (13) and beta-carbolines, norharman (14), harman (15) and methyl derivative (16), which are beneficial to the host and the environment.	[Wahidullah, Solimabi; Naik, Deepak N.; Devi, Prabha] Natl Inst Oceanog, CSIR, Chem Oceanog Div, Bioorgan Chem Lab, Panaji, Goa, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - National Institute of Oceanography (NIO)	Wahidullah, S (corresponding author), Natl Inst Oceanog, CSIR, Chem Oceanog Div, Bioorgan Chem Lab, Panaji, Goa, India.	solima@nio.org			NIO-CSIR	NIO-CSIR(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by NIO-CSIR. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Bae FA, 1998, BIOL PHARM BULL, V21, P990, DOI 10.1248/bpb.21.990; Barnes CC, 2003, J NAT PROD, V66, P1457, DOI 10.1021/np030197j; Berner M, 2006, J BACTERIOL, V188, P2666, DOI 10.1128/JB.188.7.2666-2673.2006; Burt S, 2004, INT J FOOD MICROBIOL, V94, P223, DOI 10.1016/j.ijfoodmicro.2004.03.022; BUSWELL JA, 1980, FEMS MICROBIOL LETT, V8, P135, DOI 10.1016/0378-1097(80)90016-6; Cardoso AM, 1999, EUR MASS SPECTROM, V5, P11, DOI 10.1255/ejms.244; Chalabaev S, 2008, APPL ENVIRON MICROB, V74, P1717, DOI 10.1128/AEM.02589-07; Cheng KC, 2011, APPL MICROBIOL BIOT, V92, P29, DOI 10.1007/s00253-011-3477-y; COHEN SP, 1993, J BACTERIOL, V175, P7856, DOI 10.1128/JB.175.24.7856-7862.1993; CRAWFORD RL, 1976, CAN J MICROBIOL, V22, P276, DOI 10.1139/m76-037; Crouse BA, 2012, ENVIRON RES, V112, P92, DOI 10.1016/j.envres.2011.11.011; Devi P, 2006, MAR BIOTECHNOL, V8, P129, DOI 10.1007/s10126-005-5021-5; Draget KI, 1997, INT J BIOL MACROMOL, V21, P47, DOI 10.1016/S0141-8130(97)00040-8; Fang NB, 2002, J AGR FOOD CHEM, V50, P3579, DOI 10.1021/jf0201327; FINKLE BJ, 1962, J BIOL CHEM, V237, P2926; Gaille C, 2002, J BIOL CHEM, V277, P21768, DOI 10.1074/jbc.M202410200; GOETZ FE, 1992, FEMS MICROBIOL LETT, V97, P45; GREGG K, 1994, BIO-TECHNOL, V12, P1361, DOI 10.1038/nbt1294-1361; GRUND E, 1990, APPL ENVIRON MICROB, V56, P1459, DOI 10.1128/AEM.56.5.1459-1464.1990; Hakkinen S, 2000, THESIS; HARIBABU B, 1984, FEMS MICROBIOL LETT, V21, P197; Henschel KP, 1997, REGUL TOXICOL PHARM, V25, P220, DOI 10.1006/rtph.1997.1102; Hossain MB, 2010, J AGR FOOD CHEM, V58, P10576, DOI 10.1021/jf102042g; Ishiyama D, 2004, APPL ENVIRON MICROB, V70, P1297, DOI 10.1128/AEM.70.3.1297-1306.2004; Jia Yan, 2008, Huanjing Kexue, V29, P756; Jimenez JI, 2002, ENVIRON MICROBIOL, V4, P824, DOI 10.1046/j.1462-2920.2002.00370.x; Karegoudar TB, 2000, J MICROBIOL, V38, P53; Korkina LG, 2007, CELL MOL BIOL, V53, P15, DOI 10.1170/T772; Lemoigne M, 1923, CR HEBD ACAD SCI, V176, P1761; Manohar S., 1995, Indian Journal of Experimental Biology, V33, P353; McIntyre C, 2001, RAPID COMMUN MASS SP, V15, P1974, DOI 10.1002/rcm.452.abs; Crotti AEM, 2010, MOL NUTR FOOD RES, V54, P433, DOI 10.1002/mnfr.200900064; OGINO H, 1994, APPL ENVIRON MICROB, V60, P3884, DOI 10.1128/AEM.60.10.3884-3886.1994; Parveen I, 2011, PHYTOCHEMISTRY, V72, P2376, DOI 10.1016/j.phytochem.2011.08.015; Rani M, 1996, BIOCHEM BIOPH RES CO, V220, P377, DOI 10.1006/bbrc.1996.0413; SHAMSUZZ.KM, 1974, J GEN MICROBIOL, V83, P165, DOI 10.1099/00221287-83-1-165; SPAIN JC, 1979, BIOCHEM BIOPH RES CO, V88, P634, DOI 10.1016/0006-291X(79)92095-3; STEINBUCHEL A, 1995, FEMS MICROBIOL LETT, V128, P219, DOI 10.1016/0378-1097(95)00125-O; STOLZ A, 1993, FEMS MICROBIOL LETT, V108, P219, DOI 10.1111/j.1574-6968.1993.tb06102.x; SUEMORI A, 1995, FEMS MICROBIOL LETT, V125, P31, DOI 10.1111/j.1574-6968.1995.tb07331.x; SUZUKI K, 1981, BIOCHIM BIOPHYS ACTA, V657, P530, DOI 10.1016/0005-2744(81)90337-5; Tao XQ, 2007, PROCESS BIOCHEM, V42, P401, DOI 10.1016/j.procbio.2006.09.018; Travkin VM, 1997, FEBS LETT, V407, P69, DOI 10.1016/S0014-5793(97)00297-4; Wells JE, 2005, APPL ENVIRON MICROB, V71, P7974, DOI 10.1128/AEM.71.12.7974-7979.2005; Williams JS, 2005, MICROBIOL-SGM, V151, P2543, DOI 10.1099/mic.0.28136-0; Xiang LK, 2002, J BIOL CHEM, V277, P32505, DOI 10.1074/jbc.M204171200	46	3	3	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83647	10.1371/journal.pone.0083647	http://dx.doi.org/10.1371/journal.pone.0083647			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391802	Green Published, Green Submitted, gold			2022-12-25	WOS:000329325200100
J	Xiao, X; Yang, JK; Li, RJ; Liu, SF; Xu, YX; Zheng, WL; Yi, Y; Luo, YY; Gong, FJ; Peng, HL; Pei, MF; Deng, MY; Zhang, GS				Xiao, Xiang; Yang, Jingke; Li, Ruijuan; Liu, Sufang; Xu, Yunxiao; Zheng, Wenli; Yi, Yan; Luo, Yunya; Gong, Fanjie; Peng, Honglin; Pei, Minfei; Deng, Mingyang; Zhang, Guangsen			Deregulation of Mitochondrial ATPsyn-beta in Acute Myeloid Leukemia Cells and with Increased Drug Resistance	PLOS ONE			English	Article							BIOENERGETIC SIGNATURE; CANCER-CELLS; OXIDATIVE-PHOSPHORYLATION; DOWN-REGULATION; PROTEIN MRP; LUNG; METABOLISM; EXPRESSION; DIAGNOSIS; SYNTHASE	The mechanisms underlying the development of multidrug resistance in acute myeloid leukemia are not fully understood. Here we analyzed the expressions of mitochondrial ATPsyn-beta in adriamycin-resistant cell line HL-60/ADM and its parental cell line HL-60. Meanwhile we compared the differences of mitochondrial ATPsyn-beta expression and ATP synthase activity in 110 acute myeloid leukemia (AML, non-M3) patients between relapsed/refractory and those in remission. Our results showed that down-regulation of ATPsyn-beta expression by siRNA in HL-60 cells increased cell viability and apoptotic resistance to adriamycin, while up-regulation of mitochondrial ATPsyn-beta in HL-60/ADM cells enhanced cell sensitivity to adriamycin and promoted apoptosis. Mitochondrial ATPsyn-beta expression and ATP synthase activity in relapsed/refractory acute myeloid leukemia patients were downregulated. This downregulated ATPsyn-beta expression exhibited a positive correlation with the response to adriamycin of primary cells. A lower expression of ATPsyn-beta in newly diagnosed or relapsed/refractory patients was associated with a shorter first remission duration or overall survival. Our findings show mitochondrial ATPsyn-beta plays an important role in the mechanism of multidrug resistance in AML thus may present both a new marker for prognosis assessment and a new target for reversing drug resistance.	[Xiao, Xiang; Yang, Jingke; Li, Ruijuan; Liu, Sufang; Xu, Yunxiao; Zheng, Wenli; Yi, Yan; Luo, Yunya; Gong, Fanjie; Peng, Honglin; Pei, Minfei; Deng, Mingyang; Zhang, Guangsen] Cent S Univ, Xiangya Hosp 2, Inst Mol Hematol, Div Hematol, Changsha, Hunan, Peoples R China	Central South University	Zhang, GS (corresponding author), Cent S Univ, Xiangya Hosp 2, Inst Mol Hematol, Div Hematol, Changsha, Hunan, Peoples R China.	zgsllzy@163.com	Yang, Jingke/ABH-8787-2020; xiao, xiang/GWU-6035-2022		Doctor training foundation of Ministry of Education of P.R of China; Scientific Research Program for Public Interests from Health Ministry of China [201202017]; Clinical Research Program from Health Ministry of China	Doctor training foundation of Ministry of Education of P.R of China; Scientific Research Program for Public Interests from Health Ministry of China; Clinical Research Program from Health Ministry of China	This study was supported by Doctor training foundation of Ministry of Education of P.R of China (2010-2012), Scientific Research Program for Public Interests from The Health Ministry of China (No: 201202017) and Clinical Research Program from Health Ministry of China (key project 2011-2014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldea M, 2011, CANCER LETT, V311, P210, DOI 10.1016/j.canlet.2011.07.022; ARBER DA, 2008, ACUTE MYELOID LEUKEM; Boyer PD, 1997, ANNU REV BIOCHEM, V66, P717, DOI 10.1146/annurev.biochem.66.1.717; Cheson BD, 2003, J CLIN ONCOL, V21, P4642, DOI 10.1200/JCO.2003.04.036; Chevallier P, 2011, LEUKEMIA, V25, P939, DOI 10.1038/leu.2011.25; Chonghaile TN, 2011, SCIENCE, V334, P1129, DOI 10.1126/science.1206727; COLE SPC, 1992, SCIENCE, V258, P1650, DOI 10.1126/science.1360704; Cuezva JM, 2004, CARCINOGENESIS, V25, P1157, DOI 10.1093/carcin/bgh113; Cuezva JM, 2002, CANCER RES, V62, P6674; Cuezva JM, 2009, BBA-MOL BASIS DIS, V1792, P1145, DOI 10.1016/j.bbadis.2009.01.006; Dey R, 2000, J BIOL CHEM, V275, P7087, DOI 10.1074/jbc.275.10.7087; Dohner H, 2010, BLOOD, V115, P453, DOI 10.1182/blood-2009-07-235358; Formentini L, 2012, MOL CELL, V45, P731, DOI 10.1016/j.molcel.2012.01.008; Formentini L, 2010, IUBMB LIFE, V62, P554, DOI 10.1002/iub.352; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Harris MH, 2000, MOL CELL BIOL, V20, P3590, DOI 10.1128/MCB.20.10.3590-3596.2000; Harris NL, 1999, ANN ONCOL, V10, P1419, DOI 10.1023/A:1008375931236; He SM, 2011, CURR MED CHEM, V18, P439, DOI 10.2174/092986711794839197; Hernlund E, 2008, INT J CANCER, V123, P476, DOI 10.1002/ijc.23525; Hernlund E, 2009, MOL CANCER THER, V8, P1916, DOI 10.1158/1535-7163.MCT-09-0179; Isidoro A, 2005, CARCINOGENESIS, V26, P2095, DOI 10.1093/carcin/bgi188; Isidoro A, 2004, BIOCHEM J, V378, P17, DOI 10.1042/BJ20031541; Kroemer G, 2008, CANCER CELL, V13, P472, DOI 10.1016/j.ccr.2008.05.005; Leith CP, 1997, BLOOD, V89, P3323; Li RJ, 2010, ANN ONCOL, V21, P1506, DOI 10.1093/annonc/mdp569; Lin PC, 2008, INT J COLORECTAL DIS, V23, P1223, DOI 10.1007/s00384-008-0539-4; Lopez-Rios F, 2007, CANCER RES, V67, P9013, DOI 10.1158/0008-5472.CAN-07-1678; Lowenberg B, 1999, NEW ENGL J MED, V341, P1051, DOI 10.1056/NEJM199909303411407; Matsuyama S, 1998, MOL CELL, V1, P327, DOI 10.1016/S1097-2765(00)80033-7; Milligan DW, 2006, BRIT J HAEMATOL, V135, P450, DOI 10.1111/j.1365-2141.2006.06314.x; Oguri T, 1998, BRIT J CANCER, V77, P1089, DOI 10.1038/bjc.1998.181; Ortega AD, 2005, NEW FRONTIERS IN MITOCHONDRIAL BIOGENESIS AND DISEASE 2005, P111; Ortega AD, 2008, CARCINOGENESIS, V29, P2053, DOI 10.1093/carcin/bgn185; Pelicano H, 2006, ONCOGENE, V25, P4633, DOI 10.1038/sj.onc.1209597; Sanchez-Arago M, 2010, CARCINOGENESIS, V31, P567, DOI 10.1093/carcin/bgq012; Sanchez-Cenizo L, 2010, J BIOL CHEM, V285, P25308, DOI 10.1074/jbc.M110.146480; SANCHEZARAGO M, 2012, ANTIOXID REDOX SIGN; SANCHEZARAGO M, 2011, BIOENERGTIC SINGA T; Santamaria G, 2006, CARCINOGENESIS, V27, P925, DOI 10.1093/carcin/bgi315; Schulz TJ, 2006, J BIOL CHEM, V281, P977, DOI 10.1074/jbc.M511064200; Shin YK, 2005, CANCER RES, V65, P3162, DOI 10.1158/0008-5472.CAN-04-3300; SLAPAK CA, 1994, CANCER RES, V54, P5607; Tennant DA, 2010, NAT REV CANCER, V10, P267, DOI 10.1038/nrc2817; Wang XD, 2001, GENE DEV, V15, P2922; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; WARBURG O, 1930, METABOLISM TUMORS; Willers IM, 2011, BBA-BIOENERGETICS, V1807, P543, DOI 10.1016/j.bbabio.2010.10.016	47	16	18	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83610	10.1371/journal.pone.0083610	http://dx.doi.org/10.1371/journal.pone.0083610			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391795	Green Published, Green Submitted, gold			2022-12-25	WOS:000329325200092
J	Cai, Y; Futcher, B				Cai, Ying; Futcher, Bruce			Effects of the Yeast RNA-Binding Protein Whi3 on the Half-Life and Abundance of CLN3 mRNA and Other Targets	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; BUDDING YEAST; CYCLIN CLN3; P-BODIES; IN-VIVO; SUBCELLULAR-LOCALIZATION; CLN3-CDC28 KINASE; CELL-DIVISION; LATE G1; GENE	Whi3 is an RNA binding protein known to bind the mRNA of the yeast G1 cyclin gene CLN3. It inhibits CLN3 function, but the mechanism of this inhibition is unclear; in previous studies, Whi3 made no observable difference to CLN3 mRNA levels, translation, or protein abundance. Here, we re-approach this issue using microarrays, RNA-Seq, ribosome profiling, and other methods. By multiple methods, we find that the whi3 mutation causes a small but consistent increase in the abundance of hundreds of mRNAs, including the CLN3 mRNA. The effect on various mRNAs is roughly in proportion to the density of GCAU or UGCAU motifs carried by these mRNAs, which may be a binding site for Whi3. mRNA instability of Whi3 targets may in part depend on a 3' AU rich element (ARE), AUUUUA. In addition, the whi3 mutation causes a small increase in the translational efficiency of CLN3 mRNA. The increase in CLN3 mRNA half-life and abundance together with the increase in translational efficiency is fully sufficient to explain the small-cell phenotype of whi3 mutants. Under stress conditions, Whi3 becomes a component of P-bodies or stress granules, but Whi3 also acts under non-stress condition, when no P-bodies are visible. We suggest that Whi3 may be a very broadly-acting, but mild, modulator of mRNA stability. In CLN3, Whi3 may bind to the 3' GCAU motifs to attract the Ccr4-Not complex to promote RNA deadenylation and turnover, and Whi3 may bind to the 5' GCAU motifs to inhibit translation.	[Cai, Ying; Futcher, Bruce] SUNY Stony Brook, Dept Mol Genet & Microbiol, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Futcher, B (corresponding author), SUNY Stony Brook, Dept Mol Genet & Microbiol, Stony Brook, NY 11794 USA.	bfutcher@gmail.com			National Institutes of Health [RO1 GM039978-25]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM039978] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is supported by National Institutes of Health grants RO1 GM039978-25 Size Control and Commitment to Division in S. cerevisiae (http://http://www.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beckham C, 2008, MOL BIOL CELL, V19, P984, DOI 10.1091/mbc.E07-09-0954; Brar GA, 2012, SCIENCE, V335, P552, DOI 10.1126/science.1215110; Buchan JR, 2008, J CELL BIOL, V183, P441, DOI 10.1083/jcb.200807043; Buchan JR, 2009, MOL CELL, V36, P932, DOI 10.1016/j.molcel.2009.11.020; Budovskaya YV, 2005, P NATL ACAD SCI USA, V102, P13933, DOI 10.1073/pnas.0501046102; Chen HM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026804; Collart MA, 2012, GENE, V492, P42, DOI 10.1016/j.gene.2011.09.033; Colomina N, 2008, J BIOL CHEM, V283, P28670, DOI 10.1074/jbc.M804604200; Dunckley T, 1999, EMBO J, V18, P5411, DOI 10.1093/emboj/18.19.5411; Elemento O, 2007, MOL CELL, V28, P337, DOI 10.1016/j.molcel.2007.09.027; Gallego C, 1997, EMBO J, V16, P7196, DOI 10.1093/emboj/16.23.7196; Gari E, 2001, GENE DEV, V15, P2803; GILLIS P, 1991, J BIOL CHEM, V266, P3172; Gu W, 2004, GENE DEV, V18, P1452, DOI 10.1101/gad.1189004; Haim L, 2007, NAT METHODS, V4, P409, DOI 10.1038/NMETH1040; Hall DD, 1998, EMBO J, V17, P4370, DOI 10.1093/emboj/17.15.4370; HSU CL, 1993, MOL CELL BIOL, V13, P4826, DOI 10.1128/MCB.13.8.4826; Ingolia NT, 2012, NAT PROTOC, V7, P1534, DOI 10.1038/nprot.2012.086; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Kertesz M, 2010, NATURE, V467, P103, DOI 10.1038/nature09322; Kshirsagar M, 2004, GENETICS, V166, P729, DOI 10.1534/genetics.166.2.729; Laabs TL, 2003, P NATL ACAD SCI USA, V100, P10275, DOI 10.1073/pnas.1833999100; LARIMER FW, 1990, GENE, V95, P85, DOI 10.1016/0378-1119(90)90417-P; Lee C, 2013, DEV CELL, V25, P572, DOI 10.1016/j.devcel.2013.05.007; Lockshon D, 2007, GENETICS, V175, P77, DOI 10.1534/genetics.106.064428; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Malcher M, 2011, GENETICS, V187, P717, DOI 10.1534/genetics.110.125708; MALTER JS, 1990, ENZYME, V44, P203, DOI 10.1159/000468758; Miller ME, 2000, MOL CELL BIOL, V20, P542, DOI 10.1128/MCB.20.2.542-555.2000; Miller ME, 2001, MOL CELL BIOL, V21, P6292, DOI 10.1128/MCB.21.18.6292-6311.2001; Mizunuma M, 2013, J BIOL CHEM, V288, P10558, DOI 10.1074/jbc.M112.402214; MUHLRAD D, 1994, GENE DEV, V8, P855, DOI 10.1101/gad.8.7.855; MUHLRAD D, 1995, MOL CELL BIOL, V15, P2145; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; NASH R, 1988, EMBO J, V7, P4335, DOI 10.1002/j.1460-2075.1988.tb03332.x; Nash RS, 2001, GENETICS, V157, P1469; Nissan T, 2008, METHOD ENZYMOL, V448, P507, DOI 10.1016/S0076-6879(08)02625-6; Polymenis M, 1997, GENE DEV, V11, P2522, DOI 10.1101/gad.11.19.2522; Reijns MAM, 2008, J CELL SCI, V121, P2463, DOI 10.1242/jcs.024976; Riordan DP, 2011, NUCLEIC ACIDS RES, V39, P1501, DOI 10.1093/nar/gkq920; SALLES FJ, 1995, PCR METH APPL, V4, P317; Salles FJ, 1999, METH MOL B, V118, P441; Santoso A, 2000, CELL, V100, P277, DOI 10.1016/S0092-8674(00)81565-2; Schneider BL, 2004, MOL CELL BIOL, V24, P10802, DOI 10.1128/MCB.24.24.10802-10813.2004; Sengupta DJ, 1999, RNA, V5, P596, DOI 10.1017/S1355838299002113; Shah KH, 2013, GENETICS, V193, P109, DOI 10.1534/genetics.112.146993; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Swisher KD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010006; Tarassov K, 2008, SCIENCE, V320, P1465, DOI 10.1126/science.1153878; Teixeira D, 2005, RNA, V11, P371, DOI 10.1261/rna.7258505; Tucker M, 2000, ANNU REV BIOCHEM, V69, P571, DOI 10.1146/annurev.biochem.69.1.571; Tucker M, 2002, EMBO J, V21, P1427, DOI 10.1093/emboj/21.6.1427; Tucker M, 2001, CELL, V104, P377, DOI 10.1016/S0092-8674(01)00225-2; TYERS M, 1991, COLD SH Q B, V56, P21; TYERS M, 1992, EMBO J, V11, P1773, DOI 10.1002/j.1460-2075.1992.tb05229.x; Vasudevan S, 2001, MOL CELL, V7, P1191, DOI 10.1016/S1097-2765(01)00279-9; Verges E, 2007, MOL CELL, V26, P649, DOI 10.1016/j.molcel.2007.04.023; Wahle E, 2013, BBA-GENE REGUL MECH, V1829, P561, DOI 10.1016/j.bbagrm.2013.01.003; Wang HY, 2004, EMBO J, V23, P180, DOI 10.1038/sj.emboj.7600022; Wiederhold K, 2010, BIOCHEM SOC T, V38, P1531, DOI 10.1042/BST0381531	61	26	27	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e84630	10.1371/journal.pone.0084630	http://dx.doi.org/10.1371/journal.pone.0084630			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386402	gold, Green Published, Green Submitted			2022-12-25	WOS:000329194700114
J	Casas, L; Szucs, R; Vij, S; Goh, CH; Kathiresan, P; Nemeth, S; Jeney, Z; Bercsenyi, M; Orban, L				Casas, Laura; Szucs, Reka; Vij, Shubha; Goh, Chin Heng; Kathiresan, Purushothaman; Nemeth, Sandor; Jeney, Zsigmond; Bercsenyi, Miklos; Orban, Laszlo			Disappearing Scales in Carps: Re-Visiting Kirpichnikov's Model on the Genetics of Scale Pattern Formation	PLOS ONE			English	Article							COMMON CARP; CYPRINUS-CARPIO; LINKAGE MAP; SADDLEBACK-SYNDROME; COVER PATTERN; ZEBRAFISH; LINE; L.; WILD; MICROSATELLITE	The body of most fishes is fully covered by scales that typically form tight, partially overlapping rows. While some of the genes controlling the formation and growth of fish scales have been studied, very little is known about the genetic mechanisms regulating scale pattern formation. Although the existence of two genes with two pairs of alleles (S&s and N&n) regulating scale coverage in cyprinids has been predicted by Kirpichnikov and colleagues nearly eighty years ago, their identity was unknown until recently. In 2009, the 'S' gene was found to be a paralog of fibroblast growth factor receptor 1, fgfr1a1, while the second gene called 'N' has not yet been identified. We re-visited the original model of Kirpichnikov that proposed four major scale pattern types and observed a high degree of variation within the so-called scattered phenotype due to which this group was divided into two sub-types: classical mirror and irregular. We also analyzed the survival rates of offspring groups and found a distinct difference between Asian and European crosses. Whereas nude 6 nude crosses involving at least one parent of Asian origin or hybrid with Asian parent(s) showed the 25% early lethality predicted by Kirpichnikov (due to the lethality of the NN genotype), those with two Hungarian nude parents did not. We further extended Kirpichnikov's work by correlating changes in phenotype (scale-pattern) to the deformations of fins and losses of pharyngeal teeth. We observed phenotypic changes which were not restricted to nudes, as described by Kirpichnikov, but were also present in mirrors (and presumably in linears as well; not analyzed in detail here). We propose that the gradation of phenotypes observed within the scattered group is caused by a gradually decreasing level of signaling (a dose-dependent effect) probably due to a concerted action of multiple pathways involved in scale formation.	[Casas, Laura; Vij, Shubha; Kathiresan, Purushothaman; Orban, Laszlo] Temasek Life Sci Lab, Strateg Res Program, Reprod Genom Grp, Singapore, Singapore; [Szucs, Reka; Nemeth, Sandor; Bercsenyi, Miklos; Orban, Laszlo] Univ Pannonia, Georgikon Fac, Dept Anim Sci & Anim Husb, Keszthely, Hungary; [Goh, Chin Heng] Temasek Life Sci Lab, Fish Facil, Singapore, Singapore; [Jeney, Zsigmond] Res Inst Fisheries Aquaculture & Irrigat, Szarvas, Hungary; [Orban, Laszlo] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore	University of Pannonia; National University of Singapore	Bercsenyi, M (corresponding author), Univ Pannonia, Georgikon Fac, Dept Anim Sci & Anim Husb, Keszthely, Hungary.	bm@georgikon.hu; laszlo@tll.org.sg	Orbán, László/A-3030-2009; Casas, Laura/G-9347-2015	Orbán, László/0000-0001-5435-5948; Casas, Laura/0000-0001-6617-8731	Galician Government (Xunta de Galicia, Spain); Strategic Research Program of Temasek Life Sciences Laboratory; National Research Foundation of Hungary [OTKA-K-77681]	Galician Government (Xunta de Galicia, Spain)(Xunta de Galicia); Strategic Research Program of Temasek Life Sciences Laboratory(National University of Singapore); National Research Foundation of Hungary	This work was supported by: 1. Galician Government (Xunta de Galicia, Spain), 2. Internal funds from the Strategic Research Program of Temasek Life Sciences Laboratory, 3. National Research Foundation of Hungary (OTKA-K-77681). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe G, 2007, DEV BIOL, V304, P355, DOI 10.1016/j.ydbio.2006.12.040; Balon EK, 2004, J FISH BIOL, V65, P1, DOI 10.1111/j.0022-1112.2004.00563.x; BALON EK, 1995, AQUACULTURE, V129, P3, DOI 10.1016/0044-8486(94)00227-F; Bercsenyi M., 2011, Allattenyesztes es Takarmanyozas, V60, P267; Cheng L, 2010, ANIM GENET, V41, P191, DOI 10.1111/j.1365-2052.2009.01985.x; Christoffels A, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S5-S2; Colosimo PF, 2005, SCIENCE, V307, P1928, DOI 10.1126/science.1107239; Czuczka P, 2002, STUDIES INHERITANCE, P1; Diggles BK, 2013, J FISH DIS, V36, P521, DOI 10.1111/jfd.12021; Drew CF, 2007, DEV BIOL, V305, P232, DOI 10.1016/j.ydbio.2007.02.011; Froufe E, 2002, J FISH BIOL, V61, P301, DOI [10.1006/jfbi.2002.2046, 10.1111/j.1095-8649.2002.tb01756.x]; Gallardo VE, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-120; Gibert Y, 2010, FASEB J, V24, P3298, DOI 10.1096/fj.09-147488; Gomelsky B, 2012, J FISH BIOL, V81, P1201, DOI 10.1111/j.1095-8649.2012.03398.x; GOMELSKY BI, 1992, AQUACULTURE, V106, P233, DOI 10.1016/0044-8486(92)90255-J; Harris MP, 2012, J APPL ICHTHYOL, V28, P306, DOI 10.1111/j.1439-0426.2012.01999.x; Harris MP, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000206; Haworth KE, 2007, DEV BIOL, V303, P244, DOI 10.1016/j.ydbio.2006.11.009; Henkel CV, 2012, ZEBRAFISH, V9, P59, DOI 10.1089/zeb.2012.0773; HORVATH L, 1984, SPECIAL METHODS POND, P1; Houghton L, 2005, DEVELOPMENT, V132, P863, DOI 10.1242/dev.01651; Ji PF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035152; Kangas AT, 2004, NATURE, V432, P211, DOI 10.1038/nature02927; Kirpichnikov V. S., 1936, Biol J Moscow, V5, P327; Kirpichnikov V. S., 1967, GENETIKA, V8, P65; Kirpichnikov VS, 1981, GENETIC BASES FISH S, P1; KIRPICNIKOV V. S., 1935, Zoologicheskii Zhurnal, V14, P45; Kirpitchnikov Valentin S., 1999, P1; Kohlmann K, 2005, AQUACULTURE, V247, P253, DOI 10.1016/j.aquaculture.2005.02.024; Kohlmann K, 2003, AQUAT LIVING RESOUR, V16, P421, DOI 10.1016/S0990-7440(03)00082-2; Komen J, 1990, CLONES COMMON CARP C, P1; Kondo S, 2001, CURR BIOL, V11, P1202, DOI 10.1016/S0960-9822(01)00324-4; Koumoundouros G, 2008, J FISH BIOL, V72, P737, DOI 10.1111/j.1095-8649.2007.01714.x; Ma EY, 2009, CURR BIOL, V19, pR381, DOI 10.1016/j.cub.2009.03.057; McGraw HF, 2011, DEVELOPMENT, V138, P3921, DOI 10.1242/dev.062554; Memis D, 2006, AQUACULTURE, V258, P257, DOI 10.1016/j.aquaculture.2006.03.041; Michaels VK, 1998, CARP FARMING, P1; Mikkola ML, 2003, CYTOKINE GROWTH F R, V14, P211, DOI 10.1016/S1359-6101(03)00020-0; Moav R, 1963, ISR J AQUACULTURE BA, V15, P3; MORRISON C, 1981, J FISH DIS, V4, P243, DOI 10.1111/j.1365-2761.1981.tb01131.x; Mou C, 2006, P NATL ACAD SCI USA, V103, P9075, DOI 10.1073/pnas.0600825103; Nicolescu C, 2004, B U AGR MED VET ZOOT, V60, P78; Orban Laszlo, 2008, V2, P45, DOI 10.1007/978-3-540-73837-4_2; Ortubay S, 2000, ENVIRON BIOL FISH, V58, P144, DOI 10.1023/A:1007694308513; Poss FD, 2000, DEV BIOL, V222, P347, DOI 10.1006/dbio.2000.9722; Prykhozhij SV, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-91; Purdom CE, 1993, GENETICS FISH BREEDI, P1; Rohner N, 2009, CURR BIOL, V19, P1642, DOI 10.1016/j.cub.2009.07.065; Rudzinsky E, 1928, FISCHEREI Z, V31, P613; Rudzinsky E, 1928, FISCH ZTG, V30, P593; Sarrazin AF, 2010, J NEUROSCI, V30, P8234, DOI 10.1523/JNEUROSCI.5137-09.2010; Seritrakul P, 2012, FASEB J, V26, P5014, DOI 10.1096/fj.12-209304; Setiadi E, 2006, J APPL ICHTHYOL, V22, P49, DOI 10.1111/j.1439-0426.2006.00524.x; Stoick-Cooper CL, 2007, GENE DEV, V21, P1292, DOI 10.1101/gad.1540507; TAVE D, 1983, J FISH DIS, V6, P59, DOI 10.1111/j.1365-2761.1983.tb00051.x; Tave D, 1993, GENETICS FISH HATCHE, P1; Tucker AS, 2004, DEV BIOL, V268, P185, DOI 10.1016/j.ydbio.2003.12.019; Wells KL, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-257; Williams DR, 2008, J FISH BIOL, V72, P2095, DOI 10.1111/j.1095-8649.2008.01875.x; Woynarovich E, 1962, ISR J AQUACULT-BAMID, V4, P38; Yokoi H, 2007, DEV BIOL, V304, P326, DOI 10.1016/j.ydbio.2006.12.043; Zhang XF, 2013, MAR BIOTECHNOL, V15, P275, DOI 10.1007/s10126-012-9485-9; Zheng XH, 2011, MOL GENET GENOMICS, V286, P261, DOI 10.1007/s00438-011-0644-x; Zhou J, 2004, J ZOOL SYST EVOL RES, V42, P266, DOI 10.1111/j.1439-0469.2004.00266.x; Zhou JF, 2003, CHINESE SCI BULL, V48, P465, DOI 10.1360/03tb9098	65	6	6	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e83327	10.1371/journal.pone.0083327	http://dx.doi.org/10.1371/journal.pone.0083327			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386179	Green Published, gold, Green Submitted			2022-12-25	WOS:000329194700033
J	Wang, S; Feng, QH; Han, XD				Wang, Sen; Feng, Qihong; Han, Xiaodong			A Hybrid Analytical/Numerical Model for the Characterization of Preferential Flow Path with Non-Darcy Flow	PLOS ONE			English	Article							FLUID-FLOW; INTERWELL CONNECTIVITY; SANDSTONE; RESERVOIRS; WELL; OPTIMIZATION; IDENTIFICATION; PERMEABILITY; COEFFICIENTS; FRACTURE	Due to the long-term fluid-solid interactions in waterflooding, the tremendous variation of oil reservoir formation parameters will lead to the widespread evolution of preferential flow paths, thereby preventing the further enhancement of recovery efficiency because of unstable fingering and premature breakthrough. To improve oil recovery, the characterization of preferential flow paths is essential and imperative. In efforts that have been previously documented, fluid flow characteristics within preferential paths are assumed to obey Darcy's equation. However, the occurrence of non-Darcy flow behavior has been increasingly suggested. To examine this conjecture, the Forchheimer number with the inertial coefficient estimated from different empirical formulas is applied as the criterion. Considering a 10% non-Darcy effect, the fluid flow in a preferential path may do experience non-Darcy behavior. With the objective of characterizing the preferential path with non-Darcy flow, a hybrid analytical/numerical model has been developed to investigate the pressure transient response, which dynamically couples a numerical model describing the non-Darcy effect of a preferential flow path with an analytical reservoir model. The characteristics of the pressure transient behavior and the sensitivities of corresponding parameters have also been discussed. In addition, an interpretation approach for pressure transient testing is also proposed, in which the Gravitational Search Algorithm is employed as a non-linear regression technology to match measured pressure with this hybrid model. Examples of applications from different oilfields are also presented to illustrate this method. This cost-effective approach provides more accurate characterization of a preferential flow path with non-Darcy flow, which will lay a solid foundation for the design and operation of conformance control treatments, as well as several other Enhanced Oil Recovery projects.	[Wang, Sen; Feng, Qihong; Han, Xiaodong] China Univ Petr East China, Dept Petr Engn, Qingdao, Peoples R China	China University of Petroleum	Wang, S (corresponding author), China Univ Petr East China, Dept Petr Engn, Qingdao, Peoples R China.	fwforest@gmail.com	Wang, Sen/K-8834-2012; han, xiao/HDN-9782-2022	Wang, Sen/0000-0003-2472-6204; 	Fundamental Research Funds for the Central Universities [13CX06028A]	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work is supported by the Fundamental Research Funds for the Central Universities (13CX06028A). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGARWAL RG, 1970, SOC PETROL ENG J, V10, P279, DOI 10.2118/2466-PA; Ahmed T.H., 2005, ADV RESERVOIR ENG; Al-Gosayir M, 2012, J PETROL SCI ENG, V98-99, P61, DOI 10.1016/j.petrol.2012.09.008; Al-Kobaisi M, 2006, SPE RESERV EVAL ENG, V9, P345, DOI 10.2118/92040-PA; Albertoni A, 2003, SPE RESERV EVAL ENG, V6, P6, DOI 10.2118/83381-PA; Andrade JS, 1999, PHYS REV LETT, V82, P5249, DOI 10.1103/PhysRevLett.82.5249; [Anonymous], 1957, J PETROL TECHNOL, DOI DOI 10.2118/741-G; [Anonymous], RES C FLOW NAT GAS R; Bane RK, 1994, PERML BAS OIL GAS RE; Bear J., 2013, DYNAMICS FLUIDS PORO; Behrang MA, 2011, ENERGY, V36, P5649, DOI 10.1016/j.energy.2011.07.002; Belhaj HA, 2003, SPE LAT AM CAR PETR; BEVC D, 1991, GEOPHYSICS, V56, P769, DOI 10.1190/1.1443094; Blick E.F., 1988, SPE RESERV ENG, V3, P1048, DOI [10.2118/16202-PA, DOI 10.2118/16202-PA]; BRIGHAM WE, 1987, J PETROL TECHNOL, V39, P519, DOI 10.2118/14102-PA; Chai ZH, 2010, COMPUT FLUIDS, V39, P2069, DOI 10.1016/j.compfluid.2010.07.012; Chatterjee A., 2010, Progress In Electromagnetics Research B, V25, P331, DOI 10.2528/PIERB10080405; [陈程 Chen Cheng], 2012, [石油学报, Acta Petrolei Sinica], V33, P257; Chen D, 2011, SPE ENH OIL REC C KU; Chilton TH, 1931, IND ENG CHEM, V23, P913, DOI 10.1021/ie50260a016; Chukwudozie CP, 2012, TRANSPORT POROUS MED, V95, P563, DOI 10.1007/s11242-012-0062-5; CINCOLEY H, 1981, J PETROL TECHNOL, V33, P1749, DOI 10.2118/7490-PA; Coles ME, 1998, SPE GAS TECHN S CALG, DOI 10.2118/39977-MS; Colon CFJ, 2004, GEOCHIM COSMOCHIM AC, V68, P805, DOI 10.1016/j.gca.2003.06.002; Comiti J, 2000, CHEM ENG SCI, V55, P3057, DOI 10.1016/S0009-2509(99)00556-4; Cui C., 2009, J OIL GAS TECHNOL, V31, P122; DATTAGUPTA A, 1995, SPE FORMATION EVAL, V10, P40, DOI 10.2118/24139-PA; Dinges D.D., 1988, SPE FORMATION EVAL, V3, P743, DOI DOI 10.2118/15582-PA; Dorigo M, 1996, IEEE T SYST MAN CY B, V26, P29, DOI 10.1109/3477.484436; Duman S, 2012, ENERG CONVERS MANAGE, V59, P86, DOI 10.1016/j.enconman.2012.02.024; DUPLESSIS JP, 1988, TRANSPORT POROUS MED, V3, P145, DOI 10.1007/BF00820342; Dybbs A., 1984, FUNDAMENTALS TRANSPO, V82, P199, DOI DOI 10.1007/978-94-009-6175-3_4; Ehlig-Economides C. A., 1987, SPE FORM EVAL, V2, P261, DOI DOI 10.2118/14167-PA; Eldos T, 2013, INT J ADV COMPUT SC, V4, P74; Engler TW, 2001, SPE W REG M BAK CAL; ERGUN S, 1952, CHEM ENG PROG, V48, P89; Ezulike O, 2012, J PETROL SCI ENG, V96-97, P120, DOI 10.1016/j.petrol.2012.09.002; Fancher GH, 1933, IND ENG CHEM, V25, P1139, DOI 10.1021/ie50286a020; Fattahpour V, 2012, J PETROL SCI ENG, V86-87, P172, DOI 10.1016/j.petrol.2012.03.023; Feng QH, 2013, J PETROL SCI ENG, V110, P55, DOI 10.1016/j.petrol.2013.08.042; Feng QH, 2010, J PETROL SCI ENG, V75, P13, DOI 10.1016/j.petrol.2010.10.005; Forchheimer P, 1901, Z VER DTSCH ING, V45, P1782; Fourar M, 2004, ADV WATER RESOUR, V27, P669, DOI 10.1016/j.advwatres.2004.02.021; Friedel T, 2006, J PETROL SCI ENG, V54, P112, DOI 10.1016/j.petrol.2006.07.002; Gao N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062156; Garrouch AA, 2001, TRANSPORT POROUS MED, V44, P487, DOI 10.1023/A:1010671012287; GEERTSMA J, 1974, SOC PETROL ENG J, V14, P445, DOI 10.2118/4706-PA; Ghahri P, 2012, FUEL, V97, P24, DOI 10.1016/j.fuel.2012.03.030; GREEN L, 1951, J APPL MECH-T ASME, V18, P39; GRINGARTEN AC, 1974, SOC PETROL ENG J, V14, P413, DOI 10.2118/3819-PA; GRINGARTEN AC, 1973, SOC PETROL ENG J, V13, P285, DOI 10.2118/3818-PA; GUPPY KH, 1981, SOC PETROL ENG J, V21, P390, DOI 10.2118/9344-PA; GUPPY KH, 1982, SOC PETROL ENG J, V22, P681, DOI 10.2118/8281-PA; Hajizadeh Y, 2011, J PETROL SCI ENG, V77, P78, DOI 10.1016/j.petrol.2011.02.005; Halliday D., 2013, FUNDAMENTALS PHYS, VTenth; Hamadneh N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066080; Horne RN, 1990, MODERN WELL TEST ANA; Jones S.C., 1987, SPE ANN TECHN C EXH, P10; Kaviani D, 2012, J PETROL SCI ENG, V90-91, P79, DOI 10.1016/j.petrol.2012.04.008; Kennedy J, 1995, 1995 IEEE INTERNATIONAL CONFERENCE ON NEURAL NETWORKS PROCEEDINGS, VOLS 1-6, P1942, DOI 10.1109/icnn.1995.488968; KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671; Kuchuk F.J., 2010, PRESSURE TRANSIENT F; Li B, 2008, ANN TECHN C EXH DENV; Li CS, 2011, ENERG CONVERS MANAGE, V52, P374, DOI 10.1016/j.enconman.2010.07.012; Li Shuxia, 1994, J U PETROLEUM CHIN S, V18, P1; Li XT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051199; Liu R, 2010, PETROL GEOL OILFIELD, V29, P65; Liu X, 2005, INT THERM OP HEAV OI; Liu YZ, 2010, OIL GAS SCI TECHNOL, V65, P859, DOI 10.2516/ogst/2009057; MA H, 1993, TRANSPORT POROUS MED, V13, P139, DOI 10.1007/BF00654407; MACDONALD IF, 1979, IND ENG CHEM FUND, V18, P199, DOI 10.1021/i160071a001; Macini P, 2011, J PETROL SCI ENG, V77, P365, DOI 10.1016/j.petrol.2011.04.016; Mahdiyar H, 2011, J PETROL SCI ENG, V78, P149, DOI 10.1016/j.petrol.2011.05.013; Newman M.S, 2011, SPE ANN TECHN C EXH SPE ANN TECHN C EXH; Ozkan E., 1989, SPE CAL REG M VENT C, V4, P567, DOI DOI 10.2118/16378-PA; Ozkan E., 1995, SPE ADV TECHNOLOGY, V3, P85, DOI DOI 10.2118/24683-PA; Pascal H., 1980, P SPE ANN TECHN C EX, DOI [10.2118/9348-MS.SPE-9348-MS, DOI 10.2118/9348-MS.SPE-9348-MS]; Perera MSA, 2011, FUEL, V90, P547, DOI 10.1016/j.fuel.2010.09.029; Rashedi E, 2009, INFORM SCIENCES, V179, P2232, DOI 10.1016/j.ins.2009.03.004; Samaniego-V F, 1977, SPE ANN TECHN C EXH; Sayarpour M, 2009, J PETROL SCI ENG, V69, P227, DOI 10.1016/j.petrol.2009.09.006; Scheidegger A. E., 1974, PHYS FLOW POROUS MED; Shaw B, 2014, INT J ELEC POWER, V55, P29, DOI 10.1016/j.ijepes.2013.08.010; Smith DH, 1965, FIELD EVALUATION WAT; Stanley HE, 2001, PHYSICA A, V295, P17, DOI 10.1016/S0378-4371(01)00140-6; Szymczak P, 2009, J GEOPHYS RES-SOL EA, V114, DOI 10.1029/2008JB006122; Tang KS, 1996, IEEE SIGNAL PROC MAG, V13, P22, DOI 10.1109/79.543973; Thauvin F, 1998, TRANSPORT POROUS MED, V31, P19, DOI 10.1023/A:1006558926606; Wang SL, 2011, TRANSPORT POROUS MED, V86, P513, DOI 10.1007/s11242-010-9634-4; Wang XZ, 2010, PETROL SCI, V7, P106, DOI 10.1007/s12182-010-0013-0; Wu YS, 2002, WATER RESOUR RES, V38, DOI 10.1029/2001WR000713; Zeng ZW, 2006, TRANSPORT POROUS MED, V63, P57, DOI 10.1007/s11242-005-2720-3; Zhang J, 2012, GEOTHERMICS, V42, P78, DOI 10.1016/j.geothermics.2011.11.002	94	8	8	2	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e83536	10.1371/journal.pone.0083536	http://dx.doi.org/10.1371/journal.pone.0083536			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386224	gold, Green Published, Green Submitted			2022-12-25	WOS:000329194700048
J	Benedetto, S; Drai-Zerbib, V; Pedrotti, M; Tissier, G; Baccino, T				Benedetto, Simone; Drai-Zerbib, Veronique; Pedrotti, Marco; Tissier, Geoffrey; Baccino, Thierry			E-Readers and Visual Fatigue	PLOS ONE			English	Article							COMPUTER VISION SYNDROME; E-INK DISPLAYS; BLINK RATE; CONFIDENCE-INTERVALS; EYES; SIZE; LCD	The mass digitization of books is changing the way information is created, disseminated and displayed. Electronic book readers (e-readers) generally refer to two main display technologies: the electronic ink (E-ink) and the liquid crystal display (LCD). Both technologies have advantages and disadvantages, but the question whether one or the other triggers less visual fatigue is still open. The aim of the present research was to study the effects of the display technology on visual fatigue. To this end, participants performed a longitudinal study in which two last generation e-readers (LCD, E-ink) and paper book were tested in three different prolonged reading sessions separated by - on average - ten days. Results from both objective (Blinks per second) and subjective (Visual Fatigue Scale) measures suggested that reading on the LCD (Kindle Fire HD) triggers higher visual fatigue with respect to both the E-ink (Kindle Paperwhite) and the paper book. The absence of differences between E-ink and paper suggests that, concerning visual fatigue, the E-ink is indeed very similar to the paper.	[Benedetto, Simone; Tissier, Geoffrey; Baccino, Thierry] Univ Paris 08, CHArt LUTIN, Paris, France; [Drai-Zerbib, Veronique; Pedrotti, Marco] Univ Paris 06, CHArt LUTIN, Paris, France	Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Universite Paris-VIII; UDICE-French Research Universities; Sorbonne Universite; Universite Paris-Est-Creteil-Val-de-Marne (UPEC)	Benedetto, S (corresponding author), Univ Paris 08, CHArt LUTIN, Paris, France.	benedetto.simone@gmail.com	Pedrotti, Marco/AAI-9524-2020	Pedrotti, Marco/0000-0002-3821-5408; Baccino, Thierry/0000-0002-2406-5306; Benedetto, Simone/0000-0002-6053-1052				Acosta MC, 1999, EXP EYE RES, V68, P663, DOI 10.1006/exer.1998.0656; Baccino T, 2004, LECT EL; Bentivoglio AR, 1997, MOVEMENT DISORD, V12, P1028, DOI 10.1002/mds.870120629; Blehm C, 2005, SURV OPHTHALMOL, V50, P253, DOI 10.1016/j.survophthal.2005.02.008; Bonferroni C. E., 1936, TEORIA STAT CLASSI C; BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; BRIDGEMAN B, 1993, P SOC PHOTO-OPT INS, V1913, P134, DOI 10.1117/12.152738; Cardona G, 2011, CURR EYE RES, V36, P190, DOI 10.3109/02713683.2010.544442; Chang PC, 2013, DISPLAYS IN PRESS; Chen H, 1993, PSYCHOL SCI, V4, P237; Cousineau D, 2005, TUTOR QUANT METHODS, V1, P42, DOI 10.20982/tqmp.01.1.p042; De Leeuw E., 1965, READ BETTER READ FAS; Friedman M, 1937, J AM STAT ASSOC, V32, P675, DOI 10.2307/2279372; Fry FB, 1963, TEACHING FASTER READ; Fukuda K, 2005, AVIAT SPACE ENVIR MD, V76, pC75; Garnham A., 1996, MODELS UNDERSTANDING, P313; GERNSBACHER MA, 1991, PSYCHOL LEARN MOTIV, V27, P217, DOI 10.1016/S0079-7421(08)60125-5; GREENHOUSE SW, 1959, PSYCHOMETRIKA, V24, P95, DOI 10.1007/BF02289823; HEUER H, 1989, Z EXP ANGEW PSYCHOL, V36, P538; Hirota M, 2013, OPTOMETRY VISION SCI, V90, P650, DOI 10.1097/OPX.0b013e31829962ec; Kang YY, 2009, DISPLAYS, V30, P49, DOI 10.1016/j.displa.2008.12.002; Kintsch W, 1998, COMPREHENSION PARADI; Kretzschmar F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056178; Kumashiro M, 1995, EVALUATION HUMAN WOR; Lee DS, 2011, DISPLAYS, V32, P1, DOI 10.1016/j.displa.2010.09.001; Liversedge SP, 2006, CURR BIOL, V16, P1726, DOI 10.1016/j.cub.2006.07.051; Loewenfeld I. E., 1993, PUPIL ANATOMY PHYSL, V1; Maupassant GD, 2004, BEL AMI; Menozzi M, 2001, DISPLAYS, V22, P79, DOI 10.1016/S0141-9382(01)00054-3; Michelson A. A., 1927, STUDIES OPTICS; Morey RD, 2008, TUTOR QUANT METHODS, V4, P61, DOI 10.20982/tqmp.04.2.p061; OREGAN JK, 1983, PERCEPT PSYCHOPHYS, V34, P457, DOI 10.3758/BF03203061; PATEL S, 1991, OPTOMETRY VISION SCI, V68, P888, DOI 10.1097/00006324-199111000-00010; Pedrotti M, 2011, BEHAV RES METHODS, V43, P372, DOI 10.3758/s13428-010-0055-7; Rosenfield M, 2011, OPHTHAL PHYSL OPT, V31, P502, DOI 10.1111/j.1475-1313.2011.00834.x; SHAPIRO SS, 1968, J AM STAT ASSOC, V63, P1343, DOI 10.2307/2285889; Shen IH, 2009, DISPLAYS, V30, P53, DOI 10.1016/j.displa.2008.12.001; Siegenthaler E, 2012, J EYE MOVEMENT RES, V5; Siegenthaler E, 2012, OPHTHAL PHYSL OPT, V32, P367, DOI 10.1111/j.1475-1313.2012.00928.x; Siegenthaler E, 2011, DISPLAYS, V32, P268, DOI 10.1016/j.displa.2011.05.005; STERN JA, 1994, HUM FACTORS, V36, P285, DOI 10.1177/001872089403600209; TAPTAGAPORN S, 1990, ERGONOMICS, V33, P201, DOI 10.1080/00140139008927110; Tinker MA, 1955, J APPL PSYCHOL, V39, P444, DOI 10.1037/h0041553; TSUBOTA K, 1993, NEW ENGL J MED, V328, P584, DOI 10.1056/NEJM199302253280817; WILCOXON F, 1946, J ECON ENTOMOL, V39, P269, DOI 10.1093/jee/39.2.269; Yamada F, 1998, ERGONOMICS, V41, P678, DOI 10.1080/001401398186847; Zambarbieri D, 2012, OPHTHAL PHYSL OPT, V32, P390, DOI 10.1111/j.1475-1313.2012.00930.x	47	90	93	3	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e83676	10.1371/journal.pone.0083676	http://dx.doi.org/10.1371/journal.pone.0083676			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	281RE	24386252	Green Published, gold, Green Submitted			2022-12-25	WOS:000329117900052
J	Chen, CY; Hofmann, CS; Cottrell, BJ; Strobaugh, TP; Paoli, GC; Nguyen, LH; Yan, XH; Uhlich, GA				Chen, Chin-Yi; Hofmann, Christopher S.; Cottrell, Bryan J.; Strobaugh, Terence P., Jr.; Paoli, George C.; Ly-Huong Nguyen; Yan, Xianghe; Uhlich, Gaylen A.			Phenotypic and Genotypic Characterization of Biofilm Forming Capabilities in Non-O157 Shiga Toxin-Producing Escherichia coli Strains	PLOS ONE			English	Article							IN-GROUND BEEF; CSGD PROMOTER; SALMONELLA-TYPHIMURIUM; EXTRACELLULAR-MATRIX; UNITED-STATES; FOOD; EXPRESSION; MOTILITY; O157-H7; BACTERIOPHAGES	The biofilm life style helps bacteria resist oxidative stress, desiccation, antibiotic treatment, and starvation. Biofilm formation involves a complex regulatory gene network controlled by various environmental signals. It was previously shown that prophage insertions in mlrA and heterogeneous mutations in rpoS constituted major obstacles limiting biofilm formation and the expression of extracellular curli fibers in strains of Escherichia coli serotype O157: H7. The purpose of this study was to test strains from other important serotypes of Shiga toxin-producing E. coli (STEC) (O26, O45, O103, O111, O113, O121, and O145) for similar regulatory restrictions. In a small but diverse collection of biofilm-forming and non-forming strains, mlrA prophage insertions were identified in only 4 of the 19 strains (serotypes O103, O113, and O145). Only the STEC O103 and O113 strains could be complemented by a trans-copy of mlrA to restore curli production and Congo red (CR) dye affinity. RpoS mutations were found in 5 strains (4 serotypes), each with low CR affinity, and the defects were moderately restored by a wild-type copy of rpoS in 2 of the 3 strains attempted. Fourteen strains in this study showed no or weak biofilm formation, of which 9 could be explained by prophage insertions or rpoS mutations. However, each of the remaining five biofilm-deficient strains, as well as the two O145 strains that could not be complemented by mlrA, showed complete or nearly complete lack of motility. This study indicates that mlrA prophage insertions and rpoS mutations do limit biofilm and curli expression in the non-serotype O157: H7 STEC but prophage insertions may not be as common as in serotype O157: H7 strains. The results also suggest that lack of motility provides a third major factor limiting biofilm formation in the non-O157: H7 STEC. Understanding biofilm regulatory mechanisms will prove beneficial in reducing pathogen survival and enhancing food safety.	[Chen, Chin-Yi; Hofmann, Christopher S.; Cottrell, Bryan J.; Strobaugh, Terence P., Jr.; Paoli, George C.; Ly-Huong Nguyen; Yan, Xianghe; Uhlich, Gaylen A.] ARS, Mol Characterizat Foodborne Pathogens Res Unit, Eastern Reg Res Ctr, USDA, Wyndmoor, PA 19038 USA	United States Department of Agriculture (USDA)	Chen, CY (corresponding author), ARS, Mol Characterizat Foodborne Pathogens Res Unit, Eastern Reg Res Ctr, USDA, Wyndmoor, PA 19038 USA.	chin-yi.chen@ars.usda.gov		Hofmann, Christopher/0000-0003-4918-6769	National Program 108 Food Safety Project of the United States Department of Agriculture-Agriculture Research Service (USDA-ARS).	National Program 108 Food Safety Project of the United States Department of Agriculture-Agriculture Research Service (USDA-ARS).	This research was funded by the National Program 108 Food Safety Project of the United States Department of Agriculture-Agriculture Research Service (USDA-ARS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beutin L, 2007, APPL ENVIRON MICROB, V73, P4769, DOI 10.1128/AEM.00873-07; Biscola FT, 2011, APPL ENVIRON MICROB, V77, P2201, DOI 10.1128/AEM.01920-10; Bokranz W, 2005, J MED MICROBIOL, V54, P1171, DOI 10.1099/jmm.0.46064-0; Bosilevac JM, 2011, APPL ENVIRON MICROB, V77, P2103, DOI 10.1128/AEM.02833-10; Brooks JT, 2005, J INFECT DIS, V192, P1422, DOI 10.1086/466536; Brown PK, 2001, MOL MICROBIOL, V41, P349, DOI 10.1046/j.1365-2958.2001.02529.x; Burkart M, 1998, P NATL ACAD SCI USA, V95, P2568, DOI 10.1073/pnas.95.5.2568; DebRoy C, 2011, FOODBORNE PATHOG DIS, V8, P651, DOI 10.1089/fpd.2010.0769; Fratamico PM, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00152; Gerstel U, 2003, RES MICROBIOL, V154, P659, DOI 10.1016/j.resmic.2003.08.005; Gerstel U, 2003, MOL MICROBIOL, V49, P639, DOI 10.1046/j.1365-2958.2003.03594.x; Gerstel U, 2006, FEMS MICROBIOL LETT, V261, P109, DOI 10.1111/j.1574-6968.2006.00332.x; Karmali MA, 2003, J CLIN MICROBIOL, V41, P4930, DOI 10.1128/JCM.41.11.4930-4940.2003; Medina MB, 2012, J FOOD PROTECT, V75, P819, DOI 10.4315/0362-028X.JFP-11-430; Miller J.H., 1972, EXPT MOL GENETICS; Ogasawara H, 2010, FEMS MICROBIOL LETT, V312, P160, DOI 10.1111/j.1574-6968.2010.02112.x; Ogasawara H, 2010, MICROBIOL-SGM, V156, P2470, DOI 10.1099/mic.0.039131-0; Parsek MR, 2003, ANNU REV MICROBIOL, V57, P677, DOI 10.1146/annurev.micro.57.030502.090720; Pesavento C, 2008, GENE DEV, V22, P2434, DOI 10.1101/gad.475808; Pesavento C, 2012, NUCLEIC ACIDS RES, V40, P4783, DOI 10.1093/nar/gks055; Pratt LA, 1998, MOL MICROBIOL, V30, P285, DOI 10.1046/j.1365-2958.1998.01061.x; Rangel JM, 2005, EMERG INFECT DIS, V11, P603, DOI 10.3201/eid1104.040739; Serra-Moreno R, 2007, J BACTERIOL, V189, P6645, DOI 10.1128/JB.00466-07; Shaikh N, 2003, J BACTERIOL, V185, P3596, DOI 10.1128/JB.185.12.3596-3605.2003; Takkinen J., 2011, SHIGA TOXIN VEROTOXI; Uhlich GA, 2001, APPL ENVIRON MICROB, V67, P2367, DOI 10.1128/AEM.67.5.2367-2370.2001; Uhlich GA, 2013, MICROBIOL-SGM, V159, P1586, DOI 10.1099/mic.0.066118-0; van Hoek AHAM, 2013, FEMS MICROBIOL LETT, V338, P18, DOI 10.1111/1574-6968.12024; Van Houdt R, 2010, J APPL MICROBIOL, V109, P1117, DOI 10.1111/j.1365-2672.2010.04756.x; Wang R, 2012, J FOOD PROTECT, V75, P1418, DOI 10.4315/0362-028X.JFP-11-427; Wasilenko JL, 2012, J FOOD PROTECT, V75, P1939, DOI 10.4315/0362-028X.JFP-12-087; Zogaj X, 2001, MOL MICROBIOL, V39, P1452, DOI 10.1046/j.1365-2958.2001.02337.x	32	20	20	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e84863	10.1371/journal.pone.0084863	http://dx.doi.org/10.1371/journal.pone.0084863			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281RE	24386426	Green Published, gold, Green Submitted			2022-12-25	WOS:000329117900115
J	Ernst, N; Yay, A; Biro, T; Tiede, S; Humphries, M; Paus, R; Kloepper, JE				Ernst, Nancy; Yay, Arzu; Biro, Tamas; Tiede, Stephan; Humphries, Martin; Paus, Ralf; Kloepper, Jennifer E.			beta 1 Integrin Signaling Maintains Human Epithelial Progenitor Cell Survival In Situ and Controls Proliferation, Apoptosis and Migration of Their Progeny	PLOS ONE			English	Article							INTEGRIN-LINKED KINASE; FOLLICLE STEM-CELLS; TRANSIT-AMPLIFYING CELLS; HAIR FOLLICLE; MONOCLONAL-ANTIBODY; BASEMENT-MEMBRANE; DIFFERENTIAL EXPRESSION; INHIBITOR QLT0267; BULGE REGION; ADHESION	beta 1 integrin regulates multiple epithelial cell functions by connecting cells with the extracellular matrix (ECM). While beta 1 integrin-mediated signaling in murine epithelial stem cells is well-studied, its role in human adult epithelial progenitor cells (ePCs) in situ remains to be defined. Using microdissected, organ-cultured human scalp hair follicles (HFs) as a clinically relevant model for studying human ePCs within their natural topobiological habitat, beta 1 integrin-mediated signaling in ePC biology was explored by beta 1 integrin siRNA silencing, specific beta 1 integrin-binding antibodies and pharmacological inhibition of integrin-linked kinase (ILK), a key component of the integrin-induced signaling cascade. beta 1 integrin knock down reduced keratin 15 (K15) expression as well as the proliferation of outer root sheath keratinocytes (ORSKs). Embedding of HF epithelium into an ECM rich in beta 1 integrin ligands that mimic the HF mesenchyme significantly enhanced proliferation and migration of ORSKs, while K15 and CD200 gene and protein expression were inhibited. Employing ECM-embedded beta 1 integrin-activating or -inhibiting antibodies allowed to identify functionally distinct human ePC subpopulations in different compartments of the HF epithelium. The beta 1 integrin-inhibitory antibody reduced beta 1 integrin expression in situ and selectively enhanced proliferation of bulge ePCs, while the beta 1 integrin-stimulating antibody decreased hair matrix keratinocyte apoptosis and enhanced transferrin receptor (CD71) immunoreactivity, a marker of transit amplifying cells, but did not affect bulge ePC proliferation. That the putative ILK inhibitor QLT0267 significantly reduced ORSK migration and proliferation and induced massive ORSK apoptosis suggests a key role for ILK in mediating the beta 1 integrin effects. Taken together, these findings demonstrate that ePCs in human HFs require beta 1 integrin-mediated signaling for survival, adhesion, and migration, and that different human HF ePC subpopulations differ in their response to beta 1 integrin signaling. These insights may be exploited for cell-based regenerative medicine strategies that employ human HF-derived ePCs.	[Ernst, Nancy; Paus, Ralf; Kloepper, Jennifer E.] Med Univ Lubeck, Dept Dermatol, D-23538 Lubeck, Germany; [Yay, Arzu] Erciyes Univ, Dept Histol & Embryol, Kayseri, Turkey; [Biro, Tamas] Univ Debrecen, Dept Physiol, DE MTA Lendulet Cellular Physiol Grp, H-4012 Debrecen, Hungary; [Tiede, Stephan] Euroimmun AG, Inst Expt Immunol, Lubeck, Germany; [Humphries, Martin] Univ Manchester, Fac Life Sci, Manchester, Lancs, England; [Paus, Ralf] Univ Manchester, Inst Inflammat & Repair, Manchester, Lancs, England	University of Lubeck; Erciyes University; University of Debrecen; EUROIMMUN; University of Manchester; University of Manchester	Paus, R (corresponding author), Med Univ Lubeck, Dept Dermatol, D-23538 Lubeck, Germany.	ralf.paus@uksh.de	Hundt, Jennifer/AAU-4504-2020; Kloepper, Jennifer E/B-7403-2015; Yay, Arzu/AAP-4395-2021; Paus, Ralf/B-5279-2015	Paus, Ralf/0000-0002-3492-9358; Tiede, Stephan/0000-0002-6045-3736; Ernst, Nancy/0000-0002-3248-2425; Humphries, Martin/0000-0002-4331-6967	medical faculty of the University of Luebeck [E42-2010]; DFG [PA 345/13-1]	medical faculty of the University of Luebeck; DFG(German Research Foundation (DFG))	This study was supported by a fellowship of the medical faculty of the University of Luebeck to J.K. (E42-2010) and a grant from the DFG (PA 345/13-1) to RP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aasen T, 2010, NAT PROTOC, V5, P371, DOI 10.1038/nprot.2009.241; AKIYAMA SK, 1989, J CELL BIOL, V109, P863, DOI 10.1083/jcb.109.2.863; Assi K, 2011, BMC IMMUNOL, V12, DOI 10.1186/1471-2172-12-42; Attwell S, 2000, ONCOGENE, V19, P3811, DOI 10.1038/sj.onc.1203711; Azimifar SB, 2012, J CELL SCI, V125, P435, DOI 10.1242/jcs.091652; Beck B, 2012, EMBO J, V31, P2067, DOI 10.1038/emboj.2012.67; Benoit YD, 2009, BIOL CELL, V101, P695, DOI 10.1042/BC20090060; Brakebusch C, 2000, EMBO J, V19, P3990, DOI 10.1093/emboj/19.15.3990; Byron A, 2013, INT J EXP PATHOL; Byron A, 2010, CURR BIOL, V20, pR1063, DOI 10.1016/j.cub.2010.10.059; Campbell ID, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004994; Chen SY, 2013, DEVELOPMENT, V140, P255, DOI 10.1242/dev.083139; Commo S, 1997, CELL MOL LIFE SCI, V53, P466, DOI 10.1007/s000180050057; COTSARELIS G, 1990, CELL, V61, P1329, DOI 10.1016/0092-8674(90)90696-C; Cotsarelis G, 1999, EXP DERMATOL, V8, P80, DOI 10.1111/j.1600-0625.1999.tb00351.x; Cotsarelis G, 2006, J INVEST DERMATOL, V126, P1459, DOI 10.1038/sj.jid.5700376; Devalliere J, 2012, FASEB J, V26, P2592, DOI 10.1096/fj.11-193383; Eke I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006434; FASSLER R, 1995, GENE DEV, V9, P1896, DOI 10.1101/gad.9.15.1896; Fujiwara H, 2011, CELL, V144, P577, DOI 10.1016/j.cell.2011.01.014; Garza LA, 2011, J CLIN INVEST, V121, P613, DOI 10.1172/JCI44478; Gendronneau G, 2008, MOL BIOL CELL, V19, P5541, DOI 10.1091/mbc.E08-02-0166; Ghatak S, 2013, BIOCHEM SOC T, V41, P995, DOI 10.1042/BST20130062; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; Gibson RM, 2005, MOL CELL NEUROSCI, V28, P588, DOI 10.1016/j.mcn.2004.11.004; Gilcrease MZ, 2007, CANCER LETT, V247, P1, DOI 10.1016/j.canlet.2006.03.031; Goel HL, 2010, J CELL PHYSIOL, V224, P210, DOI 10.1002/jcp.22116; Hannigan GE, 2011, ONCOGENE, V30, P4375, DOI 10.1038/onc.2011.177; Harries MJ, 2010, AM J PATHOL, V177, P2152, DOI 10.2353/ajpath.2010.100454; Harries MJ, 2013, AM J PATHOL; Hehlgans S, 2007, BBA-REV CANCER, V1775, P163, DOI 10.1016/j.bbcan.2006.09.001; HOTCHIN NA, 1995, J CELL BIOL, V128, P1209, DOI 10.1083/jcb.128.6.1209; Hughes CS, 2010, PROTEOMICS, V10, P1886, DOI 10.1002/pmic.200900758; Humphries MJ, 2002, ARTHRITIS RES THER, V4, pS69, DOI 10.1186/ar563; Huttenlocher A, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005074; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Inoue K, 2009, LAB INVEST, V89, P844, DOI 10.1038/labinvest.2009.48; JONES PH, 1993, CELL, V73, P713, DOI 10.1016/0092-8674(93)90251-K; Judah D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036704; Kalra J, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2252; Kaur P, 2004, J INVEST DERM SYMP P, V9, P238, DOI 10.1111/j.1087-0024.2004.09306.x; Kim YN, 2012, INT J CELL BIOL, V2012, DOI DOI 10.1155/2012/306879; KLEINMAN HK, 1986, BIOCHEMISTRY-US, V25, P312, DOI 10.1021/bi00350a005; Kloepper JE, 2008, EXP CELL RES, V314, P498, DOI 10.1016/j.yexcr.2007.10.030; Kloepper JE, 2008, EXP DERMATOL, V17, P592, DOI 10.1111/j.1600-0625.2008.00720.x; Kloepper JE, 2010, EXP DERMATOL, V19, P305, DOI 10.1111/j.1600-0625.2009.00939.x; Kotogany E, 2010, PLANT METHODS, V6, DOI 10.1186/1746-4811-6-5; Lange A, 2009, NATURE, V461, P1002, DOI 10.1038/nature08468; Lavker RM, 2000, P NATL ACAD SCI USA, V97, P13473, DOI 10.1073/pnas.250380097; Legate KR, 2009, GENE DEV, V23, P397, DOI 10.1101/gad.1758709; Leyme A, 2012, MOL BIOL CELL, V23, P3461, DOI 10.1091/mbc.E11-11-0918; Lim S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053702; LINK RE, 1990, J INVEST DERMATOL, V95, P202, DOI 10.1111/1523-1747.ep12478002; Liu ZZ, 2011, CHINESE MED J-PEKING, V124, P2934, DOI 10.3760/cma.j.issn.0366-6999.2011.18.025; Lopez-Rovira T, 2005, J INVEST DERMATOL, V125, P1215, DOI 10.1111/j.0022-202X.2005.23956.x; Lorenz K, 2007, J CELL BIOL, V177, P501, DOI 10.1083/jcb.200608125; Lyle S, 1998, J CELL SCI, V111, P3179; Lyle S, 1999, J INVEST DERM SYMP P, V4, P296, DOI 10.1038/sj.jidsp.5640233; Ma W, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-90; Margadant C, 2010, FASEB J, V24, P4133, DOI 10.1096/fj.09-151449; Maydan M, 2010, PLOS ONE, V5, P8, DOI DOI 10.1371/J0URNAL.P0NE.0012356.PUBMED:20827300; McDonald PC, 2008, J CELL SCI, V121, P3121, DOI 10.1242/jcs.017996; Meng Y, 2010, FASEB J, V24, P1056, DOI 10.1096/fj.08-126821; Meves A, 2013, J INVEST DERMATOL; Meyer KC, 2008, BRIT J DERMATOL, V159, P1077, DOI 10.1111/j.1365-2133.2008.08818.x; Morisaki N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055947; Morris RJ, 2004, NAT BIOTECHNOL, V22, P411, DOI 10.1038/nbt950; Mould AP, 1996, J BIOL CHEM, V271, P20365, DOI 10.1074/jbc.271.34.20365; MOULD AP, 1995, FEBS LETT, V363, P118, DOI 10.1016/0014-5793(95)00301-O; Murphy DA, 2011, NAT REV MOL CELL BIO, V12, P413, DOI 10.1038/nrm3141; Nakrieko KA, 2008, MOL BIOL CELL, V19, P1462, DOI 10.1091/mbc.E07-06-0526; Ohyama M, 2006, J CLIN INVEST, V116, P249, DOI 10.1172/JCI26043; Ohyama Manabu, 2012, Methods Mol Biol, V879, P389, DOI 10.1007/978-1-61779-815-3_24; Ohyama M, 2013, J DERMATOL SCI, V70, P78, DOI 10.1016/j.jdermsci.2013.02.004; Paus R, 2005, TRENDS IMMUNOL, V26, P32, DOI 10.1016/j.it.2004.09.014; Philip D, 2005, STEM CELLS, V23, P288, DOI 10.1634/stemcells.2002-0109; Philpott M P, 1994, J Dermatol Sci, V7 Suppl, pS55, DOI 10.1016/0923-1811(94)90036-1; Piwko-Czuchra A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005488; Raghavan S, 2000, J CELL BIOL, V150, P1149, DOI 10.1083/jcb.150.5.1149; Roh C, 2005, J INVEST DERMATOL, V125, P1099, DOI 10.1111/j.0022-202X.2005.23958.x; Rosenblum MD, 2006, J DERMATOL SCI, V41, P165, DOI 10.1016/j.jdermsci.2005.11.003; Rothnagel JA, 1999, DIFFERENTIATION, V65, P119, DOI 10.1046/j.1432-0436.1999.6520119.x; Sakai T, 2003, GENE DEV, V17, P926, DOI 10.1101/gad.255603; Samuelov L, 2012, J INVEST DERMATOL, V132, P2332, DOI 10.1038/jid.2012.171; Schneider MR, 2009, CURR BIOL, V19, pR132, DOI 10.1016/j.cub.2008.12.005; STENN KS, 1989, J INVEST DERMATOL, V93, P287, DOI 10.1111/1523-1747.ep12277593; Stenn KS, 2001, PHYSIOL REV, V81, P449, DOI 10.1152/physrev.2001.81.1.449; Streuli CH, 2009, J CELL SCI, V122, P171, DOI 10.1242/jcs.018945; Sugawara K, 2012, J ALLERGY CLIN IMMUN, V129; Sun XY, 2011, BIOL PHARM BULL, V34, P1037, DOI 10.1248/bpb.34.1037; Tehrani S, 2007, P NATL ACAD SCI USA, V104, P11933, DOI 10.1073/pnas.0701077104; Tiede S, 2007, EUR J CELL BIOL, V86, P355, DOI 10.1016/j.ejcb.2007.03.006; Tiede S, 2009, STEM CELLS, V27, P2793, DOI 10.1002/stem.213; Tuckwell DS, 2000, BIOCHEM J, V350, P485, DOI 10.1042/0264-6021:3500485; Uemura M, 2010, J NEUROSCI RES, V88, P542, DOI 10.1002/jnr.22223; Villa-Diaz LG, 2013, STEM CELLS, V31, P1, DOI 10.1002/stem.1260; Vollmers A, 2012, STEM CELL REV REP, V8, P402, DOI 10.1007/s12015-011-9314-y; Wang Qing-Qing, 2011, Chin J Cancer, V30, P853, DOI 10.5732/cjc.011.10362; Wang XF, 2011, MED ONCOL, V28, P1596, DOI 10.1007/s12032-010-9616-y; Watt FM, 2009, EMBO MOL MED, V1, P260, DOI 10.1002/emmm.200900033; Watt FM, 2002, EMBO J, V21, P3919, DOI 10.1093/emboj/cdf399; Webb A, 2004, DIFFERENTIATION, V72, P387, DOI 10.1111/j.1432-0436.2004.07208005.x; Wickstrom SA, 2010, EMBO J, V29, P281, DOI 10.1038/emboj.2009.376; Wickstrom Sara A, 2011, Cold Spring Harb Perspect Biol, V3, DOI 10.1101/cshperspect.a005116; Widmaier M, 2012, J CELL SCI, V125, P1839, DOI 10.1242/jcs.093864; Xu XW, 2003, AM J PATHOL, V163, P969, DOI 10.1016/S0002-9440(10)63456-6; Younes MN, 2007, ARCH OTOLARYNGOL, V133, P15, DOI 10.1001/archotol.133.1.15; Yu YP, 2011, ONCOGENE, V30, P4855, DOI 10.1038/onc.2011.200	108	15	18	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e84356	10.1371/journal.pone.0084356	http://dx.doi.org/10.1371/journal.pone.0084356			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281RE	24386370	gold, Green Accepted, Green Published			2022-12-25	WOS:000329117900089
J	Jamaluddin, MS; Yan, SY; Lu, JM; Liang, ZD; Yao, QZ; Chen, CY				Jamaluddin, Md Saha; Yan, Shaoyu; Lu, Jianming; Liang, Zhengdong; Yao, Qizhi; Chen, Changyi			Resistin Increases Monolayer Permeability of Human Coronary Artery Endothelial Cells	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; ACTIVATED PROTEIN-KINASES; TIGHT JUNCTION PROTEINS; P38 MAP KINASE; OXIDATIVE STRESS; BARRIER FUNCTION; NADPH OXIDASE; CARDIOVASCULAR-DISEASES; ACTIN CYTOSKELETON; ADIPOSE-TISSUE	Resistin has been linked to obesity, insulin resistance, atherosclerosis, and the development of cardiovascular disease. Nevertheless, the effects and the molecular mechanisms of resistin on endothelial permeability, a key event in the development of atherosclerosis, inflammation, and vascular disease, are largely unknown. In order to determine the effect of resistin on endothelial permeability, human coronary artery endothelial cells (HCAECs) were treated with clinically relevant concentrations of resistin and the endothelial permeability was measured using the Transwell system with a Texas-Red-labeled dextran tracer. The permeability of HCAEC monolayers treated with resistin (80 ng/mL) was 51% higher than the permeability of control monolayers (P < 0.05). The mRNA levels of tight junction proteins zonula occludens-1 (ZO-1) and occludin in resistin-treated cells were 37% and 42% lower, respectively, than the corresponding levels in untreated cells. The protein levels of these molecules in resistin-treated cells were significantly reduced by 35% and 37%, respectively (P < 0.05), as shown by flow cytometry and Western blot analysis. Superoxide dismutase (SOD) mimetic MnTBAP effectively blocked the resistin-mediated reduction of ZO-1 and occludin levels in HCAECs. In addition, superoxide anion production was increased from 21% (untreated cells) to 55% (cells treated with 40 ng/mL resistin), and 64% (resistin, 80 mg/mL) (P < 0.05). The natural antioxidant Ginkgolide A effectively inhibited resistin-induced increase in permeability and the increase in superoxide anion production in HCAECs. Furthermore, resistin treatment significantly activated p38 MAPK, but not ERK1/2. Pretreatment of HCAECs with a p38 inhibitor effectively blocked resistin-induced permeability. These results provide new evidence that resistin may contribute to the vascular lesion formation via increasing endothelial permeability through the mechanism of oxidative stress and the activation of p38 MAPK.	[Jamaluddin, Md Saha; Yan, Shaoyu; Lu, Jianming; Liang, Zhengdong; Yao, Qizhi; Chen, Changyi] Baylor Coll Med, Michael E DeBakey Dept Surg, Div Surg Res, Mol Surg Res Ctr, Houston, TX 77030 USA	Baylor College of Medicine	Chen, CY (corresponding author), Baylor Coll Med, Michael E DeBakey Dept Surg, Div Surg Res, Mol Surg Res Ctr, Houston, TX 77030 USA.	jchen@bcm.tmc.edu			Baylor College of Medicine, Houston, Texas; National Institutes of Health [T32HL083774]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL083774] Funding Source: NIH RePORTER	Baylor College of Medicine, Houston, Texas; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research was supported by the Baylor College of Medicine, Houston, Texas. ZL was supported by a grant from National Institutes of Health (T32HL083774). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Amerongen GPV, 2002, VASC PHARMACOL, V39, P257, DOI 10.1016/S1537-1891(03)00014-4; Antonetti DA, 2002, J NEUROCHEM, V80, P667, DOI 10.1046/j.0022-3042.2001.00740.x; Baldwin AL, 1998, AM J PHYSIOL-HEART C, V274, pH1776, DOI 10.1152/ajpheart.1998.274.5.H1776; Bazzoni G, 2006, THROMB HAEMOSTASIS, V95, P36, DOI 10.1160/TH05-07-0488; Bazzoni G, 2004, PHYSIOL REV, V84, P869, DOI 10.1152/physrev.00035.2003; Beutler B, 2004, NATURE, V430, P257, DOI 10.1038/nature02761; Bolton SJ, 1998, NEUROSCIENCE, V86, P1245, DOI 10.1016/S0306-4522(98)00058-X; Boueiz A, 2009, MICROVASC RES, V77, P26, DOI 10.1016/j.mvr.2008.10.005; Cai H, 2000, CIRC RES, V87, P840, DOI 10.1161/01.RES.87.10.840; Chen CY, 2008, ARTERIOSCL THROM VAS, V28, P906, DOI 10.1161/ATVBAHA.108.163667; Chen CY, 2010, AM J PHYSIOL-HEART C, V299, pH193, DOI 10.1152/ajpheart.00431.2009; Chen CY, 2005, BIOCHEM BIOPH RES CO, V335, P874, DOI 10.1016/j.bbrc.2005.07.155; Chen J, 2008, MOL BIOL CELL, V19, P3701, DOI 10.1091/mbc.E08-02-0175; Chen QD, 2003, J IMMUNOL, V170, P5302, DOI 10.4049/jimmunol.170.10.5302; Deak M, 1998, EMBO J, V17, P4426, DOI 10.1093/emboj/17.15.4426; Dejana E, 2009, DEV CELL, V16, P209, DOI 10.1016/j.devcel.2009.01.004; DIEKMANN D, 1994, SCIENCE, V265, P531, DOI 10.1126/science.8036496; Eiserich JP, 1999, P NATL ACAD SCI USA, V96, P6365, DOI 10.1073/pnas.96.11.6365; Fain JN, 2003, BIOCHEM BIOPH RES CO, V300, P674, DOI 10.1016/S0006-291X(02)02864-4; Fang C, 2013, CHINESE MED J-PEKING, V126, P646, DOI 10.3760/cma.j.issn.0366-6999.20120970; Force T, 1996, CIRC RES, V78, P947, DOI 10.1161/01.RES.78.6.947; Groeneveld ABJ, 2002, VASC PHARMACOL, V39, P247, DOI 10.1016/S1537-1891(03)00013-2; Harhaj NS, 2002, J CELL PHYSIOL, V193, P349, DOI 10.1002/jcp.10183; Hoefen RJ, 2002, VASC PHARMACOL, V38, P271, DOI 10.1016/S1537-1891(02)00251-3; Hogan SP, 2006, J ALLERGY CLIN IMMUN, V118, P257, DOI 10.1016/j.jaci.2006.04.039; Holcomb IN, 2000, EMBO J, V19, P4046, DOI 10.1093/emboj/19.15.4046; Huang H, 2004, MOL PHARMACOL, V66, P302, DOI 10.1124/mol.66.2.302; Jamaluddin MS, 2010, ATHEROSCLEROSIS, V208, P104, DOI 10.1016/j.atherosclerosis.2009.07.029; Jamaluddin MS, 2009, ARTERIOSCL THROM VAS, V29, P2146, DOI 10.1161/ATVBAHA.109.194134; Jiang WG, 1998, BIOCHEM BIOPH RES CO, V244, P414, DOI 10.1006/bbrc.1998.8288; Kennedy NJ, 2007, CANCER CELL, V11, P101, DOI 10.1016/j.ccr.2007.01.009; Kondo T, 2009, J ATHEROSCLER THROMB, V16, P532, DOI 10.5551/jat.1255; Krouwer VJD, 2012, VASC CELL, V4, DOI 10.1186/2045-824X-4-12; Kwon T, 2000, J BIOL CHEM, V275, P423, DOI 10.1074/jbc.275.1.423; Laird MHW, 2009, J LEUKOCYTE BIOL, V85, P966, DOI 10.1189/jlb.1208763; Langheim S, 2010, AM J PHYSIOL-HEART C, V298, pH746, DOI 10.1152/ajpheart.00617.2009; Laudes M, 2010, HORM METAB RES, V42, P268, DOI 10.1055/s-0029-1243638; Lin FY, 2006, ARTERIOSCL THROM VAS, V26, P2630, DOI 10.1161/01.ATV.0000247259.01257.b3; Matter K, 2003, NAT REV MOL CELL BIO, V4, P225, DOI 10.1038/nrm1055; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; McDonald DM, 2002, CANCER RES, V62, P5381; Menzaghi C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064729; New LG, 1998, TRENDS CARDIOVAS MED, V8, P220, DOI 10.1016/S1050-1738(98)00012-7; Ohmori R, 2005, J AM COLL CARDIOL, V46, P379, DOI 10.1016/j.jacc.2005.04.022; Pacquelet S, 2007, BIOCHEM J, V403, P451, DOI 10.1042/BJ20061184; Pai AB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049209; Pang L, 2013, INT J MOL SCI, V14, P9751, DOI 10.3390/ijms14059751; Parinandi NL, 2003, AM J PHYSIOL-LUNG C, V284, pL26, DOI 10.1152/ajplung.00123.2002; Patel L, 2003, BIOCHEM BIOPH RES CO, V300, P472, DOI 10.1016/S0006-291X(02)02841-3; Reilly MP, 2005, CIRCULATION, V111, P932, DOI 10.1161/01.CIR.0000155620.10387.43; Rochette L, 2013, PHARMACOL THERAPEUT, V140, P239, DOI 10.1016/j.pharmthera.2013.07.004; Runkle EA, 2013, CANCER LETT, V337, P41, DOI 10.1016/j.canlet.2013.05.038; Savage DB, 2001, DIABETES, V50, P2199, DOI 10.2337/diabetes.50.10.2199; Spindler V, 2010, CARDIOVASC RES, V87, P243, DOI 10.1093/cvr/cvq086; Steed E, 2010, TRENDS CELL BIOL, V20, P142, DOI 10.1016/j.tcb.2009.12.002; Steinberg D, 1997, ATHEROSCLEROSIS, V131, pS5, DOI 10.1016/S0021-9150(97)06115-7; Stelwagen K, 1999, MOL CELL ENDOCRINOL, V156, P55, DOI 10.1016/S0303-7207(99)00145-8; Steppan CM, 2001, NATURE, V409, P307, DOI 10.1038/35053000; Steppan CM, 2001, P NATL ACAD SCI USA, V98, P502, DOI 10.1073/pnas.98.2.502; Stevens T, 2000, AM J PHYSIOL-LUNG C, V279, pL419, DOI 10.1152/ajplung.2000.279.3.L419; Sudo T, 2005, BIOCHEM BIOPH RES CO, V337, P415, DOI 10.1016/j.bbrc.2005.09.063; Sugden PH, 1998, CIRC RES, V83, P345, DOI 10.1161/01.RES.83.4.345; Tan Y, 1996, EMBO J, V15, P4629, DOI 10.1002/j.1460-2075.1996.tb00840.x; Tapryal N, 2009, J BIOL CHEM, V284, P1873, DOI 10.1074/jbc.M804079200; Tarkowski A, 2010, J CELL MOL MED, V14, P1419, DOI 10.1111/j.1582-4934.2009.00899.x; Terry S, 2010, PHYSIOLOGY, V25, P16, DOI 10.1152/physiol.00034.2009; Tsiotra PC, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/487081; Tsukita S, 1999, CURR OPIN CELL BIOL, V11, P628, DOI 10.1016/S0955-0674(99)00016-2; Wojciak-Stothard B, 1998, J CELL PHYSIOL, V176, P150, DOI 10.1002/(SICI)1097-4652(199807)176:1<150::AID-JCP17>3.0.CO;2-B; Wu TH, 2013, TRANSL RES, V162, P45, DOI 10.1016/j.trsl.2013.03.005; Xing J, 1998, MOL CELL BIOL, V18, P1946, DOI 10.1128/MCB.18.4.1946; Yan SY, 2006, SURGERY, V140, P243, DOI 10.1016/j.surg.2006.04.001; Yan SY, 2005, SURGERY, V138, P464, DOI 10.1016/j.surg.2005.06.027; Yoshizumi M, 2012, J PHARMACOL SCI, V120, P259, DOI 10.1254/jphs.12R11CP; Zhong Y, 2012, J NEUROSCI, V32, P143, DOI 10.1523/JNEUROSCI.4266-11.2012; Zhou XM, 2008, P NATL ACAD SCI USA, V105, P5620, DOI 10.1073/pnas.0801453105	76	45	47	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e84576	10.1371/journal.pone.0084576	http://dx.doi.org/10.1371/journal.pone.0084576			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281RE	24386395	Green Published, gold, Green Submitted			2022-12-25	WOS:000329117900101
J	Kadlcik, S; Kucera, T; Chalupska, D; Gazak, R; Koberska, M; Ulanova, D; Kopecky, J; Kutejova, E; Najmanova, L; Janata, J				Kadlcik, Stanislav; Kucera, Tomas; Chalupska, Dominika; Gazak, Radek; Koberska, Marketa; Ulanova, Dana; Kopecky, Jan; Kutejova, Eva; Najmanova, Lucie; Janata, Jiri			Adaptation of an L-Proline Adenylation Domain to Use 4-Propyl-L-Proline in the Evolution of Lincosamide Biosynthesis	PLOS ONE			English	Article							NONRIBOSOMAL PEPTIDE SYNTHETASES; GENE-CLUSTER; BIOCHEMICAL-CHARACTERIZATION; MOLECULAR CHARACTERIZATION; SEQUENCE-ANALYSIS; POLYKETIDE SYNTHASE; THIOESTERASE DOMAIN; NUCLEOTIDE-SEQUENCE; ANATOXIN-A; CLONING	Clinically used lincosamide antibiotic lincomycin incorporates in its structure 4-propyl-L-proline (PPL), an unusual amino acid, while celesticetin, a less efficient related compound, makes use of proteinogenic L-proline. Biochemical characterization, as well as phylogenetic analysis and homology modelling combined with the molecular dynamics simulation were employed for complex comparative analysis of the orthologous protein pair LmbC and CcbC from the biosynthesis of lincomycin and celesticetin, respectively. The analysis proved the compared proteins to be the standalone adenylation domains strictly preferring their own natural substrate, PPL or L-proline. The LmbC substrate binding pocket is adapted to accomodate a rare PPL precursor. When compared with L-proline specific ones, several large amino acid residues were replaced by smaller ones opening a channel which allowed the alkyl side chain of PPL to be accommodated. One of the most important differences, that of the residue corresponding to V306 in CcbC changing to G308 in LmbC, was investigated in vitro and in silico. Moreover, the substrate binding pocket rearrangement also allowed LmbC to effectively adenylate 4-butyl-L-proline and 4-pentyl-L-proline, substrates with even longer alkyl side chains, producing more potent lincosamides. A shift of LmbC substrate specificity appears to be an integral part of biosynthetic pathway adaptation to the PPL acquisition. A set of genes presumably coding for the PPL biosynthesis is present in the lincomycin - but not in the celesticetin cluster; their homologs are found in biosynthetic clusters of some pyrrolobenzodiazepines (PBD) and hormaomycin. Whereas in the PBD and hormaomycin pathways the arising precursors are condensed to another amino acid moiety, the LmbC protein is the first functionally proved part of a unique condensation enzyme connecting PPL to the specialized amino sugar building unit.	[Kadlcik, Stanislav; Kucera, Tomas; Chalupska, Dominika; Gazak, Radek; Koberska, Marketa; Ulanova, Dana; Kopecky, Jan; Kutejova, Eva; Najmanova, Lucie; Janata, Jiri] Acad Sci Czech Republ, Inst Microbiol, Prague, Czech Republic; [Kutejova, Eva] Slovak Acad Sci, Inst Mol Biol, Dept Biochem & Struct Biol, Bratislava, Slovakia	Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences; Slovak Academy of Sciences	Janata, J (corresponding author), Acad Sci Czech Republ, Inst Microbiol, Prague, Czech Republic.	janata@biomed.cas.cz	Kutejova, Eva/K-6550-2014; Najmanova, Lucie/H-3663-2014; Kadlčík, Stanislav/K-8851-2014; Janata, Jiri/K-4554-2014; Koběrská, Markéta/AAE-4877-2019; Kopecky, Jan/C-7400-2013; Gažák, Radek/H-2443-2014; Kutejova, Eva/AAI-2544-2021; Chalupska, Dominika/H-1369-2014	Kutejova, Eva/0000-0002-0973-679X; Najmanova, Lucie/0000-0003-0691-7250; Kadlčík, Stanislav/0000-0001-8989-7157; Janata, Jiri/0000-0002-4582-2062; Koběrská, Markéta/0000-0002-9787-4227; Kopecky, Jan/0000-0002-3437-257X; Gažák, Radek/0000-0003-3881-0327; Kutejova, Eva/0000-0002-0973-679X; 	Ministry of Education, Youth and Sports of the Czech Republic [CZ.1.07/2.3.00/20.0055, CZ.1.07/2.3.00/30.0003]; BIOCEV - Biotechnology and Biomedicine Centre of the Academy of Sciences; Charles University [CZ.1.05/1.1.00/02.0109]; European Regional Development Fund in the Czech Republic	Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); BIOCEV - Biotechnology and Biomedicine Centre of the Academy of Sciences; Charles University; European Regional Development Fund in the Czech Republic	This work was supported by the Ministry of Education, Youth and Sports of the Czech Republic projects CZ.1.07/2.3.00/20.0055 and CZ.1.07/2.3.00/30.0003 and BIOCEV - Biotechnology and Biomedicine Centre of the Academy of Sciences and Charles University No. CZ. 1.05/1.1.00/02.0109, from the European Regional Development Fund in the Czech Republic. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARGOUDELIS AD, 1965, BIOCHEMISTRY-US, V4, P698, DOI 10.1021/bi00880a014; Becker JE, 2004, GENE, V325, P35, DOI 10.1016/j.gene.2003.09.034; BRAHME NM, 1984, J AM CHEM SOC, V106, P7873, DOI 10.1021/ja00337a038; Bushley KE, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-328; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Challis GL, 2000, CHEM BIOL, V7, P211, DOI 10.1016/S1074-5521(00)00091-0; CHUNG ST, 1997, BIOTECHNOLOGY IND AN, P165; Conti E, 1997, EMBO J, V16, P4174, DOI 10.1093/emboj/16.14.4174; Crusemann M, 2013, CHEM SCI, V4, P1041, DOI 10.1039/c2sc21722h; deCrecyLagard V, 1997, J BACTERIOL, V179, P705, DOI 10.1128/jb.179.3.705-713.1997; Duitman EH, 1999, P NATL ACAD SCI USA, V96, P13294, DOI 10.1073/pnas.96.23.13294; Fischbach MA, 2008, P NATL ACAD SCI USA, V105, P4601, DOI 10.1073/pnas.0709132105; Garneau S, 2005, BIOCHEMISTRY-US, V44, P2770, DOI 10.1021/bi0476329; Gerratana B, 2012, MED RES REV, V32, P254, DOI 10.1002/med.20212; Harris AKP, 2004, MICROBIOL-SGM, V150, P3547, DOI 10.1099/mic.0.27222-0; Hofer I, 2011, CHEM BIOL, V18, P381, DOI 10.1016/j.chembiol.2010.12.018; Hoffmann D, 2003, GENE, V311, P171, DOI 10.1016/S0378-1119(03)00587-0; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Hu Y, 2007, CHEM BIOL, V14, P691, DOI 10.1016/j.chembiol.2007.05.009; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kawasaki T, 2009, J ANTIBIOT, V62, P271, DOI 10.1038/ja.2009.27; Kim D, 2006, J MICROBIOL BIOTECHN, V16, P1912; Koberska M, 2008, FOLIA MICROBIOL, V53, P395, DOI 10.1007/s12223-008-0060-8; Kopp M, 2011, MOL BIOSYST, V7, P1549, DOI 10.1039/c0mb00240b; Kurmayer R, 2005, MICROBIOL-SGM, V151, P1525, DOI 10.1099/mic.0.27779-0; Kyselkova M, 2010, ARCH MICROBIOL, V192, P195, DOI 10.1007/s00203-010-0545-0; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lautru S, 2004, MICROBIOL-SGM, V150, P1629, DOI 10.1099/mic.0.26837-0; Li CX, 2009, CHEMBIOCHEM, V10, P1064, DOI 10.1002/cbic.200800822; Li W, 2009, APPL ENVIRON MICROB, V75, P2958, DOI 10.1128/AEM.02325-08; Li W, 2009, APPL ENVIRON MICROB, V75, P2869, DOI 10.1128/AEM.02326-08; Liscombe DK, 2012, NAT PROD REP, V29, P1238, DOI 10.1039/c2np20029e; Luesch H, 2003, J ORG CHEM, V68, P83, DOI 10.1021/jo026479q; Magerlein BJ, 1971, STRUCTURE ACTIVITY R, P600; Maharjan S, 2012, APPL MICROBIOL BIOT, V93, P687, DOI 10.1007/s00253-011-3567-x; Marahiel MA, 1997, CHEM REV, V97, P2651, DOI 10.1021/cr960029e; Meiser P, 2008, CHEM BIOL, V15, P771, DOI 10.1016/j.chembiol.2008.06.005; Mejean A, 2010, BIOCHEMISTRY-US, V49, P103, DOI 10.1021/bi9018785; Mejean A, 2009, J AM CHEM SOC, V131, P7512, DOI 10.1021/ja9024353; Milo R, 2012, SCIENCE, V336, P1663, DOI 10.1126/science.1217665; Mootz HD, 1997, J BACTERIOL, V179, P6843, DOI 10.1128/jb.179.21.6843-6850.1997; Muller C, 2007, ANTIMICROB AGENTS CH, V51, P1028, DOI 10.1128/AAC.00942-06; Najmanova L, 2013, CHEMBIOCHEM, V14, P2259, DOI 10.1002/cbic.201300389; Neusser D, 1998, ARCH MICROBIOL, V169, P322, DOI 10.1007/s002030050578; Novotna J, 2004, EUR J BIOCHEM, V271, P3678, DOI 10.1111/j.1432-1033.2004.04308.x; O'Brien PJ, 1999, CHEM BIOL, V6, pR91, DOI 10.1016/S1074-5521(99)80033-7; PESCHKE U, 1995, MOL MICROBIOL, V16, P1137, DOI 10.1111/j.1365-2958.1995.tb02338.x; Pfennig F, 1999, J BIOL CHEM, V274, P12508, DOI 10.1074/jbc.274.18.12508; Pohle S, 2011, J AM CHEM SOC, V133, P6194, DOI 10.1021/ja108971p; Pojer F, 2002, MICROBIOL-SGM, V148, P3901, DOI 10.1099/00221287-148-12-3901; Popov AV, 2013, J COMPUT CHEM, V34, P319, DOI 10.1002/jcc.23135; Rantala-Ylinen A, 2011, APPL ENVIRON MICROB, V77, P7271, DOI 10.1128/AEM.06022-11; SAITO F, 1994, J BIOCHEM-TOKYO, V116, P357, DOI 10.1093/oxfordjournals.jbchem.a124532; Samel SA, 2006, J MOL BIOL, V359, P876, DOI 10.1016/j.jmb.2006.03.062; Scholz-Schroeder BK, 2003, MOL PLANT MICROBE IN, V16, P271, DOI 10.1094/MPMI.2003.16.4.271; Schrodinger L., 2020, PYMOL; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Shaw-Reid CA, 1999, CHEM BIOL, V6, P385, DOI 10.1016/S1074-5521(99)80050-7; Stachelhaus T, 1999, CHEM BIOL, V6, P493, DOI 10.1016/S1074-5521(99)80082-9; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thomas MG, 2002, CHEM BIOL, V9, P171, DOI 10.1016/S1074-5521(02)00100-X; Tsuge K, 1999, ANTIMICROB AGENTS CH, V43, P2183, DOI 10.1128/AAC.43.9.2183; Tsuge K, 2001, J BACTERIOL, V183, P6265, DOI 10.1128/JB.183.21.6265-6273.2001; Ulanova D, 2010, ANTIMICROB AGENTS CH, V54, P927, DOI 10.1128/AAC.00918-09; Wang Y, 2011, GENE, V483, P11, DOI 10.1016/j.gene.2011.05.005; Wang ZX, 2000, ANTIMICROB AGENTS CH, V44, P3040, DOI 10.1128/AAC.44.11.3040-3048.2000; Wenzel SC, 2005, CHEMBIOCHEM, V6, P375, DOI 10.1002/cbic.200400282; Wu QL, 2011, ANTIMICROB AGENTS CH, V55, P974, DOI 10.1128/AAC.01130-10; Yonus H, 2008, J BIOL CHEM, V283, P32484, DOI 10.1074/jbc.M800557200; Zhang XJ, 2007, ANTIMICROB AGENTS CH, V51, P946, DOI 10.1128/AAC.01214-06	70	18	20	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e84902	10.1371/journal.pone.0084902	http://dx.doi.org/10.1371/journal.pone.0084902			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281RE	24386435	Green Submitted, Green Published, gold			2022-12-25	WOS:000329117900118
J	Meyer, AN; Drafahl, KA; McAndrew, CW; Gilda, JE; Gallo, LH; Haas, M; Brill, LM; Donoghue, DJ				Meyer, April N.; Drafahl, Kristine A.; McAndrew, Christopher W.; Gilda, Jennifer E.; Gallo, Leandro H.; Haas, Martin; Brill, Laurence M.; Donoghue, Daniel J.			Tyrosine Phosphorylation Allows Integration of Multiple Signaling Inputs by IKK beta	PLOS ONE			English	Article							NF-KAPPA-B; GROWTH-FACTOR RECEPTOR-2; RHEUMATOID-ARTHRITIS; 2 FGFR2; KINASE; COMPLEX; ACTIVATION; MUTATIONS; ALPHA; CYTOKINE	Signaling regulated by NF kappa B and related transcription factors is centrally important to many inflammatory and autoimmune diseases, cancer, and stress responses. The kinase that directly regulates the canonical NF kappa B transcriptional pathway, Inhibitor of kappa B kinase beta (IKK beta), undergoes activation by Ser phosphorylation mediated by NIK or TAK1 in response to inflammatory signals. Using titanium dioxide-based phosphopeptide enrichment (TiO2)-liquid chromatography (LC)-high mass accuracy tandem mass spectrometry (MS/MS), we analyzed IKK beta phosphorylation in human HEK293 cells expressing IKK beta and FGFR2, a Receptor tyrosine kinase (RTK) essential for embryonic differentiation and dysregulated in several cancers. We attained unusually high coverage of IKK beta, identifying an abundant site of Tyr phosphorylation at Tyr169 within the Activation Loop. The phosphomimic at this site confers a level of kinase activation and NF kappa B nuclear localization exceeding the iconic mutant S177E/S181E, demonstrating that RTK-mediated Tyr phosphorylation of IKK beta has the potential to directly regulate NF kappa B transcriptional activation.	[Meyer, April N.; Drafahl, Kristine A.; McAndrew, Christopher W.; Gilda, Jennifer E.; Gallo, Leandro H.; Donoghue, Daniel J.] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Haas, Martin; Donoghue, Daniel J.] Univ Calif San Diego, Moores UCSD Canc Ctr, La Jolla, CA 92093 USA; [Brill, Laurence M.] Sanford Burnham Med Res Inst, La Jolla, CA USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Sanford Burnham Prebys Medical Discovery Institute	Donoghue, DJ (corresponding author), Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA.	ddonoghue@ucsd.edu			University of California Cancer Research Coordinating Committee; UC San Diego Foundation	University of California Cancer Research Coordinating Committee(University of California System); UC San Diego Foundation	Financial support provided by the University of California Cancer Research Coordinating Committee and the UC San Diego Foundation is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed KM, 2006, ANTICANCER RES, V26, P4235; Andreakos E, 2003, ARTHRITIS RHEUM, V48, P1901, DOI 10.1002/art.11044; Annunziata CM, 2007, CANCER CELL, V12, P115, DOI 10.1016/j.ccr.2007.07.004; [Anonymous], J BIOL CHEM, V277, P45129, DOI [10.1074/jbc.M205165200, DOI 10.1074/JBC.M205165200.]; Aupperle KR, 2001, J IMMUNOL, V166, P2705, DOI 10.4049/jimmunol.166.4.2705; Barisic S, 2010, BIOCHEM PHARMACOL, V80, P439, DOI 10.1016/j.bcp.2010.04.028; Bartova I, 2005, PROTEIN SCI, V14, P445, DOI 10.1110/ps.04959705; Cai DS, 2005, NAT MED, V11, P183, DOI 10.1038/nm1166; CHEN ZJ, 1995, GENE DEV, V9, P1586, DOI 10.1101/gad.9.13.1586; Courtois G, 2006, ONCOGENE, V25, P6831, DOI 10.1038/sj.onc.1209939; Delhase M, 1999, SCIENCE, V284, P309, DOI 10.1126/science.284.5412.309; DiDonato JA, 1997, NATURE, V388, P548, DOI 10.1038/41493; Drafahl KA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014412; Eswarakumar VP, 2005, CYTOKINE GROWTH F R, V16, P139, DOI 10.1016/j.cytogfr.2005.01.001; Gartside MG, 2009, MOL CANCER RES, V7, P41, DOI 10.1158/1541-7786.MCR-08-0021; Ghosh S, 2012, IMMUNOL REV, V246, P5, DOI 10.1111/j.1600-065X.2012.01111.x; Gilmore TD, 2007, CANCER CELL, V12, P95, DOI 10.1016/j.ccr.2007.07.010; Hart KC, 2001, MOL BIOL CELL, V12, P931, DOI 10.1091/mbc.12.4.931; Henson ES, 2003, J CELL BIOCHEM, V89, P1177, DOI 10.1002/jcb.10597; Hideshima T, 2009, BLOOD, V114, P1046, DOI 10.1182/blood-2009-01-199604; Hu MCT, 2004, CELL, V117, P225, DOI 10.1016/S0092-8674(04)00302-2; Hunter DJ, 2007, NAT GENET, V39, P870, DOI 10.1038/ng2075; Huttlin EL, 2010, CELL, V143, P1174, DOI 10.1016/j.cell.2010.12.001; Jang JH, 2001, CANCER RES, V61, P3541; Kao DD, 2013, MOL CELL BIOCH; Krappmann D, 2000, J BIOL CHEM, V275, P29779, DOI 10.1074/jbc.M003902200; Lee DF, 2008, CLIN CANCER RES, V14, P5656, DOI 10.1158/1078-0432.CCR-08-0123; Li ZW, 2008, CURR OPIN HEMATOL, V15, P391, DOI 10.1097/MOH.0b013e328302c7f4; Lin Y, 2010, EXPERT OPIN THER TAR, V14, P45, DOI 10.1517/14728220903431069; Liu F, 2012, IMMUNOL REV, V246, P239, DOI 10.1111/j.1600-065X.2012.01107.x; Liu HB, 2004, ANAL CHEM, V76, P4193, DOI 10.1021/ac0498563; Liu SH, 2013, J CHEM-NY, V2013, DOI 10.1155/2013/651901; Locascio LE, 2013, TRENDS BIOCHEM SCI, V38, P75, DOI 10.1016/j.tibs.2012.12.001; Ma L, 2013, CELL, V152, P599, DOI 10.1016/j.cell.2012.12.028; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Mercurio F, 1997, SCIENCE, V278, P860, DOI 10.1126/science.278.5339.860; Meyer AN, 2008, CANCER RES, V68, P7362, DOI 10.1158/0008-5472.CAN-08-0575; Naimi B, 2002, PROSTATE, V52, P245, DOI 10.1002/pros.10104; Ninomiya-Tsuji J, 1999, NATURE, V398, P252, DOI 10.1038/18465; Nogueira L, 2011, ONCOTARGET, V2, P646, DOI 10.18632/oncotarget.322; Pahl HL, 1999, ONCOGENE, V18, P6853, DOI 10.1038/sj.onc.1203239; PATI UK, 1992, GENE, V114, P285, DOI 10.1016/0378-1119(92)90589-H; Perkins ND, 2012, NAT REV CANCER, V12, P121, DOI 10.1038/nrc3204; Polley S, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001581; Ricol D, 1999, ONCOGENE, V18, P7234, DOI 10.1038/sj.onc.1203186; Robertson SC, 1998, P NATL ACAD SCI USA, V95, P4567, DOI 10.1073/pnas.95.8.4567; Rudolph D, 2000, GENE DEV, V14, P854; Schomer-Miller B, 2006, J BIOL CHEM, V281, P15268, DOI 10.1074/jbc.M513793200; Sethi G, 2007, ONCOGENE, V26, P7324, DOI 10.1038/sj.onc.1210544; TOBE BTD, 2012, CELL RESEARCH, V8, P16; Wei W, 2012, MOL CELL BIOL; Woronicz JD, 1997, SCIENCE, V278, P866, DOI 10.1126/science.278.5339.866; Xu GZ, 2011, NATURE, V472, P325, DOI 10.1038/nature09853; Yamaguchi H, 2013, ONCOGENE; Yamaoka S, 1998, CELL, V93, P1231, DOI 10.1016/S0092-8674(00)81466-X; Zandi E, 1997, CELL, V91, P243, DOI 10.1016/S0092-8674(00)80406-7; Zhang YH, 2013, CALCIFIED TISSUE INT, V93, P78, DOI 10.1007/s00223-013-9735-5; Zhang YZ, 1999, GENE, V230, P69, DOI 10.1016/S0378-1119(99)00047-5	58	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e84497	10.1371/journal.pone.0084497	http://dx.doi.org/10.1371/journal.pone.0084497			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281RE	24386391	Green Published, gold, Green Submitted			2022-12-25	WOS:000329117900100
J	Zhu, WQ; Chen, GS; Jiang, N; Liu, JH; Mou, MJ				Zhu, Wenquan; Chen, Guangsheng; Jiang, Nan; Liu, Jianhong; Mou, Minjie			Estimating Carbon Flux Phenology with Satellite-Derived Land Surface Phenology and Climate Drivers for Different Biomes: A Synthesis of AmeriFlux Observations	PLOS ONE			English	Article							GROWING-SEASON LENGTH; NET ECOSYSTEM PRODUCTIVITY; NDVI TIME-SERIES; DECIDUOUS FOREST; SPRING PHENOLOGY; INTERANNUAL VARIABILITY; WATER-VAPOR; VEGETATION; SEQUESTRATION; PHOTOSYNTHESIS	Carbon Flux Phenology (CFP) can affect the interannual variation in Net Ecosystem Exchange (NEE) of carbon between terrestrial ecosystems and the atmosphere. In this study, we proposed a methodology to estimate CFP metrics with satellite-derived Land Surface Phenology (LSP) metrics and climate drivers for 4 biomes (i.e., deciduous broadleaf forest, evergreen needleleaf forest, grasslands and croplands), using 159 site-years of NEE and climate data from 32 AmeriFlux sites and MODIS vegetation index time-series data. LSP metrics combined with optimal climate drivers can explain the variability in Start of Carbon Uptake (SCU) by more than 70% and End of Carbon Uptake (ECU) by more than 60%. The Root Mean Square Error (RMSE) of the estimations was within 8.5 days for both SCU and ECU. The estimation performance for this methodology was primarily dependent on the optimal combination of the LSP retrieval methods, the explanatory climate drivers, the biome types, and the specific CFP metric. This methodology has a potential for allowing extrapolation of CFP metrics for biomes with a distinct and detectable seasonal cycle over large areas, based on synoptic multi-temporal optical satellite data and climate data.	[Zhu, Wenquan] Beijing Normal Univ, State Key Lab Earth Surface Proc & Resource Ecol, Beijing 100875, Peoples R China; [Zhu, Wenquan; Jiang, Nan; Liu, Jianhong; Mou, Minjie] Beijing Normal Univ, Coll Resources Sci & Technol, Beijing 100875, Peoples R China; [Chen, Guangsheng] Oak Ridge Natl Lab, Div Environm Sci, Oak Ridge, TN 37831 USA	Beijing Normal University; Beijing Normal University; United States Department of Energy (DOE); Oak Ridge National Laboratory	Zhu, WQ (corresponding author), Beijing Normal Univ, State Key Lab Earth Surface Proc & Resource Ecol, Beijing 100875, Peoples R China.	zhuwq75@bnu.edu.cn	JIANG, NAN/HHN-3354-2022; Chen, Guangsheng/AAC-4462-2022; Liu, Jianhong/E-6312-2018	JIANG, NAN/0000-0001-5151-5715; Liu, Jianhong/0000-0002-8050-4780	National Natural Science Foundation of China [41371389]; State Key Laboratory of Earth Surface Processes and Resource Ecology [2013-ZY-14]; Fundamental Research Funds for the Central University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Laboratory of Earth Surface Processes and Resource Ecology; Fundamental Research Funds for the Central University	This work was supported by the National Natural Science Foundation of China (Grant No. 41371389), the State Key Laboratory of Earth Surface Processes and Resource Ecology (Grant No. 2013-ZY-14), and the Fundamental Research Funds for the Central University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badeck FW, 2004, NEW PHYTOL, V162, P295, DOI 10.1111/j.1469-8137.2004.01059.x; Baldocchi D, 2001, B AM METEOROL SOC, V82, P2415, DOI 10.1175/1520-0477(2001)082<2415:FANTTS>2.3.CO;2; Baldocchi DD, 2005, INT J BIOMETEOROL, V49, P377, DOI 10.1007/s00484-005-0256-4; Baldocchi DD, 2001, ECOL MODEL, V142, P155, DOI 10.1016/S0304-3800(01)00287-3; Beck PSA, 2006, REMOTE SENS ENVIRON, V100, P321, DOI 10.1016/j.rse.2005.10.021; Bergeron O, 2007, GLOBAL CHANGE BIOL, V13, P89, DOI 10.1111/j.1365-2486.2006.01281.x; Black TA, 2000, GEOPHYS RES LETT, V27, P1271, DOI 10.1029/1999GL011234; Campbell JB., 2007, INTRO REMOTE SENSING; Chen J, 2004, REMOTE SENS ENVIRON, V91, P332, DOI 10.1016/j.rse.2004.03.014; Chen WJ, 1999, GLOBAL CHANGE BIOL, V5, P41, DOI 10.1046/j.1365-2486.1998.00201.x; Churkina G, 2005, GLOBAL CHANGE BIOL, V11, P1777, DOI 10.1111/j.1365-2486.2005.001012.x; Cong N, 2013, GLOBAL CHANGE BIOL, V19, P881, DOI 10.1111/gcb.12077; Cramer W, 2001, GLOBAL CHANGE BIOL, V7, P357, DOI 10.1046/j.1365-2486.2001.00383.x; Dragoni D, 2011, GLOBAL CHANGE BIOL, V17, P886, DOI 10.1111/j.1365-2486.2010.02281.x; FISCHER A, 1994, REMOTE SENS ENVIRON, V48, P220, DOI 10.1016/0034-4257(94)90143-0; Garrity SR, 2011, AGR FOREST METEOROL, V151, P1741, DOI 10.1016/j.agrformet.2011.07.008; Gonsamo A, 2012, AGR FOREST METEOROL, V165, P127, DOI 10.1016/j.agrformet.2012.06.006; Gonsamo A, 2012, J GEOPHYS RES-BIOGEO, V117, DOI 10.1029/2012JG002070; Hird JN, 2009, REMOTE SENS ENVIRON, V113, P248, DOI 10.1016/j.rse.2008.09.003; HOLBEN B, 1984, INT J REMOTE SENS, V5, P145, DOI 10.1080/01431168408948795; Jonsson P, 2002, IEEE T GEOSCI REMOTE, V40, P1824, DOI 10.1109/TGRS.2002.802519; Kobayashi H, 2005, REMOTE SENS ENVIRON, V97, P519, DOI 10.1016/j.rse.2005.06.007; KRAMER K, 1995, CLIMATE RES, V5, P119, DOI 10.3354/cr005119; Lindroth A, 2008, TELLUS B, V60, P129, DOI 10.1111/j.1600-0889.2007.00330.x; LLOYD D, 1990, INT J REMOTE SENS, V11, P2269, DOI 10.1080/01431169008955174; Markon Carl J., 1995, Polar Record, V31, P179; MYNENI RB, 1995, REMOTE SENS ENVIRON, V51, P169, DOI 10.1016/0034-4257(94)00073-V; Peng Y, 2011, REMOTE SENS ENVIRON, V115, P978, DOI 10.1016/j.rse.2010.12.001; Piao SL, 2008, NATURE, V451, P49, DOI 10.1038/nature06444; Piao SL, 2006, GLOBAL CHANGE BIOL, V12, P672, DOI 10.1111/j.1365-2486.2006.01123.x; REED BC, 1994, J VEG SCI, V5, P703, DOI 10.2307/3235884; Richardson AD, 2013, AGR FOREST METEOROL, V169, P156, DOI 10.1016/j.agrformet.2012.09.012; Richardson AD, 2010, PHILOS T R SOC B, V365, P3227, DOI 10.1098/rstb.2010.0102; Richardson AD, 2009, TREE PHYSIOL, V29, P321, DOI 10.1093/treephys/tpn040; SHAO J, 1993, J AM STAT ASSOC, V88, P486, DOI 10.2307/2290328; Sparks TH, 2002, INT J CLIMATOL, V22, P1715, DOI 10.1002/joc.821; Tanja S, 2003, GLOBAL CHANGE BIOL, V9, P1410, DOI 10.1046/j.1365-2486.2003.00597.x; White MA, 1997, GLOBAL BIOGEOCHEM CY, V11, P217, DOI 10.1029/97GB00330; White MA, 2003, GLOBAL CHANGE BIOL, V9, P967, DOI 10.1046/j.1365-2486.2003.00585.x; White MA, 1999, INT J BIOMETEOROL, V42, P139, DOI 10.1007/s004840050097; White MA, 2009, GLOBAL CHANGE BIOL, V15, P2335, DOI 10.1111/j.1365-2486.2009.01910.x; Wu CY, 2013, GLOBAL ECOL BIOGEOGR, V22, P994, DOI 10.1111/geb.12044; Wu CY, 2012, AGR FOREST METEOROL, V164, P29, DOI 10.1016/j.agrformet.2012.05.002; Wu CY, 2012, GLOBAL PLANET CHANGE, V92-93, P179, DOI 10.1016/j.gloplacha.2012.05.021; Zhang WJ, 2011, BIOGEOSCIENCES, V8, P1667, DOI 10.5194/bg-8-1667-2011; Zhang XY, 2004, GLOBAL CHANGE BIOL, V10, P1133, DOI 10.1111/j.1529-8817.2003.00784.x; Zhang XY, 2003, REMOTE SENS ENVIRON, V84, P471, DOI 10.1016/S0034-4257(02)00135-9; Zhu WQ, 2012, GLOBAL ECOL BIOGEOGR, V21, P260, DOI 10.1111/j.1466-8238.2011.00675.x	48	12	13	2	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e84990	10.1371/journal.pone.0084990	http://dx.doi.org/10.1371/journal.pone.0084990			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281RE	24386441	Green Submitted, Green Published, gold			2022-12-25	WOS:000329117900119
J	Nicholas, LM; Morrison, JL; Rattanatray, L; Ozanne, SE; Kleemann, DO; Walker, SK; MacLaughlin, SM; Zhang, S; Martin-Gronert, MS; McMillen, IC				Nicholas, Lisa M.; Morrison, Janna L.; Rattanatray, Leewen; Ozanne, Susan E.; Kleemann, Dave O.; Walker, Simon K.; MacLaughlin, Severence M.; Zhang, Song; Martin-Gronert, Malgorzata S.; McMillen, Isabella C.			Differential Effects of Exposure to Maternal Obesity or Maternal Weight Loss during the Periconceptional Period in the Sheep on Insulin Signalling Molecules in Skeletal Muscle of the Offspring at 4 Months of Age	PLOS ONE			English	Article							GLYCOGEN-SYNTHASE KINASE-3; DIET-INDUCED OBESITY; LOW-BIRTH-WEIGHT; GLUCOSE-TOLERANCE; YOUNG MEN; RESISTANCE; METABOLISM; GROWTH; LEADS; UNDERNUTRITION	Exposure to maternal obesity before and/or throughout pregnancy may increase the risk of obesity and insulin resistance in the offspring in childhood and adult life, therefore, resulting in its transmission into subsequent generations. We have previously shown that exposure to maternal obesity around the time of conception alone resulted in increased adiposity in female lambs. Changes in the abundance of insulin signalling molecules in skeletal muscle and adipose tissue precede the development of insulin resistance and type 2 diabetes. It is not clear, however, whether exposure to maternal obesity results in insulin resistance in her offspring as a consequence of the impact of increased adiposity on skeletal muscle or as a consequence of the programming of specific changes in the abundance of insulin signalling molecules in this tissue. We have used an embryo transfer model in the sheep to investigate the effects of exposure to either maternal obesity or to weight loss in normal and obese mothers preceding and for one week after conception on the expression and abundance of insulin signalling molecules in muscle in the offspring. We found that exposure to maternal obesity resulted in lower muscle GLUT-4 and Ser 9 phospho-GSK3 alpha and higher muscle GSK3 alpha abundance in lambs when compared to lambs conceived in normally nourished ewes. Exposure to maternal weight loss in normal or obese mothers, however, resulted in lower muscle IRS1, PI3K, p110 beta, aPKC zeta, Thr 642 phospho-AS160 and GLUT-4 abundance in the offspring. In conclusion, maternal obesity or weight loss around conception have each programmed specific changes on subsets of molecules in the insulin signalling, glucose transport and glycogen synthesis pathways in offspring. There is a need for a stronger evidence base to ensure that weight loss regimes in obese women seeking to become pregnant minimize the metabolic costs for the next generation.	[Nicholas, Lisa M.; Morrison, Janna L.; Rattanatray, Leewen; MacLaughlin, Severence M.; Zhang, Song; McMillen, Isabella C.] Univ S Australia, Sansom Inst Hlth Res, Sch Pharm & Med Sci, Adelaide, SA 5001, Australia; [Rattanatray, Leewen] Univ Adelaide, Discipline Physiol, Sch Mol & Life Sci, Adelaide, SA, Australia; [Ozanne, Susan E.; Martin-Gronert, Malgorzata S.] Univ Cambridge, Addenbrookes Hosp, Metab Res Labs, Wellcome Trust MRC Inst Metab Sci, Cambridge CB2 2QQ, England; [Kleemann, Dave O.; Walker, Simon K.] South Australian Res & Dev Inst, Turretfield Res Ctr, Rosedale, SA, Australia	University of South Australia; University of Adelaide; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; South Australian Research & Development Institute (SARDI)	McMillen, IC (corresponding author), Univ S Australia, Sansom Inst Hlth Res, Sch Pharm & Med Sci, Adelaide, SA 5001, Australia.	caroline.mcmillen@newcastle.edu.au	Morrison, Janna/B-8308-2009; McMillen, Isabella Caroline/N-5540-2019	Morrison, Janna/0000-0002-8602-8519; Ozanne, Susan/0000-0001-8753-5144; Nicholas, Lisa/0000-0003-1976-1953	National Health and Medical Research Council [631928]; South Australian Cardiovascular Research Network Fellowship [CR10A4988]; British Heart Foundation [FS/09/029/27902] Funding Source: researchfish	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); South Australian Cardiovascular Research Network Fellowship; British Heart Foundation(British Heart Foundation)	This work was funded by National Health and Medical Research Council Project, Grant 631928. JLM was funded by a South Australian Cardiovascular Research Network Fellowship (CR10A4988). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Alderman G., 1993, ENERGY PROTEIN REQUI; Alkhateeb H, 2009, AM J PHYSIOL-ENDOC M, V297, pE1056, DOI 10.1152/ajpendo.90908.2008; Boney CM, 2005, PEDIATRICS, V115, pE290, DOI 10.1542/peds.2004-1808; Buckley AJ, 2005, METABOLISM, V54, P500, DOI 10.1016/j.metabol.2004.11.003; CAMPS M, 1992, BIOCHEM J, V282, P765, DOI 10.1042/bj2820765; Cartee GD, 2007, APPL PHYSIOL NUTR ME, V32, P557, DOI 10.1139/H07-026; Catalano PM, 2006, BJOG-INT J OBSTET GY, V113, P1126, DOI 10.1111/j.1471-0528.2006.00989.x; Catalano PM, 2003, J CLIN ENDOCR METAB, V88, P3505, DOI 10.1210/jc.2003-031046; de Rooij SR, 2006, DIABETES CARE, V29, P1897, DOI 10.2337/dc06-0460; Dokken BB, 2005, AM J PHYSIOL-ENDOC M, V288, pE1188, DOI 10.1152/ajpendo.00547.2004; DORNER G, 1994, HORM METAB RES, V26, P213, DOI 10.1055/s-2007-1001668; Eldar-Finkelman H, 1999, DIABETES, V48, P1662, DOI 10.2337/diabetes.48.8.1662; Farese RV, 2005, BIOCHEM SOC T, V33, P350, DOI 10.1042/BST0330350; Farese RV, 2002, AM J PHYSIOL-ENDOC M, V283, pE1, DOI 10.1152/ajpendo.00045.2002; Flegal KM, 2002, JAMA-J AM MED ASSOC, V288, P1723, DOI 10.1001/jama.288.14.1723; Forhead AJ, 2008, J PHYSIOL-LONDON, V586, P2393, DOI 10.1113/jphysiol.2007.149237; Greenfield JR, 2004, CLIN DERMATOL, V22, P289, DOI 10.1016/j.clindermatol.2004.01.011; Greenwood PL, 2000, REPROD FERT DEVELOP, V12, P149, DOI 10.1071/RD00053; Henriksen EJ, 2006, CURR DRUG TARGETS, V7, P1435, DOI 10.2174/1389450110607011435; Jensen CB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003738; Kakar MA, 2005, THERIOGENOLOGY, V64, P1090, DOI 10.1016/j.theriogenology.2004.12.017; KERN M, 1990, BIOCHEM J, V270, P397, DOI 10.1042/bj2700397; Khan AH, 2002, DIABETOLOGIA, V45, P1475, DOI 10.1007/s00125-002-0974-7; Kockeritz L, 2006, CURR DRUG TARGETS, V7, P1377, DOI 10.2174/1389450110607011377; Kumanyika SK, 2008, CIRCULATION, V118, P428, DOI 10.1161/CIRCULATIONAHA.108.189702; Li XH, 2007, NATURE, V447, P1012, DOI 10.1038/nature05861; Long NM, 2010, J ANIM SCI, V88, P3546, DOI 10.2527/jas.2010-3083; Mauvais-Jarvis F, 2002, J CLIN INVEST, V109, P141, DOI 10.1172/JCI200213305; Nikoulina SE, 2000, DIABETES, V49, P263, DOI 10.2337/diabetes.49.2.263; Nivoit P, 2009, DIABETOLOGIA, V52, P1133, DOI 10.1007/s00125-009-1316-9; Ogden CL, 2007, GASTROENTEROLOGY, V132, P2087, DOI 10.1053/j.gastro.2007.03.052; Ozanne SE, 2006, DIABETOLOGIA, V49, P2993, DOI 10.1007/s00125-006-0466-2; Ozanne SE, 2005, DIABETOLOGIA, V48, P547, DOI 10.1007/s00125-005-1669-7; Ozanne SE, 2003, J ENDOCRINOL, V177, P235, DOI 10.1677/joe.0.1770235; PETTITT DJ, 1993, DIABETES CARE, V16, P310, DOI 10.2337/diacare.16.1.310; Poston L, 2011, PEDIATR RES, V69, P175, DOI 10.1203/PDR.0b013e3182055ede; Rattanatray L, 2010, ENDOCRINOLOGY, V151, P5195, DOI 10.1210/en.2010-0501; RUSSEL AJF, 1981, J AGR SCI, V97, P723, DOI 10.1017/S0021859600037096; Samuelsson AM, 2008, HYPERTENSION, V51, P383, DOI 10.1161/HYPERTENSIONAHA.107.101477; Savage DB, 2007, PHYSIOL REV, V87, P507, DOI 10.1152/physrev.00024.2006; Shepherd PR, 1999, NEW ENGL J MED, V341, P248, DOI 10.1056/NEJM199907223410406; Silverman BL, 1998, DIABETES CARE, V21, pB142; Smith NA, 2010, ANIM REPROD SCI, V121, P94, DOI 10.1016/j.anireprosci.2010.05.001; *STAT ABO, 2007, AUSTR SOC TRENDS; Tamashiro KLK, 2009, DIABETES, V58, P1116, DOI 10.2337/db08-1129; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; Taniguchi CM, 2007, MOL CELL BIOL, V27, P2830, DOI 10.1128/MCB.00079-07; Taylor PD, 2005, AM J PHYSIOL-REG I, V288, pR134, DOI 10.1152/ajpregu.00355.2004; Todd SE, 2009, PEDIATR RES, V65, P409, DOI 10.1203/PDR.0b013e3181975efa; Whitaker RC, 2004, PEDIATRICS, V114, pE29, DOI 10.1542/peds.114.1.e29; Yan X, 2011, BIOL REPROD, V85, P172, DOI 10.1095/biolreprod.110.089649; Zhang S, 2011, PROG BIOPHYS MOL BIO, V106, P307, DOI 10.1016/j.pbiomolbio.2010.12.004; Zhang S, 2011, EXP DIABETES RES, DOI 10.1155/2011/585749; Zhang S, 2010, FASEB J, V24, P2772, DOI 10.1096/fj.09-154294; Zierath JR, 2000, DIABETOLOGIA, V43, P821, DOI 10.1007/s001250051457	55	25	26	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e84594	10.1371/journal.pone.0084594	http://dx.doi.org/10.1371/journal.pone.0084594			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281QS	24386400	Green Published, Green Submitted, gold			2022-12-25	WOS:000329116700111
J	Qu, JL; Li, X; Qu, XJ; Zhu, ZT; Zhou, LZ; Teng, YE; Zhang, JD; Jin, B; Zhao, MF; Yu, P; Liu, YP				Qu, Jing-lei; Li, Xin; Qu, Xiu-juan; Zhu, Zhi-tu; Zhou, Li-zhong; Teng, Yue-e; Zhang, Jing-dong; Jin, Bo; Zhao, Ming-fang; Yu, Ping; Liu, Yun-peng			Optimal Duration of Fluorouracil-Based Adjuvant Chemotherapy for Patients with Resectable Gastric Cancer	PLOS ONE			English	Article							LYMPH-NODE DISSECTION; PHASE-III TRIAL; STAGE-II; SURGERY; CAPECITABINE; OXALIPLATIN; PACLITAXEL; SURVIVAL; BENEFIT; CYCLES	Background: Although several clinical trials have suggested that postoperative adjuvant chemotherapy can improve survival of patients with gastric cancer, the optimal treatment duration has not been studied. This retrospective analysis evaluated the outcomes of patients with gastric cancer treated with six cycles of fluorouracil-based treatment compared with a cohort treated with four or eight cycles. Methods: We retrospectively identified 237 patients with stage IB-IIIC gastric cancer who received four, six, or eight cycles of fluorouracil-based adjuvant chemotherapy administered every 3 weeks after radical gastrectomy. The endpoint was overall survival (OS). Factors associated with prognosis were also analyzed. Results: The estimated 3-year OS rates for the four-, six-, and eight-cycle cohorts were 54.4%, 76.1%, and 68.9%, respectively; and the estimated 5-year OS rates were 41.2%, 74.0%, and 65.8%, respectively. Patients who received six cycles were more likely to have a better OS than those who received four cycles (P = 0.002). Eight cycles failed to show an additional survival benefit (P = 0.454). In the multivariate analysis, the number of chemotherapy cycles was associated with OS independent of clinical covariates (P<0.05). Subgroup analysis suggested that among patients in all age groups examined, male patients, and subgroups of fluorouracil plus oxaliplatin combined chemotherapy, stage III, poor differentiation, and gastrectomy with D2 lymphadenectomy, six cycles of adjuvant chemotherapy were associated with a statistically significant benefit of OS compared with four cycles (P<0.05). Conclusions: Six cycles of adjuvant chemotherapy might lead to a favorable outcome for patients with gastric cancer, and two further cycles could not provide an additional clinical benefit.	[Qu, Jing-lei; Li, Xin; Qu, Xiu-juan; Teng, Yue-e; Zhang, Jing-dong; Jin, Bo; Zhao, Ming-fang; Yu, Ping; Liu, Yun-peng] China Med Univ, Hosp 1, Dept Med Oncol, Shenyang, Peoples R China; [Zhu, Zhi-tu] Liaoning Med Univ, Affiliated Hosp 1, Dept Oncol, Jinzhou, Peoples R China; [Zhou, Li-zhong] Fourth Hosp Anshan, Dept Med Oncol, Anshan, Peoples R China	China Medical University; Jinzhou Medical University	Qu, XJ (corresponding author), China Med Univ, Hosp 1, Dept Med Oncol, Shenyang, Peoples R China.	qu_xiujuan@hotmail.com; cmuliuyunpeng@hotmail.com	Zhang, Jing/HII-4294-2022; Zhang, Jing/GWZ-7332-2022		National Natural Science Foundation of China [31000607, 81172369]; National Science and Technology Major Project of the Ministry of Science and Technology of China [2013JX09303002]; Program for Liaoning Excellent Talents in University, LNET [LJQ2011082]; Key Laboratory Project of Liaoning Provincial Education Department [LS2010169]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science and Technology Major Project of the Ministry of Science and Technology of China; Program for Liaoning Excellent Talents in University, LNET; Key Laboratory Project of Liaoning Provincial Education Department	This study was supported by the National Natural Science Foundation of China (No. 31000607, NO. 81172369), National Science and Technology Major Project of the Ministry of Science and Technology of China (No. 2013JX09303002), Program for Liaoning Excellent Talents in University, LNET (No. LJQ2011082), and The Key Laboratory Project of Liaoning Provincial Education Department (No. LS2010169). No conflict of interest to be declared. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoyama T, 2012, GASTRIC CANCER, V15, P76, DOI 10.1007/s10120-011-0068-7; Bang YJ, 2012, LANCET, V379, P315, DOI 10.1016/S0140-6736(11)61873-4; Bennett BK, 2012, SUPPORT CARE CANCER, V20, P2959, DOI 10.1007/s00520-012-1428-5; Chansky K, 2005, CANCER-AM CANCER SOC, V103, P1165, DOI 10.1002/cncr.20878; Chen S, 2011, AM J CLIN ONCOL-CANC, V34, P309, DOI 10.1097/COC.0b013e3181dea94e; Cunningham D, 2006, NEW ENGL J MED, V355, P11, DOI 10.1056/NEJMoa055531; Des Guetz G, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007046.pub2; Dikken JL, 2010, J CLIN ONCOL, V28, P2430, DOI 10.1200/JCO.2009.26.9654; Dizon DS, 2006, GYNECOL ONCOL, V100, P417, DOI 10.1016/j.ygyno.2005.10.031; Edge SB, 2009, AM JOINT COMMITTEE C; Jin Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053149; Lee J, 2012, J CLIN ONCOL, V30, P268, DOI 10.1200/JCO.2011.39.1953; Macdonald JS, 2001, NEW ENGL J MED, V345, P725, DOI 10.1056/NEJMoa010187; Muratore A, 2009, EJSO-EUR J SURG ONC, V35, P588, DOI 10.1016/j.ejso.2008.12.012; Neugut AI, 2006, J CLIN ONCOL, V24, P2368, DOI 10.1200/JCO.2005.04.5005; Paoletti X, 2010, JAMA-J AM MED ASSOC, V303, P1729, DOI 10.1001/jama.2010.534; Rougier P, 2011, ANN ONCOL, V22, pv14; Sasako M, 2011, J CLIN ONCOL, V29, P4387, DOI 10.1200/JCO.2011.36.5908; Shulman LN, 2012, J CLIN ONCOL, V30, P4071, DOI 10.1200/JCO.2011.40.6405; Socinski MA, 2007, J CLIN ONCOL, V25, P5155, DOI 10.1200/JCO.2007.13.4015; Van Cutsem E, 2011, ANN ONCOL, V22, pv1, DOI 10.1093/annonc/mdr284	21	13	14	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e83196	10.1371/journal.pone.0083196	http://dx.doi.org/10.1371/journal.pone.0083196			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281QS	24386161	Green Submitted, gold, Green Published			2022-12-25	WOS:000329116700035
J	Chen, BB; Zhang, Y; Chen, LH; Huang, SW; Li, ST; Yao, JY				Chen, Binbin; Zhang, Yi; Chen, Lianhua; Huang, Shiwei; Li, Shitong; Yao, Junyan			Dose-Effects of Aorta-Infused Clenbuterol on Spinal Cord Ischemia-Reperfusion Injury in Rabbits	PLOS ONE			English	Article							TRANSIENT FOREBRAIN ISCHEMIA; DELAYED-ONSET PARAPLEGIA; BETA(2)-ADRENOCEPTOR AGONIST; BETA-2-ADRENERGIC RECEPTOR; ACTIVATES ASTROCYTES; CEREBRAL-ISCHEMIA; RAT HIPPOCAMPUS; STROKE MODEL; BRAIN-INJURY; DAMAGE	Background: The beta(2) adrenergic receptor (beta(2)AR) plays an important role in ischemia-reperfusion (I/R) injury in various organs. Recently, a selective beta(2)AR agonist clenbuterol was suggested to protect against cerebral I/R injury. This study was designed to investigate changes of beta(2)ARs after spinal cord I/R injury and dose-effects of aorta-infused clenbuterol on spinal cord I/R injury in rabbits. Methods: Spinal cord ischemia was induced in New Zealand white rabbits by infrarenal abdominal aortic occlusion with a balloon catheter for 30 minutes except the sham group. During occlusion, nothing (I/R group), normal saline (NS group) or clenbuterol at different doses of 0.005, 0.01, 0.05, 0.1, 0.5, or 1 mg/kg (C-0.005, C-0.01, C-0.05, C-0.1, C-0.5, and C-1 groups) was infused into the occluded aortic segments. The hemodynamic data, blood glucose and serum electrolytes were measured during experimental period. Neurological function was assessed according to the modified Tarlov scales until 48 hours after reperfusion. After that, the lumbar spinal cord was harvested for beta(2)AR immunohistochemistry and histopathologic evaluation in the anterior horns. Results: The beta(2)AR expression in the anterior horns of the spinal cord was significantly higher in the I/R group than in the sham group. Tarlov scores and the number of viable a-motor neurons were higher in C-0.01-C-0.5 groups than in the NS group, C0.005 and C-1 groups and were highest in the C-0.1 group. Hypotension and hyperglycemia were found in the C-1 group. Conclusion: beta(2)ARs in the anterior horn were upregulated after spinal cord I/R injury. Aortic-infused clenbuterol (0.01-0.5 mg/kg) can attenuate spinal cord I/R injury dose-dependently during the ischemic period. The Optimal dosage was 0.1 mg/kg. Activation of beta(2)AR could be a new therapeutic strategy for the treatment of spinal cord I/R injury.	[Chen, Binbin; Zhang, Yi; Chen, Lianhua; Huang, Shiwei; Li, Shitong; Yao, Junyan] Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 1, Dept Anesthesiol, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University	Yao, JY (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 1, Dept Anesthesiol, Shanghai 200030, Peoples R China.	sunshineyao@163.com			National Natural Science Foundation of China [30901392]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (Grant No. 30901392, www.nsfc.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apaydin AZ, 2001, TEX HEART I J, V28, P172; Bai FS, 2010, PFLUG ARCH EUR J PHY, V460, P657, DOI 10.1007/s00424-010-0852-y; Ballard Jeffrey L, 2005, Perspect Vasc Surg Endovasc Ther, V17, P207, DOI 10.1177/153100350501700305; Baptiste DC, 2006, J NEUROTRAUM, V23, P318, DOI 10.1089/neu.2006.23.318; Culmsee C, 2004, STROKE, V35, P1197, DOI 10.1161/01.STR.0000125855.17686.6d; Culmsee C, 1999, EUR J PHARMACOL, V379, P33, DOI 10.1016/S0014-2999(99)00452-5; Culmsee C, 1999, NEUROCHEM INT, V35, P47, DOI 10.1016/S0197-0186(99)00032-7; Culmsee C, 2009, ANESTH ANALG, V108, P3, DOI 10.1213/ane.0b013e31818db6f6; de Haan P, 2001, J NEUROSURG ANESTH, V13, P3, DOI 10.1097/00008506-200101000-00002; Ehrlich M, 1999, J THORAC CARDIOV SUR, V117, P285, DOI 10.1016/S0022-5223(99)70424-1; Hamaishi M, 2009, ANN VASC SURG, V23, P128, DOI 10.1016/j.avsg.2008.05.010; Han RQ, 2009, ANESTH ANALG, V108, P280, DOI 10.1213/ane.0b013e318187ba6b; Herlambang B, 2011, J VASC SURG, V54, P1109, DOI 10.1016/j.jvs.2011.04.043; Hoffman RJ, 2001, J TOXICOL-CLIN TOXIC, V39, P339, DOI 10.1081/CLT-100105152; Hwang J, 2012, SPINAL CORD, V50, P208, DOI 10.1038/sc.2011.136; Iwamoto Satoshi, 2009, Interact Cardiovasc Thorac Surg, V8, P606, DOI 10.1510/icvts.2008.197244; JACOBS TP, 1987, STROKE, V18, P741, DOI 10.1161/01.STR.18.4.741; Junker V, 2002, EUR J PHARMACOL, V446, P25, DOI 10.1016/S0014-2999(02)01814-9; Kaptanoglu E, 2002, J NEUROSURG ANESTH, V14, P114, DOI 10.1097/00008506-200204000-00005; Kiyoshima T, 2003, ANESTH ANALG, V96, P839, DOI 10.1213/01.ANE.0000047268.41102.D4; Lee BY, 2011, ARCH MED SCI, V7, P597, DOI 10.5114/aoms.2011.24128; Maslov L N, 2012, Angiol Sosud Khir, V18, P27; Mieno S, 2005, SCAND CARDIOVASC J, V39, P313, DOI 10.1080/14017430510009104; Mizukami Tetsuya, 2004, Kurume Medical Journal, V51, P175; MOORE WM, 1991, ANN SURG, V213, P427, DOI 10.1097/00000658-199105000-00007; MUTCH WAC, 1993, STROKE, V24, P1554, DOI 10.1161/01.STR.24.10.1554; Okita Y, 2011, GEN THORAC CARDIOVAS, V59, P79, DOI 10.1007/s11748-010-0668-x; OSBORNE KA, 1987, J NEUROL NEUROSUR PS, V50, P402, DOI 10.1136/jnnp.50.4.402; Patterson AJ, 2004, CRIT CARE MED, V32, P1041, DOI 10.1097/01.CCM.0000120049.43113.90; Penna C, 2007, J STEROID BIOCHEM, V107, P106, DOI 10.1016/j.jsbmb.2007.05.005; Rami A, 2003, NEUROSCI RES, V47, P373, DOI 10.1016/j.neures.2003.07.002; SALORINNE Y, 1975, EUR J CLIN PHARMACOL, V8, P189, DOI 10.1007/BF00567113; Schnell L, 1999, EUR J NEUROSCI, V11, P3648, DOI 10.1046/j.1460-9568.1999.00792.x; Semkova I, 1996, BRAIN RES, V717, P44, DOI 10.1016/0006-8993(95)01567-1; Shi EY, 2007, J THORAC CARDIOV SUR, V133, P942, DOI 10.1016/j.jtcvs.2006.12.017; SMITH ML, 1988, ACTA NEUROPATHOL, V76, P253, DOI 10.1007/BF00687772; SMITH ML, 1984, ACTA NEUROPATHOL, V64, P319, DOI 10.1007/BF00690397; Takahashi S, 2013, J VASC SURG IN PRESS; TARLOV IM, 1972, J NEUROSURG, V36, P10, DOI 10.3171/jns.1972.36.1.0010; WARNER DS, 1987, STROKE, V18, P464, DOI 10.1161/01.STR.18.2.464; WATERFIELD CJ, 1995, EUR J PHARM-ENVIRON, V293, P141, DOI 10.1016/0926-6917(95)00010-0; White R, 2012, FILM QUART, V65, P4, DOI 10.1525/FQ.2012.65.3.04; Wu Q, 2008, EXP PHYSIOL, V93, P1034, DOI 10.1113/expphysiol.2007.041939; Yu QJ, 2008, ANN VASC SURG, V22, P432, DOI 10.1016/j.avsg.2008.03.003; Zeman RJ, 2006, J NEUROTRAUM, V23, P170, DOI 10.1089/neu.2006.23.170; Zeman RJ, 1999, EXP NEUROL, V159, P267, DOI 10.1006/exnr.1999.7146; Zhang QF, 2010, BRIT J PHARMACOL, V160, P1561, DOI 10.1111/j.1476-5381.2010.00813.x; Zhu Y, 1998, J CEREBR BLOOD F MET, V18, P1032, DOI 10.1097/00004647-199809000-00013; Zhu Y, 1999, NEUROSCIENCE, V90, P1255, DOI 10.1016/S0306-4522(98)00564-8; ZIVIN JA, 1980, STROKE, V11, P200, DOI 10.1161/01.STR.11.2.200; Zvara David A, 2002, J Extra Corpor Technol, V34, P11	51	8	10	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84095	10.1371/journal.pone.0084095	http://dx.doi.org/10.1371/journal.pone.0084095			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391890	Green Published, Green Submitted, gold			2022-12-25	WOS:000329323900033
J	Degos, B; Deniau, JM; Chavez, M; Maurice, N				Degos, Bertrand; Deniau, Jean-Michel; Chavez, Mario; Maurice, Nicolas			Subthalamic Nucleus High-Frequency Stimulation Restores Altered Electrophysiological Properties of Cortical Neurons in Parkinsonian Rat	PLOS ONE			English	Article							DEEP-BRAIN-STIMULATION; MOTOR CORTEX EXCITABILITY; NIGRA PARS RETICULATA; GENETICALLY-DETERMINED SPIKE; BASAL GANGLIA; WAVE DISCHARGES; STRIATAL NEURONS; THALAMIC NEURONS; ABSENCE EPILEPSY; IN-VIVO	Electrophysiological recordings performed in parkinsonian patients and animal models have confirmed the occurrence of alterations in firing rate and pattern of basal ganglia neurons, but the outcome of these changes in thalamo-cortical networks remains unclear. Using rats rendered parkinsonian, we investigated, at a cellular level in vivo, the electrophysiological changes induced in the pyramidal cells of the motor cortex by the dopaminergic transmission interruption and further characterized the impact of high-frequency electrical stimulation of the subthalamic nucleus, a procedure alleviating parkinsonian symptoms. We provided evidence that a lesion restricted to the substantia nigra pars compacta resulted in a marked increase in the mean firing rate and bursting pattern of pyramidal neurons of the motor cortex. These alterations were underlain by changes of the electrical membranes properties of pyramidal cells including depolarized resting membrane potential and increased input resistance. The modifications induced by the dopaminergic loss were more pronounced in cortico-striatal than in cortico-subthalamic neurons. Furthermore, subthalamic nucleus high-frequency stimulation applied at parameters alleviating parkinsonian signs regularized the firing pattern of pyramidal cells and restored their electrical membrane properties.	[Degos, Bertrand; Deniau, Jean-Michel; Maurice, Nicolas] CNRS UMR7241, INSERM U1050, Coll France, Team Dynam & Pathophysiol Neuronal Networks,CIRB, Paris, France; [Degos, Bertrand] Hop La Pitie Salpetriere, APHP, Ctr Reference Malad Parkinson, Dept Neurol, Paris, France; [Chavez, Mario] Univ Paris 06, CNRS UMR 7225, Inst Cerveau & Moelle Epiniere, Ctr Rech, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; College de France; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite	Degos, B (corresponding author), CNRS UMR7241, INSERM U1050, Coll France, Team Dynam & Pathophysiol Neuronal Networks,CIRB, Paris, France.	bertrand.degos@psl.aphp.fr	Chavez, Mario/D-8495-2011	Chavez, Mario/0000-0003-0390-4833	Agence Nationale de la Recherche [ANR-05-JCJC-0076, ANR-05-NEUR-013]; Institut National de la Sante et de la Recherche Medicale (INSERM)	Agence Nationale de la Recherche(French National Research Agency (ANR)); Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm))	This work was supported by Agence Nationale de la Recherche (grants number: ANR-05-JCJC-0076 and ANR-05-NEUR-013). B. D. was the recipient of a poste d'accueil from the Institut National de la Sante et de la Recherche Medicale (INSERM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBIN RL, 1989, TRENDS NEUROSCI, V12, P366, DOI 10.1016/0166-2236(89)90074-X; Ballion B, 2008, EUR J NEUROSCI, V27, P2313, DOI 10.1111/j.1460-9568.2008.06192.x; BARANYI A, 1993, J NEUROPHYSIOL, V69, P1850, DOI 10.1152/jn.1993.69.6.1850; BENAZZOUZ A, 1993, EUR J NEUROSCI, V5, P382, DOI 10.1111/j.1460-9568.1993.tb00505.x; Blandini F, 1996, FUNCT NEUROL, V11, P3; Boraud T, 2002, PROG NEUROBIOL, V66, P265, DOI 10.1016/S0301-0082(01)00033-8; Bosch C, 2011, J PHYSIOL-LONDON, V589, P4189, DOI 10.1113/jphysiol.2011.211367; Bruno RM, 2003, J NEUROSCI, V23, P9565; Calabresi P, 2000, TRENDS NEUROSCI, V23, pS57, DOI 10.1016/S1471-1931(00)00017-3; CARLSSON M, 1990, TRENDS NEUROSCI, V13, P272, DOI 10.1016/0166-2236(90)90108-M; Ceballos-Baumann AO, 1999, ARCH NEUROL-CHICAGO, V56, P997, DOI 10.1001/archneur.56.8.997; Chen R, 2001, CLIN NEUROPHYSIOL, V112, P600, DOI 10.1016/S1388-2457(01)00466-7; Costa RM, 2006, NEURON, V52, P359, DOI 10.1016/j.neuron.2006.07.030; Cruikshank SJ, 2007, NAT NEUROSCI, V10, P462, DOI 10.1038/nn1861; Cunic D, 2002, NEUROLOGY, V58, P1665, DOI 10.1212/WNL.58.11.1665; Dauper J, 2002, NEUROLOGY, V59, P700, DOI 10.1212/WNL.59.5.700; Degenetais E, 2002, CEREB CORTEX, V12, P1, DOI 10.1093/cercor/12.1.1; Degos B, 2005, J NEUROSCI, V25, P7687, DOI 10.1523/JNEUROSCI.1056-05.2005; Degos B, 2008, EUR J NEUROSCI, V27, P2599, DOI 10.1111/j.1460-9568.2008.06229.x; Degos B, 2009, CEREB CORTEX, V19, P1616, DOI 10.1093/cercor/bhn199; Dejean C, 2009, CEREB CORTEX, V19, P1055, DOI 10.1093/cercor/bhn149; DELONG MR, 1990, TRENDS NEUROSCI, V13, P281, DOI 10.1016/0166-2236(90)90110-V; DOUDET DJ, 1990, EXP BRAIN RES, V80, P177; Fogelson N, 2006, CEREB CORTEX, V16, P64, DOI 10.1093/cercor/bhi084; Fraix V, 2008, CLIN NEUROPHYSIOL, V119, P2513, DOI 10.1016/j.clinph.2008.07.217; Galati S, 2006, EUR J NEUROSCI, V23, P2923, DOI 10.1111/j.1460-9568.2006.04816.x; Garcia L, 2003, J NEUROSCI, V23, P8743; Goldberg JA, 2002, J NEUROSCI, V22, P4639, DOI 10.1523/JNEUROSCI.22-11-04639.2002; Gradinaru V, 2009, SCIENCE, V324, P354, DOI 10.1126/science.1167093; Grill WM, 2008, J COMPUT NEUROSCI, V24, P81, DOI 10.1007/s10827-007-0043-9; Gubellini P, 2006, EUR J NEUROSCI, V24, P1802, DOI 10.1111/j.1460-9568.2006.05047.x; HALL RD, 1974, BRAIN RES, V66, P23, DOI 10.1016/0006-8993(74)90076-6; Hashimoto T, 2003, J NEUROSCI, V23, P1916; Haslinger B, 2005, NEUROIMAGE, V28, P598, DOI 10.1016/j.neuroimage.2005.06.034; HERKENHAM M, 1979, J COMP NEUROL, V183, P487, DOI 10.1002/cne.901830304; Hershey T, 2003, NEUROLOGY, V61, P816, DOI 10.1212/01.WNL.0000083991.81859.73; Hilker R, 2003, MOVEMENT DISORD, V18, P41, DOI 10.1002/mds.10297; Kita T, 2012, J NEUROSCI, V32, P5990, DOI 10.1523/JNEUROSCI.5717-11.2012; Kuriakose R, 2010, CEREB CORTEX, V20, P1926, DOI 10.1093/cercor/bhp269; LEGENDY CR, 1985, J NEUROPHYSIOL, V53, P926, DOI 10.1152/jn.1985.53.4.926; Li Q, 2012, NEURON, V76, P1030, DOI 10.1016/j.neuron.2012.09.032; Li S, 2007, J NEUROPHYSIOL, V98, P3525, DOI 10.1152/jn.00808.2007; Limousin P, 1997, ANN NEUROL, V42, P283, DOI 10.1002/ana.410420303; Lopes da Silva F, 1989, Brain Topogr, V2, P9; Mahon S, 2003, J PHYSIOL-LONDON, V550, P947, DOI 10.1113/jphysiol.2003.043125; Mahon S, 2006, J NEUROSCI, V26, P12587, DOI 10.1523/JNEUROSCI.3987-06.2006; Mallet N, 2008, J NEUROSCI, V28, P4795, DOI 10.1523/JNEUROSCI.0123-08.2008; Meeren HKM, 2002, J NEUROSCI, V22, P1480, DOI 10.1523/JNEUROSCI.22-04-01480.2002; NEAFSEY EJ, 1986, BRAIN RES REV, V11, P77, DOI 10.1016/0165-0173(86)90011-1; Parr-Brownlie LC, 2005, J NEUROSCI, V25, P5700, DOI 10.1523/JNEUROSCI.0523-05.2005; Paxinos G., 2005, RAT BRAIN STEREOTAXI, V5th Edn, DOI 10.1016/c2009-0-63235-9; Payoux P, 2004, ARCH NEUROL-CHICAGO, V61, P1307, DOI 10.1001/archneur.61.8.1307; Paz JT, 2007, J NEUROSCI, V27, P929, DOI 10.1523/JNEUROSCI.4677-06.2007; Paz JT, 2005, J NEUROSCI, V25, P2092, DOI 10.1523/JNEUROSCI.4689-04.2005; Pessiglione M, 2005, J NEUROSCI, V25, P1523, DOI 10.1523/JNEUROSCI.4056-04.2005; Pierantozzi M, 2002, CLIN NEUROPHYSIOL, V113, P108, DOI 10.1016/S1388-2457(01)00694-0; Pinault D, 1998, J PHYSIOL-LONDON, V509, P449, DOI 10.1111/j.1469-7793.1998.449bn.x; Polack PO, 2009, CEREB CORTEX, V19, P2078, DOI 10.1093/cercor/bhn237; RALL W, 1969, BIOPHYS J, V9, P1483, DOI 10.1016/S0006-3495(69)86467-2; Robin K, 2009, J NEUROSCI METH, V179, P142, DOI 10.1016/j.jneumeth.2009.01.020; Sabatini U, 2000, BRAIN, V123, P394, DOI 10.1093/brain/123.2.394; Scholz B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001589; SIMONS DJ, 1989, J NEUROPHYSIOL, V61, P311, DOI 10.1152/jn.1989.61.2.311; Slaght S, 2004, J NEUROSCI, V24, P6816, DOI 10.1523/JNEUROSCI.1449-04.2004; Slaght SNJ, 2002, J NEUROSCI, V22, P2323, DOI 10.1523/JNEUROSCI.22-06-02323.2002; Strafella AP, 2000, CLIN NEUROPHYSIOL, V111, P1198, DOI 10.1016/S1388-2457(00)00316-3; Tai CH, 2003, FASEB J, V17, P1820, DOI 10.1096/fj.03-0163com; Thomson AM, 2003, CEREB CORTEX, V13, P5, DOI 10.1093/cercor/13.1.5; Tseng KY, 2001, J NEUROSCI, V21, P6430, DOI 10.1523/JNEUROSCI.21-16-06430.2001; Welter ML, 2004, ARCH NEUROL-CHICAGO, V61, P89, DOI 10.1001/archneur.61.1.89; Wichmann T, 1999, EXP BRAIN RES, V125, P397, DOI 10.1007/s002210050696; ZHENG F, 2011, J PHYSL, V11, P2781; ZOLD CL, 2008, NEUR M PLANN	73	22	23	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83608	10.1371/journal.pone.0083608	http://dx.doi.org/10.1371/journal.pone.0083608			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391793	Green Published, gold, Green Submitted			2022-12-25	WOS:000329325200090
J	Fornace, KM; Clark, EL; Macdonald, SE; Namangala, B; Karimuribo, E; Awuni, JA; Thieme, O; Blake, DP; Rushton, J				Fornace, Kimberly M.; Clark, Emily L.; Macdonald, Sarah E.; Namangala, Boniface; Karimuribo, Esron; Awuni, Joseph A.; Thieme, Olaf; Blake, Damer P.; Rushton, Jonathan			Occurrence of Eimeria Species Parasites on Small-Scale Commercial Chicken Farms in Africa and Indication of Economic Profitability	PLOS ONE			English	Article							BROILER-CHICKENS; AVIAN EIMERIA; COCCIDIOSIS; DIAGNOSIS; BIOLOGY; MODEL	Small-scale commercial poultry production is emerging as an important form of livestock production in Africa, providing sources of income and animal protein to many poor households, yet the occurrence and impact of coccidiosis on this relatively new production system remains unknown. The primary objective of this study was to examine Eimeria parasite occurrence on small-scale commercial poultry farms in Ghana, Tanzania and Zambia. Additionally, farm economic viability was measured by calculating the farm gross margin and enterprise budget. Using these economic measures as global assessments of farm productivity, encompassing the diversity present in regional husbandry systems with a measure of fundamental local relevance, we investigated the detection of specific Eimeria species as indicators of farm profitability. Faecal samples and data on production parameters were collected from small-scale (less than 2,000 birds per batch) intensive broiler and layer farms in peri-urban Ghana, Tanzania and Zambia. All seven Eimeria species recognised to infect the chicken were detected in each country. Furthermore, two of the three genetic variants (operational taxonomic units) identified previously in Australia have been described outside of Australia for the first time. Detection of the most pathogenic Eimeria species associated with decreased farm profitability and may be considered as an indicator of likely farm performance. While a causal link remains to be demonstrated, the presence of highly pathogenic enteric parasites may pose a threat to profitable, sustainable small-scale poultry enterprises in Africa.	[Fornace, Kimberly M.] London Sch Hyg & Trop Med, London WC1, England; [Clark, Emily L.; Macdonald, Sarah E.; Blake, Damer P.; Rushton, Jonathan] Royal Vet Coll, N Mymms, Herts, England; [Namangala, Boniface] Univ Zambia, Fac Vet Med, Dept Paraclin Studies, Lusaka, Zambia; [Karimuribo, Esron] Southern African Ctr Infect Dis Surveillance, Morogoro, Tanzania; [Awuni, Joseph A.] Accra Vet Lab, Accra, Ghana; [Thieme, Olaf] Food & Agr Org, Rome, Italy	University of London; London School of Hygiene & Tropical Medicine; University of London; University of London Royal Veterinary College; University of Zambia; Food & Agriculture Organization of the United Nations (FAO)	Blake, DP (corresponding author), Royal Vet Coll, N Mymms, Herts, England.	dblake@rvc.ac.uk; jrushton@rvc.ac.uk	Fornace, Kimberly/ABF-7147-2020; Rushton, Jonathan/I-3518-2014; Clark, Emily/GVR-7159-2022	Fornace, Kimberly/0000-0002-5484-241X; Rushton, Jonathan/0000-0001-5450-4202; Awuni, Joseph Agebase/0000-0003-0940-9462; Blake, Damer/0000-0003-1077-2306; Clark, Emily/0000-0002-9550-7407	Food and Agriculture Organization of the United Nations; Biotechnology and Biological Sciences Research Council/Department for International Development [BB/H009337/2]; Biotechnology and Biological Sciences Research Council [BB/H009337/2] Funding Source: researchfish; BBSRC [BB/H009337/2] Funding Source: UKRI	Food and Agriculture Organization of the United Nations; Biotechnology and Biological Sciences Research Council/Department for International Development(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This project was funded by the Food and Agriculture Organization of the United Nations (www.fao.com) and the Biotechnology and Biological Sciences Research Council/Department for International Development grant BB/H009337/2 (www.bbsrc.ac.uk; www.gov.uk/government/organisations/department-for-international-development). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aanensen DM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006968; AgricultureFish F, 1986, MANUAL VET PARASITOL; Allen PC, 2002, CLIN MICROBIOL REV, V15, P58, DOI 10.1128/CMR.15.1.58-65.2002; Ashenafi H, 2004, TROP ANIM HEALTH PRO, V36, P693, DOI 10.1023/B:TROP.0000042852.82477.af; Babiker M. A., 2009, International Journal of Poultry Science, V8, P264; Barry A. M., 2009, Bulletin of Animal Health and Production in Africa, V57, P93; Bennett R, 2005, J AGR ECON, V56, P135, DOI 10.1111/j.1477-9552.2005.tb00126.x; Blake DP, 2006, INT J PARASITOL, V36, P97, DOI 10.1016/j.ijpara.2005.09.011; Bukar-Kolo Y. M., 2006, Nigerian Veterinary Journal, V27, P75; Cantacessi C, 2008, VET PARASITOL, V152, P226, DOI 10.1016/j.vetpar.2007.12.028; Chanie M, 2009, TROP ANIM HEALTH PRO, V41, P1309, DOI 10.1007/s11250-009-9316-9; Graat EAM, 1998, PREV VET MED, V33, P297, DOI 10.1016/S0167-5877(97)00008-1; Grossman M, 2001, POULTRY SCI, V80, P859, DOI 10.1093/ps/80.7.859; Haug A, 2008, AVIAN PATHOL, V37, P333, DOI 10.1080/03079450802050705; Kinung'hi S. M., 2002, Bulletin of Animal Health and Production in Africa, V50, P41; LONG P L, 1976, Folia Veterinaria Latina, V6, P201; McDonald V, 2009, PARASITOLOGY, P1, DOI 10.1017/S0031182009006349; Musa I. W., 2010, International Journal of Poultry Science, V9, P1112; Nowzari N, 2005, VET PARASITOL, V128, P59, DOI 10.1016/j.vetpar.2004.11.015; Nsamba P., 2000, Tanzanian Veterinary Journal, V20, P199; Ogedengbe M. E., 2009, Tropical Veterinarian, V27, P36; Otte MJ, 2007, IND LIVESTOCK PRODUC; Otte MJ, 2008, NUTR NATURAL RESOURC, V80, P1; Rushton J, 2009, ECONOMICS OF ANIMAL HEALTH AND PRODUCTION, P1; Rushton J, 1998, WORLD ANIM REV, P43; Schwarz RS, 2009, J PARASITOL, V95, P871, DOI 10.1645/GE-1898.1; Shirley MW, 2005, ADV PARASIT, V60, P285, DOI 10.1016/S0065-308X(05)60005-X; Shirzad MR, 2011, TROP ANIM HEALTH PRO, V43, P1601, DOI 10.1007/s11250-011-9876-3; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thornton PK, 2010, PHILOS T R SOC B, V365, P2853, DOI 10.1098/rstb.2010.0134; Vrba V, 2010, VET PARASITOL, V174, P183, DOI 10.1016/j.vetpar.2010.09.006; Williams RB, 1999, INT J PARASITOL, V29, P341, DOI 10.1016/S0020-7519(98)00212-4; Williams RB, 1999, INT J PARASITOL, V29, P1209, DOI 10.1016/S0020-7519(99)00086-7	33	15	15	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84254	10.1371/journal.pone.0084254	http://dx.doi.org/10.1371/journal.pone.0084254			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391923	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000329323900066
J	Goemans, N; Klingels, K; van den Hauwe, M; Boons, S; Verstraete, L; Peeters, C; Feys, H; Buyse, G				Goemans, Nathalie; Klingels, Katrijn; van den Hauwe, Marleen; Boons, Stefanie; Verstraete, Liese; Peeters, Charlotte; Feys, Hilde; Buyse, Gunnar			Six-Minute Walk Test: Reference Values and Prediction Equation in Healthy Boys Aged 5 to 12 Years	PLOS ONE			English	Article							DUCHENNE MUSCULAR-DYSTROPHY; MUSCLE FORCE; CHILDREN; RELIABILITY; DISTANCE	OBJECTIVE: This study aimed to (1) generate normative data in healthy boys aged 5-12 years for the six-minute walk test (6MWT), an outcome measure currently used in clinical trials in Duchenne muscular dystrophy (DMD), (2) to describe the relation with anthropometric variables and myometry, and (3) to compare our data with published equations. METHODS: The 6MWT was conducted in 442 boys according to a standardized protocol, as currently used in clinical trials in DMD. Maximal voluntary isometric contractions for knee flexion and extension were recorded with a hand-held myometer. RESULTS: The 6MWD increased significantly with age, from 478.0 +/- 44.1 m at age 5, to 650.0 +/- 76.8 m at age 12, with the steepest increase between 5 and 8 years. Age-and height related percentile curves of the 6MWD were developed. Correlations with anthropometric variables were fair to good (age r = 0.60, height r = 0.57, weight r = 0.44). Myometric variables (knee flexors and extensors) showed correlations of 0.46 and 0.50 respectively. When dividing into two age categories (5-8 years, 9-12 years), these magnitudes of correlations only applied to the younger age group. Additionally, predicted values were calculated according to available reference equations (Geiger and Ben Saad), indicating an overestimation by those equations. Finally, the Geiger equation was refitted to our population. CONCLUSION: The percentile curves according to age and height provide a useful tool in the assessment of ambulatory capacity in boys aged 5 to 12 years. Significant correlations with anthropometric variables and myometry were only found in the 5-8 years age group. The Geiger prediction equation, currently used to assess ambulatory capacity in DMD was refitted to obtain a more accurate prediction model based on a large sample with a homogenous distribution across the age categories 5 to 12 years and applying the methodology as currently used in clinical trials in DMD.	[Goemans, Nathalie; van den Hauwe, Marleen; Buyse, Gunnar] Katholieke Univ Leuven Hosp, Dept Child Neurol, Louvain, Belgium; [Klingels, Katrijn; Boons, Stefanie; Verstraete, Liese; Peeters, Charlotte; Feys, Hilde] Katholieke Univ Leuven, Dept Rehabil Sci, Louvain, Belgium	Flanders Institute for Biotechnology (VIB); KU Leuven; University Hospital Leuven; KU Leuven	Goemans, N (corresponding author), Katholieke Univ Leuven Hosp, Dept Child Neurol, Louvain, Belgium.	nathalie.goemans@uzleuven.be	Akkal, Maureen/P-6919-2014	Klingels, Katrijn/0000-0001-5853-9680				Beenakker EAC, 2005, EUR J PAEDIATR NEURO, V9, P387, DOI 10.1016/j.ejpn.2005.06.004; Beenakker EAC, 2001, NEUROMUSCULAR DISORD, V11, P441, DOI 10.1016/S0960-8966(01)00193-6; Ben Saad H, 2009, PEDIATR PULM, V44, P316, DOI 10.1002/ppul.20942; Clarke LA, 2009, PEDIATRICS, V123, P229, DOI 10.1542/peds.2007-3847; Crapo RO, 2002, AM J RESP CRIT CARE, V166, P111, DOI 10.1164/rccm.166/1/111; CRAPO RO, 1981, AM REV RESPIR DIS, V123, P659; D'silva C, 2012, INDIAN J PEDIATR, V79, P597, DOI 10.1007/s12098-011-0559-x; FELLINGHAM GW, 1978, MED SCI SPORT EXER, V10, P132; Geiger R, 2007, J PEDIAT, V150, P395; Geiger R, 2007, J PEDIATR-US, V150, P395, DOI 10.1016/j.jpeds.2006.12.052; Goemans N, 2013, NEUROMUSCUL DISORD; Goemans N, 2013, NEUROMUSCULAR DISORD, V23, P19, DOI 10.1016/j.nmd.2012.10.019; Hankinson JL, 1999, AM J RESP CRIT CARE, V159, P179, DOI 10.1164/ajrccm.159.1.9712108; Henricson E, 2013, PLOS CURR, V5; Henricson Erik, 2012, PLoS Curr, V3, pRRN1297, DOI 10.1371/currents.RRN1297; Hinkle D., 2003, APPL STAT BEHAV SCI, P756; Klepper SE, 2011, PEDIATR PHYS THER, V23, P32, DOI 10.1097/PEP.0b013e3182095e44; Lammers AE, 2008, ARCH DIS CHILD, V93, P464, DOI 10.1136/adc.2007.123653; Li AM, 2007, AM J RESP CRIT CARE, V176, P174, DOI 10.1164/rccm.200607-883OC; Li AM, 2005, EUR RESPIR J, V25, P1057, DOI 10.1183/09031936.05.00134904; Limsuwan A, 2010, ACTA PAEDIATR, V99, P438, DOI 10.1111/j.1651-2227.2009.01602.x; Manzur AY, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003725.pub3; Mazzone E, 2011, NEUROLOGY, V77, P250, DOI 10.1212/WNL.0b013e318225ab2e; Mazzone ES, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052512; McDonald CM, 2010, MUSCLE NERVE, V42, P966, DOI 10.1002/mus.21808; McDonald CM, 2010, MUSCLE NERVE, V41, P500, DOI 10.1002/mus.21544; MENIER DR, 1968, J PHYSIOL-LONDON, V197, P717, DOI 10.1113/jphysiol.1968.sp008584; Poh H, 2006, RESPIROLOGY, V11, P211, DOI 10.1111/j.1440-1843.2006.00820.x; Priesnitz CV, 2009, PEDIATR PULM, V44, P1174, DOI 10.1002/ppul.21062	29	42	43	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84120	10.1371/journal.pone.0084120	http://dx.doi.org/10.1371/journal.pone.0084120			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391899	Green Submitted, Green Published, gold			2022-12-25	WOS:000329323900042
J	Schwartz, MW; Smith, LM; Steel, ZL				Schwartz, Mark W.; Smith, Lacy M.; Steel, Zachary L.			Conservation Investment for Rare Plants in Urban Environments	PLOS ONE			English	Article							EXTINCTION RATES; HABITAT; FRAGMENTATION; BIODIVERSITY; URBANIZATION; CALIFORNIA	Budgets for species conservation limit actions. Expending resources in areas of high human density is costly and generally considered less likely to succeed. Yet, coastal California contains both a large fraction of narrowly endemic at-risk plant species as well as the state's three largest metropolitan regions. Hence understanding the capacity to protect species along the highly urbanized coast is a conservation priority. We examine at-risk plant populations along California's coastline from San Diego to north of San Francisco to better understand whether there is a relationship between human population density and: i) performance of at-risk plant populations; and ii) conservation spending. Answering these questions can help focus appropriate strategic conservation investment. Rare plant performance was measured using the annualized growth rate estimate between census periods using the California Natural Diversity Database. Human density was estimated using Census Bureau statistics from the year 2000. We found strong evidence for a lack of a relationship between human population density and plant population performance in California's coastal counties. Analyzing US Endangered Species expenditure reports, we found large differences in expenditures among counties, with plants in San Diego County receiving much higher expenditures than other locations. We found a slight positive relationship between expenditures on behalf of endangered species and human density. Together these data support the argument that conservation efforts by protecting habitats within urban environments are not less likely to be successful than in rural areas. Expenditures on behalf of federally listed endangered and threatened plants do not appear to be related to proximity to human populations. Given the evidence of sufficient performance in urban environments, along with a high potential to leverage public support for nature in urban environments, expenditures in these areas appear to be an appropriate use of conservation funds.	[Schwartz, Mark W.] Univ Calif Davis, John Muir Inst Environm, Davis, CA 95616 USA; [Schwartz, Mark W.; Smith, Lacy M.] Univ Calif Davis, Dept Environm Sci & Policy, Davis, CA 95616 USA; [Steel, Zachary L.] Univ Calif Davis, Grad Grp Ecol, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Schwartz, MW (corresponding author), Univ Calif Davis, John Muir Inst Environm, Davis, CA 95616 USA.	mwschwartz@ucdavis.edu	Schwartz, Mark/G-1066-2011	Schwartz, Mark/0000-0002-3739-6542; Steel, Zachary/0000-0002-1659-3141				Akû║akaya H.R., 1999, APPL POPULATION ECOL; Ando A, 1998, SCIENCE, V279, P2126, DOI 10.1126/science.279.5359.2126; [Anonymous], POP STAT; Bastin L, 1999, LANDSCAPE ECOL, V14, P493, DOI 10.1023/A:1008036207944; California Department of Fish and Game [CDFG], 2003, ATL BIOD CAL; CNDDB, 2009, CAL NAT DIV DAT; [CNPS Society CNP], 2011, ONLN INV RAR END PLA; Dallimer M, 2012, BIOSCIENCE, V62, P47, DOI 10.1525/bio.2012.62.1.9; Dobson AP, 1997, SCIENCE, V275, P550, DOI 10.1126/science.275.5299.550; Duncan RP, 2011, GLOBAL ECOL BIOGEOGR, V20, P509, DOI 10.1111/j.1466-8238.2010.00633.x; Feldman TD, 2000, ANN ASSOC AM GEOGR, V90, P256, DOI 10.1111/0004-5608.00195; Franklin J, 2011, AM J BOT, V98, P559, DOI 10.3732/ajb.1000292; Fuller RA, 2007, BIOLOGY LETT, V3, P390, DOI 10.1098/rsbl.2007.0149; Gibb H, 2002, BIOL CONSERV, V106, P91, DOI 10.1016/S0006-3207(01)00232-4; Hahs AK, 2009, ECOL LETT, V12, P1165, DOI 10.1111/j.1461-0248.2009.01372.x; Lawson DM, 2008, CONSERV BIOL, V22, P922, DOI 10.1111/j.1523-1739.2008.00936.x; Loarie SR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002502; McKinney ML, 2006, BIOL CONSERV, V127, P247, DOI 10.1016/j.biocon.2005.09.005; McKinney ML, 2002, BIOSCIENCE, V52, P883, DOI 10.1641/0006-3568(2002)052[0883:UBAC]2.0.CO;2; Miller JR, 2002, CONSERV BIOL, V16, P330, DOI 10.1046/j.1523-1739.2002.00420.x; Moilanen A, 2011, ECOL APPL, V21, P1419, DOI 10.1890/10-1865.1; Press DM., 2002, SAVING OPEN SPACE PO; Radeloff VC, 2005, ECOL APPL, V15, P799, DOI 10.1890/04-1413; Schwartz MW, 2006, CONSERV BIOL, V20, P1550, DOI 10.1111/j.1523-1739.2006.00421.x; Schwartz MW, 2006, BIOL CONSERV, V127, P282, DOI 10.1016/j.biocon.2005.05.017; Schwartz MW, 2002, BIOSCIENCE, V52, P601, DOI 10.1641/0006-3568(2002)052[0601:CSDUP]2.0.CO;2; Schwartz MW, 1999, ANNU REV ECOL SYST, V30, P83, DOI 10.1146/annurev.ecolsys.30.1.83; Seabloom EW, 2002, P NATL ACAD SCI USA, V99, P11229, DOI 10.1073/pnas.162064899; Thomas CW, 2001, POLIT SOC, V29, P105, DOI 10.1177/0032329201029001005; U.S. Fish and Wildlife Service (USFWS), 2007, FED STAT END THREAT; Underwood EC, 2009, CONSERV LETT, V2, P130, DOI 10.1111/j.1755-263X.2008.00018.x; United Nations (UN), 2005, DEM YB 2005; [USFWS Interior Do], 2008, FED STAT END THREAT; USFWS, 2009, ENV CONS ONL SYST; [USFWS Interior UDf], 2006, FED AD STAT END THRE; Viers JH, 2006, SAN FRANCISCO ESTUAR; von der Dunk A, 2011, LANDSCAPE URBAN PLAN, V101, P149, DOI 10.1016/j.landurbplan.2011.02.007; West P, 2006, ANNU REV ANTHROPOL, V35, P251, DOI 10.1146/annurev.anthro.35.081705.123308; Williams NSG, 2009, J ECOL, V97, P4, DOI 10.1111/j.1365-2745.2008.01460.x	39	11	11	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83809	10.1371/journal.pone.0083809	http://dx.doi.org/10.1371/journal.pone.0083809			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391830	Green Published, Green Submitted, gold			2022-12-25	WOS:000329325200128
J	Wang, T; Kusudo, T; Takeuchi, T; Yamashita, Y; Kontani, Y; Okamatsu, Y; Saito, M; Mori, N; Yamashita, H				Wang, Ting; Kusudo, Tatsuya; Takeuchi, Tamaki; Yamashita, Yukari; Kontani, Yasuhide; Okamatsu, Yuko; Saito, Masayuki; Mori, Nozomu; Yamashita, Hitoshi			Evodiamine Inhibits Insulin-Stimulated mTOR-S6K Activation and IRS1 Serine Phosphorylation in Adipocytes and Improves Glucose Tolerance in Obese/Diabetic Mice	PLOS ONE			English	Article							BROWN ADIPOSE-TISSUE; DIET-INDUCED OBESITY; PROTEIN-KINASE; 3T3-L1 ADIPOCYTES; PHOSPHATIDYLINOSITOL 3-KINASE; RECEPTOR SUBSTRATE-1; GENE-EXPRESSION; ADULT HUMANS; ENERGY; HOMEOSTASIS	Evodiamine, an alkaloid extracted from the dried unripe fruit of the tree Evodia rutaecarpa Bentham (Rutaceae), reduces obesity and insulin resistance in obese/diabetic mice; however, the mechanism underlying the effect of evodiamine on insulin resistance is unknown. This study investigated the effect of evodiamine on signal transduction relating to insulin resistance using obese/diabetic KK-Ay mice and an in vitro adipocyte culture. There is a significant decrease in the mammalian target of rapamycin (mTOR) and ribosomal S6 protein kinase (S6K) signaling in white adipose tissue (WAT) in KK-Ay mice treated with evodiamine, in which glucose tolerance is improved. In addition, reduction of insulin receptor substrate 1 (IRS1) serine phosphorylation, an indicator of insulin resistance, was detected in their WAT, suggesting suppression of the negative feedback loop from S6K to IRS1. As well as the stimulation of IRS1 and Akt serine phosphorylation, insulin-stimulated phosphorylation of mTOR and S6K is time-dependent in 3T3-L1 adipocytes, whereas evodiamine does not affect their phosphorylation except for an inhibitory effect on mTOR phosphorylation. Moreover, evodiamine inhibits the insulin-stimulated phosphorylation of mTOR and S6K, leading to down-regulation of IRS1 serine phosphorylation in the adipocytes. Evodiamine also stimulates phosphorylation of AMP-activated protein kinase (AMPK), an important regulator of energy metabolism, which may cause down-regulation of mTOR signaling in adipocytes. A similar effect on AMPK, mTOR and IRS1 phosphorylation was found in adipocytes treated with rosiglitazone. These results suggest evodiamine improves glucose tolerance and prevents the progress of insulin resistance associated with obese/diabetic states, at least in part, through inhibition of mTOR-S6K signaling and IRS1 serine phosphorylation in adipocytes.	[Wang, Ting; Kusudo, Tatsuya; Takeuchi, Tamaki; Yamashita, Yukari; Yamashita, Hitoshi] Chubu Univ, Coll Life & Hlth Sci, Dept Biomed Sci, Kasugai, Aichi 487, Japan; [Yamashita, Yukari; Yamashita, Hitoshi] Chubu Univ, Nutrit Hlth Sci Res Ctr, Kasugai, Aichi 487, Japan; [Kontani, Yasuhide] Minami Kyushu Univ, Dept Food Sci Hlth, Miyazaki, Japan; [Okamatsu, Yuko] Hokkaido Univ, Grad Sch Vet Med, Dept Biomed Sci, Sapporo, Hokkaido, Japan; [Saito, Masayuki] Tenshi Coll, Sch Nursing & Nutr, Dept Nutr, Sapporo, Hokkaido, Japan; [Mori, Nozomu] Nagasaki Univ, Sch Med, Dept Anat & Neurobiol, Nagasaki 852, Japan	Chubu University; Chubu University; Hokkaido University; Nagasaki University	Yamashita, H (corresponding author), Chubu Univ, Coll Life & Hlth Sci, Dept Biomed Sci, Kasugai, Aichi 487, Japan.	hyamashi@isc.chubu.ac.jp		Yamashita, Hitoshi/0000-0002-5785-5208	MEXT	MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a grant from MEXT-Supported program for Strategic Research Foundation at Private Universities (to H.Y.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bak EJ, 2010, INT J OBESITY, V34, P250, DOI 10.1038/ijo.2009.223; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Cannon B, 2012, J CLIN INVEST, V122, P486, DOI 10.1172/JCI60941; Ching LC, 2012, MOL MED, V18, P805, DOI 10.2119/molmed.2011.00461; CHIOU WF, 1992, EUR J PHARMACOL, V215, P277, DOI 10.1016/0014-2999(92)90039-7; Cho H, 2001, J BIOL CHEM, V276, P38349, DOI 10.1074/jbc.C100462200; Cunningham JT, 2007, NATURE, V450, P736, DOI 10.1038/nature06322; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Draznin B, 2006, DIABETES, V55, P2392, DOI 10.2337/db06-0391; Enerback S, 1997, NATURE, V387, P90, DOI 10.1038/387090a0; Esposito DL, 2001, ENDOCRINOLOGY, V142, P2833, DOI 10.1210/en.142.7.2833; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; Hemati N, 1997, J BIOL CHEM, V272, P25913, DOI 10.1074/jbc.272.41.25913; Heo SK, 2009, J CELL BIOCHEM, V107, P123, DOI 10.1002/jcb.22109; Inoki K, 2006, CELL, V126, P955, DOI 10.1016/j.cell.2006.06.055; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Kennedy BK, 2007, CELL MOL LIFE SCI, V64, P1323, DOI 10.1007/s00018-007-6470-y; Kobayashi Y, 2001, PLANTA MED, V67, P628, DOI 10.1055/s-2001-17353; Kolonin MG, 2004, NAT MED, V10, P625, DOI 10.1038/nm1048; Kontani Y, 2005, AGING CELL, V4, P147, DOI 10.1111/j.1474-9726.2005.00157.x; Kopelman PG, 2000, NATURE, V404, P635, DOI 10.1038/35007508; Kotani K, 1998, MOL CELL BIOL, V18, P6971, DOI 10.1128/MCB.18.12.6971; Lamming DW, 2012, SCIENCE, V335, P1638, DOI 10.1126/science.1215135; Le Good JA, 1998, SCIENCE, V281, P2042, DOI 10.1126/science.281.5385.2042; Peng XD, 2003, GENE DEV, V17, P1352, DOI 10.1101/gad.1089403; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; Saito K, 2011, ANAL BIOCHEM, V412, P9, DOI 10.1016/j.ab.2011.01.022; Saito M, 2009, DIABETES, V58, P1526, DOI 10.2337/db09-0530; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781; Shima H, 1998, EMBO J, V17, P6649, DOI 10.1093/emboj/17.22.6649; Standaert ML, 1997, J BIOL CHEM, V272, P30075, DOI 10.1074/jbc.272.48.30075; Summers SA, 1998, BIOCHEM BIOPH RES CO, V246, P76, DOI 10.1006/bbrc.1998.8575; Takada Y, 2005, J BIOL CHEM, V280, P17203, DOI 10.1074/jbc.M500077200; Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866; Um SH, 2006, CELL METAB, V3, P393, DOI 10.1016/j.cmet.2006.05.003; Wang T, 2008, ENDOCRINOLOGY, V149, P358, DOI 10.1210/en.2007-0467; Wang YX, 2006, PFLUG ARCH EUR J PHY, V452, P363, DOI 10.1007/s00424-005-0036-3; White MF, 2002, AM J PHYSIOL-ENDOC M, V283, pE413, DOI 10.1152/ajpendo.00514.2001; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	40	27	34	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83264	10.1371/journal.pone.0083264	http://dx.doi.org/10.1371/journal.pone.0083264			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391749	gold, Green Submitted, Green Published			2022-12-25	WOS:000329325200046
J	Yan, K; Zhang, R; Sun, CM; Chen, L; Li, P; Liu, Y; Peng, LM; Sun, HT; Qin, K; Chen, FF; Huang, WY; Chen, YX; Lv, BK; Du, MX; Zou, YX; Cai, YQ; Qin, LS; Tang, YP; Jiang, XD				Yan, Ke; Zhang, Run; Sun, Chengmei; Chen, Lei; Li, Peng; Liu, Yi; Peng, Lingmei; Sun, Haitao; Qin, Kun; Chen, Fanfan; Huang, Weiyi; Chen, Yuxin; Lv, Bingke; Du, Mouxuan; Zou, Yuxi; Cai, Yingqian; Qin, Lingsha; Tang, Yanping; Jiang, Xiaodan			Bone Marrow-Derived Mesenchymal Stem Cells Maintain the Resting Phenotype of Microglia and Inhibit Microglial Activation	PLOS ONE			English	Article							STROMAL CELLS; NITRIC-OXIDE; PROLIFERATION; BRAIN; INTERLEUKIN-10; PHAGOCYTOSIS; PROTECTION; NEURONS; MODEL	Many studies have shown that microglia in the activated state may be neurotoxic. It has been proven that uncontrolled or over-activated microglia play an important role in many neurodegenerative disorders. Bone marrow-derived mesenchymal stem cells (BMSCs) have been shown in many animal models to have a therapeutic effect on neural damage. Such a therapeutic effect is attributed to the fact that BMSCs have the ability to differentiate into neurons and to produce trophic factors, but there is little information available in the literature concerning whether BMSCs play a therapeutic role by affecting microglial activity. In this study, we triggered an inflammatory response situation in vitro by stimulating microglia with the bacterial endotoxin lipopolysaccharide (LPS), and then culturing these microglia with BMSC-conditioned medium (BMSC-CM). We found that BMSC-CM significantly inhibited proliferation and secretion of pro-inflammatory factors by activated microglia. Furthermore, we found that the phagocytic capacity of microglia was also inhibited by BMSC-CM. Finally, we investigated whether the induction of apoptosis and the production of nitric oxide (NO) were involved in the inhibition of microglial activation. We found that BMSC-CM significantly induced apoptosis of microglia, while no apoptosis was apparent in the LPS-stimulated microglia. Our study also provides evidence that NO participates in the inhibitory effect of BMSCs. Our experimental results provide evidence that BMSCs have the ability to maintain the resting phenotype of microglia or to control microglial activation through their production of several factors, indicating that BMSCs could be a promising therapeutic tool for treatment of diseases associated with microglial activation.	[Yan, Ke; Zhang, Run; Sun, Chengmei; Chen, Lei; Li, Peng; Liu, Yi; Peng, Lingmei; Sun, Haitao; Qin, Kun; Chen, Fanfan; Huang, Weiyi; Chen, Yuxin; Lv, Bingke; Du, Mouxuan; Zou, Yuxi; Cai, Yingqian; Qin, Lingsha; Tang, Yanping; Jiang, Xiaodan] Southern Med Univ, Guangdong Prov Key Lab Brain Funct Repair & Regen, Neurosurg Inst Guangdong Prov, Natl Key Clin Specialty,Dept Neurosurg,Zhujian Ho, Guangzhou, Guangdong, Peoples R China; [Chen, Lei] Shenzhen Univ, Affiliated Hosp 1, Shenzhen Peoples Hosp 2, Dept Neurosurg, Shenzhen, Peoples R China; [Li, Peng; Chen, Fanfan] Guangzhou First Peoples Hosp, Dept Neurosurg, Guangzhou, Guangdong, Peoples R China; [Peng, Lingmei] First Peoples Hosp Foshan, Dept Neurol, Foshan, Peoples R China; [Qin, Kun] Guangdong Acad Med Sci, Guangdong Gen Hosp, Dept Neurosurg, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China; Shenzhen University; South China University of Technology; Guangdong Academy of Medical Sciences & Guangdong General Hospital	Jiang, XD (corresponding author), Southern Med Univ, Guangdong Prov Key Lab Brain Funct Repair & Regen, Neurosurg Inst Guangdong Prov, Natl Key Clin Specialty,Dept Neurosurg,Zhujian Ho, Guangzhou, Guangdong, Peoples R China.	jiangxiao_dan@163.com		/0000-0001-7925-9506	funds for National Key Clinic Department; Natural Science Fund of China [81171179, 81272439]; Guandong Natural Science Foundation [S2013020012754]; Funds for Key Sci-Tech Research Projects of Guangdong [2008A030201019]; Funds for Key Sci-Tech Research Projects of Guangzhou [09B52120112-2009J1-C418-2, 2008A1-E4011-6]	funds for National Key Clinic Department; Natural Science Fund of China(National Natural Science Foundation of China (NSFC)); Guandong Natural Science Foundation; Funds for Key Sci-Tech Research Projects of Guangdong; Funds for Key Sci-Tech Research Projects of Guangzhou	This work was supported by grants from the funds for National Key Clinic Department, the Natural Science Fund of China (No. 81171179 and No. 81272439), the Guandong Natural Science Foundation (No. S2013020012754), the Funds for Key Sci-Tech Research Projects of Guangdong (No. 2008A030201019), and Funds for Key Sci-Tech Research Projects of Guangzhou (No. 09B52120112-2009J1-C418-2, No. 2008A1-E4011-6) to professor Xiaodan Jiang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Augello A, 2005, EUR J IMMUNOL, V35, P1482, DOI 10.1002/eji.200425405; Baker AH, 2007, P NATL ACAD SCI USA, V104, P3597, DOI 10.1073/pnas.0611112104; Bogdan C, 2001, NAT IMMUNOL, V2, P907, DOI 10.1038/ni1001-907; Bouffi C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014247; Burguillos MA, 2011, NATURE, V472, P319, DOI 10.1038/nature09788; Di Nicola M, 2002, BLOOD, V99, P3838, DOI 10.1182/blood.V99.10.3838; Garedew A, 2010, CELL DEATH DIFFER, V17, P1540, DOI 10.1038/cdd.2010.27; Ghoshal A, 2007, GLIA, V55, P483, DOI 10.1002/glia.20474; GIULIAN D, 1986, J NEUROSCI, V6, P2163; Hess DC, 2004, ARCH NEUROL-CHICAGO, V61, P483, DOI 10.1001/archneur.61.4.483; Honma T, 2006, EXP NEUROL, V199, P56, DOI 10.1016/j.expneurol.2005.05.004; Hughes MM, 2010, GLIA, V58, P2017, DOI 10.1002/glia.21070; Jeong SR, 2012, EXP NEUROL, V233, P312, DOI 10.1016/j.expneurol.2011.10.021; Jiang XX, 2005, BLOOD, V105, P4120, DOI 10.1182/blood-2004-02-0586; Kingham PJ, 1999, J NEUROCHEM, V73, P538, DOI 10.1046/j.1471-4159.1999.0730538.x; Koh SH, 2012, EXP NEUROL, V233, P472, DOI 10.1016/j.expneurol.2011.11.021; Kuo YR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035459; Le Blanc K, 2004, LANCET, V363, P1439, DOI 10.1016/S0140-6736(04)16104-7; Levesque S, 2010, BRAIN, V133, P808, DOI 10.1093/brain/awp333; Liu W, 2013, THEOR APPL MECH LETT, V3, DOI [10.1063/2.1306201, 10.1186/2045-9912-3-3]; Meisel R, 2004, BLOOD, V103, P4619, DOI 10.1182/blood-2003-11-3909; Miyahara Y, 2006, NAT MED, V12, P459, DOI 10.1038/nm1391; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Nauta AJ, 2007, BLOOD, V110, P3499, DOI 10.1182/blood-2007-02-069716; Neher JJ, 2011, J IMMUNOL, V186, P4973, DOI 10.4049/jimmunol.1003600; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Norden DM, 2013, NEUROPATH APPL NEURO, V39, P19, DOI 10.1111/j.1365-2990.2012.01306.x; Pestka S, 2004, ANNU REV IMMUNOL, V22, P929, DOI 10.1146/annurev.immunol.22.012703.104622; Raivich G, 2005, TRENDS NEUROSCI, V28, P571, DOI 10.1016/j.tins.2005.09.001; Rock RB, 2004, CLIN MICROBIOL REV, V17, P942, DOI 10.1128/CMR.17.4.942-964.2004; Saijo K, 2013, GLIA, V61, P104, DOI 10.1002/glia.22423; Sanchez-Ramos J, 2000, EXP NEUROL, V164, P247, DOI 10.1006/exnr.2000.7389; Sasaki M, 2009, J NEUROSCI, V29, P14932, DOI 10.1523/JNEUROSCI.2769-09.2009; Sato K, 2007, BLOOD, V109, P228, DOI 10.1182/blood-2006-02-002246; Shi YF, 2012, TRENDS IMMUNOL, V33, P136, DOI 10.1016/j.it.2011.11.004; Sotiropoulou PA, 2006, STEM CELLS, V24, P74, DOI 10.1634/stemcells.2004-0359; Spaggiari GM, 2008, BLOOD, V111, P1327, DOI 10.1182/blood-2007-02-074997; Uccelli A, 2008, NAT REV IMMUNOL, V8, P726, DOI 10.1038/nri2395; Walter L, 2009, SEMIN IMMUNOPATHOL, V31, P513, DOI 10.1007/s00281-009-0180-5; Wilkins A, 2009, STEM CELL RES, V3, P63, DOI 10.1016/j.scr.2009.02.006; Wu DC, 2002, J NEUROSCI, V22, P1763, DOI 10.1523/JNEUROSCI.22-05-01763.2002; Zanone MM, 2010, J CLIN ENDOCR METAB, V95, P3788, DOI 10.1210/jc.2009-2350	42	45	48	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84116	10.1371/journal.pone.0084116	http://dx.doi.org/10.1371/journal.pone.0084116			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391898	Green Published, Green Submitted, gold			2022-12-25	WOS:000329323900041
J	Fjaer, S; Bo, L; Lundervold, A; Myhr, KM; Pavlin, T; Torkildsen, O; Wergeland, S				Fjaer, Sveinung; Bo, Lars; Lundervold, Arvid; Myhr, Kjell-Morten; Pavlin, Tina; Torkildsen, Oivind; Wergeland, Stig			Deep Gray Matter Demyelination Detected by Magnetization Transfer Ratio in the Cuprizone Model	PLOS ONE			English	Article							PROGRESSIVE MULTIPLE-SCLEROSIS; CORTICAL LESION DETECTION; WHITE-MATTER; TRANSFER MRI; GREY-MATTER; MS; BRAIN; REMYELINATION; PATHOLOGY	In multiple sclerosis (MS), the correlation between lesion load on conventional magnetic resonance imaging (MRI) and clinical disability is weak. This clinico-radiological paradox might partly be due to the low sensitivity of conventional MRI to detect gray matter demyelination. Magnetization transfer ratio (MTR) has previously been shown to detect white matter demyelination in mice. In this study, we investigated whether MTR can detect gray matter demyelination in cuprizone exposed mice. A total of 54 female C57BL/6 mice were split into one control group () and eight cuprizone exposed groups (N-S = 6). The mice were exposed to 0.2% (w/w) cuprizone for up to six weeks. MTR images were obtained at a 7 Tesla Bruker MR-scanner before cuprizone exposure, weekly for six weeks during cuprizone exposure, and once two weeks after termination of cuprizone exposure. Immunohistochemistry staining for myelin (anti-Proteolopid Protein) and oligodendrocytes (anti-Neurite Outgrowth Inhibitor Protein A) was obtained after each weekly scanning. Rates of MTR change and correlations between MTR values and histological findings were calculated in five brain regions. In the corpus callosum and the deep gray matter a significant rate of MTR value decrease was found, 0.96% per week (p<.0001) and 0.39% per week (p<.0001) respectively. The MTR values correlated to myelin loss as evaluated by immunohistochemistry (Corpus callosum: R-2 = (.)43, p<0001. Deep gray matter: R-2 = .21, p<.001), but did not correlate to oligodendrocyte density. Significant results were not found in the cerebellum, the olfactory bulb or the cerebral cortex. This study shows that MTR can be used to detect demyelination in the deep gray matter, which is of particular interest for imaging of patients with MS, as deep gray matter demyelination is common in MS, and is not easily detected on conventional clinical MRI.	[Fjaer, Sveinung; Bo, Lars; Myhr, Kjell-Morten; Torkildsen, Oivind; Wergeland, Stig] Univ Bergen, Dept Clin Med, KG Jebsen Ctr MS Res, Bergen, Norway; [Fjaer, Sveinung; Bo, Lars; Myhr, Kjell-Morten; Torkildsen, Oivind; Wergeland, Stig] Haukeland Hosp, Dept Neurol, Norwegian Multiple Sclerosis Competence Ctr, N-5021 Bergen, Norway; [Lundervold, Arvid] Univ Bergen, Neuroinformat & Image Anal Lab, Dept Biomed, Bergen, Norway; [Pavlin, Tina] Univ Bergen, Mol Imaging Ctr, Dept Biomed, Bergen, Norway; [Lundervold, Arvid; Pavlin, Tina] Haukeland Hosp, Dept Radiol, N-5021 Bergen, Norway	University of Bergen; University of Bergen; Haukeland University Hospital; University of Bergen; University of Bergen; University of Bergen; Haukeland University Hospital	Fjaer, S (corresponding author), Univ Bergen, Dept Clin Med, KG Jebsen Ctr MS Res, Bergen, Norway.	sveinung@fjaer.com	Myhr, Kjell-Morten/H-1528-2018; Torkildsen, Øivind/A-1606-2008	Myhr, Kjell-Morten/0000-0002-0980-510X; Torkildsen, Øivind/0000-0001-5294-2866				Agosta F, 2006, BRAIN, V129, P2620, DOI 10.1093/brain/awl208; Aharoni R, 2012, EXPT NEUROLOGY; Barkhof F, 2002, CURR OPIN NEUROL, V15, P239, DOI 10.1097/00019052-200206000-00003; Boretius S, 2012, NEUROIMAGE, V59, P2678, DOI 10.1016/j.neuroimage.2011.08.051; Cercignani M, 2001, AM J NEURORADIOL, V22, P952; Chen JTH, 2013, NEUROLOGY, V80, P246, DOI 10.1212/WNL.0b013e31827deb99; Ciccarelli O, 2001, NEUROLOGY, V56, P926, DOI 10.1212/WNL.56.7.926; Dehmeshki J, 2003, J NEUROL, V250, P67, DOI 10.1007/s00415-003-0955-x; Deloire-Grassin MSA, 2000, J NEUROL SCI, V178, P10, DOI 10.1016/S0022-510X(00)00331-2; Dousset V, 1998, NEUROLOGY, V51, P1150, DOI 10.1212/WNL.51.4.1150; DOUSSET V, 1992, RADIOLOGY, V182, P483, DOI 10.1148/radiology.182.2.1732968; Filippi M, 1998, J NEUROL SCI, V159, P162, DOI 10.1016/S0022-510X(98)00162-2; FILIPPI M, 1995, NEUROLOGY, V45, P478, DOI 10.1212/WNL.45.3.478; Filippi M, 1999, NEUROLOGY, V52, P588, DOI 10.1212/WNL.52.3.588; Filippi M, 2013, NEUROLOGY; Geurts JJG, 2008, LANCET NEUROL, V7, P841, DOI 10.1016/S1474-4422(08)70191-1; Geurts JJG, 2008, J NEUROL, V255, P183, DOI 10.1007/s00415-008-0620-5; Geurts JJG, 2005, RADIOLOGY, V236, P254, DOI 10.1148/radiol.2361040450; Gudi V, 2009, BRAIN RES, V1283, P127, DOI 10.1016/j.brainres.2009.06.005; Hackmack K, 2012, J NEUROL, V259, P2151, DOI 10.1007/s00415-012-6475-9; LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876; Merkler D, 2005, NMR BIOMED, V18, P395, DOI 10.1002/nbm.972; Minagar A, 2013, NEUROLOGY, V80, P210, DOI 10.1212/WNL.0b013e31827b910b; Nijeholt GJLA, 2001, BRAIN, V124, P154, DOI 10.1093/brain/124.1.154; Rausch M, 2009, MULT SCLER, V15, P16, DOI 10.1177/1352458508096006; Rocca MA, 1999, AM J NEURORADIOL, V20, P821; Seewann A, 2012, NEUROLOGY, V78, P302, DOI 10.1212/WNL.0b013e31824528a0; Sharma J, 2006, J NEUROIMAGING, V16, P302, DOI 10.1111/j.1552-6569.2006.00054.x; Thiessen JD, 2013, NMR BIOMED, V26, P1562, DOI 10.1002/nbm.2992; Vavasour IM, 2011, J MAGN RESON IMAGING, V33, P713, DOI 10.1002/jmri.22441; Vrenken H, 2007, MULT SCLER, V13, P708, DOI 10.1177/1352458506075521; Vrenken H, 2006, RADIOLOGY, V240, P811, DOI 10.1148/radiol.2403050569; Wergeland S, 2012, APMIS, V120, P648, DOI 10.1111/j.1600-0463.2012.02882.x; Wergeland S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026262; Wilhelm MJ, 2012, P NATL ACAD SCI USA, V109, P9605, DOI 10.1073/pnas.1115107109; Zaaraoui W, 2008, MAGN RESON MATER PHY, V21, P357, DOI 10.1007/s10334-008-0141-3	36	38	38	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e84162	10.1371/journal.pone.0084162	http://dx.doi.org/10.1371/journal.pone.0084162			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386344	Green Submitted, Green Published, gold			2022-12-25	WOS:000329194700094
J	Gao, RM; Wan, ZY; Wong, SM				Gao, Ruimin; Wan, Zi Yi; Wong, Sek-Man			Plant Growth Retardation and Conserved miRNAs Are Correlated to Hibiscus Chlorotic Ringspot Virus Infection	PLOS ONE			English	Article							SMALL RNAS; MICRORNA; EXPRESSION; CARMOVIRUS; TARGETS; ROLES	Virus infection may cause a multiplicity of symptoms in their host including discoloration, distortion and growth retardation. Hibiscus chlorotic ringspot virus (HCRSV) infection was studied using kenaf (Hibiscus cannabinus L.), a non-wood fiber-producing crop in this study. Infection by HCRSV reduced the fiber yield and concomitant economic value of kenaf. We investigated kenaf growth retardation and fluctuations of four selected miRNAs after HCRSV infection. Vegetative growth (including plant height, leaf size and root development) was severely retarded. From the transverse and radial sections of the mock and HCRSV-infected kenaf stem, the vascular bundles of HCRSV-infected plants were severely disrupted. In addition, four conserved plant developmental and defence related microRNAs (miRNAs) (miR165, miR167, miR168 and miR171) and their respective target genes phabulosa (PHB), auxin response factor 8 (ARF8), argonaute 1 (AGO1) and scarecrow-like protein 1 (SCL1) displayed variation in expression levels after HCRSV infection. Compared with the mock inoculated kenaf plants, miR171 and miR168 and their targets SCL1 and AGO1 showed greater fluctuations after HCRSV infection. As HCRSV upregulates plant SO transcript in kenaf and upregulated AGO1 in HCRSV-infected plants, the expression level of AGO1 transcript was further investigated under sulfite oxidase (SO) overexpression or silencing condition. Interestingly, the four selected miRNAs were also up-or down-regulated upon overexpression or silencing of SO. Plant growth retardation and fluctuation of four conserved miRNAs are correlated to HCRSV infection.	[Gao, Ruimin; Wan, Zi Yi; Wong, Sek-Man] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore; [Wong, Sek-Man] Temasek Life Sci Lab, Singapore, Singapore; [Wong, Sek-Man] Natl Univ Singapore, Suzhou Res Inst, Suzhou, Jiangsu, Peoples R China	National University of Singapore; National University of Singapore	Wong, SM (corresponding author), Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore.	dbswsm@nus.edu.sg			National University of Singapore [R-154-000-552-112]	National University of Singapore(National University of Singapore)	This work was supported by the National University of Singapore research grant R-154-000-552-112. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Brunt AA, 2000, PLANT PATHOL, V49, P798, DOI 10.1046/j.1365-3059.2000.00501.x; Chen XM, 2012, CURR OPIN GENET DEV, V22, P361, DOI 10.1016/j.gde.2012.04.004; Duan CG, 2012, PLANT CELL, V24, P259, DOI 10.1105/tpc.111.092718; Dunoyer P, 2004, PLANT CELL, V16, P1235, DOI 10.1105/tpc.020719; Feng JL, 2009, GENE, V437, P14, DOI 10.1016/j.gene.2009.01.017; Gao RM, 2012, MOL PLANT MICROBE IN, V25, P1574, DOI 10.1094/MPMI-08-12-0203-R; Hellens R, 2000, TRENDS PLANT SCI, V5, P446, DOI 10.1016/S1360-1385(00)01740-4; Huang M, 2000, J VIROL, V74, P3149, DOI 10.1128/JVI.74.7.3149-3155.2000; Jay F, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002035; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Khraiwesh B, 2012, BBA-GENE REGUL MECH, V1819, P137, DOI 10.1016/j.bbagrm.2011.05.001; Kidner CA, 2005, CURR OPIN PLANT BIOL, V8, P38, DOI 10.1016/j.pbi.2004.11.008; Li SC, 2002, PLANT PATHOL, V51, P803, DOI 10.1046/j.1365-3059.2002.00775.x; Llave C, 2002, SCIENCE, V297, P2053, DOI 10.1126/science.1076311; Lu YD, 2008, PLANT CELL REP, V27, P1571, DOI 10.1007/s00299-008-0584-z; Mlotshwa S, 2008, TRENDS PLANT SCI, V13, P375, DOI 10.1016/j.tplants.2008.04.009; Moissiard G, 2006, P NATL ACAD SCI USA, V103, P19593, DOI 10.1073/pnas.0604627103; Navarro L, 2006, SCIENCE, V312, P436, DOI 10.1126/science.1126088; Shimura H, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002021; Simon-Mateo C, 2006, J VIROL, V80, P2429, DOI 10.1128/JVI.80.5.2429-2436.2006; Smith NA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002022; Tang J, 2008, PLANT DIS, V92, P1367, DOI 10.1094/PDIS-92-9-1367A; Varkonyi-Gasic E, 2007, PLANT METHODS, V3, DOI 10.1186/1746-4811-3-12; Vaucheret H, 2006, MOL CELL, V22, P129, DOI 10.1016/j.molcel.2006.03.011; WATERWORTH HE, 1976, PHYTOPATHOLOGY, V66, P570, DOI 10.1094/Phyto-66-570; Yu H, 2004, NAT GENET, V36, P157, DOI 10.1038/ng1286; Zhang BH, 2006, PLANT J, V46, P243, DOI 10.1111/j.1365-313X.2006.02697.X; Zhang JG, 2008, GENE, V423, P1, DOI 10.1016/j.gene.2008.05.023; Zhang X, 2009, J GEN VIROL, V90, P3042, DOI 10.1099/vir.0.012112-0; Zhou T, 2006, MOL PLANT MICROBE IN, V19, P948, DOI 10.1094/MPMI-19-0948	32	14	14	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e85476	10.1371/journal.pone.0085476	http://dx.doi.org/10.1371/journal.pone.0085476			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386476	Green Published, Green Submitted, gold			2022-12-25	WOS:000329194700137
J	Snowden, JN; Beaver, M; Beenken, K; Smeltzer, M; Horswill, AR; Kielian, T				Snowden, Jessica N.; Beaver, Matt; Beenken, Karen; Smeltzer, Mark; Horswill, Alexander R.; Kielian, Tammy			Staphylococcus aureus sarA Regulates Inflammation and Colonization during Central Nervous System Biofilm Formation	PLOS ONE			English	Article							EXPERIMENTAL BRAIN ABSCESSES; IMMUNE-RESPONSE; RISK-FACTORS; AGR; EPIDERMIDIS; INFECTIONS; STRAIN; ACTIVATION; VIRULENCE; MUTANTS	Infection is a frequent and serious complication following the treatment of hydrocephalus with CSF shunts, with limited therapeutic options because of biofilm formation along the catheter surface. Here we evaluated the possibility that the sarA regulatory locus engenders S. aureus more resistant to immune recognition in the central nervous system (CNS) based on its reported ability to regulate biofilm formation. We utilized our established model of CNS catheter-associated infection, similar to CSF shunt infections seen in humans, to compare the kinetics of bacterial titers, cytokine production and inflammatory cell influx elicited by wild type S. aureus versus an isogenic sarA mutant. The sarA mutant was more rapidly cleared from infected catheters compared to its isogenic wild type strain. Consistent with this finding, several pro-inflammatory cytokines and chemokines, including IL-17, CXCL1, and IL-1 beta were significantly increased in the brain following infection with the sarA mutant versus wild type S. aureus, in agreement with the fact that the sarA mutant displayed impaired biofilm growth and favored a planktonic state. Neutrophil influx into the infected hemisphere was also increased in the animals infected with the sarA mutant compared to wild type bacteria. These changes were not attributable to extracellular protease activity, which is increased in the context of SarA mutation, since similar responses were observed between sarA and a sarA/protease mutant. Overall, these results demonstrate that sarA plays an important role in attenuating the inflammatory response during staphylococcal biofilm infection in the CNS via a mechanism that remains to be determined.	[Snowden, Jessica N.; Beaver, Matt] Univ Nebraska Med Ctr, Dept Pediat, Omaha, NE 68198 USA; [Snowden, Jessica N.; Kielian, Tammy] Univ Nebraska Med Ctr, Dept Pathol & Microbiol, Omaha, NE USA; [Beenken, Karen; Smeltzer, Mark] Univ Arkansas Med Sci, Dept Microbiol & Immunol, Little Rock, AR 72205 USA; [Horswill, Alexander R.] Univ Iowa, Dept Microbiol, Carver Coll Med, Iowa City, IA 52242 USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Arkansas System; University of Arkansas Medical Sciences; University of Iowa	Snowden, JN (corresponding author), Univ Nebraska Med Ctr, Dept Pediat, Omaha, NE 68198 USA.	jsnowden@unmc.edu	; Smeltzer, Mark/M-2009-2018	Snowden, Jessica/0000-0002-0715-151X; Kielian, Tammy/0000-0001-7624-670X; Smeltzer, Mark/0000-0002-0878-0692	National Institute of Neurological Disorders and Stroke [1K08NS069812-01]; National Institute of Allergy and Infectious Disease [P01 AI083211]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI083211] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS069812] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute of Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants from the National Institute of Neurological Disorders and Stroke to JNS (1K08NS069812-01) and National Institute of Allergy and Infectious Disease P01 AI083211 Project 4 to TK. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Beenken KE, 2004, J BACTERIOL, V186, P4665, DOI 10.1128/JB.186.14.4665-4684.2004; Beenken KE, 2003, INFECT IMMUN, V71, P4206, DOI 10.1128/IAI.71.7.4206-4211.2003; Bernthal NM, 2011, J ORTHOP RES, V29, P1621, DOI 10.1002/jor.21414; Blevins JS, 2002, INFECT IMMUN, V70, P470, DOI 10.1128/IAI.70.2.470-480.2002; Blevins JS, 1999, MOL MICROBIOL, V33, P317, DOI 10.1046/j.1365-2958.1999.01475.x; Cassat J, 2006, MICROBIOL-SGM, V152, P3075, DOI 10.1099/mic.0.29033-0; Cassat James E., 2007, V391, P127; Fey PD, 2010, FUTURE MICROBIOL, V5, P917, DOI 10.2217/FMB.10.56; Forsman H, 2012, INFECT IMMUN, V80, P1987, DOI 10.1128/IAI.05906-11; Fux CA, 2006, CLIN MICROBIOL INFEC, V12, P331, DOI 10.1111/j.1469-0691.2006.01361.x; Gill SR, 2005, J BACTERIOL, V187, P2426, DOI 10.1128/JB.187.7.2426-2438.2005; Hanamsagar R, 2011, J NEUROCHEM, V119, P736, DOI 10.1111/j.1471-4159.2011.07481.x; Hanke ML, 2013, J IMMUNOL, V190, P2159, DOI 10.4049/jimmunol.1202348; Hanke ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042476; Jones RC, 2008, J BACTERIOL, V190, P5265, DOI 10.1128/JB.00383-08; Kielian T, 2005, INFECT IMMUN, V73, P7428, DOI 10.1128/IAI.73.11.7428-7435.2005; Kielian T, 2001, INFECT IMMUN, V69, P6902, DOI 10.1128/IAI.69.11.6902-6911.2001; Kielian T, 2001, J IMMUNOL, V166, P4634, DOI 10.4049/jimmunol.166.7.4634; Kielian T, 2007, J IMMUNOL, V178, P4528, DOI 10.4049/jimmunol.178.7.4528; Kockro RA, 2000, J MED MICROBIOL, V49, P441, DOI 10.1099/0022-1317-49-5-441; Lee JK, 2012, J KOREAN MED SCI, V27, P1563, DOI 10.3346/jkms.2012.27.12.1563; McGirt MJ, 2003, CLIN INFECT DIS, V36, P858, DOI 10.1086/368191; Mootz JM, 2013, INFECT IMMUN, V81, P3227, DOI 10.1128/IAI.00377-13; Mrak LN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038453; Nichols JR, 2009, J IMMUNOL, V182, P7119, DOI 10.4049/jimmunol.0802656; Otto M, 2012, SEMIN IMMUNOPATHOL, V34, P201, DOI 10.1007/s00281-011-0296-2; Otto M, 2010, ANNU REV MICROBIOL, V64, P143, DOI 10.1146/annurev.micro.112408.134309; Prabhakara R, 2011, INFECT IMMUN, V79, P1789, DOI 10.1128/IAI.01386-10; Schommer NN, 2011, INFECT IMMUN, V79, P2267, DOI 10.1128/IAI.01142-10; Snowden JN, 2012, INFECT IMMUN, V80, P3206, DOI 10.1128/IAI.00645-12; Stenzel W, 2008, AM J PATHOL, V172, P132, DOI 10.2353/ajpath.2008.070567; Thurlow LR, 2011, J IMMUNOL, V186, P6585, DOI 10.4049/jimmunol.1002794; Trotonda MP, 2009, J INFECT DIS, V199, P209, DOI 10.1086/595740; Tsang LH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003361; Tunkel AR, 2004, CLIN INFECT DIS, V39, P1267, DOI 10.1086/425368; Weiss EC, 2009, ANTIMICROB AGENTS CH, V53, P4096, DOI 10.1128/AAC.00484-09; Wormann ME, 2011, J BACTERIOL, V193, P5279, DOI 10.1128/JB.00369-11; Xiong YQ, 2006, J INFECT DIS, V194, P1267, DOI 10.1086/508210; Zhu Y, 2007, INFECT IMMUN, V75, P4219, DOI 10.1128/IAI.00509-07; Zielinska AK, 2012, MOL MICROBIOL, V86, P1183, DOI 10.1111/mmi.12048; Zielinska AK, 2011, J BACTERIOL, V193, P2948, DOI 10.1128/JB.01517-10	41	20	20	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e84089	10.1371/journal.pone.0084089	http://dx.doi.org/10.1371/journal.pone.0084089			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386336	gold, Green Published, Green Submitted			2022-12-25	WOS:000329194700091
J	Barsotti, MC; Losi, P; Briganti, E; Sanguinetti, E; Magera, A; Al Kayal, T; Feriani, R; Di Stefano, R; Soldani, G				Barsotti, Maria Chiara; Losi, Paola; Briganti, Enrica; Sanguinetti, Elena; Magera, Angela; Al Kayal, Tamer; Feriani, Roberto; Di Stefano, Rossella; Soldani, Giorgio			Effect of Platelet Lysate on Human Cells Involved in Different Phases of Wound Healing	PLOS ONE			English	Article							MESENCHYMAL STROMAL CELLS; TISSUE REGENERATION; OXIDATIVE STRESS; ENDOTHELIAL-CELL; RICH PLASMA; IN-VITRO; ANGIOGENESIS; EXPRESSION; EXPANSION; REPAIR	Background: Platelets are rich in mediators able to positively affect cell activity in wound healing. Aim of this study was to characterize the effect of different concentrations of human pooled allogeneic platelet lysate on human cells involved in the different phases of wound healing (inflammatory phase, angiogenesis, extracellular matrix secretion and epithelialization). Methodology/Principal Findings: Platelet lysate effect was studied on endothelial cells, monocytes, fibroblasts and keratinocytes, in terms of viability and proliferation, migration, angiogenesis, tissue repair pathway activation (ERK1/2) and inflammatory response evaluation (NF kappa B). Results were compared both with basal medium and with a positive control containing serum and growth factors. Platelet lysate induced viability and proliferation at the highest concentrations tested (10% and 20% v/v). Whereas both platelet lysate concentrations increased cell migration, only 20% platelet lysate was able to significantly promote angiogenic activity (p<0.05 vs. control), comparably to the positive control. Both platelet lysate concentrations activated important inflammatory pathways such as ERK1/2 and NF kappa B with the same early kinetics, whereas the effect was different for later time-points. Conclusion/Significance: These data suggest the possibility of using allogeneic platelet lysate as both an alternative to growth factors commonly used for cell culture and as a tool for clinical regenerative application for wound healing.	[Barsotti, Maria Chiara; Feriani, Roberto; Di Stefano, Rossella] Univ Pisa, Dept Surg Med Mol & Crit Area Pathol, Pisa, Italy; [Losi, Paola; Briganti, Enrica; Sanguinetti, Elena; Al Kayal, Tamer; Soldani, Giorgio] CNR, Inst Clin Physiol, Massa, Italy; [Magera, Angela] Kedrion SpA, Castelvecchio Pascoli, Italy	University of Pisa; Consiglio Nazionale delle Ricerche (CNR); Istituto di Fisiologia Clinica (IFC-CNR)	Barsotti, MC (corresponding author), Univ Pisa, Dept Surg Med Mol & Crit Area Pathol, Pisa, Italy.	mariachiara1970@yahoo.it	Di Stefano, Rossella/C-3880-2009; Barsotti, Maria Chiara/C-5222-2009	Barsotti, Maria Chiara/0000-0002-7957-0131; Al Kayal, Tamer/0000-0002-5700-5326	KEDRION S.p.A (Castelvecchio Pascoli, Lucca, Italy; BANDO UNICO R&D Regional Program; Regione Toscana	KEDRION S.p.A (Castelvecchio Pascoli, Lucca, Italy; BANDO UNICO R&D Regional Program; Regione Toscana(Regione Toscana)	The authors acknowledge the support of KEDRION S.p.A (Castelvecchio Pascoli, Lucca, Italy) by a Research Agreement for the Project of the BANDO UNICO R&D Regional Program 2008 "Nanostructured materials based on fibrin and platelet factors for angiogenesis promotion," funded by Regione Toscana. KEDRION S. p. A had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anitua E, 2006, TRENDS BIOTECHNOL, V24, P227, DOI 10.1016/j.tibtech.2006.02.010; Battinelli EM, 2011, BLOOD, V118, P1359, DOI 10.1182/blood-2011-02-334524; Bernardi M, 2013, CYTOTHERAPY, V15, P920, DOI 10.1016/j.jcyt.2013.01.219; Borzini P, 2005, TRANSFUSION, V45, P1759, DOI 10.1111/j.1537-2995.2005.00600.x; Burnouf T, 2013, TRANSFUSION, V53, P138, DOI 10.1111/j.1537-2995.2012.03668.x; Da Pozzo E, 2012, THROMB RES, V130, pE113, DOI 10.1016/j.thromres.2012.03.013; de la Rosa CM, 2013, J PHARMACOL EXP THER, V345, P15, DOI 10.1124/jpet.112.200881; Doucet C, 2005, J CELL PHYSIOL, V205, P228, DOI 10.1002/jcp.20391; Dulmovits BM, 2012, INT J BIOCHEM CELL B, V44, P1800, DOI 10.1016/j.biocel.2012.06.031; El Backly R, 2011, TISSUE ENG PT A, V17, P1787, DOI 10.1089/ten.tea.2010.0729; Fekete N, 2012, CYTOTHERAPY, V14, P540, DOI 10.3109/14653249.2012.655420; Felice F, 2010, MICROVASC RES, V80, P332, DOI 10.1016/j.mvr.2010.05.004; Ito R, 2013, TISSUE ENG PT A, V19, P1398, DOI [10.1089/ten.tea.2012.0375, 10.1089/ten.TEA.2012.0375]; Jonsdottir-Buch SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068984; Kajdaniuk D, 2011, ENDOKRYNOL POL, V62, P444; Kim YW, 2013, J MOL MED, V91, P323, DOI 10.1007/s00109-013-1007-3; Lan WW, 2012, OCUL SURF, V10, P137, DOI 10.1016/j.jtos.2012.04.001; Lee SH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048791; Losi P, 2013, ACTA BIOMATER, V9, P7814, DOI 10.1016/j.actbio.2013.04.019; Mazzucco L, 2004, TRANSFUSION, V44, P1013, DOI 10.1111/j.1537-2995.2004.03366.x; Mazzucco L, 2012, TRANSFUS APHER SCI, V47, P207, DOI 10.1016/j.transci.2012.06.006; Melchionna R, 2012, J INVEST DERMATOL, V132, P1908, DOI 10.1038/jid.2012.51; Novosel EC, 2011, ADV DRUG DELIVER REV, V63, P300, DOI 10.1016/j.addr.2011.03.004; Nurden AT, 2011, THROMB HAEMOSTASIS, V105, pS13, DOI 10.1160/THS10-11-0720; Occleston NL, 2011, WOUND REPAIR REGEN, V19, pS38, DOI 10.1111/j.1524-475X.2011.00711.x; Papanas N, 2012, CURR DIABETES REV, V8, P209, DOI 10.2174/157339912800563963; Pawitan JA, 2012, CURR STEM CELL RES T, V7, P329; Radziwon-Balicka A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059281; Radziwon-Balicka A, 2012, CAN J PHYSIOL PHARM, V90, P679, DOI [10.1139/Y2012-036, 10.1139/y2012-036]; Ranzato E, 2008, BRIT J DERMATOL, V159, P537, DOI 10.1111/j.1365-2133.2008.08699.x; Ranzato E, 2011, EXP DERMATOL, V20, P308, DOI 10.1111/j.1600-0625.2010.01173.x; Ranzato E, 2010, J CELL BIOCHEM, V110, P783, DOI 10.1002/jcb.22591; Ranzato E, 2009, J CELL MOL MED, V13, P2030, DOI 10.1111/j.1582-4934.2008.00467.x; Reinisch A, 2007, REGEN MED, V2, P371, DOI 10.2217/17460751.2.4.371; Roskoski R, 2012, PHARMACOL RES, V66, P105, DOI 10.1016/j.phrs.2012.04.005; Rossi S, 2013, INT J PHARMACEUT, V440, P207, DOI 10.1016/j.ijpharm.2012.07.056; Sum R, 2007, TRANSFUSION, V47, P672, DOI 10.1111/j.1537-2995.2007.01170.x; Valacchi G, 2011, CHEM BIOL DRUG DES, V77, P460, DOI 10.1111/j.1747-0285.2011.01121.x; Watson A, 2009, ARCH DERMATOL RES, V301, P307, DOI 10.1007/s00403-009-0945-7; Yang DHA, 2013, INT J BIOCHEM CELL B, V45, P419, DOI 10.1016/j.biocel.2012.11.007	40	71	74	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e84753	10.1371/journal.pone.0084753	http://dx.doi.org/10.1371/journal.pone.0084753			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281RE	24386412	gold, Green Published, Green Submitted			2022-12-25	WOS:000329117900109
J	Konig, SLB; Hadzic, M; Fiorini, E; Borner, R; Kowerko, D; Blanckenhorn, WU; Sigel, RKO				Koenig, Sebastian L. B.; Hadzic, Melodie; Fiorini, Erica; Boerner, Richard; Kowerko, Danny; Blanckenhorn, Wolf U.; Sigel, Roland K. O.			BOBA FRET: Bootstrap-Based Analysis of Single-Molecule FRET Data	PLOS ONE			English	Article							ALTERNATING-LASER EXCITATION; STRUCTURAL DYNAMICS; TIME-SERIES; METAL-IONS; RNA; TRAJECTORIES; CATALYSIS; MODEL; SUBPOPULATIONS; SPECTROSCOPY	Time-binned single-molecule Forster resonance energy transfer (smFRET) experiments with surface-tethered nucleic acids or proteins permit to follow folding and catalysis of single molecules in real-time. Due to the intrinsically low signal-to-noise ratio (SNR) in smFRET time traces, research over the past years has focused on the development of new methods to extract discrete states (conformations) from noisy data. However, limited observation time typically leads to pronounced cross-sample variability, i.e., single molecules display differences in the relative population of states and the corresponding conversion rates. Quantification of cross-sample variability is necessary to perform statistical testing in order to assess whether changes observed in response to an experimental parameter (metal ion concentration, the presence of a ligand, etc.) are significant. However, such hypothesis testing has been disregarded to date, precluding robust biological interpretation. Here, we address this problem by a bootstrap-based approach to estimate the experimental variability. Simulated time traces are presented to assess the robustness of the algorithm in conjunction with approaches commonly used in thermodynamic and kinetic analysis of time-binned smFRET data. Furthermore, a pair of functionally important sequences derived from the self-cleaving group II intron Sc.ai5 gamma (d3'EBS1*/IBS1*) is used as a model system. Through statistical hypothesis testing, divalent metal ions are shown to have a statistically significant effect on both thermodynamic and kinetic aspects of their interaction. The Matlab source code used for analysis (bootstrap-based analysis of smFRET data, BOBA FRET), as well as a graphical user interface, is available via http://www.aci.uzh.ch/rna/.	[Koenig, Sebastian L. B.; Hadzic, Melodie; Fiorini, Erica; Boerner, Richard; Kowerko, Danny; Sigel, Roland K. O.] Univ Zurich, Inst Inorgan Chem, CH-8057 Zurich, Switzerland; [Blanckenhorn, Wolf U.] Univ Zurich, Zurich, Switzerland	University of Zurich; University of Zurich	Konig, SLB (corresponding author), Univ Zurich, Inst Inorgan Chem, CH-8057 Zurich, Switzerland.	sebastian.koenig@uzh.ch; roland.sigel@aci.uzh.ch	Sigel, Roland/O-9883-2016; Börner, Richard/AAV-4493-2020; Kowerko, Danny/J-4847-2019	Sigel, Roland/0000-0002-1307-7993; Kowerko, Danny/0000-0002-4538-7814	University of Zurich; Forschungskredit of the University of Zurich [57010302, FK-13-092]; European Research Council [259092]	University of Zurich; Forschungskredit of the University of Zurich; European Research Council(European Research Council (ERC)European Commission)	This work was supported by the University of Zurich, the Forschungskredit of the University of Zurich (57010302, to SLBK, FK-13-092, to MH, http://www.researchers.uzh.ch/promotion/forschungskredit_en.html) and the European Research Council (MIRNA No 259092, to RKOS., http://erc.europa.eu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonik M, 2006, J PHYS CHEM B, V110, P6970, DOI 10.1021/jp057257+; Blanco M, 2010, METHOD ENZYMOL, V472, P153, DOI 10.1016/S0076-6879(10)72011-5; Borner R, 2012, J CHEM PHYS, V137, DOI 10.1063/1.4759108; Bokinsky G, 2003, P NATL ACAD SCI USA, V100, P9302, DOI 10.1073/pnas.1133280100; Bronson JE, 2009, BIOPHYS J, V97, P3196, DOI 10.1016/j.bpj.2009.09.031; Cardo Lucia, 2012, Methods Mol Biol, V848, P227, DOI 10.1007/978-1-61779-545-9_15; Cheng W, 2011, SCIENCE, V333, P1746, DOI 10.1126/science.1206023; Chung HS, 2010, BIOPHYS J, V98, P696, DOI 10.1016/j.bpj.2009.12.4322; CHUNG SH, 1991, J NEUROSCI METH, V40, P71, DOI 10.1016/0165-0270(91)90118-J; Dahan M, 1999, CHEM PHYS, V247, P85, DOI 10.1016/S0301-0104(99)00132-9; Ditzler MA, 2008, NUCLEIC ACIDS RES, V36, P7088, DOI 10.1093/nar/gkn871; Eddy SR, 2004, NAT BIOTECHNOL, V22, P1315, DOI 10.1038/nbt1004-1315; EFRON B, 1979, ANN STAT, V7, P1, DOI 10.1214/aos/1176344552; Ennifar E, 2003, NUCLEIC ACIDS RES, V31, P2671, DOI 10.1093/nar/gkg350; Giudici P, 2000, BIOMETRICS, V56, P742, DOI 10.1111/j.0006-341X.2000.00742.x; Gopich IV, 2007, J PHYS CHEM B, V111, P12925, DOI 10.1021/jp075255e; Gopich IV, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2180770; Greenfeld M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030024; Ha T, 2012, ANNU REV PHYS CHEM, V63, P595, DOI 10.1146/annurev-physchem-032210-103340; Haar A, 1910, MATH ANN, V69, P331, DOI 10.1007/BF01456326; Haran G, 2004, CHEM PHYS, V307, P137, DOI 10.1016/j.chemphys.2004.05.017; Hellriegel C, 2004, J PHYS CHEM B, V108, P14699, DOI 10.1021/jp049412a; Henzler-Wildman KA, 2007, NATURE, V450, P838, DOI 10.1038/nature06410; Hess ST, 2006, BIOPHYS J, V91, P4258, DOI 10.1529/biophysj.106.091116; Hoefling M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019791; Holden SJ, 2010, BIOPHYS J, V99, P3102, DOI 10.1016/j.bpj.2010.09.005; Jung S, 2009, J PHYS CHEM B, V113, P13886, DOI 10.1021/jp907019p; Kalinin S, 2010, J PHYS CHEM B, V114, P6197, DOI 10.1021/jp100025v; Kapanidis AN, 2004, P NATL ACAD SCI USA, V101, P8936, DOI 10.1073/pnas.0401690101; Kapanidis AN, 2005, ACCOUNTS CHEM RES, V38, P523, DOI 10.1021/ar0401348; Kelly D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029703; Keough MJ, 2011, EXPT DESIGN DATA ANA; Kim HK, 2007, NAT CHEM BIOL, V3, P763, DOI 10.1038/nchembio.2007.45; Konig SLB, 2013, CHIMIA, V67, P240, DOI 10.2533/chimia.2013.240; Konig SLB, 2013, RNA BIOL, V10, P133, DOI 10.4161/rna.23507; Konig SLB, 2013, CATION DEPENDE UNPUB; Kowerko D, 2013, METAL ION INDU UNPUB; Krause S, 2011, CHEMPHYSCHEM, V12, P303, DOI 10.1002/cphc.201000678; Kruschel D, 2013, RNA IN PRESS; Kruschel D, 2008, J INORG BIOCHEM, V102, P2147, DOI 10.1016/j.jinorgbio.2008.08.006; Lakowicz J.R., 1999, PRINCIPLES FLUORESCE, V2nd, DOI 10.1007/978-0-387-46312-4; Lee HK, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00017; Lee TH, 2007, BIOPHYS J, V92, P3275, DOI 10.1529/biophysj.106.094623; Lee TH, 2009, J PHYS CHEM B, V113, P11535, DOI 10.1021/jp903831z; Little MA, 2011, P ROY SOC A-MATH PHY, V467, P3088, DOI 10.1098/rspa.2010.0671; Liu Y, 2010, J PHYS CHEM B, V114, P5386, DOI 10.1021/jp9057669; MACQUEEN JT, 1967, J CHEM EDUC, V44, P755, DOI 10.1021/ed044p755; Manly B.F.J, 2007, RANDOMIZATION BOOTST, DOI DOI 10.1201/9780429329203; McKinney SA, 2003, NAT STRUCT BIOL, V10, P93, DOI 10.1038/nsb883; McKinney SA, 2006, BIOPHYS J, V91, P1941, DOI 10.1529/biophysj.106.082487; Nir E, 2006, J PHYS CHEM B, V110, P22103, DOI 10.1021/jp063483n; Okamoto K, 2008, BIOORGAN MED CHEM, V16, P6873, DOI 10.1016/j.bmc.2008.05.053; Okamoto K, 2008, J PHYS CHEM B, V112, P7308, DOI 10.1021/jp712104h; Okamoto K, 2012, BIOPHYS J, V103, P1315, DOI 10.1016/j.bpj.2012.07.047; Pattengale ND, 2010, J COMPUT BIOL, V17, P337, DOI 10.1089/cmb.2009.0179; Pla L, 2004, J AGR BIOL ENVIR ST, V9, P42, DOI 10.1198/1085711043136; Politis DN, 2003, STAT SCI, V18, P219, DOI 10.1214/ss/1063994977; Pyle AM, 2010, CRIT REV BIOCHEM MOL, V45, P215, DOI 10.3109/10409231003796523; Qin F, 2004, BIOPHYS J, V87, P1657, DOI 10.1529/biophysj.103.037531; Qin F, 2004, BIOPHYS J, V86, P1488, DOI 10.1016/S0006-3495(04)74217-4; Roy R, 2008, NAT METHODS, V5, P507, DOI 10.1038/NMETH.1208; Rueda D, 2004, P NATL ACAD SCI USA, V101, P10066, DOI 10.1073/pnas.0403575101; Schlegel G, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.137401; Schuler B, 2013, CURR OPIN STRUC BIOL, V23, P36, DOI 10.1016/j.sbi.2012.10.008; Selvin P R, 2007, SINGLE MOL TECHNIQUE; Solomatin SV, 2010, NATURE, V463, P681, DOI 10.1038/nature08717; Steiner M, 2008, P NATL ACAD SCI USA, V105, P13853, DOI 10.1073/pnas.0804034105; Steiner M, 2009, ANGEW CHEM INT EDIT, V48, P9739, DOI 10.1002/anie.200903809; Su LHJ, 2001, J MOL BIOL, V306, P655, DOI 10.1006/jmbi.2000.4323; Szoszkiewicz R, 2008, LANGMUIR, V24, P1356, DOI 10.1021/la702368b; Taylor JN, 2011, J PHYS CHEM B, V115, P1105, DOI 10.1021/jp1050707; Taylor JN, 2010, BIOPHYS J, V98, P164, DOI 10.1016/j.bpj.2009.09.047; Uphoff S, 2011, CHEMPHYSCHEM, V12, P571, DOI 10.1002/cphc.201000834; Walter NG, 2001, METHODS, V25, P19, DOI 10.1006/meth.2001.1212; Yang H, 2003, SCIENCE, V302, P262, DOI 10.1126/science.1086911; Yang H, 2002, CHEM PHYS, V284, P423, DOI 10.1016/S0301-0104(02)00672-9; Zhao R, 2013, BIOPHYSICS LIFE SCI, P117; Zhao R, 2009, METHODS, V49, P112, DOI 10.1016/j.ymeth.2009.04.017; Zhuang XW, 2002, SCIENCE, V296, P1473, DOI 10.1126/science.1069013; Zhuang XW, 2000, SCIENCE, V288, P2048, DOI 10.1126/science.288.5473.2048	80	26	26	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e84157	10.1371/journal.pone.0084157	http://dx.doi.org/10.1371/journal.pone.0084157			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281RE	24386343	Green Accepted, Green Published, Green Submitted, gold			2022-12-25	WOS:000329117900078
J	Wera, E; Velthuis, AGJ; Geong, M; Hogeveen, H				Wera, Ewaldus; Velthuis, Annet G. J.; Geong, Maria; Hogeveen, Henk			Costs of Rabies Control: An Economic Calculation Method Applied to Flores Island	PLOS ONE			English	Article							PARENTERAL VACCINATION CAMPAIGN; OWNED-DOG POPULATION; CANINE RABIES; RURAL AFRICA; COVERAGE; PREVENTION; NDJAMENA; IMPACT	Background: Rabies is a zoonotic disease that, in most human cases, is fatal once clinical signs appear. The disease transmits to humans through an animal bite. Dogs are the main vector of rabies in humans on Flores Island, Indonesia, resulting in about 19 human deaths each year. Currently, rabies control measures on Flores Island include mass vaccination and culling of dogs, laboratory diagnostics of suspected rabid dogs, putting imported dogs in quarantine, and pre-and post-exposure treatment (PET) of humans. The objective of this study was to estimate the costs of the applied rabies control measures on Flores Island. Methodology/principal findings: A deterministic economic model was developed to calculate the costs of the rabies control measures and their individual cost components from 2000 to 2011. The inputs for the economic model were obtained from (i) relevant literature, (ii) available data on Flores Island, and (iii) experts such as responsible policy makers and veterinarians involved in rabies control measures in the past. As a result, the total costs of rabies control measures were estimated to be US$1.12 million (range: US$0.60-1.47 million) per year. The costs of culling roaming dogs were the highest portion, about 39 percent of the total costs, followed by PET (35 percent), mass vaccination (24 percent), pre-exposure treatment (1.4 percent), and others (1.3 percent) (dog-bite investigation, diagnostic of suspected rabid dogs, trace-back investigation of human contact with rabid dogs, and quarantine of imported dogs). Conclusions/significance: This study demonstrates that rabies has a large economic impact on the government and dog owners. Control of rabies by culling dogs is relatively costly for the dog owners in comparison with other measures. Providing PET for humans is an effective way to prevent rabies, but is costly for government and does not provide a permanent solution to rabies in the future.	[Wera, Ewaldus] Kupang State Agr Polytech, Anim Hlth Study Program, West Timor, Indonesia; [Wera, Ewaldus; Velthuis, Annet G. J.; Hogeveen, Henk] Wageningen Univ, Business Econ Grp, NL-6700 AP Wageningen, Netherlands	Wageningen University & Research	Wera, E (corresponding author), Kupang State Agr Polytech, Anim Hlth Study Program, West Timor, Indonesia.	ewaldus.wera@wur.nl	Wera, Ewaldus/AAS-7146-2021	Wera, Ewaldus/0000-0002-1259-8359; Hogeveen, Henk/0000-0002-9443-1412; Velthuis, Annet/0000-0002-5869-8144	Directorate General of Higher Education, Republic of Indonesia	Directorate General of Higher Education, Republic of Indonesia	The authors would like to acknowledge the Directorate General of Higher Education, Republic of Indonesia for funding this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bingham J, 2001, RABIES FLORES ISLAND; BPS, 2013, POP IND VILL; Briggs DJ, 2010, INT HEALTH, V2, P161, DOI 10.1016/j.inhe.2010.07.005; Briggs DJ, 2007, RABIES; Childs JE, 2007, PREV VET MED, V78, P246, DOI 10.1016/j.prevetmed.2006.10.014; Chulasugandha P, 2006, VACCINE, V24, P1478, DOI 10.1016/j.vaccine.2005.03.059; Cleaveland S, 2003, VACCINE, V21, P1965, DOI 10.1016/S0264-410X(02)00778-8; Davlin SL, 2012, VACCINE, V30, P3492, DOI 10.1016/j.vaccine.2012.03.069; FISHBEIN DB, 1991, VACCINE, V9, P581, DOI 10.1016/0264-410X(91)90246-3; GLOSSER JW, 1970, J AM VET MED ASSOC, V157, P820; Gongal G, 2011, ADV PREVENTIVE MED; Goswami A, 2005, VACCINE, V23, P2970, DOI 10.1016/j.vaccine.2004.12.008; Green Alice L, 2011, Vet Clin North Am Exot Anim Pract, V14, P507, DOI 10.1016/j.cvex.2011.05.012; Hutabarat T, 2003, URB AN MAN C P ACIAR; IHM, 2000, PET PER PEN KAS GIG; IQ, 2008, PET TEKN PERS TIND K; Jackson AC, 2003, CLIN INFECT DIS, V36, P60, DOI 10.1086/344905; Jackson AC, 2007, RABIES; Kaare M, 2009, VACCINE, V27, P152, DOI 10.1016/j.vaccine.2008.09.054; Kamoltham T, 2003, B WORLD HEALTH ORGAN, V81, P375; KAPLAN MM, 1962, B WORLD HEALTH ORGAN, V26, P765; Kayali U, 2006, TROP MED INT HEALTH, V11, P1058, DOI 10.1111/j.1365-3156.2006.01663.x; Kayali U, 2003, B WORLD HEALTH ORGAN, V81, P739; KING AA, 1993, J COMP PATHOL, V108, P1, DOI 10.1016/S0021-9975(08)80224-1; Knobel D, 2009, BALI RABIES CONTROL; Knobel DL, 2005, B WORLD HEALTH ORGAN, V83, P360; Knobel DL, 2005, B WHO, V83; Kongkaew W, 2004, PREV VET MED, V65, P105, DOI 10.1016/j.prevetmed.2004.05.009; Kreindel SM, 1998, PUBLIC HEALTH REP, V113, P247; Linscott A. J., 2012, Clinical Microbiology Newsletter, V34, P177, DOI 10.1016/j.clinmicnews.2012.10.003; Manning S, 2008, HUMAN RABIES PREVENT; Meltzer MI, 1998, PHARMACOECONOMICS, V14, P365, DOI 10.2165/00019053-199814040-00004; Mitchell J, 2003, BEST PRACTICE WILD P; Muir P, 2005, LANCET, V365, P2175, DOI 10.1016/S0140-6736(05)66769-4; Putra AAG, 2013, EMERG INFECT DIS, V19, P648, DOI 10.3201/eid1904.120380; Recuenco S, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-47; Scott-Orr H., 2009, P 12 S INT SOC VET E; Shwiff SA, 2011, ZOONOSES PUBLIC HLTH, V58, P169, DOI 10.1111/j.1863-2378.2010.01335.x; Si H, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-113; Suzuki K, 2008, ZOONOSES PUBLIC HLTH, V55, P177, DOI 10.1111/j.1863-2378.2008.01114.x; Switzerland World Health Organization, 2010, Weekly Epidemiological Record, V85, P309; Tenzin, 2010, EMERG INFECT DIS, V16, P1925, DOI 10.3201/eid1612.100958; Tierkel ES, 1950, AM J PUBLIC HEALTH N, V40, P1084; Vallat B., 2011, OIE B, V3, P1; Voelker R, 2007, JAMA-J AM MED ASSOC, V298, P1749, DOI 10.1001/jama.298.15.1749; Wera E., 2001, EPIDEMIOLOGI USAHA P; Whitfield SG, 2001, J VIROL METHODS, V95, P145, DOI 10.1016/S0166-0934(01)00304-4; WHO, 2005, WHO TECH REP SER, V931, P1; Wilde H, 1999, J TRAVEL MED, V6, P238, DOI 10.1111/j.1708-8305.1999.tb00525.x; Windiyaningsih Caecilia, 2004, Journal of the Medical Association of Thailand, V87, P1389; WOODRUFF BA, 1991, AM J PUBLIC HEALTH, V81, P1328, DOI 10.2105/AJPH.81.10.1328; Wunner WH, 2005, VIRUS RES, V111, P1, DOI 10.1016/j.virusres.2005.03.005	53	25	26	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e83654	10.1371/journal.pone.0083654	http://dx.doi.org/10.1371/journal.pone.0083654			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281RE	24386244	Green Published, gold, Green Submitted			2022-12-25	WOS:000329117900049
J	Garcia-Murillas, I; Lambros, M; Turner, NC				Garcia-Murillas, Isaac; Lambros, Maryou; Turner, Nicholas C.			Determination of HER2 Amplification Status on Tumour DNA by Digital PCR	PLOS ONE			English	Article							POLYMERASE CHAIN-REACTION; BREAST-CANCER; IN-SITU; HYBRIDIZATION; RECEPTOR	Determination of the presence of HER2 amplification by quantitative PCR has been challenging, in part due to chromosomal instability and identification of a robust a reference region. We assessed the potential of digital PCR for highly accurate assessment of DNA concentration with EFTUD2 as chromosome 17 reference probe. We assessed a HER2: EFTDU2 ratio by digital PCR assay in the microdissected DNA from 18 HER2 amplified and 58 HER2 non-amplified cancers. The HER2: EFTUD2 ratio had high concordance with conventionally defined HER2 status with a sensitivity of 100% (18/18) and a specificity of 98% (57/58). The HER2: EFTUD2 digital PCR assay has potential to accurately assess HER2 amplification status.	[Garcia-Murillas, Isaac; Lambros, Maryou; Turner, Nicholas C.] Inst Canc Res, Breakthrough Breast Canc Res Ctr, London SW3 6JB, England; [Turner, Nicholas C.] Royal Marsden Hosp, Breast Unit, London SW3 6JJ, England	Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Royal Marsden NHS Foundation Trust	Turner, NC (corresponding author), Inst Canc Res, Breakthrough Breast Canc Res Ctr, London SW3 6JB, England.	nicholas.turner@icr.ac.uk		Turner, Nicholas/0000-0001-8937-0873; garcia-murillas, isaac/0000-0001-8183-7969	Breakthrough Breast Cancer; Cancer Research UK [16642] Funding Source: researchfish	Breakthrough Breast Cancer; Cancer Research UK(Cancer Research UK)	Breakthrough Breast Cancer http://www.breakthrough.org.uk/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baehner FL, 2010, J CLIN ONCOL, V28, P4300, DOI 10.1200/JCO.2009.24.8211; Buerger H, 1999, J PATHOL, V187, P396, DOI 10.1002/(SICI)1096-9896(199903)187:4<396::AID-PATH286>3.0.CO;2-L; Buerger H, 2001, J CLIN PATHOL, V54, P836, DOI 10.1136/jcp.54.11.836; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; Dabbs DJ, 2011, J CLIN ONCOL, V29, P4279, DOI 10.1200/JCO.2011.34.7963; Dube S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002876; Garraway LA, 2013, J CLIN ONCOL, V31, P1806, DOI 10.1200/JCO.2012.46.8934; Gevensleben H, 2013, CLIN CANCER RES, V19, P3276, DOI 10.1158/1078-0432.CCR-12-3768; Heredia NJ, 2013, METHODS, V59, pS20, DOI 10.1016/j.ymeth.2012.09.012; Hurvitz SA, 2013, CANCER TREAT REV, V39, P219, DOI 10.1016/j.ctrv.2012.04.008; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Lehmann-Che J, 2011, BRIT J CANCER, V104, P1739, DOI 10.1038/bjc.2011.135; Moelans CB, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-4; Muller BM, 2011, DIAGN MOL PATHOL, V20, P1, DOI 10.1097/PDM.0b013e3181e3630c; Natrajan R, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3154; Turner NC, 2007, ONCOGENE, V26, P2126, DOI 10.1038/sj.onc.1210014; Whale AS, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks203; Wolff AC, 2007, J CLIN ONCOL, V25, P118, DOI 10.1200/JCO.2006.09.2775	18	28	30	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e83409	10.1371/journal.pone.0083409	http://dx.doi.org/10.1371/journal.pone.0083409			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281QS	24386193	Green Published, gold, Green Submitted			2022-12-25	WOS:000329116700048
J	Levesque, S; Fournier, E; Carrier, N; Frost, E; Arbeit, RD; Michaud, S				Levesque, Simon; Fournier, Eric; Carrier, Nathalie; Frost, Eric; Arbeit, Robert D.; Michaud, Sophie			Campylobacteriosis in Urban versus Rural Areas: A Case-Case Study Integrated with Molecular Typing to Validate Risk Factors and to Attribute Sources of Infection	PLOS ONE			English	Article							MULTILOCUS SEQUENCE TYPES; NEW-ZEALAND; THERMOPHILIC CAMPYLOBACTERS; ENVIRONMENTAL WATER; CLONAL COMPLEXES; PUBLIC-HEALTH; RAW-MILK; JEJUNI; COLI; EPIDEMIOLOGY	Campylobacter infection is a leading cause of bacterial gastroenteritis worldwide, and most clinical cases appear as isolated, sporadic infections for which the source is rarely apparent. From July 2005 to December 2007 we conducted a prospective case-case study of sporadic, domestically-acquired Campylobacter enteritis in rural versus urban areas and a prevalence study of Campylobacter in animal and environmental sources in the Eastern Townships, Quebec. Isolates were typed using Multilocus Sequence Typing (MLST) to reinforce the case-case findings and to assign a source probability estimate for each human isolate. The risk of human campylobacteriosis was 1.89-fold higher in rural than urban areas. Unconditional multivariate logistic regression analysis identified two independent risk factors associated with human Campylobacter infections acquired in rural area: occupational exposure to animals (OR = 10.6, 95% CI: 1.2-91, p = 0.032), and household water coming from a private well (OR = 8.3, 95% CI: 3.4-20.4, p < 0.0001). A total of 851 C. jejuni isolates (178 human, 257 chicken, 87 bovine, 266 water, 63 wild bird) were typed using MLST. Among human isolates, the incidence rates of clonal complexes (CC) CC-21, CC-45, and CC-61 were higher in rural than urban areas. MLST-based source attribution analysis indicated that 64.5% of human C. jejuni isolates were attributable to chicken, followed by cattle (25.8%), water (7.4%), and wild birds (2.3%). Chicken was the attributable source for the majority of cases, independent of residential area, sex and age. The increased incidence in rural compared to urban areas was associated with occupational exposure to animals, particularly cattle among those aged 15-34 years, and with consumption of private well water. Both bovine and water exposure appeared to contribute to the seasonal variation in campylobacteriosis. These results provide a basis for developing public education and preventive programs targeting the risk factors identified.	[Levesque, Simon; Frost, Eric; Michaud, Sophie] Univ Sherbrooke, Fac Med, Dept Microbiol & Infect Dis, Quebec City, PQ, Canada; [Fournier, Eric] Inst Natl Sante Publ Quebec, Lab Sante Publ Quebec, Ste Anne De Bellevue, PQ, Canada; [Carrier, Nathalie; Frost, Eric] Ctr Hosp Univ Sherbrooke, Ctr Rech Clin Etienne Le Bel, Sherbrooke, PQ, Canada; [Arbeit, Robert D.] Tufts Univ, Sch Med, Infect Dis Sect, Boston, MA 02111 USA	Laval University; University of Sherbrooke; Institut national de sante publique du Quebec (INSPQ); University of Sherbrooke; Tufts University	Michaud, S (corresponding author), Univ Sherbrooke, Fac Med, Dept Microbiol & Infect Dis, Quebec City, PQ, Canada.	Sophie.Michaud@USherbrooke.ca		Levesque, Simon/0000-0002-4356-9702; Frost, Eric/0000-0001-8958-4388	Canadian Institutes of Health Research (CIHR); Natural Sciences and Engineering Research Council of Canada (NSERC); Centre de Recherche Clinique Etienne Le-Bel	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Centre de Recherche Clinique Etienne Le-Bel	The study was funded by the Canadian Institutes of Health Research (CIHR), the Natural Sciences and Engineering Research Council of Canada (NSERC) and the Centre de Recherche Clinique Etienne Le-Bel. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altekruse SF, 1999, EMERG INFECT DIS, V5, P28, DOI 10.3201/eid0501.990104; [Anonymous], 2000, Can Commun Dis Rep, V26, P170; Arsenault J, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-32; Buettner S, 2010, EPIDEMIOL INFECT, V138, P1748, DOI 10.1017/S095026881000155X; CARTER AM, 1987, APPL ENVIRON MICROB, V53, P523, DOI 10.1128/AEM.53.3.523-526.1987; Carter PE, 2009, APPL ENVIRON MICROB, V75, P6038, DOI 10.1128/AEM.01039-09; Cawthraw SA, 2000, CLIN EXP IMMUNOL, V122, P55, DOI 10.1046/j.1365-2249.2000.01349.x; Colles FM, 2003, APPL ENVIRON MICROB, V69, P7409, DOI 10.1128/AEM.69.12.7409-7413.2003; Danis K, 2009, EURO SURVEILL, V14; de Haan CPA, 2010, APPL ENVIRON MICROB, V76, P5228, DOI 10.1128/AEM.00581-10; Dingle KE, 2001, J CLIN MICROBIOL, V39, P14, DOI 10.1128/JCM.39.1.14-23.2001; Doorduyn Y, 2010, EPIDEMIOL INFECT, V138, P1391, DOI 10.1017/S095026881000052X; Fajo-Pascual M, 2010, EUR J PUBLIC HEALTH, V20, P443, DOI 10.1093/eurpub/ckp206; Feil EJ, 2004, J BACTERIOL, V186, P1518, DOI 10.1128/JB.186.5.1518-1530.2004; Fitzenberger J, 2010, EUROSURVEILL, V15; French NP, 2009, APPL ENVIRON MICROB, V75, P779, DOI 10.1128/AEM.01979-08; Gilpin BJ, 2008, ZOONOSES PUBLIC HLTH, V55, P352, DOI 10.1111/j.1863-2378.2008.01142.x; Gras LM, 2013, EPIDEMIOL INFECT, V141, P2526, DOI 10.1017/S0950268813000356; Gras LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042599; Green Chris G, 2006, Int J Health Geogr, V5, P2, DOI 10.1186/1476-072X-5-2; Gripp E, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-584; Habib I, 2010, FOOD MICROBIOL, V27, P829, DOI 10.1016/j.fm.2010.04.009; Hanninen ML, 2003, APPL ENVIRON MICROB, V69, P1391, DOI 10.1128/AEM.69.3.1391-1396.2003; Havelaar AH, 2009, CRIT REV MICROBIOL, V35, P1, DOI 10.1080/10408410802636017; Hepworth PJ, 2011, ENVIRON MICROBIOL, P2011; Heuvelink AE, 2009, INT J FOOD MICROBIOL, V134, P70, DOI 10.1016/j.ijfoodmicro.2008.12.026; Kabore H, 2010, ZOONOSES PUBLIC HLTH, V57, pE195, DOI 10.1111/j.1863-2378.2010.01328.x; Koenraad PMFJ, 1997, WATER ENVIRON RES, V69, P52, DOI 10.2175/106143097X125182; Kovats RS, 2005, INT J BIOMETEOROL, V49, P207, DOI 10.1007/s00484-004-0241-3; Levesque S, 2012, APPL ENV MICROBIOL; Levesque S, 2008, J CLIN MICROBIOL, V46, P3404, DOI 10.1128/JCM.00042-08; Levesque S, 2011, J MICROBIOL METH, V86, P82, DOI 10.1016/j.mimet.2011.04.001; Levesque S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016167; Manning G, 2003, APPL ENVIRON MICROB, V69, P6370, DOI 10.1128/AEM.69.11.6370-6379.2003; McCarthy N, 1999, INT J EPIDEMIOL, V28, P764, DOI 10.1093/ije/28.4.764; McCarthy ND, 2007, EMERG INFECT DIS, V13, P267, DOI 10.3201/eid1302.060620; McTavish SM, 2009, FEMS MICROBIOL LETT, V298, P149, DOI 10.1111/j.1574-6968.2009.01712.x; Michaud S, 2004, EMERG INFECT DIS, V10, P1844, DOI 10.3201/eid1010.040228; Michaud S, 2001, J MED MICROBIOL, V50, P1075, DOI 10.1099/0022-1317-50-12-1075; Mickan L, 2007, J APPL MICROBIOL, V102, P144, DOI 10.1111/j.1365-2672.2006.03049.x; Miller WG, 2005, J CLIN MICROBIOL, V43, P2315, DOI 10.1128/JCM.43.5.2315-2329.2005; Ministere de l'Agriculture dPedlA Direction regionale de l'Estrie, 2010, AGR AGR ESTR GOUV QU; Moreno Y, 2003, APPL ENVIRON MICROB, V69, P1181, DOI 10.1128/AEM.69.2.1181-1186.2003; Mullner P, 2010, EPIDEMIOL INFECT, V138, P1372, DOI 10.1017/S0950268809991579; Mullner P, 2009, INFECT GENET EVOL, V9, P1311, DOI 10.1016/j.meegid.2009.09.003; Nachamkin I., 2003, MANUAL CLIN MICROBIO, P902; Nylen G, 2002, EPIDEMIOL INFECT, V128, P383, DOI 10.1017/S0950268802006830; Oporto B, 2007, J APPL MICROBIOL, V103, P977, DOI 10.1111/j.1365-2672.2007.03328.x; Peterson MC, 2003, J ENVIRON HEALTH, V65, P20; POPOVICUROIC T, 1989, EPIDEMIOL INFECT, V102, P59, DOI 10.1017/S095026880002968X; Pritchard JK, 2000, GENETICS, V155, P945; Sails AD, 2003, J CLIN MICROBIOL, V41, P4058, DOI 10.1128/JCM.41.9.4058-4067.2003; Sheppard SK, 2010, APPL ENVIRON MICROB, V76, P5269, DOI 10.1128/AEM.00124-10; Sheppard SK, 2009, CLIN INFECT DIS, V48, P1072, DOI 10.1086/597402; Silva J, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00200; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; SKIRROW MB, 1987, EPIDEMIOL INFECT, V99, P647, DOI 10.1017/S0950268800066504; Slater ER, 1997, LETT APPL MICROBIOL, V25, P274, DOI 10.1046/j.1472-765X.1997.00218.x; Sopwith W, 2008, EMERG INFECT DIS, V14, P1769, DOI 10.3201/eid1411.071678; Sopwith W, 2006, EMERG INFECT DIS, V12, P1500, DOI 10.3201/eid1210.060048; Spratt BG, 2004, FEMS MICROBIOL LETT, V241, P129, DOI 10.1016/j.femsle.2004.11.015; St-Pierre K, 2009, APPL ENVIRON MICROB, V75, P6736, DOI 10.1128/AEM.00486-09; Strachan NJC, 2009, J INFECT DIS, V199, P1205, DOI 10.1086/597417; Studahl A, 2000, EPIDEMIOL INFECT, V125, P269, DOI 10.1017/S0950268899004562; Tam CC, 2009, EMERG INFECT DIS, V15, P1402, DOI 10.3201/eid1509.080773; Thomas C, 1999, J APPL MICROBIOL, V85, p168S, DOI 10.1111/j.1365-2672.1998.tb05296.x; THOMPSON JS, 1986, J CLIN MICROBIOL, V24, P876, DOI 10.1128/JCM.24.5.876-878.1986; Weir E, 2005, CAN MED ASSOC J, V172, P1438, DOI 10.1503/cmaj.050377; Williams NJ, 2010, APPL ENVIRON MICROB, V76, P7318, DOI 10.1128/AEM.00511-10; Wilson DJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000203; Young I, 2009, EPIDEMIOL INFECT, V137, P1217, DOI 10.1017/S0950268809002635	71	70	71	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e83731	10.1371/journal.pone.0083731	http://dx.doi.org/10.1371/journal.pone.0083731			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281QS	24386265	gold, Green Submitted, Green Published			2022-12-25	WOS:000329116700074
J	Nanjo, S; Yamada, T; Nishihara, H; Takeuchi, S; Sano, T; Nakagawa, T; Ishikawa, D; Zhao, L; Ebi, H; Yasumoto, K; Matsumoto, K; Yano, S				Nanjo, Shigeki; Yamada, Tadaaki; Nishihara, Hiroshi; Takeuchi, Shinji; Sano, Takako; Nakagawa, Takayuki; Ishikawa, Daisuke; Zhao, Lu; Ebi, Hiromichi; Yasumoto, Kazuo; Matsumoto, Kunio; Yano, Seiji			Ability of the Met Kinase Inhibitor Crizotinib and New Generation EGFR Inhibitors to Overcome Resistance to EGFR Inhibitors	PLOS ONE			English	Article							CELL LUNG-CANCER; HEPATOCYTE GROWTH-FACTOR; ACQUIRED-RESISTANCE; GEFITINIB RESISTANCE; T790M MUTATION; PHASE-III; RECEPTOR; ERLOTINIB; AMPLIFICATION; GENE	Purpose: Although EGF receptor tyrosine kinase inhibitors (EGFR-TKI) have shown dramatic effects against EGFR mutant lung cancer, patients ultimately develop resistance by multiple mechanisms. We therefore assessed the ability of combined treatment with the Met inhibitor crizotinib and new generation EGFR-TKIs to overcome resistance to first-generation EGFR-TKIs. Experimental Design: Lung cancer cell lines made resistant to EGFR-TKIs by the gatekeeper EGFR-T790M mutation, Met amplification, and HGF overexpression and mice with tumors induced by these cells were treated with crizotinib and a new generation EGFR-TKI. Results: The new generation EGFR-TKI inhibited the growth of lung cancer cells containing the gatekeeper EGFR-T790M mutation, but did not inhibit the growth of cells with Met amplification or HGF overexpression. In contrast, combined therapy with crizotinib plus afatinib or WZ4002 was effective against all three types of cells, inhibiting EGFR and Met phosphorylation and their downstream molecules. Crizotinib combined with afatinib or WZ4002 potently inhibited the growth of mouse tumors induced by these lung cancer cell lines. However, the combination of high dose crizotinib and afatinib, but not WZ4002, triggered severe adverse events. Conclusions: Our results suggest that the dual blockade of mutant EGFR and Met by crizotinib and a new generation EGFR-TKI may be promising for overcoming resistance to reversible EGFR-TKIs but careful assessment is warranted clinically.	[Nanjo, Shigeki; Yamada, Tadaaki; Takeuchi, Shinji; Sano, Takako; Nakagawa, Takayuki; Ishikawa, Daisuke; Zhao, Lu; Ebi, Hiromichi; Yasumoto, Kazuo; Yano, Seiji] Kanazawa Univ, Canc Res Inst, Div Med Oncol, Kanazawa, Ishikawa 920, Japan; [Nishihara, Hiroshi] Hokkaido Univ, Grad Sch Med, Lab Translat Pathol, Sapporo, Hokkaido, Japan; [Matsumoto, Kunio] Kanazawa Univ, Canc Res Inst, Div Tumor Dynam & Regulat, Kanazawa, Ishikawa 920, Japan	Kanazawa University; Hokkaido University; Kanazawa University	Yano, S (corresponding author), Kanazawa Univ, Canc Res Inst, Div Med Oncol, Kanazawa, Ishikawa 920, Japan.	syano@staff.kanazawa-u.ac.jp	Ebi, Hiromichi/AAA-7358-2019; YANO, SEIJI/D-8465-2015; Yamada, Tadaaki/L-5378-2015; Matsumoto, Kunio/D-8441-2015	Ebi, Hiromichi/0000-0003-3155-7576; Yamada, Tadaaki/0000-0002-6945-281X; Matsumoto, Kunio/0000-0002-6532-4482	KAKENHI; Ministry of Education, Culture, Sports, Science and Technology (MEXT)	KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported by KAKENHI (Grants-in-Aid for Scientific Research on Innovative Areas "Integrative Research on Cancer Microenvironment Network" (to SY) and Grant-in-Aid for Young Scientists [to TY and ST]), and Grants-in-Aid for Project for Development of Innovative Research on Cancer Therapeutics (P-Direct) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Engelman JA, 2007, CANCER RES, V67, P11924, DOI 10.1158/0008-5472.CAN-07-1885; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; GREEN LM, 1984, J IMMUNOL METHODS, V70, P257, DOI 10.1016/0022-1759(84)90190-X; Inoue A, 2013, ANN ONCOL, V24, P54, DOI 10.1093/annonc/mds214; Kobayashi S, 2005, CANCER RES, V65, P7096, DOI 10.1158/0008-5472.CAN-05-1346; Kobayashi S, 2005, NEW ENGL J MED, V352, P786, DOI 10.1056/NEJMoa044238; Kwak EL, 2005, P NATL ACAD SCI USA, V102, P7665, DOI 10.1073/pnas.0502860102; Kwak EL, 2010, NEW ENGL J MED, V363, P1693, DOI 10.1056/NEJMoa1006448; Li D, 2008, ONCOGENE, V27, P4702, DOI 10.1038/onc.2008.109; Ludovini V, 2011, J THORAC ONCOL, V6, P707, DOI 10.1097/JTO.0b013e31820a3a6b; Matsumoto K, 2006, INT J CANCER, V119, P477, DOI 10.1002/ijc.21808; Miller VA, 2012, LANCET ONCOL, V13, P528, DOI 10.1016/S1470-2045(12)70087-6; Mitsudomi T, 2007, CANCER SCI, V98, P1817, DOI 10.1111/j.1349-7006.2007.00607.x; Mitsudomi T, 2010, LANCET ONCOL, V11, P121, DOI 10.1016/S1470-2045(09)70364-X; NAKAMURA T, 1989, NATURE, V342, P440, DOI 10.1038/342440a0; Nishioka Y, 1997, INT J CANCER, V71, P170; Pao W, 2005, PLOS MED, V2, P225, DOI 10.1371/journal.pmed.0020073; Pao W, 2010, NAT REV CANCER, V10, P760, DOI 10.1038/nrc2947; Regales L, 2009, J CLIN INVEST, V119, P3000, DOI 10.1172/JCI38746; Rosell R, 2012, LANCET ONCOL, V13, P239, DOI 10.1016/S1470-2045(11)70393-X; Sano T, 2013, INT J CANCER, V133, P505, DOI 10.1002/ijc.28034; Sequist LV, 2013, J CLIN ONCOL, V31, P3327, DOI 10.1200/JCO.2012.44.2806; Sequist LV, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002003; Shimamura T, 2008, CANCER RES, V68, P5827, DOI 10.1158/0008-5472.CAN-07-5428; Suda K, 2011, J THORAC ONCOL, V6, P1152, DOI 10.1097/JTO.0b013e318216ee52; Suda K, 2010, CLIN CANCER RES, V16, P5489, DOI 10.1158/1078-0432.CCR-10-1371; Turke AB, 2010, CANCER CELL, V17, P77, DOI 10.1016/j.ccr.2009.11.022; Xu L, 2012, CANCER RES, V72, P3302, DOI 10.1158/0008-5472.CAN-11-3720; Yamada T, 2010, CLIN CANCER RES, V16, P174, DOI 10.1158/1078-0432.CCR-09-1204; Yamamoto C, 2010, CANCER RES, V70, P8715, DOI 10.1158/0008-5472.CAN-10-0043; Yano S, 2008, CANCER RES, V68, P9479, DOI 10.1158/0008-5472.CAN-08-1643; Yano S, 2011, J THORAC ONCOL, V6, P2011, DOI 10.1097/JTO.0b013e31823ab0dd; Yu Z, 2007, CANCER RES, V67, P10417, DOI 10.1158/0008-5472.CAN-07-1248; Yun CH, 2008, P NATL ACAD SCI USA, V105, P2070, DOI 10.1073/pnas.0709662105; Zhang ZF, 2012, NAT GENET, V44, P852, DOI 10.1038/ng.2330; Zhou WJ, 2009, NATURE, V462, P1070, DOI 10.1038/nature08622	36	38	40	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e84700	10.1371/journal.pone.0084700	http://dx.doi.org/10.1371/journal.pone.0084700			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281QS	24386407	gold, Green Published, Green Submitted			2022-12-25	WOS:000329116700116
J	Semple-Rowland, S; Madorsky, I; Bolch, S; Berry, J; Smith, WC				Semple-Rowland, Susan; Madorsky, Irina; Bolch, Susan; Berry, Jonathan; Smith, W. Clay			Activation of Phospholipase C Mimics the Phase Shifting Effects of Light on Melatonin Rhythms in Retinal Photoreceptors	PLOS ONE			English	Article							ROD OUTER SEGMENT; CIRCADIAN REGULATION; MEDIATED BREAKDOWN; SIGNALING PATHWAY; CHICKEN RETINA; CLOCK; EXPRESSION; CELLS; RAT; IDENTIFICATION	Many aspects of retinal photoreceptor function and physiology are regulated by the circadian clocks in these cells. It is well established that light is the primary stimulus that entrains these clocks; yet, the biochemical cascade(s) mediating light's effects on these clocks remains unknown. This deficiency represents a significant gap in our fundamental understanding of photoreceptor signaling cascades and their functions. In this study, we utilized re-aggregated spheroid cultures prepared from embryonic chick retina to determine if activation of phospholipase C in photoreceptors in the absence of light can phase shift the melatonin secretion rhythms of these cells in a manner similar to that induced by light. We show that spheroid cultures rhythmically secrete melatonin and that these melatonin rhythms can be dynamically phase shifted by exposing the cultures to an appropriately timed light pulse. Importantly, we show that activation of phospholipase C using m-3M3FBS in the absence of light induces a phase delay in photoreceptor melatonin rhythms that mirrors that induced by light. The implication of this finding is that the light signaling cascade that entrains photoreceptor melatonin rhythms involves activation of phospholipase C.	[Semple-Rowland, Susan; Madorsky, Irina; Berry, Jonathan] Univ Florida, Dept Neurosci, Gainesville, FL 32610 USA; [Bolch, Susan; Smith, W. Clay] Univ Florida, Dept Ophthalmol, Gainesville, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida	Semple-Rowland, S (corresponding author), Univ Florida, Dept Neurosci, Gainesville, FL 32610 USA.	rowland@ufl.edu	Smith, W. Clay/AAQ-1589-2021		National Eye Institute [EY014864, EY021721, EY011388]; Research to Prevent Blindness, Inc; University of Florida Faculty Enhancement Opportunity grant; C.M. Overstreet Retinal Eye Disease ARMD Research Fund; NATIONAL EYE INSTITUTE [R01EY011388, R01EY014864, P30EY021721] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Research to Prevent Blindness, Inc(Research to Prevent Blindness (RPB)); University of Florida Faculty Enhancement Opportunity grant; C.M. Overstreet Retinal Eye Disease ARMD Research Fund; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	National Eye Institute (EY014864, EY021721, EY011388); Research to Prevent Blindness, Inc; University of Florida Faculty Enhancement Opportunity grant; C.M. Overstreet Retinal Eye Disease ARMD Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts B, 2002, MOL BIOL CELL; Bae YS, 2003, MOL PHARMACOL, V63, P1043, DOI 10.1124/mol.63.5.1043; Bernard M, 1999, REPROD NUTR DEV, V39, P325, DOI 10.1051/rnd:19990305; BESHARSE JC, 1983, NATURE, V305, P133, DOI 10.1038/305133a0; Brancaccio M, 2013, NEURON, V78, P714, DOI 10.1016/j.neuron.2013.03.011; BROWN JE, 1987, BIOCHEM BIOPH RES CO, V146, P1392, DOI 10.1016/0006-291X(87)90804-7; CAHILL GM, 1992, VISUAL NEUROSCI, V8, P487, DOI 10.1017/S0952523800005009; CAHILL GM, 1993, NEURON, V10, P573, DOI 10.1016/0896-6273(93)90160-S; CAHILL GM, 1990, J NEUROCHEM, V54, P716, DOI 10.1111/j.1471-4159.1990.tb01932.x; Cailleau V, 2005, MOL VIS, V11, P472; Chong NW, 2000, J BIOL CHEM, V275, P32991, DOI 10.1074/jbc.M005671200; Collins B, 2013, NEURON, V78, P580, DOI 10.1016/j.neuron.2013.05.008; Contin MA, 2006, FASEB J, V20, P2648, DOI 10.1096/fj.06-6133fje; Contin MA, 2010, INVEST OPHTH VIS SCI, V51, P5491, DOI 10.1167/iovs.10-5643; Dwyer L, 2010, EUR J PHARMACOL, V628, P187, DOI 10.1016/j.ejphar.2009.11.029; FLANNERY JG, 1984, INVEST OPHTH VIS SCI, V25, P229; Frohns F, 2009, EUR J NEUROSCI, V29, P1931, DOI 10.1111/j.1460-9568.2009.06738.x; Garbarino-Pico E, 2004, J BIOL CHEM, V279, P51172, DOI 10.1074/jbc.M309248200; GEHM BD, 1991, BIOCHEMISTRY-US, V30, P11302, DOI 10.1021/bi00111a016; GHALAYINI A, 1984, BIOCHEM BIOPH RES CO, V124, P503, DOI 10.1016/0006-291X(84)91582-1; Ghalayini AJ, 1998, J NEUROCHEM, V70, P171; GHALAYINI AJ, 1991, J NEUROCHEM, V57, P1405, DOI 10.1111/j.1471-4159.1991.tb08307.x; GHALAYINI AJ, 1992, J BIOL CHEM, V267, P17977; GOLDMAN AI, 1980, INVEST OPHTH VIS SCI, V19, P1257; HAMM HE, 1980, P NATL ACAD SCI-BIOL, V77, P4998, DOI 10.1073/pnas.77.8.4998; HAYASHI F, 1985, BIOCHEM BIOPH RES CO, V128, P954, DOI 10.1016/0006-291X(85)90139-1; Helfrich-Forster C, 2001, NEURON, V30, P249, DOI 10.1016/S0896-6273(01)00277-X; Hughes S, 2012, PROG BRAIN RES, V199, P19, DOI 10.1016/B978-0-444-59427-3.00002-2; Kasahara T, 2002, J NEUROSCI, V22, P7321; Ko GYP, 2001, NEURON, V29, P255, DOI 10.1016/S0896-6273(01)00195-7; Ko ML, 2007, J NEUROCHEM, V103, P784, DOI 10.1111/j.1471-4159.2007.04816.x; Krjukova J, 2004, BRIT J PHARMACOL, V143, P3, DOI 10.1038/sj.bjp.0705911; Larkin P, 1999, MOL BRAIN RES, V70, P253, DOI 10.1016/S0169-328X(99)00154-0; LAVAIL MM, 1980, INVEST OPHTH VIS SCI, V19, P407; Layer PG, 1997, EUR J NEUROSCI, V9, P1795, DOI 10.1111/j.1460-9568.1997.tb00746.x; Liu SI, 2013, CHINESE J PHYSIOL, V56, P26, DOI 10.4077/CJP.2013.BAA091; MILLAR FA, 1988, BIOCHIM BIOPHYS ACTA, V970, P205, DOI 10.1016/0167-4889(88)90180-2; PANFOLI I, 1990, BIOCHEM BIOPH RES CO, V173, P283, DOI 10.1016/S0006-291X(05)81054-X; Peng YW, 1997, P NATL ACAD SCI USA, V94, P1995, DOI 10.1073/pnas.94.5.1995; PIERCE ME, 1993, NEURON, V10, P579, DOI 10.1016/0896-6273(93)90161-J; REPPERT SM, 1983, INVEST OPHTH VIS SCI, V24, P294; Rothermel A, 2005, TISSUE ENG, V11, P1749, DOI 10.1089/ten.2005.11.1749; Rothermel A, 2001, EUR J NEUROSCI, V13, P949, DOI 10.1046/j.1460-9568.2001.01469.x; Rothermel A, 1997, P ROY SOC B-BIOL SCI, V264, P1293, DOI 10.1098/rspb.1997.0179; Sakamoto K, 2006, MOL VIS, V12, P117; Sakamoto K, 2004, J NEUROCHEM, V90, P1019, DOI 10.1111/j.1471-4159.2004.02571.x; Sandu C, 2011, EUR J NEUROSCI, V34, P507, DOI 10.1111/j.1460-9568.2011.07772.x; Schneider K, 2010, J NEUROCHEM, V115, P585, DOI 10.1111/j.1471-4159.2010.06953.x; THOMAS KB, 1993, BRAIN RES, V601, P303; Tosini G, 2007, FASEB J, V21, P3866, DOI 10.1096/fj.07-8371com; Verra DM, 2011, INVEST OPHTH VIS SCI, V52, P5111, DOI 10.1167/iovs.11-75301; Voisin P, 2012, CELL TISSUE RES, V348, P417, DOI 10.1007/s00441-012-1374-z; Volpert Katja N, 2009, J Ocul Biol Dis Infor, V2, P1, DOI 10.1007/s12177-009-9014-x; Willbold E, 2002, DEV NEUROSCI-BASEL, V24, P504, DOI 10.1159/000069361; Willbold E, 1998, HISTOL HISTOPATHOL, V13, P531, DOI 10.14670/HH-13.531; YAMAGATA K, 1990, NEURON, V4, P469, DOI 10.1016/0896-6273(90)90059-O	56	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e83378	10.1371/journal.pone.0083378	http://dx.doi.org/10.1371/journal.pone.0083378			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281QS	24386190	gold, Green Published, Green Submitted			2022-12-25	WOS:000329116700046
J	Bouchet, A; Sakakini, N; El Atifi, M; Le Clec'h, C; Brauer, E; Moisan, A; Deman, P; Rihet, P; Le Duc, G; Pelletier, L				Bouchet, Audrey; Sakakini, Nathalie; El Atifi, Michele; Le Clec'h, Celine; Brauer, Elke; Moisan, Anaick; Deman, Pierre; Rihet, Pascal; Le Duc, Geraldine; Pelletier, Laurent			Early Gene Expression Analysis in 9L Orthotopic Tumor-Bearing Rats Identifies Immune Modulation in Molecular Response to Synchrotron Microbeam Radiation Therapy	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; X-RAY MICROBEAMS; HUMAN TH17 CELLS; IONIZING-RADIATION; IN-VIVO; MOUSE-BRAIN; DENDRITIC CELLS; GROWTH-FACTOR; GLIOSARCOMA; INFILTRATION	Synchrotron Microbeam Radiation Therapy (MRT) relies on the spatial fractionation of the synchrotron photon beam into parallel micro-beams applying several hundred of grays in their paths. Several works have reported the therapeutic interest of the radiotherapy modality at preclinical level, but biological mechanisms responsible for the described efficacy are not fully understood to date. The aim of this study was to identify the early transcriptomic responses of normal brain and glioma tissue in rats after MRT irradiation (400Gy). The transcriptomic analysis of similarly irradiated normal brain and tumor tissues was performed 6 hours after irradiation of 9 L orthotopically tumor-bearing rats. Pangenomic analysis revealed 1012 overexpressed and 497 repressed genes in the irradiated contralateral normal tissue and 344 induced and 210 repressed genes in tumor tissue. These genes were grouped in a total of 135 canonical pathways. More than half were common to both tissues with a predominance for immunity or inflammation (64 and 67% of genes for normal and tumor tissues, respectively). Several pathways involving HMGB1, toll-like receptors, C-type lectins and CD36 may serve as a link between biochemical changes triggered by irradiation and inflammation and immunological challenge. Most immune cell populations were involved: macrophages, dendritic cells, natural killer, T and B lymphocytes. Among them, our results highlighted the involvement of Th17 cell population, recently described in tumor. The immune response was regulated by a large network of mediators comprising growth factors, cytokines, lymphokines. In conclusion, early response to MRT is mainly based on inflammation and immunity which appear therefore as major contributors to MRT efficacy.	[Bouchet, Audrey; El Atifi, Michele; Pelletier, Laurent] INSERM, U836, Team Nanomed & Brain, La Tronche, France; [Bouchet, Audrey; Le Clec'h, Celine; Brauer, Elke; Le Duc, Geraldine] ESRF, Grenoble, France; [El Atifi, Michele; Pelletier, Laurent] Grenoble Univ Hosp, Grenoble, France; [Sakakini, Nathalie; Rihet, Pascal] INSERM, Unite Mixte Rech 1090, Team Technl Adv Genom & Clin TAGC, F-13258 Marseille, France; [Sakakini, Nathalie; Rihet, Pascal] Aix Marseille Univ, Marseille, France; [Moisan, Anaick] INSERM, U836, Team Funct NeuroImaging & Brain Perfus, La Tronche, France; [Deman, Pierre] INSERM, U836, Team Synchrotron Radiat & Med Res, La Tronche, France	Institut National de la Sante et de la Recherche Medicale (Inserm); European Synchrotron Radiation Facility (ESRF); CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm)	Pelletier, L (corresponding author), INSERM, U836, Team Nanomed & Brain, La Tronche, France.	laurent.pelletier@ujf-grenoble.fr	Rihet, Pascal/GQP-1381-2022; Moisan, Anaïck/P-4838-2014; Brӓuer-Krisch, Elke/O-6026-2017; Audrey, Bouchet/AAR-5929-2021; Rihet, Pascal/L-2173-2016; Rihet, Pascal/AAD-2018-2022	Rihet, Pascal/0000-0002-9459-3905; Moisan, Anaïck/0000-0002-6680-8593; Brӓuer-Krisch, Elke/0000-0003-4587-1160; Audrey, Bouchet/0000-0001-7228-8830; Rihet, Pascal/0000-0002-9459-3905; Rihet, Pascal/0000-0002-9459-3905	French National Institute of Health and Medical Research INSERM [U836]; European Synchrotron Radiation Facility; Institut National du Cancer (INCa - Bioresis program)	French National Institute of Health and Medical Research INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)); European Synchrotron Radiation Facility; Institut National du Cancer (INCa - Bioresis program)	This work was supported by the French National Institute of Health and Medical Research INSERM (U836), European Synchrotron Radiation Facility and Institut National du Cancer (INCa - Bioresis program). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amor S, 2010, IMMUNOLOGY, V129, P154, DOI 10.1111/j.1365-2567.2009.03225.x; Archer DW, 1998, COLLIMATOR PRODUCING; Barth RF, 2009, J NEURO-ONCOL, V94, P299, DOI 10.1007/s11060-009-9875-7; BENDA P, 1971, J NEUROSURG, V34, P310, DOI 10.3171/jns.1971.34.3.0310; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Boerma M, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-6; Bouchet A, 2012, J SYNCHROTRON RADIAT, V19, P478, DOI 10.1107/S0909049512015105; Bouchet A, 2010, INT J RADIAT ONCOL, V78, P1503, DOI 10.1016/j.ijrobp.2010.06.021; Brauer-Krisch E, 2009, REV SCI INSTRUM, V80, DOI 10.1063/1.3170035; Brauer-Krisch E, 2003, MED PHYS, V30, P583, DOI 10.1118/1.1562169; Crosbie JC, 2010, INT J RADIAT ONCOL, V77, P886, DOI 10.1016/j.ijrobp.2010.01.035; Demaria S, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00153; DeRisi J, 1996, NAT GENET, V14, P457; Desmarais G, 2012, INT J RADIAT BIOL, V88, P565, DOI 10.3109/09553002.2012.692495; Dilmanian F.A., 2003, BIOL MECH UNDERLYING; Dilmanian FA, 2002, NEURO-ONCOLOGY, V4, P26, DOI 10.1093/neuonc/4.1.26; Dilmanian FA, 2001, CELL MOL BIOL, V47, P485; Driessens G, 2004, CANCER RES, V64, P8435, DOI 10.1158/0008-5472.CAN-04-0774; Driessens G, 2008, CANCER IMMUNOL IMMUN, V57, P1745, DOI 10.1007/s00262-008-0500-y; Fung A, 2012, BRAIN RES, V1446, P144, DOI 10.1016/j.brainres.2012.01.061; Gabrilovich DI, 1996, NAT MED, V2, P1096, DOI 10.1038/nm1096-1096; Gasser S, 2005, NATURE, V436, P1186, DOI 10.1038/nature03884; Harrington LE, 2006, CURR OPIN IMMUNOL, V18, P349, DOI 10.1016/j.coi.2006.03.017; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Klune JR, 2008, MOL MED, V14, P476, DOI 10.2119/2008-00034.Klune; KURESHI SA, 1994, NEUROSURGERY, V35, P822, DOI 10.1227/00006123-199411000-00004; Laissue JA, 2001, P SOC PHOTO-OPT INS, V4508, P65, DOI 10.1117/12.450774; Laissue JA, 1998, INT J CANCER, V78, P654, DOI 10.1002/(SICI)1097-0215(19981123)78:5<654::AID-IJC21>3.0.CO;2-L; Liu WM, 2002, BIOINFORMATICS, V18, P1593, DOI 10.1093/bioinformatics/18.12.1593; Mahmoud-Ahmed AS, 2006, RADIAT RES, V165, P142, DOI 10.1667/RR3485.1; Miura M, 2006, BRIT J RADIOL, V79, P71, DOI 10.1259/bjr/50464795; Multhoff G, 2012, FRONT ONCOL, V2, P1, DOI 10.3389/fonc.2012.00058; Peterson KE, 2009, IMMUNOL RES, V43, P149, DOI 10.1007/s12026-008-8060-y; Prezado Y, 2011, MED PHYS, V38, P5012, DOI 10.1118/1.3608908; Regnard P, 2008, PHYS MED BIOL, V53, P861, DOI 10.1088/0031-9155/53/4/003; Regnard P, 2008, EUR J RADIOL, V68, pS151, DOI 10.1016/j.ejrad.2008.04.049; Salvat F, 2009, PENELOPE 2008 COD SY; Serduc R, 2006, INT J RADIAT ONCOL, V64, P1519, DOI 10.1016/j.ijrobp.2005.11.047; Serduc R, 2008, PHYS MED BIOL, V53, P3609, DOI 10.1088/0031-9155/53/13/015; Serduc R, 2008, PHYS MED BIOL, V53, P1153, DOI 10.1088/0031-9155/53/5/001; Serduc R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009028; Shimizu Kenji, 2005, Journal of Nippon Medical School, V72, P335, DOI 10.1272/jnms.72.335; Shin SC, 2011, GENOMICS, V97, P358, DOI 10.1016/j.ygeno.2011.01.005; SLATKIN DN, 1992, MED PHYS, V19, P1395, DOI 10.1118/1.596771; SLATKIN DN, 1995, P NATL ACAD SCI USA, V92, P8783, DOI 10.1073/pnas.92.19.8783; Slatkin DN, 1994, METHOD MICROBEAM RAD, V1; Sprung CN, 2012, RADIAT RES, V178, P249, DOI 10.1667/RR2885.1; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Su XM, 2010, J IMMUNOL, V184, P1630, DOI 10.4049/jimmunol.0902813; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Witham TF, 2003, J NEURO-ONCOL, V64, P63, DOI 10.1007/BF02700021; Ye J, 2013, AM J PATHOL, V182, P10, DOI 10.1016/j.ajpath.2012.08.041; Yin E, 2003, INT J RADIAT BIOL, V79, P759, DOI 10.1080/09553000310001610961; Zhao WL, 2006, CLIN CANCER RES, V12, P3823, DOI 10.1158/1078-0432.CCR-05-2418	55	43	43	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e81874	10.1371/journal.pone.0081874	http://dx.doi.org/10.1371/journal.pone.0081874			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391709	Green Published, gold, Green Submitted			2022-12-25	WOS:000329325200006
J	Cordeiro, CMM; Esmaili, H; Ansah, G; Hincke, MT				Cordeiro, Cristianne M. M.; Esmaili, Hamed; Ansah, George; Hincke, Maxwell T.			Ovocalyxin-36 Is a Pattern Recognition Protein in Chicken Eggshell Membranes	PLOS ONE			English	Article							BACTERICIDAL/PERMEABILITY-INCREASING PROTEIN; LIPOPOLYSACCHARIDE-BINDING PROTEIN; PSEUDOMONAS-AERUGINOSA; PROTEOMIC ANALYSIS; FUNCTIONAL VARIANT; TERMINAL FRAGMENT; STATISTICAL-MODEL; SPLUNC1 PROTEIN; BPI; IDENTIFICATION	The avian eggshell membranes are essential elements in the fabrication of the calcified shell as a defense against bacterial penetration. Ovocalyxin-36 (OCX-36) is an abundant avian eggshell membrane protein, which shares protein sequence homology to bactericidal permeability-increasing protein (BPI), lipopolysaccharide-binding protein (LBP) and palate, lung and nasal epithelium clone (PLUNC) proteins. We have developed an efficient method to extract OCX-36 from chicken eggshell membranes for purification with cation and anion exchange chromatographies. Purified OCX-36 protein exhibited lipopolysaccharide (LPS) binding activity and bound lipopolysaccharide (LPS) from Escherichia coli O111:B4 in a dose-dependent manner. OCX-36 showed inhibitory activity against growth of Staphylococcus aureus ATCC 6538. OCX-36 single nucleotide polymorphisms (SNPs) were verified at cDNA 211 position and the corresponding proteins proline-71 (Pro-71) or serine-71 (Ser-71) were purified from eggs collected from genotyped hens. A significant difference between Pro-71 and Ser71 OCX-36 for S. aureus lipoteichoic acid (LTA) binding activity was detected. The current study is a starting point to understand the innate immune role that OCX-36 may play in protection against bacterial invasion of both embryonated eggs (relevant to avian reproductive success) and unfertilized table eggs (relevant to food safety).	[Cordeiro, Cristianne M. M.; Esmaili, Hamed; Hincke, Maxwell T.] Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON, Canada; [Ansah, George] ISA North Amer, Div Hendrix Genet, Kitchener, ON, Canada	University of Ottawa	Hincke, MT (corresponding author), Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON, Canada.	mhincke@uottawa.ca	Cordeiro, Cristianne/AAT-7441-2020	Cordeiro, Cristianne/0000-0001-7970-7989	Canadian Natural Sciences and Engineering Research Council [STPGP 365046]	Canadian Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC))	Funding for this study was provided by the Canadian Natural Sciences and Engineering Research Council (STPGP 365046). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript (http://www.nserc-crsng.gc.ca/index_eng.asp).	Abdolhosseini M, 2012, PEPTIDES, V35, P231, DOI 10.1016/j.peptides.2012.03.017; Ahlborn GJ, 2006, PROTEIN J, V25, P71, DOI 10.1007/s10930-006-0010-8; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; ARIAS JL, 1991, CONNECT TISSUE RES, V26, P37, DOI 10.3109/03008209109152162; Barber RC, 2003, AM J RESP CRIT CARE, V167, P1316, DOI 10.1164/rccm.200209-1064OC; Bartlett J, 2011, BIOCHEM SOC T, V39, P1012, DOI 10.1042/BST0391012; Bingle CD, 2011, BIOCHEM SOC T, V39, P977, DOI 10.1042/BST0390977; Chiang SC, 2011, DEV COMP IMMUNOL, V35, P285, DOI 10.1016/j.dci.2010.09.013; Chien JW, 2008, BLOOD, V111, P2462, DOI 10.1182/blood-2007-09-101709; Chu HW, 2007, J IMMUNOL, V179, P3995, DOI 10.4049/jimmunol.179.6.3995; Cordeiro Cristianne M M, 2011, Recent Pat Food Nutr Agric, V3, P1; Fernandez MS, 1997, MATRIX BIOL, V16, P13, DOI 10.1016/S0945-053X(97)90112-8; Gautron J, 2001, CONNECT TISSUE RES, V42, P255, DOI 10.3109/03008200109016840; Gautron J, 2007, J BIOL CHEM, V282, P5273, DOI 10.1074/jbc.M610294200; Gautron J, 2011, BIOCHEM SOC T, V39, P971, DOI 10.1042/BST0390971; GAZZANOSANTORO H, 1992, INFECT IMMUN, V60, P4754, DOI 10.1128/IAI.60.11.4754-4761.1992; Ghafouri B, 2004, BBA-PROTEINS PROTEOM, V1699, P57, DOI 10.1016/j.bbapap.2004.01.001; Gorr SU, 2011, BIOCHEM SOC T, V39, P1028, DOI 10.1042/BST0391028; Guerin-Dubiard C, 2005, J CHROMATOGR A, V1090, P58, DOI 10.1016/j.chroma.2005.06.083; Haigh B, 2008, MOL IMMUNOL, V45, P1944, DOI 10.1016/j.molimm.2007.10.032; Hincke MT, 2012, FRONT BIOSCI-LANDMRK, V17, P1266, DOI 10.2741/3985; HINCKE MT, 1992, BIOCHEM J, V282, P877, DOI 10.1042/bj2820877; Hincke MT, 2000, MATRIX BIOL, V19, P443, DOI 10.1016/S0945-053X(00)00095-0; Horwitz AH, 1999, ANTIMICROB AGENTS CH, V43, P2314, DOI 10.1128/AAC.43.9.2314; Hubacek JA, 2001, CRIT CARE MED, V29, P557, DOI 10.1097/00003246-200103000-00015; Huebner C, 2010, INFLAMM BOWEL DIS, V16, P282, DOI 10.1002/ibd.21043; Ishihama Y, 2005, MOL CELL PROTEOMICS, V4, P1265, DOI 10.1074/mcp.M500061-MCP200; Kaweewong K, 2013, PROTEIN J, V32, P297, DOI 10.1007/s10930-013-9487-0; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Klein W, 2005, J CLIN GASTROENTEROL, V39, P282, DOI 10.1097/01.mcg.0000155127.20290.07; Kodali VK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018187; Krasity BC, 2011, BIOCHEM SOC T, V39, P1039, DOI 10.1042/BST0391039; Levin M, 2000, LANCET, V356, P961, DOI 10.1016/S0140-6736(00)02712-4; Levison PR, 2003, J CHROMATOGR B, V790, P17, DOI 10.1016/S1570-0232(03)00087-4; Levy O, 2000, ANTIMICROB AGENTS CH, V44, P2925, DOI 10.1128/AAC.44.11.2925-2931.2000; Levy O, 2004, J LEUKOCYTE BIOL, V76, P909, DOI 10.1189/jlb.0604320; Lukinskiene L, 2011, J IMMUNOL, V187, P382, DOI 10.4049/jimmunol.1001769; Mann K, 2008, PROTEOMICS, V8, P2322, DOI 10.1002/pmic.200800032; Mann K, 2006, PROTEOMICS, V6, P3801, DOI 10.1002/pmic.200600120; MANNION BA, 1990, J CLIN INVEST, V85, P853, DOI 10.1172/JCI114512; Mueller M, 2006, J BIOL CHEM, V281, P31448, DOI 10.1074/jbc.M605966200; Nahid AM, 2006, DEV COMP IMMUNOL, V30, P335, DOI 10.1016/j.dci.2005.04.002; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Nys Y, 2004, CR PALEVOL, V3, P549, DOI 10.1016/j.crpv.2004.08.002; OOI CE, 1991, J EXP MED, V174, P649, DOI 10.1084/jem.174.3.649; Rehault-Godbert S, 2011, WOODHEAD PUBL FOOD S, P183; Rose-Martel M, 2012, J PROTEOMICS, V75, P2697, DOI 10.1016/j.jprot.2012.03.019; Sayeed S, 2013, INFECT IMMUN, V81, P285, DOI 10.1128/IAI.00500-12; Schroder NWJ, 2004, J IMMUNOL, V173, P2683, DOI 10.4049/jimmunol.173.4.2683; Schultz H, 2007, CLIN CHIM ACTA, V384, P12, DOI 10.1016/j.cca.2007.07.005; Schumann RR, 2011, BIOCHEM SOC T, V39, P989, DOI 10.1042/BST0390989; Shai Y, 1999, BBA-BIOMEMBRANES, V1462, P55, DOI 10.1016/S0005-2736(99)00200-X; Srivastava A, 2007, INFECT IMMUN, V75, P342, DOI 10.1128/IAI.01089-06; Tian X, 2010, BIOL REPROD, V83, P893, DOI 10.1095/biolreprod.110.085019; TOBIAS PS, 1988, J BIOL CHEM, V263, P13479; TUAN RS, 1986, J EMBRYOL EXP MORPH, V97, P63; van der Schaft DWJ, 2000, BLOOD, V96, P176, DOI 10.1182/blood.V96.1.176.013k32_176_181; Wiesner J, 2010, VIRULENCE, V1, P440, DOI 10.4161/viru.1.5.12983; Wittmann I, 2008, J IMMUNOL, V180, P7546, DOI 10.4049/jimmunol.180.11.7546; Yamagata M, 2006, FASEB J, V20, P2058, DOI 10.1096/05-5662com; Yew PY, 2012, MOL CARCINOGEN, V51, pE74, DOI 10.1002/mc.21857; Zeng L, 2012, ANN SURG, V255, P147, DOI 10.1097/SLA.0b013e3182389515; Zhou HD, 2008, MOL CELL BIOCHEM, V309, P191, DOI 10.1007/s11010-007-9659-3	63	37	38	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84112	10.1371/journal.pone.0084112	http://dx.doi.org/10.1371/journal.pone.0084112			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391897	gold, Green Published, Green Submitted			2022-12-25	WOS:000329323900040
J	Dillon, ME; Frazier, MR				Dillon, Michael E.; Frazier, Melanie R.			Thermodynamics Constrains Allometric Scaling of Optimal Development Time in Insects	PLOS ONE			English	Article							EMBRYONIC-DEVELOPMENT TIME; METABOLIC-RATE; GENERAL-MODEL; BODY-SIZE; INCUBATION-TEMPERATURE; REGRESSION EQUATIONS; ONTOGENIC GROWTH; 3/4-POWER LAW; LENGTH; BIOMASS	Development time is a critical life-history trait that has profound effects on organism fitness and on population growth rates. For ectotherms, development time is strongly influenced by temperature and is predicted to scale with body mass to the quarter power based on 1) the ontogenetic growth model of the metabolic theory of ecology which describes a bioenergetic balance between tissue maintenance and growth given the scaling relationship between metabolism and body size, and 2) numerous studies, primarily of vertebrate endotherms, that largely support this prediction. However, few studies have investigated the allometry of development time among invertebrates, including insects. Abundant data on development of diverse insects provides an ideal opportunity to better understand the scaling of development time in this ecologically and economically important group. Insects develop more quickly at warmer temperatures until reaching a minimum development time at some optimal temperature, after which development slows. We evaluated the allometry of insect development time by compiling estimates of minimum development time and optimal developmental temperature for 361 insect species from 16 orders with body mass varying over nearly 6 orders of magnitude. Allometric scaling exponents varied with the statistical approach: standardized major axis regression supported the predicted quarter-power scaling relationship, but ordinary and phylogenetic generalized least squares did not. Regardless of the statistical approach, body size alone explained less than 28% of the variation in development time. Models that also included optimal temperature explained over 50% of the variation in development time. Warm-adapted insects developed more quickly, regardless of body size, supporting the "hotter is better'' hypothesis that posits that ectotherms have a limited ability to evolutionarily compensate for the depressing effects of low temperatures on rates of biological processes. The remaining unexplained variation in development time likely reflects additional ecological and evolutionary differences among insect species.	[Dillon, Michael E.] Univ Wyoming, Dept Zool & Physiol, Laramie, WY 82071 USA; [Dillon, Michael E.] Univ Wyoming, Program Ecol, Laramie, WY 82071 USA; [Frazier, Melanie R.] US EPA, Pacific Coastal Ecol Branch, Western Ecol Div, Newport, OR USA	University of Wyoming; University of Wyoming; United States Environmental Protection Agency	Dillon, ME (corresponding author), Univ Wyoming, Dept Zool & Physiol, Laramie, WY 82071 USA.	Michael.Dillon@uwyo.edu	Frazier, Melanie R/A-2367-2012		U.S. Environmental Protection Agency [AMI/GEOSS EP08D00051]; NHEERL	U.S. Environmental Protection Agency(United States Environmental Protection Agency); NHEERL	MRF was supported by U.S. Environmental Protection Agency post-doctoral fellowships (AMI/GEOSS EP08D00051 and NHEERL) during the completion of the project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angilletta MJ, 2010, PHYSIOL BIOCHEM ZOOL, V83, P197, DOI 10.1086/648567; Angilletta MJ, 2009, BIO HABIT, P1, DOI 10.1093/acprof:oso/9780198570875.001.1; Araujo MB, 2007, TRENDS ECOL EVOL, V22, P42, DOI 10.1016/j.tree.2006.09.010; ATKINSON D, 1994, ADV ECOL RES, V25, P1, DOI 10.1016/s0065-2504(08)60212-3; BATES JM, 1969, OPER RES QUART, V20, P451, DOI 10.2307/3008764; Benke AC, 1999, J N AM BENTHOL SOC, V18, P308, DOI 10.2307/1468447; Blomberg SP, 2012, SYST BIOL, V61, P382, DOI 10.1093/sysbio/syr118; BLUEWEISS L, 1978, OECOLOGIA, V37, P257, DOI 10.1007/BF00344996; Bokma F, 2004, FUNCT ECOL, V18, P184, DOI 10.1111/j.0269-8463.2004.00817.x; Bonner JT, 1965, SIZE CYCLE ESSAY STR; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; CALDER WA, 1983, ANNU REV ECOL SYST, V14, P213, DOI 10.1146/annurev.es.14.110183.001241; Calder WAI., 1996, SIZE FUNCTION LIFE H; Capellini I, 2010, ECOLOGY, V91, P2783, DOI 10.1890/09-0817.1; Charnov EL, 2003, EVOL ECOL RES, V5, P43; Chown SL, 2007, FUNCT ECOL, V21, P282, DOI 10.1111/j.1365-2435.2007.01245.x; Darveau CA, 2002, NATURE, V417, P166, DOI 10.1038/417166a; Davidson J, 1944, J ANIM ECOL, V13, P26, DOI 10.2307/1326; DeLong JP, 2010, P NATL ACAD SCI USA, V107, P12941, DOI 10.1073/pnas.1007783107; Ehnes RB, 2011, ECOL LETT, V14, P993, DOI 10.1111/j.1461-0248.2011.01660.x; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; FENCHEL T, 1974, OECOLOGIA, V14, P317, DOI 10.1007/BF00384576; Frazier MR, 2006, AM NAT, V168, P512, DOI 10.1086/506977; Ganihar SR, 1997, J BIOSCIENCE, V22, P219, DOI 10.1007/BF02704734; Garland T, 2000, AM NAT, V155, P346, DOI 10.1086/303327; GARLAND T, 1992, SYST BIOL, V41, P18, DOI 10.2307/2992503; GASTON KJ, 1988, ECOL ENTOMOL, V13, P399, DOI 10.1111/j.1365-2311.1988.tb00372.x; Gillooly JF, 2000, FRESHWATER BIOL, V44, P595, DOI 10.1046/j.1365-2427.2000.00607.x; Gillooly JF, 2000, J ZOOL, V251, P369, DOI 10.1017/S095283690000710X; Gillooly JF, 2002, NATURE, V417, P70, DOI 10.1038/417070a; Glazier DS, 2005, BIOL REV, V80, P611, DOI 10.1017/S1464793105006834; Glazier DS, 2006, BIOSCIENCE, V56, P325, DOI 10.1641/0006-3568(2006)56[325:TPLINU]2.0.CO;2; GRAFEN A, 1989, PHILOS T R SOC B, V326, P119, DOI 10.1098/rstb.1989.0106; Hamilton W.J., 1973, LIFES COLOR CODE; Hochachka P. W., 2002, BIOCH ADAPTATION MEC, DOI 10.1002/bmb.2002.494030030071; Hodar JA, 1996, ACTA OECOL, V17, P421; HOWE RW, 1967, ANNU REV ENTOMOL, V12, P15, DOI 10.1146/annurev.en.12.010167.000311; Huey RB, 2000, SCIENCE, V287, P308, DOI 10.1126/science.287.5451.308; Killen SS, 2010, ECOL LETT, V13, P184, DOI 10.1111/j.1461-0248.2009.01415.x; Kingsolver JG, 2008, EVOL ECOL RES, V10, P251; Kipyatkov VE., 2010, ENTOMOLOGICAL REV, V90, P163, DOI [10.1134/S0013873810020041, DOI 10.1134/S0013873810020041]; Kozlowski J, 2005, FUNCT ECOL, V19, P739, DOI 10.1111/j.1365-2435.2005.01021.x; Krogh A., 1914, Zeitschrift fuer Allgemeine Physiologie Jena, V16; Lovegrove BG, 2000, AM NAT, V156, P201, DOI 10.1086/303383; Martins EP, 1997, AM NAT, V149, P646, DOI 10.1086/286013; MCARDLE BH, 1988, CAN J ZOOL, V66, P2329, DOI 10.1139/z88-348; Moses ME, 2008, AM NAT, V171, P632, DOI 10.1086/587073; Orme D, 2012, CAPER COMP ANAL PHYL; Paradis E, 2011, ANAL PHYLOGENETICS E, DOI DOI 10.1086/523369; Pinheiro J., 2019, NLME LINEAR NONLINEA; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Reiss M.J., 1991, ALLOMETRY GROWTH REP; ROGERS LE, 1976, ANN ENTOMOL SOC AM, V69, P387, DOI 10.1093/aesa/69.2.387; ROGERS LE, 1977, ANN ENTOMOL SOC AM, V70, P51, DOI 10.1093/aesa/70.1.51; SAMPLE BE, 1993, AM MIDL NAT, V129, P234, DOI 10.2307/2426503; Sanderson ED, 1910, J ECON ENTOMOL, V3, P113; Savage VM, 2004, FUNCT ECOL, V18, P257, DOI 10.1111/j.0269-8463.2004.00856.x; SCHOENER TW, 1980, ANN ENTOMOL SOC AM, V73, P106, DOI 10.1093/aesa/73.1.106; Sieg AE, 2009, AM NAT, V174, P720, DOI 10.1086/606023; SMOCK LA, 1980, FRESHWATER BIOL, V10, P375, DOI 10.1111/j.1365-2427.1980.tb01211.x; Spicer J. I., 1999, PHYSL DIVERSITY ITS; Symonds MRE, 2002, EVOLUTION, V56, P2330, DOI 10.1111/j.0014-3820.2002.tb00156.x; Taskinen S, 2011, BIOMETRICAL J, V53, P652, DOI 10.1002/bimj.201000018; vanderHave TM, 1996, J THEOR BIOL, V183, P329, DOI 10.1006/jtbi.1996.0224; VONBERTALANFFY L, 1957, Q REV BIOL, V32, P217, DOI 10.1086/401873; WAGNER TL, 1984, ANN ENTOMOL SOC AM, V77, P208, DOI 10.1093/aesa/77.2.208; Walters RJ, 2006, AM NAT, V167, P510, DOI 10.1086/501029; Warton DI, 2006, BIOL REV, V81, P259, DOI 10.1017/S1464793106007007; Warton DI, 2012, METHODS ECOL EVOL, V3, P257, DOI 10.1111/j.2041-210X.2011.00153.x; West GB, 2001, NATURE, V413, P628, DOI 10.1038/35098076; West GB, 1997, SCIENCE, V276, P122, DOI 10.1126/science.276.5309.122; White CR, 2005, J EXP BIOL, V208, P1611, DOI 10.1242/jeb.01501; White CR, 2003, P NATL ACAD SCI USA, V100, P4046, DOI 10.1073/pnas.0436428100; White CR, 2006, BIOL LETTERS, V2, P125, DOI 10.1098/rsbl.2005.0378; Zuo WY, 2012, P ROY SOC B-BIOL SCI, V279, P1840, DOI 10.1098/rspb.2011.2000	76	20	20	1	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84308	10.1371/journal.pone.0084308	http://dx.doi.org/10.1371/journal.pone.0084308			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391935	Green Published, gold, Green Submitted			2022-12-25	WOS:000329323900078
J	Du, HY; Liang, ZB; Zhang, YL; Jie, FL; Li, JL; Fei, Y; Huang, Z; Pei, NN; Wang, SH; Li, A; Chen, BH; Zhang, Y; Sumners, C; Li, M; Li, HW				Du, Hongyan; Liang, Zhibing; Zhang, Yanling; Jie, Feilong; Li, Jinlong; Fei, Yang; Huang, Zhi; Pei, Nana; Wang, Suihai; Li, Andrew; Chen, Baihong; Zhang, Yi; Sumners, Colin; Li, Ming; Li, Hongwei			Effects of Angiotensin II Type 2 Receptor Overexpression on the Growth of Hepatocellular Carcinoma Cells In Vitro and In Vivo	PLOS ONE			English	Article							CONVERTING ENZYME-INHIBITOR; TRANSGENE EXPRESSION; AT(2) RECEPTORS; OVARIAN-CANCER; TUMOR-GROWTH; GENE; ANGIOGENESIS; APOPTOSIS; THERAPY; TUMORIGENESIS	Increasing evidence suggests that the renin-angiotensin system (RAS) plays an important role in tumorigenesis. The interaction between Angiotensin II (AngII) and angiotensin type 1 receptor (AT1R) may have a pivotal role in hepatocellular carcinoma (HCC) and therefore, AT1R blocker and angiotensin I-converting enzyme (ACE) inhibitors may have therapeutic potential in the treatment of hepatic cancer. Although the involvement of AT1R has been well explored, the role of the angiotensin II Type 2 receptor (AT2R) in HCC progression remains poorly understood. Thus, the aim of this study was to explore the effects of AT2R overexpression on HCC cells in vitro and in mouse models of human HCC. An AT2R recombinant adenoviral vector (Ad-G-AT2R-EGFP) was transduced into HCC cell lines and orthotopic tumor grafts. The results indicate that the high dose of Ad-G-AT2R-EGFP-induced overexpression of AT2R in transduced HCC cell lines produced apoptosis. AT2R overexpression in SMMC7721 cells inhibited cell proliferation with a significant reduction of S-phase cells and an enrichment of G1-phase cells through changing expression of CDK4 and cyclinD1. The data also indicate that overexpression of AT2R led to apoptosis via cell death signaling pathway that is dependent on activation of p38 MAPK, pJNK, caspase-8 and caspase-3 and inactivation of pp42/44 MAPK (Erk1/2). Finally, we demonstrated that moderately increasing AT2R expression could increase the growth of HCC tumors and the proliferation of HCC cells in vivo. Our findings suggest that AT2R overexpression regulates proliferation of hepatocellular carcinoma cells in vitro and in vivo, and the precise mechanisms of this phenomenon are yet to be fully determined.	[Du, Hongyan; Liang, Zhibing; Zhang, Yanling; Jie, Feilong; Li, Jinlong; Fei, Yang; Huang, Zhi; Pei, Nana; Wang, Suihai; Chen, Baihong; Li, Ming; Li, Hongwei] Southern Med Univ, Sch Biotechnol, Guangzhou, Guangdong, Peoples R China; [Li, Andrew] Univ Florida, Dept Neurosci, Gainesville, FL 32610 USA; [Zhang, Yi] Univ Florida, Dept Pharmacol, Gainesville, FL 32610 USA; [Sumners, Colin] Univ Florida, Dept Physiol & Funct Genom, Gainesville, FL USA	Southern Medical University - China; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Li, M (corresponding author), Southern Med Univ, Sch Biotechnol, Guangzhou, Guangdong, Peoples R China.	mingli1958@126.com; hongwei1@yahoo.com		Sumners, Colin/0000-0002-9689-2255	National Natural Science Foundation of China [81072113]; National 863 High Technique Development Projects of China [2012AA02A403, 2012AA020205]; State Key Laboratory of Pathogen and Biosecurity Program [SKLPBS1103]; Scientific Research Foundation of Southern Medical University [B1012076]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National 863 High Technique Development Projects of China(National High Technology Research and Development Program of China); State Key Laboratory of Pathogen and Biosecurity Program; Scientific Research Foundation of Southern Medical University	This work was supported by National Natural Science Foundation of China Grant 81072113 (H.L.), National 863 High Technique Development Projects of China Grant 2012AA02A403 (H.L.) and 2012AA020205 (M.L.), State Key Laboratory of Pathogen and Biosecurity Program SKLPBS1103 (H.L.), and Scientific Research Foundation of Southern Medical University (B1012076, H.D.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arrieta O, 2005, BRIT J CANCER, V92, P1247, DOI 10.1038/sj.bjc.6602483; Clere N, 2010, INT J CANCER, V127, P2279, DOI 10.1002/ijc.25234; D'Amore A, 2005, HYPERTENSION, V46, P1347, DOI 10.1161/01.HYP.0000193504.51489.cf; Doi C, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-67; Fabregat I, 2009, WORLD J GASTROENTERO, V15, P513, DOI 10.3748/wjg.15.513; Fujita M, 2005, CARCINOGENESIS, V26, P271, DOI 10.1093/carcin/bgh324; Fujita M, 2002, BIOCHEM BIOPH RES CO, V294, P441, DOI 10.1016/S0006-291X(02)00496-5; Fujiyama S, 2001, CIRC RES, V88, P22, DOI 10.1161/01.RES.88.1.22; Ginn SL, 2013, J GENE MED, V15, P65, DOI 10.1002/jgm.2698; Grieger JC, 2012, METHOD ENZYMOL, V507, P229, DOI 10.1016/B978-0-12-386509-0.00012-0; Honigman A, 2001, MOL THER, V4, P239, DOI 10.1006/mthe.2001.0437; Horiuchi M, 1998, ENDOCR RES, V24, P307, DOI 10.3109/07435809809032610; Ino K, 2006, BRIT J CANCER, V94, P552, DOI 10.1038/sj.bjc.6602961; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Kanehira T, 2005, CANCER RES, V65, P7660, DOI 10.1158/0008-5472.CAN-05-0275; Kawabata A, 2012, CANCER RES, V72, P2057, DOI 10.1158/0008-5472.CAN-11-3634; Kota J, 2009, CELL, V137, P1005, DOI 10.1016/j.cell.2009.04.021; Li HW, 2007, AM J PHYSIOL-HEART C, V292, pH727, DOI 10.1152/ajpheart.00938.2006; Li HW, 2009, MOL CANCER THER, V8, P3255, DOI 10.1158/1535-7163.MCT-09-0237; Li HW, 2005, BIOCHEM BIOPH RES CO, V336, P29, DOI 10.1016/j.bbrc.2005.08.035; Li HW, 2005, BIOCHEM BIOPH RES CO, V334, P1287, DOI 10.1016/j.bbrc.2005.07.025; Ma Y, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-85; Mitchell AM, 2010, CURR GENE THER, V10, P319; Miura SI, 2000, EMBO J, V19, P4026, DOI 10.1093/emboj/19.15.4026; Mueller C, 2008, GENE THER, V15, P858, DOI 10.1038/gt.2008.68; Nathwani AC, 2011, NEW ENGL J MED, V365, P2357, DOI 10.1056/NEJMoa1108046; Noguchi R, 2003, CLIN CANCER RES, V9, P6038; Pickel L, 2010, CANCER BIOL THER, V9, P277, DOI 10.4161/cbt.9.4.10643; Qi YF, 2012, EXP PHYSIOL, V97, P89, DOI 10.1113/expphysiol.2011.060673; Revankar CM, 2004, J BIOL CHEM, V279, P24578, DOI 10.1074/jbc.M402121200; Rizkalla B, 2003, J AM SOC NEPHROL, V14, P3061, DOI 10.1097/01.ASN.0000099374.58607.C9; Silvestre JS, 2002, CIRC RES, V90, P1072, DOI 10.1161/01.RES.0000019892.41157.24; STOLL M, 1995, J CLIN INVEST, V95, P651, DOI 10.1172/JCI117710; Suganuma T, 2005, CLIN CANCER RES, V11, P2686, DOI 10.1158/1078-0432.CCR-04-1946; Sun LH, 2012, BIOCHEM BIOPH RES CO, V424, P663, DOI 10.1016/j.bbrc.2012.07.003; Suzuki J, 2002, CIRCULATION, V106, P847, DOI 10.1161/01.CIR.0000024103.04821.86; Takagi T, 2002, CARCINOGENESIS, V23, P1235, DOI 10.1093/carcin/23.7.1235; Tan NY, 2009, CIRC RES, V105, P422, DOI 10.1161/CIRCRESAHA.109.203323; Tejera N, 2004, AM J PATHOL, V164, P1817, DOI 10.1016/S0002-9440(10)63740-6; TIMMERMANS PBMWM, 1993, PHARMACOL REV, V45, P205; Uemura H, 2005, MOL CANCER THER, V4, P1699, DOI 10.1158/1535-7163.MCT-04-0295; Walther T, 2003, FASEB J, V17, P2061, DOI 10.1096/fj.03-0129com; Wang SH, 2011, HEPATOLOGY, V53, P1932, DOI 10.1002/hep.24291; Wang XW, 2012, APOPTOSIS, V17, P908, DOI 10.1007/s10495-012-0721-6; Yan XH, 2003, AM J PHYSIOL-HEART C, V285, pH2179, DOI 10.1152/ajpheart.00361.2003; Yla-Herttuala S, 2012, MOL THER, V20, P1831, DOI 10.1038/mt.2012.194; Yoshiji H, 2006, ONCOL REP, V15, P155; Yoshiji H, 2005, ONCOL REP, V13, P491; Zhang XL, 2004, HYPERTENSION, V43, P276, DOI 10.1161/01.HYP.0000113628.94574.0f	49	28	33	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83754	10.1371/journal.pone.0083754	http://dx.doi.org/10.1371/journal.pone.0083754			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391821	Green Published, gold, Green Submitted			2022-12-25	WOS:000329325200119
J	Fujita, Y; van Bodegom, PM; Witte, JPM				Fujita, Yuki; van Bodegom, Peter M.; Witte, Jan-Philip M.			Relationships between Nutrient-Related Plant Traits and Combinations of Soil N and P Fertility Measures	PLOS ONE			English	Article							ELLENBERG INDICATOR VALUES; NITROGEN; VEGETATION; PHOSPHORUS; MOISTURE; AVAILABILITY; STRATEGIES; GRADIENTS; RESPONSES; STRESS	Soil fertility and nutrient-related plant functional traits are in general only moderately related, hindering the progress in trait-based prediction models of vegetation patterns. Although the relationships may have been obscured by suboptimal choices in how soil fertility is expressed, there has never been a systematic investigation into the suitability of fertility measures. This study, therefore, examined the effect of different soil fertility measures on the strength of fertility-trait relationships in 134 natural plant communities. In particular, for eight plot-mean traits we examined (1) whether different elements (N or P) have contrasting or shared influences, (2) which timescale of fertility measures (e. g. mineralization rates for one or five years) has better predictive power, and (3) if integrated fertility measures explain trait variation better than individual fertility measures. Soil N and P had large mutual effects on leaf nutrient concentrations, whereas they had element-specific effects on traits related to species composition (e. g. Grime's CSR strategy). The timescale of fertility measures only had a minor impact on fertility-trait relationships. Two integrated fertility measures (one reflecting overall fertility, another relative availability of soil N and P) were related significantly to most plant traits, but were not better in explaining trait variation than individual fertility measures. Using all fertility measures together, between-site variations of plant traits were explained only moderately for some traits (e. g. 33% for leaf N concentrations) but largely for others (e. g. 66% for whole-canopy P concentration). The moderate relationships were probably due to complex regulation mechanisms of fertility on traits, rather than to a wrong choice of fertility measures. We identified both mutual (i.e. shared) and divergent (i.e. element-specific and stoichiometric) effects of soil N and P on traits, implying the importance of explicitly considering the roles of different elements to properly interpret fertility-trait relationships.	[Fujita, Yuki; Witte, Jan-Philip M.] KWR Watercycle Res Inst, Team Ecohydrol, Nieuwegein, Netherlands; [van Bodegom, Peter M.; Witte, Jan-Philip M.] Vrije Univ Amsterdam, Dept Syst Ecol, Amsterdam, Netherlands	KWR Watercycle Research Institute; Vrije Universiteit Amsterdam	Fujita, Y (corresponding author), KWR Watercycle Res Inst, Team Ecohydrol, Nieuwegein, Netherlands.	Yuki.Fujita@kwrwater.nl	van Bodegom, Peter M./N-8150-2015	van Bodegom, Peter M./0000-0003-0771-4500	Knowledge for Climate, Dutch Water Utility sector [B222044]	Knowledge for Climate, Dutch Water Utility sector	Knowledge for Climate (http://www.klimaatonderzoeknederland.nl/), Dutch Water Utility sector (B222044). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts R, 2000, ADV ECOL RES, V30, P1, DOI 10.1016/S0065-2504(08)60016-1; BORCARD D, 1992, ECOLOGY, V73, P1045, DOI 10.2307/1940179; Cavender-Bares J, 2004, ECOL MONOGR, V74, P635, DOI 10.1890/03-4007; Ceulemans T, 2011, J APPL ECOL, V48, P1155, DOI 10.1111/j.1365-2664.2011.02023.x; CHEVAN A, 1991, AM STAT, V45, P90, DOI 10.2307/2684366; Del Grosso S, 2002, ENVIRON POLLUT, V116, pS75, DOI 10.1016/S0269-7491(01)00260-3; Douma JC, 2012, FUNCT ECOL, V26, P1355, DOI 10.1111/j.1365-2435.2012.02054.x; Douma JC, 2012, ECOGRAPHY, V35, P294, DOI 10.1111/j.1600-0587.2011.07140.x; Ertsen ACD, 1998, PLANT ECOL, V135, P113, DOI 10.1023/A:1009765529310; Fujita Y, 2013, SOIL BIOL BIOCHEM, V58, P302, DOI 10.1016/j.soilbio.2012.12.013; Fukami T, 2010, ECOL LETT, V13, P675, DOI 10.1111/j.1461-0248.2010.01465.x; Garnier Eric, 1998, P155, DOI 10.1017/CBO9780511525445.008; Gusewell S, 2004, NEW PHYTOL, V164, P243, DOI 10.1111/j.1469-8137.2004.01192.x; Hodgson JG, 1999, OIKOS, V85, P282, DOI 10.2307/3546494; Horta MD, 2010, COMMUN SOIL SCI PLAN, V41, P2358, DOI 10.1080/00103624.2010.508296; Hunt R, 2004, APPL VEG SCI, V7, P163, DOI 10.1111/j.1654-109X.2004.tb00607.x; Kafer J, 2004, J VEG SCI, V15, P647, DOI 10.1111/j.1654-1103.2004.tb02306.x; Kerkhoff AJ, 2006, AM NAT, V168, pE103, DOI 10.1086/507879; Kleyer M, 2008, J ECOL, V96, P1266, DOI 10.1111/j.1365-2745.2008.01430.x; Klotz S, 2002, SCHRIFTENREIHE VEGET, V38; LOOKMAN R, 1995, GEODERMA, V66, P285, DOI 10.1016/0016-7061(94)00084-N; Mac Nally R, 2002, BIODIVERS CONSERV, V11, P1397, DOI 10.1023/A:1016250716679; Niklas KJ, 2005, ECOL LETT, V8, P636, DOI 10.1111/j.1461-0248.2005.00759.x; Ordonez JC, 2010, ECOLOGY, V91, P3218, DOI 10.1890/09-1509.1; Ordonez JC, 2010, AM NAT, V175, P225, DOI 10.1086/649582; Ordonez JC, 2009, GLOBAL ECOL BIOGEOGR, V18, P137, DOI 10.1111/j.1466-8238.2008.00441.x; Pakeman RJ, 2007, APPL VEG SCI, V10, P91, DOI 10.1111/j.1654-109X.2007.tb00507.x; Peres-Neto PR, 2006, ECOLOGY, V87, P2614, DOI 10.1890/0012-9658(2006)87[2614:VPOSDM]2.0.CO;2; Pugnaire F.I., 2007, FUNCTIONAL PLANT ECO; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Reich PB, 2010, P ROY SOC B-BIOL SCI, V277, P877, DOI 10.1098/rspb.2009.1818; Schaffers AP, 2000, J VEG SCI, V11, P225, DOI 10.2307/3236802; Schaffers AP, 2000, PLANT SOIL, V221, P205, DOI 10.1023/A:1004716619199; Sonnier G, 2010, J VEG SCI, V21, P1014, DOI 10.1111/j.1654-1103.2010.01210.x; van Dam JC, 2008, VADOSE ZONE J, V7, P640, DOI 10.2136/vzj2007.0060; Van Duren IC, 2000, PLANT SOIL, V220, P35, DOI 10.1023/A:1004735618905; VANBODEGOM PM, 2003, BIOGEOCHEMISTRY, V64, P231, DOI DOI 10.1023/A:1024935107543; Venterink HO, 2002, ECOL APPL, V12, P1010, DOI 10.1890/1051-0761(2002)012[1010:NPAKBA]2.0.CO;2; von Asmuth JR, 2012, ENVIRON MODELL SOFTW, V38, P178, DOI 10.1016/j.envsoft.2012.06.003; Walsh C., 2008, HIER PART HIERARCHIC; Westoby M, 2002, ANNU REV ECOL SYST, V33, P125, DOI 10.1146/annurev.ecolsys.33.010802.150452; Willby NJ, 2001, NEW PHYTOL, V152, P463, DOI 10.1046/j.0028-646X.2001.00274.x; Witte JPM, 2007, J VEG SCI, V18, P605, DOI 10.1111/j.1654-1103.2007.tb02574.x; Wright IJ, 2004, NATURE, V428, P821, DOI 10.1038/nature02403	44	19	20	1	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83735	10.1371/journal.pone.0083735	http://dx.doi.org/10.1371/journal.pone.0083735			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391815	Green Published, Green Submitted, gold			2022-12-25	WOS:000329325200113
J	Legagneux, P; Harms, NJ; Gauthier, G; Chastel, O; Gilchrist, HG; Bortolotti, G; Bety, J; Soos, C				Legagneux, Pierre; Harms, N. Jane; Gauthier, Gilles; Chastel, Olivier; Gilchrist, H. Grant; Bortolotti, Gary; Bety, Joel; Soos, Catherine			Does Feather Corticosterone Reflect Individual Quality or External Stress in Arctic-Nesting Migratory Birds?	PLOS ONE			English	Article							EIDERS SOMATERIA-MOLLISSIMA; CURRENT REPRODUCTIVE EFFORT; GREATER SNOW GEESE; LONG-LIVED BIRD; COMMON EIDERS; BODY CONDITION; AVIAN CHOLERA; BASE-LINE; MOLT; REPEATABILITY	The effects of environmental perturbations or stressors on individual states can be carried over to subsequent life stages and ultimately affect survival and reproduction. The concentration of corticosterone (CORT) in feathers is an integrated measure of hypothalamic-pituitary-adrenal activity during the molting period, providing information on the total baseline and stress-induced CORT secreted during the period of feather growth. Common eiders and greater snow geese replace all flight feathers once a year during the pre-basic molt, which occurs following breeding. Thus, CORT contained in feathers of pre-breeding individuals sampled in spring reflects the total CORT secreted during the previous molting event, which may provide insight into the magnitude or extent of stress experienced during this time period. We used data from multiple recaptures to disentangle the contribution of individual quality vs. external factors (i.e., breeding investment or environmental conditions) on feather CORT in arctic-nesting waterfowl. Our results revealed no repeatability of feather CORT within individuals of either species. In common eiders, feather CORT was not affected by prior reproductive investment, nor by pre-breeding (spring) body condition prior to the molting period. Individual feather CORT greatly varied according to the year, and August-September temperatures explained most of the annual variation in feather CORT. Understanding mechanisms that affect energetic costs and stress responses during molting will require further studies either using long-term data or experiments. Although our study period encompassed only five years, it nonetheless provides evidence that CORT measured in feathers likely reflects responses to environmental conditions experienced by birds during molt, and could be used as a metric to study carry-over effects.	[Legagneux, Pierre; Bety, Joel] Univ Quebec, Dept Biol, Rimouski, PQ G5L 3A1, Canada; [Legagneux, Pierre; Bety, Joel] Univ Quebec, Ctr Etud Nord, Rimouski, PQ G5L 3A1, Canada; [Harms, N. Jane; Soos, Catherine] Univ Saskatchewan, Dept Vet Pathol, Saskatoon, SK, Canada; [Gauthier, Gilles] Univ Laval, Dept Biol, Quebec City, PQ G1K 7P4, Canada; [Gauthier, Gilles] Univ Laval, Ctr Etud Nord, Quebec City, PQ G1K 7P4, Canada; [Chastel, Olivier] CNRS UPR 1934, Ctr Etud Biol Chize, Carrefour Canauderie, Villiers En Boi, France; [Gilchrist, H. Grant] Environm Canada, Natl Wildlife Res Ctr, Ottawa, ON K1A 0H3, Canada; [Bortolotti, Gary] Univ Saskatchewan, Dept Biol, Saskatoon, SK S7N 0W0, Canada; [Soos, Catherine] Environm Canada, Saskatoon, SK, Canada	University of Quebec; University of Quebec; University of Saskatchewan; Laval University; Laval University; Centre National de la Recherche Scientifique (CNRS); Environment & Climate Change Canada; Canadian Wildlife Service; National Wildlife Research Centre - Canada; University of Saskatchewan; Environment & Climate Change Canada	Legagneux, P (corresponding author), Univ Quebec, Dept Biol, Rimouski, PQ G5L 3A1, Canada.	legagneux@gmail.com	Soos, Catherine/Q-4983-2019	Soos, Catherine/0000-0003-4610-3614; Bety, Joel/0000-0002-8775-6411; Legagneux, Pierre/0000-0002-6366-0554	Environment Canada; Natural Sciences and Engineering Research Council of Canada [STPGP-396972-2010]; Western College of Veterinary Medicine Interprovincial Graduate Fellowship; W. Garfield Weston Award for Northern Research	Environment Canada(CGIAR); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Western College of Veterinary Medicine Interprovincial Graduate Fellowship; W. Garfield Weston Award for Northern Research	This work was supported by Environment Canada (http://www.ec.gc.ca/), who supported all aspects of project including administrative, field and laboratory costs, and technical support; Natural Sciences and Engineering Research Council of Canada (Grant number STPGP-396972-2010; http://www.nserc-crsng.gc.ca/), who supported all aspects of project including administrative, field and laboratory costs, and technical support; Strategic Applications of Genomics in the Environment (http://www.ec.gc.ca/scitech/default.asp? lang = En&n = BA7C049C-1), who supported laboratory analyses, field travel costs, and costs of shipping equipment and samples to and from Arctic; Ducks Unlimited Institute for Wetland and Waterfowl Research (http://www.ducks.ca/our-science/), who supported field travel costs and laboratory analyses; Northern Scientific Training Program (http://www.polarcom.gc.ca/principal/eng/content/northern-scientific-training-program), who supported field travel costs for numerous graduate and undergraduate students; University of Saskatchewan's Wildlife Health Research Fund (http://www.usask.ca/wcvm/research/research_funds/wildlife_health_research_fund.php), who supported field travel costs and laboratory analyses; and Nunavut Wildlife Management Board (http://www.nwmb.com/), who supported all aspects of project including administrative, field and laboratory costs, and technical support. NJH was supported by a Western College of Veterinary Medicine Interprovincial Graduate Fellowship (http://www.usask.ca/wcvm/research/research_fellowships.php) and a W. Garfield Weston Award for Northern Research (http://www.westonfoundation.org/northern/Pages/gwanr.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelier F, 2010, BIOL LETTERS, V6, P846, DOI 10.1098/rsbl.2010.0376; Bergeron P, 2011, J ANIM ECOL, V80, P361, DOI 10.1111/j.1365-2656.2010.01770.x; Beukema JJ, 2009, MAR ECOL PROG SER, V384, P135, DOI 10.3354/meps07952; Bortolotti GR, 2008, FUNCT ECOL, V22, P494, DOI 10.1111/j.1365-2435.2008.01387.x; Bortolotti GR, 2009, J EXP BIOL, V212, P1477, DOI 10.1242/jeb.022152; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Buttler EI, 2011, J WILDLIFE MANAGE, V75, P283, DOI 10.1002/jwmg.38; Cockrem JF, 2009, GEN COMP ENDOCR, V163, P158, DOI 10.1016/j.ygcen.2009.03.029; Conklin JR, 2012, J AVIAN BIOL, V43, P252, DOI 10.1111/j.1600-048X.2012.05606.x; Dawson A, 2000, P ROY SOC B-BIOL SCI, V267, P2093, DOI 10.1098/rspb.2000.1254; Dawson A, 2005, FUNCT ECOL, V19, P995, DOI 10.1111/j.1365-2435.2005.01061.x; Dawson A, 2004, IBIS, V146, P493, DOI 10.1111/j.1474-919x.2004.00290.x; Descamps S, 2011, J AVIAN BIOL, V42, P39, DOI 10.1111/j.1600-048X.2010.05196.x; Descamps S, 2010, OIKOS, V119, P1526, DOI 10.1111/j.1600-0706.2010.18508.x; Dietz MW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053890; Fairhurst GD, 2013, J EXPT BIOL; Fairhurst GD, 2012, CAN J ZOOL, V90, P1422, DOI 10.1139/cjz-2012-0096; Fairhurst GD, 2012, P ROY SOC B-BIOL SCI, V279, P177, DOI 10.1098/rspb.2011.0884; Field CB, 1998, SCIENCE, V281, P237, DOI 10.1126/science.281.5374.237; GABRIELSEN G W, 1991, Norsk Polarinstitutt Skrifter, P51; Gauthier G, 2001, ECOLOGY, V82, P3105, DOI 10.1890/0012-9658(2001)082[3105:SSOGSG]2.0.CO;2; Goudie R.I., 2000, BIRDS N AM ONLINE; Griggio M, 2009, J EVOLUTION BIOL, V22, P782, DOI 10.1111/j.1420-9101.2009.01700.x; HAHN TP, 1992, ORNIS SCAND, V23, P314, DOI 10.2307/3676655; Hemborg C, 1999, ANN ZOOL FENN, V36, P1; HURRELL JW, 1995, SCIENCE, V269, P676, DOI 10.1126/science.269.5224.676; JENSSEN BM, 1989, CAN J ZOOL, V67, P669, DOI 10.1139/z89-096; Koren L, 2011, P ROYAL SOC B; Kralj-Fiser S, 2007, HORM BEHAV, V51, P239, DOI 10.1016/j.yhbeh.2006.10.006; Landys MM, 2006, GEN COMP ENDOCR, V148, P132, DOI 10.1016/j.ygcen.2006.02.013; Lattin CR, 2011, J AVIAN BIOL, V42, P247, DOI 10.1111/j.1600-048X.2010.05310.x; LEBRETON JD, 1992, ECOL MONOGR, V62, P67, DOI 10.2307/2937171; Legagneux P, 2012, P ROY SOC B-BIOL SCI, V279, P876, DOI 10.1098/rspb.2011.1351; LESSELLS CM, 1987, AUK, V104, P116, DOI 10.2307/4087240; McEwen BS, 2003, HORM BEHAV, V43, P2, DOI 10.1016/S0018-506X(02)00024-7; MIDDLETON ALA, 1986, CAN FIELD NAT, V100, P545; Morez V, 2000, J WILDLIFE MANAGE, V64, P875, DOI 10.2307/3802758; Mosbech A, 2006, ARDEA, V94, P651; Murphy Mary E., 1996, P158; Nakagawa S, 2010, BIOL REV, V85, P935, DOI 10.1111/j.1469-185X.2010.00141.x; Newton I, 2006, J ORNITHOL, V147, P146, DOI 10.1007/s10336-006-0058-4; Nilsson JA, 1996, P ROY SOC B-BIOL SCI, V263, P711, DOI 10.1098/rspb.1996.0106; Norris DR, 2004, SCIENCE, V306, P2249, DOI 10.1126/science.1103542; Ouyang JQ, 2011, HORM BEHAV, V60, P559, DOI 10.1016/j.yhbeh.2011.08.004; Petersen JK, 2003, POLAR BIOL, V26, P334, DOI 10.1007/s00300-003-0483-2; Piersma T., 2011, FLEXIBLE PHENOTYPE B; Romero LM, 2008, GEN COMP ENDOCR, V156, P27, DOI 10.1016/j.ygcen.2007.10.001; Romero LM, 2002, CONDOR, V104, P129, DOI 10.1650/0010-5422(2002)104[0129:CRIWBT]2.0.CO;2; Saino N, 2012, J AVIAN BIOL, P1; Sapolsky RM, 2000, ENDOCR REV, V21, P55, DOI 10.1210/er.21.1.55; Senechal E, 2011, OECOLOGIA, V165, P593, DOI 10.1007/s00442-010-1853-4; Serra L, 2007, J EVOLUTION BIOL, V20, P2028, DOI 10.1111/j.1420-9101.2007.01360.x; SIIKAMAKI P, 1994, FUNCT ECOL, V8, P587, DOI 10.2307/2389919; Stenseth NC, 2005, J ANIM ECOL, V74, P1195, DOI 10.1111/j.1365-2656.2005.01005.x; Stenseth NC, 2002, SCIENCE, V297, P1292, DOI 10.1126/science.1071281; Vagasi CI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040651; Vagasi CI, 2011, ARDEA, V99, P53, DOI 10.5253/078.099.0107; Vagasi CI, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014215; Vezina F, 2012, FUNCT ECOL, V26, P500, DOI 10.1111/j.1365-2435.2011.01955.x; Wada H, 2008, HORM BEHAV, V53, P472, DOI 10.1016/j.yhbeh.2007.11.018; Williams TD, 2008, PHILOS T R SOC B, V363, P1687, DOI 10.1098/rstb.2007.0003; [No title captured], DOI DOI 10.1098/rstb.2007.0012	62	31	32	1	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e82644	10.1371/journal.pone.0082644	http://dx.doi.org/10.1371/journal.pone.0082644			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391720	gold, Green Published, Green Submitted			2022-12-25	WOS:000329325200017
J	Li, XL; Geng, ZR; Chang, JY; Wang, SP; Song, XL; Hu, X; Wang, ZL				Li, Xiangli; Geng, Zhirong; Chang, Jiayin; Wang, Shuping; Song, Xiaoli; Hu, Xin; Wang, Zhilin			Identification of the Third Binding Site of Arsenic in Human Arsenic (III) Methyltransferase	PLOS ONE			English	Article							OXIDATION-STATE METHYLTRANSFERASE; S-ADENOSYLMETHIONINE METHYLTRANSFERASE; PROTEIN SECONDARY STRUCTURE; DIMETHYLARSINOUS ACID; CIRCULAR-DICHROISM; CYSTEINE RESIDUES; METHYLATION; GLUTATHIONE; HAS3MT; RAT	Arsenic (III) methyltransferase (AS3MT) catalyzes the process of arsenic methylation. Each arsenite (iAs(3+)) binds to three cysteine residues, methylarsenite (MMA(3+)) binds to two, and dimethylarsenite (DMA(3+)) binds to one. However, only two As-binding sites (Cys156 and Cys206) have been confirmed on human AS3MT (hAS3MT). The third As-binding site is still undefined. Residue Cys72 in Cyanidioschyzon merolae arsenite S-adenosylmethyltransferase (CmArsM) may be the third As-binding site. The corresponding residue in hAS3MT is Cys61. Functions of Cys32, Cys61, and Cys85 in hAS3MT are unclear though Cys32, Cys61, and Cys85 in rat AS3MT have no effect on the enzyme activity. This is why the functions of Cys32, Cys61, and Cys85 in hAS3MT merit investigation. Here, three mutants were designed, C32S, C61S, and C85S. Their catalytic activities and conformations were determined, and the catalytic capacities of C156S and C206S were studied. Unlike C85S, mutants C32S and C61S were completely inactive in the methylation of iAs(3+) and active in the methylation of MMA(3+). The catalytic activity of C85S was also less pronounced than that of WT-hAS3MT. All these findings suggest that Cys32 and Cys61 markedly influence the catalytic activity of hAS3MT. Cys32 and Cys61 are necessary to the first step of methylation but not to the second. Cys156 and Cys206 are required for both the first and second steps of methylation. The S-C32 is located far from arsenic in the WT-hAS3MT-SAM-As model. The distances between S-C61 and arsenic in WT-hAS3MT-As and WT-hAS3MT-SAM-As models are 7.5 angstrom and 4.1 angstrom, respectively. This indicates that SAM-binding to hAS3MT shortens the distance between S-C61 and arsenic and promotes As-binding to hAS3MT. This is consistent with the fact that SAM is the first substrate to bind to hAS3MT and iAs is the second. Model of WT-hAS3MT-SAM-As and the experimental results indicate that Cys61 is the third As-binding site.	[Li, Xiangli; Geng, Zhirong; Chang, Jiayin; Wang, Shuping; Wang, Zhilin] Nanjing Univ, Sch Chem & Chem Engn, State Key Lab Coordinat Chem, Nanjing 210008, Jiangsu, Peoples R China; [Song, Xiaoli] Yangzhou Univ, Sch Chem & Chem Engn, Yangzhou, Peoples R China; [Hu, Xin] Nanjing Univ, Modern Anal Ctr, Nanjing 210008, Jiangsu, Peoples R China	Nanjing University; Yangzhou University; Nanjing University	Geng, ZR (corresponding author), Nanjing Univ, Sch Chem & Chem Engn, State Key Lab Coordinat Chem, Nanjing 210008, Jiangsu, Peoples R China.	gengzr@nju.edu.cn; wangzl@nju.edu.cn	Hu, Xin/B-1792-2009; Geng, Zhirong/HGC-1447-2022	Hu, Xin/0000-0003-3400-554X; Geng, Zhirong/0000-0003-3766-9034	National Basic Research Program of China [2013CB922102]; National Natural Science Foundation of China [21075064, 21027013, 21021062, 21275072, 21201101]; Scientific Research Foundation of Graduate School of Nanjing University [2012CL16]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific Research Foundation of Graduate School of Nanjing University(Nanjing University)	This study is supported by the National Basic Research Program of China (2013CB922102), the National Natural Science Foundation of China (21075064, 21027013, 21021062, 21275072 and 21201101) and Scientific Research Foundation of Graduate School of Nanjing University (2012CL16). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajees AA, 2012, BIOCHEMISTRY-US, V51, P5476, DOI 10.1021/bi3004632; Beeby M, 2005, PLOS BIOL, V3, P1549, DOI 10.1371/journal.pbio.0030309; Benkert P, 2008, PROTEINS, V71, P261, DOI 10.1002/prot.21715; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cleland W.W., 1970, ENZYMES, P1; Coward JK, 1977, CHEM MECH METHYL TRA, P127; Delano W. L., 2004, PYMOL USERS GUIDE; DELNOMDEDIEU M, 1994, CHEM-BIOL INTERACT, V90, P139, DOI 10.1016/0009-2797(94)90099-X; Ding L, 2012, TOXICOL APPL PHARM, V264, P121, DOI 10.1016/j.taap.2012.07.024; Fass D, 2012, ANNU REV BIOPHYS, V41, P63, DOI 10.1146/annurev-biophys-050511-102321; Florea A.M., 2013, J LOCAL GLOBAL HLTH, V1, P1; Fomenko DE, 2007, SCIENCE, V315, P387, DOI 10.1126/science.1133114; Gailer J, 1999, APPL ORGANOMET CHEM, V13, P837, DOI 10.1002/(SICI)1099-0739(199911)13:11<837::AID-AOC924>3.0.CO;2-Z; Geng ZR, 2009, J BIOL INORG CHEM, V14, P485, DOI 10.1007/s00775-008-0464-6; Hayakawa T, 2005, ARCH TOXICOL, V79, P183, DOI 10.1007/s00204-004-0620-x; HENNESSEY JP, 1981, BIOCHEMISTRY-US, V20, P1085, DOI 10.1021/bi00508a007; Hu P, 2006, J AM CHEM SOC, V128, P1272, DOI 10.1021/ja056153+; Hughes MF, 2011, TOXICOL SCI, V123, P305, DOI 10.1093/toxsci/kfr184; Jiang GF, 2003, CHEM RES TOXICOL, V16, P873, DOI 10.1021/tx034053g; Kedderis GL, 2006, CHEM-BIOL INTERACT, V161, P139, DOI 10.1016/j.cbi.2006.04.001; KRIMM S, 1986, ADV PROTEIN CHEM, V38, P181, DOI 10.1016/S0065-3233(08)60528-8; Kuhn B, 2000, J AM CHEM SOC, V122, P2586, DOI 10.1021/ja992218v; KUROKI T, 1987, MUTAGENESIS, V2, P33, DOI 10.1093/mutage/2.1.33; Li JX, 2005, TOXICOL APPL PHARM, V204, P164, DOI 10.1016/j.taap.2004.12.002; Li XL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076709; Li XL, 2013, FEBS LETT, V587, P2232, DOI 10.1016/j.febslet.2013.05.052; Lin S, 2002, J BIOL CHEM, V277, P10795, DOI 10.1074/jbc.M110246200; Lu XF, 2003, ANAL CHEM, V75, P6463, DOI 10.1021/ac034868u; Marapakala K, 2012, BIOCHEMISTRY-US, V51, P944, DOI 10.1021/bi201500c; Mukhopadhyay R, 2002, ENVIRON HEALTH PERSP, V110, P745, DOI 10.1289/ehp.02110s5745; Naranmandura H, 2006, CHEM RES TOXICOL, V19, P1010, DOI 10.1021/tx060053f; Raber G, 2000, FRESEN J ANAL CHEM, V367, P181, DOI 10.1007/s002160051621; Rehman K, 2012, METALLOMICS, V4, P881, DOI 10.1039/c2mt00181k; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SARVER RW, 1991, ANAL BIOCHEM, V199, P61, DOI 10.1016/0003-2697(91)90269-Y; SCOTT N, 1993, CHEM RES TOXICOL, V6, P102, DOI 10.1021/tx00031a016; Song XL, 2011, BIOCHIMIE, V93, P369, DOI 10.1016/j.biochi.2010.10.010; Song XL, 2010, BIOCHIMIE, V92, P1397, DOI 10.1016/j.biochi.2010.07.002; Song XL, 2010, J INORG BIOCHEM, V104, P541, DOI 10.1016/j.jinorgbio.2010.01.005; Song XL, 2009, CHEM-BIOL INTERACT, V179, P321, DOI 10.1016/j.cbi.2008.12.018; Soriano A, 2006, BIOCHEMISTRY-US, V45, P14917, DOI 10.1021/bi061319k; Sun GF, 2007, ENVIRON HEALTH PERSP, V115, P648, DOI 10.1289/ehp.9271; SUREWICZ WK, 1988, BIOCHIM BIOPHYS ACTA, V952, P115, DOI 10.1016/0167-4838(88)90107-0; Suzuki KT, 2004, CHEM RES TOXICOL, V17, P914, DOI 10.1021/tx049963s; Vahter Marie, 1999, Science Progress, V82, P69; Vilkaitis G, 2000, J BIOL CHEM, V275, P38722, DOI 10.1074/jbc.M005278200; Walton FS, 2003, CHEM RES TOXICOL, V16, P261, DOI 10.1021/tx025649r; Wang SP, 2012, J BIOL CHEM, V287, P38790, DOI 10.1074/jbc.M112.368050; Waters SB, 2004, CHEM RES TOXICOL, V17, P404, DOI 10.1021/tx0342161; Wood TC, 2006, J BIOL CHEM, V281, P7364, DOI 10.1074/jbc.M512227200; Wu RB, 2008, J COMPUT CHEM, V29, P350, DOI 10.1002/jcc.20793; Xu YY, 2008, TOXICOL APPL PHARM, V232, P142, DOI 10.1016/j.taap.2008.06.010; Yang YT, 1986, METHOD ENZYMOL, V130, P208; Zhang XW, 2010, SCIENCE, V328, P240, DOI 10.1126/science.1183424	54	10	10	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84231	10.1371/journal.pone.0084231	http://dx.doi.org/10.1371/journal.pone.0084231			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391919	Green Published, gold, Green Submitted			2022-12-25	WOS:000329323900062
J	Nisa-Martinez, R; Laporte, P; Jimenez-Zurdo, JI; Frugier, F; Crespi, M; Toro, N				Nisa-Martinez, Rafael; Laporte, Philippe; Ignacio Jimenez-Zurdo, Jose; Frugier, Florian; Crespi, Martin; Toro, Nicolas			Localization of a Bacterial Group II Intron-Encoded Protein in Eukaryotic Nuclear Splicing-Related Cell Compartments	PLOS ONE			English	Article							IN-VIVO; ENDONUCLEASE DOMAIN; RMINT1; DNA; RNA; ORIGIN; IDENTIFICATION; EVOLUTION; EXCISION; MOBILITY	Some bacterial group II introns are widely used for genetic engineering in bacteria, because they can be reprogrammed to insert into the desired DNA target sites. There is considerable interest in developing this group II intron gene targeting technology for use in eukaryotes, but nuclear genomes present several obstacles to the use of this approach. The nuclear genomes of eukaryotes do not contain group II introns, but these introns are thought to have been the progenitors of nuclear spliceosomal introns. We investigated the expression and subcellular localization of the bacterial RmInt1 group II intron-encoded protein (IEP) in Arabidopsis thaliana protoplasts. Following the expression of translational fusions of the wild-type protein and several mutant variants with EGFP, the full-length IEP was found exclusively in the nucleolus, whereas the maturase domain alone targeted EGFP to nuclear speckles. The distribution of the bacterial RmInt1 IEP in plant cell protoplasts suggests that the compartmentalization of eukaryotic cells into nucleus and cytoplasm does not prevent group II introns from invading the host genome. Furthermore, the trafficking of the IEP between the nucleolus and the speckles upon maturase inactivation is consistent with the hypothesis that the spliceosomal machinery evolved from group II introns.	[Nisa-Martinez, Rafael; Ignacio Jimenez-Zurdo, Jose] CSIC, Grp Ecol Genet, Estn Expt Zaidin, Granada, Spain; [Laporte, Philippe; Frugier, Florian; Crespi, Martin; Toro, Nicolas] CNRS, Inst Sci Vegetal, Gif Sur Yvette, France	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Experimental del Zaidin (EEZ); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Toro, N (corresponding author), CNRS, Inst Sci Vegetal, Gif Sur Yvette, France.	ntoro@eez.csic.es	Toro, Nicolas/K-4909-2014; Crespi, Martin/AAB-1424-2020; Jiménez-Zurdo, José I./P-6474-2014	Toro, Nicolas/0000-0002-3614-807X; Crespi, Martin/0000-0002-5698-9482; Jiménez-Zurdo, José I./0000-0002-6378-2199	Consolider-Ingenio program, including ERDF (European Regional Development Funds) [CSD 2009-0006]; Ministerio de Economia y Competitividad [BIO2011-24401]; CSIC-CNRS [2002FR0032, 2005FR0004]; Spanish Ministerio de Ciencia e Innovacion	Consolider-Ingenio program, including ERDF (European Regional Development Funds); Ministerio de Economia y Competitividad(Spanish Government); CSIC-CNRS(Centre National de la Recherche Scientifique (CNRS)); Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government)	This work was supported by research grants CSD 2009-0006 from the Consolider-Ingenio program, including ERDF (European Regional Development Funds), BIO2011-24401 from the, currently Ministerio de Economia y Competitividad and CSIC-CNRS bilateral projects 2002FR0032 and 2005FR0004. RNM held an FPI fellowship from the Spanish Ministerio de Ciencia e Innovacion. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Boeke JD, 2003, GENOME RES, V13, P1975, DOI 10.1101/gr.1392003; CECH TR, 1986, CELL, V44, P207, DOI 10.1016/0092-8674(86)90751-8; Chalamcharla VR, 2010, GENE DEV, V24, P827, DOI 10.1101/gad.1905010; Cui X, 2005, THESIS U TEXAS AUSTI; Molina-Sanchez MD, 2011, J BIOL CHEM, V286, P21154, DOI 10.1074/jbc.M110.210013; Droillard MJ, 2002, FEBS LETT, V527, P43, DOI 10.1016/S0014-5793(02)03162-9; GRABOWSKI PJ, 1985, CELL, V42, P345, DOI 10.1016/S0092-8674(85)80130-6; Guo WH, 2013, J MOL EVOL, V77, P43, DOI 10.1007/s00239-013-9579-7; Jimenez-Zurdo JI, 2003, J MOL BIOL, V326, P413, DOI 10.1016/S0022-2836(02)01380-3; Karimi M, 2002, TRENDS PLANT SCI, V7, P193, DOI 10.1016/S1360-1385(02)02251-3; Keating KS, 2010, RNA, V16, P1, DOI 10.1261/rna.1791310; Koonin EV, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-22; Koonin EV, 2011, LOGIC CHANCE NATURE, P171; Lambowitz AM, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003616; Lorkovic ZJ, 2004, MOL BIOL CELL, V15, P3233, DOI 10.1091/mbc.E04-01-0055; Lynch M, 2003, MOL BIOL EVOL, V20, P563, DOI 10.1093/molbev/msg068; Martin W, 2006, NATURE, V440, P41, DOI 10.1038/nature04531; Martinez-Abarca F, 2000, MOL MICROBIOL, V35, P1405, DOI 10.1046/j.1365-2958.2000.01804.x; Martinez-Abarca F, 2004, NUCLEIC ACIDS RES, V32, P2880, DOI 10.1093/nar/gkh616; Mastroianni M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003121; MICHEL F, 1989, GENE, V82, P5, DOI 10.1016/0378-1119(89)90026-7; MICHEL F, 1982, BIOCHIMIE, V64, P867, DOI 10.1016/S0300-9084(82)80349-0; MICHEL F, 1995, ANNU REV BIOCHEM, V64, P435, DOI 10.1146/annurev.bi.64.070195.002251; MOHR G, 1993, NUCLEIC ACIDS RES, V21, P4991, DOI 10.1093/nar/21.22.4991; Mohr G, 2003, NUCLEIC ACIDS RES, V31, P647, DOI 10.1093/nar/gkg153; Molina-Sanchez MD, 2010, FEBS J, V277, P244, DOI 10.1111/j.1742-4658.2009.07478.x; Molina-Sanchez MD, 2006, J BIOL CHEM, V281, P28737, DOI 10.1074/jbc.M602695200; Munoz-Adelantado E, 2003, J MOL BIOL, V327, P931, DOI 10.1016/S0022-2836(03)00208-0; NAKAI K, 1992, GENOMICS, V14, P897, DOI 10.1016/S0888-7543(05)80111-9; Nisa-Martinez R, 2007, NUCLEIC ACIDS RES, V35, P214, DOI 10.1093/nar/gkl1072; Patel AA, 2003, NAT REV MOL CELL BIO, V4, P960, DOI 10.1038/nrm1259; ROBERTSEN BK, 1981, PLANT PHYSIOL, V67, P389, DOI 10.1104/pp.67.3.389; Rogozin IB, 2012, BIOL DIRECT, V7, DOI 10.1186/1745-6150-7-11; San Filippo J, 2002, J MOL BIOL, V324, P933, DOI 10.1016/S0022-2836(02)01147-6; Spector DL, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a000646; Toor N, 2008, SCIENCE, V320, P77, DOI 10.1126/science.1153803; Toro N, 2007, FEMS MICROBIOL REV, V31, P342, DOI 10.1111/j.1574-6976.2007.00068.x; VILLADAS PJ, 1995, FEMS MICROBIOL ECOL, V17, P161, DOI 10.1111/j.1574-6941.1995.tb00139.x; Zhao JH, 2005, P NATL ACAD SCI USA, V102, P16133, DOI 10.1073/pnas.0507057102	40	6	6	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84056	10.1371/journal.pone.0084056	http://dx.doi.org/10.1371/journal.pone.0084056			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391881	gold, Green Published, Green Submitted			2022-12-25	WOS:000329323900024
J	Owczarek, TB; Suchanski, J; Pula, B; Kmiecik, AM; Chadalski, M; Jethon, A; Dziegiel, P; Ugorski, M				Owczarek, Tomasz B.; Suchanski, Jaroslaw; Pula, Bartosz; Kmiecik, Alicja M.; Chadalski, Marek; Jethon, Aleksandra; Dziegiel, Piotr; Ugorski, Maciej			Galactosylceramide Affects Tumorigenic and Metastatic Properties of Breast Cancer Cells as an Anti-Apoptotic Molecule	PLOS ONE			English	Article							ALTERED SPHINGOLIPID METABOLISM; DAUNORUBICIN-INDUCED APOPTOSIS; GLUCOSYLCERAMIDE SYNTHASE; CERAMIDE GALACTOSYLTRANSFERASE; NEUTRAL GLYCOSPHINGOLIPIDS; MICROARRAY ANALYSIS; OVARIAN-CANCER; DEATH; INHIBITION; ACCUMULATION	It was recently proposed that UDP-galactose: ceramide galactosyltransferase (UGT8), enzyme responsible for synthesis of galactosylceramide (GalCer), is a significant index of tumor aggressiveness and a potential marker for the prognostic evaluation of lung metastases in breast cancer. To further reveal the role of UGT8 and GalCer in breast cancer progression, tumorigenicity and metastatic potential of control MDA-MB-231 cells (MDA/LUC) and MDA-MB-231 cells (MDA/LUC-shUGT8) with highly decreased expression of UGT8 and GalCer after stable expression of shRNA directed against UGT8 mRNA was studied in vivo in athymic nu/nu mice. Control MDA/LUC cells formed tumors and metastatic colonies much more efficiently in comparison to MDA/LUC-shUGT8 cells with suppressed synthesis of GalCer after their, respectively, orthotopic and intracardiac transplantation. These findings indicate that UGT8 and GalCer have a profound effect on tumorigenic and metastatic properties of breast cancer cells. In accordance with this finding, immunohistochemical staining of tumor specimens revealed that high expression of UGT8 accompanied by accumulation of GalCer in MDA-MB-231 cells is associated with a much higher proliferative index and a lower number of apoptotic cells in comparison to the MDA/LUC-shUGT8 cells. In addition, it was found that expression of UGT8 in MDA-MB-231 cells increased their resistance to apoptosis induced by doxorubicin in vitro. Therefore, these data suggest that accumulation of GalCer in tumor cells inhibits apoptosis, which would facilitates metastatic cells to survive in the hostile microenvironment of tumor in target organ.	[Owczarek, Tomasz B.; Kmiecik, Alicja M.; Chadalski, Marek; Ugorski, Maciej] Polish Acad Sci, Ludwik Hirszfeld Inst Immunol & Expt Therapy, Lab Glycobiol & Cell Interact, Wroclaw, Poland; [Owczarek, Tomasz B.; Suchanski, Jaroslaw; Ugorski, Maciej] Univ Environm & Life Sci, Dept Biochem Pharmacol & Toxicol, Fac Vet Med, Wroclaw, Poland; [Pula, Bartosz; Jethon, Aleksandra; Dziegiel, Piotr] Wroclaw Med Univ, Dept Histol & Embryol, Wroclaw, Poland; [Dziegiel, Piotr] Univ Wroclaw, Sch Phys Educ, Dept Physiotherapy, PL-50138 Wroclaw, Poland	Polish Academy of Sciences; Hirszfeld Institute of Immunology & Experimental Therapy of the Polish Academy of Sciences; Wroclaw University of Environmental & Life Sciences; Wroclaw Medical University; University of Wroclaw	Ugorski, M (corresponding author), Polish Acad Sci, Ludwik Hirszfeld Inst Immunol & Expt Therapy, Lab Glycobiol & Cell Interact, Wroclaw, Poland.	ugorski@iitd.pan.wroc.pl	Kmiecik, Alicja/AAY-1543-2020; Puła, Bartosz/AAO-3209-2020; Ugorsku, Maciej/AAJ-1050-2020	Kmiecik, Alicja/0000-0002-6498-717X; Puła, Bartosz/0000-0003-0116-5002; Ugorski, Maciej/0000-0003-0299-8372; Owczarek, Tomasz/0000-0002-5095-8642; Dziegiel, Piotr/0000-0002-8292-1385; Suchanski, Jaroslaw/0000-0002-2672-1020	National Science Center (Poland) [N N401 097936]	National Science Center (Poland)	Grant support for this work was provided by the National Science Center (Poland) URL: http://www.ncn.gov.pl/?language = en; grant no.: N N401 097936. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aroui S, 2009, CANCER LETT, V285, P28, DOI 10.1016/j.canlet.2009.04.044; Bartkowiak K, 2012, CANCER MICROENVIRON, V5, P59, DOI 10.1007/s12307-011-0067-6; Beier UH, 2005, INT J CANCER, V115, P6, DOI 10.1002/ijc.20851; Bieberich E, 2004, GLYCOCONJUGATE J, V21, P315, DOI 10.1023/B:GLYC.0000046274.35732.47; BOSE R, 1995, CELL, V82, P405, DOI 10.1016/0092-8674(95)90429-8; Carpinteiro A, 2008, CANCER LETT, V264, P1, DOI 10.1016/j.canlet.2008.02.020; CARTER HE, 1952, J BIOL CHEM, V199, P283; Davidoff MS, 2002, ACTA HISTOCHEM, V104, P39, DOI 10.1078/0065-1281-00630; Dziegiel P, 2010, BRIT J CANCER, V103, P524, DOI 10.1038/sj.bjc.6605750; Gomez-Munoz A, 2006, BBA-BIOMEMBRANES, V1758, P2049, DOI 10.1016/j.bbamem.2006.05.011; Grazide S, 2004, J BIOL CHEM, V279, P18256, DOI 10.1074/jbc.M314105200; Gulbins E, 2003, ONCOGENE, V22, P7070, DOI 10.1038/sj.onc.1207146; Hannun YA, 2001, BIOCHEMISTRY-US, V40, P4893, DOI 10.1021/bi002836k; Hiraoka M, 2002, J BIOL CHEM, V277, P10090, DOI 10.1074/jbc.M111977200; Itoh M, 2003, CLIN CANCER RES, V9, P415; Kok JW, 2000, INT J CANCER, V87, P172, DOI 10.1002/1097-0215(20000715)87:2<172::AID-IJC3>3.0.CO;2-K; Kultz D, 2005, ANNU REV PHYSIOL, V67, P225, DOI 10.1146/annurev.physiol.67.040403.103635; Landemaine T, 2008, CANCER RES, V68, P6092, DOI 10.1158/0008-5472.CAN-08-0436; Lavie Y, 1996, J BIOL CHEM, V271, P19530, DOI 10.1074/jbc.271.32.19530; Li CH, 2013, GASTROENTEROLOGY, V144, P1086, DOI 10.1053/j.gastro.2013.01.058; Liu Y, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-186; Liu YY, 2008, FASEB J, V22, P2541, DOI 10.1096/fj.07-092981; Liu YY, 2013, ADV CANCER RES, V117, P59, DOI 10.1016/B978-0-12-394274-6.00003-0; Liu YY, 2001, FASEB J, V15, P719, DOI 10.1096/fj.00-0223com; Luberto C, 2002, J BIOL CHEM, V277, P41128, DOI 10.1074/jbc.M206747200; Lucci A, 1999, CANCER-AM CANCER SOC, V86, P300, DOI 10.1002/(SICI)1097-0142(19990715)86:2<300::AID-CNCR14>3.0.CO;2-H; Marcus J, 2002, BBA-GEN SUBJECTS, V1573, P406, DOI 10.1016/S0304-4165(02)00410-5; MORELL P, 1969, BIOCHEMISTRY-US, V8, P506, DOI 10.1021/bi00830a008; Niimura Y, 2008, COMP BIOCHEM PHYS B, V149, P161, DOI 10.1016/j.cbpb.2007.09.002; Niimura Y, 2010, GLYCOBIOLOGY, V20, P710, DOI 10.1093/glycob/cwq018; Nikolova-Karakashian MN, 2010, ADV EXP MED BIOL, V688, P86; NILSSON O, 1982, J LIPID RES, V23, P327; OGAWA K, 1988, J CHROMATOGR-BIOMED, V426, P188, DOI 10.1016/S0378-4347(00)81942-8; Ogretmen B, 2001, DRUG RESIST UPDATE, V4, P368, DOI 10.1054/drup.2001.0225; Perry DK, 2000, J BIOL CHEM, V275, P9078, DOI 10.1074/jbc.275.12.9078; Ponnusamy S, 2010, FUTURE ONCOL, V6, P1603, DOI 10.2217/FON.10.116; Popko B, 2002, J NEUROPATH EXP NEUR, V61, P329, DOI 10.1093/jnen/61.4.329; Reynolds CP, 2004, CANCER LETT, V206, P169, DOI 10.1016/j.canlet.2003.08.034; Ruckhaberle E, 2008, BREAST CANCER RES TR, V112, P41, DOI 10.1007/s10549-007-9836-9; Ryland LK, 2011, CANCER BIOL THER, V11, P138, DOI 10.4161/cbt.11.2.14624; Solatycka A, 2012, GLYCOBIOLOGY, V22, P1042, DOI 10.1093/glycob/cws075; Spinedi A, 1998, CELL DEATH DIFFER, V5, P785, DOI 10.1038/sj.cdd.4400428; Sprong H, 1998, J BIOL CHEM, V273, P25880, DOI 10.1074/jbc.273.40.25880; Sung CC, 1996, GLYCOCONJUGATE J, V13, P433, DOI 10.1007/BF00731476; Thudichum J. L. W., 1874, RESEARCHES CHEMICAL, V5, P113; Uchida Y, 2004, CANCER RES, V64, P6271, DOI 10.1158/0008-5472.CAN-03-1476; UGORSKI M, 1989, GLYCOCONJUGATE J, V6, P303, DOI 10.1007/BF01047850; Veldman RJ, 2002, FASEB J, V16, P1111, DOI 10.1096/fj.01-0863fje; Xie KP, 2003, CLIN EXP METASTAS, V20, P31, DOI 10.1023/A:1022590402748; Yang F, 2006, ONCOGENE, V25, P1413, DOI 10.1038/sj.onc.1209165; Zeidan YH, 2008, FASEB J, V22, P183, DOI 10.1096/fj.07-8967com; Zhang X, 2012, PLOS ONE, V7	52	30	30	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84191	10.1371/journal.pone.0084191	http://dx.doi.org/10.1371/journal.pone.0084191			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391908	Green Published, gold, Green Submitted			2022-12-25	WOS:000329323900051
J	Sateriale, A; Roy, NH; Huston, CD				Sateriale, Adam; Roy, Nathan H.; Huston, Christopher D.			SNAP-Tag Technology Optimized for Use in Entamoeba histolytica	PLOS ONE			English	Article							HOST-CELLS; CYSTEINE PROTEINASES; FUSION PROTEINS; IN-VIVO; PARASITE; PHAGOCYTOSIS; CYTOTOXICITY; CULTIVATION; EXPRESSION; AMEBIASIS	Entamoeba histolytica is a protozoan parasite responsible for invasive intestinal and extraintestinal amebiasis. The pathology of amebiasis is still poorly understood, which can be largely attributed to lack of molecular tools. Here we present the optimization of SNAP-tag technology via codon optimization specific for E. histolytica. The resultant SNAP protein is highly expressed in amebic trophozoites, and shows proper localization when tagged with an endoplasmic reticulum retention signal. We further demonstrate the capabilities of this system using super resolution microscopy, done for the first time in E. histolytica.	[Sateriale, Adam; Roy, Nathan H.; Huston, Christopher D.] Univ Vermont, Cellular Mol & Biomed Sci Program, Burlington, VT 05405 USA; [Roy, Nathan H.; Huston, Christopher D.] Univ Vermont, Burlington, VT USA; [Sateriale, Adam; Huston, Christopher D.] Univ Vermont, Dept Med, Burlington, VT USA	University of Vermont; University of Vermont; University of Vermont	Huston, CD (corresponding author), Univ Vermont, Cellular Mol & Biomed Sci Program, Burlington, VT 05405 USA.	christopher.huston@uvm.edu		Sateriale, Adam/0000-0001-8947-2714	NIAID [R01 A1072021]; National Institutes of Health [R01 AI080302];  [T32 AI055402]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI080302, T32AI055402, R01AI072021] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103496] Funding Source: NIH RePORTER	NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by NIAID R01 A1072021 to Christopher Huston. STORM microscopy was funded by National Institutes of Health grant R01 AI080302 to Markus Thali. Nathan Roy was supported by T32 AI055402. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ankri S, 1999, INFECT IMMUN, V67, P421, DOI 10.1128/IAI.67.1.421-422.1999; Bojkowska K, 2011, CHEM BIOL, V18, P805, DOI 10.1016/j.chembiol.2011.03.014; Bruchhaus I, 2003, EUKARYOT CELL, V2, P501, DOI 10.1128/EC.2.3.501-509.2003; Buss SN, 2010, INT J PARASITOL, V40, P833, DOI 10.1016/j.ijpara.2009.12.007; DIAMOND LS, 1978, T ROY SOC TROP MED H, V72, P431, DOI 10.1016/0035-9203(78)90144-X; Duggal P, 2011, J CLIN INVEST, V121, P1191, DOI 10.1172/JCI45294; Ghosh TC, 2000, INT J PARASITOL, V30, P715, DOI 10.1016/S0020-7519(00)00042-4; Haque R, 2003, NEW ENGL J MED, V348, P1565, DOI 10.1056/NEJMra022710; HEIM R, 1994, P NATL ACAD SCI USA, V91, P12501, DOI 10.1073/pnas.91.26.12501; Huston CD, 2003, INFECT IMMUN, V71, P964, DOI 10.1128/IAI.71.2.964-972.2003; Huston CD, 2000, CELL MICROBIOL, V2, P617, DOI 10.1046/j.1462-5822.2000.00085.x; Iversen L, 2008, LANGMUIR, V24, P6375, DOI 10.1021/la7037075; Juillerat A, 2003, CHEM BIOL, V10, P313, DOI 10.1016/S1074-5521(03)00068-1; Keppler A, 2004, P NATL ACAD SCI USA, V101, P9955, DOI 10.1073/pnas.0401923101; Keppler A, 2009, ACS CHEM BIOL, V4, P127, DOI 10.1021/cb800298u; LEIPPE M, 1991, P NATL ACAD SCI USA, V88, P7659, DOI 10.1073/pnas.88.17.7659; LEIPPE M, 1994, MOL MICROBIOL, V14, P895, DOI 10.1111/j.1365-2958.1994.tb01325.x; Loftus B, 2005, NATURE, V433, P865, DOI 10.1038/nature03291; Marie CS, 2012, INFECT IMMUN, V80, P1934, DOI 10.1128/IAI.06140-11; Maurel D, 2008, NAT METHODS, V5, P561, DOI [10.1038/nmeth.1213, 10.1038/NMETH.1213]; MCCOY JJ, 1994, INFECT IMMUN, V62, P3045, DOI 10.1128/IAI.62.8.3045-3050.1994; Moncada D, 2003, INFECT IMMUN, V71, P838, DOI 10.1128/IAI.71.2.838-844.2003; Petri WA, 2002, ANNU REV MICROBIOL, V56, P39, DOI 10.1146/annurev.micro.56.012302.160959; Que XC, 2000, CLIN MICROBIOL REV, V13, P196, DOI 10.1128/CMR.13.2.196-206.2000; Ramakrishnan G, 1997, MOL BIOCHEM PARASIT, V84, P93, DOI 10.1016/S0166-6851(96)02784-3; RAVDIN JI, 1981, J CLIN INVEST, V68, P1305, DOI 10.1172/JCI110377; Roy NH, 2013, J VIROL, V87, P7516, DOI 10.1128/JVI.00790-13; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; Srikun D, 2010, J AM CHEM SOC, V132, P4455, DOI 10.1021/ja100117u; Vaithilingam A, 2012, INFECT IMMUN, V80, P2008, DOI 10.1128/IAI.06287-11	30	9	10	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83997	10.1371/journal.pone.0083997	http://dx.doi.org/10.1371/journal.pone.0083997			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391864	gold, Green Published, Green Submitted			2022-12-25	WOS:000329323900007
J	Kimura, S; Sato, M; Okada-Hatakeyama, M				Kimura, Shuhei; Sato, Masanao; Okada-Hatakeyama, Mariko			Inference of Vohradsky's Models of Genetic Networks by Solving Two-Dimensional Function Optimization Problems	PLOS ONE			English	Article							S-SYSTEM MODELS; REGULATORY NETWORKS; TRANSCRIPTIONAL REGULATION; PARAMETER-ESTIMATION; ALGORITHM; IDENTIFICATION; SERIES	The inference of a genetic network is a problem in which mutual interactions among genes are inferred from time-series of gene expression levels. While a number of models have been proposed to describe genetic networks, this study focuses on a mathematical model proposed by Vohradsky. Because of its advantageous features, several researchers have proposed the inference methods based on Vohradsky's model. When trying to analyze large-scale networks consisting of dozens of genes, however, these methods must solve high-dimensional non-linear function optimization problems. In order to resolve the difficulty of estimating the parameters of the Vohradsky's model, this study proposes a new method that defines the problem as several two-dimensional function optimization problems. Through numerical experiments on artificial genetic network inference problems, we showed that, although the computation time of the proposed method is not the shortest, the method has the ability to estimate parameters of Vohradsky's models more effectively with sufficiently short computation times. This study then applied the proposed method to an actual inference problem of the bacterial SOS DNA repair system, and succeeded in finding several reasonable regulations.	[Kimura, Shuhei] Tottori Univ, Grad Sch Engn, Tottori 680, Japan; [Sato, Masanao] Natl Inst Nat Sci, Okazaki Inst Integrat Biosci, Natl Inst Basic Biol, Okazaki, Aichi 4448787, Japan; [Okada-Hatakeyama, Mariko] RIKEN Ctr Integrat Med Sci, Yokohama, Kanagawa, Japan	Tottori University; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Okazaki Institute for Integrative Bioscience (OIIB); RIKEN	Kimura, S (corresponding author), Tottori Univ, Grad Sch Engn, Tottori 680, Japan.	kimura@ike.tottori-u.ac.jp	Okada, Mariko/N-6933-2015	Sato, Masanao/0000-0003-3790-8218	Ministry of Education, Culture, Sports, Science and Technology of Japan [23700266]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work is supported by the Ministry of Education, Culture, Sports, Science and Technology of Japan under Grant-in-Aid for Young Scientists (B) No. 23700266. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akutsu T, 2000, BIOINFORMATICS, V16, P727, DOI 10.1093/bioinformatics/16.8.727; Bansal M, 2007, IET SYST BIOL, V1, P306, DOI 10.1049/iet-syb:20060079; Chemmangattuvalappil N, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-119; Cho DY, 2006, BIOINFORMATICS, V22, P1631, DOI 10.1093/bioinformatics/btl122; Chou IC, 2006, THEOR BIOL MED MODEL, V3, DOI 10.1186/1742-4682-3-25; Chou IC, 2009, MATH BIOSCI, V219, P57, DOI 10.1016/j.mbs.2009.03.002; CLEVELAND WS, 1979, J AM STAT ASSOC, V74, P829, DOI 10.2307/2286407; D'haeseleer P, 2000, BIOINFORMATICS, V16, P707, DOI 10.1093/bioinformatics/16.8.707; Ergun A, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100125; Faith JJ, 2007, PLOS BIOL, V5, P54, DOI 10.1371/journal.pbio.0050008; Gardner TS, 2003, SCIENCE, V301, P102, DOI 10.1126/science.1081900; Gonzalez OR, 2007, BIOINFORMATICS, V23, P480, DOI 10.1093/bioinformatics/btl522; Kabir M, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S1-S56; Kikuchi S, 2003, BIOINFORMATICS, V19, P643, DOI 10.1093/bioinformatics/btg027; Kimura S, 2005, BIOINFORMATICS, V21, P1154, DOI 10.1093/bioinformatics/bti071; Kimura S, 2012, MATH BIOSCI, V235, P161, DOI 10.1016/j.mbs.2011.11.008; Kimura S, 2009, BIOINFORMATICS, V25, P918, DOI 10.1093/bioinformatics/btp072; Kimura S, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-23; Kobayashi S., 2009, J JPN SOC ARTIF INTE, V24, P147; Liu PK, 2008, BIOINFORMATICS, V24, P1085, DOI 10.1093/bioinformatics/btn075; Margolin AA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S1-S7; Mehrotra S, 1992, SIAM J OPTIMIZ, V2, P575, DOI 10.1137/0802028; Nakatsui M, 2008, MATH BIOSCI, V215, P105, DOI 10.1016/j.mbs.2008.06.007; Palafox L., 2012, P 2012 C EV COMP, P1865; Press WH, 1995, NUMERICAL RECIPES C; Prill RJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009202; Ronen M, 2002, P NATL ACAD SCI USA, V99, P10555, DOI 10.1073/pnas.152046799; SAVAGEAU MA, 1969, J THEOR BIOL, V25, P365, DOI 10.1016/S0022-5193(69)80026-3; Schaffter T, 2011, BIOINFORMATICS, V27, P2263, DOI 10.1093/bioinformatics/btr373; Sutton MD, 2000, ANNU REV GENET, V34, P479, DOI 10.1146/annurev.genet.34.1.479; Thieffry D, 1998, BIOESSAYS, V20, P433, DOI 10.1002/(SICI)1521-1878(199805)20:5<433::AID-BIES10>3.0.CO;2-2; Tsai KY, 2005, BIOINFORMATICS, V21, P1180, DOI 10.1093/bioinformatics/bti099; Tucker W, 2007, MATH BIOSCI, V208, P607, DOI 10.1016/j.mbs.2006.11.009; Veflingstad Siren R, 2004, Theor Biol Med Model, V1, P8, DOI 10.1186/1742-4682-1-8; Vilela M, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-35; Vilela M, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-305; Vohradsky J, 2001, FASEB J, V15, P846, DOI 10.1096/fj.00-0361com; Voit E. O., 2000, COMPUTATIONAL ANAL B; Voit EO, 2004, BIOINFORMATICS, V20, P1670, DOI 10.1093/bioinformatics/bth140; Williams RJ, 1990, NEURAL COMPUT, V2, P490, DOI 10.1162/neco.1990.2.4.490; Xu R, 2007, NEURAL NETWORKS, V20, P917, DOI 10.1016/j.neunet.2007.07.002; Xu R, 2007, IEEE ACM T COMPUT BI, V4, P681, DOI 10.1109/TCBB.2007.1057; Yeung MKS, 2002, P NATL ACAD SCI USA, V99, P6163, DOI 10.1073/pnas.092576199; Yu J, 2004, BIOINFORMATICS, V20, P3594, DOI 10.1093/bioinformatics/bth448	44	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e83308	10.1371/journal.pone.0083308	http://dx.doi.org/10.1371/journal.pone.0083308			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386175	Green Published, Green Submitted, gold			2022-12-25	WOS:000329194700032
J	Nair, DB; Chung, DKC; Schneider, J; Uchida, K; Aizawa, SI; Jarrell, KF				Nair, Divya B.; Chung, Daniel K. C.; Schneider, James; Uchida, Kaoru; Aizawa, Shin-Ichi; Jarrell, Ken F.			Identification of an Additional Minor Pilin Essential for Piliation in the Archaeon Methanococcus maripaludis	PLOS ONE			English	Article							UNIQUE MOTILITY STRUCTURE; CELL-SURFACE STRUCTURES; III SIGNAL PEPTIDES; IV PILI; PSEUDOMONAS-AERUGINOSA; SULFOLOBUS-ACIDOCALDARIUS; NEISSERIA-MENINGITIDIS; FIMBRIAL BIOGENESIS; PROTEIN-SECRETION; BIOFILM FORMATION	Methanococcus maripaludis is an archaeon with two studied surface appendages, archaella and type IV-like pili. Previously, the major structural pilin was identified as MMP1685 and three additional proteins were designated as minor pilins (EpdA, EpdB and EpdC). All of the proteins are likely processed by the pilin-specific prepilin peptidase EppA. Six other genes were identified earlier as likely encoding pilin proteins processed also by EppA. In this study, each of the six genes (mmp0528, mmp0600, mmp0601, mmp0709, mmp0903 and mmp1283) was deleted and the mutants examined by electron microscopy to determine their essentiality for pili formation. While mRNA transcripts of all genes were detected by RT-PCR, only the deletion of mmp1283 led to nonpiliated cells. This strain could be complemented back to a piliated state by supplying a wildtype copy of the mmp1283 gene in trans. This study adds to the complexity of the type IV pili system in M. maripaludis and raises questions about the functions of the remaining five pilin-like genes and whether M. maripaludis under other growth conditions may be able to assemble additional pili-like structures.	[Nair, Divya B.; Chung, Daniel K. C.; Schneider, James; Jarrell, Ken F.] Queens Univ, Dept Biomed & Mol Sci, Kingston, ON, Canada; [Uchida, Kaoru; Aizawa, Shin-Ichi] Prefectural Univ Hiroshima, Dept Life Sci, Shobara, Hiroshima, Japan	Queens University - Canada	Jarrell, KF (corresponding author), Queens Univ, Dept Biomed & Mol Sci, Kingston, ON, Canada.	jarrellk@queensu.ca		Aizawa, Shin-Ichi/0000-0002-9068-0825	Natural Sciences and Engineering Research Council of Canada	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was funded by a Discovery grant from the Natural Sciences and Engineering Research Council of Canada to KFJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Qarn M, 2006, MOL MICROBIOL, V61, P511, DOI 10.1111/j.1365-2958.2006.05252.x; Ajon M, 2011, MOL MICROBIOL, V82, P807, DOI 10.1111/j.1365-2958.2011.07861.x; Albers SV, 2003, J BACTERIOL, V185, P3918, DOI 10.1128/JB.185.13.3918-3925.2003; ALM RA, 1995, MOL MICROBIOL, V16, P485, DOI 10.1111/j.1365-2958.1995.tb02413.x; Alm RA, 1996, MOL MICROBIOL, V22, P161; BALCH WE, 1979, MICROBIOL REV, V43, P260, DOI 10.1128/MMBR.43.2.260-296.1979; Bardy SL, 2003, MOL MICROBIOL, V50, P1339, DOI 10.1046/j.1365-2958.2003.03758.x; Bardy SL, 2002, FEMS MICROBIOL LETT, V208, P53, DOI 10.1016/S0378-1097(01)00579-1; Belete B, 2008, J BACTERIOL, V190, P2023, DOI 10.1128/JB.01623-07; Boesen T, 2013, MBIO, V4, DOI 10.1128/mBio.00270-13; Brown DR, 2010, INFECT IMMUN, V78, P3053, DOI 10.1128/IAI.00099-10; Burrows LL, 2005, MOL MICROBIOL, V57, P878, DOI 10.1111/j.1365-2958.2005.04703.x; Burrows LL, 2012, MOL MICROBIOL, V86, P765, DOI 10.1111/mmi.12034; Burrows LL, 2012, ANNU REV MICROBIOL, V66, P493, DOI 10.1146/annurev-micro-092611-150055; Carbonnelle E, 2006, MOL MICROBIOL, V61, P1510, DOI 10.1111/j.1365-2958.2006.05341.x; Chaban B, 2007, MOL MICROBIOL, V66, P596, DOI 10.1111/j.1365-2958.2007.05913.x; Cisneros DA, 2012, MOL MICROBIOL, V86, P805, DOI 10.1111/mmi.12033; Desmond E, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-106; Eichler J, 2012, TRENDS MICROBIOL, V20, P512, DOI 10.1016/j.tim.2012.08.007; Esquivel RN, 2013, J BACTERIOL, V195, P3808, DOI 10.1128/JB.00572-13; Froels S, 2008, MOL MICROBIOL, V70, P938, DOI 10.1111/j.1365-2958.2008.06459.x; Ghosh A, 2011, BIOCHEM SOC T, V39, P64, DOI 10.1042/BST0390064; Giltner CL, 2012, MICROBIOL MOL BIOL R, V76, P740, DOI 10.1128/MMBR.00035-12; Giltner CL, 2010, J MOL BIOL, V398, P444, DOI 10.1016/j.jmb.2010.03.028; Heiniger RW, 2010, CELL MICROBIOL, V12, P1158, DOI 10.1111/j.1462-5822.2010.01461.x; Henche AL, 2012, ENVIRON MICROBIOL, V14, P3188, DOI 10.1111/j.1462-2920.2012.02898.x; Henche AL, 2012, ENVIRON MICROBIOL, V14, P779, DOI 10.1111/j.1462-2920.2011.02638.x; Imam S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028919; Ishiwa A, 2004, J MOL BIOL, V343, P615, DOI 10.1016/j.jmb.2004.08.059; Jarrell Ken F., 2013, Life-Basel, V3, P86, DOI 10.3390/life3010086; Jarrell KF, 2012, TRENDS MICROBIOL, V20, P307, DOI 10.1016/j.tim.2012.04.007; Jarrell KF, 2011, FEMS MICROBIOL LETT, V319, P44, DOI 10.1111/j.1574-6968.2011.02264.x; Jarrell KF, 2009, PILI AND FLAGELLA: CURRENT RESEARCH AND FUTURE TRENDS, P215; Jarrell KF, 1996, J BACTERIOL, V178, P5057, DOI 10.1128/jb.178.17.5057-5064.1996; Jarrell KF, 2010, INT J MICROBIOL; Kelly J, 2009, CARBOHYD RES, V344, P648, DOI 10.1016/j.carres.2009.01.006; Korotkov KV, 2012, NAT REV MICROBIOL, V10, P336, DOI 10.1038/nrmicro2762; Lassak K, 2012, RES MICROBIOL, V163, P630, DOI 10.1016/j.resmic.2012.10.024; Lassak K, 2012, MOL MICROBIOL, V83, P110, DOI 10.1111/j.1365-2958.2011.07916.x; Lie TJ, 2005, J BIOL CHEM, V280, P5236, DOI 10.1074/jbc.M411778200; Lie TJ, 2003, MOL MICROBIOL, V47, P235, DOI 10.1046/j.1365-2958.2003.03293.x; Lovley DR, 2011, ADV MICROB PHYSIOL, V59, P1, DOI 10.1016/B978-0-12-387661-4.00004-5; Moore BC, 2005, J BACTERIOL, V187, P972, DOI 10.1128/JB.187.3.972-979.2005; Muller DW, 2009, J BACTERIOL, V191, P6465, DOI 10.1128/JB.00858-09; Ng SYM, 2008, J BACTERIOL, V190, P6039, DOI 10.1128/JB.00546-08; Ng SYM, 2007, MICROBIOL-SGM, V153, P305, DOI 10.1099/mic.0.2006/003087-0; Ng SYM, 2006, J MOL MICROB BIOTECH, V11, P167, DOI 10.1159/000094053; Ng SYM, 2011, J BACTERIOL, V193, P804, DOI 10.1128/JB.00822-10; Ng SYM, 2009, J BACTERIOL, V191, P6732, DOI 10.1128/JB.00673-09; Orell A, 2013, ISME J, V7, P1886, DOI 10.1038/ismej.2013.68; Peabody CR, 2003, MICROBIOL-SGM, V149, P3051, DOI 10.1099/mic.0.26364-0; Pelicic V, 2008, MOL MICROBIOL, V68, P827, DOI 10.1111/j.1365-2958.2008.06197.x; Pohlschroder M, 2011, CURR OPIN MICROBIOL, V14, P357, DOI 10.1016/j.mib.2011.03.002; Pohschroder M, 2005, CURR OPIN MICROBIOL, V8, P713, DOI 10.1016/j.mib.2005.10.006; Reimann J, 2012, MOL MICROBIOL, V86, P24, DOI 10.1111/j.1365-2958.2012.08186.x; RUDEL T, 1995, NATURE, V373, P357, DOI 10.1038/373357a0; STROM MS, 1993, P NATL ACAD SCI USA, V90, P2404, DOI 10.1073/pnas.90.6.2404; STROM MS, 1993, ANNU REV MICROBIOL, V47, P565, DOI 10.1146/annurev.micro.47.1.565; Szabo Z, 2007, J BACTERIOL, V189, P772, DOI 10.1128/JB.01547-06; Takhar HK, 2013, J BIOL CHEM, V288, P9721, DOI 10.1074/jbc.M113.453506; Tripepi M, 2010, J BACTERIOL, V192, P3093, DOI 10.1128/JB.00133-10; TUMBULA DL, 1994, FEMS MICROBIOL LETT, V121, P309, DOI 10.1016/0378-1097(94)90309-3; VanDyke DJ, 2008, J BACTERIOL, V190, P5300, DOI 10.1128/JB.00474-08; VanDyke DJ, 2009, MOL MICROBIOL, V72, P633, DOI 10.1111/j.1365-2958.2009.06671.x; Wang YA, 2008, J MOL BIOL, V381, P456, DOI 10.1016/j.jmb.2008.06.017; Winther-Larsen HC, 2005, MOL MICROBIOL, V56, P903, DOI 10.1111/j.1365-2958.2005.04591.x; Winther-Larsen HC, 2001, P NATL ACAD SCI USA, V98, P15276, DOI 10.1073/pnas.261574998; Wirth R, 2012, TRENDS MICROBIOL, V20, P511, DOI 10.1016/j.tim.2012.07.007; Yu X, 2012, J MOL BIOL, V422, P274, DOI 10.1016/j.jmb.2012.05.031; Zolghadr B, 2007, MOL MICROBIOL, V64, P795, DOI 10.1111/j.1365-2958.2007.05697.x; Zolghadr B, 2011, EXTREMOPHILES, V15, P235, DOI 10.1007/s00792-010-0353-0	71	10	10	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e83961	10.1371/journal.pone.0083961	http://dx.doi.org/10.1371/journal.pone.0083961			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386316	Green Published, Green Submitted, gold			2022-12-25	WOS:000329194700082
J	Bellucci, E; Bitocchi, E; Rau, D; Nanni, L; Ferradini, N; Giardini, A; Rodriguez, M; Attene, G; Papa, R				Bellucci, Elisa; Bitocchi, Elena; Rau, Domenico; Nanni, Laura; Ferradini, Nicoletta; Giardini, Alessandro; Rodriguez, Monica; Attene, Giovanna; Papa, Roberto			Population Structure of Barley Landrace Populations and Gene-Flow with Modern Varieties	PLOS ONE			English	Article							HORDEUM-VULGARE L.; LINKAGE DISEQUILIBRIUM; PHASEOLUS-VULGARIS; COMPUTER-PROGRAM; ON-FARM; DIVERSITY; LOCI; SOFTWARE; NUMBER; WILD	Landraces are heterogeneous plant varieties that are reproduced by farmers as populations that are subject to both artificial and natural selection. Landraces are distinguished by farmers due to their specific traits, and different farmers often grow different populations of the same landrace. We used simple sequence repeats (SSRs) to analyse 12 barley landrace populations from Sardinia from two collections spanning 10 years. We analysed the population structure, and compared the population diversity of the landraces that were collected at field level (population). We used a representative pool of barley varieties for diversity comparisons and to analyse the effects of gene flow from modern varieties. We found that the Sardinian landraces are a distinct gene pool from those of both two-row and six-row barley varieties. There is also a low, but significant, mean level and population-dependent level of introgression from the modern varieties into the Sardinian landraces. Moreover, we show that the Sardinian landraces have the same level of gene diversity as the representative sample of modern commercial varieties grown in Italy in the last decades, even within population level. Thus, these populations represent crucial sources of germplasm that will be useful for crop improvement and for population genomics studies and association mapping, to identify genes, loci and genome regions responsible for adaptive variations. Our data also suggest that landraces are a source of valuable germplasm for sustainable agriculture in the context of future climate change, and that in-situ conservation strategies based on farmer use can preserve the genetic identity of landraces while allowing adaptation to local environments.	[Bellucci, Elisa; Bitocchi, Elena; Nanni, Laura; Ferradini, Nicoletta; Giardini, Alessandro; Papa, Roberto] Univ Politecn Marche, Dipartimento Sci Agr Alimentari & Ambientali, Ancona, Italy; [Rau, Domenico; Rodriguez, Monica; Attene, Giovanna] Univ Sassari, Dipartimento Agr, I-07100 Sassari, Italy; [Papa, Roberto] Cereal Res Ctr CRA CER, Consiglio Ric & Sperimentaz Agr, Foggia, Italy	Marche Polytechnic University; University of Sassari; Consiglio per la Ricerca in Agricoltura e L'analisi Dell'economia Agraria (CREA)	Papa, R (corresponding author), Univ Politecn Marche, Dipartimento Sci Agr Alimentari & Ambientali, Ancona, Italy.	r.papa@univpm.it	Nanni, Laura/HDN-7936-2022; Rodriguez, Monica/G-6731-2012; Bitocchi, Elena/J-7996-2019; Bellucci, Elisa/AAS-9237-2021; papa, roberto/F-9510-2014	Rodriguez, Monica/0000-0001-8926-2987; Bitocchi, Elena/0000-0002-2152-4634; Rau, Domenico/0000-0002-5294-9053; papa, roberto/0000-0001-9598-3131; Bellucci, Elisa/0000-0002-1636-0719	Universita Politecnica delle Marche; Universita degli Studi di Sassari	Universita Politecnica delle Marche; Universita degli Studi di Sassari	Funded by Universita Politecnica delle Marche and Universita degli Studi di Sassari. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No current external funding sources for this study.	Abdel-Ghani AH, 2004, THEOR APPL GENET, V109, P588, DOI 10.1007/s00122-004-1657-1; Alonso-Blanco C, 2000, TRENDS PLANT SCI, V5, P22, DOI 10.1016/S1360-1385(99)01510-1; Angioi SA, 2010, THEOR APPL GENET, V121, P829, DOI 10.1007/s00122-010-1353-2; [Anonymous], 1989, JMP VERS 7; Attene G., 1991, Rivista di Agronomia, V25, P54; Attene G, 1996, GENET RESOUR CROP EV, V43, P385; Beaumont MA, 2004, MOL ECOL, V13, P969, DOI 10.1111/j.1365-294X.2004.02125.x; Beaumont MA, 1996, P ROY SOC B-BIOL SCI, V263, P1619, DOI 10.1098/rspb.1996.0237; BECKER J, 1995, PLANT MOL BIOL, V27, P835, DOI 10.1007/BF00020238; Bergelson J, 2010, NAT REV GENET, V11, P867, DOI 10.1038/nrg2896; Bitocchi E, 2009, MOL ECOL, V18, P603, DOI 10.1111/j.1365-294X.2008.04064.x; Briggs DE., 1978, BARLEY, DOI 10.1007/978-94-009-5715-2; Brown AHD, 2000, GENES IN THE FIELD, P29; BRUSH SB, 1995, CROP SCI, V35, P346, DOI 10.2135/cropsci1995.0011183X003500020009x; Caldwell KS, 2006, GENETICS, V172, P557, DOI 10.1534/genetics.104.038489; Castillo G. F., 1997, GENE FLOW MAIZE LAND, P67; Ceccarelli S, 2000, GENES IN THE FIELD, P51; Ceccarelli S, 2012, AGROBIODIVERSITY CONSERVATION: SECURING THE DIVERSITY OF CROP WILD RELATIVES AND LANDRACES, P103, DOI 10.1079/9781845938512.0103; CECCARELLI S, 1987, EUPHYTICA, V36, P389, DOI 10.1007/BF00041482; Cockram J, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-16; Comadran J, 2011, THEOR APPL GENET, V122, P1363, DOI 10.1007/s00122-011-1537-4; Comadran J, 2009, THEOR APPL GENET, V119, P175, DOI 10.1007/s00122-009-1027-0; Degen B, 2001, J HERED, V92, P447, DOI 10.1093/jhered/92.5.447; Dieringer D, 2003, MOL ECOL NOTES, V3, P167, DOI 10.1046/j.1471-8286.2003.00351.x; ElMousadik A, 1996, THEOR APPL GENET, V92, P832, DOI 10.1007/BF00221895; Enjalbert J, 2011, CR BIOL, V334, P458, DOI 10.1016/j.crvi.2011.03.005; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2009, HEREDITY, V103, P285, DOI 10.1038/hdy.2009.74; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fischbeck G, 2003, DEV PL GEN, V7, P29, DOI 10.1016/S0168-7972(03)80005-1; Flowers JM, 2009, MOL BIOL EVOL, V26, P2475, DOI 10.1093/molbev/msp161; Frankel O.H., 1995, CONSERVATION PLANT B; GORHAM J, 1994, J EXP BOT, V45, P895, DOI 10.1093/jxb/45.7.895; Goudet J, 2002, FSTAT PROGRAM ESTIMA, DOI DOI 10.1093/OXFORDJOURNALS.JHERED.A111627; Hadado TT, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-121; Harlan J. R., 1968, Barley: Origin, Botany, Culture, Winter Hardiness, Genetics, Utilization & Pests., P9; Harlan JR, 1992, CROPS MAN; Hedden P, 2003, TRENDS GENET, V19, P5, DOI 10.1016/S0168-9525(02)00009-4; Jones Huw, 2008, Plant Genetic Resources Characterization and Utilization, V6, P98, DOI 10.1017/S1479262108993138; KIMURA M, 1964, GENETICS, V49, P725; LAW CN, 1978, HEREDITY, V40, P133, DOI 10.1038/hdy.1978.13; LEBOULCH V, 1994, GENET SEL EVOL, V26, pS221, DOI 10.1051/gse:19940715; LEVENE H, 1949, ANN MATH STAT, V20, P91, DOI 10.1214/aoms/1177730093; Lewontin R.C., 1972, EVOLUTIONARY BIOL, V14, P381, DOI DOI 10.1007/978-1-4684-9063-3_14; Luikart G, 2003, NAT REV GENET, V4, P981, DOI 10.1038/nrg1226; Malysheva-Otto L, 2007, MOL BREEDING, V20, P309, DOI 10.1007/s11032-007-9093-y; MANTEL N, 1967, CANCER RES, V27, P209; Mazzucato A, 2008, THEOR APPL GENET, V116, P657, DOI 10.1007/s00122-007-0699-6; MORAN PAP, 1950, BIOMETRIKA, V37, P17, DOI 10.2307/2332142; Negri V, 2002, GENET RESOUR CROP EV, V49, P511, DOI 10.1023/A:1020902508166; NEI M, 1974, GENETICS, V76, P379; Papa R, 1998, PLANT BREEDING, V117, P523, DOI 10.1111/j.1439-0523.1998.tb02201.x; Papa R, 2005, THEOR APPL GENET, V111, P1147, DOI 10.1007/s00122-005-0045-9; Papa R, 2003, THEOR APPL GENET, V106, P239, DOI 10.1007/s00122-002-1085-z; Papa R, 1993, THESIS U SASSARI ITA; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Pritchard JK, 2000, GENETICS, V155, P945; Pusadee T, 2009, P NATL ACAD SCI USA, V106, P13880, DOI 10.1073/pnas.0906720106; Ramsay L, 2000, GENETICS, V156, P1997; Ritala A, 2002, CROP SCI, V42, P278, DOI 10.2135/cropsci2002.0278; Rodriguez M, 2008, EUPHYTICA, V163, P231, DOI 10.1007/s10681-007-9635-8; Rodriguez M, 2012, THEOR APPL GENET, V125, P171, DOI 10.1007/s00122-012-1824-8; Russell JR, 2003, THEOR APPL GENET, V107, P413, DOI 10.1007/s00122-003-1261-9; SLATKIN M, 1991, GENETICS, V127, P627; SOKAL RR, 1978, BIOL J LINN SOC, V10, P199, DOI 10.1111/j.1095-8312.1978.tb00013.x; Teshome A., 2001, Plant Breeding Reviews, V21, P221; Vitalis R, 2003, J HERED, V94, P429, DOI 10.1093/jhered/esg083; Vitalis R, 2001, GENETICS, V158, P1811; WAGNER DB, 1991, J HERED, V82, P302, DOI 10.1093/oxfordjournals.jhered.a111090; Wang MH, 2012, THEOR APPL GENET, V124, P233, DOI 10.1007/s00122-011-1697-2; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; WRIGHT S, 1946, GENETICS, V31, P39; Wright S., 1978, EVOLUTION GENETICS P, V4; Yeh F.C., 1999, POPGENE VERSION 1 32	75	31	31	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e83891	10.1371/journal.pone.0083891	http://dx.doi.org/10.1371/journal.pone.0083891			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281RE	24386303	Green Submitted, gold, Green Published			2022-12-25	WOS:000329117900067
J	Chiang, EY; Johnston, RJ; Grogan, JL				Chiang, Eugene Y.; Johnston, Robert J.; Grogan, Jane L.			EBI2 Is a Negative Regulator of Type I Interferons in Plasmacytoid and Myeloid Dendritic Cells	PLOS ONE			English	Article							INNATE IMMUNE-RESPONSES; TOLL-LIKE RECEPTORS; RHEUMATOID-ARTHRITIS; MIGRATION; SIGNATURE; ALPHA; RECOGNITION; ACTIVATION; IPC	Epstein-Barr virus induced receptor 2 (EBI2), a G alpha(i)-coupled G protein-coupled receptor, is a chemotactic receptor for B, T and dendritic cells (DC). Genetic studies have also implicated EBI2 as a regulator of an interferon regulatory factor 7 (IRF7)-driven inflammatory network (IDIN) associated with autoimmune diseases, although the corollary in primary type I IFN-producing cells has not been reported. Here we demonstrate that EBI2 negatively regulates type I IFN responses in plasmacytoid DC (pDCs) and CD11b(+) myeloid cells. Activation of EBI2(-/-) pDCs and CD11b(+) cells with various TLR ligands induced elevated type I IFN production compared to wild-type cells. Moreover, in vivo challenge with endosomal TLR agonists or infection with lymphocytic choriomeningitis virus elicited more type I IFNs and proinflammatory cytokines in EBI2(-/-) mice compared to normal mice. Elevated systemic cytokines occurred despite impaired ability of EBI2-deficient pDCs and CD11b(+) cells to migrate from the blood to the spleen and peritoneal cavity under homeostatic conditions. As reported for other immune cells, pDC migration was dependent on the ligand for EBI2, 7 alpha,25-dihydroxycholesterol. Consistent with a cell intrinsic role for EBI2, type I IFN-producing cells from EBI2-deficient mice expressed higher levels of IRF7 and IDIN genes. Together these data suggest a negative regulatory role for EBI2 in balancing TLR-mediated responses to foreign and to self nucleic acids that may precipitate autoimmunity.	[Chiang, Eugene Y.; Johnston, Robert J.; Grogan, Jane L.] Genentech Inc, Dept Immunol, San Francisco, CA 94080 USA	Roche Holding; Genentech	Grogan, JL (corresponding author), Genentech Inc, Dept Immunol, San Francisco, CA 94080 USA.	jgrogan@gene.com			Genentech	Genentech(Roche HoldingGenentech)	This work was funded by Genentech, which develops and markets drugs for profit. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Anwar MA, 2013, EXP MOL MED, V45, DOI 10.1038/emm.2013.28; Asselin-Paturel C, 2005, J EXP MED, V201, P1157, DOI 10.1084/jem.20041930; Barbalat R, 2011, ANNU REV IMMUNOL, V29, P185, DOI 10.1146/annurev-immunol-031210-101340; Biron CA, 1998, SEMIN IMMUNOL, V10, P383, DOI 10.1006/smim.1998.0138; Blasius AL, 2006, BLOOD, V107, P2474, DOI 10.1182/blood-2005-09-3746; Bronson PG, 2012, CURR OPIN IMMUNOL, V24, P530, DOI 10.1016/j.coi.2012.07.008; Cao W, 2007, PLOS BIOL, V5, P2190, DOI 10.1371/journal.pbio.0050248; Cao W, 2006, J EXP MED, V203, P1399, DOI 10.1084/jem.20052454; Cao W, 2009, J EXP MED, V206, P1603, DOI 10.1084/jem.20090547; Chiang CY, 2012, CELL HOST MICROBE, V11, P306, DOI 10.1016/j.chom.2012.02.002; Colonna M, 2004, NAT IMMUNOL, V5, P1219, DOI 10.1038/ni1141; Farkas L, 2001, AM J PATHOL, V159, P237, DOI 10.1016/S0002-9440(10)61689-6; Gatto D, 2013, NAT IMMUNOL, V14, P446, DOI 10.1038/ni.2555; Gatto D, 2011, J IMMUNOL, V187, P4621, DOI 10.4049/jimmunol.1101542; Gatto D, 2009, IMMUNITY, V31, P259, DOI 10.1016/j.immuni.2009.06.016; Gilliet M, 2008, NAT REV IMMUNOL, V8, P594, DOI 10.1038/nri2358; Hannedouche S, 2011, NATURE, V475, P524, DOI 10.1038/nature10280; He JP, 2000, J EXP MED, V191, P1605, DOI 10.1084/jem.191.9.1605; Heinig M, 2010, NATURE, V467, P460, DOI 10.1038/nature09386; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Kehrl JH, 1998, IMMUNITY, V8, P1, DOI 10.1016/S1074-7613(00)80453-7; Kraan TCTMV, 2007, ANN RHEUM DIS, V66, P1008, DOI 10.1136/ard.2006.063412; Lafyatis R, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2321; Lande R, 2004, J IMMUNOL, V173, P2815, DOI 10.4049/jimmunol.173.4.2815; Li Q, 2008, P NATL ACAD SCI USA, V105, P12439, DOI 10.1073/pnas.0806439105; Li Q, 2011, CLIN IMMUNOL, V140, P3, DOI 10.1016/j.clim.2011.04.010; Liu CL, 2011, NATURE, V475, P519, DOI 10.1038/nature10226; Liu YJ, 2005, ANNU REV IMMUNOL, V23, P275, DOI 10.1146/annurev.immunol.23.021704.115633; Marshak-Rothstein A, 2006, NAT REV IMMUNOL, V6, P823, DOI 10.1038/nri1957; Mavragani CP, 2010, J AUTOIMMUN, V35, P225, DOI 10.1016/j.jaut.2010.06.012; McBride JM, 2012, ARTHRITIS RHEUM-US, V64, P3666, DOI 10.1002/art.34632; Ning S, 2011, GENES IMMUN, V12, P399, DOI 10.1038/gene.2011.21; Pena JA, 2009, INFLAMM BOWEL DIS, V15, P248, DOI 10.1002/ibd.20744; Pereira JP, 2009, NATURE, V460, P1122, DOI 10.1038/nature08226; Reizis B, 2011, ANNU REV IMMUNOL, V29, P163, DOI 10.1146/annurev-immunol-031210-101345; Reynier F, 2010, GENES IMMUN, V11, P269, DOI 10.1038/gene.2009.112; Rock J, 2007, EUR J IMMUNOL, V37, P3564, DOI 10.1002/eji.200737711; Rosenkilde MM, 2006, J BIOL CHEM, V281, P13199, DOI 10.1074/jbc.M602245200; Sozzani S, 2010, TRENDS IMMUNOL, V31, P270, DOI 10.1016/j.it.2010.05.004; Swiecki M, 2011, CURR OPIN VIROL, V1, P463, DOI 10.1016/j.coviro.2011.10.026; Tang T, 2010, NAT BIOTECHNOL, V28, P749, DOI 10.1038/nbt.1644; Umemoto E, 2012, J IMMUNOL, V189, P191, DOI 10.4049/jimmunol.1200802; van Baarsen LGM, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2912; van Baarsen LGM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001927; Wang Y, 2013, ARCH IMMUNOL THER EX; Wang YM, 2011, IMMUNOL REV, V243, P74, DOI 10.1111/j.1600-065X.2011.01049.x; Yao YH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002737; Yi TS, 2013, ELIFE, V2, DOI 10.7554/eLife.00757; Yi TS, 2012, IMMUNITY, V37, P535, DOI 10.1016/j.immuni.2012.06.015	51	26	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e83457	10.1371/journal.pone.0083457	http://dx.doi.org/10.1371/journal.pone.0083457			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281QS	24386204	Green Published, Green Submitted, gold			2022-12-25	WOS:000329116700051
J	Leavitt, SD; Lumbsch, HT; Stenroos, S; St Clair, LL				Leavitt, Steven D.; Lumbsch, H. Thorsten; Stenroos, Soili; St Clair, Larry L.			Pleistocene Speciation in North American Lichenized Fungi and the Impact of Alternative Species Circumscriptions and Rates of Molecular Evolution on Divergence Estimates	PLOS ONE			English	Article							GENUS MELANOHALEA PARMELIACEAE; POPULATION-STRUCTURE; XANTHOPARMELIA PARMELIACEAE; PHYLOGENETIC-RELATIONSHIPS; DOMINATED DIVERSIFICATION; MAXIMUM-LIKELIHOOD; CETRARIA-ACULEATA; FORMING FUNGI; DELIMITATION; ASCOMYCOTA	Pleistocene climatic fluctuations influenced patterns of genetic variation and promoted speciation across a wide range of species groups. Lichens are commonly found in habitats that were directly impacted by glacial cycles; however, the role of Pleistocene climate in driving speciation in most lichen symbionts remains unclear. This uncertainty is due in part to limitations in our ability to accurately recognize independently evolving lichen-forming fungal lineages and a lack of relevant fossil calibrations. Using a coalescent-based species tree approach, we estimated divergence times for two sister clades in the genus Xanthoparmelia (Parmeliaceae) restricted to western North America. We assessed the influence of two different species circumscription scenarios and various locus-specific rates of molecular evolution on divergence estimates. Species circumscriptions were validated using the program BP&P. although speciation was generally supported in both scenarios, divergence times differed between traditional species circumscriptions and those based on genetic data, with more recent estimates resulting from the former. Similarly, rates of evolution for different loci resulted in variable divergence time estimates. However, our results unambiguously indicate that diversification in the sampled Xanthoparmelia clades occurred during the Pleistocene. Our study highlights the potential impact of ambiguous species circumscriptions and uncertain rates of molecular evolution on estimating divergence times within a multilocus species tree framework.	[Leavitt, Steven D.] Univ Chicago, Comm Evolutionary Biol, Chicago, IL 60637 USA; [Leavitt, Steven D.; Lumbsch, H. Thorsten] Field Museum Nat Hist, Chicago, IL 60605 USA; [Leavitt, Steven D.; St Clair, Larry L.] Brigham Young Univ, Dept Biol, Provo, UT 84602 USA; [Leavitt, Steven D.; St Clair, Larry L.] Brigham Young Univ, ML Bean Life Sci Museum, Provo, UT 84602 USA; [Stenroos, Soili] Univ Helsinki, Bot Museum, Finnish Museum Nat Hist, Helsinki, Finland	University of Chicago; Field Museum of Natural History (Chicago); Brigham Young University; Brigham Young University; University of Helsinki	Leavitt, SD (corresponding author), Univ Chicago, Comm Evolutionary Biol, Chicago, IL 60637 USA.	sleavitt@fieldmuseum.org	Leavitt, Steven D./AAC-6462-2021	Leavitt, Steven D./0000-0002-5034-9724; Stenroos, Soili/0000-0003-0331-792X	California Lichen Society; Brigham Young University Office of Research and Creative Activities; NSF [DEB-0949147]	California Lichen Society; Brigham Young University Office of Research and Creative Activities; NSF(National Science Foundation (NSF))	This project was supported in part by grants from the California Lichen Society (http://californialichens.org/), the Brigham Young University Office of Research and Creative Activities (http://orca.byu.edu/), and NSF (http://nsf.gov/; "Hidden diversity in parmelioid lichens", DEB-0949147). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	de Paz GA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039683; de Paz GA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028161; de Paz GA, 2010, AUST SYST BOT, V23, P173, DOI 10.1071/SB09055; Asplund J, 2009, BASIC APPL ECOL, V10, P273, DOI 10.1016/j.baae.2008.04.003; Berbee Mary L., 2010, Fungal Biology Reviews, V24, P1, DOI 10.1016/j.fbr.2010.03.001; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; Blanco O, 2004, TAXON, V53, P959, DOI 10.2307/4135563; Brandley MC, 2011, SYST BIOL, V60, P3, DOI 10.1093/sysbio/syq045; CAMARGO A, 2013, SPECIES PROBLEM; Camargo A, 2012, EVOLUTION, V66, P2834, DOI 10.1111/j.1558-5646.2012.01640.x; Camargo A, 2012, SYST BIOL, V61, P272, DOI 10.1093/sysbio/syr105; Coats LL, 2008, QUATERNARY RES, V70, P322, DOI 10.1016/j.yqres.2008.04.006; Collins RA, 2013, MOL ECOL RESOUR, V13, P969, DOI 10.1111/1755-0998.12046; Conrad DF, 2006, NAT GENET, V38, P1251, DOI 10.1038/ng1911; Corander J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-539; Crespo A, 2007, MOL PHYLOGENET EVOL, V44, P812, DOI 10.1016/j.ympev.2006.11.029; Crespo A, 2010, IMA FUNGUS, V1, P167, DOI 10.5598/imafungus.2010.01.02.09; Crespo A, 2009, AN JARDIN BOT MADRID, V66, P71, DOI 10.3989/ajbm.2225; CULBERSON CF, 1972, J CHROMATOGR, V72, P113, DOI 10.1016/0021-9673(72)80013-X; Dayrat B, 2005, BIOL J LINN SOC, V85, P407, DOI 10.1111/j.1095-8312.2005.00503.x; de Queiroz K, 1998, ENDLESS FORMS, P57; De Queiroz K, 2007, SYST BIOL, V56, P879, DOI 10.1080/10635150701701083; Degnan JH, 2006, PLOS GENET, V2, P762, DOI 10.1371/journal.pgen.0020068; Degnan JH, 2009, TRENDS ECOL EVOL, V24, P332, DOI 10.1016/j.tree.2009.01.009; DEQUEIROZ K, 1999, GEN LINEAGE CONCEPT, P49; Divakar PK, 2012, AM J BOT, V99, P2014, DOI 10.3732/ajb.1200258; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Eckert AJ, 2008, MOL PHYLOGENET EVOL, V49, P832, DOI 10.1016/j.ympev.2008.09.008; Edwards SV, 2007, P NATL ACAD SCI USA, V104, P5936, DOI 10.1073/pnas.0607004104; Edwards SV, 2009, EVOLUTION, V63, P1, DOI 10.1111/j.1558-5646.2008.00549.x; Edwards SV, 2000, EVOLUTION, V54, P1839; Ence DD, 2011, MOL ECOL RESOUR, V11, P473, DOI 10.1111/j.1755-0998.2010.02947.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Falush D, 2003, GENETICS, V164, P1567; Falush D, 2003, SCIENCE, V299, P1582, DOI 10.1126/science.1080857; Fernandez-Mendoza F, 2011, MOL ECOL, V20, P1208, DOI 10.1111/j.1365-294X.2010.04993.x; Fernandez-Mendoza F, 2013, MOL ECOL, V22, P1961, DOI 10.1111/mec.12210; Fujita MK, 2012, TRENDS ECOL EVOL, V27, P480, DOI 10.1016/j.tree.2012.04.012; Funk DJ, 1998, EVOLUTION, V52, P1744, DOI [10.2307/2411347, 10.1111/j.1558-5646.1998.tb02254.x]; GARGAS A, 1995, SCIENCE, V268, P1492, DOI 10.1126/science.7770775; Graham, 2010, LATE CRETACEOUS CENO; Hale ME, 1990, SYNOPSIS LICHEN GENU; Heled J, 2010, MOL BIOL EVOL, V27, P570, DOI 10.1093/molbev/msp274; Hey J, 2003, TRENDS ECOL EVOL, V18, P597, DOI 10.1016/j.tree.2003.08.014; Hodkinson BP, 2011, BIBL LICHENOL, V106, P115; HONEGGER R, 1991, ANNU REV PLANT PHYS, V42, P553, DOI 10.1146/annurev.pp.42.060191.003005; Huneck S, 1999, NATURWISSENSCHAFTEN, V86, P559, DOI 10.1007/s001140050676; Kalinowski ST, 2011, HEREDITY, V106, P625, DOI 10.1038/hdy.2010.95; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; KLUGE AG, 1989, SYST ZOOL, V38, P7, DOI 10.2307/2992432; Knowles LL, 2007, SYST BIOL, V56, P887, DOI [10.1080/10635150701405560, 10.1080/10635150701701091]; Knowles LL, 2009, SYST BIOL, V58, P463, DOI 10.1093/sysbio/syp061; Kubatko LS, 2009, BIOINFORMATICS, V25, P971, DOI 10.1093/bioinformatics/btp079; Lanier HC, 2012, SYST BIOL, V61, P691, DOI 10.1093/sysbio/syr128; Leache AD, 2010, P ROY SOC B-BIOL SCI, V277, P3071, DOI 10.1098/rspb.2010.0662; Leache AD, 2009, SYST BIOL, V58, P547, DOI 10.1093/sysbio/syp057; Leavitt S. D., 2012, B CALIFORNIA LICHEN, V19, P58; Leavitt S. D., 2008, EVANSIA, V26, P85; Leavitt SD, 2013, J BIOGEOGR, V40, P1792, DOI 10.1111/jbi.12118; Leavitt SD, 2012, BIOL J LINN SOC, V107, P920, DOI 10.1111/j.1095-8312.2012.01978.x; Leavitt SD, 2013, MOL PHYLOGENET EVOL, V66, P138, DOI 10.1016/j.ympev.2012.09.013; Leavitt SD, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-176; Leavitt SD, 2012, AM J BOT, V99, P1764, DOI 10.3732/ajb.1200146; Leavitt SD, 2011, MOL PHYLOGENET EVOL, V60, P317, DOI 10.1016/j.ympev.2011.05.012; Leavitt SD, 2011, MOL PHYLOGENET EVOL, V59, P587, DOI 10.1016/j.ympev.2011.03.020; Leavitt SD, 2011, AM J BOT, V98, P175, DOI 10.3732/ajb.1000230; Lindblom L, 2006, MOL ECOL, V15, P1545, DOI 10.1111/j.1365-294X.2006.02880.x; Liu L, 2008, BIOINFORMATICS, V24, P2542, DOI 10.1093/bioinformatics/btn484; Liu L, 2007, SYST BIOL, V56, P504, DOI 10.1080/10635150701429982; Liu L, 2009, MOL PHYLOGENET EVOL, V53, P320, DOI 10.1016/j.ympev.2009.05.033; Liu YJJ, 1999, MOL BIOL EVOL, V16, P1799, DOI 10.1093/oxfordjournals.molbev.a026092; Loera I, 2012, MOL PHYLOGENET EVOL, V65, P437, DOI 10.1016/j.ympev.2012.06.025; Lucking R, 2009, MYCOLOGIA, V101, P810, DOI 10.3852/09-016; Lumbsch HT, 2011, FUNGAL DIVERS, V50, P59, DOI 10.1007/s13225-011-0123-z; Lumbsch HT, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-257; Lutzoni F, 2001, NATURE, V411, P937, DOI 10.1038/35082053; Lutzoni F, 1997, P NATL ACAD SCI USA, V94, P11422, DOI 10.1073/pnas.94.21.11422; Matheny PB, 2002, AM J BOT, V89, P688, DOI 10.3732/ajb.89.4.688; McCormack JE, 2011, EVOLUTION, V65, P184, DOI 10.1111/j.1558-5646.2010.01097.x; Myllys L, 2002, LICHENOLOGIST, V34, P237, DOI 10.1006/lich.2002.0390; NASH III, 2004, 3 NASHBD RYANP DIEDE; NASH TH, 1977, AM J BOT, V64, P664, DOI 10.1002/j.1537-2197.1977.tb11907.x; Nelson MF, 2013, ECOL EVOL, V3, P3455, DOI 10.1002/ece3.725; Niemiller ML, 2012, EVOLUTION, V66, P846, DOI 10.1111/j.1558-5646.2011.01480.x; O'Meara BC, 2010, SYST BIOL, V59, P59, DOI 10.1093/sysbio/syp077; O'Neill EM, 2013, MOL ECOL, V22, P111, DOI 10.1111/mec.12049; Orange A., 2001, MICROCHEMICAL METHOD; Osborn G, 2001, QUATERNARY SCI REV, V20, P1377, DOI 10.1016/S0277-3791(01)00002-6; Palmqvist K, 2000, PLANT CELL ENVIRON, V23, P1, DOI 10.1046/j.1365-3040.2000.00529.x; Perez-Ortega S, 2012, ANN BOT-LONDON, V109, P1133, DOI 10.1093/aob/mcs042; Pinho C, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-63; Pino-Bodas R, 2011, ORG DIVERS EVOL, V11, P343, DOI 10.1007/s13127-011-0062-2; Pino-Bodas R, 2012, MYCOL PROG, V11, P269, DOI 10.1007/s11557-011-0746-1; Plata ER, 2008, BIODIVERS CONSERV, V17, P1319, DOI 10.1007/s10531-007-9289-9; Plata ER, 2011, MOL PHYLOGENET EVOL, V61, P45, DOI 10.1016/j.ympev.2011.04.025; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Poykko H, 2005, ECOLOGY, V86, P2623, DOI 10.1890/04-1632; Prieto M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065576; Printzen C, 2003, MOL ECOL, V12, P1473, DOI 10.1046/j.1365-294X.2003.01812.x; Pritchard JK, 2000, GENETICS, V155, P945; Rambaut A, 2009, TREEANNOTATOR VERSIO; Ranius T, 2008, J VEG SCI, V19, P653, DOI 10.3170/2008-8-18433; Rannala B, 2003, GENETICS, V164, P1645; Renhorn KE, 1997, OECOLOGIA, V109, P1, DOI 10.1007/s004420050051; Roe AD, 2007, MOL ECOL, V16, P3617, DOI 10.1111/j.1365-294X.2007.03412.x; ROSENTRETER R, 1993, BRYOLOGIST, V96, P333, DOI 10.2307/3243861; Ross KG, 2010, SYST BIOL, V59, P162, DOI 10.1093/sysbio/syp089; Ruiz-Sanchez E, 2010, MOL PHYLOGENET EVOL, V54, P344, DOI 10.1016/j.ympev.2009.10.035; Rundle HD, 2005, ECOL LETT, V8, P336, DOI 10.1111/j.1461-0248.2004.00715.x; Sites JW, 2003, TRENDS ECOL EVOL, V18, P462, DOI 10.1016/S0169-5347(03)00184-8; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stiller JW, 1997, P NATL ACAD SCI USA, V94, P4520, DOI 10.1073/pnas.94.9.4520; Takamatsu Susumu, 2004, Mycoscience, V45, P340, DOI 10.1007/s10267-004-0187-7; Taylor JW, 2006, MYCOLOGIA, V98, P838, DOI 10.3852/mycologia.98.6.838; Thell A., 2009, BIBLIOTHECA LICHENOL, V99, P393; Thell A, 2012, NORD J BOT, V30, P641, DOI 10.1111/j.1756-1051.2012.00008.x; Thompson RS, 2000, J BIOGEOGR, V27, P555, DOI 10.1046/j.1365-2699.2000.00427.x; Truong C, 2013, MOL PHYLOGENET EVOL, V68, P357, DOI 10.1016/j.ympev.2013.04.005; VANDEVENDER TR, 1979, SCIENCE, V204, P701, DOI 10.1126/science.204.4394.701; Velmala S, 2009, LICHENOLOGIST, V41, P231, DOI 10.1017/S0024282909008573; Wagner CE, 2013, MOL ECOL, V22, P787, DOI 10.1111/mec.12023; Wang HY, 2010, SCI CHINA LIFE SCI, V53, P1163, DOI 10.1007/s11427-010-4063-8; Weisrock DW, 2012, MOL BIOL EVOL, V29, P1615, DOI 10.1093/molbev/mss008; Weisrock DW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009883; Wiens JJ, 2007, SYST BIOL, V56, P875, DOI 10.1080/10635150701748506; Wirtz N, 2012, ORG DIVERS EVOL, V12, P17, DOI 10.1007/s13127-011-0066-y; Yang ZH, 2010, P NATL ACAD SCI USA, V107, P9264, DOI 10.1073/pnas.0913022107; Yeates DK, 2011, SYST ENTOMOL, V36, P209, DOI 10.1111/j.1365-3113.2010.00558.x; Zhang C, 2011, SYST BIOL, V60, P747, DOI 10.1093/sysbio/syr071	133	30	31	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e85240	10.1371/journal.pone.0085240	http://dx.doi.org/10.1371/journal.pone.0085240			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281QS	24386465	Green Published, Green Submitted, gold			2022-12-25	WOS:000329116700135
J	McCann, S; Moeri, O; Jones, T; Scott, C; Khaskin, G; Gries, R; O'Donnell, S; Gries, G				McCann, Sean; Moeri, Onour; Jones, Tanya; Scott, Catherine; Khaskin, Grigori; Gries, Regine; O'Donnell, Sean; Gries, Gerhard			Strike Fast, Strike Hard: The Red-Throated Caracara Exploits Absconding Behavior of Social Wasps during Nest Predation	PLOS ONE			English	Article							SWARM-FOUNDING WASP; CHEMICAL DEFENSE; GIANT HONEYBEES; APIS-DORSATA; HYMENOPTERA; MORPHOLOGY; AUKLET; BIRDS; RATES; PREY	Red-throated Caracaras Ibycter americanus (Falconidae) are specialist predators of social wasps in the Neotropics. It had been proposed that these caracaras possess chemical repellents that allow them to take the brood of wasp nests without being attacked by worker wasps. To determine how caracaras exploit nests of social wasps and whether chemical repellents facilitate predation, we: (1) video recorded the birds attacking wasp nests; (2) analyzed surface extracts of the birds' faces, feet, and feathers for potential chemical repellents; and (3) inflicted mechanical damage on wasp nests to determine the defensive behavior of wasps in response to varying levels of disturbance. During caracara predation events, two species of large-bodied wasps mounted stinging attacks on caracaras, whereas three smaller-bodied wasp species did not. The "hit-and-run" predation tactic of caracaras when they attacked nests of large and aggressive wasps reduced the risk of getting stung. Our data reveal that the predation strategy of caracaras is based on mechanical disturbance of, and damage to, target wasp nests. Caracara attacks and severe experimental disturbance of nests invariably caused wasps to abscond (abandon their nests). Two compounds in caracara foot extracts [sulcatone and iridodial] elicited electrophysiological responses from wasp antennae, and were also present in defensive secretions of sympatric arboreal-nesting Azteca ants. These compounds appear not to be wasp repellents but to be acquired coincidentally by caracaras when they perch on trees inhabited with Azteca ants. We conclude that caracara predation success does not depend on wasp repellents but relies on the absconding response that is typical of swarm-founding polistine wasps. Our study highlights the potential importance of vertebrate predators in the ecology and evolution of social wasps.	[McCann, Sean; Moeri, Onour; Jones, Tanya; Scott, Catherine; Khaskin, Grigori; Gries, Regine; Gries, Gerhard] Simon Fraser Univ, Dept Biol Sci, Burnaby, BC V5A 1S6, Canada; [O'Donnell, Sean] Drexel Univ, Dept Biodivers Earth & Environm Sci, Philadelphia, PA 19104 USA	Simon Fraser University; Drexel University	McCann, S (corresponding author), Simon Fraser Univ, Dept Biol Sci, Burnaby, BC V5A 1S6, Canada.	smmccann@sfu.ca		Scott, Catherine/0000-0003-0860-4805; McCann, Sean/0000-0001-6030-6456	Centre National de la Recherche Scientifique; Natural Sciences and Engineering Research Council of Canada (NSERC) - Industrial Research Chair	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Natural Sciences and Engineering Research Council of Canada (NSERC) - Industrial Research Chair(Natural Sciences and Engineering Research Council of Canada (NSERC))	Funding was provided by three Project Amazonie research grants from the Centre National de la Recherche Scientifique to S. M. for travel and accommodation at the Nouragues Station in French Guiana (http://www.cnrs.fr/), and by a Natural Sciences and Engineering Research Council of Canada (NSERC) - Industrial Research Chair to G. G. (http://www.nserc-crsng.gc.ca/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARN H, 1975, Z NATURFORSCH C, V30, P722; Bouwma AM, 2007, BIOTROPICA, V39, P719, DOI 10.1111/j.1744-7429.2007.00321.x; Burger BV, 2004, J CHEM ECOL, V30, P1603, DOI 10.1023/B:JOEC.0000042071.65335.f3; Chadab R., 1979, Psyche (Cambridge), V86, P115, DOI 10.1155/1979/38164; Charles-Dominique P, 2001, MONOG BIOL, V80, P1; Do Nascimento RR, 1998, J CHEM ECOL, V24, P1629, DOI 10.1023/A:1020864427854; Douglas HD, 2004, J CHEM ECOL, V30, P1921, DOI 10.1023/B:JOEC.0000045586.59468.de; Douglas HD, 2001, NATURWISSENSCHAFTEN, V88, P330, DOI 10.1007/s001140100236; DUMBACHER JP, 1992, SCIENCE, V258, P799, DOI 10.1126/science.1439786; Dytham C., 2011, CHOOSING USING STAT, P199; Fitzgerald KT, 2006, CLIN TECH SMALL AN P, V21, P194, DOI 10.1053/j.ctsap.2006.10.002; Gries R, 2002, J CHEM ECOL, V28, P2283, DOI 10.1023/A:1021005517389; Hagen Y, 1958, FOOD SOME HONEY BUZZ; Hermann H.R., 1981, P77; Hozumi S, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.14135; Huang KY, 2004, J RAPTOR RES, V38, P367; ITAMIES J, 1972, Ornis Fennica, V49, P7; Jeanne R.L., 1991, P191; JEANNE RL, 1995, J INSECT BEHAV, V8, P433, DOI 10.1007/BF01995317; JEANNE RL, 1979, ECOLOGY, V60, P1211, DOI 10.2307/1936968; JEANNE RL, 1975, Q REV BIOL, V50, P267, DOI 10.1086/408564; JEANNE RL, 1978, BIOTROPICA, V10, P234, DOI 10.2307/2387909; Johnson DDP, 2002, TRENDS ECOL EVOL, V17, P563, DOI 10.1016/S0169-5347(02)02619-8; Kastberger G, 2000, APIDOLOGIE, V31, P727, DOI 10.1051/apido:2000157; KING WB, 1970, AUK, V87, P376, DOI 10.2307/4083939; Lee W-J, 2011, ORIENTAL HONEY BUZZA; London KB, 2003, BEHAV ECOL SOCIOBIOL, V54, P539, DOI 10.1007/s00265-003-0662-8; London KB, 2000, ETHOL ECOL EVOL, V12, P13, DOI 10.1080/03949370.2000.9728440; Lowery GH, 1951, BIRDS STATE VERACRUZ, P556; MAYS NM, 1985, WILSON BULL, V97, P231; McCann S, 2010, J RAPTOR RES, V44, P236, DOI 10.3356/JRR-09-75.1; Millar JG, 1998, METHODS CHEM ECOLOGY, P1; MONTGOMERIE RD, 1988, Q REV BIOL, V63, P167, DOI 10.1086/415838; O'Donnell Sean, 2002, Journal of Insect Science (Tucson), V2, P1; RICHARDS O. W., 1951, TRANS ROY ENT SOC LONDON, V102, P1; Richards O.W., 1978, SOCIAL WASPS AM EXCL; Servigne P, 2003, ASS ENTRE FOURMI AZT; Sievwright H, 2011, ORNITHOL SCI, V10, P131, DOI 10.2326/osj.10.131; Skutch A. F., 1959, Animal Kingdom, V62, P8; Smith AR, 2001, EVOL ECOL RES, V3, P331; STADDON BW, 1980, COMP BIOCHEM PHYS A, V65, P371, DOI 10.1016/0300-9629(80)90046-8; Thapa R, 2003, AM BEE J, V143, P540; THIOLLAY JM, 1991, IBIS, V133, P382, DOI 10.1111/j.1474-919X.1991.tb04586.x; VOOUS KH, 1969, ARDEA, V57, P117; Voss RS, 2012, BIOL REV, V87, P822, DOI 10.1111/j.1469-185X.2012.00222.x; Warham J., 1977, Proceedings of the New Zealand Ecological Society, V24, P84; Weldon PJ, 1997, J CHEM ECOL, V23, P2609, DOI 10.1023/B:JOEC.0000006670.79075.92; Wenzel JW, 1998, AM MUS NOVIT; West-Eberhard M, 1982, NATURE EVOLUTION SWA; YOUNG A M, 1979, Journal of the Kansas Entomological Society, V52, P759	51	8	8	0	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e84114	10.1371/journal.pone.0084114	http://dx.doi.org/10.1371/journal.pone.0084114			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281QS	24386338	Green Published, Green Submitted, gold			2022-12-25	WOS:000329116700098
J	Shi, J; Yuan, H; Xu, B				Shi, Jun; Yuan, Hao; Xu, Bing			Treatment of Mandibular Condyle Fractures Using a Modified Transparotid Approach via the Parotid Mini-Incision: Experience with 31 Cases	PLOS ONE			English	Article							RETROMANDIBULAR APPROACH; RIGID FIXATION; NECK	Surgery for mandibular condyle fractures must allow direct vision of the fracture, reduce surgical trauma and achieve reduction and fixation while avoiding facial nerve injury. This prospective study was conducted to introduce a new surgical approach for open reduction and internal fixation of mandibular condyle fractures using a modified transparotid approach via the parotid mini-incision, and surgical outcomes were evaluated. The modified transparotid approach via the parotid mini-incision was applied and rigid internal fixation using a small titanium plate was carried out for 36 mandibular condyle fractures in 31 cases. Postoperative follow-up of patients ranged from 3 to 26 months; in the first 3 months after surgery, outcomes for all patients were analyzed by evaluating the degree of mouth opening, occlusal relationship, facial nerve function and results of imaging studies. The occlusal relationships were excellent in all patients and none had symptoms of intraoperative ipsilateral facial nerve injury. The mean degree of mouth opening was 4.0 (maximum 4.8 cm, minimum 3.0 cm). No mandibular deviations were noted in any patient during mouth opening. CT showed complete anatomical reduction of the mandibular condyle fracture in all patients. The modified transparotid approach via the smaller, easily concealed parotid mini-incision is minimally invasive and achieves anatomical reduction and rigid internal fixation with a simplified procedure that directly exposes the fracture site. Study results showed that this procedure is safe and feasible for treating mandibular condyle fracture, and offers a short operative path, protection of the facial nerve and satisfactory aesthetic outcomes.	[Shi, Jun; Yuan, Hao; Xu, Bing] Shanghai Jiao Tong Univ, Sch Dent, Shanghai Peoples Hosp 9, Dept Craniomaxillofacial Sci, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University	Xu, B (corresponding author), Shanghai Jiao Tong Univ, Sch Dent, Shanghai Peoples Hosp 9, Dept Craniomaxillofacial Sci, Shanghai 200030, Peoples R China.	bingxu568@hotmail.com						Cho BC, 2012, ARCH PLAST SURG-APS, V39, P190, DOI [10.5999/aps.2012.39.3.190, 10.5999/aps.2012.39.4.301]; Croce A, 2010, ACTA OTORHINOLARYNGO, V30, P303; Devlin MF, 2002, BRIT J ORAL MAX SURG, V40, P23, DOI 10.1054/bjom.2001.0748; Downie JJ, 2009, BRIT J ORAL MAX SURG, V47, P370, DOI 10.1016/j.bjoms.2008.11.002; Ebenezer V, 2011, J MAXILLOFAC ORAL SU, V10, P38, DOI 10.1007/s12663-010-0145-1; ELLIS E, 1993, ORAL SURG ORAL MED O, V76, P6, DOI 10.1016/0030-4220(93)90285-C; Guerrissi JO, 2002, J CRANIOFAC SURG, V13, P568; Guven O, 2001, J CRANIO MAXILL SURG, V29, P232, DOI 10.1054/jcms.2001.0228; Kim BK, 2012, J CRANIOFAC SURG, V23, P712, DOI 10.1097/SCS.0b013e31824dbb35; Manisali M, 2003, INT J ORAL MAX SURG, V32, P253, DOI 10.1054/ijom.2002.0270; Schoen R, 2008, INT J ORAL MAX SURG, V37, P111, DOI 10.1016/j.ijom.2007.06.017; Silverman SL, 1925, DENTISUTO COSMOS, V67, P876; Strobl H, 1999, INT J ORAL MAX SURG, V28, P95; Tang W, 2009, J ORAL MAXIL SURG, V67, P552, DOI 10.1016/j.joms.2008.06.066; Villarreal PM, 2004, J ORAL MAXIL SURG, V62, P155, DOI 10.1016/j.joms.2003.08.010; ZACHARIADES N, 1990, J CRANIO MAXILL SURG, V18, P251, DOI 10.1016/S1010-5182(05)80425-1; Zachariades N, 2006, J CRANIO MAXILL SURG, V34, P421, DOI 10.1016/j.jcms.2006.07.854	17	5	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e83525	10.1371/journal.pone.0083525	http://dx.doi.org/10.1371/journal.pone.0083525			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281QS	24386221	Green Submitted, Green Published, gold			2022-12-25	WOS:000329116700058
J	Yang, YJ; Li, JY; Liu, XW; Zhang, JY; Liu, YR; Li, B				Yang, Ya-Jun; Li, Jian-Yong; Liu, Xi-Wang; Zhang, Ji-Yu; Liu, Yu-Rong; Li, Bing			A Non-Biological Method for Screening Active Components against Influenza Virus from Traditional Chinese Medicine by Coupling a LC Column with Oseltamivir Molecularly Imprinted Polymers	PLOS ONE			English	Article							MASS-SPECTROMETRY; DRUG DISCOVERY; EXTRACTION; TRANSMISSION; RECOGNITION; TECHNOLOGY; ALKALOIDS; SAMPLES; ACID	To develop a non-biological method for screening active components against influenza virus from traditional Chinese medicine (TCM) extraction, a liquid chromatography (LC) column prepared with oseltamivir molecularly imprinted polymer (OSMIP) was employed with LC-mass spectrometry (LC-MS). From chloroform extracts of compound TCM liquid preparation, we observed an affinitive component m/z 249, which was identified to be matrine following analysis of phytochemical literatures, OSMIP-LC column on-line of control compounds and MS/MS off-line. The results showed that matrine had similar bioactivities with OS against avian influenza virus H9N2 in vitro for both alleviating cytopathic effect and hemagglutination inhibition and that the stereostructures of these two compounds are similar while their two-dimensional structures were different. In addition, our results suggested that the bioactivities of those affinitive compounds were correlated with their chromatographic behaviors, in which less difference of the chromatographic behaviors might have more similar bioactivities. This indicates that matrine is a potential candidate drug to prevent or cure influenza for human or animal. In conclusion, the present study showed that molecularly imprinted polymers can be used as a non-biological method for screening active components against influenza virus from TCM.	[Yang, Ya-Jun; Li, Jian-Yong; Liu, Xi-Wang; Zhang, Ji-Yu; Liu, Yu-Rong; Li, Bing] CAAS, Gansu Prov Engn Res Ctr New Anim Drug, Key Lab New Anim Drug Project,Key Lab Vet Pharmac, Minist Agr,Lanzhou Inst Husb & Pharmaceut Sci, Lanzhou, Gansu, Peoples R China	Chinese Academy of Agricultural Sciences; Lanzhou Institute of Husbandry & Pharmaceutical Sciences, CAAS; Ministry of Agriculture & Rural Affairs	Li, JY (corresponding author), CAAS, Gansu Prov Engn Res Ctr New Anim Drug, Key Lab New Anim Drug Project,Key Lab Vet Pharmac, Minist Agr,Lanzhou Inst Husb & Pharmaceut Sci, Lanzhou, Gansu, Peoples R China.	lijy1971@163.com			National Natural Science Foundation of China [30771590]; Postdoctoral Science Foundation of China [20070420443]; earmarked fund for China Agriculture Research System [cars-38]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Postdoctoral Science Foundation of China(China Postdoctoral Science Foundation); earmarked fund for China Agriculture Research System	This work was supported by the National Natural Science Foundation of China (No. 30771590), the Postdoctoral Science Foundation of China (No. 20070420443) and the earmarked fund for China Agriculture Research System (cars-38). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdouss M, 2011, J MATER SCI-MATER M, V22, P2273, DOI 10.1007/s10856-011-4395-3; Ansell RJ, 2005, ADV DRUG DELIVER REV, V57, P1809, DOI 10.1016/j.addr.2005.07.014; Chen H, 2005, NATURE, V436, P191, DOI 10.1038/nature03974; Chen HX, 2006, CHINESE J ANAL CHEM, V34, P205; [陈佳娟 CHEN Jia-juan], 2010, [湖北农业科学, Hubei Agricultural Sciences], V49, P635; Chen Q, 2006, ANTIVIRUS, P281; Cirillo G, 2010, J PHARM PHARMACOL, V62, P577, DOI [10.1211/jpp.62.05.0003, 10.1211/jpp/62.05.0003]; Cui Rong, 2012, Zhongcaoyao = Chinese Traditional and Herbal Drugs, V43, P321; Dias ACB, 2008, TALANTA, V76, P988, DOI 10.1016/j.talanta.2008.05.040; Gomez-Caballero A, 2011, BIOSENS BIOELECTRON, V28, P25, DOI 10.1016/j.bios.2011.06.048; Gonzalez-Reiche AS, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0032873, 10.1371/journal.pone.0046852]; Gurtova O, 2013, ANAL BIOANAL CHEM, V405, P287, DOI 10.1007/s00216-012-6493-6; Hayden O, 2006, ADV FUNCT MATER, V16, P1269, DOI 10.1002/adfm.200500626; Huang MX, 2012, J PHARMACEUT BIOMED, V58, P12, DOI 10.1016/j.jpba.2011.09.010; Hurt AC, 2011, NEW ENGL J MED, V365, P2541, DOI 10.1056/NEJMc1111078; Jefferson T, 2006, LANCET, V367, P303, DOI 10.1016/S0140-6736(06)67970-1; Karasova G, 2005, J SEP SCI, V28, P2468, DOI 10.1002/jssc.200500190; Munster VJ, 2009, VACCINE, V27, P6340, DOI 10.1016/j.vaccine.2009.02.082; Nguyen HT, 2012, ANTIVIR RES, V93, P381, DOI 10.1016/j.antiviral.2012.01.006; O'Connor NA, 2007, J AM CHEM SOC, V129, P1680, DOI 10.1021/ja067276c; PU Q-L, 1987, Yaoxue Xuebao, V22, P438; Puoci F, 2011, EXPERT OPIN DRUG DEL, V8, P1379, DOI 10.1517/17425247.2011.609166; Rathbone DL, 2005, ADV DRUG DELIVER REV, V57, P1854, DOI 10.1016/j.addr.2005.07.017; Ryu YB, 2008, BIOORG MED CHEM LETT, V18, P6046, DOI 10.1016/j.bmcl.2008.10.033; Saito R, 2010, PEDIATR INFECT DIS J, V29, P898, DOI 10.1097/INF.0b013e3181de9d24; Seibert CW, 2012, J VIROL, V86, P5386, DOI 10.1128/JVI.00151-12; Szultka M, 2012, ANAL BIOANAL CHEM, V403, P785, DOI 10.1007/s00216-012-5901-2; Tokonami S, 2009, ANAL CHIM ACTA, V641, P7, DOI 10.1016/j.aca.2009.03.035; van Nostrum Cornelus F, 2005, Drug Discov Today Technol, V2, P119, DOI 10.1016/j.ddtec.2005.05.004; Wang SF, 2007, ELECTROPHORESIS, V28, P1399, DOI 10.1002/elps.200600428; Wang Xiao-yan, 2010, Nan Fang Yi Ke Da Xue Xue Bao, V30, P2154; Xie JC, 2002, ANAL CHEM, V74, P2352, DOI 10.1021/ac015755i; Xie JC, 2001, ACTA PHYS-CHIM SIN, V17, P582, DOI 10.3866/PKU.WHXB20010702; Xu SY, 2002, EXPT MODELS RES METH, P1729; Xu Xiaojie, 2006, Drug Discov Today Technol, V3, P247, DOI 10.1016/j.ddtec.2006.09.008; Yan HY, 2012, J CHROMATOGR A, V1256, P1, DOI 10.1016/j.chroma.2012.07.037; Yang YJ, 2012, MOLECULES, V17, P10370, DOI 10.3390/molecules170910370; Yang YJ, 2011, ANAL BIOANAL CHEM, V400, P3665, DOI 10.1007/s00216-011-5063-7; Ye L, 2004, ANAL BIOANAL CHEM, V378, P1887, DOI 10.1007/s00216-003-2450-8; Yu TF, 1993, CHIN TRADIT PATENT M, V15, P32; Zhao Qinqin, 2011, Zhongguo Zhong Yao Za Zhi, V36, P762; Zhou L, 2002, ACTA PHYS-CHIM SIN, V18, P808, DOI 10.3866/PKU.WHXB20020908; Zhu LL, 2003, ANAL CHEM, V75, P6381, DOI 10.1021/ac026371a	43	9	9	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e84458	10.1371/journal.pone.0084458	http://dx.doi.org/10.1371/journal.pone.0084458			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281QS	24386385	Green Submitted, Green Published, gold			2022-12-25	WOS:000329116700108
J	Borg, R; Cauchi, RJ				Borg, Rebecca; Cauchi, Ruben J.			The Gemin Associates of Survival Motor Neuron Are Required for Motor Function in Drosophila	PLOS ONE			English	Article							SPINAL MUSCULAR-ATROPHY; NUCLEAR RIBONUCLEOPROTEIN BIOGENESIS; DEAD-BOX PROTEIN; SMN COMPLEX; MESSENGER-RNA; U-BODIES; SNRNP BIOGENESIS; CIRCUIT FUNCTION; INTERACTION MAP; AXON OUTGROWTH	Membership of the survival motor neuron (SMN) complex extends to nine factors, including the SMN protein, the product of the spinal muscular atrophy (SMA) disease gene, Gemins 2-8 and Unrip. The best-characterised function of this macromolecular machine is the assembly of the Sm-class of uridine-rich small nuclear ribonucleoprotein (snRNP) particles and each SMN complex member has a key role during this process. So far, however, only little is known about the function of the individual Gemin components in vivo. Here, we make use of the Drosophila model organism to uncover loss-of-function phenotypes of Gemin2, Gemin3 and Gemin5, which together with SMN form the minimalistic fly SMN complex. We show that ectopic overexpression of the dead helicase Gem3(Delta N) mutant or knockdown of Gemin3 result in similar motor phenotypes, when restricted to muscle, and in combination cause lethality, hence suggesting that Gem3(Delta N) overexpression mimics a loss-of-function. Based on the localisation pattern of Gem3(Delta N), we predict that the nucleus is the primary site of the antimorphic or dominant-negative mechanism of Gem3(Delta N)-mediated interference. Interestingly, phenotypes induced by human SMN overexpression in Drosophila exhibit similarities to those induced by overexpression of Gem3(Delta N). Through enhanced knockdown we also uncover a requirement of Gemin2, Gemin3 and Gemin5 for viability and motor behaviour, including locomotion as well as flight, in muscle. Notably, in the case of Gemin3 and Gemin5, such function also depends on adequate levels of the respective protein in neurons. Overall, these findings lead us to speculate that absence of any one member is sufficient to arrest the SMN-Gemins complex function in a nucleocentric pathway, which is critical for motor function in vivo.	[Borg, Rebecca; Cauchi, Ruben J.] Univ Malta, Dept Physiol & Biochem, Msida, Malta; [Borg, Rebecca] Univ Malta, Dept Appl Biomed Sci, Msida, Malta	University of Malta; University of Malta	Cauchi, RJ (corresponding author), Univ Malta, Dept Physiol & Biochem, Msida, Malta.	ruben.cauchi@um.edu.mt		Cauchi, Ruben/0000-0001-6150-1608	University of Malta [PHBRP09, MDSIN08-24]; Malta Council for Science & Technology through the National Research & Innovation Programme [RI-2012-066]	University of Malta; Malta Council for Science & Technology through the National Research & Innovation Programme	This work was supported by the University of Malta (PHBRP09; MDSIN08-24) and the Malta Council for Science & Technology through the National Research & Innovation Programme 2012 (R&I-2012-066). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almstead LL, 2007, GENE DEV, V21, P1086, DOI 10.1101/gad.1535607; Baccon J, 2002, J BIOL CHEM, V277, P31957, DOI 10.1074/jbc.M203478200; Baumer D, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S1462399410001523; Baumer D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000773; Battle DJ, 2007, J BIOL CHEM, V282, P27953, DOI 10.1074/jbc.M702317200; Battle DJ, 2006, MOL CELL, V23, P273, DOI 10.1016/j.molcel.2006.05.036; BENZER S, 1973, SCI AM, V229, P24, DOI 10.1038/scientificamerican1273-24; Briese M, 2005, BIOESSAYS, V27, P946, DOI 10.1002/bies.20283; Buckingham M, 2011, EXP CELL RES, V317, P2835, DOI 10.1016/j.yexcr.2011.09.001; Burghes AHM, 2009, NAT REV NEUROSCI, V10, P597, DOI 10.1038/nrn2670; Burt Emma C., 2006, Invertebrate Neuroscience, V6, P145, DOI 10.1007/s10158-006-0027-x; Campbell L, 2000, HUM MOL GENET, V9, P1093, DOI 10.1093/hmg/9.7.1093; Carissimi C, 2006, J BIOL CHEM, V281, P8126, DOI 10.1074/jbc.M512243200; Carissimi C, 2005, FEBS LETT, V579, P2348, DOI 10.1016/j.febslet.2005.03.034; Carissimi C, 2006, J BIOL CHEM, V281, P37009, DOI 10.1074/jbc.M607505200; Carrel TL, 2006, J NEUROSCI, V26, P11014, DOI 10.1523/JNEUROSCI.1637-06.2006; Cauchi RJ, 2006, NEURODEGENER DIS, V3, P338, DOI 10.1159/000097303; Cauchi Ruben J, 2012, BMC Res Notes, V5, P120, DOI 10.1186/1756-0500-5-120; Cauchi RJ, 2011, CELL BIOL INT, V35, P1233, DOI 10.1042/CBI20110147; Cauchi RJ, 2010, BIOESSAYS, V32, P1077, DOI 10.1002/bies.201000088; Cauchi RJ, 2010, EXP CELL RES, V316, P2354, DOI 10.1016/j.yexcr.2010.05.001; Cauchi RJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000265; Chan YB, 2003, HUM MOL GENET, V12, P1367, DOI 10.1093/hmg/ddg157; Chang HCH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003209; Charroux B, 2000, J CELL BIOL, V148, P1177, DOI 10.1083/jcb.148.6.1177; Charroux B, 1999, J CELL BIOL, V147, P1181, DOI 10.1083/jcb.147.6.1181; Crivat G, 2012, TRENDS BIOTECHNOL, V30, P8, DOI 10.1016/j.tibtech.2011.08.002; Dickinson M, 2006, CURR BIOL, V16, pR309, DOI 10.1016/j.cub.2006.03.087; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Dostie J, 2003, RNA, V9, P180, DOI 10.1261/rna.2141503; Fallini C, 2012, BRAIN RES, V1462, P81, DOI 10.1016/j.brainres.2012.01.044; Fallini C, 2011, J NEUROSCI, V31, P3914, DOI 10.1523/JNEUROSCI.3631-10.2011; Feng WQ, 2005, HUM MOL GENET, V14, P1605, DOI 10.1093/hmg/ddi168; Fierro-Monti I, 2006, J PROTEOME RES, V5, P1367, DOI 10.1021/pr0504539; Gabanella F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000921; Gates J, 2004, DEVELOPMENT, V131, P25, DOI 10.1242/dev.00920; Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313; Grice SJ, 2011, BIOESSAYS, V33, P956, DOI 10.1002/bies.201100082; Grice SJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002030; Grimmler M, 2005, HUM MOL GENET, V14, P3099, DOI 10.1093/hmg/ddi343; Gubitz AK, 2002, J BIOL CHEM, V277, P5631, DOI 10.1074/jbc.M109448200; Guruharsha KG, 2012, FLY, V6, P246, DOI 10.4161/fly.22108; HERSKOWITZ I, 1987, NATURE, V329, P219, DOI 10.1038/329219a0; Imlach WL, 2012, CELL, V151, P427, DOI 10.1016/j.cell.2012.09.011; Jablonka S, 2002, P NATL ACAD SCI USA, V99, P10126, DOI 10.1073/pnas.152318699; Klowden M.J., 2007, PHYSL SYSTEMS INSECT; Kolb SJ, 2011, ARCH NEUROL-CHICAGO, V68, P979, DOI 10.1001/archneurol.2011.74; Kolb SJ, 2010, MUSCLE NERVE, V41, P5, DOI 10.1002/mus.21428; Kroiss M, 2008, P NATL ACAD SCI USA, V105, P10045, DOI 10.1073/pnas.0802287105; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lau CK, 2009, NAT STRUCT MOL BIOL, V16, P486, DOI 10.1038/nsmb.1584; Lee L, 2009, DEV BIOL, V332, P142, DOI 10.1016/j.ydbio.2009.05.553; Lemmens R, 2010, TRENDS NEUROSCI, V33, P249, DOI 10.1016/j.tins.2010.02.003; Liu JL, 2007, P NATL ACAD SCI USA, V104, P11655, DOI 10.1073/pnas.0704977104; Liu Q, 1997, CELL, V90, P1013, DOI 10.1016/S0092-8674(00)80367-0; Liu Q, 1996, EMBO J, V15, P3555, DOI 10.1002/j.1460-2075.1996.tb00725.x; Lorson CL, 1998, NAT GENET, V19, P63, DOI 10.1038/ng0598-63; Lotti F, 2012, CELL, V151, P440, DOI 10.1016/j.cell.2012.09.012; McWhorter ML, 2008, DEV NEUROBIOL, V68, P182, DOI 10.1002/dneu.20582; McWhorter ML, 2003, J CELL BIOL, V162, P919, DOI 10.1083/jcb.200303168; Miguel-Aliaga I, 2000, FEBS LETT, V486, P99, DOI 10.1016/S0014-5793(00)02243-2; Mourelatos Z, 2002, GENE DEV, V16, P720, DOI 10.1101/gad.974702; MULLER H. J., 1932, Proceedings. 6th Int. Congr. Genet., V1, P213; Murashov AK, 2007, FASEB J, V21, P656, DOI 10.1096/fj.06-6155com; Nelson PT, 2004, RNA, V10, P387, DOI 10.1261/rna.5181104; Ogawa C, 2007, J BIOL CHEM, V282, P11122, DOI 10.1074/jbc.M609297200; Otter S, 2007, J BIOL CHEM, V282, P5825, DOI 10.1074/jbc.M608528200; Pacheco A, 2009, NUCLEIC ACIDS RES, V37, P582, DOI 10.1093/nar/gkn979; Pellizzoni L, 1999, P NATL ACAD SCI USA, V96, P11167, DOI 10.1073/pnas.96.20.11167; Pellizzoni L, 2002, J BIOL CHEM, V277, P7540, DOI 10.1074/jbc.M110141200; Praveen K, 2012, CELL REPORTS, V1, P624, DOI 10.1016/j.celrep.2012.05.014; Prelich G, 2012, GENETICS, V190, P841, DOI 10.1534/genetics.111.136911; Rajendra TK, 2007, J CELL BIOL, V176, P831, DOI 10.1083/jcb.200610053; Sen A, 2013, P NATL ACAD SCI USA, V110, pE2371, DOI 10.1073/pnas.1301738110; Sheean RK, 2013, DROSOPHILA MELANOGAS, P1; Shpargel KB, 2009, MOL BIOL CELL, V20, P90, DOI 10.1091/mbc.E08-01-0024; Shpargel KB, 2005, P NATL ACAD SCI USA, V102, P17372, DOI 10.1073/pnas.0508947102; Takaku M, 2011, BIOCHEMISTRY-US, V50, P6797, DOI 10.1021/bi200828g; Takizawa Y, 2010, NUCL ACIDS RES; Taylor MV, 2006, MUSCLE DEV DROSOPHIL; Timmerman C, 2012, BRAIN RES, V1489, P66, DOI 10.1016/j.brainres.2012.10.035; Todd AG, 2010, BIOCHEM BIOPH RES CO, V397, P479, DOI 10.1016/j.bbrc.2010.05.139; Todd AG, 2010, BIOCHEM BIOPH RES CO, V394, P211, DOI 10.1016/j.bbrc.2010.02.158; Vigoreaux JO, 2006, MUSCLE DEV DROSOPHIL; Walker MP, 2008, HUM MOL GENET, V17, P3399, DOI 10.1093/hmg/ddn234; Winkler C, 2005, GENE DEV, V19, P2320, DOI 10.1101/gad.342005; Workman E, 2012, BRAIN RES, V1462, P93, DOI 10.1016/j.brainres.2012.02.051; Workman E, 2009, HUM MOL GENET, V18, P2215, DOI 10.1093/hmg/ddp157; Wu YL, 2010, CELL CYCLE, V9, P4080, DOI 10.4161/cc.9.20.13667; Yan XM, 2003, MOL CELL BIOL, V23, P414, DOI 10.1128/MCB.23.1.414-423.2003; Yong J, 2010, MOL CELL, V38, P551, DOI 10.1016/j.molcel.2010.03.014; Young PJ, 2000, HUM MOL GENET, V9, P2869, DOI 10.1093/hmg/9.19.2869; Young PJ, 2000, EXP CELL RES, V256, P365, DOI 10.1006/excr.2000.4858; Zhang HL, 2006, J NEUROSCI, V26, P8622, DOI 10.1523/JNEUROSCI.3967-05.2006; Zhang RD, 2011, CELL, V146, P384, DOI 10.1016/j.cell.2011.06.043; Zhang Z, 2008, CELL, V133, P585, DOI 10.1016/j.cell.2008.03.031	96	21	21	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83878	10.1371/journal.pone.0083878	http://dx.doi.org/10.1371/journal.pone.0083878			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391840	Green Published, Green Submitted, gold			2022-12-25	WOS:000329325200138
J	Garofalo, C; Capristo, M; Manara, MC; Mancarella, C; Landuzzi, L; Belfiore, A; Lollini, PL; Picci, P; Scotlandi, K				Garofalo, Cecilia; Capristo, Mariantonietta; Manara, Maria Cristina; Mancarella, Caterina; Landuzzi, Lorena; Belfiore, Antonino; Lollini, Pier-Luigi; Picci, Piero; Scotlandi, Katia			Metformin as an Adjuvant Drug against Pediatric Sarcomas: Hypoxia Limits Therapeutic Effects of the Drug	PLOS ONE			English	Article							INSULIN-RECEPTOR ISOFORM; HUMAN OSTEOSARCOMA CELLS; EWINGS-SARCOMA; BREAST-CANCER; P-GLYCOPROTEIN; METASTATIC ABILITY; INDUCIBLE FACTOR; AMPK ACTIVATION; IN-VITRO; GROWTH	Metformin, a well-known insulin-sensitizer commonly used for type 2 diabetes therapy, has recently emerged as potentially very attractive drug also in oncology. It is cheap, it is relatively safe and many reports have indicated effects in cancer prevention and therapy. These desirable features are particularly interesting for pediatric sarcomas, a group of rare tumors that have been shown to be dependent on IGF and insulin system for pathogenesis and progression. Metformin exerts anti-mitogenic activity in several cancer histotypes through several molecular mechanisms. In this paper, we analyzed its effects against osteosarcoma, Ewing sarcoma and rhabdomyosarcoma, the three most common pediatric sarcomas. Despite in vitro metformin gave remarkable antiproliferative and chemosensitizing effects both in sensitive and chemoresistant cells, its efficacy was not confirmed against Ewing sarcoma xenografts neither as single agent nor in combination with vincristine. This discrepancy between in vitro and in vivo effects may be due to hypoxia, a common feature of solid tumors. We provide evidences that in hypoxia conditions metformin was not able to activate AMPK and inhibit mTOR signaling, which likely prevents the inhibitory effects of metformin on tumor growth. Thus, although metformin may be considered a useful complement of conventional chemotherapy in normoxia, its therapeutic value in highly hypoxic tumors may be more limited. The impact of hypoxia should be considered when novel therapies are planned for pediatric sarcomas.	[Garofalo, Cecilia; Capristo, Mariantonietta; Manara, Maria Cristina; Mancarella, Caterina; Scotlandi, Katia] Rizzoli Orthoped Inst, CRS Dev Biomol Therapies, Expt Oncol Lab, Bologna, Italy; [Landuzzi, Lorena; Picci, Piero] Rizzoli Orthoped Inst, Expt Oncol Lab, Bologna, Italy; [Belfiore, Antonino] Univ Catanzaro, Dept Hlth, Catanzaro, Italy; [Lollini, Pier-Luigi] Univ Bologna, Dept Expt Diagnost & Specialty Med, Bologna, Italy	IRCCS Istituto Ortopedico Rizzoli; IRCCS Istituto Ortopedico Rizzoli; Magna Graecia University of Catanzaro; University of Bologna	Scotlandi, K (corresponding author), Rizzoli Orthoped Inst, CRS Dev Biomol Therapies, Expt Oncol Lab, Bologna, Italy.	katia.scotlandi@ior.it	Belfiore, Antonino/B-4652-2011; Garofalo, Cecilia/B-3834-2017; Landuzzi, Lorena/J-6511-2016; Scotlandi, Katia/J-9009-2016; Capristo, Mariantonietta/K-7627-2016; Manara, Maria Cristina/K-3366-2018; Mancarella, Caterina/C-7463-2019; Lollini, Pier Luigi/A-7644-2008; Picci, Piero/J-5979-2016	Belfiore, Antonino/0000-0002-6181-4193; Garofalo, Cecilia/0000-0001-5334-8930; Scotlandi, Katia/0000-0001-6114-9499; Capristo, Mariantonietta/0000-0001-9774-3633; Manara, Maria Cristina/0000-0001-5686-720X; Mancarella, Caterina/0000-0002-5778-4251; Landuzzi, Lorena/0000-0001-9879-8118; Lollini, Pier Luigi/0000-0003-1702-4108; Picci, Piero/0000-0002-8519-4101	Italian Association for Cancer Research [MFAG 11584, IG 10452, IG 10353]; Italian Ministry of Health (Ricerca Finalizzata) [1628/2010]; Italian Ministry of Research and Instruction [SFC2EK]	Italian Association for Cancer Research(Fondazione AIRC per la ricerca sul cancro); Italian Ministry of Health (Ricerca Finalizzata)(Ministry of Health, Italy); Italian Ministry of Research and Instruction	This work was funded by: Italian Association for Cancer Research grant (MFAG 11584 to CG; IG 10452 to KS; IG 10353 to PLL); The Italian Ministry of Health (Ricerca Finalizzata 2009 to KS 1628/2010); The Italian Ministry of Research and Instruction grant PRIN2009 cod. SFC2EK to KS. PRIN2009 to PLL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Algire C, 2011, ONCOGENE, V30, P1174, DOI 10.1038/onc.2010.483; [Anonymous], 2012, ANN ONCOL S7, V23, pvii100; Aryee DNT, 2010, CANCER RES, V70, P4015, DOI 10.1158/0008-5472.CAN-09-4333; Asensio-Lopez MC, 2011, FREE RADICAL BIO MED, V51, P1861, DOI 10.1016/j.freeradbiomed.2011.08.015; Avnet S, 2013, BBA-MOL BASIS DIS, V1832, P1105, DOI 10.1016/j.bbadis.2013.04.003; Avnet S, 2009, CANCER RES, V69, P2443, DOI 10.1158/0008-5472.CAN-08-2645; BAGNARA GP, 1990, INT J CELL CLONING, V8, P409, DOI 10.1002/stem.5530080644; Belfiore A, 2009, ENDOCR REV, V30, P586, DOI 10.1210/er.2008-0047; Ben Sahra I, 2011, CANCER RES, V71, P4366, DOI 10.1158/0008-5472.CAN-10-1769; Benini S, 1999, INT J CANCER, V80, P581, DOI 10.1002/(SICI)1097-0215(19990209)80:4<581::AID-IJC16>3.3.CO;2-F; Bodmer M, 2010, DIABETES CARE, V33, P1304, DOI 10.2337/dc09-1791; Buzzai M, 2007, CANCER RES, V67, P6745, DOI 10.1158/0008-5472.CAN-06-4447; Chen GF, 2012, J CLIN ENDOCR METAB, V97, pE510, DOI 10.1210/jc.2011-1754; CHOU TC, 1994, JNCI-J NATL CANCER I, V86, P1517, DOI 10.1093/jnci/86.20.1517; Currie CJ, 2009, DIABETOLOGIA, V52, P1766, DOI 10.1007/s00125-009-1440-6; DEGIOVANNI C, 1989, ANTICANCER RES, V9, P1943; Dowling RJO, 2012, J MOL ENDOCRINOL, V48, pR31, DOI 10.1530/JME-12-0007; Forte V, 2012, CARDIORENAL MED, V2, P143, DOI 10.1159/000337314; Fukuda R, 2007, CELL, V129, P111, DOI 10.1016/j.cell.2007.01.047; Garofalo C, 2011, ONCOGENE, V30, P2730, DOI 10.1038/onc.2010.640; Garofalo C, 2012, MOL ENDOCRINOL, V26, P1603, DOI 10.1210/me.2012-1142; Goodwin PJ, 2009, J CLIN ONCOL, V27, P3271, DOI 10.1200/JCO.2009.22.1630; Hardie DG, 2011, GENE DEV, V25, P1895, DOI 10.1101/gad.17420111; Iliopoulos D, 2011, CANCER RES, V71, P3196, DOI 10.1158/0008-5472.CAN-10-3471; Inoue M, 2012, ENDOCR-RELAT CANCER, V19, pF1, DOI 10.1530/ERC-12-0142; Jordan BF, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00094; Kilic M, 2007, ONCOGENE, V26, P2027, DOI 10.1038/sj.onc.1210008; Kim HG, 2011, BRIT J PHARMACOL, V162, P1096, DOI 10.1111/j.1476-5381.2010.01101.x; Knowles HJ, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-372; Kurmasheva RT, 2009, CANCER RES, V69, P7662, DOI 10.1158/0008-5472.CAN-09-1693; Ladanyi M, 2002, CANCER BIOL THER, V1, P330; Li DH, 2009, GASTROENTEROLOGY, V137, P482, DOI 10.1053/j.gastro.2009.04.013; LOLLINI PL, 1991, INVAS METAST, V11, P116; Magwere T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028558; Malempati S, 2012, PEDIATR BLOOD CANCER, V59, P5, DOI 10.1002/pbc.24118; Manara MC, 2010, CLIN CANCER RES, V16, P530, DOI 10.1158/1078-0432.CCR-09-0816; Mimeault M, 2013, J CELL MOL MED, V17, P30, DOI 10.1111/jcmm.12004; Naing A, 2012, CLIN CANCER RES, V18, P2625, DOI 10.1158/1078-0432.CCR-12-0061; Ohnstad HO, 2013, CANCER-AM CANCER SOC, V119, P1013, DOI 10.1002/cncr.27837; Oliveras-Ferraros C, 2009, CELL CYCLE, V8, P1633, DOI 10.4161/cc.8.10.8406; Olmos D, 2010, LANCET ONCOL, V11, P129, DOI 10.1016/S1470-2045(09)70354-7; Pandini G, 1999, CLIN CANCER RES, V5, P1935; Pappo AS, 2011, J CLIN ONCOL, V29, P4541, DOI 10.1200/JCO.2010.34.0000; Pierotti MA, 2013, ONCOGENE, V32, P1475, DOI 10.1038/onc.2012.181; Pollak M, 2012, NAT REV CANCER, V12, P159, DOI 10.1038/nrc3215; Pollak MN, 2012, CANCER DISCOV, V2, P778, DOI 10.1158/2159-8290.CD-12-0263; Potratz JC, 2010, CANCER RES, V70, P8770, DOI 10.1158/0008-5472.CAN-10-1093; Rocha GZ, 2011, CLIN CANCER RES, V17, P3993, DOI 10.1158/1078-0432.CCR-10-2243; Rozengurt E, 2010, CLIN CANCER RES, V16, P2505, DOI 10.1158/1078-0432.CCR-09-2229; Samani AA, 2007, ENDOCR REV, V28, P20, DOI 10.1210/er.2006-0001; Sciacca L, 2002, ONCOGENE, V21, P8240, DOI 10.1038/sj.onc.1206058; Scotlandi K, 2000, CANCER RES, V60, P5134; Scotlandi K, 2005, CANCER RES, V65, P3868, DOI 10.1158/0008-5472.CAN-04-3192; Scotlandi K, 1999, ONCOGENE, V18, P739, DOI 10.1038/sj.onc.1202330; Scotlandi K, 2002, CLIN CANCER RES, V8, P3893; Scotlandi K, 2008, CURR OPIN ONCOL, V20, P419, DOI 10.1097/CCO.0b013e328302edab; Serra M, 2003, J CLIN ONCOL, V21, P536, DOI 10.1200/JCO.2003.03.144; SHAPIRO DN, 1993, CANCER RES, V53, P5108; Stambolic V, 2009, BREAST CANCER RES TR, V114, P387, DOI 10.1007/s10549-008-0015-4; Subbiah V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018424; Sullivan A, 2004, ONCOGENE, V23, P3328, DOI 10.1038/sj.onc.1207428; Toguchida J, 2009, CANCER SCI, V100, P1573, DOI 10.1111/j.1349-7006.2009.01232.x; Vazquez-Martin A, 2009, CLIN TRANSL ONCOL, V11, P455, DOI 10.1007/s12094-009-0384-0; Wright JL, 2009, CANCER CAUSE CONTROL, V20, P1617, DOI 10.1007/s10552-009-9407-y; Zakikhani M, 2010, BREAST CANCER RES TR, V123, P271, DOI 10.1007/s10549-010-0763-9	65	35	35	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83832	10.1371/journal.pone.0083832	http://dx.doi.org/10.1371/journal.pone.0083832			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391834	Green Published, Green Submitted, gold			2022-12-25	WOS:000329325200132
J	Park, SY; Baek, S; Kim, S; Yoon, SY; Kwon, HS; Chang, YS; Cho, YS; Jang, AS; Park, JW; Nahm, DH; Yoon, HJ; Cho, SH; Cho, YJ; Choi, B; Moon, HB; Kim, TB				Park, So Young; Baek, Seunghee; Kim, Sujeong; Yoon, Sun-young; Kwon, Hyouk-Soo; Chang, Yoon-Seok; Cho, You Sook; Jang, An-Soo; Park, Jung Won; Nahm, Dong-Ho; Yoon, Ho-Joo; Cho, Sang-Heon; Cho, Young-Joo; Choi, ByoungWhui; Moon, Hee-Bom; Kim, Tae-Bum		COREA Study Grp	Clinical Significance of Asthma Clusters by Longitudinal Analysis in Korean Asthma Cohort	PLOS ONE			English	Article							QUALITY-OF-LIFE; ADULT ASTHMA; PHENOTYPES; IDENTIFICATION; PERCEPTION; SEVERITY; DYSPNEA	Background: We have previously identified four distinct groups of asthma patients in Korean cohorts using cluster analysis: (A) smoking asthma, (B) severe obstructive asthma, (C) early-onset atopic asthma, and (D) late-onset mild asthma. Methods and Results: A longitudinal analysis of each cluster in a Korean adult asthma cohort was performed to investigate the clinical significance of asthma clusters over 12 months. Cluster A showed relatively high asthma control test (ACT) scores but relatively low FEV1 scores, despite a high percentage of systemic corticosteroid use. Cluster B had the lowest mean FEV1, ACT, and the quality of life questionnaire for adult Korean asthmatics (QLQAKA) scores throughout the year, even though the percentage of systemic corticosteroid use was the highest among the four clusters. Cluster C was ranked second in terms of FEV1, with the second lowest percentage of systemic corticosteroid use, and showed a marked improvement in subjective symptoms over time. Cluster D consistently showed the highest FEV1, the lowest systemic corticosteroid use, and had high ACT and QLQAKA scores. Conclusion: Our asthma clusters had clinical significance with consistency among clusters over 12 months. These distinctive phenotypes may be useful in classifying asthma in real practice.	[Park, So Young; Kim, Sujeong; Yoon, Sun-young; Kwon, Hyouk-Soo; Cho, You Sook; Moon, Hee-Bom; Kim, Tae-Bum] Univ Ulsan, Coll Med, Asan Med Ctr, Div Allergy & Clin Immunol,Dept Internal Med, Seoul, South Korea; [Baek, Seunghee] Asan Med Ctr, Dept Clin Epidemiol & Biostat, Seoul, South Korea; [Chang, Yoon-Seok; Cho, Sang-Heon] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 151, South Korea; [Jang, An-Soo] Soonchunhyang Univ, Bucheon Hosp, Dept Internal Med, Puchon, South Korea; [Park, Jung Won] Yonsei Univ, Coll Med, Dept Internal Med, Seoul, South Korea; [Nahm, Dong-Ho] Ajou Univ, Coll Med, Dept Internal Med, Suwon 441749, South Korea; [Yoon, Ho-Joo] Hanyang Univ, Coll Med, Dept Internal Med, Seoul 133791, South Korea; [Cho, Young-Joo] Ewha Womans Univ, Coll Med, Dept Internal Med, Seoul, South Korea; [Choi, ByoungWhui] Chung Ang Univ, Coll Med, Dept Internal Med, Seoul 156756, South Korea	University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center; Seoul National University (SNU); Soonchunhyang University; Yonsei University; Yonsei University Health System; Ajou University; Hanyang University; Ewha Womans University; Chung Ang University; Chung Ang University Hospital	Kim, TB (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Div Allergy & Clin Immunol,Dept Internal Med, Seoul, South Korea.	allergy@medimail.co.kr	Chang, Yoon-Seok/J-5628-2012	Chang, Yoon-Seok/0000-0003-3157-0447; Cho, You Sook/0000-0001-8767-2667	Korea Healthcare Technology R&D Project, Ministry of Health and Welfare, Republic of Korea [A102065, HI13C0776]	Korea Healthcare Technology R&D Project, Ministry of Health and Welfare, Republic of Korea	This study was supported by a grant of the Korea Healthcare Technology R&D Project, Ministry of Health and Welfare, Republic of Korea (grant no. A102065 & HI13C0776). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson GP, 2008, LANCET, V372, P1107, DOI 10.1016/S0140-6736(08)61452-X; BALL GH, 1967, BEHAV SCI, V12, P153, DOI 10.1002/bs.3830120210; Bateman ED, 2008, EUR RESPIR J, V31, P143, DOI 10.1183/09031936.00138707; Cnaan A, 1997, STAT MED, V16, P2349, DOI 10.1002/(SICI)1097-0258(19971030)16:20<2349::AID-SIM667>3.0.CO;2-E; Green RH, 2007, CURR OPIN ALLERGY CL, V7, P43, DOI 10.1097/ACI.0b013e3280118a32; Haldar P, 2008, AM J RESP CRIT CARE, V178, P218, DOI 10.1164/rccm.200711-1754OC; Ibrahim JG, 2009, TEST-SPAIN, V18, P1, DOI 10.1007/s11749-009-0138-x; JUNIPER EF, 1992, THORAX, V47, P76, DOI 10.1136/thx.47.2.76; Kim T.B, 2012, EUR RESP J; Kim TB, 2013, EUR RESPIR J, V41, P1308, DOI 10.1183/09031936.00100811; Kim TB, 2009, ANN ALLERG ASTHMA IM, V103, P311, DOI 10.1016/S1081-1206(10)60530-3; Kleis S, 2007, RESP MED, V101, P1426, DOI 10.1016/j.rmed.2007.01.019; Kwon HS, 2008, J KOREAN MED SCI, V23, P621, DOI 10.3346/jkms.2008.23.4.621; Lai CKW, 2011, RESPIROLOGY, V16, P688, DOI 10.1111/j.1440-1843.2011.01954.x; LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876; LENFANT C, 2002, GLOBAL STRATEGY ASTH; Miller MK, 2005, J ALLERGY CLIN IMMUN, V116, P990, DOI 10.1016/j.jaci.2005.08.018; Moore WC, 2010, AM J RESP CRIT CARE, V181, P315, DOI 10.1164/rccm.200906-0896OC; Nathan RA, 2004, J ALLERGY CLIN IMMUN, V113, P59, DOI 10.1016/j.jaci.2003.09.008; Polosa R, 2012, EUR RESP J; Veen JCCMI, 1998, AM J RESP CRIT CARE, V158, P1134, DOI 10.1164/ajrccm.158.4.9710087; Wenzel SE, 2006, LANCET, V368, P804, DOI 10.1016/S0140-6736(06)69290-8; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248	23	11	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83540	10.1371/journal.pone.0083540	http://dx.doi.org/10.1371/journal.pone.0083540			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391784	gold, Green Submitted, Green Published			2022-12-25	WOS:000329325200081
J	Phillips, AC; Sleigh, A; McAllister, CJ; Brage, S; Carpenter, TA; Kemp, GJ; Holland, AJ				Phillips, Alexander C.; Sleigh, Alison; McAllister, Catherine J.; Brage, Soren; Carpenter, T. Adrian; Kemp, Graham J.; Holland, Anthony J.			Defective Mitochondrial Function In Vivo in Skeletal Muscle in Adults with Down's Syndrome: A P-31-MRS Study	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; CHROMOSOME-21 TRISOMY; PRECURSOR PROTEIN; EXERCISE; DYSFUNCTION; METABOLISM; EXPRESSION; OBESITY; BRAINS; GENE	Down's syndrome (DS) is a developmental disorder associated with intellectual disability (ID). We have previously shown that people with DS engage in very low levels of exercise compared to people with ID not due to DS. Many aspects of the DS phenotype, such as dementia, low activity levels and poor muscle tone, are shared with disorders of mitochondrial origin, and mitochondrial dysfunction has been demonstrated in cultured DS tissue. We undertook a phosphorus magnetic resonance spectroscopy (P-31-MRS) study in the quadriceps muscle of 14 people with DS and 11 non-DS ID controls to investigate the post-exercise resynthesis kinetics of phosphocreatine (PCr), which relies on mitochondrial respiratory function and yields a measure of muscle mitochondrial function in vivo. We found that the PCr recovery rate constant was significantly decreased in adults with DS compared to non-DS ID controls (1.7 +/- 0.1 min(-1) vs 2.1 +/- 0.1 min(-1) respectively) who were matched for physical activity levels, indicating that muscle mitochondrial function in vivo is impaired in DS. This is the first study to investigate mitochondrial function in vivo in DS using P-31-MRS. Our study is consistent with previous in vitro studies, supporting a theory of a global mitochondrial defect in DS.	[Phillips, Alexander C.; McAllister, Catherine J.; Holland, Anthony J.] Univ Cambridge, Dept Psychiat, Cambridge, England; [Sleigh, Alison; Carpenter, T. Adrian] Univ Cambridge, Wolfson Brain Imaging Ctr, Cambridge, England; [Brage, Soren] Univ Cambridge, Inst Metab Sci, MRC Epidemiol Unit, Cambridge, England; [Kemp, Graham J.] Univ Liverpool, Dept Musculoskeletal Biol, Liverpool L69 3BX, Merseyside, England	University of Cambridge; University of Cambridge; University of Cambridge; University of Liverpool	Sleigh, A (corresponding author), Univ Cambridge, Wolfson Brain Imaging Ctr, Cambridge, England.	as626@wbic.cam.ac.uk	Brage, Soren/C-6415-2013; Kemp, Graham J/A-7540-2008	Brage, Soren/0000-0002-1265-7355; Kemp, Graham J/0000-0002-8324-9666; Sleigh, Alison/0000-0002-3859-8701; McAllister, Catherine/0000-0001-6147-6449	DS Association; Special Olympics; Health Foundation; National Institute for Health Research (NIHR)/Wellcome Trust Cambridge Clinical Research Facility; NIHR Collaborations in Leadership for Applied Health Research (CLAHRC) for Cambridgeshire and Peterborough; Medical Research Council [MC_UU_12015/3, G0701532, MC_U106179473] Funding Source: researchfish; National Institute for Health Research [NF-SI-0509-10211] Funding Source: researchfish; MRC [G0701532, MC_U106179473, MC_UU_12015/3] Funding Source: UKRI	DS Association; Special Olympics; Health Foundation; National Institute for Health Research (NIHR)/Wellcome Trust Cambridge Clinical Research Facility; NIHR Collaborations in Leadership for Applied Health Research (CLAHRC) for Cambridgeshire and Peterborough; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The study was funded by grants from the DS Association, the Special Olympics and the Health Foundation. ACP was supported by a grant from the DS Association, AS by core staff funding from the National Institute for Health Research (NIHR)/Wellcome Trust Cambridge Clinical Research Facility, and AJH by funding from the Health Foundation and the NIHR Collaborations in Leadership for Applied Health Research (CLAHRC) for Cambridgeshire and Peterborough. The authors are grateful for their support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agiovlasitis S, 2011, MED SCI SPORT EXER, V43, P1322, DOI 10.1249/MSS.0b013e31820936c4; Apabhai S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022294; ARNOLD DL, 1984, MAGNET RESON MED, V1, P307, DOI 10.1002/mrm.1910010303; Askanas V, 1996, P NATL ACAD SCI USA, V93, P1314, DOI 10.1073/pnas.93.3.1314; BELL AJ, 1992, J INTELL DISABIL RES, V36, P359; Busciglio J, 2002, NEURON, V33, P677, DOI 10.1016/S0896-6273(02)00604-9; COLDWELLS A, 1994, ERGONOMICS, V37, P79, DOI 10.1080/00140139408963625; Conti A, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-268; Coskun Pinar E, 2012, Curr Gerontol Geriatr Res, V2012, P383170, DOI 10.1155/2012/383170; Coskun PE, 2010, J ALZHEIMERS DIS, V20, pS293, DOI 10.3233/JAD-2010-100351; Devi L, 2010, BBA-MOL BASIS DIS, V1802, P11, DOI 10.1016/j.bbadis.2009.07.007; EYMAN RK, 1991, AM J MENT RETARD, V95, P603; Frid C, 1999, J INTELL DISABIL RES, V43, P234, DOI 10.1046/j.1365-2788.1999.00198.x; Helguera P, 2013, CELL METAB, V17, P132, DOI 10.1016/j.cmet.2012.12.005; Jawis MN, 2005, BRIT J SPORT MED, V39, P825, DOI 10.1136/bjsm.2004.016915; JOACHIM CL, 1989, NATURE, V341, P226, DOI 10.1038/341226a0; Kemp GJ, 2012, DIABETES, V61, P1927, DOI 10.2337/db11-1725; Kim SH, 2001, J NEURAL TRANSM-SUPP, P109; Kim SH, 2000, CELL MOL LIFE SCI, V57, P1810, DOI 10.1007/PL00000661; LAI F, 1989, ARCH NEUROL-CHICAGO, V46, P849, DOI 10.1001/archneur.1989.00520440031017; Larson-Meyer DE, 2000, AM J PHYSIOL-ENDOC M, V278, pE153, DOI 10.1152/ajpendo.2000.278.1.E153; Lee SH, 2003, MOL CELLS, V15, P181; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; Lytle ME, 2004, ALZ DIS ASSOC DIS, V18, P57, DOI 10.1097/01.wad.0000126614.87955.79; Mendonca GV, 2010, THER CLIN RISK MANAG, V6, P601, DOI 10.2147/TCRM.S10235; Moreira PI, 2006, J ALZHEIMERS DIS, V9, P101; Mortensen SP, 2008, J PHYSIOL-LONDON, V586, P2621, DOI 10.1113/jphysiol.2007.149401; Naressi A, 2001, MAGN RESON MATER PHY, V12, P141, DOI 10.1016/S1352-8661(01)00111-9; Petersen CAH, 2008, P NATL ACAD SCI USA, V105, P13145, DOI 10.1073/pnas.0806192105; Phillips AC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028618; PRINCE J, 1994, J NEURAL TRANSM-PARK, V8, P171, DOI 10.1007/BF02260938; Roizen NJ, 2003, LANCET, V361, P1281, DOI 10.1016/S0140-6736(03)12987-X; Shields N, 2009, ADAPT PHYS ACT Q, V26, P307, DOI 10.1123/apaq.26.4.307; Sleigh A, 2011, J CLIN INVEST, V121, P2457, DOI 10.1172/JCI46405; Stoll C, 1998, ANN GENET-PARIS, V41, P44; TAYLOR DJ, 1994, J NEUROL SCI, V127, P198, DOI 10.1016/0022-510X(94)90073-6; Valenti D, 2010, BIOCHEM J, V431, P299, DOI 10.1042/BJ20100581; Vanhamme L, 1997, J MAGN RESON, V129, P35, DOI 10.1006/jmre.1997.1244; Whitt-Glover Melicia C, 2006, Pediatr Rehabil, V9, P158, DOI 10.1080/13638490500353202	39	19	19	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84031	10.1371/journal.pone.0084031	http://dx.doi.org/10.1371/journal.pone.0084031			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391872	gold, Green Published, Green Submitted			2022-12-25	WOS:000329323900015
J	Stanley, D; Geier, MS; Hughes, RJ; Denman, SE; Moore, RJ				Stanley, Dragana; Geier, Mark S.; Hughes, Robert J.; Denman, Stuart E.; Moore, Robert J.			Highly Variable Microbiota Development in the Chicken Gastrointestinal Tract	PLOS ONE			English	Article							BACTERIAL COMMUNITY; DIVERSITY; IDENTIFICATION; COLONIZATION; MICROFLORA; GUT	Studies investigating the role that complex microbiotas associated with animals and humans play in health and wellbeing have been greatly facilitated by advances in DNA sequencing technology. Due to the still relatively high sequencing costs and the expense of establishing and running animal trials and collecting clinical samples, most of the studies reported in the literature are limited to a single trial and relatively small numbers of samples. Results from different laboratories, investigating similar trials and samples, have often produced quite different pictures of microbiota composition. This study investigated batch to batch variations in chicken cecal microbiota across three similar trials, represented by individually analysed samples from 207 birds. Very different microbiota profiles were found across the three flocks. The flocks also differed in the efficiency of nutrient use as indicated by feed conversion ratios. In addition, large variations in the microbiota of birds within a single trial were noted. It is postulated that the large variability in microbiota composition is due, at least in part, to the lack of colonisation of the chicks by maternally derived bacteria. The high hygiene levels maintained in modern commercial hatcheries, although effective in reducing the burden of specific diseases, may have the undesirable effect of causing highly variable bacterial colonization of the gut. Studies in humans and other animals have previously demonstrated large variations in microbiota composition when comparing individuals from different populations and from different environments but this study shows that even under carefully controlled conditions large variations in microbiota composition still occur.	[Stanley, Dragana; Moore, Robert J.] CSIRO, Anim Food & Hlth Sci, Geelong, Vic, Australia; [Denman, Stuart E.] CSIRO, Anim Food & Hlth Sci, St Lucia, Qld, Australia; [Geier, Mark S.; Hughes, Robert J.] South Australian Res & Dev Inst, Pig & Poultry Prod Inst, Roseworthy, SA, Australia; [Stanley, Dragana; Geier, Mark S.; Hughes, Robert J.; Moore, Robert J.] Univ New England, Poultry Cooperat Res Ctr, Armidale, NSW, Australia; [Geier, Mark S.; Hughes, Robert J.] Univ Adelaide, Sch Anim & Vet Sci, Roseworthy, SA, Australia; [Stanley, Dragana] Cent Queensland Univ, Sch Med & Appl Sci, Rockhampton, Qld 4702, Australia; [Moore, Robert J.] Monash Univ, Dept Microbiol, Clayton, Vic 3168, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO); Commonwealth Scientific & Industrial Research Organisation (CSIRO); South Australian Research & Development Institute (SARDI); University of New England; University of Adelaide; Central Queensland University; Monash University	Moore, RJ (corresponding author), CSIRO, Anim Food & Hlth Sci, Geelong, Vic, Australia.	rob.moore@csiro.au	Moore, Robert J/D-8352-2011; Denman, Stuart E/A-5823-2011; Stanley, Dragana/AAC-2596-2020	Moore, Robert J/0000-0002-0776-5861; Denman, Stuart E/0000-0002-9910-3709; Stanley, Dragana/0000-0001-7019-4726; Geier, Mark/0000-0002-5152-3018	Australian Government's Cooperative Research Centres Program	Australian Government's Cooperative Research Centres Program(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme)	This project was conducted within the Poultry Cooperative Research Centre, established and supported under the Australian Government's Cooperative Research Centres Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adlerberth I, 2006, PEDIATR RES, V59, P96, DOI 10.1203/01.pdr.0000191137.12774.b2; Apajalahti J, 2004, WORLD POULTRY SCI J, V60, P223, DOI 10.1079/WPS200415; Ashelford KE, 2005, APPL ENVIRON MICROB, V71, P7724, DOI 10.1128/AEM.71.12.7724-7736.2005; Callaway TR, 2009, POULTRY SCI, V88, P298, DOI 10.3382/ps.2008-00222; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chessel D., 2004, R NEWS, V4, P5, DOI DOI 10.2307/3780087; Chun J, 2007, INT J SYST EVOL MICR, V57, P2259, DOI 10.1099/ijs.0.64915-0; Cressman MD, 2010, APPL ENVIRON MICROB, V76, P6572, DOI 10.1128/AEM.00180-10; Crhanova M, 2011, INFECT IMMUN, V79, P2755, DOI 10.1128/IAI.01375-10; Danzeisen JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027949; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dominguez-Bello MG, 2010, P NATL ACAD SCI USA, V107, P11971, DOI 10.1073/pnas.1002601107; Durso LM, 2010, APPL ENVIRON MICROB, V76, P4858, DOI 10.1128/AEM.00207-10; Edgar RC, 2011, OTUPIPE OTU CLUSTERI; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Gong JH, 2007, FEMS MICROBIOL ECOL, V59, P147, DOI 10.1111/j.1574-6941.2006.00193.x; Lane DJ, 1991, 16S 23S RRNA SEQUENC, P115; Lee KW, 2010, COMP IMMUNOL MICROB, V33, pE105, DOI 10.1016/j.cimid.2010.06.001; Li KR, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0068157, 10.1371/journal.pone.0084171, 10.1371/journal.pone.0058057, 10.1371/journal.pone.0067018, 10.1371/journal.pone.0063139]; Martin R, 2010, BENEF MICROBES, V1, P367, DOI 10.3920/BM2010.0027; Quinlan AR, 2008, NAT METHODS, V5, P179, DOI 10.1038/NMETH.1172; SALANITRO JP, 1974, APPL MICROBIOL, V27, P678, DOI 10.1128/AEM.27.4.678-687.1974; Sekelja M, 2012, APPL ENVIRON MICROB, V78, P2941, DOI 10.1128/AEM.05391-11; Sekirov I, 2008, INFECT IMMUN, V76, P4726, DOI 10.1128/IAI.00319-08; Snell-Castro R, 2005, FEMS MICROBIOL ECOL, V52, P229, DOI 10.1016/j.femsec.2004.11.016; Stanley D, 2012, APPL MICROBIOL BIOT, V96, P1361, DOI 10.1007/s00253-011-3847-5; Stanley D, 2012, VET MICROBIOL, V159, P155, DOI 10.1016/j.vetmic.2012.03.032; Wise MG, 2007, J APPL MICROBIOL, V102, P1138, DOI 10.1111/j.1365-2672.2006.03153.x; Yu ZT, 2004, BIOTECHNIQUES, V36, P808, DOI 10.2144/04365ST04; Zhu XY, 2002, APPL ENVIRON MICROB, V68, P124, DOI 10.1128/AEM.68.1.124-137.2002	31	171	180	1	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84290	10.1371/journal.pone.0084290	http://dx.doi.org/10.1371/journal.pone.0084290			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391931	Green Published, Green Submitted, gold			2022-12-25	WOS:000329323900074
J	Umemura, M; Koike, H; Nagano, N; Ishii, T; Kawano, J; Yamane, N; Kozone, I; Horimoto, K; Shin-ya, K; Asai, K; Yu, JJ; Bennett, JW; Machida, M				Umemura, Myco; Koike, Hideaki; Nagano, Nozomi; Ishii, Tomoko; Kawano, Jin; Yamane, Noriko; Kozone, Ikuko; Horimoto, Katsuhisa; Shin-ya, Kazuo; Asai, Kiyoshi; Yu, Jiujiang; Bennett, Joan W.; Machida, Masayuki			MIDDAS-M: Motif-Independent De Novo Detection of Secondary Metabolite Gene Clusters through the Integration of Genome Sequencing and Transcriptome Data	PLOS ONE			English	Article							FALSE SMUT BALLS; KOJIC ACID; AFLATOXIN BIOSYNTHESIS; ASPERGILLUS-ORYZAE; IDENTIFICATION; PERSPECTIVE; USTILOXIN; REGIONS	Many bioactive natural products are produced as "secondary metabolites" by plants, bacteria, and fungi. During the middle of the 20th century, several secondary metabolites from fungi revolutionized the pharmaceutical industry, for example, penicillin, lovastatin, and cyclosporine. They are generally biosynthesized by enzymes encoded by clusters of coordinately regulated genes, and several motif-based methods have been developed to detect secondary metabolite biosynthetic (SMB) gene clusters using the sequence information of typical SMB core genes such as polyketide synthases (PKS) and non-ribosomal peptide synthetases (NRPS). However, no detection method exists for SMB gene clusters that are functional and do not include core SMB genes at present. To advance the exploration of SMB gene clusters, especially those without known core genes, we developed MIDDAS-M, a motif-independent de novo detection algorithm for SMB gene clusters. We integrated virtual gene cluster generation in an annotated genome sequence with highly sensitive scoring of the cooperative transcriptional regulation of cluster member genes. MIDDAS-M accurately predicted 38 SMB gene clusters that have been experimentally confirmed and/or predicted by other motif-based methods in 3 fungal strains. MIDDAS-M further identified a new SMB gene cluster for ustiloxin B, which was experimentally validated. Sequence analysis of the cluster genes indicated a novel mechanism for peptide biosynthesis independent of NRPS. Because it is fully computational and independent of empirical knowledge about SMB core genes, MIDDAS-M allows a large-scale, comprehensive analysis of SMB gene clusters, including those with novel biosynthetic mechanisms that do not contain any functionally characterized genes.	[Umemura, Myco; Ishii, Tomoko; Kawano, Jin; Machida, Masayuki] Natl Inst Adv Ind Sci & Technol, Bioprod Res Inst, Sapporo, Hokkaido, Japan; [Koike, Hideaki; Yamane, Noriko] Natl Inst Adv Ind Sci & Technol, Bioprod Res Inst, Tsukuba, Ibaraki, Japan; [Nagano, Nozomi; Asai, Kiyoshi] Natl Inst Adv Ind Sci & Technol, Computat Biol Res Ctr, Koto Ku, Tokyo, Japan; [Kozone, Ikuko; Shin-ya, Kazuo] Japan Biol Informat Consortium, Koto Ku, Tokyo, Japan; [Horimoto, Katsuhisa] Natl Inst Adv Ind Sci & Technol, Mol Profiling Res Ctr Drug Discovery, Koto Ku, Tokyo, Japan; [Shin-ya, Kazuo] Natl Inst Adv Ind Sci & Technol, Biomed Res Inst, Koto Ku, Tokyo, Japan; [Yu, Jiujiang] USDA, Beltsville Agr Reg Res Ctr, Agr Res Serv, Beltsville, MD 20705 USA; [Bennett, Joan W.] Rutgers State Univ, Dept Plant Biol & Pathol, New Brunswick, NJ 08903 USA	National Institute of Advanced Industrial Science & Technology (AIST); National Institute of Advanced Industrial Science & Technology (AIST); National Institute of Advanced Industrial Science & Technology (AIST); National Institute of Advanced Industrial Science & Technology (AIST); National Institute of Advanced Industrial Science & Technology (AIST); United States Department of Agriculture (USDA); Rutgers State University New Brunswick	Machida, M (corresponding author), Natl Inst Adv Ind Sci & Technol, Bioprod Res Inst, Sapporo, Hokkaido, Japan.	m.machida@aist.go.jp	Umemura, Maiko/M-4092-2018; Asai, Kiyoshi/AAT-8344-2020; Bennett, Joan W./AAT-1267-2021; Nagano, Nozomi/A-5717-2017; Shin-ya, Kazuo/L-9613-2018	Umemura, Maiko/0000-0001-8730-1380; Asai, Kiyoshi/0000-0003-0909-4982; Nagano, Nozomi/0000-0002-2779-685X; Shin-ya, Kazuo/0000-0002-4702-0661; Kozone, Ikuko/0000-0001-6298-1121	commission for Development of Artificial Gene Synthesis Technology for Creating Innovative Biomaterial from the Ministry of Economy, Trade and Industry (METI), Japan	commission for Development of Artificial Gene Synthesis Technology for Creating Innovative Biomaterial from the Ministry of Economy, Trade and Industry (METI), Japan	This work was partly supported by the commission for Development of Artificial Gene Synthesis Technology for Creating Innovative Biomaterial from the Ministry of Economy, Trade and Industry (METI), Japan (http://www.meti.go.jp/information/data/c120522aj.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andersen MR, 2013, P NATL ACAD SCI USA, V110, pE99, DOI 10.1073/pnas.1205532110; Apweiler R, 2012, NUCLEIC ACIDS RES, V40, pD71, DOI 10.1093/nar/gkr981; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Bentley R, 2006, NAT PROD REP, V23, P1046, DOI 10.1039/b603758p; Blin K, 2013, NUCLEIC ACIDS RES, V41, pW204, DOI 10.1093/nar/gkt449; Brodhun F, 2011, FEBS J, V278, P1047, DOI 10.1111/j.1742-4658.2011.08027.x; Brown DW, 2012, FUNGAL GENET BIOL, V49, P521, DOI 10.1016/j.fgb.2012.05.010; CABANES J, 1994, J PHARM PHARMACOL, V46, P982, DOI 10.1111/j.2042-7158.1994.tb03253.x; Chang PK, 2009, FUNGAL GENET BIOL, V46, P176, DOI 10.1016/j.fgb.2008.11.002; Chang PK, 2005, FUNGAL GENET BIOL, V42, P914, DOI 10.1016/j.fgb.2005.07.004; Coleman JJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000486; Futamura T, 2001, J BIOSCI BIOENG, V92, P360, DOI 10.1263/jbb.92.360; Galagan JE, 2005, NATURE, V438, P1105, DOI 10.1038/nature04341; Georgianna DR, 2010, MOL PLANT PATHOL, V11, P213, DOI 10.1111/j.1364-3703.2009.00594.x; Georgianna DR, 2009, FUNGAL GENET BIOL, V46, P113, DOI 10.1016/j.fgb.2008.10.011; Hawksworth DL, 2004, STUD MYCOL, P9; Keller NP, 2005, NAT REV MICROBIOL, V3, P937, DOI 10.1038/nrmicro1286; Khaldi N, 2010, FUNGAL GENET BIOL, V47, P736, DOI 10.1016/j.fgb.2010.06.003; KOISO Y, 1994, J ANTIBIOT, V47, P765, DOI 10.7164/antibiotics.47.765; Koiso Y, 1998, J ANTIBIOT, V51, P418, DOI 10.7164/antibiotics.51.418; KOISO Y, 1992, TETRAHEDRON LETT, V33, P4157, DOI 10.1016/S0040-4039(00)74677-6; Kusumoto K, 2000, CURR GENET, V37, P104, DOI 10.1007/s002940050016; Machida M, 2005, NATURE, V438, P1157, DOI 10.1038/nature04300; Machida M, 2008, FOOD ADDIT CONTAM A, V25, P1147, DOI 10.1080/02652030802273114; Marui J, 2011, J BIOSCI BIOENG, V112, P40, DOI 10.1016/j.jbiosc.2011.03.010; Medema MH, 2011, NUCLEIC ACIDS RES, V39, pW339, DOI 10.1093/nar/gkr466; Nicholson MJ, 2009, APPL ENVIRON MICROB, V75, P7469, DOI 10.1128/AEM.02146-08; Nierman WC, 2005, NATURE, V438, P1151, DOI 10.1038/nature04332; Proctor RH, 2003, FUNGAL GENET BIOL, V38, P237, DOI 10.1016/S1087-1845(02)00525-X; Rank C, 2010, ASPERGILLUS: MOLECULAR BIOLOGY AND GENOMICS, P173; Saito K, 1907, BOT MAG TOKYO, V21, P7, DOI [DOI 10.15281/JPLANTRES1887.21.240_7, 10.15281/jplantres1887.21.240_7]; Sanchez JF, 2012, NAT PROD REP, V29, P351, DOI 10.1039/c2np00084a; Tamano K, 2008, FUNGAL GENET BIOL, V45, P139, DOI 10.1016/j.fgb.2007.09.005; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Terabayashi Y, 2010, FUNGAL GENET BIOL, V47, P953, DOI 10.1016/j.fgb.2010.08.014; Umemura M, 2012, DNA RES, V19, P375, DOI 10.1093/dnares/dss019; Wan HM, 2005, J IND MICROBIOL BIOT, V32, P227, DOI 10.1007/s10295-005-0230-5; Weber T, 2009, J BIOTECHNOL, V140, P13, DOI 10.1016/j.jbiotec.2009.01.007; Weitzel C, 2013, PHYTOCHEM REV; Wiemann P, 2009, MOL MICROBIOL, V72, P931, DOI 10.1111/j.1365-2958.2009.06695.x; Yin WB, 2011, J MICROBIOL, V49, P329, DOI 10.1007/s12275-011-1009-1; Yu Jiujiang, 2002, Revista Iberoamericana de Micologia, V19, P191; Yu JJ, 2012, TOXINS, V4, P1024, DOI 10.3390/toxins4111024	45	65	67	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84028	10.1371/journal.pone.0084028	http://dx.doi.org/10.1371/journal.pone.0084028			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391870	Green Published, Green Submitted, gold			2022-12-25	WOS:000329323900013
J	Zhang, T; Guo, YS; Guo, XJ; Zhou, T; Chen, DZ; Xiang, JY; Zhou, ZM				Zhang, Ting; Guo, Yueshuai; Guo, Xuejiang; Zhou, Tao; Chen, Daozhen; Xiang, Jingying; Zhou, Zuomin			Comparative Proteomics Analysis of Placenta from Pregnant Women with Intrahepatic Cholestasis of Pregnancy	PLOS ONE			English	Article							URSODEOXYCHOLIC ACID; APOPTOSIS; CELLS; STRESS; OVEREXPRESSION; IDENTIFICATION; PREECLAMPSIA; PEROXIDATION; EXPRESSION; PATHWAY	Introduction: Intrahepatic cholestasis of pregnancy (ICP) usually occurs in the third trimester and associated with increased risks in fetal complications. Currently, the exact cause of this disease is unknown. In this study we aim to investigate the potential proteins in placenta, which may participate in the molecular mechanisms of ICP-related fetal complications using iTRAQ-based proteomics approach. Methods: The iTRAQ analysis combined with liquid chromatography-tandem mass spectrometry (LC-MS/MS) was performed to separate differentially expressed placental proteins from 4 pregnant women with ICP and 4 healthy pregnant women. Bioinformatics analysis was used to find the relative processes that these differentially expressed proteins were involved in. Three apoptosis related proteins ERp29, PRDX6 and MPO that resulted from iTRAQ-based proteomics were further verified in placenta by Western blotting and immunohistochemistry. Placental apoptosis was also detected by TUNEL assay. Results: Proteomics results showed there were 38 differentially expressed proteins from pregnant women with ICP and healthy pregnant women, 29 were upregulated and 9 were downregulated in placenta from pregnant women with ICP. Bioinformatics analysis showed most of the identified proteins was functionally related to specific cell processes, including apoptosis, oxidative stress, lipid metabolism. The expression levels of ERp29, PRDX6 and MPO were consistent with the proteomics data. The apoptosis index in placenta from ICP patients was significantly increased. Conclusion: This preliminary work provides a better understanding of the proteomic alterations of placenta from pregnant women with ICP and may provide us some new insights into the pathophysiology and potential novel treatment targets for ICP.	[Zhang, Ting; Guo, Yueshuai; Guo, Xuejiang; Zhou, Tao; Zhou, Zuomin] Nanjing Med Univ, Dept Histol & Embryol, State Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China; [Zhang, Ting; Chen, Daozhen; Xiang, Jingying] Nanjing Med Univ, Wuxi Matern & Child Hlth Care Hosp, Wuxi, Peoples R China	Nanjing Medical University; Nanjing Medical University	Chen, DZ (corresponding author), Nanjing Med Univ, Wuxi Matern & Child Hlth Care Hosp, Wuxi, Peoples R China.	chendaozhen@163.com; zhouzm@njmu.edu.cn	Zhou, Tao/H-1094-2013; Guo, Xuejiang/J-9600-2014	Zhou, Tao/0000-0003-2219-6385; Guo, Xuejiang/0000-0002-0475-5705; Guo, Yueshuai/0000-0002-2719-1244; chen, daozhen/0000-0003-4791-8065	National Natural Science Foundation of China [81202043]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (81202043). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bacq Y, 2012, GASTROENTEROLOGY, V143, P1492, DOI 10.1053/j.gastro.2012.08.004; Bambang IF, 2009, LAB INVEST, V89, P1229, DOI 10.1038/labinvest.2009.87; Belkacemi L, 2009, PLACENTA, V30, P739, DOI 10.1016/j.placenta.2009.06.003; Chowdhury I, 2009, FREE RADICAL BIO MED, V46, P146, DOI 10.1016/j.freeradbiomed.2008.09.027; COSTOYA AL, 1980, PLACENTA, V1, P361, DOI 10.1016/S0143-4004(80)80038-5; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Deutsch EW, 2010, PROTEOMICS, V10, P1150, DOI 10.1002/pmic.200900375; Dixon PH, 2009, GUT, V58, P537, DOI 10.1136/gut.2008.159541; El Kebir D, 2008, CIRC RES, V103, P352, DOI 10.1161/01.RES.0000326772.76822.7a; Fang HY, 2011, PHYTOMEDICINE, V18, P697, DOI 10.1016/j.phymed.2010.11.012; Geenes VL, 2011, PLACENTA, V32, P1026, DOI 10.1016/j.placenta.2011.09.006; Geenes V, 2009, WORLD J GASTROENTERO, V15, P2049, DOI 10.3748/wjg.15.2049; Gharesi-Fard B, 2010, PLACENTA, V31, P121, DOI 10.1016/j.placenta.2009.11.004; Glantz A, 2004, HEPATOLOGY, V40, P467, DOI 10.1002/hep.20336; Glantz A, 2008, HEPATOLOGY, V47, P544, DOI 10.1002/hep.21987; Kersey PJ, 2004, PROTEOMICS, V4, P1985, DOI 10.1002/pmic.200300721; Kim YN, 2007, PROTEOM CLIN APPL, V1, P1625, DOI 10.1002/prca.200700034; Lee H, 2005, PLACENTA, V26, P226, DOI 10.1016/j.placenta.2004.05.012; Lee RH, 2009, OBSTET GYNECOL, V113, P528, DOI 10.1097/AOG.0b013e31818db1c9; Manevich Y, 2002, P NATL ACAD SCI USA, V99, P11599, DOI 10.1073/pnas.182384499; Marin JJG, 2003, PLACENTA, V24, P431, DOI 10.1053/plac.2002.0951; Marin Jose J. G., 2004, Current Drug Delivery, V1, P275, DOI 10.2174/1567201043334731; Nikitin A, 2003, BIOINFORMATICS, V19, P2155, DOI 10.1093/bioinformatics/btg290; Pak JH, 2002, J BIOL CHEM, V277, P49927, DOI 10.1074/jbc.M204222200; Perez MJ, 2006, PLACENTA, V27, P34, DOI 10.1016/j.placenta.2004.10.020; Rao RV, 2004, CELL DEATH DIFFER, V11, P372, DOI 10.1038/sj.cdd.4401378; Rook M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028343; Saed GM, 2010, GYNECOL ONCOL, V116, P276, DOI 10.1016/j.ygyno.2009.11.004; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Wei J, 2010, ARCH GYNECOL OBSTET, V281, P801, DOI 10.1007/s00404-009-1156-3; Zhang DH, 2011, INT J BIOCHEM CELL B, V43, P33, DOI 10.1016/j.biocel.2010.09.019; Zhao C, 2009, PROTEOMICS, V9, P1385, DOI 10.1002/pmic.200800353	32	20	24	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83281	10.1371/journal.pone.0083281	http://dx.doi.org/10.1371/journal.pone.0083281			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391750	Green Published, gold, Green Submitted			2022-12-25	WOS:000329325200047
J	Zhang, YH; Xu, XL; Zhou, XJ; Chen, RM; Yang, PL; Meng, QC; Meng, K; Luo, HY; Yuan, JH; Bin Yao, B; Zhang, W				Zhang, Yuhong; Xu, Xiaolu; Zhou, Xiaojin; Chen, Rumei; Yang, Peilong; Meng, Qingchang; Meng, Kun; Luo, Huiying; Yuan, Jianhua; Yao, Bin; Zhang, Wei			Overexpression of an Acidic Endo-beta-1,3-1,4-glucanase in Transgenic Maize Seed for Direct Utilization in Animal Feed	PLOS ONE			English	Article							ACIDOTHERMUS-CELLULOLYTICUS ENDOGLUCANASE; THERMOSTABLE BETA-1,3-1,4-GLUCANASE; NUTRIENT DIGESTIBILITY; BROILER-CHICKENS; BARLEY; EXPRESSION; GLUCANASE; XYLANASE; GLUCOSE; BIOMASS	Background: Incorporation of exogenous glucanase into animal feed is common practice to remove glucan, one of the anti-nutritional factors, for efficient nutrition absorption. The acidic endo-beta-1,3-1,4-glucanase (Bgl7A) from Bispora sp. MEY-1 has excellent properties and represents a potential enzyme supplement to animal feed. Methodology/Principal Findings: Here we successfully developed a transgenic maize producing a high level of Bgl7AM (codon modified Bgl7A) by constructing a recombinant vector driven by the embryo-specific promoter ZM-leg1A. Southern and Western blot analysis indicated the stable integration and specific expression of the transgene in maize seeds over four generations. The beta-glucanase activity of the transgenic maize seeds reached up to 779,800 U/kg, about 236-fold higher than that of non-transgenic maize. The beta-glucanase derived from the transgenic maize seeds had an optimal pH of 4.0 and was stable at pH 1.0-8.0, which is in agreement with the normal environment of digestive tract. Conclusion/Significance: Our study offers a transgenic maize line that could be directly used in animal feed without any glucanase production, purification and supplementation, consequently simplifying the feed enzyme processing procedure.	[Zhang, Yuhong; Zhou, Xiaojin; Chen, Rumei; Zhang, Wei] Chinese Acad Agr Sci, Biotechnol Res Inst, Beijing 100193, Peoples R China; [Xu, Xiaolu; Yang, Peilong; Meng, Kun; Luo, Huiying; Yao, Bin] Chinese Acad Agr Sci, Feed Res Inst, Minist Agr, Key Lab Feed Biotechnol, Beijing 100193, Peoples R China; [Meng, Qingchang; Yuan, Jianhua] Jiangsu Acad Agr Sci, Inst Food Crops, Nanjing, Jiangsu, Peoples R China	Chinese Academy of Agricultural Sciences; Biotechnology Research Institute, CAAS; Chinese Academy of Agricultural Sciences; Feed Research Institute, CAAS; Ministry of Agriculture & Rural Affairs; Jiangsu Academy of Agricultural Sciences	Bin Yao, B (corresponding author), Chinese Acad Agr Sci, Feed Res Inst, Minist Agr, Key Lab Feed Biotechnol, Beijing 100193, Peoples R China.	binyao@caas.cn; zhangwei02@caas.cn			Key Program of Transgenic Plant Breeding [2013ZX08003-002, 2009ZX08003-020B]; China Modern Agriculture Research System [CARS-42]	Key Program of Transgenic Plant Breeding; China Modern Agriculture Research System	This research was supported by the Key Program of Transgenic Plant Breeding 2013ZX08003-002, 2009ZX08003-020B (http://www.nmp.gov.cn/zxjs/zjy/201012/t20101208_2129.htm) and the China Modern Agriculture Research System CARS-42 (http://english.agri.gov.cn/hottopics/five/201304/t20130421_19483.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029302; ALMIRALL M, 1995, J NUTR, V125, P947; Armstrong C. L., 1991, Maize Genetics Cooperation News Letter, P92; Armstrong JD, 2002, AM J POTATO RES, V79, P39, DOI 10.1007/BF02883522; Biswas GCG, 2006, PLANT SCI, V171, P617, DOI 10.1016/j.plantsci.2006.06.004; BULIGA GS, 1986, CARBOHYD RES, V157, P139, DOI 10.1016/0008-6215(86)85065-0; Chen RM, 2008, TRANSGENIC RES, V17, P633, DOI 10.1007/s11248-007-9138-3; Choct M, 2006, WORLD POULTRY SCI J, V62, P5, DOI 10.1079/WPS200480; DENG F, 2009, CHIN AGR SCI B, V25, P7; Flickinger EA, 2000, J NUTR, V130, P1267, DOI 10.1093/jn/130.5.1267; Grishutin SG, 2006, CARBOHYD RES, V341, P218, DOI 10.1016/j.carres.2005.11.011; HOLWERDA BC, 1992, PLANT CELL, V4, P307, DOI 10.1105/tpc.4.3.307; Horvath H, 2000, P NATL ACAD SCI USA, V97, P1914, DOI 10.1073/pnas.030527497; Hua CW, 2010, APPL MICROBIOL BIOT, V88, P509, DOI 10.1007/s00253-010-2759-0; Jensen LG, 1996, P NATL ACAD SCI USA, V93, P3487, DOI 10.1073/pnas.93.8.3487; Jia HY, 2012, J BIOTECHNOL, V159, P50, DOI 10.1016/j.jbiotec.2012.02.007; Jozefiak D, 2010, BRIT POULTRY SCI, V51, P546, DOI 10.1080/00071668.2010.507243; Kiarie E, 2012, LIVEST SCI, V148, P129, DOI 10.1016/j.livsci.2012.05.020; Liu HM, 2010, MOL BIOL REP, V37, P677, DOI 10.1007/s11033-009-9521-7; Luo HY, 2010, APPL MICROBIOL BIOT, V85, P1015, DOI 10.1007/s00253-009-2119-0; Mathlouthi N, 2002, ANIM RES, V51, P395, DOI 10.1051/animres:2002034; McCarthy T, 2003, INT J BIOL MACROMOL, V33, P141, DOI 10.1016/S0141-8130(03)00080-1; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Oraby H, 2007, TRANSGENIC RES, V16, P739, DOI 10.1007/s11248-006-9064-9; Ransom C, 2007, APPL BIOCHEM BIOTECH, V137, P207, DOI 10.1007/s12010-007-9053-3; Ribeiro T, 2012, BRIT POULTRY SCI, V53, P224, DOI 10.1080/00071668.2012.674632; Sridevi G, 2008, PLANT SCI, V175, P283, DOI 10.1016/j.plantsci.2008.04.011; Taylor LE, 2008, TRENDS BIOTECHNOL, V26, P413, DOI 10.1016/j.tibtech.2008.05.002; Tomes D. T., 1995, P197; Verma D, 2010, PLANT BIOTECHNOL J, V8, P332, DOI 10.1111/j.1467-7652.2009.00486.x; von Wettstein D, 2000, P NATL ACAD SCI USA, V97, P13512, DOI 10.1073/pnas.97.25.13512; Wang LL, 2007, J FOOD SCI, V72, pC452, DOI 10.1111/j.1750-3841.2007.00549.x; Woo YM, 2001, PLANT CELL, V13, P2297, DOI 10.1105/tpc.13.10.2297; Yamagata T, 2003, J EXP BOT, V54, P913, DOI 10.1093/jxb/erg090; Zhang Q, 2012, PROTEIN EXPRES PURIF, V82, P279, DOI 10.1016/j.pep.2012.01.011; Ziegler MT, 2000, MOL BREEDING, V6, P37, DOI 10.1023/A:1009667524690	36	4	5	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e81993	10.1371/journal.pone.0081993	http://dx.doi.org/10.1371/journal.pone.0081993			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391711	gold, Green Submitted, Green Published			2022-12-25	WOS:000329325200008
J	Santamaria, CA; Mateos, M; Taiti, S; DeWitt, TJ; Hurtado, LA				Santamaria, Carlos A.; Mateos, Mariana; Taiti, Stefano; DeWitt, Thomas J.; Hurtado, Luis A.			A Complex Evolutionary History in a Remote Archipelago: Phylogeography and Morphometrics of the Hawaiian Endemic Ligia Isopods	PLOS ONE			English	Article							HALOCARIDINA-RUBRA; DIVERSIFICATION; BIOGEOGRAPHY; CONFIDENCE; PHYLOGENY; CRUSTACEA; LIGIIDAE; DIPTERA; ORIGIN; OCCIDENTALIS	Compared to the striking diversification and levels of endemism observed in many terrestrial groups within the Hawaiian Archipelago, marine invertebrates exhibit remarkably lower rates of endemism and diversification. Supralittoral invertebrates restricted to specific coastal patchy habitats, however, have the potential for high levels of allopatric diversification. This is the case of Ligia isopods endemic to the Hawaiian Archipelago, which most likely arose from a rocky supralittoral ancestor that colonized the archipelago via rafting, and diversified into rocky supralittoral and inland lineages. A previous study on populations of this isopod from O. ahu and Kaua. i revealed high levels of allopatric differentiation, and suggested inter-island historical dispersal events have been rare. To gain a better understanding on the diversity and evolution of this group, we expanded prior phylogeographic work by incorporating populations from unsampled main Hawaiian Islands (Maui, Moloka. i, Lana. i, and Hawai. i), increasing the number of gene markers (four mitochondrial and two nuclear genes), and conducting Maximum likelihood and Bayesian phylogenetic analyses. Our study revealed new lineages and expanded the distribution range of several lineages. The phylogeographic patterns of Ligia in the study area are complex, with Hawai. i, O. ahu, and the Maui-Nui islands sharing major lineages, implying multiple inter-island historical dispersal events. In contrast, the oldest and most geographically distant of the major islands (Kaua. i) shares no lineages with the other islands. Our results did not support the monophyly of all the supralittoral lineages (currently grouped into L. hawaiensis), or the monophyly of the terrestrial lineages (currently grouped into L. perkinsi), implying more than one evolutionary transition between coastal and inland forms. Geometric-morphometric analyses of three supralittoral clades revealed significant body shape differences among them. A taxonomic revision of Hawaiian Ligia is warranted. Our results are relevant for the protection of biodiversity found in an environment subject to high pressure from disturbances.	[Santamaria, Carlos A.; Mateos, Mariana; DeWitt, Thomas J.; Hurtado, Luis A.] Texas A&M Univ, Dept Wildlife & Fisheries Sci, College Stn, TX 77843 USA; [Santamaria, Carlos A.] Sam Houston State Univ, Dept Biol Sci, Huntsville, TX 77340 USA; [Taiti, Stefano] CNR, Ist Studio Ecosistemi, Florence, Italy	Texas A&M University System; Texas A&M University College Station; Texas State University System; Sam Houston State University; Consiglio Nazionale delle Ricerche (CNR); Istituto per lo Studio degli Ecosistemi (ISE-CNR)	Hurtado, LA (corresponding author), Texas A&M Univ, Dept Wildlife & Fisheries Sci, College Stn, TX 77843 USA.	lhurtado@tamu.edu	Hurtado, Luis A/B-5953-2008; Santamaria, Carlos A/T-9447-2017; Taiti, Stefano/O-2202-2019; Mateos, Mariana/B-5235-2008	Hurtado, Luis A/0000-0002-9773-4996; Santamaria, Carlos A/0000-0001-8576-463X; Mateos, Mariana/0000-0001-5738-0145; DeWitt, Thomas/0000-0001-7405-3904	Alfred P. Sloan Foundation Minority Ph. D. Program in Mathematics, Science and Engineering Fellowship; National Science Foundation (NSF) [DEB 0743782]; Texas A&M Hispanics Leaders in Agriculture and the Environment Fellowship; Tom Slick Senior Graduate Fellowship; Division Of Environmental Biology [0743782] Funding Source: National Science Foundation	Alfred P. Sloan Foundation Minority Ph. D. Program in Mathematics, Science and Engineering Fellowship; National Science Foundation (NSF)(National Science Foundation (NSF)); Texas A&M Hispanics Leaders in Agriculture and the Environment Fellowship; Tom Slick Senior Graduate Fellowship; Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Fieldwork was partially supported by funds from an Alfred P. Sloan Foundation Minority Ph. D. Program in Mathematics, Science and Engineering Fellowship to CAS. Reagents and laboratory expenses were supported by National Science Foundation (NSF) grant DEB 0743782 to LAH and MM. This grant also provided partial support for CAS. Additional support for CAS was provided by a Texas A&M Hispanics Leaders in Agriculture and the Environment Fellowship, and by the Tom Slick Senior Graduate Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arcangeli A., 1954, Atti Accad Torino Cl Sci fiz mat e nat, V88, P147; Baldwin Bruce G., 1995, P259; Bertocchi S, 2008, J NAT HIST, V42, P2063, DOI 10.1080/00222930802254664; Bird CE, 2011, MOL ECOL, V20, P2128, DOI 10.1111/j.1365-294X.2011.05081.x; Bookstein F. L., 1997, MORPHOMETRIC TOOLS L; Bucklin A, 2011, ANNU REV MAR SCI, V3, P471, DOI 10.1146/annurev-marine-120308-080950; Carefoot T. H., 1995, TERRESTRIAL ISOPOD B, P47; Carefoot TH, 2000, CAN J ZOOL, V78, P588, DOI 10.1139/cjz-78-4-588; CAREFOOT TH, 1973, MAR BIOL, V18, P302; Carson Hampton L., 1995, P14; CARSON HL, 1976, ANNU REV ECOL SYST, V7, P311, DOI 10.1146/annurev.es.07.110176.001523; CARSON HL, 1982, HEREDITY, V48, P3, DOI 10.1038/hdy.1982.2; Carvajal-Rodriguez Antonio, 2006, Iberus, V24, P81; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Craft JD, 2008, LIMNOL OCEANOGR, V53, P675, DOI 10.4319/lo.2008.53.2.0675; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Degnan JH, 2009, TRENDS ECOL EVOL, V24, P332, DOI 10.1016/j.tree.2009.01.009; Eberl R, 2013, J BIOGEOGR, V40, P2361, DOI 10.1111/jbi.12168; Eberl R, 2012, J NAT HIST, V46, P1779, DOI 10.1080/00222933.2012.700334; Eroukhmanoff F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006173; Fleischer RC, 1998, MOL ECOL, V7, P533, DOI 10.1046/j.1365-294x.1998.00364.x; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Francuski L, 2009, ZOOL SCI, V26, P301, DOI 10.2108/zsj.26.301; GILLESPIE RG, 1994, P NATL ACAD SCI USA, V91, P2290, DOI 10.1073/pnas.91.6.2290; Holland BS, 2004, MOL PHYLOGENET EVOL, V32, P588, DOI 10.1016/j.ympev.2004.01.003; Hornung Elisabeth, 2011, Terrestrial Arthropod Reviews, V4, P95, DOI 10.1163/187498311X576262; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hurtado LA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067827; Hurtado LA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011633; Jackson HG, 1922, P ZOOL SOC LOND, V1922, P683; Jordan S, 2005, MOL ECOL, V14, P3457, DOI 10.1111/j.1365-294X.2005.02669.x; Jung J, 2008, MOL CELLS, V25, P523; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Khalaji-Pirbalouty V, 2010, ORG DIVERS EVOL, V10, P135, DOI 10.1007/s13127-010-0003-5; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Langerhans RB, 2004, AM NAT, V164, P335, DOI 10.1086/422857; LEE JD, 1994, CRUSTACEANA, V66, P110, DOI 10.1163/156854094X00198; Lewis P, 2008, PHYCAS SOFTWARE PHYL; Lewis PO, 2005, SYST BIOL, V54, P241, DOI 10.1080/10635150590924208; Lichtwardt R.W., 1986, TRICHOMYCETES FUNGAL; Magnacca KN, 2006, CLADISTICS, V22, P393, DOI 10.1111/j.1096-0031.2006.00119.x; Mateos M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032066; Merritt TJS, 1998, MOL MAR BIOL BIOTECH, V7, P7; Milankov V, 2009, ZOOL J LINN SOC-LOND, V155, P819, DOI 10.1111/j.1096-3642.2008.00462.x; Mitrovski-Bogdanovic A, 2013, ANN ENTOMOL SOC AM, V106, P170, DOI 10.1603/AN12100; Nunomura Noboru, 2011, Bulletin of the Toyama Science Museum, V34, P73; Nunomura Noboru, 2001, Bulletin of the Toyama Science Museum, V24, P1; Nunomura Noburo, 2009, Bulletin of the Toyama Science Museum, V32, P75; Nylander JAA, 2008, BIOINFORMATICS, V24, P581, DOI 10.1093/bioinformatics/btm388; O'Grady P, 2008, BIOL LETTERS, V4, P195, DOI 10.1098/rsbl.2007.0575; Palumbi S. R., 1996, MOL SYSTEMATICS, V2, P205, DOI DOI 10.1080/17451000.2014.902536; Penn O, 2010, MOL BIOL EVOL, V27, P1759, DOI 10.1093/molbev/msq066; Penn O, 2010, NUCLEIC ACIDS RES, V38, pW23, DOI 10.1093/nar/gkq443; Podsiadlowski L, 2005, MAR BIOTECHNOL, V7, P618, DOI 10.1007/s10126-005-0017-8; Price Jonathan Paul, 2004, Pacific Science, V58, P27, DOI 10.1353/psc.2004.0008; Rambaut A, 2009, TRACER V1 5; Rohlf F. J., 2004, TPSDIG VERSION 1 40; Rohlf FJ, 2005, TPSREGR VERSION 1 31; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rubinoff D, 2008, PHILOS T R SOC B, V363, P3459, DOI 10.1098/rstb.2008.0115; Rundell RJ, 2004, MOL PHYLOGENET EVOL, V31, P246, DOI 10.1016/j.ympev.2003.07.014; Santos SR, 2006, MOL ECOL, V15, P2699, DOI 10.1111/j.1365-294X.2006.02965.x; Schmalfuss Helmut, 2003, Stuttgarter Beitraege zur Naturkunde Serie A (Biologie), V654, P1; Schultz G. A, 1974, STUD FAUNA CURACAO, V45, P162; SCHULTZ GA, 1984, J CRUSTACEAN BIOL, V4, P154, DOI 10.2307/1547904; Shimodaira H, 2001, BIOINFORMATICS, V17, P1246, DOI 10.1093/bioinformatics/17.12.1246; Stamatakis A., 2006, P 20 INT PAR DISTR P, DOI DOI 10.1109/IPDPS.2006.1639535; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Sukumaran J, 2010, BIOINFORMATICS, V26, P1569, DOI 10.1093/bioinformatics/btq228; Suzuki Y, 2002, P NATL ACAD SCI USA, V99, P16138, DOI 10.1073/pnas.212646199; Tabachnick B. G., 2001, USING MULTIVARIATE S; Taiti S, 2003, CRUSTACEANA MONOGR, V2, P85; Taiti S., 1991, Bishop Museum Occasional Papers, V31, P202; Taiti Stefano, 2004, V20, P211; Taiti Stefano, 1996, Bishop Museum Occasional Papers, V45, P59; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tarr Cheryl L., 1995, P147; TEMPLETON AR, 1992, GENETICS, V132, P619; Tsang LM, 2008, MOL PHYLOGENET EVOL, V48, P359, DOI 10.1016/j.ympev.2008.04.009; Tsuge Maki, 2008, Bulletin of the Toyama Science Museum, V31, P51; VANDEL ALBERT, 1960, FAUNE DE FRANCE, V64, P1; Wagner WL, 1995, HAWAIIAN BIOGEOGRAPH; Whiting MF, 2002, ZOOL SCR, V31, P93, DOI 10.1046/j.0300-3256.2001.00095.x; Yang, 2006, COMPUTATIONAL MOL EV, P357; Zelditch M.L., 2004, GEOMETRIC MORPHOMETR, DOI DOI 10.1016/B978-0-12-778460-1.X5000-5; Zuykova EI, 2013, HYDROBIOLOGIA, V715, P135, DOI 10.1007/s10750-012-1423-3; Zwickl D., 2006, GARLI GENETIC ALGORI; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]	94	23	26	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e85199	10.1371/journal.pone.0085199	http://dx.doi.org/10.1371/journal.pone.0085199			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386463	Green Published, Green Submitted, gold			2022-12-25	WOS:000329194700131
J	van Wijk, E; Kobayashi, M; van Wijk, R; van der Greef, J				van Wijk, Eduard; Kobayashi, Masaki; van Wijk, Roeland; van der Greef, Jan			Imaging of Ultra-Weak Photon Emission in a Rheumatoid Arthritis Mouse Model	PLOS ONE			English	Article							OXIDATIVE STRESS; CHEMILUMINESCENCE; OXYGEN; CELLS; ACIDS	Ultra-weak photon emission (UPE) of a living system received scientific attention because of its potential for monitoring increased levels of reactive oxygen species (ROS) in the pathogenesis of rheumatoid arthritis (RA). In this study, a highly sensitive cryogenic charge-coupled device (CCD) camera was used to monitor in a RA mouse model the photon emission both without and with luminol. For that purpose, arthritis was induced in mice utilizing a repeated co-administration of type II collagen with lipopolysaccharide. Quantitative imaging of ultra-weak photon emission of the front and back paws of the animals was initiated 70 days after the first injection. All of the animals were measured once without luminol and once again immediately after luminol injection. Data illustrated a higher UPE intensity after initiating arthritis by CII-injection of the animals. The increase in UPE intensity was measured with and without using luminol indicating that this imaging technology may be useful for the future study of human RA.	[van Wijk, Eduard; van Wijk, Roeland; van der Greef, Jan] Leiden Univ, Sino Dutch Ctr Prevent & Personalized Med, Ctr Photon Living Syst, Leiden, Netherlands; [Kobayashi, Masaki] Tohoku Inst Technol, Dept Elect & Intelligent Syst, Sendai, Miyagi 982, Japan; [van Wijk, Eduard; van der Greef, Jan] Leiden Univ, LACDR, Netherlands Metabol Ctr, Div Analyt Biosci, Leiden, Netherlands; [van der Greef, Jan] TNO Netherlands Org Appl Sci Res, Zeist, Netherlands; [van Wijk, Eduard; van Wijk, Roeland] Meluna Res, Geldermalsen, Netherlands; [van Wijk, Eduard] Samueli Inst, Alexandria, VA USA	Leiden University; Leiden University - Excl LUMC; Tohoku Institute Technology; Leiden University; Leiden University - Excl LUMC; Netherlands Organization Applied Science Research	van Wijk, E (corresponding author), Leiden Univ, Sino Dutch Ctr Prevent & Personalized Med, Ctr Photon Living Syst, Leiden, Netherlands.	epa.vanwijk@lacdr.leidenuniv.nl			Samueli Institute of Information Biology; Rockefeller-Samueli Center for Research in Mind-Body Energy	Samueli Institute of Information Biology; Rockefeller-Samueli Center for Research in Mind-Body Energy	This work was supported by an independent research grant from the Samueli Institute of Information Biology and the Rockefeller-Samueli Center for Research in Mind-Body Energy (www.siib.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMANO T, 1995, UROL RES, V23, P315, DOI 10.1007/BF00300020; BOVERIS A, 1980, P NATL ACAD SCI-BIOL, V77, P347, DOI 10.1073/pnas.77.1.347; CADENAS E, 1980, BIOCHEM J, V186, P659, DOI 10.1042/bj1860659; Chen Wei-Tsung, 2004, Mol Imaging, V3, P159, DOI 10.1162/1535350042380290; CILENTO G, 1988, EXPERIENTIA, V44, P572, DOI 10.1007/bf01953304; COURTENAY JS, 1980, NATURE, V283, P666, DOI 10.1038/283666a0; Darlington LG, 2001, BRIT J NUTR, V85, P251, DOI 10.1079/BJN2000239; FAULKNER K, 1993, FREE RADICAL BIO MED, V15, P447, DOI 10.1016/0891-5849(93)90044-U; GRASSO F, 1992, EXPERIENTIA, V48, P10, DOI 10.1007/BF01923595; Hadjigogos K, 2003, PANMINERVA MED, V45, P7; IRIE S, 1960, Curr Ther Res Clin Exp, V2, P107; Ishibashi T, 2013, CURR PHARM DESIGN, V19, P6375; Kobayashi M, 2005, Biophotonics: Optical Science and Engineering for the 21st Century, P155, DOI 10.1007/0-387-24996-6_12; Kobayashi M, 2003, ENERGY AND INFORMATION TRANSFER BIOLOGICAL SYSTEMS, PROCEEDINGS, P157, DOI 10.1142/9789812705181_0008; Kobayashi M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006256; KRUK I, 1989, Z NATURFORSCH C, V44, P895; Kundu S, 2012, FREE RADICAL RES, V46, P1482, DOI 10.3109/10715762.2012.727991; Musumeci F, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1900317; Nakano M., 2005, J BIOLUMIN CHEMILUM, V4, P231, DOI DOI 10.1002/BI0.1170040133; NIGGLI HJ, 1992, J PHOTOCH PHOTOBIO B, V14, P144, DOI 10.1016/1011-1344(92)85090-H; Prasad A, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.8.085004; Prasad A, 2011, J BIOPHOTONICS, V4, P840, DOI 10.1002/jbio.201100073; Prasad A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022345; SCHOLZ W, 1988, CELL BIOPHYS, V13, P55, DOI 10.1007/BF02797365; Stamp LK, 2012, RHEUMATOLOGY, V51, P1796, DOI 10.1093/rheumatology/kes193; Takeda M, 2004, CANCER SCI, V95, P656, DOI 10.1111/j.1349-7006.2004.tb03325.x; Van Wijk R, 2006, J PHOTOCH PHOTOBIO B, V83, P69, DOI 10.1016/j.jphotobiol.2005.12.005; Van Wijk R, 2007, BIOPHOTONICS AND COHERENT SYSTEMS IN BIOLOGY, P177; VANWIJK R, 1993, J PHOTOCH PHOTOBIO B, V18, P75, DOI 10.1016/1011-1344(93)80042-8; VANWIJK R, 1991, CELL BIOPHYS, V18, P15, DOI 10.1007/BF02990513; VANWIJK R, 1988, EXPERIENTIA, V44, P586; WATTS BP, 1995, ARCH BIOCHEM BIOPHYS, V317, P324, DOI 10.1006/abbi.1995.1170; Winyard PG, 2011, BIOCHEM SOC T, V39, P1226, DOI 10.1042/BST0391226; WOOLEY PH, 1981, J EXP MED, V154, P688, DOI 10.1084/jem.154.3.688; Wruck CJ, 2011, ANN RHEUM DIS, V70, P844, DOI 10.1136/ard.2010.132720; Yoshino S, 2000, IMMUNOLOGY, V99, P607, DOI 10.1046/j.1365-2567.2000.00015.x	36	22	25	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e84579	10.1371/journal.pone.0084579	http://dx.doi.org/10.1371/journal.pone.0084579			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386396	Green Submitted, Green Published, gold			2022-12-25	WOS:000329194700112
J	Chang, DK; Li, PC; Lu, RM; Jane, WN; Wu, HC				Chang, De-Kuan; Li, Pi-Chun; Lu, Ruei-Min; Jane, Wann-Neng; Wu, Han-Chung			Peptide-Mediated Liposomal Doxorubicin Enhances Drug Delivery Efficiency and Therapeutic Efficacy in Animal Models	PLOS ONE			English	Article							TUMOR VASCULATURE; ANTI-HER2 IMMUNOLIPOSOMES; CANCER-CELLS; ENDOCYTOSIS; MECHANISM; NANOPARTICLES; CHEMOTHERAPY; EXOCYTOSIS; CARCINOMA; MEMBRANE	Lung cancer ranks among the most common malignancies, and is the leading cause of cancer-related mortality worldwide. Chemotherapy for lung cancer can be made more specific to tumor cells, and less toxic to normal tissues, through the use of ligand-mediated drug delivery systems. In this study, we investigated the targeting mechanism of the ligand-mediated drug delivery system using a peptide, SP5-2, which specifically binds to non-small cell lung cancer (NSCLC) cells. Conjugation of SP5-2 to liposomes enhanced the amount of drug delivered directly into NSCLC cells, through receptor-mediated endocytosis. Functional SP5-2 improved the therapeutic index of Lipo-Dox by enhancing therapeutic efficacy, reducing side effects, and increasing the survival rate of tumor-bearing mice in syngenic, metastatic and orthotopic animal models. Accumulation of SP5-2-conjugated liposomal doxorubicin (SP5-2-LD) in tumor tissues was 11.2-fold higher than that of free doxorubicin, and the area under the concentration-time curve (AUC(0-72) (hours)) was increased 159.2-fold. Furthermore, the experiment of bioavailability was assessed to confirm that SP5-2 elevates the uptake of the liposomal drugs by the tumor cells in vivo. In conclusion, the use of SP5-2-conjugated liposomes enhances pharmacokinetic properties, improves efficacy and safety profiles, and allows for controlled biodistribution and drug release.	[Chang, De-Kuan; Li, Pi-Chun; Lu, Ruei-Min; Wu, Han-Chung] Acad Sinica, Inst Cellular & Organism Biol, Taipei 115, Taiwan; [Jane, Wann-Neng] Acad Sinica, Inst Plant & Microbial Biol, Taipei 115, Taiwan	Academia Sinica - Taiwan; Academia Sinica - Taiwan	Wu, HC (corresponding author), Acad Sinica, Inst Cellular & Organism Biol, Taipei 115, Taiwan.	hcw0928@gate.sinica.edu.tw	Wu, Han-Chung/B-1209-2011; Lu, Ruei-Min/ABF-4388-2021	Wu, Han-Chung/0000-0002-5185-1169; Lu, Ruei-Min/0000-0003-3792-5499	Academia Sinica; National Science Council, Taiwan [NSC-100-2325-B-001-011, NSC-100-2321-B-001-038]	Academia Sinica(Academia Sinica - Taiwan); National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by Academia Sinica and the National Science Council (NSC-100-2325-B-001-011 and NSC-100-2321-B-001-038), Taiwan (to HC Wu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen TM, 2004, SCIENCE, V303, P1818, DOI 10.1126/science.1095833; Allen TM, 2002, NAT REV CANCER, V2, P750, DOI 10.1038/nrc903; Andreopoulou E, 2007, ANN ONCOL, V18, P716, DOI 10.1093/annonc/mdl484; ARTALEJO CR, 1995, P NATL ACAD SCI USA, V92, P8328, DOI 10.1073/pnas.92.18.8328; Baish JW, 1996, MICROVASC RES, V51, P327, DOI 10.1006/mvre.1996.0031; Bosslet K, 1998, CANCER RES, V58, P1195; Cai WB, 2008, NAT PROTOC, V3, P89, DOI 10.1038/nprot.2007.478; Camus P, 2004, BRIT J CANCER, V91, pS18, DOI 10.1038/sj.bjc.6602063; Chang DK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004171; Chinn P, 2003, CANCER IMMUNOL IMMUN, V52, P257, DOI 10.1007/s00262-002-0347-6; Cho KJ, 2008, CLIN CANCER RES, V14, P1310, DOI 10.1158/1078-0432.CCR-07-1441; Dharap SS, 2005, P NATL ACAD SCI USA, V102, P12962, DOI 10.1073/pnas.0504274102; Falciani C, 2011, CHEMMEDCHEM, V6, P678, DOI 10.1002/cmdc.201000463; Farge E, 1999, AM J PHYSIOL-CELL PH, V276, pC725, DOI 10.1152/ajpcell.1999.276.3.C725; FREI E, 1980, AM J MED, V69, P585, DOI 10.1016/0002-9343(80)90472-6; Frei E, 1998, CLIN CANCER RES, V4, P2027; Frenkel V, 2006, ACAD RADIOL, V13, P469, DOI 10.1016/j.acra.2005.08.024; Gay LJ, 2011, NAT REV CANCER, V11, P123, DOI 10.1038/nrc3004; GAZIT Y, 1995, PHYS REV LETT, V75, P2428, DOI 10.1103/PhysRevLett.75.2428; HARAN G, 1993, BIOCHIM BIOPHYS ACTA, V1151, P201, DOI 10.1016/0005-2736(93)90105-9; HARDING C, 1983, J CELL BIOL, V97, P329, DOI 10.1083/jcb.97.2.329; Harrington KJ, 2001, CLIN CANCER RES, V7, P243; Heldin CH, 2004, NAT REV CANCER, V4, P806, DOI 10.1038/nrc1456; Jain RK, 2001, NAT MED, V7, P987, DOI 10.1038/nm0901-987; Kim ES, 2001, LUNG CANCER-J IASLC, V34, P427, DOI 10.1016/S0169-5002(01)00278-1; Kirpotin D, 1997, BIOCHEMISTRY-US, V36, P66, DOI 10.1021/bi962148u; Kok MB, 2009, MAGN RESON MED, V61, P1022, DOI 10.1002/mrm.21910; Laginha KM, 2005, CLIN CANCER RES, V11, P6944, DOI 10.1158/1078-0432.CCR-05-0343; Lee RJ, 1998, BIOSCIENCE REP, V18, P69, DOI 10.1023/A:1020132226113; Lee TY, 2007, CANCER RES, V67, P10958, DOI 10.1158/0008-5472.CAN-07-2233; Lee TY, 2004, CANCER RES, V64, P8002, DOI 10.1158/0008-5472.CAN-04-1948; Li TH, 2010, LUNG CANCER, V68, P89, DOI 10.1016/j.lungcan.2009.05.009; Lo A, 2008, MOL CANCER THER, V7, P579, DOI 10.1158/1535-7163.MCT-07-2359; Lu RM, 2011, BIOMATERIALS, V32, P3265, DOI 10.1016/j.biomaterials.2010.12.061; Maule M, 2007, JNCI-J NATL CANCER I, V99, P790, DOI 10.1093/jnci/djk180; Mayer LD, 1997, J PHARMACOL EXP THER, V280, P1406; MELLMAN I, 1986, ANNU REV BIOCHEM, V55, P663, DOI 10.1146/annurev.biochem.55.1.663; Miller AD, 2003, CURR MED CHEM, V10, P1195, DOI 10.2174/0929867033457485; Miller Andrew D, 2004, Methods Mol Med, V90, P107; Muggia F, 2001, EUR J CANCER, V37, pS15; Mukherjee S, 1997, PHYSIOL REV, V77, P759, DOI 10.1152/physrev.1997.77.3.759; Novello Silvia, 2003, Oncology (Williston Park), V17, P357; Park JW, 2002, CLIN CANCER RES, V8, P1172; Pastorino F, 2006, CANCER RES, V66, P10073, DOI 10.1158/0008-5472.CAN-06-2117; Peto R, 1999, NAT MED, V5, P15, DOI 10.1038/4691; Petros RA, 2010, NAT REV DRUG DISCOV, V9, P615, DOI 10.1038/nrd2591; Provenzano PP, 2012, CANCER CELL, V21, P418, DOI 10.1016/j.ccr.2012.01.007; Ross JS, 2004, AM J CLIN PATHOL, V122, P598, DOI 10.1309/5CWPU41AFR1VYM3F; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Singal PK, 1998, NEW ENGL J MED, V339, P900, DOI 10.1056/NEJM199809243391307; THOMAS P, 1994, J CELL BIOL, V124, P667, DOI 10.1083/jcb.124.5.667; Tseng YL, 2002, MOL PHARMACOL, V62, P864, DOI 10.1124/mol.62.4.864; Voigt W, 2005, METH MOLEC MED, V110, P39; Wu HC, 2010, J ONCOL, V2010, DOI 10.1155/2010/723798; Zuhorn IS, 2002, J MEMBRANE BIOL, V189, P167, DOI 10.1007/s00232-002-1015-7	55	35	36	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e83239	10.1371/journal.pone.0083239	http://dx.doi.org/10.1371/journal.pone.0083239			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281RE	24386166	gold, Green Published, Green Submitted			2022-12-25	WOS:000329117900027
J	Paintain, LS; Kolaczinski, J; Renshaw, M; Filler, S; Kilian, A; Webster, J; Lokko, K; Lynch, M				Paintain, Lucy Smith; Kolaczinski, Jan; Renshaw, Melanie; Filler, Scott; Kilian, Albert; Webster, Jayne; Lokko, Kojo; Lynch, Matthew			Sustaining Fragile Gains: The Need to Maintain Coverage with Long-Lasting Insecticidal Nets for Malaria Control and Likely Implications of Not Doing So	PLOS ONE			English	Article							TREATED NETS; PROTECTIVE EFFICACY; UNIVERSAL COVERAGE; CHILD-MORTALITY; MOSQUITO NETS; IMPACT; SURVIVAL; TANZANIA; AFRICA; MODEL	Global commitment to malaria control has greatly increased over the last decade. Long-lasting insecticidal nets (LLINs) have become a core intervention of national malaria control strategies and over 450 million nets were distributed in sub-Saharan Africa between 2008 and 2012. Despite the impressive gains made as a result of increased investment in to malaria control, such gains remain fragile. Existing funding commitments for LLINs in the pipeline to 2016 were collated for 40 sub-Saharan African countries. The population-based model NetCALC was used to estimate the potential LLIN coverage achievable with these commitments and identify remaining gaps, and the Lives Saved Tool (LiST) was used to estimate likely consequences for mortality impact if these gaps remain unfilled. Overall, countries calculated a total need of 806 million LLINs for 2013-16. Current funding commitments meet just over half of this need, leaving approximately 374 million LLINs unfunded, most of which are needed to maintain coverage in 2015 and 2016. An estimated additional 938,500 child lives (uncertainty range: 559,400-1,364,200) could be saved from 2013 through 2016 with existing funding (relative to 2009 LLIN coverage taken as the 'baseline' for this analysis); if the funding gap were closed this would increase to 1,180,500 lives saved (uncertainty range: 707,000-1,718,900). Overall, the funding gap equates to approximately 242,000 avoidable malaria-attributable deaths amongst under-fives. Substantial additional resources will need to be mobilized to meet the full LLIN need of sub-Saharan countries to maintain universal coverage. Unless these resources are mobilized, the impressive gains made to date will not be sustained and tens of thousands of avoidable child deaths will occur.	[Paintain, Lucy Smith; Webster, Jayne] London Sch Hyg & Trop Med, Dept Dis Control, London WC1, England; [Kolaczinski, Jan; Filler, Scott] Global Fund Fight AIDS TB & Malaria, Strategy Investment & Impact Div, Geneva, Switzerland; [Renshaw, Melanie] African Leaders Malaria Alliance, Geneva, Switzerland; [Kilian, Albert] Trop Hlth LLP, Montagut, Girona, Spain; [Lokko, Kojo; Lynch, Matthew] Johns Hopkins Univ, Ctr Commun Programs, Bloomberg Sch Publ Hlth, Baltimore, MD USA	University of London; London School of Hygiene & Tropical Medicine; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Paintain, LS (corresponding author), London Sch Hyg & Trop Med, Dept Dis Control, London WC1, England.	Lucy.Paintain@lshtm.ac.uk		Webster, Jayne/0000-0002-0498-8883	United States Agency for International Development (USAID) under the terms of USAID/JHU Cooperative Agreement [GHS-A-00-09-00014-00]	United States Agency for International Development (USAID) under the terms of USAID/JHU Cooperative Agreement(United States Agency for International Development (USAID))	This study was made possible by the generous support of the American people through the United States Agency for International Development (USAID) under the terms of USAID/JHU Cooperative Agreement No. GHS-A-00-09-00014-00 for the NetWorks Project. The contents are the responsibility of the authors and do not necessarily reflect the views of USAID or the United States Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulla S, 2001, BMJ-BRIT MED J, V322, P270, DOI 10.1136/bmj.322.7281.270; [Anonymous], GLOB MAL ACT PLAN; [Anonymous], 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000363.PUB2; [Anonymous], RES MOB STRAT 2012 2; Briet OJT, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-20; Cairns M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1879; Cohen JM, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-122; Craig MH, 1999, PARASITOL TODAY, V15, P105, DOI 10.1016/S0169-4758(99)01396-4; Eisele TP, 2010, INT J EPIDEMIOL, V39, P88, DOI 10.1093/ije/dyq026; Fegan GW, 2007, LANCET, V370, P1035, DOI 10.1016/S0140-6736(07)61477-9; Gatton ML, 2013, EVOLUTION, V67, P1218, DOI 10.1111/evo.12063; Kilian A, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-330; Kilian A, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-49; Koenker HM, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-150; Korenromp EL, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-94; Larsen DA, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S3-S34; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; O'Meara WP, 2010, LANCET INFECT DIS, V10, P545, DOI 10.1016/S1473-3099(10)70096-7; Okell LC, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-327; Schellenberg JRMA, 2001, LANCET, V357, P1241, DOI 10.1016/S0140-6736(00)04404-4; Thwing J, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S3-S14; UN General Assembly, 2012, GEN ASS CALLS ACC EF; UNPOP, 2006, WORLD POP PROSP 2006; Webster J, 2007, HEALTH POLICY PLANN, V22, P277, DOI 10.1093/heapol/czm021; WHO, 2012, WORLD MALARIA REPORT 2012, P1; WHO, 2010, WORLD MALARIA REPORT 2010, P1; Willey BA, 2012, B WORLD HEALTH ORGAN, V90, P672, DOI 10.2471/BLT.11.094771; Winfrey W, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S3-S32; Yukich J, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-174	29	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e83816	10.1371/journal.pone.0083816	http://dx.doi.org/10.1371/journal.pone.0083816			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281RE	24386283	Green Submitted, Green Published, gold, Green Accepted			2022-12-25	WOS:000329117900060
J	Tsang, TM; Wiese, JS; Felek, S; Kronshage, M; Krukonis, ES				Tsang, Tiffany M.; Wiese, Jeffrey S.; Felek, Suleyman; Kronshage, Malte; Krukonis, Eric S.			Ail Proteins of Yersinia pestis and Y-pseudotuberculosis Have Different Cell Binding and Invasion Activities	PLOS ONE			English	Article							OUTER-MEMBRANE PROTEIN; ESCHERICHIA-COLI; EPITHELIAL-CELLS; YOP DELIVERY; BACTERIAL ATTACHMENT; MEDIATES BINDING; PLAGUE VIRULENCE; HOST-CELLS; O-ANTIGEN; FACTOR-H	The Yersinia pestis adhesin Ail mediates host cell binding and facilitates delivery of cytotoxic Yop proteins. Ail from Y. pestis and Y. pseudotuberculosis is identical except for one or two amino acids at positions 43 and 126 depending on the Y. pseudotuberculosis strain. Ail from Y. pseudotuberculosis strain YPIII has been reported to lack host cell binding ability, thus we sought to determine which amino acid difference(s) are responsible for the difference in cell adhesion. Y. pseudotuberculosis YPIII Ail expressed in Escherichia coli bound host cells, albeit at -50% the capacity of Y. pestis Ail. Y. pestis Ail single mutants, Ail-E43D and Ail-F126V, both have decreased adhesion and invasion in E. coli when compared to wildtype Y. pestis Ail. Y. pseudotuberculosis YPIII Ail also had decreased binding to the Ail substrate fibronectin, relative to Y. pestis Ail in E. coli. When expressed in Y. pestis, there was a 30-50% decrease in adhesion and invasion depending on the substitution. Ail-mediated Yop delivery by both Y. pestis Ail and Y. pseudotuberculosis Ail were similar when expressed in Y. pestis, with only Ail-F126V giving a statistically significant reduction in Yop delivery of 25%. In contrast to results in E. coli and Y. pestis, expression of Ail in Y. pseudotuberculosis led to no measurable adhesion or invasion, suggesting the longer LPS of Y. pseudotuberculosis interferes with Ail cell-binding activity. Thus, host context affects the binding activities of Ail and both Y. pestis and Y. pseudotuberculosis Ail can mediate cell binding, cell invasion and facilitate Yop delivery.	[Tsang, Tiffany M.; Krukonis, Eric S.] Univ Michigan, Sch Med Ann Arbor, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA; [Wiese, Jeffrey S.; Krukonis, Eric S.] Univ Detroit, Dept Biomed & Diagnost Sci, Mercy Sch Dent, Detroit, MI 48221 USA; [Felek, Suleyman; Kronshage, Malte] Univ Michigan, Sch Dent, Dept Biol & Mat Sci, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Detroit Mercy; University of Michigan System; University of Michigan	Krukonis, ES (corresponding author), Univ Michigan, Sch Med Ann Arbor, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA.	krukones@udmercy.edu			NIH [R03 AI092318, R21 AI090194]; University of Michigan Department of Microbiology and Immunology; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI090194, R03AI092318] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Michigan Department of Microbiology and Immunology; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH grants R03 AI092318 and R21 AI090194 to ESK and the Dr. Frances Wang Chin Fellowship to TMT from the University of Michigan Department of Microbiology and Immunology. The funders of the work had no role in study design, data collection or the decision to publish.	Achtman M, 2004, P NATL ACAD SCI USA, V101, P17837, DOI 10.1073/pnas.0408026101; Bartra SS, 2008, INFECT IMMUN, V76, P612, DOI 10.1128/IAI.01125-07; Biedzka-Sarek M, 2008, INFECT IMMUN, V76, P5016, DOI 10.1128/IAI.00314-08; BLISKA JB, 1993, INFECT IMMUN, V61, P3914, DOI 10.1128/IAI.61.9.3914-3921.1993; BLISKA JB, 1992, P NATL ACAD SCI USA, V89, P3561, DOI 10.1073/pnas.89.8.3561; BLOMFIELD IC, 1991, MOL MICROBIOL, V5, P1439, DOI 10.1111/j.1365-2958.1991.tb00790.x; Boyd A.P., 2001, PRINCIPLES BACTERIAL, P227; Boyd AP, 2000, EUR J CELL BIOL, V79, P659, DOI 10.1078/0171-9335-00098; Cornelis GR, 1998, MICROBIOL MOL BIOL R, V62, P1315, DOI 10.1128/MMBR.62.4.1315-1352.1998; Cowan C, 2000, INFECT IMMUN, V68, P4523, DOI 10.1128/IAI.68.8.4523-4530.2000; Eitel J, 2002, INFECT IMMUN, V70, P4880, DOI 10.1128/IAI.70.9.4880-4891.2002; Felek S, 2010, INFECT IMMUN, V78, P4134, DOI 10.1128/IAI.00167-10; Felek S, 2009, INFECT IMMUN, V77, P825, DOI 10.1128/IAI.00913-08; Fernandez C, 2001, FEBS LETT, V504, P173, DOI 10.1016/S0014-5793(01)02742-9; FURSTE JP, 1986, GENE, V48, P119, DOI 10.1016/0378-1119(86)90358-6; HEESEMANN J, 1987, FEMS MICROBIOL LETT, V40, P37, DOI 10.1016/0378-1097(87)90512-X; Ho DK, 2012, J IMMUNOL, V189, P3593, DOI 10.4049/jimmunol.1201145; Ho DK, 2012, J IMMUNOL, V188, P4450, DOI 10.4049/jimmunol.1103149; Isberg RR, 2000, MICROBES INFECT, V2, P793, DOI 10.1016/S1286-4579(00)90364-2; ISBERG RR, 1987, CELL, V50, P769, DOI 10.1016/0092-8674(87)90335-7; Kirjavainen V, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000140; Kolodziejek AM, 2007, MICROBIOL-SGM, V153, P2941, DOI 10.1099/mic.0.2006/005694-0; Kolodziejek AM, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00103; Kolodziejek AM, 2010, INFECT IMMUN, V78, P5233, DOI 10.1128/IAI.00783-10; Krasikova IN, 2000, BIOCHEMISTRY-MOSCOW+, V65, P1272; Kukkonen M, 2004, MOL MICROBIOL, V51, P215, DOI 10.1046/j.1365-2958.2003.03817.x; Lahteenmaki K, 1998, INFECT IMMUN, V66, P5755; LINDLER LE, 1990, INFECT IMMUN, V58, P2569, DOI 10.1128/IAI.58.8.2569-2577.1990; Makarova O, 2000, BIOTECHNIQUES, V29, P970, DOI 10.2144/00295bm08; MILLER VL, 1990, J BACTERIOL, V172, P1062, DOI 10.1128/jb.172.2.1062-1069.1990; MILLER VL, 1988, INFECT IMMUN, V56, P1242, DOI 10.1128/IAI.56.5.1242-1248.1988; Miller VL, 2001, MOL MICROBIOL, V41, P1053, DOI 10.1046/j.1365-2958.2001.02575.x; MORALES VM, 1991, GENE, V97, P39, DOI 10.1016/0378-1119(91)90007-X; MOSHER DF, 1980, SCIENCE, V209, P927, DOI 10.1126/science.7403857; PATTI JM, 1994, ANNU REV MICROBIOL, V48, P585, DOI 10.1146/annurev.mi.48.100194.003101; Perry RD, 1997, CLIN MICROBIOL REV, V10, P35, DOI 10.1128/CMR.10.1.35; PIERSON DE, 1993, INFECT IMMUN, V61, P1846, DOI 10.1128/IAI.61.5.1846-1852.1993; ROSQVIST R, 1990, MOL MICROBIOL, V4, P657, DOI 10.1111/j.1365-2958.1990.tb00635.x; Skurnik M, 2003, CARBOHYD RES, V338, P2521, DOI 10.1016/S0008-6215(03)00305-7; Skurnik M, 2000, MOL MICROBIOL, V37, P316, DOI 10.1046/j.1365-2958.2000.01993.x; TERTTI R, 1992, INFECT IMMUN, V60, P3021, DOI 10.1128/IAI.60.7.3021-3024.1992; Tsang TM, 2012, J BIOL CHEM, V287, P16759, DOI 10.1074/jbc.M112.358978; Tsang TM, 2010, INFECT IMMUN, V78, P3358, DOI 10.1128/IAI.00238-10; Vogt J, 1999, STRUCTURE, V7, P1301, DOI 10.1016/S0969-2126(00)80063-5; WACHTEL MR, 1995, INFECT IMMUN, V63, P2541, DOI 10.1128/IAI.63.7.2541-2548.1995; Yamashita S, 2011, STRUCTURE, V19, P1672, DOI 10.1016/j.str.2011.08.010; YANG YX, 1993, INFECT IMMUN, V61, P3907, DOI 10.1128/IAI.61.9.3907-3913.1993; Yang YX, 1996, INFECT IMMUN, V64, P2483, DOI 10.1128/IAI.64.7.2483-2489.1996	48	26	27	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e83621	10.1371/journal.pone.0083621	http://dx.doi.org/10.1371/journal.pone.0083621			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281RE	24386237	Green Published, gold, Green Submitted			2022-12-25	WOS:000329117900047
J	Xiang, J; deGrauw, X; Korman, AM; Allen, JR; O'Brien, HL; Kabbouche, MA; Powers, SW; Hershey, AD				Xiang, Jing; deGrauw, Xinyao; Korman, Abraham M.; Allen, Janelle R.; O'Brien, Hope L.; Kabbouche, Marielle A.; Powers, Scott W.; Hershey, Andrew D.			Neuromagnetic Abnormality of Motor Cortical Activation and Phases of Headache Attacks in Childhood Migraine	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; HIGH-FREQUENCY OSCILLATIONS; VISUAL-CORTEX EXCITABILITY; HEMIPLEGIC MIGRAINE; EVOKED POTENTIALS; EPILEPSY; AURA; HYPEREXCITABILITY; DIAGNOSIS; SIGNALS	The cerebral cortex serves a primary role in the pathogenesis of migraine. This aberrant brain activation in migraine can be noninvasively detected with magnetoencephalography (MEG). The objective of this study was to investigate the differences in motor cortical activation between attacks (ictal) and pain free intervals (interictal) in children and adolescents with migraine using both low-and high-frequency neuromagnetic signals. Thirty subjects with an acute migraine and 30 subjects with a history of migraine, while pain free, were compared to age-and gender-matched controls using MEG. Motor cortical activation was elicited by a standardized, validated finger-tapping task. Low-frequency brain activation (1 similar to 50 Hz) was analyzed with waveform measurements and high-frequency oscillations (65-150 Hz) were analyzed with wavelet-based beamforming. MEG waveforms showed that the ictal latency of low-frequency brain activation was significantly delayed as compared with controls, while the interictal latency of brain activation was similar to that of controls. The ictal amplitude of low-frequency brain activation was significantly increased as compared with controls, while the interictal amplitude of brain activation was similar to that of controls. The ictal source power of high-frequency oscillations was significantly stronger than that of the controls, while the interictal source power of high-frequency oscillations was significantly weaker than that of controls. The results suggest that aberrant low-frequency brain activation in migraine during a headache attack returned to normal interictally. However, high-frequency oscillations changed from ictal hyper-activation to interictal hypo-activation. Noninvasive assessment of cortical abnormality in migraine with MEG opens a new window for developing novel therapeutic strategies for childhood migraine by maintaining a balanced cortical excitability.	[Xiang, Jing; deGrauw, Xinyao; Korman, Abraham M.; O'Brien, Hope L.; Kabbouche, Marielle A.; Hershey, Andrew D.] Cincinnati Childrens Hosp Med Ctr, Div Neurol, Cincinnati, OH 45229 USA; [Xiang, Jing; O'Brien, Hope L.; Kabbouche, Marielle A.; Hershey, Andrew D.] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH USA; [Allen, Janelle R.; Powers, Scott W.] Cincinnati Childrens Hosp Med Ctr, Div Behav Med & Clin Psychol, Cincinnati, OH 45229 USA	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center	Xiang, J (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Neurol, Cincinnati, OH 45229 USA.	jing.xiang@cchmc.org	O'Brien, Hope Lorraine/AHB-9810-2022; Hershey, Andrew D./K-1245-2019; O'Brien, Hope/AAZ-9717-2020	Hershey, Andrew D./0000-0002-1598-7536; Powers, Scott/0000-0002-5348-9650; Xiang, Jing/0000-0003-0242-5590	National Institute of Neurological Disorders and Stroke (NINDS), National Institutes of Health [R21NS072817]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS072817] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke (NINDS), National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The project described was supported by Grant Number R21NS072817 from the National Institute of Neurological Disorders and Stroke (NINDS), National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aurora SK, 1999, CEPHALALGIA, V19, P708, DOI 10.1046/j.1468-2982.1999.019008708.x; Bartos M, 2007, NAT REV NEUROSCI, V8, P45, DOI 10.1038/nrn2044; Bianchin MM, 2010, CURR PAIN HEADACHE R, V14, P276, DOI 10.1007/s11916-010-0121-y; Bigal ME, 2008, HEADACHE, V48, P1157, DOI 10.1111/j.1526-4610.2008.01217.x; Bigal ME, 2003, EPILEPSY BEHAV, V4, pS13, DOI 10.1016/j.yebeh.2003.07.003; Bohotin V, 2003, CEPHALALGIA, V23, P264, DOI 10.1046/j.1468-2982.2003.00475.x; Bowyer SM, 2005, J CLIN NEUROPHYSIOL, V22, P65, DOI 10.1097/01.WNP.0000150928.23523.A9; Bowyer SM, 1999, BRAIN RES, V843, P79, DOI 10.1016/S0006-8993(99)01893-4; Bowyer SM, 2001, ANN NEUROL, V50, P582, DOI 10.1002/ana.1293; Bramanti P, 2005, FUNCT NEUROL, V20, P29; Brighina F, 2010, CEPHALALGIA, V30, P46, DOI 10.1111/j.1468-2982.2009.01870.x; Brigo F, 2012, J HEADACHE PAIN, V13, P339, DOI 10.1007/s10194-012-0445-6; Caraballo R, 2009, J CHILD NEUROL, V24, P1536, DOI 10.1177/0883073809332395; Chen WT, 2009, CEPHALALGIA, V29, P1202, DOI 10.1111/j.1468-2982.2009.01857.x; Chen WT, 2012, CEPHALALGIA, V32, P537, DOI 10.1177/0333102412443337; Chen WT, 2011, BRAIN, V134, P2387, DOI 10.1093/brain/awr157; Clarke T, 2009, EPILEPSIA, V50, P2428, DOI 10.1111/j.1528-1167.2009.02240.x; Conforto AB, 2012, J HEADACHE PAIN, V13, P29, DOI 10.1007/s10194-011-0379-4; Conte A, 2010, PAIN, V148, P43, DOI 10.1016/j.pain.2009.09.031; Coppola G, 2007, CEPHALALGIA, V27, P803, DOI 10.1111/j.1468-2982.2007.01323.x; Coppola G, 2012, CEPHALALGIA, V32, P700, DOI 10.1177/0333102412446313; Coppola G, 2012, CURR PAIN HEADACHE R, V16, P93, DOI 10.1007/s11916-011-0231-1; de Tommaso M, 2010, J HEADACHE PAIN, V11, P505, DOI 10.1007/s10194-010-0247-7; DENOORDHOUT AM, 1992, ELECTROEN CLIN NEURO, V85, P110, DOI 10.1016/0168-5597(92)90076-N; Esposito M, 2012, EUR J PEDIATR, V171, P1599, DOI 10.1007/s00431-012-1759-8; FRIBERG L, 1987, BRAIN, V110, P917, DOI 10.1093/brain/110.4.917; Fumal A, 2003, ACTA NEUROL BELG, V103, P144; Guo XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050095; Hall SD, 2004, HEADACHE, V44, P204, DOI 10.1111/j.1526-4610.2004.04048.x; Haut SR, 2006, LANCET NEUROL, V5, P148, DOI 10.1016/S1474-4422(06)70348-9; Hershey AD, 2005, PEDIATR ANN, V34, P426, DOI 10.3928/0090-4481-20050601-04; Hershey AD, 2005, HEADACHE, V45, P1288, DOI 10.1111/j.1526-4610.2005.00260.x; Hershey AD, 2010, PEDIATR ANN, V39, P416, DOI 10.3928/00904481-20100623-06; Hershey AD, 2010, CURR OPIN NEUROL, V23, P249, DOI 10.1097/WCO.0b013e3283391888; Hershey AD, 2010, LANCET NEUROL, V9, P190, DOI 10.1016/S1474-4422(09)70303-5; Huo XL, 2011, BRAIN TOPOGR, V23, P375, DOI 10.1007/s10548-010-0151-0; Huo XL, 2010, BRAIN DEV-JPN, V32, P619, DOI 10.1016/j.braindev.2009.09.021; Jen JC, 1993, FAMILIAL HEMIPLEGIC; Kedia S, 2012, HEADACHE, V52, P674, DOI 10.1111/j.1526-4610.2012.02116.x; Khedr EM, 2006, NEUROPHYSIOL CLIN, V36, P13, DOI 10.1016/j.neucli.2006.01.007; Korostenskaja M, 2011, INT J NEUROSCI, V121, P355, DOI 10.3109/00207454.2011.560312; Korostenskaja M, 2010, EPILEPSY RES, V92, P63, DOI 10.1016/j.eplepsyres.2010.08.008; Lewis DW, 2009, NEUROL CLIN, V27, P481, DOI 10.1016/j.ncl.2008.11.003; Lipton RB, 2004, JAMA-J AM MED ASSOC, V291, P493, DOI 10.1001/jama.291.4.493; Lipton RB, 2010, NEUROTHERAPEUTICS, V7, P204, DOI 10.1016/j.nurt.2010.03.002; Lo YL, 2010, NAT REV NEUROL, V6, P425, DOI 10.1038/nrneurol.2010.109; Mackert B M, 2004, Neurol Clin Neurophysiol, V2004, P41; Magis D, 2011, CURR OPIN NEUROL, V24, P203, DOI 10.1097/WCO.0b013e3283462c3f; Minks E, 2010, BIOMED PAP, V154, P133, DOI 10.5507/bp.2010.020; Papadelis C, 2011, NEUROIMAGE, V54, P60, DOI 10.1016/j.neuroimage.2010.07.054; Papadelis C, 2009, CLIN NEUROPHYSIOL, V120, P1958, DOI 10.1016/j.clinph.2009.08.018; Piccinelli P, 2006, HEADACHE, V46, P413, DOI 10.1111/j.1526-4610.2006.00373.x; Rapoport A, 2011, NEUROL SCI, V32, pS105, DOI 10.1007/s10072-011-0542-3; Restuccia D, 2012, CLIN NEUROPHYSIOL, V123, P2050, DOI 10.1016/j.clinph.2012.03.009; Sakai Y, 2008, NEUROLOGY, V70, P431, DOI 10.1212/01.wnl.0000299095.65331.6f; Sand T, 2003, CEPHALALGIA, V23, P5, DOI 10.1046/j.1468-2982.2003.00570.x; Sankar R, 2004, NEUROLOGY, V63, pS30, DOI 10.1212/WNL.63.10_suppl_4.S30; Scherer P, 1997, ACTA NEUROL SCAND, V96, P392; Siniatchkin M, 2012, CEREB CORTEX, V22, P2207, DOI 10.1093/cercor/bhr248; SORGE F, 1988, CEPHALALGIA, V8, P1, DOI 10.1046/j.1468-2982.1988.0801001.x; Teepker M, 2010, CEPHALALGIA, V30, P137, DOI 10.1111/j.1468-2982.2009.01911.x; Toldo I, 2011, CEPHALALGIA, V31, P751, DOI 10.1177/0333102410392068; Turk W R, 2000, Adv Pediatr, V47, P161; Vincent MB, 2011, CEPHALALGIA, V31, P13, DOI 10.1177/0333102410372424; Wang XS, 2010, HEADACHE, V50, P1005, DOI 10.1111/j.1526-4610.2010.01674.x; Wang YY, 2011, CLIN NEUROPHYSIOL, V122, P1706, DOI 10.1016/j.clinph.2011.02.008; Ward TN, 2010, HEADACHE, V50, P1629, DOI 10.1111/j.1526-4610.2010.01786.x; Wilke M, 2008, NEUROIMAGE, V41, P903, DOI 10.1016/j.neuroimage.2008.02.056; Xiang J, 2013, J PAIN; Xiang J, 2010, J NEUROS-PEDIATR, V5, P113, DOI 10.3171/2009.8.PEDS09345; Yoshino A, 2012, J PAIN, V13, P628, DOI 10.1016/j.jpain.2011.12.005; Young WB, 2007, J NEUROL NEUROSUR PS, V78, P600, DOI 10.1136/jnnp.2006.100214; Yu DH, 2012, NMR BIOMED, V25, P806, DOI 10.1002/nbm.1796; Zach V, 2010, J HEADACHE PAIN, V11, P79, DOI 10.1007/s10194-009-0181-8	74	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e83669	10.1371/journal.pone.0083669	http://dx.doi.org/10.1371/journal.pone.0083669			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281RE	24386250	Green Published, Green Submitted, gold			2022-12-25	WOS:000329117900051
J	Destici, E; Jacobs, EH; Tamanini, F; Loos, M; van der Horst, GTJ; Oklejewicz, M				Destici, Eugin; Jacobs, Edwin H.; Tamanini, Filippo; Loos, Maarten; van der Horst, Gijsbertus T. J.; Oklejewicz, Malgorzata			Altered Phase-Relationship between Peripheral Oscillators and Environmental Time in Cry1 or Cry2 Deficient Mouse Models for Early and Late Chronotypes	PLOS ONE			English	Article							INTRINSIC CIRCADIAN CLOCK; GENE-EXPRESSION; IN-VITRO; RHYTHMS; TRANSCRIPTION; LIVER; PACEMAKER; MUTATION; DBP; CORTICOSTERONE	The mammalian circadian system is composed of a light-entrainable central clock in the suprachiasmatic nuclei (SCN) of the brain and peripheral clocks in virtually any other tissue. It allows the organism to optimally adjust metabolic, physiological and behavioral functions to the physiological needs it will have at specific time of the day. According to the resonance theory, such rhythms are only advantageous to an organism when in tune with the environment, which is illustrated by the adverse health effects originating from chronic circadian disruption by jetlag and shift work. Using short-period Cry1 and long-period Cry2 deficient mice as models for morningness and eveningness, respectively, we explored the effect of chronotype on the phase relationship between the central SCN clock and peripheral clocks in other organs. Whereas the behavioral activity patterns and circadian gene expression in the SCN of light-entrained Cry1(-/-) and Cry2(-/-) mice largely overlapped with that of wild type mice, expression of clock and clock controlled genes in liver, kidney, small intestine, and skin was shown to be markedly phase-advanced or phase-delayed, respectively. Likewise, circadian rhythms in urinary corticosterone were shown to display a significantly altered phase relationship similar to that of gene expression in peripheral tissues. We show that the daily dissonance between peripheral clocks and the environment did not affect the lifespan of Cry1(-/-) or Cry2(-/-) mice. Nonetheless, the phase-shifted peripheral clocks in light-entrained mice with morningness and eveningness-like phenotypes may have implications for personalized preventive and therapeutic (i.e. chronomodulation-based) health care for people with early and late chronotypes.	[Destici, Eugin; Jacobs, Edwin H.; Tamanini, Filippo; van der Horst, Gijsbertus T. J.; Oklejewicz, Malgorzata] Erasmus MC, Ctr Biomed Genet, Dept Genet, Rotterdam, Netherlands; [Loos, Maarten] Vrije Univ Amsterdam, Dept Mol & Cellular Neurobiol, Ctr Neurogen & Cognit Res, Amsterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Vrije Universiteit Amsterdam	van der Horst, GTJ (corresponding author), Erasmus MC, Ctr Biomed Genet, Dept Genet, Rotterdam, Netherlands.	g.vanderhorst@erasmusmc.nl; m.oklejewicz@erasmusmc.nl	van der Horst, Gijsbertus TJ/E-3661-2015; Loos, Maarten/A-2768-2012	van der Horst, Gijsbertus TJ/0000-0002-7773-6396; Loos, Maarten/0000-0003-1629-2928; Destici, Eugin/0000-0002-8472-1766	ZonMW Vici grant [918.36.619]; Neuro-Bsik [BSIK03053]; "EUCLOCK" [LSHG-CT-2006-018741]	ZonMW Vici grant; Neuro-Bsik; "EUCLOCK"(European Commission)	This work was supported by ZonMW Vici grant no. 918.36.619; Neuro-Bsik BSIK03053; and "EUCLOCK" LSHG-CT-2006-018741. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bell-Pedersen D, 2005, NAT REV GENET, V6, P544, DOI 10.1038/nrg1633; Brown S, 2005, AM POETRY REV, V34, P3; Brown SA, 2008, P NATL ACAD SCI USA, V105, P1602, DOI 10.1073/pnas.0707772105; Cheng MY, 2002, NATURE, V417, P405, DOI 10.1038/417405a; Damiola F, 2000, GENE DEV, V14, P2950, DOI 10.1101/gad.183500; Dickmeis T, 2009, J ENDOCRINOL, V200, P3, DOI 10.1677/JOE-08-0415; Do MTH, 2010, PHYSIOL REV, V90, P1547, DOI 10.1152/physrev.00013.2010; Duffy JF, 2001, BEHAV NEUROSCI, V115, P895, DOI 10.1037//0735-7044.115.4.895; Filipski E, 2004, CANCER RES, V64, P7879, DOI 10.1158/0008-5472.CAN-04-0674; Froy O, 2010, ENDOCR REV, V31, P1, DOI 10.1210/er.2009-0014; Fu LN, 2003, NAT REV CANCER, V3, P350, DOI 10.1038/nrc1072; Gachon F, 2006, CELL METAB, V4, P25, DOI 10.1016/j.cmet.2006.04.015; Guo HN, 2005, P NATL ACAD SCI USA, V102, P3111, DOI 10.1073/pnas.0409734102; Hughes ME, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000442; Hurd MW, 1998, J BIOL RHYTHM, V13, P430, DOI 10.1177/074873098129000255; Jilg A, 2010, HIPPOCAMPUS, V20, P377, DOI 10.1002/hipo.20637; Kornmann B, 2007, PLOS BIOL, V5, P179, DOI 10.1371/journal.pbio.0050034; Lamia KA, 2008, P NATL ACAD SCI USA, V105, P15172, DOI 10.1073/pnas.0806717105; Liu AC, 2007, CELL, V129, P605, DOI 10.1016/j.cell.2007.02.047; Martino TA, 2008, AM J PHYSIOL-REG I, V294, pR1675, DOI 10.1152/ajpregu.00829.2007; MEIER AH, 1976, ENDOCRINOLOGY, V98, P1475, DOI 10.1210/endo-98-6-1475; MOORE RY, 1972, BRAIN RES, V42, P201, DOI 10.1016/0006-8993(72)90054-6; Mrosovsky N, 1999, CHRONOBIOL INT, V16, P415, DOI 10.3109/07420529908998717; Novakova M, 2013, CHRONOBIOL INT, V30, P607, DOI 10.3109/07420528.2012.754455; OTTENWELLER JE, 1982, ENDOCRINOLOGY, V111, P1334, DOI 10.1210/endo-111-4-1334; Pagani L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013376; Pan XY, 2009, J LIPID RES, V50, P1800, DOI 10.1194/jlr.M900085-JLR200; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Pendergast JS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008552; Pendergast JS, 2009, J NEUROSCI, V29, P14681, DOI 10.1523/JNEUROSCI.3261-09.2009; PITTENDR.CS, 1972, P NATL ACAD SCI USA, V69, P1537, DOI 10.1073/pnas.69.6.1537; PITTENDRIGH CS, 1960, COLD SPRING HARB SYM, V25, P159, DOI 10.1101/SQB.1960.025.01.015; Ptacek LJ, 2007, COLD SPRING HARB SYM, V72, P273; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Ripperger JA, 2000, GENE DEV, V14, P679; Ripperger JRA, 2006, NAT GENET, V38, P369, DOI 10.1038/ng1738; Roenneberg T, 2004, CURR BIOL, V14, pR1038, DOI 10.1016/j.cub.2004.11.039; Schmidt C, 2009, SCIENCE, V324, P516, DOI 10.1126/science.1167337; Sewlall Seshni, 2010, Current Drug Delivery, V7, P370, DOI 10.2174/156720110793566236; Sosniyenko S, 2010, AM J PHYSIOL-REG I, V298, pR959, DOI 10.1152/ajpregu.00561.2009; Sosniyenko S, 2009, EUR J NEUROSCI, V30, P1802, DOI 10.1111/j.1460-9568.2009.06945.x; Spoelstra K, 2004, J BIOL RHYTHM, V19, P518, DOI 10.1177/0748730404268122; STEPHAN FK, 1972, P NATL ACAD SCI USA, V69, P1583, DOI 10.1073/pnas.69.6.1583; Stokkan KA, 2001, SCIENCE, V291, P490, DOI 10.1126/science.291.5503.490; Storch KF, 2007, CELL, V130, P730, DOI 10.1016/j.cell.2007.06.045; Storch KF, 2002, NATURE, V417, P78, DOI 10.1038/nature744; Stratmann M, 2010, GENE DEV, V24, P1317, DOI 10.1101/gad.578810; Sumova A, 2003, J BIOL RHYTHM, V18, P134, DOI 10.1177/0748730403251801; Takahashi JS, 2008, NAT REV GENET, V9, P764, DOI 10.1038/nrg2430; Thorpe JB, 2012, HORM METAB RES, V44, P429, DOI 10.1055/s-0032-1306307; Toh KL, 2001, SCIENCE, V291, P1040, DOI 10.1126/science.1057499; Ueda HR, 2002, NATURE, V418, P534, DOI 10.1038/nature00906; UEDA HR, 2007, COLD SPRING HARB SYM, V72, P365; van der Horst GTJ, 1999, NATURE, V398, P627, DOI 10.1038/19323; Vollmers C, 2009, P NATL ACAD SCI USA, V106, P21453, DOI 10.1073/pnas.0909591106; Wittmann M, 2006, CHRONOBIOL INT, V23, P497, DOI 10.1080/07420520500545979; Woelfle MA, 2004, CURR BIOL, V14, P1481, DOI 10.1016/j.cub.2004.08.023; Xu Y, 2007, CELL, V128, P59, DOI 10.1016/j.cell.2006.11.043; Xu Y, 2005, NATURE, V434, P640, DOI 10.1038/nature03453; Yagita K, 2001, SCIENCE, V292, P278, DOI 10.1126/science.1059542; Yan OY, 1998, P NATL ACAD SCI USA, V95, P8660, DOI 10.1073/pnas.95.15.8660; Yang XY, 2006, CELL, V126, P801, DOI 10.1016/j.cell.2006.06.050; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101	63	14	15	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e83602	10.1371/journal.pone.0083602	http://dx.doi.org/10.1371/journal.pone.0083602			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281QS	24386234	Green Published, gold, Green Submitted			2022-12-25	WOS:000329116700063
J	Debiec, R; Christofidou, P; Denniff, M; Bloomer, LD; Bogdanski, P; Wojnar, L; Musialik, K; Charchar, FJ; Thompson, JR; Waterworth, D; Song, KJ; Vollenweider, P; Waeber, G; Zukowska-Szczechowska, E; Samani, NJ; Lambert, D; Tomaszewski, M				Debiec, Radoslaw; Christofidou, Paraskevi; Denniff, Matthew; Bloomer, Lisa D.; Bogdanski, Pawel; Wojnar, Lukasz; Musialik, Katarzyna; Charchar, Fadi J.; Thompson, John R.; Waterworth, Dawn; Song, Kijoung; Vollenweider, Peter; Waeber, Gerard; Zukowska-Szczechowska, Ewa; Samani, Nilesh J.; Lambert, David; Tomaszewski, Maciej			Urotensin-II System in Genetic Control of Blood Pressure and Renal Function	PLOS ONE			English	Article							ESSENTIAL-HYPERTENSION; RECEPTOR GENE; ASSOCIATION; RAT; EXPRESSION; LINKAGE; PEPTIDE; IMMUNOREACTIVITY; VASOCONSTRICTOR; POLYMORPHISMS	Urotensin-II controls ion/water homeostasis in fish and vascular tone in rodents. We hypothesised that common genetic variants in urotensin-II pathway genes are associated with human blood pressure or renal function. We performed family-based analysis of association between blood pressure, glomerular filtration and genes of the urotensin-II pathway (urotensin-II, urotensin-II related peptide, urotensin-II receptor) saturated with 28 tagging single nucleotide polymorphisms in 2024 individuals from 520 families; followed by an independent replication in 420 families and 7545 unrelated subjects. The expression studies of the urotensin-II pathway were carried out in 97 human kidneys. Phylogenetic evolutionary analysis was conducted in 17 vertebrate species. One single nucleotide polymorphism (rs531485 in urotensin-II gene) was associated with adjusted estimated glomerular filtration rate in the discovery cohort (p = 0.0005). It showed no association with estimated glomerular filtration rate in the combined replication resource of 8724 subjects from 6 populations. Expression of urotensin-II and its receptor showed strong linear correlation (r = 0.86, p<0.0001). There was no difference in renal expression of urotensin-II system between hypertensive and normotensive subjects. Evolutionary analysis revealed accumulation of mutations in urotensin-II since the divergence of primates and weaker conservation of urotensin-II receptor in primates than in lower vertebrates. Our data suggest that urotensin-II system genes are unlikely to play a major role in genetic control of human blood pressure or renal function. The signatures of evolutionary forces acting on urotensin-II system indicate that it may have evolved towards loss of function since the divergence of primates.	[Debiec, Radoslaw; Christofidou, Paraskevi; Denniff, Matthew; Bloomer, Lisa D.; Thompson, John R.; Samani, Nilesh J.; Lambert, David; Tomaszewski, Maciej] Univ Leicester, Dept Cardiovasc Sci, Leicester, Leics, England; [Bogdanski, Pawel; Musialik, Katarzyna] Med Univ Poznan, Dept Internal Med Metab Disorders & Hypertens, Poznan, Poland; [Wojnar, Lukasz] Med Univ Poznan, Dept Urol & Oncol Urol, Poznan, Poland; [Charchar, Fadi J.] Univ Ballarat, Sch Sci & Engn, Ballarat, Vic 3353, Australia; [Waterworth, Dawn; Song, Kijoung] GlaxoSmithKline, Philadelphia, PA USA; [Vollenweider, Peter; Waeber, Gerard] CHU Vaudois, Dept Med, CH-1011 Lausanne, Switzerland; [Zukowska-Szczechowska, Ewa] Med Univ Silesia, Dept Internal Med Diabetol & Nephrol, Zabrze, Poland	University of Leicester; Poznan University of Medical Sciences; Poznan University of Medical Sciences; Federation University Australia; GlaxoSmithKline; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Medical University Silesia	Tomaszewski, M (corresponding author), Univ Leicester, Dept Cardiovasc Sci, Leicester, Leics, England.	mt142@le.ac.uk	Bogdański, Paweł/ABB-2938-2020; Charchar, Fadi/I-6656-2017; Colaus, PsyColaus/K-6607-2013	Bogdański, Paweł/0000-0002-0563-1624; Charchar, Fadi/0000-0002-6164-9941; Waeber, Gerard/0000-0003-4193-788X; Musialik, Katarzyna Maria/0000-0003-3299-5455; Tomaszewski, Maciej/0000-0001-8215-6567; Debiec, Radoslaw/0000-0003-2292-467X	University of Leicester Anniversary Scholarship; National Institute for Health Research [ACF-2012-11-001] Funding Source: researchfish	University of Leicester Anniversary Scholarship; National Institute for Health Research(National Institute for Health Research (NIHR))	This study was supported by the University of Leicester Anniversary Scholarship to RD, DL and MT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiyar N, 2004, PEPTIDES, V25, P1339, DOI 10.1016/j.peptides.2004.05.015; Almasy L, 1998, AM J HUM GENET, V62, P1198, DOI 10.1086/301844; Ames RS, 1999, NATURE, V401, P282, DOI 10.1038/45809; Behm DJ, 2004, EUR J PHARMACOL, V492, P113, DOI 10.1016/j.ejphar.2004.03.059; Burton P, 1998, STAT MED, V17, P1261, DOI 10.1002/(SICI)1097-0258(19980615)17:11<1261::AID-SIM846>3.0.CO;2-Z; Charles CJ, 2005, PEPTIDES, V26, P2211, DOI 10.1016/j.peptides.2005.03.043; Cheung BMY, 2004, J HYPERTENS, V22, P1341, DOI 10.1097/01.hjh.0000125452.28861.f1; Coulouarn Y, 1999, FEBS LETT, V457, P28, DOI 10.1016/S0014-5793(99)01003-0; Coulouarn Y, 1998, P NATL ACAD SCI USA, V95, P15803, DOI 10.1073/pnas.95.26.15803; Deeks~ JJ, 2001, SYSTEMATIC REV HLTH; Delport W, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000885; DEWARDENER HE, 1978, AM J PHYSIOL, V235, pF163, DOI 10.1152/ajprenal.1978.235.3.F163; Dikensoy E, 2010, EUR J OBSTET GYN R B, V151, P140, DOI 10.1016/j.ejogrb.2010.03.030; Douglas SA, 2004, TRENDS PHARMACOL SCI, V25, P76, DOI 10.1016/j.tips.2003.12.005; Douglas SA, 2002, LANCET, V359, P1990, DOI 10.1016/S0140-6736(02)08831-1; Douglas SA, 2000, BRIT J PHARMACOL, V131, P1262, DOI 10.1038/sj.bjp.0703690; Firmann M, 2008, BMC CARDIOVASC DISOR, V8, DOI 10.1186/1471-2261-8-6; Hanada K, 2007, MOL BIOL EVOL, V24, P2235, DOI 10.1093/molbev/msm152; Hassan GS, 2005, PEPTIDES, V26, P2464, DOI 10.1016/j.peptides.2005.05.028; Heringlake M, 2004, REGUL PEPTIDES, V121, P129, DOI 10.1016/j.regpep.2004.04.012; Keating BJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003583; Langham RG, 2004, AM J KIDNEY DIS, V44, P826, DOI 10.1053/j.ajkd.2004.07.021; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Mancia G, 2007, J HYPERTENS, V25, P1751, DOI 10.1097/HJH.0b013e3282f0580f; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Marco J, 2008, PEPTIDES, V29, P852, DOI 10.1016/j.peptides.2007.08.025; Matsushita M, 2001, J HYPERTENS, V19, P2185, DOI 10.1097/00004872-200112000-00011; McCormick SD, 2001, AM ZOOL, V41, P781, DOI 10.1668/0003-1569(2001)041[0781:ECOOIT]2.0.CO;2; Nyholt DR, 2004, AM J HUM GENET, V74, P765, DOI 10.1086/383251; Ong KL, 2006, PEPTIDES, V27, P1659, DOI 10.1016/j.peptides.2006.02.008; PEARSON D, 1980, P NATL ACAD SCI-BIOL, V77, P5021, DOI 10.1073/pnas.77.8.5021; Poirot O, 2003, NUCLEIC ACIDS RES, V31, P3503, DOI 10.1093/nar/gkg522; Price AL, 2010, NAT REV GENET, V11, P459, DOI 10.1038/nrg2813; Prosser HCG, 2006, PEPTIDES, V27, P3261, DOI 10.1016/j.peptides.2006.09.012; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Shenouda A, 2002, J HISTOCHEM CYTOCHEM, V50, P885, DOI 10.1177/002215540205000702; Shi Y, 2008, PEPTIDES, V29, P783, DOI 10.1016/j.peptides.2008.02.015; Tobin MD, 2008, HYPERTENSION, V51, P1658, DOI 10.1161/HYPERTENSIONAHA.108.112664; Tobin MD, 2005, STAT MED, V24, P2911, DOI 10.1002/sim.2165; Tomaszewski M, 2002, HYPERTENSION, V40, P286, DOI 10.1161/01.HYP.0000029105.21202.FE; Tomaszewski M, 2007, CIRCULATION, V116, P1915, DOI 10.1161/CIRCULATIONAHA.107.710293; Tomaszewski M, 2011, J AM SOC NEPHROL, V22, P947, DOI 10.1681/ASN.2010080829; Tomaszewski M, 2010, HYPERTENSION, V56, P1069, DOI 10.1161/HYPERTENSIONAHA.110.155721; Tomaszewski M, 2009, ARTERIOSCL THROM VAS, V29, P1316, DOI 10.1161/ATVBAHA.109.185355; Totsune K, 2001, LANCET, V358, P810, DOI 10.1016/S0140-6736(01)06002-0; Vaudry H, 2010, ANN NY ACAD SCI, V1200, P53, DOI 10.1111/j.1749-6632.2010.05514.x; Vogt L, 2010, HYPERTENSION, V55, P1206, DOI 10.1161/HYPERTENSIONAHA.109.149559; Wernersson R, 2003, NUCLEIC ACIDS RES, V31, P3537, DOI 10.1093/nar/gkg609; Yi L, 2006, J INT MED RES, V34, P272, DOI 10.1177/147323000603400306; Zhang AY, 2003, AM J PHYSIOL-RENAL, V285, pF792, DOI 10.1152/ajprenal.00342.2002	50	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83137	10.1371/journal.pone.0083137	http://dx.doi.org/10.1371/journal.pone.0083137			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391740	Green Published, gold			2022-12-25	WOS:000329325200037
J	Gao, P; Wang, B; Geng, GP; Zhang, GC				Gao Peng; Wang Bing; Geng Guangpo; Zhang Guangcan			Spatial Distribution of Soil Organic Carbon and Total Nitrogen Based on GIS and Geostatistics in a Small Watershed in a Hilly Area of Northern China	PLOS ONE			English	Article							LAND-USE CHANGE; LOESS PLATEAU; PREDICTION; SEQUESTRATION; CATCHMENT; VARIABLES	The spatial variability of soil organic carbon (SOC) and total nitrogen (STN) levels is important in both global carbon-nitrogen cycle and climate change research. There has been little research on the spatial distribution of SOC and STN at the watershed scale based on geographic information systems (GIS) and geostatistics. Ninety-seven soil samples taken at depths of 0-20 cm were collected during October 2010 and 2011 from the Matiyu small watershed (4.2 km(2)) of a hilly area in Shandong Province, northern China. The impacts of different land use types, elevation, vegetation coverage and other factors on SOC and STN spatial distributions were examined using GIS and a geostatistical method, regression-kriging. The results show that the concentration variations of SOC and STN in the Matiyu small watershed were moderate variation based on the mean, median, minimum and maximum, and the coefficients of variation (CV). Residual values of SOC and STN had moderate spatial autocorrelations, and the Nugget/Sill were 0.2% and 0.1%, respectively. Distribution maps of regression-kriging revealed that both SOC and STN concentrations in the Matiyu watershed decreased from southeast to northwest. This result was similar to the watershed DEM trend and significantly correlated with land use type, elevation and aspect. SOC and STN predictions with the regression-kriging method were more accurate than those obtained using ordinary kriging. This research indicates that geostatistical characteristics of SOC and STN concentrations in the watershed were closely related to both land-use type and spatial topographic structure and that regression-kriging is suitable for investigating the spatial distributions of SOC and STN in the complex topography of the watershed.	[Gao Peng; Geng Guangpo; Zhang Guangcan] Shandong Agr Univ, Coll Forestry, Taishan Mt Forest Ecosyst Res Stn, Shandong Prov Key Lab Soil Eros & Ecol Restorat, Tai An, Shandong, Peoples R China; [Wang Bing] Chinese Acad Forestry, Res Inst Forest Ecol Environm Protect, Beijing, Peoples R China	Shandong Agricultural University; Chinese Academy of Forestry; Research Institute of Forest Ecology, Environment and Protection, CAF	Gao, P (corresponding author), Shandong Agr Univ, Coll Forestry, Taishan Mt Forest Ecosyst Res Stn, Shandong Prov Key Lab Soil Eros & Ecol Restorat, Tai An, Shandong, Peoples R China.	gaopengy@163.com; wangbing@caf.ac.cn			Special Fund for Forestry Scientific Research in the Public Interest [201204101]; National Basic Research and Development Program of China (973 Program) [2011CB403201, 2012CB416904]; CFERN&GENE Award Funds on Ecological Paper	Special Fund for Forestry Scientific Research in the Public Interest; National Basic Research and Development Program of China (973 Program)(National Basic Research Program of China); CFERN&GENE Award Funds on Ecological Paper	This research was funded by the Special Fund for Forestry Scientific Research in the Public Interest (No. 201204101), the National Basic Research and Development Program of China (973 Program, Nos. 2011CB403201 and 2012CB416904), and was subsidized by CFERN&GENE Award Funds on Ecological Paper. Funders had a role in the data collection and decision to publish the manuscript.	[Anonymous], 1982, AGRONOMY MONOGRAPH; Batjes NH, 1997, GLOBAL CHANGE BIOL, V3, P161, DOI 10.1046/j.1365-2486.1997.00062.x; Cao LiHua, 2007, Journal of Northwest A & F University - Natural Science Edition, V35, P177; Dou FG, 2010, GEODERMA, V154, P328, DOI 10.1016/j.geoderma.2009.10.020; ELLIOTT ET, 1986, SOIL SCI SOC AM J, V50, P627, DOI 10.2136/sssaj1986.03615995005000030017x; Fang X, 2012, CATENA, V88, P6, DOI 10.1016/j.catena.2011.07.012; Fantappie M, 2011, GEOMORPHOLOGY, V135, P343, DOI 10.1016/j.geomorph.2011.02.006; Guo LB, 2002, GLOBAL CHANGE BIOL, V8, P345, DOI 10.1046/j.1354-1013.2002.00486.x; Harris P, 2010, MATH GEOSCI, V42, P657, DOI 10.1007/s11004-010-9284-7; Hengl T, 2004, GEODERMA, V120, P75, DOI 10.1016/j.geoderma.2003.08.018; HICKS RR, 1984, FOREST ECOL MANAG, V8, P281, DOI 10.1016/0378-1127(84)90060-4; Kucharik CJ, 2001, ECOSYSTEMS, V4, P237, DOI 10.1007/s10021\N001\N0007-2; Kumar S, 2012, GEODERMA, V189, P627, DOI 10.1016/j.geoderma.2012.05.022; Lal R, 2004, SCIENCE, V304, P1623, DOI 10.1126/science.1097396; Li Y, 2010, GEODERMA, V159, P63, DOI 10.1016/j.geoderma.2010.06.017; Liu DW, 2006, AGR ECOSYST ENVIRON, V113, P73, DOI 10.1016/j.agee.2005.09.006; LIU S., 2010, J GEOINFORMATION SCI, V12, P180; Lu WD, 2005, SPSS12 0 WINDOWS STA, P1; McGrath DA, 2001, ECOSYSTEMS, V4, P625, DOI 10.1007/s10021-001-0033-0; Mohammadi J, 2011, PEDOSPHERE, V21, P389, DOI 10.1016/S1002-0160(11)60140-9; ODEH IOA, 1995, GEODERMA, V67, P215, DOI 10.1016/0016-7061(95)00007-B; Simbahan GC, 2006, GEODERMA, V132, P471, DOI 10.1016/j.geoderma.2005.07.001; Stacey KF, 2006, GEODERMA, V135, P107, DOI 10.1016/j.geoderma.2005.11.008; Su ZY, 2006, PEDOSPHERE, V16, P10, DOI 10.1016/S1002-0160(06)60020-9; Sumfleth K, 2008, ECOL INDIC, V8, P485, DOI 10.1016/j.ecolind.2007.05.005; Sun W, 2012, GEODERMA, V171, P16, DOI 10.1016/j.geoderma.2011.02.010; Tan ZX, 2005, AGR ECOSYST ENVIRON, V111, P140, DOI 10.1016/j.agee.2005.05.012; Tesfahunegn GB, 2011, SOIL TILL RES, V117, P124, DOI 10.1016/j.still.2011.09.005; Wang HJ, 2009, SOIL TILL RES, V105, P300, DOI 10.1016/j.still.2008.08.010; Wang HQ, 2002, LANDSCAPE ECOL, V17, P671, DOI 10.1023/A:1022962116313; Wang J, 2003, CATENA, V54, P17, DOI 10.1016/S0341-8162(03)00054-7; [王库 Wang Ku], 2013, [中国农学通报, Chinese Agricultural Science Bulletin], V29, P142; Wang YQ, 2009, PEDOSPHERE, V19, P486, DOI 10.1016/S1002-0160(09)60141-7; Zhang SW, 2012, GEODERMA, V171, P35, DOI 10.1016/j.geoderma.2011.07.012; Zhao YongCun, 2005, Acta Pedologica Sinica, V42, P379; Zhao Zhong, 2000, Yingyong Shengtai Xuebao, V11, P37	36	23	29	4	81	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83592	10.1371/journal.pone.0083592	http://dx.doi.org/10.1371/journal.pone.0083592			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391791	Green Submitted, Green Published, gold			2022-12-25	WOS:000329325200088
J	Gregori, J; Esteban, JI; Cubero, M; Garcia-Cehic, D; Perales, C; Casillas, R; Alvarez-Tejado, M; Rodriguez-Frias, F; Guardia, J; Domingo, E; Quer, J				Gregori, Josep; Esteban, Juan I.; Cubero, Maria; Garcia-Cehic, Damir; Perales, Celia; Casillas, Rosario; Alvarez-Tejado, Miguel; Rodriguez-Frias, Francisco; Guardia, Jaume; Domingo, Esteban; Quer, Josep			Ultra-Deep Pyrosequencing (UDPS) Data Treatment to Study Amplicon HCV Minor Variants	PLOS ONE			English	Article							HEPATITIS-C VIRUS; GENERATION SEQUENCING DATA; QUASI-SPECIES RECONSTRUCTION; ERROR-CORRECTION; INFECTION; POPULATION; RESISTANCE; DIVERSITY; ACCURACY; SOFTWARE	We have investigated the reliability and reproducibility of HCV viral quasispecies quantification by ultra-deep pyrosequencing (UDPS) methods. Our study has been divided in two parts. First of all, by UDPS sequencing of clone mixes samples we have established the global noise level of UDPS and fine tuned a data treatment workflow previously optimized for HBV sequence analysis. Secondly, we have studied the reproducibility of the methodology by comparing 5 amplicons from two patient samples on three massive sequencing platforms (FLX+, FLX and Junior) after applying the error filters developed from the clonal/control study. After noise filtering the UDPS results, the three replicates showed the same 12 polymorphic sites above 0.7%, with a mean CV of 4.86%. Two polymorphic sites below 0.6% were identified by two replicates and one replicate respectively. A total of 25, 23 and 26 haplotypes were detected by GS-Junior, GS-FLX and GS-FLX+. The observed CVs for the normalized Shannon entropy (Sn), the mutation frequency (Mf), and the nucleotidic diversity (Pi) were 1.46%, 3.96% and 3.78%. The mean absolute difference in the two patients (5 amplicons each), in the GS-FLX and GS-FLX+, were 1.46%, 3.96% and 3.78% for Sn, Mf and Pi. No false polymorphic site was observed above 0.5%. Our results indicate that UDPS is an optimal alternative to molecular cloning for quantitative study of HCV viral quasispecies populations, both in complexity and composition. We propose an UDPS data treatment workflow for amplicons from the RNA viral quasispecies which, at a sequencing depth of at least 10,000 reads per strand, enables to obtain sequences and frequencies of consensus haplotypes above 0.5% abundance with no erroneous mutations, with high confidence, resistant mutants as minor variants at the level of 1%, with high confidence that variants are not missed, and highly confident measures of quasispecies complexity.	[Gregori, Josep; Esteban, Juan I.; Cubero, Maria; Garcia-Cehic, Damir; Casillas, Rosario; Guardia, Jaume; Quer, Josep] VHIR HUVH, Lab Malalties Hepatiques, Liver Unit, Barcelona, Spain; [Gregori, Josep; Alvarez-Tejado, Miguel] Roche Diagnost SL, Sant Cugat Del Valles, Spain; [Esteban, Juan I.; Cubero, Maria; Garcia-Cehic, Damir; Perales, Celia; Rodriguez-Frias, Francisco; Guardia, Jaume; Domingo, Esteban; Quer, Josep] Inst Salud Carlos III, CIBERehd, Madrid, Spain; [Esteban, Juan I.; Rodriguez-Frias, Francisco; Guardia, Jaume; Quer, Josep] Univ Autonoma Barcelona, Bellaterra, Spain; [Perales, Celia; Domingo, Esteban] UAM, Ctr Biol Mol Severo Ochoa CBM, Madrid, Spain; [Casillas, Rosario; Rodriguez-Frias, Francisco] HUVH, Biochem Unit, Barcelona, Spain	Roche Holding; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; Instituto de Salud Carlos III; Autonomous University of Barcelona; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Hospital Universitari Vall d'Hebron	Gregori, J (corresponding author), VHIR HUVH, Lab Malalties Hepatiques, Liver Unit, Barcelona, Spain.	josep.gregori@vhir.org	Quer, Josep/A-6741-2012; Rodriguez-Frias, Francisco/AAC-3507-2020; Gregori, Josep/J-2586-2015; Domingo, Esteban/K-3937-2014	Quer, Josep/0000-0003-0014-084X; Gregori, Josep/0000-0002-4253-8015; Perales Viejo, Celia Belen/0000-0003-1618-1937; Casillas, Rosario/0000-0002-6758-6734; rodriguez-frias, francisco/0000-0002-9128-7013; Garcia-Cehic, Damir/0000-0002-0009-038X; Domingo, Esteban/0000-0002-0573-1676	CDTI (Centro para el Desarrollo Tecnologico Industrial); Spanish Ministry of Economics and Competitiveness (MINECO) [IDI-20110115]; MINECO projects [SAF 2009-10403]; Spanish Ministry of Health Instituto de Salud Carlos III (FISS) projects [PI10/01505]; Instituto de Salud Carlos III, Madrid; FIPSE; Fundacion Ramon.Areces;  [BFU2011-23604]	CDTI (Centro para el Desarrollo Tecnologico Industrial); Spanish Ministry of Economics and Competitiveness (MINECO)(Spanish Government); MINECO projects(Spanish Government); Spanish Ministry of Health Instituto de Salud Carlos III (FISS) projects; Instituto de Salud Carlos III, Madrid(Instituto de Salud Carlos III); FIPSE; Fundacion Ramon.Areces; 	This study has been supported by CDTI (Centro para el Desarrollo Tecnologico Industrial), Spanish Ministry of Economics and Competitiveness (MINECO), IDI-20110115. It has also been supported by MINECO projects SAF 2009-10403, and also by the Spanish Ministry of Health Instituto de Salud Carlos III (FISS) projects PI10/01505. CIBERehd is funded by the Instituto de Salud Carlos III, Madrid. Work at CBMSO was supported by grant BFU2011-23604, FIPSE and Fundacion Ramon.Areces. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beerenwinkel N, 2011, CURR OPIN VIROL, V1, P413, DOI 10.1016/j.coviro.2011.07.008; C ore Team R, 2012, R LANG ENV STAT COMP; Cubero M, 2008, VIROLOGY, V370, P237, DOI 10.1016/j.virol.2007.10.006; Domingo E, 1988, RNA GENETICS, P3; Domingo Esteban, 1994, P161; Eriksson N, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000074; Flaherty P, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr861; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gilles A, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-245; Hedskog C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011345; Herrmann E, 2000, ANTIVIR THER, V5, P85; Huse SM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r143; KWOK S, 1989, NATURE, V339, P237, DOI 10.1038/339237a0; Kwong Ann D, 2011, Gastroenterology, V140, P755, DOI 10.1053/j.gastro.2011.01.029; Macalalad AR, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002417; Mardis ER, 2008, ANNU REV GENOM HUM G, V9, P387, DOI 10.1146/annurev.genom.9.081307.164359; MARTELL M, 1992, J VIROL, V66, P3225, DOI 10.1128/JVI.66.5.3225-3229.1992; Neumann AU, 1998, SCIENCE, V282, P103, DOI 10.1126/science.282.5386.103; OKAMOTO H, 1992, VIROLOGY, V190, P894, DOI 10.1016/0042-6822(92)90933-G; Pabinger S, 2013, BRIEF BIOINFORM; Pages H, 2012, BIOSTRINGS STRING OB; Prosperi MCF, 2012, BIOINFORMATICS, V28, P132, DOI 10.1093/bioinformatics/btr627; Prosperi MCF, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-5; Quer J, 2005, J VIROL, V79, P15131, DOI 10.1128/JVI.79.24.15131-15141.2005; Quince C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-38; Ramirez C, 2013, ANTIVIR RES, V98, P273, DOI 10.1016/j.antiviral.2013.03.007; Vandenbroucke I, 2011, BIOTECHNIQUES, V51, P167, DOI 10.2144/000113733; Vermehren J, 2012, J VIRAL HEPATITIS, V19, P120, DOI 10.1111/j.1365-2893.2011.01449.x; Vermehren J, 2012, BEST PRACT RES CL GA, V26, P487, DOI 10.1016/j.bpg.2012.09.011; Vignuzzi M, 2006, NATURE, V439, P344, DOI 10.1038/nature04388; Wang CL, 2007, GENOME RES, V17, P1195, DOI 10.1101/gr.6468307; Zagordi O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047046; Zagordi O, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-119; Zagordi O, 2010, NUCLEIC ACIDS RES, V38, P7400, DOI 10.1093/nar/gkq655; Zagordi O, 2010, J COMPUT BIOL, V17, P417, DOI 10.1089/cmb.2009.0164	35	45	45	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83361	10.1371/journal.pone.0083361	http://dx.doi.org/10.1371/journal.pone.0083361			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391758	gold, Green Published, Green Submitted			2022-12-25	WOS:000329325200055
J	Hovakimyan, M; Meyer, A; Lukas, J; Luo, JK; Gudziol, V; Hummel, T; Rolfs, A; Wree, A; Witt, M				Hovakimyan, Marina; Meyer, Anja; Lukas, Jan; Luo, Jiankai; Gudziol, Volker; Hummel, Thomas; Rolfs, Arndt; Wree, Andreas; Witt, Martin			Olfactory Deficits in Niemann-Pick Type C1 (NPC1) Disease	PLOS ONE			English	Article							MURINE MODEL; LYSOSOMAL DYSFUNCTION; COGNITIVE IMPAIRMENT; PARKINSONS-DISEASE; GLIAL-CELLS; MOUSE MODEL; CHOLESTEROL; EXPRESSION; NEURODEGENERATION; PROTEIN	Background: Niemann-Pick type C disease (NPC) is a rare autosomal recessive lipid storage disease characterized by progressive neurodegeneration. As only a few studies have been conducted on the impact of NPC on sensory systems, we used a mutant mouse model (NPC1(-/-)) to examine the effects of this disorder to morphologically distinct regions of the olfactory system, namely the olfactory epithelium (OE) and olfactory bulb (OB). Methodology/Principal findings: For structural and functional analysis immunohistochemistry, electron microscopy, western blotting, and electrophysiology have been applied. For histochemistry and western blotting, we used antibodies against a series of neuronal and glia marker proteins, as well as macrophage markers. NPC1(-/-) animals present myelin-like lysosomal deposits in virtually all types of cells of the peripheral and central olfactory system. Especially supporting cells of the OE and central glia cells are affected, resulting in pronounced astrocytosis and microgliosis in the OB and other olfactory cortices. Up-regulation of Galectin-3, Cathepsin D and GFAP in the cortical layers of the OB underlines the critical role and location of the OB as a possible entrance gate for noxious substances. Unmyelinated olfactory afferents of the lamina propria seem less affected than ensheathing cells. Supporting the structural findings, electro-olfactometry of the olfactory mucosa suggests that NPC1(-/-) animals exhibit olfactory and trigeminal deficits. Conclusions/Significance: Our data demonstrate a pronounced neurodegeneration and glia activation in the olfactory system of NPC1(-/-), which is accompanied by sensory deficits.	[Hovakimyan, Marina; Meyer, Anja; Wree, Andreas; Witt, Martin] Univ Rostock, Inst Anat, Med Ctr, D-18055 Rostock, Germany; [Lukas, Jan; Luo, Jiankai; Rolfs, Arndt] Univ Rostock, Albrecht Kossel Inst Neuroregenerat, Med Ctr, D-18055 Rostock, Germany; [Gudziol, Volker; Hummel, Thomas] Univ Dresden, Sch Med, Dept Otorhinolaryngol, Dresden, Germany	University of Rostock; University of Rostock; Technische Universitat Dresden	Witt, M (corresponding author), Univ Rostock, Inst Anat, Med Ctr, D-18055 Rostock, Germany.	martin.witt@uni-rostock.de	Witt, Martin/AAU-7529-2020	Witt, Martin/0000-0002-4538-877X				Amritraj A, 2013, J BIOL CHEM, V288, P3136, DOI 10.1074/jbc.M112.412460; Amritraj A, 2009, AM J PATHOL, V175, P2540, DOI 10.2353/ajpath.2009.081096; Attems J, 2006, CLIN NEUROPATHOL, V25, P265; Au E, 2003, GLIA, V41, P224, DOI 10.1002/glia.10160; Bahar-Fuchs A, 2010, J ALZHEIMERS DIS, V22, P1081, DOI 10.3233/JAD-2010-100696; Baldisseri DM, 2002, J MOL BIOL, V319, P823, DOI 10.1016/S0022-2836(02)00282-6; BARNETT EM, 1993, NEUROSCIENCE, V57, P1007, DOI 10.1016/0306-4522(93)90045-H; Baudry M, 2003, EXP NEUROL, V184, P887, DOI 10.1016/S0014-4886(03)00345-5; Bejarano-Escobar R, 2011, DEV DYNAM, V240, P1841, DOI 10.1002/dvdy.22673; Benes P, 2008, CRIT REV ONCOL HEMAT, V68, P12, DOI 10.1016/j.critrevonc.2008.02.008; Berendse HW, 2001, ANN NEUROL, V50, P34, DOI 10.1002/ana.1049; Bi XN, 2007, AUTOPHAGY, V3, P646, DOI 10.4161/auto.5074; Bodzioch M, 1999, NAT GENET, V22, P347, DOI 10.1038/11914; Carstea ED, 1997, SCIENCE, V277, P228, DOI 10.1126/science.277.5323.228; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Chen G, 2007, GLIA, V55, P1509, DOI 10.1002/glia.20563; Claudepierre T, 2010, MOL CELL NEUROSCI, V43, P164, DOI 10.1016/j.mcn.2009.10.007; Dahm R, 2003, HISTOCHEM CELL BIOL, V119, P219, DOI 10.1007/s00418-003-0508-5; Davidson CD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006951; Dhaka A, 2008, J NEUROSCI, V28, P566, DOI 10.1523/JNEUROSCI.3976-07.2008; Doetsch F, 2003, NAT NEUROSCI, V6, P1127, DOI 10.1038/nn1144; Doty RL, 2008, ANN NEUROL, V63, P7, DOI 10.1002/ana.21327; Duda JE, 1999, EXP NEUROL, V160, P515, DOI 10.1006/exnr.1999.7228; Erickson RP, 2005, AM J PHYSIOL-GASTR L, V289, pG300, DOI 10.1152/ajpgi.00568.2004; Frasnelli J, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00288; Garver WS, 2007, AM J MED GENET A, V143A, P1204, DOI 10.1002/ajmg.a.31735; German DC, 2002, NEUROSCIENCE, V109, P437, DOI 10.1016/S0306-4522(01)00517-6; Getchell ML, 2002, BRAIN RES, V945, P232, DOI 10.1016/S0006-8993(02)02805-6; Gudziol V, 2010, EUR ARCH OTO-RHINO-L, V267, P239, DOI 10.1007/s00405-009-1076-7; Hawkes CH, 2009, ANN NY ACAD SCI, V1170, P615, DOI 10.1111/j.1749-6632.2009.04365.x; Henderson NC, 2009, IMMUNOL REV, V230, P160, DOI 10.1111/j.1600-065X.2009.00794.x; HIGASHI Y, 1993, ACTA NEUROPATHOL, V85, P175; Hovakimyan M, 2013, NEUROSCIENC IN PRESS; Hovakimyan M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028418; HSU SM, 1981, J HISTOCHEM CYTOCHEM, V29, P577, DOI 10.1177/29.4.6166661; Hubner R, 2010, BIOCHEM BIOPH RES CO, V400, P358, DOI 10.1016/j.bbrc.2010.08.066; Hummel T, 2010, J NEUROL SCI, V289, P119, DOI 10.1016/j.jns.2009.08.026; Kaltner H, 2002, CELL TISSUE RES, V307, P35, DOI 10.1007/s004410100457; Karasinska JM, 2013, NEUROBIOL DIS; Li H, 2005, J NEUROPATH EXP NEUR, V64, P323, DOI 10.1093/jnen/64.4.323; Liao GH, 2007, AM J PATHOL, V171, P962, DOI 10.2353/ajpath.2007.070052; Lledo PM, 2003, NEUROREPORT, V14, P1655, DOI 10.1097/00001756-200309150-00001; Loftus SK, 2002, HUM MOL GENET, V11, P3107, DOI 10.1093/hmg/11.24.3107; Loftus SK, 1997, SCIENCE, V277, P232, DOI 10.1126/science.277.5323.232; Lopez ME, 2011, J NEUROSCI, V31, P4367, DOI 10.1523/JNEUROSCI.5981-10.2011; Mackay-Sim A, 2000, PROG NEUROBIOL, V62, P527, DOI 10.1016/S0301-0082(00)00009-5; Margolis F L, 1982, Scand J Immunol Suppl, V9, P181; McNeill A, 2012, MOVEMENT DISORD, V27, P526, DOI 10.1002/mds.24945; Mellon S, 2004, ENDOCR RES, V30, P727, DOI 10.1081/ERC-200044016; Morris JA, 1999, BIOCHEM BIOPH RES CO, V261, P493, DOI 10.1006/bbrc.1999.1070; MULLEN RJ, 1992, DEVELOPMENT, V116, P201; Neufeld EB, 1999, J BIOL CHEM, V274, P9627, DOI 10.1074/jbc.274.14.9627; Ostalska-Nowicka D, 2007, HISTOPATHOLOGY, V51, P468, DOI 10.1111/j.1365-2559.2007.02818.x; Pasquini LA, 2011, CELL DEATH DIFFER, V18, P1746, DOI 10.1038/cdd.2011.40; Patel SC, 1999, P NATL ACAD SCI USA, V96, P1657, DOI 10.1073/pnas.96.4.1657; Patterson M., 2001, METABOLIC MOL BASES, VII, P3611; Pentchev PG, 2004, BBA-MOL CELL BIOL L, V1685, P3, DOI 10.1016/j.bbalip.2004.08.005; Pfrieger FW, 2003, BIOESSAYS, V25, P72, DOI 10.1002/bies.10195; Reid PC, 2003, J LIPID RES, V44, P1010, DOI 10.1194/jlr.M300009-JLR200; Rosenbaum AI, 2011, J NEUROCHEM, V116, P789, DOI 10.1111/j.1471-4159.2010.06976.x; Rotshenker S, 2008, GLIA, V56, P1607, DOI 10.1002/glia.20713; Sarna JR, 2003, J COMP NEUROL, V456, P279, DOI 10.1002/cne.10522; Saunders-Pullman R, 2010, MOVEMENT DISORD, V25, P1364, DOI 10.1002/mds.23046; Schmitz G, 2001, CURR OPIN LIPIDOL, V12, P129, DOI 10.1097/00041433-200104000-00006; Schwob James E., 2002, Anatomical Record, V269, P33, DOI 10.1002/ar.10047; Spiegel R, 2009, AM J MED GENET A, V149A, P446, DOI 10.1002/ajmg.a.32642; Suzuki H, 2003, PEDIATR INT, V45, P1, DOI 10.1046/j.1442-200X.2003.01651.x; Suzuki M, 2007, J NEUROSCI, V27, P1879, DOI 10.1523/JNEUROSCI.5282-06.2007; TAYLOR CR, 1994, HUM PATHOL, V25, P263, DOI 10.1016/0046-8177(94)90198-8; Vanier MT, 2003, CLIN GENET, V64, P269, DOI 10.1034/j.1399-0004.2003.00147.x; Voikar V, 2002, BEHAV BRAIN RES, V132, P1, DOI 10.1016/S0166-4328(01)00380-1; Ward S, 2010, PEDIATR RES, V68, P52, DOI [10.1203/PDR.0b013e3181df4623, 10.1203/00006450-201011001-00099]; Weiler E, 2005, J NEUROCYTOL, V34, P217, DOI 10.1007/s11068-005-8355-z; Wesson DW, 2010, EXPERT REV NEUROTHER, V10, P633, DOI [10.1586/ern.10.33, 10.1586/ERN.10.33]; Witt M, 2009, MOVEMENT DISORD, V24, P906, DOI 10.1002/mds.22464; Xie CL, 2000, J NEUROPATH EXP NEUR, V59, P1106, DOI 10.1093/jnen/59.12.1106; Yamada A, 2001, BRAIN DEV-JPN, V23, P288, DOI 10.1016/S0387-7604(01)00209-1; Yan X, 2011, METAB BRAIN DIS, V26, P299, DOI 10.1007/s11011-011-9263-9; Yanjanin NM, 2010, AM J MED GENET B, V153B, P132, DOI 10.1002/ajmg.b.30969; Zervas M, 2001, J NEUROPATH EXP NEUR, V60, P49, DOI 10.1093/jnen/60.1.49	80	23	24	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e82216	10.1371/journal.pone.0082216	http://dx.doi.org/10.1371/journal.pone.0082216			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391715	Green Submitted, Green Published, gold			2022-12-25	WOS:000329325200012
J	Jiang, WB; Zhu, JQ; Song, C; Li, XY; Yang, Y; Yu, WD				Jiang, Weibin; Zhu, Jianqing; Song, Chao; Li, Xiaoyan; Yang, Yue; Yu, Weidong			Molecular Phylogeny of the Butterfly Genus Polytremis (Hesperiidae, Hesperiinae, Baorini) in China	PLOS ONE			English	Article							BEETLES COLEOPTERA; LEPIDOPTERA; EVOLUTION; BIOLOGY	Background: The genus Polytremis, restricted to the continental part of the southeastern Palaearctic and northern Oriental regions, is one of the largest and most diverse lineages of the tribe Baorini. Previous studies on the genus were focused mainly on morphological classification and identification of new species. Due to the lack of effective and homologous traits of morphology, there were many challenges in the traditional classification. In this report, we reconstruct the phylogeny to provide a solid framework for these studies and to test the traditional limits and relationships of taxa. Methodology and Principal Findings: We sequenced a mitochondrial and three nuclear gene fragments, coupled with an evaluation of traditional morphological characters, to determine the phylogenetic relationships for a total of 15 species representing all major species groups of the Polytremis genus in China, and to elucidate their taxonomic status. Conclusions and Significance: Analysis of mitochrondial and nuclear DNA showed considerable congruent phylogenetic signal in topology at the inter-species level. We found strong support for the monophyly of Polytremis and some clades were recognized with morphological data. Thus, the COI sequence in our study could be used as a DNA barcode to identify almost all members of the genus. However, incongruences of phylogenetic analyses occurred: in contrast to the phylogenetic trees of mitochondrial COI, it was not possible for nuclear rDNA to discriminate P. gotama from P. caerulescens, suggesting a possible recent separation of these two species. Additionally, P. theca was the only species with a greater intraspecific genetic distance compared to some inter-specific genetic distances in this study and some problems associated with the cryptic diversity of the species are discussed. The results of this study will helpful to reveal the causes of the high degree of diversity of butterflies, and possibly other groups of insects in China.	[Jiang, Weibin; Song, Chao; Li, Xiaoyan; Yang, Yue; Yu, Weidong] Shanghai Normal Univ, Coll Life & Environm Sci, Shanghai, Peoples R China; [Zhu, Jianqing] Shanghai Zool Pk, Shanghai, Peoples R China	Shanghai Normal University	Zhu, JQ (corresponding author), Shanghai Zool Pk, Shanghai, Peoples R China.	zzzjjq@gmail.com; yuwd0127@gmail.com	Yu, Wei/GZL-3831-2022		Shanghai Municipal Education Commission [14YZ068]; Shanghai Normal University [SK201340]	Shanghai Municipal Education Commission(Shanghai Municipal Education Commission (SHMEC)); Shanghai Normal University	This study was financially supported by grants from Shanghai Municipal Education Commission (No. 14YZ068) and Shanghai Normal University (No. SK201340). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Boggs CL, 2003, BUTTERFLIES EVOLUTIO, P14; Chou I., 1994, MONOGRAPHIA RHOPALOC; Eastwood R, 2003, MOL PHYLOGENET EVOL, V27, P93, DOI 10.1016/S1055-7903(02)00370-6; Elias M, 2007, P ROY SOC B-BIOL SCI, V274, P2881, DOI 10.1098/rspb.2007.1035; Eliot JN, 1992, BUTTERFLIES MALAY PE, P384; Evans WH, 1949, CATALOGUE HESPERIIDA, P1; Fan XL, 2006, THESIS S CHINA AGR U; Fordyce JA, 2008, ANN ENTOMOL SOC AM, V101, P794, DOI 10.1603/0013-8746(2008)101[794:POGVBT]2.0.CO;2; Forister ML, 2004, MOL ECOL, V13, P3489, DOI 10.1111/j.1365-294X.2004.02349.x; Funk DJ, 2003, ANNU REV ECOL EVOL S, V34, P397, DOI 10.1146/annurev.ecolsys.34.011802.132421; Gillespie JJ, 2008, ZOOL SCR, V37, P195, DOI 10.1111/j.1463-6409.2007.00320.x; Goloboff PA, 1999, CLADISTICS, V15, P415, DOI 10.1111/j.1096-0031.1999.tb00278.x; Goloboff P, 2008, CLADISTICS, V24, P91; Hajibabaei M, 2006, P NATL ACAD SCI USA, V103, P968, DOI 10.1073/pnas.0510466103; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Hao JS, 2012, COMP FUNCT GENOM, DOI 10.1155/2012/328049; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Huang Hao, 2003, Neue Entomologische Nachrichten, V55, P3; Huang Hao, 2002, Atalanta (Marktleuthen), V33, P109; Hwang UW, 2000, ZOOL SCI, V17, P111, DOI 10.2108/zsj.17.111; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Liu J, 2011, MOL ECOL, V20, P4332, DOI 10.1111/j.1365-294X.2011.05275.x; Maddison WP, 2009, MESQUITE MODULAR SYS; Meyer CP, 2005, PLOS BIOL, V3, P2229, DOI 10.1371/journal.pbio.0030422; Nixon KC, 1999, CLADISTICS, V15, P407, DOI 10.1111/j.1096-0031.1999.tb00277.x; Nixon KC, 2008, WINCLADA VER 1 7; Oliver JC, 2007, MOL ECOL, V16, P4308, DOI 10.1111/j.1365-294X.2007.03494.x; Rand DB, 2000, MOL PHYLOGENET EVOL, V17, P85, DOI 10.1006/mpev.2000.0820; Raupach MJ, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-26; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; Sugiyama H, 1999, PALLARGE, V6, P1; Sugiyama Hitoshi, 1999, Pallarge, V7, P1; SWOFFORD DL, 2002, PAUP PHYLOGENETIC AN; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tautz D, 2003, TRENDS ECOL EVOL, V18, P70, DOI 10.1016/S0169-5347(02)00041-1; Tsukiyama H, 1997, JAPANESE BUTTERFLIES, VI, P292; Vodolazhsky DI, 2010, MOSCOW U BIOL SCI B, V65, P158; Warren AD, 2008, CLADISTICS, V24, P642, DOI 10.1111/j.1096-0031.2008.00218.x; Warren AD, 2009, SYST ENTOMOL, V34, P467, DOI 10.1111/j.1365-3113.2008.00463.x; Wiemers M, 2007, FRONT ZOOL, V4, DOI 10.1186/1742-9994-4-8; Xia X, 2001, J HERED, V92, P371, DOI 10.1093/jhered/92.4.371; Zakharov EV, 2009, HEREDITY, V102, P590, DOI 10.1038/hdy.2009.26; Zhu JQ, 2012, ZOOTAXA, P63, DOI 10.11646/zootaxa.3274.1.7; Zhu JQ, 2012, THESIS SHANGHAI NORM	47	31	31	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84098	10.1371/journal.pone.0084098	http://dx.doi.org/10.1371/journal.pone.0084098			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391893	Green Submitted, Green Published, gold			2022-12-25	WOS:000329323900036
J	Weng, PH; Chen, JH; Chen, TF; Sun, Y; Wen, LL; Yip, PK; Chu, YM; Chen, YC				Weng, Pei-Hsuan; Chen, Jen-Hau; Chen, Ta-Fu; Sun, Yu; Wen, Li-Li; Yip, Ping-Keung; Chu, Yi-Min; Chen, Yen-Ching			CHRNA7 Polymorphisms and Response to Cholinesterase Inhibitors in Alzheimer's Disease	PLOS ONE			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTORS; CENTRAL-NERVOUS-SYSTEM; APOLIPOPROTEIN-E; DONEPEZIL; GALANTAMINE; GENOTYPE; EFFICACY; CHAT; THERAPY; GENES	Background: CHRNA7 encodes the alpha 7 nicotinic acetylcholine receptor subunit, which is important to Alzheimer's disease (AD) pathogenesis and cholinergic neurotransmission. Previously, CHRNA7 polymorphisms have not been related to cholinesterase inhibitors (ChEI) response. Methods: Mild to moderate AD patients received ChEIs were recruited from the neurology clinics of three teaching hospitals from 2007 to 2010 (n = 204). Nine haplotype-tagging single nucleotide polymorphisms of CHRNA7 were genotyped. Cognitive responders were those showing improvement in the Mini-Mental State Examination score >= 2 between baseline and 6 months after ChEI treatment. Results: AD women carrying rs8024987 variants [GG+GC vs. CC: adjusted odds ratio (AOR) = 3.62, 95% confidence interval (CI) = 1.47-8.89] and GG haplotype in block1 (AOR = 3.34, 95% CI = 1.38-8.06) had significantly better response to ChEIs (false discovery rate <0.05). These variant carriers using galantamine were 11 times more likely to be responders than female non-carriers using donepezil or rivastigmine. Conclusion: For the first time, this study found a significant association between CHRNA7 polymorphisms and better ChEI response. If confirmed by further studies, CHRNA7 polymorphisms may aid in predicting ChEI response and refining treatment choice.	[Weng, Pei-Hsuan] Taiwan Adventist Hosp, Dept Family Med, Taipei, Taiwan; [Weng, Pei-Hsuan; Chen, Jen-Hau; Chen, Yen-Ching] Natl Taiwan Univ, Inst Epidemiol & Prevent Med, Coll Publ Hlth, Taipei 10764, Taiwan; [Chen, Jen-Hau] Natl Taiwan Univ Hosp, Dept Geriatr & Gerontol, Taipei, Taiwan; [Chen, Ta-Fu] Natl Taiwan Univ Hosp, Dept Neurol, Taipei, Taiwan; [Sun, Yu] En Chu Kong Hosp, Dept Neurol, Taipei, Taiwan; [Wen, Li-Li] En Chu Kong Hosp, Dept Lab Med, Taipei, Taiwan; [Yip, Ping-Keung] Cardinal Tien Hosp, Ctr Neurol Med, Taipei, Taiwan; [Yip, Ping-Keung] Fu Jen Catholic Univ, Sch Med, Taipei, Taiwan; [Chu, Yi-Min] Cardinal Tien Hosp, Dept Lab Med, Taipei, Taiwan; [Chen, Yen-Ching] Natl Taiwan Univ, Coll Publ Hlth, Dept Publ Hlth, Taipei 10764, Taiwan; [Chen, Yen-Ching] Natl Taiwan Univ, Coll Publ Hlth, Res Ctr Genes Environm & Human Hlth, Taipei 10764, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; Fu Jen Catholic University; National Taiwan University; National Taiwan University	Chen, YC (corresponding author), Natl Taiwan Univ, Inst Epidemiol & Prevent Med, Coll Publ Hlth, Taipei 10764, Taiwan.	karenchen@ntu.edu.tw	Chen, Yen-Ching/D-1098-2010; Chen, Jen-Hau/AFP-2878-2022	Chen, Yen-Ching/0000-0002-8159-7202; Chen, Ta-Fu/0000-0003-1988-6924	National Science Council [96-2314-B-002-197, 97-2314-B-002-168-MY3]	National Science Council(Ministry of Science and Technology, Taiwan)	Funding for the study was provided by National Science Council grants 96-2314-B-002-197 and 97-2314-B-002-168-MY3. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaike A, 2010, J MOL NEUROSCI, V40, P211, DOI 10.1007/s12031-009-9236-1; Albuquerque EX, 2001, ALZ DIS ASSOC DIS, V15, pS19, DOI 10.1097/00002093-200108001-00004; Barabash A, 2009, NEUROBIOL AGING, V30, P1254, DOI 10.1016/j.neurobiolaging.2007.11.003; Barash Y, 2010, NATURE, V465, P53, DOI 10.1038/nature09000; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blesa R, 2006, PHARMACOGENET GENOM, V16, P771, DOI 10.1097/01.fpc.0000220573.05714.ac; Cacabelos R, 2008, EUR ARCH PSY CLIN N, V258, P28, DOI 10.1007/s00406-007-1006-x; Calabria M, 2009, ARCH GERONTOL GERIAT, V49, pE6, DOI 10.1016/j.archger.2008.07.006; Carson R, 2008, J MED GENET, V45, P244, DOI 10.1136/jmg.2007.052704; Chapman J, 1996, NEUROLOGY, V46, P1484, DOI 10.1212/WNL.46.5.1484-a; Chen YC, 2005, CANCER RES, V65, P11771, DOI 10.1158/0008-5472.CAN-05-2078; Chianella C, 2011, EUR J CLIN PHARMACOL, V67, P1147, DOI 10.1007/s00228-011-1064-x; COYLE JT, 1983, SCIENCE, V219, P1184, DOI 10.1126/science.6338589; Doraiswamy PM, 1997, NEUROLOGY, V48, P1511, DOI 10.1212/WNL.48.6.1511; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Frazier CJ, 1998, J NEUROSCI, V18, P8228; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Geerts H, 2005, BRAIN RES, V1033, P186, DOI 10.1016/j.brainres.2004.11.042; Harold D, 2006, PHARMACOGENET GENOM, V16, P75, DOI 10.1097/01.fpc.0000189799.88596.04; KATZMAN R, 1988, J CLIN EPIDEMIOL, V41, P971, DOI 10.1016/0895-4356(88)90034-0; Koylu E, 1997, LIFE SCI, V61, pPL185, DOI 10.1016/S0024-3205(97)00665-6; Kumar V, 2000, EUR J NEUROL, V7, P159, DOI 10.1046/j.1468-1331.2000.00046.x; Kume T, 2005, EUR J PHARMACOL, V527, P77, DOI 10.1016/j.ejphar.2005.10.028; Lam Benjamin, 2009, Human Genomics, V4, P91; Liao PY, 2010, BIOCHEM ENG J, V49, P149, DOI 10.1016/j.bej.2009.12.021; Lin KP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020573; LONDON ED, 1989, NEUROCHEM RES, V14, P745, DOI 10.1007/BF00964952; LUINE VN, 1986, NEUROBIOL AGING, V7, P193, DOI 10.1016/0197-4580(86)90042-4; Mannens GSJ, 2002, DRUG METAB DISPOS, V30, P553, DOI 10.1124/dmd.30.5.553; Martinelli-Boneschi F, 2013, NEUROBIOL AGING, V34, DOI 10.1016/j.neurobiolaging.2012.12.008; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; MEHTA CR, 1995, STAT MED, V14, P2143, DOI 10.1002/sim.4780141908; Mitsushima D, 2010, VITAM HORM, V82, P263, DOI 10.1016/S0083-6729(10)82014-X; Murcray CE, 2009, AM J EPIDEMIOL, V169, P219, DOI 10.1093/aje/kwn353; Noetzli M, 2013, CLIN PHARMACOKINET, V52, P225, DOI 10.1007/s40262-013-0038-9; O'Brien KK, 2003, PHARMACOGENETICS, V13, P231, DOI 10.1097/00008571-200304000-00008; Patterson CE, 2011, PHARMACOGENOMICS J, V11, P444, DOI 10.1038/tpj.2010.61; Pilotto A, 2009, NEUROLOGY, V73, P761, DOI 10.1212/WNL.0b013e3181b6bbe3; Poirier J, 1995, P NATL ACAD SCI USA, V92, P12260, DOI 10.1073/pnas.92.26.12260; Rhodes ME, 1999, BRAIN RES REV, V30, P135, DOI 10.1016/S0165-0173(99)00011-9; Scacchi R, 2009, AM J MED GENET B, V150B, P502, DOI 10.1002/ajmg.b.30846; Stram DO, 2003, HUM HERED, V55, P179, DOI 10.1159/000073202; Takada-Takatori Y, 2006, NEUROPHARMACOLOGY, V51, P474, DOI 10.1016/j.neuropharm.2006.04.007; Taylor P, 1998, NEUROLOGY, V51, pS30, DOI 10.1212/WNL.51.1_Suppl_1.S30; Texido L, 2005, BRIT J PHARMACOL, V145, P672, DOI 10.1038/sj.bjp.0706221; US Food and Drug Administration, 1989, PER CENTR NERV SYST, P227; Wonnacott S, 2006, J MOL NEUROSCI, V30, P137, DOI 10.1385/JMN:30:1:137	47	19	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84059	10.1371/journal.pone.0084059	http://dx.doi.org/10.1371/journal.pone.0084059			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391883	Green Submitted, Green Published, gold			2022-12-25	WOS:000329323900026
J	Hampton, M; Melvin, RG; Andrews, MT				Hampton, Marshall; Melvin, Richard G.; Andrews, Matthew T.			Transcriptomic Analysis of Brown Adipose Tissue across the Physiological Extremes of Natural Hibernation	PLOS ONE			English	Article							INSULIN-RESISTANCE; ADENYLATE-CYCLASE; MICE LACKING; PROTEIN; FAT; EXPRESSION; RECEPTOR; MOUSE; IDENTIFICATION; PGC-1-ALPHA	We used RNAseq to generate a comprehensive transcriptome of Brown Adipose Tissue (BAT) over the course of a year in the naturally hibernating thirteen-lined ground squirrel, Ictidomys tridecemlineatus. During hibernation ground squirrels do not feed and use fat stored in White Adipose Tissue (WAT) as their primary source of fuel. Stored lipid is consumed at high rates by BAT to generate heat at specific points during the hibernation season. The highest rate of BAT activity occurs during periodic arousals from hypothermic torpor bouts, referred to as Interbout Arousals (IBAs). IBAs are characterized by whole body re-warming (from 5 to 37 degrees C) in 2-3 hours, and provide a unique opportunity to determine the genes responsible for the highly efficient lipid oxidation and heat generation that drives the arousal process. Illumina HighSeq sequencing identified 14,573 distinct BAT mRNAs and quantified their levels at four points: active ground squirrels in April and October, and hibernating animals during both torpor and IBA. Based on significant changes in mRNA levels across the four collection points, 2,083 genes were shown to be differentially expressed. In addition to providing detail on the expression of nuclear genes encoding mitochondrial proteins, and genes involved in beta-adrenergic and lipolytic pathways, we identified differentially expressed genes encoding various transcription factors and other regulatory proteins which may play critical roles in high efficiency fat catabolism, non-shivering thermogenesis, and transitions into and out of the torpid state.	[Hampton, Marshall] Univ Minnesota, Dept Math & Stat, Duluth, MN 55812 USA; [Melvin, Richard G.; Andrews, Matthew T.] Univ Minnesota, Dept Biol, Duluth, MN 55812 USA	University of Minnesota System; University of Minnesota Duluth; University of Minnesota System; University of Minnesota Duluth	Andrews, MT (corresponding author), Univ Minnesota, Dept Biol, Duluth, MN 55812 USA.	mandrews@d.umn.edu		Hampton, Marshall/0000-0002-9725-3316; Melvin, Richard George/0000-0001-6428-6763	National Institutes of Health [1RC2HL101625-01]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [RC2HL101625] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was funded by National Institutes of Health grant 1RC2HL101625-01 to MTA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Amsellem S, 2010, J AM SOC NEPHROL, V21, P1859, DOI 10.1681/ASN.2010050492; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Andrews MT, 2007, BIOESSAYS, V29, P431, DOI 10.1002/bies.20560; Andrews MT, 1998, P NATL ACAD SCI USA, V95, P8392, DOI 10.1073/pnas.95.14.8392; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Aziz A, 2010, EPIGENETICS-US, V5, P691, DOI 10.4161/epi.5.8.13045; Barger JL, 2006, J APPL PHYSIOL, V101, P339, DOI 10.1152/japplphysiol.01260.2005; Bauer VW, 2001, AM J PHYSIOL-REG I, V281, pR1186, DOI 10.1152/ajpregu.2001.281.4.R1186; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Boettger T, 2002, NATURE, V416, P874, DOI 10.1038/416874a; Bordicchia M, 2012, J CLIN INVEST, V122, P1022, DOI 10.1172/JCI59701; Bourgon R, 2010, P NATL ACAD SCI USA, V107, P9546, DOI 10.1073/pnas.0914005107; Bourova L, 2000, MOL CELL ENDOCRINOL, V167, P23, DOI 10.1016/S0303-7207(00)00303-8; Brasaemle DL, 2007, J LIPID RES, V48, P2547, DOI 10.1194/jlr.R700014-JLR200; Bullard JH, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-94; Burmeister R, 2001, J BIOL CHEM, V276, P13295, DOI 10.1074/jbc.M010679200; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Chen M, 2004, ENDOCRINOLOGY, V145, P4094, DOI 10.1210/en.2004-0038; Cinti S, 2007, ADIPOSE TISSUE ADIPO, P3, DOI [10.1007/978-1-59745-370-7_1, DOI 10.1007/978-1-59745-370-7_1]; Cypess AM, 2010, CURR OPIN PEDIATR, V22, P478, DOI 10.1097/MOP.0b013e32833a8d6e; Cypess AM, 2010, CURR OPIN ENDOCRINOL, V17, P143, DOI 10.1097/MED.0b013e328337a81f; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; FAIN JN, 1972, J BIOL CHEM, V247, P6866; Fisher FM, 2012, GENE DEV, V26, P271, DOI 10.1101/gad.177857.111; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; GIBBINS JM, 1985, BIOCHEM J, V228, P751, DOI 10.1042/bj2280751; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Hampton M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027021; Hampton M, 2010, AM J PHYSIOL-REG I, V299, pR1478, DOI 10.1152/ajpregu.00273.2010; Hondares E, 2011, J BIOL CHEM, V286, P12983, DOI 10.1074/jbc.M110.215889; Honma S, 2002, NATURE, V419, P841, DOI 10.1038/nature01123; Jung HS, 2012, NAT REV NEUROSCI, V13, P308, DOI 10.1038/nrn3210; Kanzleiter T, 2005, PHYSIOL GENOMICS, V24, P37, DOI 10.1152/physiolgenomics.00204.2005; Kleiner S, 2012, P NATL ACAD SCI USA, V109, P9635, DOI 10.1073/pnas.1207287109; Kozyraki R, 1999, NAT MED, V5, P656, DOI 10.1038/9504; Kramarova LI, 2007, COMP BIOCHEM PHYS A, V146, P408, DOI 10.1016/j.cbpa.2006.11.017; Larigauderie G, 2006, FEBS J, V273, P3498, DOI 10.1111/j.1742-4658.2006.05357.x; Lassi G, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002706; Legan PK, 1997, J BIOL CHEM, V272, P8791, DOI 10.1074/jbc.272.13.8791; MCMAHON KK, 1982, LIFE SCI, V30, P1185, DOI 10.1016/0024-3205(82)90661-0; Millman EE, 2008, TRAFFIC, V9, P1958, DOI 10.1111/j.1600-0854.2008.00813.x; Mount MP, 2013, J BIOL CHEM, V288, P14362, DOI 10.1074/jbc.M112.439216; Mukherjee AB, 2007, ENDOCR REV, V28, P707, DOI 10.1210/er.2007-0018; Nedergaard J, 2007, AM J PHYSIOL-ENDOC M, V293, pE444, DOI 10.1152/ajpendo.00691.2006; POST SR, 1995, BIOCHEM J, V311, P75, DOI 10.1042/bj3110075; Rodriguez A, 2011, CELL CYCLE, V10, P1548, DOI 10.4161/cc.10.10.15672; Roux I, 2006, CELL, V127, P277, DOI 10.1016/j.cell.2006.08.040; Saito H, 2004, CELL, V119, P679, DOI 10.1016/j.cell.2004.11.021; Saito M, 2009, DIABETES, V58, P1526, DOI 10.2337/db09-0530; Sas K, 2007, J NEUROL SCI, V257, P221, DOI 10.1016/j.jns.2007.01.033; Schwartz C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058427; Seale P, 2007, CELL METAB, V6, P38, DOI 10.1016/j.cmet.2007.06.001; She H, 2011, J CLIN INVEST, V121, P930, DOI 10.1172/JCI43871; SHERIDAN JD, 1971, J CELL BIOL, V50, P795, DOI 10.1083/jcb.50.3.795; Singh H, 2007, FEBS J, V274, P6306, DOI 10.1111/j.1742-4658.2007.06145.x; Squire TL, 2003, PHYSIOL GENOMICS, V16, P131, DOI 10.1152/physiolgenomics.00168.2002; Takemori H, 2007, FEBS J, V274, P3202, DOI 10.1111/j.1742-4658.2007.05889.x; Tseng YH, 2010, NAT REV DRUG DISCOV, V9, P465, DOI 10.1038/nrd3138; Tupone D, 2013, J NEUROSCI, V33, P14512, DOI 10.1523/JNEUROSCI.1980-13.2013; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; Walden TB, 2012, AM J PHYSIOL-ENDOC M, V302, pE19, DOI 10.1152/ajpendo.00249.2011; WINKLER E, 1994, J BIOL CHEM, V269, P2508; Wolins NE, 2003, J BIOL CHEM, V278, P37713, DOI 10.1074/jbc.M304025200; Wu J, 2013, GENE DEV, V27, P234, DOI 10.1101/gad.211649.112; Yamashita A, 2009, BBA-MOL CELL BIOL L, V1791, P1011, DOI 10.1016/j.bbalip.2009.05.008; Yan W, 2005, J BIOL CHEM, V280, P26669, DOI 10.1074/jbc.M502358200; Yu SH, 2000, J CLIN INVEST, V105, P615, DOI 10.1172/JCI8437	69	57	59	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e85157	10.1371/journal.pone.0085157	http://dx.doi.org/10.1371/journal.pone.0085157			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386461	Green Submitted, Green Published, gold			2022-12-25	WOS:000329194700130
J	Moroz, A; Delella, FK; Almeida, R; Lacorte, LM; Favaro, WJ; Deffune, E; Felisbino, SL				Moroz, Andrei; Delella, Flavia K.; Almeida, Rodrigo; Lacorte, Livia Maria; Favaro, Wagner Jose; Deffune, Elenice; Felisbino, Sergio L.			Finasteride Inhibits Human Prostate Cancer Cell Invasion through MMP2 and MMP9 Downregulation	PLOS ONE			English	Article							MATRIX METALLOPROTEINASES; ANDROGEN RECEPTOR; TISSUE INHIBITORS; DIFFERENTIAL EXPRESSION; CHEMOPREVENTION; TESTOSTERONE; OVEREXPRESSION; RESISTANCE; APOPTOSIS; SURVIVAL	Introduction: The use of the 5-alpha reductase inhibitors (5-ARIs) finasteride and dutasteride for prostate cancer prevention is still under debate. The FDA recently concluded that the increased prevalence of high-grade tumors among 5-ARI-treated patients must not be neglected, and they decided to disallow the use of 5-ARIs for prostate cancer prevention. This study was conducted to verify the effects of finasteride on prostate cell migration and invasion and the related enzymes/proteins in normal human and tumoral prostatic cell lines. Materials and Methods: RWPE-1, LNCaP, PC3 and DU145 cells were cultivated to 60% confluence and exposed for different periods to either 10 mu M or 50 mu M finasteride that was diluted in culture medium. The conditioned media were collected and concentrated, and MMP2 and MMP9 activities and TIMP-1 and TIMP-2 protein expression were determined. Cell viability, migration and invasion were analyzed, and the remaining cell extracts were submitted to androgen receptor (AR) detection by western blotting techniques. Experiments were carried out in triplicate. Results: Cell viability was not significantly affected by finasteride exposure. Finasteride significantly downregulated MMP2 and MMP9 activities in RWPE-1 and PC3 cells and MMP2 in DU145 cells. TIMP-2 expression in RWPE-1 cells was upregulated after exposure. The cell invasion of all four tested cell lines was inhibited by exposure to 50 mM of finasteride, and migration inhibition only occurred for RWPE-1 and LNCaP cells. AR was expressed by LNCaP, RWPE-1 and PC3 cells. Conclusions: Although the debate on the higher incidence of high-grade prostate cancer among 5-ARI-treated patients remains, our findings indicate that finasteride may attenuate tumor aggressiveness and invasion, which could vary depending on the androgen responsiveness of a patient's prostate cells.	[Moroz, Andrei; Delella, Flavia K.; Almeida, Rodrigo; Lacorte, Livia Maria; Felisbino, Sergio L.] Univ Estadual Paulista, UNESP, Inst Biosci, Dept Morphol,Extracellular Matrix Lab, Sao Paulo, Brazil; [Moroz, Andrei; Deffune, Elenice] Univ Estadual Paulista, UNESP, Botucatu Med Sch, Blood Transfus Ctr,Cell Engn Lab, Sao Paulo, Brazil; [Lacorte, Livia Maria; Favaro, Wagner Jose] Univ Estadual Campinas, UNICAMP, Inst Biol, Dept Struct & Funct Biol, Sao Paulo, Brazil; [Deffune, Elenice] Univ Estadual Paulista, UNESP, Botucatu Med Sch, Dept Urol, Sao Paulo, Brazil	Universidade Estadual Paulista; Universidade Estadual Paulista; Universidade de Sao Paulo; Universidade Estadual de Campinas; Universidade Estadual Paulista	Felisbino, SL (corresponding author), Univ Estadual Paulista, UNESP, Inst Biosci, Dept Morphol,Extracellular Matrix Lab, Sao Paulo, Brazil.	felisbin@ibb.unesp.br	Fávaro, Wagner José/AAS-7463-2020; Deffune, Elenice/K-6263-2012; de Almeida, Rodrigo/E-6189-2014; Felisbino, Sergio L/K-7641-2012; Delella, Flavia K/C-7731-2012; Moroz, Andrei/K-7767-2012	Fávaro, Wagner José/0000-0001-5830-8938; Deffune, Elenice/0000-0002-0533-3248; Delella, Flavia K/0000-0001-6362-5882; Moroz, Andrei/0000-0002-4498-9784	FAPESP (the Research Council for the State of Sao Paulo) [2010/16671-3]; CAPES	FAPESP (the Research Council for the State of Sao Paulo)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by a FAPESP (the Research Council for the State of Sao Paulo) funding (process n. 2010/16671-3) and a CAPES Ph.D. scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alimirah F, 2006, FEBS LETT, V580, P2294, DOI 10.1016/j.febslet.2006.03.041; Andriole G, 2005, J UROLOGY, V174, P2098, DOI 10.1097/01.ju.0000181216.71605.38; [Anonymous], 5 ALPH RED INH 5 ARI; Bass R, 2009, J UROLOGY, V181, P615, DOI 10.1016/j.juro.2008.10.029; Benbrahim-Tallaa L, 2005, ENVIRON HEALTH PERSP, V113, P1134, DOI 10.1289/ehp.7832; Bonaccorsi L, 2003, INT J ANDROL, V26, P21, DOI 10.1046/j.1365-2605.2003.00375.x; Boxler S, 2010, AM J PATHOL, V177, P2216, DOI 10.2353/ajpath.2010.091190; Buchanan G, 2004, PROSTATE, V60, P352, DOI 10.1002/pros.20079; Byrns MC, 2012, J STEROID BIOCHEM, V130, P7, DOI 10.1016/j.jsbmb.2011.12.012; Castoria G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017218; Chatterjee B, 2003, MOL CELL BIOCHEM, V253, P89, DOI 10.1023/A:1026057402945; Chignalia AZ, 2012, HYPERTENSION, V59, P1263, DOI 10.1161/HYPERTENSIONAHA.111.180620; Cussenot O, 2007, EUR UROL, V52, P1082, DOI 10.1016/j.eururo.2007.04.008; Daja MM, 2003, PROSTATE CANCER P D, V6, P15, DOI 10.1038/sj.pcan.4500609; Das K, 2010, ENDOCR-RELAT CANCER, V17, P757, DOI 10.1677/ERC-10-0022; Delella FK, 2010, INT J ANDROL, V33, pE114, DOI 10.1111/j.1365-2605.2009.00970.x; Deryugina EI, 2006, CANCER METAST REV, V25, P9, DOI 10.1007/s10555-006-7886-9; Dillard PR, 2008, MOL CELL ENDOCRINOL, V295, P115, DOI 10.1016/j.mce.2008.08.013; Golbano JM, 2008, INT J ONCOL, V32, P919; Higgins AZ, 2011, J NEUROSCI METH, V201, P9, DOI 10.1016/j.jneumeth.2011.06.033; Justulin LA, 2010, INT J ANDROL, V33, P489, DOI 10.1111/j.1365-2605.2009.00963.x; Klein EA, 2012, WORLD J UROL, V30, P189, DOI 10.1007/s00345-011-0822-9; Kobayashi N, 2012, ONCOTARGET, V3, P1455; Lokeshwar BL, 1991, ANN NY ACAD SCI, V878, P271; Ludwig S, 2011, TOXICOL SCI, V122, P52, DOI 10.1093/toxsci/kfr099; Moroz A, 2013, BIOCHEM BIOPH RES CO, V430, P1319, DOI 10.1016/j.bbrc.2012.12.031; Opoku-Acheampong AB, 2012, PLOS ONE, DOI [10.1371/journal.pone.0029068, DOI 10.1371/J0URNAL.P0NE.0029068]; Opoku-Acheampong AB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077738; PAJOUH MS, 1991, J CANCER RES CLIN, V117, P144, DOI 10.1007/BF01613138; Racioppi Marco, 2012, Arch Ital Urol Androl, V84, P47; Rittmaster RS, 2011, ACTA ONCOL, V50, P127, DOI 10.3109/0284186X.2010.527367; Sawaya ME, 2002, J CUTAN MED SURG, V6, P1, DOI 10.1007/s10227-001-0024-y; Thompson IM, 2003, EUR UROL, V44, P650, DOI 10.1016/j.eururo.2003.11.001; TILLEY WD, 1995, STEROIDS, V60, P180, DOI 10.1016/0039-128X(94)00031-7; Tokar EJ, 2005, DIFFERENTIATION, V73, P463, DOI 10.1111/j.1432-0436.2005.00047.x; Tsui KH, 2008, ANTICANCER RES, V28, P1977; Visse R, 2003, CIRC RES, V92, P827, DOI 10.1161/01.RES.0000070112.80711.3D; Wang P, 2007, ASIAN J ANDROL, V9, P353, DOI 10.1111/j.1745-7262.2007.00278.x; Zhang J, 2002, PROSTATE, V50, P38, DOI 10.1002/pros.10030	39	32	36	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e84757	10.1371/journal.pone.0084757	http://dx.doi.org/10.1371/journal.pone.0084757			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386413	Green Submitted, gold, Green Published			2022-12-25	WOS:000329194700116
J	Moussaid, M				Moussaid, Mehdi			Opinion Formation and the Collective Dynamics of Risk Perception	PLOS ONE			English	Article							SOCIAL-INFLUENCE; BOUNDED CONFIDENCE; IMPACT; AMPLIFICATION; INFORMATION; CULTURE; BENEFITS; SPREAD; MODEL	The formation of collective opinion is a complex phenomenon that results from the combined effects of mass media exposure and social influence between individuals. The present work introduces a model of opinion formation specifically designed to address risk judgments, such as attitudes towards climate change, terrorist threats, or children vaccination. The model assumes that people collect risk information from the media environment and exchange them locally with other individuals. Even though individuals are initially exposed to the same sample of information, the model predicts the emergence of opinion polarization and clustering. In particular, numerical simulations highlight two crucial factors that determine the collective outcome: the propensity of individuals to search for independent information, and the strength of social influence. This work provides a quantitative framework to anticipate and manage how the public responds to a given risk, and could help understanding the systemic amplification of fears and worries, or the underestimation of real dangers.	[Moussaid, Mehdi] Max Planck Inst Human Dev, Ctr Adapt Behav & Cognit, Berlin, Germany; [Moussaid, Mehdi] Max Planck Inst Human Dev, Ctr Adapt Rat, Berlin, Germany	Max Planck Society; Max Planck Society	Moussaid, M (corresponding author), Max Planck Inst Human Dev, Ctr Adapt Behav & Cognit, Berlin, Germany.	mehdi.moussaid@gmail.com			Max Planck Society	Max Planck Society(Max Planck SocietyFoundation CELLEX)	The author is funded by the Max Planck Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, EUROBAROMETER SURVEY; ASCH SE, 1955, SCI AM, V193, P31, DOI 10.1038/scientificamerican1155-31; Axelrod R, 1997, J CONFLICT RESOLUT, V41, P203, DOI 10.1177/0022002797041002001; Bernardes AT, 2002, EUR PHYS J B, V25, P123, DOI 10.1140/e10051-002-0013-y; Betsch C, 2011, MED DECIS MAKING, V31, P742, DOI 10.1177/0272989X11400419; BIKHCHANDANI S, 1992, J POLIT ECON, V100, P992, DOI 10.1086/261849; Binder AR, 2011, RISK ANAL, V31, P324, DOI 10.1111/j.1539-6924.2010.01516.x; Caldarelli Guido, 2013, INFLUENCE MEDIA COLL; Castellano C, 2009, REV MOD PHYS, V81, P591, DOI 10.1103/RevModPhys.81.591; Centola D, 2011, SCIENCE, V334, P1269, DOI 10.1126/science.1207055; Centola D, 2010, SCIENCE, V329, P1194, DOI 10.1126/science.1185231; Christakis NA, 2008, NEW ENGL J MED, V358, P2249, DOI 10.1056/NEJMsa0706154; Crane R, 2008, P NATL ACAD SCI USA, V105, P15649, DOI 10.1073/pnas.0803685105; Deffuant G, 2002, JASSS-J ARTIF SOC S, V5; Deffuant G, 2000, APPLICATIONS OF SIMULATION TO SOCIAL SCIENCES, P87, DOI 10.1142/S0219525900000078; Festinger L, 1954, HUM RELAT, V7, P117, DOI 10.1177/001872675400700202; Fortunato S, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.138701; Funk S, 2009, P NATL ACAD SCI USA, V106, P6872, DOI 10.1073/pnas.0810762106; Ginsberg J, 2009, NATURE, V457, P1012, DOI 10.1038/nature07634; Gonzalez-Avella JC, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/1/013010; Gonzalez-Avella JC, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.065102; Gonzalez-Avella JC, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.046119; Hegselmann R, 2002, JASSS-J ARTIF SOC S, V5; ISENBERG DJ, 1986, J PERS SOC PSYCHOL, V50, P1141, DOI 10.1037/0022-3514.50.6.1141; Kahan DM, 2012, NAT CLIM CHANGE, V2, P732, DOI 10.1038/NCLIMATE1547; Kahan DM, 2009, NAT NANOTECHNOL, V4, P87, DOI [10.1038/nnano.2008.341, 10.1038/NNANO.2008.341]; LATANE B, 1981, AM PSYCHOL, V36, P343, DOI 10.1037/0003-066X.36.4.343; Latane B, 1996, J COMMUN, V46, P13, DOI 10.1111/j.1460-2466.1996.tb01501.x; Lorenz J, 2007, INT J MOD PHYS C, V18, P1819, DOI 10.1142/S0129183107011789; Lorenz J, 2011, P NATL ACAD SCI USA, V108, P9020, DOI 10.1073/pnas.1008636108; Mas M, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000959; Mason WA, 2007, PERS SOC PSYCHOL REV, V11, P279, DOI 10.1177/1088868307301032; Moussaid M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078433; Moussaid M, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002442; Muchnik L, 2013, SCIENCE, V341, P647, DOI 10.1126/science.1240466; MYERS DG, 1970, SCIENCE, V169, P778, DOI 10.1126/science.169.3947.778; Nickerson R.S., 1998, REV GEN PSYCHOL, V2, P175, DOI [10.1037/1089-2680.2.2.175, DOI 10.1037/1089-2680.2.2.175]; Pruitt JN, 2011, P ROY SOC B-BIOL SCI, V278, P1209, DOI 10.1098/rspb.2010.1700; RENN O, 1992, J SOC ISSUES, V48, P137, DOI 10.1111/j.1540-4560.1992.tb01949.x; Salganik MJ, 2006, SCIENCE, V311, P854, DOI 10.1126/science.1121066; Schelling T.C, 2006, MICROMOTIVES MACROBE; Scherer CW, 2003, RISK ANAL, V23, P261, DOI 10.1111/1539-6924.00306; Shibanai Y, 2001, J CONFLICT RESOLUT, V45, P80, DOI 10.1177/0022002701045001004; SLOVIC P, 1987, SCIENCE, V236, P280, DOI 10.1126/science.3563507; Slovic P, 2000, PERCEPTION RISK; STASSER G, 1985, J PERS SOC PSYCHOL, V48, P1467, DOI 10.1037/0022-3514.48.6.1467; Sznajd-Weron K, 2000, INT J MOD PHYS C, V11, P1157, DOI 10.1142/S0129183100000936; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Watts DJ, 2007, J CONSUM RES, V34, P441, DOI 10.1086/518527; Wu F, 2007, P NATL ACAD SCI USA, V104, P17599, DOI 10.1073/pnas.0704916104	51	60	61	1	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e84592	10.1371/journal.pone.0084592	http://dx.doi.org/10.1371/journal.pone.0084592			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	282SX	24386398	Green Submitted, Green Published, gold			2022-12-25	WOS:000329194700113
J	Reynaud, Y; Pitchford, S; De Decker, S; Wikfors, GH; Brown, CL				Reynaud, Yann; Pitchford, Steven; De Decker, Sophie; Wikfors, Gary H.; Brown, Christopher L.			Molecular Typing of Environmental and Clinical Strains of Vibrio vulnificus Isolated in the Northeastern USA	PLOS ONE			English	Article							ESCHERICHIA-COLI; SIALIC-ACID; PCR ASSAY; IDENTIFICATION; PATHOGENESIS; POLYMORPHISM; EVOLUTION; OYSTERS; SEROVAR; CLADE	Vibrio vulnificus is a ubiquitous marine bacterium that is responsible for infections and some seafood-related illnesses and deaths in the United States, mainly in individuals with compromised health status in the Gulf of Mexico region. Most phylogenetic studies focus on V. vulnificus strains isolated in the southern United States, but almost no genetic data are available on northeastern bacterial isolates of clinical or environmental origin. Our goal in this study was to examine the genetic diversity of environmental strains isolated from commercially-produced oysters and in clinical strains of known pathogenicity in northeastern United States. We conducted analyses of a total of eighty-three strains of V. vulnificus, including 18 clinical strains known to be pathogenic. A polyphasic, molecular-typing approach was carried out, based upon established biotypes, vcg, CPS, 16S rRNA types and three other genes possibly associated with virulence (arylsulfatase A, mtlABC, and nanA). An established Multi Locus Sequence Typing (MLST) method was also performed. Phylogenetic analyses of these markers and MLST results produced similar patterns of clustering of strains into two main lineages (we categorized as 'LI' and 'LII'), with clinical and environmental strains clustering together in both lineages. Lineage LII was comprised primarily but not entirely of clinical bacterial isolates. Putative virulence markers were present in both clinical and environmental strains. These results suggest that some northeastern environmental strains of V. vulnificus are phylogenetically close to clinical strains and probably are capable of virulence. Further studies are necessary to assess the risk of human illness from consuming raw oysters harvested in the northeastern US.	[Reynaud, Yann; Pitchford, Steven; De Decker, Sophie; Wikfors, Gary H.; Brown, Christopher L.] NOAA, NEFSC, Milford Lab, Milford, CT 06460 USA	National Oceanic Atmospheric Admin (NOAA) - USA	Brown, CL (corresponding author), NOAA, NEFSC, Milford Lab, Milford, CT 06460 USA.	Christopher.L.Brown@noaa.gov	Reynaud, Yann/ABD-7936-2021	Reynaud, Yann/0000-0002-1966-7249	National Academy of Science [P102628]	National Academy of Science	Funding by the National Academy of Science as part of the Research Associate Program (No P102628). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AZNAR R, 1994, INT J SYST BACTERIOL, V44, P330, DOI 10.1099/00207713-44-2-330; Bisharat N, 2005, EMERG INFECT DIS, V11, P30, DOI 10.3201/eid1101.040440; Bisharat N, 2007, INFECT GENET EVOL, V7, P685, DOI 10.1016/j.meegid.2007.07.007; Canigral I, 2010, MICROBIOL RES, V165, P657, DOI 10.1016/j.micres.2009.11.012; Chatzidaki-Livanis M, 2006, J BACTERIOL, V188, P1987, DOI 10.1128/JB.188.5.1987-1998.2006; Chatzidaki-Livanis M, 2006, APPL ENVIRON MICROB, V72, P6136, DOI 10.1128/AEM.00341-06; Chen CY, 2003, GENOME RES, V13, P2577, DOI 10.1101/gr.1295503; Cohen ALV, 2007, APPL ENVIRON MICROB, V73, P5553, DOI 10.1128/AEM.00635-07; Didelot X, 2007, GENETICS, V175, P1251, DOI 10.1534/genetics.106.063305; Drake SL, 2010, FOODBORNE PATHOG DIS, V7, P97, DOI 10.1089/fpd.2009.0362; Fouz B, 2007, MICROBIOL-SGM, V153, P1926, DOI 10.1099/mic.0.2006/005405-0; Gascuel O, 1997, MOL BIOL EVOL, V14, P685, DOI 10.1093/oxfordjournals.molbev.a025808; Gelman A., 1992, STAT SCI, V7, P457, DOI [DOI 10.1214/SS/1177011136, 10.1214/ss/1177011136]; Gordon KV, 2008, APPL ENVIRON MICROB, V74, P1704, DOI 10.1128/AEM.01100-07; Gulig PA, 2005, J MICROBIOL, V43, P118; Gulig PA, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-512; GUTTMAN DS, 1994, SCIENCE, V266, P1380, DOI 10.1126/science.7973728; Hall T, 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008; Jeong HG, 2009, INFECT IMMUN, V77, P3209, DOI 10.1128/IAI.00109-09; Jones MK, 2009, INFECT IMMUN, V77, P1723, DOI 10.1128/IAI.01046-08; Kaysner CA., 2004, BACTERIOLOGICAL ANAL; Kim YR, 2003, INFECT IMMUN, V71, P5461, DOI 10.1128/IAI.71.10.5461-5471.2003; KORBER B, 2000, COMPUTATIONAL ANAL H, P55, DOI DOI 10.1007/B112102; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lubin JB, 2012, APPL ENVIRON MICROB, V78, P3407, DOI 10.1128/AEM.07395-11; MILKMAN R, 1990, GENETICS, V126, P505; Morrison SS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037553; NEI M, 1986, MOL BIOL EVOL, V3, P418; Nilsson WB, 2003, J CLIN MICROBIOL, V41, P442, DOI 10.1128/JCM.41.1.442-446.2003; Oliver JD, 2006, BIOLOGY OF VIBRIOS, P349; ONEILL KR, 1990, FEMS MICROBIOL LETT, V72, P163, DOI 10.1111/j.1574-6968.1990.tb03882.x; ONEILL KR, 1992, APPL ENVIRON MICROB, V58, P3257, DOI 10.1128/AEM.58.10.3257-3262.1992; Park JH, 2011, J BACTERIOL, V193, P2062, DOI 10.1128/JB.00110-11; Rosche TM, 2005, MICROBIOL IMMUNOL, V49, P381, DOI 10.1111/j.1348-0421.2005.tb03731.x; Sambrook J, 2001, MOL CLONING LAB MANU; Sanjuan E, 2007, APPL ENVIRON MICROB, V73, P2029, DOI 10.1128/AEM.02320-06; Sanjuan E, 2011, APPL ENVIRON MICROB, V77, P688, DOI 10.1128/AEM.01263-10; Strom MS, 2000, MICROBES INFECT, V2, P177, DOI 10.1016/S1286-4579(00)00270-7; Thiaville PC, 2011, INFECT IMMUN, V79, P1194, DOI 10.1128/IAI.01031-10; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TILTON RC, 1987, DIAGN MICR INFEC DIS, V6, P109, DOI 10.1016/0732-8893(87)90094-0; Vickery MCL, 2007, J MICROBIOL METH, V68, P376, DOI 10.1016/j.mimet.2006.02.018; Warner E, 2008, APPL ENVIRON MICROB, V74, P80, DOI 10.1128/AEM.01434-07; Warner E, 2007, APPL ENVIRON MICROB, V73, P3098, DOI 10.1128/AEM.02245-06; Warner JM, 1999, APPL ENVIRON MICROB, V65, P1141	45	18	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e83357	10.1371/journal.pone.0083357	http://dx.doi.org/10.1371/journal.pone.0083357			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386187	Green Submitted, gold, Green Published			2022-12-25	WOS:000329194700036
J	Adukpo, S; Kusi, KA; Ofori, MF; Tetteh, JKA; Amoako-Sakyi, D; Goka, BQ; Adjei, GO; Edoh, DA; Akanmori, BD; Gyan, BA; Dodoo, D				Adukpo, Selorme; Kusi, Kwadwo A.; Ofori, Michael F.; Tetteh, John K. A.; Amoako-Sakyi, Daniel; Goka, Bamenla Q.; Adjei, George O.; Edoh, Dominic A.; Akanmori, Bartholomew D.; Gyan, Ben A.; Dodoo, Daniel			High Plasma Levels of Soluble Intercellular Adhesion Molecule (ICAM)-1 Are Associated with Cerebral Malaria	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM MALARIA; MICROVESSEL ENDOTHELIAL-CELLS; VARIANT SURFACE-ANTIGENS; RED-BLOOD-CELLS; INFECTED ERYTHROCYTES; HUMAN BRAIN; PARASITIZED ERYTHROCYTES; AFRICAN CHILDREN; DISEASE SEVERITY; FLOW CONDITIONS	Background: Cerebral malaria (CM) is responsible for most of the malaria-related deaths in children in sub-Saharan Africa. Although, not well understood, the pathogenesis of CM involves parasite and host factors which contribute to parasite sequestration through cytoadherence to the vascular endothelium. Cytoadherence to brain microvasculature is believed to involve host endothelial receptor, CD54 or intercellular adhesion molecule (ICAM)-1, while other receptors such as CD36 are generally involved in cytoadherence of parasites in other organs. We therefore investigated the contributions of host ICAM-1 expression and levels of antibodies against ICAM-1 binding variant surface antigen (VSA) on parasites to the development of CM. Methodology/Principal Findings: Paediatric malaria patients, 0.5 to 13 years were recruited and grouped into CM and uncomplicated malaria (UM) patients, based on well defined criteria. Standardized ELISA protocol was used to measure soluble ICAM-1 (sICAM-1) levels from acute plasma samples. Levels of IgG to CD36- or ICAM-1-binding VSA were measured by flow cytometry during acute and convalescent states. Wilcoxon sign rank-test analysis to compare groups revealed association between sICAM-1 levels and CM (p<0.0037). Median levels of antibodies to CD36-binding VSA were comparable in the two groups at the time of admission and 7 days after treatment was initiated (p>0.05). Median levels of antibodies to CD36-binding VSAs were also comparable between acute and convalescent samples within any patient group. Median levels of antibodies to ICAM-1-binding VSAs were however significantly lower at admission time than during recovery in both groups. Conclusions/Significance: High levels of sICAM-1 were associated with CM, and the sICAM-1 levels may reflect expression levels of the membrane bound form. Anti-VSA antibody levels to ICAM-binding parasites was more strongly associated with both UM and CM than antibodies to CD36 binding parasites. Thus, increasing host sICAM-1 levels were associated with CM whilst antibodies to parasite expressing non-ICAM-1-binding VSAs were not.	[Adukpo, Selorme; Kusi, Kwadwo A.; Ofori, Michael F.; Tetteh, John K. A.; Amoako-Sakyi, Daniel; Akanmori, Bartholomew D.; Gyan, Ben A.; Dodoo, Daniel] Univ Ghana, Coll Hlth Sci, Noguchi Mem Inst Med Res, Dept Immunol, Legon, Accra, Ghana; [Adukpo, Selorme; Edoh, Dominic A.] Univ Ghana, Dept Anim Biol & Conservat Sci, Legon, Accra, Ghana; [Goka, Bamenla Q.; Adjei, George O.] Univ Ghana, Coll Hlth Sci, Sch Med, Dept Child Hlth, Legon, Accra, Ghana	University of Ghana; University of Ghana; University of Ghana	Adukpo, S (corresponding author), Univ Ghana, Coll Hlth Sci, Noguchi Mem Inst Med Res, Dept Immunol, Legon, Accra, Ghana.	sadukpo812@gmail.com	Kusi, Kwadwo Asamoah/J-5941-2019; Ofori, Michael F/H-9072-2013	Kusi, Kwadwo Asamoah/0000-0001-5483-9985; Ofori, Michael F/0000-0003-2341-7514	Multinational Initiative on Malaria-Training in Tropical Diseases (MIM-TDR) [A11034]	Multinational Initiative on Malaria-Training in Tropical Diseases (MIM-TDR)	The study was funded by Multinational Initiative on Malaria-Training in Tropical Diseases (MIM-TDR grant A11034). However, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armah H, 2005, ANN TROP MED PARASIT, V99, P629, DOI 10.1179/136485905X51508; Armah Henry, 2005, Int J Environ Res Public Health, V2, P123, DOI 10.3390/ijerph2005010123; Baruch DI, 1996, P NATL ACAD SCI USA, V93, P3497, DOI 10.1073/pnas.93.8.3497; Budnik A, 1996, EXP HEMATOL, V24, P352; Bull PC, 1999, INFECT IMMUN, V67, P733, DOI 10.1128/IAI.67.2.733-739.1999; Bull PC, 1998, NAT MED, V4, P358, DOI 10.1038/nm0398-358; Cooke BM, 1996, BLOOD, V88, P4040, DOI 10.1182/blood.V88.10.4040.bloodjournal88104040; Cox-Singh J, 2008, CLIN INFECT DIS, V46, P165, DOI 10.1086/524888; Cserti-Gazdewich CM, 2012, BRIT J HAEMATOL, V159, P223, DOI 10.1111/bjh.12014; Cserti-Gazdewich CM, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-233; Day NPJ, 1999, J INFECT DIS, V180, P1288, DOI 10.1086/315016; Dodoo D, 2001, INFECT IMMUN, V69, P3713, DOI 10.1128/IAI.69.6.3713-3718.2001; Erdman LK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017440; GRAU GE, 1990, IMMUNOL LETT, V25, P189, DOI 10.1016/0165-2478(90)90113-5; Gray C, 2003, MOL BIOCHEM PARASIT, V128, P187, DOI 10.1016/S0166-6851(03)00075-6; GREENWOOD B, 1991, PARASITOL TODAY, V7, P277, DOI 10.1016/0169-4758(91)90096-7; Ho M, 2000, J EXP MED, V192, P1205, DOI 10.1084/jem.192.8.1205; HVIID L, 1993, IMMUNOL LETT, V36, P51, DOI 10.1016/0165-2478(93)90068-D; Joergensen L, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001083; Kampfl A, 1997, AM J TROP MED HYG, V56, P585, DOI 10.4269/ajtmh.1997.56.585; KAUL DK, 1991, BLOOD, V78, P812; KERN P, 1992, J INFECT DIS, V166, P930, DOI 10.1093/infdis/166.4.930; Kurtzhals JAL, 1998, LANCET, V351, P1768, DOI 10.1016/S0140-6736(97)09439-7; KWIATKOWSKI D, 1990, LANCET, V336, P1201, DOI 10.1016/0140-6736(90)92827-5; Lee KS, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-73; Mayengue PI, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-276; McGilvray ID, 2000, BLOOD, V96, P3231, DOI 10.1182/blood.V96.9.3231; McGuire W, 1996, T ROY SOC TROP MED H, V90, P274, DOI 10.1016/S0035-9203(96)90244-8; Mendez MP, 2008, AM J PHYSIOL-LUNG C, V294, pL807, DOI 10.1152/ajplung.00398.2007; MOLYNEUX ME, 1989, Q J MED, V71, P441; Newbold C, 1997, AM J TROP MED HYG, V57, P389, DOI 10.4269/ajtmh.1997.57.389; NTOUMI F, 1995, AM J TROP MED HYG, V52, P81, DOI 10.4269/ajtmh.1995.52.81; OCKENHOUSE CF, 1991, J INFECT DIS, V164, P163, DOI 10.1093/infdis/164.1.163; Ofori MF, 2002, INFECT IMMUN, V70, P2982, DOI 10.1128/IAI.70.6.2982-2988.2002; PAUL F, 1981, LANCET, V2, P70; Ponsford MJ, 2012, J INFECT DIS, V205, P663, DOI 10.1093/infdis/jir812; ROBERTS DD, 1985, NATURE, V318, P64, DOI 10.1038/318064a0; Silamut K, 1999, AM J PATHOL, V155, P395, DOI 10.1016/S0002-9440(10)65136-X; Singh B, 2013, CLIN MICROBIOL REV, V26, P165, DOI 10.1128/CMR.00079-12; Staalsoe T, 1999, CYTOMETRY, V35, P329, DOI 10.1002/(SICI)1097-0320(19990401)35:4&lt;329::AID-CYTO5&gt;3.0.CO;2-Y; Staalsoe T, 2003, PARASITE IMMUNOL, V25, P421, DOI 10.1111/j.1365-3024.2003.00652.x; Tang THT, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-219; Tchinda VHM, 2007, ACTA TROP, V102, P20, DOI 10.1016/j.actatropica.2007.02.011; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Treutiger CJ, 1997, NAT MED, V3, P1405, DOI 10.1038/nm1297-1405; Tsakadze NL, 2006, J BIOL CHEM, V281, P3157, DOI 10.1074/jbc.M510797200; Turner GDH, 1998, AM J PATHOL, V152, P1477; TURNER GDH, 1994, AM J PATHOL, V145, P1057; Vastag M, 1999, MICROVASC RES, V57, P52, DOI 10.1006/mvre.1998.2115; WARRELL DA, 1987, PARASITOLOGY, V94, pS53, DOI 10.1017/S0031182000085826; WHO, 2011, WORLD MALARIA REPORT 2011, P1; WONG D, 1992, J NEUROIMMUNOL, V39, P11, DOI 10.1016/0165-5728(92)90170-P	52	11	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e84181	10.1371/journal.pone.0084181	http://dx.doi.org/10.1371/journal.pone.0084181			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281RE	24386348	Green Published, gold			2022-12-25	WOS:000329117900081
J	Inayathullah, M; Satheeshkumar, KS; Malkovskiy, AV; Carre, AL; Sivanesan, S; Hardesty, JO; Rajadas, J				Inayathullah, Mohammed; Satheeshkumar, K. S.; Malkovskiy, Andrey V.; Carre, Antoine L.; Sivanesan, Senthilkumar; Hardesty, Jasper O.; Rajadas, Jayakumar			Solvent Microenvironments and Copper Binding Alters the Conformation and Toxicity of a Prion Fragment	PLOS ONE			English	Article							PROTEIN SECONDARY STRUCTURE; CIRCULAR-DICHROISM; ALZHEIMERS-DISEASE; OCTAREPEAT DOMAIN; NEUROTOXICITY; PEPTIDES; POLYMORPHISM; AGGREGATION; CONVERSION; NEURONS	The secondary structures of amyloidogenic proteins are largely influenced by various intra and extra cellular microenvironments and metal ions that govern cytotoxicity. The secondary structure of a prion fragment, PrP(111-126), was determined using circular dichroism (CD) spectroscopy in various microenvironments. The conformational preferences of the prion peptide fragment were examined by changing solvent conditions and pH, and by introducing external stress (sonication). These physical and chemical environments simulate various cellular components at the water-membrane interface, namely differing aqueous environments and metal chelating ions. The results show that PrP(111-126) adopts different conformations in assembled and non-assembled forms. Aging studies on the PrP(111-126) peptide fragment in aqueous buffer demonstrated a structural transition from random coil to a stable beta-sheet structure. A similar, but significantly accelerated structural transition was observed upon sonication in aqueous environment. With increasing TFE concentrations, the helical content of PrP(111-126) increased persistently during the structural transition process from random coil. In aqueous SDS solution, PrP(111-126) exhibited beta-sheet conformation with greater a-helical content. No significant conformational changes were observed under various pH conditions. Addition of Cu2+ ions inhibited the structural transition and fibril formation of the peptide in a cell free in vitro system. The fact that Cu2+ supplementation attenuates the fibrillar assemblies and cytotoxicity of PrP(111-126) was witnessed through structural morphology studies using AFM as well as cytotoxicity using MTT measurements. We observed negligible effects during both physical and chemical stimulation on conformation of the prion fragment in the presence of Cu2+ ions. The toxicity of PrP(111-126) to cultured astrocytes was reduced following the addition of Cu2+ ions, owing to binding affinity of copper towards histidine moiety present in the peptide.	[Inayathullah, Mohammed; Malkovskiy, Andrey V.; Sivanesan, Senthilkumar; Rajadas, Jayakumar] Stanford Univ, Sch Med, Biomat & Adv Drug Delivery Lab, Stanford, CA 94305 USA; [Satheeshkumar, K. S.] Cent Leather Res Inst, Bioorgan & Neurochem Lab, Madras 600020, Tamil Nadu, India; [Carre, Antoine L.] Stanford Univ, Dept Surg, Sch Med, Stanford, CA 94305 USA; [Hardesty, Jasper O.] Stanford Univ, Dept Chem Engn, Stanford, CA 94305 USA; [Rajadas, Jayakumar] Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA; [Rajadas, Jayakumar] Stanford Univ, Sch Med, Cardiovasc Pharmacol Div, Cardiovasc Inst, Stanford, CA 94305 USA	Stanford University; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Leather Research Institute (CLRI); Stanford University; Stanford University; Stanford University; Stanford University	Rajadas, J (corresponding author), Stanford Univ, Sch Med, Biomat & Adv Drug Delivery Lab, Stanford, CA 94305 USA.	jayraja@stanford.edu	Inayathullah, Mohammed/C-6953-2015; Rajadas, Jayakumar/AHC-0630-2022	Inayathullah, Mohammed/0000-0001-7646-1709; Rajadas, Jayakumar/0000-0001-6520-3923; Sivanesan, Senthilkumar/0000-0001-5133-7090				Abe K, 1996, JPN J PHARMACOL, V72, P299, DOI 10.1254/jjp.72.299; Aguzzi A, 2009, NEURON, V64, P783, DOI 10.1016/j.neuron.2009.12.016; Andrews ME, 2009, J STRUCT BIOL, V166, P116, DOI 10.1016/j.jsb.2008.12.011; Ashe KH, 2013, PRION, V7, P55, DOI 10.4161/pri.23061; BALDWIN MA, 1995, J BIOL CHEM, V270, P19197, DOI 10.1074/jbc.270.33.19197; Bate C, 2002, NEUROREPORT, V13, P1695, DOI 10.1097/00001756-200209160-00025; Bocharova OV, 2005, BIOCHEMISTRY-US, V44, P6776, DOI 10.1021/bi050251q; Bodanszky M, 1984, PRACTICE PEPTIDE SYN, Vxvii; Brown DR, 1997, NATURE, V390, P684, DOI 10.1038/37733; Brown DR, 1998, J NEUROCHEM, V70, P1686; Brown DR, 1999, J NEUROCHEM, V73, P1105, DOI 10.1046/j.1471-4159.1999.0731105.x; Burns CS, 2002, BIOCHEMISTRY-US, V41, P3991, DOI 10.1021/bi011922x; Caughey B, 1997, TRENDS CELL BIOL, V7, P56, DOI 10.1016/S0962-8924(96)10054-4; Chacon MA, 2003, MOL PSYCHIATR, V8, P853, DOI [10.1038/sj.mp.4001400, 10.1038/sj.mp.4001414]; Chattopadhyay M, 2005, J AM CHEM SOC, V127, P12647, DOI 10.1021/ja053254z; Chen H, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S4-S14; Chen SM, 2002, P NATL ACAD SCI USA, V99, P11884, DOI 10.1073/pnas.182276099; Chun YS, 2002, CHEM COMMUN, P1846, DOI 10.1039/b205046c; Costanzo M, 2013, BIOCHEM J, V452, P1, DOI 10.1042/BJ20121898; Das D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011420; De Armond S J, 1989, Prog Clin Biol Res, V317, P601; DEGIOIA L, 1994, J BIOL CHEM, V269, P7859; Di Natale G, 2005, ORG BIOMOL CHEM, V3, P490, DOI 10.1039/b407928k; Donne DG, 1997, P NATL ACAD SCI USA, V94, P13452, DOI 10.1073/pnas.94.25.13452; Falsig J, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002985; Fernandez-Funez P, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000507; Ferreiro E, 2008, J NEUROCHEM, V104, P766, DOI 10.1111/j.1471-4159.2007.05048.x; Fezoui Y, 2000, NAT STRUCT BIOL, V7, P1095, DOI 10.1038/81937; Forloni G, 1996, PROG NEUROBIOL, V49, P287, DOI 10.1016/0301-0082(96)00013-5; GASSET M, 1992, P NATL ACAD SCI USA, V89, P10940, DOI 10.1073/pnas.89.22.10940; Grenier C, 2006, J NEUROCHEM, V97, P1456, DOI 10.1111/j.1471-4159.2006.03837.x; Huang Z, 1996, CURR TOP MICROBIOL, V207, P49; Inayathullah M, 2011, AMYLOID, V18, P98, DOI 10.3109/13506129.2011.580399; Jaikaran ETAS, 2001, J MOL BIOL, V308, P515, DOI 10.1006/jmbi.2001.4593; Jao SC, 1997, AMYLOID, V4, P240, DOI 10.3109/13506129709003835; JASANOFF A, 1994, BIOCHEMISTRY-US, V33, P2129, DOI 10.1021/bi00174a020; Jellinger KA, 2012, J CELL MOL MED, V16, P1166, DOI 10.1111/j.1582-4934.2011.01507.x; Jobling MF, 2001, BIOCHEMISTRY-US, V40, P8073, DOI 10.1021/bi0029088; Kawahara M, 2011, METALLOMICS, V3, P726, DOI 10.1039/c1mt00015b; Klewpatinond M, 2007, BIOCHEM J, V404, P393, DOI 10.1042/BJ20061893; Kristiansen M, 2005, J BIOL CHEM, V280, P38851, DOI 10.1074/jbc.M506600200; Kristiansen M, 2007, MOL CELL, V26, P175, DOI 10.1016/j.molcel.2007.04.001; Levy Y, 2002, PROTEINS, V47, P458, DOI 10.1002/prot.10095; Luidens MK, 1996, BIOPOLYMERS, V39, P367, DOI 10.1002/(SICI)1097-0282(199609)39:3<367::AID-BIP8>3.3.CO;2-C; Ma JY, 2002, SCIENCE, V298, P1781, DOI 10.1126/science.1073725; Maji SK, 2009, J BIOL CHEM, V284, P23580, DOI 10.1074/jbc.M109.038133; Marella M, 2004, J NEUROSCI, V24, P620, DOI 10.1523/JNEUROSCI.4303-03.2004; Masilamoni JG, 2005, BBA-MOL BASIS DIS, V1740, P411, DOI 10.1016/j.bbadis.2004.11.002; Millhauser GL, 2007, ANNU REV PHYS CHEM, V58, P299, DOI 10.1146/annurev.physchem.58.032806.104657; Moreno JA, 2012, NATURE, V485, P507, DOI 10.1038/nature11058; Moses JP, 2003, LANGMUIR, V19, P3413, DOI 10.1021/la026661m; Murali J, 2005, J STRUCT BIOL, V150, P180, DOI 10.1016/j.jsb.2005.02.009; NELSON J W, 1986, Proteins Structure Function and Genetics, V1, P211, DOI 10.1002/prot.340010303; Ono K, 2008, J BIOL CHEM, V283, P32176, DOI 10.1074/jbc.M806154200; Ono K, 2009, P NATL ACAD SCI USA, V106, P14745, DOI 10.1073/pnas.0905127106; PAN KM, 1992, PROTEIN SCI, V1, P1343, DOI 10.1002/pro.5560011014; PAN KM, 1993, P NATL ACAD SCI USA, V90, P10962, DOI 10.1073/pnas.90.23.10962; Petchanikow C, 2001, FEBS LETT, V509, P451, DOI 10.1016/S0014-5793(01)03147-7; Prusiner SB, 1997, SCIENCE, V278, P245, DOI 10.1126/science.278.5336.245; Prusiner SB, 1998, CELL, V93, P337, DOI 10.1016/S0092-8674(00)81163-0; Ragg E, 1999, EUR J BIOCHEM, V266, P1192, DOI 10.1046/j.1432-1327.1999.00985.x; RAPOPORT TA, 1986, CRC CR REV BIOCH MOL, V20, P73, DOI 10.3109/10409238609115901; REDDY GL, 1989, J BIOL CHEM, V264, P16591; Rivillas-Acevedo L, 2011, INORG CHEM, V50, P1956, DOI 10.1021/ic102381j; Ronga L, 2007, BIOINORG CHEM APPL, V2017, DOI 10.1155/2007/10720; Satheeshkumar KS, 2004, J STRUCT BIOL, V148, P176, DOI 10.1016/j.jsb.2004.05.006; Satheeshkumar KS, 2003, BIOPHYS J, V85, P473, DOI 10.1016/S0006-3495(03)74492-0; SELVAGGINI C, 1993, BIOCHEM BIOPH RES CO, V194, P1380, DOI 10.1006/bbrc.1993.1977; Shanmugam G, 2004, BIOPOLYMERS, V76, P421, DOI 10.1002/bip.20131; Simon D., 2013, NEUROPATHOL APPL NEU; Simoneau S, 2007, PLOS PATHOG, V3, P1175, DOI 10.1371/journal.ppat.0030125; Singh A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004468; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Stewart JM, 1984, SOLID PHASE PEPTIDE, Vxvi; Stockel J, 1998, BIOCHEMISTRY-US, V37, P7185, DOI 10.1021/bi972827k; Sureshbabu N, 2009, EUR BIOPHYS J BIOPHY, V38, P355, DOI 10.1007/s00249-008-0379-8; TAGLIAVINI F, 1993, P NATL ACAD SCI USA, V90, P9678, DOI 10.1073/pnas.90.20.9678; TAGLIAVINI F, 1994, CELL, V79, P695, DOI 10.1016/0092-8674(94)90554-1; Tcherkasskaya O, 2003, J BIOMOL STRUCT DYN, V21, P353, DOI 10.1080/07391102.2003.10506931; Thakur AK, 2011, J BIOL CHEM, V286, P38533, DOI 10.1074/jbc.M111.265645; Tizzano B, 2005, PROTEINS, V59, P72, DOI 10.1002/prot.20395; Viles JH, 2008, BIOCHEM SOC T, V36, P1288, DOI 10.1042/BST0361288; Whittal RM, 2000, PROTEIN SCI, V9, P332; WICKNER WT, 1985, SCIENCE, V230, P400, DOI 10.1126/science.4048938; Wille H, 2002, P NATL ACAD SCI USA, V99, P3563, DOI 10.1073/pnas.052703499; You HT, 2012, P NATL ACAD SCI USA, V109, P1737, DOI 10.1073/pnas.1110789109; Zhou GP, 2013, CURR TOP MED CHEM, V13, P1152, DOI 10.2174/15680266113139990003	87	7	7	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e85160	10.1371/journal.pone.0085160	http://dx.doi.org/10.1371/journal.pone.0085160			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281RE	24386462	gold, Green Published, Green Submitted			2022-12-25	WOS:000329117900128
J	LeBoldus, JM; Isabel, N; Floate, KD; Blenis, P; Thomas, BR				LeBoldus, Jared M.; Isabel, Nathalie; Floate, Kevin D.; Blenis, Peter; Thomas, Barb R.			Testing the 'Hybrid Susceptibility' and 'Phenological Sink' Hypotheses Using the P. balsamifera - P. deltoides Hybrid Zone and Septoria Leaf Spot [Septoria musiva]	PLOS ONE			English	Article							STEM CANKER; POPULUS; RESISTANCE; POPLAR; HYBRIDIZATION; POPULICOLA	Hybrid genotypes that arise between plant species frequently have increased susceptibility to arthropod pests and fungal pathogens. This pattern has been attributed to the breakdown of plant defenses ('Hybrid susceptibility' hypothesis) and (or) to extended periods of susceptibility attributed to plant phenologies in zones of species overlap and (or) hybridization ('phenological sink' hypothesis). We examined these hypotheses by assessing the susceptibility of parental and hybrid Populus host genotypes to a leaf spot disease caused by the fungal pathogen Septoria musiva. For this purpose, 214 genotypes were obtained from morphologically pure zones of P. balsamifera and P. deltoides, and from an intervening zone of overlap and hybridization on the drainage of the Red Deer River, Alberta, Canada. Genotypes were identified as P. balsamifera, P. deltoides, or hybrid using a suite of 27 species-specific SNP markers. Initially the genetic structure of the hybrid zone was characterized with 27.7% of trees classified as admixed individuals. To test the hybrid susceptibility hypothesis, a subset of 52 genotypes was inoculated with four isolates of S. musiva. Levels of susceptibility were P. balsamifera > F-1 hybrid > P. deltoides. A further 53 genotypes were grown in a common garden to assess the effect of genotype on variation in leaf phenology. Leaf phenology was more variable within the category of hybrid genotypes than within categories of either parental species. Leaf phenology was also more variable for the category of trees originating in the hybrid (P. balsamifera - P. deltoides [hybrid and parental genotypes combined]) zone than in adjacent pure zones of the parental species. The results from the inoculation experiment support the hybrid intermediacy hypothesis. The results from the common garden experiment support the 'phenological sink' hypothesis. These findings have greatly increased our understanding of the epidemiology and ecology of fungal pathogens in plant hybrid zones.	[LeBoldus, Jared M.] N Dakota State Univ, Dept Plant Pathol, Fargo, ND 58105 USA; [Isabel, Nathalie] Nat Resources Canada, Canadian Forest Serv, Laurentian Forestry Ctr, Ste Foy, PQ, Canada; [Floate, Kevin D.] Agr & Agri Food Canada, Lethbridge Res Ctr, Lethbridge, AB, Canada; [Blenis, Peter; Thomas, Barb R.] Univ Alberta, Dept Renewable Resources, Edmonton, AB, Canada; [Thomas, Barb R.] Alberta Pacific Forest Ind Inc, Boyle, AB, Canada	North Dakota State University Fargo; Natural Resources Canada; Canadian Forest Service; Agriculture & Agri Food Canada; University of Alberta	LeBoldus, JM (corresponding author), N Dakota State Univ, Dept Plant Pathol, Fargo, ND 58105 USA.	jared.leboldus@ndsu.edu	Floate, Kevin/AAD-9856-2019	Floate, Kevin/0000-0002-7485-5170; Isabel, Nathalie/0000-0001-8621-9801; Thomas, Barb R./0000-0002-9718-9297	CFS-NSERC-Industry Forest Research Partnership; NSERC-IPS-2; Alberta-pacific Forest Industries Inc.; West Fraser Timber Company; University of Alberta's Queen Elizabeth II	CFS-NSERC-Industry Forest Research Partnership(Natural Resources CanadaCanadian Forest Service); NSERC-IPS-2; Alberta-pacific Forest Industries Inc.; West Fraser Timber Company; University of Alberta's Queen Elizabeth II	CFS-NSERC-Industry Forest Research Partnership to PB. NSERC-IPS-2, Alberta-pacific Forest Industries Inc., West Fraser Timber Company for the West Fraser Scholarship in Enhanced Forest Management, and The University of Alberta's Queen Elizabeth II scholarship to JL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], BIOL POPULUS ITS IMP; BIER J. E., 1939, CANADIAN JOUR RES SECT C BOT SCI, V17, P195; CEULEMANS R, 1992, CAN J FOREST RES, V22, P1937, DOI 10.1139/x92-253; Desrochers A, 2003, NEW FOREST, V26, P17, DOI 10.1023/A:1024492103150; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Feau N, 2005, MYCOL RES, V109, P1015, DOI 10.1017/S0953756205003242; Feau N, 2010, CAN J PLANT PATHOL, V32, P122, DOI 10.1080/07060661003740009; Floate KD, 2004, CAN J BOT, V82, P253, DOI [10.1139/B03-135, 10.1139/b03-135]; FLOATE KD, 1993, ECOLOGY, V74, P2056, DOI 10.2307/1940851; Fritz RS, 1999, ANNU REV ECOL SYST, V30, P565, DOI 10.1146/annurev.ecolsys.30.1.565; Hamzeh M, 2007, CAN J BOT, V85, P1227, DOI 10.1139/B07-105; Isabel N, 2013, TREE GENET GENOMES, V9, P621, DOI 10.1007/s11295-012-0569-5; KAHN RP, 1958, PHYTOPATHOLOGY, V48, P25; Lamari L, 2008, ASSESS 20 IMAGE ANAL; LeBoldus JM, 2010, PLANT DIS, V94, P1238, DOI 10.1094/PDIS-02-10-0094; Littell RC, 2006, SAS MIXED MODELS, V2nd; Luley CJ, 1989, PHYTOPATHOLOGY, V87, P381; McIntire EJB, 2002, AM J BOT, V89, P642, DOI 10.3732/ajb.89.4.642; Meirmans PG, 2007, CAN J BOT, V85, P1082, DOI 10.1139/B07-069; Newcombe G, 1998, PHYTOPATHOLOGY, V88, P114, DOI 10.1094/PHYTO.1998.88.2.114; Newcombe G, 1996, CAN J FOREST RES, V26, P1943, DOI 10.1139/x26-219; Newcombe G, 2001, PHYTOPATHOLOGY, V91, P1081, DOI 10.1094/PHYTO.2001.91.11.1081; OSTRY ME, 1987, EUR J FOREST PATHOL, V17, P158; OSTRY ME, 1985, PLANT DIS, V69, P755, DOI 10.1094/PD-69-755; PARLEVLIET JE, 1979, ANNU REV PHYTOPATHOL, V17, P203, DOI 10.1146/annurev.py.17.090179.001223; Pritchard JK, 2000, GENETICS, V155, P945; Stanosz JC, 2002, FOREST PATHOL, V32, P145, DOI 10.1046/j.1439-0329.2002.00278.x; STRAUSS SY, 1994, TRENDS ECOL EVOL, V9, P209, DOI 10.1016/0169-5347(94)90245-3; Talbot P, 2012, FOREST ECOL MANAG, V285, P142, DOI 10.1016/j.foreco.2012.07.036; Thompson SL, 2010, MOL ECOL, V19, P132, DOI 10.1111/j.1365-294X.2009.04442.x; WATERMAN A. M., 1954, Circular. United States Department of Agriculture; WHITHAM TG, 1989, SCIENCE, V244, P1490, DOI 10.1126/science.244.4911.1490; Whitham TG, 1999, ECOLOGY, V80, P416	33	14	14	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e84437	10.1371/journal.pone.0084437	http://dx.doi.org/10.1371/journal.pone.0084437			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281RE	24386379	Green Published, gold, Green Submitted			2022-12-25	WOS:000329117900093
J	Joyee, AG; Yang, X				Joyee, Antony George; Yang, Xi			Plasmacytoid Dendritic Cells Mediate the Regulation of Inflammatory Type T Cell Response for Optimal Immunity against Respiratory Chlamydia Pneumoniae Infection	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; IFN-GAMMA; PROTECTIVE IMMUNITY; TOXOPLASMA-GONDII; ADAPTIVE IMMUNITY; TNF-ALPHA; IN-VIVO; MICE; IL-10; ANTIGEN	Chlamydia pneumoniae (Cpn) infection is a leading cause for a variety of respiratory diseases and has been implicated in the pathogenesis of chronic inflammatory diseases. The regulatory mechanisms in host defense against Cpn infection are less understood. In this study, we investigated the role of plasmacytoid dendritic cells (pDCs) in immune regulation in Cpn respiratory tract infection. We found that in vivo depletion of pDCs increased the severity of infection and lung pathology. Mice depleted of pDC had greater body weight loss, higher lung bacterial burden and excessive tissue inflammation compared to the control mice. Analysis of specific T cell cytokine production pattern in the lung following Cpn infection revealed that pDC depleted mice produced significantly higher amounts of inflammatory cytokines, especially TNF-alpha, but lower IL-10 compared to the controls. In particular, pDC depleted mice showed pathogenic T cell responses characterized by inflammatory type-1 (CD8 and CD4) and inflammatory Th2 cell responses. Moreover, pDC depletion dramatically reduced CD4 regulatory T cells (Tregs) in the lungs and draining lymph nodes. Furthermore, pDC-T cell co-culture experiments showed that pDCs isolated from Cpn infected mice were potent in inducing IL-10 producing CD4 Tregs. Together, these findings provide in vivo evidence for a critical role of pDCs in homeostatic regulation of immunity during Cpn infection. Our findings highlight the importance of a 'balanced' immune response for host protective immunity and preventing detrimental immunopathology during microbial infections.	[Yang, Xi] Univ Manitoba, Fac Med, Dept Med Microbiol, Lab Infect & Immun, Winnipeg, MB, Canada; Univ Manitoba, Fac Med, Dept Immunol, Winnipeg, MB R3E 0W3, Canada	University of Manitoba; University of Manitoba	Yang, X (corresponding author), Univ Manitoba, Fac Med, Dept Med Microbiol, Lab Infect & Immun, Winnipeg, MB, Canada.	Xi.Yang@med.umanitoba.ca		Yang, Xi/0000-0002-8831-7488	Canadian Institutes for Health Research (CIHR); Manitoba Health Research Council (MHRC); International Centre for Infectious Diseases/CIHR National Training Program; MHRC	Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Manitoba Health Research Council (MHRC); International Centre for Infectious Diseases/CIHR National Training Program; MHRC	This work was supported by operating grants from the Canadian Institutes for Health Research (CIHR) and the Manitoba Health Research Council (MHRC) to X.Y. A.G.J. was a recipient of Postdoctoral Fellowship Awards from the International Centre for Infectious Diseases/CIHR National Training Program and the MHRC. X.Y. is Canada Research Chair in Infection and Immunity. The funders of the study had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ang DKY, 2010, J IMMUNOL, V184, P5429, DOI 10.4049/jimmunol.1000128; Apostolaki M, 2010, CURR DIR AUTOIMMUN, V11, P1, DOI 10.1159/000289195; Balin BJ, 1998, MED MICROBIOL IMMUN, V187, P23, DOI 10.1007/s004300050071; Belkaid Y, 2002, NATURE, V420, P502, DOI 10.1038/nature01152; Belkaid Y, 2009, ANNU REV IMMUNOL, V27, P551, DOI 10.1146/annurev.immunol.021908.132723; Brunham RC, 2005, NAT REV IMMUNOL, V5, P149, DOI 10.1038/nri1551; Crother TR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048655; de Heer HJ, 2004, J EXP MED, V200, P89, DOI 10.1084/jem.20040035; Droemann D, 2007, AM J RESP CRIT CARE, V175, P791, DOI 10.1164/rccm.200607-926OC; Ejrnaes M, 2006, J EXP MED, V203, P2461, DOI 10.1084/jem.20061462; Freeman CM, 2010, J IMMUNOL, V184, P6504, DOI 10.4049/jimmunol.1000006; Gazzinelli RT, 1996, J IMMUNOL, V157, P798; Gencay Mesut, 2003, Am J Respir Med, V2, P31; Goubier A, 2008, IMMUNITY, V29, P464, DOI 10.1016/j.immuni.2008.06.017; Grimaldi LME, 2003, MULT SCLER, V9, P467, DOI 10.1191/1352458503ms944oa; Guilliams M, 2007, J IMMUNOL, V179, P2748, DOI 10.4049/jimmunol.179.5.2748; Jewell NA, 2007, J VIROL, V81, P9790, DOI 10.1128/JVI.00530-07; Johnston SC, 2001, STROKE, V32, P2748, DOI 10.1161/hs1201.099631; Joyee AG, 2008, AM J RESP CRIT CARE, V178, P745, DOI 10.1164/rccm.200804-517OC; Joyee AG, 2007, J IMMUNOL, V178, P1048, DOI 10.4049/jimmunol.178.2.1048; Joyee AG, 2010, J IMMUNOL, V184, P2095, DOI 10.4049/jimmunol.0901348; Kool M, 2009, J IMMUNOL, V183, P1074, DOI 10.4049/jimmunol.0900471; KUO CC, 1995, CLIN MICROBIOL REV, V8, P451, DOI 10.1128/CMR.8.4.451; Liu CW, 2008, J CLIN INVEST, V118, P1165, DOI 10.1172/JCI33583; Lundblad LKA, 2005, AM J RESP CRIT CARE, V171, P1363, DOI 10.1164/rccm.200410-1349OC; Ochando JC, 2006, NAT IMMUNOL, V7, P652, DOI 10.1038/ni1333; Penttila JM, 1999, IMMUNOLOGY, V97, P490, DOI 10.1046/j.1365-2567.1999.00809.x; Penttila T, 2008, MICROB PATHOGENESIS, V45, P25, DOI 10.1016/j.micpath.2008.02.004; Pepper M, 2008, J IMMUNOL, V180, P6229, DOI 10.4049/jimmunol.180.9.6229; Reizis B, 2011, ANNU REV IMMUNOL, V29, P163, DOI 10.1146/annurev-immunol-031210-101345; Rottenberg ME, 2000, J IMMUNOL, V164, P4812, DOI 10.4049/jimmunol.164.9.4812; Rottenberg ME, 1999, J IMMUNOL, V162, P2829; Srikiatkhachorn A, 2010, VIRAL IMMUNOL, V23, P639, DOI 10.1089/vim.2010.0076; Stockinger S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000355; Sun K, 2010, J VIROL, V84, P5007, DOI 10.1128/JVI.02408-09; Swiecki M, 2010, IMMUNITY, V33, P955, DOI 10.1016/j.immuni.2010.11.020; Takagi H, 2011, IMMUNITY, V35, P958, DOI 10.1016/j.immuni.2011.10.014; Voisine C, 2010, INT J PARASITOL, V40, P711, DOI 10.1016/j.ijpara.2009.11.005; Wang SH, 1999, EUR J IMMUNOL, V29, P3782, DOI 10.1002/(SICI)1521-4141(199911)29:11<3782::AID-IMMU3782>3.0.CO;2-B; Wantia N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026101; Wilson EH, 2005, J NEUROIMMUNOL, V165, P63, DOI 10.1016/j.jneuroim.2005.04.018; Wizel B, 2002, J IMMUNOL, V169, P2524, DOI 10.4049/jimmunol.169.5.2524; Yang X, 1999, J IMMUNOL, V162, P1010; Yang X, 2003, CURR PHARM DESIGN, V9, P67, DOI 10.2174/1381612033392486; Yang X, 1996, J IMMUNOL, V156, P4338	45	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e83463	10.1371/journal.pone.0083463	http://dx.doi.org/10.1371/journal.pone.0083463			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281QS	24386207	Green Published, Green Submitted, gold			2022-12-25	WOS:000329116700053
J	Tiburzy, B; Szyska, M; Iwata, H; Chrobok, N; Kulkarni, U; Hirose, M; Ludwig, RJ; Kalies, K; Westermann, J; Wong, D; Manz, RA				Tiburzy, Benjamin; Szyska, Martin; Iwata, Hiroaki; Chrobok, Navina; Kulkarni, Upasana; Hirose, Misa; Ludwig, Ralf J.; Kalies, Kathrin; Westermann, Juergen; Wong, David; Manz, Rudolf Armin			Persistent Autoantibody-Production by Intermediates between Short- and Long-Lived Plasma Cells in Inflamed Lymph Nodes of Experimental Epidermolysis Bullosa Acquisita	PLOS ONE			English	Article							DERMAL-EPIDERMAL SEPARATION; MEMORY B-CELLS; VII COLLAGEN; T-CELLS; BONE-MARROW; NZB/W MICE; CD154 EXPRESSION; HUMORAL IMMUNITY; PASSIVE TRANSFER; MAJOR SITE	Autoantibodies are believed to be maintained by either the continuous generation of short-lived plasma cells in secondary lymphoid tissues or by long-lived plasma cells localized in bone marrow and spleen. Here, we show in a mouse model for the autoimmune blistering skin disease epidermolysis bullosa acquisita (EBA) that chronic autoantibody production can also be maintained in inflamed lymph nodes, by plasma cells exhibiting intermediate lifetimes. After EBA induction by immunization with a mCOL7c-GST-fusion protein, antigen-specific plasma cells and CD4 T cells were analyzed. Plasma cells were maintained for months in stable numbers in the draining lymph nodes, but not in spleen and bone marrow. In contrast, localization of mCOL7c-GST -specific CD4 T cells was not restricted to lymph nodes, indicating that availability of T cell help does not limit plasma cell localization to this site. BrdU-incorporation studies indicated that pathogenic mCOL7c- and non-pathogenic GST-specific plasma cells resemble intermediates between short-and long-lived plasma cells with half-lives of about 7 weeks. Immunization with mCOL7c-GST also yielded considerable numbers of plasma cells neither specific for mCOL7c- nor GST. These bystander-activated plasma cells exhibited much shorter half-lives and higher population turnover, suggesting that plasma cell lifetimes were only partly determined by the lymph node environment but also by the mode of activation. These results indicate that inflamed lymph nodes can harbor pathogenic plasma cells exhibiting distinct properties and hence may resemble a so far neglected site for chronic autoantibody production.	[Tiburzy, Benjamin; Szyska, Martin; Kulkarni, Upasana; Wong, David; Manz, Rudolf Armin] Univ Lubeck, Inst Syst Inflammat Res ISEF, Lubeck, Germany; [Iwata, Hiroaki; Hirose, Misa; Ludwig, Ralf J.] Univ Lubeck, Dept Dermatol, Lubeck, Germany; [Chrobok, Navina; Kalies, Kathrin; Westermann, Juergen] Univ Lubeck, Inst Anat, Lubeck, Germany	University of Lubeck; University of Lubeck; University of Lubeck	Manz, RA (corresponding author), Univ Lubeck, Inst Syst Inflammat Res ISEF, Lubeck, Germany.	Rudolf.Manz@uksh.de	Ludwig, Ralf/F-3996-2018; Manz, Rudolf A/C-8340-2011; Kalies, Kathrin/A-8114-2014; Hirose, Misa/A-2858-2014; Ludwig, Ralf J/A-2629-2008	Ludwig, Ralf/0000-0002-1394-1737; Ludwig, Ralf J/0000-0002-1394-1737; Kalies, Kathrin/0000-0002-8929-4249	Deutsche Forschungsgemeinschaft DFG [GRK1727/1]; University of Luebeck	Deutsche Forschungsgemeinschaft DFG(German Research Foundation (DFG)); University of Luebeck	This work was supported by the Deutsche Forschungsgemeinschaft DFG via GRK1727/1. David Wong and Upasana Kulkarni were supported by an internal grant of the University of Luebeck. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blink EJ, 2005, J EXP MED, V201, P545, DOI 10.1084/jem.20042060; Cassese G, 2003, J IMMUNOL, V171, P1684, DOI 10.4049/jimmunol.171.4.1684; Cassese G, 2001, EUR J IMMUNOL, V31, P2726, DOI 10.1002/1521-4141(200109)31:9<2726::AID-IMMU2726>3.0.CO;2-H; Chen M, 2007, AM J PATHOL, V170, P2009, DOI 10.2353/ajpath.2007.061212; Ferraro AJ, 2008, EUR J IMMUNOL, V38, P292, DOI 10.1002/eji.200737557; Frentsch M, 2005, NAT MED, V11, P1118, DOI 10.1038/nm1292; Frey O, 2011, J AUTOIMMUN, V36, P161, DOI 10.1016/j.jaut.2010.12.006; Gupta R, 2012, CLIN DERMATOL, V30, P60, DOI 10.1016/j.clindermatol.2011.03.011; Hargreaves DC, 2001, J EXP MED, V194, P45, DOI 10.1084/jem.194.1.45; Hauser AE, 2002, J IMMUNOL, V169, P1277, DOI 10.4049/jimmunol.169.3.1277; Hiepe F, 2011, NAT REV RHEUMATOL, V7, P170, DOI 10.1038/nrrheum.2011.1; HO F, 1986, EUR J IMMUNOL, V16, P1297, DOI 10.1002/eji.1830161018; Hoyer BF, 2004, J EXP MED, V199, P1577, DOI 10.1084/jem.20040168; Kasperkiewicz M, 2011, J AM ACAD DERMATOL, V65, P552, DOI 10.1016/j.jaad.2010.07.032; Kirchhoff D, 2007, EUR J IMMUNOL, V37, P2370, DOI 10.1002/eji.200737322; Le Roux-Villet C, 2011, ARCH DERMATOL, V147, P843, DOI 10.1001/archdermatol.2011.54; Ludwig RJ, 2012, AUTOIMMUNITY, V45, P102, DOI 10.3109/08916934.2011.606451; Ludwig RJ, 2011, DERMATOL CLIN, V29, P493, DOI 10.1016/j.det.2011.03.003; Ludwig RJ, 2011, J INVEST DERMATOL, V131, P167, DOI 10.1038/jid.2010.248; Manz RA, 1997, NATURE, V388, P133, DOI 10.1038/40540; Manz RA, 2005, ANNU REV IMMUNOL, V23, P367, DOI 10.1146/annurev.immunol.23.021704.115723; Manz RA, 2002, CURR OPIN IMMUNOL, V14, P517, DOI 10.1016/S0952-7915(02)00356-4; Moser K, 2006, CURR OPIN IMMUNOL, V18, P265, DOI 10.1016/j.coi.2006.03.004; Moser K, 2012, ARTHRITIS RHEUM-US, V64, P1237, DOI 10.1002/art.33424; Muehlinghaus G, 2005, BLOOD, V105, P3965, DOI 10.1182/blood-2004-08-2992; Mumtaz IM, 2012, J AUTOIMMUN, V39, P180, DOI 10.1016/j.jaut.2012.05.010; Nagel A, 2009, J INVEST DERMATOL, V129, P289, DOI 10.1038/jid.2008.192; Orsini MJ, 2000, J BIOL CHEM, V275, P25876; Ryan KR, 2007, J AUTOIMMUN, V29, P262, DOI 10.1016/j.jaut.2007.07.014; Schmidt E, 2006, ARCH DERMATOL, V142, P147, DOI 10.1001/archderm.142.2.147; Schmidt E, 2000, ARCH DERMATOL, V136, P174, DOI 10.1001/archderm.136.2.174; Sitaru AG, 2010, J IMMUNOL, V184, P1596, DOI 10.4049/jimmunol.0901412; Sitaru C, 2005, J CLIN INVEST, V115, P870, DOI 10.1172/JCI200521386; Sitaru C, 2002, AM J PATHOL, V161, P301, DOI 10.1016/S0002-9440(10)64182-X; Sitaru C, 2006, J IMMUNOL, V177, P3461, DOI 10.4049/jimmunol.177.5.3461; Slifka MK, 1998, IMMUNITY, V8, P363, DOI 10.1016/S1074-7613(00)80541-5; Starke C, 2011, EUR J IMMUNOL, V41, P2107, DOI 10.1002/eji.201041315; TESCH H, 1984, EUR J IMMUNOL, V14, P188, DOI 10.1002/eji.1830140215; Toellner KM, 2002, J EXP MED, V195, P383, DOI 10.1084/jem.20011112; Winter O, 2010, BLOOD, V116, P1867, DOI 10.1182/blood-2009-12-259457; Woodley DT, 2006, J INVEST DERMATOL, V126, P1323, DOI 10.1038/sj.jid.5700254	41	18	18	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e83631	10.1371/journal.pone.0083631	http://dx.doi.org/10.1371/journal.pone.0083631			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281QS	24386241	gold, Green Published, Green Submitted			2022-12-25	WOS:000329116700066
J	Zhao, P; Elks, CM; Stephens, JM				Zhao, Peng; Elks, Carrie M.; Stephens, Jacqueline M.			The Induction of Lipocalin-2 Protein Expression in Vivo and in Vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Adipocyte; Adipose Tissue; ERK; Interferon; Tumor Necrosis Factor (TNF); NF-B; STAT	NECROSIS-FACTOR-ALPHA; NF-KAPPA-B; INDUCED INSULIN-RESISTANCE; 3T3-L1 ADIPOCYTES; ADIPOSE-TISSUE; TYROSINE PHOSPHORYLATION; SERINE PHOSPHORYLATION; INTERFERON-GAMMA; INNATE IMMUNITY; BINDING-PROTEIN	Background: Lipocalin-2 is induced in obesity/type 2 diabetes. Results: TNF and IFN induce LCN2 in vivo. STAT1 and NF-B are required for LCN2 induction and bind the human LCN2 promoter. Conclusion: An interplay between ERKs, STAT1, and NF-B signaling pathways mediates the IFN and TNF induction of LCN2. Significance: Cytokine modulation of LCN2 increases our understanding of gene regulation in obesity/type 2 diabetes. Lipocalin-2 (LCN2) is secreted from adipocytes, and its expression is up-regulated in obese and diabetic mice and humans. LCN2 expression and secretion have been shown to be induced by two proinflammatory cytokines, IFN and TNF, in cultured murine and human adipocytes. In these studies, we demonstrated that IFN and TNF induced LCN2 expression and secretion in vivo. Although we observed a strong induction of LCN2 expression and secretion from white adipose tissue (WAT) depots, the induction of LCN2 varied among different insulin-sensitive tissues. Knockdown experiments also demonstrated that STAT1 is required for IFN-induced lipocalin-2 expression in murine adipocytes. Similarly, knockdown of p65 in adipocytes demonstrated the necessity of the NF-B signaling pathway for TNF-mediated effects on LCN2. Activation of ERKs by IFN and TNF also affected STAT1 and NF-B signaling through modulation of serine phosphorylation. ERK activation-induced serine phosphorylation of both STAT1 and p65 mediated the additive effects of IFN and TNF on LCN2 expression. Our results suggest that these same mechanisms occur in humans as we observed STAT1 and NF-B binding to the human LCN2 promoter in chromatin immunoprecipitation assays performed in human fat cells. These studies substantially increase our knowledge regarding the requirements and mechanisms used by proinflammatory cytokines to induce LCN2 expression.	[Stephens, Jacqueline M.] Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA; Pennington Biomed Res Ctr, Adipocyte Biol Lab, Baton Rouge, LA 70808 USA	Louisiana State University System; Louisiana State University; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center	Stephens, JM (corresponding author), Louisiana State Univ, Dept Biol Sci, 202 Life Sci Bldg, Baton Rouge, LA 70803 USA.	jsteph1@lsu.edu	Stephens, Jacqueline M/R-5217-2018; Zhao, Peng/G-3562-2019; Elks, Carrie Marie/N-1961-2017		National Institutes of Health [R01DK052968-15]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052968, P30DK072476] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R01DK052968-15 (to J. M. S.).	Catalan V, 2009, J MOL MED, V87, P803, DOI 10.1007/s00109-009-0486-8; COWAN SW, 1990, PROTEINS, V8, P44, DOI 10.1002/prot.340080108; Flo TH, 2004, NATURE, V432, P917, DOI 10.1038/nature03104; Goetz DH, 2002, MOL CELL, V10, P1033, DOI 10.1016/S1097-2765(02)00708-6; GRANDALIANO G, 1994, J LAB CLIN MED, V123, P282; Guo H, 2013, ENDOCRINOLOGY, V154, P3525, DOI 10.1210/en.2013-1289; Guo H, 2010, DIABETES, V59, P1376, DOI 10.2337/db09-1735; HOTAMISLIGIL GS, 1994, DIABETES, V43, P1271, DOI 10.2337/diabetes.43.11.1271; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; HOTAMISLIGIL GS, 1994, P NATL ACAD SCI USA, V91, P4854, DOI 10.1073/pnas.91.11.4854; Hu J, 2004, CARCINOGENESIS, V25, P1991, DOI 10.1093/carcin/bgh198; Hu JB, 2001, J BIOL CHEM, V276, P287, DOI 10.1074/jbc.M004885200; Jun LS, 2011, AM J PHYSIOL-ENDOC M, V301, pE825, DOI 10.1152/ajpendo.00147.2011; Kershaw EE, 2004, J CLIN ENDOCR METAB, V89, P2548, DOI 10.1210/jc.2004-0395; KJELDSEN L, 1993, J BIOL CHEM, V268, P10425; Law IKM, 2010, DIABETES, V59, P872, DOI 10.2337/db09-1541; Mattioli I, 2004, J IMMUNOL, V172, P6336, DOI 10.4049/jimmunol.172.10.6336; Nelson AL, 2005, CELL MICROBIOL, V7, P1404, DOI 10.1111/j.1462-5822.2005.00566.x; Ruan H, 2002, DIABETES, V51, P1319, DOI 10.2337/diabetes.51.5.1319; STEPHENS JM, 1991, J BIOL CHEM, V266, P21839; Stephens JM, 1997, J BIOL CHEM, V272, P971, DOI 10.1074/jbc.272.2.971; Varinou L, 2003, IMMUNITY, V19, P793, DOI 10.1016/S1074-7613(03)00322-4; Vermeulen L, 2003, EMBO J, V22, P1313, DOI 10.1093/emboj/cdg139; VIETOR I, 1993, J BIOL CHEM, V268, P18994; Waite KJ, 2001, J BIOL CHEM, V276, P7062, DOI 10.1074/jbc.M007894200; Wang Y, 2007, CLIN CHEM, V53, P34, DOI 10.1373/clinchem.2006.075614; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; WEN ZL, 1995, CELL, V82, P241, DOI 10.1016/0092-8674(95)90311-9; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Yan QW, 2007, DIABETES, V56, P2533, DOI 10.2337/db07-0007; Zhang JH, 2008, MOL ENDOCRINOL, V22, P1416, DOI 10.1210/me.2007-0420; Zhao P., 2013, JAKSTAT, V2; Zhao P, 2013, MOL METAB, V2, P161, DOI 10.1016/j.molmet.2013.04.003; Zhong HH, 1997, CELL, V89, P413, DOI 10.1016/S0092-8674(00)80222-6; Zhu XJ, 1997, MOL CELL BIOL, V17, P6618, DOI 10.1128/MCB.17.11.6618	35	61	61	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 28	2014	289	9					5960	5969		10.1074/jbc.M113.532234	http://dx.doi.org/10.1074/jbc.M113.532234			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB8BQ	24391115	Green Published, hybrid			2022-12-25	WOS:000332015500052
J	Cai, LB; Ma, X; Liu, S; Liu, JJ; Wang, W; Cui, YG; Ding, W; Mao, YD; Chen, HP; Huang, J; Zhou, ZM; Liu, JY				Cai, Lingbo; Ma, Xiang; Liu, Shan; Liu, Jinjuan; Wang, Wei; Cui, Yugui; Ding, Wei; Mao, Yundong; Chen, Huiping; Huang, Jie; Zhou, Zuomin; Liu, Jiayin			Effects of Upregulation of Hsp27 Expression on Oocyte Development and Maturation Derived from Polycystic Ovary Syndrome	PLOS ONE			English	Article							OXIDATIVE STRESS; CELL-DEATH; APOPTOSIS; ACTIVATION; RESISTANCE; PROGRESS; QUALITY; WOMEN	Heat shock protein 27 (Hsp27) is a heat shock protein family member which can inhibit apoptosis. Our previous studies reported down-regulated Hsp27 in ovarian tissue derived from women with polycystic ovary syndrome (PCOS) however, the exact effect of Hsp27 on oocyte maturation and developmental competence in PCOS is unclear. The effect of Hsp27 overexpression was studied in vitro using oocytes derived from PCOS patients. An artificial GFP-plasmid was injected into human oocyte to increase Hsp27 protein level. Oocyte maturation was evaluated by morphological observation. Mature oocytes were fertilized by intracytoplasmic sperm injection (ICSI) and embryonic developmental competence was evaluated. Critical apoptotic factors and cytokines were measured at both the mRNA and protein level. Our results revealed that Overexpression of HSP27 lowered the maturation rate of oocytes derived from PCOS patients. Meanwhile, fertilization rate and high quality embryo rate were similar between the Hsp27 overexpressing group and controls; however, the blastocyst formation rate in this group was significantly higher than control. Expression analysis revealed that the oocyte-secreted factors, BMP15 and GDF9, and the apoptotic-related regulators, Caspase 3, 8 and 9, were all significantly decreased in Hsp27 overexpressing oocytes. In conclusion, upregulation of Hsp27 inhibits oocyte maturation from PCOS patients, but improves embryonic developmental potential.	[Cai, Lingbo; Ma, Xiang; Liu, Shan; Liu, Jinjuan; Wang, Wei; Cui, Yugui; Ding, Wei; Mao, Yundong; Chen, Huiping; Huang, Jie; Zhou, Zuomin; Liu, Jiayin] Nanjing Med Univ, Affiliated Hosp 1, Clin Ctr Reprod Med, State Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University	Zhou, ZM (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Clin Ctr Reprod Med, State Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China.	zhouzm@njmu.edu.cn; jyliu_nj@126.com		cai, lingbo/0000-0001-5094-0082	National Natural Projects of China [30800394, 81070465]; National Natural Projects of China 973 Program [2012CB944703, 2012CB944902]	National Natural Projects of China; National Natural Projects of China 973 Program(National Basic Research Program of China)	This work was supported by grants from the National Natural Projects of China (30800394 and 81070465) and 973 Program (2012CB944703 and 2012CB944902). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal A, 2012, REPROD BIOL ENDOCRIN, V10, DOI 10.1186/1477-7827-10-49; Behrman HR, 2001, J SOC GYNECOL INVEST, V8, pS40, DOI 10.1016/S1071-5576(00)00106-4; Bilodeau-Goeseels S, 2002, ANIM REPROD SCI, V71, P143, DOI 10.1016/S0378-4320(01)00188-9; Bruey JM, 2000, NAT CELL BIOL, V2, P645, DOI 10.1038/35023595; Charette SJ, 2000, MOL CELL BIOL, V20, P7602, DOI 10.1128/MCB.20.20.7602-7612.2000; Concannon CG, 2003, APOPTOSIS, V8, P61, DOI 10.1023/A:1021601103096; de Wit AAC, 2001, ANIM REPROD SCI, V65, P51, DOI 10.1016/S0378-4320(00)00215-3; DELOOS F, 1992, MOL REPROD DEV, V31, P208, DOI 10.1002/mrd.1080310308; Dunaif A, 1997, ENDOCR REV, V18, P774, DOI 10.1210/er.18.6.774; FRANKS S, 1995, NEW ENGL J MED, V333, P853, DOI 10.1056/NEJM199509283331307; Garrido C, 2003, CELL CYCLE, V2, P579, DOI 10.4161/cc.2.6.521; Heijnen EMEW, 2006, HUM REPROD UPDATE, V12, P13, DOI 10.1093/humupd/dmi036; Hendriksen PJM, 2000, THERIOGENOLOGY, V53, P11, DOI 10.1016/S0093-691X(99)00236-8; Hooper PL, 2003, DIABETES CARE, V26, P951, DOI 10.2337/diacare.26.3.951; Hughes C, 2006, HUM REPROD, V21, P2766, DOI 10.1093/humrep/del222; Jaroudi S, 2007, MUTAT RES-REV MUTAT, V635, P53, DOI 10.1016/j.mrrev.2006.09.002; Kammanadiminti SJ, 2006, J BIOL CHEM, V281, P26112, DOI 10.1074/jbc.M601988200; Karlstrom PO, 1997, HUM REPROD, V12, P1263; Lanneau D, 2008, J CELL MOL MED, V12, P743, DOI 10.1111/j.1582-4934.2008.00273.x; Li HJ, 2009, ANIM REPROD SCI, V114, P89, DOI 10.1016/j.anireprosci.2008.09.018; Liu JJ, 2010, REPROD BIOL ENDOCRIN, V8, DOI 10.1186/1477-7827-8-47; Ma X, 2007, MOL HUM REPROD, V13, P527, DOI 10.1093/molehr/gam036; Matwee C, 2000, ZYGOTE, V8, P57, DOI 10.1017/S0967199400000836; Mehlen P, 1996, J BIOL CHEM, V271, P16510, DOI 10.1074/jbc.271.28.16510; MEHLEN P, 1995, J IMMUNOL, V154, P363; Moran L, 2009, HUM REPROD UPDATE, V15, P477, DOI 10.1093/humupd/dmp008; Morita Y, 1999, DEV BIOL, V213, P1, DOI 10.1006/dbio.1999.9344; Pandey P, 2000, ONCOGENE, V19, P1975, DOI 10.1038/sj.onc.1203531; Perez GI, 1999, NAT GENET, V21, P200, DOI 10.1038/5985; Perez GI, 1997, NAT MED, V3, P1228, DOI 10.1038/nm1197-1228; Schoolcraft WB, 1999, FERTIL STERIL, V72, P604, DOI 10.1016/S0015-0282(99)00311-8; Tilly JL, 2001, NAT REV MOL CELL BIO, V2, P838, DOI 10.1038/35099086; Toulis KA, 2009, HUM REPROD UPDATE, V15, P297, DOI 10.1093/humupd/dmp006; VandenAbbeel E, 1997, HUM REPROD, V12, P2006, DOI 10.1093/humrep/12.9.2006; Whitlock NA, 2005, INVEST OPHTH VIS SCI, V46, P1085, DOI 10.1167/iovs.04-0042; Wood JR, 2007, J CLIN ENDOCR METAB, V92, P705, DOI 10.1210/jc.2006-2123; Yuan YQ, 2005, THERIOGENOLOGY, V63, P2147, DOI 10.1016/j.theriogenology.2004.09.054	37	17	20	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83402	10.1371/journal.pone.0083402	http://dx.doi.org/10.1371/journal.pone.0083402			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391762	gold, Green Submitted, Green Published			2022-12-25	WOS:000329325200059
J	Park, S; Nahm, MH				Park, Saeyoung; Nahm, Moon H.			L-Rhamnose Is Often an Important Part of Immunodominant Epitope for Pneumococcal Serotype 23F Polysaccharide Antibodies in Human Sera Immunized with PPV23	PLOS ONE			English	Article							STREPTOCOCCUS-PNEUMONIAE; CAPSULAR POLYSACCHARIDE; CONJUGATE VACCINES; OLIGOSACCHARIDE-PROTEIN; GENE USAGE; IMMUNOGENICITY; IDENTIFICATION; REPERTOIRE; EMERGENCE; INFANTS	Streptococcus pneumoniae is a major human pathogen which expresses more than 90 serologically distinct capsular polysaccharides (PS) on the surface. Since pneumococcal PSs elicit protective antibodies against pneumococcal diseases, it is important to identify the immunological epitope eliciting anti-pneumococcal PS antibodies. L-rhamnose is a part of the 23F PS repeating unit and is known to be a critical part of immunodominant epitope which elicits antibodies against pneumococcal serotype 23F PS. In order to determine if L-rhamnose is a part of epitope recognized by functional antibodies specific for serotype 23F PS in human serum samples, we evaluated the opsonophagocytic killing of serotype 23F pneumococci by serum antibodies specific for L-rhamnose. Using 10 mM L-rhamnose, opsonic capacities (opsonic indices) of serum antibodies were inhibited by 60% in 19 sera (36%) and 30-60% in 16 sera (30%) out of 53 sera from young and old adults immunized with 23-valent pneumococcal polysaccharide vaccine (PPV23). Interestingly, when IgM antibodies were depleted from immune sera in order to preferentially study IgG antibodies, the proportion of young adult sera showing more than 60% inhibition in opsonic capacity by 10 mM of L-rhamnose increased from 33% (11/31) to 68% (21/31). On the other hand, IgM depletion did not alter the proportion for old adult sera. Therefore, young and old adults may produce different antigen binding profiles of IgG antibodies against serotype 23F PS.	[Park, Saeyoung; Nahm, Moon H.] Univ Alabama Birmingham, Birmingham, AL USA	University of Alabama System; University of Alabama Birmingham	Park, S (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Infect Dis, Boston, MA 02115 USA.	spark13@rics.bwh.harvard.edu		Nahm, Moon/0000-0002-6922-1042	National Institutes of Health from the National Institute of Allergy and Infectious Diseases [R01-AI-69509]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI069509] Funding Source: NIH RePORTER	National Institutes of Health from the National Institute of Allergy and Infectious Diseases; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding provided by the National Institutes of Health Grant R01-AI-69509 from the National Institute of Allergy and Infectious Diseases to MHN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anonymous, 2010, Morbidity and Mortality Weekly Report, V59, P258; AVERY OSWALD T., 1931, JOUR EXP MED, V54, P73, DOI 10.1084/jem.54.1.73; Benaissa-Trouw B, 2001, INFECT IMMUN, V69, P4698, DOI 10.1128/IAI.69.7.4698-4701.2001; Bratcher PE, 2010, MICROBIOL-SGM, V156, P555, DOI 10.1099/mic.0.034116-0; Bryant KA, 2010, PEDIATRICS, V125, P866, DOI 10.1542/peds.2009-1405; Burton RL, 2006, CLIN VACCINE IMMUNOL, V13, P1004, DOI 10.1128/CVI.00112-06; Calix JJ, 2010, J INFECT DIS, V202, P29, DOI 10.1086/653123; CISAR J, 1975, J EXP MED, V142, P435, DOI 10.1084/jem.142.2.435; Danieli E, 2012, BIOORGAN MED CHEM, V20, P6403, DOI 10.1016/j.bmc.2012.08.048; DEVELASCO EA, 1994, INFECT IMMUN, V62, P799; Frasca D, 2008, J IMMUNOL, V180, P5283, DOI 10.4049/jimmunol.180.8.5283; Frasca D, 2009, CURR OPIN IMMUNOL, V21, P425, DOI 10.1016/j.coi.2009.06.001; Gening ML, 2010, INFECT IMMUN, V78, P764, DOI 10.1128/IAI.01093-09; HAGLUND LA, 1993, J INFECT DIS, V168, P1532, DOI 10.1093/infdis/168.6.1532; HEIDELBERGER M, 1967, J IMMUNOL, V99, P794; Hill PC, 2008, CLIN INFECT DIS, V46, P807, DOI 10.1086/528688; Huang SS, 2005, PEDIATRICS, V116, pE408, DOI 10.1542/peds.2004-2338; Jackson LA, 2007, VACCINE, V25, P4029, DOI 10.1016/j.vaccine.2007.02.062; Jansen WTM, 2004, INDIAN J MED RES, V119, P7; Jansen WTM, 2001, INFECT IMMUN, V69, P787, DOI 10.1128/IAI.69.2.787-793.2001; Kamerling JP., 2000, STREPTOCOCCUS PNEUMO, P81; Kolar GR, 2006, SCAND J IMMUNOL, V64, P314, DOI 10.1111/j.1365-3083.2006.01817.x; Leggat DJ, 2013, J INFECT DIS, V208, P101, DOI 10.1093/infdis/jit139; Park IH, 2007, J CLIN MICROBIOL, V45, P1225, DOI 10.1128/JCM.02199-06; Park S, 2011, INFECT IMMUN, V79, P314, DOI 10.1128/IAI.00768-10; Pelton SI, 2007, PEDIATR INFECT DIS J, V26, P468, DOI 10.1097/INF.0b013e31803df9ca; Reason DC, 2004, CLIN IMMUNOL, V111, P132, DOI 10.1016/j.clim.2003.12.004; Richter SS, 2009, CLIN INFECT DIS, V48, pE23, DOI 10.1086/595857; ROBBINS JB, 1983, J INFECT DIS, V148, P1136, DOI 10.1093/infdis/148.6.1136; Rubins JB, 1998, J INFECT DIS, V178, P431, DOI 10.1086/515644; Safari D, 2008, INFECT IMMUN, V76, P4615, DOI 10.1128/IAI.00472-08; Shinefield HR, 2000, PEDIATR INFECT DIS J, V19, P394, DOI 10.1097/00006454-200004000-00036; Smithson SL, 2005, INFECT IMMUN, V73, P7477, DOI 10.1128/IAI.73.11.7477-7484.2005; Verez-Bencomo V, 2004, SCIENCE, V305, P522, DOI 10.1126/science.1095209; Vesikari T, 2009, PEDIATR INFECT DIS J, V28, pS66, DOI 10.1097/INF.0b013e318199f8ef; Wernette CM, 2003, CLIN DIAGN LAB IMMUN, V10, P514, DOI 10.1128/CDLI.10.4.514-519.2003; Zhou JH, 2002, INFECT IMMUN, V70, P4083, DOI 10.1128/IAI.70.8.4083-4091.2002; Zhou ZH, 2007, J AUTOIMMUN, V29, P219, DOI 10.1016/j.jaut.2007.07.015; Zhou ZH, 2007, CELL HOST MICROBE, V1, P51, DOI 10.1016/j.chom.2007.01.002	39	7	11	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83810	10.1371/journal.pone.0083810	http://dx.doi.org/10.1371/journal.pone.0083810			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391831	Green Submitted, gold, Green Published			2022-12-25	WOS:000329325200129
J	Piper, SK; Habermehl, C; Schmitz, CH; Kuebler, WM; Obrig, H; Steinbrink, J; Mehnert, J				Piper, Sophie K.; Habermehl, Christina; Schmitz, Christoph H.; Kuebler, Wolfgang M.; Obrig, Hellmuth; Steinbrink, Jens; Mehnert, Jan			Towards Whole-Body Fluorescence Imaging in Humans	PLOS ONE			English	Article							INDOCYANINE GREEN; BREAST-CANCER; RELEVANCE; FUTURE; LIGHT	Dynamic near-infrared fluorescence (DNIF) whole-body imaging of small animals has become a popular tool in experimental biomedical research. In humans, however, the field of view has been limited to body parts, such as rheumatoid hands, diabetic feet or sentinel lymph nodes. Here we present a new whole-body DNIF-system suitable for adult subjects. We explored whether this system (i) allows dynamic whole-body fluorescence imaging and (ii) can detect modulations in skin perfusion. The non-specific fluorescent probe indocyanine green (ICG) was injected intravenously into two subjects, and fluorescence images were obtained at 5 Hz. The in-and out-flow kinetics of ICG have been shown to correlate with tissue perfusion. To validate the system, skin perfusion was modulated by warming and cooling distinct areas on the chest and the abdomen. Movies of fluorescence images show a bolus passage first in the face, then in the chest, abdomen and finally in the periphery (similar to 10, 15, 20 and 30 seconds, respectively). When skin perfusion is augmented by warming, bolus arrives about 5 seconds earlier than when the skin is cooled and perfusion decreased. Calculating bolus arrival times and spatial fitting of basis time courses extracted from different regions of interest allowed a mapping of local differences in subcutaneous skin perfusion. This experiment is the first to demonstrate the feasibility of whole-body dynamic fluorescence imaging in humans. Since the whole-body approach demonstrates sensitivity to circumscribed alterations in skinperfusion, it may be used to target autonomous changes in polyneuropathy and to screen for peripheral vascular diseases.	[Piper, Sophie K.; Habermehl, Christina; Schmitz, Christoph H.; Obrig, Hellmuth; Steinbrink, Jens; Mehnert, Jan] Charite, Dept Neurol, D-13353 Berlin, Germany; [Piper, Sophie K.; Habermehl, Christina; Mehnert, Jan] Berlin Inst Technol, Machine Learning Dept, Berlin, Germany; [Schmitz, Christoph H.] NIRx Med Tech, Berlin, Germany; [Kuebler, Wolfgang M.] Charite, Inst Physiol, D-13353 Berlin, Germany; [Obrig, Hellmuth] Max Planck Inst Human Cognit & Brain Sci, Dept Neurol, Leipzig, Germany; [Obrig, Hellmuth] Univ Hosp Leipzig, Clin Cognit Neurol, Leipzig, Germany; [Piper, Sophie K.; Habermehl, Christina; Steinbrink, Jens; Mehnert, Jan] Charite, Ctr Stroke Res, D-13353 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Technical University of Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Max Planck Society; Leipzig University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Piper, SK (corresponding author), Charite, Dept Neurol, D-13353 Berlin, Germany.	sophie.piper@charite.de	Mehnert, Jan/AAX-8791-2020	Mehnert, Jan/0000-0001-7088-740X; Kuebler, Wolfgang/0000-0003-4100-2961; Piper, Sophie K./0000-0002-0147-8992; Habermehl, Christina/0000-0001-5245-9727	Sonnenfeld Stiftung; NIRx Medizintechnik GmbH	Sonnenfeld Stiftung; NIRx Medizintechnik GmbH	The technical equipment of this study was financed by the Sonnenfeld Stiftung (http://www.sonnenfeld-stiftung.de/) and NIRx Medizintechnik GmbH (http://www.nirx.net). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alacam B, 2008, PHYS MED BIOL, V53, P837, DOI 10.1088/0031-9155/53/4/002; Alander JT, 2012, INT J BIOMED IMAGING, V2012, DOI 10.1155/2012/940585; Corlu A, 2007, OPT EXPRESS, V15, P6696, DOI 10.1364/OE.15.006696; Ebert Bernd, 2013, Recent Results Cancer Res, V187, P331, DOI 10.1007/978-3-642-10853-2_11; Gao M, 2005, APPL OPTICS, V44, P5468, DOI 10.1364/AO.44.005468; Habermehl C, 2011, OPT EXPRESS, V19, P18636, DOI 10.1364/OE.19.018636; Hillman EMC, 2007, NAT PHOTONICS, V1, P526, DOI 10.1038/nphoton.2007.146; Hillman EMC, 2011, PHILOS T R SOC A, V369, P4620, DOI 10.1098/rsta.2011.0264; Humeau-Heurtier A, 2013, IEEE T BIO-MED ENG, V60, P659, DOI 10.1109/TBME.2013.2243449; Imaizumi M, 2012, J NUCL MED, V53; Ingrisch M, 2013, J PHARMACOKINET PHAR; Jelzow A, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.5.057003; Klohs J, 2008, STROKE, V39, P2845, DOI 10.1161/STROKEAHA.107.509844; Klohs J, 2006, MOL IMAGING, V5, P180; Leblond F, 2010, J PHOTOCH PHOTOBIO B, V98, P77, DOI 10.1016/j.jphotobiol.2009.11.007; Liebert A, 2006, NEUROIMAGE, V31, P600, DOI 10.1016/j.neuroimage.2005.12.046; Lodge M, 2012, J NUCL MED, V53; Marshall Milton V, 2010, Open Surg Oncol J, V2, P12; Ntziachristos V, 2003, EUR RADIOL, V13, P195, DOI 10.1007/s00330-002-1524-x; Ntziachristos V, 2005, NAT BIOTECHNOL, V23, P313, DOI 10.1038/nbt1074; Nuiachristos V, 2006, ANNU REV BIOMED ENG, V8, P1, DOI 10.1146/annurev.bioeng.8.061505.095831; Patel JK, 2008, EUR J DERMATOL, V18, P617, DOI 10.1684/ejd.2008.0508; Perry Diana, 2012, J Diabetes Sci Technol, V6, P204; Poellinger A, 2012, J BIOPHOTONICS, V5, P815, DOI 10.1002/jbio.201200123; Poellinger A, 2011, INVEST RADIOL, V46, P697, DOI 10.1097/RLI.0b013e318229ff25; Poellinger A, 2011, RADIOLOGY, V258, P409, DOI 10.1148/radiol.10100258; Polom K, 2012, BRIT J DERMATOL, V166, P682, DOI 10.1111/j.1365-2133.2011.10634.x; Polom K, 2011, CANCER-AM CANCER SOC, V117, P4812, DOI 10.1002/cncr.26087; Rasmussen JC, 2009, CURR OPIN BIOTECH, V20, P74, DOI 10.1016/j.copbio.2009.01.009; Redpath TW, 1997, BRIT J RADIOL, V70, pS70, DOI 10.1259/bjr.1997.0010; Rijpkema M, 2001, J MAGN RESON IMAGING, V14, P457, DOI 10.1002/jmri.1207; Ring Francis, 2010, J Diabetes Sci Technol, V4, P857; Sevick-Muraca EM, 2012, ANNU REV MED, V63, P217, DOI 10.1146/annurev-med-070910-083323; Steinbrink J, 2006, J THORAC CARDIOV SUR, V132, P1172, DOI 10.1016/j.jtcvs.2006.05.065; Stemmer N, 2012, CURR MED CHEM, V19, P4786, DOI 10.2174/092986712803341494; Taruttis A, 2012, AM J ROENTGENOL, V199, P263, DOI 10.2214/AJR.11.8431; TOGAWA T, 1994, PHYSIOL MEAS, V15, P291, DOI 10.1088/0967-3334/15/3/007; VandenBrande P, 1997, INT J MICROCIRC, V17, P55, DOI 10.1159/000179207; Werner SG, 2012, ANN RHEUM DIS, V71, P504, DOI 10.1136/annrheumdis-2010-148288; Williams SP, 2012, AAPS J, V14, P389, DOI 10.1208/s12248-012-9348-3; Zhang Hua, 2011, Expert Opin Med Diagn, V5, P241	41	10	10	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83749	10.1371/journal.pone.0083749	http://dx.doi.org/10.1371/journal.pone.0083749			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391820	Green Submitted, Green Published, gold			2022-12-25	WOS:000329325200118
J	Xu, BY; Tan, WT; Tan, S; Dan, YJ; Luo, XL; Deng, GH				Xu, Bao-Yan; Tan, Wen-Ting; Tan, Shun; Dan, Yun-Jie; Luo, Xiao-Li; Deng, Guo-Hong			Serum Testosterone Levels and Androgen Receptor CAG Polymorphism Correlate with Hepatitis B Virus (HBV)-Related Acute Liver Failure in Male HBV Carriers	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; X-CHROMOSOME; RISK; DISEASE; GENE; LOCALIZATION; EXACERBATION; ASSOCIATION; REPEATS; TRACT	Background: Augmentation of androgen/androgen receptor (AR) pathway may influence chronic hepatitis B (CHB) more likely in males. AR activity is modulated by a polymorphic CAG repeat sequence in AR exon 1. This study aimed to investigate the relationship between serum testosterone levels, CAG repeat numbers and hepatitis B virus (HBV)-related acute liver failure (ALF). Methods: Three hundred and seventy eight male CHB patients with ALF and 441 asymptomatic HBV carriers (AsCs) were recruited. AR CAG repeats numbers were analyzed. The serum testosterone levels of AsCs, ALFs and patients with hepatitis B flare groups, and sequential serum samples, were assessed quantitatively. Results: The median CAG repeat (M-CAG) frequency was significantly higher in ALF patients than AsCs (P<0.001). Patients with M-CAG alleles (P<0.001, OR 3.0, 95% CI 2.1-4.2) had the highest risk for ALF. Serum testosterone levels were significantly higher (P<0.001) at hepatitis flare point (8.2 +/- 3.0 ng/mL) than inactive phase (6.4 +/- 2.0 ng/mL). CHB (8.30 +/- 2.71 ng/mL, P = 7.6x10(-6)) and ALF group (2.61 +/- 1.83 ng/mL, P = 1.7x10(-17)) had significantly different levels of testosterone in comparison with AsCs group (6.56 +/- 2.36 ng/mL). The serum testosterone levels sharply decreased from hepatitis flare phase to liver failure phase, and tended to be normal at the recovery phase. Male AsCs with M-CAG alleles had significantly lower serum testosterone levels (P<0.05). Conclusions: There was a serum testosterone fluctuation during hepatitis B flare and HBV-related ALF, and the median CAG repeats in AR gene exon 1 were associated with lower serum testosterone levels in asymptomatic HBV carriers and an increased susceptibility to HBV-related ALF.	[Xu, Bao-Yan; Tan, Wen-Ting; Tan, Shun; Dan, Yun-Jie; Luo, Xiao-Li; Deng, Guo-Hong] Third Mil Med Univ, Southwest Hosp, Dept Infect Dis, Chongqing, Peoples R China; [Xu, Bao-Yan; Tan, Wen-Ting; Tan, Shun; Dan, Yun-Jie; Luo, Xiao-Li; Deng, Guo-Hong] Chongqing Key Lab Res Infect Dis, Chongqing, Peoples R China; [Deng, Guo-Hong] Third Mil Med Univ, Inst Immunol, Chongqing, Peoples R China	Army Medical University; Army Medical University	Deng, GH (corresponding author), Third Mil Med Univ, Southwest Hosp, Dept Infect Dis, Chongqing, Peoples R China.	gh_deng@hotmail.com			Chongqing Natural Science Foundation [CSTC-2008BB5129, CSTC-2010BB5037, CSTC-2011JJJQ10005]; State Key Project Specialized for Infectious Diseases [2012ZX10002007-002-005]; Third Military Medical University (TMMU) [2012XLC05]	Chongqing Natural Science Foundation(Natural Science Foundation of Chongqing); State Key Project Specialized for Infectious Diseases; Third Military Medical University (TMMU)	This work was supported by the Chongqing Natural Science Foundation [Grant numbers CSTC-2008BB5129, CSTC-2010BB5037, and CSTC-2011JJJQ10005]; the State Key Project Specialized for Infectious Diseases [2012ZX10002007-002-005]; and the Third Military Medical University (TMMU) key project for clinical research [2012XLC05]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BROWN CJ, 1989, AM J HUM GENET, V44, P264; Buchanan G, 2004, HUM MOL GENET, V13, P1677, DOI 10.1093/hmg/ddh181; CHEN DS, 1993, J GASTROEN HEPATOL, V8, P470, DOI 10.1111/j.1440-1746.1993.tb01551.x; Chen S, 2009, HEPATOL RES, V39, P716, DOI 10.1111/j.1872-034X.2009.00503.x; Dasgupta S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012401; Evans AA, 2002, CANCER EPIDEM BIOMAR, V11, P369; Gapstur SM, 2002, CANCER EPIDEM BIOMAR, V11, P1041; Hsing AW, 2000, CANCER RES, V60, P5111; Huhtaniemi IT, 2009, J CLIN ENDOCR METAB, V94, P277, DOI 10.1210/jc.2008-0848; Jalan R, 2012, J HEPATOL, V57, P1336, DOI 10.1016/j.jhep.2012.06.026; Ke WM, 2006, J GASTROENTEROL, V41, P347, DOI 10.1007/s00535-005-1781-y; Lok ASF, 2007, HEPATOLOGY, V45, P507, DOI 10.1002/hep.21513; Lotter H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055694; LUBAHN DB, 1988, SCIENCE, V240, P327, DOI 10.1126/science.3353727; Nenonen H, 2010, MOL HUM REPROD, V16, P153, DOI 10.1093/molehr/gap097; Nenonen HA, 2011, INT J ANDROL, V34, P327, DOI 10.1111/j.1365-2605.2010.01084.x; Palazzolo I, 2008, J STEROID BIOCHEM, V108, P245, DOI 10.1016/j.jsbmb.2007.09.016; Rajender S, 2007, ASIAN J ANDROL, V9, P147, DOI 10.1111/j.1745-7262.2007.00250.x; Sarin SK, 2009, HEPATOL INT, V3, P269, DOI 10.1007/s12072-008-9106-x; Tian YJ, 2012, J VIROL, V86, P1904, DOI 10.1128/JVI.06707-11; Verthelyi D, 2001, INT IMMUNOPHARMACOL, V1, P983, DOI 10.1016/S1567-5769(01)00044-3; Wang SH, 2009, HEPATOLOGY, V50, P1392, DOI 10.1002/hep.23163; Wong VWS, 2009, J GASTROEN HEPATOL, V24, P1179, DOI 10.1111/j.1440-1746.2009.05924.x; Wu JF, 2010, GASTROENTEROLOGY, V138, P942, DOI 10.1053/j.gastro.2009.11.051; Xing T, 2007, CLIN EXP IMMUNOL, V147, P184, DOI 10.1111/j.1365-2249.2006.03259.x; Yang WJ, 2009, HEPATOLOGY, V49, P1515, DOI 10.1002/hep.22833; Yu MW, 2001, J NATL CANCER I, V93, P1644, DOI 10.1093/jnci/93.21.1644; Yu MW, 2000, J NATL CANCER I, V92, P2023, DOI 10.1093/jnci/92.24.2023; Yuen MF, 2003, CLIN INFECT DIS, V37, P593, DOI 10.1086/376988	29	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84213	10.1371/journal.pone.0084213	http://dx.doi.org/10.1371/journal.pone.0084213			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391916	gold, Green Published, Green Submitted			2022-12-25	WOS:000329323900059
J	Chuchuen, O; Henderson, MH; Sykes, C; Kim, MS; Kashuba, ADM; Katz, DF				Chuchuen, Oranat; Henderson, Marcus H.; Sykes, Craig; Kim, Min Sung; Kashuba, Angela D. M.; Katz, David F.			Quantitative Analysis of Microbicide Concentrations in Fluids, Gels and Tissues Using Confocal Raman Spectroscopy	PLOS ONE			English	Article							EXCISED HUMAN SKIN; IN-VITRO; BUCCAL MUCOSA; COMPARATIVE PERMEABILITY; PERCUTANEOUS-ABSORPTION; TOPICAL MICROBICIDES; DEPTH RESOLUTION; EX-VIVO; SPECTRA; DAPIVIRINE	Topical vaginal anti-HIV microbicides are an important focus in female-based strategies to prevent the sexual transmission of HIV. Understanding microbicide pharmacokinetics is essential to development, characterization and implementation of efficacious microbicide drug delivery formulations. Current methods to measure drug concentrations in tissue (e. g., LC-MS/MS, liquid chromatography coupled with tandem mass spectrometry) are highly sensitive, but destructive and complex. This project explored the use of confocal Raman spectroscopy to detect microbicide drugs and to measure their local concentrations in fluids, drug delivery gels, and tissues. We evaluated three candidate microbicide drugs: tenofovir, Dapivirine and IQP-0528. Measurements were performed in freshly excised porcine buccal tissue specimens, gel vehicles and fluids using two Horiba Raman microscopes, one of which is confocal. Characteristic spectral peak calibrations for each drug were obtained using serial dilutions in the three matrices. These specific Raman bands demonstrated strong linear concentration dependences in the matrices and were characterized with respect to their unique vibrational signatures. At least one specific Raman feature was identified for each drug as a marker band for detection in tissue. Sensitivity of detection was evaluated in the three matrices. A specific peak was also identified for tenofovir diphosphate, the anti-HIV bioactive product of tenofovir after phosphorylation in host cells. Z-scans of drug concentrations vs. depth in excised tissue specimens, incubated under layers of tenofovir solution in a Transwell assay, showed decreasing concentration with depth from the surface into the tissue. Time-dependent concentration profiles were obtained from tissue samples incubated in the Transwell assay, for times ranging 30 minutes - 6 hours. Calibrations and measurements from tissue permeation studies for tenofovir showed good correlation with gold standard LC-MS/MS data. These results demonstrate that confocal Raman spectroscopy holds promise as a tool for practical, minimally invasive, label-free measurement of microbicide drug concentrations in fluids, gels and tissues.	[Chuchuen, Oranat; Henderson, Marcus H.; Kim, Min Sung; Katz, David F.] Duke Univ, Dept Biomed Engn, Durham, NC 27706 USA; [Sykes, Craig; Kashuba, Angela D. M.] Univ N Carolina, Eshelman Sch Pharm, Chapel Hill, NC USA; [Sykes, Craig; Kashuba, Angela D. M.] Univ N Carolina, Ctr AIDS Res, Chapel Hill, NC USA; [Kashuba, Angela D. M.] Univ N Carolina, Sch Med, Dept Infect Dis, Chapel Hill, NC USA; [Katz, David F.] Duke Univ, Dept Obstet & Gynecol, Durham, NC USA	Duke University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Duke University	Katz, DF (corresponding author), Duke Univ, Dept Biomed Engn, Durham, NC 27706 USA.	dkatz@duke.edu	Chuchuen, Oranat/GQA-4250-2022	Chuchuen, Oranat/0000-0002-4152-683X	National Institutes of Health [RO1 HD072702, P30 AI50410]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD072702] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI050410] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health RO1 HD072702 and P30 AI50410. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abner SR, 2005, J INFECT DIS, V192, P1545, DOI 10.1086/462424; ARMSTRONG RS, 1990, APPL ORGANOMET CHEM, V4, P569, DOI 10.1002/aoc.590040519; Baldwin KJ, 2001, APPL SPECTROSC, V55, P517, DOI 10.1366/0003702011952190; Bell SEJ, 2007, J PHARM PHARMACOL, V59, P203, DOI 10.1211/jpp.59.2.0007; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; BRONAUGH RL, 1986, J PHARM SCI, V75, P1094, DOI 10.1002/jps.2600751115; Bruneel JL, 2002, J RAMAN SPECTROSC, V33, P815, DOI 10.1002/jrs.915; Buckheit KW, 2011, ANTIMICROB AGENTS CH, V55, P5243, DOI 10.1128/AAC.05237-11; Centre for the AIDS Programme of Research in South Africa, 2007, SAF EFF STUD CAND VA; Chernenko T, 2009, ACS NANO, V3, P3552, DOI 10.1021/nn9010973; Choi SO, 2010, J CHROMATOGR SCI, V48, P219, DOI 10.1093/chromsci/48.3.219; Chrit L, 2005, J BIOMED OPT, V10, DOI 10.1117/1.2003747; Conrad, 2011, SAF EFF TEN GEL PREV; Cost M, 2012, ANTIMICROB AGENTS CH, V56, P3058, DOI 10.1128/AAC.06284-11; Cummins JE, 2007, ANTIMICROB AGENTS CH, V51, P1770, DOI 10.1128/AAC.01129-06; Cutler B, 2008, LANCET INFECT DIS, V8, P685, DOI 10.1016/S1473-3099(08)70254-8; das Neves J, 2012, J CHROMATOGR B, V911, P76, DOI 10.1016/j.jchromb.2012.10.034; Dezzutti CS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048328; Dezzutti CS, 2012, ANTIVIR RES, V96, P221, DOI 10.1016/j.antiviral.2012.08.004; Doncel GF, 2010, ANTIVIR RES, V88, pS10, DOI 10.1016/j.antiviral.2010.09.018; Dong J, 2000, BIOCHEMISTRY-US, V39, P13241, DOI 10.1021/bi001437m; Erckens RJ, 2001, J CATARACT REFR SURG, V27, P1065, DOI 10.1016/S0886-3350(00)00828-2; Everall NJ, 2000, APPL SPECTROSC, V54, P1515, DOI 10.1366/0003702001948439; Everall NJ, 2000, APPL SPECTROSC, V54, P773, DOI 10.1366/0003702001950382; FDA, 2018, BIOANALYTICAL METHOD; FRANZ TJ, 1975, J INVEST DERMATOL, V64, P190, DOI 10.1111/1523-1747.ep12533356; Franzen L, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.6.061210; Gao YJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074404; GRASS GM, 1988, PHARMACEUT RES, V5, P372, DOI 10.1023/A:1015911712079; Hendrix CW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055013; HERSHEY FB, 1958, J HISTOCHEM CYTOCHEM, V6, P191, DOI 10.1177/6.3.191; Holtz M, 1999, ANAL CHEM, V71, P2934, DOI 10.1021/ac981261i; Imbert D, 1999, J CONTROL RELEASE, V58, P39, DOI 10.1016/S0168-3659(98)00143-6; International Partnership for Microbicides, 2012, SAF EFF TRIAL DAP VA; International Partnership for Microbicides, 2012, PHAS 3 SAF EFF TRIAL; Johnson TJ, 2010, EUR J PHARM SCI, V41, P736, DOI 10.1016/j.ejps.2010.09.010; Joint United Nations Programme on HIV/ AIDS, 2012, GLOB REP UNAIDS REP; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; Kashuba AD, 2010, 18 INT AIDS C VIENN; Keller MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016475; Khan KM, 2013, J BIOPHOTONICS; Kiser PF, 2012, AIDS REV, V14, P62; KUWAE A, 1979, SPECTROCHIM ACTA A, V35, P841, DOI 10.1016/0584-8539(79)80043-4; Lai BE, 2010, ANTIVIR RES, V88, P143, DOI 10.1016/j.antiviral.2010.08.006; Lambert J.B., 1987, INTRO ORGANIC SPECTR; LANIR A, 1979, J BIOL CHEM, V254, P5882; Mahalingam A, 2011, ANTIMICROB AGENTS CH, V55, P1650, DOI 10.1128/AAC.01368-10; MATHLOUTHI M, 1984, CARBOHYD RES, V131, P1, DOI 10.1016/0008-6215(84)85398-7; Microbicide Trials Network, 2010, PHAS 2B SAF EFF STUD; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Movasaghi Z, 2007, APPL SPECTROSC REV, V42, P493, DOI 10.1080/05704920701551530; Nel AM, 2010, AIDS RES HUM RETROV, V26, P1181, DOI 10.1089/aid.2009.0227; Nel AM, 2010, JAIDS-J ACQ IMM DEF, V55, P161, DOI 10.1097/QAI.0b013e3181e3293a; Ng SF, 2010, AAPS PHARMSCITECH, V11, P1432, DOI 10.1208/s12249-010-9522-9; NIAID, 2008, SAF EFF TEN 1 GEL TE; Nicolazzo JA, 2003, J PHARM SCI-US, V92, P2399, DOI 10.1002/jps.10505; Plosker GL, 2013, DRUGS, V73, P1; Ramkumaar GR, 2013, J CHEM-NY, V2013, DOI 10.1155/2013/126502; Robbins BL, 1998, ANTIMICROB AGENTS CH, V42, P612, DOI 10.1128/AAC.42.3.612; Rohan LC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009310; Romano J, 2009, AIDS RES HUM RETROV, V25, P483, DOI 10.1089/aid.2008.0184; Schwartz JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025974; Shojaei A H, 1998, J Pharm Pharm Sci, V1, P15; Singh JS, 2008, J MOL STRUCT, V876, P127, DOI 10.1016/j.molstruc.2007.06.014; Skoog D.A., 1992, PRINCIPLES INSTRUMEN; SLATER TF, 1963, BIOCHIM BIOPHYS ACTA, V77, P383, DOI 10.1016/0006-3002(63)90513-4; Squier CA, 2008, J PHARM SCI-US, V97, P9, DOI 10.1002/jps.21077; Supino Rosa, 1995, V43, P137; Surmacki J, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-48; Sykova E, 2008, PHYSIOL REV, V88, P1277, DOI 10.1152/physrev.00027.2007; Tfayli A, 2008, J BIOPHOTONICS, V1, P140, DOI 10.1002/jbio.200710004; Tfayli A, 2007, EUR BIOPHYS J BIOPHY, V36, P1049, DOI 10.1007/s00249-007-0191-x; Tien D, 2005, AIDS RES HUM RETROV, V21, P845, DOI 10.1089/aid.2005.21.845; van der Bijl P, 1997, EUR J ORAL SCI, V105, P571; van Eyk AD, 2004, ARCH ORAL BIOL, V49, P387, DOI 10.1016/j.archoralbio.2003.12.002; WERTZ PW, 1993, ADV DRUG DELIVER REV, V12, P1, DOI 10.1016/0169-409X(93)90037-5; WILLIAMS AC, 1994, ANALYST, V119, P563, DOI 10.1039/an9941900563; Xiao CH, 2004, APPL SPECTROSC, V58, P382, DOI 10.1366/000370204773580202; Zeng HS, 2008, J INNOV OPT HEAL SCI, V1, P95, DOI 10.1142/S1793545808000054; Zhang GJ, 2007, J INVEST DERMATOL, V127, P1205, DOI 10.1038/sj.jid.5700690; Zhang Y, 2010, CURR PHARM BIOTECHNO, V11, P654, DOI 10.2174/138920110792246483; ZHELYASKOV V, 1992, BIOCHEM J, V287, P561, DOI 10.1042/bj2870561	82	20	20	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e85124	10.1371/journal.pone.0085124	http://dx.doi.org/10.1371/journal.pone.0085124			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386455	Green Published, gold, Green Submitted			2022-12-25	WOS:000329194700129
J	Sensi, L; Tedesco, D; Mimmi, S; Rucci, P; Pisano, E; Pedrini, L; McDonald, KM; Fantini, MP				Sensi, Luigi; Tedesco, Dario; Mimmi, Stefano; Rucci, Paola; Pisano, Emilio; Pedrini, Luciano; McDonald, Kathryn M.; Fantini, Maria Pia		AAA-Working Grp	Hospitalization Rates and Post-Operative Mortality for Abdominal Aortic Aneurysm in Italy over the Period 2000-2011	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; OPEN REPAIR; INCREASING INCIDENCE; ENDOVASCULAR REPAIR; ADMINISTRATIVE DATA; SMOKING BAN; EPIDEMIOLOGY; ENGLAND; WALES; RISK	Background: Recent studies have reported declines in incidence, prevalence and mortality for abdominal aortic aneurysms (AAAs) in various countries, but evidence from Mediterranean countries is lacking. The aim of this study is to examine the trend of hospitalization and post-operative mortality rates for AAAs in Italy during the period 2000-2011, taking into account the introduction of endovascular aneurysm repair (EVAR) in 1990s. Methods: This retrospective cohort study was carried out in Emilia-Romagna, an Italian region with 4.5 million inhabitants. A total of 19,673 patients hospitalized for AAAs between 2000 and 2011, were identified from the hospital discharge records (HDR) database. Hospitalization rates, percentage of OSR and EVAR and 30-day mortality rates were calculated for unruptured (uAAAs) and ruptured AAAs (rAAAs). Results: Adjusted hospitalization rates decreased on average by 2.9% per year for uAAAs and 3.2% for rAAAs (p<0.001). The temporal trend of 30-day mortality rates remained stable for both groups. The percentage of EVAR for uAAAs increased significantly from 2006 to 2011 (42.7 versus 60.9% respectively, mean change of 3.9% per year, p<0.001). No significant difference in mortality was found between OSR and EVAR for uAAAs and rAAAs. Conclusions: The incidence and trend of hospitalization rates for rAAAs and uAAAs decreased significantly in the last decade, while 30-day mortality rates in operated patients remained stable. OSR continued to be the most common surgery in rAAAs, although the gap between OSR and EVAR recently declined. The EVAR technique became the preferred surgery for uAAAs since 2008.	[Sensi, Luigi; Pisano, Emilio; Pedrini, Luciano] Maggiore Hosp, Dept Surg, Vasc Surg Unit, Bologna, Italy; [Tedesco, Dario; Mimmi, Stefano; Rucci, Paola; Fantini, Maria Pia] Alma Mater Studiorum Univ Bologna, Dept Biomed & Neuromotor Sci, Bologna, Italy; [McDonald, Kathryn M.] Stanford Univ, Ctr Primary Care & Outcomes Res, Stanford Ctr Hlth Policy, Stanford, CA 94305 USA; Maggiore Hosp, Vasc Surg Unit, Bologna, Italy	AUSL di Bologna; University of Bologna; Stanford University; AUSL di Bologna	Fantini, MP (corresponding author), Alma Mater Studiorum Univ Bologna, Dept Biomed & Neuromotor Sci, Bologna, Italy.	mariapia.fantini@unibo.it	Tedesco, Dario/AAD-8342-2022; Tedesco, Dario/AAC-1848-2019	Tedesco, Dario/0000-0002-5027-5446; Rucci, Paola/0000-0002-7704-0831				Anjum A, 2012, EUR J VASC ENDOVASC, V43, P161, DOI 10.1016/j.ejvs.2011.11.014; [Anonymous], 2013, NHS ABD AORT AN SCRE; Aylin P, 2007, BMJ-BRIT MED J, V334, P1044, DOI 10.1136/bmj.39168.496366.55; Barone-Adesi F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017419; Blanchard JF, 1999, EPIDEMIOL REV, V21, P207, DOI 10.1093/oxfordjournals.epirev.a017997; Bown MJ, 2011, AM J HUM GENET, V89, P619, DOI 10.1016/j.ajhg.2011.10.002; Buonanno P, 2013, HEALTH POLICY, V109, P192, DOI 10.1016/j.healthpol.2012.10.009; Burns H., 2010, SCOTTISH ABDOMINAL A; Casey K, 2013, J VASC SURG, V57, P89, DOI 10.1016/j.jvs.2012.07.005; Cesaroni G, 2008, CIRCULATION, V117, P1183, DOI 10.1161/CIRCULATIONAHA.107.729889; Cheng SWK, 2003, WORLD J SURG, V27, P241, DOI 10.1007/s00268-002-6470-x; Choke E, 2012, EUR J VASC ENDOVASC, V44, P549, DOI 10.1016/j.ejvs.2012.08.011; Choke E, 2012, CIRCULATION, V125, P1617, DOI 10.1161/CIRCULATIONAHA.111.077503; FOWKES FGR, 1989, BRIT MED J, V298, P33, DOI 10.1136/bmj.298.6665.33; Giardina S, 2011, J VASC SURG, V54, P938, DOI 10.1016/j.jvs.2011.03.264; Greenblatt DY, 2012, ANN SURG, V256, P595, DOI 10.1097/SLA.0b013e31826b4bfe; Greenhalgh RM, 2005, LANCET, V365, P2179, DOI 10.1016/S0140-6736(05)66627-5; Greenhalgh RM, 2004, LANCET, V364, P843, DOI 10.1016/S0140-6736(04)16979-1; Gretarsdottir S, 2010, NAT GENET, V42, P692, DOI 10.1038/ng.622; Gupta PK, 2012, EUR J VASC ENDOVASC, V43, P506, DOI 10.1016/j.ejvs.2012.02.006; Hernandez-Boussard T, 2012, J AM COLL SURGEONS, V214, P788, DOI 10.1016/j.jamcollsurg.2012.01.045; Hultgren R, 2012, BRIT J SURG, V99, P647, DOI 10.1002/bjs.8685; Istituto Superiore di Sanita, 2010, RAPP ANN FUM IT ANN; Kuivaniemi H, 2012, ANN VASC SURG, V26, P862, DOI 10.1016/j.avsg.2012.02.005; Lederle FA, 2009, JAMA-J AM MED ASSOC, V302, P1535, DOI 10.1001/jama.2009.1426; Min SI, 2012, J KOREAN MED SCI, V27, P416, DOI 10.3346/jkms.2012.27.4.416; Ministero della Salute, 2011, DOC TECN IND RID CAR; Mofidi R, 2008, BRIT J SURG, V95, P1475, DOI 10.1002/bjs.6432; Norman PE, 2007, CONNECT TISSUE RES, V48, P125, DOI 10.1080/03008200701331524; Norman PE, 2011, J VASC SURG, V53, P274, DOI 10.1016/j.jvs.2010.08.087; Palombo D, 2010, J CARDIOVASC SURG, V51, P777; Parodi J C, 1991, Ann Vasc Surg, V5, P491, DOI 10.1007/BF02015271; Pieroni L, 2013, HEALTH POLICY, V111, P116, DOI 10.1016/j.healthpol.2013.04.001; Reitsma JB, 1996, EUR J VASC ENDOVASC, V12, P446, DOI 10.1016/S1078-5884(96)80012-8; Sandiford P, 2011, BRIT J SURG, V98, P645, DOI 10.1002/bjs.7461; Schermerhorn ML, 2011, J AM COLL SURGEONS, V212, P349, DOI 10.1016/j.jamcollsurg.2010.12.003; Schwarze ML, 2009, J VASC SURG, V50, P722, DOI 10.1016/j.jvs.2009.05.010; Shteinberg D, 2000, EUR J VASC ENDOVASC, V20, P462, DOI 10.1053/ejvs.2000.1210; Sternbergh WC, 2000, J VASC SURG, V31, P237, DOI 10.1016/S0741-5214(00)90154-X; Svensjo S, 2011, CIRCULATION, V124, P1118, DOI 10.1161/CIRCULATIONAHA.111.030379; Yuen E, 2011, TUMORI, V97, P428, DOI 10.1700/950.10393; 1998, LANCET, V352, P1649	42	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e83855	10.1371/journal.pone.0083855	http://dx.doi.org/10.1371/journal.pone.0083855			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386294	Green Published, Green Submitted, gold			2022-12-25	WOS:000329194700075
J	Vidick, S; Leroy, B; Palmeira, L; Machiels, B; Mast, J; Francois, S; Wattiez, R; Vanderplasschen, A; Gillet, L				Vidick, Sarah; Leroy, Baptiste; Palmeira, Leonor; Machiels, Benedicte; Mast, Jan; Francois, Sylvie; Wattiez, Ruddy; Vanderplasschen, Alain; Gillet, Laurent			Proteomic Characterization of Murid Herpesvirus 4 Extracellular Virions	PLOS ONE			English	Article							CHEMOKINE-BINDING-PROTEIN; SARCOMA-ASSOCIATED HERPESVIRUS; GAMMAHERPESVIRUS-68 GLYCOPROTEIN-B; CELLULAR ANNEXIN-II; SIMPLEX-VIRUS; HUMAN CYTOMEGALOVIRUS; KAPOSIS-SARCOMA; IN-VIVO; STRUCTURAL PROTEINS; VIRAL SPREAD	Gammaherpesvirinae, such as the human Epstein-Barr virus (EBV) and the Kaposi's sarcoma associated herpesvirus (KSHV) are highly prevalent pathogens that have been associated with several neoplastic diseases. As EBV and KSHV are host-range specific and replicate poorly in vitro, animal counterparts such as Murid herpesvirus-4 (MuHV-4) have been widely used as models. In this study, we used MuHV-4 in order to improve the knowledge about proteins that compose gammaherpesviruses virions. To this end, MuHV-4 extracellular virions were isolated and structural proteins were identified using liquid chromatography tandem mass spectrometry-based proteomic approaches. These analyses allowed the identification of 31 structural proteins encoded by the MuHV-4 genome which were classified as capsid (8), envelope (9), tegument (13) and unclassified (1) structural proteins. In addition, we estimated the relative abundance of the identified proteins in MuHV-4 virions by using exponentially modified protein abundance index analyses. In parallel, several host proteins were found in purified MuHV-4 virions including Annexin A2. Although Annexin A2 has previously been detected in different virions from various families, its role in the virion remains controversial. Interestingly, despite its relatively high abundance in virions, Annexin A2 was not essential for the growth of MuHV-4 in vitro. Altogether, these results extend previous work aimed at determining the composition of gammaherpesvirus virions and provide novel insights for understanding MuHV-4 biology.	[Vidick, Sarah; Palmeira, Leonor; Machiels, Benedicte; Francois, Sylvie; Vanderplasschen, Alain; Gillet, Laurent] Univ Liege, Dept Infect Dis, Fac Vet Med, Liege, Belgium; [Leroy, Baptiste; Wattiez, Ruddy] Univ Mons, Dept Prote & Microbiol, Res Inst Biosci Interdisciplinary Mass Spectromet, B-7000 Mons, Belgium; [Mast, Jan] Vet & Agrochem Res Ctr, Electron Microscopy Unit, Brussels, Belgium	University of Liege; University of Mons	Gillet, L (corresponding author), Univ Liege, Dept Infect Dis, Fac Vet Med, Liege, Belgium.	L.gillet@ulg.ac.be		Leroy, Baptiste/0000-0001-7166-4478; Gillet, Laurent/0000-0002-1047-2525; Machiels, Benedicte/0000-0003-1326-3865; wattiez, ruddy/0000-0003-2071-4310; Mast, Jan/0000-0002-4879-3367	GLYVIR ARC of the University of Liege [F.4510.10]; FRFC of the F.R.S. - FNRS [2.4622.10]; belgian federal BELVIR Interuniversity attraction pole;  [C-11/57]	GLYVIR ARC of the University of Liege; FRFC of the F.R.S. - FNRS(Fonds de la Recherche Scientifique - FNRS); belgian federal BELVIR Interuniversity attraction pole; 	This work was supported by the following grants: starting grant (C-11/57) and GLYVIR ARC of the University of Liege (http://www.ulg.ac.be), Scientific impulse grant (no F.4510.10) and FRFC grant (2.4622.10) of the F.R.S. - FNRS (http://www.frs-fnrs.be), and the belgian federal BELVIR Interuniversity attraction pole. S. V. is a Research Fellow of the "Fonds de la Recherche Scientifique - Fonds National Belge de la Recherche Scientifique" (F.R.S. - FNRS). P.G.S. is a Wellcome Trust Senior Clinical Fellow (GR076956MA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamiak B, 2007, J VIROL, V81, P13424, DOI 10.1128/JVI.01528-07; Adler H, 2000, J VIROL, V74, P6964, DOI 10.1128/JVI.74.15.6964-6974.2000; BAINES JD, 1992, J VIROL, V66, P5168, DOI 10.1128/JVI.66.8.5168-5174.1992; Baines JD, 2011, TRENDS MICROBIOL, V19, P606, DOI 10.1016/j.tim.2011.09.001; BALAN P, 1994, J GEN VIROL, V75, P1245, DOI 10.1099/0022-1317-75-6-1245; Baldick CJ, 1996, J VIROL, V70, P6097, DOI 10.1128/JVI.70.9.6097-6105.1996; Bechtel JT, 2005, J VIROL, V79, P4952, DOI 10.1128/JVI.79.8.4952-4964.2005; Benach J, 2007, J BIOL CHEM, V282, P31534, DOI 10.1074/jbc.M705637200; BLASKOVIC D, 1980, ACTA VIROL, V24, P468; Bohannon KP, 2013, P NATL ACAD SCI USA, V110, pE1613, DOI 10.1073/pnas.1221896110; Bold S, 1996, J GEN VIROL, V77, P2297, DOI 10.1099/0022-1317-77-9-2297; Bortz E, 2003, J VIROL, V77, P13425, DOI 10.1128/JVI.77.24.13425-13432.2003; Bortz E, 2007, J VIROL, V81, P10137, DOI 10.1128/JVI.01233-06; Bridgeman A, 2001, J EXP MED, V194, P301, DOI 10.1084/jem.194.3.301; Brown JC, 2011, CURR OPIN VIROL, V1, P142, DOI 10.1016/j.coviro.2011.06.003; Bryant NA, 2003, EMBO J, V22, P833, DOI 10.1093/emboj/cdg092; Charif D, 2007, SEQINR 1 0 2 CONTRIB; Chertova E, 2006, J VIROL, V80, P9039, DOI 10.1128/JVI.01013-06; Costes B, 2005, J GEN VIROL, V86, P3209, DOI 10.1099/vir.0.81388-0; Dai W, 2008, J STRUCT BIOL, V161, P428, DOI 10.1016/j.jsb.2007.10.010; DAVISON AJ, 1995, VIROLOGY, V206, P1035, DOI 10.1006/viro.1995.1026; Derry MEC, 2007, J GEN VIROL, V88, P19, DOI 10.1099/vir.0.82294-0; Dry I, 2008, J VIROL, V82, P5390, DOI 10.1128/JVI.00094-08; Francois S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003292; Francois S, 2010, J GEN VIROL, V91, P2553, DOI 10.1099/vir.0.023481-0; Gaspar M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002781; Gerke V, 2005, NAT REV MOL CELL BIO, V6, P449, DOI 10.1038/nrm1661; Gill MB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001808; Gillet L, 2008, J GEN VIROL, V89, P1352, DOI 10.1099/vir.0.83519-0; Gillet L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000705; Gillet L, 2007, J VIROL, V81, P13082, DOI 10.1128/JVI.01141-07; Gillet L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000347; Gillet L, 2007, J VIROL, V81, P280, DOI 10.1128/JVI.01616-06; Gillet L, 2006, J GEN VIROL, V87, P3515, DOI 10.1099/vir.0.82313-0; Gillet L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002811; Gillet L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001669; Guo HT, 2009, J VIROL, V83, P10582, DOI 10.1128/JVI.00497-09; Guo HD, 2010, INT J DIGIT EARTH, V3, P1, DOI 10.1080/17538941003650702; Han J, 2011, J VIROL, V85, P9437, DOI 10.1128/JVI.05207-11; Heldwein EE, 2008, CELL MOL LIFE SCI, V65, P1653, DOI 10.1007/s00018-008-7570-z; Hughes DJ, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001321; Hwang SM, 2009, CELL HOST MICROBE, V5, P166, DOI 10.1016/j.chom.2008.12.013; Ishihama Y, 2005, MOL CELL PROTEOMICS, V4, P1265, DOI 10.1074/mcp.M500061-MCP200; Johannsen E, 2004, P NATL ACAD SCI USA, V101, P16286, DOI 10.1073/pnas.0407320101; Johnson DC, 2011, NAT REV MICROBIOL, V9, P382, DOI 10.1038/nrmicro2559; Jons A, 1998, J VIROL, V72, P550; Kattenhorn LM, 2004, J VIROL, V78, P11187, DOI 10.1128/JVI.78.20.11187-11197.2004; Koyano S, 2003, J GEN VIROL, V84, P1485, DOI 10.1099/vir.0.18941-0; Kramer T, 2011, J VIROL, V85, P6427, DOI 10.1128/JVI.02253-10; Le Sage V, 2013, J VIROL, V87, P5904, DOI 10.1128/JVI.03489-12; Lete C, 2012, J VIROL, V86, P11567, DOI 10.1128/JVI.00456-12; Lete C, 2012, J VIROL, V86, P2653, DOI 10.1128/JVI.06238-11; Ling Q, 2004, J CLIN INVEST, V113, P38, DOI 10.1172/JCI200419684; Lopes FB, 2004, J VIROL, V78, P13370, DOI 10.1128/JVI.78.23.13370-13375.2004; Loret S, 2008, J VIROL, V82, P8605, DOI 10.1128/JVI.00904-08; Mastroleo F, 2009, J PROTEOME RES, V8, P2530, DOI 10.1021/pr900007d; May JS, 2005, TRAFFIC, V6, P780, DOI 10.1111/j.1600-0854.2005.00316.x; May JS, 2005, J VIROL, V79, P5059, DOI 10.1128/JVI.79.8.5059-5068.2005; May JS, 2005, J VIROL, V79, P3459, DOI 10.1128/JVI.79.6.3459-3467.2005; Mesri EA, 2010, NAT REV CANCER, V10, P707, DOI 10.1038/nrc2888; Mettenleiter TC, 2009, VIRUS RES, V143, P222, DOI 10.1016/j.virusres.2009.03.018; Moerdyk-Schauwecker M, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-166; Mounce BC, 2013, J VIROL, V87, P7314, DOI 10.1128/JVI.02713-12; Nozawa N, 2005, J VIROL, V79, P6947, DOI 10.1128/JVI.79.11.6947-6956.2005; O'Connor CM, 2006, J VIROL, V80, P1574, DOI 10.1128/JVI.80.3.1574-1583.2006; Ohno S, 2012, J GEN VIROL, V93, P1076, DOI 10.1099/vir.0.041129-0; Palmeira L, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-406; Parry CM, 2000, J EXP MED, V191, P573, DOI 10.1084/jem.191.3.573; Peng L, 2010, STRUCTURE, V18, P47, DOI 10.1016/j.str.2009.10.017; Perkins EM, 2008, J VIROL, V82, P7201, DOI 10.1128/JVI.00423-08; Pietropaolo R, 1999, J GEN VIROL, V80, P1807, DOI 10.1099/0022-1317-80-7-1807; Pietropaolo RL, 1997, J VIROL, V71, P9803, DOI 10.1128/JVI.71.12.9803-9807.1997; Raab-Traub N, 2012, CURR OPIN VIROL, V2, P453, DOI 10.1016/j.coviro.2012.07.001; Rai T, 2010, J VIROL, V84, P9783, DOI 10.1128/JVI.01584-09; Rappsilber J, 2002, GENOME RES, V12, P1231, DOI 10.1101/gr.473902; Raynor CM, 1999, BIOCHEMISTRY-US, V38, P5089, DOI 10.1021/bi982095b; Rozen R, 2008, J VIROL, V82, P4742, DOI 10.1128/JVI.02745-07; Santos S, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-65; Sathish N, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00098; Saxena V, 2012, J VIROL, V86, P4139, DOI 10.1128/JVI.06327-11; Shaw ML, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000085; Stewart JP, 1996, J VIROL, V70, P3528, DOI 10.1128/JVI.70.6.3528-3535.1996; Team RDC, 2010, R LANG ENV STAT COMP; Tran LC, 2000, P NATL ACAD SCI USA, V97, P1818, DOI 10.1073/pnas.020510297; Van Berkel V, 2000, J VIROL, V74, P6741, DOI 10.1128/JVI.74.15.6741-6747.2000; van Berkel V, 2002, J CLIN INVEST, V109, P905, DOI 10.1172/JCI14358; van Berkel V, 1999, J VIROL, V73, P4524, DOI 10.1128/JVI.73.5.4524-4529.1999; van Beurden SJ, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-105; Vanderplasschen A, 1998, P NATL ACAD SCI USA, V95, P7544, DOI 10.1073/pnas.95.13.7544; Varnum SM, 2004, J VIROL, V78, P10960, DOI 10.1128/JVI.78.20.10960-10966.2004; Virgin HW, 1997, J VIROL, V71, P5894, DOI 10.1128/JVI.71.8.5894-5904.1997; Wang LL, 2012, J VIROL, V86, P1348, DOI 10.1128/JVI.05497-11; Woodham AW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043519; WRIGHT JF, 1995, J VIROL, V69, P4784, DOI 10.1128/JVI.69.8.4784-4791.1995; WRIGHT JF, 1994, BIOCHEM BIOPH RES CO, V198, P983, DOI 10.1006/bbrc.1994.1140; Zhu FX, 2005, J VIROL, V79, P800, DOI 10.1128/JVI.79.2.800-811.2005	96	18	18	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e83842	10.1371/journal.pone.0083842	http://dx.doi.org/10.1371/journal.pone.0083842			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386290	Green Published, gold, Green Submitted			2022-12-25	WOS:000329194700073
J	Pohlon, E; Fandino, AO; Marxsen, J				Pohlon, Elisabeth; Fandino, Adriana Ochoa; Marxsen, Juergen			Bacterial Community Composition and Extracellular Enzyme Activity in Temperate Streambed Sediment during Drying and Rewetting	PLOS ONE			English	Article							MICROBIAL COMMUNITIES; CLIMATE-CHANGE; DROUGHT; SOIL; IMPACT; WATER; DESICCATION; CARBON; RECOLONIZATION; BREITENBACH	Droughts are among the most important disturbance events for stream ecosystems; they not only affect stream hydrology but also the stream biota. Although desiccation of streams is common in Mediterranean regions, phases of dryness in headwaters have been observed more often and for longer periods in extended temperate regions, including Central Europe, reflecting global climate change and enhanced water withdrawal. The effects of desiccation and rewetting on the bacterial community composition and extracellular enzyme activity, a key process in the carbon flow of streams and rivers, were investigated in a typical Central European stream, the Breitenbach (Hesse, Germany). Wet streambed sediment is an important habitat in streams. It was sampled and exposed in the laboratory to different drying scenarios (fast, intermediate, slow) for 13 weeks, followed by rewetting of the sediment from the fast drying scenario via a sediment core perfusion technique for 2 weeks. Bacterial community structure was analyzed using CARD-FISH and TGGE, and extracellular enzyme activity was assessed using fluorogenic model substrates. During desiccation the bacterial community composition shifted toward composition in soil, exhibiting increasing proportions of Actinobacteria and Alphaproteobacteria and decreasing proportions of Bacteroidetes and Betaproteobacteria. Simultaneously the activities of extracellular enzymes decreased, most pronounced with aminopeptidases and less pronounced with enzymes involved in the degradation of polymeric carbohydrates. After rewetting, the general ecosystem functioning, with respect to extracellular enzyme activity, recovered after 10 to 14 days. However, the bacterial community composition had not yet achieved its original composition as in unaffected sediments within this time. Thus, whether the bacterial community eventually recovers completely after these events remains unknown. Perhaps this community undergoes permanent changes, especially after harsh desiccation, followed by loss of the specialized functions of specific groups of bacteria.	[Pohlon, Elisabeth; Fandino, Adriana Ochoa; Marxsen, Juergen] Univ Giessen, Inst Allgemeine & Spezielle Zool, Giessen, Germany; [Marxsen, Juergen] Max Planck Inst Limnol, Limnol Flussstn, Schlitz, Germany	Justus Liebig University Giessen; Max Planck Society	Pohlon, E (corresponding author), Univ Giessen, Inst Allgemeine & Spezielle Zool, Heinrich Buff Ring 29, Giessen, Germany.	Elisabeth.Pohlon@allzool.bio.uni-giessen.de	Marxsen, Juergen/AAE-5939-2020; Marxsen, Juergen/D-9628-2011	Marxsen, Juergen/0000-0003-3954-0998; Marxsen, Juergen/0000-0003-3954-0998	Deutsche Forschungsgemeinschaft (German Research Foundation) [PO 1505/1-1]	Deutsche Forschungsgemeinschaft (German Research Foundation)(German Research Foundation (DFG))	This research was supported by a grant (PO 1505/1-1) from Deutsche Forschungsgemeinschaft (German Research Foundation; www.dfg.de) to EP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison SD, 2008, P NATL ACAD SCI USA, V105, P11512, DOI 10.1073/pnas.0801925105; Amalfitano S, 2008, MICROB ECOL, V55, P270, DOI 10.1007/s00248-007-9274-6; [Anonymous], 1996, ISO10694 NORM DIN; [Anonymous], 1998, 13878 NORM DIN ISO; Arnell NW, 1998, CLIMATIC CHANGE, V39, P83, DOI 10.1023/A:1005339412565; Austin BJ, 2011, HYDROBIOLOGIA, V658, P183, DOI 10.1007/s10750-010-0462-x; Baldwin DS, 2000, REGUL RIVER, V16, P457, DOI 10.1002/1099-1646(200009/10)16:5&lt;457::AID-RRR597&gt;3.0.CO;2-B; Bardgett RD, 2008, ISME J, V2, P805, DOI 10.1038/ismej.2008.58; Blagodatskaya E, 2013, SOIL BIOL BIOCHEM, V67, P192, DOI 10.1016/j.soilbio.2013.08.024; Buesing N, 2005, LIMNOL OCEANOGR-METH, V3, P101, DOI 10.4319/lom.2005.3.101; Dahm CN, 2003, FRESHWATER BIOL, V48, P1219, DOI 10.1046/j.1365-2427.2003.01082.x; Dodds WK, 2004, OECOLOGIA, V140, P458, DOI 10.1007/s00442-004-1599-y; Fazi S, 2008, ENVIRON MICROBIOL, V10, P2760, DOI 10.1111/j.1462-2920.2008.01695.x; Fiebig DM, 1997, LIMNOL OCEANOGR, V42, P763, DOI 10.4319/lo.1997.42.4.0763; FIEBIG DM, 1995, ARCH HYDROBIOL, V134, P129; Fierer N, 2003, MICROB ECOL, V45, P63, DOI 10.1007/s00248-002-1007-2; Fierer N, 2007, ECOLOGY, V88, P1354, DOI 10.1890/05-1839; FREEMAN C, 1994, FRESHWATER BIOL, V32, P223, DOI 10.1111/j.1365-2427.1994.tb00878.x; Fromin N, 2010, ECOHYDROLOGY, V3, P339, DOI 10.1002/eco.115; Frossard A, 2012, ISME J, V6, P680, DOI 10.1038/ismej.2011.134; Gao XQ, 2005, AQUAT MICROB ECOL, V40, P51, DOI 10.3354/ame040051; Gomez R, 2012, HYDROBIOLOGIA, V679, P43, DOI 10.1007/s10750-011-0854-6; Halverson LJ, 2000, SOIL SCI SOC AM J, V64, P1630, DOI 10.2136/sssaj2000.6451630x; HLUG - Hessisches Landesamt fur Umwelt und Geologie, 2012, KLIM SEIN FOLG HESS; HOPPE HG, 1983, MAR ECOL PROG SER, V11, P299, DOI 10.3354/meps011299; Kirchman DL, 2002, FEMS MICROBIOL ECOL, V39, P91, DOI 10.1111/j.1574-6941.2002.tb00910.x; Krysanova V, 2008, HYDROLOG SCI J, V53, P519, DOI 10.1623/hysj.53.3.519; Labat D, 2004, ADV WATER RESOUR, V27, P631, DOI 10.1016/j.advwatres.2004.02.020; Lake PS, 2003, FRESHWATER BIOL, V48, P1161, DOI 10.1046/j.1365-2427.2003.01086.x; Ledger ME, 2001, ARCH HYDROBIOL, V152, P1; Lehner B, 2006, CLIMATIC CHANGE, V75, P273, DOI 10.1007/s10584-006-6338-4; Manz W, 1999, MICROB ECOL, V37, P225, DOI 10.1007/s002489900148; Marxsen J, 1997, J N AM BENTHOL SOC, V16, P28, DOI 10.2307/1468227; MARXSEN J, 1993, HYDROBIOLOGIA, V253, P207, DOI 10.1007/BF00050739; MARXSEN J, 1993, FEMS MICROBIOL ECOL, V13, P1; Marxsen J, 2001, ARCH HYDROBIOL, V152, P543; Marxsen J, 1996, FEMS MICROBIOL ECOL, V21, P313, DOI 10.1016/S0168-6496(96)00067-0; MARXSEN J, 1980, Archiv fuer Hydrobiologie Supplement, V57, P461; MARXSEN J, 1991, BROCK SPR S, P270; Marxsen J, 2011, CENTRAL EUROPEAN STR, P131; Marxsen J, 2011, CENTRAL EUROPEAN STR, P5; Marxsen J, 2006, FRESHWATER BIOL, V51, P1838, DOI 10.1111/j.1365-2427.2006.01620.x; Marxsen J, 2010, FEMS MICROBIOL ECOL, V71, P374, DOI 10.1111/j.1574-6941.2009.00819.x; McClain ME, 2003, ECOSYSTEMS, V6, P301, DOI 10.1007/s10021-003-0161-9; Mosisch TD, 2001, NEW ZEAL J MAR FRESH, V35, P173, DOI 10.1080/00288330.2001.9516987; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; PEREZMATEOS M, 1991, J SCI FOOD AGR, V55, P229, DOI 10.1002/jsfa.2740550208; Pernthaler A., 2004, Molecular microbial ecology manual. Volumes 1 and 2, P711; Pesaro M, 2004, APPL ENVIRON MICROB, V70, P2577, DOI 10.1128/AEM.70.5.2577-2587.2004; Peter H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023225; Pohlon E, 2013, FUND APPL LIMNOL, V182, P123, DOI 10.1127/1863-9135/2013/0465; Polz MF, 1998, APPL ENVIRON MICROB, V64, P3724; Prudhomme C, 2012, HYDROL PROCESS, V26, P1115, DOI 10.1002/hyp.8434; Rees GN, 2006, J N AM BENTHOL SOC, V25, P370, DOI 10.1899/0887-3593(2006)25[370:VISMCI]2.0.CO;2; Robson BJ, 2008, FRESHWATER BIOL, V53, P2385, DOI 10.1111/j.1365-2427.2008.02061.x; Romani AM, 1997, ARCH HYDROBIOL, V140, P261; Sabater Sergi, 2008, Freshwater Reviews, V1, P75, DOI 10.1608/FRJ-1.1.5; SCHIMEL J, 1995, ECOL STU AN, V113, P239; Schimel J, 2007, ECOLOGY, V88, P1386, DOI 10.1890/06-0219; Schlief J, 2011, INT REV HYDROBIOL, V96, P633, DOI 10.1002/iroh.201111322; Sirova D, 2006, AQUAT MICROB ECOL, V44, P11, DOI 10.3354/ame044011; Sutherland WJ, 2008, J APPL ECOL, V45, P821, DOI 10.1111/j.1365-2664.2008.01474.x; Toberman H, 2008, FEMS MICROBIOL ECOL, V66, P426, DOI 10.1111/j.1574-6941.2008.00560.x; VDLUFA, 1991, UNT BOD; Wagner R., 2011, CENTRAL EUROPEAN STR; Ylla I, 2011, AQUAT SCI, V73, P523, DOI 10.1007/s00027-011-0211-x; Zoppini A, 2011, SOIL BIOL, V22, P103, DOI 10.1007/978-3-642-14225-3_6; Zoppini A, 2010, HYDROBIOLOGIA, V657, P37, DOI 10.1007/s10750-010-0199-6	68	48	49	7	97	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e83365	10.1371/journal.pone.0083365	http://dx.doi.org/10.1371/journal.pone.0083365			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281RE	24386188	Green Submitted, Green Published, gold			2022-12-25	WOS:000329117900033
J	Xiong, HZ; Maraver, A; Latkowski, JA; Henderson, T; Schlessinger, K; Ding, Y; Shen, J; Tadokoro, CE; Lafaille, JJ				Xiong, Huizhong; Maraver, Antonio; Latkowski, Jo-Ann; Henderson, Tanya; Schlessinger, Karni; Ding, Yi; Shen, Jie; Tadokoro, Carlos E.; Lafaille, Juan J.			Characterization of Two Distinct Lymphoproliferative Diseases Caused by Ectopic Expression of the Notch Ligand DLL4 on T Cells	PLOS ONE			English	Article							DELTA-LIKE 4; TUMOR-SUPPRESSOR; LINEAGE COMMITMENT; DONOR CELLS; ALPHA; INACTIVATION; ACTIVATION; LEUKEMIA; GENE; THYMOCYTES	Notch signaling is essential for the development of T cell progenitors through the interaction of NOTCH1 receptor on their surface with the ligand, Delta-like 4 (DLL4), which is expressed by the thymic epithelial cells. Notch signaling is quickly shut down once the cells pass beta-selection, and CD4/CD8 double positive (DP) cells are unresponsive to Notch. Over the past two decades a number of papers reported that over-activation of Notch signaling causes T cell acute lymphoblastic leukemia (T-ALL), a cancer that prominently features circulating monoclonal CD4/CD8 double positive T cells in different mouse models. However, the possible outcomes of Notch over-activation at different stages of T cell development are unknown, and the fine timing of Notch signaling that results in T-ALL is poorly understood. Here we report, by using a murine model that ectopically expresses DLL4 on developing T cells, that the T-ALL onset is highly dependent on a sustained Notch activity throughout the DP stage, which induces additional mutations to further boost the signaling. In contrast, a shorter period of Notch activation that terminates at the DP stage causes a polyclonal, non-transmissible lymphoproliferative disorder that is also lethal. These observations resolved the discrepancy of previous papers on DLL4 driven hematological diseases in mice, and show the critical importance of the timing and duration of Notch activity.	[Xiong, Huizhong; Maraver, Antonio; Latkowski, Jo-Ann; Henderson, Tanya; Schlessinger, Karni; Ding, Yi; Tadokoro, Carlos E.; Lafaille, Juan J.] NYU, Sch Med, Skirball Inst, Kimmel Ctr Biol & Med, New York, NY USA; [Xiong, Huizhong] NYU, Sch Med, Sackler Inst Grad Biomed Sci, New York, NY USA; [Latkowski, Jo-Ann] NYU, Dept Dermatol, Langone Med Ctr, New York, NY 10016 USA; [Ding, Yi; Lafaille, Juan J.] NYU, Sch Med, Dept Pathol, New York, NY USA; [Shen, Jie] Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Neurol Dis, Boston, MA 02115 USA	New York University; New York University; New York University; NYU Langone Medical Center; New York University; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Maraver, A (corresponding author), Spanish Natl Canc Res Ctr, Tumor Suppress Grp, Madrid, Spain.	amaraver@cnio.es; juan.lafaille@med.nyu.edu	Tadokoro, Carlos E/D-5111-2011; Shen, Jie/GXH-9449-2022; Maraver, Antonio/G-2666-2015	Maraver, Antonio/0000-0002-5527-5680; Tadokoro, Carlos Eduardo/0000-0002-7874-5657; Xiong, Huizhong/0000-0002-1043-1627	Spanish Ministry of Science; NYU Cancer Institute Center; NIH/NCI [5 P30CA16087-31]; NIH/NIAID; National Multiple Sclerosis Society; Helmsley Charitable Trust; NATIONAL CANCER INSTITUTE [P30CA016087] Funding Source: NIH RePORTER	Spanish Ministry of Science(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); NYU Cancer Institute Center; NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Multiple Sclerosis Society(National Multiple Sclerosis Society); Helmsley Charitable Trust; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	A.M. is the recipient of a postdoctoral contract of the "Miguel Servet" Program of the Spanish Ministry of Science. The NYU Cancer Institute Center Support Grant partially funds this core through grant NIH/NCI 5 P30CA16087-31. Work in JJL lab is supported by the NIH/NIAID, National Multiple Sclerosis Society, and the Helmsley Charitable Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aifantis I, 2008, NAT REV IMMUNOL, V8, P380, DOI 10.1038/nri2304; Balint K, 2005, J CLIN INVEST, V115, P3166, DOI 10.1172/JCI25001; Besseyrias V, 2007, J EXP MED, V204, P331, DOI 10.1084/jem.20061442; BOYD CN, 1982, LEUKEMIA RES, V6, P833, DOI 10.1016/0145-2126(82)90067-4; Bray S, 2010, CURR TOP DEV BIOL, V92, P253, DOI 10.1016/S0070-2153(10)92008-5; Chandu D, 2006, J NEUROCHEM, V96, P228, DOI 10.1111/j.1471-4159.2005.03547.x; Curtis DJ, 2010, CLIN CANCER RES, V16, P5618, DOI 10.1158/1078-0432.CCR-10-0440; Demarest RM, 2008, ONCOGENE, V27, P5082, DOI 10.1038/onc.2008.222; DIAZ P, 1994, IMMUNITY, V1, P207, DOI 10.1016/1074-7613(94)90099-X; Dorsch M, 2002, BLOOD, V100, P2046, DOI 10.1182/blood.V100.6.2046.h81802002046_2046_2055; ELLISEN LW, 1991, CELL, V66, P649, DOI 10.1016/0092-8674(91)90111-B; Feng H, 2010, CANCER CELL, V18, P353, DOI 10.1016/j.ccr.2010.09.009; Ferrando Adolfo A, 2009, Hematology Am Soc Hematol Educ Program, P353, DOI 10.1182/asheducation-2009.1.353; Fryer CJ, 2004, MOL CELL, V16, P509, DOI 10.1016/j.molcel.2004.10.014; Hanlon L, 2010, CANCER RES, V70, P4280, DOI 10.1158/0008-5472.CAN-09-4645; Hass MR, 2009, SEMIN CELL DEV BIOL, V20, P201, DOI 10.1016/j.semcdb.2008.11.014; Heitzler P, 2010, CURR TOP DEV BIOL, V92, P457, DOI 10.1016/S0070-2153(10)92014-0; Hertenstein B, 2005, HAEMATOLOGICA, V90, P969; HO IC, 1989, P NATL ACAD SCI USA, V86, P6714, DOI 10.1073/pnas.86.17.6714; Hozumi K, 2008, J EXP MED, V205, P2507, DOI 10.1084/jem.20080134; Klinakis A, 2011, NATURE, V473, P230, DOI 10.1038/nature09999; Koch U, 2008, J EXP MED, V205, P2515, DOI 10.1084/jem.20080829; LAFAILLE JJ, 1994, CELL, V78, P399, DOI 10.1016/0092-8674(94)90419-7; Lino MM, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-72; Liu JN, 2010, CURR TOP DEV BIOL, V92, P367, DOI [10.1016/S0070-2153(10)92012-7, 10.1016/S0070-2153(10)91012-7]; Maillard I, 2006, J EXP MED, V203, P2239, DOI 10.1084/jem.20061020; Maraver A, 2007, BLOOD, V110, P3218, DOI 10.1182/blood-2007-01-070359; Mazur PK, 2010, P NATL ACAD SCI USA, V107, P13438, DOI 10.1073/pnas.1002423107; NEHLS M, 1994, NATURE, V372, P103, DOI 10.1038/372103a0; Nicolas M, 2003, NAT GENET, V33, P416, DOI 10.1038/ng1099; NICOLETTI I, 1991, J IMMUNOL METHODS, V139, P271, DOI 10.1016/0022-1759(91)90198-O; O'Neil J, 2007, J EXP MED, V204, P1813, DOI 10.1084/jem.20070876; Radtke F, 1999, IMMUNITY, V10, P547, DOI 10.1016/S1074-7613(00)80054-0; Roy M, 2007, CURR OPIN GENET DEV, V17, P52, DOI 10.1016/j.gde.2006.12.001; Tanigaki K, 2004, IMMUNITY, V20, P611, DOI 10.1016/S1074-7613(04)00109-8; Thompson BJ, 2007, J EXP MED, V204, P1825, DOI 10.1084/jem.20070872; Tosello V, 2013, THER ADV HEMATOL, V4, P199, DOI 10.1177/2040620712471368; van Es JH, 2005, NATURE, V435, P959, DOI 10.1038/nature03659; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; WINOTO A, 1989, CELL, V59, P649, DOI 10.1016/0092-8674(89)90010-X; WINOTO A, 1989, EMBO J, V8, P729, DOI 10.1002/j.1460-2075.1989.tb03432.x; Wiseman DH, 2011, BIOL BLOOD MARROW TR, V17, P771, DOI 10.1016/j.bbmt.2010.10.010; Wolfer A, 2002, IMMUNITY, V16, P869, DOI 10.1016/S1074-7613(02)00330-8; Wolfer A, 2001, NAT IMMUNOL, V2, P235, DOI 10.1038/85294; Yan XQ, 2001, BLOOD, V98, P3793, DOI 10.1182/blood.V98.13.3793; Yashiro-Ohtani Y, 2010, SEMIN IMMUNOL, V22, P261, DOI 10.1016/j.smim.2010.04.015	46	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e84841	10.1371/journal.pone.0084841	http://dx.doi.org/10.1371/journal.pone.0084841			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281RE	24386421	Green Submitted, Green Published, gold			2022-12-25	WOS:000329117900112
J	Zhang, S; Yang, Y; Liang, ZX; Duan, WX; Yang, J; Yan, JJ; Wang, N; Feng, WQ; Ding, ML; Nie, YZ; Jin, ZX				Zhang, Song; Yang, Yang; Liang, Zhenxing; Duan, Weixun; Yang, Jian; Yan, Juanjuan; Wang, Ning; Feng, Wenqiang; Ding, Meiling; Nie, Yongzhan; Jin, Zhenxiao			Silybin-Mediated Inhibition of Notch Signaling Exerts Antitumor Activity in Human Hepatocellular Carcinoma Cells	PLOS ONE			English	Article							HUMAN OSTEOSARCOMA CELLS; CANCER CELLS; HEPATOMA-CELLS; IN-VITRO; SILIBININ; PATHWAY; APOPTOSIS; ACTIVATION; INVASION; GROWTH	Hepatocellular carcinoma (HCC) is a global health burden that is associated with limited treatment options and poor patient prognoses. Silybin (SIL), an antioxidant derived from the milk thistle plant (Silybum marianum), has been reported to exert hepatoprotective and antitumorigenic effects both in vitro and in vivo. While SIL has been shown to have potent antitumor activity against various types of cancer, including HCC, the molecular mechanisms underlying the effects of SIL remain largely unknown. The Notch signaling pathway plays crucial roles in tumorigenesis and immune development. In the present study, we assessed the antitumor activity of SIL in human HCC HepG2 cells in vitro and in vivo and explored the roles of the Notch pathway and of the apoptosis-related signaling pathway on the activity of SIL. SIL treatment resulted in a dose-and time-dependent inhibition of HCC cell viability. Additionally, SIL exhibited strong antitumor activity, as evidenced not only by reductions in tumor cell adhesion, migration, intracellular glutathione (GSH) levels and total antioxidant capability (T-AOC) but also by increases in the apoptotic index, caspase3 activity, and reactive oxygen species (ROS). Furthermore, SIL treatment decreased the expression of the Notch1 intracellular domain (NICD), RBP-J kappa, and Hes1 proteins, upregulated the apoptosis pathway-related protein Bax, and downregulated Bcl2, survivin, and cyclin D1. Notch1 siRNA (in vitro) or DAPT (a known Notch1 inhibitor, in vivo) further enhanced the antitumor activity of SIL, and recombinant Jagged1 protein (a known Notch ligand in vitro) attenuated the antitumor activity of SIL. Taken together, these data indicate that SIL is a potent inhibitor of HCC cell growth that targets the Notch signaling pathway and suggest that the inhibition of Notch signaling may be a novel therapeutic intervention for HCC.	[Zhang, Song; Feng, Wenqiang; Ding, Meiling; Nie, Yongzhan] Fourth Mil Med Univ, State Key Lab Canc Biol, Dept Gastroenterol, Xijing Hosp, Xian 710032, Peoples R China; [Yang, Yang; Liang, Zhenxing; Duan, Weixun; Yang, Jian; Wang, Ning; Jin, Zhenxiao] Fourth Mil Med Univ, Dept Cardiovasc Surg, Xijing Hosp, Xian 710032, Peoples R China; [Yan, Juanjuan] Fourth Mil Med Univ, Dept Prosthodont, Sch Stomatol, Xian 710032, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University	Nie, YZ (corresponding author), Fourth Mil Med Univ, State Key Lab Canc Biol, Dept Gastroenterol, Xijing Hosp, Xian 710032, Peoples R China.	nieyongzhan210@126.com; zhenxiaojin210@126.com	Jin, Zhenxiao/AAJ-5777-2020		12th National Five Years Supporting Project of China [2011BAI11B20]; National Natural Science Foundation of China [81120108005, 81225003, 81102687, 81270170, 81070198, 81000938]; Social Development Project of Shaanxi Province [2012JQ4001, 2012K15-02-01, 2012SF2-21-1]	12th National Five Years Supporting Project of China(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Social Development Project of Shaanxi Province	This study was supported by grants from the 12th National Five Years Supporting Project of China (2011BAI11B20), the National Natural Science Foundation of China (81120108005, 81225003, 81102687, 81270170, 81070198, and 81000938), and the Social Development Project of Shaanxi Province (2012JQ4001, 2012K15-02-01, and 2012SF2-21-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn S, 2013, HEPATOB PANCREAT DIS, V12, P286, DOI 10.1016/S1499-3872(13)60046-6; Budihardjo I, 1999, ANNU REV CELL DEV BI, V15, P269, DOI 10.1146/annurev.cellbio.15.1.269; Capaccione KM, 2013, CARCINOGENESIS, V34, P1420, DOI 10.1093/carcin/bgt127; Chang HR, 2011, MOL CARCINOGEN, V50, P812, DOI 10.1002/mc.20756; Chen YQ, 2011, CANCER BIOL THER, V11, P14, DOI 10.4161/cbt.11.1.13730; Cheng YD, 2013, EUR J PHARMACOL, V715, P219, DOI 10.1016/j.ejphar.2013.05.017; Cho H.J., 2013, J AGR FOOD CHEM; Deep G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034630; Deep G, 2010, CANCER METAST REV, V29, P447, DOI 10.1007/s10555-010-9237-0; Dill MT, 2013, HEPATOLOGY, V57, P1607, DOI 10.1002/hep.26165; Dizaji MZ, 2012, NEUROCHEM RES, V37, P370, DOI 10.1007/s11064-011-0620-1; Angeli JPF, 2010, MUTAGENESIS, V25, P223, DOI 10.1093/mutage/gep064; Gao J, 2010, EXP CELL RES, V316, P149, DOI 10.1016/j.yexcr.2009.09.025; Ghasemi R, 2013, NUTR CANCER, V65, P590, DOI 10.1080/01635581.2013.770043; Guo WJ, 2011, CANCER LETT, V312, P55, DOI 10.1016/j.canlet.2011.07.024; Janicke RU, 1998, J BIOL CHEM, V273, P9357, DOI 10.1074/jbc.273.16.9357; Kauntz H, 2012, INT J ONCOL, V41, P849, DOI 10.3892/ijo.2012.1526; Khan M, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/719858; Liu YW, 2013, TOXICOLOGY, V304, P120, DOI 10.1016/j.tox.2012.12.018; McAuliffe SM, 2012, P NATL ACAD SCI USA, V109, pE2939, DOI 10.1073/pnas.1206400109; Meng RD, 2009, CANCER RES, V69, P573, DOI 10.1158/0008-5472.CAN-08-2088; Naganuma S, 2012, AM J CANCER RES, V2, P459; Nguyen KC, 2013, TOXICOLOGY, V306, P114, DOI 10.1016/j.tox.2013.02.010; Post-White J, 2007, INTEGR CANCER THER, V6, P104, DOI 10.1177/1534735407301632; Raina K, 2013, MOL CARCINOGEN, V52, P195, DOI 10.1002/mc.21843; Ristorcelli E, 2009, INT J CANCER, V125, P1016, DOI 10.1002/ijc.24375; Singh RR, 2009, CLIN CANCER RES, V15, P613, DOI 10.1158/1078-0432.CCR-08-1846; Yang LL, 2013, MAR DRUGS, V11, P1961, DOI 10.3390/md11061961; Yang Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062652; Zhou L, 2013, DIGEST DIS SCI, V58, P1016, DOI 10.1007/s10620-012-2434-7	30	27	30	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e83699	10.1371/journal.pone.0083699	http://dx.doi.org/10.1371/journal.pone.0083699			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281RE	24386256	gold, Green Submitted, Green Published			2022-12-25	WOS:000329117900054
J	Sant'Anna, RTP; Monteiro, EV; Pereira, JRT; Faria, RB				Sant'Anna, Rafaela T. P.; Monteiro, Emily V.; Pereira, Juliano R. T.; Faria, Roberto B.			The Ozone-Iodine-Chlorate Clock Reaction	PLOS ONE			English	Article							CHLORINE DIOXIDE; MECHANISM; KINETICS; ION	This work presents a new clock reaction based on ozone, iodine, and chlorate that differs from the known chlorate-iodine clock reaction because it does not require UV light. The induction period for this new clock reaction depends inversely on the initial concentrations of ozone, chlorate, and perchloric acid but is independent of the initial iodine concentration. The proposed mechanism considers the reaction of ozone and iodide to form HOI, which is a key species for producing nonlinear autocatalytic behavior. The novelty of this system lies in the presence of ozone, whose participation has never been observed in complex systems such as clock or oscillating reactions. Thus, the autocatalysis demonstrated in this new clock reaction should open the possibility for a new family of oscillating reactions.	[Sant'Anna, Rafaela T. P.; Monteiro, Emily V.; Pereira, Juliano R. T.; Faria, Roberto B.] Univ Fed Rio de Janeiro, Inst Quim, Rio De Janeiro, RJ, Brazil	Universidade Federal do Rio de Janeiro	Faria, RB (corresponding author), Univ Fed Rio de Janeiro, Inst Quim, Rio De Janeiro, RJ, Brazil.	faria@iq.ufrj.br	Faria, Roberto B./B-5455-2013	FARIA, ROBERTO/0000-0001-9337-4324	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [303988/2009-6]; Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro [E-26/110-107/2007]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, grant 303988/2009-6 (www.cnpq.br); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro, E-26/110-107/2007 (www.faperj.br); and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (www.capes.gov.br). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chance B., 1973, BIOL BIOCH OSCILLATO; Danino T, 2010, NATURE, V463, P326, DOI 10.1038/nature08753; de Violet PF, 1973, J CHIM PHYS PCB, V70, P1404; EDBLOM EC, 1986, J AM CHEM SOC, V108, P2826, DOI 10.1021/ja00271a007; Epstein I.R., 1998, INTRO NONLINEAR CHEM; Galajda M, 2007, J AM CHEM SOC, V129, P7738, DOI 10.1021/ja072361l; Goldbeter A, 1997, BIOCH OSCILLATIONS C; Jowza M, 2005, J PHYS CHEM A, V109, P1873, DOI 10.1021/jp0457895; KAPS P, 1979, NUMER MATH, V33, P55, DOI 10.1007/BF01396495; Landolt H., 1886, BER DTSCH CHEM GES, V19, P1317; Lengyel I, 1996, J AM CHEM SOC, V118, P3708, DOI 10.1021/ja953938e; Lente G, 2007, NEW J CHEM, V31, P1707, DOI 10.1039/b708846a; Liu Q, 2001, INORG CHEM, V40, P4436, DOI 10.1021/ic000919j; Neuenschwander U, 2013, J PHYS CHEM A, V117, P4343, DOI 10.1021/jp400879d; Oliveira AP, 2005, J AM CHEM SOC, V127, P18022, DOI 10.1021/ja0570537; Rabai G, 2001, J PHYS CHEM A, V105, P6167, DOI 10.1021/jp010370p; RABAI G, 1987, INORG CHEM, V26, P1195, DOI 10.1021/ic00255a004; Shakhashiri BZ, 1985, CLOCK REACTIONS CHEM, V2, P3	18	8	8	5	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e83706	10.1371/journal.pone.0083706	http://dx.doi.org/10.1371/journal.pone.0083706			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281QS	24386257	Green Published, Green Submitted, gold			2022-12-25	WOS:000329116700071
J	Trebicka, J; Krag, A; Gansweid, S; Schiedermaier, P; Strunk, HM; Fimmers, R; Strassburg, CP; Bendtsen, F; Moller, S; Sauerbruch, T; Spengler, U				Trebicka, Jonel; Krag, Aleksander; Gansweid, Stefan; Schiedermaier, Peter; Strunk, Holger M.; Fimmers, Rolf; Strassburg, Christian P.; Bendtsen, Fleming; Moller, Soren; Sauerbruch, Tilman; Spengler, Ulrich			Soluble TNF-Alpha-Receptors I Are Prognostic Markers in TIPS-Treated Patients with Cirrhosis and Portal Hypertension	PLOS ONE			English	Article							INTRAHEPATIC PORTOSYSTEMIC SHUNT; NECROSIS-FACTOR RECEPTORS; BACTERIAL TRANSLOCATION; LIVER-CIRRHOSIS; SERUM-LEVELS; P55; P75; CIRRHOTICS; EXPRESSION; RESISTANCE	Background: TNF alpha levels are increased in liver cirrhosis even in the absence of infection, most likely owing to a continuous endotoxin influx into the portal blood. Soluble TNF alpha receptors (sTNFR type I and II) reflect release of the short-lived TNF alpha, because they are cleaved from the cells after binding of TNF alpha. The aims were to investigate the circulating levels of soluble TNFR-I and -II in cirrhotic patients receiving TIPS. Methods: Forty-nine patients with liver cirrhosis and portal hypertension (12 viral, 37 alcoholic) received TIPS for prevention of re-bleeding (n = 14), therapy-refractory ascites (n = 20), or both (n = 15). Portal and hepatic venous blood was drawn in these patients during the TIPS procedure and during the control catheterization two weeks later. sTNFR-I and sTNFR-II were measured by ELISA, correlated to clinical and biochemical characteristics. Results: Before TIPS insertion, sTNFR-II levels were lower in portal venous blood than in the hepatic venous blood, as well as in portal venous blood after TIPS insertion. No significant differences were measured in sTNFR-I levels. Hepatic venous levels of sTNFR-I above 4.5 ng/mL (p = 0.036) and sTNFR-II above 7 ng/mL (p = 0.05) after TIPS insertion were associated with decreased survival. A multivariate Cox-regression survival analysis identified the hepatic venous levels of sTNFR-I (p = 0.004) two weeks after TIPS, and Child score (p = 0.002) as independent predictors of mortality, while MELD-score was not. Conclusion: Hepatic venous levels of sTNFR-I after TIPS insertion may predict mortality in patients with severe portal hypertension.	[Trebicka, Jonel; Gansweid, Stefan; Schiedermaier, Peter; Strassburg, Christian P.; Sauerbruch, Tilman; Spengler, Ulrich] Univ Bonn, Dept Internal Med 1, Bonn, Germany; [Trebicka, Jonel; Krag, Aleksander; Bendtsen, Fleming] Univ Copenhagen, Hvidovre Hosp, Div Med, Gastrounit, Copenhagen, Denmark; [Krag, Aleksander] Univ Southern Denmark, Odense Univ Hosp, Dept Gastroenterol, Odense, Denmark; [Strunk, Holger M.] Univ Bonn, Dept Radiol, Bonn, Germany; [Fimmers, Rolf] Univ Bonn, Inst Med Biometry Informat & Epidemiol, Bonn, Germany; [Moller, Soren] Univ Copenhagen, Hvidovre Hosp, Dept Clin Physiol & Nucl Med, Ctr Funct Imaging & Res, Copenhagen, Denmark	University of Bonn; University of Copenhagen; University of Southern Denmark; Odense University Hospital; University of Bonn; University of Bonn; University of Copenhagen	Trebicka, J (corresponding author), Univ Bonn, Dept Internal Med 1, Bonn, Germany.	jonel.trebicka@ukb.uni-bonn.de	Krag, Aleksander/ABH-9649-2020	Krag, Aleksander/0000-0002-9598-4932; Moller, Soren/0000-0001-9684-7764; Trebicka, Jonel/0000-0002-7028-3881	Deutsche Forschungsgemeinschaft [SFB TRR57]; H.J. & W. Hector Stiftung; Capital Region of Denmark Foundation of Health Research; Hvidovre Hospital Foundation for Liver Diseases; Novo Nordisk Fonden [NNF11OC1015075, NNF13OC0006329, NNF11OC1014467] Funding Source: researchfish	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); H.J. & W. Hector Stiftung; Capital Region of Denmark Foundation of Health Research; Hvidovre Hospital Foundation for Liver Diseases; Novo Nordisk Fonden(Novo Nordisk Foundation)	The study was supported by grants of Deutsche Forschungsgemeinschaft (SFB TRR57 to P12 and P18), by grants of H.J. & W. Hector Stiftung, as well as by the Capital Region of Denmark Foundation of Health Research and Hvidovre Hospital Foundation for Liver Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bari K, 2012, WORLD J GASTROENTERO, V18, P1166, DOI 10.3748/wjg.v18.i11.1166; Bosch J, 2000, J HEPATOL, V32, P141, DOI 10.1016/S0168-8278(00)80422-5; Brensing KA, 2000, GUT, V47, P288, DOI 10.1136/gut.47.2.288; Brensing KA, 2002, SCAND J GASTROENTERO, V37, P1070, DOI 10.1080/003655202320378284; Garcia-Pagan JC, 2010, NEW ENGL J MED, V362, P2370, DOI 10.1056/NEJMoa0910102; Cubillas R, 2010, HEPAT RES TREAT, V2010; DIEZRUIZ A, 1995, HEPATOLOGY, V21, P976; Fickert P, 2010, LAB INVEST, V90, P844, DOI 10.1038/labinvest.2010.61; Fidelman N, 2012, AM J ROENTGENOL, V199, P746, DOI 10.2214/AJR.12.9101; Gonzalez-Calvin JL, 2004, J CLIN ENDOCR METAB, V89, P4325, DOI 10.1210/jc.2004-0077; Grunhage F, 2008, CLIN GASTROENTEROL H, V6, P1255, DOI 10.1016/j.cgh.2008.06.018; Hanck C, 2000, J HEPATOL, V32, P51, DOI 10.1016/S0168-8278(00)80189-0; Ingaramo PI, 2011, MOL IMMUNOL, V48, P1397, DOI 10.1016/j.molimm.2011.03.015; Itoh Y, 1999, AM J GASTROENTEROL, V94, P1332, DOI 10.1111/j.1572-0241.1999.01083.x; Jalan R, 2011, J HEPATOL; Kakumu S, 1997, CLIN EXP IMMUNOL, V109, P458, DOI 10.1046/j.1365-2249.1997.4861382.x; Kallinowski B, 1998, CLIN EXP IMMUNOL, V111, P269; Kitamura K, 2002, LAB INVEST, V82, P571, DOI 10.1038/labinvest.3780452; Lin SY, 2004, METABOLISM, V53, P922, DOI 10.1016/j.metabol.2004.01.016; Machado MV, 2009, EUR J GASTROEN HEPAT, V21, P201, DOI 10.1097/MEG.0b013e32831016e0; Moreau R, 2013, GASTROENTEROLOGY, V144, P1426, DOI 10.1053/j.gastro.2013.02.042; Moreland LW, 2001, ISR MED ASSOC J, V3, P686; Moura AS, 2010, EUR J CLIN MICROBIOL, V29, P1153, DOI 10.1007/s10096-010-0981-4; Naveau S, 2001, AM J GASTROENTEROL, V96, P3361; Naveau S, 1998, J HEPATOL, V28, P778, DOI 10.1016/S0168-8278(98)80227-4; Pandey M, 2003, AM J PATHOL, V162, P933, DOI 10.1016/S0002-9440(10)63888-6; Riordan SM, 2003, HEPATOLOGY, V37, P1154, DOI 10.1053/jhep.2003.50180; Salerno F, 2007, GASTROENTEROLOGY, V133, P825, DOI 10.1053/j.gastro.2007.06.020; Schlatter R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018646; Shiraki M, 2010, NUTRITION, V26, P269, DOI 10.1016/j.nut.2009.04.016; Tarrats N, 2011, HEPATOLOGY, V54, P319, DOI 10.1002/hep.24388; Toda K, 2010, BBA-MOL CELL BIOL L, V1801, P655, DOI 10.1016/j.bbalip.2010.03.002; Trebicka J, 2011, EUR J GASTROEN HEPAT, V23, P1218, DOI 10.1097/MEG.0b013e32834a75dc; Wiest R, 1999, J CLIN INVEST, V104, P1223, DOI 10.1172/JCI7458; Wiest R, 2005, HEPATOLOGY, V41, P422, DOI 10.1002/hep.20632; Yang YY, 2009, LIVER INT, V29, P678, DOI 10.1111/j.1478-3231.2009.01983.x; Yang YY, 2009, BIOCHEM BIOPH RES CO, V380, P666, DOI 10.1016/j.bbrc.2009.01.160; Zekri Abdel-Rahman N, 2010, Comp Hepatol, V9, P1, DOI 10.1186/1476-5926-9-1; Zimmerer JM, 2012, TRANSPLANTATION, V94, P1103, DOI 10.1097/TP.0b013e318270f3c0	39	27	28	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e83341	10.1371/journal.pone.0083341	http://dx.doi.org/10.1371/journal.pone.0083341			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281QS	24386183	Green Published, gold, Green Submitted			2022-12-25	WOS:000329116700043
J	Pais, RS; Moreno-Barriuso, N; Hernandez-Porras, I; Lopez, IP; De Las Rivas, J; Pichel, JG				Sofia Pais, Rosete; Moreno-Barriuso, Nuria; Hernandez-Porras, Isabel; Paula Lopez, Iciar; De Las Rivas, Javier; Garcia Pichel, Jose			Transcriptome Analysis in Prenatal IGF1-Deficient Mice Identifies Molecular Pathways and Target Genes Involved in Distal Lung Differentiation	PLOS ONE			English	Article							GROWTH-FACTOR-I; MESSENGER-RNA EXPRESSION; CELL-PROLIFERATION; BRANCHING MORPHOGENESIS; BINDING-PROTEINS; MOUSE LUNG; IGF-I; BRONCHOPULMONARY DYSPLASIA; ALVEOLAR DEVELOPMENT; ENTERIC INNERVATION	Background: Insulin-like Growth Factor 1 (IGF1) is a multifunctional regulator of somatic growth and development throughout evolution. IGF1 signaling through IGF type 1 receptor (IGF1R) controls cell proliferation, survival and differentiation in multiple cell types. IGF1 deficiency in mice disrupts lung morphogenesis, causing altered prenatal pulmonary alveologenesis. Nevertheless, little is known about the cellular and molecular basis of IGF1 activity during lung development. Methods/Principal Findings: Prenatal Igf1(-/-) mutant mice with a C57Bl/6J genetic background displayed severe disproportional lung hypoplasia, leading to lethal neonatal respiratory distress. Immuno-histological analysis of their lungs showed a thickened mesenchyme, alterations in extracellular matrix deposition, thinner smooth muscles and dilated blood vessels, which indicated immature and delayed distal pulmonary organogenesis. Transcriptomic analysis of Igf1(-/-) E18.5 lungs using RNA microarrays identified deregulated genes related to vascularization, morphogenesis and cellular growth, and to MAP-kinase, Wnt and cell-adhesion pathways. Up-regulation of immunity-related genes was verified by an increase in inflammatory markers. Increased expression of Nfib and reduced expression of Klf2, Egr1 and Ctgf regulatory proteins as well as activation of ERK2 MAP-kinase were corroborated by Western blot. Among IGF-system genes only IGFBP2 revealed a reduction in mRNA expression in mutant lungs. Immuno-staining patterns for IGF1R and IGF2, similar in both genotypes, correlated to alterations found in specific cell compartments of Igf1(-/-) lungs. IGF1 addition to Igf1(-/-) embryonic lungs cultured ex vivo increased airway septa remodeling and distal epithelium maturation, processes accompanied by upregulation of Nfib and Klf2 transcription factors and Cyr61 matricellular protein. Conclusions/Significance: We demonstrated the functional tissue specific implication of IGF1 on fetal lung development in mice. Results revealed novel target genes and gene networks mediators of IGF1 action on pulmonary cellular proliferation, differentiation, adhesion and immunity, and on vascular and distal epithelium maturation during prenatal lung development.	[Sofia Pais, Rosete; Paula Lopez, Iciar; Garcia Pichel, Jose] Fdn Rioja Salud, Ctr Invest Biomed Rioja, Logrono, Spain; [Moreno-Barriuso, Nuria; Hernandez-Porras, Isabel; De Las Rivas, Javier] Univ Salamanca, CSIC, Ctr Invest Canc, Inst Biol Mol & Celular Canc, E-37008 Salamanca, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigacion del Cancer (CIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); University of Salamanca	Pichel, JG (corresponding author), Fdn Rioja Salud, Ctr Invest Biomed Rioja, Logrono, Spain.	jgpichel@riojasalud.es	Pichel, Jose G/AAF-2255-2019; De Las Rivas, Javier/G-5936-2014	Pichel, Jose G/0000-0001-8580-0952; De Las Rivas, Javier/0000-0002-0984-9946	Fundacion Rioja Salud (Logrono); Ministerio de Ciencia e Innovacion (Spain) [BFU200501437]	Fundacion Rioja Salud (Logrono); Ministerio de Ciencia e Innovacion (Spain)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work was partially supported by the Fundacion Rioja Salud (Logrono) and Ministerio de Ciencia e Innovacion (BFU200501437) (Spain). R. S. P. was a pre-doctoral fellow from Fundacion Rioja Salud, N.M.-B. was a doctoral fellow from the Ministerio de Ciencia e Innovacion and I.H.-P. was a JAE fellow from the Consejo Superior de Investigaciones Cientificas (Spain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akram A, 2010, AM J RESP CRIT CARE, V182, P489, DOI 10.1164/rccm.200906-0925OC; Al-Shahrour F, 2005, NUCLEIC ACIDS RES, V33, pW460, DOI 10.1093/nar/gki456; Asaoka Y, 2010, J BIOCHEM, V148, P393, DOI 10.1093/jb/mvq098; Baguma-Nibasheka M, 2008, DEV DYNAM, V237, P485, DOI 10.1002/dvdy.21433; BAKER J, 1993, CELL, V75, P73, DOI 10.1016/0092-8674(93)90680-O; Banski P, 2010, J BIOL CHEM, V285, P21858, DOI 10.1074/jbc.M110.117291; Berg K, 1996, BRIT J CANCER, V74, P688, DOI 10.1038/bjc.1996.423; Bourbon J, 2005, PEDIATR RES, V57, p38R, DOI 10.1203/01.PDR.0000159630.35883.BE; Brigstock DR, 2003, J ENDOCRINOL, V178, P169, DOI 10.1677/joe.0.1780169; Camarero G, 2001, J NEUROSCI, V21, P7630, DOI 10.1523/JNEUROSCI.21-19-07630.2001; Capoluongo E, 2008, CLIN CHEM LAB MED, V46, P1061, DOI 10.1515/CCLM.2008.211; Carmona-Saez P, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r3; Castellano E, 2007, ONCOGENE, V26, P917, DOI 10.1038/sj.onc.1209845; Chen CC, 2009, INT J BIOCHEM CELL B, V41, P771, DOI 10.1016/j.biocel.2008.07.025; CHEN JM, 1987, DEV BIOL, V120, P311, DOI 10.1016/0012-1606(87)90234-X; Chen PP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000534; Chen XN, 2006, P NATL ACAD SCI USA, V103, P11724, DOI 10.1073/pnas.0604946103; Chetty A, 2004, PEDIATR PULM, V37, P128, DOI 10.1002/ppul.10415; Chetty A, 2006, PEDIATR RES, V60, P389, DOI 10.1203/01.pdr.0000238257.15502.f4; Chien W, 2006, MOL CANCER RES, V4, P591, DOI 10.1158/1541-7786.MCR-06-0029; Chinoy MR, 2003, FRONT BIOSCI-LANDMRK, V8, pD392, DOI 10.2741/974; COCCIA EM, 1992, MOL CELL BIOL, V12, P3514, DOI 10.1128/MCB.12.8.3514; Compernolle V, 2002, NAT MED, V8, P702, DOI 10.1038/nm721; Da Cruz S, 2003, J BIOL CHEM, V278, P41566, DOI 10.1074/jbc.M304940200; Demidyuk IV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055752; Dolinay T, 2006, PHYSIOL GENOMICS, V26, P68, DOI 10.1152/physiolgenomics.00110.2005; Dooley AL, 2011, GENE DEV, V25, P1470, DOI 10.1101/gad.2046711; Dupont J, 2001, ENDOCRINOLOGY, V142, P4969, DOI 10.1210/en.142.11.4969; Epaud R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048071; FLEMING TJ, 1993, J IMMUNOL, V151, P2399; Frago LM, 2000, HISTOL HISTOPATHOL, V15, P657, DOI 10.14670/HH-15.657; Fredriksson L, 2004, EMBO J, V23, P3793, DOI 10.1038/sj.emboj.7600397; Ghosh MC, 2013, AM J PHYSIOL-LUNG C, V305, P1222, DOI 10.1152/ajplung.00014.2013; Grunder A, 2002, MECH DEVELOP, V112, P69, DOI 10.1016/S0925-4773(01)00640-2; Han RNN, 2003, AM J RESP CELL MOL, V28, P159, DOI 10.1165/rcmb.4764; Hetzel M, 2005, LUNG, V183, P225, DOI 10.1007/s00408-004-2534-z; Hsieh T, 2003, J BIOL CHEM, V278, P42886, DOI 10.1074/jbc.M303835200; Hsu YC, 2011, DEV BIOL, V354, P242, DOI 10.1016/j.ydbio.2011.04.002; Inanlou MR, 2005, DEV DYNAM, V233, P772, DOI 10.1002/dvdy.20381; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jiang Y, 2006, J CELL BIOCHEM, V98, P208, DOI 10.1002/jcb.20771; Kang JH, 2004, EUR J BIOCHEM, V271, P2452, DOI 10.1111/j.1432-1033.2004.04175.x; Kim HS, 1997, P NATL ACAD SCI USA, V94, P12981, DOI 10.1073/pnas.94.24.12981; Kohno K, 2003, BIOESSAYS, V25, P691, DOI 10.1002/bies.10300; Krein PM, 2002, CHEST, V122, p289S, DOI 10.1378/chest.122.6_suppl.289S; Krop I, 2005, CANCER RES, V65, P9659, DOI 10.1158/0008-5472.CAN-05-1663; Kruis T, 2010, J CLIN ENDOCR METAB, V95, P1137, DOI 10.1210/jc.2009-1433; Lawan A, 2013, CELL MOL LIFE SCI, V70, P223, DOI 10.1007/s00018-012-1041-2; Lebeche D, 1999, MECH DEVELOP, V86, P125, DOI 10.1016/S0925-4773(99)00124-0; Lee GH, 2003, ONCOGENE, V22, P2374, DOI 10.1038/sj.onc.1206387; Lee JH, 2001, AM J PHYSIOL-LUNG C, V280, pL1019, DOI 10.1152/ajplung.2001.280.5.L1019; Lee JI, 2003, J MOL BIOL, V328, P147, DOI 10.1016/S0022-2836(03)00237-7; LeRoith D, 2003, CANCER LETT, V195, P127, DOI 10.1016/S0304-3835(03)00159-9; LIU JP, 1993, CELL, V75, P59, DOI 10.1016/S0092-8674(05)80084-4; Liu Y, 2008, DEV BIOL, V314, P224, DOI 10.1016/j.ydbio.2007.12.003; Lu D, 2007, BIOCHEM J, V401, P559, DOI 10.1042/BJ20061081; Maeda Y, 2007, PHYSIOL REV, V87, P219, DOI 10.1152/physrev.00028.2006; Matsumoto N, 2006, BLOOD, V107, P1357, DOI 10.1182/blood-2005-05-1916; Mesas-Burgos C, 2009, J PEDIATR SURG, V44, P720, DOI 10.1016/j.jpedsurg.2008.06.020; Millien G, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-35; MINER JH, 1994, J CELL BIOL, V127, P879, DOI 10.1083/jcb.127.3.879; Miyazaki E, 1998, J PEDIATR SURG, V33, P1476, DOI 10.1016/S0022-3468(98)90478-X; Mo FE, 2002, MOL CELL BIOL, V22, P8709, DOI 10.1128/MCB.22.24.8709-8720.2002; Moreno-Barriuso N, 2006, DEV DYNAM, V235, P2040, DOI 10.1002/dvdy.20842; Morris DG, 2003, NATURE, V422, P169, DOI 10.1038/nature01413; Morrisey EE, 2010, DEV CELL, V18, P8, DOI 10.1016/j.devcel.2009.12.010; Muglia LJ, 1999, AM J RESP CELL MOL, V20, P181, DOI 10.1165/ajrcmb.20.2.3381; Nagata K, 2007, PEDIATR SURG INT, V23, P953, DOI 10.1007/s00383-007-1977-8; Neufeld G, 1999, FASEB J, V13, P9, DOI 10.1096/fasebj.13.1.9; Nguyet NM, 2005, DEV BIOL, V282, P111, DOI 10.1016/j.ydbio.2005.02.031; Nogueira-Silva C, 2008, EARLY HUM DEV, V84, pS79; Pauling MH, 2004, CURR TOP DEV BIOL, V64, P73, DOI 10.1016/S0070-2153(04)64005-1; Perez-Moreno M, 2006, CELL, V124, P631, DOI 10.1016/j.cell.2005.11.043; Pichel JG, 1996, COLD SPRING HARB SYM, V61, P445; Pichel JG, 2003, MECH DEVELOP, V120, P349, DOI 10.1016/S0925-4773(02)00449-5; Pichel JG, 1996, NATURE, V382, P73, DOI 10.1038/382073a0; Pollak M, 2008, NAT REV CANCER, V8, P915, DOI 10.1038/nrc2536; Ponticos M, 2013, VASC PHARMACOL, V58, P189, DOI 10.1016/j.vph.2013.01.004; POWELLBRAXTON L, 1993, GENE DEV, V7, P2609, DOI 10.1101/gad.7.12b.2609; Prince LS, 2004, AM J PHYSIOL-LUNG C, V287, pL999, DOI 10.1152/ajplung.00111.2004; Qiang Y, 2003, J IMMUNOL, V170, P1473, DOI 10.4049/jimmunol.170.3.1473; Ramirez MI, 2003, DEV BIOL, V256, P61, DOI 10.1016/S0012-1606(02)00098-2; RetschBogart GZ, 1996, AM J RESP CELL MOL, V14, P61, DOI 10.1165/ajrcmb.14.1.8534487; ROBACK EW, 1991, AM J MED GENET, V38, P74, DOI 10.1002/ajmg.1320380117; Saiga H, 2008, J IMMUNOL, V181, P8521, DOI 10.4049/jimmunol.181.12.8521; Sakai T, 2003, NATURE, V423, P876, DOI 10.1038/nature01712; Sanchez-Calderon H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008699; Schniedermann J, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-50; SCHULLER AGP, 1995, J MOL ENDOCRINOL, V14, P349, DOI 10.1677/jme.0.0140349; Shapiro P, 1997, AM J PHYSIOL-LUNG C, V273, pL459, DOI 10.1152/ajplung.1997.273.2.L459; Shen HC, 2012, FEBS OPEN BIO, V2, P1, DOI 10.1016/j.fob.2011.12.001; Silva D, 2006, ENDOCRINOLOGY, V147, P5584, DOI 10.1210/en.2006-0498; Soriano C, 2012, LUNG CANCER, V77, P38, DOI 10.1016/j.lungcan.2012.01.017; Srisuma S, 2010, AM J RESP CRIT CARE, V181, P838, DOI 10.1164/rccm.200904-0544OC; Starcher BC, 2000, CHEST, V117, p229S, DOI 10.1378/chest.117.5_suppl_1.229S-a; Steele-Perkins G, 2005, MOL CELL BIOL, V25, P685, DOI 10.1128/MCB.25.2.685-698.2005; Stewart CEH, 1996, PHYSIOL REV, V76, P1005, DOI 10.1152/physrev.1996.76.4.1005; Svegliati-Baroni G, 1999, HEPATOLOGY, V29, P1743, DOI 10.1002/hep.510290632; TENHAVEOPBROEK AAW, 1991, EXP LUNG RES, V17, P111, DOI 10.3109/01902149109064406; Thrane EV, 2001, EXP LUNG RES, V27, P387, DOI 10.1080/019021401750193638; Tong XJ, 2004, ONCOGENE, V23, P4847, DOI 10.1038/sj.onc.1207628; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Usui H, 2004, BIOCHEM BIOPH RES CO, V322, P887, DOI 10.1016/j.bbrc.2004.07.198; Ventura JJ, 2007, NAT GENET, V39, P750, DOI 10.1038/ng2037; Wagner KF, 2004, AM J RESP CELL MOL, V31, P276, DOI 10.1165/rcmb.2003-0319OC; Walenkamp MJE, 2005, J CLIN ENDOCR METAB, V90, P2855, DOI 10.1210/jc.2004-1254; Wang J, 2005, TISSUE CELL, V37, P25, DOI 10.1016/j.tice.2004.09.002; Wani MA, 1999, J BIOL CHEM, V274, P21180, DOI 10.1074/jbc.274.30.21180; Warner JR, 2009, MOL CELL, V34, P3, DOI 10.1016/j.molcel.2009.03.006; Wendel DP, 2000, AM J RESP CELL MOL, V23, P320, DOI 10.1165/ajrcmb.23.3.3906; Werner Haim, 2008, Archives of Physiology and Biochemistry, V114, P17, DOI [10.1080/13813450801900694, 10.1080/13813450801900694 ]; Williams MC, 2003, ANNU REV PHYSIOL, V65, P669, DOI 10.1146/annurev.physiol.65.092101.142446; Winnay JN, 2000, J BIOL CHEM, V275, P10545, DOI 10.1074/jbc.275.14.10545; Wu JH, 2008, J BIOL CHEM, V283, P3942, DOI 10.1074/jbc.M707882200; Wu S, 2009, PEDIATR RES, V65, P381, DOI 10.1203/PDR.0b013e3181991c67; Xie P, 2011, BIOCHEM BIOPH RES CO, V407, P254, DOI 10.1016/j.bbrc.2011.03.016; Xu Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037046; Zhang YJ, 2013, TUMOR BIOL, V34, P1605, DOI 10.1007/s13277-013-0691-5; Zhao L, 2008, BLOOD CELL MOL DIS, V41, P188, DOI 10.1016/j.bcmd.2008.03.006	119	26	28	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83028	10.1371/journal.pone.0083028	http://dx.doi.org/10.1371/journal.pone.0083028			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391734	Green Published, Green Submitted, gold			2022-12-25	WOS:000329325200031
J	Chen, WH; Cheng, SJ; Tzen, JTC; Cheng, CM; Lin, YW				Chen, Wei-Hsin; Cheng, Sin-Jhong; Tzen, Jason T. C.; Cheng, Chao-Min; Lin, Yi-Wen			Probing Relevant Molecules in Modulating the Neurite Outgrowth of Hippocampal Neurons on Substrates of Different Stiffness	PLOS ONE			English	Article							CELL-ADHESION; IN-VITRO; EXTRACELLULAR-MATRIX; PYRAMIDAL NEURONS; MECHANOTRANSDUCTION; FIBRONECTIN; ACTIVATION; LAMININ; REGENERATION; INITIATION	Hippocampal neurons play a critical role in learning and memory; however, the effects of environmental mechanical forces on neurite extension and associated underlying mechanisms are largely unexplored, possibly due to difficulties in maintaining central nervous system neurons. Neuron adhesion, neurite length, and mechanotransduction are mainly influenced by the extracellular matrix (ECM), which is often associated with structural scaffolding. In this study, we investigated the relationship between substrate stiffness and hippocampal neurite outgrowth by controlling the ratios of polydimethylsiloxane (PDMS) base to curing agent to create substrates of varying stiffness. Immunostaining results demonstrated that hippocampal neurons have longer neurite elongation in 35: 1 PDMS substrate compared those grown on 15: 1 PDMS, indicating that soft substrates provide a more optimal stiffness for hippocampal neurons. Additionally, we discovered that pPKC alpha expression was higher in the 15: 1 and 35: 1 PDMS groups than in the poly-L-lysine-coated glass group. However, when we used a fibronectin (FN) coating, we found that pFAKy397 and pFAKy925 expression were higher in glass group than in the 15:1 or 35:1 PDMS groups, but pPKC alpha and pERK1/2 expression were higher in the 35: 1 PDMS group than in the glass group. These results support the hypothesis that environmental stiffness influences hippocampal neurite outgrowth and underlying signaling pathways.	[Chen, Wei-Hsin; Tzen, Jason T. C.] Natl Chung Hsing Univ, Grad Inst Biotechnol, Taichung 40227, Taiwan; [Cheng, Sin-Jhong] Natl Taiwan Univ, Dept Life Sci, Taipei 10764, Taiwan; [Cheng, Sin-Jhong] Natl Taiwan Univ, Inst Zool, Taipei 10764, Taiwan; [Cheng, Chao-Min] Natl Tsing Hua Univ, Inst Nanoengn & Microsyst, Hsinchu, Taiwan; [Lin, Yi-Wen] China Med Univ, Grad Inst Acupuncture Sci, Taichung, Taiwan; [Lin, Yi-Wen] China Med Univ, Acupuncture Res Ctr, Taichung, Taiwan	National Chung Hsing University; National Taiwan University; Academia Sinica - Taiwan; National Taiwan University; National Tsing Hua University; China Medical University Taiwan; China Medical University Taiwan	Lin, YW (corresponding author), China Med Univ, Grad Inst Acupuncture Sci, Taichung, Taiwan.	yiwenlin@mail.cmu.edu.tw	Chang, Sin-Jhong/AAL-4118-2020; Lin, Yi-Wen/O-3541-2015	Lin, Yi-Wen/0000-0001-7204-8837	NSC [101-2320-B-039-014-MY3]; Taiwan Department of Health Clinical Trial and Research Center of Excellence [DOH102-TD-B-111-004]	NSC(Ministry of Science and Technology, Taiwan); Taiwan Department of Health Clinical Trial and Research Center of Excellence	This work was supported by NSC 101-2320-B-039-014-MY3 and in part by the Taiwan Department of Health Clinical Trial and Research Center of Excellence (DOH102-TD-B-111-004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aplin AE, 2001, J CELL BIOL, V153, P273, DOI 10.1083/jcb.153.2.273; Bass MD, 2002, BIOCHEM J, V368, P1, DOI 10.1042/BJ20021228; Beaudoin GMJ, 2012, NAT PROTOC, V7, P1741, DOI 10.1038/nprot.2012.099; Chen ZL, 2003, MOL BIOL CELL, V14, P2665, DOI 10.1091/mbc.E02-12-0832; Cheng CM, 2011, J BIOMECH, V44, P856, DOI 10.1016/j.jbiomech.2010.12.006; Cheng CM, 2010, NAT PROTOC, V5, P714, DOI 10.1038/nprot.2010.15; Choi KM, 2003, J AM CHEM SOC, V125, P4060, DOI 10.1021/ja029973k; Chou SY, 2011, SOFT MATTER, V7, P9871, DOI 10.1039/c1sm06336g; Dadsetan M, 2009, BIOMATERIALS, V30, P3874, DOI 10.1016/j.biomaterials.2009.04.018; Dehmelt L, 2004, J NEUROBIOL, V58, P18, DOI 10.1002/neu.10284; Delmas P, 2011, NAT REV NEUROSCI, V12, P139, DOI 10.1038/nrn2993; Dent EW, 2007, NAT CELL BIOL, V9, P1347, DOI 10.1038/ncb1654; Elston GN, 2003, CEREB CORTEX, V13, P1124, DOI 10.1093/cercor/bhg093; Evans ND, 2009, EUR CELLS MATER, V18, P1; Flanagan LA, 2002, NEUROREPORT, V13, P2411, DOI 10.1097/00001756-200212200-00007; FLETCHER TL, 1989, DEV BIOL, V136, P446, DOI 10.1016/0012-1606(89)90269-8; Garcia-Lopez P, 2006, J NEUROSCI, V26, P11249, DOI 10.1523/JNEUROSCI.3543-06.2006; Hattori N, 2007, BIOMED RES-TOKYO, V28, P139, DOI 10.2220/biomedres.28.139; Hinsby AM, 2004, J NEUROCHEM, V91, P694, DOI 10.1111/j.1471-4159.2004.02772.x; Hodgkinson GN, 2007, BIOMATERIALS, V28, P2590, DOI 10.1016/j.biomaterials.2007.01.038; HORACEK MJ, 1993, ACTA ANAT, V147, P69; Ivankovic-Dikic I, 2000, NAT CELL BIOL, V2, P574, DOI 10.1038/35023515; Kiryushko D, 2004, ANN NY ACAD SCI, V1014, P140, DOI 10.1196/annals.1294.015; Korobova F, 2008, MOL BIOL CELL, V19, P1561, DOI 10.1091/mbc.E07-09-0964; LETOURNEAU PC, 1994, J NEUROSCI, V14, P915, DOI 10.1523/JNEUROSCI.14-03-00915.1994; Lim ST, 2003, J BIOL CHEM, V278, P13795, DOI 10.1074/jbc.M208300200; Lin YW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004293; Lobato RD, 2008, NEUROCIRUGIA, V19, P456; Lydolph MC, 2009, EXP CELL RES, V315, P3312, DOI 10.1016/j.yexcr.2009.09.022; Mallavarapu A, 1999, J CELL BIOL, V146, P1097, DOI 10.1083/jcb.146.5.1097; Morgan MR, 2007, NAT REV MOL CELL BIO, V8, P957, DOI 10.1038/nrm2289; Plantman S, 2008, MOL CELL NEUROSCI, V39, P50, DOI 10.1016/j.mcn.2008.05.015; Previtera ML, 2010, ANN BIOMED ENG, V38, P3733, DOI 10.1007/s10439-010-0112-5; Previtera ML, 2010, J BIOSCI BIOENG, V110, P459, DOI 10.1016/j.jbiosc.2010.04.004; Ramon y Cajal S, 1991, CAJALS DEGENERATION, Vxvi; Santama N, 1996, EUR J NEUROSCI, V8, P892, DOI 10.1111/j.1460-9568.1996.tb01576.x; Spruston N, 2008, NAT REV NEUROSCI, V9, P206, DOI 10.1038/nrn2286; Tonge DA, 2012, BRAIN RES, V1453, P8, DOI 10.1016/j.brainres.2012.03.024; VUORI K, 1993, J BIOL CHEM, V268, P21459; Wang XH, 2011, BBA-MOL CELL RES, V1813, P827, DOI 10.1016/j.bbamcr.2011.01.027; Webb DJ, 2004, NAT CELL BIOL, V6, P154, DOI 10.1038/ncb1094; WOODS A, 1994, MOL BIOL CELL, V5, P183, DOI 10.1091/mbc.5.2.183; WOODS A, 1992, J CELL SCI, V101, P277	43	19	19	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e83394	10.1371/journal.pone.0083394	http://dx.doi.org/10.1371/journal.pone.0083394			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386192	Green Published, gold, Green Submitted			2022-12-25	WOS:000329194700038
J	Degauque, N; Ngono, AE; Akl, A; Lepetit, M; Crochette, R; Giral, M; Lepourry, J; Pallier, A; Castagnet, S; Dugast, E; Guillot-Gueguen, C; Jacq-Foucher, M; Saulquin, X; Cesbron, A; Laplaud, D; Nicot, A; Brouard, S; Soulillou, JP				Degauque, Nicolas; Ngono, Annie Elong; Akl, Ahmed; Lepetit, Maud; Crochette, Romain; Giral, Magali; Lepourry, Julie; Pallier, Annaick; Castagnet, Stephanie; Dugast, Emilie; Guillot-Gueguen, Cecile; Jacq-Foucher, Marylene; Saulquin, Xavier; Cesbron, Anne; Laplaud, David; Nicot, Arnaud; Brouard, Sophie; Soulillou, Jean-Paul			Characterization of Antigen-Specific B Cells Using Nominal Antigen-Coated Flow-Beads	PLOS ONE			English	Article							T-CELLS; RHEUMATOID-ARTHRITIS; MULTIPLE-SCLEROSIS; SELF-ANTIGEN; GRANZYME-B; FOLLOW-UP; B10 CELLS; MOUSE; INDIVIDUALS; TOLERANCE	In order to characterize the reactivity of B cells against nominal antigens, a method based on the coupling of antigens onto the surface of fluorescent core polystyrene beads was developed. We first demonstrate that murine B cells with a human MOG-specific BCR are able to interact with MOG-coated beads and do not recognize beads coated with human albumin or pp65. B cells purified from human healthy volunteer blood or immunized individuals were tested for their ability to interact with various nominal antigens, including viral, vaccine, self and alloantigens, chosen for their usefulness in studying a variety of pathological processes. A substantial amount of B cells binding self-antigen MOG-coated beads can be detected in normal blood. Furthermore, greater frequencies of B cell against anti-Tetanic Toxin or anti-EBNA1 were observed in primed individuals. This method can reveal increased frequencies of anti-HLA committed B cells in patients with circulating anti-HLA antibodies compared to unsensitized patients and normal individuals. Of interest, those specific CD19 cells were preferentially identified within CD27(-)IgD(+) (i-e naive) subset. These observations suggest that a broad range of medical situations could benefit from a tool that allows the detection, the quantification and the characterization of antigen-specific blood B cells.	[Degauque, Nicolas; Ngono, Annie Elong; Akl, Ahmed; Lepetit, Maud; Crochette, Romain; Giral, Magali; Lepourry, Julie; Pallier, Annaick; Castagnet, Stephanie; Dugast, Emilie; Laplaud, David; Nicot, Arnaud; Brouard, Sophie; Soulillou, Jean-Paul] INSERM, UMR 1064, Nantes, France; [Degauque, Nicolas; Ngono, Annie Elong; Akl, Ahmed; Lepetit, Maud; Crochette, Romain; Giral, Magali; Lepourry, Julie; Pallier, Annaick; Castagnet, Stephanie; Dugast, Emilie; Guillot-Gueguen, Cecile; Laplaud, David; Nicot, Arnaud; Brouard, Sophie; Soulillou, Jean-Paul] CHU Nantes, ITUN, F-44035 Nantes 01, France; [Degauque, Nicolas; Ngono, Annie Elong; Akl, Ahmed; Lepetit, Maud; Crochette, Romain; Giral, Magali; Lepourry, Julie; Pallier, Annaick; Castagnet, Stephanie; Dugast, Emilie; Saulquin, Xavier; Laplaud, David; Nicot, Arnaud; Brouard, Sophie; Soulillou, Jean-Paul] Univ Nantes, Fac Med, Nantes, France; [Jacq-Foucher, Marylene; Laplaud, David] INSERM, CIC 004, Nantes, France; [Saulquin, Xavier] INSERM, UMR892, Nantes, France; [Cesbron, Anne] Lab HLA, Etab Francais Sang, Nantes, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; CHU de Nantes; Nantes Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm)	Soulillou, JP (corresponding author), INSERM, UMR 1064, Nantes, France.	jean-paul.soulillou@univ-nantes.fr	Nicot, Arnaud/L-8898-2016; LAPLAUD, David/AAG-4367-2020; brouard, sophie c/Q-1285-2016; SAULQUIN, Xavier/L-2886-2015; Degauque, Nicolas/R-4944-2017; akl, ahmed/X-2562-2018	Nicot, Arnaud/0000-0003-2695-3304; Degauque, Nicolas/0000-0003-2990-3513; Dugast, Emilie/0000-0001-7439-1903; Saulquin, Xavier/0000-0002-5209-7030; Laplaud, David/0000-0001-6113-6938; akl, ahmed/0000-0002-7447-5530	ITERT Transplantation Sciences post doctorate grant; Region Pays de la Loire; DGOS FCB-REC (DIRECTION GENERALE DE L'ORGANISATION DES SOINS - "Frequence des cellules B dans le rejet chronique")	ITERT Transplantation Sciences post doctorate grant; Region Pays de la Loire(Region Pays de la Loire); DGOS FCB-REC (DIRECTION GENERALE DE L'ORGANISATION DES SOINS - "Frequence des cellules B dans le rejet chronique")	A.A was supported by the ITERT Transplantation Sciences post doctorate grant. A.N. is supported by Region Pays de la Loire. A DGOS FCB-REC (DIRECTION GENERALE DE L'ORGANISATION DES SOINS - "Frequence des cellules B dans le rejet chronique") supported the work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amanna IJ, 2010, IMMUNOL REV, V236, P125, DOI 10.1111/j.1600-065X.2010.00912.x; Bahbouhi B, 2009, J LEUKOCYTE BIOL, V86, P1049, DOI 10.1189/jlb.1008666; Berthelot L, 2008, EUR J IMMUNOL, V38, P1889, DOI 10.1002/eji.200838023; Bodinier M, 2000, NAT MED, V6, P707, DOI 10.1038/76292; Bromage E, 2009, J IMMUNOL METHODS, V346, P75, DOI 10.1016/j.jim.2009.05.005; Brulhart L, 2006, ANN RHEUM DIS, V65, P1255, DOI 10.1136/ard.2005.051169; Carsetti R, 2004, IMMUNOL REV, V197, P179, DOI 10.1111/j.0105-2896.2004.0109.x; Damoiseaux J, 2007, ANN NY ACAD SCI, V1109, P454, DOI 10.1196/annals.1398.051; Frommer F, 2008, J IMMUNOL, V181, P5748, DOI 10.4049/jimmunol.181.8.5748; Hagn M, 2010, EUR J IMMUNOL, V40, P2060, DOI 10.1002/eji.200940113; Hagn M, 2009, J IMMUNOL, V183, P1838, DOI 10.4049/jimmunol.0901066; Halverson R, 2004, NAT IMMUNOL, V5, P645, DOI 10.1038/ni1076; Hawker K, 2009, ANN NEUROL, V66, P460, DOI 10.1002/ana.21867; Hippen BE, 2005, AM J TRANSPLANT, V5, P2248, DOI 10.1111/j.1600-6143.2005.01009.x; Hwang HS, 2010, TRANSPLANTATION, V89, P1489, DOI 10.1097/TP.0b013e3181dd35b8; Iwata Y, 2011, BLOOD, V117, P530, DOI 10.1182/blood-2010-07-294249; Klinman Dennis, 2008, Curr Protoc Immunol, VChapter 6, DOI 10.1002/0471142735.im0619s83; Lang J, 1997, J EXP MED, V186, P1513, DOI 10.1084/jem.186.9.1513; Litzenburger T, 1998, J EXP MED, V188, P169, DOI 10.1084/jem.188.1.169; Lycke N Y, 2001, Curr Protoc Immunol, VChapter 7, DOI 10.1002/0471142735.im0714s17; Meffre E, 2000, NAT IMMUNOL, V1, P379, DOI 10.1038/80816; Ngono AE, 2012, CLIN IMMUNOL, V144, P117, DOI 10.1016/j.clim.2012.05.009; Olkhanud PB, 2011, CANCER RES, V71, P3505, DOI 10.1158/0008-5472.CAN-10-4316; PASCUAL V, 1994, J EXP MED, V180, P329, DOI 10.1084/jem.180.1.329; Pei R, 2003, TRANSPLANTATION, V75, P43, DOI 10.1097/00007890-200301150-00008; Pollinger B, 2009, J EXP MED, V206, P1303, DOI 10.1084/jem.20090299; RUDOLPHI U, 1993, CLIN EXP IMMUNOL, V92, P404, DOI 10.1111/j.1365-2249.1993.tb03412.x; Sis B, 2010, AM J TRANSPLANT, V10, P464, DOI 10.1111/j.1600-6143.2009.02987.x; Taylor JJ, 2012, J EXP MED, V209, P2065, DOI 10.1084/jem.20112272; Terasaki PI, 2007, AM J TRANSPLANT, V7, P408, DOI 10.1111/j.1600-6143.2006.01644.x; Wardemann H, 2003, SCIENCE, V301, P1374, DOI 10.1126/science.1086907; Yanaba K, 2009, J IMMUNOL, V182, P7459, DOI 10.4049/jimmunol.0900270; Zarkhin V, 2008, KIDNEY INT, V74, P664, DOI 10.1038/ki.2008.249; Zikherman J, 2012, NATURE, V489, P160, DOI 10.1038/nature11311	34	13	13	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e84273	10.1371/journal.pone.0084273	http://dx.doi.org/10.1371/journal.pone.0084273			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386360	gold, Green Published, Green Submitted			2022-12-25	WOS:000329194700099
J	Melis, RJF; Marengoni, A; Rizzuto, D; Teerenstra, S; Kivipelto, M; Angleman, SB; Fratiglioni, L				Melis, Rene J. F.; Marengoni, Alessandra; Rizzuto, Debora; Teerenstra, Steven; Kivipelto, Miia; Angleman, Sara B.; Fratiglioni, Laura			The Influence of Multimorbidity on Clinical Progression of Dementia in a Population-Based Cohort	PLOS ONE			English	Article							MINI-MENTAL-STATE; ALZHEIMERS-DISEASE; MEDICAL COMORBIDITY; COGNITIVE DECLINE; PREVALENCE; AGE; ASSOCIATION; PATTERNS; ILLNESS; HEALTH	Introduction: Co-occurrence with other chronic diseases may influence the progression of dementia, especially in case of multiple chronic diseases. We aimed to verify whether multimorbidity influenced cognitive and daily functioning during nine years after dementia diagnosis compared with the influence in persons without dementia. Methods: In the Kungsholmen Project, a population-based cohort study, we followed 310 persons with incident dementia longitudinally. We compared their trajectories with those of 679 persons without dementia. Progression was studied for cognition and activities of daily life (ADLs), measured by MMSE and Katz Index respectively. The effect of multimorbidity and its interaction with dementia status was studied using individual growth models. Results: The mean (SD) follow-up time was 4.7 (2.3) years. As expected, dementia related to both the decline in cognitive and daily functioning. Irrespective of dementia status, persons with more diseases had significantly worse baseline daily functioning. In dementia patients having more diseases also related to a significantly faster decline in daily functioning. Due to the combination of lower functioning in ADLs at baseline and faster decline, dementia patients with multimorbidity were about one to two years ahead of the decline of dementia patients without any co-morbidity. In persons without dementia, no significant decline in ADLs over time was present, nor was multimorbidity related to the decline rate. Cognitive decline measured with MMSE remained unrelated to the number of diseases present at baseline. Conclusion: Multimorbidity was related to baseline daily function in both persons with and without dementia, and with accelerated decline in people with dementia but not in non-demented individuals. No relationship of multimorbidity with cognitive functioning was established. These findings imply a strong interconnection between physical and mental health, where the greatest disablement occurs when both somatic and mental disorders are present.	[Melis, Rene J. F.] Radboud Univ Nijmegen Med Ctr, Radboud Alzheimer Ctr, Dept Geriatr Med, Nijmegen, Netherlands; [Marengoni, Alessandra] Univ Brescia, Dept Med & Surg Sci, Brescia, Italy; [Rizzuto, Debora; Kivipelto, Miia; Angleman, Sara B.; Fratiglioni, Laura] Karolinska Inst, Dept Neurobiol Care Sci & Soc, Aging Res Ctr, Stockholm, Sweden; [Rizzuto, Debora; Kivipelto, Miia; Angleman, Sara B.; Fratiglioni, Laura] Stockholm Univ, S-10691 Stockholm, Sweden; [Teerenstra, Steven] Radboud Univ Nijmegen Med Ctr, Dept Hlth Evidence, Nijmegen, Netherlands	Radboud University Nijmegen; University of Brescia; Karolinska Institutet; Stockholm University; Radboud University Nijmegen	Melis, RJF (corresponding author), Radboud Univ Nijmegen Med Ctr, Radboud Alzheimer Ctr, Dept Geriatr Med, Nijmegen, Netherlands.	rene.melis@radboudumc.nl	Rizzuto, Debora/V-1890-2018; Kivipelto, Miia/AAS-3557-2021; Melis, René/J-5943-2012; Teerenstra, Steven/C-2870-2018; Rizzuto, Debora/X-7065-2019	Melis, René/0000-0002-7863-4738; Teerenstra, Steven/0000-0003-4103-7451; Rizzuto, Debora/0000-0001-6199-9629; Angleman, Sara/0000-0002-9520-5716; Kivipelto, Miia/0000-0003-0992-3875; marengoni, alessandra/0000-0002-4851-1825	Rubicon Travel grant, Netherlands Organisation for Scientific Research [825.08.008]	Rubicon Travel grant, Netherlands Organisation for Scientific Research	This work was supported by a Rubicon Travel grant, Netherlands Organisation for Scientific Research (825.08.008) to Rene Melis (http://www.nwo.nl/nwohome.nsf/pages/NWOP_6H2G7R_Eng). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarts S, 2011, INT J GERIATR PSYCH, V26, P1046, DOI 10.1002/gps.2642; Aarts S, 2011, INT PSYCHOGERIATR, V23, P616, DOI 10.1017/S1041610210002024; American Psychiatric Association, 1987, DIAGN STAT MAN MENT; Backman L, 2003, J GERONTOL B-PSYCHOL, V58, pP228, DOI 10.1093/geronb/58.4.P228; Boyle PA, 2009, ARCH NEUROL-CHICAGO, V66, P1339, DOI 10.1001/archneurol.2009.240; Clark CM, 1999, ARCH NEUROL-CHICAGO, V56, P857, DOI 10.1001/archneur.56.7.857; Doraiswamy PM, 2002, J GERONTOL A-BIOL, V57, pM173, DOI 10.1093/gerona/57.3.M173; Elias MF, 2000, ARCH NEUROL-CHICAGO, V57, P808, DOI 10.1001/archneur.57.6.808; Euser SM, 2008, EPIDEMIOLOGY, V19, P440, DOI 10.1097/EDE.0b013e31816a1d31; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fotuhi M, 2009, NAT REV NEUROL, V5, P649, DOI 10.1038/nrneurol.2009.175; FRATIGLIONI L, 1991, NEUROLOGY, V41, P1886, DOI 10.1212/WNL.41.12.1886; FRATIGLIONI L, 1992, ARCH NEUROL-CHICAGO, V49, P927, DOI 10.1001/archneur.1992.00530330049015; FRATIGLIONI L, 1992, NEUROEPIDEMIOLOGY, V11, P29, DOI 10.1159/000110958; Fratiglioni L, 2007, PHYSIOL BEHAV, V92, P98, DOI 10.1016/j.physbeh.2007.05.059; KATZ S, 1963, JAMA-J AM MED ASSOC, V185, P914, DOI 10.1001/jama.1963.03060120024016; Leoutsakos JMS, 2012, INT PSYCHOGERIATR, V24, P1561, DOI 10.1017/S104161021200049X; Lyketsos CG, 2005, AM J GERIAT PSYCHIAT, V13, P656, DOI 10.1176/appi.ajgp.13.8.656; MacDonald SWS, 2011, DEMENT GERIATR COGN, V31, P202, DOI 10.1159/000325666; Marengoni A, 2011, AGEING RES REV; Marengoni A, 2008, AM J PUBLIC HEALTH, V98, P1198, DOI 10.2105/AJPH.2007.121137; Marengoni A, 2009, J AM GERIATR SOC, V57, P225, DOI 10.1111/j.1532-5415.2008.02109.x; MCCORMICK WC, 1994, J AM GERIATR SOC, V42, P517, DOI 10.1111/j.1532-5415.1994.tb04974.x; MILLER MD, 1992, PSYCHIAT RES, V41, P237, DOI 10.1016/0165-1781(92)90005-N; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; Savva GM, 2009, NEW ENGL J MED, V360, P2302, DOI 10.1056/NEJMoa0806142; Scarmeas N, 2009, JAMA-J AM MED ASSOC, V302, P627, DOI 10.1001/jama.2009.1144; Singer J.D., 2003, APPL LONGITUDINAL DA, DOI 10.1093/acprof:oso/9780195152968.001.0001; Solomon A, 2011, INT J GERIATR PSYCHI; van den Akker M, 1998, J CLIN EPIDEMIOL, V51, P367, DOI 10.1016/S0895-4356(97)00306-5; van den Akker M, 2001, J CLIN EPIDEMIOL, V54, P675, DOI 10.1016/S0895-4356(00)00358-9; Wang L, 2006, ARCH INTERN MED, V166, P1115, DOI 10.1001/archinte.166.10.1115; World Health Organization. WHO, 1987, INT CLASS DIS INJ CA	33	55	57	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e84014	10.1371/journal.pone.0084014	http://dx.doi.org/10.1371/journal.pone.0084014			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	282SX	24386324	Green Published, gold			2022-12-25	WOS:000329194700085
J	Permenter, MG; Dennis, WE; Sutto, TE; Jackson, DA; Lewis, JA; Stallings, JD				Permenter, Matthew G.; Dennis, William E.; Sutto, Thomas E.; Jackson, David A.; Lewis, John A.; Stallings, Jonathan D.			Exposure to Cobalt Causes Transcriptomic and Proteomic Changes in Two Rat Liver Derived Cell Lines	PLOS ONE			English	Article							GENE-EXPRESSION; IN-VITRO; OXIDATIVE STRESS; HYPOXIC STRESS; PROTEINS; MECHANISM; TUNGSTEN; OXYGEN; PROGRESSION; TOXICOLOGY	Cobalt is a transition group metal present in trace amounts in the human diet, but in larger doses it can be acutely toxic or cause adverse health effects in chronic exposures. Its use in many industrial processes and alloys worldwide presents opportunities for occupational exposures, including military personnel. While the toxic effects of cobalt have been widely studied, the exact mechanisms of toxicity remain unclear. In order to further elucidate these mechanisms and identify potential biomarkers of exposure or effect, we exposed two rat liver-derived cell lines, H4-II-E-C3 and MH1C1, to two concentrations of cobalt chloride. We examined changes in gene expression using DNA microarrays in both cell lines and examined changes in cytoplasmic protein abundance in MH1C1 cells using mass spectrometry. We chose to closely examine differentially expressed genes and proteins changing in abundance in both cell lines in order to remove cell line specific effects. We identified enriched pathways, networks, and biological functions using commercial bioinformatic tools and manual annotation. Many of the genes, proteins, and pathways modulated by exposure to cobalt appear to be due to an induction of a hypoxic-like response and oxidative stress. Genes that may be differentially expressed due to a hypoxic-like response are involved in Hif-1 alpha signaling, glycolysis, gluconeogenesis, and other energy metabolism related processes. Gene expression changes linked to oxidative stress are also known to be involved in the NRF2-mediated response, protein degradation, and glutathione production. Using microarray and mass spectrometry analysis, we were able to identify modulated genes and proteins, further elucidate the mechanisms of toxicity of cobalt, and identify biomarkers of exposure and effect in vitro, thus providing targets for focused in vivo studies.	[Permenter, Matthew G.] Excet Inc, Ft Detrick, MD USA; [Dennis, William E.; Jackson, David A.; Lewis, John A.; Stallings, Jonathan D.] US Army Ctr Environm Hlth Res, Ft Detrick, MD USA; [Sutto, Thomas E.] Naval Res Lab, Washington, DC USA	United States Department of Defense; United States Navy; Naval Research Laboratory	Stallings, JD (corresponding author), US Army Ctr Environm Hlth Res, Ft Detrick, MD USA.	jonathan.d.stallings.mil@mail.mil	Jackson, David/E-9984-2014; Stallings, Jonathan D/H-7779-2013	Stallings, Jonathan D/0000-0002-6430-5888	U.S. Army Medical Research and Materiel Command, Military Operational Medicine Research Program	U.S. Army Medical Research and Materiel Command, Military Operational Medicine Research Program(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC))	The research described herein was sponsored by the U.S. Army Medical Research and Materiel Command, Military Operational Medicine Research Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, WWW DOC; Archer KJ, 2010, BRIEF BIOINFORM, V11, P244, DOI 10.1093/bib/bbp055; Barceloux DG, 1999, J TOXICOL-CLIN TOXIC, V37, P201, DOI 10.1081/CLT-100102420; Beyersmann D, 2008, ARCH TOXICOL, V82, P493, DOI 10.1007/s00204-008-0313-y; Bianchet MA, 2004, METHOD ENZYMOL, V382, P144; BRAHMACHARI HD, 1973, AEROSPACE MED, V44, P636; del Peso L, 2003, J BIOL CHEM, V278, P48690, DOI 10.1074/jbc.M308862200; DEMATTEIS F, 1977, BIOCHEM J, V162, P213, DOI 10.1042/bj1620213; Dinkova-Kostova AT, 2005, BIOCHEMISTRY-US, V44, P6889, DOI 10.1021/bi047434h; Dinkova-Kostova AT, 2005, CHEM RES TOXICOL, V18, P1779, DOI 10.1021/tx050217c; EATON RP, 1973, AM J PHYSIOL, V225, P67, DOI 10.1152/ajplegacy.1973.225.1.67; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Finley BL, 2012, REGUL TOXICOL PHARM, V64, P491, DOI 10.1016/j.yrtph.2012.08.022; Gong PF, 2001, J BIOL CHEM, V276, P27018, DOI 10.1074/jbc.M103658200; Griffith OW, 1999, FREE RADICAL BIO MED, V27, P922, DOI 10.1016/S0891-5849(99)00176-8; GROSS RT, 1955, PEDIATRICS, V15, P284; Grune T, 1997, FASEB J, V11, P526, DOI 10.1096/fasebj.11.7.9212076; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Hartwig A, 2001, ANTIOXID REDOX SIGN, V3, P625, DOI 10.1089/15230860152542970; Hayes JD, 2005, ANNU REV PHARMACOL, V45, P51, DOI 10.1146/annurev.pharmtox.45.120403.095857; HOCHBERG Y, 1990, STAT MED, V9, P811, DOI 10.1002/sim.4780090710; Hoet PMH, 2002, ARCH TOXICOL, V76, P1, DOI 10.1007/s00204-001-0300-z; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Kalinich JF, 2005, ENVIRON HEALTH PERSP, V113, P729, DOI 10.1289/ehp.7791; Kocher T, 2009, J PROTEOME RES, V8, P4743, DOI 10.1021/pr900451u; KUSAKA Y, 1986, BRIT J IND MED, V43, P486; KUSAKA Y, 1986, BRIT J IND MED, V43, P474; Leggett RW, 2008, SCI TOTAL ENVIRON, V389, P259, DOI 10.1016/j.scitotenv.2007.08.054; Lewis JA, 2010, J PROTEOME RES, V9, P5794, DOI 10.1021/pr1005668; Lison D, 1996, EUR RESPIR J, V9, P1024, DOI 10.1183/09031936.96.09051024; Liu Ya-ke, 2010, Orthop Surg, V2, P134, DOI 10.1111/j.1757-7861.2010.00076.x; LLESUY SF, 1994, BBA-MOL CELL RES, V1223, P9, DOI 10.1016/0167-4889(94)90067-1; Mates JM, 2000, TOXICOLOGY, V153, P83, DOI 10.1016/S0300-483X(00)00306-1; MATHESON NR, 1979, BIOCHEM BIOPH RES CO, V88, P402, DOI 10.1016/0006-291X(79)92062-X; Miller Alexandra C., 2007, Reviews on Environmental Health, V22, P75; MOGER WH, 1983, BIOL REPROD, V28, P528, DOI 10.1095/biolreprod28.3.528; Morimoto RI, 2011, COLD SPRING HARB SYM, V76, P91, DOI DOI 10.1101/SQB.2012.76.010637; Motohashi H, 2004, TRENDS MOL MED, V10, P549, DOI 10.1016/j.molmed.2004.09.003; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Omenn GS, 2005, PROTEOMICS, V5, P3226, DOI 10.1002/pmic.200500358; Ostergaard L, 2009, PROTEOMICS, V9, P4457, DOI 10.1002/pmic.200800130; Pawan K, 2007, BBA-GENE STRUCT EXPR, V1769, P117, DOI 10.1016/j.bbaexp.2006.12.005; Permenter MG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027730; Rutledge AC, 2010, BIOCHEM CELL BIOL, V88, P251, DOI [10.1139/O09-168, 10.1139/o09-168]; Salnikow K, 2004, J BIOL CHEM, V279, P40337, DOI 10.1074/jbc.M403057200; Schmechel DE, 2007, NEUROTOXICOLOGY, V28, P899, DOI 10.1016/j.neuro.2007.05.011; Schmitt J, 2012, BIOCHEM BIOPH RES CO, V418, P445, DOI 10.1016/j.bbrc.2012.01.036; Schuster BE, 2012, TOXICOL APPL PHARM, V265, P128, DOI 10.1016/j.taap.2012.08.025; SCHWARTZ L, 1945, J ALLERGY, V16, P51, DOI 10.1016/0021-8707(45)90040-2; Semenza GL, 1996, J BIOL CHEM, V271, P32529, DOI 10.1074/jbc.271.51.32529; Shadforth IP, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-145; Simonsen LO, 2012, SCI TOTAL ENVIRON, V432, P210, DOI 10.1016/j.scitotenv.2012.06.009; STOKINGER H E, 1958, AMA Arch Ind Health, V17, P273; Sutto T. E., 2011, PRIORITIZATION ORAL; Takahara Y, 2006, WORLD J GASTROENTERO, V12, P6473, DOI 10.3748/wjg.v12.i40.6473; Uyeda K, 1979, Adv Enzymol Relat Areas Mol Biol, V48, P193; van der Voet GB, 2007, MIL MED, V172, P1002, DOI 10.7205/MILMED.172.9.1002; WATAHA JC, 1994, DENT MATER, V10, P156, DOI 10.1016/0109-5641(94)90025-6	59	36	38	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e83751	10.1371/journal.pone.0083751	http://dx.doi.org/10.1371/journal.pone.0083751			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386269	gold, Green Published, Green Submitted			2022-12-25	WOS:000329194700063
J	Sastre, C; Rubio-Navarro, A; Buendia, I; Gomez-Guerrero, C; Blanco, J; Mas, S; Egido, J; Blanco-Colio, LM; Ortiz, A; Moreno, JA				Sastre, Cristina; Rubio-Navarro, Alfonso; Buendia, Irene; Gomez-Guerrero, Carmen; Blanco, Julia; Mas, Sebastian; Egido, Jesus; Miguel Blanco-Colio, Luis; Ortiz, Alberto; Antonio Moreno, Juan			Hyperlipidemia-Associated Renal Damage Decreases Klotho Expression in Kidneys from ApoE Knockout Mice	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; NF-KAPPA-B; ACTIVATED PROTEIN-KINASE; OXIDIZED LDL; DOWN-REGULATION; LIPOPROTEIN ABNORMALITIES; ENDOTHELIAL DYSFUNCTION; OXIDATIVE STRESS; APOLIPOPROTEIN-E; HORMONE KLOTHO	Background: Klotho is a renal protein with anti-aging properties that is downregulated in conditions related to kidney injury. Hyperlipidemia accelerates the progression of renal damage, but the mechanisms of the deleterious effects of hyperlipidemia remain unclear. Methods: We evaluated whether hyperlipidemia modulates Klotho expression in kidneys from C57BL/6 and hyperlipidemic apolipoprotein E knockout (ApoE KO) mice fed with a normal chow diet (ND) or a Western-type high cholesterol-fat diet (HC) for 5 to 10 weeks, respectively. Results: In ApoE KO mice, the HC diet increased serum and renal cholesterol levels, kidney injury severity, kidney macrophage infiltration and inflammatory chemokine expression. A significant reduction in Klotho mRNA and protein expression was observed in kidneys from hypercholesteromic ApoE KO mice fed a HC diet as compared with controls, both at 5 and 10 weeks. In order to study the mechanism involved in Klotho down-regulation, murine tubular epithelial cells were treated with ox-LDL. Oxidized-LDL were effectively uptaken by tubular cells and decreased both Klotho mRNA and protein expression in a time-and dose-dependent manner in these cells. Finally, NF-kappa B and ERK inhibitors prevented ox-LDL induced Klotho downregulation. Conclusion: Our results suggest that hyperlipidemia-associated kidney injury decreases renal expression of Klotho. Therefore, Klotho could be a key element explaining the relationship between hyperlipidemia and aging with renal disease.	[Sastre, Cristina; Rubio-Navarro, Alfonso; Buendia, Irene; Gomez-Guerrero, Carmen; Mas, Sebastian; Egido, Jesus; Miguel Blanco-Colio, Luis; Ortiz, Alberto; Antonio Moreno, Juan] Univ Autonoma Madrid, IIS Fdn Jimenez Diaz, Vasc & Renal Res Lab, Madrid, Spain; [Blanco, Julia] Hosp Clin San Carlos, Madrid, Spain; [Egido, Jesus] Spanish Biomed Res Ctr Diabet & Associated Metab, Madrid, Spain	Autonomous University of Madrid; Fundacion Jimenez Diaz; Hospital Clinico San Carlos	Moreno, JA (corresponding author), Univ Autonoma Madrid, IIS Fdn Jimenez Diaz, Vasc & Renal Res Lab, Madrid, Spain.	jamoreno@fjd.es	Mas, S/T-1489-2018; Blanco-Colio, Luis M./Z-2390-2019; Rubio, Alfonso/ABH-5028-2020; ortiz, alberto/Y-7582-2018; Moreno, Juan Antonio/B-3487-2018	Mas, S/0000-0001-6604-3327; Rubio, Alfonso/0000-0001-5677-3123; ortiz, alberto/0000-0002-9805-9523; Moreno, Juan Antonio/0000-0002-7468-2871; BUENDIA, IRENE/0000-0003-0593-1368; Blanco-Colio, Luis Miguel/0000-0002-1560-6609	FIS (Programa Miguel Servet) [CP10/00479]; ISCIII (Programa de Estabilizacion); PI10/00234; Fundacion Conchita Rabago; Ministry of Science [SAF2012/38830]; Sociedad Espanola de Nefrologia; ISCIII; FEDER [PS09/00447]; ISCIII-RETIC [REDinREN/RD06/0016]; Comunidad de Madrid [CIFRA/S2010/BMD-2378]; ISCIII-Redes RECAVA [RD06/0014/0035]; REDINREN [RD12/0021/]; European Network [HEALTH F2-2008-200647]; Euro Salud [EUS2005-03565]; cvREMOD; Fundacion Lilly; FRIAT; ISCIII fund [PI10/00072]	FIS (Programa Miguel Servet); ISCIII (Programa de Estabilizacion); PI10/00234; Fundacion Conchita Rabago; Ministry of Science(Ministry of Science, ICT & Future Planning, Republic of Korea); Sociedad Espanola de Nefrologia; ISCIII(Instituto de Salud Carlos III); FEDER(European Commission); ISCIII-RETIC(Instituto de Salud Carlos III); Comunidad de Madrid(Comunidad de Madrid); ISCIII-Redes RECAVA; REDINREN; European Network; Euro Salud; cvREMOD; Fundacion Lilly; FRIAT; ISCIII fund	This work has been supported by grants from FIS (Programa Miguel Servet: CP10/00479) to JAM and ISCIII (Programa de Estabilizacion) and PI10/00234 to LMBC. Fundacion Conchita Rabago to CS and ARN. Ministry of Science (SAF2012/38830) and Sociedad Espanola de Nefrologia to CGG. ISCIII and FEDER funds PS09/00447, Sociedad Espanola de Nefrologia, ISCIII-RETIC REDinREN/RD06/0016, Comunidad de Madrid/CIFRA/S2010/BMD-2378 to AO, and ISCIII-Redes RECAVA (RD06/0014/0035) REDINREN (RD12/0021/), European Network (HEALTH F2-2008-200647), Euro Salud EUS2005-03565, cvREMOD, Fundacion Lilly, FRIAT and ISCIII fund PI10/00072 to JE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal A, 1996, AM J PHYSIOL-RENAL, V271, pF814, DOI 10.1152/ajprenal.1996.271.4.F814; Aizawa H, 1998, BIOCHEM BIOPH RES CO, V249, P865, DOI 10.1006/bbrc.1998.9246; Apostolov EO, 2010, J AM SOC NEPHROL, V21, P1852, DOI 10.1681/ASN.2010040365; Attman PO, 1999, KIDNEY INT, V56, pS14, DOI 10.1046/j.1523-1755.1999.07104.x; Sanz AB, 2010, J AM SOC NEPHROL, V21, P1254, DOI 10.1681/ASN.2010020218; Bentley MD, 2002, KIDNEY INT, V61, P1056, DOI 10.1046/j.1523-1755.2002.00211.x; Bosmans JL, 2001, KIDNEY INT, V59, P2346, DOI 10.1046/j.1523-1755.2001.00752.x; Catalan MPE, 2005, KIDNEY INT, V68, P1303; Chade AR, 2002, CIRCULATION, V106, P1165, DOI 10.1161/01.CIR.0000027105.02327.48; Chai YC, 1996, J BIOL CHEM, V271, P17791, DOI 10.1074/jbc.271.30.17791; Chien MW, 2003, J LIPID RES, V44, P1667, DOI 10.1194/jlr.M300006-JLR200; Choi BH, 2010, GENE, V450, P121, DOI 10.1016/j.gene.2009.11.004; Collins AJ, 2003, KIDNEY INT, V64, pS24, DOI 10.1046/j.1523-1755.64.s87.5.x; Drueke TB, 2001, KIDNEY INT, V59, pS114, DOI 10.1046/j.1523-1755.2001.59780114.x; Ha H, 2005, NEPHROLOGY, V10, pS7, DOI 10.1111/j.1440-1797.2005.00448.x; Haruna Y, 2007, P NATL ACAD SCI USA, V104, P2331, DOI 10.1073/pnas.0611079104; Jing Q, 1999, CIRC RES, V84, P831; Koh N, 2001, BIOCHEM BIOPH RES CO, V280, P1015, DOI 10.1006/bbrc.2000.4226; Kuroo M, 1997, NATURE, V390, P45, DOI 10.1038/36285; Kurosu H, 2005, SCIENCE, V309, P1829, DOI 10.1126/science.1112766; Kusuhara M, 1997, ARTERIOSCL THROM VAS, V17, P141, DOI 10.1161/01.ATV.17.1.141; Kuwahara N, 2008, INT J CARDIOL, V123, P84, DOI 10.1016/j.ijcard.2007.02.029; Lanske B, 2007, AGEING RES REV, V6, P73, DOI 10.1016/j.arr.2007.02.002; Lee HS, 1999, DIABETES RES CLIN PR, V45, P117, DOI 10.1016/S0168-8227(99)00040-6; Lopez-Franco O, 2006, ARTERIOSCL THROM VAS, V26, P1864, DOI 10.1161/01.ATV.0000229659.94020.53; Maekawa Y, 2009, ENDOCRINE, V35, P341, DOI 10.1007/s12020-009-9181-3; Malle E, 1997, AM J PATHOL, V150, P603; Manea A, 2010, BIOCHEM BIOPH RES CO, V396, P901, DOI 10.1016/j.bbrc.2010.05.019; Mas S, 2007, ANALYST, V132, P24, DOI 10.1039/b614619h; Mitani H, 2002, HYPERTENSION, V39, P838, DOI 10.1161/01.HYP.0000013734.33441.EA; Mitobe M, 2005, NEPHRON EXP NEPHROL, V101, pE67, DOI 10.1159/000086500; Moreno JA, 2011, J AM SOC NEPHROL, V22, P1315, DOI 10.1681/ASN.2010101073; Munoz-Garcia B, 2009, ARTERIOSCL THROM VAS, V29, P2061, DOI 10.1161/ATVBAHA.109.194852; Nagai R, 2000, CELL MOL LIFE SCI, V57, P738, DOI 10.1007/s000180050038; Narumiya H, 2004, CARDIOVASC RES, V64, P331, DOI 10.1016/j.cardiores.2004.07.011; Oda H, 1997, KIDNEY INT, V52, pS36; Ohyama Y, 1998, BIOCHEM BIOPH RES CO, V251, P920, DOI 10.1006/bbrc.1998.9576; Prie D, 2005, CURR OPIN NEPHROL HY, V14, P318, DOI 10.1097/01.mnh.0000172716.41853.1e; Robbesyn F, 2004, FREE RADICAL RES, V38, P541, DOI 10.1080/10715760410001665244; Saito K, 2003, FEBS LETT, V551, P58, DOI 10.1016/S0014-5793(03)00894-9; Saito Y, 2000, BIOCHEM BIOPH RES CO, V276, P767, DOI 10.1006/bbrc.2000.3470; Samuelsson O, 1997, NEPHROL DIAL TRANSPL, V12, P1908, DOI 10.1093/ndt/12.9.1908; Scheuer H, 2000, AM J PHYSIOL-RENAL, V278, pF63, DOI 10.1152/ajprenal.2000.278.1.F63; Stenvinkel P, 2008, CLIN J AM SOC NEPHRO, V3, P505, DOI 10.2215/CJN.03670807; Stevens LA, 2010, ADV CHRONIC KIDNEY D, V17, P293, DOI 10.1053/j.ackd.2010.03.010; STRUTZ F, 1995, J CELL BIOL, V130, P393, DOI 10.1083/jcb.130.2.393; Sugiura H, 2005, NEPHROL DIAL TRANSPL, V20, P2636, DOI 10.1093/ndt/gfi165; Urakawa I, 2006, NATURE, V444, P770, DOI 10.1038/nature05315; Wang YH, 2009, AGEING RES REV, V8, P43, DOI 10.1016/j.arr.2008.10.002; Wen M, 2002, LAB INVEST, V82, P999, DOI 10.1097/01.LAB.0000022222.03120.D4; Yamamoto M, 2005, J BIOL CHEM, V280, P38029, DOI 10.1074/jbc.M509039200; Yu J, 2010, BIOCHEM BIOPH RES CO, V391, P261, DOI 10.1016/j.bbrc.2009.11.046; ZHANG SH, 1992, SCIENCE, V258, P468, DOI 10.1126/science.1411543	53	45	47	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e83713	10.1371/journal.pone.0083713	http://dx.doi.org/10.1371/journal.pone.0083713			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386260	gold, Green Published, Green Submitted			2022-12-25	WOS:000329194700058
J	Danjon, F; Khuder, H; Stokes, A				Danjon, Frederic; Khuder, Hayfa; Stokes, Alexia			Deep Phenotyping of Coarse Root Architecture in R. pseudoacacia Reveals That Tree Root System Plasticity Is Confined within Its Architectural Model	PLOS ONE			English	Article							SHALLOW-SLOPE STABILITY; RESOURCE ACQUISITION; FRACTAL DIMENSIONS; PLANT ARCHITECTURE; YOUNG TREES; GROWTH; ANCHORAGE; SEEDLINGS; SIMULATION; ALLOCATION	This study aims at assessing the influence of slope angle and multi-directional flexing and their interaction on the root architecture of Robinia pseudoacacia seedlings, with a particular focus on architectural model and trait plasticity. 36 trees were grown from seed in containers inclined at 0 degrees (control) or 45 degrees (slope) in a glasshouse. The shoots of half the plants were gently flexed for 5 minutes a day. After 6 months, root systems were excavated and digitized in 3D, and biomass measured. Over 100 root architectural traits were determined. Both slope and flexing increased significantly plant size. Non-flexed trees on 45 degrees slopes developed shallow roots which were largely aligned perpendicular to the slope. Compared to the controls, flexed trees on 0 degrees slopes possessed a shorter and thicker taproot held in place by regularly distributed long and thin lateral roots. Flexed trees on the 45 degrees slope also developed a thick vertically aligned taproot, with more volume allocated to upslope surface lateral roots, due to the greater soil volume uphill. We show that there is an inherent root system architectural model, but that a certain number of traits are highly plastic. This plasticity will permit root architectural design to be modified depending on external mechanical signals perceived by young trees.	[Danjon, Frederic] INRA, BIOGECO UMR1202, Cestas, France; [Danjon, Frederic] Univ Bordeaux, BIOGECO UMR1202, Cestas, France; [Khuder, Hayfa] Univ Bordeaux, UMR 5295, Inst Mecan & Ingn Bordeaux I2M, Dept Genie Civil & Environm GCE, Bordeaux, France; [Stokes, Alexia] INRA, UMR AMAP Bot & Bioinformat Architecture Plantes, F-34060 Montpellier, France	INRAE; UDICE-French Research Universities; Universite de Bordeaux; Arts et Metiers Institute of Technology; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; Universite de Bordeaux; CIRAD; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; INRAE	Danjon, F (corresponding author), INRA, BIOGECO UMR1202, Cestas, France.	frederic.danjon@pierroton.inra.fr		stokes, alexia/0000-0002-2276-0911	Syrian government	Syrian government	The PhD grant of H.Khuder was financed by the Syrian government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASHBY WC, 1979, FOREST SCI, V25, P212; Barthelemy D, 2007, ANN BOT-LONDON, V99, P375, DOI 10.1093/aob/mcl260; Basu P, 2011, PLANT PHYSIOL, V155, P2056, DOI 10.1104/pp.110.168229; BERTHIER S, 2001, THESIS U BORDEAUX 1; BIDDINGTON NL, 1986, PLANT GROWTH REGUL, V4, P103, DOI 10.1007/BF00025193; Braam J, 2005, NEW PHYTOL, V165, P373, DOI 10.1111/j.1469-8137.2004.01263.x; Canham CD, 1996, CAN J FOREST RES, V26, P1521, DOI 10.1139/x26-171; Collet C, 2006, PLANT SOIL, V279, P367, DOI 10.1007/s11104-005-2419-9; COUTTS MP, 1991, NEW PHYTOL, V119, P227, DOI 10.1111/j.1469-8137.1991.tb01025.x; COUTTS MP, 1983, PLANT SOIL, V71, P171, DOI 10.1007/BF02182653; COUTTS MP, 1983, FORESTRY, V56, P1, DOI 10.1093/forestry/56.1.1; Danjon F, 1999, PLANT SOIL, V211, P241, DOI 10.1023/A:1004680824612; Danjon F, 1999, PLANT SOIL, V217, P49, DOI 10.1023/A:1004686119796; Danjon F, 2008, ANN BOT-LONDON, V101, P1281, DOI 10.1093/aob/mcm199; Danjon F, 2008, PLANT SOIL, V303, P1, DOI 10.1007/s11104-007-9470-7; Drexhage M, 1999, CAN J FOREST RES, V29, P600, DOI 10.1139/cjfr-29-5-600; Eis S., 1974, Canadian Journal of Forest Research, V4, P28, DOI 10.1139/x74-005; ENNOS AR, 1993, J THEOR BIOL, V161, P61, DOI 10.1006/jtbi.1993.1040; Eshel A, 1998, PLANT CELL ENVIRON, V21, P247, DOI 10.1046/j.1365-3040.1998.00252.x; Ferrari AE, 2007, BIOL FERT SOILS, V43, P471, DOI 10.1007/s00374-006-0125-2; FITTER AH, 1987, NEW PHYTOL, V106, P61, DOI 10.1111/j.1469-8137.1987.tb04683.x; Fourcaud T, 2003, TREES-STRUCT FUNCT, V17, P31, DOI 10.1007/s00468-002-0203-5; Genet M, 2005, PLANT SOIL, V278, P1, DOI 10.1007/s11104-005-8768-6; Ghestem M, 2014, PLANT SOIL, V377, P43, DOI 10.1007/s11104-012-1572-1; Godin C, 1999, ANN BOT-LONDON, V84, P343, DOI 10.1006/anbo.1999.0923; Godin C, 1997, SILVA FENNICA, V31, P355, DOI DOI 10.14214/sf.a8533; Izumi Y, 1996, JPN J CROP SCI, V65, P303, DOI 10.1626/jcs.65.303; JAFFE MJ, 1973, PLANTA, V114, P143, DOI 10.1007/BF00387472; Jourdan C, 1995, PLANT SOIL, V177, P63, DOI 10.1007/BF00010338; KHUDER H, 2007, THESIS U BORDEAUX 1; Khuder H., 2006, P 5 PLANT BIOM C STO, P299; Khuder H, 2007, PLANT SOIL, V294, P87, DOI 10.1007/s11104-007-9232-6; Korndorfer CL, 2008, TREES-STRUCT FUNCT, V22, P835, DOI 10.1007/s00468-008-0244-5; Larjavaara M, 2012, AM J BOT, V99, P165, DOI 10.3732/ajb.1100324; LYNCH J, 1995, PLANT PHYSIOL, V109, P7, DOI 10.1104/pp.109.1.7; Malamy JE, 2005, PLANT CELL ENVIRON, V28, P67, DOI 10.1111/j.1365-3040.2005.01306.x; Mooney SJ, 2012, PLANT SOIL, V352, P1, DOI 10.1007/s11104-011-1039-9; Nicoll B, 1999, DEV PLANT SOIL SCI, V87, P61; Nicoll BC, 2006, TREES-STRUCT FUNCT, V20, P701, DOI 10.1007/s00468-006-0085-z; Nicoll BC, 2005, CAN J FOREST RES, V35, P2360, DOI [10.1139/x05-157, 10.1139/X05-157]; NICOLL BC, 1997, WIND WIND RELATED DA, P276; Oppelt AL, 2000, ANN FOREST SCI, V57, P463; Pages L, 2000, ANN FOR SCI, V57, P513; Perez FL, 2012, GEOMORPHOLOGY, V138, P29, DOI 10.1016/j.geomorph.2011.08.021; Read J, 2006, AM J BOT, V93, P1546, DOI 10.3732/ajb.93.10.1546; REES DJ, 1980, FORESTRY, V53, P155, DOI 10.1093/forestry/53.2.155; Reubens B, 2007, TREES-STRUCT FUNCT, V21, P385, DOI 10.1007/s00468-007-0132-4; Reubens B, 2009, TREES-STRUCT FUNCT, V23, P1213, DOI 10.1007/s00468-009-0360-x; Schenk HJ, 2002, ECOL MONOGR, V72, P311, DOI 10.1890/0012-9615(2002)072[0311:TGBOR]2.0.CO;2; Scippa GS, 2006, ANN BOT-LONDON, V97, P857, DOI 10.1093/aob/mcj603; Smith VC, 2003, J EXP BOT, V54, P845, DOI 10.1093/jxb/erg068; Soethe N, 2007, ECOL MODEL, V207, P363, DOI 10.1016/j.ecolmodel.2007.05.007; Soethe N, 2006, PLANT SOIL, V279, P173, DOI 10.1007/s11104-005-1005-5; SPEK LY, 1994, PLANT SOIL, V164, P119, DOI 10.1007/BF00010117; STOKES A, 1995, J EXP BOT, V46, P1139, DOI 10.1093/jxb/46.9.1139; Stokes A, 1996, ANN BOT-LONDON, V78, P415, DOI 10.1006/anbo.1996.0137; Stokes A, 2012, J VEG SCI, V23, P325, DOI 10.1111/j.1654-1103.2011.01349.x; Tamasi E, 2005, TREES-STRUCT FUNCT, V19, P374, DOI 10.1007/s00468-004-0396-x; Telewski F. W., 1995, P237, DOI 10.1017/CBO9780511600425.015; Telewski FW, 2006, AM J BOT, V93, P1466, DOI 10.3732/ajb.93.10.1466; Tokgoz N, 2005, GEOTECH GEOL ENG, V23, P519, DOI 10.1007/s10706-004-8679-y; Tracy SR, 2012, ANN BOT-LONDON, V110, P511, DOI 10.1093/aob/mcs031	62	23	25	7	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e83548	10.1371/journal.pone.0083548	http://dx.doi.org/10.1371/journal.pone.0083548			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281RE	24386227	Green Published, Green Submitted, gold			2022-12-25	WOS:000329117900045
J	Choi, J; Jeong, B; Lee, SW; Go, HJ				Choi, Jeewook; Jeong, Bumseok; Lee, Sang Won; Go, Hyo-Jin			Aberrant Development of Functional Connectivity among Resting State-Related Functional Networks in Medication-Naive ADHD Children	PLOS ONE			English	Article							DEFICIT HYPERACTIVITY DISORDER; DEFAULT-MODE NETWORK; HUMAN BRAIN; ATTENTION; CHILDHOOD; ADOLESCENCE; DYSFUNCTION; COMPONENTS; CINGULATE; SYSTEMS	Objective: The aim of this study was to investigate the compromised developmental trajectory of the functional connectivity among resting-state-related functional networks (RSFNs) in medication-naive children with attention-deficit/hyperactivity disorder (ADHD). Subjects and Methods: Using both independent component analysis and dual regression, subject-specific time courses of 12 RSFNs were extracted from both 20 medication-naive children with ADHD, and 20 age and gender-matched control children showing typical development (TDC). Both partial correlation coefficients among the 12 RSFNs and a resting-state resource allocation index (rsRAI) of the salience network (SN) were entered into multiple linear regression analysis to investigate the compromised, age-related change in medication-naive ADHD children. Finally, correlation analyses were performed between the compromised RSFN connections showing significant group-by-age interaction and rsRAI of SN or clinical variables. Results: Medication-naive ADHD subjects failed to show age-related increment of functional connectivity in both rsRAI of SN and two RSFN connections, SN-Sensory/motor and posterior default mode/precuneus network (pDMN/prec) - anterior DMN. Lower SN-Sensory/motor connectivity was related with higher scores on the ADHD Rating Scale, and with poor scores on the continuous performance test. The pDMN/prec-aDMN connectivity was positively related with rsRAI of SN. Conclusions: Our results suggest that medication-naive ADHD subjects may have delayed maturation of the two functional connections, SN-Sensory/Motor and aDMN-pDMN/prec. Interventions that enhance the functional connectivity of these two connections may merit attention as potential therapeutic or preventive options in both ADHD and TDC.	[Choi, Jeewook; Go, Hyo-Jin] Catholic Univ Korea, Coll Med, Daejeon St Marys Hosp, Dept Psychiat, Taejon, South Korea; [Jeong, Bumseok; Lee, Sang Won] Korea Adv Inst Sci & Technol, Grad Sch Med Sci & Engn, Lab Clin Neurosci & Dev, Taejon 305701, South Korea	Catholic University of Korea; Korea Advanced Institute of Science & Technology (KAIST)	Jeong, B (corresponding author), Korea Adv Inst Sci & Technol, Grad Sch Med Sci & Engn, Lab Clin Neurosci & Dev, Taejon 305701, South Korea.	bs.jeong@kaist.ac.kr	Jeong, Bumseok/G-2722-2011	Jeong, Bumseok/0000-0001-6805-6535	National Research Foundation [NRF-2012R1A1A2001, NRF-2006-2005372]; Ministry of Education, Science and Technology [N01130009, N01130010, G04110085]	National Research Foundation; Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by grants NRF-2012R1A1A2001 and NRF-2006-2005372 (to B. Jeong) from National Research Foundation, and in part by grant for KAIST Future Systems Healthcare Project from the Ministry of Education, Science and Technology (N01130009, N01130010, G04110085 to B. Jeong). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai F, 2012, CORTEX, V48, P604, DOI 10.1016/j.cortex.2011.02.011; Beckmann CF, 2004, IEEE T MED IMAGING, V23, P137, DOI 10.1109/TMI.2003.822821; Beckmann CF, 2005, PHILOS T R SOC B, V360, P1001, DOI 10.1098/rstb.2005.1634; Broyd SJ, 2009, NEUROSCI BIOBEHAV R, V33, P279, DOI 10.1016/j.neubiorev.2008.09.002; Bush G, 2011, BIOL PSYCHIAT, V69, P1160, DOI 10.1016/j.biopsych.2011.01.022; Castellanos FX, 2008, BIOL PSYCHIAT, V63, P332, DOI 10.1016/j.biopsych.2007.06.025; Castellanos FX, 2012, TRENDS COGN SCI, V16, P17, DOI 10.1016/j.tics.2011.11.007; Cho S-Z, 2000, J KOREAN ACAD CHILD, V11, P91; Cho SC, 2006, J KOREAN ACAD CHILD, V18, P138; Corbetta M, 2008, NEURON, V58, P306, DOI 10.1016/j.neuron.2008.04.017; Cortese S, 2013, BIOL PSYCHIAT; De Pisapia N, 2012, CEREB CORTEX, V22, P639, DOI 10.1093/cercor/bhr146; Dickstein SG, 2006, J CHILD PSYCHOL PSYC, V47, P1051, DOI 10.1111/j.1469-7610.2006.01671.x; DuPaul G. J., 1998, ADHD RATING SCALE 4; EFRON B, 1987, J AM STAT ASSOC, V82, P171, DOI 10.2307/2289144; Fair DA, 2008, P NATL ACAD SCI USA, V105, P4028, DOI 10.1073/pnas.0800376105; Fair DA, 2010, BIOL PSYCHIAT, V68, P1084, DOI 10.1016/j.biopsych.2010.07.003; Filippini N, 2009, P NATL ACAD SCI USA, V106, P7209, DOI 10.1073/pnas.0811879106; Fox MD, 2006, NAT NEUROSCI, V9, P23, DOI 10.1038/nn1616; Giedd JN, 1999, NAT NEUROSCI, V2, P861, DOI 10.1038/13158; Gogtay N, 2004, P NATL ACAD SCI USA, V101, P8174, DOI 10.1073/pnas.0402680101; GREENBERG LM, 1993, J CHILD PSYCHOL PSYC, V34, P1019, DOI 10.1111/j.1469-7610.1993.tb01105.x; Jafri MJ, 2008, NEUROIMAGE, V39, P1666, DOI 10.1016/j.neuroimage.2007.11.001; Jeong B, 2012, KOREAN J RADIOL, V13, P265, DOI 10.3348/kjr.2012.13.3.265; Kelly AMC, 2008, NEUROIMAGE, V39, P527, DOI 10.1016/j.neuroimage.2007.08.008; Keshavan MS, 2002, LIFE SCI, V70, P1909, DOI 10.1016/S0024-3205(02)01492-3; Konrad A, 2010, EUR J NEUROSCI, V31, P912, DOI 10.1111/j.1460-9568.2010.07110.x; Lebel C, 2008, NEUROIMAGE, V40, P1044, DOI 10.1016/j.neuroimage.2007.12.053; Lebel C, 2011, J NEUROSCI, V31, P10937, DOI 10.1523/JNEUROSCI.5302-10.2011; Liao W, 2010, NEUROIMAGE, V52, P1549, DOI 10.1016/j.neuroimage.2010.05.010; Makris N, 2008, CEREB CORTEX, V18, P1210, DOI 10.1093/cercor/bhm156; Mennes M, 2011, NEUROIMAGE, V54, P2950, DOI 10.1016/j.neuroimage.2010.10.046; Mennes M, 2010, NEUROIMAGE, V50, P1690, DOI 10.1016/j.neuroimage.2010.01.002; Nakao T, 2011, AM J PSYCHIAT, V168, P1154, DOI 10.1176/appi.ajp.2011.11020281; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Park K., 1996, DEV KEDI WISC INDIVI; Pavuluri MN, 2009, BIOL PSYCHIAT, V65, P586, DOI 10.1016/j.biopsych.2008.10.015; Proal E, 2011, ARCH GEN PSYCHIAT, V68, P1122, DOI 10.1001/archgenpsychiatry.2011.117; Sato JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045671; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Selemon LD, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.7; Shaw P, 2013, BIOL PSYCHIAT; Simon V, 2009, BRIT J PSYCHIAT, V194, P204, DOI 10.1192/bjp.bp.107.048827; Smith SM, 2011, NEUROIMAGE, V54, P875, DOI 10.1016/j.neuroimage.2010.08.063; Sonuga-Barke EJS, 2007, NEUROSCI BIOBEHAV R, V31, P977, DOI 10.1016/j.neubiorev.2007.02.005; Sridharan D, 2008, P NATL ACAD SCI USA, V105, P12569, DOI 10.1073/pnas.0800005105; Sun L, 2012, PSYCHIAT RES-NEUROIM, V201, P120, DOI 10.1016/j.pscychresns.2011.07.001; Supekar K, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002374; Tomasi D, 2012, BIOL PSYCHIAT, V71, P443, DOI 10.1016/j.biopsych.2011.11.003; Tremblay ME, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000527; Uddin LQ, 2008, J NEUROSCI METH, V169, P249, DOI 10.1016/j.jneumeth.2007.11.031; Uddin LQ, 2011, J NEUROSCI, V31, P18578, DOI 10.1523/JNEUROSCI.4465-11.2011; Wang X, 2013, EUR J RADIOL; 소유경, 2002, [JOURNAL OF THE KOREAN NEUROPSYCHIATRIC ASSOCIATION, 신경정신의학], V41, P283	54	41	41	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e83516	10.1371/journal.pone.0083516	http://dx.doi.org/10.1371/journal.pone.0083516			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281QS	24386219	gold, Green Submitted, Green Published			2022-12-25	WOS:000329116700057
J	Lonskaya, I; Desforges, NM; Hebron, ML; Moussa, CEH				Lonskaya, Irina; Desforges, Nicole M.; Hebron, Michaeline L.; Moussa, Charbel E-H.			Ubiquitination Increases Parkin Activity to Promote Autophagic alpha-Synuclein Clearance	PLOS ONE			English	Article							DISEASE INSIGHTS; PROTEIN LIGASE; LEWY BODIES; MUTATIONS; PHOSPHORYLATION; MITOCHONDRIA; BETA; ACCUMULATION; DEGRADATION; ASSOCIATION	Parkinson's disease (PD) is a movement disorder associated with genetic and age related causes. Although autosomal recessive early onset PD linked to parkin mutations does not exhibit alpha-Synuclein accumulation, while autosomal dominant and sporadic PD manifest with alpha-Synuclein inclusions, loss of dopaminergic substantia nigra neurons is a common denominator in PD. Here we show that decreased parkin ubiquitination and loss of parkin stability impair interaction with Beclin-1 and alter alpha-Synuclein degradation, leading to death of dopaminergic neurons. Tyrosine kinase inhibition increases parkin ubiquitination and interaction with Beclin-1, promoting autophagic alpha-Synuclein clearance and nigral neuron survival. However, loss of parkin via deletion increases alpha-Synuclein in the blood compared to the brain, suggesting that functional parkin prevents alpha-Synuclein release into the blood. These studies demonstrate that parkin ubiquitination affects its protein stability and E3 ligase activity, possibly leading to alpha-Synuclein sequestration and subsequent clearance.	[Lonskaya, Irina; Desforges, Nicole M.; Hebron, Michaeline L.; Moussa, Charbel E-H.] Georgetown Univ, Med Ctr, Lab Dementia & Parkinsonism, Dept Neurosci, Washington, DC 20007 USA	Georgetown University	Moussa, CEH (corresponding author), Georgetown Univ, Med Ctr, Lab Dementia & Parkinsonism, Dept Neurosci, Washington, DC 20007 USA.	cem46@georgetown.edu			NIH [NIA 30378]; Georgetown University	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Georgetown University	These studies were supported by NIH grant NIA 30378 and Georgetown University funding to Charbel E-H Moussa. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benner EJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001376; Burns MP, 2009, HUM MOL GENET, V18, P3206, DOI 10.1093/hmg/ddp258; Chaugule VK, 2011, EMBO J, V30, P2853, DOI 10.1038/emboj.2011.204; Cookson MR, 2010, HUM MOL GENET, V19, pR21, DOI 10.1093/hmg/ddq167; Dawson TM, 2010, MOVEMENT DISORD, V25, pS32, DOI 10.1002/mds.22798; de Lavallade H, 2008, J CLIN ONCOL, V26, P3358, DOI 10.1200/JCO.2007.15.8154; Farrer M, 2001, ANN NEUROL, V50, P293, DOI 10.1002/ana.1132; Gasser T, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001148; Giasson BI, 2002, NEURON, V34, P521, DOI 10.1016/S0896-6273(02)00682-7; Goedert M, 2001, NAT REV NEUROSCI, V2, P492, DOI 10.1038/35081564; Goldberg MS, 2003, J BIOL CHEM, V278, P43628, DOI 10.1074/jbc.M308947200; Hampe C, 2006, HUM MOL GENET, V15, P2059, DOI 10.1093/hmg/ddl131; Hattori N, 1998, BIOCHEM BIOPH RES CO, V249, P754, DOI 10.1006/bbrc.1998.9134; Hebron ML, 2013, HUM MOL GENET, V22, P3315, DOI 10.1093/hmg/ddt192; Hebron ML, 2013, J BIOL CHEM, V288, P4103, DOI 10.1074/jbc.M112.419945; Henn IH, 2005, J NEUROCHEM, V92, P114, DOI 10.1111/j.1471-4159.2004.02854.x; Herman AM, 2011, AUTOPHAGY, V7, P919, DOI 10.4161/auto.7.8.15814; Iguchi M, 2013, J BIOL CHEM, V288, DOI 10.1074/jbc.M113.467530; Imai Y, 2000, J BIOL CHEM, V275, P35661, DOI 10.1074/jbc.C000447200; Imam SZ, 2011, J NEUROSCI, V31, P157, DOI 10.1523/JNEUROSCI.1833-10.2011; Jiang HB, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1669; Kantarjian HM, 2007, BLOOD, V110, P3540, DOI 10.1182/blood-2007-03-080689; Khandelwal PJ, 2011, HUM MOL GENET, V20, P2091, DOI 10.1093/hmg/ddr091; Khandelwal PJ, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-47; Kim NC, 2013, NEURON, V78, P65, DOI 10.1016/j.neuron.2013.02.029; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Kitada T, 2009, J NEUROCHEM, V110, P613, DOI 10.1111/j.1471-4159.2009.06152.x; Ko HS, 2010, P NATL ACAD SCI USA, V107, P16691, DOI 10.1073/pnas.1006083107; Kuhn DM, 2006, ANN NY ACAD SCI, V1074, P31, DOI 10.1196/annals.1369.003; Lagier-Tourenne C, 2012, NAT NEUROSCI, V15, P1488, DOI 10.1038/nn.3230; Lazarou M, 2013, J CELL BIOL, V200, P163, DOI 10.1083/jcb.201210111; Lonskaya I, 2013, NEUROSCIENCE, V232, P90, DOI 10.1016/j.neuroscience.2012.12.018; Lonskaya I, 2013, EMBO MOL MED; Lonskaya I, 2012, J ALZHEIMERS DIS; Lonskaya I, 2013, EMBO MOL MED, V5, P1247, DOI 10.1002/emmm.201302771; Lonskaya I, 2013, J ALZHEIMERS DIS, V33, P231, DOI 10.3233/JAD-2012-121141; Lucking CB, 2000, NEW ENGL J MED, V342, P1560, DOI 10.1056/NEJM200005253422103; Matsuda N, 2010, J CELL BIOL, V189, P211, DOI 10.1083/jcb.200910140; Mizuno Y, 2001, CURR OPIN NEUROL, V14, P477, DOI 10.1097/00019052-200108000-00008; Mollenhauer B, 2012, J NEURAL TRANSM, V119, P739, DOI 10.1007/s00702-012-0784-0; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Olzmann JA, 2008, AUTOPHAGY, V4, P85, DOI 10.4161/auto.5172; Pramstaller PP, 2005, ANN NEUROL, V58, P411, DOI 10.1002/ana.20587; Reynolds AD, 2008, J NEUROIMMUNE PHARM, V3, P59, DOI 10.1007/s11481-008-9100-z; Riley BE, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2982; Rodriguez-Navarro JA, 2008, HUM MOL GENET, V17, P3128, DOI 10.1093/hmg/ddn210; Rosen KM, 2010, J NEUROSCI RES, V88, P167, DOI 10.1002/jnr.22178; Sasaki S, 2004, NEUROLOGY, V63, P678, DOI 10.1212/01.WNL.0000134657.25904.0B; Shimura H, 2000, NAT GENET, V25, P302, DOI 10.1038/77060; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Spratt DE, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2983; Sriram SR, 2005, HUM MOL GENET, V14, P2571, DOI 10.1093/hmg/ddi292; Trempe JF, 2013, SCIENCE, V340, P1451, DOI 10.1126/science.1237908; Vincow ES, 2013, P NATL ACAD SCI USA, V110, P6400, DOI 10.1073/pnas.1221132110; Wauer T, 2013, EMBO J, V32, P2099, DOI 10.1038/emboj.2013.125; Wenzel DM, 2011, NATURE, V474, P105, DOI 10.1038/nature09966; Winslow AR, 2011, AUTOPHAGY, V7, P429, DOI 10.4161/auto.7.4.14393; Winslow AR, 2010, J CELL BIOL, V190, P1023, DOI 10.1083/jcb.201003122; Zhang Y, 2000, P NATL ACAD SCI USA, V97, P13354, DOI 10.1073/pnas.240347797; Zheng XD, 2013, CELL RES, V23, P886, DOI 10.1038/cr.2013.66	61	55	55	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e83914	10.1371/journal.pone.0083914	http://dx.doi.org/10.1371/journal.pone.0083914			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281QS	24386307	Green Submitted, Green Published, gold			2022-12-25	WOS:000329116700087
J	Chockalingam, S; Ghosh, SS				Chockalingam, S.; Ghosh, Siddhartha Sankar			Amelioration of Cancer Stem Cells in Macrophage Colony Stimulating Factor-Expressing U87MG-Human Glioblastoma upon 5-Fluorouracil Therapy	PLOS ONE			English	Article							DRUG-RESISTANCE; OVARIAN-CANCER; FACTOR-I; RECEPTOR; CSF-1; PHENOTYPE; MICE	Macrophage colony stimulating factor (MCSF) regulates growth, proliferation and differentiation of haematopoietic cell lineages. Many cancers are known to secrete high level of MCSF, which recruit macrophages into the tumour micro-environment, supporting tumour growth. Herein, we report the cloning of MCSF and subsequent generation of U87MG expressing MCSF stable cell line (U87-MCSF). Cytotoxicity of anti-cancer drug 5-fluorouracil (5-FU) was evaluated on both U87MG and U87-MCSF cells. Interestingly, the proliferation of U87-MCSF cells was less (p<0.001) than that of U87MG cells alone, after treatment with 5-FU. Significant decrease in expression levels of cyclin E and A2 quantified by real time PCR analysis corroborated the reduced proliferation of 5-FU treated U87-MCSF cells. However, JC-1 staining did not reveal any apoptosis upon 5-FU treatment. Notch-1 upregulation induced a possible epithelial-mesenchymal transition in U87-MCSF cells, which accounted for an increase in the proportion of CD24(high)/CD44(less) cancer stem cells in U87-MCSF cells after 5-FU treatment. The elevated resistance of U87-MCSF cells towards 5-FU was due to the increase in the expressions (10.2 and 6 fold) of ABCB1 and mdm2, respectively. Furthermore, increase in expressions of ABCG1, mdm2 and CD24 was also observed in U87MG cells after prolonged incubation with 5-FU. Our studies provided mechanistic insights into drug resistance of U87MG cells and also described the pivotal role played by MCSF in augmenting the resistance of U87MG cells to 5-FU.	[Chockalingam, S.; Ghosh, Siddhartha Sankar] Indian Inst Technol Guwahati, Dept Biotechnol, Gauhati, Assam, India; [Ghosh, Siddhartha Sankar] Indian Inst Technol Guwahati, Ctr Nanotechnol, Gauhati, Assam, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Guwahati; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Guwahati	Ghosh, SS (corresponding author), Indian Inst Technol Guwahati, Dept Biotechnol, Gauhati, Assam, India.	sghosh@iitg.ernet.in	S, Chockalingam/H-1666-2019	S, Chockalingam/0000-0003-2930-7658	Department of Biotechnology [BT/49/NE/TBP/2010, BT/01/NE/PS/08]	Department of Biotechnology	Funding provided by Department of Biotechnology No. BT/49/NE/TBP/2010 and BT/01/NE/PS/08. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed MAH, 2012, BREAST CANCER RES TR, V133, P979, DOI 10.1007/s10549-011-1865-8; Awasthi S, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-61; Bao B, 2011, CANCER LETT, V307, P26, DOI 10.1016/j.canlet.2011.03.012; Bellail AC, 2004, INT J BIOCHEM CELL B, V36, P1046, DOI 10.1016/j.biocel.2004.01.013; Bredel M, 2002, LANCET ONCOL, V3, P397, DOI 10.1016/S1470-2045(02)00786-6; Chambers SK, 1997, CLIN CANCER RES, V3, P999; Curry JM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003405; Das AB, 2012, CANCER LETT, V318, P189, DOI 10.1016/j.canlet.2011.12.013; Dean M, 2005, NAT REV CANCER, V5, P275, DOI 10.1038/nrc1590; Dembinski JL, 2009, CLIN EXP METASTAS, V26, P611, DOI 10.1007/s10585-009-9260-0; Deng JP, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/517172; Douglass TG, 2008, INT IMMUNOPHARMACOL, V8, P1354, DOI 10.1016/j.intimp.2008.04.016; Drake KJ, 2007, INT J ONCOL, V30, P139; Finkel E, 2001, SCIENCE, V292, P624, DOI 10.1126/science.292.5517.624; Jadus MR, 2003, CANCER GENE THER, V10, P411, DOI 10.1038/sj.cgt.7700583; Jaggupilli A, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/708036; Kacinski BM, 1997, MOL REPROD DEV, V46, P71, DOI 10.1002/(SICI)1098-2795(199701)46:1<71::AID-MRD11>3.0.CO;2-6; Kawakami Y, 2000, EUR J CANCER, V36, P1991, DOI 10.1016/S0959-8049(00)00282-3; Lewis CE, 2006, CANCER RES, V66, P605, DOI 10.1158/0008-5472.CAN-05-4005; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Michaelson MD, 1996, DEVELOPMENT, V122, P2661; Mroczko B, 2007, CLIN CHIM ACTA, V380, P208, DOI 10.1016/j.cca.2007.02.037; Nakai E, 2009, CANCER INVEST, V27, P901, DOI 10.3109/07357900801946679; POLLARD JW, 1994, P NATL ACAD SCI USA, V91, P9312, DOI 10.1073/pnas.91.20.9312; Roesch A, 2010, CELL, V141, P583, DOI 10.1016/j.cell.2010.04.020; Sethi N, 2011, BRIT J CANCER, V105, P1805, DOI 10.1038/bjc.2011.497; Sharma S, 2014, ADV HEALTHC MATER, V3, P106, DOI 10.1002/adhm.201300090; Singh A, 2010, ONCOGENE, V29, P4741, DOI 10.1038/onc.2010.215; SMITH HO, 1995, CLIN CANCER RES, V1, P313; Stanley ER, 1997, MOL REPROD DEV, V46, P4, DOI 10.1002/(SICI)1098-2795(199701)46:1<4::AID-MRD2>3.0.CO;2-V; T Hoa N, 2007, LAB INVEST, V87, P115, DOI 10.1038/labinvest.3700506; YUE X, 1993, MOL CELL BIOL, V13, P3191, DOI 10.1128/MCB.13.6.3191; Zhang CJ, 2011, J CANCER RES CLIN, V137, P1679, DOI 10.1007/s00432-011-1038-5; Zwaenepoel O, 2012, FASEB J, V26, P691, DOI 10.1096/fj.11-189753	34	14	14	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83877	10.1371/journal.pone.0083877	http://dx.doi.org/10.1371/journal.pone.0083877			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391839	gold, Green Submitted, Green Published			2022-12-25	WOS:000329325200137
J	Gan, HL; Zhang, JQ; Huang, XY; Yu, W				Gan, Hui-Li; Zhang, Jian-Qun; Huang, Xiao-Yong; Yu, Wei			The Wall Eclipsing Sign on Pulmonary Artery Computed Tomography Angiography Is Pathognomonic for Pulmonary Artery Sarcoma	PLOS ONE			English	Article							SURGICAL-TREATMENT; INTIMAL SARCOMA; DIAGNOSIS; LUNG	Background: The objective of this study was to evaluate the imaging characteristics of pulmonary artery sarcoma (PAS) on pulmonary artery computed tomography angiography (PACTA) that can be used to differentiate between PAS and pulmonary thromboembolic diseases, including chronic thromboembolic pulmonary hypertension (CTEPH) and acute pulmonary embolism (APE). Methods: The clinical data and imaging characteristics of 12 patients with PAS, 156 patients with CTEPH, and 426 patients with APE who were treated at Beijing Anzhen Hospital from January 2007 to August 2013 were retrospectively analyzed. All patients underwent PACTA before treatment, and the diagnoses of PAS and CTEPH were all confirmed by surgical biopsy. Results: All 12 PAS patients were initially misdiagnosed and received inappropriate thrombolytic and/or anticoagulant therapy before they were referred for surgical intervention. The mean time from PACTA to surgical intervention was 5.5 +/- 3.7 months (range 2-11 months). On PACTA, the PAS lesion always eclipsed the wall of the pulmonary artery before infiltrating outside the pulmonary artery, which was termed the wall eclipsing sign. This sign was observed in all PAS patients but was not observed in any CTEPH or APE patients. Conclusions: PAS is a rare neoplasm with a poor prognosis, and is easily misdiagnosed as thromboembolic disease. The wall eclipsing sign on PACTA is pathognomonic for PAS, and patients with this sign should be investigated to confirm the diagnosis and should undergo surgical intervention as soon as possible, rather than receiving thrombolytic or anticoagulant therapy.	[Gan, Hui-Li; Zhang, Jian-Qun] Capital Med Univ, Beijing Inst Heart Lung & Blood Vessel Dis, Beijing Anzhen Hosp, Dept Cardiac Surg, Beijing, Peoples R China; [Huang, Xiao-Yong; Yu, Wei] Capital Med Univ, Beijing Inst Heart Lung & Blood Vessel Dis, Beijing Anzhen Hosp, Dept Image Diagnosing, Beijing, Peoples R China	Capital Medical University; Capital Medical University	Gan, HL (corresponding author), Capital Med Univ, Beijing Inst Heart Lung & Blood Vessel Dis, Beijing Anzhen Hosp, Dept Cardiac Surg, Beijing, Peoples R China.	ganhuili@hotmail.com			China Nature Science Foundation Committee [81070041]; Beijing health system special foundation for building high-level health personnel [2013-2-002]; Beijing Science and Technology Project [Z121107001012067]	China Nature Science Foundation Committee; Beijing health system special foundation for building high-level health personnel; Beijing Science and Technology Project	This project was supported by a grant (#81070041) from China Nature Science Foundation Committee, a grant (#2013-2-002) from Beijing health system special foundation for building high-level health personnel, and a grant (#Z121107001012067) from the Beijing Science and Technology Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson BM, 1995, ANN THORAC SURG, V59, P1487; Attina D, 2013, RADIOL MED; BURKE AP, 1993, CANCER, V71, P1761, DOI 10.1002/1097-0142(19930301)71:5<1761::AID-CNCR2820710510>3.0.CO;2-7; Chhaya NC, 2006, J THORAC CARDIOV SUR, V131, P1410, DOI 10.1016/j.jtcvs.2005.11.045; Coelho LS, 2010, BMJ CASE REP, V2010; Dimitrakakis G, 2006, HEART SURG FORUM, V9, pE897, DOI 10.1532/HSF98.20061112; Etienne-Mastroianni B, 2002, LUNG CANCER-J IASLC, V38, P283, DOI 10.1016/S0169-5002(02)00303-3; Furest I, 2006, ARCH BRONCONEUMOL, V42, P148, DOI 10.1157/13085566; Gan HL, 2011, J THORAC CARDIOV SUR, V142, P1469, DOI 10.1016/j.jtcvs.2011.03.013; Huo L, 2006, AM J CLIN PATHOL, V125, P419, DOI 10.1309/9H8RHUV1JL1WE0QF; Huo Lei, 2005, Ann Diagn Pathol, V9, P209, DOI 10.1016/j.anndiagpath.2005.04.012; KRUGER I, 1990, THORAC CARDIOV SURG, V38, P91, DOI 10.1055/s-2007-1014001; Mandelstamm M, 1923, VIRCHOWS ARCH A, V245, P43, DOI 10.1007/BF01992097; Mayer E, 2001, J THORAC CARDIOV SUR, V121, P77, DOI 10.1067/mtc.2001.111423; MCGLENNEN RC, 1989, MODERN PATHOL, V2, P486; Miura S, 2005, PATHOL RES PRACT, V201, P469, DOI 10.1016/j.prp.2005.06.001; NONOMURA A, 1988, ACTA PATHOL JAPON, V38, P883; Parish JM, 1996, CHEST, V110, P1480, DOI 10.1378/chest.110.6.1480; RAMP U, 1992, J CANCER RES CLIN, V118, P551, DOI 10.1007/BF01225272; Regnard JF, 1999, ANN THORAC SURG, V68, P227, DOI 10.1016/S0003-4975(99)00398-7; Scheffel H, 2008, J THORAC CARDIOV SUR, V135, P949, DOI 10.1016/j.jtcvs.2007.11.041; Shehatha J, 2009, ANN THORAC SURG, V87, P1269, DOI 10.1016/j.athoracsur.2008.08.030; Singh A, 2006, CHEST, V130, P1244, DOI 10.1378/chest.130.4.1244; Winchester PA, 1996, AM J ROENTGENOL, V167, P657, DOI 10.2214/ajr.167.3.8751674	24	38	42	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83200	10.1371/journal.pone.0083200	http://dx.doi.org/10.1371/journal.pone.0083200			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391746	gold, Green Published, Green Submitted			2022-12-25	WOS:000329325200043
J	Graffelman, J; Sanchez, M; Cook, S; Moreno, V				Graffelman, Jan; Sanchez, Milagros; Cook, Samantha; Moreno, Victor			Statistical Inference for Hardy-Weinberg Proportions in the Presence of Missing Genotype Information	PLOS ONE			English	Article							EXACT TESTS; EQUILIBRIUM; DISEASE	In genetic association studies, tests for Hardy-Weinberg proportions are often employed as a quality control checking procedure. Missing genotypes are typically discarded prior to testing. In this paper we show that inference for Hardy-Weinberg proportions can be biased when missing values are discarded. We propose to use multiple imputation of missing values in order to improve inference for Hardy-Weinberg proportions. For imputation we employ a multinomial logit model that uses information from allele intensities and/or neighbouring markers. Analysis of an empirical data set of single nucleotide polymorphisms possibly related to colon cancer reveals that missing genotypes are not missing completely at random. Deviation from Hardy-Weinberg proportions is mostly due to a lack of heterozygotes. Inbreeding coefficients estimated by multiple imputation of the missings are typically lowered with respect to inbreeding coefficients estimated by discarding the missings. Accounting for missings by multiple imputation qualitatively changed the results of 10 to 17% of the statistical tests performed. Estimates of inbreeding coefficients obtained by multiple imputation showed high correlation with estimates obtained by single imputation using an external reference panel. Our conclusion is that imputation of missing data leads to improved statistical inference for Hardy-Weinberg proportions.	[Graffelman, Jan] Univ Politecn Cataluna, Dept Stat & Operat Res, Barcelona, Spain; [Sanchez, Milagros] Vall dHebron Res Inst, Biomed Res Unit, Barcelona, Spain; [Cook, Samantha] Financial Network Analyt, Barcelona, Spain; [Moreno, Victor] CIBERESP, Biomed Res Inst Bellvitge IDIBELL, ICO, Canc Prevent & Control Program, Barcelona, Spain; [Moreno, Victor] UB, Sch Med, Barcelona, Spain	Universitat Politecnica de Catalunya; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona	Graffelman, J (corresponding author), Univ Politecn Cataluna, Dept Stat & Operat Res, Barcelona, Spain.	jan.graffelman@upc.edu	Moreno, Victor/A-1697-2010; Graffelman, Jan/L-8056-2014; Sánchez-Mayor, Milagros/AFP-1432-2022	Moreno, Victor/0000-0002-2818-5487; Graffelman, Jan/0000-0003-3900-0780; Cook, Samantha/0000-0002-2173-4471; Sanchez-Mayor, Milagros/0000-0001-5243-7608	Spanish Ministry of Education and Science [ECO2011-28875, CODARSS MTM2012-33236]; Instituto de Salud Carlos III [PS09-1037, PI11-01439]; CIBERESP [CB07/02/2005]; Agencia d'Informacion Avaluacio i Qualitat en Salut [209/12/2009]; Catalan Government DURSI [2009SGR1489]	Spanish Ministry of Education and Science(Spanish Government); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); CIBERESP; Agencia d'Informacion Avaluacio i Qualitat en Salut; Catalan Government DURSI	This study was supported by grants ECO2011-28875 and CODARSS MTM2012-33236 of the Spanish Ministry of Education and Science. Data were obtained from the colorectal cancer study and the latter was supported by the Instituto de Salud Carlos III, grants PS09-1037 and PI11-01439, by CIBERESP CB07/02/2005, by Agencia d'Informacion Avaluacio i Qualitat en Salut, grant 209/12/2009 and by the Catalan Government DURSI, grant 2009SGR1489. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agresti A., 2013, CATEGORICAL DATA ANA, V3rd; Attia J, 2010, STAT APPL GENET MOL, V9, DOI 10.2202/1544-6115.1463; Chen JB, 2007, HUM HERED, V63, P196, DOI 10.1159/000099996; Chen JB, 2012, STAT MED, V31, P2516, DOI 10.1002/sim.4460; CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; Delaneau O, 2013, NAT METHODS, V10, P5, DOI 10.1038/nmeth.2307; Gomes I, 1999, ANN HUM GENET, V63, P535, DOI 10.1017/S0003480099007824; Graffelman J, 2013, J STAT SOFT IN PRESS; Graffelman J, 2008, HUM HERED, V65, P77, DOI 10.1159/000108939; Graffelman J, 2013, STAT APPL GENET MOL, V12, P433, DOI 10.1515/sagmb-2012-0039; Hardin J. W., 2007, GEN LINEAR MODELS EX, DOI DOI 10.1016/j.marpol.2012.12.026; Hardy GH, 1908, SCIENCE, V28, P49, DOI 10.1126/science.28.706.49; Hartl D.L., 1989, PRINCIPLES POPULATIO, V2nd; Hedrick P. W., 2011, GENETICS POPULATIONS; Hosking L, 2004, EUR J HUM GENET, V12, P395, DOI 10.1038/sj.ejhg.5201164; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Laird N.M., 2011, FUNDAMENTALS MODERN; Lee WC, 2003, AM J EPIDEMIOL, V158, P397, DOI 10.1093/aje/kwg150; Li MY, 2008, GENET EPIDEMIOL, V32, P589, DOI 10.1002/gepi.20335; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Little R.J.A., 2002, STAT ANAL MISSING DA; Rohlfs RV, 2008, GENETICS, V180, P1609, DOI 10.1534/genetics.108.088005; Rubin DB, 2004, MULTIPLE IMPUTATION; Salanti G, 2005, EUR J HUM GENET, V13, P840, DOI 10.1038/sj.ejhg.5201410; Schafer JL, 1997, ANAL INCOMPLETE MULT, V1st, DOI 10.1201/9781439821862; van Buuren S., 2018, FLEXIBLE IMPUTATION, V2nd, DOI DOI 10.1201/9780429492259; van Buuren S, 2011, J STAT SOFTW, V45, P1; Weinberg W., 1908, PAPERS HUMAN GENETIC; Weir BS., 1996, GENETIC DATA ANAL; Wigginton JE, 2005, AM J HUM GENET, V76, P887, DOI 10.1086/429864	30	8	8	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83316	10.1371/journal.pone.0083316	http://dx.doi.org/10.1371/journal.pone.0083316			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391752	Green Published, Green Submitted, gold			2022-12-25	WOS:000329325200049
J	Palazzo, P; Maggio, P; Altavilla, R; Di Flaviani, A; Giordani, I; Malandrucco, I; Picconi, F; Passarelli, F; Pasqualetti, P; Ercolani, M; Vernieri, F; Frontoni, S				Palazzo, Paola; Maggio, Paola; Altavilla, Riccardo; Di Flaviani, Alessandra; Giordani, Ilaria; Malandrucco, Ilaria; Picconi, Fabiana; Passarelli, Francesco; Pasqualetti, Patrizio; Ercolani, Matilde; Vernieri, Fabrizio; Frontoni, Simona			Cerebral Hemodynamics and Systemic Endothelial Function Are Already Impaired in Well-Controlled Type 2 Diabetic Patients, with Short-Term Disease	PLOS ONE			English	Article							FLOW-MEDIATED DILATION; NITRIC-OXIDE SYNTHASE; CEREBROVASCULAR REACTIVITY; SYMPATHETIC ACTIVATION; VASOMOTOR REACTIVITY; COGNITIVE DECLINE; RESERVE CAPACITY; BRACHIAL-ARTERY; BLOOD-FLOW; RISK	Objective: Impaired cerebral vasomotor reactivity (VMR) and flow-mediated dilation (FMD) were found in selected subgroups of type 2 diabetes mellitus (T2DM) patients with long-term disease. Our study aimed to evaluate cerebral hemodynamics, systemic endothelial function and sympatho-vagal balance in a selected population of well-controlled T2DM patients with short-term disease and without cardiac autonomic neuropathy (CAN). Research Design and Methods: Twenty-six T2DM patients with short-term (4.40 +/- 4.80 years) and well-controlled (HbA1C = 6.71 +/- 1.29%) disease, without any complications, treated with diet and/or metformin, were consecutively recruited. Eighteen controls, comparable by sex and age, were enrolled also. Results: FMD and shear rate FMD were found to be reduced in T2DM subjects with short-term disease (8.5% SD 3.5 and 2.5 SD 1.3, respectively) compared to controls (15.4% SD 4.1 and 3.5 SD 1.4; p<.001 and p<.05). T2DM patients also displayed reduced VMR values than controls (39.4% SD 12.4 vs 51.7%, SD 15.5; p<.05). Sympatho-vagal balance was not different in T2DM patients compared to healthy subjects. FMD and shear rate FMD did not correlate with VMR in T2DM patients or in controls (p>.05). Conclusions: In well-controlled T2DM patients with short-term disease cerebral hemodynamics and systemic endothelial function are altered while autonomic balance appeared to be preserved.	[Palazzo, Paola; Maggio, Paola; Altavilla, Riccardo; Vernieri, Fabrizio] Campus Biomed Univ, Dept Neurol, Rome, Italy; [Palazzo, Paola; Passarelli, Francesco; Ercolani, Matilde] S Giovanni Calibita Fatebenefratelli Hosp, Dept Neurol, Rome, Italy; [Di Flaviani, Alessandra; Giordani, Ilaria; Malandrucco, Ilaria; Picconi, Fabiana; Frontoni, Simona] Univ Roma Tor Vergata, S Giovanni Calibita Fatebenefratelli Hosp, Rome, Italy; [Pasqualetti, Patrizio] Fatebenefratelli Assoc Res, Serv Med Stat & IT, SeSMIT, Rome, Italy	University Campus Bio-Medico - Rome Italy; University of Rome Tor Vergata	Palazzo, P (corresponding author), Campus Biomed Univ, Dept Neurol, Rome, Italy.	p.palazzo@unicampus.it	Picconi, Fabiana/AAB-9012-2019; Maggio, Paola/ABC-7526-2021; FRONTONI, SIMONA/J-4893-2012; Pasqualetti, Patrizio/D-4496-2013	Maggio, Paola/0000-0001-8393-7699; FRONTONI, SIMONA/0000-0001-8241-7552; VERNIERI, FABRIZIO/0000-0002-9594-9336; Pasqualetti, Patrizio/0000-0001-5560-1979				Agelink MW, 2001, CLIN AUTON RES, V11, P99, DOI 10.1007/BF02322053; Ceriello A, 2008, DIABETES, V57, P1349, DOI 10.2337/db08-0063; Corretti MC, 2002, J AM COLL CARDIOL, V39, P257, DOI 10.1016/S0735-1097(01)01746-6; Cosentino F, 1997, CIRCULATION, V96, P25; Di Flaviani A, 2011, DIABETES CARE, V34, P1605, DOI 10.2337/dc11-0034; Dyson KS, 2006, AM J PHYSIOL-HEART C, V290, pH1446, DOI 10.1152/ajpheart.00771.2005; Engelke KA, 1997, CLIN AUTON RES, V7, P85, DOI 10.1007/BF02267752; EWING DJ, 1985, DIABETES CARE, V8, P491, DOI 10.2337/diacare.8.5.491; Farrell B, 1998, LANCET, V351, P1379, DOI 10.1016/s0140-6736(97)09292-1; Fulesdi B, 1999, J DIABETES COMPLICAT, V13, P191, DOI 10.1016/S1056-8727(99)00044-6; IADECOLA C, 1994, J CEREBR BLOOD F MET, V14, P175, DOI 10.1038/jcbfm.1994.25; Kotb NA, 2012, EXP CLIN ENDOCR DIAB, V120, P460, DOI 10.1055/s-0032-1306349; Kozera GM, 2009, DIABETES CARE, V32, P878, DOI 10.2337/dc08-1805; LeMarbre G, 2003, J PHYSIOL-LONDON, V551, P609, DOI 10.1113/jphysiol.2003.046987; Markus H, 2001, BRAIN, V124, P457, DOI 10.1093/brain/124.3.457; Moens AL, 2005, CHEST, V127, P2254, DOI 10.1378/chest.127.6.2254; Palazzo P, 2010, NEUROLOGY, V75, P2003, DOI 10.1212/WNL.0b013e3181ffe4e4; Palazzo P, 2013, ULTRASOUND MED BIOL, V39, P10, DOI 10.1016/j.ultrasmedbio.2012.08.022; PRETNAROBLAK J, 2007, ENDOTHELIUM, V14, P1; Pyke KE, 2005, J PHYSIOL-LONDON, V568, P357, DOI 10.1113/jphysiol.2005.089755; Santos-Garcia D, 2011, CEREBROVASC DIS, V32, P155, DOI 10.1159/000328651; Shechter M, 2009, INT J CARDIOL, V134, P52, DOI 10.1016/j.ijcard.2008.01.021; Silvestrini M, 2000, JAMA-J AM MED ASSOC, V283, P2122, DOI 10.1001/jama.283.16.2122; Silvestrini M, 2006, STROKE, V37, P1010, DOI 10.1161/01.STR.0000206439.62025.97; Tesfaye S, 2010, DIABETES CARE, V33, P2285, DOI 10.2337/dc10-1303; Touboul PJ, 2007, CEREBROVASC DIS, V23, P75, DOI 10.1159/000097034; van Oers CAMM, 2006, CEREBROVASC DIS, V22, P46, DOI 10.1159/000092337; Verdelho A, 2010, NEUROLOGY, V75, P160, DOI 10.1212/WNL.0b013e3181e7ca05; Vernieri F, 2001, STROKE, V32, P1552, DOI 10.1161/01.STR.32.7.1552; Vernieri F, 2010, STROKE, V41, P2087, DOI 10.1161/STROKEAHA.110.583088; Vuletic V, 2011, COLLEGIUM ANTROPOL, V35, P27; WANG Q, 1995, J CEREBR BLOOD F MET, V15, P774, DOI 10.1038/jcbfm.1995.97; White RP, 1998, STROKE, V29, P467, DOI 10.1161/01.STR.29.2.467; WOLFF SP, 1987, BIOCHEM J, V245, P243, DOI 10.1042/bj2450243; Yokoyama H, 2011, J ATHEROSCLER THROMB, V18, P744, DOI 10.5551/jat.7526	35	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83287	10.1371/journal.pone.0083287	http://dx.doi.org/10.1371/journal.pone.0083287			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391751	Green Submitted, Green Published, gold			2022-12-25	WOS:000329325200048
J	Salaberria, C; Muriel, J; de Luna, M; Gil, D; Puerta, M				Salaberria, Concepcion; Muriel, Jaime; de Luna, Maria; Gil, Diego; Puerta, Marisa			The PHA Test as an Indicator of Phagocytic Activity in a Passerine Bird	PLOS ONE			English	Article							BACTERICIDAL ACTIVITIES; INNATE IMMUNITY; BLOOD-CHEMISTRY; WELCOME SWALLOW; TREE SWALLOWS; PHYTOHEMAGGLUTININ; IMMUNOCOMPETENCE; WHITE; CICONIA; AGE	Several techniques in ecological immunology have been used to assess bird immunocompetence thus providing useful information to understand the contribution of the immunological system in life-history decisions. The phytohaemagglutinin (PHA)-skin test has been the most widely employed technique being interpreted as the sole result of T lymphocytes proliferation and hence used to evaluate acquired immunological capacity. However, the presence of high numbers of phagocytic cells in the swelling point has cast some doubt about such an assumption. To address this issue, we collected blood from 14 days-old nestlings of spotless starling (Sturnus unicolor), administered subcutaneous PHA immediately after and then measured the swelling response 24 hours later. Differential counts of white blood cells suggested that an intense development of acquired immunological defences was taking place. The phagocytic activity of both heterophiles and monocytes was also very intense as it was the swelling response. Moreover, our results show, for the first time in birds, a positive relationship between the phagocytic activity of both kinds of cells and the swelling response. This broadens the significance of the PHA test from reflecting T lymphocytes proliferation -as previously proposed but still undetermined in vivo-to evaluate phagocytosis as well. In other words, our data suggest that the PHA swelling response may not be considered as the only consequence of processes of specific and induced immunity -T lymphocytes proliferation-but also of constitutive and nonspecific immunity -heterophiles and monocytes phagocytosis. We propose the extensive use of PHA-skin test as an optimal technique to assess immunocompetence.	[Salaberria, Concepcion; Muriel, Jaime; de Luna, Maria; Gil, Diego] CSIC, Museo Nacl Ciencias Nat, Dept Evolut Ecol, E-28006 Madrid, Spain; [de Luna, Maria; Puerta, Marisa] Univ Complutense Madrid, Fac Ciencias Biol, Dept Anim Physiol, E-28040 Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Museo Nacional de Ciencias Naturales (MNCN); Complutense University of Madrid	Salaberria, C (corresponding author), Univ Nacl Autonoma Mexico, Ctr Invest Ecosistemas, Dept Funct Ecol, Morelia, Michoacan, Mexico.	salaberria@cieco.unam.mx	Gil, Diego/L-1666-2014; Muriel, Jaime/C-3000-2016	Gil, Diego/0000-0003-3179-1987; Muriel, Jaime/0000-0003-4580-6406; SALABERRIA, CONCEPCION/0000-0003-4196-9443	Spanish Ministry of Science [CGL2008-03501/BOS]	Spanish Ministry of Science(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work was supported by the grant "Las hormonas esteroideas como moduladores de los compromisos de historia vital en aves" (CGL2008-03501/BOS) from the Spanish Ministry of Science given to Diego Gil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABELENDA M, 1993, COMP BIOCHEM PHYS A, V104, P575, DOI 10.1016/0300-9629(93)90466-H; ALONSO JC, 1991, COMP BIOCHEM PHYS A, V98, P395, DOI 10.1016/0300-9629(91)90421-8; Alonso-Alvarez C, 2001, CAN J ZOOL, V79, P101, DOI 10.1139/cjz-79-1-101; ANDERSON EL, 1970, APPL MICROBIOL, V19, P726, DOI 10.1128/AEM.19.5.726-730.1970; Ardia DR, 2005, ECOLOGY, V86, P2040, DOI 10.1890/04-1619; Blount JD, 2003, SCIENCE, V300, P125, DOI 10.1126/science.1082142; Bonato M, 2009, ANIM BEHAV, V77, P1027, DOI 10.1016/j.anbehav.2008.12.019; Brommer JE, 2004, P ROY SOC B-BIOL SCI, V271, pS110, DOI 10.1098/rsbl.2003.0103; BROWN SJ, 1982, J IMMUNOL, V129, P790; Christe P, 2001, OECOLOGIA, V126, P333, DOI 10.1007/s004420000527; Cichon M, 2005, J EVOLUTION BIOL, V18, P962, DOI 10.1111/j.1420-9101.2005.00910.x; Cucco M, 2006, CAN J ZOOL, V84, P72, DOI 10.1139/Z05-179; Davis AK, 2008, FUNCT ECOL, V22, P760, DOI 10.1111/j.1365-2435.2008.01467.x; Dehnhard N, 2011, J COMP PHYSIOL B, V181, P83, DOI 10.1007/s00360-010-0508-4; Demas GE, 2004, HORM BEHAV, V45, P173, DOI 10.1016/j.yhbeh.2003.11.002; Demas GE, 2011, J ANIM ECOL, V80, P710, DOI 10.1111/j.1365-2656.2011.01813.x; Dhabhar FS, 2002, INTEGR COMP BIOL, V42, P556, DOI 10.1093/icb/42.3.556; Duffy DL, 2002, P ROY SOC B-BIOL SCI, V269, P847, DOI 10.1098/rspb.2002.1956; Finkelstein M, 2003, ARCH ENVIRON CON TOX, V44, P502, DOI 10.1007/s00244-002-2075-5; Gil D, 2011, FUNCT ECOL, V25, P1278, DOI 10.1111/j.1365-2435.2011.01878.x; Gonzalez G, 1999, J ANIM ECOL, V68, P1225, DOI 10.1046/j.1365-2656.1999.00364.x; GOTO N, 1978, POULTRY SCI, V57, P246, DOI 10.3382/ps.0570246; Hoffmann-Jagielska M, 2003, VET RES COMMUN, V27, P643, DOI 10.1023/A:1027376530463; Howlett JC, 2002, J WILDLIFE DIS, V38, P804, DOI 10.7589/0090-3558-38.4.804; Kampen AH, 2004, VET IMMUNOL IMMUNOP, V97, P105, DOI 10.1016/j.vetimm.2003.08.018; Kennedy MW, 2006, TRENDS ECOL EVOL, V21, P653, DOI 10.1016/j.tree.2006.09.017; Klasing Kirk C., 2004, Acta Zoologica Sinica, V50, P961; Krams I, 2012, COMP BIOCHEM PHYS A, V161, P422, DOI 10.1016/j.cbpa.2011.12.018; Levy O, 2007, NAT REV IMMUNOL, V7, P379, DOI 10.1038/nri2075; LOCHMILLER RL, 1993, AUK, V110, P503, DOI 10.2307/4088414; Lopez-Rull I, 2011, FUNCT ECOL, V25, P500, DOI 10.1111/j.1365-2435.2010.01783.x; Lowry VK, 1997, FEMS IMMUNOL MED MIC, V19, P95, DOI 10.1016/S0928-8244(97)00073-4; Lucas AM, 1974, ATLAS AVIAN HEMATOLO; Luster AD, 2002, CURR OPIN IMMUNOL, V14, P129, DOI 10.1016/S0952-7915(01)00308-9; Martin LB, 2006, FUNCT ECOL, V20, P290, DOI 10.1111/j.1365-2435.2006.01094.x; Matson KD, 2005, DEV COMP IMMUNOL, V29, P275, DOI 10.1016/j.dci.2004.07.006; MCCORKLE F, 1980, POULTRY SCI, V59, P616, DOI 10.3382/ps.0590616; McNamara JM, 1996, NATURE, V380, P215, DOI 10.1038/380215a0; Medzhitov R, 1997, CURR OPIN IMMUNOL, V9, P4, DOI 10.1016/S0952-7915(97)80152-5; MOLLER AP, 1990, ECOLOGY, V71, P2345, DOI 10.2307/1938645; Moreno J, 1999, BEHAV ECOL SOCIOBIOL, V47, P47, DOI 10.1007/s002650050648; NOWELL PC, 1960, CANCER RES, V20, P462; Owen JP, 2010, TRENDS PARASITOL, V26, P530, DOI 10.1016/j.pt.2010.06.005; Palacios MG, 2009, DEV COMP IMMUNOL, V33, P456, DOI 10.1016/j.dci.2008.09.006; PUERTA ML, 1989, COMP BIOCHEM PHYS A, V94, P201, DOI 10.1016/0300-9629(89)90535-5; PUERTA ML, 1992, COMP BIOCHEM PHYS A, V102, P683, DOI 10.1016/0300-9629(92)90723-4; Rogers CA, 1991, BIRD PARASITE INTERA, P123; Saino N, 2004, FUNCT ECOL, V18, P50, DOI 10.1046/j.0269-8463.2004.00808.x; Schmid-Hempel P, 2003, TRENDS ECOL EVOL, V18, P27, DOI 10.1016/S0169-5347(02)00013-7; Simmons P, 2006, COMP BIOCHEM PHYS A, V143, P459, DOI 10.1016/j.cbpa.2005.12.018; Sindik A, 2009, J WILDLIFE DIS, V45, P1203, DOI 10.7589/0090-3558-45.4.1203; Smits JE, 1999, FUNCT ECOL, V13, P567, DOI 10.1046/j.1365-2435.1999.00338.x; Sorci G, 1997, P ROY SOC B-BIOL SCI, V264, P1593, DOI 10.1098/rspb.1997.0222; STABLER JG, 1994, VET MICROBIOL, V38, P293, DOI 10.1016/0378-1135(94)90148-1; STADECKER MJ, 1977, J IMMUNOL, V118, P1564; Stearns S.C., 1992, pi; Stearns SC, 2000, NATURWISSENSCHAFTEN, V87, P476, DOI 10.1007/s001140050763; STRAIN JG, 1991, AVIAN DIS, V35, P221, DOI 10.2307/1591318; Szabo Z, 2010, J ZOO WILDLIFE MED, V41, P17, DOI 10.1638/2008-0164.1; Tella JL, 2002, P ROY SOC B-BIOL SCI, V269, P1059, DOI 10.1098/rspb.2001.1951; Veiga JP, 2011, ESTORNINO NEGRO STUR; Vinkler M, 2010, FUNCT ECOL, V24, P1081, DOI 10.1111/j.1365-2435.2010.01711.x; Wells LL, 1998, DEV COMP IMMUNOL, V22, P103, DOI 10.1016/S0145-305X(97)00024-4; Zuk M, 1998, P ROY SOC B-BIOL SCI, V265, P1631, DOI 10.1098/rspb.1998.0481	64	29	29	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84108	10.1371/journal.pone.0084108	http://dx.doi.org/10.1371/journal.pone.0084108			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391896	Green Published, gold, Green Submitted			2022-12-25	WOS:000329323900039
J	Shoji, A; Elliott, KH; O'Reilly, KM; Gaston, AJ				Shoji, Akiko; Elliott, Kyle H.; O'Reilly, Kathleen M.; Gaston, Anthony J.			High Corticosterone, Not High Energy Cost, Correlates with Reproductive Success in the Burrow-Nesting Ancient Murrelet	PLOS ONE			English	Article							BASE-LINE; FOOD AVAILABILITY; FORAGING BEHAVIOR; STRESS-RESPONSE; HORMONE-LEVELS; BODY CONDITION; LIFE-HISTORY; PERFORMANCE; EXPENDITURE; INCUBATION	Theory and observations suggest that offspring abandonment in animals may occur when the costs to future reproductive output of current reproductive effort outweigh the fitness benefits of rearing the current brood. While hormonal cues (i.e. corticosterone) or energy reserves are believed to be involved, few studies have directly focused on the proximate cues influencing behaviours directly related to reproductive success. To address this information gap, we determined the incubation metabolic rates and corticosterone (CORT) levels of naturally fasting and freely incubating ancient murrelets (Synthliboramphus antiquus). Respiratory quotient (RQ) increased with date, suggesting that incubating ancient murrelets shifted from strictly lipid-based metabolism towards more protein-based metabolism as incubation progressed. Birds that hatched only one nestling had higher levels of circulating CORT than those which hatched two, suggesting that birds which laid only a single egg found incubation more stressful than those which laid two. However, CORT levels and incubation shift lengths were not correlated, suggesting that birds that undertook prolonged incubation shifts did so only when their energy stores were not jeopardized.	[Shoji, Akiko; Gaston, Anthony J.] Environm Canada, Natl Wildlife Res Ctr, Ottawa, ON K1A 0H3, Canada; [Elliott, Kyle H.] Univ Manitoba, Dept Zool, Winnipeg, MB R3T 2N2, Canada; [O'Reilly, Kathleen M.] Univ Portland, Dept Biol, Portland, OR 97203 USA; [Gaston, Anthony J.] Univ Ottawa, Dept Biol, Ottawa, ON, Canada	Environment & Climate Change Canada; Canadian Wildlife Service; National Wildlife Research Centre - Canada; University of Manitoba; University of Portland; University of Ottawa	Shoji, A (corresponding author), Environm Canada, Natl Wildlife Res Ctr, Ottawa, ON K1A 0H3, Canada.	akikosho@gmail.com	Elliott, Kyle/S-9185-2019	Elliott, Kyle/0000-0001-5304-3993	M.J. Murdock Charitable Trust; Environment Canada	M.J. Murdock Charitable Trust; Environment Canada(CGIAR)	This work was supported by the M.J. Murdock Charitable Trust and Environment Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelier F, 2008, GEN COMP ENDOCR, V156, P134, DOI 10.1016/j.ygcen.2007.12.001; Angelier F, 2007, PHYSIOL BIOCHEM ZOOL, V80, P283, DOI 10.1086/512585; Angelier F, 2009, J EXP BIOL, V212, P2824, DOI 10.1242/jeb.027722; Angelier F, 2009, GEN COMP ENDOCR, V163, P142, DOI 10.1016/j.ygcen.2009.03.028; Angelier F, 2009, FUNCT ECOL, V23, P784, DOI 10.1111/j.1365-2435.2009.01545.x; Benowitz-Fredericks ZM, 2008, DEEP-SEA RES PT II, V55, P1868, DOI 10.1016/j.dsr2.2008.04.007; Bernard SF, 2003, AM J PHYSIOL-REG I, V285, pR313, DOI 10.1152/ajpregu.00094.2003; Biro PA, 2010, TRENDS ECOL EVOL, V25, P653, DOI 10.1016/j.tree.2010.08.003; Blackmer AL, 2005, BEHAV ECOL, V16, P906, DOI 10.1093/beheco/ari069; Bonier F, 2009, GEN COMP ENDOCR, V163, P208, DOI 10.1016/j.ygcen.2008.12.013; BROWN CR, 1988, OSTRICH, V59, P67, DOI 10.1080/00306525.1988.9633699; Buck CL, 2007, GEN COMP ENDOCR, V150, P430, DOI 10.1016/j.ygcen.2006.10.011; Buntin John D., 1996, Advances in the Study of Behavior, V25, P161; Chastel O, 2005, HORM BEHAV, V47, P459, DOI 10.1016/j.yhbeh.2004.10.009; CHAURAND T, 1994, IBIS, V136, P285, DOI 10.1111/j.1474-919X.1994.tb01097.x; Crespi EJ, 2013, FUNCT ECOL, V27, P93, DOI 10.1111/1365-2435.12009; Cyr NE, 2007, GEN COMP ENDOCR, V151, P82, DOI 10.1016/j.ygcen.2006.12.003; DRENT RH, 1980, ARDEA, V68, P225; Elliott KJ, 2013, J MOL CELL CARDIOL, V62, P1, DOI 10.1016/j.yjmcc.2013.05.005; Elliott KH, 2012, MAR ECOL PROG SER, V466, P1, DOI 10.3354/meps09975; Elliott KH, 2008, J AVIAN BIOL, V39, P619, DOI 10.1111/j.1600-048X.2008.04316.x; Ellis Hugh I., 2002, P359; Gaston, 1992, ANCIENT MURRELET NAT; Gaston A.J., 1998, AUKS ALCIDAE; Gaston AJ, 1996, COLON WATERBIRD, V19, P116, DOI 10.2307/1521814; GOODMAN MN, 1980, AM J PHYSIOL, V239, pE277; Groscolas R, 2001, COMP BIOCHEM PHYS A, V128, P645, DOI 10.1016/S1095-6433(00)00341-X; Groscolas R., 1990, P269; Hammond KA, 1997, NATURE, V386, P457, DOI 10.1038/386457a0; Heath JP, 2010, P ROY SOC B-BIOL SCI, V277, P3179, DOI 10.1098/rspb.2010.0812; Heidinger BJ, 2006, P ROY SOC B-BIOL SCI, V273, P2227, DOI 10.1098/rspb.2006.3557; Jacobs SR, 2011, COMP BIOCHEM PHYS B, V158, P77, DOI 10.1016/j.cbpb.2010.09.011; Kitaysky AS, 2007, MAR ECOL PROG SER, V352, P245, DOI 10.3354/meps07074; Kitaysky AS, 2006, P ROY SOC B-BIOL SCI, V273, P445, DOI 10.1098/rspb.2005.3351; Kitaysky AS, 2003, HORM BEHAV, V43, P140, DOI 10.1016/S0018-506X(02)00030-2; Kitaysky AS, 1999, FUNCT ECOL, V13, P577, DOI 10.1046/j.1365-2435.1999.00352.x; Landys MM, 2006, GEN COMP ENDOCR, V148, P132, DOI 10.1016/j.ygcen.2006.02.013; LEMAHO Y, 1981, AM J PHYSIOL, V241, pE342, DOI 10.1152/ajpendo.1981.241.5.E342; Lighton JRB, 2019, MEASURING METABOLIC RATES: A MANUAL FOR SCIENTISTS, 2ND EDITION, DOI 10.1093/oso/9780198830399.001.0001; Newman Scott H., 2005, Marine Ornithology, V33, P147; Niizuma Y, 2002, CAN J ZOOL, V80, P1549, DOI 10.1139/Z02-158; Ouyang JQ, 2011, P ROY SOC B-BIOL SCI, V278, P2537, DOI 10.1098/rspb.2010.2490; PETTIT TN, 1988, OECOLOGIA, V74, P546, DOI 10.1007/BF00380052; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Reed TE, 2010, P ROY SOC B-BIOL SCI, V277, P3391, DOI 10.1098/rspb.2010.0771; Reid JM, 2003, J ANIM ECOL, V72, P36, DOI 10.1046/j.1365-2656.2003.00673.x; ROBIN JP, 1988, AM J PHYSIOL, V254, pR61, DOI 10.1152/ajpregu.1988.254.1.R61; Romero LM, 2005, COMP BIOCHEM PHYS A, V140, P73, DOI 10.1016/j.cbpb.2004.11.004; Shoji A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017760; SILVERIN B, 1990, COMP PHYSIOL, V9, P129; SILVERIN B, 1986, GEN COMP ENDOCR, V64, P67, DOI 10.1016/0016-6480(86)90029-8; Silverin B, 1998, ANIM BEHAV, V55, P1411, DOI 10.1006/anbe.1997.0717; Speakman J.R., 1997, DOUBLY LABELLED WATE; Speakman JR, 2004, PHYSIOL BIOCHEM ZOOL, V77, P900, DOI 10.1086/427059; Stearns S.C., 1992, pi; Walsberg GE, 1997, J EXP BIOL, V200, P2115; Weimerskirch H, 2002, J EXP BIOL, V205, P475; Whittow G. C., 1984, SEABIRD ENERGETICS; Williams CT, 2008, GEN COMP ENDOCR, V158, P29, DOI 10.1016/j.ygcen.2008.04.018; Williams T., 2012, PHYSL ADAPTATIONS BR	60	2	2	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84280	10.1371/journal.pone.0084280	http://dx.doi.org/10.1371/journal.pone.0084280			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391929	Green Submitted, Green Published, gold			2022-12-25	WOS:000329323900072
J	Westhoff, MA; Faham, N; Marx, D; Nonnenmacher, L; Jennewein, C; Enzenmuller, S; Gonzalez, P; Fulda, S; Debatin, KM				Westhoff, Mike-Andrew; Faham, Najmeh; Marx, Daniela; Nonnenmacher, Lisa; Jennewein, Claudia; Enzenmueller, Stefanie; Gonzalez, Patrick; Fulda, Simone; Debatin, Klaus-Michael			Sequential Dosing in Chemosensitization: Targeting the PI3K/Akt/mTOR Pathway in Neuroblastoma	PLOS ONE			English	Article							HIGH-RISK NEUROBLASTOMA; CELL-DEATH; GLIOBLASTOMA CELLS; TOPOISOMERASE-II; AKT; ACTIVATION; INHIBITOR; APOPTOSIS; CHEMOTHERAPY; AUTOPHAGY	Breaking resistance to chemotherapy is a major goal of combination therapy in many tumors, including advanced neuroblastoma. We recently demonstrated that increased activity of the PI3K/Akt network is associated with poor prognosis, thus providing an ideal target for chemosensitization. Here we show that targeted therapy using the PI3K/mTOR inhibitor NVP-BEZ235 significantly enhances doxorubicin-induced apoptosis in neuroblastoma cells. Importantly, this increase in apoptosis was dependent on scheduling: while pretreatment with the inhibitor reduced doxorubicin-induced apoptosis, the sensitizing effect in co-treatment could further be increased by delayed addition of the inhibitor post chemotherapy. Desensitization for doxorubicin-induced apoptosis seemed to be mediated by a combination of cell cycle-arrest and autophagy induction, whereas sensitization was found to occur at the level of mitochondria within one hour of NVP-BEZ235 posttreatment, leading to a rapid loss of mitochondrial membrane potential with subsequent cytochrome c release and caspase-3 activation. Within the relevant time span we observed marked alterations in a similar to 30 kDa protein associated with mitochondrial proteins and identified it as VDAC1/Porin protein, an integral part of the mitochondrial permeability transition pore complex. VDAC1 is negatively regulated by the PI3K/Akt pathway via GSK3 beta and inhibition of GSK3b, which is activated when Akt is blocked, ablated the sensitizing effect of NVP-BEZ235 posttreatment. Our findings show that cancer cells can be sensitized for chemotherapy induced cell death - at least in part - by NVP-BEZ235-mediated modulation of VDAC1. More generally, we show data that suggest that sequential dosing, in particular when multiple inhibitors of a single pathway are used in the optimal sequence, has important implications for the general design of combination therapies involving molecular targeted approaches towards the PI3K/Akt/mTOR signaling network.	[Westhoff, Mike-Andrew; Faham, Najmeh; Marx, Daniela; Nonnenmacher, Lisa; Jennewein, Claudia; Enzenmueller, Stefanie; Gonzalez, Patrick; Fulda, Simone; Debatin, Klaus-Michael] Univ Med Ctr Ulm, Dept Pediat & Adolescent Med, Ulm, Germany	Ulm University	Fulda, S (corresponding author), Goethe Univ Frankfurt, Inst Expt Canc Res Pediat, Frankfurt, Germany.	simone.fulda@kgu.de; klaus-michael.debatin@uniklinik-ulm.de	Westhoff, Mike-Andrew/ABA-9272-2021; Debatin, Klaus-Michael/J-9704-2014	Westhoff, Mike-Andrew/0000-0003-3256-7100; Debatin, Klaus-Michael/0000-0002-8397-1886; Fulda, Simone/0000-0002-0459-6417	Deutsche Krebshilfe; Deutsche Forschungsgemeinschaft; International Graduate School in Molecular Medicine Ulm	Deutsche Krebshilfe(Deutsche Krebshilfe); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); International Graduate School in Molecular Medicine Ulm	This work has been partially supported by grants from Deutsche Krebshilfe (SF and KMD), Deutsche Forschungsgemeinschaft (LN) and the International Graduate School in Molecular Medicine Ulm (CJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammirante M, 2010, NATURE, V464, P302, DOI 10.1038/nature08782; Baumann P, 2009, EXP CELL RES, V315, P485, DOI 10.1016/j.yexcr.2008.11.007; Bender A, 2011, ONCOGENE, V30, P494, DOI 10.1038/onc.2010.429; Berthold F, 2005, LANCET ONCOL, V6, P649, DOI 10.1016/S1470-2045(05)70291-6; Bien S, 2010, BIOCHEM PHARMACOL, V80, P1466, DOI 10.1016/j.bcp.2010.07.036; Boller D, 2008, CLIN CANCER RES, V14, P1172, DOI 10.1158/1078-0432.CCR-07-0737; Brodeur GM, 2003, NAT REV CANCER, V3, P203, DOI 10.1038/nrc1014; Buki A, 2000, J NEUROSCI, V20, P2825; Burden DA, 1998, BBA-GENE STRUCT EXPR, V1400, P139, DOI 10.1016/S0167-4781(98)00132-8; Caren H, 2010, P NATL ACAD SCI USA, V107, P4323, DOI 10.1073/pnas.0910684107; Caren H, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-353; CHEUNG NKV, 1991, J CLIN ONCOL, V9, P1050, DOI 10.1200/JCO.1991.9.6.1050; Coughlin CM, 2010, BREAST CANCER RES TR, V124, P1, DOI 10.1007/s10549-010-1108-4; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Davidoff AM, 2012, SEMIN PEDIATR SURG, V21, P2, DOI 10.1053/j.sempedsurg.2011.10.009; Degtyarev M, 2008, J CELL BIOL, V183, P101, DOI 10.1083/jcb.200801099; Dubrovska A, 2010, CLIN CANCER RES, V16, P5692, DOI 10.1158/1078-0432.CCR-10-1601; Enzenmuller S, 2013, CANCER LETT, V329, P27, DOI 10.1016/j.canlet.2012.09.007; Enzenmuller S, 2013, ANTI-CANCER DRUG, V24, P14, DOI 10.1097/CAD.0b013e32835a36db; Ferraro C, 2000, CANCER RES, V60, P1901; Franke TF, 2008, ONCOGENE, V27, P6473, DOI 10.1038/onc.2008.313; Gardai SJ, 2004, J BIOL CHEM, V279, P21085, DOI 10.1074/jbc.M400063200; Gonzalez P, 2012, CELL DEATH DIFFER, V19, P1337, DOI 10.1038/cdd.2012.10; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Hixon ML, 2010, REV RECENT CLIN TRIA, V5, P189, DOI 10.2174/157488710792007329; Hui RCY, 2008, MOL CANCER THER, V7, P670, DOI 10.1158/1535-7163.MCT-07-0397; Konstantinidou G, 2009, CANCER RES, V69, P7644, DOI 10.1158/0008-5472.CAN-09-0823; Lee MJ, 2012, CELL, V149, P780, DOI 10.1016/j.cell.2012.03.031; Levine B, 2005, J CLIN INVEST, V115, P2679, DOI 10.1172/JCI26390; Li XQ, 2005, BREAST CANCER RES, V7, pR589, DOI 10.1186/bcr1259; Li ZJ, 2007, EXPERT OPIN THER TAR, V11, P1611, DOI 10.1517/14728222.11.12.1611; Magan N, 2012, ANTI-CANCER DRUG, V23, P627, DOI 10.1097/CAD.0b013e328350900f; Marzo I, 1998, J EXP MED, V187, P1261, DOI 10.1084/jem.187.8.1261; Mueller S, 2011, CANCER LETT, V306, P223, DOI 10.1016/j.canlet.2011.03.010; Opel D, 2008, CANCER RES, V68, P6271, DOI 10.1158/0008-5472.CAN-07-6769; Opel D, 2007, CANCER RES, V67, P735, DOI 10.1158/0008-5472.CAN-06-2201; Pan T, 2009, NEUROSCIENCE, V164, P541, DOI 10.1016/j.neuroscience.2009.08.014; Park JR, 2010, HEMATOL ONCOL CLIN N, V24, P65, DOI 10.1016/j.hoc.2009.11.011; Pastorino JG, 2005, CANCER RES, V65, P10545, DOI 10.1158/0008-5472.CAN-05-1925; Paz-Ares L, 2009, CLIN TRANSL ONCOL, V11, P572, DOI 10.1007/s12094-009-0407-x; Prasad G, 2011, NEURO-ONCOLOGY, V13, P384, DOI 10.1093/neuonc/noq193; Qayum N, 2012, CLIN CANCER RES, V18, P161, DOI 10.1158/1078-0432.CCR-11-1413; Qi XJ, 2006, J BIOL CHEM, V281, P813, DOI 10.1074/jbc.M505546200; ROSS RA, 1983, J NATL CANCER I, V71, P741; Shoshan-Barmatz V, 2010, MOL ASPECTS MED, V31, P227, DOI 10.1016/j.mam.2010.03.002; Sims JT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055509; Swift LP, 2006, CANCER RES, V66, P4863, DOI 10.1158/0008-5472.CAN-05-3410; Westhoff MA, 2009, ONCOGENE, V28, P3586, DOI 10.1038/onc.2009.215; Zeng R, 2012, ACTA PHARMACOL SIN, V33, P91, DOI 10.1038/aps.2011.143	49	40	44	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83128	10.1371/journal.pone.0083128	http://dx.doi.org/10.1371/journal.pone.0083128			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391739	Green Submitted, Green Published, gold			2022-12-25	WOS:000329325200036
J	Yamanaka, T; Tosaki, A; Kurosawa, M; Akimoto, K; Hirose, T; Ohno, S; Hattori, N; Nukina, N				Yamanaka, Tomoyuki; Tosaki, Asako; Kurosawa, Masaru; Akimoto, Kazunori; Hirose, Tomonori; Ohno, Shigeo; Hattori, Nobutaka; Nukina, Nobuyuki			Loss of aPKC lambda in Differentiated Neurons Disrupts the Polarity Complex but Does Not Induce Obvious Neuronal Loss or Disorientation in Mouse Brains	PLOS ONE			English	Article							PROTEIN-KINASE-C; DENDRITIC SPINE MORPHOGENESIS; ASYMMETRIC CELL-DIVISION; TRANSCRIPTION FACTOR; EPITHELIAL POLARITY; CEREBRAL-CORTEX; PAR-COMPLEX; PKM-ZETA; MICE; ESTABLISHMENT	Cell polarity plays a critical role in neuronal differentiation during development of the central nervous system (CNS). Recent studies have established the significance of atypical protein kinase C (aPKC) and its interacting partners, which include PAR-3, PAR-6 and Lgl, in regulating cell polarization during neuronal differentiation. However, their roles in neuronal maintenance after CNS development remain unclear. Here we performed conditional deletion of aPKC lambda, a major aPKC isoform in the brain, in differentiated neurons of mice by camk2a-cre or synapsinI-cre mediated gene targeting. We found significant reduction of aPKC lambda and total aPKCs in the adult mouse brains. The aPKC lambda deletion also reduced PAR-6 beta, possibly by its destabilization, whereas expression of other related proteins such as PAR-3 and Lgl-1 was unaffected. Biochemical analyses suggested that a significant fraction of aPKC lambda formed a protein complex with PAR-6 beta and Lgl-1 in the brain lysates, which was disrupted by the aPKC lambda deletion. Notably, the aPKC lambda deletion mice did not show apparent cell loss/degeneration in the brain. In addition, neuronal orientation/distribution seemed to be unaffected. Thus, despite the polarity complex disruption, neuronal deletion of aPKC lambda does not induce obvious cell loss or disorientation in mouse brains after cell differentiation.	[Yamanaka, Tomoyuki; Tosaki, Asako; Kurosawa, Masaru; Nukina, Nobuyuki] RIKEN Brain Sci Inst, Lab Struct Neuropathol, Saitama, Japan; [Yamanaka, Tomoyuki; Kurosawa, Masaru; Nukina, Nobuyuki] Juntendo Univ, Grad Sch Med, Dept Neurosci Neurodegenerat Disorders, Tokyo, Japan; [Akimoto, Kazunori] Tokyo Univ Sci, Fac Pharmaceut Sci, Dept Mol Med Sci, Chiba, Japan; [Hirose, Tomonori; Ohno, Shigeo] Yokohama City Univ, Grad Sch Med Sci, Dept Mol Biol, Yokohama, Kanagawa 232, Japan; [Hattori, Nobutaka] Juntendo Univ, Grad Sch Med, Dept Neurol, Tokyo, Japan; [Nukina, Nobuyuki] Japan Sci & Technol Agcy, Core Res Evolutionary Sci & Technol, Tokyo, Japan	RIKEN; Juntendo University; Tokyo University of Science; Yokohama City University; Juntendo University; Japan Science & Technology Agency (JST)	Yamanaka, T (corresponding author), RIKEN Brain Sci Inst, Lab Struct Neuropathol, Saitama, Japan.	yamanakat@brain.riken.jp; nnukina@juntendo.ac.jp	Hirose, Tomonori/F-6015-2010; Hirose, Tomonori/M-8872-2019; Hattori, Nobutaka/ACR-0069-2022; Nukina, Nobuyuki/GPP-6265-2022; Ohno, Shigeo/B-1768-2010	Hirose, Tomonori/0000-0003-2428-0919; Hirose, Tomonori/0000-0003-2428-0919; Ohno, Shigeo/0000-0002-1294-5269	Ministry of Education, Culture, Sports, Science and Technology of Japan [24111553, 23700430, 22110004, 22240037, 24659436]; RIKEN; Japan Science and Technology Agency; Ministry of Health, Welfare and Labor	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); RIKEN; Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Ministry of Health, Welfare and Labor(Ministry of Health, Labour and Welfare, Japan)	This work was supported by a Grant-in-Aid from Ministry of Education, Culture, Sports, Science and Technology of Japan for TY (24111553, 23700430) and NN (22110004, 22240037, 24659436) (http://www.mext.go.jp/), by Special Postdoctoral Researchers Program of RIKEN for TY. (http://www.riken.go.jp/en/careers/programs/spdr/), by Core Research for Evolutionary Science and Technology from Japan Science and Technology Agency for NN. (http://www.jst.go.jp/kisoken/crest/); and by Grant-in-Aid for the Research on Measures for Ataxic Diseases from the Ministry of Health, Welfare and Labor for NN (http://ataxia.umin.jp/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arimura N, 2007, NAT REV NEUROSCI, V8, P194, DOI 10.1038/nrn2056; Atwood SX, 2013, NATURE, V494, P484, DOI 10.1038/nature11889; Baye LM, 2007, J NEUROSCI, V27, P10143, DOI 10.1523/JNEUROSCI.2754-07.2007; Bultje RS, 2009, NEURON, V63, P189, DOI 10.1016/j.neuron.2009.07.004; Caldwell JH, 2000, P NATL ACAD SCI USA, V97, P5616, DOI 10.1073/pnas.090034797; Chen YM, 2006, P NATL ACAD SCI USA, V103, P8534, DOI 10.1073/pnas.0509955103; Cheng PL, 2011, NEURON, V69, P231, DOI 10.1016/j.neuron.2010.12.021; Costa MR, 2008, DEVELOPMENT, V135, P11, DOI 10.1242/dev.009951; Duman JG, 2013, J NEUROSCI, V33, P6964, DOI 10.1523/JNEUROSCI.3978-12.2013; Fiala JC, 2002, BRAIN RES REV, V39, P29, DOI 10.1016/S0165-0173(02)00158-3; Goldstein B, 2007, DEV CELL, V13, P609, DOI 10.1016/j.devcel.2007.10.007; Halpain S, 2005, PROG BRAIN RES, V147, P29, DOI 10.1016/S0079-6123(04)47003-4; Hengst U, 2009, NAT CELL BIOL, V11, P1024, DOI 10.1038/ncb1916; Hirano Y, 2004, J BIOL CHEM, V279, P31883, DOI 10.1074/jbc.M403092200; Hirose T, 2006, DEVELOPMENT, V133, P1389, DOI 10.1242/dev.02294; Hirose T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004194; Hutterer A, 2004, DEV CELL, V6, P845, DOI 10.1016/j.devcel.2004.05.003; Iden S, 2012, CANCER CELL, V22, P389, DOI 10.1016/j.ccr.2012.08.004; Imai F, 2006, DEVELOPMENT, V133, P1735, DOI 10.1242/dev.02330; Insolera R, 2011, DEV NEUROBIOL, V71, P483, DOI 10.1002/dneu.20867; Klezovitch O, 2004, GENE DEV, V18, P559, DOI 10.1101/gad.1178004; Knoblich JA, 2008, CELL, V132, P583, DOI 10.1016/j.cell.2008.02.007; Kobayashi Y, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00017; Koike C, 2005, J NEUROSCI, V25, P10290, DOI 10.1523/JNEUROSCI.3657-05.2005; Lee AM, 2013, NATURE, V493, P416, DOI 10.1038/nature11803; McCaffrey LM, 2012, CANCER CELL, V22, P601, DOI 10.1016/j.ccr.2012.10.003; McCaffrey LM, 2011, TRENDS CELL BIOL, V21, P727, DOI 10.1016/j.tcb.2011.06.005; McCaffrey LM, 2009, GENE DEV, V23, P1450, DOI 10.1101/gad.1795909; Mori D, 2009, NAT CELL BIOL, V11, P1057, DOI 10.1038/ncb1919; Nishimura I, 2004, CELL, V116, P671, DOI 10.1016/S0092-8674(04)00170-9; Nishimura T, 2005, NAT CELL BIOL, V7, P270, DOI 10.1038/ncb1227; Nishimura T, 2004, NAT CELL BIOL, V6, P328, DOI 10.1038/ncb1118; Ogiwara I, 2007, J NEUROSCI, V27, P5903, DOI 10.1523/JNEUROSCI.5270-06.2007; Ohno S, 2001, CURR OPIN CELL BIOL, V13, P641, DOI 10.1016/S0955-0674(00)00264-7; Ossipova O, 2009, DEV CELL, V17, P222, DOI 10.1016/j.devcel.2009.06.010; Regala RP, 2009, CANCER RES, V69, P7603, DOI 10.1158/0008-5472.CAN-09-2066; Rempe D, 2006, GENESIS, V44, P44, DOI 10.1002/gene.20183; Ren SQ, 2013, EMBO J, V32, P1365, DOI 10.1038/emboj.2013.60; Rolls MM, 2004, NAT NEUROSCI, V7, P1293, DOI 10.1038/nn1346; Sabherwal N, 2009, DEVELOPMENT, V136, P2767, DOI 10.1242/dev.034454; Sacktor TC, 2008, PROG BRAIN RES, V169, P27, DOI 10.1016/S0079-6123(07)00002-7; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Seidl S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062756; Shi SH, 2003, CELL, V112, P63, DOI 10.1016/S0092-8674(02)01249-7; Shi SH, 2004, CURR BIOL, V14, P2025, DOI 10.1016/j.cub.2004.11.009; Siller KH, 2009, NAT CELL BIOL, V11, P365, DOI 10.1038/ncb0409-365; Solecki DJ, 2009, NEURON, V63, P63, DOI 10.1016/j.neuron.2009.05.028; Solecki DJ, 2004, NAT NEUROSCI, V7, P1195, DOI 10.1038/nn1332; Sugiyama Y, 2009, DEV BIOL, V336, P246, DOI 10.1016/j.ydbio.2009.10.010; Suzuki A, 2004, CURR BIOL, V14, P1425, DOI 10.1016/j.cub.2004.08.021; Suzuki A, 2003, J BIOCHEM, V133, P9, DOI 10.1093/jb/mvg018; Suzuki A, 2006, J CELL SCI, V119, P979, DOI 10.1242/jcs.02898; Suzuki A, 2001, J CELL BIOL, V152, P1183, DOI 10.1083/jcb.152.6.1183; Tanabe K, 2010, J NEUROSCI, V30, P16983, DOI 10.1523/JNEUROSCI.3352-10.2010; Tsien JZ, 1996, CELL, V87, P1317, DOI 10.1016/S0092-8674(00)81826-7; Viloria-Petit AM, 2009, P NATL ACAD SCI USA, V106, P14028, DOI 10.1073/pnas.0906796106; Volk LJ, 2013, NATURE, V493, P420, DOI 10.1038/nature11802; Wang T, 2011, DEV CELL, V21, P431, DOI 10.1016/j.devcel.2011.07.007; Wilson MI, 2003, MOL CELL, V12, P39, DOI 10.1016/S1097-2765(03)00246-6; Wodarz A, 2005, CURR OPIN CELL BIOL, V17, P475, DOI 10.1016/j.ceb.2005.08.005; Wolf AM, 2008, J NEUROSCI, V28, P3456, DOI 10.1523/JNEUROSCI.0029-08.2008; Xue B, 2013, NAT CELL BIOL, V15, P189, DOI 10.1038/ncb2663; Yamanaka T, 2003, CURR BIOL, V13, P734, DOI 10.1016/S0960-9822(03)00244-6; Yamanaka T, 2001, GENES CELLS, V6, P721, DOI 10.1046/j.1365-2443.2001.00453.x; Yamanaka T, 2008, FRONT BIOSCI-LANDMRK, V13, P6693, DOI 10.2741/3182; Yamanaka T, 2008, EMBO J, V27, P827, DOI 10.1038/emboj.2008.23; Yamanaka T, 2006, J CELL SCI, V119, P2107, DOI 10.1242/jcs.02938; Yamanaka T, 2010, HUM MOL GENET, V19, P2099, DOI 10.1093/hmg/ddq087; Yi JJ, 2010, CELL, V142, P144, DOI 10.1016/j.cell.2010.06.010; Zarnescu DC, 2005, DEV CELL, V8, P43, DOI 10.1016/j.devcel.2004.10.020; Zhang HY, 2008, DEV CELL, V14, P216, DOI 10.1016/j.devcel.2007.11.020; Zhang HY, 2006, NAT CELL BIOL, V8, P227, DOI 10.1038/ncb1368; Zhu Y, 2001, GENE DEV, V15, P859, DOI 10.1101/gad.862101	73	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84036	10.1371/journal.pone.0084036	http://dx.doi.org/10.1371/journal.pone.0084036			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391875	Green Submitted, Green Published, gold			2022-12-25	WOS:000329323900018
J	Bruel, A; Roze, JC; Flamant, C; Simeoni, U; Roussey-Kesler, G; Allain-Launay, E				Bruel, Alexandra; Roze, Jean-Christophe; Flamant, Cyril; Simeoni, Umberto; Roussey-Kesler, Gwenaelle; Allain-Launay, Emma			Critical Serum Creatinine Values in Very Preterm Newborns	PLOS ONE			English	Article							ACUTE KIDNEY INJURY; BIRTH-WEIGHT INFANTS; ACUTE-RENAL-FAILURE; GLOMERULAR-FILTRATION-RATE; RIFLE CRITERIA; MORTALITY; LABORATORIES; MANAGEMENT; CHILDREN	Background: Renal failure in neonates is associated with an increased risk of mortality and morbidity. But critical values are not known. Objective: To define critical values for serum creatinine levels by gestational age in preterm infants, as a predictive factor for mortality and morbidity. Study Design: This was a retrospective study of all preterm infants born before 33 weeks of gestational age, hospitalized in Nantes University Hospital NICU between 2003 and 2009, with serum creatinine levels measured between postnatal days 3 to 30. Children were retrospectively randomized into either training or validation set. Critical creatinine values were defined within the training set as the 90th percentile values of highest serum creatinine (HSCr) in infants with optimal neurodevelopmental at two years of age. The relationship between these critical creatinine values and neonatal mortality, and non-optimal neural development at two years, was then assessed in the validation set. Results and Conclusion: The analysis involved a total of 1,461 infants (gestational ages of 24-27 weeks (n=322), 28-29 weeks (n=336), and 30-32 weeks (803)), and 14,721 creatinine assessments. The critical values determined in the training set (n=485) were 1.6, 1.1 and 1.0 mg/dL for each gestational age group, respectively. In the validation set (n=976), a serum creatinine level above the critical value was significantly associated with neonatal mortality (Odds ratio: 8.55 (95% confidence interval: 4.23-17.28); p<0.01) after adjusting for known renal failure risk factors, and with non-optimal neurodevelopmental outcome at two years (odds ratio: 2.06 (95% confidence interval: 1.26-3.36); p=0.004) before adjustment. Creatinine values greater than 1.6, 1.1 and 1.0 mg/dL respectively at 24-27, 28-29, 30-32 weeks of gestation were associated with mortality before and after adjustment for risk factors, and with non-optimal neurodevelopmental outcome, before adjustment.	[Bruel, Alexandra; Roussey-Kesler, Gwenaelle; Allain-Launay, Emma] Univ Nantes, Nantes Univ Hosp, Dept Pediat, Nantes, France; [Roze, Jean-Christophe; Flamant, Cyril] Univ Nantes, Nantes Univ Hosp, Dept Neonatal, Nantes, France; [Roze, Jean-Christophe; Flamant, Cyril] Nantes Univ Hosp, INSERM, CIC 004, Nantes, France; [Roze, Jean-Christophe; Flamant, Cyril] Nantes Univ Hosp, INRA, UMR Physiol Adaptat Nutr 1280, Nantes, France; [Simeoni, Umberto] AP HM, Dept Neonatal, Marseille, France; [Simeoni, Umberto] Aix Marseille Univ, Marseille, France	Nantes Universite; CHU de Nantes; Nantes Universite; CHU de Nantes; Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; CHU de Nantes; INRAE; Nantes Universite; CHU de Nantes; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite	Roze, JC (corresponding author), Univ Nantes, Nantes Univ Hosp, Dept Neonatal, Nantes, France.	jcroze@chu-nantes.fr	Rozé, Jean-Christophe/AAS-1314-2021; Simeoni, Umberto/GRO-6971-2022; SIMEONI, Umberto/AAQ-1870-2021	Simeoni, Umberto/0000-0003-0730-9337; SIMEONI, Umberto/0000-0003-0730-9337; Roze, Jean-Christophe/0000-0003-3367-512X	Regional Health Agency of Pays de la Loire	Regional Health Agency of Pays de la Loire	The LIFT cohort is supported by grants from the Regional Health Agency of Pays de la Loire. The sponsor has no role in this manuscript.	Abitbol CL, 2003, PEDIATR NEPHROL, V18, P887, DOI 10.1007/s00467-003-1186-1; Akcan-Arikan A, 2007, KIDNEY INT, V71, P1028, DOI 10.1038/sj.ki.5002231; Askenazi DJ, 2011, J PEDIATR-US, V159, P907, DOI 10.1016/j.jpeds.2011.05.045; Askenazi DJ, 2009, PEDIATR NEPHROL, V24, P265, DOI 10.1007/s00467-008-1060-2; Auron A, 2006, J PERINATOL, V26, P755, DOI 10.1038/sj.jp.7211604; Baraton L, 2009, PEDIATRICS, V124, pE655, DOI 10.1542/peds.2008-3415; Bargnoux AS, 2011, ANN BIOL CLIN-PARIS, V69, P9, DOI 10.1684/abc.2010.0510; Boussicault G, 2013, J PEDIATR-US, V163, P460, DOI 10.1016/j.jpeds.2013.01.052; Cataldi L, 2005, ARCH DIS CHILD-FETAL, V90, pF514, DOI 10.1136/adc.2004.060434; Choker G, 2004, BIOL NEONATE, V86, P212, DOI 10.1159/000079619; Cobbaert CM, 2009, CLIN CHEM, V55, P549, DOI 10.1373/clinchem.2008.116863; COLE TJ, 1990, EUR J CLIN NUTR, V44, P45; Csaicsich D, 2008, WIEN KLIN WOCHENSCHR, V120, P153, DOI 10.1007/s00508-008-0941-5; Drion I, 2012, BMC NEPHROL, V13, DOI 10.1186/1471-2369-13-133; Fily A, 2006, PEDIATRICS, V117, P357, DOI 10.1542/peds.2005-0236; Flamant C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020004; Gallini F, 2000, PEDIATR NEPHROL, V15, P119, DOI 10.1007/s004670000356; Gong Y, 2009, CLIN BIOCHEM, V42, P1610, DOI 10.1016/j.clinbiochem.2009.08.004; GORDJANI N, 1988, EUR J PEDIATR, V148, P143, DOI 10.1007/BF00445923; Gouyon JB, 2000, PEDIATR NEPHROL, V14, P1037, DOI 10.1007/s004670050068; GUIGNARD JP, 1975, J PEDIATR-US, V87, P268, DOI 10.1016/S0022-3476(75)80600-7; Iacobelli S, 2009, J PERINATOL, V29, P232, DOI 10.1038/jp.2008.203; Koralkar R, 2011, PEDIATR RES, V69, P354, DOI 10.1203/PDR.0b013e31820b95ca; LUNDBERG GD, 1990, JAMA-J AM MED ASSOC, V263, P709, DOI 10.1001/jama.263.5.709; Lunn AJF, 2006, ARCH DIS CHILD-FETAL, V91, P388, DOI 10.1136/adc.2005.092023; McCoy L, 1999, ARCH DIS CHILD-FETAL, V80, pF38; Mehta RL, 2007, CRIT CARE, V11, DOI 10.1186/cc5713; Olsen IE, 2010, PEDIATRICS, V125, pE214, DOI 10.1542/peds.2009-0913; Ostermann M, 2011, QJM-INT J MED, V104, P237, DOI 10.1093/qjmed/hcq185; Ricci Z, 2008, KIDNEY INT, V73, P538, DOI 10.1038/sj.ki.5002743; Seronie-Vivien S, 2004, ANN BIOL CLIN-PARIS, V62, P165; Toth-Heyn P, 2000, PEDIATR NEPHROL, V14, P227, DOI 10.1007/s004670050048; Vieux R, 2010, PEDIATRICS, V125, pE1186, DOI 10.1542/peds.2009-1426; Walker MW, 2011, J PERINATOL, V31, P199, DOI 10.1038/jp.2010.82	34	24	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e84892	10.1371/journal.pone.0084892	http://dx.doi.org/10.1371/journal.pone.0084892			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386431	Green Published, Green Submitted, gold			2022-12-25	WOS:000329194700121
J	Jackson, SA; Flemer, B; McCann, A; Kennedy, J; Morrissey, JP; O'Gara, F; Dobson, ADW				Jackson, Stephen A.; Flemer, Burkhardt; McCann, Angela; Kennedy, Jonathan; Morrissey, John P.; O'Gara, Fergal; Dobson, Alan D. W.			Archaea Appear to Dominate the Microbiome of Inflatella pellicula Deep Sea Sponges	PLOS ONE			English	Article							AMMONIA-OXIDIZING ARCHAEA; 16S RIBOSOMAL-RNA; MARINE SPONGE; PHYLOGENETIC DIVERSITY; TRANSMISSION; COMMUNITIES; BACTERIAL; POPULATIONS; SYMBIONTS; ECOLOGY	Microbes associated with marine sponges play significant roles in host physiology. Remarkable levels of microbial diversity have been observed in sponges worldwide through both culture-dependent and culture-independent studies. Most studies have focused on the structure of the bacterial communities in sponges and have involved sponges sampled from shallow waters. Here, we used pyrosequencing of 16S rRNA genes to compare the bacterial and archaeal communities associated with two individuals of the marine sponge Inflatella pellicula from the deep-sea, sampled from a depth of 2,900 m, a depth which far exceeds any previous sequence-based report of sponge-associated microbial communities. Sponge-microbial communities were also compared to the microbial community in the surrounding seawater. Sponge-associated microbial communities were dominated by archaeal sequencing reads with a single archaeal OTU, comprising similar to 60% and similar to 72% of sequences, being observed from Inflatella pellicula. Archaeal sequencing reads were less abundant in seawater (similar to 11% of sequences). Sponge-associated microbial communities were less diverse and less even than any other sponge-microbial community investigated to date with just 210 and 273 OTUs (97% sequence identity) identified in sponges, with 4 and 6 dominant OTUs comprising similar to 88% and similar to 89% of sequences, respectively. Members of the candidate phyla, SAR406, NC10 and ZB3 are reported here from sponges for the first time, increasing the number of bacterial phyla or candidate divisions associated with sponges to 43. A minor cohort from both sponge samples (similar to 0.2% and similar to 0.3% of sequences) were not classified to phylum level. A single OTU, common to both sponge individuals, dominates these unclassified reads and shares sequence homology with a sponge associated clone which itself has no known close relative and may represent a novel taxon.	[Jackson, Stephen A.; Flemer, Burkhardt; McCann, Angela; Kennedy, Jonathan; Morrissey, John P.; O'Gara, Fergal; Dobson, Alan D. W.] Natl Univ Ireland Univ Coll Cork, Ctr Marine Biotechnol, Environm Res Inst, Cork, Ireland; [Morrissey, John P.; O'Gara, Fergal; Dobson, Alan D. W.] Natl Univ Ireland Univ Coll Cork, Dept Microbiol, Cork, Ireland; [O'Gara, Fergal] Natl Univ Ireland Univ Coll Cork, BIOMERIT Res Ctr, Cork, Ireland	University College Cork; University College Cork; University College Cork	Dobson, ADW (corresponding author), Natl Univ Ireland Univ Coll Cork, Ctr Marine Biotechnol, Environm Res Inst, Cork, Ireland.	a.dobson@ucc.ie	Morrissey, John/AAD-2255-2019; Dobson, Alan D W/M-7844-2017; Jackson, Stephen/J-4368-2019	Dobson, Alan D W/0000-0002-7713-5574; Jackson, Stephen/0000-0001-7869-9032; Flemer, Burkhardt/0000-0003-4614-4432; O'Gara, Fergal/0000-0002-2659-0673; Morrissey, John/0000-0001-7960-2001	Department of Agriculture, Fisheries and Food [FIRM08/RDC/629]; Beaufort Marine Biodiscovery Research award; Irish Government under the National Development Plan	Department of Agriculture, Fisheries and Food; Beaufort Marine Biodiscovery Research award; Irish Government under the National Development Plan	This research was supported in part by grants awarded by the Department of Agriculture, Fisheries and Food (FIRM08/RDC/629) and the Beaufort Marine Biodiscovery Research award funded by the Irish Government under the National Development Plan (2007-2013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Baker PW, 2009, MAR BIOTECHNOL, V11, P540, DOI 10.1007/s10126-008-9169-7; Bavestrello G, 2000, BIOL BULL, V198, P29, DOI 10.2307/1542801; Brady SF, 2007, NAT PROTOC, V2, P1297, DOI 10.1038/nprot.2007.195; Bragg L, 2012, NAT METHODS, V9, P425, DOI 10.1038/nmeth.1990; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cerrano C, 2004, CHEM ECOL, V20, pS57, DOI 10.1080/02757540310001629198; Dupont S, 2013, FEMS MICROBIOL ECOL, V2013, P1; Flemer B., 2013, THESIS U COLL CORK I; Hallam SJ, 2006, P NATL ACAD SCI USA, V103, P18296, DOI 10.1073/pnas.0608549103; Han MQ, 2013, MICROB ECOL, V66, P427, DOI 10.1007/s00248-013-0197-0; Han MQ, 2012, MAR BIOTECHNOL, V14, P701, DOI 10.1007/s10126-012-9436-5; Hentschel U, 2006, FEMS MICROBIOL ECOL, V55, P167, DOI 10.1111/j.1574-6941.2005.00046.x; Hoffmann F, 2009, ENVIRON MICROBIOL, V11, P2228, DOI 10.1111/j.1462-2920.2009.01944.x; Jackson SA, 2012, MICROB ECOL, V64, P105, DOI 10.1007/s00248-011-0002-x; Kennedy J, 2008, ENVIRON MICROBIOL, V10, P1888, DOI 10.1111/j.1462-2920.2008.01614.x; Kennedy J, 2010, MAR DRUGS, V8, P608, DOI 10.3390/md8030608; Kennedy J, 2009, MAR BIOTECHNOL, V11, P384, DOI 10.1007/s10126-008-9154-1; Konneke M, 2005, NATURE, V437, P543, DOI 10.1038/nature03911; Kumar PS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020956; Kunin V, 2010, ENVIRON MICROBIOL, V12, P118, DOI 10.1111/j.1462-2920.2009.02051.x; Lee OO, 2011, ISME J, V2010, P1; Liu F, 2011, EVID-BASED COMPL ALT, V2011, DOI 10.1155/2011/723696; Margot H, 2002, MAR BIOL, V140, P739, DOI 10.1007/s00227-001-0740-2; Meyer B, 2008, MICROB ECOL, V56, P306, DOI 10.1007/s00248-007-9348-5; Mohamed NM, 2010, ISME J, V4, P38, DOI 10.1038/ismej.2009.84; Moin NS, 2009, APPL ENVIRON MICROB, V75, P7461, DOI 10.1128/AEM.01001-09; Pape T, 2006, POLAR BIOL, V29, P662, DOI 10.1007/s00300-005-0103-4; Preston CM, 1996, P NATL ACAD SCI USA, V93, P6241, DOI 10.1073/pnas.93.13.6241; Radax R, 2012, ENVIRON MICROBIOL, V14, P909, DOI 10.1111/j.1462-2920.2011.02661.x; REISWIG HM, 1975, CAN J ZOOL, V53, P582, DOI 10.1139/z75-072; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schauss K, 2009, ENVIRON MICROBIOL, V11, P446, DOI 10.1111/j.1462-2920.2008.01783.x; Schmitt S, 2012, ISME J, V6, P564, DOI 10.1038/ismej.2011.116; Sharp KH, 2007, APPL ENVIRON MICROB, V73, P622, DOI 10.1128/AEM.01493-06; Simister RL, 2012, ENVIRON MICROBIOL, V14, P517, DOI 10.1111/j.1462-2920.2011.02664.x; Sipkema D, 2009, MICROB ECOL, V58, P903, DOI 10.1007/s00248-009-9534-8; Steger D, 2008, ENVIRON MICROBIOL, V10, P1087, DOI 10.1111/j.1462-2920.2007.01515.x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Taylor MW, 2007, MICROBIOL MOL BIOL R, V71, P295, DOI 10.1128/MMBR.00040-06; Usher KM, 2004, MICROB ECOL, V48, P167, DOI 10.1007/s00248-003-1062-3; VACELET J, 1977, J EXP MAR BIOL ECOL, V30, P301, DOI 10.1016/0022-0981(77)90038-7; Webster NS, 2010, ENVIRON MICROBIOL, V12, P2070, DOI 10.1111/j.1462-2920.2009.02065.x; Webster NS, 2004, ENVIRON MICROBIOL, V6, P288, DOI 10.1111/j.1462-2920.2004.00570.x; White JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038204; WILKINSON CR, 1983, SCIENCE, V219, P410, DOI 10.1126/science.219.4583.410; WILKINSON CR, 1978, MAR BIOL, V49, P161, DOI 10.1007/BF00387115; Zhang HT, 2006, ANTON LEEUW INT J G, V90, P159, DOI 10.1007/s10482-006-9070-1	48	38	38	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e84438	10.1371/journal.pone.0084438	http://dx.doi.org/10.1371/journal.pone.0084438			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386380	gold, Green Published, Green Submitted			2022-12-25	WOS:000329194700107
J	Nelson, TM; Rogers, TL; Brown, MV				Nelson, Tiffanie M.; Rogers, Tracey L.; Brown, Mark V.			The Gut Bacterial Community of Mammals from Marine and Terrestrial Habitats	PLOS ONE			English	Article							CHEMICAL ECOLOGY; ZOSTERA-MARINA; MICROBIOTA; DIET; INVERTEBRATES; PHYLOGENY; TAXONOMY; DEFENSE; GROWTH; LEAVES	After birth, mammals acquire a community of bacteria in their gastro-intestinal tract, which harvests energy and provides nutrients for the host. Comparative studies of numerous terrestrial mammal hosts have identified host phylogeny, diet and gut morphology as primary drivers of the gut bacterial community composition. To date, marine mammals have been excluded from these comparative studies, yet they represent distinct examples of evolutionary history, diet and lifestyle traits. To provide an updated understanding of the gut bacterial community of mammals, we compared bacterial 16S rRNA gene sequence data generated from faecal material of 151 marine and terrestrial mammal hosts. This included 42 hosts from a marine habitat. When compared to terrestrial mammals, marine mammals clustered separately and displayed a significantly greater average relative abundance of the phylum Fusobacteria. The marine carnivores (Antarctic and Arctic seals) and the marine herbivore (dugong) possessed significantly richer gut bacterial community than terrestrial carnivores and terrestrial herbivores, respectively. This suggests that evolutionary history and dietary items specific to the marine environment may have resulted in a gut bacterial community distinct to that identified in terrestrial mammals. Finally we hypothesize that reduced marine trophic webs, whereby marine carnivores (and herbivores) feed directly on lower trophic levels, may expose this group to high levels of secondary metabolites and influence gut microbial community richness.	[Nelson, Tiffanie M.] Univ New S Wales, Sch Biol Earth & Environm Sci, Evolut & Ecol Res Ctr, POB 1, Kensington, NSW 2033, Australia; [Nelson, Tiffanie M.; Rogers, Tracey L.] Australian Inst Marine Sci, Arafura Timor Res Facil, Casuarina, Australia; [Brown, Mark V.] Univ New S Wales, Sch Biotechnol & Biomol Sci, Evolut & Ecol Res Ctr, Kensington, NSW 2033, Australia	University of New South Wales Sydney; Australian Institute of Marine Science; University of New South Wales Sydney	Nelson, TM (corresponding author), Univ New S Wales, Sch Biol Earth & Environm Sci, Evolut & Ecol Res Ctr, POB 1, Kensington, NSW 2033, Australia.	t.nelson@aims.gov.au	Rogers, Tracey L/C-3419-2008; Nelson, Tiffanie/A-9907-2013	Nelson, Tiffanie/0000-0002-5341-312X; Rogers, Tracey/0000-0002-7141-4177	Secretaria de Ciencia y Tecnologia; Direccion Nacional del Antartico (PICTO) [36054]; Australian Research Council; Winifred Scott Foundation; Evolution and Ecology Research Centre, University of New South Wales, Sydney, Australia	Secretaria de Ciencia y Tecnologia(Secretaria de Ciencia y Tecnologia (SECYT)); Direccion Nacional del Antartico (PICTO); Australian Research Council(Australian Research Council); Winifred Scott Foundation; Evolution and Ecology Research Centre, University of New South Wales, Sydney, Australia	Funding for the field support was provided by the Secretaria de Ciencia y Tecnologia and the Direccion Nacional del Antartico (PICTO No. 36054), the Australian Research Council, Winifred Scott Foundation, and the Evolution and Ecology Research Centre, University of New South Wales, Sydney, Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnarsson I, 2010, MOL PHYLOGENET EVOL, V54, P726, DOI 10.1016/j.ympev.2009.10.033; BENNETT KW, 1993, J MED MICROBIOL, V39, P246, DOI 10.1099/00222615-39-4-246; BRAY JR, 1957, ECOL MONOGR, V27, P326, DOI 10.2307/1942268; CHAO A, 1984, SCAND J STAT, V11, P265; Choat JH, 1998, ANNU REV ECOL SYST, V29, P375, DOI 10.1146/annurev.ecolsys.29.1.375; Clarke KR, 2006, PRIMER V 6 USER MANU; COLLINSON ME, 1991, PHILOS T ROY SOC B, V333, P197, DOI 10.1098/rstb.1991.0068; Colwell R.K, 1997, ESTIMATES STAT ESTIM; Davis CS, 2004, MOL PHYLOGENET EVOL, V33, P363, DOI 10.1016/j.ympev.2004.06.006; De Filippo C, 2010, P NATL ACAD SCI USA, V107, P14691, DOI 10.1073/pnas.1005963107; Dethlefsen L, 2008, PLOS BIOL, V6, P2383, DOI 10.1371/journal.pbio.0060280; Engel S, 2002, J CHEM ECOL, V28, P1971, DOI 10.1023/A:1020793726898; Glad T, 2010, MICROB ECOL, V60, P320, DOI 10.1007/s00248-010-9690-x; GUTTMAN L, 1968, PSYCHOMETRIKA, V33, P469, DOI 10.1007/BF02290164; HARRISON PG, 1982, MAR BIOL, V67, P225, DOI 10.1007/BF00401288; HAY ME, 1988, ANNU REV ECOL SYST, V19, P111, DOI 10.1146/annurev.es.19.110188.000551; Heijtza RD, 2011, P NATL ACAD SCI USA, V108, P3047, DOI 10.1073/pnas.1010529108; Hooper LV, 2009, NAT REV MICROBIOL, V7, P367, DOI 10.1038/nrmicro2114; Hooper LV, 2001, SCIENCE, V292, P1115, DOI 10.1126/science.1058709; Kapatral V, 2002, J BACTERIOL, V184, P2005, DOI 10.1128/JB.184.7.2005-2018.2002; Kovacs A, 2011, MICROB ECOL, V61, P423, DOI 10.1007/s00248-010-9787-2; Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725; Lippert H, 2003, POLAR BIOL, V26, P591, DOI 10.1007/s00300-003-0525-9; Lombardo MP, 2008, BEHAV ECOL SOCIOBIOL, V62, P479, DOI 10.1007/s00265-007-0428-9; Marsh H, 1992, J WILDL RES, V9, P55; McClintock JB, 1997, AM ZOOL, V37, P329; Muegge BD, 2011, SCIENCE, V332, P970, DOI 10.1126/science.1198719; Nagaraja TG, 2005, ANAEROBE, V11, P239, DOI 10.1016/j.anaerobe.2005.01.007; Nelson T, 2012, DRYAD DIGIT REPOS; Nelson TM, 2013, ENVIRON MICROBIOL, V15, P1132, DOI 10.1111/1462-2920.12022; Ochman H, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000546; OSTERHAUS ADME, 1988, NATURE, V335, P20, DOI 10.1038/335020a0; Palmer C, 2007, PLOS BIOL, V5, P1556, DOI 10.1371/journal.pbio.0050177; Potrykus J, 2007, PROTEOMICS, V7, P1839, DOI 10.1002/pmic.200600464; PREEN A, 1995, J MAMMAL, V76, P163, DOI 10.2307/1382325; Rawls JF, 2006, CELL, V127, P423, DOI 10.1016/j.cell.2006.08.043; SAVAGE DC, 1977, ANNU REV MICROBIOL, V31, P107, DOI 10.1146/annurev.mi.31.100177.000543; Schreiber A, 1998, EXP CLIN IMMUNOGENET, V15, P154, DOI 10.1159/000019067; Staley J. T., 2005, BERGEYS MANUAL SYSTE, P747; Suau A, 2001, SYST APPL MICROBIOL, V24, P139, DOI 10.1078/0723-2020-00015; Trosvik P, 2010, ISME J, V4, P151, DOI 10.1038/ismej.2009.96; Tsukinowa E, 2008, J GEN APPL MICROBIOL, V54, P25, DOI 10.2323/jgam.54.25; Vergeer LHT, 1997, AQUAT BOT, V58, P65, DOI 10.1016/S0304-3770(96)01115-1; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Yildirim S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013963	45	48	51	2	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e83655	10.1371/journal.pone.0083655	http://dx.doi.org/10.1371/journal.pone.0083655			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386245	Green Published, gold, Green Submitted			2022-12-25	WOS:000329194700055
J	Rai, RK; Barbhuyan, T; Singh, C; Mittal, M; Khan, MP; Sinha, N; Chattopadhyay, N				Rai, Ratan Kumar; Barbhuyan, Tarun; Singh, Chandan; Mittal, Monika; Khan, Mohd Parvez; Sinha, Neeraj; Chattopadhyay, Naibedya			Total Water, Phosphorus Relaxation and Inter-Atomic Organic to Inorganic Interface Are New Determinants of Trabecular Bone Integrity	PLOS ONE			English	Article							SOLID-STATE NMR; NUCLEAR-MAGNETIC-RESONANCE; MECHANICAL-PROPERTIES; COMPUTED-TOMOGRAPHY; CANCELLOUS BONE; SPECTROSCOPY; LACTATION; DEHYDRATION; COLLAGEN; MICE	Bone is the living composite biomaterial having unique structural property. Presently, there is a considerable gap in our understanding of bone structure and composition in the native state, particularly with respect to the trabecular bone, which is metabolically more active than cortical bones, and is readily lost in post-menopausal osteoporosis. We used solid-state nuclear magnetic resonance (NMR) to compare trabecular bone structure and composition in the native state between normal, bone loss and bone restoration conditions in rat. Trabecular osteopenia was induced by lactation as well as prolonged estrogen deficiency (bilateral ovariectomy, Ovx). Ovx rats with established osteopenia were administered with PTH (parathyroid hormone, trabecular restoration group), and restoration was allowed to become comparable to sham Ovx (control) group using bone mineral density (BMD) and mu CT determinants. We used a technique combining H-1 NMR spectroscopy with P-31 and C-13 to measure various NMR parameters described below. Our results revealed that trabecular bones had diminished total water content, inorganic phosphorus NMR relaxation time (T-1) and space between the collagen and inorganic phosphorus in the osteopenic groups compared to control, and these changes were significantly reversed in the bone restoration group. Remarkably, bound water was decreased in both osteopenic and bone restoration groups compared to control. Total water and T-1 correlated strongly with trabecular bone density, volume, thickness, connectivity, spacing and resistance to compression. Bound water did not correlate with any of the microarchitectural and compression parameters. We conclude that total water, T-1 and atomic space between the crystal and organic surface are altered in the trabecular bones of osteopenic rats, and PTH reverses these parameters. Furthermore, from these data, it appears that total water and T-1 could serve as trabecular surrogates of micro-architecture and compression strength.	[Rai, Ratan Kumar; Singh, Chandan; Sinha, Neeraj] Ctr Biomed Res, Lucknow, Uttar Pradesh, India; [Barbhuyan, Tarun; Mittal, Monika; Khan, Mohd Parvez; Chattopadhyay, Naibedya] Cent Drug Res Inst, Div Endocrinol, CSIR, Lucknow, Uttar Pradesh, India; [Barbhuyan, Tarun; Mittal, Monika; Khan, Mohd Parvez; Chattopadhyay, Naibedya] Cent Drug Res Inst, CSIR, Ctr Res Anabol Skeletal Targets Hlth & Illness AS, Lucknow 226001, Uttar Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI)	Sinha, N (corresponding author), Ctr Biomed Res, SGPGIMS Campus, Lucknow, Uttar Pradesh, India.	neeraj.sinha@cbmr.res.in; n_chattopadhyay@cdri.res.in	Chattopadhyay, Naibedya/AAF-2058-2019; Chattopadhyay, Naibedya/AAQ-3213-2021; Rai, Ratan K/N-6344-2018; Rai, Ratan/L-9787-2019	Chattopadhyay, Naibedya/0000-0003-2473-0246; Rai, Ratan K/0000-0001-6015-5539; Rai, Ratan/0000-0001-6015-5539; Sinha, Neeraj/0000-0003-3235-6127; Mittal, Monika/0000-0002-3328-7787; Singh, Dr. Chandan/0000-0001-8006-1329	Council of Scientific and Industrial Research, Government of India [BSC0201]; University Grants Commission, Government of India; Indian Council of Medical Research, Government of India; Department of Biotechnology, Government of India [BT/PR12700/BRB/10/719/2009]	Council of Scientific and Industrial Research, Government of India(Council of Scientific & Industrial Research (CSIR) - India); University Grants Commission, Government of India(University Grants Commission, India); Indian Council of Medical Research, Government of India(Indian Council of Medical Research (ICMR)); Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	This study was supported by the Council of Scientific and Industrial Research (BSC0201, ASTHI), Government of India. Fellowship grants from the Council of Scientific and Industrial Research (RKR, TB, CS), University Grants Commission (MM), Indian Council of Medical Research (MPK), Department of Biotechnology (BT/PR12700/BRB/10/719/2009), Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ardeshirpour L, 2007, ENDOCRINOLOGY, V148, P3875, DOI 10.1210/en.2006-1467; BAUD CA, 1978, CLIN ORTHOP RELAT R, P270; BELANGER LF, 1969, CALC TISS RES, V4, P1, DOI 10.1007/BF02279101; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Cho GY, 2003, SCIENCE, V300, P1123, DOI 10.1126/science.1078470; Clarke B, 2008, CLIN J AM SOC NEPHRO, V3, pS131, DOI 10.2215/CJN.04151206; Compston J, 2011, J OSTEOPOROSIS, V2011, P4; Fernandez-Seara MA, 2004, J BONE MINER RES, V19, P289, DOI 10.1359/JBMR.0301227; GULLION T, 1989, J MAGN RESON, V81, P196, DOI 10.1016/0022-2364(89)90280-1; Iida-Klein A, 2007, BONE, V40, P391, DOI 10.1016/j.bone.2006.09.010; Jerome CP, 2001, BONE, V28, P150, DOI 10.1016/S8756-3282(00)00430-0; Kaflak A, 2007, SOLID STATE NUCL MAG, V31, P174, DOI 10.1016/j.ssnmr.2007.04.005; Kalkwarf HJ, 1999, J MAMMARY GLAND BIOL, V4, P319, DOI 10.1023/A:1018780425600; Khan K, 2013, OSTEOPOROSIS INT, V24, P1455, DOI 10.1007/s00198-012-2121-8; Kovacs CS, 1997, ENDOCR REV, V18, P832, DOI 10.1210/er.18.6.832; Maes C, 2002, MECH DEVELOP, V111, P61, DOI 10.1016/S0925-4773(01)00601-3; MEIER DE, 1984, ANN INTERN MED, V101, P605, DOI 10.7326/0003-4819-101-5-605; Mroue KH, 2012, J PHYS CHEM B, V116, P11656, DOI 10.1021/jp307935g; Nikel O, 2012, J PHYS CHEM C, V116, P6320, DOI 10.1021/jp2125312; Nyman JS, 2008, BONE, V42, P193, DOI 10.1016/j.bone.2007.09.049; ODGAARD A, 1993, BONE, V14, P173, DOI 10.1016/8756-3282(93)90245-6; Portal-Nunez S, 2012, HISTOL HISTOPATHOL, V27, P559, DOI 10.14670/HH-27.559; Qing H, 2012, J BONE MINER RES, V27, P1018, DOI 10.1002/jbmr.1567; Raggatt LJ, 2010, J BIOL CHEM, V285, P25103, DOI 10.1074/jbc.R109.041087; Rai RK, 2011, J PHYS CHEM C, V115, P14219, DOI 10.1021/jp2025768; Recker RR, 2009, BONE, V44, P113, DOI 10.1016/j.bone.2008.09.019; Reichert D, 2004, MAGN RESON CHEM, V42, P276, DOI 10.1002/mrc.1334; ROBINSON RA, 1975, CLIN ORTHOP RELAT R, P263; SAITO H, 1992, J BIOCHEM-TOKYO, V111, P376, DOI 10.1093/oxfordjournals.jbchem.a123765; Sharan K, 2011, J BONE MINER RES, V26, P2096, DOI 10.1002/jbmr.434; Sharan K, 2010, MENOPAUSE, V17, P577, DOI [10.1097/gme.0b013e3181bfae38, 10.1097/gme.0b013e3181d2ce7f]; Siddiqui JA, 2011, MENOPAUSE, V18, P198, DOI 10.1097/gme.0b013e3181e84e67; Singh C, 2013, SOLID STATE NUCL MAG, V54, P18, DOI 10.1016/j.ssnmr.2013.05.003; Srivastava K, 2013, EVID-BASED COMPL ALT, V2013, P12; Takata Shinjiro, 2004, J Med Invest, V51, P133, DOI 10.2152/jmi.51.133; Trivedi R, 2009, MOL CELL ENDOCRINOL, V302, P86, DOI 10.1016/j.mce.2009.01.011; Tyagi AM, 2012, MENOPAUSE, V19, P856, DOI 10.1097/gme.0b013e31824f9306; Vinogradov E, 1999, CHEM PHYS LETT, V314, P443, DOI 10.1016/S0009-2614(99)01174-4; Wehrli FW, 2005, ANN BIOMED ENG, V33, P79, DOI 10.1007/s10439-005-8965-8; Weiner S, 1998, ANNU REV MATER SCI, V28, P271, DOI 10.1146/annurev.matsci.28.1.271; Wilson EE, 2006, BIOPHYS J, V90, P3722, DOI 10.1529/biophysj.105.070243; Wilson EE, 2005, J BONE MINER RES, V20, P625, DOI 10.1359/JBMR.041217; Xu JD, 2011, J PHYS CHEM B, V115, P9948, DOI 10.1021/jp205663z; Zhang G, 2005, CLIN BIOMECH, V20, P729, DOI 10.1016/j.clinbiomech.2005.03.016; Zhang QB, 2009, RADIAT RES, V172, P607, DOI 10.1667/RR1715.1; Zhu PZ, 2009, J AM CHEM SOC, V131, P17064, DOI 10.1021/ja9081028	46	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e83478	10.1371/journal.pone.0083478	http://dx.doi.org/10.1371/journal.pone.0083478			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386209	gold, Green Published, Green Submitted			2022-12-25	WOS:000329194700043
J	Srisen, K; Rohrl, C; Meisslitzer-Ruppitsch, C; Ranftler, C; Ellinger, A; Pavelka, M; Neumuller, J				Srisen, Kaemisa; Roehrl, Clemens; Meisslitzer-Ruppitsch, Claudia; Ranftler, Carmen; Ellinger, Adolf; Pavelka, Margit; Neumueller, Josef			Human Endothelial Progenitor Cells Internalize High-Density Lipoprotein	PLOS ONE			English	Article							SMOOTH-MUSCLE CELLS; RECEPTOR SR-BI; MEDIATED ENDOCYTOSIS; CHOLESTEROL; EFFLUX; TRANSPORT; BINDING; VISUALIZATION; TRANSCYTOSIS; METABOLISM	Endothelial progenitor cells (EPCs) originate either directly from hematopoietic stem cells or from a subpopulation of monocytes. Controversial views about intracellular lipid traffic prompted us to analyze the uptake of human high density lipoprotein (HDL), and HDL-cholesterol in human monocytic EPCs. Fluorescence and electron microscopy were used to investigate distribution and intracellular trafficking of HDL and its associated cholesterol using fluorescent surrogates (bodipy-cholesterol and bodipy-cholesteryl oleate), cytochemical labels and fluorochromes including horseradish peroxidase and Alexa Fluor (R) 568. Uptake and intracellular transport of HDL were demonstrated after internalization periods from 0.5 to 4 hours. In case of HDL-Alexa Fluor (R) 568, bodipy-cholesterol and bodipy-cholesteryl oleate, a photooxidation method was carried out. HDL-specific reaction products were present in invaginations of the plasma membrane at each time of treatment within endocytic vesicles, in multivesicular bodies and at longer periods of uptake, also in lysosomes. Some HDL-positive endosomes were arranged in form of "strings of pearl"-like structures. HDL-positive multivesicular bodies exhibited intensive staining of limiting and vesicular membranes. Multivesicular bodies of HDL-Alexa Fluor (R) 568-treated EPCs showed multilamellar intra-vacuolar membranes. At all periods of treatment, labeled endocytic vesicles and organelles were apparent close to the cell surface and in perinuclear areas around the Golgi apparatus. No HDL-related particles could be demonstrated close to its cisterns. Electron tomographic reconstructions showed an accumulation of HDL-containing endosomes close to the trans-Golgi-network. HDL-derived bodipy-cholesterol was localized in endosomal vesicles, multivesicular bodies, lysosomes and in many of the stacked Golgi cisternae and the trans-Golgi-network Internalized HDL-derived bodipy-cholesteryl oleate was channeled into the lysosomal intraellular pathway and accumulated prominently in all parts of the Golgi apparatus and in lipid droplets. Subsequently, also the RER and mitochondria were involved. These studies demonstrated the different intracellular pathway of HDL-derived bodipy-cholesterol and HDL-derived bodipy-cholesteryl oleate by EPCs, with concomitant.	[Srisen, Kaemisa; Meisslitzer-Ruppitsch, Claudia; Ranftler, Carmen; Ellinger, Adolf; Pavelka, Margit; Neumueller, Josef] Med Univ Vienna, Ctr Anat & Cell Biol, Dept Cell Biol & Ultrastruct Res, Vienna, Austria; [Roehrl, Clemens] Med Univ Vienna, Inst Med Chem, Ctr Pathobiochem & Genet, Vienna, Austria	Medical University of Vienna; Medical University of Vienna	Neumuller, J (corresponding author), Med Univ Vienna, Ctr Anat & Cell Biol, Dept Cell Biol & Ultrastruct Res, Vienna, Austria.	josef.neumueller@meduniwien.ac.at		Rohrl, Clemens/0000-0002-1192-0748	Austrian Science Fund (FWF) [P22838]; Thailand Government	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Thailand Government	This project is supported by the Austrian Science Fund (FWF) grant P22838 and Thailand Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Babitt J, 1997, J BIOL CHEM, V272, P13242, DOI 10.1074/jbc.272.20.13242; Balazs Z, 2004, J NEUROCHEM, V89, P939, DOI 10.1111/j.1471-4159.2004.02373.x; Baumgart T, 2007, P NATL ACAD SCI USA, V104, P3165, DOI 10.1073/pnas.0611357104; Chao WT, 2002, HISTOCHEM J, V34, P233, DOI 10.1023/A:1021789429893; DANIELS RJ, 1981, J BIOL CHEM, V256, P4978; DELAMATRE JG, 1990, J LIPID RES, V31, P191; FIELDING PE, 1995, BIOCHEMISTRY-US, V34, P14288, DOI 10.1021/bi00044a004; GOLDSTEIN JL, 1985, ANNU REV CELL BIOL, V1, P1, DOI 10.1146/annurev.cb.01.110185.000245; Gonzalez-Pecchi V, 2002, J CELL SCI THER, V3, P8; GORDON T, 1977, AM J MED, V62, P707, DOI 10.1016/0002-9343(77)90874-9; Hill JM, 2003, NEW ENGL J MED, V348, P593, DOI 10.1056/NEJMoa022287; Holtta-Vuori M, 2008, TRAFFIC, V9, P1839, DOI 10.1111/j.1600-0854.2008.00801.x; INNERARITY TL, 1982, ARTERIOSCLEROSIS, V2, P114, DOI 10.1161/01.ATV.2.2.114; Ishida T, 2004, CELL TISSUE RES, V318, P533, DOI 10.1007/s00441-004-0962-y; JOHNSON WJ, 1990, J BIOL CHEM, V265, P5546; KAMBOURIS AM, 1990, ARTERIOSCLEROSIS, V10, P582, DOI 10.1161/01.ATV.10.4.582; Kuzmenko ES, 2004, INT J BIOCHEM CELL B, V36, P519, DOI 10.1016/j.biocel.2003.09.010; Li D, 2010, ARTERIOSCL THROM VAS, V30, P1354, DOI 10.1161/ATVBAHA.110.204230; Li ZG, 2006, J ORG CHEM, V71, P1718, DOI 10.1021/jo052029x; Meisslitzer-Ruppitsch C, HISTOCHEM CELL BIOL, V135, P159; Meisslitzer-Ruppitsch C, 2008, HISTOCHEM CELL BIOL, V130, P407, DOI 10.1007/s00418-008-0429-4; Noor R, 2007, ATHEROSCLEROSIS, V192, P92, DOI 10.1016/j.atherosclerosis.2006.06.023; O'Connell BJ, 2004, CIRCULATION, V110, P2881, DOI 10.1161/01.CIR.0000146333.20727.2B; Pagler TA, 2006, J BIOL CHEM, V281, P38159, DOI 10.1074/jbc.M603334200; PALADE GE, 1952, J EXP MED, V95, P285, DOI 10.1084/jem.95.3.285; Phillips MC, 1998, ATHEROSCLEROSIS, V137, pS13, DOI 10.1016/S0021-9150(97)00312-2; RAJAN VP, 1987, BIOCHIM BIOPHYS ACTA, V921, P25, DOI 10.1016/0005-2760(87)90166-4; Reaven E, 1996, J BIOL CHEM, V271, P16208, DOI 10.1074/jbc.271.27.16208; Rigotti A, 2003, ENDOCR REV, V24, P357, DOI 10.1210/er.2001-0037; Rohrl C, 2012, CURR PHARM BIOTECHNO, V13, P331, DOI 10.2174/138920112799095338; Rohrl C, 2010, HISTOCHEM CELL BIOL, V133, P261, DOI 10.1007/s00418-009-0672-3; ROGLER G, 1992, GASTROENTEROLOGY, V103, P469, DOI 10.1016/0016-5085(92)90836-N; Rohrer L, 2006, BBA-MOL CELL BIOL L, V1761, P186, DOI 10.1016/j.bbalip.2006.01.009; Rohrer L, 2009, CIRC RES, V104, P1142, DOI 10.1161/CIRCRESAHA.108.190587; Rosengren BI, 2002, J VASC RES, V39, P230, DOI 10.1159/000063688; RUTLEDGE JC, 1995, AM J PHYSIOL-HEART C, V268, pH1982, DOI 10.1152/ajpheart.1995.268.5.H1982; Schmid SL, 1997, ANNU REV BIOCHEM, V66, P511, DOI 10.1146/annurev.biochem.66.1.511; SCHUMAKER VN, 1986, METHOD ENZYMOL, V128, P155; SLOTTE JP, 1987, J BIOL CHEM, V262, P12904; Stein O, 1999, ATHEROSCLEROSIS, V144, P285, DOI 10.1016/S0021-9150(99)00065-9; Tarling EJ, 2011, P NATL ACAD SCI USA, V108, P19719, DOI 10.1073/pnas.1113021108; Tso C, 2006, ARTERIOSCL THROM VAS, V26, P1144, DOI 10.1161/01.ATV.0000216600.37436.cf; Vantourout P, 2010, WORLD J GASTROENTERO, V16, P5925, DOI 10.3748/wjg.v16.i47.5925; VASILE E, 1983, J CELL BIOL, V96, P1677, DOI 10.1083/jcb.96.6.1677; Wadsack C, 2003, PLACENTA, V24, P131, DOI 10.1053/plac.2002.0912; Yeh YC, 2002, ATHEROSCLEROSIS, V161, P95, DOI 10.1016/S0021-9150(01)00642-6	47	3	3	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e83189	10.1371/journal.pone.0083189	http://dx.doi.org/10.1371/journal.pone.0083189			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386159	Green Published, gold, Green Submitted			2022-12-25	WOS:000329194700027
J	Lieberman-Lazarovich, M; Melamed-Bessudo, C; de Pater, S; Levy, AA				Lieberman-Lazarovich, Michal; Melamed-Bessudo, Cathy; de Pater, Sylvia; Levy, Avraham A.			Epigenetic Alterations at Genomic Loci Modified by Gene Targeting in Arabidopsis thaliana	PLOS ONE			English	Article							DNA METHYLATION; HOMOLOGOUS RECOMBINATION; RNA; MUTAGENESIS; EFFICIENT; STRAND; MODEL; MULTIPLEX; REVEALS; CELLS	Gene Targeting (GT) is the integration of an introduced vector into a specific chromosomal site, via homologous recombination. It is considered an effective tool for precise genome editing, with far-reaching implications in biological research and biotechnology, and is widely used in mice, with the potential of becoming routine in many species. Nevertheless, the epigenetic status of the targeted allele remains largely unexplored. Using GT-modified lines of the model plant Arabidopsis thaliana, we show that the DNA methylation profile of the targeted locus is changed following GT. This effect is non-directional as methylation can be either completely lost, maintained with minor alterations or show instability in the generations subsequent to GT. As DNA methylation is known to be involved in several cellular processes, GT-related alterations may result in unexpected or even unnoticed perturbations. Our analysis shows that GT may be used as a new tool for generating epialleles, for example, to study the role of gene body methylation. In addition, the analysis of DNA methylation at the targeted locus may be utilized to investigate the mechanism of GT, many aspects of which are still unknown.	[Lieberman-Lazarovich, Michal] Univ Geneva, Dept Plant Biol, Geneva, Switzerland; [Lieberman-Lazarovich, Michal; Melamed-Bessudo, Cathy; Levy, Avraham A.] Weizmann Inst Sci, Dept Plant Sci, IL-76100 Rehovot, Israel; [de Pater, Sylvia] Leiden Univ, Dept Mol & Dev Genet, Inst Biol, Leiden, Netherlands	University of Geneva; Weizmann Institute of Science; Leiden University; Leiden University - Excl LUMC	Lieberman-Lazarovich, M (corresponding author), Univ Geneva, Dept Plant Biol, Geneva, Switzerland.	michal.lieberman@unige.ch			European Union [LSHG-CT-2005-018785, KBBE-2008-227190]	European Union(European Commission)	This work was supported by the European Union FP6 TAGIP (LSHG-CT-2005-018785) and FP7 RECBREED (KBBE-2008-227190) grants (URL: http://cordis.europa.eu/home_en.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker C, 2011, NATURE, V480, P245, DOI 10.1038/nature10555; Bogue CW, 2003, J APPL PHYSIOL, V94, P2502, DOI 10.1152/japplphysiol.00209.2003; Capecchi MR, 2005, NAT REV GENET, V6, P507, DOI 10.1038/nrg1619; Carroll D, 2013, NAT BIOTECHNOL, V31, P807, DOI 10.1038/nbt.2684; Carroll D, 2011, GENETICS, V188, P773, DOI 10.1534/genetics.111.131433; Chang NN, 2013, CELL RES, V23, P465, DOI 10.1038/cr.2013.45; Chodavarapu RK, 2010, NATURE, V466, P388, DOI 10.1038/nature09147; Cokus SJ, 2008, NATURE, V452, P215, DOI 10.1038/nature06745; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cubas P, 1999, NATURE, V401, P157, DOI 10.1038/43657; de Pater S, 2013, PLANT BIOTECHNOL J, V11, P510, DOI 10.1111/pbi.12040; Deleris A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003062; Dowen RH, 2012, P NATL ACAD SCI USA, V109, pE2183, DOI 10.1073/pnas.1209329109; Even-Faitelson L, 2011, PLANT J, V68, P929, DOI 10.1111/j.1365-313X.2011.04741.x; FROMMER M, 1992, P NATL ACAD SCI USA, V89, P1827, DOI 10.1073/pnas.89.5.1827; Gruntman E, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-371; Hanin M, 2003, CURR OPIN PLANT BIOL, V6, P157, DOI 10.1016/S1369-5266(03)00016-5; Hanin M, 2001, PLANT J, V28, P671, DOI 10.1046/j.1365-313x.2001.01183.x; Hesson LB, 2010, CURR OPIN GENET DEV, V20, P290, DOI 10.1016/j.gde.2010.02.005; Hicks WM, 2010, SCIENCE, V329, P82, DOI 10.1126/science.1191125; Ho CK, 2010, MOL CELL, V40, P988, DOI 10.1016/j.molcel.2010.11.016; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Jiang WY, 2013, NAT BIOTECHNOL, V31, P233, DOI 10.1038/nbt.2508; Jiang WZ, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt780; Kilian O, 2011, P NATL ACAD SCI USA, V108, P21265, DOI 10.1073/pnas.1105861108; Kinoshita Y, 2007, PLANT J, V49, P38, DOI 10.1111/j.1365-313X.2006.02936.x; Leung WY, 1997, P NATL ACAD SCI USA, V94, P6851, DOI 10.1073/pnas.94.13.6851; Li HJ, 2011, NATURE, V475, P217, DOI 10.1038/nature10177; Li JF, 2013, NAT BIOTECHNOL, V31, P688, DOI 10.1038/nbt.2654; Lienert F, 2011, NAT GENET, V43, P1091, DOI 10.1038/ng.946; Lister R, 2008, CELL, V133, P523, DOI 10.1016/j.cell.2008.03.029; Liu JY, 2012, J GENET GENOMICS, V39, P209, DOI 10.1016/j.jgg.2012.04.003; Mak TW, 2007, CELL, V131, P1027, DOI 10.1016/j.cell.2007.11.033; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Melamed-Bessudo C, 2012, P NATL ACAD SCI USA, V109, pE981, DOI 10.1073/pnas.1120742109; Miao J, 2013, CELL RES, V23, P1233, DOI 10.1038/cr.2013.123; Mirouze M, 2012, P NATL ACAD SCI USA, V109, P5880, DOI 10.1073/pnas.1120841109; Nekrasov V, 2013, NAT BIOTECHNOL, V31, P691, DOI 10.1038/nbt.2655; PUCHTA H, 1993, NUCLEIC ACIDS RES, V21, P5034, DOI 10.1093/nar/21.22.5034; Rhee I, 2002, NATURE, V416, P552, DOI 10.1038/416552a; Rigal M, 2012, EMBO J, V31, P2981, DOI 10.1038/emboj.2012.141; Ripoche MA, 1997, GENE DEV, V11, P1596, DOI 10.1101/gad.11.12.1596; ROTHSTEIN R, 1991, METHOD ENZYMOL, V194, P281; Schmitz RJ, 2013, NATURE, V495, P193, DOI 10.1038/nature11968; Shaked H, 2005, P NATL ACAD SCI USA, V102, P12265, DOI 10.1073/pnas.0502601102; Shan QW, 2013, NAT BIOTECHNOL, V31, P686, DOI 10.1038/nbt.2650; Shukla VK, 2009, NATURE, V459, P437, DOI 10.1038/nature07992; Soppe WJJ, 2002, EMBO J, V21, P6549, DOI 10.1093/emboj/cdf657; SZOSTAK JW, 1983, CELL, V33, P25, DOI 10.1016/0092-8674(83)90331-8; Townsend JA, 2009, NATURE, V459, P442, DOI 10.1038/nature07845; Tsai TF, 2003, GENESIS, V37, P151, DOI 10.1002/gene.10237; Wienholz BL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001106; Yelina NE, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002844; Zhang Y, 2013, PLANT PHYSIOL, V161, P20, DOI 10.1104/pp.112.205179; Zilberman D, 2007, NAT GENET, V39, P61, DOI 10.1038/ng1929	55	7	7	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e85383	10.1371/journal.pone.0085383	http://dx.doi.org/10.1371/journal.pone.0085383			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281QS	24386472	Green Published, gold, Green Submitted			2022-12-25	WOS:000329116700137
J	Nanni, L; Brahnam, S; Ghidoni, S; Menegatti, E; Barrier, T				Nanni, Loris; Brahnam, Sheryl; Ghidoni, Stefano; Menegatti, Emanuele; Barrier, Tonya			Different Approaches for Extracting Information from the Co-Occurrence Matrix	PLOS ONE			English	Article							TEXTURE DESCRIPTORS; IMAGE; CLASSIFICATION; FEATURES; SEGMENTATION; RECOGNITION; MULTIPLE; SCALE	In 1979 Haralick famously introduced a method for analyzing the texture of an image: a set of statistics extracted from the co-occurrence matrix. In this paper we investigate novel sets of texture descriptors extracted from the co-occurrence matrix; in addition, we compare and combine different strategies for extending these descriptors. The following approaches are compared: the standard approach proposed by Haralick, two methods that consider the co-occurrence matrix as a three-dimensional shape, a gray-level run-length set of features and the direct use of the co-occurrence matrix projected onto a lower dimensional subspace by principal component analysis. Texture descriptors are extracted from the co-occurrence matrix evaluated at multiple scales. Moreover, the descriptors are extracted not only from the entire co-occurrence matrix but also from subwindows. The resulting texture descriptors are used to train a support vector machine and ensembles. Results show that our novel extraction methods improve the performance of standard methods. We validate our approach across six medical datasets representing different image classification problems using the Wilcoxon signed rank test. The source code used for the approaches tested in this paper will be available at: http://www.dei.unipd.it/wdyn/?IDsezione = 3314&IDgruppo_pass = 124&preview=.	[Nanni, Loris; Ghidoni, Stefano; Menegatti, Emanuele] Univ Padua, Dept Informat Engn, Padua, Italy; [Brahnam, Sheryl; Barrier, Tonya] Missouri State Univ, Dept Comp Informat Syst, Springfield, MO 65897 USA	University of Padua; Missouri State University	Brahnam, S (corresponding author), Missouri State Univ, Dept Comp Informat Syst, Springfield, MO 65897 USA.	sbrahnam@facescience.org	Ghidoni, Stefano/AAC-4100-2022	Menegatti, Emanuele/0000-0001-5794-9979				Akono A., 2005, TELEDETECTION, V5, P227; Ameling S., 2009, BILDVERARBEITUNG MED, P346, DOI DOI 10.1007/978-3-540-93860-6_70; [Anonymous], 2013, INT C BIOIN COMP BIO; Bay H, 2006, LECT NOTES COMPUT SC, V3951, P404, DOI 10.1007/11744023_32; Benco M, 2007, RADIOENGINEERING, V16, P64; Boland MV, 1998, CYTOMETRY, V33, P366; Braz G, 2009, COMPUT BIOL MED, V39, P1063, DOI 10.1016/j.compbiomed.2009.08.009; Chen S, 2009, 2009 IEEE INTERNATIONAL CONFERENCE ON INTELLIGENT COMPUTING AND INTELLIGENT SYSTEMS, PROCEEDINGS, VOL 4, P482, DOI 10.1109/ICICISYS.2009.5357627; Coggins J.M., 1982, THESIS; Cruz-Roa A, 2011, ARTIF INTELL MED, V52, P91, DOI 10.1016/j.artmed.2011.04.010; Dalal N, 2005, 9 EUR C COMP VIS SAN; Demsar J, 2006, J MACH LEARN RES, V7, P1; Dominio F, 2013, PATTERN REC IN PRESS; Eaton C., 2012, UNDERSTANDING BIG DA; Fawcett T., 2004, ROC GRAPHS NOTES PRA; FREEMAN WT, 1991, IEEE T PATTERN ANAL, V13, P891, DOI 10.1109/34.93808; Gelzinis A, 2007, PATTERN RECOGN, V40, P2367, DOI 10.1016/j.patcog.2006.12.004; Ghidoni S, 2012, INT C INT AUT SYST I; Gong R, 2012, OPT COMMUN, V285, P4961, DOI 10.1016/j.optcom.2012.07.121; Hamilton NA, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-94; HARALICK RM, 1979, P IEEE, V67, P786, DOI 10.1109/PROC.1979.11328; HARALICK RM, 1973, IEEE T SYST MAN CYB, VSMC3, P610, DOI 10.1109/TSMC.1973.4309314; Hoang ND, 2010, 2010 THIRD INTERNATIONAL CONFERENCE ON COMMUNICATIONS AND ELECTRONICS (ICCE), P169, DOI 10.1109/ICCE.2010.5670704; Hu Y., 2009, P IEEE IND APPL SOC, P1, DOI DOI 10.1109/IAS.2009.5324874; Huang J, 1997, PROC CVPR IEEE, P762, DOI 10.1109/CVPR.1997.609412; JAIN AK, 1991, PATTERN RECOGN, V24, P1167, DOI 10.1016/0031-3203(91)90143-S; Jantzen J., 2005, P NISIS, P1; Karkanis SA, 2003, IEEE T INF TECHNOL B, V7, P141, DOI 10.1109/TITB.2003.813794; Kuncheva LI, 2003, MACH LEARN, V51, P181, DOI 10.1023/A:1022859003006; Kylberg G, 2011, LECT NOTES COMPUT SC, V7042, P573, DOI 10.1007/978-3-642-25085-9_68; Lowe DG, 2004, INT J COMPUT VISION, V60, P91, DOI 10.1023/B:VISI.0000029664.99615.94; Mikolajczyk K, 2005, IEEE T PATTERN ANAL, V27, P1615, DOI 10.1109/TPAMI.2005.188; Mitrea D, 2012, COMPUT MATH METHOD M, V2012, DOI 10.1155/2012/348135; Murphy RF, 2006, NAT BIOTECHNOL, V24, P1223, DOI 10.1038/nbt1006-1223; Nanni L, 2013, COMPUTER CO IN PRESS; Nanni L, 2008, ARTIF INTELL MED, V43, P87, DOI 10.1016/j.artmed.2008.03.005; Nanni L, 2010, J THEOR BIOL, V264, P1024, DOI 10.1016/j.jtbi.2010.03.020; Ojala T, 1996, PATTERN RECOGN, V29, P51, DOI 10.1016/0031-3203(95)00067-4; Ojala T, 2002, IEEE T PATTERN ANAL, V24, P971, DOI 10.1109/TPAMI.2002.1017623; Oliver A, 2007, LECT NOTES COMPUT SC, V4791, P286; Paci M, 2013, CURR BIOINFORM, V8, P208, DOI 10.2174/1574893611308020009; Pacifici F., 2008, 2008 IEEE International Geoscience and Remote Sensing Symposium, IGARSS 2008, P342, DOI 10.1109/IGARSS.2008.4780098; Pass G, 1996, P ACM INT C MULT, P65, DOI DOI 10.1145/244130.244148; Qian XM, 2011, PATTERN RECOGN, V44, P2502, DOI 10.1016/j.patcog.2011.03.029; Rakwatin P, 2010, INT GEOSCI REMOTE SE, P1234, DOI 10.1109/IGARSS.2010.5651347; Ren XM, 2012, LECT NOTES ARTIF INT, V7390, P237, DOI 10.1007/978-3-642-31576-3_31; Samant A, 2000, COMPUT-AIDED CIV INF, V15, P241, DOI 10.1111/0885-9507.00188; Sastry S. S., 2012, ADV CONDENSED MATTER, V2012, P1; Shen L, 2007, IMAGE VISION COMPUT, V25, P553, DOI 10.1016/j.imavis.2006.05.002; SKLANSKY J, 1978, IEEE T SYST MAN CYB, V8, P237, DOI 10.1109/TSMC.1978.4309944; Sun X, 2012, IEEE WORLD C COMP IN; SWAIN MJ, 1991, INT J COMPUT VISION, V7, P11, DOI 10.1007/BF00130487; Tan XY, 2007, LECT NOTES COMPUT SC, V4778, P168; Tang XO, 1998, IEEE T IMAGE PROCESS, V7, P1602, DOI 10.1109/83.725367; Tuzel O, 2006, LECT NOTES COMPUT SC, V3952, P589; Unay D, 2008, I S BIOMED IMAGING, P241, DOI 10.1109/ISBI.2008.4540977; Vapnik V., 1964, AUTOMATION REMOTE CO, V25; Vapnik V., 1963, AUTOM REMOTE, V24, P774; Vecsei A, 2011, COMPUT BIOL MED, V41, P313, DOI 10.1016/j.compbiomed.2011.03.009; Walker RF, 2003, INT J PATTERN RECOGN, V17, P17, DOI 10.1142/S0218001403002228; Wolpert DH, 2002, SOFT COMPUTING AND INDUSTRY, P25; Wu B, 2005, IEEE I CONF COMP VIS, P90; Zhang R, 2010, IEEE IMAGE PROC, P1073, DOI 10.1109/ICIP.2010.5651261; Zucker SW., 1976, COMPUTER GRAPHICS IM, V5, P190, DOI [10.1016/0146-664X(76)90027-7, DOI 10.1016/0146-664X(76)90027-7]	64	63	64	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e83554	10.1371/journal.pone.0083554	http://dx.doi.org/10.1371/journal.pone.0083554			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281QS	24386228	Green Submitted, gold, Green Published			2022-12-25	WOS:000329116700059
J	Figueiredo, J; Simoes, MJ; Gomes, P; Barroso, C; Pinho, D; Conceicao, L; Fonseca, L; Abrantes, I; Pinheiro, M; Egas, C				Figueiredo, Joana; Simoes, Maria Jose; Gomes, Paula; Barroso, Cristina; Pinho, Diogo; Conceicao, Luci; Fonseca, Luis; Abrantes, Isabel; Pinheiro, Miguel; Egas, Conceicao			Assessment of the Geographic Origins of Pinewood Nematode Isolates via Single Nucleotide Polymorphism in Effector Genes	PLOS ONE			English	Article							BURSAPHELENCHUS-XYLOPHILUS NEMATODA; ROOT-LESION NEMATODE; WOOD NEMATODE; WILT DISEASE; TRANSCRIPTOME ANALYSIS; SPREAD ROUTES; SNP DISCOVERY; APHELENCHOIDIDAE; EVOLUTION; IDENTIFICATION	The pinewood nematode, Bursaphelenchus xylophilus, is native to North America but it only causes damaging pine wilt disease in those regions of the world where it has been introduced. The accurate detection of the species and its dispersal routes are thus essential to define effective control measures. The main goals of this study were to analyse the genetic diversity among B. xylophilus isolates from different geographic locations and identify single nucleotide polymorphism (SNPs) markers for geographic origin, through a comparative transcriptomic approach. The transcriptomes of seven B. xylophilus isolates, from Continental Portugal (4), China (1), Japan (1) and USA (1), were sequenced in the next generation platform Roche 454. Analysis of effector gene transcripts revealed inter-isolate nucleotide diversity that was validated by Sanger sequencing in the genomic DNA of the seven isolates and eight additional isolates from different geographic locations: Madeira Island (2), China (1), USA (1), Japan (2) and South Korea (2). The analysis identified 136 polymorphic positions in 10 effector transcripts. Pairwise comparison of the 136 SNPs through Neighbor-Joining and the Maximum Likelihood methods and 5-mer frequency analysis with the alignment-independent bilinear multivariate modelling approach correlated the SNPs with the isolates geographic origin. Furthermore, the SNP analysis indicated a closer proximity of the Portuguese isolates to the Korean and Chinese isolates than to the Japanese or American isolates. Each geographic cluster carried exclusive alleles that can be used as SNP markers for B. xylophilus isolate identification.	[Figueiredo, Joana] Univ Coimbra, Dept Life Sci, Coimbra, Portugal; [Simoes, Maria Jose; Gomes, Paula; Barroso, Cristina; Pinho, Diogo; Pinheiro, Miguel; Egas, Conceicao] Genoinseq, Next Generat Sequencing Unit, Biocant, Cantanhede, Portugal; [Conceicao, Luci; Fonseca, Luis; Abrantes, Isabel] Univ Coimbra, Dept Life Sci, IMAR CMA, Coimbra, Portugal	Universidade de Coimbra; Universidade de Coimbra	Egas, C (corresponding author), Genoinseq, Next Generat Sequencing Unit, Biocant, Cantanhede, Portugal.	cegas@biocant.pt	Conceição, I L/AAC-8173-2020; Simoes, Manuel J/H-2642-2014; Abrantes, Isabel/CAG-1426-2022; Egas, Conceição/K-4866-2014; Pinho, Diogo/ABG-5993-2021; Pinheiro, Miguel/K-4467-2017	Conceição, I L/0000-0002-3017-0639; Simoes, Manuel J/0000-0003-2770-8618; Abrantes, Isabel/0000-0002-8761-2151; Egas, Conceição/0000-0002-2307-5414; Pinho, Diogo/0000-0002-0377-2802; Barroso, Cristina/0000-0001-5476-0986; Pinheiro, Miguel/0000-0002-6601-7513; Figueiredo, Joana/0000-0002-1995-1231; Fonseca, Luis/0000-0001-7405-8916; Pinto Simoes, Maria Jose/0000-0001-9810-1683	FEDER funds through Programa Operacional Factores de Competitividade (COMPETE); Portuguese Foundation for Science and Technology, FCT [PTDC/AGR-CFL/098916/2008, FCOMP-01-0124-FEDER-008794]; Direccao Regional de Florestas, Fundo Florestal Permanente and Autoridade Florestal Nacional	FEDER funds through Programa Operacional Factores de Competitividade (COMPETE); Portuguese Foundation for Science and Technology, FCT(Portuguese Foundation for Science and Technology); Direccao Regional de Florestas, Fundo Florestal Permanente and Autoridade Florestal Nacional	The study was funded from FEDER funds through the Programa Operacional Factores de Competitividade (COMPETE) and by national funds through the Portuguese Foundation for Science and Technology, FCT project PTDC/AGR-CFL/098916/2008, FCOMP-01-0124-FEDER-008794 (www.fct.pt), and from Direccao Regional de Florestas, Fundo Florestal Permanente and Autoridade Florestal Nacional, through a national project "O nematode-da-madeira-do-pinheiro (NMP), Bursaphelenchus xylophilus". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abelleira A, 2011, PLANT DIS, V95, P776, DOI 10.1094/PDIS-12-10-0902; Adams DJ, 2004, MICROBIOL-SGM, V150, P2029, DOI 10.1099/mic.0.26980-0; Akbulut S, 2012, FOREST PATHOL, V42, P89, DOI 10.1111/j.1439-0329.2011.00733.x; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Appleby Nikki, 2009, V513, P19, DOI 10.1007/978-1-59745-427-8_2; Baum Thomas J, 2007, Genet Eng (N Y), V28, P17, DOI 10.1007/978-0-387-34504-8_2; Beldade P, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-130; Blanca J, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-280; Bouck A, 2007, MOL ECOL, V16, P907, DOI 10.1111/j.1365-294X.2006.03195.x; Brumfield RT, 2003, TRENDS ECOL EVOL, V18, P249, DOI 10.1016/S0169-5347(03)00018-1; Cahais V, 2012, MOL ECOL RESOUR, V12, P834, DOI 10.1111/j.1755-0998.2012.03148.x; Cantacessi C, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000684; Cheng XY, 2008, HEREDITY, V100, P356, DOI 10.1038/sj.hdy.6801082; Chevreux B, 2004, GENOME RES, V14, P1147, DOI 10.1101/gr.1917404; Daniels R, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-223; Davis EL, 2004, TRENDS PARASITOL, V20, P134, DOI 10.1016/j.pt.2004.01.005; Davis EL, 2008, CURR OPIN PLANT BIOL, V11, P360, DOI 10.1016/j.pbi.2008.04.003; Dubreuil G, 2007, NEW PHYTOL, V176, P426, DOI 10.1111/j.1469-8137.2007.02181.x; EPPO/OEPP, 1986, B OEPP EPPO, V16, P55; Estelle M, 2001, CURR OPIN PLANT BIOL, V4, P254, DOI 10.1016/S1369-5266(00)00169-2; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; Fonseca L, 2012, HELMINTHOLOGIA, V49, P96, DOI 10.2478/s11687-012-0020-3; Fonseca L, 2008, PHYTOPATHOL MEDITERR, V47, P223; Fu Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041639; Gao BL, 2003, MOL PLANT MICROBE IN, V16, P720, DOI 10.1094/MPMI.2003.16.8.720; Hackett NR, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-82; Haegeman A, 2012, GENE, V492, P19, DOI 10.1016/j.gene.2011.10.040; Haegeman A, 2011, MOL BIOCHEM PARASIT, V178, P7, DOI 10.1016/j.molbiopara.2011.04.001; Haegeman A, 2009, MOL BIOCHEM PARASIT, V167, P32, DOI 10.1016/j.molbiopara.2009.04.004; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Hoffmann TJ, 2011, GENOMICS, V98, P79, DOI 10.1016/j.ygeno.2011.04.005; Holterman M, 2006, MOL BIOL EVOL, V23, P1792, DOI 10.1093/molbev/msl044; Hunter S, 2009, NUCLEIC ACIDS RES, V37, pD211, DOI 10.1093/nar/gkn785; Hyten DL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-38; Ichihara Y, 2000, PLANT DIS, V84, P675, DOI 10.1094/PDIS.2000.84.6.675; Iseli C, 1999, Proc Int Conf Intell Syst Mol Biol, P138; Jones JT, 2008, MOL PLANT PATHOL, V9, P357, DOI 10.1111/J.1364-3703.2007.00461.X; JUKES T H, 1969, P21; Jung J, 2010, ANIM CELLS SYST, V14, P31, DOI 10.1080/19768351003770889; Kawasaki T, 1999, DEV GROWTH DIFFER, V41, P273; Kikuchi T, 2006, MOL PLANT MICROBE IN, V19, P280, DOI 10.1094/MPMI-19-0280; Kikuchi T, 2004, FEBS LETT, V572, P201, DOI 10.1016/j.febslet.2004.07.039; Kikuchi T, 2007, MOL BIOCHEM PARASIT, V155, P9, DOI 10.1016/j.molbiopara.2007.05.002; Kikuchi T, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002219; Kikuchi T, 2009, NEMATOLOGY, V11, P355, DOI 10.1163/156854109X446953; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Kuroda K, PINE WILT DIS, P204; Lin SF, 2011, EXP PARASITOL, V127, P440, DOI 10.1016/j.exppara.2010.10.013; Mamiya Y, 2004, NEMATOL MONOGR PERSP, V1, P9; MAMIYA Y, 1972, NEMATOLOGICA, V18, P159, DOI 10.1163/187529272X00395; Margam VM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021388; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Metge K, 2006, J PLANT DIS PROTECT, V113, P275, DOI 10.1007/BF03356193; Mitchum MG, 2007, BIOTECHNOLOGY AND PLANT DISEASE MANAGEMENT, P58, DOI 10.1079/9781845932886.0058; Morin PA, 2004, TRENDS ECOL EVOL, V19, P208, DOI 10.1016/j.tree.2004.01.009; Mota MM, 2006, J NEMATOL, V38, P429; Mota MM, 1999, NEMATOLOGY, V1, P727, DOI 10.1163/156854199508757; Nicol P, 2012, INT J PARASITOL, V42, P225, DOI 10.1016/j.ijpara.2011.11.010; Oliver RE, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-77; Pereira F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056288; Rudi K, 2006, INT J SYST EVOL MICR, V56, P1565, DOI 10.1099/ijs.0.63936-0; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Samarakoon U, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-116; Santos CS, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-599; Schuster LN, 2012, GENE, V506, P274, DOI 10.1016/j.gene.2012.07.013; Sekelja M, 2011, ISME J, V5, P519, DOI 10.1038/ismej.2010.129; Sommer RJ, 2011, ANNU REV GENET, V45, P1, DOI 10.1146/annurev-genet-110410-132417; Sousa E, 2001, NEMATOLOGY, V3, P89, DOI 10.1163/156854101300106937; Syvanen AC, 2005, NAT GENET, V37, pS5, DOI 10.1038/ng1558; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Trebbi D, 2011, THEOR APPL GENET, V123, P555, DOI 10.1007/s00122-011-1607-7; Umebayashi T, 2011, PLANT PHYSIOL, V156, P943, DOI 10.1104/pp.110.170282; Valadas V, 2013, J HELMINTHOL, V87, P457, DOI 10.1017/S0022149X12000673; Valadas V, 2012, NEMATOLOGY, V14, P899, DOI 10.1163/156854112X632673; van Megen H, 2009, NEMATOLOGY, V11, P927, DOI 10.1163/156854109X456862; Vera JC, 2008, MOL ECOL, V17, P1636, DOI 10.1111/j.1365-294X.2008.03666.x; Vieira P, 2007, J NEMATOL, V39, P118; Villar E, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-538; Wang ZY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-307; Wheat Christopher W, 2012, Methods Mol Biol, V888, P33, DOI 10.1007/978-1-61779-870-2_3; Wheat CW, 2010, GENETICA, V138, P433, DOI 10.1007/s10709-008-9326-y; Yan JB, 2010, MOL BREEDING, V25, P441, DOI 10.1007/s11032-009-9343-2; Yoo J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-290; Zhang KY, 2008, J NEMATOL, V40, P127; Zhang Q, 2006, BIOSCI BIOTECH BIOCH, V70, P2727, DOI 10.1271/bbb.60330; Zhou ZH, 2007, PHYTOPATHOLOGY, V97, P304, DOI 10.1094/PHYTO-97-3-0304; Zhulidov PA, 2005, RUSS J BIOORG CHEM+, V31, P170, DOI 10.1007/s11171-005-0023-7	87	19	22	4	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83542	10.1371/journal.pone.0083542	http://dx.doi.org/10.1371/journal.pone.0083542			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391785	gold, Green Published, Green Submitted			2022-12-25	WOS:000329325200082
J	Shen, HL; Tao, DC; Ma, DF				Shen, Hualei; Tao, Dacheng; Ma, Dianfu			Dual-Force ISOMAP: A New Relevance Feedback Method for Medical Image Retrieval	PLOS ONE			English	Article							DIMENSIONALITY REDUCTION; CLASSIFICATION; ANNOTATION; SUBSPACE	With great potential for assisting radiological image interpretation and decision making, content-based image retrieval in the medical domain has become a hot topic in recent years. Many methods to enhance the performance of content-based medical image retrieval have been proposed, among which the relevance feedback (RF) scheme is one of the most promising. Given user feedback information, RF algorithms interactively learn a user's preferences to bridge the "semantic gap" between low-level computerized visual features and high-level human semantic perception and thus improve retrieval performance. However, most existing RF algorithms perform in the original high-dimensional feature space and ignore the manifold structure of the low-level visual features of images. In this paper, we propose a new method, termed dual-force ISOMAP (DFISOMAP), for content-based medical image retrieval. Under the assumption that medical images lie on a low-dimensional manifold embedded in a high-dimensional ambient space, DFISOMAP operates in the following three stages. First, the geometric structure of positive examples in the learned low-dimensional embedding is preserved according to the isometric feature mapping (ISOMAP) criterion. To precisely model the geometric structure, a reconstruction error constraint is also added. Second, the average distance between positive and negative examples is maximized to separate them; this margin maximization acts as a force that pushes negative examples far away from positive examples. Finally, the similarity propagation technique is utilized to provide negative examples with another force that will pull them back into the negative sample set. We evaluate the proposed method on a subset of the IRMA medical image dataset with a RF-based medical image retrieval framework. Experimental results show that DFISOMAP outperforms popular approaches for content-based medical image retrieval in terms of accuracy and stability.	[Shen, Hualei; Ma, Dianfu] Beihang Univ, Sch Comp Sci & Engn, State Key Lab Software Dev Environm, Beijing, Peoples R China; [Tao, Dacheng] Univ Technol Sydney, Fac Engn & Informat Technol, Ctr Quantum Computat & Intelligent Syst, Sydney, NSW 2007, Australia; [Shen, Hualei] Henan Normal Univ, Sch Comp & Informat Engn, Xinxiang, Peoples R China	Beihang University; University of Technology Sydney; Henan Normal University	Tao, DC (corresponding author), Univ Technol Sydney, Fac Engn & Informat Technol, Ctr Quantum Computat & Intelligent Syst, Sydney, NSW 2007, Australia.	dacheng.tao@uts.edu.au; dfma@buaa.edu.cn			National Natural Science Foundation of China [61003017]; Project of State Key Laboratory of Software Development Environment [SKLSDE-2013ZX-30]; ARC [DP140102164]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Project of State Key Laboratory of Software Development Environment; ARC(Australian Research Council)	This work was supported in part by the following projects: 1. National Natural Science Foundation of China under grant number 61003017, 2. Project of State Key Laboratory of Software Development Environment under grant number SKLSDE-2013ZX-30, 3. ARC Discovery Project under grant number DP140102164. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akgul CB, 2011, J DIGIT IMAGING, V24, P208, DOI 10.1007/s10278-010-9290-9; Barlow WE, 2004, JNCI-J NATL CANCER I, V96, P1840, DOI 10.1093/jnci/djh333; Bian W, 2010, IEEE T IMAGE PROCESS, V19, P545, DOI 10.1109/TIP.2009.2035223; Datta R, 2008, ACM COMPUT SURV, V40, DOI 10.1145/1348246.1348248; Deselaers T, 2008, INFORM RETRIEVAL, V11, P77, DOI 10.1007/s10791-007-9039-3; Deserno TM, 2009, 15363 IRMA IMAGES 19; Dimitrovski I, 2011, PATTERN RECOGN, V44, P2436, DOI 10.1016/j.patcog.2011.03.026; Doulamis N, 2006, SIGNAL PROCESS-IMAGE, V21, P334, DOI 10.1016/j.image.2005.11.006; Duda R.O., 2006, PATTERN CLASSIFICATI; Fei-Fei L, 2005, PROC CVPR IEEE, P524; Fu Y, 2008, IEEE T IMAGE PROCESS, V17, P226, DOI 10.1109/TIP.2007.914203; Guo GD, 2002, IEEE T NEURAL NETWOR, V13, P811, DOI 10.1109/TNN.2002.1021882; He XF, 2004, ADV NEUR IN, V16, P153; Hoi CH, 2004, IEEE IJCNN, P3189; Hoi SCH, 2009, ACM T INFORM SYST, V27, DOI 10.1145/1508850.1508854; Hong ZB, 2012, LECT NOTES COMPUT SC, V7572, P513, DOI 10.1007/978-3-642-33718-5_37; Huiskes MJ, 2008, P 2008 INT C CONT BA, P239; Kherfi ML, 2006, IEEE T IMAGE PROCESS, V15, P1017, DOI 10.1109/TIP.2005.863969; Ko BC, 2012, J DIGIT IMAGING, V25, P454, DOI 10.1007/s10278-011-9443-5; Kurita T., 1993, Proceedings of the Second International Conference on Document Analysis and Recognition (Cat. No.93TH0578-5), P547, DOI 10.1109/ICDAR.1993.395676; Lehmann TM, 2003, PROC SPIE, V5033, P440, DOI 10.1117/12.480677; Liu W, 2010, AAAI CONF ARTIF INTE, P518; Liu WF, 2013, IEEE T IMAGE PROCESS, V22, P2676, DOI 10.1109/TIP.2013.2255302; Lowe DG, 2004, INT J COMPUT VISION, V60, P91, DOI 10.1023/B:VISI.0000029664.99615.94; Ojala T, 2002, IEEE T PATTERN ANAL, V24, P971, DOI 10.1109/TPAMI.2002.1017623; Rahman MM, 2007, IEEE T INF TECHNOL B, V11, P58, DOI 10.1109/TITB.2006.884364; Rahman MM, 2011, IEEE T INF TECHNOL B, V15, P640, DOI 10.1109/TITB.2011.2151258; Roweis ST, 2000, SCIENCE, V290, P2323, DOI 10.1126/science.290.5500.2323; Rui Y, 2000, PROC CVPR IEEE, P236, DOI 10.1109/CVPR.2000.855825; Siegle RL, 1998, ACAD RADIOL, V5, P148, DOI 10.1016/S1076-6332(98)80277-8; Sugiyama M, 2007, J MACH LEARN RES, V8, P1027; Tao DC, 2006, IEEE T MULTIMEDIA, V8, P716, DOI 10.1109/TMM.2005.861375; Tao DC, 2009, IEEE T PATTERN ANAL, V31, P260, DOI 10.1109/TPAMI.2008.70; Tao DC, 2006, IEEE T PATTERN ANAL, V28, P1088, DOI 10.1109/TPAMI.2006.134; Tenenbaum JB, 2000, SCIENCE, V290, P2319, DOI 10.1126/science.290.5500.2319; Tong S., 2020, P ACM INT C MULT C E, P107; Wang JY, 2011, IEEE T MED IMAGING, V30, P1996, DOI 10.1109/TMI.2011.2161673; Wang SJ, 2011, NEUROCOMPUTING, V74, P3654, DOI 10.1016/j.neucom.2011.07.007; Xu D, 2007, IEEE T IMAGE PROCESS, V16, P2811, DOI 10.1109/TIP.2007.906769; Xu X, 2006, MED IMAGING 2006 PAC; Xu XQ, 2009, NEUROCOMPUTING, V72, P2259, DOI 10.1016/j.neucom.2008.12.029; Yang L, 2010, IEEE T PATTERN ANAL, V32, P30, DOI 10.1109/TPAMI.2008.273; Zhou TY, 2013, IEEE T IMAGE PROCESS, V22, P244, DOI 10.1109/TIP.2012.2202678; Zhou XS, 2001, PROC CVPR IEEE, P11; Zhou XS, 2003, MULTIMEDIA SYST, V8, P536, DOI 10.1007/s00530-002-0070-3	45	2	2	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84096	10.1371/journal.pone.0084096	http://dx.doi.org/10.1371/journal.pone.0084096			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391891	gold, Green Published, Green Submitted			2022-12-25	WOS:000329323900034
J	Shi, XB; Pan, HP; Xie, W; Wu, QJ; Wang, SL; Liu, Y; Fang, Y; Chen, G; Gao, XW; Zhang, YJ				Shi, Xiaobin; Pan, Huipeng; Xie, Wen; Wu, Qingjun; Wang, Shaoli; Liu, Yang; Fang, Yong; Chen, Gong; Gao, Xiwu; Zhang, Youjun			Plant Virus Differentially Alters the Plant's Defense Response to Its Closely Related Vectors	PLOS ONE			English	Article							LEAF-CURL-VIRUS; BEMISIA-TABACI; SALICYLIC-ACID; MEDIATED INTERACTIONS; TOMATO DEFENSE; ARABIDOPSIS; INSECT; TRANSMISSION; MECHANISMS; INFECTION	Background: The whitefly, Bemisia tabaci (Hemiptera: Aleyrodidae), is one of the most widely distributed agricultural pests. In recent years, B. tabaci Q has invaded China, and Q has displaced B in many areas now. In a number of regions of the world, invasion by B and/or Q has been followed by outbreaks of tomato yellow leaf curl virus (TYLCV). Our previous study showed TYLCV directly and indirectly modified the feeding behavior of B. tabaci in favor of Q rather than B. Methodology/Principal Findings: In this study, we quantified the salicylic acid (SA) titers and relative gene expression of SA in tomato leaves that were infested with viruliferous or non-viruliferous B and Q. We also measured the impacts of exogenous SA on the performance of B and Q, including the effects on ovary development. SA titer was always higher in leaves that were infested with viruliferous B than with viruliferous Q, whereas the SA titer did not differ between leaves infested with non-viruliferous B and Q. The relative gene expression of SA signaling was increased by feeding of viruliferous B but was not increased by feeding of viruliferous Q. The life history traits of B and Q were adversely affected on SA-treated plants. On SA-treated plants, both B and Q had lower fecundity, shorter longevity, longer developmental time and lower survival rate than on untreated plants. Compared with whiteflies feeding on control plants, those feeding on SA-treated plants had fewer oocytes and slower ovary development. On SA-treated plants, viruliferous B had fewer oocytes than viruliferous Q. Conclusions/Significance: These results indicate that TYLCV tends to induce SA-regulated plant defense against B but SA-regulated plant defense against Q was reduced. In other words, Q may have a mutualistic relationship with TYLCV that results in the reduction of the plant's defense response.	[Shi, Xiaobin; Pan, Huipeng; Xie, Wen; Wu, Qingjun; Wang, Shaoli; Liu, Yang; Fang, Yong; Chen, Gong; Zhang, Youjun] Chinese Acad Agr Sci, Inst Vegetables & Flowers, Dept Plant Protect, Beijing 100193, Peoples R China; [Shi, Xiaobin; Gao, Xiwu] China Agr Univ, Dept Entomol, Beijing 100094, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Vegetables & Flowers, CAAS; China Agricultural University	Zhang, YJ (corresponding author), Chinese Acad Agr Sci, Inst Vegetables & Flowers, Dept Plant Protect, Beijing 100193, Peoples R China.	zhangyoujun@caas.cn	Khitov, Sergey/P-1280-2019; Zhang, Youjun/AAY-7948-2020	Zhang, Youjun/0000-0003-3508-6695	National Science Fund for Distinguished Young Scholars [31025020]; Beijing Natural Science Foundation [6131002]; 973 Program [2013CB127602]; Beijing Key Laboratory for Pest Control and Sustainable Cultivation of Vegetables	National Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); Beijing Natural Science Foundation(Beijing Natural Science Foundation); 973 Program(National Basic Research Program of China); Beijing Key Laboratory for Pest Control and Sustainable Cultivation of Vegetables	This research was supported by the National Science Fund for Distinguished Young Scholars (31025020), the Beijing Natural Science Foundation (6131002), the 973 Program (2013CB127602), and the Beijing Key Laboratory for Pest Control and Sustainable Cultivation of Vegetables. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 2012, PLANT CELL PHYSIOL, V53, P204, DOI 10.1093/pcp/pcr173; Alba JM, 2011, J PLANT INTERACT, V6, P221, DOI 10.1080/17429145.2010.551670; Andret-Link P, 2005, J PLANT PATHOL, V87, P153; Avila CA, 2012, PLANT PHYSIOL, V158, P2028, DOI 10.1104/pp.111.191262; Barrett LG, 2012, TRENDS PLANT SCI, V17, P282, DOI 10.1016/j.tplants.2012.02.009; Belliure B, 2005, ECOL LETT, V8, P70, DOI 10.1111/j.1461-0248.2004.00699.x; Blande JD, 2010, TREE PHYSIOL, V30, P404, DOI 10.1093/treephys/tpp124; Bosque-Perez NA, 2011, VIRUS RES, V159, P201, DOI 10.1016/j.virusres.2011.04.020; BROWN JK, 1995, ANNU REV ENTOMOL, V40, P511, DOI 10.1146/annurev.en.40.010195.002455; Carolan JC, 2009, PROTEOMICS, V9, P2457, DOI 10.1002/pmic.200800692; Chu D, 2006, FLA ENTOMOL, V89, P168, DOI 10.1653/0015-4040(2006)89[168:TIOTEQ]2.0.CO;2; Chu D, 2010, ENVIRON ENTOMOL, V39, P1028, DOI 10.1603/EN09161; COHEN S, 1966, PHYTOPATHOLOGY, V56, P1127; Colvin J, 2006, ADV VIRUS RES, V67, P419, DOI 10.1016/S0065-3527(06)67011-5; Czosnek H, 1997, ARCH VIROL, V142, P1391, DOI 10.1007/s007050050168; De Barro PJ, 2011, ANNU REV ENTOMOL, V56, P1, DOI 10.1146/annurev-ento-112408-085504; De Vos M, 2005, MOL PLANT MICROBE IN, V18, P923, DOI 10.1094/MPMI-18-0923; de Vos M, 2007, BIOESSAYS, V29, P871, DOI 10.1002/bies.20624; De Vos M, 2009, PLANT CELL ENVIRON, V32, P1548, DOI 10.1111/j.1365-3040.2009.02019.x; DELANEY TP, 1994, SCIENCE, V266, P1247, DOI 10.1126/science.266.5188.1247; Donovan MP, 2013, ARTHROPOD-PLANT INTE, V7, P45, DOI 10.1007/s11829-012-9220-5; Erb M, 2012, TRENDS PLANT SCI, V17, P250, DOI 10.1016/j.tplants.2012.01.003; Giordanengo P, 2010, CR BIOL, V333, P516, DOI 10.1016/j.crvi.2010.03.007; Glazebrook J, 2005, ANNU REV PHYTOPATHOL, V43, P205, DOI 10.1146/annurev.phyto.43.040204.135923; Goggin FL, 2007, CURR OPIN PLANT BIOL, V10, P399, DOI 10.1016/j.pbi.2007.06.004; Gottlieb Y, 2010, J VIROL, V84, P9310, DOI 10.1128/JVI.00423-10; Guo JY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011713; Gutierrez S, 2013, FUNCT ECOL, V27, P610, DOI 10.1111/1365-2435.12070; Hohn T, 2007, P NATL ACAD SCI USA, V104, P17905, DOI 10.1073/pnas.0709178104; Huang L, 2012, PLANT BIOLOGY, V14, P905, DOI 10.1111/j.1438-8677.2012.00582.x; Jung HW, 2009, SCIENCE, V324, P89, DOI 10.1126/science.1170025; Kachroo A, 2009, ANNU REV PHYTOPATHOL, V47, P153, DOI 10.1146/annurev-phyto-080508-081820; Katsir L, 2008, P NATL ACAD SCI USA, V105, P7100, DOI 10.1073/pnas.0802332105; Liu BM, 2013, J VIROL, V87, P4929, DOI 10.1128/JVI.03571-12; Luo Chen, 2002, Acta Entomologica Sinica, V45, P759; Mascia T, 2010, MOL PLANT PATHOL, V11, P805, DOI [10.1111/j.1364-3703.2010.00646.x, 10.1111/j.1365-3059.2009.02239.x]; Matros A, 2006, PLANT CELL ENVIRON, V29, P126, DOI 10.1111/j.1365-3040.2005.01406.x; Mauck K, 2012, FUNCT ECOL, V26, P1162, DOI 10.1111/j.1365-2435.2012.02026.x; Moran PJ, 2002, ARCH INSECT BIOCHEM, V51, P182, DOI 10.1002/arch.10064; Moran PJ, 2001, PLANT PHYSIOL, V125, P1074, DOI 10.1104/pp.125.2.1074; Moreno-Delafuente A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061543; Moriones E, 2000, VIRUS RES, V71, P123, DOI 10.1016/S0168-1702(00)00193-3; Navas-Castillo J, 2011, ANNU REV PHYTOPATHOL, V49, P219, DOI 10.1146/annurev-phyto-072910-095235; Pan HP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034817; Pan HP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030760; Pan HP, 2011, J ECON ENTOMOL, V104, P978, DOI 10.1603/EC11009; Pegadaraju V, 2005, PLANT PHYSIOL, V139, P1927, DOI 10.1104/pp.105.070433; Peng JY, 2004, Z NATURFORSCH C, V59, P856; Pieterse CMJ, 2007, TRENDS PLANT SCI, V12, P564, DOI 10.1016/j.tplants.2007.09.004; Polston JE, 1999, PLANT DIS, V83, P984, DOI 10.1094/PDIS.1999.83.4.397A; Rodriguez-Saona CR, 2010, J CHEM ECOL, V36, P1043, DOI 10.1007/s10886-010-9854-7; Rubinstein G, 1997, J GEN VIROL, V78, P2683, DOI 10.1099/0022-1317-78-10-2683; Sarmento RA, 2011, ECOL LETT, V14, P229, DOI 10.1111/j.1461-0248.2010.01575.x; Schulze B, 2006, ANAL BIOCHEM, V348, P269, DOI 10.1016/j.ab.2005.10.021; Stout MJ, 2006, ANNU REV ENTOMOL, V51, P663, DOI 10.1146/annurev.ento.51.110104.151117; Thaler JS, 2010, ECOLOGY, V91, P1075, DOI 10.1890/08-2347.1; Thatcher LF, 2009, PLANT J, V58, P927, DOI 10.1111/j.1365-313X.2009.03831.x; Walling LL, 2009, ADV BOT RES, V51, P551, DOI 10.1016/S0065-2296(09)51013-0; Walling LL, 2000, J PLANT GROWTH REGUL, V19, P195; Whitfield AE, 2005, ANNU REV PHYTOPATHOL, V43, P459, DOI 10.1146/annurev.phyto.43.040204.140017; Wu JB, 2006, PLANT DIS, V90, P1359, DOI 10.1094/PD-90-1359C; Wu W, 2012, ANN APPL BIOL, V161, P36, DOI 10.1111/j.1744-7348.2012.00550.x; Yang JW, 2011, J ECOL, V99, P46, DOI 10.1111/j.1365-2745.2010.01756.x; Zambrano K, 2007, PLANT DIS, V91, P768, DOI 10.1094/PDIS-91-6-0768A; Zarate SI, 2007, PLANT PHYSIOL, V143, P866, DOI 10.1104/pp.106.090035; Zhou Y, 1949, CHIN J ENTOMOL, V3, P1	66	37	42	1	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83520	10.1371/journal.pone.0083520	http://dx.doi.org/10.1371/journal.pone.0083520			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391779	gold, Green Published, Green Submitted			2022-12-25	WOS:000329325200076
J	White, WT; Furumitsu, K; Yamaguchi, A				White, William T.; Furumitsu, Keisuke; Yamaguchi, Atsuko			A New Species of Eagle Ray Aetobatus narutobiei from the Northwest Pacific: An Example of the Critical Role Taxonomy Plays in Fisheries and Ecological Sciences	PLOS ONE			English	Article							FLAGELLUM; IDENTIFICATION	Recent taxonomic and molecular work on the eagle rays (Family Myliobatidae) revealed a cryptic species in the northwest Pacific. This species is formally described as Aetobatus narutobiei sp. nov. and compared to its congeners. Aetobatus narutobiei is found in eastern Vietnam, Hong Kong, China, Korea and southern Japan. It was previously considered to be conspecific with Aetobatus flagellum, but these species differ in size, structure of the NADH2 and CO1 genes, some morphological and meristic characters and colouration. Aetobatus narutobiei is particularly abundant in Ariake Bay in southern Japan where it is considered a pest species that predates heavily on farmed bivalve stocks and is culled annually as part of a 'predator control' program. The discovery of A. narutobiei highlights the paucity of detailed taxonomic research on this group of rays. This discovery impacts on current conservation assessments of A. flagellum and these need to be revised based on the findings of this study.	[White, William T.] CSIRO Marine & Atmospher Res, Wealth Oceans Flagship, Hobart, Tas, Australia; [Furumitsu, Keisuke; Yamaguchi, Atsuko] Nagasaki Univ, Fac Fisheries, Nagasaki 852, Japan	Commonwealth Scientific & Industrial Research Organisation (CSIRO); Nagasaki University	White, WT (corresponding author), CSIRO Marine & Atmospher Res, Wealth Oceans Flagship, Hobart, Tas, Australia.	william.white@csiro.au	White, William T/B-9748-2009	White, William T/0000-0001-9705-2453	National Science Foundation (NSF) [DEB-01132229]; CSIRO;  [20580205];  [23380112]	National Science Foundation (NSF)(National Science Foundation (NSF)); CSIRO(Commonwealth Scientific & Industrial Research Organisation (CSIRO)); ; 	The senior author was supported by a National Science Foundation (NSF; http://www.nsf.gov) grant (Jaws and Backbone: Chondrichthyan Phylogeny and a Spine for the Vertebrate Tree of Life; DEB-01132229; www.nsf.gov) and the CSIRO's Wealth from Oceans Flagship. The other authors (AY and KF) were supported by Grant-in-Aid for Scientific Research (C) 20580205, Grant-in-Aid for Scientific Research (B) 23380112 (www.jsps.go.jp). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Bleeker P, 1852, VERHANDELINGEN BATAV, V24, P1, DOI DOI 10.1163/22134379-90000832; BRANDER K, 1981, NATURE, V290, P48, DOI 10.1038/290048a0; COMPAGNO LJV, 1999, FAO SPECIES IDENTIFI, V3, P1511; Dulvy NK, 2013, E LIFE IN PRESS; Fukuda Y, 2010, NIPPON SUISAN GAKK, V76, P10, DOI 10.2331/suisan.76.10; Iglesias SP, 2010, AQUAT CONSERV, V20, P319, DOI 10.1002/aqc.1083; Kamei Y, 2009, B FISH EXP STN OKAYA, V24, P32; Kamei Y, 2009, B FISHERIES EXPT STA, V24, P28; Manjaji B.M., 2004, THESIS U TASMANIA HO; Nakabo T, 2001, FISH KUROSHIO CURREN, P143; Naylor GJP, 2012, B AM MUS NAT HIST, P1; Ni IH, 1999, ZOOL STUD, V38, P130; NISHDA K, 1990, Memoirs of the Faculty of Fisheries Hokkaido University, V37, P1; Oh Jina, 2006, Ocean Science Journal, V41, P53; Richards VP, 2009, J HERED, V100, P273, DOI 10.1093/jhered/esp005; Richardson SJ, 1846, BRIT ASS ADV SCI 15, V15, P187, DOI DOI 10.5962/BHL.TITLE.59530; Sakiyama T, 2011, KANAGAWA NATURE ARTI, V32, P101; Schwartz FJ, 2007, RAFFLES B ZOOL, P121; Shimizu Takaaki, 1997, I.O.P. Diving News, V8, P2; SIMPFENDORFER CA, 2011, MARINE FRESHWATER RE, V62, P583; Suzuki Toshiyuki, 1994, I.O.P. Diving News, V5, P2; Ward RD, 2008, MAR FRESHWATER RES, V59, P57, DOI 10.1071/MF07148; White WT, 2006, AETOBATUS FLAGELLUM; White WT, 2013, ZOOTAXA IN PRESS; White WT, 2010, DESCRIPTIONS NEW SHA, P141; Yagishita N, 2009, MOL ECOL RESOUR, V9, P1034, DOI 10.1111/j.1755-0998.2009.02568.x; Yamada U, 1989, SEIKAIKU SUISAN KENK, V61, P1; Yamaguchi A, 2005, ENVIRON BIOL FISH, V74, P229, DOI 10.1007/s10641-005-0217-0; Yamaguchi A, 2013, FISHES JAPAN PICTORI, P228; Yoon HK, 2009, BIOCHIP J, V3, P87; Zhu Y, 2001, FAUNA SINICA CYCLOST, P450	31	11	12	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83785	10.1371/journal.pone.0083785	http://dx.doi.org/10.1371/journal.pone.0083785			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391827	gold, Green Submitted, Green Published			2022-12-25	WOS:000329325200125
J	Bakhoum, MT; Fall, M; Fall, AG; Bellis, GA; Gottlieb, Y; Labuschagne, K; Venter, GJ; Diop, M; Mall, I; Seck, MT; Allene, X; Diarra, M; Gardes, L; Bouyer, J; Delecolle, JC; Balenghien, T; Garros, C				Bakhoum, Mame T.; Fall, Moussa; Fall, Assane G.; Bellis, Glenn A.; Gottlieb, Yuval; Labuschagne, Karien; Venter, Gert J.; Diop, Mariame; Mall, Iba; Seck, Momar T.; Allene, Xavier; Diarra, Maryam; Gardes, Laetitia; Bouyer, Jeremy; Delecolle, Jean-Claude; Balenghien, Thomas; Garros, Claire			First Record of Culicoides oxystoma Kieffer and Diversity of Species within the Schultzei Group of Culicoides Latreille (Diptera: Ceratopogonidae) Biting Midges in Senegal	PLOS ONE			English	Article							AFRICAN HORSE SICKNESS; BLUETONGUE VIRUS; CLIMATE-CHANGE; TRANSMISSION; REGION; GENE	The Schultzei group of Culicoides Latreille (Diptera: Ceratopogonidae) is distributed throughout Africa to northern Asia and Australasia and includes several potential vector species of livestock pathogens. The taxonomy of the species belonging to this species group is confounded by the wide geographical distribution and morphological variation exhibited by many species. In this work, morphological and molecular approaches were combined to assess the taxonomic validity of the species and morphological variants of the Schultzei group found in Senegal by comparing their genetic diversity with that of specimens from other geographical regions. The species list for Senegal was updated with four species: Culicoides kingi, C. oxystoma, C. enderleini and C. nevilli being recorded. This is the first record of C. oxystoma from Africa south of Sahara, and its genetic relationship with samples from Israel, Japan and Australia is presented. This work provides a basis for ecological studies of the seasonal and spatial dynamics of species of this species group that will contribute to better understanding of the epidemiology of the viruses they transmit.	[Bakhoum, Mame T.; Fall, Moussa; Fall, Assane G.; Diop, Mariame; Mall, Iba; Seck, Momar T.; Diarra, Maryam; Bouyer, Jeremy] Inst Senegalais Rech Agr, Lab Natl Elevage & Rech Vet, Dakar, Senegal; [Bellis, Glenn A.] Dept Agr, Winnellie, Australia; [Gottlieb, Yuval] Hebrew Univ Jerusalem, Koret Sch Vet Med, Robert H Smith Fac Agr Food & Environm, IL-76100 Rehovot, Israel; [Labuschagne, Karien; Venter, Gert J.] Onderstepoort Vet Inst, Agr Res Council, Onderstepoort, South Africa; [Labuschagne, Karien] Univ Pretoria, Dept Zool & Entomol, ZA-0002 Pretoria, South Africa; [Venter, Gert J.] Univ Pretoria, Dept Vet Trop Dis, Onderstepoort, South Africa; [Allene, Xavier; Gardes, Laetitia; Bouyer, Jeremy; Balenghien, Thomas; Garros, Claire] INRA, Cirad, Controle Malad UMR15, Controle Malad UMR1309, Montpellier, France; [Delecolle, Jean-Claude] Inst Parasitol & Pathol Trop Strasbourg, Fac Med, Strasbourg, France	Hebrew University of Jerusalem; Agricultural Research Council of South Africa; Onderstepoort Veterinary Institute, Agricultural Research Council; University of Pretoria; University of Pretoria; CIRAD; INRAE	Bakhoum, MT (corresponding author), Inst Senegalais Rech Agr, Lab Natl Elevage & Rech Vet, Dakar, Senegal.	thierbakhoum2@yahoo.fr; claire.garros@cirad.fr	Bouyer, Jérémy/AAK-7370-2020; Garros, Claire/C-2715-2011; Labuschagne, Karien/J-9084-2019; Gottlieb, Yuval/H-6461-2013	Bouyer, Jérémy/0000-0002-1913-416X; Diarra, Maryam/0000-0001-9110-4435; Bakhoum, Mame Thierno/0000-0001-6794-4426; Labuschagne, Karien/0000-0002-8352-0313	Centre de Cooperation Internationale en Recherche Agronomique pour le Developpement (Cirad); EU [261504 EDENext]	Centre de Cooperation Internationale en Recherche Agronomique pour le Developpement (Cirad); EU(European Commission)	This study was funded partly by the Centre de Cooperation Internationale en Recherche Agronomique pour le Developpement (Cirad), and by the EU FP7-HEALTH-2010-single-stage grant 261504 EDENext. This paper is catalogued by the EDENext Steering Committee as EDENext177 (http://www.edenext.eu). The contents of this publication are the sole responsibility of the authors and do not necessarily reflect the views of the European Commission. The funders had no role in study design, data collection and analysis, the decision to publish or the preparation of the manuscript.	Akakpo A. J., 2011, Bulletin of Animal Health and Production in Africa, V59, P1; Alahmed A. M., 2010, Journal of Entomology, V7, P227; Augot D, 2013, B SOC PATHOL EXOT; Barnard BJH, 1998, ONDERSTEPOORT J VET, V65, P145; Bellis GA, 2013, ZOOTAXA, V3680, P15, DOI 10.11646/zootaxa.3680.1.4; Boorman J., 1989, Fauna of Saudi Arabia, V10, P160; Borkent A, 2012, CATALOG CERATOPOGONI; Borkent A, 2012, SUBGENERIC CLASSIFIC; Carpenter S, 2009, TRENDS MICROBIOL, V17, P172, DOI 10.1016/j.tim.2009.01.001; Cornet Michel, 1994, Bulletin de la Societe Entomologique de France, V99, P149; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; De Meillon B, 1961, REV ENTOMOL MOCAMBAI, V4, P34; Dik B, 2006, J NAT HIST, V40, P1947, DOI 10.1080/00222930601046634; Diouf ND, 2013, VET REC, V172, P152, DOI 10.1136/vr.101083; Dyce A.L., 2007, PICTORIAL ATLAS AUST; Gerdes GH, 2004, VETER ITAL SER, V40, P39; GLICK JI, 1990, J MED ENTOMOL, V27, P85, DOI 10.1093/jmedent/27.2.85; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Hilali Musaad, 2003, Veterinarski Arhiv, V73, P285; Hoffmann B, 2012, EMERG INFECT DIS, V18, P469, DOI 10.3201/eid1803.111905; KHAMALA CPM, 1971, T ROY ENT SOC LONDON, V123, P1; Labuschagne K, 2007, ONDERSTEPOORT J VET, V74, P343; Mardulyn P, 2013, MOL ECOL, V22, P2456, DOI 10.1111/mec.12264; Matsumoto Y, 2009, J MED ENTOMOL, V46, P1099, DOI 10.1603/033.046.0517; Meiswinkel R, 2004, INFECT DIS LIVESTOCK; Mellor PS, 2009, BIOL ANIM INFECT, P1; MELLOR PS, 1993, VET RES, V24, P199; MELLOR PS, 1984, J HYG-CAMBRIDGE, V93, P621, DOI 10.1017/S0022172400065190; Morag N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033610; Oem JK, 2013, J VET SCI, V14, P91, DOI 10.4142/jvs.2013.14.1.91; Purse BV, 2005, NAT REV MICROBIOL, V3, P171, DOI 10.1038/nrmicro1090; Rambaut A., 2007, TRACER V1 4; Rawlings P, 1998, MED VET ENTOMOL, V12, P155, DOI 10.1046/j.1365-2915.1998.00094.x; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; SEN PURNENDU., 1959, ANN ENT SOC AMER, V52, P617; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; Solano P, 1997, ACTA TROP, V65, P175, DOI 10.1016/S0001-706X(97)00663-3; Standfast H.A., 1985, Progress in Clinical and Biological Research, V178, P177; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tsutsui T, 2011, PARASITOL RES, V108, P1575, DOI 10.1007/s00436-010-2048-y; Venail R., 2012, P77; Venter GJ, 2007, MED VET ENTOMOL, V21, P239, DOI 10.1111/j.1365-2915.2007.00687.x; Venter GJ, 2009, MED VET ENTOMOL, V23, P367, DOI 10.1111/j.1365-2915.2009.00829.x; Viennet E, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-119; Wirth W.W., 1985, Progress in Clinical and Biological Research, V178, P151; Wirth W.W., 1989, MEMOIRS AM ENTOMOLOG, P1; Xia X, 2001, J HERED, V92, P371, DOI 10.1093/jhered/92.4.371; Yanase T, 2005, J MED ENTOMOL, V42, P63, DOI 10.1603/0022-2585(2005)042[0063:IOBAFC]2.0.CO;2; Yu YX, 2005, CERATOPOGONIDAE CHIN	49	35	35	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e84316	10.1371/journal.pone.0084316	http://dx.doi.org/10.1371/journal.pone.0084316			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386366	Green Published, gold			2022-12-25	WOS:000329194700103
J	Gustafsson, JK; Navabi, N; Rodriguez-Pineiro, AM; Alomran, AHA; Premaratne, P; Fernandez, HR; Banerjee, D; Sjovall, H; Hansson, GC; Linden, SK				Gustafsson, Jenny K.; Navabi, Nazanin; Rodriguez-Pineiro, Ana M.; Alomran, Ala H. A.; Premaratne, Pushpa; Fernandez, Harvey R.; Banerjee, Debashish; Sjovall, Henrik; Hansson, Gunnar C.; Linden, Sara K.			Dynamic Changes in Mucus Thickness and Ion Secretion during Citrobacter rodentium Infection and Clearance	PLOS ONE			English	Article							CYSTIC-FIBROSIS; INTESTINAL MUCUS; MUCOSAL BARRIER; MUCIN DYNAMICS; MOUSE SMALL; BICARBONATE; CFTR; CELLS; COLON; IDENTIFICATION	Citrobacter rodentium is an attaching and effacing pathogen used as a murine model for enteropathogenic Escherichia coli. The mucus layers are a complex matrix of molecules, and mucus swelling, hydration and permeability are affected by many factors, including ion composition. Here, we used the C. rodentium model to investigate mucus dynamics during infection. By measuring the mucus layer thickness in tissue explants during infection, we demonstrated that the thickness changes dynamically during the course of infection and that its thickest stage coincides with the start of a decrease of bacterial density at day 14 after infection. Although quantitative PCR analysis demonstrated that mucin mRNA increases during early infection, the increased mucus layer thickness late in infection was not explained by increased mRNA levels. Proteomic analysis of mucus did not demonstrate the appearance of additional mucins, but revealed an increased number of proteins involved in defense responses. Ussing chamber-based electrical measurements demonstrated that ion secretion was dynamically altered during the infection phases. Furthermore, the bicarbonate ion channel Bestrophin-2 mRNA nominally increased, whereas the Cftr mRNA decreased during the late infection clearance phase. Microscopy of Muc2 immunostained tissues suggested that the inner striated mucus layer present in the healthy colon was scarce during the time point of most severe infection (10 days post infection), but then expanded, albeit with a less structured appearance, during the expulsion phase. Together with previously published literature, the data implies a model for clearance where a change in secretion allows reformation of the mucus layer, displacing the pathogen to the outer mucus layer, where it is then outcompeted by the returning commensal flora. In conclusion, mucus and ion secretion are dynamically altered during the C. rodentium infection cycle.	[Gustafsson, Jenny K.; Navabi, Nazanin; Rodriguez-Pineiro, Ana M.; Alomran, Ala H. A.; Premaratne, Pushpa; Fernandez, Harvey R.; Banerjee, Debashish; Hansson, Gunnar C.; Linden, Sara K.] Univ Gothenburg, Sahlgrenska Acad, Dept Med Biochem & Cell Biol, Gothenburg, Sweden; [Sjovall, Henrik] Univ Gothenburg, Sahlgrenska Acad, Dept Internal Med, Gothenburg, Sweden	University of Gothenburg; University of Gothenburg	Linden, SK (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Dept Med Biochem & Cell Biol, Gothenburg, Sweden.	sara.linden@gu.se	Hansson, Gunnar C/A-1236-2009; Hansson, Gunnar C./AAF-7324-2019; Rodriguez-Pineiro, Ana M./AAF-6353-2020; Linden, Sara/A-3271-2011	Hansson, Gunnar C/0000-0002-1900-1869; Hansson, Gunnar C./0000-0002-1900-1869; Fernandez, Harvey/0000-0003-0878-5570; Linden, Sara/0000-0002-7751-9586	Swedish Research Council [7461, 21027, 21372, 21955]; Swedish Research Council Formas [221-2011-1036]; Swedish Cancer Foundation; Ake Wibergs Foundation; Knut and Alice Wallenberg Foundation; Inga Britt and Arne Lundberg Foundation; Wilhelm and Martina Lundgren's Foundation; Torsten och Ragnar Soderbergs Stiftelser; Swedish Foundation for Strategic Research - The Mucus-Bacteria-Colitis Center (MBC) of the Innate Immunity Program; Jeansson Foundation; Ake Wiberg Foundation; Wilhelm och Martina Lundgrens Vetenskapsfond; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI095473] Funding Source: NIH RePORTER	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Research Council Formas(Swedish Research CouncilSwedish Research Council Formas); Swedish Cancer Foundation; Ake Wibergs Foundation; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Inga Britt and Arne Lundberg Foundation; Wilhelm and Martina Lundgren's Foundation; Torsten och Ragnar Soderbergs Stiftelser; Swedish Foundation for Strategic Research - The Mucus-Bacteria-Colitis Center (MBC) of the Innate Immunity Program; Jeansson Foundation; Ake Wiberg Foundation; Wilhelm och Martina Lundgrens Vetenskapsfond; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Swedish Research Council (no. 7461, 21027, 21372 and 21955, http://www.vr.se/), the Swedish Research Council Formas (221-2011-1036, http://www.formas.se/), The Swedish Cancer Foundation, Ake Wibergs Foundation, The Knut and Alice Wallenberg Foundation, Inga Britt and Arne Lundberg Foundation, Wilhelm and Martina Lundgren's Foundation, Torsten och Ragnar Soderbergs Stiftelser (http://www.ragnarsoderbergsstiftelse.se/), The Swedish Foundation for Strategic Research - The Mucus-Bacteria-Colitis Center (MBC) of the Innate Immunity Program, (www.cancerfonden.se), the Jeansson Foundation (www.jeanssonsstiftelser.se/), the Ake Wiberg Foundation (www.ake-wiberg.com/) and Wilhelm och Martina Lundgrens Vetenskapsfond (http://www.wmlundgren.se/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMANN RI, 1990, APPL ENVIRON MICROB, V56, P1919, DOI 10.1128/AEM.56.6.1919-1925.1990; Ambort D, 2012, P NATL ACAD SCI USA, V109, P5645, DOI 10.1073/pnas.1120269109; Bergstrom KSB, 2008, INFECT IMMUN, V76, P796, DOI 10.1128/IAI.00093-07; Bergstrom KSB, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000902; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Conlin VS, 2009, AM J PHYSIOL-GASTR L, V297, pG735, DOI 10.1152/ajpgi.90551.2008; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Erdem AL, 2007, J BACTERIOL, V189, P7426, DOI 10.1128/JB.00464-07; Garcia MAS, 2009, J CLIN INVEST, V119, P2613, DOI 10.1172/JCI38662; Golin-Bisello F, 2005, AM J PHYSIOL-CELL PH, V289, pC708, DOI 10.1152/ajpcell.00544.2004; Greger R, 2000, ANNU REV PHYSIOL, V62, P467, DOI 10.1146/annurev.physiol.62.1.467; Gustafsson JK, 2012, J EXP MED, V209, P1263, DOI 10.1084/jem.20120562; Gustafsson JK, 2012, AM J PHYSIOL-GASTR L, V302, pG430, DOI [10.1152/ajpgi.00405.2011, 10.1152/ajpgi.00405.2011.]; Gustafsson JK, 2012, METHODS MOL BIOL, V842, P237, DOI 10.1007/978-1-61779-513-8_14; Hasnain SZ, 2011, J EXP MED, V208, P893, DOI 10.1084/jem.20102057; Ishikawa N, 1997, GASTROENTEROLOGY, V113, P542, DOI 10.1053/gast.1997.v113.pm9247474; Johansson MEV, 2013, NAT REV GASTRO HEPAT, V10, P352, DOI 10.1038/nrgastro.2013.35; Johansson MEV, 2011, P NATL ACAD SCI USA, V108, P4659, DOI 10.1073/pnas.1006451107; Johansson MEV, 2009, J PROTEOME RES, V8, P3549, DOI 10.1021/pr9002504; Johansson MEV, 2008, P NATL ACAD SCI USA, V105, P15064, DOI 10.1073/pnas.0803124105; Joo N S, 2001, JOP, V2, P280; Kamada N, 2012, SCIENCE, V336, P1325, DOI 10.1126/science.1222195; KHAN WI, 1995, PARASITE IMMUNOL, V17, P485, DOI 10.1111/j.1365-3024.1995.tb00919.x; Linden S, 2004, BIOCHEM J, V384, P263, DOI 10.1042/BJ20040402; Linden SK, 2008, MUCOSAL IMMUNOL, V1, P183, DOI 10.1038/mi.2008.5; Linden SK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003952; Maaser C, 2004, INFECT IMMUN, V72, P3315, DOI 10.1128/IAI.72.6.3315-3324.2004; Malmberg EK, 2006, AM J PHYSIOL-GASTR L, V291, pG203, DOI 10.1152/ajpgi.00491.2005; McAuley JL, 2007, J CLIN INVEST, V117, P2313, DOI 10.1172/JCI26705; McGuckin MA, 2011, NAT REV MICROBIOL, V9, P265, DOI 10.1038/nrmicro2538; Muchekehu RW, 2010, J PHYSIOL-LONDON, V588, P2329, DOI 10.1113/jphysiol.2010.187237; Navabi N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068761; Navabi N, 2013, INFECT IMMUN, V81, P829, DOI 10.1128/IAI.01000-12; Parmley RR, 1998, J CLIN INVEST, V102, P1798, DOI 10.1172/JCI3820; Philips MA, 2009, BIOL CELL, V101, P361, DOI 10.1042/BC20080086; Rodriguez-Pineiro AM, 2012, J PROTEOME RES, V11, P1879, DOI 10.1021/pr2010988; Schweinfest CW, 2006, J BIOL CHEM, V281, P37962, DOI 10.1074/jbc.M607527200; Shiomi H, 2010, INFECT IMMUN, V78, P2653, DOI 10.1128/IAI.01343-09; Singh AK, 2013, J PHYSIOL-LONDON, V591, P2189, DOI 10.1113/jphysiol.2012.247874; Skinn AC, 2006, CAN J PHYSIOL PHARM, V84, P1301, DOI 10.1139/Y06-086; SPECIAN RD, 1980, J CELL BIOL, V85, P626, DOI 10.1083/jcb.85.3.626; Stefanovic B, 2004, MOL CELL BIOL, V24, P1758, DOI 10.1128/MCB.24.4.1758-1768.2004; Sterling D, 2002, AM J PHYSIOL-CELL PH, V283, pC1522, DOI 10.1152/ajpcell.00115.2002; Sugi K, 2001, GASTROENTEROLOGY, V120, P1393, DOI 10.1053/gast.2001.24045; TAM PY, 1981, NATURE, V292, P340, DOI 10.1038/292340a0; Tan J, 2008, J VIROL, V82, P4275, DOI 10.1128/JVI.02249-07; Umar S, 2000, AM J PHYSIOL-GASTR L, V278, pG753, DOI 10.1152/ajpgi.2000.278.5.G753; VERDUGO P, 1991, AM REV RESPIR DIS, V144, pS33, DOI 10.1164/ajrccm/144.3_pt_2.S33; Verdugo P, 1991, MUCIN EXOCYTOSIS, V144, pS33; Vidyasagar S, 2004, AM J PHYSIOL-CELL PH, V287, pC612, DOI 10.1152/ajpcell.00474.2003; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/nmeth.1322, 10.1038/NMETH.1322]; Yu K, 2010, J CLIN INVEST, V120, P1722, DOI 10.1172/JCI41129	53	36	36	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e84430	10.1371/journal.pone.0084430	http://dx.doi.org/10.1371/journal.pone.0084430			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386378	Green Published, gold, Green Submitted			2022-12-25	WOS:000329194700106
J	Liu, QH; He, SH; Groysman, L; Shaked, D; Russin, J; Cen, S; Mack, WJ				Liu, Qinghai; He, Shuhan; Groysman, Leonid; Shaked, David; Russin, Jonathan; Cen, Steven; Mack, William J.			White Matter Injury Due to Experimental Chronic Cerebral Hypoperfusion Is Associated with C5 Deposition	PLOS ONE			English	Article							COMPLEMENT COMPONENT; ALZHEIMERS-DISEASE; GLIAL ACTIVATION; MURINE MODELS; MOUSE MODEL; LESIONS; EXPRESSION; C3A; DYSFUNCTION; IMPAIRMENT	The C5 complement protein is a potent inflammatory mediator that has been implicated in the pathogenesis of both stroke and neurodegenerative disease. Microvascular failure is proposed as a potential mechanism of injury. Along these lines, this investigation examines the role of C5 in the setting of chronic cerebral hypoperfusion. Following experimental bilateral carotid artery stenosis, C5 protein deposition increases in the corpus callosum over thirty days (p<0.05). The time course is temporally consistent with the appearance of white matter injury. Concurrently, systemic serum C5 levels do not appear to differ between bilateral carotid artery stenosis and sham-operated mice, implicating a local cerebral process. Following bilateral carotid artery stenosis, C5 deficient mice demonstrate decreased white matter ischemia in the corpus callosum when compared to C5 sufficient controls (p<0.05). Further, the C5 deficient mice exhibit fewer reactive astrocytes and microglia (p<0.01). This study reveals that the C5 complement protein may play a critical role in mediating white matter injury through inflammation in the setting of chronic cerebral hypoperfusion.	[Liu, Qinghai; Mack, William J.] Univ So Calif, Keck Sch Med, Zilkha Neurogenet Inst, Los Angeles, CA 90033 USA; [He, Shuhan; Groysman, Leonid; Shaked, David; Russin, Jonathan; Mack, William J.] Univ So Calif, Keck Sch Med, Dept Neurosurg, Los Angeles, CA 90033 USA; [Cen, Steven] Univ So Calif, Keck Sch Med, Dept Preventat Med, Los Angeles, CA 90033 USA	University of Southern California; University of Southern California; University of Southern California	He, SH (corresponding author), Univ So Calif, Keck Sch Med, Dept Neurosurg, Los Angeles, CA 90033 USA.	Shuhanhe@usc.edu	He, Shuhan/AAF-1764-2020	He, Shuhan/0000-0002-9902-5077	NIH KL2 grant through the Southern California CTSI; SC CTSI (NIH/NCRR/NCATS) [KL2RR031991]; Wright Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR031991] Funding Source: NIH RePORTER	NIH KL2 grant through the Southern California CTSI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); SC CTSI (NIH/NCRR/NCATS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Wright Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	WJM is supported by an NIH KL2 grant through the Southern California CTSI. This publication/project was supported by SC CTSI (NIH/NCRR/NCATS) through Grant KL2RR031991, http://www.nih.gov/. SH is supported by the Wright Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afagh A, 1996, EXP NEUROL, V138, P22, DOI 10.1006/exnr.1996.0043; Ager RR, 2010, J NEUROCHEM, V113, P389, DOI 10.1111/j.1471-4159.2010.06595.x; Brouns R, 2009, CLIN NEUROL NEUROSUR, V111, P483, DOI 10.1016/j.clineuro.2009.04.001; de Groot JC, 2001, NEUROLOGY, V56, P1539, DOI 10.1212/WNL.56.11.1539; de la Torre JC, 2004, NEUROL RES, V26, P517, DOI 10.1179/016164104225016254; del Zoppo Gregory J, 2008, Rev Neurol Dis, V5 Suppl 1, pS12; Duan W, 2009, J NEUROL SCI, V285, P39, DOI 10.1016/j.jns.2009.05.010; Ducruet AF, 2008, J CEREBR BLOOD F MET, V28, P1048, DOI 10.1038/sj.jcbfm.9600608; Ducruet AF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038664; Fonseca MI, 2009, J IMMUNOL, V183, P1375, DOI 10.4049/jimmunol.0901005; Foreman KE, 1996, INFLAMMATION, V20, P1, DOI 10.1007/BF01487740; HAVILAND DL, 1991, J BIOL CHEM, V266, P11818; Ihara M, 2001, J CEREBR BLOOD F MET, V21, P828, DOI 10.1097/00004647-200107000-00008; Johnson NA, 2005, RADIOLOGY, V234, P851, DOI 10.1148/radiol.2343040197; Kim GH, 2008, NEUROSURGERY, V63, P122, DOI 10.1227/01.NEU.0000335079.70222.8D; Mack WJ, 2008, ACTA NEUROCHIR, V150, P779, DOI 10.1007/s00701-008-1618-6; Mack WJ, 2006, J NEUROSCI RES, V83, P883, DOI 10.1002/jnr.20775; Masumura M, 2001, NEUROSCI RES, V39, P401, DOI 10.1016/S0168-0102(01)00195-X; Miki K, 2009, J NEUROSCI RES, V87, P1270, DOI 10.1002/jnr.21925; Minkner K, 2005, NEURORADIOLOGY, V47, P425, DOI 10.1007/s00234-005-1358-8; Mocco J, 2006, CIRC RES, V99, P209, DOI 10.1161/01.RES.0000232544.90675.42; Morigi M, 2011, J IMMUNOL, V187, P172, DOI 10.4049/jimmunol.1100491; Mulligan MS, 1997, J IMMUNOL, V158, P1857; Pavlovski D, 2012, FASEB J, V26, P3680, DOI 10.1096/fj.11-202382; Rezkalla SH, 2002, CIRCULATION, V105, P656, DOI 10.1161/hc0502.102867; Rosenberg GA, 2001, STROKE, V32, P1162, DOI 10.1161/01.STR.32.5.1162; Sahu A, 1998, IMMUNOL RES, V17, P109, DOI 10.1007/BF02786436; Shibata M, 2004, STROKE, V35, P2598, DOI 10.1161/01.STR.0000143725.19053.60; Shibata M, 2007, STROKE, V38, P2826, DOI 10.1161/STROKEAHA.107.490151; Suemoto CK, 2011, STROKE, V42, P3614, DOI 10.1161/STROKEAHA.111.628156; Sunyer JO, 1998, IMMUNOL REV, V166, P39, DOI 10.1111/j.1600-065X.1998.tb01251.x; Sunyer JO, 1998, IMMUNOL TODAY, V19, P519; Tomimoto H, 1996, STROKE, V27, P2069, DOI 10.1161/01.STR.27.11.2069; WAKITA H, 1994, ACTA NEUROPATHOL, V87, P484; Webster S, 1997, NEUROBIOL AGING, V18, P415, DOI 10.1016/S0197-4580(97)00042-0; WETSEL RA, 1990, J BIOL CHEM, V265, P2435; WHEAT WH, 1987, J EXP MED, V165, P1442, DOI 10.1084/jem.165.5.1442; Zanjani H, 2005, ALZ DIS ASSOC DIS, V19, P55, DOI 10.1097/01.wad.0000165506.60370.94	38	19	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e84802	10.1371/journal.pone.0084802	http://dx.doi.org/10.1371/journal.pone.0084802			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386419	Green Published, Green Submitted, gold			2022-12-25	WOS:000329194700119
J	Terris-Prestholt, F; Hanson, K; MacPhail, C; Vickerman, P; Rees, H; Watts, C				Terris-Prestholt, Fern; Hanson, Kara; MacPhail, Catherine; Vickerman, Peter; Rees, Helen; Watts, Charlotte			How Much Demand for New HIV Prevention Technologies Can We Really Expect? Results from a Discrete Choice Experiment in South Africa	PLOS ONE			English	Article							VACCINE ACCEPTABILITY; PREEXPOSURE PROPHYLAXIS; EPIDEMIOLOGIC IMPACT; VAGINAL MICROBICIDES; COST-EFFECTIVENESS; MEN; INFECTION; DIAPHRAGM; GEL; SEX	Background: For the first time in the history of HIV, new bio-medical interventions have been shown to be effective in preventing HIV transmission. For these new HIV prevention technologies (NPTs) to have an impact on the epidemic, they must be widely used. This study uses a discrete choice experiment (DCE) to: understand the relative strength of women's preferences for product characteristics, understand the implications for substitution away from male condoms, and inform realistic modelling of their potential impact and cost-effectiveness. Methods: A DCE was conducted among 1017 women in urban South Africa. Women were presented with choices between potential women's NPTs (microbicides, diaphragm, female condom) and 'what I did last time' (use or not use a condom) with different HIV and pregnancy prevention effectiveness' and prices. Choice probabilities are estimated using the nested logit model and used to predict uptake. Results: In this high HIV prevalence setting, HIV prevention effectiveness is the main driver of uptake followed by pregnancy prevention effectiveness. For example a microbicide with poor effectiveness would have niche appeal at just 11% predicted uptake, while a highly effective microbicide (95% effective against HIV and pregnancy) would have far wider appeal (56% predicted uptake). Though women who reported not using condoms were more likely to choose the NPTs, at current very high rates of male condom use in South Africa (60%), about half of microbicide uptake is projected to be among those currently not using condoms. Conclusions: Women are very interested in NPTs, especially if highly effective in preventing HIV and pregnancy. Women in greatest need were also most likely to switch to the new products. Where products are not yet available for distribution, proxy data, such as that generated by DCEs, can bring realism to overly optimistic uptake scenarios found in many current impact models.	[Terris-Prestholt, Fern; Hanson, Kara; Vickerman, Peter; Watts, Charlotte] London Sch Hyg & Trop Med, Dept Global Hlth & Dev, London WC1, England; [MacPhail, Catherine; Rees, Helen] Wits Reprod Hlth & HIV Inst, Johannesburg, Gauteng, South Africa; [MacPhail, Catherine] Univ New England, Collaborat Res Network Mental Hlth & Wellbeing Ru, Armidale, NSW, Australia	University of London; London School of Hygiene & Tropical Medicine; University of New England	Terris-Prestholt, F (corresponding author), London Sch Hyg & Trop Med, Dept Global Hlth & Dev, London WC1, England.	Fern.Terris-Prestholt@lshtm.ac.uk	MacPhail, Catherine/N-4234-2014	MacPhail, Catherine/0000-0002-0614-0157; Rees, Helen/0000-0003-1442-6734; Vickerman, Peter/0000-0002-8291-5890; Terris-Prestholt, Fern/0000-0003-1693-5196	Faculty of Public Health and Policy at the London School of Hygiene and Tropical Medicine; Microbicide Development Programme (MDP); British Department for International Development (DfID); UK Medical Research Council	Faculty of Public Health and Policy at the London School of Hygiene and Tropical Medicine; Microbicide Development Programme (MDP); British Department for International Development (DfID); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was funded by a fellowship supported by the Faculty of Public Health and Policy at the London School of Hygiene and Tropical Medicine and the Microbicide Development Programme (MDP). MDP is a partnership of African UK and Spanish academic/government institutions and commercial organisations. MDP was funded by the British Department for International Development (DfID) and the UK Medical Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsallaq RA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054575; Barnighausen T, 2012, P NATL ACAD SCI USA, V109, P21271, DOI 10.1073/pnas.1209017110; Baeten JM, 2012, NEW ENGL J MED, V367, P399, DOI 10.1056/NEJMoa1108524; Beksinska ME, 2012, SEX HEALTH, V9, P51, DOI 10.1071/SH11011; Brau R, 2008, HEALTH ECON, V17, P411, DOI 10.1002/hec.1271; Cameron MP, 2013, VACCINE, V31, P3712, DOI 10.1016/j.vaccine.2013.05.089; ChoiceMetrics Pty Ltd, 2010, NGEN 1 1, V1; Clark MR, 2011, INFECT DIS OBSTET GY, V2011; Cohen J., 2003, APPL MULTIPLE REGRES; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; Cremin I, 2013, AIDS, V27, P447, DOI 10.1097/QAD.0b013e32835ca2dd; Department of Health Medical Research Council OrcMacro, 2007, S AFR DEM HLTH SURV; Dimitrov DT, 2011, J THEOR BIOL, V288, P9, DOI 10.1016/j.jtbi.2011.08.001; FACTS consortium, 2012, FACTS 001 STUD; Friend DR, 2010, ANTIVIR RES, V88, pS47, DOI 10.1016/j.antiviral.2010.09.005; Gafos M, 2013, AIDS CARE, V25, P573, DOI 10.1080/09540121.2012.722604; Galea JT, 2011, INT J STD AIDS, V22, P256, DOI 10.1258/ijsa.2009.009255; Gomez GB, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001323; Granich R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030216; Gray RT, 2011, VACCINE, V29, P6125, DOI 10.1016/j.vaccine.2011.06.061; Greene William H., 2012, ECONOMETRIC ANAL, Vseventh; Hallett TB, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001123; Harrison PF, 2013, AIDS RES TREAT, V2013, DOI 10.1155/2013/790154; Henscher D, 2005, APPL CHOICE ANAL PRI; Hensher DA, 2010, TRANSPORT RES B-METH, V44, P735, DOI 10.1016/j.trb.2009.12.012; Holt BY, 2010, CONTRACEPTION, V81, P177, DOI 10.1016/j.contraception.2009.11.009; Holt K, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002208; KARIM QA, 2010, SCIENCE; Kinsler JJ, 2012, AIDS BEHAV, V16, P1436, DOI 10.1007/s10461-011-0045-5; Lee SJ, 2012, INT J STD AIDS, V23, P235, DOI 10.1258/ijsa.2011.011189; Lee SJ, 2008, AIDS CARE, V20, P1161, DOI 10.1080/09540120701855375; Luchters S, 2007, EUR J CONTRACEP REPR, V12, P345, DOI 10.1080/13625180701516989; MacPhail C, 2008, MICROBICIDES 2008; MacPhail C, 2009, CULT HEALTH SEX, V11, P485, DOI 10.1080/13691050902803537; Marrazzo J, 2013, PREEXPOSURE PROPHYLA; McCormack S, 2010, LANCET, V376, P1329, DOI 10.1016/S0140-6736(10)61086-0; Mensch BS, 2012, CURR OPIN HIV AIDS, V7, P534, DOI 10.1097/COH.0b013e3283590632; Montgomery CM, 2008, AIDS CARE, V20, P733, DOI 10.1080/09540120701693974; Newman PA, 2010, VACCINE, V28, P958, DOI 10.1016/j.vaccine.2009.10.142; Newman PA, 2009, HEALTH SERV RES, V44, P2167, DOI 10.1111/j.1475-6773.2009.01039.x; Nunn A, 2009, TRIALS, V10, DOI 10.1186/1745-6215-10-99; OANDA, 2013, OANDA CURR CONV; Padian NS, 2007, LANCET, V370, P251, DOI 10.1016/S0140-6736(07)60950-7; Phillips AE, 2010, INT J EPIDEMIOL, V39, P1541, DOI 10.1093/ije/dyq114; Schwartz JL, 2008, CONTRACEPTION, V78, P237, DOI 10.1016/j.contraception.2008.04.118; Shisana O, 2009, S AFRICAN NATL HIV P; Shisana O., 2002, N MANDELA HSRC STUDY; Terris-Prestholt F., 2010, DETERMINANTS WOMENS; Terris-Prestholt F, 2009, VARIATION WOMENS PRE; Underhill K, 2013, SOC SCI MED; Verguet S, 2010, SEX TRANSM INFECT, V86, P212, DOI 10.1136/sti.2009.037176; Verguet S, 2013, SEXUALLY TRANSMITTED; Walensky RP, 2012, CLIN INFECT DIS, V54, P1504, DOI 10.1093/cid/cis225; Williams BG, 2011, JAIDS-J ACQ IMM DEF, V58, P207, DOI 10.1097/QAI.0b013e3182253c19	54	43	43	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e83193	10.1371/journal.pone.0083193	http://dx.doi.org/10.1371/journal.pone.0083193			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	282SX	24386160	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000329194700028
J	Yang, MX; Li, XM; Li, ZB; Ou, ZM; Liu, M; Liu, SH; Li, XJ; Yang, SY				Yang, Mingxing; Li, Xiumin; Li, Zhibin; Ou, Zhimin; Liu, Ming; Liu, Suhuan; Li, Xuejun; Yang, Shuyu			Gene Features Selection for Three-Class Disease Classification via Multiple Orthogonal Partial Least Square Discriminant Analysis and S-Plot Using Microarray Data	PLOS ONE			English	Article							DIFFERENTIALLY EXPRESSED GENES; MOLECULAR CLASSIFICATION; MATRIX FACTORIZATION; TUMOR CLASSIFICATION; PLS-DA; CANCER; MULTICLASS; PREDICTION; REGRESSION; MODELS	Motivation: DNA microarray analysis is characterized by obtaining a large number of gene variables from a small number of observations. Cluster analysis is widely used to analyze DNA microarray data to make classification and diagnosis of disease. Because there are so many irrelevant and insignificant genes in a dataset, a feature selection approach must be employed in data analysis. The performance of cluster analysis of this high-throughput data depends on whether the feature selection approach chooses the most relevant genes associated with disease classes. Results: Here we proposed a new method using multiple Orthogonal Partial Least Squares-Discriminant Analysis (mOPLS-DA) models and S-plots to select the most relevant genes to conduct three-class disease classification and prediction. We tested our method using Golub's leukemia microarray data. For three classes with subtypes, we proposed hierarchical orthogonal partial least squares-discriminant analysis (OPLS-DA) models and S-plots to select features for two main classes and their subtypes. For three classes in parallel, we employed three OPLS-DA models and S-plots to choose marker genes for each class. The power of feature selection to classify and predict three-class disease was evaluated using cluster analysis. Further, the general performance of our method was tested using four public datasets and compared with those of four other feature selection methods. The results revealed that our method effectively selected the most relevant features for disease classification and prediction, and its performance was better than that of the other methods.	[Yang, Mingxing; Li, Xiumin; Li, Zhibin; Ou, Zhimin; Liu, Ming; Liu, Suhuan; Li, Xuejun; Yang, Shuyu] Xiamen Univ, Affiliated Hosp 1, Xiamen Diabet Inst, Xiamen, Peoples R China; [Li, Xuejun] Xiamen Univ, Affiliated Hosp 1, Dept Endocrinol & Diabet, Xiamen, Peoples R China; [Yang, Mingxing] Xiamen Univ, Sch Phys & Mech & Elect Engn, Dept Elect Sci, Xiamen, Peoples R China	Xiamen University; Xiamen University; Xiamen University	Li, XJ (corresponding author), Xiamen Univ, Affiliated Hosp 1, Xiamen Diabet Inst, Xiamen, Peoples R China.	lixuejun99@aliyun.com; xmyangshuyu@126.com	li, xiu/GXV-1745-2022		Xiamen Science and Technology Bureau [3502Z20100001]; National Natural Science Foundation [30973912, 81073113, 81270901]	Xiamen Science and Technology Bureau; National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	This work was supported by Xiamen Science and Technology Bureau (Xiamen Research Platform for Systems Biology of Metabolic Disease,3502Z20100001), National Natural Science Foundation to Shuyu Yang (30973912), Xuejun Li (81073113) and Suhuan Liu (81270901). The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the menuscript.	Alon U, 1999, P NATL ACAD SCI USA, V96, P6745, DOI 10.1073/pnas.96.12.6745; Armstrong SA, 2002, NAT GENET, V30, P41, DOI 10.1038/ng765; Bicciato S, 2003, BIOINFORMATICS, V19, P571, DOI 10.1093/bioinformatics/btg051; Brown MPS, 2000, P NATL ACAD SCI USA, V97, P262, DOI 10.1073/pnas.97.1.262; Bylesjo M, 2006, J CHEMOMETR, V20, P341, DOI 10.1002/cem.1006; Caraux G, 2005, BIOINFORMATICS, V21, P1280, DOI 10.1093/bioinformatics/bti141; Devore J., 1997, STAT EXPLORATION ANA; Dudoit S, 2002, J AM STAT ASSOC, V97, P77, DOI 10.1198/016214502753479248; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Eriksson L, 2003, ENVIRON HEALTH PERSP, V111, P1361, DOI 10.1289/ehp.5758; Eriksson L., 2006, MULTI MEGAVARIATE 1; Eriksson L., 2008, DESIGN EXPT PRINCIPL, V3rd ed.; Eriksson L, 2008, J CHEMOMETR, V22, P594, DOI 10.1002/cem.1187; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Haury AC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028210; He QH, 2012, J NUTR BIOCHEM, V23, P133, DOI 10.1016/j.jnutbio.2010.11.007; Huang CY, 2013, J PROTEOME RES, V12, P537, DOI 10.1021/pr301033a; Jenssen R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042947; Khan J, 2001, NAT MED, V7, P673, DOI 10.1038/89044; Lee DD, 1999, NATURE, V401, P788, DOI 10.1038/44565; Lee KR, 2003, PROTEOMICS, V3, P1680, DOI 10.1002/pmic.200300515; Lee Y, 2003, BIOINFORMATICS, V19, P1132, DOI 10.1093/bioinformatics/btg102; Li LP, 2001, BIOINFORMATICS, V17, P1131, DOI 10.1093/bioinformatics/17.12.1131; Liao W, 2012, J PROTEOME RES, V11, P3436, DOI 10.1021/pr300284h; Molteni CG, 2009, QSAR COMB SCI, V28, P822, DOI 10.1002/qsar.200860195; Nguyen DV, 2002, BIOINFORMATICS, V18, P1625, DOI 10.1093/bioinformatics/18.12.1625; Nguyen DV, 2002, BIOINFORMATICS, V18, P39, DOI 10.1093/bioinformatics/18.1.39; PAATERO P, 1994, ENVIRONMETRICS, V5, P111, DOI 10.1002/env.3170050203; Perez-Enciso M, 2003, HUM GENET, V112, P581, DOI 10.1007/s00439-003-0921-9; Porto-Pazos AB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019109; Purohit PV, 2003, PROTEOMICS, V3, P1699, DOI 10.1002/pmic.200300518; Ramaswamy S, 2001, P NATL ACAD SCI USA, V98, P15149, DOI 10.1073/pnas.211566398; Shi XH, 2013, J PROTEOME RES; Skupin A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058779; Statnikov A, 2005, BIOINFORMATICS, V21, P631, DOI 10.1093/bioinformatics/bti033; Stephanopoulos G, 2002, BIOINFORMATICS, V18, P1054, DOI 10.1093/bioinformatics/18.8.1054; Su AI, 2001, CANCER RES, V61, P7388; Tan YX, 2004, COMPUT BIOL CHEM, V28, P235, DOI 10.1016/j.compbiolchem.2004.05.002; Thomas JG, 2001, GENOME RES, V11, P1227, DOI 10.1101/gr.165101; Tian Y, 2012, J PROTEOME RES, V11, P1397, DOI 10.1021/pr2011507; Troyanskaya OG, 2002, BIOINFORMATICS, V18, P1454, DOI 10.1093/bioinformatics/18.11.1454; Trygg J, 2002, J CHEMOMETR, V16, P283, DOI 10.1002/cem.724; Trygg J, 2002, J CHEMOMETR, V16, P119, DOI 10.1002/cem.695; Trygg J, 2007, J PROTEOME RES, V6, P469, DOI 10.1021/pr060594q; Wang J, 2012, 21 INT C PATT REC IC; Wang JJY, 2013, PATTERN RECOGN, V46, P2840, DOI 10.1016/j.patcog.2013.03.007; Wang JJY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-107; Whelehan OP, 2006, CHEMOMETR INTELL LAB, V84, P82, DOI 10.1016/j.chemolab.2006.03.008; Wiklund S, 2008, ANAL CHEM, V80, P115, DOI 10.1021/ac0713510; Wold H., 1975, PERSPECTIVES PROBABI, V12, P117, DOI [10.1017/s0021900200047604, DOI 10.1017/S0021900200047604, 10.1017/S0021900200047604]; Wold S, 1998, CHEMOMETR INTELL LAB, V44, P175, DOI 10.1016/S0169-7439(98)00109-9; WOLD S, 1987, CHEMOMETR INTELL LAB, V2, P37, DOI 10.1016/0169-7439(87)80084-9; Wold S, 2001, CHEMOMETR INTELL LAB, V58, P109, DOI 10.1016/S0169-7439(01)00155-1; WOLD S, 1984, SIAM J SCI STAT COMP, V5, P735, DOI 10.1137/0905052; Xie GX, 2012, J PROTEOME RES, V11, P3449, DOI 10.1021/pr300318m; Yang MX, 2012, TALANTA, V88, P136, DOI 10.1016/j.talanta.2011.10.022; Yeung KY, 2005, BIOINFORMATICS, V21, P2394, DOI 10.1093/bioinformatics/bti319	57	31	34	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e84253	10.1371/journal.pone.0084253	http://dx.doi.org/10.1371/journal.pone.0084253			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386356	gold, Green Submitted, Green Published			2022-12-25	WOS:000329194700097
J	Zeng, J; Chen, XX; Dai, JP; Zhao, XF; Xin, G; Su, Y; Wang, GF; Li, R; Yan, YX; Su, JH; Deng, YX; Li, KS				Zeng, Jun; Chen, Xiao Xuan; Dai, Jian Ping; Zhao, Xiang Feng; Xin, Gang; Su, Yun; Wang, Ge Fei; Li, Rui; Yan, Yin Xia; Su, Jing Hua; Deng, Yu Xue; Li, Kang Sheng			An Attenuated Coxsackievirus B3 Vector: A Potential Tool for Viral Tracking Study and Gene Delivery	PLOS ONE			English	Article							HEART-FAILURE; EXPRESSION; CARDIOVIRULENT; TRANSDUCTION; GENERATION; THERAPY; GENOME; MICE	Cardiomyocytes are quite resistant to gene transfer using standard techniques. We developed an expression vector carrying an attenuated but infectious and replicative coxsackievirus B3 (CVB3) genome, and unique ClaI-StuI cloning sites for an exogenous gene, whose product can be released from the nascent viral polyprotein by 2A(pro) cleavage. This vector was tested as an expression vehicle for green fluorescent protein (GFP). The vector transiently expressed GFP in cell cultures for at least ten passages and delivered functional GFP to the infected cardiomyocytes for at least 6 days. Moreover, the recombinant viruses showed virulence attenuation in vitro and in vivo. The findings suggest that the recombinant CVB3 vector could be a useful tool for viral tracking study and delivering exogenous proteins to cardiomyocytes.	[Zeng, Jun; Chen, Xiao Xuan; Dai, Jian Ping; Zhao, Xiang Feng; Xin, Gang; Su, Yun; Wang, Ge Fei; Li, Rui; Yan, Yin Xia; Su, Jing Hua; Deng, Yu Xue; Li, Kang Sheng] Shantou Univ, Dept Microbiol & Immunol, Coll Med, Shantou, Guangdong, Peoples R China; [Zeng, Jun] Three Gorges Univ, Coll Med, Dept Endocrinol, Hosp Yichang 1, Yichang, Hubei, Peoples R China	Shantou University; China Three Gorges University	Wang, GF (corresponding author), Shantou Univ, Dept Microbiol & Immunol, Coll Med, Shantou, Guangdong, Peoples R China.	gfwangcn@gmail.com; ksli@stu.edu.cn		Li, Kangsheng/0000-0002-6981-9263; Zeng, Jun/0000-0002-4317-2182	National Natural Science Foundation of China [81001322, 30972766, 31170852, 31300761]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (81001322, 30972766 and 31170852). This study was also supported in part by National Natural Science Foundation of China (31300761). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey JM, 2007, J VIROL, V81, P650, DOI 10.1128/JVI.01327-06; Bonci D, 2003, GENE THER, V10, P630, DOI 10.1038/sj.gt.3301936; Chaanine AH, 2010, SEMIN THORAC CARDIOV, V22, P127, DOI 10.1053/j.semtcvs.2010.09.009; Chapman NM, 2000, J VIROL, V74, P7952, DOI 10.1128/JVI.74.17.7952-7962.2000; Coyne CB, 2006, CELL, V124, P119, DOI 10.1016/j.cell.2005.10.035; Djurovic S, 2004, MOL BIOTECHNOL, V28, P21, DOI 10.1385/MB:28:1:21; Esfandiarei M, 2008, ANNU REV PATHOL-MECH, V3, P127, DOI 10.1146/annurev.pathmechdis.3.121806.151534; Harvala H, 2005, J GEN VIROL, V86, P1897, DOI 10.1099/vir.0.80603-0; Hofling K, 2000, J VIROL, V74, P4570, DOI 10.1128/JVI.74.10.4570-4578.2000; Kim DS, 2010, EXPERT OPIN BIOL TH, V10, P179, DOI 10.1517/14712590903379502; Ly HQ, 2008, J CARDIOVASC TRANSL, V1, P127, DOI 10.1007/s12265-008-9022-4; Meyer RG, 2004, VIRUS RES, V104, P17, DOI 10.1016/j.virusres.2004.02.037; Molin Y, 2009, MICROBES INFECT, V11, P493, DOI 10.1016/j.micinf.2009.02.002; Mueller S, 1998, J VIROL, V72, P20, DOI 10.1128/JVI.72.1.20-31.1998; Pan JY, 2011, J VIROL, V85, P7436, DOI 10.1128/JVI.00503-11; Tilemann L, 2012, CIRC RES, V110, P777, DOI 10.1161/CIRCRESAHA.111.252981; Toivonen R, 2010, HISTOCHEM CELL BIOL, V133, P349, DOI 10.1007/s00418-009-0666-1; TRACY S, 1992, ARCH VIROL, V122, P399, DOI 10.1007/BF01317202; TU ZG, 1995, J VIROL, V69, P4607, DOI 10.1128/JVI.69.8.4607-4618.1995	19	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e83753	10.1371/journal.pone.0083753	http://dx.doi.org/10.1371/journal.pone.0083753			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386270	gold, Green Published, Green Submitted			2022-12-25	WOS:000329194700064
J	Akhmedov, K; Rizzo, V; Kadakkuzha, BM; Carter, CJ; Magoski, NS; Capo, TR; Puthanveettil, SV				Akhmedov, Komolitdin; Rizzo, Valerio; Kadakkuzha, Beena M.; Carter, Christopher J.; Magoski, Neil S.; Capo, Thomas R.; Puthanveettil, Sathyanarayanan V.			Decreased Response to Acetylcholine during Aging of Aplysia Neuron R15	PLOS ONE			English	Article							AGE-RELATED-CHANGES; CHOLINERGIC SYNAPTIC-TRANSMISSION; MESSENGER-RNA EXPRESSION; CALCIUM-CHANNELS; ELECTROPHYSIOLOGICAL PROPERTIES; ABDOMINAL-GANGLION; IDENTIFIED NEURONS; BEHAVIORAL-CHANGES; PYRAMIDAL CELLS; HUMAN BRAIN	How aging affects the communication between neurons is poorly understood. To address this question, we have studied the electrophysiological properties of identified neuron R15 of the marine mollusk Aplysia californica. R15 is a bursting neuron in the abdominal ganglia of the central nervous system and is implicated in reproduction, water balance, and heart function. Exposure to acetylcholine (ACh) causes an increase in R15 burst firing. Whole-cell recordings of R15 in the intact ganglia dissected from mature and old Aplysia showed specific changes in burst firing and properties of action potentials induced by ACh. We found that while there were no significant changes in resting membrane potential and latency in response to ACh, the burst number and burst duration is altered during aging. The action potential waveform analysis showed that unlike mature neurons, the duration of depolarization and the repolarization amplitude and duration did not change in old neurons in response to ACh. Furthermore, single neuron quantitative analysis of acetylcholine receptors (AChRs) suggested alteration of expression of specific AChRs in R15 neurons during aging. These results suggest a defect in cholinergic transmission during aging of the R15 neuron.	[Akhmedov, Komolitdin; Rizzo, Valerio; Kadakkuzha, Beena M.; Puthanveettil, Sathyanarayanan V.] Scripps Florida, Scripps Res Inst, Dept Neurosci, Jupiter, FL 33458 USA; [Carter, Christopher J.; Magoski, Neil S.] Queens Univ, Dept Biomed & Mol Sci, Kingston, ON, Canada; [Capo, Thomas R.] Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, Div Marine Biol & Fisheries, Miami, FL 33149 USA	Scripps Research Institute; State University System of Florida; University of Florida; Queens University - Canada; University of Miami	Puthanveettil, SV (corresponding author), Scripps Florida, Scripps Res Inst, Dept Neurosci, Jupiter, FL 33458 USA.	sputhanv@scripps.edu	Kadakkuzha, Beena/B-8344-2014	Kadakkuzha, Beena/0000-0001-8225-5231; Rizzo, Valerio/0000-0002-6610-7324	Landenberger Foundation; Whitehall foundation; Scripps Research Institute; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010952] Funding Source: NIH RePORTER	Landenberger Foundation; Whitehall foundation; Scripps Research Institute; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We gratefully acknowledge funding support from Landenberger Foundation, Whitehall foundation, and start up funds from The Scripps Research Institute to carry out this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS WB, 1985, J PHYSIOL-LONDON, V360, P51, DOI 10.1113/jphysiol.1985.sp015603; ADAMS WB, 1985, PROG BIOPHYS MOL BIO, V46, P1, DOI 10.1016/0079-6107(85)90011-2; Akhmedov K, 2014, JOVE-J VIS EXP, DOI 10.3791/51075; ALEVIZOS A, 1991, J NEUROSCI, V11, P1275; ALEVIZOS A, 1991, J NEUROSCI, V11, P1263; ALEVIZOS A, 1991, J NEUROSCI, V11, P1282; Almaguer W, 2002, NEUROBIOL AGING, V23, P319, DOI 10.1016/S0197-4580(01)00278-0; BAILEY CH, 1983, BEHAV NEURAL BIOL, V38, P70, DOI 10.1016/S0163-1047(83)90399-0; Bean BP, 2007, NAT REV NEUROSCI, V8, P451, DOI 10.1038/nrn2148; Bertoni-Freddari C, 2007, ANN NY ACAD SCI, V1096, P128, DOI 10.1196/annals.1397.078; BLANKENSHIP JE, 1971, J NEUROPHYSIOL, V34, P76, DOI 10.1152/jn.1971.34.1.76; BUTERA RJ, 1995, J COMPUT NEUROSCI, V2, P19, DOI 10.1007/BF00962706; Cai SQ, 2009, NAT NEUROSCI, V12, P611, DOI 10.1038/nn.2291; CANAVIER CC, 1991, J NEUROPHYSIOL, V66, P2107, DOI 10.1152/jn.1991.66.6.2107; CARPENTER DO, 1978, ABNORMAL NEURONAL DI, P189; CEPEDA C, 1992, NEUROSCIENCE, V51, P411, DOI 10.1016/0306-4522(92)90325-V; Charpantier E, 1999, DEV BRAIN RES, V118, P153, DOI 10.1016/S0165-3806(99)00157-1; DRACHMAN DA, 1974, ARCH NEUROL-CHICAGO, V30, P113, DOI 10.1001/archneur.1974.00490320001001; Ferrari R, 1999, NEUROBIOL AGING, V20, P37, DOI 10.1016/S0197-4580(99)00015-9; Fieber LA, 2010, BRAIN RES, V1343, P28, DOI 10.1016/j.brainres.2010.05.001; Flinn Jane M., 1997, Invertebrate Neuroscience, V2, P253, DOI 10.1007/BF02211938; FRAZIER WT, 1967, J NEUROPHYSIOL, V30, P1288, DOI 10.1152/jn.1967.30.6.1288; Gerdes R, 2006, J AM ASSOC LAB ANIM, V45, P40; HERMANN A, 1981, J GEN PHYSIOL, V78, P63, DOI 10.1085/jgp.78.1.63; Jung DK, 2005, NEUROL RES, V27, P436, DOI 10.1179/016164105X22011; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; Kelly KM, 2003, EPILEPSY RES, V57, P15, DOI 10.1016/j.eplepsyres.2003.10.007; KINDY MS, 1991, NEUROREPORT, V2, P465, DOI 10.1097/00001756-199108000-00014; LANDFIELD PW, 1978, BRAIN RES, V150, P85, DOI 10.1016/0006-8993(78)90655-8; Leal SL, 2013, AGEING RES REV, V12, P823, DOI 10.1016/j.arr.2013.01.006; LEVITAN ES, 1987, P NATL ACAD SCI USA, V84, P6307, DOI 10.1073/pnas.84.17.6307; Luebke JI, 2007, NEUROSCIENCE, V150, P556, DOI 10.1016/j.neuroscience.2007.09.042; Luebke JI, 2004, NEUROSCIENCE, V125, P277, DOI 10.1016/j.neuroscience.2004.01.035; Luebke JI, 2003, J COMP NEUROL, V460, P573, DOI 10.1002/cne.10668; Martella G, 2008, NEUROSCIENCE, V152, P469, DOI 10.1016/j.neuroscience.2007.12.040; Marutle A, 1998, BRAIN RES, V801, P143, DOI 10.1016/S0006-8993(98)00558-7; MEYER EM, 1984, NEUROBIOL AGING, V5, P315, DOI 10.1016/0197-4580(84)90008-3; Moroz LL, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/neuro.24.006.2010; Mostany R, 2013, J NEUROSCI, V33, P4094, DOI 10.1523/JNEUROSCI.4825-12.2013; Murphy GG, 2004, CURR BIOL, V14, P1907, DOI 10.1016/j.cub.2004.10.021; Nygard M, 2005, BRAIN RES BULL, V65, P149, DOI 10.1016/j.brainresbull.2004.12.006; PAPKA R, 1981, J NEUROBIOL, V12, P455, DOI 10.1002/neu.480120505; PERETZ B, 1984, P NATL ACAD SCI-BIOL, V81, P4232; PERETZ B, 1982, J NEUROBIOL, V13, P141, DOI 10.1002/neu.480130206; Perry E, 2000, EUR J PHARMACOL, V393, P215, DOI 10.1016/S0014-2999(00)00064-9; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; RATTAN KS, 1981, J NEUROBIOL, V12, P469, DOI 10.1002/neu.480120506; Rex CS, 2005, J NEUROSCI, V25, P5956, DOI 10.1523/JNEUROSCI.0880-05.2005; Rogers SW, 1998, J NEUROSCI, V18, P4825; Rosenzweig ES, 2003, PROG NEUROBIOL, V69, P143, DOI 10.1016/S0301-0082(02)00126-0; Schliebs R, 2011, BEHAV BRAIN RES, V221, P555, DOI 10.1016/j.bbr.2010.11.058; Shen JM, 1996, NEUROBIOL AGING, V17, P439, DOI 10.1016/0197-4580(96)00020-6; Sibille Etienne, 2013, Dialogues Clin Neurosci, V15, P53; Sloan MA, 1999, J BIOL RHYTHM, V14, P151, DOI 10.1177/074873099129000542; SMITH DO, 1987, J NEUROCHEM, V48, P1834, DOI 10.1111/j.1471-4159.1987.tb05744.x; Southall MD, 1997, COMP BIOCHEM PHYS C, V118, P137, DOI 10.1016/S0742-8413(97)00109-6; Srivatsan M, 1996, BEHAV BRAIN RES, V77, P115, DOI 10.1016/0166-4328(95)00207-3; Stanley EM, 2012, SYNAPSE, V66, P445, DOI 10.1002/syn.21533; Stocker PJ, 2006, J GEN PHYSIOL, V127, P253, DOI 10.1085/jgp.200509423; Stommes D, 2005, CONTEMP TOP LAB ANIM, V44, P31; Tanaka Y, 1996, J NEUROSCI RES, V43, P63, DOI 10.1002/jnr.490430108; Tanaka Y, 2001, NEUROSCI RES, V39, P213, DOI 10.1016/S0168-0102(00)00212-1; TAYLOR L, 1993, NEUROBIOL AGING, V14, P509, DOI 10.1016/0197-4580(93)90110-W; Thibault O, 1996, SCIENCE, V272, P1017, DOI 10.1126/science.272.5264.1017; Tombaugh GC, 2002, J NEUROSCI, V22, P9932; TREMBLAY JP, 1976, BRAIN RES, V109, P61, DOI 10.1016/0006-8993(76)90380-2; Utsugisawa K, 1999, NEUROSCI LETT, V270, P145, DOI 10.1016/S0304-3940(99)00473-5; Wang Y, 2009, NEUROBIOL AGING, V30, P1061, DOI 10.1016/j.neurobiolaging.2007.10.009; Woodruff-Pak DS, 2010, P NATL ACAD SCI USA, V107, P1624, DOI 10.1073/pnas.0914207107; Yankner BA, 2008, ANNU REV PATHOL-MECH, V3, P41, DOI 10.1146/annurev.pathmechdis.2.010506.092044; Yu XT, 2004, J NEUROPHYSIOL, V91, P2297, DOI 10.1152/jn.00787.2003; ZOLMAN JF, 1987, BEHAV NEUROSCI, V101, P524, DOI 10.1037/0735-7044.101.4.524	72	16	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e84793	10.1371/journal.pone.0084793	http://dx.doi.org/10.1371/journal.pone.0084793			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281RE	24386417	Green Published, Green Submitted, gold			2022-12-25	WOS:000329117900111
J	Menon, R; Boldogh, I; Urrabaz-Garza, R; Polettini, J; Syed, TA; Saade, GR; Papaconstantinou, J; Taylor, RN				Menon, Ramkumar; Boldogh, Istvan; Urrabaz-Garza, Rheanna; Polettini, Jossimara; Syed, Tariq Ali; Saade, George R.; Papaconstantinou, John; Taylor, Robert N.			Senescence of Primary Amniotic Cells via Oxidative DNA Damage	PLOS ONE			English	Article							PRETERM PREMATURE RUPTURE; FACTOR-KAPPA-B; CIGARETTE-SMOKE; EPITHELIAL-CELLS; IN-VIVO; STRESS; ACTIVATION; MEMBRANES; OXYGEN; APOPTOSIS	Objective: Oxidative stress is a postulated etiology of spontaneous preterm birth (PTB) and preterm prelabor rupture of the membranes (pPROM); however, the precise mechanistic role of reactive oxygen species (ROS) in these complications is unclear. The objective of this study is to examine impact of a water soluble cigarette smoke extract (wsCSE), a predicted cause of pregnancy complications, on human amnion epithelial cells. Methods: Amnion cells isolated from fetal membranes were exposed to wsCSE prepared in cell culture medium and changes in ROS levels, DNA base and strand damage was determined by using 2 ' 7 '-dichlorodihydro-fluorescein and comet assays as well as Fragment Length Analysis using Repair Enzymes (FLARE) assays, respectively. Western blot analyses were used to determine the changes in mass and post-translational modification of apoptosis signal-regulating kinase (ASK1), phospho-p38 (P-p38 MAPK), and p19(arf). Expression of senescence-associated beta-galectosidase (SA beta-gal) was used to confirm cell ageing in situ. Results: ROS levels in wsCSE-exposed amnion cells increased rapidly (within 2 min) and significantly (p < 0.01) at all-time points, and DNA strand and base damage was evidenced by comet and FLARE assays. Activation of ASK1, P-p38 MAPK and p19(Arf) correlated with percentage of SA beta-gal expressing cells after wsCSE treatment. The antioxidant N-acetyl-L-cysteine (NAC) prevented ROS-induced DNA damage and phosphorylation of p38 MAPK, whereas activation of ASK1 and increased expression of p19(Arf) were not significantly affected by NAC. Conclusions: The findings support the hypothesis that compounds in wsCSE induces amnion cell senescence via a mechanism involving ROS and DNA damage. Both pathways may contribute to PTB and pPROM. Our results imply that antioxidant interventions that control ROS may interrupt pathways leading to pPROM and other causes of PTB.	[Menon, Ramkumar; Urrabaz-Garza, Rheanna; Polettini, Jossimara; Syed, Tariq Ali; Saade, George R.] Univ Texas Med Branch, Dept Obstet & Gynecol, Div Maternal Fetal Med Perinatal Res, Galveston, TX 77555 USA; [Boldogh, Istvan] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA; [Papaconstantinou, John] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA; [Taylor, Robert N.] Wake Forest Sch Med, Dept Obstet & Gynecol, Winston Salem, NC USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; Wake Forest University	Menon, R (corresponding author), Univ Texas Med Branch, Dept Obstet & Gynecol, Div Maternal Fetal Med Perinatal Res, Galveston, TX 77555 USA.	Ram.menon@utmb.edu	Polettini, Jossimara/K-9437-2014; Polettini, Jossimara/M-8562-2019; Polettini, Jossimara/C-5814-2012	Polettini, Jossimara/0000-0002-6719-8715; Polettini, Jossimara/0000-0002-6719-8715; Polettini, Jossimara/0000-0002-6719-8715	UTMB development funds	UTMB development funds	This work was supported by UTMB development funds provided to RM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal A, 2005, REPROD BIOL ENDOCRIN, V3, DOI 10.1186/1477-7827-3-28; Barreiro E, 2010, AM J RESP CRIT CARE, V182, P477, DOI 10.1164/rccm.200908-1220OC; BENNETT PR, 1987, AM J OBSTET GYNECOL, V156, P649, DOI 10.1016/0002-9378(87)90070-6; Boldogh I, 2012, J BIOL CHEM, V287, P20769, DOI 10.1074/jbc.C112.364620; Burton GJ, 2011, BEST PRACT RES CL OB, V25, P287, DOI 10.1016/j.bpobgyn.2010.10.016; Burton GJ, 2009, J ANAT, V215, P27, DOI 10.1111/j.1469-7580.2008.00978.x; Cha J, 2012, CELL CYCLE, V11, P205, DOI 10.4161/cc.11.2.18781; Cindrova-Davies T, 2007, AM J PATHOL, V170, P1511, DOI 10.2353/ajpath.2007.061035; Colombo G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029930; Colombo G, 2010, ANTIOXID REDOX SIGN, V12, P349, DOI 10.1089/ars.2009.2806; Coughlan MT, 2004, J CLIN ENDOCR METAB, V89, P3585, DOI 10.1210/jc.2003-031953; Cukusic A, 2008, CYTOGENET GENOME RES, V122, P263, DOI 10.1159/000167812; d'Adda di Fagagna F, 2003, NATURE, V426, P194, DOI [10.1038/nature02118, DOI 10.1038/NATURE02118]; De Boeck M, 2000, MUTAT RES-GEN TOX EN, V469, P181, DOI 10.1016/S1383-5718(00)00075-9; Dennery PA, 2010, FREE RADICAL BIO MED, V49, P1147, DOI 10.1016/j.freeradbiomed.2010.07.011; Dietrich M, 2003, AM J CLIN NUTR, V77, P160, DOI 10.1093/ajcn/77.1.160; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Faux SP, 2009, BIOMARKERS, V14, P90, DOI 10.1080/13547500902965047; Freund A, 2011, EMBO J, V30, P1536, DOI 10.1038/emboj.2011.69; Herbig U, 2004, MOL CELL, V14, P501, DOI 10.1016/S1097-2765(04)00256-4; Hill JW, 2001, NUCLEIC ACIDS RES, V29, P430, DOI 10.1093/nar/29.2.430; Hirota Y, 2011, P NATL ACAD SCI USA, V108, P18073, DOI 10.1073/pnas.1108180108; Hoenicke L, 2012, CARCINOGENESIS, V33, P1123, DOI 10.1093/carcin/bgs124; Hsieh CC, 2010, AGING-US, V2, P582, DOI 10.18632/aging.100194; Hsieh CC, 2009, AGING-US, V1, P784, DOI 10.18632/aging.100077; Kniss DA, 2002, PLACENTA, V23, P32, DOI 10.1053/plac.2001.0749; Lappas M, 2003, J CLIN ENDOCR METAB, V88, P1723, DOI 10.1210/jc.2002-021677; LEANDERSON P, 1993, ANN NY ACAD SCI, V686, P249, DOI 10.1111/j.1749-6632.1993.tb39183.x; Lim R, 2013, REPROD SCI, V20, P957, DOI 10.1177/1933719112472741; Longini M, 2007, CLIN BIOCHEM, V40, P793, DOI 10.1016/j.clinbiochem.2007.03.004; Menon R, 2004, J PERINAT MED, V32, P391, DOI 10.1515/JPM.2004.134; Menon R, 2011, PLACENTA, V32, P317, DOI 10.1016/j.placenta.2011.01.015; Menon R, 2008, ACTA OBSTET GYN SCAN, V87, P590, DOI 10.1080/00016340802005126; Menon R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031136; Menon R, 2011, OBSTET GYNECOL, V118, P121, DOI 10.1097/AOG.0b013e3182204eaa; Mercer BM, 1997, INFECT DIS CLIN N AM, V11, P177, DOI 10.1016/S0891-5520(05)70348-2; Milyavsky M, 2001, NUCLEIC ACIDS RES, V29, P5207, DOI 10.1093/nar/29.24.5207; Mitra S, 2001, ENVIRON MOL MUTAGEN, V38, P180, DOI 10.1002/em.1070; MOORE JJ, 1991, J CLIN ENDOCR METAB, V72, P1073, DOI 10.1210/jcem-72-5-1073; Moore RM, 2003, PLACENTA, V24, P173, DOI 10.1053/plac.2002.0886; Myatt L, 2010, PLACENTA, V31, pS66, DOI 10.1016/j.placenta.2009.12.021; Papaconstantinou J, 2010, CELL CYCLE, V9, P3831, DOI 10.4161/cc.9.19.13324; Passos JF, 2006, FREE RADICAL RES, V40, P1277, DOI 10.1080/10715760600917151; Reaper PM, 2004, CELL CYCLE, V3, P543; Rodgman A, 2000, HUM EXP TOXICOL, V19, P573, DOI 10.1191/096032700701546514; Romero R, 2006, BJOG-INT J OBSTET GY, V113, P17, DOI 10.1111/j.1471-0528.2006.01120.x; Saitoh M, 1998, EMBO J, V17, P2596, DOI 10.1093/emboj/17.9.2596; Saquib Q, 2012, MUTAT RES-GEN TOX EN, V744, P125, DOI 10.1016/j.mrgentox.2012.01.001; Saquib Q, 2012, TOXICOL IN VITRO, V26, P351, DOI 10.1016/j.tiv.2011.12.011; SINGH NP, 1988, EXP CELL RES, V175, P184, DOI 10.1016/0014-4827(88)90265-0; SPENCER JPE, 1995, FEBS LETT, V375, P179, DOI 10.1016/0014-5793(95)01199-O; Takeda K, 2000, J BIOL CHEM, V275, P9805, DOI 10.1074/jbc.275.13.9805; Tarry-Adkins JL, 2008, FASEB J, V22, P2037, DOI 10.1096/fj.07-099523; van der Vaart H, 2004, THORAX, V59, P713, DOI 10.1136/thx.2003.012468; Vande Loock K, 2012, MUTAGENESIS, V27, P573, DOI 10.1093/mutage/ges022; Wall PD, 2002, J PERINAT MED, V30, P447, DOI 10.1515/JPM.2002.071; Wang ZL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000951; WISDOM SJ, 1991, AM J OBSTET GYNECOL, V165, P1701, DOI 10.1016/0002-9378(91)90018-M; Woods JR, 2001, PLACENTA, V22, pS38, DOI 10.1053/plac.2001.0638	59	82	83	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e83416	10.1371/journal.pone.0083416	http://dx.doi.org/10.1371/journal.pone.0083416			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281RE	24386195	Green Submitted, gold, Green Published			2022-12-25	WOS:000329117900034
J	Snyder, JC; Rochelle, LK; Barak, LS; Caron, MG				Snyder, Joshua C.; Rochelle, Lauren K.; Barak, Larry S.; Caron, Marc G.			The Stem Cell-Expressed Receptor Lgr5 Possesses Canonical and Functionally Active Molecular Determinants Critical to beta-arrestin-2 Recruitment	PLOS ONE			English	Article							PROTEIN-COUPLED-RECEPTOR; CYSTINE KNOT PROTEIN; BETA-ARRESTIN; BETA(2)-ADRENERGIC RECEPTOR; STIMULATING-HORMONE; WNT/BETA-CATENIN; STRUCTURAL BASIS; WNT RECEPTORS; DESENSITIZATION; PHOSPHORYLATION	Lgr5 is a membrane protein related to G protein-coupled receptors (GPCR)s whose expression identifies stem cells in multiple tissues and is strongly correlated with cancer. Despite the recent identification of endogenous ligands for Lgr5, its mode of signaling remains enigmatic. The ability to couple to G proteins and beta arrestins are classical molecular behaviors of GPCRs that have yet to be observed for Lgr5. Therefore, the goal of this study was to determine if Lgr5 can engage a classical GPCR behavior and elucidate the molecular determinants of this process. Structural analysis of Lgr5 revealed several motifs consistent with its ability to recruit beta arr2. Among them, a "SSS" serine cluster located at amino acid position 873-875 within the C-terminal tail (C-tail), is in a region consistent with other GPCRs that bind beta arr2 with high-affinity. To test its functionality, a ligand-independent beta arr2 translocation assay was implemented. We show that Lgr5 recruits beta arr2 and that the "SSS" amino acids (873-875) are absolutely critical to this process. We also demonstrate that for full efficacy, this cluster requires other Lgr5 C-tail serines that were previously shown to be important for constitutive and beta arr2 independent internalization of Lgr5. These data are proof of principle that a classical GPCR behavior can be manifested by Lgr5. The existence of alternative ligands or missing effectors of Lgr5 that scaffold this classical GPCR behavior and the downstream signaling pathways engaged should be considered. Characterizing Lgr5 signaling will be invaluable for assessing its role in tissue maintenance, repair, and disease.	[Snyder, Joshua C.; Rochelle, Lauren K.; Barak, Larry S.; Caron, Marc G.] Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA; [Caron, Marc G.] Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA; [Caron, Marc G.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA	Duke University; Duke University; Duke University	Caron, MG (corresponding author), Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA.	marc.caron@dm.duke.edu		Snyder, Joshua/0000-0002-9787-3371	Duke Cancer Center Stewart Trust; Duke Cancer Center Cancer and the Environment; NIDA [P30 5P30DA29925]; NIMH [F32 NRSA 5F32MH092013-03]; NATIONAL CANCER INSTITUTE [R21CA173245] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [F32MH092013] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P30DA029925] Funding Source: NIH RePORTER	Duke Cancer Center Stewart Trust; Duke Cancer Center Cancer and the Environment; NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by a Duke Cancer Center Stewart Trust and Duke Cancer Center Cancer and the Environment to JCS, LKR, LSB, and MGC; and NIDA P30 5P30DA29925 to LSB and MGC, and an NIMH F32 NRSA 5F32MH092013-03 to JCS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barak LS, 2013, BIOCHEMISTRY-US, V52, P5403, DOI 10.1021/bi400217r; BARAK LS, 1994, J BIOL CHEM, V269, P2790; BARAK LS, 1995, BIOCHEMISTRY-US, V34, P15407, DOI 10.1021/bi00047a003; Barak LS, 1997, J BIOL CHEM, V272, P27497, DOI 10.1074/jbc.272.44.27497; Barak LS, 2001, P NATL ACAD SCI USA, V98, P93, DOI 10.1073/pnas.011303698; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Barker N, 2013, DEVELOPMENT, V140, P2484, DOI 10.1242/dev.083113; Beaulieu JM, 2009, ANNU REV PHARMACOL, V49, P327, DOI 10.1146/annurev.pharmtox.011008.145634; Carmon KS, 2012, MOL CELL BIOL, V32, P2054, DOI 10.1128/MCB.00272-12; Carmon KS, 2011, P NATL ACAD SCI USA, V108, P11452, DOI 10.1073/pnas.1106083108; de Lau W, 2011, NATURE, V476, P293, DOI 10.1038/nature10337; Deng C, 2013, J CELL SCI, V126, P2060, DOI 10.1242/jcs.123471; Evron T, 2012, TRENDS PHARMACOL SCI, V33, P154, DOI 10.1016/j.tips.2011.12.003; FERGUSON SSG, 1995, J BIOL CHEM, V270, P24782, DOI 10.1074/jbc.270.42.24782; Ferguson SSG, 1996, SCIENCE, V271, P363, DOI 10.1126/science.271.5247.363; Frenzel R, 2006, ENDOCRINOLOGY, V147, P3114, DOI 10.1210/en.2005-0687; Gainetdinov RR, 2004, ANNU REV NEUROSCI, V27, P107, DOI 10.1146/annurev.neuro.27.070203.144206; Glinka A, 2011, EMBO REP, V12, P1055, DOI 10.1038/embor.2011.175; Gong X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037137; Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313; Gurevich EV, 2012, PHARMACOL THERAPEUT, V133, P40, DOI 10.1016/j.pharmthera.2011.08.001; Gurevich VV, 2006, PHARMACOL THERAPEUT, V110, P465, DOI 10.1016/j.pharmthera.2005.09.008; Hao HX, 2012, NATURE, V485, P195, DOI 10.1038/nature11019; Harwood BN, 2013, MOL PHARMACOL, V83, P814, DOI 10.1124/mol.112.081570; Hearn MTW, 2000, J MOL RECOGNIT, V13, P223, DOI 10.1002/1099-1352(200009/10)13:5<223::AID-JMR501>3.3.CO;2-C; Hsu SY, 1998, MOL ENDOCRINOL, V12, P1830, DOI 10.1210/me.12.12.1830; Hsu SY, 2000, MOL ENDOCRINOL, V14, P1257, DOI 10.1210/me.14.8.1257; Kapur A, 2009, J BIOL CHEM, V284, P29817, DOI 10.1074/jbc.M109.050187; Kara E, 2006, MOL ENDOCRINOL, V20, P3014, DOI 10.1210/me.2006-0098; Kemper K, 2012, STEM CELLS, V30, P2378, DOI 10.1002/stem.1233; Kingston R.E., 2001, CURRENT PROTOCOLS IM; Kwon MS, 2013, MOL CELLS, V36, P267, DOI 10.1007/s10059-013-0173-z; Laporte SA, 2000, J BIOL CHEM, V275, P23120, DOI 10.1074/jbc.M002581200; Laporte SA, 1999, P NATL ACAD SCI USA, V96, P3712, DOI 10.1073/pnas.96.7.3712; Leushacke M, 2012, ONCOGENE, V31, P3009, DOI 10.1038/onc.2011.479; Luo CW, 2005, P NATL ACAD SCI USA, V102, P2820, DOI 10.1073/pnas.0409916102; Marion S, 2006, J BIOL CHEM, V281, P2932, DOI 10.1074/jbc.M508074200; McDonald T, 1998, BIOCHEM BIOPH RES CO, V247, P266, DOI 10.1006/bbrc.1998.8774; Menard L, 1996, BIOCHEMISTRY-US, V35, P4155, DOI 10.1021/bi952961+; Nakamura K, 2000, J BIOL CHEM, V275, P241, DOI 10.1074/jbc.275.1.241; Nobles KN, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001707; Oakley RH, 2001, J BIOL CHEM, V276, P19452, DOI 10.1074/jbc.M101450200; Oakley RH, 1999, J BIOL CHEM, V274, P32248, DOI 10.1074/jbc.274.45.32248; Oakley RH, 2000, J BIOL CHEM, V275, P17201, DOI 10.1074/jbc.M910348199; Oakley RH, 2006, METHOD ENZYMOL, V414, P50, DOI 10.1016/S0076-6879(06)14004-5; Premont RT, 2007, ANNU REV PHYSIOL, V69, P511, DOI 10.1146/annurev.physiol.69.022405.154731; Rajagopal S, 2010, NAT REV DRUG DISCOV, V9, P373, DOI 10.1038/nrd3024; Salon JA, 2011, PHARMACOL REV, V63, P901, DOI 10.1124/pr.110.003350; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schubert RL, 2003, ENDOCRINOLOGY, V144, P129, DOI 10.1210/en.2002-220829; Sharman JL, 2013, NUCLEIC ACIDS RES, V41, pD1083, DOI 10.1093/nar/gks960; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Snyder JC, 2013, J BIOL CHEM; Troispoux C, 1999, MOL ENDOCRINOL, V13, P1599, DOI 10.1210/me.13.9.1599; Verkaar F, 2008, BIOTECHNOL ANN REV, V14, P253, DOI 10.1016/S1387-2656(08)00010-0; Wang DL, 2013, GENE DEV, V27, P1339, DOI 10.1101/gad.219360.113; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Wilbanks AM, 2002, BIOCHEMISTRY-US, V41, P11981, DOI 10.1021/bi020275m; Zhang J, 1999, J BIOL CHEM, V274, P10999, DOI 10.1074/jbc.274.16.10999; Zhang R, 2012, ACTA PHARMACOL SIN, V33, P372, DOI 10.1038/aps.2011.173	60	9	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e84476	10.1371/journal.pone.0084476	http://dx.doi.org/10.1371/journal.pone.0084476			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281RE	24386388	Green Published, Green Submitted, gold			2022-12-25	WOS:000329117900098
J	Thorpe, AS; Perakis, S; Catricala, C; Kaye, TN				Thorpe, Andrea S.; Perakis, Steven; Catricala, Christina; Kaye, Thomas N.			Nutrient Limitation of Native and Invasive N-2-Fixing Plants in Northwest Prairies	PLOS ONE			English	Article							N-15 ISOTOPE-DILUTION; NITROGEN-FIXATION; NATURAL-ABUNDANCE; CRITICAL LOADS; ROOT-NODULES; N-2 FIXATION; PHOSPHORUS; SOIL; AVAILABILITY; ECOSYSTEMS	Nutrient rich conditions often promote plant invasions, yet additions of non-nitrogen (N) nutrients may provide a novel approach for conserving native symbiotic N-fixing plants in otherwise N-limited ecosystems. Lupinus oreganus is a threatened N-fixing plant endemic to prairies in western Oregon and southwest Washington (USA). We tested the effect of non-N fertilizers on the growth, reproduction, tissue N content, and stable isotope delta(15) N composition of Lupinus at three sites that differed in soil phosphorus (P) and N availability. We also examined changes in other Fabaceae (primarily Vicia sativa and V. hirsuta) and cover of all plant species. Variation in background soil P and N availability shaped patterns of nutrient limitation across sites. Where soil P and N were low, P additions increased Lupinus tissue N and altered foliar d delta N-15, suggesting P limitation of N fixation. Where soil P was low but N was high, P addition stimulated growth and reproduction in Lupinus. At a third site, with higher soil P, only micro-and macronutrient fertilization without N and P increased Lupinus growth and tissue N. Lupinus foliar delta(15) N averaged 20.010% across all treatments and varied little with tissue N, suggesting consistent use of fixed N. In contrast, foliar delta(15) N of Vicia spp. shifted towards 0% as tissue N increased, suggesting that conditions fostering N fixation may benefit these exotic species. Fertilization increased cover, N fixation, and tissue N of nontarget, exotic Fabaceae, but overall plant community structure shifted at only one site, and only after the dominant Lupinus was excluded from analyses. Our finding that non-N fertilization increased the performance of Lupinus with few community effects suggests a potential strategy to aid populations of threatened legume species. The increase in exotic Fabaceae species that occurred with fertilization further suggests that monitoring and adaptive management should accompany any large scale applications.	[Thorpe, Andrea S.; Kaye, Thomas N.] Inst Appl Ecol, Corvallis, OR USA; [Perakis, Steven; Catricala, Christina] US Geol Survey, Forest & Rangeland Ecosyst Sci Ctr, Corvallis, OR USA	United States Department of the Interior; United States Geological Survey	Thorpe, AS (corresponding author), Natl Ecol Observ Network Inc, Boulder, CO 80301 USA.	athorpe@neoninc.org	Thorpe, Andrea/AAH-2684-2020	Thorpe, Andrea/0000-0002-0670-4135	US Geological Survey; Forest and Rangeland Ecosystem Science Center	US Geological Survey(United States Geological Survey); Forest and Rangeland Ecosystem Science Center	Funding for this project was provided by the US Geological Survey, Forest and Rangeland Ecosystem Science Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida JPF, 2000, J EXP BOT, V51, P1289, DOI 10.1093/jexbot/51.348.1289; Barron AR, 2009, NAT GEOSCI, V2, P42, DOI 10.1038/NGEO366; BERGERSEN FJ, 1986, SOIL BIOL BIOCHEM, V18, P97, DOI 10.1016/0038-0717(86)90109-4; Boyd R., 1999, INDIANS FIRE LAND PA; Brown JR, 1996, P S 7 8 MAR COL MISS; CHARTER RA, 1995, COMMUN SOIL SCI PLAN, V26, P3051, DOI 10.1080/00103629509369508; Ehrenfeld JG, 2003, ECOSYSTEMS, V6, P503, DOI 10.1007/s10021-002-0151-3; EVANS J, 1987, FIELD CROP RES, V17, P109, DOI 10.1016/0378-4290(87)90086-4; Finzi AC, 2009, BIOGEOCHEMISTRY, V95, P309, DOI 10.1007/s10533-009-9338-4; Fisher K., 2002, Nitrogen fixation at the millennium, P1, DOI 10.1016/B978-044450965-9/50001-X; FRANKLIN JF, 1993, ECOL APPL, V3, P202, DOI 10.2307/1941820; Geiser LH, 2010, ENVIRON POLLUT, V158, P2412, DOI 10.1016/j.envpol.2010.04.001; Goergen E, 2009, APPL SOIL ECOL, V42, P200, DOI 10.1016/j.apsoil.2009.04.001; Gosling P, 2005, PLANT ECOL, V178, P141, DOI 10.1007/s11258-004-2782-2; HARDARSON G, 1991, PLANT SOIL, V131, P161, DOI 10.1007/BF00009445; Harpole WS., 2007, CALIFORNIA GRASSLAND; Haubensak K. A., 2001, THESIS U CALIFORNIA; Haubensak KA, 2011, BIOL INVASIONS, V13, P1275, DOI 10.1007/s10530-010-9904-7; HAYNES RJ, 1993, ADV AGRON, V49, P119, DOI 10.1016/S0065-2113(08)60794-4; Hogberg P, 1997, NEW PHYTOL, V137, P179, DOI 10.1046/j.1469-8137.1997.00808.x; HOWARTH RW, 1985, SCIENCE, V229, P653, DOI 10.1126/science.229.4714.653; HUENNEKE LF, 1990, ECOLOGY, V71, P478, DOI 10.2307/1940302; Johansen C., 1997, Molybdenum in agriculture., P202, DOI 10.1017/CBO9780511574689.014; LeBauer DS, 2008, ECOLOGY, V89, P371, DOI 10.1890/06-2057.1; Leidi EO, 2000, NEW PHYTOL, V147, P337, DOI 10.1046/j.1469-8137.2000.00703.x; LONSDALE WM, 1993, J ENVIRON MANAGE, V39, P77, DOI 10.1006/jema.1993.1055; Lotscher M, 1997, J ECOL, V85, P341, DOI 10.2307/2960506; Maron JL, 1999, ECOLOGY, V80, P443, DOI 10.1890/0012-9658(1999)080[0443:BLMARA]2.0.CO;2; McCune B., 2005, MULTIVARIATE ANAL PC; McCune B., 2002, ANAL ECOLOGICAL COMM, DOI 10.1016/S0022-0981(03)00091-1; Myrold DD, 2003, PLANT SOIL, V254, P47, DOI 10.1023/A:1024951115548; Oregon State College Experiment Station, 1958, MOL PROBL OR; Pardo LH, 2011, ECOL APPL, V21, P3049, DOI 10.1890/10-2341.1; Perakis SS, 2011, ECOSPHERE, V3, P1; RITCHIE ME, 1995, ECOLOGY, V76, P2648, DOI 10.2307/2265835; Roscher C, 2011, PLANT SOIL, V341, P333, DOI 10.1007/s11104-010-0647-0; SCHINDLER DW, 1977, SCIENCE, V195, P260, DOI 10.1126/science.195.4275.260; Sheley RL, 2003, WEED SCI, V51, P260, DOI 10.1614/0043-1745(2003)051[0260:PFRIPI]2.0.CO;2; SMITH VH, 1992, BIOGEOCHEMISTRY, V18, P19, DOI 10.1007/BF00000424; Stanley AG, 2008, NATIVE PLANTS J, V9, P255; Stanley AG, 2011, NORTHWEST SCI, V85, P233, DOI 10.3955/046.085.0212; Suding KN, 2005, P NATL ACAD SCI USA, V102, P4387, DOI 10.1073/pnas.0408648102; Tang C, 1998, AUST J AGR RES, V49, P657, DOI 10.1071/A97145; TURNER GL, 1983, SOIL BIOL BIOCHEM, V15, P525, DOI 10.1016/0038-0717(83)90045-7; U.S. Fish and Wildlife Service, 2010, REC PLAN PRAIR SPEC, pxi; Unkovich M, 2001, CURR PLANT SCI BIOT, V40, P103; USDA NRCS, 2012, PLANTS DAT; VanAuken OW, 1997, INT J PLANT SCI, V158, P325, DOI 10.1086/297444; VITOUSEK PM, 1991, BIOGEOCHEMISTRY, V13, P87; VITOUSEK PM, 1989, ECOL MONOGR, V59, P247, DOI 10.2307/1942601; Vitousek PM, 2013, PHILOS T RS B; Wall LG, 2000, SYMBIOSIS, V29, P91; Walsh MK, 2010, QUATERNARY SCI REV, V29, P1093, DOI 10.1016/j.quascirev.2010.02.011; West JB, 2005, NEW PHYTOL, V167, P523, DOI 10.1111/j.1469-8137.2005.01444.x; WITKOWSKI ETF, 1991, J APPL ECOL, V28, P1, DOI 10.2307/2404109; Wurzburger N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033710; Yelenik SG, 2007, BIOL INVASIONS, V9, P117, DOI 10.1007/s10530-006-0008-3	57	5	5	1	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e84593	10.1371/journal.pone.0084593	http://dx.doi.org/10.1371/journal.pone.0084593			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281RE	24386399	Green Published, Green Submitted, gold			2022-12-25	WOS:000329117900103
J	Fecteau, S; Levasseur-Moreau, J; Garcia-Molina, A; Kumru, H; Vergara, RP; Bernabeu, M; Roig, T; Pascual-Leone, A; Tormos, JM				Fecteau, Shirley; Levasseur-Moreau, Jean; Garcia-Molina, Alberto; Kumru, Hatiche; Pelayo Vergara, Raul; Bernabeu, Monste; Roig, Teresa; Pascual-Leone, Alvaro; Maria Tormos, Jose			Risk Taking in Hospitalized Patients with Acute and Severe Traumatic Brain Injury	PLOS ONE			English	Article							DECISION-MAKING PROCESSES; COGNITIVE REHABILITATION; EXECUTIVE FUNCTION; HEAD-INJURY; TASK BART; ATTENTION; DYSFUNCTION; PROPENSITY; MORTALITY; BEHAVIOR	Rehabilitation can improve cognitive deficits observed in patients with traumatic brain injury (TBI). However, despite rehabilitation, the ability of making a choice often remains impaired. Risk taking is a daily activity involving numerous cognitive processes subserved by a complex neural network. In this work we investigated risk taking using the Balloon Analogue Risk Task (BART) in patients with acute TBI and healthy controls. We hypothesized that individuals with TBI will take less risk at the BART as compared to healthy individuals. We also predicted that within the TBI group factors such as the number of days since the injury, severity of the injury, and sites of the lesion will play a role in risk taking as assessed with the BART. Main findings revealed that participants with TBI displayed abnormally cautious risk taking at the BART as compared to healthy subjects. Moreover, healthy individuals showed increased risk taking throughout the task which is in line with previous work. However, individuals with TBI did not show this increased risk taking during the task. We also investigated the influence of three patients' characteristics on their performance at the BART: Number of days post injury, Severity of the head injury, and Status of the frontal lobe. Results indicate that performance at the BART was influenced by the number of days post injury and the status of the frontal lobe, but not by the severity of the head injury. Reported findings are encouraging for risk taking seems to naturally improve with time postinjury. They support the need of conducting longitudinal prospective studies to ultimately identify impaired and intact cognitive skills that should be trained postinjury.	[Fecteau, Shirley; Levasseur-Moreau, Jean] Univ Laval, Ctr Rech Univ Sante Mentale Quebec, Ctr Interdisciplinaire Rech Readaptat & Integrat, Sch Med, Quebec City, PQ, Canada; [Fecteau, Shirley; Pascual-Leone, Alvaro] Harvard Univ, Beth Israel Deaconess Med Ctr, Berenson Allen Ctr Noninvas Brain Stimulat, Sch Med, Boston, MA 02215 USA; [Garcia-Molina, Alberto; Kumru, Hatiche; Pelayo Vergara, Raul; Bernabeu, Monste; Roig, Teresa; Pascual-Leone, Alvaro; Maria Tormos, Jose] Inst Univ Neurorehabil Adscrit UAB, Inst Guttmann, Barcelona, Spain; [Garcia-Molina, Alberto; Kumru, Hatiche; Pelayo Vergara, Raul; Bernabeu, Monste; Roig, Teresa; Pascual-Leone, Alvaro; Maria Tormos, Jose] Univ Autonoma Barcelona, Bellaterra, Cerdanyola Del, Spain; [Garcia-Molina, Alberto; Kumru, Hatiche; Pelayo Vergara, Raul; Bernabeu, Monste; Roig, Teresa; Pascual-Leone, Alvaro; Maria Tormos, Jose] Fundacio Inst Invest Ciencies Salut Germans Trias, Barcelona, Spain	Laval University; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Autonomous University of Barcelona; Fundacio Institut d'Investigacio en Ciencies de la Salut Germans Trias i Pujol (IGTP)	Fecteau, S (corresponding author), Univ Laval, Ctr Rech Univ Sante Mentale Quebec, Ctr Interdisciplinaire Rech Readaptat & Integrat, Sch Med, Quebec City, PQ, Canada.	shirley.fecteau@fmed.ulaval.ca	Kumru, Hatice/ABB-1109-2021; Pascual-Leone, Alvaro/AAC-5101-2019; Fecteau, Shirley/N-3017-2016	Pascual-Leone, Alvaro/0000-0001-8975-0382; Fecteau, Shirley/0000-0002-9781-4451; Garcia-Molina, Alberto/0000-0002-5014-7591; Kumru, Hatice/0000-0002-0501-1660; Tormos Munoz, Jose Maria/0000-0002-8764-2289	Canada Research Chair in Cognitive Neuroplasticity; National Center for Research Resources: Harvard-Thorndike General Clinical Research Center at BIDMC [NCRR MO1 RR01032]; Harvard Clinical and Translational Science Center [UL1 RR025758]; NIH [K24 RR018875]; Foundation La Marato TV3 [071931]; Instituto de Salud Carlos III [PI082004]; NATIONAL CENTER FOR RESEARCH RESOURCES [K24RR018875, UL1RR025758, M01RR001032] Funding Source: NIH RePORTER	Canada Research Chair in Cognitive Neuroplasticity; National Center for Research Resources: Harvard-Thorndike General Clinical Research Center at BIDMC(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Harvard Clinical and Translational Science Center; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Foundation La Marato TV3; Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by grants from the Canada Research Chair in Cognitive Neuroplasticity to SF, from the National Center for Research Resources: Harvard-Thorndike General Clinical Research Center at BIDMC (NCRR MO1 RR01032) and Harvard Clinical and Translational Science Center (UL1 RR025758), NIH grant K24 RR018875 to APL, and by the Foundation La Marato TV3 (071931) and grant PI082004 from the Instituto de Salud Carlos III to JMT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aklin WM, 2005, BEHAV RES THER, V43, P215, DOI 10.1016/j.brat.2003.12.007; American Psychiatric Association, 2013, DIAGN STAT MAN MENT, V5, DOI 10.1176/appi.books.9780890425596; Arciniegas D, 1999, BRAIN INJURY, V13, P1, DOI 10.1080/026990599121827; Arciniegas David B., 2002, Curr Treat Options Neurol, V4, P43, DOI 10.1007/s11940-002-0004-6; Baguley I, 2000, BRAIN INJURY, V14, P505; Bechara A, 2000, CEREB CORTEX, V10, P295, DOI 10.1093/cercor/10.3.295; Bechara A, 2004, BRAIN COGNITION, V55, P30, DOI 10.1016/j.bandc.2003.04.001; Bechara A, 2001, NEUROPSYCHOLOGIA, V39, P376, DOI 10.1016/S0028-3932(00)00136-6; BECHARA A, 1994, COGNITION, V50, P7, DOI 10.1016/0010-0277(94)90018-3; Bechara A, 1996, CEREB CORTEX, V6, P215, DOI 10.1093/cercor/6.2.215; Bonatti E, 2008, COGN BEHAV NEUROL, V21, P164, DOI 10.1097/WNN.0b013e318184e688; Boyle PA, 2011, BMC GERIATR, V11, DOI 10.1186/1471-2318-11-53; Cernich AN, 2010, CURR TREAT OPTION NE, V12, P412, DOI 10.1007/s11940-010-0085-6; Chiu CYP, 2012, DEV NEUROPSYCHOL, V37, P176, DOI 10.1080/87565641.2011.632796; Christensen BK, 2008, ARCH PHYS MED REHAB, V89, pS3, DOI 10.1016/j.apmr.2008.10.002; Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024; Cicerone KD, 2000, ARCH PHYS MED REHAB, V81, P1596, DOI 10.1053/apmr.2000.19240; Cicerone K, 2006, J COGNITIVE NEUROSCI, V18, P1212, DOI 10.1162/jocn.2006.18.7.1212; Clark L, 2003, NEUROPSYCHOLOGIA, V41, P1474, DOI 10.1016/S0028-3932(03)00081-2; Dams-O'Connor K, 2010, PSYCHIAT CLIN N AM, V33, P893, DOI 10.1016/j.psc.2010.08.002; Donovan NJ, 2011, BRAIN INJURY, V25, P348, DOI 10.3109/02699052.2011.556105; Drechsler R, 2008, J NEURAL TRANSM, V115, P201, DOI 10.1007/s00702-007-0814-5; Floden D, 2008, NEUROPSYCHOLOGIA, V46, P213, DOI 10.1016/j.neuropsychologia.2007.07.020; Garcia-Molina A, 2007, NEUROLOGIA, V22, P206; Gentleman D, 2001, TRAUMA, V3, P193, DOI DOI 10.1177/146040860100300401; GOLDENBERG G, 1992, J NEUROL NEUROSUR PS, V55, P362, DOI 10.1136/jnnp.55.5.362; Gordon W.A., 2005, TXB TRAUMATIC BRAIN, P655; Kennedy MRT, 2006, NEUROPSYCHOL REV, V16, P151, DOI 10.1007/s11065-006-9012-8; Kersel DA, 2001, BRAIN INJURY, V15, P283, DOI 10.1080/02699050010005887; Krishnan M, 2012, CLIN NEUROPSYCHOL, V26, P951, DOI 10.1080/13854046.2012.708166; Leblanc N, 2005, DEV NEUROPSYCHOL, V28, P829, DOI 10.1207/s15326942dn2803_5; Leigh BC, 1999, ADDICTION, V94, P371, DOI 10.1046/j.1360-0443.1999.9433717.x; Lejuez C, 2003, J ADOLESCENCE, V26, P475, DOI 10.1016/S0140-1971(03)00036-8; Lejuez CW, 2005, NICOTINE TOB RES, V7, P71, DOI 10.1080/14622200412331328484; Lejuez CW, 2004, ADDICT BEHAV, V29, P1643, DOI 10.1016/j.addbeh.2004.02.035; Lejuez CW, 2003, EXP CLIN PSYCHOPHARM, V11, P26, DOI 10.1037/1064-1297.11.1.26; Lejuez CW, 2002, J EXP PSYCHOL-APPL, V8, P75, DOI 10.1037//1076-898X.8.2.75; Lu J, 2005, ACT NEUR S, V95, P281; Manes F, 2002, BRAIN, V125, P624, DOI 10.1093/brain/awf049; Matheson L, 2010, WORK, V36, P413, DOI 10.3233/WOR-2010-1043; Mathias JL, 2004, J INT NEUROPSYCH SOC, V10, P286, DOI 10.1017/S1355617704102117; Mazaux JM, 1997, ARCH PHYS MED REHAB, V78, P1316, DOI 10.1016/S0003-9993(97)90303-8; McDowell S, 1997, NEUROPSYCHOLOGIA, V35, P1341, DOI 10.1016/S0028-3932(97)00082-1; Millis SR, 2001, J HEAD TRAUMA REHAB, V16, P343, DOI 10.1097/00001199-200108000-00005; Novack TA, 2000, BRAIN INJURY, V14, P987; Nybo T, 1999, BRAIN INJURY, V13, P759; Park NW, 2001, NEUROPSYCHOLOGY, V15, P199, DOI 10.1037/0894-4105.15.2.199; Rahman S, 2001, TRENDS COGN SCI, V5, P271, DOI 10.1016/S1364-6613(00)01650-8; Robertson IH, 1997, NEUROPSYCHOLOGIA, V35, P747, DOI 10.1016/S0028-3932(97)00015-8; Schlund MW, 2002, BRAIN INJURY, V16, P527, DOI 10.1080/02699050110113679; Sherer M, 2002, ARCH PHYS MED REHAB, V83, P183, DOI 10.1053/apmr.2002.28802; Shore AD, 2005, BRAIN INJURY, V19, P613, DOI 10.1080/02699050400013568; Sigurdardottir S, 2010, NEUROPSYCHOLOGY, V24, P504, DOI 10.1037/a0018934; Silver JM, 2005, TXB TRAUMATIC BRAIN, P259; Smith K, 2002, MANAGE SCI, V48, P711, DOI 10.1287/mnsc.48.6.711.194; Stiefel MF, 2005, J NEUROSURG, V103, P805, DOI 10.3171/jns.2005.103.5.0805; STUSS DT, 1989, J NEUROL NEUROSUR PS, V52, P742, DOI 10.1136/jnnp.52.6.742; TEASDALE G, 1974, LANCET, V2, P81; Tranel D, 2002, CORTEX, V38, P589, DOI 10.1016/S0010-9452(08)70024-8; Tsaousides T, 2009, MT SINAI J MED, V76, P173, DOI 10.1002/msj.20099; Whyte J, 2004, AM J PHYS MED REHAB, V83, P401, DOI 10.1097/01.PHM.0000128789.75375.D3; Zak PJ, 2004, PHILOS T R SOC B, V359, P1737, DOI 10.1098/rstb.2004.1544	62	5	5	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e83598	10.1371/journal.pone.0083598	http://dx.doi.org/10.1371/journal.pone.0083598			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	281QS	24386232	gold, Green Published, Green Submitted			2022-12-25	WOS:000329116700061
J	Capomaccio, S; Vitulo, N; Verini-Supplizi, A; Barcaccia, G; Albiero, A; D'Angelo, M; Campagna, D; Valle, G; Felicetti, M; Silvestrelli, M; Cappelli, K				Capomaccio, Stefano; Vitulo, Nicola; Verini-Supplizi, Andrea; Barcaccia, Gianni; Albiero, Alessandro; D'Angelo, Michela; Campagna, Davide; Valle, Giorgio; Felicetti, Michela; Silvestrelli, Maurizio; Cappelli, Katia			RNA Sequencing of the Exercise Transcriptome in Equine Athletes	PLOS ONE			English	Article							BLOOD MONONUCLEAR-CELLS; GENE-EXPRESSION; NONCODING RNAS; DIFFERENTIAL EXPRESSION; ANTISENSE TRANSCRIPTS; MICROARRAY ANALYSIS; OXIDATIVE STRESS; REVEALS; HORSES; INTERLEUKIN-6	The horse is an optimal model organism for studying the genomic response to exercise-induced stress, due to its natural aptitude for athletic performance and the relative homogeneity of its genetic and environmental backgrounds. Here, we applied RNA-sequencing analysis through the use of SOLiD technology in an experimental framework centered on exercise-induced stress during endurance races in equine athletes. We monitored the transcriptional landscape by comparing gene expression levels between animals at rest and after competition. Overall, we observed a shift from coding to non-coding regions, suggesting that the stress response involves the differential expression of not annotated regions. Notably, we observed significant post-race increases of reads that correspond to repeats, especially the intergenic and intronic L1 and L2 transposable elements. We also observed increased expression of the antisense strands compared to the sense strands in intronic and regulatory regions (1 kb up- and downstream) of the genes, suggesting that antisense transcription could be one of the main mechanisms for transposon regulation in the horse under stress conditions. We identified a large number of transcripts corresponding to intergenic and intronic regions putatively associated with new transcriptional elements. Gene expression and pathway analysis allowed us to identify several biological processes and molecular functions that may be involved with exercise-induced stress. Ontology clustering reflected mechanisms that are already known to be stress activated (e.g., chemokine-type cytokines, Toll-like receptors, and kinases), as well as "nucleic acid binding" and "signal transduction activity" functions. There was also a general and transient decrease in the global rates of protein synthesis, which would be expected after strenuous global stress. In sum, our network analysis points toward the involvement of specific gene clusters in equine exercise-induced stress, including those involved in inflammation, cell signaling, and immune interactions.	[Capomaccio, Stefano; Verini-Supplizi, Andrea; Felicetti, Michela; Silvestrelli, Maurizio; Cappelli, Katia] Univ Perugia, Sport Horse Res Ctr, Diagnost & Vet Clin, Dept Pathol, I-06100 Perugia, Italy; [Vitulo, Nicola; Albiero, Alessandro; D'Angelo, Michela; Campagna, Davide; Valle, Giorgio] Univ Padua, CRIBI, Padua, Italy; [Barcaccia, Gianni] Univ Padua, DAFNAE, Lab Genet & Genom, Legnaro, Italy	University of Perugia; University of Padua; University of Padua	Capomaccio, S (corresponding author), Univ Perugia, Sport Horse Res Ctr, Diagnost & Vet Clin, Dept Pathol, I-06100 Perugia, Italy.	capemaster@gmail.com	Vitulo, Nicola/GVT-2319-2022; CAPPELLI, Katia/K-6047-2015; Capomaccio, Stefano/K-6042-2015	CAPPELLI, Katia/0000-0002-3141-771X; Capomaccio, Stefano/0000-0002-0004-9272; Vitulo, Nicola/0000-0002-9571-0747; VALLE, GIORGIO/0000-0003-4377-5685; BARCACCIA, GIANNI/0000-0001-7478-5048	Progetto Ricerca e INNOVAzione nelle attivita di miglioramento GENetico animale (INNOVAGEN) [J81J11000500001]; Ministero delle Politiche Agricole e Forestali	Progetto Ricerca e INNOVAzione nelle attivita di miglioramento GENetico animale (INNOVAGEN); Ministero delle Politiche Agricole e Forestali	This research received support from "Progetto Ricerca e INNOVAzione nelle attivita di miglioramento GENetico animale (INNOVAGEN)" J81J11000500001, funded by the "Ministero delle Politiche Agricole e Forestali." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Art T, 2006, Equine Vet J Suppl, P298; Beyeen AD, 2010, J IMMUNOL, V185, P6883, DOI 10.4049/jimmunol.1001392; Bowman TV, 2006, STEM CELLS, V24, P662, DOI 10.1634/stemcells.2005-0552; Bu D., 2011, NUCL ACIDS RES; Campagna D, 2009, BIOINFORMATICS, V25, P967, DOI 10.1093/bioinformatics/btp087; Capomaccio S, 2010, ANIM GENET, V41, P166, DOI 10.1111/j.1365-2052.2010.02129.x; Capomaccio S, 2010, ANIM GENET, V41, P23, DOI 10.1111/j.1365-2052.2010.02094.x; Cappelli K, 2013, VET J, V195, P373, DOI 10.1016/j.tvjl.2012.07.021; Cappelli K, 2007, RES VET SCI, V82, P335, DOI 10.1016/j.rvsc.2006.08.009; Cappelli Katia, 2009, BMC Physiology, V9, P12, DOI 10.1186/1472-6793-9-12; Cappelli K, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-49; Cooper TA, 2009, CELL, V136, P777, DOI 10.1016/j.cell.2009.02.011; Crujeiras AB, 2008, OMICS, V12, P251, DOI 10.1089/omi.2008.0001; de Nadal E, 2011, NAT REV GENET, V12, P833, DOI 10.1038/nrg3055; Derrien T, 2012, GENOME RES, V22, P1775, DOI 10.1101/gr.132159.111; Djebali S, 2012, NATURE, V489, P101, DOI 10.1038/nature11233; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Ebisuya M, 2008, NAT CELL BIOL, V10, P1106, DOI 10.1038/ncb1771; Fernandes JMO, 2007, J EXP BIOL, V210, P3461, DOI 10.1242/jeb.009183; Fischer CP, 2006, EXERC IMMUNOL REV, V12, P6; Gleeson M, 2007, J APPL PHYSIOL, V103, P693, DOI 10.1152/japplphysiol.00008.2007; Guttman M, 2011, NATURE, V477, P295, DOI 10.1038/nature10398; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Hashimoto K, 2009, J TOXICOL SCI, V34, P445, DOI 10.2131/jts.34.445; Jacquier A, 2009, NAT REV GENET, V10, P833, DOI 10.1038/nrg2683; Kalsotra A, 2011, NAT REV GENET, V12, P715, DOI 10.1038/nrg3052; Ki SH, 2010, HEPATOLOGY, V52, P1291, DOI 10.1002/hep.23837; Klevebring D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009762; Konig D, 2001, EXERC IMMUNOL REV, V7, P108; Lira FS, 2009, CELL BIOCHEM FUNCT, V27, P458, DOI 10.1002/cbf.1594; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Mastorakos G, 2006, ANN NY ACAD SCI, V1088, P373, DOI 10.1196/annals.1366.021; Mercer TR, 2009, NAT REV GENET, V10, P155, DOI 10.1038/nrg2521; Morrissy AS, 2011, GENOME RES, V21, P1203, DOI 10.1101/gr.113431.110; Muller-Werdan U, 2003, INTERNIST, V44, P864, DOI 10.1007/s00108-003-0956-y; Nakamura S, 2010, BIOCHEM BIOPH RES CO, V391, P846, DOI 10.1016/j.bbrc.2009.11.150; Neubauer O, 2008, EXERC IMMUNOL REV, V14, P51; Numata K, 2012, FRONT BIOSCI-LANDMRK, V17, P300, DOI 10.2741/3928; Nurmi JT, 2005, PROSTAG LEUKOTR ESS, V73, P343, DOI 10.1016/j.plefa.2005.07.004; Ozsolak F, 2011, NAT REV GENET, V12, P87, DOI 10.1038/nrg2934; Pandey R, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-11-r117; Park SJ, 2012, COMP FUNCT GENOM, DOI 10.1155/2012/170208; Pedersen BK, 2008, PHYSIOL REV, V88, P1379, DOI 10.1152/physrev.90100.2007; Petersen AMW, 2006, J PHYSIOL PHARMACOL, V57, P43; Purvis D, 2010, PM&R, V2, P442, DOI 10.1016/j.pmrj.2010.03.025; Radom-Aizik S, 2009, PEDIATR RES, V65, P447, DOI 10.1203/PDR.0b013e3181993473; Rieder S, 2001, MAMM GENOME, V12, P450, DOI 10.1007/s003350020017; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Schmitz J, 2011, BIOCHIMIE, V93, P1928, DOI 10.1016/j.biochi.2011.07.014; Sela N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010907; Smith LL, 2003, SPORTS MED, V33, P347, DOI 10.2165/00007256-200333050-00002; Struhl K, 2007, NAT STRUCT MOL BIOL, V14, P103, DOI 10.1038/nsmb0207-103; Su WY, 2010, BIOCHEM BIOPH RES CO, V396, P177, DOI 10.1016/j.bbrc.2010.04.147; Tariq MA, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr547; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Werner A, 2009, RNA BIOL, V6, P43, DOI 10.4161/rna.6.1.7568; Yang N, 2006, NAT STRUCT MOL BIOL, V13, P763, DOI 10.1038/nsmb1141	57	33	34	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83504	10.1371/journal.pone.0083504	http://dx.doi.org/10.1371/journal.pone.0083504			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391776	Green Submitted, Green Published, gold			2022-12-25	WOS:000329325200073
J	Miyata, M; Suzuki, S; Misaka, T; Shishido, T; Saitoh, S; Ishigami, A; Kubota, I; Takeishi, Y				Miyata, Makiko; Suzuki, Satoshi; Misaka, Tomofumi; Shishido, Tetsuro; Saitoh, Shu-ichi; Ishigami, Akihito; Kubota, Isao; Takeishi, Yasuchika			Senescence Marker Protein 30 Has a Cardio-Protective Role in Doxorubicin-Induced Cardiac Dysfunction	PLOS ONE			English	Article							OXIDATIVE STRESS; SMP30 DEFICIENCY; TRANSGENIC MICE; KNOCKOUT MICE; CARDIOTOXICITY; CARDIOMYOPATHY; MODULATION; LIVER; PATHOGENESIS; ANGIOTENSIN	Background: Senescence marker protein 30 (SMP30), which was originally identified as an aging marker protein, is assumed to act as a novel anti-aging factor in the liver, lungs and brain. We hypothesized that SMP30 has cardio-protective function due to its anti-aging and anti-oxidant effects on doxorubicin (DOX)-induced cardiac dysfunction. Methods and Results: SMP30 knockout (SMP30 KO) mice, SMP30 transgenic (SMP30 TG) mice with cardiac-specific overexpression of SMP30 gene and wild-type (WT) littermate mice at 12-14 weeks of age were given intra-peritoneal injection of DOX (20 mg/kg) or saline. Five days after DOX injection, echocardiography revealed that left ventricular ejection fraction was more severely reduced in the DOX-treated SMP30 KO mice than in the DOX-treated WT mice, but was preserved in the DOX-treated SMP30 TG mice. Generation of reactive oxygen species and oxidative DNA damage in the myocardium were greater in the DOX-treated SMP30 KO mice than in the DOX-treated WT mice, but much less in the SMP30 TG mice. The numbers of deoxynucleotidyltransferase-mediated dUTP nick end-labeling positive nuclei in the myocardium, apoptotic signaling pathways such as caspase-3 activity, Bax/Bcl-2 ratio and phosphorylation activity of c-Jun N-terminal kinase were increased in SMP30 KO mice and decreased in SMP30 TG mice compared with WT mice after DOX injection. Conclusions: SMP30 has a cardio-protective role by anti-oxidative and anti-apoptotic effects in DOX-induced cardiotoxicity, and can be a new therapeutic target to prevent DOX-induced heart failure.	[Miyata, Makiko; Suzuki, Satoshi; Misaka, Tomofumi; Saitoh, Shu-ichi; Takeishi, Yasuchika] Fukushima Med Univ, Dept Cardiol & Hematol, Fukushima, Japan; [Shishido, Tetsuro; Kubota, Isao] Yamagata Univ, Sch Med, Dept Internal Med 1, Yamagata 99023, Japan; [Ishigami, Akihito] Tokyo Metropolitan Inst Gerontol, Tokyo, Japan	Fukushima Medical University; Yamagata University; Tokyo Metropolitan Institute of Gerontology	Takeishi, Y (corresponding author), Fukushima Med Univ, Dept Cardiol & Hematol, Fukushima, Japan.	takeishi@fmu.ac.jp		Ishigami, Akihito/0000-0001-7875-7482	Japan Society for the Promotion of Science [21590935, 24591100]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported in part by grants-in-aid for Scientific Research (Nos. 21590935 and 24591100) from Japan Society for the Promotion of Science. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arimoto T, 2006, CIRCULATION, V113, P60, DOI 10.1161/CIRCULATIONAHA.105.560771; Bernhard D, 2008, GERONTOLOGY, V54, P24, DOI 10.1159/000113503; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Du JF, 2008, AM J PHYSIOL-HEART C, V294, pH2604, DOI 10.1152/ajpheart.91506.2007; Ewer MS, 2005, J CLIN ONCOL, V23, P2900, DOI 10.1200/JCO.2005.05.827; FUJITA T, 1992, BIOCHIM BIOPHYS ACTA, V1116, P122, DOI 10.1016/0304-4165(92)90108-7; Fujita T, 1998, BIOCHEM BIOPH RES CO, V250, P374, DOI 10.1006/bbrc.1998.9327; FUJITA T, 1995, BBA-GENE STRUCT EXPR, V1263, P249, DOI 10.1016/0167-4781(95)00120-6; Hasegawa G, 2010, ENDOCRINOLOGY, V151, P529, DOI 10.1210/en.2009-1163; Ichiseki T, 2005, RHEUMATOLOGY, V44, P456, DOI 10.1093/rheumatology/keh518; Iliskovic N, 1998, MOL CELL BIOCHEM, V188, P161, DOI 10.1023/A:1006845120287; Ishigami A, 2004, BIOCHEM BIOPH RES CO, V315, P575, DOI 10.1016/j.bbrc.2004.01.091; Ishigami A, 2002, AM J PATHOL, V161, P1273, DOI 10.1016/S0002-9440(10)64404-5; Jung KJ, 2004, EXP GERONTOL, V39, P1169, DOI 10.1016/j.exger.2004.04.005; Kondo Y, 2006, P NATL ACAD SCI USA, V103, P5723, DOI 10.1073/pnas.0511225103; Machii H, 2010, MECH AGEING DEV, V131, P710, DOI 10.1016/j.mad.2010.09.009; Martinet W, 2002, CIRCULATION, V106, P927, DOI 10.1161/01.CIR.0000026393.47805.21; Menna P, 2007, CELL BIOL TOXICOL, V23, P49, DOI 10.1007/s10565-006-0143-8; Misaka T, 2011, CIRCULATION, V124; Mollnau H, 2002, CIRC RES, V90, pE58, DOI 10.1161/01.RES.0000012569.55432.02; Neilan TG, 2007, CIRCULATION, V116, P506, DOI 10.1161/CIRCULATIONAHA.106.652339; Nozaki N, 2004, CIRCULATION, V110, P2869, DOI 10.1161/01.CIR.0000146889.46519.27; Pai VB, 2000, DRUG SAFETY, V22, P263, DOI 10.2165/00002018-200022040-00002; Sato T, 2006, AM J RESP CRIT CARE, V174, P530, DOI 10.1164/rccm.200511-1816OC; Singal PK, 1998, NEW ENGL J MED, V339, P900, DOI 10.1056/NEJM199809243391307; Smith LA, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-337; Son TG, 2008, ARCH PHARM RES, V31, P872, DOI 10.1007/s12272-001-1240-3; Son TG, 2006, MECH AGEING DEV, V127, P451, DOI 10.1016/j.mad.2006.01.005; Takemura G, 2007, PROG CARDIOVASC DIS, V49, P330, DOI 10.1016/j.pcad.2006.10.002; Takimoto E, 2005, J CLIN INVEST, V115, P1221, DOI 10.1172/JCI200521968; TSAO CS, 1987, J NUTR, V117, P291, DOI 10.1093/jn/117.2.291; VONHOFF DD, 1979, ANN INTERN MED, V91, P710, DOI 10.7326/0003-4819-91-5-710; Wang MY, 2010, J MOL CELL CARDIOL, V48, P765, DOI 10.1016/j.yjmcc.2010.01.006; Wu JA, 2010, J ULTRAS MED, V29, P1771, DOI 10.7863/jum.2010.29.12.1771; Yeh ETH, 2004, CIRCULATION, V109, P3122, DOI 10.1161/01.CIR.0000133187.74800.B9; Yumura W, 2006, HISTOL HISTOPATHOL, V21, P1151, DOI 10.14670/HH-21.1151	36	18	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e79093	10.1371/journal.pone.0079093	http://dx.doi.org/10.1371/journal.pone.0079093			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391705	Green Published, Green Submitted, gold			2022-12-25	WOS:000329325200002
J	Monahan, WB; Cook, T; Melton, F; Connor, J; Bobowski, B				Monahan, William B.; Cook, Tammy; Melton, Forrest; Connor, Jeff; Bobowski, Ben			Forecasting Distributional Responses of Limber Pine to Climate Change at Management-Relevant Scales in Rocky Mountain National Park	PLOS ONE			English	Article							SPECIES DISTRIBUTIONS; UNITED-STATES; FLEXILIS; COLORADO; FOREST; RANGE; CONSERVATION; MECHANISMS; SUCCESSION; DISPERSAL	Resource managers at parks and other protected areas are increasingly expected to factor climate change explicitly into their decision making frameworks. However, most protected areas are small relative to the geographic ranges of species being managed, so forecasts need to consider local adaptation and community dynamics that are correlated with climate and affect distributions inside protected area boundaries. Additionally, niche theory suggests that species' physiological capacities to respond to climate change may be underestimated when forecasts fail to consider the full breadth of climates occupied by the species rangewide. Here, using correlative species distribution models that contrast estimates of climatic sensitivity inferred from the two spatial extents, we quantify the response of limber pine (Pinus flexilis) to climate change in Rocky Mountain National Park (Colorado, USA). Models are trained locally within the park where limber pine is the community dominant tree species, a distinct structural-compositional vegetation class of interest to managers, and also rangewide, as suggested by niche theory. Model forecasts through 2100 under two representative concentration pathways (RCP 4.5 and 8.5 W/m(2)) show that the distribution of limber pine in the park is expected to move upslope in elevation, but changes in total and core patch area remain highly uncertain. Most of this uncertainty is biological, as magnitudes of projected change are considerably more variable between the two spatial extents used in model training than they are between RCPs, and novel future climates only affect local model predictions associated with RCP 8.5 after 2091. Combined, these results illustrate the importance of accounting for unknowns in species' climatic sensitivities when forecasting distributional scenarios that are used to inform management decisions. We discuss how our results for limber pine may be interpreted in the context of climate change vulnerability and used to help guide adaptive management.	[Monahan, William B.] Natl Pk Serv, Inventory & Monitoring Div, Ft Collins, CO 80525 USA; [Cook, Tammy] Natl Pk Serv, Biol Resource Management Div, Ft Collins, CO USA; [Melton, Forrest] Calif State Univ Monterey Bay, Seaside, CA USA; [Melton, Forrest] NASA, Ames Res Ctr, Cooperat Res Earth Sci & Technol, Moffett Field, CA 94035 USA; [Connor, Jeff; Bobowski, Ben] Rocky Mt Natl Pk, Estes Pk, CO USA	United States Department of the Interior; United States Department of the Interior; California State University System; California State University Monterey Bay; National Aeronautics & Space Administration (NASA); NASA Ames Research Center	Monahan, WB (corresponding author), Natl Pk Serv, Inventory & Monitoring Div, Ft Collins, CO 80525 USA.	Bill_Monahan@nps.gov	Connor, Jeff/T-7345-2019		National Park Service; NASA Applied Sciences program [10-BIOCLIM10-0034]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000128] Funding Source: NIH RePORTER	National Park Service; NASA Applied Sciences program(National Aeronautics & Space Administration (NASA)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	Support for this study was provided by the National Park Service, and by the NASA Applied Sciences program through award number 10-BIOCLIM10-0034. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson RS, 2000, PALAEOGEOGR PALAEOCL, V155, P31, DOI 10.1016/S0031-0182(99)00093-0; [Anonymous], 2011, SCANNING CONSERVATIO; Araujo MB, 2004, GLOBAL CHANGE BIOL, V10, P1618, DOI 10.1111/j.1365-2486.2004.00828.x; Ashton I, 2010, NPSROMNNRR2010277; Ashton I, 2011, NPSROMNNRDS2011148; Baumeister D, 2006, ECOLOGY, V87, P1816, DOI 10.1890/0012-9658(2006)87[1816:FBPFDS]2.0.CO;2; BENKMAN CW, 1995, EVOLUTION, V49, P585, DOI 10.2307/2410312; Boland GJ, 2004, CAN J PLANT PATHOL, V26, P335; Brown PM, 2013, OLDLIST; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Cheever F, 1997, DENVER U LAW REV, V74, P625; Commission for Environmental Cooperation, 2011, N AM TERR EC LEV 3; Coop JD, 2009, FOREST ECOL MANAG, V257, P893, DOI 10.1016/j.foreco.2008.10.034; CORTNER HJ, 1994, ENVIRON MANAGE, V18, P167, DOI 10.1007/BF02393759; Donnegan JA, 1999, ECOLOGY, V80, P1370, DOI 10.1890/0012-9658(1999)080[1370:RAMOSF]2.0.CO;2; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Elith J, 2010, METHODS ECOL EVOL, V1, P330, DOI 10.1111/j.2041-210X.2010.00036.x; Gesch D, 2002, PHOTOGRAMM ENG REM S, V68, P5; Gibson K., 2008, MOUNTAIN PINE BEETLE; Hannah L, 2007, FRONT ECOL ENVIRON, V5, P131, DOI 10.1890/1540-9295(2007)5[131:PANIAC]2.0.CO;2; Hannah L, 2002, CONSERV BIOL, V16, P264, DOI 10.1046/j.1523-1739.2002.00465.x; Harsch MA, 2009, ECOL LETT, V12, P1040, DOI 10.1111/j.1461-0248.2009.01355.x; Hessl AE, 1997, ARCTIC ALPINE RES, V29, P173, DOI 10.2307/1552044; Hijmans R, 2006, BIOCLIM AML VERSION; Jackson ST, 2009, P NATL ACAD SCI USA, V106, P19685, DOI 10.1073/pnas.0901644106; Johnson D. W., 2000, Plant Disease, V84, P595, DOI 10.1094/PDIS.2000.84.5.595D; LANNER RM, 1980, J FOREST, V78, P637; Little EL, 1971, USDA MISCELLANEOUS P, V1; Lockman I. Blakey, 2007, R6NRFHP200701 USDA F; Logan J.A., 2001, AM ENTOMOL, V47, P160; Maurer EP, 2008, HYDROL EARTH SYST SC, V12, P551; McCutchen HE, 1996, GREAT BASIN NAT, V56, P90; McLaughlin BC, 2012, GLOBAL CHANGE BIOL, V18, P2301, DOI 10.1111/j.1365-2486.2011.02630.x; McWethy D., 2010, NPSGRYNNRR2010260; Means RE, 2011, FUTURE HIGH ELEVATIO; Midgley GF, 2010, ECOGRAPHY, V33, P612, DOI 10.1111/j.1600-0587.2009.06000.x; Millar CI, 2007, CAN J FOREST RES, V37, P2508, DOI 10.1139/X07-097; Mitton JB, 2012, AM NAT, V179, pE163, DOI 10.1086/665007; Moyes AB, 2013, OECOLOGIA, V171, P271, DOI 10.1007/s00442-012-2410-0; Natural Resources Conservation Service, 2006, SOIL SURV ROCK MOUNT; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; PRISM Climate Group, 2012, PRISM CLIM DAT; Raffa KF, 2008, BIOSCIENCE, V58, P501, DOI 10.1641/B580607; REBERTUS AJ, 1991, J VEG SCI, V2, P445, DOI 10.2307/3236026; Reinhardt K, 2011, TREE PHYSIOL, V31, P615, DOI 10.1093/treephys/tpr055; Rochefort R. M., 1994, Holocene, V4, P89, DOI 10.1177/095968369400400112; Rocky Mountain National Park, 2010, LIST SPEC MAN; Rodrigues ASL, 2004, NATURE, V428, P640, DOI 10.1038/nature02422; Rogelj J, 2012, NAT CLIM CHANGE, V2, P248, DOI [10.1038/NCLIMATE1385, 10.1038/nclimate1385]; Salas DE, 2005, 82600502 BUR RECL; Schoettle AW, 2007, J FOREST RES-JPN, V12, P327, DOI 10.1007/s10310-007-0024-x; Schoettle AW, 2000, AM J BOT, V87, P1797, DOI 10.2307/2656832; Schoettle AW, 2011, FUTURE HIGH ELEVATIO; Schoettle AW, 2004, USDA FOR SERV P; SCOTT JM, 1993, WILDLIFE MONOGR, P1; Secretary of the Interior, 2009, 3289 SECR INT; Seo C, 2009, BIOL LETTERS, V5, P39, DOI 10.1098/rsbl.2008.0476; Sibold JS, 2006, J BIOGEOGR, V33, P833, DOI 10.1111/j.1365-2699.2006.01456.x; Smith CM, 2011, FUTURE HIGH ELEVATIO; Soulu M., 1999, CONTINENTAL CONSERVA; Stohlgren TJ, 1997, ECOLOGY, V78, P632, DOI 10.1890/0012-9658(1997)078[0632:LPPCEI]2.0.CO;2; Stohlgren TJ, 2000, BIODIVERS CONSERV, V9, P65, DOI 10.1023/A:1008995726486; Thrasher Bridget, 2013, Eos, Transactions American Geophysical Union, V94, P321; Trivedi MR, 2008, GLOBAL CHANGE BIOL, V14, P1089, DOI 10.1111/j.1365-2486.2008.01553.x; Warren DL, 2011, ECOL APPL, V21, P335, DOI 10.1890/10-1171.1; Warren DL, 2010, ECOGRAPHY, V33, P607, DOI 10.1111/j.1600-0587.2009.06142.x; Wood AW, 2004, CLIMATIC CHANGE, V62, P189, DOI 10.1023/B:CLIM.0000013685.99609.9e; Wood AW, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2001JD000659	70	17	17	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83163	10.1371/journal.pone.0083163	http://dx.doi.org/10.1371/journal.pone.0083163			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391742	gold, Green Published, Green Submitted			2022-12-25	WOS:000329325200039
J	Oba, Y; Yoshida, N; Kanie, S; Ojika, M; Inouye, S				Oba, Yuichi; Yoshida, Naoki; Kanie, Shusei; Ojika, Makoto; Inouye, Satoshi			Biosynthesis of Firefly Luciferin in Adult Lantern: Decarboxylation of L-Cysteine Is a Key Step for Benzothiazole Ring Formation in Firefly Luciferin Synthesis	PLOS ONE			English	Article							COLEOPTERA; BIOLUMINESCENCE; BENZOQUINONES; HILGENDORFII	Background: Bioluminescence in fireflies and click beetles is produced by a luciferase-luciferin reaction. The luminescence property and protein structure of firefly luciferase have been investigated, and its cDNA has been used for various assay systems. The chemical structure of firefly luciferin was identified as the D-form in 1963 and studies on the biosynthesis of firefly luciferin began early in the 1970's. Incorporation experiments using C-14-labeled compounds were performed, and cysteine and benzoquinone/hydroquinone were proposed to be biosynthetic component for firefly luciferin. However, there have been no clear conclusions regarding the biosynthetic components of firefly luciferin over 30 years. Methodology/Principal Findings: Incorporation studies were performed by injecting stable isotope-labeled compounds, including L-[U-C-13(3)]-cysteine, L-[1-C-13]-cysteine, L-[3-C-13]-cysteine, 1,4-[D-6]-hydroquinone, and p-[2,3,5,6-D]-benzoquinone, into the adult lantern of the living Japanese firefly Luciola lateralis. After extracting firefly luciferin from the lantern, the incorporation of stable isotope-labeled compounds into firefly luciferin was identified by LC/ESI-TOF-MS. The positions of the stable isotope atoms in firefly luciferin were determined by the mass fragmentation of firefly luciferin. Conclusions: We demonstrated for the first time that D-and L-firefly luciferins are biosynthesized in the lantern of the adult firefly from two L-cysteine molecules with p-benzoquinone/1,4-hydroquinone, accompanied by the decarboxylation of L-cysteine.	[Oba, Yuichi; Yoshida, Naoki; Kanie, Shusei; Ojika, Makoto] Nagoya Univ, Grad Sch Bioagr Sci, Nagoya, Aichi 4648601, Japan; [Inouye, Satoshi] JNC Corp, Yokohama Res Ctr, Yokohama, Kanagawa, Japan	Nagoya University	Oba, Y (corresponding author), Nagoya Univ, Grad Sch Bioagr Sci, Nagoya, Aichi 4648601, Japan.	oba@agr.nagoya-u.ac.jp; sinouye@jnc-corp.co.jp	YOSHIDA, NAOKI/G-4986-2014; Oba, Yuichi/AAZ-7796-2021	Inouye, Satoshi/0000-0001-8732-7839	Japan Society for the Promotion of Science [23310159]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by a grant from Japan Society for the Promotion of Science (23310159). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CHADHA MS, 1961, J INSECT PHYSIOL, V7, P46, DOI 10.1016/0022-1910(61)90043-9; COLEPICOLO P, 1988, COMP BIOCHEM PHYS B, V91, P143, DOI 10.1016/0305-0491(88)90126-5; da Silva LP, 2011, PHOTOCH PHOTOBIO SCI, V10, P1039, DOI 10.1039/c0pp00379d; Derikvand F, 2010, J CATAL, V271, P99, DOI 10.1016/j.jcat.2010.02.015; GNANASUNDERAM C, 1985, J CHEM ECOL, V11, P465, DOI 10.1007/BF00989557; Gomi K, 2001, J BIOL CHEM, V276, P36508, DOI 10.1074/jbc.M105528200; Head JF, 2000, NATURE, V405, P372, DOI 10.1038/35012659; Holliday AE, 2009, J CHEM ECOL, V35, P1302, DOI 10.1007/s10886-009-9712-7; Inouye S, 2010, CELL MOL LIFE SCI, V67, P387, DOI 10.1007/s00018-009-0170-8; Kato S, 2004, TETRAHEDRON, V60, P11427, DOI 10.1016/j.tet.2004.09.080; Kato S, 2007, HETEROCYCLES, V72, P673; Lembert N, 1996, BIOCHEM J, V317, P273, DOI 10.1042/bj3170273; Lloyd J.E., 1978, P241; MCCAPRA F, 1976, J CHEM SOC CHEM COMM, P153, DOI 10.1039/c39760000153; MCCAPRA F, 1975, J CHEM SOC CHEM COMM, P42, DOI 10.1039/c3975000042b; Niwa K, 2006, FEBS LETT, V580, P5283, DOI 10.1016/j.febslet.2006.08.073; Oba Y, 2002, TETRAHEDRON LETT, V43, P2389, DOI 10.1016/S0040-4039(02)00257-5; Oba Y, 2008, BIOSCI BIOTECH BIOCH, V72, P1384, DOI 10.1271/bbb.80017; Oba Y, 2013, PHOTOCH PHOTOBIO SCI, V12, P854, DOI 10.1039/c3pp25363e; Oba Y, 2009, BIOCHEM BIOPH RES CO, V390, P684, DOI 10.1016/j.bbrc.2009.10.028; OKADA K, 1976, J CHEM SOC CHEM COMM, P32, DOI 10.1039/c39760000032; OKADA K, 1974, TETRAHEDRON LETT, P2771; Reinhard J, 2002, J CHEM ECOL, V28, P1, DOI 10.1023/A:1013554100310; SELIGER HH, 1961, P NATL ACAD SCI USA, V47, P1129, DOI 10.1073/pnas.47.8.1129; Shimomura O, 2006, BIOLUMINESCENCE: CHEMICAL PRINCIPLES AND METHODS, P1; Toya Y, 2005, Bioluminescence & Chemiluminescence: Progress and Perspectives, P129, DOI 10.1142/9789812702203_0030; WHITE EH, 1961, J AM CHEM SOC, V83, P2402, DOI 10.1021/ja01471a051; WHITE EH, 1963, J AM CHEM SOC, V85, P337, DOI 10.1021/ja00886a019; Wilson T., 2013, BIOLUMINESCENCE LIVI; Zhao W, 2011, BIOORGAN MED CHEM, V19, P3192, DOI 10.1016/j.bmc.2011.03.063	30	34	35	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84023	10.1371/journal.pone.0084023	http://dx.doi.org/10.1371/journal.pone.0084023			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391868	Green Published, gold, Green Submitted			2022-12-25	WOS:000329323900011
J	Ogawa, K; Ishizaki, A; Takai, K; Kitamura, Y; Kiwada, T; Shiba, K; Odani, A				Ogawa, Kazuma; Ishizaki, Atsushi; Takai, Kenichiro; Kitamura, Yoji; Kiwada, Tatsuto; Shiba, Kazuhiro; Odani, Akira			Development of Novel Radiogallium-Labeled Bone Imaging Agents Using Oligo-Aspartic Acid Peptides as Carriers	PLOS ONE			English	Article							DRUG-DELIVERY SYSTEM; CONJUGATED BISPHOSPHONATE; CALCIUM MINERALIZATION; RADIONUCLIDE UPTAKE; F-18-FLUORIDE PET; SEEKING AGENT; METASTASES; SCINTIGRAPHY; PALLIATION; THERAPY	Ga-68 (T-1/2 = 68 min, a generator-produced nuclide) has great potential as a radionuclide for clinical positron emission tomography (PET). Because poly-glutamic and poly-aspartic acids have high affinity for hydroxyapatite, to develop new bone targeting Ga-68-labeled bone imaging agents for PET, we used 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid (DOTA) as a chelating site and conjugated aspartic acid peptides of varying lengths. Subsequently, we compared Ga complexes, Ga-DOTA-(Asp) n (n = 2, 5, 8, 11, or 14) with easy-to-handle Ga-67, with the previously described Ga-67-DOTA complex conjugated bisphosphonate, Ga-67-DOTA-Bn-SCN-HBP. After synthesizing DOTA-(Asp) n by a Fmoc-based solidphase method, complexes were formed with Ga-67, resulting in Ga-67-DOTA-(Asp)(n) with a radiochemical purity of over 95% after HPLC purification. In hydroxyapatite binding assays, the binding rate of Ga-67-DOTA-(Asp)(n) increased with the increase in the length of the conjugated aspartate peptide. Moreover, in biodistribution experiments, Ga-67-DOTA-(Asp)(8), Ga-67-DOTA(Asp)(11), and Ga-67-DOTA-(Asp)(14) showed high accumulation in bone (10.5 +/- 1.5, 15.1 +/- 2.6, and 12.8 +/- 1.7% ID/g, respectively) but were barely observed in other tissues at 60 min after injection. Although bone accumulation of Ga-67-DOTA-(Asp)(n) was lower than that of Ga-67-DOTA-Bn-SCN-HBP, blood clearance of Ga-67-DOTA-(Asp)(n) was more rapid. Accordingly, the bone/blood ratios of Ga-67-DOTA-(Asp)(11) and Ga-67-DOTA-(Asp)(14) were comparable with those of Ga-67-DOTA-Bn-SCN-HBP. In conclusion, these data provide useful insights into the drug design of Ga-68-PET tracers for the diagnosis of bone disorders, such as bone metastases.	[Ogawa, Kazuma; Ishizaki, Atsushi; Takai, Kenichiro; Kiwada, Tatsuto; Odani, Akira] Kanazawa Univ, Grad Sch Med Sci, Kanazawa, Ishikawa, Japan; [Kitamura, Yoji; Shiba, Kazuhiro] Kanazawa Univ, Adv Sci Res Ctr, Kanazawa, Ishikawa, Japan	Kanazawa University; Kanazawa University	Ogawa, K (corresponding author), Kanazawa Univ, Grad Sch Med Sci, Kanazawa, Ishikawa, Japan.	kogawa@p.kanazawa-u.ac.jp	ODANI, Akira/B-3043-2011; Ogawa, Kazuma/D-8406-2015	ODANI, Akira/0000-0003-3786-6740; Ogawa, Kazuma/0000-0002-1691-7302	Ministry of Education, Culture, Sports, Science and Technology of Japan [21791174, 23791401]; Terumo Life Science Foundation; Mochida Memorial Foundation for Medical and Pharmaceutical Research	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Terumo Life Science Foundation(Terumo Life Science Foundation); Mochida Memorial Foundation for Medical and Pharmaceutical Research	This work was supported in part by Grants-in-Aid for Young Scientists (B) (KAKENHI Grant Number 21791174 and 23791401) from the Ministry of Education, Culture, Sports, Science and Technology of Japan, Terumo Life Science Foundation, and Mochida Memorial Foundation for Medical and Pharmaceutical Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLAU M, 1962, J NUCL MED, V3, P332; BUDD RS, 1989, BRIT J RADIOL, V62, P314, DOI 10.1259/0007-1285-62-736-314; BUDD RS, 1989, BRIT J RADIOL, V62, P318, DOI 10.1259/0007-1285-62-736-318; BUTLER WT, 1989, CONNECT TISSUE RES, V23, P123, DOI 10.3109/03008208909002412; de Rosales RTM, 2009, CHEM COMMUN, P4847, DOI 10.1039/b908652h; de Rosales RTM, 2010, BIOCONJUGATE CHEM, V21, P811, DOI 10.1021/bc100071k; Demirkan B, 2005, TUMORI, V91, P77, DOI 10.1177/030089160509100115; DOMSTAD PA, 1980, RADIOLOGY, V136, P209, DOI 10.1148/radiology.136.1.6446106; Even-Sapir E, 2006, J NUCL MED, V47, P287; Fellner M, 2012, NUCL MED BIOL, V39, P993, DOI 10.1016/j.nucmedbio.2012.04.007; Fellner M, 2010, EUR J NUCL MED MOL I, V37, P834, DOI 10.1007/s00259-009-1355-y; GALASKO CSB, 1980, CLIN NUCL MED, V5, P565; KAISER E, 1970, ANAL BIOCHEM, V34, P595, DOI 10.1016/0003-2697(70)90146-6; Kasugai S, 2000, J BONE MINER RES, V15, P936, DOI 10.1359/jbmr.2000.15.5.936; Kruger S, 2009, EUR J NUCL MED MOL I, V36, P1807, DOI 10.1007/s00259-009-1181-2; Kubicek V, 2005, J AM CHEM SOC, V127, P16477, DOI 10.1021/ja054905u; LAVENDER JP, 1979, J NUCL MED, V20, P413; LIBSON K, 1980, J AM CHEM SOC, V102, P2476, DOI 10.1021/ja00527a066; Love C, 2003, RADIOGRAPHICS, V23, P341, DOI 10.1148/rg.232025103; Mari C, 1999, Q J NUCL MED, V43, P259; MEYER JL, 1973, CALC TISS RES, V13, P295, DOI 10.1007/BF02015419; Notni J, 2012, EJNMMI RES, V2, DOI 10.1186/2191-219X-2-28; Notni J, 2012, EJNMMI RES, V2, DOI 10.1186/2191-219X-2-13; Ogawa K, 2005, BIOCONJUGATE CHEM, V16, P751, DOI 10.1021/bc040249w; Ogawa K, 2004, J LABELLED COMPD RAD, V47, P753, DOI 10.1002/jlcr.864; Ogawa K, 2012, CURR MED CHEM, V19, P3290, DOI 10.2174/092986712801215865; Ogawa K, 2009, J DRUG DELIV SCI TEC, V19, P171, DOI 10.1016/S1773-2247(09)50032-9; Ogawa K, 2011, INT J MOL IMAGING, V2011; Ogawa K, 2007, J NUCL MED, V48, P122; Ogawa K, 2006, NUCL MED BIOL, V33, P513, DOI 10.1016/j.nucmedbio.2006.03.006; Ogawa K, 2011, NUCL MED BIOL, V38, P631, DOI 10.1016/j.nucmedbio.2010.12.004; Ogawa K, 2009, EUR J NUCL MED MOL I, V36, P115, DOI 10.1007/s00259-008-0925-8; Ogawa K, 2009, NUCL MED BIOL, V36, P129, DOI 10.1016/j.nucmedbio.2008.11.007; Ogawa K, 2006, J NUCL MED, V47, P2042; OLDBERG A, 1986, P NATL ACAD SCI USA, V83, P8819, DOI 10.1073/pnas.83.23.8819; OLDBERG A, 1988, J BIOL CHEM, V263, P19430; Palma E, 2007, J BIOL INORG CHEM, V12, P667, DOI 10.1007/s00775-007-0215-0; Sekido T, 2001, J DRUG TARGET, V9, P111, DOI 10.3109/10611860108997922; SUBRAMANIAN G, 1975, J NUCL MED, V16, P744; Suzuki K, 2011, NUCL MED BIOL, V38, P1011, DOI 10.1016/j.nucmedbio.2011.02.015; TANABE S, 1983, INT J APPL RADIAT IS, V34, P1577, DOI 10.1016/0020-708X(83)90002-9; Uehara T, 2007, NUCL MED BIOL, V34, P79, DOI 10.1016/j.nucmedbio.2006.10.001; Verbeke K, 2002, BIOCONJUGATE CHEM, V13, P16, DOI 10.1021/bc0001600; Vitha T, 2008, J MED CHEM, V51, P677, DOI 10.1021/jm7012776; Wang D, 2003, BIOCONJUGATE CHEM, V14, P853, DOI 10.1021/bc034090j; Wang D, 2007, BIOCONJUGATE CHEM, V18, P1375, DOI 10.1021/bc7002132; Yokogawa K, 2001, ENDOCRINOLOGY, V142, P1228, DOI 10.1210/en.142.3.1228; YONEDA T, 1994, BREAST CANCER RES TR, V32, P73, DOI 10.1007/BF00666208; Zhernosekov KP, 2007, J NUCL MED, V48, P1741, DOI 10.2967/jnumed.107.040378	49	32	32	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84335	10.1371/journal.pone.0084335	http://dx.doi.org/10.1371/journal.pone.0084335			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391942	Green Published, gold, Green Submitted			2022-12-25	WOS:000329323900085
J	Parker, D; Picone, J; Harati, A; Lu, S; Jenkyns, MH; Polgreen, PM				Parker, Danny; Picone, Joseph; Harati, Amir; Lu, Shuang; Jenkyns, Marion H.; Polgreen, Philip M.			Detecting Paroxysmal Coughing from Pertussis Cases Using Voice Recognition Technology	PLOS ONE			English	Article							PATIENT	Background: Pertussis is highly contagious; thus, prompt identification of cases is essential to control outbreaks. Clinicians experienced with the disease can easily identify classic cases, where patients have bursts of rapid coughing followed by gasps, and a characteristic whooping sound. However, many clinicians have never seen a case, and thus may miss initial cases during an outbreak. The purpose of this project was to use voice-recognition software to distinguish pertussis coughs from croup and other coughs. Methods: We collected a series of recordings representing pertussis, croup and miscellaneous coughing by children. We manually categorized coughs as either pertussis or non-pertussis, and extracted features for each category. We used Mel-frequency cepstral coefficients (MFCC), a sampling rate of 16 KHz, a frame Duration of 25 msec, and a frame rate of 10 msec. The coughs were filtered. Each cough was divided into 3 sections of proportion 3-4-3. The average of the 13 MFCCs for each section was computed and made into a 39-element feature vector used for the classification. We used the following machine learning algorithms: Neural Networks, K-Nearest Neighbor (KNN), and a 200 tree Random Forest (RF). Data were reserved for cross-validation of the KNN and RF. The Neural Network was trained 100 times, and the averaged results are presented. Results: After categorization, we had 16 examples of non-pertussis coughs and 31 examples of pertussis coughs. Over 90% of all pertussis coughs were properly classified as pertussis. The error rates were: Type I errors of 7%, 12%, and 25% and Type II errors of 8%, 0%, and 0%, using the Neural Network, Random Forest, and KNN, respectively. Conclusion: Our results suggest that we can build a robust classifier to assist clinicians and the public to help identify pertussis cases in children presenting with typical symptoms.	[Parker, Danny] GTD Unltd, Oxford, MS USA; [Picone, Joseph; Harati, Amir; Lu, Shuang] Temple Univ, Dept Elect & Comp Engn, Philadelphia, PA 19122 USA; [Jenkyns, Marion H.] Jenkyns Oxford High Sch, Oxford, England; [Polgreen, Philip M.] Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA; [Polgreen, Philip M.] Univ Iowa, Dept Epidemiol, Iowa City, IA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University of Iowa; University of Iowa	Polgreen, PM (corresponding author), Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA.	Philip-polgreen@uiowa.edu		Polgreen, Philip/0000-0002-0630-5898	National Institute of Allergy and Infectious Diseases/National Institutes of Health [AI75089]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K01AI075089] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This project was funded in part by a K01 award (AI75089) from The National Institute of Allergy and Infectious Diseases/National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Banfield RE, 2007, IEEE T PATTERN ANAL, V29, P173, DOI 10.1109/TPAMI.2007.250609; Birring SS, 2008, EUR RESPIR J, V31, P1013, DOI 10.1183/09031936.00057407; Cherry James D, 2005, Pediatr Infect Dis J, V24, pS25, DOI 10.1097/01.inf.0000160926.89577.3b; Cornia PB, 2010, JAMA-J AM MED ASSOC, V304, P890, DOI 10.1001/jama.2010.1181; COVER TM, 1967, IEEE T INFORM THEORY, V13, P21, DOI 10.1109/TIT.1967.1053964; Ganapathiraju A, 2004, IEEE T SIGNAL PROCES, V52, P2348, DOI 10.1109/TSP.2004.831018; Lippmann R. P., 1987, IEEE ASSP Magazine, V4, P4, DOI 10.1145/44571.44572; Matos S, 2006, IEEE T BIO-MED ENG, V53, P1078, DOI 10.1109/TBME.2006.873548; PICONE JW, 1993, P IEEE, V81, P1215, DOI 10.1109/5.237532; Smith J, 2008, LUNG, V186, pS48, DOI 10.1007/s00408-007-9059-1; Tracey BH, 2011, IEEE ENG MED BIO, P6017, DOI 10.1109/IEMBS.2011.6091487; Versteegh FGA, 2012, ARCH PEDIAT ADOL MED, V166, P389, DOI 10.1001/archpediatrics.2011.1243; Wood N, 2008, PAEDIATR RESPIR REV, V9, P201, DOI 10.1016/j.prrv.2008.05.010	13	12	12	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e82971	10.1371/journal.pone.0082971	http://dx.doi.org/10.1371/journal.pone.0082971			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391730	Green Published, gold, Green Submitted			2022-12-25	WOS:000329325200027
J	Fraix, V; Bastin, J; David, O; Goetz, L; Ferraye, M; Benabid, AL; Chabardes, S; Pollak, P; Debu, B				Fraix, Valerie; Bastin, Julien; David, Olivier; Goetz, Laurent; Ferraye, Murielle; Benabid, Alim-Louis; Chabardes, Stephan; Pollak, Pierre; Debu, Bettina			Pedunculopontine Nucleus Area Oscillations during Stance, Stepping and Freezing in Parkinson's Disease	PLOS ONE			English	Article							DEEP BRAIN-STIMULATION; LOCAL-FIELD POTENTIALS; SUBTHALAMIC NUCLEUS; BASAL GANGLIA; GAIT; RECORDINGS; PATHOPHYSIOLOGY; CONNECTIVITY; RELEVANT; TARGET	The pedunculopontine area (PPNa) including the pedunculopontine and cuneiform nuclei, belongs to the mesencephalic locomotor region. Little is known about the oscillatory mechanisms underlying the function of this region in postural and gait control. We examined the modulations of the oscillatory activity of the PPNa and cortex during stepping, a surrogate of gait, and stance in seven Parkinson's disease patients who received bilateral PPNa implantation for disabling freezing of gait (FOG). In the days following the surgery, we recorded behavioural data together with the local field potentials of the PPNa during sitting, standing and stepping-in-place, under two dopaminergic medication conditions (OFF and ON levodopa). Our results showed that OFF levodopa, all subjects had FOG during step-in-place trials, while ON levodopa, stepping was effective (mean duration of FOG decreasing from 61.7+/-36.1% to 7.3+/-10.1% of trial duration). ON levodopa, there was an increase in PPNa alpha (5-12 Hz) oscillatory activity and a decrease in beta (13-35 Hz) and gamma (65-90 Hz) bands activity. PPNa activity was not modulated during quiet standing and sitting. Our results confirm the role of the PPNa in the regulation of gait and suggest that, in Parkinson disease, gait difficulties could be related to an imbalance between low and higher frequencies.	[Fraix, Valerie; Pollak, Pierre] Univ Hosp, Dept Neurol, Grenoble, France; [Fraix, Valerie; Bastin, Julien; Goetz, Laurent; Chabardes, Stephan; Pollak, Pierre; Debu, Bettina] Univ Grenoble 1, Grenoble, France; [Fraix, Valerie; Bastin, Julien; David, Olivier; Goetz, Laurent; Chabardes, Stephan; Pollak, Pierre; Debu, Bettina] INSERM, U836, Grenoble Inst Neurosci, Grenoble, France; [Ferraye, Murielle] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands; [Chabardes, Stephan] Univ Hosp, Dept Neurosurg, Grenoble, France; [Benabid, Alim-Louis] Clinatec CEA Leti, Grenoble, France; [Pollak, Pierre] Univ Hosp Geneva, Dept Neurol, Geneva, Switzerland	CHU Grenoble Alpes; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Radboud University Nijmegen; CHU Grenoble Alpes; CEA; University of Geneva	Fraix, V (corresponding author), Univ Hosp, Dept Neurol, Grenoble, France.	Valerie.Fraix@ujf-grenoble.fr	David, Olivier/A-6068-2009; David, Olivier/S-9463-2019; Benabid, Alim L/Q-3506-2017; Debû, Bettina/AAB-9935-2019; FRAIX, VALERIE/AAC-3616-2019; bastin, julien JDP/H-8785-2017; Goetz, Laurent/L-9954-2018	David, Olivier/0000-0003-0776-0216; David, Olivier/0000-0003-0776-0216; Debû, Bettina/0000-0002-2195-8846; bastin, julien JDP/0000-0002-0533-7564; Goetz, Laurent/0000-0001-5807-131X	University Hospital of Grenoble, France,; Michael J. Fox Foundation; Fondation de France, Paris, France	University Hospital of Grenoble, France,; Michael J. Fox Foundation; Fondation de France, Paris, France(Fondation de France)	This work was supported by the University Hospital of Grenoble, France, the Michael J. Fox Foundation and Fondation de France, Paris, France. Medtronic provided the implantable pulse generators. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abosch A, 2012, NEUROSURGERY, V71, P804, DOI 10.1227/NEU.0b013e3182676b91; Alam M, 2011, BRAIN, V134, P11, DOI 10.1093/brain/awq322; Androulidakis AG, 2008, EXP NEUROL, V211, P59, DOI 10.1016/j.expneurol.2008.01.002; Androulidakis AG, 2008, NEUROREPORT, V19, P59, DOI 10.1097/WNR.0b013e3282f2e2d1; Arnulf I, 2010, ANN NEUROL, V67, P546, DOI 10.1002/ana.21912; Aziz TZ, 2008, EXP NEUROL, V212, P247, DOI 10.1016/j.expneurol.2008.04.029; Ballanger B, 2009, HUM BRAIN MAPP, V30, P3901, DOI 10.1002/hbm.20815; Bonneville F, 2005, NEUROLOGY, V64, P1598, DOI 10.1212/01.WNL.0000160401.24880.83; Brown P, 2004, EXP NEUROL, V188, P480, DOI 10.1016/j.expneurol.2004.05.009; Brown P, 2003, MOVEMENT DISORD, V18, P357, DOI 10.1002/mds.10358; Brown P, 2005, CLIN NEUROPHYSIOL, V116, P2510, DOI 10.1016/j.clinph.2005.05.009; Castrioto A, 2011, ARCH NEUROL-CHICAGO, V68, P1550, DOI 10.1001/archneurol.2011.182; Faist M, 2001, BRAIN, V124, P1590, DOI 10.1093/brain/124.8.1590; Fasano A, 2010, BRAIN, V133, P2664, DOI 10.1093/brain/awq221; Ferraye M, 2010, THESIS J FOURIER U G; Ferraye MU, 2010, BRAIN, V133, P205, DOI 10.1093/brain/awp229; Fling BW, 2013, BRAIN, V136, P2405, DOI 10.1093/brain/awt172; GARCIARILL E, 1987, BRAIN RES BULL, V18, P731, DOI 10.1016/0361-9230(87)90208-5; Giannicola G, 2012, EXP NEUROL, V237, P312, DOI 10.1016/j.expneurol.2012.06.012; Giladi N, 2008, MOVEMENT DISORD, V23, pS423, DOI 10.1002/mds.21927; Grabli D, 2012, J NEUROL NEUROSUR PS, V83, P979, DOI 10.1136/jnnp-2012-302263; Jahn K, 2008, NEUROIMAGE, V39, P786, DOI 10.1016/j.neuroimage.2007.09.047; Jenkinson N, 2009, MOVEMENT DISORD, V24, P319, DOI 10.1002/mds.22189; Jerbi K, 2009, HUM BRAIN MAPP, V30, P1758, DOI 10.1002/hbm.20750; Kleiner-Fisman G, 2006, MOVEMENT DISORD, V21, pS290, DOI 10.1002/mds.20962; Krack P, 2003, NEW ENGL J MED, V349, P1925, DOI 10.1056/NEJMoa035275; Lempka SF, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/4/046001; Marani E, 2008, ADV ANAT EMBRYOL CEL, V198, P1, DOI 10.1007/978-3-540-79460-8; Marsden JF, 2001, BRAIN, V124, P378, DOI 10.1093/brain/124.2.378; Mazzone P, 2007, NEUROREPORT, V18, P1407, DOI 10.1097/WNR.0b013e3282638614; Mena-Segovia J, 2004, TRENDS NEUROSCI, V27, P585, DOI 10.1016/j.tins.2004.07.009; Moro E, 2010, BRAIN, V133, P215, DOI 10.1093/brain/awp261; Nantel J, 2011, GAIT POSTURE, V34, P329, DOI 10.1016/j.gaitpost.2011.05.020; Neagu B, 2013, EXP NEUROL, V250, P221, DOI 10.1016/j.expneurol.2013.09.018; Piallat B, 2009, NEUROSCIENCE, V158, P1201, DOI 10.1016/j.neuroscience.2008.10.046; Plaha P, 2005, NEUROREPORT, V16, P1883, DOI 10.1097/01.wnr.0000187637.20771.a0; Rosa M, 2011, NEUROSIGNALS, V19, P151, DOI 10.1159/000328508; Rosa M, 2010, EXP NEUROL, V222, P184, DOI 10.1016/j.expneurol.2009.12.013; Schweder PM, 2010, NEUROREPORT, V21, P1065, DOI 10.1097/WNR.0b013e32833ce607; Shimamoto SA, 2010, J NEUROL NEUROSUR PS, V81, P80, DOI 10.1136/jnnp.2009.179069; Shine JM, 2013, BRAIN, V136, P1204, DOI 10.1093/brain/awt049; Snijders AH, 2011, BRAIN, V134, P59, DOI 10.1093/brain/awq324; Stefani A, 2007, BRAIN, V130, P1596, DOI 10.1093/brain/awl346; Takakusaki K, 2008, BRAIN RES REV, V57, P192, DOI 10.1016/j.brainresrev.2007.06.024; Thevathasan W, 2012, BRAIN; Thevathasan W, 2012, BRAIN, V135, P148, DOI 10.1093/brain/awr315; Tsang EW, 2010, NEUROLOGY, V75, P950, DOI 10.1212/WNL.0b013e3181f25b35; Weinberger M, 2008, EXP BRAIN RES, V188, P165, DOI 10.1007/s00221-008-1349-1; Williams D, 2002, BRAIN, V125, P1558, DOI 10.1093/brain/awf156; Yelnik J, 2007, BRAIN, V130, DOI 10.1093/brain/awm138; Yeo SS, 2011, STEREOT FUNCT NEUROS, V89, P152, DOI 10.1159/000324890; Zrinzo L, 2008, Br J Neurosurg, V22 Suppl 1, pS19, DOI 10.1080/02688690802448426; Zrinzo L, 2008, BRAIN, V131, P1588, DOI 10.1093/brain/awn075; Zrinzo L, 2007, BRAIN, V130, DOI 10.1093/brain/awm079	54	57	58	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e83919	10.1371/journal.pone.0083919	http://dx.doi.org/10.1371/journal.pone.0083919			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386308	Green Published, Green Submitted, gold			2022-12-25	WOS:000329194700078
J	Ko, JH; Llopis, PM; Heinritz, J; Jacobs-Wagner, C; Soll, D				Ko, Jae-hyeong; Llopis, Paula Montero; Heinritz, Jennifer; Jacobs-Wagner, Christine; Soell, Dieter			Suppression of Amber Codons in Caulobacter crescentus by the Orthogonal Escherichia coli Histidyl-tRNA Synthetase/tRNA(His) Pair	PLOS ONE			English	Article							HOST STRAINS; GENE; EXPRESSION; SEQUENCE; TRANSLATION; DECAY; CYCLE; UAG	While translational read-through of stop codons by suppressor tRNAs is common in many bacteria, archaea and eukaryotes, this phenomenon has not yet been observed in the alpha-proteobacterium Caulobacter crescentus. Based on a previous report that C. crescentus and Escherichia coli tRNA(His) have distinctive identity elements, we constructed E. coli tRNA(CUA)(His), a UAG suppressor tRNA for C. crescentus. By examining the expression of three UAG codon-containing reporter genes (encoding a beta-lactamase, the fluorescent mCherry protein, or the C. crescentus xylonate dehydratase), we demonstrated that the E. coli histidyl-tRNA synthetase/tRNA(CUA)(His) pair enables in vivo UAG suppression in C. crescentus. E. coli histidyl-tRNA synthetase (HisRS) or tRNA(CUA)(His) alone did not achieve suppression; this indicates that the E. coli HisRS/tRNA(CUA)(His) pair is orthogonal in C. crescentus. These results illustrate that UAG suppression can be achieved in C. crescentus with an orthogonal aminoacyl-tRNA synthetase/suppressor tRNA pair.	[Ko, Jae-hyeong; Soell, Dieter] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Llopis, Paula Montero; Jacobs-Wagner, Christine] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT USA; [Heinritz, Jennifer; Jacobs-Wagner, Christine] Yale Univ, Howard Hughes Med Inst, New Haven, CT 06511 USA; [Jacobs-Wagner, Christine] Yale Univ, Sch Med, Dept Microbial Pathogenesis, New Haven, CT USA; [Soell, Dieter] Yale Univ, Dept Chem, New Haven, CT USA	Yale University; Yale University; Howard Hughes Medical Institute; Yale University; Yale University; Yale University	Soll, D (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA.	dieter.soll@yale.edu	Llopis, Paula Montero/AAG-2853-2019	Jacobs-Wagner, Christine/0000-0003-0980-5334	National Institutes of Health [GM022854, GM065835]; DARPA [N66001-12-C-4211]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM022854, R01GM065835, R01GM022854] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DARPA(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health (GM022854, D. S. and GM065835, C.J-W.), and by DARPA contract (N66001-12-C-4211; D. S.). C.J.-W. is a Howard Hughes Medical Institute Investigator. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ardell DH, 2006, NUCLEIC ACIDS RES, V34, P893, DOI 10.1093/nar/gkj449; Avedissian M, 1996, MOL MICROBIOL, V19, P79, DOI 10.1046/j.1365-2958.1996.347879.x; BOLTEN SL, 1984, P NATL ACAD SCI-BIOL, V81, P6784, DOI 10.1073/pnas.81.21.6784; BOSSI L, 1983, J MOL BIOL, V164, P73, DOI 10.1016/0022-2836(83)90088-8; Bunjun S, 2000, P NATL ACAD SCI USA, V97, P12997, DOI 10.1073/pnas.230444397; Chan PP, 2009, NUCLEIC ACIDS RES, V37, pD93, DOI 10.1093/nar/gkn787; Chang YF, 2007, ANNU REV BIOCHEM, V76, P51, DOI 10.1146/annurev.biochem.76.050106.093909; Cridge AG, 2006, NUCLEIC ACIDS RES, V34, P1959, DOI 10.1093/nar/gkl074; EGGERTSSON G, 1988, MICROBIOL REV, V52, P354, DOI 10.1128/MMBR.52.3.354-374.1988; EVINGER M, 1977, J BACTERIOL, V132, P294, DOI 10.1128/JB.132.1.294-301.1977; Frischmeyer PA, 1999, HUM MOL GENET, V8, P1893, DOI 10.1093/hmg/8.10.1893; GILCHRIST A, 1992, CAN J MICROBIOL, V38, P193, DOI 10.1139/m92-033; GORINI L, 1970, ANNU REV GENET, V4, P107, DOI 10.1146/annurev.ge.04.120170.000543; Grote A, 2005, NUCLEIC ACIDS RES, V33, pW526, DOI 10.1093/nar/gki376; HIMENO H, 1989, NUCLEIC ACIDS RES, V17, P7855, DOI 10.1093/nar/17.19.7855; HOESL MG, 2012, CURR OPIN BIOTECHNOL; MARTIN J, 1993, NATURE, V366, P228, DOI 10.1038/366228a0; MILLER JH, 1983, J MOL BIOL, V164, P59, DOI 10.1016/0022-2836(83)90087-6; ONEILL VA, 1985, J BIOL CHEM, V260, P2501; Ozawa Y, 2003, J MOL EVOL, V56, P665, DOI 10.1007/s00239-002-2435-9; PALZKILL T, 1992, PROTEINS, V14, P29, DOI 10.1002/prot.340140106; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; SHERMAN F, 1982, MOL BIOL YEAST SACCH, P463; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; Sliusarenko O, 2011, MOL MICROBIOL, V80, P612, DOI 10.1111/j.1365-2958.2011.07579.x; Stephens C, 2007, J BACTERIOL, V189, P2181, DOI 10.1128/JB.01438-06; TAYLOR RG, 1993, NUCLEIC ACIDS RES, V21, P1677, DOI 10.1093/nar/21.7.1677; Terpe K, 2006, APPL MICROBIOL BIOT, V72, P211, DOI 10.1007/s00253-006-0465-8; Thanbichler M, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm818; Wang CX, 2007, J BACTERIOL, V189, P1954, DOI 10.1128/JB.01203-06; Wang L, 2001, CHEM BIOL, V8, P883, DOI 10.1016/S1074-5521(01)00063-1; Wang Q, 2009, CHEM BIOL, V16, P323, DOI 10.1016/j.chembiol.2009.03.001; West L, 2002, J BACTERIOL, V184, P2155, DOI 10.1128/JB.184.8.2155-2166.2002; WILLS N, 1983, CELL, V33, P575, DOI 10.1016/0092-8674(83)90438-5; Winzeler E, 1997, J MOL BIOL, V272, P665, DOI 10.1006/jmbi.1997.1261; Xie JM, 2005, CURR OPIN CHEM BIOL, V9, P548, DOI 10.1016/j.cbpa.2005.10.011; Yan W, 1996, BIOCHEMISTRY-US, V35, P6559, DOI 10.1021/bi952889f; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9; Yuan J, 2011, NUCLEIC ACIDS RES, V39, P2286, DOI 10.1093/nar/gkq1176	39	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e83630	10.1371/journal.pone.0083630	http://dx.doi.org/10.1371/journal.pone.0083630			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386240	Green Published, Green Submitted, gold			2022-12-25	WOS:000329194700053
J	Liu, ZN; Kong, LJ; Zhang, M; Lv, YX; Liu, YP; Zou, MH; Lu, G; Cao, JS; Yu, XL				Liu, Zhenning; Kong, Lijun; Zhang, Mei; Lv, Yanxia; Liu, Yapei; Zou, Minghau; Lu, Gang; Cao, Jiashu; Yu, Xiaolin			Genome-Wide Identification, Phylogeny, Evolution and Expression Patterns of AP2/ERF Genes and Cytokinin Response Factors in Brassica rapa ssp pekinensis	PLOS ONE			English	Article							TRANSCRIPTION FACTOR FAMILY; DNA-BINDING DOMAIN; SIGNALING PATHWAY; DUPLICATED GENES; ARABIDOPSIS; PROTEIN; ERF; DIVERGENCE; ETHYLENE; DATABASE	The AP2/ERF transcription factor family is one of the largest families involved in growth and development, hormone responses, and biotic or abiotic stress responses in plants. In this study, 281 AP2/ERF transcription factor unigenes were identified in Chinese cabbage. These superfamily members were classified into three families (AP2, ERF, and RAV). The ERF family was subdivided into the DREB subfamily and the ERF subfamily with 13 groups (I-XI) based on sequence similarity. Duplication, evolution and divergence of the AP2/ERF genes in B. rapa and Arabidopsis thaliana were investigated and estimated. Cytokinin response factors (CRFs), as a subclade of the AP2/ERF family, are important transcription factors that define a branch point in the cytokinin two-component signal (TCS) transduction pathway. Up to 21 CRFs with a conserved CRF domain were retrieved and designated as BrCRFs. The amino acid sequences, conserved regions and motifs, phylogenetic relationships, and promoter regions of the 21 BrCRFs were analyzed in detail. The BrCRFs broadly expressed in various tissues and organs. The transcripts of BrCRFs were regulated by factors such as drought, high salinity, and exogenous 6-BA, NAA, and ABA, suggesting their involvement in abiotic stress conditions and regulatory mechanisms of plant hormone homeostasis. These results provide new insight into the divergence, variation, and evolution of AP2/ERF genes at the genome-level in Chinese cabbage.	[Liu, Zhenning; Kong, Lijun; Zhang, Mei; Lv, Yanxia; Liu, Yapei; Zou, Minghau; Lu, Gang; Cao, Jiashu; Yu, Xiaolin] Zhejiang Univ, Inst Vegetable Sci, Lab Cell & Mol Biol, Hangzhou 310003, Zhejiang, Peoples R China; [Liu, Zhenning; Kong, Lijun; Zhang, Mei; Lv, Yanxia; Liu, Yapei; Zou, Minghau; Lu, Gang; Cao, Jiashu; Yu, Xiaolin] Minist Agr, Lab Hort Plant Growth & Qual Regulat, Hangzhou, Zhejiang, Peoples R China	Zhejiang University; Ministry of Agriculture & Rural Affairs	Yu, XL (corresponding author), Zhejiang Univ, Inst Vegetable Sci, Lab Cell & Mol Biol, Hangzhou 310003, Zhejiang, Peoples R China.	xlyu@zju.edu.cn			National Program on Key Basic Research Projects [2012CB113900]; Hi-Tech Research and Development Program of China [2012AA100104-4]; Zhejiang Provincial Natural Science Foundation of China [Y13C150001]; Breeding Project of the Sci-tech Foundation of Zhejiang Province [2012C12903]; Department of Education of Zhejiang Province [Y200909433]	National Program on Key Basic Research Projects(National Basic Research Program of China); Hi-Tech Research and Development Program of China(National High Technology Research and Development Program of China); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); Breeding Project of the Sci-tech Foundation of Zhejiang Province; Department of Education of Zhejiang Province	This work was partially supported by the National Program on Key Basic Research Projects (2012CB113900), the Hi-Tech Research and Development Program of China (2012AA100104-4), Zhejiang Provincial Natural Science Foundation of China (Y13C150001), the Breeding Project of the Sci-tech Foundation of Zhejiang Province (2012C12903), and the Program of Department of Education of Zhejiang Province (Y200909433). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altenhoff AM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000262; Bailey TL, 2006, NUCLEIC ACIDS RES, V34, pW369, DOI 10.1093/nar/gkl198; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Beilstein MA, 2010, P NATL ACAD SCI USA, V107, P18724, DOI 10.1073/pnas.0909766107; Berrocal-Lobo M, 2002, PLANT J, V29, P23, DOI 10.1046/j.1365-313x.2002.01191.x; Blanc G, 2004, PLANT CELL, V16, P1679, DOI 10.1105/tpc.021410; Blanc G, 2004, PLANT CELL, V16, P1667, DOI 10.1105/tpc.021345; Blanc G, 2003, GENOME RES, V13, P137, DOI 10.1101/gr.751803; Brenner WG, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00008; Cannon Steven B., 2004, BMC Plant Biology, V4, P10, DOI 10.1186/1471-2229-4-10; Cheng F, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00198; Cheng F, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-136; Chu ZX, 2011, GENET MOL RES, V10, P3316, DOI 10.4238/2011.December.8.3; Cutcliffe JW, 2011, J EXP BOT, V62, P4995, DOI 10.1093/jxb/err199; Dietz KJ, 2010, PROTOPLASMA, V245, P3, DOI 10.1007/s00709-010-0142-8; Du DL, 2013, PLANT MOL BIOL REP, V31, P741, DOI 10.1007/s11105-012-0531-6; Le DT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042411; Fang YJ, 2008, MOL GENET GENOMICS, V280, P547, DOI 10.1007/s00438-008-0386-6; Fujimoto SY, 2000, PLANT CELL, V12, P393, DOI 10.1105/tpc.12.3.393; Fujita M, 2006, CURR OPIN PLANT BIOL, V9, P436, DOI 10.1016/j.pbi.2006.05.014; Goodstein DM, 2012, NUCLEIC ACIDS RES, V40, pD1178, DOI 10.1093/nar/gkr944; Guo AY, 2005, BIOINFORMATICS, V21, P2568, DOI 10.1093/bioinformatics/bti334; Higo K, 1999, NUCLEIC ACIDS RES, V27, P297, DOI 10.1093/nar/27.1.297; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; Hu LF, 2011, GENET MOL BIOL, V34, P624, DOI 10.1590/S1415-47572011005000054; Hu YX, 2004, CELL RES, V14, P8, DOI 10.1038/sj.cr.7290197; Iida K, 2005, DNA RES, V12, P247, DOI 10.1093/dnares/dsi011; Karniely S, 2005, EMBO REP, V6, P420, DOI 10.1038/sj.embor.7400394; Koch MA, 2000, MOL BIOL EVOL, V17, P1483, DOI 10.1093/oxfordjournals.molbev.a026248; Kong H, 2007, PLANT J, V50, P873, DOI 10.1111/j.1365-313X.2007.03097.x; Kovacs-Bogdan E, 2010, BBA-MOL CELL RES, V1803, P740, DOI 10.1016/j.bbamcr.2010.01.015; Kubo M, 2000, PLANT J, V23, P385, DOI 10.1046/j.1365-313x.2000.00796.x; Lai Y, 2013, PLANT PHYSIOL BIOCH, V62, P70, DOI 10.1016/j.plaphy.2012.10.010; Lee JM, 2012, PLANT J, V70, P191, DOI 10.1111/j.1365-313X.2011.04863.x; Lee TH, 2013, NUCLEIC ACIDS RES, V41, pD1152, DOI 10.1093/nar/gks1104; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr201, 10.1093/nar/gkr931]; Li MY, 2013, PLANT MOL BIOL REP, V31, P1002, DOI 10.1007/s11105-013-0570-7; Liang HX, 2008, J EXP BOT, V59, P3111, DOI 10.1093/jxb/ern165; Liang YS, 2010, J KOREAN SOC APPL BI, V53, P142, DOI 10.3839/jksabc.2010.024; Licausi F, 2011, NATURE, V479, P419, DOI 10.1038/nature10536; Liu LS, 1999, EUR J BIOCHEM, V262, P247, DOI 10.1046/j.1432-1327.1999.00349.x; Liu Q, 1998, PLANT CELL, V10, P1391, DOI 10.1105/tpc.10.8.1391; Liu ZN, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-594; Lorenzo O, 2003, PLANT CELL, V15, P165, DOI 10.1105/tpc.007468; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Lysak MA, 2005, GENOME RES, V15, P516, DOI 10.1101/gr.3531105; Magnani E, 2004, PLANT CELL, V16, P2265, DOI 10.1105/tpc.104.023135; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; Mine T, 2003, PLANT CELL PHYSIOL, V44, P10, DOI 10.1093/pcp/pcg004; Mizoi J, 2012, BBA-GENE REGUL MECH, V1819, P86, DOI 10.1016/j.bbagrm.2011.08.004; Mun JH, 2012, MOL GENET GENOMICS, V287, P765, DOI 10.1007/s00438-012-0718-4; Mun JH, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-10-r111; Nakano T, 2006, PLANT PHYSIOL, V140, P411, DOI 10.1104/pp.105.073783; Niu XP, 2002, PLANT CELL, V14, P2565, DOI 10.1105/tpc.003400; Nowak MA, 1997, NATURE, V388, P167, DOI 10.1038/40618; Nuruzzaman M, 2010, GENE, V465, P30, DOI 10.1016/j.gene.2010.06.008; Okazaki K, 2009, PLANT CELL, V21, P1769, DOI 10.1105/tpc.109.067785; Park JM, 2001, PLANT CELL, V13, P1035, DOI 10.1105/tpc.13.5.1035; Rashid M, 2012, EVOL BIOINFORM, V8, P321, DOI 10.4137/EBO.S9369; Rashotte AM, 2006, P NATL ACAD SCI USA, V103, P11081, DOI 10.1073/pnas.0602038103; Rashotte AM, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-74; Riechmann JL, 1998, BIOL CHEM, V379, P633; Riechmann JL, 2000, SCIENCE, V290, P2105, DOI 10.1126/science.290.5499.2105; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Sakuma Y, 2002, BIOCHEM BIOPH RES CO, V290, P998, DOI 10.1006/bbrc.2001.6299; Seoighe C, 2004, TRENDS GENET, V20, P461, DOI 10.1016/j.tig.2004.07.008; Shan HY, 2007, MOL PHYLOGENET EVOL, V44, P26, DOI 10.1016/j.ympev.2007.02.016; Sharma MK, 2010, MOL GENET GENOMICS, V284, P455, DOI 10.1007/s00438-010-0580-1; Sharoni AM, 2011, PLANT CELL PHYSIOL, V52, P344, DOI 10.1093/pcp/pcq196; Shi XL, 2012, J EXP BOT, V63, P973, DOI 10.1093/jxb/err325; Shigyo M, 2006, GENE, V366, P256, DOI 10.1016/j.gene.2005.08.009; Shiu SH, 2004, PLANT CELL, V16, P1220, DOI 10.1105/tpc.020834; Solano R, 1998, GENE DEV, V12, P3703, DOI 10.1101/gad.12.23.3703; Song XM, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-573; Sun S, 2008, J BIOL CHEM, V283, P6261, DOI 10.1074/jbc.M706800200; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tang HB, 2008, SCIENCE, V320, P486, DOI 10.1126/science.1153917; Town CD, 2006, PLANT CELL, V18, P1348, DOI 10.1105/tpc.106.041665; Wagner A, 2002, GENOME BIOL, V3; Walther D, 2007, PLOS GENET, V3, P216, DOI 10.1371/journal.pgen.0030011; Wang XW, 2011, NAT GENET, V43, P1035, DOI 10.1038/ng.919; Wellmer F, 2005, INT J DEV BIOL, V49, P745, DOI 10.1387/ijdb.051991fw; Werner T, 2009, CURR OPIN PLANT BIOL, V12, P527, DOI 10.1016/j.pbi.2009.07.002; Wessler SR, 2005, TRENDS PLANT SCI, V10, P54, DOI 10.1016/j.tplants.2004.12.007; Wu J, 2012, MOL GENET GENOMICS, V287, P295, DOI 10.1007/s00438-012-0675-y; Xu ZS, 2008, BOTANY, V86, P969, DOI 10.1139/B08-041; Yang HJ, 2002, PLANT MOL BIOL, V50, P379, DOI 10.1023/A:1019859612791; Yang XH, 2006, PLANT PHYSIOL, V142, P820, DOI 10.1104/pp.106.083642; Yang YW, 1999, J MOL EVOL, V48, P597, DOI 10.1007/PL00006502; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Zhang GY, 2008, J EXP BOT, V59, P4095, DOI 10.1093/jxb/ern248; Zhang JH, 2006, FIELD CROP RES, V97, P111, DOI 10.1016/j.fcr.2005.08.018; Zhuang J, 2008, BIOCHEM BIOPH RES CO, V371, P468, DOI 10.1016/j.bbrc.2008.04.087; Zhuang J, 2010, PLANT GROWTH REGUL, V62, P51, DOI 10.1007/s10725-010-9484-7; Zhuang J, 2010, MOL BIOL REP, V37, P2485, DOI 10.1007/s11033-009-9763-4; Zhuang J, 2009, SCI HORTIC-AMSTERDAM, V123, P73, DOI 10.1016/j.scienta.2009.08.002; Ziolkowski PA, 2006, PLANT J, V47, P63, DOI 10.1111/j.1365-313X.2006.02762.x; Zwack PJ, 2012, PLANT CELL PHYSIOL, V53, P1683, DOI 10.1093/pcp/pcs110	98	81	88	2	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e83444	10.1371/journal.pone.0083444	http://dx.doi.org/10.1371/journal.pone.0083444			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386201	gold, Green Submitted, Green Published			2022-12-25	WOS:000329194700042
J	Soora, M; Cypionka, H				Soora, Maya; Cypionka, Heribert			Light Enhances Survival of Dinoroseobacter shibae during Long-Term Starvation	PLOS ONE			English	Article							ANOXYGENIC PHOTOTROPHIC BACTERIA; MARINE ROSEOBACTER LINEAGE; PHOTOSYNTHETIC BACTERIA; HIGH ABUNDANCES; AEROBIC GROWTH; BALTIC SEA; GEN. NOV.; BACTERIOCHLOROPHYLL; DIVERSITY; OCEAN	Aerobic anoxygenic phototrophs (AAPs) as being photoheterotrophs require organic substrates for growth and use light as a supplementary energy source under oxic conditions. We hypothesized that AAPs benefit from light particularly under carbon and electron donor limitation. The effect of light was determined in long-term starvation experiments with Dinoroseobacter shibae DFL 12(T) in both complex marine broth and defined minimal medium with succinate as the sole carbon source. The cells were starved over six months under three conditions: continuous darkness (DD), continuous light (LL), and light/dark cycle (LD, 12 h/12 h, 12 mu mol photons m(-2) s(-1)). LD starvation at low light intensity resulted in 10-fold higher total cell and viable counts, and higher bacteriochlorophyll a and polyhydroxyalkanoate contents. This coincided with better physiological fitness as determined by respiration rates, proton translocation and ATP concentrations. In contrast, LD starvation at high light intensity (>22 mu mol photons m(-2) s(-1), LD conditions) resulted in decreasing cell survival rates but increasing carotenoid concentrations, indicating a photo-protective response. Cells grown in complex medium survived longer starvation (more than 20 weeks) than those grown in minimal medium. Our experiments show that D. shibae benefits from the light and dark cycle, particularly during starvation.	[Soora, Maya; Cypionka, Heribert] Carl von Ossietzky Univ Oldenburg, Inst Chem & Biol Marine Environm ICBM, D-26111 Oldenburg, Germany	Carl von Ossietzky Universitat Oldenburg	Cypionka, H (corresponding author), Carl von Ossietzky Univ Oldenburg, Inst Chem & Biol Marine Environm ICBM, D-26111 Oldenburg, Germany.	heribert.cypionka@uni-oldenburg.de			German Science Foundation within the Collaborative Research Centre [SFB-TRR51]	German Science Foundation within the Collaborative Research Centre	This study has been funded by the German Science Foundation within the Collaborative Research Centre SFB-TRR51 (Roseobacter). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beja O, 2002, NATURE, V415, P630, DOI 10.1038/415630a; Biebl H, 2005, INT J SYST EVOL MICR, V55, P1089, DOI 10.1099/ijs.0.63511-0; Biebl H, 2006, PROCESS BIOCHEM, V41, P2153, DOI 10.1016/j.procbio.2006.06.029; Brinkhoff T, 2008, ARCH MICROBIOL, V189, P531, DOI 10.1007/s00203-008-0353-y; Buchan A, 2005, APPL ENVIRON MICROB, V71, P5665, DOI 10.1128/AEM.71.10.5665-5677.2005; Clayton RK, 1963, BACTERIAL PHOTOSYNTH, P95; Cottrell MT, 2010, ISME J, V4, P945, DOI 10.1038/ismej.2010.13; Cottrell MT, 2006, APPL ENVIRON MICROB, V72, P557, DOI 10.1128/AEM.72.1.557-564.2006; Csotonyi JT, 2010, ENV MICROBIOL REP, V2, P651, DOI 10.1111/j.1758-2229.2010.00151.x; Cuperova Z, 2013, APPL ENV MICROBIOL; Glaeser J, 2005, MICROBIOL-SGM, V151, P1927, DOI 10.1099/mic.0.27789-0; Goericke R, 2002, LIMNOL OCEANOGR, V47, P290, DOI 10.4319/lo.2002.47.1.0290; Gomez-Consarnau L, 2007, NATURE, V445, P210, DOI 10.1038/nature05381; Gomez-Consarnau L, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000358; HARASHIMA K, 1980, PLANT CELL PHYSIOL, V21, P1283, DOI 10.1093/oxfordjournals.pcp.a076127; HARASHIMA K, 1987, PLANT CELL PHYSIOL, V28, P365; Hauruseu D, 2012, APPL ENVIRON MICROB, V78, P7414, DOI 10.1128/AEM.01747-12; Hiraishi A, 2000, INT J SYST EVOL MICR, V50, P1539, DOI 10.1099/00207713-50-4-1539; Holert J, 2011, ENV MICROBIOL REP, V3, P136, DOI 10.1111/j.1758-2229.2010.00199.x; IBA K, 1989, PLANT CELL PHYSIOL, V30, P471, DOI 10.1093/oxfordjournals.pcp.a077765; Jiang HC, 2009, FEMS MICROBIOL ECOL, V67, P268, DOI 10.1111/j.1574-6941.2008.00616.x; Jiao NZ, 2007, ENVIRON MICROBIOL, V9, P3091, DOI 10.1111/j.1462-2920.2007.01419.x; Kolber ZS, 2000, NATURE, V407, P177, DOI 10.1038/35025044; Kolber ZS, 2001, SCIENCE, V292, P2492, DOI 10.1126/science.1059707; Lami R, 2007, APPL ENVIRON MICROB, V73, P4198, DOI 10.1128/AEM.02652-06; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Masin M, 2008, ENVIRON MICROBIOL, V10, P1988, DOI 10.1111/j.1462-2920.2008.01615.x; Masin M, 2006, AQUAT MICROB ECOL, V45, P247, DOI 10.3354/ame045247; Medova H, 2011, FEMS MICROBIOL ECOL, V76, P393, DOI 10.1111/j.1574-6941.2011.01059.x; OKAMURA K, 1986, J BACTERIOL, V168, P1142, DOI 10.1128/jb.168.3.1142-1146.1986; OSTLE AG, 1982, APPL ENVIRON MICROB, V44, P238, DOI 10.1128/AEM.44.1.238-241.1982; Pfennig N, 1982, FAMILY CHROMATIACEAE, P3584; Salka I, 2008, APPL ENVIRON MICROB, V74, P4398, DOI 10.1128/AEM.02447-07; Schwalbach MS, 2005, LIMNOL OCEANOGR, P50; SHIBA T, 1984, J GEN APPL MICROBIOL, V30, P239, DOI 10.2323/jgam.30.239; SHNEOUR EA, 1962, BIOCHIM BIOPHYS ACTA, V62, P534, DOI 10.1016/0006-3002(62)90235-4; Sieracki ME, 2006, LIMNOL OCEANOGR, P51; Spring S, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-117; Steindler L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019725; Tomasch J, 2011, ISME J, V5, P1957, DOI 10.1038/ismej.2011.68; Wagner-Dobler I, 2006, ANNU REV MICROBIOL, V60, P255, DOI 10.1146/annurev.micro.60.080805.142115; Waidner LA, 2008, APPL ENVIRON MICROB, V74, P4012, DOI 10.1128/AEM.02324-07; YURKOV VV, 1993, ARCH MICROBIOL, V159, P84, DOI 10.1007/BF00244268; Yurkov VV, 1998, MICROBIOL MOL BIOL R, V62, P695, DOI 10.1128/MMBR.62.3.695-724.1998; Zong R, 2012, MICROBES ENVIRON, V27, P430, DOI 10.1264/jsme2.ME12029	46	14	16	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e83960	10.1371/journal.pone.0083960	http://dx.doi.org/10.1371/journal.pone.0083960			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386315	Green Published, Green Submitted, gold			2022-12-25	WOS:000329194700081
J	Wu, TF; Jia, J; Xiong, XP; He, HJ; Bu, LL; Zhao, ZL; Huang, CF; Zhang, WF				Wu, Tianfu; Jia, Jun; Xiong, Xuepeng; He, Haijun; Bu, Linlin; Zhao, Zhili; Huang, Congfa; Zhang, Wenfeng			Increased Expression of Lin28B Associates with Poor Prognosis in Patients with Oral Squamous Cell Carcinoma	PLOS ONE			English	Article							BINDING PROTEIN LIN28; MICRORNA BIOGENESIS; CANCER PROGRESSION; HEAD; SURVIVAL; MARKER	Recent studies showed that incomplete cell reprogramming can transform cells into tumour-like cells. Lin28A is associated with fibroblast and sarcoma cell reprogramming, whereas its homologue Lin28B is associated with hematopoietic cell reprogramming. This study aimed to investigate the expression and prognostic difference between Lin28A and Lin28B in oral squamous cell carcinoma (OSCC). Expression level was assessed by immunohistochemistry and staining location was confirmed by immunofluorescence. Prognostic values were analysed and compared by the Kaplan-Meier analysis and uni and multivariate Cox regression models. Besides, in vitro cell assays and in vivo nude mice xenograft were used to demonstrate the influence of increased Lin28B expression in OSCC. Lin28A and Lin28B expression increased in OSCC, and co-expression of Lin28A and Lin28B showed no significant association with patient prognosis. Kaplan-Meier analysis showed that patients with high Lin28B but not Lin28A expression had lower overall survival (OS) rates than those with low Lin28B expression. Further Univariate analysis showed that patients with increased Lin28B expression had shorter disease-free survival (DFS) and shorter OS, while multivariate analysis showed Lin28B overexpression with TNM stage predicted poor prognosis in patients with OSCC. Besides, stable expressing Lin28B in oral cancer cells promoted cell migration, invasion, colony formation, in vivo proliferation and increased the expression of cancer suppressor miRNA let-7 targeted genes IL-6, HMGA2, the EMT markers Snail and Twist, the angiogenesis inducer VEGF, and the apoptosis inhibitor Survivin. These combined results indicate that Lin28B is a novel marker for predicting prognosis in patients with OSCC and may be a therapeutic target.	[Wu, Tianfu; Jia, Jun; Zhao, Zhili] Wuhan Univ, Sch & Hosp Stomatol, State Key Lab Breeding Base Basic Sci Stomatol Hu, Wuhan 430072, Peoples R China; [Wu, Tianfu; Jia, Jun; Zhao, Zhili] Wuhan Univ, Key Lab Oral Biomed, Minist Educ, Wuhan 430072, Peoples R China; [Xiong, Xuepeng; He, Haijun; Bu, Linlin; Huang, Congfa; Zhang, Wenfeng] Wuhan Univ, Sch & Hosp Stomatol, Dept Oral Maxillofacial Head Neck Oncol, Wuhan 430072, Peoples R China	Wuhan University; Wuhan University; Wuhan University	Zhang, WF (corresponding author), Wuhan Univ, Sch & Hosp Stomatol, Dept Oral Maxillofacial Head Neck Oncol, Wuhan 430072, Peoples R China.	zhangwf59@163.com	Bu, Lin-Lin/AAK-8357-2020; zhao, zhili/F-4137-2016; Wu, Tianfu/AAB-4992-2021	zhao, zhili/0000-0002-9030-1979; Wu, Tianfu/0000-0003-4705-2687	Fundamental Research Funds from the Central Universities of Wuhan University [2012304020209]; National Natural Science Foundation of China [81272964]	Fundamental Research Funds from the Central Universities of Wuhan University; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the Fundamental Research Funds from the Central Universities of Wuhan University in 2012 (No.2012304020209) and the National Natural Science Foundation of China (No. 81272964). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal N, 2011, SCIENCE, V333, P1154, DOI 10.1126/science.1206923; Alajez NM, 2012, ONCOTARGET, V3, P1641; AMBROS V, 1984, SCIENCE, V226, P409, DOI 10.1126/science.6494891; Andric M, 2010, ORAL DIS, V16, P156, DOI 10.1111/j.1601-0825.2009.01612.x; Balzer E, 2007, RNA BIOL, V4, P16, DOI 10.4161/rna.4.1.4364; Cao DF, 2011, MODERN PATHOL, V24, P288, DOI 10.1038/modpathol.2010.195; Chen CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050104; Childs AJ, 2012, STEM CELLS DEV; Childs AJ, 2012, STEM CELLS DEV, V21, P2343, DOI 10.1089/scd.2011.0730; Hayashi S, 2013, EXP CELL RES, V319, P1220, DOI 10.1016/j.yexcr.2013.03.004; Heo I, 2009, CELL, V138, P696, DOI 10.1016/j.cell.2009.08.002; Huang Y, 2012, WILEY INTERDISCIP RE; Iliopoulos D, 2009, CELL, V139, P693, DOI 10.1016/j.cell.2009.10.014; King CE, 2011, CANCER RES, V71, P4260, DOI 10.1158/0008-5472.CAN-10-4637; Lei XX, 2012, NUCLEIC ACIDS RES, V40, P3574, DOI 10.1093/nar/gkr1279; Leonardi R, 2010, ORAL DIS, V16, P795, DOI 10.1111/j.1601-0825.2010.01690.x; Li JS, 2009, CLIN CANCER RES, V15, P3998, DOI 10.1158/1078-0432.CCR-08-3053; Liu YH, 2013, MED ONCOL, V30, DOI 10.1007/s12032-012-0426-2; Moss EG, 1997, CELL, V88, P637, DOI 10.1016/S0092-8674(00)81906-6; Perry JRB, 2009, NAT GENET, V41, P648, DOI 10.1038/ng.386; Piskounova E, 2011, CELL, V147, P1066, DOI 10.1016/j.cell.2011.10.039; Qu Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068724; Shinriki S, 2011, J PATHOL, V225, P142, DOI 10.1002/path.2935; Shkeir O, 2013, HEAD NECK; Stransky N, 2011, SCIENCE, V333, P1157, DOI 10.1126/science.1208130; Sun ZJ, 2010, J PHARMACOL EXP THER, V334, P500, DOI 10.1124/jpet.110.167692; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Wang AX, 2008, ONCOL RES, V17, P175, DOI 10.3727/096504008785114129; Wang Q, 2013, TUMOUR BIOL; Wang Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061640; Wang YC, 2010, CARCINOGENESIS, V31, P1516, DOI 10.1093/carcin/bgq107; Warnakulasuriya S, 2009, ORAL ONCOL, V45, P309, DOI 10.1016/j.oraloncology.2008.06.002; West JA, 2009, NATURE, V460, P909, DOI 10.1038/nature08210; Wu TF, 2013, CELLS TISSUES ORGANS, V197, P239, DOI 10.1159/000342926; Xu CY, 2013, MED ONCOL, V30, DOI 10.1007/s12032-012-0382-x; Xue DB, 2011, HISTOPATHOLOGY, V59, P452, DOI 10.1111/j.1365-2559.2011.03949.x; Yang XJ, 2010, CANCER RES, V70, P9463, DOI 10.1158/0008-5472.CAN-10-2388; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Yu SY, 2011, ORAL SURG ORAL MED O, V112, P616, DOI 10.1016/j.tripleo.2011.02.053; Yuan J, 2012, SCIENCE, V335, P1195, DOI 10.1126/science.1216557; ZHANG X, 2012, ONCOGENE	41	44	47	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e83869	10.1371/journal.pone.0083869	http://dx.doi.org/10.1371/journal.pone.0083869			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386298	gold, Green Published, Green Submitted			2022-12-25	WOS:000329194700076
J	Hasegawa, D; Tamura, S; Nakamoto, Y; Matsuki, N; Takahashi, K; Fujita, M; Uchida, K; Yamato, O				Hasegawa, Daisuke; Tamura, Shinji; Nakamoto, Yuya; Matsuki, Naoaki; Takahashi, Kimimasa; Fujita, Michio; Uchida, Kazuyuki; Yamato, Osamu			Magnetic Resonance Findings of the Corpus Callosum in Canine and Feline Lysosomal Storage Diseases	PLOS ONE			English	Article							NEURONAL CEROID-LIPOFUSCINOSIS; JAPANESE DOMESTIC CAT; SANDHOFF-LIKE DISEASE; GM2 GANGLIOSIDOSIS; TOY POODLES; VARIANT; MUTATION; GENE; MRI	Several reports have described magnetic resonance (MR) findings in canine and feline lysosomal storage diseases such as gangliosidoses and neuronal ceroid lipofuscinosis. Although most of those studies described the signal intensities of white matter in the cerebrum, findings of the corpus callosum were not described in detail. A retrospective study was conducted on MR findings of the corpus callosum as well as the rostral commissure and the fornix in 18 cases of canine and feline lysosomal storage diseases. This included 6 Shiba Inu dogs and 2 domestic shorthair cats with GM1 gangliosidosis; 2 domestic shorthair cats, 2 familial toy poodles, and a golden retriever with GM2 gangliosidosis; and 2 border collies and 3 chihuahuas with neuronal ceroid lipofuscinoses, to determine whether changes of the corpus callosum is an imaging indicator of those diseases. The corpus callosum and the rostral commissure were difficult to recognize in all cases of juvenile-onset gangliosidoses (GM1 gangliosidosis in Shiba Inu dogs and domestic shorthair cats and GM2 gangliosidosis in domestic shorthair cats) and GM2 gangliosidosis in toy poodles with late juvenile-onset. In contrast, the corpus callosum and the rostral commissure were confirmed in cases of GM2 gangliosidosis in a golden retriever and canine neuronal ceroid lipofuscinoses with late juvenile-to early adult-onset, but were extremely thin. Abnormal findings of the corpus callosum on midline sagittal images may be a useful imaging indicator for suspecting lysosomal storage diseases, especially hypoplasia (underdevelopment) of the corpus callosum in juvenile-onset gangliosidoses.	[Hasegawa, Daisuke; Fujita, Michio] Nippon Vet & Life Sci Univ, Div Vet Radiol, Dept Vet Sci, Tokyo, Japan; [Tamura, Shinji] Tamura Anim Clin, Hiroshima, Japan; [Nakamoto, Yuya] Kyoto Anim Referral Med Ctr, Kyoto, Japan; [Matsuki, Naoaki] Univ Tokyo, Dept Vet Clin Pathobiol, Grad Sch Agr & Life Sci, Tokyo, Japan; [Takahashi, Kimimasa] Nippon Vet & Life Sci Univ, Div Vet Pathol, Dept Vet Sci, Tokyo, Japan; [Uchida, Kazuyuki] Univ Tokyo, Dept Vet Pathol, Grad Sch Agr & Life Sci, Tokyo, Japan; [Yamato, Osamu] Kagoshima Univ, Dept Vet Med, Clin Pathol Lab, Kagoshima 890, Japan	Nippon Veterinary & Life Science University; University of Tokyo; Nippon Veterinary & Life Science University; University of Tokyo; Kagoshima University	Hasegawa, D (corresponding author), Nippon Vet & Life Sci Univ, Div Vet Radiol, Dept Vet Sci, Tokyo, Japan.	disk-hsgw@nvlu.ac.jp	Hasegawa, Daisuke/H-7510-2019; Tamura, Shinji/AAC-6783-2019	Hasegawa, Daisuke/0000-0002-7554-9108; Tamura, Shinji/0000-0002-1005-2598; Yamato, Osamu/0000-0002-4430-5645				Arrol LP, 2011, J FELINE MED SURG, V13, P120, DOI 10.1016/j.jfms.2010.09.001; Freeman AC, 2013, J VET INTERN MED, V27, P771, DOI 10.1111/jvim.12118; Gross B, 2010, VET RADIOL ULTRASOUN, V51, P361, DOI 10.1111/j.1740-8261.2010.01681.x; Hasegawa D, 2007, J FELINE MED SURG, V9, P232, DOI 10.1016/j.jfms.2006.11.003; Hasegawa D, 2012, SCI WORLD J, DOI 10.1100/2012/250197; Koie H, 2004, J VET MED SCI, V66, P1453, DOI 10.1292/jvms.66.1453; Matsuki N, 2005, CAN VET J, V46, P275; Mizukami K, 2012, SCI WORLD J, DOI 10.1100/2012/383174; Nakamoto Y, 2011, J AM ANIM HOSP ASSOC, V47, pE64, DOI 10.5326/JAAHA-MS-5564; Rahman MM, 2012, VET J, V194, P412, DOI 10.1016/j.tvjl.2012.05.021; SHULL RM, 1982, AM J PATHOL, V109, P244; Takahashi E, 2011, CEREB CORTEX, V21, P200, DOI 10.1093/cercor/bhq084; Tamura S, 2010, J VET INTERN MED, V24, P1013, DOI 10.1111/j.1939-1676.2010.0564.x; Uddin MM, 2013, J VET MED SCI, V75, P395, DOI 10.1292/jvms.12-0307; Vite CH, 2013, COMPARATIVE MED, V63, P163; Yamato O, 2008, J VET MED SCI, V70, P813, DOI 10.1292/jvms.70.813	16	13	13	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e83455	10.1371/journal.pone.0083455	http://dx.doi.org/10.1371/journal.pone.0083455			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281RE	24386203	gold, Green Published, Green Submitted			2022-12-25	WOS:000329117900037
J	Tautzenberger, A; Fortsch, C; Zwerger, C; Dmochewitz, L; Kreja, L; Ignatius, A; Barth, H				Tautzenberger, Andrea; Foertsch, Christina; Zwerger, Christian; Dmochewitz, Lydia; Kreja, Ludwika; Ignatius, Anita; Barth, Holger			C3 Rho-Inhibitor for Targeted Pharmacological Manipulation of Osteoclast-Like Cells	PLOS ONE			English	Article							ADP-RIBOSYLATING TOXINS; BOTULINUM C2 TOXIN; CYTOSKELETAL ORGANIZATION; DELIVERY; RIBOSYLTRANSFERASE; MACROPHAGES; EXOENZYMES; INSIGHTS; PROTEIN	The C3 toxins from Clostridium botulinum (C3bot) and Clostridium limosum (C3lim) as well as C3-derived fusion proteins are selectively taken up into the cytosol of monocytes/macrophages where the C3-catalyzed ADP-ribosylation of Rho results in inhibition of Rho-signalling and characteristic morphological changes. Since the fusion toxin C2IN-C3lim was efficiently taken up into and inhibited proliferation of murine macrophage-like RAW 264.7 cells, its effects on RAW 264.7-derived osteoclasts were investigated. C2IN-C3lim was taken up into differentiated osteoclasts and decreased their resorption activity. In undifferentiated RAW 264.7 cells, C2IN-C3lim-treatment significantly decreased their differentiation into osteoclasts as determined by counting the multi-nucleated, TRAP-positive cells. This inhibitory effect was concentration-and time-dependent and most efficient when C2IN-C3lim was applied in the early stage of osteoclast-formation. A single-dose application of C2IN-C3lim at day 0 and its subsequent removal at day 1 reduced the number of osteoclasts in a comparable manner while C2IN-C3lim-application at later time points did not reduce the number of osteoclasts to a comparable degree. Control experiments with an enzymatically inactive C3 protein revealed that the ADP-ribosylation of Rho was essential for the observed effects. In conclusion, the results indicate that Rho-activity is crucial during the early phase of osteoclast-differentiation. Other bone cell types such as pre-osteoblastic cells were not affected by C2IN-C3lim. Due to their cell-type selective and specific mode of action, C3 proteins and C3-fusions might be valuable tools for targeted pharmacological manipulation of osteoclast formation and activity, which could lead to development of novel therapeutic strategies against osteoclast-associated diseases.	[Tautzenberger, Andrea; Kreja, Ludwika; Ignatius, Anita] Univ Ulm, Inst Orthopaed Res & Biomech, Ctr Musculoskeletal Res, D-89069 Ulm, Germany; [Foertsch, Christina; Zwerger, Christian; Dmochewitz, Lydia; Barth, Holger] Univ Ulm, Med Ctr, Inst Pharmacol & Toxicol, D-89069 Ulm, Germany	Ulm University; Ulm University	Ignatius, A (corresponding author), Univ Ulm, Inst Orthopaed Res & Biomech, Ctr Musculoskeletal Res, D-89069 Ulm, Germany.	anita.ignatius@uni-ulm.de; holger.barth@uni-ulm.de	Ignatius, Anita/M-6012-2013	Ignatius, Anita/0000-0002-4782-1979	Medical Faculty of the University of Ulm; International Graduate School in Molecular Medicine Ulm (IGradU)	Medical Faculty of the University of Ulm; International Graduate School in Molecular Medicine Ulm (IGradU)	The work was supported by the Medical Faculty of the University of Ulm and the International Graduate School in Molecular Medicine Ulm (IGradU). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agholme F, 2012, J MATER SCI-MATER M, V23, P743, DOI 10.1007/s10856-011-4539-5; Aktories K, 2005, REV PHYSIOL BIOCH P, V152, P1, DOI 10.1007/s10254-004-0034-4; AKTORIES K, 1987, BIOCHEM J, V247, P363, DOI 10.1042/bj2470363; AKTORIES K, 1995, BIOCHIMIE, V77, P326, DOI 10.1016/0300-9084(96)88142-9; ALLEY MC, 1988, CANCER RES, V48, P589; Barth H, 1998, INFECT IMMUN, V66, P1364, DOI 10.1128/IAI.66.4.1364-1369.1998; Barth H, 2008, CURR MED CHEM, V15, P459, DOI 10.2174/092986708783503195; Barth H, 2011, EUR J CELL BIOL, V90, P944, DOI 10.1016/j.ejcb.2010.11.007; Brazier H, 2006, J BONE MINER RES, V21, P1387, DOI 10.1359/JBMR.060613; Chellaiah MA, 2005, J BIOL CHEM, V280, P32930, DOI 10.1074/jbc.M500154200; Christow H, 2013, TOXICON, V75, P144, DOI 10.1016/j.toxicon.2013.02.002; Dmochewitz L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054517; Fahrer J, 2010, CELL MICROBIOL, V12, P233, DOI 10.1111/j.1462-5822.2009.01393.x; Hsu HL, 1999, P NATL ACAD SCI USA, V96, P3540, DOI 10.1073/pnas.96.7.3540; Hu YW, 2005, FEBS LETT, V579, P4937, DOI 10.1016/j.febslet.2005.07.078; Itzstein Cecile, 2011, Small GTPases, V2, P117; JUST I, 1992, J BIOL CHEM, V267, P10274; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lillich M, 2012, BIOCONJUGATE CHEM, V23, P1426, DOI 10.1021/bc300041z; Saltel F, 2008, EUR J CELL BIOL, V87, P459, DOI 10.1016/j.ejcb.2008.01.001; Vogelsgesang M, 2007, N-S ARCH PHARMACOL, V374, P347, DOI 10.1007/s00210-006-0113-y; Wang YW, 2012, BIOMATERIALS, V33, P8540, DOI 10.1016/j.biomaterials.2012.07.039; Yavropoulou M. P., 2008, Journal of Musculoskeletal & Neuronal Interactions, V8, P204; ZHANG D, 1995, J CELL SCI, V108, P2285	24	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e85695	10.1371/journal.pone.0085695	http://dx.doi.org/10.1371/journal.pone.0085695			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281RE	24386487	Green Published, gold, Green Submitted			2022-12-25	WOS:000329117900133
J	Fan, SF; Yu, D; Liu, CH				Fan, Shufeng; Yu, Dan; Liu, Chunhua			The Invasive Plant Alternanthera philoxeroides Was Suppressed More Intensively than Its Native Congener by a Native Generalist: Implications for the Biotic Resistance Hypothesis	PLOS ONE			English	Article							PHENOTYPIC PLASTICITY; INSECT HERBIVORES; NATURAL ENEMIES; EXOTIC PLANTS; PHOTOSYNTHESIS; RESPONSES; VEGETATION; SUCCESS; GROWTH; LEAVES	Prior studies on preferences of native herbivores for native or exotic plants have tested both the enemy release hypothesis and the biotic resistance hypothesis and have reported inconsistent results. The different levels of resistance of native and exotic plants to native herbivores could resolve this controversy, but little attention has been paid to this issue. In this study, we investigated population performance, photosynthesis, leaf nitrogen concentration, and the constitutive and induced resistances of the successful invasive plant, Alternanthera philoxeroides, and its native congener, Alternanthera sessilis, in the presence of three population densities of the grasshopper, Atractomorpha sinensis. When the grasshopper was absent, leaf biomass, total biomass, photosynthesis, and leaf nitrogen concentration of A. philoxeroides were higher than those of A. sessilis. However, the morphological and physiological performances of A. philoxeroides were all decreased more intensively than A. sessilis after herbivory by grasshoppers. Especially as the concentrations of constitutive lignin and cellulose in leaf of A. philoxeroides were higher than A. sessilis, A. philoxeroides exhibited increased leaf lignin concentration to reduce its palatability only at severe herbivore load, whereas, leaf lignin, cellulose, and polyphenolic concentrations of A. sessilis all increased with increasing herbivory pressure, and cellulose and polyphenolic concentrations were higher in A. sessilis than in A. philoxeroides after herbivory. Our study indicated that the capability of the invasive plant to respond to native insect damage was lower than the native plant, and the invasive plant was suppressed more intensively than its native congener by the native insect. Our results support the biotic resistance hypothesis and suggest that native herbivores can constrain the abundance and reduce the adverse effects of invasive species.	[Fan, Shufeng; Yu, Dan; Liu, Chunhua] Wuhan Univ, Coll Life Sci, Natl Field Stn Freshwater Ecosyst Liangzi Lake, Wuhan 430072, Peoples R China	Wuhan University	Yu, D (corresponding author), Wuhan Univ, Coll Life Sci, Natl Field Stn Freshwater Ecosyst Liangzi Lake, Wuhan 430072, Peoples R China.	yudan01@public.wh.hb.cn		Fan, Shufeng/0000-0002-5930-2631	National Natural Science Foundation of China [30930011, 31170339]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by the National Natural Science Foundation of China (30930011 and 31170339). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AA, 2003, ECOL LETT, V6, P712, DOI 10.1046/j.1461-0248.2003.00498.x; BERENBAUM M, 1981, ECOLOGY, V62, P1254, DOI 10.2307/1937290; BERNAYS EA, 1981, ECOL ENTOMOL, V6, P353, DOI 10.1111/j.1365-2311.1981.tb00625.x; Biqinluoke X.H., 1987, ANAL METHODS PLANT B; BOX JD, 1983, WATER RES, V17, P511, DOI 10.1016/0043-1354(83)90111-2; Carrillo-Gavilan A, 2012, FUNCT ECOL, V26, P283, DOI 10.1111/j.1365-2435.2011.01931.x; Coulson JR, 1977, USDA TECHNICAL B, V1547; Dietz H, 2004, BIOL INVASIONS, V6, P511, DOI 10.1023/B:BINV.0000041566.23330.60; Dini J., 1995, African Journal of Range and Forage Science, V12, P49, DOI 10.1080/10220119.1995.9647863; Elton C. S., 1958, ECOLOGY INVASIONS AN; EVANS JR, 1989, OECOLOGIA, V78, P9, DOI 10.1007/BF00377192; Feeny P., 1976, BIOCHEMICAL INTERACT, V10, P1, DOI [10.1007/978-1-4684-2646-5_1, DOI 10.1007/978-1-4684-2646-5_1]; Geng YP, 2006, ACTA OECOL, V30, P380, DOI 10.1016/j.actao.2006.07.002; Goecker ME, 2005, MAR ECOL PROG SER, V286, P239, DOI 10.3354/meps286239; Han XM, 2008, PLANT ECOL, V198, P197, DOI 10.1007/s11258-008-9395-0; Harborne J. B., 1993, INTRO ECOLOGICAL BIO, V4th; Hu, 1990, J JIANGSU AGR COLL, V11, P57; Huang W, 2010, J ECOL, V98, P1157, DOI 10.1111/j.1365-2745.2010.01704.x; Jogesh T, 2008, BIOL INVASIONS, V10, P797, DOI 10.1007/s10530-008-9236-z; KARBAN R, 1989, ANNU REV ECOL SYST, V20, P331, DOI 10.1146/annurev.es.20.110189.001555; KARBAN R, 1987, OECOLOGIA, V73, P414, DOI 10.1007/BF00385258; Keane RM, 2002, TRENDS ECOL EVOL, V17, P164, DOI 10.1016/S0169-5347(02)02499-0; Levine JM, 2004, ECOL LETT, V7, P975, DOI 10.1111/j.1461-0248.2004.00657.x; Li HS, 2000, PRINCIPLES TECHNIQUE, P274; Li Z., 2002, INVADING ALIEN SPECI; Lind EM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010429; Marlin D, 2013, AQUAT BOT, V104, P60, DOI 10.1016/j.aquabot.2012.09.005; Morrison WE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017227; Muller-Scharer H, 2004, TRENDS ECOL EVOL, V19, P417, DOI 10.1016/j.tree.2004.05.010; Nabity PD, 2009, ANN BOT-LONDON, V103, P655, DOI 10.1093/aob/mcn127; Nnuez-Farfan J, 2007, ANNU REV ECOL EVOL S, V38, P541; Pan X., 2008, SHAANXI FOREST SCI T, V4, P6; Pan XY, 2006, ACTA OECOL, V30, P333, DOI 10.1016/j.actao.2006.03.003; Parker JD, 2005, ECOL LETT, V8, P959, DOI 10.1111/j.1461-0248.2005.00799.x; Parker JD, 2006, SCIENCE, V311, P1459, DOI 10.1126/science.1121407; Pearse IS, 2009, P NATL ACAD SCI USA, V106, P18097, DOI 10.1073/pnas.0904867106; Rhoades D.F., 1976, RECENT ADV PHYTOCHEM, P168, DOI DOI 10.1007/978-1-4684-2646-5_4; Sainty G., 1997, WETLANDS ECOLOGY MAN, V5, P195, DOI DOI 10.1023/A:1008248921849; Schooler SS, 2012, HANDBOOK OF GLOBAL FRESHWATER INVASIVE SPECIES, P25; Siemann E, 2003, ECOLOGY, V84, P1489, DOI 10.1890/0012-9658(2003)084[1489:HDRLAS]2.0.CO;2; Sosa AJ, 2003, CANB P 11 INT S BIOL, P180; Verhoeven KJF, 2009, ECOL LETT, V12, P107, DOI 10.1111/j.1461-0248.2008.01248.x; Vogt GB, 1979, USDA TECHNICAL B; Wardle DA, 2002, FUNCT ECOL, V16, P585, DOI 10.1046/j.1365-2435.2002.00659.x; Wu ZY, 2003, FLORA CHINA, V5; Xiong W, 2008, FRESHWATER BIOL, V53, P2256, DOI 10.1111/j.1365-2427.2008.02058.x; Zangerl AR, 2002, P NATL ACAD SCI USA, V99, P1088, DOI 10.1073/pnas.022647099; Zas R, 2011, J ECOL, V99, P1316, DOI 10.1111/j.1365-2745.2011.01872.x	48	23	24	0	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e83619	10.1371/journal.pone.0083619	http://dx.doi.org/10.1371/journal.pone.0083619			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281QS	24386236	Green Published, gold, Green Submitted			2022-12-25	WOS:000329116700064
J	Narayanan, R; Yepuru, M; Coss, CC; Wu, ZZ; Bauler, MN; Barrett, CM; Mohler, ML; Wang, Y; Kim, J; Snyder, LM; He, YL; Levy, N; Miller, DD; Dalton, JT				Narayanan, Ramesh; Yepuru, Muralimohan; Coss, Christopher C.; Wu, Zhongzhi; Bauler, Matthew N.; Barrett, Christina M.; Mohler, Michael L.; Wang, Yun; Kim, Juhyun; Snyder, Linda M.; He, Yali; Levy, Nelson; Miller, Duane D.; Dalton, James T.			Discovery and Preclinical Characterization of Novel Small Molecule TRK and ROS1 Tyrosine Kinase Inhibitors for the Treatment of Cancer and Inflammation	PLOS ONE			English	Article							NERVE GROWTH-FACTOR; NGF; MOUSE; GLIOBLASTOMA; EXPRESSION; PSORIASIS; CELLS; AIR	Receptor tyrosine kinases (RTKs), in response to their growth factor ligands, phosphorylate and activate downstream signals important for physiological development and pathological transformation. Increased expression, activating mutations and rearrangement fusions of RTKs lead to cancer, inflammation, pain, neurodegenerative diseases, and other disorders. Activation or over-expression of ALK, ROS1, TRK (A, B, and C), and RET are associated with oncogenic phenotypes of their respective tissues, making them attractive therapeutic targets. Cancer cDNA array studies demonstrated over-expression of TRK-A and ROS1 in a variety of cancers, compared to their respective normal tissue controls. We synthesized a library of small molecules that inhibit the above indicated RTKs with picomolar to nanomolar potency. The lead molecule GTx-186 inhibited RTK-dependent cancer cell and tumor growth. In vitro and in vivo growth of TRK-A-dependent IMR-32 neuroblastoma cells and ROS1-overexpressing NIH3T3 cells were inhibited by GTx-186. GTx-186 also inhibited inflammatory signals mediated by NF kappa B, AP-1, and TRK-A and potently reduced atopic dermatitis and air-pouch inflammation in mice and rats. Moreover, GTx-186 effectively inhibited ALK phosphorylation and ALK-dependent cancer cell growth. Collectively, the RTK inhibitor GTx-186 has a unique kinase profile with potential to treat cancer, inflammation, and neuropathic pain.	[Narayanan, Ramesh; Yepuru, Muralimohan; Coss, Christopher C.; Wu, Zhongzhi; Bauler, Matthew N.; Barrett, Christina M.; Mohler, Michael L.; Wang, Yun; Kim, Juhyun; Snyder, Linda M.; He, Yali; Miller, Duane D.; Dalton, James T.] GTx Inc, Preclin Res & Dev, Memphis, TN USA; [Levy, Nelson] Chembridge Res Lab, San Diego, CA USA		Narayanan, R (corresponding author), GTx Inc, Preclin Res & Dev, Memphis, TN USA.	rnarayanan@gtxinc.com; jdalton@gtxinc.com	Wang, Yun/G-3203-2015	Dalton, James T/0000-0002-3915-7326; Coss, Christopher/0000-0002-8184-9190				Albert L, 2003, J CELL PHYSIOL, V195, P168, DOI 10.1002/jcp.10252; Barouch R, 2001, J LEUKOCYTE BIOL, V69, P1019; Bilsland JG, 2008, NEUROPSYCHOPHARMACOL, V33, P685, DOI 10.1038/sj.npp.1301446; BIRCHMEIER C, 1990, P NATL ACAD SCI USA, V87, P4799, DOI 10.1073/pnas.87.12.4799; Bonini S, 1999, INT ARCH ALLERGY IMM, V118, P159, DOI 10.1159/000024055; BOYLE MDP, 1985, J IMMUNOL, V134, P564; BURCHILL SA, 1995, J NEUROL SCI, V133, P3, DOI 10.1016/0022-510X(95)00163-V; Cantarella G, 2002, FASEB J, V16, P1307, DOI 10.1096/fj.01-1000fje; Casaletto JB, 2012, NAT REV CANCER, V12, P386, DOI 10.1038/nrc3277; Cattaneo A, 2010, CURR OPIN MOL THER, V12, P94; Charest A, 2003, GENE CHROMOSOME CANC, V37, P58, DOI 10.1002/gcc.10207; Deininger MWN, 1997, BLOOD, V90, P3691, DOI 10.1182/blood.V90.9.3691; EDWARDS JCW, 1981, J PATHOL, V134, P147, DOI 10.1002/path.1711340205; Eggert A, 2000, MED PEDIATR ONCOL, V35, P623, DOI 10.1002/1096-911X(20001201)35:6<623::AID-MPO29>3.0.CO;2-H; El-Deeb IM, 2010, MED RES REV; Ghoreschi K, 2009, NAT IMMUNOL, V10, P356, DOI 10.1038/ni.1701; Gu TL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015640; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Jardi F, 2012, NEUROGASTROENT MOTIL, V24, pe580, DOI 10.1111/nmo.12027; JEPSEN S, 1992, CRIT CARE MED, V20, P918, DOI 10.1097/00003246-199207000-00004; KAPLAN DR, 1991, NATURE, V350, P158, DOI 10.1038/350158a0; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; KIMATA H, 1994, ARCH DIS CHILD, V70, P119, DOI 10.1136/adc.70.2.119; Krause DS, 2005, NEW ENGL J MED, V353, P172, DOI 10.1056/NEJMra044389; Kwak EL, 2010, NEW ENGL J MED, V363, P1693, DOI 10.1056/NEJMoa1006448; Lagadec C, 2009, ONCOGENE, V28, P1960, DOI 10.1038/onc.2009.61; Lee J, 2013, CANCER; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Liang SB, 2011, CLIN CANCER RES, V17, P4693, DOI 10.1158/1078-0432.CCR-10-3097; McKelvey L, 2013, J NEUROCHEM, V124, P276, DOI 10.1111/jnc.12093; McMahon SB, 1996, PHILOS T R SOC B, V351, P431, DOI 10.1098/rstb.1996.0039; MORGAN JI, 1989, TRENDS NEUROSCI, V12, P459, DOI 10.1016/0166-2236(89)90096-9; Narayanan R, 2010, CANCER RES, V70, P842, DOI 10.1158/0008-5472.CAN-09-3206; Nelson V, 2013, ONCOTARGETS THER, V6, P135, DOI 10.2147/OTT.S23165; Oddiah D, 1998, NEUROREPORT, V9, P1455, DOI 10.1097/00001756-199805110-00038; Raychaudhuri SK, 2009, ANN NY ACAD SCI, V1173, P470, DOI 10.1111/j.1749-6632.2009.04652.x; REYNOLDS CP, 1981, J NEUROSCI RES, V6, P319, DOI 10.1002/jnr.490060307; Rikova K, 2007, CELL, V131, P1190, DOI 10.1016/j.cell.2007.11.025; Rohn TA, 2011, J IMMUNOL, V186, P1769, DOI 10.4049/jimmunol.1000030; Romano M, 1997, MEDIAT INFLAMM, V6, P32, DOI 10.1080/09629359791901; Sachs M, 1996, J CELL BIOL, V133, P1095, DOI 10.1083/jcb.133.5.1095; Sammons MJ, 2000, BRAIN RES, V876, P48, DOI 10.1016/S0006-8993(00)02596-8; Shin S, 2010, J VET SCI, V11, P43, DOI 10.4142/jvs.2010.11.1.43; TUBARO A, 1986, AGENTS ACTIONS, V17, P347, DOI 10.1007/BF01982641; Wang F, 2013, ENV TOXICOL; Warmuth M, 2007, CURR OPIN ONCOL, V19, P55, DOI 10.1097/CCO.0b013e328011a25f; Xu AM, 2010, CANCER RES, V70, P3857, DOI 10.1158/0008-5472.CAN-10-0163; Yamaguchi J, 2009, J DERMATOL SCI, V53, P48, DOI 10.1016/j.jdermsci.2008.08.011; Yang CH, 2010, CANCER RES, V70, P8108, DOI 10.1158/0008-5472.CAN-10-2579; Yeung CH, 1999, BIOL REPROD, V61, P1062, DOI 10.1095/biolreprod61.4.1062; ZHAO JF, 1995, CANCER GENET CYTOGEN, V83, P148, DOI 10.1016/0165-4608(95)00043-O	51	18	41	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e83380	10.1371/journal.pone.0083380	http://dx.doi.org/10.1371/journal.pone.0083380			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281QS	24386191	Green Submitted, Green Published, gold			2022-12-25	WOS:000329116700047
J	Yu, Y; Walia, V; Elble, RC				Yu, Yang; Walia, Vijay; Elble, Randolph C.			Loss of CLCA4 Promotes Epithelial-to-Mesenchymal Transition in Breast Cancer Cells	PLOS ONE			English	Article							CYSTIC-FIBROSIS; EXPRESSION; PROTEIN; METALLOPROTEASE; PROGRESSION; METASTASIS; PROGNOSIS; CLEAVAGE; FAMILY; MCLCA3	The epithelial to mesenchymal transition (EMT) is a developmental program in which epithelial cells downregulate their cell-cell junctions, acquire spindle cell morphology and exhibit cellular motility. In breast cancer, EMT facilitates invasion of surrounding tissues and correlates closely with cancer metastasis and relapse. We found previously that the candidate tumor suppressor CLCA2 is expressed in differentiated, growth-arrested mammary epithelial cells but is downregulated during tumor progression and EMT. We further demonstrated that CLCA2 is a p53-inducible proliferation-inhibitor whose loss indicates an increased risk of metastasis. We show here that another member of the CLCA gene family, CLCA4, is expressed in mammary epithelial cells and is similarly downregulated in breast tumors and in breast cancer cell lines. Like CLCA2, the gene is stress-inducible, and ectopic expression inhibits colony formation. Transcriptional profiling studies revealed that CLCA4 and CLCA2 together are markers for mammary epithelial differentiation, and both are downregulated by TGF beta. Moreover, knockdown of CLCA4 in immortalized cells by shRNAs caused downregulation of epithelial marker E-cadherin and CLCA2, while mesenchymal markers N-cadherin, vimentin, and fibronectin were upregulated. Double knockdown of CLCA2 and CLCA4 enhanced the mesenchymal profile. These findings suggest that CLCA4 and CLCA2 play complementary but distinct roles in epithelial differentiation. Clinically, low expression of CLCA4 signaled lower relapse-free survival in basal and luminal B breast cancers.	[Walia, Vijay; Elble, Randolph C.] So Illinois Univ, Sch Med, Dept Pharmacol, Springfield, IL 62794 USA; [Yu, Yang; Walia, Vijay; Elble, Randolph C.] So Illinois Univ, Sch Med, Simmons Canc Inst, Springfield, IL USA; [Walia, Vijay] NCI, Lab Cell & Dev Signaling, Ctr Canc Res, Frederick, MD 21701 USA	Southern Illinois University System; Southern Illinois University; Southern Illinois University System; Southern Illinois University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Elble, RC (corresponding author), So Illinois Univ, Sch Med, Dept Pharmacol, Springfield, IL 62794 USA.	relble2@siumed.edu			NIH [R15CA151094]; Department of Defense [W81XWH-10-1-0402]; NATIONAL CANCER INSTITUTE [R15CA151094] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NIH grant R15CA151094 and Department of Defense grant number W81XWH-10-1-0402 to RCE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnel M, 1999, FEBS LETT, V455, P295, DOI 10.1016/S0014-5793(99)00891-1; Asiedu MK, 2011, CANCER RES, V71, P4707, DOI 10.1158/0008-5472.CAN-10-4554; Bothe M, 2011, MOL CELLS, V32, P535, DOI 10.1007/s10059-011-0158-8; Britschgi A, 2013, P NATL ACAD SCI USA, V110, pE1026, DOI 10.1073/pnas.1217072110; Bustin SA, 2001, DNA CELL BIOL, V20, P331, DOI 10.1089/10445490152122442; Cheng HC, 1998, J BIOL CHEM, V273, P24207, DOI 10.1074/jbc.273.37.24207; Creighton CJ, 2009, P NATL ACAD SCI USA, V106, P13820, DOI 10.1073/pnas.0905718106; Derichs N, 2013, EUR RESPIR REV, V22, P58, DOI 10.1183/09059180.00008412; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Elenbaas B, 2001, GENE DEV, V15, P50, DOI 10.1101/gad.828901; Elmore LW, 2002, J BIOL CHEM, V277, P35509, DOI 10.1074/jbc.M205477200; Fuller CM, 2001, PFLUG ARCH EUR J PHY, V443, pS107, DOI 10.1007/s004240100655; Gupta PB, 2009, CELL, V138, P645, DOI 10.1016/j.cell.2009.06.034; Gyorffy B, 2010, BREAST CANCER RES TR, V123, P725, DOI 10.1007/s10549-009-0674-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hennessy BT, 2009, CANCER RES, V69, P4116, DOI 10.1158/0008-5472.CAN-08-3441; Hsu YM, 2007, J CELL PHYSIOL, V210, P626, DOI 10.1002/jcp.20859; Kolbe EW, 2013, EUR J HUM GENET, V21, P691, DOI 10.1038/ejhg.2012.234; Lin XJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067496; Liu SL, 2010, J CLIN ONCOL, V28, P4006, DOI 10.1200/JCO.2009.27.5388; Liu W, 2012, CANCER LETT, V326, P41, DOI 10.1016/j.canlet.2012.07.015; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Marshall A, 2009, CELL TISSUE RES, V335, P383, DOI 10.1007/s00441-008-0719-0; Mundhenk L, 2006, J BIOL CHEM, V281, P30072, DOI 10.1074/jbc.M606489200; Onder TT, 2008, CANCER RES, V68, P3645, DOI 10.1158/0008-5472.CAN-07-2938; Pawlowski K, 2006, PROTEINS, V63, P424, DOI 10.1002/prot.20887; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Porter DA, 2001, CANCER RES, V61, P5697; Ruiz C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043265; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Walia V, 2012, ONCOGENE, V31, P2237, DOI 10.1038/onc.2011.392; Walia V, 2010, STEM CELLS DEV, V19, P1175, DOI 10.1089/scd.2009.0430; Walia V, 2009, CANCER RES, V69, P6624, DOI 10.1158/0008-5472.CAN-08-4101; Wang XH, 2007, CANCER RES, V67, P7184, DOI 10.1158/0008-5472.CAN-06-4729; Xie C, 2013, ONCOGENE, V32, P2282, DOI 10.1038/onc.2012.251; Yang B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060861; Yurtsever Z, 2012, J BIOL CHEM, V287, P42138, DOI 10.1074/jbc.M112.410282; Zhang JT, 2013, BBA-MOL CELL RES, V1833, P2961, DOI 10.1016/j.bbamcr.2013.07.021	38	40	41	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e83943	10.1371/journal.pone.0083943	http://dx.doi.org/10.1371/journal.pone.0083943			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281QS	24386311	gold, Green Published, Green Submitted			2022-12-25	WOS:000329116700090
J	Butzin, NC; Lapierre, P; Green, AG; Swithers, KS; Gogarten, JP; Noll, KM				Butzin, Nicholas C.; Lapierre, Pascal; Green, Anna G.; Swithers, Kristen S.; Gogarten, J. Peter; Noll, Kenneth M.			Reconstructed Ancestral Myo-Inositol-3-Phosphate Synthases Indicate That Ancestors of the Thermococcales and Thermotoga Species Were More Thermophilic than Their Descendants	PLOS ONE			English	Article							DIFFERENTIAL SCANNING FLUOROMETRY; SP-NOV; RESURRECTED PROTEINS; EVOLUTION; BACTERIA; MARITIMA; SEQUENCE; MODELS; ORIGIN; ALGORITHM	The bacterial genomes of Thermotoga species show evidence of significant interdomain horizontal gene transfer from the Archaea. Members of this genus acquired many genes from the Thermococcales, which grow at higher temperatures than Thermotoga species. In order to study the functional history of an interdomain horizontally acquired gene we used ancestral sequence reconstruction to examine the thermal characteristics of reconstructed ancestral proteins of the Thermotoga lineage and its archaeal donors. Several ancestral sequence reconstruction methods were used to determine the possible sequences of the ancestral Thermotoga and Archaea myo-inositol-3-phosphate synthase (MIPS). These sequences were predicted to be more thermostable than the extant proteins using an established sequence composition method. We verified these computational predictions by measuring the activities and thermostabilities of purified proteins from the Thermotoga and the Thermococcales species, and eight ancestral reconstructed proteins. We found that the ancestral proteins from both the archaeal donor and the Thermotoga most recent common ancestor recipient were more thermostable than their descendants. We show that there is a correlation between the thermostability of MIPS protein and the optimal growth temperature (OGT) of its host, which suggests that the OGT of the ancestors of these species of Archaea and the Thermotoga grew at higher OGTs than their descendants.	[Butzin, Nicholas C.; Lapierre, Pascal; Green, Anna G.; Swithers, Kristen S.; Gogarten, J. Peter; Noll, Kenneth M.] Univ Connecticut, Dept Mol & Cell Biol, Storrs, CT 06260 USA	University of Connecticut	Butzin, NC (corresponding author), Univ Connecticut, Dept Mol & Cell Biol, Storrs, CT 06260 USA.	nicholas.butzin@gmail.edu	Green, Anna/AAE-7645-2019	Green, Anna/0000-0001-7548-3682; Gogarten, Johann Peter/0000-0001-6459-6518; Butzin, Nicholas/0000-0003-3807-8666	National Aeronautics and Space Administration Exobiology program [NNX08AQ10G]; US Department of Energy Office of Biological and Environmental Research [DE-PS02-08ER08-12]; National Science Foundation Assembling the Tree of Life program [DEB0830024]	National Aeronautics and Space Administration Exobiology program(National Aeronautics & Space Administration (NASA)); US Department of Energy Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Science Foundation Assembling the Tree of Life program(National Science Foundation (NSF))	This work was supported by funds from the National Aeronautics and Space Administration Exobiology program (NNX08AQ10G), the US Department of Energy Office of Biological and Environmental Research (DE-PS02-08ER08-12), and the National Science Foundation Assembling the Tree of Life program (DEB0830024). Funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Akanuma S, 2013, P NATL ACAD SCI USA, V110, P11067, DOI 10.1073/pnas.1308215110; Barabote RD, 2009, GENOME RES, V19, P1033, DOI 10.1101/gr.084848.108; Boucher N, 2011, APPL ENVIRON MICROB, V77, P6395, DOI 10.1128/AEM.05418-11; Cai W, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-33; Chang BSW, 2002, MOL BIOL EVOL, V19, P1483, DOI 10.1093/oxfordjournals.molbev.a004211; Chen LJ, 2000, BIOCHEMISTRY-US, V39, P12415, DOI 10.1021/bi001517q; Dutheil J, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-255; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; EISENBERG F, 1987, METHOD ENZYMOL, V141, P127; Gaucher EA, 2003, NATURE, V425, P285, DOI 10.1038/nature01977; Gaucher EA, 2008, NATURE, V451, P704, DOI 10.1038/nature06510; Goncalves LG, 2011, ENV MICROBIOL; Green AG, 2013, MOL BIOL EVOL; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Harms MJ, 2010, CURR OPIN STRUC BIOL, V20, P360, DOI 10.1016/j.sbi.2010.03.005; Hobbs JK, 2012, MOL BIOL EVOL, V29, P825, DOI 10.1093/molbev/msr253; HUBER R, 1986, ARCH MICROBIOL, V144, P324, DOI 10.1007/BF00409880; JANNASCH HW, 1988, ARCH MICROBIOL, V150, P103, DOI 10.1007/BF00409725; Ju SL, 2004, J BIOL CHEM, V279, P21759, DOI 10.1074/jbc.M312078200; Maddison WP, 2011, MESQUITE MODULAR SYS; Majumder A.L., 2006, BIOL INOSITOLS PHOSP; Michell RH, 2008, NAT REV MOL CELL BIO, V9, P151, DOI 10.1038/nrm2334; Michell RH, 2011, ADV ENZYME REGUL, V51, P84, DOI 10.1016/j.advenzreg.2010.10.002; Mizuguchi K, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S1-S15; Nelson KE, 1999, NATURE, V399, P323, DOI 10.1038/20601; Nesbo CL, 2001, MOL BIOL EVOL, V18, P362, DOI 10.1093/oxfordjournals.molbev.a003812; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Park SH, 2004, J MICROBIOL, V42, P20; Poptsova MS, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-120; Rodionov DA, 2007, P NATL ACAD SCI USA, V104, P4279, DOI 10.1073/pnas.0609279104; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Ronquist F., 2003, BIOINFORMATICS, V19, P1572; Santos H, 2002, ENVIRON MICROBIOL, V4, P501, DOI 10.1046/j.1462-2920.2002.00335.x; Takahata Y, 2001, INT J SYST EVOL MICR, V51, P1901, DOI 10.1099/00207713-51-5-1901; Thornton JW, 2003, SCIENCE, V301, P1714, DOI 10.1126/science.1086185; Voordeckers K, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001446; Williams PD, 2006, PLOS COMPUT BIOL, V2, P598, DOI 10.1371/journal.pcbi.0020069; Zeldovich KB, 2007, PLOS COMPUT BIOL, V3, P62, DOI 10.1371/journal.pcbi.0030005; Zhaxybayeva O, 2009, P NATL ACAD SCI USA, V106, P5865, DOI 10.1073/pnas.0901260106	40	20	21	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84300	10.1371/journal.pone.0084300	http://dx.doi.org/10.1371/journal.pone.0084300			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391933	Green Submitted, gold, Green Published			2022-12-25	WOS:000329323900076
J	Duijvesz, D; Burnum-Johnson, KE; Gritsenko, MA; Hoogland, AM; Vredenbregt-van den Berg, MS; Willemsen, R; Luider, T; Pasa-Tolic, L; Jenster, G				Duijvesz, Diederick; Burnum-Johnson, Kristin E.; Gritsenko, Marina A.; Hoogland, A. Marije; Vredenbregt-van den Berg, Mirella S.; Willemsen, Rob; Luider, Theo; Pasa-Tolic, Ljiljana; Jenster, Guido			Proteomic Profiling of Exosomes Leads to the Identification of Novel Biomarkers for Prostate Cancer	PLOS ONE			English	Article							FATTY-ACID SYNTHASE; GENE-EXPRESSION; MODEL SYSTEM; XENOGRAFT; THROUGHPUT; DATABASE; DISPLAY; REGION; SIGNAL; ATLAS	Background: Current markers for prostate cancer, such as PSA lack specificity. Therefore, novel biomarkers are needed. Unfortunately, the complexity of body fluids often hampers biomarker discovery. An attractive alternative approach is the isolation of small vesicles, i.e. exosomes, similar to 100 nm, which contain proteins that are specific to the tissue from which they are derived and therefore can be considered as treasure chests for disease-specific biomarker discovery. Materials and Methods: Exosomes were isolated from 2 immortalized primary prostate epithelial cells (PNT2C2 and RWPE-1) and 2 PCa cell lines (PC346C and VCaP) by ultracentrifugation. After tryptic digestion, proteomic analyses utilized a nanoLC coupled with an LTQ-Orbitrap operated in tandem MS (MS/MS) mode. Accurate Mass and Time (AMT) tag approach was employed for peptide identification and quantitation. Candidate biomarkers were validated by Western blotting and Immunohistochemistry. Results: Proteomic characterization resulted in the identification of 248, 233, 169, and 216 proteins by at least 2 peptides in exosomes from PNT2C2, RWPE-1, PC346C, and VCaP, respectively. Statistical analyses revealed 52 proteins differently abundant between PCa and control cells, 9 of which were more abundant in PCa. Validation by Western blotting confirmed a higher abundance of FASN, XPO1 and PDCD6IP (ALIX) in PCa exosomes. Conclusions: Identification of exosomal proteins using high performance LC-FTMS resulted in the discovery of PDCD6IP, FASN, XPO1 and ENO1 as new candidate biomarkers for prostate cancer.	[Duijvesz, Diederick; Vredenbregt-van den Berg, Mirella S.; Jenster, Guido] Erasmus MC, Dept Urol, Rotterdam, Netherlands; [Burnum-Johnson, Kristin E.; Gritsenko, Marina A.] Pacific NW Natl Lab, Fundamental & Computat Sci Div, Richland, WA 99352 USA; [Hoogland, A. Marije] Erasmus MC, Dept Pathol, Rotterdam, Netherlands; [Willemsen, Rob] Erasmus MC, Dept Genet, Rotterdam, Netherlands; [Luider, Theo] Erasmus MC, Dept Neurol, Rotterdam, Netherlands; [Pasa-Tolic, Ljiljana] Pacific NW Natl Lab, Environm Mol Sci Lab, Richland, WA 99352 USA	Erasmus University Rotterdam; Erasmus MC; United States Department of Energy (DOE); Pacific Northwest National Laboratory; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; United States Department of Energy (DOE); Pacific Northwest National Laboratory	Jenster, G (corresponding author), Erasmus MC, Dept Urol, Rotterdam, Netherlands.	g.jenster@erasmusmc.nl	Duijvesz, Diederick/W-6029-2019; Burnum, Kristin E/B-1308-2011	Burnum, Kristin E/0000-0002-2722-4149; Duijvesz, Diederick/0000-0001-6678-3384	Department of Energy's Office of Biological and Environmental Research	Department of Energy's Office of Biological and Environmental Research(United States Department of Energy (DOE))	We would like to acknowledge Prof. Dr. N. Maitland from the University of York for kindly providing us with the PNT2C2 cell line. Proteomic analyses were performed using EMSL, a national scientific user facility sponsored by the Department of Energy's Office of Biological and Environmental Research and located at Pacific Northwest National Laboratory.	Anderson NL, 2002, MOL CELL PROTEOMICS, V1, P845, DOI 10.1074/mcp.R200007-MCP200; BERTHON P, 1995, INT J ONCOL, V6, P333; Di Vizio D, 2009, CANCER RES, V69, P5601, DOI 10.1158/0008-5472.CAN-08-3860; Duijvesz D, 2010, EUR UROL; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Gallouzi IE, 2001, SCIENCE, V294, P1895, DOI 10.1126/science.1064693; Ge XJ, 2005, GENOMICS, V86, P127, DOI 10.1016/j.ygeno.2005.04.008; Guescini M, 2010, EXP CELL RES, V316, P1977, DOI 10.1016/j.yexcr.2010.04.006; Hegmans JPJJ, 2004, AM J PATHOL, V164, P1807, DOI 10.1016/S0002-9440(10)63739-X; Hemming FJ, 2004, NEUROSCIENCE, V123, P887, DOI 10.1016/j.neuroscience.2003.10.036; Hosseini-Beheshti E, 2012, MOL CELL PROTEOMICS, V11, P863, DOI 10.1074/mcp.M111.014845; Jansen FH, 2009, MOL CELL PROTEOMICS, V8, P1192, DOI 10.1074/mcp.M800443-MCP200; JIMENEZ CR, 2010, PROTEOMICS, V73, P1873; Jongeneel CV, 2005, GENOME RES, V15, P1007, DOI 10.1101/gr.4041005; Korenchuk S, 2001, IN VIVO, V15, P163; Liu Hailan, 2010, Int J Biochem Mol Biol, V1, P69; Livesay EA, 2008, ANAL CHEM, V80, P294, DOI 10.1021/ac701727r; Marques RB, 2006, EUR UROL, V49, P245, DOI 10.1016/j.eururo.2005.12.035; MATHIVANAN S, 2010, PROTEOMICS, V9, P197; Migita T, 2009, JNCI-J NATL CANCER I, V101, P519, DOI 10.1093/jnci/djp030; Monroe ME, 2007, BIOINFORMATICS, V23, P2021, DOI 10.1093/bioinformatics/btm281; Noske A, 2008, CANCER-AM CANCER SOC, V112, P1733, DOI 10.1002/cncr.23354; Odorizzi G, 2006, J CELL SCI, V119, P3025, DOI 10.1242/jcs.03072; Polpitiya AD, 2008, BIOINFORMATICS, V24, P1556, DOI 10.1093/bioinformatics/btn217; Prasad TSK, 2009, METHODS MOL BIOL, V577, P67, DOI 10.1007/978-1-60761-232-2_6; Principe S, 2013, PROTEOMICS, V13, P1667, DOI 10.1002/pmic.201200561; Raj DA, 2012, KIDNEY INT; Sandvig K, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.012914; Saporita AJ, 2003, J BIOL CHEM, V278, P41998, DOI 10.1074/jbc.M302460200; Schroeder FH, 2009, NEW ENGL J MED, V360, P1320, DOI 10.1056/NEJMoa0810084; Shah US, 2006, HUM PATHOL, V37, P401, DOI 10.1016/j.humpath.2005.11.022; Shyamsundar R, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-3-r22; Son CG, 2005, GENOME RES, V15, P443, DOI 10.1101/gr.3124505; Stade K, 1997, CELL, V90, P1041, DOI 10.1016/S0092-8674(00)80370-0; STAMEY TA, 1987, NEW ENGL J MED, V317, P909, DOI 10.1056/NEJM198710083171501; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Subramanian A, 2000, J BIOL CHEM, V275, P5958, DOI 10.1074/jbc.275.8.5958; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Taylor DD, 2008, GYNECOL ONCOL, V110, P13, DOI 10.1016/j.ygyno.2008.04.033; vanWeerden WM, 1996, AM J PATHOL, V149, P1055; Veldhoven A, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-192; WELTON JL, 2010, PROTEOMICS, V9, P1324; YATES JR, 1995, ANAL CHEM, V67, P1426, DOI 10.1021/ac00104a020; Zimmer JSD, 2006, MASS SPECTROM REV, V25, P450, DOI 10.1002/mas.20071	44	152	157	2	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e82589	10.1371/journal.pone.0082589	http://dx.doi.org/10.1371/journal.pone.0082589			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391718	Green Published, Green Submitted, gold			2022-12-25	WOS:000329325200015
J	Paroly, SS; Wang, FW; Spraggon, L; Merregaert, J; Batourina, E; Tycko, B; Schmidt-Ott, KM; Grimmond, S; Little, M; Mendelsohn, C				Paroly, Suneeta S.; Wang, Fengwei; Spraggon, Lee; Merregaert, Joseph; Batourina, Ekatherina; Tycko, Benjamin; Schmidt-Ott, Kai M.; Grimmond, Sean; Little, Melissa; Mendelsohn, Cathy			Stromal Protein Ecm1 Regulates Ureteric Bud Patterning and Branching	PLOS ONE			English	Article							EXTRACELLULAR-MATRIX PROTEIN-1; RETINOL-BINDING-PROTEIN; LIPOID PROTEINOSIS; KIDNEY DEVELOPMENT; RENAL DEVELOPMENT; VITAMIN-A; MOLECULAR-CLONING; LICHEN-SCLEROSUS; GENE ECM1; MORPHOGENESIS	The interactions between the nephrogenic mesenchyme and the ureteric bud during kidney development are well documented. While recent studies have shed some light on the importance of the stroma during renal development, many of the signals generated in the stroma, the genetic pathways and interaction networks involving the stroma are yet to be identified. Our previous studies demonstrate that retinoids are crucial for branching of the ureteric bud and for patterning of the cortical stroma. In the present study we demonstrate that autocrine retinoic acid (RA) signaling in stromal cells is critical for their survival and patterning, and show that Extracellular matrix 1, Ecm1, a gene that in humans causes irritable bowel syndrome and lipoid proteinosis, is a novel RA-regulated target in the developing kidney, which is secreted from the cortical stromal cells surrounding the cap mesenchyme and ureteric bud. Our studies suggest that Ecm1 is required in the ureteric bud for regulating the distribution of Ret which is normally restricted to the tips, as inhibition of Ecm1 results in an expanded domain of Ret expression and reduced numbers of branches. We propose a model in which retinoid signaling in the stroma activates expression of Ecm1, which in turn down-regulates Ret expression in the ureteric bud cleft, where bifurcation normally occurs and normal branching progresses.	[Paroly, Suneeta S.; Wang, Fengwei; Spraggon, Lee; Batourina, Ekatherina; Mendelsohn, Cathy] Columbia Univ, Irving Canc Res Ctr, Dept Urol, New York, NY USA; [Tycko, Benjamin] Columbia Univ, Inst Canc Genet, New York, NY USA; [Tycko, Benjamin] Columbia Univ, Taub Inst Res Alzheimers Dis & Aging Brain, New York, NY USA; [Merregaert, Joseph] Univ Antwerp, Dept Biochem, Mol Biotechnol Lab, Antwerp, Belgium; [Schmidt-Ott, Kai M.] Max Delbrueck Ctr Mol Med, Berlin, Germany; [Grimmond, Sean; Little, Melissa] Univ Queensland, Inst Mol Biosci, St Lucia, Qld, Australia	Columbia University; Columbia University; Columbia University; University of Antwerp; Helmholtz Association; Max Delbruck Center for Molecular Medicine; University of Queensland	Paroly, SS (corresponding author), Early Coll, Bard High Sch, Long Isl City, NY USA.	sparoly@bhsec.bard.edu	Schmidt-Ott, Kai/F-4588-2011; Little, Melissa H/A-6170-2010; Grimmond, Sean M/J-5304-2016; Mendelsohn, Cathy/H-4280-2016; Grimmond, Sean/K-3246-2019	Schmidt-Ott, Kai/0000-0002-7700-7142; Little, Melissa H/0000-0003-0380-2263; Grimmond, Sean M/0000-0002-8102-7998; Mendelsohn, Cathy/0000-0002-4026-4073; Grimmond, Sean/0000-0002-8102-7998	NIH [DK055388]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by NIH grant DK055388 to CM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akoglu G, 2011, J DERMATOL TREAT, V22, P178, DOI 10.3109/09546631003639407; Batourina E, 2001, NAT GENET, V27, P74, DOI 10.1038/83792; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; BHALERAO J, 1995, J BIOL CHEM, V270, P16385, DOI 10.1074/jbc.270.27.16385; Blaner WS, 2007, CELL METAB, V5, P164, DOI 10.1016/j.cmet.2007.02.006; Challen G, 2005, PHYSIOL GENOMICS, V23, P159, DOI 10.1152/physiolgenomics.00043.2005; Chan I, 2004, CLIN EXP DERMATOL, V29, P52, DOI 10.1111/j.1365-2230.2004.01440.x; Costantini F, 2010, DEV CELL, V18, P698, DOI 10.1016/j.devcel.2010.04.008; DALY AK, 1990, METHOD ENZYMOL, V189, P239; de The H, 1990, Nouv Rev Fr Hematol, V32, P30; Dressler GR, 2002, TRENDS CELL BIOL, V12, P390, DOI 10.1016/S0962-8924(02)02334-6; Dressler GR, 2006, ANNU REV CELL DEV BI, V22, P509, DOI 10.1146/annurev.cellbio.22.010305.104340; Fisher SA, 2008, NAT GENET, V40, P710, DOI 10.1038/ng.145; Frey-Wagner I, 2013, INFLAMM BOWEL DIS; Gruber F, 1996, ACTA DERM-VENEREOL, V76, P154; Hamada T, 2003, J INVEST DERMATOL, V120, P345, DOI 10.1046/j.1523-1747.2003.12073.x; Hamada T, 2002, HUM MOL GENET, V11, P833, DOI 10.1093/hmg/11.7.833; Hatini V, 1996, GENE DEV, V10, P1467, DOI 10.1101/gad.10.12.1467; Jain S, 2009, ORGANOGENESIS, V5, P177, DOI 10.4161/org.5.4.10048; Kawaguchi R, 2007, SCIENCE, V315, P820, DOI 10.1126/science.1136244; Kim HY, 2012, ORGANOGENESIS, V8, P56, DOI 10.4161/org.19813; Kong L, 2010, MATRIX BIOL, V29, P276, DOI 10.1016/j.matbio.2010.01.007; Levinson R, 2003, SEMIN CELL DEV BIOL, V14, P225, DOI 10.1016/S1084-9521(03)00025-9; Levinson RS, 2005, DEVELOPMENT, V132, P529, DOI 10.1242/dev.01604; Mendelsohn C, 1999, DEVELOPMENT, V126, P1139; MENDELSOHN C, 1994, DEV BIOL, V166, P246, DOI 10.1006/dbio.1994.1311; Mongiat M, 2003, J BIOL CHEM, V278, P17491, DOI 10.1074/jbc.M210529200; Noy N, 2010, ANNU REV NUTR, V30, P201, DOI 10.1146/annurev.nutr.28.061807.155509; Patterson LT, 2001, DEVELOPMENT, V128, P2153; Powell J, 2002, J REPROD MED, V47, P706; Quaggin SE, 1999, DEVELOPMENT, V126, P5771; Rosselot C, 2010, DEVELOPMENT, V137, P283, DOI 10.1242/dev.040287; Sariola H, 1997, CURR OPIN CELL BIOL, V9, P877, DOI 10.1016/S0955-0674(97)80091-9; Sercu S, 2009, MATRIX BIOL, V28, P160, DOI 10.1016/j.matbio.2009.02.003; Smits P, 1999, GENE, V226, P253, DOI 10.1016/S0378-1119(98)00558-7; Stine ZE, 2011, HUM MOL GENET, V20, P3746, DOI 10.1093/hmg/ddr291; Tasker GL, 2003, CLIN EXP DERMATOL, V28, P128, DOI 10.1046/j.1365-2230.2003.01211.x; Toosi S, 2009, J EUR ACAD DERMATOL, V23, P482, DOI 10.1111/j.1468-3083.2008.02928.x; Vainio S, 2002, NAT REV GENET, V3, P533, DOI 10.1038/nrg842; Vilar J, 1996, KIDNEY INT, V49, P1478, DOI 10.1038/ki.1996.208; Yallowitz AR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023410	41	24	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84155	10.1371/journal.pone.0084155	http://dx.doi.org/10.1371/journal.pone.0084155			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391906	Green Published, gold, Green Accepted			2022-12-25	WOS:000329323900049
J	Talley, LE; Boyd, E				Talley, Leisel E.; Boyd, Erin			Challenges to the Programmatic Implementation of Ready to Use Infant Formula in the Post-Earthquake Response, Haiti, 2010: A Program Review	PLOS ONE			English	Review								Background and Objectives: Following the 2010 earthquake in Haiti, infant and young child feeding was identified as a priority nutrition intervention. A new approach to support breastfeeding mothers and distribute ready-to-use infant formula (RUIF) to infants unable to breastfeed was established. The objective of the evaluation was to assess the implementation of infant feeding programs using RUIF in displaced persons camps in Port-au-Prince, Haiti during the humanitarian response. Methods: A retrospective record review was conducted from April-July, 2010 to obtain data on infants receiving RUIF in 30 baby tents. A standardized data collection form was created based on data collected across baby tents and included: basic demographics, admission criteria, primary caretaker, feeding practices, and admission and follow-up anthropometrics. Main Findings: Orphans and abandoned infants were the most frequent enrollees (41%) in the program. While the program targeted these groups, it is unlikely that this is a true reflection of population demographics. Despite programmatic guidance, admission criteria were not consistently applied across programs. Thirty-four percent of infants were undernourished (weight for age Z score <-2) at the time of admission. Defaulting accounted for 50% of all program exits and there was no follow-up of these children. Low data quality was a significant barrier. Conclusions: The design, implementation and magnitude of the 'baby tents' using RUIF was novel in response to infant and young child feeding (IYCF) in emergencies and presented multiple challenges that should not be overlooked, including adherence to protocols and the adaption of emergency programs to existing programs. The implementation of IYCF programs should be closely monitored to ensure that they achieve the objectives set by the humanitarian community and national government. IYCF is an often overlooked component of emergency preparedness; however to improve response, generic protocols and pre-emergency training and preparedness should be established for humanitarian agencies.	[Talley, Leisel E.] Ctr Dis Control & Prevent, Emergency Response & Recovery Branch, Atlanta, GA 30329 USA; [Boyd, Erin] United Nations Childrens Fund, Nutr Sect, Program Div, New York, NY USA	Centers for Disease Control & Prevention - USA; UNICEF	Talley, LE (corresponding author), Ctr Dis Control & Prevent, Emergency Response & Recovery Branch, Atlanta, GA 30329 USA.	Ltalley@cdc.gov						Angood C, 2007, WEIGHING SCALES USED; Ayoya MA, 2013, B WORLD HEALTH ORGAN, V91, P612, DOI 10.2471/BLT.12.113936; Dean AG, 2007, EPI INFO DATABASE ST; Infant Feeding in Emergencies Core Group, 2007, OP GUID INF YOUNG CH; Kliegman RM, 2011, NELSON TXB PEDIAT; Le Cluster Nutrition Ministere de la Sante Publique et de la Population, 2010, POINTS CONS NUTR BEB; Ministry of Public Health and Population of Haiti Action Contre la Faim United Nations Children's Fund & European Commission, 2009, ANTHR SURV CHILDR 6; NutritionWorks Emergency Nutriton Network and the Global Nutrition Cluster, 2011, HARM TRAIN PACK HTP; O'Connor M E, 2001, Prehosp Disaster Med, V16, P231; *SAS I INC, 1999, SAS ONLINEDOC VERS 8; Victora CG, 2000, LANCET, V355, P451, DOI 10.1016/S0140-6736(00)82011-5; WHO Multicentre Growth Reference Study Group, 2006, WHO CHILD GROWTH STA	12	4	4	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84043	10.1371/journal.pone.0084043	http://dx.doi.org/10.1371/journal.pone.0084043			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391877	Green Submitted, gold, Green Published			2022-12-25	WOS:000329323900020
J	Vega-Zuniga, T; Medina, FS; Fredes, F; Zuniga, C; Severin, D; Palacios, AG; Karten, HJ; Mpodozis, J				Vega-Zuniga, Tomas; Medina, Felipe S.; Fredes, Felipe; Zuniga, Claudio; Severin, Daniel; Palacios, Adrian G.; Karten, Harvey J.; Mpodozis, Jorge			Does Nocturnality Drive Binocular Vision? Octodontine Rodents as a Case Study	PLOS ONE			English	Article							VISUAL-FIELDS; ORBIT ORIENTATION; RETINOFUGAL PROJECTIONS; SUPERIOR COLLICULUS; RETINAL PROJECTIONS; EVOLUTION; MAMMALS; EYE; PRIMATES; ACUITY	Binocular vision is a visual property that allows fine discrimination of in-depth distance (stereopsis), as well as enhanced light and contrast sensitivity. In mammals enhanced binocular vision is structurally associated with a large degree of frontal binocular overlap, the presence of a corresponding retinal specialization containing a fovea or an area centralis, and well-developed ipsilateral retinal projections to the lateral thalamus (GLd). We compared these visual traits in two visually active species of the genus Octodon that exhibit contrasting visual habits: the diurnal Octodon degus, and the nocturnal Octodon lunatus. The O. lunatus visual field has a prominent 100 degrees frontal binocular overlap, much larger than the 50 degrees of overlap found in O. degus. Cells in the retinal ganglion cell layer were 40% fewer in O. lunatus (180,000) than in O. degus (300,000). O. lunatus has a poorly developed visual streak, but a well developed area centralis, located centrally near the optic disk (peak density of 4,352 cells/mm(2)). O. degus has a highly developed visual streak, and an area centralis located more temporally (peak density of 6,384 cells/mm(2)). The volumes of the contralateral GLd and superior colliculus (SC) are 15% larger in O. degus compared to O. lunatus. However, the ipsilateral projections to GLd and SC are 500% larger in O. lunatus than in O. degus. Other retinorecipient structures related to ocular movements and circadian activity showed no statistical differences between species. Our findings strongly suggest that nocturnal visual behavior leads to an enhancement of the structures associated with binocular vision, at least in the case of these rodents. Expansion of the binocular visual field in nocturnal species may have a beneficial effect in light and contrast sensitivity, but not necessarily in stereopsis. We discuss whether these conclusions can be extended to other mammalian and non-mammalian amniotes.	[Vega-Zuniga, Tomas; Medina, Felipe S.; Fredes, Felipe; Zuniga, Claudio; Severin, Daniel; Mpodozis, Jorge] Univ Chile, Fac Ciencias, Dept Biol, Santiago, Chile; [Palacios, Adrian G.] Univ Valparaiso, Fac Ciencias, Ctr Interdisciplinario Neurociencia Valparaiso, Valparaiso, Chile; [Karten, Harvey J.] Univ Calif San Diego, Sch Med, Dept Neurosci, La Jolla, CA 92093 USA	Universidad de Chile; Universidad de Valparaiso; University of California System; University of California San Diego	Mpodozis, J (corresponding author), Univ Chile, Fac Ciencias, Dept Biol, Santiago, Chile.	epistemo@uchile.cl	Palacios, Adrian G/E-9846-2015; Vega-Zuniga, Tomas/AFQ-2110-2022	Palacios, Adrian G/0000-0003-1532-7527; 	Fondecyt [1080094, 1120124, 1090794]; Iniciativa Cientifica Milenio [ICM-P05-002]; Proyecto Fondo Basal [PFB-23-CONICYT]; STFC [ST/I005765/1, ST/L001314/1] Funding Source: UKRI	Fondecyt(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Iniciativa Cientifica Milenio; Proyecto Fondo Basal(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT PIA/BASAL); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	This work was supported by Fondecyt 1080094, Fondecyt 1120124 to Jorge Mpodozis; Fondecyt 1090794, Iniciativa Cientifica Milenio ICM-P05-002, Proyecto Fondo Basal PFB-23-CONICYT to Rodrigo Vasquez. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], VERTEBRATE EYE ITS A, DOI 10.1097/00005053-194409000-00057; Barton RA, 2004, P NATL ACAD SCI USA, V101, P10113, DOI 10.1073/pnas.0401955101; BISHOP PO, 1986, VISION RES, V26, P1587, DOI 10.1016/0042-6989(86)90177-X; CAMPBELL FW, 1965, NATURE, V208, P191, DOI 10.1038/208191a0; Cartmill Matt, 1992, Evolutionary Anthropology, V1, P105, DOI 10.1002/evan.1360010308; Chavez AE, 2003, INVEST OPHTH VIS SCI, V44, P2290, DOI 10.1167/iovs.02-0670; Clark B, 1935, AM J PSYCHOL, V47, P485, DOI 10.2307/1416342; Corfield JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022945; FITE KV, 1973, VISION RES, V13, P219, DOI 10.1016/0042-6989(73)90101-6; FUKUDA Y, 1989, J NEUROSCI, V9, P2353; Gaillard Frederic, 2013, J Comp Neurol, V521, pSpc1, DOI 10.1002/cne.23330; Gallardo Milton H., 2001, Journal of Mammalian Evolution, V8, P73, DOI 10.1023/A:1011345000786; Glanz WE, 1982, ECOLOGICAL COMP SMAL, P220; GROBSTEIN P, 1980, J COMP NEUROL, V190, P175, DOI 10.1002/cne.901900112; GULLEY RL, 1975, J COMP NEUROL, V162, P309, DOI 10.1002/cne.901620303; Hall MI, 2007, J ZOOL, V271, P437, DOI 10.1111/j.1469-7998.2006.00227.x; Hanke FD, 2009, BRAIN BEHAV EVOLUT, V74, P102, DOI 10.1159/000235612; Heesy CP, 2008, BRAIN BEHAV EVOLUT, V71, P54, DOI 10.1159/000108621; Heesy CP, 2010, BRAIN BEHAV EVOLUT, V75, P195, DOI 10.1159/000314278; Heesy CP, 2009, EVOL ANTHROPOL, V18, P21, DOI 10.1002/evan.20195; Heesy CP, 2004, ANAT REC PART A, V281A, P1104, DOI 10.1002/ar.a.20116; Hilbig H, 2000, BRAIN RES BULL, V51, P255, DOI 10.1016/S0361-9230(99)00230-0; Hughes A., 1977, VISUAL SYSTEM VERTEB; Iwaniuk AN, 2008, J COMP PHYSIOL A, V194, P267, DOI 10.1007/s00359-007-0304-0; Iwaniuk AN, 2006, J COMP PHYSIOL A, V192, P1313, DOI 10.1007/s00359-006-0161-2; Iwaniuk AN, 2007, J COMP NEUROL, V500, P211, DOI 10.1002/cne.21098; Jeffery G, 2005, PROG RETIN EYE RES, V24, P721, DOI 10.1016/j.preteyeres.2005.04.005; Katzir G, 1998, IBIS, V140, P157, DOI 10.1111/j.1474-919X.1998.tb04554.x; Land MF, 2012, OXF ANIMAL BIOL SER, P1; LENT R, 1976, BRAIN RES, V107, P9, DOI 10.1016/0006-8993(76)90092-5; Major DE, 2003, J COMP NEUROL, V463, P317, DOI 10.1002/cne.10764; MARTIN GR, 1994, J COMP PHYSIOL A, V174, P787; Martin GR, 2007, J ORNITHOL, V148, pS547, DOI 10.1007/s10336-007-0213-6; Martin GR, 2009, J VISION, V9, DOI 10.1167/9.11.14; McComb DM, 2009, J EXP BIOL, V212, P4010, DOI 10.1242/jeb.032615; McComb DM, 2008, J EXP BIOL, V211, P482, DOI 10.1242/jeb.014506; Merzin M, 2008, THESIS U TARTU ESTON; MESERVE PL, 1993, OECOLOGIA, V94, P153, DOI 10.1007/BF00341311; MUNOZ A, 1990, ACTA OECOL, V11, P251; OSWALDOCRUZ E, 1979, VISION RES, V19, P263, DOI 10.1016/0042-6989(79)90172-X; Pettigrew J.D., 1986, P208; Pettigrew JD, 2010, BRAIN BEHAV EVOLUT, V75, P251, DOI 10.1159/000314898; RAPAPORT DH, 1984, NEUROSCIENCE, V11, P289, DOI 10.1016/0306-4522(84)90024-1; REESE BE, 1988, BRAIN RES REV, V13, P119, DOI 10.1016/0165-0173(88)90017-3; REESE BE, 1987, NEUROSCIENCE, V20, P951, DOI 10.1016/0306-4522(87)90255-7; REESE BE, 1983, NEUROSCIENCE, V10, P1233, DOI 10.1016/0306-4522(83)90110-0; RETTIG G, 1986, CELL TISSUE RES, V243, P385; ROSA MGP, 1994, VISUAL NEUROSCI, V11, P1037, DOI 10.1017/S0952523800006878; Ross CF, 2007, J HUM EVOL, V52, P294, DOI 10.1016/j.jhevol.2006.09.006; Ross CF, 2000, ANNU REV ANTHROPOL, V29, P147, DOI 10.1146/annurev.anthro.29.1.147; ROYCE GJ, 1976, J COMP NEUROL, V170, P391, DOI 10.1002/cne.901700309; RUSAK B, 1979, PHYSIOL REV, V59, P449, DOI 10.1152/physrev.1979.59.3.449; SANDERSON KJ, 1969, VISION RES, V9, P1297, DOI 10.1016/0042-6989(69)90117-5; SILVEIRA LCL, 1989, VISUAL NEUROSCI, V2, P221, DOI 10.1017/S0952523800001140; SIMPSON JI, 1984, ANNU REV NEUROSCI, V7, P13, DOI 10.1146/annurev.ne.07.030184.000305; TIGGES J, 1970, BRAIN BEHAV EVOLUT, V3, P121, DOI 10.1159/000125466; Troscianko J, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2111; Upham NS, 2012, MOL PHYLOGENET EVOL, V63, P417, DOI 10.1016/j.ympev.2012.01.020; VAIDYA PRABHAKER GOPAL, 1965, Z ANAT ENTWICK LUNGSGESCH, V124, P505, DOI 10.1007/BF00520843; Warrant E, 2004, J COMP PHYSIOL A, V190, P765, DOI 10.1007/s00359-004-0546-z; Warrant EJ, 1999, VISION RES, V39, P1611, DOI 10.1016/S0042-6989(98)00262-4; Watson P., 2006, RAT BRAIN STEREOTAXI	62	19	19	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84199	10.1371/journal.pone.0084199	http://dx.doi.org/10.1371/journal.pone.0084199			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391911	Green Published, gold, Green Submitted			2022-12-25	WOS:000329323900054
J	Simoens, S				Simoens, Steven			Assessment of Methodological Quality of Economic Evaluations in Belgian Drug Reimbursement Applications	PLOS ONE			English	Article								Objectives: This paper aims to assess the methodological quality of economic evaluations included in Belgian reimbursement applications for Class 1 drugs. Materials and Methods: For 19 reimbursement applications submitted during 2011 and Spring 2012, a descriptive analysis assessed the methodological quality of the economic evaluation, evaluated the assessment of that economic evaluation by the Drug Reimbursement Committee and the response to that assessment by the company. Compliance with methodological guidelines issued by the Belgian Healthcare Knowledge Centre was assessed using a detailed checklist of 23 methodological items. The rate of compliance was calculated based on the number of economic evaluations for which the item was applicable. Results: Economic evaluations tended to comply with guidelines regarding perspective, target population, subgroup analyses, comparator, use of comparative clinical data and final outcome measures, calculation of costs, incremental analysis, discounting and time horizon. However, more attention needs to be paid to the description of limitations of indirect comparisons, the choice of an appropriate analytic technique, the expression of unit costs in values for the current year, the estimation and valuation of outcomes, the presentation of results of sensitivity analyses, and testing the face validity of model inputs and outputs. Also, a large variation was observed in the scope and depth of the quality assessment by the Drug Reimbursement Committee. Conclusions: Although general guidelines exist, pharmaceutical companies and the Drug Reimbursement Committee would benefit from the existence of a more detailed checklist of methodological items that need to be reported in an economic evaluation.	Katholieke Univ Leuven, Dept Pharmaceut & Pharmacol Sci, Louvain, Belgium	KU Leuven	Simoens, S (corresponding author), Katholieke Univ Leuven, Dept Pharmaceut & Pharmacol Sci, Louvain, Belgium.	steven.simoens@pharm.kuleuven.be		Simoens, Steven/0000-0002-9512-2005	Pharma.be, the Belgian association of the innovative pharmaceutical industry	Pharma.be, the Belgian association of the innovative pharmaceutical industry	Financial support for this research was received from Pharma.be, the Belgian association of the innovative pharmaceutical industry. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cleemput I, 2008, GUIDELINES PHARMACOE; De Rijdt T, 2010, PHARMACOECONOMICS EU, P60; Denis A, 2011, PHARMACOECONOMICS, V29, P883, DOI 10.2165/11585980-000000000-00000; Hoomans T, 2012, PHARMACOECONOMICS, V30, P219, DOI 10.2165/11539850-000000000-00000; Simoens S, 2012, J CLIN PHARM THER, V37, P182, DOI 10.1111/j.1365-2710.2011.01277.x; Simoens S, 2010, INT J ENV RES PUB HE, V7, P1835, DOI 10.3390/ijerph7041835; Yong JHE, 2013, PHARMACOECONOMICS, V31, P229, DOI 10.1007/s40273-012-0022-5	7	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e85411	10.1371/journal.pone.0085411	http://dx.doi.org/10.1371/journal.pone.0085411			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386474	gold, Green Published, Green Submitted			2022-12-25	WOS:000329194700136
J	Niu, JP; Liberda, EN; Qu, S; Guo, XB; Li, XM; Zhang, JJ; Meng, JL; Yan, B; Li, NR; Zhong, MH; Ito, K; Wildman, R; Liu, H; Chen, LC; Qu, QS				Niu, Jingping; Liberda, Eric N.; Qu, Song; Guo, Xinbiao; Li, Xiaomei; Zhang, Jingjing; Meng, Junliang; Yan, Bing; Li, Nairong; Zhong, Mianhua; Ito, Kazuhiko; Wildman, Rachel; Liu, Hong; Chen, Lung Chi; Qu, Qingshan			The Role of Metal Components in the Cardiovascular Effects of PM2.5	PLOS ONE			English	Article							ENDOTHELIAL PROGENITOR CELLS; PARTICULATE AIR-POLLUTION; INHALATION EXPOSURE; VASCULAR FUNCTION; OXIDATIVE STRESS; ARSENIC EXPOSURE; CARDIAC-FUNCTION; EXPERT PANEL; NICKEL; HEALTH	Exposure to ambient fine particulate matter (PM2.5) increases risks for cardiovascular disorders (CVD). However, the mechanisms and components responsible for the effects are poorly understood. Based on our previous murine exposure studies, a translational pilot study was conducted in female residents of Jinchang and Zhangye, China, to test the hypothesis that specific chemical component of PM2.5 is responsible for PM2.5 associated CVD. Daily ambient and personal exposures to PM2.5 and 35 elements were measured in the two cities. A total of 60 healthy nonsmoking adult women residents were recruited for measurements of inflammation biomarkers. In addition, circulating endothelial progenitor cells (CEPCs) were also measured in 20 subjects. The ambient levels of PM2.5 were comparable between Jinchang and Zhangye (47.4 and 54.5 mu g/m(3), respectively). However, the levels of nickel, copper, arsenic, and selenium in Jinchang were 82, 26, 12, and 6 fold higher than Zhangye, respectively. The levels of C-reactive protein (3.44 +/- 3.46 vs. 1.55 +/- 1.13), interleukin-6 (1.65 +/- 1.17 vs. 1.09 +/- 0.60), and vascular endothelial growth factor (117.6 +/- 217.0 vs. 22.7 +/- 21.3) were significantly higher in Jinchang. Furthermore, all phenotypes of CEPCs were significantly lower in subjects recruited from Jinchang than those from Zhangye. These results suggest that specific metals may be important components responsible for PM2.5-induced cardiovascular effects and that the reduced capacity of endothelial repair may play a critical role.	[Niu, Jingping; Zhang, Jingjing; Meng, Junliang; Yan, Bing; Li, Nairong] Lanzhou Univ, Sch Publ Hlth, Lanzhou 730000, Peoples R China; [Liberda, Eric N.; Li, Xiaomei; Zhong, Mianhua; Ito, Kazuhiko; Chen, Lung Chi; Qu, Qingshan] NYU, Sch Med, Nelson Inst Environm Med, Tuxedo Pk, NY USA; [Qu, Song] NYU, Coll Arts & Sci, New York, NY USA; [Guo, Xinbiao; Liu, Hong] Peking Univ, Sch Publ Hlth, Beijing 100871, Peoples R China; [Wildman, Rachel] Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY 10467 USA	Lanzhou University; New York University; New York University; Peking University; Yeshiva University; Albert Einstein College of Medicine	Chen, LC (corresponding author), NYU, Sch Med, Nelson Inst Environm Med, Tuxedo Pk, NY USA.	lung-chi.chen@nyumc.org; qingshan.qu@nyumc.org	Zhang, Jing/HII-4294-2022	Chen, Lung Chi/0000-0003-1154-2107	NIEHS [R21ES016570, R01ES015495, P30 ES00260]; NATIONAL CANCER INSTITUTE [P30CA016087] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES015495, P30ES000260, R21ES016570] Funding Source: NIH RePORTER	NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work supported by NIEHS R21ES016570, R01ES015495, and P30 ES00260. Personnel support by CIHR-DRA to E.N. Liberda. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. (Work supported by the National Institute of Environmental Health Sciences R21ES016570, 385 R01ES015495, and P30 ES00260. Personnel support by Canadian Institutes of Health Research 386 to E.N. Liberda.)	ARIEL SC, 2011, ENV HLTH PERSPECT, V119, P559, DOI DOI 10.1289/EHP.1002653.PUBMED:21216722; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; AXELSON O, 1978, BRIT J IND MED, V35, P8; Balakumar P, 2009, CARDIOVASC TOXICOL, V9, P169, DOI 10.1007/s12012-009-9050-6; Bell ML, 2009, AM J RESP CRIT CARE, V179, P1115, DOI 10.1164/rccm.200808-1240OC; Bonello L, 2006, ARCH MAL COEUR VAISS, V99, P607; Brauner EV, 2008, AM J RESP CRIT CARE, V177, P419, DOI 10.1164/rccm.200704-632OC; Brook RD, 2004, CIRCULATION, V109, P2655, DOI 10.1161/01.CIR.0000128587.30041.C8; CAHILL TA, 2010, AAAR, P201; Chakrabarti SK, 1999, BIOCHEM PHARMACOL, V58, P1501, DOI 10.1016/S0006-2952(99)00232-4; Chen CY, 2003, ARCH TOXICOL, V77, P123, DOI 10.1007/s00204-002-0427-6; CHEN L, 2005, INHAL TOXICOL, P4; CHEN LC, 2005, INHAL TOXICOL, V17, P4; Chen LC, 2010, INHAL TOXICOL, V22, P580, DOI 10.3109/08958371003596579; Cuevas AK, 2010, INHAL TOXICOL, V22, P100, DOI 10.3109/08958378.2010.521206; Das KK, 2008, INDIAN J MED RES, V128, P412; Dominici F, 2010, EPIDEMIOLOGY, V21, P187, DOI 10.1097/EDE.0b013e3181cc86e8; Feletou M, 2006, AM J PHYSIOL-HEART C, V291, pH985, DOI 10.1152/ajpheart.00292.2006; Florescu A, 2009, THER DRUG MONIT, V31, P14, DOI 10.1097/FTD.0b013e3181957a3b; Giannotti G, 2007, HERZ, V32, P568, DOI 10.1007/s00059-007-3073-1; Hill JM, 2003, NEW ENGL J MED, V348, P593, DOI 10.1056/NEJMoa022287; Hoenig MR, 2008, CURR DRUG TARGETS, V9, P422, DOI 10.2174/138945008784221215; Jevon M, 2008, CELL PROLIFERAT, V41, P146, DOI 10.1111/j.1365-2184.2008.00488.x; Joshi S, 2005, HUM EXP TOXICOL, V24, P13, DOI 10.1191/0960327105ht493oa; Kang GS, 2011, ENVIRON HEALTH PERSP, V119, P176, DOI 10.1289/ehp.1002508; Laclaustra M, 2010, ATHEROSCLEROSIS, V210, P643, DOI 10.1016/j.atherosclerosis.2010.01.005; Liberda EN, 2010, INHAL TOXICOL, V22, P95, DOI 10.3109/08958378.2010.515269; Lippmann M, 2005, ENVIRON HEALTH PERSP, V113, P1575, DOI 10.1289/ehp.8091; Lippmann M, 2006, ENVIRON HEALTH PERSP, V114, P1662, DOI 10.1289/ehp.9150; Meyers Melissa R, 2007, Curr Opin Endocrinol Diabetes Obes, V14, P365, DOI 10.1097/MED.0b013e3282be90a8; Michaud SE, 2006, ATHEROSCLEROSIS, V187, P423, DOI 10.1016/j.atherosclerosis.2005.10.009; Miller KA, 2007, NEW ENGL J MED, V356, P447, DOI 10.1056/NEJMoa054409; O'Toole TE, 2010, CIRC RES, V107, P200, DOI 10.1161/CIRCRESAHA.110.222679; Pearson TA, 2003, CIRCULATION, V107, P645, DOI 10.1161/01.CIR.0000054482.38437.13; Peltier RE, 2009, J EXPO SCI ENV EPID, V19, P603, DOI 10.1038/jes.2008.60; Pope CA, 2004, ENVIRON HEALTH PERSP, V112, P339, DOI 10.1289/ehp.6588; Povsic Thomas J, 2008, Ther Adv Cardiovasc Dis, V2, P199, DOI 10.1177/1753944708093412; Srivastava S, 2009, TOXICOL APPL PHARM, V241, P90, DOI 10.1016/j.taap.2009.08.004; Sun QH, 2005, JAMA-J AM MED ASSOC, V294, P3003, DOI 10.1001/jama.294.23.3003; Tepper OM, 2005, BLOOD, V105, P1068, DOI 10.1182/blood-2004-03-1051; *US EPA, 2008, INT SCI ASS PART MAT; Wang CH, 2007, TOXICOL APPL PHARM, V222, P315, DOI 10.1016/j.taap.2006.12.022; Wang CH, 2010, CARDIOVASC TOXICOL, V10, P17, DOI 10.1007/s12012-009-9059-x; Werner N, 2006, ARTERIOSCL THROM VAS, V26, P257, DOI 10.1161/01.ATV.0000198239.41189.5d; Werner N, 2005, NEW ENGL J MED, V353, P999, DOI 10.1056/NEJMoa043814; Werner N, 2007, ANN MED, V39, P82, DOI 10.1080/07853890601073429; Xun PC, 2010, ATHEROSCLEROSIS, V210, P662, DOI 10.1016/j.atherosclerosis.2010.01.021; Ying ZK, 2013, TOXICOL SCI, V135, P72, DOI 10.1093/toxsci/kft136	48	53	59	4	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e83782	10.1371/journal.pone.0083782	http://dx.doi.org/10.1371/journal.pone.0083782			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281RE	24386277	Green Published, Green Submitted, gold			2022-12-25	WOS:000329117900058
J	Shi, S; Gao, SN; Cao, TC; Liu, J; Gao, X; Hao, J; Lv, CY; Huang, HL; Xu, J; Yao, TM				Shi, Shuo; Gao, Shane; Cao, Tongcheng; Liu, Jie; Gao, Xing; Hao, Jian; Lv, Chunyan; Huang, Hailiang; Xu, Jun; Yao, Tianming			Targeting Human Telomeric G-Quadruplex DNA and Inhibition of Telomerase Activity With [(dmb)(2)Ru(obip)Ru(dmb)(2)](4+)	PLOS ONE			English	Article							MOLECULAR LIGHT SWITCH; RNA G-QUADRUPLEXES; 2 DIFFERENT FORMS; CIRCULAR-DICHROISM; METAL-COMPLEXES; RUTHENIUM COMPLEXES; CRYSTAL-STRUCTURE; BINDING; LIGAND; DESIGN	Inhibition of telomerase by inducing/stabilizing G-quadruplex formation is a promising strategy to design new anticancer drugs. We synthesized and characterized a new dinuclear complex [(dmb)(2)Ru(obip)Ru(dmb)(2)](4+) (dmb = 4,4'-dimethyl-2,2'-bipyridine, obip = (2-(2-pyridyl)imidazo[4,5-f][1,10] phenanthroline) with high affinity for both antiparallel and mixed parallel /antiparallel G-quadruplex DNA. This complex can promote the formation and stabilize G-quadruplex DNA. Dialysis and TRAP experiments indicated that [(dmb)(2)Ru(obip)Ru(dmb)(2)](4+) acted as an excellent telomerase inhibitor due to its obvious selectivity for G-quadruplex DNA rather than double stranded DNA. In vitro co-culture experiments implied that [(dmb)(2)Ru(obip)Ru(dmb)(2)](4+) inhibited telomerase activity and hindered cancer cell proliferation without side effects to normal fibroblast cells. TUNEL assay indicated that inhibition of telomerase activity induced DNA cleavage further apoptosis in cancer cells. Therefore, Ru-II complex represents an exciting opportunity for anticancer drug design by specifically targeting cancer cell G-quadruplexes DNA.	[Shi, Shuo; Cao, Tongcheng; Gao, Xing; Hao, Jian; Lv, Chunyan; Huang, Hailiang; Yao, Tianming] Tongji Univ, Dept Chem, Shanghai 200092, Peoples R China; [Gao, Shane; Xu, Jun] Tongji Univ, Sch Med, East Hosp, Shanghai 200092, Peoples R China; [Liu, Jie] Jinan Univ, Dept Chem, Guangzhou, Guangdong, Peoples R China	Tongji University; Tongji University; Jinan University	Shi, S (corresponding author), Tongji Univ, Dept Chem, Shanghai 200092, Peoples R China.	shishuo@tongji.edu.cn; xunymc2000@yahoo.com; tmyao@tongji.edu.cn	Shi, Shuo/S-8717-2019; Shi, Shuo/H-5025-2013	Shi, Shuo/0000-0003-4387-3445; Gao, Shane/0000-0002-7871-1537	National Programme on Key Basic Research Project (973 Program) [2010CB945200, 2011CB966200]; National Natural Science Foundation of China [20901060, 31170776, 20871094, 81171646, 20707015, 81070910]; New Century Excellent Talents in University [NCET-10-0606]; Shanghai Rising-Star program [11QA1407100]; Projects of International Cooperation and Exchanges NSFC [81261130318]; Fundamental Research Funds for the Central Universities	National Programme on Key Basic Research Project (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Shanghai Rising-Star program; Projects of International Cooperation and Exchanges NSFC; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by National Programme on Key Basic Research Project (973 Program) (2010CB945200, 2011CB966200); the National Natural Science Foundation of China (20901060, 31170776, 20871094, 81171646, 20707015, 81070910); New Century Excellent Talents in University (NCET-10-0606); Shanghai Rising-Star program (11QA1407100); Projects of International Cooperation and Exchanges NSFC (81261130318) and the Fundamental Research Funds for the Central Universities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti P, 2003, MINI-REV MED CHEM, V3, P23, DOI 10.2174/1389557033405485; Ambrus A, 2006, NUCLEIC ACIDS RES, V34, P2723, DOI 10.1093/nar/gkl348; Bailey SM, 2004, DNA REPAIR, V3, P349, DOI 10.1016/j.dnarep.2003.11.007; Baker ES, 2006, J AM CHEM SOC, V128, P2641, DOI 10.1021/ja0564968; Balasubramanian S, 2011, NAT REV DRUG DISCOV, V10, P261, DOI 10.1038/nrd3428; Bertrand H, 2007, ORG BIOMOL CHEM, V5, P2555, DOI 10.1039/b708635k; Bertrand H, 2007, J BIOL INORG CHEM, V12, P1003, DOI 10.1007/s00775-007-0273-3; Biffi G, 2013, NAT CHEM, V5, P182, DOI [10.1038/NCHEM.1548, 10.1038/nchem.1548]; BLACKBURN EH, 1994, CELL, V77, P621, DOI 10.1016/0092-8674(94)90046-9; Blackburn EH, 1995, TELOMERES; Bugaut A, 2012, NUCLEIC ACIDS RES, V40, P4727, DOI 10.1093/nar/gks068; Campbell NH, 2012, J MED CHEM, V55, P209, DOI 10.1021/jm201140v; Chen WZ, 2011, CHEM-EUR J, V17, P5595, DOI 10.1002/chem.201002168; Collie GW, 2011, CHEM SOC REV, V40, P5867, DOI 10.1039/c1cs15067g; Cuesta J, 2003, MINI-REV MED CHEM, V3, P11, DOI 10.2174/1389557033405502; Georgiades SN, 2010, ANGEW CHEM INT EDIT, V49, P4020, DOI 10.1002/anie.200906363; Giri P, 2008, MOL BIOSYST, V4, P341, DOI 10.1039/b716356h; Giri P, 2008, J PHOTOCH PHOTOBIO A, V194, P111, DOI 10.1016/j.jphotochem.2007.07.022; Granotier C, 2005, NUCLEIC ACIDS RES, V33, P4182, DOI 10.1093/nar/gki722; Huppert JL, 2007, PHILOS T R SOC A, V365, P2969, DOI 10.1098/rsta.2007.0011; Incles CM, 2004, MOL CANCER THER, V3, P1201; Jiang YL, 2010, MINI-REV MED CHEM, V10, P726, DOI 10.2174/138955710791572433; Karlseder J, 1999, SCIENCE, V283, P1321, DOI 10.1126/science.283.5406.1321; Karsisiotis AI, 2011, ANGEW CHEM INT EDIT, V50, P10645, DOI 10.1002/anie.201105193; Kieltyka R, 2008, J AM CHEM SOC, V130, P10040, DOI 10.1021/ja8014023; KUMAR CV, 1985, J AM CHEM SOC, V107, P5518, DOI 10.1021/ja00305a032; Kumari S, 2007, NAT CHEM BIOL, V3, P218, DOI 10.1038/nchembio864; Leonetti C, 2004, MOL PHARMACOL, V66, P1138, DOI 10.1124/mol.104.001537; Lipps HJ, 2009, TRENDS CELL BIOL, V19, P414, DOI 10.1016/j.tcb.2009.05.002; Ma DL, 2009, J AM CHEM SOC, V131, P1835, DOI 10.1021/ja806045x; MABROUK PA, 1986, INORG CHEM, V25, P526, DOI 10.1021/ic00224a027; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Makarov VL, 1997, CELL, V88, P657, DOI 10.1016/S0092-8674(00)81908-X; Masiero S, 2010, ORG BIOMOL CHEM, V8, P2683, DOI 10.1039/c003428b; Neidle S, 2009, CURR OPIN STRUC BIOL, V19, P239, DOI 10.1016/j.sbi.2009.04.001; Paramasivan S, 2007, METHODS, V43, P324, DOI 10.1016/j.ymeth.2007.02.009; Parkinson GN, 2002, NATURE, V417, P876, DOI 10.1038/nature755; Qi HY, 2006, CANCER RES, V66, P11808, DOI 10.1158/0008-5472.CAN-06-1225; Ragazzon P, 2007, METHODS, V43, P313, DOI 10.1016/j.ymeth.2007.08.003; Read M, 2001, P NATL ACAD SCI USA, V98, P4844, DOI 10.1073/pnas.081560598; Reed J, 2008, ANAL BIOCHEM, V380, P99, DOI 10.1016/j.ab.2008.05.013; Reed JE, 2006, J AM CHEM SOC, V128, P5992, DOI 10.1021/ja058509n; Ren JS, 1999, BIOCHEMISTRY-US, V38, P16067, DOI 10.1021/bi992070s; Rezler EM, 2005, J AM CHEM SOC, V127, P9439, DOI 10.1021/ja0505088; Roos WP, 2013, CANCER LETT, V332, P237, DOI 10.1016/j.canlet.2012.01.007; Sahoo D, 2010, J PHYS CHEM B, V114, P2044, DOI 10.1021/jp910766q; Schaffitzel C, 2001, P NATL ACAD SCI USA, V98, P8572, DOI 10.1073/pnas.141229498; Shi S, 2008, INORG CHEM, V47, P2910, DOI 10.1021/ic7021209; Shi S, 2013, J INORG BIOCHEM, V121, P19, DOI 10.1016/j.jinorgbio.2012.12.011; Shi S, 2012, INORG CHEM COMMUN, V24, P212, DOI 10.1016/j.inoche.2012.07.015; Shi S, 2012, DALTON T, V41, P5789, DOI 10.1039/c2dt30076a; Shi S, 2010, BIOCHIMIE, V92, P370, DOI 10.1016/j.biochi.2010.01.003; Shi S, 2010, DALTON T, V39, P2490, DOI 10.1039/b916094a; Sparapani S, 2010, J AM CHEM SOC, V132, P12263, DOI 10.1021/ja1003944; Suntharalingam K, 2010, INORG CHEM, V49, P8371, DOI 10.1021/ic100884p; Teulade-Fichou MP, 2003, J AM CHEM SOC, V125, P4732, DOI 10.1021/ja021299j; Vorlickova M, 2012, CHIRALITY, V24, P691, DOI 10.1002/chir.22064; WANG Y, 1993, STRUCTURE, V1, P263, DOI 10.1016/0969-2126(93)90015-9; Xu Y, 2010, J AM CHEM SOC, V130, P11579; Xu Y, 2006, BIOORGAN MED CHEM, V14, P5584, DOI 10.1016/j.bmc.2006.04.033; Yao JL, 2013, DALTON T, V42, P5661, DOI 10.1039/c3dt32640c; Yao JL, 2012, INORG CHEM, V51, P12591, DOI 10.1021/ic301305q; ZAKIAN VA, 1995, SCIENCE, V270, P1601, DOI 10.1126/science.270.5242.1601; Zou XH, 2001, INORG CHEM, V40, P7091, DOI 10.1021/ic001429u	65	14	14	1	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e84419	10.1371/journal.pone.0084419	http://dx.doi.org/10.1371/journal.pone.0084419			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281RE	24386376	Green Submitted, Green Published, gold			2022-12-25	WOS:000329117900092
J	Liu, GL; Zhang, FF; Wang, RX; London, L; London, SD				Liu, Guangliang; Zhang, Fangfang; Wang, Ruixue; London, Lucille; London, Steven D.			Protective MCMV immunity by vaccination of the salivary gland via Wharton's duct: replication-deficient recombinant adenovirus expressing individual MCMV genes elicits protection similar to that of MCMV	FASEB JOURNAL			English	Article						vaccine development; mucosal immunity; inflammation	TRANSGENE EXPRESSION; AQUAPORIN-1 CDNA; PAROTID-GLANDS; MUCOSAL; VECTOR; IMMUNIZATION; INDUCTION; INFECTION; PROTEIN; MODEL	Salivary glands, a major component of the mucosal immune system, confer antigen-specific immunity to mucosally acquired pathogens. We investigated whether a physiological route of inoculation and a subunit vaccine approach elicited MCMV-specific and protective immunity. Mice were inoculated by retrograde perfusion of the submandibular salivary glands via Wharton's duct with tcMCMV or MCMV proteins focused to the salivary gland via replication-deficient adenovirus expressing individual MCMV genes (gB, gH, IE1; controls: saline and replication deficient adenovirus without MCMV inserts). Mice were evaluated for MCMV-specific antibodies, T-cell responses, germinal center formation, and protection against a lethal MCMV challenge. Retrograde perfusion with tcMCMV or adenovirus expressed MCMV proteins induced a 2- to 6-fold increase in systemic and mucosal MCMV-specific antibodies, a 3- to 6-fold increase in GC marker expression, and protection against a lethal systemic challenge, as evidenced by up to 80% increased survival, decreased splenic pathology, and decreased viral titers from 10(6) pfu to undetectable levels. Thus, a focused salivary gland immunization via a physiological route with a protein antigen induced systemic and mucosal protective immune responses. Therefore, salivary gland immunization can serve as an alternative mucosal route for administering vaccines, which is directly applicable for use in humans.-Liu, G., Zhang, F., Wang, R., London, L., London, S. D. Protective MCMV immunity by vaccination of the salivary gland via Wharton's duct: replication-deficient recombinant adenovirus expressing individual MCMV genes elicits protection similar to that of MCMV.	[Liu, Guangliang; Zhang, Fangfang; Wang, Ruixue; London, Lucille; London, Steven D.] SUNY Stony Brook, Sch Dent Med, Dept Oral Biol & Pathol, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	London, SD (corresponding author), SUNY Stony Brook, Sch Dent Med, Dept Oral Biol & Pathol, Stony Brook, NY 11794 USA.	steven.london@stonybrook.edu	Zhang, Fang/HHN-2153-2022		U.S. National Institutes of Health/National Institute of Dental and Craniofacial Research [1R01 DE016652]; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE016652] Funding Source: NIH RePORTER	U.S. National Institutes of Health/National Institute of Dental and Craniofacial Research; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	The authors thank Dr. Changyu Zheng (National Institute of Dental and Craniofacial Research, U.S. National Institutes of Health, Bethesda, MD, USA) for providing training in the salivary gland cannulation technique. The authors also thank Drs. John D. Shanley and Carol A. Wu (University of Connecticut, Storrs, CT, USA) for providing recombinant adenovirus vectors and cell lines. This project was supported by U.S. National Institutes of Health/National Institute of Dental and Craniofacial Research grant 1R01 DE016652 (S.D.L.). The work described in this manuscript has not been previously published and is not being considered concurrently by another publication. All authors concur with this submission. The authors declare no conflicts of interest.	Acosta A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026137; Adriaansen J, 2011, HUM GENE THER, V22, P84, DOI 10.1089/hum.2010.097; Amerongen AVN, 2002, ORAL DIS, V8, P12, DOI 10.1034/j.1601-0825.2002.1o816.x; Baum B J, 2000, Adv Dent Res, V14, P84; Baum BJ, 2004, TRENDS MOL MED, V10, P585, DOI 10.1016/j.molmed.2004.10.003; Baum BJ, 2012, P NATL ACAD SCI USA, V109, P19403, DOI 10.1073/pnas.1210662109; Benihoud K, 1999, CURR OPIN BIOTECH, V10, P440, DOI 10.1016/S0958-1669(99)00007-5; Bohm V, 2008, MED MICROBIOL IMMUN, V197, P135, DOI 10.1007/s00430-008-0092-3; Brandtzaeg P, 1999, IMMUNOL TODAY, V20, P141, DOI 10.1016/S0167-5699(98)01413-3; Brandtzaeg P, 2007, VACCINE, V25, P5467, DOI 10.1016/j.vaccine.2006.12.001; Brune W, 2001, Curr Protoc Immunol, VChapter 19, DOI 10.1002/0471142735.im1907s43; Gao R, 2011, GENE THER, V18, P38, DOI 10.1038/gt.2010.128; Grewal JS, 2011, FASEB J, V25, P1680, DOI 10.1096/fj.10-174656; Honjo T, 2002, ANNU REV IMMUNOL, V20, P165, DOI 10.1146/annurev.immunol.20.090501.112049; Kasman LM, 2009, ORAL DIS, V15, P587, DOI 10.1111/j.1601-0825.2009.01600.x; Klein U, 2008, NAT REV IMMUNOL, V8, P22, DOI 10.1038/nri2217; Kuriki Y., 2011, JOVE-J VIS EXP, V14, P3074; Liu GL, 2009, J VIROL, V83, P6963, DOI 10.1128/JVI.00284-09; Macpherson AJ, 2008, MUCOSAL IMMUNOL, V1, P11, DOI 10.1038/mi.2007.6; Massie B, 1998, J VIROL, V72, P2289, DOI 10.1128/JVI.72.3.2289-2296.1998; Neutra MR, 2006, NAT REV IMMUNOL, V6, P148, DOI 10.1038/nri1777; Ogorelkova M., 2003, METHOD MOL BIOL, V246, P15; Omnell K A, 1983, Dentomaxillofac Radiol, V12, P13; Perez P, 2011, ORAL DIS, V17, P476, DOI 10.1111/j.1601-0825.2010.01775.x; Pilgrim MJ, 2007, EXP MOL PATHOL, V82, P269, DOI 10.1016/j.yexmp.2006.12.010; Russell WC, 2000, J GEN VIROL, V81, P2573, DOI 10.1099/0022-1317-81-11-2573; Samuni Y, 2011, BBA-MOL BASIS DIS, V1812, P1515, DOI 10.1016/j.bbadis.2011.06.014; SCHMIDT NJ, 1976, J CLIN MICROBIOL, V4, P61; Shanley JD, 2005, VACCINE, V23, P996, DOI 10.1016/j.vaccine.2004.07.041; Shanley JD, 2003, VACCINE, V21, P2632, DOI 10.1016/S0264-410X(03)00037-9; Takahashi I, 2009, CURR OPIN IMMUNOL, V21, P352, DOI 10.1016/j.coi.2009.04.002; Tarlinton D, 2008, CURR OPIN IMMUNOL, V20, P162, DOI 10.1016/j.coi.2008.03.016; Tucker SN, 2004, VACCINE, V22, P2500, DOI 10.1016/j.vaccine.2003.12.034; Voutetakis A, 2004, J CELL PHYSIOL, V199, P1, DOI 10.1002/jcp.10429; Voutetakis A, 2010, GENE THER, V17, P50, DOI 10.1038/gt.2009.123; Voutetakis A, 2008, HUM GENE THER, V19, P1401, DOI [10.1089/hum.2008.034, 10.1089/hgt.2008.034]; Woodrow KA, 2012, ANNU REV BIOMED ENG, V14, P17, DOI 10.1146/annurev-bioeng-071811-150054; Zheng C, 2012, ORAL DIS, V18, P477, DOI 10.1111/j.1601-0825.2011.01895.x; Zheng C, 2011, ORAL DIS, V17, P77, DOI 10.1111/j.1601-0825.2010.01707.x; Zheng CY, 2012, HUM GENE THER METHOD, V23, P169, DOI 10.1089/hgtb.2011.175; Zheng CY, 2011, CLIN CANCER RES, V17, P2842, DOI 10.1158/1078-0432.CCR-10-2982; Zheng CY, 2010, J GENE MED, V12, P3, DOI 10.1002/jgm.1416; Zufferey R, 2004, GENE THER, V11, P1425, DOI 10.1038/sj.gt.3302321	43	6	6	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2014	28	4					1698	1710		10.1096/fj.13-244178	http://dx.doi.org/10.1096/fj.13-244178			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AG3UC	24391133	Green Published			2022-12-25	WOS:000335344300017
J	Boutin, RD; Buonocore, MH; Immerman, I; Ashwell, Z; Sonico, GJ; Szabo, RM; Chaudhari, AJ				Boutin, Robert D.; Buonocore, Michael H.; Immerman, Igor; Ashwell, Zachary; Sonico, Gerald J.; Szabo, Robert M.; Chaudhari, Abhijit J.			Real-Time Magnetic Resonance Imaging (MRI) during Active Wrist Motion-Initial Observations	PLOS ONE			English	Article							DISTAL RADIOULNAR JOINT; CARPAL INSTABILITY; LIGAMENT INJURIES; STRESS VIEWS; STEADY-STATE; ARTHROGRAPHY; KINEMATICS; TRUEFISP; CT; MOVEMENT	Background: Non-invasive imaging techniques such as magnetic resonance imaging (MRI) provide the ability to evaluate the complex anatomy of bone and soft tissues of the wrist without the use of ionizing radiation. Dynamic instability of wrist - occurring during joint motion - is a complex condition that has assumed increased importance in musculoskeletal medicine. The objective of this study was to develop an MRI protocol for evaluating the wrist during continuous active motion, to show that dynamic imaging of the wrist is realizable, and to demonstrate that the resulting anatomical images enable the measurement of metrics commonly evaluated for dynamic wrist instability. Methods: A 3-Tesla "active-MRI" protocol was developed using a bSSFP sequence with 475 ms temporal resolution for continuous imaging of the moving wrist. Fifteen wrists of 10 asymptomatic volunteers were scanned during active supination/pronation, radial/ulnar deviation, "clenched-fist", and volarflexion/dorsiflexion maneuvers. Two physicians evaluated distal radioulnar joint (DRUJ) congruity, extensor carpi ulnaris (ECU) tendon translation, the scapholunate (SL) interval, and the SL, radiolunate (RL) and capitolunate (CL) angles from the resulting images. Results: The mean DRUJ subluxation ratio was 0.04 in supination, 0.10 in neutral, and 0.14 in pronation. The ECU tendon was subluxated or translated out of its groove in 3 wrists in pronation, 9 wrists in neutral, and 11 wrists in supination. The mean SL interval was 1.43 mm for neutral, ulnar deviation, radial deviation positions, and increased to 1.64 mm during the clenched-fist maneuver. Measurement of SL, RL and CL angles in neutral and dorsiflexion was also accomplished. Conclusion: This study demonstrates the initial performance of active-MRI, which may be useful in the investigation of dynamic wrist instability in vivo.	[Boutin, Robert D.; Buonocore, Michael H.; Ashwell, Zachary; Chaudhari, Abhijit J.] Univ Calif Davis, Sch Med, Dept Radiol, Sacramento, CA 95817 USA; [Buonocore, Michael H.] Univ Calif Davis, Imaging Res Ctr, Sacramento, CA 95817 USA; [Immerman, Igor; Sonico, Gerald J.; Szabo, Robert M.] Univ Calif Davis, Sch Med, Dept Orthoped Surg, Sacramento, CA 95817 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Chaudhari, AJ (corresponding author), Univ Calif Davis, Sch Med, Dept Radiol, Sacramento, CA 95817 USA.	ajchaudhari@ucdavis.edu	Chaudhari, Abhijit/P-4982-2019	Chaudhari, Abhijit/0000-0002-4211-1900	Building Interdisciplinary Research Careers in Women's Health award [K12 HD051958]; National Institute of Child Health and Human Development of the National Institutes of Health (NIH); Office of Research on Women's Health of the National Institutes of Health (NIH); Office of Dietary Supplements of the National Institutes of Health (NIH); National Institute of Aging of the National Institutes of Health (NIH); NIH-NIBIB [R03EB015099]; UC Davis Imaging Research Center; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD051958] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P50AR060752] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R03EB015099] Funding Source: NIH RePORTER	Building Interdisciplinary Research Careers in Women's Health award; National Institute of Child Health and Human Development of the National Institutes of Health (NIH); Office of Research on Women's Health of the National Institutes of Health (NIH); Office of Dietary Supplements of the National Institutes of Health (NIH); National Institute of Aging of the National Institutes of Health (NIH); NIH-NIBIB(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); UC Davis Imaging Research Center; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by the Building Interdisciplinary Research Careers in Women's Health award (K12 HD051958) funded by the National Institute of Child Health and Human Development, Office of Research on Women's Health, Office of Dietary Supplements, and the National Institute of Aging of the National Institutes of Health (NIH) to AJC, the NIH-NIBIB R03EB015099 grant to AJC and the UC Davis Imaging Research Center. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burgess RA, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-273; Cerezal L, 2005, RADIOL CLIN N AM, V43, P709, DOI 10.1016/j.rcl.2005.02.004; Cerezal L, 2012, SEMIN MUSCULOSKEL R, V16, P27, DOI 10.1055/s-0032-1304299; Choi YS, 2013, YONSEI MED J, V54, P1026, DOI 10.3349/ymj.2013.54.4.1026; Crisco JJ, 2005, J BONE JOINT SURG AM, V87A, P2729, DOI 10.2106/JBJS.D.03058; d'Entremont AG, 2013, MAGN RESON MED, V69, P1634, DOI 10.1002/mrm.24425; Foumani M, 2009, J BIOMECH, V42, P2664, DOI 10.1016/j.jbiomech.2009.08.016; Garcia-Elias M, 1999, J HAND SURG-AM, V24A, P866; GarciaElias M, 1997, J BONE JOINT SURG BR, V79B, P684, DOI 10.1302/0301-620X.79B4.14192; Gheno R, 2010, SKELETAL RADIOL, V39, P799, DOI 10.1007/s00256-009-0796-5; Haims AH, 2003, RADIOLOGY, V227, P701, DOI 10.1148/radiol.2273020398; Huang JI, 2012, HAND CLIN, V28, P157, DOI 10.1016/j.hcl.2012.03.002; Huang TY, 2002, MAGNET RESON MED, V48, P684, DOI 10.1002/mrm.10260; Kalia V, 2009, AM J ROENTGENOL, V192, pW295, DOI 10.2214/AJR.08.1793; Kwon BC, 2008, CLIN ORTHOP RELAT R, V466, P969, DOI 10.1007/s11999-008-0126-6; LARSEN CF, 1991, J HAND SURG-AM, V16A, P888; Lee KS, 2009, AM J ROENTGENOL, V193, P651, DOI 10.2214/AJR.08.1725; Lee SK, 2011, J HAND SURG-AM, V36A, P1149, DOI 10.1016/j.jhsa.2011.05.009; Leng SA, 2011, MED PHYS, V38, pS50, DOI 10.1118/1.3577759; Maizlin ZV, 2012, J DIGIT IMAGING, P1; Matsuki KO, 2010, CLIN BIOMECH, V25, P979, DOI 10.1016/j.clinbiomech.2010.07.006; MIKIC ZD, 1984, J BONE JOINT SURG AM, V66A, P371, DOI 10.2106/00004623-198466030-00009; Moser T, 2007, AM J ROENTGENOL, V188, P1278, DOI 10.2214/AJR.06.0288; Park MJ, 2008, J BONE JOINT SURG AM, V90A, P145, DOI 10.2106/JBJS.F.01603; Quick HH, 2002, J MAGN RESON IMAGING, V15, P710, DOI 10.1002/jmri.10120; Sanderson PL, 1997, J HAND SURG-BRIT EUR, V22B, P21, DOI 10.1016/S0266-7681(97)80007-1; Scheffler K, 2001, MAGNET RESON MED, V45, P1075, DOI 10.1002/mrm.1142; SCHERNBERG F, 1990, J HAND SURG-BRIT EUR, V15B, P220, DOI 10.1016/0266-7681(90)90127-P; Shapiro LM, 2012, OSTEOARTHR CARTILAGE, V20, P69, DOI 10.1016/j.joca.2011.11.003; Shores JT, 2013, EPLASTY, V13; TALEISNIK J, 1988, J BONE JOINT SURG AM, V70A, P1262, DOI 10.2106/00004623-198870080-00025; Theumann NH, 2006, RADIOLOGY, V238, P950, DOI 10.1148/radiol.2383050013; TON ERTA, 1995, RADIOLOGY, V196, P863, DOI 10.1148/radiology.196.3.7644657; WATSON HK, 1986, J BONE JOINT SURG AM, V68A, P345, DOI 10.2106/00004623-198668030-00005; Wolfe SW, 2000, J HAND SURG-AM, V25A, P860, DOI 10.1053/jhsu.2000.9423; Yen P, 2013, AM J NEURORADIOL, V34, pE24, DOI 10.3174/ajnr.A2734; Zanetti M, 1997, JMRI-J MAGN RESON IM, V7, P590, DOI 10.1002/jmri.1880070322	37	32	32	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84004	10.1371/journal.pone.0084004	http://dx.doi.org/10.1371/journal.pone.0084004			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391865	Green Published, gold, Green Submitted			2022-12-25	WOS:000329323900008
J	Brimblecombe, J; Ferguson, M; Liberato, SC; O'Dea, K; Riley, M				Brimblecombe, Julie; Ferguson, Megan; Liberato, Selma C.; O'Dea, Kerin; Riley, Malcolm			Optimisation Modelling to Assess Cost of Dietary Improvement in Remote Aboriginal Australia	PLOS ONE			English	Article							SOCIOECONOMIC DIFFERENCES; NUTRIENT DENSITY; HEALTHY DIET; PATTERNS; ADULTS; CONSUMPTION; VEGETABLES; CONSTRAINT; QUALITY; WOMEN	Background: The cost and dietary choices required to fulfil nutrient recommendations defined nationally, need investigation, particularly for disadvantaged populations. Objective: We used optimisation modelling to examine the dietary change required to achieve nutrient requirements at minimum cost for an Aboriginal population in remote Australia, using where possible minimally-processed whole foods. Design: A twelve month cross-section of population-level purchased food, food price and nutrient content data was used as the baseline. Relative amounts from 34 food group categories were varied to achieve specific energy and nutrient density goals at minimum cost while meeting model constraints intended to minimise deviation from the purchased diet. Results: Simultaneous achievement of all nutrient goals was not feasible. The two most successful models (A & B) met all nutrient targets except sodium (146.2% and 148.9% of the respective target) and saturated fat (12.0% and 11.7% of energy). Model A was achieved with 3.2% lower cost than the baseline diet (which cost approximately AUD$13.01/person/day) and Model B at 7.8% lower cost but with a reduction in energy of 4.4%. Both models required very large reductions in sugar sweetened beverages (-90%) and refined cereals (-90%) and an approximate four-fold increase in vegetables, fruit, dairy foods, eggs, fish and seafood, and wholegrain cereals. Conclusion: This modelling approach suggested population level dietary recommendations at minimal cost based on the baseline purchased diet. Large shifts in diet in remote Aboriginal Australian populations are needed to achieve national nutrient targets. The modeling approach used was not able to meet all nutrient targets at less than current food expenditure.	[Brimblecombe, Julie; Ferguson, Megan; Liberato, Selma C.; O'Dea, Kerin] Menzies Sch Hlth Res, Darwin, NT, Australia; [O'Dea, Kerin] Univ S Australia, Sch Populat Hlth, Div Hlth Sci, Adelaide, SA 5001, Australia; [Riley, Malcolm] Commonwealth Sci Ind Res Org Anim Food & Hlth Sci, Parkville, Vic, Australia	Charles Darwin University; Menzies School of Health Research; University of South Australia; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Brimblecombe, J (corresponding author), Menzies Sch Hlth Res, Darwin, NT, Australia.	julie.brimblecombe@menzies.edu.au	Ferguson, Megan/Y-3511-2018; Riley, Malcolm/B-5296-2011	Ferguson, Megan/0000-0002-4435-0948; Riley, Malcolm/0000-0003-3040-8616; Brimblecombe, Julie/0000-0002-1977-276X	National Aboriginal and Torres Strait Islander Health Equity Council; National Health and Medical Research Council [NHMRC] [ID545253, 1039074]	National Aboriginal and Torres Strait Islander Health Equity Council; National Health and Medical Research Council [NHMRC](National Health and Medical Research Council (NHMRC) of Australia)	The study was funded through the National Aboriginal and Torres Strait Islander Health Equity Council. The National Health and Medical Research Council provided people support for JB Salary support for JB [NHMRC: Public Health Training Fellowship ID545253] and MF [NHMRC PhD scholarship ID 1039074] to conduct this work. The views expressed in this publication are those of the authors and do not reflect the views of NHMRC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An RP, 2013, PUBLIC HEALTH NUTR, V16, P1215, DOI 10.1017/S1368980012004715; [Anonymous], 2006, NUTR REF VAL AUSTR N; Australian Bureau of Statistics, 2011, 12160 AUSTR BUR STAT; Australian Bureau of Statistics, 2013, 13700 AUSTR BUR STA; Australian Bureau of Statistics, 2007, BIRTHS AUSTR 2006; Australian Bureau of Statistics, 2007, 2006 CENS POP HOUS; Australian Government Department of Health and Ageing National Health and Medical Research Council, 2011, MOD SYSTEM INFORM RE; Australian Government National Health and Medical Council Ministry of Health: Manatu Hauora, 2011, NUTR REF VAL AUSTR N; Ball K, 2004, PUBLIC HEALTH NUTR, V7, P443, DOI 10.1079/PHN2003538; Briend A, 2003, J PEDIATR GASTR NUTR, V36, P12, DOI 10.1097/00005176-200301000-00006; Briend A, 2000, PEDIATRICS, V106, P1288; Brimblecombe J, 2008, KEEPING TRACK HLTH; Brimblecombe J., 2012, PUBLIC HEALTH NUTR, P1; Brimblecombe JK, 2013, MED J AUSTRALIA, V198, P380, DOI 10.5694/mja12.11407; Burns C M, 2004, Rural Remote Health, V4, P311; Cade J, 1999, PUBLIC HEALTH NUTR, V2, P505, DOI 10.1017/S1368980099000683; Conforti P, 2000, PUBLIC HEALTH NUTR, V3, P367, DOI 10.1017/S1368980000000410; Darmon N, 2006, J NUTR EDUC BEHAV, V38, P82, DOI 10.1016/j.jneb.2005.11.028; Darmon N, 2002, J NUTR, V132, P3764, DOI 10.1093/jn/132.12.3764; Darmon N, 2002, AM J CLIN NUTR, V75, P245, DOI 10.1093/ajcn/75.2.245; De Irala-Estevez J, 2000, EUR J CLIN NUTR, V54, P706, DOI 10.1038/sj.ejcn.1601080; Drewnowski A, 2004, AM J PUBLIC HEALTH, V94, P1555, DOI 10.2105/AJPH.94.9.1555; Food Standards Australia New Zealand (FSANZ), 1999, AUSNUT; Food Standards Australia New Zealand (FSANZ), NUTT; Food Standards Australia New Zealand (FSANZ), AUSNUT 2007 DAT FIL; Giskes K, 2002, J HUM NUTR DIET, V15, P375, DOI 10.1046/j.1365-277X.2002.00387.x; Guenther PM, 2013, AM J CLIN NUTR, V97, P842, DOI 10.3945/ajcn.112.047779; Harrison MS, 2007, MED J AUSTRALIA, V186, P9, DOI 10.5694/j.1326-5377.2007.tb00778.x; He FJ, 2009, J HUM HYPERTENS, V23, P363, DOI 10.1038/jhh.2008.144; He FJ, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004937.pub2; Jetter KM, 2006, AM J PREV MED, V30, P38, DOI 10.1016/j.amepre.2005.08.039; Lasdon LS, 1982, GRG2 USERS GUIDE; LEE AJ, 1995, ECOL FOOD NUTR, V34, P19, DOI 10.1080/03670244.1995.9991444; Lino M, 2001, FAM EC NUTR REV, V13, P50; Mackerras D, 1997, AUST NZ J PUBL HEAL, V21, P218, DOI 10.1111/j.1467-842X.1997.tb01689.x; Martikainen P, 2003, SOC SCI MED, V56, P1397, DOI 10.1016/S0277-9536(02)00137-5; Masset G, 2009, J NUTR, V139, P1541, DOI 10.3945/jn.109.104398; MATTES RD, 1991, J AM COLL NUTR, V10, P383; MCALLISTER M, 1994, J NUTR EDUC, V26, P131; Mhurchu CN, 2012, HEALTH PROMOT INT, V27, P331, DOI 10.1093/heapro/dar042; Mishra G, 2002, EUR J CLIN NUTR, V56, P687, DOI 10.1038/sj.ejcn.1601391; National Health and Medical Research Council, 2000, NUTR AB TORR STRAIT; Ni Mhurchu Cliona, 2007, N Z Med J, V120, pU2388; Nnoaham KE, 2009, INT J EPIDEMIOL, V38, P1324, DOI 10.1093/ije/dyp214; Northern Territory Government, 2012, NO TERR MARK BASK SU; Rambeloson ZJ, 2008, PUBLIC HEALTH NUTR, V11, P395, DOI 10.1017/S1368980007000511; Rehm CD, 2011, AM J CLIN NUTR, V94, P1333, DOI 10.3945/ajcn.111.015560; ROSS R, 1992, AUST J SOC ISSUES, V27, P92, DOI 10.1002/j.1839-4655.1992.tb01280.x; Strategic Inter-Governmental Nutrition Alliance of the National Public Health Partnership, 2001, EAT WELL AUSTR AG AC; Thow AM, 2010, B WORLD HEALTH ORGAN, V88, P609, DOI 10.2471/BLT.09.070987; US Department of Agriculture Food and Nutrition Service, SUPPL NUTR ASS PROGR; WHO, 2003, DIET NUTR PREVENTION, V916; Wilson N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059648	53	13	13	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83587	10.1371/journal.pone.0083587	http://dx.doi.org/10.1371/journal.pone.0083587			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	284NF	24391790	gold, Green Published, Green Accepted, Green Submitted			2022-12-25	WOS:000329325200087
J	Chen, Y; Xu, JJ; Liu, S; Hou, XH				Chen, Yan; Xu, Juan Juan; Liu, Shi; Hou, Xiao Hua			Electroacupuncture at ST36 Ameliorates Gastric Emptying and Rescues Networks of Interstitial Cells of Cajal in the Stomach of Diabetic Rats	PLOS ONE			English	Article							ADULT GUINEA-PIGS; DYSPEPTIC SYMPTOMS; REPERFUSION INJURY; SMALL-INTESTINE; CONSCIOUS RATS; IN-VIVO; GASTROPARESIS; MECHANISMS; MOTILITY; PROLIFERATION	Depletion of interstitial cells of Cajal (ICC) is certified in the stomach of diabetic patients. Though electroacupuncture (EA) at ST36 is an effective therapy to regulate gastric motility, the mechanisms of EA at ST36 on gastric emptying and networks of ICC remain to be elucidated. The aims of this study were to investigate the effects of EA on gastric emptying and on the alterations of ICC networks. Rats were randomized into the control, diabetic rats (DM), diabetic rats with sham EA (DM+SEA), diabetic rats with low frequency EA (DM+LEA) and diabetic rats with high frequency EA groups (DM+HEA). The expression of c-kit in each layer of gastric wall was assessed by western blotting. The proliferation of ICC was identified by immunolabeling of c-kit and Ki67 as the apoptosis of ICC was examined by TUNEL staining. The results were as follows: (1) Gastric emptying was severely delayed in the DM group, but accelerated in the LEA and HEA group, especially in the LEA group. (2) The expression of c-kit in each layer was reduced apparently in the DM group, but also up-regulated in the LEA and HEA group. (3) Plentiful proliferated ICC (c-kit+/Ki67+) forming bushy networks with c-kit+cells were observed in the LEA and HEA group, while the apoptotic cells (c-kit+/TUNEL+) were hardly captured in the LEA and HEA group. Collectively, low and high frequency EA at ST36 rescue the damaged networks of ICC by inhibiting the apoptosis and enhancing the proliferation in the stomach of diabetic rats, resulting in an improved gastric emptying.	[Chen, Yan; Xu, Juan Juan; Liu, Shi; Hou, Xiao Hua] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Div Gastroenterol, Wuhan 430074, Peoples R China	Huazhong University of Science & Technology	Liu, S (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Div Gastroenterol, Wuhan 430074, Peoples R China.	shiliugao@yahoo.com		Liu, Shi/0000-0003-2289-9160	National Natural Science Foundation of China [30670775, 81270458]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The work was partially supported by grants from the National Natural Science Foundation of China (No. 30670775, No. 81270458). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Rodrigues MLC, 2012, J PEDIAT-BRAZIL, V88, P17, DOI 10.2223/JPED.2153; Deng Jing-Jing, 2011, Zhen Ci Yan Jiu, V36, P176; Di Marzo V, 2008, BRIT J PHARMACOL, V153, P1272, DOI 10.1038/sj.bjp.0707682; Farrugia G, 2008, NEUROGASTROENT MOTIL, V20, P54, DOI 10.1111/j.1365-2982.2008.01109.x; Forster J, 2005, J GASTROINTEST SURG, V9, P102, DOI 10.1016/j.gassur.2004.10.001; Gao JF, 2011, NEUROL SCI, V32, P369, DOI 10.1007/s10072-010-0402-6; Gibbons SJ, 2009, NEUROGASTROENT MOTIL, V21, P85, DOI 10.1111/j.1365-2982.2008.01185.x; Harberson J, 2010, DIGEST DIS SCI, V55, P359, DOI 10.1007/s10620-009-1071-2; Hirst GDS, 2006, J PHYSIOL-LONDON, V576, P659, DOI 10.1113/jphysiol.2006.116491; Imai K, 2008, AUTON NEUROSCI-BASIC, V138, P91, DOI 10.1016/j.autneu.2007.11.003; Iwa M, 2006, DIGEST DIS SCI, V51, P1493, DOI 10.1007/s10620-006-9083-7; Kim EH, 2002, NEUROSCI LETT, V327, P33, DOI 10.1016/S0304-3940(02)00372-5; Komuro T, 1996, J AUTONOM NERV SYST, V61, P169, DOI 10.1016/S0165-1838(96)00078-1; Luo D, 2008, DIGEST DIS SCI, V53, P689, DOI 10.1007/s10620-007-9929-7; Manneschi LI, 2004, HISTOL HISTOPATHOL, V19, P1153, DOI 10.14670/HH-19.1153; Mei F, 2006, VIRCHOWS ARCH, V449, P348, DOI 10.1007/s00428-006-0258-6; Mei F, 2009, ANAT REC, V292, P985, DOI 10.1002/ar.20928; Mei F, 2009, VIRCHOWS ARCH, V454, P401, DOI 10.1007/s00428-009-0739-5; Ordog T, 2000, DIABETES, V49, P1731, DOI 10.2337/diabetes.49.10.1731; Ouyang H, 2002, AM J PHYSIOL-GASTR L, V282, pG390, DOI 10.1152/ajpgi.00272.2001; Sfarti C, 2010, J GASTROINTEST LIVER, V19, P279; Shuai X, 2008, DIS ESOPHAGUS, V21, P170, DOI 10.1111/j.1442-2050.2007.00757.x; Silva JRT, 2011, J PAIN, V12, P51, DOI 10.1016/j.jpain.2010.04.008; Sun Jian-Hua, 2011, Zhen Ci Yan Jiu, V36, P171; Tharayil VS, 2010, NEUROGASTROENT MOTIL, V22, P462, DOI 10.1111/j.1365-2982.2009.01435.x; Vittal H, 2007, NAT CLIN PRACT GASTR, V4, P336, DOI 10.1038/ncpgasthep0838; Wang XY, 2009, NEUROGASTROENT MOTIL, V21, DOI 10.1111/j.1365-2982.2009.01336.x; Wang Yan-chun, 2010, Zhen Ci Yan Jiu, V35, P415; Xu JJ, 2012, J EVID-BASED INTEGR, V17, P117, DOI 10.1177/2156587211436235; Xu SP, 2006, DIGEST DIS SCI, V51, P2154, DOI 10.1007/s10620-006-9412-x; Yin J, 2008, J CELL MOL MED, V12, P1118, DOI 10.1111/j.1582-4934.2008.00352.x; Yin JY, 2010, AM J PHYSIOL-GASTR L, V298, pG563, DOI 10.1152/ajpgi.00252.2009; Zhao JX, 2011, J TRADIT CHIN MED, V31, P349, DOI 10.1016/S0254-6272(12)60017-X	34	21	30	3	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83904	10.1371/journal.pone.0083904	http://dx.doi.org/10.1371/journal.pone.0083904			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391842	Green Published, gold, Green Submitted			2022-12-25	WOS:000329325200140
J	Danda, R; Krishnan, G; Ganapathy, K; Krishnan, UM; Vikas, K; Elchuri, S; Chatterjee, N; Krishnakumar, S				Danda, Ravikanth; Krishnan, Gopinath; Ganapathy, Kalaivani; Krishnan, Uma Maheswari; Vikas, Khetan; Elchuri, Sailaja; Chatterjee, Nivedita; Krishnakumar, Subramanian			Targeted Expression of Suicide Gene by Tissue-Specific Promoter and MicroRNA Regulation for Cancer Gene Therapy	PLOS ONE			English	Article							VIRUS-THYMIDINE-KINASE; MALIGNANT BRAIN-TUMORS; TRANSGENE EXPRESSION; HUMAN RETINOBLASTOMA; BREAST-CANCER; MURINE MODEL; PHASE-I; CELLS; GANCICLOVIR; CARCINOMA	In order to realise the full potential of cancer suicide gene therapy that allows the precise expression of suicide gene in cancer cells, we used a tissue specific Epithelial cell adhesion molecule (EpCAM) promoter (EGP-2) that directs transgene Herpes simplex virus-thymidine kinase (HSV-TK) expression preferentially in EpCAM over expressing cancer cells. EpCAM levels are considerably higher in retinoblastoma (RB), a childhood eye cancer with limited expression in normal cells. Use of miRNA regulation, adjacent to the use of the tissue-specific promoter, would provide the second layer of control to the transgene expression only in the tumor cells while sparing the normal cells. To test this hypothesis we cloned let-7b miRNA targets in the 3'UTR region of HSV-TK suicide gene driven by EpCAM promoter because let-7 family miRNAs, including let7b, were found to be down regulated in the RB tumors and cell lines. We used EpCAM over expressing and let-7 down regulated RB cell lines Y79, WERI-Rb1 (EpCAM (+ve)/let-7b(down-regulated)), EpCAM down regulated, let-7 over expressing normal retinal Muller glial cell line MIO-M1(EpCAM (-ve)/let-7b(up-regulated)), and EpCAM up regulated, let-7b up-regulated normal thyroid cell line N-Thy-Ori-3.1(EpCAM (+ve)/let-7b (up-regulated)) in the study. The cell proliferation was measured by MTT assay, apoptosis was measured by probing cleaved Caspase3, EpCAM and TK expression were quantified by Western blot. Our results showed that the EGP2-promoter HSV-TK (EGP2-TK) construct with 2 or 4 copies of let-7b miRNA targets expressed TK gene only in Y79, WERI-Rb-1, while the TK gene did not express in MIO-M1. In summary, we have developed a tissuespecific, miRNA-regulated dual control vector, which selectively expresses the suicide gene in EpCAM over expressing cells.	[Danda, Ravikanth; Krishnan, Gopinath; Ganapathy, Kalaivani; Elchuri, Sailaja; Chatterjee, Nivedita; Krishnakumar, Subramanian] Sankara Nethralaya, Vis Res Fdn, Dept Ocular Pathol, Madras, Tamil Nadu, India; [Danda, Ravikanth; Krishnan, Gopinath; Krishnan, Uma Maheswari] Shanmugha Arts Sci Technol & Res Acad Univ, Ctr Nanotechnol & Adv Biomat, Tanjore, India; [Vikas, Khetan] Sankara Nethralaya, Med Res Fdn, Dept Ocular Oncol, Madras, Tamil Nadu, India; [Vikas, Khetan] Sankara Nethralaya, Med Res Fdn, Dept Vitreoretina, Madras, Tamil Nadu, India	Shanmugha Arts, Science, Technology & Research Academy (SASTRA)	Krishnakumar, S (corresponding author), Sankara Nethralaya, Vis Res Fdn, Dept Ocular Pathol, Madras, Tamil Nadu, India.	drkk@snmail.org	Krishnan, Gopinath/AGZ-1565-2022	Krishnan, Gopinath/0000-0002-3508-1133; Khetan, Vikas/0000-0003-4396-9877	Indian Council of Medical Research [35/6/2010/-BMS]; Department of Biotechnology, Government of India [BT/01/CE1B/11/V/16]	Indian Council of Medical Research(Indian Council of Medical Research (ICMR)); Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	This work was supported by the Indian Council of Medical Research, Grant no 35/6/2010/-BMS Nano for performing cloning, transfection, and functional analysis. In part this work was supported by the Department of Biotechnology, Government of India, Grant no BT/01/CE1B/11/V/16 for performing the let-7miRNA family profile. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi Y, 2000, CANCER RES, V60, P4305; Brown BD, 2007, NAT BIOTECHNOL, V25, P1457, DOI 10.1038/nbt1372; Card PB, 2012, CANCER GENE THER, V19, P451, DOI 10.1038/cgt.2012.16; Chevez-Barrios P, 2005, J CLIN ONCOL, V23, P7927, DOI 10.1200/JCO.2004.00.1883; Denny WA, 2001, EUR J MED CHEM, V36, P577, DOI 10.1016/S0223-5234(01)01253-3; Duarte S, 2012, CANCER LETT, V324, P160, DOI 10.1016/j.canlet.2012.05.023; Ebara S, 2002, PROSTATE CANCER P D, V5, P316, DOI 10.1038/sj.pcan.4500610; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; Gommans WM, 2006, CANCER GENE THER, V13, P150, DOI 10.1038/sj.cgt.7700882; Gunduz K, 2004, OPHTHALMOLOGY, V111, P1917, DOI 10.1016/j.ophtha.2004.04.016; Haviv YS, 2001, ADV DRUG DELIVER REV, V53, P135, DOI 10.1016/S0169-409X(01)00225-3; Hayashi N, 1999, INVEST OPHTH VIS SCI, V40, P265; Huang JC, 2007, NAT METHODS, V4, P1045, DOI 10.1038/nmeth1130; Hurwitz MY, 1999, HUM GENE THER, V10, P441, DOI 10.1089/10430349950018887; Ji XD, 2009, EXP EYE RES, V89, P193, DOI 10.1016/j.exer.2009.03.007; Kelly EJ, 2009, MOL THER, V17, P409, DOI 10.1038/mt.2008.288; Krishnakumar S, 2004, INVEST OPHTH VIS SCI, V45, P4247, DOI 10.1167/iovs.04-0591; Kucharczuk JC, 1996, HUM GENE THER, V7, P2225, DOI 10.1089/hum.1996.7.18-2225; Kuzmin D, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-58; Lanuti M, 1999, HUM GENE THER, V10, P463, DOI 10.1089/10430349950018904; LEMOINE NR, 1989, BRIT J CANCER, V60, P897, DOI 10.1038/bjc.1989.387; Limb GA, 2002, INVEST OPHTH VIS SCI, V43, P864; Lindsay MA, 2008, TRENDS IMMUNOL, V29, P343, DOI 10.1016/j.coph.2009.05.003; Majumdar AS, 2001, GENE THER, V8, P568, DOI 10.1038/sj.gt.3301421; Mathis JM, 2006, J GENE MED, V8, P1105, DOI 10.1002/jgm.935; McLaughlin PMJ, 2004, CANCER GENE THER, V11, P603, DOI 10.1038/sj.cgt.7700725; Mu GY, 2010, HUM PATHOL, V41, P493, DOI 10.1016/j.humpath.2009.08.022; Nanda D, 2001, CANCER RES, V61, P8743; Osta WA, 2004, CANCER RES, V64, P5818, DOI 10.1158/0008-5472.CAN-04-0754; Pichard V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051952; Qiao J, 2002, GENE THER, V9, P168, DOI 10.1038/sj.gt.3301618; Ram Z, 1997, NAT MED, V3, P1354, DOI 10.1038/nm1297-1354; Rodriguez-Galindo Carlos, 2007, Curr Treat Options Neurol, V9, P294, DOI 10.1007/s11940-007-0015-4; Sakurai F, 2011, FRONT BIOSCI-LANDMRK, V16, P2389, DOI 10.2741/3861; Sastre X, 2009, ARCH PATHOL LAB MED, V133, P1199, DOI 10.1043/1543-2165-133.8.1199; Sengupta S, 2013, PEDIATR BLOOD CANCER, V60, P336, DOI 10.1002/pbc.24357; Skalsky RL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024248; Sterman DH, 2005, CLIN CANCER RES, V11, P7444, DOI 10.1158/1078-0432.CCR-05-0405; Sterman DH, 1998, HUM GENE THER, V9, P1083, DOI 10.1089/hum.1998.9.7-1083; Suzuki T, 2008, MOL THER, V16, P1719, DOI 10.1038/mt.2008.159; Takamizawa J, 2004, CANCER RES, V64, P3753, DOI 10.1158/0008-5472.CAN-04-0637; Trask TW, 2000, MOL THER, V1, P195, DOI 10.1006/mthe.2000.0030; Tsitsiou E, 2009, CURR OPIN PHARMACOL, V9, P514, DOI 10.1016/j.coph.2009.05.003; Tuncel M, 2007, CANCER BIOTHER RADIO, V22, P443, DOI 10.1089/cbr.2006.319.A; van der Gun BTF, 2010, CARCINOGENESIS, V31, P1913, DOI 10.1093/carcin/bgq187; Vassaux G, 2004, EXPERT OPIN BIOL TH, V4, P519; Wang Y, 2009, J CELL MOL MED, V13, P12, DOI 10.1111/j.1582-4934.2008.00510.x; Wu CX, 2009, MOL THER, V17, P2058, DOI 10.1038/mt.2009.225; Xu Y, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-39; Yazawa K, 2002, WORLD J SURG, V26, P783, DOI 10.1007/s00268-002-4053-5; Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054	51	20	23	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83398	10.1371/journal.pone.0083398	http://dx.doi.org/10.1371/journal.pone.0083398			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391761	gold, Green Submitted, Green Published			2022-12-25	WOS:000329325200058
J	Dong, J; Xu, H; Xu, H; Wang, PF; Cai, GJ; Song, HF; Wang, CC; Dong, ZT; Ju, YJ; Jiang, ZY				Dong, Jing; Xu, Huan; Xu, Huan; Wang, Peng-fei; Cai, Gui-ju; Song, Hai-feng; Wang, Chang-chen; Dong, Zhao-tong; Ju, Yan-jiao; Jiang, Zheng-yao			Nesfatin-1 Stimulates Fatty-Acid Oxidation by Activating AMP-Activated Protein Kinase in STZ-Induced Type 2 Diabetic Mice	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; INSULIN SENSITIVITY; ENERGY-BALANCE; SECRETION; NUTRIENT; RECEPTOR; GLUCOSE; MODEL; RAT	Nesfatin-1 is an anorexigenic peptide involved in energy homeostasis. Recently, nesfatin-1 was reported to decrease blood glucose level and improve insulin sensitivity in high-fat diet-fed rats. However, little information is known about the influence of nesfatin-1 on lipid metabolism either in physiological or diabetic condition. This study undertook whether nesfatin-1 was involved in the pathophysiology in Streptozotocin-induced type 2 diabetic mice (T2DM), which was induced by a combination of high-calorie diet and two low-doses Streptozotocin. We observed that plasma nesfatin-1 was significantly increased while expression of nesfatin-1 neurons were decreased in hypothalamus in diabetes group compared to only high-calorie diet control group; intravenous injection of nesfatin-1 decreased 0-1h, 0-2h, 0-3h cumulative food intake in T2DM, but 0-24h total food intake had no difference between groups. Body weight and plasma FFA were normalized after nesfatin-1(10 mu g/Kg) administration for 6 days. These results suggested that nesfatin-1 improved lipid disorder in T2DM. It was found that blood glucose and insulin resistance coefficient decreased with treatment of nesfatin-1 (both in 1 mu g/Kg and 10 mu g/Kg doses) in diabetes mice. For further understanding the role of nesfatin-1 on lipid metabolism, we detected p-AMPK and p-ACC of skeletal muscle in T2DM using western blotting. The expression of p-AMPK and p-ACC increased when nesfatin-1 was given with doses 1 mu g/Kg but not in doses 10 mu g/Kg. Taken together, nesfatin-1 participated in the development of T2DM and stimulated free fatty acid utilization via AMPK-ACC pathway in skeletal muscle in T2DM.	[Dong, Jing; Jiang, Zheng-yao] Qingdao Univ, Coll Med, Dept Physiol, Qingdao 266071, Peoples R China; [Dong, Jing] Qingdao Univ, Coll Med, Special Med Dept, Qingdao 266071, Peoples R China; [Xu, Huan; Xu, Huan; Wang, Peng-fei; Cai, Gui-ju; Song, Hai-feng; Wang, Chang-chen; Dong, Zhao-tong; Ju, Yan-jiao] Qingdao Univ, Coll Med, Qingdao 266071, Peoples R China	Qingdao University; Qingdao University; Qingdao University	Dong, J (corresponding author), Qingdao Univ, Coll Med, Dept Physiol, Qingdao 266071, Peoples R China.	dongjing6@hotmail.com; qd-zyj@163.com		wang, pengfei/0000-0003-0416-2632	Natural Science Foundation of China [31371168, 31071013]; Qingdao Municipal of Science and Technology Commission, Shandong, China [09-2-1-4-nsh]; Natural Science Foundation of Shandong Province China [Y2008C60]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Qingdao Municipal of Science and Technology Commission, Shandong, China; Natural Science Foundation of Shandong Province China(Natural Science Foundation of Shandong Province)	This work is supported by the Natural Science Foundation of China (No. 31371168 to J. Dong and No. 31071013 to Z-Y Jiang); Qingdao Municipal of Science and Technology Commission (NO. 09-2-1-4-nsh), Shandong, China; and Natural Science Foundation of Shandong Province China (No. Y2008C60). The funders had no role in our study design, data collection and analysis, decision to publish and preparation for the manuscript.	Abbott MJ, 2012, EXP PHYSIOL, V97, P603, DOI 10.1113/expphysiol.2012.064402; Atkinson BJ, 2013, DIABETES; Bikman BT, 2010, J OBES, V2010, DOI 10.1155/2010/970865; Brailoiu GC, 2007, ENDOCRINOLOGY, V148, P5088, DOI 10.1210/en.2007-0701; Camina JP, 2004, ENDOCRINOLOGY, V145, P930, DOI 10.1210/en.2003-0974; Chow L, 2010, METABOLISM, V59, P70, DOI 10.1016/j.metabol.2009.07.009; Foo KS, 2010, J ENDOCRINOL, V204, P255, DOI 10.1677/JOE-09-0254; Gantulga D, 2012, BIOCHEM BIOPH RES CO, V420, P811, DOI 10.1016/j.bbrc.2012.03.079; Goebel-Stengel M, 2013, CURRENT PHARM DESIGN; Gonzalez R, 2011, ENDOCRINOLOGY, V152, P3628, DOI 10.1210/en.2010-1471; KIM J, 2013, NATL GEOGR, V224, P8; Li QC, 2010, REGUL PEPTIDES, V159, P72, DOI 10.1016/j.regpep.2009.11.003; Luo J, 1998, METABOLISM, V47, P663, DOI 10.1016/S0026-0495(98)90027-0; Minokoshi Y, 2002, NATURE, V415, P339, DOI 10.1038/415339a; Muniyappa R, 2008, AM J PHYSIOL-ENDOC M, V294, pE15, DOI 10.1152/ajpendo.00645.2007; Nakata M, 2011, ENDOCR J, V58, P305, DOI 10.1507/endocrj.K11E-056; Oh-I S, 2006, NATURE, V443, P709, DOI 10.1038/nature05162; Pan WH, 2007, PEPTIDES, V28, P2223, DOI 10.1016/j.peptides.2007.09.005; Poucher SM, 2012, DIABETES OBES METAB, V14, P918, DOI 10.1111/j.1463-1326.2012.01619.x; Price TO, 2007, PEPTIDES, V28, P2372, DOI 10.1016/j.peptides.2007.10.008; Ramanjaneya M, 2010, ENDOCRINOLOGY, V151, P3169, DOI 10.1210/en.2009-1358; Reed MJ, 2000, METABOLISM, V49, P1390, DOI 10.1053/meta.2000.17721; Riva M, 2011, CELL TISSUE RES, V346, P393, DOI 10.1007/s00441-011-1268-5; Ruderman NB, 1999, AM J PHYSIOL-ENDOC M, V276, pE1, DOI 10.1152/ajpendo.1999.276.1.E1; Su YJ, 2010, BIOCHEM BIOPH RES CO, V391, P1039, DOI 10.1016/j.bbrc.2009.12.014; Viollet B, 2003, J CLIN INVEST, V111, P91, DOI 10.1172/JCI200316567; Xia YQ, 2011, DIABETOL METAB SYNDR, V3, DOI 10.1186/1758-5996-3-31; Xue BZ, 2006, J PHYSIOL-LONDON, V574, P73, DOI 10.1113/jphysiol.2006.113217; Yang ML, 2012, DIABETES, V61, P1959, DOI 10.2337/db11-1755; Zhang Z, 2012, EXP CLIN ENDOCR DIAB, V120, P91, DOI 10.1055/s-0031-1286339	30	30	33	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83397	10.1371/journal.pone.0083397	http://dx.doi.org/10.1371/journal.pone.0083397			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391760	Green Submitted, gold, Green Published			2022-12-25	WOS:000329325200057
J	Gautier, L; Lund, O				Gautier, Laurent; Lund, Ole			Low-Bandwidth and Non-Compute Intensive Remote Identification of Microbes from Raw Sequencing Reads	PLOS ONE			English	Article							ALIGNMENT	Cheap DNA sequencing may soon become routine not only for human genomes but also for practically anything requiring the identification of living organisms from their DNA: tracking of infectious agents, control of food products, bioreactors, or environmental samples. We propose a novel general approach to the analysis of sequencing data where a reference genome does not have to be specified. Using a distributed architecture we are able to query a remote server for hints about what the reference might be, transferring a relatively small amount of data. Our system consists of a server with known reference DNA indexed, and a client with raw sequencing reads. The client sends a sample of unidentified reads, and in return receives a list of matching references. Sequences for the references can be retrieved and used for exhaustive computation on the reads, such as alignment. To demonstrate this approach we have implemented a web server, indexing tens of thousands of publicly available genomes and genomic regions from various organisms and returning lists of matching hits from query sequencing reads. We have also implemented two clients: one running in a web browser, and one as a python script. Both are able to handle a large number of sequencing reads and from portable devices (the browser-based running on a tablet), perform its task within seconds, and consume an amount of bandwidth compatible with mobile broadband networks. Such client-server approaches could develop in the future, allowing a fully automated processing of sequencing data and routine instant quality check of sequencing runs from desktop sequencers. A web access is available at http://tapir.cbs.dtu.dk. The source code for a python command-line client, a server, and supplementary data are available at http://bit.ly/1aURxkc.	[Gautier, Laurent; Lund, Ole] Tech Univ Denmark, Ctr Biol Sequence Anal CBS, Dept Syst Biol, DK-2800 Lyngby, Denmark; [Gautier, Laurent] Tech Univ Denmark, DTU Multiassay Core DMAC, DK-2800 Lyngby, Denmark	Technical University of Denmark; Technical University of Denmark	Gautier, L (corresponding author), Tech Univ Denmark, Ctr Biol Sequence Anal CBS, Dept Syst Biol, DK-2800 Lyngby, Denmark.	laurent@cbs.dtu.dk	Lund, Ole/F-4437-2014	Lund, Ole/0000-0003-1108-0491	DTU Multi-Assay Core; Technical University of Denmark; Danish Council for Strategic Research [09-067103/DSF]	DTU Multi-Assay Core; Technical University of Denmark; Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF))	Laurent Gautier's work was supported by the DTU Multi-Assay Core funded by the Technical University of Denmark, and Ole Lund was funded by grant 09-067103/DSF from the Danish Council for Strategic Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Cox AJ, 2012, BIOINFORMATICS, V28, P1415, DOI 10.1093/bioinformatics/bts173; Devos D, 2000, PROTEINS, V41, P98, DOI 10.1002/1097-0134(20001001)41:1<98::AID-PROT120>3.3.CO;2-J; Ferragina P, 2000, ANN IEEE SYMP FOUND, P390, DOI 10.1109/SFCS.2000.892127; Hirabayashi M, KYOTO CABINET STRAIG; Hoffmann S, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000502; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Leiserson CE, 2001, INTRO ALGORITHMS; Li H, 2010, BRIEF BIOINFORM, V11, P473, DOI 10.1093/bib/bbq015; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liao Y, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt214; Lindner MS, 2013, BIOINFORMATICS, V29, P1260, DOI 10.1093/bioinformatics/btt147; Ning Z, 2004, COMP SYST BIOINF C, P519; Ning ZM, 2001, GENOME RES, V11, P1725, DOI 10.1101/gr.194201; Rost B, 2002, J MOL BIOL, V318, P595, DOI 10.1016/S0022-2836(02)00016-5; Rumble SM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000386; Rusk N, 2009, NAT METHODS, V6, P244, DOI 10.1038/nmeth0409-244a; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5	20	3	3	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83784	10.1371/journal.pone.0083784	http://dx.doi.org/10.1371/journal.pone.0083784			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391826	Green Published, gold, Green Submitted			2022-12-25	WOS:000329325200124
J	Kraemer, A; Chen, IP; Henning, S; Faust, A; Volkmer, B; Atkinson, MJ; Moertl, S; Greinert, R				Kraemer, Anne; Chen, I-Peng; Henning, Stefan; Faust, Alexandra; Volkmer, Beate; Atkinson, Michael J.; Moertl, Simone; Greinert, Ruediger			UVA and UVB Irradiation Differentially Regulate microRNA Expression in Human Primary Keratinocytes	PLOS ONE			English	Article							NONMELANOMA SKIN-CANCER; BASAL-CELL CARCINOMA; INDUCED DNA-DAMAGE; THYROID-HORMONE; TARGET GENES; HEPATOCELLULAR-CARCINOMA; MESENCHYMAL TRANSITION; MALIGNANT-MELANOMA; RADIATION; IDENTIFICATION	MicroRNA (miRNA)-mediated regulation of the cellular transcriptome is an important epigenetic mechanism for fine-tuning regulatory pathways. These include processes related to skin cancer development, progression and metastasis. However, little is known about the role of microRNA as an intermediary in the carcinogenic processes following exposure to UV-radiation. We now show that UV irradiation of human primary keratinocytes modulates the expression of several cellular miRNAs. A common set of miRNAs was influenced by exposure to both UVA and UVB. However, each wavelength band also activated a distinct subset of miRNAs. Common sets of UVA- and UVB-regulated miRNAs harbor the regulatory elements GLYCA-nTRE, GATA-1-undefined-site-13 or Hox-2.3-undefined-site-2 in their promoters. In silico analysis indicates that the differentially expressed miRNAs responding to UV have potential functions in the cellular pathways of cell growth and proliferation. Interestingly, the expression of miR-23b, which is a differentiation marker of human keratinocytes, is remarkably up-regulated after UVA irradiation. Studying the interaction between miR-23b and its putative skin-relevant targets using a Luciferase reporter assay revealed that RRAS2 (related RAS viral oncogene homolog 2), which is strongly expressed in highly aggressive malignant skin cancer, to be a direct target of miR-23b. This study demonstrates for the first time a differential miRNA response to UVA and UVB in human primary keratinocytes. This suggests that selective regulation of signaling pathways occurs in response to different UV energies. This may shed new light on miRNA-regulated carcinogenic processes involved in UV-induced skin carcinogenesis.	[Kraemer, Anne; Atkinson, Michael J.; Moertl, Simone] Helmholtz Ctr Munich, Inst Radiat Biol, Neuherberg, Germany; [Chen, I-Peng; Henning, Stefan; Faust, Alexandra; Volkmer, Beate; Greinert, Ruediger] Elbekliniken Stade Buxtehude, Dept Mol Cell Biol, Ctr Dermatol, Buxtehude, Germany; [Atkinson, Michael J.] Tech Univ Munich, D-80290 Munich, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich	Greinert, R (corresponding author), Elbekliniken Stade Buxtehude, Dept Mol Cell Biol, Ctr Dermatol, Buxtehude, Germany.	ruediger.greinert@elbekliniken.de	Atkinson, Michael/AAU-5127-2020; Moertl, Simone/M-7353-2014; Atkinson, Michael J/E-5537-2011	Atkinson, Michael/0000-0003-3358-2089; Moertl, Simone/0000-0003-0644-0878; Atkinson, Michael J/0000-0003-3358-2089	Bundesministerium fuer Bildung und Forschung, Germany [BMBF-02NUK003D]	Bundesministerium fuer Bildung und Forschung, Germany	The work was supported by BMBF-02NUK003D (Bundesministerium fuer Bildung und Forschung, Germany). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arora S, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-11-r166; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Boehnke K, 2012, CARCINOGENESIS; Boukamp P, 2005, CARCINOGENESIS, V26, P1657, DOI 10.1093/carcin/bgi123; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; CHATTERJEE VKK, 1989, P NATL ACAD SCI USA, V86, P9114, DOI 10.1073/pnas.86.23.9114; Chaudhry MA, 2013, J RADIAT RES, V54, P808, DOI 10.1093/jrr/rrt014; Chen LC, 2012, NEURO-ONCOLOGY, V14, P1026, DOI 10.1093/neuonc/nos122; Davalos V, 2010, CURR OPIN ONCOL, V22, P35, DOI 10.1097/CCO.0b013e328333dcbb; de Gruijl FR, 2002, SKIN PHARMACOL APPL, V15, P316, DOI 10.1159/000064535; de Gruijl FR, 2001, J PHOTOCH PHOTOBIO B, V63, P19, DOI 10.1016/S1011-1344(01)00199-3; de Gruijl FR, 2008, PHOTOCHEM PHOTOBIOL, V84, P382, DOI 10.1111/j.1751-1097.2007.00275.x; Dong HY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012136; Dong HY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004610; Duan HH, 2010, TOXICOL IN VITRO, V24, P928, DOI 10.1016/j.tiv.2009.11.013; Dziunycz P, 2010, J INVEST DERMATOL, V130, P2686, DOI 10.1038/jid.2010.169; El Ghissassi F, 2009, LANCET ONCOL, V10, P751, DOI 10.1016/S1470-2045(09)70213-X; ELWOOD JM, 1993, MELANOMA RES, V3, P113; Farazi TA, 2011, J PATHOL, V223, P102, DOI 10.1002/path.2806; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Girardi C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031293; Greinert R, 2009, PATHOBIOLOGY, V76, P64, DOI 10.1159/000201675; Grimson A, 2008, NATURE, V455, P1193, DOI 10.1038/nature07415; Guo L, 2009, PHOTOCHEM PHOTOBIOL, V85, P765, DOI 10.1111/j.1751-1097.2008.00482.x; Guo Z, 2013, J DERMATOL SCI, V69, P68, DOI 10.1016/j.jdermsci.2012.10.014; He YH, 2011, NEOPLASIA, V13, P841, DOI 10.1593/neo.11698; Heffelfinger C, 2012, G3-GENES GENOM GENET, V2, P279, DOI 10.1534/g3.111.001115; Hildebrand J, 2011, J INVEST DERMATOL, V131, P20, DOI 10.1038/jid.2010.268; Huang SL, 2008, INT J CANCER, V123, P972, DOI 10.1002/ijc.23580; Huang XX, 2012, MOL GENET METAB, V106, P127, DOI 10.1016/j.ymgme.2012.02.017; Huang YH, 2013, CANCER RES, V73, P2505, DOI 10.1158/0008-5472.CAN-12-2218; Humphreys DT, 2005, P NATL ACAD SCI USA, V102, P16961, DOI 10.1073/pnas.0506482102; Kanitz A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049568; Kanwar Jagat R, 2010, Front Biosci (Schol Ed), V2, P1113; Kim WK, 2011, CLIN CANCER RES, V17, P7584, DOI 10.1158/1078-0432.CCR-11-0166; Kraemer A, 2011, RADIAT RES, V176, P575, DOI 10.1667/RR2638.1; Kunz M, 2013, ADV EXP MED BIOL, V774, P103, DOI 10.1007/978-94-007-5590-1_6; Laczny C, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-36; Lavon I, 2010, NEURO-ONCOLOGY, V12, P422, DOI 10.1093/neuonc/nop061; Lee HST, 1997, EXP DERMATOL, V6, P105, DOI 10.1111/j.1600-0625.1997.tb00155.x; Lee JH, 2011, INT J DERMATOL, V50, P956, DOI 10.1111/j.1365-4632.2010.04846.x; Leidinger P, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-262; Leiter U, 2008, ADV EXP MED BIOL, V624, P89, DOI 10.1007/978-0-387-77574-6_8; Lena AM, 2012, BIOCH BIOPHYS RES CO; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li AGQ, 2006, MOL CARCINOGEN, V45, P389, DOI 10.1002/mc.20229; Lin YH, 2013, ONCOGENE, V32, P4509, DOI 10.1038/onc.2013.309; Liu LH, 2010, LIFE SCI, V86, P192, DOI 10.1016/j.lfs.2009.12.002; Lu XZ, 2013, CELL SIGNAL, V25, P1949, DOI 10.1016/j.cellsig.2013.06.005; Mayburd AL, 2006, CLIN CANCER RES, V12, P1820, DOI 10.1158/1078-0432.CCR-05-2149; Melo SA, 2011, FEBS LETT, V585, P2087, DOI 10.1016/j.febslet.2010.08.009; Mouret S, 2006, P NATL ACAD SCI USA, V103, P13765, DOI 10.1073/pnas.0604213103; Mouret S, 2010, ORG BIOMOL CHEM, V8, P1706, DOI 10.1039/b924712b; Mueller DW, 2009, J INVEST DERMATOL, V129, P1740, DOI 10.1038/jid.2008.452; Ohdaira H, 2012, CELL PROLIFERAT, V45, P32, DOI 10.1111/j.1365-2184.2011.00798.x; Park SW, 2005, MOL CELL, V19, P643, DOI 10.1016/j.molcel.2005.08.008; Peter ME, 2009, CELL CYCLE, V8, P843, DOI 10.4161/cc.8.6.7907; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Philippidou D, 2010, CANCER RES, V70, P4163, DOI 10.1158/0008-5472.CAN-09-4512; Pillai RS, 2005, SCIENCE, V309, P1573, DOI 10.1126/science.1115079; Pinheiro I, 2011, BIOESSAYS, V33, P791, DOI 10.1002/bies.201100047; Pothof J, 2009, EMBO J, V28, P2090, DOI 10.1038/emboj.2009.156; Rong R, 2002, ONCOGENE, V21, P1062, DOI 10.1038/sj.onc.1205154; Ruan W, 2012, CARDIOVASC RES, V93, P623, DOI 10.1093/cvr/cvr290; Sand M, 2012, MOL CARCINOGEN, V51, P916, DOI 10.1002/mc.20861; Stadler PF, 2009, MOL BIOL EVOL, V26, P1975, DOI 10.1093/molbev/msp112; Syed DN, 2012, PHOTOCHEM PHOTOBIOL; Voller D, 2013, CLIN BIOCHEM, V46, P909, DOI 10.1016/j.clinbiochem.2013.01.008; Wu LG, 2006, P NATL ACAD SCI USA, V103, P4034, DOI 10.1073/pnas.0510928103; Ye G, 2011, J CELL SCI, V124, P359, DOI 10.1242/jcs.072223; Zhang HS, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1555; Zhang SA, 2011, BIOMED PHARMACOTHER, V65, P436, DOI 10.1016/j.biopha.2011.04.010; Zhang Y, 2013, NEOPLASMA, V60, P247, DOI 10.4149/neo_2013_033; Zhou BR, 2012, EXP DERMATOL, V21, P317, DOI 10.1111/j.1600-0625.2012.01465.x	74	39	41	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83392	10.1371/journal.pone.0083392	http://dx.doi.org/10.1371/journal.pone.0083392			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391759	Green Submitted, gold, Green Published			2022-12-25	WOS:000329325200056
J	Lee, JK; Park, SR; Jung, BK; Jeon, YK; Lee, YS; Kim, MK; Kim, YG; Jang, JY; Kim, CW				Lee, Jong-Kuen; Park, Sae-Ra; Jung, Bong-Kwang; Jeon, Yoon-Kyung; Lee, Yeong-Shin; Kim, Min-Kyoung; Kim, Yong-Goo; Jang, Ji-Young; Kim, Chul-Woo			Exosomes Derived from Mesenchymal Stem Cells Suppress Angiogenesis by Down-Regulating VEGF Expression in Breast Cancer Cells	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; TUMOR-GROWTH; MICRORNAS; INHIBITION; GENE; PROLIFERATION; MECHANISM; THERAPY	Exosomes are small membrane vesicles released by a variety of cell types. Exosomes contain genetic materials, such as mRNAs and microRNAs (miRNAs), implying that they may play a pivotal role in cell-to-cell communication. Mesenchymal stem cells (MSCs), which potentially differentiate into multiple cell types, can migrate to the tumor sites and have been reported to exert complex effects on tumor progression. To elucidate the role of MSCs within the tumor microenvironment, previous studies have suggested various mechanisms such as immune modulation and secreted factors of MSCs. However, the paracrine effects of MSC-derived exosomes on the tumor microenvironment remain to be explored. The hypothesis of this study was that MSC-derived exosomes might reprogram tumor behavior by transferring their molecular contents. To test this hypothesis, exosomes from MSCs were isolated and characterized. MSC-derived exosomes exhibited different protein and RNA profiles compared with their donor cells and these vesicles could be internalized by breast cancer cells. The results demonstrated that MSC-derived exosomes significantly down-regulated the expression of vascular endothelial growth factor (VEGF) in tumor cells, which lead to inhibition of angiogenesis in vitro and in vivo. Additionally, miR-16, a miRNA known to target VEGF, was enriched in MSC-derived exosomes and it was partially responsible for the anti-angiogenic effect of MSC-derived exosomes. The collective results suggest that MSC-derived exosomes may serve as a significant mediator of cell-to-cell communication within the tumor microenvironment and suppress angiogenesis by transferring anti-angiogenic molecules.	[Lee, Jong-Kuen; Park, Sae-Ra; Jung, Bong-Kwang; Jeon, Yoon-Kyung; Lee, Yeong-Shin; Kim, Min-Kyoung; Kim, Yong-Goo; Jang, Ji-Young; Kim, Chul-Woo] Seoul Natl Univ, Coll Med, Canc Res Inst, Tumor Immun Med Res Ctr, Seoul, South Korea; [Jeon, Yoon-Kyung; Kim, Chul-Woo] Seoul Natl Univ, Coll Med, Dept Pathol, Seoul 151, South Korea	Seoul National University (SNU); Seoul National University (SNU)	Jang, JY (corresponding author), Seoul Natl Univ, Coll Med, Canc Res Inst, Tumor Immun Med Res Ctr, Seoul, South Korea.	jjy93@daum.net; cwkim@snu.ac.kr	Jung, Bong-Kwang/GYQ-6442-2022	Jung, Bong-Kwang/0000-0001-7581-3899; Park, Sae-ra/0000-0003-0910-3471	Global Core Research Center (GCRC) from the National Research Foundation (NRF) [2012-0001190]; Ministry of Education, Science and Technology (MEST), Republic of Korea	Global Core Research Center (GCRC) from the National Research Foundation (NRF); Ministry of Education, Science and Technology (MEST), Republic of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by the Global Core Research Center (GCRC) grant (No. 2012-0001190) from the National Research Foundation (NRF), Ministry of Education, Science and Technology (MEST), Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beckermann BM, 2008, BRIT J CANCER, V99, P622, DOI 10.1038/sj.bjc.6604508; Bergfeld SA, 2010, CANCER METAST REV, V29, P249, DOI 10.1007/s10555-010-9222-7; Bernatchez PN, 1999, J BIOL CHEM, V274, P31047, DOI 10.1074/jbc.274.43.31047; Borgstrom P, 1996, CANCER RES, V56, P4032; Camussi G, 2012, CURR MOL MED; Camussi G, 2011, AM J CANCER RES, V1, P98; Chamorro-Jorganes A, 2011, ARTERIOSCL THROM VAS, V31, P2595, DOI 10.1161/ATVBAHA.111.236521; Cho JA, 2009, CANCER LETT, V275, P256, DOI 10.1016/j.canlet.2008.10.021; Collino F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011803; Dejean E, 2011, LEUKEMIA, V25, P1882, DOI 10.1038/leu.2011.168; Djouad F, 2003, BLOOD, V102, P3837, DOI 10.1182/blood-2003-04-1193; Dvorak HF, 1999, CURR TOP MICROBIOL, V237, P97; Galie M, 2008, ONCOGENE, V27, P2542, DOI 10.1038/sj.onc.1210920; Garofalo M, 2011, ANNU REV PHARMACOL, V51, P25, DOI 10.1146/annurev-pharmtox-010510-100517; Grange C, 2011, CANCER RES, V71, P5346, DOI 10.1158/0008-5472.CAN-11-0241; Hall B., 2007, V180, P263; Ho IA, 2012, STEM CELLS; Hua Z, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000116; Itoh T, 1998, CANCER RES, V58, P1048; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; Khakoo AY, 2006, J EXP MED, V203, P1235, DOI 10.1084/jem.20051921; Klopp AH, 2011, STEM CELLS, V29, P11, DOI 10.1002/stem.559; Kogure T, 2011, HEPATOLOGY, V54, P1237, DOI 10.1002/hep.24504; Kosaka N, 2010, CANCER SCI, V101, P2087, DOI 10.1111/j.1349-7006.2010.01650.x; Lee YS, 2011, EXP MOL MED, V43, P281, DOI 10.3858/emm.2011.43.5.029; Liu BS, 2012, INT J ANAL CHEM, V2012, DOI 10.1155/2012/408057; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; McMahon G, 2000, Oncologist, V5 Suppl 1, P3; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Otsu K, 2009, BLOOD, V113, P4197, DOI 10.1182/blood-2008-09-176198; Raposo G, 1996, J EXP MED, V183, P1161, DOI 10.1084/jem.183.3.1161; Roland CL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007669; Uccelli A, 2008, NAT REV IMMUNOL, V8, P726, DOI 10.1038/nri2395; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Viaud S, 2008, HORM METAB RES, V40, P82, DOI 10.1055/s-2007-1022548; Wagatsuma A, 2007, MOL CELL BIOCHEM, V298, P151, DOI 10.1007/s11010-006-9361-x; Wang SS, 2009, CURR OPIN GENET DEV, V19, P205, DOI 10.1016/j.gde.2009.04.002; Winter J, 2009, NAT CELL BIOL, V11, P228, DOI 10.1038/ncb0309-228; Wu Y, 2006, INT J CANCER, V119, P1519, DOI 10.1002/ijc.21865; Wu YJ, 2007, STEM CELLS, V25, P2648, DOI 10.1634/stemcells.2007-0226; Yang M, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-117; Yu H, 2007, BIOCHEM BIOPH RES CO, V361, P946, DOI 10.1016/j.bbrc.2007.07.114; Yuan A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004722; Zhu W, 2012, CANCER LETT, V315, P28, DOI 10.1016/j.canlet.2011.10.002; Zhu Y, 2009, LEUKEMIA, V23, P925, DOI 10.1038/leu.2008.384	45	430	461	3	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84256	10.1371/journal.pone.0084256	http://dx.doi.org/10.1371/journal.pone.0084256			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391924	gold, Green Submitted, Green Published			2022-12-25	WOS:000329323900067
J	Sheehan, EV; Stevens, TF; Gall, SC; Cousens, SL; Attrill, MJ				Sheehan, Emma V.; Stevens, Timothy F.; Gall, Sarah C.; Cousens, Sophie L.; Attrill, Martin J.			Recovery of a Temperate Reef Assemblage in a Marine Protected Area following the Exclusion of Towed Demersal Fishing	PLOS ONE			English	Article							COMMUNITY STRUCTURE; TRAWL DISTURBANCE; RESERVES; MANAGEMENT; HABITAT; IMPACT; BOUNDARIES; BENEFITS; SIZE	Marine Protected Areas MPA have been widely used over the last 2 decades to address human impacts on marine habitats within an ecosystem management context. Few studies have quantified recovery of temperate rocky reef communities following the cessation of scallop dredging or demersal trawling. This is critical information for the future management of these habitats to contribute towards conservation and fisheries targets. The Lyme Bay MPA, in south west UK, has excluded towed demersal fishing gear from 206 km(2) of sensitive reef habitat using a Statutory Instrument since July 2008. To assess benthic recovery in this MPA we used a flying video array to survey macro epi-benthos annually from 2008 to 2011. 4 treatments (the New Closure, previously voluntarily Closed Controls and Near or Far Open to fishing Controls) were sampled to test a recovery hypothesis that was defined as 'the New Closure becoming more similar to the Closed Controls and less similar to the Open Controls'. Following the cessation of towed demersal fishing, within three years positive responses were observed for species richness, total abundance, assemblage composition and seven of 13 indicator taxa. Definitive evidence of recovery was noted for species richness and three of the indicator taxa (Pentapora fascialis, Phallusia mammillata and Pecten maximus). While it is hoped that MPAs, which exclude anthropogenic disturbance, will allow functional restoration of goods and services provided by benthic communities, it is an unknown for temperate reef systems. Establishing the likely timescales for restoration is key to future marine management. We demonstrate the early stages of successful recruitment and link these to the potential wider ecosystem benefits including those to commercial fisheries.	[Sheehan, Emma V.; Gall, Sarah C.; Cousens, Sophie L.; Attrill, Martin J.] Univ Plymouth, Inst Marine, Plymouth PL4 8AA, Devon, England; [Stevens, Timothy F.] Griffith Univ, Griffith Sch Environm, Gold Coast, NSW, Australia; [Stevens, Timothy F.] Griffith Univ, Australian Rivers Inst Coasts & Estuaries, Gold Coast, NSW, Australia	University of Plymouth; Griffith University; Griffith University	Sheehan, EV (corresponding author), Univ Plymouth, Inst Marine, Plymouth PL4 8AA, Devon, England.	emma.sheehan@plymouth.ac.uk		Sheehan, Emma/0000-0002-1066-8237; Gall, Sarah/0000-0002-1187-3267; Attrill, Martin/0000-0002-4039-031X	Department for Environment, Food and Rural Affairs (United Kingdom)	Department for Environment, Food and Rural Affairs (United Kingdom)(Department for Environment, Food & Rural Affairs (DEFRA))	The Department for Environment, Food and Rural Affairs (United Kingdom) funded this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGARDY MT, 1994, TRENDS ECOL EVOL, V9, P267, DOI 10.1016/0169-5347(94)90297-6; Allison GW, 1998, ECOL APPL, V8, pS79, DOI 10.1890/1051-0761(1998)8[S79:MRANBN]2.0.CO;2; Anderson MJ, 2004, J EXP MAR BIOL ECOL, V305, P191, DOI 10.1016/j.jembe.2003.12.011; Anderson MJ, 2001, CAN J FISH AQUAT SCI, V58, P626, DOI 10.1139/cjfas-58-3-626; Anderson MJ, 2003, J STAT COMPUT SIM, V73, P85, DOI 10.1080/00949650215733; Auster Peter J., 1996, Reviews in Fisheries Science, V4, P185; Auster Peter J., 2000, Northeastern Naturalist, V7, P419, DOI 10.1656/1092-6194(2000)007[0419:MPAFTT]2.0.CO;2; Babcock RC, 2010, P NATL ACAD SCI USA, V107, P18256, DOI 10.1073/pnas.0908012107; Babcock RC, 1999, MAR ECOL PROG SER, V189, P125, DOI 10.3354/meps189125; Beaumont NJ, 2009, EVOL BIOL, V36, P256, DOI 10.1007/s11692-008-9047-2; Beukers-Stewart BD, 2005, MAR ECOL PROG SER, V298, P189, DOI 10.3354/meps298189; Blyth RE, 2004, J APPL ECOL, V41, P951, DOI 10.1111/j.0021-8901.2004.00945.x; Botsford LW, 1997, SCIENCE, V277, P509, DOI 10.1126/science.277.5325.509; Bradshaw C, 2003, MAR BIOL, V143, P783, DOI 10.1007/s00227-003-1115-7; Bradshaw C, 2001, HYDROBIOLOGIA, V465, P129, DOI 10.1023/A:1014573731609; Clarke KR, 2006, MAR ECOL PROG SER, V320, P11, DOI 10.3354/meps320011; Clarke KR., 2001, CHANGE MARINE COMMUN, V2; Claudet J, 2008, ECOL LETT, V11, P481, DOI 10.1111/j.1461-0248.2008.01166.x; Cocito S, 2001, FACIES, V45, P25, DOI 10.1007/BF02668102; DAYTON PK, 1995, AQUAT CONSERV, V5, P205, DOI 10.1002/aqc.3270050305; De Groot S.J, 1994, ENV IMPACT BOTTOM GE; Elliott M, 2007, ESTUAR COAST SHELF S, V74, P349, DOI 10.1016/j.ecss.2007.05.034; Foden J, 2010, MAR ECOL PROG SER, V411, P259, DOI 10.3354/meps08662; Freese L, 1999, MAR ECOL PROG SER, V182, P119, DOI 10.3354/meps182119; Gaston KJ, 2008, ANNU REV ECOL EVOL S, V39, P93, DOI 10.1146/annurev.ecolsys.39.110707.173529; Gauthier C, 2008, COMP BIOCHEM PHYS A, V151, P526, DOI 10.1016/j.cbpa.2008.07.010; Gell FR, 2003, TRENDS ECOL EVOL, V18, P448, DOI 10.1016/S0169-5347(03)00189-7; Glasby TM, 1997, AUST J ECOL, V22, P448, DOI 10.1111/j.1442-9993.1997.tb00696.x; Grecian WJ, 2010, IBIS, V152, P683, DOI 10.1111/j.1474-919X.2010.01048.x; Halpern BS, 2003, ECOL APPL, V13, pS117; Halpern BS, 2003, OC 2003 P, V1; Hiddink JG, 2006, ECOSYSTEMS, V9, P1190, DOI 10.1007/s10021-005-0164-9; Hiddink JG, 2008, CAN J FISH AQUAT SCI, V65, P1393, DOI 10.1139/F08-064; Hinz H, 2011, MAR ECOL PROG SER, V432, P91, DOI 10.3354/meps09166; Hiscock K., 2007, MARINE BIODIVERSITY; Idjadi JA, 2006, CORAL REEFS, V25, P209, DOI 10.1007/s00338-006-0088-7; Jackson D, 2000, HDB UK STATUS EC HAB, P180; Jackson E., 2008, IDENTIFICATION INDIC; Jennings S, 1998, ADV MAR BIOL, V34, P201, DOI 10.1016/S0065-2881(08)60212-6; Jennings S, 1996, AMBIO, V25, P44; Kaiser MJ, 1996, J ANIM ECOL, V65, P348, DOI 10.2307/5881; Langmead O, 2010, ASSESSMENT LONG TERM; McClanahan TR, 2007, ECOL APPL, V17, P1055, DOI 10.1890/06-1450; McClanahan TR, 2005, MAR ECOL PROG SER, V294, P241, DOI 10.3354/meps294241; McKinney F.K., 1989, BRYOZOAN EVOLUTION; Mumby PJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008657; Murawski SA, 2000, B MAR SCI, V66, P775; Parsons DM, 2004, MAR FRESHWATER RES, V55, P257, DOI 10.1071/MF03190; Roberts CM, 2005, PHILOS T R SOC B, V360, P123, DOI 10.1098/rstb.2004.1578; Shears NT, 2002, OECOLOGIA, V132, P131, DOI 10.1007/s00442-002-0920-x; Sheehan EV, 2013, MAR POLLUT BULL, V76, P194, DOI 10.1016/j.marpolbul.2013.09.004; Sheehan EV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014461; Smith F, 1999, ECOLOGY, V80, P51, DOI 10.2307/176979; Stevens T, MONITORING IN PRESS; Stokesbury KDE, 2004, J SHELLFISH RES, V23, P33; Walters K, 2006, J EXP MAR BIOL ECOL, V330, P81, DOI 10.1016/j.jembe.2005.12.018	56	48	48	4	107	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83883	10.1371/journal.pone.0083883	http://dx.doi.org/10.1371/journal.pone.0083883			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391841	Green Submitted, Green Published, gold			2022-12-25	WOS:000329325200139
J	Vecsler, M; Lazar, I; Tzur, A				Vecsler, Manuela; Lazar, Itay; Tzur, Amit			Using Standard Optical Flow Cytometry for Synchronizing Proliferating Cells in the G1 Phase	PLOS ONE			English	Article							SIZE HOMEOSTASIS; MITOSIS; UBIQUITIN; COMPLEX; GROWTH	Cell cycle research greatly relies on synchronization of proliferating cells. However, effective synchronization of mammalian cells is commonly achieved by long exposure to one or more cell cycle blocking agents. These chemicals are, by definition, hazardous (some more than others), pose uneven cell cycle arrest, thus introducing unwanted variables. The challenge of synchronizing proliferating cells in G1 is even greater; this process typically involves the release of drug-arrested cells into the cycle that follows, a heterogeneous process that can truly limit synchronization. Moreover, drug-based synchronization decouples the cell cycle from cell growth in ways that are understudied and intolerable for those who investigate the relationship between these two processes. In this study we showed that cell size, as approximated by a single light-scatter parameter available in all standard sorters, can be used for synchronizing proliferating mammalian cells in G1 with minimal or no risk to either the cell cycle or cell growth. The power and selectivity of our method are demonstrated for human HEK293 cells that, despite their many advantages, are suboptimal for synchronization, let alone in G1. Our approach is readily available, simple, fast, and inexpensive; it is independent of any drugs or dyes, and nonhazardous. These properties are relevant for the study of the mammalian cell cycle, specifically in the context of G1 and cell growth.	[Vecsler, Manuela; Lazar, Itay; Tzur, Amit] Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, Ramat Gan, Israel; [Vecsler, Manuela; Tzur, Amit] Bar Ilan Univ, Adv Mat & Nanotechnol Inst, Ramat Gan, Israel	Bar Ilan University; Bar Ilan University	Tzur, A (corresponding author), Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, Ramat Gan, Israel.	amit.tzur@biu.ac.il			Marie Curie International Reintegration Grant [PIRG-GA-2010-277062]; Israeli Centers of Research Excellence (I-CORE), Gene Regulation in Complex Human Disease, Center [41/11]; Israel Cancer Research Fund (ICRF) postdoctoral fellowship	Marie Curie International Reintegration Grant(European Commission); Israeli Centers of Research Excellence (I-CORE), Gene Regulation in Complex Human Disease, Center; Israel Cancer Research Fund (ICRF) postdoctoral fellowship	Funding by the Marie Curie International Reintegration Grant no. PIRG-GA-2010-277062 (A. T.); the Israeli Centers of Research Excellence (I-CORE), Gene Regulation in Complex Human Disease, Center no. 41/11 (A. T.); and the Israel Cancer Research Fund (ICRF) postdoctoral fellowship (M. V.) is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cooper S, 2006, CELL TISSUE RES, V324, P237, DOI 10.1007/s00441-005-0118-8; Cooper S, 2003, CELL MOL LIFE SCI, V60, P1099, DOI 10.1007/s00018-003-2253-2; GORDON CN, 1977, J BACTERIOL, V129, P97, DOI 10.1128/JB.129.1.97-100.1977; KING RW, 1995, CELL, V81, P279, DOI 10.1016/0092-8674(95)90338-0; LeBleu VS, 2006, CYTOTECHNOLOGY, V51, P149, DOI 10.1007/s10616-006-9024-5; McGarry TJ, 1998, CELL, V93, P1043, DOI 10.1016/S0092-8674(00)81209-X; Pfleger CM, 2000, GENE DEV, V14, P655; Shaw J, 2012, LAB CHIP, V12, P2656, DOI [10.1039/c21c40277g, 10.1039/c2lc40277g]; Son S, 2012, NAT METHODS, V9, P910, DOI 10.1038/nmeth.2133; SUDAKIN V, 1995, MOL BIOL CELL, V6, P185, DOI 10.1091/mbc.6.2.185; Sung YJ, 2013, P NATL ACAD SCI USA, V110, P16687, DOI 10.1073/pnas.1315290110; Tzur A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016053; Tzur A, 2009, SCIENCE, V325, P167, DOI 10.1126/science.1174294; Vassilev LT, 2006, CELL CYCLE, V5, P2555, DOI 10.4161/cc.5.22.3463; Walker Graeme M., 1999, Methods in Cell Science, V21, P87, DOI 10.1023/A:1009824520278	15	16	16	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83935	10.1371/journal.pone.0083935	http://dx.doi.org/10.1371/journal.pone.0083935			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391848	Green Published, Green Submitted, gold			2022-12-25	WOS:000329325200146
J	Verani, JR; McCracken, J; Arvelo, W; Estevez, A; Lopez, MR; Reyes, L; Moir, JC; Bernart, C; Moscoso, F; Gray, J; Olsen, SJ; Lindblade, KA				Verani, Jennifer R.; McCracken, John; Arvelo, Wences; Estevez, Alejandra; Renee Lopez, Maria; Reyes, Lissette; Carlos Moir, Juan; Bernart, Chris; Moscoso, Fabiola; Gray, Jennifer; Olsen, Sonja J.; Lindblade, Kim A.			Surveillance for Hospitalized Acute Respiratory Infection in Guatemala	PLOS ONE			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; SYNCYTIAL VIRUS-INFECTIONS; CLINICAL CHARACTERISTICS; YOUNG-CHILDREN; EPIDEMIOLOGY; DIAGNOSIS; ETIOLOGY; RADIOGRAPHS; POPULATION; AMERICA	Acute respiratory infections (ARI) are an important cause of illness and death worldwide, yet data on the etiology of ARI and the population-level burden in developing countries are limited. Surveillance for ARI was conducted at two hospitals in Guatemala. Patients admitted with at least one sign of acute infection and one sign or symptom of respiratory illness met the criteria for a case of hospitalized ARI. Nasopharyngeal/oropharyngeal swabs were collected and tested by polymerase chain reaction for adenovirus, parainfluenza virus types 1,2 and 3, respiratory syncytial virus, influenza A and B viruses, human metapneumovirus, Chlamydia pneumioniae, and Mycoplasma pneumoniae. Urine specimens were tested for Streptococcus pneumoniae antigen. Blood culture and chest radiograph were done at the discretion of the treating physician. Between November 2007 and December 2011, 3,964 case-patients were enrolled. While cases occurred among all age groups, 2,396 (60.4%) cases occurred in children <5 years old and 463 (11.7%) among adults >= 65 years old. Viruses were found in 52.6% of all case-patients and 71.8% of those aged <1 year old; the most frequently detected was respiratory syncytial virus, affecting 26.4% of case-patients. Urine antigen testing for Streptococcus pneumoniae performed for case-patients >= 15 years old was positive in 15.1% of those tested. Among 2,364 (59.6%) of case-patients with a radiograph, 907 (40.0%) had findings suggestive of bacterial pneumonia. Overall, 230 (5.9%) case-patients died during the hospitalization. Using population denominators, the observed hospitalized ARI incidence was 128 cases per 100,000, with the highest rates seen among children <1 year old (1,703 per 100,000), followed by adults >= 65 years old (292 per 100,000). These data, which demonstrate a substantial burden of hospitalized ARI in Guatemala due to a variety of pathogens, can help guide public health policies aimed at reducing the burden of illness and death due to respiratory infections.	[Verani, Jennifer R.] Ctr Dis Control & Prevent, Resp Dis Branch, Atlanta, GA 30333 USA; [McCracken, John; Estevez, Alejandra; Renee Lopez, Maria; Bernart, Chris; Moscoso, Fabiola; Gray, Jennifer] Univ Valle Guatemala, Ctr Estudios Salud, Guatemala City, Guatemala; [Arvelo, Wences; Lindblade, Kim A.] Ctr Dis Control & Prevent, Reg Off Cent Amer & Panama, Int Emerging Infect Program, Guatemala City, Guatemala; [Arvelo, Wences; Lindblade, Kim A.] Ctr Dis Control & Prevent, Div Global Dis Detect & Emergency Response, Atlanta, GA USA; [Reyes, Lissette] Minist Salud Publ & Asistencia Social, Field Epidemiol Training Program, Guatemala City, Guatemala; [Reyes, Lissette] Minist Salud Publ & Asistencia Social, Area Salud Santa Rosa, Cuilapa, Guatemala; [Carlos Moir, Juan] Minist Salud Publ & Asistencia Social, Area Salud Quetzaltenango, Quetzaltenango, Guatemala; [Olsen, Sonja J.] Ctr Dis Control & Prevent, Influenza Div, Atlanta, GA USA	Centers for Disease Control & Prevention - USA; Universidad del Valle de Guatemala; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Verani, JR (corresponding author), Ctr Dis Control & Prevent, Resp Dis Branch, Atlanta, GA 30333 USA.	qzr7@cdc.gov		Lindblade, Kim/0000-0002-5593-0470	United States Centers for Disease Control and Prevention (CDC) [UO1 GH000028-02]	United States Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This publication was supported by Cooperative Agreement Number UO1 GH000028-02 from the United States Centers for Disease Control and Prevention (CDC). The CDC participated in all aspects of study design, data collection, data analysis and manuscript preparation.	Andrade AL, 2011, VACCINE; [Anonymous], 2005, TECHN UPD GUID INT M; Asturias Edwin J., 2003, Rev Panam Salud Publica, V14, P377, DOI 10.1590/S1020-49892003001100002; Berkley JA, 2010, JAMA-J AM MED ASSOC, V303, P2051, DOI 10.1001/jama.2010.675; Bruno R, 2009, NEW MICROBIOL, V32, P297; Carneiro BM, 2009, J MED VIROL, V81, P1814, DOI 10.1002/jmv.21555; Cherian T, 2005, B WORLD HEALTH ORGAN, V83, P353; Danovaro-Holliday MC, 2008, PLOS MED, V5, P530, DOI 10.1371/journal.pmed.0050087; Dean A., OPENEPI OPEN SOURCE; Debiaggi M, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-247; Deutscher M, 2012, J EPIDEMIOL GLOB HEA, V2, P73, DOI 10.1016/j.jegh.2012.03.001; Falsey AR, 2000, CLIN MICROBIOL REV, V13, P371, DOI 10.1128/CMR.13.3.371-384.2000; Feikin DR, 2013, PEDIATR INFECT DIS J, V32, pE14, DOI 10.1097/INF.0b013e31826fd39b; Feikin DR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043656; Gentile A, INT J INFECT DIS; Instituto Nacional de Estadistica, 2004, EST PROYECC POBL PER; Isturiz RE, 2010, INT J INFECT DIS, V14, pE852, DOI 10.1016/j.ijid.2010.02.2262; Jansen RR, 2011, J CLIN MICROBIOL, V49, P2631, DOI 10.1128/JCM.02094-10; JOKINEN C, 1993, AM J EPIDEMIOL, V137, P977, DOI 10.1093/oxfordjournals.aje.a116770; Juven T, 2004, EUR J PEDIATR, V163, P140, DOI 10.1007/s00431-003-1397-2; Klugman KP, 2008, CLIN INFECT DIS, V47, pS202, DOI 10.1086/591405; Kwofie TB, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-78; Langley GF, 2013, PEDIATR INFECT DIS J, V32, P629, DOI 10.1097/INF.0b013e318289e3bc; Langley GF, 2011, PEDIATR INFECT DIS J, V30, P510, DOI 10.1097/INF.0b013e3182184ae7; Lindblade KA, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-885; Lindblade KA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015826; Mathisen M, 2011, PEDIATR INFECT DIS J, V30, P1032, DOI 10.1097/INF.0b013e31822f845f; Mathisen Maria, 2010, Pediatr Infect Dis J, V29, pe1, DOI 10.1097/INF.0b013e3181c2a1b9; Matute AJ, 2006, INT J ANTIMICROB AG, V28, P423, DOI 10.1016/j.ijantimicag.2006.07.016; Morgan OW, 2010, INT C EM INF DIS ATL; Nair H, 2010, LANCET, V375, P1545, DOI 10.1016/S0140-6736(10)60206-1; Noyola DE, 2005, J MED MICROBIOL, V54, P969, DOI 10.1099/jmm.0.46052-0; Olsen SJ, 2006, INT J INFECT DIS, V10, P439, DOI 10.1016/j.ijid.2006.06.004; Reyes L, 2010, INFLUENZA OTHER RESP, V4, P129, DOI 10.1111/j.1750-2659.2010.00138.x; Ropero-Alvarez AM, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-361; Rudan I, 2004, B WORLD HEALTH ORGAN, V82, P895; Rudan I, 2008, B WORLD HEALTH ORGAN, V86, P408, DOI 10.2471/BLT.07.048769; Ruuskanen O, 2011, LANCET, V377, P1264, DOI 10.1016/S0140-6736(10)61459-6; Shafik CF, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-350; Singeton RJ, 2010, J MED VIROL, V82, P1282, DOI 10.1002/jmv.21790; Suzuki A, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-267; Thavagnanam S, 2010, ACTA PAEDIATR, V99, P394, DOI 10.1111/j.1651-2227.2009.01627.x; Tondella MLC, 2002, J CLIN MICROBIOL, V40, P575, DOI 10.1128/JCM.40.2.575-583.2002; Vernet G, 2011, CLIN MICROBIOL INFEC, V17, P1, DOI 10.1111/j.1469-0691.2011.03496.x; Watt JP, 2010, EPIDEMIOL INFECT, V138, P1146, DOI 10.1017/S0950268809991464; Werno AM, 2008, CLIN INFECT DIS, V46, P926, DOI 10.1086/528798; Whitehouse RW, 1999, J ROY SOC MED, V92, P178, DOI 10.1177/014107689909200404; World Health Organization, 2001, STAND INT CHEST RAD; World Health Organization/The United Nations Children's Fund, 2013, PREV DEATHS GLOB ACT; Zhang M, 1999, 99 GEN M AM SOC MICR	50	34	34	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83600	10.1371/journal.pone.0083600	http://dx.doi.org/10.1371/journal.pone.0083600			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391792	Green Published, gold			2022-12-25	WOS:000329325200089
J	Chiang, CC; Lin, CL; Tsai, YY; Peng, CL; Liao, YT; Sung, FC				Chiang, Chun-Chi; Lin, Cheng-Li; Tsai, Yi-Yu; Peng, Chiao-Ling; Liao, Ya-Tang; Sung, Fung-Chang			Patients with Blepharitis Are at Elevated Risk of Anxiety and Depression	PLOS ONE			English	Article							FILM LIPID LAYER; MEIBOMIAN GLAND; DRY EYE; ANDROGEN DEFICIENCY; GENDER-DIFFERENCES; SEX STEROIDS; INFLAMMATION; PREVALENCE; EPIDEMIOLOGY; PROFILES	Purpose: Population-based cohort study on the risk of anxiety and depression in patients with blepharitis is limited. This study evaluated whether blepharitis patients are at a higher risk of anxiety and depression. Design: A retrospective cohort study. Methods: We used the universal insurance claims data from 1997 to 2010 in Taiwan to identify annually patients with newly diagnosed blepharitis (N = 9764) and without the disease (N = 39056). Incidences, rate ratios (IRR) and hazard ratios (HR) of anxiety and depression were measured for both cohorts by baseline demographic characteristics and comorbidities until the end of 2010. Results: Compared with the non-blepharitis cohort, the blepharitis cohort had higher incidence of anxiety (15.9 vs. 9.5 per 1000 person-years), with an adjusted HR of 1.58 (95% confidence interval (CI) = 1.46-1.70). The incidence of depression was also higher in the blepharitis cohort (7.66 vs. 5.05 per 1000 person-years), with an adjusted HR of 1.42 (95% CI = 1.28-1.58). The blepharitis cohort to the non-blepharitis cohort IRR decreased from 1.73 in the first quartile to 1.32 in the 4th quartile for anxiety, and from 1.67 to 1.29 for depression. Conclusions: Patients with blepharitis are at elevated risks of anxiety and depression. The risk is higher in earlier period after the diagnosis of blepharitis, and declines by time, but remains significantly higher for those with blepharitis than those without blepharitis.	[Chiang, Chun-Chi; Tsai, Yi-Yu] China Med Univ Hosp, Dept Ophthalmol, Taichung, Taiwan; [Chiang, Chun-Chi; Tsai, Yi-Yu] China Med Univ, Sch Med, Taichung, Taiwan; [Lin, Cheng-Li; Peng, Chiao-Ling; Liao, Ya-Tang; Sung, Fung-Chang] China Med Univ Hosp, Management Off Hlth Data, Taichung, Taiwan; [Sung, Fung-Chang] China Med Univ, Coll Publ Hlth, Dept Publ Hlth, Taichung, Taiwan	China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan	Sung, FC (corresponding author), China Med Univ Hosp, Management Off Hlth Data, Taichung, Taiwan.	fcsung@mail.cmu.edu.tw			Executive Yuan National Sciences Council [NSC 100-2621-M-039-001]; China Medical University Hospital [1MS1, DMR-101-075]; Taiwan Department of Health Clinical Trial and Research Center for Excellence [DOH101-TD-B-111-004]; Cancer Research Center of Excellence [DOH101-TD-C-111-005]	Executive Yuan National Sciences Council; China Medical University Hospital; Taiwan Department of Health Clinical Trial and Research Center for Excellence; Cancer Research Center of Excellence	This study was supported in part by the Executive Yuan National Sciences Council (grant numbers NSC 100-2621-M-039-001), China Medical University Hospital (grant number 1MS1 and DMR-101-075), and Taiwan Department of Health Clinical Trial and Research Center for Excellence (grant number DOH101-TD-B-111-004) and Cancer Research Center of Excellence (DOH101-TD-C-111-005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AAO 2008 American Academy of Ophthalmology Retina Panel, 2008, PREF PRACT PATT GUID; Aggarwal BB, 2006, BIOCHEM PHARMACOL, V72, P1605, DOI 10.1016/j.bcp.2006.06.029; Anisman H, 2008, PROG NEUROBIOL, V85, P1, DOI 10.1016/j.pneurobio.2008.01.004; Cheng TM, 2009, 6 COUNTRIES 6 REFORM, P171, DOI [10.1142/9789814261593_000710, 1142/9789814261593_0007, DOI 10.1142/9789814261593_0007]; Cohen CI, 2006, PSYCHIAT SERV, V57, P1719, DOI 10.1176/appi.ps.57.12.1719; Dantzer R, 2008, NAT REV NEUROSCI, V9, P46, DOI 10.1038/nrn2297; Foulks GN, 2007, SURV OPHTHALMOL, V52, P369, DOI 10.1016/j.survophthal.2007.04.009; Foulks Gary N, 2003, Ocul Surf, V1, P107; Henderson AS, 1998, PSYCHOL MED, V28, P1321, DOI 10.1017/S0033291798007570; Hybels CF, 2003, CLIN GERIATR MED, V19, P663, DOI 10.1016/S0749-0690(03)00042-9; Jeste DV, 2005, BIOL PSYCHIAT, V58, P265, DOI 10.1016/j.biopsych.2005.02.004; Kessler R.C., 2006, WOMEN DEPRESSION HDB, P22, DOI DOI 10.1017/CBO9780511841262.004; Korb DR, 2005, OPTOMETRY VISION SCI, V82, P594, DOI 10.1097/01.opx.0000171818.01353.8c; Kuehner C, 2003, ACTA PSYCHIAT SCAND, V108, P163, DOI 10.1034/j.1600-0447.2003.00204.x; Lam H, 2009, AM J OPHTHALMOL, V147, P198, DOI 10.1016/j.ajo.2008.08.032; Lemp MA, 2009, OCUL SURF, V7, pS1, DOI 10.1016/S1542-0124(12)70620-1; MCCULLEY JP, 1982, OPHTHALMOLOGY, V89, P1173; McDonald MB, 2009, OCUL SURF, V7, pS17, DOI 10.1016/S1542-0124(12)70622-5; Mehta KM, 2003, J AM GERIATR SOC, V51, P499, DOI 10.1046/j.1532-5415.2003.51158.x; Miller AH, 2009, BRAIN BEHAV IMMUN, V23, P149, DOI 10.1016/j.bbi.2008.08.006; Moussavi S, 2007, LANCET, V370, P851, DOI 10.1016/S0140-6736(07)61415-9; Nemet AY, 2011, OPHTHALMOLOGY, V118, P1062, DOI 10.1016/j.ophtha.2010.10.015; Palanza P, 2001, NEUROSCI BIOBEHAV R, V25, P219, DOI 10.1016/S0149-7634(01)00010-0; Pflugfelder SC, 2000, CORNEA, V19, P644, DOI 10.1097/00003226-200009000-00009; Pigott TA, 1999, J CLIN PSYCHIAT, V60, P4; Pisella PJ, 2000, OPHTHALMOLOGY, V107, P1841, DOI 10.1016/S0161-6420(00)00347-X; Raison CL, 2006, TRENDS IMMUNOL, V27, P24, DOI 10.1016/j.it.2005.11.006; Ridker PM, 2007, NUTR REV, V65, pS253, DOI [10.1111/j.1753-4887.2007.tb00372.x, 10.1301/nr.2007.dec.S253-S259]; Rubin M, 2006, J OCUL PHARMACOL TH, V22, P47, DOI 10.1089/jop.2006.22.47; Salim S, 2012, ADV PROTEIN CHEM STR, V88, P1, DOI 10.1016/B978-0-12-398314-5.00001-5; Solomon A, 2001, INVEST OPHTH VIS SCI, V42, P2283; Sullivan BD, 2002, ADV EXP MED BIOL, V506, P449; Sullivan BD, 2002, ARCH OPHTHALMOL-CHIC, V120, P1689; Sullivan BD, 2000, J CLIN ENDOCR METAB, V85, P4866, DOI 10.1210/jc.85.12.4866; Sullivan DA, 2000, INVEST OPHTH VIS SCI, V41, P3732; Sullivan DA, 1999, INVEST OPHTH VIS SCI, V40, P1261; Sullivan DA, 1998, ADV EXP MED BIOL, V438, P327; Sullivan DA, 2002, ADV EXP MED BIOL, V506, P389; Sullivan DA, 2002, ANN NY ACAD SCI, V966, P211, DOI 10.1111/j.1749-6632.2002.tb04217.x; Sullivan DA, 2009, MOL VIS, V15, P1553; Vogelzangs N, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.8; Warrington TP, 2006, MAYO CLIN PROC, V81, P1361, DOI 10.4065/81.10.1361; Weissman MM, 1996, JAMA-J AM MED ASSOC, V276, P293, DOI 10.1001/jama.276.4.293; Zorrilla EP, 2001, BRAIN BEHAV IMMUN, V15, P199, DOI 10.1006/brbi.2000.0597	44	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e83335	10.1371/journal.pone.0083335	http://dx.doi.org/10.1371/journal.pone.0083335			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386181	gold, Green Submitted, Green Published			2022-12-25	WOS:000329194700034
J	Ma, ZG; Li, CF; Pan, GQ; Li, ZH; Han, B; Xu, JS; Lan, XQ; Chen, J; Yang, DL; Chen, QM; Sang, Q; Ji, XC; Li, T; Long, MX; Zhou, ZY				Ma, Zhengang; Li, Chunfeng; Pan, Guoqing; Li, Zhihong; Han, Bing; Xu, Jinshan; Lan, Xiqian; Chen, Jie; Yang, Donglin; Chen, Quanmei; Sang, Qi; Ji, Xiaocun; Li, Tian; Long, Mengxian; Zhou, Zeyang			Genome-Wide Transcriptional Response of Silkworm (Bombyx mori) to Infection by the Microsporidian Nosema bombycis	PLOS ONE			English	Article							SPORE WALL PROTEIN; JUVENILE-HORMONE; GENE-EXPRESSION; IMMUNE-RESPONSE; DROSOPHILA-MELANOGASTER; DOMESTICATED SILKWORM; MOLECULAR ACTIONS; POLAR TUBE; IDENTIFICATION; INVASION	Microsporidia have attracted much attention because they infect a variety of species ranging from protists to mammals, including immunocompromised patients with AIDS or cancer. Aside from the study on Nosema ceranae, few works have focused on elucidating the mechanism in host response to microsporidia infection. Nosema bombycis is a pathogen of silkworm pebrine that causes great economic losses to the silkworm industry. Detailed understanding of the host (Bombyx mori) response to infection by N. bombycis is helpful for prevention of this disease. A genome-wide survey of the gene expression profile at 2, 4, 6 and 8 days post-infection by N. bombycis was performed and results showed that 64, 244, 1,328, 1,887 genes were induced, respectively. Up to 124 genes, which are involved in basal metabolism pathways, were modulated. Notably, B. mori genes that play a role in juvenile hormone synthesis and metabolism pathways were induced, suggesting that the host may accumulate JH as a response to infection. Interestingly, N. bombycis can inhibit the silkworm serine protease cascade melanization pathway in hemolymph, which may be due to the secretion of serpins in the microsporidia. N. bombycis also induced up-regulation of several cellular immune factors, in which CTL11 has been suggested to be involved in both spore recognition and immune signal transduction. Microarray and real-time PCR analysis indicated the activation of silkworm Toll and JAK/STAT pathways. The notable up-regulation of antimicrobial peptides, including gloverins, lebocins and moricins, strongly indicated that antimicrobial peptide defense mechanisms were triggered to resist the invasive microsporidia. An analysis of N. bombycis-specific response factors suggested their important roles in anti-microsporidia defense. Overall, this study primarily provides insight into the potential molecular mechanisms for the host-parasite interaction between B. mori and N. bombycis and may provide a foundation for further work on host-parasite interaction between insects and microsporidia.	[Ma, Zhengang; Li, Chunfeng; Pan, Guoqing; Li, Zhihong; Han, Bing; Lan, Xiqian; Chen, Jie; Yang, Donglin; Chen, Quanmei; Sang, Qi; Ji, Xiaocun; Li, Tian; Long, Mengxian; Zhou, Zeyang] Southwest Univ, State Key Lab Silkworm Genome Biol, Chongqing, Peoples R China; [Xu, Jinshan; Zhou, Zeyang] Chongqing Normal Univ, Coll Life Sci, Chongqing, Peoples R China; [Ma, Zhengang; Li, Chunfeng; Pan, Guoqing; Li, Zhihong; Han, Bing; Chen, Jie; Yang, Donglin; Chen, Quanmei; Sang, Qi; Ji, Xiaocun; Li, Tian; Long, Mengxian; Zhou, Zeyang] Southwest Univ, Key Lab Sericulture Funct Genom & Biotechnol, Minist Agr, Chongqing, Peoples R China	Southwest University - China; Chongqing Normal University; Ministry of Agriculture & Rural Affairs; Southwest University - China	Zhou, ZY (corresponding author), Southwest Univ, State Key Lab Silkworm Genome Biol, Chongqing, Peoples R China.	zyzhou@swu.edu.cn			National Basic Research Program of China (973 Program) [2012CB114604]; Natural Science Foundation of China [30930067, 31072089, 31001036]; National High-Tech R&D Program (863 Program) [2012AA101301, 2013AA102507]; Doctorial Innovation Fund of Southwest University [KB2010004]; Natural Science Foundation Program of Chongqing [CSTC2011jjA0533]; Natural Science Foundation Project of China SWU [SWUB2008008]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High-Tech R&D Program (863 Program)(National High Technology Research and Development Program of China); Doctorial Innovation Fund of Southwest University; Natural Science Foundation Program of Chongqing; Natural Science Foundation Project of China SWU(National Natural Science Foundation of China (NSFC))	This work was supported by the National Basic Research Program of China (973 Program, No. 2012CB114604, http://www.most.gov.cn/eng/), the Natural Science Foundation of China (No. 30930067, No. 31072089 and No. 31001036, http://www.nsfc.gov.cn/Portal0/default166.htm), the National High-Tech R&D Program (863 Program, No. 2012AA101301 and No. 2013AA102507, http://www.most.gov.cn/eng/), the Doctorial Innovation Fund of Southwest University (No. KB2010004 for ZM, http://www.swu.edu.cn/english/), the Natural Science Foundation Program of Chongqing (No. CSTC2011jjA0533, http://www.ctin.ac.cn/Index.aspx), the Natural Science Foundation Project of China SWU (SWUB2008008 for XL, http://www.swu.edu.cn/english/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agaisse H, 2004, IMMUNOL REV, V198, P72, DOI 10.1111/j.0105-2896.2004.0133.x; ASHIDA M, 1990, RES IMMUNOL, V141, P908, DOI 10.1016/0923-2494(90)90191-Z; Bao YY, 2011, INSECT BIOCHEM MOLEC, V41, P696, DOI 10.1016/j.ibmb.2011.05.001; Bede JC, 2001, PLANT PHYSIOL, V127, P584, DOI 10.1104/pp.010264; Bigliardi E, 2001, MICROBES INFECT, V3, P373, DOI 10.1016/S1286-4579(01)01393-4; BLALOCK JE, 1984, J IMMUNOL, V132, P1067; Borghetti P, 2009, VET IMMUNOL IMMUNOP, V130, P141, DOI 10.1016/j.vetimm.2009.01.013; Bouzahzah B, 2010, INFECT IMMUN, V78, P2745, DOI 10.1128/IAI.01205-09; BREY PT, 1993, P NATL ACAD SCI USA, V90, P6275, DOI 10.1073/pnas.90.13.6275; Bulet P, 1999, DEV COMP IMMUNOL, V23, P329, DOI 10.1016/S0145-305X(99)00015-4; Chaimanee V, 2012, J INSECT PHYSIOL, V58, P1090, DOI 10.1016/j.jinsphys.2012.04.016; Chaudhuri A, 2008, BLOOD, V111, P2062, DOI 10.1182/blood-2007-05-091207; Dang XQ, 2013, J INVERTEBR PATHOL, V112, P166, DOI 10.1016/j.jip.2012.10.009; Didier ES, 1998, ADV PARASIT, V40, P283, DOI 10.1016/S0065-308X(08)60125-6; Dussaubat C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037017; Ellis J, 2010, MOL BIOCHEM PARASIT, V174, P117, DOI 10.1016/j.molbiopara.2010.08.007; FINLAYSON LH, 1957, NATURE, V180, P713, DOI 10.1038/180713b0; FISHER FM, 1964, BIOL BULL, V126, P235, DOI 10.2307/1539522; Flatt T, 2008, J EXP BIOL, V211, P2712, DOI 10.1242/jeb.014878; Freitak D, 2003, P ROY SOC B-BIOL SCI, V270, pS220, DOI 10.1098/rsbl.2003.0069; Frixione E, 1997, J EUKARYOT MICROBIOL, V44, P109, DOI 10.1111/j.1550-7408.1997.tb05946.x; Gatehouse HS, 1998, J INVERTEBR PATHOL, V71, P97, DOI 10.1006/jipa.1997.4737; Glinski Zdzislaw, 1997, Archivum Immunologiae et Therapiae Experimentalis, V45, P149; Grace Michael J., 2004, Antiviral Chemistry & Chemotherapy, V15, P287; HARA S, 1995, J BIOL CHEM, V270, P29923, DOI 10.1074/jbc.270.50.29923; Herve C, 1996, J MOL BIOL, V258, P778, DOI 10.1006/jmbi.1996.0286; Hetru C, 2003, J INFECT DIS, V187, pS327, DOI 10.1086/374758; Hinnebusch BJ, 2002, SCIENCE, V296, P733, DOI 10.1126/science.1069972; Huang L, 2009, INSECT MOL BIOL, V18, P517, DOI 10.1111/j.1365-2583.2009.00896.x; HUANG L, 2010, THESIS SW U CHONGQIN, P43; Huang LL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008098; Law RHP, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-5-216; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Li YH, 2009, INT J PARASITOL, V39, P391, DOI 10.1016/j.ijpara.2008.08.011; Li Z, 2012, EUKARYOT CELL, V11, P229, DOI 10.1128/EC.05127-11; Liu HD, 2008, J INVERTEBR PATHOL, V99, P235, DOI 10.1016/j.jip.2008.06.012; Luo H, 2001, BIOESSAYS, V23, P1138, DOI 10.1002/bies.10016; Muniz CA, 2007, CELL MICROBIOL, V9, P106, DOI 10.1111/j.1462-5822.2006.00771.x; NAPPI AJ, 1993, PIGM CELL RES, V6, P117, DOI 10.1111/j.1600-0749.1993.tb00590.x; Neill JD, 2003, BIOLOGICALS, V31, P97, DOI 10.1016/S1045-1056(03)00022-8; Nishiguchi M, 2002, MOL GENET GENOMICS, V267, P506, DOI 10.1007/s00438-002-0683-4; O'Shea JJ, 2002, CELL, V109, pS121, DOI 10.1016/S0092-8674(02)00701-8; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Pan GQ, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-186; RIDDIFORD LM, 1994, ADV INSECT PHYSIOL, V24, P213, DOI 10.1016/S0065-2806(08)60084-3; Rosenblum EB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006494; Roxstrom-Lindquist K, 2004, EMBO REP, V5, P207, DOI 10.1038/sj.embor.7400073; Seleznev K.V., 2003, Parazitologiya (St. Petersburg), V37, P428; Shinoda T, 2003, P NATL ACAD SCI USA, V100, P11986, DOI 10.1073/pnas.2134232100; Strand MR, 2008, INSECT IMMUNOLOGY, P25, DOI 10.1016/S0965-1748(02)00092-9; Takase H, 2009, DEV COMP IMMUNOL, V33, P789, DOI 10.1016/j.dci.2009.01.005; Tanaka H, 2008, INSECT BIOCHEM MOLEC, V38, P1087, DOI 10.1016/j.ibmb.2008.09.001; Tian L, 2010, J MOL CELL BIOL, V2, P255, DOI 10.1093/jmcb/mjq020; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Vieira CU, 2008, ARCH INSECT BIOCHEM, V67, P97, DOI 10.1002/arch.20224; Wang F, 2006, VIRUS GENES, V33, P351, DOI 10.1007/s11262-006-0075-7; Wang Y, 2007, DEV COMP IMMUNOL, V31, P1002, DOI 10.1016/j.dci.2007.01.001; Watanabe A, 2006, J IMMUNOL, V177, P4594, DOI 10.4049/jimmunol.177.7.4594; WEIDNER E, 1982, J CELL BIOL, V93, P970, DOI 10.1083/jcb.93.3.970; WITTNER M, 1999, MICROSPORIDIA MICROS, P447; Wyatt GR, 1996, ADV INSECT PHYSIOL, V26, P1, DOI 10.1016/S0065-2806(08)60030-2; Xia QY, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r162; Xia QY, 2004, SCIENCE, V306, P1937, DOI 10.1126/science.1102210; Xu YJ, 2005, INT J PARASITOL, V35, P941, DOI 10.1016/j.ijpara.2005.04.003; Xu YJ, 2006, INFECT IMMUN, V74, P239, DOI 10.1128/IAI.74.1.239-247.2006; Yang WY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018109; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15; Yang YL, 2010, INFECT IMMUN, V78, P1040, DOI 10.1128/IAI.01009-09; Zhang QR, 2005, INSECT BIOCHEM MOLEC, V35, P153, DOI 10.1016/j.ibmb.2004.10.010; Zhou YJ, 2002, BIOSCI BIOTECH BIOCH, V66, P1488, DOI 10.1271/bbb.66.1488; Zouali M, 2001, ARCH IMMUNOL THER EX, V49, P361	71	47	58	2	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e84137	10.1371/journal.pone.0084137	http://dx.doi.org/10.1371/journal.pone.0084137			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386341	gold, Green Published, Green Submitted			2022-12-25	WOS:000329194700093
J	Hufnagel, TC; Vempati, UK; Almer, JD				Hufnagel, Todd C.; Vempati, Uday K.; Almer, Jonathan D.			Crack-Tip Strain Field Mapping and the Toughness of Metallic Glasses	PLOS ONE			English	Article							FRACTURE MORPHOLOGY; BEHAVIOR; DUCTILE; DEFORMATION; BRITTLENESS; PLASTICITY; MECHANISM	We have used high-energy x-ray scattering to map the strain fields around crack tips in fracture specimens of a bulk metallic glass under load at room temperature and below. From the measured strain fields we can calculate the components of the stress tensor as a function of position and determine the size and shape of the plastic process zone around the crack tip. Specimens tested at room temperature develop substantial plastic zones and achieve high stress intensities ((K) over bar (If) = 76MPam(1/2)) prior to fracture. Specimens tested at cryogenic temperatures fail at reduced but still substantial stress intensities ((K) over bar (If) = 39MPam(1/2)) and show only limited evidence of crack-tip plasticity. We propose that the difference in behavior is associated with changes in the flow stress and elastic constants, which influence the number density of shear bands in the plastic zone and thus the strain required to initiate fracture on an individual band. A secondary effect is a change in the triaxial state of stress around the crack tip due to the temperature dependence of Poisson's ratio. It is likely that this ability to map elastic strains on the microscale will be useful in other contexts, although interpreting shifts in the position of the scattering peaks in amorphous materials in terms of elastic strains must be done with caution.	[Hufnagel, Todd C.; Vempati, Uday K.] Johns Hopkins Univ, Dept Mat Sci & Engn, Baltimore, MD 21218 USA; [Almer, Jonathan D.] Argonne Natl Lab, Adv Photon Source, Argonne, IL 60439 USA	Johns Hopkins University; United States Department of Energy (DOE); Argonne National Laboratory	Hufnagel, TC (corresponding author), Johns Hopkins Univ, Dept Mat Sci & Engn, Baltimore, MD 21218 USA.	hufnagel@jhu.edu	Hufnagel, Todd C/A-3309-2010	Hufnagel, Todd C/0000-0002-6373-9377	National Science Foundation [0705517, 1107838, 1066293]; hospitality of the Aspen Center for Physics; U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-06CH1135]; Division Of Materials Research [1107838] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); hospitality of the Aspen Center for Physics; U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); Division Of Materials Research(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	Funding from the National Science Foundation under grants 0705517, 1107838, 1066293 and the hospitality of the Aspen Center for Physics. Use of the Advanced Photon Source was supported by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract No. DE-AC02-06CH1135. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand L, 2005, J MECH PHYS SOLIDS, V53, P1362, DOI 10.1016/j.jmps.2004.12.006; Anderson T.L., 1995, FRACTURE MECH FUNDAM; ARGON AS, 1976, MATER SCI ENG, V23, P219, DOI 10.1016/0025-5416(76)90198-1; Choi-Yim H, 2002, ACTA MATER, V50, P2737, DOI 10.1016/S1359-6454(02)00113-1; Demetriou MD, 2011, NAT MATER, V10, P123, DOI [10.1038/nmat2930, 10.1038/NMAT2930]; Fitzpatrick M., 2003, ANAL RESIDUAL STRESS; Flores KM, 1999, SCRIPTA MATER, V41, P937, DOI 10.1016/S1359-6462(99)00243-2; Gilbert CJ, 1999, METALL MATER TRANS A, V30, P1739, DOI 10.1007/s11661-999-0173-y; Gu X, 2002, J NON-CRYST SOLIDS, V311, P77, DOI 10.1016/S0022-3093(02)01193-6; Hammersley AP, 1996, HIGH PRESSURE RES, V14, P235, DOI 10.1080/08957959608201408; Hufnagel TC, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.064204; Hufnagel TC, 2002, J MATER RES, V17, P1441, DOI 10.1557/JMR.2002.0214; Kawashima A, 2005, MATER TRANS, V46, P1725, DOI 10.2320/matertrans.46.1725; KELLY A, 1967, PHILOS MAG, V15, P567, DOI 10.1080/14786436708220903; Lewandowski JJ, 2005, PHIL MAG LETT, V85, P77, DOI 10.1080/09500830500080474; Li HQ, 2006, ADV MATER, V18, P752, DOI 10.1002/adma.200501990; Liu XF, 2010, SCRIPTA MATER, V62, P254, DOI 10.1016/j.scriptamat.2009.11.010; Mear FO, 2008, PHIL MAG LETT, V88, P757, DOI 10.1080/09500830802235776; Nye J.F., 1984, PHYS PROPERTIES CRYS; PICK M, 1979, NATURE, V281, P658, DOI 10.1038/281658a0; Poulsen HF, 2005, NAT MATER, V4, P33, DOI 10.1038/nmat1266; Ravichandran G, 2005, ACTA MATER, V53, P4087, DOI 10.1016/j.actamat.2005.05.011; Rice J.R., 1967, ASTM STP, P247, DOI DOI 10.1520/STP47234S; Schneibel JH, 2001, METALL MATER TRANS A, V32, P2819, DOI 10.1007/s11661-001-1032-7; Schroers J, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.255506; Schuh CA, 2007, ACTA MATER, V55, P4067, DOI 10.1016/j.actamat.2007.01.052; SPAEPEN F, 1975, ACTA METALL MATER, V23, P615, DOI 10.1016/0001-6160(75)90102-9; STEIF PS, 1983, J MECH PHYS SOLIDS, V31, P359, DOI 10.1016/0022-5096(83)90005-4; Suh JY, 2010, J MATER RES, V25, P982, DOI 10.1557/JMR.2010.0112; Suresh S., 1998, FATIGUE MAT; SUZUKI Y, 1987, PHYS REV B, V35, P2162, DOI 10.1103/PhysRevB.35.2162; Tandaiya P, 2013, ACTA MATER, V61, P1558, DOI 10.1016/j.actamat.2012.11.033; Tandaiya P, 2008, ACTA MATER, V56, P6077, DOI 10.1016/j.actamat.2008.08.018; Vempati UK, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.214201; Wang WH, 2012, PROG MATER SCI, V57, P487, DOI 10.1016/j.pmatsci.2011.07.001; WU TW, 1990, PHILOS MAG B, V61, P739, DOI 10.1080/13642819008219307; Xi XK, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.125510	37	17	17	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e83289	10.1371/journal.pone.0083289	http://dx.doi.org/10.1371/journal.pone.0083289			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281RE	24386172	Green Submitted, gold, Green Published			2022-12-25	WOS:000329117900031
J	Yu, Y; Gao, MX; Li, HT; Zhang, F; Gu, CX				Yu, Yang; Gao, Mingxin; Li, Haitao; Zhang, Fan; Gu, Chengxiong			Pulmonary Artery Perfusion with Anti-Tumor Necrosis Factor Alpha Antibody Reduces Cardiopulmonary Bypass-Induced Inflammatory Lung Injury in a Rabbit Model	PLOS ONE			English	Article							APOPTOSIS; EXPRESSION; CYTOKINE; RECEPTOR; BLOOD	Inflammatory lung injury is one of the main complications associated with cardiopulmonary bypass (CPB). Tumor necrosis factor-a (TNF-alpha) is one of the key factors mediating the CPB-induced inflammatory reactions. Our previous studies have shown that endotracheal administration of anti-tumor necrosis factor-alpha antibody (TNF-alpha Ab) produces some beneficial effects on lung in a rabbit CPB model. In this study, we further examined the effects of pulmonary artery perfusion with TNF-alpha Ab (27 ng/ kg) on lung tissue integrity and pulmonary inflammation during CPB and investigated the mechanism underlying the TNF-alpha Ab-mediated effects in a rabbit model of CPB. Our results from transmission electron microscopy showed that the perfusion with TNF-alpha Ab alleviated CPB-induced histopathological changes in lung tissue. The perfusion with TNF-alpha Ab also prevented CPB-induced pulmonary edema and improved oxygenation index. Parameters indicating pulmonary inflammation, including neutrophil count and plasma TNF-alpha and malondialdehyde (MDA) levels, were significantly reduced during CPB by pulmonary artery perfusion with TNF-alpha Ab, suggesting that the perfusion with TNF-alpha Ab reduces CPB-induced pulmonary inflammation. We further investigated the molecular mechanism underlying the protective effects of TNF-alpha Ab on lung. Our quantitative RT-PCR analysis revealed that pulmonary artery perfusion with TNFa Ab significantly decreased TNF-alpha expression in lung tissue during CPB. The apoptotic index in lung tissue and the expression of proteins that play stimulatory roles in apoptosis pathways including the fas ligand (FasL) and Bax were markedly reduced during CPB by the perfusion with TNF-alpha Ab. In contrast, the expression of Bcl-2, which plays an inhibitory role in apoptosis pathways, was significantly increased during CPB by the perfusion with TNF-alpha Ab, indicating that the perfusion with TNF-alpha Ab significantly reduces CPB-induced apoptosis in lung. Thus, our study suggests that pulmonary artery perfusion with TNF-alpha Ab might be a promising approach for attenuating CPB-induced inflammatory lung injury.	[Yu, Yang; Gao, Mingxin; Li, Haitao; Zhang, Fan; Gu, Chengxiong] Capital Med Univ, Dept Cardiac Surg, Beijing An Zhen Hosp, Beijing, Peoples R China	Capital Medical University	Gu, CX (corresponding author), Capital Med Univ, Dept Cardiac Surg, Beijing An Zhen Hosp, Beijing, Peoples R China.	anzhengu@sina.com	yu, yang/HGC-6679-2022	Yu, Yang/0000-0002-8482-4626	National Natural Science Foundation of China [81070204]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (No. 81070204). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Binns OAR, 1996, J THORAC CARDIOV SUR, V112, P1515, DOI 10.1016/S0022-5223(96)70010-7; Delmotte P, 2012, AM J PHYSIOL-CELL PH, V303, pC244, DOI 10.1152/ajpcell.00414.2011; Goebel U, 2008, EUR J CARDIO-THORAC, V34, P1165, DOI 10.1016/j.ejcts.2008.07.031; Kakishita T, 2010, ANN THORAC SURG, V89, P1773, DOI 10.1016/j.athoracsur.2010.02.077; Kearney CJ, 2013, J BIOL CHEM, V288, P4878, DOI 10.1074/jbc.M112.422410; Klass O, 2007, J INVEST SURG, V20, P349, DOI 10.1080/08941930701772165; Kroon A, 2012, ARCH DIS CHILD, V97, pA67; Li Tao, 2012, Front Med, V6, P296, DOI 10.1007/s11684-012-0219-1; Lisby S, 2007, BIOCHEM PHARMACOL, V73, P526, DOI 10.1016/j.bcp.2006.11.006; Luan ZG, 2013, CLIN EXP IMMUNOL, V172, P417, DOI 10.1111/cei.12062; Qi DN, 2013, ARTIF ORGANS, V37, P142, DOI 10.1111/j.1525-1594.2012.01542.x; Radovits T, 2012, EUR J CARDIO-THORAC, V41, P391, DOI 10.1016/j.ejcts.2011.05.056; Rong J, 2013, ASAIO J, V59, P302, DOI 10.1097/MAT.0b013e318290504e; Santini F, 2012, EUR J CARDIO-THORAC, V42, P942, DOI 10.1093/ejcts/ezs199; Sewing ACP, 2012, AM J PHYSIOL-LUNG C, V303, pL75, DOI 10.1152/ajplung.00072.2012; Sugimoto R, 2012, EUR J CARDIO-THORAC, V42, P1035, DOI 10.1093/ejcts/ezs298; Szlosarek PW, 2006, MOL CANCER THER, V5, P382, DOI 10.1158/1535-7163.MCT-05-0303; Veltkamp C, 2011, GUT, V60, P1345, DOI 10.1136/gut.2010.217117; Wang CT, 2012, LAB INVEST, V92, P910, DOI 10.1038/labinvest.2012.50; Yan XC, 2010, EXP BIOL MED, V235, P623, DOI 10.1258/ebm.2009.009293; Yu Y, 2003, CHINESE J CLIN THORA, V10, P151; Yu Y, 2004, CHINESE J CLIN THORA, V11, P35	22	13	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e83236	10.1371/journal.pone.0083236	http://dx.doi.org/10.1371/journal.pone.0083236			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281RE	24386164	Green Published, gold, Green Submitted			2022-12-25	WOS:000329117900026
J	Alexander, LEC; Marsh, BJ; Timmer, AM; Lin, AE; Zainabadi, K; Czopik, A; Guarente, L; Nizet, V				Alexander, Laura E. Crotty; Marsh, Brenda J.; Timmer, Anjuli M.; Lin, Ann E.; Zainabadi, Kayvan; Czopik, Agnieszka; Guarente, Leonard; Nizet, Victor			Myeloid Cell Sirtuin-1 Expression Does Not Alter Host Immune Responses to Gram-Negative Endotoxemia or Gram-Positive Bacterial Infection	PLOS ONE			English	Article							LEUKEMIA-CELLS; LIFE-SPAN; IN-VITRO; KAPPA-B; SIRT1; MACROPHAGES; RESVERATROL; ACTIVATION; PROTEIN; OXYGEN	The role of sirtuin-1 (SIRT1) in innate immunity, and in particular the influence of SIRT1 on antimicrobial defense against infection, has yet to be reported but is important to define since SIRT1 inhibitors are being investigated as therapeutic agents in the treatment of cancer, Huntington's disease, and autoimmune diseases. Given the therapeutic potential of SIRT1 suppression, we sought to characterize the role of SIRT1 in host defense. Utilizing both pharmacologic methods and a genetic knockout, we demonstrate that SIRT1 expression has little influence on macrophage and neutrophil antimicrobial functions. Myeloid SIRT1 expression does not change mortality in gram-negative toxin-induced shock or gram-positive bacteremia, suggesting that therapeutic suppression of SIRT1 may be done safely without suppression of myeloid cell-specific immune responses to severe bacterial infections.	[Alexander, Laura E. Crotty; Marsh, Brenda J.] Vet Affairs San Diego Healthcare Syst, Pulm Crit Care Sect, San Diego, CA USA; [Alexander, Laura E. Crotty; Marsh, Brenda J.] Univ Calif San Diego, Dept Med, San Diego, CA 92103 USA; [Timmer, Anjuli M.; Lin, Ann E.; Nizet, Victor] Univ Calif San Diego, Dept Pediat, San Diego, CA 92103 USA; [Zainabadi, Kayvan; Czopik, Agnieszka; Guarente, Leonard] MIT, Dept Biol, Cambridge, MA USA; [Nizet, Victor] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, San Diego, CA 92103 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; University of California System; University of California San Diego; University of California System; University of California San Diego; Massachusetts Institute of Technology (MIT); University of California System; University of California San Diego	Alexander, LEC (corresponding author), Vet Affairs San Diego Healthcare Syst, Pulm Crit Care Sect, San Diego, CA USA.	lcrotty@ucsd.edu	Nizet, Victor/AAF-3190-2019; Alexander, Laura Crotty/AIC-1001-2022	Alexander, Laura Crotty/0000-0002-5091-2660; Nizet, Victor/0000-0003-3847-0422; marsh, brenda/0000-0003-1481-9036	American Asthma Foundation; Veterans Affairs Career Development Award-2 [1154866]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057153] Funding Source: NIH RePORTER	American Asthma Foundation; Veterans Affairs Career Development Award-2; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by two Stephen Silberstein Senior Fellowship Awards from the American Asthma Foundation (PI Victor Nizet and PI Leonard Guarente; http://www.americanasthmafoundation.org) and a Veterans Affairs Career Development Award-2 (PI Laura E. Crotty Alexander; Project Number 1154866; http://www.research.va.gov/funding/CDP.cfm#.UbpFS-C2vlI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baur JA, 2012, NAT REV DRUG DISCOV, V11, P443, DOI 10.1038/nrd3738; Beier UH, 2011, MOL CELL BIOL, V31, P1022, DOI 10.1128/MCB.01206-10; Briceno JC, 2004, AM J PHYSIOL-HEART C, V286, pH1223, DOI 10.1152/ajpheart.00666.2003; Caballero B, 2003, AM J CLIN NUTR, V78, P308; Cabana VG, 2004, J LIPID RES, V45, P317, DOI 10.1194/jlr.M300414-JLR200; Cabell CH, 2003, CIRCULATION, V107, pE185, DOI 10.1161/01.CIR.0000071082.36561.F1; Cakir Z, 2011, J CANCER RES CLIN, V137, P279, DOI 10.1007/s00432-010-0884-x; Cheng HL, 2003, P NATL ACAD SCI USA, V100, P10794, DOI 10.1073/pnas.1934713100; Choi SH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032378; Clement MV, 1998, BLOOD, V92, P996; Fernandes CA, 2012, BIOCHEM BIOPH RES CO, V420, P857, DOI 10.1016/j.bbrc.2012.03.088; Fregosi RF, 2003, J APPL PHYSIOL, V95, P2030, DOI 10.1152/japplphysiol.00293.2003; Hangai-Hoger N, 2004, AM J PHYSIOL-HEART C, V286, pH878, DOI 10.1152/ajpheart.00913.2003; HOESS RH, 1982, P NATL ACAD SCI-BIOL, V79, P3398, DOI 10.1073/pnas.79.11.3398; Hu N, 2009, SCAND J RHEUMATOL, V38, P464, DOI 10.3109/03009740902895750; Kassotis J, 2003, J CARDIOVASC ELECTR, V14, P1233, DOI 10.1046/j.1540-8167.2003.02413.x; Kozako T, 2012, INT J CANCER, V131, P2044, DOI 10.1002/ijc.27481; Lara E, 2009, ONCOGENE, V28, P781, DOI 10.1038/onc.2008.436; Lee SM, 2011, DIABETOLOGIA, V54, P1136, DOI 10.1007/s00125-011-2064-1; Li L, 2012, CANCER CELL, V21, P266, DOI 10.1016/j.ccr.2011.12.020; Mbaruku Godfrey, 2003, Afr J Reprod Health, V7, P84, DOI 10.2307/3583293; McBurney MW, 2003, MOL CELL BIOL, V23, P38, DOI 10.1128/MCB.23.1.38-54.2003; Mwangangi JM, 2003, J AM MOSQUITO CONTR, V19, P371; Nakamaru Y, 2009, FASEB J, V23, P2810, DOI 10.1096/fj.08-125468; Radhakrishnan K, 2003, ADV EXP MED BIOL, V530, P547; Schug TT, 2010, MOL CELL BIOL, V30, P4712, DOI 10.1128/MCB.00657-10; Sequeira J, 2008, EXP CELL RES, V314, P3069, DOI 10.1016/j.yexcr.2008.07.011; Shen Z, 2009, AM J PHYSIOL-GASTR L, V296, pG1047, DOI 10.1152/ajpgi.00016.2009; Singh UP, 2010, J PHARMACOL EXP THER, V332, P829, DOI 10.1124/jpet.109.160838; Stervbo U, 2006, CELL PROLIFERAT, V39, P479, DOI 10.1111/j.1365-2184.2006.00406.x; Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638; van Loosdregt J, 2010, BLOOD, V115, P965, DOI 10.1182/blood-2009-02-207118; Wampfler J, 2009, BRIT J HAEMATOL, V146, P337, DOI 10.1111/j.1365-2141.2009.07749.x; Weischenfeldt J, 2008, GENE DEV, V22, P1381, DOI 10.1101/gad.468808; Yang SR, 2007, AM J PHYSIOL-LUNG C, V292, pL567, DOI 10.1152/ajplung.00308.2006; Yoshizaki T, 2010, AM J PHYSIOL-ENDOC M, V298, pE419, DOI 10.1152/ajpendo.00417.2009; Zhang Q, 2012, EMBO MOL MED, V4, P298, DOI 10.1002/emmm.201100211; Zhang R, 2010, J BIOL CHEM, V285, P7097, DOI 10.1074/jbc.M109.038604	38	6	7	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e84481	10.1371/journal.pone.0084481	http://dx.doi.org/10.1371/journal.pone.0084481			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281QS	24386389	Green Submitted, Green Published, gold			2022-12-25	WOS:000329116700110
J	Boon, E; Zimmerman, E; St-Arnaud, M; Hijri, M				Boon, Eva; Zimmerman, Erin; St-Arnaud, Marc; Hijri, Mohamed			Allelic Differences within and among Sister Spores of the Arbuscular Mycorrhizal Fungus iSuggest Segregation at Sporulation	PLOS ONE			English	Article							RIBOSOMAL-RNA GENES; ANASTOMOSIS FORMATION; RARE BIOSPHERE; HYPHAL FUSION; DIVERSITY; EVOLUTION; GLOMEROMYCOTA; EXCHANGE; POLYMORPHISMS; COMMUNITIES	Arbuscular mycorrhizal fungi (AMF) are root-inhabiting fungi that form mutualistic symbioses with their host plants. AMF are made up of coenocytic networks of hyphae through which nuclei and organelles can freely migrate. In this study, we investigated the possibility of a genetic bottleneck and segregation of allelic variation at sporulation for a low-copy Polymerase1-like gene, PLS. Specifically, our objectives were (1) to estimate what allelic diversity is passed on to a single spore (2) to determine whether this diversity is less than the total amount of variation found in all spores (3) to investigate whether there is any differential segregation of allelic variation. We inoculated three tomato plants with a single spore of Glomus etunicatum each and after six months sampled between two and three daughter spores per tomato plant. Pyrosequencing PLS amplicons in eight spores revealed high levels of allelic diversity; between 43 and 152 alleles per spore. We corroborated the spore pyrosequencing results with Sanger- and pyrosequenced allele distributions from the original parent isolate. Both sequencing methods retrieved the most abundant alleles from the offspring spore allele distributions. Our results indicate that individual spores contain only a subset of the total allelic variation from the pooled spores and parent isolate. Patterns of allele diversity between spores suggest the possibility for segregation of PLS alleles among spores. We conclude that a genetic bottleneck could potentially occur during sporulation in AMF, with resulting differences in genetic variation among sister spores. We suggest that the effects of this bottleneck may be countered by anastomosis (hyphal fusion) between related hyphae.	[Boon, Eva; Zimmerman, Erin; St-Arnaud, Marc; Hijri, Mohamed] Univ Montreal, Dept Sci Biol, Inst Rech Biol Vegetale, Montreal, PQ H3C 3J7, Canada	Universite de Montreal	St-Arnaud, M (corresponding author), Univ Montreal, Dept Sci Biol, Inst Rech Biol Vegetale, CP 6128, Montreal, PQ H3C 3J7, Canada.	marc.st-arnaud@umontreal.ca	Hijri, Mohamed/ABC-5969-2021; Boon, Eva/Y-3884-2019; St-Arnaud, Marc/D-1184-2017; Hijri, Mohamed/AAL-5737-2021	Hijri, Mohamed/0000-0001-6112-8372; Boon, Eva/0000-0002-3398-8946; St-Arnaud, Marc/0000-0002-7181-9895; 	NSERC; Alexander Graham Bell and Vanier Canada Graduate Scholarships from NSERC	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Alexander Graham Bell and Vanier Canada Graduate Scholarships from NSERC	This work was supported jointly by two NSERC discovery grants allocated to M. St-Arnaud and M. Hijri. E. Zimmerman and E. Boon received Alexander Graham Bell and Vanier Canada Graduate Scholarships from NSERC, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Angelard C, 2014, ISME J, V8, P284, DOI 10.1038/ismej.2013.154; Angelard C, 2011, NEW PHYTOL, V189, P652, DOI 10.1111/j.1469-8137.2010.03602.x; Angelard C, 2010, CURR BIOL, V20, P1216, DOI 10.1016/j.cub.2010.05.031; BERTANI G, 1951, J BACTERIOL, V62, P293, DOI 10.1128/JB.62.3.293-300.1951; Bever J. D., 2008, MYCORRHIZA, P135, DOI [DOI 10.1007/978-3-540-78826-3_7, 10.1007/978-3-540-78826-3_7]; Bever JD, 2005, NATURE, V433, pE3, DOI 10.1038/nature03294; Boon E, 2010, J EVOLUTION BIOL, V23, P1519, DOI 10.1111/j.1420-9101.2010.02019.x; Buss L., 1987, EVOLUTION INDIVIDUAL; Cardenas-Flores A, 2010, MYCORRHIZA, V20, P415, DOI 10.1007/s00572-009-0295-5; Chao A, 2005, ECOL LETT, V8, P148, DOI 10.1111/j.1461-0248.2004.00707.x; Chao A, 2010, SPADE SPECIES PREDIC; Corradi N, 2004, FUNGAL GENET BIOL, V41, P1037, DOI 10.1016/j.fgb.2004.08.005; Corradi N, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-21; Corradi N, 2007, APPL ENVIRON MICROB, V73, P366, DOI 10.1128/AEM.01574-06; Croll D, 2009, NEW PHYTOL, V181, P924, DOI 10.1111/j.1469-8137.2008.02726.x; de la Providencia IE, 2005, NEW PHYTOL, V165, P261, DOI 10.1111/j.1469-8137.2004.01236.x; de la Providencia IE, 2013, NEW PHYTOL, V200, P211, DOI 10.1111/nph.12372; Ehinger MO, 2012, NEW PHYTOL, V196, P853, DOI 10.1111/j.1469-8137.2012.04278.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Gilles A, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-245; Giovannetti M, 1999, APPL ENVIRON MICROB, V65, P5571; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Helgason T, 2003, FEMS MICROBIOL LETT, V229, P127, DOI 10.1016/S0378-1097(03)00802-4; Hijri M, 2005, NATURE, V433, P160, DOI 10.1038/nature03069; Huse SM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r143; Huse SM, 2010, ENVIRON MICROBIOL, V12, P1889, DOI 10.1111/j.1462-2920.2010.02193.x; Jany JL, 2010, AM NAT, V175, P424, DOI 10.1086/650725; KONDRASHOV AS, 1991, NATURE, V351, P314, DOI 10.1038/351314a0; Kuhn G, 2001, NATURE, V414, P745, DOI 10.1038/414745a; KUHN G, 2003, ORG GENETIC VARIATIO; Kunin V, 2010, ENVIRON MICROBIOL, V12, P118, DOI 10.1111/j.1462-2920.2009.02051.x; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Lozupone C, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-371; Marleau J, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-51; Martin AP, 2002, APPL ENVIRON MICROB, V68, P3673, DOI 10.1128/AEM.68.8.3673-3682.2002; Meissner R, 1997, PLANT J, V12, P1465, DOI 10.1046/j.1365-313x.1997.12061465.x; Michod RE, 2001, HEREDITY, V86, P1, DOI 10.1046/j.1365-2540.2001.00808.x; Pawlowska TE, 2005, NATURE, V433, pE4, DOI 10.1038/nature03295; Pawlowska TE, 2004, NATURE, V427, P733, DOI 10.1038/nature02290; Pineda-Krch M, 2004, J EVOLUTION BIOL, V17, P1192, DOI 10.1111/j.1420-9101.2004.00815.x; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Queller DC, 2009, PHILOS T R SOC B, V364, P3143, DOI 10.1098/rstb.2009.0095; Rodriguez A, 2004, J ECOL, V92, P986, DOI 10.1111/j.1365-2745.2004.00935.x; Rodriguez A, 2001, NEW PHYTOL, V152, P159, DOI 10.1046/j.0028-646X.2001.00237.x; Sanders IR, 2010, ANNU REV GENET, V44, P271, DOI 10.1146/annurev-genet-102108-134239; SANDERS IR, 1995, NEW PHYTOL, V130, P419, DOI 10.1111/j.1469-8137.1995.tb01836.x; Sanders IR, 2002, AM NAT, V160, pS128, DOI 10.1086/342085; Santelices B, 2004, J EVOLUTION BIOL, V17, P1187, DOI 10.1111/j.1420-9101.2004.00813.x; Santelices B, 1999, TRENDS ECOL EVOL, V14, P152, DOI 10.1016/S0169-5347(98)01519-5; Schloss PD, 2008, ISME J, V2, P265, DOI 10.1038/ismej.2008.5; Schloss PD, 2013, ISME J, V7, P457, DOI 10.1038/ismej.2012.102; Schloss PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027310; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schussler A, 2001, MYCOL RES, V105, P1413, DOI 10.1017/S0953756201005196; Smith S.E., 2008, MYCORRHIZAL SYMBIOSI, V3rd ed; St-Arnaud M., 2007, MYCORRHIZAE CROP PRO, P67; Stewart CN, 1996, J EVOLUTION BIOL, V9, P153, DOI 10.1046/j.1420-9101.1996.9020153.x; Subramanian KS, 1999, MYCORRHIZA, V9, P69, DOI 10.1007/s005720050002; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thiery O, 2012, SYMBIOSIS, V58, P135, DOI 10.1007/s13199-012-0212-0; Tisserant E, 2012, NEW PHYTOL, V193, P755, DOI 10.1111/j.1469-8137.2011.03948.x; van der Heijden MGA, 2007, NEW PHYTOL, V174, P244, DOI 10.1111/j.1469-8137.2007.02041.x; van der Heijden MGA, 1998, NATURE, V396, P69, DOI 10.1038/23932; Villesen P, 2007, MOL ECOL NOTES, V7, P965, DOI 10.1111/j.1471-8286.2007.01821.x; Wang GCY, 1997, APPL ENVIRON MICROB, V63, P4645, DOI 10.1128/AEM.63.12.4645-4650.1997	68	17	17	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e83301	10.1371/journal.pone.0083301	http://dx.doi.org/10.1371/journal.pone.0083301			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281QS	24386173	Green Published, Green Submitted, gold			2022-12-25	WOS:000329116700038
J	Clark, J; Grznarova, P; Stansell, E; Diehl, W; Lipov, J; Spearman, P; Ruml, T; Hunter, E				Clark, Jasmine; Grznarova, Petra; Stansell, Elizabeth; Diehl, William; Lipov, Jan; Spearman, Paul; Ruml, Tomas; Hunter, Eric			A Mason-Pfizer Monkey Virus Gag-GFP Fusion Vector Allows Visualization of Capsid Transport in Live Cells and Demonstrates a Role for Microtubules	PLOS ONE			English	Article							TARGETING-RETENTION SIGNAL; GREEN FLUORESCENT PROTEIN; DEPENDENT MOVEMENT; CYTOPLASMIC DOMAIN; MATRIX PROTEIN; IDENTIFICATION; GLYCOPROTEIN; POLYPEPTIDES; REPLICATION; INFECTIVITY	Immature capsids of the Betaretrovirus, Mason-Pfizer Monkey virus (M-PMV), are assembled in the pericentriolar region of the cell, and are then transported to the plasma membrane for budding. Although several studies, utilizing mutagenesis, biochemistry, and immunofluorescence, have defined the role of some viral and host cells factors involved in these processes, they have the disadvantage of population analysis, rather than analyzing individual capsid movement in real time. In this study, we created an M-PMV vector in which the enhanced green fluorescent protein, eGFP, was fused to the carboxyl-terminus of the M-PMV Gag polyprotein, to create a Gag-GFP fusion that could be visualized in live cells. In order to express this fusion protein in the context of an M-PMV proviral backbone, it was necessary to codon-optimize gag, optimize the Kozak sequence preceding the initiating methionine, and mutate an internal methionine codon to one for alanine (M100A) to prevent internal initiation of translation. Co-expression of this pSARM-Gag-GFP-M100A vector with a WT M-PMV provirus resulted in efficient assembly and release of capsids. Results from fixed-cell immunofluorescence and pulse-chase analyses of wild type and mutant Gag-GFP constructs demonstrated comparable intracellular localization and release of capsids to untagged counterparts. Real-time, live-cell visualization and analysis of the GFP-tagged capsids provided strong evidence for a role for microtubules in the intracellular transport of M-PMV capsids. Thus, this M-PMV Gag-GFP vector is a useful tool for identifying novel virus-cell interactions involved in intracellular M-PMV capsid transport in a dynamic, real-time system.	[Clark, Jasmine; Stansell, Elizabeth; Diehl, William; Hunter, Eric] Emory Univ, Yerkes Natl Primate Res Ctr, Emory Vaccine Ctr, Atlanta, GA 30322 USA; [Grznarova, Petra; Lipov, Jan; Ruml, Tomas] Inst Chem Technol, Dept Biochem & Microbiol, CR-16628 Prague, Czech Republic; [Spearman, Paul] Emory Univ, Dept Pediat, Atlanta, GA 30322 USA; [Hunter, Eric] Emory Univ, Dept Pathol, Atlanta, GA 30322 USA	Emory University; University of Chemistry & Technology, Prague; Emory University; Emory University	Hunter, E (corresponding author), Emory Univ, Yerkes Natl Primate Res Ctr, Emory Vaccine Ctr, Atlanta, GA 30322 USA.	ehunte4@emory.edu	Prokšová, Petra Grznarova/AAE-3231-2022; Lipov, Jan/AAF-6232-2019; Ruml, Tomas/R-2543-2017; Lipov, Jan/Q-5880-2017; Lipov, Jan/Y-2414-2019	Lipov, Jan/0000-0002-3244-5827; Ruml, Tomas/0000-0002-5698-4366; Lipov, Jan/0000-0002-3244-5827; Diehl, William/0000-0001-7943-1214	NIH from the National Cancer Institute [R01-CA-27834]; Czech Science Foundation [P302/12/1895]; Czech and Ministry of Education [LH12011]; American Society for Microbiology Robert D. Watkins fellowship; NATIONAL CANCER INSTITUTE [R01CA027834] Funding Source: NIH RePORTER	NIH from the National Cancer Institute; Czech Science Foundation(Grant Agency of the Czech Republic); Czech and Ministry of Education; American Society for Microbiology Robert D. Watkins fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was financially supported by NIH grant R01-CA-27834 from the National Cancer Institute, and by a Czech Science Foundation grant P302/12/1895. International travel for Petra Grznarova was supported by the Czech and Ministry of Education grant LH12011. Jasmine Clark was also the recipient of the American Society for Microbiology Robert D. Watkins fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amorim MJ, 2011, J VIROL, V85, P4143, DOI 10.1128/JVI.02606-10; BRADAC J, 1984, VIROLOGY, V138, P260, DOI 10.1016/0042-6822(84)90350-7; Chambers R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010994; CHATTERJEE S, 1985, VIROLOGY, V141, P65, DOI 10.1016/0042-6822(85)90183-7; Choi G, 1999, J VIROL, V73, P5431, DOI 10.1128/JVI.73.7.5431-5437.1999; CHOPRA HC, 1970, CANCER RES, V30, P2081; Chung HY, 2008, J VIROL, V82, P4884, DOI 10.1128/JVI.02667-07; Desai P, 1998, J VIROL, V72, P7563, DOI 10.1128/JVI.72.9.7563-7568.1998; Dohner K, 2005, TRENDS MICROBIOL, V13, P320, DOI 10.1016/j.tim.2005.05.010; GLUZMAN Y, 1981, CELL, V23, P175, DOI 10.1016/0092-8674(81)90282-8; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Hollinshead M, 2001, J CELL BIOL, V154, P389, DOI 10.1083/jcb.200104124; JENSEN EM, 1970, CANCER RES, V30, P2388; KESSLER SW, 1975, J IMMUNOL, V115, P1617; Kohoutova Z, 2009, VIROLOGY, V384, P59, DOI 10.1016/j.virol.2008.10.048; Linkert M, 2010, J CELL BIOL, V189, P777, DOI 10.1083/jcb.201004104; Lux K, 2005, J VIROL, V79, P11776, DOI 10.1128/JVI.79.18.11776-11787.2005; MASON MM, 1972, J NATL CANCER I, V48, P1323; Muller B, 2004, J VIROL, V78, P10803, DOI 10.1128/JVI.78.19.10803-10813.2004; Murray JW, 2000, MOL BIOL CELL, V11, P419, DOI 10.1091/mbc.11.2.419; PENFOLD MET, 1994, P NATL ACAD SCI USA, V91, P6529, DOI 10.1073/pnas.91.14.6529; Prchal J, 2011, PROTEIN EXPRES PURIF, V79, P122, DOI 10.1016/j.pep.2011.05.010; Punnonen EL, 1998, EUR J CELL BIOL, V75, P344, DOI 10.1016/S0171-9335(98)80067-8; RHEE SS, 1990, CELL, V63, P77, DOI 10.1016/0092-8674(90)90289-Q; RHEE SS, 1987, J VIROL, V61, P1045, DOI 10.1128/JVI.61.4.1045-1053.1987; Rietdorf J, 2001, NAT CELL BIOL, V3, P992, DOI 10.1038/ncb1101-992; Sakalian M, 1999, J VIROL, V73, P8073, DOI 10.1128/JVI.73.10.8073-8082.1999; Sbalzarini IF, 2005, J STRUCT BIOL, V151, P182, DOI 10.1016/j.jsb.2005.06.002; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Sfakianos JN, 2003, TRAFFIC, V4, P660, DOI 10.1034/j.1600-0854.2003.00125.x; Sfakianos JN, 2003, TRAFFIC, V4, P671, DOI 10.1034/j.1600-0854.2003.00126.x; Song C, 2003, J VIROL, V77, P5192, DOI 10.1128/JVI.77.9.5192-5200.2003; Song CS, 2005, J VIROL, V79, P11559, DOI 10.1128/JVI.79.18.11559-11568.2005; Stansell E, 2004, J VIROL, V78, P5023, DOI 10.1128/JVI.78.10.5023-5031.2004; Stansell E, 2007, J VIROL, V81, P8977, DOI 10.1128/JVI.00657-07	35	6	6	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e83863	10.1371/journal.pone.0083863	http://dx.doi.org/10.1371/journal.pone.0083863			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281QS	24386297	Green Submitted, Green Published, gold			2022-12-25	WOS:000329116700084
J	Hennis, MR; Seamans, KW; Marvin, MA; Casey, BH; Goldberg, MS				Hennis, Meghan R.; Seamans, Katherine W.; Marvin, Marian A.; Casey, Bradford H.; Goldberg, Matthew S.			Behavioral and Neurotransmitter Abnormalities in Mice Deficient for Parkin, DJ-1 and Superoxide Dismutase	PLOS ONE			English	Article							MITOCHONDRIAL COMPLEX-I; RECESSIVE JUVENILE PARKINSONISM; CYSTEINE-SULFINIC ACID; OXIDATIVE STRESS; DJ-1-DEFICIENT MICE; DOPAMINERGIC-NEURONS; SUBSTANTIA-NIGRA; TRANSGENIC MICE; NULL MICE; RETROGRADE DEGENERATION	Parkinson's disease (PD) is a progressive neurodegenerative disease characterized by loss of neurons in the substantia nigra that project to the striatum and release dopamine. The cause of PD remains uncertain, however, evidence implicates mitochondrial dysfunction and oxidative stress. Although most cases of PD are sporadic, 5-10% of cases are caused by inherited mutations. Loss-of-function mutations in Parkin and DJ-1 were the first to be linked to recessively inherited Parkinsonism. Surprisingly, mice bearing similar loss-of-function mutations in Parkin and DJ-1 do not show age-dependent loss of nigral dopaminergic neurons or depletion of dopamine in the striatum. Although the normal cellular functions of Parkin and DJ-1 are not fully understood, we hypothesized that loss-of-function mutations in Parkin and DJ-1 render cells more sensitive to mitochondrial dysfunction and oxidative stress. To test this hypothesis, we crossed mice deficient for Parkin and DJ-1 with mice deficient for the mitochondrial antioxidant protein Mn-superoxide dismutase (SOD2) or the cytosolic antioxidant protein Cu-Zn-superoxide dismutase (SOD1). Aged Parkin(-/-)DJ-1(-/-) and Mn-superoxide dismutase triple deficient mice have enhanced performance on the rotorod behavior test. Cu/Zn-superoxide dismutase triple deficient mice have elevated levels of dopamine in the striatum in the absence of nigral cell loss. Our studies demonstrate that on a Parkin/DJ-1 null background, mice that are also deficient for major antioxidant proteins do not have progressive loss of dopaminergic neurons but have behavioral and striatal dopamine abnormalities.	[Hennis, Meghan R.; Seamans, Katherine W.; Marvin, Marian A.; Casey, Bradford H.; Goldberg, Matthew S.] Univ Texas SW Med Ctr Dallas, Dept Neurol & Neurotherapeut, Dallas, TX 75390 USA; [Goldberg, Matthew S.] Univ Texas SW Med Ctr Dallas, Dept Psychiat, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Goldberg, MS (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Neurol & Neurotherapeut, Dallas, TX 75390 USA.	Matthew.Goldberg@UTSouthwestern.edu	Goldberg, Matthew/T-7827-2019	Goldberg, Matthew/0000-0002-5172-9841	Parkinson's Disease Foundation; NIH from the National Institute of General Medical Sciences [5T32GM00820322]; David M. Crowley Foundation; Parkinson's Benefactors	Parkinson's Disease Foundation; NIH from the National Institute of General Medical Sciences(General Electric); David M. Crowley Foundation; Parkinson's Benefactors(Parkinson's UK)	The following sources of funding supported this work: Parkinson's Disease Foundation, NIH Training Grant 5T32GM00820322 from the National Institute of General Medical Sciences, the David M. Crowley Foundation and Parkinson's Benefactors. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam ZI, 1997, J NEUROCHEM, V69, P1196, DOI 10.1046/j.1471-4159.1997.69031196.x; Andreassen OA, 2001, EXP NEUROL, V167, P189, DOI 10.1006/exnr.2000.7525; Andres-Mateos E, 2007, P NATL ACAD SCI USA, V104, P14807, DOI 10.1073/pnas.0703219104; Andrews AM, 1996, MOL PHARMACOL, V50, P1511; Asanuma M, 1998, NEUROSCIENCE, V85, P907, DOI 10.1016/S0306-4522(97)00665-9; Barkats M, 2006, J NEUROSCI RES, V83, P233, DOI 10.1002/jnr.20696; Belluzzi E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038026; Ben-Shachar D, 2004, BIOCHEM PHARMACOL, V67, P1965, DOI 10.1016/j.bcp.2004.02.015; BERNHEIMER H, 1973, J NEUROL SCI, V20, P415, DOI 10.1016/0022-510X(73)90175-5; Bian MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039953; Blackinton J, 2009, J BIOL CHEM, V284, P6476, DOI 10.1074/jbc.M806599200; Boll MC, 2008, NEUROCHEM RES, V33, P1717, DOI 10.1007/s11064-008-9610-3; Bonifati V, 2003, SCIENCE, V299, P256, DOI 10.1126/science.1077209; Brooks SP, 2012, BRAIN RES BULL, V88, P81, DOI 10.1016/j.brainresbull.2011.10.002; Callio J, 2005, J BIOL CHEM, V280, P18536, DOI 10.1074/jbc.M413224200; Canet-Aviles RM, 2004, P NATL ACAD SCI USA, V101, P9103, DOI 10.1073/pnas.0402959101; Chandran JS, 2008, NEUROBIOL DIS, V29, P505, DOI 10.1016/j.nbd.2007.11.011; Chen LN, 2005, J BIOL CHEM, V280, P21418, DOI 10.1074/jbc.M413955200; Cheng HC, 2011, J NEUROSCI, V31, P2125, DOI 10.1523/JNEUROSCI.5519-10.2011; Choi J, 2006, J BIOL CHEM, V281, P10816, DOI 10.1074/jbc.M509079200; Corti O, 2011, PHYSIOL REV, V91, P1161, DOI 10.1152/physrev.00022.2010; Dawson TM, 2010, NEURON, V66, P646, DOI 10.1016/j.neuron.2010.04.034; DEXTER DT, 1989, J NEUROCHEM, V52, P381, DOI 10.1111/j.1471-4159.1989.tb09133.x; Fleming SM, 2006, BEHAV PHARMACOL, V17, P383, DOI 10.1097/00008877-200609000-00004; Fleming Sheila M, 2005, NeuroRx, V2, P495, DOI 10.1602/neurorx.2.3.495; Floor E, 1998, J NEUROCHEM, V70, P268; Frank-Cannon TC, 2008, J NEUROSCI, V28, P10825, DOI 10.1523/JNEUROSCI.3001-08.2008; Goldberg MS, 2003, J BIOL CHEM, V278, P43628, DOI 10.1074/jbc.M308947200; Goldberg MS, 2005, NEURON, V45, P489, DOI 10.1016/j.neuron.2005.01.041; Hattori Nobutaka, 2012, Parkinsonism Relat Disord, V18 Suppl 1, pS1, DOI 10.1016/S1353-8020(11)70003-7; Hattori N, 2009, PARKINSONISM RELAT D, V15, pS35, DOI 10.1016/S1353-8020(09)70010-0; Hauser DN, 2013, NEUROBIOL DIS, V51, P35, DOI 10.1016/j.nbd.2012.10.011; Hayashi T, 2009, BIOCHEM BIOPH RES CO, V390, P667, DOI 10.1016/j.bbrc.2009.10.025; Hennis MR, 2014, NEUROBIOL DIS, V62, P113, DOI 10.1016/j.nbd.2013.09.009; Hirata H, 1998, MOL BRAIN RES, V58, P209, DOI 10.1016/S0169-328X(98)00055-2; Horowitz MP, 2010, CLIN PHARMACOL THER, V88, P467, DOI 10.1038/clpt.2010.138; Ihara Y, 1999, J NEUROL SCI, V170, P90, DOI 10.1016/S0022-510X(99)00192-6; Itier JM, 2003, HUM MOL GENET, V12, P2277, DOI 10.1093/hmg/ddg239; Jiang HB, 2004, J BIOL CHEM, V279, P54380, DOI 10.1074/jbc.M409282200; Jiang HB, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1669; Joyce PI, 2011, MAMM GENOME, V22, P420, DOI 10.1007/s00335-011-9339-1; Junn E, 2009, J NEUROSCI RES, V87, P123, DOI 10.1002/jnr.21831; Keithley EM, 2005, HEARING RES, V209, P76, DOI 10.1016/j.heares.2005.06.009; Kim RH, 2005, P NATL ACAD SCI USA, V102, P5215, DOI 10.1073/pnas.0501282102; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Kitada T, 2009, J NEUROCHEM, V111, P696, DOI 10.1111/j.1471-4159.2009.06350.x; Kondo T, 1997, J NEUROSCI, V17, P4180; Kubo S, 2001, J NEUROCHEM, V78, P42, DOI 10.1046/j.1471-4159.2001.00364.x; Kuhn K, 2004, DEV BRAIN RES, V149, P131, DOI 10.1016/j.devbrainres.2004.02.001; Kunikowska G, 2003, BRAIN RES, V968, P206, DOI 10.1016/S0006-8993(03)02240-6; Lenzken SC, 2011, HUM MUTAT, V32, P168, DOI 10.1002/humu.21394; Lev N, 2008, NEUROTOXICOLOGY, V29, P397, DOI 10.1016/j.neuro.2008.01.007; LI YB, 1995, NAT GENET, V11, P376, DOI 10.1038/ng1295-376; Liang LP, 2004, J NEUROCHEM, V90, P1076, DOI 10.1111/j.1471-4159.2004.02567.x; Liddell JR, 2010, GLIA, V58, P1500, DOI 10.1002/glia.21024; Lo Bianco C, 2004, P NATL ACAD SCI USA, V101, P17510, DOI 10.1073/pnas.0405313101; Lopez G, 2010, BIOMARK MED, V4, P713, DOI 10.2217/bmm.10.96; Manning-Bog AB, 2007, NEUROBIOL DIS, V27, P141, DOI 10.1016/j.nbd.2007.03.014; McFadyen MP, 2003, GENES BRAIN BEHAV, V2, P214, DOI 10.1034/j.1601-183X.2003.00028.x; Muftuoglu M, 2004, MOVEMENT DISORD, V19, P544, DOI 10.1002/mds.10695; Mullett SJ, 2011, J NEUROCHEM, V117, P375, DOI 10.1111/j.1471-4159.2011.07175.x; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Oliveras-Salva M, 2011, J PARKINSON DIS, V1, P229, DOI 10.3233/JPD-2011-11041; Palacino JJ, 2004, J BIOL CHEM, V279, P18614, DOI 10.1074/jbc.M401135200; Paterna JC, 2007, MOL THER, V15, P698, DOI 10.1038/sj.mt.6300067; Perez FA, 2005, P NATL ACAD SCI USA, V102, P2174, DOI 10.1073/pnas.0409598102; Perez FA, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-71; Perucho J, 2010, EXP NEUROL, V221, P54, DOI 10.1016/j.expneurol.2009.09.029; Pham AH, 2012, HUM MOL GENET, V21, P4817, DOI 10.1093/hmg/dds311; Pham TT, 2010, GENES BRAIN BEHAV, V9, P305, DOI 10.1111/j.1601-183X.2009.00559.x; Raman AV, 2013, FEBS LETT, V587, P1562, DOI 10.1016/j.febslet.2013.04.001; Ramaswamy S, 2009, NEUROBIOL DIS, V34, P40, DOI 10.1016/j.nbd.2008.12.005; Rodriguez-Navarro JA, 2007, J NEUROCHEM, V103, P98, DOI 10.1111/j.1471-4159.2007.04762.x; Rousseaux MWC, 2012, P NATL ACAD SCI USA, V109, P15918, DOI 10.1073/pnas.1205102109; Sato S, 2006, J NEUROSCI RES, V84, P1350, DOI 10.1002/jnr.21032; Shang H, 2004, NEUROSCI LETT, V367, P273, DOI 10.1016/j.neulet.2004.06.002; Shimura H, 2000, NAT GENET, V25, P302, DOI 10.1038/77060; Shimura H, 1999, ANN NEUROL, V45, P668, DOI 10.1002/1531-8249(199905)45:5<668::AID-ANA19>3.0.CO;2-Z; Stichel CC, 2000, EUR J NEUROSCI, V12, P4181, DOI 10.1111/j.1460-9568.2000.01314.x; Sun SY, 2012, BRAIN RES BULL, V88, P609, DOI 10.1016/j.brainresbull.2012.05.013; Nguyen T, 2013, J COAT TECHNOL RES, V10, P1, DOI 10.1007/s11998-012-9455-1; Tripanichkul W, 2007, BRAIN RES, V1164, P24, DOI 10.1016/j.brainres.2007.05.076; Usami Y, 2011, NEUROBIOL DIS, V43, P651, DOI 10.1016/j.nbd.2011.05.014; Van Remmen H, 1999, ARCH BIOCHEM BIOPHYS, V363, P91, DOI 10.1006/abbi.1998.1060; Varcin M, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/624925; Vercammen L, 2006, MOL THER, V14, P716, DOI 10.1016/j.ymthe.2006.06.009; Vincent A, 2012, HUM MOL GENET, V21, P1760, DOI 10.1093/hmg/ddr609; Vincow ES, 2013, P NATL ACAD SCI USA, V110, P6400, DOI 10.1073/pnas.1221132110; Vinish M, 2011, ACTA BIOCHIM POL, V58, P165; von Coelln R, 2004, P NATL ACAD SCI USA, V101, P10744, DOI 10.1073/pnas.0401297101; Wang DF, 2006, P NATL ACAD SCI USA, V103, P13244, DOI 10.1073/pnas.0605551103; Wang ZQ, 2011, ANN NEUROL, V70, P591, DOI 10.1002/ana.22514; Williams MD, 1998, J BIOL CHEM, V273, P28510, DOI 10.1074/jbc.273.43.28510; Xie ZG, 2009, NEUROSCI LETT, V465, P214, DOI 10.1016/j.neulet.2009.09.024; Yang W, 2007, HUM MOL GENET, V16, P2900, DOI 10.1093/hmg/ddm249; Zhang J, 1999, AM J PATHOL, V154, P1423, DOI 10.1016/S0002-9440(10)65396-5; Zhang J, 2000, J NEUROPATH EXP NEUR, V59, P53, DOI 10.1093/jnen/59.1.53; Zhou WB, 2005, J BIOL CHEM, V280, P43150, DOI 10.1074/jbc.M507124200; Zhu XR, 2007, EUR J NEUROSCI, V26, P1902, DOI 10.1111/j.1460-9568.2007.05812.x	99	19	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e84894	10.1371/journal.pone.0084894	http://dx.doi.org/10.1371/journal.pone.0084894			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281QS	24386432	gold, Green Published, Green Submitted			2022-12-25	WOS:000329116700124
J	Altobelli, G; Bogdarina, IG; Stupka, E; Clark, AJL; Langley-Evans, S				Altobelli, Gioia; Bogdarina, Irina G.; Stupka, Elia; Clark, Adrian J. L.; Langley-Evans, Simon			Genome-Wide Methylation and Gene Expression Changes in Newborn Rats following Maternal Protein Restriction and Reversal by Folic Acid	PLOS ONE			English	Article							JUVENILE-PUBERTAL PERIOD; EMBRYONIC STEM-CELLS; DNA METHYLATION; PRENATAL EXPOSURE; BLOOD-PRESSURE; EPIGENETIC MODIFICATION; DEVELOPMENTAL ORIGINS; PREGNANT RATS; DIET; SUPPLEMENTATION	A large body of evidence from human and animal studies demonstrates that the maternal diet during pregnancy can programme physiological and metabolic functions in the developing fetus, effectively determining susceptibility to later disease. The mechanistic basis of such programming is unclear but may involve resetting of epigenetic marks and fetal gene expression. The aim of this study was to evaluate genome-wide DNA methylation and gene expression in the livers of newborn rats exposed to maternal protein restriction. On day one postnatally, there were 618 differentially expressed genes and 1183 differentially methylated regions (FDR 5%). The functional analysis of differentially expressed genes indicated a significant effect on DNA repair/cycle/maintenance functions and of lipid, amino acid metabolism and circadian functions. Enrichment for known biological functions was found to be associated with differentially methylated regions. Moreover, these epigenetically altered regions overlapped genetic loci associated with metabolic and cardiovascular diseases. Both expression changes and DNA methylation changes were largely reversed by supplementing the protein restricted diet with folic acid. Although the epigenetic and gene expression signatures appeared to underpin largely different biological processes, the gene expression profile of DNA methyl transferases was altered, providing a potential link between the two molecular signatures. The data showed that maternal protein restriction is associated with widespread differential gene expression and DNA methylation across the genome, and that folic acid is able to reset both molecular signatures.	[Altobelli, Gioia; Bogdarina, Irina G.; Clark, Adrian J. L.] Queen Mary Univ London, Barts & London Sch Med & Dent, William Harvey Res Ctr, Ctr Endocrinol, London, England; [Stupka, Elia] Queen Mary Univ London, Barts & London Sch Med & Dent, Inst Cell & Mol Biosci, London, England; [Langley-Evans, Simon] Univ Nottingham, Sch Biosci, Loughborough, Leics, England	University of London; Queen Mary University London; University of London; Queen Mary University London; University of Nottingham	Altobelli, G (corresponding author), UCL, Ctr Rheumatol Res, London, England.	g.altobelli@ucl.ac.uk	Langley-Evans, Simon C/F-3564-2012; Langley-Evans, Simon/AAR-4181-2020	Langley-Evans, Simon C/0000-0002-1969-8416; Altobelli, Gioia/0000-0001-9338-3466; Stupka, Elia/0000-0003-3154-4011	Medical Research Council (MRC) [G0801269]; MRC [G0801269] Funding Source: UKRI; Diabetes UK [12/0004456] Funding Source: researchfish; Medical Research Council [G0801269] Funding Source: researchfish	Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Diabetes UK(Diabetes UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by the Medical Research Council (MRC) under grant no. G0801269. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. MRC website: http://www.mrc.ac.uk/index.htm.	Barker DJP, 2006, HYPERTENSION, V48, P357, DOI 10.1161/01.HYP.0000236552.04251.42; Bell CG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014040; Bellinger L, 2006, INT J OBESITY, V30, P729, DOI 10.1038/sj.ijo.0803205; Bird A, 2007, NATURE, V447, P396, DOI 10.1038/nature05913; Blue GM, 2012, MED J AUSTRALIA, V197, P155, DOI 10.5694/mja12.10811; Bogdarina I, 2007, CIRC RES, V100, P520, DOI 10.1161/01.RES.0000258855.60637.58; Bogdarina I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009237; Bracken AP, 2003, EMBO J, V22, P5323, DOI 10.1093/emboj/cdg542; Brinkman AB, 2010, METHODS, V52, P232, DOI 10.1016/j.ymeth.2010.06.012; Burdge GC, 2009, J NUTR, V139, P1054, DOI 10.3945/jn.109.104653; Carone BR, 2010, CELL, V143, P1084, DOI 10.1016/j.cell.2010.12.008; Chavez L, 2010, GENOME RES, V20, P1441, DOI 10.1101/gr.110114.110; Chen HA, 2009, GENE DEV, V23, P975, DOI 10.1101/gad.1742509; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Coelho D, 2008, NEW ENGL J MED, V358, P1454, DOI 10.1056/NEJMoa072200; Culhane AC, 2012, NUCLEIC ACIDS RES, V40, pD1060, DOI 10.1093/nar/gkr901; da Costa RMA, 2005, ONCOGENE, V24, P1359, DOI 10.1038/sj.onc.1208288; Delage B, 2008, ANNU REV NUTR, V28, P347, DOI 10.1146/annurev.nutr.28.061807.155354; Engeham SF, 2010, BRIT J NUTR, V103, P996, DOI 10.1017/S0007114509992662; Erhuma A, 2007, BRIT J NUTR, V98, P517, DOI 10.1017/S0007114507721505; Erhuma A, 2007, AM J PHYSIOL-ENDOC M, V292, pE1702, DOI 10.1152/ajpendo.00605.2006; Erhuma A, 2009, ENDOCRINE, V36, P333, DOI 10.1007/s12020-009-9225-8; Eriksson J, 2001, INT J OBESITY, V25, P735, DOI 10.1038/sj.ijo.0801602; Eriksson JG, 2007, J NUTR, V137, P1063, DOI 10.1093/jn/137.4.1063; Feinberg AP, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001262; Foundation BH, 2010, COR HEART DIS STAT 2; Gluckman PD, 2004, PEDIATR RES, V56, P311, DOI 10.1203/01.PDR.0000135998.08025.FB; Gluckman PD, 2007, P NATL ACAD SCI USA, V104, P12796, DOI 10.1073/pnas.0705667104; Godfrey KM, 2007, PEDIATR RES, V61, p5R, DOI 10.1203/pdr.0b013e318045bedb; Heijmans BT, 2008, P NATL ACAD SCI USA, V105, P17046, DOI 10.1073/pnas.0806560105; Jackson AA, 2002, CLIN SCI, V103, P633, DOI 10.1042/cs1030633; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; Langley-Evans SC, 2009, J ANAT, V215, P36, DOI 10.1111/j.1469-7580.2008.00977.x; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lillycrop KA, 2005, J NUTR, V135, P1382, DOI 10.1093/jn/135.6.1382; Lillycrop KA, 2008, BRIT J NUTR, V100, P278, DOI 10.1017/S0007114507894438; Lillycrop KA, 2007, BRIT J NUTR, V97, P1064, DOI 10.1017/S000711450769196X; Lillycrop KA, 2011, J DEV ORIG HLTH DIS, V2, pS7; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Liu Y, 2013, NAT BIOTECHNOL, V31, P142, DOI 10.1038/nbt.2487; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; McMullen S, 2005, AM J PHYSIOL-REG I, V288, pR85, DOI 10.1152/ajpregu.00435.2004; McMullen S, 2004, BRIT J NUTR, V91, P133, DOI 10.1079/BJN20031029; McMullen S, 2012, MED HYPOTHESES, V78, P88, DOI 10.1016/j.mehy.2011.09.047; Nakai J, 2002, NAT GENET, V32, P245, DOI 10.1038/ng890; Nuytten M, 2008, ONCOGENE, V27, P1449, DOI 10.1038/sj.onc.1210774; Ouyang W, 2010, NAT IMMUNOL, V11, P618, DOI 10.1038/ni.1884; Rees WD, 2002, P NUTR SOC, V61, P71, DOI 10.1079/PNS2001137; Roychoudhuri R, 2013, NATURE; Sinclair KD, 2007, P NATL ACAD SCI USA, V104, P19351, DOI 10.1073/pnas.0707258104; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Swali A, 2012, PLOS ONE IN PRESS; Swali A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023189; Torrens C, 2006, HYPERTENSION, V47, P982, DOI 10.1161/01.HYP.0000215580.43711.d1; Yu XP, 2009, INT J EXP PATHOL, V90, P638, DOI 10.1111/j.1365-2613.2009.00687.x; Zhang X, 2010, PROSTATE, V70, P765, DOI 10.1002/pros.21109; Zhou ZF, 2011, P NATL ACAD SCI USA, V108, P6626, DOI 10.1073/pnas.1018514108	58	41	41	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e82989	10.1371/journal.pone.0082989	http://dx.doi.org/10.1371/journal.pone.0082989			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391732	Green Published, gold, Green Submitted			2022-12-25	WOS:000329325200029
J	Andreyenkova, NG; Kolesnikova, TD; Makunin, IV; Pokholkova, GV; Boldyreva, LV; Zykova, TY; Zhimulev, IF; Belyaeva, ES				Andreyenkova, Natalya G.; Kolesnikova, Tatyana D.; Makunin, Igor V.; Pokholkova, Galina V.; Boldyreva, Lidiya V.; Zykova, Tatyana Yu.; Zhimulev, Igor F.; Belyaeva, Elena S.			Late Replication Domains Are Evolutionary Conserved in the Drosophila Genome	PLOS ONE			English	Article							HUMAN COMPARATIVE MAP; MAMMALIAN CHROMOSOMAL EVOLUTION; INTERCALARY HETEROCHROMATIN; DNA UNDERREPLICATION; PERICENTRIC HETEROCHROMATIN; POLYTENE CHROMOSOMES; BREAKPOINT REUSE; GENE ORDER; MELANOGASTER; CHROMATIN	Drosophila chromosomes are organized into distinct domains differing in their predominant chromatin composition, replication timing and evolutionary conservation. We show on a genome-wide level that genes whose order has remained unaltered across 9 Drosophila species display late replication timing and frequently map to the regions of repressive chromatin. This observation is consistent with the existence of extensive domains of repressive chromatin that replicate extremely late and have conserved gene order in the Drosophila genome. We suggest that such repressive chromatin domains correspond to a handful of regions that complete replication at the very end of S phase. We further demonstrate that the order of genes in these regions is rarely altered in evolution. Substantial proportion of such regions significantly coincide with large synteny blocks. This indicates that there are evolutionary mechanisms maintaining the integrity of these late-replicating chromatin domains. The synteny blocks corresponding to the extremely late-replicating regions in the D. melanogaster genome consistently display two-fold lower gene density across different Drosophila species.	[Andreyenkova, Natalya G.; Kolesnikova, Tatyana D.; Makunin, Igor V.; Pokholkova, Galina V.; Boldyreva, Lidiya V.; Zykova, Tatyana Yu.; Zhimulev, Igor F.; Belyaeva, Elena S.] Russian Acad Sci, Siberian Branch, Inst Mol & Cellular Biol, Novosibirsk, Russia; [Makunin, Igor V.] Univ Queensland, Ctr Res Comp, St Lucia, Qld, Australia	Russian Academy of Sciences; University of Queensland	Zhimulev, IF (corresponding author), Russian Acad Sci, Siberian Branch, Inst Mol & Cellular Biol, Novosibirsk, Russia.	zhimulev@mcb.nsc.ru	Pokholkova, Galina/N-7554-2015; Zykova (Vatolina), Tatyana/I-3897-2014; Zhimulev, Igor F/N-7978-2015; Belyaeva, Elena S/N-8066-2015; Kolesnikova, Tatyana/N-5461-2015; Andreyenkova, Natalya G/N-4003-2015; Boldyreva, Lidiya/N-6978-2015	Kolesnikova, Tatyana/0000-0002-5107-1445; Andreyenkova, Natalya G/0000-0002-5981-8857; Boldyreva, Lidiya/0000-0003-0716-4545; Zhimulev, Igor/0000-0002-6220-3028	Russian Academy of Sciences; SB RAS [51, 82]; Russian Foundation for Basic Research [13-04-01669-a]	Russian Academy of Sciences(Russian Academy of Sciences); SB RAS(Russian Academy of Sciences); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR))	The research was funded by program of Russian Academy of Sciences "Molecular and Cellular Biology" 6.3; Integration projects of SB RAS #51 and #82, and the Russian Foundation for Basic Research (#13-04-01669-a). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreyeva EN, 2008, CHROMOSOME RES, V16, P851, DOI 10.1007/s10577-008-1244-4; Attie O, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S9-S1; Bailey JA, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-4-r23; Belyaeva ES, 2008, CHROMOSOMA, V117, P411, DOI 10.1007/s00412-008-0163-7; Belyaeva ES, 2006, CHROMOSOMA, V115, P355, DOI 10.1007/s00412-006-0063-7; Belyaeva ES, 2012, PLOS ONE, V7, P352, DOI 10.1371/journal.pone.0030035; Belyaeva ES, 1998, P NATL ACAD SCI USA, V95, P7532, DOI 10.1073/pnas.95.13.7532; Belyakin SN, 2005, P NATL ACAD SCI USA, V102, P8269, DOI 10.1073/pnas.0502702102; Belyakin SN, 2010, CHROMOSOMA, V119, P589, DOI 10.1007/s00412-010-0280-y; Bhutkar A, 2008, GENETICS, V179, P1657, DOI 10.1534/genetics.107.086108; Bulazel KV, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r170; Cardoso-Moreira M, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002340; Cardoso-Moreira MM, 2010, TRENDS GENET, V26, P243, DOI 10.1016/j.tig.2010.03.002; Clark AG, 2007, NATURE, V450, P203, DOI 10.1038/nature06341; de Wit E, 2009, CHROMOSOMA, V118, P25, DOI 10.1007/s00412-008-0186-0; Diaz-Castillo C, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002475; Engstrom PG, 2007, GENOME RES, V17, P1898, DOI 10.1101/gr.6669607; Everts-van der Wind A, 2005, P NATL ACAD SCI USA, V102, P18526, DOI 10.1073/pnas.0509285102; Everts-van der Wind A, 2004, GENOME RES, V14, P1424, DOI 10.1101/gr.2554404; Filion GJ, 2010, CELL, V143, P212, DOI 10.1016/j.cell.2010.09.009; Grewal SIS, 2003, SCIENCE, V301, P798, DOI 10.1126/science.1086887; HAMMOND MP, 1985, CHROMOSOMA, V91, P279, DOI 10.1007/BF00328223; Kaufmann BP, 1939, P NATL ACAD SCI USA, V25, P571, DOI 10.1073/pnas.25.11.571; Kemkemer C, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-84; Kharchenko PV, 2011, NATURE, V471, P480, DOI 10.1038/nature09725; Larkin DM, 2009, GENOME RES, V19, P770, DOI 10.1101/gr.086546.108; Larkin DM, 2003, GENOME RES, V13, P1966, DOI 10.1101/gr.1560203; Leach TJ, 2000, MOL CELL BIOL, V20, P6308, DOI 10.1128/MCB.20.17.6308-6316.2000; Lindsley D.L., 1992, GENOME DROSOPHILA ME, Veighth; MacAlpine HK, 2010, GENOME RES, V20, P201, DOI 10.1101/gr.097873.109; Makunin IV, 2002, GENETICS, V160, P1023; Moshkin YM, 2002, CHROMOSOMA, V111, P114, DOI 10.1007/s00412-002-0190-8; Murphy WJ, 2005, SCIENCE, V309, P613, DOI 10.1126/science.1111387; Nordman J, 2011, GENOME RES, V21, P175, DOI 10.1101/gr.114611.110; Pevzner P, 2003, P NATL ACAD SCI USA, V100, P7672, DOI 10.1073/pnas.1330369100; Pindyurin AV, 2007, J CELL SCI, V120, P2344, DOI 10.1242/jcs.006007; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Ranz JM, 2012, MOL BIOL EVOL, V29, P13, DOI 10.1093/molbev/msr178; Roy S, 2010, SCIENCE, V330, P1787, DOI 10.1126/science.1198374; Ruiz-Herrera A, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-12-r115; Sahagun V, 2012, GENOME BIOL EVOL, V4, P1054, DOI 10.1093/gbe/evs089; Schibler L, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-194; Schwaiger M, 2009, GENE DEV, V23, P589, DOI 10.1101/gad.511809; Sher N, 2012, GENOME RES, V22, P64, DOI 10.1101/gr.126003.111; Stamatoyannopoulos JA, 2009, NAT GENET, V41, P393, DOI 10.1038/ng.363; van Bemmel JG, 2013, MOL CELL, V49, P759, DOI 10.1016/j.molcel.2013.01.040; Vatolina TY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025960; von Grotthuss M, 2010, GENOME RES, V20, P1084, DOI 10.1101/gr.103713.109; Weber CC, 2012, MOL BIOL EVOL, V29, P873, DOI 10.1093/molbev/msr265; Weber CC, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-3-r23; ZHIMULEV IF, 1982, CHROMOSOMA, V87, P197, DOI 10.1007/BF00338489; Zhimulev IF, 2003, CHROMOSOMA, V111, P377, DOI 10.1007/s00412-002-0218-0	52	8	8	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83319	10.1371/journal.pone.0083319	http://dx.doi.org/10.1371/journal.pone.0083319			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391753	Green Submitted, gold, Green Published			2022-12-25	WOS:000329325200050
J	Bosson, JA; Blomberg, A; Stenfors, N; Helleday, R; Kelly, FJ; Behndig, AF; Mudway, IS				Bosson, Jenny A.; Blomberg, Anders; Stenfors, Nikolai; Helleday, Ragnberth; Kelly, Frank J.; Behndig, Annelie F.; Mudway, Ian S.			Peripheral Blood Neutrophilia as a Biomarker of Ozone-Induced Pulmonary Inflammation	PLOS ONE			English	Article							EXHALED BREATH CONDENSATE; BRONCHOALVEOLAR LAVAGE FLUID; TIME-DEPENDENT CHANGES; AIR-POLLUTION; INHALED OZONE; HUMAN EXPOSURE; MARKERS; MEDIATORS; MORTALITY; CHILDREN	Background: Ozone concentrations are predicted to increase over the next 50 years due to global warming and the increased release of precursor chemicals. It is therefore urgent that good, reliable biomarkers are available to quantify the toxicity of this pollutant gas at the population level. Such a biomarker would need to be easily performed, reproducible, economically viable, and reflective of ongoing pathological processes occurring within the lung. Methodology: We examined whether blood neutrophilia occurred following a controlled ozone challenge and addressed whether this could serve as a biomarker for ozone-induced airway inflammation. Three separate groups of healthy subjects were exposed to ozone (0.2 ppm, 2h) and filtered air (FA) on two separate occasions. Peripheral blood samples were collected and bronchoscopy with biopsy sampling and lavages was performed at 1.5h post exposures in group 1 (n=13), at 6h in group 2 (n=15) and at 18h in group 3 (n=15). Total and differential cell counts were assessed in blood, bronchial tissue and airway lavages. Results: In peripheral blood, we observed fewer neutrophils 1.5h after ozone compared with the parallel air exposure (-1.1 +/- 1.0x10(9) cells/L, p<0.01), at 6h neutrophil numbers were increased compared to FA (+1.2 +/- 1.3x10(9) cells/L, p<0.01), and at 18h this response had fully attenuated. Ozone induced a peak in neutrophil numbers at 6h post exposure in all compartments examined, with a positive correlation between the response in blood and bronchial biopsies. Conclusions: These data demonstrate a systemic neutrophilia in healthy subjects following an acute ozone exposure, which mirrors the inflammatory response in the lung mucosa and lumen. This relationship suggests that blood neutrophilia could be used as a relatively simple functional biomarker for the effect of ozone on the lung.	[Bosson, Jenny A.; Blomberg, Anders; Stenfors, Nikolai; Helleday, Ragnberth; Behndig, Annelie F.] Umea Univ, Dept Publ Hlth & Clin Med, Div Med Resp Med & Allergy, Umea, Sweden; [Stenfors, Nikolai] Dept Med, Div Resp Med & Allergy, Ostersund, Sweden; [Kelly, Frank J.; Mudway, Ian S.] Kings Coll London, MRC PHE Ctr Environm & Hlth, Sch Biomed Sci, London WC2R 2LS, England	Umea University; University of London; King's College London	Mudway, IS (corresponding author), Kings Coll London, MRC PHE Ctr Environm & Hlth, Sch Biomed Sci, London WC2R 2LS, England.	ian.mudway@kcl.ac.uk	Kelly, Frank J/C-6125-2009; Kelly, Frank/ABG-3411-2021; Stenfors, Nikolai/AAK-5334-2020	Kelly, Frank J/0000-0003-2558-8392; Kelly, Frank/0000-0003-2558-8392; Stenfors, Nikolai/0000-0002-1684-1301; Bosson Damewood, Jenny/0000-0003-2380-2607; Blomberg, Anders/0000-0002-2452-7347; Mudway, Ian/0000-0003-1239-5014	Swedish Heart and Lung Foundation; MRC [G0801056] Funding Source: UKRI; Medical Research Council [G1000758, G0801056] Funding Source: researchfish; Asthma UK [MRC-AsthmaUKCentre] Funding Source: researchfish	Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Asthma UK	The study was generously supported by the Swedish Heart and Lung Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Alexis NE, 2004, CLIN IMMUNOL, V111, P126, DOI 10.1016/j.clim.2003.12.002; ARIS RM, 1993, AM REV RESPIR DIS, V148, P1363, DOI 10.1164/ajrccm/148.5.1363; Arjomandi M, 2005, CHEST, V128, P416, DOI 10.1378/chest.128.1.416; BATES DV, 1970, CAN MED ASSOC J, V103, P833; Bell ML, 2004, JAMA-J AM MED ASSOC, V292, P2372, DOI 10.1001/jama.292.19.2372; Blomberg A, 1999, EUR RESPIR J, V13, P1418, DOI 10.1034/j.1399-3003.1999.13f31.x; Brook RD, 2009, HYPERTENSION, V54, P659, DOI 10.1161/HYPERTENSIONAHA.109.130237; Christian DL, 1998, AM J RESP CRIT CARE, V158, P532, DOI 10.1164/ajrccm.158.2.9709023; Corradi M, 2002, TOXICOL LETT, V134, P219, DOI 10.1016/S0378-4274(02)00169-8; Devlin RB, 1996, TOXICOL APPL PHARM, V138, P176, DOI 10.1006/taap.1996.0111; Ghio AJ, 2003, INHAL TOXICOL, V15, P1465, DOI 10.1080/08958370390249111; Halonen JI, 2010, ENVIRON HEALTH-GLOB, V9, DOI 10.1186/1476-069X-9-42; Hermans C, 1999, AM J RESP CRIT CARE, V159, P646, DOI 10.1164/ajrccm.159.2.9806064; Hernandez ML, 2010, J ALLERGY CLIN IMMUN, V126, P537, DOI 10.1016/j.jaci.2010.06.043; Hunt J, 2007, IMMUNOL ALLERGY CLIN, V27, P587, DOI 10.1016/j.iac.2007.09.001; Jorres RA, 2000, AM J RESP CRIT CARE, V161, P1855; KEHRL HR, 1987, AM REV RESPIR DIS, V135, P1124; Kharitonov SA, 2000, EUR RESPIR J, V16, P781, DOI 10.1183/09031936.00.16478100; KOREN HS, 1991, TOXICOL PATHOL, V19, P406, DOI 10.1177/0192623391019004-109; KOREN HS, 1989, AM REV RESPIR DIS, V139, P407, DOI 10.1164/ajrccm/139.2.407; McConnell R, 2002, LANCET, V359, P386, DOI 10.1016/S0140-6736(02)07597-9; MCDONNELL WF, 1991, ARCH ENVIRON HEALTH, V46, P145, DOI 10.1080/00039896.1991.9937441; Miller MD, 2010, ENVIRON HEALTH PERSP, V118, P1155, DOI 10.1289/ehp.0901856; Mills NL, 2009, NAT CLIN PRACT CARD, V6, P36, DOI 10.1038/ncpcardio1399; Montuschi Paolo, 2007, Ther Adv Respir Dis, V1, P5, DOI 10.1177/1753465807082373; Mudway I. S., 2000, Molecular Aspects of Medicine, V21, P1, DOI 10.1016/S0098-2997(00)00003-0; Mudway IS, 2006, FREE RADICAL BIO MED, V40, P1702, DOI 10.1016/j.freeradbiomed.2005.10.050; Mudway IS, 1999, EUR RESPIR J, V13, P1429, DOI 10.1183/09031936.99.13614399; Mudway IS, 2004, AM J RESP CRIT CARE, V169, P1089, DOI 10.1164/rccm.200309-1325PP; Nightingale JA, 1999, THORAX, V54, P1061, DOI 10.1136/thx.54.12.1061; PEDEN DB, 1995, AM J RESP CRIT CARE, V151, P1336, DOI 10.1164/ajrccm.151.5.7735583; Plopper CG, 1998, AM J RESP CELL MOL, V19, P387, DOI 10.1165/ajrcmb.19.3.3183; Ratto J, 2006, ENVIRON HEALTH PERSP, V114, P209, DOI 10.1289/ehp.8341; Robroeks CMHHT, 2010, CLIN EXP ALLERGY, V40, P77, DOI 10.1111/j.1365-2222.2009.03397.x; Rosias PP, 2008, EUR RESPIR J, V31, P934, DOI 10.1183/09031936.00073207; Ruidavets JB, 2005, CIRCULATION, V111, P563, DOI 10.1161/01.CIR.0000154546.32135.6E; SCHELEGLE ES, 1991, AM REV RESPIR DIS, V143, P1353, DOI 10.1164/ajrccm/143.6.1353; Stenfors N, 2002, RESP MED, V96, P352, DOI 10.1053/rmed.2001.1265; Stieb DM, 2009, ENVIRON HEALTH-GLOB, V8, DOI 10.1186/1476-069X-8-25; Tan WC, 2000, AM J RESP CRIT CARE, V161, P1213, DOI 10.1164/ajrccm.161.4.9904084; Thompson AMS, 2010, ENVIRON HEALTH PERSP, V118, P120, DOI 10.1289/ehp.0900550; Thurston GD, 1997, AM J RESP CRIT CARE, V155, P654, DOI 10.1164/ajrccm.155.2.9032209; WHO, 2006, AIR QUAL GUID; Zanobetti A, 2008, AM J RESP CRIT CARE, V177, P184, DOI 10.1164/rccm.200706-823OC	44	10	10	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e81816	10.1371/journal.pone.0081816	http://dx.doi.org/10.1371/journal.pone.0081816			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391708	Green Published, Green Submitted, gold			2022-12-25	WOS:000329325200005
J	Chen, H; Dong, SF; Liu, L; Ma, CA; Zhang, T; Zhu, XM; Mo, JM				Chen, Hao; Dong, Shaofeng; Liu, Lei; Ma, Chuan; Zhang, Tao; Zhu, Xiaomin; Mo, Jiangming			Effects of Experimental Nitrogen and Phosphorus Addition on Litter Decomposition in an Old-Growth Tropical Forest	PLOS ONE			English	Article							SOIL MICROBIAL COMMUNITIES; SIMULATED N DEPOSITION; FATTY-ACID ANALYSIS; SOUTHERN CHINA; ORGANIC-MATTER; TERRESTRIAL ECOSYSTEMS; SUBTROPICAL FORESTS; INORGANIC NITROGEN; MATURE FORESTS; FOLIAR LITTER	The responses of litter decomposition to nitrogen (N) and phosphorus (P) additions were examined in an old-growth tropical forest in southern China to test the following hypotheses: (1) N addition would decrease litter decomposition; (2) P addition would increase litter decomposition, and (3) P addition would mitigate the inhibitive effect of N addition. Two kinds of leaf litter, Schima superba Chardn. & Champ. (S.S.) and Castanopsis chinensis Hance (C.C.), were studied using the litterbag technique. Four treatments were conducted at the following levels: control, N-addition (150 kg N ha(-1) yr(-1)), P-addition (150 kg P ha(-1) yr(-1)) and NP-addition (150 kg N ha(-1) yr(-1) plus 150 kg P ha(-1) yr(-1)). While N addition significantly decreased the decomposition of both litters, P addition significantly inhibited decomposition of C.C., but did not affect the decomposition of S.S. The negative effect of N addition on litter decomposition might be related to the high N-saturation in this old-growth tropical forest; however, the negative effect of P addition might be due to the suppression of "microbial P mining". Significant interaction between N and P addition was found on litter decomposition, which was reflected by the less negative effect in NP-addition plots than those in N-addition plots. Our results suggest that P addition may also have negative effect on litter decomposition and that P addition would mitigate the negative effect of N deposition on litter decomposition in tropical forests.	[Chen, Hao; Dong, Shaofeng; Liu, Lei; Ma, Chuan; Zhang, Tao; Zhu, Xiaomin; Mo, Jiangming] Chinese Acad Sci, South China Bot Garden, Key Lab Vegetat Restorat & Management Degraded Ec, Guangzhou, Guangdong, Peoples R China; [Liu, Lei] Chinese Acad Sci, State Key Lab Urban & Reg Ecol, Res Ctr Ecoenvironm Sci, Beijing, Peoples R China; [Zhang, Tao] Zhanjiang Normal Univ, Inst Trop Pratacultural Sci, Zhanjiang, Peoples R China; [Chen, Hao; Zhu, Xiaomin] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; South China Botanical Garden, CAS; Chinese Academy of Sciences; Research Center for Eco-Environmental Sciences (RCEES); LingNan Normal University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Mo, JM (corresponding author), Chinese Acad Sci, South China Bot Garden, Key Lab Vegetat Restorat & Management Degraded Ec, Guangzhou, Guangdong, Peoples R China.	mojm@scib.ac.cn	Lei, Liu/J-7929-2017; Chen, Hao/U-4752-2017	Lei, Liu/0000-0002-8063-610X; Chen, Hao/0000-0003-3577-2345	National Natural Science Foundation of China [41273143]; National Key Basic Research 973 Programme [2010CB833502]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research 973 Programme(National Basic Research Program of China)	This study was founded by National Natural Science Foundation of China (No: 41273143) and the National Key Basic Research 973 Programme (2010CB833502). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts R, 1997, ECOLOGY, V78, P244, DOI 10.1890/0012-9658(1997)078[0244:NAPMCO]2.0.CO;2; Agren GI, 2001, OECOLOGIA, V128, P94, DOI 10.1007/s004420100646; Anderson JM., 1989, TROPICAL SOIL BIOL F; [Anonymous], 1982, TROP SUBTROP ECOSYS; Barantal S, 2012, ECOSYSTEMS, V15, P1039, DOI 10.1007/s10021-012-9564-9; Bardgett RD, 1996, BIOL FERT SOILS, V22, P261, DOI 10.1007/BF00382522; Bossio DA, 1998, MICROBIAL ECOL, V35, P265, DOI 10.1007/s002489900082; Cleveland CC, 2006, ECOLOGY, V87, P492, DOI 10.1890/05-0525; Cleveland CC, 2006, P NATL ACAD SCI USA, V103, P10316, DOI 10.1073/pnas.0600989103; Craine JM, 2007, ECOLOGY, V88, P2105, DOI 10.1890/06-1847.1; Demoling F, 2008, SOIL BIOL BIOCHEM, V40, P370, DOI 10.1016/j.soilbio.2007.08.019; Downs MR, 1996, OECOLOGIA, V105, P141, DOI 10.1007/BF00328539; Elser JJ, 2007, ECOL LETT, V10, P1135, DOI 10.1111/j.1461-0248.2007.01113.x; Fang H, 2007, PLANT SOIL, V297, P233, DOI 10.1007/s11104-007-9339-9; Fang YT, 2008, BIOGEOSCIENCES, V5, P339, DOI 10.5194/bg-5-339-2008; Fang YT, 2011, GLOBAL CHANGE BIOL, V17, P872, DOI 10.1111/j.1365-2486.2010.02283.x; FOG K, 1988, BIOL REV, V63, P433, DOI 10.1111/j.1469-185X.1988.tb00725.x; Fraterrigo JM, 2006, ECOLOGY, V87, P570, DOI 10.1890/05-0638; Frostegard A, 1996, BIOL FERT SOILS, V22, P59, DOI 10.1007/BF00384433; FROSTEGARD A, 1993, SOIL BIOL BIOCHEM, V25, P723, DOI 10.1016/0038-0717(93)90113-P; Galloway JN, 2004, BIOGEOCHEMISTRY, V70, P153, DOI 10.1007/s10533-004-0370-0; Hammel K. E., 1997, P33; Hietz P, 2011, SCIENCE, V334, P664, DOI 10.1126/science.1211979; Hobbie SE, 2000, ECOLOGY, V81, P1867, DOI 10.1890/0012-9658(2000)081[1867:NLODIH]2.0.CO;2; Huang WJ, 2012, ACTA OECOL, V44, P20, DOI 10.1016/j.actao.2011.06.005; Kaspari M, 2008, ECOL LETT, V11, P35, DOI 10.1111/j.1461-0248.2007.01124.x; KIRK TK, 1987, ANNU REV MICROBIOL, V41, P465, DOI 10.1146/annurev.mi.41.100187.002341; Knorr M, 2005, ECOLOGY, V86, P3252, DOI 10.1890/05-0150; Liu L, 2012, SOIL BIOL BIOCHEM, V44, P31, DOI 10.1016/j.soilbio.2011.08.017; Lu XK, 2012, BIOTROPICA, V44, P302, DOI 10.1111/j.1744-7429.2011.00831.x; Magill AH, 1998, PLANT SOIL, V203, P301, DOI 10.1023/A:1004367000041; Marklein AR, 2012, NEW PHYTOL, V193, P696, DOI 10.1111/j.1469-8137.2011.03967.x; McGroddy ME, 2004, ECOSYSTEMS, V7, P172, DOI 10.1007/s10021-003-0208-y; Micks P, 2004, FOREST ECOL MANAG, V196, P71, DOI 10.1016/j.foreco.2004.03.013; Mo HM, 2003, FOREST ECOL MANAG, V175, P573; Mo J, 2008, GLOBAL CHANGE BIOL, V14, P403, DOI 10.1111/j.1365-2486.2007.01503.x; Mo JM, 2006, PLANT SOIL, V282, P135, DOI 10.1007/s11104-005-5446-7; Moorhead DL, 2006, ECOL MONOGR, V76, P151, DOI 10.1890/0012-9615(2006)076[0151:ATMOLD]2.0.CO;2; OCONNELL AM, 1994, BIOL FERT SOILS, V17, P159, DOI 10.1007/BF00337749; Olander LP, 2000, BIOGEOCHEMISTRY, V49, P175, DOI 10.1023/A:1006316117817; OLSON JS, 1963, ECOLOGY, V44, P322, DOI 10.2307/1932179; Olsson PA, 1999, FEMS MICROBIOL ECOL, V29, P303, DOI 10.1111/j.1574-6941.1999.tb00621.x; Osono T, 2004, ECOL RES, V19, P593, DOI 10.1111/j.1440-1703.2004.00675.x; Prescott CE, 1999, CAN J FOREST RES, V29, P393, DOI 10.1139/cjfr-29-3-393; PRESCOTT CE, 1995, PLANT SOIL, V168, P83, DOI 10.1007/BF00029316; Reay DS, 2008, NAT GEOSCI, V1, P430, DOI 10.1038/ngeo230; Sollins P, 1996, GEODERMA, V74, P65, DOI 10.1016/S0016-7061(96)00036-5; Swift M.J., 1979, DECOMPOSITION TERRES, V5; Treseder KK, 2008, ECOL LETT, V11, P1111, DOI 10.1111/j.1461-0248.2008.01230.x; TUNLID A, 1989, APPL ENVIRON MICROB, V55, P1368, DOI 10.1128/AEM.55.6.1368-1374.1989; Vestgarden LS, 2001, SOIL BIOL BIOCHEM, V33, P465, DOI 10.1016/S0038-0717(00)00187-5; Vitousek PM, 2010, ECOL APPL, V20, P5, DOI 10.1890/08-0127.1; VITOUSEK PM, 1991, BIOGEOCHEMISTRY, V13, P87; Vitousek PM, 1998, ECOSYSTEMS, V1, P401, DOI 10.1007/s100219900033; Waldrop MP, 2004, SOIL BIOL BIOCHEM, V36, P1443, DOI 10.1016/j.soilbio.2004.04.023; WALKER TW, 1976, GEODERMA, V15, P1, DOI 10.1016/0016-7061(76)90066-5; Xu GL, 2006, PEDOSPHERE, V16, P596, DOI 10.1016/S1002-0160(06)60093-3; Zak DR, 1996, ECOL APPL, V6, P257, DOI 10.2307/2269568; Zelles L, 1999, BIOL FERT SOILS, V29, P111, DOI 10.1007/s003740050533; Zhang D.Q., 2000, ACTA ECOL SIN, V20, P938; Zhang T, 2011, BIOGEOSCIENCES, V8, P2847, DOI 10.5194/bg-8-2847-2011	62	48	56	14	173	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84101	10.1371/journal.pone.0084101	http://dx.doi.org/10.1371/journal.pone.0084101			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391895	Green Published, gold, Green Submitted			2022-12-25	WOS:000329323900038
J	Hittinger, M; Czyz, ZT; Huesemann, Y; Maneck, M; Botteron, C; Kaeufl, S; Klein, CA; Polzer, B				Hittinger, Markus; Czyz, Zbigniew T.; Huesemann, Yves; Maneck, Matthias; Botteron, Catherine; Kaeufl, Stephanie; Klein, Christoph A.; Polzer, Bernhard			Molecular Profiling of Single Sca-1(+)/CD34(+,-) Cells-The Putative Murine Lung Stem Cells	PLOS ONE			English	Article							ADULT-MOUSE LUNG; GENE-EXPRESSION; QUANTIFICATION; ADENOCARCINOMA; IDENTIFICATION; GELSOLIN; PROTEIN; AIRWAY; NOISE	Murine bronchioalveolar stem cells play a key role in pulmonary epithelial maintenance and repair but their molecular profile is poorly described so far. In this study, we used antibodies directed against Sca-1 and CD34, two markers originally ascribed to pulmonary cells harboring regenerative potential, to isolate single putative stem cells from murine lung tissue. The mean detection rate of positive cells was 8 per 10(6) lung cells. We then isolated and globally amplified the mRNA of positive cells to analyze gene expression in single cells. The resulting amplicons were then used for molecular profiling by transcript specific polymerase chain reaction (PCR) and global gene expression analysis using microarrays. Single marker-positive cells displayed a striking heterogeneity for the expression of epithelial and mesenchymal transcripts on the single cell level. Nevertheless, they could be subdivided into two cell populations: Sca-1(+)/CD34(-) and Sca-1(+)/CD34(+) cells. In these subpopulations, transcripts of the epithelial marker Epcam (CD326) were exclusively detected in Sca-1(+)/CD34(-) cells (p = 0.03), whereas mRNA of the mesenchymal marker Pdgfr alpha (CD140a) was detected in both subpopulations and more frequently in Sca-1(+)/CD34(+) cells (p = 0.04). FACS analysis confirmed the existence of a Pdgfra positive subpopulation within Epcam(+)/Sca-1(+)/CD34(-) epithelial cells. Gene expression analysis by microarray hybridization identified transcripts differentially expressed between the two cell types as well as between epithelial reference cells and Sca-1(+)/CD34(+) single cells, and selected transcripts were validated by quantitative PCR. Our results suggest a more mesenchymal commitment of Sca-1(+)/CD34(+) cells and a more epithelial commitment of Sca-1(+)/CD34(-) cells. In summary, the study shows that single cell analysis enables the identification of novel molecular markers in yet poorly characterized populations of rare cells. Our results could further improve our understanding of Sca-1(+)/CD34(+,-) cells in the biology of the murine lung.	[Hittinger, Markus; Czyz, Zbigniew T.; Huesemann, Yves; Maneck, Matthias; Kaeufl, Stephanie; Klein, Christoph A.; Polzer, Bernhard] Univ Regensburg, Chair Expt Med & Therapy Res, D-93053 Regensburg, Germany; [Maneck, Matthias] Univ Regensburg, Inst Funct Genom, D-93053 Regensburg, Germany; [Botteron, Catherine; Klein, Christoph A.; Polzer, Bernhard] Fraunhofer Inst Expt Med & Toxicol, Project Grp Personalized Tumor Therapy, Regensburg, Germany	University of Regensburg; University of Regensburg; Fraunhofer Gesellschaft	Polzer, B (corresponding author), Univ Regensburg, Chair Expt Med & Therapy Res, D-93053 Regensburg, Germany.	Bernhard.polzer@klinik.uni-regensburg.de		Klein, Christoph A./0000-0001-7128-1725	German Research Foundation (DFG) [HI 1101/1]; Bavarian Genome Research Network (BayGene)	German Research Foundation (DFG)(German Research Foundation (DFG)); Bavarian Genome Research Network (BayGene)	The work was supported by German Research Foundation (DFG) grant HI 1101/1 (to M. H.) and the Bavarian Genome Research Network (BayGene, C. A. K.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander CM, 2009, CELL STEM CELL, V5, P579, DOI 10.1016/j.stem.2009.11.008; BEARER EL, 1991, J CELL BIOL, V115, P1629, DOI 10.1083/jcb.115.6.1629; Bengtsson M, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-63; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Chen HY, 2012, STEM CELLS, V30, P1948, DOI 10.1002/stem.1150; Chubb JR, 2006, CURR BIOL, V16, P1018, DOI 10.1016/j.cub.2006.03.092; Fine A, 2009, CELL STEM CELL, V4, P468, DOI 10.1016/j.stem.2009.05.012; Hartmann CH, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl740; Huh D, 2011, NAT GENET, V43, P95, DOI 10.1038/ng.729; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Kim CFB, 2005, CELL, V121, P823, DOI 10.1016/j.cell.2005.03.032; Klein CA, 2002, NAT BIOTECHNOL, V20, P387, DOI 10.1038/nbt0402-387; LEE WH, 1986, P NATL ACAD SCI USA, V83, P6790, DOI 10.1073/pnas.83.18.6790; McQualter JL, 2010, P NATL ACAD SCI USA, V107, P1414, DOI 10.1073/pnas.0909207107; McQualter JL, 2009, STEM CELLS, V27, P623, DOI 10.1634/stemcells.2008-0866; Nolen-Walston RD, 2008, AM J PHYSIOL-LUNG C, V294, pL1158, DOI 10.1152/ajplung.00298.2007; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Qian S, 2008, BIOCHEM BIOPH RES CO, V377, P668, DOI 10.1016/j.bbrc.2008.10.052; Raj A, 2008, CELL, V135, P216, DOI 10.1016/j.cell.2008.09.050; Raj A, 2006, PLOS BIOL, V4, P1707, DOI 10.1371/journal.pbio.0040309; Rawlins EL, 2009, CELL STEM CELL, V4, P525, DOI 10.1016/j.stem.2009.04.002; Recktenwald CV, 2008, CANCER RES, V68, P10086, DOI 10.1158/0008-5472.CAN-08-0360; Reiter M, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr505; ROMARIS M, 1991, BIOCHIM BIOPHYS ACTA, V1093, P229, DOI 10.1016/0167-4889(91)90127-J; Shao FC, 2011, TOHOKU J EXP MED, V225, P95, DOI 10.1620/tjem.225.95; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Spence HJ, 2000, ONCOGENE, V19, P1266, DOI 10.1038/sj.onc.1203433; Summer R, 2003, AM J PHYSIOL-LUNG C, V285, pL97, DOI 10.1152/ajplung.00009.2003; Teisanu RM, 2009, STEM CELLS, V27, P612, DOI 10.1634/stemcells.2008-0838; Tiozzo C, 2009, AM J RESP CRIT CARE, V180, P701, DOI 10.1164/rccm.200901-0100OC; Tufvesson E, 2003, J CELL SCI, V116, P4857, DOI 10.1242/jcs.00808; Wiedl T, 2011, J PROTEOMICS, V74, P1884, DOI 10.1016/j.jprot.2011.04.030	33	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83917	10.1371/journal.pone.0083917	http://dx.doi.org/10.1371/journal.pone.0083917			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391845	Green Published, Green Submitted, gold			2022-12-25	WOS:000329325200143
J	Karami, N; Helldal, L; Welinder-Olsson, C; Ahren, C; Moore, ERB				Karami, Nahid; Helldal, Lisa; Welinder-Olsson, Christina; Ahren, Christina; Moore, Edward R. B.			Sub-Typing of Extended-Spectrum-beta-Lactamase-Producing Isolates from a Nosocomial Outbreak: Application of a 10-Loci Generic Escherichia coli Multi-Locus Variable Number Tandem Repeat Analysis	PLOS ONE			English	Article							FIELD GEL-ELECTROPHORESIS; RAPID DETECTION; ENTEROBACTERIACEAE; COLLECTION; CTX-M-15	Extended-spectrum beta-lactamase producing Escherichia coli (ESBL-E. coli) were isolated from infants hospitalized in a neonatal, post-surgery ward during a four-month-long nosocomial outbreak and six-month follow-up period. A multi-locus variable number tandem repeat analysis (MLVA), using 10 loci (GECM-10), for 'generic' (i.e., non-STEC) E. coli was applied for sub-species-level (i.e., sub-typing) delineation and characterization of the bacterial isolates. Ten distinct GECM-10 types were detected among 50 isolates, correlating with the types defined by pulsed-field gel electrophoresis (PFGE), which is recognized to be the 'gold-standard' method for clinical epidemiological analyses. Multi-locus sequence typing (MLST), multiplex PCR genotyping of bla(CTX-M), bla(TEM), bla(OXA) and bla(SHV) genes and antibiotic resistance profiling, as well as a PCR assay specific for detecting isolates of the pandemic O25b-ST131 strain, further characterized the outbreak isolates. Two clusters of isolates with distinct GECM-10 types (G06-04 and G07-02), corresponding to two major PFGE types and the MLST-based sequence types (STs) 131 and 1444, respectively, were confirmed to be responsible for the outbreak. The application of GECM-10 sub-typing provided reliable, rapid and cost-effective epidemiological characterizations of the ESBL-producing isolates from a nosocomial outbreak that correlated with and may be used to replace the laborious PFGE protocol for analyzing generic E. coli.	[Karami, Nahid; Helldal, Lisa; Welinder-Olsson, Christina; Ahren, Christina; Moore, Edward R. B.] Univ Gothenburg, Sahlgrenska Acad, Sahlgrenska Univ Hosp, Dept Clin Microbiol, Gothenburg, Sweden; [Karami, Nahid; Helldal, Lisa; Welinder-Olsson, Christina; Ahren, Christina; Moore, Edward R. B.] Univ Gothenburg, Sahlgrenska Acad, Inst Biomed, Dept Infect Dis, Gothenburg, Sweden; [Ahren, Christina] Sahlgrens Univ Hosp, Gothenburg, Sweden; [Ahren, Christina] Swedish Strateg Programme Antibiot Resistance STR, Gothenburg, Sweden	Sahlgrenska University Hospital; University of Gothenburg; University of Gothenburg; Sahlgrenska University Hospital	Moore, ERB (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Sahlgrenska Univ Hosp, Dept Clin Microbiol, Gothenburg, Sweden.	erbmoore@ccug.se			Vastra Gotaland Region projects [ALFGBG-11574, ALFGBG-210591, VGFOUREG-30781, VGFOUREG-157801]; STRAMA (the Swedish Strategic Programme against Antibiotic Resistance)	Vastra Gotaland Region projects; STRAMA (the Swedish Strategic Programme against Antibiotic Resistance)	The study described in this manuscript was supported by funding from Vastra Gotaland Region projects: ALFGBG-11574; ALFGBG-210591; VGFOUREG-30781; VGFOUREG-157801; and from STRAMA (the Swedish Strategic Programme against Antibiotic Resistance). http://www.fou.nu/is/alfgbg/. http://www.fou.nu/is/vgregion. http://en.strama.se/dyn/,84,,.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amezquita-Lopez BA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051565; Birkett CI, 2007, J MED MICROBIOL, V56, P52, DOI 10.1099/jmm.0.46909-0; Bustamante AV, 2010, INT J MED MICROBIOL, V300, P212, DOI 10.1016/j.ijmm.2009.08.020; Christiansson M, 2011, SCAND J INFECT DIS, V43, P579, DOI 10.3109/00365548.2011.568953; Clermont O, 2009, J ANTIMICROB CHEMOTH, V64, P274, DOI 10.1093/jac/dkp194; Fang H, 2008, J CLIN MICROBIOL, V46, P707, DOI 10.1128/JCM.01943-07; Gautom RK, 1997, J CLIN MICROBIOL, V35, P2977, DOI 10.1128/JCM.35.11.2977-2980.1997; Helldal L, 2013, CLIN MICROBIOL INFEC, V19, pE87, DOI 10.1111/1469-0691.12086; Hussein AIA, 2009, MICROBIOL IMMUNOL, V53, P595, DOI 10.1111/j.1348-0421.2009.00168.x; Jenke C, 2011, J CLIN MICROBIOL, V49, P3644, DOI 10.1128/JCM.05035-11; Johnson JR, 2012, ANTIMICROB AGENTS CH, V56, P2364, DOI 10.1128/AAC.05824-11; Johnson JR, 2012, EMERG INFECT DIS, V18, P598, DOI 10.3201/eid1804.111627; Karama M, 2010, ZOONOSES PUBLIC HLTH, V57, P447, DOI 10.1111/j.1863-2378.2009.01259.x; Lau SH, 2008, J ANTIMICROB CHEMOTH, V62, P1241, DOI 10.1093/jac/dkn380; LEGRAND P, 1989, EUR J CLIN MICROBIOL, V8, P527, DOI 10.1007/BF01967473; Lindstedt BA, 2007, J MICROBIOL METH, V69, P197, DOI 10.1016/j.mimet.2007.01.001; Lobersli I, 2012, J MICROBIOL METH, V88, P134, DOI 10.1016/j.mimet.2011.11.003; Melzer M, 2007, J INFECTION, V55, P254, DOI 10.1016/j.jinf.2007.04.007; Naseer U, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041232; Noller AC, 2003, J CLIN MICROBIOL, V41, P5389, DOI 10.1128/JCM.41.12.5389-5397.2003; Nordmann P, 2011, EMERG INFECT DIS, V17, P1791, DOI 10.3201/eid1710.110655; Peirano G, 2010, INT J ANTIMICROB AG, V36, P19, DOI 10.1016/j.ijantimicag.2010.02.016; Saladin M, 2002, FEMS MICROBIOL LETT, V209, P161, DOI 10.1016/S0378-1097(02)00484-6; Svensson-Stadler LA, 2012, FEMS MICROBIOL LETT, V327, P15, DOI 10.1111/j.1574-6968.2011.02452.x; van Belkum A, 2007, CLIN MICROBIOL INFEC, V13, P1, DOI 10.1111/j.1469-0691.2007.01786.x; Welinder-Olsson C, 2000, EUR J CLIN MICROBIOL, V19, P843, DOI 10.1007/s100960000380; Wirth T, 2006, MOL MICROBIOL, V60, P1136, DOI 10.1111/j.1365-2958.2006.05172.x; Woodford N, 2011, FEMS MICROBIOL REV, V35, P736, DOI 10.1111/j.1574-6976.2011.00268.x; Xu L, 2011, J ANTIMICROB CHEMOTH, V66, P505, DOI 10.1093/jac/dkq482	29	23	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83030	10.1371/journal.pone.0083030	http://dx.doi.org/10.1371/journal.pone.0083030			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391735	Green Published, Green Submitted, gold			2022-12-25	WOS:000329325200032
J	Lustgarten, MS; Price, LL; Phillips, EM; Fielding, RA				Lustgarten, Michael S.; Price, Lori Lyn; Phillips, Edward M.; Fielding, Roger A.			Serum Glycine Is Associated with Regional Body Fat and Insulin Resistance in Functionally-Limited Older Adults	PLOS ONE			English	Article							ADIPOSE-TISSUE DISTRIBUTION; HOMEOSTASIS MODEL ASSESSMENT; AMINO-ACID-METABOLISM; INDUCED DIABETIC-RATS; CARDIOVASCULAR-DISEASE; DEHYDROGENASE-DEFICIENCY; ABDOMINAL OBESITY; SKELETAL-MUSCLE; GLUCOSE; PLASMA	Background: Metabolic profiling may provide insight into biologic mechanisms related to age-related increases in regional adiposity and insulin resistance. Objectives: The objectives of the current study were to characterize the association between mid-thigh intermuscular and subcutaneous adipose tissue (IMAT, SCAT, respectively) and, abdominal adiposity with the serum metabolite profile, to identify significant metabolites as further associated with the homeostasis model assessment of insulin resistance (HOMA-IR), and, to develop a HOMA-IR associated metabolite predictor set representative of regional adiposity, in 73 functionally-limited (short physical performance battery <= 10; SPPB) older adults (age range, 70-85 y). Methods: Fasting levels of 181 total metabolites, including amino acids, fatty acids and acylcarnitines were measured with use of an untargeted mass spectrometry-based metabolomic approach. Multivariable-adjusted linear regression was used in all analyses. Results: Thirty-two, seven and one metabolite(s) were found to be associated with IMAT, abdominal adiposity and, SCAT, respectively, including the amino acid glycine, which was positively associated with SCAT and, negatively associated with both IMAT and abdominal adiposity. Glycine and four metabolites found to be significantly associated with regional adiposity were additionally associated with HOMA-IR. Separate stepwise regression models identified glycine as a HOMA-IR associated marker of both IMAT (model R-2 = 0.51, p < 0.0001) and abdominal adiposity (model R-2 = 0.41, p < 0.0001). Conclusion: Our findings for a positive association between glycine with SCAT but, a negative association between glycine with IMAT and abdominal adiposity supports the hypothesis that SCAT metabolic processes are different from that found in other fat depots. In addition, because of the significant associations found between glycine with HOMA-IR, IMAT, SCAT and abdominal adiposity, our results suggest glycine as a serum biomarker of both insulin sensitivity and regional fat mass in functionally-limited older adults.	[Lustgarten, Michael S.; Phillips, Edward M.; Fielding, Roger A.] Tufts Univ, Jean Mayer USDA Human Nutr Res Ctr, Nutr Exercise Physiol & Sarcopenia Lab, Boston, MA 02111 USA; [Price, Lori Lyn] Tufts Univ, Tufts Med Ctr, Inst Clin Res & Hlth Policy Studies, Boston, MA 02111 USA; [Price, Lori Lyn] Tufts Univ, Tufts Clin & Translat Sci Inst, Boston, MA 02111 USA	Tufts University; United States Department of Agriculture (USDA); Tufts Medical Center; Tufts University; Tufts University	Fielding, RA (corresponding author), Tufts Univ, Jean Mayer USDA Human Nutr Res Ctr, Nutr Exercise Physiol & Sarcopenia Lab, Boston, MA 02111 USA.	Roger.Fielding@tufts.edu	Phillips, Edward/AAN-9693-2020		Dairy Research Institute; Boston Claude D. Pepper Older Americans Independence Center [1P30AG031679]; DOD [W911SR06C0001]; U.S. Department of Agriculture [58-1950-0-014]; NATIONAL INSTITUTE ON AGING [P30AG031679] Funding Source: NIH RePORTER	Dairy Research Institute; Boston Claude D. Pepper Older Americans Independence Center; DOD(United States Department of Defense); U.S. Department of Agriculture(United States Department of Agriculture (USDA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the Dairy Research Institute, the Boston Claude D. Pepper Older Americans Independence Center (1P30AG031679), DOD contract #W911SR06C0001 and in part by the U.S. Department of Agriculture, under agreement No. 58-1950-0-014. Any opinions, findings, conclusion, or recommendations expressed in this publication are those of the author(s) and do not necessarily reflect the view of the U.S. Dept. of Agriculture. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albu JB, 2007, AM J CLIN NUTR, V86, P100, DOI 10.1093/ajcn/86.1.100; Alvarado-Vasquez N, 2003, COMP BIOCHEM PHYS C, V134, P521, DOI 10.1016/S1532-0456(03)00046-2; AVOGARO A, 1989, J LIPID RES, V30, P1811; Bain JR, 2009, DIABETES, V58, P2429, DOI 10.2337/db09-0580; Barbieri M, 2001, DIABETES-METAB RES, V17, P19, DOI 10.1002/dmrr.178; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BODEN G, 1995, J CLIN INVEST, V96, P1261, DOI 10.1172/JCI118160; Boden G, 2001, ENDOCRIN METAB CLIN, V30, P801, DOI 10.1016/S0889-8529(05)70216-4; Bonora E, 2007, DIABETES CARE, V30, P318, DOI 10.2337/dc06-0919; Chale A, 2012, J GERONTOL A; Chen KH, 2011, AM J PHYSIOL-ENDOC M, V301, pE853, DOI 10.1152/ajpendo.00048.2011; Cheng SS, 2012, CIRCULATION, V125, P2222, DOI 10.1161/CIRCULATIONAHA.111.067827; Chevalier S, 2006, DIABETES, V55, P675, DOI 10.2337/diabetes.55.03.06.db05-1117; Connor SC, 2010, MOL BIOSYST, V6, P909, DOI 10.1039/b914182k; Cruz M, 2008, J ENDOCRINOL INVEST, V31, P694, DOI 10.1007/BF03346417; Delmonico MJ, 2009, AM J CLIN NUTR, V90, P1579, DOI 10.3945/ajcn.2009.28047; DENEKE SM, 1989, AM J PHYSIOL, V257, pL163, DOI 10.1152/ajplung.1989.257.4.L163; El Hafidi M, 2004, AM J PHYSIOL-REG I, V287, pR1387, DOI 10.1152/ajpregu.00159.2004; Elbein SC, 2011, DIABETES, V60, P1019, DOI 10.2337/db10-1270; Evans AM, 2009, ANAL CHEM, V81, P6656, DOI 10.1021/ac901536h; FELIG P, 1969, NEW ENGL J MED, V281, P811, DOI 10.1056/NEJM196910092811503; Ferrier D.R., 2013, LIPPINCOTTS ILLUSTRA; Fiehn O, 2002, PLANT MOL BIOL, V48, P155, DOI 10.1023/A:1013713905833; Friedrich N, 2012, OMICS, V16, P612, DOI 10.1089/omi.2012.0066; Frontera WR, 2008, J APPL PHYSIOL, V105, P637, DOI 10.1152/japplphysiol.90332.2008; Gannon MC, 2002, AM J CLIN NUTR, V76, P1302, DOI 10.1093/ajcn/76.6.1302; Ginsberg HN, 2000, J CLIN INVEST, V106, P453, DOI 10.1172/JCI10762; Goodpaster BH, 2000, AM J CLIN NUTR, V71, P885; Goodpaster BH, 2003, DIABETES CARE, V26, P372, DOI 10.2337/diacare.26.2.372; Goss AM, 2012, METABOLISM, V61, P1817, DOI 10.1016/j.metabol.2012.05.016; Ha CY, 2012, CLIN ENDOCRINOL, V76, P674, DOI 10.1111/j.1365-2265.2011.04244.x; Hanley AJG, 2002, DIABETES CARE, V25, P1177, DOI 10.2337/diacare.25.7.1177; Jethva R, 2008, MOL GENET METAB, V95, P195, DOI 10.1016/j.ymgme.2008.09.007; KOHRT WM, 1993, DIABETES, V42, P273, DOI 10.2337/diabetes.42.2.273; Kohrt WM, 1998, CORONARY ARTERY DIS, V9, P489, DOI 10.1097/00019501-199809080-00004; Li M, 2008, P NATL ACAD SCI USA, V105, P2117, DOI 10.1073/pnas.0712038105; Lim SC, 2002, INT J OBESITY, V26, P1511, DOI 10.1038/sj.ijo.0802140; Lim U, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043502; Macotela Y, 2012, DIABETES, V61, P1691, DOI 10.2337/db11-1753; MAGGS DG, 1995, J CLIN INVEST, V96, P370, DOI 10.1172/JCI118043; Magnusson M, 2012, EUR HEART J; MAMER OA, 1992, J BIOL CHEM, V267, P22141; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; MCFARLAN.IG, 1969, BIOCHEM J, V111, P557, DOI 10.1042/bj1110557; Memisogullari R, 2003, CELL BIOCHEM FUNCT, V21, P291, DOI 10.1002/cbf.1025; Meyers KJ, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-160; Murin R, 2008, J NEUROCHEM, V105, P1176, DOI 10.1111/j.1471-4159.2008.05298.x; Newgard CB, 2009, CELL METAB, V9, P311, DOI 10.1016/j.cmet.2009.02.002; Nguyen D, 2013, AGING CELL; Noale M, 2012, DIABETES METAB, V38, P135, DOI 10.1016/j.diabet.2011.09.005; Pietilainen KH, 2008, PLOS MED, V5, DOI 10.1371/journal.pmed.0050051; Sekhar RV, 2011, DIABETES CARE, V34, P162, DOI 10.2337/dc10-1006; She PX, 2007, AM J PHYSIOL-ENDOC M, V293, pE1552, DOI 10.1152/ajpendo.00134.2007; SHIMOKATA H, 1989, J GERONTOL, V44, pM66, DOI 10.1093/geronj/44.2.M66; Smith SR, 2001, METABOLISM, V50, P425, DOI 10.1053/meta.2001.21693; Snijder MB, 2005, DIABETOLOGIA, V48, P301, DOI 10.1007/s00125-004-1637-7; Stern SE, 2005, DIABETES, V54, P333, DOI 10.2337/diabetes.54.2.333; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Tran TT, 2008, CELL METAB, V7, P410, DOI 10.1016/j.cmet.2008.04.004; VESSBY B, 1994, DIABETOLOGIA, V37, P1044, DOI 10.1007/s001250050215; Wang TJ, 2011, NAT MED, V17, P448, DOI 10.1038/nm.2307; Wijekoon EP, 2004, CAN J PHYSIOL PHARM, V82, P506, DOI [10.1139/y04-067, 10.1139/Y04-067]; Wu TF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037210; Yang J, 2004, J CHROMATOGR B, V813, P59, DOI 10.1016/j.jchromb.2004.09.032; Zhang DY, 2007, P NATL ACAD SCI USA, V104, P17075, DOI 10.1073/pnas.0707060104	65	50	50	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84034	10.1371/journal.pone.0084034	http://dx.doi.org/10.1371/journal.pone.0084034			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391874	Green Published, gold, Green Submitted			2022-12-25	WOS:000329323900017
J	Molden, S; Moldestad, O; Storm, JF				Molden, Sturla; Moldestad, Olve; Storm, Johan F.			Estimating Extracellular Spike Waveforms from CA1 Pyramidal Cells with Multichannel Electrodes	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; SINGLE NEURONS; PLACE FIELDS; HIPPOCAMPUS; RECORDINGS; REPRESENTATION; OSCILLATIONS; SEPARATION; FREQUENCY; LIMULUS	Extracellular (EC) recordings of action potentials from the intact brain are embedded in background voltage fluctuations known as the "local field potential" (LFP). In order to use EC spike recordings for studying biophysical properties of neurons, the spike waveforms must be separated from the LFP. Linear low-pass and high-pass filters are usually insufficient to separate spike waveforms from LFP, because they have overlapping frequency bands. Broad-band recordings of LFP and spikes were obtained with a 16-channel laminar electrode array (silicone probe). We developed an algorithm whereby local LFP signals from spike-containing channel were modeled using locally weighted polynomial regression analysis of adjoining channels without spikes. The modeled LFP signal was subtracted from the recording to estimate the embedded spike waveforms. We tested the method both on defined spike waveforms added to LFP recordings, and on in vivo-recorded extracellular spikes from hippocampal CA1 pyramidal cells in anaesthetized mice. We show that the algorithm can correctly extract the spike waveforms embedded in the LFP. In contrast, traditional high-pass filters failed to recover correct spike shapes, albeit produceing smaller standard errors. We found that high-pass RC or 2-pole Butterworth filters with cut-off frequencies below 12.5 Hz, are required to retrieve waveforms comparable to our method. The method was also compared to spike-triggered averages of the broad-band signal, and yielded waveforms with smaller standard errors and less distortion before and after the spike.	[Molden, Sturla; Moldestad, Olve; Storm, Johan F.] Univ Oslo, Dept Physiol, Insitute Basic Med Sci, Oslo 3, Norway	University of Oslo	Molden, S (corresponding author), Univ Oslo, Dept Physiol, Insitute Basic Med Sci, Oslo 3, Norway.	sturla.molden@medisin.uio.no			Norwegian Research Council [178872, 214079]	Norwegian Research Council(Research Council of NorwayEuropean Commission)	Funding from the Norwegian Research Council, grant no. 178872 and 214079. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrian E.D., 1928, BASIS SENSATION ACTI; Anderson E., 1999, LAPACK USERS GUIDE; Bean BP, 2007, NAT REV NEUROSCI, V8, P451, DOI 10.1038/nrn2148; Bialek W., 1996, SPIKES EXPLORING NEU; Bierer SM, 1999, NEUROCOMPUTING, V26-7, P947, DOI 10.1016/S0925-2312(99)00090-9; Buzsaki G, 1998, J NEUROPHYSIOL, V79, P1587, DOI 10.1152/jn.1998.79.3.1587; Buzsaki G, 2002, NEURON, V33, P325, DOI 10.1016/S0896-6273(02)00586-X; COCHRANE D, 1949, J AM STAT ASSOC, V44, P32, DOI 10.2307/2280349; Colgin LL, 2009, NATURE, V462, P353, DOI 10.1038/nature08573; Fyhn M, 2004, SCIENCE, V305, P1258, DOI 10.1126/science.1099901; Fyhn M, 2002, NEURON, V35, P555, DOI 10.1016/S0896-6273(02)00784-5; Gold C, 2006, J NEUROPHYSIOL, V95, P3113, DOI 10.1152/jn.00979.2005; Golub G.H, 1996, J HOPKINS STUDIES MA; Gonzalez R. C., 2008, DIGITAL IMAGE PROCES; Gray CM, 1995, J NEUROSCI METH, V63, P43, DOI 10.1016/0165-0270(95)00085-2; Hafting T, 2005, NATURE, V436, P801, DOI 10.1038/nature03721; Harris KD, 2000, J NEUROPHYSIOL, V84, P401, DOI 10.1152/jn.2000.84.1.401; Hartline HK, 1930, J GEN PHYSIOL, V13, P379, DOI 10.1085/jgp.13.3.379; Henze DA, 2000, J NEUROPHYSIOL, V84, P390, DOI 10.1152/jn.2000.84.1.390; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Hollup SA, 2001, EUR J NEUROSCI, V13, P1197, DOI 10.1046/j.0953-816x.2001.01487.x; Hollup SA, 2001, J NEUROSCI, V21, P1635, DOI 10.1523/JNEUROSCI.21-05-01635.2001; Horowitz P., 2015, ART ELECT; James CJ, 1997, IEEE T BIO-MED ENG, V44, P775, DOI 10.1109/10.605438; KRAMER MA, 1991, AICHE J, V37, P233, DOI 10.1002/aic.690370209; Leutgeb JK, 2007, SCIENCE, V315, P961, DOI 10.1126/science.1135801; Lewicki MS, 1998, NETWORK-COMP NEURAL, V9, pR53, DOI 10.1088/0954-898X/9/4/001; Lin YS, 2005, P ANN INT IEEE EMBS, P7345; Liu JS, 2011, J BIOL RHYTHM, V26, P335, DOI 10.1177/0748730411409712; LLINAS RR, 1988, SCIENCE, V242, P1654, DOI 10.1126/science.3059497; MCNAUGHTON BL, 1983, J NEUROSCI METH, V8, P391, DOI 10.1016/0165-0270(83)90097-3; MCNAUGHTON BL, 1983, EXP BRAIN RES, V52, P41; Moldestad O, 2009, J NEUROSCI METH, V176, P57, DOI 10.1016/j.jneumeth.2008.08.015; Montgomery D. C., 1992, INTRO LINEAR REGRESS; Musial PG, 2002, J NEUROSCI METH, V115, P29, DOI 10.1016/S0165-0270(01)00516-7; Neuralynx Inc, 2000, LYNX 8 AMPL US MAN; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; Oweiss KG, 2001, NEUROCOMPUTING, V38, P1687, DOI 10.1016/S0925-2312(01)00533-1; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Press W. H., 2007, NUMERICAL RECEIPES A; Quiroga RQ, 2009, J NEUROSCI METH, V177, P194, DOI 10.1016/j.jneumeth.2008.09.033; Quiroga RQ, 2013, SCI AM, V308, P30, DOI 10.1038/scientificamerican0213-30; Quiroga RQ, 2012, CURR BIOL, V22, pR45, DOI 10.1016/j.cub.2011.11.005; Quiroga RQ, 2009, CURR BIOL, V19, P1308, DOI 10.1016/j.cub.2009.06.060; Quiroga RQ, 2005, NATURE, V435, P1102, DOI 10.1038/nature03687; RANCK JB, 1973, EXP NEUROL, V41, P462, DOI 10.1016/0014-4886(73)90290-2; Renshaw B, 1940, J NEUROPHYSIOL, V3, P74, DOI 10.1152/jn.1940.3.1.74; Shao LR, 1999, J PHYSIOL-LONDON, V521, P135, DOI 10.1111/j.1469-7793.1999.00135.x; Smith SW, 1997, SCI ENG GUIDE DIGITA; STORM JF, 1990, PROG BRAIN RES, V83, P161; Sullivan D, 2011, J NEUROSCI, V31, P8605, DOI 10.1523/JNEUROSCI.0294-11.2011; Van Drongelen W., 2018, SIGNAL PROCESSING NE, DOI 10.1016/B978-0-12-370867-0.X5000-1; VANDERWOLF CH, 1969, ELECTROEN CLIN NEURO, V26, P407, DOI 10.1016/0013-4694(69)90092-3; VanDrongelen W, 2010, SIGNAL PROCESSING FOR NEUROSCIENTISTS, A COMPANION VOLUME: ADVANCED TOPICS, NONLINEAR TECHNIQUES AND MULTI-CHANNEL ANALYSIS, P1; WIDROW B, 1975, P IEEE, V63, P1692, DOI 10.1109/PROC.1975.10036; YLINEN A, 1995, J NEUROSCI, V15, P30	56	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e82141	10.1371/journal.pone.0082141	http://dx.doi.org/10.1371/journal.pone.0082141			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391714	Green Published, gold, Green Submitted			2022-12-25	WOS:000329325200011
J	Paton, D; Toure, M; Sacko, A; Coulibaly, MB; Traore, SF; Tripet, F				Paton, Doug; Toure, Mahamoudou; Sacko, Adama; Coulibaly, Mamadou B.; Traore, Sekou F.; Tripet, Frederic			Genetic and Environmental Factors Associated with Laboratory Rearing Affect Survival and Assortative Mating but Not Overall Mating Success in Anopheles gambiae Sensu Stricto	PLOS ONE			English	Article							COMPLEX CHROMOSOMAL-ABERRATION; MOLECULAR-FORMS; INCIPIENT SPECIATION; MALARIA VECTORS; MOSQUITOS; FIELD; DIPTERA; COMPETITIVENESS; MALES; CULICIDAE	Anopheles gambiae sensu stricto, the main vector of malaria in Africa, is characterized by its vast geographical range and complex population structure. Assortative mating amongst the reproductively isolated cryptic forms that co-occur in many areas poses unique challenges for programs aiming to decrease malaria incidence via the release of sterile or genetically-modified mosquitoes. Importantly, whether laboratory-rearing affects the ability of An. gambiae individuals of a given cryptic taxa to successfully mate with individuals of their own form in field conditions is still unknown and yet crucial for mosquito-releases. Here, the independent effects of genetic and environmental factors associated with laboratory rearing on male and female survival, mating success and assortative mating were evaluated in the Mopti form of An. gambiae over 2010 and 2011. In semi-field enclosures experiments and despite strong variation between years, the overall survival and mating success of male and female progeny from a laboratory strain was not found to be significantly lower than those of the progeny of field females from the same population. Adult progeny from field-caught females reared at the larval stage in the laboratory and from laboratory females reared outdoors exhibited a significant decrease in survival but not in mating success. Importantly, laboratory individuals reared as larvae indoors were unable to mate assortatively as adults, whilst field progeny reared either outdoors or in the laboratory, as well as laboratory progeny reared outdoors all mated significantly assortatively. These results highlight the importance of genetic and environment interactions for the development of An. gambiae's full mating behavioral repertoire and the challenges this creates for mosquito rearing and release-based control strategies.	[Paton, Doug; Tripet, Frederic] Keele Univ, Inst Sci & Technol Med, Ctr Appl Entomol & Parasitol, Keele, Staffs, England; [Toure, Mahamoudou; Sacko, Adama; Coulibaly, Mamadou B.; Traore, Sekou F.] Univ Sci Tech & Technol Bamako, Fac Med Pharm & Dent, Malaria Res & Training Ctr, Bamako, Mali	Keele University; University of Science & Technology of Bamako	Tripet, F (corresponding author), Keele Univ, Inst Sci & Technol Med, Ctr Appl Entomol & Parasitol, Keele, Staffs, England.	f.tripet@keele.ac.uk	Paton, Douglas/ABB-4877-2020; Coulibaly, Mamadou/AAE-7006-2019; Tripet, Frederic/M-6693-2015	Tripet, Frederic/0000-0002-7939-0712; Paton, Douglas/0000-0001-5755-2410	Wellcome Trust [041085]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by a Wellcome Trust (www.wellcome.ac.uk/) Program Grant (#041085) to FT (co-PI) and PE (PI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboagye-Antwi F, 2010, MALARIA J, V9; Aboagye-Antwi F, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-243; Alphey L, 2002, SCIENCE, V298, P119, DOI 10.1126/science.1078278; ARNOLD SJ, 1994, AM NAT, V143, P317, DOI 10.1086/285606; ASMAN SM, 1981, ANNU REV ENTOMOL, V26, P289, DOI 10.1146/annurev.en.26.010181.001445; BAKER RH, 1980, ANN ENTOMOL SOC AM, V73, P581, DOI 10.1093/aesa/73.5.581; BAKER RH, 1979, ANN ENTOMOL SOC AM, V72, P751, DOI 10.1093/aesa/72.6.751; BATEMAN AJ, 1948, HEREDITY, V2, P349, DOI 10.1038/hdy.1948.21; Benedict MQ, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-S2-S4; Benedict MQ, 2003, TRENDS PARASITOL, V19, P349, DOI 10.1016/S1471-4922(03)00144-2; CHARLWOOD JD, 1980, PHYSIOL ENTOMOL, V5, P315, DOI 10.1111/j.1365-3032.1980.tb00241.x; Coetzee M, 2000, PARASITOL TODAY, V16, P74, DOI 10.1016/S0169-4758(99)01563-X; Coetzee M, 2013, ZOOTAXA, V3619, P246, DOI 10.11646/zootaxa.3619.3.2; COLUZZI M, 1985, B ZOOL, V52, P45, DOI 10.1080/11250008509440343; Costantini C, 1996, MED VET ENTOMOL, V10, P203, DOI 10.1111/j.1365-2915.1996.tb00733.x; Coulibaly MB, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-133; Dao A, 2008, J MED ENTOMOL, V45, P643, DOI 10.1603/0022-2585(2008)45[643:AOAMSI]2.0.CO;2; de Valdez MRW, 2011, P NATL ACAD SCI USA, V108, P4772, DOI 10.1073/pnas.1019295108; della Torre A, 2001, INSECT MOL BIOL, V10, P9, DOI 10.1046/j.1365-2583.2001.00235.x; della Torre A, 2002, SCIENCE, V298, P115, DOI 10.1126/science.1078170; Diabate A, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-184; Diabate A, 2009, P ROY SOC B-BIOL SCI, V276, P4215, DOI 10.1098/rspb.2009.1167; Facchinelli L, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002001; Fanello C, 2002, MED VET ENTOMOL, V16, P461, DOI 10.1046/j.1365-2915.2002.00393.x; Favia G, 2001, INSECT MOL BIOL, V10, P19, DOI 10.1046/j.1365-2583.2001.00236.x; Gary RE, 2009, PARASITE VECTOR, V2, DOI 10.1186/1756-3305-2-19; Gentile G, 2001, INSECT MOL BIOL, V10, P25, DOI 10.1046/j.1365-2583.2001.00237.x; GROVER KK, 1976, B ENTOMOL RES, V66, P469, DOI 10.1017/S0007485300006878; Harris AF, 2011, NAT BIOTECHNOL, V29, P1034, DOI 10.1038/nbt.2019; Hassan MM, 2010, MALAR WORLD J, V1, P2; Ho DH, 2010, J EXP BIOL, V213, P3, DOI 10.1242/jeb.019752; Howell PI, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-S2-S8; JONES MDR, 1978, PHYSIOL ENTOMOL, V3, P213, DOI 10.1111/j.1365-3032.1978.tb00151.x; Klassen W, 2005, STERILE INSECT TECHNIQUE: PRINCIPLES AND PRACTICE IN AREA-WIDE INTEGRATED PEST MANAGEMENT, P3, DOI 10.1007/1-4020-4051-2_1; Lanzaro GC, 2003, WAG UR FRON, V2, P109; Lee HL, 2013, TRANSGENIC RES, V22, P47, DOI 10.1007/s11248-012-9625-z; Lee Y, 2009, J MED ENTOMOL, V46, P316, DOI 10.1603/033.046.0216; Lengeler C, 2004, B WORLD HEALTH ORGAN, V82, P84; Lindsay SW, 1998, P ROY SOC B-BIOL SCI, V265, P847, DOI 10.1098/rspb.1998.0369; MARCHAND RP, 1985, J AM MOSQUITO CONTR, V1, P234; Marrelli MT, 2006, TRENDS PARASITOL, V22, P197, DOI 10.1016/j.pt.2006.03.004; Mitchell SN, 2012, P NATL ACAD SCI USA, V109, P6147, DOI 10.1073/pnas.1203452109; Norris DE, 2001, J MED ENTOMOL, V38, P336, DOI 10.1603/0022-2585-38.2.336; Pennetier C, 2010, CURR BIOL, V20, P131, DOI 10.1016/j.cub.2009.11.040; Pluess B, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006657.pub2; Ranson H, 2011, TRENDS PARASITOL, V27, P91, DOI 10.1016/j.pt.2010.08.004; REISEN WK, 1980, ANN ENTOMOL SOC AM, V73, P479, DOI 10.1093/aesa/73.4.479; Reisen WK, 2003, WAG UR FRON, V2, P25; Sanford MR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027920; Scott TW, 2002, SCIENCE, V298, P117, DOI 10.1126/science.298.5591.117; Sinka ME, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-69; Takken W, 2006, BRIDGING LAB FIELD R, P157; Toure Y. T., 1998, Parassitologia (Rome), V40, P477; Toure YT, 1998, MED VET ENTOMOL, V12, P74, DOI 10.1046/j.1365-2915.1998.00071.x; Tripet F, 2005, J MED ENTOMOL, V42, P596, DOI 10.1603/0022-2585(2005)042[0596:EOSFIM]2.0.CO;2; Tripet F, 2001, MOL ECOL, V10, P1725, DOI 10.1046/j.0962-1083.2001.01301.x; WEIDHAAS DE, 1974, AM J TROP MED HYG, V23, P298, DOI 10.4269/ajtmh.1974.23.298	57	10	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e82631	10.1371/journal.pone.0082631	http://dx.doi.org/10.1371/journal.pone.0082631			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391719	Green Submitted, Green Published, Green Accepted, gold			2022-12-25	WOS:000329325200016
J	Wolf, AB; Vos, M; de Boer, W; Kowalchuk, GA				Wolf, Alexandra B.; Vos, Michiel; de Boer, Wietse; Kowalchuk, George A.			Impact of Matric Potential and Pore Size Distribution on Growth Dynamics of Filamentous and Non-Filamentous Soil Bacteria	PLOS ONE			English	Article							ORGANIC-MATTER; FUNGI; RESPIRATION; DIVERSITY	The filamentous growth form is an important strategy for soil microbes to bridge air-filled pores in unsaturated soils. In particular, fungi perform better than bacteria in soils during drought, a property that has been ascribed to the hyphal growth form of fungi. However, it is unknown if, and to what extent, filamentous bacteria may also display similar advantages over non-filamentous bacteria in soils with low hydraulic connectivity. In addition to allowing for microbial interactions and competition across connected micro-sites, water films also facilitate the motility of non-filamentous bacteria. To examine these issues, we constructed and characterized a series of quartz sand microcosms differing in matric potential and pore size distribution and, consequently, in connection of micro-habitats via water films. Our sand microcosms were used to examine the individual and competitive responses of a filamentous bacterium (Streptomyces atratus) and a motile rod-shaped bacterium (Bacillus weihenstephanensis) to differences in pore sizes and matric potential. The Bacillus strain had an initial advantage in all sand microcosms, which could be attributed to its faster growth rate. At later stages of the incubation, Streptomyces became dominant in microcosms with low connectivity (coarse pores and dry conditions). These data, combined with information on bacterial motility (expansion potential) across a range of pore-size and moisture conditions, suggest that, like their much larger fungal counterparts, filamentous bacteria also use this growth form to facilitate growth and expansion under conditions of low hydraulic conductivity. The sand microcosm system developed and used in this study allowed for precise manipulation of hydraulic properties and pore size distribution, thereby providing a useful approach for future examinations of how these properties influence the composition, diversity and function of soil-borne microbial communities.	[Wolf, Alexandra B.; Vos, Michiel; de Boer, Wietse; Kowalchuk, George A.] Netherlands Inst Ecol NIOO KNAW, Dept Microbial Ecol, Wageningen, Netherlands; [de Boer, Wietse] Wageningen Univ, Dept Soil Qual, NL-6700 AP Wageningen, Netherlands; [Kowalchuk, George A.] Free Univ Amsterdam, Dept Ecol Sci, Amsterdam, Netherlands; [Kowalchuk, George A.] Univ Utrecht, Inst Environm Biol, Utrecht, Netherlands	Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW); Wageningen University & Research; Vrije Universiteit Amsterdam; Utrecht University	Kowalchuk, GA (corresponding author), Netherlands Inst Ecol NIOO KNAW, Dept Microbial Ecol, Wageningen, Netherlands.	g.a.kowalchuk@uu.nl	Kowalchuk, George A/C-4298-2011; de Boer, Wietse/C-2737-2011; KNAW, NIOO-KNAW/A-4320-2012	de Boer, Wietse/0000-0002-5380-2993; Kowalchuk, George/0000-0003-3866-0832; KNAW, NIOO-KNAW/0000-0002-3835-159X	Vici grant of GAK from the Dutch Science Foundation (NWO)	Vici grant of GAK from the Dutch Science Foundation (NWO)(Netherlands Organization for Scientific Research (NWO))	This work was funded by the Vici grant of GAK from the Dutch Science Foundation (NWO) entitled "Crossing the frontiers of microbial ecology". MV was partly supported by investment from the European Regional Development Fund and the European Social Fund Convergence Program for Cornwall and the Isles of Scilly to the ECEHH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON JP, 1973, ARCH MIKROBIOL, V93, P113, DOI 10.1007/BF00424942; Baltz RH., 2007, MICROBE, V2, P125; Carson JK, 2010, APPL ENVIRON MICROB, V76, P3936, DOI 10.1128/AEM.03085-09; Chowdhury N, 2011, SOIL BIOL BIOCHEM, V43, P1229, DOI 10.1016/j.soilbio.2011.02.012; Crawford JW, 2005, TRENDS ECOL EVOL, V20, P81, DOI 10.1016/j.tree.2004.11.014; Danielson R. E., 1986, METHODS SOIL ANAL PH; FAEGRI A, 1977, SOIL BIOL BIOCHEM, V9, P105, DOI 10.1016/0038-0717(77)90045-1; Griffin DM, 1985, BACTERIA NATURE, P221; HORN R, 1994, SOIL TILL RES, V30, P187, DOI 10.1016/0167-1987(94)90005-1; Kohlmeier S, 2005, ENVIRON SCI TECHNOL, V39, P4640, DOI 10.1021/es047979z; Lehmann J, 2008, NAT GEOSCI, V1, P238, DOI 10.1038/ngeo155; MCCARTHY AJ, 1992, GENE, V115, P189, DOI 10.1016/0378-1119(92)90558-7; Nimmo J. R., 2004, ENCY SOILS ENV, V3, P295, DOI DOI 10.1016/B978-0-12-409548-9.05265-9; Or D, 2007, ADV WATER RESOUR, V30, P1505, DOI 10.1016/j.advwatres.2006.05.025; Otten W, 1999, SOIL BIOL BIOCHEM, V31, P1803, DOI 10.1016/S0038-0717(99)00099-1; Papendick R. I., 1981, SPECIAL PUBLICATION, V9, P1; Remus-Emsermann M, 2012, THESIS; Ruamps LS, 2011, SOIL BIOL BIOCHEM, V43, P280, DOI 10.1016/j.soilbio.2010.10.010; Schrempf H., 2007, PROKARYOTES HDB BIOL, P21; Treves DS, 2003, MICROB ECOL, V45, P20, DOI 10.1007/s00248-002-1044-x; van Genuchten M.T., 1991, EPA600291065 US SAL; Vos M, 2013, FEMS MICROBIOL REV, V37, P936, DOI 10.1111/1574-6976.12023; Vreeken-Buijs MJ, 1998, SOIL BIOL BIOCHEM, V30, P97, DOI 10.1016/S0038-0717(97)00064-3; Warmink JA, 2011, SOIL BIOL BIOCHEM, V43, P760, DOI 10.1016/j.soilbio.2010.12.009; Warmink JA, 2009, APPL ENVIRON MICROB, V75, P2820, DOI 10.1128/AEM.02110-08; Watve MG, 2001, ARCH MICROBIOL, V176, P386, DOI 10.1007/s002030100345; WILSON JM, 1975, SOIL BIOL BIOCHEM, V7, P269, DOI 10.1016/0038-0717(75)90066-8; WONG PTW, 1976, SOIL BIOL BIOCHEM, V8, P215, DOI 10.1016/0038-0717(76)90006-7; Young IM, 2008, ADV AGRON, V100, P81, DOI 10.1016/S0065-2113(08)00604-4; Yuste JC, 2011, GLOBAL CHANGE BIOL, V17, P1475, DOI 10.1111/j.1365-2486.2010.02300.x	30	63	63	2	83	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83661	10.1371/journal.pone.0083661	http://dx.doi.org/10.1371/journal.pone.0083661			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391805	Green Published, gold, Green Submitted			2022-12-25	WOS:000329325200103
J	Caffrey, E; Ingoldsby, H; Wall, D; Webber, M; Dinneen, K; Murillo, LS; Inderhaug, C; Newell, J; Gupta, S; Callagy, G				Caffrey, Emer; Ingoldsby, Helen; Wall, Deirdre; Webber, Mark; Dinneen, Kate; Murillo, Laura S.; Inderhaug, Celine; Newell, John; Gupta, Sanjeev; Callagy, Grace			Prognostic Significance of Deregulated Dicer Expression in Breast Cancer	PLOS ONE			English	Article							CENTRALLY REVIEWED EXPRESSION; IMMUNOHISTOCHEMICAL ANALYSIS; PROGESTERONE-RECEPTORS; PROLIFERATION MARKERS; ADJUVANT THERAPY; PREDICTIVE-VALUE; BCL-2 PROTEIN; DROSHA; MICRORNAS; ESTROGEN	Background: Dicer, an RNase III-type endonuclease, is the key enzyme involved in RNA interference and microRNA pathways. Aberrant expression of Dicer is reported in several human cancers. Our aim was to assess the prognostic role of Dicer in breast cancer. Methods: The entire series comprised 666 invasive breast cancers (IBCs), 480 DCIS cases (397 associated with IBC and 83 pure DCIS) and 305 lymph node metastases. Cytoplasmic Dicer expression by immunohistochemistry was scored as negative (no staining) and positive (weak, moderate or strong staining). Results: Dicer staining was assessable in 446 IBC, 128 DCIS and 101 lymph node metastases. Expression of Dicer was observed in 33% (145/446) of IBCs, 34% (44/128) of DCIS and 57% (58/101) of lymph node metastases. Dicer expression was increased in nodal metastases compared to primary tumours (p< 0.001); and was associated with ER negativity (p<0.001), HER2 positivity (p<0.001), high Ki67 labeling index (p<0.001) and expression of basal-like biomarkers (p = 0.002). Dicer positivity was more frequent in the HER2 overexpressing (p<0.001) and basal-like (p = 0.002) subtypes compared to luminal A subtype. Dicer expression was associated with reduced overall survival (OS) on univariate analysis (p = 0.058) and remained an independent predictor of OS on multivariate analysis (HR 2.84, 95% CI 1.43-5.62, p = 0.003), with nodal status (HR 2.61, 95% CI 1.18-5.80, p = 0.018) and PR (HR 0.28, 95% CI 0.13-0.59, p = 0.001). Further, moderate or strong expression of Dicer was associated with improved disease-free survival in the HER2-overexpressing subtype compared to negative or weak expression (p = 0.038). Conclusion: Deregulated Dicer expression is associated with aggressive tumour characteristics and is an independent prognostic factor for OS. Our findings suggest that Dicer is an important prognostic marker in breast cancer and that its prognostic role may be subtype specific.	[Caffrey, Emer; Ingoldsby, Helen; Webber, Mark; Dinneen, Kate; Murillo, Laura S.; Inderhaug, Celine; Gupta, Sanjeev; Callagy, Grace] Natl Univ Ireland, Inst Clin Sci, Sch Med, Galway, Ireland; [Wall, Deirdre] Natl Univ Ireland, Sch Math Stat & Appl Math, Galway, Ireland; [Newell, John] Natl Univ Ireland, HRB Clin Res Facil, Galway, Ireland	Ollscoil na Gaillimhe-University of Galway; Ollscoil na Gaillimhe-University of Galway; Health Research Board - Ireland; Ollscoil na Gaillimhe-University of Galway	Callagy, G (corresponding author), Natl Univ Ireland, Inst Clin Sci, Sch Med, Galway, Ireland.	grace.callagy@nuigalway.ie	Gupta, Sanjeev/AAG-9749-2020; gupta, sanjeev/B-2824-2008	Gupta, Sanjeev/0000-0002-4691-6853; gupta, sanjeev/0000-0002-4691-6853; Newell, John/0000-0001-7685-6655; Wall, Deirdre/0000-0001-6510-6082; Murillo, Laura/0000-0002-2493-8584	Health Research Board [HRA_HSR/2010/24]; National University of Ireland, Galway; Breast Cancer Campaign [2011PR26]	Health Research Board; National University of Ireland, Galway; Breast Cancer Campaign	This publication has emanated from research conducted with the financial support of the Health Research Board [grant number HRA_HSR/2010/24], Millennium Fund from National University of Ireland, Galway to S. G. and Breast Cancer Campaign [grant number 2011PR26 (to G.C.)]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2005, NHSBSP PUBL, V58; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Beezhold KJ, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-134; Blenkiron C, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r214; Brown RW, 1996, CLIN CANCER RES, V2, P585; Bu Y, 2009, ONCOL REP, V21, P13, DOI 10.3892/or_00000183; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Cancer IUA, 2009, TNM CLASSIFICATION M; Cheng C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-r90; Chin K, 2006, CANCER CELL, V10, P529, DOI 10.1016/j.ccr.2006.10.009; Chiosea SI, 2008, VIRCHOWS ARCH, V452, P629, DOI 10.1007/s00428-007-0574-5; Chiosea S, 2007, CANCER RES, V67, P2345, DOI 10.1158/0008-5472.CAN-06-3533; Chiosea S, 2006, AM J PATHOL, V169, P1812, DOI 10.2353/ajpath.2006.060480; Cochrane Dawn R., 2010, Hormones & Cancer, V1, P306, DOI 10.1007/s12672-010-0043-5; Dedes KJ, 2011, EUR J CANCER, V47, P138, DOI 10.1016/j.ejca.2010.08.007; Dowsett M, 2008, J CLIN ONCOL, V26, P1059, DOI 10.1200/JCO.2007.12.9437; Elledge RM, 1997, J CLIN ONCOL, V15, P1916, DOI 10.1200/JCO.1997.15.5.1916; ELSTON CW, 1991, HISTOPATHOLOGY, V19, P403, DOI 10.1111/j.1365-2559.1991.tb00229.x; Emmerth S, 2010, DEV CELL, V18, P102, DOI 10.1016/j.devcel.2009.11.011; Faber C, 2011, EUR J CANCER, V47, P1414, DOI 10.1016/j.ejca.2011.01.006; Faggad A, 2012, HISTOPATHOLOGY; Faggad A, 2010, J PATHOL, V220, P382, DOI 10.1002/path.2658; Farazi TA, 2011, CANCER RES, V71, P4443, DOI 10.1158/0008-5472.CAN-11-0608; Flavin RJ, 2008, MODERN PATHOL, V21, P676, DOI 10.1038/modpathol.2008.33; Gregory RI, 2005, CELL, V123, P631, DOI 10.1016/j.cell.2005.10.022; Grelier G, 2009, BRIT J CANCER, V101, P673, DOI 10.1038/sj.bjc.6605193; Guo XF, 2012, J CANCER RES CLIN, V138, P49, DOI 10.1007/s00432-011-1058-1; Harbeck N, 1999, BRIT J CANCER, V80, P419, DOI 10.1038/sj.bjc.6690373; Hill DA, 2009, SCIENCE, V325, P965, DOI 10.1126/science.1174334; Hinkal GW, 2011, BRIT J CANCER, V104, P387, DOI 10.1038/sj.bjc.6606022; Jansen RLH, 1998, BRIT J CANCER, V78, P460, DOI 10.1038/bjc.1998.515; Karube Y, 2005, CANCER SCI, V96, P111, DOI 10.1111/j.1349-7006.2005.00015.x; Khoshnaw SM, 2012, BREAST CANCER RES TR, V135, P403, DOI 10.1007/s10549-012-2169-3; Kononen J, 1998, NAT MED, V4, P844, DOI 10.1038/nm0798-844; Kumar MS, 2007, NAT GENET, V39, P673, DOI 10.1038/ng2003; Kumar MS, 2009, GENE DEV, V23, P2700, DOI 10.1101/gad.1848209; Lambertz I, 2010, CELL DEATH DIFFER, V17, P633, DOI 10.1038/cdd.2009.202; Le MG, 1999, INT J CANCER, V84, P562, DOI 10.1002/(SICI)1097-0215(19991222)84:6<562::AID-IJC4>3.0.CO;2-0; Ma ZH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020494; Martello G, 2010, CELL, V141, P1195, DOI 10.1016/j.cell.2010.05.017; Melo SA, 2010, CANCER CELL, V18, P303, DOI 10.1016/j.ccr.2010.09.007; Melo SA, 2009, NAT GENET, V41, P365, DOI 10.1038/ng.317; Menard S, 1999, BREAST CANCER RES TR, V55, P169; Merritt WM, 2008, NEW ENGL J MED, V359, P2641, DOI 10.1056/NEJMoa0803785; Moran MS, 2009, BREAST J, V15, P571, DOI 10.1111/j.1524-4741.2009.00833.x; Noh Hyangsoon, 2011, Genes Cancer, V2, P140, DOI 10.1177/1947601911408888; Osanai T, 2005, JPN J CLIN ONCOL, V35, P121, DOI 10.1093/jjco/hyi036; Papachristou DJ, 2012, HISTOPATHOLOGY, V60, pE28, DOI 10.1111/j.1365-2559.2012.04192.x; Papachristou DJ, 2012, CANCER INVEST, V30, P172, DOI 10.3109/07357907.2011.633293; Passon N, 2012, J CLIN PATHOL, V65, P320, DOI 10.1136/jclinpath-2011-200496; Pawitan Y, 2005, BREAST CANCER RES, V7, pR953, DOI 10.1186/bcr1325; Regan MM, 2006, JNCI-J NATL CANCER I, V98, P1571, DOI 10.1093/jnci/djj415; Shu GS, 2012, PATHOL RES PRACT, V208, P392, DOI 10.1016/j.prp.2012.05.001; SILVESTRINI R, 1994, J NATL CANCER I, V86, P499, DOI 10.1093/jnci/86.7.499; Sinkkonen L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012175; Slade I, 2011, J MED GENET, V48, P273, DOI 10.1136/jmg.2010.083790; Spyratos F, 2002, CANCER-AM CANCER SOC, V94, P2151, DOI 10.1002/cncr.10458; Stratmann J, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-345; Sugito N, 2006, CLIN CANCER RES, V12, P7322, DOI 10.1158/1078-0432.CCR-06-0515; Tan P, 1997, CANCER RES, V57, P1259; Tchemitsa O, 2010, J PATHOL, V222, P310, DOI 10.1002/path.2759; Vaksman O, 2012, HUMAN PATHOLOGY; VERONESE SM, 1993, CANCER, V71, P3926, DOI 10.1002/1097-0142(19930615)71:12<3926::AID-CNCR2820711221>3.0.CO;2-2; Viale G, 2008, J CLIN ONCOL, V26, P1404, DOI 10.1200/JCO.2007.10.6393; Viale G, 2007, J CLIN ONCOL, V25, P3846, DOI 10.1200/JCO.2007.11.9453; Wolff AC, 2007, ARCH PATHOL LAB MED, V131, P18, DOI 10.1043/1543-2165(2007)131[18:ASOCCO]2.0.CO;2; Yan M, 2012, PATHOL ONCOL RES, V18, P343, DOI 10.1007/s12253-011-9450-3; Yi R, 2003, GENE DEV, V17, P3011, DOI 10.1101/gad.1158803	68	17	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e83724	10.1371/journal.pone.0083724	http://dx.doi.org/10.1371/journal.pone.0083724			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386264	Green Published, gold, Green Submitted			2022-12-25	WOS:000329194700060
J	Tsai, LY; Chang, YW; Lin, PY; Chou, HJ; Liu, TJ; Lee, PT; Huang, WH; Tsou, YL; Huang, YS				Tsai, Li-Yun; Chang, Yu-Wei; Lin, Pei-Yi; Chou, Hsin-Jung; Liu, Ta-Jen; Lee, Ping-Tao; Huang, Wen-Hsuan; Tsou, Yueh-Liang; Huang, Yi-Shuian			CPEB4 Knockout Mice Exhibit Normal Hippocampus-Related Synaptic Plasticity and Memory	PLOS ONE			English	Article							TRANSLATIONAL CONTROL; CELLULAR SENESCENCE; RNA TRANSLATION; MESSENGER-RNA; NEURONS; FORMS; CYCLE; GENE	Regulated RNA translation is critical to provide proteins needed to maintain persistent modification of synaptic strength, which underlies the molecular basis of long-term memory (LTM). Cytoplasmic polyadenylation element-binding proteins (CPEBs) are sequence-specific RNA-binding proteins and regulate translation in various tissues. All four CPEBs in vertebrates are expressed in the brain, including the hippocampal neurons, suggesting their potential roles in translation-dependent plasticity and memory. Although CPEB1 and CPEB3 have been shown to control specific kinds of hippocampus-related LTM, the role of CPEB2 and CPEB4 in learning and memory remains elusive. Thus, we generated CPEB4 knockout (KO) mice and analyzed them using several behavioral tests. No difference was found in the anxiety level, motor coordination, hippocampus-dependent learning and memory between the KO mice and their wild-type (WT) littermates. Electrophysiological recordings of multiple forms of synaptic plasticity in the Schaffer collateral pathway-CA1 neurons also showed normal responses in the KO hippocampal slices. Morphological analyses revealed that the CPEB4-lacking pyramidal neurons possessed slightly elongated dendritic spines. Unlike its related family members, CPEB1 and CPEB3, CPEB4 seems to be dispensable for hippocampus-dependent plasticity, learning and memory.	[Tsai, Li-Yun; Chang, Yu-Wei; Lin, Pei-Yi; Chou, Hsin-Jung; Liu, Ta-Jen; Lee, Ping-Tao; Huang, Wen-Hsuan; Tsou, Yueh-Liang; Huang, Yi-Shuian] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan; [Chang, Yu-Wei; Huang, Yi-Shuian] Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan; [Liu, Ta-Jen; Huang, Yi-Shuian] Natl Yang Ming Univ, Inst Neurosci, Taipei 112, Taiwan	Academia Sinica - Taiwan; National Defense Medical Center; National Yang Ming Chiao Tung University	Huang, YS (corresponding author), Acad Sinica, Inst Biomed Sci, Taipei, Taiwan.	yishuian@ibms.sinica.edu.tw	Huang, Yi-Shuian/P-2824-2018	Huang, Yi-Shuian/0000-0001-9000-7748; Lin, Pei-Yi/0000-0001-7447-3212	National Science Council [NSC 102-2628-B-001-007-MY3]; Academia Sinica in Taiwan [AS-100-TP-B09]	National Science Council(Ministry of Science and Technology, Taiwan); Academia Sinica in Taiwan(Academia Sinica - Taiwan)	This work was supported by National Science Council [NSC 102-2628-B-001-007-MY3] and Academia Sinica [AS-100-TP-B09] in Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alarcon JM, 2004, LEARN MEMORY, V11, P318, DOI 10.1101/lm.72704; Alexandrov IM, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002457; Berger-Sweeney J, 2006, LEARN MEMORY, V13, P4, DOI 10.1101/lm.73706; Burns DM, 2008, GENE DEV, V22, P3449, DOI 10.1101/gad.1697808; Chao HW, 2013, J NEUROSCI, V 33, P17008, DOI 10.1523/JNEUROSCI.3043-13.2013; Chao HW, 2012, NUCLEIC ACIDS RES, V40, P8484, DOI 10.1093/nar/gks598; Chen PJ, 2012, EMBO J, V31, P959, DOI 10.1038/emboj.2011.448; Groisman I, 2002, CELL, V109, P473, DOI 10.1016/S0092-8674(02)00733-X; Groisman I, 2006, GENE DEV, V20, P2701, DOI 10.1101/gad.1438906; Huang YS, 2006, EMBO J, V25, P4865, DOI 10.1038/sj.emboj.7601322; Igea A, 2010, EMBO J, V29, P2182, DOI 10.1038/emboj.2010.111; Kan MC, 2010, MOL CELL BIOL, V30, P5658, DOI 10.1128/MCB.00716-10; Keleman K, 2007, NAT NEUROSCI, V10, P1587, DOI 10.1038/nn1996; LeFur N, 1996, GENOMICS, V37, P245; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Novoa I, 2010, NAT CELL BIOL, V12, P447, DOI 10.1038/ncb2046; Ortiz-Zapater E, 2012, NAT MED, V18, P83, DOI 10.1038/nm.2540; Patterson SL, 2001, NEURON, V32, P123, DOI 10.1016/S0896-6273(01)00443-3; Pavlopoulos E, 2011, CELL, V147, P1369, DOI 10.1016/j.cell.2011.09.056; Tay J, 2001, DEV CELL, V1, P201, DOI 10.1016/S1534-5807(01)00025-9; Theis M, 2003, P NATL ACAD SCI USA, V100, P9602, DOI 10.1073/pnas.1133424100; Wang CF, 2012, MOL CELL BIOL, V32, P3321, DOI 10.1128/MCB.00296-12; Xi HK, 2006, IMMUNITY, V24, P813, DOI 10.1016/j.immuni.2006.03.023	23	23	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e84978	10.1371/journal.pone.0084978	http://dx.doi.org/10.1371/journal.pone.0084978			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386439	Green Published, Green Submitted, gold			2022-12-25	WOS:000329194700124
J	Yatsuda, J; Irie, A; Harada, K; Michibata, Y; Tsukamoto, H; Senju, S; Tomita, Y; Yuno, A; Hirayama, M; Abu Sayem, M; Takeda, N; Shibuya, I; Sogo, S; Fujiki, F; Sugiyama, H; Eto, M; Nishimura, Y				Yatsuda, Junji; Irie, Atsushi; Harada, Kumiko; Michibata, Yayoi; Tsukamoto, Hirotake; Senju, Satoru; Tomita, Yusuke; Yuno, Akira; Hirayama, Masatoshi; Abu Sayem, Mohammad; Takeda, Naoki; Shibuya, Isao; Sogo, Shinji; Fujiki, Fumihiro; Sugiyama, Haruo; Eto, Masatoshi; Nishimura, Yasuharu			Establishment of HLA-DR4 Transgenic Mice for the Identification of CD4(+) T Cell Epitopes of Tumor-Associated Antigens	PLOS ONE			English	Article							DENDRITIC CELLS; MELANOMA; HELPER; VACCINATION; GENERATION; PEPTIDES; SURVIVAL; IMMUNITY; COMPLEX; MEMORY	Reports have shown that activation of tumor-specific CD4(+) helper T (Th) cells is crucial for effective anti-tumor immunity and identification of Th-cell epitopes is critical for peptide vaccine-based cancer immunotherapy. Although computer algorithms are available to predict peptides with high binding affinity to a specific HLA class II molecule, the ability of those peptides to induce Th-cell responses must be evaluated. We have established HLA-DR4 (HLA-DRA*01:01/HLA-DRB1*04:05) transgenic mice (Tgm), since this HLA-DR allele is most frequent (13.6%) in Japanese population, to evaluate HLA-DR4-restricted Th-cell responses to tumor-associated antigen (TAA)-derived peptides predicted to bind to HLA-DR4. To avoid weak binding between mouse CD4 and HLA-DR4, Tgm were designed to express chimeric HLA-DR4/I-E-d, where I-E-d alpha 1 and beta 1 domains were replaced with those from HLA-DR4. Th cells isolated from Tgm immunized with adjuvant and HLA-DR4-binding cytomegalovirus-derived peptide proliferated when stimulated with peptide-pulsed HLA-DR4-transduced mouse L cells, indicating chimeric HLA-DR4/I-E-d has equivalent antigen presenting capacity to HLA-DR4. Immunization with CDCA1(55-78) peptide, a computer algorithm-predicted HLA-DR4-binding peptide derived from TAA CDCA1, successfully induced Th-cell responses in Tgm, while immunization of HLA-DR4-binding Wilms' tumor 1 antigen-derived peptide with identical amino acid sequence to mouse ortholog failed. This was overcome by using peptide-pulsed syngeneic bone marrow-derived dendritic cells (BM-DC) followed by immunization with peptide/CFA booster. BM-DC-based immunization of KIF20A(494-517) peptide from another TAA KIF20A, with an almost identical HLA-binding core amino acid sequence to mouse ortholog, successfully induced Th-cell responses in Tgm. Notably, both CDCA1(55-78) and KIF20A(494-517) peptides induced human Th-cell responses in PBMCs from HLA-DR4-positive donors. Finally, an HLA-DR4 binding DEPDC1(191-213) peptide from a new TAA DEPDC1 overexpressed in bladder cancer induced strong Th-cell responses both in Tgm and in PBMCs from an HLA-DR4-positive donor. Thus, the HLA-DR4 Tgm combined with computer algorithm was useful for preliminary screening of candidate peptides for vaccination.	[Yatsuda, Junji; Irie, Atsushi; Harada, Kumiko; Michibata, Yayoi; Tsukamoto, Hirotake; Senju, Satoru; Tomita, Yusuke; Yuno, Akira; Hirayama, Masatoshi; Abu Sayem, Mohammad; Nishimura, Yasuharu] Kumamoto Univ, Grad Sch Med Sci, Dept Immunogenet, Kumamoto, Japan; [Yatsuda, Junji; Eto, Masatoshi] Kumamoto Univ, Grad Sch Med Sci, Dept Urol, Kumamoto, Japan; [Abu Sayem, Mohammad] Mawlana Bhashani Sci & Technol Univ, Dept Biotechnol & Genet Engn, Tangail, Bangladesh; [Takeda, Naoki] Kumamoto Univ, Inst Resource Dev & Anal, Div Transgen Technol, Kumamoto, Japan; [Shibuya, Isao; Sogo, Shinji] Otsuka Pharmaceut Co Ltd, Microbiol Res Inst, Tokushima 77101, Japan; [Fujiki, Fumihiro] Osaka Univ, Grad Sch Med, Dept Canc Immunol, Osaka, Japan; [Sugiyama, Haruo] Osaka Univ, Grad Sch Med, Dept Funct Diagnost Sci, Osaka, Japan	Kumamoto University; Kumamoto University; Mawlana Bhashani Science & Technology University; Kumamoto University; Otsuka Pharmaceutical; Osaka University; Osaka University	Nishimura, Y (corresponding author), Kumamoto Univ, Grad Sch Med Sci, Dept Immunogenet, Kumamoto, Japan.	mxnishim@gpo.kumamoto-u.ac.jp	Tsukamoto, Hirotake/GRJ-7436-2022; Tsukamoto, Hirotake/S-2448-2019	Tsukamoto, Hirotake/0000-0003-3214-1652; Sayem, Mohammad Abu/0000-0001-9903-6959	Ministry of Education, Culture, Sports, Science, and Technology, Japan [22133005, 24300334]; Otsuka Pharmaceutical Co., Ltd.; Grants-in-Aid for Scientific Research [24700991, 23510243] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Otsuka Pharmaceutical Co., Ltd.(Otsuka Pharmaceutical); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants-in-aid Nos. 22133005 and 24300334 to YN from the Ministry of Education, Culture, Sports, Science, and Technology, Japan (http://www.mext.go.jp/) and a collaborative research funding from Otsuka Pharmaceutical Co., Ltd. (http://www.otsuka.co.jp/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banchereau J, 2005, NAT REV IMMUNOL, V5, P296, DOI 10.1038/nri1592; Bevan MJ, 2004, NAT REV IMMUNOL, V4, P595, DOI 10.1038/nri1413; BRINSTER RL, 1985, P NATL ACAD SCI USA, V82, P4438, DOI 10.1073/pnas.82.13.4438; Castellino F, 2006, ANNU REV IMMUNOL, V24, P519, DOI 10.1146/annurev.immunol.23.021704.115825; Claerhout S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024662; Corthay A, 2005, IMMUNITY, V22, P371, DOI 10.1016/j.immuni.2005.02.003; Dobrzanski MJ, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00063; Fujiki F, 2007, J IMMUNOTHER, V30, P282, DOI 10.1097/01.cji.0000211337.91513.94; Giuntoli RL, 2002, CLIN CANCER RES, V8, P922; Gritzapis AD, 2010, CANCER RES, V70, P2686, DOI 10.1158/0008-5472.CAN-09-2517; Harada Y, 2010, CANCER RES, V70, P5829, DOI 10.1158/0008-5472.CAN-10-0255; Harao M, 2008, INT J CANCER, V123, P2616, DOI 10.1002/ijc.23823; Hayama S, 2006, CANCER RES, V66, P10339, DOI 10.1158/0008-5472.CAN-06-2137; Imai K, 2011, BRIT J CANCER, V104, P300, DOI 10.1038/sj.bjc.6606052; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; Janssen EM, 2003, NATURE, V421, P852, DOI 10.1038/nature01441; Kanehira M, 2007, ONCOGENE, V26, P6448, DOI 10.1038/sj.onc.1210466; Kantoff PW, 2010, NEW ENGL J MED, V363, P411, DOI 10.1056/NEJMoa1001294; Labeur MS, 1999, J IMMUNOL, V162, P168; Obara W, 2012, JPN J CLIN ONCOL, V42, P591, DOI 10.1093/jjco/hys069; Osawa R, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/848042; Osen W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014137; Patel SD, 1997, P NATL ACAD SCI USA, V94, P8082, DOI 10.1073/pnas.94.15.8082; Quezada SA, 2010, J EXP MED, V207, P637, DOI 10.1084/jem.20091918; Ridge JP, 1998, NATURE, V393, P474, DOI 10.1038/30989; Schoenberger SP, 1998, NATURE, V393, P480, DOI 10.1038/31002; Shedlock DJ, 2003, SCIENCE, V300, P337, DOI 10.1126/science.1082305; Slingluff CL, 2013, CLIN CANCER RES, V19, P4228, DOI 10.1158/1078-0432.CCR-13-0002; Sugita S, 2006, INVEST OPHTH VIS SCI, V47, P2547, DOI 10.1167/iovs.05-1547; Taniuchi K, 2005, CANCER RES, V65, P105; TOMITA Y, 2013, INT J CANC IN PRESS; Tomita Y, 2013, CLIN CANCER RES, V19, P4508, DOI 10.1158/1078-0432.CCR-13-0197; Williams MA, 2006, IMMUNOL REV, V211, P146, DOI 10.1111/j.0105-2896.2006.00389.x; WOODS A, 1994, J EXP MED, V180, P173, DOI 10.1084/jem.180.1.173; Woods K, 2013, CLIN CANCER RES, V19, P4021, DOI 10.1158/1078-0432.CCR-13-1349; Xie Y, 2010, J EXP MED, V207, P651, DOI 10.1084/jem.20091921; Yamashita J, 2012, ACTA DERM-VENEREOL, V92, P593, DOI 10.2340/00015555-1416	37	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e84908	10.1371/journal.pone.0084908	http://dx.doi.org/10.1371/journal.pone.0084908			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386437	Green Published, gold, Green Submitted			2022-12-25	WOS:000329194700122
J	Grammes, F; Reveco, FE; Romarheim, OH; Landsverk, T; Mydland, LT; Overland, M				Grammes, Fabian; Reveco, Felipe Eduardo; Romarheim, Odd Helge; Landsverk, Thor; Mydland, Liv Torunn; Overland, Margareth			Candida utilis and Chlorella vulgaris Counteract Intestinal Inflammation in Atlantic Salmon (Salmo salar L.)	PLOS ONE			English	Article							TROUT ONCORHYNCHUS-MYKISS; MEAL-INDUCED ENTERITIS; SOYBEAN-MEAL; DISTAL INTESTINE; ANTIMICROBIAL PEPTIDES; ULCERATIVE-COLITIS; CROHNS-DISEASE; PROTEIN; MAINTENANCE; ENTEROPATHY	Intestinal inflammation, caused by impaired intestinal homeostasis, is a serious condition in both animals and humans. The use of conventional extracted soybean meal (SBM) in diets for Atlantic salmon and several other fish species is known to induce enteropathy in the distal intestine, a condition often referred to as SBM induced enteropathy (SBMIE). In the present study, we investigated the potential of different microbial ingredients to alleviate SBMIE in Atlantic salmon, as a model of feed-induced inflammation. The dietary treatments consisted of a negative control based on fish meal (FM), a positive control based on 20% SBM, and four experimental diets combining 20% SBM with either one of the three yeasts Candida utilis (CU), Kluyveromyces marxianus (KM), Saccharomyces cerevisiae (SC) or the microalgae Chlorella vulgaris (CV). Histopathological examination of the distal intestine showed that all fish fed the SC or SBM diets developed characteristic signs of SBMIE, while those fed the FM, CV or CU diets showed a healthy intestine. Fish fed the KM diet showed intermediate signs of SBMIE. Corroborating results were obtained when measuring the relative length of PCNA positive cells in the crypts of the distal intestine. Gene set enrichment analysis revealed decreased expression of amino acid, fat and drug metabolism pathways as well as increased expression of the pathways for NOD-like receptor signalling and chemokine signalling in both the SC and SBM groups while CV and CU were similar to FM and KM was intermediate. Gene expression of antimicrobial peptides was reduced in the groups showing SBMIE. The characterisation of microbial communities using PCR-DGGE showed a relative increased abundance of Firmicutes bacteria in fish fed the SC or SBM diets. Overall, our results show that both CU and CV were highly effective to counteract SBMIE, while KM had less effect and SC had no functional effects.	[Grammes, Fabian; Reveco, Felipe Eduardo; Romarheim, Odd Helge; Mydland, Liv Torunn; Overland, Margareth] Norwegian Univ Life Sci, Dept Anim & Aquacultural Sci, CoE, Aquaculture Prot Ctr, As, Norway; [Landsverk, Thor] Norwegian Sch Vet Sci, Dept Basic Sci & Aquat Med, Oslo, Norway	Norwegian University of Life Sciences; Norwegian University of Life Sciences	Overland, M (corresponding author), Norwegian Univ Life Sci, Dept Anim & Aquacultural Sci, CoE, Aquaculture Prot Ctr, As, Norway.	margareth.overland@umb.no	Mydland, Liv Torunn/AAO-2783-2020	Grammes, Fabian/0000-0002-9551-9280	Research Council of Norway [417091]	Research Council of Norway(Research Council of Norway)	The research was financed by the Research Council of Norway (www.forskningsradet.no), grant no. 417091. The yeast was provided by Borregaard ASA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Artis D, 2008, NAT REV IMMUNOL, V8, P411, DOI 10.1038/nri2316; Baeverfjord G, 1996, J FISH DIS, V19, P375, DOI 10.1111/j.1365-2761.1996.tb00376.x; Bakke-McKellep AM, 2007, J FISH DIS, V30, P13, DOI 10.1111/j.1365-2761.2007.00769.x; Bakke-McKellep AM, 2007, BRIT J NUTR, V97, P699, DOI 10.1017/S0007114507381397; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berge KE, 2000, SCIENCE, V290, P1771, DOI 10.1126/science.290.5497.1771; Bevins CL, 2011, NAT REV MICROBIOL, V9, P356, DOI 10.1038/nrmicro2546; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Burrells C, 1999, VET IMMUNOL IMMUNOP, V72, P277, DOI 10.1016/S0165-2427(99)00143-9; Crosnier C, 2006, NAT REV GENET, V7, P349, DOI 10.1038/nrg1840; Desai AR, 2012, AQUACULTURE, V350, P134, DOI 10.1016/j.aquaculture.2012.04.005; Escaffre AM, 2007, AQUACULTURE, V273, P127, DOI 10.1016/j.aquaculture.2007.09.028; Findley MK, 2009, IUBMB LIFE, V61, P431, DOI 10.1002/iub.175; Frankel G, 1998, MOL MICROBIOL, V30, P911, DOI 10.1046/j.1365-2958.1998.01144.x; Gatlin DM, 2007, AQUAC RES, V38, P551, DOI 10.1111/j.1365-2109.2007.01704.x; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Hanzelmann S, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-7; Hardin JA, 2004, CELL TISSUE RES, V318, P313, DOI 10.1007/s00441-004-0932-4; Hashimoto T, 2012, NATURE, V487, P477, DOI 10.1038/nature11228; Hylemon PB, 2009, J LIPID RES, V50, P1509, DOI 10.1194/jlr.R900007-JLR200; Janczyk P, 2007, ANIM FEED SCI TECH, V132, P163, DOI 10.1016/j.anifeedsci.2006.03.007; Khor B, 2011, NATURE, V474, P307, DOI 10.1038/nature10209; Kimball SR, 2006, AM J CLIN NUTR, V83, p500S; Kleiveland CR, 2013, APPL ENVIRON MICROB, V79, P48, DOI 10.1128/AEM.02464-12; Kobayashi KS, 2005, SCIENCE, V307, P731, DOI 10.1126/science.1104911; Kortner T. M., 2012, BR J NUTR, V30, P1; Kortner TM, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-101; Krogdahl A, 2003, AQUACULT NUTR, V9, P361, DOI 10.1046/j.1365-2095.2003.00264.x; Krogdahl A, 2010, AQUAC RES, V41, P333, DOI 10.1111/j.1365-2109.2009.02426.x; Lomax AE, 2005, NEUROGASTROENT MOTIL, V17, P4, DOI 10.1111/j.1365-2982.2004.00607.x; Manocha M, 2012, CLIN TRANSL GASTROEN, V3, pe13, DOI [10.1038/ctg.2012.8, DOI 10.1038/CTG.2012.8]; Mansfield GS, 2010, AQUACULTURE, V307, P95, DOI 10.1016/j.aquaculture.2010.07.014; Marjara IS, 2012, CYTOKINE, V60, P186, DOI 10.1016/j.cyto.2012.05.027; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; Muise AM, 2009, GUT, V58, P1121, DOI 10.1136/gut.2008.175117; Nordrum S, 2000, COMP BIOCHEM PHYS B, V125, P317, DOI 10.1016/S0305-0491(99)00190-X; Nuding S, 2007, GUT, V56, P1240, DOI 10.1136/gut.2006.118646; Ogata H., 1999, NUCLEIC ACIDS RES, V27, P29, DOI DOI 10.1093/nar/27.1.29; Overland M, 2009, AQUACULTURE, V288, P305, DOI 10.1016/j.aquaculture.2008.12.012; Overland M, 2013, AQUACULTURE, V402, P1, DOI 10.1016/j.aquaculture.2013.03.016; Overland M, 2010, ARCH ANIM NUTR, V64, P171, DOI 10.1080/17450391003691534; Penn MH, 2011, AQUACULTURE, V310, P267, DOI 10.1016/j.aquaculture.2010.10.040; Refstie S, 2006, AQUACULTURE, V261, P392, DOI 10.1016/j.aquaculture.2006.08.005; Romarheim O.H., 2012, BR J NUTR, P1, DOI [10.1017/S0007114512002899, DOI 10.1017/S0007114512002899]; Romarheim OH, 2013, AQUACULTURE, V402, P13, DOI 10.1016/j.aquaculture.2013.03.011; Romarheim OH, 2011, J NUTR, V141, P124, DOI 10.3945/jn.110.128900; Sahlmann C, 2013, FISH SHELLFISH IMMUN, V34, P599, DOI 10.1016/j.fsi.2012.11.031; Salzman NH, 2010, NAT IMMUNOL, V11, P76, DOI 10.1038/ni.1825; Samarakoon K, 2012, FOOD RES INT, V48, P948, DOI 10.1016/j.foodres.2012.03.013; Samiec PS, 2000, TOXICOL SCI, V54, P52, DOI 10.1093/toxsci/54.1.52; Silphaduang U, 2006, DIS AQUAT ORGAN, V72, P241, DOI 10.3354/dao072241; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Sveinbjornsson B, 1996, J FISH DIS, V19, P349, DOI 10.1111/j.1365-2761.1996.tb00373.x; Troyanskaya O, 2001, BIOINFORMATICS, V17, P520, DOI 10.1093/bioinformatics/17.6.520; Uran PA, 2008, FISH SHELLFISH IMMUN, V25, P751, DOI 10.1016/j.fsi.2008.02.013; vandenIngh TSGAM, 1996, J FISH DIS, V19, P47; VANDENINGH TSGAM, 1991, AQUACULTURE, V94, P297, DOI 10.1016/0044-8486(91)90174-6; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wakasugi T, 1997, P NATL ACAD SCI USA, V94, P5967, DOI 10.1073/pnas.94.11.5967; Wehkamp J, 2005, P NATL ACAD SCI USA, V102, P18129, DOI 10.1073/pnas.0505256102; Wells JM, 2011, P NATL ACAD SCI USA, V108, P4607, DOI 10.1073/pnas.1000092107; Yu ZT, 2004, APPL ENVIRON MICROB, V70, P4800, DOI 10.1128/AEM.70.8.4800-4806.2004; Zar JH, 1996, BIOSTAT ANAL, P211	65	57	58	5	91	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e83213	10.1371/journal.pone.0083213	http://dx.doi.org/10.1371/journal.pone.0083213			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281RE	24386162	Green Submitted, Green Published, Green Accepted, gold			2022-12-25	WOS:000329117900025
J	White, JR; McCormick, MI; Meekan, MG				White, James R.; McCormick, Mark I.; Meekan, Mark G.			Syndromes or Flexibility: Behavior during a Life History Transition of a Coral Reef Fish	PLOS ONE			English	Article							INDIVIDUAL-DIFFERENCES; PERSONALITY-TRAITS; GASTEROSTEUS-ACULEATUS; PUMPKINSEED SUNFISH; ANIMAL PERSONALITY; BOLDNESS; MORTALITY; ECOLOGY; SELECTION; SHYNESS	The theory of behavioral syndromes focuses on quantifying variation in behavior within and among individual organisms and attempts to account for the maintenance of differences in behavior that occur in a consistent manner among individuals. Behavioral syndromes have potentially important ecological consequences (e.g. survivorship tradeoffs) and can be shaped by population dynamics through selective mortality. Here, we search for any evidence for consistency of behavior across situations in juveniles of a common damselfish, Pomacentrus amboinensis (Pomacentridae) at the transition between larval habitats in the plankton and juvenile habitats on the reef. Naive fish leaving the pelagic phase to settle on reefs were caught by light traps and their behaviors observed using similar methods across three different situations (small aquaria, large aquaria, field setting); all of which represent low risk and well-sheltered environments. Seven behavioral traits were compared within and among individuals across situations to determine if consistent behavioral syndromes existed. No consistency was found in any single or combination of behavioral traits for individuals across all situations. We suggest that high behavioral flexibility is likely beneficial for newly-settled fish at this ontogenetic transition and it is possible that consistent behavioral syndromes are unlikely to emerge in juveniles until environmental experience is gained or certain combinations of behaviors are favored by selective mortality.	[White, James R.; McCormick, Mark I.] James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia; [Meekan, Mark G.] Univ Western Australia, Australian Inst Marine Sci, Crawley, WA, Australia	James Cook University; Australian Institute of Marine Science; University of Western Australia	White, JR (corresponding author), James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia.	james.ryan.white@gmail.com	McCormick, Mark I/J-8301-2014	McCormick, Mark I/0000-0001-9289-1645; White, James/0000-0001-7977-1956; Meekan, Mark/0000-0002-3067-9427	ARC Centre of Excellence for Coral Reef Studies	ARC Centre of Excellence for Coral Reef Studies(Australian Research Council)	This work was supported by the ARC Centre of Excellence for Coral Reef Studies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adriaenssens B, 2011, BEHAV ECOL, V22, P135, DOI 10.1093/beheco/arq185; Almany GR, 2006, CORAL REEFS, V25, P19, DOI 10.1007/s00338-005-0044-y; Ambrose R, 2006, ANIM BEHAV, V72, P1135, DOI [10.1016/j.anbehav.2006.04.001., DOI 10.1016/J.ANBEHAV.2006.04.001]; Bell AM, 2007, ECOL LETT, V10, P828, DOI 10.1111/j.1461-0248.2007.01081.x; Bell AM, 2005, J EVOLUTION BIOL, V18, P464, DOI 10.1111/j.1420-9101.2004.00817.x; Biro PA, 2008, TRENDS ECOL EVOL, V23, P361, DOI 10.1016/j.tree.2008.04.003; Biro PA, 2010, P ROY SOC B-BIOL SCI, V277, P71, DOI 10.1098/rspb.2009.1346; Brown C, 2005, ANIM BEHAV, V70, P1003, DOI 10.1016/j.anbehav.2004.12.022; Budaev SV, 2010, ETHOLOGY, V116, P472, DOI 10.1111/j.1439-0310.2010.01758.x; Careau V, 2008, OIKOS, V117, P641, DOI 10.1111/j.0030-1299.2008.16513.x; Clarke A, 1999, J ANIM ECOL, V68, P893, DOI 10.1046/j.1365-2656.1999.00337.x; Coleman K, 1998, ANIM BEHAV, V56, P927, DOI 10.1006/anbe.1998.0852; Conrad JL, 2011, J FISH BIOL, V78, P395, DOI 10.1111/j.1095-8649.2010.02874.x; Corp IBM., 2017, IBM SPSS STAT WINDOW; Dall SRX, 2004, ECOL LETT, V7, P734, DOI 10.1111/j.1461-0248.2004.00618.x; Dingemanse NJ, 2005, BEHAVIOUR, V142, P1159, DOI 10.1163/156853905774539445; Doherty PJ, 2004, ECOLOGY, V85, P2422, DOI 10.1890/04-0366; Dugatkin LA, 2003, ETHOL ECOL EVOL, V15, P43; Frost AJ, 2007, P ROY SOC B-BIOL SCI, V274, P333, DOI 10.1098/rspb.2006.3751; Fuiman LA, 2010, OECOLOGIA, V164, P99, DOI 10.1007/s00442-010-1712-3; Gerlai R, 2003, BEHAV GENET, V33, P461, DOI 10.1023/A:1025762314250; Gosling SD, 2001, PSYCHOL BULL, V127, P45, DOI 10.1037//0033-2909.127.1.45; Gosselin LA, 1997, MAR ECOL PROG SER, V146, P265, DOI 10.3354/meps146265; Holmes TH, 2010, MAR ECOL PROG SER, V399, P273, DOI 10.3354/meps08337; Houston AI, 1999, MODELS ADAPTIVE BEHA; Kerrigan BA, 1996, MAR ECOL PROG SER, V135, P27, DOI 10.3354/meps135027; Koolhaas JM, 1999, NEUROSCI BIOBEHAV R, V23, P925, DOI 10.1016/S0149-7634(99)00026-3; Lonnstedt OM, 2012, P R SOC B, DOI [10.1098/rspb.2001.2516., DOI 10.1098/RSPB.2001.2516]; Marks C, 2005, COPEIA, P901, DOI 10.1643/0045-8511(2005)005[0901:DEACAI]2.0.CO;2; McCormick MI, 2010, MAR ECOL PROG SER, V407, P173, DOI 10.3354/meps08583; McCormick MI, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007096; McCormick MI, 1997, MAR ECOL PROG SER, V153, P247, DOI 10.3354/meps153247; McCormick MI, 2002, MAR BIOL, V141, P841, DOI 10.1007/s00227-002-0883-9; Meekan MG, 2010, ANIM BEHAV, V79, P803, DOI 10.1016/j.anbehav.2009.12.002; Meekan MG, 2001, MAR BIOL, V139, P373; Munday PL, 2001, ECOLOGY, V82, P2177, DOI 10.1890/0012-9658(2001)082[2177:ICACIA]2.0.CO;2; PITCHER CR, 1988, CORAL REEFS, V7, P105, DOI 10.1007/BF00300969; Quinn GP, 2003, EXPT DESIGN DATA ANA; Reale D, 2007, BIOL REV, V82, P291, DOI 10.1111/j.1469-185X.2007.00010.x; Sih A, 2004, TRENDS ECOL EVOL, V19, P372, DOI 10.1016/j.tree.2004.04.009; Sih A, 2008, ADV STUD BEHAV, V38, P227, DOI 10.1016/S0065-3454(08)00005-3; Sinn DL, 2005, J COMP PSYCHOL, V119, P99, DOI 10.1037/0735-7036.119.1.99; Sneddon LU, 2003, J FISH BIOL, V62, P971, DOI 10.1046/j.1095-8649.2003.00084.x; STAMPS JA, 1991, AM ZOOL, V31, P338; Stamps JA, 2007, ECOL LETT, V10, P355, DOI 10.1111/j.1461-0248.2007.01034.x; Sundstrom LF, 2004, BEHAV ECOL, V15, P192, DOI 10.1093/beheco/arg089; Toms CN., 2010, INT J COMPPSYCHOL, V23, P1, DOI DOI 10.1002/CPMO.17; White JR, 2013, PLOS ONE, P8; Wilson ADM, 2009, BEHAV ECOL, V20, P231, DOI 10.1093/beheco/arp018; WILSON DS, 1993, J COMP PSYCHOL, V107, P250, DOI 10.1037/0735-7036.107.3.250; Wilson DS, 1998, PHILOS T R SOC B, V353, P199, DOI 10.1098/rstb.1998.0202; WILSON DS, 1994, TRENDS ECOL EVOL, V9, P442, DOI 10.1016/0169-5347(94)90134-1	52	9	9	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e84262	10.1371/journal.pone.0084262	http://dx.doi.org/10.1371/journal.pone.0084262			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	281RE	24386358	Green Accepted, Green Published, gold, Green Submitted			2022-12-25	WOS:000329117900087
J	Liu, Q; Liu, SL; Zhao, HD; Deng, L; Wang, C; Zhao, QH; Dong, SK				Liu, Qi; Liu, Shiliang; Zhao, Haidi; Deng, Li; Wang, Cong; Zhao, Qinghe; Dong, Shikui			Longitudinal Variability of Phosphorus Fractions in Sediments of a Canyon Reservoir Due to Cascade Dam Construction: A Case Study in Lancang River, China	PLOS ONE			English	Article							MANWAN RESERVOIR; LAKE-SEDIMENTS; TRACE-ELEMENTS; DALIAO RIVER; HEAVY-METALS; HAIHE RIVER; GRAIN-SIZE; RELEASE; WATER; SORPTION	Dam construction causes the accumulation of phosphorus in the sediments of reservoirs and increases the release rate of internal phosphorus (P) loading. This study investigated the longitudinal variability of phosphorus fractions in sediments and the relationship between the contents of phosphorus fractions and its influencing factors of the Manwan Reservoir, Lancang River, Yunnan Province, China. Five sedimentary phosphorus fractions were quantified separately: loosely bound P (ex-P); reductant soluble P (BD-P); metal oxide-bound P (NaOH-P); calcium-bound P (HCl-P), and residual-P. The results showed that the total phosphorus contents ranged from 623 to 899 mu g/g and were correlated positively with iron content in the sediments of the reservoir. The rank order of P fractions in sediments of the mainstream was HCl-P. NaOHP. residual-P. BD-P. ex-P, while it was residual-P. HCl-P. NaOH-P. BD-P. ex-P in those of the tributaries. The contents of bio-available phosphorus in the tributaries, including ex-P, BD-P and NaOH-P, were significantly lower than those in the mainstream. The contents of ex-P, BD-P, NaOH-P showed a similar increasing trend from the tail to the head of the Manwan Reservoir, which contributed to the relatively higher content of bio-available phosphorus, and represents a high bio-available phosphorus releasing risk within a distance of 10 km from Manwan Dam. Correlation and redundancy analyses showed that distance to Manwan Dam and the silt/clay fraction of sediments were related closely to the spatial variation of bio-available phosphorus.	[Liu, Qi; Liu, Shiliang; Zhao, Haidi; Deng, Li; Wang, Cong; Zhao, Qinghe; Dong, Shikui] Beijing Normal Univ, Sch Environm, State Key Lab Water Environm Simulat, Beijing 100875, Peoples R China	Beijing Normal University	Liu, SL (corresponding author), Beijing Normal Univ, Sch Environm, State Key Lab Water Environm Simulat, Beijing 100875, Peoples R China.	shiliangliu@bnu.edu.cn	Liu, Shiliang/N-1885-2019		Non-profit Environment Protection Specific Project of China [201209029-4]; National Natural Sciences Foundation of China [50939001]	Non-profit Environment Protection Specific Project of China; National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC))	This research was funded by the Non-profit Environment Protection Specific Project of China (No. 201209029-4) and the National Natural Sciences Foundation of China (No. 50939001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrieux-Loyer F, 2001, ESTUAR COAST SHELF S, V52, P617, DOI 10.1006/ecss.2001.0766; [Anonymous], [No title captured]; Birks H.J.B., 1995, STAT MODELING QUATER, P116, DOI DOI 10.1002/JQS.3390010111; BOSTROM B, 1988, HYDROBIOLOGIA, V170, P229, DOI 10.1007/BF00024907; Christophoridis C, 2006, J ENVIRON QUAL, V35, P1181, DOI 10.2134/jeq2005.0213; COOKE GD, 1977, HYDROBIOLOGIA, V56, P129, DOI 10.1007/BF00023351; DANENLOUWERSE H, 1993, HYDROBIOLOGIA, V253, P311, DOI 10.1007/BF00050751; de Vicente I, 2010, HYDROBIOLOGIA, V651, P253, DOI 10.1007/s10750-010-0304-x; Dittrich M, 2013, WATER RES, V47, P1433, DOI 10.1016/j.watres.2012.12.006; FARMER JG, 1994, AQUAT CONSERV, V4, P45, DOI 10.1002/aqc.3270040105; Fu KD, 2008, QUATERN INT, V186, P91, DOI 10.1016/j.quaint.2007.09.041; Fytianos K, 2005, ENVIRON MONIT ASSESS, V100, P191, DOI 10.1007/s10661-005-4770-y; GOLTERMAN HL, 1988, HYDROBIOLOGIA, V159, P149, DOI 10.1007/BF00014722; Gong GC, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL025800; Gonzalez CM, 1998, J ENVIRON MANAGE, V53, P73, DOI 10.1006/jema.1998.0194; Han L, 2011, SOIL SEDIMENT CONTAM, V20, P30, DOI 10.1080/15320383.2011.528469; [He Daming 何大明], 2004, [云南大学学报. 自然科学版, Journal of Yunnan University (Natural Science)], V26, P220; [何大明 He Daming], 2005, [地球科学进展, Advance in Earth Sciences], V20, P338; Heath SK, 2010, WATER RES, V44, P4226, DOI 10.1016/j.watres.2010.05.026; Hong YN, 2010, J HAZARD MATER, V181, P556, DOI 10.1016/j.jhazmat.2010.05.049; Huang KM, 2003, CHEMOSPHERE, V53, P1113, DOI 10.1016/S0045-6535(03)00592-7; Hupfer M, 1995, AQUAT SCI, V57, P305, DOI 10.1007/BF00878395; Jacobs JW, 2002, GEOGR J, V168, P354, DOI 10.1111/j.0016-7398.2002.00061.x; JACOBY JM, 1982, WATER RES, V16, P911, DOI 10.1016/0043-1354(82)90022-7; Jin XC, 2006, ENVIRON POLLUT, V139, P288, DOI 10.1016/j.envpol.2005.05.010; Kaiserli A, 2002, CHEMOSPHERE, V46, P1147, DOI 10.1016/S0045-6535(01)00242-9; Kim LH, 2003, CHEMOSPHERE, V50, P53, DOI 10.1016/S0045-6535(02)00310-7; Kopacek J, 2005, ENVIRON SCI TECHNOL, V39, P8784, DOI 10.1021/es050916b; Kozerski HP, 2007, INT REV HYDROBIOL, V83, P77; Lanza GR, 2011, EUTROPHICATION: CAUSES, CONSEQUENCES AND CONTROL, P373, DOI 10.1007/978-90-481-9625-8_19; Lin CY, 2009, J HAZARD MATER, V170, P278, DOI 10.1016/j.jhazmat.2009.04.102; Liu H., 1998, ADV WATER SCI, V9, P70; Liu SL, 2008, ECOL ENG, V34, P91, DOI 10.1016/j.ecoleng.2008.07.006; Luo XX, 2012, GEOMORPHOLOGY, V179, P126, DOI 10.1016/j.geomorph.2012.05.034; Maazouzi C, 2013, J SOIL SEDIMENT, V13, P207, DOI 10.1007/s11368-012-0622-x; MORSE JW, 1978, LIMNOL OCEANOGR, V23, P825, DOI 10.4319/lo.1978.23.4.0825; Onema JMK, 2006, PHYS CHEM EARTH, V31, P870, DOI 10.1016/j.pce.2006.08.022; Ouyang W, 2011, WATER RESOUR MANAG, V25, P913, DOI 10.1007/s11269-010-9733-6; Pan K, 2012, SCI TOTAL ENVIRON, V421, P3, DOI 10.1016/j.scitotenv.2011.03.013; Pettersson K, 2001, SCI TOTAL ENVIRON, V266, P79, DOI 10.1016/S0048-9697(00)00737-3; Psenner R., 1988, ADV LIMNOLOGY, V30, P43; Psenner R, 1984, ARCH HYDROBIOL, V1; Ramm K, 1997, HYDROBIOLOGIA, V342, P43, DOI 10.1023/A:1017092618517; Ribeiro DC, 2008, CHEMOSPHERE, V70, P1256, DOI 10.1016/j.chemosphere.2007.07.064; Rubio B, 2000, MAR POLLUT BULL, V40, P968, DOI 10.1016/S0025-326X(00)00039-4; RUTTENBERG KC, 1992, LIMNOL OCEANOGR, V37, P1460, DOI 10.4319/lo.1992.37.7.1460; SanClements MD, 2009, FOREST ECOL MANAG, V258, P2318, DOI 10.1016/j.foreco.2009.03.016; Spears BM, 2006, WATER RES, V40, P383, DOI 10.1016/j.watres.2005.11.013; STONE M, 1993, HYDROBIOLOGIA, V253, P17, DOI 10.1007/BF00050719; Sun SJ, 2009, J ENVIRON SCI-CHINA, V21, P291, DOI 10.1016/S1001-0742(08)62266-4; Topping DJ, 2000, WATER RESOUR RES, V36, P515, DOI 10.1029/1999WR900285; van Dobben HF, 2001, ENVIRON POLLUT, V112, P163, DOI 10.1016/S0269-7491(00)00121-4; Vollenweider R. A., 1982, EUTROPHICATION WATER; Wang C, 2012, ECOTOX ENVIRON SAFE, V82, P32, DOI 10.1016/j.ecoenv.2012.05.006; Wang P, 2009, ESTUAR COAST SHELF S, V84, P246, DOI 10.1016/j.ecss.2009.06.020; Wang SR, 2006, COLLOID SURFACE A, V273, P109, DOI 10.1016/j.colsurfa.2005.08.015; Warner RF, 2012, J ENVIRON MANAGE, V104, P35, DOI 10.1016/j.jenvman.2012.03.011; Wei GL, 2009, WATER RESOUR MANAG, V23, P1763, DOI 10.1007/s11269-008-9351-8; Williams GP., 1984, DOWNSTREAM EFFECTS D; Xiang SL, 2011, INT J SEDIMENT RES, V26, P230, DOI 10.1016/S1001-6279(11)60089-9; Zhang B, 2012, ECOL ENG, V40, P153, DOI 10.1016/j.ecoleng.2011.12.024; Zhang CS, 2002, APPL GEOCHEM, V17, P59, DOI 10.1016/S0883-2927(01)00079-8; Zhang ZJ, 2012, HYDROL PROCESS, V26, P15, DOI 10.1002/hyp.8105; Zhao Q, 2012, ENVIRON MONIT ASSESS, P1; Zhao QH, 2012, ENVIRON MONIT ASSESS, V184, P4253, DOI 10.1007/s10661-011-2260-y; Zhao QH, 2012, INT J APPL EARTH OBS, V16, P17, DOI 10.1016/j.jag.2011.11.009; Zhou AM, 2005, J ENVIRON SCI-CHINA, V17, P384; Zhou QX, 2001, CHEMOSPHERE, V42, P221, DOI 10.1016/S0045-6535(00)00129-6	68	12	16	5	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e83329	10.1371/journal.pone.0083329	http://dx.doi.org/10.1371/journal.pone.0083329			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281QS	24386180	Green Published, Green Submitted, gold			2022-12-25	WOS:000329116700042
J	Song, SJ; Zhou, L; Si, SY; Liu, JL; Zhou, JL; Feng, K; Wu, J; Zhang, WY				Song, Shu Jun; Zhou, Ling; Si, Shaoyan; Liu, Junli; Zhou, Jinlian; Feng, Kai; Wu, Jie; Zhang, Wenying			The High Prevalence of Vitamin D Deficiency and Its Related Maternal Factors in Pregnant Women in Beijing	PLOS ONE			English	Article							D SUPPLEMENTATION; POSTMENOPAUSAL WOMEN; CUTANEOUS SYNTHESIS; HEALTH; EXPOSURE; SUNLIGHT; INFANTS; IMPACT; POLLUTION; CHILDREN	Maternal vitamin D deficiency has been suggested to influence fetal and neonatal health. Little is known about vitamin D status in Chinese pregnant women. The purpose of this study was to assess the vitamin D status of pregnant women residing in Beijing in winter and evaluate the impact of maternal factors on serum 25-hydroxyvitamin D [25(OH)D] levels. The study was conducted on 125 healthy pregnant women. For each individual, data concerning pre-pregnancy weight, educational status, use of multivitamins and behavioral factors such as daily duration of computer use, walking and sun exposure were obtained. Serum concentrations of 25(OH)D were measured by enzyme-linked immunosorbent assay. The prevalence of vitamin D deficiency (25(OH)D < 50 nmol/L) was 96.8% and almost half (44.8%) of women were severely vitamin D deficiency (25(OH)D < 25 nmol/L). The concentration of 25(OH) D was lower in women with shorter duration of sun exposure (<= 0.5 h/day, 25.3 +/- 8.9 nmol/L) than that in women with longer duration of sun exposure (> 0.5 h/day; 30.3 +/- 9.5 nmol/L; P = 0.003). Thirty six women (28.8%) had sun exposure duration >= 1.5h/day. The 25(OH)D concentration in these women was 31.5 +/- 9.4 nmol/L which was also much lower than the normal level. Women who reported taking a multivitamin supplement had significantly higher 25(OH)D concentrations (32.3 +/- 9.5 nmol/L) when compared with non-users (24.9 +/- 8.2 nmol/L; P < 0.001). Pregnant women in Beijing are at very high risk of vitamin D deficiency in winter. Duration of Sun exposure and the use of multivitamin were the most important determinants for vitamin D status. However, neither prolonging the time of sunlight exposure nor multivitamin supplements can effectively prevent pregnant women from vitamin D deficiency. Other measures might have to be taken for pregnant women to improve their vitamin D status in winter.	[Song, Shu Jun; Si, Shaoyan; Liu, Junli; Zhou, Jinlian; Feng, Kai] PLA, Hosp 306, Dept Pathol & Expt Med, Beijing, Peoples R China; [Zhou, Ling; Zhang, Wenying] PLA, Hosp 306, Dept Obstet & Gynecol, Beijing, Peoples R China; [Wu, Jie] PLA, Hosp 306, Dept Outpatient, Beijing, Peoples R China		Zhang, WY (corresponding author), PLA, Hosp 306, Dept Obstet & Gynecol, Beijing, Peoples R China.	zh1365440@163.com			The Medical Research Grant of 306 Hospital of PLA	The Medical Research Grant of 306 Hospital of PLA	This work was supported by "The Medical Research Grant of 306 Hospital of PLA". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal KS, 2002, ARCH DIS CHILD, V87, P111, DOI 10.1136/adc.87.2.111; Aly YF, 2013, PEDIATRIC REP, V5, P24, DOI 10.4081/pr.2013.e6; Arantes HP, 2013, OSTEOPOROSIS INT, V24, P2707, DOI 10.1007/s00198-013-2366-x; ARONSSON CA, 2013, PUBLIC HEALTH NUTR, V16, P1390, DOI DOI 10.1017/S1368980013000293.PUBMED:23452986; Barnard WF, 2003, J AIR WASTE MANAGE, V53, P237, DOI 10.1080/10473289.2003.10466134; Bischoff-Ferrari HA, 2010, OSTEOPOROSIS INT, V21, P1121, DOI 10.1007/s00198-009-1119-3; Bodnar LM, 2007, J NUTR, V137, P2437, DOI 10.1093/jn/137.11.2437; Borradale D, 2009, NUTR RES REV, V22, P118, DOI 10.1017/S0954422409990102; Christesen HT, 2012, ACTA OBSTET GYN SCAN, V91, P1368, DOI 10.1111/aogs.12006; Dawson-Hughes B, 2010, OSTEOPOROSIS INT, V21, P1151, DOI 10.1007/s00198-010-1285-3; Dawson-Hughes B, 2005, OSTEOPOROSIS INT, V16, P713, DOI 10.1007/s00198-005-1867-7; Dror DK, 2010, NUTR REV, V68, P465, DOI 10.1111/j.1753-4887.2010.00306.x; Food and Nutrition Board IOM, 1997, DIET REF INT CALC MA; Gale CR, 2008, EUR J CLIN NUTR, V62, P68, DOI 10.1038/sj.ejcn.1602680; Hatun S, 2005, J NUTR, V135, P279, DOI 10.1093/jn/135.2.279; HOLICK MF, 1981, SCIENCE, V211, P590, DOI 10.1126/science.6256855; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Holick MF, 2011, J CLIN ENDOCR METAB, V96, P1911, DOI 10.1210/jc.2011-0385; Holick MF, 2011, CURR DRUG TARGETS, V12, P4; Hollis BW, 2011, J BONE MINER RES, V26, P2341, DOI 10.1002/jbmr.463; HOLLIS BW, 1984, J CLIN ENDOCR METAB, V59, P652, DOI 10.1210/jcem-59-4-652; Hosseinpanah F, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-519; Kung AWC, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-226; Looker AC, 2005, J CLIN ENDOCR METAB, V90, P635, DOI 10.1210/jc.2004-1765; Madar AA, 2009, BRIT J NUTR, V101, P1052, DOI 10.1017/S0007114508055712; MALLET E, 1986, OBSTET GYNECOL, V68, P300, DOI 10.1097/00006250-198609000-00002; Manicourt DH, 2008, J CLIN ENDOCR METAB, V93, P3893, DOI 10.1210/jc.2007-2663; MATSUOKA LY, 1990, J AM ACAD DERMATOL, V22, P772, DOI 10.1016/0190-9622(90)70107-S; MATSUOKA LY, 1989, J LAB CLIN MED, V114, P301; Mulligan ML, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2009.09.002; NHS, 2013, VIT MIN VIT D WHAT D; Nicolaidou P, 2006, CALCIFIED TISSUE INT, V78, P337, DOI 10.1007/s00223-006-0007-5; Paxton GA, 2013, MED J AUSTRALIA, V198, P142, DOI 10.5694/mja11.11592; Pope SJ, 2008, PHOTOCHEM PHOTOBIOL, V84, P1277, DOI 10.1111/j.1751-1097.2008.00373.x; Sahu M, 2009, CLIN ENDOCRINOL, V70, P680, DOI 10.1111/j.1365-2265.2008.03360.x; Salek M, 2008, EXP CLIN ENDOCR DIAB, V116, P352, DOI 10.1055/s-2008-1042403; Samanek AJ, 2006, MED J AUSTRALIA, V184, P338, DOI 10.5694/j.1326-5377.2006.tb00267.x; Song SJ, 2013, PUBLIC HEALTH NUTR, V16, P687, DOI 10.1017/S1368980012003084; van der Meer IM, 2006, AM J CLIN NUTR, V84, P350; van Oort RVA, 2004, PREV MED, V39, P1126, DOI 10.1016/j.ypmed.2004.04.025; Vieth R, 2007, AM J CLIN NUTR, V85, P649, DOI 10.1093/ajcn/85.3.649; Wagner CL, 2013, AM J OBSTET GYNECOL, V208, DOI 10.1016/j.ajog.2012.10.888; Wang J, 2010, WORLD J PEDIATR, V6, P265, DOI 10.1007/s12519-010-0224-x; WEBB AR, 1988, J CLIN ENDOCR METAB, V67, P373, DOI 10.1210/jcem-67-2-373; Wicherts IS, 2011, OSTEOPOROSIS INT, V22, P873, DOI 10.1007/s00198-010-1343-x; Wortsman J, 2000, AM J CLIN NUTR, V72, P690, DOI 10.1093/ajcn/72.3.690; Yu CKH, 2009, CLIN ENDOCRINOL, V70, P685, DOI 10.1111/j.1365-2265.2008.03403.x	47	37	43	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e85081	10.1371/journal.pone.0085081	http://dx.doi.org/10.1371/journal.pone.0085081			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281QS	24386450	Green Submitted, gold, Green Published			2022-12-25	WOS:000329116700131
J	Tseng, WY; Hsu, SH; Huang, CH; Tu, YC; Tseng, SC; Chen, HL; Chen, MH; Su, WF; Lin, LD				Tseng, Wan-Yu; Hsu, Sheng-Hao; Huang, Chieh-Hsiun; Tu, Yu-Chieh; Tseng, Shao-Chin; Chen, Hsuen-Li; Chen, Min-Huey; Su, Wei-Fang; Lin, Li-Deh			Low Pressure Radio-Frequency Oxygen Plasma Induced Oxidation of Titanium - Surface Characteristics and Biological Effects	PLOS ONE			English	Article							OXIDE; ROUGHNESS; WETTABILITY; TOPOGRAPHY; IMMERSION; TIO2	Objective: This research was designed to investigate the effects of low pressure radio-frequency (RF) oxygen plasma treatment (OPT) on the surface of commercially pure titanium (CP-Ti) and Ti6Al4V. Surface topography, elemental composition, water contact angle, cell viability, and cell morphology were surveyed to evaluate the biocompatibility of titanium samples with different lengths of OP treating time. Materials and Methods: CP-Ti and Ti6Al4V discs were both classified into 4 groups: untreated, treated with OP generated by using oxygen (99.98%) for 5, 10, and 30 min, respectively. After OPT on CP-Ti and Ti6Al4V samples, scanning probe microscopy, X-ray photoelectron spectrometry (XPS), and contact angle tests were conducted to determine the surface topography, elemental composition and hydrophilicity, respectively. The change of surface morphology was further studied using sputtered titanium on silicon wafers. 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide (MTT) assay and F-actin immunofluorescence stain were performed to investigate the viability and spreading behavior of cultivated MG-63 cells on the samples. Results: The surface roughness was most prominent after 5 min OPT in both CP-Ti and Ti6Al4V, and the surface morphology of sputtered Ti sharpened after the 5 min treatment. From the XPS results, the intensity of Ti degrees, Ti2+, and Ti3+ of the samples' surface decreased indicating the oxidation of titanium after OPT. The water contact angles of both CP-Ti and Ti6Al4V were increased after 5 min OPT. The results of MTT assay demonstrated MG-63 cells proliferated best on the 5 min OP treated titanium sample. The F-actin immunofluorescence stain revealed the cultivated cell number of 5 min treated CP-Ti/Ti6Al4V was greater than other groups and most of the cultivated cells were spindle-shaped. Conclusions: Low pressure RF oxygen plasma modified both the composition and the morphology of titanium samples' surface. The CP-Ti/Ti6Al4V treated with 5 min OPT displayed the roughest surface, sharpest surface profile and best biocompatibility.	[Tseng, Wan-Yu; Huang, Chieh-Hsiun; Chen, Min-Huey; Lin, Li-Deh] Natl Taiwan Univ, Sch Dent, Taipei 10764, Taiwan; [Tseng, Wan-Yu; Chen, Min-Huey; Lin, Li-Deh] Natl Taiwan Univ Hosp, Dept Dent, Taipei, Taiwan; [Hsu, Sheng-Hao; Su, Wei-Fang] Natl Taiwan Univ, Inst Polymer Sci & Engn, Taipei 10764, Taiwan; [Tu, Yu-Chieh; Tseng, Shao-Chin; Chen, Hsuen-Li; Su, Wei-Fang] Natl Taiwan Univ, Dept Mat Sci & Engn, Taipei 10764, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University	Lin, LD (corresponding author), Natl Taiwan Univ, Sch Dent, Taipei 10764, Taiwan.	lidehlin@ntu.edu.tw	su, wei/GZM-3986-2022; Su, Wei-Fang/C-2646-2009; Su, Wei-Fang/AHB-8796-2022; Tseng, Wan-Yu/V-4444-2019	Su, Wei-Fang/0000-0002-3375-4664; TSENG, WAN-YU/0000-0002-9012-3703; CHEN, MIN-HUEY/0000-0002-4853-1906; LIN, LI-DEH/0000-0002-6050-7394	NSC (National Science Council, Taiwan); National Taiwan University Hospital [NSC-100-2314-B-002-154-, NTUH.100-N1753]	NSC (National Science Council, Taiwan)(Ministry of Science and Technology, Taiwan); National Taiwan University Hospital(National Taiwan University)	This work was supported by the NSC (National Science Council, Taiwan) and the National Taiwan University Hospital (NSC-100-2314-B-002-154- and NTUH.100-N1753). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adell R, 1985, Swed Dent J Suppl, V28, P175; Anselme K, 2005, ACTA BIOMATER, V1, P211, DOI 10.1016/j.actbio.2004.11.009; BILLIAU A, 1977, ANTIMICROB AGENTS CH, V12, P11, DOI 10.1128/AAC.12.1.11; Boyan B. D., 2003, European Cells & Materials, V6, P22; Brandt ES, 2012, J VAC SCI TECHNOL A, V30, DOI 10.1116/1.3666026; Cai KY, 2006, COLLOID SURFACE B, V49, P136, DOI 10.1016/j.colsurfb.2006.02.016; Casaletto MP, 2001, APPL SURF SCI, V172, P167, DOI 10.1016/S0169-4332(00)00844-8; Cho YH, 2010, MICROFLUID NANOFLUID, V9, P163, DOI 10.1007/s10404-009-0509-3; Chu PK, 2002, MAT SCI ENG R, V36, P143, DOI 10.1016/S0927-796X(02)00004-9; Coelho PG, 2009, J BIOMED MATER RES B, V88B, P579, DOI 10.1002/jbm.b.31264; Duske K, 2012, J CLIN PERIODONTOL, V39, P400, DOI 10.1111/j.1600-051X.2012.01853.x; Fridman A, 2004, PLASMA PHYS ENG; Gentsch R, 2011, MACROMOLECULES, V44, P453, DOI 10.1021/ma102847a; Giljean S, 2012, SCANNING, P1; Gotfredsen K, 2000, Clin Implant Dent Relat Res, V2, P120, DOI 10.1111/j.1708-8208.2000.tb00002.x; Hara Toshihiro, 2012, Bull Tokyo Dent Coll, V53, P45; Harmankaya N, 2013, ACTA BIOMATER, V9, P7064, DOI 10.1016/j.actbio.2013.02.040; Hsu SH, 2013, ACS APPL MATER INTER, V5, P2991, DOI 10.1021/am302446t; Kawasaki A, 2012, J DENT SCI, V7, P94, DOI 10.1016/j.jds.2012.03.002; Langmuir I, 1928, P NATL ACAD SCI USA, V14, P627, DOI 10.1073/pnas.14.8.627; Mandl S, 2002, BIOMOL ENG, V19, P129, DOI 10.1016/S1389-0344(02)00025-4; Marino CEB, 2004, THIN SOLID FILMS, V468, P109, DOI 10.1016/j.tsf.2004.05.006; Martin IT, 2007, PLASMA PROCESS POLYM, V4, P414, DOI 10.1002/ppap.200600197; Meffert R M, 1987, Int J Periodontics Restorative Dent, V7, P9; Mejia MI, 2009, APPL CATAL B-ENVIRON, V91, P481, DOI 10.1016/j.apcatb.2009.06.017; Nakamura T, 2009, APPL SURF SCI, V256, P1096, DOI 10.1016/j.apsusc.2009.05.121; Ponsonnet L, 2003, MAT SCI ENG C-BIO S, V23, P551, DOI 10.1016/S0928-4931(03)00033-X; Pouilleau J, 1997, MAT SCI ENG B-SOLID, V47, P235, DOI 10.1016/S0921-5107(97)00043-3; RATNER BD, 1993, J BIOMED MATER RES, V27, P837, DOI 10.1002/jbm.820270702; Rotenberg S, 2006, DENT MATER, V22, P759, DOI 10.1016/j.dental.2005.11.003; Rupf S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025893; Schneider GB, 2003, J DENT RES, V82, P372, DOI 10.1177/154405910308200509; Slaney AM, 2011, ACS APPL MATER INTER, V3, P1601, DOI 10.1021/am200158y; SMITH DC, 1991, J BIOMED MATER RES, V25, P1045, DOI 10.1002/jbm.820250902; Sugita Y, 2011, BIOMATERIALS, V32, P8374, DOI 10.1016/j.biomaterials.2011.07.077; Sul YT, 2002, BIOMATERIALS, V23, P491, DOI 10.1016/S0142-9612(01)00131-4; Uzumaki ET, 2006, KEY ENG MATER, V309-311, P367, DOI 10.4028/www.scientific.net/KEM.309-311.367; Vesel A, 2006, PLASMA CHEM PLASMA P, V26, P577, DOI 10.1007/s11090-006-9025-3; Wataha JC, 2003, DENT MATER, V19, P25, DOI 10.1016/S0109-5641(02)00012-X; Yang CH, 2011, CLIN ORAL IMPLAN RES, V22, P1426, DOI 10.1111/j.1600-0501.2010.02132.x; Youngblood T, 2003, Implant Dent, V12, P54; Zuo J, 2013, J BIOMED MATER RES A, V101, P3278, DOI 10.1002/jbm.a.34612	42	7	7	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e84898	10.1371/journal.pone.0084898	http://dx.doi.org/10.1371/journal.pone.0084898			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281QS	24386433	Green Published, Green Submitted, gold			2022-12-25	WOS:000329116700125
J	Brind'Amour, A; Dubois, SF				Brind'Amour, Anik; Dubois, Stanislas F.			Isotopic Diversity Indices: How Sensitive to Food Web Structure?	PLOS ONE			English	Article							COMMUNITY-WIDE MEASURES; TROPHIC STRUCTURE; STABLE-ISOTOPES; FUNCTIONAL DIVERSITY; SPATIAL VARIATION; RATIOS PROVIDE; NICHE; ASSEMBLAGES; POPULATION; DELTA-N-15	Recently revisited, the concept of niche ecology has lead to the formalisation of functional and trophic niches using stable isotope ratios. Isotopic diversity indices (IDI) derived from a set of measures assessing the dispersion/distribution of points in the delta-space were recently suggested and increasingly used in the literature. However, three main critics emerge from the use of these IDI: 1) they fail to account for the isotopic sources overlap, 2) some indices are highly sensitive to the number of species and/or the presence of rare species, and 3) the lack of standardization prevents any spatial and temporal comparisons. Using simulations we investigated the ability of six commonly used IDI to discriminate among different trophic food web structures, with a focus on the first two critics. We tested the sensitivity of the IDI to five food web structures along a gradient of sources overlap, varying from two distinct food chains with differentiated sources to two superimposed food chains sharing two sources. For each of the food web structure we varied the number of species (from 10 to 100 species) and the type of species feeding behaviour (i.e. random or selective feeding). Values of IDI were generally larger in food webs with distinct basal sources and tended to decrease as the superimposition of the food chains increased. This was more pronounced when species displayed food preferences in comparison to food webs where species fed randomly on any prey. The number of species composing the food web also had strong effects on the metrics, including those that were supposedly less sensitive to small sample size. In all cases, computing IDI on food webs with low numbers of species always increases the uncertainty of the metrics. A threshold of similar to 20 species was detected above which several metrics can be safely used.	[Brind'Amour, Anik] IFREMER, Fisheries Ecol & Modelling Dept, Nantes, France; [Dubois, Stanislas F.] IFREMER, DYNECO Benth Ecol Lab, Plouzane, France	Ifremer; Ifremer	Brind'Amour, A (corresponding author), IFREMER, Fisheries Ecol & Modelling Dept, Nantes, France.	Anik.Brindamour@ifremer.fr	Dubois, Stanislas/F-2939-2010	Brind'Amour, Anik/0000-0003-4072-2588; Dubois, Stanislas/0000-0002-3326-4892	EC2CO National program on Coastal Environments; Total Foundation for Biodiversity; Sea; EU project BENTHIS (Benthic ecosystem fisheries impact study)	EC2CO National program on Coastal Environments; Total Foundation for Biodiversity; Sea; EU project BENTHIS (Benthic ecosystem fisheries impact study)	Financial support comes from the EC2CO National program on Coastal Environments, by the Total Foundation for Biodiversity and the Sea, and from the EU project BENTHIS (Benthic ecosystem fisheries impact study). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bertolo A, 2005, OIKOS, V111, P534, DOI 10.1111/j.0030-1299.2005.13930.x; Bolnick DI, 2002, ECOLOGY, V83, P2936, DOI 10.2307/3072028; BORCARD D, 1992, ECOLOGY, V73, P1045, DOI 10.2307/1940179; Botto F, 2011, ESTUAR COAST SHELF S, V92, P70, DOI 10.1016/j.ecss.2010.12.014; Caut S, 2009, J APPL ECOL, V46, P443, DOI 10.1111/j.1365-2664.2009.01620.x; COHEN JE, 1992, EVOL ECOL, V6, P73, DOI 10.1007/BF02285335; Colombo F, 2013, J SEA RES, V77, P93, DOI 10.1016/j.seares.2012.10.005; Cooper Ryan N, 2012, Aquat Biosyst, V8, P6, DOI 10.1186/2046-9063-8-6; Cornwell WK, 2006, ECOLOGY, V87, P1465, DOI 10.1890/0012-9658(2006)87[1465:ATTFHF]2.0.CO;2; Costa MJ, 2002, FISHES IN ESTUARIES, P54, DOI 10.1002/9780470995228.ch3; Darnaude AM, 2004, MAR ECOL PROG SER, V275, P47, DOI 10.3354/meps275047; Daugherty MP, 2007, ENVIRON ENTOMOL, V36, P776, DOI 10.1603/0046-225X(2007)36[776:MSOIVI]2.0.CO;2; Dubois S, 2007, AQUACULTURE, V271, P336, DOI 10.1016/j.aquaculture.2007.03.023; Elton C. S., 1927, ANIMAL ECOLOGY; Flaherty EA, 2010, OIKOS, V119, P1409, DOI 10.1111/j.1600-0706.2010.18259.x; France R, 1995, OIKOS, V18, P318; Fry B., 2006, STABLE ISOTOPE ECOLO; Gido KB, 2006, ENVIRON BIOL FISH, V75, P197, DOI 10.1007/s10641-006-0009-1; Grippo MA, 2011, LIMNOL OCEANOGR, V56, P841, DOI 10.4319/lo.2011.56.3.0841; Hoeinghaus DJ, 2008, ECOLOGY, V89, P2353, DOI 10.1890/07-1143.1; HUTCHINSON GE, 1957, COLD SPRING HARB SYM, V22, P415, DOI 10.1101/SQB.1957.022.01.039; Jackson AL, 2011, J ANIM ECOL, V80, P595, DOI 10.1111/j.1365-2656.2011.01806.x; Jackson M, 2012, BETWEEN ONE AND ONE ANOTHER, P1; Kopp D, 2013, J SEA RES, V81, P40, DOI 10.1016/j.seares.2013.03.013; Laliberte E, 2010, ECOLOGY, V91, P299, DOI 10.1890/08-2244.1; Layman CA, 2007, ECOL LETT, V10, P937, DOI 10.1111/j.1461-0248.2007.01087.x; Layman CA, 2007, ECOLOGY, V88, P42, DOI 10.1890/0012-9658(2007)88[42:CSIRPF]2.0.CO;2; Layman CA, 2012, BIOL REV, V87, P545, DOI 10.1111/j.1469-185X.2011.00208.x; Le Loc'h F, 2008, J MARINE SYST, V72, P17, DOI 10.1016/j.jmarsys.2007.05.011; Mason NWH, 2005, OIKOS, V111, P112, DOI 10.1111/j.0030-1299.2005.13886.x; McCutchan JH, 2003, OIKOS, V102, P378, DOI 10.1034/j.1600-0706.2003.12098.x; Mouillot D, 2005, OECOLOGIA, V142, P353, DOI 10.1007/s00442-004-1744-7; Newsome SD, 2007, FRONT ECOL ENVIRON, V5, P429, DOI 10.1890/060150.1; Newsome SD, 2009, ECOLOGY, V90, P961, DOI 10.1890/07-1812.1; Paez-Rosas D, 2012, J EXP MAR BIOL ECOL, V424, P44, DOI 10.1016/j.jembe.2012.05.001; Peres-Neto PR, 2006, ECOLOGY, V87, P2614, DOI 10.1890/0012-9658(2006)87[2614:VPOSDM]2.0.CO;2; PETERSON BJ, 1987, ANNU REV ECOL SYST, V18, P293, DOI 10.1146/annurev.es.18.110187.001453; Pigolotti S, 2010, THEOR ECOL-NETH, V3, P89, DOI 10.1007/s12080-009-0056-2; Purvis A, 2000, NATURE, V405, P212, DOI 10.1038/35012221; Quevedo M, 2009, ECOLOGY, V90, P2263, DOI 10.1890/07-1580.1; R Team, 2010, R LANG ENV STAT COMP; Ricklefs RE, 1998, FUNCT ECOL, V12, P871, DOI 10.1046/j.1365-2435.1998.00263.x; Schaal G, 2008, ESTUAR COAST SHELF S, V77, P523, DOI 10.1016/j.ecss.2007.10.008; Schmidt SN, 2007, ECOLOGY, V88, P2793, DOI 10.1890/07-0121.1; Sweetman AK, 2013, MAR ECOL PROG SER, V473, P115, DOI 10.3354/meps10050; Syvaranta J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056094; Syvaranta J, 2011, AQUAT SCI, V73, P79, DOI 10.1007/s00027-010-0161-8; Vander Zanden HB, 2010, BIOL LETTERS, V6, P711, DOI 10.1098/rsbl.2010.0124; Villeger S, 2008, MAR ECOL PROG SER, V364, P135, DOI 10.3354/meps07471; Villeger S, 2008, ECOLOGY, V89, P2290, DOI 10.1890/07-1206.1	50	34	34	0	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84198	10.1371/journal.pone.0084198	http://dx.doi.org/10.1371/journal.pone.0084198			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391910	gold, Green Published			2022-12-25	WOS:000329323900053
J	Chen, PT; Lin, CJ; Jou, IM; Chieh, HF; Su, FC; Kuo, LC				Chen, Po-Tsun; Lin, Chien-Ju; Jou, I-Ming; Chieh, Hsiao-Feng; Su, Fong-Chin; Kuo, Li-Chieh			One Digit Interruption: The Altered Force Patterns during Functionally Cylindrical Grasping Tasks in Patients with Trigger Digits	PLOS ONE			English	Article							MULTIFINGER PREHENSION; PERCUTANEOUS RELEASE; COORDINATION; SYNERGIES; PULLEY	Most trigger digit (TD) patients complain that they have problems using their hand in daily or occupational tasks due to single or multiple digits being affected. Unfortunately, clinicians do not know much about how this disease affects the subtle force coordination among digits during manipulation. Thus, this study examined the differences in force patterns during cylindrical grasp between TD and healthy subjects. Forty-two TD patients with single digit involvement were included and sorted into four groups based on the involved digits, including thumb, index, middle and ring fingers. Twelve healthy subjects volunteered as healthy controls. Two testing tasks, holding and drinking, were performed by natural grasping with minimal forces. The relations between the force of the thumb and each finger were examined by Pearson correlation coefficients. The force amount and contribution of each digit were compared between healthy controls and each TD group by the independent t test. The results showed all TD groups demonstrated altered correlation patterns of the thumb relative to each finger. Larger forces and higher contributions of the index finger were found during holding by patients with index finger involved, and also during drinking by patients with affected thumb and with affected middle finger. Although no triggering symptom occurred during grasping, the patients showed altered force patterns which may be related to the role of the affected digit in natural grasping function. In conclusion, even if only one digit was affected, the subtle force coordination of all the digits was altered during simple tasks among the TD patients. This study provides the information for the future studies to further comprehend the possible injuries secondary to the altered finger coordination and also to adopt suitable treatment strategies.	[Chen, Po-Tsun; Su, Fong-Chin] Natl Cheng Kung Univ, Dept Biomed Engn, Tainan 70101, Taiwan; [Lin, Chien-Ju; Chieh, Hsiao-Feng; Su, Fong-Chin; Kuo, Li-Chieh] Natl Cheng Kung Univ, Med Device Innovat Ctr, Tainan 70101, Taiwan; [Jou, I-Ming] Natl Cheng Kung Univ, Dept Orthoped Surg, Tainan 70101, Taiwan; [Kuo, Li-Chieh] Natl Cheng Kung Univ, Dept Occupat Therapy, Tainan 70101, Taiwan	National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University	Su, FC (corresponding author), Natl Cheng Kung Univ, Dept Biomed Engn, Tainan 70101, Taiwan.	fcsu@mail.ncku.edu.tw; jkkuo@mail.ncku.edu.tw	Lin, Chien-Ju/AAP-5725-2020; Chieh, Hsiao-Feng/AAP-5236-2020; SU, FONG-CHIN/C-8094-2011; Kuo, Li-Chieh/ABC-3826-2021	Lin, Chien-Ju/0000-0001-9571-8610; Chieh, Hsiao-Feng/0000-0001-8844-8026; SU, FONG-CHIN/0000-0002-3870-4842; Kuo, Li-Chieh/0000-0001-7728-0096; Chen, Po-Tsun/0000-0003-4913-6876; Kuo, Li-Chieh/0000-0002-5644-655X	National Science Council [NSC 99-2627-B-006-012]; National Health Research Institute of Taiwan [NHRI-EX100-10040EI]	National Science Council(Ministry of Science and Technology, Taiwan); National Health Research Institute of Taiwan(National Health Research Institutes - Taiwan)	This study was supported by National Science Council grant NSC 99-2627-B-006-012 and National Health Research Institute under grant NHRI-EX100-10040EI of Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AFIFI M, 2012, CLIN NEUROPHYSIOL; Budgeon MK, 2008, EXP BRAIN RES, V189, P345, DOI 10.1007/s00221-008-1430-9; Flanagan JR, 1999, J NEUROPHYSIOL, V81, P1706, DOI 10.1152/jn.1999.81.4.1706; Hsu HY, 2009, J ORTHOP RES, V27, P1534, DOI 10.1002/jor.20903; Jou IM, 2006, J HAND SURG-BRIT EUR, V31B, P191, DOI 10.1016/j.jhsb.2005.11.003; Kuo LC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060509; Li ZN, 1998, EXP BRAIN RES, V122, P71, DOI 10.1007/s002210050492; LU SC, 2013, J ORTHOP RES; Rojo-Manaute JM, 2012, J ULTRAS MED, V31, P417, DOI 10.7863/jum.2012.31.3.417; Rearick MP, 2003, J NEUROPHYSIOL, V89, P1317, DOI 10.1152/jn.00581.2002; Redmond CL, 2009, J RHEUMATOL, V36, P2766, DOI 10.3899/jrheum.090239; Santello M, 2000, EXP BRAIN RES, V133, P457, DOI 10.1007/s002210000420; Shim JK, 2004, J APPL PHYSIOL, V97, P213, DOI 10.1152/japplphysiol.00045.2004; Tung WL, 2010, CLIN BIOMECH, V25, P535, DOI 10.1016/j.clinbiomech.2010.02.009; Zatsiorsky VM, 2008, J MOTOR BEHAV, V40, P446, DOI 10.3200/JMBR.40.5.446-476; Zatsiorsky VM, 2003, EXP BRAIN RES, V148, P77, DOI 10.1007/s00221-002-1278-3; Zatsiorsky VM, 2002, BIOL CYBERN, V87, P50, DOI 10.1007/s00422-002-0321-6; Zatsiorsky VM, 2000, EXP BRAIN RES, V131, P187, DOI 10.1007/s002219900261; Zhang W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027715	19	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83632	10.1371/journal.pone.0083632	http://dx.doi.org/10.1371/journal.pone.0083632			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391799	Green Published, gold, Green Submitted			2022-12-25	WOS:000329325200096
J	Kim, EC; Choi, SK; Lim, M; Yeon, SI; Lee, YH				Kim, Eok-Cheon; Choi, Soo-Kyoung; Lim, Mihwa; Yeon, Soo-In; Lee, Young-Ho			Role of Endogenous ENaC and TRP Channels in the Myogenic Response of Rat Posterior Cerebral Arteries	PLOS ONE			English	Article							VASCULAR SMOOTH-MUSCLE; BLOOD-FLOW; CAENORHABDITIS-ELEGANS; SIGNALING MECHANISMS; ACTIVATION; TRANSDUCTION; PROTEINS; TONE; MECHANOTRANSDUCTION; AUTOREGULATION	Aims: Mechanogated ion channels are predicted to mediate pressure-induced myogenic vasoconstriction in small resistance arteries. Recent findings have indicated that transient receptor potential (TRP) channels and epithelial sodium channels (ENaC) are involved in mechanotransduction. The purpose of this study was to investigate the role of TRP channels and ENaC in the myogenic response. Our previous study suggested that ENaC could be a component of the mechanosensitive ion channels in rat posterior cerebral arteries (PCA). However, the specific ion channel proteins mediating myogenic constriction are unknown. Here we found, for the first time, that ENaC interacted with TRPM4 but not with TRPC6 using immunoprecipitation and confocal microscopy. Methods and Results: Treatment with a specific beta ENaC inhibitor, amiloride, a specific TRPM4 inhibitor, 9-phenanthrol, and a TRPC6 inhibitor, SKF96365, resulted in inhibition of the pressure-induced myogenic response. Moreover, the myogenic response was inhibited in rat PCA transfected with small interfering RNA of beta ENaC, TRPM4, and TRPC6. Co-treatment with amiloride and 9-phenanthrol showed a similar inhibitory effect on myogenic contraction compared to single treatment with amiloride or 9-phenanthrol. The myogenic response was not affected by 9-phenanthrol or amiloride treatment in PCA transfected with beta ENaC or TRPM4 siRNA, respectively. However, pressure-induced myogenic response was fully inhibited by co-treatment with amiloride, 9-phenanthrol, and SKF96365, and by treatment with SKF96365 in PCA transfected with beta ENaC siRNA. Conclusion: Our results suggest that ENaC, TRPM4, and TRPC6 play important roles in the pressure-induced myogenic response, and that ENaC and TRPM4 interact in rat PCA.	[Kim, Eok-Cheon; Choi, Soo-Kyoung; Lim, Mihwa; Yeon, Soo-In; Lee, Young-Ho] Yonsei Univ, Coll Med, Dept Physiol, Brain Korea PLUS Project Med Sci 21, Seoul, South Korea	Yonsei University; Yonsei University Health System	Lee, YH (corresponding author), Yonsei Univ, Coll Med, Dept Physiol, Brain Korea PLUS Project Med Sci 21, Seoul, South Korea.	yhlee@yuhs.ac		Lee, Young-Ho/0000-0002-5749-1045; Choi, Soo-Kyoung/0000-0002-7115-6358	Basic Science Research Program of the National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology [2010-0007540]	Basic Science Research Program of the National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by the Basic Science Research Program of the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2010-0007540). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Broughton BRS, 2008, AM J PHYSIOL-LUNG C, V294, pL797, DOI 10.1152/ajplung.00253.2007; Chen XP, 2010, J CELL MOL MED, V14, P2483, DOI 10.1111/j.1582-4934.2009.00890.x; Cho YE, 2011, CARDIOVASC RES, V91, P162, DOI 10.1093/cvr/cvr043; Choi SK, 2009, CARDIOVASC RES, V82, P324, DOI 10.1093/cvr/cvp054; Christensen AP, 2007, NAT REV NEUROSCI, V8, P510, DOI 10.1038/nrn2149; Clapham DE, 2001, NAT REV NEUROSCI, V2, P387, DOI 10.1038/35077544; DANGELO G, 1994, HYPERTENSION, V23, P1096, DOI 10.1161/01.HYP.23.6.1096; Davis MJ, 1999, PHYSIOL REV, V79, P387, DOI 10.1152/physrev.1999.79.2.387; Dora KA, 2005, AM J PHYSIOL-HEART C, V289, pH1323, DOI 10.1152/ajpheart.00513.2005; Drummond HA, 2004, HYPERTENSION, V44, P643, DOI 10.1161/01.HYP.0000144465.56360.ad; Drummond HA, 2008, PHYSIOLOGY, V23, P23, DOI 10.1152/physiol.00034.2007; Earley S, 2004, CIRC RES, V95, P922, DOI 10.1161/01.RES.0000147311.54833.03; Earley S, 2007, AM J PHYSIOL-HEART C, V292, pH2613, DOI 10.1152/ajpheart.01286.2006; Gebremedhin D, 2000, CIRC RES, V87, P60, DOI 10.1161/01.RES.87.1.60; Gillespie PG, 2001, NATURE, V413, P194, DOI 10.1038/35093011; Gonzales AL, 2010, AM J PHYSIOL-CELL PH, V299, pC1195, DOI 10.1152/ajpcell.00269.2010; Goodman MB, 2003, ANNU REV PHYSIOL, V65, P429, DOI 10.1146/annurev.physiol.65.092101.142659; Grand T, 2008, BRIT J PHARMACOL, V153, P1697, DOI 10.1038/bjp.2008.38; Guan ZR, 2009, HYPERTENSION, V54, P1062, DOI 10.1161/HYPERTENSIONAHA.109.137992; Hill MA, 2006, CLIN HEMORHEOL MICRO, V34, P67; Hill MA, 2001, J APPL PHYSIOL, V91, P973, DOI 10.1152/jappl.2001.91.2.973; HUDSPETH AJ, 1992, SOC GEN PHY, V47, P357; Inoue R, 2001, CIRC RES, V88, P325, DOI 10.1161/01.RES.88.3.325; Jernigan NL, 2006, AM J PHYSIOL-RENAL, V291, pF1184, DOI 10.1152/ajprenal.00177.2006; Jernigan NL, 2005, AM J PHYSIOL-RENAL, V289, pF891, DOI 10.1152/ajprenal.00019.2005; JOHNSON PC, 1986, CIRC RES, V59, P483, DOI 10.1161/01.RES.59.5.483; Kim EC, 2012, EXP PHYSIOL, V97, P544, DOI 10.1113/expphysiol.2011.062232; Liu JD, 1996, SCIENCE, V273, P361, DOI 10.1126/science.273.5273.361; Liu Y, 2011, HYPERTENS RES, V34, P630, DOI 10.1038/hr.2011.5; Loutzenhiser R, 2002, CIRC RES, V90, P1316, DOI 10.1161/01.RES.0000024262.11534.18; Matchkov VV, 2002, AM J PHYSIOL-HEART C, V283, pH118, DOI 10.1152/ajpheart.00690.2001; Mazzochi C, 2006, J BIOL CHEM, V281, P6528, DOI 10.1074/jbc.M509386200; Oyabe A, 2000, FUND CLIN PHARMACOL, V14, P369, DOI 10.1111/j.1472-8206.2000.tb00418.x; Reading SA, 2007, STROKE, V38, P2322, DOI 10.1161/STROKEAHA.107.483404; Schubert R, 1999, CLIN SCI, V96, P313, DOI 10.1042/CS19980403; Sun YH, 2010, BIOCHEM BIOPH RES CO, V394, P955, DOI 10.1016/j.bbrc.2010.03.096; Syntichaki P, 2004, PHYSIOL REV, V84, P1097, DOI 10.1152/physrev.00043.2003; VanBavel E, 1998, CIRC RES, V82, P210; Voets T, 2003, J MEMBRANE BIOL, V192, P1, DOI 10.1007/s00232-002-1059-8; Welsh DG, 2002, CIRC RES, V90, P248, DOI 10.1161/hh0302.105662; Zhu ZM, 2011, PFLUG ARCH EUR J PHY, V461, P211, DOI 10.1007/s00424-010-0902-5; Zunker P, 2000, ULTRASOUND OBST GYN, V16, P179, DOI 10.1046/j.1469-0705.2000.00194.x	42	22	22	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84194	10.1371/journal.pone.0084194	http://dx.doi.org/10.1371/journal.pone.0084194			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391909	Green Submitted, gold, Green Published			2022-12-25	WOS:000329323900052
J	Nishiyama, K; Ochiai, A; Tsubokawa, D; Ishihara, K; Yamamoto, Y; Mukai, T				Nishiyama, Keita; Ochiai, Ayaka; Tsubokawa, Daigo; Ishihara, Kazuhiko; Yamamoto, Yuji; Mukai, Takao			Identification and Characterization of Sulfated Carbohydrate-Binding Protein from Lactobacillus reuteri	PLOS ONE			English	Article							ELONGATION-FACTOR TU; HELICOBACTER-PYLORI; MYCOPLASMA-PNEUMONIAE; ADHESION PROPERTIES; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; PSEUDOMONAS-AERUGINOSA; FIBRONECTIN-BINDING; MUCUS GLYCOPROTEIN; SURFACE PROTEIN; GASTRIC MUCIN	We previously purified a putative sulfated-galactosylceramide (sulfatide)-binding protein with a molecular weight of 47 kDa from the cell surface of Lactobacillus reuteri JCM1081. The aim of this study was to identify the 47-kDa protein, examine its binding to sulfated glycolipids and mucins, and evaluate its role in bacterial adhesion to mucosal surfaces. By cloning and sequencing analysis, the 47-kDa protein was identified as elongation factor-Tu (EF-Tu). Adhesion properties were examined using 6xHistidine-fused EF-Tu (His(6)-EF-Tu). Surface plasmon resonance analysis demonstrated pH-dependent binding of His(6)-EF-Tu to sulfated glycolipids, but not to neutral or sialylated glycolipids, suggesting that a sulfated galactose residue was responsible for EF-Tu binding. Furthermore, His(6)-EF-Tu was found to bind to porcine gastric mucin (PGM) by enzyme-linked immunosorbent assay. Binding was markedly reduced by sulfatase treatment of PGM and in the presence of acidic and desialylated oligosaccharide fractions containing sulfated carbohydrate residues prepared from PGM, demonstrating that sulfated carbohydrate moieties mediated binding. Histochemical staining revealed similar localization of His(6)-EF-Tu and high iron diamine staining in porcine mucosa. These results indicated that EF-Tu bound PGM via sulfated carbohydrate moieties. To characterize the contribution of EF-Tu to the interaction between bacterial cells and PGM, we tested whether anti-EF-Tu antibodies could inhibit the interaction. Binding of L. reuteri JCM1081 to PGM was significantly blocked in a concentration-dependent matter, demonstrating the involvement of EF-Tu in bacterial adhesion. In conclusion, the present results demonstrated, for the first time, that EF-Tu bound sulfated carbohydrate moieties of sulfated glycolipids and sulfomucin, thereby promoting adhesion of L. reuteri to mucosal surfaces.	[Nishiyama, Keita; Ochiai, Ayaka; Yamamoto, Yuji; Mukai, Takao] Kitasato Univ, Dept Anim Sci, Sch Vet Med, Towada, Aomori, Japan; [Tsubokawa, Daigo] Kitasato Univ, Sch Med, Dept Parasitol, Sagamihara, Kanagawa 228, Japan; [Ishihara, Kazuhiko] Kitasato Univ, Grad Sch Med Sci, Sagamihara, Kanagawa 228, Japan	Kitasato University; Kitasato University; Kitasato University	Mukai, T (corresponding author), Kitasato Univ, Dept Anim Sci, Sch Vet Med, Towada, Aomori, Japan.	mukai@vmas.kitasato-u.ac.jp	Tsubokawa, Daigo/AHD-3762-2022	Tsubokawa, Daigo/0000-0002-4344-5128	Japan Society for the Promotion of Science (JSPS) [21580334, 24580397]; Grants-in-Aid for Scientific Research [24580397] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by a Grant-in-Aid for Scientific Research C (21580334 and 24580397) from the Japan Society for the Promotion of Science (JSPS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Antikainen J, 2007, J BACTERIOL, V189, P4539, DOI 10.1128/JB.00378-07; Balasubramanian S, 2008, INFECT IMMUN, V76, P3116, DOI 10.1128/IAI.00173-08; Balasubramanian S, 2009, INFECT IMMUN, V77, P3533, DOI 10.1128/IAI.00081-09; Boekhorst J, 2006, MICROBIOL-SGM, V152, P273, DOI 10.1099/mic.0.28415-0; Brockhausen I, 2003, BIOCHEM SOC T, V31, P318, DOI 10.1042/BST0310318; Brockhausen I, 1997, TRENDS GLYCOSCI GLYC, V9, P379, DOI 10.4052/tigg.9.379; Coic YM, 2012, J BIOL CHEM, V287, P15916, DOI 10.1074/jbc.M111.310003; Croix JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024447; Dallo SF, 2002, MOL MICROBIOL, V46, P1041, DOI 10.1046/j.1365-2958.2002.03207.x; Dallo SF, 2012, SCI WORLD J, DOI 10.1100/2012/128705; de Leeuw E, 2006, FEMS MICROBIOL LETT, V260, P210, DOI 10.1111/j.1574-6968.2006.00313.x; Deepika G, 2010, ADV APPL MICROBIOL, V70, P127, DOI 10.1016/S0065-2164(10)70004-6; Derrien M, 2010, GUT MICROBES, V1, P254, DOI 10.4161/gmic.1.4.12778; Dhanani AS, 2013, J APPL MICROBIOL, V115, P546, DOI 10.1111/jam.12249; Duary RK, 2012, MOL BIOL REP, V39, P2541, DOI 10.1007/s11033-011-1006-9; Francius G, 2008, ACS NANO, V2, P1921, DOI 10.1021/nn800341b; Goso Y, 1999, J BIOCHEM-TOKYO, V126, P375, DOI 10.1093/oxfordjournals.jbchem.a022460; Granato D, 2004, INFECT IMMUN, V72, P2160, DOI 10.1128/IAI.72.4.2160-2169.2004; Gross G, 2010, BENEF MICROBES, V1, P61, DOI 10.3920/BM2008.1006; Huang IN, 2013, J APPL MICROBIOL, V114, P854, DOI 10.1111/jam.12063; Huesca M, 1998, INFECT IMMUN, V66, P4061; Jansson L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004487; Kamisago S, 1996, INFECT IMMUN, V64, P624, DOI 10.1128/IAI.64.2.624-628.1996; Kinoshita H, 2008, RES MICROBIOL, V159, P685, DOI 10.1016/j.resmic.2008.07.005; Kobayashi M, 2009, GLYCOBIOLOGY, V19, P453, DOI 10.1093/glycob/cwp004; KOMURO Y, 1992, GASTROENTEROL JPN, V27, P466; Kunert A, 2007, J IMMUNOL, V179, P2979, DOI 10.4049/jimmunol.179.5.2979; Linden SK, 2008, MUCOSAL IMMUNOL, V1, P183, DOI 10.1038/mi.2008.5; LORTAL S, 1992, J GEN MICROBIOL, V138, P611, DOI 10.1099/00221287-138-3-611; MacKenzie DA, 2010, MICROBIOL-SGM, V156, P3368, DOI 10.1099/mic.0.043265-0; McGuckin MA, 2011, NAT REV MICROBIOL, V9, P265, DOI 10.1038/nrmicro2538; Mukai T, 2002, FEMS IMMUNOL MED MIC, V32, P105, DOI 10.1111/j.1574-695X.2002.tb00541.x; Ouwehand AC, 2002, ANTON LEEUW INT J G, V82, P279, DOI 10.1023/A:1020620607611; PLOUG M, 1989, ANAL BIOCHEM, V181, P33, DOI 10.1016/0003-2697(89)90390-4; Pretzer G, 2005, J BACTERIOL, V187, P6128, DOI 10.1128/JB.187.17.6128-6136.2005; Ramiah K, 2007, INT J FOOD MICROBIOL, V116, P405, DOI 10.1016/j.ijfoodmicro.2007.02.011; ROBERTON AM, 1993, BIOCHEM J, V293, P683, DOI 10.1042/bj2930683; Rojas M, 2002, APPL ENVIRON MICROB, V68, P2330, DOI 10.1128/AEM.68.5.2330-2336.2002; Roos S, 2002, MICROBIOL-SGM, V148, P433, DOI 10.1099/00221287-148-2-433; Scharfman A, 2000, GLYCOCONJUGATE J, V17, P735, DOI 10.1023/A:1011091112884; Schaumburg J, 2004, PROTEOMICS, V4, P2991, DOI 10.1002/pmic.200400928; Servin AL, 2003, BEST PRACT RES CL GA, V17, P741, DOI 10.1016/S1521-6918(03)00052-0; SPICER SS, 1965, J HISTOCHEM CYTOCHEM, V13, P599, DOI 10.1177/13.7.599; Teneberg S, 1997, J BIOL CHEM, V272, P19067, DOI 10.1074/jbc.272.30.19067; Tsubokawa D, 2007, FEBS J, V274, P1833, DOI 10.1111/j.1742-4658.2007.05731.x; Van Tassell ML, 2011, NUTRIENTS, V3, P613, DOI 10.3390/nu3050613; Veerman ECI, 1997, GLYCOBIOLOGY, V7, P737, DOI 10.1093/glycob/7.6.737; Velez MP, 2007, FEMS MICROBIOL LETT, V276, P140, DOI 10.1111/j.1574-6968.2007.00908.x; von Ossowski I, 2010, APPL ENVIRON MICROB, V76, P2049, DOI 10.1128/AEM.01958-09	49	33	34	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83703	10.1371/journal.pone.0083703	http://dx.doi.org/10.1371/journal.pone.0083703			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391811	Green Published, Green Submitted, gold			2022-12-25	WOS:000329325200109
J	Boechat, AL; Kaihami, GH; Politi, MJ; Lepine, F; Baldini, RL				Boechat, Ana Laura; Kaihami, Gilberto Hideo; Politi, Mario Jose; Lepine, Francois; Baldini, Regina L.			A Novel Role for an ECF Sigma Factor in Fatty Acid Biosynthesis and Membrane Fluidity in Pseudomonas aeruginosa	PLOS ONE			English	Article							VIRULENCE FACTOR PRODUCTION; ESCHERICHIA-COLI; OUTER-MEMBRANE; GENE-EXPRESSION; MUTANT LIBRARY; LIPOIC ACID; PROTEIN-F; PATHWAYS; IRON; SYNTHASE	Extracytoplasmic function (ECF) sigma factors are members of cell-surface signaling systems, abundant in the opportunistic pathogen Pseudomonas aeruginosa. Twenty genes coding for ECF sigma factors are present in P. aeruginosa sequenced genomes, most of them being part of TonB systems related to iron uptake. In this work, poorly characterized sigma factors were overexpressed in strain PA14, in an attempt to understand their role in the bacterium's physiology. Cultures overexpressing SigX displayed a biphasic growth curve, reaching stationary phase earlier than the control strain, followed by subsequent growth resumption. During the first stationary phase, most cells swell and die, but the remaining cells return to the wild type morphology and proceed to a second exponential growth. This is not due to compensatory mutations, since cells recovered from late time points and diluted into fresh medium repeated this behavior. Swollen cells have a more fluid membrane and contain higher amounts of shorter chain fatty acids. A proteomic analysis was performed to identify differentially expressed proteins due to overexpression of sigX, revealing the induction of several fatty acid synthesis (FAS) enzymes. Using qRT-PCR, we showed that at least one isoform from each of the FAS pathway enzymes were upregulated at the mRNA level in the SigX overexpressing strain thus pointing to a role for this ECF sigma factor in the FAS regulation in P. aeruginosa.	[Boechat, Ana Laura; Kaihami, Gilberto Hideo; Politi, Mario Jose; Baldini, Regina L.] Univ Sao Paulo, Inst Quim, Dept Bioquim, BR-01498 Sao Paulo, Brazil; [Lepine, Francois] Univ Quebec, INRS Inst Armand Frappier, Laval, PQ, Canada	Universidade de Sao Paulo; University of Quebec; Institut national de la recherche scientifique (INRS)	Baldini, RL (corresponding author), Univ Sao Paulo, Inst Quim, Dept Bioquim, BR-01498 Sao Paulo, Brazil.	baldini@iq.usp.br	Borges, Ana Laura/AAQ-4158-2020; Baldini, Regina L/C-4035-2012; Politi, Mario J/F-2605-2016; Kaihami, Gilberto/E-9542-2014	Baldini, Regina L/0000-0003-4349-6352; Kaihami, Gilberto/0000-0002-8161-0403	Sao Paulo Research Foundation (FAPESP) [2009/09211-2, 2008/03528-0]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [304349/2010-0]	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by grants 2009/09211-2 for RLB and 2008/03528-0 for ALB, Sao Paulo Research Foundation (FAPESP, www.fapesp.br) and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES, www.capes.gov.br). RLB was partially supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, 304349/2010-0, www.cnpq.br). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banin E, 2005, P NATL ACAD SCI USA, V102, P11076, DOI 10.1073/pnas.0504266102; Baysse C, 2005, MICROBIOL-SGM, V151, P2529, DOI 10.1099/mic.0.28185-0; Beare PA, 2003, MOL MICROBIOL, V47, P195, DOI 10.1046/j.1365-2958.2003.03288.x; BOUFFARTIGUES E, 2012, J BACTERIOL; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Braun V, 2006, BIOMETALS, V19, P103, DOI 10.1007/s10534-005-8253-y; Brinkman FSL, 1999, J BACTERIOL, V181, P4746, DOI 10.1128/JB.181.16.4746-4754.1999; Campbell JW, 2001, J BACTERIOL, V183, P5982, DOI 10.1128/JB.183.20.5982-5990.2001; Chan DI, 2010, BIOCHEM J, V430, P1, DOI 10.1042/BJ20100462; Cronan JE, 2006, MOL MICROBIOL, V60, P256, DOI 10.1111/j.1365-2958.2006.05107.x; Cronan JE, 1998, MOL MICROBIOL, V29, P937, DOI 10.1046/j.1365-2958.1998.00917.x; Cronan JE, 1996, ESCHERICHIA COLI SAL, V1, P612; Dubois-Brissonnet F, 2000, INT J FOOD MICROBIOL, V55, P79, DOI 10.1016/S0168-1605(00)00198-7; FAURE L, 2013, MICROBIOLOGY; Feng YJ, 2009, J BIOL CHEM, V284, P29526, DOI 10.1074/jbc.M109.023440; Gago G, 2011, FEMS MICROBIOL REV, V35, P475, DOI 10.1111/j.1574-6976.2010.00259.x; GARWIN JL, 1980, J BIOL CHEM, V255, P3263; GOTOH N, 1989, J BACTERIOL, V171, P983, DOI 10.1128/jb.171.2.983-990.1989; HANCOCK REW, 1981, J BACTERIOL, V145, P628, DOI 10.1128/JB.145.1.628-631.1981; Hancock REW, 1998, CLIN INFECT DIS, V27, pS93, DOI 10.1086/514909; HAYDEN MA, 1992, J BIOL CHEM, V267, P9512; Hoang TT, 1999, J BACTERIOL, V181, P5489, DOI 10.1128/JB.181.17.5489-5497.1999; Hoang TT, 1997, J BACTERIOL, V179, P5326, DOI 10.1128/jb.179.17.5326-5332.1997; Hoang TT, 2000, PLASMID, V43, P59, DOI 10.1006/plas.1999.1441; Inoue K, 1997, J BACTERIOL, V179, P2872, DOI 10.1128/jb.179.9.2872-2878.1997; Jacobs MA, 2003, P NATL ACAD SCI USA, V100, P14339, DOI 10.1073/pnas.2036282100; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kingston AW, 2011, MOL MICROBIOL, V81, P69, DOI 10.1111/j.1365-2958.2011.07679.x; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Kutchma AJ, 1999, J BACTERIOL, V181, P5498, DOI 10.1128/JB.181.17.5498-5504.1999; Lamont IL, 2002, P NATL ACAD SCI USA, V99, P7072, DOI 10.1073/pnas.092016999; Leoni L, 2000, J BACTERIOL, V182, P1481, DOI 10.1128/JB.182.6.1481-1491.2000; Lewenza S, 2005, GENOME RES, V15, P583, DOI 10.1101/gr.3513905; Liberati NT, 2006, P NATL ACAD SCI USA, V103, P2833, DOI 10.1073/pnas.0511100103; LITMAN BJ, 1982, METHOD ENZYMOL, V81, P678; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Llamas MA, 2006, J BACTERIOL, V188, P1882, DOI 10.1128/JB.188.5.1882-1891.2006; Llamas MA, 2008, MOL MICROBIOL, V67, P458; Llamas MA, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000572; Los DA, 2004, BBA-BIOMEMBRANES, V1666, P142, DOI 10.1016/j.bbamem.2004.08.002; Lu YJ, 2004, BIOCHEM CELL BIOL, V82, P145, DOI 10.1139/o03-076; MAGNUSON K, 1993, MICROBIOL REV, V57, P522, DOI 10.1128/MMBR.57.3.522-542.1993; Mansilla MC, 2004, J BACTERIOL, V186, P6681, DOI 10.1128/JB.186.20.6681-6688.2004; Marrakchi H, 2002, BIOCHEM SOC T, V30, P1050, DOI 10.1042/bst0301050; Mathee K, 1997, J BACTERIOL, V179, P3711, DOI 10.1128/jb.179.11.3711-3720.1997; Micevski Dimce, 2013, Subcell Biochem, V66, P105, DOI 10.1007/978-94-007-5940-4_5; Najjar MB, 2007, APPL ENVIRON MICROB, V73, P6429, DOI 10.1128/AEM.00980-07; Newman JR, 1999, GENE, V227, P197, DOI 10.1016/S0378-1119(98)00601-5; NICAS TI, 1983, J BACTERIOL, V153, P281, DOI 10.1128/JB.153.1.281-285.1983; Ochsner UA, 2000, MICROBIOL-UK, V146, P185, DOI 10.1099/00221287-146-1-185; Pukatzki S, 2002, P NATL ACAD SCI USA, V99, P3159, DOI 10.1073/pnas.052704399; RAHME LG, 1995, SCIENCE, V268, P1899, DOI 10.1126/science.7604262; Rahme LG, 2000, P NATL ACAD SCI USA, V97, P8815, DOI 10.1073/pnas.97.16.8815; Ravel J, 2003, TRENDS MICROBIOL, V11, P195, DOI 10.1016/S0966-842X(03)00076-3; Redly GA, 2003, J BACTERIOL, V185, P1261, DOI 10.1128/JB.185.4.1261-1265.2003; Redly GA, 2005, J BACTERIOL, V187, P5648, DOI 10.1128/JB.187.16.5648-5657.2005; RICK PD, 1977, J BIOL CHEM, V252, P4895; SCHNAITMAN CA, 1993, MICROBIOL REV, V57, P655, DOI 10.1128/MMBR.57.3.655-682.1993; Schobel S, 2004, MOL MICROBIOL, V52, P1091, DOI 10.1111/j.1365-2958.2004.04031.x; Schweizer E, 2004, MICROBIOL MOL BIOL R, V68, P501, DOI 10.1128/MMBR.68.3.501-517.2004; Schweizer HP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045646; SHINITZKY M, 1978, BIOCHIM BIOPHYS ACTA, V515, P367, DOI 10.1016/0304-4157(78)90010-2; Smith S, 2003, PROG LIPID RES, V42, P289, DOI 10.1016/S0163-7827(02)00067-X; SMITH S, 1994, FASEB J, V8, P1248, DOI 10.1096/fasebj.8.15.8001737; Staron A, 2009, MOL MICROBIOL, V74, P557, DOI 10.1111/j.1365-2958.2009.06870.x; Stover CK, 2000, NATURE, V406, P959, DOI 10.1038/35023079; Subramanian C, 2010, J BACTERIOL, V192, P280, DOI 10.1128/JB.00404-09; Tehlivets O, 2007, BBA-MOL CELL BIOL L, V1771, P255, DOI 10.1016/j.bbalip.2006.07.004; Tiburzi F, 2008, MOL MICROBIOL, V67, P213, DOI 10.1111/j.1365-2958.2007.06051.x; TSAY JT, 1992, J BIOL CHEM, V267, P6807; VANDENBOOM TJ, 1991, J BACTERIOL, V173, P6411, DOI 10.1128/jb.173.20.6411-6420.1991; Visca P, 2002, MOL MICROBIOL, V45, P1177, DOI 10.1046/j.1365-2958.2002.03088.x; Walsh AG, 1999, FEMS MICROBIOL LETT, V173, P27, DOI 10.1111/j.1574-6968.1999.tb13480.x; White SW, 2005, ANNU REV BIOCHEM, V74, P791, DOI 10.1146/annurev.biochem.74.082803.133524; Winsor GL, 2011, NUCLEIC ACIDS RES, V39, pD596, DOI 10.1093/nar/gkq869; Winsor GL, 2009, NUCLEIC ACIDS RES, V37, pD483, DOI 10.1093/nar/gkn861; Yuan JS, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-85; Yuan YQ, 2012, J BACTERIOL, V194, P5171, DOI 10.1128/JB.00792-12; Yuan YQ, 2012, J BACTERIOL, V194, P5185, DOI 10.1128/JB.00860-12; Zhang YM, 2012, J BACTERIOL, V194, P5159, DOI 10.1128/JB.01198-12; Zhu K, 2006, MOL MICROBIOL, V60, P260, DOI 10.1111/j.1365-2958.2006.05088.x; Zhu L, 2010, ANTIMICROB AGENTS CH, V54, P689, DOI 10.1128/AAC.01152-09	82	18	19	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e84775	10.1371/journal.pone.0084775	http://dx.doi.org/10.1371/journal.pone.0084775			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386415	Green Submitted, Green Accepted, Green Published, gold			2022-12-25	WOS:000329194700117
J	Lambers, FM; Bouman, AR; Rimnac, CM; Hernandez, CJ				Lambers, Floor M.; Bouman, Amanda R.; Rimnac, Clare M.; Hernandez, Christopher J.			Microdamage Caused by Fatigue Loading in Human Cancellous Bone: Relationship to Reductions in Bone Biomechanical Performance	PLOS ONE			English	Article							VERTEBRAL TRABECULAR BONE; CORTICAL BONE; MINERAL DENSITY; YIELD STRAIN; COMPACT-BONE; ACCUMULATION; BEHAVIOR; DAMAGE; FAILURE; CREEP	Vertebral fractures associated with osteoporosis are often the result of tissue damage accumulated over time. Microscopic tissue damage (microdamage) generated in vivo is believed to be a mechanically relevant aspect of bone quality that may contribute to fracture risk. Although the presence of microdamage in bone tissue has been documented, the relationship between loading, microdamage accumulation and mechanical failure is not well understood. The aim of the current study was to determine how microdamage accumulates in human vertebral cancellous bone subjected to cyclic fatigue loading. Cancellous bone cores (n = 32) from the third lumbar vertebra of 16 donors (10 male, 6 female, age 76 +/- 8.8, mean +/- SD) were subjected to compressive cyclic loading at sigma/E-0 = 0.0035 (where sigma is stress and E-0 is the initial Young's modulus). Cyclic loading was suspended before failure at one of seven different amounts of loading and specimens were stained for microdamage using lead uranyl acetate. Damage volume fraction (DV/BV) varied from 0.8 +/- 0.5% (no loading) to 3.4 +/- 2.1% (fatigue-loaded to complete failure) and was linearly related to the reductions in Young's modulus caused by fatigue loading (r(2) = 0.60, p<0.01). The relationship between reductions in Young's modulus and proportion of fatigue life was nonlinear and suggests that most microdamage generation occurs late in fatigue loading, during the tertiary phase. Our results indicate that human vertebral cancellous bone tissue with a DV/BV of 1.5% is expected to have, on average, a Young's modulus 31% lower than the same tissue without microdamage and is able to withstand 92% fewer cycles before failure than the same tissue without microdamage. Hence, even small amounts of microscopic tissue damage in human vertebral cancellous bone may have large effects on subsequent biomechanical performance.	[Lambers, Floor M.; Bouman, Amanda R.; Hernandez, Christopher J.] Cornell Univ, Sibley Sch Mech & Aerosp Engn, Ithaca, NY 14853 USA; [Hernandez, Christopher J.] Cornell Univ, Dept Biomed Engn, Ithaca, NY USA; [Rimnac, Clare M.] Case Western Reserve Univ, Dept Mech & Aerosp Engn, Cleveland, OH 44106 USA; [Hernandez, Christopher J.] Hosp Special Surg, New York, NY 10021 USA	Cornell University; Cornell University; Case Western Reserve University	Hernandez, CJ (corresponding author), Cornell Univ, Sibley Sch Mech & Aerosp Engn, Ithaca, NY 14853 USA.	cjh275@cornell.edu	Hernandez, Christopher J/B-5290-2009	Hernandez, Christopher J/0000-0002-0712-6533; Rimnac, Clare/0000-0001-9981-8723	NIAMS/NIH [R01 AR057362]; NIH [8U42OD011158-22]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR057362] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD012287, U42OD011158] Funding Source: NIH RePORTER	NIAMS/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This publication was made possible by Grant Number R01 AR057362 from NIAMS/NIH (PI CJH). The authors acknowledge use of human vertebral bodies provided by the National Disease Research Interchange (NDRI, Philadelphia, PA), with support from NIH grant 8U42OD011158-22. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akkus O, 2001, J BIOMECH, V34, P757, DOI 10.1016/S0021-9290(01)00025-2; Arlot ME, 2008, J BONE MINER RES, V23, P1613, DOI 10.1359/JBMR.080517; Bevill G, 2006, BONE, V39, P1218, DOI 10.1016/j.bone.2006.06.016; Bowman SM, 1998, J BIOMECH ENG-T ASME, V120, P647, DOI 10.1115/1.2834757; BRINCKMANN P, 1983, SPINE, V8, P851, DOI 10.1097/00007632-198311000-00007; Brock GR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057942; Burr DB, 1998, J BIOMECH, V31, P337, DOI 10.1016/S0021-9290(98)00016-5; BURR DB, 1995, BONE, V17, P431, DOI 10.1016/S8756-3282(95)00241-3; Burr DB, 1997, J BONE MINER RES, V12, P6, DOI 10.1359/jbmr.1997.12.1.6; CARTER DR, 1976, J BIOMECH, V9, P27, DOI 10.1016/0021-9290(76)90136-6; COOPER C, 1992, J BONE MINER RES, V7, P221, DOI 10.1002/jbmr.5650070214; COOPER C, 1992, TRENDS ENDOCRIN MET, V3, P224, DOI 10.1016/1043-2760(92)90032-V; Diab T, 2005, BONE, V37, P96, DOI 10.1016/j.bone.2005.03.014; Fazzalari NL, 1998, BONE, V22, P381, DOI 10.1016/S8756-3282(97)00298-6; FORWOOD MR, 1989, CALCIFIED TISSUE INT, V45, P47, DOI 10.1007/BF02556660; Giambini H, 2013, CLIN BIOMECH, V28, P10, DOI 10.1016/j.clinbiomech.2012.10.005; Gong H, 2007, ANN BIOMED ENG, V35, P1622, DOI 10.1007/s10439-007-9332-8; Green JO, 2011, J BIOMECH, V44, P2659, DOI 10.1016/j.jbiomech.2011.08.006; Haddock SM, 2004, J BIOMECH, V37, P181, DOI 10.1016/S0021-9290(03)00245-8; Hayat MA, 2000, PRINCIPLES AND TECHNIQUES OF ELECTRON MICROSCOPY: BIOLOGICAL APPLICATIONS, FOURTH EDITION, P1; Hernandez CJ, 2006, BONE, V39, P1173, DOI 10.1016/j.bone.2006.06.001; Hernandez CJ, 2011, STAT POWER MEASURES; Karim L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035047; Karim L, 2011, J ORTHOP RES, V29, P1739, DOI 10.1002/jor.21448; Keaveny TM, 1999, J ORTHOPAED RES, V17, P346, DOI 10.1002/jor.1100170308; Keaveny TM, 1997, J ORTHOPAED RES, V15, P101, DOI 10.1002/jor.1100150115; Kopperdahl DL, 1998, J BIOMECH, V31, P601, DOI 10.1016/S0021-9290(98)00057-8; Kopperdahl DL, 2000, J ORTHOPAED RES, V18, P685, DOI 10.1002/jor.1100180502; Kummari SR, 2009, CALCIFIED TISSUE INT, V85, P127, DOI 10.1007/s00223-009-9257-3; Landrigan MD, 2011, BONE, V48, P443, DOI 10.1016/j.bone.2010.10.160; Lee TC, 2000, J ORTHOPAED RES, V18, P322, DOI 10.1002/jor.1100180222; Lee TC, 2003, J ANAT, V203, P161, DOI 10.1046/j.1469-7580.2003.00211.x; Lynch JA, 2008, BONE, V42, P942, DOI 10.1016/j.bone.2008.01.004; MICHEL MC, 1993, J BIOMECH, V26, P453, DOI 10.1016/0021-9290(93)90009-4; Moore TLA, 2004, J BIOMECH ENG-T ASME, V126, P321, DOI 10.1115/1.1762892; Moore TLA, 2003, J BIOMECH ENG-T ASME, V125, P769, DOI 10.1115/1.1631584; Moore TLA, 2003, J BIOMECH ENG-T ASME, V125, P761, DOI 10.1115/1.1631583; Moore TLA, 2002, J BIOMECH ENG-T ASME, V124, P63, DOI 10.1115/1.1428745; Morgan EF, 2001, J BIOMECH, V34, P569, DOI 10.1016/S0021-9290(01)00011-2; Morgan EF, 2001, J BIOMECH ENG-T ASME, V123, P1, DOI 10.1115/1.1338122; Mori S, 1997, BONE, V21, P521, DOI 10.1016/S8756-3282(97)00200-7; Nalla RK, 2003, NAT MATER, V2, P164, DOI 10.1038/nmat832; O'Brien FJ, 2003, J BIOMECH, V36, P973, DOI 10.1016/S0021-9290(03)00066-6; Pattin CA, 1996, J BIOMECH, V29, P69, DOI 10.1016/0021-9290(94)00156-1; RIGGS BL, 1995, BONE, V17, pS505, DOI 10.1016/8756-3282(95)00258-4; RIMNAC CM, 1993, J BIOMECH, V26, P219, DOI 10.1016/0021-9290(93)90360-Q; Schaffler MB, 1995, BONE, V17, P521, DOI 10.1016/8756-3282(95)00370-3; SCHAFFLER MB, 1989, BONE, V10, P207, DOI 10.1016/8756-3282(89)90055-0; SCHAFFLER MB, 1994, BONE, V15, P483, DOI 10.1016/8756-3282(94)90271-2; Seref-Ferlengez Z, 2012, DIFFUSE MICRODAMAGE, P1348; Shi XT, 2010, J BIOMECH, V43, P2460, DOI 10.1016/j.jbiomech.2010.05.032; Sobelman OS, 2004, J BIOMECH, V37, P1295, DOI 10.1016/j.jbiomech.2003.12.034; Sun XH, 2012, BONE, V51, P860, DOI 10.1016/j.bone.2012.08.116; Sun XH, 2010, J BIOMECH, V43, P1989, DOI 10.1016/j.jbiomech.2010.03.011; Tang SY, 2007, BONE, V40, P1259, DOI 10.1016/j.bone.2006.10.031; Thurner PJ, 2006, BONE, V39, P289, DOI 10.1016/j.bone.2006.01.147; Uthgenannt BA, 2007, J BIOMECH, V40, P317, DOI 10.1016/j.jbiomech.2006.01.005; Vashishth D, 2000, BONE, V26, P147, DOI 10.1016/S8756-3282(99)00253-7; Vashishth D, 2007, INT J FATIGUE, V29, P1024, DOI 10.1016/j.ijfatigue.2006.09.010; Wachtel EF, 1997, J ORTHOPAED RES, V15, P781, DOI 10.1002/jor.1100150522; Wang XA, 2006, J BIOMECH, V39, P781, DOI 10.1016/j.jbiomech.2005.02.007; Wang X, 2007, J BIOMECH, V40, P3397, DOI 10.1016/j.jbiomech.2007.05.009; Wenzel TE, 1996, BONE, V19, P89, DOI 10.1016/8756-3282(96)88871-5; Wu ZH, 2013, BONE, V55, P208, DOI 10.1016/j.bone.2013.02.019; Xu ZB, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3514633; Yamamoto E, 2006, J BIOMECH, V39, P1812, DOI 10.1016/j.jbiomech.2005.05.017; Zimmermann EA, 2011, P NATL ACAD SCI USA, V108, P14416, DOI 10.1073/pnas.1107966108	67	42	45	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e83662	10.1371/journal.pone.0083662	http://dx.doi.org/10.1371/journal.pone.0083662			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386247	Green Published, Green Submitted, gold			2022-12-25	WOS:000329194700056
J	Liu, C; Gotz, J				Liu, Chang; Goetz, Juergen			Profiling Murine Tau with 0N, 1N and 2N Isoform-Specific Antibodies in Brain and Peripheral Organs Reveals Distinct Subcellular Localization, with the 1N Isoform Being Enriched in the Nucleus	PLOS ONE			English	Article							MICROTUBULE-ASSOCIATED PROTEIN; ALZHEIMERS-DISEASE; TRANSGENIC MICE; NEUROBLASTOMA-CELLS; FILAMENT FORMATION; AXONAL-TRANSPORT; BETA TOXICITY; MOUSE-BRAIN; P301L TAU; PHOSPHORYLATION	In the adult murine brain, the microtubule-associated protein tau exists as three major isoforms, which have four microtubule-binding repeats (4R), with either no (0N), one (1N) or two (2N) amino-terminal inserts. The human brain expresses three additional isoforms with three microtubule-binding repeats (3R) each. However, little is known about the role of the amino-terminal inserts and how the 0N, 1N and 2N tau species differ. In order to investigate this, we generated a series of isoform-specific antibodies and performed a profiling by Western blotting and immunohistochemical analyses using wild-type mice in three age groups: two months, two weeks and postnatal day 0 (P0). This revealed that the brain is the only organ to express tau at significant levels, with 0N4R being the predominant isoform in the two month-old adult. Subcellular fractionation of the brain showed that the 1N isoform is over-represented in the soluble nuclear fraction. This is in agreement with the immunohistochemical analysis as the 1N isoform strongly localizes to the neuronal nucleus, although it is also found in cell bodies and dendrites, but not axons. The 0N isoform is mainly found in cell bodies and axons, whereas nuclei and dendrites are only slightly stained with the 0N antibody. The 2N isoform is highly expressed in axons and in cell bodies, with a detectable expression in dendrites and a very slight expression in nuclei. The 2N isoform that was undetectable at P0, in adult brain was mainly found localized to cell bodies and dendrites. Together these findings reveal significant differences between the three murine tau isoforms that are likely to reflect different neuronal functions.	[Liu, Chang; Goetz, Juergen] Univ Sydney, Sydney Med Sch, Brain & Mind Res Inst, Camperdown, NSW, Australia; [Goetz, Juergen] Univ Queensland, Queensland Brain Inst, CJCADR, Brisbane, Qld, Australia	University of Sydney; University of Queensland	Gotz, J (corresponding author), Univ Queensland, Queensland Brain Inst, CJCADR, St Lucia Campus, Brisbane, Qld, Australia.	j.goetz@uq.edu.au	Götz, Jürgen/C-2448-2014	Götz, Jürgen/0000-0001-8501-7896	Estate of Dr Clem Jones AO; Australian Research Council (ARC); National Health and Medical Research Council of Australia (NHMRC)	Estate of Dr Clem Jones AO; Australian Research Council (ARC)(Australian Research Council); National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	This study was supported by the Estate of Dr Clem Jones AO, and grants from the Australian Research Council (ARC) and the National Health and Medical Research Council of Australia (NHMRC) to JG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASHMAN JB, 1992, BIOL REPROD, V46, P120, DOI 10.1095/biolreprod46.1.120; Bhaskar K, 2005, J BIOL CHEM, V280, P35119, DOI 10.1074/jbc.M505895200; Bi M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026860; BRADY ST, 1985, NATURE, V317, P73, DOI 10.1038/317073a0; BRANDT R, 1995, J CELL BIOL, V131, P1327, DOI 10.1083/jcb.131.5.1327; BRION JP, 1993, J NEUROCHEM, V61, P2071, DOI 10.1111/j.1471-4159.1993.tb07444.x; Bullmann T, 2007, HIPPOCAMPUS, V17, P98, DOI 10.1002/hipo.20255; Bullmann T, 2009, INT J DEV NEUROSCI, V27, P591, DOI 10.1016/j.ijdevneu.2009.06.001; Clavaguera F, 2013, P NATL ACAD SCI USA, V110, P9535, DOI 10.1073/pnas.1301175110; Deters N, 2008, EUR J NEUROSCI, V28, P137, DOI 10.1111/j.1460-9568.2008.06318.x; GOEDERT M, 1989, EMBO J, V8, P393, DOI 10.1002/j.1460-2075.1989.tb03390.x; GOEDERT M, 1989, NEURON, V3, P519, DOI 10.1016/0896-6273(89)90210-9; GOEDERT M, 1993, P NATL ACAD SCI USA, V90, P5066, DOI 10.1073/pnas.90.11.5066; Gotz J, 2009, CELL MOL LIFE SCI, V66, P1321, DOI 10.1007/s00018-009-9070-1; GOTZ J, 1995, EMBO J, V14, P1304, DOI 10.1002/j.1460-2075.1995.tb07116.x; Gotz J, 2001, J BIOL CHEM, V276, P529, DOI 10.1074/jbc.M006531200; Gu YJ, 1996, J NEUROCHEM, V67, P1235; Hanger DP, 2002, FEBS LETT, V531, P538, DOI 10.1016/S0014-5793(02)03611-6; Hong M, 1998, SCIENCE, V282, P1914, DOI 10.1126/science.282.5395.1914; Hua Q, 2003, BBA-PROTEINS PROTEOM, V1645, P205, DOI 10.1016/S1570-9639(02)00538-1; Ingelsson M, 2007, ACTA NEUROPATHOL, V114, P471, DOI 10.1007/s00401-007-0280-z; Ittner LM, 2008, P NATL ACAD SCI USA, V105, P15997, DOI 10.1073/pnas.0808084105; Ittner LM, 2010, CELL, V142, P387, DOI 10.1016/j.cell.2010.06.036; Karch CM, 2012, J BIOL CHEM, V287, P42751, DOI 10.1074/jbc.M112.380642; Ke YZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035678; Lee G, 1998, J CELL SCI, V111, P3167; LEE G, 1989, NEURON, V2, P1615, DOI 10.1016/0896-6273(89)90050-0; Lee G, 2004, J NEUROSCI, V24, P2304, DOI 10.1523/JNEUROSCI.4162-03.2004; Lim YA, 2012, BBA-MOL BASIS DIS, V1822, P1247, DOI 10.1016/j.bbadis.2012.04.007; LOOMIS PA, 1990, P NATL ACAD SCI USA, V87, P8422, DOI 10.1073/pnas.87.21.8422; Maas T, 2000, J BIOL CHEM, V275, P15733, DOI 10.1074/jbc.M000389200; McMillan P, 2008, J COMP NEUROL, V511, P788, DOI 10.1002/cne.21867; Monroy-Ramirez HC, 2013, J ALZHEIMERS DIS, V36, P503, DOI 10.3233/JAD-122401; MULOT SFC, 1994, FEBS LETT, V349, P359, DOI 10.1016/0014-5793(94)00702-0; Panda D, 2003, P NATL ACAD SCI USA, V100, P9548, DOI 10.1073/pnas.1633508100; Patel VP, 2011, INT J CLIN EXP PATHO, V4, P215; Probst A, 2000, ACTA NEUROPATHOL, V99, P469, DOI 10.1007/s004010051148; Sjoberg MK, 2006, J CELL SCI, V119, P2025, DOI 10.1242/jcs.02907; Sultan A, 2011, J BIOL CHEM, V286, P4566, DOI 10.1074/jbc.M110.199976; Tucker KL, 2001, NAT NEUROSCI, V4, P29, DOI 10.1038/82868; van Eersel J, 2010, P NATL ACAD SCI USA, V107, P13888, DOI 10.1073/pnas.1009038107; Wei Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002600; Zhong Q, 2012, J BIOL CHEM, V287, P20711, DOI 10.1074/jbc.M112.364067	43	77	80	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e84849	10.1371/journal.pone.0084849	http://dx.doi.org/10.1371/journal.pone.0084849			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386422	gold, Green Submitted, Green Published			2022-12-25	WOS:000329194700120
J	Shamis, Y; Silva, EA; Hewitt, KJ; Brudno, Y; Levenberg, S; Mooney, DJ; Garlick, JA				Shamis, Yulia; Silva, Eduardo A.; Hewitt, Kyle J.; Brudno, Yevgeny; Levenberg, Shulamit; Mooney, David J.; Garlick, Jonathan A.			Fibroblasts Derived from Human Pluripotent Stem Cells Activate Angiogenic Responses In Vitro and In Vivo	PLOS ONE			English	Article							MESENCHYMAL CELLS; VESSEL FORMATION; STROMAL CELLS; NEURAL CREST; HUMAN ORGANS; PERICYTES; DIFFERENTIATION; FUNCTIONALITY; MECHANISMS; NETWORKS	Human embryonic and induced pluripotent stem cells (hESC/hiPSC) are promising cell sources for the derivation of large numbers of specific cell types for tissue engineering and cell therapy applications. We have describe a directed differentiation protocol that generates fibroblasts from both hESC and hiPSC (EDK/iPDK) that support the repair and regeneration of epithelial tissue in engineered, 3D skin equivalents. In the current study, we analyzed the secretory profiles of EDK and iPDK cells to investigate the production of factors that activate and promote angiogenesis. Analysis of in vitro secretion profiles from EDK and iPDK cells demonstrated the elevated secretion of pro-angiogenic soluble mediators, including VEGF, HGF, IL-8, PDGF-AA, and Ang-1, that stimulated endothelial cell sprouting in a 3D model of angiogenesis in vitro. Phenotypic analysis of EDK and iPDK cells during the course of differentiation from hESCs and iPSCs revealed that both cell types progressively acquired pericyte lineage markers NG2, PDGFR beta, CD105, and CD73 and demonstrated transient induction of pericyte progenitor markers CD31, CD34, and Flk1/VEGFR2. Furthermore, when co-cultured with endothelial cells in 3D fibrin-based constructs, EDK and iPDK cells promoted self-assembly of vascular networks and vascular basement membrane deposition. Finally, transplantation of EDK cells into mice with hindlimb ischemia significantly reduced tissue necrosis and improved blood perfusion, demonstrating the potential of these cells to stimulate angiogenic responses in vivo. These findings demonstrate that stable populations of pericyte-like angiogenic cells can be generated with high efficiency from hESC and hiPSC using a directed differentiation approach. This provides new cell sources and opportunities for vascular tissue engineering and for the development of novel strategies in regenerative medicine.	[Shamis, Yulia; Hewitt, Kyle J.; Garlick, Jonathan A.] Tufts Univ, Sackler Sch Grad Biomed Sci, Sch Med, Program Cell Mol & Dev Biol, Boston, MA 02111 USA; [Silva, Eduardo A.; Brudno, Yevgeny; Mooney, David J.] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Silva, Eduardo A.; Brudno, Yevgeny] Harvard Univ, Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA; [Levenberg, Shulamit; Mooney, David J.] Technion Israel Inst Technol, Dept Biomed Engn, IL-32000 Haifa, Israel	Tufts University; Harvard University; Harvard University; Technion Israel Institute of Technology	Garlick, JA (corresponding author), Tufts Univ, Sackler Sch Grad Biomed Sci, Sch Med, Program Cell Mol & Dev Biol, Boston, MA 02111 USA.	Jonathan.Garlick@tufts.edu	Silva, Eduardo A./M-2711-2015; Hewitt, Kyle/S-6512-2019	Silva, Eduardo A./0000-0003-3173-7622; Levenberg, Shulamit/0000-0001-5471-7339; Mooney, David/0000-0001-6299-1194; Brudno, Yevgeny/0000-0003-2963-3293	National Institute for Dental Research (NIDCR) [DE017413];  [HL069957]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL069957] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE017413] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK098055] Funding Source: NIH RePORTER	National Institute for Dental Research (NIDCR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grant #DE017413 to Dr. Jonathan A. Garlick from National Institute for Dental Research (NIDCR) and grant #HL069957 to Dr. David Mooney. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armulik A, 2011, DEV CELL, V21, P193, DOI 10.1016/j.devcel.2011.07.001; Bergers G, 2005, NEURO-ONCOLOGY, V7, P452, DOI 10.1215/S1152851705000232; Boyd NL, 2011, TISSUE ENG PT A, V17, P1537, DOI [10.1089/ten.tea.2010.0397, 10.1089/ten.TEA.2010.0397]; Caplan AI, 2008, CELL STEM CELL, V3, P229, DOI 10.1016/j.stem.2008.08.008; Caplan AI, 2006, J CELL BIOCHEM, V98, P1076, DOI 10.1002/jcb.20886; Cassiman D, 2006, J HEPATOL, V44, P1098, DOI 10.1016/j.jhep.2005.09.023; Chen LW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001886; Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003; Crisan M, 2009, ANN NY ACAD SCI, V1176, P118, DOI 10.1111/j.1749-6632.2009.04967.x; Dar A, 2012, CIRCULATION, V125, P87, DOI 10.1161/CIRCULATIONAHA.111.048264; Etchevers HC, 2002, TRENDS CARDIOVAS MED, V12, P299, DOI 10.1016/S1050-1738(02)00178-0; Evensen L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005798; Gaengel K, 2009, ARTERIOSCL THROM VAS, V29, P630, DOI 10.1161/ATVBAHA.107.161521; Grainger SJ, 2013, TISSUE ENG PT A, V19, P1209, DOI [10.1089/ten.TEA.2012.0281, 10.1089/ten.tea.2012.0281]; Gruenloh W, 2011, TISSUE ENG PT A, V17, P1517, DOI [10.1089/ten.tea.2010.0460, 10.1089/ten.TEA.2010.0460]; Hewitt KJ, 2009, TISSUE ENG PT A, V15, P3417, DOI [10.1089/ten.tea.2009.0060, 10.1089/ten.TEA.2009.0060]; Hewitt KJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017128; Jain RK, 2003, NAT MED, V9, P685, DOI 10.1038/nm0603-685; Kinnaird T, 2004, CIRCULATION, V109, P1543, DOI 10.1161/01.CIR.0000124062.31102.57; Lai RC, 2010, STEM CELL RES, V4, P214, DOI 10.1016/j.scr.2009.12.003; Lesman A, 2011, BIOMATERIALS, V32, P7856, DOI 10.1016/j.biomaterials.2011.07.003; Lian QZ, 2010, CIRCULATION, V121, P1113, DOI 10.1161/CIRCULATIONAHA.109.898312; Marcelo KL, 2013, CIRC RES, V112, P1272, DOI 10.1161/CIRCRESAHA.113.300506; Meirelles LD, 2009, CYTOKINE GROWTH F R, V20, P419, DOI 10.1016/j.cytogfr.2009.10.002; Powell DW, 2011, ANNU REV PHYSIOL, V73, P213, DOI 10.1146/annurev.physiol.70.113006.100646; Que JW, 2008, P NATL ACAD SCI USA, V105, P16626, DOI 10.1073/pnas.0808649105; Salgado AJ, 2010, CURR STEM CELL RES T, V5, P103; Shamis Y, 2012, IN VITRO CELL DEV-AN, V48, P112, DOI 10.1007/s11626-011-9478-4; Shamis Y, 2011, STEM CELL RES THER, V2, DOI 10.1186/scrt51; Silva EA, 2010, BIOMATERIALS, V31, P1235, DOI 10.1016/j.biomaterials.2009.10.052; Vailhe B, 2001, LAB INVEST, V81, P439, DOI 10.1038/labinvest.3780252; Vo E, 2010, STEM CELL REV REP, V6, P237, DOI 10.1007/s12015-010-9144-3; Wu YJ, 2007, STEM CELLS, V25, P2648, DOI 10.1634/stemcells.2007-0226; Zachariah MA, 2010, SCIENCE, V328, P1129, DOI 10.1126/science.1188222	34	20	22	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e83755	10.1371/journal.pone.0083755	http://dx.doi.org/10.1371/journal.pone.0083755			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386271	Green Published, Green Submitted, gold			2022-12-25	WOS:000329194700065
J	Kirchner, M; AbuOun, M; Mafura, M; Bagnall, M; Hunt, T; Thomas, C; Weile, J; Anjum, MF				Kirchner, Miranda; AbuOun, Manal; Mafura, Muriel; Bagnall, Mary; Hunt, Theresa; Thomas, Christopher; Weile, Jan; Anjum, Muna F.			Cefotaxime Resistant Escherichia coli Collected from a Healthy Volunteer; Characterisation and the Effect of Plasmid Loss	PLOS ONE			English	Article							SPECTRUM BETA-LACTAMASE; MOLECULAR CHARACTERIZATION; ANTIBIOTIC-RESISTANCE; EFFLUX PUMP; SALMONELLA; STRAINS; GENES; IDENTIFICATION; MICROARRAY; MUTATIONS	In this study 6 CTX-M positive E. coli isolates collected during a clinical study examining the effect of antibiotic use in a human trial were analysed. The aim of the study was to analyse these isolates and assess the effect of full or partial loss of plasmid genes on bacterial fitness and pathogenicity. A DNA array was utilised to assess resistance and virulence gene carriage. Plasmids were characterised by PCR-based replicon typing and addiction system multiplex PCR. A phenotypic array and insect virulence model were utilised to assess the effect of plasmid-loss in E. coli of a large multi-resistance plasmid. All six E. coli carrying blaCTX-M-14 were detected from a single participant and were identical by pulse field gel electrophoresis and MLST. Plasmid profiling and arrays indicated absence of a large multi-drug resistance (MDR) F-replicon plasmid carrying blaTEM, aadA4, strA, strB, dfrA17/19, sul1, and tetB from one isolate. Although this isolate partially retained the plasmid it showed altered fitness characteristics e. g. inability to respire in presence of antiseptics, similar to a plasmid-cured strain. However, unlike the plasmid-cured or plasmid harbouring strains, the survival rate for Galleria mellonella infected by the former strain was approximately 5-times lower, indicating other possible changes accompanying partial plasmid loss. In conclusion, our results demonstrated that an apparently healthy individual can harbour blaCTX-M-14 E. coli strains. In one such strain, isolated from the same individual, partial absence of a large MDR plasmid resulted in altered fitness and virulence characteristics, which may have implications in the ability of this strain to infect and any subsequent treatment.	[Kirchner, Miranda; AbuOun, Manal; Mafura, Muriel; Bagnall, Mary; Hunt, Theresa; Anjum, Muna F.] Anim Hlth & Vet Labs, Dept Bacteriol & Food Safety, Addlestone, Surrey, England; [Thomas, Christopher] Univ Birmingham, Sch Biosci, Birmingham, W Midlands, England; [Weile, Jan] Ruhr Univ Bochum, Univ Hosp, Heart & Diabet Ctr, Inst Lab & Transfus Med, Bochum, Germany	University of Birmingham; Ruhr University Bochum	Anjum, MF (corresponding author), Anim Hlth & Vet Labs, Dept Bacteriol & Food Safety, Addlestone, Surrey, England.	Muna.Anjum@ahvla.gsi.gov.uk	Thomas, Christopher M/J-8258-2017; anjum, muna/C-5213-2011	Thomas, Christopher M/0000-0002-2810-0455; 	EU [241446]	EU(European Commission)	This work was supported by an EU FP7 project "Antiresdev" (Grant number 241446) of which MFA was a work package leader. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson DI, 2010, NAT REV MICROBIOL, V8, P260, DOI 10.1038/nrmicro2319; Anjum MF, 2011, J ANTIMICROB CHEMOTH, V66, P550, DOI 10.1093/jac/dkq498; Batchelor M, 2005, MICROB DRUG RESIST, V11, P58, DOI 10.1089/mdr.2005.11.58; Batchelor M, 2008, INT J ANTIMICROB AG, V31, P440, DOI 10.1016/j.ijantimicag.2007.11.017; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Bochner BR, 2001, GENOME RES, V11, P1246, DOI 10.1101/gr.186501; Carattoli A, 2005, J MICROBIOL METH, V63, P219, DOI 10.1016/j.mimet.2005.03.018; Card R, 2013, ANTIMICROB AGENTS CH, V57, P458, DOI 10.1128/AAC.01223-12; Dhanji H, 2012, ANTIMICROB AGENTS CH, V56, P3376, DOI 10.1128/AAC.00313-12; ESCANDE F, 1991, VET MICROBIOL, V26, P107, DOI 10.1016/0378-1135(91)90047-J; Fang CT, 2002, ANTIMICROB AGENTS CH, V46, P2024, DOI 10.1128/AAC.46.6.2024-2028.2002; Hale L, 2010, BIOTECHNIQUES, V48, P223, DOI 10.2144/000113366; Held KG, 2007, APPL ENVIRON MICROB, V73, P7622, DOI 10.1128/AEM.01000-07; KADO CI, 1981, J BACTERIOL, V145, P1365, DOI 10.1128/JB.145.3.1365-1373.1981; Karisik E, 2006, J ANTIMICROB CHEMOTH, V58, P665, DOI 10.1093/jac/dkl309; Kirchner M, 2011, MICROB DRUG RESIST, V17, P463, DOI 10.1089/mdr.2010.0151; Lau SH, 2008, J ANTIMICROB CHEMOTH, V62, P1241, DOI 10.1093/jac/dkn380; Leuko S, 2012, INFECT IMMUN, V80, P3077, DOI 10.1128/IAI.00081-12; Liebana E, 2006, J CLIN MICROBIOL, V44, P1630, DOI 10.1128/JCM.44.5.1630-1634.2006; Marcusson LL, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000541; Mnif B, 2010, J ANTIMICROB CHEMOTH, V65, P1599, DOI 10.1093/jac/dkq181; Morita Y, 2003, J ANTIMICROB CHEMOTH, V51, P991, DOI 10.1093/jac/dkg173; Pitout JDD, 2004, CLIN LAB MED, V24, P605, DOI 10.1016/j.cll.2004.05.006; Ribot EM, 2006, FOODBORNE PATHOG DIS, V3, P59, DOI 10.1089/fpd.2006.3.59; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Senior NJ, 2011, J MED MICROBIOL, V60, P661, DOI 10.1099/jmm.0.026658-0; Simarro E, 2000, J CLIN MICROBIOL, V38, P4676, DOI 10.1128/JCM.38.12.4676-4678.2000; Thomas CM, 2005, NAT REV MICROBIOL, V3, P711, DOI 10.1038/nrmicro1234; THRELFALL EJ, 1986, J HYG-CAMBRIDGE, V97, P419, DOI 10.1017/S0022172400063609; Valverde A, 2009, ANTIMICROB AGENTS CH, V53, P5204, DOI 10.1128/AAC.01706-08; Wickramasinghe NH, 2012, J ANTIMICROB CHEMOTH, V67, P1108, DOI 10.1093/jac/dks018; Wirth T, 2006, MOL MICROBIOL, V60, P1136, DOI 10.1111/j.1365-2958.2006.05172.x; Zorzet A, 2010, MOL MICROBIOL, V75, P1299, DOI 10.1111/j.1365-2958.2010.07057.x	33	11	12	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e84142	10.1371/journal.pone.0084142	http://dx.doi.org/10.1371/journal.pone.0084142			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281RE	24386342	gold, Green Published, Green Submitted			2022-12-25	WOS:000329117900077
J	Xu, XY; Tian, Y; Li, SY; Li, YZ; Wang, GL; Tian, X				Xu, Xinyu; Tian, Yu; Li, Shuangyan; Li, Yize; Wang, Guolin; Tian, Xin			Inhibition of Propofol Anesthesia on Functional Connectivity between LFPs in PFC during Rat Working Memory Task	PLOS ONE			English	Article							DIRECTED TRANSFER-FUNCTION; SCALE CORTICAL NETWORKS; LOCAL-FIELD POTENTIALS; BRAIN NETWORKS; GRANGER CAUSALITY; INFORMATION-FLOW; EEG; SYNCHRONIZATION; OSCILLATIONS; CORTEX	Working memory (WM) refers to the temporary storage and manipulation of information necessary for performance of complex cognitive tasks. There is a growing interest in whether and how propofol anesthesia inhibits WM function. The aim of this study is to investigate the possible inhibition mechanism of propofol anesthesia based on the functional connections of multi-local field potentials (LFPs) and behavior during WM tasks. Adult SD rats were randomly divided into 3 groups: pro group (0.5 mg.kg(-1).min(-1),2 h), PRO group (0.9 mg.kg(-1).min(-1), 2 h) and control group. The experimental data were 16-channel LFPs obtained at prefrontal cortex with implanted microelectrode array in SD rats during WM tasks in Y-maze at 24, 48, 72, 96, 120 hours (day 1-day 5) after propofol anesthesia, and the behavior results of WM were recoded at the same time. Directed transfer function (DTF) method was applied to analyze the connections among LFPs directly. Furthermore, the causal networks were identified by DTF. The clustering coefficient (C), network density (D) and global efficiency (E-global) were selected to describe the functional connectivity quantitatively. The results show that: comparing with the control group, the LFPs functional connectivity in pro group were no significantly difference (p > 0.05); the connectivity in PRO group were significantly decreased (p < 0.05 at 24 hours, p < 0.05 at 48 hours), while no significant difference at 72, 96 and 120 hours for rats (p > 0.05), which were consistent with the behavior results. These findings could lead to improved understanding the mechanism of inhibition of anesthesia on WM functions from the view of connections among LFPs.	[Xu, Xinyu; Tian, Yu; Li, Shuangyan; Tian, Xin] Tianjin Med Univ, Sch Biomed Engn, Tianjin, Peoples R China; [Li, Yize; Wang, Guolin] Tianjin Med Univ, Gen Hosp, Dept Anesthesiol, Tianjin, Peoples R China	Tianjin Medical University; Tianjin Medical University	Tian, X (corresponding author), Tianjin Med Univ, Sch Biomed Engn, Tianjin, Peoples R China.	tianx@tmu.edu.cn			National Natural Science Foundation of China (NSFC) [91132722, 61375113, 61301252]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (NSFC 91132722, 61375113 and 61301252). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard S, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.036104; Achard S, 2007, PLOS COMPUT BIOL, V3, P174, DOI 10.1371/journal.pcbi.0030017; Amodio DM, 2006, NAT REV NEUROSCI, V7, P268, DOI 10.1038/nrn1884; Astolfi L, 2004, MAGN RESON IMAGING, V22, P1457, DOI 10.1016/j.mri.2004.10.006; Babiloni F, 2005, NEUROIMAGE, V24, P118, DOI 10.1016/j.neuroimage.2004.09.036; Baddeley A, 2003, NAT REV NEUROSCI, V4, P829, DOI 10.1038/nrn1201; Baddeley A, 2010, CURR BIOL, V20, pR136, DOI 10.1016/j.cub.2009.12.014; Bannerman DM, 2008, J NEUROSCI, V28, P3623, DOI 10.1523/JNEUROSCI.3639-07.2008; Barnett L, 2011, J NEUROSCI METH, V201, P404, DOI 10.1016/j.jneumeth.2011.08.010; Barr G, 2001, ACTA ANAESTH SCAND, V45, P834, DOI 10.1034/j.1399-6576.2001.045007834.x; Bassett DS, 2011, P NATL ACAD SCI USA, V108, P7641, DOI 10.1073/pnas.1018985108; Bassett DS, 2009, P NATL ACAD SCI USA, V106, P11747, DOI 10.1073/pnas.0903641106; Bercker S, 2009, NEUROTOX RES, V16, P140, DOI 10.1007/s12640-009-9063-8; Binder JR, 2009, CEREB CORTEX, V19, P2767, DOI 10.1093/cercor/bhp055; BRESSLER SL, 1995, BRAIN RES REV, V20, P288, DOI 10.1016/0165-0173(94)00016-I; Bressler SL, 2010, TRENDS COGN SCI, V14, P277, DOI 10.1016/j.tics.2010.04.004; Brzezicka A, 2011, BRAIN TOPOGR, V24, P1, DOI 10.1007/s10548-010-0158-6; Buckner RL, 2007, TRENDS COGN SCI, V11, P49, DOI 10.1016/j.tics.2006.11.004; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Cardin JA, 2009, NATURE, V459, P663, DOI 10.1038/nature08002; D'Esposito M, 2007, PHILOS T R SOC B, V362, P761, DOI 10.1098/rstb.2007.2086; DeCoteau WE, 2007, J NEUROPHYSIOL, V97, P3800, DOI 10.1152/jn.00108.2007; Dejean C, 2008, J NEUROPHYSIOL, V100, P385, DOI 10.1152/jn.90466.2008; Dosenbach NUF, 2008, TRENDS COGN SCI, V12, P99, DOI 10.1016/j.tics.2008.01.001; Dressler I, 2007, EUR J ANAESTH, V24, P347, DOI 10.1017/S0265021506001530; Eichler M, 2006, BIOL CYBERN, V94, P469, DOI 10.1007/s00422-006-0062-z; Erasso DM, 2012, BRAIN RES, V1441, P38, DOI 10.1016/j.brainres.2011.11.025; Fairhall AL, 2001, NATURE, V412, P787, DOI 10.1038/35090500; Fell J, 2011, NAT REV NEUROSCI, V12, P105, DOI 10.1038/nrn2979; FRANASZCZUK PJ, 1994, ELECTROEN CLIN NEURO, V91, P413, DOI 10.1016/0013-4694(94)90163-5; Fries P, 2005, TRENDS COGN SCI, V9, P474, DOI 10.1016/j.tics.2005.08.011; Giessing C, 2013, J NEUROSCI, V33, P5903, DOI 10.1523/JNEUROSCI.4854-12.2013; Ginestet CE, 2011, NEUROIMAGE, V55, P688, DOI 10.1016/j.neuroimage.2010.11.030; He H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038195; He Y, 2010, CURR OPIN NEUROL, V23, P341, DOI 10.1097/WCO.0b013e32833aa567; Heitger MH, 2012, NEUROIMAGE, V61, P633, DOI 10.1016/j.neuroimage.2012.03.067; Hsieh LT, 2011, J NEUROSCI, V31, P10803, DOI 10.1523/JNEUROSCI.0828-11.2011; Hyafil A, 2009, J NEUROSCI, V29, P5135, DOI 10.1523/JNEUROSCI.2828-08.2009; Jones RH, 2011, STAT MED, V30, P3050, DOI 10.1002/sim.4323; Jutras MJ, 2009, J NEUROSCI, V29, P12521, DOI 10.1523/JNEUROSCI.0640-09.2009; Kaminski M, 2001, BIOL CYBERN, V85, P145, DOI 10.1007/s004220000235; Kawasaki M, 2007, NEUROSCI LETT, V422, P141, DOI 10.1016/j.neulet.2007.04.079; Koenig T, 2005, NEUROBIOL AGING, V26, P165, DOI 10.1016/j.neurobiolaging.2004.03.008; Korzeniewska A, 2003, J NEUROSCI METH, V125, P195, DOI 10.1016/S0165-0270(03)00052-9; LeBeau FEN, 2002, J PHYSIOL-LONDON, V542, P167, DOI 10.1113/jphysiol.2002.015933; Leistedt SJJ, 2009, HUM BRAIN MAPP, V30, P2207, DOI 10.1002/hbm.20662; Marceglia S, 2007, EXPERT REV MED DEVIC, V4, P605, DOI 10.1586/17434440.4.5.605; Mesulam MM, 1998, BRAIN, V121, P1013, DOI 10.1093/brain/121.6.1013; Milner B, 2005, PSYCHIAT CLIN N AM, V28, P599, DOI 10.1016/j.psc.2005.06.002; Murias M, 2007, BIOL PSYCHIAT, V62, P270, DOI 10.1016/j.biopsych.2006.11.012; N'Kaoua B, 2002, J CLIN EXP NEUROPSYC, V24, P713, DOI 10.1076/jcen.24.6.713.8401; Nagashima K, 2005, ANESTHESIOLOGY, V103, P318, DOI 10.1097/00000542-200508000-00015; Price CC, 2008, ANESTHESIOLOGY, V108, P8, DOI 10.1097/01.anes.0000296072.02527.18; Rossi AF, 2009, EXP BRAIN RES, V192, P489, DOI 10.1007/s00221-008-1642-z; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Sanou J, 1996, NEUROREPORT, V7, P1130, DOI 10.1097/00001756-199604260-00005; Schindler KA, 2008, CHAOS, V18, DOI 10.1063/1.2966112; Schlogl A, 2006, PROG BRAIN RES, V159, P135, DOI 10.1016/S0079-6123(06)59009-0; Semba K, 2005, ANESTHESIOLOGY, V102, P616, DOI 10.1097/00000542-200503000-00021; Seth AK, 2010, J NEUROSCI METH, V186, P262, DOI 10.1016/j.jneumeth.2009.11.020; Singer W, 1999, NEURON, V24, P49, DOI 10.1016/S0896-6273(00)80821-1; Sohal VS, 2009, NATURE, V459, P698, DOI 10.1038/nature07991; Supekar K, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000100; Uhlhaas PJ, 2011, SCHIZOPHRENIA BULL, V37, P514, DOI 10.1093/schbul/sbr034; Wang JH, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00016; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wilder RT, 2009, ANESTHESIOLOGY, V110, P796, DOI 10.1097/01.anes.0000344728.34332.5d; Wilke C, 2011, EPILEPSIA, V52, P84, DOI 10.1111/j.1528-1167.2010.02785.x; Womelsdorf T, 2007, SCIENCE, V316, P1609, DOI [10.1126/science.1139597, 10.1126/science.1139178]	69	9	12	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e83653	10.1371/journal.pone.0083653	http://dx.doi.org/10.1371/journal.pone.0083653			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281RE	24386243	Green Published, Green Submitted, gold			2022-12-25	WOS:000329117900048
J	Bertier, L; Leus, L; D'hondt, L; de Cock, AWAM; Hofte, M				Bertier, Lien; Leus, Leen; D'hondt, Liesbet; de Cock, Arthur W. A. M.; Hofte, Monica			Host Adaptation and Speciation through Hybridization and Polyploidy in Phytophthora	PLOS ONE			English	Article							PCR-MEDIATED RECOMBINATION; PATHOGEN PHYTOPHTHORA; MITOCHONDRIAL GENOME; CONCERTED EVOLUTION; NATURAL HYBRIDS; DNA; NUCLEAR; ALLOPOLYPLOIDS; NICOTIANAE; ALNI	It is becoming increasingly evident that interspecific hybridization is a common event in phytophthora evolution. Yet, the fundamental processes underlying interspecific hybridization and the consequences for its ecological fitness and distribution are not well understood. We studied hybridization events in phytophthora clade 8b. This is a cold-tolerant group of plant pathogenic oomycetes in which six host-specific species have been described that mostly attack winter-grown vegetables. Hybrid characterization was done by sequencing and cloning of two nuclear (ITS and Ypt1) and two mitochondrial loci (Cox1 and Nadh1) combined with DNA content estimation using flow cytometry. Three different mtDNA haplotypes were recovered among the presumed hybrid isolates, dividing the hybrids into three types, with different parental species involved. In the nuclear genes, additivity, i.e. the presence of two alleles coming from different parents, was detected. Hybrid isolates showed large variations in DNA content, which was positively correlated with the additivity in nuclear loci, indicating allopolyploid hybridization followed by a process of diploidization. Moreover, indications of homeologous recombination were found in the hybrids by cloning ITS products. The hybrid isolates have been isolated from a range of hosts that have not been reported previously for clade 8b species, indicating that they have novel pathogenic potential. Next to this, DNA content measurements of the non-hybrid clade 8b species suggest that polyploidy is a common feature of this clade. We hypothesize that interspecific hybridization and polyploidy are two linked phenomena in phytophthora, and that these processes might play an important and ongoing role in the evolution of this genus.	[Bertier, Lien; Hofte, Monica] Univ Ghent, Dept Crop Protect, B-9000 Ghent, Belgium; [Leus, Leen; D'hondt, Liesbet] Inst Agr Fisheries Res ILVO, Plant Sci Unit, Melle, Belgium; [de Cock, Arthur W. A. M.] Fungal Biodivers Ctr CBS KNAW, Utrecht, Netherlands	Ghent University; Institute For Agricultural & Fisheries Research; Royal Netherlands Academy of Arts & Sciences; Westerdijk Fungal Biodiversity Institute (KNAW)	Hofte, M (corresponding author), Univ Ghent, Dept Crop Protect, B-9000 Ghent, Belgium.	monica.hofte@ugent.be	Hofte, Monica MR/A-6154-2008; LEUS, LEEN/GPW-8377-2022	Hofte, Monica/0000-0002-0850-3249	Agency for Innovation by Science and Technology in Flanders (IWT)	Agency for Innovation by Science and Technology in Flanders (IWT)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT))	This work was funded by a PhD grant of the Agency for Innovation by Science and Technology in Flanders (IWT; http://www.iwt.be/) given to LB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AL ET, 2004, BIOL J LINN SOC, V82, P615, DOI DOI 10.1111/J.1095-8312.2004.00345.X; Bala K, 2010, PERSOONIA, V25, P22, DOI 10.3767/003158510X524754; Beakes GW, 2012, PROTOPLASMA, V249, P3, DOI 10.1007/s00709-011-0269-2; Bertier L, 2013, PERSOONIA, V31, P63, DOI 10.3767/003158513X668554; Bonants PJM, 2000, PHYTOPATHOLOGY, V90, P867, DOI 10.1094/PHYTO.2000.90.8.867; Boutet X, 2010, FUNGAL BIOL-UK, V114, P369, DOI 10.1016/j.funbio.2010.02.009; Brasier C, 2000, NATURE, V405, P134, DOI 10.1038/35012193; Brasier CM, 2004, MYCOL RES, V108, P1172, DOI 10.1017/S0953756204001005; Brasier CM, 1999, P NATL ACAD SCI USA, V96, P5878, DOI 10.1073/pnas.96.10.5878; Catal M, 2010, CYTOM PART A, V77A, P769, DOI 10.1002/cyto.a.20888; Comai L, 2005, NAT REV GENET, V6, P836, DOI 10.1038/nrg1711; Cronn R, 2002, THEOR APPL GENET, V104, P482, DOI 10.1007/s001220100741; Declercq B, 2010, EUR J PLANT PATHOL, V127, P341, DOI 10.1007/s10658-010-9601-5; DOLEZEL J, 1992, PHYSIOL PLANTARUM, V85, P625, DOI 10.1111/j.1399-3054.1992.tb04764.x; Donahoo RS, 2008, MYCOLOGIA, V100, P911, DOI 10.3852/08-028; ERSEK T, 1995, PHYTOPATHOLOGY, V85, P1343, DOI 10.1094/Phyto-85-1343; Erwin DC, 1996, PHYTOPHTHORA DIS WOR; Gaeta RT, 2010, NEW PHYTOL, V186, P18, DOI 10.1111/j.1469-8137.2009.03089.x; GALBRAITH DW, 1983, SCIENCE, V220, P1049, DOI 10.1126/science.220.4601.1049; GOODWIN SB, 1994, EXP MYCOL, V18, P20, DOI 10.1006/emyc.1994.1003; Goss EM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024543; Greilhuber J, 2009, CHROMOSOMA, V118, P391, DOI 10.1007/s00412-009-0205-9; Grunwald NJ, 2012, PLANT PATHOL, V61, P610, DOI 10.1111/j.1365-3059.2011.02538.x; Haas BJ, 2009, NATURE, V461, P393, DOI 10.1038/nature08358; Hurtado-Gonzales OP, 2009, MYCOLOGIA, V101, P496, DOI 10.3852/08-079; Ioos R, 2006, FUNGAL GENET BIOL, V43, P511, DOI 10.1016/j.fgb.2006.02.006; Kovarik A, 2005, GENETICS, V169, P931, DOI 10.1534/genetics.104.032839; Kroon LPNM, 2004, FUNGAL GENET BIOL, V41, P766, DOI 10.1016/j.fgb.2004.03.007; LaFave MC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000411; Lahr DJG, 2009, BIOTECHNIQUES, V47, P857, DOI 10.2144/000113219; Martens C, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-353; Martin FN, 2007, CURR GENET, V51, P285, DOI 10.1007/s00294-007-0121-6; Nagel JH, 2013, FUNGAL BIOL-UK, V117, P329, DOI 10.1016/j.funbio.2013.03.004; Nirenberg HI, 2009, MYCOLOGIA, V101, P220, DOI 10.3852/06-157; Renny-Byfield S, 2013, PLANT J, V74, P829, DOI 10.1111/tpj.12168; Robideau GP, 2011, MOL ECOL RESOUR, V11, P1002, DOI 10.1111/j.1755-0998.2011.03041.x; SANSOME E, 1991, MYCOL RES, V95, P273, DOI 10.1016/S0953-7562(09)81232-X; SANSOME E, 1977, J GEN MICROBIOL, V99, P311, DOI 10.1099/00221287-99-2-311; SANSOME E, 1974, T BRIT MYCOL SOC, V63, P461, DOI 10.1016/S0007-1536(74)80093-8; Schena L, 2006, J MICROBIOL METH, V67, P70, DOI 10.1016/j.mimet.2006.03.003; Soltis PS, 2009, ANNU REV PLANT BIOL, V60, P561, DOI 10.1146/annurev.arplant.043008.092039; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; TOOLEY PW, 1989, PHYT RECT S BRIT MYC, pCH13; VELD WAM, 2006, EUR J PLANT PATHOL, V117, DOI DOI 10.1007/S10658-006-9065-9.AVAILABLE; VELD WAM, 1998, PHYTOPATHOLOGY, V88, P922, DOI DOI 10.1094/PHYTO.1998.88.9.922; Vercauteren A, 2011, FUNGAL GENET BIOL, V48, P537, DOI 10.1016/j.fgb.2011.01.008; WENDEL JF, 1995, P NATL ACAD SCI USA, V92, P280, DOI 10.1073/pnas.92.1.280; Whisson SC, 2007, NATURE, V450, P115, DOI 10.1038/nature06203; White T., 1990, PCR PROTOCOLS GUIDE, P315; Yoshida K, 2013, ELIFE, V2, DOI 10.7554/eLife.00731	50	54	58	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e85385	10.1371/journal.pone.0085385	http://dx.doi.org/10.1371/journal.pone.0085385			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281QS	24386473	gold, Green Published, Green Submitted			2022-12-25	WOS:000329116700138
J	Pushpakumar, SB; Kundu, S; Metreveli, N; Sen, U				Pushpakumar, Sathnur B.; Kundu, Sourav; Metreveli, Naira; Sen, Utpal			Folic Acid Mitigates Angiotensin-II-Induced Blood Pressure and Renal Remodeling	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; ENDOTHELIAL GROWTH-FACTOR; MATRIX METALLOPROTEINASES; FOLATE INTAKE; HYPERHOMOCYSTEINAEMIC SUBJECTS; ASYMMETRIC DIMETHYLARGININE; ESSENTIAL-HYPERTENSION; DIABETIC-NEPHROPATHY; GLOMERULAR INJURY; DOWN-REGULATION	Clinical data suggests an association between systolic hypertension, renal function and hyperhomocysteinemia (HHcy). HHcy is a state of elevated plasma homocysteine (Hcy) levels and is known to cause vascular complications. In this study, we tested the hypothesis whether Ang II-induced hypertension increases plasma Hcy levels and contributes to renovascular remodeling. We also tested whether folic acid (FA) treatment reduces plasma Hcy levels by enhancing Hcy remethylation and thus mitigating renal remodeling. Hypertension was induced in WT mice by infusing Ang II using Alzet mini osmotic pumps. Blood pressure, Hcy level, renal vascular density, oxidative stress, inflammation and fibrosis markers, and angiogenic-and anti-angiogenic factors were measured. Ang II hypertension increased plasma Hcy levels and reduced renal cortical blood flow and microvascular density. Elevated Hcy in Ang II hypertension was associated with decreased 4, 5-Diaminofluorescein (DAF-2DA) staining suggesting impaired endothelial function. Increased expression of Nox-2, -4 and dihydroethidium stain revealed oxidative stress. Excess collagen IV deposition in the peri-glomerular area and increased MMP-2, and -9 expression and activity indicated renal remodeling. The mRNA and protein expression of asymmetric dimethylarginine (ADMA) was increased and eNOS protein was decreased suggesting the involvement of this pathway in Hcy mediated hypertension. Decreased expressions of VEGF and increased anti-angiogenic factors, angiostatin and endostatin indicated impaired vasculogenesis. FA treatment partially reduced hypertension by mitigating HHcy in Ang II-treated animals and alleviated pro-inflammatory, pro-fibrotic and anti-angiogenic factors. These results suggest that renovascular remodeling in Ang II-induced hypertension is, in part, due to HHcy.	[Pushpakumar, Sathnur B.; Kundu, Sourav; Metreveli, Naira; Sen, Utpal] Univ Louisville, Sch Med, Dept Physiol & Biophys, Louisville, KY 40292 USA	University of Louisville	Sen, U (corresponding author), Univ Louisville, Sch Med, Dept Physiol & Biophys, Louisville, KY 40292 USA.	u0sen001@louisville.edu	Kundu, Sourav/J-1531-2015	KUNDU, SOURAV/0000-0001-9027-5734	National Institutes of Health [HL-104103]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL104103] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported, in part, by National Institutes of Health grant HL-104103 to US. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Advani A, 2007, P NATL ACAD SCI USA, V104, P14448, DOI 10.1073/pnas.0703577104; AK A, 2009, J HLTH SCI, V55, P473; Arendshorst WJ, 1999, J AM SOC NEPHROL, V10, pS149; Bellamy MF, 1999, EUR J CLIN INVEST, V29, P659, DOI 10.1046/j.1365-2362.1999.00527.x; Boini KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045020; Chang PY, 2008, CIRC RES, V102, P933, DOI 10.1161/CIRCRESAHA.108.171082; Chen LH, 2012, ARTERIOSCL THROM VAS, V32, P3024, DOI 10.1161/ATVBAHA.112.254052; Chirco R, 2006, CANCER METAST REV, V25, P99, DOI 10.1007/s10555-006-7893-x; Christen WG, 2009, ARCH INTERN MED, V169, P335, DOI 10.1001/archinternmed.2008.574; Cichocka E, 1995, Pediatr Pol, V70, P171; Clarke ZL, 2006, EUR J PHARMACOL, V551, P92, DOI 10.1016/j.ejphar.2006.08.085; Doshi SN, 2001, ARTERIOSCL THROM VAS, V21, P1196, DOI 10.1161/hq0701.092000; Ericson U, 2007, AM J CLIN NUTR, V86, P434, DOI 10.1093/ajcn/86.2.434; Feng WG, 2012, HYPERTENSION, V60, P1226, DOI 10.1161/HYPERTENSIONAHA.112.197871; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Fiedler L, 2008, CELL ADHES MIGR, V2, P149, DOI 10.4161/cam.2.3.6819; Geisel J, 2001, CLIN CHEM LAB MED, V39, P698, DOI 10.1515/CCLM.2001.115; Granger JP, 2009, HYPERTENSION, V54, P465, DOI 10.1161/HYPERTENSIONAHA.109.132274; Hajitou A, 2002, FASEB J, V16, P1802, DOI 10.1096/fj.02-0109fje; Harding P, 2011, AM J PHYSIOL-HEART C, V300, pH1053, DOI 10.1152/ajpheart.00772.2010; Hayden MR, 2004, NUTR J, V3, DOI 10.1186/1475-2891-3-4; Holven KB, 2003, BRIT J NUTR, V89, P359, DOI 10.1079/BJN2002779; Horvath B, 2012, FREE RADICAL BIO MED, V52, P1325, DOI 10.1016/j.freeradbiomed.2012.01.014; Joseph J, 2008, J HEART LUNG TRANSPL, V27, P1237, DOI 10.1016/j.healun.2008.07.024; Kahleova R, 2002, AM J HYPERTENS, V15, P857, DOI 10.1016/S0895-7061(02)02984-9; Kennedy BP, 2003, J HYPERTENS, V21, P1307, DOI 10.1097/00004872-200307000-00018; Kitayama H, 2006, AM J HYPERTENS, V19, P718, DOI 10.1016/j.amjhyper.2005.09.022; Kumagai H, 2002, KIDNEY INT, V62, P1219, DOI 10.1046/j.1523-1755.2002.00558.x; Lim U, 2002, AM J EPIDEMIOL, V156, P1105, DOI 10.1093/aje/kwf157; Loscalzo J, 2009, J CLIN INVEST, V119, P3203, DOI 10.1172/JCI40924; McLennan SV, 2002, DIABETOLOGIA, V45, P268, DOI 10.1007/s00125-001-0730-4; McNulty M, 2006, J HUM HYPERTENS, V20, P867, DOI 10.1038/sj.jhh.1002015; Melendez-Zajgla J, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-85; Moens AL, 2008, CIRCULATION, V117, P1810, DOI 10.1161/CIRCULATIONAHA.107.725481; Nagase H, 2006, CARDIOVASC RES, V69, P562, DOI 10.1016/j.cardiores.2005.12.002; Nakano E, 2001, BRIT J NUTR, V86, P637, DOI 10.1079/BJN2001478; Neves MF, 2004, J HYPERTENS, V22, P959, DOI 10.1097/00004872-200405000-00018; Papandreou D, 2010, INT J FOOD SCI NUTR, V61, P11, DOI 10.3109/09637480903286371; Persson EC, 2013, CANCER EPIDEM BIOMAR, V22, P415, DOI 10.1158/1055-9965.EPI-12-1169; Petry A, 2006, ANTIOXID REDOX SIGN, V8, P1473, DOI 10.1089/ars.2006.8.1473; POUSSE H, 1990, ANN PEDIATR-PARIS, V37, P189; Qipshidze N, 2012, AM J PHYSIOL-HEART C, V302, pH688, DOI 10.1152/ajpheart.00777.2011; Rodrigo R, 2003, J CARDIOVASC PHARM, V42, P453, DOI 10.1097/00005344-200310000-00001; Sen U, 2008, AM J PHYSIOL-ENDOC M, V295, pE1205, DOI 10.1152/ajpendo.90534.2008; Sen U, 2007, CLIN CHEM LAB MED, V45, P1771, DOI 10.1515/CCLM.2007.354; Sen U, 2007, AM J PHYSIOL-CELL PH, V293, pC1779, DOI 10.1152/ajpcell.00207.2007; Sen U, 2006, J CELL PHYSIOL, V209, P767, DOI 10.1002/jcp.20752; Sen U, 2010, PPAR RES, V2010, DOI 10.1155/2010/806538; Sen U, 2010, AM J NEPHROL, V31, P442, DOI 10.1159/000296717; Sen U, 2009, AM J PHYSIOL-RENAL, V297, pF410, DOI 10.1152/ajprenal.00145.2009; SHAW GM, 1995, EPIDEMIOLOGY, V6, P219, DOI 10.1097/00001648-199505000-00005; Sodha NR, 2009, AM J PHYSIOL-HEART C, V296, pH428, DOI 10.1152/ajpheart.00283.2008; Soetikno V, 2012, MOL NUTR FOOD RES; Soler MJ, 2007, KIDNEY INT, V72, P614, DOI 10.1038/sj.ki.5002373; Solini A, 2006, DIABETOLOGIA, V49, P2499, DOI 10.1007/s00125-006-0377-2; Stopper H, 2008, NEPHROL DIAL TRANSPL, V23, P3272, DOI 10.1093/ndt/gfn254; Stuhlinger MC, 2001, CIRCULATION, V104, P2569, DOI 10.1161/hc4601.098514; SuttonTyrrell K, 1997, CIRCULATION, V96, P1745, DOI 10.1161/01.CIR.96.6.1745; Taimeh Z, 2013, NAT REV CARDIOL, V10, P519, DOI 10.1038/nrcardio.2013.94; Tanaka T, 2013, NAT REV NEPHROL, V9, P211, DOI 10.1038/nrneph.2013.35; Title LM, 2000, J AM COLL CARDIOL, V36, P758, DOI 10.1016/S0735-1097(00)00809-3; Tummalapalli CM, 1999, J CELL BIOCHEM, V75, P515, DOI 10.1002/(SICI)1097-4644(19991201)75:3<515::AID-JCB15>3.0.CO;2-C; Tyagi Neetu, 2011, Int J Physiol Pathophysiol Pharmacol, V3, P210; Varga EA, 2005, CIRCULATION, V111, pE289, DOI 10.1161/01.CIR.0000165142.37711.E7; Verhaar MC, 1999, CIRCULATION, V100, P335, DOI 10.1161/01.CIR.100.4.335; Virdis A, 2003, ARTERIOSCL THROM VAS, V23, P1352, DOI 10.1161/01.ATV.0000083297.47245.DA; Wang XB, 2007, LANCET, V369, P1876, DOI 10.1016/S0140-6736(07)60854-X; Wentzel P, 2005, DIABETES, V54, P546, DOI 10.2337/diabetes.54.2.546; Wilmink HW, 2000, ARTERIOSCL THROM VAS, V20, P185, DOI 10.1161/01.ATV.20.1.185; Wollesen F, 1999, KIDNEY INT, V55, P1028, DOI 10.1046/j.1523-1755.1999.0550031028.x; Woo KS, 1999, J AM COLL CARDIOL, V34, P2002, DOI 10.1016/S0735-1097(99)00469-6; Xun P, 2012, AM J CLIN NUTR, V95, P1023, DOI 10.3945/ajcn.111.027250; Yang ZZ, 2003, KIDNEY INT, V63, P1012, DOI 10.1046/j.1523-1755.2003.00825.x; Yi F, 2006, KIDNEY INT, V70, P88, DOI 10.1038/sj.ki.5001517; Yi F, 2009, HYPERTENSION, V53, P90, DOI 10.1161/HYPERTENSIONAHA.108.115675; Zhu XY, 2011, J HYPERTENS, V29, P1972, DOI 10.1097/HJH.0b013e32834ae611	76	23	26	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e83813	10.1371/journal.pone.0083813	http://dx.doi.org/10.1371/journal.pone.0083813			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281QS	24386282	gold, Green Published, Green Submitted			2022-12-25	WOS:000329116700079
J	Safavian, D; Goring, DR				Safavian, Darya; Goring, Daphne R.			Secretory Activity Is Rapidly Induced in Stigmatic Papillae by Compatible Pollen, but Inhibited for Self-Incompatible Pollen in the Brassicaceae	PLOS ONE			English	Article							S-LOCUS GLYCOPROTEIN; EXOCYST COMPLEX; PISTIL INTERACTIONS; ARABIDOPSIS-LYRATA; PLASMA-MEMBRANE; TUBE GROWTH; DRY STIGMAS; PROTEIN; CELL; POLLINATION	In the Brassicaceae, targeted exocytosis to the stigmatic papillar plasma membrane under the compatible pollen grain is hypothesized to be essential for pollen hydration and pollen tube penetration. In contrast, polarized secretion is proposed to be inhibited in the stigmatic papillae during the rejection of self-incompatible pollen. Using transmission electron microscopy (TEM), we performed a detailed time-course of post-pollination events to view the cytological responses of the stigmatic papillae to compatible and self-incompatible pollinations. For compatible pollinations in Arabidopsis thaliana and Arabidopsis lyrata, vesicle secretion was observed at the stigmatic papillar plasma membrane under the pollen grain while Brassica napus stigmatic papillae appeared to use multivesicular bodies (MVBs) for secretion. Exo70A1, a component of the exocyst complex, has been previously implicated in the compatible pollen responses, and disruption of Exo70A1 in both A. thaliana and B. napus resulted in a loss of secretory vesicles/MVBs at the stigmatic papillar plasma membrane. Similarly, for self-incompatible pollinations, secretory vesicles/MVBs were absent from the stigmatic papillar plasma membrane in A. lyrata and B. napus; and furthermore, autophagy appeared to be induced to direct vesicles/MVBs to the vacuole for degradation. Thus, these findings support a model where the basal pollen recognition pathway in the stigmatic papilla promotes exocytosis to accept compatible pollen, and the basal pollen recognition pathway is overridden by the self-incompatibility pathway to prevent exocytosis and reject self-pollen.	[Safavian, Darya; Goring, Daphne R.] Univ Toronto, Dept Cell & Syst Biol, Toronto, ON, Canada; [Goring, Daphne R.] Univ Toronto, Ctr Anal Genome Evolut & Funct, Toronto, ON, Canada	University of Toronto; University of Toronto	Goring, DR (corresponding author), Univ Toronto, Dept Cell & Syst Biol, Toronto, ON, Canada.	d.goring@utoronto.ca		Goring, Daphne/0000-0001-5295-4744	Ontario Graduate Scholarship (OGS); Natural Sciences and Engineering Research Council of Canada (NSERC); Canada Research Chair (CRC)	Ontario Graduate Scholarship (OGS)(Ontario Graduate Scholarship); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Research Chair (CRC)(Canada Research Chairs)	DS is supported by an Ontario Graduate Scholarship (OGS https://osap.gov.on.ca/OSAPPortal). This research was supported by grants from Natural Sciences and Engineering Research Council of Canada (NSERC www.nserc-crsng.gc.ca) and a Canada Research Chair (CRC www.chairs-chaires.gc.ca) to DRG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An QL, 2006, CELL MICROBIOL, V8, P1009, DOI 10.1111/j.1462-5822.2006.00683.x; Barile M, 2005, MOL CELL PROTEOMICS, V4, P1095, DOI 10.1074/mcp.M500049-MCP200; BIEDERBICK A, 1995, EUR J CELL BIOL, V66, P3; Bodemann BO, 2011, CELL, V144, P253, DOI 10.1016/j.cell.2010.12.018; Bohlenius H, 2010, PLANT CELL, V22, P3831, DOI 10.1105/tpc.110.078063; Boyd C, 2004, J CELL BIOL, V167, P889, DOI 10.1083/jcb.200408124; CARTER AL, 1976, EUPHYTICA, V25, P531, DOI 10.1007/BF00041588; Chapman LA, 2010, J EXP BOT, V61, P1987, DOI 10.1093/jxb/erq021; Chen X, 2011, CURR OPIN PLANT BIOL, V14, P674, DOI 10.1016/j.pbi.2011.08.006; Chong YT, 2010, NEW PHYTOL, V185, P401, DOI 10.1111/j.1469-8137.2009.03070.x; Contento AL, 2005, PLANT J, V42, P598, DOI 10.1111/j.1365-313X.2005.02396.x; Dearnaley JDW, 1999, NEW PHYTOL, V141, P199, DOI 10.1046/j.1469-8137.1999.00334.x; Dearnaley JDW, 1997, PLANT CELL PHYSIOL, V38, P985, DOI 10.1093/oxfordjournals.pcp.a029278; Dearnaley JDW, 2001, SEX PLANT REPROD, V13, P265, DOI 10.1007/s004970000062; Dhonukshe P, 2007, CURR BIOL, V17, P520, DOI 10.1016/j.cub.2007.01.052; DICKINSON H, 1995, SEX PLANT REPROD, V8, P1, DOI 10.1007/BF00228756; DICKINSON HG, 1985, MICRON MICROSC ACTA, V16, P255, DOI 10.1016/0739-6260(85)90050-4; Ding Y, 2012, TRENDS PLANT SCI, V17, P606, DOI 10.1016/j.tplants.2012.06.004; Doughty J, 1998, PLANT CELL, V10, P1333, DOI 10.1105/tpc.10.8.1333; Drdova EJ, 2013, PLANT J, V73, P709, DOI 10.1111/tpj.12074; ELLEMAN CJ, 1988, NEW PHYTOL, V109, P111, DOI 10.1111/j.1469-8137.1988.tb00225.x; ELLEMAN CJ, 1990, NEW PHYTOL, V114, P511, DOI 10.1111/j.1469-8137.1990.tb00419.x; Elleman CJ, 1996, NEW PHYTOL, V133, P197, DOI 10.1111/j.1469-8137.1996.tb01886.x; ELLEMAN CJ, 1986, J CELL SCI, V80, P141; ELLEMAN CJ, 1992, NEW PHYTOL, V121, P413, DOI 10.1111/j.1469-8137.1992.tb02941.x; Fendrych M, 2010, PLANT CELL, V22, P3053, DOI 10.1105/tpc.110.074351; Fobis-Loisy I, 2007, PLANT CELL REP, V26, P745, DOI 10.1007/s00299-006-0282-7; Foster E, 2005, SEX PLANT REPROD, V17, P261, DOI 10.1007/s00497-004-0236-6; Franklin TM, 1996, SEX PLANT REPROD, V9, P203, DOI 10.1007/BF02173099; GORING DR, 1992, MOL GEN GENET, V234, P185, DOI 10.1007/BF00283838; Gu TS, 1998, P NATL ACAD SCI USA, V95, P382, DOI 10.1073/pnas.95.1.382; Guo W, 1999, J BIOL CHEM, V274, P23558, DOI 10.1074/jbc.274.33.23558; Hala M, 2008, PLANT CELL, V20, P1330, DOI 10.1105/tpc.108.059105; He B, 2009, CURR OPIN CELL BIOL, V21, P537, DOI 10.1016/j.ceb.2009.04.007; Heider MR, 2012, TRAFFIC, V13, P898, DOI 10.1111/j.1600-0854.2012.01353.x; Hiscock SJ, 2008, NEW PHYTOL, V179, P286, DOI 10.1111/j.1469-8137.2008.02457.x; HISCOCK SJ, 1994, PLANTA, V193, P377, DOI 10.1007/BF00201816; Hiscock SJ, 2002, SEX PLANT REPROD, V15, P65, DOI 10.1007/s00497-002-0143-7; Indriolo E, 2012, PLANT CELL, V24, P4607, DOI 10.1105/tpc.112.104943; Inoue Y, 2006, PLANT CELL PHYSIOL, V47, P1641, DOI 10.1093/pcp/pcl031; Ivanov R, 2010, TRENDS PLANT SCI, V15, P387, DOI 10.1016/j.tplants.2010.04.010; Iwano M, 2004, PLANT PHYSIOL, V136, P3562, DOI 10.1104/pp.104.046961; Iwano M, 2007, PLANT PHYSIOL, V144, P72, DOI 10.1104/pp.106.095273; Iwano M, 2012, CURR OPIN PLANT BIOL, V15, P78, DOI 10.1016/j.pbi.2011.09.003; Jiang LX, 2005, PLANT CELL, V17, P584, DOI 10.1105/tpc.104.027631; Kakita M, 2007, PLANT CELL, V19, P3961, DOI 10.1105/tpc.106.049999; KANDASAMY MK, 1994, DEVELOPMENT, V120, P3405; Kivimaki M, 2007, MOL ECOL, V16, P453, DOI 10.1111/j.1365-294X.2007.03109.x; Kulich I, 2013, TRAFFIC, V14, P1155, DOI 10.1111/tra.12101; Kulich I, 2010, NEW PHYTOL, V188, P615, DOI 10.1111/j.1469-8137.2010.03372.x; Li FQ, 2012, TRENDS PLANT SCI, V17, P526, DOI 10.1016/j.tplants.2012.05.006; Li SP, 2013, PLANT CELL, V25, P1774, DOI 10.1105/tpc.113.112144; Liu YM, 2012, ANNU REV PLANT BIOL, V63, P215, DOI 10.1146/annurev-arplant-042811-105441; Lu CF, 2008, PLANT CELL REP, V27, P273, DOI 10.1007/s00299-007-0454-0; Luu DT, 1997, SEX PLANT REPROD, V10, P227, DOI 10.1007/s004970050091; Luu DT, 1999, PLANT CELL, V11, P251; MATTSON O, 1974, NATURE, V247, P298, DOI 10.1038/247298a0; Meyer D, 2009, PLANT J, V57, P986, DOI 10.1111/j.1365-313X.2008.03743.x; Micali CO, 2011, CELL MICROBIOL, V13, P210, DOI 10.1111/j.1462-5822.2010.01530.x; Murase K, 2004, SCIENCE, V303, P1516, DOI 10.1126/science.1093586; NOVICK P, 1980, CELL, V21, P205, DOI 10.1016/0092-8674(80)90128-2; OCKENDON DJ, 1978, THEOR APPL GENET, V52, P113, DOI 10.1007/BF00264743; PREUSS D, 1993, GENE DEV, V7, P974, DOI 10.1101/gad.7.6.974; ROBERTS IN, 1980, THEOR APPL GENET, V58, P241, DOI 10.1007/BF00265173; Samuel M. A., 2008, P173, DOI 10.1007/978-3-540-68486-2_8; Samuel MA, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.011338; Samuel MA, 2009, PLANT CELL, V21, P2655, DOI 10.1105/tpc.109.069740; SARKER RH, 1988, P NATL ACAD SCI USA, V85, P4340, DOI 10.1073/pnas.85.12.4340; Simons M, 2009, CURR OPIN CELL BIOL, V21, P575, DOI 10.1016/j.ceb.2009.03.007; SMYTH DR, 1990, PLANT CELL, V2, P755, DOI 10.1105/tpc.2.8.755; Soldati T, 2006, NAT REV MOL CELL BIO, V7, P897, DOI 10.1038/nrm2060; STEAD AD, 1980, J CELL SCI, V42, P417; STEAD AD, 1979, PLANTA, V146, P211, DOI 10.1007/BF00388234; Stone SL, 1999, SCIENCE, V286, P1729, DOI 10.1126/science.286.5445.1729; Stone SL, 2003, PLANT CELL, V15, P885, DOI 10.1105/tpc.009845; Swanson R, 2004, ANNU REV GENET, V38, P793, DOI 10.1146/annurev.genet.38.072902.092356; Synek L, 2006, PLANT J, V48, P54, DOI 10.1111/j.1365-313X.2006.02854.x; Takayama S, 2000, P NATL ACAD SCI USA, V97, P3765, DOI 10.1073/pnas.040580797; Tantikanjana T, 2010, CURR OPIN PLANT BIOL, V13, P520, DOI 10.1016/j.pbi.2010.06.004; Thompson AR, 2005, PLANT PHYSIOL, V138, P2097, DOI 10.1104/pp.105.060673; ZUBERI MI, 1985, J CELL SCI, V76, P321	81	56	60	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e84286	10.1371/journal.pone.0084286	http://dx.doi.org/10.1371/journal.pone.0084286			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281QS	24386363	Green Submitted, gold, Green Published			2022-12-25	WOS:000329116700102
J	Tarrade, A; Rousseau-Ralliard, D; Aubriere, MC; Peynot, N; Dahirel, M; Bertrand-Michel, J; Aguirre-Lavin, T; Morel, O; Beaujean, N; Duranthon, V; Chavatte-Palmer, P				Tarrade, Anne; Rousseau-Ralliard, Delphine; Aubriere, Marie-Christine; Peynot, Nathalie; Dahirel, Michele; Bertrand-Michel, Justine; Aguirre-Lavin, Tiphaine; Morel, Olivier; Beaujean, Nathalie; Duranthon, Veronique; Chavatte-Palmer, Pascale			Sexual Dimorphism of the Feto-Placental Phenotype in Response to a High Fat and Control Maternal Diets in a Rabbit Model	PLOS ONE			English	Article							INDUCED HYPERLIPIDEMIA; DENSITY-LIPOPROTEIN; EXPRESSION PROFILES; ADAPTIVE RESPONSES; ACID TRANSPORTER; GENE-EXPRESSION; FETAL-GROWTH; CHOLESTEROL; RECEPTOR; HYPERCHOLESTEROLEMIA	Maternal environment during early developmental stages plays a seminal role in the establishment of adult phenotype. Using a rabbit model, we previously showed that feeding dams with a diet supplemented with 8% fat and 0.2% cholesterol (HH diet) from the prepubertal period and throughout gestation induced metabolic syndrome in adult offspring. Here, we examined the effects of the HH diet on feto-placental phenotype at 28 days post-coitum (term = 31days) in relation to earlier effects in the blastocyst (Day 6). At 28 days, both male and female HH fetuses were intrauterine growth retarded and dyslipidemic, with males more affected than females. Lipid droplets accumulated in the HH placentas' trophoblast, consistent with the increased concentrations in cholesteryl esters (3.2-fold), triacylglycerol (2.5-fold) and stored FA (2.12-fold). Stored FA concentrations were significantly higher in female compared to male HH placentas (2.18-fold, p < 0.01), whereas triacylglycerol was increased only in HH males. Trophoblastic lipid droplet accumulation was also observed at the blastocyst stage. The expression of numerous genes involved in lipid pathways differed significantly according to diet both in term placenta and at the blastocyst stage. Among them, the expression of LXR-alpha in HH placentas was reduced in HH males but not females. These data demonstrate that maternal HH diet affects the blastocyst and induces sex-dependent metabolic adaptations in the placenta, which appears to protect female fetuses from developing severe dyslipidemia.	[Tarrade, Anne; Rousseau-Ralliard, Delphine; Aubriere, Marie-Christine; Peynot, Nathalie; Dahirel, Michele; Aguirre-Lavin, Tiphaine; Morel, Olivier; Beaujean, Nathalie; Duranthon, Veronique; Chavatte-Palmer, Pascale] INRA, Biol Dev & Reprod UMR1198, Jouy En Josas, France; [Tarrade, Anne; Rousseau-Ralliard, Delphine; Aubriere, Marie-Christine; Peynot, Nathalie; Dahirel, Michele; Aguirre-Lavin, Tiphaine; Morel, Olivier; Beaujean, Nathalie; Duranthon, Veronique; Chavatte-Palmer, Pascale] ENVA, Maisons Alfort, France; [Tarrade, Anne; Rousseau-Ralliard, Delphine; Aubriere, Marie-Christine; Dahirel, Michele; Morel, Olivier; Chavatte-Palmer, Pascale] PremUp Fdn, Paris, France; [Bertrand-Michel, Justine] Fac Med Toulouse, INSERM, Inst Malad Metab & Cardiovasc, UMR 1048, F-31073 Toulouse, France	INRAE; UDICE-French Research Universities; Universite Paris Saclay; Ecole Nationale Veterinaire d'Alfort (ENVA); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Chavatte-Palmer, P (corresponding author), INRA, Biol Dev & Reprod UMR1198, Jouy En Josas, France.	Pascale.Chavatte-Palmer@jouy.inra.fr	ROUSSEAU-RALLIARD, Delphine/AAA-4035-2020; Beaujean, Nathalie/C-9883-2011; Chavatte-Palmer, Pascale/K-7349-2012; Duranthon, Véronique/D-8855-2019	Beaujean, Nathalie/0000-0003-0188-9190; Chavatte-Palmer, Pascale/0000-0002-4581-6092; Duranthon, Véronique/0000-0001-8120-7481; Couturier-Tarrade, Anne/0000-0003-1559-5476; Rousseau (Rousseau-Ralliard), Delphine/0000-0003-2684-1791	INRA	INRA	This work was supported by INRA with dedicated help from the INRA PhASE and AlimH departments. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amusquivar E, 2003, BIOL NEONATE, V83, P136, DOI 10.1159/000067963; Aoun M, 2012, BRIT J NUTR, V107, P647, DOI 10.1017/S000711451100331X; Armitage JA, 2005, J PHYSIOL-LONDON, V565, P3, DOI 10.1113/jphysiol.2004.079756; Aye ILMH, 2010, BBA-MOL CELL BIOL L, V1801, P1013, DOI 10.1016/j.bbalip.2010.05.015; Barker DJP, 2010, INT J DEV BIOL, V54, P525, DOI 10.1387/ijdb.082760db; BARKER DJP, 1992, EUR J CLIN NUTR, V46, pS3; BARKER DJP, 1993, LANCET, V341, P938, DOI 10.1016/0140-6736(93)91224-A; BARRANS A, 1994, J BIOL CHEM, V269, P11572; Bausenwein J, 2010, MOL HUM REPROD, V16, P117, DOI 10.1093/molehr/gap078; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Burke KT, 2009, J LIPID RES, V50, P1146, DOI 10.1194/jlr.M800538-JLR200; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Crunk AE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067631; Diaz-Hernandez V, 2008, SEX DEV, V2, P152, DOI 10.1159/000143433; Dubuisson C, 2010, BRIT J NUTR, V103, P1035, DOI 10.1017/S0007114509992625; Duranthon V, 2012, TRANSGENIC RES, V21, P699, DOI 10.1007/s11248-012-9599-x; Duttaroy AK, 2009, PROG LIPID RES, V48, P52, DOI 10.1016/j.plipres.2008.11.001; Enders AC, 2009, PLACENTA, V30, pS15, DOI 10.1016/j.placenta.2008.09.018; Ethier-Chiasson M, 2007, BIOCHEM BIOPH RES CO, V359, P8, DOI 10.1016/j.bbrc.2007.05.002; Fischer B, 2012, REPRODUCTION, V144, P1, DOI 10.1530/REP-12-0091; FOLCH J, 1957, J BIOL CHEM, V226, P497; Gabory A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047986; Glazier JD, 1997, PEDIATR RES, V42, P514, DOI 10.1203/00006450-199710000-00016; Gluckman PD, 2007, AM J HUM BIOL, V19, P1, DOI 10.1002/ajhb.20590; Jansson T, 2002, PLACENTA, V23, P392, DOI 10.1053/plac.2002.0826; Jungheim ES, 2010, ENDOCRINOLOGY, V151, P4039, DOI 10.1210/en.2010-0098; Kevorkova O, 2007, BIOL REPROD, V76, P487, DOI 10.1095/biolreprod.106.055285; Kwong WY, 2000, DEVELOPMENT, V127, P4195; Larigauderie G, 2006, FEBS J, V273, P3498, DOI 10.1111/j.1742-4658.2006.05357.x; Leese HJ, 2008, REPROD FERT DEVELOP, V20, P1, DOI 10.1071/RD07153; Leroy JLMR, 2010, HUM REPROD, V25, P768, DOI 10.1093/humrep/dep420; Mamo S, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-67; Mao J, 2006, P NATL ACAD SCI USA, V103, P8552, DOI 10.1073/pnas.0603115103; Mao J, 2010, P NATL ACAD SCI USA, V107, P5557, DOI 10.1073/pnas.1000440107; McArdle AM, 2009, PLACENTA, V30, P590, DOI 10.1016/j.placenta.2009.04.006; Montoudis A, 1999, LIFE SCI, V64, P2439, DOI 10.1016/S0024-3205(99)00201-5; MORRISON WR, 1964, J LIPID RES, V5, P600; Myatt L, 2006, J PHYSIOL-LONDON, V572, P25, DOI 10.1113/jphysiol.2006.104968; Napoli C, 1999, LANCET, V354, P1234, DOI 10.1016/S0140-6736(99)02131-5; Napoli C, 2000, CIRC RES, V87, P946, DOI 10.1161/01.RES.87.10.946; Okamoto I, 2011, NATURE, V472, P370, DOI 10.1038/nature09872; Picone O, 2011, THERIOGENOLOGY, V75, P287, DOI 10.1016/j.theriogenology.2010.08.015; Plosch T, 2007, PLACENTA, V28, P604, DOI 10.1016/j.placenta.2006.10.009; Ramin N, 2010, ENDOCRINOLOGY, V151, P4158, DOI 10.1210/en.2010-0187; Silva ARRE, 2012, EPIGENETICS-US, V7, P440, DOI 10.4161/epi.19563; Roseboom TJ, 2000, AM J CLIN NUTR, V72, P1101; Rousseau D, 2003, AM J PHYSIOL-HEART C, V285, pH1294, DOI 10.1152/ajpheart.00651.2002; Santos AN, 2004, REPRODUCTION, V128, P503, DOI 10.1530/rep.1.00203; Springer MS, 2007, BIOL REV, V82, P375, DOI 10.1111/j.1469-185X.2007.00016.x; Tobin KAR, 2006, J LIPID RES, V47, P815, DOI 10.1194/jlr.M500527-JLR200; van Straten EME, 2010, AM J PHYSIOL-REG I, V298, pR275, DOI 10.1152/ajpregu.00413.2009; Watkins AJ, 2008, BIOL REPROD, V78, P299, DOI 10.1095/biolreprod.107.064220; Watkins AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028745; Weedon-Fekjaer MS, 2010, PLACENTA, V31, P818, DOI 10.1016/j.placenta.2010.06.015; WEHRMAN ME, 1991, BIOL REPROD, V45, P514, DOI 10.1095/biolreprod45.3.514; Woollett LA, 2005, AM J CLIN NUTR, V82, P1155, DOI 10.1093/ajcn/82.6.1155; Zhou J, 2008, GASTROENTEROLOGY, V134, P556, DOI 10.1053/j.gastro.2007.11.037	57	55	56	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e83458	10.1371/journal.pone.0083458	http://dx.doi.org/10.1371/journal.pone.0083458			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281QS	24386205	gold, Green Published, Green Submitted			2022-12-25	WOS:000329116700052
J	Wang, HF; Jiang, L; Liu, X; Yang, J; Wei, JL; Xu, JG; Zhang, Q; Liu, JF				Wang, Haifei; Jiang, Li; Liu, Xuan; Yang, Jie; Wei, Julong; Xu, Jingen; Zhang, Qin; Liu, Jian-Feng			A Post-GWAS Replication Study Confirming the PTK2 Gene Associated with Milk Production Traits in Chinese Holstein	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; FOCAL ADHESION KINASE; MESSENGER-RNA STABILITY; DAIRY-CATTLE BREEDS; SOMATIC-CELL SCORE; LINKAGE DISEQUILIBRIUM; BOVINE CHROMOSOME-14; SECONDARY STRUCTURE; ATOPIC-DERMATITIS; ALZHEIMER-DISEASE	Our initial genome-wide association study (GWAS) demonstrated that two SNPs (ARS-BFGL-NGS-33248, UA-IFASA-9288) within the protein tyrosine kinase 2 (PTK2) gene were significantly associated with milk production traits in Chinese Holstein dairy cattle. To further validate if the statistical evidence provided in GWAS were true-positive findings, a replication study was performed herein through genotype-phenotype associations. The two tested SNPs were found to show significant associations with milk production traits, which confirmed the associations observed in the original study. Specifically, SNPs lying in the PTK2 gene were also detected by sequencing 14 unrelated sires in Chinese Holsteins and a total of thirty-three novel SNPs were identified. Thirteen out of these identified SNPs were genotyped and tested for association with milk production traits in an independent resource population. After Bonferroni correction for multiple testing, twelve SNPs were statistically significant for more than two milk production traits. Analyses of pairwise D' measures of linkage disequilibrium (LD) between all SNPs were also explored. Two haplotype blocks were inferred and the association study at haplotype level revealed similar effects on milk production traits. In addition, the RNA expression analyses revealed that a non-synonymous coding SNP (g.4061098T>G) was involved in the regulation of gene expression. Thus the findings presented here provide strong evidence for associations of PTK2 variants with dairy production traits and may be applied in Chinese Holstein breeding program.	[Wang, Haifei; Jiang, Li; Liu, Xuan; Yang, Jie; Wei, Julong; Xu, Jingen; Zhang, Qin; Liu, Jian-Feng] China Agr Univ, Coll Anim Sci & Technol, Key Lab Anim Genet Breeding & Reprod, Natl Engn Lab Anim Breeding,Minist Agr, Beijing 100094, Peoples R China	China Agricultural University; Ministry of Agriculture & Rural Affairs	Liu, JF (corresponding author), China Agr Univ, Coll Anim Sci & Technol, Key Lab Anim Genet Breeding & Reprod, Natl Engn Lab Anim Breeding,Minist Agr, Beijing 100094, Peoples R China.	liujf@cau.edu.cn		Liu, Jian-Feng/0000-0002-5766-7864; Jiang, Li/0000-0002-0648-2173	National High Technology Research and Development Program of China (863 Program) [2011AA100302, 2013AA102503]; Program for Changjiang Scholar and Innovation Research Team in University [IRT1191]; National Natural Science Foundations of China [31272419]; New-Century Training Program Foundation for the Talents by the State Education Commission of China [NETC-10-0783]	National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); Program for Changjiang Scholar and Innovation Research Team in University; National Natural Science Foundations of China(National Natural Science Foundation of China (NSFC)); New-Century Training Program Foundation for the Talents by the State Education Commission of China	This work was financially supported by the National High Technology Research and Development Program of China (863 Program 2011AA100302, 2013AA102503), Program for Changjiang Scholar and Innovation Research Team in University (IRT1191), the National Natural Science Foundations of China (31272419) and the New-Century Training Program Foundation for the Talents by the State Education Commission of China (NETC-10-0783). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akey J, 2001, EUR J HUM GENET, V9, P291, DOI 10.1038/sj.ejhg.5200619; Aljanabi SM, 1997, NUCLEIC ACIDS RES, V25, P4692, DOI 10.1093/nar/25.22.4692; Ashwell MS, 2004, J DAIRY SCI, V87, P468, DOI 10.3168/jds.S0022-0302(04)73186-0; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bennewitz J, 2004, J DAIRY SCI, V87, P431, DOI 10.3168/jds.S0022-0302(04)73182-3; Blott S, 2003, GENETICS, V163, P253; Boichard D, 2003, GENET SEL EVOL, V35, P77, DOI 10.1051/gse:2002037; Bouwman AC, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-43; Cance WG, 2000, CLIN CANCER RES, V6, P2417; Cantor RM, 2010, AM J HUM GENET, V86, P6, DOI 10.1016/j.ajhg.2009.11.017; Capasso M, 2009, J CANCER RES CLIN, V135, P1799, DOI 10.1007/s00432-009-0628-y; Capon F, 2004, HUM MOL GENET, V13, P2361, DOI 10.1093/hmg/ddh273; Cho SY, 2002, J CELL BIOL, V156, P725, DOI 10.1083/jcb.200111032; Coppieters W, 1998, MAMM GENOME, V9, P540, DOI 10.1007/s003359900815; Daetwyler HD, 2008, J DAIRY SCI, V91, P3225, DOI 10.3168/jds.2007-0333; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Ertekin-Taner N, 2010, ALZHEIMERS RES THER, V2, DOI 10.1186/alzrt26; Ezratty EJ, 2005, NAT CELL BIOL, V7, P581, DOI 10.1038/ncb1262; Faraldo MM, 2005, J MAMMARY GLAND BIOL, V10, P211, DOI 10.1007/s10911-005-9582-8; Farber CR, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002038; Farnir F, 2002, GENETICS, V161, P275; Fontanesi L, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-583; Ganguly KK, 2012, J CANC THER, V03, P7, DOI DOI 10.4236/JCT.2012.31002; Garcia-Gamez E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047782; Goldstein DB, 2009, NEW ENGL J MED, V360, P1696, DOI 10.1056/NEJMp0806284; Grisart B, 2004, P NATL ACAD SCI USA, V101, P2398, DOI 10.1073/pnas.0308518100; Hampe J, 2007, NAT GENET, V39, P207, DOI 10.1038/ng1954; Hardy J, 2009, NEW ENGL J MED, V360, P1759, DOI 10.1056/NEJMra0808700; Harte MT, 1996, J BIOL CHEM, V271, P13649, DOI 10.1074/jbc.271.23.13649; Hayes BJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006676; Heyen DW, 1999, PHYSIOL GENOMICS, V1, P165, DOI 10.1152/physiolgenomics.1999.1.3.165; Hirschhorn JN, 2009, NEW ENGL J MED, V360, P1699, DOI 10.1056/NEJMp0808934; Israel C, 1998, J DAIRY SCI, V81, P1653, DOI 10.3168/jds.S0022-0302(98)75733-9; Jairath L, 1998, J DAIRY SCI, V81, P550, DOI 10.3168/jds.S0022-0302(98)75607-3; Jiang L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013661; KANNER SB, 1990, P NATL ACAD SCI USA, V87, P3328, DOI 10.1073/pnas.87.9.3328; Kolbehdari D, 2009, J ANIM BREED GENET, V126, P216, DOI 10.1111/j.1439-0388.2008.00793.x; Kraft P, 2009, STAT SCI, V24, P561, DOI 10.1214/09-STS290; Kraft P, 2009, NEW ENGL J MED, V360, P1701, DOI 10.1056/NEJMp0810107; Liu JF, 2009, GENET EPIDEMIOL, V33, P217, DOI 10.1002/gepi.20372; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Looft C, 2001, MAMM GENOME, V12, P646, DOI 10.1007/s003350020003; Magwire MM, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003057; Mai MD, 2010, J ANIM SCI, V88, P3522, DOI 10.2527/jas.2009-2713; Martin ER, 2000, AM J HUM GENET, V67, P383, DOI 10.1086/303003; Mathews DH, 2004, P NATL ACAD SCI USA, V101, P7287, DOI 10.1073/pnas.0401799101; Meredith BK, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-21; Nackley AG, 2006, SCIENCE, V314, P1930, DOI 10.1126/science.1131262; Nagy T, 2007, J BIOL CHEM, V282, P31766, DOI 10.1074/jbc.M705403200; Oktay MH, 2003, HUM PATHOL, V34, P240, DOI 10.1053/hupa.2003.40; Ozaki K, 2002, NAT GENET, V32, P650, DOI 10.1038/ng1047; Palazzo AF, 2004, SCIENCE, V303, P836, DOI 10.1126/science.1091325; Palmer CA, 2006, J MAMMARY GLAND BIOL, V11, P269, DOI 10.1007/s10911-006-9023-3; Pei YF, 2009, ANN HUM GENET, V73, P456, DOI 10.1111/j.1469-1809.2009.00527.x; Pryce JE, 2010, J DAIRY SCI, V93, P3331, DOI 10.3168/jds.2009-2893; Riquet J, 1999, P NATL ACAD SCI USA, V96, P9252, DOI 10.1073/pnas.96.16.9252; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Scheet P, 2006, AM J HUM GENET, V78, P629, DOI 10.1086/502802; Schroder W, 2012, ANIM GENET, V43, P392, DOI 10.1111/j.1365-2052.2011.02265.x; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; Sun LD, 2011, NAT GENET, V43, P690, DOI 10.1038/ng.851; Thomsen H, 2001, J ANIM BREED GENET, V118, P357, DOI 10.1046/j.1439-0388.2001.00302.x; Tokuhiro S, 2003, NAT GENET, V35, P341, DOI 10.1038/ng1267; Turner LB, 2010, ANIM PROD SCI, V50, P235, DOI 10.1071/AN09135; VANRADEN PM, 1991, J DAIRY SCI, V74, P2737, DOI 10.3168/jds.S0022-0302(91)78453-1; Vasilopoulos Y, 2007, ALLERGY, V62, P514, DOI 10.1111/j.1398-9995.2007.01350.x; Viitala SM, 2003, J DAIRY SCI, V86, P1828, DOI 10.3168/jds.S0022-0302(03)73769-2; Xie L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030910; Yano H, 2004, J CELL BIOL, V166, P283, DOI 10.1083/jcb.200312013; Zaykin DV, 2002, HUM HERED, V53, P79, DOI 10.1159/000057986	70	13	13	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e83625	10.1371/journal.pone.0083625	http://dx.doi.org/10.1371/journal.pone.0083625			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281QS	24386238	gold, Green Published, Green Submitted			2022-12-25	WOS:000329116700065
J	Hall, HI; Tang, T; Westfall, AO; Mugavero, MJ				Hall, H. Irene; Tang, Tian; Westfall, Andrew O.; Mugavero, Michael J.			HIV Care Visits and Time to Viral Suppression, 19 US Jurisdictions, and Implications for Treatment, Prevention and the National HIV/AIDS Strategy	PLOS ONE			English	Article							INFECTED PERSONS; ANTIRETROVIRAL TREATMENT; EARLY RETENTION; RECOMMENDATIONS; SOCIETY; ASSOCIATION; GUIDELINES; MANAGEMENT; ENGAGEMENT; SPECTRUM	Objective: Early and regular care and treatment for human immunodeficiency virus (HIV) infection are associated with viral suppression, reductions in transmission risk and improved health outcomes for persons with HIV. We determined, on a population level, the association of care visits with time from HIV diagnosis to viral suppression. Methods: Using data from 19 areas reporting HIV-related tests to national HIV surveillance, we determined time from diagnosis to viral suppression among 17,028 persons diagnosed with HIV during 2009, followed through December 2011, using data reported through December 2012. Using Cox proportional hazards models, we assessed factors associated with viral suppression, including linkage to care within 3 months of diagnosis, a goal set forth by the National HIV/AIDS Strategy, and number of HIV care visits as determined by CD4 and viral load test results, while controlling for demographic, clinical, and risk characteristics. Results: Of 17,028 persons diagnosed with HIV during 2009 in the 19 areas, 76.6% were linked to care within 3 months of diagnosis and 57.0% had a suppressed viral load during the observation period. Median time from diagnosis to viral suppression was 19 months overall, and 8 months among persons with an initial CD4 count <= 350 cells/mu L. During the first 12 months after diagnosis, persons linked to care within 3 months experienced shorter times to viral suppression (higher rate of viral suppression per unit time, hazard ratio [HR] = 4.84 versus not linked within 3 months; 95% confidence interval [CI] 4.27, 5.48). Persons with a higher number of time- updated care visits also experienced a shorter time to viral suppression (HR = 1.51 per additional visit, 95% CI 1.49, 1.52). Conclusions: Timely linkage to care and greater frequency of care visits were associated with faster time to viral suppression with implications for individual health outcomes and for secondary prevention.	[Hall, H. Irene] Ctr Dis Control & Prevent, Div HIV AIDS Prevent, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Atlanta, GA 30329 USA; [Tang, Tian] ICF Int, Atlanta, GA USA; [Westfall, Andrew O.; Mugavero, Michael J.] Univ Alabama Birmingham, Ctr AIDS Res, Birmingham, AL USA; [Mugavero, Michael J.] Univ Alabama Birmingham, Dept Med, Div Infect Dis, Birmingham, AL 35294 USA	Centers for Disease Control & Prevention - USA; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Hall, HI (corresponding author), Ctr Dis Control & Prevent, Div HIV AIDS Prevent, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Atlanta, GA 30329 USA.	ixh1@cdc.gov		Westfall, Andrew/0000-0002-0468-4695	Centers for Disease Control and Prevention (CDC)	Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	The Centers for Disease Control and Prevention (CDC) provides funding to state and local health departments to conduct surveillance of HIV disease in accordance with their own disease reporting regulations. CDC provides technical guidance for the collection of data by the state and local health departments and data are sent to CDC for national-level analyses. Role of the Sponsors: The CDC reviewed and approved final submission but the findings and conclusions in this report are those of the authors and do not necessarily represent the views of the CDC.	Aberg JA, 2009, CLIN INFECT DIS, V49, P651, DOI 10.1086/605292; [Anonymous], 2010, NAT HIV AIDS STRAT U; [Anonymous], MON HIV CAR US IND D; [Anonymous], 2011, GUID US ANT AG HIV 1, P1; Bradford JB, 2007, AIDS PATIENT CARE ST, V21, pS85, DOI 10.1089/apc.2007.9983; Centers for Disease Control and Prevention, 2012, 17 CDCP A; Centers for Disease Control and Prevention, 2010, 16 CDCP; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; Cohen Stacy M., 2011, Morbidity and Mortality Weekly Report, V60, P1618; Department of agriculture forestry and fisheries, 2012, GUID US ANT AG HIV 1, P1; Fleishman JA, 2012, JAIDS-J ACQ IMM DEF, V60, P249, DOI 10.1097/QAI.0b013e318258c696; Gardner EM, 2011, CLIN INFECT DIS, V52, P793, DOI 10.1093/cid/ciq243; Gardner LI, 2005, AIDS, V19, P423, DOI 10.1097/01.aids.0000161772.51900.eb; Giordano TP, 2007, CLIN INFECT DIS, V44, P1493, DOI 10.1086/516778; Gray KM, 2013, AM J PUBLIC HEALTH, V103, P141, DOI 10.2105/AJPH.2012.300859; Hall HI, 2013, JAMA INTERN MED, V173, P1337, DOI 10.1001/jamainternmed.2013.6841; Hall HI, 2012, JAIDS-J ACQ IMM DEF, V60, P77, DOI 10.1097/QAI.0b013e318249fe90; Higa DH, 2012, CURR HIV-AIDS REP, V9, P313, DOI 10.1007/s11904-012-0136-6; Horstmann E, 2010, CLIN INFECT DIS, V50, P752, DOI 10.1086/649933; Marks G, 2011, CLIN INFECT DIS, V53, P1168, DOI 10.1093/cid/cir678; Marks G, 2010, AIDS, V24, P2665, DOI 10.1097/QAD.0b013e32833f4b1b; Mugavero MJ, 2012, JAIDS-J ACQ IMM DEF, V59, P86, DOI 10.1097/QAI.0b013e318236f7d2; Mugavero MJ, 2009, CLIN INFECT DIS, V48, P248, DOI 10.1086/595705; Rebeiro P, 2013, JAIDS-J ACQ IMM DEF, V62, P356, DOI 10.1097/QAI.0b013e31827f578a; Rynn L., 2008, Morbidity and Mortality Weekly Report, V57, P1; Smith JC., 2012, INCOME POVERTY HLTH; Thompson MA, 2012, JAMA-J AM MED ASSOC, V308, P387, DOI 10.1001/jama.2012.7961; Thompson MA, 2012, ANN INTERN MED, V156, P817, DOI 10.7326/0003-4819-156-11-201206050-00419; Thompson MA, 2010, JAMA-J AM MED ASSOC, V304, P321, DOI 10.1001/jama.2010.1004; Ulett KB, 2009, AIDS PATIENT CARE ST, V23, P41, DOI 10.1089/apc.2008.0132; Wohl AR, 2011, AIDS BEHAV, V15, P1098, DOI 10.1007/s10461-010-9833-6; Wohl AR, 2011, AIDS CARE, V23, P988, DOI 10.1080/09540121.2010.542125	32	32	32	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84318	10.1371/journal.pone.0084318	http://dx.doi.org/10.1371/journal.pone.0084318			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	284MV	24391937	Green Submitted, Green Published, gold			2022-12-25	WOS:000329323900080
J	Shahbaaz, M; Hassan, MI; Ahmad, F				Shahbaaz, Mohd.; Hassan, Md. Imtaiyaz; Ahmad, Faizan			Functional Annotation of Conserved Hypothetical Proteins from Haemophilus influenzae Rd KW20	PLOS ONE			English	Article							SUBCELLULAR-LOCALIZATION; BACTERIAL-INFECTION; VIRULENCE; DATABASE; PREDICTION; HOMOLOGY; SEQUENCE; CLASSIFICATION; TRANSFERRIN; SECRETION	Haemophilus influenzae is a Gram negative bacterium that belongs to the family Pasteurellaceae, causes bacteremia, pneumonia and acute bacterial meningitis in infants. The emergence of multi-drug resistance H. influenzae strain in clinical isolates demands the development of better/new drugs against this pathogen. Our study combines a number of bioinformatics tools for function predictions of previously not assigned proteins in the genome of H. influenzae. This genome was extensively analyzed and found 1,657 functional proteins in which function of 429 proteins are unknown, termed as hypothetical proteins (HPs). Amino acid sequences of all 429 HPs were extensively annotated and we successfully assigned the function to 296 HPs with high confidence. We also characterized the function of 124 HPs precisely, but with less confidence. We believed that sequence of a protein can be used as a framework to explain known functional properties. Here we have combined the latest versions of protein family databases, protein motifs, intrinsic features from the amino acid sequence, pathway and genome context methods to assign a precise function to hypothetical proteins for which no experimental information is available. We found these HPs belong to various classes of proteins such as enzymes, transporters, carriers, receptors, signal transducers, binding proteins, virulence and other proteins. The outcome of this work will be helpful for a better understanding of the mechanism of pathogenesis and in finding novel therapeutic targets for H. influenzae.	[Shahbaaz, Mohd.] Jamia Millia Islamia, Dept Comp Sci, New Delhi 110025, India; [Hassan, Md. Imtaiyaz; Ahmad, Faizan] Jamia Millia Islamia, Ctr Interdisciplinary Res Basic Sci, New Delhi 110025, India	Jamia Millia Islamia; Jamia Millia Islamia	Hassan, MI (corresponding author), Jamia Millia Islamia, Ctr Interdisciplinary Res Basic Sci, New Delhi 110025, India.	mihassan@jmi.ac.in	Shahbaaz, Mohd/ABG-4269-2020; Ahmad, Faizan/AGH-4493-2022; Hassan, Imtaiyaz/ABF-6485-2020; Hassan, Mohammad/GZA-7507-2022; Hassan, Md Imtaiyaz/G-7072-2017	Shahbaaz, Mohd/0000-0001-8901-7113; Ahmad, Faizan/0000-0001-7021-7502; Hassan, Imtaiyaz/0000-0002-3663-4940; Hassan, Mohammad/0000-0002-1712-0004; Hassan, Md Imtaiyaz/0000-0002-3663-4940	Indian Council of Medical Research [BIC/12(04)/2012]	Indian Council of Medical Research(Indian Council of Medical Research (ICMR))	The authors sincerely thank Indian Council of Medical Research for financial assistance (Grant No. BIC/12(04)/2012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akerley BJ, 2002, P NATL ACAD SCI USA, V99, P966, DOI 10.1073/pnas.012602299; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ariyachet C, 2013, INFECT IMMUN, V81, P1267, DOI 10.1128/IAI.00864-12; Attwood Terri K, 2002, Brief Bioinform, V3, P252, DOI 10.1093/bib/3.3.252; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Bairoch A, 2000, NUCLEIC ACIDS RES, V28, P45, DOI 10.1093/nar/28.1.45; Ball P, 1996, Curr Opin Pulm Med, V2, P181, DOI 10.1097/00063198-199605000-00004; Baron Christian, 2007, Infectious Disorders - Drug Targets, V7, P19, DOI 10.2174/187152607780090685; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Bendtsen JD, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-58; BERNSTEIN FC, 1978, ARCH BIOCHEM BIOPHYS, V185, P584, DOI 10.1016/0003-9861(78)90204-7; BERNSTEIN FC, 1977, EUR J BIOCHEM, V80, P319, DOI 10.1111/j.1432-1033.1977.tb11885.x; Bhasin M, 2005, BIOINFORMATICS, V21, P2522, DOI 10.1093/bioinformatics/bti309; BJORNSON HS, 1984, REV INFECT DIS, V6, pS21; Bru C, 2005, NUCLEIC ACIDS RES, V33, pD212, DOI 10.1093/nar/gki034; Bukowski M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3012; Cai CZ, 2003, NUCLEIC ACIDS RES, V31, P3692, DOI 10.1093/nar/gkg600; Cash P, 1997, ELECTROPHORESIS, V18, P1472, DOI 10.1002/elps.1150180822; Cheng Y, 2004, CELL, V116, P565, DOI 10.1016/S0092-8674(04)00130-8; Christiansen JK, 2004, J BACTERIOL, V186, P3355, DOI 10.1128/JB.186.11.3355-3362.2004; Davey L, 2013, J BIOL CHEM, V288, P16416, DOI 10.1074/jbc.M113.464578; Doerks T, 2004, NUCLEIC ACIDS RES, V32, P6321, DOI 10.1093/nar/gkh973; Doern CD, 2008, MICROBIOL-SGM, V154, P1998, DOI 10.1099/mic.0.2007/013466-0; Dunn MF, 2009, MICROBIOL-SGM, V155, P3166, DOI 10.1099/mic.0.030858-0; Edelstein PH, 2005, INFECT IMMUN, V73, P6567, DOI 10.1128/IAI.73.10.6567-6576.2005; Edwards JS, 1999, J BIOL CHEM, V274, P17410, DOI 10.1074/jbc.274.25.17410; Ejim LJ, 2004, INFECT IMMUN, V72, P3310, DOI 10.1128/IAI.72.6.3310-3314.2004; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Eng J, 2013, ROC ANAL WEB BASED C; Engh RA, 2002, PHARMACOL THERAPEUT, V93, P99, DOI 10.1016/S0163-7258(02)00180-8; Evers S, 1998, ELECTROPHORESIS, V19, P1980, DOI 10.1002/elps.1150191116; Fasshauer D, 1998, P NATL ACAD SCI USA, V95, P15781, DOI 10.1073/pnas.95.26.15781; FLEISCHMANN RD, 1995, SCIENCE, V269, P496, DOI 10.1126/science.7542800; Freeman ZN, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003201; Galperin MY, 2004, NUCLEIC ACIDS RES, V32, P5452, DOI 10.1093/nar/gkh885; Garg A, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-62; Garmory HS, 2004, INFECT IMMUN, V72, P6757, DOI 10.1128/IAI.72.12.6757-6763.2004; Gasteiger E, 2001, Curr Issues Mol Biol, V3, P47; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Geer LY, 2002, GENOME RES, V12, P1619, DOI 10.1101/gr.278202; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Gough J, 2001, J MOL BIOL, V313, P903, DOI 10.1006/jmbi.2001.5080; Grinter R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033033; GURUPRASAD K, 1990, PROTEIN ENG, V4, P155, DOI 10.1093/protein/4.2.155; Hassan MI, 2007, J PEPT SCI, V13, P849, DOI 10.1002/psc.911; Hassan MI, 2007, CHEM BIOL DRUG DES, V70, P261, DOI 10.1111/j.1747-0285.2007.00553.x; Hawkins Troy, 2007, J Bioinform Comput Biol, V5, P1, DOI 10.1142/S0219720007002503; Henikoff JG, 1996, METHOD ENZYMOL, V266, P88; Herbert MA, 2002, MICROB PATHOGENESIS, V33, P211, DOI 10.1006/mpat.2002.0530; Huang JN, 2004, J BIOL CHEM, V279, P54110, DOI 10.1074/jbc.M410583200; Hubbard T, 2002, NUCLEIC ACIDS RES, V30, P38, DOI 10.1093/nar/30.1.38; Hubbard TJP, 1999, NUCLEIC ACIDS RES, V27, P254, DOI 10.1093/nar/27.1.254; Hunter S, 2012, NUCLEIC ACIDS RES, V40, pD306, DOI 10.1093/nar/gkr948; IKAI A, 1980, J BIOCHEM-TOKYO, V88, P1895; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Kaito C, 2006, MOL MICROBIOL, V62, P1601, DOI 10.1111/j.1365-2958.2006.05480.x; Kanehisa M, 1997, TRENDS BIOCHEM SCI, V22, P442, DOI 10.1016/S0968-0004(97)01130-4; Kelil Abdellali, 2008, International Journal of Computational Biology and Drug Design, V1, P122, DOI 10.1504/IJCBDD.2008.020190; Kelil A, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-286; Kondo Y, 2010, INFECT IMMUN, V78, P2846, DOI 10.1128/IAI.01448-09; Kovacs-Simon A, 2011, INFECT IMMUN, V79, P548, DOI 10.1128/IAI.00682-10; Kratz F, 1998, J PHARM SCI-US, V87, P338, DOI 10.1021/js970246a; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr201, 10.1093/nar/gkr931]; Li Q, 2012, BIOCHEM J, V441, P859, DOI 10.1042/BJ20111604; Loewenstein Y, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-2-207; Lubec G, 2005, PROG NEUROBIOL, V77, P90, DOI 10.1016/j.pneurobio.2005.10.001; Makioka A, 1995, J PARASITOL, V81, P1021, DOI 10.2307/3284064; McQuiston JR, 1999, INFECT IMMUN, V67, P3830, DOI 10.1128/IAI.67.8.3830-3835.1999; Meinel T, 2005, NUCLEIC ACIDS RES, V33, pD226; METZ CE, 1978, SEMIN NUCL MED, V8, P283, DOI 10.1016/S0001-2998(78)80014-2; Mi HY, 2013, NAT PROTOC, V8, P1551, DOI 10.1038/nprot.2013.092; Minion FC, 2004, J BACTERIOL, V186, P7123, DOI 10.1128/JB.186.21.7123-7133.2004; MURPHY TF, 1992, AM REV RESPIR DIS, V146, P1067, DOI 10.1164/ajrccm/146.4.1067; Nagy G, 2002, INFECT IMMUN, V70, P4406, DOI 10.1128/IAI.70.8.4406-4413.2002; Nimrod G, 2008, STRUCTURE, V16, P1755, DOI 10.1016/j.str.2008.10.017; Okan NA, 2013, MBIO, V4, DOI 10.1128/mBio.00638-12; Okugawa S, 2012, MOL MICROBIOL, V83, P96, DOI 10.1111/j.1365-2958.2011.07915.x; Olekhnovich IN, 2002, J BACTERIOL, V184, P4148, DOI 10.1128/JB.184.15.4148-4160.2002; Papin JA, 2002, J THEOR BIOL, V215, P67, DOI 10.1006/jtbi.2001.2499; Parveen N, 2011, MOL MICROBIOL, V79, P7, DOI 10.1111/j.1365-2958.2010.07455.x; Poole K, 2004, CELL MOL LIFE SCI, V61, P2200, DOI 10.1007/s00018-004-4060-9; Quevillon E, 2005, NUCLEIC ACIDS RES, V33, pW116, DOI 10.1093/nar/gki442; Rappoport N, 2012, NUCLEIC ACIDS RES, V40, pD313, DOI 10.1093/nar/gkr1027; Reffuveille F, 2012, INFECT IMMUN, V80, P1728, DOI 10.1128/IAI.06251-11; Rost B, 1996, CURR OPIN BIOTECH, V7, P457, DOI 10.1016/S0958-1669(96)80124-8; SAaP Shanmughavel, 2008, J COMPUT SCI SYST BI, V1, P50; Saha Sudipto, 2006, Genomics Proteomics & Bioinformatics, V4, P42, DOI 10.1016/S1672-0229(06)60015-6; Schilling CH, 2000, J THEOR BIOL, V203, P249, DOI 10.1006/jtbi.2000.1088; Sethi S, 2001, CLIN MICROBIOL REV, V14, P336, DOI 10.1128/CMR.14.2.336-363.2001; Sigrist CJA, 2010, NUCLEIC ACIDS RES, V38, pD161, DOI 10.1093/nar/gkp885; Sillitoe I, 2013, NUCLEIC ACIDS RES, V41, pD490, DOI 10.1093/nar/gks1211; Simossis VA, 2005, NUCLEIC ACIDS RES, V33, pW289, DOI 10.1093/nar/gki390; Singh M, 1999, CURR PHARM DESIGN, V5, P443; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Stephenson K., 2002, Current Drug Targets - Infectious Disorders, V2, P235, DOI 10.2174/1568005023342443; Swets JA, 2000, SCI AM, V283, P82, DOI 10.1038/scientificamerican1000-82; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Thakur Prasoon Kumar, 2013, J Nat Sci Biol Med, V4, P51, DOI 10.4103/0976-9668.107260; TheUniProtConsortium, 2017, Nucleic Acids Res, V45, pD158, DOI 10.1093/nar/gkw1099; Tusnady GE, 2001, BIOINFORMATICS, V17, P849, DOI 10.1093/bioinformatics/17.9.849; Vetrivel U, HUGO J, V5, P25; Wang L, 2013, J BACTERIOL, V195, P1959, DOI 10.1128/JB.02299-12; Wong Sandy M. S., 2008, V416, P27, DOI 10.1007/978-1-59745-321-9_3; Yu CS, 2006, PROTEINS, V64, P643, DOI 10.1002/prot.21018; Yu CS, 2004, PROTEIN SCI, V13, P1402, DOI 10.1110/ps.03479604; Yu NY, 2010, BIOINFORMATICS, V26, P1608, DOI 10.1093/bioinformatics/btq249; Zehr ES, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-331; Zou KH, 2003, ACAD RADIOL, V10, P1359, DOI 10.1016/S1076-6332(03)00538-5	110	61	66	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84263	10.1371/journal.pone.0084263	http://dx.doi.org/10.1371/journal.pone.0084263			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391926	gold, Green Published, Green Submitted			2022-12-25	WOS:000329323900069
J	Xin, YH; Bian, BSJ; Yang, XJ; Cui, W; Cui, HJ; Cui, YH; Zhang, X; Xu, C; Bian, XW				Xin, Yan-hong; Bian, Bai-shi-jiao; Yang, Xiao-jun; Cui, Wei; Cui, Hong-juan; Cui, You-hong; Zhang, Xia; Xu, Chuan; Bian, Xiu-wu			POU5F1 Enhances the Invasiveness of Cancer Stem-Like Cells in Lung Adenocarcinoma by Upregulation of MMP-2 Expression	PLOS ONE			English	Article							MATRIX METALLOPROTEINASE-2; POOR-PROGNOSIS; INVASION; MIGRATION; PROLIFERATION; PROGRESSION; SURVIVAL; OCT4	Lung cancer is the leading cause of cancer-related human deaths. Exploration of the mechanisms underlying the metastasis of cancer stem-like cells (CSLCs) will open new avenues in lung cancer diagnosis and therapy. Here, we demonstrated that CSLCs-derived from lung adenocarcinoma (LAC) cells displayed highly invasive and migratory capabilities via expressing high levels of POU5F1 and MMP-2. We found that POU5F1 directly regulated MMP-2 transcription via interaction with the promoter of MMP-2. POU5F1 knockdown in LACSLCs reduced MMP-2 protein abundance, leading to inhibition of the cell invasion, migration and tumorigenesis potentials of LAC cells. Clinically, aberrantly high expressions of POU5F1 and MMP-2 were inversely correlated with the survival of LAC patients, and the double-positive POU5F1 and MMP-2 showed the worst prediction for the patient's poor survival. These results indicate that POU5F1 can bind to the MMP-2 promoter for the degradation of surrounding extracellular matrix, and therefore promote invasive and migratory capabilities of LACSLCs. Moreover, our data implicate that the pathological detection of the double-positive expressions for POU5F1 and MMP-2 will be useful as diagnostic and prognostic biomarkers in LAC to advance anti-metastasis therapy.	[Xin, Yan-hong; Bian, Bai-shi-jiao; Yang, Xiao-jun; Cui, Wei; Cui, You-hong; Zhang, Xia; Xu, Chuan; Bian, Xiu-wu] Third Mil Med Univ, Inst Pathol, Chongqing, Peoples R China; [Xin, Yan-hong; Bian, Bai-shi-jiao; Yang, Xiao-jun; Cui, Wei; Cui, You-hong; Zhang, Xia; Xu, Chuan; Bian, Xiu-wu] Third Mil Med Univ, Southwest Hosp, Southwest Canc Ctr, Chongqing, Peoples R China; [Xin, Yan-hong; Bian, Bai-shi-jiao; Yang, Xiao-jun; Cui, Wei; Cui, You-hong; Zhang, Xia; Xu, Chuan; Bian, Xiu-wu] Minist Educ China, Key Lab Tumor Immunopathol, Chongqing, Peoples R China; [Xu, Chuan] Gen Hosp PLA Chengdu Mil Area Command, Dept Oncol, Chengdu, Peoples R China; [Cui, Hong-juan] Southwest Univ, Inst Sericulture & Syst Biol, State Key Lab Silkworm Genome Biol, Chongqing, Peoples R China; [Bian, Bai-shi-jiao] Chongqing Med Univ, Yongchuan Hosp, Chongqing, Peoples R China	Army Medical University; Army Medical University; Ministry of Education, China; Southwest University - China; Chongqing Medical University	Xu, C (corresponding author), Third Mil Med Univ, Inst Pathol, Chongqing, Peoples R China.	xuchuan100@163.com; bianxiuwu@263.net	Bian, Xiu-Wu/D-4736-2017; Zhang, Xia/B-8152-2008	Bian, Xiu-Wu/0000-0003-4383-0197; Zhang, Xia/0000-0002-9040-1486; XU, CHUAN/0000-0002-5320-2277	National Basic Research Program of China (973 Program) [2010CB529403]; National Natural Science Foundations of China [81272598]; China Postdoctoral Science Foundation [2012T50852]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundations of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was supported by grants from the National Basic Research Program of China (973 Program, Grant No.2010CB529403), National Natural Science Foundations of China (Grant No.81272598) and China Postdoctoral Science Foundation (Grant No.2012T50852). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babaie Y, 2007, STEM CELLS, V25, P500, DOI 10.1634/stemcells.2006-0426; Badiga AV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020614; Bjorklund M, 2005, BBA-REV CANCER, V1755, P37, DOI 10.1016/j.bbcan.2005.03.001; Bruna A, 2007, CANCER CELL, V11, P147, DOI 10.1016/j.ccr.2006.11.023; Chang CC, 2008, CANCER RES, V68, P6281, DOI 10.1158/0008-5472.CAN-08-0094; Chen YC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002637; Chien MH, 2013, EXPERT OPIN THER TAR, V17, P203, DOI 10.1517/14728222.2013.740012; Chiou SH, 2010, CANCER RES, V70, P10433, DOI 10.1158/0008-5472.CAN-10-2638; Duan JJ, 2013, STEM CELLS DEV, V22, P2221, DOI 10.1089/scd.2012.0613; Eramo A, 2008, CELL DEATH DIFFER, V15, P504, DOI 10.1038/sj.cdd.4402283; He LR, 2010, ANN ONCOL, V21, P1675, DOI 10.1093/annonc/mdp592; Jung M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010709; Kim Y, 2009, BMB REP, V42, P758, DOI 10.5483/BMBRep.2009.42.11.758; Kobayashi K, 2012, J CELL BIOCHEM, V113, P508, DOI 10.1002/jcb.23374; Levina V, 2010, CANCER RES, V70, P338, DOI 10.1158/0008-5472.CAN-09-1102; Littlepage LE, 2010, CANCER RES, V70, P2224, DOI 10.1158/0008-5472.CAN-09-3515; Marsden CG, 2009, METHODS MOL BIOL, V590, P363, DOI 10.1007/978-1-60327-378-7_23; Nagrath S, 2007, NATURE, V450, P1235, DOI 10.1038/nature06385; Qian QA, 2010, CANCER INVEST, V28, P661, DOI 10.3109/07357901003735634; Rivera C, 2011, J ONCOL, V2011, DOI 10.1155/2011/549181; Shi MM, 2013, MOL BIOL REP, V40, P617, DOI 10.1007/s11033-012-2100-3; Sobin, 2009, UICC TNM CLASSIFICAT; Sueblinvong V, 2010, TRANSL RES, V156, P188, DOI 10.1016/j.trsl.2010.06.007; Sullivan JP, 2010, CELL STEM CELL, V7, P2, DOI 10.1016/j.stem.2010.06.005; Sutherland KD, 2010, MOL ONCOL, V4, P397, DOI 10.1016/j.molonc.2010.05.002; Wang CK, 2010, CANCER LETT, V292, P261, DOI 10.1016/j.canlet.2009.12.010; Wang J, 2013, MOL CANCER THER, V12, P925, DOI 10.1158/1535-7163.MCT-12-1045; Wu KC, 2012, ANTICANCER RES, V32, P4833; Xu C, 2013, CANCER RES, V73, P3181, DOI 10.1158/0008-5472.CAN-12-4403; Xu XF, 2013, INT J BIOCHEM CELL B, V45, P536, DOI 10.1016/j.biocel.2012.12.010; Ye XZ, 2012, J IMMUNOL, V189, P444, DOI 10.4049/jimmunol.1103248; Yu SC, 2012, STEM CELLS, V30, P108, DOI 10.1002/stem.1685; Zhang XY, 2010, JPN J CLIN ONCOL, V40, P961, DOI 10.1093/jjco/hyq066	33	24	24	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e83373	10.1371/journal.pone.0083373	http://dx.doi.org/10.1371/journal.pone.0083373			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386189	Green Published, Green Submitted, gold			2022-12-25	WOS:000329194700037
J	Biot, FV; Lopez, MM; Poyot, T; Neulat-Ripoll, F; Lignon, S; Caclard, A; Thibault, FM; Peinnequin, A; Pages, JM; Valade, E				Biot, Fabrice Vincent; Lopez, Melanie Monique; Poyot, Thomas; Neulat-Ripoll, Fabienne; Lignon, Sabrina; Caclard, Arnaud; Thibault, Francois Michel; Peinnequin, Andre; Pages, Jean-Marie; Valade, Eric			Interplay between Three RND Efflux Pumps in Doxycycline-Selected Strains of Burkholderia thailandensis	PLOS ONE			English	Article							TIME QUANTITATIVE PCR; GENE-EXPRESSION DATA; MEXA-MEXB-OPRM; BPEAB-OPRB; PSEUDOMONAS-AERUGINOSA; ANTIBIOTIC-RESISTANCE; MULTIDRUG-RESISTANCE; PSEUDOMALLEI; CHLORAMPHENICOL; STANDARDIZATION	Background: Efflux systems are involved in multidrug resistance in most Gram-negative non-fermentative bacteria. We have chosen Burkholderia thailandensis to dissect the development of multidrug resistance phenotypes under antibiotic pressure. Methodology/Principal Findings: We used doxycycline selection to obtain several resistant B. thailandensis variants. The minimal inhibitory concentrations of a large panel of structurally unrelated antibiotics were determined 6 the efflux pump inhibitor phenylalanine-arginine SS-naphthylamide (PASSN). Membrane proteins were identified by proteomic method and the expressions of major efflux pumps in the doxycycline selected variants were compared to those of the parental strains by a quantitative RT-PCR analysis. Doxycycline selected variants showed a multidrug resistance in two major levels corresponding to the overproduction of two efflux pumps depending on its concentration: AmrAB-OprA and BpeEF-OprC. The study of two mutants, each lacking one of these pumps, indicated that a third pump, BpeAB-OprB, could substitute for the defective pump. Surprisingly, we observed antagonistic effects between PASSN and aminoglycosides or some ss-lactams. PA beta N induced the overexpression of AmrAB-OprA and BpeAB-OprB pump genes, generating this unexpected effect. Conclusions/Significance: These results may account for the weak activity of PASSN in some Gram-negative species. We clearly demonstrated two antagonistic effects of this molecule on bacterial cells: the blocking of antibiotic efflux and an increase in efflux pump gene expression. Thus, doxycycline is a very efficient RND efflux pump inducer and PASSN may promote the production of some efflux pumps. These results should be taken into account when considering antibiotic treatments and in future studies on efflux pump inhibitors.	[Biot, Fabrice Vincent; Lopez, Melanie Monique; Neulat-Ripoll, Fabienne; Caclard, Arnaud; Thibault, Francois Michel; Valade, Eric] Inst Rech Biomed Armees, Unite Bacteriol UMR MD 1, Bretigny Sur Orge, France; [Biot, Fabrice Vincent; Neulat-Ripoll, Fabienne; Caclard, Arnaud; Thibault, Francois Michel; Pages, Jean-Marie; Valade, Eric] Aix Marseille Univ, UMR MD 1, IRBA, Fac Med & Pharm, Marseille, France; [Poyot, Thomas; Peinnequin, Andre] Inst Rech Biomed Armees, Bretigny Sur Orge, France; [Lignon, Sabrina] Aix Marseille Univ, FR Plate Forme Proteom 3479, CNRS, Marseille, France; [Valade, Eric] Ecole Val de Grace, Paris, France	UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Biot, FV (corresponding author), Inst Rech Biomed Armees, Unite Bacteriol UMR MD 1, Bretigny Sur Orge, France.	fabrice.biot@irba.fr	PAGES, jean-marie/F-2555-2013	PAGES, jean-marie/0000-0001-7092-7977; BIOT, Fabrice/0000-0002-3632-2146; neulat-ripoll, fabienne/0000-0001-5387-0382	French Ministry of Defense [PDH-2-NRBC-4-B-201]; Aix Marseille Universite	French Ministry of Defense; Aix Marseille Universite	This work was supported by the French Ministry of Defense (grant number PDH-2-NRBC-4-B-201) and by the Aix Marseille Universite. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biot FV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016892; Blouzard JC, 2010, PROTEOMICS, V10, P541, DOI 10.1002/pmic.200900311; Bolla JM, 2011, FEBS LETT, V585, P1682, DOI 10.1016/j.febslet.2011.04.054; Bornet C, 2003, BIOCHEM BIOPH RES CO, V301, P985, DOI 10.1016/S0006-291X(03)00074-3; Brett PJ, 1998, INT J SYST BACTERIOL, V48, P317, DOI 10.1099/00207713-48-1-317; Carr G, 2011, ORG LETT, V13, P3048, DOI 10.1021/ol200922s; Chan YY, 2005, J BACTERIOL, V187, P4707, DOI 10.1128/JB.187.14.4707-4719.2005; Chan YY, 2004, ANTIMICROB AGENTS CH, V48, P1128, DOI 10.1128/AAC.48.4.1128-1135.2004; Chevalier J, 2004, ANTIMICROB AGENTS CH, V48, P1043, DOI 10.1128/AAC.48.3.1043-1046.2004; Cortez-Cordova J, 2011, INT J ANTIMICROB AG, V37, P420, DOI 10.1016/j.ijantimicag.2011.01.006; DANCE DAB, 1989, J ANTIMICROB CHEMOTH, V24, P295, DOI 10.1093/jac/24.3.295; Gelhaus HC, 2013, SCI REP-UK, V3, DOI 10.1038/srep01146; Ghisalberti D, 2005, BIOCHEM BIOPH RES CO, V328, P1113, DOI 10.1016/j.bbrc.2005.01.069; Glass MB, 2006, J CLIN MICROBIOL, V44, P4601, DOI 10.1128/JCM.01585-06; Gotoh N, 1998, ANTIMICROB AGENTS CH, V42, P1938, DOI 10.1128/AAC.42.8.1938; Griffin MO, 2010, AM J PHYSIOL-CELL PH, V299, pC539, DOI 10.1152/ajpcell.00047.2010; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Jeannot K, 2005, J BACTERIOL, V187, P5341, DOI 10.1128/JB.187.15.5341-5346.2005; Kumar A, 2006, ANTIMICROB AGENTS CH, V50, P3460, DOI 10.1128/AAC.00440-06; Kumar Ayush, 2008, Trans R Soc Trop Med Hyg, V102 Suppl 1, pS145, DOI 10.1016/S0035-9203(08)70032-4; LI XZ, 1995, ANTIMICROB AGENTS CH, V39, P1948, DOI 10.1128/AAC.39.9.1948; Lister IM, 2012, ANTIMICROB AGENTS CH, V56, P1120, DOI 10.1128/AAC.05338-11; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mima T, 2011, J ANTIMICROB CHEMOTH, V66, P73, DOI 10.1093/jac/dkq391; Mima T, 2010, ANTIMICROB AGENTS CH, V54, P3113, DOI 10.1128/AAC.01803-09; Nikaido H, 2009, ANNU REV BIOCHEM, V78, P119, DOI 10.1146/annurev.biochem.78.082907.145923; Nikaido H, 2009, BBA-PROTEINS PROTEOM, V1794, P769, DOI 10.1016/j.bbapap.2008.10.004; Pages JM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004817; Pannek S, 2006, J ANTIMICROB CHEMOTH, V57, P970, DOI 10.1093/jac/dkl081; Peinnequin Andre, 2004, BMC Immunology, V5, P1, DOI 10.1186/1471-2172-5-3; Pugniere P, 2011, ANAL BIOCHEM, V415, P151, DOI 10.1016/j.ab.2011.04.008; Rajendran R, 2010, INT J ANTIMICROB AG, V36, P151, DOI 10.1016/j.ijantimicag.2010.03.009; Sarkar-Tyson M, 2011, FUTURE MICROBIOL, V6, P667, DOI [10.2217/FMB.11.50, 10.2217/fmb.11.50]; Schweizer HP, 2012, FUTURE MICROBIOL, V7, P1389, DOI [10.2217/fmb.12.116, 10.2217/FMB.12.116]; Simpson AJH, 1999, ANTIMICROB AGENTS CH, V43, P2332, DOI 10.1128/AAC.43.9.2332; Thongdee M, 2008, APPL ENVIRON MICROB, V74, P2985, DOI 10.1128/AEM.00030-08; Trunck LA, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000519; Udani RA, 2006, ANTIMICROB AGENTS CH, V50, P2971, DOI 10.1128/AAC.00015-06; Viktorov Dimitry V, 2008, Trans R Soc Trop Med Hyg, V102 Suppl 1, pS103, DOI 10.1016/S0035-9203(08)70025-7; Willems E, 2008, ANAL BIOCHEM, V379, P127, DOI 10.1016/j.ab.2008.04.036; Yu YT, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-46	42	24	24	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e84068	10.1371/journal.pone.0084068	http://dx.doi.org/10.1371/journal.pone.0084068			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281RE	24386333	Green Submitted, gold, Green Published			2022-12-25	WOS:000329117900074
J	Dietrich, D; Jung, M; Puetzer, S; Leisse, A; Holmes, EE; Meller, S; Uhl, B; Schatz, P; Ivascu, C; Kristiansen, G				Dietrich, Dimo; Jung, Maria; Puetzer, Svenja; Leisse, Annette; Holmes, Emily Eva; Meller, Sebastian; Uhl, Barbara; Schatz, Philipp; Ivascu, Claudia; Kristiansen, Glen			Diagnostic and Prognostic Value of SHOX2 and SEPT9 DNA Methylation and Cytology in Benign, Paramalignant and Malignant Pleural Effusions	PLOS ONE			English	Article							COLORECTAL-CANCER; TUMOR-MARKERS; BIOMARKERS; MANAGEMENT; FLUID; ASSAY; MESOTHELIOMA; PERFORMANCE; EXPERIENCE; EPIGENOME	Pleural effusions (PE) are a common clinical problem. The discrimination between benign (BPE), malignant (MPE) and paramalignant (PPE) pleural effusions is highly important to ensure appropriate patient treatment. Today, cytology is the gold standard for diagnosing malignant pleural effusions. However, its sensitivity is limited due to the sometimes low abundance of tumor cells and the challenging assessment of cell morphology in cytological samples. This study aimed to develop and validate a diagnostic test, which allows for the highly specific detection of malignant cells in pleural effusions based on the DNA methylation biomarkers SHOX2 and SEPT9. A quantitative real-time PCR assay was developed which enabled the accurate and sensitive detection of SHOX2 and SEPT9 in PEs. Cytological and DNA methylation analyses were conducted in a case control study comprised of PEs from 114 patients (58 cases, 56 controls). Cytological analysis as well as SHOX2 and SEPT9 methylation resulted in 100% specificity. 21% of the cases were cytologically positive and 26% were SHOX2 or SEPT9 methylation positive. The combined analysis of cytology and DNA methylation resulted in an increase of 71% positively classified PEs from cancer patients as compared to cytological analysis alone. The absolute sensitivity of cytology and DNA methylation was not determinable due to the lack of an appropriate gold standard diagnostic for distinguishing between MPEs and PPEs. Therefore, it was unclear which PEs from cancer patients were malignant (containing tumor cells) and which PEs were paramalignant and resulted from benign conditions in cancer patients, respectively. Furthermore, DNA methylation analysis in PEs allowed the prognosis of the overall survival in cancer patients (Kaplan-Meier analysis, log rank test, p = 0.02 (SHOX2), p = 0.02 (SEPT9)). The developed test may be used as a diagnostic and prognostic adjunct to existing clinical and cytopathological investigations in patients with PEs of unclear etiology.	[Dietrich, Dimo; Jung, Maria; Puetzer, Svenja; Leisse, Annette; Holmes, Emily Eva; Meller, Sebastian; Uhl, Barbara; Kristiansen, Glen] Univ Hosp Bonn UKB, Inst Pathol, Bonn, Germany; [Schatz, Philipp] Metan Hlth GmbH, Berlin, Germany; [Ivascu, Claudia] Roche Pharma AG, Hematol Oncol, Grenzach Wyhlen, Germany	University of Bonn; Roche Holding	Dietrich, D (corresponding author), Univ Hosp Bonn UKB, Inst Pathol, Bonn, Germany.	dimo.dietrich@gmail.com						Alatas F, 2001, LUNG CANCER, V31, P9, DOI 10.1016/S0169-5002(00)00153-7; [Anonymous], ONCOLOGIST, V10, P501; Antony VB, 2001, EUR RESPIR J, V18, P402, DOI 10.1183/09031936.01.00225601; Baylin SB, 2011, NAT REV CANCER, V11, P726, DOI 10.1038/nrc3130; Bennett KL, 2008, CANCER RES, V68, P4494, DOI 10.1158/0008-5472.CAN-07-6509; Bhatnagar R, 2013, CLIN CHEST MED, V34, P47, DOI 10.1016/j.ccm.2012.11.004; Brock MV, 2005, ANN THORAC SURG, V80, P1241, DOI 10.1016/j.athoracsur.2005.05.088; Church TR, 2014, GUT, V63, P317, DOI 10.1136/gutjnl-2012-304149; deVos T, 2009, CLIN CHEM, V55, P1337, DOI 10.1373/clinchem.2008.115808; DIBONITO L, 1992, ACTA CYTOL, V36, P329; Dietrich D, 2012, DIAGN MOL PATHOL, V21, P93, DOI 10.1097/PDM.0b013e318240503b; Dietrich D, 2012, INT J ONCOL, V40, P825, DOI 10.3892/ijo.2011.1264; Gonzalez AV, 2010, CHEST, V137, P1375, DOI 10.1378/chest.09-2020; Grutzmann R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003759; Heffner JE, 2000, CHEST, V117, P79, DOI 10.1378/chest.117.1.79; Heffner JE, 2008, RESPIROLOGY, V13, P5, DOI 10.1111/j.1440-1843.2007.01154.x; Heichman KA, 2012, CLIN CHEM LAB MED, V50, P1707, DOI 10.1515/cclm-2011-0935; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; JAY SJ, 1985, CLIN CHEST MED, V6, P33; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; Kneip C, 2011, J THORAC ONCOL, V6, P1632, DOI 10.1097/JTO.0b013e318220ef9a; Kneip C, 2009, BIOTECHNIQUES, V47, P737, DOI 10.2144/000113208; LEUALLEN EC, 1955, NEW ENGL J MED, V252, P79, DOI 10.1056/NEJM195501202520301; Lewin J., 2011, United States Patent Application, Patent No. 20110027789; Liang QL, 2008, THORAX, V63, P35, DOI 10.1136/thx.2007.077958; Lofton-Day C, 2008, CLIN CHEM, V54, P414, DOI 10.1373/clinchem.2007.095992; MAREL M, 1995, CHEST, V107, P1598, DOI 10.1378/chest.107.6.1598; Maskell NA, 2003, THORAX, V58, pII8, DOI 10.1136/thorax.58.suppl_2.ii8; Mitrouska I, 2005, CAN RESPIR J, V11, P499; Park DS, 2012, CLIN EXP METASTAS, V29, P83, DOI 10.1007/s10585-011-9431-7; Pass HI, 2008, ANN THORAC SURG, V85, P265, DOI 10.1016/j.athoracsur.2007.07.042; Porcel JM, 2004, CHEST, V126, P1757, DOI 10.1378/chest.126.6.1757; Porcel JM, 2013, DM-DIS MON, V59, P29, DOI 10.1016/j.disamonth.2012.11.002; Roberts ME, 2010, THORAX, V65, P32, DOI 10.1136/thx.2010.136994; Rodriguez-Panadero F, 2008, RESPIRATION, V76, P363, DOI 10.1159/000158545; Scherpereel A, 2006, AM J RESP CRIT CARE, V173, P1155, DOI 10.1164/rccm.200511-1789OC; Schmidt B, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-600; Schneider KU, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-102; Shen H, 2013, CELL, V153, P38, DOI 10.1016/j.cell.2013.03.008; Suva ML, 2013, SCIENCE, V339, P1567, DOI 10.1126/science.1230184; Tanzer M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009061; Woenckhaus M, 2005, J MOL DIAGN, V7, P517, DOI 10.1016/S1525-1578(10)60583-1	42	48	53	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e84225	10.1371/journal.pone.0084225	http://dx.doi.org/10.1371/journal.pone.0084225			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281RE	24386354	Green Published, gold, Green Submitted			2022-12-25	WOS:000329117900086
J	Gomez-Laplaza, LM; Gerlai, R				Gomez-Laplaza, Luis M.; Gerlai, Robert			The Role of Body Surface Area in Quantity Discrimination in Angelfish (Pterophyllum scalare)	PLOS ONE			English	Article							CONTOUR LENGTH; INFANTS DISCRIMINATION; NUMERICAL COMPETENCE; SHOALING DECISIONS; NUMBER; SIZE; JUDGMENTS; CHOICE; ZEBRAFISH; FISH	Although some fish species have been shown to be able to discriminate between two groups (shoals) of conspecifics differing in the number of members, most studies have not controlled for continuous variables that covary with number. Previously, using angelfish (Pterophyllum scalare) we started the systematic analysis of the potential influence of such continuous variables, and found that they play different roles in shoal discrimination depending on whether large (>= 4 fish) or small (< 4 fish) shoals were contrasted. Here, we examine the potential role of the overall body surface area of stimulus fish in shoal preference, a prominent variable not yet examined in angelfish. We report that both when numerically large (5 versus 10 fish) and when small (2 versus 3 fish) shoals were contrasted, angelfish were unable to discriminate the numerically different shoals as long as the surface area of the contrasted shoals was equated. Thus, we conclude that body surface may be an important continuous variable in shoal discrimination. This conclusion was further supported by the analysis of preference when shoals of the same numerical size but different body surface area were contrasted. We found subjects to spend significantly more time close to the shoals with the greater overall surface area. Last, we conducted an experiment in which we simultaneously controlled a set of continuous variables, including overall surface area, and found angelfish to use the number of shoal members as a cue only in large shoal contrasts but not in small shoal contrasts. This result suggests the potential existence of different processing systems for large and small numbers in fish.	[Gomez-Laplaza, Luis M.] Univ Oviedo, Dept Psychol, Oviedo, Spain; [Gerlai, Robert] Univ Toronto, Dept Psychol, Mississauga, ON L5L 1C6, Canada	University of Oviedo; University of Toronto; University Toronto Mississauga	Gomez-Laplaza, LM (corresponding author), Univ Oviedo, Dept Psychol, Oviedo, Spain.	lmgomez@uniovi.es; robert_gerlai@yahoo.com	Laplaza, Luis M. Gómez/ABF-6852-2021	Laplaza, Luis M. Gómez/0000-0003-1572-0580	Ministerio de Ciencia e Innovacion (Spain) [MICINN-10-PSI2010-16487]; NSERC (Canada) Discovery grant	Ministerio de Ciencia e Innovacion (Spain)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); NSERC (Canada) Discovery grant(Natural Sciences and Engineering Research Council of Canada (NSERC))	This research was supported by grant MICINN-10-PSI2010-16487 from the Ministerio de Ciencia e Innovacion (Spain) to LMG-L, and an NSERC (Canada) Discovery grant to RG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrillo C, DEV PSYCHOBIOL, DOI 10-1002/dev.21122; Agrillo C, 2008, ANIM COGN, V11, P495, DOI 10.1007/s10071-008-0140-9; Agrillo C, 2006, ETHOLOGY, V112, P592, DOI 10.1111/j.1439-0310.2006.01188.x; Agrillo C, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00483; Agrillo C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031923; Agrillo C, 2012, BEHAV BRAIN RES, V230, P343, DOI 10.1016/j.bbr.2012.02.025; Agrillo C, 2011, COGNITION, V119, P281, DOI 10.1016/j.cognition.2010.10.022; Agrillo C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015232; Agrillo C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004786; Armstrong N, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00584; Benson-Amram S, 2011, ANIM BEHAV, V82, P743, DOI 10.1016/j.anbehav.2011.07.004; Beran MJ, 2008, ANIM BEHAV, V75, P1793, DOI 10.1016/j.anbehav.2007.10.035; Beran MJ, 2007, J EXP PSYCHOL-ANIM B, V33, P42, DOI 10.1037/0097-7403.33.1.42; Bisazza A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015516; Bonanni R, 2011, ANIM COGN, V14, P103, DOI 10.1007/s10071-010-0348-3; Booksmythe I, 2013, ANIM BEHAV, V85, P371, DOI 10.1016/j.anbehav.2012.11.009; Brannon EM, 2006, DEVELOPMENTAL SCI, V9, pF59, DOI 10.1111/j.1467-7687.2006.00530.x; Brannon EM, 2004, COGNITION, V93, pB59, DOI 10.1016/j.cognition.2004.01.004; Buckingham JN, 2007, BEHAVIOUR, V144, P1333, DOI 10.1163/156853907782418196; Clearfield MW, 2001, J COGN DEV, V2, P243, DOI 10.1207/S15327647JCD0203_1; Clearfield MW, 1999, PSYCHOL SCI, V10, P408, DOI 10.1111/1467-9280.00177; Cordes S, 2008, DEVELOPMENTAL SCI, V11, P803, DOI 10.1111/j.1467-7687.2008.00770.x; Dadda M, 2009, COGNITION, V112, P343, DOI 10.1016/j.cognition.2009.05.009; Emmerton J, 1998, ANIM LEARN BEHAV, V26, P243, DOI 10.3758/BF03199218; Emmerton J, 2009, ANIM COGN, V12, P511, DOI 10.1007/s10071-009-0212-5; Feigenson L, 2002, PSYCHOL SCI, V13, P150, DOI 10.1111/1467-9280.00427; Feigenson L, 2004, TRENDS COGN SCI, V8, P307, DOI 10.1016/j.tics.2004.05.002; Feigenson L, 2002, COGNITIVE PSYCHOL, V44, P33, DOI 10.1006/cogp.2001.0760; Frommen JG, 2009, BEHAV ECOL SOCIOBIOL, V63, P1141, DOI 10.1007/s00265-009-0767-9; Gebuis T, 2012, J EXP PSYCHOL GEN, V141, P642, DOI 10.1037/a0026218; Gomez-Laplaza LM, 2013, ANIM COGN, V16, P373, DOI 10.1007/s10071-012-0578-7; Gomez-Laplaza LM, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00484; Gomez-Laplaza LM, 2011, ANIM COGN, V14, P565, DOI 10.1007/s10071-011-0392-7; Hanus D, 2007, J COMP PSYCHOL, V121, P241, DOI 10.1037/0735-7036.121.3.241; Hunt S, 2008, P ROY SOC B-BIOL SCI, V275, P2373, DOI 10.1098/rspb.2008.0702; Irie-Sugimoto N, 2009, ANIM COGN, V12, P193, DOI 10.1007/s10071-008-0185-9; Jones KA, 2010, ETHOLOGY, V116, P147, DOI 10.1111/j.1439-0310.2009.01727.x; Jones Sarah M, 2012, Front Psychol, V3, P550, DOI 10.3389/fpsyg.2012.00550; Kilian A, 2003, LEARN BEHAV, V31, P133; Krause J, 2002, LIVING GROUPS; Krusche P, 2010, J EXP BIOL, V213, P1822, DOI 10.1242/jeb.039297; LANDEAU L, 1986, ANIM BEHAV, V34, P1372, DOI 10.1016/S0003-3472(86)80208-1; Low J, 2009, IBIS, V151, P775, DOI 10.1111/j.1474-919X.2009.00951.x; Lyon BE, 2003, NATURE, V422, P495, DOI 10.1038/nature01505; Pahl M, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00162; Perdue BM, 2012, ANIM COGN, V15, P955, DOI 10.1007/s10071-012-0521-y; Peuhkuri N, 1997, ANIM BEHAV, V54, P271, DOI 10.1006/anbe.1996.0453; Piffer L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062466; Pisa P, 2009, J ETHOL, V27, P289, DOI 10.1007/s10164-008-0121-0; Pritchard VL, 2001, ANIM BEHAV, V62, P1085, DOI 10.1006/anbe.2001.1858; RANTA E, 1992, ANIM BEHAV, V43, P160, DOI 10.1016/S0003-3472(05)80082-X; Reznikova Z, 2011, BEHAVIOUR, V148, P405, DOI 10.1163/000579511X568562; Rohlf F. J., 2004, TPSDIG VERSION 1 40; Rugani R, 2008, J EXP PSYCHOL-ANIM B, V34, P388, DOI 10.1037/0097-7403.34.3.388; Rugani R, 2009, P ROY SOC B-BIOL SCI, V276, P2451, DOI 10.1098/rspb.2009.0044; Saverino C, 2008, BEHAV BRAIN RES, V191, P77, DOI 10.1016/j.bbr.2008.03.013; Scerbina T, 2012, AMINO ACIDS, V43, P2059, DOI 10.1007/s00726-012-1284-0; Stancher G, 2013, ANIM COGN, V16, P307, DOI 10.1007/s10071-012-0590-y; Stevens JR, 2007, ANIM COGN, V10, P429, DOI 10.1007/s10071-007-0081-8; Svensson PA, 2000, J FISH BIOL, V56, P1477, DOI 10.1111/j.1095-8649.2000.tb02158.x; Utrata Ewelina, 2012, Front Psychol, V3, P505, DOI 10.3389/fpsyg.2012.00505; Vonk J, 2012, ANIM BEHAV, V84, P231, DOI 10.1016/j.anbehav.2012.05.001; Ward AJW, 2001, ANIM BEHAV, V62, P617, DOI 10.1006/anbe.2001.1785; Ward C, 2007, ANIM COGN, V10, P71, DOI 10.1007/s10071-006-0042-7; Wilson ML, 2012, ANIM BEHAV, V83, P277, DOI 10.1016/j.anbehav.2011.11.004; Wood JN, 2005, DEVELOPMENTAL SCI, V8, P173, DOI 10.1111/j.1467-7687.2005.00404.x	66	24	24	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e83880	10.1371/journal.pone.0083880	http://dx.doi.org/10.1371/journal.pone.0083880			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	281RE	24386299	Green Published, gold, Green Submitted			2022-12-25	WOS:000329117900064
J	Costa, MA; Marques, JV; Dalisay, DS; Herman, B; Bedgar, DL; Davin, LB; Lewis, NG				Costa, Michael A.; Marques, Joaquim V.; Dalisay, Doralyn S.; Herman, Barrington; Bedgar, Diana L.; Davin, Laurence B.; Lewis, Norman G.			Transgenic Hybrid Poplar for Sustainable and Scalable Production of the Commodity/Specialty Chemical, 2-Phenylethanol	PLOS ONE			English	Article							AMINO-ACID DECARBOXYLASES; BIOTECHNOLOGICAL PRODUCTION; PHENYLPROPANOID METABOLISM; MEDIATED TRANSFORMATION; POPULUS; BIOSYNTHESIS; SALICYLATE; ENZYME; ASPEN	Fast growing hybrid poplar offers the means for sustainable production of specialty and commodity chemicals, in addition to rapid biomass production for lignocellulosic deconstruction. Herein we describe transformation of fast-growing transgenic hybrid poplar lines to produce 2-phenylethanol, this being an important fragrance, flavor, aroma, and commodity chemical. It is also readily converted into styrene or ethyl benzene, the latter being an important commodity aviation fuel component. Introducing this biochemical pathway into hybrid poplars marks the beginnings of developing a platform for a sustainable chemical delivery system to afford this and other valuable specialty/commodity chemicals at the scale and cost needed. These modified plant lines mainly sequester 2-phenylethanol via carbohydrate and other covalently linked derivatives, thereby providing an additional advantage of effective storage until needed. The future potential of this technology is discussed. MALDI metabolite tissue imaging also established localization of these metabolites in the leaf vasculature.	[Costa, Michael A.; Marques, Joaquim V.; Dalisay, Doralyn S.; Herman, Barrington; Bedgar, Diana L.; Davin, Laurence B.; Lewis, Norman G.] Washington State Univ, Inst Biol Chem, Pullman, WA 99164 USA; [Lewis, Norman G.] Ealasid Inc, Pullman, WA USA	Washington State University	Lewis, NG (corresponding author), Washington State Univ, Inst Biol Chem, Pullman, WA 99164 USA.	lewisn@wsu.edu	Dalisay, Doralyn S/I-7558-2016	Davin, Laurence/0000-0002-3248-6485; Lewis, Norman/0000-0001-5742-032X; Dalisay, Doralyn/0000-0003-2850-7797	Washington State University Agricultural Research Center federal special grant [WNP00768]; U.S. Department of Agriculture National Institutes for Food and Agriculture (USDA-NIFA); USDA-NIFA [683A757612]; G. Thomas and Anita Hargrove Center for Plant Genomic Research; Div Of Biological Infrastructure [1229749] Funding Source: National Science Foundation	Washington State University Agricultural Research Center federal special grant; U.S. Department of Agriculture National Institutes for Food and Agriculture (USDA-NIFA); USDA-NIFA(United States Department of Agriculture (USDA)); G. Thomas and Anita Hargrove Center for Plant Genomic Research; Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This research was supported in part by Washington State University Agricultural Research Center federal special grant Project No. WNP00768 "Aegilops Cylindrica, WA," one of whose various objectives focused on transgenic poplar development with funding received from the U.S. Department of Agriculture National Institutes for Food and Agriculture (USDA-NIFA). Additionally, the authors thank USDA-NIFA (#683A757612), and the G. Thomas and Anita Hargrove Center for Plant Genomic Research for generous financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu IN, 2011, J CHEM ECOL, V37, P857, DOI 10.1007/s10886-011-9991-7; Alouisius RN, 2008, European Patent, Patent No. [EP2231559, 2231559]; [Anonymous], 2010, CHEM ENG NEWS, V88, P33; Bertoldi M, 2002, J BIOL CHEM, V277, P36357, DOI 10.1074/jbc.M204867200; Chen CS, 2004, APPL CATAL A-GEN, V260, P207, DOI 10.1016/j.apcata.2003.10.022; Chen XM, 2011, J PLANT PHYSIOL, V168, P88, DOI 10.1016/j.jplph.2010.06.011; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; CRAWFORD DJ, 1974, BRITTONIA, V26, P74, DOI 10.2307/2805923; DEBLOCK M, 1990, PLANT PHYSIOL, V93, P1110, DOI 10.1104/pp.93.3.1110; Ehrlich F, 1907, BER DTSCH CHEM GES, V40, P1027, DOI 10.1002/cber.190704001156; Etschmann MMW, 2002, APPL MICROBIOL BIOT, V59, P1, DOI 10.1007/s00253-002-0992-x; Facchini PJ, 2000, PHYTOCHEMISTRY, V54, P121, DOI 10.1016/S0031-9422(00)00050-9; Farhi M, 2010, PLANT MOL BIOL, V72, P235, DOI 10.1007/s11103-009-9564-0; GLEAVE AP, 1992, PLANT MOL BIOL, V20, P1203, DOI 10.1007/BF00028910; Han X, 2013, INT J MOL SCI, V14, P2515, DOI 10.3390/ijms14022515; Harding SA, 2009, J EXP BOT, V60, P3443, DOI 10.1093/jxb/erp180; HOLSTERS M, 1978, MOL GEN GENET, V163, P181, DOI 10.1007/BF00267408; Hua DL, 2011, BIOTECHNOL ADV, V29, P654, DOI 10.1016/j.biotechadv.2011.05.001; Jones P, 2001, PLANTA, V213, P164, DOI 10.1007/s004250000492; Kaminaga Y, 2006, J BIOL CHEM, V281, P23357, DOI 10.1074/jbc.M602708200; Karimi M, 2002, TRENDS PLANT SCI, V7, P193, DOI 10.1016/S1360-1385(02)02251-3; Lindroth RL, 1996, BIOCHEM SYST ECOL, V24, P357, DOI 10.1016/0305-1978(96)00043-9; Ma C. P., 2004, Plant Molecular Biology Reporter, V22, P311, DOI 10.1007/BF02773145; Morreel K, 2006, PLANT J, V47, P224, DOI 10.1111/j.1365-313X.2006.02786.x; Patten AM, 2010, COMPREHENSIVE NATURAL PRODUCTS II: CHEMISTRY AND BIOLOGY, VOL 3: DEVELOPMENT & MODIFICATION OF BIOACTIVITY, P1173; Reineccius G. A., 2007, FLAVOURS FRAGRANCES; SHU CK, 1994, J AGR FOOD CHEM, V42, P1732, DOI 10.1021/jf00044a029; Tieman D, 2006, P NATL ACAD SCI USA, V103, P8287, DOI 10.1073/pnas.0602469103; Tieman DM, 2007, PHYTOCHEMISTRY, V68, P2660, DOI 10.1016/j.phytochem.2007.06.005; Tsai CJ, 2006, NEW PHYTOL, V172, P47, DOI 10.1111/j.1469-8137.2006.01798.x; Warren JM, 2003, TREE PHYSIOL, V23, P527, DOI 10.1093/treephys/23.8.527	31	24	24	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e83169	10.1371/journal.pone.0083169	http://dx.doi.org/10.1371/journal.pone.0083169			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281QS	24386157	Green Published, Green Submitted, gold			2022-12-25	WOS:000329116700033
J	Harada, T; Ozaki, S; Oda, A; Tsuji, D; Ikegame, A; Iwasa, M; Udaka, K; Fujii, S; Nakamura, S; Miki, H; Kagawa, K; Kuroda, Y; Kawai, S; Itoh, K; Yamada-Okabe, H; Matsumoto, T; Abe, M				Harada, Takeshi; Ozaki, Shuji; Oda, Asuka; Tsuji, Daisuke; Ikegame, Akishige; Iwasa, Masami; Udaka, Kengo; Fujii, Shiro; Nakamura, Shingen; Miki, Hirokazu; Kagawa, Kumiko; Kuroda, Yoshiaki; Kawai, Shigeto; Itoh, Kohji; Yamada-Okabe, Hisafumi; Matsumoto, Toshio; Abe, Masahiro			Combination with a Defucosylated Anti-HM1.24 Monoclonal Antibody plus Lenalidomide Induces Marked ADCC against Myeloma Cells and Their Progenitors	PLOS ONE			English	Article							DEPENDENT CELLULAR CYTOTOXICITY; FC-GAMMA-RIIIA; MULTIPLE-MYELOMA; STEM-CELLS; STAGING SYSTEM; DEXAMETHASONE; ANTIGEN; IMMUNOTHERAPY; CHEMOTHERAPY; POLYMORPHISM	The immunomodulatory drug lenalidomide (Len) has drawn attention to potentiate antibody-dependent cellular cytotoxicity (ADCC)-mediated immunotherapies. We developed the defucosylated version (YB-AHM) of humanized monoclonal antibody against HM1.24 (CD317) overexpressed in multiple myeloma (MM) cells. In this study, we evaluated ADCC by YB-AHM and Len in combination against MM cells and their progenitors. YB-AHM was able to selectively kill via ADCC MM cells in bone marrow samples from patients with MM with low effector/target ratios, which was further enhanced by treatment with Len. Interestingly, Len also up-regulated HM1.24 expression on MM cells in an effector-dependent manner. HM1.24 was found to be highly expressed in a drug-resistant clonogenic "side population" in MM cells; and this combinatory treatment successfully reduced SP fractions in RPMI 8226 and KMS-11 cells in the presence of effector cells, and suppressed a clonogenic potential of MM cells in colony-forming assays. Collectively, the present study suggests that YB-AHM and Len in combination may become an effective therapeutic strategy in MM, warranting further study to target drug-resistant MM clonogenic cells.	[Harada, Takeshi; Oda, Asuka; Iwasa, Masami; Udaka, Kengo; Fujii, Shiro; Nakamura, Shingen; Miki, Hirokazu; Kagawa, Kumiko; Matsumoto, Toshio; Abe, Masahiro] Univ Tokushima, Grad Sch Med Sci, Dept Med & Bioregulatory Sci, Tokushima 770, Japan; [Ozaki, Shuji] Tokushima Prefectural Cent Hosp, Dept Hematol, Tokushima, Japan; [Tsuji, Daisuke; Itoh, Kohji] Univ Tokushima, Grad Sch Pharmaceut Sci, Dept Med Biotechnol, Tokushima 770, Japan; [Ikegame, Akishige] Tokushima Univ Hosp, Div Med Technol, Tokushima, Japan; [Kuroda, Yoshiaki] Hiroshima Univ, Dept Hematol & Oncol, RIRBM, Hiroshima, Japan; [Kawai, Shigeto] Forerunner Pharma Res Co Ltd, Div Res, Tokyo, Japan; [Yamada-Okabe, Hisafumi] Chugai Pharmaceut Co Ltd, Div Res, Kamakura, Kanagawa, Japan	Tokushima University; Tokushima University; Tokushima University; Hiroshima University; Chugai Pharmaceutical Co., Ltd.; Roche Holding	Ozaki, S (corresponding author), Tokushima Prefectural Cent Hosp, Dept Hematol, Tokushima, Japan.	ozaki@tph.gr.jp	Tsuji, Daisuke/F-7085-2013	Tsuji, Daisuke/0000-0002-1528-7820; Kawai, Shigeto/0000-0002-3746-0794	Ministry of Education, Culture, Sports, Science and Technology of Japan; Grants-in-Aid for Scientific Research [25460389] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants-in-Aid for Scientific Research (C) for S.O. and M. A. and (A) for T. M. from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Anderson KC, 2011, ANNU REV PATHOL-MECH, V6, P249, DOI 10.1146/annurev-pathol-011110-130249; Cao W, 2010, IMMUNOL REV, V234, P163, DOI 10.1111/j.0105-2896.2009.00867.x; Cao W, 2009, J EXP MED, V206, P1603, DOI 10.1084/jem.20090547; Cartron G, 2002, BLOOD, V99, P754, DOI 10.1182/blood.V99.3.754; Challen GA, 2006, STEM CELLS, V24, P3, DOI 10.1634/stemcells.2005-0116; de Weers M, 2011, J IMMUNOL, V186, P1840, DOI 10.4049/jimmunol.1003032; Dimopoulos MA, 2009, LEUKEMIA, V23, P2147, DOI 10.1038/leu.2009.147; Dimopoulos M, 2007, NEW ENGL J MED, V357, P2123, DOI 10.1056/NEJMoa070594; DURIE BGM, 1975, CANCER, V36, P842, DOI 10.1002/1097-0142(197509)36:3<842::AID-CNCR2820360303>3.0.CO;2-U; ELLIS JH, 1995, J IMMUNOL, V155, P925; Gay F, 2011, BLOOD, V117, P3025, DOI 10.1182/blood-2010-09-307645; Goodell MA, 1996, J EXP MED, V183, P1797, DOI 10.1084/jem.183.4.1797; GOTO T, 1994, BLOOD, V84, P1922; Greipp PR, 2005, J CLIN ONCOL, V23, P3412, DOI 10.1200/JCO.2005.04.242; HAMBURGER A, 1977, J CLIN INVEST, V60, P846, DOI 10.1172/JCI108839; Harada T, 2013, INT J HEMATOL, V97, P743, DOI 10.1007/s12185-013-1321-0; Hsi ED, 2008, CLIN CANCER RES, V14, P2775, DOI 10.1158/1078-0432.CCR-07-4246; Ikegame A, 2012, LEUKEMIA, V26, P2124, DOI 10.1038/leu.2012.78; Ishiguro T, 2010, CANCER SCI, V101, P2227, DOI 10.1111/j.1349-7006.2010.01663.x; Jakubikova J, 2011, BLOOD, V117, P4409, DOI 10.1182/blood-2010-02-267344; Kawai S, 2006, LEUKEMIA RES, V30, P949, DOI 10.1016/j.leukres.2005.11.023; Kawai S, 2008, CANCER SCI, V99, P2461, DOI 10.1111/j.1349-7006.2008.00968.x; Koene HR, 1997, BLOOD, V90, P1109, DOI 10.1182/blood.V90.3.1109.1109_1109_1114; Kumar SK, 2008, BLOOD, V111, P2516, DOI 10.1182/blood-2007-10-116129; Kyle RA, 2003, BRIT J HAEMATOL, V121, P749; Lapalombella R, 2008, BLOOD, V112, P5180, DOI 10.1182/blood-2008-01-133108; Nowakowski GS, 2011, LEUKEMIA, V25, P1877, DOI 10.1038/leu.2011.165; Ohtomo T, 1999, BIOCHEM BIOPH RES CO, V258, P583, DOI 10.1006/bbrc.1999.0683; Ono K, 1999, MOL IMMUNOL, V36, P387, DOI 10.1016/S0161-5890(99)00029-2; Ozaki S, 1997, BLOOD, V90, P3179, DOI 10.1182/blood.V90.8.3179; Ozaki S, 1999, BLOOD, V93, P3922, DOI 10.1182/blood.V93.11.3922.411a32_3922_3930; Palumbo A, 2011, NEW ENGL J MED, V364, P1046, DOI 10.1056/NEJMra1011442; Plesner T, 2012, BLOOD, V120, DOI 10.1182/blood.V120.21.73.73; Powles R, 2001, BLOOD, V98, p165A; Quach H, 2010, LEUKEMIA, V24, P22, DOI 10.1038/leu.2009.236; Raje N, 2012, BLOOD, V120, DOI 10.1182/blood.V120.21.202.202; Tai YT, 2005, CANCER RES, V65, P11712, DOI 10.1158/0008-5472.CAN-05-1657; Tai YT, 2008, BLOOD, V112, P1329, DOI 10.1182/blood-2007-08-107292; Tai YT, 2012, BLOOD, V119, P2074, DOI 10.1182/blood-2011-06-364521; van der Veer MS, 2011, HAEMATOL-HEMATOL J, V96, P284, DOI 10.3324/haematol.2010.030759; Weber DM, 2007, NEW ENGL J MED, V357, P2133, DOI 10.1056/NEJMoa070596; Weiner LM, 2009, LANCET, V373, P1033, DOI 10.1016/S0140-6736(09)60251-8; Weng WK, 2003, J CLIN ONCOL, V21, P3940, DOI 10.1200/JCO.2003.05.013; Zonder JA, 2012, BLOOD, V120, P552, DOI 10.1182/blood-2011-06-360552	44	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e83905	10.1371/journal.pone.0083905	http://dx.doi.org/10.1371/journal.pone.0083905			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281QS	24386306	Green Submitted, Green Published, gold			2022-12-25	WOS:000329116700086
J	Ma, J; Hu, YT; Guo, MX; Huang, Z; Li, WX; Wu, YL				Ma, Jian; Hu, Youtian; Guo, Mingxiong; Huang, Zan; Li, Wenxin; Wu, Yingliang			hERG Potassium Channel Blockage by Scorpion Toxin BmKKx2 Enhances Erythroid Differentiation of Human Leukemia Cells K562	PLOS ONE			English	Article							K+ CHANNEL; HEMATOPOIETIC PROGENITORS; AUTOIMMUNE-DISEASES; REGULATES LINEAGE; MYELOID-LEUKEMIA; STRUCTURAL BASIS; KV1.3 CHANNEL; ION CHANNELS; PEPTIDE; RECOGNITION	Background: The hERG potassium channel can modulate the proliferation of the chronic myelogenous leukemic K562 cells, and its role in the erythroid differentiation of K562 cells still remains unclear. Principal Findings: The hERG potassium channel blockage by a new 36-residue scorpion toxin BmKKx2, a potent hERG channel blocker with IC50 of 6.7 +/- 1.7 nM, enhanced the erythroid differentiation of K562 cells. The mean values of GPA (CD235a) fluorescence intensity in the group of K562 cells pretreated by the toxin for 24 h and followed by cytosine arabinoside (Ara-C) treatment for 72 h were about 2-fold stronger than those of K562 cells induced by Ara-C alone. Such unique role of hERG potassium channel was also supported by the evidence that the effect of the toxin BmKKx2 on cell differentiation was nullified in hERG-deficient cell lines. During the K562 cell differentiation, BmKKx2 could also suppress the expression of hERG channels at both mRNA and protein levels. Besides the function of differentiation enhancement, BmKKx2 was also found to promote the differentiation-dependent apoptosis during the differentiation process of K562 cells. In addition, the blockage of hERG potassium channel by toxin BmKKx2 was able to decrease the intracellular Ca2+ concentration during the K562 cell differentiation, providing an insight into the mechanism of hERG potassium channel regulating this cellular process. Conclusions/Significance: Our results revealed scorpion toxin BmKKx2 could enhance the erythroid differentiation of leukemic K562 cells via inhibiting hERG potassium channel currents. These findings would not only accelerate the functional research of hERG channel in different leukemic cells, but also present the prospects of natural scorpion toxins as anti-leukemic drugs.	[Ma, Jian; Hu, Youtian; Guo, Mingxiong; Li, Wenxin; Wu, Yingliang] Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Peoples R China; [Huang, Zan] Wuhan Univ, Dept Biochem & Mol Biol, Coll Life Sci, Wuhan 430072, Peoples R China	Wuhan University; Wuhan University	Li, WX (corresponding author), Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Peoples R China.	liwxlab@whu.edu.cn; ylwu@whu.edu.cn	Hu, Youtian/G-5408-2014	Huang, Zan/0000-0001-5623-6950	National Basic Research Program of China [2010CB529800]; National High Technology Research and Development Program of China [2012AA020304]; National Natural Sciences Foundation of China [31170789]; New Century Excellent Talents in Wuhan University by the Ministry of Education of China [NCET-10-0651]; Wuhan City Science and Technology Foundation of China [2013070204020046]	National Basic Research Program of China(National Basic Research Program of China); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); New Century Excellent Talents in Wuhan University by the Ministry of Education of China; Wuhan City Science and Technology Foundation of China	This work was supported by grants from the National Basic Research Program of China (2010CB529800), National High Technology Research and Development Program of China (2012AA020304), and National Natural Sciences Foundation of China (number 31170789). New Century Excellent Talents in Wuhan University by the Ministry of Education of China (No. NCET-10-0651), and Wuhan City Science and Technology Foundation of China (No. 2013070204020046). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta JC, 2008, MOL CELL BIOL, V28, P7286, DOI 10.1128/MCB.00752-08; Ashcroft FM, 2006, NATURE, V440, P440, DOI 10.1038/nature04707; Beeton C, 2008, J BIOL CHEM, V283, P988, DOI 10.1074/jbc.M706008200; Bellantuono H, 2004, INT J BIOCHEM CELL B, V36, P607, DOI 10.1016/j.biocel.2003.10.008; Cahalan MD, 2009, IMMUNOL REV, V231, P59, DOI 10.1111/j.1600-065X.2009.00816.x; Cavarra MS, 2007, J MEMBRANE BIOL, V219, P49, DOI 10.1007/s00232-007-9060-x; Crociani O, 2003, J BIOL CHEM, V278, P2947, DOI 10.1074/jbc.M210789200; Fang GF, 2000, BLOOD, V96, P2246, DOI 10.1182/blood.V96.6.2246.h8002246_2246_2253; Feng J, 2013, J BIOL CHEM, V288, P12544, DOI 10.1074/jbc.M112.433888; Gan GL, 2008, J BIOL CHEM, V283, P24177, DOI 10.1074/jbc.M800179200; Han S, 2008, J BIOL CHEM, V283, P19058, DOI 10.1074/jbc.M802054200; Han S, 2010, J PROTEOME RES, V9, P3118, DOI 10.1021/pr100027k; Hattangadi SM, 2011, BLOOD, V118, P6258, DOI 10.1182/blood-2011-07-356006; Hietakangas V, 2003, MOL CELL BIOL, V23, P1278, DOI 10.1128/MCB.23.4.1278-1291.2003; Hodge D, 2006, BLOOD, V107, P3359, DOI 10.1182/blood-2005-07-2888; Huang M, 2004, LEUKEMIA, V18, P1857, DOI 10.1038/sj.leu.2403490; Jimenez-Vargas JM, 2012, TOXICON, V60, P492, DOI 10.1016/j.toxicon.2012.03.024; Kamiya K, 2006, MOL PHARMACOL, V69, P1709, DOI 10.1124/mol.105.020990; Kaneko H, 2010, CURR OPIN HEMATOL, V17, P163, DOI 10.1097/MOH.0b013e32833800b8; Korolkova YV, 2001, J BIOL CHEM, V276, P9868, DOI 10.1074/jbc.M005973200; Li HY, 2008, INT J HEMATOL, V87, P387, DOI 10.1007/s12185-008-0056-9; Li Z, 2012, J BIOL CHEM, V287, P29479, DOI 10.1074/jbc.M112.379594; Manabe Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052592; Mouhat S, 2008, CURR PHARM DESIGN, V14, P2503, DOI 10.2174/138161208785777441; Park KS, 2011, MOL CELLS, V32, P181, DOI 10.1007/s10059-011-0068-9; Pillozzi S, 2002, LEUKEMIA, V16, P1791, DOI 10.1038/sj.leu.2402572; Pillozzi S, 2007, BLOOD, V110, P1238, DOI 10.1182/blood-2006-02-003772; Schmitz A, 2005, MOL PHARMACOL, V68, P1254, DOI 10.1124/mol.105.015669; Shieh CC, 2000, PHARMACOL REV, V52, P557; Smith GAM, 2002, J BIOL CHEM, V277, P18528, DOI 10.1074/jbc.M200592200; Walters MJ, 2002, DEVELOPMENT, V129, P1455; Wayman GA, 2000, J CELL BIOL, V151, P811, DOI 10.1083/jcb.151.4.811; Wulff H, 2008, CHEM REV, V108, P1744, DOI 10.1021/cr078234p; Yao XQ, 2000, J BIOL CHEM, V275, P10859, DOI 10.1074/jbc.275.15.10859; Yi H, 2008, PROTEINS, V70, P844, DOI 10.1002/prot.21706; Yi H, 2007, J PROTEOME RES, V6, P611, DOI 10.1021/pr060368g; Yin SJ, 2008, J PROTEOME RES, V7, P4890, DOI 10.1021/pr800494a; Zeng XC, 2006, PEPTIDES, V27, P1745, DOI 10.1016/j.peptides.2006.01.012; Zeng Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029518	39	8	9	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e84903	10.1371/journal.pone.0084903	http://dx.doi.org/10.1371/journal.pone.0084903			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281QS	24386436	gold, Green Published, Green Submitted			2022-12-25	WOS:000329116700126
J	Zschorlich, VR; Kohling, R				Zschorlich, Volker R.; Koehling, Ruediger			How Thoughts Give Rise to Action - Conscious Motor Intention Increases the Excitability of Target-Specific Motor Circuits	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; EVOKED-POTENTIALS; CORTICOSPINAL EXCITABILITY; CORTEX EXCITABILITY; MOVEMENT PREPARATION; MENTAL-IMAGERY; H-REFLEXES; MUSCLE; FACILITATION; AWARENESS	The present study shows evidence for conscious motor intention in motor preparation prior to movement execution. We demonstrate that conscious motor intention of directed movement, combined with minimally supra-threshold transcranial magnetic stimulation (TMS) of the motor cortex, determines the direction and the force of resulting movements, whilst a lack of intention results in weak and omni-directed muscle activation. We investigated changes of consciously intended goal directed movements by analyzing amplitudes of motor-evoked potentials of the forearm muscle, flexor carpi radialis (FCR), and extensor carpi radialis (ECR), induced by transcranial magnetic stimulation over the right motor cortex and their motor outcome. Right-handed subjects were asked to develop a strong intention to move their left wrist (flexion or extension), without any overt motor output at the wrist, prior to brain stimulation. Our analyses of hand acceleration and electromyography showed that during the strong motor intention of wrist flexion movement, it evoked motor potential responses that were significantly larger in the FCR muscle than in the ECR, whilst the opposite was true for an extension movement. The acceleration data on flexion/extension corresponded to this finding. Under no-intention conditions again, which served as a reference for motor evoked potentials, brain stimulation resulted in undirected and minimally simultaneous extension/flexion innervation and virtually no movement. These results indicate that conscious intentions govern motor function, which in turn shows that a neuronal activation representing an "intention network" in the human brain pre-exists, and that it functionally represents target specific motor circuits. Until today, it was unclear whether conscious motor intention exists prior to movement, or whether the brain constructs such an intention after movement initiation. Our study gives evidence that motor intentions become aware before any motor execution.	[Zschorlich, Volker R.] Univ Rostock, Dept Movement Sci, D-18055 Rostock, Germany; [Zschorlich, Volker R.; Koehling, Ruediger] Univ Rostock, Dept Aging Sci, Interdisciplinary Fac, D-18055 Rostock, Germany; [Zschorlich, Volker R.; Koehling, Ruediger] Univ Rostock, Fac Med, D-18055 Rostock, Germany; [Zschorlich, Volker R.] Univ Rostock, Fac Philosophy, D-18055 Rostock, Germany; [Koehling, Ruediger] Univ Rostock, Oscar Langendorff Inst Physiol, D-18055 Rostock, Germany	University of Rostock; University of Rostock; University of Rostock; University of Rostock; University of Rostock	Zschorlich, VR (corresponding author), Univ Rostock, Dept Movement Sci, D-18055 Rostock, Germany.	volker.zschorlich@uni-rostock.de; ruediger.koehling@uni-rostock.de	, volker.zschorlich@uni-rostock.de/ABH-8796-2020; Köhling, Rüdiger/K-8647-2013	, volker.zschorlich@uni-rostock.de/0000-0001-8158-6223; Köhling, Rüdiger/0000-0003-3330-4898				AMMON K, 1990, J NEUROL NEUROSUR PS, V53, P705, DOI 10.1136/jnnp.53.8.705; Aranyi Z, 1998, MUSCLE NERVE, V21, P1309, DOI 10.1002/(SICI)1097-4598(199810)21:10<1309::AID-MUS10>3.0.CO;2-X; Auksztulewicz R, 2012, J NEUROSCI, V32, P799, DOI 10.1523/JNEUROSCI.3974-11.2012; Becchio C, 2008, COGNITION, V106, P894, DOI 10.1016/j.cognition.2007.05.004; Bonnard M, 2009, EUR J NEUROSCI, V30, P913, DOI 10.1111/j.1460-9568.2009.06864.x; Boussaoud D, 2001, NEUROIMAGE, V14, pS40, DOI 10.1006/nimg.2001.0816; BRASILNETO JP, 1992, J NEUROL NEUROSUR PS, V55, P964, DOI 10.1136/jnnp.55.10.964; Brooke JD, 2000, J ELECTROMYOGR KINES, V10, P211, DOI 10.1016/S1050-6411(00)00005-5; CASTIELLO U, 1991, BRAIN, V114, P2639, DOI 10.1093/brain/114.6.2639; CASTIELLO U, 1991, NEUROREPORT, V2, P797, DOI 10.1097/00001756-199112000-00017; Cisek P, 2010, ANNU REV NEUROSCI, V33, P269, DOI 10.1146/annurev.neuro.051508.135409; Collinger JL, 2013, LANCET, V381, P557, DOI 10.1016/S0140-6736(12)61816-9; Crammond DJ, 2000, J NEUROPHYSIOL, V84, P986, DOI 10.1152/jn.2000.84.2.986; Cros D, 2007, BRAIN RES, V1185, P103, DOI 10.1016/j.brainres.2007.09.003; Decety J, 1996, BEHAV BRAIN RES, V77, P45, DOI 10.1016/0166-4328(95)00225-1; Desmurget M, 2013, J COGNITIVE NEUROSCI, V25, P830, DOI 10.1162/jocn_a_00368; Desmurget M, 2012, CURR OPIN NEUROBIOL, V22, P1004, DOI 10.1016/j.conb.2012.06.006; Desmurget M, 2009, TRENDS COGN SCI, V13, P411, DOI 10.1016/j.tics.2009.08.001; Ethier C, 2012, NATURE, V485, P368, DOI 10.1038/nature10987; Facchini S, 2002, ACTA NEUROL SCAND, V105, P146, DOI 10.1034/j.1600-0404.2002.1o004.x; Fadiga L, 1999, NEUROPSYCHOLOGIA, V37, P147; Filippi MM, 2001, NEUROLOGY, V57, P55, DOI 10.1212/WNL.57.1.55; FRIED I, 1991, J NEUROSCI, V11, P3656; Fried I, 2011, NEURON, V69, P548, DOI 10.1016/j.neuron.2010.11.045; Gabbard C, 2009, CONSCIOUS COGN, V18, P300, DOI 10.1016/j.concog.2008.07.003; Gallivan JP, 2011, J NEUROSCI, V31, P9599, DOI 10.1523/JNEUROSCI.0080-11.2011; GANDEVIA SC, 1987, BRAIN, V110, P1117, DOI 10.1093/brain/110.5.1117; Graziano MSA, 2002, NEURON, V36, P349, DOI 10.1016/S0896-6273(02)01003-6; Haggard P, 1999, EXP BRAIN RES, V126, P128, DOI 10.1007/s002210050722; Hasegawa Y, 2001, EXP BRAIN RES, V140, P387, DOI 10.1007/s002210100842; Herrmann CS, 2008, INT J PSYCHOPHYSIOL, V67, P151, DOI 10.1016/j.ijpsycho.2007.10.013; HESS CW, 1987, J PHYSIOL-LONDON, V388, P397, DOI 10.1113/jphysiol.1987.sp016621; Hetu S, 2013, NEUROSCI BIOBEHAV R, V37, P930, DOI 10.1016/j.neubiorev.2013.03.017; Hochberg LR, 2012, NATURE, V485, P372, DOI 10.1038/nature11076; Holl N, 2011, EXP BRAIN RES, V210, P229, DOI 10.1007/s00221-011-2618-y; JEANNEROD M, 1995, NEUROPSYCHOLOGIA, V33, P1419, DOI 10.1016/0028-3932(95)00073-C; Jeannerod M, 2006, MOTOR COGNITION WHAT, DOI 10.1093/acprof:oso/9780198569657.001.0001/acprof-9780198569657; Kamen G, 2004, MED SCI SPORT EXER, V36, P1574, DOI 10.1249/01.MSS.0000139804.02576.6A; Kasai T, 1997, BRAIN RES, V744, P147, DOI 10.1016/S0006-8993(96)01101-8; Kaufman MT, 2010, J NEUROPHYSIOL, V104, P799, DOI 10.1152/jn.00231.2009; Kaufman MT, 2013, J NEUROPHYS IN PRESS, DOI [10.1152/jn.00892.2011, DOI 10.1152/JN.00892.2011)]; KORNHUBE.HH, 1965, PFLUG ARCH GES PHYS, V284, P1, DOI 10.1007/BF00412364; Lau HC, 2004, SCIENCE, V303, P1208, DOI 10.1126/science.1090973; Li S, 2004, J NEUROSCI, V24, P9674, DOI 10.1523/JNEUROSCI.2781-04.2004; LIBET B, 1983, BRAIN, V106, P623, DOI 10.1093/brain/106.3.623; MacKinnon CD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063417; Merletti R., 2004, ELECTROMYOGRAPHY PHY, DOI [10.1002/0471678384, DOI 10.1002/0471678384.CH5]; Moritz CT, 2008, NATURE, V456, P639, DOI 10.1038/nature07418; Muellbacher W, 2000, CLIN NEUROPHYSIOL, V111, P1002, DOI 10.1016/S1388-2457(00)00284-4; Munzert J, 2009, BRAIN RES REV, V60, P306, DOI 10.1016/j.brainresrev.2008.12.024; Nicolelis MAL, 2001, NATURE, V409, P403, DOI 10.1038/35053191; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Overduin SA, 2012, NEURON, V76, P1071, DOI 10.1016/j.neuron.2012.10.018; Park WH, 2011, NEUROSCI LETT, V494, P255, DOI 10.1016/j.neulet.2011.03.027; PASCUALLEONE A, 1992, BRAIN, V115, P1045, DOI 10.1093/brain/115.4.1045; Patuzzo S, 2003, NEUROPSYCHOLOGIA, V41, P1272, DOI 10.1016/S0028-3932(02)00293-2; Ramos-Estebanez C, 2007, J NEUROSCI, V27, P4178, DOI 10.1523/JNEUROSCI.5468-06.2007; Ricciardi E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058632; Schlegel A, 2013, EXPT BRAIN RES, V229, P1; Schneider L, 2013, J COGNITIVE NEUROSCI, V25, P822, DOI 10.1162/jocn_a_00360; Searle John, 1983, INTENTIONALITY; Senot P, 2011, EXP BRAIN RES, V211, P161, DOI 10.1007/s00221-011-2635-x; Sohn YH, 2003, J NEUROPHYSIOL, V90, P2303, DOI 10.1152/jn.00206.2003; Sparing R, 2002, BRAIN RES, V938, P92, DOI 10.1016/S0006-8993(02)02478-2; Stinear CM, 2003, CLIN NEUROPHYSIOL, V114, P909, DOI 10.1016/S1388-2457(02)00373-5; Sugawara K, 2002, HUM MOVEMENT SCI, V21, P203, DOI 10.1016/S0167-9457(02)00099-4; Trevena JA, 2002, CONSCIOUS COGN, V11, P162, DOI 10.1006/ccog.2002.0548; Trevena J, 2010, CONSCIOUS COGN, V19, P447, DOI 10.1016/j.concog.2009.08.006; Urbach D, 2002, EXP BRAIN RES, V142, P25, DOI 10.1007/s00221-001-0911-x; van Elswijk G, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-51; Wegner DM, 2003, TRENDS COGN SCI, V7, P65, DOI 10.1016/S1364-6613(03)00002-0; Yahagi S, 1999, NEUROSCI LETT, V276, P185, DOI 10.1016/S0304-3940(99)00823-X; Yahagi S, 1996, PERCEPT MOTOR SKILL, V83, P288, DOI 10.2466/pms.1996.83.1.288; Yoo SS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060410; ZSCHORLICH V R, 1989, Electromyography and Clinical Neurophysiology, V29, P81	75	12	12	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e83845	10.1371/journal.pone.0083845	http://dx.doi.org/10.1371/journal.pone.0083845			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	281QS	24386291	gold, Green Published, Green Submitted			2022-12-25	WOS:000329116700082
J	Kowalczyk-Quintas, C; Willen, L; Dang, AT; Sarrasin, H; Tardivel, A; Hermes, K; Schneider, H; Gaide, O; Donze, O; Kirby, N; Headon, DJ; Schneider, P				Kowalczyk-Quintas, Christine; Willen, Laure; Anh Thu Dang; Sarrasin, Heidi; Tardivel, Aubry; Hermes, Katharina; Schneider, Holm; Gaide, Olivier; Donze, Olivier; Kirby, Neil; Headon, Denis J.; Schneider, Pascal			Generation and Characterization of Function-blocking Anti-ectodysplasin A (EDA) Monoclonal Antibodies That Induce Ectodermal Dysplasia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Antibodies; Embryo; Receptors; Tooth; Tumor Necrosis Factor (TNF)	HAIR FOLLICLE INDUCTION; KAPPA-B; SIGNALING PATHWAYS; SHH EXPRESSION; FEATHER TRACT; GENE; RECEPTOR; MOUSE; MUTATIONS; HOMOLOG	Background: The TNF family ligand EDA1 is required for development of hair, teeth, and many glands. Results: Mouse fetuses exposed to anti-EDA antibodies develop a permanent ectodermal dysplasia. Conclusion: Monoclonal anti-EDA antibodies block EDA at stoichiometric ratio in vitro and in vivo. Significance: Down-modulation of EDA has useful research and potentially therapeutic applications. Development of ectodermal appendages, such as hair, teeth, sweat glands, sebaceous glands, and mammary glands, requires the action of the TNF family ligand ectodysplasin A (EDA). Mutations of the X-linked EDA gene cause reduction or absence of many ectodermal appendages and have been identified as a cause of ectodermal dysplasia in humans, mice, dogs, and cattle. We have generated blocking antibodies, raised in Eda-deficient mice, against the conserved, receptor-binding domain of EDA. These antibodies recognize epitopes overlapping the receptor-binding site and prevent EDA from binding and activating EDAR at close to stoichiometric ratios in in vitro binding and activity assays. The antibodies block EDA1 and EDA2 of both mammalian and avian origin and, in vivo, suppress the ability of recombinant Fc-EDA1 to rescue ectodermal dysplasia in Eda-deficient Tabby mice. Moreover, administration of EDA blocking antibodies to pregnant wild type mice induced in developing wild type fetuses a marked and permanent ectodermal dysplasia. These function-blocking anti-EDA antibodies with wide cross-species reactivity will enable study of the developmental and postdevelopmental roles of EDA in a variety of organisms and open the route to therapeutic intervention in conditions in which EDA may be implicated.	[Kowalczyk-Quintas, Christine; Willen, Laure; Anh Thu Dang; Sarrasin, Heidi; Tardivel, Aubry; Schneider, Pascal] Univ Lausanne, Dept Biochem, CH-1066 Epalinges, Switzerland; [Hermes, Katharina; Schneider, Holm] Univ Hosp Erlangen, Dept Pediat, D-91054 Erlangen, Germany; [Gaide, Olivier] Univ Lausanne, Dept Dermatol, CH-1011 Lausanne, Switzerland; [Donze, Olivier] Adipogen, CH-1066 Epalinges, Switzerland; [Kirby, Neil] Edimer Pharmaceut, Cambridge, MA 02142 USA; [Headon, Denis J.] Univ Edinburgh, Roslin Inst, Roslin EH25 9RG, Midlothian, Scotland; [Headon, Denis J.] Univ Edinburgh, Royal Dick Sch Vet Studies, Roslin EH25 9RG, Midlothian, Scotland	University of Lausanne; University of Erlangen Nuremberg; University of Lausanne; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Edinburgh	Schneider, P (corresponding author), Univ Lausanne, Dept Biochem, Boveresses 155, CH-1066 Epalinges, Switzerland.	pascal.schneider@unil.ch		Schneider, Pascal/0000-0003-0677-9409	Swiss National Science Foundation; Edimer Pharmaceuticals; Biotechnology and Biological Sciences Research Council [BBS/E/D/20221657, BB/J017183/1] Funding Source: researchfish; BBSRC [BBS/E/D/20221657, BB/J017183/1] Funding Source: UKRI	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Edimer Pharmaceuticals; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by grants from the Swiss National Science Foundation (to P. S.) and by project funding from Edimer Pharmaceuticals (to O. G., H. S., D. H., and P. S.). O. G. and P. S. are shareholders of Edimer Pharmaceuticals. N. K. is shareholder, director, and employee of Edimer Pharmaceuticals. H. S. is a member of the clinical advisory board of Edimer Pharmaceuticals.	Bossen C, 2006, J BIOL CHEM, V281, P13964, DOI 10.1074/jbc.M601553200; Casal ML, 2007, AM J HUM GENET, V81, P1050, DOI 10.1086/521988; Chen YW, 2001, P NATL ACAD SCI USA, V98, P7218, DOI 10.1073/pnas.131076098; Colosimo PF, 2005, SCIENCE, V307, P1928, DOI 10.1126/science.1107239; Cui CY, 2003, HUM MOL GENET, V12, P2931, DOI 10.1093/hmg/ddg325; Ferguson BM, 1997, HUM MOL GENET, V6, P1589, DOI 10.1093/hmg/6.9.1589; Fessing MY, 2006, AM J PATHOL, V169, P2075, DOI 10.2353/ajpath.2006.060227; Gaide O, 2003, NAT MED, V9, P614, DOI 10.1038/nm861; Hammerschmidt B, 2007, DEV BIOL, V305, P246, DOI 10.1016/j.ydbio.2007.02.010; Hashimoto T, 2008, CELL CYCLE, V7, P106, DOI 10.4161/cc.7.1.5135; Headon DJ, 1999, NAT GENET, V22, P370, DOI 10.1038/11943; Headon DJ, 2001, NATURE, V414, P913, DOI 10.1038/414913a; Heath J, 2009, J INVEST DERMATOL, V129, P2358, DOI 10.1038/jid.2009.102; Hill NL, 2002, J COMP PATHOL, V126, P220, DOI 10.1053/jcpa.2001.0531; Houghton L, 2005, DEVELOPMENT, V132, P863, DOI 10.1242/dev.01651; Houghton L, 2007, DEV DYNAM, V236, P3020, DOI 10.1002/dvdy.21337; Huelsken J, 2001, CELL, V105, P533, DOI 10.1016/S0092-8674(01)00336-1; Hymowitz SG, 2003, STRUCTURE, V11, P1513, DOI 10.1016/j.str.2003.11.009; Israel EJ, 1997, IMMUNOLOGY, V92, P69, DOI 10.1046/j.1365-2567.1997.00326.x; Kere J, 1996, NAT GENET, V13, P409, DOI 10.1038/ng0895-409; Kowalczyk C, 2011, J BIOL CHEM, V286, P30769, DOI 10.1074/jbc.M111.267997; KRAEHENBUHL JP, 1969, J CELL BIOL, V42, P345, DOI 10.1083/jcb.42.2.345; Monreal AW, 1998, AM J HUM GENET, V63, P380, DOI 10.1086/301984; Morrison S. L., 2002, CURRENT PROTOCOLS IM, V47; Mou C, 2006, P NATL ACAD SCI USA, V103, P9075, DOI 10.1073/pnas.0600825103; Mues G, 2010, EUR J HUM GENET, V18, P19, DOI 10.1038/ejhg.2009.127; NAKATA M, 1980, AM J HUM GENET, V32, P908; Newton K, 2004, MOL CELL BIOL, V24, P1608, DOI 10.1128/MCB.24.4.1608-1613.2004; Pantalacci S, 2008, MOL BIOL EVOL, V25, P912, DOI 10.1093/molbev/msn038; PINHEIRO M, 1979, AM J MED GENET, V4, P113, DOI 10.1002/ajmg.1320040202; Pispa J, 1999, DEV BIOL, V216, P521, DOI 10.1006/dbio.1999.9514; Pispa J, 2008, HUM MOL GENET, V17, P3380, DOI 10.1093/hmg/ddn232; Pummila M, 2007, DEVELOPMENT, V134, P117, DOI 10.1242/dev.02708; Rawlins EL, 2005, DEV DYNAM, V233, P1378, DOI 10.1002/dvdy.20461; Schmidt-Ullrich R, 2006, DEVELOPMENT, V133, P1045, DOI 10.1242/dev.02278; Schneider P, 2000, METHOD ENZYMOL, V322, P325; Schneider P, 2001, J BIOL CHEM, V276, P18819, DOI 10.1074/jbc.M101280200; Schneider P, 1998, J EXP MED, V187, P1205, DOI 10.1084/jem.187.8.1205; Srivastava AK, 1997, P NATL ACAD SCI USA, V94, P13069, DOI 10.1073/pnas.94.24.13069; Swee LK, 2009, J BIOL CHEM, V284, P27567, DOI 10.1074/jbc.M109.042259; Tucker AS, 2000, DEVELOPMENT, V127, P4691; Wang ZD, 2000, J IMMUNOL METHODS, V233, P167, DOI 10.1016/S0022-1759(99)00184-2; Yan MH, 2000, SCIENCE, V290, P523, DOI 10.1126/science.290.5491.523; Zankl A, 2001, EUR J PEDIATR, V160, P296, DOI 10.1007/s004310100738; Zhang YH, 2009, DEV CELL, V17, P49, DOI 10.1016/j.devcel.2009.05.011	45	23	27	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 14	2014	289	7					4273	4285		10.1074/jbc.M113.535740	http://dx.doi.org/10.1074/jbc.M113.535740			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA9HG	24391090	Green Published, hybrid			2022-12-25	WOS:000331403800038
J	Fiorentino, M; Bastard, G; Sembene, M; Fortin, S; Traissac, P; Landais, E; Icard-Verniere, C; Wieringa, FT; Berger, J				Fiorentino, Marion; Bastard, Guillaume; Sembene, Malick; Fortin, Sonia; Traissac, Pierre; Landais, Edwige; Icard-Verniere, Christele; Wieringa, Frank T.; Berger, Jacques			Anthropometric and Micronutrient Status of School-Children in an Urban West Africa Setting: A Cross-Sectional Study in Dakar (Senegal)	PLOS ONE			English	Article							VITAMIN-A-DEFICIENCY; PRIMARY-SCHOOL CHILDREN; IRON-DEFICIENCY; TRANSFERRIN RECEPTOR; NUTRITIONAL-STATUS; ZINC-DEFICIENCY; AGED CHILDREN; PREVALENCE; RETINOL; INDICATORS	Background: Urban areas in West Africa are not immune to undernutrition with recent urbanization and high food prices being important factors. School children often have a poor nutritional status, potentially affecting their health and schooling performance. Yet, generally school children do not benefit from nutrition programs. The objective of the study was to assess the anthropometric and micronutrient status of children from state schools in the Dakar area. Methods: School children (n = 604) aged from 5 to 17 y (52.5% girls, 47.5% >= 10 y) were selected through a two-stage random cluster sample of children attending urban primary state schools in the Dakar area (30 schools x 20 children). The prevalence of stunting (height-for-age <-2 z-scores) and thinness (BMI-for-age, <-2 z-scores, WHO 2006, and three grades of thinness corresponding to BMI of 18.5, 17.0 and 16.0 kg/m2 in adults) were calculated from weight and height. Hemoglobin, plasma concentrations of ferritin (FER), transferrin receptors (TfR), retinol binding protein (RBP), and zinc, and urinary iodine concentrations were measured. Correction factors were used for FER and RBP in subjects with inflammation determined with C-reactive protein and alpha 1-acid-glycoprotein. Results: 4.9% of children were stunted, 18.4% were thin, 5.6% had severe thinness (BMI-for-age,<-3 z-scores). Only one child had a BMI-for-age. > 2 z-scores. Prevalence of anemia, iron deficiency and iron deficiency anemia was 14.4%, 39.1% and 10.6% respectively. 3.0% had vitamin A deficiency, 35.9% a marginal vitamin A status, and 25.9% zinc deficiency. Urinary iodine was, < 50 mu g/L in 7.3% of children and >= 200 mu g/L in 22.3%. The prevalence of marginal vitamin A, zinc deficiency, high TfR was significantly higher in boys than in girls (P < 0.05). Height-for-age and retinol were significantly lower in participants >= 10 y and < 10 y respectively. Conclusion: Undernutrition, especially thinness, iron and zinc deficiencies in school children in the Dakar area requires special targeted nutrition interventions.	[Fiorentino, Marion; Bastard, Guillaume] GRET, Dakar, Senegal; [Sembene, Malick] Minist Educ Natl, DCMS, Dakar, Senegal; [Fortin, Sonia; Traissac, Pierre; Landais, Edwige; Icard-Verniere, Christele; Wieringa, Frank T.; Berger, Jacques] IRD UM2 UM1, UMR Nutripass 204, IRD, Montpellier, France	Institut de Recherche pour le Developpement (IRD); Universite de Montpellier	Fiorentino, M (corresponding author), GRET, Dakar, Senegal.	marionfiorentino@hotmail.com	Wieringa, Frank Tammo/K-7565-2017; Bastard, Gerald A/K-8983-2017; ICARD-VERNIERE, Christèle CV/A-2625-2011; landais, edwige/AAK-2356-2020	Wieringa, Frank Tammo/0000-0002-6010-355X; ICARD-VERNIERE, Christèle CV/0000-0002-5626-6639; landais, edwige/0000-0002-7291-2012; fiorentino, marion/0000-0002-1615-4579; Traissac, Pierre/0000-0002-3184-5597	Danone	Danone(Danone Nutricia)	The study was funded by Danone. www.danone.com www.danonecommunities.com The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2007, ASS IOD DEF DIS MON; [Anonymous], 2004, ASS IR STAT POP INCL; ANSD, 2009, SIT EC SOC REG DAK A; Becquey E, 2010, IMP HAUSS PRIX SEC A, V140, p2079S; Becquey E, 2010, J NUTR, V140, p2079S, DOI 10.3945/jn.110.123356; Benkhala A, 2009, MEMOIRE DEA; Benkhala A., 2009, RECHERCHER REPONSES; Best C, 2010, FOOD NUTR BULL, V31, P400, DOI 10.1177/156482651003100303; Black RE, 2001, BRIT J NUTR, V85, pS125, DOI 10.1079/BJN2000304; Bovet P, 2011, NUTR J, V10, DOI 10.1186/1475-2891-10-65; Bryan J, 2004, NUTR REV, V62, P295, DOI [10.1301/nr.2004.aug.295-306, 10.1111/j.1753-4887.2004.tb00055.x]; CAVAN KR, 1993, AM J CLIN NUTR, V57, P334, DOI 10.1093/ajcn/57.3.334; Cole TJ, 2007, BMJ-BRIT MED J, V335, P194, DOI 10.1136/bmj.39238.399444.55; Cook JD, 2003, BLOOD, V101, P3359, DOI 10.1182/blood-2002-10-3071; Dabone C, 2011, NUTR J, V10, DOI 10.1186/1475-2891-10-34; de Benoist B, 2008, WHO GLOBAL DATABASE; de Benoist B, 2007, FOOD NUTR BULL, V28, pS480, DOI 10.1177/15648265070283S306; de Onis M, 2007, B WORLD HEALTH ORGAN, V85, P660, DOI 10.2471/BLT.07.043497; de Pee S, 2002, J NUTR, V132, p2895S, DOI 10.1093/jn/132.9.2895S; Diagne I, 2003, MED TROPICALE, P513; Dijkhuizen MA, 2001, AM J CLIN NUTR, V73, P786; Dreyfuss ML, 2000, J NUTR, V130, P2527, DOI 10.1093/jn/130.10.2527; El Hioui M, 2008, East Afr J Public Health, V5, P62; Erhardt JG, 2004, J NUTR, V134, P3127, DOI 10.1093/jn/134.11.3127; FAO, 1999, DEV FOOD INS VULN MA; Gibson RS, 2007, BRIT J NUTR, V97, P167, DOI 10.1017/S0007114507250445; Gibson RS, PRINCIPLES NUTR ASSE, P378; Gordon RC, 2009, AM J CLIN NUTR, V90, P1264, DOI 10.3945/ajcn.2009.28145; Idohou-Dossou N, 2003, BRIT J NUTR, V90, P1123, DOI 10.1079/BJN2003990; International Zinc Nutrition Consultative Group (IZiNCG), 2004, Food Nutr Bull, V25, pS99; Kaiser R, 2006, DISASTERS, V30, P199, DOI 10.1111/j.0361-3666.2006.00315.x; Kassaye T, 2001, B WORLD HEALTH ORGAN, V79, P415; Martorell R, FOOD NUTR B, V20; Pandey A, 1996, Indian J Public Health, V40, P13; Pino S, 1996, CLIN CHEM, V42, P239; Qin Y, 2009, ASIA PAC J CLIN NUTR, V18, P15; Thurlow RA, 2006, EUR J CLIN NUTR, V60, P623, DOI 10.1038/sj.ejcn.1602361; Thurnham DI, 2010, AM J CLIN NUTR, V92, P546, DOI 10.3945/ajcn.2010.29284; Thurnham DI, 2003, LANCET, V362, P2052, DOI 10.1016/S0140-6736(03)15099-4; UNDP, 2011, HUMAN DEV REPORT; WAHED MA, 1995, AM J CLIN NUTR, V61, P1253, DOI 10.1093/ajcn/61.6.1253; WFP/UNICEF/FAO/ANSD, 2008, PROF NUTR SEN; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; WHO, 2012, SEN STAT; Wieringa FT, 2007, BRIT J NUTR, V98, P1070, DOI 10.1017/S0007114507756945; World Health Organization, 2011, HAEM CONC DIAGN AN A; World Health Organization, 2001, 2 DEC IMPR AD HLTH D; World Health Organization, 2010, AN NUTR LANDSC INF S; Zimmermann MB, 2005, AM J CLIN NUTR, V81, P615; Zimmermann MB, 2008, LANCET, V372, P1251, DOI 10.1016/S0140-6736(08)61005-3	50	19	19	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84328	10.1371/journal.pone.0084328	http://dx.doi.org/10.1371/journal.pone.0084328			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391938	Green Published, gold, Green Submitted			2022-12-25	WOS:000329323900081
J	Kisiel-Sajewicz, K; Siemionow, V; Seyidova-Khoshknabi, D; Davis, MP; Wyant, A; Ranganathan, VK; Walsh, D; Yan, JH; Hou, J; Yue, GH				Kisiel-Sajewicz, Katarzyna; Siemionow, Vlodek; Seyidova-Khoshknabi, Dilara; Davis, Mellar P.; Wyant, Alexandria; Ranganathan, Vinoth K.; Walsh, Declan; Yan, Jin H.; Hou, Juliet; Yue, Guang H.			Myoelectrical Manifestation of Fatigue Less Prominent in Patients with Cancer Related Fatigue	PLOS ONE			English	Article							MOTOR-UNIT RECRUITMENT; ELBOW FLEXOR MUSCLES; HUMAN BICEPS-BRACHII; CONDUCTION-VELOCITY; SUPRASPINAL FACTORS; FREQUENCY CONTENT; EMG AMPLITUDE; TASK FAILURE; FORCE; MECHANISMS	Purpose: A lack of fatigue-related muscle contractile property changes at time of perceived physical exhaustion and greater central than peripheral fatigue detected by twitch interpolation technique have recently been reported in cancer survivors with fatigue symptoms. Based on these observations, it was hypothesized that compared to healthy people, myoelectrical manifestation of fatigue in the performing muscles would be less significant in these individuals while sustaining a prolonged motor task to self-perceived exhaustion (SPE) since their central fatigue was more prominent. The purpose of this study was to test this hypothesis by examining electromyographic (EMG) signal changes during fatiguing muscle performance. Methods: Twelve individuals who had advanced solid cancer and cancer-related fatigue (CRF), and 12 age-and gender-matched healthy controls performed a sustained elbow flexion at 30% maximal voluntary contraction till SPE. Amplitude and mean power frequency (MPF) of EMG signals of the biceps brachii, brachioradialis, and triceps brachii muscles were evaluated when the individuals experienced minimal, moderate, and severe fatigue. Results: CRF patients perceived physical "exhaustion" significantly sooner than the controls. The myoelectrical manifestation of muscular fatigue assessed by EMG amplitude and MPF was less significant in CRF than controls. The lower MPF even at minimal fatigue stage in CRF may indicate pathophysiologic condition of the muscle. Conclusions: CRF patients experience less myoelectrical manifestation of muscle fatigue than healthy individuals near the time of SPE. The data suggest that central nervous system fatigue plays a more important role in limiting endurance-type of motor performance in patients with CRF.	[Kisiel-Sajewicz, Katarzyna; Siemionow, Vlodek; Wyant, Alexandria; Ranganathan, Vinoth K.; Yue, Guang H.] Cleveland Clin, Lerner Res Inst, Dept Biomed Engn, Cleveland, OH 44106 USA; [Seyidova-Khoshknabi, Dilara; Davis, Mellar P.; Walsh, Declan] Cleveland Clin, Taussig Canc Ctr, Harry R Horvitz Ctr Palliat Med, Cleveland, OH 44106 USA; [Siemionow, Vlodek; Ranganathan, Vinoth K.; Hou, Juliet; Yue, Guang H.] Cleveland Clin, Neurol Inst, Dept Phys Med & Rehabil, Cleveland, OH 44106 USA; [Kisiel-Sajewicz, Katarzyna] Univ Sch Phys Educ Wroclaw, Fac Physiotherapy, Dept Kinesiol, Wroclaw, Poland; [Yan, Jin H.] Shenzhen Univ, Inst Affect & Social Neurosci, Shenzhen, Peoples R China; [Yan, Jin H.] Tsinghuan Univ, Dept Psychol, Beijing, Peoples R China; [Yue, Guang H.] Kessler Fdn Res Ctr, W Orange, NJ USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Shenzhen University; Tsinghua University; Kessler Institute for Rehabilitation	Yan, JH (corresponding author), Shenzhen Univ, Inst Affect & Social Neurosci, Shenzhen, Peoples R China.	jin.yan@sjsu.edu; gyue@kesslerfoundation.org		Walsh, (Thomas) Declan/0000-0002-9310-1729; Seyidova-Khoshknabi, Dilara/0000-0003-2291-2185; Kisiel-Sajewicz, Katarzyna/0000-0002-3137-2646	Cleveland Clinic grant [RPC6700]; Ministry of Science and Higher Education of Republic of Poland [10/MOB/2007/0]	Cleveland Clinic grant; Ministry of Science and Higher Education of Republic of Poland(Ministry of Science and Higher Education, Poland)	This study was supported by a Cleveland Clinic grant [RPC6700]; and a Ministry of Science and Higher Education grant [10/MOB/2007/0] of Republic of Poland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amann M, 2009, J PHYSIOL-LONDON, V587, P271, DOI 10.1113/jphysiol.2008.163303; Andreasen AK, 2009, MULT SCLER J, V15, P818, DOI 10.1177/1352458509105383; Bilodeau M, 2003, J ELECTROMYOGR KINES, V13, P83, DOI 10.1016/S1050-6411(02)00050-0; Bilodeau M, 2001, J APPL PHYSIOL, V91, P2654, DOI 10.1152/jappl.2001.91.6.2654; Botter A, 2009, INT J SPORTS MED, V30, P408, DOI 10.1055/s-0028-1112142; BROMAN H, 1985, J APPL PHYSIOL, V58, P1428, DOI 10.1152/jappl.1985.58.5.1428; BUCHTHAL F, 1950, ELECTROEN CLIN NEURO, V2, P425, DOI 10.1016/0013-4694(50)90079-4; Burke R. E., 1981, HDB PHYSL NERVOUS SY, VII, P354; Cheville AL, 2008, J CLIN ONCOL, V26, P2621, DOI 10.1200/JCO.2007.12.3075; Dideriksen JL, 2012, J NEUROPHYSIOL, V107, P3357, DOI 10.1152/jn.00938.2011; Dideriksen JL, 2011, J APPL PHYSIOL, V111, P485, DOI 10.1152/japplphysiol.00186.2011; Dimitrova NA, 2002, J ELECTROMYOGR KINES, V12, P339, DOI 10.1016/S1050-6411(02)00046-9; EBERSTEIN A, 1985, MUSCLE NERVE, V8, P768, DOI 10.1002/mus.880080905; ENOKA RM, 1992, J APPL PHYSIOL, V72, P1631, DOI 10.1152/jappl.1992.72.5.1631; Farina D, 2002, J APPL PHYSIOL, V93, P1753, DOI 10.1152/japplphysiol.00314.2002; Farina D, 2010, CLIN NEUROPHYSIOL, V121, P1616, DOI 10.1016/j.clinph.2009.10.040; FITTS RH, 1994, PHYSIOL REV, V74, P49, DOI 10.1152/physrev.1994.74.1.49; FUGLEVAND AJ, 1993, J PHYSIOL-LONDON, V460, P549, DOI 10.1113/jphysiol.1993.sp019486; Gandevia SC, 2001, PHYSIOL REV, V81, P1725, DOI 10.1152/physrev.2001.81.4.1725; Gandevia SC, 1996, J PHYSIOL-LONDON, V490, P529, DOI 10.1113/jphysiol.1996.sp021164; Garland SJ, 1995, ADV EXP MED BIOL, V384, P271; GARLAND SJ, 1994, J APPL PHYSIOL, V76, P2411, DOI 10.1152/jappl.1994.76.6.2411; GERDLE B, 1990, Electromyography and Clinical Neurophysiology, V30, P483; HAGG GM, 1992, J APPL PHYSIOL, V73, P1211, DOI 10.1152/jappl.1992.73.4.1211; Holtermann A, 2009, J ELECTROMYOGR KINES, V19, P232, DOI 10.1016/j.jelekin.2007.08.008; Hunter SK, 2008, J APPL PHYSIOL, V105, P1199, DOI 10.1152/japplphysiol.01246.2007; Kattla S, 2010, EXP BRAIN RES, V202, P89, DOI 10.1007/s00221-009-2110-0; Kisiel-Sajewicz K, 2012, J PAIN SYMPTOM MANAG, V44, P351, DOI 10.1016/j.jpainsymman.2011.08.007; Klass M, 2008, J NEUROPHYSIOL, V99, P1096, DOI 10.1152/jn.01252.2007; KRANZ H, 1983, J APPL PHYSIOL, V55, P392, DOI 10.1152/jappl.1983.55.2.392; Levenez M, 2008, J NEUROPHYSIOL, V99, P554, DOI 10.1152/jn.00963.2007; Liu JZ, 2003, J NEUROPHYSIOL, V90, P300, DOI 10.1152/jn.00821.2002; Martin PG, 2006, J NEUROSCI, V26, P4796, DOI 10.1523/JNEUROSCI.5487-05.2006; MASUDA T, 1991, J ELECTROMYOGR KINES, V1, P116, DOI 10.1016/1050-6411(91)90005-P; Mendoza TR, 1999, CANCER-AM CANCER SOC, V85, P1186, DOI 10.1002/(SICI)1097-0142(19990301)85:5<1186::AID-CNCR24>3.0.CO;2-N; MERLETTI R, 1990, J APPL PHYSIOL, V69, P1810, DOI 10.1152/jappl.1990.69.5.1810; Merletti R., 2004, ELECTROMYOGRAPHY PHY, DOI [10.1002/0471678384, DOI 10.1002/0471678384]; Mesin L, 2009, J ELECTROMYOGR KINES, V19, P851, DOI 10.1016/j.jelekin.2008.08.003; Moritz CT, 2005, J NEUROPHYSIOL, V93, P2449, DOI 10.1152/jn.01122.2004; Negro F, 2009, J PHYSIOL-LONDON, V587, P5925, DOI 10.1113/jphysiol.2009.178509; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Place N, 2010, EUR J APPL PHYSIOL, V110, P1, DOI 10.1007/s00421-010-1480-0; Rainoldi A, 2008, PHYSIOL MEAS, V29, P331, DOI 10.1088/0967-3334/29/3/004; Rainoldi A, 2008, J ELECTROMYOGR KINES, V18, P1032, DOI 10.1016/j.jelekin.2007.05.008; Riley ZA, 2008, J PHYSIOL-LONDON, V586, P2183, DOI 10.1113/jphysiol.2008.150698; Ryan JL, 2007, ONCOLOGIST, V12, P22, DOI 10.1634/theoncologist.12-S1-22; Semmler JG, 2002, EXERC SPORT SCI REV, V30, P8, DOI 10.1097/00003677-200201000-00003; Siemionow V, 2004, CLIN NEUROPHYSIOL, V115, P2372, DOI 10.1016/j.clinph.2004.05.012; Siemionow V, 2008, SOC NEUROSCI; Smets EMA, 1998, BRIT J CANCER, V78, P907, DOI 10.1038/bjc.1998.600; Sood Amit, 2005, Curr Oncol Rep, V7, P277, DOI 10.1007/s11912-005-0051-8; Stephenson DG, 1995, ADV EXP MED BIOL, V384, P45; Swart J, 2012, BRIT J SPORT MED, V46, P42, DOI 10.1136/bjsports-2011-090337; Trontelj JV, 1995, ADV EXP MED BIOL, V384, P109; VANZUYLEN EJ, 1988, J BIOMECH, V21, P183, DOI 10.1016/0021-9290(88)90168-6; Vogelzang NJ, 1997, SEMIN HEMATOL, V34, P4; Weis J, 2011, EXPERT REV PHARM OUT, V11, P441, DOI [10.1586/ERP.11.44, 10.1586/erp.11.44]; Yao WX, 2004, MOTOR CONTROL, V8, P64, DOI 10.1123/mcj.8.1.64; Yao WX, 2000, J NEUROPHYSIOL, V83, P441, DOI 10.1152/jn.2000.83.1.441; Yavuzsen T, 2009, J PAIN SYMPTOM MANAG, V38, P587, DOI 10.1016/j.jpainsymman.2008.12.003; Yue GH, 1997, EXP PHYSIOL, V82, P567, DOI 10.1113/expphysiol.1997.sp004048; Zlott DA, 2010, PM&R, V2, P451, DOI 10.1016/j.pmrj.2010.04.018	62	18	18	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83636	10.1371/journal.pone.0083636	http://dx.doi.org/10.1371/journal.pone.0083636			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391800	Green Published, Green Submitted, gold			2022-12-25	WOS:000329325200097
J	La Marca, M; Beffy, P; Pugliese, A; Longo, V				La Marca, Margherita; Beffy, Pascale; Pugliese, Annalisa; Longo, Vincenzo			Fermented Wheat Powder Induces the Antioxidant and Detoxifying System in Primary Rat Hepatocytes	PLOS ONE			English	Article							ALPHA-LIPOIC ACID; NF-KAPPA-B; HEME OXYGENASE-1 GENE; OXIDATIVE STRESS; LISOSAN-G; CHEMOPREVENTIVE COMPOUNDS; ENDOTHELIAL-CELLS; FREE-RADICALS; UP-REGULATION; WHOLE GRAINS	Many plants exhibit antioxidant properties which may be useful in the prevention of oxidative stress reactions, such as those mediated by the formation of free radical species in different pathological situations. In recent years a number of studies have shown that whole grain products in particular have strong antioxidant activity. Primary cultures of rat hepatocytes were used to investigate whether and how a fermented powder of wheat (Lisosan G) is able to modulate antioxidant and detoxifying enzymes, and whether or not it can activate Nrf2 transcription factor or inhibit NF-kB activation. All of the antioxidant and detoxifying enzymes studied were significantly up-regulated by 0.7 mg/ml Lisosan G treatment. In particular, NAD(P) H: quinone oxidoreductase and heme oxygenase-1 were induced, although to different degrees, at the transcriptional, protein and/or activity levels by the treatment. As for the Nrf2 transcription factor, a partial translocation of its protein from the cytosol to the nucleus after 1 h of Lisosan G treatment was revealed by immunoblotting. Lisosan G was also observed to decrease H2O2-induced toxicity Taken together, these results show that this powder of wheat is an effective inducer of ARE/Nrf2-regulated antioxidant and detoxifying genes and has the potential to inhibit the translocation of NF-kB into the nucleus.	[La Marca, Margherita; Pugliese, Annalisa; Longo, Vincenzo] CNR, Ist Biol & Biotecnol Agr, I-56100 Pisa, Italy; [Beffy, Pascale] CNR, Ist Fisiol Clin, I-56100 Pisa, Italy	Consiglio Nazionale delle Ricerche (CNR); Consiglio Nazionale delle Ricerche (CNR)	Longo, V (corresponding author), CNR, Ist Biol & Biotecnol Agr, I-56100 Pisa, Italy.	v.longo@ibba.cnr.it	Longo, Vincenzo/K-3695-2018	Longo, Vincenzo/0000-0001-8972-8564				Alam J, 2000, J BIOL CHEM, V275, P27694; Balogun E, 2003, BIOCHEM J, V371, P887, DOI 10.1042/BJ20021619; Bao W, 2010, J ETHNOPHARMACOL, V128, P549, DOI 10.1016/j.jep.2010.01.029; Baublis AJ, 2000, J AM COLL NUTR, V19, p308S, DOI 10.1080/07315724.2000.10718965; Beken S, 1998, Methods Mol Biol, V107, P303; BENSON AM, 1980, P NATL ACAD SCI-BIOL, V77, P5216, DOI 10.1073/pnas.77.9.5216; Buckley BJ, 2003, BIOCHEM BIOPH RES CO, V307, P973, DOI 10.1016/S0006-291X(03)01308-1; Cao ZX, 2002, BIOCHEM BIOPH RES CO, V292, P50, DOI 10.1006/bbrc.2002.6614; Chen C, 2004, FREE RADICAL BIO MED, V36, P1505, DOI 10.1016/j.freeradbiomed.2004.03.015; Curtin JF, 2002, J IMMUNOL METHODS, V265, P49, DOI 10.1016/S0022-1759(02)00070-4; De Oliveira SQ, 2003, FREE RADICAL RES, V37, P555, DOI 10.1080/1071576031000076259; De Smet K, 1998, Methods Mol Biol, V107, P295; DECKER T, 1988, J IMMUNOL METHODS, V115, P61, DOI 10.1016/0022-1759(88)90310-9; DUNN JCY, 1991, BIOTECHNOL PROGR, V7, P237, DOI 10.1021/bp00009a007; Elangovan S, 2008, INT J ONCOL, V33, P833, DOI 10.3892/ijo_00000071; Flight I, 2006, EUR J CLIN NUTR, V60, P1145, DOI 10.1038/sj.ejcn.1602435; Gaesser GA, 2007, J AM DIET ASSOC, V107, P1768, DOI 10.1016/j.jada.2007.07.011; Gilmore TD, 2006, ONCOGENE, V25, P6680, DOI 10.1038/sj.onc.1209954; HABIG WH, 1974, J BIOL CHEM, V249, P7130; HALLIWELL B, 1995, FOOD CHEM TOXICOL, V33, P601, DOI 10.1016/0278-6915(95)00024-V; Heiss E, 2001, J BIOL CHEM, V276, P32008, DOI 10.1074/jbc.M104794200; HISSIN PJ, 1976, ANAL BIOCHEM, V74, P214, DOI 10.1016/0003-2697(76)90326-2; Itoh K, 1999, GENE DEV, V13, P76, DOI 10.1101/gad.13.1.76; Jeong WS, 2005, J BIOCHEM MOL BIOL, V38, P167; Jia ZQ, 2008, NEUROCHEM RES, V33, P790, DOI 10.1007/s11064-007-9496-5; Kamata H, 2005, CELL, V120, P649, DOI 10.1016/j.cell.2004.12.041; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Karuri AR, 2006, J PHARMACOL EXP THER, V317, P61, DOI 10.1124/jpet.105.096396; Kim HS, 2007, EXP MOL MED, V39, P106, DOI 10.1038/emm.2007.12; Kuhnt K, 2012, EUR J LIPID SCI TECH, V114, P153, DOI 10.1002/ejlt.201100008; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Laus MN, 2013, MED WETER, V69, P235; Lee SH, 2006, EUR J PHARMACOL, V532, P178, DOI 10.1016/j.ejphar.2006.01.005; Lii CK, 2010, J NUTR, V140, P885, DOI 10.3945/jn.110.121418; Liu YC, 2007, LIFE SCI, V80, P1420, DOI 10.1016/j.lfs.2006.12.040; Longo V, 2011, FOOD CHEM TOXICOL, V49, P233, DOI 10.1016/j.fct.2010.10.021; Longo V, 2007, BIOTECHNOL LETT, V29, P1155, DOI 10.1007/s10529-007-9378-6; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lubrano V, 2012, INDIAN J MED RES, V136, P82; Masella R, 2005, J NUTR BIOCHEM, V16, P577, DOI 10.1016/j.jnutbio.2005.05.013; McKeown NM, 2002, AM J CLIN NUTR, V76, P390, DOI 10.1093/ajcn/76.2.390; Naughton P, 2002, J BIOL CHEM, V277, P40666, DOI 10.1074/jbc.M203863200; Nguyen T, 2003, ANNU REV PHARMACOL, V43, P233, DOI 10.1146/annurev.pharmtox.43.100901.140229; Ogborne RM, 2005, ARTERIOSCL THROM VAS, V25, P2100, DOI 10.1161/01.ATV.0000183745.37161.6e; PACKER L, 1995, FREE RADICAL BIO MED, V19, P227, DOI 10.1016/0891-5849(95)00017-R; Pal M, 2012, FOOD CHEM TOXICOL, V50, P1066, DOI 10.1016/j.fct.2011.12.042; Pastore A, 2003, CLIN CHIM ACTA, V333, P19, DOI 10.1016/S0009-8981(03)00200-6; Payen L, 2001, BIOCHEM BIOPH RES CO, V282, P257, DOI 10.1006/bbrc.2001.4531; Prawan A, 2009, CHEM-BIOL INTERACT, V179, P202, DOI 10.1016/j.cbi.2008.12.014; Randi G, 2010, NUTR REV, V68, P389, DOI 10.1111/j.1753-4887.2010.00299.x; Russo GL, 2009, BIOCHEM PHARMACOL, V77, P937, DOI 10.1016/j.bcp.2008.10.020; Sakon S, 2003, EMBO J, V22, P3898, DOI 10.1093/emboj/cdg379; Saw Constance Lay-Lay, 2010, Chin Med, V5, P37, DOI 10.1186/1749-8546-5-37; Schreck R, 1991, Trends Cell Biol, V1, P39, DOI 10.1016/0962-8924(91)90072-H; Slavin J, 2004, NUTR RES REV, V17, P99, DOI 10.1079/NRR200374; Slavin JL, 2001, J AM DIET ASSOC, V101, P780, DOI 10.1016/S0002-8223(01)00194-8; STACEY NH, 1980, TOXICOL APPL PHARM, V53, P470, DOI 10.1016/0041-008X(80)90359-2; Steffen LM, 2003, AM J CLIN NUTR, V78, P383, DOI 10.1093/ajcn/78.3.383; Storz Peter, 2006, Sci STKE, V2006, pre3, DOI 10.1126/stke.3322006re3; Swift B, 2010, DRUG METAB REV, V42, P446, DOI 10.3109/03602530903491881; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Valko M, 2006, CHEM-BIOL INTERACT, V160, P1, DOI 10.1016/j.cbi.2005.12.009; Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001; VENN B, 2012, J NUTR METABOLISM, V2012, P1; VONJAGOW R, 1965, N-S ARCH EX PATH PH, V251, P73, DOI 10.1007/BF00245731; Wakabayashi N, 2010, ANTIOXID REDOX SIGN, V13, P1649, DOI 10.1089/ars.2010.3216; Weisburger JH, 1999, FOOD CHEM TOXICOL, V37, P943, DOI 10.1016/S0278-6915(99)00086-1; Wu X, 2009, ACTA PHARMACOL SIN, V30, P501, DOI 10.1038/aps.2009.50	68	31	31	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83538	10.1371/journal.pone.0083538	http://dx.doi.org/10.1371/journal.pone.0083538			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391783	Green Submitted, Green Published, gold			2022-12-25	WOS:000329325200080
J	Siddharth, J; Holway, N; Parkinson, SJ				Siddharth, Jay; Holway, Nicholas; Parkinson, Scott J.			A Western Diet Ecological Module Identified from the 'Humanized' Mouse Microbiota Predicts Diet in Adults and Formula Feeding in Children	PLOS ONE			English	Article							GUT	The interplay between diet and the microbiota has been implicated in the growing frequency of chronic diseases associated with the Western lifestyle. However, the complexity and variability of microbial ecology in humans and preclinical models has hampered identification of the molecular mechanisms underlying the association of the microbiota in this context. We sought to address two key questions. Can the microbial ecology of preclinical models predict human populations? And can we identify underlying principles that surpass the plasticity of microbial ecology in humans? To do this, we focused our study on diet; perhaps the most influential factor determining the composition of the gut microbiota. Beginning with a study in 'humanized' mice we identified an interactive module of 9 genera allied with Western diet intake. This module was applied to a controlled dietary study in humans. The abundance of the Western ecological module correctly predicted the dietary intake of 19/21 top and 21/21 of the bottom quartile samples inclusive of all 5 Western and 'low-fat' diet subjects, respectively. In 98 volunteers the abundance of the Western module correlated appropriately with dietary intake of saturated fatty acids, fat-soluble vitamins and fiber. Furthermore, it correlated with the geographical location and dietary habits of healthy adults from the Western, developing and third world. The module was also coupled to dietary intake in children (and piglets) correlating with formula (vs breast) feeding and associated with a precipitous development of the ecological module in young children. Our study provides a conceptual platform to translate microbial ecology from preclinical models to humans and identifies an ecological network module underlying the association of the gut microbiota with Western dietary habits.	[Siddharth, Jay; Parkinson, Scott J.] Novartis Inst Biomed Res, Host Commensal Hub, Basel, Switzerland; [Holway, Nicholas] Novartis Inst Biomed Res, NIBR IT, Basel, Switzerland	Novartis; Novartis	Parkinson, SJ (corresponding author), Novartis Inst Biomed Res, Host Commensal Hub, Basel, Switzerland.	scott.parkinson@novartis.com		Siddharth, Jay/0000-0003-3288-400X; Holway, Nicholas/0000-0002-2126-5118				[Anonymous], 2003, DIET NUTR PREV CHRON; Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Brenna JT, 2007, AM J CLIN NUTR, V85, P1457, DOI 10.1093/ajcn/85.6.1457; Cummings JH, 1997, JPEN-PARENTER ENTER, V21, P357, DOI 10.1177/0148607197021006357; Fewtrell M, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.c5955; GIBSON RA, 1981, AM J CLIN NUTR, V34, P252, DOI 10.1093/ajcn/34.2.252; Goodman AL, 2011, P NATL ACAD SCI USA, V108, P6252, DOI 10.1073/pnas.1102938108; Gordon JI, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004347; Hvistendahl M, 2012, SCIENCE, V336, P1250, DOI 10.1126/science.336.6086.1250; Koletzko B, 2009, ADV EXP MED BIOL, V646, P15, DOI 10.1007/978-1-4020-9173-5_2; Little AEF, 2008, ANNU REV MICROBIOL, V62, P375, DOI 10.1146/annurev.micro.030608.101423; McCance R, 2002, MCCANCE WIDDOWSONS C, P131; Poroyko V, 2011, NUTR HOSP, V26, P1283, DOI [10.3305/nh.2011.26.6.5362, 10.1590/S0212-16112011000600015]; Schloss PD, 2011, APPL ENVIRON MICROB, V77, P3219, DOI 10.1128/AEM.02810-10; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Scientific Advisory Committee on Nutrition Subgroup on Maternal and Child Nutrition (SMCN), 2011, INFL MAT FET CHILD N; Smith P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030273; Strom SL, 2008, SCIENCE, V320, P1043, DOI 10.1126/science.1153527; UNICEF, 2007, UNICEF PUBL; Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053	21	13	13	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83689	10.1371/journal.pone.0083689	http://dx.doi.org/10.1371/journal.pone.0083689			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391809	Green Submitted, Green Published, Green Accepted, gold			2022-12-25	WOS:000329325200107
J	Twomey, EC; Cordasco, DF; Kozuch, SD; Wei, YF				Twomey, Edward C.; Cordasco, Dana F.; Kozuch, Stephen D.; Wei, Yufeng			Substantial Conformational Change Mediated by Charge-Triad Residues of the Death Effector Domain in Protein-Protein Interactions	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; DIPOLAR COUPLINGS; PHOSPHOLIPASE D1; PEA-15 REVEALS; ERK2; PED/PEA-15; MECHANISM; MACROMOLECULES; ALIGNMENT; BINDING	Protein conformational changes are commonly associated with the formation of protein complexes. The non-catalytic death effector domains (DEDs) mediate protein-protein interactions in a variety of cellular processes, including apoptosis, proliferation and migration, and glucose metabolism. Here, using NMR residual dipolar coupling (RDC) data, we report a conformational change in the DED of the phosphoprotein enriched in astrocytes, 15 kDa (PEA-15) protein in the complex with a mitogen-activated protein (MAP) kinase, extracellular regulated kinase 2 (ERK2), which is essential in regulating ERK2 cellular distribution and function in cell proliferation and migration. The most significant conformational change in PEA-15 happens at helices alpha 2, alpha 3, and alpha 4, which also possess the highest flexibility among the six-helix bundle of the DED. This crucial conformational change is modulated by the D/E-RxDL charge-triad motif, one of the prominent structural features of DEDs, together with a number of other electrostatic and hydrogen bonding interactions on the protein surface. Chargetriad motif promotes the optimal orientation of key residues and expands the binding interface to accommodate proteinprotein interactions. However, the charge-triad residues are not directly involved in the binding interface between PEA-15 and ERK2.	[Twomey, Edward C.; Cordasco, Dana F.; Wei, Yufeng] Seton Hall Univ, Inst NeuroImmune Pharmacol, S Orange, NJ 07079 USA; [Twomey, Edward C.; Cordasco, Dana F.; Kozuch, Stephen D.] Seton Hall Univ, Dept Chem & Biochem, S Orange, NJ 07079 USA; [Twomey, Edward C.] Columbia Univ, Integrated Program Cellular Mol & Biomed Studies, New York, NY USA	Seton Hall University; Seton Hall University; Columbia University	Wei, YF (corresponding author), Seton Hall Univ, Inst NeuroImmune Pharmacol, S Orange, NJ 07079 USA.	Yufeng.Wei@shu.edu	Wei, Yufeng/H-2733-2019	Wei, Yufeng/0000-0001-6608-8488; Twomey, Edward/0000-0002-1855-1586	United States National Institutes of Health [R15CA179410]; Eric F. Ross Research Foundation; Celgene Corporation/Independent College Fund of New Jersey; New Jersey Space Grant Consortium/National Aeronautics and Space Administration; NATIONAL CANCER INSTITUTE [R15CA179410] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Eric F. Ross Research Foundation; Celgene Corporation/Independent College Fund of New Jersey; New Jersey Space Grant Consortium/National Aeronautics and Space Administration; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The project was supported by United States National Institutes of Health grant R15CA179410 to YW, and the Eric F. Ross Research Foundation, Celgene Corporation/Independent College Fund of New Jersey, and New Jersey Space Grant Consortium/National Aeronautics and Space Administration to ECT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen FH, 2002, ACTA CRYSTALLOGR B, V58, P380, DOI 10.1107/S0108768102003890; Blackledge M, 2005, PROG NUCL MAG RES SP, V46, P23, DOI 10.1016/j.pnmrs.2004.11.002; Callaway K, 2005, BBA-PROTEINS PROTEOM, V1754, P316, DOI 10.1016/j.bbapap.2005.11.002; Callaway K, 2007, BIOCHEMISTRY-US, V46, P9187, DOI 10.1021/bi700206u; Carrington PE, 2006, MOL CELL, V22, P599, DOI 10.1016/j.molcel.2006.04.018; Courvoisier E, 2012, CHEM COMMUN, V48, P2761, DOI 10.1039/c2cc17203h; Farina B, 2013, BIOCH BIOPHYS ACTA; Fiory F, 2009, AM J PHYSIOL-ENDOC M, V297, pE592, DOI 10.1152/ajpendo.00228.2009; Formstecher E, 2001, DEV CELL, V1, P239, DOI 10.1016/S1534-5807(01)00035-1; Hansen MR, 1998, NAT STRUCT BIOL, V5, P1065, DOI 10.1038/4176; Hansen MR, 2000, METHOD ENZYMOL, V317, P220; Hill JM, 2002, EMBO J, V21, P6494, DOI 10.1093/emboj/cdf641; Kaoud TS, 2011, BIOCHEMISTRY-US, V50, P4568, DOI 10.1021/bi200202y; Lerche MH, 1999, J MAGN RESON, V140, P259, DOI 10.1006/jmre.1999.1820; Li FY, 2006, J BIOL CHEM, V281, P2960, DOI 10.1074/jbc.M511074200; Losonczi JA, 1999, J MAGN RESON, V138, P334, DOI 10.1006/jmre.1999.1754; Mace PD, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2687; Macrae CF, 2008, J APPL CRYSTALLOGR, V41, P466, DOI 10.1107/S0021889807067908; McDermott A, 1998, ABSTR PAP AM CHEM S, V216, pU697; Meot-Ner M, 2012, CHEM REV, V112, pRP22, DOI 10.1021/cr200430n; Park HH, 2007, CELL, V128, P533, DOI 10.1016/j.cell.2007.01.019; Park HH, 2007, ANNU REV IMMUNOL, V25, P561, DOI 10.1146/annurev.immunol.25.022106.141656; Prestegard JH, 2000, Q REV BIOPHYS, V33, P371, DOI 10.1017/S0033583500003656; Ruckert M, 2000, J AM CHEM SOC, V122, P7793, DOI 10.1021/ja001068h; Thomas IR, 2010, J APPL CRYSTALLOGR, V43, P362, DOI 10.1107/S0021889810000452; Twomey EC, 2012, BBA-PROTEINS PROTEOM, V1824, P1382, DOI 10.1016/j.bbapap.2012.07.001; Twomey EC, 2012, BIOCHEM BIOPH RES CO, V424, P141, DOI 10.1016/j.bbrc.2012.06.091; Valmiki MG, 2009, CELL MOL LIFE SCI, V66, P814, DOI 10.1007/s00018-008-8489-0; Viparelli F, 2008, J BIOL CHEM, V283, P21769, DOI 10.1074/jbc.M803771200; Wang LW, 2010, NAT STRUCT MOL BIOL, V17, P1324, DOI 10.1038/nsmb.1920; Wei YF, 2006, J BIOMOL NMR, V35, P17, DOI 10.1007/s10858-006-9009-x; Yang JK, 2005, MOL CELL, V20, P939, DOI 10.1016/j.molcel.2005.10.023; Zhang Y, 2000, J BIOL CHEM, V275, P35224, DOI 10.1074/jbc.M003329200	33	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83421	10.1371/journal.pone.0083421	http://dx.doi.org/10.1371/journal.pone.0083421			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391764	Green Published, Green Submitted, gold			2022-12-25	WOS:000329325200061
J	Wang, MY; Wang, FP; Yang, JB; Zhao, DF; Wang, HP; Shao, F; Wang, WJ; Sun, RL; Ling, MZ; Zhai, JJ; Song, SJ				Wang, Mingyong; Wang, Fanping; Yang, Jianbin; Zhao, Dongfang; Wang, Hongpo; Shao, Feng; Wang, Wenjun; Sun, Ruili; Ling, Mingzhi; Zhai, Jingjing; Song, Shijun			Mannan-Binding Lectin Inhibits Candida albicans-Induced Cellular Responses in PMA-Activated THP-1 Cells through Toll-Like Receptor 2 and Toll-Like Receptor 4	PLOS ONE			English	Article							INNATE IMMUNITY; DENDRITIC CELLS; INFLAMMATORY RESPONSES; ADAPTIVE IMMUNITY; RECOGNITION; LIPOPOLYSACCHARIDE; YEAST; TOLL-LIKE-RECEPTOR-2; OPSONIZATION; ASSOCIATION	Background: Candida albicans (C. albicans), the most common human fungal pathogen, can cause fatal systemic infections under certain circumstances. Mannan-binding lectin (MBL), a member of the collectin family in the C-type lectin superfamily, is an important serum component associated with innate immunity. Toll-like receptors (TLRs) are expressed extensively, and have been shown to be involved in C. albicans-induced cellular responses. We first examined whether MBL modulated heat-killed (HK) C. albicans-induced cellular responses in phorbol 12-myristate 13-acetate (PMA)-activated human THP-1 macrophages. We then investigated the possible mechanisms of its inhibitory effect. Methodology/Principal Finding: Enzyme-linked immunosorbent assay (ELISA) and reverse transcriptasepolymerase chain reaction (RT-PCR) analysis showed that MBL at higher concentrations (10-20 mu g/ml) significantly attenuated C. albicans-induced chemokine (e.g., IL-8) and proinflammatory cytokine (e.g., TNF-alpha) production from PMA-activated THP-1 cells at both protein and mRNA levels. Electrophoretic mobility shift assay (EMSA) and Western blot (WB) analysis showed that MBL could inhibit C. albicans-induced nuclear factor-kB (NF-kB) DNA binding and its translocation in PMA-activated THP-1 cells. MBL could directly bind to PMA-activated THP-1 cells in the presence of Ca2+, and this binding decreased TLR2 and TLR4 expressions in C. albicans-induced THP-1 macrophages. Furthermore, the binding could be partially inhibited by both anti-TLR2 monoclonal antibody (clone TL2.1) and anti-TLR4 monoclonal antibody (clone HTA125). In addition, coimmunoprecipitation experiments and microtiter wells assay showed that MBL could directly bind to the recombinant soluble form of extracellular TLR2 domain (sTLR2) and sTLR4. Conclusions/Significance: Our study demonstrates that MBL can affect proinflammatory cytokine and chemokine expressions by modifying C. albicans-/TLR-signaling pathways. This study supports an important role for MBL on the regulation of C. albicans-induced cellular responses.	[Wang, Mingyong; Wang, Fanping; Sun, Ruili; Ling, Mingzhi; Zhai, Jingjing] Xinxiang Med Univ, Dept Lab Med, Xinxiang, Peoples R China; [Yang, Jianbin; Zhao, Dongfang; Wang, Hongpo] Xinxiang Med Univ, Affiliated Hosp 1, Dept Clin Lab, Xinxiang, Peoples R China; [Shao, Feng; Song, Shijun] Xinxiang Med Univ, Affiliated Hosp 3, Dept Clin Lab, Xinxiang, Peoples R China; [Wang, Wenjun] Southern Med Univ, Canc Res Inst, Guangzhou, Guangdong, Peoples R China	Xinxiang Medical University; Xinxiang Medical University; Xinxiang Medical University; Southern Medical University - China	Wang, MY (corresponding author), Xinxiang Med Univ, Dept Lab Med, Xinxiang, Peoples R China.	cxaini118@163.com			National Natural Science Foundation of China [31100645, 81373120]; Program for New Century Excellent Talents in University [NCET-13-0990]; Project of Science and Technology Innovation Talents in Universities of Henan Province [2012HASTIT024]; Foundation for University Key Teacher of Henan Province [2010GGJS-117]; Foundation of Henan Educational Committee [12A320017]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Project of Science and Technology Innovation Talents in Universities of Henan Province; Foundation for University Key Teacher of Henan Province; Foundation of Henan Educational Committee	This work was supported by grants from the National Natural Science Foundation of China (Grant No. 31100645, 81373120), Program for New Century Excellent Talents in University (NCET-13-0990), Project of Science and Technology Innovation Talents in Universities of Henan Province (2012HASTIT024), Foundation for University Key Teacher of Henan Province (2010GGJS-117) and Foundation of Henan Educational Committee (12A320017). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Attas SA, 2010, ANN SAUDI MED, V30, P101, DOI 10.4103/0256-4947.60514; Baggiolini M, 1998, NATURE, V392, P565, DOI 10.1038/33340; Bahri R, 2010, J CELL PHYSIOL, V222, P209, DOI 10.1002/jcp.21939; Bellocchio S, 2004, J IMMUNOL, V172, P3059, DOI 10.4049/jimmunol.172.5.3059; Brouwer N, 2008, J IMMUNOL, V180, P4124, DOI 10.4049/jimmunol.180.6.4124; Clemons KV, 2011, IMMUNOL INVEST, V40, P553, DOI 10.3109/08820139.2011.569627; Dean MM, 2011, IMMUNOLOGY, V132, P296, DOI 10.1111/j.1365-2567.2010.03365.x; Decanis N, 2009, CYTOKINE, V45, P132, DOI 10.1016/j.cyto.2008.11.011; Downing I, 2005, SCAND J IMMUNOL, V62, P507, DOI 10.1111/j.1365-3083.2005.01693.x; Dumestre-Perard C, 2002, MOL IMMUNOL, V39, P465, DOI 10.1016/S0161-5890(02)00119-0; Ferwerda G, 2010, VACCINE, V28, P614, DOI 10.1016/j.vaccine.2009.10.082; Fischer J, 2008, INFECT IMMUN, V76, P4737, DOI 10.1128/IAI.00733-08; FLEIT HB, 1991, J LEUKOCYTE BIOL, V49, P556, DOI 10.1002/jlb.49.6.556; Fraser IP, 1998, SEMIN IMMUNOL, V10, P363, DOI 10.1006/smim.1998.0141; Gale CA, 1998, SCIENCE, V279, P1355, DOI 10.1126/science.279.5355.1355; Hoffmann JA, 1999, SCIENCE, V284, P1313, DOI 10.1126/science.284.5418.1313; Hyakushima N, 2004, J IMMUNOL, V173, P6949, DOI 10.4049/jimmunol.173.11.6949; Ip WKE, 2008, J EXP MED, V205, P169, DOI 10.1084/jem.20071164; Ip WKE, 2009, IMMUNOL REV, V230, P9, DOI 10.1111/j.1600-065X.2009.00789.x; Iwaki D, 2002, J BIOL CHEM, V277, P24315, DOI 10.1074/jbc.M107057200; Jouault T, 2003, J INFECT DIS, V188, P165, DOI 10.1086/375784; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Lane S, 2001, J BIOL CHEM, V276, P48988, DOI 10.1074/jbc.M104484200; Li M, 2009, CHINESE MED J-PEKING, V122, P496, DOI 10.3760/cma.j.issn.0366-6999.2009.05.003; Gil ML, 2009, FRONT BIOSCI-LANDMRK, V14, P570, DOI 10.2741/3263; Nauta AJ, 2004, J IMMUNOL, V173, P3044, DOI 10.4049/jimmunol.173.5.3044; Netea MG, 2008, NAT REV MICROBIOL, V6, P67, DOI 10.1038/nrmicro1815; Newman SL, 2001, INFECT IMMUN, V69, P6813, DOI 10.1128/IAI.69.11.6813-6822.2001; Oliveira PM, 2011, BRAZ J INFECT DIS, V15, P239, DOI 10.1016/S1413-8670(11)70182-9; Ono S, 2003, SURGERY, V134, P92, DOI 10.1067/msy.2003.189; Pereira CA, 2011, MYCOPATHOLOGIA, V171, P103, DOI 10.1007/s11046-010-9353-y; Pivarcsi A, 2003, INT IMMUNOL, V15, P721, DOI 10.1093/intimm/dxg068; Ren MY, 2010, IMMUNOL CELL BIOL, V88, P529, DOI 10.1038/icb.2010.6; Sano H, 2000, J BIOL CHEM, V275, P22442, DOI 10.1074/jbc.M001107200; Shimizu T, 2009, BBA-GEN SUBJECTS, V1790, P1705, DOI 10.1016/j.bbagen.2009.10.006; SUPER M, 1989, LANCET, V2, P1236; Tan SM, 1996, BIOCHEM J, V319, P329, DOI 10.1042/bj3190329; Torosantucci A, 2000, J LEUKOCYTE BIOL, V68, P923; Vallespi MG, 2003, INT IMMUNOPHARMACOL, V3, P247, DOI 10.1016/S1567-5769(02)00277-1; Van Asbeck EC, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-229; Wang MY, 2011, CELL MOL IMMUNOL, V8, P265, DOI 10.1038/cmi.2011.1; Wang MY, 2011, BMC IMMUNOL, V12, DOI 10.1186/1471-2172-12-1; Zheng XD, 2003, MOL MICROBIOL, V49, P1391, DOI 10.1046/j.1365-2958.2003.03646.x	44	13	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83517	10.1371/journal.pone.0083517	http://dx.doi.org/10.1371/journal.pone.0083517			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391778	Green Submitted, Green Published, gold			2022-12-25	WOS:000329325200075
J	Wong, EB; Akilimali, NA; Govender, P; Sullivan, ZA; Cosgrove, C; Pillay, M; Lewinsohn, DM; Bishai, WR; Walker, BD; Ndung'u, T; Klenerman, P; Kasprowicz, VO				Wong, Emily B.; Akilimali, Ngomu Akeem; Govender, Pamla; Sullivan, Zuri A.; Cosgrove, Cormac; Pillay, Mona; Lewinsohn, David M.; Bishai, William R.; Walker, Bruce D.; Ndung'u, Thumbi; Klenerman, Paul; Kasprowicz, Victoria O.			Low Levels of Peripheral CD161++CD8+Mucosal Associated Invariant T (MAIT) Cells Are Found in HIV and HIV/TB Co-Infection	PLOS ONE			English	Article							CD161 EXPRESSION; TUBERCULOSIS; POPULATION; ACTIVATION; INFECTION; RESPONSES; PATHWAY; DEFINES; HEALTH; CXCR6	Background: High expression of CD161 on CD8+ T cells is associated with a population of cells thought to play a role in mucosal immunity. We wished to investigate this subset in an HIV and Mycobacterium tuberculosis (MTB) endemic African setting. Methods: A flow cytometric approach was used to assess the frequency and phenotype of CD161++CD8+ T cells. 80 individuals were recruited for cross-sectional analysis: controls (n = 18), latent MTB infection (LTBI) only (n = 16), pulmonary tuberculosis (TB) only (n = 8), HIV only (n = 13), HIV and LTBI co-infection (n = 15) and HIV and TB co-infection (n = 10). The impact of acute HIV infection was assessed in 5 individuals recruited within 3 weeks of infection. The frequency of CD161++CD8+ T cells was assessed prior to and during antiretroviral therapy (ART) in 14 HIV-positive patients. Results: CD161++CD8+ T cells expressed high levels of the HIV co-receptor CCR5, the tissue-homing marker CCR6, and the Mucosal-Associated Invariant T (MAIT) cell TCR V alpha 7.2. Acute and chronic HIV were associated with lower frequencies of CD161++CD8+ T cells, which did not correlate with CD4 count or HIV viral load. ART was not associated with an increase in CD161++CD8+ T cell frequency. There was a trend towards lower levels of CD161++CD8+ T cells in HIV-negative individuals with active and latent TB. In those co-infected with HIV and TB, CD161++CD8+T cells were found at low levels similar to those seen in HIV mono-infection. Conclusions: The frequencies and phenotype of CD161++CD8+ T cells in this South African cohort are comparable to those published in European and US cohorts. Low-levels of this population were associated with acute and chronic HIV infection. Lower levels of the tissue-trophic CD161++CD8+ T cell population may contribute to weakened mucosal immune defense, making HIV-infected subjects more susceptible to pulmonary and gastrointestinal infections and detrimentally impacting on host defense against TB.	[Wong, Emily B.; Akilimali, Ngomu Akeem; Govender, Pamla; Sullivan, Zuri A.; Bishai, William R.; Ndung'u, Thumbi; Kasprowicz, Victoria O.] KwaZulu Natal Res Inst TB & HIV, Durban, South Africa; [Wong, Emily B.] Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02114 USA; [Akilimali, Ngomu Akeem; Govender, Pamla; Pillay, Mona; Walker, Bruce D.; Ndung'u, Thumbi; Kasprowicz, Victoria O.] Univ KwaZulu Natal, HIV Pathogenesis Programme, Durban, South Africa; [Sullivan, Zuri A.; Bishai, William R.] Johns Hopkins Sch Med, Div Infect Dis, Baltimore, MD USA; [Cosgrove, Cormac; Klenerman, Paul] Univ Oxford, Oxford, England; [Lewinsohn, David M.] Oregon Hlth & Sci Univ, Div Pulm & Crit Care Med, Portland, OR 97201 USA; [Lewinsohn, David M.] Portland VA Med Ctr, Portland, OR USA; [Walker, Bruce D.; Ndung'u, Thumbi; Kasprowicz, Victoria O.] Harvard Univ, Sch Med, Ragon Inst MGH Massachusetts Inst Technol & Harva, Cambridge, MA 02138 USA; [Ndung'u, Thumbi] Max Planck Inst Infekt Biol, D-10117 Berlin, Germany	Harvard University; Massachusetts General Hospital; University of Kwazulu Natal; Johns Hopkins University; Johns Hopkins Medicine; University of Oxford; Oregon Health & Science University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Portland VA Medical Center; Harvard University; Massachusetts Institute of Technology (MIT); Ragon Institute; Max Planck Society	Wong, EB (corresponding author), KwaZulu Natal Res Inst TB & HIV, Durban, South Africa.	emilybethwong@gmail.com	; Lewinsohn, David/I-4936-2013	Ndung'u, Thumbi/0000-0003-2962-3992; Sullivan, Zuri/0000-0002-6111-6512; Lewinsohn, David/0000-0001-9906-9494; klenerman, paul/0000-0003-4307-9161	Howard Hughes Medical Institute (HHMI); KwaZulu-Natal Research Institute for Tuberculosis and HIV (K-RITH); Harvard University CFAR [P30 AI060354]; NIH [AI 097138, AI 007387]; Wellcome Trust [WT019663MA]; Oxford Martin School; NIAID U19 Bio-defense Program [NIH NIAID 1U19AI082630-01]; NIHR Biomedical Research Centre, Oxford; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI060354, U01AI095776, R01AI097138, T32AI007387, U19AI082630] Funding Source: NIH RePORTER; National Institute for Health Research [NF-SI-0510-10204] Funding Source: researchfish	Howard Hughes Medical Institute (HHMI)(Howard Hughes Medical Institute); KwaZulu-Natal Research Institute for Tuberculosis and HIV (K-RITH); Harvard University CFAR; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome TrustEuropean Commission); Oxford Martin School; NIAID U19 Bio-defense Program; NIHR Biomedical Research Centre, Oxford(National Institute for Health Research (NIHR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute for Health Research(National Institute for Health Research (NIHR))	The authors would like to thank the following funders: the Howard Hughes Medical Institute (HHMI), the KwaZulu-Natal Research Institute for Tuberculosis and HIV (K-RITH), the Harvard University CFAR grant (P30 AI060354), the NIH (grant AI 097138 and AI 007387), the Wellcome Trust (WT019663MA), the Oxford Martin School, the NIAID U19 Bio-defense Program (NIH NIAID 1U19AI082630-01), and the NIHR Biomedical Research Centre, Oxford. PK is an NIHR Senior Investigator. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnighausen T, 2008, AIDS, V22, P139, DOI 10.1097/QAD.0b013e3282f2ef43; Bateman C, 2010, SAMJ S AFR MED J, V100, P207, DOI 10.7196/SAMJ.4103; Bateman C, 2009, SAMJ S AFR MED J, V99, P852; Billerbeck E, 2010, P NATL ACAD SCI USA, V107, P3006, DOI 10.1073/pnas.0914839107; Chua WJ, 2012, INFECT IMMUN, V80, P3256, DOI 10.1128/IAI.00279-12; Chung DR, 2003, J IMMUNOL, V170, P1958, DOI 10.4049/jimmunol.170.4.1958; Cosgrove C, 2013, BLOOD, V121, P951, DOI 10.1182/blood-2012-06-436436; Day CL, 2008, J INFECT DIS, V197, P990, DOI 10.1086/529048; Dusseaux M, 2011, BLOOD, V117, P1250, DOI 10.1182/blood-2010-08-303339; Dye C, 2008, J R SOC INTERFACE, V5, P653, DOI 10.1098/rsif.2007.1138; Georgel P, 2011, MOL IMMUNOL, V48, P769, DOI 10.1016/j.molimm.2010.12.002; Gold MC, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000407; Houlihan CF, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-23; Huang WT, 2004, J INFECT DIS, V190, P624, DOI 10.1086/422329; Khader SA, 2007, NAT IMMUNOL, V8, P369, DOI 10.1038/ni1449; Le Bourhis L, 2010, NAT IMMUNOL, V11, P701, DOI 10.1038/ni.1890; Leeansyah E, 2013, BLOOD, V121, P1124, DOI 10.1182/blood-2012-07-445429; Martin E, 2009, PLOS BIOL, V7, P525, DOI 10.1371/journal.pbio.1000054; Morgan AJ, 2005, CLIN EXP ALLERGY, V35, P1572, DOI 10.1111/j.1365-2222.2005.02383.x; Morgan AJ, 2008, IMMUNOBIOLOGY, V213, P599, DOI 10.1016/j.imbio.2008.01.005; Nigam P, 2011, J IMMUNOL, V186, P745, DOI 10.4049/jimmunol.1002807; Northfield JW, 2008, HEPATOLOGY, V47, P396, DOI 10.1002/hep.22040; Puel A, 2011, SCIENCE, V332, P65, DOI 10.1126/science.1200439; Radebe M, 2011, J INFECT DIS, V204, P768, DOI 10.1093/infdis/jir394; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; Sandberg JK, 2013, AIDS; Sonnenberg P, 2005, J INFECT DIS, V191, P150, DOI 10.1086/426827; Sutherland R, 2006, AIDS, V20, P821, DOI 10.1097/01.aids.0000218545.31716.a4; Takahashi T, 2006, J IMMUNOL, V176, P211, DOI 10.4049/jimmunol.176.1.211; Treiner E, 2003, NATURE, V422, P164, DOI 10.1038/nature01433; Turtle CJ, 2011, BLOOD, V118, P2752, DOI 10.1182/blood-2011-02-334698; UNAIDS G, 2008, REP GLOB AIDS EP; Walker LJ, 2012, BLOOD, V119, P422, DOI 10.1182/blood-2011-05-353789	33	68	70	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83474	10.1371/journal.pone.0083474	http://dx.doi.org/10.1371/journal.pone.0083474			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391773	Green Published, gold, Green Submitted			2022-12-25	WOS:000329325200070
J	Li, AY; Liang, H; Li, W; Wang, ZZ; Pang, T; Li, J; Shi, H; Zhang, CQ				Li, Aiyin; Liang, Hui; Li, Wei; Wang, Zhongzhou; Pang, Tao; Li, Jun; Shi, Hao; Zhang, Chengqi			Spectral CT Imaging of Laryngeal and Hypopharyngeal Squamous Cell Carcinoma: Evaluation of Image Quality and Status of Lymph Nodes	PLOS ONE			English	Article							DUAL-ENERGY CT; COMPUTED-TOMOGRAPHY; LOCAL-CONTROL; TUMOR VOLUME; FDG PET; NECK; HEAD; CANCER; METASTASES; PREDICTOR	Purpose: The purpose of this study was to evaluate image quality and status of lymph nodes in laryngeal and hypopharyngeal squamous cell carcinoma (SCC) patients using spectral CT imaging. Materials and Methods: Thirty-eight patients with laryngeal and hypopharyngeal SCCs were scanned with spectral CT mode in venous phase. The conventional 140-kVp polychromatic images and one hundred and one sets of monochromatic images were generated ranging from 40 keV to 140 keV. The mean optimal keV was calculated on the monochromatic images. The image quality of the mean optimal keV monochromatic images and polychromatic images was compared with two different methods including a quantitative analysis method and a qualitative analysis method. The HU curve slope (lambda(HU)) in the target lymph nodes and the primary lesion was calculated respectively. The ratio of lambda(HU) was studied between metastatic and non-metastatic lymph nodes group. Results: A total of 38 primary lesions were included. The mean optimal keV was obtained at 55 +/- 1.77 keV on the monochromatic images. The image quality evaluated by two different methods including a quantitative analysis method and a qualitative analysis method was obviously increased on monochromatic images than polychromatic images (p<0.05). The ratio of lambda(HU) between metastatic and non-metastatic lymph nodes was significantly different in the venous phase images (p<0.05). Conclusion: The monochromatic images obtained with spectral CT can be used to improve the image quality of laryngeal and hypopharyngeal SCC and the N-staging accuracy. The quantitative ratio of lambda(HU) may be helpful for differentiating between metastatic and non-metastatic cervical lymph nodes.	[Li, Aiyin; Li, Wei; Wang, Zhongzhou; Pang, Tao; Li, Jun; Shi, Hao; Zhang, Chengqi] Shandong Univ, Qianfoshan Hosp, Dept Radiol, Jinan 250100, Shandong, Peoples R China; [Liang, Hui] Shandong Univ, Qianfoshan Hosp, Dept Otolaryngol, Jinan 250100, Shandong, Peoples R China	Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University	Zhang, CQ (corresponding author), Shandong Univ, Qianfoshan Hosp, Dept Radiol, Jinan 250100, Shandong, Peoples R China.	zhangchengqi@sdhospital.com.cn	zhang, chi/GRX-3610-2022					Boll DT, 2010, RADIOLOGY, V254, P270, DOI 10.1148/radiol.09090068; Chu MMAY, 2010, RADIOGRAPHICS, V30, P1353, DOI 10.1148/rg.305095764; Coursey CA, 2010, RADIOGRAPHICS, V30, P1037, DOI 10.1148/rg.304095175; Daisne JF, 2004, RADIOLOGY, V233, P93, DOI 10.1148/radiol.2331030660; Dietz A, 2000, OTOLARYNG HEAD NECK, V122, P596, DOI 10.1067/mhn.2000.98175; DON DM, 1995, LARYNGOSCOPE, V105, P669, DOI 10.1288/00005537-199507000-00001; Guimaraes LS, 2010, RADIOLOGY, V257, P732, DOI 10.1148/radiol.10092016; Hermans R, 1999, INT J RADIAT ONCOL, V44, P755, DOI 10.1016/S0360-3016(99)00039-5; Hoorweg JJ, 2006, OTOLARYNG HEAD NECK, V135, P129, DOI 10.1016/j.otohns.2006.01.024; Unzurrunzaga EI, 2011, ACTA OTORRINOLAR ESP, V62, P443, DOI 10.1016/j.otorri.2011.06.004; JOHNSON JT, 1990, RADIOLOGY, V175, P607, DOI 10.1148/radiology.175.3.2188292; Keberle M, 2004, EUR RADIOL, V14, P286, DOI 10.1007/s00330-003-1994-5; Kraas JR, 2001, HEAD NECK-J SCI SPEC, V23, P1031, DOI 10.1002/hed.10030; Krestan C, 2006, EUR J RADIOL, V58, P360, DOI 10.1016/j.ejrad.2005.12.040; Kuno H, 2012, RADIOLOGY, V265, P488, DOI 10.1148/radiol.12111719; Li M, 2012, INVEST RADIOL, V47, P58, DOI 10.1097/RLI.0b013e318229fef3; Lyshchik A, 2007, RADIOLOGY, V243, P258, DOI 10.1148/radiol.2431052032; Mancuso AA, 1999, J CLIN ONCOL, V17, P631, DOI 10.1200/JCO.1999.17.2.631; MANCUSO AA, 1983, RADIOLOGY, V148, P715, DOI 10.1148/radiology.148.3.6878692; Matsumoto K, 2011, RADIOLOGY, V259, P257, DOI 10.1148/radiol.11100978; Mukherji SK, 2000, HEAD NECK-J SCI SPEC, V22, P282, DOI 10.1002/(SICI)1097-0347(200005)22:3<282::AID-HED11>3.0.CO;2-K; Pan ZL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053651; Park SR, 2010, ANN SURG, V251, P428, DOI 10.1097/SLA.0b013e3181ca69a7; Silverman Paul M, 2005, Cancer Imaging, V5 Spec No A, pS57, DOI 10.1102/1470-7330.2005.0031; SOM PM, 1987, RADIOLOGY, V165, P593, DOI 10.1148/radiology.165.3.3317494; SOM PM, 1992, AM J ROENTGENOL, V158, P961, DOI 10.2214/ajr.158.5.1566697; Sumi M, 2006, AM J ROENTGENOL, V186, P749, DOI 10.2214/AJR.04.1832	27	12	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e83492	10.1371/journal.pone.0083492	http://dx.doi.org/10.1371/journal.pone.0083492			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386214	Green Published, gold, Green Submitted			2022-12-25	WOS:000329194700045
J	Garcia-Caballero, L; Quintas, V; Prada-Lopez, I; Seoane, J; Donos, N; Tomas, I				Garcia-Caballero, Lucia; Quintas, Victor; Prada-Lopez, Isabel; Seoane, Juan; Donos, Nikos; Tomas, Inmaculada			Chlorhexidine Substantivity on Salivary Flora and Plaque-Like Biofilm: An In Situ Model	PLOS ONE			English	Article							LASER-SCANNING MICROSCOPY; DENTAL BIOFILMS; BACTERIAL BIOFILMS; ANTIMICROBIAL AGENTS; ORAL HYGIENE; VIVO; MICROORGANISMS; HYBRIDIZATION; COLONIZATION; STREPTOCOCCI	Objective: To evaluate the in situ antibacterial activity of a mouthrinse with 0.2% Chlorhexidine (M-0.2% CHX) on undisturbed de novo plaque-like biofilm (PL-biofilm) and on salivary flora up to 7 hours after its application. Methods: A special acrylic appliance was designed, with 3 inserted glass disks on each buccal side, allowing for PL-biofilm growth. Fifteen healthy volunteers wore the appliance for 48 hours and then performed an M-0.2% CHX; disks were removed at 30 seconds and 1, 3, 5 and 7 hours after the mouth-rinsing. Applying a washout period, saliva samples were collected from each volunteer at 30 seconds and 1, 3, 5 and 7 hours after performing an M-0.2% CHX. The PL-biofilm and saliva samples were analysed by confocal laser scanning and epifluorescence microscopes, respectively. Results: At 30 seconds after M-0.2% CHX, the levels of viable bacteria detected in saliva were significantly lower than those observed in PL-biofilm. The difference in the percentage of live bacteria detected in saliva was significantly higher than that observed in PL-biofilm at 5 and 7 hours after M-0.2% CHX. Conclusion: After a single mouthrinse of the 0.2% CHX formulation tested in the present study, the 2-day PL-biofilm presented a significantly higher resistance to this antiseptic in situ than that observed in salivary flora. However, this 0.2% CHX formulation showed a higher substantivity on PL-biofilm than on salivary flora at 5 and 7 hours after mouth-rinsing, which could be related to the slower growth rate of PL-biofilm and the possible reservoir function for antimicrobial agents associated with the undisturbed de novo PL-biofilm.	[Garcia-Caballero, Lucia; Quintas, Victor; Prada-Lopez, Isabel; Seoane, Juan; Tomas, Inmaculada] Univ Santiago de Compostela, Oral Sci Res Grp, Sch Med & Dent, Santiago De Compostela, Spain; [Donos, Nikos] UCL Eastman Dent Inst, Periodontol Unit, London, England	Universidade de Santiago de Compostela; University of London; University College London	Tomas, I (corresponding author), Univ Santiago de Compostela, Oral Sci Res Grp, Sch Med & Dent, Santiago De Compostela, Spain.	inmaculada.tomas@usc.es	TOMAS-CARMONA, INMACULADA/M-1135-2014	TOMAS-CARMONA, INMACULADA/0000-0002-3317-0853; seoane, Juan/0000-0003-4751-591X	Carlos III Institute of Health (Ministry of Economy and Competitiveness, Madrid, Spain) [FIS PI11/01383]	Carlos III Institute of Health (Ministry of Economy and Competitiveness, Madrid, Spain)	This work was supported by project FIS PI11/01383 from Carlos III Institute of Health (Ministry of Economy and Competitiveness, Madrid, Spain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Ahmad A, 2010, J BIOMED MATER RES B, V95B, P101, DOI 10.1002/jbm.b.31688; Al-Ahmad A, 2007, J MED MICROBIOL, V56, P681, DOI 10.1099/jmm.0.47094-0; Al-Ahmad A, 2010, CLIN ORAL INVEST, V14, P391, DOI 10.1007/s00784-009-0318-9; Aparna MSPBD, 2008, BRAZ J INFECT DIS, V12, P526, DOI 10.1590/S1413-86702008000600016; Arweiler NB, 2006, J CLIN PERIODONTOL, V33, P334, DOI 10.1111/j.1600-051X.2006.00917.x; Arweiler NB, 2004, CARIES RES, V38, P442, DOI 10.1159/000079625; Arweiler NB, 2008, CLIN ORAL INVEST, V12, P203, DOI 10.1007/s00784-008-0188-6; Auschill T M, 2004, Clin Oral Investig, V8, P97; Auschill TM, 2005, J CLIN PERIODONTOL, V32, P147, DOI 10.1111/j.1600-051X.2005.00650.x; Auschill TM, 2002, EUR J ORAL SCI, V110, P48, DOI 10.1046/j.0909-8836.2001.101160.x; Auschill TM, 2001, ARCH ORAL BIOL, V46, P471, DOI 10.1016/S0003-9969(00)00136-9; Balbuena L, 1998, OTOLARYNG HEAD NECK, V118, P625, DOI 10.1016/S0194-5998(98)70231-1; Chalmers NI, 2007, APPL ENVIRON MICROB, V73, P630, DOI 10.1128/AEM.02164-06; Cousido MC, 2010, CLIN ORAL INVEST, V14, P397, DOI 10.1007/s00784-009-0320-2; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Daneshmand N, 2002, J PERIODONTAL RES, V37, P375, DOI 10.1034/j.1600-0765.2002.01003.x; Diaz J., 2010, MICROSCOPY SCI TECHN, P597; Diaz PI, 2006, APPL ENVIRON MICROB, V72, P2837, DOI 10.1128/AEM.72.4.2837-2848.2006; Dige I, 2009, ORAL MICROBIOL IMMUN, V24, P69, DOI 10.1111/j.1399-302X.2008.00482.x; Dige I, 2007, EUR J ORAL SCI, V115, P459, DOI 10.1111/j.1600-0722.2007.00494.x; Elworthy A, 1996, J PERIODONTOL, V67, P572, DOI 10.1902/jop.1996.67.6.572; Gu F, 2005, J MICROBIOL METH, V62, P145, DOI 10.1016/j.mimet.2005.02.013; Hannig C, 2009, CLIN ORAL INVEST, V13, P123, DOI 10.1007/s00784-008-0243-3; JENKINS S, 1994, J CLIN PERIODONTOL, V21, P397, DOI 10.1111/j.1600-051X.1994.tb00736.x; Jung DJ, 2010, J MICROBIOL METH, V81, P166, DOI 10.1016/j.mimet.2010.03.002; Loivukene Krista, 2005, Stomatologija, V7, P45; NAVAZESH M, 1982, J DENT RES, V61, P1158, DOI 10.1177/00220345820610100901; NETUSCHIL L, 1983, DEUT ZAHNAERZTL Z, V38, P914; Netuschil L, 1998, ARCH ORAL BIOL, V43, P277, DOI 10.1016/S0003-9969(97)00121-0; Palmer Jr R. J., 2010, COMPEND CONTIN ED DE, V31, P108; Palmer Jr RJ, 2010, COMPEND CONTIN ED DE, V31, P138; Palmer Jr RJ, 2010, COMPEND CONTIN ED DE, V31, P124; Palmer Jr RJ, 2010, COMPEND CONTIN ED DE, V31, P110; Palmer RJ, 2003, J BACTERIOL, V185, P3400, DOI 10.1128/JB.185.11.3400-3409.2003; Palmer RJ, 2001, METHOD ENZYMOL, V337, P393, DOI 10.1016/S0076-6879(01)37028-3; Palmer RJ, 2006, J BACTERIOL, V188, P4117, DOI 10.1128/JB.01958-05; Palmer Robert J Jr, 2010, Compend Contin Educ Dent, V31, P104; Roberts SK, 1999, DENT PLAQUE REVISITE, P1; Robinson C, 2006, ARCH ORAL BIOL, V51, P1006, DOI 10.1016/j.archoralbio.2006.04.010; Robinson C, 1997, CARIES RES, V31, P194, DOI 10.1159/000262398; Sreenivasan PK, 2004, ORAL MICROBIOL IMMUN, V19, P297, DOI 10.1111/j.1399-302x.2004.00158.x; Stewart PS, 2003, J BACTERIOL, V185, P1485, DOI 10.1128/JB.185.5.1485-1491.2003; Tomas I, 2010, J DENT, V38, P541, DOI 10.1016/j.jdent.2010.03.012; Tomas I, 2009, ORAL DIS, V15, P428, DOI 10.1111/j.1601-0825.2009.01570.x; van der Mei HC, 2006, J CLIN PERIODONTOL, V33, P14, DOI 10.1111/j.1600-051X.2005.00859.x; von Ohle C, 2010, APPL ENVIRON MICROB, V76, P2326, DOI 10.1128/AEM.02090-09; Watson PS, 2005, J DENT RES, V84, P451, DOI 10.1177/154405910508400510; Wecke J, 2000, FEMS MICROBIOL LETT, V191, P95, DOI 10.1016/S0378-1097(00)00376-1; Wilson M, 1996, J MED MICROBIOL, V44, P79, DOI 10.1099/00222615-44-2-79; Wood S, 1999, J PHOTOCH PHOTOBIO B, V50, P1, DOI 10.1016/S1011-1344(99)00056-1; Wood SR, 2000, J DENT RES, V79, P21, DOI 10.1177/00220345000790010201; World Health Organization, 1997, WHO OR HLTH SURV BAS, V4th; Zaura-Arite E, 2001, J DENT RES, V80, P1436, DOI 10.1177/00220345010800051001	53	34	34	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e83522	10.1371/journal.pone.0083522	http://dx.doi.org/10.1371/journal.pone.0083522			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281RE	24386220	Green Published, Green Submitted, gold			2022-12-25	WOS:000329117900042
J	Suvorov, A; Nolte, V; Pandey, RV; Franssen, SU; Futschik, A; Schlotterer, C				Suvorov, Anton; Nolte, Viola; Pandey, Ram Vinay; Franssen, Susanne U.; Futschik, Andreas; Schloetterer, Christian			Intra-Specific Regulatory Variation in Drosophila pseudoobscura	PLOS ONE			English	Article							ALLELE-SPECIFIC EXPRESSION; RNA-SEQ DATA; GENE-EXPRESSION; CIS; TRANS; DIVERGENCE; MELANOGASTER; EVOLUTION; SIMULANS; YEAST	It is generally accepted that gene regulation serves an important role in determining the phenotype. To shed light on the evolutionary forces operating on gene regulation, previous studies mainly focused on the expression differences between species and their inter-specific hybrids. Here, we use RNA-Seq to study the intra-specific distribution of cis- and trans-regulatory variation in Drosophila pseudoobscura. Consistent with previous results, we find almost twice as many genes (26%) with significant trans-effects than genes with significant cis- effects (18%). While this result supports the previous suggestion of a larger mutational target of trans-effects, we also show that trans-effects may be subjected to purifying selection. Our results underline the importance of intra-specific analyses for the understanding of the evolution of gene expression.	[Suvorov, Anton; Nolte, Viola; Pandey, Ram Vinay; Franssen, Susanne U.; Futschik, Andreas; Schloetterer, Christian] Vetmeduni Vienna, Inst Populat Genet, Vienna, Austria; [Suvorov, Anton] Vienna Grad Sch Populat Genet, Vienna, Austria; [Futschik, Andreas] Univ Linz, Dept Appl Stat, A-4040 Linz, Austria	University of Veterinary Medicine Vienna; Johannes Kepler University Linz	Schlotterer, C (corresponding author), Vetmeduni Vienna, Inst Populat Genet, Vienna, Austria.	christian.schloetterer@vetmeduni.ac.at	Schlötterer, Christian/G-6326-2010; Suvorov, Anton/AAB-1774-2019; Schlötterer, Christian/Q-5264-2019; Pandey, Ram Vinay/AAA-3544-2022; Pandey, Ram Vinay/AAL-1701-2021; Futschik, Andreas/G-3697-2010	Schlötterer, Christian/0000-0003-4710-6526; Suvorov, Anton/0000-0003-3898-9195; Schlötterer, Christian/0000-0003-4710-6526; Futschik, Andreas/0000-0002-7980-0304; Pandey, Ram Vinay/0000-0002-2533-8687; Franssen, Susanne U./0000-0002-4725-1793	Austrian Science Fund (FWF) [P22834, W1225]; European Research Council (ERC, ArchAdapt); Austrian Science Fund (FWF) [P 22834] Funding Source: researchfish	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); European Research Council (ERC, ArchAdapt); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	The laboratory of CS is supported by Austrian Science Fund (FWF, P22834, W1225) and the European Research Council (ERC, ArchAdapt). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bedford T, 2009, P NATL ACAD SCI USA, V106, P1133, DOI 10.1073/pnas.0812009106; Berriz GF, 2009, BIOINFORMATICS, V25, P3043, DOI 10.1093/bioinformatics/btp498; Degner JF, 2009, BIOINFORMATICS, V25, P3207, DOI 10.1093/bioinformatics/btp579; Doss S, 2005, GENOME RES, V15, P681, DOI 10.1101/gr.3216905; Emerson JJ, 2010, GENOME RES, V20, P826, DOI 10.1101/gr.101576.109; Genissel A, 2008, MOL BIOL EVOL, V25, P101, DOI 10.1093/molbev/msm247; Graze RM, 2009, GENETICS, V183, P547, DOI 10.1534/genetics.109.105957; Kiekens R, 2006, NUCLEIC ACIDS RES, V34, P3677, DOI 10.1093/nar/gkl510; Kliman RM, 2000, GENETICS, V156, P1913; Kofler R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015925; Landry CR, 2007, SCIENCE, V317, P118, DOI 10.1126/science.1140247; Landry CR, 2005, GENETICS, V171, P1813, DOI 10.1534/genetics.105.047449; Legrand D, 2009, GENETICS, V182, P1197, DOI 10.1534/genetics.108.092080; Lemos B, 2008, P NATL ACAD SCI USA, V105, P14471, DOI 10.1073/pnas.0805160105; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; McManus CJ, 2010, GENOME RES, V20, P816, DOI 10.1101/gr.102491.109; Osada N, 2006, MOL BIOL EVOL, V23, P1585, DOI 10.1093/molbev/msl023; Palmieri N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046415; Pandey RV, 2013, MOL ECOL RESOUR, V13, P740, DOI 10.1111/1755-0998.12110; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Schaefke B, 2013, MOL BIOL EVOL, V30, P2121, DOI 10.1093/molbev/mst114; Shi XL, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1954; Tirosh I, 2009, SCIENCE, V324, P659, DOI 10.1126/science.1169766; Wayne ML, 2004, GENETICS, V168, P1413, DOI 10.1534/genetics.104.030973; Wittkopp PJ, 2008, NAT GENET, V40, P346, DOI 10.1038/ng.77; Wittkopp PJ, 2012, NAT REV GENET, V13, P59, DOI 10.1038/nrg3095; Wittkopp PJ, 2004, NATURE, V430, P85, DOI 10.1038/nature02698; Wittkopp PJ, 2005, CELL MOL LIFE SCI, V62, P1779, DOI 10.1007/s00018-005-5064-9; Wray GA, 2007, NAT REV GENET, V8, P206, DOI 10.1038/nrg2063; Wu TD, 2010, BIOINFORMATICS, V26, P873, DOI 10.1093/bioinformatics/btq057; Zhang X, 2009, GENETICS, V182, P943, DOI 10.1534/genetics.109.103499	31	18	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e83547	10.1371/journal.pone.0083547	http://dx.doi.org/10.1371/journal.pone.0083547			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281RE	24386226	Green Submitted, Green Published, gold			2022-12-25	WOS:000329117900044
J	Wang, J; Hui, DF; Ren, H; Liu, ZF; Yang, L				Wang, Jun; Hui, Dafeng; Ren, Hai; Liu, Zhanfeng; Yang, Long			Effects of Understory Vegetation and Litter on Plant Nitrogen (N), Phosphorus (P), N:P Ratio and Their Relationships with Growth Rate of Indigenous Seedlings in Subtropical Plantations	PLOS ONE			English	Article							SOIL; NUTRITION; FERTILIZATION; STOICHIOMETRY; NUTRIENTS; REMOVAL; FOREST; CHINA; WATER	Establishing seedlings in subtropical plantations is very important for forest health, succession and management. Information on seedling nutrient concentrations is essential for both the selection of suitable indigenous tree species to accelerate succession of the established plantation and sustainable forest management. In this study, we investigated the concentrations of nitrogen ([N]), phosphorus ([P]), and N: P ratio in leaves, stems and roots of seedlings of three indigenous tree species (Castanopsis chinensis, Michelia chapensis and Psychotria rubra) transplanted with removing or retaining understory vegetation and litter at two typical subtropical forest plantations (Eucalyptus plantation and native species plantation). We also measured the relative growth rate (RGR) of seedling height, and developed the relationships between RGR and leaf [N], [P] and N: P ratio. Results showed that treatments of understory vegetation and associated litter (i.e. removal or retained) generally had no significant effects on leaf [N], [P], N: P ratio and RGR of the transplanted tree seedlings for the experimental period. But among different species, there were significant differences in nutrient concentrations. M. chapensis and P. rubra had higher [N] and [P] compared to C. chinensis. [N] and [P] also varied among different plant tissues with much higher values in leaves than in roots for all indigenous species. RGR of indigenous tree seedlings was mostly positively correlated with leaf [N] and [P], but negatively correlated with leaf N: P ratio. Considering the low [P] and high N: P ratio observed in the introduced indigenous tree seedlings, we propose that the current experimental plantations might be P limited for plant growth.	[Wang, Jun; Ren, Hai; Liu, Zhanfeng] Chinese Acad Sci, South China Bot Garden, Key Lab Vegetat Restorat & Management Degraded Ec, Guangzhou, Guangdong, Peoples R China; [Hui, Dafeng] Tennessee State Univ, Dept Biol Sci, Nashville, TN 37203 USA; [Yang, Long] Guangzhou Inst Geog, Ctr Resource & Environm, Guangzhou, Guangdong, Peoples R China	Chinese Academy of Sciences; South China Botanical Garden, CAS; Tennessee State University; Guangdong Academy of Sciences; Guangzhou Institute of Geography, Guangdong Academy of Sciences	Ren, H (corresponding author), Chinese Acad Sci, South China Bot Garden, Key Lab Vegetat Restorat & Management Degraded Ec, Guangzhou, Guangdong, Peoples R China.	renhai@scbg.ac.cn	Liu, Zhanfeng/ABD-3933-2021	Liu, Zhanfeng/0000-0002-6602-6196; Wang, Jun/0000-0003-4492-4953; Hui, Dafeng/0000-0002-5284-2897	National Natural Science Foundation of China [31100469]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (31100469). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chapin F.S., 2002, PRINCIPLES TERRESTRI, DOI 10.1007/978-1-4419-9504-9; Chen Y, 2011, ECOGRAPHY, V34; Crous JW, 2008, FOREST ECOL MANAG, V256, P712, DOI 10.1016/j.foreco.2008.05.024; Davis MR, 2007, FOREST ECOL MANAG, V240, P122, DOI 10.1016/j.foreco.2006.12.023; dos Santos UM, 2006, FOREST ECOL MANAG, V226, P299, DOI 10.1016/j.foreco.2006.01.042; Du YJ, 2008, FOREST ECOL MANAG, V255, P2495, DOI 10.1016/j.foreco.2008.01.013; Duan WJ, 2010, RESTOR ECOL, V18, P206, DOI 10.1111/j.1526-100X.2008.00444.x; Graciano C, 2006, FOREST ECOL MANAG, V236, P202, DOI 10.1016/j.foreco.2006.09.005; Gusewell S, 2004, NEW PHYTOL, V164, P243, DOI 10.1111/j.1469-8137.2004.01192.x; Han WX, 2005, NEW PHYTOL, V168, P377, DOI 10.1111/j.1469-8137.2005.01530.x; Heiskanen J, 2006, FOREST ECOL MANAG, V222, P410, DOI 10.1016/j.foreco.2005.10.047; Ibanez I, 2002, J ARID ENVIRON, V52, P209, DOI 10.1006/jare.2002.0988; Institute of soil science, 1978, SOIL PHYS CHEM AN; Kazda M, 2004, PLANT SOIL, V264, P25, DOI 10.1023/B:PLSO.0000047715.95176.63; Kranabetter JM, 2010, PLANT SOIL, V327, P389, DOI 10.1007/s11104-009-0062-6; Liu Y. H., 1996, FLORA OF CHINA; Matsushima M, 2006, FOREST ECOL MANAG, V236, P332, DOI 10.1016/j.foreco.2006.09.018; Olsen S., 1954, ESTIMATION AVAILABLE; Oskarsson H, 2006, FOREST ECOL MANAG, V229, P88, DOI 10.1016/j.foreco.2006.03.018; Park BB, 2009, FOREST ECOL MANAG, V258, P1153, DOI 10.1016/j.foreco.2009.06.003; Parker WC, 2012, FOREST ECOL MANAG, V271, P104, DOI 10.1016/j.foreco.2012.01.042; PARKINSON JA, 1975, COMMUN SOIL SCI PLAN, V6, P1, DOI 10.1080/00103627509366539; Peng YH, 2011, J PLANT ECOL-UK, V4, P147, DOI 10.1093/jpe/rtq026; Ren H, 2002, FOREST RESOURCES ITS; REN H, 1997, ACTA PHYTOECOLOGICA, V21, P386; Ribeiro C, 2002, FOREST ECOL MANAG, V171, P31, DOI 10.1016/S0378-1127(02)00459-0; Sardans J, 2006, ACTA OECOL, V29, P221, DOI 10.1016/j.actao.2005.10.006; Schuler JL, 2010, NEW FOREST, V40, P119, DOI 10.1007/s11056-009-9187-y; STANFORD S, 1949, AGRON J, V41, P446, DOI DOI 10.2134/AGRONJ1949.00021962004100090012X; Wang GG, 1997, FOREST ECOL MANAG, V98, P89, DOI 10.1016/S0378-1127(97)00048-0; Wang J, 2011, NEW FOREST, V42, P19, DOI 10.1007/s11056-010-9234-8; Wang J, 2010, FOREST ECOL MANAG, V259, P2390, DOI 10.1016/j.foreco.2010.03.015; Wu CC, 2007, FOREST ECOL MANAG, V239, P81, DOI 10.1016/j.foreco.2006.11.008; Yu Z., 1996, ECOLOGICAL STUDIES V	34	6	7	5	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e84130	10.1371/journal.pone.0084130	http://dx.doi.org/10.1371/journal.pone.0084130			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281RE	24386340	Green Submitted, Green Published, gold			2022-12-25	WOS:000329117900076
J	Zhang, YH; Yan, WS; Chen, XB				Zhang, Yanhong; Yan, Wensheng; Chen, Xinbin			Mutant p53 Cooperates with Knockdown of Endogenous Wild-Type p53 to Disrupt Tubulogenesis in Madin-Darby Canine Kidney Cells	PLOS ONE			English	Article							HEPATOCYTE GROWTH-FACTOR; EPITHELIAL-MESENCHYMAL TRANSITIONS; LI-FRAUMENI-SYNDROME; GAIN-OF-FUNCTION; SCATTER FACTOR; E6 ONCOPROTEIN; MUTATIONS; PROTEIN; CANCER; CARCINOMA	Mutation of the p53 gene is the most common genetic alteration in human malignances and associated clinically with tumor progression and metastasis. To determine the effect of mutant p53 on epithelial differentiation, we developed three-dimensional culture (3-D) of Madin-Darby canine kidney (MDCK) cells. We found that parental MDCK cells undergo a series of morphological changes and form polarized and growth-arrested cysts with hollow lumen, which resembles branching tubules in vitro. We also found that upon knockdown of endogenous wild-type p53 (p53-KD), MDCK cells still form normal cysts in 3-D culture, indicating that p53-KD alone is not sufficient to disrupt cysts formation. However, we found that ectopic expression of mutant R163H (human equivalent R175H) or R261H (human equivalent R273H) in MDCK cells leads to disruption of cyst polarity and formation of invasive aggregates, which is further compounded by knockdown of endogenous wild-type p53. Consistently, we found that expression of E-cadherin, beta-catenin, and epithelial-to-mesenchymal transition (EMT) transcription factors (Snail-1, Slug and Twist) is altered by mutant p53, which is also compounded by knockdown of wild-type p53. Moreover, the expression level of c-Met, the hepatocyte growth factor receptor and a key regulator of kidney cell tubulogenesis, is enhanced by combined knockdown of endogenous wild-type p53 and ectopic expression of mutant R163H or R261H but not by each individually. Together, our data suggest that upon inactivating mutation of the p53 gene, mutant p53 acquires its gain of function by altering morphogenesis and promoting cell migration and invasion in part by upregulating EMT and c-Met.	[Chen, Xinbin] Univ Calif Davis, Comparat Oncol Lab, Sch Med, Davis, CA 95616 USA; Univ Calif Davis, Comparat Oncol Lab, Sch Vet Med, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis	Chen, XB (corresponding author), Univ Calif Davis, Comparat Oncol Lab, Sch Med, Davis, CA 95616 USA.	xbchen@ucdavis.edu			National Institutes of Health Grant [CA 121137, CA 076069]; NATIONAL CANCER INSTITUTE [R29CA076069, R01CA121137, R01CA076069] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by National Institutes of Health Grant CA 121137 and CA 076069. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ang HC, 2006, J BIOL CHEM, V281, P21934, DOI 10.1074/jbc.M604209200; Blandino G, 1999, ONCOGENE, V18, P477, DOI 10.1038/sj.onc.1202314; Bossi G, 2008, CELL CYCLE, V7, P1870, DOI 10.4161/cc.7.12.6161; BOTTARO DP, 1991, SCIENCE, V251, P802, DOI 10.1126/science.1846706; Brosh R, 2009, NAT REV CANCER, V9, P701, DOI 10.1038/nrc2693; Cadwell C, 2001, GENE, V277, P15, DOI 10.1016/S0378-1119(01)00696-5; CHO YJ, 1994, SCIENCE, V265, P346, DOI 10.1126/science.8023157; Chow WH, 1999, JAMA-J AM MED ASSOC, V281, P1628, DOI 10.1001/jama.281.17.1628; CLARK P, 1994, J CELL SCI, V107, P1265; Comoglio PM, 2001, SEMIN CANCER BIOL, V11, P153, DOI 10.1006/scbi.2000.0366; Conant JL, 2011, J CLIN PATHOL, V64, P1088, DOI 10.1136/jclinpath-2011-200216; Dong P, 2013, ONCOGENE, V32, P3286, DOI 10.1038/onc.2012.334; El-Hizawi S, 2002, CANCER RES, V62, P3264; Engelberg JA, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002030; Freed-Pastor WA, 2012, CELL, V148, P244, DOI 10.1016/j.cell.2011.12.017; Girgin C, 2001, UROL INT, V66, P78, DOI 10.1159/000056575; HOLLSTEIN M, 1994, NUCLEIC ACIDS RES, V22, P3551; HUIBREGTSE JM, 1993, MOL CELL BIOL, V13, P775, DOI 10.1128/MCB.13.2.775; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Jiang W, 1999, CRIT REV ONCOL HEMAT, V29, P209, DOI 10.1016/S1040-8428(98)00019-5; Keleti J, 1996, AM J PATHOL, V149, P143; Kirpensteijn J, 2008, VET SURG, V37, P454, DOI 10.1111/j.1532-950X.2008.00407.x; Ko LJ, 1996, GENE DEV, V10, P1054, DOI 10.1101/gad.10.9.1054; Kogan-Sakin I, 2011, CELL DEATH DIFFER, V18, P271, DOI 10.1038/cdd.2010.94; LANE DP, 1979, NATURE, V278, P261, DOI 10.1038/278261a0; Lang GA, 2004, CELL, V119, P861, DOI 10.1016/j.cell.2004.11.006; Lim SO, 2010, FEBS LETT, V584, P2231, DOI 10.1016/j.febslet.2010.04.006; Lindsay J, 2011, J BIOL CHEM, V286, P3915, DOI 10.1074/jbc.M110.162511; MCATEER JA, 1987, ANAT REC, V217, P229, DOI 10.1002/ar.1092170303; MILNER J, 1991, CELL, V65, P765, DOI 10.1016/0092-8674(91)90384-B; Muller PAJ, 2013, ONCOGENE, V32, P1252, DOI 10.1038/onc.2012.148; Muller PAJ, 2011, J CELL BIOL, V192, P209, DOI 10.1083/jcb.201009059; O'Brien LE, 2006, METHOD ENZYMOL, V406, P676, DOI 10.1016/S0076-6879(06)06053-8; Olive KP, 2004, CELL, V119, P847, DOI 10.1016/j.cell.2004.11.004; Oren M, 1999, J BIOL CHEM, V274, P36031, DOI 10.1074/jbc.274.51.36031; Petitjean A, 2007, ONCOGENE, V26, P2157, DOI 10.1038/sj.onc.1210302; Petitjean A, 2007, HUM MUTAT, V28, P622, DOI 10.1002/humu.20495; Pisters LL, 1997, J UROLOGY, V158, P724, DOI 10.1016/S0022-5347(01)64301-5; Prives C, 1999, J PATHOL, V187, P112; REITER RE, 1993, CANCER RES, V53, P3092; SAH VP, 1995, NAT GENET, V10, P175, DOI 10.1038/ng0695-175; Saifudeen Z, 2002, AM J PHYSIOL-RENAL, V283, pF727, DOI 10.1152/ajprenal.00114.2002; Sarig R, 2010, J EXP MED, V207, P2127, DOI 10.1084/jem.20100797; SAXEN L, 1987, PEDIATR NEPHROL, V1, P385, DOI 10.1007/BF00849241; SCHEFFNER M, 1992, J VIROL, V66, P5100, DOI 10.1128/JVI.66.8.5100-5105.1992; SONNENBERG E, 1993, J CELL BIOL, V123, P223, DOI 10.1083/jcb.123.1.223; Strano S, 2002, J BIOL CHEM, V277, P18817, DOI 10.1074/jbc.M201405200; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Tucci P, 2012, P NATL ACAD SCI USA, V109, P15312, DOI 10.1073/pnas.1110977109; Wang SP, 2009, NAT CELL BIOL, V11, P694, DOI 10.1038/ncb1875; Wang XW, 1997, J CELL PHYSIOL, V173, P247, DOI 10.1002/(SICI)1097-4652(199711)173:2<247::AID-JCP30>3.0.CO;2-A; Willis A, 2004, ONCOGENE, V23, P2330, DOI 10.1038/sj.onc.1207396; Zeisberg M, 2009, J CLIN INVEST, V119, P1429, DOI 10.1172/JCI36183; Zhang Y, 2013, ONCOGENE; Zhang YH, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.214585; Zigeuner R, 2004, UROLOGY, V63, P651, DOI 10.1016/j.urology.2003.11.011	56	6	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e85624	10.1371/journal.pone.0085624	http://dx.doi.org/10.1371/journal.pone.0085624			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281RE	24386484	Green Submitted, gold, Green Published			2022-12-25	WOS:000329117900131
J	Berry, M; Jaquiery, A; Oliver, M; Harding, J; Bloomfield, F				Berry, Mary; Jaquiery, Anne; Oliver, Mark; Harding, Jane; Bloomfield, Frank			Preterm Birth Has Sex-Specific Effects on Autonomic Modulation of Heart Rate Variability in Adult Sheep	PLOS ONE			English	Article							LEFT-VENTRICULAR MASS; GESTATIONAL-AGE; BLOOD-PRESSURE; RISK-FACTORS; YOUNG; HYPERTENSION; CONTRIBUTES; STRESS; SYSTEM; FETAL	Introduction: Globally, 11% of infants are born preterm. In adulthood, individuals born preterm are at increased risk of cardiovascular morbidity and mortality, but the mechanistic basis of this remains unknown. Clinically overt cardiovascular disease may be preceded by altered cardiac autonomic activity characterised by increased sympathetic activity and/or reduced parasympathetic activity. Thus, altered cardiac autonomic activity in survivors of preterm birth may underlie later cardiovascular risk. Objective: To investigate the impact of gestational age on cardiac autonomic activity in juvenile and adult sheep. Methods and Results: Singleton-bearing ewes were randomised antenatally to spontaneous term birth (TC; n=73) or corticosteroid induced preterm birth (PT; n=60). Cardiac autonomic modulation was assessed using heart rate variability analysis in juvenile and adult offspring. Preterm birth in adult males was associated with altered sympathovagal modulation (LFnu: PT 64 +/- 4 vs. TC 49 +/- 4, p<0.05; LogLF/HF: PT 1.8 +/- 0.1 vs. TC 1.5 +/- 0.1, p<0.05) and reduced parasympathetic modulation (LogRMSSD: PT 2.9 +/- 0.2 vs. TC 3.4 +/- 0.1, p<0.05; LogNN50: PT 0.3 +/- 0.4 vs. TC 1.6 +/- 0.4, p<0.05). Within the range of term birth, each one-day increment in gestational age was associated with a decrement in LFnu in juvenile females and with a decrement in LFnu and LF/HF ratio, but an increment in RMSSD and NN50 in adult females. Conclusions: Cardiac autonomic function in adult sheep is affected in a sex-specific manner by gestational age at birth, even within the term range. Altered cardiac autonomic function may contribute to increased later cardiovascular morbidity in those born preterm.	[Berry, Mary; Jaquiery, Anne; Oliver, Mark; Harding, Jane; Bloomfield, Frank] Univ Auckland, Liggins Inst, Auckland 1, New Zealand; [Jaquiery, Anne; Oliver, Mark; Bloomfield, Frank] Univ Auckland, Natl Ctr Growth & Dev, Auckland 1, New Zealand; [Jaquiery, Anne; Bloomfield, Frank] Univ Auckland, Dept Paediat Child & Youth Hlth, Auckland 1, New Zealand	University of Auckland; University of Auckland; University of Auckland	Berry, M (corresponding author), Univ Auckland, Liggins Inst, Auckland 1, New Zealand.	max.berry@otago.ac.nz	Harding, Jane E/J-5853-2015	Harding, Jane E/0000-0003-2697-1422; Oliver, Mark/0000-0002-0359-2297; Bloomfield, Frank/0000-0001-6424-6577	Health Research Council, New Zealand; National Research Centre for Growth and Development, New Zealand	Health Research Council, New Zealand(Health Research Council of New Zealand); National Research Centre for Growth and Development, New Zealand	Funding provided by Health Research Council, New Zealand, National Research Centre for Growth and Development, New Zealand. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	ANZNN (Australian and New Zealand Neonatal Network), 2011, REP AUSTR NZ NEON NE; Billman GE, 2013, FRONT PHYSIOL, V4, DOI [10.3389/fphys.2013.00026, 10.3389/fphys.2013.00222]; Bonamy AKE, 2007, J INTERN MED, V262, P635, DOI 10.1111/j.1365-2796.2007.01868.x; Bonamy AKE, 2008, ACTA PAEDIATR, V97, P1080, DOI 10.1111/j.1651-2227.2008.00890.x; Bonamy AKE, 2008, ACTA PAEDIATR, V97, P434, DOI 10.1111/j.1651-2227.2008.00723.x; Boudreau P, 2012, CHRONOBIOL INT, V29, P757, DOI 10.3109/07420528.2012.674592; Boyle EM, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e896; Burns J, 2007, CIRCULATION, V115, P1999, DOI 10.1161/CIRCULATIONAHA.106.668863; Camm AJ, 1996, CIRCULATION, V93, P1043; Cohen G, 2008, CIRCULATION, V118, P1848, DOI 10.1161/CIRCULATIONAHA.108.783902; Crump C, 2011, JAMA-J AM MED ASSOC, V306, P1233, DOI 10.1001/jama.2011.1331; Crump C, 2011, AM J EPIDEMIOL, V173, P797, DOI 10.1093/aje/kwq440; Dalziel SR, 2007, INT J EPIDEMIOL, V36, P907, DOI 10.1093/ije/dym067; Dart AM, 2002, CARDIOVASC RES, V53, P678, DOI 10.1016/S0008-6363(01)00508-9; Davrath LR, 2003, AM J PHYSIOL-HEART C, V285, pH1697, DOI 10.1152/ajpheart.00208.2003; De Matteo R, 2010, REPROD SCI, V17, P724, DOI 10.1177/1933719110369182; Erami C, 2005, AM J PHYSIOL-HEART C, V289, pH744, DOI 10.1152/ajpheart.00129.2005; Feldt K, 2007, J HUM HYPERTENS, V21, P401, DOI 10.1038/sj.jhh.1002176; Fisher JP, 2012, J HUM HYPERTENS, V26, P463, DOI 10.1038/jhh.2011.66; Frasch MG, 2007, J PHYSIOL-LONDON, V579, P893, DOI 10.1113/jphysiol.2006.124800; Giuffre M, 2012, J MATERN-FETAL NEO M, V25, P6, DOI 10.3109/14767058.2012.712350; Hernandez CE, 2009, BEHAV BRAIN RES, V204, P82, DOI 10.1016/j.bbr.2009.05.019; Kuo TBJ, 2010, ENDOCRINOLOGY, V151, P2613, DOI 10.1210/en.2009-1410; Lewandowski AJ, 2013, CIRCULATION, V127, P197, DOI 10.1161/CIRCULATIONAHA.112.126920; Lucini D, 2002, CIRCULATION, V106, P2673, DOI 10.1161/01.CIR.0000039106.89299.AB; Masuo K, 1997, AM J HYPERTENS, V10, P77, DOI 10.1016/S0895-7061(96)00303-2; Mitoff PR, 2011, HEART, V97, P382, DOI 10.1136/hrt.2010.199760; Patural H, 2008, EARLY HUM DEV, V84, P681, DOI 10.1016/j.earlhumdev.2008.04.010; Patural H, 2010, RES VET SCI, V89, P242, DOI 10.1016/j.rvsc.2010.01.019; Reefmann N, 2009, PHYSIOL BEHAV, V98, P235, DOI 10.1016/j.physbeh.2009.05.017; Ribatti D, 2007, PHARMACOL REV, V59, P185, DOI 10.1124/pr.59.2.3; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046; Segar JL, 1998, AM J PHYSIOL-REG I, V274, pR160, DOI 10.1152/ajpregu.1998.274.1.R160; Thompson JMD, 2006, PAEDIATR PERINAT EP, V20, P182, DOI 10.1111/j.1365-3016.2006.00711.x; Vaseghi M, 2008, PROG CARDIOVASC DIS, V50, P404, DOI 10.1016/j.pcad.2008.01.003; von Borell E, 2007, PHYSIOL BEHAV, V92, P293, DOI 10.1016/j.physbeh.2007.01.007; WALKER AM, 1978, BIOL NEONATE, V33, P135, DOI 10.1159/000241063; Yang S, 2010, AM J EPIDEMIOL, V171, P399, DOI 10.1093/aje/kwp413	38	9	9	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e85468	10.1371/journal.pone.0085468	http://dx.doi.org/10.1371/journal.pone.0085468			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281QS	24386475	Green Submitted, gold, Green Published			2022-12-25	WOS:000329116700139
J	Franciotti, R; D'Ascenzo, S; Di Domenico, A; Onofrj, M; Tommasi, L; Laeng, B				Franciotti, Raffaella; D'Ascenzo, Stefania; Di Domenico, Alberto; Onofrj, Marco; Tommasi, Luca; Laeng, Bruno			Focusing Narrowly or Broadly Attention When Judging Categorical and Coordinate Spatial Relations: A MEG Study	PLOS ONE			English	Article							HEMISPHERIC-SPECIALIZATION; VISUAL-ATTENTION; UNILATERAL STROKE; PARIETAL CORTEX; TASK-DIFFICULTY; TIME-COURSE; STIMULI; RESOLUTION; VOLUNTARY; OBJECTS	We measured activity in the dorsal system of the human cortex with magnetoencephalography (MEG) during a matching-to-sample plus cueing paradigm, where participants judged the occurrence of changes in either categorical or coordinate spatial relations (e. g., exchanges of left versus right positions or changes in the relative distances) between images of pairs of animals. The attention window was primed in each trial to be either small or large by using cues that immediately preceded the matching image. In this manner, we could assess the modulatory effects of the scope of attention on the activity of the dorsal system of the human cortex during spatial relations processing. The MEG measurements revealed that large spatial cues yielded greater activations and longer peak latencies in the right inferior parietal lobe for coordinate trials, whereas small cues yielded greater activations and longer peak latencies in the left inferior parietal lobe for categorical trials. The activity in the superior parietal lobe, middle frontal gyrus, and visual cortex, was also modulated by the size of the spatial cues and by the type of spatial relation change. The present results support the theory that the lateralization of each kind of spatial processing hinges on differences in the sizes of regions of space attended to by the two hemispheres. In addition, the present findings are inconsistent with the idea of a right-hemispheric dominance for all kinds of challenging spatial tasks, since response times and accuracy rates showed that the categorical spatial relation task was more difficult than the coordinate task and the cortical activations were overall greater in the left hemisphere than in the right hemisphere.	[Franciotti, Raffaella; D'Ascenzo, Stefania; Di Domenico, Alberto; Onofrj, Marco] Univ G DAnnunzio, Dept Neurosci & Imaging, Chieti, Italy; [Franciotti, Raffaella] Univ G dAnnunzio, ITAB, Chieti, Italy; [Tommasi, Luca] Univ G DAnnunzio, Dept Psychol Humanities & Terr, Chieti, Italy; [Laeng, Bruno] Univ Oslo, Dept Psychol, Oslo, Norway	G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara; University of Oslo	Franciotti, R (corresponding author), Univ G DAnnunzio, Dept Neurosci & Imaging, Chieti, Italy.	raffaella.franciotti@itab.unich.it	onofrj, marco/K-7710-2016; Di Domenico, Alberto/AIB-7965-2022; Franciotti, Raffaella/AAC-2664-2022; Di Domenico, Alberto/O-2111-2015	onofrj, marco/0000-0002-0480-2495; Di Domenico, Alberto/0000-0002-9962-2891; Di Domenico, Alberto/0000-0002-9962-2891; Tommasi, Luca/0000-0003-0664-714X				Amorapanth PX, 2010, J COGNITIVE NEUROSCI, V22, P1739, DOI 10.1162/jocn.2009.21322; Baciu M, 1999, NEUROREPORT, V10, P1373, DOI 10.1097/00001756-199904260-00040; Ballard BH, 1986, BEHAV BRAIN SCI, V9, P67; Baumann O, 2012, NEUROIMAGE, V60, P1630, DOI 10.1016/j.neuroimage.2012.01.089; Borst G, 2010, NEUROPSYCHOLOGIA, V48, P2769, DOI 10.1016/j.neuropsychologia.2010.04.027; Brancucci A, 2011, J NEUROSCI, V31, P16611, DOI 10.1523/JNEUROSCI.3949-11.2011; Brookes MJ, 2011, NEUROIMAGE, V56, P1082, DOI 10.1016/j.neuroimage.2011.02.054; Cabeza R, 2012, TRENDS COGN SCI, V16, P338, DOI 10.1016/j.tics.2012.04.008; Carpenter PS, 1999, J COGNITIVE NEUROSCI, V31, P16611; CASTIELLO U, 1990, ACTA PSYCHOL, V73, P195, DOI 10.1016/0001-6918(90)90022-8; Chen Y, 2008, NAT NEUROSCI, V11, P974, DOI 10.1038/nn.2147; Della Penna S, 2004, NEUROIMAGE, V22, P1438, DOI 10.1016/j.neuroimage.2004.03.045; Della Penna S, 2000, PHILOS MAG B, V80, P937, DOI 10.1080/01418630008221960; ERIKSEN CW, 1986, PERCEPT PSYCHOPHYS, V40, P225, DOI 10.3758/BF03211502; Eurich CW, 1997, BIOL CYBERN, V76, P357, DOI 10.1007/s004220050349; FAHLE M, 1981, PROC R SOC SER B-BIO, V213, P451, DOI 10.1098/rspb.1981.0075; FOLK CL, 1992, J EXP PSYCHOL HUMAN, V18, P1030, DOI 10.1037/0096-1523.18.4.1030; Franciotti R, 2009, NEUROIMAGE, V46, P1082, DOI 10.1016/j.neuroimage.2009.03.034; Franconeri SL, 2012, COGNITION, V122, P210, DOI 10.1016/j.cognition.2011.11.002; Goense JBM, 2008, CURR BIOL, V18, P631, DOI 10.1016/j.cub.2008.03.054; HAYWARD WG, 1995, COGNITION, V55, P39, DOI 10.1016/0010-0277(94)00643-Y; Hellige JB., 2010, 2 HALVES BRAIN, V2002, P379, DOI [10.7551/mitpress/9780262014137.003.0279, DOI 10.7551/MITPRESS/9780262014137.003.0279]; Hemond CC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000574; Hinton G. E., 1986, FOUNDATIONS, V1, P77; Hubner R, 2002, PERCEPT PSYCHOPHYS, V64, P1290, DOI 10.3758/BF03194772; HUMPHREYS GW, 1981, Q J EXP PSYCHOL-A, V33, P17, DOI 10.1080/14640748108400765; JACOBS RA, 1994, COGNITIVE SCI, V18, P361, DOI 10.1207/s15516709cog1803_1; Jager G, 2003, NEUROPSYCHOLOGIA, V41, P504, DOI 10.1016/S0028-3932(02)00086-6; Jonides J., 1981, ATTENTION PERFORM, P187, DOI DOI 10.1037/0096-1523.29.5.835; Kosslyn S.M., 1994, IMAGE BRAIN RESOLUTI, P516; KOSSLYN SM, 1989, J EXP PSYCHOL HUMAN, V15, P723, DOI 10.1037/0096-1523.15.4.723; KOSSLYN SM, 1992, J EXP PSYCHOL HUMAN, V18, P562, DOI 10.1037/0096-1523.18.2.562; KOSSLYN SM, 1987, PSYCHOL REV, V94, P148, DOI 10.1037/0033-295X.94.2.148; Kosslyn SM, 1998, PSYCHOBIOLOGY, V26, P333; Laeng B, 2003, ASYMMETRICAL BRAIN, P303; Laeng B, 2002, COGN NEUROPSYCHOL, V19, P697, DOI 10.1080/02643290244000121; Laeng B, 1999, COGNITION, V70, P53, DOI 10.1016/S0010-0277(98)00077-8; LAENG B, 1994, J COGNITIVE NEUROSCI, V6, P189, DOI 10.1162/jocn.1994.6.3.189; Laeng B, 2006, NEUROPSYCHOLOGIA, V44, P1595, DOI 10.1016/j.neuropsychologia.2006.01.023; Laeng B, 2011, COGNITIVE SCI, V35, P297, DOI 10.1111/j.1551-6709.2010.01139.x; Liu HH, 2006, NEUROREPORT, V17, P19, DOI 10.1097/01.wnr.0000195666.22714.35; LOFTUS GR, 1994, PSYCHON B REV, V1, P476, DOI 10.3758/BF03210951; LURIA AR, 1973, WORKING BRAIN INTRO, P398; Maringelli F, 1998, EUR J COGN PSYCHOL, V10, P225; Martin R, 2008, NEUROPSYCHOLOGIA, V46, P576, DOI 10.1016/j.neuropsychologia.2007.10.010; Michimata C, 2011, BRAIN COGNITION, V77, P292, DOI 10.1016/j.bandc.2011.07.008; MULLER HJ, 1989, J EXP PSYCHOL HUMAN, V15, P315, DOI 10.1037/0096-1523.15.2.315; NAKAYAMA K, 1989, VISION RES, V29, P1631, DOI 10.1016/0042-6989(89)90144-2; Okubo M, 2010, ACTA PSYCHOL, V135, P1, DOI 10.1016/j.actpsy.2010.04.004; Palermo L, 2008, NEUROPSYCHOLOGIA, V46, P2802, DOI 10.1016/j.neuropsychologia.2008.05.020; Pascual-Marqui RD, 2002, METHOD FIND EXP CLIN, V24, P91; Prinzmetal W, 2005, PERCEPT PSYCHOPHYS, V67, P48, DOI 10.3758/BF03195012; Robertson LC, 1999, PSYCHOL SCI, V10, P76, DOI 10.1111/1467-9280.00110; Samonas M, 1997, IEEE T BIO-MED ENG, V44, P386, DOI 10.1109/10.568914; Silver MA, 2009, TRENDS COGN SCI, V13, P488, DOI 10.1016/j.tics.2009.08.005; Slotnick SD, 2006, NEUROPSYCHOLOGIA, V44, P1560, DOI 10.1016/j.neuropsychologia.2006.01.018; Slotnick SD, 2001, J COGNITIVE NEUROSCI, V13, P1088, DOI 10.1162/089892901753294383; Steger J, 2001, PSYCHOPHYSIOLOGY, V38, P243; STOFFER TH, 1993, PSYCHOL RES-PSYCH FO, V56, P14, DOI 10.1007/BF00572129; THEEUWES J, 1994, PERCEPTION, V23, P429, DOI 10.1068/p230429; Trojano L, 2002, NEUROPSYCHOLOGIA, V40, P1666, DOI 10.1016/S0028-3932(02)00021-0; Trojano L, 2006, NEUROPSYCHOLOGIA, V44, P1569, DOI 10.1016/j.neuropsychologia.2006.01.017; Turatto M, 2000, PERCEPT PSYCHOPHYS, V62, P935, DOI 10.3758/BF03212079; van der Ham IJM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038644; VANKLEECK MH, 1989, NEUROPSYCHOLOGIA, V27, P1165, DOI 10.1016/0028-3932(89)90099-7; VanVeen BD, 1997, IEEE T BIO-MED ENG, V44, P867, DOI 10.1109/10.623056; Vilberg KL, 2008, NEUROPSYCHOLOGIA, V46, P1787, DOI 10.1016/j.neuropsychologia.2008.01.004; Volberg G, 2007, EXP PSYCHOL, V54, P83, DOI 10.1027/1618-3169.54.1.83; Waberski TD, 2001, NEUROSCI LETT, V308, P107, DOI 10.1016/S0304-3940(01)01988-7; WARD LM, 1982, J EXP PSYCHOL HUMAN, V8, P562, DOI 10.1037/0096-1523.8.4.562; YANTIS S, 1994, J EXP PSYCHOL HUMAN, V20, P95, DOI 10.1037/0096-1523.20.1.95; Yeshurun Y, 2008, PERCEPT PSYCHOPHYS, V70, P104, DOI 10.3758/PP.70.1.104	72	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e83434	10.1371/journal.pone.0083434	http://dx.doi.org/10.1371/journal.pone.0083434			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	281QS	24386197	Green Published, Green Submitted, gold			2022-12-25	WOS:000329116700049
J	Blenner, MA; Dong, XC; Springer, TA				Blenner, Mark A.; Dong, Xianchi; Springer, Timothy A.			Structural Basis of Regulation of von Willebrand Factor Binding to Glycoprotein Ib	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Directed Evolution; Immunology; Protein Folding; Structural Biology; von Willebrand Factor; Glycoprotein Ib; Yeast Display	FACTOR A1 DOMAIN; LEUCINE-RICH REPEATS; IX-V COMPLEX; CRYSTAL-STRUCTURE; ALPHA-THROMBIN; SNAKE-VENOM; DISEASE; RECEPTOR; ADHESION; REVEALS	Background: Force in fluid flow regulates von Willebrand factor (VWF) A1 domain binding to glycoprotein Ib (GPIb). Results: X-ray crystal structures of high affinity A1-GPIb complexes and mutations reveal interactions involving central leucine-rich repeats of GPIb. Conclusion: Structural changes are on a pathway to a force-induced super high affinity state. Significance: A1-GPIb complexes provide insight into mechanochemistry of bleeding disorders. Activation by elongational flow of von Willebrand factor (VWF) is critical for primary hemostasis. Mutations causing type 2B von Willebrand disease (VWD), platelet-type VWD (PT-VWD), and tensile force each increase affinity of the VWF A1 domain and platelet glycoprotein Ib (GPIb) for one another; however, the structural basis for these observations remains elusive. Directed evolution was used to discover a further gain-of-function mutation in A1 that shifts the long range disulfide bond by one residue. We solved multiple crystal structures of this mutant A1 and A1 containing two VWD mutations complexed with GPIb containing two PT-VWD mutations. We observed a gained interaction between A1 and the central leucine-rich repeats (LRRs) of GPIb, previously shown to be important at high shear stress, and verified its importance mutationally. These findings suggest that structural changes, including central GPIb LRR-A1 contact, contribute to VWF affinity regulation. Among the mutant complexes, variation in contacts and poor complementarity between the GPIb -finger and the region of A1 harboring VWD mutations lead us to hypothesize that the structures are on a pathway to, but have not yet reached, a force-induced super high affinity state.	[Springer, Timothy A.] Harvard Univ, Sch Med, Boston Childrens Hosp, Program Cellular & Mol Med, Boston, MA 02115 USA; [Springer, Timothy A.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Harvard Medical School	Springer, TA (corresponding author), Harvard Univ, Sch Med, Boston Childrens Hosp, Program Cellular & Mol Med, 3 Blackfan Circle, Boston, MA 02115 USA.	timothy.springer@childrens.harvard.edu	Blenner, Mark/AAP-9422-2021; Dong, Xianchi/C-1393-2015	Dong, Xianchi/0000-0001-5121-1236	National Institutes of Health [HL-103526, NIH-1F32HL-099167]; American Heart Association [AHA-10POST4170043]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL099167, R01HL108248, P01HL103526] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL-103526 and Postdoctoral Fellowship NIH-1F32HL-099167 (to M. A. B.). This work was also supported by American Heart Association Postdoctoral Fellowship AHA-10POST4170043 (to M. A. B.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Boder ET, 1997, NAT BIOTECHNOL, V15, P553, DOI 10.1038/nbt0697-553; Cauwenberghs N, 2001, BLOOD, V98, P652, DOI 10.1182/blood.V98.3.652; Celikel R, 2000, NAT STRUCT BIOL, V7, P881; Celikel R, 2003, SCIENCE, V301, P218, DOI 10.1126/science.1084183; Celikel R, 1998, NAT STRUCT BIOL, V5, P189, DOI 10.1038/nsb0398-189; Chao G, 2006, NAT PROTOC, V1, P755, DOI 10.1038/nprot.2006.94; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; De Luca M, 2000, BLOOD, V95, P164; Dong JF, 2001, BLOOD, V97, P162, DOI 10.1182/blood.V97.1.162; Dumas JJ, 2004, J BIOL CHEM, V279, P23327, DOI 10.1074/jbc.M401659200; Dumas JJ, 2003, SCIENCE, V301, P222, DOI 10.1126/science.1083917; Emsley J, 1998, J BIOL CHEM, V273, P10396, DOI 10.1074/jbc.273.17.10396; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Enkhbayar P, 2004, PROTEINS, V54, P394, DOI 10.1002/prot.10605; Flood VH, 2009, J THROMB HAEMOST, V7, P1832, DOI 10.1111/j.1538-7836.2009.03594.x; Flood VH, 2010, BLOOD, V116, P280, DOI 10.1182/blood-2009-10-249102; Fukuda K, 2005, NAT STRUCT MOL BIOL, V12, P152, DOI 10.1038/nsmb892; Fukuda K, 2002, STRUCTURE, V10, P943, DOI 10.1016/S0969-2126(02)00787-6; GINSBURG D, 1993, THROMB HAEMOSTASIS, V69, P177; Huang RH, 2009, STRUCTURE, V17, P1476, DOI 10.1016/j.str.2009.09.011; Huizinga EG, 2002, SCIENCE, V297, P1176, DOI 10.1126/science.107355; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Kim J, 2010, NATURE, V466, P992, DOI 10.1038/nature09295; Luo BH, 2007, ANNU REV IMMUNOL, V25, P619, DOI 10.1146/annurev.immunol.25.022106.141618; Maita N, 2003, J BIOL CHEM, V278, P37777, DOI 10.1074/jbc.M305566200; McEwan PA, 2009, BLOOD, V114, P4883, DOI 10.1182/blood-2009-05-224170; Mi LZ, 2008, BIOCHEMISTRY-US, V47, P10314, DOI 10.1021/bi801006s; Miura S, 2000, J BIOL CHEM, V275, P7539, DOI 10.1074/jbc.275.11.7539; Othman M, 2013, SEMIN THROMB HEMOST, V39, P663, DOI 10.1055/s-0033-1353442; Ruggeri ZM, 2007, CIRC RES, V100, P1673, DOI 10.1161/01.RES.0000267878.97021.ab; Sadler JE, 2005, ANNU REV MED, V56, P173, DOI 10.1146/annurev.med.56.082103.104713; Sadler JE, 1998, ANNU REV BIOCHEM, V67, P395, DOI 10.1146/annurev.biochem.67.1.395; Savage B, 1996, CELL, V84, P289, DOI 10.1016/S0092-8674(00)80983-6; Schneider SW, 2007, P NATL ACAD SCI USA, V104, P7899, DOI 10.1073/pnas.0608422104; Schurpf T, 2011, EMBO J, V30, P4712, DOI 10.1038/emboj.2011.333; Shen Y, 2000, BLOOD, V95, P903, DOI 10.1182/blood.V95.3.903.003k37_903_910; Shen Y, 2006, J BIOL CHEM, V281, P26419, DOI 10.1074/jbc.M604296200; Song GJ, 2012, P NATL ACAD SCI USA, V109, P21420, DOI 10.1073/pnas.1218581109; Springer TA, 2011, J THROMB HAEMOST, V9, P130, DOI 10.1111/j.1538-7836.2011.04320.x; Tait AS, 2001, BLOOD, V98, P1812, DOI 10.1182/blood.V98.6.1812; Uff S, 2002, J BIOL CHEM, V277, P35657, DOI 10.1074/jbc.M205271200; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Varughese KI, 2004, ACTA CRYSTALLOGR D, V60, P405, DOI 10.1107/S0907444903026805; WAGNER DD, 1990, ANNU REV CELL BIOL, V6, P217, DOI 10.1146/annurev.cellbio.6.1.217; Yago T, 2008, J CLIN INVEST, V118, P3195, DOI 10.1172/JCI35754; Zaccolo M, 1996, J MOL BIOL, V255, P589, DOI 10.1006/jmbi.1996.0049; Zarpellon A, 2011, P NATL ACAD SCI USA, V108, P8628, DOI 10.1073/pnas.1017042108; Zhang XH, 2009, SCIENCE, V324, P1330, DOI 10.1126/science.1170905; Zhou YF, 2011, EMBO J, V30, P4098, DOI 10.1038/emboj.2011.297	51	47	49	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 28	2014	289	9					5565	5579		10.1074/jbc.M113.511220	http://dx.doi.org/10.1074/jbc.M113.511220			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB8BQ	24391089	hybrid, Green Published			2022-12-25	WOS:000332015500022
J	Hoffmann, C; Zimmermann, A; Hinney, A; Volckmar, AL; Jarrett, HW; Fromme, T; Klingenspor, M				Hoffmann, Christoph; Zimmermann, Anika; Hinney, Anke; Volckmar, Anna-Lena; Jarrett, Harry W.; Fromme, Tobias; Klingenspor, Martin			A Novel SP1/SP3 Dependent Intronic Enhancer Governing Transcription of the UCP3 Gene in Brown Adipocytes	PLOS ONE			English	Article							ACTIVATED RECEPTOR-GAMMA; FREE FATTY-ACIDS; UNCOUPLING PROTEIN-3; SKELETAL-MUSCLE; ADIPOSE-TISSUE; PPAR-DELTA; EXPRESSION; METABOLISM; PATHWAYS; EXERCISE	Uncoupling protein (UCP) 3 is a mitochondrial inner membrane protein implicated in lipid handling and metabolism of reactive oxygen species. Its transcription is mainly regulated by peroxisome proliferator-activated receptors (PPAR), a family of nuclear hormone receptors. Employing bandshift assays, RNA interference and reporter gene assays we examine an intronic region in the UCP3 gene harboring a cis-element essential for expression in brown adipocytes. We demonstrate binding of SP1 and SP3 to this element which is adjacent to a direct repeat 1 element mediating activation of UCP3 expression by PPAR gamma agonists. Transactivation mediated by these elements is interdependent and indispensable for UCP3 expression. Systematic deletion uncovered a third binding element, a putative NF1 site, in close proximity to the SP1/3 and PPAR gamma binding elements. Data mining demonstrated binding of MyoD and Myogenin to this third element in C2C12 cells, and, furthermore, revealed recruitment of p300. Taken together, this intronic region is the main enhancer driving UCP3 expression with SP1/3 and PPAR gamma as the core factors required for expression.	[Hoffmann, Christoph; Zimmermann, Anika; Fromme, Tobias; Klingenspor, Martin] Tech Univ Munich, Else Kroner Fresenius Ctr, Freising Weihenstephan, Germany; [Hoffmann, Christoph; Zimmermann, Anika; Fromme, Tobias; Klingenspor, Martin] Tech Univ Munich, Res Ctr Nutr & Food Sci, Freising Weihenstephan, Germany; [Hinney, Anke; Volckmar, Anna-Lena] Univ Duisburg Essen, Univ Klinikum Essen, Dept Child & Adolescent Psychiat Psychosomat & Ps, Essen, Germany; [Jarrett, Harry W.] Univ Texas San Antonio, Dept Chem, San Antonio, TX USA	Technical University of Munich; Technical University of Munich; University of Duisburg Essen; University of Texas System; University of Texas at San Antonio (UTSA)	Klingenspor, M (corresponding author), Tech Univ Munich, Else Kroner Fresenius Ctr, Freising Weihenstephan, Germany.	mk@tum.de	Fromme, Tobias/AAU-8982-2020; Klingenspor, Martin/K-5033-2019; Klingenspor, Martin/D-6930-2011; Hinney, Anke/D-6953-2011; Volckmar, Anna-Lena/ABE-3676-2021	Fromme, Tobias/0000-0001-9150-2513; Klingenspor, Martin/0000-0002-4502-6664; Hinney, Anke/0000-0001-5659-0706; 	German Research Foundation [DFG - KL 973/8-1]; Else Kroner-Fresenius Foundation (EKFS); Federal Ministry for Education and Research [BMBF 01KU0903, NGFNplus 01GS0822, 01GS0820]; EU FP7 project DIABAT [HEALTH-F2-2011-278373]; National Institutes of Health (NIH) [5R01GM043609]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM043609] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007591] Funding Source: NIH RePORTER	German Research Foundation(German Research Foundation (DFG)); Else Kroner-Fresenius Foundation (EKFS); Federal Ministry for Education and Research(Federal Ministry of Education & Research (BMBF)); EU FP7 project DIABAT; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This study was supported by grants from the German Research Foundation (DFG - KL 973/8-1), the Else Kroner-Fresenius Foundation (EKFS), the Federal Ministry for Education and Research (BMBF 01KU0903, NGFNplus 01GS0822, 01GS0820) and the EU FP7 project DIABAT (HEALTH-F2-2011-278373). HWJ was supported by National Institutes of Health (NIH) (5R01GM043609). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boss O, 1997, FEBS LETT, V408, P39, DOI 10.1016/S0014-5793(97)00384-0; Bugge A, 2010, J BIOL CHEM, V285, P17310, DOI 10.1074/jbc.M110.120584; Cadenas S, 1999, FEBS LETT, V462, P257, DOI 10.1016/S0014-5793(99)01540-9; Chou CJ, 2001, OBES RES, V9, P313, DOI 10.1038/oby.2001.39; Criscuolo F, 2006, BBA-BIOENERGETICS, V1757, P1284, DOI 10.1016/j.bbabio.2006.06.002; CUNNINGHAM S, 1985, CLIN SCI, V69, P343, DOI 10.1042/cs0690343; dos Santos RS, 2013, BIOL OPEN, V2, P82, DOI 10.1242/bio.20122295; Echtay KS, 2002, NATURE, V415, P96, DOI 10.1038/415096a; Fritz T, 2006, DIABETES-METAB RES, V22, P492, DOI 10.1002/dmrr.656; Fromme T, 2009, PHYSIOL GENOMICS, V38, P54, DOI 10.1152/physiolgenomics.00249.2007; Fromme T, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-1; Giacobino JP, 1999, INT J OBESITY, V23, pS60, DOI 10.1038/sj.ijo.0800949; Girousse A, 2009, DIABETOLOGIA, V52, P1638, DOI 10.1007/s00125-009-1385-9; Goglia F, 2003, FASEB J, V17, P1585, DOI 10.1096/fj.03-0159hyp; Golozoubova V, 2001, FASEB J, V15, P2048, DOI 10.1096/fj.00-0536fje; Himms-Hagen J, 2001, EXP BIOL MED, V226, P78, DOI 10.1177/153537020122600204; Hinney A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001361; Hwang CS, 1999, BIOCHEM BIOPH RES CO, V258, P464, DOI 10.1006/bbrc.1999.0662; Jucker BM, 2007, AM J PHYSIOL-ENDOC M, V293, pE1256, DOI 10.1152/ajpendo.00218.2007; Kelly LJ, 1998, ENDOCRINOLOGY, V139, P4920, DOI 10.1210/en.139.12.4920; KLAUS S, 1994, J CELL SCI, V107, P313; Liebig M, 2004, PHYSIOL BIOCHEM ZOOL, V77, P116, DOI 10.1086/381464; Matsuda J, 1997, FEBS LETT, V418, P200, DOI 10.1016/S0014-5793(97)01381-1; Millet L, 1997, J CLIN INVEST, V100, P2665, DOI 10.1172/JCI119811; Nau K, 2008, J COMP PHYSIOL B, V178, P269, DOI 10.1007/s00360-007-0219-7; Patane G, 2002, DIABETES, V51, P2749, DOI 10.2337/diabetes.51.9.2749; Schrauwen P, 2004, P NUTR SOC, V63, P287, DOI 10.1079/PNS2003336; Solanes G, 2003, MOL ENDOCRINOL, V17, P1944, DOI 10.1210/me.2002-0395; Sugawara A, 2002, J BIOL CHEM, V277, P9676, DOI 10.1074/jbc.M104560200; Suzuki T, 2000, GENES CELLS, V5, P29, DOI 10.1046/j.1365-2443.2000.00302.x; Teruel T, 2000, BIOCHEM BIOPH RES CO, V273, P560, DOI 10.1006/bbrc.2000.2982; Trenker M, 2007, NAT CELL BIOL, V9, P445, DOI 10.1038/ncb1556; Uldry M, 2006, CELL METAB, V3, P333, DOI 10.1016/j.cmet.2006.04.002; VidalPuig A, 1997, BIOCHEM BIOPH RES CO, V235, P79, DOI 10.1006/bbrc.1997.6740; von Praun C, 2001, PHYSIOL BIOCHEM ZOOL, V74, P203, DOI 10.1086/319665; Weigle DS, 1998, DIABETES, V47, P298, DOI 10.2337/diabetes.47.2.298	36	8	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83426	10.1371/journal.pone.0083426	http://dx.doi.org/10.1371/journal.pone.0083426			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391766	Green Published, Green Submitted, gold			2022-12-25	WOS:000329325200063
J	Hoyo-Becerra, C; Huebener, A; Trippler, M; Lutterbeck, M; Liu, ZJJ; Truebner, K; Bajanowski, T; Gerken, G; Hermann, DM; Schlaak, JF				Hoyo-Becerra, Carolina; Huebener, Anastasia; Trippler, Martin; Lutterbeck, Melanie; Liu, Zijian J.; Truebner, Kurt; Bajanowski, Thomas; Gerken, Guido; Hermann, Dirk M.; Schlaak, Joerg F.			Concomitant Interferon Alpha Stimulation and TLR3 Activation Induces Neuronal Expression of Depression-Related Genes That Are Elevated in the Brain of Suicidal Persons	PLOS ONE			English	Article							HEPATITIS-C VIRUS; TOLL-LIKE RECEPTOR-3; PLUS RIBAVIRIN; HIPPOCAMPAL NEUROGENESIS; PEGINTERFERON ALPHA-2A; MAJOR DEPRESSION; PLASMA-LEVELS; INFLAMMATION; STRESS; CELLS	We have previously identified 15 genes that are associated with the development of severe depressive side effects during the standard therapy with interferon alpha and ribavirin in the peripheral blood of hepatitis C virus infected patients. An enhanced expression of these genes was also found in the blood of psychiatric patients suffering severe depressive episode. Herein, we demonstrate that the same depression-related interferon-inducible genes (DRIIs) are also upregulated in postmortem brains of suicidal individuals. Using cultured mouse hippocampal and prefrontal neurons we show that costimulation with murine IFN (mIFN) and the TLR3 agonist poly(I: C) promotes the expression of the described DRIIs, at the same time inducing pro-inflammatory cytokine expression through Stat1 and Stat3 activation, promoting neuronal apoptosis. Consequently, the upregulation of selective DRIIs, production of inflammatory cytokines and inhibition of neuronal plasticity may be involved in the pathogenesis of IFN-associated depression.	[Hoyo-Becerra, Carolina; Huebener, Anastasia; Trippler, Martin; Lutterbeck, Melanie; Gerken, Guido; Schlaak, Joerg F.] Univ Hosp Essen, Dept Gastroenterol & Hepatol, Essen, Germany; [Truebner, Kurt; Bajanowski, Thomas] Univ Hosp Essen, Inst Forens Med, Essen, Germany; [Hermann, Dirk M.] Univ Hosp Essen, Dept Neurol, Essen, Germany; [Liu, Zijian J.] Huazhong Univ Sci & Technol, Tongji Med Coll Huazhong, Dept Anat, Wuhan 430074, Peoples R China	University of Duisburg Essen; University of Duisburg Essen; University of Duisburg Essen; Huazhong University of Science & Technology	Schlaak, JF (corresponding author), Univ Hosp Essen, Dept Gastroenterol & Hepatol, Essen, Germany.	joerg.schlaak@uni-due.de	Hermann, Dirk M./AAT-3652-2021; Hermann, Dirk M/AAP-5538-2020; Hermann, Dirk/GZB-9350-2022	Hermann, Dirk M./0000-0003-0198-3152; 	Deutsche Forschungsgemeinschaft [SCHL377/2-2, SCHL377/6-2, TRR60]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Jorg F Schlaak was supported by the Deutsche Forschungsgemeinschaft (SCHL377/2-2 & 6-2, TRR60). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bale TL, 2003, J NEUROSCI, V23, P5295; Basterzi AD, 2005, HUM PSYCHOPHARM CLIN, V20, P473, DOI 10.1002/hup.717; Blugeot A, 2011, J NEUROSCI, V31, P12889, DOI 10.1523/JNEUROSCI.1309-11.2011; Broering R, 2008, J HEPATOL, V48, P914, DOI 10.1016/j.jhep.2008.01.028; Chuang JH, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-65; Dranovsky A, 2006, BIOL PSYCHIAT, V59, P1136, DOI 10.1016/j.biopsych.2006.03.082; Dunn AJ, 2005, NEUROSCI BIOBEHAV R, V29, P891, DOI 10.1016/j.neubiorev.2005.03.023; Dwivedi Y, 2001, J NEUROCHEM, V77, P916, DOI 10.1046/j.1471-4159.2001.00300.x; Felger JC, 2007, BIOL PSYCHIAT, V62, P1324, DOI 10.1016/j.biopsych.2007.05.026; Feng PF, 2003, BRAIN RES, V991, P195, DOI 10.1016/j.brainres.2003.08.018; Fishman SL, 2008, J INFECT DIS, V197, P597, DOI 10.1086/526519; Fossati P, 2004, EUR NEUROPSYCHOPHARM, V14, pS503, DOI 10.1016/j.euroneuro.2004.09.001; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; Girotti M, 2011, PSYCHONEUROENDOCRINO, V36, P1164, DOI 10.1016/j.psyneuen.2011.02.008; Grassi-Oliveira R, 2009, PSYCHIAT CLIN NEUROS, V63, P202, DOI 10.1111/j.1440-1819.2008.01918.x; Harwood D, 2001, INT J GERIATR PSYCH, V16, P155, DOI 10.1002/1099-1166(200102)16:2<155::AID-GPS289>3.0.CO;2-0; Hayley S, 2005, NEUROSCIENCE, V135, P659, DOI 10.1016/j.neuroscience.2005.03.051; HENRIKSSON MM, 1993, AM J PSYCHIAT, V150, P935; Hiles SA, 2012, BRAIN BEHAV IMMUN, V26, P1180, DOI 10.1016/j.bbi.2012.06.001; Hoofnagle JH, 2002, HEPATOLOGY, V36, pS21, DOI 10.1053/jhep.2002.36227; Huang CC, 2006, PHYSIOL GENOMICS, V26, P125, DOI 10.1152/physiolgenomics.00002.2006; HUBER C, 1984, J EXP MED, V160, P310, DOI 10.1084/jem.160.1.310; HUBER C, 1983, J IMMUNOL, V130, P1047; Jun HC, 2012, NEURAL PLAST, V2012, DOI 10.1155/2012/854285; Kamata M, 2000, EUR NEUROPSYCHOPHARM, V10, P129, DOI 10.1016/S0924-977X(99)00067-X; Keefe Brian, 2007, Curr Psychiatry Rep, V9, P255, DOI 10.1007/s11920-007-0028-4; Kim H, 2008, IMMUNOLOGY, V124, P480, DOI 10.1111/j.1365-2567.2007.02799.x; Kitagami T, 2003, BRAIN RES, V978, P104, DOI 10.1016/S0006-8993(03)02776-8; Kubera M, 2000, POL J PHARMACOL, V52, P237; Kumar M, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-73; Monique L, 2006, J MOL NEUROSCI, V29, P185, DOI 10.1385/JMN/29:03:185; Lindqvist D, 2009, BIOL PSYCHIAT, V66, P287, DOI 10.1016/j.biopsych.2009.01.030; Loftis JM, 2008, NEUROSCI LETT, V430, P264, DOI 10.1016/j.neulet.2007.11.001; Lorenzl S, 2008, INT PSYCHOGERIATR, V20, P67, DOI 10.1017/S1041610207005790; Lotrich Francis E, 2005, Neuropsychiatr Dis Treat, V1, P17, DOI 10.2147/nedt.1.1.17.52301; Lucassen Paul J., 2006, CNS & Neurological Disorders-Drug Targets, V5, P531, DOI 10.2174/187152706778559273; Maes M, 1997, CYTOKINE, V9, P853, DOI 10.1006/cyto.1997.0238; Miller AH, 2009, BIOL PSYCHIAT, V65, P732, DOI 10.1016/j.biopsych.2008.11.029; Miller AH, 2009, BRAIN BEHAV IMMUN, V23, P149, DOI 10.1016/j.bbi.2008.08.006; Monaco S, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/236148; Monje FJ, 2011, J NEUROSCI, V31, P9075, DOI 10.1523/JNEUROSCI.1537-11.2011; Moore CS, 2012, AM J PATHOL, V180, P12, DOI 10.1016/j.ajpath.2011.09.008; Morikawa O, 1998, EUR J PHARMACOL, V349, P317, DOI 10.1016/S0014-2999(98)00187-3; O'Connor JC, 2009, MOL PSYCHIATR, V14, P511, DOI 10.1038/sj.mp.4002148; O'Donovan A, 2013, DEPRESS ANXIETY, V30, P307, DOI 10.1002/da.22087; Okulski P, 2007, BIOL PSYCHIAT, V62, P359, DOI 10.1016/j.biopsych.2006.09.012; Orsal AS, 2008, NEUROPSYCHOBIOLOGY, V58, P211, DOI 10.1159/000201718; Oxenkrug G, 2011, AGING DIS, V2, P474; Ping FF, 2012, NEUROSCI LETT, V514, P173, DOI 10.1016/j.neulet.2012.02.087; Radkowski M, 2002, J VIROL, V76, P600, DOI 10.1128/JVI.76.2.600-608.2002; Raison CL, 2006, TRENDS IMMUNOL, V27, P24, DOI 10.1016/j.it.2005.11.006; Raison CL, 2005, J CLIN PSYCHIAT, V66, P41, DOI 10.4088/JCP.v66n0106; Reif A, 2006, MOL PSYCHIATR, V11, P514, DOI 10.1038/sj.mp.4001791; RONDEAU E, 1990, CLIN NEPHROL, V33, P55; Schlaak JF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038668; Seminowicz DA, 2004, NEUROIMAGE, V22, P409, DOI 10.1016/j.neuroimage.2004.01.015; Sheline YI, 2003, BIOL PSYCHIAT, V54, P338, DOI 10.1016/S0006-3223(03)00347-0; Shelton RC, 2011, MOL PSYCHIATR, V16, P751, DOI 10.1038/mp.2010.52; Soares JC, 1997, BIOL PSYCHIAT, V41, P86, DOI 10.1016/S0006-3223(96)00006-6; TALLEY R, 1983, AM J CLIN ONCOL-CANC, V6, P369, DOI 10.1097/00000421-198306000-00019; Tejima E, 2009, J NEUROTRAUM, V26, P1935, DOI 10.1089/neu.2009.0959; Thirumangalakudi L, 2006, J ALZHEIMERS DIS, V10, P111; Thomas RM, 2007, J NEUROSCI, V27, P2734, DOI 10.1523/JNEUROSCI.3849-06.2007; Todorovic C, 2009, NEUROPSYCHOPHARMACOL, V34, P1416, DOI 10.1038/npp.2008.178; Turbic A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025406; Wang JP, 2005, J VIROL, V79, P8295, DOI 10.1128/JVI.79.13.8295-8302.2005; Wichers MC, 2007, J PSYCHOSOM RES, V62, P207, DOI 10.1016/j.jpsychores.2006.09.007; Wilkinson J, 2010, GUT, V59, P1394, DOI 10.1136/gut.2009.199356; Wilkinson J, 2009, J VIROL, V83, P1312, DOI 10.1128/JVI.01890-08; Yang EV, 2002, J NEUROIMMUNOL, V133, P144, DOI 10.1016/S0165-5728(02)00270-9; Yu ML, 2006, ANTIVIR THER, V11, P1015; Zhao LJ, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-157; Zhao SH, 2010, CLIN THER, V32, P1565, DOI 10.1016/j.clinthera.2010.08.009	73	27	27	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83149	10.1371/journal.pone.0083149	http://dx.doi.org/10.1371/journal.pone.0083149			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391741	Green Published, gold, Green Submitted			2022-12-25	WOS:000329325200038
J	Jo, YH; Patnaik, BB; Kang, SW; Chae, SH; Oh, S; Kim, DH; Noh, MY; Seo, GW; Jeong, HC; Noh, JY; Jeong, JE; Hwang, HJ; Ko, K; Han, YS; Lee, YS				Jo, Yong Hun; Patnaik, Bharat Bhusan; Kang, Se Won; Chae, Sung-Hwa; Oh, Seunghan; Kim, Dong Hyun; Noh, Mi Young; Seo, Gi Won; Jeong, Heon Cheon; Noh, Ju Young; Jeong, Ji Eun; Hwang, Hee Ju; Ko, Kisung; Han, Yeon Soo; Lee, Yong Seok			Analysis of the Genome of a Korean Isolate of the Pieris rapae Granulovirus Enabled by Its Separation from Total Host Genomic DNA by Pulse-Field Electrophoresis	PLOS ONE			English	Article							NUCLEAR POLYHEDROSIS-VIRUS; ENVELOPE FUSION PROTEIN; LATE GENE-EXPRESSION; SINGLE NUCLEOCAPSID NUCLEOPOLYHEDROVIRUS; BOMBYX-MORI NUCLEOPOLYHEDROVIRUS; OPEN READING FRAMES; SEQUENCE-ANALYSIS; FOSMID LIBRARY; HELICOVERPA-ARMIGERA; MOLECULAR-IDENTIFICATION	Background: Most traditional genome sequencing projects involving viruses include the culture and purification of the virus particles. However, purification of virions may yield insufficient material for traditional sequencing. The electrophoretic method described here provides a strategy whereby the genomic DNA of the Korean isolate of Pieris rapae granulovirus (PiraGV-K) could be recovered in sufficient amounts for sequencing by purifying it directly from total host DNA by pulse-field gel electrophoresis (PFGE). Methodology/Principal Findings: The total genomic DNA of infected P. rapae was embedded in agarose plugs, treated with restriction nuclease and methylase, and then PFGE was used to separate PiraGV-K DNA from the DNA of P. rapae, followed by mapping of fosmid clones of the purified viral DNA. The double-stranded circular genome of PiraGV-K was found to encode 120 open reading frames (ORFs), which covered 92% of the sequence. BLAST and ORF arrangement showed the presence of 78 homologs to other genes in the database. The mean overall amino acid identity of PiraGV-K ORFs was highest with the Chinese isolate of PiraGV (similar to 99%), followed up with Choristoneura occidentalis ORFs at 58%. PiraGV-K ORFs were grouped, according to function, into 10 genes involved in transcription, 11 involved in replication, 25 structural protein genes, and 15 auxiliary genes. Genes for Chitinase (ORF 10) and cathepsin (ORF 11), involved in the liquefaction of the host, were found in the genome. Conclusions/Significance: The recovery of PiraGV-K DNA genome by pulse-field electrophoretic separation from host genomic DNA had several advantages, compared with its isolation from particles harvested as virions or inclusions from the P. rapae host. We have sequenced and analyzed the 108,658 bp PiraGV-K genome purified by the electrophoretic method. The method appears to be generally applicable to the analysis of genomes of large viruses.	[Kang, Se Won; Jeong, Ji Eun; Hwang, Hee Ju; Lee, Yong Seok] Soonchunhyang Univ, Coll Nat Sci, Dept Life Sci & Biotechnol, Asan, South Korea; [Jo, Yong Hun; Patnaik, Bharat Bhusan; Oh, Seunghan; Kim, Dong Hyun; Noh, Mi Young; Seo, Gi Won; Han, Yeon Soo] Chonnam Natl Univ, Coll Agr & Life Sci, Div Plant Biotechnol, Kwangju, South Korea; [Jeong, Heon Cheon; Noh, Ju Young] Hampyeong Cty Agr Technol Ctr, Hampyeong Cty Insect Inst, Hampyeong, South Korea; [Ko, Kisung] Chung Ang Univ, Coll Med, Med Res Inst, Dept Med, Seoul 156756, South Korea; [Chae, Sung-Hwa] GnC Bio Co Ltd, Taejon, South Korea	Soonchunhyang University; Chonnam National University; Chung Ang University; Chung Ang University Hospital	Lee, YS (corresponding author), Soonchunhyang Univ, Coll Nat Sci, Dept Life Sci & Biotechnol, Asan, South Korea.	yslee@sch.ac.kr	LEE, YONGSEOK/AAF-3965-2020; Patnaik, Bharat Bhusan/CAG-0338-2022; Patnaik, Bharat Bhusan/H-2973-2019	Patnaik, Bharat Bhusan/0000-0003-1383-6758; Patnaik, Bharat Bhusan/0000-0003-1383-6758; Lee, Yongseok/0000-0002-8687-589X	NRF; MEST [2010-0027694]	NRF; MEST(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This study was supported by Mid-career researcher program through NRF grant funded by the MEST (No. 2010-0027694). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonso CL, 2001, J VIROL, V75, P11157, DOI 10.1128/JVI.75.22.11157-11165.2001; Alkan C, 2011, NAT METHODS, V8, P61, DOI 10.1038/NMETH.1527; Ariyadasa R, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/184854; AYRES MD, 1994, VIROLOGY, V202, P586, DOI 10.1006/viro.1994.1380; BIRNBAUM MJ, 1994, J VIROL, V68, P2521, DOI 10.1128/JVI.68.4.2521-2528.1994; Bocs S, 2003, NUCLEIC ACIDS RES, V31, P3723, DOI 10.1093/nar/gkg590; BORODOVSKY M, 1993, COMPUT CHEM, V17, P123, DOI 10.1016/0097-8485(93)85004-V; Chen XW, 2001, J GEN VIROL, V82, P241, DOI 10.1099/0022-1317-82-1-241; Coupland P, 2012, BIOTECHNIQUES, V53, P365, DOI 10.2144/000113962; CROOK NE, 1993, J VIROL, V67, P2168, DOI 10.1128/JVI.67.4.2168-2174.1993; Dall D, 2001, BIOESSAYS, V23, P184, DOI 10.1002/1521-1878(200102)23:2&lt;184::AID-BIES1026&gt;3.0.CO;2-H; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636; DONOFRIO G, 1991, J MOL EVOL, V32, P504, DOI 10.1007/BF02102652; Escasa SR, 2006, J GEN VIROL, V87, P1917, DOI 10.1099/vir.0.81792-0; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Feuillet C, 2011, TRENDS PLANT SCI, V16, P77, DOI 10.1016/j.tplants.2010.10.005; Friesen PD, 1997, BACULOVIRUSES, P141; Garcia-Maruniak A, 2004, J VIROL, V78, P7036, DOI 10.1128/JVI.78.13.7036-7051.2004; Gomi S, 1997, VIROLOGY, V230, P35, DOI 10.1006/viro.1997.8457; Gomi S, 1999, J GEN VIROL, V80, P1323, DOI 10.1099/0022-1317-80-5-1323; Hao DC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021220; Harrison RL, 2008, VIRUS GENES, V36, P565, DOI 10.1007/s11262-008-0218-0; Hashimoto Y, 2000, VIROLOGY, V275, P358, DOI 10.1006/viro.2000.0530; Hawtin RE, 1997, VIROLOGY, V238, P243, DOI 10.1006/viro.1997.8816; Hayakawa T, 1999, VIROLOGY, V262, P277, DOI 10.1006/viro.1999.9894; Hayakawa T, 2000, VIROLOGY, V278, P1, DOI 10.1006/viro.2000.0668; Hilton S, 2008, J GEN VIROL, V89, P2898, DOI 10.1099/vir.0.2008/002881-0; Huang SW, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-242; Hyink O, 2002, J GEN VIROL, V83, P957, DOI 10.1099/0022-1317-83-4-957; IJkel WFJ, 2000, VIROLOGY, V275, P30, DOI 10.1006/viro.2000.0483; Jehle JA, 2006, VIROLOGY, V346, P180, DOI 10.1016/j.virol.2005.10.032; Jiang HB, 2009, INSECT BIOCHEM MOLEC, V39, P646, DOI 10.1016/j.ibmb.2009.07.002; JUKES TH, 1986, J MOL EVOL, V24, P39, DOI 10.1007/BF02099949; Karlin S, 1998, CURR OPIN MICROBIOL, V1, P598, DOI 10.1016/S1369-5274(98)80095-7; Kim CG, 2003, GENOMICS, V82, P571, DOI 10.1016/S0888-7543(03)00174-5; Ko R, 2000, J VIROL, V74, P11240, DOI 10.1128/JVI.74.23.11240-11246.2000; Kuzio J, 1999, VIROLOGY, V253, P17, DOI 10.1006/viro.1998.9469; Lange M, 2004, VIROLOGY, V325, P36, DOI 10.1016/j.virol.2004.04.023; Lange M, 2003, VIROLOGY, V317, P220, DOI 10.1016/S0042-6822(03)00515-4; Lauzon HAM, 2006, J GEN VIROL, V87, P1477, DOI 10.1099/vir.0.81727-0; LEISY DJ, 1995, VIROLOGY, V208, P742, DOI 10.1006/viro.1995.1206; Li LL, 2002, VIROLOGY, V297, P226, DOI 10.1006/viro.2002.1411; Li QJ, 2002, VIROLOGY, V294, P106, DOI 10.1006/viro.2001.1313; Lu A, 1997, BACULOVIRUSES, P193; Luque T, 2001, J GEN VIROL, V82, P2531, DOI 10.1099/0022-1317-82-10-2531; Malboeuf CM, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks794; Meyer JDF, 2008, MOL GENET GENOMICS, V279, P473, DOI 10.1007/s00438-008-0326-5; Mizutani T, 2007, EMERG INFECT DIS, V13, P322, DOI 10.3201/eid1302.061032; Monsma SA, 1996, J VIROL, V70, P4607, DOI 10.1128/JVI.70.7.4607-4616.1996; MORRIS TD, 1994, VIROLOGY, V200, P360; Moser BA, 2001, J GEN VIROL, V82, P283, DOI 10.1099/0022-1317-82-2-283; Mount DW, 2001, BIOINFORMATICS SEQUE, P308; Ninomiya M, 2012, J CLIN MICROBIOL, V50, P857, DOI 10.1128/JCM.05715-11; Oh S, 2013, ARCH VIROL, V158, P1701, DOI 10.1007/s00705-013-1649-z; Oh S, 2013, J INVERTEBR PATHOL, V113, P7, DOI 10.1016/j.jip.2012.12.003; Pang Y, 2001, VIROLOGY, V287, P391, DOI 10.1006/viro.2001.1056; Park TH, 2011, J GENET GENOMICS, V38, P47, DOI 10.1016/j.jcg.2010.12.002; Pearson MN, 2000, J VIROL, V74, P6126, DOI 10.1128/JVI.74.13.6126-6131.2000; Pearson MN, 1998, J VIROL, V72, P9142, DOI 10.1128/JVI.72.11.9142-9149.1998; Rapp JC, 1998, J VIROL, V72, P10197, DOI 10.1128/JVI.72.12.10197-10206.1998; Schatz MC, 2010, GENOME RES, V20, P1165, DOI 10.1101/gr.101360.109; Song JJ, 2008, J GEN VIROL, V89, P2331, DOI 10.1099/vir.0.2008/002352-0; TOMALSKI MD, 1991, VIROLOGY, V184, P149, DOI 10.1016/0042-6822(91)90831-U; VanOers MM, 1997, J INVERTEBR PATHOL, V70, P1, DOI 10.1006/jipa.1997.4675; Vucic D, 1997, P NATL ACAD SCI USA, V94, P10183, DOI 10.1073/pnas.94.19.10183; Wan HH, 2000, COMPUT CHEM, V24, P71, DOI 10.1016/S0097-8485(99)00048-0; Wang P, 1998, J INVERTEBR PATHOL, V72, P57, DOI 10.1006/jipa.1998.4759; Wang RR, 2010, J VIROL, V84, P7233, DOI 10.1128/JVI.00040-10; Wang XF, 2011, J PROTEOME RES, V10, P2817, DOI 10.1021/pr2000804; Wang Y, 2011, NEURAL REGEN RES, V6, P6, DOI 10.3969/j.issn.1673-5374.2011.01.001; WINSTANLEY D, 1993, J GEN VIROL, V74, P1599, DOI 10.1099/0022-1317-74-8-1599; WOLGAMOT GM, 1993, J GEN VIROL, V74, P103, DOI 10.1099/0022-1317-74-1-103; Wormleaton S, 2003, VIROLOGY, V311, P350, DOI 10.1016/S0042-6822(03)00149-1; Xiang XW, 2011, VIRUS RES, V155, P69, DOI 10.1016/j.virusres.2010.08.024; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9; Zhang BQ, 2012, J VIROL, V86, P9544, DOI 10.1128/JVI.01431-12	77	2	3	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84183	10.1371/journal.pone.0084183	http://dx.doi.org/10.1371/journal.pone.0084183			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391907	Green Published, gold, Green Submitted			2022-12-25	WOS:000329323900050
J	Li, WY; Sun, S; Chen, Y; Yu, HQ; Chen, ZY; Li, HW				Li, Wenyan; Sun, Shan; Chen, Yan; Yu, Huiqian; Chen, Zheng-Yi; Li, Huawei			Disrupting the Interaction between Retinoblastoma Protein and Raf-1 Leads to Defects in Progenitor Cell Proliferation and Survival during Early Inner Ear Development	PLOS ONE			English	Article							RB-RAF-1 INTERACTION; SENSORY EPITHELIA; POCKET PROTEINS; CYCLE CONTROL; HAIR-CELLS; STEM-CELLS; IN-VIVO; CANCER; ANGIOGENESIS; INACTIVATION	The retinoblastoma protein (pRb) is required for cell-cycle exit of embryonic mammalian hair cells but is not required for hair cell fate determination and early differentiation, and this provides a strategy for hair cell regeneration by manipulating the pRb pathway. To reveal the mechanism of pRb functional modification in the inner ear, we compared the effects of attenuated pRb phosphorylation by an inhibitor of the Mitogen-Activated Protein (MAP) kinase pathway and an inhibitor of the Rb-Raf-1 interaction on cultured chicken otocysts. We demonstrated that the activity of pRb is correlated with its phosphorylation state, which is regulated by a newly established cell cycle-independent pathway mediated by the physical interaction between Raf-1 and pRb. The phosphorylation of pRb plays an important role during the early stage of inner ear development, and attenuated phosphorylation in progenitor cells leads to cell cycle arrest and increased apoptosis along with a global down-regulation of the genes involved in cell cycle progression. Our study provides novel routes to modulate pRb function for hair cell regeneration.	[Li, Wenyan; Yu, Huiqian] Fudan Univ, Dept Otorhinolaryngol, Affiliated Eye & ENT Hosp, Shanghai 200433, Peoples R China; [Sun, Shan; Chen, Yan] Fudan Univ, Res Ctr, Affiliated Eye & ENT Hosp, Shanghai 200433, Peoples R China; [Li, Huawei] Fudan Univ, Inst Stem Cell & Regenerat Med, Inst Biomed Sci, Shanghai 200433, Peoples R China; [Li, Huawei] Fudan Univ, State Key Lab Med Neurobiol, Shanghai 200433, Peoples R China; [Li, Wenyan; Chen, Zheng-Yi] Harvard Univ, Sch Med, Dept Otolaryngol, Boston, MA 02115 USA; [Li, Wenyan; Chen, Zheng-Yi] Harvard Univ, Sch Med, Program Neurosci, Boston, MA 02115 USA; [Li, Wenyan; Chen, Zheng-Yi] Massachusetts Eye & Ear Infirm, Eaton Peabody Lab, Boston, MA 02114 USA	Fudan University; Fudan University; Fudan University; Fudan University; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Massachusetts Eye & Ear Infirmary	Li, HW (corresponding author), Fudan Univ, Inst Stem Cell & Regenerat Med, Inst Biomed Sci, Shanghai 200433, Peoples R China.	lihuawei63@gmail.com	Sun, Shan/GLR-2365-2022	Sun, Shan/0000-0003-2142-4307; Li, Wenyan/0000-0001-9575-7812	Major State Basic Research Development Program of China (973 Program) [2011CB504506, 2010CB945503]; National Natural Science Foundation of China [81230019, 81070793, 30901668]; Program for Changjiang Scholars and Innovative Research Team in Universities [IRT1010]; Medical Guiding Fund of the Science and Technology Commission of Shanghai Municipality [10411962100]; Program of Outstanding Shanghai Academic Leaders [11XD1401300]; Specialized Research Fund for the Doctor Program of Higher Education [20120071110077]; Shanghai Rising-Star Program [12QA1400500]; Program of Leading Medical Personnel in Shanghai; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC006908] Funding Source: NIH RePORTER	Major State Basic Research Development Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Changjiang Scholars and Innovative Research Team in Universities(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Medical Guiding Fund of the Science and Technology Commission of Shanghai Municipality; Program of Outstanding Shanghai Academic Leaders; Specialized Research Fund for the Doctor Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Shanghai Rising-Star Program; Program of Leading Medical Personnel in Shanghai; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by grants from the Major State Basic Research Development Program of China (973 Program) (2011CB504506, 2010CB945503), the National Natural Science Foundation of China (No. 81230019, 81070793, 30901668), the Program for Changjiang Scholars and Innovative Research Team in Universities (IRT1010), the Medical Guiding Fund of the Science and Technology Commission of Shanghai Municipality (10411962100), the Program of Outstanding Shanghai Academic Leaders (11XD1401300), the Specialized Research Fund for the Doctor Program of Higher Education (20120071110077), the Shanghai Rising-Star Program (12QA1400500) and the Program of Leading Medical Personnel in Shanghai. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BUCHKOVICH K, 1989, CELL, V58, P1097, DOI 10.1016/0092-8674(89)90508-4; Cobrinik D, 2005, ONCOGENE, V24, P2796, DOI 10.1038/sj.onc.1208619; Dasgupta P, 2004, MOL CELL BIOL, V24, P9527, DOI 10.1128/MCB.24.21.9527-9541.2004; Davis RK, 2008, DRUG NEWS PERSPECT, V21, P331, DOI 10.1358/dnp.2008.21.6.1246832; Di Fiore R, 2013, J CELL PHYSIOL, V228, P1676, DOI 10.1002/jcp.24329; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; Hamburger V, 1992, SERIES NORMAL STAGES; Kelley MW, 2006, NAT REV NEUROSCI, V7, P837, DOI 10.1038/nrn1987; Kinkade R, 2008, CANCER RES, V68, P3810, DOI 10.1158/0008-5472.CAN-07-6672; Knudsen ES, 2006, EXP BIOL MED, V231, P1271; Lang HN, 2000, J COMP NEUROL, V417, P205, DOI 10.1002/(SICI)1096-9861(20000207)417:2<205::AID-CNE6>3.0.CO;2-Y; Li HW, 2005, BMC DEV BIOL, V5, DOI 10.1186/1471-213X-5-16; Li HW, 2004, J NEUROBIOL, V60, P61, DOI 10.1002/neu.20013; Li HW, 2003, NAT MED, V9, P1293, DOI 10.1038/nm925; Lin Q, 2013, NEUROREPORT, V24, P190, DOI 10.1097/WNR.0b013e32835e3279; Loponen H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027360; Lu N, 2013, BIOCHEM BIOPH RES CO, V430, P700, DOI 10.1016/j.bbrc.2012.11.088; Magarinos M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014435; Martinez-Monedero R, 2008, DEV NEUROBIOL, V68, P669, DOI 10.1002/dneu.20616; Sage C, 2005, SCIENCE, V307, P1114, DOI 10.1126/science.1106642; Sage C, 2006, P NATL ACAD SCI USA, V103, P7345, DOI 10.1073/pnas.0510631103; Shukla S, 2007, CELL CYCLE, V6, P1102, DOI 10.4161/cc.6.9.4146; Singh S, 2010, MOL CANCER THER, V9, P3330, DOI 10.1158/1535-7163.MCT-10-0442; Stengel KR, 2009, J BIOL CHEM, V284, P19265, DOI 10.1074/jbc.M808740200; SWANSON GJ, 1990, DEV BIOL, V137, P243, DOI 10.1016/0012-1606(90)90251-D; Wang S, 1998, MOL CELL BIOL, V18, P7487, DOI 10.1128/MCB.18.12.7487; Weber T, 2008, P NATL ACAD SCI USA, V105, P781, DOI 10.1073/pnas.0708061105; WEINBERG RA, 1995, CELL, V81, P323, DOI 10.1016/0092-8674(95)90385-2; Yu YL, 2010, J NEUROSCI, V30, P5927, DOI 10.1523/JNEUROSCI.5989-09.2010	29	5	5	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83726	10.1371/journal.pone.0083726	http://dx.doi.org/10.1371/journal.pone.0083726			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391814	Green Published, gold, Green Submitted			2022-12-25	WOS:000329325200112
J	Mi, JJ; Shaw, AE; Pak, CW; Walsh, KP; Minamide, LS; Bernstein, BW; Kuhn, TB; Bamburg, JR				Mi, Jianjie; Shaw, Alisa E.; Pak, Chi W.; Walsh, Keifer P.; Minamide, Laurie S.; Bernstein, Barbara W.; Kuhn, Thomas B.; Bamburg, James R.			A Genetically Encoded Reporter for Real-Time Imaging of Cofilin-Actin Rods in Living Neurons	PLOS ONE			English	Article							HIPPOCAMPAL-NEURONS; AMYLOID-BETA; DEPOLYMERIZING FACTOR; TRANSGENE EXPRESSION; ADF/COFILIN; PROTEIN; TRAFFICKING; OLIGOMERS; DEPENDS; DISEASE	Filament bundles (rods) of cofilin and actin (1:1) form in neurites of stressed neurons where they inhibit synaptic function. Live-cell imaging of rod formation is hampered by the fact that overexpression of a chimera of wild type cofilin with a fluorescent protein causes formation of spontaneous and persistent rods, which is exacerbated by the photostress of imaging. The study of rod induction in living cells calls for a rod reporter that does not cause spontaneous rods. From a study in which single cofilin surface residues were mutated, we identified a mutant, cofilinR21Q, which when fused with monomeric Red Fluorescent Protein (mRFP) and expressed several fold above endogenous cofilin, does not induce spontaneous rods even during the photostress of imaging. CofilinR21Q- mRFP only incorporates into rods when they form from endogenous proteins in stressed cells. In neurons, cofilinR21Q-mRFP reports on rods formed from endogenous cofilin and induced by all modes tested thus far. Rods have a half-life of 30-60 min upon removal of the inducer. Vesicle transport in neurites is arrested upon treatments that form rods and recovers as rods disappear. CofilinR21Q- mRFP is a genetically encoded rod reporter that is useful in live cell imaging studies of induced rod formation, including rod dynamics, and kinetics of rod elimination.	[Mi, Jianjie; Shaw, Alisa E.; Pak, Chi W.; Walsh, Keifer P.; Minamide, Laurie S.; Bernstein, Barbara W.; Kuhn, Thomas B.; Bamburg, James R.] Colorado State Univ, Dept Biochem & Mol Biol, Ft Collins, CO 80523 USA; [Mi, Jianjie; Shaw, Alisa E.; Pak, Chi W.; Walsh, Keifer P.; Minamide, Laurie S.; Bernstein, Barbara W.; Kuhn, Thomas B.; Bamburg, James R.] Colorado State Univ, Mol Cellular & Integrat Neurosci Program, Ft Collins, CO 80523 USA; [Kuhn, Thomas B.] Univ Alaska, Dept Chem & Biochem, Fairbanks, AK 99701 USA	Colorado State University; Colorado State University; University of Alaska System; University of Alaska Fairbanks	Bamburg, JR (corresponding author), Colorado State Univ, Dept Biochem & Mol Biol, Ft Collins, CO 80523 USA.	James.Bamburg@colostate.edu			Colorado State University Core Infrastructure Grant; National Institutes of Health [NS040371, AG044812]; National Science Foundation [DGE-0234615]; Colorado State University Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040371] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG044812] Funding Source: NIH RePORTER	Colorado State University Core Infrastructure Grant; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Colorado State University Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Funding was provided in part from a Colorado State University Core Infrastructure Grant for supporting the Microscope Imaging Network (JRB), National Institutes of Health grants NS040371 and AG044812 (JRB), National Science Foundation predoctoral fellowship DGE-0234615 (CWP), and generous donations in support of research through the Colorado State University Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or in preparation of the manuscript.	ADAMS ME, 1990, BIOCHEMISTRY-US, V29, P7414, DOI 10.1021/bi00484a009; Akerboom J, 2013, FRONT MOL NEUROSCI, V6, DOI 10.3389/fnmol.2013.00002; Ashworth SL, 2003, AM J PHYSIOL-RENAL, V284, pF852, DOI 10.1152/ajprenal.00210.2002; Bamburg JR, 2010, CURR ALZHEIMER RES, V7, P241, DOI 10.2174/156720510791050902; BARTLETT WP, 1984, J NEUROSCI, V4, P1944; Bernstein BW, 2006, AM J PHYSIOL-CELL PH, V291, pC828, DOI 10.1152/ajpcell.00066.2006; Bernstein BW, 2012, J NEUROSCI, V32, P6670, DOI 10.1523/JNEUROSCI.6020-11.2012; Bernstein BW, 2011, ADV NEUROBIOL, V5, P201, DOI 10.1007/978-1-4419-7368-9_11; Bernstein BW, 2010, TRENDS CELL BIOL, V20, P187, DOI 10.1016/j.tcb.2010.01.001; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; Bugyi B, 2010, ANNU REV BIOPHYS, V39, P449, DOI 10.1146/annurev-biophys-051309-103849; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Chen H, 2004, BIOCHEMISTRY-US, V43, P7127, DOI 10.1021/bi049797n; Cichon J, 2012, J BIOL CHEM, V287, P3919, DOI 10.1074/jbc.M111.301911; Cleary JP, 2005, NAT NEUROSCI, V8, P79, DOI 10.1038/nn1372; Davis RC, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-10; Ehehalt R, 2003, J CELL BIOL, V160, P113, DOI 10.1083/jcb.200207113; Fan J, 2013, J MOL BIOL, V425, P1225, DOI 10.1016/j.jmb.2013.01.020; Fath T, 2011, EUR J CELL BIOL, V90, P291, DOI 10.1016/j.ejcb.2010.10.014; Galkin VE, 2011, P NATL ACAD SCI USA, V108, P20568, DOI 10.1073/pnas.1110109108; Garvalov BK, 2007, J NEUROSCI, V27, P13117, DOI 10.1523/JNEUROSCI.3322-07.2007; Gu JP, 2010, NAT NEUROSCI, V13, P1208, DOI 10.1038/nn.2634; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Homma K, 2008, MOL CELL NEUROSCI, V37, P261, DOI 10.1016/j.mcn.2007.10.001; Hotulainen P, 2009, J CELL BIOL, V185, P323, DOI 10.1083/jcb.200809046; Jakobsson J, 2003, J NEUROSCI RES, V73, P876, DOI 10.1002/jnr.10719; Jang DH, 2005, P NATL ACAD SCI USA, V102, P16072, DOI 10.1073/pnas.0507675102; Kim JS, 2009, MOL BIOL CELL, V20, P2650, DOI 10.1091/mbc.E09-02-0131; Klejnot M, 2013, ACTA CRYSTALLOGR D, V69, P1780, DOI 10.1107/S0907444913014418; Maloney MT, 2005, J NEUROSCI, V25, P11313, DOI 10.1523/JNEUROSCI.3711-05.2005; MATTSON MP, 1988, INT J DEV NEUROSCI, V6, P439, DOI 10.1016/0736-5748(88)90050-0; Minamide LS, 2010, J BIOL CHEM, V285, P5450, DOI 10.1074/jbc.M109.063768; Minamide LS, 2000, NAT CELL BIOL, V2, P628, DOI 10.1038/35023579; Minamide LS, 2003, METHOD CELL BIOL, V71, P387, DOI 10.1016/S0091-679X(03)01019-7; MORGAN TE, 1993, J CELL BIOL, V122, P623, DOI 10.1083/jcb.122.3.623; Munsie LN, 2012, J CELL SCI, V125, P3977, DOI 10.1242/jcs.097667; Pal R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063989; PARDEE JD, 1982, METHOD ENZYMOL, V85, P164; PODLISNY MB, 1995, J BIOL CHEM, V270, P9564, DOI 10.1074/jbc.270.16.9564; Shaw AE, 2004, ELECTROPHORESIS, V25, P2611, DOI 10.1002/elps.200406017; Thinakaran G, 2008, J BIOL CHEM, V283, P29615, DOI 10.1074/jbc.R800019200; Van Troys M, 2008, EUR J CELL BIOL, V87, P649, DOI 10.1016/j.ejcb.2008.04.001; Whiteman IT, 2009, J NEUROSCI, V29, P12994, DOI 10.1523/JNEUROSCI.3531-09.2009; Wiggan ON, 2006, CELL SIGNAL, V18, P1501, DOI 10.1016/j.cellsig.2005.12.002; Wiggan O, 2012, DEV CELL, V22, P530, DOI 10.1016/j.devcel.2011.12.026	45	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83609	10.1371/journal.pone.0083609	http://dx.doi.org/10.1371/journal.pone.0083609			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391794	Green Published, Green Submitted, gold			2022-12-25	WOS:000329325200091
J	Navarra, J; Fernandez-Prieto, I; Garcia-Morera, J				Navarra, Jordi; Fernandez-Prieto, Irune; Garcia-Morera, Joel			Realigning Thunder and Lightning: Temporal Adaptation to Spatiotemporally Distant Events	PLOS ONE			English	Article							MULTISENSORY INTEGRATION; UNITY ASSUMPTION; VISUAL SPEECH; PERCEPTION; RECALIBRATION; EXPOSURE; ORDER; DETERMINANTS; SYNCHRONY; WINDOW	The brain is able to realign asynchronous signals that approximately coincide in both space and time. Given that many experience-based links between visual and auditory stimuli are established in the absence of spatiotemporal proximity, we investigated whether or not temporal realignment arises in these conditions. Participants received a 3-min exposure to visual and auditory stimuli that were separated by 706 ms and appeared either from the same (Experiment 1) or from different spatial positions (Experiment 2). A simultaneity judgment task (SJ) was administered right afterwards. Temporal realignment between vision and audition was observed, in both Experiment 1 and 2, when comparing the participants' SJs after this exposure phase with those obtained after a baseline exposure to audiovisual synchrony. However, this effect was present only when the visual stimuli preceded the auditory stimuli during the exposure to asynchrony. A similar pattern of results (temporal realignment after exposure to visual-leading asynchrony but not after exposure to auditory-leading asynchrony) was obtained using temporal order judgments (TOJs) instead of SJs (Experiment 3). Taken together, these results suggest that temporal recalibration still occurs for visual and auditory stimuli that fall clearly outside the so-called temporal window for multisensory integration and appear from different spatial positions. This temporal realignment may be modulated by long-term experience with the kind of asynchrony (vision-leading) that we most frequently encounter in the outside world (e. g., while perceiving distant events).	[Navarra, Jordi; Fernandez-Prieto, Irune; Garcia-Morera, Joel] Fundacio St Joan de Deu, Barcelona, Catalonia, Spain; [Navarra, Jordi; Fernandez-Prieto, Irune; Garcia-Morera, Joel] Fundacio St Joan de Deu, CIBERSAM, Barcelona, Catalonia, Spain; [Fernandez-Prieto, Irune] Univ Barcelona, IR3C, Barcelona, Catalonia, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM; University of Barcelona; University of Barcelona	Navarra, J (corresponding author), Fundacio St Joan de Deu, Parc Sanitari St Joan de Deu, Barcelona, Catalonia, Spain.	jnavarrao@fsjd.org	Fernandez Prieto, Irune/V-4251-2017; Navarra, Jordi/AAB-1649-2019	Fernandez Prieto, Irune/0000-0002-1669-5842; Navarra, Jordi/0000-0003-0779-4117	Ministerio de Economia y Competitividad (Spanish Government) [PSI2009-12859, PSI2012-39149, RYC-2008-03672]; European COST action [TD0904]	Ministerio de Economia y Competitividad (Spanish Government); European COST action	This research was supported by grants PSI2009-12859, PSI2012-39149 and RYC-2008-03672 from Ministerio de Economia y Competitividad (Spanish Government), and the European COST action TD0904. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Di Luca M, 2009, J VISION, V9, DOI 10.1167/9.12.7; Fujisaki W, 2004, NAT NEUROSCI, V7, P773, DOI 10.1038/nn1268; Hanson JVM, 2008, EXP BRAIN RES, V185, P347, DOI 10.1007/s00221-008-1282-3; Harrar V, 2008, EXP BRAIN RES, V186, P517, DOI 10.1007/s00221-007-1253-0; Heron J, 2012, EXP BRAIN RES, V218, P477, DOI 10.1007/s00221-012-3038-3; Heron J, 2007, J VISION, V7, DOI 10.1167/7.13.5; Keetels M, 2007, EXP BRAIN RES, V182, P559, DOI 10.1007/s00221-007-1012-2; Lavond DG, 2010, HDB CLASSICAL CONDIT; MEREDITH MA, 1987, J NEUROSCI, V7, P3215; Meredith MA, 1996, J NEUROPHYSIOL, V75, P1843, DOI 10.1152/jn.1996.75.5.1843; Munhall KG, 1996, PERCEPT PSYCHOPHYS, V58, P351, DOI 10.3758/BF03206811; Navarra J, 2005, COGNITIVE BRAIN RES, V25, P499, DOI 10.1016/j.cogbrainres.2005.07.009; Navarra J, 2010, BRAIN RES, V1323, P84, DOI 10.1016/j.brainres.2010.01.059; Navarra J, 2009, P NATL ACAD SCI USA, V106, P9169, DOI 10.1073/pnas.0810486106; Roach NW, 2011, P ROY SOC B-BIOL SCI, V278, P1314, DOI 10.1098/rspb.2010.1737; Roseboom W, 2011, PSYCHOL SCI, V22, P872, DOI 10.1177/0956797611413293; Sanabria D, 2005, NEUROSCI LETT, V377, P59, DOI 10.1016/j.neulet.2004.11.069; Schroeder CE, 2008, TRENDS COGN SCI, V12, P106, DOI 10.1016/j.tics.2008.01.002; Spence C., 2004, HDB MULTISENSORY PRO, P3; Stekelenburg JJ, 2007, J COGNITIVE NEUROSCI, V19, P1964, DOI 10.1162/jocn.2007.19.12.1964; van Eijk RLJ, 2008, PERCEPT PSYCHOPHYS, V70, P955, DOI 10.3758/PP.70.6.955; van Wassenhove V, 2005, P NATL ACAD SCI USA, V102, P1181, DOI 10.1073/pnas.0408949102; van Wassenhove V, 2007, NEUROPSYCHOLOGIA, V45, P598, DOI 10.1016/j.neuropsychologia.2006.01.001; Vatakis A, 2008, ACTA PSYCHOL, V127, P12, DOI 10.1016/j.actpsy.2006.12.002; Vatakis A, 2008, EXP BRAIN RES, V185, P521, DOI 10.1007/s00221-007-1168-9; Vatakis A, 2007, PERCEPT PSYCHOPHYS, V69, P744, DOI 10.3758/BF03193776; Vatakis A, 2007, EXP BRAIN RES, V181, P173, DOI 10.1007/s00221-007-0918-z; Vroomen J, 2004, COGNITIVE BRAIN RES, V22, P32, DOI 10.1016/j.cogbrainres.2004.07.003; Yarrow K, 2011, CONSCIOUS COGN, V20, P1518, DOI 10.1016/j.concog.2011.07.003; Yarrow K, 2011, J EXP PSYCHOL HUMAN, V37, P1657, DOI 10.1037/a0024235	30	7	7	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84278	10.1371/journal.pone.0084278	http://dx.doi.org/10.1371/journal.pone.0084278			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391928	Green Published, gold, Green Submitted			2022-12-25	WOS:000329323900071
J	Zhang, XM; Chen, QS; Han, XG				Zhang, Ximei; Chen, Quansheng; Han, Xingguo			Soil Bacterial Communities Respond to Mowing and Nutrient Addition in a Steppe Ecosystem	PLOS ONE			English	Article							MICROBIAL COMMUNITY; NITROGEN ADDITION; SP-NOV; DEPOSITION; DIVERSITY; STABILITY; DYNAMICS; RESOURCE	In many grassland ecosystems, nitrogen (N) and phosphorus (P) are added to improve plant productivity, and the aboveground plant biomass is mowed and stored as hay for the bullamacow. Nutrient addition and mowing affect the biodiversity and ecosystem functioning, and most of the previous studies have primarily focused on their effects on macro-organisms, neglecting the responses of soil microbial communities. In this study, we examined the changes in three community attributes (abundance, richness, and composition) of the entire bacterial kingdom and 16 dominant bacterial phyla/classes in response to mowing, N addition, P addition, and their combinations, by conducting a 5-year experiment in a steppe ecosystem in Inner Mongolia, China. Overall, N addition had a greater effect than mowing and P addition on most of these bacterial groups, as indicated by changes in the abundance, richness and composition in response to these treatments. N addition affected these soil bacterial groups primarily through reducing soil pH and increasing available N content. Meanwhile, the 16 bacterial phyla/classes responded differentially to these experimental treatments, with Acidobacteria, Acidimicrobidae, Deltaproteobacteria, and Gammaproteobacteria being the most sensitive. The changes in the abundance, richness, and composition of various bacterial groups could imply some potential shift in their ecosystem functions. Furthermore, the important role of decreased soil pH caused by N addition in affecting soil bacterial communities suggests the importance of restoring acidified soil to maintain soil bacterial diversity.	[Zhang, Ximei; Han, Xingguo] Chinese Acad Sci, Inst Appl Ecol, State Key Lab Forest & Soil Ecol, Shenyang 110016, Peoples R China; [Chen, Quansheng; Han, Xingguo] Chinese Acad Sci, Inst Bot, State Key Lab Vegetat & Environm Change, Beijing, Peoples R China	Chinese Academy of Sciences; Shenyang Institute of Applied Ecology, CAS; Chinese Academy of Sciences; Institute of Botany, CAS	Han, XG (corresponding author), Chinese Acad Sci, Inst Appl Ecol, State Key Lab Forest & Soil Ecol, Shenyang 110016, Peoples R China.	xghan@ibcas.ac.cn	Han, Xingguo/K-7552-2016; Chen, Quansheng/AGH-8083-2022	Han, Xingguo/0000-0002-1836-975X; Chen, Quansheng/0000-0003-2498-3278	National Natural Science Foundation [30830026]; Postdoctoral Science Foundation of China [2012T50158, 2011M500440]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Postdoctoral Science Foundation of China(China Postdoctoral Science Foundation)	This work was supported by the National Natural Science Foundation (30830026) and Postdoctoral Science Foundation (2012T50158, 2011M500440) of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MJ, 2005, PERMANOVA FORTRAN CO; Bai YF, 2010, GLOBAL CHANGE BIOL, V16, P358, DOI 10.1111/j.1365-2486.2009.01950.x; Bao S.D, 2000, SOIL AGRO CHEM ANAL, P49; Berg G, 2009, FEMS MICROBIOL ECOL, V68, P1, DOI 10.1111/j.1574-6941.2009.00654.x; BRAY J. ROGER, 1957, ECOL MONOGR, V27, P325, DOI 10.2307/1942268; Cease AJ, 2012, SCIENCE, V335, P467, DOI 10.1126/science.1214433; Chen Q, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016909; Chrzanowski TH, 1996, AQUAT MICROB ECOL, V11, P119, DOI 10.3354/ame011119; Cusack DF, 2011, ECOLOGY, V92, P621, DOI 10.1890/10-0459.1; Deiglmayr K, 2006, SOIL BIOL BIOCHEM, V38, P2980, DOI 10.1016/j.soilbio.2006.04.034; EHRICH S, 1995, ARCH MICROBIOL, V164, P16; Fierer N, 2006, P NATL ACAD SCI USA, V103, P626, DOI 10.1073/pnas.0507535103; Fierer N, 2005, APPL ENVIRON MICROB, V71, P4117, DOI 10.1128/AEM.71.7.4117-4120.2005; Fierer N, 2012, ISME J, V6, P1007, DOI 10.1038/ismej.2011.159; Fierer N, 2009, ECOL LETT, V12, P1238, DOI 10.1111/j.1461-0248.2009.01360.x; Frey SD, 2004, FOREST ECOL MANAG, V196, P159, DOI 10.1016/j.foreco.2004.03.018; Hamady M, 2008, NAT METHODS, V5, P235, DOI 10.1038/NMETH.1184; HANADA S, 1995, INT J SYST BACTERIOL, V45, P676, DOI 10.1099/00207713-45-4-676; Hogenhout SA, 2008, CURR OPIN PLANT BIOL, V11, P449, DOI 10.1016/j.pbi.2008.05.007; Kandeler E, 2009, FEMS MICROBIOL ECOL, V67, P444, DOI 10.1111/j.1574-6941.2008.00632.x; Klappenbach JA, 2004, ARCH MICROBIOL, V181, P17, DOI 10.1007/s00203-003-0615-7; Kowalchuk GA, 2002, ANTON LEEUW INT J G, V81, P509, DOI 10.1023/A:1020565523615; Liu YY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057599; Lovett GM, 2011, ECOSYSTEMS, V14, P615, DOI 10.1007/s10021-011-9432-z; Makino W, 2003, FUNCT ECOL, V17, P121, DOI 10.1046/j.1365-2435.2003.00712.x; PIERSON BK, 1974, ARCH MICROBIOL, V100, P5, DOI 10.1007/BF00446302; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Quaiser A, 2003, MOL MICROBIOL, V50, P563, DOI 10.1046/j.1365-2958.2003.03707.x; Ramirez KS, 2010, ECOLOGY, V91, P3463, DOI 10.1890/10-0426.1; Rousk J, 2010, ISME J, V4, P1340, DOI 10.1038/ismej.2010.58; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schonbach P, 2011, PLANT SOIL, V340, P103, DOI 10.1007/s11104-010-0366-6; Torsvik V, 2002, SCIENCE, V296, P1064, DOI 10.1126/science.1071698; Wang J. W., 1988, Research on Grassland Ecosystem, P23; Watson SW, 1994, ARCH MICROBIOL, V144, P62; Wei CZ, 2013, GLOBAL CHANGE BIOL, V19, P3688, DOI 10.1111/gcb.12348; Xu HT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062025; Yang HJ, 2012, ECOL LETT, V15, P619, DOI 10.1111/j.1461-0248.2012.01778.x; Zhang LX, 2004, ACTA BOT SIN, V46, P259; Zhang XM, 2012, J ENVIRON SCI-CHINA, V24, P1483, DOI 10.1016/S1001-0742(11)60900-5; Zhang XM, 2011, MOL ECOL, V20, P429, DOI 10.1111/j.1365-294X.2010.04933.x; Zhou JZ, 2012, NAT CLIM CHANGE, V2, P106, DOI 10.1038/NCLIMATE1331	43	29	33	1	113	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84210	10.1371/journal.pone.0084210	http://dx.doi.org/10.1371/journal.pone.0084210			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391915	gold, Green Submitted, Green Published			2022-12-25	WOS:000329323900058
J	D'Anselmi, F; Masiello, MG; Cucina, A; Proietti, S; Dinicola, S; Pasqualato, A; Ricci, G; Dobrowolny, G; Catizone, A; Palombo, A; Bizzarri, M				D'Anselmi, Fabrizio; Masiello, Maria Grazia; Cucina, Alessandra; Proietti, Sara; Dinicola, Simona; Pasqualato, Alessia; Ricci, Giulia; Dobrowolny, Gabriella; Catizone, Angela; Palombo, Alessandro; Bizzarri, Mariano			Microenvironment Promotes Tumor Cell Reprogramming in Human Breast Cancer Cell Lines (Publication with Expression of Concern. See vol. 14, 2019)	PLOS ONE			English	Article; Publication with Expression of Concern							MESENCHYMAL TRANSITION; PHENOTYPE; TARGET; DIFFERENTIATION; TRANSPLANTATION; CARCINOGENESIS; ORGANIZATION; APOPTOSIS; MIGRATION; REVERSION	The microenvironment drives mammary gland development and function, and may influence significantly both malignant behavior and cell growth of mammary cancer cells. By restoring context, and forcing cells to properly interpret native signals from the microenvironment, the cancer cell aberrant behavior can be quelled, and organization re-established. In order to restore functional and morphological differentiation, human mammary MCF-7 and MDA-MB-231 cancer cells were allowed to grow in a culture medium filled with a 10% of the albumen (EW, Egg White) from unfertilized chicken egg. That unique microenvironment behaves akin a 3D culture and induces MCF-7 cells to produce acini and branching duct-like structures, distinctive of mammary gland differentiation. EW-treated MDA-MB-231 cells developed buds of acini and duct-like structures. Both MCF-7 and MDA-MB-231 cells produced beta-casein, a key milk component. Furthermore, E-cadherin expression was reactivated in MDA-MB-231 cells, as a consequence of the increased cdh1 expression; meanwhile beta-catenin - a key cytoskeleton component - was displaced behind the inner cell membrane. Such modification hinders the epithelial-mesenchymal transition in MDA-MB-231 cells. This differentiating pathway is supported by the contemporary down-regulation of canonical pluripotency markers (Klf4, Nanog). Given that egg-conditioned medium behaves as a 3D-medium, it is likely that cancer phenotype reversion could be ascribed to the changed interactions between cells and their microenvironment.	[D'Anselmi, Fabrizio; Bizzarri, Mariano] Univ Roma La Sapienza, Dept Expt Med, I-00185 Rome, Italy; [D'Anselmi, Fabrizio; Cucina, Alessandra] Univ Roma La Sapienza, Dept Surg Pietro Valdoni, I-00185 Rome, Italy; [Masiello, Maria Grazia; Proietti, Sara; Dinicola, Simona] Univ Roma La Sapienza, Dept Clin & Mol Med, I-00185 Rome, Italy; [Pasqualato, Alessia] Univ G DAnnunzio, Dept Basic & Appl Med Sci, Chieti, Italy; [Ricci, Giulia] Univ Naples 2, Dept Expt Med, Naples, Italy; [Dobrowolny, Gabriella; Catizone, Angela] Univ Roma La Sapienza, Dept Anat Histol Forens Med & Orthoped, Sect Histol & Med Embryol, I-00185 Rome, Italy; [Palombo, Alessandro] Univ Roma Tor Vergata, Ctr Space Biomed, Rome, Italy; [Bizzarri, Mariano] ASI, Rome, Italy	Sapienza University Rome; Sapienza University Rome; Sapienza University Rome; G d'Annunzio University of Chieti-Pescara; Universita della Campania Vanvitelli; Sapienza University Rome; University of Rome Tor Vergata; Agenzia Spaziale Italiana (ASI)	Bizzarri, M (corresponding author), Univ Roma La Sapienza, Dept Expt Med, I-00185 Rome, Italy.	mariano.bizzarri@uniroma1.it	Ricci, Giulia/AAO-1856-2020; Bizzarri, Mariano/U-8300-2017	Ricci, Giulia/0000-0002-2199-170X; Bizzarri, Mariano/0000-0003-0408-4136; catizone, angela/0000-0002-7836-9495; Dobrowolny, Gabriella/0000-0001-8693-0724; Cucina, Alessandra/0000-0001-5469-6419; Masiello, Maria Grazia/0000-0002-7474-5553	Fondazione Roma Terzo Settore [8.1.3.3.19.1]	Fondazione Roma Terzo Settore(Fondazione Roma)	The present study was partially supported by the Fondazione Roma Terzo Settore (grant no. 8.1.3.3.19.1; URL: http://www.fondazioneroma-terzosettore.it/it/index.html). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agus DB, 2013, SCI REP-UK, V3, DOI 10.1038/srep01449; Alberio R, 2006, REPRODUCTION, V132, P709, DOI 10.1530/rep.1.01077; Allegrucci C, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-7; Baker SG, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-151; Berlutti F, 2010, INT J IMMUNOPATH PH, V23, P1253, DOI 10.1177/039463201002300430; Berx G, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a003129; Biskind MS, 1944, P SOC EXP BIOL MED, V55, P176; Bissell MJ, 2011, NAT MED, V17, P320, DOI 10.1038/nm.2328; Bizzarri M, 2008, ACTA BIOTHEOR, V56, P173, DOI 10.1007/s10441-008-9047-8; Bizzarri M, 2013, HISTOL HISTOPATHOL, V28, P155, DOI 10.14670/HH-28.155; Bizzarri M, 2011, CURR PHARM BIOTECHNO, V12, P243, DOI 10.2174/138920111794295701; Bourhis XFDL, 1997, INT J CANCER, V71, P42, DOI 10.1002/(SICI)1097-0215(19970328)71:1<42::AID-IJC9>3.0.CO;2-3; BOVERI T, 1929, ORIGIN MALIGNANT TUM, P62; BRINSTER RL, 1974, J EXP MED, V140, P1049, DOI 10.1084/jem.140.4.1049; Catizone A, 2008, J CELL PHYSIOL, V216, P253, DOI 10.1002/jcp.21400; Christofori G, 2010, EMBO J, V29, P1787, DOI 10.1038/emboj.2010.92; Cooper, 2009, MED STUD, V1, P55, DOI [10.1007/s12376-008-0002-4, DOI 10.1007/S12376-008-0002-4]; Cucina A, 2006, APOPTOSIS, V11, P1617, DOI 10.1007/s10495-006-8895-4; D'Anselmi F, 2011, CURR PHARM BIOTECHNO, V12, P261, DOI 10.2174/138920111794295864; D'Anselmi F, 2011, INT J BIOCHEM CELL B, V43, P1052, DOI 10.1016/j.biocel.2010.05.002; Dhimolea E, 2012, J BIOMED MATER RES A, V100A, P2905, DOI 10.1002/jbm.a.34227; Dobrowolny G, 2008, CELL METAB, V8, P425, DOI 10.1016/j.cmet.2008.09.002; Ewald AJ, 2008, DEV CELL, V14, P570, DOI 10.1016/j.devcel.2008.03.003; Ferranti F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076192; Gilbert SF, 1996, DEV BIOL, V173, P357, DOI 10.1006/dbio.1996.0032; Hochedlinger K, 2004, GENE DEV, V18, P1875, DOI 10.1101/gad.1213504; Inoue T, 2001, J INVEST DERMATOL, V117, P244, DOI 10.1046/j.0022-202x.2001.01431.x; Kasemeier-Kulesa JC, 2008, DEV DYNAM, V237, P2657, DOI 10.1002/dvdy.21613; Kenny PA, 2007, MOL ONCOL, V1, P84, DOI 10.1016/j.molonc.2007.02.004; Krause S, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-263; Lee JT, 2006, NAT MED, V12, P882, DOI 10.1038/nm0806-882; Lee LMJ, 2005, DEV DYNAM, V233, P1560, DOI 10.1002/dvdy.20471; LI ML, 1987, P NATL ACAD SCI USA, V84, P136, DOI 10.1073/pnas.84.1.136; Li-Chan EC., 1995, EGG SCI TECHNOL, P105; Lombaerts M, 2006, BRIT J CANCER, V94, P661, DOI 10.1038/sj.bjc.6602996; Maffini MV, 2004, J CELL SCI, V117, P1495, DOI 10.1242/jcs.01000; Mann K, 2011, PROTEOME SCI, V9, DOI 10.1186/1477-5956-9-7; McCullough KD, 1997, CANCER RES, V57, P1807; Micalizzi DS, 2010, J MAMMARY GLAND BIOL, V15, P117, DOI 10.1007/s10911-010-9178-9; MINTZ B, 1975, P NATL ACAD SCI USA, V72, P3585, DOI 10.1073/pnas.72.9.3585; Niwa H, 2007, DEVELOPMENT, V134, P635, DOI 10.1242/dev.02787; PIERCE GB, 1983, AM J PATHOL, V113, P115; Postovit LM, 2008, P NATL ACAD SCI USA, V105, P4329, DOI 10.1073/pnas.0800467105; Sonnenschein C, 1996, J STEROID BIOCHEM, V59, P147, DOI 10.1016/S0960-0760(96)00112-4; Sonnenschein C, 2008, SEMIN CANCER BIOL, V18, P372, DOI 10.1016/j.semcancer.2008.03.012; Soto AM, 2011, BIOESSAYS, V33, P332, DOI 10.1002/bies.201100025; Tafani M, 2012, J CANC SCI THER, V4; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Underwood JM, 2006, J CELL PHYSIOL, V208, P141, DOI 10.1002/jcp.20639; Weaver VM, 1997, J CELL BIOL, V137, P231, DOI 10.1083/jcb.137.1.231	50	32	32	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e83770	10.1371/journal.pone.0083770	http://dx.doi.org/10.1371/journal.pone.0083770			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386275	Green Submitted, Green Published, gold			2022-12-25	WOS:000329194700067
J	Kagawa, Y; Matsumoto, S; Kamioka, Y; Mimori, K; Naito, Y; Ishii, T; Okuzaki, D; Nishida, N; Maeda, S; Naito, A; Kikuta, J; Nishikawa, K; Nishimura, J; Haraguchi, N; Takemasa, I; Mizushima, T; Ikeda, M; Yamamoto, H; Sekimoto, M; Ishii, H; Doki, Y; Matsuda, M; Kikuchi, A; Mori, M; Ishii, M				Kagawa, Yoshinori; Matsumoto, Shinji; Kamioka, Yuji; Mimori, Koshi; Naito, Yoko; Ishii, Taeko; Okuzaki, Daisuke; Nishida, Naohiro; Maeda, Sakae; Naito, Atsushi; Kikuta, Junichi; Nishikawa, Keizo; Nishimura, Junichi; Haraguchi, Naotsugu; Takemasa, Ichiro; Mizushima, Tsunekazu; Ikeda, Masataka; Yamamoto, Hirofumi; Sekimoto, Mitsugu; Ishii, Hideshi; Doki, Yuichiro; Matsuda, Michiyuki; Kikuchi, Akira; Mori, Masaki; Ishii, Masaru			Cell Cycle-Dependent Rho GTPase Activity Dynamically Regulates Cancer Cell Motility and Invasion In Vivo	PLOS ONE			English	Article							IMMUNE-SYSTEM; MOUSE MODEL; KINASE; MIGRATION; ROCK; PROLIFERATION; ACTIVATION; EXPRESSION; INHIBITOR; PROTEINS	The mechanism behind the spatiotemporal control of cancer cell dynamics and its possible association with cell proliferation has not been well established. By exploiting the intravital imaging technique, we found that cancer cell motility and invasive properties were closely associated with the cell cycle. In vivo inoculation of human colon cancer cells bearing fluorescence ubiquitination-based cell cycle indicator (Fucci) demonstrated an unexpected phenomenon: S/G2/M cells were more motile and invasive than G1 cells. Microarray analyses showed that Arhgap11a, an uncharacterized Rho GTPase-activating protein (RhoGAP), was expressed in a cell-cycle-dependent fashion. Expression of ARHGAP11A in cancer cells suppressed RhoA-dependent mechanisms, such as stress fiber formation and focal adhesion, which made the cells more prone to migrate. We also demonstrated that RhoA suppression by ARHGAP11A induced augmentation of relative Rac1 activity, leading to an increase in the invasive properties. RNAi-based inhibition of Arhgap11a reduced the invasion and in vivo expansion of cancers. Additionally, analysis of human specimens showed the significant up-regulation of Arhgap11a in colon cancers, which was correlated with clinical invasion status. The present study suggests that ARHGAP11A, a cell cycle-dependent RhoGAP, is a critical regulator of cancer cell mobility and is thus a promising therapeutic target in invasive cancers.	[Kagawa, Yoshinori; Naito, Yoko; Ishii, Taeko; Maeda, Sakae; Naito, Atsushi; Kikuta, Junichi; Ishii, Masaru] Osaka Univ, Grad Sch Med, Dept Immunol & Cell Biol, Suita, Osaka, Japan; [Kagawa, Yoshinori; Naito, Yoko; Ishii, Taeko; Maeda, Sakae; Naito, Atsushi; Kikuta, Junichi; Nishikawa, Keizo; Ishii, Masaru] Osaka Univ, Lab Cellular Dynam, WPI Immunol Frontier Res Ctr, Suita, Osaka, Japan; [Kagawa, Yoshinori; Kikuta, Junichi; Nishikawa, Keizo; Ishii, Masaru] CREST, JST, Chiyoda Ku, Tokyo, Japan; [Kagawa, Yoshinori; Nishida, Naohiro; Maeda, Sakae; Naito, Atsushi; Nishimura, Junichi; Haraguchi, Naotsugu; Takemasa, Ichiro; Mizushima, Tsunekazu; Ikeda, Masataka; Yamamoto, Hirofumi; Sekimoto, Mitsugu; Ishii, Hideshi; Doki, Yuichiro; Mori, Masaki] Osaka Univ, Grad Sch Med, Dept Surg Gastroenterol, Suita, Osaka, Japan; [Matsumoto, Shinji; Kikuchi, Akira] Osaka Univ, Dept Mol Biol & Biochem, Grad Sch Med, Suita, Osaka, Japan; [Kamioka, Yuji; Matsuda, Michiyuki] Kyoto Univ, Grad Sch Med, Dept Pathol & Biol Dis, Kyoto, Japan; [Mimori, Koshi; Nishida, Naohiro] Kyushu Univ, Dept Surg, Med Inst Bioregulat, Beppu, Oita, Japan; [Okuzaki, Daisuke] Osaka Univ, Microbial Dis Res Inst, DNA Chip Dev Ctr Infect Dis, Suita, Osaka 565, Japan	Osaka University; Osaka University; Japan Science & Technology Agency (JST); Osaka University; Osaka University; Kyoto University; Kyushu University; Osaka University	Mori, M (corresponding author), Osaka Univ, Grad Sch Med, Dept Surg Gastroenterol, Suita, Osaka, Japan.	mmori@gesurg.med.osaka-u.ac.jp; mishii@icb.med.osaka-u.ac.jp	Okuzaki, Daisuke/AAN-5641-2020; Sekimoto, Mitsugu/T-2217-2019; Kikuta, Junichi/HHS-8875-2022; Ishii, Hideshi/AAV-5317-2020; Nishimura, Junichi/K-8390-2015; Sekimoto, MItsugu/AAE-5878-2019	Okuzaki, Daisuke/0000-0002-4552-783X; Nishimura, Junichi/0000-0001-8220-3423; Matsuda, Michiyuki/0000-0002-5876-9969; Mimori, Koshi/0000-0003-3897-9974	Ministry of Education, Science, Sports and Culture of Japan; International Human Frontier Science Program [RGY0077/2011]; Takeda Science Foundation; Cell Science Research Foundation; Kanae Foundation for the Promotion of Medical Science; Nakajima Foundation;  [22113007]; Grants-in-Aid for Scientific Research [22113007] Funding Source: KAKEN	Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); International Human Frontier Science Program(Human Frontier Science Program); Takeda Science Foundation(Takeda Science Foundation (TSF)); Cell Science Research Foundation(Cell Science Research Foundation, Japan); Kanae Foundation for the Promotion of Medical Science; Nakajima Foundation; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was funded by Grants-in-Aid for Scientific Research on Innovative Areas (22113007), by the FIRST Program from the Ministry of Education, Science, Sports and Culture of Japan, by grants from the International Human Frontier Science Program (RGY0077/2011); and by grants from the Takeda Science Foundation, the Cell Science Research Foundation, the Kanae Foundation for the Promotion of Medical Science, and the Nakajima Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki K, 2009, NAT PROTOC, V4, P1623, DOI 10.1038/nprot.2009.175; Artacho-Cordon F, 2012, SURG ONCOL, V21, pE143, DOI 10.1016/j.suronc.2012.06.001; Besson A, 2004, GENE DEV, V18, P862, DOI 10.1101/gad.1185504; Bravou V, 2005, INT J ONCOL, V27, P1511; Cahalan MD, 2002, NAT REV IMMUNOL, V2, P872, DOI 10.1038/nri935; Calvo F, 2011, NAT CELL BIOL, V13, P819, DOI 10.1038/ncb2271; Cance WG, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004021; Chen HZ, 2009, NAT REV CANCER, V9, P785, DOI 10.1038/nrc2696; Coleman ML, 2004, NAT REV MOL CELL BIO, V5, P355, DOI 10.1038/nrm1365; Comen E, 2011, NAT REV CLIN ONCOL, V8, P369, DOI 10.1038/nrclinonc.2011.64; Denicourt C, 2004, GENE DEV, V18, P851, DOI 10.1101/gad.1205304; Funato Y, 2010, CURR BIOL, V20, P1945, DOI 10.1016/j.cub.2010.09.065; Germain RN, 2008, IMMUNOL REV, V221, P163, DOI 10.1111/j.1600-065X.2008.00591.x; Germain RN, 2006, NAT REV IMMUNOL, V6, P497, DOI 10.1038/nri1884; Giampieri S, 2009, NAT CELL BIOL, V11, P1287, DOI 10.1038/ncb1973; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Ishii M, 2009, NATURE, V458, P524, DOI 10.1038/nature07713; Ishizaki T, 2000, MOL PHARMACOL, V57, P976; Itoh K, 1999, NAT MED, V5, P221, DOI 10.1038/5587; Kogo R, 2011, CANCER RES, V71, P6320, DOI 10.1158/0008-5472.CAN-11-1021; Komatsu N, 2011, MOL BIOL CELL, V22, P4647, DOI 10.1091/mbc.E11-01-0072; Kostourou V, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3020; KOVESDI I, 1986, CELL, V45, P219, DOI 10.1016/0092-8674(86)90386-7; Kupershmidt I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013066; Machacek M, 2009, NATURE, V461, P99, DOI 10.1038/nature08242; Martin-Belmonte F, 2007, CELL, V128, P383, DOI 10.1016/j.cell.2006.11.051; Martinelli R, 2009, MOL BIOL CELL, V20, P995, DOI 10.1091/mbc.E08-06-0636; Miyoshi H, 1998, J VIROL, V72, P8150, DOI 10.1128/JVI.72.10.8150-8157.1998; Mori M, 2002, SURGERY, V131, pS39, DOI 10.1067/msy.2002.119292; Narumiya S, 2009, CANCER METAST REV, V28, P65, DOI 10.1007/s10555-008-9170-7; Nishikaw K, 2010, P NATL ACAD SCI USA, V107, P3117, DOI 10.1073/pnas.0912779107; Nobes CD, 1999, J CELL BIOL, V144, P1235, DOI 10.1083/jcb.144.6.1235; Rashidi B, 2000, CLIN CANCER RES, V6, P2556; Regala RP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026439; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Romanov VS, 2012, BIOCHEMISTRY-MOSCOW+, V77, P575, DOI 10.1134/S000629791206003X; Rothenfluh A, 2006, CELL, V127, P199, DOI 10.1016/j.cell.2006.09.010; Roussos ET, 2011, NAT REV CANCER, V11, P573, DOI 10.1038/nrc3078; Roussos ET, 2011, J CELL SCI, V124, P2120, DOI 10.1242/jcs.086231; Sahai E, 2002, NAT REV CANCER, V2, P133, DOI 10.1038/nrc725; Sakaue-Sawano A, 2008, CELL, V132, P487, DOI 10.1016/j.cell.2007.12.033; Salhia B, 2005, CANCER RES, V65, P8792, DOI 10.1158/0008-5472.CAN-05-0160; Sanz-Moreno V, 2008, CELL, V135, P510, DOI 10.1016/j.cell.2008.09.043; Sanz-Moreno V, 2011, CANCER CELL, V20, P229, DOI 10.1016/j.ccr.2011.06.018; Sanz-Moreno V, 2010, CURR OPIN CELL BIOL, V22, P690, DOI 10.1016/j.ceb.2010.08.020; Sato A, 2010, EMBO J, V29, P41, DOI 10.1038/emboj.2009.322; Shitashige M, 2010, CANCER RES, V70, P5024, DOI 10.1158/0008-5472.CAN-10-0306; Sobin, 2009, UICC TNM CLASSIFICAT; Subauste MC, 2000, J BIOL CHEM, V275, P9725, DOI 10.1074/jbc.275.13.9725; Takeshita F, 2005, P NATL ACAD SCI USA, V102, P12177, DOI 10.1073/pnas.0501753102; Walmod PS, 2004, EXP CELL RES, V295, P407, DOI 10.1016/j.yexcr.2004.01.011; Wyckoff JB, 2006, CURR BIOL, V16, P1515, DOI 10.1016/j.cub.2006.05.065; Xu J, 2013, CELL REP, V3, P1526, DOI 10.1016/j.celrep.2013.04.017; Yamauchi K, 2006, CANCER RES, V66, P4208, DOI 10.1158/0008-5472.CAN-05-3927; Yoshida K, 2004, ONCOGENE, V23, P58, DOI 10.1038/sj.onc.1206987	55	48	51	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e83629	10.1371/journal.pone.0083629	http://dx.doi.org/10.1371/journal.pone.0083629			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386239	Green Published, Green Submitted, gold			2022-12-25	WOS:000329194700052
J	Li, ZP; Zhang, XS; Wang, RS; Liu, HW; Zhang, SH				Li, Zhenping; Zhang, Xiang-Sun; Wang, Rui-Sheng; Liu, Hongwei; Zhang, Shihua			Discovering Link Communities in Complex Networks by an Integer Programming Model and a Genetic Algorithm	PLOS ONE			English	Article							FUNCTIONAL MODULES	Identification of communities in complex networks is an important topic and issue in many fields such as sociology, biology, and computer science. Communities are often defined as groups of related nodes or links that correspond to functional subunits in the corresponding complex systems. While most conventional approaches have focused on discovering communities of nodes, some recent studies start partitioning links to find overlapping communities straightforwardly. In this paper, we propose a new quantity function for link community identification in complex networks. Based on this quantity function we formulate the link community partition problem into an integer programming model which allows us to partition a complex network into overlapping communities. We further propose a genetic algorithm for link community detection which can partition a network into overlapping communities without knowing the number of communities. We test our model and algorithm on both artificial networks and real-world networks. The results demonstrate that the model and algorithm are efficient in detecting overlapping community structure in complex networks.	[Li, Zhenping; Liu, Hongwei] Beijing Wuzi Univ, Sch Informat, Beijing, Peoples R China; [Zhang, Xiang-Sun; Zhang, Shihua] Chinese Acad Sci, Acad Math & Syst Sci, Natl Ctr Math & Interdisciplinary Sci, Beijing, Peoples R China; [Wang, Rui-Sheng] Penn State Univ, Dept Phys, University Pk, PA 16802 USA	Beijing Wuzi University; Chinese Academy of Sciences; Academy of Mathematics & System Sciences, CAS; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Zhang, SH (corresponding author), Chinese Acad Sci, Acad Math & Syst Sci, Natl Ctr Math & Interdisciplinary Sci, Beijing, Peoples R China.	zsh@amss.ac.cn		Wang, Ruisheng/0000-0003-4920-4357	National Natural Science Foundation of China [11131009]; Funding Project for Academic Human Resources Development in Institutions of Higher Learning under the Jurisdiction of Beijing Municipality [PHR201006217, CITTCD20130327]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Funding Project for Academic Human Resources Development in Institutions of Higher Learning under the Jurisdiction of Beijing Municipality	This work is supported by National Natural Science Foundation of China under grant number 11131009. It is also partially supported by the Funding Project for Academic Human Resources Development in Institutions of Higher Learning under the Jurisdiction of Beijing Municipality (No.PHR201006217, CIT&TCD20130327). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn YY, 2010, NATURE, V466, P761, DOI 10.1038/nature09182; Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Esquivel AV, 2011, PHYS REV X, V1, DOI 10.1103/PhysRevX.1.021025; Evans TS, 2010, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2010/12/P12037; Evans TS, 2010, EUR PHYS J B, V77, P265, DOI 10.1140/epjb/e2010-00261-8; Evans TS, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.016105; Fortunato S, 2007, P NATL ACAD SCI USA, V104, P36, DOI 10.1073/pnas.0605965104; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; Gregory S, 2011, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2011/02/P02017; He DX, 2012, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2012/10/P10015; Holland JH., 1975, Q REV BIOL; Hu YQ, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.026121; Knuth DE., 1993, STANFORD GRAPH BASE; Kovacs IA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012528; Lee JG, 2013, SCI REP-UK, V3, DOI [10.1038/srep01034, 10.1038/srep02197]; Li K, 2012, PHYSICA A, V391, P1788, DOI 10.1016/j.physa.2011.09.027; Li ZP, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.036109; Nepusz T, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.016107; Newman MEJ, 2012, NAT PHYS, V8, P25, DOI 10.1038/nphys2162; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Nicosia V, 2009, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2009/03/P03024; Palla G, 2005, NATURE, V435, P814, DOI 10.1038/nature03607; Salathe M, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000736; Shen HW, 2009, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2009/07/P07042; Spirin V, 2003, P NATL ACAD SCI USA, V100, P12123, DOI 10.1073/pnas.2032324100; Szalay-Beko M, 2012, BIOINFORMATICS, V28, P2202, DOI 10.1093/bioinformatics/bts352; Tasgin M., 2006, COMMUNITY DETECTION; Vicsek T, 2007, PHYSICA A, V378, P20, DOI 10.1016/j.physa.2006.11.075; Wang RS, 2007, LECT NOTES ARTIF INT, V4682, P1090; Weng L, 2013, SCI REP-UK, V3, DOI [10.1038/srep02304, 10.1038/srep02522]; ZACHARY WW, 1977, J ANTHROPOL RES, V33, P452, DOI 10.1086/jar.33.4.3629752; Zhan WH, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.066120; Zhang S, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.046103; Zhang SH, 2007, PROTEOMICS, V7, P2856, DOI 10.1002/pmic.200700095; Zhang SH, 2007, PHYSICA A, V374, P483, DOI 10.1016/j.physa.2006.07.023; Zhang SH, 2009, INT J DATA MIN BIOIN, V3, P68, DOI 10.1504/IJDMB.2009.023885; Zhang XS, 2009, EPL-EUROPHYS LETT, V87, DOI 10.1209/0295-5075/87/38002	37	13	14	1	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e83739	10.1371/journal.pone.0083739	http://dx.doi.org/10.1371/journal.pone.0083739			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386268	Green Published, gold, Green Submitted			2022-12-25	WOS:000329194700062
J	Liu, F; Gao, MQ; Zhang, X; Du, FJ; Jia, HY; Yang, XT; Wang, ZT; Zhang, LQ; Ma, LP; Wu, XG; Xie, L; Zhang, ZD				Liu, Fei; Gao, Mengqiu; Zhang, Xia; Du, Fengjiao; Jia, Hongyan; Yang, Xinting; Wang, Zitong; Zhang, Liqun; Ma, Liping; Wu, Xiaoguang; Xie, Li; Zhang, Zongde			Interferon-Gamma Release Assay Performance of Pleural Fluid and Peripheral Blood in Pleural Tuberculosis	PLOS ONE			English	Article							ENZYME-LINKED IMMUNOSPOT; POLYMERASE-CHAIN-REACTION; ADENOSINE-DEAMINASE; MYCOBACTERIUM-TUBERCULOSIS; ACTIVE TUBERCULOSIS; T-CELLS; DIAGNOSIS; INFECTION; EFFUSIONS	Background: The diagnosis of pleural tuberculosis (TB) remains to be difficult. Interferon-gamma release assay (IGRA) is a promising method for diagnosing TB in low TB burden countries. The release of interferon-gamma (IFN-gamma) y T lymphocytes increases at a localized site of infection with Mycobacterium tuberculosis antigen. This study aimed to examine the clinical accuracy of T-SPOT.TB on pleural fluid and peripheral blood for the diagnosis of pleural TB in high TB burden country. Methods: 168 subjects with pleural effusion were enrolled prospectively and examined with T-SPOT.TB on pleural fluid and peripheral blood samples simultaneously. Results: The receiver operating characteristic (ROC) curve and cut-off value of pleural fluid T-SPOT.TB was established according to spot forming cells (SFC) between culture/biopsy-confirmed pleural TB group and no pleural TB group. The sensitivity of pleural fluid T-SPOT. TB and peripheral blood T-SPOT.TB was similar (96.3% and 92.7%, respectively) (P= 0.691). In contrast, the specificity of pleural fluid T-SPOT.TB (94.5%) was significantly higher than that of peripheral blood T-SPOT.TB (76.1%) (P=0.002). 2% (2/98) of pleural fluid T-SPOT.TB results were indeterminate. Conclusion: The diagnostic accuracy of peripheral blood T-SPOT.TB is low in high TB burden countries due to latent tuberculosis infection. Pleural fluid T-SPOT.TB is a relatively useful and supplementary test to explore pleural TB in high TB burden countries, but its diagnostic accuracy needs to be validated in further large scale research.	[Liu, Fei; Zhang, Xia; Du, Fengjiao; Jia, Hongyan; Zhang, Zongde] Capital Med Univ, Beijing Key Lab Drug Resistant TB Res, Beijing Chest Hosp, Beijing TB & Thorac Tumor Res Inst, Beijing, Peoples R China; [Gao, Mengqiu; Yang, Xinting; Zhang, Liqun; Ma, Liping; Wu, Xiaoguang; Xie, Li] Capital Med Univ, TB Dept, Beijing Chest Hosp, Beijing TB & Thorac Tumor Res Inst, Beijing, Peoples R China; [Wang, Zitong] Capital Med Univ, Dept Thorac Surg, Beijing Chest Hosp, Beijing TB & Thorac Tumor Res Inst, Beijing, Peoples R China	Capital Medical University; Capital Medical University; Capital Medical University	Zhang, ZD (corresponding author), Capital Med Univ, Beijing Key Lab Drug Resistant TB Res, Beijing Chest Hosp, Beijing TB & Thorac Tumor Res Inst, Beijing, Peoples R China.	zzd417@163.com	Zhang, Li/GWM-7501-2022		National Major Project [2012ZX10003002-003]; Beijing health systems of high-level health and technical personnel training plan [2009-3-51]; Capital Science &Development fund [2009-3146]	National Major Project; Beijing health systems of high-level health and technical personnel training plan; Capital Science &Development fund	This work was supported by grants of the National Major Project (2012ZX10003002-003), Beijing health systems of high-level health and technical personnel training plan (2009-3-51). It was also supported by Capital Science &Development fund (2009-3146). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BUENO CE, 1990, ARCH INTERN MED, V150, P1190, DOI 10.1001/archinte.1990.00390180034005; Chen XC, 2009, CLIN VACCINE IMMUNOL, V16, P879, DOI 10.1128/CVI.00044-09; Duanmu Hongjin, 2002, Zhonghua Jiehe He Huxi Zazhi, V25, P3; Gopi A, 2007, CHEST, V131, P880, DOI 10.1378/chest.06-2063; Greco S, 2003, INT J TUBERC LUNG D, V7, P777; Jafari C, 2006, AM J RESP CRIT CARE, V174, P1048, DOI 10.1164/rccm.200604-465OC; Jafari C, 2009, AM J RESP CRIT CARE, V180, P666, DOI 10.1164/rccm.200904-0557OC; Kang JY, 2012, TUBERC RESPIR DIS, V73, P143, DOI 10.4046/trd.2012.73.3.143; Lalvani A, 2007, CHEST, V131, P1898, DOI 10.1378/chest.06-2471; Lee LN, 2009, CLIN MICROBIOL INFEC, V15, P173, DOI 10.1111/j.1469-0691.2008.02655.x; Li H, 2012, INT J TUBERC LUNG D, V16, P1668, DOI 10.5588/ijtld.12.0292; Liang QL, 2008, RESP MED, V102, P744, DOI 10.1016/j.rmed.2007.12.007; Lima DM, 2003, CHEST, V124, P909, DOI 10.1378/chest.124.3.909; Losi M, 2007, EUR RESPIR J, V30, P1173, DOI 10.1183/09031936.00067307; Menzies D, 2007, ANN INTERN MED, V146, P340, DOI 10.7326/0003-4819-146-5-200703060-00006; Nagesh BS, 2001, CHEST, V119, P1737, DOI 10.1378/chest.119.6.1737; Nemeth J, 2009, J INTERN MED, V265, P163, DOI 10.1111/j.1365-2796.2008.02012.x; Pai M, 2008, ANN INTERN MED, V149, P177, DOI 10.7326/0003-4819-149-3-200808050-00241; Patel VB, 2010, AM J RESP CRIT CARE, V182, P569, DOI 10.1164/rccm.200912-1931OC; Perez-Rodriguez E, 2000, Curr Opin Pulm Med, V6, P259, DOI 10.1097/00063198-200007000-00002; Rangaka MX, 2012, LANCET INFECT DIS, V12, P45, DOI 10.1016/S1473-3099(11)70210-9; Santin M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032482; Valdes L, 1996, EUR RESPIR J, V9, P747, DOI 10.1183/09031936.96.09040747; Valdes L, 1998, ARCH INTERN MED, V158, P2017, DOI 10.1001/archinte.158.18.2017; Valdes L, 1996, CHEST, V109, P158, DOI 10.1378/chest.109.1.158; Wang SM, 2006, PROTOCOL BACTERIOLOG; Wilkinson KA, 2005, CLIN INFECT DIS, V40, P184, DOI 10.1086/426139; Wu X, 2008, CLIN EXP IMMUNOL, V152, P81, DOI 10.1111/j.1365-2249.2008.03605.x	28	23	30	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e83857	10.1371/journal.pone.0083857	http://dx.doi.org/10.1371/journal.pone.0083857			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281RE	24386296	Green Published, gold, Green Submitted			2022-12-25	WOS:000329117900063
J	Mordini, S; Osera, C; Marini, S; Scavone, F; Bellazzi, R; Galizzi, A; Calvio, C				Mordini, Serena; Osera, Cecilia; Marini, Simone; Scavone, Francesco; Bellazzi, Riccardo; Galizzi, Alessandro; Calvio, Cinzia			The Role of SwrA, DegU and P-D3 in fla/che Expression in B. subtilis	PLOS ONE			English	Article							RESPONSE REGULATOR DEGU; BACILLUS-SUBTILIS; SWARMING MOTILITY; GENES; MUTATIONS; OPERON; PHOSPHORYLATION; PROMOTERS; ENZYMES; SIGD	In B. subtilis swarming and robust swimming motility require the positive trigger of SwrA on fla/che operon expression. Despite having an essential and specific activity, how SwrA executes this task has remained elusive thus far. We demonstrate here that SwrA acts at the main sA-dependent fla/che promoter P-A(fla/che) through DegU. Electrophoretic mobility shift assays (EMSA) reveal that SwrA forms a complex with the phosphorylated form of DegU (DegU similar to P) at P-A(fla/che) while it is unable to do so with either unphosphorylated DegU or the DegU32(Hy) mutant protein. Motility assays show that a highly phosphorylated DegU is not detrimental for flagellar motility provided that SwrA is present; however, DegU similar to P represses P-A(fla/che) in the absence of SwrA. Overall, our data support a model in which DegU similar to P is a dual regulator, acting either as a repressor when alone or as a positive regulator of PA(fla/che) when combined with SwrA. Finally, we demonstrate that the sD-dependent P-D3(fla/che) promoter plays an important role in motility, representing a contingent feedback loop necessary to maintain basal motility when swrA is switched to the non-functional swrA-status.	[Mordini, Serena; Osera, Cecilia; Scavone, Francesco; Galizzi, Alessandro; Calvio, Cinzia] Univ Pavia, Dept Biol & Biotechnol, I-27100 Pavia, Italy; [Marini, Simone; Bellazzi, Riccardo] Univ Pavia, Dept Elect Comp & Biomed Engn, I-27100 Pavia, Italy	University of Pavia; University of Pavia	Calvio, C (corresponding author), Univ Pavia, Dept Biol & Biotechnol, Via Palestro 3, I-27100 Pavia, Italy.	cinzia.calvio@unipv.it	Cinzia, Calvio/E-1353-2011; Bellazzi, Riccardo/J-6432-2018; Osera, Cecilia/K-3677-2016	Cinzia, Calvio/0000-0003-1631-0452; Bellazzi, Riccardo/0000-0002-6974-9808; Osera, Cecilia/0000-0002-7406-7166; Marini, Simone/0000-0002-5704-3533	Ministero dell'Universita e della Ricerca; PRIN [2008KY8WN9]; Alma Mater Ticinensis Foundation	Ministero dell'Universita e della Ricerca(Ministry of Education, Universities and Research (MIUR)); PRIN(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); Alma Mater Ticinensis Foundation	This work was supported by grants from Ministero dell'Universita e della Ricerca to CC and AG, PRIN # 2008KY8WN9 (http://prin.miur.it/), and from the Alma Mater Ticinensis Foundation (www.almamaterticinensis.eu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amati G, 2004, J BACTERIOL, V186, P6003, DOI 10.1128/jb.186.18.6003-6014.2004; AMORY A, 1987, J BACTERIOL, V169, P324, DOI 10.1128/jb.169.1.324-333.1987; Arnaud M, 2004, APPL ENVIRON MICROB, V70, P6887, DOI 10.1128/AEM.70.11.6887-6891.2004; Buelow DR, 2010, MOL MICROBIOL, V75, P547, DOI 10.1111/j.1365-2958.2009.06982.x; Cairns LS, 2013, MOL MICROBIOL, V90, P6, DOI 10.1111/mmi.12342; Calvio C, 2005, J BACTERIOL, V187, P5356, DOI 10.1128/JB.187.15.5356-5366.2005; Calvio C, 2008, J BACTERIOL, V190, P5720, DOI 10.1128/JB.00455-08; Carey Michael F, 2012, Cold Spring Harb Protoc, V2012, P18, DOI 10.1101/pdb.top067470; DAHL MK, 1992, J BIOL CHEM, V267, P14509; Estacio W, 1998, J BACTERIOL, V180, P3548, DOI 10.1128/JB.180.14.3548-3555.1998; Gordon AJE, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003595; HENNER DJ, 1988, J BACTERIOL, V170, P5102, DOI 10.1128/jb.170.11.5102-5109.1988; Kearns DB, 2005, GENE DEV, V19, P3083, DOI 10.1101/gad.1373905; Kearns DB, 2004, MOL MICROBIOL, V52, P357, DOI 10.1111/j.1365-2958.2004.03996.x; Kearns DB, 2003, MOL MICROBIOL, V49, P581, DOI 10.1046/j.1365-2958.2003.03584.x; Kobayashi K, 2007, MOL MICROBIOL, V66, P395, DOI 10.1111/j.1365-2958.2007.05923.x; KUNST F, 1974, BIOCHIMIE, V56, P1481; Mader U, 2002, MOL GENET GENOMICS, V268, P455, DOI 10.1007/s00438-002-0774-2; MSADEK T, 1991, J BACTERIOL, V173, P2366, DOI 10.1128/JB.173.7.2366-2377.1991; MSADEK T, 1990, J BACTERIOL, V172, P824, DOI 10.1128/jb.172.2.824-834.1990; MUKAI K, 1992, J BACTERIOL, V174, P7954, DOI 10.1128/JB.174.24.7954-7962.1992; Murray EJ, 2009, MICROBIOL-SGM, V155, P1, DOI 10.1099/mic.0.023903-0; NAGAMI Y, 1986, J BACTERIOL, V166, P20, DOI 10.1128/jb.166.1.20-28.1986; NAKANO MM, 1992, MOL GEN GENET, V232, P313, DOI 10.1007/BF00280011; Ogura M, 2012, J BIOCHEM, V151, P643, DOI 10.1093/jb/mvs036; Osera C, 2009, MICROBIOL-SGM, V155, P2282, DOI 10.1099/mic.0.026435-0; Patrick JE, 2012, MOL MICROBIOL, V83, P14, DOI 10.1111/j.1365-2958.2011.07917.x; Patrick JE, 2009, J BACTERIOL, V191, P7129, DOI 10.1128/JB.00905-09; TANAKA T, 1991, J BACTERIOL, V173, P5507, DOI 10.1128/jb.173.17.5507-5515.1991; TOKUNAGA T, 1994, J BACTERIOL, V176, P5177, DOI 10.1128/jb.176.16.5177-5180.1994; Verhamme DT, 2007, MOL MICROBIOL, V65, P554, DOI 10.1111/j.1365-2958.2007.05810.x; West JT, 2000, J BACTERIOL, V182, P4841, DOI 10.1128/JB.182.17.4841-4848.2000; Zeigler DR, 2008, J BACTERIOL, V190, P6983, DOI 10.1128/JB.00722-08	33	27	29	3	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e85065	10.1371/journal.pone.0085065	http://dx.doi.org/10.1371/journal.pone.0085065			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281RE	24386445	Green Published, gold, Green Submitted			2022-12-25	WOS:000329117900121
J	Peng, Y; Zhang, F; Gui, SL; Qiao, HP; Hose, GC				Peng, Yu; Zhang, Fan; Gui, Shaolan; Qiao, Huping; Hose, Grant C.			Comparative Growth and Development of Spiders Reared on Live and Dead Prey	PLOS ONE			English	Article							ARANEAE; PREDATORS	Scavenging (feeding on dead prey) has been demonstrated across a number of spider families, yet the implications of feeding on dead prey for the growth and development of individuals and population is unknown. In this study we compare the growth, development, and predatory activity of two species of spiders that were fed on live and dead prey. Pardosa astrigera (Lycosidae) and Hylyphantes graminicola (Lyniphiidae) were fed live or dead fruit flies, Drosophila melanogaster. The survival of P. astrigera and H. graminicola was not affected by prey type. The duration of late instars of P. astrigera fed dead prey were longer and mature spiders had less protein content than those fed live prey, whereas there were no differences in the rate of H. graminicola development, but the mass of mature spiders fed dead prey was greater than those fed live prey. Predation rates by P. astrigera did not differ between the two prey types, but H. graminicola had a higher rate of predation on dead than alive prey, presumably because the dead flies were easier to catch and handle. Overall, the growth, development and reproduction of H. graminicola reared with dead flies was better than those reared on live flies, yet for the larger P. astrigera, dead prey may suit smaller instars but mature spiders may be best maintained with live prey. We have clearly demonstrated that dead prey may be suitable for rearing spiders, although the success of the spiders fed such prey appears size-and species specific.	[Peng, Yu; Zhang, Fan; Gui, Shaolan; Qiao, Huping] Hubei Univ, Coll Life Sci, Wuhan, Hubei, Peoples R China; [Hose, Grant C.] Macquarie Univ, Dept Biol Sci, Sydney, NSW 2109, Australia	Hubei University; Macquarie University	Hose, GC (corresponding author), Macquarie Univ, Dept Biol Sci, Sydney, NSW 2109, Australia.	grant.hose@mq.edu.au		Hose, Grant/0000-0003-2106-5543	National Natural Science Fund of China [31071895]; Natural Science Fund of Hubei Province [2011CDB071]; Key Scientific and Technological Projects of Wuhan [201120722216-3]	National Natural Science Fund of China(National Natural Science Foundation of China (NSFC)); Natural Science Fund of Hubei Province; Key Scientific and Technological Projects of Wuhan	This work was supported by the National Natural Science Fund of China [31071895]; the Natural Science Fund of Hubei Province [2011CDB071], and the Key Scientific and Technological Projects of Wuhan [201120722216-3]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chen XQ, 2012, B ENVIRON CONTAM TOX, V88, P654, DOI 10.1007/s00128-012-0584-0; Chen XQ, 2011, B ENVIRON CONTAM TOX, V86, P203, DOI 10.1007/s00128-011-0194-2; Chen XQ, 2010, B INSECTOL, V63, P203; Cross FR, 2009, NEW ZEAL J ZOOL, V36, P75, DOI 10.1080/03014220909510142; Deng LL, 2006, ENVIRON TOXICOL CHEM, V25, P3073, DOI 10.1897/06-194R.1; Foelix R. F., 2011, BIOL SPIDERS; Holling C. S., 1959, Canadian Entomologist, V91, P385; MANSOUR F, 1993, ENTOMOPHAGA, V38, P79, DOI 10.1007/BF02373142; Marc P, 1999, AGR ECOSYST ENVIRON, V74, P229, DOI 10.1016/S0167-8809(99)00038-9; Meehan CJ, 2009, CURR BIOL, V19, pR892, DOI 10.1016/j.cub.2009.08.049; Miliczky ER, 2002, PAN-PAC ENTOMOL, V78, P140; NYFFELER M, 1990, J APPL ENTOMOL, V109, P490, DOI 10.1111/j.1439-0418.1990.tb00080.x; Peng Y, 2010, AGR FOREST ENTOMOL, V12, P343, DOI 10.1111/j.1461-9563.2010.00481.x; PFANNENSTIEL RS, 2004, P BELTW COTT C NAT C, P1594; Riechert S.E., 1987, P645; SAMU F, 1993, OECOLOGIA, V94, P139, DOI 10.1007/BF00317315; Sandidge JS, 2003, NATURE, V426, P30, DOI 10.1038/426030a; Schmidt JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049223; Taylor RM, 2000, ENVIRON ENTOMOL, V37, P996; UETZ GW, 1992, J ARACHNOL, V20, P207; Vetter RS, 2011, J ECON ENTOMOL, V104, P986, DOI 10.1603/EC10428; Wang M, 2007, KOREAN ARACHNOL, V23, P107; Xiao XQ, 2003, HUNAN GUIDING J TCMP, V8, P563; Xu HJ, 2013, KOREAN ARACHNOL, V29, P168; Zhao ZJ, 1993, COTTON SPIDERS CHINA	26	6	6	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e83663	10.1371/journal.pone.0083663	http://dx.doi.org/10.1371/journal.pone.0083663			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281RE	24386248	Green Submitted, gold, Green Published			2022-12-25	WOS:000329117900050
J	Symes, AJ; Eilertsen, M; Millar, M; Nariculam, J; Freeman, A; Notara, M; Feneley, MR; Patel, HRH; Masters, JRW; Ahmed, A				Symes, Andrew J.; Eilertsen, Marte; Millar, Michael; Nariculam, Joseph; Freeman, Alex; Notara, Maria; Feneley, Mark R.; Patel, Hitenedra R. H.; Masters, John R. W.; Ahmed, Aamir			Quantitative Analysis of BTF3, HINT1, NDRG1 and ODC1 Protein Over-Expression in Human Prostate Cancer Tissue	PLOS ONE			English	Article							IMMUNOHISTOCHEMISTRY; TRANSCRIPTION; BIOMARKERS; UTILITY; BCL-2; P53	Prostate carcinoma is the most common cancer in men with few, quantifiable, biomarkers. Prostate cancer biomarker discovery has been hampered due to subjective analysis of protein expression in tissue sections. An unbiased, quantitative immunohistochemical approach provided here, for the diagnosis and stratification of prostate cancer could overcome this problem. Antibodies against four proteins BTF3, HINT1, NDRG1 and ODC1 were used in a prostate tissue array (> 500 individual tissue cores from 82 patients, 41 case pairs matched with one patient in each pair had biochemical recurrence). Protein expression, quantified in an unbiased manner using an automated analysis protocol in ImageJ software, was increased in malignant vs non-malignant prostate (by 2-2.5 fold, p<0.0001). Operating characteristics indicate sensitivity in the range of 0.68 to 0.74; combination of markers in a logistic regression model demonstrates further improvement in diagnostic power. Triple-labeled immunofluorescence (BTF3, HINT1 and NDRG1) in tissue array showed a significant (p<0.02) change in co-localization coefficients for BTF3 and NDRG1 co-expression in biochemical relapse vs non-relapse cancer epithelium. BTF3, HINT1, NDRG1 and ODC1 could be developed as epithelial specific biomarkers for tissue based diagnosis and stratification of prostate cancer.	[Symes, Andrew J.; Eilertsen, Marte; Nariculam, Joseph; Notara, Maria; Feneley, Mark R.; Masters, John R. W.; Ahmed, Aamir] UCL, Div Surg, Prostate Canc Res Ctr, London, England; [Millar, Michael] Univ Edinburgh, Queens Med Res Inst, Edinburgh, Midlothian, Scotland; [Freeman, Alex] Univ Coll London Hosp, Dept Histopathol, London, England; [Patel, Hitenedra R. H.] Univ Hosp Northern Norway, Div Surg Oncol Urol & Womens Hlth, Tromso, Norway	University of London; University College London; University of Edinburgh; University College London Hospitals NHS Foundation Trust; University of London; University College London; UiT The Arctic University of Tromso; University Hospital of North Norway	Ahmed, A (corresponding author), UCL, Div Surg, Prostate Canc Res Ctr, London, England.	aamir.ahmed@ucl.ac.uk	Freeman, Alex/J-8344-2019		Prostate Cancer Research Centre charity; St Peter's Trust	Prostate Cancer Research Centre charity; St Peter's Trust	This research was funded by the Prostate Cancer Research Centre charity and St Peter's Trust. The authors are grateful to Mike Millar, Sheila MacPherson and Nancy Evans of Edinburgh University for help with staining and to Daniel Ciantar, UCL for Huygens software use. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADELSON EH, 1993, SCIENCE, V262, P2042, DOI 10.1126/science.8266102; Bandyopadhyay S, 2003, CANCER RES, V63, P1731; Bombari D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038023; Brey EM, 2003, J HISTOCHEM CYTOCHEM, V51, P575, DOI 10.1177/002215540305100503; Cangul H, 2002, CELL BIOL TOXICOL, V18, P87, DOI 10.1023/A:1015376032736; Costes SV, 2004, BIOPHYS J, V86, P3993, DOI [10.1529/biophysj.103.038422, 10.1529/biophysi.103.038422]; Deeks JJ, 2004, BRIT MED J, V329, P168, DOI 10.1136/bmj.329.7458.168; Diamandis EP, 2010, J NATL CANCER I, V102, P1462, DOI 10.1093/jnci/djq306; Guo YJ, 2005, CANCER RES, V65, P1146, DOI 10.1158/0008-5472.CAN-04-3244; Hogarty MD, 2008, CANCER RES, V68, P9735, DOI 10.1158/0008-5472.CAN-07-6866; Holmstrom B, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3537; Hosmer W. D., 2000, APPL LOGISTIC REGRES, P143, DOI [10.1002/0471722146.ch5, DOI 10.1002/0471722146.CH5]; Howe HL, 2001, J NATL CANCER I, V93, P824, DOI 10.1093/jnci/93.11.824; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kusumawidjaja G, 2007, CANCER BIOL THER, V6, P367, DOI 10.4161/cbt.6.3.3704; Lapointe J, 2004, P NATL ACAD SCI USA, V101, P811, DOI 10.1073/pnas.0304146101; Luo J, 2001, CANCER RES, V61, P4683; Martinez ME, 2003, P NATL ACAD SCI USA, V100, P7859, DOI 10.1073/pnas.1332465100; Nariculam J, 2009, ASIAN J ANDROL, V11, P109, DOI 10.1038/aja.2008.22; PEARSON JD, 1990, J BIOL CHEM, V265, P4583; Pflueger D, 2009, NEOPLASIA, V11, P804, DOI 10.1593/neo.09572; Rasband W, 1997, IMAGEJ SOFTWARE VERS; Rubin MA, 2004, AM J PATHOL, V164, P831, DOI 10.1016/S0002-9440(10)63171-9; Singh D, 2002, CANCER CELL, V1, P203, DOI 10.1016/S1535-6108(02)00030-2; Su T, 2003, P NATL ACAD SCI USA, V100, P7824, DOI 10.1073/pnas.1332160100; TABOR CW, 1976, ANNU REV BIOCHEM, V45, P285, DOI 10.1146/annurev.bi.45.070176.001441; Tu LC, 2007, MOL CELL PROTEOMICS, V6, P575, DOI 10.1074/mcp.M600249-MCP200; Tulchin N, 2010, AM J PATHOL, V176, P1203, DOI 10.2353/ajpath.2010.081063; Varma M, 2005, HISTOPATHOLOGY, V47, P1, DOI 10.1111/j.1365-2559.2005.02188.x; Wang L, 2009, INT J CANCER, V124, P1526, DOI 10.1002/ijc.24072; Wang Q, 2007, ONCOGENE, V26, P6560, DOI 10.1038/sj.onc.1210472; Wang Q, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010456; Welsh JB, 2001, CANCER RES, V61, P5974; Zaytoun OM, 2011, INT J UROL, V18, P557, DOI 10.1111/j.1442-2042.2011.02798.x; Zell JA, 2009, CLIN CANCER RES, V15, P6208, DOI 10.1158/1078-0432.CCR-09-0592; ZHENG XM, 1987, CELL, V50, P361, DOI 10.1016/0092-8674(87)90490-9; Zlobec I, 2006, MODERN PATHOL, V19, P1236, DOI 10.1038/modpathol.3800642	37	35	35	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e84295	10.1371/journal.pone.0084295	http://dx.doi.org/10.1371/journal.pone.0084295			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281RE	24386364	Green Published, gold, Green Submitted			2022-12-25	WOS:000329117900088
J	Houben, ML; Nordkamp, MJMO; Nikkels, PGJ; van der Ent, CK; Meyaard, L; Bont, L				Houben, Michiel L.; Nordkamp, Marloes J. M. Olde; Nikkels, Peter G. J.; van der Ent, Cornelis K.; Meyaard, Linde; Bont, Louis			Soluble Leukocyte-Associated Ig-Like Receptor-1 in Amniotic Fluid Is of Fetal Origin and Positively Associates with Lung Compliance	PLOS ONE			English	Article							PASSIVE RESPIRATORY MECHANICS; INTRAUTERINE INFLAMMATION; LAIR-1; DISEASE; RISK; CYTOKINES; PULMONARY; ENDOTOXIN; RESPONSES; NEWBORNS	The soluble form of the inhibitory immune receptor leukocyte-Associated Ig-like Receptor-1 (sLAIR-1) is present in plasma, urine and synovial fluid and correlates to inflammation. We and others previously showed inflammatory protein expression in normal amniotic fluid at term. We hypothesized that sLAIR-1 is present in amniotic fluid during term parturition and is related to fetal lung function development. sLAIR-1 was detectable in all amniotic fluid samples (n=355) collected during term spontaneous deliveries. First, potential intra-uterine origins of amniotic fluid sLAIR-1 were explored. Although LAIR-1 was expressed on the surface of amniotic fluid neutrophils, LAIR-1 was not secreted upon ex vivo neutrophil stimulation with LPS, or PMA/ionomycin. Cord blood concentrations of sLAIR-1 were fourfold lower than and not related to amniotic fluid concentrations and placentas showed no or only sporadic LAIR-1 positive cells. Similarly, in post-mortem lung tissue of term neonates that died of non-pulmonary disorders LAIR-1 positive cells were absent or only sporadically present. In fetal urine samples, however, sLAIR-1 levels were even higher than in amniotic fluid and correlated with amniotic fluid sLAIR-1 concentrations. Second, the potential relevance of amniotic fluid sLAIR-1 was studied. sLAIR-1 concentrations had low correlation to amniotic fluid cytokines. We measured neonatal lung function in a convenient subset of 152 infants, using the single occlusion technique, at a median age of 34 days (IQR 30-39). The amniotic fluid concentration of sLAIR-1 was independently correlated to airway compliance (rho=0.29, P=.001). Taken together, we show the consistent presence of sLAIR-1 in amniotic fluid, which originates from fetal urine. Concentrations of sLAIR-1 in amniotic fluid during term deliveries are independent from levels of other soluble immune mediators. The positive association between concentrations of amniotic fluid sLAIR-1 and neonatal lung compliance suggests that amniotic fluid sLAIR-1 may be useful as a novel independent marker of neonatal lung maturation.	[Houben, Michiel L.; van der Ent, Cornelis K.; Bont, Louis] Univ Med Ctr Utrecht, Dept Pediat, Utrecht, Netherlands; [Nordkamp, Marloes J. M. Olde; Meyaard, Linde; Bont, Louis] Univ Med Ctr Utrecht, Dept Immunol, Lab Translat Immunol, Utrecht, Netherlands; [Nikkels, Peter G. J.] Univ Med Ctr Utrecht, Dept Pathol, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	Bont, L (corresponding author), Univ Med Ctr Utrecht, Dept Pediat, Utrecht, Netherlands.	L.J.Bont@umcutrecht.nl		Meyaard, Linde/0000-0003-0707-4793	European Society for Paediatric Infectious Diseases (ESPID); Wilhelmina Children's Hospital Research Fund [2004.02]; Catharijne Stichting; Dutch Asthma Foundation [3.2.07.001, 06-1-403]; Dutch Arthritis Foundation [06-1-403]	European Society for Paediatric Infectious Diseases (ESPID); Wilhelmina Children's Hospital Research Fund; Catharijne Stichting; Dutch Asthma Foundation; Dutch Arthritis Foundation	The study was funded by a fellowship award of the European Society for Paediatric Infectious Diseases (ESPID, 2005, MLH), The Wilhelmina Children's Hospital Research Fund (grant 2004.02), the Catharijne Stichting, the Dutch Asthma Foundation (grant 3.2.07.001 and grant 06-1-403), and the Dutch Arthritis Foundation (grant 06-1-403). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; de Jager W, 2003, CLIN DIAGN LAB IMMUN, V10, P133, DOI 10.1128/CDLI.10.1.133-139.2003; DeVincenzo J, 2010, P NATL ACAD SCI USA, V107, P8800, DOI 10.1073/pnas.0912186107; GLUCK L, 1973, AM J OBSTET GYNECOL, V115, P539, DOI 10.1016/0002-9378(73)90404-3; Gravett MG, 2004, JAMA-J AM MED ASSOC, V292, P462, DOI 10.1001/jama.292.4.462; Haddad R, 2006, AM J OBSTET GYNECOL, V195, P394, DOI 10.1016/j.ajog.2005.08.057; Haland G, 2006, NEW ENGL J MED, V355, P1682, DOI 10.1056/NEJMoa052885; Houben ML, 2012, PEDIATR INFECT DIS J, V31, P931, DOI 10.1097/INF.0b013e31826366e3; Houben ML, 2011, PEDIATRICS, V127, P35, DOI 10.1542/peds.2010-0581; Houben ML, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006572; Kallapur SG, 2011, AM J PHYSIOL-LUNG C, V301, pL285, DOI 10.1152/ajplung.00446.2010; Katier N, 2006, PEDIATR PULM, V41, P1058, DOI 10.1002/ppul.20492; Katier N, 2005, CHEST, V128, P1822, DOI 10.1378/chest.128.3.1822; Kramer BW, 2005, BIOL NEONATE, V88, P202, DOI 10.1159/000087583; Kramer BW, 2001, AM J RESP CRIT CARE, V164, P982, DOI 10.1164/ajrccm.164.6.2103061; Lahra MM, 2009, PEDIATRICS, V123, P1314, DOI 10.1542/peds.2008-0656; Lakwijk N, 1998, CLIN EXP ALLERGY, V28, P454; Lebbink RJ, 2008, J IMMUNOL, V180, P1662, DOI 10.4049/jimmunol.180.3.1662; Lebbink RJ, 2007, MOL IMMUNOL, V44, P2153, DOI 10.1016/j.molimm.2006.11.014; Lebbink RJ, 2006, J EXP MED, V203, P1419, DOI 10.1084/jem.20052554; LESOUEF PN, 1984, AM REV RESPIR DIS, V129, P552; Martinez Fernando D, 2009, Proc Am Thorac Soc, V6, P272, DOI 10.1513/pats.200808-092RM; Meyaard L, 1997, IMMUNITY, V7, P283, DOI 10.1016/S1074-7613(00)80530-0; Meyaard L, 2008, J LEUKOCYTE BIOL, V83, P799, DOI 10.1189/jlb.0907609; Newnham JP, 2002, AM J OBSTET GYNECOL, V186, P1062, DOI 10.1067/mob.2002.122293; Nordkamp MJMO, 2011, ARTHRITIS RHEUM-US, V63, P3749, DOI 10.1002/art.30612; Olszewska W, 2009, EXPERT OPIN EMERG DR, V14, P207, DOI 10.1517/14728210902946399; Ouyang WM, 2004, J IMMUNOL METHODS, V292, P109, DOI 10.1016/j.jim.2004.06.005; Prendergast M, 2011, ARCH DIS CHILD-FETAL, V96, pF270, DOI 10.1136/adc.2010.189480; Ravetch JV, 2000, SCIENCE, V290, P84, DOI 10.1126/science.290.5489.84; Sadowsky DW, 2006, AM J OBSTET GYNECOL, V195, P1578, DOI 10.1016/j.ajog.2006.06.072; Simoes EAF, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-78; Smith R, 2007, NEW ENGL J MED, V356, P271, DOI 10.1056/NEJMra061360; Stern DA, 2007, LANCET, V370, P758, DOI 10.1016/S0140-6736(07)61379-8; Vonk JM, 2004, J ALLERGY CLIN IMMUN, V114, P270, DOI 10.1016/j.jaci.2004.03.051; WHO, 2007, TRAIN MAN WHO PACK E, P1; Wijnberger L D E, 2003, J Matern Fetal Neonatal Med, V14, P373, DOI 10.1080/14767050412331312210; Willet KE, 2002, AM J PHYSIOL-LUNG C, V282, pL411, DOI 10.1152/ajplung.00097.2001	38	4	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e83920	10.1371/journal.pone.0083920	http://dx.doi.org/10.1371/journal.pone.0083920			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281QS	24386309	Green Published, Green Submitted, gold			2022-12-25	WOS:000329116700088
J	Huang, RX; Ma, YY; Holm, R; Trope, CG; Nesland, JM; Suo, ZH				Huang, Ruixia; Ma, Yuanyuan; Holm, Ruth; Trope, Claes G.; Nesland, Jahn M.; Suo, Zhenhe			Sex Hormone-Binding Globulin (SHBG) Expression in Ovarian Carcinomas and Its Clinicopathological Associations	PLOS ONE			English	Article							PROSTATE ANDROGEN RECEPTOR; CIRCULATING LEVELS; STEROID-HORMONES; GENE-EXPRESSION; INVASIVE FRONT; CANCER-RISK; MCF-7 CELLS; PROTEIN; VARIANT; LNCAP	Sex hormone-binding globulin (SHBG) is known as a carrier protein. It is classically thought to be mainly synthesized in the liver and then secreted into the circulating system, where it binds to sex steroids with a high affinity and modulates the bioavailability of the hormones. Other organs known to produce SHBG include brain, uterus, testis, prostate, breast and ovary, and the local expressed SHBG may play an important role in tumor development. However, SHBG expression status and its clinicopathological significance in ovarian cancer cells are not reported yet. In our present study, we examined and found the variable SHBG expression in four ovarian cancer cell lines (OV-90, OVCAR-3, SKOV-3 and ES-2) by immunocytochemistry and Western blotting. We then extended our study to 248 ovarian carcinoma samples, which were collected at The Norwegian Radium Hospital, Oslo University Hospital with complete clinical information, and discovered that SHBG was variably expressed in these ovarian carcinomas. Higher level of SHBG expression was significantly associated with more aggressive histological subtype (p = 0.022), higher FIGO stage (p = 0.018) and higher histological grade (grade of differentiation, p = 0.020), although association between SHBG expression and OS/PFS was not observed. Our results demonstrate that ovarian cancer cells produce SHBG and higher SHBG expression in ovarian carcinoma is associated with unfavorable clinicopathological features.	[Huang, Ruixia; Ma, Yuanyuan; Holm, Ruth; Nesland, Jahn M.; Suo, Zhenhe] Oslo Univ Hosp, Norwegian Radium Hosp, Dept Pathol, Oslo, Norway; [Huang, Ruixia; Ma, Yuanyuan; Nesland, Jahn M.; Suo, Zhenhe] Univ Oslo, Fac Med, Inst Clin Med, Dept Pathol, Oslo, Norway; [Trope, Claes G.] Oslo Univ Hosp, Norwegian Radium Hosp, Dept Gynecol, Oslo, Norway; [Trope, Claes G.] Univ Oslo, Fac Med, Inst Clin Med, Dept Gynecol, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo; University of Oslo	Suo, ZH (corresponding author), Oslo Univ Hosp, Norwegian Radium Hosp, Dept Pathol, Oslo, Norway.	zhenhes@medisin.uio.no		Huang, Ruixia/0000-0001-7214-647X	Inger and John Fredriksen Foundation; Radium Hospital Research Foundation; Norwegian Cancer Society	Inger and John Fredriksen Foundation; Radium Hospital Research Foundation; Norwegian Cancer Society(Norwegian Cancer Society)	This study was funded by grants from Inger and John Fredriksen Foundation and Radium Hospital Research Foundation and The Norwegian Cancer Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON DC, 1974, CLIN ENDOCRINOL, V3, P69, DOI 10.1111/j.1365-2265.1974.tb03298.x; Anglesio MS, 2011, GYNECOL ONCOL, V121, P407, DOI 10.1016/j.ygyno.2011.01.005; Avoranta ST, 2012, WORLD J GASTROENTERO, V18, P4549, DOI 10.3748/wjg.v18.i33.4549; Berndt SI, 2007, CANCER EPIDEM BIOMAR, V16, P165, DOI 10.1158/1055-9965.EPI-06-0689; Bobe J, 2008, ENDOCRINOLOGY, V149, P2980, DOI 10.1210/en.2007-1652; Bosland M C, 2000, J Natl Cancer Inst Monogr, P39; Chen WY, 2008, BEST PRACT RES CL EN, V22, P573, DOI 10.1016/j.beem.2008.08.001; Cho KR, 2009, ANNU REV PATHOL-MECH, V4, P287, DOI 10.1146/annurev.pathol.4.110807.092246; Chu LW, 2010, CANCER EPIDEM BIOMAR, V19, P1848, DOI 10.1158/1055-9965.EPI-10-0101; Chua TC, 2010, AUST NZ J OBSTET GYN, V50, P478, DOI 10.1111/j.1479-828X.2010.01201.x; Ding VDH, 1998, ENDOCRINOLOGY, V139, P213, DOI 10.1210/en.139.1.213; Elattar A, 2012, GYNECOL ONCOL, V124, P142, DOI 10.1016/j.ygyno.2011.09.004; FISSORE F, 1994, STEROIDS, V59, P661, DOI 10.1016/0039-128X(94)90023-X; Forges T, 2005, HISTOCHEM CELL BIOL, V124, P285, DOI 10.1007/s00418-005-0006-z; Forges T, 2004, MOL CELL ENDOCRINOL, V219, P61, DOI 10.1016/j.mce.2004.01.011; Fortunati N, 2010, MOL CELL ENDOCRINOL, V316, P86, DOI 10.1016/j.mce.2009.09.012; Fortunati N, 1999, J STEROID BIOCHEM, V70, P73, DOI 10.1016/S0960-0760(99)00092-8; Garcia-Closas M, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-60; Gregoraszczuk E L, 2011, Endocr Regul, V45, P125; HAGEN FS, 1992, FEBS LETT, V299, P23, DOI 10.1016/0014-5793(92)80091-T; Herbert Z, 2005, NEUROENDOCRINOLOGY, V81, P287, DOI 10.1159/000088170; Hryb DJ, 2002, J BIOL CHEM, V277, P26618, DOI 10.1074/jbc.M202495200; JOSEPH DR, 1991, J STEROID BIOCHEM, V40, P771, DOI 10.1016/0960-0760(91)90302-L; Kahn SM, 2008, ADV EXP MED BIOL, V617, P557, DOI 10.1007/978-0-387-69080-3_57; Langdon SP, 2009, ONKOLOGIE, V32, P623, DOI 10.1159/000246764; LARREA F, 1993, J STEROID BIOCHEM, V46, P497, DOI 10.1016/0960-0760(93)90104-5; LAU DHM, 1991, CANCER RES, V51, P5181; Lewis JG, 1999, STEROIDS, V64, P259, DOI 10.1016/S0039-128X(98)00119-6; Li AJ, 2007, GYNECOL ONCOL, V107, P420, DOI 10.1016/j.ygyno.2007.07.059; Liu ZY, 2011, J CLIN PATHOL, V64, P325, DOI 10.1136/jcp.2010.083956; Lukanova A, 2003, INT J CANCER, V104, P636, DOI 10.1002/ijc.10990; Lurie G, 2011, PLOS ONE, V6; MAHLCK CG, 1986, ACTA OBSTET GYN SCAN, V65, P533; MAHLCK CG, 1989, GYNECOL OBSTET INVES, V28, P41, DOI 10.1159/000293502; Maliqueo M, 2007, FERTIL STERIL, V87, P321, DOI 10.1016/j.fertnstert.2006.06.038; Martinez-Garcia MA, 2012, HUM REPROD; Misao R, 1995, GYNECOL ENDOCRINOL, V9, P317, DOI 10.3109/09513599509160466; MISAO R, 1995, REPROD NUTR DEV, V35, P155, DOI 10.1051/rnd:19950204; Nakhla AM, 1997, J BIOL CHEM, V272, P6838, DOI 10.1074/jbc.272.11.6838; NAKHLA AM, 1990, J CLIN ENDOCR METAB, V71, P398, DOI 10.1210/jcem-71-2-398; Nakhla AM, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-37; Paterson EL, 2013, NEOPLASIA, V15, P180, DOI 10.1593/neo.121828; Planaguma J, 2011, HUM PATHOL, V42, P57, DOI 10.1016/j.humpath.2010.01.025; Prat J, 2012, VIRCHOWS ARCH, V460, P237, DOI 10.1007/s00428-012-1203-5; Rinaldi S, 2007, CANCER EPIDEM BIOMAR, V16, P23, DOI 10.1158/1055-9965.EPI-06-0755; Risch HA, 1998, JNCI-J NATL CANCER I, V90, P1774, DOI 10.1093/jnci/90.23.1774; SELBY C, 1990, ANN CLIN BIOCHEM, V27, P532, DOI 10.1177/000456329002700603; Selva DM, 2006, HORM METAB RES, V38, P230, DOI 10.1055/s-2006-925336; SIITERI PK, 1982, RECENT PROG HORM RES, V38, P457; Simo R, 2012, DIABETES, V61, P372, DOI 10.2337/db11-0727; SOLOMON M, 1979, LANCET, V1, P984; Staff AC, 2010, GYNECOL ONCOL, V118, P237, DOI 10.1016/j.ygyno.2010.05.032; Xita N, 2010, MOL CELL ENDOCRINOL, V316, P60, DOI 10.1016/j.mce.2009.08.025; Yusra, 2012, INT J ONCOL, V41, P201, DOI 10.3892/ijo.2012.1459; Zivanovic O, 2010, GYNECOL ONCOL, V116, P351, DOI 10.1016/j.ygyno.2009.11.022	55	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e83238	10.1371/journal.pone.0083238	http://dx.doi.org/10.1371/journal.pone.0083238			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281QS	24386165	Green Published, Green Submitted, gold			2022-12-25	WOS:000329116700036
J	Lodha, N; Misra, G; Coombes, SA; Christou, EA; Cauraugh, JH				Lodha, Neha; Misra, Gaurav; Coombes, Stephen A.; Christou, Evangelos A.; Cauraugh, James H.			Increased Force Variability in Chronic Stroke: Contributions of Force Modulation below 1 Hz	PLOS ONE			English	Article							MUSCLE; FLUCTUATIONS; COHERENCE; DISCHARGE; DEFICITS	Increased force variability constitutes a hallmark of arm disabilities following stroke. Force variability is related to the modulation of force below 1 Hz in healthy young and older adults. However, whether the increased force variability observed post stroke is related to the modulation of force below 1 Hz remains unknown. Thus, the purpose of this study was to compare force modulation below 1 Hz in chronic stroke and age-matched healthy individuals. Both stroke and control individuals (N = 26) performed an isometric grip task to submaximal force levels. Coefficient of variation quantified force variability, and power spectrum density of force quantified force modulation below 1 Hz with a high resolution (0.07 Hz). Analyses indicated that force variability was greater for the stroke group compared with to healthy controls and for the paretic hand compared with the non-paretic hand. Force modulation below 1 Hz differentiated the stroke individuals and healthy controls, as well as the paretic and non-paretic hands. Specifically, stroke individuals (paretic hand) exhibited greater power similar to 0.2 Hz (0.07-0.35 Hz) and lesser power,0.6 Hz (0.49-0.77 Hz) compared to healthy controls (non-dominant hand). Similarly, the paretic hand exhibited greater power,0.2 Hz, and lesser power similar to 0.6 Hz than the non-paretic hand. Moreover, variability of force was strongly predicted from the modulation of specific frequencies below 1 Hz (R-2 = 0.80). Together, these findings indicate that the modulation of force below 1 Hz provides significant insight into changes in motor control after stroke.	[Lodha, Neha; Misra, Gaurav; Coombes, Stephen A.; Christou, Evangelos A.; Cauraugh, James H.] Univ Florida, Malcom Randall VA Med Ctr, Dept Appl Physiol & Kinesiol, Gainesville, FL 32610 USA; [Christou, Evangelos A.] Univ Florida, Malcom Randall VA Med Ctr, Dept Phys Therapy, Gainesville, FL USA; [Lodha, Neha] Univ Florida, Malcom Randall VA Med Ctr, Brain Rehabil Res Ctr Excellence, Gainesville, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Lodha, N (corresponding author), Univ Florida, Malcom Randall VA Med Ctr, Dept Appl Physiol & Kinesiol, Gainesville, FL 32610 USA.	lodhaneha@hhp.ufl.edu	Lodha, Neha/AAG-9581-2020		American Heart Association [12POST10920002, 0093013]; National Institutes of Health [R01 AG031769]; NATIONAL INSTITUTE ON AGING [R01AG031769] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported in part by an American Heart Association Postdoctoral Fellowship (12POST10920002) to NL, National Institutes of Health grant (R01 AG031769) to EAC, and an American Heart Association grant (0093013) to JC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Urls 1.AHA:http://my.americanheart.org/ 2.NIH:http://grants.nih.gov/grants/funding/r01.htm The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annoni J M, 1990, Int Disabil Stud, V12, P78; Baker MR, 2003, J PHYSIOL-LONDON, V546, P931, DOI 10.1113/jphysiol.2002.029553; Bensmail D, 2012, NEUROSCIENCE, V210, P128, DOI 10.1016/j.neuroscience.2012.03.015; BOHANNON RW, 1987, PHYS THER, V67, P206, DOI 10.1093/ptj/67.2.206; Chou LW, 2013, J NEUROPHYSIOL, V109, P2947, DOI 10.1152/jn.00615.2012; Christou EA, 2001, J GERONTOL A-BIOL, V56, pB524, DOI 10.1093/gerona/56.12.B524; Christou EA, 2006, AGING VARIABILITY MO; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fox EJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055970; FUGLMEYER AR, 1975, SCAND J REHABIL MED, V7, P13; Gladstone DJ, 2002, NEUROREHAB NEURAL RE, V16, P232, DOI 10.1177/154596802401105171; HAGBARTH KE, 1979, BRAIN, V102, P509, DOI 10.1093/brain/102.3.509; Keogh J, 2006, EUR J APPL PHYSIOL, V97, P76, DOI 10.1007/s00421-006-0151-7; Laidlaw DH, 2000, MUSCLE NERVE, V23, P600, DOI 10.1002/(SICI)1097-4598(200004)23:4<600::AID-MUS20>3.3.CO;2-4; Li S, 2007, NEUROSCI LETT, V412, P243, DOI 10.1016/j.neulet.2006.11.013; Liang LY, 2010, J MED BIOL ENG, V30, P17; Lindberg PG, 2012, BRAIN RES, V1452, P96, DOI 10.1016/j.brainres.2012.03.007; Lodha N, 2012, CLIN NEUROPHYSIOL, V123, P787, DOI 10.1016/j.clinph.2011.08.014; Lodha N, 2010, CLIN NEUROPHYSIOL, V121, P1952, DOI 10.1016/j.clinph.2010.04.005; Marsden JF, 2000, BRAIN, V123, P1459, DOI 10.1093/brain/123.7.1459; Moritz CT, 2005, J NEUROPHYSIOL, V93, P2449, DOI 10.1152/jn.01122.2004; Mottram CJ, 2010, J NEUROPHYSIOL, V104, P3168, DOI 10.1152/jn.00463.2010; Naik SK, 2011, EXP BRAIN RES, V211, P1, DOI 10.1007/s00221-011-2637-8; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Rothwell JC, 1998, MOVEMENT DISORD, V13, P24; SIMON JR, 1969, PERCEPT MOTOR SKILL, V28, P91, DOI 10.2466/pms.1969.28.1.91; Slifkin A, 1999, J EXP PSYCHOL HUMAN, V25, P837, DOI 10.1037/0096-1523.25.3.837; Tracy BL, 2007, MED SCI SPORT EXER, V39, P469, DOI 10.1249/mss.0b013e31802d3ad3; Vaillancourt DE, 2003, J APPL PHYSIOL, V94, P903, DOI 10.1152/japplphysiol.00166.2002	29	36	36	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e83468	10.1371/journal.pone.0083468	http://dx.doi.org/10.1371/journal.pone.0083468			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281QS	24386208	gold, Green Submitted, Green Published			2022-12-25	WOS:000329116700054
J	Wong, MCS; Ching, JYL; Hirai, HH; Lam, TYT; Griffiths, SM; Chan, FKL; Sung, JJY				Wong, Martin C. S.; Ching, Jessica Y. L.; Hirai, Hoyee H.; Lam, Thomas Y. T.; Griffiths, Sian M.; Chan, Francis K. L.; Sung, Joseph J. Y.			Perceived Obstacles of Colorectal Cancer Screening and Their Associated Factors among 10,078 Chinese Participants	PLOS ONE			English	Article								Purpose: to evaluate the proportion of self-referred screening participants having various psychological barriers and the factors associated with these barriers. Methods: A territory-wide bowel cancer screening centre sent an invitation via the media to all Hong Kong residents aged 50-70 years who were asymptomatic of CRC to join a free screening programme. Upon attendance they were requested to complete self-administered surveys on their perceived barriers of screening. Binary logistic regression analyses were used to evaluate the factors associated with these barriers. Results: From 10,078 consecutive screening participants (mean age 57.5 years; female 56.4%) completed the surveys between May 2008 to September 2012. There were high proportions who agreed or strongly agreed with the following barriers: financial difficulty (86.0%), limited service accessibility (58.2%), screening-induced bodily discomfort (55.2%), physical harm (44.4%), embarrassment (40.1%), apprehension (38.8%) and time constraints (13.9%). From regression models, older participants (aged >= 56) were less likely to have these barriers (Adjusted odds ratio [AOR] ranged from 0.738 to 0.952) but they encountered more difficulties to access to screening services (AOR ranged from 1.141 to 1.371). Female subjects were more likely to encounter most of these barriers (AOR ranged from 1.188 to 2.179). Participants who were uncertain of the necessity of CRC screening for people aged >= 50 were more likely to report these barriers (AOR ranged from 1.151 to 1.671). Conclusion: The proportions of perceptual barriers of CRC screening were high among these participants. Those with these associated factors should receive more thorough explanation of the screening test procedures.	[Wong, Martin C. S.; Ching, Jessica Y. L.; Hirai, Hoyee H.; Lam, Thomas Y. T.; Chan, Francis K. L.; Sung, Joseph J. Y.] Chinese Univ Hong Kong, Fac Med, Inst Digest Dis, Hong Kong, Hong Kong, Peoples R China; [Wong, Martin C. S.; Griffiths, Sian M.] Chinese Univ Hong Kong, Sch Publ Hlth & Primary Care, Hong Kong, Hong Kong, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong	Wong, MCS (corresponding author), Chinese Univ Hong Kong, Fac Med, Inst Digest Dis, Hong Kong, Hong Kong, Peoples R China.	wong_martin@cuhk.edu.hk	Wong, Martin/L-4568-2014; Chan, Francis K. L./F-4851-2010; Sung, Joseph J. Y./R-3203-2018	Wong, Martin/0000-0001-7706-9370; Chan, Francis K. L./0000-0001-7388-2436; Sung, Joseph J. Y./0000-0003-3125-5199	Hong Kong Jockey Club Charities Trust	Hong Kong Jockey Club Charities Trust	The authors acknowledged the support of the Hong Kong Jockey Club Charities Trust for the full funding support of this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Advisory Comm Canc Prevention, 2000, EUR J CANCER, V36, P1473; Berkowitz Z, 2008, J AM GERIATR SOC, V56, P307, DOI 10.1111/j.1532-5415.2007.01547.x; Calonge N, 2008, ANN INTERN MED, V149, P627, DOI 10.7326/0003-4819-149-9-200811040-00243; Champion V L, 1984, ANS Adv Nurs Sci, V6, P73; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Goulard H., 2007, EVALUATION EPIDEMIOL; Guessous I, 2010, PREV MED, V50, P3, DOI 10.1016/j.ypmed.2009.12.005; Hewitson P, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001216.pub2; JANZ NK, 1984, HEALTH EDUC QUART, V11, P1, DOI 10.1177/109019818401100101; Jorgensen OD, 2002, GUT, V50, P29, DOI 10.1136/gut.50.1.29; Katz MH, 2006, MULTIVARIABLE ANALYSIS: A PRACTICAL GUIDE FOR CLINICIANS, 2ND EDITION, P68; Klabunde CN, 2006, AM J PREV MED, V30, P313, DOI 10.1016/j.amepre.2005.11.006; Levin B, 2008, CA-CANCER J CLIN, V58, P130, DOI 10.3322/CA.2007.0018; Lewis SF, 1996, J GEN INTERN MED, V11, P542, DOI 10.1007/BF02599602; Mandel JS, 1999, J NATL CANCER I, V91, P434, DOI 10.1093/jnci/91.5.434; McCaffery K, 2001, SOC SCI MED, V53, P679, DOI 10.1016/S0277-9536(00)00375-0; Pignone M, 2002, ANN INTERN MED, V137, P132, DOI 10.7326/0003-4819-137-2-200207160-00015; Rawl SM, 2000, CANCER PRACT, V8, P32, DOI 10.1046/j.1523-5394.2000.81006.x; Regula J, 2006, NEW ENGL J MED, V355, P1863, DOI 10.1056/NEJMoa054967; ROSENSTOCK IM, 1988, HEALTH EDUC QUART, V15, P175, DOI 10.1177/109019818801500203; Saito H, 2006, J MED SCREEN, V13, pS6; Stacy R, 2008, J CANCER EDUC, V23, P238, DOI 10.1080/08858190802189030; Sung JJY, 2008, GUT, V57, P1166, DOI 10.1136/gut.2007.146316; Sung JJY, 2005, LANCET ONCOL, V6, P871, DOI 10.1016/S1470-2045(05)70422-8; Sung JJY, 2008, AM J GASTROENTEROL, V103, P974, DOI 10.1111/j.1572-0241.2007.01649.x; Weller D, 2007, BRIT J CANCER, V97, P1601, DOI 10.1038/sj.bjc.6604089; Whitlock EP, 2008, ANN INTERN MED, V149, P638, DOI 10.7326/0003-4819-149-9-200811040-00245; Wong CKH, 2012, J EVAL CLIN PRACT, V18, P1203, DOI 10.1111/j.1365-2753.2011.01776.x; Wong MCS, 2010, ALIMENT PHARM THER, V32, P74, DOI 10.1111/j.1365-2036.2010.04312.x; Wong MCS, 2012, CANCER CAUSE CONTROL, V23, P1541, DOI 10.1007/s10552-012-0031-x	31	39	41	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e70209	10.1371/journal.pone.0070209	http://dx.doi.org/10.1371/journal.pone.0070209			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V41SG	24386367	Green Submitted, gold, Green Published			2022-12-25	WOS:000209565300001
J	Gong, ZH; Tang, JL; Xiang, TX; Zhang, LL; Liao, QH; Liu, W; Wang, YL				Gong, Zhenghua; Tang, Jialin; Xiang, Tianxin; Zhang, Lunli; Liao, Qinghua; Liu, Wei; Wang, Yalin			Association between Regulated upon Activation, Normal T Cells Expressed and Secreted (RANTES)-28C/G Polymorphism and Susceptibility to HIV-1 Infection: A Meta-Analysis	PLOS ONE			English	Article							DISEASE PROGRESSION; GENETIC-VARIATION; TYPE-1 INFECTION; DENDRITIC CELLS; VIRUS-INFECTION; CC-CHEMOKINES; RANTES; PROMOTER; INDIVIDUALS; ENTRY	Background: Many studies have investigated the distributions of RANTES genotypes between HIV-1 infected patients and uninfected individuals. However, no definite results have been put forward about whether the RANTES -28C/G polymorphism can affect HIV-1 susceptibility. Methods: We performed a meta-analysis of 12 studies including 7473 subjects for whom the RANTES -28C/G polymorphism was genotyped. Odds ratios (ORs) with 95% confidence intervals (CIs) were employed to assess the association of the polymorphism with HIV-1 susceptibility. By dividing the controls into healthy controls and HIV-1 exposed but seronegative (HESN) controls, we explored the both allelic and dominant genetic models. Results: By using the healthy controls, we found a marginally significant association between the -28C/G polymorphism and susceptibility to HIV-1 infection in the allelic model (OR = 0.82, 95%CI = 0.70-0.97). But sensitivity analysis suggested that the association was driven by one study. We further performed stratified analysis according to ethnicity. The -28G allele decreased susceptibility to HIV-1 infection in the allelic model among Asians (OR = 0.79, 95%CI = 0.66-0.94). By using the HESN controls, no association between the polymorphism -28C/G and the susceptibility to HIV-1 infection was revealed in either the allelic model (OR = 0.84, 95%CI = 0.60-1.17) or the dominant model (OR = 0.77, 95%CI = 0.54-1.10). Conclusions: Our findings suggested that the RANTES -28G allele might play a role in resistance to HIV-1 infection among Asians. Additional well-designed studies were required for the validation of this association.	[Gong, Zhenghua; Tang, Jialin; Liao, Qinghua; Liu, Wei; Wang, Yalin] Ctr Dis Control & Prevent Jiangxi Prov, Dept Publ Hlth, Nanchang, Peoples R China; [Xiang, Tianxin; Zhang, Lunli] Nanchang Univ, Hosp 1, Dept Infect Dis, Nanchang, Peoples R China	Nanchang University	Wang, YL (corresponding author), Ctr Dis Control & Prevent Jiangxi Prov, Dept Publ Hlth, Nanchang, Peoples R China.	yalinwang2012@hotmail.com		gong, zhenghua/0000-0002-4363-1043	National Natural Science Foundation of China [81060127]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China (No. 81060127). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlenstiel G, 2005, WORLD J GASTROENTERO, V11, P7631, DOI 10.3748/wjg.v11.i48.7631; Aouizerat Bradley E, 2011, Curr HIV/AIDS Rep, V8, P38, DOI 10.1007/s11904-010-0065-1; Crawford A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002098; Dieu MC, 1998, J EXP MED, V188, P373, DOI 10.1084/jem.188.2.373; Ding DL, 2011, MOL MED REP, V4, P181, DOI 10.3892/mmr.2010.400; Dolan MJ, 2007, NAT IMMUNOL, V8, P1324, DOI 10.1038/ni1521; DONLON TA, 1990, GENOMICS, V6, P548, DOI 10.1016/0888-7543(90)90485-D; Doranz BJ, 1996, CELL, V85, P1149, DOI 10.1016/S0092-8674(00)81314-8; Dragic T, 1996, NATURE, V381, P667, DOI 10.1038/381667a0; Fatkenheuer G, 2005, NAT MED, V11, P1170, DOI 10.1038/nm1319; Fernandez RM, 2003, AIDS RES HUM RETROV, V19, P349, DOI 10.1089/088922203765551692; Glass WG, 2005, J EXP MED, V202, P1087, DOI 10.1084/jem.20042530; Gonzalez E, 2001, P NATL ACAD SCI USA, V98, P5199, DOI 10.1073/pnas.091056898; Guergnon J, 2012, IMMUNOL LETT, V145, P15, DOI 10.1016/j.imlet.2012.04.010; Jang DH, 2008, INT J IMMUNOGENET, V35, P101, DOI 10.1111/j.1744-313X.2007.00743.x; Kaslow RA, 2005, J INFECT DIS, V191, pS68, DOI 10.1086/425269; Li H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042972; Lim JK, 2010, J INFECT DIS, V201, P178, DOI 10.1086/649426; Liu HL, 1999, P NATL ACAD SCI USA, V96, P4581, DOI 10.1073/pnas.96.8.4581; Liu HL, 1999, AIDS, V13, P2602, DOI 10.1097/00002030-199912240-00020; Liu SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035020; [刘雪林 Liu Xuelin], 2004, [解放军医学杂志, Medical Journal of Chinese People's Liberation Army], V29, P489; Loetscher P, 1996, J IMMUNOL, V156, P322; Mack M, 1998, J EXP MED, V187, P1215, DOI 10.1084/jem.187.8.1215; McDermott DH, 2000, AIDS, V14, P2671, DOI 10.1097/00002030-200012010-00006; Nair MPN, 2011, LIFE SCI, V88, P987, DOI 10.1016/j.lfs.2010.09.019; Pantaleo G, 1997, RES IMMUNOL, V148, P417, DOI 10.1016/S0923-2494(97)82875-1; Rathore A, 2008, J MED VIROL, V80, P1133, DOI 10.1002/jmv.21201; Sironi M, 2012, J IMMUNOL, V188, P818, DOI 10.4049/jimmunol.1102179; Sobieszczyk ME, 2011, CURR OPIN HIV AIDS, V6, P427, DOI 10.1097/COH.0b013e3283497155; Suresh P, 2006, J CLIN IMMUNOL, V26, P476, DOI 10.1007/s10875-006-9036-0; Vidal F, 2006, JAIDS-J ACQ IMM DEF, V41, P17, DOI 10.1097/01.qai.0000188335.86466.ea; Young JM, 2011, AIDS RES HUM RETROV, V27, P737, DOI [10.1089/aid.2010.0313, 10.1089/AID.2010.0313]; Zeremski M, 2011, J HEPATOL, V55, P545, DOI 10.1016/j.jhep.2010.12.033; Zhao XY, 2004, EUR J IMMUNOGENET, V31, P179, DOI 10.1111/j.1365-2370.2004.00466.x	35	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2013	8	4							e60683	10.1371/journal.pone.0060683	http://dx.doi.org/10.1371/journal.pone.0060683			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RZ	24386362	Green Submitted, gold, Green Published			2022-12-25	WOS:000319109800087
J	Huang, WT; Yang, HW; Liao, TL; Wu, WJ; Yang, SE; Chih, YC; Chuang, JH				Huang, Wan-Ting; Yang, Hsu-Wen; Liao, Tzu-Lin; Wu, Wan-Jen; Yang, Shu-Er; Chih, Yi-Chien; Chuang, Jen-Hsiang			Safety of Pandemic (H1N1) 2009 Monovalent Vaccines in Taiwan: A Self-Controlled Case Series Study	PLOS ONE			English	Article							GUILLAIN-BARRE-SYNDROME; INFLUENZA-A H1N1; EVENT REPORTING SYSTEM; ADVERSE EVENTS; DATALINK PROJECT; UNITED-STATES; BELLS-PALSY; VACCINATION; RISK; SURVEILLANCE	In Taiwan, new H1N1 monovalent vaccines without adjuvant and with MF59 (R) adjuvant were used in the nationwide vaccination campaign beginning on November 1, 2009. From November 2009 through February 2010, the authors identified recipients of H1N1 vaccines who were diagnosed with adverse events of special interest (AESIs) in a large-linked safety database, and used the self-controlled case series (SCCS) method to examine the risk of each AESI in the 0-42 days after H1N1 vaccination. Of the 3.5 million doses of H1N1 vaccines administered and captured in the linked database, the SCCS analysis of Guillain-Barre syndrome (GBS) found an incidence rate ratio of 3.81 (95% confidence interval 0.43-33.85) within 0-42 days after nonadjuvanted H1N1 vaccination and no cases after MF59 (R)-adjuvanted H1N1 vaccination. The risks of other AESIs were, in general, not increased in any of the predefined postvaccination risk periods and age groups. The databases and infrastructure created for H1N1 vaccine safety evaluation may serve as a model for safety, effectiveness and coverage studies of licensed vaccines in Taiwan.	[Huang, Wan-Ting; Yang, Hsu-Wen; Liao, Tzu-Lin; Wu, Wan-Jen; Chuang, Jen-Hsiang] Taiwan Ctr Dis Control, Epidem Intelligence Ctr, Taipei, Taiwan; [Yang, Shu-Er; Chih, Yi-Chien] Taiwan Ctr Dis Control, Div 4, Taipei, Taiwan		Huang, WT (corresponding author), Taiwan Ctr Dis Control, Epidem Intelligence Ctr, Taipei, Taiwan.	muagi@cdc.gov.tw	Huang, Wan-Ting/E-3497-2010; Chuang, Jen-Hsiang/G-4356-2010; Huang, Wei-Chien/D-1740-2012	Huang, Wan-Ting/0000-0002-4344-9567; Chuang, Jen-Hsiang/0000-0002-7114-3418; Chen, Chia-Hung/0000-0003-1158-9722; Huang, Wei-Chien/0000-0001-6467-8716	Taiwan Centers for Disease Control [DOH99-DC-2038]	Taiwan Centers for Disease Control	This study was supported by a grant (DOH99-DC-2038) from the Taiwan Centers for Disease Control (http://www.cdc.gov.tw). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, Wkly Epidemiol Rec, V84, P249; [Anonymous], NAT HLTH INS TAIW 20; Bardage C, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5956; Black S, 2009, LANCET, V374, P2115, DOI 10.1016/S0140-6736(09)61877-8; Campbell KE, 2002, AM J EPIDEMIOL, V156, P32, DOI 10.1093/aje/kwf009; Chuang JH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036120; Clark TW, 2009, NEW ENGL J MED, V361, P2424, DOI 10.1056/NEJMoa0907650; De Wals P, 2012, JAMA-J AM MED ASSOC, V308, P175, DOI 10.1001/jama.2012.7342; Dieleman Jeanne, 2011, BMJ, V343, pd3908, DOI 10.1136/bmj.d3908; FARRINGTON P, 1995, LANCET, V345, P567, DOI 10.1016/S0140-6736(95)90471-9; FINE PEM, 1992, AM J EPIDEMIOL, V136, P121, DOI 10.1093/oxfordjournals.aje.a116479; Glanz JM, 2006, J CLIN EPIDEMIOL, V59, P808, DOI 10.1016/j.jclinepi.2005.11.012; Glaser CA, 2012, CLIN INFECT DIS, V55, P514, DOI 10.1093/cid/cis454; Greene SK, 2012, AM J EPIDEMIOL, V175, P1100, DOI 10.1093/aje/kws195; Greene SK, 2010, AM J EPIDEMIOL, V171, P177, DOI 10.1093/aje/kwp345; Grimaldi-Bensouda L, 2011, AM J EPIDEMIOL, V174, P326, DOI 10.1093/aje/kwr072; Hambidge SJ, 2006, JAMA-J AM MED ASSOC, V296, P1990, DOI 10.1001/jama.296.16.1990; Huang WT, 2012, VACCINE, V30, P2168, DOI 10.1016/j.vaccine.2012.01.013; Huang WT, 2010, VACCINE, V28, P7161, DOI 10.1016/j.vaccine.2010.08.069; Jackson ML, 2008, LANCET, V372, P398, DOI 10.1016/S0140-6736(08)61160-5; Kung HC, 2010, VACCINE, V28, P7337, DOI 10.1016/j.vaccine.2010.08.073; Lasky T, 1998, NEW ENGL J MED, V339, P1797, DOI 10.1056/NEJM199812173392501; Lee GM, 2011, AM J PREV MED, V41, P121, DOI 10.1016/j.amepre.2011.04.004; Lu CY, 2010, VACCINE, V28, P5864, DOI 10.1016/j.vaccine.2010.06.059; McMahon AW, 2005, PEDIATRICS, V115, P453, DOI 10.1542/peds.2004-1519; Rowhani-Rahbar A, 2012, VACCINE, V31, P271, DOI 10.1016/j.vaccine.2012.07.024; SCHONBERGER LB, 1979, AM J EPIDEMIOL, V110, P105, DOI 10.1093/oxfordjournals.aje.a112795; Smeeth L, 2004, NEW ENGL J MED, V351, P2611, DOI 10.1056/NEJMoa041747; Stowe J, 2009, AM J EPIDEMIOL, V169, P382, DOI 10.1093/aje/kwn310; Tokars JI, 2012, PHARMACOEPIDEM DR S, V21, P546, DOI 10.1002/pds.3220; Tse A, 2012, VACCINE, V30, P2024, DOI 10.1016/j.vaccine.2012.01.027; Vellozzi C, 2009, VACCINE, V27, P2114, DOI 10.1016/j.vaccine.2009.01.125; Whitaker HJ, 2006, STAT MED, V25, P1768, DOI 10.1002/sim.2302; Wise ME, 2012, AM J EPIDEMIOL, V175, P1110, DOI 10.1093/aje/kws196; Yih WK, 2012, AM J EPIDEMIOL, V175, P1120, DOI 10.1093/aje/kws197; Zhou WG, 2004, PHARMACOEPIDEM DR S, V13, P505, DOI 10.1002/pds.998	36	52	52	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2013	8	3							e58827	10.1371/journal.pone.0058827	http://dx.doi.org/10.1371/journal.pone.0058827			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WI	23536827	Green Published, Green Submitted, gold			2022-12-25	WOS:000316251100092
J	Kang, HS; Liao, G; DeGraff, LM; Gerrish, K; Bortner, CD; Garantziotis, S; Jetten, AM				Kang, Hong Soon; Liao, Grace; DeGraff, Laura M.; Gerrish, Kevin; Bortner, Carl D.; Garantziotis, Stavros; Jetten, Anton M.			CD44 Plays a Critical Role in Regulating Diet-Induced Adipose Inflammation, Hepatic Steatosis, and Insulin Resistance	PLOS ONE			English	Article							GENE-EXPRESSION; MACROPHAGE ACCUMULATION; PROFILING REVEALS; LIVER STEATOSIS; ROR-ALPHA; OBESITY; OSTEOPONTIN; TISSUE; RECRUITMENT; HYALURONAN	CD44 is a multifunctional membrane receptor implicated in the regulation of several biological processes, including inflammation. CD44 expression is elevated in liver and white adipose tissue (WAT) during obesity suggesting a possible regulatory role for CD44 in metabolic syndrome. To study this hypothesis, we examined the effect of the loss of CD44 expression on the development of various features of metabolic syndrome using CD44 null mice. Our study demonstrates that CD44-deficient mice (CD44KO) exhibit a significantly reduced susceptibility to the development of high fat-diet (HFD)-induced hepatic steatosis, WAT-associated inflammation, and insulin resistance. The decreased expression of genes involved in fatty acid synthesis and transport (Fasn and Cd36), de novo triglyceride synthesis (Mogat1), and triglyceride accumulation (Cidea, Cidec) appears in part responsible for the reduced hepatic lipid accumulation in CD44KO(HFD) mice. In addition, the expression of various inflammatory and cell matrix genes, including several chemokines and its receptors, osteopontin, and several matrix metalloproteinases and collagen genes was greatly diminished in CD44KO(HFD) liver consistent with reduced inflammation and fibrogenesis. In contrast, lipid accumulation was significantly increased in CD44KO(HFD) WAT, whereas inflammation as indicated by the reduced infiltration of macrophages and expression of macrophage marker genes, was significantly diminished in WAT of CD44KO(HFD) mice compared to WT(HFD) mice. CD44KO(HFD) mice remained considerably more insulin sensitive and glucose tolerant than WT(HFD) mice and exhibited lower blood insulin levels. Our study indicates that CD44 plays a critical role in regulating several aspects of metabolic syndrome and may provide a new therapeutic target in the management of insulin resistance.	[Kang, Hong Soon; Liao, Grace; DeGraff, Laura M.; Jetten, Anton M.] NIH, Cell Biol Sect, Res Triangle Pk, NC USA; [Gerrish, Kevin] NIH, Microarray Grp, Res Triangle Pk, NC USA; [Bortner, Carl D.] NIEHS, Lab Signal Transduct, Div Intramural Res, NIH, Res Triangle Pk, NC 27709 USA; [Garantziotis, Stavros] NIH, Matrix Biol Sect, LRB, Res Triangle Pk, NC USA	National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA	Jetten, AM (corresponding author), NIH, Cell Biol Sect, Res Triangle Pk, NC USA.	jetten@niehs.nih.gov	yu, qing/HGC-4611-2022; Jetten, Anton/C-3736-2019; Yu, Qinghua/T-3261-2019; Garantziotis, Stavros/A-6903-2009	Jetten, Anton/0000-0003-0954-4445; Garantziotis, Stavros/0000-0003-4007-375X	Intramural Research Program of the NIEHS, NIH [Z01-ES-101586]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES101586, ZICES102445, ZIAES102605, ZICES102486, Z01ES101586] Funding Source: NIH RePORTER	Intramural Research Program of the NIEHS, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This research was supported by the Intramural Research Program of the NIEHS, NIH (Z01-ES-101586). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bertola A, 2009, DIABETES, V58, P125, DOI 10.2337/db08-0400; Browning JD, 2004, HEPATOLOGY, V40, P1387, DOI 10.1002/hep.20466; Buechler C, 2011, WORLD J GASTROENTERO, V17, P2801, DOI 10.3748/wjg.v17.i23.2801; Chapman J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013959; Consolo M, 2009, INT J MOL MED, V24, P143, DOI 10.3892/ijmm_00000217; Donath MY, 2011, NAT REV IMMUNOL, V11, P98, DOI 10.1038/nri2925; Fabbrini E, 2010, HEPATOLOGY, V51, P679, DOI 10.1002/hep.23280; Fujii H, 2012, J GASTROENTEROL, V47, P215, DOI 10.1007/s00535-012-0527-x; Gong JY, 2009, CURR OPIN LIPIDOL, V20, P121, DOI 10.1097/MOL.0b013e328328d0bb; Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322; Guillen N, 2009, PHYSIOL GENOMICS, V37, P187, DOI 10.1152/physiolgenomics.90339.2008; Hajri T, 2002, J CLIN INVEST, V109, P1381, DOI [10.1172/JCI200214596, 10.1172/JCI0214596]; Hebbard L, 2011, NAT REV GASTRO HEPAT, V8, P34, DOI 10.1038/nrgastro.2010.191; Hemmann S, 2007, J HEPATOL, V46, P955, DOI 10.1016/j.jhep.2007.02.003; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Hollingsworth JW, 2007, AM J RESP CELL MOL, V37, P248, DOI 10.1165/rcmb.2006-0363OC; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Hursting SD, 2012, ARTERIOSCL THROM VAS, V32, P1766, DOI 10.1161/ATVBAHA.111.241927; Jiang DH, 2011, PHYSIOL REV, V91, P221, DOI 10.1152/physrev.00052.2009; Johnson Pauline, 2009, Inflammation & Allergy Drug Targets, V8, P208; Kang HS, 2007, PHYSIOL GENOMICS, V31, P281, DOI 10.1152/physiolgenomics.00098.2007; Kang HS, 2011, PHYSIOL GENOMICS, V43, P818, DOI 10.1152/physiolgenomics.00206.2010; Kang HS, 2011, DIABETES, V60, P177, DOI 10.2337/db10-0628; Keller P, 2008, J BIOL CHEM, V283, P14355, DOI 10.1074/jbc.M708323200; Kiefer FW, 2011, DIABETOLOGIA, V54, P2132, DOI 10.1007/s00125-011-2170-0; Kitade H, 2012, DIABETES; Kodama K, 2012, P NATL ACAD SCI US; Li L, 2012, VITAM HORM, V90, P375, DOI 10.1016/B978-0-12-398313-8.00014-2; Li YJ, 2011, J EXP MED, V208, P1459, DOI 10.1084/jem.20102510; Lumeng CN, 2011, J CLIN INVEST, V121, P2111, DOI 10.1172/JCI57132; Mandrekar P, 2011, HEPATOLOGY, V54, P2185, DOI 10.1002/hep.24599; McKee CM, 1996, J CLIN INVEST, V98, P2403, DOI 10.1172/JCI119054; Miletti-Gonzalez KE, 2012, J BIOL CHEM, V287, P18995, DOI 10.1074/jbc.M111.318774; Morimoto J, 2010, CURR DRUG TARGETS, V11, P494, DOI 10.2174/138945010790980321; Nagle CA, 2009, J LIPID RES, V50, pS74, DOI 10.1194/jlr.R800053-JLR200; Nakamachi T, 2007, DIABETES, V56, P1662, DOI 10.2337/db06-1177; Nicholls HT, 2011, DIABETES, V60, P1100, DOI 10.2337/db10-1353; Nio Y, 2012, DIABETOLOGIA; Nishimura S, 2009, NAT MED, V15, P914, DOI 10.1038/nm.1964; Nishino N, 2008, J CLIN INVEST, V118, P2808, DOI 10.1172/JCI34090; Nystrom T, 2007, EXP CELL RES, V313, P1149, DOI 10.1016/j.yexcr.2006.12.026; Odegaard JI, 2008, CELL METAB, V7, P496, DOI 10.1016/j.cmet.2008.04.003; Ogden CL, 2012, JAMA-J AM MED ASSOC, V307, P483, DOI 10.1001/jama.2012.40; Ouchi N, 2011, NAT REV IMMUNOL, V11, P85, DOI 10.1038/nri2921; Pivetta E, 2011, J CELL PHYSIOL, V226, P769, DOI 10.1002/jcp.22398; Samuel VT, 2012, CELL, V148, P852, DOI 10.1016/j.cell.2012.02.017; Schenk S, 2008, J CLIN INVEST, V118, P2992, DOI 10.1172/JCI34260; Schmits R, 1997, BLOOD, V90, P2217, DOI 10.1182/blood.V90.6.2217.2217_2217_2233; Shevde LA, 2010, CURR MOL MED, V10, P71, DOI 10.2174/156652410791065381; Solis MA, 2012, BIOCHEM RES INT, V2012, DOI 10.1155/2012/346972; Toole BP, 2009, CLIN CANCER RES, V15, P7462, DOI 10.1158/1078-0432.CCR-09-0479; Tsou CL, 2007, J CLIN INVEST, V117, P902, DOI 10.1172/JCI29919; Wan ZX, 2012, OBESITY, V20, P453, DOI 10.1038/oby.2011.252; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wouters K, 2008, HEPATOLOGY, V48, P474, DOI 10.1002/hep.22363; Zeyda M, 2011, ENDOCRINOLOGY, V152, P2219, DOI 10.1210/en.2010-1328; Zheng YH, 2012, J CELL PHYSIOL, V227, P127, DOI 10.1002/jcp.22709; Zhou LK, 2012, HEPATOLOGY, V56, P95, DOI 10.1002/hep.25611; Zhou ZH, 2003, NAT GENET, V35, P49, DOI 10.1038/ng1225; Zhu BQ, 2004, J CELL PHYSIOL, V198, P155, DOI 10.1002/jcp.10394; Zoller M, 2011, NAT REV CANCER, V11, P254, DOI 10.1038/nrc3023	61	75	77	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e58417	10.1371/journal.pone.0058417	http://dx.doi.org/10.1371/journal.pone.0058417			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	24391892	Green Published, Green Submitted, gold			2022-12-25	WOS:000318334500081
J	Kang, HH; Yan, MF; Yu, QH; Yang, Q				Kang, Haihong; Yan, Mengfei; Yu, Qinghua; Yang, Qian			Characteristics of Nasal-Associated Lymphoid Tissue (NALT) and Nasal Absorption Capacity in Chicken	PLOS ONE			English	Article							OVIDUCTAL EPITHELIAL-CELLS; IMMUNE-SYSTEM; MUCOSAL IMMUNITY; INFLUENZA-VIRUS; FALLOPIAN-TUBE; PARTICLES; ANTIGENS; ORGAN; SITE	As the main mucosal immune inductive site of nasal cavity, nasal-associated lymphoid tissue (NALT) plays an important role in both antigen recognition and immune activation after intranasal immunization. However, the efficiency of intranasal vaccines is commonly restricted by the insufficient intake of antigen by the nasal mucosa, resulting from the nasal mucosal barrier and the nasal mucociliary clearance. The distribution of NALT and the characteristic of nasal cavity have already been described in humans and many laboratory rodents, while data about poultry are scarce. For this purpose, histological sections of the chicken nasal cavities were used to examine the anatomical structure and histological characteristics of nasal cavity. Besides, the absorptive capacity of chicken nasal mucosa was also studied using the materials with different particle size. Results showed that the NALT of chicken was located on the bottom of nasal septum and both sides of choanal cleft, which mainly consisted of second lymphoid follicle. A large number of lymphocytes were distributed under the mucosal epithelium of inferior nasal meatus. In addition, there were also diffuse lymphoid tissues located under the epithelium of the concha nasalis media and the walls of nasal cavity. The results of absorption experiment showed that the chicken nasal mucosa was capable to absorb trypan blue, OVA, and fluorescent latex particles. Inactivated avian influenza virus (IAIV) could be taken up by chicken nasal mucosa except for the stratified squamous epithelium sites located on the forepart of nasal cavity. The intake of IAIV by NALT was greater than that of the nasal mucosa covering on non-lymphoid tissue, which could be further enhanced after intranasal inoculation combined with sodium cholate or CpG DNA. The study on NALT and nasal absorptive capacity will be benefit for further understanding of immune mechanisms after nasal vaccination and development of nasal vaccines for poultry.	[Kang, Haihong; Yan, Mengfei; Yu, Qinghua; Yang, Qian] Nanjing Agr Univ, Coll Vet Med, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University	Yang, Q (corresponding author), Nanjing Agr Univ, Coll Vet Med, Nanjing, Jiangsu, Peoples R China.	zxbyq@njau.edu.cn	yu, qing/HGC-4611-2022; Jetten, Anton/C-3736-2019; Yu, Qinghua/T-3261-2019; Garantziotis, Stavros/A-6903-2009	Jetten, Anton/0000-0003-0954-4445; Garantziotis, Stavros/0000-0003-4007-375X	National Science Grant of China [31172302]; Priority Academic Program Development of Jiangsu Higher Education Institutions; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES101586, ZICES102445, ZIAES102605, ZICES102486, Z01ES101586] Funding Source: NIH RePORTER	National Science Grant of China; Priority Academic Program Development of Jiangsu Higher Education Institutions; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the National Science Grant of China (31172302, http://www.nsfc.gov.cn/), and a Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (http://www.ec.js.edu.cn/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARAI N, 1988, JPN J VET SCI, V50, P183; BANG BG, 1968, AM J PATHOL, V53, P735; Brandtzaeg P, 2004, TRENDS IMMUNOL, V25, P570, DOI 10.1016/j.it.2004.09.005; Brayden DJ, 2001, EUR J PHARM SCI, V14, P183, DOI 10.1016/S0928-0987(01)00175-0; Casteleyn C, 2010, VET IMMUNOL IMMUNOP, V133, P212, DOI 10.1016/j.vetimm.2009.08.011; FAGERLAND JA, 1993, AVIAN DIS, V37, P10, DOI 10.2307/1591451; FAGERLAND JA, 1990, AM J ANAT, V189, P24, DOI 10.1002/aja.1001890104; Fagerland Jane A., 1993, Regional Immunology, V5, P28; Fujimura Y, 2000, VIRCHOWS ARCH, V436, P560, DOI 10.1007/s004289900177; Golias J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037156; HAMELEERS DMH, 1989, CELL TISSUE RES, V256, P431, DOI 10.1007/BF00218901; Harkema JR, 2006, TOXICOL PATHOL, V34, P252, DOI 10.1080/01926230600713475; Harmsen A, 2002, J IMMUNOL, V168, P986, DOI 10.4049/jimmunol.168.3.986; Heritage PL, 1997, AM J RESP CRIT CARE, V156, P1256, DOI 10.1164/ajrccm.156.4.97-03017; Hiller AS, 1998, SCAND J IMMUNOL, V47, P159; Illum L, 2003, J CONTROL RELEASE, V87, P187, DOI 10.1016/S0168-3659(02)00363-2; Itoh H, 2006, AM J REPROD IMMUNOL, V56, P91, DOI 10.1111/j.1600-0897.2006.00389.x; Kanaya T, 2012, NAT IMMUNOL, V13, P729, DOI 10.1038/ni.2352; KUPER CF, 1992, IMMUNOL TODAY, V13, P219; Lathers DMR, 1998, INVEST OPHTH VIS SCI, V39, P1005; Lee HJ, 2005, EXP MOL MED, V37, P297, DOI 10.1038/emm.2005.40; Liu GY, 2013, BEHAV BRAIN FUNCT, V9, DOI 10.1186/1744-9081-9-36; Liu HS, 2005, INVEST OPHTH VIS SCI, V46, P4217, DOI 10.1167/iovs.05-0280; LOO SK, 1974, J ANAT, V117, P249; Louis KS, 2011, METHODS MOL BIOL, V740, P7, DOI 10.1007/978-1-61779-108-6_2; Mabbott NA, 2013, MUCOSAL IMMUNOL, V6, P666, DOI 10.1038/mi.2013.30; MAIR TS, 1987, J COMP PATHOL, V97, P575, DOI 10.1016/0021-9975(87)90008-9; MAIR TS, 1988, J COMP PATHOL, V99, P159, DOI 10.1016/0021-9975(88)90069-2; Maldonado-Contreras AL, 2011, CELL TISSUE RES, V343, P5, DOI 10.1007/s00441-010-1082-5; Nasu K, 2007, HUM REPROD, V22, P356, DOI 10.1093/humrep/del385; Ohshima K, 2000, HISTOL HISTOPATHOL, V15, P713, DOI 10.14670/HH-15.713; PAPPO J, 1989, CLIN EXP IMMUNOL, V76, P144; Pawar D, 2010, AAPS J, V12, P130, DOI 10.1208/s12248-009-9169-1; Qian L, 2002, ACTA BIOCH BIOPH SIN, V34, P719; Quinteiro P, 2005, ANATOMIA HISTOLOGIA, V34, P41; Reese S, 2006, VET RES, V37, P311, DOI 10.1051/vetres:2006003; Sato S, 2012, CURR OPIN VIROL, V2, P225, DOI 10.1016/j.coviro.2012.03.009; Smialek M, 2011, POL J VET SCI, V14, P291, DOI 10.2478/v10181-011-0047-2; SPIT BJ, 1989, CELL TISSUE RES, V255, P193; Strober Warren, 2015, Curr Protoc Immunol, V111, DOI 10.1002/0471142735.ima03bs111; Tamura S, 1998, J GEN VIROL, V79, P291, DOI 10.1099/0022-1317-79-2-291; TlaskalovaHogenova H, 1995, FOLIA MICROBIOL, V40, P385, DOI 10.1007/BF02814746; Yuanji G, 1997, INFLUENZA VIRUS EXPT; Zhang XW, 2009, VACCINE, V27, P5628, DOI 10.1016/j.vaccine.2009.07.023; Zhao K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053314; Zuercher AW, 2002, J IMMUNOL, V168, P1796, DOI 10.4049/jimmunol.168.4.1796	46	75	77	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84097	10.1371/journal.pone.0084097	http://dx.doi.org/10.1371/journal.pone.0084097			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391892	Green Submitted, Green Published, gold			2022-12-25	WOS:000329323900035
J	Grange, LJ; Smith, CR				Grange, Laura J.; Smith, Craig R.			Megafaunal Communities in Rapidly Warming Fjords along the West Antarctic Peninsula: Hotspots of Abundance and Beta Diversity	PLOS ONE			English	Article							DEPTH-RELATED CHANGES; CLIMATE-CHANGE; SUBMARINE CANYONS; MARINE ECOSYSTEM; SEDIMENTATION; BIOMASS; VARIABILITY; SEA; MACROBENTHOS; PYCNOGONIDA	Glacio-marine fjords occur widely at high latitudes and have been extensively studied in the Arctic, where heavy meltwater inputs and sedimentation yield low benthic faunal abundance and biodiversity in inner-middle fjords. Fjord benthic ecosystems remain poorly studied in the subpolar Antarctic, including those in extensive fjords along the West Antarctic Peninsula (WAP). Here we test ecosystem predictions from Arctic fjords on three subpolar, glacio-marine fjords along the WAP. With seafloor photographic surveys we evaluate benthic megafaunal abundance, community structure, and species diversity, as well as the abundance of demersal nekton and macroalgal detritus, in soft-sediment basins of Andvord, Flandres and Barilari Bays at depths of 436-725 m. We then contrast these fjord sites with three open shelf stations of similar depths. Contrary to Arctic predictions, WAP fjord basins exhibited 3 to 38-fold greater benthic megafaunal abundance than the open shelf, and local species diversity and trophic complexity remained high from outer to inner fjord basins. Furthermore, WAP fjords contained distinct species composition, substantially contributing to beta and gamma diversity at 400-700 m depths along the WAP. The abundance of demersal nekton and macroalgal detritus was also substantially higher in WAP fjords compared to the open shelf. We conclude that WAP fjords are important hotspots of benthic abundance and biodiversity as a consequence of weak meltwater influences, low sedimentation disturbance, and high, varied food inputs. We postulate that WAP fjords differ markedly from their Arctic counterparts because they are in earlier stages of climate warming, and that rapid warming along the WAP will increase meltwater and sediment inputs, deleteriously impacting these biodiversity hotspots. Because WAP fjords also provide important habitat and foraging areas for Antarctic krill and baleen whales, there is an urgent need to develop better understanding of the structure, dynamics and climate-sensitivity of WAP subpolar fjord ecosystems.	[Grange, Laura J.; Smith, Craig R.] Univ Hawaii Manoa, Dept Oceanog, Honolulu, HI 96822 USA	University of Hawaii System; University of Hawaii Manoa	Grange, LJ (corresponding author), Univ Southampton, Natl Oceanog Ctr, Southampton, Hants, England.	J.Grange@noc.soton.ac.uk	Grange, Laura/E-8495-2014	Grange, Laura/0000-0001-9222-6848	Office of Polar Programs (OPP), United States National Science Foundation [OPP-0636806, OPP-0732711]; Biological Oceanography Program (BIO OCE), United States National Science Foundation [BIO OCE-1155703]	Office of Polar Programs (OPP), United States National Science Foundation; Biological Oceanography Program (BIO OCE), United States National Science Foundation	This material is based upon work supported by the Office of Polar Programs (OPP), United States National Science Foundation under the LARISSA and FOODBANCS2 Projects Grant Nos. OPP-0636806 and OPP-0732711 respectively to C. R. S. Writing and publication costs were supported in part by the Biological Oceanography Program (BIO OCE), United States National Science Foundation under the BOWLs Project Grant No. BIO OCE-1155703 to C. R. S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson WB, 2004, FOOD WEB AT THE LANDSCAPE LEVEL, P82; [Anonymous], 1995, GLACIAL ENV; Arango CP, 2011, DEEP-SEA RES PT II, V58, P212, DOI 10.1016/j.dsr2.2010.05.019; ARNAUD F, 1987, ADV MAR BIOL, V24, P1; Ashley GM, 2000, GEOL SOC AM BULL, V112, P657, DOI 10.1130/0016-7606(2000)112<0657:MSAACG>2.3.CO;2; Barnes DKA, 2007, PHILOS T R SOC B, V362, P11, DOI 10.1098/rstb.2006.1951; Barry James P., 2003, Antarctic Research Series, V78, P327; Clarke A, 2007, PHILOS T R SOC B, V362, P149, DOI 10.1098/rstb.2006.1958; Clarke K., 2015, GETTING STARTED PRIM, V91, P192; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Clarke KR., 2001, CHANGE MARINE COMMUN, V2; Cook AJ, 2005, SCIENCE, V308, P541, DOI 10.1126/science.1104235; De Leo FC, 2010, P ROY SOC B-BIOL SCI, V277, P2783, DOI 10.1098/rspb.2010.0462; Domack E.W., 1996, ANTARCT RES SER, V70, P135, DOI [10.1029/AR070p0135, DOI 10.1029/AR070P0135]; DOMACK EW, 1993, ANTAR RES S, V60, P265; DOMACK EW, 1993, GEOL SOC AM BULL, V105, P1175, DOI 10.1130/0016-7606(1993)105<1175:OAPCOM>2.3.CO;2; Ducklow HW, 2007, PHILOS T R SOC B, V362, P67, DOI 10.1098/rstb.2006.1955; Fetzer I, 2002, POLAR BIOL, V25, P303, DOI 10.1007/s00300-001-0345-8; Glud RN, 2002, MAR ECOL PROG SER, V238, P15, DOI 10.3354/meps238015; GRIFFITH TW, 1989, MAR GEOL, V85, P181, DOI 10.1016/0025-3227(89)90153-9; Holte B, 1998, POLAR BIOL, V19, P375, DOI 10.1007/s003000050262; Hop H, 2002, POLAR RES, V21, P167, DOI 10.1111/j.1751-8369.2002.tb00073.x; Howe JA, 2010, SPECIAL PUBLICATION, V344; Jones DOB, 2007, POLAR BIOL, V30, P1579, DOI 10.1007/s00300-007-0319-6; Jones DOB, 2007, MAR BIOL RES, V3, P191, DOI 10.1080/17451000701455287; Kedra M, 2010, POLAR BIOL, V33, P1, DOI 10.1007/s00300-009-0679-1; Leibold MA, 2004, ECOL LETT, V7, P601, DOI 10.1111/j.1461-0248.2004.00608.x; MAGURRAN A. E., 2004, MEASURING BIOLOGICAL; Mahon AR, 2008, MAR BIOL, V155, P315, DOI 10.1007/s00227-008-1029-5; McLeod RJ, 2010, LIMNOL OCEANOGR, V55, P2097, DOI 10.4319/lo.2010.55.5.2097; Meredith MP, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL024042; Nowacek DP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019173; Pabis K, 2011, POLAR BIOL, V34, P489, DOI 10.1007/s00300-010-0903-z; Pabis K, 2010, POLAR BIOL, V33, P141, DOI 10.1007/s00300-009-0692-4; Piepenburg D, 2002, POLAR BIOL, V25, P146, DOI 10.1007/s003000100322; Polis GA, 1997, ANNU REV ECOL SYST, V28, P289, DOI 10.1146/annurev.ecolsys.28.1.289; Renaud PE, 2007, POLAR BIOL, V30, P295, DOI 10.1007/s00300-006-0183-9; Rex MA, 2006, MAR ECOL PROG SER, V317, P1, DOI 10.3354/meps317001; Roman J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013255; Runge JP, 2006, AM NAT, V167, P925, DOI 10.1086/503531; Schmidt K, 2011, LIMNOL OCEANOGR, V56, P1411, DOI 10.4319/lo.2011.56.4.1411; Sicinski J, 2011, DEEP-SEA RES PT II, V58, P30, DOI 10.1016/j.dsr2.2010.09.005; Simard Y, 1999, CAN J FISH AQUAT SCI, V56, P1182, DOI 10.1139/cjfas-56-7-1182; Skold M, 2003, MAR ECOL PROG SER, V250, P163, DOI 10.3354/meps250163; Smith CR, 2012, OCEANOGRAPHY, V25, P188, DOI 10.5670/oceanog.2012.94; Starmans A, 1999, MAR BIOL, V135, P269, DOI 10.1007/s002270050624; Steig EJ, 2009, NATURE, V457, P459, DOI 10.1038/nature07669; Sumida PYG, 2008, DEEP-SEA RES PT II, V55, P2465, DOI 10.1016/j.dsr2.2008.06.006; Syvitski J.P.M., 1987, FJORDS PROCESSES PRO; SYVITSKI JPM, 1989, ARCTIC, V42, P232; Thiele D, 2004, DEEP-SEA RES PT II, V51, P2311, DOI 10.1016/j.dsr2.2004.07.007; Trivelpiece WZ, 2011, P NATL ACAD SCI USA, V108, P7625, DOI 10.1073/pnas.1016560108; Ugland KI, 2003, J ANIM ECOL, V72, P888, DOI 10.1046/j.1365-2656.2003.00748.x; Vetter EW, 2010, MAR ECOL-EVOL PERSP, V31, P183, DOI 10.1111/j.1439-0485.2009.00351.x; Ware C, 2011, MAR MAMMAL SCI, V27, P587, DOI 10.1111/j.1748-7692.2010.00427.x; Weslawski Jan Marcin, 2011, Marine Biodiversity, V41, P71, DOI 10.1007/s12526-010-0073-9; Wlodarska-Kowalczuk M, 1998, POLAR BIOL, V20, P66, DOI 10.1007/s003000050277; Wlodarska-Kowalczuk M, 2005, MAR ECOL PROG SER, V303, P31, DOI 10.3354/meps303031; Wlodarska-Kowalczuk M, 2004, POLAR BIOL, V27, P155, DOI 10.1007/s00300-003-0568-y; Wlodarska-Kowalczuk M, 2007, ESTUAR COAST SHELF S, V74, P274, DOI 10.1016/j.ecss.2007.04.017; Wlodarska-Kowalczuk M, 2012, MAR ECOL PROG SER, V463, P73, DOI 10.3354/meps09858	61	140	140	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2013	8	12							e77917	10.1371/journal.pone.0077917	http://dx.doi.org/10.1371/journal.pone.0077917			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265JR	24312442	Green Submitted, Green Published, gold, Green Accepted			2022-12-25	WOS:000327947800002
J	Manrique-Poyato, MI; Lopez-Leon, MD; Gomez, R; Perfectti, F; Camacho, JPM				Inmaculada Manrique-Poyato, Maria; Dolores Lopez-Leon, Maria; Gomez, Ricardo; Perfectti, Francisco; Martinez Camacho, Juan Pedro			Population Genetic Structure of the Grasshopper Eyprepocnemis plorans in the South and East of the Iberian Peninsula	PLOS ONE			English	Article							SEQUENCE REPEAT POLYMORPHISMS; B-CHROMOSOME; ALLELIC DROPOUT; FEMALE FITNESS; RAPD MARKERS; ISSR-PCR; DIVERSITY; IDENTIFICATION; DYNAMICS; GENOME	The grasshopper Eyprepocnemis plorans subsp. plorans harbors a very widespread polymorphism for supernumerary (B) chromosomes which appear to have arisen recently. These chromosomes behave as genomic parasites because they are harmful for the individuals carrying them and show meiotic drive in the initial stages of population invasion. The rapid increase in B chromosome frequency at intrapopulation level is thus granted by meiotic drive, but its spread among populations most likely depends on interpopulation gene flow. We analyze here the population genetic structure in 10 natural populations from two regions (in the south and east) of the Iberian Peninsula. The southern populations were coastal whereas the eastern ones were inland populations located at 260-655 m altitude. The analysis of 97 ISSR markers revealed significant genetic differentiation among populations (average G(ST) = 0.129), and the Structure software and AMOVA indicated a significant genetic differentiation between southern and eastern populations. There was also significant isolation by distance (IBD) between populations. Remarkably, these results were roughly similar to those found when only the markers showing low or no dropout were included, suggesting that allelic dropout had negligible effects on population genetic analysis. We conclude that high gene flow helped this parasitic B chromosome to spread through most of the geographical range of the subspecies E. plorans plorans.	[Inmaculada Manrique-Poyato, Maria; Dolores Lopez-Leon, Maria; Perfectti, Francisco; Martinez Camacho, Juan Pedro] Univ Granada, Dept Genet, Granada, Spain; [Inmaculada Manrique-Poyato, Maria] Ctr Andaluz Biol Mol & Med Regenerat CABIMER, Dept Celulas Troncales, Seville, Spain; [Gomez, Ricardo] Univ Castilla La Mancha, Dept Ciencia & Tecnol Agroforestal, Albacete, Spain	University of Granada; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Pablo de Olavide; University of Sevilla; CSIC - Centro Andaluz de Biologia Molecular y Medicina Regenerativa (CABIMER); Universidad de Castilla-La Mancha	Camacho, JPM (corresponding author), Univ Granada, Dept Genet, Granada, Spain.	jpmcamac@ugr.es	Perfectti, Francisco/C-5087-2008; López-León, María Dolores/L-9026-2014; Camacho, Juan Pedro M/L-6869-2014; Cabrero, Josefa/L-8899-2014	Perfectti, Francisco/0000-0002-5551-213X; López-León, María Dolores/0000-0003-2337-7313; Camacho, Juan Pedro M/0000-0002-2507-9814; Cabrero, Josefa/0000-0002-5848-6985; Gomez Ladron de Guevara, Ricardo/0000-0003-3430-0346	Spanish Ministerio de Ciencia e Innovacion [CGL2009-11917]; Spanish Ministerio de Ciencia e Innovacion; FEDER funds	Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); FEDER funds(European Commission)	This study was supported by a grant from the Spanish Ministerio de Ciencia e Innovacion (CGL2009-11917), and was partially performed by FEDER funds. MIMP was supported by a fellowship (FPU) from the Spanish Ministerio de Ciencia e Innovacion. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avise J.C., 2004, MOL MARKERS NATURAL; Bonnet E, 2002, J STAT SOFTW, V7, P1, DOI DOI 10.18637/JSS.V007.I10; Cabrero J, 1999, HEREDITY, V83, P435, DOI 10.1038/sj.hdy.6885960; Cabrero J, 1997, CHROMOSOME RES, V5, P194, DOI 10.1023/A:1018499015091; Camacho JPM, 1997, AM NAT, V149, P1030, DOI 10.1086/286037; Camacho Juan Pedro M., 2005, P223, DOI 10.1016/B978-012301463-4/50006-1; Cano J, 2005, J DERMATOL SCI, V39, P17, DOI 10.1016/j.jdermsci.2005.01.016; Datwyler SL, 2004, SYST BOT, V29, P165, DOI 10.1600/036364404772974077; de Leon JH, 2005, J INSECT SCI, V5; DICE LR, 1945, ECOLOGY, V26, P297, DOI 10.2307/1932409; Dirsh V. M., 1958, Proceedings of the Royal Entomological Society of London (B), V27, P33; Earl DA, 2011, CONSERV GENET RESOUR, V4, P359, DOI DOI 10.1007/S12686-011-9548-7; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Falush D, 2007, MOL ECOL NOTES, V7, P574, DOI 10.1111/j.1471-8286.2007.01758.x; Felsenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Fernandez ME, 2002, THEOR APPL GENET, V104, P845, DOI 10.1007/s00122-001-0848-2; Hernandez F., 1984, Boletin del Servicio de Defensa contra Plagas e Inspeccion Fitopatologica, V10, P245; Herrera JA, 1996, HEREDITY, V76, P633, DOI 10.1038/hdy.1996.90; Holsinger KE, 2002, MOL ECOL, V11, P1157, DOI 10.1046/j.1365-294X.2002.01512.x; Hundsdoerfer AK, 2005, ORG DIVERS EVOL, V5, P173, DOI 10.1016/j.ode.2004.11.012; Munoz-Pajares A, 2011, GENETICS, V187, P853, DOI 10.1534/genetics.110.122713; JONES RN, 1991, AM NAT, V137, P430, DOI 10.1086/285175; KANTETY RV, 1995, MOL BREEDING, V1, P365, DOI 10.1007/BF01248414; Kar PK, 2005, GENETICA, V125, P173, DOI 10.1007/s10709-005-7002-z; Kojima T, 1998, THEOR APPL GENET, V96, P37, DOI 10.1007/s001220050706; Lopez-Leon MD, 2008, CYTOGENET GENOME RES, V121, P260, DOI 10.1159/000138894; Lu ZX, 2006, PLANT SCI, V170, P407, DOI 10.1016/j.plantsci.2005.09.009; Munoz E, 1998, P ROY SOC B-BIOL SCI, V265, P1903, DOI 10.1098/rspb.1998.0518; Nagaoka T, 1997, THEOR APPL GENET, V94, P597, DOI 10.1007/s001220050456; PARDO MC, 1995, HEREDITY, V74, P654, DOI 10.1038/hdy.1995.89; Perfectti F, 2004, CYTOGENET GENOME RES, V106, P376, DOI 10.1159/000079315; Phillips CB, 2002, NEW ZEAL J AGR RES, V45, P295, DOI 10.1080/00288233.2002.9513519; Pinedo-Cancino V, 2006, AM J TROP MED HYG, V75, P238, DOI 10.4269/ajtmh.2006.75.238; Pradeep Appukuttan R., 2005, Journal of Applied Genetics, V46, P291; Ratnaparkhe MB, 1998, THEOR APPL GENET, V97, P515, DOI 10.1007/s001220050925; Ren ZM, 2008, GENETICA, V132, P103, DOI 10.1007/s10709-007-9153-6; Roux O, 2007, MOL PHYLOGENET EVOL, V43, P240, DOI 10.1016/j.ympev.2006.09.017; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schluter PM, 2006, MOL ECOL NOTES, V6, P569, DOI 10.1111/j.1471-8286.2006.01225.x; Sesarini C, 2008, GENETICA, V133, P295, DOI 10.1007/s10709-007-9213-y; Slatkin Montgomery, 1994, P3; Soulsbury CD, 2007, CONSERV GENET, V8, P733, DOI 10.1007/s10592-006-9194-x; Spiegelhalter DJ, 2002, J R STAT SOC B, V17, P37; Taberlet P, 1996, NUCLEIC ACIDS RES, V24, P3189, DOI 10.1093/nar/24.16.3189; Tester DJ, 2006, HEART RHYTHM, V3, P815, DOI 10.1016/j.hrthm.2006.03.016; Tsumura Y, 1996, THEOR APPL GENET, V92, P40, DOI 10.1007/BF00222949; Vandergast AG, 2009, J INSECT CONSERV, V13, P329, DOI 10.1007/s10841-008-9176-z; Vekemans X, 2002, MOL ECOL, V11, P139, DOI 10.1046/j.0962-1083.2001.01415.x; Vijayan K, 2006, J INSECT SCI, V6, DOI 10.1673/2006_6_30.1; WRIGHT S, 1951, ANN EUGENIC, V15, P323; Wu W, 2005, BIOCHEM SYST ECOL, V33, P1141, DOI 10.1016/j.bse.2005.02.010; Zhang XP, 2006, BIOCHEM SYST ECOL, V34, P38, DOI 10.1016/j.bse.2005.05.007; ZIETKIEWICZ E, 1994, GENOMICS, V20, P176, DOI 10.1006/geno.1994.1151	54	14	15	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2013	8	3							e59041	10.1371/journal.pone.0059041	http://dx.doi.org/10.1371/journal.pone.0059041			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140TZ	23520552	Green Published, gold, Green Submitted			2022-12-25	WOS:000318679900112
J	Li, K; Chi, Y; Gao, K; Yan, QJ; Matsue, H; Takeda, M; Kitamura, M; Yao, J				Li, Kai; Chi, Yuan; Gao, Kun; Yan, Qiaojing; Matsue, Hiroyuki; Takeda, Masayuki; Kitamura, Masanori; Yao, Jian			Connexin43 Hemichannel-Mediated Regulation of Connexin43	PLOS ONE			English	Article							JUNCTIONAL INTERCELLULAR COMMUNICATION; GAP-JUNCTIONS; SIGNAL-TRANSDUCTION; OXIDATIVE STRESS; GENE-EXPRESSION; LLC-PK1 CELLS; CADMIUM CD2+; C-JUN; PLASMA-MEMBRANE; UP-REGULATION	Background: Many signaling molecules and pathways that regulate gap junctions (GJs) protein expression and function are, in fact, also controlled by GJs. We, therefore, speculated an existence of the GJ channel-mediated self-regulation of GJs. Using a cell culture model in which nonjunctional connexin43 (Cx43) hemichannels were activated by cadmium (Cd2+), we tested this hypothesis. Principal Findings: Incubation of Cx43-transfected LLC-PK1 cells with Cd2+ led to an increased expression of Cx43. This effect of Cd2+ was tightly associated with JNK activation. Inhibition of JNK abolished the elevation of Cx43. Further analysis revealed that the changes of JNK and Cx43 were controlled by GSH. Supplement of a membrane-permeable GSH analogue GSH ethyl ester or GSH precursor N-acetyl-cystein abrogated the effects of Cd2+ on JNK activation and Cx43 expression. Indeed, Cd2+ induced extracellular release of GSH. Blockade of Cx43 hemichannels with heptanol or Cx43 mimetic peptide Gap26 to prevent the efflux of GSH significantly attenuated the Cx43-elevating effects of Cd2+. Conclusions: Collectively, our results thus indicate that Cd2+-induced upregulation of Cx43 is through activation of nonjunctional Cx43 hemichannels. Our findings thus support the existence of a hemichannel-mediated self-regulation of Cx43 and provide novel insights into the molecular mechanisms of Cx43 expression and function.	[Li, Kai; Chi, Yuan; Gao, Kun; Yan, Qiaojing; Kitamura, Masanori; Yao, Jian] Univ Yamanashi, Dept Mol Signaling, Interdisciplinary Grad Sch Med & Engn, Chuo Ku, Yamanashi, Japan; [Li, Kai; Takeda, Masayuki] Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Dept Urol, Chuo Ku, Yamanashi, Japan; [Li, Kai] China Med Univ, Hosp 1, Dept Surg Oncol & Gen Surg, Shenyang, Peoples R China; [Matsue, Hiroyuki] Chiba Univ, Sch Med, Dept Dermatol, Chiba 280, Japan	University of Yamanashi; University of Yamanashi; China Medical University; Chiba University	Li, K (corresponding author), Univ Yamanashi, Dept Mol Signaling, Interdisciplinary Grad Sch Med & Engn, Chuo Ku, Yamanashi, Japan.	cmu_likai@hotmail.com; yao@yamanashi.ac.jp	; Li, Ke/I-3804-2013	Yao, Jian/0000-0003-2622-0215; Li, Ke/0000-0003-4869-5393	Ministry of Education, Culture, Sports, Science and Technology, Japan [17659255, 20590953, B21390324]	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology, Japan (17659255 and 20590953 to JY; B21390324 to HM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berthoud VM, 2009, ANTIOXID REDOX SIGN, V11, P339, DOI 10.1089/ars.2008.2119; Carmeli C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029341; Chaytor AT, 1998, J PHYSIOL-LONDON, V508, P561, DOI 10.1111/j.1469-7793.1998.561bq.x; Cherian PP, 2005, MOL BIOL CELL, V16, P3100, DOI 10.1091/mbc.E04-10-0912; D'hondt C, 2007, INVEST OPHTH VIS SCI, V48, P120, DOI 10.1167/iovs.06-0770; Evans WH, 2006, BIOCHEM J, V397, P1, DOI 10.1042/BJ20060175; Evans WH, 2012, J MEMBRANE BIOL, V245, P437, DOI 10.1007/s00232-012-9488-5; Fang X, 2011, ANTIOXID REDOX SIGN, V14, P2427, DOI 10.1089/ars.2010.3150; Gao FH, 2007, BIOCHEM BIOPH RES CO, V356, P505, DOI 10.1016/j.bbrc.2007.03.009; Gennari A, 2003, TOXICOLOGY, V183, P211, DOI 10.1016/S0300-483X(02)00546-2; Giepmans BNG, 2004, CARDIOVASC RES, V62, P233, DOI 10.1016/j.cardiores.2003.12.009; HEW KW, 1993, BIOL REPROD, V49, P840, DOI 10.1095/biolreprod49.4.840; Huang T, 2010, CANCER SCI, V101, P713, DOI 10.1111/j.1349-7006.2009.01421.x; Lawal AO, 2010, J TOXICOL SCI, V35, P465, DOI 10.2131/jts.35.465; Li K, 2011, J BIOL CHEM, V286, P41552, DOI 10.1074/jbc.M111.274449; Liu J, 2009, TOXICOL APPL PHARM, V238, P209, DOI 10.1016/j.taap.2009.01.029; Loch-Caruso R, 2005, TOXICOL SCI, V85, P694, DOI 10.1093/toxsci/kfi123; Majoul IV, 2009, HISTOCHEM CELL BIOL, V132, P263, DOI 10.1007/s00418-009-0617-x; Martin PEM, 2001, J CELL SCI, V114, P3845; Mendoza-Naranjo A, 2007, J IMMUNOL, V178, P6949, DOI 10.4049/jimmunol.178.11.6949; Mitchell JA, 2001, CELL COMMUN ADHES, V8, P299, DOI 10.3109/15419060109080741; Oviedo-Orta E, 2001, FASEB J, V15, P768, DOI 10.1096/fj.00-0288com; Ponsaerts R, 2010, FASEB J, V24, P4378, DOI 10.1096/fj.09-153007; PROZIALECK WC, 1991, TOXICOL APPL PHARM, V107, P81, DOI 10.1016/0041-008X(91)90333-A; PROZIALECK WC, 1995, TOXICOL APPL PHARM, V134, P285, DOI 10.1006/taap.1995.1194; Prozialeck WC, 1997, IN VITRO CELL DEV-AN, V33, P516; Prozialeck WC, 1998, TOXICOL IN VITRO, V12, P633, DOI 10.1016/S0887-2333(98)00054-X; Ramachandran S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000712; Retamal MA, 2007, P NATL ACAD SCI USA, V104, P8322, DOI 10.1073/pnas.0702456104; Saez JC, 2003, PHYSIOL REV, V83, P1359, DOI 10.1152/physrev.00007.2003; Salameh A, 2008, J PHARMACOL EXP THER, V326, P315, DOI 10.1124/jpet.108.136663; Shyu KG, 2004, CARDIOVASC RES, V63, P98, DOI 10.1016/j.cardiores.2004.02.018; Son MH, 2001, BIOCHEM PHARMACOL, V62, P1379, DOI 10.1016/S0006-2952(01)00780-8; Stridh MH, 2008, J BIOL CHEM, V283, P10347, DOI 10.1074/jbc.M704153200; Stridh MH, 2010, NEUROCHEM RES, V35, P1231, DOI 10.1007/s11064-010-0179-2; Tacheau C, 2008, J CELL PHYSIOL, V217, P759, DOI 10.1002/jcp.21551; Thevenod F, 2000, J BIOL CHEM, V275, P1887, DOI 10.1074/jbc.275.3.1887; Thomas T, 2005, J CELL SCI, V118, P4451, DOI 10.1242/jcs.02569; Thompson RJ, 2006, SCIENCE, V312, P924, DOI 10.1126/science.1126241; Upham BL, 1997, CARCINOGENESIS, V18, P37, DOI 10.1093/carcin/18.1.37; Upham BL, 2009, ANTIOXID REDOX SIGN, V11, P297, DOI 10.1089/ars.2008.2146; Wilhelm D, 1997, MOL CELL BIOL, V17, P4792, DOI 10.1128/MCB.17.8.4792; Yao J, 2003, CIRC RES, V93, P338, DOI 10.1161/01.RES.0000086802.21850.5D; Yao J, 2010, BRIT J PHARM, P9999; Yao J, 2007, J MEMBRANE BIOL, V217, P123, DOI 10.1007/s00232-007-9023-2; Yao J, 2009, AM J PHYSIOL-RENAL, V296, pF939, DOI 10.1152/ajprenal.90612.2008; Yokouchi M, 2008, J BIOL CHEM, V283, P4252, DOI 10.1074/jbc.M705951200	47	256	266	2	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e58057	10.1371/journal.pone.0058057	http://dx.doi.org/10.1371/journal.pone.0058057			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23874530	Green Submitted, Green Published, gold			2022-12-25	WOS:000315519000181
J	Li, KR; Zhang, ZQ; Yao, J; Zhao, YX; Duan, J; Cao, C; Jiang, Q				Li, Ke-ran; Zhang, Zhi-qing; Yao, Jin; Zhao, Yu-xia; Duan, Jing; Cao, Cong; Jiang, Qin			Ginsenoside Rg-1 Protects Retinal Pigment Epithelium (RPE) Cells from Cobalt Chloride (CoCl2) and Hypoxia Assaults	PLOS ONE			English	Article							N-TERMINAL KINASE; SIGNALING PATHWAY; INDUCED APOPTOSIS; OXIDATIVE STRESS; IN-VITRO; RG1 PROTECTS; CANCER CELLS; PC12 CELLS; P38 MAPK; ACTIVATION	Severe retinal ischemia causes persistent visual impairments in eye diseases. Retinal pigment epithelium (RPE) cells are located near the choroidal capillaries, and are easily affected by ischemic or hypoxia. Ginsenoside Rg-1 has shown significant neuroprotective effects. This study was performed to test the cytoprotective effect of ginsenoside Rg-1 in RPE cells against hypoxia and cobalt chloride (CoCl2) assaults, and to understand the underlying mechanisms. We found that Rg-1 pre-administration significantly inhibited CoCl2- and hypoxia-induced RPE cell death and apoptosis. Reactive oxygen specisis (ROS)-dependent p38 and c-Jun NH(2)-terminal kinases (JNK) MAPK activation was required for CoCl2-induced RPE cell death, and Rg-1 pre-treatment significantly inhibited ROS production and following p38/JNK activation. Further, CoCl2 suppressed pro-survival mTOR complex 1 (mTORC1) activation in RPE cells through activating of AMP-activated protein kinase (AMPK), while Rg-1 restored mTORC1 activity through inhibiting AMPK activation. CoCl2-induced AMPK activation was also dependent on ROS production, and anti-oxidant N-acetylcysteine (NAC) prevented AMPK activation and RPE cell death by CoCl2. Our results indicated that Rg-1 could be further investigated as a novel cell-protective agent for retinal ischemia.	[Li, Ke-ran; Yao, Jin; Zhao, Yu-xia; Jiang, Qin] Nanjing Med Univ, Affiliated Eye Hosp, Dept Eye, Nanjing, Jiangsu, Peoples R China; [Zhang, Zhi-qing; Cao, Cong] Soochow Univ, Inst Neurosci, Suzhou, Jiangsu, Peoples R China; [Duan, Jing] China Pharmaceut Univ, Acad Inst Pharmaceut Sci, Ctr Safety Evaluat Drugs, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Soochow University - China; China Pharmaceutical University	Cao, C (corresponding author), Soochow Univ, Inst Neurosci, Suzhou, Jiangsu, Peoples R China.	caocong@suda.edu.cn; dryaojin@yahoo.com	; Li, Ke/I-3804-2013	Yao, Jian/0000-0003-2622-0215; Li, Ke/0000-0003-4869-5393	National Natural Science Foundation of China [81070744, 81271028]; Jiangsu Province [1002009B]; Medical Science and Technology Development Project Fund of Nanjing [ZKX12047, YKK12208, YKK12207]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Province; Medical Science and Technology Development Project Fund of Nanjing	This work was generously supported by grants from the National Natural Science Foundation of China (Nos. 81070744, 81271028), post-doc fund of Jiangsu Province (No. 1002009B) and Medical Science and Technology Development Project Fund of Nanjing (ZKX12047, YKK12208, YKK12207). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Borutaite Vilmante, 2008, Biochem J, V412, pe15, DOI 10.1042/BJ20080712; Boulton M, 2001, EYE, V15, P384, DOI 10.1038/eye.2001.141; Brunn GJ, 1996, EMBO J, V15, P5256, DOI 10.1002/j.1460-2075.1996.tb00911.x; Buettner C, 2006, ANN PHARMACOTHER, V40, P83, DOI 10.1345/aph.1G216; Cao C, 2008, J BIOL CHEM, V283, P28897, DOI 10.1074/jbc.M804144200; Chen L, 2010, LAB INVEST, V90, P762, DOI 10.1038/labinvest.2010.36; Chen MB, 2012, INT J CANC; Chen MB, 2011, J CELL PHYSIOL, V226, P1915, DOI 10.1002/jcp.22522; Chen MB, 2011, CELL BIOCHEM BIOPHYS, V60, P311, DOI 10.1007/s12013-011-9153-0; Chen WF, 2013, NEUROCHEM INT, V62, P1065, DOI 10.1016/j.neuint.2013.03.018; Chen XC, 2002, ACTA PHARMACOL SIN, V23, P829; Chen ZY, 2013, MOL CELL BIOCHEM, V377, P35, DOI 10.1007/s11010-013-1568-z; Du JH, 2005, BIOCHEM BIOPH RES CO, V337, P1139, DOI 10.1016/j.bbrc.2005.09.174; Du ZJ, 2011, INVEST OPHTH VIS SCI, V52, P987, DOI 10.1167/iovs.10-5557; Fang F, 2012, BBA-MOL BASIS DIS, V1822, P286, DOI 10.1016/j.bbadis.2011.10.004; Fernandes AF, 2008, J BIOL CHEM, V283, P20745, DOI 10.1074/jbc.M800268200; Giordano FJ, 2005, J CLIN INVEST, V115, P500, DOI 10.1172/JCI200524408; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Hardy P, 2005, PROSTAG LEUKOTR ESS, V72, P301, DOI 10.1016/j.plefa.2005.02.004; Hayashi T, 2000, DIABETES, V49, P527, DOI 10.2337/diabetes.49.4.527; Huong NTT, 1998, BIOL PHARM BULL, V21, P978, DOI 10.1248/bpb.21.978; Imamura K, 2001, BIOCHEM BIOPH RES CO, V287, P562, DOI 10.1006/bbrc.2001.5627; Inoki K, 2012, ANNU REV PHARMACOL, V52, P381, DOI 10.1146/annurev-pharmtox-010611-134537; Joo SS, 2005, PLANTA MED, V71, P476, DOI 10.1055/s-2005-864145; Kang MR, 2012, ONCOL REP, V27, P1407, DOI 10.3892/or.2012.1644; Kefas BA, 2003, J MOL ENDOCRINOL, V30, P151, DOI 10.1677/jme.0.0300151; Kim HJ, 2013, J GINSENG RES, V37, P8, DOI 10.5142/jgr.2013.37.8; Kim MH, 2008, APOPTOSIS, V13, P295, DOI 10.1007/s10495-007-0160-y; Kunz M, 2001, CELL GROWTH DIFFER, V12, P137; Lee MS, 2010, PHYTOTHER RES, V24, P1857, DOI 10.1002/ptr.3210; Leung KW, 2007, NEUROPHARMACOLOGY, V52, P827, DOI 10.1016/j.neuropharm.2006.10.001; Li CY, 2002, AM J PHYSIOL-CELL PH, V282, pC227, DOI 10.1152/ajpcell.00112.2001; Li J, 2005, CIRC RES, V97, P872, DOI 10.1161/01.RES.0000187458.77026.10; Li J. Q., 1997, Yaoxue Xuebao, V32, P406; Li W, 2012, BRAIN RES BULL, V88, P501, DOI 10.1016/j.brainresbull.2012.05.002; Liao BS, 2002, EXP NEUROL, V173, P224, DOI 10.1006/exnr.2001.7841; Liu QA, 2011, NEUROCHEM INT, V58, P119, DOI 10.1016/j.neuint.2010.11.004; Liu ZJ, 2010, BRAIN RES, V1333, P1, DOI 10.1016/j.brainres.2010.03.096; Meisse D, 2002, FEBS LETT, V526, P38, DOI 10.1016/S0014-5793(02)03110-1; Mihaylova MM, 2011, NAT CELL BIOL, V13, P1016, DOI 10.1038/ncb2329; Mizushina Y, 2000, BIOCHEM J, V350, P757, DOI 10.1042/0264-6021:3500757; Mu Yan-Yue, 2012, Zhongguo Zhong Xi Yi Jie He Za Zhi, V32, P1539; Nag SA, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00025; Okoshi R, 2008, J BIOL CHEM, V283, P3979, DOI 10.1074/jbc.M705232200; Osborne NN, 2004, PROG RETIN EYE RES, V23, P91, DOI 10.1016/j.preteyeres.2003.12.001; Shen L, 2007, ACTA PHARMACOL SIN, V28, P392, DOI 10.1111/j.1745-7254.2007.00511.x; Strauss O, 2005, PHYSIOL REV, V85, P845, DOI 10.1152/physrev.00021.2004; Terai K, 2005, MOL CELL BIOL, V25, P9554, DOI 10.1128/MCB.25.21.9554-9575.2005; Vogler BK, 1999, EUR J CLIN PHARMACOL, V55, P567, DOI 10.1007/s002280050674; Wan X, 2007, ONCOGENE, V26, P1932, DOI 10.1038/sj.onc.1209990; Wang Qiao-Yun, 2013, Zhongguo Zhong Xi Yi Jie He Za Zhi, V33, P229; Wang Wei-xia, 2005, Zhongguo Zhong Xi Yi Jie He Za Zhi, V25, P89; Wu CF, 2007, INT IMMUNOPHARMACOL, V7, P313, DOI 10.1016/j.intimp.2006.04.021; Wu JY, 2012, NEUROPHARMACOLOGY, V63, P349, DOI 10.1016/j.neuropharm.2012.04.005; Xu HM, 2010, NEUROPHARMACOLOGY, V58, P488, DOI 10.1016/j.neuropharm.2009.09.002; Yang XH, 2010, WORLD J GASTROENTERO, V16, P3385, DOI 10.3748/wjg.v16.i27.3385; Yao J, 2013, INT J MOL SCI, V14, P10355, DOI 10.3390/ijms140510355; Yap TA, 2011, J CLIN ONCOL, V29, P4688, DOI 10.1200/JCO.2011.35.5263; Zhang XY, 2008, INVEST OPHTH VIS SCI, V49, P3622, DOI 10.1167/iovs.07-1559; Zheng QY, 2012, BIOCH BIOPHYS RES CO; Zhu D, 2009, J CELL BIOCHEM, V108, P117, DOI 10.1002/jcb.22233; Zong Y, 2012, CURR MED CHEM, V19, P770, DOI 10.2174/092986712798992066	62	256	266	2	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e84171	10.1371/journal.pone.0084171	http://dx.doi.org/10.1371/journal.pone.0084171			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281RE	23874530	Green Published, Green Submitted, gold			2022-12-25	WOS:000329117900080
